id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
105987987|NCT02783599|365616344|FG000|Overall Study|Progressive disease|23|||
105987988|NCT02783599|365616344|FG000|Overall Study|Surgical Resection|10|||
105987989|NCT02783599|365616344|FG000|Overall Study|Adverse Event|4|||
105987990|NCT02783599|365616344|FG000|Overall Study|Physician Decision|2|||
105987991|NCT02783599|365616344|FG000|Overall Study|Death|1|||
105987992|NCT01815840|365616345|FG000|Overall Study|Missing|1|||
105987993|NCT01815840|365616346|FG001|Overall Study|Missing|0|||
106097730|NCT00920426|366016387|FG000|ITZ111451|Adverse Event|1|||
106097731|NCT00920426|366016388|FG001|ITZ111451|Adverse Event|0|||
105987994|NCT01815840|365616345|FG000|Overall Study|Withdrew Consent|31|||
105987995|NCT01815840|365616346|FG001|Overall Study|Withdrew Consent|30|||
105987996|NCT01815840|365616345|FG000|Overall Study|Administrative/Other|1|||
105987997|NCT01815840|365616346|FG001|Overall Study|Administrative/Other|3|||
105987998|NCT01815840|365616345|FG000|Overall Study|Adverse Event|10|||
105987999|NCT01815840|365616346|FG001|Overall Study|Adverse Event|16|||
105988000|NCT01815840|365616345|FG000|Overall Study|Death|2|||
105988001|NCT01815840|365616346|FG001|Overall Study|Death|2|||
105988002|NCT01815840|365616345|FG000|Overall Study|Disease progression|3|||
105988003|NCT01815840|365616346|FG001|Overall Study|Disease progression|2|||
105988004|NCT01815840|365616345|FG000|Overall Study|Investigators Decision|2|||
105988005|NCT01815840|365616346|FG001|Overall Study|Investigators Decision|3|||
105988006|NCT01815840|365616345|FG000|Overall Study|Lost to Follow-up|3|||
105988007|NCT01815840|365616346|FG001|Overall Study|Lost to Follow-up|6|||
105988008|NCT01815840|365616345|FG000|Overall Study|Refused Treatment|5|||
105988009|NCT01815840|365616346|FG001|Overall Study|Refused Treatment|1|||
105988010|NCT01815840|365616345|FG000|Overall Study|Sponsor Termination Treatment|1|||
105988011|NCT01815840|365616346|FG001|Overall Study|Sponsor Termination Treatment|0|||
105988012|NCT01832155|365616347|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
105988013|NCT01832155|365616348|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
105988014|NCT01832155|365616347|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
105988015|NCT01832155|365616348|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
105988016|NCT03387020|365616351|FG000|Overall Study|Adverse Event|0|||
105988017|NCT03387020|365616352|FG001|Overall Study|Adverse Event|2|||
105988018|NCT03387020|365616353|FG002|Overall Study|Adverse Event|0|||
105988019|NCT03387020|365616351|FG000|Overall Study|Withdrawal by Subject|2|||
105988020|NCT03387020|365616352|FG001|Overall Study|Withdrawal by Subject|0|||
105988021|NCT03387020|365616353|FG002|Overall Study|Withdrawal by Subject|0|||
105988022|NCT05249569|365616356|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
105988023|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105988024|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105988025|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
105769226|NCT03267511|364807345|FG000|Overall Study|Lost to Follow-up|0|||
105988026|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
105988027|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
105988028|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105988029|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
105988030|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
105988031|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
105988032|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105988033|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105988034|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105988035|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
105988036|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
105769227|NCT03267511|364807346|FG001|Overall Study|Lost to Follow-up|0|||
105769228|NCT03267511|364807347|FG002|Overall Study|Lost to Follow-up|0|||
105769229|NCT03267511|364807348|FG003|Overall Study|Lost to Follow-up|1|||
105988037|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
105988038|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
105988039|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
105988040|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
105988041|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
105988042|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
105988043|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
105988044|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
105988045|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
106097732|NCT00920426|366016389|FG002|ITZ111451|Adverse Event|0|||
106097733|NCT00920426|366016390|FG003|ITZ111451|Adverse Event|0|||
106097734|NCT02367911|366016391|FG000|Overall Study|Withdrawal by Subject|3|||
105769230|NCT00439309|364807349|FG000|Follow-Up|Death|1|||
105988046|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
106097735|NCT02367911|366016392|FG001|Overall Study|Withdrawal by Subject|2|||
106097736|NCT02367911|366016391|FG000|Overall Study|Lost to Follow-up|2|||
106097737|NCT02367911|366016392|FG001|Overall Study|Lost to Follow-up|2|||
105769231|NCT00439309|364807350|FG001|Follow-Up|Death|0|||
106097738|NCT00773968|366016398|FG000|Overall Study|Adverse Event|2|||
106097739|NCT00773968|366016398|FG000|Overall Study|Death|1|||
106097740|NCT00773968|366016398|FG000|Overall Study|Failure to Return|2|||
105988047|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
105988048|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
105988049|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105988050|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
105988051|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
105988052|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105988053|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105988054|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
105988055|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
105988056|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105988057|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105769232|NCT00439309|364807349|FG000|Follow-Up|Lost to Follow-up|2|||
105988058|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105988059|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105988060|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105988061|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
105988062|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105988063|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
105988064|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
105988065|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105988066|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105988067|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105988068|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
105988069|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105988070|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
105769233|NCT00439309|364807350|FG001|Follow-Up|Lost to Follow-up|0|||
105769234|NCT00439309|364807349|FG000|Follow-Up|Withdrawal by Subject|0|||
105769235|NCT00439309|364807350|FG001|Follow-Up|Withdrawal by Subject|1|||
105769236|NCT00439309|364807349|FG000|Follow-Up|Late response by subject|0|||
105769237|NCT00439309|364807350|FG001|Follow-Up|Late response by subject|1|||
105988071|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105769238|NCT01977040|364807353|FG000|Overall Study|Vasa previa not confirmed|2|||
105769239|NCT02667236|364807354|FG000|Overall Study|Adverse Event|1|||
105769240|NCT02667236|364807355|FG001|Overall Study|Adverse Event|1|||
105769241|NCT02667236|364807354|FG000|Overall Study|Withdrawal by Subject|2|||
105769242|NCT02667236|364807355|FG001|Overall Study|Withdrawal by Subject|0|||
105769243|NCT00444951|364807356|FG000|Overall Study|Lost to Follow-up|1|||
105769244|NCT00444951|364807357|FG001|Overall Study|Lost to Follow-up|1|||
105769245|NCT00444951|364807358|FG002|Overall Study|Lost to Follow-up|0|||
105769246|NCT00444951|364807356|FG000|Overall Study|Withdrawal by Subject|4|||
105769247|NCT00444951|364807357|FG001|Overall Study|Withdrawal by Subject|5|||
105769248|NCT00444951|364807358|FG002|Overall Study|Withdrawal by Subject|3|||
105769249|NCT01998906|364807359|FG000|Overall Study|Participants ongoing in follow-up|77|||
105769250|NCT01998906|364807360|FG001|Overall Study|Participants ongoing in follow-up|60|||
105769251|NCT01998906|364807361|FG002|Overall Study|Participants ongoing in follow-up|58|||
105769252|NCT01998906|364807359|FG000|Overall Study|Death|21|||
105769253|NCT01998906|364807360|FG001|Overall Study|Death|30|||
105769254|NCT01998906|364807361|FG002|Overall Study|Death|17|||
105769255|NCT01998906|364807359|FG000|Overall Study|Lack of Efficacy|10|||
105769256|NCT01998906|364807360|FG001|Overall Study|Lack of Efficacy|9|||
105769257|NCT01998906|364807361|FG002|Overall Study|Lack of Efficacy|8|||
105769258|NCT01998906|364807359|FG000|Overall Study|Failure to return|0|||
105769259|NCT01998906|364807360|FG001|Overall Study|Failure to return|2|||
105769260|NCT01998906|364807361|FG002|Overall Study|Failure to return|4|||
105769261|NCT01998906|364807359|FG000|Overall Study|Violation of Selection Criteria|0|||
105769262|NCT01998906|364807360|FG001|Overall Study|Violation of Selection Criteria|0|||
105769263|NCT01998906|364807361|FG002|Overall Study|Violation of Selection Criteria|1|||
105769264|NCT01998906|364807359|FG000|Overall Study|Withdrawal by Subject|1|||
105769265|NCT01998906|364807360|FG001|Overall Study|Withdrawal by Subject|4|||
105769266|NCT01998906|364807361|FG002|Overall Study|Withdrawal by Subject|3|||
105769267|NCT01998906|364807359|FG000|Overall Study|Administrative/Other|2|||
105769268|NCT01998906|364807360|FG001|Overall Study|Administrative/Other|1|||
106097741|NCT00773968|366016398|FG000|Overall Study|Lack of Efficacy|3|||
105769269|NCT01998906|364807361|FG002|Overall Study|Administrative/Other|3|||
105769270|NCT01998906|364807359|FG000|Overall Study|Other|3|||
105769271|NCT01998906|364807360|FG001|Overall Study|Other|8|||
105769272|NCT01998906|364807361|FG002|Overall Study|Other|4|||
105769273|NCT02996110|364807365|FG000|Pre-Treatment|Other Reasons|0|||
105769274|NCT02996110|364807366|FG001|Pre-Treatment|Other Reasons|1|||
105769275|NCT02996110|364807367|FG002|Pre-Treatment|Other Reasons|0|||
105988072|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105988073|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105988074|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
105988075|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988076|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988077|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988078|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
105988079|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105769276|NCT02996110|364807368|FG003|Pre-Treatment|Other Reasons|0|||
105769277|NCT02996110|364807369|FG004|Pre-Treatment|Other Reasons|1|||
105769278|NCT02996110|364807365|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
105769279|NCT02996110|364807366|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
105769280|NCT02996110|364807367|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
105769281|NCT02996110|364807368|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
105769282|NCT02996110|364807369|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
105769283|NCT02996110|364807365|FG000|Track 1|Disease Progression|15|||
105769284|NCT02996110|364807366|FG001|Track 1|Disease Progression|17|||
105769285|NCT02996110|364807367|FG002|Track 1|Disease Progression|0|||
105769286|NCT02996110|364807368|FG003|Track 1|Disease Progression|0|||
105769287|NCT02996110|364807369|FG004|Track 1|Disease Progression|0|||
105769288|NCT02996110|364807365|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
105769289|NCT02996110|364807366|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
105769290|NCT02996110|364807367|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
105769291|NCT02996110|364807368|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
105769292|NCT02996110|364807369|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
105769293|NCT02996110|364807365|FG000|Track 1|Study Drug Toxicity|5|||
105769294|NCT02996110|364807366|FG001|Track 1|Study Drug Toxicity|3|||
105988080|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988081|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105769295|NCT02996110|364807367|FG002|Track 1|Study Drug Toxicity|0|||
105769296|NCT02996110|364807368|FG003|Track 1|Study Drug Toxicity|0|||
105988082|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
105988083|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988084|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988085|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988086|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988087|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
105988088|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988089|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988090|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988091|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
105988092|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988093|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988094|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
105988095|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988096|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988097|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988098|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988099|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988100|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
105988101|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988102|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
105988103|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105769297|NCT02996110|364807369|FG004|Track 1|Study Drug Toxicity|0|||
105769298|NCT02996110|364807365|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
105769299|NCT02996110|364807366|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
105988104|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988105|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105769300|NCT02996110|364807367|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
105769301|NCT02996110|364807368|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
105769302|NCT02996110|364807369|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
105769303|NCT02996110|364807365|FG000|Track 1|Administrative Reason by Sponsor|0|||
105769304|NCT02996110|364807366|FG001|Track 1|Administrative Reason by Sponsor|1|||
105769305|NCT02996110|364807367|FG002|Track 1|Administrative Reason by Sponsor|0|||
105769306|NCT02996110|364807368|FG003|Track 1|Administrative Reason by Sponsor|0|||
105769307|NCT02996110|364807369|FG004|Track 1|Administrative Reason by Sponsor|0|||
105769308|NCT02996110|364807365|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
105769309|NCT02996110|364807366|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
105769310|NCT02996110|364807367|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
105769311|NCT02996110|364807368|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
105988106|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988107|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988108|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105769312|NCT02996110|364807369|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
105769313|NCT02996110|364807365|FG000|Track 2|Disease Progression|33|||
105769314|NCT02996110|364807366|FG001|Track 2|Disease Progression|26|||
105769315|NCT02996110|364807367|FG002|Track 2|Disease Progression|19|||
105769316|NCT02996110|364807368|FG003|Track 2|Disease Progression|16|||
105769317|NCT02996110|364807369|FG004|Track 2|Disease Progression|15|||
105988109|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988110|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988111|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988112|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988113|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
105988114|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
105988115|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988116|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988117|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988118|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105769318|NCT02996110|364807365|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
105769319|NCT02996110|364807366|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
105769320|NCT02996110|364807367|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
105769321|NCT02996110|364807368|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
105769322|NCT02996110|364807369|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
105769323|NCT02996110|364807365|FG000|Track 2|Death|0|||
105769324|NCT02996110|364807366|FG001|Track 2|Death|0|||
105769325|NCT02996110|364807367|FG002|Track 2|Death|1|||
105769326|NCT02996110|364807368|FG003|Track 2|Death|0|||
105769327|NCT02996110|364807369|FG004|Track 2|Death|1|||
105769328|NCT02996110|364807365|FG000|Track 2|Study Drug Toxicity|4|||
105769329|NCT02996110|364807366|FG001|Track 2|Study Drug Toxicity|1|||
105769330|NCT02996110|364807367|FG002|Track 2|Study Drug Toxicity|4|||
105769331|NCT02996110|364807368|FG003|Track 2|Study Drug Toxicity|1|||
105769332|NCT02996110|364807369|FG004|Track 2|Study Drug Toxicity|0|||
105769333|NCT02996110|364807365|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
105769334|NCT02996110|364807366|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
105769335|NCT02996110|364807367|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
105769336|NCT02996110|364807368|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
105769337|NCT02996110|364807369|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
105769338|NCT02996110|364807365|FG000|Track 2|Participant Withdrew Consent|1|||
105769339|NCT02996110|364807366|FG001|Track 2|Participant Withdrew Consent|2|||
105769340|NCT02996110|364807367|FG002|Track 2|Participant Withdrew Consent|3|||
105769341|NCT02996110|364807368|FG003|Track 2|Participant Withdrew Consent|1|||
105769342|NCT02996110|364807369|FG004|Track 2|Participant Withdrew Consent|1|||
105769343|NCT02996110|364807365|FG000|Track 2|Other Reasons|0|||
105769344|NCT02996110|364807366|FG001|Track 2|Other Reasons|0|||
105769345|NCT02996110|364807367|FG002|Track 2|Other Reasons|1|||
105769346|NCT02996110|364807368|FG003|Track 2|Other Reasons|0|||
105769347|NCT02996110|364807369|FG004|Track 2|Other Reasons|1|||
105769348|NCT01518309|364807370|FG000|Overall Study|Adverse Event|6|||
105769349|NCT01518309|364807370|FG000|Overall Study|Death|6|||
105988119|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988120|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988121|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988122|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988123|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988124|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988125|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105988126|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
105769350|NCT01518309|364807370|FG000|Overall Study|Lack of Efficacy|7|||
105769351|NCT01518309|364807370|FG000|Overall Study|Withdrawal by Subject|6|||
105769352|NCT01518309|364807370|FG000|Overall Study|Physician Decision|3|||
105769353|NCT01518309|364807370|FG000|Overall Study|Sponsor Decision|2|||
105769354|NCT01518309|364807370|FG000|Overall Study|Not in Predefined Categories|9|||
105988127|NCT03100058|365616362|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105659642|NCT00816556|364418794|FG000|Overall Study|Adverse Event|1|||
105659643|NCT00816556|364418795|FG001|Overall Study|Adverse Event|1|||
105769355|NCT00863317|364807371|FG000|Overall Study|Lost to Follow-up|8|||
105659644|NCT00816556|364418796|FG002|Overall Study|Adverse Event|1|||
105769356|NCT00863317|364807372|FG001|Overall Study|Lost to Follow-up|9|||
105769357|NCT02579863|364807373|FG000|Overall Study|Final Disposition Unknown|2|||
105769358|NCT02579863|364807374|FG001|Overall Study|Final Disposition Unknown|1|||
105769359|NCT02579863|364807373|FG000|Overall Study|Adverse Event|18|||
105769360|NCT02579863|364807374|FG001|Overall Study|Adverse Event|11|||
105769361|NCT02579863|364807373|FG000|Overall Study|Death|31|||
105769362|NCT02579863|364807374|FG001|Overall Study|Death|29|||
105769363|NCT02579863|364807373|FG000|Overall Study|Lost to Follow-up|2|||
105769364|NCT02579863|364807374|FG001|Overall Study|Lost to Follow-up|1|||
105988128|NCT03100058|365616363|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105988129|NCT03100058|365616364|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105769365|NCT02579863|364807373|FG000|Overall Study|Physician Decision|1|||
105769366|NCT02579863|364807374|FG001|Overall Study|Physician Decision|2|||
105769367|NCT02579863|364807373|FG000|Overall Study|Screen Failure|0|||
105769368|NCT02579863|364807374|FG001|Overall Study|Screen Failure|2|||
105769369|NCT02579863|364807373|FG000|Overall Study|Study Terminated at Selected Sites|82|||
105769370|NCT02579863|364807374|FG001|Overall Study|Study Terminated at Selected Sites|88|||
105769371|NCT02579863|364807373|FG000|Overall Study|Withdrawal by Subject|20|||
105769372|NCT02579863|364807374|FG001|Overall Study|Withdrawal by Subject|20|||
105769373|NCT03878160|364807380|FG000|Overall Study|Lost to Follow-up|1|||
105769374|NCT03878160|364807381|FG001|Overall Study|Lost to Follow-up|1|||
105988130|NCT03100058|365616365|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105769375|NCT03878160|364807382|FG002|Overall Study|Lost to Follow-up|1|||
105769376|NCT03878160|364807380|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
105769377|NCT03878160|364807381|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
105769378|NCT03878160|364807382|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
105769379|NCT01100658|364807383|FG000|Overall Study|Withdrawal by Subject|1|||
105769380|NCT00038142|364807384|FG000|Overall Study|Ineligible|1|||
105769381|NCT00038142|364807385|FG001|Overall Study|Ineligible|0|||
105769382|NCT00038142|364807384|FG000|Overall Study|Progressive Disease|11|||
105769383|NCT00038142|364807385|FG001|Overall Study|Progressive Disease|7|||
105769384|NCT00038142|364807384|FG000|Overall Study|Death|1|||
105769385|NCT00038142|364807385|FG001|Overall Study|Death|0|||
105769386|NCT00038142|364807384|FG000|Overall Study|Adverse Event|1|||
105769387|NCT00038142|364807385|FG001|Overall Study|Adverse Event|0|||
105769388|NCT00038142|364807384|FG000|Overall Study|Unknown Reason|8|||
105769389|NCT00038142|364807385|FG001|Overall Study|Unknown Reason|0|||
105769390|NCT00673816|364807400|FG000|Overall Study|Adverse Event|1|||
105769391|NCT00673816|364807400|FG000|Overall Study|Withdrawal by Subject|1|||
105769392|NCT00809614|364807401|FG000|Overall Study|Lack of Efficacy|2|||
105769393|NCT00809614|364807402|FG001|Overall Study|Lack of Efficacy|3|||
105769394|NCT00809614|364807401|FG000|Overall Study|Withdrawal by Subject|1|||
105769395|NCT00809614|364807402|FG001|Overall Study|Withdrawal by Subject|1|||
105769396|NCT02658149|364807406|FG000|Overall Study|Physician Decision|1|||
105769397|NCT02658149|364807407|FG001|Overall Study|Physician Decision|0|||
105769398|NCT01804842|364807411|FG000|Overall Study|Adverse Event|1|||
105769399|NCT01804842|364807412|FG001|Overall Study|Adverse Event|1|||
105769400|NCT01804842|364807413|FG002|Overall Study|Adverse Event|0|||
105769401|NCT01804842|364807411|FG000|Overall Study|Lost to Follow-up|1|||
105769402|NCT01804842|364807412|FG001|Overall Study|Lost to Follow-up|0|||
105769403|NCT01804842|364807413|FG002|Overall Study|Lost to Follow-up|0|||
105769404|NCT01804842|364807411|FG000|Overall Study|Non-Compliance|1|||
105769405|NCT01804842|364807412|FG001|Overall Study|Non-Compliance|1|||
105769406|NCT01804842|364807413|FG002|Overall Study|Non-Compliance|0|||
105769407|NCT01804842|364807411|FG000|Overall Study|Personal Reason|0|||
105769408|NCT01804842|364807412|FG001|Overall Study|Personal Reason|0|||
105769409|NCT01804842|364807413|FG002|Overall Study|Personal Reason|1|||
105769410|NCT01017549|364807414|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
105769411|NCT01017549|364807414|FG000|One-year Follow-up|Lost to Follow-up|2|||
105769412|NCT01017549|364807414|FG000|One-year Follow-up|Withdrawal by Subject|5|||
105769413|NCT01017549|364807414|FG000|5 Year Follow-up|Lost to Follow-up|9|||
105769414|NCT01017549|364807414|FG000|5 Year Follow-up|Mastectomy|3|||
105769415|NCT01440972|364807419|FG000|Overall Study|Withdrawal by Subject|3|||
105769416|NCT01440972|364807420|FG001|Overall Study|Withdrawal by Subject|2|||
105769417|NCT05049122|364807421|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
105769418|NCT05049122|364807421|FG000|Overall Study|Participant moved|1|||
105769419|NCT05049122|364807421|FG000|Overall Study|At the direction of the doctor|1|||
105769420|NCT02352090|364807422|FG000|Overall Study|general malaise|1|||
105988131|NCT03100058|365616366|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105988132|NCT03100058|365616367|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105988133|NCT03100058|365616368|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
105988134|NCT03100058|365616369|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105988135|NCT03100058|365616370|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105769421|NCT02352090|364807423|FG001|Overall Study|general malaise|0|||
105769422|NCT02352090|364807424|FG002|Overall Study|general malaise|0|||
105769423|NCT02352090|364807422|FG000|Overall Study|non-specified mild side-effects|0|||
105769424|NCT02352090|364807423|FG001|Overall Study|non-specified mild side-effects|0|||
105769425|NCT02352090|364807424|FG002|Overall Study|non-specified mild side-effects|2|||
105769426|NCT00735072|364807427|FG000|Overall Study|interrupted study med during ARV change|1|||
105769427|NCT00735072|364807428|FG001|Overall Study|interrupted study med during ARV change|0|||
105769428|NCT00735072|364807427|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
105769429|NCT00735072|364807428|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
105988136|NCT03100058|365616371|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105988137|NCT03100058|365616372|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
106097742|NCT00773968|366016398|FG000|Overall Study|Protocol Violation|1|||
106097743|NCT00773968|366016398|FG000|Overall Study|Withdrawal by Subject|11|||
106097744|NCT00773968|366016398|FG000|Overall Study|Screen Failure|17|||
106097745|NCT00773968|366016398|FG000|Overall Study|Other|8|||
106097746|NCT02492100|366016399|FG000|Overall Study|Death|1|||
106097747|NCT02460991|366016409|FG000|Overall Study|Withdrawal by Subject|0|||
106097748|NCT02460991|366016410|FG001|Overall Study|Withdrawal by Subject|2|||
106097749|NCT00856856|366016411|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
106097750|NCT00856856|366016411|FG000|4-year Clinical Follow-up|Missed visit|1|||
106097751|NCT00321854|366016412|FG000|Overall Study|Adverse Event|41|||
106097752|NCT00321854|366016413|FG001|Overall Study|Adverse Event|43|||
106097753|NCT00321854|366016412|FG000|Overall Study|Lack of Efficacy|9|||
106097754|NCT00321854|366016413|FG001|Overall Study|Lack of Efficacy|14|||
106097755|NCT00321854|366016412|FG000|Overall Study|Protocol Violation|6|||
106097756|NCT00321854|366016413|FG001|Overall Study|Protocol Violation|5|||
106097757|NCT00321854|366016412|FG000|Overall Study|Lost to Follow-up|0|||
106097758|NCT00321854|366016413|FG001|Overall Study|Lost to Follow-up|2|||
106097759|NCT00321854|366016412|FG000|Overall Study|Withdrawal by Subject|6|||
106097760|NCT00321854|366016413|FG001|Overall Study|Withdrawal by Subject|17|||
106097761|NCT00321854|366016412|FG000|Overall Study|Other|1|||
106097762|NCT00321854|366016413|FG001|Overall Study|Other|1|||
105769430|NCT00911144|364807430|FG000|Overall Study|Withdrawal by Subject|16|||
105769431|NCT00911144|364807431|FG001|Overall Study|Withdrawal by Subject|5|||
105769432|NCT00537771|364807434|FG000|Overall Study|Withdrawal by Subject|6|||
105769433|NCT00537771|364807435|FG001|Overall Study|Withdrawal by Subject|23|||
105769434|NCT00537771|364807434|FG000|Overall Study|Adverse Event|8|||
105769435|NCT00537771|364807435|FG001|Overall Study|Adverse Event|15|||
105769436|NCT00537771|364807434|FG000|Overall Study|Lost to Follow-up|9|||
105769437|NCT00537771|364807435|FG001|Overall Study|Lost to Follow-up|15|||
105769438|NCT00537771|364807434|FG000|Overall Study|Protocol Violation|2|||
105769439|NCT00537771|364807435|FG001|Overall Study|Protocol Violation|6|||
105769440|NCT00537771|364807434|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
105769441|NCT00537771|364807435|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
105769442|NCT02348840|364807438|FG000|Overall Study|Withdrawal by Subject|2|||
105769443|NCT02348840|364807439|FG001|Overall Study|Withdrawal by Subject|1|||
105769444|NCT02348840|364807440|FG002|Overall Study|Withdrawal by Subject|0|||
105769445|NCT02348840|364807441|FG003|Overall Study|Withdrawal by Subject|0|||
105769446|NCT03748420|364807442|FG000|Overall Study|No 12 month medication adherence data available|0|||
105769447|NCT03748420|364807443|FG001|Overall Study|No 12 month medication adherence data available|1|||
105769448|NCT03748420|364807442|FG000|Overall Study|Death|24|||
105769449|NCT03748420|364807443|FG001|Overall Study|Death|28|||
105769450|NCT03748420|364807442|FG000|Overall Study|Lost to Follow-up|231|||
105769451|NCT03748420|364807443|FG001|Overall Study|Lost to Follow-up|230|||
105769452|NCT01263444|364807444|FG000|Overall Study|Adverse Event|8|||
105769453|NCT01263444|364807444|FG000|Overall Study|Withdrawal by Subject|1|||
105769454|NCT01263444|364807444|FG000|Overall Study|Protocol Violation|1|||
105769455|NCT00621244|364807452|FG000|Overall Study|Withdrawal by Subject|7|||
105769456|NCT00621244|364807453|FG001|Overall Study|Withdrawal by Subject|3|||
105769457|NCT00621244|364807454|FG002|Overall Study|Withdrawal by Subject|3|||
105769458|NCT00621244|364807455|FG003|Overall Study|Withdrawal by Subject|3|||
105769459|NCT00621244|364807452|FG000|Overall Study|Disease progression|44|||
105769460|NCT00621244|364807453|FG001|Overall Study|Disease progression|20|||
105769461|NCT00621244|364807454|FG002|Overall Study|Disease progression|20|||
105769462|NCT00621244|364807455|FG003|Overall Study|Disease progression|15|||
105769463|NCT00621244|364807452|FG000|Overall Study|Death|3|||
105769464|NCT00621244|364807453|FG001|Overall Study|Death|3|||
105769465|NCT00621244|364807454|FG002|Overall Study|Death|1|||
105769466|NCT00621244|364807455|FG003|Overall Study|Death|1|||
105769467|NCT00621244|364807452|FG000|Overall Study|Adverse Event|27|||
105769468|NCT00621244|364807453|FG001|Overall Study|Adverse Event|7|||
105769469|NCT00621244|364807454|FG002|Overall Study|Adverse Event|9|||
105769470|NCT00621244|364807455|FG003|Overall Study|Adverse Event|2|||
105769471|NCT00621244|364807452|FG000|Overall Study|Administrative problems|5|||
105769472|NCT00621244|364807453|FG001|Overall Study|Administrative problems|1|||
105769473|NCT00621244|364807454|FG002|Overall Study|Administrative problems|0|||
105769474|NCT00621244|364807455|FG003|Overall Study|Administrative problems|2|||
105769475|NCT00338806|364807470|FG000|Acute Phase|Withdrawal by Subject|0|||
105769476|NCT00338806|364807471|FG001|Acute Phase|Withdrawal by Subject|1|||
106097763|NCT01949480|366016417|FG000|Overall Study|Physician Decision|5|||
106097764|NCT01949480|366016418|FG001|Overall Study|Physician Decision|8|||
105769477|NCT00338806|364807470|FG000|Follow-up|Lost to Follow-up|1|||
105769478|NCT00338806|364807471|FG001|Follow-up|Lost to Follow-up|3|||
105769479|NCT00744991|364807474|FG000|Overall Study|Progressive Disease|11|||
105769480|NCT00744991|364807474|FG000|Overall Study|Withdrawal by Subject|8|||
105769481|NCT00744991|364807474|FG000|Overall Study|Physician Decision|3|||
105769482|NCT00744991|364807474|FG000|Overall Study|Adverse Event|2|||
105769483|NCT00744991|364807474|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
105769484|NCT01487863|364807483|FG000|Overall Study|Death|19|||
105769485|NCT01487863|364807484|FG001|Overall Study|Death|19|||
105988138|NCT03100058|365616373|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105988139|NCT03100058|365616374|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
105988140|NCT03100058|365616362|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105988141|NCT03100058|365616363|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
106097765|NCT02372396|366016423|FG000|Overall Study|Lost to Follow-up|7|||
106097766|NCT02372396|366016424|FG001|Overall Study|Lost to Follow-up|9|||
105988142|NCT03100058|365616364|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
106097767|NCT01226745|366016425|FG000|Overall Study|Did not complete schedule of assessments|8|||
106097768|NCT01226745|366016426|FG001|Overall Study|Did not complete schedule of assessments|3|||
106097769|NCT01226745|366016427|FG002|Overall Study|Did not complete schedule of assessments|6|||
105988143|NCT03100058|365616365|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105988144|NCT03100058|365616366|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105988145|NCT03100058|365616367|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105988146|NCT03100058|365616368|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
106097770|NCT01226745|366016428|FG003|Overall Study|Did not complete schedule of assessments|0|||
106097771|NCT01226745|366016429|FG004|Overall Study|Did not complete schedule of assessments|0|||
106097772|NCT01226745|366016430|FG005|Overall Study|Did not complete schedule of assessments|1|||
106097773|NCT01226745|366016425|FG000|Overall Study|Lost to Follow-up|2|||
106097774|NCT01226745|366016426|FG001|Overall Study|Lost to Follow-up|6|||
106097775|NCT01226745|366016427|FG002|Overall Study|Lost to Follow-up|6|||
105988147|NCT03100058|365616369|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105988148|NCT03100058|365616370|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105988149|NCT03100058|365616371|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
105988150|NCT03100058|365616372|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
105988151|NCT03100058|365616373|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
105988152|NCT03100058|365616374|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
105988153|NCT03100058|365616362|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988154|NCT03100058|365616363|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988155|NCT03100058|365616364|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988156|NCT03100058|365616365|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988157|NCT03100058|365616366|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988158|NCT03100058|365616367|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988159|NCT03100058|365616368|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988160|NCT03100058|365616369|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105769486|NCT03198728|364807488|FG000|Overall Study|Adverse Event|10|||
105769487|NCT03198728|364807489|FG001|Overall Study|Adverse Event|5|||
105769488|NCT03198728|364807488|FG000|Overall Study|Lost to Follow-up|21|||
105769489|NCT03198728|364807489|FG001|Overall Study|Lost to Follow-up|7|||
105769490|NCT03198728|364807488|FG000|Overall Study|Physician Decision|7|||
105769491|NCT03198728|364807489|FG001|Overall Study|Physician Decision|2|||
105769492|NCT03198728|364807488|FG000|Overall Study|Withdrawal by Subject|14|||
105769493|NCT03198728|364807489|FG001|Overall Study|Withdrawal by Subject|10|||
105769494|NCT04157751|364807498|FG000|Overall Study|Withdrawal by Subject|12|||
105769495|NCT04157751|364807499|FG001|Overall Study|Withdrawal by Subject|17|||
105769496|NCT04157751|364807498|FG000|Overall Study|Lost to Follow-up|6|||
105769497|NCT04157751|364807499|FG001|Overall Study|Lost to Follow-up|2|||
105769498|NCT04157751|364807498|FG000|Overall Study|Adverse Event|34|||
105769499|NCT04157751|364807499|FG001|Overall Study|Adverse Event|23|||
105769500|NCT04157751|364807498|FG000|Overall Study|Not treated|1|||
105769501|NCT04157751|364807499|FG001|Overall Study|Not treated|5|||
106097776|NCT01226745|366016428|FG003|Overall Study|Lost to Follow-up|1|||
106097777|NCT01226745|366016429|FG004|Overall Study|Lost to Follow-up|1|||
106097778|NCT01226745|366016430|FG005|Overall Study|Lost to Follow-up|2|||
105769502|NCT04157751|364807498|FG000|Overall Study|Other reason not stated above|10|||
105769503|NCT04157751|364807499|FG001|Overall Study|Other reason not stated above|10|||
105769504|NCT01332851|364807500|FG000|Overall Study|Withdrawal by Subject|4|||
105769505|NCT01332851|364807501|FG001|Overall Study|Withdrawal by Subject|2|||
105769506|NCT01332851|364807500|FG000|Overall Study|Lost to Follow-up|7|||
105769507|NCT01332851|364807501|FG001|Overall Study|Lost to Follow-up|11|||
105769508|NCT01437267|364807503|FG000|Overall Study|Withdrawal by Subject|0|||
105769509|NCT01437267|364807504|FG001|Overall Study|Withdrawal by Subject|0|||
105769510|NCT01437267|364807505|FG002|Overall Study|Withdrawal by Subject|0|||
105769511|NCT01437267|364807506|FG003|Overall Study|Withdrawal by Subject|1|||
105769512|NCT01437267|364807507|FG004|Overall Study|Withdrawal by Subject|0|||
106097779|NCT01226745|366016425|FG000|Overall Study|Death|1|||
106097780|NCT01226745|366016426|FG001|Overall Study|Death|0|||
105769513|NCT01437267|364807508|FG005|Overall Study|Withdrawal by Subject|0|||
105769514|NCT01437267|364807503|FG000|Overall Study|Protocol Violation|0|||
105769515|NCT01437267|364807504|FG001|Overall Study|Protocol Violation|1|||
105769516|NCT01437267|364807505|FG002|Overall Study|Protocol Violation|0|||
105769517|NCT01437267|364807506|FG003|Overall Study|Protocol Violation|0|||
105769518|NCT01437267|364807507|FG004|Overall Study|Protocol Violation|0|||
106097781|NCT01226745|366016427|FG002|Overall Study|Death|0|||
106097782|NCT01226745|366016428|FG003|Overall Study|Death|0|||
106097783|NCT01226745|366016429|FG004|Overall Study|Death|0|||
106097784|NCT01226745|366016430|FG005|Overall Study|Death|1|||
106097785|NCT01226745|366016425|FG000|Overall Study|Other|6|||
106097786|NCT01226745|366016426|FG001|Overall Study|Other|7|||
105659645|NCT00816556|364418794|FG000|Overall Study|Withdrawal by Subject|1|||
105769519|NCT01437267|364807508|FG005|Overall Study|Protocol Violation|0|||
105988161|NCT03100058|365616370|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988162|NCT03100058|365616371|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988163|NCT03100058|365616372|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
105988164|NCT03100058|365616373|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
105988165|NCT03100058|365616374|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
105988166|NCT03100058|365616362|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988167|NCT03100058|365616363|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988168|NCT03100058|365616364|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988169|NCT03100058|365616365|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988170|NCT03100058|365616366|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988171|NCT03100058|365616367|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988172|NCT03100058|365616368|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988173|NCT03100058|365616369|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988174|NCT03100058|365616370|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988175|NCT03100058|365616371|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
105988176|NCT03100058|365616372|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
105988177|NCT03100058|365616373|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
105988178|NCT03100058|365616374|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
105988179|NCT03100058|365616362|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988180|NCT03100058|365616363|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988181|NCT03100058|365616364|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988182|NCT03100058|365616365|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988183|NCT03100058|365616366|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988184|NCT03100058|365616367|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988185|NCT03100058|365616368|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988186|NCT03100058|365616369|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988187|NCT03100058|365616370|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988188|NCT03100058|365616371|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988189|NCT03100058|365616372|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
105988190|NCT03100058|365616373|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988191|NCT03100058|365616374|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
105988192|NCT03100058|365616362|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988193|NCT03100058|365616363|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988194|NCT03100058|365616364|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988195|NCT03100058|365616365|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988196|NCT03100058|365616366|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988197|NCT03100058|365616367|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988198|NCT03100058|365616368|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988199|NCT03100058|365616369|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988200|NCT03100058|365616370|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988201|NCT03100058|365616371|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105988202|NCT03100058|365616372|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
105769520|NCT00333970|364807509|FG000|Overall Study|Withdrawal by Subject|13|||
105659646|NCT00816556|364418795|FG001|Overall Study|Withdrawal by Subject|1|||
105659647|NCT00816556|364418796|FG002|Overall Study|Withdrawal by Subject|1|||
105659648|NCT00816556|364418794|FG000|Overall Study|Lost to Follow-up|0|||
105659649|NCT00816556|364418795|FG001|Overall Study|Lost to Follow-up|0|||
105659650|NCT00816556|364418796|FG002|Overall Study|Lost to Follow-up|1|||
105769521|NCT00333970|364807510|FG001|Overall Study|Withdrawal by Subject|7|||
105769522|NCT01810380|364807511|FG000|Overall Study|Randomised not treated|2|||
105769523|NCT01810380|364807512|FG001|Overall Study|Randomised not treated|1|||
105769524|NCT01810380|364807513|FG002|Overall Study|Randomised not treated|1|||
105769525|NCT01810380|364807511|FG000|Overall Study|Adverse Event|11|||
105769526|NCT01810380|364807512|FG001|Overall Study|Adverse Event|14|||
105769527|NCT01810380|364807513|FG002|Overall Study|Adverse Event|4|||
105769528|NCT01810380|364807511|FG000|Overall Study|Lack of Efficacy|24|||
105769529|NCT01810380|364807512|FG001|Overall Study|Lack of Efficacy|10|||
105769530|NCT01810380|364807513|FG002|Overall Study|Lack of Efficacy|11|||
105988203|NCT03100058|365616373|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
106097787|NCT01226745|366016427|FG002|Overall Study|Other|8|||
106097788|NCT01226745|366016428|FG003|Overall Study|Other|4|||
105659651|NCT01010204|364418797|FG000|Overall Study|Lost to Follow-up|2|||
105769531|NCT01810380|364807511|FG000|Overall Study|Protocol Violation|1|||
105769532|NCT01810380|364807512|FG001|Overall Study|Protocol Violation|0|||
105769533|NCT01810380|364807513|FG002|Overall Study|Protocol Violation|1|||
105769534|NCT01810380|364807511|FG000|Overall Study|Withdrawal by Subject|6|||
105769535|NCT01810380|364807512|FG001|Overall Study|Withdrawal by Subject|0|||
105769536|NCT01810380|364807513|FG002|Overall Study|Withdrawal by Subject|6|||
105769537|NCT01810380|364807511|FG000|Overall Study|Administrative or other reasons|11|||
105769538|NCT01810380|364807512|FG001|Overall Study|Administrative or other reasons|13|||
105988204|NCT03100058|365616374|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
105988205|NCT03100058|365616362|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988206|NCT03100058|365616363|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988207|NCT03100058|365616364|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988208|NCT03100058|365616365|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988209|NCT03100058|365616366|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988210|NCT03100058|365616367|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988211|NCT03100058|365616368|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105769539|NCT01810380|364807513|FG002|Overall Study|Administrative or other reasons|9|||
105769540|NCT00441480|364807514|FG000|Overall Study|Protocol Violation|1|||
105769541|NCT00441480|364807515|FG001|Overall Study|Protocol Violation|1|||
105769542|NCT00441480|364807514|FG000|Overall Study|Withdrawal by Subject|2|||
105769543|NCT00441480|364807515|FG001|Overall Study|Withdrawal by Subject|3|||
105769544|NCT02829775|364807516|FG000|Overall Study|Death|1|||
105769545|NCT02829775|364807516|FG000|Overall Study|Withdrawal by Subject|3|||
105769546|NCT02829775|364807516|FG000|Overall Study|Disease remission|1|||
105769547|NCT00033371|364807517|FG000|Overall Study|Adverse Event|1|||
105769548|NCT00033371|364807518|FG001|Overall Study|Adverse Event|5|||
105769549|NCT00033371|364807517|FG000|Overall Study|Lost to Follow-up|2|||
105769550|NCT00033371|364807518|FG001|Overall Study|Lost to Follow-up|1|||
105769551|NCT00033371|364807517|FG000|Overall Study|Withdrawal by Subject|3|||
105769552|NCT00033371|364807518|FG001|Overall Study|Withdrawal by Subject|3|||
105769553|NCT00033371|364807517|FG000|Overall Study|Disease Progression|0|||
105769554|NCT00033371|364807518|FG001|Overall Study|Disease Progression|1|||
105769555|NCT00062647|364807521|FG000|Overall Study|Death|2|||
105769556|NCT00062647|364807522|FG001|Overall Study|Death|2|||
105769557|NCT00062647|364807521|FG000|Overall Study|Adverse Event|1|||
105769558|NCT00062647|364807522|FG001|Overall Study|Adverse Event|1|||
105769559|NCT00062647|364807521|FG000|Overall Study|Withdrawal by Subject|2|||
105769560|NCT00062647|364807522|FG001|Overall Study|Withdrawal by Subject|1|||
105769561|NCT00062647|364807521|FG000|Overall Study|Protocol Violation|1|||
105769562|NCT00062647|364807522|FG001|Overall Study|Protocol Violation|0|||
105769563|NCT00062647|364807521|FG000|Overall Study|Lost to Follow-up|1|||
105769564|NCT00062647|364807522|FG001|Overall Study|Lost to Follow-up|2|||
105769565|NCT00062647|364807521|FG000|Overall Study|Failed continuation criteria|4|||
105769566|NCT00062647|364807522|FG001|Overall Study|Failed continuation criteria|2|||
105769567|NCT00062647|364807521|FG000|Overall Study|Other|4|||
105769568|NCT00062647|364807522|FG001|Overall Study|Other|4|||
105769569|NCT00062647|364807521|FG000|Overall Study|Never received study treatment|1|||
105769570|NCT00062647|364807522|FG001|Overall Study|Never received study treatment|1|||
105769571|NCT00002981|364807528|FG000|Overall Study|Inevaluable|6|||
105769572|NCT02201472|364807532|FG000|Overall Study|Lack of Efficacy|2|||
105769573|NCT00262314|364807533|FG000|Overall Study|Changing physicians|38|||
105769574|NCT00262314|364807533|FG000|Overall Study|Death|12|||
105769575|NCT00262314|364807533|FG000|Overall Study|Patient's decision|92|||
105769576|NCT00262314|364807533|FG000|Overall Study|Other|95|||
105769577|NCT00262314|364807533|FG000|Overall Study|Lost to Follow-up|70|||
105769578|NCT00262314|364807533|FG000|Overall Study|Administrative withdrawal|30|||
105769579|NCT01201967|364807535|FG000|Overall Study|Lost to Follow-up|6|||
105769580|NCT01201967|364807536|FG001|Overall Study|Lost to Follow-up|5|||
105769581|NCT03128307|364807537|FG000|Overall Study|Lost to Follow-up|29|||
105769582|NCT03128307|364807537|FG000|Overall Study|Withdrawal by Subject|5|||
105769583|NCT00736385|364809324|FG000|Overall Study|Withdrawal by Subject|2|||
105769584|NCT00736385|364809325|FG001|Overall Study|Withdrawal by Subject|2|||
105769585|NCT00736385|364809324|FG000|Overall Study|Adverse Event|0|||
105769586|NCT00736385|364809325|FG001|Overall Study|Adverse Event|1|||
105769587|NCT01594749|364809326|FG000|Overall Study|Adverse Event|2|||
105769588|NCT01594749|364809327|FG001|Overall Study|Adverse Event|1|||
105769589|NCT01594749|364809326|FG000|Overall Study|Withdrawal by Subject|2|||
105769590|NCT01594749|364809327|FG001|Overall Study|Withdrawal by Subject|2|||
105769591|NCT01594749|364809326|FG000|Overall Study|Protocol Violation|2|||
105769592|NCT01594749|364809327|FG001|Overall Study|Protocol Violation|0|||
105769593|NCT01594749|364809326|FG000|Overall Study|Physician Decision|1|||
105769594|NCT01594749|364809327|FG001|Overall Study|Physician Decision|1|||
105769595|NCT01594749|364809326|FG000|Overall Study|Non-compliance with Protocol|0|||
105769596|NCT01594749|364809327|FG001|Overall Study|Non-compliance with Protocol|1|||
105769597|NCT01594749|364809326|FG000|Overall Study|Lost to Follow-up|1|||
105769598|NCT01594749|364809327|FG001|Overall Study|Lost to Follow-up|0|||
105769599|NCT01594749|364809326|FG000|Overall Study|Death|9|||
105769600|NCT01594749|364809327|FG001|Overall Study|Death|3|||
105769601|NCT01594749|364809326|FG000|Overall Study|Not Treated|4|||
105769602|NCT01594749|364809327|FG001|Overall Study|Not Treated|10|||
105769603|NCT01594749|364809326|FG000|Overall Study|Lost Source Documentation|1|||
105769604|NCT01594749|364809327|FG001|Overall Study|Lost Source Documentation|0|||
105769605|NCT00364351|364809328|FG000|Overall Study|Adverse Event|90|||
105769606|NCT00364351|364809329|FG001|Overall Study|Adverse Event|44|||
105769607|NCT00364351|364809328|FG000|Overall Study|Condition under investigation worsened|469|||
105769608|NCT00364351|364809329|FG001|Overall Study|Condition under investigation worsened|497|||
105769609|NCT00364351|364809328|FG000|Overall Study|Prohibited concomitant medication|0|||
105769610|NCT00364351|364809329|FG001|Overall Study|Prohibited concomitant medication|2|||
105769611|NCT00364351|364809328|FG000|Overall Study|Lost to Follow-up|1|||
105769612|NCT00364351|364809329|FG001|Overall Study|Lost to Follow-up|1|||
105769613|NCT00364351|364809328|FG000|Overall Study|Withdrawal by Subject|30|||
105769614|NCT00364351|364809329|FG001|Overall Study|Withdrawal by Subject|29|||
105769615|NCT00364351|364809328|FG000|Overall Study|Incorrect enrollment|1|||
105769616|NCT00364351|364809329|FG001|Overall Study|Incorrect enrollment|1|||
105769617|NCT00364351|364809328|FG000|Overall Study|Sponsor decision|1|||
105769618|NCT00364351|364809329|FG001|Overall Study|Sponsor decision|0|||
105769619|NCT00364351|364809328|FG000|Overall Study|Poor treatment compliance|0|||
105769620|NCT00364351|364809329|FG001|Overall Study|Poor treatment compliance|3|||
105769621|NCT00364351|364809328|FG000|Overall Study|Investigator error|0|||
105769622|NCT00364351|364809329|FG001|Overall Study|Investigator error|2|||
105769623|NCT00364351|364809328|FG000|Overall Study|Patient could not travel to site|0|||
105769624|NCT00364351|364809329|FG001|Overall Study|Patient could not travel to site|1|||
105769625|NCT00364351|364809328|FG000|Overall Study|Randomised treatment not started|0|||
105769626|NCT00364351|364809329|FG001|Overall Study|Randomised treatment not started|3|||
105769627|NCT00976963|364809351|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
105769628|NCT00976963|364809352|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
105769629|NCT00976963|364809351|FG000|Overall Study|administrative error|1|||
105769630|NCT00976963|364809352|FG001|Overall Study|administrative error|0|||
105769631|NCT00976963|364809351|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
105769632|NCT00976963|364809352|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
105769633|NCT01426009|364809353|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
105769634|NCT01426009|364809353|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
105769635|NCT01426009|364809353|FG000|Washout 1|Withdrawal by Subject|1|||
105769636|NCT01426009|364809353|FG000|Washout 1|Personal Reasons|1|||
105769637|NCT01426009|364809353|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
105769638|NCT01426009|364809353|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
105769639|NCT01426009|364809353|FG000|Washout 2|electrive surgery|1|||
105769640|NCT01426009|364809353|FG000|Washout 3|personal reasons|1|||
105769641|NCT01426009|364809353|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
105769642|NCT01426009|364809353|FG000|Washout 4|Lost to Follow-up|1|||
105769643|NCT01688999|364809360|FG000|Overall Study|Withdrawal by Subject|5|||
105769644|NCT01688999|364809361|FG001|Overall Study|Withdrawal by Subject|1|||
105769645|NCT01688999|364809362|FG002|Overall Study|Withdrawal by Subject|1|||
105769646|NCT01688999|364809360|FG000|Overall Study|Adverse Event|2|||
105769647|NCT01688999|364809361|FG001|Overall Study|Adverse Event|0|||
105769648|NCT01688999|364809362|FG002|Overall Study|Adverse Event|2|||
105769649|NCT01688999|364809360|FG000|Overall Study|Ineligible/Not treated|1|||
105769650|NCT01688999|364809361|FG001|Overall Study|Ineligible/Not treated|0|||
105769651|NCT01688999|364809362|FG002|Overall Study|Ineligible/Not treated|0|||
105988212|NCT03100058|365616369|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988213|NCT03100058|365616370|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988214|NCT03100058|365616371|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
105988215|NCT03100058|365616372|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988216|NCT03100058|365616373|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988217|NCT03100058|365616374|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
105988218|NCT03671304|365616375|FG000|Overall Study|study terminated|7|||
105988219|NCT02718716|365616376|FG000|Overall Study|Lack of Efficacy|1|||
105988220|NCT02718716|365616377|FG001|Overall Study|Lack of Efficacy|0|||
105988221|NCT02718716|365616378|FG002|Overall Study|Lack of Efficacy|0|||
105988222|NCT02718716|365616379|FG003|Overall Study|Lack of Efficacy|0|||
105988223|NCT02718716|365616380|FG004|Overall Study|Lack of Efficacy|0|||
105988224|NCT00395850|365616382|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
105769652|NCT02768103|364809363|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
105769653|NCT02182999|364809380|FG000|Overall Study|Adverse Event|4|||
105769654|NCT02182999|364809381|FG001|Overall Study|Adverse Event|3|||
105769655|NCT02182999|364809380|FG000|Overall Study|Physician Decision|1|||
105769656|NCT02182999|364809381|FG001|Overall Study|Physician Decision|0|||
105769657|NCT00373880|364809388|FG000|Overall Study|Physician Decision|3|||
105769658|NCT00373880|364809388|FG000|Overall Study|Arrested|1|||
105769659|NCT00373880|364809388|FG000|Overall Study|Protocol Violation|14|||
105769660|NCT01899768|364809389|FG000|Part A|Adverse Event|2|||
105988225|NCT00395850|365616383|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
105988226|NCT00395850|365616384|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
105988227|NCT00395850|365616385|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
105988228|NCT00395850|365616382|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
105988229|NCT00395850|365616383|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
105988230|NCT00395850|365616384|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
105988231|NCT00395850|365616385|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
105988232|NCT00395850|365616382|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
105988233|NCT00395850|365616383|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
105988234|NCT00395850|365616384|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
105988235|NCT00395850|365616385|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
105988236|NCT00395850|365616382|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
105988237|NCT00395850|365616383|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
105988238|NCT00395850|365616384|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
105988239|NCT00395850|365616385|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
105988240|NCT00395850|365616382|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
106097789|NCT01226745|366016429|FG004|Overall Study|Other|3|||
105769661|NCT01899768|364809389|FG000|Part A|Withdrawal by Subject|1|||
105769662|NCT01899768|364809389|FG000|Part B|Adverse Event|1|||
105769663|NCT01899768|364809389|FG000|Part B|Withdrawal by Subject|1|||
105769664|NCT01347073|364809390|FG000|Overall Study|Adverse Event|1|||
105769665|NCT01347073|364809390|FG000|Overall Study|Liver Transplant|1|||
105769666|NCT02203916|364809391|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105769667|NCT02203916|364809392|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
105769668|NCT02203916|364809393|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
105769669|NCT02203916|364809391|FG000|Overall Study|Major Protocol Deviation|1|||
105769670|NCT02203916|364809392|FG001|Overall Study|Major Protocol Deviation|1|||
105769671|NCT02203916|364809393|FG002|Overall Study|Major Protocol Deviation|0|||
105769672|NCT02203916|364809391|FG000|Overall Study|Lost to Follow-up|0|||
105769673|NCT02203916|364809392|FG001|Overall Study|Lost to Follow-up|1|||
105769674|NCT02203916|364809393|FG002|Overall Study|Lost to Follow-up|0|||
105769675|NCT02203916|364809391|FG000|Overall Study|Voluntary Withdrawal|3|||
105769676|NCT02203916|364809392|FG001|Overall Study|Voluntary Withdrawal|3|||
105769677|NCT02203916|364809393|FG002|Overall Study|Voluntary Withdrawal|8|||
105769678|NCT02203916|364809391|FG000|Overall Study|Lack of Efficacy|3|||
105769679|NCT02203916|364809392|FG001|Overall Study|Lack of Efficacy|0|||
105769680|NCT02203916|364809393|FG002|Overall Study|Lack of Efficacy|0|||
105769681|NCT02203916|364809391|FG000|Overall Study|Reason Not Specified|0|||
105769682|NCT02203916|364809392|FG001|Overall Study|Reason Not Specified|2|||
105769683|NCT02203916|364809393|FG002|Overall Study|Reason Not Specified|1|||
105769684|NCT03152110|364809394|FG000|Overall Study|Withdrawal by Subject|3|||
105769685|NCT01925014|364809395|FG000|Overall Study|Inappropriate enrollment|4|||
105769686|NCT01925014|364809396|FG001|Overall Study|Inappropriate enrollment|6|||
105769687|NCT01925014|364809395|FG000|Overall Study|Withdrawal by Subject|5|||
105769688|NCT01925014|364809396|FG001|Overall Study|Withdrawal by Subject|13|||
105769689|NCT01634100|364809406|FG000|Overall Study|Withdrawal by Subject|1|||
105769690|NCT01634100|364809407|FG001|Overall Study|Withdrawal by Subject|0|||
105769691|NCT01634100|364809408|FG002|Overall Study|Withdrawal by Subject|1|||
105769692|NCT01634100|364809409|FG003|Overall Study|Withdrawal by Subject|0|||
105769693|NCT01634100|364809410|FG004|Overall Study|Withdrawal by Subject|0|||
105769694|NCT01634100|364809411|FG005|Overall Study|Withdrawal by Subject|0|||
105769695|NCT01662986|364809412|FG000|Overall Study|Adverse Event|5|||
105769696|NCT01662986|364809413|FG001|Overall Study|Adverse Event|4|||
105769697|NCT01662986|364809412|FG000|Overall Study|Protocol Violation|2|||
105769698|NCT01662986|364809413|FG001|Overall Study|Protocol Violation|3|||
105769699|NCT01662986|364809412|FG000|Overall Study|Lost to Follow-up|5|||
105769700|NCT01662986|364809413|FG001|Overall Study|Lost to Follow-up|4|||
105769701|NCT01662986|364809412|FG000|Overall Study|Withdrawal by Subject|2|||
105769702|NCT01662986|364809413|FG001|Overall Study|Withdrawal by Subject|2|||
105769703|NCT01662986|364809412|FG000|Overall Study|Not Treated|1|||
105769704|NCT01662986|364809413|FG001|Overall Study|Not Treated|0|||
105769705|NCT01662986|364809412|FG000|Overall Study|Other than stated above|3|||
105769706|NCT01662986|364809413|FG001|Overall Study|Other than stated above|0|||
105769707|NCT00623766|364809414|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
105769708|NCT00623766|364809415|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
105769709|NCT00623766|364809414|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
105769710|NCT00623766|364809415|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
105769711|NCT00623766|364809414|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
105769712|NCT00623766|364809415|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
105769713|NCT00623766|364809414|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
105769714|NCT00623766|364809415|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
105769715|NCT00623766|364809414|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
105769716|NCT00623766|364809415|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
105769717|NCT00486889|364809417|FG000|Overall Study|Death|3|||
105769718|NCT00486889|364809417|FG000|Overall Study|Non-compliant|2|||
105769719|NCT00486889|364809417|FG000|Overall Study|Withdrawal by Subject|6|||
105769720|NCT02324049|364809418|FG000|Part C|Study terminated|11|||
105769721|NCT03797144|364809422|FG000|Enrollment|Protocol Violation|4|||
105769722|NCT03797144|364809423|FG001|Enrollment|Protocol Violation|1|||
105769723|NCT03797144|364809422|FG000|Surgery|Protocol Violation|1|||
105769724|NCT03797144|364809423|FG001|Surgery|Protocol Violation|0|||
105769725|NCT03797144|364809422|FG000|3 Month|Early termination cut-off date|2|||
105769726|NCT03797144|364809423|FG001|3 Month|Early termination cut-off date|0|||
105769727|NCT03797144|364809422|FG000|12 Month|Early termination cut-off date|8|||
105769728|NCT03797144|364809423|FG001|12 Month|Early termination cut-off date|9|||
105769729|NCT03797144|364809422|FG000|24 Month|Early termination cut-off date|1|||
105769730|NCT03797144|364809423|FG001|24 Month|Early termination cut-off date|1|||
105769731|NCT01878175|364809425|FG000|Overall Study|Developed contraindicated health problem|2|||
105769732|NCT04051944|364809426|FG000|Overall Study|Study ending|1|||
105769733|NCT04051944|364809427|FG001|Overall Study|Study ending|1|||
105769734|NCT04051944|364809426|FG000|Overall Study|Early study termination by participant|1|||
105769735|NCT04051944|364809427|FG001|Overall Study|Early study termination by participant|0|||
105769736|NCT04051944|364809426|FG000|Overall Study|Withdrawal by Subject|2|||
105769737|NCT04051944|364809427|FG001|Overall Study|Withdrawal by Subject|2|||
105769738|NCT04051944|364809426|FG000|Overall Study|Lack of Efficacy|3|||
105769739|NCT04051944|364809427|FG001|Overall Study|Lack of Efficacy|0|||
105769740|NCT04051944|364809426|FG000|Overall Study|Adverse event, non- fatal|1|||
105769741|NCT04051944|364809427|FG001|Overall Study|Adverse event, non- fatal|1|||
105769742|NCT00614991|364809432|FG000|Overall Study|Adverse Event|3|||
105769743|NCT00614991|364809433|FG001|Overall Study|Adverse Event|3|||
105769744|NCT00614991|364809434|FG002|Overall Study|Adverse Event|0|||
105769745|NCT00614991|364809435|FG003|Overall Study|Adverse Event|0|||
105769746|NCT00614991|364809436|FG004|Overall Study|Adverse Event|1|||
105769747|NCT00614991|364809437|FG005|Overall Study|Adverse Event|0|||
105769748|NCT03799627|364809438|FG000|Overall Study|Adverse Event|1|||
105769749|NCT03799627|364809439|FG001|Overall Study|Adverse Event|2|||
105769750|NCT03799627|364809440|FG002|Overall Study|Adverse Event|0|||
105769751|NCT03799627|364809441|FG003|Overall Study|Adverse Event|0|||
105769752|NCT03799627|364809442|FG004|Overall Study|Adverse Event|2|||
105769753|NCT03799627|364809443|FG005|Overall Study|Adverse Event|5|||
105769754|NCT03799627|364809444|FG006|Overall Study|Adverse Event|0|||
105769755|NCT03799627|364809445|FG007|Overall Study|Adverse Event|2|||
105769756|NCT03799627|364809446|FG008|Overall Study|Adverse Event|0|||
105769757|NCT03799627|364809438|FG000|Overall Study|Physician Decision|2|||
105769758|NCT03799627|364809439|FG001|Overall Study|Physician Decision|2|||
105769759|NCT03799627|364809440|FG002|Overall Study|Physician Decision|0|||
105769760|NCT03799627|364809441|FG003|Overall Study|Physician Decision|0|||
105769761|NCT03799627|364809442|FG004|Overall Study|Physician Decision|2|||
105769762|NCT03799627|364809443|FG005|Overall Study|Physician Decision|2|||
105769763|NCT03799627|364809444|FG006|Overall Study|Physician Decision|0|||
105769764|NCT03799627|364809445|FG007|Overall Study|Physician Decision|0|||
105769765|NCT03799627|364809446|FG008|Overall Study|Physician Decision|0|||
105769766|NCT03799627|364809438|FG000|Overall Study|Withdrawal by Subject|1|||
105769767|NCT03799627|364809439|FG001|Overall Study|Withdrawal by Subject|1|||
105769768|NCT03799627|364809440|FG002|Overall Study|Withdrawal by Subject|0|||
105769769|NCT03799627|364809441|FG003|Overall Study|Withdrawal by Subject|2|||
105769770|NCT03799627|364809442|FG004|Overall Study|Withdrawal by Subject|0|||
105769771|NCT03799627|364809443|FG005|Overall Study|Withdrawal by Subject|3|||
105769772|NCT03799627|364809444|FG006|Overall Study|Withdrawal by Subject|0|||
105769773|NCT03799627|364809445|FG007|Overall Study|Withdrawal by Subject|0|||
105769774|NCT03799627|364809446|FG008|Overall Study|Withdrawal by Subject|0|||
105769775|NCT03799627|364809438|FG000|Overall Study|Lack of Efficacy|0|||
105769776|NCT03799627|364809439|FG001|Overall Study|Lack of Efficacy|0|||
105769777|NCT03799627|364809440|FG002|Overall Study|Lack of Efficacy|0|||
105769778|NCT03799627|364809441|FG003|Overall Study|Lack of Efficacy|1|||
105769779|NCT03799627|364809442|FG004|Overall Study|Lack of Efficacy|0|||
105769780|NCT03799627|364809443|FG005|Overall Study|Lack of Efficacy|0|||
105769781|NCT03799627|364809444|FG006|Overall Study|Lack of Efficacy|0|||
105769782|NCT03799627|364809445|FG007|Overall Study|Lack of Efficacy|0|||
105769783|NCT03799627|364809446|FG008|Overall Study|Lack of Efficacy|0|||
105769784|NCT03799627|364809438|FG000|Overall Study|Lost to Follow-up|0|||
105769785|NCT03799627|364809439|FG001|Overall Study|Lost to Follow-up|0|||
105769786|NCT03799627|364809440|FG002|Overall Study|Lost to Follow-up|0|||
105769787|NCT03799627|364809441|FG003|Overall Study|Lost to Follow-up|0|||
105769788|NCT03799627|364809442|FG004|Overall Study|Lost to Follow-up|0|||
105769789|NCT03799627|364809443|FG005|Overall Study|Lost to Follow-up|0|||
105769790|NCT03799627|364809444|FG006|Overall Study|Lost to Follow-up|1|||
105769791|NCT03799627|364809445|FG007|Overall Study|Lost to Follow-up|0|||
105769792|NCT03799627|364809446|FG008|Overall Study|Lost to Follow-up|1|||
105769793|NCT03799627|364809438|FG000|Overall Study|Death|0|||
105769794|NCT03799627|364809439|FG001|Overall Study|Death|0|||
105769795|NCT03799627|364809440|FG002|Overall Study|Death|0|||
105769796|NCT03799627|364809441|FG003|Overall Study|Death|1|||
105769797|NCT03799627|364809442|FG004|Overall Study|Death|0|||
105769798|NCT03799627|364809443|FG005|Overall Study|Death|0|||
105769799|NCT03799627|364809444|FG006|Overall Study|Death|0|||
105769800|NCT03799627|364809445|FG007|Overall Study|Death|0|||
105769801|NCT03799627|364809446|FG008|Overall Study|Death|0|||
105769802|NCT03799627|364809438|FG000|Overall Study|Study Drug Put on Hold|1|||
105769803|NCT03799627|364809439|FG001|Overall Study|Study Drug Put on Hold|0|||
105769804|NCT03799627|364809440|FG002|Overall Study|Study Drug Put on Hold|0|||
105769805|NCT03799627|364809441|FG003|Overall Study|Study Drug Put on Hold|0|||
105769806|NCT03799627|364809442|FG004|Overall Study|Study Drug Put on Hold|0|||
105769807|NCT03799627|364809443|FG005|Overall Study|Study Drug Put on Hold|0|||
105769808|NCT03799627|364809444|FG006|Overall Study|Study Drug Put on Hold|0|||
105769809|NCT03799627|364809445|FG007|Overall Study|Study Drug Put on Hold|0|||
105769810|NCT03799627|364809446|FG008|Overall Study|Study Drug Put on Hold|0|||
105769811|NCT03799627|364809438|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
105769812|NCT03799627|364809439|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
105769813|NCT03799627|364809440|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769814|NCT03799627|364809441|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
105769815|NCT03799627|364809442|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
105769816|NCT03799627|364809443|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769817|NCT03799627|364809444|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769818|NCT03799627|364809445|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769819|NCT03799627|364809446|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
105769820|NCT03799627|364809438|FG000|Overall Study|Kidney Transplantation|1|||
105769821|NCT03799627|364809439|FG001|Overall Study|Kidney Transplantation|0|||
105769822|NCT03799627|364809440|FG002|Overall Study|Kidney Transplantation|0|||
105769823|NCT03799627|364809441|FG003|Overall Study|Kidney Transplantation|1|||
105769824|NCT03799627|364809442|FG004|Overall Study|Kidney Transplantation|1|||
105769825|NCT03799627|364809443|FG005|Overall Study|Kidney Transplantation|0|||
105769826|NCT03799627|364809444|FG006|Overall Study|Kidney Transplantation|0|||
105769827|NCT03799627|364809445|FG007|Overall Study|Kidney Transplantation|0|||
105769828|NCT03799627|364809446|FG008|Overall Study|Kidney Transplantation|0|||
105769829|NCT03799627|364809438|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
105769830|NCT03799627|364809439|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
105769831|NCT03799627|364809440|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
105769832|NCT03799627|364809441|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
105769833|NCT03799627|364809442|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
105769834|NCT03799627|364809443|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
105769835|NCT03799627|364809444|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
105769836|NCT03799627|364809445|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
105769837|NCT03799627|364809446|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
105769838|NCT03799627|364809438|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769839|NCT03799627|364809439|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
105769840|NCT03799627|364809440|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769841|NCT03799627|364809441|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769842|NCT03799627|364809442|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769843|NCT03799627|364809443|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769844|NCT03799627|364809444|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769845|NCT03799627|364809445|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769846|NCT03799627|364809446|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
105769847|NCT03799627|364809438|FG000|Overall Study|Met Exclusion Criteria|0|||
105769848|NCT03799627|364809439|FG001|Overall Study|Met Exclusion Criteria|0|||
105988241|NCT00395850|365616383|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
105988242|NCT00395850|365616384|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
105769849|NCT03799627|364809440|FG002|Overall Study|Met Exclusion Criteria|0|||
105769850|NCT03799627|364809441|FG003|Overall Study|Met Exclusion Criteria|1|||
105769851|NCT03799627|364809442|FG004|Overall Study|Met Exclusion Criteria|0|||
105769852|NCT03799627|364809443|FG005|Overall Study|Met Exclusion Criteria|0|||
105769853|NCT03799627|364809444|FG006|Overall Study|Met Exclusion Criteria|0|||
105769854|NCT03799627|364809445|FG007|Overall Study|Met Exclusion Criteria|0|||
105769855|NCT03799627|364809446|FG008|Overall Study|Met Exclusion Criteria|0|||
105769856|NCT03799627|364809438|FG000|Overall Study|Investigational Product Noncompliance|0|||
105769857|NCT03799627|364809439|FG001|Overall Study|Investigational Product Noncompliance|0|||
105769858|NCT03799627|364809440|FG002|Overall Study|Investigational Product Noncompliance|0|||
105769859|NCT03799627|364809441|FG003|Overall Study|Investigational Product Noncompliance|1|||
105769860|NCT03799627|364809442|FG004|Overall Study|Investigational Product Noncompliance|0|||
106097790|NCT01226745|366016430|FG005|Overall Study|Other|1|||
105769861|NCT03799627|364809443|FG005|Overall Study|Investigational Product Noncompliance|0|||
105769862|NCT03799627|364809444|FG006|Overall Study|Investigational Product Noncompliance|0|||
105769863|NCT03799627|364809445|FG007|Overall Study|Investigational Product Noncompliance|0|||
105769864|NCT03799627|364809446|FG008|Overall Study|Investigational Product Noncompliance|0|||
105769865|NCT03799627|364809438|FG000|Overall Study|Participant Relocation|0|||
105769866|NCT03799627|364809439|FG001|Overall Study|Participant Relocation|0|||
105769867|NCT03799627|364809440|FG002|Overall Study|Participant Relocation|0|||
105769868|NCT03799627|364809441|FG003|Overall Study|Participant Relocation|1|||
105769869|NCT03799627|364809442|FG004|Overall Study|Participant Relocation|0|||
105769870|NCT03799627|364809443|FG005|Overall Study|Participant Relocation|1|||
105769871|NCT03799627|364809444|FG006|Overall Study|Participant Relocation|0|||
105769872|NCT03799627|364809445|FG007|Overall Study|Participant Relocation|0|||
105769873|NCT03799627|364809446|FG008|Overall Study|Participant Relocation|0|||
105769874|NCT03799627|364809438|FG000|Overall Study|Eurofin Issue|0|||
105769875|NCT03799627|364809439|FG001|Overall Study|Eurofin Issue|0|||
105769876|NCT03799627|364809440|FG002|Overall Study|Eurofin Issue|0|||
105769877|NCT03799627|364809441|FG003|Overall Study|Eurofin Issue|0|||
105769878|NCT03799627|364809442|FG004|Overall Study|Eurofin Issue|1|||
105769879|NCT03799627|364809443|FG005|Overall Study|Eurofin Issue|0|||
105769880|NCT03799627|364809444|FG006|Overall Study|Eurofin Issue|0|||
105769881|NCT03799627|364809445|FG007|Overall Study|Eurofin Issue|0|||
105769882|NCT03799627|364809446|FG008|Overall Study|Eurofin Issue|0|||
105769883|NCT03799627|364809438|FG000|Overall Study|Noncompliance with Site Instructions|0|||
105769884|NCT03799627|364809439|FG001|Overall Study|Noncompliance with Site Instructions|0|||
105769885|NCT03799627|364809440|FG002|Overall Study|Noncompliance with Site Instructions|0|||
105769886|NCT03799627|364809441|FG003|Overall Study|Noncompliance with Site Instructions|0|||
105769887|NCT03799627|364809442|FG004|Overall Study|Noncompliance with Site Instructions|1|||
105769888|NCT03799627|364809443|FG005|Overall Study|Noncompliance with Site Instructions|0|||
105769889|NCT03799627|364809444|FG006|Overall Study|Noncompliance with Site Instructions|0|||
105769890|NCT03799627|364809445|FG007|Overall Study|Noncompliance with Site Instructions|0|||
105769891|NCT03799627|364809446|FG008|Overall Study|Noncompliance with Site Instructions|0|||
105769892|NCT03799627|364809438|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769893|NCT03799627|364809439|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769894|NCT03799627|364809440|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769895|NCT03799627|364809441|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769896|NCT03799627|364809442|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
105769897|NCT03799627|364809443|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769898|NCT03799627|364809444|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769899|NCT03799627|364809445|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769900|NCT03799627|364809446|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
105769901|NCT03799627|364809438|FG000|Overall Study|Changes In Hemoglobin Values|1|||
105769902|NCT03799627|364809439|FG001|Overall Study|Changes In Hemoglobin Values|2|||
105769903|NCT03799627|364809440|FG002|Overall Study|Changes In Hemoglobin Values|1|||
105769904|NCT03799627|364809441|FG003|Overall Study|Changes In Hemoglobin Values|0|||
105769905|NCT03799627|364809442|FG004|Overall Study|Changes In Hemoglobin Values|0|||
105769906|NCT03799627|364809443|FG005|Overall Study|Changes In Hemoglobin Values|2|||
105769907|NCT03799627|364809444|FG006|Overall Study|Changes In Hemoglobin Values|1|||
105769908|NCT03799627|364809445|FG007|Overall Study|Changes In Hemoglobin Values|0|||
105769909|NCT03799627|364809446|FG008|Overall Study|Changes In Hemoglobin Values|1|||
105769910|NCT01833806|364809455|FG000|Overall Study|Alternative treatment|2|||
105769911|NCT01833806|364809455|FG000|Overall Study|Death|5|||
105769912|NCT01833806|364809455|FG000|Overall Study|Physician Decision|1|||
105769913|NCT01833806|364809455|FG000|Overall Study|Lost to Follow-up|1|||
105769914|NCT05083949|364809456|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
105769915|NCT05083949|364809457|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
105769916|NCT05083949|364809456|FG000|Period 1|Adverse Event|1|||
105769917|NCT05083949|364809457|FG001|Period 1|Adverse Event|1|||
105769918|NCT05083949|364809456|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
105769919|NCT05083949|364809457|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
105769920|NCT05083949|364809456|FG000|Period 2|Adverse Event|0|||
105769921|NCT05083949|364809457|FG001|Period 2|Adverse Event|2|||
105769922|NCT05104749|364809460|FG000|Overall Study|Lost to Follow-up|2|||
105769923|NCT05104749|364809461|FG001|Overall Study|Lost to Follow-up|3|||
105769924|NCT02470429|364809464|FG000|Overall Study|Adverse Event|1|||
105769925|NCT02470429|364809465|FG001|Overall Study|Adverse Event|0|||
106097791|NCT01650259|366016431|FG000|Overall Study|Improvement|105|||
105769926|NCT02470429|364809464|FG000|Overall Study|Withdrawal by Subject|1|||
105769927|NCT02470429|364809465|FG001|Overall Study|Withdrawal by Subject|0|||
105769928|NCT01300767|364809466|FG000|Overall Study|Discomfort|2|||
105769929|NCT01300767|364809466|FG000|Overall Study|Biomicroscopy|1|||
105769930|NCT01300767|364809466|FG000|Overall Study|Unacceptable fit|1|||
105769931|NCT00117572|364809471|FG000|Overall Study|Site withdrew before starting treatment|2|||
105806431|NCT01464827|364948984|FG003|Overall Study|Lost to Follow-up|2|||
105769932|NCT00117572|364809472|FG001|Overall Study|Site withdrew before starting treatment|3|||
105769933|NCT00117572|364809471|FG000|Overall Study|Withdrawal by Subject|3|||
105769934|NCT00117572|364809472|FG001|Overall Study|Withdrawal by Subject|3|||
105769935|NCT00117572|364809471|FG000|Overall Study|Protocol Violation|1|||
105769936|NCT00117572|364809472|FG001|Overall Study|Protocol Violation|0|||
105769937|NCT00322387|364809473|FG000|Treatment Period|Adverse Event|0|||
105769938|NCT00322387|364809474|FG001|Treatment Period|Adverse Event|1|||
105769939|NCT00322387|364809473|FG000|Follow-up Period|Final assessment not done|1|||
105769940|NCT00322387|364809474|FG001|Follow-up Period|Final assessment not done|3|||
105769941|NCT00322387|364809473|FG000|Follow-up Period|Death|1|||
105769942|NCT00322387|364809474|FG001|Follow-up Period|Death|0|||
105769943|NCT01188811|364809475|FG000|Overall Study|Withdrawal by Subject|0|||
105769944|NCT01188811|364809476|FG001|Overall Study|Withdrawal by Subject|2|||
105769945|NCT01188811|364809475|FG000|Overall Study|Adverse Event|6|||
105769946|NCT01188811|364809476|FG001|Overall Study|Adverse Event|0|||
105769947|NCT02485860|364809477|FG000|Overall Study|Lost to Follow-up|4|||
105769948|NCT02485860|364809478|FG001|Overall Study|Lost to Follow-up|1|||
105769949|NCT02485860|364809477|FG000|Overall Study|Physician Decision|1|||
105769950|NCT02485860|364809478|FG001|Overall Study|Physician Decision|2|||
105769951|NCT02485860|364809477|FG000|Overall Study|Health context (COVID-19)|1|||
105769952|NCT02485860|364809478|FG001|Overall Study|Health context (COVID-19)|0|||
105769953|NCT04412668|364809489|FG000|Overall Study|Death - multiple comorbidities|2|||
105769954|NCT04412668|364809490|FG001|Overall Study|Death - multiple comorbidities|0|||
105769955|NCT04412668|364809491|FG002|Overall Study|Death - multiple comorbidities|0|||
105769956|NCT04412668|364809489|FG000|Overall Study|Withdrawal by Subject|3|||
105769957|NCT04412668|364809490|FG001|Overall Study|Withdrawal by Subject|0|||
105769958|NCT04412668|364809491|FG002|Overall Study|Withdrawal by Subject|0|||
105769959|NCT04412668|364809489|FG000|Overall Study|Other than Specified|2|||
105769960|NCT04412668|364809490|FG001|Overall Study|Other than Specified|0|||
105769961|NCT04412668|364809491|FG002|Overall Study|Other than Specified|0|||
105769962|NCT00374127|364809494|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
105769963|NCT00374127|364809494|FG000|Overall Study|Blood could not be drawn.|2|||
105769964|NCT00374127|364809494|FG000|Overall Study|Protocol Violation|5|||
105769965|NCT00374127|364809494|FG000|Overall Study|Pregnancy|1|||
105769966|NCT02875366|364809495|FG000|Overall Study|Adverse Event|0|||
105769967|NCT02875366|364809496|FG001|Overall Study|Adverse Event|2|||
105769968|NCT02875366|364809495|FG000|Overall Study|Noncompliance|0|||
105769969|NCT02875366|364809496|FG001|Overall Study|Noncompliance|1|||
105769970|NCT00636155|364811000|FG000|Overall Study|Adverse Event|8|||
105988243|NCT00395850|365616385|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
105988244|NCT00395850|365616382|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
105988245|NCT00395850|365616383|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
105988246|NCT00395850|365616384|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
105988247|NCT00395850|365616385|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
105988248|NCT00395850|365616382|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
105988249|NCT00395850|365616383|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
105988250|NCT00395850|365616384|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
105988251|NCT00395850|365616385|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
105988252|NCT01844778|365616386|FG000|Overall Study|Protocol deviation|0|||
105988253|NCT01844778|365616387|FG001|Overall Study|Protocol deviation|1|||
105988254|NCT01844778|365616388|FG002|Overall Study|Protocol deviation|2|||
105988255|NCT01844778|365616386|FG000|Overall Study|Withdrawal by Subject|2|||
105988256|NCT01844778|365616387|FG001|Overall Study|Withdrawal by Subject|0|||
105988257|NCT01844778|365616388|FG002|Overall Study|Withdrawal by Subject|0|||
105988258|NCT01844778|365616386|FG000|Overall Study|Adverse Event|0|||
105988259|NCT01844778|365616387|FG001|Overall Study|Adverse Event|2|||
105988260|NCT01844778|365616388|FG002|Overall Study|Adverse Event|2|||
105988261|NCT02409719|365616389|FG000|Overall Study|Lost to Follow-up|3|||
105988262|NCT02409719|365616390|FG001|Overall Study|Lost to Follow-up|3|||
105988263|NCT00588094|365616391|FG000|Overall Study|Adverse Event|3|||
105988264|NCT00588094|365616391|FG000|Overall Study|Progression of Disease|2|||
105988265|NCT02951429|365616396|FG000|Overall Study|Adverse Event|3|||
105988266|NCT02951429|365616397|FG001|Overall Study|Adverse Event|7|||
105988267|NCT02951429|365616396|FG000|Overall Study|Death|28|||
105988268|NCT02951429|365616397|FG001|Overall Study|Death|36|||
105988269|NCT02951429|365616396|FG000|Overall Study|Lack of Efficacy|0|||
105988270|NCT02951429|365616397|FG001|Overall Study|Lack of Efficacy|1|||
105988271|NCT02951429|365616396|FG000|Overall Study|Lost to Follow-up|0|||
105988272|NCT02951429|365616397|FG001|Overall Study|Lost to Follow-up|1|||
105988273|NCT02951429|365616396|FG000|Overall Study|Lung Transplantation|9|||
105988274|NCT02951429|365616397|FG001|Overall Study|Lung Transplantation|6|||
105988275|NCT02951429|365616396|FG000|Overall Study|Other|1|||
105988276|NCT02951429|365616397|FG001|Overall Study|Other|3|||
105988277|NCT02951429|365616396|FG000|Overall Study|Progressive Disease|1|||
105988278|NCT02951429|365616397|FG001|Overall Study|Progressive Disease|1|||
105988279|NCT02951429|365616396|FG000|Overall Study|Withdrawal by Subject|7|||
105769971|NCT00636155|364811000|FG000|Overall Study|Lack of Efficacy|1|||
105769972|NCT00636155|364811000|FG000|Overall Study|Withdrawal by Subject|3|||
105769973|NCT00636155|364811000|FG000|Overall Study|Stem cell transplant|1|||
105769974|NCT00636155|364811000|FG000|Overall Study|Physician Decision|5|||
105769975|NCT01432756|364811001|FG000|Overall Study|Lost to Follow-up|1|||
105769976|NCT01432756|364811002|FG001|Overall Study|Lost to Follow-up|0|||
105769977|NCT01432756|364811003|FG002|Overall Study|Lost to Follow-up|2|||
105769978|NCT01432756|364811004|FG003|Overall Study|Lost to Follow-up|1|||
105769979|NCT00098865|364811009|FG000|Overall Study|Progressive Disease|6|||
105769980|NCT00098865|364811009|FG000|Overall Study|Adverse Event|2|||
105769981|NCT00098865|364811009|FG000|Overall Study|Alternative Therapy|1|||
105769982|NCT00413777|364811014|FG000|Fixed-dose Period|Lost to Follow-up|1|||
105769983|NCT00413777|364811015|FG001|Fixed-dose Period|Lost to Follow-up|1|||
106097792|NCT01650259|366016432|FG001|Overall Study|Improvement|0|||
106097793|NCT01650259|366016431|FG000|Overall Study|Adverse Event|127|||
106097794|NCT01650259|366016432|FG001|Overall Study|Adverse Event|0|||
106097795|NCT01650259|366016431|FG000|Overall Study|Lack of Efficacy|143|||
106097796|NCT01650259|366016432|FG001|Overall Study|Lack of Efficacy|0|||
106097797|NCT01650259|366016431|FG000|Overall Study|Lost to Follow-up|435|||
106097798|NCT01650259|366016432|FG001|Overall Study|Lost to Follow-up|0|||
105769984|NCT00413777|364811014|FG000|Fixed-dose Period|Adverse Event|2|||
105769985|NCT00413777|364811015|FG001|Fixed-dose Period|Adverse Event|1|||
105769986|NCT00413777|364811014|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
105769987|NCT00413777|364811015|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
106097799|NCT01650259|366016431|FG000|Overall Study|Patients had no visit after entry|70|||
106097800|NCT01650259|366016432|FG001|Overall Study|Patients had no visit after entry|0|||
106097801|NCT01650259|366016431|FG000|Overall Study|CRF not collected|98|||
106097802|NCT01650259|366016432|FG001|Overall Study|CRF not collected|82|||
106097803|NCT01650259|366016431|FG000|Overall Study|Not treated|1|||
106097804|NCT01650259|366016432|FG001|Overall Study|Not treated|7|||
106097805|NCT01650259|366016431|FG000|Overall Study|Other than listed|64|||
106097806|NCT01650259|366016432|FG001|Overall Study|Other than listed|146|||
106097807|NCT01808313|366016433|FG000|Overall Study|Adverse Event|5|||
106097808|NCT01808313|366016433|FG000|Overall Study|Protocol Violation|2|||
106097809|NCT01808313|366016433|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105769988|NCT00413777|364811014|FG000|Fixed-dose Period|Withdrew Consent|0|||
105769989|NCT00413777|364811015|FG001|Fixed-dose Period|Withdrew Consent|1|||
105769990|NCT02148952|364811016|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
105769991|NCT02148952|364811017|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
105769992|NCT02148952|364811016|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
105769993|NCT02148952|364811017|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
105769994|NCT02148952|364811016|FG000|Follow-Up|Lost to Follow-up|219|||
105769995|NCT02148952|364811017|FG001|Follow-Up|Lost to Follow-up|231|||
105769996|NCT02148952|364811016|FG000|Follow-Up|Withdrawal by Subject|46|||
105769997|NCT02148952|364811017|FG001|Follow-Up|Withdrawal by Subject|48|||
105769998|NCT01764022|364811020|FG000|Overall Study|Death|3|||
105769999|NCT01764022|364811021|FG001|Overall Study|Death|5|||
105770000|NCT01764022|364811020|FG000|Overall Study|Withdrawal by Subject|2|||
105770001|NCT01764022|364811021|FG001|Overall Study|Withdrawal by Subject|6|||
105770002|NCT01764022|364811020|FG000|Overall Study|Lack of Efficacy|0|||
105770003|NCT01764022|364811021|FG001|Overall Study|Lack of Efficacy|1|||
105770004|NCT01764022|364811020|FG000|Overall Study|Physician Decision|0|||
105770005|NCT01764022|364811021|FG001|Overall Study|Physician Decision|2|||
105770006|NCT01764022|364811020|FG000|Overall Study|Lost to Follow-up|2|||
105770007|NCT01764022|364811021|FG001|Overall Study|Lost to Follow-up|0|||
105770008|NCT01764022|364811020|FG000|Overall Study|Protocol Violation|1|||
105770009|NCT01764022|364811021|FG001|Overall Study|Protocol Violation|0|||
105770010|NCT03236506|364811022|FG000|Overall Study|Death|1|||
105770011|NCT03236506|364811023|FG001|Overall Study|Death|1|||
105770012|NCT03236506|364811024|FG002|Overall Study|Death|1|||
105770013|NCT03236506|364811022|FG000|Overall Study|Withdrawal by Subject|3|||
105770014|NCT03236506|364811023|FG001|Overall Study|Withdrawal by Subject|3|||
105770015|NCT03236506|364811024|FG002|Overall Study|Withdrawal by Subject|4|||
105770016|NCT03236506|364811022|FG000|Overall Study|Did not initiate treatment|2|||
105770017|NCT03236506|364811023|FG001|Overall Study|Did not initiate treatment|1|||
106097810|NCT01808313|366016433|FG000|Overall Study|Lost to Follow-up|1|||
106097811|NCT01808313|366016433|FG000|Overall Study|Physician Decision|1|||
105770018|NCT03236506|364811024|FG002|Overall Study|Did not initiate treatment|2|||
105770019|NCT00376675|364811025|FG000|Overall Study|Withdrawal by Subject|9|||
105770020|NCT00376675|364811026|FG001|Overall Study|Withdrawal by Subject|2|||
106097812|NCT03325712|366016434|FG000|Overall Study|Protocol Violation|0|||
105770021|NCT00376675|364811025|FG000|Overall Study|Adverse Event|10|||
105770022|NCT00376675|364811026|FG001|Overall Study|Adverse Event|5|||
105770023|NCT00376675|364811025|FG000|Overall Study|Other Reason|1|||
105770024|NCT00376675|364811026|FG001|Overall Study|Other Reason|7|||
105770025|NCT00736450|364811029|FG000|Overall Study|Not ABC gene eligible|19|||
105770026|NCT00736450|364811029|FG000|Overall Study|Withdrawal by Subject|5|||
105770027|NCT00736450|364811029|FG000|Overall Study|Physician Decision|1|||
105770028|NCT02943668|364811033|FG000|Overall Study|Disease Progression|1|||
105770029|NCT01313039|364811038|FG000|Overall Study|Physician Decision|1|||
105770030|NCT01313039|364811038|FG000|Overall Study|Adverse Event|1|||
105770031|NCT03630016|364811039|FG000|Overall Study|Poor Sensor Placement|1|||
105770032|NCT01678560|364811040|FG000|Overall Study|Physician Decision|4|||
105770033|NCT01678560|364811041|FG001|Overall Study|Physician Decision|4|||
105770034|NCT01678560|364811040|FG000|Overall Study|Death|0|||
105770035|NCT01678560|364811041|FG001|Overall Study|Death|1|||
105770036|NCT01678560|364811040|FG000|Overall Study|Withdrawal by Subject|0|||
105770037|NCT01678560|364811041|FG001|Overall Study|Withdrawal by Subject|1|||
105770038|NCT04489940|364811042|FG000|Overall Study|Other|2|||
105770039|NCT04489940|364811042|FG000|Overall Study|Withdrawal by Subject|2|||
105770040|NCT04489940|364811042|FG000|Overall Study|Death|5|||
105770041|NCT04489940|364811042|FG000|Overall Study|Lost to Follow-up|1|||
105770042|NCT03964493|364811045|FG000|Overall Study|Withdrawal by Subject|4|||
105770043|NCT03964493|364811046|FG001|Overall Study|Withdrawal by Subject|1|||
105770044|NCT03964493|364811045|FG000|Overall Study|Lost to Follow-up|13|||
105770045|NCT03964493|364811046|FG001|Overall Study|Lost to Follow-up|4|||
105770046|NCT04973085|364811047|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
105770047|NCT04973085|364811048|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
105770048|NCT01828567|364811049|FG000|Overall Study|Lost to Follow-up|27|||
105770049|NCT01828567|364811050|FG001|Overall Study|Lost to Follow-up|9|||
105770050|NCT01828567|364811049|FG000|Overall Study|Excluded - did not meet criteria|4|||
105770051|NCT01828567|364811050|FG001|Overall Study|Excluded - did not meet criteria|1|||
105770052|NCT00090766|364811060|FG000|Overall Study|Nephrectomy Planned|0|||
105770053|NCT00090766|364811061|FG001|Overall Study|Nephrectomy Planned|0|||
105770054|NCT00090766|364811062|FG002|Overall Study|Nephrectomy Planned|1|||
105770055|NCT00090766|364811060|FG000|Overall Study|Death|1|||
105988280|NCT02951429|365616397|FG001|Overall Study|Withdrawal by Subject|11|||
105988281|NCT02951429|365616396|FG000|Overall Study|Participant ongoing in the study|23|||
105988282|NCT02951429|365616397|FG001|Overall Study|Participant ongoing in the study|17|||
105988283|NCT01894022|365616401|FG000|Overall Study|Death|1|||
105988284|NCT01894022|365616402|FG001|Overall Study|Death|0|||
105988285|NCT01894022|365616401|FG000|Overall Study|Adverse Event, non-fatal|1|||
105988286|NCT01894022|365616402|FG001|Overall Study|Adverse Event, non-fatal|0|||
105988287|NCT01894022|365616401|FG000|Overall Study|Study Closed/terminated|7|||
105988288|NCT01894022|365616402|FG001|Overall Study|Study Closed/terminated|10|||
105988289|NCT00391625|365616404|FG000|Month 14|Withdrawal by Subject|1|||
105988290|NCT00391625|365616404|FG000|Month 50|Physician Decision|1|||
105988291|NCT00767819|365616405|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
105988292|NCT00767819|365616406|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
105988293|NCT00767819|365616407|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105988294|NCT00767819|365616405|FG000|Overall Study|Withdrawal by Subject|1|||
105988295|NCT00767819|365616406|FG001|Overall Study|Withdrawal by Subject|1|||
105988296|NCT00767819|365616407|FG002|Overall Study|Withdrawal by Subject|0|||
105988297|NCT00767819|365616405|FG000|Overall Study|Administrative problems|0|||
105988298|NCT00767819|365616406|FG001|Overall Study|Administrative problems|1|||
105988299|NCT00767819|365616407|FG002|Overall Study|Administrative problems|0|||
105988300|NCT00767819|365616405|FG000|Overall Study|Death|2|||
105988301|NCT00767819|365616406|FG001|Overall Study|Death|3|||
105988302|NCT00767819|365616407|FG002|Overall Study|Death|0|||
105988303|NCT00767819|365616405|FG000|Overall Study|Adverse Event|2|||
105988304|NCT00767819|365616406|FG001|Overall Study|Adverse Event|0|||
105988305|NCT00767819|365616407|FG002|Overall Study|Adverse Event|0|||
105988306|NCT00767819|365616405|FG000|Overall Study|Abnormal lab values|1|||
105988307|NCT00767819|365616406|FG001|Overall Study|Abnormal lab values|0|||
105988308|NCT00767819|365616407|FG002|Overall Study|Abnormal lab values|0|||
105988309|NCT00767819|365616405|FG000|Overall Study|Lost to Follow-up|1|||
105988310|NCT00767819|365616406|FG001|Overall Study|Lost to Follow-up|0|||
105988311|NCT00767819|365616407|FG002|Overall Study|Lost to Follow-up|0|||
105988312|NCT05392803|365616412|FG000|Overall Study|Lost to Follow-up|0|||
105988313|NCT05392803|365616413|FG001|Overall Study|Lost to Follow-up|2|||
105988314|NCT04294147|365616414|FG000|Overall Study|Protocol Violation|2|||
105988315|NCT04294147|365616415|FG001|Overall Study|Protocol Violation|0|||
105988316|NCT00699335|365616425|FG000|Overall Study|Combination of multiple reasons|176|||
105988317|NCT00699335|365616425|FG000|Overall Study|Missing data|52|||
105988318|NCT00915551|365616426|FG000|Overall Study|Withdrawal by Subject|0|||
105988319|NCT00915551|365616427|FG001|Overall Study|Withdrawal by Subject|1|||
105988320|NCT01371734|365616428|FG000|Overall Study|Other|2|||
105988321|NCT01371734|365616429|FG001|Overall Study|Other|1|||
105988322|NCT01371734|365616430|FG002|Overall Study|Other|2|||
105988323|NCT01371734|365616428|FG000|Overall Study|Withdrawal by Subject|3|||
105988324|NCT01371734|365616429|FG001|Overall Study|Withdrawal by Subject|4|||
105770056|NCT00090766|364811061|FG001|Overall Study|Death|0|||
105770057|NCT00090766|364811062|FG002|Overall Study|Death|0|||
105770058|NCT00090766|364811060|FG000|Overall Study|Admin|0|||
105770059|NCT00090766|364811061|FG001|Overall Study|Admin|2|||
105770060|NCT00090766|364811062|FG002|Overall Study|Admin|0|||
105988325|NCT01371734|365616430|FG002|Overall Study|Withdrawal by Subject|9|||
105988326|NCT01371734|365616428|FG000|Overall Study|Lost to Follow-up|5|||
105770061|NCT00090766|364811060|FG000|Overall Study|Lost to Follow-up|2|||
105988327|NCT01371734|365616429|FG001|Overall Study|Lost to Follow-up|3|||
105988328|NCT01371734|365616430|FG002|Overall Study|Lost to Follow-up|1|||
105988329|NCT01371734|365616428|FG000|Overall Study|Protocol Violation|3|||
105988330|NCT01371734|365616429|FG001|Overall Study|Protocol Violation|1|||
105988331|NCT01371734|365616430|FG002|Overall Study|Protocol Violation|2|||
106097813|NCT03325712|366016435|FG001|Overall Study|Protocol Violation|0|||
105988332|NCT01371734|365616428|FG000|Overall Study|Adverse Event|8|||
105988333|NCT01371734|365616429|FG001|Overall Study|Adverse Event|8|||
105988334|NCT01371734|365616430|FG002|Overall Study|Adverse Event|3|||
105988335|NCT01371734|365616428|FG000|Overall Study|Lack of Efficacy|2|||
105988336|NCT01371734|365616429|FG001|Overall Study|Lack of Efficacy|2|||
105988337|NCT01371734|365616430|FG002|Overall Study|Lack of Efficacy|0|||
105988338|NCT01743040|365616431|FG000|Overall Study|Death|1|||
105988339|NCT01743040|365616431|FG000|Overall Study|Lost to Follow-up|66|||
105988340|NCT01743040|365616431|FG000|Overall Study|Physician Decision|40|||
105988341|NCT01743040|365616431|FG000|Overall Study|Protocol Violation|1|||
105988342|NCT01743040|365616431|FG000|Overall Study|Withdrawal by Subject|121|||
105988343|NCT01620944|365616433|FG000|Overall Study|Early termination of Study|2|||
105988344|NCT01620944|365616434|FG001|Overall Study|Early termination of Study|1|||
105988345|NCT01123707|365616435|FG000|Overall Study|Lost to Follow-up|3|||
105988346|NCT01123707|365616436|FG001|Overall Study|Lost to Follow-up|1|||
105988347|NCT01123707|365616437|FG002|Overall Study|Lost to Follow-up|3|||
105988348|NCT01123707|365616438|FG003|Overall Study|Lost to Follow-up|2|||
105988349|NCT01123707|365616435|FG000|Overall Study|Adverse Event|5|||
105988350|NCT01123707|365616436|FG001|Overall Study|Adverse Event|7|||
105988351|NCT01123707|365616437|FG002|Overall Study|Adverse Event|5|||
105988352|NCT01123707|365616438|FG003|Overall Study|Adverse Event|3|||
105988353|NCT01123707|365616435|FG000|Overall Study|Sponsor Discontinued Study|30|||
105988354|NCT01123707|365616436|FG001|Overall Study|Sponsor Discontinued Study|24|||
105988355|NCT01123707|365616437|FG002|Overall Study|Sponsor Discontinued Study|25|||
105988356|NCT01123707|365616438|FG003|Overall Study|Sponsor Discontinued Study|40|||
105988357|NCT01123707|365616435|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
105988358|NCT01123707|365616436|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
105988359|NCT01123707|365616437|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
105988360|NCT01123707|365616438|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
105988361|NCT01123707|365616435|FG000|Overall Study|Investigator Withdrew Participant|0|||
106097814|NCT03325712|366016436|FG002|Overall Study|Protocol Violation|0|||
106097815|NCT03325712|366016437|FG003|Overall Study|Protocol Violation|0|||
106097816|NCT03325712|366016438|FG004|Overall Study|Protocol Violation|1|||
106097817|NCT03325712|366016439|FG005|Overall Study|Protocol Violation|0|||
106097818|NCT03325712|366016440|FG006|Overall Study|Protocol Violation|0|||
106097819|NCT03325712|366016441|FG007|Overall Study|Protocol Violation|0|||
106097820|NCT03325712|366016434|FG000|Overall Study|Adverse Event|0|||
106097821|NCT03325712|366016435|FG001|Overall Study|Adverse Event|0|||
106097822|NCT03325712|366016436|FG002|Overall Study|Adverse Event|0|||
106097823|NCT03325712|366016437|FG003|Overall Study|Adverse Event|0|||
106097824|NCT03325712|366016438|FG004|Overall Study|Adverse Event|1|||
105988362|NCT01123707|365616436|FG001|Overall Study|Investigator Withdrew Participant|1|||
105988363|NCT01123707|365616437|FG002|Overall Study|Investigator Withdrew Participant|1|||
105988364|NCT01123707|365616438|FG003|Overall Study|Investigator Withdrew Participant|1|||
105988365|NCT01123707|365616435|FG000|Overall Study|Subject Withdrew Consent|4|||
105988366|NCT01123707|365616436|FG001|Overall Study|Subject Withdrew Consent|5|||
105988367|NCT01123707|365616437|FG002|Overall Study|Subject Withdrew Consent|1|||
105988368|NCT01123707|365616438|FG003|Overall Study|Subject Withdrew Consent|2|||
105988369|NCT01123707|365616435|FG000|Overall Study|Lack of Efficacy|1|||
106097825|NCT03325712|366016439|FG005|Overall Study|Adverse Event|0|||
106097826|NCT03325712|366016440|FG006|Overall Study|Adverse Event|0|||
105770062|NCT00090766|364811061|FG001|Overall Study|Lost to Follow-up|0|||
105770063|NCT00090766|364811062|FG002|Overall Study|Lost to Follow-up|2|||
105770064|NCT00707486|364811063|FG000|Overall Study|Withdrawal by Subject|1|||
105770065|NCT00654368|364811064|FG000|Overall Study|Ineligibility determined|6|||
105770066|NCT00654368|364811065|FG001|Overall Study|Ineligibility determined|0|||
105770067|NCT00654368|364811066|FG002|Overall Study|Ineligibility determined|0|||
105770068|NCT00654368|364811064|FG000|Overall Study|Protocol deviation|3|||
105770069|NCT00654368|364811065|FG001|Overall Study|Protocol deviation|2|||
106097827|NCT03325712|366016441|FG007|Overall Study|Adverse Event|0|||
106097828|NCT02265237|366016443|FG000|As Treated (Overall Study)|Adverse Event|1|||
105770070|NCT00654368|364811066|FG002|Overall Study|Protocol deviation|1|||
106097829|NCT02265237|366016444|FG001|As Treated (Overall Study)|Adverse Event|1|||
105770071|NCT00654368|364811064|FG000|Overall Study|Non-compliance|2|||
106097830|NCT02265237|366016445|FG002|As Treated (Overall Study)|Adverse Event|0|||
105770072|NCT00654368|364811065|FG001|Overall Study|Non-compliance|1|||
105988370|NCT01123707|365616436|FG001|Overall Study|Lack of Efficacy|2|||
105988371|NCT01123707|365616437|FG002|Overall Study|Lack of Efficacy|1|||
105988372|NCT01123707|365616438|FG003|Overall Study|Lack of Efficacy|0|||
105988373|NCT01123707|365616435|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
105988374|NCT01123707|365616436|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
105988375|NCT01123707|365616437|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
105988376|NCT01123707|365616438|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
105988377|NCT01959243|365616439|FG000|Overall Study|Investigator Decision|3|||
105988378|NCT01959243|365616440|FG001|Overall Study|Investigator Decision|0|||
105988379|NCT01959243|365616439|FG000|Overall Study|Adverse Event|5|||
105988380|NCT01959243|365616440|FG001|Overall Study|Adverse Event|2|||
105988381|NCT01959243|365616439|FG000|Overall Study|Administrative reasons|2|||
105988382|NCT01959243|365616440|FG001|Overall Study|Administrative reasons|1|||
105988383|NCT01959243|365616439|FG000|Overall Study|Lost to Follow-up|3|||
105988384|NCT01959243|365616440|FG001|Overall Study|Lost to Follow-up|1|||
105988385|NCT02554981|365616443|FG000|Overall Study|Adverse Event|1|||
105988386|NCT02554981|365616443|FG000|Overall Study|Administrative Reasons|1|||
105988387|NCT02554981|365616443|FG000|Overall Study|Other Miscellaneous Reasons|3|||
105988388|NCT00428844|365616444|FG000|Completed Study Drug Treatment|Adverse Event|2|||
105988389|NCT00428844|365616445|FG001|Completed Study Drug Treatment|Adverse Event|4|||
105988390|NCT00428844|365616446|FG002|Completed Study Drug Treatment|Adverse Event|4|||
105988391|NCT00428844|365616444|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
105988392|NCT00428844|365616445|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
105988393|NCT00428844|365616446|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
105988394|NCT00428844|365616444|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
105988395|NCT00428844|365616445|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
105988396|NCT00428844|365616446|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
105988397|NCT00428844|365616444|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
105988398|NCT00428844|365616445|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
105988399|NCT00428844|365616446|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
105988400|NCT00428844|365616444|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
105988401|NCT00428844|365616445|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
105988402|NCT00428844|365616446|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
105988403|NCT00428844|365616444|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
105988404|NCT00428844|365616445|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
105988405|NCT00428844|365616446|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
105988406|NCT00428844|365616444|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
105988407|NCT00428844|365616445|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
105988408|NCT00428844|365616446|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
105988409|NCT00428844|365616444|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
105988410|NCT00428844|365616445|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
105988411|NCT00428844|365616446|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
105988412|NCT00428844|365616444|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
105988413|NCT00428844|365616445|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
105988414|NCT00428844|365616446|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
105988415|NCT03208088|365616452|FG000|Period 2|Withdrawal by Subject|0|||
105988416|NCT03208088|365616453|FG001|Period 2|Withdrawal by Subject|0|||
105988417|NCT03208088|365616454|FG002|Period 2|Withdrawal by Subject|0|||
105988418|NCT03208088|365616455|FG003|Period 2|Withdrawal by Subject|0|||
105988419|NCT03208088|365616456|FG004|Period 2|Withdrawal by Subject|0|||
105988420|NCT03208088|365616457|FG005|Period 2|Withdrawal by Subject|0|||
105988421|NCT03208088|365616458|FG006|Period 2|Withdrawal by Subject|0|||
105988422|NCT03208088|365616459|FG007|Period 2|Withdrawal by Subject|0|||
105988423|NCT03208088|365616460|FG008|Period 2|Withdrawal by Subject|1|||
105988424|NCT03208088|365616461|FG009|Period 2|Withdrawal by Subject|0|||
105988425|NCT03208088|365616452|FG000|Period 3|Unsatisfactory Test Article|0|||
105988426|NCT03208088|365616453|FG001|Period 3|Unsatisfactory Test Article|0|||
105988427|NCT03208088|365616454|FG002|Period 3|Unsatisfactory Test Article|0|||
105988428|NCT03208088|365616455|FG003|Period 3|Unsatisfactory Test Article|1|||
105988429|NCT03208088|365616456|FG004|Period 3|Unsatisfactory Test Article|0|||
105988430|NCT03208088|365616457|FG005|Period 3|Unsatisfactory Test Article|0|||
105988431|NCT03208088|365616458|FG006|Period 3|Unsatisfactory Test Article|0|||
105988432|NCT03208088|365616459|FG007|Period 3|Unsatisfactory Test Article|0|||
105988433|NCT03208088|365616460|FG008|Period 3|Unsatisfactory Test Article|0|||
105988434|NCT03208088|365616461|FG009|Period 3|Unsatisfactory Test Article|0|||
105988435|NCT03208088|365616452|FG000|Period 4|Unsatisfactory Test Article|0|||
105988436|NCT03208088|365616453|FG001|Period 4|Unsatisfactory Test Article|0|||
105988437|NCT03208088|365616454|FG002|Period 4|Unsatisfactory Test Article|0|||
105988438|NCT03208088|365616455|FG003|Period 4|Unsatisfactory Test Article|1|||
105988439|NCT03208088|365616456|FG004|Period 4|Unsatisfactory Test Article|0|||
105988440|NCT03208088|365616457|FG005|Period 4|Unsatisfactory Test Article|0|||
105988441|NCT03208088|365616458|FG006|Period 4|Unsatisfactory Test Article|0|||
105988442|NCT03208088|365616459|FG007|Period 4|Unsatisfactory Test Article|0|||
105988443|NCT03208088|365616460|FG008|Period 4|Unsatisfactory Test Article|0|||
105988444|NCT03208088|365616461|FG009|Period 4|Unsatisfactory Test Article|0|||
105988445|NCT01068158|365616464|FG000|Overall Study|Withdrawal by Subject|1|||
105988446|NCT01068158|365616465|FG001|Overall Study|Withdrawal by Subject|2|||
105988447|NCT01068158|365616464|FG000|Overall Study|Lost to Follow-up|7|||
105988448|NCT01068158|365616465|FG001|Overall Study|Lost to Follow-up|0|||
105988449|NCT01068158|365616464|FG000|Overall Study|Protocol Violation|0|||
105988450|NCT01068158|365616465|FG001|Overall Study|Protocol Violation|2|||
105988451|NCT00991406|365616466|FG000|Overall Study|One participant did not respond to FES.|1|||
105988452|NCT01300572|365616467|FG000|Overall Study|HAMA + post dosimetry|1|||
105988453|NCT00986362|365616468|FG000|Overall Study|Death|2|||
105988454|NCT00986362|365616469|FG001|Overall Study|Death|0|||
105988455|NCT00986362|365616468|FG000|Overall Study|Lost to Follow-up|0|||
105988456|NCT00986362|365616469|FG001|Overall Study|Lost to Follow-up|1|||
105988457|NCT00384332|365616470|FG000|Overall Study|Lost to Follow-up|4|||
105988458|NCT00384332|365616471|FG001|Overall Study|Lost to Follow-up|0|||
105988459|NCT03597061|365616472|FG000|Overall Study|Lost to Follow-up|1|||
105988460|NCT03597061|365616473|FG001|Overall Study|Lost to Follow-up|0|||
105988461|NCT03597061|365616472|FG000|Overall Study|Protocol Violation|0|||
105988462|NCT03597061|365616473|FG001|Overall Study|Protocol Violation|1|||
105988463|NCT02006979|365616474|FG000|Overall Study|Withdrawal by Subject|1|||
105988464|NCT02006979|365616475|FG001|Overall Study|Withdrawal by Subject|1|||
105988465|NCT02006979|365616474|FG000|Overall Study|Protocol Violation|0|||
105988466|NCT02006979|365616475|FG001|Overall Study|Protocol Violation|1|||
105988467|NCT00375518|365616476|FG000|Overall Study|Withdrawal by Subject|2|||
105988468|NCT00375518|365616477|FG001|Overall Study|Withdrawal by Subject|10|||
105988469|NCT00375518|365616476|FG000|Overall Study|Patient Not Treated|6|||
105988470|NCT00375518|365616477|FG001|Overall Study|Patient Not Treated|6|||
105988471|NCT00375518|365616476|FG000|Overall Study|Death|0|||
105988472|NCT00375518|365616477|FG001|Overall Study|Death|1|||
105988473|NCT03170193|365616478|FG000|Overall Study|Withdrawal by Subject|0|||
105988474|NCT03170193|365616479|FG001|Overall Study|Withdrawal by Subject|0|||
105988475|NCT03170193|365616480|FG002|Overall Study|Withdrawal by Subject|0|||
105988476|NCT03170193|365616481|FG003|Overall Study|Withdrawal by Subject|1|||
105988477|NCT03170193|365616482|FG004|Overall Study|Withdrawal by Subject|0|||
105988478|NCT03170193|365616483|FG005|Overall Study|Withdrawal by Subject|0|||
105988479|NCT03170193|365616484|FG006|Overall Study|Withdrawal by Subject|0|||
105988480|NCT03170193|365616478|FG000|Overall Study|Lost to Follow-up|1|||
105988481|NCT03170193|365616479|FG001|Overall Study|Lost to Follow-up|1|||
105988482|NCT03170193|365616480|FG002|Overall Study|Lost to Follow-up|0|||
105988483|NCT03170193|365616481|FG003|Overall Study|Lost to Follow-up|0|||
105988484|NCT03170193|365616482|FG004|Overall Study|Lost to Follow-up|0|||
105988485|NCT03170193|365616483|FG005|Overall Study|Lost to Follow-up|0|||
105988486|NCT03170193|365616484|FG006|Overall Study|Lost to Follow-up|0|||
105988487|NCT02596945|365616485|FG000|Overall Study|No documentation of study drug dosing|3|||
105988488|NCT02596945|365616485|FG000|Overall Study|Other|32|||
105988489|NCT02596945|365616485|FG000|Overall Study|Change to hemodialysis|15|||
105988490|NCT02596945|365616485|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
105988491|NCT02596945|365616485|FG000|Overall Study|Withdrawal by Subject|1|||
105988492|NCT02596945|365616485|FG000|Overall Study|Missing|1|||
105988493|NCT00411632|365616486|FG000|Overall Study|Death|1|||
105988494|NCT02560012|365616488|FG000|Overall Study|Study Terminated|2|||
105988495|NCT00238238|365616489|FG000|Overall Study|Withdrawal by Subject|0|||
105988496|NCT00238238|365616490|FG001|Overall Study|Withdrawal by Subject|3|||
105988497|NCT00238238|365616491|FG002|Overall Study|Withdrawal by Subject|0|||
105988498|NCT01108523|365616492|FG000|Overall Study|Protocol Violation|4|||
105988499|NCT03052816|365616494|FG000|Overall Study|Withdrawal by Subject|1|||
105988500|NCT03052816|365616495|FG001|Overall Study|Withdrawal by Subject|0|||
105988501|NCT03052816|365616494|FG000|Overall Study|Desired opioids|2|||
105988502|NCT03052816|365616495|FG001|Overall Study|Desired opioids|0|||
105988503|NCT02218008|365616496|FG000|Stage 1 (S1)|Adverse Event|6|||
105988504|NCT02218008|365616497|FG001|Stage 1 (S1)|Adverse Event|5|||
105988505|NCT02218008|365616498|FG002|Stage 1 (S1)|Adverse Event|11|||
105988506|NCT02218008|365616499|FG003|Stage 1 (S1)|Adverse Event|0|||
105988507|NCT02218008|365616500|FG004|Stage 1 (S1)|Adverse Event|0|||
105988508|NCT02218008|365616501|FG005|Stage 1 (S1)|Adverse Event|0|||
105988509|NCT02218008|365616496|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
105988510|NCT02218008|365616497|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
105988511|NCT02218008|365616498|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
105988512|NCT02218008|365616499|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
105988513|NCT02218008|365616500|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
105988514|NCT02218008|365616501|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
105988515|NCT02218008|365616496|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
105988516|NCT02218008|365616497|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
105988517|NCT02218008|365616498|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
105988518|NCT02218008|365616499|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
105988519|NCT02218008|365616500|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
105988520|NCT02218008|365616501|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
105988521|NCT02218008|365616496|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
105988522|NCT02218008|365616497|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
105988523|NCT02218008|365616498|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
105988524|NCT02218008|365616499|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
105988525|NCT02218008|365616500|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
105988526|NCT02218008|365616501|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
105988527|NCT02218008|365616496|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
105988528|NCT02218008|365616497|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
105988529|NCT02218008|365616498|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
105988530|NCT02218008|365616499|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
105988531|NCT02218008|365616500|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
105988532|NCT02218008|365616501|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
105988533|NCT02218008|365616496|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
105988534|NCT02218008|365616497|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
105988535|NCT02218008|365616498|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
105988536|NCT02218008|365616499|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
105988537|NCT02218008|365616500|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
105988538|NCT02218008|365616501|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
105988539|NCT02218008|365616496|FG000|Stage 1 (S1)|Pregnancy|0|||
105988540|NCT02218008|365616497|FG001|Stage 1 (S1)|Pregnancy|0|||
105988541|NCT02218008|365616498|FG002|Stage 1 (S1)|Pregnancy|1|||
105988542|NCT02218008|365616499|FG003|Stage 1 (S1)|Pregnancy|0|||
105988543|NCT02218008|365616500|FG004|Stage 1 (S1)|Pregnancy|0|||
105988544|NCT02218008|365616501|FG005|Stage 1 (S1)|Pregnancy|0|||
105988545|NCT02218008|365616496|FG000|Stage 1 (S1)|Protocol Violation|0|||
105988546|NCT02218008|365616497|FG001|Stage 1 (S1)|Protocol Violation|0|||
105988547|NCT02218008|365616498|FG002|Stage 1 (S1)|Protocol Violation|1|||
105988548|NCT02218008|365616499|FG003|Stage 1 (S1)|Protocol Violation|0|||
105988549|NCT02218008|365616500|FG004|Stage 1 (S1)|Protocol Violation|0|||
105988550|NCT02218008|365616501|FG005|Stage 1 (S1)|Protocol Violation|0|||
105988551|NCT02218008|365616496|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
105988552|NCT02218008|365616497|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105988553|NCT02218008|365616498|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105988554|NCT02218008|365616499|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105988555|NCT02218008|365616500|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
106097831|NCT02265237|366016446|FG003|As Treated (Overall Study)|Adverse Event|0|||
106097832|NCT02265237|366016443|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
106097833|NCT02265237|366016444|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
106097834|NCT02265237|366016445|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
106097835|NCT02265237|366016446|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
106097836|NCT02265237|366016443|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
105770073|NCT00654368|364811066|FG002|Overall Study|Non-compliance|2|||
105770074|NCT00654368|364811064|FG000|Overall Study|Withdrawal by Subject|5|||
105770075|NCT00654368|364811065|FG001|Overall Study|Withdrawal by Subject|2|||
105770076|NCT00654368|364811066|FG002|Overall Study|Withdrawal by Subject|2|||
105770077|NCT00654368|364811064|FG000|Overall Study|Disease progression|21|||
105770078|NCT00654368|364811065|FG001|Overall Study|Disease progression|31|||
105770079|NCT00654368|364811066|FG002|Overall Study|Disease progression|13|||
105770080|NCT00654368|364811064|FG000|Overall Study|Requirement for alternative therapy|1|||
105770081|NCT00654368|364811065|FG001|Overall Study|Requirement for alternative therapy|1|||
105770082|NCT00654368|364811066|FG002|Overall Study|Requirement for alternative therapy|1|||
105770083|NCT00654368|364811064|FG000|Overall Study|Physician Decision|0|||
105770084|NCT00654368|364811065|FG001|Overall Study|Physician Decision|0|||
105770085|NCT00654368|364811066|FG002|Overall Study|Physician Decision|2|||
105770086|NCT00654368|364811064|FG000|Overall Study|Death|1|||
105770087|NCT00654368|364811065|FG001|Overall Study|Death|0|||
105770088|NCT00654368|364811066|FG002|Overall Study|Death|0|||
105770089|NCT00654368|364811064|FG000|Overall Study|Pregnancy|0|||
105770090|NCT00654368|364811065|FG001|Overall Study|Pregnancy|0|||
105770091|NCT00654368|364811066|FG002|Overall Study|Pregnancy|2|||
105770092|NCT00654368|364811064|FG000|Overall Study|Other|0|||
105770093|NCT00654368|364811065|FG001|Overall Study|Other|2|||
105770094|NCT00654368|364811066|FG002|Overall Study|Other|3|||
105770095|NCT00654368|364811064|FG000|Overall Study|Adverse Event|14|||
105770096|NCT00654368|364811065|FG001|Overall Study|Adverse Event|9|||
105770097|NCT00654368|364811066|FG002|Overall Study|Adverse Event|6|||
105770098|NCT00804986|364811073|FG000|Overall Study|Adverse Event|0|||
105770099|NCT00804986|364811074|FG001|Overall Study|Adverse Event|1|||
105770100|NCT00804986|364811075|FG002|Overall Study|Adverse Event|2|||
105988556|NCT02218008|365616501|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
105988557|NCT02218008|365616496|FG000|Stage 2 (S2)|Adverse Event|0|||
105988558|NCT02218008|365616497|FG001|Stage 2 (S2)|Adverse Event|0|||
105988559|NCT02218008|365616498|FG002|Stage 2 (S2)|Adverse Event|0|||
105770101|NCT00804986|364811076|FG003|Overall Study|Adverse Event|1|||
105770102|NCT00804986|364811077|FG004|Overall Study|Adverse Event|3|||
105770103|NCT00804986|364811078|FG005|Overall Study|Adverse Event|0|||
105770104|NCT00804986|364811073|FG000|Overall Study|Lack of Efficacy|0|||
105770105|NCT00804986|364811074|FG001|Overall Study|Lack of Efficacy|0|||
105770106|NCT00804986|364811075|FG002|Overall Study|Lack of Efficacy|0|||
105770107|NCT00804986|364811076|FG003|Overall Study|Lack of Efficacy|1|||
105770108|NCT00804986|364811077|FG004|Overall Study|Lack of Efficacy|0|||
105770109|NCT00804986|364811078|FG005|Overall Study|Lack of Efficacy|3|||
105988560|NCT02218008|365616499|FG003|Stage 2 (S2)|Adverse Event|2|||
105988561|NCT02218008|365616500|FG004|Stage 2 (S2)|Adverse Event|3|||
105988562|NCT02218008|365616501|FG005|Stage 2 (S2)|Adverse Event|3|||
105988563|NCT02218008|365616496|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
105988564|NCT02218008|365616497|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
105988565|NCT02218008|365616498|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
105988566|NCT02218008|365616499|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
105988567|NCT02218008|365616500|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
105988568|NCT02218008|365616501|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
105988569|NCT02218008|365616496|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
105988570|NCT02218008|365616497|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
105988571|NCT02218008|365616498|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
105988572|NCT02218008|365616499|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
105988573|NCT02218008|365616500|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
105988574|NCT02218008|365616501|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
105988575|NCT02218008|365616496|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105988576|NCT02218008|365616497|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105988577|NCT02218008|365616498|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105988578|NCT02218008|365616499|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
105988579|NCT02218008|365616500|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105988580|NCT02218008|365616501|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
105988581|NCT02218008|365616496|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
105988582|NCT02218008|365616497|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
105988583|NCT02218008|365616498|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
105988584|NCT02218008|365616499|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
105988585|NCT02218008|365616500|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
105988586|NCT02218008|365616501|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
105988587|NCT01736618|365616505|FG000|Overall Study|Death|294|||
105988588|NCT01736618|365616505|FG000|Overall Study|Lost to Follow-up|193|||
105988589|NCT01736618|365616505|FG000|Overall Study|Withdrawal by Subject|54|||
105988590|NCT01736618|365616505|FG000|Overall Study|Subject unable to be followed at study location|223|||
105988591|NCT01736618|365616505|FG000|Overall Study|Physician Decision|33|||
105988592|NCT01736618|365616505|FG000|Overall Study|Transplant or removal of target organ|19|||
105988593|NCT01736618|365616505|FG000|Overall Study|Change in indication or condition|78|||
105988594|NCT01736618|365616505|FG000|Overall Study|Study device explant|103|||
105988595|NCT01736618|365616505|FG000|Overall Study|Unable to complete implant|2|||
105988596|NCT04167137|365616507|FG000|Overall Study|Disease progression|1|||
105988597|NCT04167137|365616508|FG001|Overall Study|Disease progression|1|||
105988598|NCT04167137|365616509|FG002|Overall Study|Disease progression|3|||
105988599|NCT04167137|365616510|FG003|Overall Study|Disease progression|3|||
105988600|NCT04167137|365616511|FG004|Overall Study|Disease progression|2|||
105988601|NCT04167137|365616512|FG005|Overall Study|Disease progression|3|||
105988602|NCT04167137|365616513|FG006|Overall Study|Disease progression|2|||
105988603|NCT04167137|365616514|FG007|Overall Study|Disease progression|2|||
105988604|NCT04167137|365616507|FG000|Overall Study|Withdrawal by Subject|1|||
106097837|NCT02265237|366016444|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
106097838|NCT02265237|366016445|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
106097839|NCT02265237|366016446|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
105988605|NCT04167137|365616508|FG001|Overall Study|Withdrawal by Subject|0|||
106097840|NCT02265237|366016443|FG000|As Treated (Overall Study)|Other|2|||
106097841|NCT02265237|366016444|FG001|As Treated (Overall Study)|Other|0|||
106097842|NCT02265237|366016445|FG002|As Treated (Overall Study)|Other|3|||
106097843|NCT02265237|366016446|FG003|As Treated (Overall Study)|Other|1|||
106097844|NCT01178853|366016449|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
106097845|NCT01178853|366016450|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
106097846|NCT01178853|366016449|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
106097847|NCT01178853|366016450|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
106097848|NCT01178853|366016449|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
106097849|NCT01178853|366016450|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
106097850|NCT01178853|366016449|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
106097851|NCT01178853|366016450|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
106097852|NCT01178853|366016449|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
106097853|NCT01178853|366016450|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
106097854|NCT03550313|366016451|FG000|Overall Study|Adverse Event|0|||
105659652|NCT01010204|364418798|FG001|Overall Study|Lost to Follow-up|2|||
105988606|NCT04167137|365616509|FG002|Overall Study|Withdrawal by Subject|0|||
105988607|NCT04167137|365616510|FG003|Overall Study|Withdrawal by Subject|1|||
105988608|NCT04167137|365616511|FG004|Overall Study|Withdrawal by Subject|0|||
106097855|NCT03550313|366016452|FG001|Overall Study|Adverse Event|1|||
106097856|NCT03550313|366016453|FG002|Overall Study|Adverse Event|0|||
105988609|NCT04167137|365616512|FG005|Overall Study|Withdrawal by Subject|2|||
105988610|NCT04167137|365616513|FG006|Overall Study|Withdrawal by Subject|1|||
105988611|NCT04167137|365616514|FG007|Overall Study|Withdrawal by Subject|0|||
105988612|NCT04167137|365616507|FG000|Overall Study|Adverse Event|0|||
105988613|NCT04167137|365616508|FG001|Overall Study|Adverse Event|0|||
106097857|NCT03550313|366016451|FG000|Overall Study|Lost to Follow-up|5|||
105659653|NCT01010204|364418797|FG000|Overall Study|Adverse Event|1|||
105770110|NCT00804986|364811073|FG000|Overall Study|Lost to Follow-up|0|||
105770111|NCT00804986|364811074|FG001|Overall Study|Lost to Follow-up|0|||
105770112|NCT00804986|364811075|FG002|Overall Study|Lost to Follow-up|0|||
105770113|NCT00804986|364811076|FG003|Overall Study|Lost to Follow-up|1|||
105770114|NCT00804986|364811077|FG004|Overall Study|Lost to Follow-up|1|||
105770115|NCT00804986|364811078|FG005|Overall Study|Lost to Follow-up|3|||
105770116|NCT00804986|364811073|FG000|Overall Study|Protocol Violation|0|||
105770117|NCT00804986|364811074|FG001|Overall Study|Protocol Violation|1|||
105770118|NCT00804986|364811075|FG002|Overall Study|Protocol Violation|0|||
105770119|NCT00804986|364811076|FG003|Overall Study|Protocol Violation|1|||
105770120|NCT00804986|364811077|FG004|Overall Study|Protocol Violation|0|||
105770121|NCT00804986|364811078|FG005|Overall Study|Protocol Violation|0|||
105770122|NCT00804986|364811073|FG000|Overall Study|Withdrawal by Subject|0|||
105770123|NCT00804986|364811074|FG001|Overall Study|Withdrawal by Subject|3|||
105770124|NCT00804986|364811075|FG002|Overall Study|Withdrawal by Subject|0|||
105770125|NCT00804986|364811076|FG003|Overall Study|Withdrawal by Subject|3|||
105770126|NCT00804986|364811077|FG004|Overall Study|Withdrawal by Subject|5|||
105770127|NCT00804986|364811078|FG005|Overall Study|Withdrawal by Subject|3|||
105770128|NCT00804986|364811073|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
105770129|NCT00804986|364811074|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
105770130|NCT00804986|364811075|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
105770131|NCT00804986|364811076|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
105770132|NCT00804986|364811077|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
105770133|NCT00804986|364811078|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
105770134|NCT00804986|364811073|FG000|Overall Study|Sponsor Decision|0|||
105770135|NCT00804986|364811074|FG001|Overall Study|Sponsor Decision|1|||
105770136|NCT00804986|364811075|FG002|Overall Study|Sponsor Decision|0|||
105770137|NCT00804986|364811076|FG003|Overall Study|Sponsor Decision|0|||
105770138|NCT00804986|364811077|FG004|Overall Study|Sponsor Decision|0|||
105770139|NCT00804986|364811078|FG005|Overall Study|Sponsor Decision|0|||
105770140|NCT00804986|364811073|FG000|Overall Study|Physician Decision|1|||
105770141|NCT00804986|364811074|FG001|Overall Study|Physician Decision|0|||
105770142|NCT00804986|364811075|FG002|Overall Study|Physician Decision|0|||
105770143|NCT00804986|364811076|FG003|Overall Study|Physician Decision|0|||
105770144|NCT00804986|364811077|FG004|Overall Study|Physician Decision|0|||
105770145|NCT00804986|364811078|FG005|Overall Study|Physician Decision|0|||
105770146|NCT01602744|364811079|FG000|Overall Study|Death|17|||
105770147|NCT01602744|364811080|FG001|Overall Study|Death|15|||
105770148|NCT01602744|364811079|FG000|Overall Study|Lost to Follow-up|13|||
105770149|NCT01602744|364811080|FG001|Overall Study|Lost to Follow-up|8|||
105770150|NCT00959699|364811085|FG000|Treatment Period|Adverse Event|3|||
105770151|NCT00959699|364811086|FG001|Treatment Period|Adverse Event|13|||
105770152|NCT00959699|364811085|FG000|Treatment Period|Lack of Efficacy|15|||
105770153|NCT00959699|364811086|FG001|Treatment Period|Lack of Efficacy|6|||
105770154|NCT00959699|364811085|FG000|Treatment Period|Lost to Follow-up|0|||
105770155|NCT00959699|364811086|FG001|Treatment Period|Lost to Follow-up|1|||
105770156|NCT00959699|364811085|FG000|Treatment Period|Withdrawal by Subject|1|||
105770157|NCT00959699|364811086|FG001|Treatment Period|Withdrawal by Subject|3|||
105770158|NCT00959699|364811085|FG000|Treatment Period|Non-Compliance with Protocol|0|||
105770159|NCT00959699|364811086|FG001|Treatment Period|Non-Compliance with Protocol|1|||
105770160|NCT00959699|364811085|FG000|Treatment Period|Did not receive treatment|0|||
105770161|NCT00959699|364811086|FG001|Treatment Period|Did not receive treatment|1|||
105770162|NCT00959699|364811085|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
105770163|NCT00959699|364811086|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
105770164|NCT00959699|364811085|FG000|Follow-up Period|Lost to Follow-up|3|||
105770165|NCT00959699|364811086|FG001|Follow-up Period|Lost to Follow-up|2|||
105770166|NCT00959699|364811085|FG000|Follow-up Period|Withdrawal by Subject|3|||
105770167|NCT00959699|364811086|FG001|Follow-up Period|Withdrawal by Subject|4|||
105770168|NCT00606294|364811091|FG000|Overall Study|Withdrawal by Subject|36|||
105770169|NCT00606294|364811092|FG001|Overall Study|Withdrawal by Subject|0|||
105770170|NCT01387594|364811094|FG000|Overall Study|Withdrawal by Subject|0|||
105770171|NCT01387594|364811095|FG001|Overall Study|Withdrawal by Subject|2|||
105770172|NCT01387594|364811094|FG000|Overall Study|Lost to Follow-up|0|||
105770173|NCT01387594|364811095|FG001|Overall Study|Lost to Follow-up|1|||
105770174|NCT02332876|364811096|FG000|Overall Study|Lost to Follow-up|1|||
105770175|NCT02332876|364811097|FG001|Overall Study|Lost to Follow-up|1|||
105770176|NCT00471315|364811100|FG000|Overall Study|Adverse Event|7|||
105770177|NCT00471315|364811100|FG000|Overall Study|Withdrawal by Subject|1|||
105770178|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
105770179|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
105770180|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
105770181|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105770182|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
105770183|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105770184|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
106097858|NCT03550313|366016452|FG001|Overall Study|Lost to Follow-up|7|||
106097859|NCT03550313|366016453|FG002|Overall Study|Lost to Follow-up|12|||
106097860|NCT03550313|366016451|FG000|Overall Study|Study terminated by sponsor|44|||
106097861|NCT03550313|366016452|FG001|Overall Study|Study terminated by sponsor|37|||
105770185|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105770186|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
105770187|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
105770188|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105770189|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105770190|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
105770191|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
105770192|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
105770193|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
105770194|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
105770195|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
105770196|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
105770197|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
105770198|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
105770199|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
105770200|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
105770201|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
105770202|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Screen failure|0|||
105770203|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Screen failure|1|||
105770204|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Screen failure|2|||
105770205|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Screen failure|0|||
105770206|NCT02614261|364811101|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
105770207|NCT02614261|364811102|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
105770208|NCT02614261|364811103|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
105770209|NCT02614261|364811104|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105770210|NCT02614261|364811101|FG000|Open-Label Extension Phase|Adverse Event|23|||
106097862|NCT03550313|366016453|FG002|Overall Study|Study terminated by sponsor|48|||
106097863|NCT03550313|366016451|FG000|Overall Study|No longer met eligibility criteria|3|||
106097864|NCT03550313|366016452|FG001|Overall Study|No longer met eligibility criteria|5|||
106097865|NCT03550313|366016453|FG002|Overall Study|No longer met eligibility criteria|6|||
105770211|NCT02614261|364811102|FG001|Open-Label Extension Phase|Adverse Event|12|||
105770212|NCT02614261|364811103|FG002|Open-Label Extension Phase|Adverse Event|11|||
105770213|NCT02614261|364811104|FG003|Open-Label Extension Phase|Adverse Event|0|||
106097866|NCT03550313|366016451|FG000|Overall Study|Withdrawal by parent/guardian|20|||
106097867|NCT03550313|366016452|FG001|Overall Study|Withdrawal by parent/guardian|18|||
106097868|NCT03550313|366016453|FG002|Overall Study|Withdrawal by parent/guardian|26|||
106097869|NCT03550313|366016451|FG000|Overall Study|Other|4|||
106097870|NCT03550313|366016452|FG001|Overall Study|Other|2|||
106097871|NCT03550313|366016453|FG002|Overall Study|Other|2|||
106097872|NCT03550313|366016451|FG000|Overall Study|Randomized but not vaccinated|3|||
106097873|NCT03550313|366016452|FG001|Overall Study|Randomized but not vaccinated|23|||
106097874|NCT03550313|366016453|FG002|Overall Study|Randomized but not vaccinated|2|||
106097875|NCT03550313|366016451|FG000|Overall Study|Sites terminated due to quality issues|18|||
106097876|NCT03550313|366016452|FG001|Overall Study|Sites terminated due to quality issues|17|||
106097877|NCT03550313|366016453|FG002|Overall Study|Sites terminated due to quality issues|18|||
106097878|NCT00839072|366016454|FG000|First Intervention Period|Withdrawal by Subject|1|||
106097879|NCT00839072|366016455|FG001|First Intervention Period|Withdrawal by Subject|0|||
106097880|NCT00839072|366016454|FG000|First Intervention Period|Adverse Event|1|||
106097881|NCT00839072|366016455|FG001|First Intervention Period|Adverse Event|1|||
106097882|NCT00839072|366016454|FG000|Second Intervention Period|Withdrawal by Subject|1|||
106097883|NCT00839072|366016455|FG001|Second Intervention Period|Withdrawal by Subject|0|||
106097884|NCT01458574|366016456|FG000|Overall Study|Adverse Event|5|||
106097885|NCT01458574|366016457|FG001|Overall Study|Adverse Event|9|||
106097886|NCT01458574|366016458|FG002|Overall Study|Adverse Event|7|||
106097887|NCT01458574|366016456|FG000|Overall Study|Lack of Efficacy|70|||
106097888|NCT01458574|366016457|FG001|Overall Study|Lack of Efficacy|53|||
106097889|NCT01458574|366016458|FG002|Overall Study|Lack of Efficacy|132|||
106097890|NCT01458574|366016456|FG000|Overall Study|Lost to Follow-up|3|||
106097891|NCT01458574|366016457|FG001|Overall Study|Lost to Follow-up|2|||
106097892|NCT01458574|366016458|FG002|Overall Study|Lost to Follow-up|1|||
106097893|NCT01458574|366016456|FG000|Overall Study|Pregnancy|1|||
105659654|NCT01010204|364418798|FG001|Overall Study|Adverse Event|3|||
105770214|NCT02614261|364811101|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
106097894|NCT01458574|366016457|FG001|Overall Study|Pregnancy|1|||
106097895|NCT01458574|366016458|FG002|Overall Study|Pregnancy|0|||
106097896|NCT01458574|366016456|FG000|Overall Study|Protocol Violation|0|||
105770215|NCT02614261|364811102|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
105878750|NCT01120184|365209742|FG000|Overall Study|Adverse Event|0|||
106097897|NCT01458574|366016457|FG001|Overall Study|Protocol Violation|1|||
106097898|NCT01458574|366016458|FG002|Overall Study|Protocol Violation|0|||
105659655|NCT01010204|364418797|FG000|Overall Study|Withdrawal by Subject|2|||
105659656|NCT01010204|364418798|FG001|Overall Study|Withdrawal by Subject|3|||
105659657|NCT01010204|364418797|FG000|Overall Study|psychiatric hospitalization|2|||
105770216|NCT02614261|364811103|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
105770217|NCT02614261|364811104|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
105770218|NCT02614261|364811101|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
105770219|NCT02614261|364811102|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
105770220|NCT02614261|364811103|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
105770221|NCT02614261|364811104|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
105770222|NCT02614261|364811101|FG000|Open-Label Extension Phase|Physician Decision|2|||
105770223|NCT02614261|364811102|FG001|Open-Label Extension Phase|Physician Decision|0|||
105770224|NCT02614261|364811103|FG002|Open-Label Extension Phase|Physician Decision|0|||
105770225|NCT02614261|364811104|FG003|Open-Label Extension Phase|Physician Decision|0|||
105770226|NCT02614261|364811101|FG000|Open-Label Extension Phase|Pregnancy|1|||
105770227|NCT02614261|364811102|FG001|Open-Label Extension Phase|Pregnancy|2|||
105770228|NCT02614261|364811103|FG002|Open-Label Extension Phase|Pregnancy|1|||
105770229|NCT02614261|364811104|FG003|Open-Label Extension Phase|Pregnancy|0|||
105770230|NCT02614261|364811101|FG000|Open-Label Extension Phase|Protocol Violation|3|||
105770231|NCT02614261|364811102|FG001|Open-Label Extension Phase|Protocol Violation|4|||
105770232|NCT02614261|364811103|FG002|Open-Label Extension Phase|Protocol Violation|1|||
105770233|NCT02614261|364811104|FG003|Open-Label Extension Phase|Protocol Violation|0|||
105770234|NCT02614261|364811101|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
105770235|NCT02614261|364811102|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
105770236|NCT02614261|364811103|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
105770237|NCT02614261|364811104|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
105770238|NCT02614261|364811101|FG000|Follow-up Phase|Adverse Event|2|||
105770239|NCT02614261|364811102|FG001|Follow-up Phase|Adverse Event|0|||
105770240|NCT02614261|364811103|FG002|Follow-up Phase|Adverse Event|1|||
105770241|NCT02614261|364811104|FG003|Follow-up Phase|Adverse Event|0|||
105770242|NCT02614261|364811101|FG000|Follow-up Phase|Lost to Follow-up|12|||
105770243|NCT02614261|364811102|FG001|Follow-up Phase|Lost to Follow-up|5|||
105770244|NCT02614261|364811103|FG002|Follow-up Phase|Lost to Follow-up|2|||
105770245|NCT02614261|364811104|FG003|Follow-up Phase|Lost to Follow-up|0|||
105770246|NCT02614261|364811101|FG000|Follow-up Phase|Physician Decision|5|||
105770247|NCT02614261|364811102|FG001|Follow-up Phase|Physician Decision|1|||
105770248|NCT02614261|364811103|FG002|Follow-up Phase|Physician Decision|0|||
105770249|NCT02614261|364811104|FG003|Follow-up Phase|Physician Decision|0|||
105770250|NCT02614261|364811101|FG000|Follow-up Phase|Pregnancy|0|||
105770251|NCT02614261|364811102|FG001|Follow-up Phase|Pregnancy|1|||
105770252|NCT02614261|364811103|FG002|Follow-up Phase|Pregnancy|0|||
105770253|NCT02614261|364811104|FG003|Follow-up Phase|Pregnancy|0|||
105770254|NCT02614261|364811101|FG000|Follow-up Phase|Protocol Violation|1|||
105770255|NCT02614261|364811102|FG001|Follow-up Phase|Protocol Violation|0|||
105770256|NCT02614261|364811103|FG002|Follow-up Phase|Protocol Violation|0|||
105770257|NCT02614261|364811104|FG003|Follow-up Phase|Protocol Violation|0|||
105770258|NCT02614261|364811101|FG000|Follow-up Phase|Withdrawal by Subject|12|||
105770259|NCT02614261|364811102|FG001|Follow-up Phase|Withdrawal by Subject|4|||
105770260|NCT02614261|364811103|FG002|Follow-up Phase|Withdrawal by Subject|11|||
105770261|NCT02614261|364811104|FG003|Follow-up Phase|Withdrawal by Subject|0|||
105770262|NCT02614261|364811101|FG000|Israel Addendum|Withdrawal by Subject|0|||
105770263|NCT02614261|364811102|FG001|Israel Addendum|Withdrawal by Subject|0|||
105770264|NCT02614261|364811103|FG002|Israel Addendum|Withdrawal by Subject|0|||
105770265|NCT02614261|364811104|FG003|Israel Addendum|Withdrawal by Subject|4|||
105770266|NCT03860844|364811106|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
105770267|NCT03860844|364811107|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
105770268|NCT03860844|364811108|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
105770269|NCT03860844|364811106|FG000|Overall Study|Progressive disease|5|||
105770270|NCT03860844|364811107|FG001|Overall Study|Progressive disease|3|||
105770271|NCT03860844|364811108|FG002|Overall Study|Progressive disease|4|||
105770272|NCT03860844|364811106|FG000|Overall Study|Other, Not related to COVID-19|0|||
105988614|NCT04167137|365616509|FG002|Overall Study|Adverse Event|0|||
105988615|NCT04167137|365616510|FG003|Overall Study|Adverse Event|0|||
105988616|NCT04167137|365616511|FG004|Overall Study|Adverse Event|0|||
105988617|NCT04167137|365616512|FG005|Overall Study|Adverse Event|1|||
105988618|NCT04167137|365616513|FG006|Overall Study|Adverse Event|0|||
105988619|NCT04167137|365616514|FG007|Overall Study|Adverse Event|1|||
105988620|NCT04167137|365616507|FG000|Overall Study|Physician Decision|0|||
105988621|NCT04167137|365616508|FG001|Overall Study|Physician Decision|0|||
105988622|NCT04167137|365616509|FG002|Overall Study|Physician Decision|0|||
105988623|NCT04167137|365616510|FG003|Overall Study|Physician Decision|1|||
105988624|NCT04167137|365616511|FG004|Overall Study|Physician Decision|0|||
105988625|NCT04167137|365616512|FG005|Overall Study|Physician Decision|0|||
105770273|NCT03860844|364811107|FG001|Overall Study|Other, Not related to COVID-19|1|||
105770274|NCT03860844|364811108|FG002|Overall Study|Other, Not related to COVID-19|0|||
105988626|NCT04167137|365616513|FG006|Overall Study|Physician Decision|1|||
106097899|NCT01458574|366016456|FG000|Overall Study|Withdrawal by Subject|6|||
106097900|NCT01458574|366016457|FG001|Overall Study|Withdrawal by Subject|3|||
106097901|NCT01458574|366016458|FG002|Overall Study|Withdrawal by Subject|5|||
106097902|NCT01458574|366016456|FG000|Overall Study|Other|2|||
106097903|NCT01458574|366016457|FG001|Overall Study|Other|1|||
106097904|NCT01458574|366016458|FG002|Overall Study|Other|0|||
106097905|NCT01458574|366016456|FG000|Overall Study|Randomized but not treated|0|||
106097906|NCT01458574|366016457|FG001|Overall Study|Randomized but not treated|1|||
106097907|NCT01458574|366016458|FG002|Overall Study|Randomized but not treated|0|||
106097908|NCT02125786|366016459|FG000|Overall Study|Still in Follow-up|3|||
106097909|NCT02125786|366016459|FG000|Overall Study|Screen Failure|2|||
105988627|NCT04167137|365616514|FG007|Overall Study|Physician Decision|0|||
105988628|NCT04167137|365616507|FG000|Overall Study|Death|0|||
105988629|NCT04167137|365616508|FG001|Overall Study|Death|1|||
105988630|NCT04167137|365616509|FG002|Overall Study|Death|0|||
105988631|NCT04167137|365616510|FG003|Overall Study|Death|0|||
105988632|NCT04167137|365616511|FG004|Overall Study|Death|0|||
106097910|NCT02125786|366016459|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
105770275|NCT03512275|364811109|FG000|Overall Study|Withdrawal by Subject|1|||
105770276|NCT03512275|364811110|FG001|Overall Study|Withdrawal by Subject|3|||
105770277|NCT03512275|364811109|FG000|Overall Study|Physician Decision|0|||
105770278|NCT03512275|364811110|FG001|Overall Study|Physician Decision|1|||
105770279|NCT03512275|364811109|FG000|Overall Study|Lost to Follow-up|0|||
105770280|NCT03512275|364811110|FG001|Overall Study|Lost to Follow-up|3|||
105770281|NCT03512275|364811109|FG000|Overall Study|Other|1|||
105770282|NCT03512275|364811110|FG001|Overall Study|Other|0|||
105770283|NCT03073200|364811111|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105770284|NCT03073200|364811112|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105770285|NCT03073200|364811113|FG002|Double Blind Treatment Period|Protocol Violation|0|||
105770286|NCT03073200|364811114|FG003|Double Blind Treatment Period|Protocol Violation|0|||
105770287|NCT03073200|364811115|FG004|Double Blind Treatment Period|Protocol Violation|0|||
105770288|NCT03073200|364811116|FG005|Double Blind Treatment Period|Protocol Violation|0|||
105770289|NCT03073200|364811117|FG006|Double Blind Treatment Period|Protocol Violation|0|||
105770290|NCT03073200|364811118|FG007|Double Blind Treatment Period|Protocol Violation|0|||
105770291|NCT03073200|364811119|FG008|Double Blind Treatment Period|Protocol Violation|0|||
105770292|NCT03073200|364811120|FG009|Double Blind Treatment Period|Protocol Violation|0|||
105770293|NCT03073200|364811121|FG010|Double Blind Treatment Period|Protocol Violation|0|||
105770294|NCT03073200|364811122|FG011|Double Blind Treatment Period|Protocol Violation|0|||
105770295|NCT03073200|364811123|FG012|Double Blind Treatment Period|Protocol Violation|0|||
105770296|NCT03073200|364811124|FG013|Double Blind Treatment Period|Protocol Violation|0|||
105770297|NCT03073200|364811125|FG014|Double Blind Treatment Period|Protocol Violation|0|||
105770298|NCT03073200|364811111|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770299|NCT03073200|364811112|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
105770300|NCT03073200|364811113|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770301|NCT03073200|364811114|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770302|NCT03073200|364811115|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770303|NCT03073200|364811116|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770304|NCT03073200|364811117|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770305|NCT03073200|364811118|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770306|NCT03073200|364811119|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770307|NCT03073200|364811120|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770308|NCT03073200|364811121|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770309|NCT03073200|364811122|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770310|NCT03073200|364811123|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770311|NCT03073200|364811124|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770312|NCT03073200|364811125|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
105770313|NCT03073200|364811111|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
105770314|NCT03073200|364811112|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
105988633|NCT04167137|365616512|FG005|Overall Study|Death|0|||
105988634|NCT04167137|365616513|FG006|Overall Study|Death|0|||
105988635|NCT04167137|365616514|FG007|Overall Study|Death|0|||
105988636|NCT04167137|365616507|FG000|Overall Study|Study terminated by Sponsor|0|||
105988637|NCT04167137|365616508|FG001|Overall Study|Study terminated by Sponsor|0|||
105770315|NCT03073200|364811113|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770316|NCT03073200|364811114|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770317|NCT03073200|364811115|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770318|NCT03073200|364811116|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
105988638|NCT04167137|365616509|FG002|Overall Study|Study terminated by Sponsor|0|||
105988639|NCT04167137|365616510|FG003|Overall Study|Study terminated by Sponsor|0|||
106097911|NCT02125786|366016459|FG000|Overall Study|Progressive Disease|44|||
106097912|NCT02125786|366016459|FG000|Overall Study|Death|8|||
106097913|NCT04782323|366016460|FG000|Overall Study|Death|1|||
106097914|NCT04782323|366016461|FG001|Overall Study|Death|0|||
105770319|NCT03073200|364811117|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770320|NCT03073200|364811118|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770321|NCT03073200|364811119|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770322|NCT03073200|364811120|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770323|NCT03073200|364811121|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770324|NCT03073200|364811122|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770325|NCT03073200|364811123|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770326|NCT03073200|364811124|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770327|NCT03073200|364811125|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
105770328|NCT03073200|364811111|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770329|NCT03073200|364811112|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770330|NCT03073200|364811113|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770331|NCT03073200|364811114|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
105770332|NCT03073200|364811115|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
105770333|NCT03073200|364811116|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770334|NCT03073200|364811117|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770335|NCT03073200|364811118|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770336|NCT03073200|364811119|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770337|NCT03073200|364811120|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770338|NCT03073200|364811121|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770339|NCT03073200|364811122|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770340|NCT03073200|364811123|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770341|NCT03073200|364811124|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770342|NCT03073200|364811125|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
105770343|NCT03073200|364811111|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
105770344|NCT03073200|364811112|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
105770345|NCT03073200|364811113|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
105770346|NCT03073200|364811114|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
105770347|NCT03073200|364811115|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
105770348|NCT03073200|364811116|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
105770349|NCT03073200|364811117|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
105770350|NCT03073200|364811118|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
105988640|NCT04167137|365616511|FG004|Overall Study|Study terminated by Sponsor|0|||
105988641|NCT04167137|365616512|FG005|Overall Study|Study terminated by Sponsor|0|||
105770351|NCT03073200|364811119|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
105770352|NCT03073200|364811120|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
105770353|NCT03073200|364811121|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
105770354|NCT03073200|364811122|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
105770355|NCT03073200|364811123|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
105770356|NCT03073200|364811124|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
105770357|NCT03073200|364811125|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
105770358|NCT03073200|364811111|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770359|NCT03073200|364811112|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770360|NCT03073200|364811113|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770361|NCT03073200|364811114|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770362|NCT03073200|364811115|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
105770363|NCT03073200|364811116|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770364|NCT03073200|364811117|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770365|NCT03073200|364811118|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770366|NCT03073200|364811119|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770367|NCT03073200|364811120|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770368|NCT03073200|364811121|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770369|NCT03073200|364811122|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770370|NCT03073200|364811123|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770371|NCT03073200|364811124|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770372|NCT03073200|364811125|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
105770373|NCT03073200|364811111|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770374|NCT03073200|364811112|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770375|NCT03073200|364811113|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770376|NCT03073200|364811114|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
105770377|NCT03073200|364811115|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
105770378|NCT03073200|364811116|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770379|NCT03073200|364811117|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105988642|NCT04167137|365616513|FG006|Overall Study|Study terminated by Sponsor|0|||
106097915|NCT04782323|366016462|FG002|Overall Study|Death|0|||
105770380|NCT03073200|364811118|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770381|NCT03073200|364811119|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770382|NCT03073200|364811120|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770383|NCT03073200|364811121|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770384|NCT03073200|364811122|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770385|NCT03073200|364811123|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770386|NCT03073200|364811124|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770387|NCT03073200|364811125|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
105770388|NCT03073200|364811111|FG000|Extension Period|Lost to Follow-up|0|||
105770389|NCT03073200|364811112|FG001|Extension Period|Lost to Follow-up|0|||
105770390|NCT03073200|364811113|FG002|Extension Period|Lost to Follow-up|0|||
105770391|NCT03073200|364811114|FG003|Extension Period|Lost to Follow-up|0|||
105770392|NCT03073200|364811115|FG004|Extension Period|Lost to Follow-up|0|||
105770393|NCT03073200|364811116|FG005|Extension Period|Lost to Follow-up|0|||
105770394|NCT03073200|364811117|FG006|Extension Period|Lost to Follow-up|1|||
105770395|NCT03073200|364811118|FG007|Extension Period|Lost to Follow-up|1|||
105770396|NCT03073200|364811119|FG008|Extension Period|Lost to Follow-up|0|||
105770397|NCT03073200|364811120|FG009|Extension Period|Lost to Follow-up|0|||
105770398|NCT03073200|364811121|FG010|Extension Period|Lost to Follow-up|0|||
105770399|NCT03073200|364811122|FG011|Extension Period|Lost to Follow-up|0|||
105770400|NCT03073200|364811123|FG012|Extension Period|Lost to Follow-up|0|||
105770401|NCT03073200|364811124|FG013|Extension Period|Lost to Follow-up|0|||
105770402|NCT03073200|364811125|FG014|Extension Period|Lost to Follow-up|0|||
105770403|NCT03073200|364811111|FG000|Extension Period|Sponsor Decision|0|||
105770404|NCT03073200|364811112|FG001|Extension Period|Sponsor Decision|0|||
105770405|NCT03073200|364811113|FG002|Extension Period|Sponsor Decision|0|||
105770406|NCT03073200|364811114|FG003|Extension Period|Sponsor Decision|0|||
105770407|NCT03073200|364811115|FG004|Extension Period|Sponsor Decision|0|||
105770408|NCT03073200|364811116|FG005|Extension Period|Sponsor Decision|0|||
105770409|NCT03073200|364811117|FG006|Extension Period|Sponsor Decision|0|||
105770410|NCT03073200|364811118|FG007|Extension Period|Sponsor Decision|0|||
105770411|NCT03073200|364811119|FG008|Extension Period|Sponsor Decision|1|||
105770412|NCT03073200|364811120|FG009|Extension Period|Sponsor Decision|0|||
105770413|NCT03073200|364811121|FG010|Extension Period|Sponsor Decision|0|||
105770414|NCT03073200|364811122|FG011|Extension Period|Sponsor Decision|0|||
105770415|NCT03073200|364811123|FG012|Extension Period|Sponsor Decision|0|||
105770416|NCT03073200|364811124|FG013|Extension Period|Sponsor Decision|0|||
105770417|NCT03073200|364811125|FG014|Extension Period|Sponsor Decision|0|||
105770418|NCT03073200|364811111|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
105770419|NCT03073200|364811112|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
105770420|NCT03073200|364811113|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
105770421|NCT03073200|364811114|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
105770422|NCT03073200|364811115|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
105770423|NCT03073200|364811116|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
105770424|NCT03073200|364811117|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
105770425|NCT03073200|364811118|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
105770426|NCT03073200|364811119|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
105770427|NCT03073200|364811120|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
105770428|NCT03073200|364811121|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
105770429|NCT03073200|364811122|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
105770430|NCT03073200|364811123|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
105770431|NCT03073200|364811124|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
105770432|NCT03073200|364811125|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
105770433|NCT03073200|364811111|FG000|Extension Period|Withdrawal by Subject|0|||
105988643|NCT04167137|365616514|FG007|Overall Study|Study terminated by Sponsor|1|||
105988644|NCT01431963|365616518|FG000|Overall Study|Adverse Event|18|||
105770434|NCT03073200|364811112|FG001|Extension Period|Withdrawal by Subject|0|||
105770435|NCT03073200|364811113|FG002|Extension Period|Withdrawal by Subject|0|||
105770436|NCT03073200|364811114|FG003|Extension Period|Withdrawal by Subject|0|||
105770437|NCT03073200|364811115|FG004|Extension Period|Withdrawal by Subject|0|||
105770438|NCT03073200|364811116|FG005|Extension Period|Withdrawal by Subject|0|||
105770439|NCT03073200|364811117|FG006|Extension Period|Withdrawal by Subject|1|||
105770440|NCT03073200|364811118|FG007|Extension Period|Withdrawal by Subject|2|||
105988645|NCT01431963|365616518|FG000|Overall Study|Lack of Efficacy|7|||
105988646|NCT01431963|365616518|FG000|Overall Study|Protocol Violation|1|||
105770441|NCT03073200|364811119|FG008|Extension Period|Withdrawal by Subject|0|||
105770442|NCT03073200|364811120|FG009|Extension Period|Withdrawal by Subject|0|||
105770443|NCT03073200|364811121|FG010|Extension Period|Withdrawal by Subject|0|||
105770444|NCT03073200|364811122|FG011|Extension Period|Withdrawal by Subject|0|||
105770445|NCT03073200|364811123|FG012|Extension Period|Withdrawal by Subject|0|||
105770446|NCT03073200|364811124|FG013|Extension Period|Withdrawal by Subject|0|||
105770447|NCT03073200|364811125|FG014|Extension Period|Withdrawal by Subject|0|||
105770448|NCT03073200|364811111|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770449|NCT03073200|364811112|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770450|NCT03073200|364811113|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770451|NCT03073200|364811114|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770452|NCT03073200|364811115|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770453|NCT03073200|364811116|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770454|NCT03073200|364811117|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770455|NCT03073200|364811118|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770456|NCT03073200|364811119|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770457|NCT03073200|364811120|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770458|NCT03073200|364811121|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770459|NCT03073200|364811122|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
105770460|NCT03073200|364811123|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770461|NCT03073200|364811124|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770462|NCT03073200|364811125|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
105770463|NCT03073200|364811111|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770464|NCT03073200|364811112|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770465|NCT03073200|364811113|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770466|NCT03073200|364811114|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770467|NCT03073200|364811115|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770468|NCT03073200|364811116|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770469|NCT03073200|364811117|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770470|NCT03073200|364811118|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770471|NCT03073200|364811119|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770472|NCT03073200|364811120|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770473|NCT03073200|364811121|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770474|NCT03073200|364811122|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
105770475|NCT03073200|364811123|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770476|NCT03073200|364811124|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770477|NCT03073200|364811125|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
105770478|NCT03073200|364811111|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770479|NCT03073200|364811112|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770480|NCT03073200|364811113|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770481|NCT03073200|364811114|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770482|NCT03073200|364811115|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770483|NCT03073200|364811116|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770484|NCT03073200|364811117|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770485|NCT03073200|364811118|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770486|NCT03073200|364811119|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770487|NCT03073200|364811120|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770488|NCT03073200|364811121|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
105770489|NCT03073200|364811122|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
105770490|NCT03073200|364811123|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770491|NCT03073200|364811124|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770492|NCT03073200|364811125|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105770493|NCT03073200|364811111|FG000|Randomized Withdrawal Period|Adverse Event|0|||
105770494|NCT03073200|364811112|FG001|Randomized Withdrawal Period|Adverse Event|0|||
105770495|NCT03073200|364811113|FG002|Randomized Withdrawal Period|Adverse Event|0|||
105770496|NCT03073200|364811114|FG003|Randomized Withdrawal Period|Adverse Event|0|||
105770497|NCT03073200|364811115|FG004|Randomized Withdrawal Period|Adverse Event|0|||
105770498|NCT03073200|364811116|FG005|Randomized Withdrawal Period|Adverse Event|0|||
105770499|NCT03073200|364811117|FG006|Randomized Withdrawal Period|Adverse Event|0|||
105770500|NCT03073200|364811118|FG007|Randomized Withdrawal Period|Adverse Event|0|||
105770501|NCT03073200|364811119|FG008|Randomized Withdrawal Period|Adverse Event|0|||
105770502|NCT03073200|364811120|FG009|Randomized Withdrawal Period|Adverse Event|0|||
105770503|NCT03073200|364811121|FG010|Randomized Withdrawal Period|Adverse Event|1|||
105770504|NCT03073200|364811122|FG011|Randomized Withdrawal Period|Adverse Event|0|||
105770505|NCT03073200|364811123|FG012|Randomized Withdrawal Period|Adverse Event|0|||
105770506|NCT03073200|364811124|FG013|Randomized Withdrawal Period|Adverse Event|0|||
105770507|NCT03073200|364811125|FG014|Randomized Withdrawal Period|Adverse Event|0|||
105770508|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770509|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770510|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770511|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770512|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770513|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770514|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770515|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
105988647|NCT01431963|365616518|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
105770516|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770517|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770518|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770519|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770520|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770521|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
105770522|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
105770523|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770524|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770525|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770526|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770527|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770528|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770529|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770530|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770531|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770532|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770533|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770534|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105988648|NCT01431963|365616518|FG000|Overall Study|Physician Decision|4|||
105988649|NCT01431963|365616518|FG000|Overall Study|Withdrawal by Subject|3|||
105988650|NCT03369236|365616519|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
105988651|NCT03369236|365616520|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
105988652|NCT03369236|365616519|FG000|Open-label Extension Period|Lack of Efficacy|2|||
105988653|NCT03369236|365616520|FG001|Open-label Extension Period|Lack of Efficacy|1|||
105988654|NCT03369236|365616519|FG000|Open-label Extension Period|Adverse Event|0|||
105988655|NCT03369236|365616520|FG001|Open-label Extension Period|Adverse Event|1|||
105988656|NCT03369236|365616519|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
105988657|NCT03369236|365616520|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
105988658|NCT04230213|365616522|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
105988659|NCT04230213|365616523|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
105988660|NCT04230213|365616524|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
105988661|NCT04230213|365616522|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
105988662|NCT04230213|365616523|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
105988663|NCT04230213|365616524|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
105988664|NCT04230213|365616522|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
105988665|NCT04230213|365616523|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
105988666|NCT04230213|365616524|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
105988667|NCT04230213|365616522|FG000|TP2: Week 10 to Week 16|Other|0|||
105770535|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770536|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
105988668|NCT04230213|365616523|FG001|TP2: Week 10 to Week 16|Other|2|||
105988669|NCT04230213|365616524|FG002|TP2: Week 10 to Week 16|Other|1|||
105988670|NCT04230213|365616522|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
105988671|NCT04230213|365616523|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
105988672|NCT04230213|365616524|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
105988673|NCT04230213|365616522|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
105988674|NCT04230213|365616523|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
105988675|NCT04230213|365616524|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
105988676|NCT04230213|365616522|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
105988677|NCT04230213|365616523|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
105988678|NCT04230213|365616524|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
105988679|NCT04230213|365616522|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
105988680|NCT04230213|365616523|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
105988681|NCT04230213|365616524|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
105988682|NCT04230213|365616522|FG000|TP3: Week 16 to Week 22|Other|0|||
105770537|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105770538|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770539|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105988683|NCT04230213|365616523|FG001|TP3: Week 16 to Week 22|Other|1|||
105988684|NCT04230213|365616524|FG002|TP3: Week 16 to Week 22|Other|3|||
105988685|NCT04230213|365616522|FG000|TP4: Week 22 to Week 32|Other|0|||
105770540|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770541|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770542|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770543|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105659658|NCT01010204|364418798|FG001|Overall Study|psychiatric hospitalization|1|||
105770544|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105806432|NCT01464827|364948985|FG004|Overall Study|Lost to Follow-up|3|||
105988686|NCT04230213|365616523|FG001|TP4: Week 22 to Week 32|Other|5|||
105988687|NCT04230213|365616524|FG002|TP4: Week 22 to Week 32|Other|5|||
105988688|NCT04230213|365616522|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
105988689|NCT04230213|365616523|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
105988690|NCT04230213|365616524|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
105988691|NCT04230213|365616522|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
105988692|NCT04230213|365616523|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
105988693|NCT04230213|365616524|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
105988694|NCT04230213|365616522|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
105988695|NCT04230213|365616523|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
105988696|NCT04230213|365616524|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
105988697|NCT04230213|365616522|FG000|Follow up: Week 32 to Week 36|Other|0|||
105988698|NCT04230213|365616523|FG001|Follow up: Week 32 to Week 36|Other|1|||
105988699|NCT04230213|365616524|FG002|Follow up: Week 32 to Week 36|Other|1|||
105988700|NCT01769196|365617867|FG000|Overall Study|Adverse Event|24|||
105988701|NCT01769196|365617868|FG001|Overall Study|Adverse Event|20|||
105988702|NCT01769196|365617867|FG000|Overall Study|Death|21|||
105988703|NCT01769196|365617868|FG001|Overall Study|Death|26|||
105988704|NCT01769196|365617867|FG000|Overall Study|Investigator Discretion|7|||
105988705|NCT01769196|365617868|FG001|Overall Study|Investigator Discretion|3|||
105988706|NCT01769196|365617867|FG000|Overall Study|Lack of Efficacy|3|||
105988707|NCT01769196|365617868|FG001|Overall Study|Lack of Efficacy|2|||
105988708|NCT01769196|365617867|FG000|Overall Study|Progressive disease|11|||
105988709|NCT01769196|365617868|FG001|Overall Study|Progressive disease|6|||
105988710|NCT01769196|365617867|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
105988711|NCT01769196|365617868|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
105988712|NCT01769196|365617867|FG000|Overall Study|Protocol Violation|0|||
105988713|NCT01769196|365617868|FG001|Overall Study|Protocol Violation|3|||
105988714|NCT01769196|365617867|FG000|Overall Study|Study terminated by sponsor|160|||
105988715|NCT01769196|365617868|FG001|Overall Study|Study terminated by sponsor|161|||
105988716|NCT01769196|365617867|FG000|Overall Study|Participant never dosed with study drug|1|||
105988717|NCT01769196|365617868|FG001|Overall Study|Participant never dosed with study drug|0|||
105988718|NCT01769196|365617867|FG000|Overall Study|Withdrew consent|36|||
105988719|NCT01769196|365617868|FG001|Overall Study|Withdrew consent|40|||
105988720|NCT00742417|365617869|FG000|Randomized|Withdrawal by legal representative|0|||
105988721|NCT00742417|365617870|FG001|Randomized|Withdrawal by legal representative|1|||
105988722|NCT00742417|365617869|FG000|Randomized|Withdrawal by Subject|1|||
105988723|NCT00742417|365617870|FG001|Randomized|Withdrawal by Subject|0|||
105988724|NCT00742417|365617869|FG000|Randomized|Physician Decision|1|||
105659659|NCT00243022|364418800|FG000|Overall Study|Withdrawal by Subject|1|||
105659660|NCT00243022|364418801|FG001|Overall Study|Withdrawal by Subject|0|||
105659661|NCT00243022|364418800|FG000|Overall Study|Death|1|||
105659662|NCT00243022|364418801|FG001|Overall Study|Death|0|||
105659663|NCT00243022|364418800|FG000|Overall Study|Difficult Travel Distance|0|||
105659664|NCT00243022|364418801|FG001|Overall Study|Difficult Travel Distance|1|||
105659665|NCT00723125|364418802|FG000|Overall Study|Met Dx|1|||
105659666|NCT00723125|364418803|FG001|Overall Study|Met Dx|0|||
105659667|NCT00723125|364418802|FG000|Overall Study|Withdrawal by Subject|15|||
105659668|NCT00723125|364418803|FG001|Overall Study|Withdrawal by Subject|6|||
105659669|NCT00723125|364418802|FG000|Overall Study|Adverse Event|2|||
105659670|NCT00723125|364418803|FG001|Overall Study|Adverse Event|0|||
105659671|NCT04706793|364418804|FG000|Treatment|Disease worsening|10|||
105659672|NCT04706793|364418805|FG001|Treatment|Disease worsening|10|||
105659673|NCT04706793|364418804|FG000|Follow-up|Lack of Efficacy|1|||
105659674|NCT04706793|364418805|FG001|Follow-up|Lack of Efficacy|0|||
105659675|NCT04706793|364418804|FG000|Follow-up|Disease worsening|8|||
105659676|NCT04706793|364418805|FG001|Follow-up|Disease worsening|10|||
105659677|NCT04706793|364418804|FG000|Follow-up|Adverse Event|1|||
105659678|NCT04706793|364418805|FG001|Follow-up|Adverse Event|0|||
105659679|NCT00823836|364418809|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
105659680|NCT00823836|364418810|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
105659681|NCT00823836|364418809|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
105659682|NCT00823836|364418810|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
105659683|NCT00823836|364418809|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
105659684|NCT00823836|364418810|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
105659685|NCT00823836|364418809|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
105659686|NCT00823836|364418810|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
105659687|NCT00823836|364418809|FG000|Long-term Phase|Adverse Event|3|||
105659688|NCT00823836|364418810|FG001|Long-term Phase|Adverse Event|2|||
105659689|NCT00823836|364418809|FG000|Long-term Phase|Physician Decision|1|||
105659690|NCT00823836|364418810|FG001|Long-term Phase|Physician Decision|2|||
105659691|NCT00823836|364418809|FG000|Long-term Phase|Withdrawal by Subject|1|||
105659692|NCT00823836|364418810|FG001|Long-term Phase|Withdrawal by Subject|1|||
105659693|NCT01099579|364418811|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
105659694|NCT01099579|364418812|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
105988725|NCT00742417|365617870|FG001|Randomized|Physician Decision|0|||
105988726|NCT00742417|365617869|FG000|Intensive Period|Withdrawal by Subject|1|||
105988727|NCT00742417|365617870|FG001|Intensive Period|Withdrawal by Subject|1|||
105988728|NCT00742417|365617869|FG000|Intensive Period|Adverse Event|2|||
105806433|NCT01464827|364948986|FG005|Overall Study|Lost to Follow-up|1|||
105988729|NCT00742417|365617870|FG001|Intensive Period|Adverse Event|0|||
105988730|NCT03499314|365617871|FG000|Overall Study|Time Commitment|1|||
105988731|NCT03499314|365617872|FG001|Overall Study|Time Commitment|2|||
105988732|NCT03499314|365617871|FG000|Overall Study|Medical issue unrelated to research study|1|||
105988733|NCT03499314|365617872|FG001|Overall Study|Medical issue unrelated to research study|1|||
105988734|NCT02291419|365617875|FG000|Overall Study|Early study termination|1|||
105988735|NCT02291419|365617876|FG001|Overall Study|Early study termination|5|||
105988736|NCT00965575|365617880|FG000|Overall Study|subject unwillingness to swallow study c|1|||
105988737|NCT00965575|365617881|FG001|Overall Study|subject unwillingness to swallow study c|0|||
105988738|NCT03679624|365617884|FG000|Overall Study|Adverse Event|1|||
105988739|NCT03679624|365617885|FG001|Overall Study|Adverse Event|0|||
105988740|NCT00767806|365617886|FG000|Overall Study|Adverse Event|30|||
105988741|NCT00767806|365617887|FG001|Overall Study|Adverse Event|11|||
105988742|NCT00767806|365617886|FG000|Overall Study|Withdrawal by Subject|8|||
105988743|NCT00767806|365617887|FG001|Overall Study|Withdrawal by Subject|13|||
105988744|NCT00767806|365617886|FG000|Overall Study|Protocol Violation|6|||
105988745|NCT00767806|365617887|FG001|Overall Study|Protocol Violation|5|||
105988746|NCT00767806|365617886|FG000|Overall Study|Lack of Efficacy|1|||
105988747|NCT00767806|365617887|FG001|Overall Study|Lack of Efficacy|9|||
105988748|NCT00767806|365617886|FG000|Overall Study|Physician Decision|4|||
105988749|NCT00767806|365617887|FG001|Overall Study|Physician Decision|3|||
105988750|NCT00767806|365617886|FG000|Overall Study|Lost to Follow-up|1|||
105988751|NCT00767806|365617887|FG001|Overall Study|Lost to Follow-up|4|||
105988752|NCT00767806|365617886|FG000|Overall Study|Entry Criteria Not Met|1|||
105988753|NCT00767806|365617887|FG001|Overall Study|Entry Criteria Not Met|1|||
105988754|NCT00767806|365617886|FG000|Overall Study|Sponsor Decision|0|||
105988755|NCT00767806|365617887|FG001|Overall Study|Sponsor Decision|1|||
105988756|NCT00539305|365617890|FG000|Overall Study|Adverse Event|1|||
105988757|NCT00539305|365617891|FG001|Overall Study|Adverse Event|0|||
105988758|NCT00539305|365617890|FG000|Overall Study|Substance Use|0|||
105988759|NCT00539305|365617891|FG001|Overall Study|Substance Use|1|||
105988760|NCT00539305|365617890|FG000|Overall Study|Withdrawal by Subject|0|||
105988761|NCT00539305|365617891|FG001|Overall Study|Withdrawal by Subject|1|||
105988762|NCT01363908|365617894|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
105988763|NCT01363908|365617895|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
105988764|NCT01363908|365617894|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
105988765|NCT01363908|365617895|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
105988766|NCT01363908|365617894|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
105988767|NCT01363908|365617895|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
105988768|NCT01363908|365617894|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
105988769|NCT01363908|365617895|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
105988770|NCT03282097|365617899|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
105988771|NCT03282097|365617900|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
105988772|NCT03282097|365617899|FG000|Intervention Visit Complete|Patient Death|13|||
105988773|NCT03282097|365617900|FG001|Intervention Visit Complete|Patient Death|15|||
105988774|NCT03282097|365617899|FG000|Intervention Visit Complete|Caregiver Death|0|||
105988775|NCT03282097|365617900|FG001|Intervention Visit Complete|Caregiver Death|3|||
105988776|NCT03282097|365617899|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
105988777|NCT03282097|365617900|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
105988778|NCT03282097|365617899|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
105988779|NCT03282097|365617900|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
105988780|NCT03282097|365617899|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
105988781|NCT03282097|365617900|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
105988782|NCT03282097|365617899|FG000|Primary Outcome Data Collection Complete|Missing|2|||
105988783|NCT03282097|365617900|FG001|Primary Outcome Data Collection Complete|Missing|3|||
105988784|NCT03282097|365617899|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
105988785|NCT03282097|365617900|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
105988786|NCT03282097|365617899|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
105988787|NCT03282097|365617900|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
105988788|NCT03282097|365617899|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
105988789|NCT03282097|365617900|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
105988790|NCT00183625|365617901|FG000|Overall Study|Withdrawal by Subject|18|||
105988791|NCT00183625|365617902|FG001|Overall Study|Withdrawal by Subject|18|||
105988792|NCT00183625|365617903|FG002|Overall Study|Withdrawal by Subject|19|||
105988793|NCT00183625|365617904|FG003|Overall Study|Withdrawal by Subject|14|||
105988794|NCT03250182|365617905|FG000|Overall Study|Withdrawal by Subject|1|||
105988795|NCT04752358|365617917|FG000|Overall Study|Death|2|||
105988796|NCT04752358|365617918|FG001|Overall Study|Death|1|||
105988797|NCT00296140|365617922|FG000|Overall Study|Lost to Follow-up|1|||
105988798|NCT00296140|365617923|FG001|Overall Study|Lost to Follow-up|0|||
105988799|NCT00296140|365617922|FG000|Overall Study|Withdrawal by Subject|1|||
105988800|NCT00296140|365617923|FG001|Overall Study|Withdrawal by Subject|0|||
105988801|NCT00296140|365617922|FG000|Overall Study|Discharge to Nursing Home|1|||
105988802|NCT00296140|365617923|FG001|Overall Study|Discharge to Nursing Home|0|||
105988803|NCT04369950|365617930|FG000|Overall Study|Protocol Violation|2|||
105988804|NCT04369950|365617931|FG001|Overall Study|Protocol Violation|2|||
105988805|NCT00596830|365617932|FG000|Overall Study|Death|258|||
105988806|NCT00596830|365617933|FG001|Overall Study|Death|247|||
105988807|NCT00596830|365617932|FG000|Overall Study|Lost to Follow-up|7|||
105988808|NCT00596830|365617933|FG001|Overall Study|Lost to Follow-up|11|||
105988809|NCT00596830|365617932|FG000|Overall Study|Withdrawal by Subject|22|||
105988810|NCT00596830|365617933|FG001|Overall Study|Withdrawal by Subject|12|||
105988811|NCT00596830|365617932|FG000|Overall Study|Study terminated by sponsor|51|||
105988812|NCT00596830|365617933|FG001|Overall Study|Study terminated by sponsor|62|||
105988813|NCT00596830|365617932|FG000|Overall Study|Follow-up was discontinued|1|||
105988814|NCT00596830|365617933|FG001|Overall Study|Follow-up was discontinued|0|||
105988815|NCT00596830|365617932|FG000|Overall Study|Randomized but not treated|3|||
105988816|NCT00596830|365617933|FG001|Overall Study|Randomized but not treated|7|||
105988817|NCT00646399|365617937|FG000|Overall Study|Death|63|||
105988818|NCT00646399|365617938|FG001|Overall Study|Death|53|||
105988819|NCT00646399|365617937|FG000|Overall Study|Withdrawal by Subject|9|||
105988820|NCT00646399|365617938|FG001|Overall Study|Withdrawal by Subject|10|||
105988821|NCT00646399|365617937|FG000|Overall Study|Other Reason|11|||
105988822|NCT00646399|365617938|FG001|Overall Study|Other Reason|11|||
105988823|NCT05198843|365617939|FG000|Overall Study|Lack of Efficacy|1|||
105988824|NCT03068754|365617940|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
105988825|NCT03068754|365617941|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
105988826|NCT03068754|365617942|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
105988827|NCT03068754|365617943|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
105988828|NCT03068754|365617940|FG000|Randomized Treatment Period (RTP)|Death|2|||
105988829|NCT03068754|365617941|FG001|Randomized Treatment Period (RTP)|Death|2|||
105988830|NCT03068754|365617942|FG002|Randomized Treatment Period (RTP)|Death|0|||
105988831|NCT03068754|365617943|FG003|Randomized Treatment Period (RTP)|Death|0|||
105988832|NCT03068754|365617940|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
105988833|NCT03068754|365617941|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
105988834|NCT03068754|365617942|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
105988835|NCT03068754|365617943|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
105988836|NCT03068754|365617940|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
105988837|NCT03068754|365617941|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
105988838|NCT03068754|365617942|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
105988839|NCT03068754|365617943|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
105988840|NCT03068754|365617940|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
105988841|NCT03068754|365617941|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
105988842|NCT03068754|365617942|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
105988843|NCT03068754|365617943|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
105988844|NCT03068754|365617940|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
105988845|NCT03068754|365617941|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
105988846|NCT03068754|365617942|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
105988847|NCT03068754|365617943|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
105988848|NCT03068754|365617940|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
105988849|NCT03068754|365617941|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
105988850|NCT03068754|365617942|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
105988851|NCT03068754|365617943|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
105988852|NCT03068754|365617940|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
105988853|NCT03068754|365617941|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
105988854|NCT03068754|365617942|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
105988855|NCT03068754|365617943|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
105988856|NCT03068754|365617940|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
105988857|NCT03068754|365617941|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
105988858|NCT03068754|365617942|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
105988859|NCT03068754|365617943|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
105988860|NCT03068754|365617940|FG000|Open Label Extension Period (OLE)|Death|0|||
105988861|NCT03068754|365617941|FG001|Open Label Extension Period (OLE)|Death|0|||
105988862|NCT03068754|365617942|FG002|Open Label Extension Period (OLE)|Death|0|||
105988863|NCT03068754|365617943|FG003|Open Label Extension Period (OLE)|Death|1|||
105988864|NCT03068754|365617940|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
105988865|NCT03068754|365617941|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
105988866|NCT03068754|365617942|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
105988867|NCT03068754|365617943|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
105988868|NCT03068754|365617940|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
105988869|NCT03068754|365617941|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
105988870|NCT03068754|365617942|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
106097916|NCT04782323|366016463|FG003|Overall Study|Death|0|||
106097917|NCT04782323|366016464|FG004|Overall Study|Death|1|||
105988871|NCT03068754|365617943|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
105988872|NCT03068754|365617940|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
105988873|NCT03068754|365617941|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
105988874|NCT03068754|365617942|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
105988875|NCT03068754|365617943|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
105988876|NCT03068754|365617940|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
105988877|NCT03068754|365617941|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
105988878|NCT03068754|365617942|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
105988879|NCT03068754|365617943|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
105988880|NCT00098306|365617947|FG000|Double Blind|Randomized, not treated|9|||
105988881|NCT00098306|365617948|FG001|Double Blind|Randomized, not treated|5|||
105988882|NCT00098306|365617949|FG002|Double Blind|Randomized, not treated|2|||
105988883|NCT00098306|365617950|FG003|Double Blind|Randomized, not treated|0|||
105988884|NCT00098306|365617951|FG004|Double Blind|Randomized, not treated|0|||
105988885|NCT00098306|365617952|FG005|Double Blind|Randomized, not treated|0|||
105988886|NCT00098306|365617953|FG006|Double Blind|Randomized, not treated|0|||
105988887|NCT00098306|365617947|FG000|Double Blind|Ongoing at cut-off date|151|||
105988888|NCT00098306|365617948|FG001|Double Blind|Ongoing at cut-off date|166|||
105988889|NCT00098306|365617949|FG002|Double Blind|Ongoing at cut-off date|72|||
105988890|NCT00098306|365617950|FG003|Double Blind|Ongoing at cut-off date|0|||
105988891|NCT00098306|365617951|FG004|Double Blind|Ongoing at cut-off date|0|||
105988892|NCT00098306|365617952|FG005|Double Blind|Ongoing at cut-off date|0|||
105988893|NCT00098306|365617953|FG006|Double Blind|Ongoing at cut-off date|0|||
105988894|NCT00098306|365617947|FG000|Double Blind|Adverse Event|11|||
105988895|NCT00098306|365617948|FG001|Double Blind|Adverse Event|10|||
105988896|NCT00098306|365617949|FG002|Double Blind|Adverse Event|6|||
105988897|NCT00098306|365617950|FG003|Double Blind|Adverse Event|0|||
105988898|NCT00098306|365617951|FG004|Double Blind|Adverse Event|0|||
105988899|NCT00098306|365617952|FG005|Double Blind|Adverse Event|0|||
105988900|NCT00098306|365617953|FG006|Double Blind|Adverse Event|0|||
105988901|NCT00098306|365617947|FG000|Double Blind|Lack of Efficacy|43|||
105988902|NCT00098306|365617948|FG001|Double Blind|Lack of Efficacy|34|||
105988903|NCT00098306|365617949|FG002|Double Blind|Lack of Efficacy|17|||
105988904|NCT00098306|365617950|FG003|Double Blind|Lack of Efficacy|0|||
105988905|NCT00098306|365617951|FG004|Double Blind|Lack of Efficacy|0|||
105988906|NCT00098306|365617952|FG005|Double Blind|Lack of Efficacy|0|||
105988907|NCT00098306|365617953|FG006|Double Blind|Lack of Efficacy|0|||
105988908|NCT00098306|365617947|FG000|Double Blind|Death|1|||
105988909|NCT00098306|365617948|FG001|Double Blind|Death|4|||
105988910|NCT00098306|365617949|FG002|Double Blind|Death|1|||
105988911|NCT00098306|365617950|FG003|Double Blind|Death|0|||
105988912|NCT00098306|365617951|FG004|Double Blind|Death|0|||
105988913|NCT00098306|365617952|FG005|Double Blind|Death|0|||
105988914|NCT00098306|365617953|FG006|Double Blind|Death|0|||
105988915|NCT00098306|365617947|FG000|Double Blind|Participant defaulted|19|||
105988916|NCT00098306|365617948|FG001|Double Blind|Participant defaulted|18|||
105988917|NCT00098306|365617949|FG002|Double Blind|Participant defaulted|11|||
105988918|NCT00098306|365617950|FG003|Double Blind|Participant defaulted|0|||
105988919|NCT00098306|365617951|FG004|Double Blind|Participant defaulted|0|||
105988920|NCT00098306|365617952|FG005|Double Blind|Participant defaulted|0|||
105988921|NCT00098306|365617953|FG006|Double Blind|Participant defaulted|0|||
105988922|NCT00098306|365617947|FG000|Double Blind|Un-specified|7|||
105988923|NCT00098306|365617948|FG001|Double Blind|Un-specified|3|||
105988924|NCT00098306|365617949|FG002|Double Blind|Un-specified|11|||
105988925|NCT00098306|365617950|FG003|Double Blind|Un-specified|0|||
105988926|NCT00098306|365617951|FG004|Double Blind|Un-specified|0|||
105988927|NCT00098306|365617952|FG005|Double Blind|Un-specified|0|||
105988928|NCT00098306|365617953|FG006|Double Blind|Un-specified|0|||
105988929|NCT00098306|365617947|FG000|Open Label|Lack of Efficacy|0|||
105988930|NCT00098306|365617948|FG001|Open Label|Lack of Efficacy|0|||
105988931|NCT00098306|365617949|FG002|Open Label|Lack of Efficacy|0|||
105988932|NCT00098306|365617950|FG003|Open Label|Lack of Efficacy|13|||
105988933|NCT00098306|365617951|FG004|Open Label|Lack of Efficacy|0|||
105988934|NCT00098306|365617952|FG005|Open Label|Lack of Efficacy|0|||
105988935|NCT00098306|365617953|FG006|Open Label|Lack of Efficacy|0|||
105988936|NCT00098306|365617947|FG000|Open Label|Adverse Event|0|||
105988937|NCT00098306|365617948|FG001|Open Label|Adverse Event|0|||
105988938|NCT00098306|365617949|FG002|Open Label|Adverse Event|0|||
105988939|NCT00098306|365617950|FG003|Open Label|Adverse Event|2|||
105806434|NCT01464827|364948987|FG006|Overall Study|Lost to Follow-up|2|||
105988940|NCT00098306|365617951|FG004|Open Label|Adverse Event|0|||
105988941|NCT00098306|365617952|FG005|Open Label|Adverse Event|0|||
105988942|NCT00098306|365617953|FG006|Open Label|Adverse Event|0|||
105988943|NCT00098306|365617947|FG000|Open Label|Death|0|||
105988944|NCT00098306|365617948|FG001|Open Label|Death|0|||
105988945|NCT00098306|365617949|FG002|Open Label|Death|0|||
105988946|NCT00098306|365617950|FG003|Open Label|Death|4|||
105988947|NCT00098306|365617951|FG004|Open Label|Death|0|||
105988948|NCT00098306|365617952|FG005|Open Label|Death|0|||
105988949|NCT00098306|365617953|FG006|Open Label|Death|0|||
105988950|NCT00098306|365617947|FG000|Open Label|Participant defaulted|0|||
105988951|NCT00098306|365617948|FG001|Open Label|Participant defaulted|0|||
105988952|NCT00098306|365617949|FG002|Open Label|Participant defaulted|0|||
105988953|NCT00098306|365617950|FG003|Open Label|Participant defaulted|24|||
105988954|NCT00098306|365617951|FG004|Open Label|Participant defaulted|0|||
105988955|NCT00098306|365617952|FG005|Open Label|Participant defaulted|0|||
105988956|NCT00098306|365617953|FG006|Open Label|Participant defaulted|0|||
105988957|NCT00098306|365617947|FG000|Open Label|Un-specified|0|||
105988958|NCT00098306|365617948|FG001|Open Label|Un-specified|0|||
105988959|NCT00098306|365617949|FG002|Open Label|Un-specified|0|||
105988960|NCT00098306|365617950|FG003|Open Label|Un-specified|15|||
105988961|NCT00098306|365617951|FG004|Open Label|Un-specified|0|||
105988962|NCT00098306|365617952|FG005|Open Label|Un-specified|0|||
105988963|NCT00098306|365617953|FG006|Open Label|Un-specified|0|||
105988964|NCT00098306|365617947|FG000|Open Label|Ongoing at cut-off date|0|||
105988965|NCT00098306|365617948|FG001|Open Label|Ongoing at cut-off date|0|||
105988966|NCT00098306|365617949|FG002|Open Label|Ongoing at cut-off date|0|||
105988967|NCT00098306|365617950|FG003|Open Label|Ongoing at cut-off date|269|||
105988968|NCT00098306|365617951|FG004|Open Label|Ongoing at cut-off date|62|||
105988969|NCT00098306|365617952|FG005|Open Label|Ongoing at cut-off date|0|||
105988970|NCT00098306|365617953|FG006|Open Label|Ongoing at cut-off date|0|||
105988971|NCT00098306|365617947|FG000|Observational Phase|Death|0|||
105988972|NCT00098306|365617948|FG001|Observational Phase|Death|0|||
105988973|NCT00098306|365617949|FG002|Observational Phase|Death|0|||
105988974|NCT00098306|365617950|FG003|Observational Phase|Death|0|||
105988975|NCT00098306|365617951|FG004|Observational Phase|Death|0|||
105988976|NCT00098306|365617952|FG005|Observational Phase|Death|5|||
105988977|NCT00098306|365617953|FG006|Observational Phase|Death|4|||
105988978|NCT00098306|365617947|FG000|Observational Phase|Participant defaulted|0|||
105988979|NCT00098306|365617948|FG001|Observational Phase|Participant defaulted|0|||
105988980|NCT00098306|365617949|FG002|Observational Phase|Participant defaulted|0|||
105988981|NCT00098306|365617950|FG003|Observational Phase|Participant defaulted|0|||
105988982|NCT00098306|365617951|FG004|Observational Phase|Participant defaulted|0|||
105988983|NCT00098306|365617952|FG005|Observational Phase|Participant defaulted|34|||
105988984|NCT00098306|365617953|FG006|Observational Phase|Participant defaulted|18|||
105988985|NCT00098306|365617947|FG000|Observational Phase|Un-specified|0|||
105988986|NCT00098306|365617948|FG001|Observational Phase|Un-specified|0|||
105988987|NCT00098306|365617949|FG002|Observational Phase|Un-specified|0|||
105988988|NCT00098306|365617950|FG003|Observational Phase|Un-specified|0|||
105988989|NCT00098306|365617951|FG004|Observational Phase|Un-specified|0|||
105988990|NCT00098306|365617952|FG005|Observational Phase|Un-specified|7|||
105988991|NCT00098306|365617953|FG006|Observational Phase|Un-specified|4|||
105988992|NCT02106403|365617954|FG000|Follow-Up Visit 3|Other Reason|0|||
105988993|NCT02106403|365617955|FG001|Follow-Up Visit 3|Other Reason|0|||
105988994|NCT02106403|365617956|FG002|Follow-Up Visit 3|Other Reason|0|||
105988995|NCT02106403|365617957|FG003|Follow-Up Visit 3|Other Reason|0|||
105988996|NCT02106403|365617958|FG004|Follow-Up Visit 3|Other Reason|0|||
105988997|NCT02106403|365617959|FG005|Follow-Up Visit 3|Other Reason|1|||
105988998|NCT01069705|365617960|FG000|Overall Study|Adverse Event|1|||
105988999|NCT01069705|365617960|FG000|Overall Study|Withdrawal by Subject|2|||
105989000|NCT00923845|365617961|FG000|Induction Therapy|Poor performance status|0|||
105989001|NCT00923845|365617962|FG001|Induction Therapy|Poor performance status|2|||
105989002|NCT01628965|365617969|FG000|Overall Study|Adverse Event|30|||
105989003|NCT01628965|365617969|FG000|Overall Study|Lack of Efficacy|7|||
105989004|NCT01628965|365617969|FG000|Overall Study|Withdrawal by Subject|3|||
105989005|NCT01628965|365617969|FG000|Overall Study|Lost to Follow-up|1|||
105989006|NCT01628965|365617969|FG000|Overall Study|Discontinuation criteria|8|||
105989007|NCT00148941|365617970|FG000|Overall Study|Lost to Follow-up|17|||
105989008|NCT00148941|365617971|FG001|Overall Study|Lost to Follow-up|24|||
105989009|NCT00148941|365617972|FG002|Overall Study|Lost to Follow-up|18|||
105989010|NCT00148941|365617973|FG003|Overall Study|Lost to Follow-up|22|||
105989011|NCT00148941|365617970|FG000|Overall Study|Withdrawal by Subject|1|||
105989012|NCT00148941|365617971|FG001|Overall Study|Withdrawal by Subject|0|||
105989013|NCT00148941|365617972|FG002|Overall Study|Withdrawal by Subject|1|||
105989014|NCT00148941|365617973|FG003|Overall Study|Withdrawal by Subject|0|||
105989015|NCT00148941|365617970|FG000|Overall Study|Other|0|||
105989016|NCT00148941|365617971|FG001|Overall Study|Other|0|||
105989017|NCT00148941|365617972|FG002|Overall Study|Other|1|||
105989018|NCT00148941|365617973|FG003|Overall Study|Other|2|||
105989019|NCT01339897|365617974|FG000|Overall Study|Adverse Event|1|||
105989020|NCT01339897|365617975|FG001|Overall Study|Adverse Event|0|||
105989021|NCT01339897|365617976|FG002|Overall Study|Adverse Event|0|||
105989022|NCT01339897|365617977|FG003|Overall Study|Adverse Event|1|||
105989023|NCT00400569|365617990|FG000|Overall Study|Death|1|||
105989024|NCT01811186|365617991|FG000|Overall Study|Adverse Event|54|||
105989025|NCT01811186|365617992|FG001|Overall Study|Adverse Event|38|||
105989026|NCT01811186|365617991|FG000|Overall Study|Protocol Violation|5|||
105989027|NCT01811186|365617992|FG001|Overall Study|Protocol Violation|6|||
105989028|NCT01811186|365617991|FG000|Overall Study|Withdrawal by Subject|5|||
105989029|NCT01811186|365617992|FG001|Overall Study|Withdrawal by Subject|10|||
105989030|NCT01811186|365617991|FG000|Overall Study|Lack of Efficacy|3|||
105989031|NCT01811186|365617992|FG001|Overall Study|Lack of Efficacy|6|||
105989032|NCT01811186|365617991|FG000|Overall Study|Lost to Follow-up|4|||
105989033|NCT01811186|365617992|FG001|Overall Study|Lost to Follow-up|2|||
105989034|NCT00620113|365617997|FG000|Overall Study|Adverse Event|3|||
105989035|NCT00620113|365617998|FG001|Overall Study|Adverse Event|2|||
105989036|NCT00620113|365617999|FG002|Overall Study|Adverse Event|2|||
105989037|NCT00620113|365618000|FG003|Overall Study|Adverse Event|1|||
105989038|NCT00620113|365617997|FG000|Overall Study|Lack of Efficacy|2|||
105989039|NCT00620113|365617998|FG001|Overall Study|Lack of Efficacy|3|||
105989040|NCT00620113|365617999|FG002|Overall Study|Lack of Efficacy|0|||
105989041|NCT00620113|365618000|FG003|Overall Study|Lack of Efficacy|2|||
105989042|NCT00620113|365617997|FG000|Overall Study|Physician Decision|1|||
105989043|NCT00620113|365617998|FG001|Overall Study|Physician Decision|0|||
105989044|NCT00620113|365617999|FG002|Overall Study|Physician Decision|0|||
105989045|NCT00620113|365618000|FG003|Overall Study|Physician Decision|2|||
105989046|NCT00620113|365617997|FG000|Overall Study|Protocol Violation|2|||
105989047|NCT00620113|365617998|FG001|Overall Study|Protocol Violation|1|||
105989048|NCT00620113|365617999|FG002|Overall Study|Protocol Violation|0|||
105989049|NCT00620113|365618000|FG003|Overall Study|Protocol Violation|0|||
105989050|NCT00620113|365617997|FG000|Overall Study|Withdrawal by Subject|5|||
105989051|NCT00620113|365617998|FG001|Overall Study|Withdrawal by Subject|1|||
105989052|NCT00620113|365617999|FG002|Overall Study|Withdrawal by Subject|3|||
105989053|NCT00620113|365618000|FG003|Overall Study|Withdrawal by Subject|5|||
105989054|NCT02461745|365618005|FG000|Overall Study|Lack of Efficacy|9|||
105989055|NCT02461745|365618006|FG001|Overall Study|Lack of Efficacy|1|||
105989056|NCT02461745|365618005|FG000|Overall Study|Lost to Follow-up|2|||
105989057|NCT02461745|365618006|FG001|Overall Study|Lost to Follow-up|2|||
105989058|NCT02461745|365618005|FG000|Overall Study|Withdrawal by Subject|3|||
105989059|NCT02461745|365618006|FG001|Overall Study|Withdrawal by Subject|1|||
105989060|NCT00211887|365618007|FG000|Overall Study|Adverse Event|8|||
105989061|NCT00211887|365618008|FG001|Overall Study|Adverse Event|4|||
105989062|NCT00211887|365618009|FG002|Overall Study|Adverse Event|6|||
105989063|NCT00211887|365618007|FG000|Overall Study|Death|1|||
105989064|NCT00211887|365618008|FG001|Overall Study|Death|1|||
105989065|NCT00211887|365618009|FG002|Overall Study|Death|1|||
105989066|NCT00211887|365618007|FG000|Overall Study|Lost to Follow-up|28|||
105989067|NCT00211887|365618008|FG001|Overall Study|Lost to Follow-up|13|||
105989068|NCT00211887|365618009|FG002|Overall Study|Lost to Follow-up|9|||
105989069|NCT00211887|365618007|FG000|Overall Study|Non-medical reason|31|||
105989070|NCT00211887|365618008|FG001|Overall Study|Non-medical reason|14|||
105989071|NCT00211887|365618009|FG002|Overall Study|Non-medical reason|8|||
105989072|NCT00211887|365618007|FG000|Overall Study|Other medical reason|15|||
105989073|NCT00211887|365618008|FG001|Overall Study|Other medical reason|11|||
105989074|NCT00211887|365618009|FG002|Overall Study|Other medical reason|7|||
105989075|NCT00211887|365618007|FG000|Overall Study|Side effects|19|||
105989076|NCT00211887|365618008|FG001|Overall Study|Side effects|13|||
105989077|NCT00211887|365618009|FG002|Overall Study|Side effects|5|||
105989078|NCT02353728|365618014|FG000|Overall Study|Subject non-compliance|1|||
105989079|NCT05066165|365619486|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
105989080|NCT05066165|365619487|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
105989081|NCT05066165|365619486|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
105989082|NCT05066165|365619487|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
105989083|NCT03109184|365619489|FG000|Overall Study|Lost to Follow-up|6|||
105989084|NCT03109184|365619490|FG001|Overall Study|Lost to Follow-up|6|||
105989085|NCT03109184|365619489|FG000|Overall Study|Withdrawal by Subject|1|||
105989086|NCT03109184|365619490|FG001|Overall Study|Withdrawal by Subject|1|||
105989087|NCT00649428|365619491|FG000|Overall Study|Adverse Event|2|||
105989088|NCT00649428|365619492|FG001|Overall Study|Adverse Event|2|||
105989089|NCT00649428|365619491|FG000|Overall Study|Withdrawal by Subject|6|||
105989090|NCT00649428|365619492|FG001|Overall Study|Withdrawal by Subject|6|||
105989091|NCT00649428|365619491|FG000|Overall Study|Lost to Follow-up|1|||
105989092|NCT00649428|365619492|FG001|Overall Study|Lost to Follow-up|3|||
105989093|NCT00649428|365619491|FG000|Overall Study|Insufficient manufacturing yield|5|||
105989094|NCT00649428|365619492|FG001|Overall Study|Insufficient manufacturing yield|1|||
105989095|NCT00649428|365619491|FG000|Overall Study|Protocol Violation|6|||
105989096|NCT00649428|365619492|FG001|Overall Study|Protocol Violation|2|||
105989097|NCT00649428|365619491|FG000|Overall Study|Physician Decision|0|||
105989098|NCT00649428|365619492|FG001|Overall Study|Physician Decision|1|||
105989099|NCT04566601|365619495|FG000|Overall Study|Other than listed|13|||
105989100|NCT04566601|365619496|FG001|Overall Study|Other than listed|4|||
105989101|NCT04566601|365619497|FG002|Overall Study|Other than listed|2|||
105989102|NCT04566601|365619498|FG003|Overall Study|Other than listed|1|||
105989103|NCT04566601|365619499|FG004|Overall Study|Other than listed|4|||
105989104|NCT04566601|365619495|FG000|Overall Study|Protocol deviation|3|||
105989105|NCT04566601|365619496|FG001|Overall Study|Protocol deviation|0|||
105989106|NCT04566601|365619497|FG002|Overall Study|Protocol deviation|1|||
105989107|NCT04566601|365619498|FG003|Overall Study|Protocol deviation|1|||
105989108|NCT04566601|365619499|FG004|Overall Study|Protocol deviation|1|||
105989109|NCT04566601|365619495|FG000|Overall Study|Technical problems|0|||
105989110|NCT04566601|365619496|FG001|Overall Study|Technical problems|0|||
105989111|NCT04566601|365619497|FG002|Overall Study|Technical problems|1|||
105989112|NCT04566601|365619498|FG003|Overall Study|Technical problems|0|||
105989113|NCT04566601|365619499|FG004|Overall Study|Technical problems|0|||
105989114|NCT04566601|365619495|FG000|Overall Study|No reason available|3|||
105989115|NCT04566601|365619496|FG001|Overall Study|No reason available|2|||
105989116|NCT04566601|365619497|FG002|Overall Study|No reason available|7|||
105989117|NCT04566601|365619498|FG003|Overall Study|No reason available|1|||
105989118|NCT04566601|365619499|FG004|Overall Study|No reason available|5|||
105989119|NCT04566601|365619495|FG000|Overall Study|Burden of study procedures|3|||
105989120|NCT04566601|365619496|FG001|Overall Study|Burden of study procedures|0|||
105989121|NCT04566601|365619497|FG002|Overall Study|Burden of study procedures|0|||
105989122|NCT04566601|365619498|FG003|Overall Study|Burden of study procedures|3|||
105989123|NCT04566601|365619499|FG004|Overall Study|Burden of study procedures|1|||
105989124|NCT04566601|365619495|FG000|Overall Study|Change of residence|2|||
105989125|NCT04566601|365619496|FG001|Overall Study|Change of residence|2|||
105989126|NCT04566601|365619497|FG002|Overall Study|Change of residence|0|||
105989127|NCT04566601|365619498|FG003|Overall Study|Change of residence|1|||
105989128|NCT04566601|365619499|FG004|Overall Study|Change of residence|2|||
105989129|NCT04566601|365619495|FG000|Overall Study|Perceived lack of efficacy|2|||
105989130|NCT04566601|365619496|FG001|Overall Study|Perceived lack of efficacy|0|||
105989131|NCT04566601|365619497|FG002|Overall Study|Perceived lack of efficacy|1|||
105989132|NCT04566601|365619498|FG003|Overall Study|Perceived lack of efficacy|1|||
105989133|NCT04566601|365619499|FG004|Overall Study|Perceived lack of efficacy|2|||
105989134|NCT04566601|365619495|FG000|Overall Study|Adverse Event|7|||
105989135|NCT04566601|365619496|FG001|Overall Study|Adverse Event|4|||
105989136|NCT04566601|365619497|FG002|Overall Study|Adverse Event|6|||
105989137|NCT04566601|365619498|FG003|Overall Study|Adverse Event|5|||
105989138|NCT04566601|365619499|FG004|Overall Study|Adverse Event|12|||
105989139|NCT01618695|365619501|FG000|Core Phase|Adverse Event|4|||
105989140|NCT01618695|365619502|FG001|Core Phase|Adverse Event|5|||
105989141|NCT01618695|365619503|FG002|Core Phase|Adverse Event|15|||
105989142|NCT01618695|365619504|FG003|Core Phase|Adverse Event|20|||
105989143|NCT01618695|365619501|FG000|Core Phase|Lost to Follow-up|0|||
105989144|NCT01618695|365619502|FG001|Core Phase|Lost to Follow-up|0|||
105989145|NCT01618695|365619503|FG002|Core Phase|Lost to Follow-up|1|||
105989146|NCT01618695|365619504|FG003|Core Phase|Lost to Follow-up|0|||
105989147|NCT01618695|365619501|FG000|Core Phase|Withdrawal by Subject|16|||
105989148|NCT01618695|365619502|FG001|Core Phase|Withdrawal by Subject|11|||
105989149|NCT01618695|365619503|FG002|Core Phase|Withdrawal by Subject|9|||
105989150|NCT01618695|365619504|FG003|Core Phase|Withdrawal by Subject|13|||
105989151|NCT01618695|365619501|FG000|Core Phase|Pregnancy|2|||
105989152|NCT01618695|365619502|FG001|Core Phase|Pregnancy|0|||
105989153|NCT01618695|365619503|FG002|Core Phase|Pregnancy|0|||
105989154|NCT01618695|365619504|FG003|Core Phase|Pregnancy|0|||
105989155|NCT01618695|365619501|FG000|Core Phase|Lack of Efficacy|1|||
105989156|NCT01618695|365619502|FG001|Core Phase|Lack of Efficacy|2|||
105989157|NCT01618695|365619503|FG002|Core Phase|Lack of Efficacy|1|||
105989158|NCT01618695|365619504|FG003|Core Phase|Lack of Efficacy|1|||
105989159|NCT01618695|365619501|FG000|Core Phase|Other than specified|1|||
105989160|NCT01618695|365619502|FG001|Core Phase|Other than specified|2|||
105989161|NCT01618695|365619503|FG002|Core Phase|Other than specified|2|||
105989162|NCT01618695|365619504|FG003|Core Phase|Other than specified|2|||
105989163|NCT01618695|365619501|FG000|Core Phase|Not treated|1|||
105989164|NCT01618695|365619502|FG001|Core Phase|Not treated|0|||
105989165|NCT01618695|365619503|FG002|Core Phase|Not treated|2|||
105989166|NCT01618695|365619504|FG003|Core Phase|Not treated|0|||
105989167|NCT01618695|365619501|FG000|Extension Phase|Lack of Efficacy|17|||
105989168|NCT01618695|365619502|FG001|Extension Phase|Lack of Efficacy|33|||
105989169|NCT01618695|365619503|FG002|Extension Phase|Lack of Efficacy|26|||
105989170|NCT01618695|365619504|FG003|Extension Phase|Lack of Efficacy|24|||
105989171|NCT01618695|365619501|FG000|Extension Phase|Pregnancy|2|||
105989172|NCT01618695|365619502|FG001|Extension Phase|Pregnancy|0|||
105989173|NCT01618695|365619503|FG002|Extension Phase|Pregnancy|1|||
105989174|NCT01618695|365619504|FG003|Extension Phase|Pregnancy|1|||
105989175|NCT01618695|365619501|FG000|Extension Phase|Withdrawal by Subject|43|||
105989176|NCT01618695|365619502|FG001|Extension Phase|Withdrawal by Subject|48|||
105989177|NCT01618695|365619503|FG002|Extension Phase|Withdrawal by Subject|42|||
105989178|NCT01618695|365619504|FG003|Extension Phase|Withdrawal by Subject|33|||
105659695|NCT01099579|364418813|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
105806435|NCT01464827|364948988|FG007|Overall Study|Lost to Follow-up|2|||
105989179|NCT01618695|365619501|FG000|Extension Phase|Adverse Event|18|||
105989180|NCT01618695|365619502|FG001|Extension Phase|Adverse Event|16|||
105989181|NCT01618695|365619503|FG002|Extension Phase|Adverse Event|9|||
105989182|NCT01618695|365619504|FG003|Extension Phase|Adverse Event|20|||
105989183|NCT01618695|365619501|FG000|Extension Phase|Lost to Follow-up|2|||
105989184|NCT01618695|365619502|FG001|Extension Phase|Lost to Follow-up|1|||
105989185|NCT01618695|365619503|FG002|Extension Phase|Lost to Follow-up|1|||
105989186|NCT01618695|365619504|FG003|Extension Phase|Lost to Follow-up|1|||
105989187|NCT01618695|365619501|FG000|Extension Phase|Other than specified|13|||
105989188|NCT01618695|365619502|FG001|Extension Phase|Other than specified|18|||
105989189|NCT01618695|365619503|FG002|Extension Phase|Other than specified|13|||
105989190|NCT01618695|365619504|FG003|Extension Phase|Other than specified|18|||
105989191|NCT02454478|365619506|FG000|Overall Study|Incomplete DLT Evaluation|1|||
105989192|NCT03521141|365619512|FG000|Overall Study|Death|1|||
105989193|NCT03521141|365619513|FG001|Overall Study|Death|0|||
105989194|NCT03521141|365619514|FG002|Overall Study|Death|1|||
105989195|NCT00705367|365619522|FG000|Long-term Extension Period|Adverse Event|2|||
105989196|NCT00705367|365619523|FG001|Long-term Extension Period|Adverse Event|0|||
105989197|NCT00705367|365619522|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
105989198|NCT00705367|365619523|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
105989199|NCT00705367|365619522|FG000|Long-term Extension Period|Lack of Efficacy|1|||
105989200|NCT00705367|365619523|FG001|Long-term Extension Period|Lack of Efficacy|0|||
105989201|NCT00705367|365619522|FG000|Long-term Extension Period|No longer met study criteria|1|||
105989202|NCT00705367|365619523|FG001|Long-term Extension Period|No longer met study criteria|0|||
105989203|NCT00705367|365619522|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
105989204|NCT00705367|365619523|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
105989205|NCT01504841|365619526|FG000|Overall Study|Withdrawal by Subject|1|||
105989206|NCT01504841|365619527|FG001|Overall Study|Withdrawal by Subject|1|||
105989207|NCT01504841|365619528|FG002|Overall Study|Withdrawal by Subject|0|||
105989208|NCT03149055|365619529|FG000|Overall Study|Not treated|4|||
105989209|NCT03056339|365619539|FG000|Overall Study|Failed Requirements|0|||
105989210|NCT03056339|365619540|FG001|Overall Study|Failed Requirements|2|||
105989211|NCT03056339|365619541|FG002|Overall Study|Failed Requirements|7|||
105989212|NCT03056339|365619542|FG003|Overall Study|Failed Requirements|1|||
105989213|NCT01496469|365619543|FG000|Overall Study|Adverse Event|1|||
105989214|NCT01496469|365619544|FG001|Overall Study|Adverse Event|0|||
105989215|NCT01496469|365619543|FG000|Overall Study|Protocol Violation|2|||
105989216|NCT01496469|365619544|FG001|Overall Study|Protocol Violation|0|||
105989217|NCT01496469|365619543|FG000|Overall Study|Lost to Follow-up|1|||
105989218|NCT01496469|365619544|FG001|Overall Study|Lost to Follow-up|1|||
105989219|NCT01496469|365619543|FG000|Overall Study|Withdrawal by Subject|4|||
105989220|NCT01496469|365619544|FG001|Overall Study|Withdrawal by Subject|4|||
105989221|NCT01496469|365619543|FG000|Overall Study|BP exceeds protocol limits|1|||
105989222|NCT01496469|365619544|FG001|Overall Study|BP exceeds protocol limits|2|||
105989223|NCT01496469|365619543|FG000|Overall Study|Other|1|||
105989224|NCT01496469|365619544|FG001|Overall Study|Other|1|||
105989225|NCT00291018|365619545|FG000|Overall Study|Not Consented or Declined PAS|12|||
105989226|NCT00291018|365619546|FG001|Overall Study|Not Consented or Declined PAS|15|||
105989227|NCT00291018|365619547|FG002|Overall Study|Not Consented or Declined PAS|15|||
105989228|NCT00291018|365619545|FG000|Overall Study|Death|3|||
105989229|NCT00291018|365619546|FG001|Overall Study|Death|3|||
105989230|NCT00291018|365619547|FG002|Overall Study|Death|4|||
105989231|NCT00291018|365619545|FG000|Overall Study|Withdrawal by Subject|2|||
105989232|NCT00291018|365619546|FG001|Overall Study|Withdrawal by Subject|8|||
105989233|NCT00291018|365619547|FG002|Overall Study|Withdrawal by Subject|1|||
105989234|NCT00291018|365619545|FG000|Overall Study|Failures|5|||
105989235|NCT00291018|365619546|FG001|Overall Study|Failures|12|||
105989236|NCT00291018|365619547|FG002|Overall Study|Failures|5|||
105989237|NCT00291018|365619545|FG000|Overall Study|Lost to Follow-up|3|||
105989238|NCT00291018|365619546|FG001|Overall Study|Lost to Follow-up|4|||
105989239|NCT00291018|365619547|FG002|Overall Study|Lost to Follow-up|18|||
105989240|NCT00082407|365619550|FG000|Overall Study|Adverse Event|20|||
105989241|NCT00082407|365619551|FG001|Overall Study|Adverse Event|0|||
105989242|NCT00082407|365619550|FG000|Overall Study|Protocol Violation|14|||
105989243|NCT00082407|365619551|FG001|Overall Study|Protocol Violation|12|||
105989244|NCT00082407|365619550|FG000|Overall Study|Patient Decision|13|||
105989245|NCT00082407|365619551|FG001|Overall Study|Patient Decision|6|||
105989246|NCT00082407|365619550|FG000|Overall Study|Physician Decision|5|||
105989247|NCT00082407|365619551|FG001|Overall Study|Physician Decision|3|||
105989248|NCT00082407|365619550|FG000|Overall Study|Loss of Glucose Control|2|||
105989249|NCT00082407|365619551|FG001|Overall Study|Loss of Glucose Control|2|||
105989250|NCT00082407|365619550|FG000|Overall Study|Death|2|||
105989251|NCT00082407|365619551|FG001|Overall Study|Death|1|||
105989252|NCT00082407|365619550|FG000|Overall Study|Lost to Follow-up|0|||
105989253|NCT00082407|365619551|FG001|Overall Study|Lost to Follow-up|3|||
105989254|NCT00630344|365619552|FG000|Overall Study|Adverse Event|5|||
105989255|NCT00630344|365619552|FG000|Overall Study|Progressive Disease|19|||
105989256|NCT00630344|365619552|FG000|Overall Study|Physician Decision|9|||
105989257|NCT00630344|365619552|FG000|Overall Study|Withdrawal by Subject|1|||
105989258|NCT00630344|365619552|FG000|Overall Study|Intercurrent Illness|1|||
105659696|NCT01099579|364418811|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
105989259|NCT00630344|365619552|FG000|Overall Study|Other|1|||
105989260|NCT05362058|365619554|FG000|Treatment Period|Adverse Event|3|||
105989261|NCT05362058|365619555|FG001|Treatment Period|Adverse Event|3|||
105989262|NCT05362058|365619554|FG000|Treatment Period|Assigned treatment by mistake|3|||
105989263|NCT05362058|365619555|FG001|Treatment Period|Assigned treatment by mistake|4|||
105989264|NCT05362058|365619554|FG000|Treatment Period|Death|1|||
105989265|NCT05362058|365619555|FG001|Treatment Period|Death|1|||
105989266|NCT05362058|365619554|FG000|Treatment Period|Lost to Follow-up|6|||
105989267|NCT05362058|365619555|FG001|Treatment Period|Lost to Follow-up|3|||
105989268|NCT05362058|365619554|FG000|Treatment Period|Non-compliance with study drug|0|||
105989269|NCT05362058|365619555|FG001|Treatment Period|Non-compliance with study drug|1|||
105989270|NCT05362058|365619554|FG000|Treatment Period|Physician Decision|1|||
105989271|NCT05362058|365619555|FG001|Treatment Period|Physician Decision|0|||
105989272|NCT05362058|365619554|FG000|Treatment Period|Protocol deviation|1|||
105989273|NCT05362058|365619555|FG001|Treatment Period|Protocol deviation|0|||
105989274|NCT05362058|365619554|FG000|Treatment Period|Withdrawal by Subject|10|||
105989275|NCT05362058|365619555|FG001|Treatment Period|Withdrawal by Subject|11|||
105989276|NCT05362058|365619554|FG000|Follow-Up Period|Death|1|||
105989277|NCT05362058|365619555|FG001|Follow-Up Period|Death|0|||
105989278|NCT05362058|365619554|FG000|Follow-Up Period|Lost to Follow-up|2|||
105989279|NCT05362058|365619555|FG001|Follow-Up Period|Lost to Follow-up|1|||
105989280|NCT05362058|365619554|FG000|Follow-Up Period|Protocol deviation|1|||
105989281|NCT05362058|365619555|FG001|Follow-Up Period|Protocol deviation|1|||
105989282|NCT05362058|365619554|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105989283|NCT05362058|365619555|FG001|Follow-Up Period|Withdrawal by Subject|3|||
105989284|NCT02688985|365619558|FG000|Overall Study|Adverse Event|1|||
105989285|NCT02688985|365619559|FG001|Overall Study|Adverse Event|2|||
105989286|NCT02688985|365619560|FG002|Overall Study|Adverse Event|2|||
105989287|NCT02688985|365619561|FG003|Overall Study|Adverse Event|0|||
105989288|NCT02688985|365619562|FG004|Overall Study|Adverse Event|0|||
105989289|NCT02688985|365619558|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
105989290|NCT02688985|365619559|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
105989291|NCT02688985|365619560|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
105989292|NCT02688985|365619561|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
105989293|NCT02688985|365619562|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
105989294|NCT02688985|365619558|FG000|Overall Study|Death|0|||
105989295|NCT02688985|365619559|FG001|Overall Study|Death|0|||
105989296|NCT02688985|365619560|FG002|Overall Study|Death|0|||
105989297|NCT02688985|365619561|FG003|Overall Study|Death|0|||
105989298|NCT02688985|365619562|FG004|Overall Study|Death|1|||
105989299|NCT02688985|365619558|FG000|Overall Study|Lack of Efficacy|0|||
105989300|NCT02688985|365619559|FG001|Overall Study|Lack of Efficacy|0|||
105989301|NCT02688985|365619560|FG002|Overall Study|Lack of Efficacy|0|||
105989302|NCT02688985|365619561|FG003|Overall Study|Lack of Efficacy|0|||
105989303|NCT02688985|365619562|FG004|Overall Study|Lack of Efficacy|1|||
105989304|NCT02688985|365619558|FG000|Overall Study|Lost to Follow-up|2|||
105989305|NCT02688985|365619559|FG001|Overall Study|Lost to Follow-up|0|||
105989306|NCT02688985|365619560|FG002|Overall Study|Lost to Follow-up|1|||
105989307|NCT02688985|365619561|FG003|Overall Study|Lost to Follow-up|1|||
105989308|NCT02688985|365619562|FG004|Overall Study|Lost to Follow-up|1|||
105989309|NCT02688985|365619558|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105989310|NCT02688985|365619559|FG001|Overall Study|Non-Compliance With Study Drug|3|||
105989311|NCT02688985|365619560|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105989312|NCT02688985|365619561|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105989313|NCT02688985|365619562|FG004|Overall Study|Non-Compliance With Study Drug|1|||
105989314|NCT02688985|365619558|FG000|Overall Study|Other|3|||
105989315|NCT02688985|365619559|FG001|Overall Study|Other|4|||
105989316|NCT02688985|365619560|FG002|Overall Study|Other|1|||
105989317|NCT02688985|365619561|FG003|Overall Study|Other|0|||
105989318|NCT02688985|365619562|FG004|Overall Study|Other|0|||
105989319|NCT02688985|365619558|FG000|Overall Study|Physician Decision|2|||
105989320|NCT02688985|365619559|FG001|Overall Study|Physician Decision|2|||
105989321|NCT02688985|365619560|FG002|Overall Study|Physician Decision|0|||
105989322|NCT02688985|365619561|FG003|Overall Study|Physician Decision|0|||
105989323|NCT02688985|365619562|FG004|Overall Study|Physician Decision|1|||
105989324|NCT02688985|365619558|FG000|Overall Study|Pregnancy|0|||
105989325|NCT02688985|365619559|FG001|Overall Study|Pregnancy|0|||
105989326|NCT02688985|365619560|FG002|Overall Study|Pregnancy|2|||
105989327|NCT02688985|365619561|FG003|Overall Study|Pregnancy|1|||
105989328|NCT02688985|365619562|FG004|Overall Study|Pregnancy|0|||
105989329|NCT02688985|365619558|FG000|Overall Study|Study Terminated By Sponsor|0|||
105989330|NCT02688985|365619559|FG001|Overall Study|Study Terminated By Sponsor|0|||
105989331|NCT02688985|365619560|FG002|Overall Study|Study Terminated By Sponsor|0|||
105989332|NCT02688985|365619561|FG003|Overall Study|Study Terminated By Sponsor|1|||
105989333|NCT02688985|365619562|FG004|Overall Study|Study Terminated By Sponsor|0|||
105989334|NCT02688985|365619558|FG000|Overall Study|Withdrawal by Subject|2|||
105989335|NCT02688985|365619559|FG001|Overall Study|Withdrawal by Subject|8|||
105989336|NCT02688985|365619560|FG002|Overall Study|Withdrawal by Subject|7|||
105989337|NCT02688985|365619561|FG003|Overall Study|Withdrawal by Subject|1|||
105989338|NCT02688985|365619562|FG004|Overall Study|Withdrawal by Subject|4|||
105989339|NCT00930553|365619563|FG000|Overall Study|Adverse Event|1|||
105989340|NCT00930553|365619563|FG000|Overall Study|Lack of Efficacy|7|||
105989341|NCT00930553|365619563|FG000|Overall Study|Physician Decision|39|||
105989342|NCT00930553|365619563|FG000|Overall Study|Protocol Violation|1|||
105989343|NCT00930553|365619563|FG000|Overall Study|Pregnancy|1|||
105989344|NCT00930553|365619563|FG000|Overall Study|Withdrawal by Subject|88|||
105989345|NCT00930553|365619563|FG000|Overall Study|Lost to Follow-up|25|||
105989346|NCT00930553|365619563|FG000|Overall Study|Death|9|||
105989347|NCT00930553|365619563|FG000|Overall Study|Study terminated by sponsor|24|||
105989348|NCT00930553|365619563|FG000|Overall Study|Other than specified above|28|||
105989349|NCT01235234|365619564|FG000|Overall Study|Adverse Event|2|||
105989350|NCT01235234|365619565|FG001|Overall Study|Adverse Event|2|||
105989351|NCT01235234|365619566|FG002|Overall Study|Adverse Event|1|||
105989352|NCT02352753|365619567|FG000|6-Month Dosing Period|Decision by sponsor|2|||
105989353|NCT02352753|365619567|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
105989354|NCT02352753|365619567|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
105989355|NCT02352753|365619567|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
105989356|NCT02352753|365619567|FG000|3-Month Dosing Period|Decision by sponsor|14|||
105989357|NCT02352753|365619567|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
105989358|NCT01279616|365619568|FG000|Overall Study|donor could not be located|5|||
105989359|NCT01279616|365619568|FG000|Overall Study|no signs of sickle cell disease|2|||
105989360|NCT02206035|365619570|FG000|Overall Study|Physician Decision|10|||
105989361|NCT02206035|365619571|FG001|Overall Study|Physician Decision|0|||
105989362|NCT02206035|365619572|FG002|Overall Study|Physician Decision|175|||
105989363|NCT01934010|365619573|FG000|Overall Study|Adverse Event|1|||
105989364|NCT01934010|365619574|FG001|Overall Study|Adverse Event|1|||
105989365|NCT01934010|365619575|FG002|Overall Study|Adverse Event|0|||
105989366|NCT01934010|365619573|FG000|Overall Study|Withdrawal by Subject|15|||
105989367|NCT01934010|365619574|FG001|Overall Study|Withdrawal by Subject|6|||
105989368|NCT01934010|365619575|FG002|Overall Study|Withdrawal by Subject|2|||
105989369|NCT01934010|365619573|FG000|Overall Study|Lost to Follow-up|7|||
105989370|NCT01934010|365619574|FG001|Overall Study|Lost to Follow-up|4|||
105989371|NCT01934010|365619575|FG002|Overall Study|Lost to Follow-up|0|||
105989372|NCT01068769|365619576|FG000|Overall Study|Ineligible|1|||
105989373|NCT03245398|365619580|FG000|Overall Study|Travelled to another island|1|||
105989374|NCT03245398|365619581|FG001|Overall Study|Travelled to another island|0|||
105989375|NCT00887926|365619582|FG000|Overall Study|Withdrawal by Subject|0|||
105989376|NCT00887926|365619583|FG001|Overall Study|Withdrawal by Subject|1|||
105989377|NCT00887926|365619584|FG002|Overall Study|Withdrawal by Subject|0|||
105989378|NCT00887926|365619585|FG003|Overall Study|Withdrawal by Subject|0|||
105989379|NCT00880191|365619586|FG000|Overall Study|Refused further treatment|4|||
105989380|NCT00880191|365619587|FG001|Overall Study|Refused further treatment|1|||
105989381|NCT00880191|365619586|FG000|Overall Study|Adverse Event|8|||
105989382|NCT00880191|365619587|FG001|Overall Study|Adverse Event|6|||
105989383|NCT00880191|365619586|FG000|Overall Study|Hospitalization/efficacy|1|||
105989384|NCT00880191|365619587|FG001|Overall Study|Hospitalization/efficacy|1|||
105989385|NCT01331109|365619588|FG000|Overall Study|Adverse Event|6|||
105989386|NCT01331109|365619588|FG000|Overall Study|Lack of Efficacy|2|||
105989387|NCT01331109|365619588|FG000|Overall Study|Protocol Violation|3|||
105989388|NCT01331109|365619588|FG000|Overall Study|Withdrawal by Subject|7|||
105989389|NCT01331109|365619588|FG000|Overall Study|Lost to Follow-up|1|||
105989390|NCT01331109|365619588|FG000|Overall Study|Study Terminated by Sponsor|38|||
105989391|NCT00988091|365619589|FG000|Double-blind Period|Withdrawal by Subject|15|||
105989392|NCT00988091|365619590|FG001|Double-blind Period|Withdrawal by Subject|13|||
105989393|NCT00988091|365619589|FG000|Double-blind Period|Lost to Follow-up|12|||
105989394|NCT00988091|365619590|FG001|Double-blind Period|Lost to Follow-up|14|||
105989395|NCT00988091|365619589|FG000|Double-blind Period|Other|8|||
105989396|NCT00988091|365619590|FG001|Double-blind Period|Other|8|||
105989397|NCT00988091|365619589|FG000|Double-blind Period|Adverse Event|6|||
105989398|NCT00988091|365619590|FG001|Double-blind Period|Adverse Event|9|||
105989399|NCT00988091|365619589|FG000|Double-blind Period|Use of exclusionary medication|2|||
105989400|NCT00988091|365619590|FG001|Double-blind Period|Use of exclusionary medication|3|||
105989401|NCT00988091|365619589|FG000|Open-label Period|Adverse Event|4|||
105989402|NCT00988091|365619590|FG001|Open-label Period|Adverse Event|7|||
105989403|NCT00988091|365619589|FG000|Open-label Period|Use of exclusionary medication|1|||
105989404|NCT00988091|365619590|FG001|Open-label Period|Use of exclusionary medication|1|||
105989405|NCT00988091|365619589|FG000|Open-label Period|Protocol Violation|1|||
105989406|NCT00988091|365619590|FG001|Open-label Period|Protocol Violation|1|||
105989407|NCT00988091|365619589|FG000|Open-label Period|Withdrawal by Subject|10|||
105989408|NCT00988091|365619590|FG001|Open-label Period|Withdrawal by Subject|16|||
105989409|NCT00988091|365619589|FG000|Open-label Period|Lost to Follow-up|3|||
105989410|NCT00988091|365619590|FG001|Open-label Period|Lost to Follow-up|5|||
105989411|NCT00988091|365619589|FG000|Open-label Period|Other|2|||
105989412|NCT00988091|365619590|FG001|Open-label Period|Other|3|||
105989413|NCT02649894|365619593|FG000|Overall Study|Adverse Event|1|||
105989414|NCT02649894|365619594|FG001|Overall Study|Adverse Event|0|||
105989415|NCT02649894|365619593|FG000|Overall Study|Physician Decision|0|||
105989416|NCT02649894|365619594|FG001|Overall Study|Physician Decision|1|||
105989417|NCT02649894|365619593|FG000|Overall Study|Withdrawal by Subject|5|||
105989418|NCT02649894|365619594|FG001|Overall Study|Withdrawal by Subject|2|||
105989419|NCT02649894|365619593|FG000|Overall Study|Lost to Follow-up|2|||
105989420|NCT02649894|365619594|FG001|Overall Study|Lost to Follow-up|1|||
105989421|NCT02649894|365619593|FG000|Overall Study|Death|30|||
105989422|NCT02649894|365619594|FG001|Overall Study|Death|7|||
105989423|NCT02649894|365619593|FG000|Overall Study|Other, not specified|6|||
105989424|NCT02649894|365619594|FG001|Overall Study|Other, not specified|0|||
105989425|NCT04302545|365619597|FG000|Overall Study|Lost to Follow-up|3|||
105989426|NCT04302545|365619598|FG001|Overall Study|Lost to Follow-up|4|||
105989427|NCT02473367|365619602|FG000|Wait 1|Withdrawal by Subject|1|||
105989428|NCT02473367|365619602|FG000|Period 4|Lost to Follow-up|1|||
105989429|NCT04079114|365619604|FG000|Overall Study|Study prematuely terminated.|166|||
105989430|NCT01007838|365619605|FG000|Overall Study|Withdrawal by Subject|1|||
105989431|NCT01007838|365619606|FG001|Overall Study|Withdrawal by Subject|0|||
105989432|NCT01007838|365619607|FG002|Overall Study|Withdrawal by Subject|0|||
105989433|NCT01007838|365619608|FG003|Overall Study|Withdrawal by Subject|0|||
105989434|NCT01007838|365619605|FG000|Overall Study|Physician Decision|1|||
105989435|NCT01007838|365619606|FG001|Overall Study|Physician Decision|0|||
105989436|NCT01007838|365619607|FG002|Overall Study|Physician Decision|0|||
105989437|NCT01007838|365619608|FG003|Overall Study|Physician Decision|0|||
105989438|NCT01007838|365619605|FG000|Overall Study|Started home haemodialysis|1|||
105989439|NCT01007838|365619606|FG001|Overall Study|Started home haemodialysis|0|||
105989440|NCT01007838|365619607|FG002|Overall Study|Started home haemodialysis|0|||
105989441|NCT01007838|365619608|FG003|Overall Study|Started home haemodialysis|0|||
105989442|NCT00408434|365619609|FG000|Overall Study|Adverse Event|0|||
105989443|NCT00408434|365619610|FG001|Overall Study|Adverse Event|0|||
105989444|NCT00408434|365619611|FG002|Overall Study|Adverse Event|1|||
105989445|NCT00408434|365619612|FG003|Overall Study|Adverse Event|0|||
105989446|NCT00408434|365619613|FG004|Overall Study|Adverse Event|0|||
105989447|NCT00408434|365619614|FG005|Overall Study|Adverse Event|0|||
105989448|NCT00408434|365619615|FG006|Overall Study|Adverse Event|0|||
105989449|NCT00408434|365619609|FG000|Overall Study|Progressive disease|6|||
105989450|NCT00408434|365619610|FG001|Overall Study|Progressive disease|3|||
105989451|NCT00408434|365619611|FG002|Overall Study|Progressive disease|4|||
105989452|NCT00408434|365619612|FG003|Overall Study|Progressive disease|3|||
105989453|NCT00408434|365619613|FG004|Overall Study|Progressive disease|3|||
105989454|NCT00408434|365619614|FG005|Overall Study|Progressive disease|1|||
105989455|NCT00408434|365619615|FG006|Overall Study|Progressive disease|4|||
105989456|NCT00408434|365619609|FG000|Overall Study|Other|0|||
105989457|NCT00408434|365619610|FG001|Overall Study|Other|0|||
105989458|NCT00408434|365619611|FG002|Overall Study|Other|1|||
105989459|NCT00408434|365619612|FG003|Overall Study|Other|0|||
105989460|NCT00408434|365619613|FG004|Overall Study|Other|2|||
105989461|NCT00408434|365619614|FG005|Overall Study|Other|1|||
105989462|NCT00408434|365619615|FG006|Overall Study|Other|0|||
105989463|NCT00408434|365619609|FG000|Overall Study|Terminated by Investigator|0|||
105989464|NCT00408434|365619610|FG001|Overall Study|Terminated by Investigator|0|||
105989465|NCT00408434|365619611|FG002|Overall Study|Terminated by Investigator|0|||
105989466|NCT00408434|365619612|FG003|Overall Study|Terminated by Investigator|0|||
105989467|NCT00408434|365619613|FG004|Overall Study|Terminated by Investigator|1|||
105989468|NCT00408434|365619614|FG005|Overall Study|Terminated by Investigator|1|||
105989469|NCT00408434|365619615|FG006|Overall Study|Terminated by Investigator|0|||
105989470|NCT00588354|365619616|FG000|Baseline to 2 Weeks|Adverse Event|1|||
105989471|NCT00588354|365619617|FG001|Baseline to 2 Weeks|Adverse Event|0|||
105989472|NCT00588354|365619616|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
105989473|NCT00588354|365619617|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
105989474|NCT00588354|365619616|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
105989475|NCT00588354|365619617|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
105989476|NCT00061633|365619620|FG000|Overall Study|Adverse Event|1|||
105989477|NCT00061633|365619621|FG001|Overall Study|Adverse Event|2|||
105989478|NCT00061633|365619620|FG000|Overall Study|Withdrawal by Subject|2|||
105989479|NCT00061633|365619621|FG001|Overall Study|Withdrawal by Subject|2|||
105989480|NCT00061633|365619620|FG000|Overall Study|Lost to Follow-up|1|||
105989481|NCT00061633|365619621|FG001|Overall Study|Lost to Follow-up|4|||
105989482|NCT00061633|365619620|FG000|Overall Study|Other|1|||
105989483|NCT00061633|365619621|FG001|Overall Study|Other|1|||
105989484|NCT00061633|365619620|FG000|Overall Study|Never received study treatment|0|||
105989485|NCT00061633|365619621|FG001|Overall Study|Never received study treatment|2|||
105989486|NCT02301624|365619622|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
105989487|NCT02301624|365619623|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
105989488|NCT02301624|365619622|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
105989489|NCT02301624|365619623|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
105989490|NCT02301624|365619622|FG000|Open-label Maintenance Phase|Adverse Event|2|||
105989491|NCT02301624|365619623|FG001|Open-label Maintenance Phase|Adverse Event|5|||
105989492|NCT02301624|365619622|FG000|Open-label Maintenance Phase|Physician Decision|3|||
105989493|NCT02301624|365619623|FG001|Open-label Maintenance Phase|Physician Decision|3|||
105989494|NCT02301624|365619622|FG000|Open-label Maintenance Phase|Death|2|||
105989495|NCT02301624|365619623|FG001|Open-label Maintenance Phase|Death|1|||
105989496|NCT02301624|365619622|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
105989497|NCT02301624|365619623|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
105989498|NCT00895310|365619624|FG000|Overall Study|Withdrawal by Subject|1|||
105989499|NCT00659230|365619625|FG000|Overall Study|Lost to Follow-up|2|||
105989500|NCT00659230|365619626|FG001|Overall Study|Lost to Follow-up|5|||
105989501|NCT00659230|365619625|FG000|Overall Study|Lost source documentation|5|||
105989502|NCT00659230|365619626|FG001|Overall Study|Lost source documentation|4|||
105989503|NCT00659230|365619625|FG000|Overall Study|Did not return post-randomization|2|||
105989504|NCT00659230|365619626|FG001|Overall Study|Did not return post-randomization|3|||
105989505|NCT00534976|365619627|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
105989506|NCT00534976|365619628|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
105989507|NCT00534976|365619627|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
105989508|NCT00534976|365619628|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
105989509|NCT00534976|365619627|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
105989510|NCT00534976|365619628|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
105989511|NCT02147288|365619629|FG000|Overall Study|post-operative hematoma|1|||
105989512|NCT02147288|365619630|FG001|Overall Study|post-operative hematoma|1|||
105989513|NCT02147288|365619631|FG002|Overall Study|post-operative hematoma|0|||
105989514|NCT02147288|365619632|FG003|Overall Study|post-operative hematoma|0|||
105989515|NCT02147288|365619633|FG004|Overall Study|post-operative hematoma|0|||
105989516|NCT02147288|365619634|FG005|Overall Study|post-operative hematoma|0|||
105989517|NCT02147288|365619635|FG006|Overall Study|post-operative hematoma|0|||
105989518|NCT02147288|365619636|FG007|Overall Study|post-operative hematoma|0|||
105989519|NCT02147288|365619637|FG008|Overall Study|post-operative hematoma|0|||
105989520|NCT02147288|365619638|FG009|Overall Study|post-operative hematoma|0|||
105989521|NCT02147288|365619629|FG000|Overall Study|complications from concurrent hernia rep|0|||
105989522|NCT02147288|365619630|FG001|Overall Study|complications from concurrent hernia rep|1|||
105989523|NCT02147288|365619631|FG002|Overall Study|complications from concurrent hernia rep|0|||
105989524|NCT02147288|365619632|FG003|Overall Study|complications from concurrent hernia rep|0|||
105989525|NCT02147288|365619633|FG004|Overall Study|complications from concurrent hernia rep|0|||
105989526|NCT02147288|365619634|FG005|Overall Study|complications from concurrent hernia rep|0|||
105989527|NCT02147288|365619635|FG006|Overall Study|complications from concurrent hernia rep|0|||
105989528|NCT02147288|365619636|FG007|Overall Study|complications from concurrent hernia rep|0|||
105989529|NCT02147288|365619637|FG008|Overall Study|complications from concurrent hernia rep|0|||
105989530|NCT02147288|365619638|FG009|Overall Study|complications from concurrent hernia rep|0|||
105989531|NCT00861471|365619639|FG000|Overall Study|Withdrawal by Subject|1|||
105989532|NCT00861471|365619639|FG000|Overall Study|Adverse Event|2|||
105989533|NCT00861471|365619639|FG000|Overall Study|Lack of Efficacy|3|||
105989534|NCT00861471|365619639|FG000|Overall Study|treatment for lumbar laminectomy|1|||
105989535|NCT00861471|365619639|FG000|Overall Study|Physician Decision|2|||
105989536|NCT02069392|365619642|FG000|Overall Study|Withdrawal by Subject|4|||
105989537|NCT02069392|365619643|FG001|Overall Study|Withdrawal by Subject|2|||
105989538|NCT00269633|365619644|FG000|Overall Study|Withdrawal by Subject|1|||
105989539|NCT00269633|365619645|FG001|Overall Study|Withdrawal by Subject|0|||
105989540|NCT00445770|365619646|FG000|Overall Study|Adverse Event|9|||
105989541|NCT00445770|365619647|FG001|Overall Study|Adverse Event|15|||
105989542|NCT00445770|365619648|FG002|Overall Study|Adverse Event|19|||
105989543|NCT00445770|365619646|FG000|Overall Study|Lack of Efficacy|38|||
105989544|NCT00445770|365619647|FG001|Overall Study|Lack of Efficacy|13|||
105989545|NCT00445770|365619648|FG002|Overall Study|Lack of Efficacy|6|||
105989546|NCT00445770|365619646|FG000|Overall Study|Lost to Follow-up|0|||
105989547|NCT00445770|365619647|FG001|Overall Study|Lost to Follow-up|2|||
105989548|NCT00445770|365619648|FG002|Overall Study|Lost to Follow-up|0|||
105989549|NCT00445770|365619646|FG000|Overall Study|Other|6|||
105989550|NCT00445770|365619647|FG001|Overall Study|Other|5|||
105989551|NCT00445770|365619648|FG002|Overall Study|Other|6|||
105989552|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Adverse Event|33|||
105989553|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
105989554|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
105989555|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
105989556|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Physician Decision|6|||
105989557|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
105989558|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
105989559|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
105989560|NCT00965419|365619649|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
105989561|NCT00965419|365619649|FG000|Follow-up Phase|Adverse Event|9|||
105989562|NCT00965419|365619649|FG000|Follow-up Phase|Protocol Violation|4|||
105989563|NCT00965419|365619649|FG000|Follow-up Phase|Withdrawal by Subject|8|||
105989564|NCT00965419|365619649|FG000|Follow-up Phase|Physician Decision|4|||
105989565|NCT00965419|365619649|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
105989566|NCT00965419|365619649|FG000|Follow-up Phase|Lack of Efficacy|28|||
105989567|NCT03857542|365619650|FG000|Overall Study|Adverse Event|1|||
105989568|NCT03857542|365619651|FG001|Overall Study|Adverse Event|3|||
105989569|NCT03857542|365619650|FG000|Overall Study|Withdrawal by Subject|2|||
106097918|NCT04782323|366016465|FG005|Overall Study|Death|1|||
105989570|NCT03857542|365619651|FG001|Overall Study|Withdrawal by Subject|1|||
105989571|NCT03857542|365619650|FG000|Overall Study|Lost to Follow-up|2|||
105989572|NCT03857542|365619651|FG001|Overall Study|Lost to Follow-up|1|||
105989573|NCT03857542|365619650|FG000|Overall Study|Reason not Specified|1|||
105989574|NCT03857542|365619651|FG001|Overall Study|Reason not Specified|0|||
105989575|NCT02927938|365619652|FG000|Overall Study|Death|0|||
105989576|NCT02927938|365619653|FG001|Overall Study|Death|1|||
105989577|NCT02927938|365619654|FG002|Overall Study|Death|0|||
105989578|NCT02927938|365619655|FG003|Overall Study|Death|4|||
105989579|NCT02927938|365619652|FG000|Overall Study|Early Study Termination|1|||
105989580|NCT02927938|365619653|FG001|Overall Study|Early Study Termination|5|||
105989581|NCT02927938|365619654|FG002|Overall Study|Early Study Termination|4|||
105989582|NCT02927938|365619655|FG003|Overall Study|Early Study Termination|3|||
105989583|NCT02834247|365619657|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
105989584|NCT02834247|365619658|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
105989585|NCT02834247|365619659|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
105989586|NCT02834247|365619660|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
105989587|NCT02834247|365619657|FG000|Dose Escalation Phase|Death|5|||
105989588|NCT02834247|365619658|FG001|Dose Escalation Phase|Death|6|||
105989589|NCT02834247|365619659|FG002|Dose Escalation Phase|Death|5|||
105989590|NCT02834247|365619660|FG003|Dose Escalation Phase|Death|0|||
105989591|NCT02834247|365619657|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
105989592|NCT02834247|365619658|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
105989593|NCT02834247|365619659|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
105989594|NCT02834247|365619660|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
105989595|NCT02834247|365619657|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
105989596|NCT02834247|365619658|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
105989597|NCT02834247|365619659|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
105989598|NCT02834247|365619660|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105989599|NCT02834247|365619657|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
105989600|NCT02834247|365619658|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
105989601|NCT02834247|365619659|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
105989602|NCT02834247|365619660|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
105989603|NCT02834247|365619657|FG000|Dose Expansion Phase|Death|0|||
105989604|NCT02834247|365619658|FG001|Dose Expansion Phase|Death|0|||
105989605|NCT02834247|365619659|FG002|Dose Expansion Phase|Death|0|||
105989606|NCT02834247|365619660|FG003|Dose Expansion Phase|Death|8|||
105989607|NCT02834247|365619657|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
105989608|NCT02834247|365619658|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
105989609|NCT02834247|365619659|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
105989610|NCT02834247|365619660|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
105989611|NCT02834247|365619657|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
105989612|NCT02834247|365619658|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
105989613|NCT02834247|365619659|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
105989614|NCT02834247|365619660|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
105989615|NCT02476006|365619667|FG000|Overall Study|Death|4|||
105989616|NCT02476006|365619667|FG000|Overall Study|Lack of treatment efficacy|2|||
105989617|NCT02476006|365619667|FG000|Overall Study|Pregnancy|1|||
105989618|NCT02476006|365619667|FG000|Overall Study|Participant did not wish to continue|39|||
105989619|NCT02476006|365619667|FG000|Overall Study|Adverse Event|41|||
105989620|NCT02476006|365619667|FG000|Overall Study|Poor compliance to study protocol|3|||
105989621|NCT02476006|365619667|FG000|Overall Study|Sponsor decision|6|||
105989622|NCT02476006|365619667|FG000|Overall Study|Lost to Follow-up|5|||
105989623|NCT02476006|365619667|FG000|Overall Study|Physician Decision|5|||
105989624|NCT02476006|365619667|FG000|Overall Study|Study ended treatment not available|4|||
105989625|NCT02476006|365619667|FG000|Overall Study|Switched to commercial drug|4|||
105989626|NCT02476006|365619667|FG000|Overall Study|Excluded from study|1|||
105989627|NCT02476006|365619667|FG000|Overall Study|Protocol Violation|1|||
105989628|NCT02476006|365619667|FG000|Overall Study|Enrolled but not treated|4|||
105989629|NCT03210961|365621945|FG000|Overall Study|Adverse Event|0|||
105989630|NCT03210961|365621946|FG001|Overall Study|Adverse Event|0|||
105989631|NCT03210961|365621947|FG002|Overall Study|Adverse Event|0|||
105989632|NCT03210961|365621948|FG003|Overall Study|Adverse Event|0|||
105989633|NCT03210961|365621949|FG004|Overall Study|Adverse Event|0|||
105989634|NCT03210961|365621950|FG005|Overall Study|Adverse Event|0|||
105989635|NCT03210961|365621951|FG006|Overall Study|Adverse Event|0|||
105989636|NCT03210961|365621952|FG007|Overall Study|Adverse Event|0|||
105989637|NCT03210961|365621953|FG008|Overall Study|Adverse Event|0|||
105989638|NCT03210961|365621954|FG009|Overall Study|Adverse Event|0|||
105989639|NCT03210961|365621955|FG010|Overall Study|Adverse Event|0|||
105989640|NCT03210961|365621956|FG011|Overall Study|Adverse Event|0|||
105989641|NCT03210961|365621957|FG012|Overall Study|Adverse Event|0|||
105989642|NCT03210961|365621958|FG013|Overall Study|Adverse Event|1|||
105989643|NCT03210961|365621959|FG014|Overall Study|Adverse Event|0|||
105989644|NCT03210961|365621945|FG000|Overall Study|Lost to Follow-up|0|||
105989645|NCT03210961|365621946|FG001|Overall Study|Lost to Follow-up|0|||
105989646|NCT03210961|365621947|FG002|Overall Study|Lost to Follow-up|0|||
105989647|NCT03210961|365621948|FG003|Overall Study|Lost to Follow-up|0|||
105989648|NCT03210961|365621949|FG004|Overall Study|Lost to Follow-up|0|||
105989649|NCT03210961|365621950|FG005|Overall Study|Lost to Follow-up|0|||
105989650|NCT03210961|365621951|FG006|Overall Study|Lost to Follow-up|0|||
105989651|NCT03210961|365621952|FG007|Overall Study|Lost to Follow-up|0|||
105989652|NCT03210961|365621953|FG008|Overall Study|Lost to Follow-up|0|||
105989653|NCT03210961|365621954|FG009|Overall Study|Lost to Follow-up|0|||
105989654|NCT03210961|365621955|FG010|Overall Study|Lost to Follow-up|0|||
105989655|NCT03210961|365621956|FG011|Overall Study|Lost to Follow-up|0|||
105989656|NCT03210961|365621957|FG012|Overall Study|Lost to Follow-up|0|||
105989657|NCT03210961|365621958|FG013|Overall Study|Lost to Follow-up|0|||
105989658|NCT03210961|365621959|FG014|Overall Study|Lost to Follow-up|1|||
105989659|NCT03210961|365621945|FG000|Overall Study|Withdrawal by Subject|0|||
105989660|NCT03210961|365621946|FG001|Overall Study|Withdrawal by Subject|0|||
105989661|NCT03210961|365621947|FG002|Overall Study|Withdrawal by Subject|0|||
105989662|NCT03210961|365621948|FG003|Overall Study|Withdrawal by Subject|0|||
105989663|NCT03210961|365621949|FG004|Overall Study|Withdrawal by Subject|0|||
105989664|NCT03210961|365621950|FG005|Overall Study|Withdrawal by Subject|0|||
105989665|NCT03210961|365621951|FG006|Overall Study|Withdrawal by Subject|0|||
105989666|NCT03210961|365621952|FG007|Overall Study|Withdrawal by Subject|0|||
105989667|NCT03210961|365621953|FG008|Overall Study|Withdrawal by Subject|0|||
105989668|NCT03210961|365621954|FG009|Overall Study|Withdrawal by Subject|0|||
105989669|NCT03210961|365621955|FG010|Overall Study|Withdrawal by Subject|0|||
105989670|NCT03210961|365621956|FG011|Overall Study|Withdrawal by Subject|0|||
105989671|NCT03210961|365621957|FG012|Overall Study|Withdrawal by Subject|0|||
105989672|NCT03210961|365621958|FG013|Overall Study|Withdrawal by Subject|0|||
105989673|NCT03210961|365621959|FG014|Overall Study|Withdrawal by Subject|1|||
105989674|NCT03210961|365621945|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989675|NCT03210961|365621946|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989676|NCT03210961|365621947|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989677|NCT03210961|365621948|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989678|NCT03210961|365621949|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989679|NCT03210961|365621950|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989680|NCT03210961|365621951|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989681|NCT03210961|365621952|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989682|NCT03210961|365621953|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989683|NCT03210961|365621954|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989684|NCT03210961|365621955|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989685|NCT03210961|365621956|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989686|NCT03210961|365621957|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989687|NCT03210961|365621958|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
105989688|NCT03210961|365621959|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
105989689|NCT03210961|365621945|FG000|Overall Study|Other|0|||
105989690|NCT03210961|365621946|FG001|Overall Study|Other|0|||
105989691|NCT03210961|365621947|FG002|Overall Study|Other|0|||
105989692|NCT03210961|365621948|FG003|Overall Study|Other|1|||
105989693|NCT03210961|365621949|FG004|Overall Study|Other|0|||
105989694|NCT03210961|365621950|FG005|Overall Study|Other|0|||
105989695|NCT03210961|365621951|FG006|Overall Study|Other|1|||
105989696|NCT03210961|365621952|FG007|Overall Study|Other|0|||
105989697|NCT03210961|365621953|FG008|Overall Study|Other|0|||
105989698|NCT03210961|365621954|FG009|Overall Study|Other|0|||
105989699|NCT03210961|365621955|FG010|Overall Study|Other|1|||
105989700|NCT03210961|365621956|FG011|Overall Study|Other|0|||
105989701|NCT03210961|365621957|FG012|Overall Study|Other|2|||
105989702|NCT03210961|365621958|FG013|Overall Study|Other|2|||
105989703|NCT03210961|365621959|FG014|Overall Study|Other|0|||
105989704|NCT02467582|365621960|FG000|Allocation|Withdrawal by Subject|1|||
105989705|NCT02467582|365621961|FG001|Allocation|Withdrawal by Subject|0|||
105989706|NCT02467582|365621960|FG000|Follow-up|Death|5|||
105989707|NCT02467582|365621961|FG001|Follow-up|Death|4|||
105989708|NCT02467582|365621960|FG000|Follow-up|Lost to Follow-up|6|||
105989709|NCT02467582|365621961|FG001|Follow-up|Lost to Follow-up|5|||
105989710|NCT03831100|365621969|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
105989711|NCT03831100|365621970|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
105989712|NCT02008227|365621974|FG000|Overall Study|Lost to Follow-up|7|||
105989713|NCT02008227|365621975|FG001|Overall Study|Lost to Follow-up|9|||
105989714|NCT02008227|365621974|FG000|Overall Study|Death|494|||
105989715|NCT02008227|365621975|FG001|Overall Study|Death|485|||
105989716|NCT02008227|365621974|FG000|Overall Study|Withdrawal by Subject|67|||
105989717|NCT02008227|365621975|FG001|Overall Study|Withdrawal by Subject|36|||
105989718|NCT02008227|365621974|FG000|Overall Study|Study Terminated By Sponsor|44|||
105989719|NCT02008227|365621975|FG001|Overall Study|Study Terminated By Sponsor|83|||
105989720|NCT03354273|365621978|FG000|Overall Study|Adverse Event|5|||
105989721|NCT03354273|365621978|FG000|Overall Study|Screen Failure|21|||
105989722|NCT03354273|365621978|FG000|Overall Study|Withdrawal by Subject|34|||
105989723|NCT03354273|365621978|FG000|Overall Study|Technical Problems|30|||
105989724|NCT03354273|365621978|FG000|Overall Study|Lost to Follow-up|4|||
105989725|NCT03354273|365621978|FG000|Overall Study|Investigator Decision|3|||
105989726|NCT03354273|365621978|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
105989727|NCT03354273|365621978|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
105989728|NCT03354273|365621978|FG000|Overall Study|COVID-19 Restrictions|9|||
105989729|NCT03354273|365621978|FG000|Overall Study|Other|5|||
105989730|NCT03229109|365621982|FG000|Overall Study|Withdrawal by Subject|0|||
105989731|NCT03229109|365621983|FG001|Overall Study|Withdrawal by Subject|0|||
105989732|NCT03229109|365621984|FG002|Overall Study|Withdrawal by Subject|0|||
105989733|NCT03229109|365621985|FG003|Overall Study|Withdrawal by Subject|1|||
105989734|NCT04207749|365621986|FG000|Overall Study|Lost to Follow-up|0|||
105989735|NCT04207749|365621987|FG001|Overall Study|Lost to Follow-up|2|||
105989736|NCT04207749|365621986|FG000|Overall Study|Protocol Violation|0|||
105989737|NCT04207749|365621987|FG001|Overall Study|Protocol Violation|1|||
105989738|NCT04207749|365621986|FG000|Overall Study|Withdrawal by Subject|3|||
105989739|NCT04207749|365621987|FG001|Overall Study|Withdrawal by Subject|0|||
105989740|NCT04207749|365621986|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
105989741|NCT04207749|365621987|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
105989742|NCT00655629|365621988|FG000|Overall Study|Adverse Event|4|||
105989743|NCT00655629|365621989|FG001|Overall Study|Adverse Event|1|||
105989744|NCT00655629|365621988|FG000|Overall Study|Lack of Efficacy|2|||
105989745|NCT00655629|365621989|FG001|Overall Study|Lack of Efficacy|12|||
105989746|NCT00655629|365621988|FG000|Overall Study|Lost to Follow-up|4|||
105989747|NCT00655629|365621989|FG001|Overall Study|Lost to Follow-up|3|||
105989748|NCT00655629|365621988|FG000|Overall Study|Protocol Violation|5|||
105989749|NCT00655629|365621989|FG001|Overall Study|Protocol Violation|3|||
105989750|NCT00655629|365621988|FG000|Overall Study|consent withdrawn|6|||
105989751|NCT00655629|365621989|FG001|Overall Study|consent withdrawn|4|||
105989752|NCT01835223|365621990|FG000|Overall Study|Adverse Event|1|||
105989753|NCT01835223|365621991|FG001|Overall Study|Adverse Event|0|||
105989754|NCT01835223|365621990|FG000|Overall Study|Withdrawal by Subject|2|||
105989755|NCT01835223|365621991|FG001|Overall Study|Withdrawal by Subject|0|||
105989756|NCT01835223|365621990|FG000|Overall Study|Disease progression|2|||
105989757|NCT01835223|365621991|FG001|Overall Study|Disease progression|1|||
105989758|NCT01835223|365621990|FG000|Overall Study|Became Inelligible|4|||
105989759|NCT01835223|365621991|FG001|Overall Study|Became Inelligible|0|||
105989760|NCT02629822|365621994|FG000|Base Study|Lost to Follow-up|2|||
105989761|NCT02629822|365621994|FG000|Base Study|Non-Compliance With Study Drug|1|||
105989762|NCT02629822|365621994|FG000|Extension Study|Adverse Event|1|||
105989763|NCT02629822|365621994|FG000|Extension Study|Lost to Follow-up|1|||
105989764|NCT01610336|365621995|FG000|Overall Study|Progressive Disease|4|||
105989765|NCT01610336|365621996|FG001|Overall Study|Progressive Disease|6|||
105989766|NCT01610336|365621997|FG002|Overall Study|Progressive Disease|6|||
105989767|NCT01610336|365621998|FG003|Overall Study|Progressive Disease|5|||
105989768|NCT01610336|365621999|FG004|Overall Study|Progressive Disease|3|||
105989769|NCT01610336|365622000|FG005|Overall Study|Progressive Disease|10|||
105989770|NCT01610336|365622001|FG006|Overall Study|Progressive Disease|1|||
105989771|NCT01610336|365622002|FG007|Overall Study|Progressive Disease|6|||
105989772|NCT01610336|365622003|FG008|Overall Study|Progressive Disease|6|||
105989773|NCT01610336|365622004|FG009|Overall Study|Progressive Disease|40|||
105989774|NCT01610336|365622005|FG010|Overall Study|Progressive Disease|36|||
105989775|NCT01610336|365621995|FG000|Overall Study|Adverse Event|0|||
105989776|NCT01610336|365621996|FG001|Overall Study|Adverse Event|0|||
105989777|NCT01610336|365621997|FG002|Overall Study|Adverse Event|0|||
105989778|NCT01610336|365621998|FG003|Overall Study|Adverse Event|1|||
105989779|NCT01610336|365621999|FG004|Overall Study|Adverse Event|1|||
105989780|NCT01610336|365622000|FG005|Overall Study|Adverse Event|1|||
105989781|NCT01610336|365622001|FG006|Overall Study|Adverse Event|0|||
105989782|NCT01610336|365622002|FG007|Overall Study|Adverse Event|0|||
105989783|NCT01610336|365622003|FG008|Overall Study|Adverse Event|2|||
105989784|NCT01610336|365622004|FG009|Overall Study|Adverse Event|8|||
105989785|NCT01610336|365622005|FG010|Overall Study|Adverse Event|6|||
105989786|NCT01610336|365621995|FG000|Overall Study|Subject/Guardian decision|1|||
105989787|NCT01610336|365621996|FG001|Overall Study|Subject/Guardian decision|1|||
105989788|NCT01610336|365621997|FG002|Overall Study|Subject/Guardian decision|0|||
105989789|NCT01610336|365621998|FG003|Overall Study|Subject/Guardian decision|1|||
105989790|NCT01610336|365621999|FG004|Overall Study|Subject/Guardian decision|0|||
105989791|NCT01610336|365622000|FG005|Overall Study|Subject/Guardian decision|0|||
105989792|NCT01610336|365622001|FG006|Overall Study|Subject/Guardian decision|0|||
105989793|NCT01610336|365622002|FG007|Overall Study|Subject/Guardian decision|1|||
105989794|NCT01610336|365622003|FG008|Overall Study|Subject/Guardian decision|0|||
105989795|NCT01610336|365622004|FG009|Overall Study|Subject/Guardian decision|2|||
105989796|NCT01610336|365622005|FG010|Overall Study|Subject/Guardian decision|2|||
105989797|NCT01610336|365621995|FG000|Overall Study|Death|0|||
105989798|NCT01610336|365621996|FG001|Overall Study|Death|0|||
105989799|NCT01610336|365621997|FG002|Overall Study|Death|0|||
105989800|NCT01610336|365621998|FG003|Overall Study|Death|0|||
105989801|NCT01610336|365621999|FG004|Overall Study|Death|0|||
105989802|NCT01610336|365622000|FG005|Overall Study|Death|1|||
105989803|NCT01610336|365622001|FG006|Overall Study|Death|3|||
105989804|NCT01610336|365622002|FG007|Overall Study|Death|0|||
105989805|NCT01610336|365622003|FG008|Overall Study|Death|0|||
105989806|NCT01610336|365622004|FG009|Overall Study|Death|1|||
105989807|NCT01610336|365622005|FG010|Overall Study|Death|2|||
105989808|NCT01610336|365621995|FG000|Overall Study|Non-Compliance with study treatment|0|||
105989809|NCT01610336|365621996|FG001|Overall Study|Non-Compliance with study treatment|0|||
105989810|NCT01610336|365621997|FG002|Overall Study|Non-Compliance with study treatment|0|||
105989811|NCT01610336|365621998|FG003|Overall Study|Non-Compliance with study treatment|0|||
105989812|NCT01610336|365621999|FG004|Overall Study|Non-Compliance with study treatment|0|||
105989813|NCT01610336|365622000|FG005|Overall Study|Non-Compliance with study treatment|0|||
105989814|NCT01610336|365622001|FG006|Overall Study|Non-Compliance with study treatment|0|||
105989815|NCT01610336|365622002|FG007|Overall Study|Non-Compliance with study treatment|0|||
105989816|NCT01610336|365622003|FG008|Overall Study|Non-Compliance with study treatment|0|||
105989817|NCT01610336|365622004|FG009|Overall Study|Non-Compliance with study treatment|1|||
105989818|NCT01610336|365622005|FG010|Overall Study|Non-Compliance with study treatment|0|||
105989819|NCT01610336|365621995|FG000|Overall Study|Physician Decision|0|||
105989820|NCT01610336|365621996|FG001|Overall Study|Physician Decision|0|||
105989821|NCT01610336|365621997|FG002|Overall Study|Physician Decision|0|||
105989822|NCT01610336|365621998|FG003|Overall Study|Physician Decision|0|||
105989823|NCT01610336|365621999|FG004|Overall Study|Physician Decision|0|||
105989824|NCT01610336|365622000|FG005|Overall Study|Physician Decision|0|||
105989825|NCT01610336|365622001|FG006|Overall Study|Physician Decision|1|||
105989826|NCT01610336|365622002|FG007|Overall Study|Physician Decision|0|||
105989827|NCT01610336|365622003|FG008|Overall Study|Physician Decision|0|||
105989828|NCT01610336|365622004|FG009|Overall Study|Physician Decision|0|||
105989829|NCT01610336|365622005|FG010|Overall Study|Physician Decision|0|||
105989830|NCT01610336|365621995|FG000|Overall Study|Protocol Deviation|0|||
105989831|NCT01610336|365621996|FG001|Overall Study|Protocol Deviation|0|||
105989832|NCT01610336|365621997|FG002|Overall Study|Protocol Deviation|0|||
105989833|NCT01610336|365621998|FG003|Overall Study|Protocol Deviation|0|||
105989834|NCT01610336|365621999|FG004|Overall Study|Protocol Deviation|0|||
105989835|NCT01610336|365622000|FG005|Overall Study|Protocol Deviation|0|||
105989836|NCT01610336|365622001|FG006|Overall Study|Protocol Deviation|0|||
105989837|NCT01610336|365622002|FG007|Overall Study|Protocol Deviation|0|||
105989838|NCT01610336|365622003|FG008|Overall Study|Protocol Deviation|0|||
105989839|NCT01610336|365622004|FG009|Overall Study|Protocol Deviation|1|||
105989840|NCT01610336|365622005|FG010|Overall Study|Protocol Deviation|0|||
105989841|NCT01610336|365621995|FG000|Overall Study|Transfer to another trial|0|||
105989842|NCT01610336|365621996|FG001|Overall Study|Transfer to another trial|0|||
105989843|NCT01610336|365621997|FG002|Overall Study|Transfer to another trial|0|||
105989844|NCT01610336|365621998|FG003|Overall Study|Transfer to another trial|0|||
105989845|NCT01610336|365621999|FG004|Overall Study|Transfer to another trial|0|||
105989846|NCT01610336|365622000|FG005|Overall Study|Transfer to another trial|0|||
105989847|NCT01610336|365622001|FG006|Overall Study|Transfer to another trial|0|||
105989848|NCT01610336|365622002|FG007|Overall Study|Transfer to another trial|0|||
105989849|NCT01610336|365622003|FG008|Overall Study|Transfer to another trial|0|||
105989850|NCT01610336|365622004|FG009|Overall Study|Transfer to another trial|0|||
105989851|NCT01610336|365622005|FG010|Overall Study|Transfer to another trial|1|||
105989852|NCT04440813|365622006|FG000|Overall Study|Lost to Follow-up|5|||
105989853|NCT04440813|365622007|FG001|Overall Study|Lost to Follow-up|5|||
105989854|NCT00741013|365622008|FG000|Overall Study|Adverse Event|1|||
105989855|NCT00741013|365622009|FG001|Overall Study|Adverse Event|0|||
105989856|NCT00741013|365622010|FG002|Overall Study|Adverse Event|0|||
105989857|NCT00741013|365622008|FG000|Overall Study|Withdrawal by Subject|0|||
105989858|NCT00741013|365622009|FG001|Overall Study|Withdrawal by Subject|0|||
105989859|NCT00741013|365622010|FG002|Overall Study|Withdrawal by Subject|1|||
105989860|NCT00741013|365622008|FG000|Overall Study|Discovered failed screen after enrolled|0|||
105989861|NCT00741013|365622009|FG001|Overall Study|Discovered failed screen after enrolled|2|||
105989862|NCT00741013|365622010|FG002|Overall Study|Discovered failed screen after enrolled|0|||
105989863|NCT03437577|365622011|FG000|Pre-Randomization|Withdrawal by Subject|0|||
105989864|NCT03437577|365622012|FG001|Pre-Randomization|Withdrawal by Subject|0|||
105989865|NCT03437577|365622013|FG002|Pre-Randomization|Withdrawal by Subject|10|||
105989866|NCT03437577|365622011|FG000|Post-Randomization|Physician Decision|0|||
105989867|NCT03437577|365622012|FG001|Post-Randomization|Physician Decision|2|||
105989868|NCT03437577|365622013|FG002|Post-Randomization|Physician Decision|0|||
105989869|NCT03704688|365622014|FG000|Overall Study|Adverse Event|0|||
105989870|NCT03704688|365622015|FG001|Overall Study|Adverse Event|0|||
105989871|NCT03704688|365622016|FG002|Overall Study|Adverse Event|0|||
105989872|NCT03704688|365622017|FG003|Overall Study|Adverse Event|4|||
105989873|NCT03704688|365622018|FG004|Overall Study|Adverse Event|1|||
105989874|NCT03704688|365622019|FG005|Overall Study|Adverse Event|0|||
105989875|NCT03704688|365622014|FG000|Overall Study|Disease Progression|0|||
105989876|NCT03704688|365622015|FG001|Overall Study|Disease Progression|0|||
105989877|NCT03704688|365622016|FG002|Overall Study|Disease Progression|0|||
105989878|NCT03704688|365622017|FG003|Overall Study|Disease Progression|3|||
105989879|NCT03704688|365622018|FG004|Overall Study|Disease Progression|1|||
105989880|NCT03704688|365622019|FG005|Overall Study|Disease Progression|0|||
105989881|NCT03704688|365622014|FG000|Overall Study|Death|0|||
105989882|NCT03704688|365622015|FG001|Overall Study|Death|0|||
105989883|NCT03704688|365622016|FG002|Overall Study|Death|0|||
105989884|NCT03704688|365622017|FG003|Overall Study|Death|0|||
105989885|NCT03704688|365622018|FG004|Overall Study|Death|3|||
105989886|NCT03704688|365622019|FG005|Overall Study|Death|0|||
105989887|NCT01440816|365622028|FG000|Overall Study|Disease Progression|0|||
105989888|NCT01440816|365622029|FG001|Overall Study|Disease Progression|9|||
105989889|NCT01440816|365622028|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
105989890|NCT01440816|365622029|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
105989891|NCT00787189|365622030|FG000|Overall Study|Lost to Follow-up|2|||
105989892|NCT00787189|365622031|FG001|Overall Study|Lost to Follow-up|2|||
105989893|NCT03920254|365622032|FG000|Overall Study|Adverse Event|1|||
105989894|NCT03920254|365622033|FG001|Overall Study|Adverse Event|0|||
105989895|NCT03920254|365622034|FG002|Overall Study|Adverse Event|0|||
105989896|NCT03920254|365622032|FG000|Overall Study|Physician Decision|0|||
105989897|NCT03920254|365622033|FG001|Overall Study|Physician Decision|1|||
105989898|NCT03920254|365622034|FG002|Overall Study|Physician Decision|2|||
105989899|NCT03920254|365622032|FG000|Overall Study|Study Terminated By Sponsor|12|||
105989900|NCT03920254|365622033|FG001|Overall Study|Study Terminated By Sponsor|17|||
105989901|NCT03920254|365622034|FG002|Overall Study|Study Terminated By Sponsor|12|||
105989902|NCT03920254|365622032|FG000|Overall Study|Withdrawal by Subject|0|||
105989903|NCT03920254|365622033|FG001|Overall Study|Withdrawal by Subject|0|||
105989904|NCT03920254|365622034|FG002|Overall Study|Withdrawal by Subject|1|||
105989905|NCT01393821|365622035|FG000|Overall Study|Cancel|1|||
105989906|NCT01393821|365622036|FG001|Overall Study|Cancel|1|||
105989907|NCT01393821|365622035|FG000|Overall Study|not evaluable for primary endpoint|4|||
105989908|NCT01393821|365622036|FG001|Overall Study|not evaluable for primary endpoint|2|||
105989909|NCT01858740|365622037|FG000|Overall Study|Death|4|||
105989910|NCT02104947|365622051|FG000|Overall Study|Withdrawal by Subject|10|||
105989911|NCT02104947|365622052|FG001|Overall Study|Withdrawal by Subject|3|||
105989912|NCT02104947|365622051|FG000|Overall Study|Lost to Follow-up|4|||
105989913|NCT02104947|365622052|FG001|Overall Study|Lost to Follow-up|4|||
105989914|NCT02104947|365622051|FG000|Overall Study|Protocol Violation|6|||
105989915|NCT02104947|365622052|FG001|Overall Study|Protocol Violation|8|||
105989916|NCT02104947|365622051|FG000|Overall Study|Adverse Event|57|||
105989917|NCT02104947|365622052|FG001|Overall Study|Adverse Event|38|||
105989918|NCT02104947|365622051|FG000|Overall Study|Other than stated above|2|||
105989919|NCT02104947|365622052|FG001|Overall Study|Other than stated above|3|||
105989920|NCT02690714|365622054|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
105989921|NCT02690714|365622054|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
105989922|NCT00095173|365622057|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
105989923|NCT00095173|365622058|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105989924|NCT00095173|365622059|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105989925|NCT00095173|365622060|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105989926|NCT00095173|365622061|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105989927|NCT00095173|365622062|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
105989928|NCT00095173|365622057|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
105989929|NCT00095173|365622058|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105989930|NCT00095173|365622059|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105989931|NCT00095173|365622060|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105989932|NCT00095173|365622061|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105989933|NCT00095173|365622062|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
105989934|NCT00095173|365622057|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
105989935|NCT00095173|365622058|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105989936|NCT00095173|365622059|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105989937|NCT00095173|365622060|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105989938|NCT00095173|365622061|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105989939|NCT00095173|365622062|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
105989940|NCT00095173|365622057|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
105989941|NCT00095173|365622058|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
105989942|NCT00095173|365622059|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
105989943|NCT00095173|365622060|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
105989944|NCT00095173|365622061|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
105989945|NCT00095173|365622062|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
105989946|NCT00095173|365622057|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
105989947|NCT00095173|365622058|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
105989948|NCT00095173|365622059|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
105989949|NCT00095173|365622060|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
105989950|NCT00095173|365622061|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
105989951|NCT00095173|365622062|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
105989952|NCT00095173|365622057|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105989953|NCT00095173|365622058|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
105989954|NCT00095173|365622059|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105989955|NCT00095173|365622060|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105989956|NCT00095173|365622061|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105989957|NCT00095173|365622062|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
105989958|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|Death|0|||
105989959|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|Death|0|||
105989960|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|Death|0|||
105989961|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|Death|0|||
105989962|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|Death|0|||
105989963|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|Death|1|||
105989964|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
105989965|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
105989966|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
105989967|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
105989968|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
105989969|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
105989970|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
105989971|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
105989972|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
105989973|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
105989974|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
105989975|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
105989976|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
105989977|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
105989978|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
105989979|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
105989980|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
105989981|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
105989982|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
105989983|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
105989984|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
105989985|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
105989986|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
105989987|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
105989988|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
105989989|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
105989990|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
105989991|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
105989992|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
105989993|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
105989994|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
105989995|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
105989996|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
105989997|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
105989998|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
105989999|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
105990000|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
105990001|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
105990002|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
105990003|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
105990004|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
105990005|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
105990006|NCT00095173|365622057|FG000|Open-Label Extension Phase (Period C)|Other|0|||
105990007|NCT00095173|365622058|FG001|Open-Label Extension Phase (Period C)|Other|0|||
105990008|NCT00095173|365622059|FG002|Open-Label Extension Phase (Period C)|Other|0|||
105990009|NCT00095173|365622060|FG003|Open-Label Extension Phase (Period C)|Other|4|||
105990010|NCT00095173|365622061|FG004|Open-Label Extension Phase (Period C)|Other|6|||
105990011|NCT00095173|365622062|FG005|Open-Label Extension Phase (Period C)|Other|8|||
105990012|NCT01620528|365622065|FG000|Treatment Period|Did Not Receive Study Drug|0|||
105990013|NCT01620528|365622066|FG001|Treatment Period|Did Not Receive Study Drug|0|||
105990014|NCT01620528|365622067|FG002|Treatment Period|Did Not Receive Study Drug|1|||
105990015|NCT01620528|365622065|FG000|Treatment Period|Withdrawal by Subject|35|||
105990016|NCT01620528|365622066|FG001|Treatment Period|Withdrawal by Subject|21|||
105990017|NCT01620528|365622067|FG002|Treatment Period|Withdrawal by Subject|16|||
105990018|NCT01620528|365622065|FG000|Treatment Period|Adverse Event|17|||
106097919|NCT04782323|366016466|FG006|Overall Study|Death|1|||
106097920|NCT04782323|366016467|FG007|Overall Study|Death|0|||
106097921|NCT04782323|366016460|FG000|Overall Study|Withdrawal by Subject|0|||
106097922|NCT04782323|366016461|FG001|Overall Study|Withdrawal by Subject|0|||
106097923|NCT04782323|366016462|FG002|Overall Study|Withdrawal by Subject|1|||
106097924|NCT04782323|366016463|FG003|Overall Study|Withdrawal by Subject|0|||
106097925|NCT04782323|366016464|FG004|Overall Study|Withdrawal by Subject|0|||
106097926|NCT04782323|366016465|FG005|Overall Study|Withdrawal by Subject|1|||
106097927|NCT04782323|366016466|FG006|Overall Study|Withdrawal by Subject|0|||
106097928|NCT04782323|366016467|FG007|Overall Study|Withdrawal by Subject|1|||
106097929|NCT04782323|366016460|FG000|Overall Study|Lost to Follow-up|0|||
106097930|NCT04782323|366016461|FG001|Overall Study|Lost to Follow-up|1|||
106097931|NCT04782323|366016462|FG002|Overall Study|Lost to Follow-up|1|||
106097932|NCT04782323|366016463|FG003|Overall Study|Lost to Follow-up|0|||
106097933|NCT04782323|366016464|FG004|Overall Study|Lost to Follow-up|0|||
106097934|NCT04782323|366016465|FG005|Overall Study|Lost to Follow-up|1|||
106097935|NCT04782323|366016466|FG006|Overall Study|Lost to Follow-up|1|||
106097936|NCT04782323|366016467|FG007|Overall Study|Lost to Follow-up|2|||
106097937|NCT04782323|366016460|FG000|Overall Study|randomization in error|1|||
106097938|NCT04782323|366016461|FG001|Overall Study|randomization in error|0|||
106097939|NCT04782323|366016462|FG002|Overall Study|randomization in error|0|||
106097940|NCT04782323|366016463|FG003|Overall Study|randomization in error|0|||
106097941|NCT04782323|366016464|FG004|Overall Study|randomization in error|0|||
106097942|NCT04782323|366016465|FG005|Overall Study|randomization in error|0|||
106097943|NCT04782323|366016466|FG006|Overall Study|randomization in error|0|||
106097944|NCT04782323|366016467|FG007|Overall Study|randomization in error|0|||
106097945|NCT03832946|366016478|FG000|Overall Study|Adverse Event|3|||
106097946|NCT03832946|366016479|FG001|Overall Study|Adverse Event|1|||
106097947|NCT03832946|366016478|FG000|Overall Study|Lost to Follow-up|1|||
106097948|NCT03832946|366016479|FG001|Overall Study|Lost to Follow-up|0|||
106097949|NCT03832946|366016478|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
106097950|NCT03832946|366016479|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
106097951|NCT03832946|366016478|FG000|Overall Study|Lack of Efficacy|1|||
106097952|NCT03832946|366016479|FG001|Overall Study|Lack of Efficacy|0|||
106097953|NCT03832946|366016478|FG000|Overall Study|Withdrawal by Subject|12|||
106097954|NCT03832946|366016479|FG001|Overall Study|Withdrawal by Subject|9|||
106097955|NCT01954017|366016482|FG000|Overall Study|Adverse Event|0|||
106097956|NCT01954017|366016483|FG001|Overall Study|Adverse Event|0|||
106097957|NCT01954017|366016484|FG002|Overall Study|Adverse Event|1|||
106097958|NCT01954017|366016482|FG000|Overall Study|Death|2|||
106097959|NCT01954017|366016483|FG001|Overall Study|Death|1|||
106097960|NCT01954017|366016484|FG002|Overall Study|Death|1|||
106097961|NCT01954017|366016482|FG000|Overall Study|Withdrawal by Subject|0|||
106097962|NCT01954017|366016483|FG001|Overall Study|Withdrawal by Subject|1|||
106097963|NCT01954017|366016484|FG002|Overall Study|Withdrawal by Subject|0|||
106097964|NCT01954017|366016482|FG000|Overall Study|Protocol Violation|0|||
106097965|NCT01954017|366016483|FG001|Overall Study|Protocol Violation|3|||
106097966|NCT01954017|366016484|FG002|Overall Study|Protocol Violation|2|||
106097967|NCT01954017|366016482|FG000|Overall Study|Necrotizing enterocolitis|1|||
106097968|NCT01954017|366016483|FG001|Overall Study|Necrotizing enterocolitis|0|||
106097969|NCT01954017|366016484|FG002|Overall Study|Necrotizing enterocolitis|1|||
106097970|NCT01954017|366016482|FG000|Overall Study|Enteral intake stopped >7 days|0|||
106097971|NCT01954017|366016483|FG001|Overall Study|Enteral intake stopped >7 days|1|||
106097972|NCT01954017|366016484|FG002|Overall Study|Enteral intake stopped >7 days|1|||
106097973|NCT01954017|366016482|FG000|Overall Study|All other reasons|2|||
106097974|NCT01954017|366016483|FG001|Overall Study|All other reasons|2|||
106097975|NCT01954017|366016484|FG002|Overall Study|All other reasons|7|||
106097976|NCT04598152|366016485|FG000|Overall Study|Lost to Follow-up|0|||
106097977|NCT04598152|366016486|FG001|Overall Study|Lost to Follow-up|1|||
106097978|NCT03346759|366016487|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
106097979|NCT03346759|366016488|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
106097980|NCT03346759|366016487|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
106097981|NCT03346759|366016488|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
106097982|NCT03346759|366016487|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
106097983|NCT03346759|366016488|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
106097984|NCT02194621|366016497|FG000|Overall Study|6 withdrew prior to randomization|2|||
106097985|NCT02194621|366016498|FG001|Overall Study|6 withdrew prior to randomization|2|||
106097986|NCT02194621|366016499|FG002|Overall Study|6 withdrew prior to randomization|2|||
106097987|NCT02194621|366016497|FG000|Overall Study|Withdrawal by Subject|4|||
106097988|NCT02194621|366016498|FG001|Overall Study|Withdrawal by Subject|4|||
106097989|NCT02194621|366016499|FG002|Overall Study|Withdrawal by Subject|7|||
106097990|NCT02121847|366016500|FG000|Overall Study|Administrative Reasons|1|||
106097991|NCT02121847|366016500|FG000|Overall Study|Adverse Event|2|||
106097992|NCT03034577|366016503|FG000|Overall Study|Withdrawal by Subject|6|||
106097993|NCT03034577|366016504|FG001|Overall Study|Withdrawal by Subject|9|||
106097994|NCT03034577|366016503|FG000|Overall Study|Lost to Follow-up|25|||
106097995|NCT03034577|366016504|FG001|Overall Study|Lost to Follow-up|26|||
106097996|NCT04177758|366016505|FG000|Overall Study|Lost to Follow-up|19|||
106097997|NCT04177758|366016506|FG001|Overall Study|Lost to Follow-up|11|||
106097998|NCT01174342|366016507|FG000|Overall Study|Conversion to cesarean section|4|||
106097999|NCT01308580|366016508|FG000|Overall Study|Lost to Follow-up|12|||
106098000|NCT01308580|366016509|FG001|Overall Study|Lost to Follow-up|7|||
106098001|NCT02535065|366016510|FG000|Overall Study|Death|13|||
106098002|NCT02535065|366016510|FG000|Overall Study|Lost to Follow-up|1|||
106098003|NCT02535065|366016510|FG000|Overall Study|Withdrawal by Subject|6|||
106098004|NCT00360529|366016511|FG000|Overall Study|Adverse Event|10|||
106098005|NCT00360529|366016512|FG001|Overall Study|Adverse Event|23|||
106098006|NCT00360529|366016513|FG002|Overall Study|Adverse Event|33|||
106098007|NCT00360529|366016511|FG000|Overall Study|Protocol Violation|3|||
106098008|NCT00360529|366016512|FG001|Overall Study|Protocol Violation|3|||
106098009|NCT00360529|366016513|FG002|Overall Study|Protocol Violation|11|||
106098010|NCT00360529|366016511|FG000|Overall Study|Lost to Follow-up|14|||
106098011|NCT00360529|366016512|FG001|Overall Study|Lost to Follow-up|10|||
106098012|NCT00360529|366016513|FG002|Overall Study|Lost to Follow-up|13|||
106098013|NCT00360529|366016511|FG000|Overall Study|Withdrawal by Subject|22|||
106098014|NCT00360529|366016512|FG001|Overall Study|Withdrawal by Subject|14|||
106098015|NCT00360529|366016513|FG002|Overall Study|Withdrawal by Subject|18|||
106098016|NCT00360529|366016511|FG000|Overall Study|Lack of Efficacy|8|||
106098017|NCT00360529|366016512|FG001|Overall Study|Lack of Efficacy|6|||
106098018|NCT00360529|366016513|FG002|Overall Study|Lack of Efficacy|5|||
106098019|NCT00360529|366016511|FG000|Overall Study|Reason discontinued not explained above|4|||
106098020|NCT00360529|366016512|FG001|Overall Study|Reason discontinued not explained above|9|||
106098021|NCT00360529|366016513|FG002|Overall Study|Reason discontinued not explained above|11|||
106098022|NCT01128413|366016520|FG000|Overall Study|Withdrawal by Subject|1|||
106098023|NCT01128413|366016521|FG001|Overall Study|Withdrawal by Subject|0|||
106098024|NCT01128413|366016520|FG000|Overall Study|NICOM Monitor Problems|2|||
106098025|NCT01128413|366016521|FG001|Overall Study|NICOM Monitor Problems|1|||
106098026|NCT01128413|366016520|FG000|Overall Study|Pt made DNR|1|||
106098027|NCT01128413|366016521|FG001|Overall Study|Pt made DNR|0|||
106098028|NCT00045110|366016523|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
106098029|NCT00045110|366016524|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
106098030|NCT00045110|366016525|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
106098031|NCT00045110|366016523|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
106098032|NCT00045110|366016524|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
106098033|NCT00045110|366016525|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
106098034|NCT00045110|366016523|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
106098035|NCT00045110|366016524|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
106098036|NCT00045110|366016525|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
106098037|NCT04602624|366016526|FG000|Overall Study|Protocol Deviation|1|||
106098038|NCT04602624|366016526|FG000|Overall Study|Withdrawal by Participant|1|||
106098039|NCT03156023|366016527|FG000|Overall Study|Withdrawal by Subject|1|||
106098040|NCT03156023|366016528|FG001|Overall Study|Withdrawal by Subject|0|||
106098041|NCT03156023|366016529|FG002|Overall Study|Withdrawal by Subject|2|||
106098042|NCT03156023|366016530|FG003|Overall Study|Withdrawal by Subject|1|||
106098043|NCT03156023|366016531|FG004|Overall Study|Withdrawal by Subject|1|||
106098044|NCT03156023|366016527|FG000|Overall Study|Lost to Follow-up|0|||
106098045|NCT03156023|366016528|FG001|Overall Study|Lost to Follow-up|0|||
106098046|NCT03156023|366016529|FG002|Overall Study|Lost to Follow-up|0|||
106098047|NCT03156023|366016530|FG003|Overall Study|Lost to Follow-up|0|||
106098048|NCT03156023|366016531|FG004|Overall Study|Lost to Follow-up|1|||
106098049|NCT02075593|366016532|FG000|Overall Study|Withdrawal by Subject|1|||
106098050|NCT00710424|366016533|FG000|Overall Study|Adverse Event|30|||
106098051|NCT00710424|366016534|FG001|Overall Study|Adverse Event|12|||
106098052|NCT00710424|366016533|FG000|Overall Study|Lack of Efficacy|4|||
106098053|NCT00710424|366016534|FG001|Overall Study|Lack of Efficacy|5|||
106098054|NCT00710424|366016533|FG000|Overall Study|Withdrawal by Subject|5|||
106098055|NCT00710424|366016534|FG001|Overall Study|Withdrawal by Subject|3|||
106098056|NCT00710424|366016533|FG000|Overall Study|Lost to Follow-up|0|||
106098057|NCT00710424|366016534|FG001|Overall Study|Lost to Follow-up|1|||
106098058|NCT00710424|366016533|FG000|Overall Study|Refused medication, no side effects|1|||
106098059|NCT00710424|366016534|FG001|Overall Study|Refused medication, no side effects|0|||
106098060|NCT00710424|366016533|FG000|Overall Study|Non-compliance with stable analgesia|1|||
106098061|NCT00710424|366016534|FG001|Overall Study|Non-compliance with stable analgesia|0|||
106098062|NCT00710424|366016533|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
106098063|NCT00710424|366016534|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
106098064|NCT00710424|366016533|FG000|Overall Study|Subject thought medication changed|1|||
106098065|NCT00710424|366016534|FG001|Overall Study|Subject thought medication changed|0|||
106098066|NCT00710424|366016533|FG000|Overall Study|Ceased treatment due to travel|1|||
106098067|NCT00710424|366016534|FG001|Overall Study|Ceased treatment due to travel|0|||
106098068|NCT00710424|366016533|FG000|Overall Study|Subject preferred paracetamol|0|||
106098069|NCT00710424|366016534|FG001|Overall Study|Subject preferred paracetamol|1|||
105990019|NCT01620528|365622066|FG001|Treatment Period|Adverse Event|13|||
105990020|NCT01620528|365622067|FG002|Treatment Period|Adverse Event|21|||
105990021|NCT01620528|365622065|FG000|Treatment Period|Lost to Follow-up|16|||
105990022|NCT01620528|365622066|FG001|Treatment Period|Lost to Follow-up|8|||
105990023|NCT01620528|365622067|FG002|Treatment Period|Lost to Follow-up|14|||
105990024|NCT01620528|365622065|FG000|Treatment Period|Other|9|||
105990025|NCT01620528|365622066|FG001|Treatment Period|Other|5|||
105990026|NCT01620528|365622067|FG002|Treatment Period|Other|7|||
105990027|NCT01620528|365622065|FG000|Treatment Period|Subject Noncompliant|11|||
105990028|NCT01620528|365622066|FG001|Treatment Period|Subject Noncompliant|2|||
105990029|NCT01620528|365622067|FG002|Treatment Period|Subject Noncompliant|2|||
105990030|NCT01620528|365622065|FG000|Treatment Period|Pregnancy|7|||
105990031|NCT01620528|365622066|FG001|Treatment Period|Pregnancy|2|||
105990032|NCT01620528|365622067|FG002|Treatment Period|Pregnancy|2|||
105990033|NCT01620528|365622065|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
105990034|NCT01620528|365622066|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
105990035|NCT01620528|365622067|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
105990036|NCT01620528|365622065|FG000|Treatment Period|Exclusionary Medication Received|0|||
105990037|NCT01620528|365622066|FG001|Treatment Period|Exclusionary Medication Received|1|||
105990038|NCT01620528|365622067|FG002|Treatment Period|Exclusionary Medication Received|0|||
105990039|NCT01620528|365622065|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
105990040|NCT01620528|365622066|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
105990041|NCT01620528|365622067|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
105990042|NCT01620528|365622065|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
105990043|NCT01620528|365622066|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
105990044|NCT01620528|365622067|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
105990045|NCT01620528|365622065|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
105990046|NCT01620528|365622066|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
105990047|NCT01620528|365622067|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
105990048|NCT01620528|365622065|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
105990049|NCT01620528|365622066|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
105990050|NCT01620528|365622067|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
105990051|NCT01620528|365622065|FG000|Post-Treatment Follow-Up Period|Other|6|||
105990052|NCT01620528|365622066|FG001|Post-Treatment Follow-Up Period|Other|4|||
105990053|NCT01620528|365622067|FG002|Post-Treatment Follow-Up Period|Other|2|||
105990054|NCT01090063|365622070|FG000|Screen|Screen Failed|4|||
105990055|NCT01090063|365622070|FG000|Treatment|Withdrawal by Subject|4|||
105990056|NCT01496846|365622071|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
105990057|NCT01496846|365622072|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
105990058|NCT01496846|365622073|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
105990059|NCT01496846|365622074|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
105990060|NCT01496846|365622075|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
105990061|NCT01496846|365622076|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
105990062|NCT04038567|365622077|FG000|Overall Study|Lost to Follow-up|6|||
105990063|NCT04038567|365622078|FG001|Overall Study|Lost to Follow-up|4|||
105990064|NCT04038567|365622079|FG002|Overall Study|Lost to Follow-up|5|||
105990065|NCT04038567|365622080|FG003|Overall Study|Lost to Follow-up|4|||
105990066|NCT04038567|365622081|FG004|Overall Study|Lost to Follow-up|6|||
105990067|NCT04038567|365622082|FG005|Overall Study|Lost to Follow-up|4|||
105990068|NCT04038567|365622083|FG006|Overall Study|Lost to Follow-up|4|||
105990069|NCT04038567|365622084|FG007|Overall Study|Lost to Follow-up|1|||
105990070|NCT04038567|365622077|FG000|Overall Study|Withdrawal by Subject|2|||
105990071|NCT04038567|365622078|FG001|Overall Study|Withdrawal by Subject|1|||
105990072|NCT04038567|365622079|FG002|Overall Study|Withdrawal by Subject|1|||
105990073|NCT04038567|365622080|FG003|Overall Study|Withdrawal by Subject|1|||
105990074|NCT04038567|365622081|FG004|Overall Study|Withdrawal by Subject|4|||
105990075|NCT04038567|365622082|FG005|Overall Study|Withdrawal by Subject|1|||
105990076|NCT04038567|365622083|FG006|Overall Study|Withdrawal by Subject|1|||
105990077|NCT04038567|365622084|FG007|Overall Study|Withdrawal by Subject|1|||
105990078|NCT04038567|365622077|FG000|Overall Study|missed survey window|1|||
105990079|NCT04038567|365622078|FG001|Overall Study|missed survey window|2|||
105990080|NCT04038567|365622079|FG002|Overall Study|missed survey window|0|||
105990081|NCT04038567|365622080|FG003|Overall Study|missed survey window|0|||
105990082|NCT04038567|365622081|FG004|Overall Study|missed survey window|1|||
105990083|NCT04038567|365622082|FG005|Overall Study|missed survey window|1|||
105990084|NCT04038567|365622083|FG006|Overall Study|missed survey window|2|||
105990085|NCT04038567|365622084|FG007|Overall Study|missed survey window|2|||
105990086|NCT04038567|365622077|FG000|Overall Study|technical issues|0|||
105990087|NCT04038567|365622078|FG001|Overall Study|technical issues|0|||
105990088|NCT04038567|365622079|FG002|Overall Study|technical issues|0|||
105990089|NCT04038567|365622080|FG003|Overall Study|technical issues|0|||
105990090|NCT04038567|365622081|FG004|Overall Study|technical issues|0|||
105990091|NCT04038567|365622082|FG005|Overall Study|technical issues|0|||
105990092|NCT04038567|365622083|FG006|Overall Study|technical issues|1|||
105990093|NCT04038567|365622084|FG007|Overall Study|technical issues|0|||
105990094|NCT04038567|365622077|FG000|Overall Study|Medical issues (i.e., illness)|0|||
105990095|NCT04038567|365622078|FG001|Overall Study|Medical issues (i.e., illness)|1|||
105990096|NCT04038567|365622079|FG002|Overall Study|Medical issues (i.e., illness)|2|||
105990097|NCT04038567|365622080|FG003|Overall Study|Medical issues (i.e., illness)|1|||
105990098|NCT04038567|365622081|FG004|Overall Study|Medical issues (i.e., illness)|1|||
105990099|NCT04038567|365622082|FG005|Overall Study|Medical issues (i.e., illness)|1|||
105990100|NCT04038567|365622083|FG006|Overall Study|Medical issues (i.e., illness)|0|||
105990101|NCT04038567|365622084|FG007|Overall Study|Medical issues (i.e., illness)|0|||
105990102|NCT04038567|365622077|FG000|Overall Study|Death|0|||
105990103|NCT04038567|365622078|FG001|Overall Study|Death|0|||
105990104|NCT04038567|365622079|FG002|Overall Study|Death|0|||
105990105|NCT04038567|365622080|FG003|Overall Study|Death|1|||
105990106|NCT04038567|365622081|FG004|Overall Study|Death|1|||
105990107|NCT04038567|365622082|FG005|Overall Study|Death|0|||
105990108|NCT04038567|365622083|FG006|Overall Study|Death|0|||
105990109|NCT04038567|365622084|FG007|Overall Study|Death|1|||
105990110|NCT01817959|365622088|FG000|Overall Study|Graft loss|1|||
105990111|NCT01817959|365622089|FG001|Overall Study|Graft loss|1|||
105990112|NCT01817959|365622088|FG000|Overall Study|forbidden medication|1|||
105990113|NCT01817959|365622089|FG001|Overall Study|forbidden medication|1|||
105990114|NCT01817959|365622088|FG000|Overall Study|Adverse Event|1|||
105990115|NCT01817959|365622089|FG001|Overall Study|Adverse Event|0|||
105990116|NCT01817959|365622088|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
105990117|NCT01817959|365622089|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
105990118|NCT01772576|365622092|FG000|Overall Study|Death|15|||
105990119|NCT01772576|365622092|FG000|Overall Study|Protocol Violation|1|||
105990120|NCT01772576|365622092|FG000|Overall Study|Lost to Follow-up|3|||
105990121|NCT01772576|365622092|FG000|Overall Study|Study device not used|3|||
105990122|NCT01772576|365622092|FG000|Overall Study|Adverse Event|6|||
105990123|NCT01772576|365622092|FG000|Overall Study|Withdrawal by Subject|6|||
105990124|NCT04356352|365622096|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
105990125|NCT04356352|365622097|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
105990126|NCT04356352|365622098|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
105990127|NCT04356352|365622096|FG000|Overall Study|Protocol Violation|0|||
105990128|NCT04356352|365622097|FG001|Overall Study|Protocol Violation|3|||
105990129|NCT04356352|365622098|FG002|Overall Study|Protocol Violation|1|||
105990130|NCT00330681|365622101|FG000|Overall Study|Adverse Event|3|||
105990131|NCT00330681|365622102|FG001|Overall Study|Adverse Event|6|||
105990132|NCT00330681|365622101|FG000|Overall Study|Protocol Violation|0|||
105990133|NCT00330681|365622102|FG001|Overall Study|Protocol Violation|1|||
105990134|NCT00330681|365622101|FG000|Overall Study|Withdrawal by Subject|5|||
105990135|NCT00330681|365622102|FG001|Overall Study|Withdrawal by Subject|5|||
105990136|NCT00330681|365622101|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
105990137|NCT00330681|365622102|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
105990138|NCT02578186|365622103|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
105990139|NCT02578186|365622104|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
105990140|NCT02578186|365622103|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
105990141|NCT02578186|365622104|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
105990142|NCT00428389|365622108|FG000|Core Phase|Adverse Event|6|||
105990143|NCT00428389|365622109|FG001|Core Phase|Adverse Event|4|||
105990144|NCT00428389|365622108|FG000|Core Phase|Lack of Efficacy|2|||
105990145|NCT00428389|365622109|FG001|Core Phase|Lack of Efficacy|0|||
105990146|NCT00428389|365622108|FG000|Core Phase|Abnormal test procedure result(s)|0|||
105990147|NCT00428389|365622109|FG001|Core Phase|Abnormal test procedure result(s)|1|||
105990148|NCT00428389|365622108|FG000|Core Phase|Withdrawal by Subject|3|||
105990149|NCT00428389|365622109|FG001|Core Phase|Withdrawal by Subject|4|||
105990150|NCT00428389|365622108|FG000|Core Phase|Protocol deviation|0|||
105990151|NCT00428389|365622109|FG001|Core Phase|Protocol deviation|2|||
105990152|NCT00428389|365622108|FG000|Extension Phase|Adverse Event|17|||
105990153|NCT00428389|365622109|FG001|Extension Phase|Adverse Event|11|||
105990154|NCT00428389|365622108|FG000|Extension Phase|Lack of Efficacy|4|||
105990155|NCT00428389|365622109|FG001|Extension Phase|Lack of Efficacy|3|||
105990156|NCT00428389|365622108|FG000|Extension Phase|Withdrawal by Subject|6|||
105990157|NCT00428389|365622109|FG001|Extension Phase|Withdrawal by Subject|6|||
105990158|NCT00428389|365622108|FG000|Extension Phase|Lost to Follow-up|0|||
105990159|NCT00428389|365622109|FG001|Extension Phase|Lost to Follow-up|3|||
105990160|NCT00428389|365622108|FG000|Extension Phase|Death|1|||
105990161|NCT00428389|365622109|FG001|Extension Phase|Death|0|||
105990162|NCT00428389|365622108|FG000|Extension Phase|Protocol Violation|3|||
105990163|NCT00428389|365622109|FG001|Extension Phase|Protocol Violation|2|||
105990164|NCT00428389|365622108|FG000|Extension Phase|Administrative problems|1|||
105990165|NCT00428389|365622109|FG001|Extension Phase|Administrative problems|1|||
105990166|NCT01019369|365622110|FG000|Overall Study|Lost to Follow-up|10|||
105990167|NCT01019369|365622111|FG001|Overall Study|Lost to Follow-up|6|||
105990168|NCT01019369|365622110|FG000|Overall Study|Withdrawal by Subject|0|||
105990169|NCT01019369|365622111|FG001|Overall Study|Withdrawal by Subject|1|||
105990170|NCT04405076|365622112|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
105990171|NCT04405076|365622113|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
105990172|NCT04405076|365622114|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
105990173|NCT04405076|365622115|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
105990174|NCT04405076|365622116|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
105990175|NCT04405076|365622117|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
105990176|NCT04405076|365622118|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
105990177|NCT04405076|365622119|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
105990178|NCT04405076|365622120|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
105990179|NCT04405076|365622112|FG000|Part A (Blinded Phase)|Physician Decision|1|||
105990180|NCT04405076|365622113|FG001|Part A (Blinded Phase)|Physician Decision|2|||
105990181|NCT04405076|365622114|FG002|Part A (Blinded Phase)|Physician Decision|0|||
105990182|NCT04405076|365622115|FG003|Part A (Blinded Phase)|Physician Decision|0|||
105990183|NCT04405076|365622116|FG004|Part A (Blinded Phase)|Physician Decision|0|||
105990184|NCT04405076|365622117|FG005|Part A (Blinded Phase)|Physician Decision|0|||
105990185|NCT04405076|365622118|FG006|Part A (Blinded Phase)|Physician Decision|0|||
105990186|NCT04405076|365622119|FG007|Part A (Blinded Phase)|Physician Decision|0|||
105990187|NCT04405076|365622120|FG008|Part A (Blinded Phase)|Physician Decision|0|||
105990188|NCT04405076|365622112|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
105990189|NCT04405076|365622113|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
105990190|NCT04405076|365622114|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
105990191|NCT04405076|365622115|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
105990192|NCT04405076|365622116|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
105990193|NCT04405076|365622117|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
105990194|NCT04405076|365622118|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
105990195|NCT04405076|365622119|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
105990196|NCT04405076|365622120|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
105990197|NCT04405076|365622112|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
105990198|NCT04405076|365622113|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105990199|NCT04405076|365622114|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105990200|NCT04405076|365622115|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105990201|NCT04405076|365622116|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105990202|NCT04405076|365622117|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105990203|NCT04405076|365622118|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105990204|NCT04405076|365622119|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105990205|NCT04405076|365622120|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
105990206|NCT04405076|365622112|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
105990207|NCT04405076|365622113|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
105990208|NCT04405076|365622114|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105990209|NCT04405076|365622115|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105990210|NCT04405076|365622116|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105990211|NCT04405076|365622117|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105990212|NCT04405076|365622118|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105990213|NCT04405076|365622119|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105990214|NCT04405076|365622120|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
105990215|NCT04405076|365622112|FG000|Part A (Blinded Phase)|Other than Specified|0|||
105990216|NCT04405076|365622113|FG001|Part A (Blinded Phase)|Other than Specified|0|||
105990217|NCT04405076|365622114|FG002|Part A (Blinded Phase)|Other than Specified|3|||
105990218|NCT04405076|365622115|FG003|Part A (Blinded Phase)|Other than Specified|0|||
105990219|NCT04405076|365622116|FG004|Part A (Blinded Phase)|Other than Specified|0|||
105990220|NCT04405076|365622117|FG005|Part A (Blinded Phase)|Other than Specified|0|||
105990221|NCT04405076|365622118|FG006|Part A (Blinded Phase)|Other than Specified|0|||
105990222|NCT04405076|365622119|FG007|Part A (Blinded Phase)|Other than Specified|0|||
105990223|NCT04405076|365622120|FG008|Part A (Blinded Phase)|Other than Specified|0|||
105990224|NCT04405076|365622112|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105990225|NCT04405076|365622113|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105990226|NCT04405076|365622114|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105990227|NCT04405076|365622115|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
105990228|NCT04405076|365622116|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
105990229|NCT04405076|365622117|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
105990230|NCT04405076|365622118|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105990231|NCT04405076|365622119|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105990232|NCT04405076|365622120|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
105990233|NCT04405076|365622112|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
106098070|NCT00710424|366016533|FG000|Overall Study|Felt good so stopped treatment|0|||
105990234|NCT04405076|365622113|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105990235|NCT04405076|365622114|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105990236|NCT04405076|365622115|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105990237|NCT04405076|365622116|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
105990238|NCT04405076|365622117|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105990239|NCT04405076|365622118|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105990240|NCT04405076|365622119|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105990241|NCT04405076|365622120|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
105990242|NCT04405076|365622112|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105990243|NCT04405076|365622113|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105990244|NCT04405076|365622114|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105990245|NCT04405076|365622115|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
105990246|NCT04405076|365622116|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
105990247|NCT04405076|365622117|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
105990248|NCT04405076|365622118|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105990249|NCT04405076|365622119|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105990250|NCT04405076|365622120|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
105990251|NCT04405076|365622112|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105990252|NCT04405076|365622113|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105990253|NCT04405076|365622114|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105990254|NCT04405076|365622115|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105990255|NCT04405076|365622116|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105990256|NCT04405076|365622117|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105990257|NCT04405076|365622118|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
105990258|NCT04405076|365622119|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
105990259|NCT04405076|365622120|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
105990260|NCT04405076|365622112|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105990261|NCT04405076|365622113|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105990262|NCT04405076|365622114|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105990263|NCT04405076|365622115|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105990264|NCT04405076|365622116|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105990265|NCT04405076|365622117|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105990266|NCT04405076|365622118|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
105990267|NCT04405076|365622119|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105990268|NCT04405076|365622120|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
105990269|NCT00895453|365622123|FG000|Overall Study|Lost to Follow-up|25|||
105990270|NCT00895453|365622124|FG001|Overall Study|Lost to Follow-up|25|||
105990271|NCT00895453|365622125|FG002|Overall Study|Lost to Follow-up|23|||
105990272|NCT00999518|365622126|FG000|Overall Study|Adverse Event|1|||
105990273|NCT00999518|365622127|FG001|Overall Study|Adverse Event|6|||
105990274|NCT00999518|365622128|FG002|Overall Study|Adverse Event|3|||
105990275|NCT00999518|365622129|FG003|Overall Study|Adverse Event|1|||
105990276|NCT00999518|365622130|FG004|Overall Study|Adverse Event|2|||
105990277|NCT00999518|365622126|FG000|Overall Study|Lack of Efficacy|2|||
105990278|NCT00999518|365622127|FG001|Overall Study|Lack of Efficacy|0|||
105990279|NCT00999518|365622128|FG002|Overall Study|Lack of Efficacy|0|||
105990280|NCT00999518|365622129|FG003|Overall Study|Lack of Efficacy|2|||
105990281|NCT00999518|365622130|FG004|Overall Study|Lack of Efficacy|2|||
105990282|NCT00999518|365622126|FG000|Overall Study|Lost to Follow-up|0|||
105990283|NCT00999518|365622127|FG001|Overall Study|Lost to Follow-up|0|||
105990284|NCT00999518|365622128|FG002|Overall Study|Lost to Follow-up|0|||
105990285|NCT00999518|365622129|FG003|Overall Study|Lost to Follow-up|4|||
105990286|NCT00999518|365622130|FG004|Overall Study|Lost to Follow-up|1|||
105990287|NCT00999518|365622126|FG000|Overall Study|Did not meet entrance criteria|0|||
105990288|NCT00999518|365622127|FG001|Overall Study|Did not meet entrance criteria|0|||
105990289|NCT00999518|365622128|FG002|Overall Study|Did not meet entrance criteria|0|||
105990290|NCT00999518|365622129|FG003|Overall Study|Did not meet entrance criteria|0|||
105990291|NCT00999518|365622130|FG004|Overall Study|Did not meet entrance criteria|1|||
105990292|NCT00999518|365622126|FG000|Overall Study|Study terminated by sponsor|10|||
105990293|NCT00999518|365622127|FG001|Overall Study|Study terminated by sponsor|6|||
105990294|NCT00999518|365622128|FG002|Overall Study|Study terminated by sponsor|5|||
105990295|NCT00999518|365622129|FG003|Overall Study|Study terminated by sponsor|5|||
105990296|NCT00999518|365622130|FG004|Overall Study|Study terminated by sponsor|9|||
105990297|NCT00999518|365622126|FG000|Overall Study|Pregnancy|0|||
105990298|NCT00999518|365622127|FG001|Overall Study|Pregnancy|0|||
105990299|NCT00999518|365622128|FG002|Overall Study|Pregnancy|1|||
105990300|NCT00999518|365622129|FG003|Overall Study|Pregnancy|0|||
105990301|NCT00999518|365622130|FG004|Overall Study|Pregnancy|0|||
105990302|NCT00999518|365622126|FG000|Overall Study|Protocol Violation|0|||
105990303|NCT00999518|365622127|FG001|Overall Study|Protocol Violation|1|||
105990304|NCT00999518|365622128|FG002|Overall Study|Protocol Violation|0|||
105990305|NCT00999518|365622129|FG003|Overall Study|Protocol Violation|0|||
105990306|NCT00999518|365622130|FG004|Overall Study|Protocol Violation|2|||
105990307|NCT00999518|365622126|FG000|Overall Study|Withdrawal by Subject|5|||
105990308|NCT00999518|365622127|FG001|Overall Study|Withdrawal by Subject|4|||
105990309|NCT00999518|365622128|FG002|Overall Study|Withdrawal by Subject|10|||
105990310|NCT00999518|365622129|FG003|Overall Study|Withdrawal by Subject|6|||
105990311|NCT00999518|365622130|FG004|Overall Study|Withdrawal by Subject|1|||
105990312|NCT00999518|365622126|FG000|Overall Study|Other|5|||
105990313|NCT00999518|365622127|FG001|Overall Study|Other|7|||
105990314|NCT00999518|365622128|FG002|Overall Study|Other|1|||
105990315|NCT00999518|365622129|FG003|Overall Study|Other|4|||
105990316|NCT00999518|365622130|FG004|Overall Study|Other|5|||
105990317|NCT00999518|365622126|FG000|Overall Study|Randomized but not Treated|1|||
105990318|NCT00999518|365622127|FG001|Overall Study|Randomized but not Treated|1|||
105990319|NCT00999518|365622128|FG002|Overall Study|Randomized but not Treated|2|||
105990320|NCT00999518|365622129|FG003|Overall Study|Randomized but not Treated|0|||
105990321|NCT00999518|365622130|FG004|Overall Study|Randomized but not Treated|1|||
105990322|NCT03343626|365624268|FG000|Overall Study|Lost to Follow-up|4|||
105990323|NCT03343626|365624269|FG001|Overall Study|Lost to Follow-up|3|||
105990324|NCT03343626|365624270|FG002|Overall Study|Lost to Follow-up|2|||
105990325|NCT03343626|365624271|FG003|Overall Study|Lost to Follow-up|5|||
105990326|NCT03343626|365624272|FG004|Overall Study|Lost to Follow-up|4|||
105990327|NCT03343626|365624273|FG005|Overall Study|Lost to Follow-up|4|||
105990328|NCT03343626|365624274|FG006|Overall Study|Lost to Follow-up|4|||
105990329|NCT03343626|365624275|FG007|Overall Study|Lost to Follow-up|7|||
105990330|NCT03343626|365624268|FG000|Overall Study|Withdrawal of Consent|2|||
105990331|NCT03343626|365624269|FG001|Overall Study|Withdrawal of Consent|1|||
105990332|NCT03343626|365624270|FG002|Overall Study|Withdrawal of Consent|0|||
105990333|NCT03343626|365624271|FG003|Overall Study|Withdrawal of Consent|3|||
105990334|NCT03343626|365624272|FG004|Overall Study|Withdrawal of Consent|3|||
105990335|NCT03343626|365624273|FG005|Overall Study|Withdrawal of Consent|1|||
105990336|NCT03343626|365624274|FG006|Overall Study|Withdrawal of Consent|1|||
105990337|NCT03343626|365624275|FG007|Overall Study|Withdrawal of Consent|2|||
105990338|NCT03343626|365624268|FG000|Overall Study|Reason not Specified|0|||
105990339|NCT03343626|365624269|FG001|Overall Study|Reason not Specified|1|||
105990340|NCT03343626|365624270|FG002|Overall Study|Reason not Specified|0|||
105990341|NCT03343626|365624271|FG003|Overall Study|Reason not Specified|0|||
105990342|NCT03343626|365624272|FG004|Overall Study|Reason not Specified|0|||
105990343|NCT03343626|365624273|FG005|Overall Study|Reason not Specified|0|||
105990344|NCT03343626|365624274|FG006|Overall Study|Reason not Specified|0|||
105990345|NCT03343626|365624275|FG007|Overall Study|Reason not Specified|1|||
105990346|NCT03343626|365624268|FG000|Overall Study|Data Entry Error|0|||
105990347|NCT03343626|365624269|FG001|Overall Study|Data Entry Error|0|||
105990348|NCT03343626|365624270|FG002|Overall Study|Data Entry Error|0|||
105990349|NCT03343626|365624271|FG003|Overall Study|Data Entry Error|0|||
105990350|NCT03343626|365624272|FG004|Overall Study|Data Entry Error|0|||
105990351|NCT03343626|365624273|FG005|Overall Study|Data Entry Error|0|||
105990352|NCT03343626|365624274|FG006|Overall Study|Data Entry Error|0|||
105990353|NCT03343626|365624275|FG007|Overall Study|Data Entry Error|1|||
105990354|NCT00602420|365624276|FG000|Overall Study|Death|1|||
105990355|NCT00602420|365624277|FG001|Overall Study|Death|4|||
105990356|NCT00602420|365624276|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
105990357|NCT00602420|365624277|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
105990358|NCT00602420|365624276|FG000|Overall Study|Withdrawal by Subject|18|||
105990359|NCT00602420|365624277|FG001|Overall Study|Withdrawal by Subject|17|||
105990360|NCT00602420|365624276|FG000|Overall Study|Adverse Event|1|||
105990361|NCT00602420|365624277|FG001|Overall Study|Adverse Event|0|||
105990362|NCT00703924|365624278|FG000|Overall Study|Withdrawal by Subject|1|||
105990363|NCT00703924|365624279|FG001|Overall Study|Withdrawal by Subject|1|||
105990364|NCT03077919|365624280|FG000|Overall Study|Lost to Follow-up|4|||
105990365|NCT03077919|365624281|FG001|Overall Study|Lost to Follow-up|1|||
105990366|NCT03738618|365624282|FG000|Overall Study|Protocol deviation|23|||
105990367|NCT03738618|365624283|FG001|Overall Study|Protocol deviation|0|||
105990368|NCT03738618|365624282|FG000|Overall Study|Adverse Event|4|||
105990369|NCT03738618|365624283|FG001|Overall Study|Adverse Event|0|||
105990370|NCT03738618|365624282|FG000|Overall Study|Lost to Follow-up|2|||
105990371|NCT03738618|365624283|FG001|Overall Study|Lost to Follow-up|0|||
105990372|NCT03738618|365624282|FG000|Overall Study|Randomization failure|1|||
105990373|NCT03738618|365624283|FG001|Overall Study|Randomization failure|0|||
105990374|NCT03738618|365624282|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
105990375|NCT03738618|365624283|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
105990376|NCT03738618|365624282|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
105990377|NCT03738618|365624283|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
106098071|NCT00710424|366016534|FG001|Overall Study|Felt good so stopped treatment|1|||
105990378|NCT01031979|365624284|FG000|Overall Study|Lost to Follow-up|5|||
105990379|NCT01031979|365624285|FG001|Overall Study|Lost to Follow-up|4|||
105990380|NCT03592368|365624286|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
105990381|NCT03592368|365624287|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
105990382|NCT03592368|365624288|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
105990383|NCT03592368|365624289|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
105990384|NCT03592368|365624286|FG000|Overall Study|Adverse Event|0|||
105990385|NCT03592368|365624287|FG001|Overall Study|Adverse Event|0|||
105990386|NCT03592368|365624288|FG002|Overall Study|Adverse Event|0|||
105990387|NCT03592368|365624289|FG003|Overall Study|Adverse Event|1|||
105990388|NCT03592368|365624286|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
105990389|NCT03592368|365624287|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
105990390|NCT03592368|365624288|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
105990391|NCT03592368|365624289|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
105990392|NCT00931606|365624294|FG000|Overall Study|Death|1|||
105990393|NCT00931606|365624295|FG001|Overall Study|Death|3|||
105990394|NCT00931606|365624296|FG002|Overall Study|Death|2|||
105990395|NCT00931606|365624297|FG003|Overall Study|Death|0|||
105990396|NCT00931606|365624294|FG000|Overall Study|Lost to Follow-up|0|||
105990397|NCT00931606|365624295|FG001|Overall Study|Lost to Follow-up|1|||
105990398|NCT00931606|365624296|FG002|Overall Study|Lost to Follow-up|0|||
105990399|NCT00931606|365624297|FG003|Overall Study|Lost to Follow-up|0|||
105990400|NCT00931606|365624294|FG000|Overall Study|Physician Decision|0|||
105990401|NCT00931606|365624295|FG001|Overall Study|Physician Decision|0|||
105990402|NCT00931606|365624296|FG002|Overall Study|Physician Decision|3|||
105990403|NCT00931606|365624297|FG003|Overall Study|Physician Decision|0|||
105990404|NCT00931606|365624294|FG000|Overall Study|Sponsor Decision|1|||
105990405|NCT00931606|365624295|FG001|Overall Study|Sponsor Decision|4|||
105990406|NCT00931606|365624296|FG002|Overall Study|Sponsor Decision|0|||
105990407|NCT00931606|365624297|FG003|Overall Study|Sponsor Decision|2|||
105990408|NCT00931606|365624294|FG000|Overall Study|Withdrawal by Subject|3|||
105990409|NCT00931606|365624295|FG001|Overall Study|Withdrawal by Subject|1|||
105990410|NCT00931606|365624296|FG002|Overall Study|Withdrawal by Subject|1|||
105990411|NCT00931606|365624297|FG003|Overall Study|Withdrawal by Subject|1|||
105990412|NCT01732770|365624298|FG000|Overall Study|Lost to Follow-up|2|||
105990413|NCT01732770|365624299|FG001|Overall Study|Lost to Follow-up|3|||
105990414|NCT01732770|365624298|FG000|Overall Study|Withdrawal by Subject|5|||
105990415|NCT01732770|365624299|FG001|Overall Study|Withdrawal by Subject|3|||
105990416|NCT01732770|365624298|FG000|Overall Study|Decision by Sponsor|2|||
105990417|NCT01732770|365624299|FG001|Overall Study|Decision by Sponsor|2|||
105990418|NCT01732770|365624298|FG000|Overall Study|Death|1|||
105990419|NCT01732770|365624299|FG001|Overall Study|Death|0|||
105990420|NCT03047031|365624303|FG000|Overall Study|Other than listed|1|||
105990421|NCT03047031|365624304|FG001|Overall Study|Other than listed|0|||
105990422|NCT03047031|365624305|FG002|Overall Study|Other than listed|0|||
105990423|NCT03047031|365624303|FG000|Overall Study|Lost to Follow-up|4|||
105990424|NCT03047031|365624304|FG001|Overall Study|Lost to Follow-up|0|||
105990425|NCT03047031|365624305|FG002|Overall Study|Lost to Follow-up|0|||
105990426|NCT03047031|365624303|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
105990427|NCT03047031|365624304|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
105990428|NCT03047031|365624305|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
105990429|NCT03047031|365624303|FG000|Overall Study|Adverse Event|1|||
106098072|NCT03069482|366018484|FG000|Overall Study|Lost to Follow-up|0|||
106098073|NCT03069482|366018485|FG001|Overall Study|Lost to Follow-up|1|||
106098074|NCT03069482|366018484|FG000|Overall Study|Physician Decision|1|||
106098075|NCT03069482|366018485|FG001|Overall Study|Physician Decision|0|||
106098076|NCT02891187|366018488|FG000|Overall Study|Lost to Follow-up|1|||
106098077|NCT02891187|366018489|FG001|Overall Study|Lost to Follow-up|2|||
106098078|NCT03836053|366018490|FG000|Overall Study|Protocol-specified criteria|0|||
106098079|NCT03836053|366018491|FG001|Overall Study|Protocol-specified criteria|2|||
106098080|NCT03836053|366018492|FG002|Overall Study|Protocol-specified criteria|1|||
106098081|NCT03836053|366018490|FG000|Overall Study|Death|1|||
106098082|NCT03836053|366018491|FG001|Overall Study|Death|6|||
106098083|NCT03836053|366018492|FG002|Overall Study|Death|4|||
106098084|NCT03836053|366018490|FG000|Overall Study|Withdrawal of consent from study|0|||
106098085|NCT03836053|366018491|FG001|Overall Study|Withdrawal of consent from study|0|||
106098086|NCT03836053|366018492|FG002|Overall Study|Withdrawal of consent from study|1|||
105990430|NCT03047031|365624304|FG001|Overall Study|Adverse Event|0|||
105990431|NCT03047031|365624305|FG002|Overall Study|Adverse Event|0|||
105990432|NCT03047031|365624303|FG000|Overall Study|Withdrawal by Subject|2|||
105990433|NCT03047031|365624304|FG001|Overall Study|Withdrawal by Subject|0|||
105990434|NCT03047031|365624305|FG002|Overall Study|Withdrawal by Subject|0|||
105990435|NCT03047031|365624303|FG000|Overall Study|Change to other medication|2|||
106098087|NCT03836053|366018490|FG000|Overall Study|Decision by sponsor|0|||
106098088|NCT03836053|366018491|FG001|Overall Study|Decision by sponsor|2|||
106098089|NCT03836053|366018492|FG002|Overall Study|Decision by sponsor|4|||
106098090|NCT02041195|366018495|FG000|Overall Study|Adverse Event|1|||
106098091|NCT02041195|366018496|FG001|Overall Study|Adverse Event|2|||
106098092|NCT02041195|366018497|FG002|Overall Study|Adverse Event|0|||
106098093|NCT02041195|366018498|FG003|Overall Study|Adverse Event|0|||
106098094|NCT02041195|366018499|FG004|Overall Study|Adverse Event|0|||
106098095|NCT02041195|366018500|FG005|Overall Study|Adverse Event|0|||
106098096|NCT02041195|366018501|FG006|Overall Study|Adverse Event|3|||
106098097|NCT02041195|366018502|FG007|Overall Study|Adverse Event|0|||
106098098|NCT02041195|366018495|FG000|Overall Study|Withdrawal by Subject|1|||
106098099|NCT02041195|366018496|FG001|Overall Study|Withdrawal by Subject|0|||
106098100|NCT02041195|366018497|FG002|Overall Study|Withdrawal by Subject|0|||
106098101|NCT02041195|366018498|FG003|Overall Study|Withdrawal by Subject|0|||
106098102|NCT02041195|366018499|FG004|Overall Study|Withdrawal by Subject|0|||
106098103|NCT02041195|366018500|FG005|Overall Study|Withdrawal by Subject|0|||
106098104|NCT02041195|366018501|FG006|Overall Study|Withdrawal by Subject|4|||
106098105|NCT02041195|366018502|FG007|Overall Study|Withdrawal by Subject|3|||
106098106|NCT02041195|366018495|FG000|Overall Study|Unable to comply with study visits|0|||
106098107|NCT02041195|366018496|FG001|Overall Study|Unable to comply with study visits|1|||
106098108|NCT02041195|366018497|FG002|Overall Study|Unable to comply with study visits|0|||
106098109|NCT02041195|366018498|FG003|Overall Study|Unable to comply with study visits|0|||
106098110|NCT02041195|366018499|FG004|Overall Study|Unable to comply with study visits|1|||
106098111|NCT02041195|366018500|FG005|Overall Study|Unable to comply with study visits|0|||
106098112|NCT02041195|366018501|FG006|Overall Study|Unable to comply with study visits|0|||
106098113|NCT02041195|366018502|FG007|Overall Study|Unable to comply with study visits|0|||
106098114|NCT00907153|366018505|FG000|Overall Study|Lost to Follow-up|1|||
106098115|NCT00907153|366018506|FG001|Overall Study|Lost to Follow-up|1|||
106098116|NCT00907153|366018505|FG000|Overall Study|Withdrawal by Subject|1|||
106098117|NCT00907153|366018506|FG001|Overall Study|Withdrawal by Subject|3|||
106098118|NCT01928719|366018507|FG000|Overall Study|Lost to Follow-up|26|||
106098119|NCT01928719|366018508|FG001|Overall Study|Lost to Follow-up|11|||
106098120|NCT01928719|366018507|FG000|Overall Study|Withdrawal by Subject|22|||
106098121|NCT01928719|366018508|FG001|Overall Study|Withdrawal by Subject|7|||
106098122|NCT01928719|366018507|FG000|Overall Study|Protocol Violation|3|||
106098123|NCT01928719|366018508|FG001|Overall Study|Protocol Violation|1|||
106098124|NCT01928719|366018507|FG000|Overall Study|Adverse Event|1|||
106098125|NCT01928719|366018508|FG001|Overall Study|Adverse Event|0|||
106098126|NCT00896168|366018512|FG000|Overall Study|Adverse Event|4|||
106098127|NCT00896168|366018513|FG001|Overall Study|Adverse Event|7|||
106098128|NCT00896168|366018512|FG000|Overall Study|Treatment failure|8|||
106098129|NCT00896168|366018513|FG001|Overall Study|Treatment failure|10|||
106098130|NCT00896168|366018512|FG000|Overall Study|Lost to Follow-up|1|||
106098131|NCT00896168|366018513|FG001|Overall Study|Lost to Follow-up|1|||
106098132|NCT00896168|366018512|FG000|Overall Study|Other|1|||
106098133|NCT00896168|366018513|FG001|Overall Study|Other|1|||
106098134|NCT01490632|366018514|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
106098135|NCT01490632|366018515|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
106098136|NCT01490632|366018516|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
106098137|NCT01490632|366018517|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
106098138|NCT01490632|366018518|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
106098139|NCT01490632|366018519|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
106098140|NCT01490632|366018520|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
106098141|NCT01490632|366018521|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
106098142|NCT01490632|366018522|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
106098143|NCT01490632|366018523|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
106098144|NCT01490632|366018524|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
106098145|NCT01490632|366018525|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
106098146|NCT01490632|366018526|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
106098147|NCT01490632|366018527|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
106098148|NCT01490632|366018528|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
106098149|NCT01490632|366018529|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
106098150|NCT01490632|366018530|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
106098151|NCT01490632|366018531|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
106098152|NCT01490632|366018532|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
106098153|NCT01490632|366018533|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
106098154|NCT01490632|366018514|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
105659697|NCT01099579|364418812|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
106098155|NCT01490632|366018515|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
106098156|NCT01490632|366018516|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
106098157|NCT01490632|366018517|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
106098158|NCT01490632|366018518|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098159|NCT01490632|366018519|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098160|NCT01490632|366018520|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098161|NCT01490632|366018521|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098162|NCT01490632|366018522|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098163|NCT01490632|366018523|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098164|NCT01490632|366018524|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098165|NCT01490632|366018525|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098166|NCT01490632|366018526|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098167|NCT01490632|366018527|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098168|NCT01490632|366018528|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098169|NCT01490632|366018529|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098170|NCT01490632|366018530|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098171|NCT01490632|366018531|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098172|NCT01490632|366018532|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098173|NCT01490632|366018533|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
106098174|NCT01490632|366018514|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098175|NCT01490632|366018515|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098176|NCT01490632|366018516|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
106098177|NCT01490632|366018517|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
106098178|NCT01490632|366018518|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
106098179|NCT01490632|366018519|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098180|NCT01490632|366018520|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098181|NCT01490632|366018521|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098182|NCT01490632|366018522|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098183|NCT01490632|366018523|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098184|NCT01490632|366018524|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098185|NCT01490632|366018525|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098186|NCT01490632|366018526|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098187|NCT01490632|366018527|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098188|NCT01490632|366018528|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098189|NCT01490632|366018529|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098190|NCT01490632|366018530|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098191|NCT01490632|366018531|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098192|NCT01490632|366018532|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098193|NCT01490632|366018533|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
106098194|NCT01490632|366018514|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
106098195|NCT01490632|366018515|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
106098196|NCT01490632|366018516|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
106098197|NCT01490632|366018517|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
106098198|NCT01490632|366018518|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
106098199|NCT01490632|366018519|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
106098200|NCT01490632|366018520|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
106098201|NCT01490632|366018521|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
106098202|NCT01490632|366018522|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
106098203|NCT01490632|366018523|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
106098204|NCT01490632|366018524|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
106098205|NCT01490632|366018525|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
106098206|NCT01490632|366018526|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
106098207|NCT01490632|366018527|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
106098208|NCT01490632|366018528|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
106098209|NCT01490632|366018529|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
106098210|NCT01490632|366018530|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
106098211|NCT01490632|366018531|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
106098212|NCT01490632|366018532|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
106098213|NCT01490632|366018533|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
106098214|NCT01490632|366018514|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
106098215|NCT01490632|366018515|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098216|NCT01490632|366018516|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098217|NCT01490632|366018517|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098218|NCT01490632|366018518|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098219|NCT01490632|366018519|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098220|NCT01490632|366018520|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098221|NCT01490632|366018521|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098222|NCT01490632|366018522|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098223|NCT01490632|366018523|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098224|NCT01490632|366018524|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098225|NCT01490632|366018525|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098226|NCT01490632|366018526|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098227|NCT01490632|366018527|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098228|NCT01490632|366018528|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098229|NCT01490632|366018529|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098230|NCT01490632|366018530|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
105990436|NCT03047031|365624304|FG001|Overall Study|Change to other medication|0|||
105990437|NCT03047031|365624305|FG002|Overall Study|Change to other medication|0|||
105990438|NCT03047031|365624303|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
105990439|NCT03047031|365624304|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
105990440|NCT03047031|365624305|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
105990441|NCT00780416|365624307|FG000|Overall Study|Physician Decision|3|||
105990442|NCT00780416|365624308|FG001|Overall Study|Physician Decision|3|||
106098231|NCT01490632|366018531|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098232|NCT01490632|366018532|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098233|NCT01490632|366018533|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
106098234|NCT01490632|366018514|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
106098235|NCT01490632|366018515|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
106098236|NCT01490632|366018516|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098237|NCT01490632|366018517|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
106098238|NCT01490632|366018518|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
106098239|NCT01490632|366018519|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098240|NCT01490632|366018520|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098241|NCT01490632|366018521|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098242|NCT01490632|366018522|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098243|NCT01490632|366018523|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098244|NCT01490632|366018524|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098245|NCT01490632|366018525|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098246|NCT01490632|366018526|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098247|NCT01490632|366018527|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098248|NCT01490632|366018528|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098249|NCT01490632|366018529|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098250|NCT01490632|366018530|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098251|NCT01490632|366018531|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098252|NCT01490632|366018532|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098253|NCT01490632|366018533|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
106098254|NCT01490632|366018514|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098255|NCT01490632|366018515|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098256|NCT01490632|366018516|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098257|NCT01490632|366018517|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098258|NCT01490632|366018518|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
106098259|NCT01490632|366018519|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098260|NCT01490632|366018520|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098261|NCT01490632|366018521|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098262|NCT01490632|366018522|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098263|NCT01490632|366018523|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098264|NCT01490632|366018524|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098265|NCT01490632|366018525|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098266|NCT01490632|366018526|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098267|NCT01490632|366018527|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098268|NCT01490632|366018528|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098269|NCT01490632|366018529|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098270|NCT01490632|366018530|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
105990443|NCT00780416|365624307|FG000|Overall Study|Protocol Violation|1|||
105990444|NCT00780416|365624308|FG001|Overall Study|Protocol Violation|0|||
105990445|NCT00780416|365624307|FG000|Overall Study|Withdrawal by Subject|8|||
105990446|NCT00780416|365624308|FG001|Overall Study|Withdrawal by Subject|6|||
105990447|NCT01702025|365624315|FG000|Overall Study|Equipment failure|1|||
105990448|NCT01702025|365624316|FG001|Overall Study|Equipment failure|0|||
105990449|NCT01702025|365624317|FG002|Overall Study|Equipment failure|0|||
105990450|NCT01702025|365624318|FG003|Overall Study|Equipment failure|0|||
105990451|NCT01702025|365624315|FG000|Overall Study|Adverse Event|1|||
105990452|NCT01702025|365624316|FG001|Overall Study|Adverse Event|1|||
105990453|NCT01702025|365624317|FG002|Overall Study|Adverse Event|1|||
105990454|NCT01702025|365624318|FG003|Overall Study|Adverse Event|0|||
105990455|NCT00303485|365624324|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
105990456|NCT00303485|365624325|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
105990457|NCT00303485|365624324|FG000|Overall Study|Failure to return|0|||
105990458|NCT00303485|365624325|FG001|Overall Study|Failure to return|1|||
105990459|NCT00303485|365624324|FG000|Overall Study|Withdrawal by Subject|1|||
105990460|NCT00303485|365624325|FG001|Overall Study|Withdrawal by Subject|0|||
105990461|NCT01128244|365624331|FG000|Overall Study|Adverse Event|1|||
106098271|NCT01490632|366018531|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098272|NCT01490632|366018532|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098273|NCT01490632|366018533|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
106098274|NCT01490632|366018514|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098275|NCT01490632|366018515|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098276|NCT01490632|366018516|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098277|NCT01490632|366018517|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098278|NCT01490632|366018518|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098279|NCT01490632|366018519|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
106098280|NCT01490632|366018520|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
106098281|NCT01490632|366018521|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098282|NCT01490632|366018522|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098283|NCT01490632|366018523|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
106098284|NCT01490632|366018524|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
106098285|NCT01490632|366018525|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
106098286|NCT01490632|366018526|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098287|NCT01490632|366018527|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098288|NCT01490632|366018528|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098289|NCT01490632|366018529|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098290|NCT01490632|366018530|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098291|NCT01490632|366018531|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098292|NCT01490632|366018532|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098293|NCT01490632|366018533|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
106098294|NCT01490632|366018514|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098295|NCT01490632|366018515|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098296|NCT01490632|366018516|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098297|NCT01490632|366018517|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098298|NCT01490632|366018518|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098299|NCT01490632|366018519|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098300|NCT01490632|366018520|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
106098301|NCT01490632|366018521|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098302|NCT01490632|366018522|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
106098303|NCT01490632|366018523|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
106098304|NCT01490632|366018524|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
106098305|NCT01490632|366018525|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098306|NCT01490632|366018526|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098307|NCT01490632|366018527|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098308|NCT01490632|366018528|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098309|NCT01490632|366018529|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098310|NCT01490632|366018530|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098311|NCT01490632|366018531|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098312|NCT01490632|366018532|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098313|NCT01490632|366018533|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
106098314|NCT01490632|366018514|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098315|NCT01490632|366018515|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098316|NCT01490632|366018516|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098317|NCT01490632|366018517|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098318|NCT01490632|366018518|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105990462|NCT01128244|365624331|FG000|Overall Study|Scheduling conflict|2|||
105990463|NCT04171219|365624332|FG000|Overall Study|Adverse Event|1|||
105990464|NCT04171219|365624333|FG001|Overall Study|Adverse Event|0|||
105990465|NCT04171219|365624332|FG000|Overall Study|Death|0|||
105990466|NCT04171219|365624333|FG001|Overall Study|Death|1|||
105990467|NCT04171219|365624332|FG000|Overall Study|Lack of Efficacy|9|||
105990468|NCT04171219|365624333|FG001|Overall Study|Lack of Efficacy|13|||
105990469|NCT04171219|365624332|FG000|Overall Study|Withdrawal by Subject|1|||
105990470|NCT04171219|365624333|FG001|Overall Study|Withdrawal by Subject|2|||
105990471|NCT04171219|365624332|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
105990472|NCT04171219|365624333|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
105990473|NCT04171219|365624332|FG000|Overall Study|Clinical PD/Patient choice|1|||
105990474|NCT04171219|365624333|FG001|Overall Study|Clinical PD/Patient choice|0|||
105990475|NCT04171219|365624332|FG000|Overall Study|Toxicity/ Patient choice|1|||
106098319|NCT01490632|366018519|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
105659698|NCT01099579|364418813|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
106098320|NCT01490632|366018520|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
105990476|NCT04171219|365624333|FG001|Overall Study|Toxicity/ Patient choice|0|||
105990477|NCT03350815|365624336|FG000|Period 1|Adverse Event|10|||
105990478|NCT03350815|365624337|FG001|Period 1|Adverse Event|0|||
105990479|NCT03350815|365624338|FG002|Period 1|Adverse Event|0|||
105990480|NCT03350815|365624339|FG003|Period 1|Adverse Event|0|||
106098321|NCT01490632|366018521|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098322|NCT01490632|366018522|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098323|NCT01490632|366018523|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
106098324|NCT01490632|366018524|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098325|NCT01490632|366018525|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098326|NCT01490632|366018526|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098327|NCT01490632|366018527|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098328|NCT01490632|366018528|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098329|NCT01490632|366018529|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098330|NCT01490632|366018530|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098331|NCT01490632|366018531|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098332|NCT01490632|366018532|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098333|NCT01490632|366018533|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
106098334|NCT01490632|366018514|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098335|NCT01490632|366018515|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098336|NCT01490632|366018516|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098337|NCT01490632|366018517|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098338|NCT01490632|366018518|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098339|NCT01490632|366018519|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098340|NCT01490632|366018520|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
106098341|NCT01490632|366018521|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098342|NCT01490632|366018522|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098343|NCT01490632|366018523|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098344|NCT01490632|366018524|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098345|NCT01490632|366018525|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098346|NCT01490632|366018526|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098347|NCT01490632|366018527|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098348|NCT01490632|366018528|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098349|NCT01490632|366018529|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098350|NCT01490632|366018530|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098351|NCT01490632|366018531|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098352|NCT01490632|366018532|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098353|NCT01490632|366018533|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
106098354|NCT01490632|366018514|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098355|NCT01490632|366018515|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098356|NCT01490632|366018516|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098357|NCT01490632|366018517|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098358|NCT01490632|366018518|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105990481|NCT03350815|365624336|FG000|Period 1|Technical problems|1|||
105990482|NCT03350815|365624337|FG001|Period 1|Technical problems|0|||
105990483|NCT03350815|365624338|FG002|Period 1|Technical problems|0|||
105990484|NCT03350815|365624339|FG003|Period 1|Technical problems|0|||
105990485|NCT03350815|365624336|FG000|Period 1|Lost to Follow-up|3|||
105990486|NCT03350815|365624337|FG001|Period 1|Lost to Follow-up|0|||
105990487|NCT03350815|365624338|FG002|Period 1|Lost to Follow-up|0|||
105990488|NCT03350815|365624339|FG003|Period 1|Lost to Follow-up|0|||
105990489|NCT03350815|365624336|FG000|Period 1|Physician Decision|1|||
105990490|NCT03350815|365624337|FG001|Period 1|Physician Decision|0|||
105990491|NCT03350815|365624338|FG002|Period 1|Physician Decision|0|||
105990492|NCT03350815|365624339|FG003|Period 1|Physician Decision|0|||
105990493|NCT03350815|365624336|FG000|Period 1|Withdrawal by Subject|8|||
105990494|NCT03350815|365624337|FG001|Period 1|Withdrawal by Subject|0|||
105990495|NCT03350815|365624338|FG002|Period 1|Withdrawal by Subject|0|||
105990496|NCT03350815|365624339|FG003|Period 1|Withdrawal by Subject|0|||
105990497|NCT03350815|365624336|FG000|Period 1|Lack of Efficacy|15|||
105990498|NCT03350815|365624337|FG001|Period 1|Lack of Efficacy|0|||
105990499|NCT03350815|365624338|FG002|Period 1|Lack of Efficacy|0|||
105990500|NCT03350815|365624339|FG003|Period 1|Lack of Efficacy|0|||
105990501|NCT03350815|365624336|FG000|Period 1|Non-compliance with study treatment|2|||
105990502|NCT03350815|365624337|FG001|Period 1|Non-compliance with study treatment|0|||
105990503|NCT03350815|365624338|FG002|Period 1|Non-compliance with study treatment|0|||
105990504|NCT03350815|365624339|FG003|Period 1|Non-compliance with study treatment|0|||
106098359|NCT01490632|366018519|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
106098360|NCT01490632|366018520|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105990505|NCT03350815|365624336|FG000|Period 1|Protocol Violation|3|||
105990506|NCT03350815|365624337|FG001|Period 1|Protocol Violation|0|||
105990507|NCT03350815|365624338|FG002|Period 1|Protocol Violation|0|||
105990508|NCT03350815|365624339|FG003|Period 1|Protocol Violation|0|||
105990509|NCT03350815|365624336|FG000|Period 2|Adverse Event|0|||
106098361|NCT01490632|366018521|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105990510|NCT03350815|365624337|FG001|Period 2|Adverse Event|3|||
105990511|NCT03350815|365624338|FG002|Period 2|Adverse Event|5|||
106098362|NCT01490632|366018522|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098363|NCT01490632|366018523|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098364|NCT01490632|366018524|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098365|NCT01490632|366018525|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098366|NCT01490632|366018526|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098367|NCT01490632|366018527|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098368|NCT01490632|366018528|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105659699|NCT01099579|364418811|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
105659700|NCT01099579|364418812|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
105659701|NCT01099579|364418813|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
105659702|NCT01099579|364418811|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
105659703|NCT01099579|364418812|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
105659704|NCT01099579|364418813|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
105659705|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
105659706|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
105659707|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
105659708|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
105659709|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
105659710|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
105659711|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
105659712|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
105659713|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
105659714|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
105659715|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
105659716|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
105659717|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
105659718|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
105659719|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
105659720|NCT01099579|364418811|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
105659721|NCT01099579|364418812|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
105990512|NCT03350815|365624339|FG003|Period 2|Adverse Event|0|||
105990513|NCT03350815|365624336|FG000|Period 2|Technical problem|0|||
105990514|NCT03350815|365624337|FG001|Period 2|Technical problem|1|||
105990515|NCT03350815|365624338|FG002|Period 2|Technical problem|0|||
105990516|NCT03350815|365624339|FG003|Period 2|Technical problem|0|||
105990517|NCT03350815|365624336|FG000|Period 2|Lost to Follow-up|0|||
105990518|NCT03350815|365624337|FG001|Period 2|Lost to Follow-up|3|||
105990519|NCT03350815|365624338|FG002|Period 2|Lost to Follow-up|3|||
105990520|NCT03350815|365624339|FG003|Period 2|Lost to Follow-up|0|||
105990521|NCT03350815|365624336|FG000|Period 2|Physician Decision|0|||
105990522|NCT03350815|365624337|FG001|Period 2|Physician Decision|0|||
105990523|NCT03350815|365624338|FG002|Period 2|Physician Decision|1|||
105990524|NCT03350815|365624339|FG003|Period 2|Physician Decision|0|||
105990525|NCT03350815|365624336|FG000|Period 2|Withdrawal by Subject|0|||
105990526|NCT03350815|365624337|FG001|Period 2|Withdrawal by Subject|3|||
105990527|NCT03350815|365624338|FG002|Period 2|Withdrawal by Subject|4|||
105990528|NCT03350815|365624339|FG003|Period 2|Withdrawal by Subject|0|||
105990529|NCT03350815|365624336|FG000|Period 2|Lack of Efficacy|0|||
105990530|NCT03350815|365624337|FG001|Period 2|Lack of Efficacy|6|||
105990531|NCT03350815|365624338|FG002|Period 2|Lack of Efficacy|2|||
105990532|NCT03350815|365624339|FG003|Period 2|Lack of Efficacy|0|||
105990533|NCT03350815|365624336|FG000|Period 2|Protocol Violation|0|||
105990534|NCT03350815|365624337|FG001|Period 2|Protocol Violation|0|||
105990535|NCT03350815|365624338|FG002|Period 2|Protocol Violation|1|||
105990536|NCT03350815|365624339|FG003|Period 2|Protocol Violation|0|||
105990537|NCT03350815|365624336|FG000|Period 2|New therapy for study indication|0|||
105990538|NCT03350815|365624337|FG001|Period 2|New therapy for study indication|0|||
105990539|NCT03350815|365624338|FG002|Period 2|New therapy for study indication|1|||
105659722|NCT01099579|364418813|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
105659723|NCT01774305|364418814|FG000|Overall Study|Physician Decision|1|||
105659724|NCT01774305|364418815|FG001|Overall Study|Physician Decision|0|||
105659725|NCT04211389|364418816|FG000|Overall Study|Adverse Event|1|||
105659726|NCT04211389|364418817|FG001|Overall Study|Adverse Event|2|||
105659727|NCT04211389|364418816|FG000|Overall Study|Lost to Follow-up|15|||
105990540|NCT03350815|365624339|FG003|Period 2|New therapy for study indication|0|||
105659728|NCT04211389|364418817|FG001|Overall Study|Lost to Follow-up|7|||
105659729|NCT04211389|364418816|FG000|Overall Study|Protocol Violation|0|||
105990541|NCT01964963|365624340|FG000|Overall Study|Case Report Forms Uncollected|888|||
105990542|NCT01964963|365624340|FG000|Overall Study|Protocol Deviation|50|||
105990543|NCT01964963|365624340|FG000|Overall Study|Data Reliability was not Assured|5|||
105990544|NCT00711971|365624345|FG000|Overall Study|Lost to Follow-up|3|||
105990545|NCT00711971|365624346|FG001|Overall Study|Lost to Follow-up|4|||
105990546|NCT00711971|365624347|FG002|Overall Study|Lost to Follow-up|1|||
106098369|NCT01490632|366018529|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105659730|NCT04211389|364418817|FG001|Overall Study|Protocol Violation|1|||
105659731|NCT04211389|364418816|FG000|Overall Study|Withdrawal by Subject|10|||
105659732|NCT04211389|364418817|FG001|Overall Study|Withdrawal by Subject|11|||
105659733|NCT02689453|364418822|FG000|Overall Study|Progressive disease|0|||
105659734|NCT02689453|364418823|FG001|Overall Study|Progressive disease|1|||
105659735|NCT02689453|364418824|FG002|Overall Study|Progressive disease|1|||
105659736|NCT01427738|364418827|FG000|Overall Study|Death|12|||
105659737|NCT01427738|364418828|FG001|Overall Study|Death|9|||
105659738|NCT01427738|364418827|FG000|Overall Study|Severe debilitation, unable to continue|0|||
105659739|NCT01427738|364418828|FG001|Overall Study|Severe debilitation, unable to continue|1|||
105659740|NCT01427738|364418827|FG000|Overall Study|Subject unable to get to clinic|5|||
105659741|NCT01427738|364418828|FG001|Overall Study|Subject unable to get to clinic|2|||
105659742|NCT01427738|364418827|FG000|Overall Study|Withdrawal by Subject|0|||
106098370|NCT01490632|366018530|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105990547|NCT04774926|365624352|FG000|Overall Study|Adverse Event|15|||
105990548|NCT04774926|365624352|FG000|Overall Study|Lost to Follow-up|3|||
105990549|NCT04774926|365624352|FG000|Overall Study|Physician Decision|6|||
105990550|NCT04774926|365624352|FG000|Overall Study|Withdrawal by Subject|3|||
105990551|NCT04774926|365624352|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
105990552|NCT00856544|365624355|FG000|Overall Study|Randomized but not treated|3|||
105990553|NCT00856544|365624356|FG001|Overall Study|Randomized but not treated|0|||
105990554|NCT00856544|365624357|FG002|Overall Study|Randomized but not treated|0|||
105990555|NCT00856544|365624358|FG003|Overall Study|Randomized but not treated|0|||
105990556|NCT00856544|365624355|FG000|Overall Study|Death|0|||
105990557|NCT00856544|365624356|FG001|Overall Study|Death|2|||
105990558|NCT00856544|365624357|FG002|Overall Study|Death|0|||
105990559|NCT00856544|365624358|FG003|Overall Study|Death|0|||
105990560|NCT00856544|365624355|FG000|Overall Study|Adverse Event|20|||
105990561|NCT00856544|365624356|FG001|Overall Study|Adverse Event|29|||
105990562|NCT00856544|365624357|FG002|Overall Study|Adverse Event|2|||
105990563|NCT00856544|365624358|FG003|Overall Study|Adverse Event|3|||
105990564|NCT00856544|365624355|FG000|Overall Study|Lack of Efficacy|16|||
105990565|NCT00856544|365624356|FG001|Overall Study|Lack of Efficacy|12|||
105990566|NCT00856544|365624357|FG002|Overall Study|Lack of Efficacy|3|||
105990567|NCT00856544|365624358|FG003|Overall Study|Lack of Efficacy|3|||
105990568|NCT00856544|365624355|FG000|Overall Study|Other|9|||
105990569|NCT00856544|365624356|FG001|Overall Study|Other|16|||
105990570|NCT00856544|365624357|FG002|Overall Study|Other|1|||
105990571|NCT00856544|365624358|FG003|Overall Study|Other|6|||
105990572|NCT00856544|365624355|FG000|Overall Study|Lost to Follow-up|1|||
105990573|NCT00856544|365624356|FG001|Overall Study|Lost to Follow-up|2|||
105990574|NCT00856544|365624357|FG002|Overall Study|Lost to Follow-up|2|||
105990575|NCT00856544|365624358|FG003|Overall Study|Lost to Follow-up|0|||
105990576|NCT00856544|365624355|FG000|Overall Study|Withdrawal by Subject|8|||
105990577|NCT00856544|365624356|FG001|Overall Study|Withdrawal by Subject|5|||
105990578|NCT00856544|365624357|FG002|Overall Study|Withdrawal by Subject|0|||
105990579|NCT00856544|365624358|FG003|Overall Study|Withdrawal by Subject|1|||
105990580|NCT05274269|365624359|FG000|Overall Study|Adverse Event|0|||
105990581|NCT05274269|365624360|FG001|Overall Study|Adverse Event|3|||
105990582|NCT05274269|365624359|FG000|Overall Study|Death|0|||
105990583|NCT05274269|365624360|FG001|Overall Study|Death|1|||
105990584|NCT05274269|365624359|FG000|Overall Study|Other|0|||
105990585|NCT05274269|365624360|FG001|Overall Study|Other|2|||
105990586|NCT05274269|365624359|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
105990587|NCT05274269|365624360|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
105990588|NCT04303572|365624363|FG000|Overall Study|Study closed due to poor enrollment|1|||
105990589|NCT06312592|365624364|FG000|Overall Study|Lost to Follow-up|29|||
105990590|NCT06312592|365624365|FG001|Overall Study|Lost to Follow-up|13|||
105990591|NCT01369641|365624368|FG000|Overall Study|Withdrawal by Subject|1|||
105990592|NCT00842543|365624369|FG000|Overall Study|Withdrawal by Subject|2|||
105990593|NCT00842543|365624370|FG001|Overall Study|Withdrawal by Subject|0|||
105990594|NCT00842543|365624371|FG002|Overall Study|Withdrawal by Subject|3|||
105990595|NCT00842543|365624372|FG003|Overall Study|Withdrawal by Subject|4|||
105990596|NCT01858766|365624373|FG000|Overall Study|Randomized but Never Treated|0|||
105659743|NCT01427738|364418828|FG001|Overall Study|Withdrawal by Subject|2|||
105990597|NCT01858766|365624374|FG001|Overall Study|Randomized but Never Treated|0|||
105990598|NCT01858766|365624375|FG002|Overall Study|Randomized but Never Treated|0|||
105770545|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105806436|NCT01464827|364948989|FG008|Overall Study|Lost to Follow-up|0|||
105990599|NCT01858766|365624376|FG003|Overall Study|Randomized but Never Treated|0|||
105990600|NCT01858766|365624377|FG004|Overall Study|Randomized but Never Treated|0|||
105990601|NCT01858766|365624378|FG005|Overall Study|Randomized but Never Treated|1|||
105990602|NCT01858766|365624379|FG006|Overall Study|Randomized but Never Treated|0|||
105990603|NCT01858766|365624380|FG007|Overall Study|Randomized but Never Treated|0|||
105990604|NCT01858766|365624381|FG008|Overall Study|Randomized but Never Treated|0|||
105990605|NCT01858766|365624382|FG009|Overall Study|Randomized but Never Treated|0|||
106098371|NCT01490632|366018531|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105990606|NCT01858766|365624383|FG010|Overall Study|Randomized but Never Treated|0|||
105990607|NCT01858766|365624384|FG011|Overall Study|Randomized but Never Treated|0|||
105990608|NCT01858766|365624385|FG012|Overall Study|Randomized but Never Treated|0|||
105990609|NCT01858766|365624386|FG013|Overall Study|Randomized but Never Treated|0|||
105990610|NCT01858766|365624387|FG014|Overall Study|Randomized but Never Treated|0|||
105990611|NCT01858766|365624388|FG015|Overall Study|Randomized but Never Treated|0|||
105990612|NCT01858766|365624389|FG016|Overall Study|Randomized but Never Treated|0|||
105990613|NCT01858766|365624390|FG017|Overall Study|Randomized but Never Treated|1|||
105990614|NCT01858766|365624391|FG018|Overall Study|Randomized but Never Treated|0|||
105990615|NCT01858766|365624373|FG000|Overall Study|Death|0|||
105990616|NCT01858766|365624374|FG001|Overall Study|Death|0|||
105990617|NCT01858766|365624375|FG002|Overall Study|Death|1|||
105990618|NCT01858766|365624376|FG003|Overall Study|Death|0|||
105990619|NCT01858766|365624377|FG004|Overall Study|Death|0|||
105990620|NCT01858766|365624378|FG005|Overall Study|Death|0|||
105990621|NCT01858766|365624379|FG006|Overall Study|Death|0|||
105990622|NCT01858766|365624380|FG007|Overall Study|Death|0|||
105990623|NCT01858766|365624381|FG008|Overall Study|Death|0|||
105990624|NCT01858766|365624382|FG009|Overall Study|Death|0|||
105990625|NCT01858766|365624383|FG010|Overall Study|Death|0|||
105990626|NCT01858766|365624384|FG011|Overall Study|Death|0|||
105990627|NCT01858766|365624385|FG012|Overall Study|Death|0|||
105990628|NCT01858766|365624386|FG013|Overall Study|Death|0|||
106098372|NCT01490632|366018532|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
105990629|NCT01858766|365624387|FG014|Overall Study|Death|0|||
105990630|NCT01858766|365624388|FG015|Overall Study|Death|0|||
105990631|NCT01858766|365624389|FG016|Overall Study|Death|0|||
105990632|NCT01858766|365624390|FG017|Overall Study|Death|0|||
105990633|NCT01858766|365624391|FG018|Overall Study|Death|0|||
105990634|NCT01858766|365624373|FG000|Overall Study|Lack of Efficacy|1|||
105990635|NCT01858766|365624374|FG001|Overall Study|Lack of Efficacy|0|||
105990636|NCT01858766|365624375|FG002|Overall Study|Lack of Efficacy|0|||
106098373|NCT01490632|366018533|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
106098374|NCT01490632|366018514|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098375|NCT01490632|366018515|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098376|NCT01490632|366018516|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098377|NCT01490632|366018517|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098378|NCT01490632|366018518|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098379|NCT01490632|366018519|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098380|NCT01490632|366018520|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
106098381|NCT01490632|366018521|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098382|NCT01490632|366018522|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
106098383|NCT01490632|366018523|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098384|NCT01490632|366018524|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
106098385|NCT01490632|366018525|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
106098386|NCT01490632|366018526|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098387|NCT01490632|366018527|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098388|NCT01490632|366018528|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098389|NCT01490632|366018529|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098390|NCT01490632|366018530|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098391|NCT01490632|366018531|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098392|NCT01490632|366018532|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098393|NCT01490632|366018533|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
106098394|NCT01490632|366018514|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098395|NCT01490632|366018515|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098396|NCT01490632|366018516|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098397|NCT01490632|366018517|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105659744|NCT01427738|364418827|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
105659745|NCT01427738|364418828|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
105659746|NCT01427738|364418827|FG000|Overall Study|Lost to Follow-up|1|||
105659747|NCT01427738|364418828|FG001|Overall Study|Lost to Follow-up|5|||
105659748|NCT00661713|364418829|FG000|Overall Study|Death|1|||
105659749|NCT00661713|364418830|FG001|Overall Study|Death|0|||
105990637|NCT01858766|365624376|FG003|Overall Study|Lack of Efficacy|0|||
105990638|NCT01858766|365624377|FG004|Overall Study|Lack of Efficacy|1|||
105990639|NCT01858766|365624378|FG005|Overall Study|Lack of Efficacy|2|||
105990640|NCT01858766|365624379|FG006|Overall Study|Lack of Efficacy|0|||
106098398|NCT01490632|366018518|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
105659750|NCT00661713|364418831|FG002|Overall Study|Death|0|||
105990641|NCT01858766|365624380|FG007|Overall Study|Lack of Efficacy|0|||
105990642|NCT01858766|365624381|FG008|Overall Study|Lack of Efficacy|0|||
105990643|NCT01858766|365624382|FG009|Overall Study|Lack of Efficacy|0|||
105990644|NCT01858766|365624383|FG010|Overall Study|Lack of Efficacy|0|||
105990645|NCT01858766|365624384|FG011|Overall Study|Lack of Efficacy|3|||
105990646|NCT01858766|365624385|FG012|Overall Study|Lack of Efficacy|5|||
105990647|NCT01858766|365624386|FG013|Overall Study|Lack of Efficacy|3|||
105990648|NCT01858766|365624387|FG014|Overall Study|Lack of Efficacy|5|||
105990649|NCT01858766|365624388|FG015|Overall Study|Lack of Efficacy|5|||
105990650|NCT01858766|365624389|FG016|Overall Study|Lack of Efficacy|2|||
105659751|NCT00661713|364418832|FG003|Overall Study|Death|0|||
105659752|NCT00661713|364418833|FG004|Overall Study|Death|1|||
105659753|NCT00661713|364418834|FG005|Overall Study|Death|0|||
105659754|NCT00661713|364418835|FG006|Overall Study|Death|0|||
105990651|NCT01858766|365624390|FG017|Overall Study|Lack of Efficacy|3|||
105990652|NCT01858766|365624391|FG018|Overall Study|Lack of Efficacy|3|||
105990653|NCT01858766|365624373|FG000|Overall Study|Lost to Follow-up|0|||
105990654|NCT01858766|365624374|FG001|Overall Study|Lost to Follow-up|0|||
105990655|NCT01858766|365624375|FG002|Overall Study|Lost to Follow-up|0|||
105990656|NCT01858766|365624376|FG003|Overall Study|Lost to Follow-up|0|||
105990657|NCT01858766|365624377|FG004|Overall Study|Lost to Follow-up|0|||
105990658|NCT01858766|365624378|FG005|Overall Study|Lost to Follow-up|1|||
105990659|NCT01858766|365624379|FG006|Overall Study|Lost to Follow-up|0|||
105990660|NCT01858766|365624380|FG007|Overall Study|Lost to Follow-up|2|||
105990661|NCT01858766|365624381|FG008|Overall Study|Lost to Follow-up|0|||
105990662|NCT01858766|365624382|FG009|Overall Study|Lost to Follow-up|0|||
105990663|NCT01858766|365624383|FG010|Overall Study|Lost to Follow-up|0|||
105990664|NCT01858766|365624384|FG011|Overall Study|Lost to Follow-up|1|||
105990665|NCT01858766|365624385|FG012|Overall Study|Lost to Follow-up|0|||
105990666|NCT01858766|365624386|FG013|Overall Study|Lost to Follow-up|0|||
105990667|NCT01858766|365624387|FG014|Overall Study|Lost to Follow-up|3|||
105990668|NCT01858766|365624388|FG015|Overall Study|Lost to Follow-up|1|||
105990669|NCT01858766|365624389|FG016|Overall Study|Lost to Follow-up|1|||
105990670|NCT01858766|365624390|FG017|Overall Study|Lost to Follow-up|0|||
105990671|NCT01858766|365624391|FG018|Overall Study|Lost to Follow-up|1|||
105990672|NCT01858766|365624373|FG000|Overall Study|Withdrew Consent|0|||
105990673|NCT01858766|365624374|FG001|Overall Study|Withdrew Consent|0|||
105990674|NCT01858766|365624375|FG002|Overall Study|Withdrew Consent|0|||
105990675|NCT01858766|365624376|FG003|Overall Study|Withdrew Consent|0|||
105990676|NCT01858766|365624377|FG004|Overall Study|Withdrew Consent|0|||
105990677|NCT01858766|365624378|FG005|Overall Study|Withdrew Consent|0|||
105990678|NCT01858766|365624379|FG006|Overall Study|Withdrew Consent|0|||
105990679|NCT01858766|365624380|FG007|Overall Study|Withdrew Consent|0|||
105990680|NCT01858766|365624381|FG008|Overall Study|Withdrew Consent|0|||
105990681|NCT01858766|365624382|FG009|Overall Study|Withdrew Consent|0|||
105990682|NCT01858766|365624383|FG010|Overall Study|Withdrew Consent|0|||
105990683|NCT01858766|365624384|FG011|Overall Study|Withdrew Consent|1|||
105990684|NCT01858766|365624385|FG012|Overall Study|Withdrew Consent|0|||
105990685|NCT01858766|365624386|FG013|Overall Study|Withdrew Consent|0|||
105990686|NCT01858766|365624387|FG014|Overall Study|Withdrew Consent|0|||
105990687|NCT01858766|365624388|FG015|Overall Study|Withdrew Consent|0|||
105990688|NCT01858766|365624389|FG016|Overall Study|Withdrew Consent|0|||
105990689|NCT01858766|365624390|FG017|Overall Study|Withdrew Consent|0|||
106098399|NCT01490632|366018519|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
106098400|NCT01490632|366018520|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
105659755|NCT00661713|364418836|FG007|Overall Study|Death|0|||
105659756|NCT00661713|364418829|FG000|Overall Study|Unable to Classify|1|||
105659757|NCT00661713|364418830|FG001|Overall Study|Unable to Classify|0|||
105659758|NCT00661713|364418831|FG002|Overall Study|Unable to Classify|0|||
105659759|NCT00661713|364418832|FG003|Overall Study|Unable to Classify|0|||
105659760|NCT00661713|364418833|FG004|Overall Study|Unable to Classify|0|||
105659761|NCT00661713|364418834|FG005|Overall Study|Unable to Classify|0|||
105659762|NCT00661713|364418835|FG006|Overall Study|Unable to Classify|0|||
105659763|NCT00661713|364418836|FG007|Overall Study|Unable to Classify|0|||
105659764|NCT00661713|364418829|FG000|Overall Study|Protocol Violation|1|||
105659765|NCT00661713|364418830|FG001|Overall Study|Protocol Violation|6|||
105659766|NCT00661713|364418831|FG002|Overall Study|Protocol Violation|3|||
105659767|NCT00661713|364418832|FG003|Overall Study|Protocol Violation|3|||
105659768|NCT00661713|364418833|FG004|Overall Study|Protocol Violation|0|||
105990690|NCT01858766|365624391|FG018|Overall Study|Withdrew Consent|0|||
105990691|NCT01483183|365624400|FG000|Overall Study|Physician Decision|0|||
105990692|NCT01483183|365624401|FG001|Overall Study|Physician Decision|0|||
105990693|NCT01483183|365624402|FG002|Overall Study|Physician Decision|0|||
105990694|NCT01483183|365624403|FG003|Overall Study|Physician Decision|0|||
105990695|NCT01483183|365624404|FG004|Overall Study|Physician Decision|0|||
105990696|NCT01483183|365624405|FG005|Overall Study|Physician Decision|0|||
105659769|NCT00661713|364418834|FG005|Overall Study|Protocol Violation|2|||
105659770|NCT00661713|364418835|FG006|Overall Study|Protocol Violation|2|||
105659771|NCT00661713|364418836|FG007|Overall Study|Protocol Violation|1|||
105659772|NCT00661713|364418829|FG000|Overall Study|Withdrawal by Subject|11|||
105659773|NCT00661713|364418830|FG001|Overall Study|Withdrawal by Subject|25|||
105990697|NCT01483183|365624406|FG006|Overall Study|Physician Decision|2|||
105990698|NCT01483183|365624407|FG007|Overall Study|Physician Decision|0|||
105990699|NCT01483183|365624408|FG008|Overall Study|Physician Decision|0|||
105659774|NCT00661713|364418831|FG002|Overall Study|Withdrawal by Subject|12|||
105659775|NCT00661713|364418832|FG003|Overall Study|Withdrawal by Subject|21|||
105659776|NCT00661713|364418833|FG004|Overall Study|Withdrawal by Subject|12|||
105659777|NCT00661713|364418834|FG005|Overall Study|Withdrawal by Subject|26|||
105659778|NCT00661713|364418835|FG006|Overall Study|Withdrawal by Subject|45|||
105659779|NCT00661713|364418836|FG007|Overall Study|Withdrawal by Subject|9|||
105659780|NCT00661713|364418829|FG000|Overall Study|Lost to Follow-up|2|||
105659781|NCT00661713|364418830|FG001|Overall Study|Lost to Follow-up|7|||
105659782|NCT00661713|364418831|FG002|Overall Study|Lost to Follow-up|2|||
105659783|NCT00661713|364418832|FG003|Overall Study|Lost to Follow-up|2|||
105659784|NCT00661713|364418833|FG004|Overall Study|Lost to Follow-up|5|||
105659785|NCT00661713|364418834|FG005|Overall Study|Lost to Follow-up|7|||
105659786|NCT00661713|364418835|FG006|Overall Study|Lost to Follow-up|14|||
105659787|NCT00661713|364418836|FG007|Overall Study|Lost to Follow-up|1|||
105659788|NCT00661713|364418829|FG000|Overall Study|Administrative Reason|0|||
105659789|NCT00661713|364418830|FG001|Overall Study|Administrative Reason|1|||
105659790|NCT00661713|364418831|FG002|Overall Study|Administrative Reason|0|||
105659791|NCT00661713|364418832|FG003|Overall Study|Administrative Reason|2|||
105659792|NCT00661713|364418833|FG004|Overall Study|Administrative Reason|2|||
105659793|NCT00661713|364418834|FG005|Overall Study|Administrative Reason|2|||
105659794|NCT00661713|364418835|FG006|Overall Study|Administrative Reason|1|||
105659795|NCT00661713|364418836|FG007|Overall Study|Administrative Reason|0|||
105659796|NCT00661713|364418829|FG000|Overall Study|Adverse Event|0|||
105659797|NCT00661713|364418830|FG001|Overall Study|Adverse Event|0|||
105659798|NCT00661713|364418831|FG002|Overall Study|Adverse Event|0|||
105659799|NCT00661713|364418832|FG003|Overall Study|Adverse Event|0|||
105659800|NCT00661713|364418833|FG004|Overall Study|Adverse Event|0|||
105659801|NCT00661713|364418834|FG005|Overall Study|Adverse Event|0|||
105659802|NCT00661713|364418835|FG006|Overall Study|Adverse Event|1|||
105659803|NCT00661713|364418836|FG007|Overall Study|Adverse Event|0|||
105659804|NCT00661713|364418829|FG000|Overall Study|Inappropriate Enrollment|0|||
105659805|NCT00661713|364418830|FG001|Overall Study|Inappropriate Enrollment|0|||
105659806|NCT00661713|364418831|FG002|Overall Study|Inappropriate Enrollment|0|||
105659807|NCT00661713|364418832|FG003|Overall Study|Inappropriate Enrollment|0|||
105770546|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
106098401|NCT01490632|366018521|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
106098402|NCT01490632|366018522|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
106098403|NCT01490632|366018523|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
106098404|NCT01490632|366018524|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
106098405|NCT01490632|366018525|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
106098406|NCT01490632|366018526|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098407|NCT01490632|366018527|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098408|NCT01490632|366018528|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098409|NCT01490632|366018529|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098410|NCT01490632|366018530|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098411|NCT01490632|366018531|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098412|NCT01490632|366018532|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098413|NCT01490632|366018533|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
106098414|NCT01490632|366018514|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098415|NCT01490632|366018515|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098416|NCT01490632|366018516|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098417|NCT01490632|366018517|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098418|NCT01490632|366018518|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098419|NCT01490632|366018519|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098420|NCT01490632|366018520|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098421|NCT01490632|366018521|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098422|NCT01490632|366018522|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098423|NCT01490632|366018523|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098424|NCT01490632|366018524|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
105659808|NCT00661713|364418833|FG004|Overall Study|Inappropriate Enrollment|0|||
105659809|NCT00661713|364418834|FG005|Overall Study|Inappropriate Enrollment|0|||
105659810|NCT00661713|364418835|FG006|Overall Study|Inappropriate Enrollment|1|||
105659811|NCT00661713|364418836|FG007|Overall Study|Inappropriate Enrollment|0|||
105659812|NCT02353871|364418837|FG000|Overall Study|Protocol deviation|0|||
105659813|NCT02353871|364418838|FG001|Overall Study|Protocol deviation|1|||
105659814|NCT02353871|364418837|FG000|Overall Study|Consent withdrawn|1|||
105659815|NCT02353871|364418838|FG001|Overall Study|Consent withdrawn|8|||
105659816|NCT02353871|364418837|FG000|Overall Study|Lost to Follow-up|2|||
105659817|NCT02353871|364418838|FG001|Overall Study|Lost to Follow-up|0|||
105659818|NCT05314374|364418839|FG000|Overall Study|Adverse Event|2|||
105659819|NCT05314374|364418840|FG001|Overall Study|Adverse Event|2|||
106098425|NCT01490632|366018525|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098426|NCT01490632|366018526|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098427|NCT01490632|366018527|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098428|NCT01490632|366018528|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
106098429|NCT01490632|366018529|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
106098430|NCT01490632|366018530|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098431|NCT01490632|366018531|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098432|NCT01490632|366018532|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098433|NCT01490632|366018533|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
106098434|NCT01490632|366018514|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098435|NCT01490632|366018515|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098436|NCT01490632|366018516|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098437|NCT01490632|366018517|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098438|NCT01490632|366018518|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098439|NCT01490632|366018519|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098440|NCT01490632|366018520|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098441|NCT01490632|366018521|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098442|NCT01490632|366018522|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098443|NCT01490632|366018523|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098444|NCT01490632|366018524|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098445|NCT01490632|366018525|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098446|NCT01490632|366018526|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098447|NCT01490632|366018527|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
106098448|NCT01490632|366018528|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098449|NCT01490632|366018529|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098450|NCT01490632|366018530|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098451|NCT01490632|366018531|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098452|NCT01490632|366018532|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098453|NCT01490632|366018533|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
106098454|NCT01490632|366018514|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098455|NCT01490632|366018515|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098456|NCT01490632|366018516|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098457|NCT01490632|366018517|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098458|NCT01490632|366018518|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098459|NCT01490632|366018519|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098460|NCT01490632|366018520|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098461|NCT01490632|366018521|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098462|NCT01490632|366018522|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098463|NCT01490632|366018523|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098464|NCT01490632|366018524|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098465|NCT01490632|366018525|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098466|NCT01490632|366018526|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098467|NCT01490632|366018527|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098468|NCT01490632|366018528|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
106098469|NCT01490632|366018529|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
106098470|NCT01490632|366018530|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098471|NCT01490632|366018531|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098472|NCT01490632|366018532|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098473|NCT01490632|366018533|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
106098474|NCT01490632|366018514|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105659820|NCT00115336|364418843|FG000|Overall Study|Hospital discharge before study drug|0|||
105659821|NCT00115336|364418844|FG001|Overall Study|Hospital discharge before study drug|1|||
105659822|NCT02658175|364418845|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
105659823|NCT02658175|364418846|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
105659824|NCT02658175|364418847|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
105659825|NCT02658175|364418845|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
105659826|NCT02658175|364418846|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
105659827|NCT02658175|364418847|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
105659828|NCT02658175|364418845|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
105659829|NCT02658175|364418846|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
105659830|NCT02658175|364418847|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
105659831|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
105659832|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
105806437|NCT01464827|364948990|FG009|Overall Study|Lost to Follow-up|0|||
106098475|NCT01490632|366018515|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105659833|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
105659834|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
105659835|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
105659836|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
105659837|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
105659838|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
105659839|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
105659840|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
105659841|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
105659842|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
105659843|NCT02658175|364418845|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
105659844|NCT02658175|364418846|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
105659845|NCT02658175|364418847|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
105659846|NCT02658175|364418845|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
105659847|NCT02658175|364418846|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
105659848|NCT02658175|364418847|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
105659849|NCT02658175|364418845|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
105659850|NCT02658175|364418846|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
105659851|NCT02658175|364418847|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
105659852|NCT01801982|364418849|FG000|Overall Study|Lost to Follow-up|1|||
105659853|NCT03561597|364418850|FG000|Overall Study|Lost to Follow-up|20|||
105659854|NCT00699842|364418854|FG000|Overall Study|Death|0|||
105659855|NCT00699842|364418855|FG001|Overall Study|Death|1|||
105659856|NCT00699842|364418856|FG002|Overall Study|Death|0|||
105659857|NCT04594733|364418857|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
105659858|NCT04594733|364418858|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
105659859|NCT04594733|364418857|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
105659860|NCT04594733|364418858|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
105659861|NCT04594733|364418857|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
105659862|NCT04594733|364418858|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
105659863|NCT00815919|364418859|FG000|Overall Study|Unrelated Fungal Infection|1|||
105659864|NCT00815919|364418859|FG000|Overall Study|AML Relapse|1|||
105659865|NCT00815919|364418859|FG000|Overall Study|Lack of Efficacy|2|||
105659866|NCT04750577|364418860|FG000|Overall Study|Adverse Event|2|||
105659867|NCT04750577|364418861|FG001|Overall Study|Adverse Event|10|||
105659868|NCT04750577|364418862|FG002|Overall Study|Adverse Event|8|||
105659869|NCT04750577|364418863|FG003|Overall Study|Adverse Event|1|||
105659870|NCT04750577|364418860|FG000|Overall Study|Change of residence|0|||
105659871|NCT04750577|364418861|FG001|Overall Study|Change of residence|0|||
105659872|NCT04750577|364418862|FG002|Overall Study|Change of residence|1|||
105659873|NCT04750577|364418863|FG003|Overall Study|Change of residence|0|||
105659874|NCT04750577|364418860|FG000|Overall Study|Burden of study procedures|0|||
105659875|NCT04750577|364418861|FG001|Overall Study|Burden of study procedures|2|||
105659876|NCT04750577|364418862|FG002|Overall Study|Burden of study procedures|2|||
105659877|NCT04750577|364418863|FG003|Overall Study|Burden of study procedures|0|||
105659878|NCT04750577|364418860|FG000|Overall Study|Prematurely discontinued|0|||
105659879|NCT04750577|364418861|FG001|Overall Study|Prematurely discontinued|0|||
105659880|NCT04750577|364418862|FG002|Overall Study|Prematurely discontinued|0|||
105659881|NCT04750577|364418863|FG003|Overall Study|Prematurely discontinued|2|||
105659882|NCT04750577|364418860|FG000|Overall Study|Protocol deviation|1|||
105659883|NCT04750577|364418861|FG001|Overall Study|Protocol deviation|1|||
105659884|NCT04750577|364418862|FG002|Overall Study|Protocol deviation|1|||
105659885|NCT04750577|364418863|FG003|Overall Study|Protocol deviation|1|||
105659886|NCT04750577|364418860|FG000|Overall Study|Other than listed|3|||
105659887|NCT04750577|364418861|FG001|Overall Study|Other than listed|2|||
105659888|NCT04750577|364418862|FG002|Overall Study|Other than listed|2|||
105659889|NCT04750577|364418863|FG003|Overall Study|Other than listed|1|||
105659890|NCT04750577|364418860|FG000|Overall Study|Not treated|0|||
105659891|NCT04750577|364418861|FG001|Overall Study|Not treated|0|||
105659892|NCT04750577|364418862|FG002|Overall Study|Not treated|0|||
105659893|NCT04750577|364418863|FG003|Overall Study|Not treated|2|||
105659894|NCT03170518|364418864|FG000|Overall Study|Lost to Follow-up|4|||
105659895|NCT03170518|364418865|FG001|Overall Study|Lost to Follow-up|1|||
105659896|NCT03170518|364418866|FG002|Overall Study|Lost to Follow-up|0|||
105659897|NCT03170518|364418864|FG000|Overall Study|Physician Decision|1|||
105659898|NCT03170518|364418865|FG001|Overall Study|Physician Decision|0|||
105659899|NCT03170518|364418866|FG002|Overall Study|Physician Decision|0|||
105659900|NCT03170518|364418864|FG000|Overall Study|Withdrawal by Subject|4|||
105659901|NCT03170518|364418865|FG001|Overall Study|Withdrawal by Subject|5|||
105659902|NCT03170518|364418866|FG002|Overall Study|Withdrawal by Subject|2|||
105659903|NCT03170518|364418864|FG000|Overall Study|Site terminated by sponsor|0|||
105659904|NCT03170518|364418865|FG001|Overall Study|Site terminated by sponsor|1|||
105770547|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105659905|NCT03170518|364418866|FG002|Overall Study|Site terminated by sponsor|0|||
105659906|NCT03170518|364418864|FG000|Overall Study|Non-compliance with study drug|1|||
105659907|NCT03170518|364418865|FG001|Overall Study|Non-compliance with study drug|0|||
106098476|NCT01490632|366018516|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098477|NCT01490632|366018517|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098478|NCT01490632|366018518|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098479|NCT01490632|366018519|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
105659908|NCT03170518|364418866|FG002|Overall Study|Non-compliance with study drug|1|||
105659909|NCT03170518|364418864|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105659910|NCT03170518|364418865|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105659911|NCT03170518|364418866|FG002|Overall Study|Withdrawal by parent/guardian|0|||
106098480|NCT01490632|366018520|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098481|NCT01490632|366018521|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098482|NCT01490632|366018522|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098483|NCT01490632|366018523|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098484|NCT01490632|366018524|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098485|NCT01490632|366018525|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098486|NCT01490632|366018526|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
106098487|NCT01490632|366018527|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
106098488|NCT01490632|366018528|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
106098489|NCT01490632|366018529|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
106098490|NCT01490632|366018530|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098491|NCT01490632|366018531|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098492|NCT01490632|366018532|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098493|NCT01490632|366018533|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
106098494|NCT01490632|366018514|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
106098495|NCT01490632|366018515|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
106098496|NCT01490632|366018516|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
106098497|NCT01490632|366018517|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
106098498|NCT01490632|366018518|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
106098499|NCT01490632|366018519|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
106098500|NCT01490632|366018520|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
106098501|NCT01490632|366018521|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
106098502|NCT01490632|366018522|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
106098503|NCT01490632|366018523|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
105659912|NCT02257918|364418867|FG000|Overall Study|Lost to Follow-up|4|||
105659913|NCT02257918|364418868|FG001|Overall Study|Lost to Follow-up|1|||
105659914|NCT02257918|364418869|FG002|Overall Study|Lost to Follow-up|0|||
105659915|NCT02257918|364418867|FG000|Overall Study|Withdrawal by Subject|0|||
105659916|NCT02257918|364418868|FG001|Overall Study|Withdrawal by Subject|0|||
105659917|NCT02257918|364418869|FG002|Overall Study|Withdrawal by Subject|1|||
105659918|NCT02257918|364418867|FG000|Overall Study|Pregnancy|0|||
105659919|NCT02257918|364418868|FG001|Overall Study|Pregnancy|0|||
105990700|NCT01483183|365624409|FG009|Overall Study|Physician Decision|0|||
105990701|NCT01483183|365624400|FG000|Overall Study|Withdrawal by Subject|0|||
105990702|NCT01483183|365624401|FG001|Overall Study|Withdrawal by Subject|0|||
105990703|NCT01483183|365624402|FG002|Overall Study|Withdrawal by Subject|0|||
105990704|NCT01483183|365624403|FG003|Overall Study|Withdrawal by Subject|0|||
105990705|NCT01483183|365624404|FG004|Overall Study|Withdrawal by Subject|0|||
105990706|NCT01483183|365624405|FG005|Overall Study|Withdrawal by Subject|0|||
105990707|NCT01483183|365624406|FG006|Overall Study|Withdrawal by Subject|0|||
105990708|NCT01483183|365624407|FG007|Overall Study|Withdrawal by Subject|0|||
105990709|NCT01483183|365624408|FG008|Overall Study|Withdrawal by Subject|0|||
105990710|NCT01483183|365624409|FG009|Overall Study|Withdrawal by Subject|1|||
105990711|NCT03781414|365624410|FG000|Overall Study|Study terminated by sponsor|39|||
105990712|NCT03781414|365624411|FG001|Overall Study|Study terminated by sponsor|34|||
105990713|NCT03781414|365624412|FG002|Overall Study|Study terminated by sponsor|25|||
105990714|NCT03781414|365624410|FG000|Overall Study|Adverse Event|3|||
105990715|NCT03781414|365624411|FG001|Overall Study|Adverse Event|6|||
105990716|NCT03781414|365624412|FG002|Overall Study|Adverse Event|3|||
105990717|NCT03781414|365624410|FG000|Overall Study|Physician Decision|2|||
105990718|NCT03781414|365624411|FG001|Overall Study|Physician Decision|0|||
105990719|NCT03781414|365624412|FG002|Overall Study|Physician Decision|1|||
105990720|NCT03781414|365624410|FG000|Overall Study|Withdrawal by Subject|2|||
105990721|NCT03781414|365624411|FG001|Overall Study|Withdrawal by Subject|3|||
105990722|NCT03781414|365624412|FG002|Overall Study|Withdrawal by Subject|3|||
105990723|NCT03781414|365624410|FG000|Overall Study|Death|1|||
105990724|NCT03781414|365624411|FG001|Overall Study|Death|4|||
105990725|NCT03781414|365624412|FG002|Overall Study|Death|0|||
105659920|NCT02257918|364418869|FG002|Overall Study|Pregnancy|1|||
105659921|NCT04969276|364418876|FG000|Overall Study|Protocol Deviation|0|||
105659922|NCT04969276|364418877|FG001|Overall Study|Protocol Deviation|1|||
105659923|NCT04969276|364418878|FG002|Overall Study|Protocol Deviation|0|||
105659924|NCT04969276|364418876|FG000|Overall Study|Withdrawal by Subject|1|||
105659925|NCT04969276|364418877|FG001|Overall Study|Withdrawal by Subject|10|||
105659926|NCT04969276|364418878|FG002|Overall Study|Withdrawal by Subject|0|||
105659927|NCT04969276|364418876|FG000|Overall Study|Lost to Follow-up|0|||
106098504|NCT01490632|366018524|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
106098505|NCT01490632|366018525|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
106098506|NCT01490632|366018526|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
106098507|NCT01490632|366018527|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
106098508|NCT01490632|366018528|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
106098509|NCT01490632|366018529|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
106098510|NCT01490632|366018530|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
106098511|NCT01490632|366018531|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
106098512|NCT01490632|366018532|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
106098513|NCT01490632|366018533|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
106098514|NCT01490632|366018514|FG000|Part D: Re-Treatment Period|Death|0|||
106098515|NCT01490632|366018515|FG001|Part D: Re-Treatment Period|Death|0|||
106098516|NCT01490632|366018516|FG002|Part D: Re-Treatment Period|Death|0|||
106098517|NCT01490632|366018517|FG003|Part D: Re-Treatment Period|Death|0|||
106098518|NCT01490632|366018518|FG004|Part D: Re-Treatment Period|Death|0|||
106098519|NCT01490632|366018519|FG005|Part D: Re-Treatment Period|Death|0|||
106098520|NCT01490632|366018520|FG006|Part D: Re-Treatment Period|Death|0|||
106098521|NCT01490632|366018521|FG007|Part D: Re-Treatment Period|Death|0|||
106098522|NCT01490632|366018522|FG008|Part D: Re-Treatment Period|Death|0|||
106098523|NCT01490632|366018523|FG009|Part D: Re-Treatment Period|Death|0|||
106098524|NCT01490632|366018524|FG010|Part D: Re-Treatment Period|Death|0|||
106098525|NCT01490632|366018525|FG011|Part D: Re-Treatment Period|Death|0|||
106098526|NCT01490632|366018526|FG012|Part D: Re-Treatment Period|Death|0|||
106098527|NCT01490632|366018527|FG013|Part D: Re-Treatment Period|Death|0|||
106098528|NCT01490632|366018528|FG014|Part D: Re-Treatment Period|Death|0|||
106098529|NCT01490632|366018529|FG015|Part D: Re-Treatment Period|Death|0|||
106098530|NCT01490632|366018530|FG016|Part D: Re-Treatment Period|Death|0|||
106098531|NCT01490632|366018531|FG017|Part D: Re-Treatment Period|Death|0|||
106098532|NCT01490632|366018532|FG018|Part D: Re-Treatment Period|Death|1|||
106098533|NCT01490632|366018533|FG019|Part D: Re-Treatment Period|Death|0|||
106098534|NCT01490632|366018514|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098535|NCT01490632|366018515|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098536|NCT01490632|366018516|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098537|NCT01490632|366018517|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098538|NCT01490632|366018518|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098539|NCT01490632|366018519|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098540|NCT01490632|366018520|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098541|NCT01490632|366018521|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098542|NCT01490632|366018522|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098543|NCT01490632|366018523|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098544|NCT01490632|366018524|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098545|NCT01490632|366018525|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098546|NCT01490632|366018526|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098547|NCT01490632|366018527|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098548|NCT01490632|366018528|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098549|NCT01490632|366018529|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098550|NCT01490632|366018530|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
106098551|NCT01490632|366018531|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
106098552|NCT01490632|366018532|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
106098553|NCT01490632|366018533|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
106098554|NCT01490632|366018514|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098555|NCT01490632|366018515|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098556|NCT01490632|366018516|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098557|NCT01490632|366018517|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098558|NCT01490632|366018518|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098559|NCT01490632|366018519|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098560|NCT01490632|366018520|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098561|NCT01490632|366018521|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098562|NCT01490632|366018522|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098563|NCT01490632|366018523|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098564|NCT01490632|366018524|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098565|NCT01490632|366018525|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
105659928|NCT04969276|364418877|FG001|Overall Study|Lost to Follow-up|1|||
105659929|NCT04969276|364418878|FG002|Overall Study|Lost to Follow-up|0|||
105770548|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105659930|NCT00356811|364418880|FG000|Overall Study|Death|35|||
105659931|NCT00356811|364418880|FG000|Overall Study|Lost to Follow-up|2|||
106098566|NCT01490632|366018526|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098567|NCT01490632|366018527|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098568|NCT01490632|366018528|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098569|NCT01490632|366018529|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098570|NCT01490632|366018530|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098571|NCT01490632|366018531|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098572|NCT01490632|366018532|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
106098573|NCT01490632|366018533|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
106098574|NCT01490632|366018514|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
106098575|NCT01490632|366018515|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
106098576|NCT01490632|366018516|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
106098577|NCT01490632|366018517|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
106098578|NCT01490632|366018518|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
106098579|NCT01490632|366018519|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
106098580|NCT01490632|366018520|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
106098581|NCT01490632|366018521|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
106098582|NCT01490632|366018522|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
106098583|NCT01490632|366018523|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
106098584|NCT01490632|366018524|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
106098585|NCT01490632|366018525|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
106098586|NCT01490632|366018526|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
106098587|NCT01490632|366018527|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
106098588|NCT01490632|366018528|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
106098589|NCT01490632|366018529|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
106098590|NCT01490632|366018530|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
106098591|NCT01490632|366018531|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
106098592|NCT01490632|366018532|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
106098593|NCT01490632|366018533|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
106098594|NCT01490632|366018514|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
106098595|NCT01490632|366018515|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
106098596|NCT01490632|366018516|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
106098597|NCT01490632|366018517|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
106098598|NCT01490632|366018518|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
106098599|NCT01490632|366018519|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
106098600|NCT01490632|366018520|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
106098601|NCT01490632|366018521|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
106098602|NCT01490632|366018522|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
106098603|NCT01490632|366018523|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
106098604|NCT01490632|366018524|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
106098605|NCT01490632|366018525|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
106098606|NCT01490632|366018526|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
106098607|NCT01490632|366018527|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
106098608|NCT01490632|366018528|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
106098609|NCT01490632|366018529|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
106098610|NCT01490632|366018530|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
106098611|NCT01490632|366018531|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
106098612|NCT01490632|366018532|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
106098613|NCT01490632|366018533|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
106098614|NCT01490632|366018514|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098615|NCT01490632|366018515|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098616|NCT01490632|366018516|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098617|NCT01490632|366018517|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098618|NCT01490632|366018518|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098619|NCT01490632|366018519|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098620|NCT01490632|366018520|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098621|NCT01490632|366018521|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098622|NCT01490632|366018522|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098623|NCT01490632|366018523|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098624|NCT01490632|366018524|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098625|NCT01490632|366018525|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098626|NCT01490632|366018526|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098627|NCT01490632|366018527|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098628|NCT01490632|366018528|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098629|NCT01490632|366018529|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098630|NCT01490632|366018530|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
106098631|NCT01490632|366018531|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
106098632|NCT01490632|366018532|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
106098633|NCT01490632|366018533|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
106098634|NCT05706506|366018538|FG000|Overall Study|Adverse Event|1|||
106098635|NCT05706506|366018538|FG000|Overall Study|Withdrawal by Subject|4|||
106098636|NCT05706506|366018538|FG000|Overall Study|Lost to Follow-up|2|||
106098637|NCT05706506|366018538|FG000|Overall Study|Inadvertent Enrolment|12|||
106098638|NCT05706506|366018538|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
106098639|NCT05706506|366018538|FG000|Overall Study|Participant Moved Out of State|1|||
106098640|NCT05732454|366018539|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
106098641|NCT05732454|366018540|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
106098642|NCT05732454|366018539|FG000|Part 1: DB Period|Adverse Event|1|||
106098643|NCT05732454|366018540|FG001|Part 1: DB Period|Adverse Event|0|||
106098644|NCT05732454|366018539|FG000|Part 1: DB Period|Lost to Follow-up|1|||
106098645|NCT05732454|366018540|FG001|Part 1: DB Period|Lost to Follow-up|0|||
106098646|NCT05732454|366018539|FG000|Part 1: DB Period|Protocol Violation|0|||
106098647|NCT05732454|366018540|FG001|Part 1: DB Period|Protocol Violation|1|||
106098648|NCT05732454|366018539|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
106098649|NCT05732454|366018540|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
106098650|NCT05732454|366018539|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
106098651|NCT05732454|366018540|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
106098652|NCT05732454|366018539|FG000|Part 1: OLE Period|Adverse Event|0|||
106098653|NCT05732454|366018540|FG001|Part 1: OLE Period|Adverse Event|1|||
106098654|NCT05732454|366018539|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
106098655|NCT05732454|366018540|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
106098656|NCT02091726|366018543|FG000|Overall Study|Lost to Follow-up|6|||
106098657|NCT06111742|366018552|FG000|Overall Study|Did not receive intervention|1|||
106098658|NCT06111742|366018553|FG001|Overall Study|Did not receive intervention|0|||
106098659|NCT06111742|366018554|FG002|Overall Study|Did not receive intervention|0|||
106098660|NCT06111742|366018552|FG000|Overall Study|Withdrawal by Subject|2|||
106098661|NCT06111742|366018553|FG001|Overall Study|Withdrawal by Subject|0|||
106098662|NCT06111742|366018554|FG002|Overall Study|Withdrawal by Subject|0|||
106098663|NCT01914926|366018555|FG000|Overall Study|Adverse Event|1|||
106098664|NCT01914926|366018556|FG001|Overall Study|Adverse Event|0|||
106098665|NCT01914926|366018555|FG000|Overall Study|uncooperative, agitated and removed|0|||
106098666|NCT01914926|366018556|FG001|Overall Study|uncooperative, agitated and removed|1|||
106098667|NCT02605954|366018557|FG000|Overall Study|Adverse Event|5|||
106098668|NCT02605954|366018558|FG001|Overall Study|Adverse Event|1|||
106098669|NCT02605954|366018557|FG000|Overall Study|Investigator's Discretion|1|||
106098670|NCT02605954|366018558|FG001|Overall Study|Investigator's Discretion|0|||
106098671|NCT02605954|366018557|FG000|Overall Study|Non-Compliance with Study Drug|1|||
106098672|NCT02605954|366018558|FG001|Overall Study|Non-Compliance with Study Drug|0|||
106098673|NCT02605954|366018557|FG000|Overall Study|Withdrew Consent|2|||
106098674|NCT02605954|366018558|FG001|Overall Study|Withdrew Consent|2|||
106098675|NCT02605954|366018557|FG000|Overall Study|Lost to Follow-up|3|||
106098676|NCT02605954|366018558|FG001|Overall Study|Lost to Follow-up|0|||
106098677|NCT02605954|366018557|FG000|Overall Study|Randomized but not treated|0|||
106098678|NCT02605954|366018558|FG001|Overall Study|Randomized but not treated|1|||
106098679|NCT04717596|366018559|FG000|Overall Study|Withdrawal by Subject|4|||
106098680|NCT03555396|366018560|FG000|Overall Study|Death|3|||
106098681|NCT03555396|366018561|FG001|Overall Study|Death|1|||
106098682|NCT03555396|366018560|FG000|Overall Study|Lost to Follow-up|0|||
106098683|NCT03555396|366018561|FG001|Overall Study|Lost to Follow-up|2|||
106098684|NCT02896855|366018563|FG000|Overall Study|Death|50|||
106098685|NCT02896855|366018564|FG001|Overall Study|Death|40|||
106098686|NCT02896855|366018563|FG000|Overall Study|Lost to Follow-up|15|||
106098687|NCT02896855|366018564|FG001|Overall Study|Lost to Follow-up|9|||
106098688|NCT02896855|366018563|FG000|Overall Study|Withdrawal by Subject|7|||
106098689|NCT02896855|366018564|FG001|Overall Study|Withdrawal by Subject|4|||
106098690|NCT01369342|366018567|FG000|Overall Study|Withdrawal by Subject|7|||
106098691|NCT01369342|366018568|FG001|Overall Study|Withdrawal by Subject|7|||
106098692|NCT01369342|366018569|FG002|Overall Study|Withdrawal by Subject|2|||
106098693|NCT01369342|366018567|FG000|Overall Study|Lost to Follow-up|5|||
106098694|NCT01369342|366018568|FG001|Overall Study|Lost to Follow-up|2|||
106098695|NCT01369342|366018569|FG002|Overall Study|Lost to Follow-up|1|||
106098696|NCT01369342|366018567|FG000|Overall Study|Not Treated|1|||
106098697|NCT01369342|366018568|FG001|Overall Study|Not Treated|0|||
106098698|NCT01369342|366018569|FG002|Overall Study|Not Treated|0|||
106098699|NCT04723576|366018570|FG000|Overall Study|Withdrawal by Subject|2133|||
106098700|NCT04723576|366018571|FG001|Overall Study|Withdrawal by Subject|3234|||
106098701|NCT03732209|366018572|FG000|Overall Study|Lost to Follow-up|4|||
106098702|NCT03732209|366018573|FG001|Overall Study|Lost to Follow-up|4|||
106098703|NCT03732209|366018572|FG000|Overall Study|Withdrawal by Subject|8|||
106098704|NCT03732209|366018573|FG001|Overall Study|Withdrawal by Subject|9|||
106098705|NCT05046795|366018574|FG000|Overall Study|Adverse Event|13|||
106098706|NCT05046795|366018575|FG001|Overall Study|Adverse Event|15|||
106098707|NCT05046795|366018574|FG000|Overall Study|Withdrawal by Subject|4|||
106098708|NCT05046795|366018575|FG001|Overall Study|Withdrawal by Subject|7|||
106098709|NCT05046795|366018574|FG000|Overall Study|Physician Decision|1|||
106098710|NCT05046795|366018575|FG001|Overall Study|Physician Decision|2|||
106098711|NCT05046795|366018574|FG000|Overall Study|Protocol Violation|1|||
106098712|NCT05046795|366018575|FG001|Overall Study|Protocol Violation|2|||
106098713|NCT05046795|366018574|FG000|Overall Study|Death|1|||
106098714|NCT05046795|366018575|FG001|Overall Study|Death|0|||
106098715|NCT05046795|366018574|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
106098716|NCT05046795|366018575|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
106098717|NCT01127178|366018576|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
106098718|NCT01127178|366018577|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
106098719|NCT01127178|366018576|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
106098720|NCT01127178|366018577|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
106098721|NCT01127178|366018576|FG000|Dose Escalation: Treatment Phase|Other|2|||
106098722|NCT01127178|366018577|FG001|Dose Escalation: Treatment Phase|Other|0|||
106098723|NCT01127178|366018576|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
106098724|NCT01127178|366018577|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
106098725|NCT01127178|366018576|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
106098726|NCT01127178|366018577|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
106098727|NCT01127178|366018576|FG000|Dose Escalation: Extension Phase|Other|1|||
106098728|NCT01127178|366018577|FG001|Dose Escalation: Extension Phase|Other|0|||
106098729|NCT06027216|366018580|FG000|Overall Study|Did not qualify|8|||
106098730|NCT00709722|366018581|FG000|Overall Study|Adverse Event|1|||
106098731|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
106098732|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
106098733|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
106098734|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
106098735|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
106098736|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
106098737|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
106098738|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
106098739|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
106098740|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
106098741|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
106098742|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
106098743|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
106098744|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
106098745|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
106098746|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
106098747|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
106098748|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
106098749|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
106098750|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
106098751|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
106098752|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
106098753|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
106098754|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
106098755|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
106098756|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
106098757|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
106098758|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
106098759|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
106098760|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
106098761|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
106098762|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
106098763|NCT04818346|366018582|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
106098764|NCT04818346|366018583|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
106098765|NCT04818346|366018584|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
106098766|NCT04818346|366018585|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
106098767|NCT04818346|366018582|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
106098768|NCT04818346|366018583|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
106098769|NCT04818346|366018584|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
106098770|NCT04818346|366018585|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
106098771|NCT04818346|366018582|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
106098772|NCT04818346|366018583|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
106098773|NCT04818346|366018584|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
106098774|NCT04818346|366018585|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
106098775|NCT04818346|366018582|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
106098776|NCT04818346|366018583|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
106098777|NCT04818346|366018584|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
106098778|NCT04818346|366018585|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
106098779|NCT04818346|366018582|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
106098780|NCT04818346|366018583|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
106098781|NCT04818346|366018584|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
106098782|NCT04818346|366018585|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
106098783|NCT04818346|366018582|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
106098784|NCT04818346|366018583|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
106098785|NCT04818346|366018584|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
106098786|NCT04818346|366018585|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
106098787|NCT04818346|366018582|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
106098788|NCT04818346|366018583|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
106098789|NCT04818346|366018584|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
106098790|NCT04818346|366018585|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
106098791|NCT01953926|366018591|FG000|Overall Study|Withdrawal by Subject|23|||
106098792|NCT01953926|366018592|FG001|Overall Study|Withdrawal by Subject|3|||
106098793|NCT01953926|366018593|FG002|Overall Study|Withdrawal by Subject|3|||
106098794|NCT01953926|366018594|FG003|Overall Study|Withdrawal by Subject|5|||
106098795|NCT01953926|366018595|FG004|Overall Study|Withdrawal by Subject|6|||
106098796|NCT01953926|366018596|FG005|Overall Study|Withdrawal by Subject|0|||
106098797|NCT01953926|366018597|FG006|Overall Study|Withdrawal by Subject|1|||
106098798|NCT01953926|366018591|FG000|Overall Study|Physician Decision|1|||
106098799|NCT01953926|366018592|FG001|Overall Study|Physician Decision|0|||
106098800|NCT01953926|366018593|FG002|Overall Study|Physician Decision|0|||
106098801|NCT01953926|366018594|FG003|Overall Study|Physician Decision|0|||
106098802|NCT01953926|366018595|FG004|Overall Study|Physician Decision|2|||
106098803|NCT01953926|366018596|FG005|Overall Study|Physician Decision|0|||
106098804|NCT01953926|366018597|FG006|Overall Study|Physician Decision|0|||
106098805|NCT01953926|366018591|FG000|Overall Study|Lost to Follow-up|18|||
106098806|NCT01953926|366018592|FG001|Overall Study|Lost to Follow-up|3|||
106098807|NCT01953926|366018593|FG002|Overall Study|Lost to Follow-up|0|||
106098808|NCT01953926|366018594|FG003|Overall Study|Lost to Follow-up|5|||
106098809|NCT01953926|366018595|FG004|Overall Study|Lost to Follow-up|3|||
106098810|NCT01953926|366018596|FG005|Overall Study|Lost to Follow-up|0|||
106098811|NCT01953926|366018597|FG006|Overall Study|Lost to Follow-up|0|||
106098812|NCT01953926|366018591|FG000|Overall Study|Protocol Violation|1|||
106098813|NCT01953926|366018592|FG001|Overall Study|Protocol Violation|0|||
106098814|NCT01953926|366018593|FG002|Overall Study|Protocol Violation|0|||
106098815|NCT01953926|366018594|FG003|Overall Study|Protocol Violation|0|||
106098816|NCT01953926|366018595|FG004|Overall Study|Protocol Violation|0|||
106098817|NCT01953926|366018596|FG005|Overall Study|Protocol Violation|0|||
106098818|NCT01953926|366018597|FG006|Overall Study|Protocol Violation|0|||
106098819|NCT01953926|366018591|FG000|Overall Study|Other, Disease progression|2|||
106098820|NCT01953926|366018592|FG001|Overall Study|Other, Disease progression|1|||
106098821|NCT01953926|366018593|FG002|Overall Study|Other, Disease progression|0|||
106098822|NCT01953926|366018594|FG003|Overall Study|Other, Disease progression|0|||
106098823|NCT01953926|366018595|FG004|Overall Study|Other, Disease progression|1|||
106098824|NCT01953926|366018596|FG005|Overall Study|Other, Disease progression|0|||
106098825|NCT01953926|366018597|FG006|Overall Study|Other, Disease progression|0|||
106098826|NCT01953926|366018591|FG000|Overall Study|Discontinuation of study by sponsor|41|||
106098827|NCT01953926|366018592|FG001|Overall Study|Discontinuation of study by sponsor|7|||
106098828|NCT01953926|366018593|FG002|Overall Study|Discontinuation of study by sponsor|5|||
106098829|NCT01953926|366018594|FG003|Overall Study|Discontinuation of study by sponsor|12|||
106098830|NCT01953926|366018595|FG004|Overall Study|Discontinuation of study by sponsor|46|||
106098831|NCT01953926|366018596|FG005|Overall Study|Discontinuation of study by sponsor|5|||
106098832|NCT01953926|366018597|FG006|Overall Study|Discontinuation of study by sponsor|6|||
106098833|NCT01953926|366018591|FG000|Overall Study|Not Treated|1|||
106098834|NCT01953926|366018592|FG001|Overall Study|Not Treated|0|||
106098835|NCT01953926|366018593|FG002|Overall Study|Not Treated|1|||
106098836|NCT01953926|366018594|FG003|Overall Study|Not Treated|0|||
106098837|NCT01953926|366018595|FG004|Overall Study|Not Treated|0|||
106098838|NCT01953926|366018596|FG005|Overall Study|Not Treated|0|||
106098839|NCT01953926|366018597|FG006|Overall Study|Not Treated|0|||
106098840|NCT00833989|366018599|FG000|Overall Study|Physician Decision|0|||
106098841|NCT00833989|366018600|FG001|Overall Study|Physician Decision|0|||
106098842|NCT00833989|366018601|FG002|Overall Study|Physician Decision|0|||
106098843|NCT00833989|366018602|FG003|Overall Study|Physician Decision|1|||
106098844|NCT00833989|366018599|FG000|Overall Study|Withdrawal by Subject|3|||
106098845|NCT00833989|366018600|FG001|Overall Study|Withdrawal by Subject|0|||
106098846|NCT00833989|366018601|FG002|Overall Study|Withdrawal by Subject|1|||
106098847|NCT00833989|366018602|FG003|Overall Study|Withdrawal by Subject|1|||
106098848|NCT01587651|366018604|FG000|Overall Study|Adverse Event|0|||
106098849|NCT01587651|366018605|FG001|Overall Study|Adverse Event|1|||
106098850|NCT01587651|366018606|FG002|Overall Study|Adverse Event|0|||
106098851|NCT01587651|366018604|FG000|Overall Study|Protocol Violation|0|||
106098852|NCT01587651|366018605|FG001|Overall Study|Protocol Violation|1|||
106098853|NCT01587651|366018606|FG002|Overall Study|Protocol Violation|1|||
106098854|NCT01587651|366018604|FG000|Overall Study|Withdrawal by Subject|0|||
106098855|NCT01587651|366018605|FG001|Overall Study|Withdrawal by Subject|1|||
106098856|NCT01587651|366018606|FG002|Overall Study|Withdrawal by Subject|0|||
106098857|NCT00092131|366018607|FG000|Treatment Period I|Adverse Event|1|||
106098858|NCT00092131|366018608|FG001|Treatment Period I|Adverse Event|0|||
106098859|NCT00092131|366018607|FG000|Treatment Period II|Adverse Event|0|||
106098860|NCT00092131|366018608|FG001|Treatment Period II|Adverse Event|1|||
106098861|NCT04403698|366018609|FG000|Overall Study|Adverse Event|1|||
106098862|NCT04403698|366018610|FG001|Overall Study|Adverse Event|1|||
106098863|NCT04403698|366018609|FG000|Overall Study|Lost to Follow-up|1|||
106098864|NCT04403698|366018610|FG001|Overall Study|Lost to Follow-up|0|||
106098865|NCT04403698|366018609|FG000|Overall Study|Protocol Violation|0|||
106098866|NCT04403698|366018610|FG001|Overall Study|Protocol Violation|1|||
106098867|NCT04323436|366018613|FG000|Overall Study|Adverse Event|7|||
106098868|NCT04323436|366018614|FG001|Overall Study|Adverse Event|0|||
106098869|NCT04323436|366018615|FG002|Overall Study|Adverse Event|0|||
106098870|NCT04323436|366018613|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
106098871|NCT04323436|366018614|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
106098872|NCT04323436|366018615|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
106098873|NCT04323436|366018613|FG000|Overall Study|Death|1|||
106098874|NCT04323436|366018614|FG001|Overall Study|Death|0|||
106098875|NCT04323436|366018615|FG002|Overall Study|Death|0|||
106098876|NCT04323436|366018613|FG000|Overall Study|Physician Decision|2|||
106098877|NCT04323436|366018614|FG001|Overall Study|Physician Decision|0|||
106098878|NCT04323436|366018615|FG002|Overall Study|Physician Decision|0|||
106098879|NCT04323436|366018613|FG000|Overall Study|Progressive disease|10|||
106098880|NCT04323436|366018614|FG001|Overall Study|Progressive disease|0|||
106098881|NCT04323436|366018615|FG002|Overall Study|Progressive disease|0|||
106098882|NCT04323436|366018613|FG000|Overall Study|Subject decision|3|||
106098883|NCT04323436|366018614|FG001|Overall Study|Subject decision|0|||
106098884|NCT04323436|366018615|FG002|Overall Study|Subject decision|0|||
106098885|NCT00047879|366018616|FG000|Overall Study|Progressive disease|4|||
106098886|NCT00047879|366018617|FG001|Overall Study|Progressive disease|3|||
106098887|NCT01165281|366018620|FG000|Overall Study|Adverse Event|12|||
106098888|NCT01165281|366018621|FG001|Overall Study|Adverse Event|14|||
106098889|NCT01165281|366018620|FG000|Overall Study|Death|3|||
106098890|NCT01165281|366018621|FG001|Overall Study|Death|4|||
106098891|NCT01165281|366018620|FG000|Overall Study|Lack of Efficacy|4|||
106098892|NCT01165281|366018621|FG001|Overall Study|Lack of Efficacy|1|||
106098893|NCT01165281|366018620|FG000|Overall Study|Lost to Follow-up|0|||
106098894|NCT01165281|366018621|FG001|Overall Study|Lost to Follow-up|1|||
106098895|NCT01165281|366018620|FG000|Overall Study|Physician Decision|8|||
106098896|NCT01165281|366018621|FG001|Overall Study|Physician Decision|1|||
106098897|NCT01165281|366018620|FG000|Overall Study|Protocol Violation|6|||
106098898|NCT01165281|366018621|FG001|Overall Study|Protocol Violation|5|||
106098899|NCT01165281|366018620|FG000|Overall Study|Withdrawal by Subject|8|||
106098900|NCT01165281|366018621|FG001|Overall Study|Withdrawal by Subject|7|||
106098901|NCT01165281|366018620|FG000|Overall Study|Noncompliance with Study Drug|1|||
106098902|NCT01165281|366018621|FG001|Overall Study|Noncompliance with Study Drug|4|||
106098903|NCT01165281|366018620|FG000|Overall Study|Progressive Disease|10|||
106098904|NCT01165281|366018621|FG001|Overall Study|Progressive Disease|14|||
106098905|NCT01165281|366018620|FG000|Overall Study|Other|6|||
106098906|NCT01165281|366018621|FG001|Overall Study|Other|0|||
106098907|NCT03277313|366018622|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
106098908|NCT03277313|366018623|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
106098909|NCT03277313|366018622|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
106098910|NCT03277313|366018623|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
106098911|NCT03277313|366018622|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
106098912|NCT03277313|366018623|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
106098913|NCT03277313|366018622|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
106098914|NCT03277313|366018623|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
106098915|NCT03277313|366018622|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
106098916|NCT03277313|366018623|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
106098917|NCT02005471|366018627|FG000|Main Study|Adverse Event|0|||
106098918|NCT02005471|366018628|FG001|Main Study|Adverse Event|1|||
106098919|NCT02005471|366018629|FG002|Main Study|Adverse Event|0|||
106098920|NCT02005471|366018630|FG003|Main Study|Adverse Event|0|||
106098921|NCT02005471|366018627|FG000|Main Study|Death|83|||
106098922|NCT02005471|366018628|FG001|Main Study|Death|52|||
106098923|NCT02005471|366018629|FG002|Main Study|Death|0|||
106098924|NCT02005471|366018630|FG003|Main Study|Death|0|||
106098925|NCT02005471|366018627|FG000|Main Study|Lost to Follow-up|4|||
106098926|NCT02005471|366018628|FG001|Main Study|Lost to Follow-up|5|||
106098927|NCT02005471|366018629|FG002|Main Study|Lost to Follow-up|0|||
106098928|NCT02005471|366018630|FG003|Main Study|Lost to Follow-up|0|||
106098929|NCT02005471|366018627|FG000|Main Study|Physician Decision|3|||
106098930|NCT02005471|366018628|FG001|Main Study|Physician Decision|1|||
106098931|NCT02005471|366018629|FG002|Main Study|Physician Decision|0|||
106098932|NCT02005471|366018630|FG003|Main Study|Physician Decision|0|||
106098933|NCT02005471|366018627|FG000|Main Study|Withdrawal by Subject|26|||
106098934|NCT02005471|366018628|FG001|Main Study|Withdrawal by Subject|11|||
106098935|NCT02005471|366018629|FG002|Main Study|Withdrawal by Subject|0|||
106098936|NCT02005471|366018630|FG003|Main Study|Withdrawal by Subject|0|||
106098937|NCT02005471|366018627|FG000|Main Study|Reason not Specified|0|||
106098938|NCT02005471|366018628|FG001|Main Study|Reason not Specified|6|||
106098939|NCT02005471|366018629|FG002|Main Study|Reason not Specified|0|||
106098940|NCT02005471|366018630|FG003|Main Study|Reason not Specified|0|||
106098941|NCT02005471|366018627|FG000|Main Study|Randomized but not Dosed|8|||
106098942|NCT02005471|366018628|FG001|Main Study|Randomized but not Dosed|0|||
106098943|NCT02005471|366018629|FG002|Main Study|Randomized but not Dosed|0|||
106098944|NCT02005471|366018630|FG003|Main Study|Randomized but not Dosed|0|||
106098945|NCT02005471|366018627|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
106098946|NCT02005471|366018628|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
106098947|NCT02005471|366018629|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
106098948|NCT02005471|366018630|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
106098949|NCT02005471|366018627|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
106098950|NCT02005471|366018628|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
106098951|NCT02005471|366018629|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
106098952|NCT02005471|366018630|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
106098953|NCT02005471|366018627|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
106098954|NCT02005471|366018628|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
106098955|NCT02005471|366018629|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
106098956|NCT02005471|366018630|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
106098957|NCT03674177|366018631|FG000|Overall Study|Lost to Follow-up|2|||
106098958|NCT03674177|366018632|FG001|Overall Study|Lost to Follow-up|1|||
106098959|NCT03674177|366018633|FG002|Overall Study|Lost to Follow-up|0|||
106098960|NCT03674177|366018634|FG003|Overall Study|Lost to Follow-up|2|||
106098961|NCT03943095|366018635|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
106098962|NCT03943095|366018636|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
106098963|NCT03943095|366018635|FG000|Overall Study|Withdrawal by Subject|1|||
106098964|NCT03943095|366018636|FG001|Overall Study|Withdrawal by Subject|0|||
106098965|NCT03387852|366018640|FG000|Overall Study|Adverse event (AE)|3|||
106098966|NCT03387852|366018641|FG001|Overall Study|Adverse event (AE)|0|||
106098967|NCT03387852|366018642|FG002|Overall Study|Adverse event (AE)|2|||
106098968|NCT03387852|366018643|FG003|Overall Study|Adverse event (AE)|0|||
106098969|NCT03387852|366018640|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
106098970|NCT03387852|366018641|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
106098971|NCT03387852|366018642|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
106098972|NCT03387852|366018643|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
106098973|NCT03387852|366018640|FG000|Overall Study|Withdrawal by participant|1|||
106098974|NCT03387852|366018641|FG001|Overall Study|Withdrawal by participant|1|||
106098975|NCT03387852|366018642|FG002|Overall Study|Withdrawal by participant|3|||
106098976|NCT03387852|366018643|FG003|Overall Study|Withdrawal by participant|2|||
106098977|NCT03387852|366018640|FG000|Overall Study|Other- Unspecified|1|||
106098978|NCT03387852|366018641|FG001|Overall Study|Other- Unspecified|1|||
106098979|NCT03387852|366018642|FG002|Overall Study|Other- Unspecified|2|||
106098980|NCT03387852|366018643|FG003|Overall Study|Other- Unspecified|1|||
106098981|NCT03387852|366018640|FG000|Overall Study|Poor compliance to protocol|0|||
106098982|NCT03387852|366018641|FG001|Overall Study|Poor compliance to protocol|0|||
106098983|NCT03387852|366018642|FG002|Overall Study|Poor compliance to protocol|0|||
106098984|NCT03387852|366018643|FG003|Overall Study|Poor compliance to protocol|1|||
106098985|NCT03387852|366018640|FG000|Overall Study|Randomized and not treated|0|||
106098986|NCT03387852|366018641|FG001|Overall Study|Randomized and not treated|0|||
106098987|NCT03387852|366018642|FG002|Overall Study|Randomized and not treated|0|||
106098988|NCT03387852|366018643|FG003|Overall Study|Randomized and not treated|1|||
106098989|NCT02763384|366018644|FG000|Overall Study|Physician Decision|1|||
106098990|NCT02763384|366018644|FG000|Overall Study|Rapid decline - went on hospice|1|||
106098991|NCT02493127|366018645|FG000|Overall Study|Lost to Follow-up|1|||
106098992|NCT02493127|366018646|FG001|Overall Study|Lost to Follow-up|1|||
106098993|NCT00714168|366018647|FG000|Overall Study|Pregnancy|5|||
106098994|NCT00714168|366018648|FG001|Overall Study|Pregnancy|4|||
106098995|NCT00714168|366018647|FG000|Overall Study|Lost to Follow-up|32|||
106098996|NCT00714168|366018648|FG001|Overall Study|Lost to Follow-up|50|||
106098997|NCT00714168|366018647|FG000|Overall Study|Relocation|4|||
106098998|NCT00714168|366018648|FG001|Overall Study|Relocation|3|||
106098999|NCT00714168|366018647|FG000|Overall Study|Non-study medical condition|3|||
106099000|NCT00714168|366018648|FG001|Overall Study|Non-study medical condition|2|||
106099001|NCT02096900|366018650|FG000|Overall Study|Did not receive medication|3|||
106099002|NCT02096900|366018651|FG001|Overall Study|Did not receive medication|1|||
106099003|NCT02096900|366018650|FG000|Overall Study|Surgery cancelled- medication received|1|||
106099004|NCT02096900|366018651|FG001|Overall Study|Surgery cancelled- medication received|1|||
106099005|NCT04764396|366018655|FG000|Overall Study|Physician Decision|1|||
106099006|NCT04764396|366018656|FG001|Overall Study|Physician Decision|0|||
106099007|NCT03077724|366018658|FG000|Overall Study|Lost to Follow-up|5|||
106099008|NCT03077724|366018659|FG001|Overall Study|Lost to Follow-up|1|||
106099009|NCT03077724|366018658|FG000|Overall Study|Withdrawal by Subject|3|||
106099010|NCT03077724|366018659|FG001|Overall Study|Withdrawal by Subject|1|||
106099011|NCT00613951|366018660|FG000|Overall Study|Adverse Event|1|||
106099012|NCT00613951|366018661|FG001|Overall Study|Adverse Event|0|||
106099013|NCT00613951|366018662|FG002|Overall Study|Adverse Event|1|||
106099014|NCT00613951|366018660|FG000|Overall Study|Lack of Efficacy|0|||
106099015|NCT00613951|366018661|FG001|Overall Study|Lack of Efficacy|1|||
106099016|NCT00613951|366018662|FG002|Overall Study|Lack of Efficacy|1|||
106099017|NCT00613951|366018660|FG000|Overall Study|Protocol Violation|1|||
106099018|NCT00613951|366018661|FG001|Overall Study|Protocol Violation|1|||
106099019|NCT00613951|366018662|FG002|Overall Study|Protocol Violation|1|||
106099020|NCT00613951|366018660|FG000|Overall Study|Unclassified|5|||
106099021|NCT00613951|366018661|FG001|Overall Study|Unclassified|3|||
106099022|NCT00613951|366018662|FG002|Overall Study|Unclassified|2|||
106099023|NCT04827576|366020406|FG000|Overall Study|Death|5|||
106099024|NCT04827576|366020407|FG001|Overall Study|Death|17|||
106099025|NCT04827576|366020408|FG002|Overall Study|Death|17|||
106099026|NCT04827576|366020409|FG003|Overall Study|Death|32|||
106099027|NCT04827576|366020406|FG000|Overall Study|Study Terminated by Sponsor|2|||
106099028|NCT04827576|366020407|FG001|Overall Study|Study Terminated by Sponsor|9|||
106099029|NCT04827576|366020408|FG002|Overall Study|Study Terminated by Sponsor|7|||
106099030|NCT04827576|366020409|FG003|Overall Study|Study Terminated by Sponsor|5|||
106099031|NCT04827576|366020406|FG000|Overall Study|Investigator's Discretion|1|||
106099032|NCT04827576|366020407|FG001|Overall Study|Investigator's Discretion|0|||
106099033|NCT04827576|366020408|FG002|Overall Study|Investigator's Discretion|2|||
106099034|NCT04827576|366020409|FG003|Overall Study|Investigator's Discretion|5|||
106099035|NCT04827576|366020406|FG000|Overall Study|Withdrew Consent|0|||
106099036|NCT04827576|366020407|FG001|Overall Study|Withdrew Consent|3|||
106099037|NCT04827576|366020408|FG002|Overall Study|Withdrew Consent|0|||
106099038|NCT04827576|366020409|FG003|Overall Study|Withdrew Consent|0|||
106099039|NCT04827576|366020406|FG000|Overall Study|Lost to Follow-up|1|||
106099040|NCT04827576|366020407|FG001|Overall Study|Lost to Follow-up|0|||
106099041|NCT04827576|366020408|FG002|Overall Study|Lost to Follow-up|0|||
106099042|NCT04827576|366020409|FG003|Overall Study|Lost to Follow-up|0|||
106099043|NCT00791765|366020410|FG000|Weeks 1 to 12|Adverse Event|0|||
106099044|NCT00791765|366020411|FG001|Weeks 1 to 12|Adverse Event|1|||
106099045|NCT00791765|366020410|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
106099046|NCT00791765|366020411|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
106099047|NCT00791765|366020410|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
106099048|NCT00791765|366020411|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
106099049|NCT00791765|366020410|FG000|Weeks 1 to 12|Physician Decision|1|||
106099050|NCT00791765|366020411|FG001|Weeks 1 to 12|Physician Decision|0|||
106099051|NCT00791765|366020410|FG000|Weeks 1 to 12|Disease progression|3|||
106099052|NCT00791765|366020411|FG001|Weeks 1 to 12|Disease progression|0|||
106099053|NCT00791765|366020410|FG000|Weeks 1 to 12|Ineligibility determined|0|||
106099054|NCT00791765|366020411|FG001|Weeks 1 to 12|Ineligibility determined|3|||
106099055|NCT00791765|366020410|FG000|Weeks 13 to 24|Protocol deviation|2|||
106099056|NCT00791765|366020411|FG001|Weeks 13 to 24|Protocol deviation|0|||
106099057|NCT00791765|366020410|FG000|Weeks 13 to 24|Adverse Event|0|||
106099058|NCT00791765|366020411|FG001|Weeks 13 to 24|Adverse Event|3|||
106099059|NCT00791765|366020410|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
106099060|NCT00791765|366020411|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
106099061|NCT00791765|366020410|FG000|Weeks 13 to 24|Disease progression|0|||
106099062|NCT00791765|366020411|FG001|Weeks 13 to 24|Disease progression|1|||
106099063|NCT00791765|366020410|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
106099064|NCT00791765|366020411|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
106099065|NCT00791765|366020410|FG000|Weeks 13 to 24|Other|0|||
106099066|NCT00791765|366020411|FG001|Weeks 13 to 24|Other|1|||
106099067|NCT01261611|366020413|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
106099068|NCT01261611|366020414|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
106099069|NCT01261611|366020415|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
106099070|NCT01261611|366020413|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
106099071|NCT01261611|366020414|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
106099072|NCT01261611|366020415|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
106099073|NCT01261611|366020413|FG000|Treatment Cycle 1|Adverse Event|0|||
106099074|NCT01261611|366020414|FG001|Treatment Cycle 1|Adverse Event|1|||
106099075|NCT01261611|366020415|FG002|Treatment Cycle 1|Adverse Event|0|||
106099076|NCT01261611|366020413|FG000|Treatment Cycle 1|Protocol Violation|0|||
106099077|NCT01261611|366020414|FG001|Treatment Cycle 1|Protocol Violation|0|||
106099078|NCT01261611|366020415|FG002|Treatment Cycle 1|Protocol Violation|2|||
106099079|NCT01261611|366020413|FG000|Treatment Cycle 2|Completed study|4|||
106099080|NCT01261611|366020414|FG001|Treatment Cycle 2|Completed study|0|||
106099081|NCT01261611|366020415|FG002|Treatment Cycle 2|Completed study|0|||
106099082|NCT01261611|366020413|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
106099083|NCT01261611|366020414|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
106099084|NCT01261611|366020415|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
106099085|NCT01261611|366020413|FG000|Treatment Cycle 2|Adverse Event|1|||
106099086|NCT01261611|366020414|FG001|Treatment Cycle 2|Adverse Event|0|||
106099087|NCT01261611|366020415|FG002|Treatment Cycle 2|Adverse Event|0|||
106099088|NCT01261611|366020413|FG000|Treatment Cycle 2|Protocol Violation|2|||
106099089|NCT01261611|366020414|FG001|Treatment Cycle 2|Protocol Violation|0|||
106099090|NCT01261611|366020415|FG002|Treatment Cycle 2|Protocol Violation|0|||
106099091|NCT01261611|366020413|FG000|Treatment Cycle 2|Not otherwise specified|2|||
106099092|NCT01261611|366020414|FG001|Treatment Cycle 2|Not otherwise specified|0|||
106099093|NCT01261611|366020415|FG002|Treatment Cycle 2|Not otherwise specified|0|||
106099094|NCT01261611|366020413|FG000|Treatment Cycle 3|Completed study|24|||
106099095|NCT01261611|366020414|FG001|Treatment Cycle 3|Completed study|0|||
106099096|NCT01261611|366020415|FG002|Treatment Cycle 3|Completed study|0|||
106099097|NCT01261611|366020413|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
106099098|NCT01261611|366020414|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
106099099|NCT01261611|366020415|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
106099100|NCT01261611|366020413|FG000|Treatment Cycle 3|Adverse Event|1|||
106099101|NCT01261611|366020414|FG001|Treatment Cycle 3|Adverse Event|0|||
106099102|NCT01261611|366020415|FG002|Treatment Cycle 3|Adverse Event|0|||
106099103|NCT01261611|366020413|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
106099104|NCT01261611|366020414|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
106099105|NCT01261611|366020415|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
106099106|NCT01261611|366020413|FG000|Treatment Cycle 4|Completed study|87|||
106099107|NCT01261611|366020414|FG001|Treatment Cycle 4|Completed study|0|||
106099108|NCT01261611|366020415|FG002|Treatment Cycle 4|Completed study|0|||
106099109|NCT01261611|366020413|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
106099110|NCT01261611|366020414|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
106099111|NCT01261611|366020415|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
106099112|NCT01261611|366020413|FG000|Treatment Cycle 4|Adverse Event|1|||
106099113|NCT01261611|366020414|FG001|Treatment Cycle 4|Adverse Event|0|||
106099114|NCT01261611|366020415|FG002|Treatment Cycle 4|Adverse Event|0|||
106099115|NCT01261611|366020413|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
106099116|NCT01261611|366020414|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
106099117|NCT01261611|366020415|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
106099118|NCT01261611|366020413|FG000|Treatment Cycle 4|Not otherwise specified|3|||
106099119|NCT01261611|366020414|FG001|Treatment Cycle 4|Not otherwise specified|0|||
106099120|NCT01261611|366020415|FG002|Treatment Cycle 4|Not otherwise specified|0|||
106099121|NCT01261611|366020413|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
106099122|NCT01261611|366020414|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
106099123|NCT01261611|366020415|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
106099124|NCT01261611|366020413|FG000|Treatment Cycle 5|Adverse Event|1|||
106099125|NCT01261611|366020414|FG001|Treatment Cycle 5|Adverse Event|0|||
106099126|NCT01261611|366020415|FG002|Treatment Cycle 5|Adverse Event|0|||
106099127|NCT01261611|366020413|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
106099128|NCT01261611|366020414|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
106099129|NCT01261611|366020415|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
106099130|NCT05349617|366020419|FG000|Overall Study|Death|1|||
106099131|NCT05349617|366020420|FG001|Overall Study|Death|1|||
106099132|NCT05349617|366020419|FG000|Overall Study|Lost to Follow-up|3|||
106099133|NCT05349617|366020420|FG001|Overall Study|Lost to Follow-up|8|||
106099134|NCT05349617|366020419|FG000|Overall Study|Withdrawal by Subject|2|||
106099135|NCT05349617|366020420|FG001|Overall Study|Withdrawal by Subject|10|||
106099136|NCT01432366|366020421|FG000|Overall Study|Non-Responder|7|||
106099137|NCT01432366|366020421|FG000|Overall Study|Adverse Event|8|||
106099138|NCT01432366|366020421|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
106099139|NCT01432366|366020421|FG000|Overall Study|Pregnancy|1|||
106099140|NCT01432366|366020421|FG000|Overall Study|Lost to Follow-up|13|||
106099141|NCT01432366|366020421|FG000|Overall Study|Lack of Efficacy|1|||
106099142|NCT01432366|366020421|FG000|Overall Study|Site Closed|20|||
106099143|NCT01432366|366020421|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
105659932|NCT00356811|364418880|FG000|Overall Study|Withdrawal by Subject|6|||
105659933|NCT00356811|364418880|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
105659934|NCT00356811|364418880|FG000|Overall Study|Study Is Terminating|3|||
106099144|NCT01432366|366020421|FG000|Overall Study|Other|14|||
106099145|NCT01808690|366020422|FG000|Overall Study|Withdrawal by Subject|1|||
106099146|NCT01808690|366020423|FG001|Overall Study|Withdrawal by Subject|2|||
106099147|NCT03870763|366020424|FG000|Overall Study|Study terminated by sponsor|0|||
106099148|NCT03870763|366020425|FG001|Overall Study|Study terminated by sponsor|2|||
106099149|NCT03870763|366020426|FG002|Overall Study|Study terminated by sponsor|0|||
106099150|NCT03870763|366020424|FG000|Overall Study|Withdrawal by Subject|0|||
106099151|NCT03870763|366020425|FG001|Overall Study|Withdrawal by Subject|1|||
106099152|NCT03870763|366020426|FG002|Overall Study|Withdrawal by Subject|0|||
106099153|NCT03870763|366020424|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
106099154|NCT03870763|366020425|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
106099155|NCT03870763|366020426|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
105806438|NCT01464827|364948991|FG010|Overall Study|Lost to Follow-up|0|||
106099156|NCT02332720|366020435|FG000|Part A and Part B|Lost to Follow-up|1|||
106099157|NCT02332720|366020436|FG001|Part A and Part B|Lost to Follow-up|0|||
106099158|NCT02332720|366020437|FG002|Part A and Part B|Lost to Follow-up|0|||
106099159|NCT02332720|366020438|FG003|Part A and Part B|Lost to Follow-up|0|||
106099160|NCT02332720|366020439|FG004|Part A and Part B|Lost to Follow-up|0|||
106099161|NCT02332720|366020440|FG005|Part A and Part B|Lost to Follow-up|2|||
106099162|NCT02332720|366020441|FG006|Part A and Part B|Lost to Follow-up|1|||
106099163|NCT02332720|366020442|FG007|Part A and Part B|Lost to Follow-up|1|||
106099164|NCT02332720|366020443|FG008|Part A and Part B|Lost to Follow-up|0|||
106099165|NCT02332720|366020444|FG009|Part A and Part B|Lost to Follow-up|0|||
106099166|NCT02332720|366020445|FG010|Part A and Part B|Lost to Follow-up|0|||
106099167|NCT02332720|366020446|FG011|Part A and Part B|Lost to Follow-up|0|||
106099168|NCT02332720|366020447|FG012|Part A and Part B|Lost to Follow-up|0|||
106099169|NCT02332720|366020448|FG013|Part A and Part B|Lost to Follow-up|0|||
106099170|NCT02332720|366020449|FG014|Part A and Part B|Lost to Follow-up|0|||
106099171|NCT02332720|366020450|FG015|Part A and Part B|Lost to Follow-up|1|||
106099172|NCT02332720|366020451|FG016|Part A and Part B|Lost to Follow-up|0|||
106099173|NCT02332720|366020452|FG017|Part A and Part B|Lost to Follow-up|0|||
106099174|NCT02332720|366020453|FG018|Part A and Part B|Lost to Follow-up|0|||
106099175|NCT02332720|366020454|FG019|Part A and Part B|Lost to Follow-up|0|||
106099176|NCT02332720|366020455|FG020|Part A and Part B|Lost to Follow-up|0|||
106099177|NCT02332720|366020456|FG021|Part A and Part B|Lost to Follow-up|0|||
106099178|NCT02332720|366020457|FG022|Part A and Part B|Lost to Follow-up|0|||
106099179|NCT02332720|366020435|FG000|Part A and Part B|Adverse Event|0|||
106099180|NCT02332720|366020436|FG001|Part A and Part B|Adverse Event|0|||
106099181|NCT02332720|366020437|FG002|Part A and Part B|Adverse Event|0|||
106099182|NCT02332720|366020438|FG003|Part A and Part B|Adverse Event|0|||
106099183|NCT02332720|366020439|FG004|Part A and Part B|Adverse Event|0|||
106099184|NCT02332720|366020440|FG005|Part A and Part B|Adverse Event|0|||
106099185|NCT02332720|366020441|FG006|Part A and Part B|Adverse Event|0|||
106099186|NCT02332720|366020442|FG007|Part A and Part B|Adverse Event|0|||
106099187|NCT02332720|366020443|FG008|Part A and Part B|Adverse Event|0|||
106099188|NCT02332720|366020444|FG009|Part A and Part B|Adverse Event|0|||
106099189|NCT02332720|366020445|FG010|Part A and Part B|Adverse Event|0|||
106099190|NCT02332720|366020446|FG011|Part A and Part B|Adverse Event|0|||
106099191|NCT02332720|366020447|FG012|Part A and Part B|Adverse Event|0|||
106099192|NCT02332720|366020448|FG013|Part A and Part B|Adverse Event|0|||
106099193|NCT02332720|366020449|FG014|Part A and Part B|Adverse Event|0|||
106099194|NCT02332720|366020450|FG015|Part A and Part B|Adverse Event|0|||
106099195|NCT02332720|366020451|FG016|Part A and Part B|Adverse Event|0|||
106099196|NCT02332720|366020452|FG017|Part A and Part B|Adverse Event|1|||
106099197|NCT02332720|366020453|FG018|Part A and Part B|Adverse Event|0|||
106099198|NCT02332720|366020454|FG019|Part A and Part B|Adverse Event|0|||
106099199|NCT02332720|366020455|FG020|Part A and Part B|Adverse Event|0|||
106099200|NCT02332720|366020456|FG021|Part A and Part B|Adverse Event|0|||
106099201|NCT02332720|366020457|FG022|Part A and Part B|Adverse Event|0|||
106099202|NCT02332720|366020435|FG000|Part A and Part B|Physician Decision|0|||
106099203|NCT02332720|366020436|FG001|Part A and Part B|Physician Decision|0|||
106099204|NCT02332720|366020437|FG002|Part A and Part B|Physician Decision|0|||
106099205|NCT02332720|366020438|FG003|Part A and Part B|Physician Decision|0|||
106099206|NCT02332720|366020439|FG004|Part A and Part B|Physician Decision|0|||
106099207|NCT02332720|366020440|FG005|Part A and Part B|Physician Decision|0|||
106099208|NCT02332720|366020441|FG006|Part A and Part B|Physician Decision|0|||
106099209|NCT02332720|366020442|FG007|Part A and Part B|Physician Decision|0|||
106099210|NCT02332720|366020443|FG008|Part A and Part B|Physician Decision|0|||
106099211|NCT02332720|366020444|FG009|Part A and Part B|Physician Decision|0|||
106099212|NCT02332720|366020445|FG010|Part A and Part B|Physician Decision|0|||
106099213|NCT02332720|366020446|FG011|Part A and Part B|Physician Decision|0|||
106099214|NCT02332720|366020447|FG012|Part A and Part B|Physician Decision|0|||
106099215|NCT02332720|366020448|FG013|Part A and Part B|Physician Decision|0|||
106099216|NCT02332720|366020449|FG014|Part A and Part B|Physician Decision|0|||
106099217|NCT02332720|366020450|FG015|Part A and Part B|Physician Decision|0|||
106099218|NCT02332720|366020451|FG016|Part A and Part B|Physician Decision|0|||
106099219|NCT02332720|366020452|FG017|Part A and Part B|Physician Decision|0|||
106099220|NCT02332720|366020453|FG018|Part A and Part B|Physician Decision|1|||
106099221|NCT02332720|366020454|FG019|Part A and Part B|Physician Decision|0|||
106099222|NCT02332720|366020455|FG020|Part A and Part B|Physician Decision|0|||
106099223|NCT02332720|366020456|FG021|Part A and Part B|Physician Decision|0|||
106099224|NCT02332720|366020457|FG022|Part A and Part B|Physician Decision|0|||
106099225|NCT02332720|366020435|FG000|Part A and Part B|Withdrawal by Subject|0|||
106099226|NCT02332720|366020436|FG001|Part A and Part B|Withdrawal by Subject|0|||
106099227|NCT02332720|366020437|FG002|Part A and Part B|Withdrawal by Subject|0|||
106099228|NCT02332720|366020438|FG003|Part A and Part B|Withdrawal by Subject|0|||
106099229|NCT02332720|366020439|FG004|Part A and Part B|Withdrawal by Subject|0|||
106099230|NCT02332720|366020440|FG005|Part A and Part B|Withdrawal by Subject|1|||
106099231|NCT02332720|366020441|FG006|Part A and Part B|Withdrawal by Subject|0|||
106099232|NCT02332720|366020442|FG007|Part A and Part B|Withdrawal by Subject|0|||
106099233|NCT02332720|366020443|FG008|Part A and Part B|Withdrawal by Subject|0|||
106099234|NCT02332720|366020444|FG009|Part A and Part B|Withdrawal by Subject|0|||
106099235|NCT02332720|366020445|FG010|Part A and Part B|Withdrawal by Subject|0|||
106099236|NCT02332720|366020446|FG011|Part A and Part B|Withdrawal by Subject|0|||
106099237|NCT02332720|366020447|FG012|Part A and Part B|Withdrawal by Subject|0|||
106099238|NCT02332720|366020448|FG013|Part A and Part B|Withdrawal by Subject|0|||
106099239|NCT02332720|366020449|FG014|Part A and Part B|Withdrawal by Subject|0|||
106099240|NCT02332720|366020450|FG015|Part A and Part B|Withdrawal by Subject|0|||
106099241|NCT02332720|366020451|FG016|Part A and Part B|Withdrawal by Subject|0|||
106099242|NCT02332720|366020452|FG017|Part A and Part B|Withdrawal by Subject|0|||
106099243|NCT02332720|366020453|FG018|Part A and Part B|Withdrawal by Subject|0|||
106099244|NCT02332720|366020454|FG019|Part A and Part B|Withdrawal by Subject|1|||
106099245|NCT02332720|366020455|FG020|Part A and Part B|Withdrawal by Subject|0|||
106099246|NCT02332720|366020456|FG021|Part A and Part B|Withdrawal by Subject|0|||
106099247|NCT02332720|366020457|FG022|Part A and Part B|Withdrawal by Subject|0|||
106099248|NCT05912400|366020458|FG000|Overall Study|Lost to Follow-up|1|||
106099249|NCT05912400|366020459|FG001|Overall Study|Lost to Follow-up|0|||
106099250|NCT05912400|366020458|FG000|Overall Study|Physician Decision|6|||
106099251|NCT05912400|366020459|FG001|Overall Study|Physician Decision|0|||
106099252|NCT05912400|366020458|FG000|Overall Study|Withdrawal by Subject|1|||
106099253|NCT05912400|366020459|FG001|Overall Study|Withdrawal by Subject|0|||
106099254|NCT00838110|366020461|FG000|Overall Study|Death|0|||
106099255|NCT00838110|366020462|FG001|Overall Study|Death|0|||
106099256|NCT00838110|366020463|FG002|Overall Study|Death|1|||
106099257|NCT00838110|366020464|FG003|Overall Study|Death|2|||
106099258|NCT00838110|366020461|FG000|Overall Study|Adverse Event|11|||
106099259|NCT00838110|366020462|FG001|Overall Study|Adverse Event|10|||
106099260|NCT00838110|366020463|FG002|Overall Study|Adverse Event|8|||
106099261|NCT00838110|366020464|FG003|Overall Study|Adverse Event|7|||
106099262|NCT00838110|366020461|FG000|Overall Study|Withdrawal by Subject|5|||
106099263|NCT00838110|366020462|FG001|Overall Study|Withdrawal by Subject|6|||
106099264|NCT00838110|366020463|FG002|Overall Study|Withdrawal by Subject|3|||
106099265|NCT00838110|366020464|FG003|Overall Study|Withdrawal by Subject|4|||
106099266|NCT00838110|366020461|FG000|Overall Study|Other|3|||
106099267|NCT00838110|366020462|FG001|Overall Study|Other|3|||
106099268|NCT00838110|366020463|FG002|Overall Study|Other|3|||
106099269|NCT00838110|366020464|FG003|Overall Study|Other|2|||
106099270|NCT00838110|366020461|FG000|Overall Study|Protocol Violation|0|||
106099271|NCT00838110|366020462|FG001|Overall Study|Protocol Violation|2|||
106099272|NCT00838110|366020463|FG002|Overall Study|Protocol Violation|1|||
106099273|NCT00838110|366020464|FG003|Overall Study|Protocol Violation|1|||
106099274|NCT00838110|366020461|FG000|Overall Study|Lost to Follow-up|3|||
106099275|NCT00838110|366020462|FG001|Overall Study|Lost to Follow-up|0|||
106099276|NCT00838110|366020463|FG002|Overall Study|Lost to Follow-up|0|||
106099277|NCT00838110|366020464|FG003|Overall Study|Lost to Follow-up|0|||
106099278|NCT00838110|366020461|FG000|Overall Study|Did not meet eligibility criteria|0|||
106099279|NCT00838110|366020462|FG001|Overall Study|Did not meet eligibility criteria|0|||
106099280|NCT00838110|366020463|FG002|Overall Study|Did not meet eligibility criteria|1|||
106099281|NCT00838110|366020464|FG003|Overall Study|Did not meet eligibility criteria|2|||
106099282|NCT00838110|366020461|FG000|Overall Study|Randomized but not treated|0|||
106099283|NCT00838110|366020462|FG001|Overall Study|Randomized but not treated|1|||
106099284|NCT00838110|366020463|FG002|Overall Study|Randomized but not treated|0|||
106099285|NCT00838110|366020464|FG003|Overall Study|Randomized but not treated|0|||
106099286|NCT01003899|366020465|FG000|Overall Study|Other Adverse Event|8|||
106099287|NCT01003899|366020465|FG000|Overall Study|Not entered|4|||
106099288|NCT01003899|366020465|FG000|Overall Study|Not treated|1|||
106099289|NCT01003899|366020465|FG000|Overall Study|Progressive disease|34|||
106099290|NCT01262651|366020466|FG000|Overall Study|Adverse Event|40|||
106099291|NCT01262651|366020467|FG001|Overall Study|Adverse Event|35|||
106099292|NCT01262651|366020466|FG000|Overall Study|Withdrawal by Subject|15|||
106099293|NCT01262651|366020467|FG001|Overall Study|Withdrawal by Subject|11|||
106099294|NCT01262651|366020466|FG000|Overall Study|Withdrawal by Investigator|2|||
106099295|NCT01262651|366020467|FG001|Overall Study|Withdrawal by Investigator|2|||
106099296|NCT01262651|366020466|FG000|Overall Study|Met Withdrawal Criteria|1|||
106099297|NCT01262651|366020467|FG001|Overall Study|Met Withdrawal Criteria|0|||
106099298|NCT03822533|366020470|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
106099299|NCT03822533|366020471|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
106099300|NCT03822533|366020470|FG000|3 Month Follow-up|Lost to Follow-up|2|||
106099301|NCT03822533|366020471|FG001|3 Month Follow-up|Lost to Follow-up|2|||
106099302|NCT03822533|366020470|FG000|6 Month Follow-up|Lost to Follow-up|3|||
106099303|NCT03822533|366020471|FG001|6 Month Follow-up|Lost to Follow-up|0|||
106099304|NCT03822533|366020470|FG000|12 Month Follow-up|Lost to Follow-up|2|||
106099305|NCT03822533|366020471|FG001|12 Month Follow-up|Lost to Follow-up|3|||
106099306|NCT03822533|366020470|FG000|12 Month Follow-up|Pregnancy|0|||
106099307|NCT03822533|366020471|FG001|12 Month Follow-up|Pregnancy|1|||
106099308|NCT03822533|366020470|FG000|12 Month Follow-up|Surgery|2|||
106099309|NCT03822533|366020471|FG001|12 Month Follow-up|Surgery|0|||
106099310|NCT03822533|366020470|FG000|12 Month Follow-up|Wrong address|1|||
106099311|NCT03822533|366020471|FG001|12 Month Follow-up|Wrong address|0|||
106099312|NCT03822533|366020470|FG000|12 Month Follow-up|No symptoms|1|||
106099313|NCT03822533|366020471|FG001|12 Month Follow-up|No symptoms|0|||
106099314|NCT03822533|366020470|FG000|12 Month Follow-up|Changed primary care center|0|||
106099315|NCT03822533|366020471|FG001|12 Month Follow-up|Changed primary care center|1|||
106099316|NCT04969783|366020472|FG000|Overall Study|Lost to Follow-up|2|||
106099317|NCT04969783|366020473|FG001|Overall Study|Lost to Follow-up|0|||
106099318|NCT04969783|366020472|FG000|Overall Study|Withdrawal by Subject|4|||
106099319|NCT04969783|366020473|FG001|Overall Study|Withdrawal by Subject|0|||
106099320|NCT04969783|366020472|FG000|Overall Study|Physician Decision|6|||
106099321|NCT04969783|366020473|FG001|Overall Study|Physician Decision|0|||
106099322|NCT00328510|366020474|FG000|Overall Study|Gag disorder, could not use frame|4|||
106099323|NCT00328510|366020475|FG001|Overall Study|Gag disorder, could not use frame|0|||
106099324|NCT00328510|366020474|FG000|Overall Study|Dentition problems, could not use frame|1|||
106099325|NCT00328510|366020475|FG001|Overall Study|Dentition problems, could not use frame|0|||
106099326|NCT00328510|366020474|FG000|Overall Study|Withdrawal by Subject|4|||
106099327|NCT00328510|366020475|FG001|Overall Study|Withdrawal by Subject|2|||
106099328|NCT00328510|366020474|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
106099329|NCT00328510|366020475|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
106099330|NCT00328510|366020474|FG000|Overall Study|Treatment changed to a single fraction|1|||
105770549|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
106099331|NCT00328510|366020475|FG001|Overall Study|Treatment changed to a single fraction|1|||
106099332|NCT02696317|366020476|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
106099333|NCT02696317|366020477|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
106099334|NCT02696317|366020476|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
106099335|NCT02696317|366020477|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
106099336|NCT04969250|366020478|FG000|Overall Study|Protocol Violation|0|||
106099337|NCT04969250|366020479|FG001|Overall Study|Protocol Violation|2|||
106099338|NCT04969250|366020480|FG002|Overall Study|Protocol Violation|3|||
106099339|NCT04969250|366020481|FG003|Overall Study|Protocol Violation|8|||
106099340|NCT04969250|366020478|FG000|Overall Study|Withdrawal by Subject|0|||
106099341|NCT04969250|366020479|FG001|Overall Study|Withdrawal by Subject|1|||
106099342|NCT04969250|366020480|FG002|Overall Study|Withdrawal by Subject|0|||
106099343|NCT04969250|366020481|FG003|Overall Study|Withdrawal by Subject|0|||
106099344|NCT00476476|366020483|FG000|Overall Study|Adverse Event|2|||
106099345|NCT00476476|366020484|FG001|Overall Study|Adverse Event|7|||
106099346|NCT00476476|366020483|FG000|Overall Study|Progressive Disease|0|||
106099347|NCT00476476|366020484|FG001|Overall Study|Progressive Disease|17|||
106099348|NCT01026974|366020485|FG000|Overall Study|Withdrawal by Subject|0|||
106099349|NCT01026974|366020486|FG001|Overall Study|Withdrawal by Subject|1|||
106099350|NCT01026974|366020487|FG002|Overall Study|Withdrawal by Subject|7|||
106099351|NCT01026974|366020488|FG003|Overall Study|Withdrawal by Subject|2|||
106099352|NCT01026974|366020485|FG000|Overall Study|Lost to Follow-up|1|||
106099353|NCT01026974|366020486|FG001|Overall Study|Lost to Follow-up|1|||
106099354|NCT01026974|366020487|FG002|Overall Study|Lost to Follow-up|4|||
106099355|NCT01026974|366020488|FG003|Overall Study|Lost to Follow-up|0|||
106099356|NCT01026974|366020485|FG000|Overall Study|Adverse Event|0|||
106099357|NCT01026974|366020486|FG001|Overall Study|Adverse Event|0|||
106099358|NCT01026974|366020487|FG002|Overall Study|Adverse Event|0|||
106099359|NCT01026974|366020488|FG003|Overall Study|Adverse Event|1|||
106099360|NCT01026974|366020485|FG000|Overall Study|Inappropriate enrollment|0|||
106099361|NCT01026974|366020486|FG001|Overall Study|Inappropriate enrollment|0|||
106099362|NCT01026974|366020487|FG002|Overall Study|Inappropriate enrollment|1|||
106099363|NCT01026974|366020488|FG003|Overall Study|Inappropriate enrollment|0|||
106099364|NCT03043664|366020489|FG000|Overall Study|Lost to Follow-up|1|||
106099365|NCT00971048|366020490|FG000|Overall Study|Protocol Violation|1|||
106099366|NCT00971048|366020491|FG001|Overall Study|Protocol Violation|2|||
106099367|NCT00971048|366020492|FG002|Overall Study|Protocol Violation|0|||
106099368|NCT00971048|366020493|FG003|Overall Study|Protocol Violation|1|||
106099369|NCT00971048|366020490|FG000|Overall Study|Adverse Event|0|||
106099370|NCT00971048|366020491|FG001|Overall Study|Adverse Event|0|||
106099371|NCT00971048|366020492|FG002|Overall Study|Adverse Event|1|||
106099372|NCT00971048|366020493|FG003|Overall Study|Adverse Event|0|||
106099373|NCT00971048|366020490|FG000|Overall Study|Physician Decision|0|||
106099374|NCT00971048|366020491|FG001|Overall Study|Physician Decision|0|||
106099375|NCT00971048|366020492|FG002|Overall Study|Physician Decision|0|||
106099376|NCT00971048|366020493|FG003|Overall Study|Physician Decision|1|||
106099377|NCT00990652|366020496|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
106099378|NCT00990652|366020496|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
106099379|NCT04009291|366020497|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
106099380|NCT04009291|366020498|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
106099381|NCT04009291|366020499|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
106099382|NCT04009291|366020500|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
106099383|NCT04009291|366020501|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
106099384|NCT04009291|366020497|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
106099385|NCT04009291|366020498|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
106099386|NCT04009291|366020499|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
106099387|NCT04009291|366020500|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
106099388|NCT04009291|366020501|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
106099389|NCT05177770|366020502|FG000|Overall Study|Death|4|||
106099390|NCT05177770|366020502|FG000|Overall Study|Withdrawal by Subject|1|||
106099391|NCT05177770|366020502|FG000|Overall Study|Adverse Event prior to dosing|1|||
106099392|NCT01362140|366020506|FG000|Overall Study|Noncompliance|1|||
106099393|NCT01362140|366020507|FG001|Overall Study|Noncompliance|0|||
106099394|NCT01362140|366020506|FG000|Overall Study|Adverse Event|2|||
106099395|NCT01362140|366020507|FG001|Overall Study|Adverse Event|2|||
106099396|NCT01362140|366020506|FG000|Overall Study|Withdrawal by Subject|3|||
106099397|NCT01362140|366020507|FG001|Overall Study|Withdrawal by Subject|3|||
106099398|NCT01362140|366020506|FG000|Overall Study|Administrative Decision|0|||
106099399|NCT01362140|366020507|FG001|Overall Study|Administrative Decision|1|||
106099400|NCT01362140|366020506|FG000|Overall Study|Death|2|||
106099401|NCT01362140|366020507|FG001|Overall Study|Death|1|||
106099402|NCT01362140|366020506|FG000|Overall Study|Other|1|||
106099403|NCT01362140|366020507|FG001|Overall Study|Other|1|||
106099404|NCT01362140|366020506|FG000|Overall Study|Protocol-specified Criteria|1|||
106099405|NCT01362140|366020507|FG001|Overall Study|Protocol-specified Criteria|2|||
106099406|NCT01362140|366020506|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
106099407|NCT01362140|366020507|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
106099408|NCT01306162|366020508|FG000|Period 1|Adverse Event|0|||
106099409|NCT01306162|366020509|FG001|Period 1|Adverse Event|0|||
106099410|NCT01306162|366020510|FG002|Period 1|Adverse Event|0|||
106099411|NCT01306162|366020511|FG003|Period 1|Adverse Event|1|||
106099412|NCT01306162|366020508|FG000|Washout 1|Non-compliance to protocol|0|||
106099413|NCT01306162|366020509|FG001|Washout 1|Non-compliance to protocol|1|||
106099414|NCT01306162|366020510|FG002|Washout 1|Non-compliance to protocol|0|||
106099415|NCT01306162|366020511|FG003|Washout 1|Non-compliance to protocol|0|||
106099416|NCT00492284|366020513|FG000|Overall Study|Adverse Event|0|||
106099417|NCT00492284|366020514|FG001|Overall Study|Adverse Event|1|||
106099418|NCT00492284|366020515|FG002|Overall Study|Adverse Event|1|||
106099419|NCT00492284|366020516|FG003|Overall Study|Adverse Event|2|||
106099420|NCT00492284|366020513|FG000|Overall Study|Lost to Follow-up|0|||
106099421|NCT00492284|366020514|FG001|Overall Study|Lost to Follow-up|0|||
106099422|NCT00492284|366020515|FG002|Overall Study|Lost to Follow-up|3|||
106099423|NCT00492284|366020516|FG003|Overall Study|Lost to Follow-up|1|||
106099424|NCT00492284|366020513|FG000|Overall Study|Death|0|||
106099425|NCT00492284|366020514|FG001|Overall Study|Death|3|||
106099426|NCT00492284|366020515|FG002|Overall Study|Death|2|||
106099427|NCT00492284|366020516|FG003|Overall Study|Death|5|||
106099428|NCT00492284|366020513|FG000|Overall Study|Withdrawal by Subject|1|||
106099429|NCT00492284|366020514|FG001|Overall Study|Withdrawal by Subject|0|||
106099430|NCT00492284|366020515|FG002|Overall Study|Withdrawal by Subject|0|||
106099431|NCT00492284|366020516|FG003|Overall Study|Withdrawal by Subject|2|||
106099432|NCT02959437|366020517|FG000|Overall Study|Death|33|||
106099433|NCT02959437|366020518|FG001|Overall Study|Death|3|||
106099434|NCT02959437|366020519|FG002|Overall Study|Death|0|||
106099435|NCT02959437|366020520|FG003|Overall Study|Death|0|||
106099436|NCT02959437|366020517|FG000|Overall Study|Lost to Follow-up|3|||
106099437|NCT02959437|366020518|FG001|Overall Study|Lost to Follow-up|1|||
106099438|NCT02959437|366020519|FG002|Overall Study|Lost to Follow-up|0|||
106099439|NCT02959437|366020520|FG003|Overall Study|Lost to Follow-up|0|||
106099440|NCT02959437|366020517|FG000|Overall Study|Withdrawal by Subject|11|||
106099441|NCT02959437|366020518|FG001|Overall Study|Withdrawal by Subject|3|||
106099442|NCT02959437|366020519|FG002|Overall Study|Withdrawal by Subject|0|||
106099443|NCT02959437|366020520|FG003|Overall Study|Withdrawal by Subject|0|||
106099444|NCT02959437|366020517|FG000|Overall Study|Progressive Disease|9|||
106099445|NCT02959437|366020518|FG001|Overall Study|Progressive Disease|1|||
106099446|NCT02959437|366020519|FG002|Overall Study|Progressive Disease|0|||
106099447|NCT02959437|366020520|FG003|Overall Study|Progressive Disease|0|||
106099448|NCT02959437|366020517|FG000|Overall Study|Study Terminated by Sponsor|4|||
106099449|NCT02959437|366020518|FG001|Overall Study|Study Terminated by Sponsor|0|||
106099450|NCT02959437|366020519|FG002|Overall Study|Study Terminated by Sponsor|0|||
105806439|NCT01464827|364948992|FG011|Overall Study|Lost to Follow-up|1|||
106099451|NCT02959437|366020520|FG003|Overall Study|Study Terminated by Sponsor|0|||
106099452|NCT02959437|366020517|FG000|Overall Study|Other Unspecified|2|||
106099453|NCT02959437|366020518|FG001|Overall Study|Other Unspecified|0|||
106099454|NCT02959437|366020519|FG002|Overall Study|Other Unspecified|0|||
106099455|NCT02959437|366020520|FG003|Overall Study|Other Unspecified|0|||
106099456|NCT03998618|366020527|FG000|Overall Study|Death|7|||
106099457|NCT03998618|366020528|FG001|Overall Study|Death|11|||
106099458|NCT03998618|366020527|FG000|Overall Study|hospice enrollment|3|||
106099459|NCT03998618|366020528|FG001|Overall Study|hospice enrollment|3|||
106099460|NCT03998618|366020527|FG000|Overall Study|Not feeling well/health problems|3|||
106099461|NCT03998618|366020528|FG001|Overall Study|Not feeling well/health problems|5|||
106099462|NCT03998618|366020527|FG000|Overall Study|Lost to Follow-up|6|||
106099463|NCT03998618|366020528|FG001|Overall Study|Lost to Follow-up|6|||
106099464|NCT03998618|366020527|FG000|Overall Study|Withdrawal by Subject|0|||
106099465|NCT03998618|366020528|FG001|Overall Study|Withdrawal by Subject|4|||
106099466|NCT01910129|366020531|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
106099467|NCT01910129|366020532|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
106099468|NCT01910129|366020533|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
106099469|NCT01910129|366020531|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
106099470|NCT01910129|366020532|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
106099471|NCT01910129|366020533|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
106099472|NCT03150056|366020535|FG000|Overall Study|Withdrawal by Subject|0|||
106099473|NCT03150056|366020536|FG001|Overall Study|Withdrawal by Subject|0|||
106099474|NCT03150056|366020537|FG002|Overall Study|Withdrawal by Subject|0|||
106099475|NCT03150056|366020538|FG003|Overall Study|Withdrawal by Subject|0|||
106099476|NCT03150056|366020539|FG004|Overall Study|Withdrawal by Subject|0|||
106099477|NCT03150056|366020540|FG005|Overall Study|Withdrawal by Subject|2|||
106099478|NCT03150056|366020535|FG000|Overall Study|Study terminated by Sponsor|1|||
106099479|NCT03150056|366020536|FG001|Overall Study|Study terminated by Sponsor|3|||
106099480|NCT03150056|366020537|FG002|Overall Study|Study terminated by Sponsor|1|||
106099481|NCT03150056|366020538|FG003|Overall Study|Study terminated by Sponsor|1|||
106099482|NCT03150056|366020539|FG004|Overall Study|Study terminated by Sponsor|5|||
106099483|NCT03150056|366020540|FG005|Overall Study|Study terminated by Sponsor|6|||
106099484|NCT03150056|366020535|FG000|Overall Study|Death|9|||
106099485|NCT03150056|366020536|FG001|Overall Study|Death|2|||
106099486|NCT03150056|366020537|FG002|Overall Study|Death|2|||
106099487|NCT03150056|366020538|FG003|Overall Study|Death|7|||
106099488|NCT03150056|366020539|FG004|Overall Study|Death|8|||
106099489|NCT03150056|366020540|FG005|Overall Study|Death|10|||
106099490|NCT02952924|366020541|FG000|Overall Study|Protocol Violation|0|||
106099491|NCT02952924|366020542|FG001|Overall Study|Protocol Violation|0|||
106099492|NCT02952924|366020543|FG002|Overall Study|Protocol Violation|0|||
106099493|NCT02952924|366020544|FG003|Overall Study|Protocol Violation|0|||
105659935|NCT00356811|364418880|FG000|Overall Study|Site Closed during Follow-up|2|||
105659936|NCT02101983|364418881|FG000|Overall Study|Physician Decision|1|||
105659937|NCT02101983|364418882|FG001|Overall Study|Physician Decision|0|||
105659938|NCT01251887|364418883|FG000|Overall Study|Scheduling conflict|1|||
105659939|NCT01251887|364418884|FG001|Overall Study|Scheduling conflict|2|||
105659940|NCT01251887|364418885|FG002|Overall Study|Scheduling conflict|2|||
105659941|NCT01251887|364418883|FG000|Overall Study|Physician Decision|0|||
105659942|NCT01251887|364418884|FG001|Overall Study|Physician Decision|1|||
105659943|NCT01251887|364418885|FG002|Overall Study|Physician Decision|0|||
105659944|NCT03494985|364418886|FG000|Overall Study|Adverse Event|3|||
105659945|NCT03494985|364418887|FG001|Overall Study|Adverse Event|2|||
105659946|NCT03494985|364418888|FG002|Overall Study|Adverse Event|3|||
105659947|NCT03494985|364418889|FG003|Overall Study|Adverse Event|0|||
105659948|NCT03494985|364418886|FG000|Overall Study|Other (Withdrawal of consent)|2|||
105659949|NCT03494985|364418887|FG001|Overall Study|Other (Withdrawal of consent)|3|||
105659950|NCT03494985|364418888|FG002|Overall Study|Other (Withdrawal of consent)|2|||
105659951|NCT03494985|364418889|FG003|Overall Study|Other (Withdrawal of consent)|5|||
105659952|NCT03494985|364418886|FG000|Overall Study|Other (Not specified)|0|||
105659953|NCT03494985|364418887|FG001|Overall Study|Other (Not specified)|1|||
105659954|NCT03494985|364418888|FG002|Overall Study|Other (Not specified)|1|||
105659955|NCT03494985|364418889|FG003|Overall Study|Other (Not specified)|0|||
105659956|NCT03668223|364418890|FG000|Overall Study|Death|10|||
105659957|NCT03668223|364418891|FG001|Overall Study|Death|5|||
105659958|NCT03668223|364418890|FG000|Overall Study|Lost to Follow-up|12|||
105659959|NCT03668223|364418891|FG001|Overall Study|Lost to Follow-up|12|||
105659960|NCT03668223|364418890|FG000|Overall Study|Withdrawal by Subject|8|||
105659961|NCT03668223|364418891|FG001|Overall Study|Withdrawal by Subject|3|||
105659962|NCT01103232|364418892|FG000|Overall Study|Withdrawal by Subject|1|||
105659963|NCT01103232|364418893|FG001|Overall Study|Withdrawal by Subject|1|||
105659964|NCT01103232|364418892|FG000|Overall Study|Protocol Violation|0|||
105659965|NCT01103232|364418893|FG001|Overall Study|Protocol Violation|1|||
105659966|NCT02394925|364418894|FG000|Overall Study|Adverse Event|1|||
105659967|NCT02394925|364418894|FG000|Overall Study|Lens Discomfort|3|||
106099494|NCT02952924|366020545|FG004|Overall Study|Protocol Violation|0|||
106099495|NCT02952924|366020546|FG005|Overall Study|Protocol Violation|0|||
105659968|NCT02394925|364418894|FG000|Overall Study|Lens handling difficulities|5|||
105659969|NCT02394925|364418894|FG000|Overall Study|Lost to Follow-up|9|||
105659970|NCT02394925|364418894|FG000|Overall Study|Protocol Violation|5|||
105659971|NCT02394925|364418894|FG000|Overall Study|No longer meet eligibility criteria|1|||
105659972|NCT02394925|364418894|FG000|Overall Study|Unsatisfactory Visual Response|5|||
105659973|NCT04577573|364418902|FG000|Overall Study|Technical - invalid protocol|0|||
105659974|NCT04577573|364418903|FG001|Overall Study|Technical - invalid protocol|2|||
106099496|NCT02952924|366020547|FG006|Overall Study|Protocol Violation|0|||
106099497|NCT02952924|366020548|FG007|Overall Study|Protocol Violation|0|||
106099498|NCT02952924|366020549|FG008|Overall Study|Protocol Violation|0|||
106099499|NCT02952924|366020550|FG009|Overall Study|Protocol Violation|0|||
106099500|NCT02952924|366020551|FG010|Overall Study|Protocol Violation|0|||
105659975|NCT04577573|364418904|FG002|Overall Study|Technical - invalid protocol|0|||
105659976|NCT05347485|364418905|FG000|Overall Study|Death|14|||
105659977|NCT05347485|364418905|FG000|Overall Study|Lost to Follow-up|2|||
105659978|NCT05347485|364418905|FG000|Overall Study|Withdrawal by Subject|13|||
105659979|NCT05347485|364418905|FG000|Overall Study|Progressive Disease|1|||
105659980|NCT05347485|364418905|FG000|Overall Study|Study Terminated by Sponsor|49|||
105659981|NCT05347485|364418905|FG000|Overall Study|Other|1|||
105659982|NCT05347485|364418905|FG000|Overall Study|Enrolled (consented) but not treated|4|||
105659983|NCT05347485|364418905|FG000|Overall Study|Disease Relapse|2|||
105659987|NCT02600897|364418907|FG000|Overall Study|Death|1|||
105659988|NCT02600897|364418908|FG001|Overall Study|Death|2|||
105659989|NCT02600897|364418909|FG002|Overall Study|Death|1|||
105659990|NCT02600897|364418910|FG003|Overall Study|Death|2|||
105659991|NCT02600897|364418911|FG004|Overall Study|Death|3|||
105659992|NCT02600897|364418912|FG005|Overall Study|Death|2|||
105659993|NCT02600897|364418913|FG006|Overall Study|Death|10|||
105659994|NCT02600897|364418914|FG007|Overall Study|Death|7|||
105659995|NCT02600897|364418915|FG008|Overall Study|Death|20|||
105659996|NCT02600897|364418907|FG000|Overall Study|Lost to Follow-up|1|||
105659997|NCT02600897|364418908|FG001|Overall Study|Lost to Follow-up|0|||
105659998|NCT02600897|364418909|FG002|Overall Study|Lost to Follow-up|0|||
105659999|NCT02600897|364418910|FG003|Overall Study|Lost to Follow-up|0|||
105660000|NCT02600897|364418911|FG004|Overall Study|Lost to Follow-up|0|||
105660001|NCT02600897|364418912|FG005|Overall Study|Lost to Follow-up|0|||
105660002|NCT02600897|364418913|FG006|Overall Study|Lost to Follow-up|0|||
105660003|NCT02600897|364418914|FG007|Overall Study|Lost to Follow-up|1|||
105660004|NCT02600897|364418915|FG008|Overall Study|Lost to Follow-up|0|||
105660005|NCT02600897|364418907|FG000|Overall Study|Withdrawal by Subject|0|||
105660006|NCT02600897|364418908|FG001|Overall Study|Withdrawal by Subject|0|||
105660007|NCT02600897|364418909|FG002|Overall Study|Withdrawal by Subject|0|||
105660008|NCT02600897|364418910|FG003|Overall Study|Withdrawal by Subject|0|||
105660009|NCT02600897|364418911|FG004|Overall Study|Withdrawal by Subject|0|||
105660010|NCT02600897|364418912|FG005|Overall Study|Withdrawal by Subject|0|||
105660011|NCT02600897|364418913|FG006|Overall Study|Withdrawal by Subject|0|||
105660012|NCT02600897|364418914|FG007|Overall Study|Withdrawal by Subject|4|||
105660013|NCT02600897|364418915|FG008|Overall Study|Withdrawal by Subject|2|||
105660014|NCT02600897|364418907|FG000|Overall Study|Reason Not Specified|0|||
105660015|NCT02600897|364418908|FG001|Overall Study|Reason Not Specified|0|||
105660016|NCT02600897|364418909|FG002|Overall Study|Reason Not Specified|0|||
105660017|NCT02600897|364418910|FG003|Overall Study|Reason Not Specified|0|||
105660018|NCT02600897|364418911|FG004|Overall Study|Reason Not Specified|0|||
105660019|NCT02600897|364418912|FG005|Overall Study|Reason Not Specified|0|||
105660020|NCT02600897|364418913|FG006|Overall Study|Reason Not Specified|0|||
105660021|NCT02600897|364418914|FG007|Overall Study|Reason Not Specified|0|||
105660022|NCT02600897|364418915|FG008|Overall Study|Reason Not Specified|1|||
105660023|NCT03733899|364418916|FG000|Period 1|Protocol Violation|0|||
105660024|NCT03733899|364418917|FG001|Period 1|Protocol Violation|0|||
105660025|NCT03733899|364418918|FG002|Period 1|Protocol Violation|0|||
105660026|NCT03733899|364418919|FG003|Period 1|Protocol Violation|0|||
105660027|NCT03733899|364418920|FG004|Period 1|Protocol Violation|0|||
105660028|NCT03733899|364418921|FG005|Period 1|Protocol Violation|1|||
105660029|NCT03733899|364418916|FG000|Period 2|Unscuccessful Treatment|0|||
105660030|NCT03733899|364418917|FG001|Period 2|Unscuccessful Treatment|1|||
105660031|NCT03733899|364418918|FG002|Period 2|Unscuccessful Treatment|0|||
105660032|NCT03733899|364418919|FG003|Period 2|Unscuccessful Treatment|0|||
105660033|NCT03733899|364418920|FG004|Period 2|Unscuccessful Treatment|0|||
105660034|NCT03733899|364418921|FG005|Period 2|Unscuccessful Treatment|0|||
105660035|NCT03733899|364418916|FG000|Period 3|Withdrawal by Subject|1|||
105660036|NCT03733899|364418917|FG001|Period 3|Withdrawal by Subject|0|||
105660037|NCT03733899|364418918|FG002|Period 3|Withdrawal by Subject|0|||
105660038|NCT03733899|364418919|FG003|Period 3|Withdrawal by Subject|0|||
105660039|NCT03733899|364418920|FG004|Period 3|Withdrawal by Subject|0|||
105660040|NCT03733899|364418921|FG005|Period 3|Withdrawal by Subject|0|||
105660041|NCT03614676|364421004|FG000|Overall Study|Delivery before planned visit|2|||
105660042|NCT03614676|364421005|FG001|Overall Study|Delivery before planned visit|0|||
105660043|NCT03614676|364421004|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
105660044|NCT03614676|364421005|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
105660045|NCT03614676|364421004|FG000|Overall Study|Migrated / moved from the study area|30|||
105660046|NCT03614676|364421005|FG001|Overall Study|Migrated / moved from the study area|22|||
105660047|NCT03614676|364421004|FG000|Overall Study|Lost to Follow-up|17|||
105660048|NCT03614676|364421005|FG001|Overall Study|Lost to Follow-up|42|||
105660049|NCT03614676|364421004|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
105660050|NCT03614676|364421005|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
105660051|NCT03614676|364421004|FG000|Overall Study|Other|16|||
105660052|NCT03614676|364421005|FG001|Overall Study|Other|47|||
105660053|NCT03614676|364421004|FG000|Overall Study|Protocol Violation|0|||
105660054|NCT03614676|364421005|FG001|Overall Study|Protocol Violation|2|||
105660055|NCT03614676|364421004|FG000|Overall Study|Neonatal event of interest|0|||
105660056|NCT03614676|364421005|FG001|Overall Study|Neonatal event of interest|6|||
105660057|NCT03614676|364421004|FG000|Overall Study|Death in infant greater than 28 days old|0|||
105660058|NCT03614676|364421005|FG001|Overall Study|Death in infant greater than 28 days old|12|||
105660059|NCT03614676|364421004|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
105660060|NCT03614676|364421005|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
105660061|NCT01256671|364421013|FG000|Overall Study|Adverse Event|29|||
105660062|NCT01256671|364421013|FG000|Overall Study|Lost to Follow-up|16|||
105660063|NCT01256671|364421013|FG000|Overall Study|Withdrawal by Subject|31|||
105660064|NCT01256671|364421013|FG000|Overall Study|Physician Decision|3|||
105660065|NCT01256671|364421013|FG000|Overall Study|Lack of Efficacy|4|||
105660066|NCT01256671|364421013|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
105660067|NCT02161406|364421014|FG000|Overall Study|Death|2|||
105660068|NCT02161406|364421015|FG001|Overall Study|Death|1|||
105660069|NCT02161406|364421014|FG000|Overall Study|Lost to Follow-up|2|||
105660070|NCT02161406|364421015|FG001|Overall Study|Lost to Follow-up|1|||
105660071|NCT02161406|364421014|FG000|Overall Study|Withdrawal by Subject|2|||
105660072|NCT02161406|364421015|FG001|Overall Study|Withdrawal by Subject|4|||
105660073|NCT02161406|364421014|FG000|Overall Study|investigator withdrew subject|3|||
105660074|NCT02161406|364421015|FG001|Overall Study|investigator withdrew subject|1|||
105660075|NCT02161406|364421014|FG000|Overall Study|Lack of Efficacy|1|||
105660076|NCT02161406|364421015|FG001|Overall Study|Lack of Efficacy|1|||
105660077|NCT02161406|364421014|FG000|Overall Study|relocation|0|||
105660078|NCT02161406|364421015|FG001|Overall Study|relocation|1|||
105660079|NCT01986114|364421016|FG000|Overall Study|Adverse Event|59|||
105660080|NCT01986114|364421016|FG000|Overall Study|Lack of Efficacy|23|||
105660081|NCT01986114|364421016|FG000|Overall Study|Withdrawal by Subject|58|||
105660082|NCT01986114|364421016|FG000|Overall Study|Noncompliance|3|||
105660083|NCT01986114|364421016|FG000|Overall Study|Protocol Violation|1|||
105660084|NCT01986114|364421016|FG000|Overall Study|Lost to Follow-up|5|||
105660085|NCT01986114|364421016|FG000|Overall Study|Other reason|7|||
105660086|NCT01190644|364421017|FG000|Overall Study|Death|2|||
105660087|NCT01190644|364421017|FG000|Overall Study|Disease progression|1|||
105660088|NCT02808975|364421018|FG000|Overall Study|Adverse Event|3|||
105660089|NCT02808975|364421019|FG001|Overall Study|Adverse Event|4|||
105660090|NCT02808975|364421018|FG000|Overall Study|Withdrew consent|9|||
105660091|NCT02808975|364421019|FG001|Overall Study|Withdrew consent|8|||
105660092|NCT02808975|364421018|FG000|Overall Study|Lost to Follow-up|4|||
105660093|NCT02808975|364421019|FG001|Overall Study|Lost to Follow-up|6|||
105660094|NCT02808975|364421018|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
105660095|NCT02808975|364421019|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
105660096|NCT02808975|364421018|FG000|Overall Study|Other, not specified|5|||
105660097|NCT02808975|364421019|FG001|Overall Study|Other, not specified|1|||
105660098|NCT02418845|364421020|FG000|Overall Study|Lost to Follow-up|7|||
105660099|NCT02418845|364421021|FG001|Overall Study|Lost to Follow-up|2|||
105660100|NCT02418845|364421020|FG000|Overall Study|Lack of Efficacy|0|||
105660101|NCT02418845|364421021|FG001|Overall Study|Lack of Efficacy|3|||
105660102|NCT02418845|364421020|FG000|Overall Study|Physician Decision|5|||
105660103|NCT02418845|364421021|FG001|Overall Study|Physician Decision|5|||
105660104|NCT02418845|364421020|FG000|Overall Study|Protocol Violation|1|||
105660105|NCT02418845|364421021|FG001|Overall Study|Protocol Violation|0|||
105660106|NCT02418845|364421020|FG000|Overall Study|Withdrawal by Subject|3|||
105660107|NCT02418845|364421021|FG001|Overall Study|Withdrawal by Subject|2|||
105660108|NCT00730015|364421026|FG000|Overall Study|Adverse Event|11|||
105660109|NCT00730015|364421027|FG001|Overall Study|Adverse Event|10|||
105660110|NCT00730015|364421028|FG002|Overall Study|Adverse Event|8|||
105660111|NCT00730015|364421026|FG000|Overall Study|Protocol Violation|2|||
105660112|NCT00730015|364421027|FG001|Overall Study|Protocol Violation|6|||
105660113|NCT00730015|364421028|FG002|Overall Study|Protocol Violation|4|||
105660114|NCT00730015|364421026|FG000|Overall Study|Withdrawal by Subject|12|||
105660115|NCT00730015|364421027|FG001|Overall Study|Withdrawal by Subject|12|||
105660116|NCT00730015|364421028|FG002|Overall Study|Withdrawal by Subject|8|||
105660117|NCT00730015|364421026|FG000|Overall Study|Lost to Follow-up|4|||
105660118|NCT00730015|364421027|FG001|Overall Study|Lost to Follow-up|10|||
105660119|NCT00730015|364421028|FG002|Overall Study|Lost to Follow-up|3|||
105660120|NCT00730015|364421026|FG000|Overall Study|Lack of Efficacy|1|||
105660121|NCT00730015|364421027|FG001|Overall Study|Lack of Efficacy|2|||
105660122|NCT00730015|364421028|FG002|Overall Study|Lack of Efficacy|8|||
105660123|NCT00730015|364421026|FG000|Overall Study|Other Reason|1|||
105660124|NCT00730015|364421027|FG001|Overall Study|Other Reason|0|||
105660125|NCT00730015|364421028|FG002|Overall Study|Other Reason|1|||
105660126|NCT03113383|364421029|FG000|Overall Study|Death|4|||
105660127|NCT03113383|364421030|FG001|Overall Study|Death|0|||
105660128|NCT04120376|364421031|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
105660129|NCT04120376|364421032|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
105660130|NCT02053610|364421033|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
105660131|NCT02053610|364421034|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
105660132|NCT02053610|364421033|FG000|Overall Study|Withdrew Consent|2|||
105660133|NCT02053610|364421034|FG001|Overall Study|Withdrew Consent|9|||
105660134|NCT02053610|364421033|FG000|Overall Study|Death|5|||
105660135|NCT02053610|364421034|FG001|Overall Study|Death|5|||
105660136|NCT02053610|364421033|FG000|Overall Study|Administrative/Other|1|||
105660137|NCT02053610|364421034|FG001|Overall Study|Administrative/Other|1|||
105660138|NCT02053610|364421033|FG000|Overall Study|Disease Progression|2|||
106099501|NCT02952924|366020552|FG011|Overall Study|Protocol Violation|0|||
106099502|NCT02952924|366020553|FG012|Overall Study|Protocol Violation|0|||
106099503|NCT02952924|366020554|FG013|Overall Study|Protocol Violation|0|||
106099504|NCT02952924|366020555|FG014|Overall Study|Protocol Violation|0|||
106099505|NCT02952924|366020556|FG015|Overall Study|Protocol Violation|0|||
106099506|NCT02952924|366020557|FG016|Overall Study|Protocol Violation|0|||
106099507|NCT02952924|366020558|FG017|Overall Study|Protocol Violation|0|||
106099508|NCT02952924|366020559|FG018|Overall Study|Protocol Violation|0|||
106099509|NCT02952924|366020560|FG019|Overall Study|Protocol Violation|1|||
106099510|NCT02952924|366020561|FG020|Overall Study|Protocol Violation|0|||
106099511|NCT02952924|366020562|FG021|Overall Study|Protocol Violation|0|||
106099512|NCT02952924|366020541|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
106099513|NCT02952924|366020542|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
106099514|NCT02952924|366020543|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
106099515|NCT02952924|366020544|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
106099516|NCT02952924|366020545|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
106099517|NCT02952924|366020546|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
106099518|NCT02952924|366020547|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
106099519|NCT02952924|366020548|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
106099520|NCT02952924|366020549|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
106099521|NCT02952924|366020550|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
106099522|NCT02952924|366020551|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
106099523|NCT02952924|366020552|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
106099524|NCT02952924|366020553|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
106099525|NCT02952924|366020554|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
106099526|NCT02952924|366020555|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
106099527|NCT02952924|366020556|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
106099528|NCT02952924|366020557|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
106099529|NCT02952924|366020558|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
106099530|NCT02952924|366020559|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
106099531|NCT02952924|366020560|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
106099532|NCT02952924|366020561|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
106099533|NCT02952924|366020562|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
106099534|NCT02952924|366020541|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099535|NCT02952924|366020542|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099536|NCT02952924|366020543|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099537|NCT02952924|366020544|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099538|NCT02952924|366020545|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099539|NCT02952924|366020546|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099540|NCT02952924|366020547|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099541|NCT02952924|366020548|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099542|NCT02952924|366020549|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099543|NCT02952924|366020550|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099544|NCT02952924|366020551|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099545|NCT02952924|366020552|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099546|NCT02952924|366020553|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099547|NCT02952924|366020554|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099548|NCT02952924|366020555|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099549|NCT02952924|366020556|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099550|NCT02952924|366020557|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099551|NCT02952924|366020558|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099552|NCT02952924|366020559|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099553|NCT02952924|366020560|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
106099554|NCT02952924|366020561|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
105660139|NCT02053610|364421034|FG001|Overall Study|Disease Progression|3|||
105660140|NCT02053610|364421033|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
106099555|NCT02952924|366020562|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
106099556|NCT02952924|366020541|FG000|Overall Study|Noncompliance with study drug|0|||
106099557|NCT02952924|366020542|FG001|Overall Study|Noncompliance with study drug|0|||
106099558|NCT02952924|366020543|FG002|Overall Study|Noncompliance with study drug|0|||
106099559|NCT02952924|366020544|FG003|Overall Study|Noncompliance with study drug|0|||
106099560|NCT02952924|366020545|FG004|Overall Study|Noncompliance with study drug|0|||
106099561|NCT02952924|366020546|FG005|Overall Study|Noncompliance with study drug|0|||
106099562|NCT02952924|366020547|FG006|Overall Study|Noncompliance with study drug|0|||
106099563|NCT02952924|366020548|FG007|Overall Study|Noncompliance with study drug|0|||
106099564|NCT02952924|366020549|FG008|Overall Study|Noncompliance with study drug|0|||
106099565|NCT02952924|366020550|FG009|Overall Study|Noncompliance with study drug|0|||
106099566|NCT02952924|366020551|FG010|Overall Study|Noncompliance with study drug|0|||
106099567|NCT02952924|366020552|FG011|Overall Study|Noncompliance with study drug|0|||
106099568|NCT02952924|366020553|FG012|Overall Study|Noncompliance with study drug|0|||
106099569|NCT02952924|366020554|FG013|Overall Study|Noncompliance with study drug|0|||
106099570|NCT02952924|366020555|FG014|Overall Study|Noncompliance with study drug|0|||
106099571|NCT02952924|366020556|FG015|Overall Study|Noncompliance with study drug|0|||
106099572|NCT02952924|366020557|FG016|Overall Study|Noncompliance with study drug|0|||
106099573|NCT02952924|366020558|FG017|Overall Study|Noncompliance with study drug|0|||
106099574|NCT02952924|366020559|FG018|Overall Study|Noncompliance with study drug|0|||
106099575|NCT02952924|366020560|FG019|Overall Study|Noncompliance with study drug|0|||
106099576|NCT02952924|366020561|FG020|Overall Study|Noncompliance with study drug|0|||
106099577|NCT02952924|366020562|FG021|Overall Study|Noncompliance with study drug|1|||
106099578|NCT02105948|366020567|FG000|Overall Study|Adverse Event|10|||
106099579|NCT02105948|366020568|FG001|Overall Study|Adverse Event|7|||
106099580|NCT02105948|366020569|FG002|Overall Study|Adverse Event|11|||
106099581|NCT02105948|366020570|FG003|Overall Study|Adverse Event|11|||
106099582|NCT02105948|366020567|FG000|Overall Study|Lack of Efficacy|0|||
106099583|NCT02105948|366020568|FG001|Overall Study|Lack of Efficacy|1|||
106099584|NCT02105948|366020569|FG002|Overall Study|Lack of Efficacy|3|||
106099585|NCT02105948|366020570|FG003|Overall Study|Lack of Efficacy|2|||
106099586|NCT02105948|366020567|FG000|Overall Study|Lost to Follow-up|0|||
106099587|NCT02105948|366020568|FG001|Overall Study|Lost to Follow-up|0|||
106099588|NCT02105948|366020569|FG002|Overall Study|Lost to Follow-up|2|||
106099589|NCT02105948|366020570|FG003|Overall Study|Lost to Follow-up|1|||
106099590|NCT02105948|366020567|FG000|Overall Study|Physician Decision|2|||
106099591|NCT02105948|366020568|FG001|Overall Study|Physician Decision|2|||
106099592|NCT02105948|366020569|FG002|Overall Study|Physician Decision|2|||
106099593|NCT02105948|366020570|FG003|Overall Study|Physician Decision|2|||
106099594|NCT02105948|366020567|FG000|Overall Study|Withdrawal by Subject|15|||
106099595|NCT02105948|366020568|FG001|Overall Study|Withdrawal by Subject|10|||
106099596|NCT02105948|366020569|FG002|Overall Study|Withdrawal by Subject|10|||
106099597|NCT02105948|366020570|FG003|Overall Study|Withdrawal by Subject|11|||
106099598|NCT02187991|366020573|FG000|Overall Study|Adverse Event|13|||
106099599|NCT02187991|366020574|FG001|Overall Study|Adverse Event|14|||
106099600|NCT02187991|366020575|FG002|Overall Study|Adverse Event|3|||
106099601|NCT02187991|366020576|FG003|Overall Study|Adverse Event|2|||
106099602|NCT02187991|366020573|FG000|Overall Study|Withdrawal by Subject|9|||
106099603|NCT02187991|366020574|FG001|Overall Study|Withdrawal by Subject|6|||
106099604|NCT02187991|366020575|FG002|Overall Study|Withdrawal by Subject|3|||
106099605|NCT02187991|366020576|FG003|Overall Study|Withdrawal by Subject|2|||
106099606|NCT02187991|366020573|FG000|Overall Study|Physician Decision|4|||
106099607|NCT02187991|366020574|FG001|Overall Study|Physician Decision|4|||
106099608|NCT02187991|366020575|FG002|Overall Study|Physician Decision|0|||
106099609|NCT02187991|366020576|FG003|Overall Study|Physician Decision|2|||
106099610|NCT02187991|366020573|FG000|Overall Study|Other, unrelated complication|7|||
106099611|NCT02187991|366020574|FG001|Overall Study|Other, unrelated complication|1|||
106099612|NCT02187991|366020575|FG002|Overall Study|Other, unrelated complication|1|||
106099613|NCT02187991|366020576|FG003|Overall Study|Other, unrelated complication|2|||
106099614|NCT02187991|366020573|FG000|Overall Study|Death|1|||
106099615|NCT02187991|366020574|FG001|Overall Study|Death|3|||
106099616|NCT02187991|366020575|FG002|Overall Study|Death|0|||
106099617|NCT02187991|366020576|FG003|Overall Study|Death|0|||
106099618|NCT01939028|366020581|FG000|Overall Study|Withdrawal by Subject|5|||
106099619|NCT01939028|366020581|FG000|Overall Study|Physician Decision|7|||
106099620|NCT00936858|366020582|FG000|Overall Study|Death|3|||
106099621|NCT00936858|366020582|FG000|Overall Study|Progression|29|||
106099622|NCT00936858|366020582|FG000|Overall Study|Withdrawal by Subject|5|||
106099623|NCT00936858|366020582|FG000|Overall Study|Adverse Event|1|||
106099624|NCT00936858|366020582|FG000|Overall Study|Physician Decision|7|||
106099625|NCT00936858|366020582|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
106099626|NCT00936858|366020582|FG000|Overall Study|Lost to Follow-up|1|||
106099627|NCT02576067|366020585|FG000|Overall Study|Death|0|||
106099628|NCT02576067|366020586|FG001|Overall Study|Death|1|||
106099629|NCT02576067|366020585|FG000|Overall Study|Lack of Efficacy|1|||
106099630|NCT02576067|366020586|FG001|Overall Study|Lack of Efficacy|0|||
105660141|NCT02053610|364421034|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
105660142|NCT02053610|364421033|FG000|Overall Study|Did not Receive Treatment|4|||
105660143|NCT02053610|364421034|FG001|Overall Study|Did not Receive Treatment|2|||
105660144|NCT02053610|364421033|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105660145|NCT02053610|364421034|FG001|Overall Study|Insufficient Therapeutic Response|1|||
105660146|NCT02053610|364421033|FG000|Overall Study|Violation of Selection Criteria|1|||
105660147|NCT02053610|364421034|FG001|Overall Study|Violation of Selection Criteria|0|||
105660148|NCT03568812|364421035|FG000|Overall Study|Physician Decision|0|||
105660149|NCT03568812|364421036|FG001|Overall Study|Physician Decision|1|||
105660150|NCT00464945|364421037|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
105660151|NCT00464945|364421038|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
105660152|NCT00464945|364421037|FG000|Infant Series|Protocol Violation|1|||
105660153|NCT00464945|364421038|FG001|Infant Series|Protocol Violation|0|||
105660154|NCT00464945|364421037|FG000|Infant Series|Lost to Follow-up|1|||
105660155|NCT00464945|364421038|FG001|Infant Series|Lost to Follow-up|0|||
105660156|NCT00464945|364421037|FG000|After Infant Series|Withdrawal by Subject|0|||
105660157|NCT00464945|364421038|FG001|After Infant Series|Withdrawal by Subject|2|||
105660158|NCT00464945|364421037|FG000|Toddler Dose|Lost to Follow-up|0|||
105660159|NCT00464945|364421038|FG001|Toddler Dose|Lost to Follow-up|1|||
105660160|NCT01496365|364421043|FG000|Overall Study|Adverse Event|2|||
105660161|NCT01496365|364421044|FG001|Overall Study|Adverse Event|3|||
105660162|NCT01496365|364421045|FG002|Overall Study|Adverse Event|3|||
105660163|NCT01496365|364421046|FG003|Overall Study|Adverse Event|2|||
105770550|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
106099631|NCT02576067|366020585|FG000|Overall Study|Lost to Follow-up|11|||
106099632|NCT02576067|366020586|FG001|Overall Study|Lost to Follow-up|0|||
106099633|NCT02576067|366020585|FG000|Overall Study|Withdrawal by Subject|11|||
106099634|NCT02576067|366020586|FG001|Overall Study|Withdrawal by Subject|2|||
106099635|NCT02576067|366020585|FG000|Overall Study|study closure of main CIRT trial)|0|||
106099636|NCT02576067|366020586|FG001|Overall Study|study closure of main CIRT trial)|8|||
106099637|NCT02576067|366020585|FG000|Overall Study|not randomized, failed run-in|7|||
106099638|NCT02576067|366020586|FG001|Overall Study|not randomized, failed run-in|0|||
106099639|NCT02576067|366020585|FG000|Overall Study|screen failure/ re-enrolled|0|||
106099640|NCT02576067|366020586|FG001|Overall Study|screen failure/ re-enrolled|25|||
106099641|NCT02576067|366020585|FG000|Overall Study|Physician Decision|4|||
106099642|NCT02576067|366020586|FG001|Overall Study|Physician Decision|0|||
106099643|NCT04773587|366020587|FG000|Overall Study|Lost to Follow-up|11|||
106099644|NCT04773587|366020588|FG001|Overall Study|Lost to Follow-up|3|||
106099645|NCT04773587|366020587|FG000|Overall Study|Adverse Event|6|||
106099646|NCT04773587|366020588|FG001|Overall Study|Adverse Event|3|||
106099647|NCT04773587|366020587|FG000|Overall Study|Lack of Efficacy|5|||
106099648|NCT04773587|366020588|FG001|Overall Study|Lack of Efficacy|2|||
106099649|NCT04773587|366020587|FG000|Overall Study|Withdrawal by Subject|4|||
106099650|NCT04773587|366020588|FG001|Overall Study|Withdrawal by Subject|5|||
106099651|NCT04773587|366020587|FG000|Overall Study|Noncompliance|1|||
106099652|NCT04773587|366020588|FG001|Overall Study|Noncompliance|0|||
106099653|NCT04773587|366020587|FG000|Overall Study|Protocol Violation|1|||
106099654|NCT04773587|366020588|FG001|Overall Study|Protocol Violation|0|||
106099655|NCT04773587|366020587|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
106099656|NCT04773587|366020588|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
106099657|NCT02372409|366020589|FG000|Overall Study|Lost to Follow-up|1|||
106099658|NCT02372409|366020590|FG001|Overall Study|Lost to Follow-up|0|||
106099659|NCT02372409|366020589|FG000|Overall Study|Disease progression|1|||
106099660|NCT02372409|366020590|FG001|Overall Study|Disease progression|1|||
106099661|NCT00136955|366022591|FG000|Overall Study|Adverse Event|8|||
106099662|NCT00136955|366022591|FG000|Overall Study|Lost to Follow-up|1|||
106099663|NCT00136955|366022591|FG000|Overall Study|Withdrawal by Subject|2|||
106099664|NCT00136955|366022591|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
106099665|NCT04450264|366022592|FG000|Overall Study|Incomplete survey|13|||
106099666|NCT04450264|366022593|FG001|Overall Study|Incomplete survey|19|||
106099667|NCT04537923|366022594|FG000|Overall Study|Adverse Event|2|||
106099668|NCT04537923|366022595|FG001|Overall Study|Adverse Event|1|||
106099669|NCT04537923|366022596|FG002|Overall Study|Adverse Event|2|||
106099670|NCT04537923|366022597|FG003|Overall Study|Adverse Event|4|||
105660164|NCT01496365|364421047|FG004|Overall Study|Adverse Event|5|||
105660165|NCT01496365|364421048|FG005|Overall Study|Adverse Event|6|||
105660166|NCT01496365|364421049|FG006|Overall Study|Adverse Event|4|||
105660167|NCT01496365|364421043|FG000|Overall Study|Withdrawal by Subject|6|||
105770551|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
106099671|NCT04537923|366022594|FG000|Overall Study|Death|3|||
106099672|NCT04537923|366022595|FG001|Overall Study|Death|3|||
106099673|NCT04537923|366022596|FG002|Overall Study|Death|1|||
106099674|NCT04537923|366022597|FG003|Overall Study|Death|11|||
106099675|NCT04537923|366022594|FG000|Overall Study|Lost to Follow-up|1|||
106099676|NCT04537923|366022595|FG001|Overall Study|Lost to Follow-up|2|||
106099677|NCT04537923|366022596|FG002|Overall Study|Lost to Follow-up|1|||
105660168|NCT01496365|364421044|FG001|Overall Study|Withdrawal by Subject|6|||
105660169|NCT01496365|364421045|FG002|Overall Study|Withdrawal by Subject|0|||
105660170|NCT01496365|364421046|FG003|Overall Study|Withdrawal by Subject|1|||
105660171|NCT01496365|364421047|FG004|Overall Study|Withdrawal by Subject|3|||
105660172|NCT01496365|364421048|FG005|Overall Study|Withdrawal by Subject|2|||
105660173|NCT01496365|364421049|FG006|Overall Study|Withdrawal by Subject|1|||
105660174|NCT01496365|364421043|FG000|Overall Study|Protocol Violation|2|||
105660175|NCT01496365|364421044|FG001|Overall Study|Protocol Violation|1|||
105660176|NCT01496365|364421045|FG002|Overall Study|Protocol Violation|1|||
105660177|NCT01496365|364421046|FG003|Overall Study|Protocol Violation|0|||
105660178|NCT01496365|364421047|FG004|Overall Study|Protocol Violation|0|||
105660179|NCT01496365|364421048|FG005|Overall Study|Protocol Violation|1|||
105660180|NCT01496365|364421049|FG006|Overall Study|Protocol Violation|0|||
105660181|NCT01496365|364421043|FG000|Overall Study|Lack of Efficacy|1|||
105660182|NCT01496365|364421044|FG001|Overall Study|Lack of Efficacy|0|||
105660183|NCT01496365|364421045|FG002|Overall Study|Lack of Efficacy|0|||
105660184|NCT01496365|364421046|FG003|Overall Study|Lack of Efficacy|0|||
105660185|NCT01496365|364421047|FG004|Overall Study|Lack of Efficacy|0|||
105660186|NCT01496365|364421048|FG005|Overall Study|Lack of Efficacy|1|||
105660187|NCT01496365|364421049|FG006|Overall Study|Lack of Efficacy|0|||
105660188|NCT01496365|364421043|FG000|Overall Study|Lost to Follow-up|0|||
105660189|NCT01496365|364421044|FG001|Overall Study|Lost to Follow-up|1|||
105660190|NCT01496365|364421045|FG002|Overall Study|Lost to Follow-up|0|||
105660191|NCT01496365|364421046|FG003|Overall Study|Lost to Follow-up|0|||
105660192|NCT01496365|364421047|FG004|Overall Study|Lost to Follow-up|2|||
105660193|NCT01496365|364421048|FG005|Overall Study|Lost to Follow-up|0|||
105660194|NCT01496365|364421049|FG006|Overall Study|Lost to Follow-up|0|||
105660195|NCT01496365|364421043|FG000|Overall Study|Other|4|||
105660196|NCT01496365|364421044|FG001|Overall Study|Other|4|||
105660197|NCT01496365|364421045|FG002|Overall Study|Other|2|||
105660198|NCT01496365|364421046|FG003|Overall Study|Other|1|||
105660199|NCT01496365|364421047|FG004|Overall Study|Other|3|||
105660200|NCT01496365|364421048|FG005|Overall Study|Other|0|||
105660201|NCT01496365|364421049|FG006|Overall Study|Other|1|||
105660202|NCT01843777|364421051|FG000|Overall Study|Withdrawal by Subject|1|||
105660203|NCT01843777|364421052|FG001|Overall Study|Withdrawal by Subject|0|||
105660204|NCT01475461|364421053|FG000|Run-in Period|Not meet eligibility criteria|16|||
105660205|NCT01475461|364421054|FG001|Run-in Period|Not meet eligibility criteria|0|||
105660206|NCT01475461|364421055|FG002|Run-in Period|Not meet eligibility criteria|0|||
105660207|NCT01475461|364421056|FG003|Run-in Period|Not meet eligibility criteria|0|||
105660208|NCT01475461|364421057|FG004|Run-in Period|Not meet eligibility criteria|0|||
105660209|NCT01475461|364421058|FG005|Run-in Period|Not meet eligibility criteria|0|||
105660210|NCT01475461|364421059|FG006|Run-in Period|Not meet eligibility criteria|0|||
105660211|NCT01475461|364421053|FG000|Run-in Period|Lost to Follow-up|7|||
105660212|NCT01475461|364421054|FG001|Run-in Period|Lost to Follow-up|0|||
105660213|NCT01475461|364421055|FG002|Run-in Period|Lost to Follow-up|0|||
105660214|NCT01475461|364421056|FG003|Run-in Period|Lost to Follow-up|0|||
105660215|NCT01475461|364421057|FG004|Run-in Period|Lost to Follow-up|0|||
105660216|NCT01475461|364421058|FG005|Run-in Period|Lost to Follow-up|0|||
105660217|NCT01475461|364421059|FG006|Run-in Period|Lost to Follow-up|0|||
105660218|NCT01475461|364421053|FG000|Run-in Period|Withdrawal by Subject|11|||
105660219|NCT01475461|364421054|FG001|Run-in Period|Withdrawal by Subject|0|||
105660220|NCT01475461|364421055|FG002|Run-in Period|Withdrawal by Subject|0|||
105660221|NCT01475461|364421056|FG003|Run-in Period|Withdrawal by Subject|0|||
105660222|NCT01475461|364421057|FG004|Run-in Period|Withdrawal by Subject|0|||
105660223|NCT01475461|364421058|FG005|Run-in Period|Withdrawal by Subject|0|||
105660224|NCT01475461|364421059|FG006|Run-in Period|Withdrawal by Subject|0|||
105660225|NCT01475461|364421053|FG000|Run-in Period|Other|3|||
105660226|NCT01475461|364421054|FG001|Run-in Period|Other|0|||
105660227|NCT01475461|364421055|FG002|Run-in Period|Other|0|||
105660228|NCT01475461|364421056|FG003|Run-in Period|Other|0|||
105660229|NCT01475461|364421057|FG004|Run-in Period|Other|0|||
105660230|NCT01475461|364421058|FG005|Run-in Period|Other|0|||
105660231|NCT01475461|364421059|FG006|Run-in Period|Other|0|||
105660232|NCT01475461|364421053|FG000|Run-in Period|Protocol Violation|4|||
105660233|NCT01475461|364421054|FG001|Run-in Period|Protocol Violation|0|||
105660234|NCT01475461|364421055|FG002|Run-in Period|Protocol Violation|0|||
105660235|NCT01475461|364421056|FG003|Run-in Period|Protocol Violation|0|||
105660236|NCT01475461|364421057|FG004|Run-in Period|Protocol Violation|0|||
105660237|NCT01475461|364421058|FG005|Run-in Period|Protocol Violation|0|||
105660238|NCT01475461|364421059|FG006|Run-in Period|Protocol Violation|0|||
105660239|NCT01475461|364421053|FG000|Treatment Period|Death|0|||
105660240|NCT01475461|364421054|FG001|Treatment Period|Death|0|||
105660241|NCT01475461|364421055|FG002|Treatment Period|Death|0|||
105660242|NCT01475461|364421056|FG003|Treatment Period|Death|1|||
105660243|NCT01475461|364421057|FG004|Treatment Period|Death|0|||
105660244|NCT01475461|364421058|FG005|Treatment Period|Death|0|||
105660245|NCT01475461|364421059|FG006|Treatment Period|Death|0|||
105660246|NCT01475461|364421053|FG000|Treatment Period|Lost to Follow-up|0|||
105660247|NCT01475461|364421054|FG001|Treatment Period|Lost to Follow-up|3|||
105660248|NCT01475461|364421055|FG002|Treatment Period|Lost to Follow-up|2|||
105660249|NCT01475461|364421056|FG003|Treatment Period|Lost to Follow-up|3|||
105660250|NCT01475461|364421057|FG004|Treatment Period|Lost to Follow-up|1|||
105660251|NCT01475461|364421058|FG005|Treatment Period|Lost to Follow-up|2|||
105660252|NCT01475461|364421059|FG006|Treatment Period|Lost to Follow-up|1|||
105660253|NCT01475461|364421053|FG000|Treatment Period|Withdrawal by Subject|0|||
105660254|NCT01475461|364421054|FG001|Treatment Period|Withdrawal by Subject|2|||
105660255|NCT01475461|364421055|FG002|Treatment Period|Withdrawal by Subject|2|||
105660256|NCT01475461|364421056|FG003|Treatment Period|Withdrawal by Subject|0|||
105660257|NCT01475461|364421057|FG004|Treatment Period|Withdrawal by Subject|2|||
105660258|NCT01475461|364421058|FG005|Treatment Period|Withdrawal by Subject|2|||
105660259|NCT01475461|364421059|FG006|Treatment Period|Withdrawal by Subject|0|||
105660260|NCT01475461|364421053|FG000|Treatment Period|Other|0|||
105660261|NCT01475461|364421054|FG001|Treatment Period|Other|1|||
105660262|NCT01475461|364421055|FG002|Treatment Period|Other|0|||
105660263|NCT01475461|364421056|FG003|Treatment Period|Other|0|||
105660264|NCT01475461|364421057|FG004|Treatment Period|Other|0|||
105660265|NCT01475461|364421058|FG005|Treatment Period|Other|0|||
105660266|NCT01475461|364421059|FG006|Treatment Period|Other|0|||
105660267|NCT01475461|364421053|FG000|Treatment Period|Protocol Violation|0|||
105660268|NCT01475461|364421054|FG001|Treatment Period|Protocol Violation|1|||
105660269|NCT01475461|364421055|FG002|Treatment Period|Protocol Violation|0|||
105660270|NCT01475461|364421056|FG003|Treatment Period|Protocol Violation|0|||
105660271|NCT01475461|364421057|FG004|Treatment Period|Protocol Violation|0|||
105660272|NCT01475461|364421058|FG005|Treatment Period|Protocol Violation|0|||
105660273|NCT01475461|364421059|FG006|Treatment Period|Protocol Violation|1|||
105660274|NCT01475461|364421053|FG000|Treatment Period|Lack of Efficacy|0|||
105660275|NCT01475461|364421054|FG001|Treatment Period|Lack of Efficacy|2|||
105660276|NCT01475461|364421055|FG002|Treatment Period|Lack of Efficacy|0|||
105660277|NCT01475461|364421056|FG003|Treatment Period|Lack of Efficacy|2|||
105660278|NCT01475461|364421057|FG004|Treatment Period|Lack of Efficacy|1|||
105660279|NCT01475461|364421058|FG005|Treatment Period|Lack of Efficacy|1|||
105660280|NCT01475461|364421059|FG006|Treatment Period|Lack of Efficacy|0|||
105660281|NCT01475461|364421053|FG000|Treatment Period|Medication Error|0|||
105660282|NCT01475461|364421054|FG001|Treatment Period|Medication Error|0|||
105660283|NCT01475461|364421055|FG002|Treatment Period|Medication Error|0|||
105660284|NCT01475461|364421056|FG003|Treatment Period|Medication Error|1|||
105660285|NCT01475461|364421057|FG004|Treatment Period|Medication Error|0|||
105660286|NCT01475461|364421058|FG005|Treatment Period|Medication Error|0|||
105660287|NCT01475461|364421059|FG006|Treatment Period|Medication Error|0|||
105660288|NCT01475461|364421053|FG000|Treatment Period|Adverse Event|0|||
105660289|NCT01475461|364421054|FG001|Treatment Period|Adverse Event|0|||
105660290|NCT01475461|364421055|FG002|Treatment Period|Adverse Event|0|||
105660291|NCT01475461|364421056|FG003|Treatment Period|Adverse Event|1|||
105660292|NCT01475461|364421057|FG004|Treatment Period|Adverse Event|0|||
105660293|NCT01475461|364421058|FG005|Treatment Period|Adverse Event|0|||
105660294|NCT01475461|364421059|FG006|Treatment Period|Adverse Event|0|||
105660295|NCT02088554|364421060|FG000|Overall Study|Exited before procedure|130|||
105660296|NCT02088554|364421060|FG000|Overall Study|Attempted but not implanted|31|||
105660297|NCT02088554|364421060|FG000|Overall Study|Implant not attempted|19|||
105660298|NCT02088554|364421060|FG000|Overall Study|Pending next visit|532|||
105660299|NCT02088554|364421060|FG000|Overall Study|Death|170|||
105660300|NCT02088554|364421060|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
105660301|NCT02088554|364421060|FG000|Overall Study|Lost to Follow-up|23|||
105660302|NCT02088554|364421060|FG000|Overall Study|Explanted|32|||
105660303|NCT02088554|364421060|FG000|Overall Study|Any other reason not covered by previous categories|11|||
105660304|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
105660305|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
105660306|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
105660307|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
105660308|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
105660309|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
105660310|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
105660311|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
105660312|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
105806440|NCT01464827|364948993|FG012|Overall Study|Lost to Follow-up|0|||
105660313|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
105660314|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
105660315|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
105660316|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
105660317|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
105660318|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
105660319|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
105660320|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
105660321|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
105660322|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
105660323|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
105660324|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
105660325|NCT04599855|364421061|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
105660326|NCT04599855|364421062|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
105660327|NCT04599855|364421063|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
105660328|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
105660329|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
105660330|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
105660331|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
105660332|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
105660333|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
105660334|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
105660335|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
105660336|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
105660337|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
105660338|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
105660339|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
105660340|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
105660341|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
105660342|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
105660343|NCT04599855|364421061|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
105660344|NCT04599855|364421062|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
105660345|NCT04599855|364421063|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
105660346|NCT02312206|364421071|FG000|Overall Study|Adverse Event|3|||
105660347|NCT02312206|364421072|FG001|Overall Study|Adverse Event|6|||
105660348|NCT02312206|364421071|FG000|Overall Study|Withdrawal by Subject|6|||
105660349|NCT02312206|364421072|FG001|Overall Study|Withdrawal by Subject|6|||
105660350|NCT02312206|364421071|FG000|Overall Study|Physician Decision|7|||
105660351|NCT02312206|364421072|FG001|Overall Study|Physician Decision|6|||
105660352|NCT02312206|364421071|FG000|Overall Study|Death|31|||
105660353|NCT02312206|364421072|FG001|Overall Study|Death|36|||
105660354|NCT02312206|364421071|FG000|Overall Study|Study Terminated by Sponsor|81|||
105660355|NCT02312206|364421072|FG001|Overall Study|Study Terminated by Sponsor|74|||
105660356|NCT02312206|364421071|FG000|Overall Study|Patient transferred to hospice|0|||
105660357|NCT02312206|364421072|FG001|Overall Study|Patient transferred to hospice|1|||
105660358|NCT02312206|364421071|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
105660359|NCT02312206|364421072|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
105660360|NCT02312206|364421071|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
105660361|NCT02312206|364421072|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
105660362|NCT02312206|364421071|FG000|Overall Study|Disease Progression|1|||
105660363|NCT02312206|364421072|FG001|Overall Study|Disease Progression|0|||
105660364|NCT00585975|364421073|FG000|Overall Study|Withdrawal by Subject|3|||
105660365|NCT00585975|364421074|FG001|Overall Study|Withdrawal by Subject|3|||
105660366|NCT00585975|364421073|FG000|Overall Study|Lost to Follow-up|2|||
105660367|NCT00585975|364421074|FG001|Overall Study|Lost to Follow-up|1|||
105660368|NCT00585975|364421073|FG000|Overall Study|Enrollment met/over-enrolled|10|||
105660369|NCT00585975|364421074|FG001|Overall Study|Enrollment met/over-enrolled|9|||
105660370|NCT02818998|364421075|FG000|Overall Study|Adverse Event|3|||
105660371|NCT02818998|364421076|FG001|Overall Study|Adverse Event|2|||
105660372|NCT02818998|364421077|FG002|Overall Study|Adverse Event|1|||
105660373|NCT02818998|364421075|FG000|Overall Study|Lost to Follow-up|4|||
105660374|NCT02818998|364421076|FG001|Overall Study|Lost to Follow-up|1|||
105660375|NCT02818998|364421077|FG002|Overall Study|Lost to Follow-up|2|||
105660376|NCT02818998|364421075|FG000|Overall Study|Withdrawal by sponsor|0|||
105660377|NCT02818998|364421076|FG001|Overall Study|Withdrawal by sponsor|1|||
105660378|NCT02818998|364421077|FG002|Overall Study|Withdrawal by sponsor|1|||
105660379|NCT02818998|364421075|FG000|Overall Study|Death|3|||
105660380|NCT02818998|364421076|FG001|Overall Study|Death|6|||
105660381|NCT02818998|364421077|FG002|Overall Study|Death|8|||
105660382|NCT02818998|364421075|FG000|Overall Study|Withdrawal by Subject|7|||
105660383|NCT02818998|364421076|FG001|Overall Study|Withdrawal by Subject|6|||
105660384|NCT02818998|364421077|FG002|Overall Study|Withdrawal by Subject|6|||
105660385|NCT02818998|364421075|FG000|Overall Study|Physician Decision|1|||
105660386|NCT02818998|364421076|FG001|Overall Study|Physician Decision|0|||
105770552|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
105770553|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105660387|NCT02818998|364421077|FG002|Overall Study|Physician Decision|0|||
105660388|NCT00832000|364421078|FG000|Overall Study|Adverse Event|2|||
105660389|NCT00832000|364421079|FG001|Overall Study|Adverse Event|0|||
105660390|NCT00832000|364421078|FG000|Overall Study|Withdrawal by Subject|1|||
105660391|NCT00832000|364421079|FG001|Overall Study|Withdrawal by Subject|0|||
105660392|NCT00832000|364421078|FG000|Overall Study|No calls to IVR in either period|1|||
105660393|NCT00832000|364421079|FG001|Overall Study|No calls to IVR in either period|1|||
105660394|NCT00832000|364421078|FG000|Overall Study|No calls to IVR in period 2|2|||
105660395|NCT00832000|364421079|FG001|Overall Study|No calls to IVR in period 2|0|||
105660396|NCT01253447|364421081|FG000|Overall Study|Adverse Event|2|||
105660397|NCT02564718|364421084|FG000|Overall Study|Withdrew from treatment|0|||
105660398|NCT02564718|364421085|FG001|Overall Study|Withdrew from treatment|1|||
105660399|NCT03856047|364421086|FG000|Overall Study|Withdrawal by Subject|0|||
105660400|NCT03856047|364421087|FG001|Overall Study|Withdrawal by Subject|1|||
105660401|NCT03856047|364421088|FG002|Overall Study|Withdrawal by Subject|1|||
105660402|NCT03856047|364421089|FG003|Overall Study|Withdrawal by Subject|0|||
105660403|NCT03856047|364421090|FG004|Overall Study|Withdrawal by Subject|3|||
105660404|NCT03856047|364421091|FG005|Overall Study|Withdrawal by Subject|0|||
105660405|NCT03856047|364421092|FG006|Overall Study|Withdrawal by Subject|2|||
105660406|NCT03856047|364421086|FG000|Overall Study|Lost to Follow-up|4|||
105660407|NCT03856047|364421087|FG001|Overall Study|Lost to Follow-up|2|||
105660408|NCT03856047|364421088|FG002|Overall Study|Lost to Follow-up|3|||
105660409|NCT03856047|364421089|FG003|Overall Study|Lost to Follow-up|1|||
105660410|NCT03856047|364421090|FG004|Overall Study|Lost to Follow-up|4|||
105660411|NCT03856047|364421091|FG005|Overall Study|Lost to Follow-up|4|||
105660412|NCT03856047|364421092|FG006|Overall Study|Lost to Follow-up|4|||
105660413|NCT01017263|364421096|FG000|Overall Study|not eligible|12|||
105660414|NCT02049515|364421097|FG000|Overall Study|Adverse Event|46|||
105660415|NCT02049515|364421098|FG001|Overall Study|Adverse Event|2|||
105660416|NCT02049515|364421097|FG000|Overall Study|Protocol-specified Disease Progression|23|||
105660417|NCT02049515|364421098|FG001|Overall Study|Protocol-specified Disease Progression|2|||
105660418|NCT02049515|364421097|FG000|Overall Study|Death|6|||
105660419|NCT02049515|364421098|FG001|Overall Study|Death|0|||
105660420|NCT02049515|364421097|FG000|Overall Study|Physician Decision|5|||
105660421|NCT02049515|364421098|FG001|Overall Study|Physician Decision|1|||
105660422|NCT02049515|364421097|FG000|Overall Study|Withdrawal by Subject|3|||
105660423|NCT02049515|364421098|FG001|Overall Study|Withdrawal by Subject|0|||
105660424|NCT02049515|364421097|FG000|Overall Study|Termination of the Study by Sponsor|2|||
105660425|NCT02049515|364421098|FG001|Overall Study|Termination of the Study by Sponsor|0|||
105660426|NCT02049515|364421097|FG000|Overall Study|Protocol Violation|1|||
105660427|NCT02049515|364421098|FG001|Overall Study|Protocol Violation|1|||
105660428|NCT02049515|364421097|FG000|Overall Study|Clinical Deterioration|1|||
105660429|NCT02049515|364421098|FG001|Overall Study|Clinical Deterioration|0|||
105660430|NCT02049515|364421097|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
105660431|NCT02049515|364421098|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
105660432|NCT02049515|364421097|FG000|Overall Study|Treatment Interruption >42 Days|1|||
105660433|NCT02049515|364421098|FG001|Overall Study|Treatment Interruption >42 Days|0|||
105660434|NCT02049515|364421097|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
105660435|NCT02049515|364421098|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
105660436|NCT00770588|364421102|FG000|Overall Study|Adverse Event|9|||
105660437|NCT00770588|364421103|FG001|Overall Study|Adverse Event|2|||
105660438|NCT00770588|364421102|FG000|Overall Study|Death caused by progression of disease|70|||
105806441|NCT01464827|364948994|FG013|Overall Study|Lost to Follow-up|1|||
106099678|NCT04537923|366022597|FG003|Overall Study|Lost to Follow-up|6|||
106099679|NCT04537923|366022594|FG000|Overall Study|Physician Decision|1|||
106099680|NCT04537923|366022595|FG001|Overall Study|Physician Decision|0|||
106099681|NCT04537923|366022596|FG002|Overall Study|Physician Decision|2|||
106099682|NCT04537923|366022597|FG003|Overall Study|Physician Decision|5|||
106099683|NCT04537923|366022594|FG000|Overall Study|Pregnancy|1|||
106099684|NCT04537923|366022595|FG001|Overall Study|Pregnancy|0|||
106099685|NCT04537923|366022596|FG002|Overall Study|Pregnancy|0|||
106099686|NCT04537923|366022597|FG003|Overall Study|Pregnancy|0|||
106099687|NCT04537923|366022594|FG000|Overall Study|Withdrawal by Subject|4|||
106099688|NCT04537923|366022595|FG001|Overall Study|Withdrawal by Subject|4|||
106099689|NCT04537923|366022596|FG002|Overall Study|Withdrawal by Subject|4|||
106099690|NCT04537923|366022597|FG003|Overall Study|Withdrawal by Subject|58|||
106099691|NCT04537923|366022594|FG000|Overall Study|Missed study visits|2|||
106099692|NCT04537923|366022595|FG001|Overall Study|Missed study visits|0|||
106099693|NCT04537923|366022596|FG002|Overall Study|Missed study visits|0|||
106099694|NCT04537923|366022597|FG003|Overall Study|Missed study visits|3|||
106099695|NCT04537923|366022594|FG000|Overall Study|Sponsor's decision|0|||
106099696|NCT04537923|366022595|FG001|Overall Study|Sponsor's decision|0|||
106099697|NCT04537923|366022596|FG002|Overall Study|Sponsor's decision|1|||
105660439|NCT00770588|364421103|FG001|Overall Study|Death caused by progression of disease|91|||
105660440|NCT00770588|364421102|FG000|Overall Study|Lost to Follow-up|1|||
105660441|NCT00770588|364421103|FG001|Overall Study|Lost to Follow-up|1|||
105660442|NCT00770588|364421102|FG000|Overall Study|Withdrawal by Subject|1|||
105660443|NCT00770588|364421103|FG001|Overall Study|Withdrawal by Subject|1|||
105660444|NCT03635086|364421107|FG000|Overall Study|Withdrawal of consent|0|||
105660445|NCT03635086|364421108|FG001|Overall Study|Withdrawal of consent|0|||
106099698|NCT04537923|366022597|FG003|Overall Study|Sponsor's decision|1|||
106099699|NCT04537923|366022594|FG000|Overall Study|Safety reasons|1|||
106099700|NCT04537923|366022595|FG001|Overall Study|Safety reasons|0|||
105660446|NCT03635086|364421109|FG002|Overall Study|Withdrawal of consent|1|||
105660447|NCT03635086|364421110|FG003|Overall Study|Withdrawal of consent|0|||
105660448|NCT03635086|364421111|FG004|Overall Study|Withdrawal of consent|0|||
105660449|NCT03635086|364421107|FG000|Overall Study|Adverse Event|0|||
105660450|NCT03635086|364421108|FG001|Overall Study|Adverse Event|1|||
105660451|NCT03635086|364421109|FG002|Overall Study|Adverse Event|0|||
105660452|NCT03635086|364421110|FG003|Overall Study|Adverse Event|0|||
105660453|NCT03635086|364421111|FG004|Overall Study|Adverse Event|0|||
105660454|NCT03635086|364421107|FG000|Overall Study|Lost to Follow-up|1|||
105660455|NCT03635086|364421108|FG001|Overall Study|Lost to Follow-up|0|||
105660456|NCT03635086|364421109|FG002|Overall Study|Lost to Follow-up|0|||
105660457|NCT03635086|364421110|FG003|Overall Study|Lost to Follow-up|0|||
105660458|NCT03635086|364421111|FG004|Overall Study|Lost to Follow-up|0|||
105660459|NCT02872012|364421112|FG000|Overall Study|Withdrawal by Subject|1|||
105660460|NCT02872012|364421113|FG001|Overall Study|Withdrawal by Subject|0|||
105660461|NCT02872012|364421114|FG002|Overall Study|Withdrawal by Subject|0|||
105660462|NCT02872012|364421115|FG003|Overall Study|Withdrawal by Subject|0|||
105660463|NCT02872012|364421116|FG004|Overall Study|Withdrawal by Subject|0|||
105660464|NCT01728623|364421117|FG000|Overall Study|Disease progression|26|||
105660465|NCT01728623|364421117|FG000|Overall Study|Adverse Event|1|||
105660466|NCT01728623|364421117|FG000|Overall Study|Withdrawal by Subject|1|||
105660467|NCT01390441|364421122|FG000|Treatment Period|Protocol Violation|0|||
105660468|NCT01390441|364421123|FG001|Treatment Period|Protocol Violation|1|||
105660469|NCT01390441|364421124|FG002|Treatment Period|Protocol Violation|0|||
105660470|NCT01390441|364421125|FG003|Treatment Period|Protocol Violation|0|||
105660471|NCT01390441|364421126|FG004|Treatment Period|Protocol Violation|0|||
105660472|NCT01390441|364421122|FG000|Treatment Period|Physician Decision|0|||
105660473|NCT01390441|364421123|FG001|Treatment Period|Physician Decision|0|||
105660474|NCT01390441|364421124|FG002|Treatment Period|Physician Decision|0|||
105660475|NCT01390441|364421125|FG003|Treatment Period|Physician Decision|1|||
105660476|NCT01390441|364421126|FG004|Treatment Period|Physician Decision|0|||
105660477|NCT01390441|364421122|FG000|Treatment Period|Lack of Efficacy|0|||
105660478|NCT01390441|364421123|FG001|Treatment Period|Lack of Efficacy|0|||
105660479|NCT01390441|364421124|FG002|Treatment Period|Lack of Efficacy|0|||
105660480|NCT01390441|364421125|FG003|Treatment Period|Lack of Efficacy|0|||
105660481|NCT01390441|364421126|FG004|Treatment Period|Lack of Efficacy|1|||
105660482|NCT01390441|364421122|FG000|Treatment Period|Unknown due to early stopping of study|0|||
105660483|NCT01390441|364421123|FG001|Treatment Period|Unknown due to early stopping of study|0|||
105660484|NCT01390441|364421124|FG002|Treatment Period|Unknown due to early stopping of study|8|||
105660485|NCT01390441|364421125|FG003|Treatment Period|Unknown due to early stopping of study|11|||
105660486|NCT01390441|364421126|FG004|Treatment Period|Unknown due to early stopping of study|7|||
105660487|NCT01390441|364421122|FG000|Treatment Period|Adverse Event|0|||
105660488|NCT01390441|364421123|FG001|Treatment Period|Adverse Event|0|||
105660489|NCT01390441|364421124|FG002|Treatment Period|Adverse Event|1|||
105660490|NCT01390441|364421125|FG003|Treatment Period|Adverse Event|1|||
105660491|NCT01390441|364421126|FG004|Treatment Period|Adverse Event|2|||
105660492|NCT01390441|364421122|FG000|Treatment Period|Withdrawal by Subject|0|||
105660493|NCT01390441|364421123|FG001|Treatment Period|Withdrawal by Subject|0|||
105660494|NCT01390441|364421124|FG002|Treatment Period|Withdrawal by Subject|1|||
105660495|NCT01390441|364421125|FG003|Treatment Period|Withdrawal by Subject|0|||
105660496|NCT01390441|364421126|FG004|Treatment Period|Withdrawal by Subject|1|||
105660497|NCT01390441|364421122|FG000|Treatment Period|Lost to Follow-up|1|||
105660498|NCT01390441|364421123|FG001|Treatment Period|Lost to Follow-up|0|||
105660499|NCT01390441|364421124|FG002|Treatment Period|Lost to Follow-up|0|||
105660500|NCT01390441|364421125|FG003|Treatment Period|Lost to Follow-up|0|||
105660501|NCT01390441|364421126|FG004|Treatment Period|Lost to Follow-up|0|||
105660502|NCT01390441|364421122|FG000|Extension Period|Protocol Violation|3|||
105660503|NCT01390441|364421123|FG001|Extension Period|Protocol Violation|1|||
105660504|NCT01390441|364421124|FG002|Extension Period|Protocol Violation|0|||
105660505|NCT01390441|364421125|FG003|Extension Period|Protocol Violation|1|||
105660506|NCT01390441|364421126|FG004|Extension Period|Protocol Violation|0|||
105660507|NCT03517111|364421127|FG000|Enrolled|Withdrawal by Subject|0|||
105660508|NCT03517111|364421128|FG001|Enrolled|Withdrawal by Subject|1|||
105660509|NCT03517111|364421129|FG002|Enrolled|Withdrawal by Subject|0|||
105660510|NCT03517111|364421127|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
105660511|NCT03517111|364421128|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
105660512|NCT03517111|364421129|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
105660513|NCT03517111|364421127|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
105660514|NCT03517111|364421128|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
105660515|NCT03517111|364421129|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
105660516|NCT03517111|364421127|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
105660517|NCT03517111|364421128|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
105660518|NCT03517111|364421129|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
105660519|NCT03517111|364421127|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
105806442|NCT01464827|364948981|FG000|Overall Study|Other|2|||
105660520|NCT03517111|364421128|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
105660521|NCT03517111|364421129|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
105660522|NCT03713320|364421130|FG000|Randomized Period|Adverse Event|1|||
105660523|NCT03713320|364421131|FG001|Randomized Period|Adverse Event|5|||
105660524|NCT03713320|364421132|FG002|Randomized Period|Adverse Event|0|||
105660525|NCT03713320|364421130|FG000|Randomized Period|Physician Decision|1|||
105660526|NCT03713320|364421131|FG001|Randomized Period|Physician Decision|1|||
105660527|NCT03713320|364421132|FG002|Randomized Period|Physician Decision|0|||
105660528|NCT03713320|364421130|FG000|Randomized Period|Withdrawal by Subject|4|||
105660529|NCT03713320|364421131|FG001|Randomized Period|Withdrawal by Subject|0|||
105660530|NCT03713320|364421132|FG002|Randomized Period|Withdrawal by Subject|0|||
105660531|NCT03713320|364421130|FG000|Randomized Period|Participant decision|3|||
105660532|NCT03713320|364421131|FG001|Randomized Period|Participant decision|1|||
105660533|NCT03713320|364421132|FG002|Randomized Period|Participant decision|0|||
105660534|NCT03713320|364421130|FG000|Randomized Period|Study terminated by sponsor|6|||
105660535|NCT03713320|364421131|FG001|Randomized Period|Study terminated by sponsor|3|||
105660536|NCT03713320|364421132|FG002|Randomized Period|Study terminated by sponsor|0|||
105660537|NCT03713320|364421130|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
105660538|NCT03713320|364421131|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
105660539|NCT03713320|364421132|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
105660540|NCT03713320|364421130|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
105660541|NCT03713320|364421131|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
105660542|NCT03713320|364421132|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
105660543|NCT00909532|364421134|FG000|Overall Study|Adverse Event|4|||
105660544|NCT00909532|364421135|FG001|Overall Study|Adverse Event|1|||
105660545|NCT00909532|364421134|FG000|Overall Study|Pregnancy|0|||
105660546|NCT00909532|364421135|FG001|Overall Study|Pregnancy|1|||
105660547|NCT00909532|364421134|FG000|Overall Study|Prohibited Medication|2|||
105660548|NCT00909532|364421135|FG001|Overall Study|Prohibited Medication|1|||
105660549|NCT00909532|364421134|FG000|Overall Study|Withdrawal of Consent|1|||
105660550|NCT00909532|364421135|FG001|Overall Study|Withdrawal of Consent|1|||
105660551|NCT00909532|364421134|FG000|Overall Study|Noncompliance with Study Requirements|0|||
105660552|NCT00909532|364421135|FG001|Overall Study|Noncompliance with Study Requirements|2|||
105660553|NCT00909532|364421134|FG000|Overall Study|Physician Decision|1|||
105660554|NCT00909532|364421135|FG001|Overall Study|Physician Decision|0|||
105660555|NCT00909532|364421134|FG000|Overall Study|Wrong Genotype|1|||
105660556|NCT00909532|364421135|FG001|Overall Study|Wrong Genotype|0|||
105660557|NCT00909532|364421134|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
105660558|NCT00909532|364421135|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
105660559|NCT02601209|364421137|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
105660560|NCT02601209|364421138|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
105660561|NCT02601209|364421139|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
105660562|NCT02601209|364421140|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660563|NCT02601209|364421141|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660564|NCT02601209|364421142|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660565|NCT02601209|364421143|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660566|NCT02601209|364421144|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660567|NCT02601209|364421145|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
105660568|NCT02601209|364421137|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660569|NCT02601209|364421138|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660570|NCT02601209|364421139|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660571|NCT02601209|364421140|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105770554|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105660572|NCT02601209|364421141|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
105660573|NCT02601209|364421142|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
105660574|NCT02601209|364421143|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
105660575|NCT02601209|364421144|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660576|NCT02601209|364421145|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
105660577|NCT00745498|364421146|FG000|Overall Study|Lost to Follow-up|1|||
105660578|NCT00745498|364421147|FG001|Overall Study|Lost to Follow-up|1|||
105660579|NCT00745498|364421148|FG002|Overall Study|Lost to Follow-up|3|||
105660580|NCT00745498|364421146|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
105660581|NCT00745498|364421147|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
105660582|NCT00745498|364421148|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
105660583|NCT00745498|364421146|FG000|Overall Study|Non-PDR related VH|0|||
105660584|NCT00745498|364421147|FG001|Overall Study|Non-PDR related VH|1|||
105660585|NCT00745498|364421148|FG002|Overall Study|Non-PDR related VH|1|||
105660586|NCT00745498|364421146|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
105660587|NCT00745498|364421147|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
105660588|NCT00745498|364421148|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
105660589|NCT00778921|364421149|FG000|Overall Study|Adverse Event|9|||
105660590|NCT00778921|364421150|FG001|Overall Study|Adverse Event|10|||
105660591|NCT00778921|364421151|FG002|Overall Study|Adverse Event|14|||
105660592|NCT00778921|364421149|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
105660593|NCT00778921|364421150|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
105660594|NCT00778921|364421151|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
105660595|NCT00778921|364421149|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
105660596|NCT00778921|364421150|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105660597|NCT00778921|364421151|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
105660598|NCT00778921|364421149|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
105660599|NCT00778921|364421150|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
105660600|NCT00778921|364421151|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
105660601|NCT00778921|364421149|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
105660602|NCT00778921|364421150|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
105660603|NCT00778921|364421151|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
105660604|NCT00778921|364421149|FG000|Overall Study|Patient withdrew request|3|||
105660605|NCT00778921|364421150|FG001|Overall Study|Patient withdrew request|1|||
105660606|NCT00778921|364421151|FG002|Overall Study|Patient withdrew request|6|||
105660607|NCT00778921|364421149|FG000|Overall Study|Lost to Follow-up|0|||
105660608|NCT00778921|364421150|FG001|Overall Study|Lost to Follow-up|2|||
105660609|NCT00778921|364421151|FG002|Overall Study|Lost to Follow-up|1|||
105660610|NCT00778921|364421149|FG000|Overall Study|Administrative Problems|1|||
105660611|NCT00778921|364421150|FG001|Overall Study|Administrative Problems|2|||
105660612|NCT00778921|364421151|FG002|Overall Study|Administrative Problems|0|||
105660613|NCT00778921|364421149|FG000|Overall Study|Protocol Violation|3|||
105660614|NCT00778921|364421150|FG001|Overall Study|Protocol Violation|0|||
105660615|NCT00778921|364421151|FG002|Overall Study|Protocol Violation|2|||
105660616|NCT00778921|364421149|FG000|Overall Study|Not treated|0|||
105660617|NCT00778921|364421150|FG001|Overall Study|Not treated|2|||
105660618|NCT00778921|364421151|FG002|Overall Study|Not treated|2|||
105660619|NCT03432390|364421164|FG000|Apnea Period|Protocol Violation|2|||
105660620|NCT03432390|364421165|FG001|Apnea Period|Protocol Violation|2|||
105660621|NCT02058836|364421168|FG000|Overall Study|Withdrawal by Subject|1|||
105660622|NCT02058836|364421169|FG001|Overall Study|Withdrawal by Subject|1|||
105660623|NCT01236352|364421170|FG000|Overall Study|Death|0|||
105660624|NCT01236352|364421171|FG001|Overall Study|Death|0|||
105660625|NCT01236352|364421172|FG002|Overall Study|Death|0|||
105660626|NCT01236352|364421173|FG003|Overall Study|Death|0|||
105660627|NCT01236352|364421174|FG004|Overall Study|Death|0|||
105660628|NCT01236352|364421175|FG005|Overall Study|Death|0|||
105660629|NCT01236352|364421176|FG006|Overall Study|Death|0|||
105660630|NCT01236352|364421177|FG007|Overall Study|Death|1|||
105660631|NCT01236352|364421178|FG008|Overall Study|Death|0|||
105660632|NCT01236352|364421179|FG009|Overall Study|Death|0|||
105660633|NCT01236352|364421180|FG010|Overall Study|Death|0|||
105660634|NCT01236352|364421170|FG000|Overall Study|Withdrawal by Subject|0|||
105660635|NCT01236352|364421171|FG001|Overall Study|Withdrawal by Subject|0|||
105660636|NCT01236352|364421172|FG002|Overall Study|Withdrawal by Subject|0|||
105660637|NCT01236352|364421173|FG003|Overall Study|Withdrawal by Subject|0|||
105660638|NCT01236352|364421174|FG004|Overall Study|Withdrawal by Subject|0|||
105660639|NCT01236352|364421175|FG005|Overall Study|Withdrawal by Subject|0|||
105660640|NCT01236352|364421176|FG006|Overall Study|Withdrawal by Subject|0|||
105660641|NCT01236352|364421177|FG007|Overall Study|Withdrawal by Subject|0|||
105660642|NCT01236352|364421178|FG008|Overall Study|Withdrawal by Subject|0|||
105660643|NCT01236352|364421179|FG009|Overall Study|Withdrawal by Subject|2|||
105660644|NCT01236352|364421180|FG010|Overall Study|Withdrawal by Subject|1|||
105660645|NCT01236352|364421170|FG000|Overall Study|Adverse Event|0|||
105660646|NCT01236352|364421171|FG001|Overall Study|Adverse Event|0|||
105660647|NCT01236352|364421172|FG002|Overall Study|Adverse Event|0|||
105660648|NCT01236352|364421173|FG003|Overall Study|Adverse Event|0|||
105660649|NCT01236352|364421174|FG004|Overall Study|Adverse Event|0|||
105660650|NCT01236352|364421175|FG005|Overall Study|Adverse Event|0|||
105660651|NCT01236352|364421176|FG006|Overall Study|Adverse Event|2|||
105660652|NCT01236352|364421177|FG007|Overall Study|Adverse Event|0|||
105660653|NCT01236352|364421178|FG008|Overall Study|Adverse Event|0|||
105660654|NCT01236352|364421179|FG009|Overall Study|Adverse Event|4|||
105660655|NCT01236352|364421180|FG010|Overall Study|Adverse Event|1|||
105660656|NCT01236352|364421170|FG000|Overall Study|Study drug toxicity|0|||
105660657|NCT01236352|364421171|FG001|Overall Study|Study drug toxicity|0|||
105660658|NCT01236352|364421172|FG002|Overall Study|Study drug toxicity|0|||
105660659|NCT01236352|364421173|FG003|Overall Study|Study drug toxicity|0|||
105660660|NCT01236352|364421174|FG004|Overall Study|Study drug toxicity|0|||
105660661|NCT01236352|364421175|FG005|Overall Study|Study drug toxicity|1|||
105660662|NCT01236352|364421176|FG006|Overall Study|Study drug toxicity|1|||
105660663|NCT01236352|364421177|FG007|Overall Study|Study drug toxicity|0|||
105660664|NCT01236352|364421178|FG008|Overall Study|Study drug toxicity|0|||
105660665|NCT01236352|364421179|FG009|Overall Study|Study drug toxicity|2|||
105660666|NCT01236352|364421180|FG010|Overall Study|Study drug toxicity|2|||
105660667|NCT01236352|364421170|FG000|Overall Study|Disease progression|1|||
105660668|NCT01236352|364421171|FG001|Overall Study|Disease progression|2|||
105660669|NCT01236352|364421172|FG002|Overall Study|Disease progression|1|||
105660670|NCT01236352|364421173|FG003|Overall Study|Disease progression|2|||
105660671|NCT01236352|364421174|FG004|Overall Study|Disease progression|2|||
105660672|NCT01236352|364421175|FG005|Overall Study|Disease progression|2|||
105660673|NCT01236352|364421176|FG006|Overall Study|Disease progression|1|||
105660674|NCT01236352|364421177|FG007|Overall Study|Disease progression|3|||
105660675|NCT01236352|364421178|FG008|Overall Study|Disease progression|2|||
105660676|NCT01236352|364421179|FG009|Overall Study|Disease progression|2|||
105660677|NCT01236352|364421180|FG010|Overall Study|Disease progression|2|||
105660678|NCT01236352|364421170|FG000|Overall Study|Poor/Non-compliance|1|||
105660679|NCT01236352|364421171|FG001|Overall Study|Poor/Non-compliance|0|||
105660680|NCT01236352|364421172|FG002|Overall Study|Poor/Non-compliance|0|||
105660681|NCT01236352|364421173|FG003|Overall Study|Poor/Non-compliance|0|||
105660682|NCT01236352|364421174|FG004|Overall Study|Poor/Non-compliance|0|||
105660683|NCT01236352|364421175|FG005|Overall Study|Poor/Non-compliance|0|||
105660684|NCT01236352|364421176|FG006|Overall Study|Poor/Non-compliance|0|||
105660685|NCT01236352|364421177|FG007|Overall Study|Poor/Non-compliance|0|||
105660686|NCT01236352|364421178|FG008|Overall Study|Poor/Non-compliance|0|||
105660687|NCT01236352|364421179|FG009|Overall Study|Poor/Non-compliance|0|||
105660688|NCT01236352|364421180|FG010|Overall Study|Poor/Non-compliance|0|||
105660689|NCT01236352|364421170|FG000|Overall Study|Maximum clinical benefit|1|||
105660690|NCT01236352|364421171|FG001|Overall Study|Maximum clinical benefit|1|||
105660691|NCT01236352|364421172|FG002|Overall Study|Maximum clinical benefit|1|||
105660692|NCT01236352|364421173|FG003|Overall Study|Maximum clinical benefit|0|||
105660693|NCT01236352|364421174|FG004|Overall Study|Maximum clinical benefit|2|||
105660694|NCT01236352|364421175|FG005|Overall Study|Maximum clinical benefit|0|||
105660695|NCT01236352|364421176|FG006|Overall Study|Maximum clinical benefit|3|||
105660696|NCT01236352|364421177|FG007|Overall Study|Maximum clinical benefit|1|||
105660697|NCT01236352|364421178|FG008|Overall Study|Maximum clinical benefit|1|||
105660698|NCT01236352|364421179|FG009|Overall Study|Maximum clinical benefit|4|||
105660699|NCT01236352|364421180|FG010|Overall Study|Maximum clinical benefit|2|||
105660700|NCT01236352|364421170|FG000|Overall Study|Subject request to discontinue treatment|0|||
105660701|NCT01236352|364421171|FG001|Overall Study|Subject request to discontinue treatment|0|||
105660702|NCT01236352|364421172|FG002|Overall Study|Subject request to discontinue treatment|1|||
105660703|NCT01236352|364421173|FG003|Overall Study|Subject request to discontinue treatment|1|||
105660704|NCT01236352|364421174|FG004|Overall Study|Subject request to discontinue treatment|0|||
105660705|NCT01236352|364421175|FG005|Overall Study|Subject request to discontinue treatment|1|||
105660706|NCT01236352|364421176|FG006|Overall Study|Subject request to discontinue treatment|0|||
105660707|NCT01236352|364421177|FG007|Overall Study|Subject request to discontinue treatment|0|||
105660708|NCT01236352|364421178|FG008|Overall Study|Subject request to discontinue treatment|0|||
105660709|NCT01236352|364421179|FG009|Overall Study|Subject request to discontinue treatment|1|||
105660710|NCT01236352|364421180|FG010|Overall Study|Subject request to discontinue treatment|4|||
105660711|NCT01236352|364421170|FG000|Overall Study|Subject to receive drug via EAP|1|||
105660712|NCT01236352|364421171|FG001|Overall Study|Subject to receive drug via EAP|1|||
105660713|NCT01236352|364421172|FG002|Overall Study|Subject to receive drug via EAP|1|||
105660714|NCT01236352|364421173|FG003|Overall Study|Subject to receive drug via EAP|0|||
105660715|NCT01236352|364421174|FG004|Overall Study|Subject to receive drug via EAP|0|||
105660716|NCT01236352|364421175|FG005|Overall Study|Subject to receive drug via EAP|0|||
105660717|NCT01236352|364421176|FG006|Overall Study|Subject to receive drug via EAP|0|||
105660718|NCT01236352|364421177|FG007|Overall Study|Subject to receive drug via EAP|2|||
105660719|NCT01236352|364421178|FG008|Overall Study|Subject to receive drug via EAP|0|||
105660720|NCT01236352|364421179|FG009|Overall Study|Subject to receive drug via EAP|4|||
105660721|NCT01236352|364421180|FG010|Overall Study|Subject to receive drug via EAP|0|||
105660722|NCT01236352|364421170|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
105660723|NCT01236352|364421171|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
105660724|NCT01236352|364421172|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
105660725|NCT01236352|364421173|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
105660726|NCT01236352|364421174|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
105660727|NCT01236352|364421175|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
105660728|NCT01236352|364421176|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
105660729|NCT01236352|364421177|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
105660730|NCT01236352|364421178|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
105660731|NCT01236352|364421179|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
105660732|NCT01236352|364421180|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
105660733|NCT01236352|364421170|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660734|NCT01236352|364421171|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660735|NCT01236352|364421172|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660736|NCT01236352|364421173|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660737|NCT01236352|364421174|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660738|NCT01236352|364421175|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660739|NCT01236352|364421176|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660740|NCT01236352|364421177|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660741|NCT01236352|364421178|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660742|NCT01236352|364421179|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
105660743|NCT01236352|364421180|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
105660744|NCT01236352|364421170|FG000|Overall Study|Lack of response to drug|0|||
105660745|NCT01236352|364421171|FG001|Overall Study|Lack of response to drug|0|||
105660746|NCT01236352|364421172|FG002|Overall Study|Lack of response to drug|0|||
105660747|NCT01236352|364421173|FG003|Overall Study|Lack of response to drug|0|||
105660748|NCT01236352|364421174|FG004|Overall Study|Lack of response to drug|0|||
105660749|NCT01236352|364421175|FG005|Overall Study|Lack of response to drug|0|||
105660750|NCT01236352|364421176|FG006|Overall Study|Lack of response to drug|0|||
105660751|NCT01236352|364421177|FG007|Overall Study|Lack of response to drug|0|||
105660752|NCT01236352|364421178|FG008|Overall Study|Lack of response to drug|0|||
105660753|NCT01236352|364421179|FG009|Overall Study|Lack of response to drug|1|||
105660754|NCT01236352|364421180|FG010|Overall Study|Lack of response to drug|1|||
105660755|NCT01236352|364421170|FG000|Overall Study|Patient transferred to IST|0|||
105660756|NCT01236352|364421171|FG001|Overall Study|Patient transferred to IST|0|||
105660757|NCT01236352|364421172|FG002|Overall Study|Patient transferred to IST|0|||
105660758|NCT01236352|364421173|FG003|Overall Study|Patient transferred to IST|0|||
105660759|NCT01236352|364421174|FG004|Overall Study|Patient transferred to IST|0|||
105660760|NCT01236352|364421175|FG005|Overall Study|Patient transferred to IST|0|||
105660761|NCT01236352|364421176|FG006|Overall Study|Patient transferred to IST|0|||
105660762|NCT01236352|364421177|FG007|Overall Study|Patient transferred to IST|0|||
105660763|NCT01236352|364421178|FG008|Overall Study|Patient transferred to IST|0|||
105660764|NCT01236352|364421179|FG009|Overall Study|Patient transferred to IST|2|||
105660765|NCT01236352|364421180|FG010|Overall Study|Patient transferred to IST|6|||
105660766|NCT02688530|364421181|FG000|Overall Study|Withdrawal by Subject|0|||
105660767|NCT02688530|364421182|FG001|Overall Study|Withdrawal by Subject|1|||
105660768|NCT02688530|364421183|FG002|Overall Study|Withdrawal by Subject|0|||
105660769|NCT02688530|364421184|FG003|Overall Study|Withdrawal by Subject|0|||
105660770|NCT02688530|364421181|FG000|Overall Study|Lost to Follow-up|0|||
105660771|NCT02688530|364421182|FG001|Overall Study|Lost to Follow-up|0|||
105660772|NCT02688530|364421183|FG002|Overall Study|Lost to Follow-up|2|||
105660773|NCT02688530|364421184|FG003|Overall Study|Lost to Follow-up|0|||
105660774|NCT01658020|364421185|FG000|Overall Study|Adverse Event|3|||
105660775|NCT01658020|364421186|FG001|Overall Study|Adverse Event|3|||
105660776|NCT01658020|364421185|FG000|Overall Study|Lost to Follow-up|1|||
105660777|NCT01658020|364421186|FG001|Overall Study|Lost to Follow-up|0|||
105660778|NCT01658020|364421185|FG000|Overall Study|Withdrawal by Subject|4|||
105660779|NCT01658020|364421186|FG001|Overall Study|Withdrawal by Subject|5|||
105660780|NCT01658020|364421185|FG000|Overall Study|Protocol Violation|0|||
105660781|NCT01658020|364421186|FG001|Overall Study|Protocol Violation|1|||
105660782|NCT00725543|364421187|FG000|Overall Study|Adverse Event|10|||
105660783|NCT00725543|364421187|FG000|Overall Study|Lack of Efficacy|3|||
105660784|NCT00725543|364421187|FG000|Overall Study|Withdrawal by Subject|10|||
105660785|NCT00725543|364421187|FG000|Overall Study|Physician Decision|5|||
105660786|NCT00725543|364421187|FG000|Overall Study|Lost to Follow-up|4|||
105660787|NCT00725543|364421187|FG000|Overall Study|Non-compliance|2|||
105660788|NCT00725543|364421187|FG000|Overall Study|Other|119|||
105660789|NCT01530087|364421188|FG000|Overall Study|Physician Decision|2|||
105660790|NCT05992922|364421189|FG000|Overall Study|Adverse Event|6|||
105660791|NCT05992922|364421190|FG001|Overall Study|Adverse Event|0|||
105660792|NCT05992922|364421189|FG000|Overall Study|Sponsor Termination of Study|14|||
105660793|NCT05992922|364421190|FG001|Overall Study|Sponsor Termination of Study|20|||
105660794|NCT02034162|364423150|FG000|Double-blind|Lost to Follow-up|3|||
105660795|NCT02034162|364423151|FG001|Double-blind|Lost to Follow-up|0|||
105660796|NCT02034162|364423152|FG002|Double-blind|Lost to Follow-up|0|||
105660797|NCT02034162|364423150|FG000|Double-blind|Physician Decision|1|||
105660798|NCT02034162|364423151|FG001|Double-blind|Physician Decision|0|||
105660799|NCT02034162|364423152|FG002|Double-blind|Physician Decision|0|||
105660800|NCT02034162|364423150|FG000|Double-blind|Protocol Violation|0|||
105660801|NCT02034162|364423151|FG001|Double-blind|Protocol Violation|1|||
105660802|NCT02034162|364423152|FG002|Double-blind|Protocol Violation|0|||
105660803|NCT02034162|364423150|FG000|Double-blind|Withdrawal by Subject|5|||
105660804|NCT02034162|364423151|FG001|Double-blind|Withdrawal by Subject|7|||
105660805|NCT02034162|364423152|FG002|Double-blind|Withdrawal by Subject|0|||
105660806|NCT03305809|364423155|FG000|Overall Study|Adverse Event|2|||
105660807|NCT03305809|364423156|FG001|Overall Study|Adverse Event|2|||
105660808|NCT03305809|364423157|FG002|Overall Study|Adverse Event|6|||
105660809|NCT03305809|364423158|FG003|Overall Study|Adverse Event|6|||
105660810|NCT03305809|364423155|FG000|Overall Study|Death|0|||
105660811|NCT03305809|364423156|FG001|Overall Study|Death|0|||
105660812|NCT03305809|364423157|FG002|Overall Study|Death|1|||
105660813|NCT03305809|364423158|FG003|Overall Study|Death|1|||
105660814|NCT03305809|364423155|FG000|Overall Study|Lost to Follow-up|1|||
105660815|NCT03305809|364423156|FG001|Overall Study|Lost to Follow-up|2|||
105660816|NCT03305809|364423157|FG002|Overall Study|Lost to Follow-up|0|||
105660817|NCT03305809|364423158|FG003|Overall Study|Lost to Follow-up|0|||
105660818|NCT03305809|364423155|FG000|Overall Study|Sponsor Decision|1|||
105660819|NCT03305809|364423156|FG001|Overall Study|Sponsor Decision|0|||
105660820|NCT03305809|364423157|FG002|Overall Study|Sponsor Decision|1|||
105660821|NCT03305809|364423158|FG003|Overall Study|Sponsor Decision|8|||
105660822|NCT03305809|364423155|FG000|Overall Study|Physician Decision|0|||
105660823|NCT03305809|364423156|FG001|Overall Study|Physician Decision|0|||
105660824|NCT03305809|364423157|FG002|Overall Study|Physician Decision|2|||
105660825|NCT03305809|364423158|FG003|Overall Study|Physician Decision|4|||
105660826|NCT03305809|364423155|FG000|Overall Study|Progressive Disease|0|||
105660827|NCT03305809|364423156|FG001|Overall Study|Progressive Disease|0|||
105660828|NCT03305809|364423157|FG002|Overall Study|Progressive Disease|1|||
105660829|NCT03305809|364423158|FG003|Overall Study|Progressive Disease|0|||
105660830|NCT03305809|364423155|FG000|Overall Study|Protocol Violation|1|||
105660831|NCT03305809|364423156|FG001|Overall Study|Protocol Violation|0|||
105660832|NCT03305809|364423157|FG002|Overall Study|Protocol Violation|2|||
105660833|NCT03305809|364423158|FG003|Overall Study|Protocol Violation|3|||
105660834|NCT03305809|364423155|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
105660835|NCT03305809|364423156|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
105660836|NCT03305809|364423157|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
105660837|NCT03305809|364423158|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
105660838|NCT03305809|364423155|FG000|Overall Study|Withdrawal by Subject|2|||
105660839|NCT03305809|364423156|FG001|Overall Study|Withdrawal by Subject|4|||
105660840|NCT03305809|364423157|FG002|Overall Study|Withdrawal by Subject|5|||
105660841|NCT03305809|364423158|FG003|Overall Study|Withdrawal by Subject|2|||
105660842|NCT03305809|364423155|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
105660843|NCT03305809|364423156|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
105660844|NCT03305809|364423157|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
105660845|NCT03305809|364423158|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
105660846|NCT01161446|364423159|FG000|Overall Study|Lost to Follow-up|18|||
105660847|NCT01161446|364423160|FG001|Overall Study|Lost to Follow-up|14|||
105660848|NCT01161446|364423159|FG000|Overall Study|Withdrawal by Subject|0|||
105660849|NCT01161446|364423160|FG001|Overall Study|Withdrawal by Subject|1|||
105660850|NCT00810342|364423163|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
105660851|NCT00810342|364423164|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
105660852|NCT00810342|364423163|FG000|Month 1 Follow-up|Pregnancy|1|||
105660853|NCT00810342|364423164|FG001|Month 1 Follow-up|Pregnancy|0|||
105660854|NCT00810342|364423163|FG000|6-month Follow-up|Lost to Follow-up|18|||
105660855|NCT00810342|364423164|FG001|6-month Follow-up|Lost to Follow-up|6|||
105660856|NCT00810342|364423163|FG000|6-month Follow-up|Pregnancy|6|||
105660857|NCT00810342|364423164|FG001|6-month Follow-up|Pregnancy|2|||
105660858|NCT00810342|364423163|FG000|12-month Followup|Pregnancy|9|||
105660859|NCT00810342|364423164|FG001|12-month Followup|Pregnancy|10|||
105660860|NCT00810342|364423163|FG000|12-month Followup|Lost to Follow-up|3|||
105660861|NCT00810342|364423164|FG001|12-month Followup|Lost to Follow-up|1|||
105660862|NCT04486313|364423165|FG000|Overall Study|Lost to Follow-up|7|||
105660863|NCT04486313|364423166|FG001|Overall Study|Lost to Follow-up|9|||
105660864|NCT04486313|364423165|FG000|Overall Study|Withdrawal by Subject|8|||
105660865|NCT04486313|364423166|FG001|Overall Study|Withdrawal by Subject|6|||
105660866|NCT04486313|364423165|FG000|Overall Study|Physician Decision|1|||
105660867|NCT04486313|364423166|FG001|Overall Study|Physician Decision|1|||
105660868|NCT04486313|364423165|FG000|Overall Study|Death|2|||
105660869|NCT04486313|364423166|FG001|Overall Study|Death|0|||
105660870|NCT04486313|364423165|FG000|Overall Study|Protocol Violation|1|||
105660871|NCT04486313|364423166|FG001|Overall Study|Protocol Violation|1|||
105660872|NCT04629443|364423167|FG000|Overall Study|Adverse Event|2|||
105660873|NCT04629443|364423168|FG001|Overall Study|Adverse Event|1|||
105660874|NCT04629443|364423169|FG002|Overall Study|Adverse Event|2|||
105660875|NCT04629443|364423167|FG000|Overall Study|Progressive Disease|2|||
105660876|NCT04629443|364423168|FG001|Overall Study|Progressive Disease|3|||
105660877|NCT04629443|364423169|FG002|Overall Study|Progressive Disease|3|||
105660878|NCT04629443|364423167|FG000|Overall Study|Physician Decision|1|||
105660879|NCT04629443|364423168|FG001|Overall Study|Physician Decision|3|||
105660880|NCT04629443|364423169|FG002|Overall Study|Physician Decision|0|||
105660881|NCT01657799|364423170|FG000|Overall Study|Adverse Event Related to progression|6|||
105660882|NCT01657799|364423171|FG001|Overall Study|Adverse Event Related to progression|8|||
105660883|NCT01657799|364423172|FG002|Overall Study|Adverse Event Related to progression|12|||
105660884|NCT01657799|364423170|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
105660885|NCT01657799|364423171|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
105660886|NCT01657799|364423172|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
105660887|NCT01657799|364423170|FG000|Overall Study|Withdrawal by Subject|13|||
105660888|NCT01657799|364423171|FG001|Overall Study|Withdrawal by Subject|10|||
105660889|NCT01657799|364423172|FG002|Overall Study|Withdrawal by Subject|10|||
105660890|NCT01657799|364423170|FG000|Overall Study|Lost to Follow-up|1|||
105660891|NCT01657799|364423171|FG001|Overall Study|Lost to Follow-up|0|||
105660892|NCT01657799|364423172|FG002|Overall Study|Lost to Follow-up|1|||
105660893|NCT01657799|364423170|FG000|Overall Study|Disease Progression|2|||
105660894|NCT01657799|364423171|FG001|Overall Study|Disease Progression|4|||
105660895|NCT01657799|364423172|FG002|Overall Study|Disease Progression|4|||
105660896|NCT01657799|364423170|FG000|Overall Study|Progressive Disease Clinical|7|||
105660897|NCT01657799|364423171|FG001|Overall Study|Progressive Disease Clinical|4|||
105660898|NCT01657799|364423172|FG002|Overall Study|Progressive Disease Clinical|7|||
105660899|NCT01657799|364423170|FG000|Overall Study|Radiographic & Clinical Progression|16|||
105660900|NCT01657799|364423171|FG001|Overall Study|Radiographic & Clinical Progression|11|||
105660901|NCT01657799|364423172|FG002|Overall Study|Radiographic & Clinical Progression|15|||
105660902|NCT01657799|364423170|FG000|Overall Study|Other|52|||
105660903|NCT01657799|364423171|FG001|Overall Study|Other|62|||
105660904|NCT01657799|364423172|FG002|Overall Study|Other|49|||
105660905|NCT01015677|364423181|FG000|Overall Study|Adverse Event|0|||
105660906|NCT01015677|364423182|FG001|Overall Study|Adverse Event|1|||
105660907|NCT01015677|364423183|FG002|Overall Study|Adverse Event|0|||
105660908|NCT01015677|364423181|FG000|Overall Study|Lack of Efficacy|0|||
105660909|NCT01015677|364423182|FG001|Overall Study|Lack of Efficacy|1|||
105660910|NCT01015677|364423183|FG002|Overall Study|Lack of Efficacy|0|||
105660911|NCT01015677|364423181|FG000|Overall Study|Protocol Violation|0|||
105660912|NCT01015677|364423182|FG001|Overall Study|Protocol Violation|1|||
105660913|NCT01015677|364423183|FG002|Overall Study|Protocol Violation|0|||
105660914|NCT01015677|364423181|FG000|Overall Study|Withdrawal by Subject|1|||
105660915|NCT01015677|364423182|FG001|Overall Study|Withdrawal by Subject|1|||
105660916|NCT01015677|364423183|FG002|Overall Study|Withdrawal by Subject|0|||
105660917|NCT02232399|364423184|FG000|Overall Study|Adverse Event|1|||
105660918|NCT02232399|364423185|FG001|Overall Study|Adverse Event|0|||
105660919|NCT02232399|364423184|FG000|Overall Study|Withdrawal by Subject|0|||
105660920|NCT02232399|364423185|FG001|Overall Study|Withdrawal by Subject|1|||
105660921|NCT00236184|364423186|FG000|Overall Study|Adverse Event|5|||
105660922|NCT00236184|364423187|FG001|Overall Study|Adverse Event|2|||
105660923|NCT00236184|364423186|FG000|Overall Study|Lack of Efficacy|0|||
105660924|NCT00236184|364423187|FG001|Overall Study|Lack of Efficacy|1|||
105660925|NCT00236184|364423186|FG000|Overall Study|Lost to Follow-up|3|||
105660926|NCT00236184|364423187|FG001|Overall Study|Lost to Follow-up|4|||
105660927|NCT00236184|364423186|FG000|Overall Study|Physician Decision|1|||
105660928|NCT00236184|364423187|FG001|Overall Study|Physician Decision|1|||
105660929|NCT00236184|364423186|FG000|Overall Study|Withdrawal by Subject|3|||
105660930|NCT00236184|364423187|FG001|Overall Study|Withdrawal by Subject|0|||
105660931|NCT00236184|364423186|FG000|Overall Study|Protocol Violation|3|||
105660932|NCT00236184|364423187|FG001|Overall Study|Protocol Violation|0|||
105660933|NCT00236184|364423186|FG000|Overall Study|non-compliance with study drug|2|||
105660934|NCT00236184|364423187|FG001|Overall Study|non-compliance with study drug|1|||
105660935|NCT00236184|364423186|FG000|Overall Study|other|1|||
105660936|NCT00236184|364423187|FG001|Overall Study|other|2|||
105660937|NCT02599688|364423188|FG000|Overall Study|Lack of Efficacy|1|||
105660938|NCT02599688|364423188|FG000|Overall Study|Withdrawal by Subject|1|||
105660939|NCT02599688|364423188|FG000|Overall Study|Termination by Sponsor|2|||
105660940|NCT03470545|364423189|FG000|Overall Study|Death|0|||
105660941|NCT03470545|364423190|FG001|Overall Study|Death|1|||
105660942|NCT03470545|364423189|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
105660943|NCT03470545|364423190|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
105660944|NCT03470545|364423189|FG000|Overall Study|Adverse Event|2|||
105660945|NCT03470545|364423190|FG001|Overall Study|Adverse Event|0|||
105660946|NCT03470545|364423189|FG000|Overall Study|Withdrawal by Subject|1|||
105660947|NCT03470545|364423190|FG001|Overall Study|Withdrawal by Subject|1|||
105660948|NCT03470545|364423189|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
105660949|NCT03470545|364423190|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
105660950|NCT01086384|364423195|FG000|2-week Run-in Period|Adverse Event|1|||
105660951|NCT01086384|364423196|FG001|2-week Run-in Period|Adverse Event|0|||
105660952|NCT01086384|364423197|FG002|2-week Run-in Period|Adverse Event|0|||
105660953|NCT01086384|364423195|FG000|2-week Run-in Period|Protocol Violation|1|||
105660954|NCT01086384|364423196|FG001|2-week Run-in Period|Protocol Violation|0|||
105660955|NCT01086384|364423197|FG002|2-week Run-in Period|Protocol Violation|0|||
105660956|NCT01086384|364423195|FG000|2-week Run-in Period|Lost to Follow-up|1|||
105660957|NCT01086384|364423196|FG001|2-week Run-in Period|Lost to Follow-up|0|||
105660958|NCT01086384|364423197|FG002|2-week Run-in Period|Lost to Follow-up|0|||
105660959|NCT01086384|364423195|FG000|2-week Run-in Period|Physician Decision|6|||
105660960|NCT01086384|364423196|FG001|2-week Run-in Period|Physician Decision|0|||
105660961|NCT01086384|364423197|FG002|2-week Run-in Period|Physician Decision|0|||
105660962|NCT01086384|364423195|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
105660963|NCT01086384|364423196|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105660964|NCT01086384|364423197|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105660965|NCT01086384|364423195|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
105660966|NCT01086384|364423196|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
105660967|NCT01086384|364423197|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
105660968|NCT01086384|364423195|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
105660969|NCT01086384|364423196|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
105660970|NCT01086384|364423197|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
105660971|NCT01086384|364423195|FG000|2-week Run-in Period|Randomized in Error|1|||
105660972|NCT01086384|364423196|FG001|2-week Run-in Period|Randomized in Error|0|||
105660973|NCT01086384|364423197|FG002|2-week Run-in Period|Randomized in Error|0|||
105660974|NCT01086384|364423195|FG000|Treatment Period|Withdrawal by Subject|0|||
105660975|NCT01086384|364423196|FG001|Treatment Period|Withdrawal by Subject|53|||
105660976|NCT01086384|364423197|FG002|Treatment Period|Withdrawal by Subject|55|||
105660977|NCT01086384|364423195|FG000|Treatment Period|Protocol Violation|0|||
105660978|NCT01086384|364423196|FG001|Treatment Period|Protocol Violation|26|||
105660979|NCT01086384|364423197|FG002|Treatment Period|Protocol Violation|17|||
105660980|NCT01086384|364423195|FG000|Treatment Period|Lack of Efficacy|0|||
105660981|NCT01086384|364423196|FG001|Treatment Period|Lack of Efficacy|22|||
105660982|NCT01086384|364423197|FG002|Treatment Period|Lack of Efficacy|13|||
105660983|NCT01086384|364423195|FG000|Treatment Period|Adverse Event|0|||
105660984|NCT01086384|364423196|FG001|Treatment Period|Adverse Event|19|||
105660985|NCT01086384|364423197|FG002|Treatment Period|Adverse Event|15|||
105660986|NCT01086384|364423195|FG000|Treatment Period|Lost to Follow-up|0|||
105660987|NCT01086384|364423196|FG001|Treatment Period|Lost to Follow-up|11|||
105660988|NCT01086384|364423197|FG002|Treatment Period|Lost to Follow-up|9|||
105660989|NCT01086384|364423195|FG000|Treatment Period|Physician Decision|0|||
105660990|NCT01086384|364423196|FG001|Treatment Period|Physician Decision|9|||
105660991|NCT01086384|364423197|FG002|Treatment Period|Physician Decision|6|||
105660992|NCT01086384|364423195|FG000|Treatment Period|Study Closed/Terminated|0|||
105660993|NCT01086384|364423196|FG001|Treatment Period|Study Closed/Terminated|7|||
105660994|NCT01086384|364423197|FG002|Treatment Period|Study Closed/Terminated|8|||
105660995|NCT01086384|364423195|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
105660996|NCT01086384|364423196|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
105660997|NCT01086384|364423197|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
105660998|NCT01086384|364423195|FG000|Treatment Period|Received Treatment in Error|0|||
105660999|NCT01086384|364423196|FG001|Treatment Period|Received Treatment in Error|1|||
105661000|NCT01086384|364423197|FG002|Treatment Period|Received Treatment in Error|0|||
105661001|NCT00952848|364423204|FG000|Overall Study|Withdrawal by Subject|4|||
105661002|NCT02250534|364423205|FG000|Overall Study|Lost to Follow-up|18|||
105661003|NCT02250534|364423206|FG001|Overall Study|Lost to Follow-up|28|||
105661004|NCT02250534|364423207|FG002|Overall Study|Lost to Follow-up|33|||
105661005|NCT02250534|364423205|FG000|Overall Study|Personal reasons|7|||
105661006|NCT02250534|364423206|FG001|Overall Study|Personal reasons|8|||
105661007|NCT02250534|364423207|FG002|Overall Study|Personal reasons|14|||
105661008|NCT02250534|364423205|FG000|Overall Study|Adverse Event|6|||
105661009|NCT02250534|364423206|FG001|Overall Study|Adverse Event|3|||
105661010|NCT02250534|364423207|FG002|Overall Study|Adverse Event|8|||
105661011|NCT02250534|364423205|FG000|Overall Study|incarcerated|2|||
105661012|NCT02250534|364423206|FG001|Overall Study|incarcerated|1|||
105661013|NCT02250534|364423207|FG002|Overall Study|incarcerated|2|||
105661014|NCT02250534|364423205|FG000|Overall Study|Withdrawal by Subject|0|||
105661015|NCT02250534|364423206|FG001|Overall Study|Withdrawal by Subject|1|||
105661016|NCT02250534|364423207|FG002|Overall Study|Withdrawal by Subject|2|||
105661017|NCT02250534|364423205|FG000|Overall Study|Death|0|||
105661018|NCT02250534|364423206|FG001|Overall Study|Death|1|||
105661019|NCT02250534|364423207|FG002|Overall Study|Death|1|||
105661020|NCT02250534|364423205|FG000|Overall Study|Physician Decision|1|||
105661021|NCT02250534|364423206|FG001|Overall Study|Physician Decision|3|||
105661022|NCT02250534|364423207|FG002|Overall Study|Physician Decision|1|||
105661023|NCT02250534|364423205|FG000|Overall Study|Protocol Violation|1|||
105661024|NCT02250534|364423206|FG001|Overall Study|Protocol Violation|0|||
105661025|NCT02250534|364423207|FG002|Overall Study|Protocol Violation|1|||
105661026|NCT02250534|364423205|FG000|Overall Study|Reason unknown|1|||
105661027|NCT02250534|364423206|FG001|Overall Study|Reason unknown|0|||
105661028|NCT02250534|364423207|FG002|Overall Study|Reason unknown|0|||
105661029|NCT00458393|364423208|FG000|Overall Study|Withdrawal by Subject|67|||
105661030|NCT00458393|364423209|FG001|Overall Study|Withdrawal by Subject|80|||
105661031|NCT00458393|364423208|FG000|Overall Study|Physician Decision|31|||
105661032|NCT00458393|364423209|FG001|Overall Study|Physician Decision|22|||
105661033|NCT00458393|364423208|FG000|Overall Study|Relocated|77|||
105661034|NCT00458393|364423209|FG001|Overall Study|Relocated|81|||
105661035|NCT00458393|364423208|FG000|Overall Study|Lost to Follow-up|115|||
105661036|NCT00458393|364423209|FG001|Overall Study|Lost to Follow-up|92|||
105661037|NCT00458393|364423208|FG000|Overall Study|Sites marked other on the form.|19|||
105661038|NCT00458393|364423209|FG001|Overall Study|Sites marked other on the form.|20|||
105661039|NCT01628692|364423210|FG000|Overall Study|Lack of Efficacy|4|||
105661040|NCT01628692|364423211|FG001|Overall Study|Lack of Efficacy|4|||
105661041|NCT01628692|364423212|FG002|Overall Study|Lack of Efficacy|5|||
105661042|NCT01628692|364423213|FG003|Overall Study|Lack of Efficacy|1|||
105661043|NCT01628692|364423214|FG004|Overall Study|Lack of Efficacy|4|||
105661044|NCT01628692|364423215|FG005|Overall Study|Lack of Efficacy|7|||
105661045|NCT01628692|364423210|FG000|Overall Study|Adverse Event|2|||
105661046|NCT01628692|364423211|FG001|Overall Study|Adverse Event|0|||
105661047|NCT01628692|364423212|FG002|Overall Study|Adverse Event|2|||
105661048|NCT01628692|364423213|FG003|Overall Study|Adverse Event|0|||
105661049|NCT01628692|364423214|FG004|Overall Study|Adverse Event|0|||
105661050|NCT01628692|364423215|FG005|Overall Study|Adverse Event|0|||
105661051|NCT01628692|364423210|FG000|Overall Study|Withdrawal by Subject|0|||
105661052|NCT01628692|364423211|FG001|Overall Study|Withdrawal by Subject|1|||
105661053|NCT01628692|364423212|FG002|Overall Study|Withdrawal by Subject|1|||
105661054|NCT01628692|364423213|FG003|Overall Study|Withdrawal by Subject|0|||
105661055|NCT01628692|364423214|FG004|Overall Study|Withdrawal by Subject|0|||
105661056|NCT01628692|364423215|FG005|Overall Study|Withdrawal by Subject|0|||
105661057|NCT01628692|364423210|FG000|Overall Study|Death|0|||
105661058|NCT01628692|364423211|FG001|Overall Study|Death|1|||
105661059|NCT01628692|364423212|FG002|Overall Study|Death|0|||
105661060|NCT01628692|364423213|FG003|Overall Study|Death|0|||
105661061|NCT01628692|364423214|FG004|Overall Study|Death|0|||
105661062|NCT01628692|364423215|FG005|Overall Study|Death|0|||
105661063|NCT01628692|364423210|FG000|Overall Study|Poor compliance/noncompliance|1|||
105661064|NCT01628692|364423211|FG001|Overall Study|Poor compliance/noncompliance|0|||
105661065|NCT01628692|364423212|FG002|Overall Study|Poor compliance/noncompliance|0|||
105661066|NCT01628692|364423213|FG003|Overall Study|Poor compliance/noncompliance|0|||
105661067|NCT01628692|364423214|FG004|Overall Study|Poor compliance/noncompliance|0|||
105661068|NCT01628692|364423215|FG005|Overall Study|Poor compliance/noncompliance|0|||
105661069|NCT01628692|364423210|FG000|Overall Study|Administrative reason by sponsor|0|||
105661070|NCT01628692|364423211|FG001|Overall Study|Administrative reason by sponsor|0|||
105661071|NCT01628692|364423212|FG002|Overall Study|Administrative reason by sponsor|0|||
105661072|NCT01628692|364423213|FG003|Overall Study|Administrative reason by sponsor|0|||
105661073|NCT01628692|364423214|FG004|Overall Study|Administrative reason by sponsor|0|||
105661074|NCT01628692|364423215|FG005|Overall Study|Administrative reason by sponsor|1|||
105661075|NCT01628692|364423210|FG000|Overall Study|Completed 12 Week only|0|||
105661076|NCT01628692|364423211|FG001|Overall Study|Completed 12 Week only|0|||
105661077|NCT01628692|364423212|FG002|Overall Study|Completed 12 Week only|0|||
105661078|NCT01628692|364423213|FG003|Overall Study|Completed 12 Week only|0|||
105661079|NCT01628692|364423214|FG004|Overall Study|Completed 12 Week only|0|||
105661080|NCT01628692|364423215|FG005|Overall Study|Completed 12 Week only|1|||
105661081|NCT02413593|364423216|FG000|Overall Study|Lost to Follow-up|3|||
105661082|NCT02413593|364423216|FG000|Overall Study|Adverse Event|1|||
105661083|NCT01101061|364423217|FG000|Overall Study|Adverse Event|0|||
105661084|NCT01101061|364423218|FG001|Overall Study|Adverse Event|0|||
105661085|NCT01101061|364423219|FG002|Overall Study|Adverse Event|1|||
105661086|NCT01101061|364423220|FG003|Overall Study|Adverse Event|0|||
105661087|NCT01101061|364423221|FG004|Overall Study|Adverse Event|0|||
105661088|NCT01101061|364423222|FG005|Overall Study|Adverse Event|0|||
105661089|NCT00857233|364423223|FG000|Overall Study|Adverse Event|24|||
105661090|NCT00857233|364423223|FG000|Overall Study|Lack of Efficacy|1|||
105661091|NCT00857233|364423223|FG000|Overall Study|Non-compliance|1|||
105661092|NCT00857233|364423223|FG000|Overall Study|Withdrawal of Consent|9|||
105661093|NCT00857233|364423223|FG000|Overall Study|Lost to Follow-up|4|||
105661094|NCT00857233|364423223|FG000|Overall Study|Nursing Home Placement|14|||
105661095|NCT00857233|364423223|FG000|Overall Study|Other Reasons|2|||
105661096|NCT05043883|364423224|FG000|Overall Study|Minimum required measurements could not be taken|4|||
105661097|NCT01587118|364423225|FG000|Overall Study|Adverse Event|3|||
105661098|NCT01587118|364423225|FG000|Overall Study|Lost to Follow-up|2|||
105661099|NCT01587118|364423225|FG000|Overall Study|Relocation|1|||
105661100|NCT01587118|364423225|FG000|Overall Study|nonresponse|1|||
105661101|NCT00263575|364423226|FG000|Titration Period|Adverse Event|14|||
105661102|NCT00263575|364423226|FG000|Titration Period|Withdrawal by Subject|10|||
105661103|NCT00263575|364423226|FG000|Titration Period|Protocol Violation|9|||
105661104|NCT00263575|364423226|FG000|Titration Period|Sponsor Decision|2|||
105661105|NCT00263575|364423226|FG000|Titration Period|Other|2|||
105661106|NCT00263575|364423226|FG000|Titration Period|Lack of Efficacy|6|||
105661107|NCT00263575|364423226|FG000|Maintence Period|Adverse Event|23|||
105661108|NCT00263575|364423226|FG000|Maintence Period|Withdrawal by Subject|8|||
105661109|NCT00263575|364423226|FG000|Maintence Period|Protocol Violation|4|||
105661110|NCT00263575|364423226|FG000|Maintence Period|Lack of Efficacy|4|||
105661111|NCT00263575|364423226|FG000|Maintence Period|Physician Decision|6|||
105661112|NCT00263575|364423226|FG000|Maintence Period|Lost to Follow-up|1|||
105661113|NCT00263575|364423226|FG000|Maintence Period|Sponsor Decision|24|||
105661114|NCT00263575|364423226|FG000|Maintence Period|Other|7|||
105661115|NCT00224029|364423228|FG000|Overall Study|Lost to Follow-up|1|||
105661116|NCT00224029|364423228|FG000|Overall Study|Withdrawal by Subject|4|||
105661117|NCT00224029|364423228|FG000|Overall Study|Other|1|||
105661118|NCT03000348|364423229|FG000|Overall Study|Adverse Event|1|||
105661119|NCT03000348|364423230|FG001|Overall Study|Adverse Event|1|||
105661120|NCT03000348|364423231|FG002|Overall Study|Adverse Event|1|||
105661121|NCT03000348|364423232|FG003|Overall Study|Adverse Event|1|||
105661122|NCT03000348|364423233|FG004|Overall Study|Adverse Event|1|||
105661123|NCT03000348|364423234|FG005|Overall Study|Adverse Event|1|||
105661124|NCT03000348|364423229|FG000|Overall Study|Lost to Follow-up|0|||
105661125|NCT03000348|364423230|FG001|Overall Study|Lost to Follow-up|0|||
105661126|NCT03000348|364423231|FG002|Overall Study|Lost to Follow-up|1|||
105661127|NCT03000348|364423232|FG003|Overall Study|Lost to Follow-up|0|||
105661128|NCT03000348|364423233|FG004|Overall Study|Lost to Follow-up|0|||
105661129|NCT03000348|364423234|FG005|Overall Study|Lost to Follow-up|0|||
105661130|NCT03000348|364423229|FG000|Overall Study|Withdrawal by Subject|0|||
105661131|NCT03000348|364423230|FG001|Overall Study|Withdrawal by Subject|1|||
105661132|NCT03000348|364423231|FG002|Overall Study|Withdrawal by Subject|0|||
105661133|NCT03000348|364423232|FG003|Overall Study|Withdrawal by Subject|0|||
105661134|NCT03000348|364423233|FG004|Overall Study|Withdrawal by Subject|0|||
105661135|NCT03000348|364423234|FG005|Overall Study|Withdrawal by Subject|0|||
105661136|NCT03000348|364423229|FG000|Overall Study|Consent|0|||
105661137|NCT03000348|364423230|FG001|Overall Study|Consent|0|||
105661138|NCT03000348|364423231|FG002|Overall Study|Consent|0|||
105661139|NCT03000348|364423232|FG003|Overall Study|Consent|0|||
105661140|NCT03000348|364423233|FG004|Overall Study|Consent|1|||
105661141|NCT03000348|364423234|FG005|Overall Study|Consent|0|||
105661142|NCT03000348|364423229|FG000|Overall Study|Failure to expectorate sputum|1|||
105661143|NCT03000348|364423230|FG001|Overall Study|Failure to expectorate sputum|0|||
105661144|NCT03000348|364423231|FG002|Overall Study|Failure to expectorate sputum|1|||
105661145|NCT03000348|364423232|FG003|Overall Study|Failure to expectorate sputum|0|||
105661146|NCT03000348|364423233|FG004|Overall Study|Failure to expectorate sputum|1|||
105661147|NCT03000348|364423234|FG005|Overall Study|Failure to expectorate sputum|0|||
105661148|NCT03000348|364423229|FG000|Overall Study|No gram negative|1|||
105661149|NCT03000348|364423230|FG001|Overall Study|No gram negative|2|||
105661150|NCT03000348|364423231|FG002|Overall Study|No gram negative|1|||
105661151|NCT03000348|364423232|FG003|Overall Study|No gram negative|1|||
105661152|NCT03000348|364423233|FG004|Overall Study|No gram negative|1|||
105661153|NCT03000348|364423234|FG005|Overall Study|No gram negative|1|||
105661154|NCT03000348|364423229|FG000|Overall Study|Patient had no transport|0|||
105661155|NCT03000348|364423230|FG001|Overall Study|Patient had no transport|0|||
105661156|NCT03000348|364423231|FG002|Overall Study|Patient had no transport|0|||
105661157|NCT03000348|364423232|FG003|Overall Study|Patient had no transport|1|||
105661158|NCT03000348|364423233|FG004|Overall Study|Patient had no transport|0|||
105661159|NCT03000348|364423234|FG005|Overall Study|Patient had no transport|0|||
105661160|NCT03000348|364423229|FG000|Overall Study|Dosing|0|||
105661161|NCT03000348|364423230|FG001|Overall Study|Dosing|0|||
105661162|NCT03000348|364423231|FG002|Overall Study|Dosing|0|||
105661163|NCT03000348|364423232|FG003|Overall Study|Dosing|0|||
105661164|NCT03000348|364423233|FG004|Overall Study|Dosing|1|||
105661165|NCT03000348|364423234|FG005|Overall Study|Dosing|0|||
105661166|NCT03636373|364423236|FG000|Overall Study|Study closure due to Covid-19|1|||
105661167|NCT03636373|364423237|FG001|Overall Study|Study closure due to Covid-19|0|||
105661168|NCT01174264|364423238|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
105661169|NCT01174264|364423239|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
105661170|NCT01174264|364423240|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
105661171|NCT01174264|364423238|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
105661172|NCT01174264|364423239|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
105661173|NCT01174264|364423240|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
105661174|NCT01174264|364423238|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
105661175|NCT01174264|364423239|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
105661176|NCT01174264|364423240|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
105661177|NCT01185171|364423247|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
105661178|NCT01185171|364423247|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
105661179|NCT01185171|364423247|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
105661180|NCT01185171|364423247|FG000|Maintenance|Elevated liver transaminases|3|||
105661181|NCT01185171|364423247|FG000|Maintenance|Rush|2|||
105661182|NCT01185171|364423247|FG000|Maintenance|Diarrhea|1|||
105661183|NCT01185171|364423247|FG000|Maintenance|Xerostomia|1|||
105661184|NCT01185171|364423247|FG000|Maintenance|Nausea|1|||
105661185|NCT01185171|364423247|FG000|Maintenance|Comorbid Illness|2|||
105661186|NCT01185171|364423247|FG000|Maintenance|Withdrawal by Subject|1|||
105661187|NCT01185171|364423247|FG000|Maintenance|Disease Recurrence|1|||
105661188|NCT01214421|364423253|FG000|Overall Study|Lost to Follow-up|7|||
105661189|NCT01214421|364423254|FG001|Overall Study|Lost to Follow-up|3|||
105661190|NCT01214421|364423255|FG002|Overall Study|Lost to Follow-up|7|||
105661191|NCT01214421|364423256|FG003|Overall Study|Lost to Follow-up|3|||
105661192|NCT01214421|364423253|FG000|Overall Study|Adverse Event|16|||
105661193|NCT01214421|364423254|FG001|Overall Study|Adverse Event|35|||
105661194|NCT01214421|364423255|FG002|Overall Study|Adverse Event|14|||
105661195|NCT01214421|364423256|FG003|Overall Study|Adverse Event|3|||
105661196|NCT01214421|364423253|FG000|Overall Study|Sponsor Discontinued Site|1|||
105990726|NCT03781414|365624410|FG000|Overall Study|Lost to Follow-up|1|||
105661197|NCT01214421|364423254|FG001|Overall Study|Sponsor Discontinued Site|2|||
105661198|NCT01214421|364423255|FG002|Overall Study|Sponsor Discontinued Site|0|||
105661199|NCT01214421|364423256|FG003|Overall Study|Sponsor Discontinued Site|0|||
105661200|NCT01214421|364423253|FG000|Overall Study|Withdrawal Criteria Met|3|||
105661201|NCT01214421|364423254|FG001|Overall Study|Withdrawal Criteria Met|0|||
105661202|NCT01214421|364423255|FG002|Overall Study|Withdrawal Criteria Met|2|||
105661203|NCT01214421|364423256|FG003|Overall Study|Withdrawal Criteria Met|1|||
105661204|NCT01214421|364423253|FG000|Overall Study|Physician Decision|2|||
105661205|NCT01214421|364423254|FG001|Overall Study|Physician Decision|0|||
105661206|NCT01214421|364423255|FG002|Overall Study|Physician Decision|4|||
105661207|NCT01214421|364423256|FG003|Overall Study|Physician Decision|0|||
105661208|NCT01214421|364423253|FG000|Overall Study|Withdrawal by Subject|21|||
105661209|NCT01214421|364423254|FG001|Overall Study|Withdrawal by Subject|18|||
105661210|NCT01214421|364423255|FG002|Overall Study|Withdrawal by Subject|11|||
105661211|NCT01214421|364423256|FG003|Overall Study|Withdrawal by Subject|2|||
105661212|NCT01018732|364423257|FG000|Overall Study|Lost to Follow-up|0|||
105661213|NCT01018732|364423258|FG001|Overall Study|Lost to Follow-up|0|||
105661214|NCT01018732|364423259|FG002|Overall Study|Lost to Follow-up|3|||
105661215|NCT01018732|364423257|FG000|Overall Study|Protocol Violation|1|||
105661216|NCT01018732|364423258|FG001|Overall Study|Protocol Violation|1|||
105661217|NCT01018732|364423259|FG002|Overall Study|Protocol Violation|0|||
105661218|NCT01018732|364423257|FG000|Overall Study|Inappropriate Enrollment|0|||
105661219|NCT01018732|364423258|FG001|Overall Study|Inappropriate Enrollment|1|||
105661220|NCT01018732|364423259|FG002|Overall Study|Inappropriate Enrollment|0|||
105661221|NCT01018732|364423257|FG000|Overall Study|Unable to Classify|0|||
105661222|NCT01018732|364423258|FG001|Overall Study|Unable to Classify|0|||
105661223|NCT01018732|364423259|FG002|Overall Study|Unable to Classify|1|||
105661224|NCT01536171|364423260|FG000|Overall Study|Withdrawal by Subject|1|||
105661225|NCT03783689|364423265|FG000|Overall Study|Adverse Event|2|||
105661226|NCT03783689|364423266|FG001|Overall Study|Adverse Event|0|||
105661227|NCT03783689|364423265|FG000|Overall Study|Lost to Follow-up|2|||
105661228|NCT03783689|364423266|FG001|Overall Study|Lost to Follow-up|1|||
105661229|NCT03783689|364423265|FG000|Overall Study|Physician Decision|2|||
105661230|NCT03783689|364423266|FG001|Overall Study|Physician Decision|1|||
105661231|NCT03783689|364423265|FG000|Overall Study|Withdrawal by Subject|3|||
105661232|NCT03783689|364423266|FG001|Overall Study|Withdrawal by Subject|3|||
105661233|NCT03448536|364423269|FG000|Overall Study|Protocol Violation|2|||
105661234|NCT03448536|364423270|FG001|Overall Study|Protocol Violation|0|||
105661235|NCT03448536|364423269|FG000|Overall Study|Pregnancy|1|||
105661236|NCT03448536|364423270|FG001|Overall Study|Pregnancy|0|||
105661237|NCT03448536|364423269|FG000|Overall Study|Withdrawal by Subject|1|||
105661238|NCT03448536|364423270|FG001|Overall Study|Withdrawal by Subject|2|||
105661239|NCT03448536|364423269|FG000|Overall Study|Lost to Follow-up|3|||
105661240|NCT03448536|364423270|FG001|Overall Study|Lost to Follow-up|2|||
105661241|NCT03448536|364423269|FG000|Overall Study|Inadequate pain reporter|1|||
105661242|NCT03448536|364423270|FG001|Overall Study|Inadequate pain reporter|0|||
105661243|NCT03448536|364423269|FG000|Overall Study|Other|3|||
105661244|NCT03448536|364423270|FG001|Overall Study|Other|0|||
105661245|NCT03448536|364423269|FG000|Overall Study|Physician Decision|1|||
105661246|NCT03448536|364423270|FG001|Overall Study|Physician Decision|0|||
105661247|NCT02636608|364423271|FG000|Overall Study|Failure to Return|4|||
105661248|NCT02636608|364423271|FG000|Overall Study|Insufficient Virological Response|1|||
105661249|NCT02636608|364423271|FG000|Overall Study|Death|3|||
105661250|NCT02636608|364423271|FG000|Overall Study|Other|2|||
105661251|NCT02636608|364423271|FG000|Overall Study|Did Not Receive Treatment|1|||
105661252|NCT01255761|364423272|FG000|Overall Study|Adverse Event|29|||
105661253|NCT01255761|364423273|FG001|Overall Study|Adverse Event|43|||
105661254|NCT01255761|364423272|FG000|Overall Study|Lack of Efficacy|86|||
105661255|NCT01255761|364423273|FG001|Overall Study|Lack of Efficacy|74|||
105661256|NCT01255761|364423272|FG000|Overall Study|Protocol Violation|9|||
105661257|NCT01255761|364423273|FG001|Overall Study|Protocol Violation|5|||
105661258|NCT01255761|364423272|FG000|Overall Study|Lost to Follow-up|10|||
105661259|NCT01255761|364423273|FG001|Overall Study|Lost to Follow-up|8|||
105661260|NCT01255761|364423272|FG000|Overall Study|Withdrawal by Subject|11|||
105661261|NCT01255761|364423273|FG001|Overall Study|Withdrawal by Subject|27|||
105770555|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
106099701|NCT04537923|366022596|FG002|Overall Study|Safety reasons|0|||
106099702|NCT04537923|366022597|FG003|Overall Study|Safety reasons|0|||
105661262|NCT01255761|364423272|FG000|Overall Study|Other Reasons|37|||
105661263|NCT01255761|364423273|FG001|Overall Study|Other Reasons|18|||
105661264|NCT00838929|364423276|FG000|Overall Study|Protocol Violation|0|||
105661265|NCT00838929|364423277|FG001|Overall Study|Protocol Violation|1|||
105661266|NCT00838929|364423278|FG002|Overall Study|Protocol Violation|0|||
105661267|NCT00838929|364423276|FG000|Overall Study|Disease progression|0|||
105661268|NCT00838929|364423277|FG001|Overall Study|Disease progression|2|||
105661269|NCT00838929|364423278|FG002|Overall Study|Disease progression|1|||
105661270|NCT00365547|364423279|FG000|Overall Study|Insurance did not cover Avastin|1|||
105661271|NCT00365547|364423279|FG000|Overall Study|Screen failure|1|||
105661272|NCT00365547|364423279|FG000|Overall Study|Withdrawal by Subject|1|||
105661273|NCT00546078|364423280|FG000|Overall Study|Lost to Follow-up|1|||
105661274|NCT00546078|364423281|FG001|Overall Study|Lost to Follow-up|3|||
105661275|NCT00546078|364423280|FG000|Overall Study|Withdrawal by Subject|2|||
105661276|NCT00546078|364423281|FG001|Overall Study|Withdrawal by Subject|3|||
105661277|NCT00546078|364423280|FG000|Overall Study|Other reason|1|||
105661278|NCT00546078|364423281|FG001|Overall Study|Other reason|1|||
105661279|NCT03512197|364423282|FG000|Overall Study|Guardian decision|1|||
105661280|NCT03512197|364423283|FG001|Overall Study|Guardian decision|1|||
105661281|NCT03512197|364423282|FG000|Overall Study|Lack of Efficacy|19|||
105661282|NCT03512197|364423283|FG001|Overall Study|Lack of Efficacy|11|||
105661283|NCT03512197|364423282|FG000|Overall Study|New Therapy for Study Indication|16|||
105661284|NCT03512197|364423283|FG001|Overall Study|New Therapy for Study Indication|16|||
105661285|NCT03512197|364423282|FG000|Overall Study|Physician Decision|60|||
105661286|NCT03512197|364423283|FG001|Overall Study|Physician Decision|60|||
105661287|NCT03512197|364423282|FG000|Overall Study|Protocol Violation|0|||
105661288|NCT03512197|364423283|FG001|Overall Study|Protocol Violation|2|||
105661289|NCT03512197|364423282|FG000|Overall Study|Terminated by Sponsored|46|||
105661290|NCT03512197|364423283|FG001|Overall Study|Terminated by Sponsored|50|||
105661291|NCT03512197|364423282|FG000|Overall Study|Subject Decision|15|||
105661292|NCT03512197|364423283|FG001|Overall Study|Subject Decision|12|||
105661293|NCT03512197|364423282|FG000|Overall Study|Withdrawal of informed consent|20|||
105661294|NCT03512197|364423283|FG001|Overall Study|Withdrawal of informed consent|14|||
105661295|NCT03512197|364423282|FG000|Overall Study|Adverse Event|30|||
105661296|NCT03512197|364423283|FG001|Overall Study|Adverse Event|34|||
105661297|NCT03512197|364423282|FG000|Overall Study|Death|14|||
105661298|NCT03512197|364423283|FG001|Overall Study|Death|9|||
105661299|NCT03512197|364423282|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
105661300|NCT03512197|364423283|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
105661301|NCT03512197|364423282|FG000|Overall Study|Missing|3|||
105661302|NCT03512197|364423283|FG001|Overall Study|Missing|13|||
105661303|NCT02386839|364423286|FG000|Overall Study|Death|1|||
105661304|NCT02386839|364423287|FG001|Overall Study|Death|0|||
105661305|NCT02386839|364423286|FG000|Overall Study|Withdrawal by Subject|9|||
105661306|NCT02386839|364423287|FG001|Overall Study|Withdrawal by Subject|10|||
105661307|NCT02386839|364423286|FG000|Overall Study|Lost to Follow-up|4|||
105661308|NCT02386839|364423287|FG001|Overall Study|Lost to Follow-up|4|||
105661309|NCT02386839|364423286|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
105661310|NCT02386839|364423287|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
105661311|NCT02386839|364423286|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
105661312|NCT02386839|364423287|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
105661313|NCT02386839|364423286|FG000|Overall Study|Other (unspecified)|1|||
105661314|NCT02386839|364423287|FG001|Overall Study|Other (unspecified)|0|||
105661315|NCT04886518|364423289|FG000|Overall Study|Noncompliance with study drug|1|||
105661316|NCT04886518|364423290|FG001|Overall Study|Noncompliance with study drug|0|||
105661317|NCT04886518|364423291|FG002|Overall Study|Noncompliance with study drug|0|||
105661318|NCT04886518|364423289|FG000|Overall Study|Adverse Event|0|||
105661319|NCT04886518|364423290|FG001|Overall Study|Adverse Event|1|||
105661320|NCT04886518|364423291|FG002|Overall Study|Adverse Event|0|||
105661321|NCT04886518|364423289|FG000|Overall Study|Withdrawal by Subject|1|||
105661322|NCT04886518|364423290|FG001|Overall Study|Withdrawal by Subject|0|||
105661323|NCT04886518|364423291|FG002|Overall Study|Withdrawal by Subject|0|||
105661324|NCT06840769|364423292|FG000|Overall Study|Withdrawal by Subject|1|||
105661325|NCT06840769|364423293|FG001|Overall Study|Withdrawal by Subject|0|||
105661326|NCT06840769|364423294|FG002|Overall Study|Withdrawal by Subject|0|||
105661327|NCT06840769|364423295|FG003|Overall Study|Withdrawal by Subject|0|||
105661328|NCT06840769|364423296|FG004|Overall Study|Withdrawal by Subject|0|||
105661329|NCT02726945|364423297|FG000|Overall Study|Withdrawal by Subject|0|||
105661330|NCT02726945|364423298|FG001|Overall Study|Withdrawal by Subject|0|||
105661331|NCT02726945|364423299|FG002|Overall Study|Withdrawal by Subject|1|||
105661332|NCT02726945|364423297|FG000|Overall Study|Elected to have total knee replacement|0|||
105661333|NCT02726945|364423298|FG001|Overall Study|Elected to have total knee replacement|1|||
105661334|NCT02726945|364423299|FG002|Overall Study|Elected to have total knee replacement|0|||
105661335|NCT02035696|364425004|FG000|Overall Study|Lost to Follow-up|0|||
105661336|NCT02035696|364425005|FG001|Overall Study|Lost to Follow-up|3|||
105661337|NCT02035696|364425006|FG002|Overall Study|Lost to Follow-up|1|||
105661338|NCT02035696|364425007|FG003|Overall Study|Lost to Follow-up|2|||
105661339|NCT02035696|364425004|FG000|Overall Study|Withdrawal by Subject|3|||
105661340|NCT02035696|364425005|FG001|Overall Study|Withdrawal by Subject|0|||
105661341|NCT02035696|364425006|FG002|Overall Study|Withdrawal by Subject|2|||
105661342|NCT02035696|364425007|FG003|Overall Study|Withdrawal by Subject|1|||
105661343|NCT00497874|364425008|FG000|Overall Study|Withdrawal by Subject|48|||
105661344|NCT00497874|364425009|FG001|Overall Study|Withdrawal by Subject|17|||
105661345|NCT00497874|364425008|FG000|Overall Study|Illness|8|||
105661346|NCT00497874|364425009|FG001|Overall Study|Illness|4|||
105661347|NCT00497874|364425008|FG000|Overall Study|Death|2|||
105661348|NCT00497874|364425009|FG001|Overall Study|Death|4|||
105661349|NCT00497874|364425008|FG000|Overall Study|Unable to contact|52|||
105661350|NCT00497874|364425009|FG001|Overall Study|Unable to contact|67|||
105661351|NCT00497874|364425008|FG000|Overall Study|Unable to schedule|37|||
105661352|NCT00497874|364425009|FG001|Overall Study|Unable to schedule|24|||
105661353|NCT01639742|364425011|FG000|Overall Study|Study Ongoing|17|||
105661354|NCT01639742|364425011|FG000|Overall Study|Lost to Follow-up|1|||
105661355|NCT01468077|364425014|FG000|Overall Study|Adverse Event|2|||
105661356|NCT01468077|364425015|FG001|Overall Study|Adverse Event|2|||
105661357|NCT01468077|364425014|FG000|Overall Study|Lack of Efficacy|1|||
105661358|NCT01468077|364425015|FG001|Overall Study|Lack of Efficacy|1|||
105661359|NCT01468077|364425014|FG000|Overall Study|Physician Decision|1|||
105661360|NCT01468077|364425015|FG001|Overall Study|Physician Decision|0|||
105661361|NCT03024996|364425016|FG000|Overall Study|Death|57|||
105661362|NCT03024996|364425017|FG001|Overall Study|Death|55|||
105661363|NCT03024996|364425016|FG000|Overall Study|Disease relapse|1|||
105661364|NCT03024996|364425017|FG001|Overall Study|Disease relapse|0|||
105661365|NCT03024996|364425016|FG000|Overall Study|Lost to Follow-up|5|||
105661366|NCT03024996|364425017|FG001|Overall Study|Lost to Follow-up|10|||
105661367|NCT03024996|364425016|FG000|Overall Study|Other|3|||
105661368|NCT03024996|364425017|FG001|Overall Study|Other|3|||
105661369|NCT03024996|364425016|FG000|Overall Study|Physician Decision|0|||
105661370|NCT03024996|364425017|FG001|Overall Study|Physician Decision|1|||
105661371|NCT03024996|364425016|FG000|Overall Study|Study terminated by sponsor|303|||
105661372|NCT03024996|364425017|FG001|Overall Study|Study terminated by sponsor|283|||
105661373|NCT03024996|364425016|FG000|Overall Study|Withdrawal by Subject|21|||
105661374|NCT03024996|364425017|FG001|Overall Study|Withdrawal by Subject|36|||
105661375|NCT00632021|364425028|FG000|Overall Study|Withdrawal/death|4|||
105661376|NCT00632021|364425029|FG001|Overall Study|Withdrawal/death|7|||
105661377|NCT03732820|364425030|FG000|Overall Study|Death|168|||
105661378|NCT03732820|364425031|FG001|Overall Study|Death|203|||
105661379|NCT03732820|364425030|FG000|Overall Study|Other|2|||
105661380|NCT03732820|364425031|FG001|Overall Study|Other|2|||
105661381|NCT03732820|364425030|FG000|Overall Study|Failure to meet randomisation criteria|1|||
105661382|NCT03732820|364425031|FG001|Overall Study|Failure to meet randomisation criteria|1|||
105661383|NCT03732820|364425030|FG000|Overall Study|Patient decision|14|||
105661384|NCT03732820|364425031|FG001|Overall Study|Patient decision|10|||
105661385|NCT03732820|364425030|FG000|Overall Study|Screen failure|0|||
105661386|NCT03732820|364425031|FG001|Overall Study|Screen failure|1|||
105661387|NCT03732820|364425030|FG000|Overall Study|Patients ongoing study at data cut off|210|||
105661388|NCT03732820|364425031|FG001|Overall Study|Patients ongoing study at data cut off|178|||
105661389|NCT03732820|364425030|FG000|Overall Study|Lost to Follow-up|4|||
105661390|NCT03732820|364425031|FG001|Overall Study|Lost to Follow-up|2|||
105661391|NCT00537329|364425032|FG000|Overall Study|Death|10|||
105661392|NCT00537329|364425032|FG000|Overall Study|Adverse Event|3|||
105661393|NCT00537329|364425032|FG000|Overall Study|Lack of Efficacy|2|||
105661394|NCT00537329|364425032|FG000|Overall Study|Lost to Follow-up|6|||
105661395|NCT00537329|364425032|FG000|Overall Study|Withdrawal by Subject|4|||
105661396|NCT00537329|364425032|FG000|Overall Study|Other|1|||
105661397|NCT00085566|364425033|FG000|Overall Study|Adverse Event|0|||
105661398|NCT00085566|364425034|FG001|Overall Study|Adverse Event|0|||
105661399|NCT00085566|364425035|FG002|Overall Study|Adverse Event|10|||
105661400|NCT00085566|364425033|FG000|Overall Study|Patient Not treated|0|||
105661401|NCT00085566|364425034|FG001|Overall Study|Patient Not treated|0|||
105661402|NCT00085566|364425035|FG002|Overall Study|Patient Not treated|3|||
105661403|NCT00085566|364425033|FG000|Overall Study|Clinical progression|0|||
105661404|NCT00085566|364425034|FG001|Overall Study|Clinical progression|0|||
105661405|NCT00085566|364425035|FG002|Overall Study|Clinical progression|1|||
105661406|NCT03174782|364425044|FG000|Overall Study|Protocol Violation|1|||
105661407|NCT03174782|364425045|FG001|Overall Study|Protocol Violation|0|||
105661408|NCT03174782|364425044|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
105661409|NCT03174782|364425045|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
105661410|NCT04805073|364425046|FG000|Overall Study|study personnel not available|2|||
105661411|NCT04805073|364425047|FG001|Overall Study|study personnel not available|0|||
105661412|NCT04805073|364425046|FG000|Overall Study|spinal anesthesia failure|0|||
105661413|NCT04805073|364425047|FG001|Overall Study|spinal anesthesia failure|1|||
105661414|NCT04805073|364425046|FG000|Overall Study|Lost to Follow-up|0|||
105661415|NCT04805073|364425047|FG001|Overall Study|Lost to Follow-up|2|||
105661416|NCT03178045|364425048|FG000|Overall Study|Withdrawal by Subject|5|||
105661417|NCT03178045|364425049|FG001|Overall Study|Withdrawal by Subject|7|||
105661418|NCT03178045|364425048|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
105661419|NCT03178045|364425049|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
105661420|NCT03178045|364425048|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
105661421|NCT03178045|364425049|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
105661422|NCT01078922|364425053|FG000|Overall Study|Adverse Event|1|||
105661423|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
105661424|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
105661425|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
105661426|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
105661427|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
105661428|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
105661429|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
105661430|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
105661431|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
105661432|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
105661433|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
105661434|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
105661435|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Other|4|||
105661436|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Other|4|||
105661437|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Other|2|||
105661438|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Other|2|||
105661439|NCT02706847|364425054|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
105661440|NCT02706847|364425055|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
105661441|NCT02706847|364425056|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
105661442|NCT02706847|364425057|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
105661443|NCT02706847|364425054|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
105661444|NCT02706847|364425055|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
105661445|NCT02706847|364425056|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
105661446|NCT02706847|364425057|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
105661447|NCT02706847|364425054|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
105661448|NCT02706847|364425055|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
105661449|NCT02706847|364425056|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
105661450|NCT02706847|364425057|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
105661451|NCT02706847|364425054|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
105661452|NCT02706847|364425055|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
105661453|NCT02706847|364425056|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
105661454|NCT02706847|364425057|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
105661455|NCT02706847|364425054|FG000|Period 1: Week 12 to Week 24|Other|1|||
105661456|NCT02706847|364425055|FG001|Period 1: Week 12 to Week 24|Other|0|||
105661457|NCT02706847|364425056|FG002|Period 1: Week 12 to Week 24|Other|1|||
105661458|NCT02706847|364425057|FG003|Period 1: Week 12 to Week 24|Other|4|||
105661459|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
105661460|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
105661461|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
105661462|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
105661463|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
105661464|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
105661465|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
105661466|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
105661467|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
105661468|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
105661469|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
105661470|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
105661471|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
105661472|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
105661473|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
105661474|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
105661475|NCT02706847|364425054|FG000|Period 2: Week 24 to Week 260|Other|8|||
105661476|NCT02706847|364425055|FG001|Period 2: Week 24 to Week 260|Other|5|||
105661477|NCT02706847|364425056|FG002|Period 2: Week 24 to Week 260|Other|15|||
105661478|NCT02706847|364425057|FG003|Period 2: Week 24 to Week 260|Other|15|||
105661479|NCT00003477|364425060|FG000|Overall Study|Not evalauable|4|||
105661480|NCT00267098|364425061|FG000|Overall Study|Death|0|||
105661481|NCT00267098|364425062|FG001|Overall Study|Death|0|||
105661482|NCT00267098|364425063|FG002|Overall Study|Death|57|||
105661483|NCT00267098|364425064|FG003|Overall Study|Death|66|||
105661484|NCT00267098|364425065|FG004|Overall Study|Death|14|||
105661485|NCT00267098|364425066|FG005|Overall Study|Death|23|||
105661486|NCT00267098|364425067|FG006|Overall Study|Death|28|||
105661487|NCT00267098|364425068|FG007|Overall Study|Death|9|||
105661488|NCT00267098|364425061|FG000|Overall Study|Lost to Follow-up|0|||
105661489|NCT00267098|364425062|FG001|Overall Study|Lost to Follow-up|0|||
105661490|NCT00267098|364425063|FG002|Overall Study|Lost to Follow-up|6|||
105661491|NCT00267098|364425064|FG003|Overall Study|Lost to Follow-up|5|||
105661492|NCT00267098|364425065|FG004|Overall Study|Lost to Follow-up|2|||
105661493|NCT00267098|364425066|FG005|Overall Study|Lost to Follow-up|3|||
105661494|NCT00267098|364425067|FG006|Overall Study|Lost to Follow-up|1|||
105661495|NCT00267098|364425068|FG007|Overall Study|Lost to Follow-up|1|||
105661496|NCT00267098|364425061|FG000|Overall Study|Withdrawal by Subject|8|||
105661497|NCT00267098|364425062|FG001|Overall Study|Withdrawal by Subject|0|||
105661498|NCT00267098|364425063|FG002|Overall Study|Withdrawal by Subject|24|||
105661499|NCT00267098|364425064|FG003|Overall Study|Withdrawal by Subject|21|||
105661500|NCT00267098|364425065|FG004|Overall Study|Withdrawal by Subject|12|||
105661501|NCT00267098|364425066|FG005|Overall Study|Withdrawal by Subject|9|||
105661502|NCT00267098|364425067|FG006|Overall Study|Withdrawal by Subject|12|||
105661503|NCT00267098|364425068|FG007|Overall Study|Withdrawal by Subject|5|||
105661504|NCT00267098|364425061|FG000|Overall Study|Physician Decision|5|||
105661505|NCT00267098|364425062|FG001|Overall Study|Physician Decision|0|||
105661506|NCT00267098|364425063|FG002|Overall Study|Physician Decision|7|||
105661507|NCT00267098|364425064|FG003|Overall Study|Physician Decision|11|||
105661508|NCT00267098|364425065|FG004|Overall Study|Physician Decision|5|||
105661509|NCT00267098|364425066|FG005|Overall Study|Physician Decision|4|||
105661510|NCT00267098|364425067|FG006|Overall Study|Physician Decision|3|||
105661511|NCT00267098|364425068|FG007|Overall Study|Physician Decision|0|||
105661512|NCT00267098|364425061|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
105661513|NCT00267098|364425062|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661514|NCT00267098|364425063|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661515|NCT00267098|364425064|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661516|NCT00267098|364425065|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
105661517|NCT00267098|364425066|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661518|NCT00267098|364425067|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661519|NCT00267098|364425068|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105661520|NCT00267098|364425061|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661521|NCT00267098|364425062|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
105661522|NCT00267098|364425063|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661523|NCT00267098|364425064|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661524|NCT00267098|364425065|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661525|NCT00267098|364425066|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661526|NCT00267098|364425067|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661527|NCT00267098|364425068|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
105661528|NCT00267098|364425061|FG000|Overall Study|Site closure|0|||
105661529|NCT00267098|364425062|FG001|Overall Study|Site closure|0|||
105661530|NCT00267098|364425063|FG002|Overall Study|Site closure|0|||
105661531|NCT00267098|364425064|FG003|Overall Study|Site closure|1|||
105661532|NCT00267098|364425065|FG004|Overall Study|Site closure|0|||
105661533|NCT00267098|364425066|FG005|Overall Study|Site closure|1|||
105661534|NCT00267098|364425067|FG006|Overall Study|Site closure|1|||
105661535|NCT00267098|364425068|FG007|Overall Study|Site closure|0|||
105661536|NCT00267098|364425061|FG000|Overall Study|Explanted Medtronic device|0|||
105661537|NCT00267098|364425062|FG001|Overall Study|Explanted Medtronic device|0|||
105661538|NCT00267098|364425063|FG002|Overall Study|Explanted Medtronic device|0|||
105661539|NCT00267098|364425064|FG003|Overall Study|Explanted Medtronic device|1|||
105661540|NCT00267098|364425065|FG004|Overall Study|Explanted Medtronic device|0|||
105661541|NCT00267098|364425066|FG005|Overall Study|Explanted Medtronic device|0|||
105661542|NCT00267098|364425067|FG006|Overall Study|Explanted Medtronic device|0|||
105661543|NCT00267098|364425068|FG007|Overall Study|Explanted Medtronic device|0|||
105770556|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770557|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770558|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770559|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770560|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770561|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770562|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770563|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770564|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770565|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770566|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
105770567|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105770568|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770569|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770570|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770571|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770572|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770573|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
106099703|NCT02527798|366022598|FG000|Overall Study|Physician Decision|1|||
106099704|NCT02527798|366022599|FG001|Overall Study|Physician Decision|0|||
106099705|NCT02527798|366022600|FG002|Overall Study|Physician Decision|1|||
105661544|NCT00267098|364425061|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661545|NCT00267098|364425062|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661546|NCT00267098|364425063|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661547|NCT00267098|364425064|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661548|NCT00267098|364425065|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
105661549|NCT00267098|364425066|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661550|NCT00267098|364425067|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661551|NCT00267098|364425068|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
105661552|NCT00267098|364425061|FG000|Overall Study|Subject listed for heart transplant|0|||
105661553|NCT00267098|364425062|FG001|Overall Study|Subject listed for heart transplant|0|||
105661554|NCT00267098|364425063|FG002|Overall Study|Subject listed for heart transplant|0|||
105661555|NCT00267098|364425064|FG003|Overall Study|Subject listed for heart transplant|0|||
105661556|NCT00267098|364425065|FG004|Overall Study|Subject listed for heart transplant|0|||
105661557|NCT00267098|364425066|FG005|Overall Study|Subject listed for heart transplant|0|||
105661558|NCT00267098|364425067|FG006|Overall Study|Subject listed for heart transplant|1|||
105661559|NCT00267098|364425068|FG007|Overall Study|Subject listed for heart transplant|0|||
105661560|NCT00267098|364425061|FG000|Overall Study|Sponsor withdrew subject|0|||
105661561|NCT00267098|364425062|FG001|Overall Study|Sponsor withdrew subject|0|||
105661562|NCT00267098|364425063|FG002|Overall Study|Sponsor withdrew subject|0|||
105661563|NCT00267098|364425064|FG003|Overall Study|Sponsor withdrew subject|1|||
105661564|NCT00267098|364425065|FG004|Overall Study|Sponsor withdrew subject|0|||
105661565|NCT00267098|364425066|FG005|Overall Study|Sponsor withdrew subject|0|||
105661566|NCT00267098|364425067|FG006|Overall Study|Sponsor withdrew subject|0|||
105661567|NCT00267098|364425068|FG007|Overall Study|Sponsor withdrew subject|0|||
105661568|NCT00547534|364425070|FG000|Overall Study|Adverse Event|7|||
105661569|NCT00547534|364425070|FG000|Overall Study|Disease Progression|4|||
105661570|NCT04206085|364425077|FG000|Overall Study|Lost to Follow-up|0|||
105661571|NCT04206085|364425078|FG001|Overall Study|Lost to Follow-up|1|||
105661572|NCT04206085|364425079|FG002|Overall Study|Lost to Follow-up|0|||
105661573|NCT04206085|364425077|FG000|Overall Study|Lost to Follow-up|0|||
105661574|NCT04206085|364425078|FG001|Overall Study|Lost to Follow-up|0|||
105661575|NCT04206085|364425079|FG002|Overall Study|Lost to Follow-up|1|||
105661576|NCT00763451|364425080|FG000|Overall Study|Adverse Event|4|||
105661577|NCT00763451|364425081|FG001|Overall Study|Adverse Event|6|||
105661578|NCT00763451|364425082|FG002|Overall Study|Adverse Event|19|||
105661579|NCT00763451|364425083|FG003|Overall Study|Adverse Event|14|||
105661580|NCT00763451|364425080|FG000|Overall Study|Lack of Efficacy|1|||
105661581|NCT00763451|364425081|FG001|Overall Study|Lack of Efficacy|4|||
105661582|NCT00763451|364425082|FG002|Overall Study|Lack of Efficacy|3|||
105661583|NCT00763451|364425083|FG003|Overall Study|Lack of Efficacy|2|||
105661584|NCT00763451|364425080|FG000|Overall Study|Withdrawal by Subject|1|||
105661585|NCT00763451|364425081|FG001|Overall Study|Withdrawal by Subject|6|||
105661586|NCT00763451|364425082|FG002|Overall Study|Withdrawal by Subject|9|||
105661587|NCT00763451|364425083|FG003|Overall Study|Withdrawal by Subject|7|||
105661588|NCT00763451|364425080|FG000|Overall Study|Protocol Violation|0|||
105661589|NCT00763451|364425081|FG001|Overall Study|Protocol Violation|0|||
105661590|NCT00763451|364425082|FG002|Overall Study|Protocol Violation|1|||
105661591|NCT00763451|364425083|FG003|Overall Study|Protocol Violation|0|||
105661592|NCT00763451|364425080|FG000|Overall Study|Poor Compliance to Protocol|1|||
105661593|NCT00763451|364425081|FG001|Overall Study|Poor Compliance to Protocol|1|||
105661594|NCT00763451|364425082|FG002|Overall Study|Poor Compliance to Protocol|2|||
105661595|NCT00763451|364425083|FG003|Overall Study|Poor Compliance to Protocol|2|||
105661596|NCT00763451|364425080|FG000|Overall Study|Familial and Personal Reasons|5|||
105661597|NCT00763451|364425081|FG001|Overall Study|Familial and Personal Reasons|3|||
105661598|NCT00763451|364425082|FG002|Overall Study|Familial and Personal Reasons|5|||
105661599|NCT00763451|364425083|FG003|Overall Study|Familial and Personal Reasons|4|||
105661600|NCT00763451|364425080|FG000|Overall Study|Randomized but not Treated|1|||
105661601|NCT00763451|364425081|FG001|Overall Study|Randomized but not Treated|1|||
105661602|NCT00763451|364425082|FG002|Overall Study|Randomized but not Treated|0|||
105661603|NCT00763451|364425083|FG003|Overall Study|Randomized but not Treated|0|||
105661604|NCT00763451|364425080|FG000|Overall Study|Study Site Reason|0|||
105661605|NCT00763451|364425081|FG001|Overall Study|Study Site Reason|1|||
105661606|NCT00763451|364425082|FG002|Overall Study|Study Site Reason|1|||
105661607|NCT00763451|364425083|FG003|Overall Study|Study Site Reason|1|||
105661608|NCT02554383|364425090|FG000|Overall Study|Ineligible|3|||
105661609|NCT02554383|364425091|FG001|Overall Study|Ineligible|2|||
105661610|NCT02554383|364425090|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
105661611|NCT02554383|364425091|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
105661612|NCT02554383|364425090|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
105661613|NCT02554383|364425091|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
105661614|NCT02554383|364425090|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
105661615|NCT02554383|364425091|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
105661616|NCT00727506|364425092|FG000|Overall Study|Adverse Event|0|||
105661617|NCT00727506|364425093|FG001|Overall Study|Adverse Event|0|||
105661618|NCT00727506|364425094|FG002|Overall Study|Adverse Event|4|||
105661619|NCT00727506|364425095|FG003|Overall Study|Adverse Event|4|||
105661620|NCT00727506|364425096|FG004|Overall Study|Adverse Event|1|||
105661621|NCT00727506|364425097|FG005|Overall Study|Adverse Event|8|||
105661622|NCT00727506|364425092|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105661623|NCT00727506|364425093|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105661624|NCT00727506|364425094|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105661625|NCT00727506|364425095|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105661626|NCT00727506|364425096|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105661627|NCT00727506|364425097|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105661628|NCT00727506|364425092|FG000|Overall Study|Progressive disease|4|||
105661629|NCT00727506|364425093|FG001|Overall Study|Progressive disease|7|||
105661630|NCT00727506|364425094|FG002|Overall Study|Progressive disease|9|||
105661631|NCT00727506|364425095|FG003|Overall Study|Progressive disease|28|||
105661632|NCT00727506|364425096|FG004|Overall Study|Progressive disease|38|||
105661633|NCT00727506|364425097|FG005|Overall Study|Progressive disease|28|||
105661634|NCT00727506|364425092|FG000|Overall Study|Refused to continue medication|0|||
105661635|NCT00727506|364425093|FG001|Overall Study|Refused to continue medication|1|||
105661636|NCT00727506|364425094|FG002|Overall Study|Refused to continue medication|2|||
105770574|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770575|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105661637|NCT00727506|364425095|FG003|Overall Study|Refused to continue medication|3|||
105661638|NCT00727506|364425096|FG004|Overall Study|Refused to continue medication|1|||
105661639|NCT00727506|364425097|FG005|Overall Study|Refused to continue medication|2|||
105661640|NCT00727506|364425092|FG000|Overall Study|Other reason not described above|0|||
105661641|NCT00727506|364425093|FG001|Overall Study|Other reason not described above|0|||
105661642|NCT00727506|364425094|FG002|Overall Study|Other reason not described above|1|||
105770576|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770577|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770578|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770579|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770580|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105770581|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
105661643|NCT00727506|364425095|FG003|Overall Study|Other reason not described above|4|||
105661644|NCT00727506|364425096|FG004|Overall Study|Other reason not described above|1|||
105661645|NCT00727506|364425097|FG005|Overall Study|Other reason not described above|1|||
105770582|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
105770583|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770584|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770585|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770586|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770587|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770588|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770589|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770590|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770591|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770592|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770593|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770594|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770595|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770596|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
105770597|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
105770598|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770599|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770600|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770601|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770602|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770603|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770604|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770605|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770606|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770607|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770608|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770609|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770610|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770611|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
105770612|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105770613|NCT03073200|364811111|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770614|NCT03073200|364811112|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770615|NCT03073200|364811113|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770616|NCT03073200|364811114|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770617|NCT03073200|364811115|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770618|NCT03073200|364811116|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105990727|NCT03781414|365624411|FG001|Overall Study|Lost to Follow-up|1|||
105990728|NCT03781414|365624412|FG002|Overall Study|Lost to Follow-up|0|||
105770619|NCT03073200|364811117|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770620|NCT03073200|364811118|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770621|NCT03073200|364811119|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770622|NCT03073200|364811120|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770623|NCT03073200|364811121|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770624|NCT03073200|364811122|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770625|NCT03073200|364811123|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770626|NCT03073200|364811124|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
105770627|NCT03073200|364811125|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
105770628|NCT00113555|364811126|FG000|Overall Study|Baseline Failure|59|||
105770629|NCT00113555|364811126|FG000|Overall Study|Permanently Explanted|7|||
105770630|NCT00113555|364811126|FG000|Overall Study|Death|1|||
105770631|NCT00113555|364811126|FG000|Overall Study|Missed Followup|4|||
105770632|NCT00113555|364811126|FG000|Overall Study|Lost to Follow-up|8|||
105770633|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
105770634|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
105770635|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
105770636|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
105770637|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
105770638|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
105770639|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
105770640|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
105770641|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
105770642|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
105770643|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
105770644|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
105770645|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
105770646|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
105770647|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
105770648|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
105770649|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
105770650|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
105770651|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
105770652|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
105770653|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
105770654|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
105770655|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
105770656|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
105770657|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
105770658|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
105770659|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
105770660|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
105770661|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
105770662|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
105770663|NCT04757376|364811127|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
105770664|NCT04757376|364811128|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
105770665|NCT04757376|364811129|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
105770666|NCT04757376|364811130|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
105770667|NCT04757376|364811131|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
105661646|NCT00383123|364425098|FG000|Overall Study|Adverse Event|1|||
105661647|NCT00383123|364425099|FG001|Overall Study|Adverse Event|0|||
105661648|NCT00383123|364425098|FG000|Overall Study|Lost to Follow-up|68|||
105661649|NCT00383123|364425099|FG001|Overall Study|Lost to Follow-up|61|||
105661650|NCT00383123|364425098|FG000|Overall Study|Protocol Violation|5|||
105661651|NCT00383123|364425099|FG001|Overall Study|Protocol Violation|1|||
105661652|NCT00383123|364425098|FG000|Overall Study|Withdrawal by Subject|27|||
105661653|NCT00383123|364425099|FG001|Overall Study|Withdrawal by Subject|18|||
105661654|NCT00383123|364425098|FG000|Overall Study|Other reason|10|||
105661655|NCT00383123|364425099|FG001|Overall Study|Other reason|6|||
105661656|NCT02781311|364425100|FG000|Overall Study|Adverse Event|2|||
105661657|NCT02781311|364425101|FG001|Overall Study|Adverse Event|6|||
105661658|NCT02781311|364425102|FG002|Overall Study|Adverse Event|1|||
105661659|NCT02781311|364425100|FG000|Overall Study|Withdrawal of Consent|11|||
105661660|NCT02781311|364425101|FG001|Overall Study|Withdrawal of Consent|12|||
105661661|NCT02781311|364425102|FG002|Overall Study|Withdrawal of Consent|2|||
105661662|NCT02781311|364425100|FG000|Overall Study|Lost to Follow-up|11|||
105661663|NCT02781311|364425101|FG001|Overall Study|Lost to Follow-up|8|||
105661664|NCT02781311|364425102|FG002|Overall Study|Lost to Follow-up|1|||
105661665|NCT02781311|364425100|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105661666|NCT02781311|364425101|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105661667|NCT02781311|364425102|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105661668|NCT02165826|364425103|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
105661669|NCT02165826|364425104|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
105661670|NCT02165826|364425105|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
105661671|NCT02165826|364425103|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
105661672|NCT02165826|364425104|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
105661673|NCT02165826|364425105|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
105661674|NCT02165826|364425103|FG000|Main Treatment Period|Lost to Follow-up|4|||
105661675|NCT02165826|364425104|FG001|Main Treatment Period|Lost to Follow-up|2|||
105661676|NCT02165826|364425105|FG002|Main Treatment Period|Lost to Follow-up|1|||
105661677|NCT02165826|364425103|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
105661678|NCT02165826|364425104|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
105661679|NCT02165826|364425105|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
105661680|NCT02165826|364425103|FG000|Main Treatment Period|Lack of Efficacy|2|||
105661681|NCT02165826|364425104|FG001|Main Treatment Period|Lack of Efficacy|0|||
105661682|NCT02165826|364425105|FG002|Main Treatment Period|Lack of Efficacy|0|||
105661683|NCT02165826|364425103|FG000|Main Treatment Period|Reason Not Specified|8|||
105661684|NCT02165826|364425104|FG001|Main Treatment Period|Reason Not Specified|5|||
105661685|NCT02165826|364425105|FG002|Main Treatment Period|Reason Not Specified|16|||
105661686|NCT02165826|364425103|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
105770668|NCT04757376|364811127|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
105770669|NCT04757376|364811128|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
105770670|NCT04757376|364811129|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
105770671|NCT04757376|364811130|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
105770672|NCT04757376|364811131|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
105770673|NCT04474366|364811132|FG000|Overall Study|Lost to Follow-up|2|||
105770674|NCT04474366|364811133|FG001|Overall Study|Lost to Follow-up|5|||
105770675|NCT04063865|364811134|FG000|Overall Study|Physician Decision|1|||
105770676|NCT04063865|364811135|FG001|Overall Study|Physician Decision|3|||
105770677|NCT04063865|364811134|FG000|Overall Study|Study Closed Prior to Completion|4|||
105770678|NCT04063865|364811135|FG001|Overall Study|Study Closed Prior to Completion|4|||
105770679|NCT04063865|364811134|FG000|Overall Study|Withdrawal by Subject|1|||
105770680|NCT04063865|364811135|FG001|Overall Study|Withdrawal by Subject|1|||
105770681|NCT00609167|364811136|FG000|Overall Study|Withdrawal by Subject|1|||
105770682|NCT00609167|364811137|FG001|Overall Study|Withdrawal by Subject|0|||
105770683|NCT00609167|364811136|FG000|Overall Study|Lack of Efficacy|1|||
105770684|NCT00609167|364811137|FG001|Overall Study|Lack of Efficacy|0|||
105770685|NCT00609167|364811136|FG000|Overall Study|Adverse Event|5|||
105770686|NCT00609167|364811137|FG001|Overall Study|Adverse Event|1|||
105770687|NCT00609167|364811136|FG000|Overall Study|Disease Progression|1|||
105770688|NCT00609167|364811137|FG001|Overall Study|Disease Progression|0|||
105770689|NCT00609167|364811136|FG000|Overall Study|Stem Cell Transplant|0|||
105770690|NCT00609167|364811137|FG001|Overall Study|Stem Cell Transplant|6|||
105770691|NCT03898323|364811138|FG000|Overall Study|Physician Decision|1|||
105770692|NCT00320190|364811140|FG000|First 12 Months|Completed but did not enter extension|5|||
105770693|NCT00320190|364811141|FG001|First 12 Months|Completed but did not enter extension|3|||
105770694|NCT00320190|364811140|FG000|First 12 Months|Sponsor terminated study|2|||
105770695|NCT00320190|364811141|FG001|First 12 Months|Sponsor terminated study|2|||
105770696|NCT00320190|364811140|FG000|First 12 Months|Lost to Follow-up|0|||
105770697|NCT00320190|364811141|FG001|First 12 Months|Lost to Follow-up|1|||
105770698|NCT00320190|364811140|FG000|First 12 Months|Enrollment failure|0|||
105770699|NCT00320190|364811141|FG001|First 12 Months|Enrollment failure|1|||
105770700|NCT00320190|364811140|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
105770701|NCT00320190|364811141|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
105770702|NCT00320190|364811140|FG000|First 12 Months|Investigator request|0|||
105770703|NCT00320190|364811141|FG001|First 12 Months|Investigator request|1|||
105770704|NCT00320190|364811140|FG000|First 12 Months|Study drug toxicity|0|||
105770705|NCT00320190|364811141|FG001|First 12 Months|Study drug toxicity|1|||
105770706|NCT00320190|364811140|FG000|First 12 Months|Withdrawal by Subject|0|||
105770707|NCT00320190|364811141|FG001|First 12 Months|Withdrawal by Subject|1|||
105770708|NCT00320190|364811140|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
105770709|NCT00320190|364811141|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
105770710|NCT00320190|364811140|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
105990729|NCT02881762|365624413|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105770711|NCT00320190|364811141|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
105770712|NCT00320190|364811140|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
105770713|NCT00320190|364811141|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
105770714|NCT02574520|364811142|FG000|Overall Study|Not dosed|2|||
105770715|NCT02574520|364811143|FG001|Overall Study|Not dosed|0|||
105770716|NCT02574520|364811144|FG002|Overall Study|Not dosed|5|||
105770717|NCT02574520|364811145|FG003|Overall Study|Not dosed|4|||
105770718|NCT02574520|364811142|FG000|Overall Study|Adverse Event|0|||
105770719|NCT02574520|364811143|FG001|Overall Study|Adverse Event|0|||
105770720|NCT02574520|364811144|FG002|Overall Study|Adverse Event|0|||
105770721|NCT02574520|364811145|FG003|Overall Study|Adverse Event|1|||
105770722|NCT02574520|364811142|FG000|Overall Study|Withdrawal by Subject|0|||
105770723|NCT02574520|364811143|FG001|Overall Study|Withdrawal by Subject|0|||
105770724|NCT02574520|364811144|FG002|Overall Study|Withdrawal by Subject|0|||
105770725|NCT02574520|364811145|FG003|Overall Study|Withdrawal by Subject|1|||
105770726|NCT02574520|364811142|FG000|Overall Study|Other|0|||
105770727|NCT02574520|364811143|FG001|Overall Study|Other|0|||
105770728|NCT02574520|364811144|FG002|Overall Study|Other|0|||
105770729|NCT02574520|364811145|FG003|Overall Study|Other|2|||
105770730|NCT01365091|364811148|FG000|Period 1|Adverse Event|1|||
105770731|NCT01365091|364811149|FG001|Period 1|Adverse Event|0|||
105770732|NCT01365091|364811150|FG002|Period 1|Adverse Event|2|||
105770733|NCT01365091|364811151|FG003|Period 1|Adverse Event|3|||
105770734|NCT01365091|364811148|FG000|Period 1|Positive test result for drugs of abuse|1|||
105770735|NCT01365091|364811149|FG001|Period 1|Positive test result for drugs of abuse|0|||
105770736|NCT01365091|364811150|FG002|Period 1|Positive test result for drugs of abuse|0|||
105770737|NCT01365091|364811151|FG003|Period 1|Positive test result for drugs of abuse|0|||
105770738|NCT01365091|364811148|FG000|Period 1|No longer met study criteria|0|||
105770739|NCT01365091|364811149|FG001|Period 1|No longer met study criteria|1|||
105770740|NCT01365091|364811150|FG002|Period 1|No longer met study criteria|0|||
105770741|NCT01365091|364811151|FG003|Period 1|No longer met study criteria|0|||
105770742|NCT01365091|364811148|FG000|Period 1|Withdrawal by Subject|0|||
105770743|NCT01365091|364811149|FG001|Period 1|Withdrawal by Subject|1|||
105770744|NCT01365091|364811150|FG002|Period 1|Withdrawal by Subject|0|||
105770745|NCT01365091|364811151|FG003|Period 1|Withdrawal by Subject|0|||
105770746|NCT01365091|364811148|FG000|Period 1|Personal reasons|0|||
105770747|NCT01365091|364811149|FG001|Period 1|Personal reasons|0|||
105770748|NCT01365091|364811150|FG002|Period 1|Personal reasons|1|||
105770749|NCT01365091|364811151|FG003|Period 1|Personal reasons|0|||
105770750|NCT01365091|364811148|FG000|Period 2|Withdrawal by Subject|1|||
105770751|NCT01365091|364811149|FG001|Period 2|Withdrawal by Subject|0|||
105770752|NCT01365091|364811150|FG002|Period 2|Withdrawal by Subject|0|||
105770753|NCT01365091|364811151|FG003|Period 2|Withdrawal by Subject|0|||
105770754|NCT01365091|364811148|FG000|Period 2|Adverse Event|0|||
105770755|NCT01365091|364811149|FG001|Period 2|Adverse Event|0|||
105770756|NCT01365091|364811150|FG002|Period 2|Adverse Event|1|||
105770757|NCT01365091|364811151|FG003|Period 2|Adverse Event|0|||
105770758|NCT01474889|364811152|FG000|Overall Study|Physician Decision|1|||
105770759|NCT01474889|364811153|FG001|Overall Study|Physician Decision|0|||
105770760|NCT01474889|364811154|FG002|Overall Study|Physician Decision|0|||
105770761|NCT01474889|364811152|FG000|Overall Study|Did not meet inclusion|1|||
105770762|NCT01474889|364811153|FG001|Overall Study|Did not meet inclusion|0|||
105770763|NCT01474889|364811154|FG002|Overall Study|Did not meet inclusion|0|||
105770764|NCT01474889|364811152|FG000|Overall Study|Withdrawal by Subject|0|||
105770765|NCT01474889|364811153|FG001|Overall Study|Withdrawal by Subject|1|||
105770766|NCT01474889|364811154|FG002|Overall Study|Withdrawal by Subject|0|||
105770767|NCT03935594|364811161|FG000|Overall Study|Physician Decision|3|||
105770768|NCT03864627|364811163|FG000|Overall Study|Adverse Event|0|||
105770769|NCT03864627|364811164|FG001|Overall Study|Adverse Event|1|||
105770770|NCT03864627|364811163|FG000|Overall Study|Lack of Efficacy|0|||
105770771|NCT03864627|364811164|FG001|Overall Study|Lack of Efficacy|1|||
105770772|NCT03864627|364811163|FG000|Overall Study|Lost to Follow-up|0|||
105770773|NCT03864627|364811164|FG001|Overall Study|Lost to Follow-up|1|||
105770774|NCT03864627|364811163|FG000|Overall Study|Withdrawal by Subject|4|||
105770775|NCT03864627|364811164|FG001|Overall Study|Withdrawal by Subject|8|||
105770776|NCT03864627|364811163|FG000|Overall Study|Study terminated by sponsor|0|||
105770777|NCT03864627|364811164|FG001|Overall Study|Study terminated by sponsor|1|||
105770778|NCT04035473|364811169|FG000|Screening/Baseline|Death|0|||
105770779|NCT04035473|364811170|FG001|Screening/Baseline|Death|1|||
105770780|NCT04035473|364811169|FG000|Screening/Baseline|Adverse Event|0|||
105770781|NCT04035473|364811170|FG001|Screening/Baseline|Adverse Event|1|||
105770782|NCT04035473|364811169|FG000|Follow-up Period|Adverse Event|2|||
105770783|NCT04035473|364811170|FG001|Follow-up Period|Adverse Event|0|||
105878751|NCT01120184|365209743|FG001|Overall Study|Adverse Event|1|||
105770784|NCT03595176|364811171|FG000|Overall Study|Death|0|||
105770785|NCT03595176|364811172|FG001|Overall Study|Death|2|||
105770786|NCT03595176|364811171|FG000|Overall Study|Lost to Follow-up|0|||
105770787|NCT03595176|364811172|FG001|Overall Study|Lost to Follow-up|1|||
105770788|NCT03039569|364811175|FG000|Overall Study|Lost to Follow-up|5|||
105770789|NCT03039569|364811176|FG001|Overall Study|Lost to Follow-up|4|||
105770790|NCT00952419|364811179|FG000|Overall Study|Adverse Event|2|||
105770791|NCT00952419|364811180|FG001|Overall Study|Adverse Event|0|||
105770792|NCT00952419|364811181|FG002|Overall Study|Adverse Event|0|||
105770793|NCT00952419|364811179|FG000|Overall Study|Protocol Violation|3|||
105770794|NCT00952419|364811180|FG001|Overall Study|Protocol Violation|7|||
105770795|NCT00952419|364811181|FG002|Overall Study|Protocol Violation|0|||
105770796|NCT00952419|364811179|FG000|Overall Study|Withdrawal by Subject|1|||
105770797|NCT00952419|364811180|FG001|Overall Study|Withdrawal by Subject|3|||
105770798|NCT00952419|364811181|FG002|Overall Study|Withdrawal by Subject|0|||
105770799|NCT01004159|364813536|FG000|Overall Study|Adverse Event|2|||
105770800|NCT01004159|364813536|FG000|Overall Study|Disease Progression|18|||
105770801|NCT02531633|364813542|FG000|Part A (52 Weeks)|Sponsor request|24|||
105770802|NCT02531633|364813543|FG001|Part A (52 Weeks)|Sponsor request|24|||
105770803|NCT02531633|364813544|FG002|Part A (52 Weeks)|Sponsor request|18|||
105770804|NCT02531633|364813545|FG003|Part A (52 Weeks)|Sponsor request|18|||
105770805|NCT02531633|364813546|FG004|Part A (52 Weeks)|Sponsor request|19|||
105770806|NCT02531633|364813547|FG005|Part A (52 Weeks)|Sponsor request|0|||
105770807|NCT02531633|364813548|FG006|Part A (52 Weeks)|Sponsor request|0|||
105770808|NCT02531633|364813549|FG007|Part A (52 Weeks)|Sponsor request|0|||
105770809|NCT02531633|364813550|FG008|Part A (52 Weeks)|Sponsor request|0|||
105770810|NCT02531633|364813551|FG009|Part A (52 Weeks)|Sponsor request|0|||
105770811|NCT02531633|364813542|FG000|Part A (52 Weeks)|Protocol Violation|1|||
105770812|NCT02531633|364813543|FG001|Part A (52 Weeks)|Protocol Violation|0|||
105770813|NCT02531633|364813544|FG002|Part A (52 Weeks)|Protocol Violation|0|||
105770814|NCT02531633|364813545|FG003|Part A (52 Weeks)|Protocol Violation|0|||
105770815|NCT02531633|364813546|FG004|Part A (52 Weeks)|Protocol Violation|0|||
105770816|NCT02531633|364813547|FG005|Part A (52 Weeks)|Protocol Violation|0|||
105770817|NCT02531633|364813548|FG006|Part A (52 Weeks)|Protocol Violation|0|||
105770818|NCT02531633|364813549|FG007|Part A (52 Weeks)|Protocol Violation|0|||
105770819|NCT02531633|364813550|FG008|Part A (52 Weeks)|Protocol Violation|0|||
105770820|NCT02531633|364813551|FG009|Part A (52 Weeks)|Protocol Violation|0|||
105770821|NCT02531633|364813542|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
105770822|NCT02531633|364813543|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
105770823|NCT02531633|364813544|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
105770824|NCT02531633|364813545|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
105770825|NCT02531633|364813546|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
105770826|NCT02531633|364813547|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
105770827|NCT02531633|364813548|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
105770828|NCT02531633|364813549|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
105770829|NCT02531633|364813550|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
105770830|NCT02531633|364813551|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
105770831|NCT02531633|364813542|FG000|Part A (52 Weeks)|Physician Decision|1|||
105770832|NCT02531633|364813543|FG001|Part A (52 Weeks)|Physician Decision|4|||
105770833|NCT02531633|364813544|FG002|Part A (52 Weeks)|Physician Decision|3|||
105770834|NCT02531633|364813545|FG003|Part A (52 Weeks)|Physician Decision|1|||
105770835|NCT02531633|364813546|FG004|Part A (52 Weeks)|Physician Decision|0|||
105770836|NCT02531633|364813547|FG005|Part A (52 Weeks)|Physician Decision|0|||
105770837|NCT02531633|364813548|FG006|Part A (52 Weeks)|Physician Decision|0|||
105770838|NCT02531633|364813549|FG007|Part A (52 Weeks)|Physician Decision|0|||
105770839|NCT02531633|364813550|FG008|Part A (52 Weeks)|Physician Decision|0|||
105770840|NCT02531633|364813551|FG009|Part A (52 Weeks)|Physician Decision|0|||
105770841|NCT02531633|364813542|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
105770842|NCT02531633|364813543|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
105770843|NCT02531633|364813544|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
105770844|NCT02531633|364813545|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
105770845|NCT02531633|364813546|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
105770846|NCT02531633|364813547|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770847|NCT02531633|364813548|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770848|NCT02531633|364813549|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770849|NCT02531633|364813550|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770850|NCT02531633|364813551|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
105770851|NCT02531633|364813542|FG000|Part A (52 Weeks)|Other|2|||
105770852|NCT02531633|364813543|FG001|Part A (52 Weeks)|Other|0|||
105770853|NCT02531633|364813544|FG002|Part A (52 Weeks)|Other|0|||
105770854|NCT02531633|364813545|FG003|Part A (52 Weeks)|Other|0|||
105770855|NCT02531633|364813546|FG004|Part A (52 Weeks)|Other|0|||
105770856|NCT02531633|364813547|FG005|Part A (52 Weeks)|Other|0|||
105770857|NCT02531633|364813548|FG006|Part A (52 Weeks)|Other|0|||
105770858|NCT02531633|364813549|FG007|Part A (52 Weeks)|Other|0|||
105770859|NCT02531633|364813550|FG008|Part A (52 Weeks)|Other|0|||
105770860|NCT02531633|364813551|FG009|Part A (52 Weeks)|Other|0|||
105770861|NCT02531633|364813542|FG000|Part B (104 Weeks)|Sponsor request|0|||
105770862|NCT02531633|364813543|FG001|Part B (104 Weeks)|Sponsor request|0|||
105770863|NCT02531633|364813544|FG002|Part B (104 Weeks)|Sponsor request|0|||
105770864|NCT02531633|364813545|FG003|Part B (104 Weeks)|Sponsor request|0|||
105770865|NCT02531633|364813546|FG004|Part B (104 Weeks)|Sponsor request|0|||
105770866|NCT02531633|364813547|FG005|Part B (104 Weeks)|Sponsor request|8|||
105770867|NCT02531633|364813548|FG006|Part B (104 Weeks)|Sponsor request|5|||
105770868|NCT02531633|364813549|FG007|Part B (104 Weeks)|Sponsor request|3|||
105770869|NCT02531633|364813550|FG008|Part B (104 Weeks)|Sponsor request|5|||
105770870|NCT02531633|364813551|FG009|Part B (104 Weeks)|Sponsor request|4|||
105770871|NCT02531633|364813542|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
105770872|NCT02531633|364813543|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
105770873|NCT02531633|364813544|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
105770874|NCT02531633|364813545|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
105770875|NCT02531633|364813546|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
105770876|NCT02531633|364813547|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
105770877|NCT02531633|364813548|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
105770878|NCT02531633|364813549|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
105770879|NCT02531633|364813550|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
105770880|NCT02531633|364813551|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
105770881|NCT00425945|364813554|FG000|Overall Study|Concern about Supplement|2|||
105770882|NCT00425945|364813555|FG001|Overall Study|Concern about Supplement|0|||
105770883|NCT00425945|364813554|FG000|Overall Study|Inconvenience|0|||
105770884|NCT00425945|364813555|FG001|Overall Study|Inconvenience|2|||
105770885|NCT00425945|364813554|FG000|Overall Study|Lost to Follow-up|0|||
105770886|NCT00425945|364813555|FG001|Overall Study|Lost to Follow-up|2|||
105770887|NCT00425945|364813554|FG000|Overall Study|Began hypertension medication|1|||
105770888|NCT00425945|364813555|FG001|Overall Study|Began hypertension medication|0|||
105770889|NCT00425945|364813554|FG000|Overall Study|Began cancer treatments|1|||
105770890|NCT00425945|364813555|FG001|Overall Study|Began cancer treatments|0|||
105770891|NCT00425945|364813554|FG000|Overall Study|Moved from area|0|||
105770892|NCT00425945|364813555|FG001|Overall Study|Moved from area|1|||
105770893|NCT01536418|364813557|FG000|Overall Study|Protocol Violation|2|||
105770894|NCT01536418|364813558|FG001|Overall Study|Protocol Violation|3|||
105770895|NCT01536418|364813557|FG000|Overall Study|Physician Decision|1|||
105770896|NCT01536418|364813558|FG001|Overall Study|Physician Decision|3|||
105770897|NCT01536418|364813557|FG000|Overall Study|Study closed/terminated|41|||
105770898|NCT01536418|364813558|FG001|Overall Study|Study closed/terminated|37|||
105770899|NCT01536418|364813557|FG000|Overall Study|Lack of Efficacy|10|||
105770900|NCT01536418|364813558|FG001|Overall Study|Lack of Efficacy|16|||
105770901|NCT01536418|364813557|FG000|Overall Study|Adverse Event|9|||
105770902|NCT01536418|364813558|FG001|Overall Study|Adverse Event|4|||
105770903|NCT01536418|364813557|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
105770904|NCT01536418|364813558|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
105770905|NCT01536418|364813557|FG000|Overall Study|Withdrawal by Subject|5|||
105770906|NCT01536418|364813558|FG001|Overall Study|Withdrawal by Subject|3|||
105770907|NCT02365506|364813559|FG000|Overall Study|Investigator's Discretion|0|||
105770908|NCT02365506|364813560|FG001|Overall Study|Investigator's Discretion|0|||
105770909|NCT02365506|364813561|FG002|Overall Study|Investigator's Discretion|1|||
105770910|NCT01680991|364813562|FG000|Overall Study|Adverse Event|1|||
105770911|NCT01680991|364813563|FG001|Overall Study|Adverse Event|0|||
105770912|NCT01680991|364813564|FG002|Overall Study|Adverse Event|0|||
105770913|NCT01680991|364813562|FG000|Overall Study|Death|1|||
105770914|NCT01680991|364813563|FG001|Overall Study|Death|0|||
105770915|NCT01680991|364813564|FG002|Overall Study|Death|1|||
105770916|NCT01680991|364813562|FG000|Overall Study|Protocol Violation|0|||
105770917|NCT01680991|364813563|FG001|Overall Study|Protocol Violation|1|||
105770918|NCT01680991|364813564|FG002|Overall Study|Protocol Violation|0|||
105770919|NCT01680991|364813562|FG000|Overall Study|Withdrawal by Subject|5|||
105770920|NCT01680991|364813563|FG001|Overall Study|Withdrawal by Subject|1|||
105770921|NCT01680991|364813564|FG002|Overall Study|Withdrawal by Subject|0|||
105770922|NCT01680991|364813562|FG000|Overall Study|Progressive disease (PD)|0|||
105770923|NCT01680991|364813563|FG001|Overall Study|Progressive disease (PD)|10|||
105770924|NCT01680991|364813564|FG002|Overall Study|Progressive disease (PD)|0|||
105770925|NCT01680991|364813562|FG000|Overall Study|Physician Decision|0|||
105770926|NCT01680991|364813563|FG001|Overall Study|Physician Decision|7|||
105770927|NCT01680991|364813564|FG002|Overall Study|Physician Decision|2|||
105770928|NCT01680991|364813562|FG000|Overall Study|Bad physical condition|0|||
105770929|NCT01680991|364813563|FG001|Overall Study|Bad physical condition|0|||
105770930|NCT01680991|364813564|FG002|Overall Study|Bad physical condition|1|||
105770931|NCT01680991|364813562|FG000|Overall Study|PD confirmed in other hospital|1|||
105770932|NCT01680991|364813563|FG001|Overall Study|PD confirmed in other hospital|0|||
105770933|NCT01680991|364813564|FG002|Overall Study|PD confirmed in other hospital|0|||
105770934|NCT00610714|364813565|FG000|Overall Study|Adverse Event|3|||
105770935|NCT00610714|364813566|FG001|Overall Study|Adverse Event|1|||
105770936|NCT00610714|364813565|FG000|Overall Study|Death|12|||
105770937|NCT00610714|364813566|FG001|Overall Study|Death|18|||
105770938|NCT00610714|364813565|FG000|Overall Study|Withdrawal by Subject|9|||
105770939|NCT00610714|364813566|FG001|Overall Study|Withdrawal by Subject|3|||
105770940|NCT00610714|364813565|FG000|Overall Study|Study completion at 120 PFS events|2|||
105770941|NCT00610714|364813566|FG001|Overall Study|Study completion at 120 PFS events|2|||
105770942|NCT02756845|364813572|FG000|Overall Study|Death|12|||
105770943|NCT02756845|364813573|FG001|Overall Study|Death|2|||
105770944|NCT02756845|364813572|FG000|Overall Study|Withdrawal by Subject|1|||
105770945|NCT02756845|364813573|FG001|Overall Study|Withdrawal by Subject|0|||
105770946|NCT00285649|364813577|FG000|Overall Study|Lost to Follow-up|6|||
105770947|NCT00285649|364813578|FG001|Overall Study|Lost to Follow-up|4|||
105770948|NCT00285649|364813579|FG002|Overall Study|Lost to Follow-up|4|||
105770949|NCT00285649|364813577|FG000|Overall Study|Withdrawal by Subject|3|||
105770950|NCT00285649|364813578|FG001|Overall Study|Withdrawal by Subject|2|||
105770951|NCT00285649|364813579|FG002|Overall Study|Withdrawal by Subject|2|||
105770952|NCT02972593|364813580|FG000|Overall Study|Lost to Follow-up|19|||
105770953|NCT02972593|364813581|FG001|Overall Study|Lost to Follow-up|15|||
105770954|NCT02972593|364813580|FG000|Overall Study|Protocol Violation|1|||
105770955|NCT02972593|364813581|FG001|Overall Study|Protocol Violation|0|||
105770956|NCT01025232|364813585|FG000|Overall Study|Study drug no longer available|3|||
105770957|NCT01025232|364813586|FG001|Overall Study|Study drug no longer available|6|||
105770958|NCT00414973|364813587|FG000|Overall Study|Withdrawal by Subject|14|||
105770959|NCT00414973|364813588|FG001|Overall Study|Withdrawal by Subject|4|||
105770960|NCT00414973|364813589|FG002|Overall Study|Withdrawal by Subject|1|||
105770961|NCT00414973|364813590|FG003|Overall Study|Withdrawal by Subject|0|||
105770962|NCT00414973|364813587|FG000|Overall Study|Adverse Event|10|||
105770963|NCT00414973|364813588|FG001|Overall Study|Adverse Event|0|||
105770964|NCT00414973|364813589|FG002|Overall Study|Adverse Event|1|||
105770965|NCT00414973|364813590|FG003|Overall Study|Adverse Event|0|||
105770966|NCT00414973|364813587|FG000|Overall Study|Protocol Violation|3|||
105770967|NCT00414973|364813588|FG001|Overall Study|Protocol Violation|4|||
105770968|NCT00414973|364813589|FG002|Overall Study|Protocol Violation|0|||
105770969|NCT00414973|364813590|FG003|Overall Study|Protocol Violation|0|||
105770970|NCT00414973|364813587|FG000|Overall Study|Lost to Follow-up|0|||
105770971|NCT00414973|364813588|FG001|Overall Study|Lost to Follow-up|2|||
105770972|NCT00414973|364813589|FG002|Overall Study|Lost to Follow-up|0|||
105770973|NCT00414973|364813590|FG003|Overall Study|Lost to Follow-up|0|||
105770974|NCT00414973|364813587|FG000|Overall Study|Sponsor Decision|1|||
105770975|NCT00414973|364813588|FG001|Overall Study|Sponsor Decision|0|||
105770976|NCT00414973|364813589|FG002|Overall Study|Sponsor Decision|0|||
105770977|NCT00414973|364813590|FG003|Overall Study|Sponsor Decision|0|||
105770978|NCT00414973|364813587|FG000|Overall Study|Death|0|||
105770979|NCT00414973|364813588|FG001|Overall Study|Death|0|||
105770980|NCT00414973|364813589|FG002|Overall Study|Death|1|||
105770981|NCT00414973|364813590|FG003|Overall Study|Death|0|||
105770982|NCT01466062|364813591|FG000|Overall Study|Adverse Event|1|||
105770983|NCT01466062|364813591|FG000|Overall Study|Withdrawal by Subject|1|||
105770984|NCT03696576|364813594|FG000|Overall Study|Soreness of throat after therapy|1|||
105770985|NCT03696576|364813595|FG001|Overall Study|Soreness of throat after therapy|1|||
105770986|NCT03696576|364813594|FG000|Overall Study|Lost to Follow-up|2|||
105770987|NCT03696576|364813595|FG001|Overall Study|Lost to Follow-up|4|||
105770988|NCT00312728|364813596|FG000|Overall Study|Progressive disease|53|||
105770989|NCT00312728|364813596|FG000|Overall Study|Adverse Event|32|||
105770990|NCT00312728|364813596|FG000|Overall Study|Withdrawal by Subject|10|||
105770991|NCT00312728|364813596|FG000|Overall Study|Required non-protocol cancer treatment|2|||
105770992|NCT00312728|364813596|FG000|Overall Study|Protocol Violation|2|||
105770993|NCT00312728|364813596|FG000|Overall Study|Other|10|||
105770994|NCT00312728|364813596|FG000|Overall Study|Other|1|||
105770995|NCT00850135|364813597|FG000|Overall Study|Physician Decision|1|||
105770996|NCT02253992|364813598|FG000|Overall Study|Study drug toxicity|1|||
105770997|NCT02253992|364813599|FG001|Overall Study|Study drug toxicity|0|||
105770998|NCT02253992|364813600|FG002|Overall Study|Study drug toxicity|10|||
105770999|NCT02253992|364813598|FG000|Overall Study|Disease progression|4|||
105771000|NCT02253992|364813599|FG001|Overall Study|Disease progression|3|||
105771001|NCT02253992|364813600|FG002|Overall Study|Disease progression|98|||
105771002|NCT02253992|364813598|FG000|Overall Study|Withdrawal by Subject|0|||
105771003|NCT02253992|364813599|FG001|Overall Study|Withdrawal by Subject|0|||
105771004|NCT02253992|364813600|FG002|Overall Study|Withdrawal by Subject|3|||
105771005|NCT02253992|364813598|FG000|Overall Study|Adverse Event|0|||
105771006|NCT02253992|364813599|FG001|Overall Study|Adverse Event|0|||
105771007|NCT02253992|364813600|FG002|Overall Study|Adverse Event|8|||
105771008|NCT02253992|364813598|FG000|Overall Study|Death|0|||
105771009|NCT02253992|364813599|FG001|Overall Study|Death|0|||
105771010|NCT02253992|364813600|FG002|Overall Study|Death|1|||
105771011|NCT02253992|364813598|FG000|Overall Study|Subject discontinued study drug|1|||
105771012|NCT02253992|364813599|FG001|Overall Study|Subject discontinued study drug|0|||
105771013|NCT02253992|364813600|FG002|Overall Study|Subject discontinued study drug|1|||
105771014|NCT02253992|364813598|FG000|Overall Study|Completed treatment as per protocol|0|||
105771015|NCT02253992|364813599|FG001|Overall Study|Completed treatment as per protocol|1|||
105771016|NCT02253992|364813600|FG002|Overall Study|Completed treatment as per protocol|22|||
105771017|NCT02253992|364813598|FG000|Overall Study|Other|0|||
105771018|NCT02253992|364813599|FG001|Overall Study|Other|0|||
105771019|NCT02253992|364813600|FG002|Overall Study|Other|1|||
105771020|NCT00772889|364813601|FG000|Overall Study|Adverse Event|7|||
105771021|NCT00772889|364813602|FG001|Overall Study|Adverse Event|4|||
105771022|NCT00772889|364813603|FG002|Overall Study|Adverse Event|0|||
105771023|NCT00772889|364813601|FG000|Overall Study|Withdrawal by Subject|9|||
105771024|NCT00772889|364813602|FG001|Overall Study|Withdrawal by Subject|8|||
105771025|NCT00772889|364813603|FG002|Overall Study|Withdrawal by Subject|9|||
105771026|NCT00772889|364813601|FG000|Overall Study|Lost to Follow-up|6|||
105771027|NCT00772889|364813602|FG001|Overall Study|Lost to Follow-up|6|||
105771028|NCT00772889|364813603|FG002|Overall Study|Lost to Follow-up|7|||
105771029|NCT00085644|364813604|FG000|Double-Blind Period|Adverse Event|5|||
105771030|NCT00085644|364813605|FG001|Double-Blind Period|Adverse Event|2|||
105771031|NCT00085644|364813606|FG002|Double-Blind Period|Adverse Event|0|||
105771032|NCT00085644|364813604|FG000|Double-Blind Period|Withdrawal by Subject|3|||
105771033|NCT00085644|364813605|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105771034|NCT00085644|364813606|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105771035|NCT00085644|364813604|FG000|Double-Blind Period|Lost to Follow-up|2|||
105771036|NCT00085644|364813605|FG001|Double-Blind Period|Lost to Follow-up|1|||
105771037|NCT00085644|364813606|FG002|Double-Blind Period|Lost to Follow-up|0|||
105771038|NCT00085644|364813604|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
105771039|NCT00085644|364813605|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
105771040|NCT00085644|364813606|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
105771041|NCT00085644|364813604|FG000|Double-Blind Period|Contemplating pregnancy|1|||
105771042|NCT00085644|364813605|FG001|Double-Blind Period|Contemplating pregnancy|0|||
105771043|NCT00085644|364813606|FG002|Double-Blind Period|Contemplating pregnancy|0|||
105771044|NCT00085644|364813604|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
105771045|NCT00085644|364813605|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
105771046|NCT00085644|364813606|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
105771047|NCT00085644|364813604|FG000|Open-Label Period|Adverse Event|0|||
105771048|NCT00085644|364813605|FG001|Open-Label Period|Adverse Event|0|||
105771049|NCT00085644|364813606|FG002|Open-Label Period|Adverse Event|38|||
105771050|NCT00085644|364813604|FG000|Open-Label Period|Withdrawal by Subject|0|||
105771051|NCT00085644|364813605|FG001|Open-Label Period|Withdrawal by Subject|0|||
105771052|NCT00085644|364813606|FG002|Open-Label Period|Withdrawal by Subject|29|||
105771053|NCT00085644|364813604|FG000|Open-Label Period|Lost to Follow-up|0|||
105771054|NCT00085644|364813605|FG001|Open-Label Period|Lost to Follow-up|0|||
105771055|NCT00085644|364813606|FG002|Open-Label Period|Lost to Follow-up|13|||
105771056|NCT00085644|364813604|FG000|Open-Label Period|Lack of Efficacy|0|||
105771057|NCT00085644|364813605|FG001|Open-Label Period|Lack of Efficacy|0|||
105771058|NCT00085644|364813606|FG002|Open-Label Period|Lack of Efficacy|15|||
105771059|NCT00085644|364813604|FG000|Open-Label Period|Pregnancy|0|||
105771060|NCT00085644|364813605|FG001|Open-Label Period|Pregnancy|0|||
105771061|NCT00085644|364813606|FG002|Open-Label Period|Pregnancy|3|||
105771062|NCT00085644|364813604|FG000|Open-Label Period|Contemplating pregnancy|0|||
105771063|NCT00085644|364813605|FG001|Open-Label Period|Contemplating pregnancy|0|||
105771064|NCT00085644|364813606|FG002|Open-Label Period|Contemplating pregnancy|3|||
105771065|NCT00085644|364813604|FG000|Open-Label Period|Protocol Violation|0|||
105771066|NCT00085644|364813605|FG001|Open-Label Period|Protocol Violation|0|||
105771067|NCT00085644|364813606|FG002|Open-Label Period|Protocol Violation|4|||
105771068|NCT00085644|364813604|FG000|Open-Label Period|Personal reason|0|||
105771069|NCT00085644|364813605|FG001|Open-Label Period|Personal reason|0|||
105771070|NCT00085644|364813606|FG002|Open-Label Period|Personal reason|4|||
105771071|NCT04259346|364813607|FG000|Overall Study|Lost to Follow-up|1|||
105771072|NCT04259346|364813608|FG001|Overall Study|Lost to Follow-up|3|||
105771073|NCT04259346|364813607|FG000|Overall Study|Protocol Violation|1|||
105771074|NCT04259346|364813608|FG001|Overall Study|Protocol Violation|0|||
105771075|NCT04259346|364813607|FG000|Overall Study|Withdrawal by Subject|1|||
105771076|NCT04259346|364813608|FG001|Overall Study|Withdrawal by Subject|0|||
105771077|NCT04259346|364813607|FG000|Overall Study|Adverse Event|1|||
105771078|NCT04259346|364813608|FG001|Overall Study|Adverse Event|1|||
105771079|NCT03330106|364813609|FG000|Part A|Withdrawal by Subject|1|||
105771080|NCT03330106|364813610|FG001|Part A|Withdrawal by Subject|1|||
105771081|NCT03330106|364813611|FG002|Part A|Withdrawal by Subject|0|||
105771082|NCT03330106|364813612|FG003|Part A|Withdrawal by Subject|0|||
105771083|NCT03330106|364813609|FG000|Part A|Death|2|||
105771084|NCT03330106|364813610|FG001|Part A|Death|1|||
105771085|NCT03330106|364813611|FG002|Part A|Death|0|||
105771086|NCT03330106|364813612|FG003|Part A|Death|0|||
105771087|NCT03330106|364813609|FG000|Part A|Adverse Event|0|||
105771088|NCT03330106|364813610|FG001|Part A|Adverse Event|1|||
105771089|NCT03330106|364813611|FG002|Part A|Adverse Event|0|||
105771090|NCT03330106|364813612|FG003|Part A|Adverse Event|0|||
105771091|NCT03330106|364813609|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
105771092|NCT03330106|364813610|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
105771093|NCT03330106|364813611|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
105771094|NCT03330106|364813612|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
105771095|NCT03330106|364813609|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
105771096|NCT03330106|364813610|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
105771097|NCT03330106|364813611|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
105771098|NCT03330106|364813612|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
105771099|NCT03330106|364813609|FG000|Part A|Progressive Disease|0|||
105771100|NCT03330106|364813610|FG001|Part A|Progressive Disease|1|||
105771101|NCT03330106|364813611|FG002|Part A|Progressive Disease|0|||
105771102|NCT03330106|364813612|FG003|Part A|Progressive Disease|0|||
105771103|NCT03330106|364813609|FG000|Part B|Lost to Follow-up|0|||
105771104|NCT03330106|364813610|FG001|Part B|Lost to Follow-up|0|||
105771105|NCT03330106|364813611|FG002|Part B|Lost to Follow-up|0|||
105771106|NCT03330106|364813612|FG003|Part B|Lost to Follow-up|1|||
105771107|NCT03330106|364813609|FG000|Part B|Withdrawal by Subject|0|||
105771108|NCT03330106|364813610|FG001|Part B|Withdrawal by Subject|0|||
105771109|NCT03330106|364813611|FG002|Part B|Withdrawal by Subject|4|||
105771110|NCT03330106|364813612|FG003|Part B|Withdrawal by Subject|0|||
105771111|NCT03330106|364813609|FG000|Part B|Death|0|||
105771112|NCT03330106|364813610|FG001|Part B|Death|0|||
105771113|NCT03330106|364813611|FG002|Part B|Death|2|||
105771114|NCT03330106|364813612|FG003|Part B|Death|0|||
105771115|NCT03330106|364813609|FG000|Part B|Clinical Progression|0|||
105771116|NCT03330106|364813610|FG001|Part B|Clinical Progression|0|||
105771117|NCT03330106|364813611|FG002|Part B|Clinical Progression|1|||
105771118|NCT03330106|364813612|FG003|Part B|Clinical Progression|1|||
105771119|NCT03330106|364813609|FG000|Part B|Symptomatic Deterioration|0|||
105771120|NCT03330106|364813610|FG001|Part B|Symptomatic Deterioration|0|||
105771121|NCT03330106|364813611|FG002|Part B|Symptomatic Deterioration|0|||
105771122|NCT03330106|364813612|FG003|Part B|Symptomatic Deterioration|1|||
105771123|NCT03330106|364813609|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
105771124|NCT03330106|364813610|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
105771125|NCT03330106|364813611|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
105771126|NCT03330106|364813612|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
105771127|NCT03330106|364813609|FG000|Part B|Progressive Disease|0|||
105771128|NCT03330106|364813610|FG001|Part B|Progressive Disease|0|||
105771129|NCT03330106|364813611|FG002|Part B|Progressive Disease|11|||
105771130|NCT03330106|364813612|FG003|Part B|Progressive Disease|4|||
105771131|NCT00893763|364813614|FG000|Overall Study|extubated|110|||
105771132|NCT00893763|364813615|FG001|Overall Study|extubated|110|||
105771133|NCT00796549|364813616|FG000|Overall Study|Adverse Event|11|||
105771134|NCT00796549|364813616|FG000|Overall Study|not entered|149|||
105771135|NCT00796549|364813616|FG000|Overall Study|Other|2|||
105771136|NCT00796549|364813616|FG000|Overall Study|Progressive disease|56|||
105771137|NCT00606229|364813618|FG000|Overall Study|Adverse Event|11|||
105771138|NCT00606229|364813618|FG000|Overall Study|Lack of Efficacy|1|||
105771139|NCT00606229|364813618|FG000|Overall Study|Withdrawal by Subject|4|||
105771140|NCT00606229|364813618|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
105771141|NCT00606229|364813618|FG000|Overall Study|change of residence or other commitments|2|||
105771142|NCT01526928|364813619|FG000|Overall Study|Progressive Disease|35|||
105771143|NCT01526928|364813620|FG001|Overall Study|Progressive Disease|17|||
105771144|NCT01526928|364813621|FG002|Overall Study|Progressive Disease|150|||
105771145|NCT01526928|364813622|FG003|Overall Study|Progressive Disease|182|||
105771146|NCT01526928|364813623|FG004|Overall Study|Progressive Disease|76|||
105771147|NCT01526928|364813624|FG005|Overall Study|Progressive Disease|4|||
105771148|NCT01526928|364813619|FG000|Overall Study|Adverse Event|2|||
105771149|NCT01526928|364813620|FG001|Overall Study|Adverse Event|1|||
105771150|NCT01526928|364813621|FG002|Overall Study|Adverse Event|29|||
105771151|NCT01526928|364813622|FG003|Overall Study|Adverse Event|40|||
105771152|NCT01526928|364813623|FG004|Overall Study|Adverse Event|13|||
105771153|NCT01526928|364813624|FG005|Overall Study|Adverse Event|2|||
105771154|NCT01526928|364813619|FG000|Overall Study|Death|0|||
105771155|NCT01526928|364813620|FG001|Overall Study|Death|0|||
105771156|NCT01526928|364813621|FG002|Overall Study|Death|3|||
106099706|NCT02527798|366022601|FG003|Overall Study|Physician Decision|1|||
106099707|NCT02527798|366022602|FG004|Overall Study|Physician Decision|0|||
106099708|NCT02527798|366022603|FG005|Overall Study|Physician Decision|0|||
106099709|NCT02527798|366022598|FG000|Overall Study|Death|0|||
106099710|NCT02527798|366022599|FG001|Overall Study|Death|0|||
106099711|NCT02527798|366022600|FG002|Overall Study|Death|1|||
106099712|NCT02527798|366022601|FG003|Overall Study|Death|0|||
105771157|NCT01526928|364813622|FG003|Overall Study|Death|0|||
105771158|NCT01526928|364813623|FG004|Overall Study|Death|0|||
105771159|NCT01526928|364813624|FG005|Overall Study|Death|0|||
105771160|NCT01526928|364813619|FG000|Overall Study|Withdrawal by Subject|1|||
105771161|NCT01526928|364813620|FG001|Overall Study|Withdrawal by Subject|0|||
105771162|NCT01526928|364813621|FG002|Overall Study|Withdrawal by Subject|13|||
105771163|NCT01526928|364813622|FG003|Overall Study|Withdrawal by Subject|11|||
105771164|NCT01526928|364813623|FG004|Overall Study|Withdrawal by Subject|3|||
106099713|NCT02527798|366022602|FG004|Overall Study|Death|0|||
105771165|NCT01526928|364813624|FG005|Overall Study|Withdrawal by Subject|0|||
105771166|NCT01526928|364813619|FG000|Overall Study|Physician Decision|0|||
105771167|NCT01526928|364813620|FG001|Overall Study|Physician Decision|0|||
105771168|NCT01526928|364813621|FG002|Overall Study|Physician Decision|2|||
105771169|NCT01526928|364813622|FG003|Overall Study|Physician Decision|5|||
105771170|NCT01526928|364813623|FG004|Overall Study|Physician Decision|0|||
106099714|NCT02527798|366022603|FG005|Overall Study|Death|0|||
105771171|NCT01526928|364813624|FG005|Overall Study|Physician Decision|0|||
105771172|NCT01526928|364813619|FG000|Overall Study|Other Reason|0|||
105771173|NCT01526928|364813620|FG001|Overall Study|Other Reason|1|||
105771174|NCT01526928|364813621|FG002|Overall Study|Other Reason|11|||
105771175|NCT01526928|364813622|FG003|Overall Study|Other Reason|4|||
105771176|NCT01526928|364813623|FG004|Overall Study|Other Reason|1|||
105771177|NCT01526928|364813624|FG005|Overall Study|Other Reason|0|||
105771178|NCT01526928|364813619|FG000|Overall Study|Lost to Follow-up|0|||
105771179|NCT01526928|364813620|FG001|Overall Study|Lost to Follow-up|0|||
105771180|NCT01526928|364813621|FG002|Overall Study|Lost to Follow-up|0|||
105771181|NCT01526928|364813622|FG003|Overall Study|Lost to Follow-up|1|||
105771182|NCT01526928|364813623|FG004|Overall Study|Lost to Follow-up|0|||
105771183|NCT01526928|364813624|FG005|Overall Study|Lost to Follow-up|0|||
105771184|NCT01526928|364813619|FG000|Overall Study|Protocol Deviation|0|||
105771185|NCT01526928|364813620|FG001|Overall Study|Protocol Deviation|0|||
105771186|NCT01526928|364813621|FG002|Overall Study|Protocol Deviation|0|||
105771187|NCT01526928|364813622|FG003|Overall Study|Protocol Deviation|2|||
105771188|NCT01526928|364813623|FG004|Overall Study|Protocol Deviation|0|||
105771189|NCT01526928|364813624|FG005|Overall Study|Protocol Deviation|0|||
105771190|NCT01526928|364813619|FG000|Overall Study|Missing|0|||
105771191|NCT01526928|364813620|FG001|Overall Study|Missing|0|||
105771192|NCT01526928|364813621|FG002|Overall Study|Missing|1|||
105771193|NCT01526928|364813622|FG003|Overall Study|Missing|0|||
105771194|NCT01526928|364813623|FG004|Overall Study|Missing|2|||
105771195|NCT01526928|364813624|FG005|Overall Study|Missing|0|||
105771196|NCT02139280|364813625|FG000|Overall Study|No longer eligible|2|||
105771197|NCT02139280|364813626|FG001|Overall Study|No longer eligible|0|||
105771198|NCT01108068|364813627|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
105771199|NCT01108068|364813628|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
105771200|NCT00836953|364813629|FG000|Overall Study|Withdrawal by Subject|1|||
105771201|NCT00836953|364813629|FG000|Overall Study|Lost to Follow-up|1|||
105771202|NCT02877134|364813630|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771203|NCT02877134|364813631|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
105771204|NCT02877134|364813632|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771205|NCT02877134|364813633|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771206|NCT02877134|364813634|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771207|NCT02877134|364813635|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
105771208|NCT02877134|364813636|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771209|NCT02877134|364813637|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771210|NCT02877134|364813638|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771211|NCT02877134|364813639|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771212|NCT02877134|364813640|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771213|NCT02877134|364813641|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
105771214|NCT02877134|364813630|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771215|NCT02877134|364813631|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
105771216|NCT02877134|364813632|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771217|NCT02877134|364813633|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
105771218|NCT02877134|364813634|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771219|NCT02877134|364813635|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771220|NCT02877134|364813636|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
105771221|NCT02877134|364813637|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771222|NCT02877134|364813638|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771223|NCT02877134|364813639|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771224|NCT02877134|364813640|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771225|NCT02877134|364813641|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
105771226|NCT02877134|364813630|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
105771227|NCT02877134|364813631|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
105771228|NCT02877134|364813632|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
105771229|NCT02877134|364813633|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
105771230|NCT02877134|364813634|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
105771231|NCT02877134|364813635|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
105771232|NCT02877134|364813636|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
105771233|NCT02877134|364813637|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771234|NCT02877134|364813638|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771235|NCT02877134|364813639|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771236|NCT02877134|364813640|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771237|NCT02877134|364813641|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
105771238|NCT02877134|364813630|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
105771239|NCT02877134|364813631|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
105771240|NCT02877134|364813632|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
105771241|NCT02877134|364813633|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
105771242|NCT02877134|364813634|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
105771243|NCT02877134|364813635|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
105771244|NCT02877134|364813636|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
105771245|NCT02877134|364813637|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771246|NCT02877134|364813638|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771247|NCT02877134|364813639|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771248|NCT02877134|364813640|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771249|NCT02877134|364813641|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
105771250|NCT02877134|364813630|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771251|NCT02877134|364813631|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771252|NCT02877134|364813632|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771253|NCT02877134|364813633|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771254|NCT02877134|364813634|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771255|NCT02877134|364813635|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771256|NCT02877134|364813636|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771257|NCT02877134|364813637|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771258|NCT02877134|364813638|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
105771259|NCT02877134|364813639|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771260|NCT02877134|364813640|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771261|NCT02877134|364813641|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
105771262|NCT02877134|364813630|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771263|NCT02877134|364813631|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771264|NCT02877134|364813632|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771265|NCT02877134|364813633|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771266|NCT02877134|364813634|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771267|NCT02877134|364813635|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771268|NCT02877134|364813636|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
105771269|NCT02877134|364813637|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
105771270|NCT02877134|364813638|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
105771271|NCT02877134|364813639|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
105771272|NCT02877134|364813640|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
105771273|NCT02877134|364813641|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
105771274|NCT02877134|364813630|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771275|NCT02877134|364813631|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771276|NCT02877134|364813632|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771277|NCT02877134|364813633|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771278|NCT02877134|364813634|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771279|NCT02877134|364813635|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771280|NCT02877134|364813636|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771281|NCT02877134|364813637|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
105771282|NCT02877134|364813638|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
105771283|NCT02877134|364813639|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
105771284|NCT02877134|364813640|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771285|NCT02877134|364813641|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
105771286|NCT02877134|364813630|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
105771287|NCT02877134|364813631|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
105771288|NCT02877134|364813632|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
105771289|NCT02877134|364813633|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
105771290|NCT02877134|364813634|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
105771291|NCT02877134|364813635|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
105771292|NCT02877134|364813636|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
105771293|NCT02877134|364813637|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
105771294|NCT02877134|364813638|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
105771295|NCT02877134|364813639|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
105771296|NCT02877134|364813640|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
105771297|NCT02877134|364813641|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
105771298|NCT01249157|364813644|FG000|Overall Study|Withdrawal by Subject|1|||
105771299|NCT04445051|364813645|FG000|Overall Study|Adverse Event|0|||
105771300|NCT04445051|364813646|FG001|Overall Study|Adverse Event|0|||
105771301|NCT04445051|364813647|FG002|Overall Study|Adverse Event|1|||
105771302|NCT04445051|364813648|FG003|Overall Study|Adverse Event|0|||
105771303|NCT04445051|364813649|FG004|Overall Study|Adverse Event|0|||
105771304|NCT04445051|364813650|FG005|Overall Study|Adverse Event|0|||
105771305|NCT01197794|364813655|FG000|Overall Study|Adverse Event|3|||
105771306|NCT01197794|364813656|FG001|Overall Study|Adverse Event|2|||
105771307|NCT01197794|364813657|FG002|Overall Study|Adverse Event|4|||
105771308|NCT01197794|364813658|FG003|Overall Study|Adverse Event|4|||
105771309|NCT01197794|364813659|FG004|Overall Study|Adverse Event|4|||
105771310|NCT01197794|364813660|FG005|Overall Study|Adverse Event|2|||
105771311|NCT01197794|364813661|FG006|Overall Study|Adverse Event|3|||
105771312|NCT01197794|364813655|FG000|Overall Study|Protocol Violation|0|||
105771313|NCT01197794|364813656|FG001|Overall Study|Protocol Violation|0|||
105771314|NCT01197794|364813657|FG002|Overall Study|Protocol Violation|0|||
105771315|NCT01197794|364813658|FG003|Overall Study|Protocol Violation|0|||
105771316|NCT01197794|364813659|FG004|Overall Study|Protocol Violation|2|||
105771317|NCT01197794|364813660|FG005|Overall Study|Protocol Violation|0|||
105771318|NCT01197794|364813661|FG006|Overall Study|Protocol Violation|1|||
105771319|NCT01197794|364813655|FG000|Overall Study|Development of study withdrawal criteria|3|||
105771320|NCT01197794|364813656|FG001|Overall Study|Development of study withdrawal criteria|0|||
105771321|NCT01197794|364813657|FG002|Overall Study|Development of study withdrawal criteria|0|||
105771322|NCT01197794|364813658|FG003|Overall Study|Development of study withdrawal criteria|1|||
105771323|NCT01197794|364813659|FG004|Overall Study|Development of study withdrawal criteria|0|||
105771324|NCT01197794|364813660|FG005|Overall Study|Development of study withdrawal criteria|0|||
105771325|NCT01197794|364813661|FG006|Overall Study|Development of study withdrawal criteria|1|||
105771326|NCT01197794|364813655|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
105771327|NCT01197794|364813656|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
105771328|NCT01197794|364813657|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
105771329|NCT01197794|364813658|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
105771330|NCT01197794|364813659|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
105771331|NCT01197794|364813660|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
105771332|NCT01197794|364813661|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
105771333|NCT01197794|364813655|FG000|Overall Study|Withdrawal by Subject|3|||
105771334|NCT01197794|364813656|FG001|Overall Study|Withdrawal by Subject|3|||
105771335|NCT01197794|364813657|FG002|Overall Study|Withdrawal by Subject|4|||
105771336|NCT01197794|364813658|FG003|Overall Study|Withdrawal by Subject|1|||
105771337|NCT01197794|364813659|FG004|Overall Study|Withdrawal by Subject|1|||
105771338|NCT01197794|364813660|FG005|Overall Study|Withdrawal by Subject|5|||
105771339|NCT01197794|364813661|FG006|Overall Study|Withdrawal by Subject|6|||
105771340|NCT01197794|364813655|FG000|Overall Study|Lost to Follow-up|1|||
105771341|NCT01197794|364813656|FG001|Overall Study|Lost to Follow-up|1|||
105771342|NCT01197794|364813657|FG002|Overall Study|Lost to Follow-up|0|||
105771343|NCT01197794|364813658|FG003|Overall Study|Lost to Follow-up|1|||
105771344|NCT01197794|364813659|FG004|Overall Study|Lost to Follow-up|0|||
105771345|NCT01197794|364813660|FG005|Overall Study|Lost to Follow-up|1|||
105771346|NCT01197794|364813661|FG006|Overall Study|Lost to Follow-up|0|||
105771347|NCT01197794|364813655|FG000|Overall Study|Other|1|||
105771348|NCT01197794|364813656|FG001|Overall Study|Other|1|||
105771349|NCT01197794|364813657|FG002|Overall Study|Other|3|||
105771350|NCT01197794|364813658|FG003|Overall Study|Other|0|||
105771351|NCT01197794|364813659|FG004|Overall Study|Other|2|||
105771352|NCT01197794|364813660|FG005|Overall Study|Other|2|||
105771353|NCT01197794|364813661|FG006|Overall Study|Other|4|||
105771354|NCT04055844|364813663|FG000|Overall Study|Adverse Event|12|||
105771355|NCT04055844|364813663|FG000|Overall Study|Poor Performance|1|||
105771356|NCT04055844|364813663|FG000|Overall Study|Death|1|||
105771357|NCT00572728|364813664|FG000|Overall Study|Withdrawal by Subject|10|||
105771358|NCT00572728|364813664|FG000|Overall Study|Ineligible|3|||
106099715|NCT02527798|366022598|FG000|Overall Study|Withdrawal by Subject|0|||
106099716|NCT02527798|366022599|FG001|Overall Study|Withdrawal by Subject|1|||
106099717|NCT02527798|366022600|FG002|Overall Study|Withdrawal by Subject|2|||
106099718|NCT02527798|366022601|FG003|Overall Study|Withdrawal by Subject|0|||
106099719|NCT02527798|366022602|FG004|Overall Study|Withdrawal by Subject|0|||
106099720|NCT02527798|366022603|FG005|Overall Study|Withdrawal by Subject|0|||
106099721|NCT02527798|366022598|FG000|Overall Study|Reason undisclosed|1|||
106099722|NCT02527798|366022599|FG001|Overall Study|Reason undisclosed|0|||
106099723|NCT02527798|366022600|FG002|Overall Study|Reason undisclosed|1|||
106099724|NCT02527798|366022601|FG003|Overall Study|Reason undisclosed|0|||
106099725|NCT02527798|366022602|FG004|Overall Study|Reason undisclosed|0|||
106099726|NCT02527798|366022603|FG005|Overall Study|Reason undisclosed|0|||
106099727|NCT02527798|366022598|FG000|Overall Study|Did not receive intervention|1|||
106099728|NCT02527798|366022599|FG001|Overall Study|Did not receive intervention|1|||
106099729|NCT02527798|366022600|FG002|Overall Study|Did not receive intervention|0|||
106099730|NCT02527798|366022601|FG003|Overall Study|Did not receive intervention|0|||
106099731|NCT02527798|366022602|FG004|Overall Study|Did not receive intervention|0|||
106099732|NCT02527798|366022603|FG005|Overall Study|Did not receive intervention|0|||
106099733|NCT01682460|366022609|FG000|Overall Study|Withdrawal by Subject|2|||
106099734|NCT01682460|366022609|FG000|Overall Study|Did not meet inclusion criteria|2|||
106099735|NCT01912612|366022612|FG000|Overall Study|Adverse Event|4|||
106099736|NCT01912612|366022613|FG001|Overall Study|Adverse Event|0|||
106099737|NCT01912612|366022614|FG002|Overall Study|Adverse Event|0|||
106099738|NCT01912612|366022612|FG000|Overall Study|Withdrew consent|1|||
105771359|NCT00572728|364813664|FG000|Overall Study|Enrolled under Amendment 4|5|||
105771360|NCT00572728|364813664|FG000|Overall Study|Offstudy due to complicating disease|1|||
105771361|NCT00572728|364813664|FG000|Overall Study|FLT1 not completed|4|||
105771362|NCT00572728|364813664|FG000|Overall Study|First Chemotherapy not initiated|2|||
105771363|NCT00572728|364813664|FG000|Overall Study|FLT2 not completed|5|||
105771364|NCT00572728|364813664|FG000|Overall Study|Second chemotherapy not initiated|1|||
105771365|NCT00572728|364813664|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
105771366|NCT00572728|364813664|FG000|Overall Study|Pathology missing|1|||
105771367|NCT00255008|364813667|FG000|Overall Study|Adverse Event|1|||
105771368|NCT00255008|364813668|FG001|Overall Study|Adverse Event|1|||
105771369|NCT00255008|364813669|FG002|Overall Study|Adverse Event|2|||
105771370|NCT00255008|364813670|FG003|Overall Study|Adverse Event|0|||
105771371|NCT00255008|364813667|FG000|Overall Study|Lost to Follow-up|1|||
105771372|NCT00255008|364813668|FG001|Overall Study|Lost to Follow-up|0|||
105771373|NCT00255008|364813669|FG002|Overall Study|Lost to Follow-up|1|||
105771374|NCT00255008|364813670|FG003|Overall Study|Lost to Follow-up|2|||
105771375|NCT00255008|364813667|FG000|Overall Study|Did not meet viral reduction criteria|4|||
105771376|NCT00255008|364813668|FG001|Overall Study|Did not meet viral reduction criteria|5|||
105771377|NCT00255008|364813669|FG002|Overall Study|Did not meet viral reduction criteria|0|||
105771378|NCT00255008|364813670|FG003|Overall Study|Did not meet viral reduction criteria|1|||
105771379|NCT00255008|364813667|FG000|Overall Study|Withdrew consent|0|||
105771380|NCT00255008|364813668|FG001|Overall Study|Withdrew consent|0|||
105771381|NCT00255008|364813669|FG002|Overall Study|Withdrew consent|2|||
105771382|NCT00255008|364813670|FG003|Overall Study|Withdrew consent|0|||
105771383|NCT00255008|364813667|FG000|Overall Study|Sponsor request|18|||
105771384|NCT00255008|364813668|FG001|Overall Study|Sponsor request|3|||
105771385|NCT00255008|364813669|FG002|Overall Study|Sponsor request|8|||
105771386|NCT00255008|364813670|FG003|Overall Study|Sponsor request|17|||
105771387|NCT00255008|364813667|FG000|Overall Study|Adverse lab experience|1|||
105771388|NCT00255008|364813668|FG001|Overall Study|Adverse lab experience|0|||
105771389|NCT00255008|364813669|FG002|Overall Study|Adverse lab experience|0|||
105771390|NCT00255008|364813670|FG003|Overall Study|Adverse lab experience|0|||
105771391|NCT00255008|364813667|FG000|Overall Study|Other|7|||
105771392|NCT00255008|364813668|FG001|Overall Study|Other|0|||
105771393|NCT00255008|364813669|FG002|Overall Study|Other|3|||
105771394|NCT00255008|364813670|FG003|Overall Study|Other|2|||
105771395|NCT03457636|364813673|FG000|Overall Study|Lost to Follow-up|2|||
105771396|NCT02724111|364813674|FG000|Overall Study|Protocol Violation|2|||
105771397|NCT02724111|364813675|FG001|Overall Study|Protocol Violation|5|||
105771398|NCT02996500|364813676|FG000|Overall Study|Adverse Event|1|||
105771399|NCT02996500|364813677|FG001|Overall Study|Adverse Event|1|||
105771400|NCT02996500|364813678|FG002|Overall Study|Adverse Event|4|||
105771401|NCT02996500|364813679|FG003|Overall Study|Adverse Event|3|||
105771402|NCT02996500|364813680|FG004|Overall Study|Adverse Event|1|||
105771403|NCT02996500|364813681|FG005|Overall Study|Adverse Event|2|||
105771404|NCT02996500|364813676|FG000|Overall Study|Lack of Efficacy|0|||
105771405|NCT02996500|364813677|FG001|Overall Study|Lack of Efficacy|0|||
105771406|NCT02996500|364813678|FG002|Overall Study|Lack of Efficacy|0|||
105771407|NCT02996500|364813679|FG003|Overall Study|Lack of Efficacy|0|||
105771408|NCT02996500|364813680|FG004|Overall Study|Lack of Efficacy|2|||
105771409|NCT02996500|364813681|FG005|Overall Study|Lack of Efficacy|0|||
105771410|NCT02996500|364813676|FG000|Overall Study|Lost to Follow-up|1|||
105771411|NCT02996500|364813677|FG001|Overall Study|Lost to Follow-up|0|||
105771412|NCT02996500|364813678|FG002|Overall Study|Lost to Follow-up|0|||
105771413|NCT02996500|364813679|FG003|Overall Study|Lost to Follow-up|0|||
105771414|NCT02996500|364813680|FG004|Overall Study|Lost to Follow-up|0|||
105771415|NCT02996500|364813681|FG005|Overall Study|Lost to Follow-up|1|||
105771416|NCT02996500|364813676|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771417|NCT02996500|364813677|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771418|NCT02996500|364813678|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
105771419|NCT02996500|364813679|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771420|NCT02996500|364813680|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771421|NCT02996500|364813681|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
105771422|NCT02996500|364813676|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105771423|NCT02996500|364813677|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105771424|NCT02996500|364813678|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105771425|NCT02996500|364813679|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105771426|NCT02996500|364813680|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105771427|NCT02996500|364813681|FG005|Overall Study|Non-Compliance With Study Drug|1|||
105771428|NCT02996500|364813676|FG000|Overall Study|Progressive Disease|1|||
105771429|NCT02996500|364813677|FG001|Overall Study|Progressive Disease|0|||
105771430|NCT02996500|364813678|FG002|Overall Study|Progressive Disease|0|||
105771431|NCT02996500|364813679|FG003|Overall Study|Progressive Disease|0|||
105771432|NCT02996500|364813680|FG004|Overall Study|Progressive Disease|0|||
105771433|NCT02996500|364813681|FG005|Overall Study|Progressive Disease|0|||
105771434|NCT02996500|364813676|FG000|Overall Study|Other|2|||
105771435|NCT02996500|364813677|FG001|Overall Study|Other|0|||
105771436|NCT02996500|364813678|FG002|Overall Study|Other|2|||
105771437|NCT02996500|364813679|FG003|Overall Study|Other|0|||
105771438|NCT02996500|364813680|FG004|Overall Study|Other|0|||
105771439|NCT02996500|364813681|FG005|Overall Study|Other|0|||
105771440|NCT02996500|364813676|FG000|Overall Study|Protocol Violation|0|||
105771441|NCT02996500|364813677|FG001|Overall Study|Protocol Violation|0|||
105771442|NCT02996500|364813678|FG002|Overall Study|Protocol Violation|0|||
105771443|NCT02996500|364813679|FG003|Overall Study|Protocol Violation|1|||
105771444|NCT02996500|364813680|FG004|Overall Study|Protocol Violation|0|||
105771445|NCT02996500|364813681|FG005|Overall Study|Protocol Violation|0|||
105771446|NCT02996500|364813676|FG000|Overall Study|Withdrawal by Subject|3|||
105771447|NCT02996500|364813677|FG001|Overall Study|Withdrawal by Subject|0|||
105771448|NCT02996500|364813678|FG002|Overall Study|Withdrawal by Subject|3|||
105771449|NCT02996500|364813679|FG003|Overall Study|Withdrawal by Subject|0|||
105771450|NCT02996500|364813680|FG004|Overall Study|Withdrawal by Subject|2|||
105771451|NCT02996500|364813681|FG005|Overall Study|Withdrawal by Subject|0|||
105771452|NCT03924427|364813684|FG000|Overall Study|Adverse Event|4|||
105771453|NCT03924427|364813684|FG000|Overall Study|Lack of Efficacy|1|||
105771454|NCT03924427|364813684|FG000|Overall Study|Withdrawal by Subject|1|||
105771455|NCT01307046|364813691|FG000|Overall Study|Adverse Event|3|||
105771456|NCT01307046|364813692|FG001|Overall Study|Adverse Event|3|||
105771457|NCT01307046|364813691|FG000|Overall Study|Lack of Efficacy|0|||
105771458|NCT01307046|364813692|FG001|Overall Study|Lack of Efficacy|2|||
105771459|NCT01307046|364813691|FG000|Overall Study|Physician Decision|2|||
105771460|NCT01307046|364813692|FG001|Overall Study|Physician Decision|0|||
105771461|NCT01307046|364813691|FG000|Overall Study|Withdrawal by Subject|1|||
105771462|NCT01307046|364813692|FG001|Overall Study|Withdrawal by Subject|1|||
105771463|NCT01307046|364813691|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
105771464|NCT01307046|364813692|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
105771465|NCT01307046|364813691|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
105771466|NCT01307046|364813692|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
105771467|NCT01435122|364813693|FG000|Overall Study|Early withdrawal due to toxicity|8|||
105771468|NCT00112840|364813694|FG000|Overall Study|Physician Decision|1|||
105771469|NCT00112840|364813695|FG001|Overall Study|Physician Decision|0|||
105771470|NCT00112840|364813696|FG002|Overall Study|Physician Decision|0|||
105771471|NCT00112840|364813694|FG000|Overall Study|Withdrawal by Subject|1|||
105771472|NCT00112840|364813695|FG001|Overall Study|Withdrawal by Subject|0|||
105771473|NCT00112840|364813696|FG002|Overall Study|Withdrawal by Subject|1|||
105771474|NCT00112840|364813694|FG000|Overall Study|Protocol Violation|0|||
105771475|NCT00112840|364813695|FG001|Overall Study|Protocol Violation|0|||
105771476|NCT00112840|364813696|FG002|Overall Study|Protocol Violation|5|||
105771477|NCT02299206|364813697|FG000|Overall Study|Lost to Follow-up|1|||
105771478|NCT02299206|364813697|FG000|Overall Study|Withdrawal by Subject|1|||
105771479|NCT00683774|364813704|FG000|Overall Study|Withdrawal by Subject|0|||
105771480|NCT00683774|364813705|FG001|Overall Study|Withdrawal by Subject|1|||
105771481|NCT00683774|364813704|FG000|Overall Study|Physician Decision|3|||
105771482|NCT00683774|364813705|FG001|Overall Study|Physician Decision|0|||
105771483|NCT01222416|364813706|FG000|Overall Study|ineligible;metastasis|3|||
105771484|NCT01222416|364813707|FG001|Overall Study|ineligible;metastasis|0|||
105771485|NCT01222416|364813706|FG000|Overall Study|Adverse Event|4|||
105771486|NCT01222416|364813707|FG001|Overall Study|Adverse Event|0|||
105771487|NCT01222416|364813706|FG000|Overall Study|Withdrawal by Subject|5|||
105771488|NCT01222416|364813707|FG001|Overall Study|Withdrawal by Subject|0|||
105771489|NCT01222416|364813706|FG000|Overall Study|scheduling|6|||
105771490|NCT01222416|364813707|FG001|Overall Study|scheduling|0|||
105771491|NCT01222416|364813706|FG000|Overall Study|missed view/scan|1|||
105771492|NCT01222416|364813707|FG001|Overall Study|missed view/scan|0|||
105771493|NCT01222416|364813706|FG000|Overall Study|Death|1|||
105771494|NCT01222416|364813707|FG001|Overall Study|Death|0|||
105771495|NCT00691054|364813708|FG000|Overall Study|Withdrawal by Subject|1|||
105771496|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
105771497|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
105771498|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
105771499|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
105771500|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
105771501|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
105771502|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
105771503|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
105771504|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
105771505|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
105771506|NCT02178592|364813709|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
105771507|NCT02178592|364813710|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
105771508|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
105771509|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
105771510|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
105771511|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
105771512|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
105771513|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
105771514|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
105771515|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
105771516|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
105771517|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
105771518|NCT02178592|364813709|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
105771519|NCT02178592|364813710|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
105771520|NCT02520141|364813711|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
105771521|NCT02735044|364813713|FG000|Overall Study|Adverse Event|3|||
105771522|NCT02735044|364813714|FG001|Overall Study|Adverse Event|3|||
105771523|NCT02735044|364813713|FG000|Overall Study|Lack of Efficacy|1|||
105771524|NCT02735044|364813714|FG001|Overall Study|Lack of Efficacy|0|||
105771525|NCT02735044|364813713|FG000|Overall Study|Poor compliance to protocol|7|||
105771526|NCT02735044|364813714|FG001|Overall Study|Poor compliance to protocol|7|||
105771527|NCT02735044|364813713|FG000|Overall Study|Randomized and not treated|0|||
105771528|NCT02735044|364813714|FG001|Overall Study|Randomized and not treated|2|||
105771529|NCT02735044|364813713|FG000|Overall Study|Other, not specified above|5|||
105771530|NCT02735044|364813714|FG001|Overall Study|Other, not specified above|11|||
105771531|NCT00397891|364813715|FG000|Overall Study|Withdrawal by Subject|1|||
105771532|NCT00397891|364813716|FG001|Overall Study|Withdrawal by Subject|0|||
105771533|NCT00397891|364813717|FG002|Overall Study|Withdrawal by Subject|0|||
105771534|NCT00397891|364813718|FG003|Overall Study|Withdrawal by Subject|0|||
105771535|NCT00397891|364813719|FG004|Overall Study|Withdrawal by Subject|1|||
105771536|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
105771537|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771538|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771539|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771540|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771541|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105771542|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
105771543|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771544|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771545|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771546|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771547|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105771548|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
105771549|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771550|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771551|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771552|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771553|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105771554|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Other|14|||
105771555|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Other|0|||
105771556|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Other|0|||
105771557|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Other|0|||
105771558|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Other|0|||
105771559|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Other|0|||
105771560|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
105771561|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771562|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771563|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771564|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771565|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
105771566|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
105771567|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771568|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771569|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771570|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771571|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105771572|NCT02141854|364813720|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
105771573|NCT02141854|364813721|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771574|NCT02141854|364813722|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771575|NCT02141854|364813723|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771576|NCT02141854|364813724|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771577|NCT02141854|364813725|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105771578|NCT02141854|364813720|FG000|Treatment Period|Protocol Violation|0|||
105771579|NCT02141854|364813721|FG001|Treatment Period|Protocol Violation|1|||
105771580|NCT02141854|364813722|FG002|Treatment Period|Protocol Violation|0|||
105771581|NCT02141854|364813723|FG003|Treatment Period|Protocol Violation|2|||
105771582|NCT02141854|364813724|FG004|Treatment Period|Protocol Violation|2|||
105771583|NCT02141854|364813725|FG005|Treatment Period|Protocol Violation|1|||
105771584|NCT02141854|364813720|FG000|Treatment Period|Noncompliance|0|||
105771585|NCT02141854|364813721|FG001|Treatment Period|Noncompliance|0|||
105771586|NCT02141854|364813722|FG002|Treatment Period|Noncompliance|0|||
105771587|NCT02141854|364813723|FG003|Treatment Period|Noncompliance|1|||
105771588|NCT02141854|364813724|FG004|Treatment Period|Noncompliance|0|||
105771589|NCT02141854|364813725|FG005|Treatment Period|Noncompliance|0|||
105771590|NCT02141854|364813720|FG000|Treatment Period|Lack of Efficacy|0|||
105771591|NCT02141854|364813721|FG001|Treatment Period|Lack of Efficacy|0|||
105771592|NCT02141854|364813722|FG002|Treatment Period|Lack of Efficacy|0|||
105771593|NCT02141854|364813723|FG003|Treatment Period|Lack of Efficacy|1|||
105771594|NCT02141854|364813724|FG004|Treatment Period|Lack of Efficacy|1|||
105771595|NCT02141854|364813725|FG005|Treatment Period|Lack of Efficacy|7|||
105771596|NCT02141854|364813720|FG000|Treatment Period|Pregnancy|0|||
105771597|NCT02141854|364813721|FG001|Treatment Period|Pregnancy|1|||
105771598|NCT02141854|364813722|FG002|Treatment Period|Pregnancy|0|||
105771599|NCT02141854|364813723|FG003|Treatment Period|Pregnancy|0|||
105771600|NCT02141854|364813724|FG004|Treatment Period|Pregnancy|0|||
105771601|NCT02141854|364813725|FG005|Treatment Period|Pregnancy|0|||
105771602|NCT02141854|364813720|FG000|Treatment Period|Other|0|||
105771603|NCT02141854|364813721|FG001|Treatment Period|Other|1|||
105771604|NCT02141854|364813722|FG002|Treatment Period|Other|2|||
105771605|NCT02141854|364813723|FG003|Treatment Period|Other|0|||
105771606|NCT02141854|364813724|FG004|Treatment Period|Other|1|||
105771607|NCT02141854|364813725|FG005|Treatment Period|Other|2|||
105771608|NCT02141854|364813720|FG000|Treatment Period|Adverse Event|0|||
105771609|NCT02141854|364813721|FG001|Treatment Period|Adverse Event|2|||
105771610|NCT02141854|364813722|FG002|Treatment Period|Adverse Event|2|||
105771611|NCT02141854|364813723|FG003|Treatment Period|Adverse Event|0|||
105771612|NCT02141854|364813724|FG004|Treatment Period|Adverse Event|2|||
105771613|NCT02141854|364813725|FG005|Treatment Period|Adverse Event|2|||
105771614|NCT02141854|364813720|FG000|Treatment Period|Withdrawal by Subject|0|||
105771615|NCT02141854|364813721|FG001|Treatment Period|Withdrawal by Subject|2|||
105771616|NCT02141854|364813722|FG002|Treatment Period|Withdrawal by Subject|3|||
105771617|NCT02141854|364813723|FG003|Treatment Period|Withdrawal by Subject|3|||
105771618|NCT02141854|364813724|FG004|Treatment Period|Withdrawal by Subject|4|||
105771619|NCT02141854|364813725|FG005|Treatment Period|Withdrawal by Subject|7|||
105771620|NCT02141854|364813720|FG000|Treatment Period|Disease progression|0|||
105771621|NCT02141854|364813721|FG001|Treatment Period|Disease progression|2|||
105771622|NCT02141854|364813722|FG002|Treatment Period|Disease progression|1|||
105771623|NCT02141854|364813723|FG003|Treatment Period|Disease progression|3|||
105771624|NCT02141854|364813724|FG004|Treatment Period|Disease progression|0|||
105771625|NCT02141854|364813725|FG005|Treatment Period|Disease progression|18|||
105771626|NCT02141854|364813720|FG000|Treatment Period|Lost to Follow-up|0|||
105771627|NCT02141854|364813721|FG001|Treatment Period|Lost to Follow-up|1|||
105771628|NCT02141854|364813722|FG002|Treatment Period|Lost to Follow-up|1|||
105771629|NCT02141854|364813723|FG003|Treatment Period|Lost to Follow-up|1|||
105771630|NCT02141854|364813724|FG004|Treatment Period|Lost to Follow-up|0|||
105771631|NCT02141854|364813725|FG005|Treatment Period|Lost to Follow-up|1|||
105771632|NCT02659098|364813726|FG000|Overall Study|Withdrawal by Subject|7|||
105771633|NCT03277794|364813727|FG000|Overall Study|Lost to Follow-up|2|||
105771634|NCT03277794|364813728|FG001|Overall Study|Lost to Follow-up|4|||
105771635|NCT03277794|364813727|FG000|Overall Study|Withdrew due to high acuity|1|||
105771636|NCT03277794|364813728|FG001|Overall Study|Withdrew due to high acuity|0|||
105771637|NCT00400946|364815475|FG000|Overall Study|Ineligible|0|||
105771638|NCT00400946|364815476|FG001|Overall Study|Ineligible|0|||
105771639|NCT00400946|364815477|FG002|Overall Study|Ineligible|0|||
105771640|NCT00400946|364815478|FG003|Overall Study|Ineligible|5|||
105771641|NCT00400946|364815479|FG004|Overall Study|Ineligible|1|||
105771642|NCT00400946|364815475|FG000|Overall Study|Induction Failure|0|||
105771643|NCT00400946|364815476|FG001|Overall Study|Induction Failure|0|||
105771644|NCT00400946|364815477|FG002|Overall Study|Induction Failure|0|||
105771645|NCT00400946|364815478|FG003|Overall Study|Induction Failure|11|||
105771646|NCT00400946|364815479|FG004|Overall Study|Induction Failure|8|||
105771647|NCT00400946|364815475|FG000|Overall Study|Induction Death|0|||
105771648|NCT00400946|364815476|FG001|Overall Study|Induction Death|0|||
105771649|NCT00400946|364815477|FG002|Overall Study|Induction Death|0|||
105771650|NCT00400946|364815478|FG003|Overall Study|Induction Death|13|||
105771651|NCT00400946|364815479|FG004|Overall Study|Induction Death|3|||
105771652|NCT00400946|364815475|FG000|Overall Study|Lost to Follow-up|1|||
105771653|NCT00400946|364815476|FG001|Overall Study|Lost to Follow-up|1|||
106099739|NCT01912612|366022613|FG001|Overall Study|Withdrew consent|0|||
105771654|NCT00400946|364815477|FG002|Overall Study|Lost to Follow-up|0|||
105771655|NCT00400946|364815478|FG003|Overall Study|Lost to Follow-up|0|||
105771656|NCT00400946|364815479|FG004|Overall Study|Lost to Follow-up|1|||
105771657|NCT00400946|364815475|FG000|Overall Study|Remission Death|1|||
105771658|NCT00400946|364815476|FG001|Overall Study|Remission Death|1|||
105771659|NCT00400946|364815477|FG002|Overall Study|Remission Death|0|||
105771660|NCT00400946|364815478|FG003|Overall Study|Remission Death|0|||
105771661|NCT00400946|364815479|FG004|Overall Study|Remission Death|1|||
105771662|NCT00400946|364815475|FG000|Overall Study|Relapse|9|||
105771663|NCT00400946|364815476|FG001|Overall Study|Relapse|2|||
105771664|NCT00400946|364815477|FG002|Overall Study|Relapse|1|||
105771665|NCT00400946|364815478|FG003|Overall Study|Relapse|1|||
105771666|NCT00400946|364815479|FG004|Overall Study|Relapse|5|||
105771667|NCT00400946|364815475|FG000|Overall Study|Transplant in CR1|0|||
105771668|NCT00400946|364815476|FG001|Overall Study|Transplant in CR1|0|||
105771669|NCT00400946|364815477|FG002|Overall Study|Transplant in CR1|0|||
105771670|NCT00400946|364815478|FG003|Overall Study|Transplant in CR1|10|||
105771671|NCT00400946|364815479|FG004|Overall Study|Transplant in CR1|1|||
105771672|NCT00400946|364815475|FG000|Overall Study|Withdrawal by Subject|2|||
105771673|NCT00400946|364815476|FG001|Overall Study|Withdrawal by Subject|5|||
105771674|NCT00400946|364815477|FG002|Overall Study|Withdrawal by Subject|1|||
105771675|NCT00400946|364815478|FG003|Overall Study|Withdrawal by Subject|5|||
105771676|NCT00400946|364815479|FG004|Overall Study|Withdrawal by Subject|8|||
105771677|NCT00400946|364815475|FG000|Overall Study|Clinical|1|||
105771678|NCT00400946|364815476|FG001|Overall Study|Clinical|2|||
105771679|NCT00400946|364815477|FG002|Overall Study|Clinical|0|||
105771680|NCT00400946|364815478|FG003|Overall Study|Clinical|2|||
105771681|NCT00400946|364815479|FG004|Overall Study|Clinical|9|||
105771682|NCT00400946|364815475|FG000|Overall Study|Other|0|||
105771683|NCT00400946|364815476|FG001|Overall Study|Other|0|||
105771684|NCT00400946|364815477|FG002|Overall Study|Other|0|||
105771685|NCT00400946|364815478|FG003|Overall Study|Other|0|||
105771686|NCT00400946|364815479|FG004|Overall Study|Other|1|||
105771687|NCT01673373|364815480|FG000|Overall Study|Death|2|||
105771688|NCT00366444|364815481|FG000|Overall Study|Withdrawal by Subject|1|||
105771689|NCT00366444|364815482|FG001|Overall Study|Withdrawal by Subject|1|||
105771690|NCT00366444|364815481|FG000|Overall Study|Lack of Efficacy|0|||
105771691|NCT00366444|364815482|FG001|Overall Study|Lack of Efficacy|1|||
105771692|NCT01405027|364815483|FG000|Overall Study|Withdrawn consent|3|||
105771693|NCT01405027|364815484|FG001|Overall Study|Withdrawn consent|0|||
105771694|NCT01405027|364815483|FG000|Overall Study|Lost to Follow-up|16|||
105771695|NCT01405027|364815484|FG001|Overall Study|Lost to Follow-up|24|||
105771696|NCT01405027|364815483|FG000|Overall Study|Investigator judgement|0|||
105771697|NCT01405027|364815484|FG001|Overall Study|Investigator judgement|2|||
105771698|NCT01405027|364815483|FG000|Overall Study|Death|1|||
105771699|NCT01405027|364815484|FG001|Overall Study|Death|0|||
105771700|NCT01405027|364815483|FG000|Overall Study|Other or Unknown|12|||
105771701|NCT01405027|364815484|FG001|Overall Study|Other or Unknown|25|||
105771702|NCT00963469|364815488|FG000|Overall Study|Adverse Event|15|||
105771703|NCT00963469|364815489|FG001|Overall Study|Adverse Event|11|||
105771704|NCT00963469|364815490|FG002|Overall Study|Adverse Event|1|||
105771705|NCT00963469|364815488|FG000|Overall Study|Lack of Efficacy|10|||
105771706|NCT00963469|364815489|FG001|Overall Study|Lack of Efficacy|7|||
105771707|NCT00963469|364815490|FG002|Overall Study|Lack of Efficacy|2|||
105771708|NCT00963469|364815488|FG000|Overall Study|Lost to Follow-up|1|||
105771709|NCT00963469|364815489|FG001|Overall Study|Lost to Follow-up|1|||
105771710|NCT00963469|364815490|FG002|Overall Study|Lost to Follow-up|0|||
105771711|NCT00963469|364815488|FG000|Overall Study|Protocol Violation|5|||
105771712|NCT00963469|364815489|FG001|Overall Study|Protocol Violation|5|||
105771713|NCT00963469|364815490|FG002|Overall Study|Protocol Violation|3|||
105771714|NCT00963469|364815488|FG000|Overall Study|Withdrawal by Subject|4|||
105771715|NCT00963469|364815489|FG001|Overall Study|Withdrawal by Subject|1|||
105771716|NCT00963469|364815490|FG002|Overall Study|Withdrawal by Subject|1|||
105771717|NCT00963469|364815488|FG000|Overall Study|Pre-randomization Adverse Event|1|||
105771718|NCT00963469|364815489|FG001|Overall Study|Pre-randomization Adverse Event|2|||
105771719|NCT00963469|364815490|FG002|Overall Study|Pre-randomization Adverse Event|0|||
105771720|NCT00963469|364815488|FG000|Overall Study|Moved|1|||
105771721|NCT00963469|364815489|FG001|Overall Study|Moved|0|||
105771722|NCT00963469|364815490|FG002|Overall Study|Moved|0|||
105771723|NCT00963469|364815488|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
105771724|NCT00963469|364815489|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
105771725|NCT00963469|364815490|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
105771726|NCT01938391|364815499|FG000|6 Month Follow up|Withdrawal by Subject|1|||
105771727|NCT01938391|364815499|FG000|12 Month Follow up|Physician Decision|1|||
105771728|NCT01938391|364815499|FG000|12 Month Follow up|Withdrawal by Subject|1|||
105771729|NCT02094612|364815504|FG000|Overall Study|Lost to Follow-up|47|||
105771730|NCT02094612|364815505|FG001|Overall Study|Lost to Follow-up|47|||
105771731|NCT02094612|364815504|FG000|Overall Study|Never started ADHD medication|32|||
105771732|NCT02094612|364815505|FG001|Overall Study|Never started ADHD medication|23|||
105771733|NCT00584987|364815510|FG000|Overall Study|Protocol Violation|1|||
105771734|NCT00584987|364815511|FG001|Overall Study|Protocol Violation|1|||
105771735|NCT00584987|364815512|FG002|Overall Study|Protocol Violation|1|||
105771736|NCT00584987|364815513|FG003|Overall Study|Protocol Violation|0|||
105771737|NCT00584987|364815510|FG000|Overall Study|Adverse Event|0|||
105771738|NCT00584987|364815511|FG001|Overall Study|Adverse Event|0|||
105771739|NCT00584987|364815512|FG002|Overall Study|Adverse Event|0|||
105771740|NCT00584987|364815513|FG003|Overall Study|Adverse Event|1|||
105771741|NCT02234050|364815515|FG000|Overall Study|Lack of Efficacy|38|||
105771742|NCT02234050|364815516|FG001|Overall Study|Lack of Efficacy|22|||
105771743|NCT02234050|364815515|FG000|Overall Study|Adverse Event|13|||
105771744|NCT02234050|364815516|FG001|Overall Study|Adverse Event|1|||
105771745|NCT02234050|364815515|FG000|Overall Study|Withdrawal by Subject|4|||
105771746|NCT02234050|364815516|FG001|Overall Study|Withdrawal by Subject|2|||
105771747|NCT02234050|364815515|FG000|Overall Study|Sponsor's decision|6|||
105771748|NCT02234050|364815516|FG001|Overall Study|Sponsor's decision|0|||
105771749|NCT04992507|364815519|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
105771750|NCT04992507|364815520|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
105771751|NCT04992507|364815519|FG000|Overall Study|Death|0|||
105771752|NCT04992507|364815520|FG001|Overall Study|Death|1|||
105771753|NCT01852591|364815522|FG000|Overall Study|Withdrawal by Subject|2|||
105771754|NCT01852591|364815522|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
105771755|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
105771756|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
105771757|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
105771758|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
105771759|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
105771760|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
105771761|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
105771762|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
105771763|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
105771764|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
105771765|NCT03774875|364815523|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
105771766|NCT03774875|364815524|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
105771767|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
105771768|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
105771769|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
105771770|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
105771771|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
105771772|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
105771773|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
105771774|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
105771775|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
105771776|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
105771777|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
105771778|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
105771779|NCT03774875|364815523|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
105771780|NCT03774875|364815524|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
105771781|NCT00729560|364815527|FG000|Overall Study|Withdrawal by Subject|3|||
105771782|NCT03233308|364815528|FG000|Overall Study|Adverse Event|1|||
105771783|NCT03233308|364815528|FG000|Overall Study|Protocol Violation|1|||
105771784|NCT03287830|364815529|FG000|Overall Study|Withdrawal by Subject|1|||
105771785|NCT03287830|364815530|FG001|Overall Study|Withdrawal by Subject|1|||
105771786|NCT03287830|364815529|FG000|Overall Study|not meeting inclusion criteria|5|||
105771787|NCT03287830|364815530|FG001|Overall Study|not meeting inclusion criteria|12|||
105771788|NCT00764322|364815531|FG000|Overall Study|Withdrawal by Subject|11|||
105771789|NCT00764322|364815531|FG000|Overall Study|No CYP2D6 genotyping|9|||
105771790|NCT00732472|364815534|FG000|Overall Study|Adverse Event|0|||
105771791|NCT00732472|364815535|FG001|Overall Study|Adverse Event|1|||
105771792|NCT00732472|364815536|FG002|Overall Study|Adverse Event|1|||
105771793|NCT00732472|364815537|FG003|Overall Study|Adverse Event|1|||
105771794|NCT00732472|364815534|FG000|Overall Study|Protocol Violation|0|||
105771795|NCT00732472|364815535|FG001|Overall Study|Protocol Violation|0|||
105771796|NCT00732472|364815536|FG002|Overall Study|Protocol Violation|0|||
105771797|NCT00732472|364815537|FG003|Overall Study|Protocol Violation|1|||
105771798|NCT00732472|364815534|FG000|Overall Study|Withdrawal by Subject|0|||
105771799|NCT00732472|364815535|FG001|Overall Study|Withdrawal by Subject|2|||
105771800|NCT00732472|364815536|FG002|Overall Study|Withdrawal by Subject|0|||
105771801|NCT00732472|364815537|FG003|Overall Study|Withdrawal by Subject|1|||
105771802|NCT02354690|364815546|FG000|Overall Study|Physician Decision|1|||
105771803|NCT02871791|364815552|FG000|Phase 1b|Death|0|||
105771804|NCT02871791|364815553|FG001|Phase 1b|Death|1|||
105771805|NCT02871791|364815552|FG000|Phase 1b|progressive disease|6|||
105771806|NCT02871791|364815553|FG001|Phase 1b|progressive disease|2|||
105771807|NCT02871791|364815552|FG000|Phase 2|Death|1|||
105771808|NCT02871791|364815553|FG001|Phase 2|Death|0|||
105771809|NCT02871791|364815552|FG000|Phase 2|Lost to Follow-up|2|||
105771810|NCT02871791|364815553|FG001|Phase 2|Lost to Follow-up|0|||
105771811|NCT00129376|364815554|FG000|Overall Study|Adverse Event|1|||
105771812|NCT00129376|364815554|FG000|Overall Study|Lack of Efficacy|1|||
105771813|NCT01849562|364815555|FG000|Overall Study|Lost to Follow-up|1|||
105771814|NCT01849562|364815556|FG001|Overall Study|Lost to Follow-up|0|||
105771815|NCT01849562|364815557|FG002|Overall Study|Lost to Follow-up|0|||
105771816|NCT01849562|364815555|FG000|Overall Study|Non-compliance with Study Drug|1|||
105771817|NCT01849562|364815556|FG001|Overall Study|Non-compliance with Study Drug|0|||
105771818|NCT01849562|364815557|FG002|Overall Study|Non-compliance with Study Drug|0|||
105771819|NCT00611767|364815558|FG000|Overall Study|Withdrawal by Subject|4|||
105771820|NCT00611767|364815559|FG001|Overall Study|Withdrawal by Subject|1|||
105771821|NCT00611767|364815558|FG000|Overall Study|Thiopental not available|3|||
105771822|NCT00611767|364815559|FG001|Overall Study|Thiopental not available|0|||
105771823|NCT00611767|364815558|FG000|Overall Study|didn't like the medication|1|||
105771824|NCT00611767|364815559|FG001|Overall Study|didn't like the medication|1|||
105771825|NCT00611767|364815558|FG000|Overall Study|Physician Decision|1|||
105771826|NCT00611767|364815559|FG001|Overall Study|Physician Decision|0|||
105771827|NCT02447952|364815568|FG000|Overall Study|Adverse Event|2|||
105771828|NCT02447952|364815568|FG000|Overall Study|Physician Decision|1|||
105771829|NCT02447952|364815568|FG000|Overall Study|Withdrawal by Subject|4|||
105771830|NCT04476108|364815569|FG000|Overall Study|Adverse Event|4|||
105771831|NCT04476108|364815570|FG001|Overall Study|Adverse Event|1|||
105771832|NCT04476108|364815569|FG000|Overall Study|Lost to Follow-up|1|||
105771833|NCT04476108|364815570|FG001|Overall Study|Lost to Follow-up|0|||
105771834|NCT04476108|364815569|FG000|Overall Study|Inadvertent Enrollment|1|||
105771835|NCT04476108|364815570|FG001|Overall Study|Inadvertent Enrollment|0|||
105771836|NCT04476108|364815569|FG000|Overall Study|Protocol Violation|1|||
105771837|NCT04476108|364815570|FG001|Overall Study|Protocol Violation|1|||
105771838|NCT04476108|364815569|FG000|Overall Study|Withdrawal by Subject|1|||
105771839|NCT04476108|364815570|FG001|Overall Study|Withdrawal by Subject|1|||
105771840|NCT04247828|364815573|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
105771841|NCT02159365|364815574|FG000|Overall Study|Disease Progression|23|||
105771842|NCT02159365|364815574|FG000|Overall Study|Other reasons|11|||
105771843|NCT02159365|364815574|FG000|Overall Study|Administrative reason by Sponsor|9|||
105771844|NCT02159365|364815574|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
105771845|NCT02159365|364815574|FG000|Overall Study|Study drug toxicity|7|||
105771846|NCT02159365|364815574|FG000|Overall Study|Maximum clinical benefit|3|||
105771847|NCT02159365|364815574|FG000|Overall Study|Subject request to discontinue treatment|3|||
105771848|NCT02159365|364815574|FG000|Overall Study|Subject withdrew consent|3|||
105771849|NCT02159365|364815574|FG000|Overall Study|Death|1|||
105771850|NCT02159365|364815574|FG000|Overall Study|Lost to Follow-up|1|||
105771851|NCT03083470|364815577|FG000|Overall Study|Lost to Follow-up|0|||
105771852|NCT03083470|364815578|FG001|Overall Study|Lost to Follow-up|0|||
105771853|NCT03083470|364815579|FG002|Overall Study|Lost to Follow-up|0|||
105771854|NCT03083470|364815580|FG003|Overall Study|Lost to Follow-up|0|||
105771855|NCT03083470|364815581|FG004|Overall Study|Lost to Follow-up|1|||
105771856|NCT03083470|364815577|FG000|Overall Study|Withdrawal by Subject|0|||
105771857|NCT03083470|364815578|FG001|Overall Study|Withdrawal by Subject|0|||
105771858|NCT03083470|364815579|FG002|Overall Study|Withdrawal by Subject|0|||
105771859|NCT03083470|364815580|FG003|Overall Study|Withdrawal by Subject|0|||
105771860|NCT03083470|364815581|FG004|Overall Study|Withdrawal by Subject|1|||
105771861|NCT03077711|364815582|FG000|Overall Study|Lost to Follow-up|2|||
105771862|NCT03077711|364815583|FG001|Overall Study|Lost to Follow-up|2|||
105771863|NCT03077711|364815582|FG000|Overall Study|noncompliant taking medication|2|||
105771864|NCT03077711|364815583|FG001|Overall Study|noncompliant taking medication|0|||
105771865|NCT01055457|364815587|FG000|Overall Study|Lost to Follow-up|0|||
105771866|NCT01055457|364815588|FG001|Overall Study|Lost to Follow-up|1|||
105771867|NCT01055457|364815589|FG002|Overall Study|Lost to Follow-up|0|||
105771868|NCT01055457|364815590|FG003|Overall Study|Lost to Follow-up|0|||
105771869|NCT01055457|364815591|FG004|Overall Study|Lost to Follow-up|0|||
105771870|NCT01055457|364815592|FG005|Overall Study|Lost to Follow-up|1|||
105771871|NCT01055457|364815593|FG006|Overall Study|Lost to Follow-up|0|||
105771872|NCT01055457|364815594|FG007|Overall Study|Lost to Follow-up|0|||
105771873|NCT01055457|364815595|FG008|Overall Study|Lost to Follow-up|0|||
105771874|NCT01055457|364815596|FG009|Overall Study|Lost to Follow-up|0|||
105771875|NCT01055457|364815587|FG000|Overall Study|Protocol Violation|0|||
105771876|NCT01055457|364815588|FG001|Overall Study|Protocol Violation|0|||
105771877|NCT01055457|364815589|FG002|Overall Study|Protocol Violation|1|||
105771878|NCT01055457|364815590|FG003|Overall Study|Protocol Violation|1|||
105771879|NCT01055457|364815591|FG004|Overall Study|Protocol Violation|1|||
105771880|NCT01055457|364815592|FG005|Overall Study|Protocol Violation|2|||
105771881|NCT01055457|364815593|FG006|Overall Study|Protocol Violation|1|||
105771882|NCT01055457|364815594|FG007|Overall Study|Protocol Violation|0|||
105771883|NCT01055457|364815595|FG008|Overall Study|Protocol Violation|0|||
105771884|NCT01055457|364815596|FG009|Overall Study|Protocol Violation|1|||
105771885|NCT01055457|364815587|FG000|Overall Study|Subject Disinterest|0|||
105771886|NCT01055457|364815588|FG001|Overall Study|Subject Disinterest|0|||
105771887|NCT01055457|364815589|FG002|Overall Study|Subject Disinterest|0|||
105771888|NCT01055457|364815590|FG003|Overall Study|Subject Disinterest|0|||
105771889|NCT01055457|364815591|FG004|Overall Study|Subject Disinterest|0|||
105771890|NCT01055457|364815592|FG005|Overall Study|Subject Disinterest|0|||
105771891|NCT01055457|364815593|FG006|Overall Study|Subject Disinterest|0|||
105771892|NCT01055457|364815594|FG007|Overall Study|Subject Disinterest|1|||
105771893|NCT01055457|364815595|FG008|Overall Study|Subject Disinterest|0|||
105771894|NCT01055457|364815596|FG009|Overall Study|Subject Disinterest|0|||
105771895|NCT01055457|364815587|FG000|Overall Study|Subject Ineligible|1|||
105771896|NCT01055457|364815588|FG001|Overall Study|Subject Ineligible|0|||
105771897|NCT01055457|364815589|FG002|Overall Study|Subject Ineligible|1|||
105771898|NCT01055457|364815590|FG003|Overall Study|Subject Ineligible|0|||
105771899|NCT01055457|364815591|FG004|Overall Study|Subject Ineligible|1|||
105771900|NCT01055457|364815592|FG005|Overall Study|Subject Ineligible|0|||
105771901|NCT01055457|364815593|FG006|Overall Study|Subject Ineligible|0|||
105771902|NCT01055457|364815594|FG007|Overall Study|Subject Ineligible|0|||
105771903|NCT01055457|364815595|FG008|Overall Study|Subject Ineligible|0|||
105771904|NCT01055457|364815596|FG009|Overall Study|Subject Ineligible|0|||
105771905|NCT01055457|364815587|FG000|Overall Study|Discomfort|0|||
105771906|NCT01055457|364815588|FG001|Overall Study|Discomfort|0|||
105771907|NCT01055457|364815589|FG002|Overall Study|Discomfort|0|||
105771908|NCT01055457|364815590|FG003|Overall Study|Discomfort|0|||
105771909|NCT01055457|364815591|FG004|Overall Study|Discomfort|1|||
105771910|NCT01055457|364815592|FG005|Overall Study|Discomfort|0|||
105771911|NCT01055457|364815593|FG006|Overall Study|Discomfort|0|||
105771912|NCT01055457|364815594|FG007|Overall Study|Discomfort|0|||
105771913|NCT01055457|364815595|FG008|Overall Study|Discomfort|0|||
105771914|NCT01055457|364815596|FG009|Overall Study|Discomfort|0|||
105771915|NCT01055457|364815587|FG000|Overall Study|Pregnancy|0|||
105771916|NCT01055457|364815588|FG001|Overall Study|Pregnancy|0|||
105771917|NCT01055457|364815589|FG002|Overall Study|Pregnancy|0|||
105771918|NCT01055457|364815590|FG003|Overall Study|Pregnancy|1|||
105771919|NCT01055457|364815591|FG004|Overall Study|Pregnancy|0|||
105771920|NCT01055457|364815592|FG005|Overall Study|Pregnancy|0|||
105771921|NCT01055457|364815593|FG006|Overall Study|Pregnancy|0|||
105771922|NCT01055457|364815594|FG007|Overall Study|Pregnancy|0|||
105771923|NCT01055457|364815595|FG008|Overall Study|Pregnancy|0|||
105771924|NCT01055457|364815596|FG009|Overall Study|Pregnancy|0|||
105771925|NCT01055457|364815587|FG000|Overall Study|Adverse Event|0|||
105771926|NCT01055457|364815588|FG001|Overall Study|Adverse Event|0|||
105771927|NCT01055457|364815589|FG002|Overall Study|Adverse Event|0|||
105771928|NCT01055457|364815590|FG003|Overall Study|Adverse Event|1|||
105771929|NCT01055457|364815591|FG004|Overall Study|Adverse Event|0|||
105771930|NCT01055457|364815592|FG005|Overall Study|Adverse Event|0|||
105771931|NCT01055457|364815593|FG006|Overall Study|Adverse Event|0|||
105771932|NCT01055457|364815594|FG007|Overall Study|Adverse Event|0|||
105771933|NCT01055457|364815595|FG008|Overall Study|Adverse Event|0|||
105771934|NCT01055457|364815596|FG009|Overall Study|Adverse Event|0|||
105771935|NCT01885104|364815597|FG000|Overall Study|Withdrawal of Consent|1|||
105771936|NCT01885104|364815598|FG001|Overall Study|Withdrawal of Consent|0|||
105771937|NCT01885104|364815597|FG000|Overall Study|Lost to Follow-up|0|||
105771938|NCT01885104|364815598|FG001|Overall Study|Lost to Follow-up|1|||
105771939|NCT01885104|364815597|FG000|Overall Study|Physician Decision|1|||
105771940|NCT01885104|364815598|FG001|Overall Study|Physician Decision|0|||
105771941|NCT01316380|364815601|FG000|Overall Study|Adverse Event|0|||
105771942|NCT01316380|364815602|FG001|Overall Study|Adverse Event|2|||
105771943|NCT01316380|364815603|FG002|Overall Study|Adverse Event|1|||
105771944|NCT01316380|364815601|FG000|Overall Study|Protocol Violation|0|||
105771945|NCT01316380|364815602|FG001|Overall Study|Protocol Violation|0|||
105771946|NCT01316380|364815603|FG002|Overall Study|Protocol Violation|1|||
105771947|NCT01316380|364815601|FG000|Overall Study|Withdrawal by Subject|1|||
105771948|NCT01316380|364815602|FG001|Overall Study|Withdrawal by Subject|2|||
105771949|NCT01316380|364815603|FG002|Overall Study|Withdrawal by Subject|0|||
105771950|NCT01316380|364815601|FG000|Overall Study|Other|0|||
105771951|NCT01316380|364815602|FG001|Overall Study|Other|1|||
105771952|NCT01316380|364815603|FG002|Overall Study|Other|1|||
105771953|NCT01316380|364815601|FG000|Overall Study|Not treated|1|||
105771954|NCT01316380|364815602|FG001|Overall Study|Not treated|0|||
105771955|NCT01316380|364815603|FG002|Overall Study|Not treated|0|||
105771956|NCT01894776|364815604|FG000|Overall Study|Withdrawal by Subject|1|||
105771957|NCT02415595|364815606|FG000|Overall Study|Administrative reason by sponsor|39|||
105771958|NCT02415595|364815607|FG001|Overall Study|Administrative reason by sponsor|40|||
105771959|NCT02415595|364815608|FG002|Overall Study|Administrative reason by sponsor|41|||
105771960|NCT02415595|364815609|FG003|Overall Study|Administrative reason by sponsor|39|||
105771961|NCT02415595|364815606|FG000|Overall Study|Adverse Event|1|||
105771962|NCT02415595|364815607|FG001|Overall Study|Adverse Event|3|||
105771963|NCT02415595|364815608|FG002|Overall Study|Adverse Event|5|||
105771964|NCT02415595|364815609|FG003|Overall Study|Adverse Event|10|||
105771965|NCT02415595|364815606|FG000|Overall Study|Lack of Efficacy|4|||
105771966|NCT02415595|364815607|FG001|Overall Study|Lack of Efficacy|4|||
105771967|NCT02415595|364815608|FG002|Overall Study|Lack of Efficacy|0|||
105771968|NCT02415595|364815609|FG003|Overall Study|Lack of Efficacy|0|||
105771969|NCT02415595|364815606|FG000|Overall Study|Lost to Follow-up|1|||
105771970|NCT02415595|364815607|FG001|Overall Study|Lost to Follow-up|3|||
105771971|NCT02415595|364815608|FG002|Overall Study|Lost to Follow-up|1|||
105771972|NCT02415595|364815609|FG003|Overall Study|Lost to Follow-up|1|||
105771973|NCT02415595|364815606|FG000|Overall Study|Poor/Non-compliance|1|||
105771974|NCT02415595|364815607|FG001|Overall Study|Poor/Non-compliance|0|||
105771975|NCT02415595|364815608|FG002|Overall Study|Poor/Non-compliance|1|||
105771976|NCT02415595|364815609|FG003|Overall Study|Poor/Non-compliance|0|||
105771977|NCT02415595|364815606|FG000|Overall Study|Reached stopping criteria|0|||
105771978|NCT02415595|364815607|FG001|Overall Study|Reached stopping criteria|1|||
105771979|NCT02415595|364815608|FG002|Overall Study|Reached stopping criteria|1|||
105771980|NCT02415595|364815609|FG003|Overall Study|Reached stopping criteria|0|||
105771981|NCT02415595|364815606|FG000|Overall Study|Withdrawal by Subject|4|||
105771982|NCT02415595|364815607|FG001|Overall Study|Withdrawal by Subject|0|||
105771983|NCT02415595|364815608|FG002|Overall Study|Withdrawal by Subject|1|||
105771984|NCT02415595|364815609|FG003|Overall Study|Withdrawal by Subject|3|||
105771985|NCT02415595|364815606|FG000|Overall Study|Other|0|||
105771986|NCT02415595|364815607|FG001|Overall Study|Other|1|||
105771987|NCT02415595|364815608|FG002|Overall Study|Other|1|||
105771988|NCT02415595|364815609|FG003|Overall Study|Other|0|||
105771989|NCT03325010|364815610|FG000|Overall Study|Adverse Event|3|||
105771990|NCT03325010|364815611|FG001|Overall Study|Adverse Event|8|||
105771991|NCT03325010|364815610|FG000|Overall Study|Protocol Violation|1|||
105771992|NCT03325010|364815611|FG001|Overall Study|Protocol Violation|8|||
105771993|NCT03325010|364815610|FG000|Overall Study|Withdrawal by Subject|1|||
105771994|NCT03325010|364815611|FG001|Overall Study|Withdrawal by Subject|3|||
105771995|NCT03325010|364815610|FG000|Overall Study|Lost to Follow-up|1|||
105771996|NCT03325010|364815611|FG001|Overall Study|Lost to Follow-up|0|||
105771997|NCT03325010|364815610|FG000|Overall Study|Physician Decision|1|||
105771998|NCT03325010|364815611|FG001|Overall Study|Physician Decision|1|||
105771999|NCT03325010|364815610|FG000|Overall Study|Lack of Efficacy|2|||
105772000|NCT03325010|364815611|FG001|Overall Study|Lack of Efficacy|0|||
105772001|NCT00712270|364815618|FG000|Overall Study|Withdrawal by Subject|11|||
105772002|NCT00712270|364815618|FG000|Overall Study|Screen Failure|3|||
105772003|NCT01060124|364815620|FG000|Overall Study|Other|16|||
105772004|NCT01060124|364815620|FG000|Overall Study|Adverse Event|14|||
105772005|NCT01060124|364815620|FG000|Overall Study|Withdrawal by Subject|7|||
105772006|NCT00901394|364815622|FG000|Overall Study|Physician Decision|1|||
105772007|NCT00901394|364815623|FG001|Overall Study|Physician Decision|1|||
105772008|NCT00901394|364815624|FG002|Overall Study|Physician Decision|2|||
105772009|NCT00102804|364815628|FG000|Overall Study|Progressive Disease (PD)|307|||
105772010|NCT00102804|364815629|FG001|Overall Study|Progressive Disease (PD)|196|||
105772011|NCT00102804|364815628|FG000|Overall Study|Withdrawal by Subject|46|||
105772012|NCT00102804|364815629|FG001|Overall Study|Withdrawal by Subject|7|||
105772013|NCT00102804|364815628|FG000|Overall Study|Adverse Event|37|||
105772014|NCT00102804|364815629|FG001|Overall Study|Adverse Event|3|||
105772015|NCT00102804|364815628|FG000|Overall Study|Physician Decision|24|||
105772016|NCT00102804|364815629|FG001|Overall Study|Physician Decision|6|||
105772017|NCT00102804|364815628|FG000|Overall Study|Death|5|||
105772018|NCT00102804|364815629|FG001|Overall Study|Death|6|||
105772019|NCT00102804|364815628|FG000|Overall Study|Enrollment Criteria Not Met|6|||
105772020|NCT00102804|364815629|FG001|Overall Study|Enrollment Criteria Not Met|0|||
105772021|NCT00102804|364815628|FG000|Overall Study|Lost to Follow-up|4|||
105772022|NCT00102804|364815629|FG001|Overall Study|Lost to Follow-up|1|||
105772023|NCT00102804|364815628|FG000|Overall Study|Protocol Violation|2|||
105772024|NCT00102804|364815629|FG001|Overall Study|Protocol Violation|1|||
105772025|NCT00102804|364815628|FG000|Overall Study|Satisfactory Response|2|||
105772026|NCT00102804|364815629|FG001|Overall Study|Satisfactory Response|0|||
105772027|NCT00102804|364815628|FG000|Overall Study|Sponsor Decision|1|||
105772028|NCT00102804|364815629|FG001|Overall Study|Sponsor Decision|0|||
105772029|NCT00102804|364815628|FG000|Overall Study|Alive, Receiving Treatment|7|||
105772030|NCT00102804|364815629|FG001|Overall Study|Alive, Receiving Treatment|2|||
105772031|NCT03858686|364815630|FG000|Period 1|Adverse Event|1|||
105772032|NCT03858686|364815631|FG001|Period 1|Adverse Event|1|||
105772033|NCT03858686|364815630|FG000|Period 1|Lack of compliance|0|||
105772034|NCT03858686|364815631|FG001|Period 1|Lack of compliance|1|||
105772035|NCT03858686|364815630|FG000|Period 1|Adverse Event|0|||
105772036|NCT03858686|364815631|FG001|Period 1|Adverse Event|1|||
105772037|NCT03858686|364815630|FG000|Period 2|Adverse Event|0|||
105772038|NCT03858686|364815631|FG001|Period 2|Adverse Event|1|||
105772039|NCT00542425|364815633|FG000|Initial 24 Weeks|Administrative reasons|0|||
105772040|NCT00542425|364815634|FG001|Initial 24 Weeks|Administrative reasons|0|||
105772041|NCT00542425|364815635|FG002|Initial 24 Weeks|Administrative reasons|1|||
105772042|NCT00542425|364815636|FG003|Initial 24 Weeks|Administrative reasons|1|||
105772043|NCT00542425|364815637|FG004|Initial 24 Weeks|Administrative reasons|0|||
105772044|NCT00542425|364815633|FG000|Initial 24 Weeks|Adverse Event|0|||
105772045|NCT00542425|364815634|FG001|Initial 24 Weeks|Adverse Event|1|||
105772046|NCT00542425|364815635|FG002|Initial 24 Weeks|Adverse Event|1|||
105772047|NCT00542425|364815636|FG003|Initial 24 Weeks|Adverse Event|3|||
105772048|NCT00542425|364815637|FG004|Initial 24 Weeks|Adverse Event|2|||
105772049|NCT00542425|364815633|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
105772050|NCT00542425|364815634|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
105772051|NCT00542425|364815635|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
105772052|NCT00542425|364815636|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
105772053|NCT00542425|364815637|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
105772054|NCT00542425|364815633|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
105772055|NCT00542425|364815634|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
105772056|NCT00542425|364815635|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
105772057|NCT00542425|364815636|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
105772058|NCT00542425|364815637|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
105772059|NCT00542425|364815633|FG000|Initial 24 Weeks|Non-compliance|0|||
105772060|NCT00542425|364815634|FG001|Initial 24 Weeks|Non-compliance|0|||
105772061|NCT00542425|364815635|FG002|Initial 24 Weeks|Non-compliance|0|||
105772062|NCT00542425|364815636|FG003|Initial 24 Weeks|Non-compliance|1|||
105772063|NCT00542425|364815637|FG004|Initial 24 Weeks|Non-compliance|1|||
105772064|NCT00542425|364815633|FG000|Initial 24 Weeks|Protocol Violation|0|||
105772065|NCT00542425|364815634|FG001|Initial 24 Weeks|Protocol Violation|0|||
105772066|NCT00542425|364815635|FG002|Initial 24 Weeks|Protocol Violation|0|||
105772067|NCT00542425|364815636|FG003|Initial 24 Weeks|Protocol Violation|1|||
105772068|NCT00542425|364815637|FG004|Initial 24 Weeks|Protocol Violation|0|||
105772069|NCT00542425|364815633|FG000|Initial 24 Weeks|Refusal of treatment|2|||
105772070|NCT00542425|364815634|FG001|Initial 24 Weeks|Refusal of treatment|2|||
105772071|NCT00542425|364815635|FG002|Initial 24 Weeks|Refusal of treatment|1|||
105772072|NCT00542425|364815636|FG003|Initial 24 Weeks|Refusal of treatment|4|||
105772073|NCT00542425|364815637|FG004|Initial 24 Weeks|Refusal of treatment|1|||
105772074|NCT00542425|364815633|FG000|Initial 24 Weeks|Other|0|||
105772075|NCT00542425|364815634|FG001|Initial 24 Weeks|Other|2|||
105772076|NCT00542425|364815635|FG002|Initial 24 Weeks|Other|1|||
105772077|NCT00542425|364815636|FG003|Initial 24 Weeks|Other|0|||
105772078|NCT00542425|364815637|FG004|Initial 24 Weeks|Other|0|||
105772079|NCT00542425|364815633|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
105772080|NCT00542425|364815634|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
105772081|NCT00542425|364815635|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
105772082|NCT00542425|364815636|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
105772083|NCT00542425|364815637|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
105772084|NCT00542425|364815633|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
105772085|NCT00542425|364815634|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
105772086|NCT00542425|364815635|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
105772087|NCT00542425|364815636|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
105772088|NCT00542425|364815637|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
105772089|NCT00542425|364815633|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
105772090|NCT00542425|364815634|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
105772091|NCT00542425|364815635|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
105772092|NCT00542425|364815636|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
105772093|NCT00542425|364815637|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
105772094|NCT00542425|364815633|FG000|Extended 24 Weeks of Treatment|Other|1|||
105772095|NCT00542425|364815634|FG001|Extended 24 Weeks of Treatment|Other|1|||
105772096|NCT00542425|364815635|FG002|Extended 24 Weeks of Treatment|Other|0|||
105772097|NCT00542425|364815636|FG003|Extended 24 Weeks of Treatment|Other|0|||
105772098|NCT00542425|364815637|FG004|Extended 24 Weeks of Treatment|Other|1|||
105772099|NCT01432938|364815638|FG000|First Intervention|Protocol Violation|1|||
105772100|NCT01432938|364815639|FG001|First Intervention|Protocol Violation|0|||
105772101|NCT01432938|364815638|FG000|First Intervention|Physician Decision|1|||
105772102|NCT01432938|364815639|FG001|First Intervention|Physician Decision|0|||
105772103|NCT01432938|364815638|FG000|Second Intervention|Adverse Event|1|||
105772104|NCT01432938|364815639|FG001|Second Intervention|Adverse Event|0|||
105772105|NCT01868594|364815640|FG000|Overall Study|Do not meet inclusion criteria|4|||
105772106|NCT01868594|364815641|FG001|Overall Study|Do not meet inclusion criteria|3|||
105772107|NCT04964557|364815642|FG000|Overall Study|Withdrawal by Subject|3|||
105772108|NCT04964557|364815643|FG001|Overall Study|Withdrawal by Subject|2|||
105772109|NCT04964557|364815642|FG000|Overall Study|Lost to Follow-up|1|||
105772110|NCT04964557|364815643|FG001|Overall Study|Lost to Follow-up|2|||
105772111|NCT04964557|364815642|FG000|Overall Study|Physician Decision|2|||
105772112|NCT04964557|364815643|FG001|Overall Study|Physician Decision|0|||
105772113|NCT04964557|364815642|FG000|Overall Study|Death|3|||
105772114|NCT04964557|364815643|FG001|Overall Study|Death|0|||
105772115|NCT04964557|364815642|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
105772116|NCT04964557|364815643|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
105772117|NCT04363944|364815644|FG000|Overall Study|Withdrawal by Subject|2|||
105772118|NCT04363944|364815645|FG001|Overall Study|Withdrawal by Subject|0|||
105772119|NCT05643170|364817539|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
105772120|NCT05643170|364817539|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
105772121|NCT02358863|364817540|FG000|Overall Study|Physician Decision|3|||
105772122|NCT05426460|364817546|FG000|Overall Study|Protocol Violation|1|||
105772123|NCT05426460|364817547|FG001|Overall Study|Protocol Violation|1|||
105772124|NCT05426460|364817548|FG002|Overall Study|Protocol Violation|1|||
105772125|NCT05426460|364817549|FG003|Overall Study|Protocol Violation|0|||
105772126|NCT03793010|364817550|FG000|Overall Study|Withdrawal by Subject|5|||
105772127|NCT03793010|364817551|FG001|Overall Study|Withdrawal by Subject|7|||
105772128|NCT03793010|364817550|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
105772129|NCT03793010|364817551|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
105772130|NCT03793010|364817550|FG000|Overall Study|Lost to Follow-up|1|||
105772131|NCT03793010|364817551|FG001|Overall Study|Lost to Follow-up|2|||
105772132|NCT03793010|364817550|FG000|Overall Study|Patient couldn't sit still for injection|1|||
105772133|NCT03793010|364817551|FG001|Overall Study|Patient couldn't sit still for injection|0|||
105772134|NCT03793010|364817550|FG000|Overall Study|Withdrew to pursue other treatment|1|||
105772135|NCT03793010|364817551|FG001|Overall Study|Withdrew to pursue other treatment|0|||
105772136|NCT03793010|364817550|FG000|Overall Study|Did not meet eligibility criteria|1|||
105772137|NCT03793010|364817551|FG001|Overall Study|Did not meet eligibility criteria|0|||
105772138|NCT01572844|364817552|FG000|Overall Study|Physician Decision|1|||
105772139|NCT01572844|364817553|FG001|Overall Study|Physician Decision|1|||
105772140|NCT01320033|364817554|FG000|Overall Study|Lack of Efficacy|0|||
105772141|NCT01320033|364817555|FG001|Overall Study|Lack of Efficacy|0|||
105772142|NCT01320033|364817556|FG002|Overall Study|Lack of Efficacy|1|||
105772143|NCT01320033|364817554|FG000|Overall Study|Adverse Event|9|||
105772144|NCT01320033|364817555|FG001|Overall Study|Adverse Event|7|||
105772145|NCT01320033|364817556|FG002|Overall Study|Adverse Event|8|||
105772146|NCT01320033|364817554|FG000|Overall Study|Withdrawal by Subject|22|||
105772147|NCT01320033|364817555|FG001|Overall Study|Withdrawal by Subject|23|||
105772148|NCT01320033|364817556|FG002|Overall Study|Withdrawal by Subject|23|||
105772149|NCT01320033|364817554|FG000|Overall Study|Protocol Violation|3|||
105772150|NCT01320033|364817555|FG001|Overall Study|Protocol Violation|5|||
105772151|NCT01320033|364817556|FG002|Overall Study|Protocol Violation|3|||
105772152|NCT01320033|364817554|FG000|Overall Study|Lost to Follow-up|22|||
105772153|NCT01320033|364817555|FG001|Overall Study|Lost to Follow-up|26|||
105772154|NCT01320033|364817556|FG002|Overall Study|Lost to Follow-up|17|||
105772155|NCT01320033|364817554|FG000|Overall Study|Other|2|||
105772156|NCT01320033|364817555|FG001|Overall Study|Other|3|||
105772157|NCT01320033|364817556|FG002|Overall Study|Other|1|||
105772158|NCT04960202|364817560|FG000|Overall Study|Other|5|||
105772159|NCT04960202|364817561|FG001|Overall Study|Other|0|||
105772160|NCT04960202|364817560|FG000|Overall Study|Withdrawal by Subject|37|||
105772161|NCT04960202|364817561|FG001|Overall Study|Withdrawal by Subject|43|||
105772162|NCT04960202|364817560|FG000|Overall Study|Lost to Follow-up|20|||
105772163|NCT04960202|364817561|FG001|Overall Study|Lost to Follow-up|16|||
105772164|NCT04960202|364817560|FG000|Overall Study|Death|0|||
105772165|NCT04960202|364817561|FG001|Overall Study|Death|15|||
105772166|NCT00378534|364817563|FG000|Overall Study|Participants did not receive transplant|3|||
105772167|NCT00378534|364817564|FG001|Overall Study|Participants did not receive transplant|0|||
105772184|NCT04566445|364817579|FG000|Overall Study|Death|4|||
105772185|NCT04566445|364817580|FG001|Overall Study|Death|1|||
105772186|NCT04566445|364817581|FG002|Overall Study|Death|1|||
105772187|NCT04566445|364817579|FG000|Overall Study|Lost to Follow-up|3|||
105772188|NCT04566445|364817580|FG001|Overall Study|Lost to Follow-up|1|||
105772189|NCT04566445|364817581|FG002|Overall Study|Lost to Follow-up|1|||
105772190|NCT04566445|364817579|FG000|Overall Study|Study terminated by sponsor|11|||
105772191|NCT04566445|364817580|FG001|Overall Study|Study terminated by sponsor|17|||
105772192|NCT04566445|364817581|FG002|Overall Study|Study terminated by sponsor|32|||
105772193|NCT04566445|364817579|FG000|Overall Study|Withdrawal by Subject|12|||
105772194|NCT04566445|364817580|FG001|Overall Study|Withdrawal by Subject|14|||
105772195|NCT04566445|364817581|FG002|Overall Study|Withdrawal by Subject|13|||
105772196|NCT04566445|364817579|FG000|Overall Study|Randomized but not treated due to AE|2|||
105772197|NCT04566445|364817580|FG001|Overall Study|Randomized but not treated due to AE|1|||
105772198|NCT04566445|364817581|FG002|Overall Study|Randomized but not treated due to AE|0|||
105772199|NCT04566445|364817579|FG000|Overall Study|Adverse Event|1|||
105772200|NCT04566445|364817580|FG001|Overall Study|Adverse Event|1|||
105772201|NCT04566445|364817581|FG002|Overall Study|Adverse Event|0|||
105772202|NCT04785144|364817582|FG000|Overall Study|Withdrawal by Subject|4|||
105772203|NCT04785144|364817583|FG001|Overall Study|Withdrawal by Subject|1|||
105772204|NCT04785144|364817584|FG002|Overall Study|Withdrawal by Subject|0|||
105772205|NCT04785144|364817585|FG003|Overall Study|Withdrawal by Subject|0|||
105772206|NCT04785144|364817586|FG004|Overall Study|Withdrawal by Subject|0|||
105772207|NCT04785144|364817587|FG005|Overall Study|Withdrawal by Subject|2|||
105772208|NCT04785144|364817588|FG006|Overall Study|Withdrawal by Subject|2|||
105772209|NCT04785144|364817589|FG007|Overall Study|Withdrawal by Subject|0|||
105772210|NCT04785144|364817590|FG008|Overall Study|Withdrawal by Subject|1|||
105772211|NCT04785144|364817591|FG009|Overall Study|Withdrawal by Subject|0|||
105772212|NCT04785144|364817582|FG000|Overall Study|Lost to Follow-up|1|||
105772213|NCT04785144|364817583|FG001|Overall Study|Lost to Follow-up|0|||
105772214|NCT04785144|364817584|FG002|Overall Study|Lost to Follow-up|0|||
105772215|NCT04785144|364817585|FG003|Overall Study|Lost to Follow-up|0|||
105772216|NCT04785144|364817586|FG004|Overall Study|Lost to Follow-up|1|||
105772217|NCT04785144|364817587|FG005|Overall Study|Lost to Follow-up|2|||
105772218|NCT04785144|364817588|FG006|Overall Study|Lost to Follow-up|1|||
105772219|NCT04785144|364817589|FG007|Overall Study|Lost to Follow-up|2|||
105772220|NCT04785144|364817590|FG008|Overall Study|Lost to Follow-up|4|||
105772221|NCT04785144|364817591|FG009|Overall Study|Lost to Follow-up|1|||
105772222|NCT04785144|364817582|FG000|Overall Study|Protocol Violation|0|||
105772223|NCT04785144|364817583|FG001|Overall Study|Protocol Violation|0|||
105772224|NCT04785144|364817584|FG002|Overall Study|Protocol Violation|0|||
105772225|NCT04785144|364817585|FG003|Overall Study|Protocol Violation|0|||
105772226|NCT04785144|364817586|FG004|Overall Study|Protocol Violation|0|||
105772227|NCT04785144|364817587|FG005|Overall Study|Protocol Violation|0|||
105772228|NCT04785144|364817588|FG006|Overall Study|Protocol Violation|1|||
105772229|NCT04785144|364817589|FG007|Overall Study|Protocol Violation|0|||
105772230|NCT04785144|364817590|FG008|Overall Study|Protocol Violation|0|||
105772231|NCT04785144|364817591|FG009|Overall Study|Protocol Violation|0|||
105772232|NCT04785144|364817582|FG000|Overall Study|Physician Decision|0|||
105772233|NCT04785144|364817583|FG001|Overall Study|Physician Decision|0|||
105772234|NCT04785144|364817584|FG002|Overall Study|Physician Decision|0|||
105772235|NCT04785144|364817585|FG003|Overall Study|Physician Decision|0|||
105772236|NCT04785144|364817586|FG004|Overall Study|Physician Decision|0|||
105772237|NCT04785144|364817587|FG005|Overall Study|Physician Decision|0|||
105772238|NCT04785144|364817588|FG006|Overall Study|Physician Decision|0|||
105772239|NCT04785144|364817589|FG007|Overall Study|Physician Decision|0|||
105772240|NCT04785144|364817590|FG008|Overall Study|Physician Decision|0|||
105772241|NCT04785144|364817591|FG009|Overall Study|Physician Decision|1|||
105772242|NCT04785144|364817582|FG000|Overall Study|Unable to continue due to work schedule|0|||
105772243|NCT04785144|364817583|FG001|Overall Study|Unable to continue due to work schedule|0|||
105772244|NCT04785144|364817584|FG002|Overall Study|Unable to continue due to work schedule|0|||
105772245|NCT04785144|364817585|FG003|Overall Study|Unable to continue due to work schedule|0|||
105772246|NCT04785144|364817586|FG004|Overall Study|Unable to continue due to work schedule|0|||
105772247|NCT04785144|364817587|FG005|Overall Study|Unable to continue due to work schedule|0|||
105772248|NCT04785144|364817588|FG006|Overall Study|Unable to continue due to work schedule|0|||
105772249|NCT04785144|364817589|FG007|Overall Study|Unable to continue due to work schedule|0|||
105772250|NCT04785144|364817590|FG008|Overall Study|Unable to continue due to work schedule|0|||
105772251|NCT04785144|364817591|FG009|Overall Study|Unable to continue due to work schedule|1|||
105772252|NCT01263470|364817592|FG000|Overall Study|Adverse Event|2|||
105772253|NCT01263470|364817593|FG001|Overall Study|Adverse Event|2|||
105772254|NCT01263470|364817594|FG002|Overall Study|Adverse Event|1|||
105772255|NCT01263470|364817595|FG003|Overall Study|Adverse Event|1|||
105772256|NCT01263470|364817596|FG004|Overall Study|Adverse Event|2|||
105772257|NCT01263470|364817597|FG005|Overall Study|Adverse Event|2|||
105772258|NCT01263470|364817592|FG000|Overall Study|Protocol Violation|0|||
105772259|NCT01263470|364817593|FG001|Overall Study|Protocol Violation|1|||
105772260|NCT01263470|364817594|FG002|Overall Study|Protocol Violation|0|||
105772261|NCT01263470|364817595|FG003|Overall Study|Protocol Violation|0|||
105772262|NCT01263470|364817596|FG004|Overall Study|Protocol Violation|0|||
105772263|NCT01263470|364817597|FG005|Overall Study|Protocol Violation|1|||
105772264|NCT01263470|364817592|FG000|Overall Study|Withdrawal by Subject|0|||
105772265|NCT01263470|364817593|FG001|Overall Study|Withdrawal by Subject|1|||
105772266|NCT01263470|364817594|FG002|Overall Study|Withdrawal by Subject|1|||
105772267|NCT01263470|364817595|FG003|Overall Study|Withdrawal by Subject|2|||
105772268|NCT01263470|364817596|FG004|Overall Study|Withdrawal by Subject|0|||
105772269|NCT01263470|364817597|FG005|Overall Study|Withdrawal by Subject|2|||
105772270|NCT01263470|364817592|FG000|Overall Study|Lack of Efficacy|0|||
105772271|NCT01263470|364817593|FG001|Overall Study|Lack of Efficacy|0|||
105772272|NCT01263470|364817594|FG002|Overall Study|Lack of Efficacy|2|||
105772273|NCT01263470|364817595|FG003|Overall Study|Lack of Efficacy|0|||
105772274|NCT01263470|364817596|FG004|Overall Study|Lack of Efficacy|0|||
105772275|NCT01263470|364817597|FG005|Overall Study|Lack of Efficacy|0|||
105772276|NCT01263470|364817592|FG000|Overall Study|Participant Unavailability|0|||
105772277|NCT01263470|364817593|FG001|Overall Study|Participant Unavailability|1|||
105772278|NCT01263470|364817594|FG002|Overall Study|Participant Unavailability|0|||
105772279|NCT01263470|364817595|FG003|Overall Study|Participant Unavailability|0|||
105772280|NCT01263470|364817596|FG004|Overall Study|Participant Unavailability|0|||
105772281|NCT01263470|364817597|FG005|Overall Study|Participant Unavailability|0|||
105772282|NCT01263470|364817592|FG000|Overall Study|Study Drug Non-compliance|0|||
105772283|NCT01263470|364817593|FG001|Overall Study|Study Drug Non-compliance|0|||
105772284|NCT01263470|364817594|FG002|Overall Study|Study Drug Non-compliance|0|||
105772285|NCT01263470|364817595|FG003|Overall Study|Study Drug Non-compliance|0|||
105772286|NCT01263470|364817596|FG004|Overall Study|Study Drug Non-compliance|1|||
105772287|NCT01263470|364817597|FG005|Overall Study|Study Drug Non-compliance|0|||
105772288|NCT01327573|364817598|FG000|Overall Study|Physician Decision|3|||
105772289|NCT01327573|364817599|FG001|Overall Study|Physician Decision|1|||
105772290|NCT01685372|364817600|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
105772291|NCT01685372|364817601|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
105772292|NCT00853112|364817605|FG000|Overall Study|Randomized but not treated|0|||
105772293|NCT00853112|364817606|FG001|Overall Study|Randomized but not treated|1|||
105772294|NCT00853112|364817607|FG002|Overall Study|Randomized but not treated|0|||
105772295|NCT00853112|364817608|FG003|Overall Study|Randomized but not treated|2|||
105772296|NCT00853112|364817609|FG004|Overall Study|Randomized but not treated|0|||
105772297|NCT00853112|364817610|FG005|Overall Study|Randomized but not treated|0|||
105772298|NCT00853112|364817611|FG006|Overall Study|Randomized but not treated|1|||
105772299|NCT01553591|364817612|FG000|Overall Study|Voluntarily withdrew|94|||
105772300|NCT01553591|364817613|FG001|Overall Study|Voluntarily withdrew|79|||
105772301|NCT01553591|364817614|FG002|Overall Study|Voluntarily withdrew|96|||
105772302|NCT01553591|364817612|FG000|Overall Study|Adverse Event|36|||
105772303|NCT01553591|364817613|FG001|Overall Study|Adverse Event|45|||
105772304|NCT01553591|364817614|FG002|Overall Study|Adverse Event|16|||
105772305|NCT01553591|364817612|FG000|Overall Study|Lost to Follow-up|25|||
105772306|NCT01553591|364817613|FG001|Overall Study|Lost to Follow-up|23|||
105772307|NCT01553591|364817614|FG002|Overall Study|Lost to Follow-up|16|||
105772308|NCT01553591|364817612|FG000|Overall Study|Physician decision: other|11|||
105772309|NCT01553591|364817613|FG001|Overall Study|Physician decision: other|14|||
105772310|NCT01553591|364817614|FG002|Overall Study|Physician decision: other|16|||
105772311|NCT01553591|364817612|FG000|Overall Study|Physician decision: lack of efficacy|2|||
105772312|NCT01553591|364817613|FG001|Overall Study|Physician decision: lack of efficacy|3|||
105772313|NCT01553591|364817614|FG002|Overall Study|Physician decision: lack of efficacy|7|||
105772314|NCT01553591|364817612|FG000|Overall Study|Protocol Violation|3|||
105772315|NCT01553591|364817613|FG001|Overall Study|Protocol Violation|4|||
105772316|NCT01553591|364817614|FG002|Overall Study|Protocol Violation|4|||
105772317|NCT01553591|364817612|FG000|Overall Study|Sponsor decision|1|||
105772318|NCT01553591|364817613|FG001|Overall Study|Sponsor decision|0|||
105772319|NCT01553591|364817614|FG002|Overall Study|Sponsor decision|3|||
105772320|NCT01553591|364817612|FG000|Overall Study|Randomized and never dispensed drug|0|||
105772321|NCT01553591|364817613|FG001|Overall Study|Randomized and never dispensed drug|1|||
105772322|NCT01553591|364817614|FG002|Overall Study|Randomized and never dispensed drug|0|||
105772323|NCT04005755|364817615|FG000|Overall Study|Adverse Event|6|||
105772324|NCT04005755|364817615|FG000|Overall Study|Physician Decision|3|||
105772325|NCT04005755|364817615|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
105772326|NCT04005755|364817615|FG000|Overall Study|Withdrawal by Subject|3|||
105772327|NCT04005755|364817615|FG000|Overall Study|Lost to Follow-up|1|||
105772328|NCT02723019|364817616|FG000|Overall Study|Death|17|||
105772329|NCT02723019|364817617|FG001|Overall Study|Death|13|||
105772330|NCT02723019|364817616|FG000|Overall Study|Withdrawal by Subject|11|||
105772331|NCT02723019|364817617|FG001|Overall Study|Withdrawal by Subject|7|||
105772332|NCT02723019|364817616|FG000|Overall Study|Lost to Follow-up|57|||
105772333|NCT02723019|364817617|FG001|Overall Study|Lost to Follow-up|70|||
105772334|NCT00958191|364817619|FG000|Overall Study|Death|4|||
105772335|NCT00958191|364817619|FG000|Overall Study|Lost to Follow-up|5|||
105772336|NCT00958191|364817619|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
105772337|NCT00958191|364817619|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
105772338|NCT00958191|364817619|FG000|Overall Study|Revision of study device|4|||
105772339|NCT00958191|364817619|FG000|Overall Study|Site termination|11|||
105772340|NCT00958191|364817619|FG000|Overall Study|No 5 yr x-rays|56|||
105772341|NCT00592072|364817620|FG000|Wash Out Period|Lost to Follow-up|1|||
105772342|NCT00592072|364817621|FG001|Wash Out Period|Lost to Follow-up|1|||
105772343|NCT01818765|364817622|FG000|Overall Study|Death|2|||
105772344|NCT01196091|364817629|FG000|Overall Study|Adverse Event|22|||
105772345|NCT01196091|364817630|FG001|Overall Study|Adverse Event|27|||
105772346|NCT01196091|364817631|FG002|Overall Study|Adverse Event|26|||
105772347|NCT01196091|364817629|FG000|Overall Study|Death|3|||
105772348|NCT01196091|364817630|FG001|Overall Study|Death|2|||
105772349|NCT01196091|364817631|FG002|Overall Study|Death|2|||
105772350|NCT01196091|364817629|FG000|Overall Study|Entry Criteria Not Met|11|||
105772351|NCT01196091|364817630|FG001|Overall Study|Entry Criteria Not Met|11|||
105772352|NCT01196091|364817631|FG002|Overall Study|Entry Criteria Not Met|10|||
105772353|NCT01196091|364817629|FG000|Overall Study|Lack of Efficacy|15|||
105772354|NCT01196091|364817630|FG001|Overall Study|Lack of Efficacy|12|||
105772355|NCT01196091|364817631|FG002|Overall Study|Lack of Efficacy|17|||
105772356|NCT01196091|364817629|FG000|Overall Study|Lost to Follow-up|5|||
105772357|NCT01196091|364817630|FG001|Overall Study|Lost to Follow-up|5|||
105772358|NCT01196091|364817631|FG002|Overall Study|Lost to Follow-up|6|||
105772359|NCT01196091|364817629|FG000|Overall Study|Parent/Caregiver Decision|0|||
105772360|NCT01196091|364817630|FG001|Overall Study|Parent/Caregiver Decision|0|||
105772361|NCT01196091|364817631|FG002|Overall Study|Parent/Caregiver Decision|1|||
105772362|NCT01196091|364817629|FG000|Overall Study|Withdrawal by Subject|16|||
105772363|NCT01196091|364817630|FG001|Overall Study|Withdrawal by Subject|19|||
105772364|NCT01196091|364817631|FG002|Overall Study|Withdrawal by Subject|22|||
105772365|NCT01196091|364817629|FG000|Overall Study|Physician Decision|3|||
105772366|NCT01196091|364817630|FG001|Overall Study|Physician Decision|3|||
105772367|NCT01196091|364817631|FG002|Overall Study|Physician Decision|4|||
105772368|NCT01196091|364817629|FG000|Overall Study|Protocol Violation|1|||
105772369|NCT01196091|364817630|FG001|Overall Study|Protocol Violation|3|||
105772370|NCT01196091|364817631|FG002|Overall Study|Protocol Violation|3|||
105772371|NCT01196091|364817629|FG000|Overall Study|Sponsor Decision|6|||
105772372|NCT01196091|364817630|FG001|Overall Study|Sponsor Decision|5|||
105772373|NCT01196091|364817631|FG002|Overall Study|Sponsor Decision|4|||
105772374|NCT01196091|364817629|FG000|Overall Study|Excluded Site|5|||
105772375|NCT01196091|364817630|FG001|Overall Study|Excluded Site|11|||
105772376|NCT01196091|364817631|FG002|Overall Study|Excluded Site|8|||
105772377|NCT01196091|364817629|FG000|Overall Study|Randomized, No Study Drug Received|1|||
105772378|NCT01196091|364817630|FG001|Overall Study|Randomized, No Study Drug Received|0|||
105772379|NCT01196091|364817631|FG002|Overall Study|Randomized, No Study Drug Received|1|||
105772380|NCT02202161|364817632|FG000|Overall Study|Adverse Event|1|||
105772381|NCT02202161|364817633|FG001|Overall Study|Adverse Event|1|||
105772382|NCT02202161|364817634|FG002|Overall Study|Adverse Event|0|||
105772383|NCT02202161|364817635|FG003|Overall Study|Adverse Event|0|||
105772384|NCT02202161|364817636|FG004|Overall Study|Adverse Event|0|||
105772385|NCT02202161|364817637|FG005|Overall Study|Adverse Event|1|||
105772386|NCT02202161|364817638|FG006|Overall Study|Adverse Event|0|||
105772387|NCT02202161|364817639|FG007|Overall Study|Adverse Event|0|||
105772388|NCT02202161|364817632|FG000|Overall Study|Did not meet continuation criteria|0|||
105772389|NCT02202161|364817633|FG001|Overall Study|Did not meet continuation criteria|0|||
105772390|NCT02202161|364817634|FG002|Overall Study|Did not meet continuation criteria|0|||
105772391|NCT02202161|364817635|FG003|Overall Study|Did not meet continuation criteria|0|||
105772392|NCT02202161|364817636|FG004|Overall Study|Did not meet continuation criteria|0|||
105772393|NCT02202161|364817637|FG005|Overall Study|Did not meet continuation criteria|0|||
105772394|NCT02202161|364817638|FG006|Overall Study|Did not meet continuation criteria|0|||
105772395|NCT02202161|364817639|FG007|Overall Study|Did not meet continuation criteria|3|||
105772396|NCT02202161|364817632|FG000|Overall Study|Physician Decision|0|||
105772397|NCT02202161|364817633|FG001|Overall Study|Physician Decision|0|||
105772398|NCT02202161|364817634|FG002|Overall Study|Physician Decision|0|||
105772399|NCT02202161|364817635|FG003|Overall Study|Physician Decision|0|||
105772400|NCT02202161|364817636|FG004|Overall Study|Physician Decision|0|||
105772401|NCT02202161|364817637|FG005|Overall Study|Physician Decision|0|||
105772402|NCT02202161|364817638|FG006|Overall Study|Physician Decision|0|||
105772403|NCT02202161|364817639|FG007|Overall Study|Physician Decision|3|||
105772404|NCT02202161|364817632|FG000|Overall Study|Withdrawal by Subject|0|||
105772405|NCT02202161|364817633|FG001|Overall Study|Withdrawal by Subject|0|||
105772406|NCT02202161|364817634|FG002|Overall Study|Withdrawal by Subject|0|||
105772407|NCT02202161|364817635|FG003|Overall Study|Withdrawal by Subject|0|||
105772408|NCT02202161|364817636|FG004|Overall Study|Withdrawal by Subject|1|||
105772409|NCT02202161|364817637|FG005|Overall Study|Withdrawal by Subject|0|||
105772410|NCT02202161|364817638|FG006|Overall Study|Withdrawal by Subject|0|||
105772411|NCT02202161|364817639|FG007|Overall Study|Withdrawal by Subject|0|||
105772412|NCT03323086|364817640|FG000|Overall Study|Lost to Follow-up|3|||
105772413|NCT03323086|364817641|FG001|Overall Study|Lost to Follow-up|2|||
105772414|NCT00832091|364817649|FG000|Overall Study|Adverse Event|1|||
105772415|NCT00832091|364817650|FG001|Overall Study|Adverse Event|1|||
105772416|NCT00832091|364817649|FG000|Overall Study|Protocol Violation|1|||
105772417|NCT00832091|364817650|FG001|Overall Study|Protocol Violation|0|||
105772418|NCT00832091|364817649|FG000|Overall Study|Withdrawal by Subject|2|||
105772419|NCT00832091|364817650|FG001|Overall Study|Withdrawal by Subject|1|||
105772420|NCT00832091|364817649|FG000|Overall Study|Prohibited Medication|1|||
105772421|NCT00832091|364817650|FG001|Overall Study|Prohibited Medication|0|||
105772422|NCT01756833|364817651|FG000|Overall Study|Withdrawal by Subject|4|||
105772423|NCT01756833|364817652|FG001|Overall Study|Withdrawal by Subject|3|||
105772424|NCT02181504|364817653|FG000|Overall Study|Adverse Event|1|||
105772425|NCT02181504|364817654|FG001|Overall Study|Adverse Event|1|||
105772426|NCT02181504|364817655|FG002|Overall Study|Adverse Event|1|||
105772427|NCT01010776|364817664|FG000|Main Phase|Withdrawal by Subject|14|||
105772428|NCT01010776|364817664|FG000|Main Phase|Lack of Efficacy|8|||
105772429|NCT01010776|364817664|FG000|Main Phase|Adverse Event|7|||
105772430|NCT01010776|364817664|FG000|Main Phase|Lost to Follow-up|6|||
105772431|NCT01010776|364817664|FG000|Main Phase|Non-compliance to study medication|5|||
105772432|NCT01010776|364817664|FG000|Main Phase|Selection failure|2|||
105772433|NCT01010776|364817664|FG000|Main Phase|Inform consent withdrawal|1|||
105772434|NCT01010776|364817664|FG000|Main Phase|Other|1|||
105772435|NCT01010776|364817664|FG000|Main Phase|Did not received study medication|5|||
105772436|NCT01010776|364817664|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
105772437|NCT01010776|364817664|FG000|Extension Phase|Other|3|||
105772438|NCT03954704|364817671|FG000|Overall Study|Death|1|||
105772439|NCT03954704|364817672|FG001|Overall Study|Death|1|||
105772440|NCT03954704|364817673|FG002|Overall Study|Death|1|||
105772441|NCT03954704|364817674|FG003|Overall Study|Death|3|||
105772442|NCT03954704|364817675|FG004|Overall Study|Death|2|||
105772443|NCT03954704|364817676|FG005|Overall Study|Death|2|||
105772444|NCT03954704|364817677|FG006|Overall Study|Death|0|||
105772445|NCT03954704|364817671|FG000|Overall Study|Withdrew Consent|0|||
105772446|NCT03954704|364817672|FG001|Overall Study|Withdrew Consent|0|||
105772447|NCT03954704|364817673|FG002|Overall Study|Withdrew Consent|1|||
105772448|NCT03954704|364817674|FG003|Overall Study|Withdrew Consent|0|||
105772449|NCT03954704|364817675|FG004|Overall Study|Withdrew Consent|0|||
105772450|NCT03954704|364817676|FG005|Overall Study|Withdrew Consent|1|||
105772451|NCT03954704|364817677|FG006|Overall Study|Withdrew Consent|0|||
105772452|NCT03954704|364817671|FG000|Overall Study|Lost to Follow-up|0|||
105772453|NCT03954704|364817672|FG001|Overall Study|Lost to Follow-up|0|||
105772454|NCT03954704|364817673|FG002|Overall Study|Lost to Follow-up|0|||
105772455|NCT03954704|364817674|FG003|Overall Study|Lost to Follow-up|0|||
105772456|NCT03954704|364817675|FG004|Overall Study|Lost to Follow-up|0|||
105772457|NCT03954704|364817676|FG005|Overall Study|Lost to Follow-up|0|||
105772458|NCT03954704|364817677|FG006|Overall Study|Lost to Follow-up|1|||
105772459|NCT03954704|364817671|FG000|Overall Study|Study Terminated by Sponsor|0|||
105772460|NCT03954704|364817672|FG001|Overall Study|Study Terminated by Sponsor|0|||
105772461|NCT03954704|364817673|FG002|Overall Study|Study Terminated by Sponsor|1|||
105772462|NCT03954704|364817674|FG003|Overall Study|Study Terminated by Sponsor|0|||
105772463|NCT03954704|364817675|FG004|Overall Study|Study Terminated by Sponsor|1|||
105772464|NCT03954704|364817676|FG005|Overall Study|Study Terminated by Sponsor|4|||
105772465|NCT03954704|364817677|FG006|Overall Study|Study Terminated by Sponsor|2|||
105772466|NCT03954704|364817671|FG000|Overall Study|Enrolled but not Treated|0|||
105772467|NCT03954704|364817672|FG001|Overall Study|Enrolled but not Treated|0|||
105772468|NCT03954704|364817673|FG002|Overall Study|Enrolled but not Treated|0|||
105772469|NCT03954704|364817674|FG003|Overall Study|Enrolled but not Treated|0|||
105772470|NCT03954704|364817675|FG004|Overall Study|Enrolled but not Treated|0|||
105772471|NCT03954704|364817676|FG005|Overall Study|Enrolled but not Treated|1|||
105772472|NCT03954704|364817677|FG006|Overall Study|Enrolled but not Treated|0|||
105772473|NCT02573012|364817680|FG000|Overall Study|Adverse Event|5|||
105772474|NCT02573012|364817681|FG001|Overall Study|Adverse Event|5|||
105772475|NCT02573012|364817680|FG000|Overall Study|Lack of Efficacy|5|||
105772476|NCT02573012|364817681|FG001|Overall Study|Lack of Efficacy|4|||
105772477|NCT02573012|364817680|FG000|Overall Study|Non-compliance|1|||
105772478|NCT02573012|364817681|FG001|Overall Study|Non-compliance|2|||
105772479|NCT02573012|364817680|FG000|Overall Study|Withdrawal by Subject|2|||
105772480|NCT02573012|364817681|FG001|Overall Study|Withdrawal by Subject|2|||
105772481|NCT02573012|364817680|FG000|Overall Study|Study Ended per Protocol|1|||
105772482|NCT02573012|364817681|FG001|Overall Study|Study Ended per Protocol|0|||
105772483|NCT02573012|364817680|FG000|Overall Study|Physician Decision|1|||
105772484|NCT02573012|364817681|FG001|Overall Study|Physician Decision|2|||
105772485|NCT01846208|364817682|FG000|Overall Study|Withdrew prior to treatment|1|||
105772486|NCT01846208|364817683|FG001|Overall Study|Withdrew prior to treatment|1|||
105772487|NCT01846208|364817684|FG002|Overall Study|Withdrew prior to treatment|1|||
105772488|NCT01846208|364817682|FG000|Overall Study|Dosing Symptoms|1|||
105772489|NCT01846208|364817683|FG001|Overall Study|Dosing Symptoms|2|||
105772490|NCT01846208|364817684|FG002|Overall Study|Dosing Symptoms|6|||
105772491|NCT01846208|364817682|FG000|Overall Study|Withdrawal by Subject|5|||
105772492|NCT01846208|364817683|FG001|Overall Study|Withdrawal by Subject|0|||
105772493|NCT01846208|364817684|FG002|Overall Study|Withdrawal by Subject|0|||
105772494|NCT01846208|364817682|FG000|Overall Study|Non-compliance|1|||
105772495|NCT01846208|364817683|FG001|Overall Study|Non-compliance|1|||
105772496|NCT01846208|364817684|FG002|Overall Study|Non-compliance|0|||
105772497|NCT01846208|364817682|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
105772498|NCT01846208|364817683|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
105772499|NCT01846208|364817684|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
105772500|NCT01846208|364817682|FG000|Overall Study|Refused SU OFC|0|||
105772501|NCT01846208|364817683|FG001|Overall Study|Refused SU OFC|0|||
105772502|NCT01846208|364817684|FG002|Overall Study|Refused SU OFC|1|||
105772503|NCT02736474|364817685|FG000|Overall Study|Lost to Follow-up|0|||
105772504|NCT02736474|364817686|FG001|Overall Study|Lost to Follow-up|1|||
105772505|NCT00703781|364817687|FG000|Overall Study|Withdrawal by Subject|1|||
105772506|NCT00703781|364817688|FG001|Overall Study|Withdrawal by Subject|2|||
105772507|NCT00703781|364817687|FG000|Overall Study|Cancelled surgery|1|||
105772508|NCT00703781|364817688|FG001|Overall Study|Cancelled surgery|0|||
105772509|NCT01682759|364817689|FG000|Overall Study|Death|2|||
105772510|NCT01682759|364817690|FG001|Overall Study|Death|1|||
105772511|NCT01682759|364817689|FG000|Overall Study|Lost to Follow-up|10|||
105772512|NCT01682759|364817690|FG001|Overall Study|Lost to Follow-up|13|||
105772513|NCT01682759|364817689|FG000|Overall Study|Physician Decision|1|||
105772514|NCT01682759|364817690|FG001|Overall Study|Physician Decision|1|||
105772515|NCT01682759|364817689|FG000|Overall Study|Withdrawal by Subject|56|||
105772516|NCT01682759|364817690|FG001|Overall Study|Withdrawal by Subject|55|||
105772517|NCT02691468|364817692|FG000|Overall Study|Bronchial blocker use|2|||
105772518|NCT02691468|364817693|FG001|Overall Study|Bronchial blocker use|1|||
105772519|NCT02691468|364817692|FG000|Overall Study|Lost to Follow-up|2|||
105772520|NCT02691468|364817693|FG001|Overall Study|Lost to Follow-up|1|||
105772521|NCT02691468|364817692|FG000|Overall Study|Failure to advance FOB|2|||
105772522|NCT02691468|364817693|FG001|Overall Study|Failure to advance FOB|0|||
105772523|NCT05815758|364819003|FG000|Overall Study|Adverse Event|6|||
105772524|NCT05815758|364819004|FG001|Overall Study|Adverse Event|2|||
105772525|NCT05815758|364819003|FG000|Overall Study|Lost to Follow-up|14|||
105772526|NCT05815758|364819004|FG001|Overall Study|Lost to Follow-up|1|||
105772527|NCT05815758|364819003|FG000|Overall Study|Withdrawal by Subject|6|||
105772528|NCT05815758|364819004|FG001|Overall Study|Withdrawal by Subject|6|||
105772529|NCT05815758|364819003|FG000|Overall Study|Protocol Violation|1|||
105772530|NCT05815758|364819004|FG001|Overall Study|Protocol Violation|1|||
105772531|NCT05815758|364819003|FG000|Overall Study|Discontinued|4|||
105772532|NCT05815758|364819004|FG001|Overall Study|Discontinued|4|||
105772533|NCT03661983|364819005|FG000|Open Label Stabilization Phase|Adverse Event|5|||
105772534|NCT03661983|364819006|FG001|Open Label Stabilization Phase|Adverse Event|0|||
105772535|NCT03661983|364819007|FG002|Open Label Stabilization Phase|Adverse Event|0|||
105772536|NCT03661983|364819008|FG003|Open Label Stabilization Phase|Adverse Event|0|||
105772537|NCT03661983|364819005|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
105772538|NCT03661983|364819006|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
105772539|NCT03661983|364819007|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
105772540|NCT03661983|364819008|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
105772541|NCT03661983|364819005|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
105772542|NCT03661983|364819006|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
105772543|NCT03661983|364819007|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
105772544|NCT03661983|364819008|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
105772545|NCT03661983|364819005|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
105772546|NCT03661983|364819006|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
105772547|NCT03661983|364819007|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
105772548|NCT03661983|364819008|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
105772549|NCT03661983|364819005|FG000|Double-blind Randomized Phase|Adverse Event|0|||
105772550|NCT03661983|364819006|FG001|Double-blind Randomized Phase|Adverse Event|1|||
105772551|NCT03661983|364819007|FG002|Double-blind Randomized Phase|Adverse Event|0|||
105772552|NCT03661983|364819008|FG003|Double-blind Randomized Phase|Adverse Event|0|||
105772553|NCT03661983|364819005|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
105772554|NCT03661983|364819006|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
105772555|NCT03661983|364819007|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
105772556|NCT03661983|364819008|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
105772557|NCT03661983|364819005|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
105772558|NCT03661983|364819006|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
105772559|NCT03661983|364819007|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
105772560|NCT03661983|364819008|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
105772561|NCT03661983|364819005|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
105772562|NCT03661983|364819006|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
105772563|NCT03661983|364819007|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
105772564|NCT03661983|364819008|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
105772565|NCT02903966|364819009|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
105772566|NCT02903966|364819010|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
105772567|NCT02903966|364819009|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
105772568|NCT02903966|364819010|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
105772569|NCT02903966|364819009|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
105772570|NCT02903966|364819010|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
105772571|NCT01077193|364819011|FG000|Overall Study|Lost to Follow-up|1|||
105772572|NCT01077193|364819011|FG000|Overall Study|Withdrawal by Subject|2|||
105772573|NCT01077193|364819011|FG000|Overall Study|Lack of Efficacy|1|||
105772574|NCT01077193|364819011|FG000|Overall Study|Study Terminated by Sponsor|40|||
105772575|NCT02987205|364819012|FG000|Overall Study|Adverse Event|1|||
105772576|NCT02987205|364819012|FG000|Overall Study|Withdrawal by Subject|3|||
105772577|NCT06048809|364819013|FG000|Overall Study|Adverse Event|2|||
105772578|NCT06048809|364819014|FG001|Overall Study|Adverse Event|0|||
105772579|NCT06048809|364819013|FG000|Overall Study|Withdrawal by Subject|1|||
105772580|NCT06048809|364819014|FG001|Overall Study|Withdrawal by Subject|1|||
105772581|NCT02943577|364819015|FG000|Overall Study|Protocol Violation|0|||
105772582|NCT02943577|364819016|FG001|Overall Study|Protocol Violation|1|||
105772583|NCT02943577|364819015|FG000|Overall Study|Adverse Event|3|||
105772584|NCT02943577|364819016|FG001|Overall Study|Adverse Event|2|||
105772585|NCT02943577|364819015|FG000|Overall Study|Lost to Follow-up|0|||
105772586|NCT02943577|364819016|FG001|Overall Study|Lost to Follow-up|1|||
105772587|NCT02943577|364819015|FG000|Overall Study|Withdrawal by Subject|1|||
105772588|NCT02943577|364819016|FG001|Overall Study|Withdrawal by Subject|1|||
105772589|NCT02943577|364819015|FG000|Overall Study|Pregnancy|1|||
105772590|NCT02943577|364819016|FG001|Overall Study|Pregnancy|0|||
105772591|NCT03991936|364819021|FG000|Overall Study|Lost to Follow-up|1|||
105772592|NCT03991936|364819022|FG001|Overall Study|Lost to Follow-up|1|||
105772593|NCT03991936|364819023|FG002|Overall Study|Lost to Follow-up|1|||
105772594|NCT03991936|364819024|FG003|Overall Study|Lost to Follow-up|1|||
105772595|NCT03991936|364819025|FG004|Overall Study|Lost to Follow-up|1|||
105772596|NCT00939055|364819026|FG000|Overall Study|Discontinuation prior to procedure|4|||
105772597|NCT00939055|364819027|FG001|Overall Study|Discontinuation prior to procedure|0|||
105772598|NCT02155712|364819032|FG000|Overall Study|Death|12|||
105772599|NCT02155712|364819033|FG001|Overall Study|Death|0|||
105772600|NCT02155712|364819032|FG000|Overall Study|Lost to Follow-up|37|||
105772601|NCT02155712|364819033|FG001|Overall Study|Lost to Follow-up|22|||
105772602|NCT02155712|364819032|FG000|Overall Study|Revision of device|4|||
105772603|NCT02155712|364819033|FG001|Overall Study|Revision of device|3|||
105772604|NCT02155712|364819032|FG000|Overall Study|Withdrawal by Subject|39|||
105772605|NCT02155712|364819033|FG001|Overall Study|Withdrawal by Subject|21|||
105772606|NCT02155712|364819032|FG000|Overall Study|Site termination|77|||
105772607|NCT02155712|364819033|FG001|Overall Study|Site termination|19|||
105772608|NCT02155712|364819032|FG000|Overall Study|Sponsor terminated study early|150|||
105772609|NCT02155712|364819033|FG001|Overall Study|Sponsor terminated study early|0|||
105772610|NCT02155712|364819032|FG000|Overall Study|Missed final 5-year protocol visit|0|||
105772611|NCT02155712|364819033|FG001|Overall Study|Missed final 5-year protocol visit|32|||
105772612|NCT02155712|364819032|FG000|Overall Study|Censored because surgery cancelled|6|||
105772613|NCT02155712|364819033|FG001|Overall Study|Censored because surgery cancelled|10|||
105772614|NCT02155712|364819032|FG000|Overall Study|Censored because study device was not implanted|61|||
105772615|NCT02155712|364819033|FG001|Overall Study|Censored because study device was not implanted|66|||
105772616|NCT02155712|364819032|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
105772617|NCT02155712|364819033|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
105772618|NCT02559115|364819035|FG000|Overall Study|Withdrawal by Subject|3|||
105772619|NCT02060903|364819038|FG000|Overall Study|Lost to Follow-up|4|||
105772620|NCT02060903|364819039|FG001|Overall Study|Lost to Follow-up|0|||
105772621|NCT02060903|364819038|FG000|Overall Study|Withdrawal by Subject|0|||
105772622|NCT02060903|364819039|FG001|Overall Study|Withdrawal by Subject|7|||
105772623|NCT00137267|364819040|FG000|Overall Study|Lost to Follow-up|15|||
105772624|NCT00137267|364819041|FG001|Overall Study|Lost to Follow-up|21|||
105772625|NCT01602822|364819048|FG000|Overall Study|Adverse Event|11|||
105772626|NCT05333289|364819056|FG000|Overall Study|Other|1|||
105772627|NCT05333289|364819057|FG001|Overall Study|Other|0|||
105772628|NCT05333289|364819058|FG002|Overall Study|Other|0|||
105772629|NCT05333289|364819059|FG003|Overall Study|Other|1|||
105772630|NCT05333289|364819060|FG004|Overall Study|Other|1|||
105772631|NCT05333289|364819061|FG005|Overall Study|Other|2|||
105772632|NCT05333289|364819062|FG006|Overall Study|Other|2|||
105772633|NCT05333289|364819063|FG007|Overall Study|Other|0|||
105772634|NCT05333289|364819056|FG000|Overall Study|Withdrawal by Subject|1|||
105772635|NCT05333289|364819057|FG001|Overall Study|Withdrawal by Subject|2|||
105772636|NCT05333289|364819058|FG002|Overall Study|Withdrawal by Subject|2|||
105772637|NCT05333289|364819059|FG003|Overall Study|Withdrawal by Subject|1|||
105772638|NCT05333289|364819060|FG004|Overall Study|Withdrawal by Subject|1|||
105772639|NCT05333289|364819061|FG005|Overall Study|Withdrawal by Subject|2|||
105772640|NCT05333289|364819062|FG006|Overall Study|Withdrawal by Subject|1|||
105772641|NCT05333289|364819063|FG007|Overall Study|Withdrawal by Subject|3|||
105772642|NCT05333289|364819056|FG000|Overall Study|Protocol Violation|1|||
105772643|NCT05333289|364819057|FG001|Overall Study|Protocol Violation|0|||
105772644|NCT05333289|364819058|FG002|Overall Study|Protocol Violation|0|||
105772645|NCT05333289|364819059|FG003|Overall Study|Protocol Violation|0|||
105772646|NCT05333289|364819060|FG004|Overall Study|Protocol Violation|0|||
105772647|NCT05333289|364819061|FG005|Overall Study|Protocol Violation|0|||
105772648|NCT05333289|364819062|FG006|Overall Study|Protocol Violation|0|||
105772649|NCT05333289|364819063|FG007|Overall Study|Protocol Violation|0|||
105772650|NCT05333289|364819056|FG000|Overall Study|Physician Decision|0|||
105772651|NCT05333289|364819057|FG001|Overall Study|Physician Decision|0|||
105772652|NCT05333289|364819058|FG002|Overall Study|Physician Decision|1|||
105772653|NCT05333289|364819059|FG003|Overall Study|Physician Decision|0|||
105772654|NCT05333289|364819060|FG004|Overall Study|Physician Decision|0|||
105772655|NCT05333289|364819061|FG005|Overall Study|Physician Decision|2|||
105772656|NCT05333289|364819062|FG006|Overall Study|Physician Decision|0|||
105772657|NCT05333289|364819063|FG007|Overall Study|Physician Decision|0|||
105772658|NCT05333289|364819056|FG000|Overall Study|Lost to Follow-up|6|||
105772659|NCT05333289|364819057|FG001|Overall Study|Lost to Follow-up|0|||
105772660|NCT05333289|364819058|FG002|Overall Study|Lost to Follow-up|1|||
105772661|NCT05333289|364819059|FG003|Overall Study|Lost to Follow-up|6|||
105772662|NCT05333289|364819060|FG004|Overall Study|Lost to Follow-up|3|||
105772663|NCT05333289|364819061|FG005|Overall Study|Lost to Follow-up|3|||
105772664|NCT05333289|364819062|FG006|Overall Study|Lost to Follow-up|2|||
105772665|NCT05333289|364819063|FG007|Overall Study|Lost to Follow-up|1|||
105772666|NCT05333289|364819056|FG000|Overall Study|Death|1|||
105772667|NCT05333289|364819057|FG001|Overall Study|Death|0|||
105772668|NCT05333289|364819058|FG002|Overall Study|Death|0|||
105772669|NCT05333289|364819059|FG003|Overall Study|Death|0|||
105772670|NCT05333289|364819060|FG004|Overall Study|Death|0|||
105772671|NCT05333289|364819061|FG005|Overall Study|Death|0|||
105772672|NCT05333289|364819062|FG006|Overall Study|Death|0|||
105772673|NCT05333289|364819063|FG007|Overall Study|Death|0|||
105772674|NCT02010567|364819068|FG000|Overall Study|Adverse Event|0|||
105772675|NCT02010567|364819069|FG001|Overall Study|Adverse Event|0|||
105772676|NCT02010567|364819070|FG002|Overall Study|Adverse Event|1|||
105772677|NCT02010567|364819071|FG003|Overall Study|Adverse Event|0|||
105772678|NCT02010567|364819072|FG004|Overall Study|Adverse Event|1|||
105772679|NCT00118040|364819073|FG000|Overall Study|Adverse Event|0|||
105772680|NCT00118040|364819074|FG001|Overall Study|Adverse Event|1|||
105772681|NCT00118040|364819075|FG002|Overall Study|Adverse Event|0|||
105772682|NCT00118040|364819073|FG000|Overall Study|Withdrawal by Subject|0|||
105772683|NCT00118040|364819074|FG001|Overall Study|Withdrawal by Subject|0|||
105772684|NCT00118040|364819075|FG002|Overall Study|Withdrawal by Subject|2|||
105772685|NCT00118040|364819073|FG000|Overall Study|Medical Contraindication|0|||
105772686|NCT00118040|364819074|FG001|Overall Study|Medical Contraindication|0|||
105772687|NCT00118040|364819075|FG002|Overall Study|Medical Contraindication|1|||
105772688|NCT00118040|364819073|FG000|Overall Study|Non-Compliant Participant|1|||
105772689|NCT00118040|364819074|FG001|Overall Study|Non-Compliant Participant|1|||
105772690|NCT00118040|364819075|FG002|Overall Study|Non-Compliant Participant|2|||
105772691|NCT00118040|364819073|FG000|Overall Study|Other|0|||
105772692|NCT00118040|364819074|FG001|Overall Study|Other|0|||
105772693|NCT00118040|364819075|FG002|Overall Study|Other|1|||
105772694|NCT02005211|364819078|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772695|NCT02005211|364819079|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772696|NCT02005211|364819080|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772697|NCT02005211|364819081|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772698|NCT02005211|364819082|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
105772699|NCT02005211|364819083|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772700|NCT02005211|364819084|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
105772701|NCT02192190|364819085|FG000|Overall Study|Adverse Event|1|||
105772702|NCT02192190|364819086|FG001|Overall Study|Adverse Event|1|||
105772703|NCT02192190|364819087|FG002|Overall Study|Adverse Event|0|||
105772704|NCT02192190|364819088|FG003|Overall Study|Adverse Event|0|||
105772705|NCT02192190|364819089|FG004|Overall Study|Adverse Event|0|||
105772706|NCT02192190|364819090|FG005|Overall Study|Adverse Event|0|||
105772707|NCT02192190|364819085|FG000|Overall Study|Lost to Follow-up|3|||
105772708|NCT02192190|364819086|FG001|Overall Study|Lost to Follow-up|3|||
105772709|NCT02192190|364819087|FG002|Overall Study|Lost to Follow-up|2|||
105772710|NCT02192190|364819088|FG003|Overall Study|Lost to Follow-up|1|||
105772711|NCT02192190|364819089|FG004|Overall Study|Lost to Follow-up|4|||
105772712|NCT02192190|364819090|FG005|Overall Study|Lost to Follow-up|3|||
105772713|NCT02192190|364819085|FG000|Overall Study|Physician Decision|2|||
105772714|NCT02192190|364819086|FG001|Overall Study|Physician Decision|0|||
105772715|NCT02192190|364819087|FG002|Overall Study|Physician Decision|0|||
105772716|NCT02192190|364819088|FG003|Overall Study|Physician Decision|0|||
105772717|NCT02192190|364819089|FG004|Overall Study|Physician Decision|0|||
105772718|NCT02192190|364819090|FG005|Overall Study|Physician Decision|0|||
105772719|NCT02192190|364819085|FG000|Overall Study|Terminated by Sponsor|43|||
105772720|NCT02192190|364819086|FG001|Overall Study|Terminated by Sponsor|23|||
105772721|NCT02192190|364819087|FG002|Overall Study|Terminated by Sponsor|20|||
105772722|NCT02192190|364819088|FG003|Overall Study|Terminated by Sponsor|23|||
105772723|NCT02192190|364819089|FG004|Overall Study|Terminated by Sponsor|21|||
105772724|NCT02192190|364819090|FG005|Overall Study|Terminated by Sponsor|23|||
105772725|NCT02192190|364819085|FG000|Overall Study|Withdrawal by Subject|4|||
105772726|NCT02192190|364819086|FG001|Overall Study|Withdrawal by Subject|1|||
105772727|NCT02192190|364819087|FG002|Overall Study|Withdrawal by Subject|2|||
105772728|NCT02192190|364819088|FG003|Overall Study|Withdrawal by Subject|1|||
105772729|NCT02192190|364819089|FG004|Overall Study|Withdrawal by Subject|5|||
105772730|NCT02192190|364819090|FG005|Overall Study|Withdrawal by Subject|3|||
105772731|NCT02192190|364819085|FG000|Overall Study|Could not Keep Visit Schedule|1|||
105772732|NCT02192190|364819086|FG001|Overall Study|Could not Keep Visit Schedule|0|||
105772733|NCT02192190|364819087|FG002|Overall Study|Could not Keep Visit Schedule|0|||
105772734|NCT02192190|364819088|FG003|Overall Study|Could not Keep Visit Schedule|0|||
105772735|NCT02192190|364819089|FG004|Overall Study|Could not Keep Visit Schedule|0|||
105772736|NCT02192190|364819090|FG005|Overall Study|Could not Keep Visit Schedule|0|||
105772737|NCT02192190|364819085|FG000|Overall Study|Positive Drug Screen|0|||
105772738|NCT02192190|364819086|FG001|Overall Study|Positive Drug Screen|0|||
105772739|NCT02192190|364819087|FG002|Overall Study|Positive Drug Screen|0|||
105772740|NCT02192190|364819088|FG003|Overall Study|Positive Drug Screen|1|||
105772741|NCT02192190|364819089|FG004|Overall Study|Positive Drug Screen|0|||
105772742|NCT02192190|364819090|FG005|Overall Study|Positive Drug Screen|0|||
105772743|NCT02192190|364819085|FG000|Overall Study|Inadequate Pain Relief|0|||
105772744|NCT02192190|364819086|FG001|Overall Study|Inadequate Pain Relief|1|||
105772745|NCT02192190|364819087|FG002|Overall Study|Inadequate Pain Relief|1|||
105772746|NCT02192190|364819088|FG003|Overall Study|Inadequate Pain Relief|0|||
105772747|NCT02192190|364819089|FG004|Overall Study|Inadequate Pain Relief|0|||
105772748|NCT02192190|364819090|FG005|Overall Study|Inadequate Pain Relief|0|||
105772749|NCT03733249|364819091|FG000|Overall Study|Death|7|||
105772750|NCT03733249|364819091|FG000|Overall Study|Disease relapse|16|||
105772751|NCT03733249|364819091|FG000|Overall Study|Lost to Follow-up|4|||
105772752|NCT03733249|364819091|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
105772753|NCT03733249|364819091|FG000|Overall Study|Withdrawal by Subject|1|||
105772754|NCT03523715|364819092|FG000|Overall Study|Lost to Follow-up|11|||
105772755|NCT03523715|364819093|FG001|Overall Study|Lost to Follow-up|14|||
105772756|NCT03523715|364819092|FG000|Overall Study|Did not meet inclusion criteria|1|||
105772757|NCT03523715|364819093|FG001|Overall Study|Did not meet inclusion criteria|0|||
105772758|NCT03523715|364819092|FG000|Overall Study|Internally inconsistent reporting|0|||
105772759|NCT03523715|364819093|FG001|Overall Study|Internally inconsistent reporting|2|||
105772760|NCT01950364|364819095|FG000|Overall Study|Adverse Event|3|||
105772761|NCT01950364|364819096|FG001|Overall Study|Adverse Event|0|||
105772762|NCT01950364|364819095|FG000|Overall Study|Stem Cell Transplant|2|||
105772763|NCT01950364|364819096|FG001|Overall Study|Stem Cell Transplant|6|||
105772764|NCT01950364|364819095|FG000|Overall Study|Disease Progression|5|||
105772765|NCT01950364|364819096|FG001|Overall Study|Disease Progression|2|||
105772766|NCT01950364|364819095|FG000|Overall Study|Withdrawal by Subject|0|||
105772767|NCT01950364|364819096|FG001|Overall Study|Withdrawal by Subject|1|||
105772768|NCT01950364|364819095|FG000|Overall Study|Protocol Violation|0|||
105772769|NCT01950364|364819096|FG001|Overall Study|Protocol Violation|1|||
105772770|NCT03299166|364819099|FG000|Overall Study|Adverse Event|9|||
105772771|NCT03299166|364819100|FG001|Overall Study|Adverse Event|4|||
105772772|NCT03299166|364819099|FG000|Overall Study|Withdrawal by Subject|6|||
105772773|NCT03299166|364819100|FG001|Overall Study|Withdrawal by Subject|5|||
105772774|NCT03299166|364819099|FG000|Overall Study|Physician Decision|1|||
105772775|NCT03299166|364819100|FG001|Overall Study|Physician Decision|1|||
105772776|NCT03299166|364819099|FG000|Overall Study|Sponsor Decision|3|||
105772777|NCT03299166|364819100|FG001|Overall Study|Sponsor Decision|0|||
105772778|NCT03299166|364819099|FG000|Overall Study|Lost to Follow-up|2|||
105772779|NCT03299166|364819100|FG001|Overall Study|Lost to Follow-up|4|||
105772780|NCT03299166|364819099|FG000|Overall Study|Randomization Error|0|||
105772781|NCT03299166|364819100|FG001|Overall Study|Randomization Error|1|||
105772782|NCT03299166|364819099|FG000|Overall Study|Subject unable to return due to COVID|1|||
105772783|NCT03299166|364819100|FG001|Overall Study|Subject unable to return due to COVID|0|||
105772784|NCT03299166|364819099|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
105772785|NCT03299166|364819100|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
105772786|NCT04048876|364819101|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
105772787|NCT04048876|364819102|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
105772788|NCT04048876|364819103|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
105772789|NCT04048876|364819104|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
105772790|NCT04048876|364819101|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
105772791|NCT04048876|364819102|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
105772792|NCT04048876|364819103|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
105772793|NCT04048876|364819104|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
105772794|NCT04048876|364819101|FG000|Placebo Controlled Phase|Adverse Event|0|||
105772795|NCT04048876|364819102|FG001|Placebo Controlled Phase|Adverse Event|1|||
105772796|NCT04048876|364819103|FG002|Placebo Controlled Phase|Adverse Event|0|||
105772797|NCT04048876|364819104|FG003|Placebo Controlled Phase|Adverse Event|0|||
105772798|NCT04048876|364819101|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
105772799|NCT04048876|364819102|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
105772800|NCT04048876|364819103|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
105772801|NCT04048876|364819104|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
105772802|NCT02187224|364819105|FG000|Overall Study|Did not show up for test day|1|||
105772803|NCT02187224|364819106|FG001|Overall Study|Did not show up for test day|0|||
105772804|NCT01436357|364819108|FG000|Overall Study|Death|5|||
105772805|NCT01436357|364819109|FG001|Overall Study|Death|1|||
105772806|NCT01436357|364819108|FG000|Overall Study|Enrolled but not vaccinated|1|||
105772807|NCT01436357|364819109|FG001|Overall Study|Enrolled but not vaccinated|1|||
106099740|NCT01912612|366022614|FG002|Overall Study|Withdrew consent|0|||
105772808|NCT01436357|364819108|FG000|Overall Study|Incarceration|18|||
105772809|NCT01436357|364819109|FG001|Overall Study|Incarceration|20|||
105772810|NCT01436357|364819108|FG000|Overall Study|Lost to Follow-up|67|||
105772811|NCT01436357|364819109|FG001|Overall Study|Lost to Follow-up|61|||
105772812|NCT01436357|364819108|FG000|Overall Study|Protocol Violation|1|||
105772813|NCT01436357|364819109|FG001|Overall Study|Protocol Violation|0|||
105772814|NCT01436357|364819108|FG000|Overall Study|Withdrawal by Subject|26|||
105772815|NCT01436357|364819109|FG001|Overall Study|Withdrawal by Subject|38|||
106099741|NCT01912612|366022612|FG000|Overall Study|Study design change|0|||
105772816|NCT01436357|364819108|FG000|Overall Study|Physician Decision|3|||
105772817|NCT01436357|364819109|FG001|Overall Study|Physician Decision|4|||
105772818|NCT01436357|364819108|FG000|Overall Study|Moved out of area|1|||
105772819|NCT01436357|364819109|FG001|Overall Study|Moved out of area|2|||
105772820|NCT01436357|364819108|FG000|Overall Study|Subject in rehab|0|||
105772821|NCT01436357|364819109|FG001|Overall Study|Subject in rehab|1|||
105772822|NCT01693562|364819988|FG000|Escalation Phase|Withdrawal by Subject|0|||
105772823|NCT01693562|364819989|FG001|Escalation Phase|Withdrawal by Subject|1|||
105772824|NCT01693562|364819990|FG002|Escalation Phase|Withdrawal by Subject|0|||
105772825|NCT01693562|364819991|FG003|Escalation Phase|Withdrawal by Subject|0|||
105772826|NCT01693562|364819992|FG004|Escalation Phase|Withdrawal by Subject|0|||
105772827|NCT01693562|364819993|FG005|Escalation Phase|Withdrawal by Subject|2|||
105772828|NCT01693562|364819994|FG006|Escalation Phase|Withdrawal by Subject|0|||
105772829|NCT01693562|364819995|FG007|Escalation Phase|Withdrawal by Subject|0|||
105772830|NCT01693562|364819996|FG008|Escalation Phase|Withdrawal by Subject|0|||
105772831|NCT01693562|364819997|FG009|Escalation Phase|Withdrawal by Subject|0|||
105772832|NCT01693562|364819998|FG010|Escalation Phase|Withdrawal by Subject|0|||
105772833|NCT01693562|364819999|FG011|Escalation Phase|Withdrawal by Subject|0|||
105772834|NCT01693562|364820000|FG012|Escalation Phase|Withdrawal by Subject|0|||
105772835|NCT01693562|364820001|FG013|Escalation Phase|Withdrawal by Subject|0|||
105772836|NCT01693562|364820002|FG014|Escalation Phase|Withdrawal by Subject|0|||
105772837|NCT01693562|364820003|FG015|Escalation Phase|Withdrawal by Subject|0|||
105772838|NCT01693562|364820004|FG016|Escalation Phase|Withdrawal by Subject|0|||
105772839|NCT01693562|364820005|FG017|Escalation Phase|Withdrawal by Subject|0|||
105772840|NCT01693562|364820006|FG018|Escalation Phase|Withdrawal by Subject|0|||
105772841|NCT01693562|364820007|FG019|Escalation Phase|Withdrawal by Subject|0|||
105772842|NCT01693562|364820008|FG020|Escalation Phase|Withdrawal by Subject|0|||
105772843|NCT01693562|364820009|FG021|Escalation Phase|Withdrawal by Subject|0|||
105772844|NCT01693562|364820010|FG022|Escalation Phase|Withdrawal by Subject|0|||
105772845|NCT01693562|364819988|FG000|Escalation Phase|Death|4|||
105772846|NCT01693562|364819989|FG001|Escalation Phase|Death|2|||
105772847|NCT01693562|364819990|FG002|Escalation Phase|Death|0|||
105772848|NCT01693562|364819991|FG003|Escalation Phase|Death|3|||
105772849|NCT01693562|364819992|FG004|Escalation Phase|Death|6|||
105772850|NCT01693562|364819993|FG005|Escalation Phase|Death|4|||
105772851|NCT01693562|364819994|FG006|Escalation Phase|Death|0|||
105772852|NCT01693562|364819995|FG007|Escalation Phase|Death|0|||
105772853|NCT01693562|364819996|FG008|Escalation Phase|Death|0|||
105772854|NCT01693562|364819997|FG009|Escalation Phase|Death|0|||
105772855|NCT01693562|364819998|FG010|Escalation Phase|Death|0|||
105772856|NCT01693562|364819999|FG011|Escalation Phase|Death|0|||
105772857|NCT01693562|364820000|FG012|Escalation Phase|Death|0|||
105772858|NCT01693562|364820001|FG013|Escalation Phase|Death|0|||
105772859|NCT01693562|364820002|FG014|Escalation Phase|Death|0|||
105772860|NCT01693562|364820003|FG015|Escalation Phase|Death|0|||
105772861|NCT01693562|364820004|FG016|Escalation Phase|Death|0|||
105772862|NCT01693562|364820005|FG017|Escalation Phase|Death|0|||
105772863|NCT01693562|364820006|FG018|Escalation Phase|Death|0|||
105772864|NCT01693562|364820007|FG019|Escalation Phase|Death|0|||
105772865|NCT01693562|364820008|FG020|Escalation Phase|Death|0|||
105772866|NCT01693562|364820009|FG021|Escalation Phase|Death|0|||
105772867|NCT01693562|364820010|FG022|Escalation Phase|Death|0|||
105772868|NCT01693562|364819988|FG000|Escalation Phase|Lost to Follow-up|0|||
105772869|NCT01693562|364819989|FG001|Escalation Phase|Lost to Follow-up|1|||
105772870|NCT01693562|364819990|FG002|Escalation Phase|Lost to Follow-up|1|||
105772871|NCT01693562|364819991|FG003|Escalation Phase|Lost to Follow-up|0|||
105772872|NCT01693562|364819992|FG004|Escalation Phase|Lost to Follow-up|0|||
105772873|NCT01693562|364819993|FG005|Escalation Phase|Lost to Follow-up|0|||
105772874|NCT01693562|364819994|FG006|Escalation Phase|Lost to Follow-up|0|||
105772875|NCT01693562|364819995|FG007|Escalation Phase|Lost to Follow-up|0|||
105772876|NCT01693562|364819996|FG008|Escalation Phase|Lost to Follow-up|0|||
105772877|NCT01693562|364819997|FG009|Escalation Phase|Lost to Follow-up|0|||
105772878|NCT01693562|364819998|FG010|Escalation Phase|Lost to Follow-up|0|||
105772879|NCT01693562|364819999|FG011|Escalation Phase|Lost to Follow-up|0|||
105772880|NCT01693562|364820000|FG012|Escalation Phase|Lost to Follow-up|0|||
105772881|NCT01693562|364820001|FG013|Escalation Phase|Lost to Follow-up|0|||
105772882|NCT01693562|364820002|FG014|Escalation Phase|Lost to Follow-up|0|||
105772883|NCT01693562|364820003|FG015|Escalation Phase|Lost to Follow-up|0|||
105772884|NCT01693562|364820004|FG016|Escalation Phase|Lost to Follow-up|0|||
106099742|NCT01912612|366022613|FG001|Overall Study|Study design change|0|||
105772885|NCT01693562|364820005|FG017|Escalation Phase|Lost to Follow-up|0|||
106099743|NCT01912612|366022614|FG002|Overall Study|Study design change|3|||
105772886|NCT01693562|364820006|FG018|Escalation Phase|Lost to Follow-up|0|||
105772887|NCT01693562|364820007|FG019|Escalation Phase|Lost to Follow-up|0|||
105772888|NCT01693562|364820008|FG020|Escalation Phase|Lost to Follow-up|0|||
105772889|NCT01693562|364820009|FG021|Escalation Phase|Lost to Follow-up|0|||
105772890|NCT01693562|364820010|FG022|Escalation Phase|Lost to Follow-up|0|||
105772891|NCT01693562|364819988|FG000|Escalation Phase|Other|0|||
105772892|NCT01693562|364819989|FG001|Escalation Phase|Other|0|||
105772893|NCT01693562|364819990|FG002|Escalation Phase|Other|2|||
105772894|NCT01693562|364819991|FG003|Escalation Phase|Other|0|||
105772895|NCT01693562|364819992|FG004|Escalation Phase|Other|0|||
105772896|NCT01693562|364819993|FG005|Escalation Phase|Other|1|||
105772897|NCT01693562|364819994|FG006|Escalation Phase|Other|0|||
105772898|NCT01693562|364819995|FG007|Escalation Phase|Other|0|||
105772899|NCT01693562|364819996|FG008|Escalation Phase|Other|0|||
105772900|NCT01693562|364819997|FG009|Escalation Phase|Other|0|||
105772901|NCT01693562|364819998|FG010|Escalation Phase|Other|0|||
105772902|NCT01693562|364819999|FG011|Escalation Phase|Other|0|||
105772903|NCT01693562|364820000|FG012|Escalation Phase|Other|0|||
105772904|NCT01693562|364820001|FG013|Escalation Phase|Other|0|||
105772905|NCT01693562|364820002|FG014|Escalation Phase|Other|0|||
105772906|NCT01693562|364820003|FG015|Escalation Phase|Other|0|||
105772907|NCT01693562|364820004|FG016|Escalation Phase|Other|0|||
105772908|NCT01693562|364820005|FG017|Escalation Phase|Other|0|||
105772909|NCT01693562|364820006|FG018|Escalation Phase|Other|0|||
105772910|NCT01693562|364820007|FG019|Escalation Phase|Other|0|||
105772911|NCT01693562|364820008|FG020|Escalation Phase|Other|0|||
105772912|NCT01693562|364820009|FG021|Escalation Phase|Other|0|||
105772913|NCT01693562|364820010|FG022|Escalation Phase|Other|0|||
105772914|NCT01693562|364819988|FG000|Exploration Phase|Withdrawal by Subject|0|||
105772915|NCT01693562|364819989|FG001|Exploration Phase|Withdrawal by Subject|0|||
105772916|NCT01693562|364819990|FG002|Exploration Phase|Withdrawal by Subject|0|||
105772917|NCT01693562|364819991|FG003|Exploration Phase|Withdrawal by Subject|0|||
105772918|NCT01693562|364819992|FG004|Exploration Phase|Withdrawal by Subject|0|||
105772919|NCT01693562|364819993|FG005|Exploration Phase|Withdrawal by Subject|0|||
105772920|NCT01693562|364819994|FG006|Exploration Phase|Withdrawal by Subject|2|||
105772921|NCT01693562|364819995|FG007|Exploration Phase|Withdrawal by Subject|0|||
105772922|NCT01693562|364819996|FG008|Exploration Phase|Withdrawal by Subject|0|||
105772923|NCT01693562|364819997|FG009|Exploration Phase|Withdrawal by Subject|0|||
105772924|NCT01693562|364819998|FG010|Exploration Phase|Withdrawal by Subject|0|||
105772925|NCT01693562|364819999|FG011|Exploration Phase|Withdrawal by Subject|0|||
105772926|NCT01693562|364820000|FG012|Exploration Phase|Withdrawal by Subject|0|||
105772927|NCT01693562|364820001|FG013|Exploration Phase|Withdrawal by Subject|0|||
105772928|NCT01693562|364820002|FG014|Exploration Phase|Withdrawal by Subject|0|||
105772929|NCT01693562|364820003|FG015|Exploration Phase|Withdrawal by Subject|0|||
105772930|NCT01693562|364820004|FG016|Exploration Phase|Withdrawal by Subject|0|||
105772931|NCT01693562|364820005|FG017|Exploration Phase|Withdrawal by Subject|0|||
105772932|NCT01693562|364820006|FG018|Exploration Phase|Withdrawal by Subject|0|||
105772933|NCT01693562|364820007|FG019|Exploration Phase|Withdrawal by Subject|0|||
105772934|NCT01693562|364820008|FG020|Exploration Phase|Withdrawal by Subject|0|||
105772935|NCT01693562|364820009|FG021|Exploration Phase|Withdrawal by Subject|0|||
105772936|NCT01693562|364820010|FG022|Exploration Phase|Withdrawal by Subject|0|||
105772937|NCT01693562|364819988|FG000|Exploration Phase|Death|0|||
105772938|NCT01693562|364819989|FG001|Exploration Phase|Death|0|||
105772939|NCT01693562|364819990|FG002|Exploration Phase|Death|0|||
105772940|NCT01693562|364819991|FG003|Exploration Phase|Death|0|||
105772941|NCT01693562|364819992|FG004|Exploration Phase|Death|0|||
105772942|NCT01693562|364819993|FG005|Exploration Phase|Death|0|||
105772943|NCT01693562|364819994|FG006|Exploration Phase|Death|17|||
105772944|NCT01693562|364819995|FG007|Exploration Phase|Death|0|||
105772945|NCT01693562|364819996|FG008|Exploration Phase|Death|0|||
105772946|NCT01693562|364819997|FG009|Exploration Phase|Death|0|||
105772947|NCT01693562|364819998|FG010|Exploration Phase|Death|0|||
105772948|NCT01693562|364819999|FG011|Exploration Phase|Death|0|||
105772949|NCT01693562|364820000|FG012|Exploration Phase|Death|0|||
105772950|NCT01693562|364820001|FG013|Exploration Phase|Death|0|||
105772951|NCT01693562|364820002|FG014|Exploration Phase|Death|0|||
105772952|NCT01693562|364820003|FG015|Exploration Phase|Death|0|||
105772953|NCT01693562|364820004|FG016|Exploration Phase|Death|0|||
105772954|NCT01693562|364820005|FG017|Exploration Phase|Death|0|||
105772955|NCT01693562|364820006|FG018|Exploration Phase|Death|0|||
105772956|NCT01693562|364820007|FG019|Exploration Phase|Death|0|||
105772957|NCT01693562|364820008|FG020|Exploration Phase|Death|0|||
105772958|NCT01693562|364820009|FG021|Exploration Phase|Death|0|||
105772959|NCT01693562|364820010|FG022|Exploration Phase|Death|0|||
105772960|NCT01693562|364819988|FG000|Exploration Phase|Other|0|||
105772961|NCT01693562|364819989|FG001|Exploration Phase|Other|0|||
105772962|NCT01693562|364819990|FG002|Exploration Phase|Other|0|||
105772963|NCT01693562|364819991|FG003|Exploration Phase|Other|0|||
105772964|NCT01693562|364819992|FG004|Exploration Phase|Other|0|||
105772965|NCT01693562|364819993|FG005|Exploration Phase|Other|0|||
105772966|NCT01693562|364819994|FG006|Exploration Phase|Other|2|||
105772967|NCT01693562|364819995|FG007|Exploration Phase|Other|0|||
105772968|NCT01693562|364819996|FG008|Exploration Phase|Other|0|||
105772969|NCT01693562|364819997|FG009|Exploration Phase|Other|0|||
105772970|NCT01693562|364819998|FG010|Exploration Phase|Other|0|||
105772971|NCT01693562|364819999|FG011|Exploration Phase|Other|0|||
105772972|NCT01693562|364820000|FG012|Exploration Phase|Other|0|||
105772973|NCT01693562|364820001|FG013|Exploration Phase|Other|0|||
105772974|NCT01693562|364820002|FG014|Exploration Phase|Other|0|||
105772975|NCT01693562|364820003|FG015|Exploration Phase|Other|0|||
105772976|NCT01693562|364820004|FG016|Exploration Phase|Other|0|||
105772977|NCT01693562|364820005|FG017|Exploration Phase|Other|0|||
105772978|NCT01693562|364820006|FG018|Exploration Phase|Other|0|||
105772979|NCT01693562|364820007|FG019|Exploration Phase|Other|0|||
105772980|NCT01693562|364820008|FG020|Exploration Phase|Other|0|||
105772981|NCT01693562|364820009|FG021|Exploration Phase|Other|0|||
105772982|NCT01693562|364820010|FG022|Exploration Phase|Other|0|||
105772983|NCT01693562|364819988|FG000|Expansion Phase|Withdrawal by Subject|0|||
105772984|NCT01693562|364819989|FG001|Expansion Phase|Withdrawal by Subject|0|||
105772985|NCT01693562|364819990|FG002|Expansion Phase|Withdrawal by Subject|0|||
105772986|NCT01693562|364819991|FG003|Expansion Phase|Withdrawal by Subject|0|||
105772987|NCT01693562|364819992|FG004|Expansion Phase|Withdrawal by Subject|0|||
105772988|NCT01693562|364819993|FG005|Expansion Phase|Withdrawal by Subject|0|||
105772989|NCT01693562|364819994|FG006|Expansion Phase|Withdrawal by Subject|0|||
105772990|NCT01693562|364819995|FG007|Expansion Phase|Withdrawal by Subject|16|||
105772991|NCT01693562|364819996|FG008|Expansion Phase|Withdrawal by Subject|2|||
105772992|NCT01693562|364819997|FG009|Expansion Phase|Withdrawal by Subject|54|||
105772993|NCT01693562|364819998|FG010|Expansion Phase|Withdrawal by Subject|2|||
105772994|NCT01693562|364819999|FG011|Expansion Phase|Withdrawal by Subject|2|||
105772995|NCT01693562|364820000|FG012|Expansion Phase|Withdrawal by Subject|3|||
105772996|NCT01693562|364820001|FG013|Expansion Phase|Withdrawal by Subject|5|||
105772997|NCT01693562|364820002|FG014|Expansion Phase|Withdrawal by Subject|16|||
105772998|NCT01693562|364820003|FG015|Expansion Phase|Withdrawal by Subject|7|||
105772999|NCT01693562|364820004|FG016|Expansion Phase|Withdrawal by Subject|40|||
105773000|NCT01693562|364820005|FG017|Expansion Phase|Withdrawal by Subject|4|||
105773001|NCT01693562|364820006|FG018|Expansion Phase|Withdrawal by Subject|8|||
105773002|NCT01693562|364820007|FG019|Expansion Phase|Withdrawal by Subject|3|||
105773003|NCT01693562|364820008|FG020|Expansion Phase|Withdrawal by Subject|1|||
105773004|NCT01693562|364820009|FG021|Expansion Phase|Withdrawal by Subject|8|||
105773005|NCT01693562|364820010|FG022|Expansion Phase|Withdrawal by Subject|1|||
105773006|NCT01693562|364819988|FG000|Expansion Phase|Death|0|||
105773007|NCT01693562|364819989|FG001|Expansion Phase|Death|0|||
105773008|NCT01693562|364819990|FG002|Expansion Phase|Death|0|||
105773009|NCT01693562|364819991|FG003|Expansion Phase|Death|0|||
105773010|NCT01693562|364819992|FG004|Expansion Phase|Death|0|||
105773011|NCT01693562|364819993|FG005|Expansion Phase|Death|0|||
105773012|NCT01693562|364819994|FG006|Expansion Phase|Death|0|||
105773013|NCT01693562|364819995|FG007|Expansion Phase|Death|42|||
105773014|NCT01693562|364819996|FG008|Expansion Phase|Death|17|||
105773015|NCT01693562|364819997|FG009|Expansion Phase|Death|208|||
105773016|NCT01693562|364819998|FG010|Expansion Phase|Death|30|||
105773017|NCT01693562|364819999|FG011|Expansion Phase|Death|8|||
105773018|NCT01693562|364820000|FG012|Expansion Phase|Death|19|||
105773019|NCT01693562|364820001|FG013|Expansion Phase|Death|42|||
105773020|NCT01693562|364820002|FG014|Expansion Phase|Death|23|||
105773021|NCT01693562|364820003|FG015|Expansion Phase|Death|23|||
105773022|NCT01693562|364820004|FG016|Expansion Phase|Death|128|||
105773023|NCT01693562|364820005|FG017|Expansion Phase|Death|16|||
105773024|NCT01693562|364820006|FG018|Expansion Phase|Death|36|||
105773025|NCT01693562|364820007|FG019|Expansion Phase|Death|16|||
105773026|NCT01693562|364820008|FG020|Expansion Phase|Death|17|||
105773027|NCT01693562|364820009|FG021|Expansion Phase|Death|35|||
105773028|NCT01693562|364820010|FG022|Expansion Phase|Death|7|||
105773029|NCT01693562|364819988|FG000|Expansion Phase|Lost to Follow-up|0|||
105773030|NCT01693562|364819989|FG001|Expansion Phase|Lost to Follow-up|0|||
105773031|NCT01693562|364819990|FG002|Expansion Phase|Lost to Follow-up|0|||
105773032|NCT01693562|364819991|FG003|Expansion Phase|Lost to Follow-up|0|||
105773033|NCT01693562|364819992|FG004|Expansion Phase|Lost to Follow-up|0|||
105773034|NCT01693562|364819993|FG005|Expansion Phase|Lost to Follow-up|0|||
105773035|NCT01693562|364819994|FG006|Expansion Phase|Lost to Follow-up|0|||
105773036|NCT01693562|364819995|FG007|Expansion Phase|Lost to Follow-up|1|||
105773037|NCT01693562|364819996|FG008|Expansion Phase|Lost to Follow-up|2|||
105773038|NCT01693562|364819997|FG009|Expansion Phase|Lost to Follow-up|10|||
105773039|NCT01693562|364819998|FG010|Expansion Phase|Lost to Follow-up|4|||
105773040|NCT01693562|364819999|FG011|Expansion Phase|Lost to Follow-up|4|||
105773041|NCT01693562|364820000|FG012|Expansion Phase|Lost to Follow-up|1|||
105773042|NCT01693562|364820001|FG013|Expansion Phase|Lost to Follow-up|3|||
105773043|NCT01693562|364820002|FG014|Expansion Phase|Lost to Follow-up|0|||
105773044|NCT01693562|364820003|FG015|Expansion Phase|Lost to Follow-up|1|||
105773045|NCT01693562|364820004|FG016|Expansion Phase|Lost to Follow-up|1|||
105773046|NCT01693562|364820005|FG017|Expansion Phase|Lost to Follow-up|0|||
105773047|NCT01693562|364820006|FG018|Expansion Phase|Lost to Follow-up|2|||
105773048|NCT01693562|364820007|FG019|Expansion Phase|Lost to Follow-up|1|||
105773049|NCT01693562|364820008|FG020|Expansion Phase|Lost to Follow-up|2|||
105773050|NCT01693562|364820009|FG021|Expansion Phase|Lost to Follow-up|2|||
105773051|NCT01693562|364820010|FG022|Expansion Phase|Lost to Follow-up|1|||
105773052|NCT01693562|364819988|FG000|Expansion Phase|Other|0|||
105773053|NCT01693562|364819989|FG001|Expansion Phase|Other|0|||
105773054|NCT01693562|364819990|FG002|Expansion Phase|Other|0|||
105773055|NCT01693562|364819991|FG003|Expansion Phase|Other|0|||
105773056|NCT01693562|364819992|FG004|Expansion Phase|Other|0|||
105773057|NCT01693562|364819993|FG005|Expansion Phase|Other|0|||
105773058|NCT01693562|364819994|FG006|Expansion Phase|Other|0|||
105773059|NCT01693562|364819995|FG007|Expansion Phase|Other|3|||
105773060|NCT01693562|364819996|FG008|Expansion Phase|Other|1|||
105773061|NCT01693562|364819997|FG009|Expansion Phase|Other|28|||
105773062|NCT01693562|364819998|FG010|Expansion Phase|Other|4|||
105773063|NCT01693562|364819999|FG011|Expansion Phase|Other|7|||
105773064|NCT01693562|364820000|FG012|Expansion Phase|Other|0|||
105773065|NCT01693562|364820001|FG013|Expansion Phase|Other|1|||
105773066|NCT01693562|364820002|FG014|Expansion Phase|Other|1|||
105773067|NCT01693562|364820003|FG015|Expansion Phase|Other|0|||
105773068|NCT01693562|364820004|FG016|Expansion Phase|Other|28|||
105773069|NCT01693562|364820005|FG017|Expansion Phase|Other|0|||
105773070|NCT01693562|364820006|FG018|Expansion Phase|Other|1|||
105773071|NCT01693562|364820007|FG019|Expansion Phase|Other|0|||
105773072|NCT01693562|364820008|FG020|Expansion Phase|Other|1|||
105773073|NCT01693562|364820009|FG021|Expansion Phase|Other|17|||
105773074|NCT01693562|364820010|FG022|Expansion Phase|Other|1|||
105773075|NCT01599585|364820013|FG000|Overall Study|Withdrawal by Subject|16|||
105773076|NCT01599585|364820014|FG001|Overall Study|Withdrawal by Subject|9|||
105773077|NCT01599585|364820013|FG000|Overall Study|Lost to Follow-up|3|||
105773078|NCT01599585|364820014|FG001|Overall Study|Lost to Follow-up|5|||
105773079|NCT01599585|364820013|FG000|Overall Study|randomized did not start treatment|3|||
105773080|NCT01599585|364820014|FG001|Overall Study|randomized did not start treatment|3|||
105773096|NCT04517253|364820020|FG000|Primary Treatment Period|Adverse Event|1|||
105773097|NCT04517253|364820021|FG001|Primary Treatment Period|Adverse Event|0|||
105773098|NCT04517253|364820022|FG002|Primary Treatment Period|Adverse Event|0|||
105773099|NCT04517253|364820020|FG000|Primary Treatment Period|Death|0|||
105773100|NCT04517253|364820021|FG001|Primary Treatment Period|Death|1|||
105773101|NCT04517253|364820022|FG002|Primary Treatment Period|Death|0|||
105773102|NCT04517253|364820020|FG000|Maintenance Period|Withdrawal by Subject|1|||
105773103|NCT04517253|364820021|FG001|Maintenance Period|Withdrawal by Subject|0|||
105773104|NCT04517253|364820022|FG002|Maintenance Period|Withdrawal by Subject|0|||
105773105|NCT04517253|364820020|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
105773106|NCT04517253|364820021|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
105773107|NCT04517253|364820022|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
105773108|NCT03598140|364820023|FG000|Overall Study|enrolled but didn't start|1|||
105773109|NCT03598140|364820024|FG001|Overall Study|enrolled but didn't start|0|||
105773110|NCT01842334|364820025|FG000|Overall Study|Withdrawal by Subject|3|||
105773111|NCT01842334|364820026|FG001|Overall Study|Withdrawal by Subject|3|||
105773112|NCT01842334|364820025|FG000|Overall Study|Moved away mid-study|0|||
105773113|NCT01842334|364820026|FG001|Overall Study|Moved away mid-study|1|||
105773114|NCT01021553|364820028|FG000|Overall Study|Adverse Event|1|||
105773115|NCT01021553|364820029|FG001|Overall Study|Adverse Event|0|||
105773116|NCT01021553|364820030|FG002|Overall Study|Adverse Event|0|||
105773117|NCT01021553|364820028|FG000|Overall Study|Lack of Efficacy|2|||
105773118|NCT01021553|364820029|FG001|Overall Study|Lack of Efficacy|2|||
105773119|NCT01021553|364820030|FG002|Overall Study|Lack of Efficacy|0|||
105773120|NCT01021553|364820028|FG000|Overall Study|Protocol Violation|0|||
105773121|NCT01021553|364820029|FG001|Overall Study|Protocol Violation|2|||
105773122|NCT01021553|364820030|FG002|Overall Study|Protocol Violation|2|||
105773123|NCT01021553|364820028|FG000|Overall Study|Lost to Follow-up|0|||
105773124|NCT01021553|364820029|FG001|Overall Study|Lost to Follow-up|0|||
105773125|NCT01021553|364820030|FG002|Overall Study|Lost to Follow-up|1|||
105773126|NCT01021553|364820028|FG000|Overall Study|Withdrawal by Subject|1|||
106099744|NCT04546581|366022615|FG000|Overall Study|Adverse Event|9|||
105773127|NCT01021553|364820029|FG001|Overall Study|Withdrawal by Subject|1|||
106099745|NCT04546581|366022616|FG001|Overall Study|Adverse Event|3|||
106099746|NCT04546581|366022615|FG000|Overall Study|Physician Decision|0|||
106099747|NCT04546581|366022616|FG001|Overall Study|Physician Decision|1|||
105773128|NCT01021553|364820030|FG002|Overall Study|Withdrawal by Subject|0|||
105773129|NCT00126425|364820035|FG000|Overall Study|Withdrawal by Subject|17|||
105773130|NCT00126425|364820036|FG001|Overall Study|Withdrawal by Subject|1|||
105773131|NCT00126425|364820035|FG000|Overall Study|Lost to Follow-up|8|||
105773132|NCT00126425|364820036|FG001|Overall Study|Lost to Follow-up|4|||
105773133|NCT00126425|364820035|FG000|Overall Study|Protocol Violation|9|||
105773134|NCT00126425|364820036|FG001|Overall Study|Protocol Violation|6|||
105773135|NCT00126425|364820035|FG000|Overall Study|Adverse Event|1|||
105773136|NCT00126425|364820036|FG001|Overall Study|Adverse Event|0|||
105773137|NCT00126425|364820035|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
105773138|NCT00126425|364820036|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
105773139|NCT00126425|364820035|FG000|Overall Study|Other|5|||
105773140|NCT00126425|364820036|FG001|Overall Study|Other|0|||
105773141|NCT00149890|364820039|FG000|Overall Study|Adverse Event|1|||
105773142|NCT00149890|364820040|FG001|Overall Study|Adverse Event|8|||
105773143|NCT00149890|364820039|FG000|Overall Study|Lack of Efficacy|8|||
105773144|NCT00149890|364820040|FG001|Overall Study|Lack of Efficacy|9|||
105773145|NCT00149890|364820039|FG000|Overall Study|Protocol Violation|1|||
105773146|NCT00149890|364820040|FG001|Overall Study|Protocol Violation|0|||
105773147|NCT00149890|364820039|FG000|Overall Study|Lost to Follow-up|1|||
105773148|NCT00149890|364820040|FG001|Overall Study|Lost to Follow-up|0|||
105773149|NCT00149890|364820039|FG000|Overall Study|Graft Loss|2|||
105773150|NCT00149890|364820040|FG001|Overall Study|Graft Loss|1|||
105773151|NCT00998985|364820044|FG000|Overall Study|Withdrawal by Subject|0|||
105773152|NCT00998985|364820045|FG001|Overall Study|Withdrawal by Subject|0|||
105773153|NCT00998985|364820046|FG002|Overall Study|Withdrawal by Subject|0|||
105773154|NCT00998985|364820047|FG003|Overall Study|Withdrawal by Subject|0|||
105773155|NCT00998985|364820048|FG004|Overall Study|Withdrawal by Subject|0|||
105773156|NCT00998985|364820049|FG005|Overall Study|Withdrawal by Subject|0|||
105773157|NCT00998985|364820050|FG006|Overall Study|Withdrawal by Subject|0|||
105773158|NCT00998985|364820051|FG007|Overall Study|Withdrawal by Subject|0|||
105773159|NCT00998985|364820052|FG008|Overall Study|Withdrawal by Subject|1|||
105773160|NCT00998985|364820053|FG009|Overall Study|Withdrawal by Subject|0|||
105773161|NCT00998985|364820054|FG010|Overall Study|Withdrawal by Subject|0|||
105773162|NCT00998985|364820055|FG011|Overall Study|Withdrawal by Subject|0|||
105773163|NCT00998985|364820056|FG012|Overall Study|Withdrawal by Subject|0|||
105773164|NCT00998985|364820057|FG013|Overall Study|Withdrawal by Subject|0|||
105773165|NCT00998985|364820044|FG000|Overall Study|Protocol Violation|0|||
105773166|NCT00998985|364820045|FG001|Overall Study|Protocol Violation|0|||
105773167|NCT00998985|364820046|FG002|Overall Study|Protocol Violation|0|||
105773168|NCT00998985|364820047|FG003|Overall Study|Protocol Violation|0|||
105773169|NCT00998985|364820048|FG004|Overall Study|Protocol Violation|0|||
105773170|NCT00998985|364820049|FG005|Overall Study|Protocol Violation|1|||
105773171|NCT00998985|364820050|FG006|Overall Study|Protocol Violation|0|||
105773172|NCT00998985|364820051|FG007|Overall Study|Protocol Violation|0|||
105773173|NCT00998985|364820052|FG008|Overall Study|Protocol Violation|0|||
105773174|NCT00998985|364820053|FG009|Overall Study|Protocol Violation|0|||
105773175|NCT00998985|364820054|FG010|Overall Study|Protocol Violation|0|||
105773176|NCT00998985|364820055|FG011|Overall Study|Protocol Violation|0|||
105773177|NCT00998985|364820056|FG012|Overall Study|Protocol Violation|0|||
105773178|NCT00998985|364820057|FG013|Overall Study|Protocol Violation|0|||
105773179|NCT01040728|364820058|FG000|Overall Study|Adverse Event|4|||
105773180|NCT01040728|364820059|FG001|Overall Study|Adverse Event|8|||
105773181|NCT01040728|364820060|FG002|Overall Study|Adverse Event|0|||
105773182|NCT01040728|364820061|FG003|Overall Study|Adverse Event|4|||
105773183|NCT01040728|364820058|FG000|Overall Study|Withdrawal by Subject|0|||
105773184|NCT01040728|364820059|FG001|Overall Study|Withdrawal by Subject|1|||
105773185|NCT01040728|364820060|FG002|Overall Study|Withdrawal by Subject|1|||
105773186|NCT01040728|364820061|FG003|Overall Study|Withdrawal by Subject|0|||
105773187|NCT01040728|364820058|FG000|Overall Study|Protocol Violation|0|||
105773188|NCT01040728|364820059|FG001|Overall Study|Protocol Violation|0|||
105773189|NCT01040728|364820060|FG002|Overall Study|Protocol Violation|0|||
105773190|NCT01040728|364820061|FG003|Overall Study|Protocol Violation|1|||
105773191|NCT01040728|364820058|FG000|Overall Study|Lack of Efficacy|0|||
105773192|NCT01040728|364820059|FG001|Overall Study|Lack of Efficacy|1|||
105773193|NCT01040728|364820060|FG002|Overall Study|Lack of Efficacy|0|||
105773194|NCT01040728|364820061|FG003|Overall Study|Lack of Efficacy|1|||
105773195|NCT01040728|364820058|FG000|Overall Study|Other reasons not listed above|0|||
105773196|NCT01040728|364820059|FG001|Overall Study|Other reasons not listed above|1|||
105773197|NCT01040728|364820060|FG002|Overall Study|Other reasons not listed above|0|||
105773198|NCT01040728|364820061|FG003|Overall Study|Other reasons not listed above|0|||
105773199|NCT02583711|364820064|FG000|Overall Study|Withdrawal by Subject|0|||
105773200|NCT02583711|364820065|FG001|Overall Study|Withdrawal by Subject|10|||
105773201|NCT02583711|364820066|FG002|Overall Study|Withdrawal by Subject|0|||
105773202|NCT01875874|364820067|FG000|Overall Study|Death|3|||
105773203|NCT02382276|364820068|FG000|Overall Study|Withdrawal by Subject|4|||
105773204|NCT02382276|364820069|FG001|Overall Study|Withdrawal by Subject|8|||
105773205|NCT02382276|364820070|FG002|Overall Study|Withdrawal by Subject|5|||
105773206|NCT02382276|364820068|FG000|Overall Study|Adverse Event|7|||
105773207|NCT02382276|364820069|FG001|Overall Study|Adverse Event|2|||
105773208|NCT02382276|364820070|FG002|Overall Study|Adverse Event|32|||
105773209|NCT02382276|364820068|FG000|Overall Study|Physician Decision|0|||
105773210|NCT02382276|364820069|FG001|Overall Study|Physician Decision|0|||
105773211|NCT02382276|364820070|FG002|Overall Study|Physician Decision|2|||
105773212|NCT03452397|364820072|FG000|Overall Study|Adverse Event|1|||
105773213|NCT03452397|364820073|FG001|Overall Study|Adverse Event|0|||
105773214|NCT03452397|364820074|FG002|Overall Study|Adverse Event|0|||
105773215|NCT03452397|364820075|FG003|Overall Study|Adverse Event|0|||
105773216|NCT03452397|364820072|FG000|Overall Study|Administrative reason|0|||
105773217|NCT03452397|364820073|FG001|Overall Study|Administrative reason|0|||
105773218|NCT03452397|364820074|FG002|Overall Study|Administrative reason|1|||
105773219|NCT03452397|364820075|FG003|Overall Study|Administrative reason|1|||
105773220|NCT03452397|364820072|FG000|Overall Study|Withdrawal by Subject|0|||
105773221|NCT03452397|364820073|FG001|Overall Study|Withdrawal by Subject|0|||
105773222|NCT03452397|364820074|FG002|Overall Study|Withdrawal by Subject|1|||
105773223|NCT03452397|364820075|FG003|Overall Study|Withdrawal by Subject|0|||
105773224|NCT00286156|364820078|FG000|Overall Study|Missed 12 month visit|0|||
105773225|NCT00286156|364820079|FG001|Overall Study|Missed 12 month visit|0|||
105773226|NCT00286156|364820080|FG002|Overall Study|Missed 12 month visit|1|||
105773227|NCT00286156|364820078|FG000|Overall Study|AE: pulmonary embolus|0|||
105773228|NCT00286156|364820079|FG001|Overall Study|AE: pulmonary embolus|1|||
105773229|NCT00286156|364820080|FG002|Overall Study|AE: pulmonary embolus|0|||
105773230|NCT00286156|364820078|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
105773231|NCT00286156|364820079|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
105773232|NCT00286156|364820080|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
105773233|NCT00286156|364820078|FG000|Overall Study|AE: pneumonia|1|||
105773234|NCT00286156|364820079|FG001|Overall Study|AE: pneumonia|0|||
105773235|NCT00286156|364820080|FG002|Overall Study|AE: pneumonia|0|||
105773236|NCT05281094|364820082|FG000|Overall Study|Adverse Event|1|||
105773237|NCT05281094|364820083|FG001|Overall Study|Adverse Event|0|||
105773238|NCT05281094|364820082|FG000|Overall Study|Lost to Follow-up|29|||
105773239|NCT05281094|364820083|FG001|Overall Study|Lost to Follow-up|22|||
105773240|NCT05281094|364820082|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
105773241|NCT05281094|364820083|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
105773242|NCT05281094|364820082|FG000|Overall Study|Death|1|||
105773243|NCT05281094|364820083|FG001|Overall Study|Death|2|||
105773244|NCT05281094|364820082|FG000|Overall Study|Not pre-specified reason|8|||
105773245|NCT05281094|364820083|FG001|Overall Study|Not pre-specified reason|5|||
105773246|NCT04459416|364821565|FG000|Overall Study|Lost to Follow-up|2|||
105773247|NCT04459416|364821566|FG001|Overall Study|Lost to Follow-up|0|||
105773248|NCT04459416|364821565|FG000|Overall Study|Withdrawal by Subject|8|||
105773249|NCT04459416|364821566|FG001|Overall Study|Withdrawal by Subject|10|||
105773250|NCT04459416|364821565|FG000|Overall Study|Disease progression|0|||
105773251|NCT04459416|364821566|FG001|Overall Study|Disease progression|3|||
105773252|NCT04418427|364821571|FG000|Overall Study|Death|0|||
105773253|NCT04418427|364821572|FG001|Overall Study|Death|1|||
105773254|NCT04418427|364821573|FG002|Overall Study|Death|0|||
105773255|NCT04418427|364821571|FG000|Overall Study|Lost to Follow-up|0|||
105773256|NCT04418427|364821572|FG001|Overall Study|Lost to Follow-up|2|||
105773257|NCT04418427|364821573|FG002|Overall Study|Lost to Follow-up|2|||
105773258|NCT04418427|364821571|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
105773259|NCT04418427|364821572|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
105773260|NCT04418427|364821573|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
105773261|NCT04418427|364821571|FG000|Overall Study|Pre-existing medical condition|0|||
105773262|NCT04418427|364821572|FG001|Overall Study|Pre-existing medical condition|1|||
105773263|NCT04418427|364821573|FG002|Overall Study|Pre-existing medical condition|0|||
105773264|NCT02554721|364821578|FG000|Overall Study|Adverse Event|1|||
105773265|NCT02554721|364821579|FG001|Overall Study|Adverse Event|0|||
105773266|NCT02554721|364821580|FG002|Overall Study|Adverse Event|0|||
105773267|NCT02554721|364821581|FG003|Overall Study|Adverse Event|0|||
105773268|NCT02554721|364821582|FG004|Overall Study|Adverse Event|1|||
105773269|NCT02554721|364821578|FG000|Overall Study|Noncompliance|0|||
105773270|NCT02554721|364821579|FG001|Overall Study|Noncompliance|0|||
105773271|NCT02554721|364821580|FG002|Overall Study|Noncompliance|0|||
105773272|NCT02554721|364821581|FG003|Overall Study|Noncompliance|0|||
105773273|NCT02554721|364821582|FG004|Overall Study|Noncompliance|1|||
105773274|NCT01888965|364821584|FG000|Overall Study|Adverse Event|5|||
105773275|NCT01888965|364821584|FG000|Overall Study|Lack of Efficacy|4|||
105773276|NCT04610827|364821585|FG000|Overall Study|Withdrawal by Subject|1|||
105773277|NCT04610827|364821586|FG001|Overall Study|Withdrawal by Subject|1|||
105773278|NCT04610827|364821587|FG002|Overall Study|Withdrawal by Subject|0|||
105773279|NCT00908895|364821589|FG000|Overall Study|Lost to Follow-up|1|||
105773280|NCT00908895|364821590|FG001|Overall Study|Lost to Follow-up|3|||
105773281|NCT00908895|364821589|FG000|Overall Study|algodystrophy|2|||
105773282|NCT00908895|364821590|FG001|Overall Study|algodystrophy|2|||
105773283|NCT00908895|364821589|FG000|Overall Study|Adverse Event|1|||
105773284|NCT00908895|364821590|FG001|Overall Study|Adverse Event|1|||
105773285|NCT00443534|364821592|FG000|Overall Study|Lack of Efficacy|67|||
105773286|NCT00443534|364821592|FG000|Overall Study|Adverse Event|16|||
105773287|NCT00443534|364821592|FG000|Overall Study|Death|9|||
105773288|NCT00443534|364821592|FG000|Overall Study|Withdrawal by Subject|8|||
105773289|NCT00443534|364821592|FG000|Overall Study|Study Terminated by Sponsor|12|||
105773290|NCT00443534|364821592|FG000|Overall Study|Other|10|||
105773291|NCT00443534|364821592|FG000|Overall Study|Enrolled, Not Treated|1|||
105773292|NCT00364611|364821594|FG000|Overall Study|Did not receive study medication|0|||
105773293|NCT00364611|364821595|FG001|Overall Study|Did not receive study medication|1|||
105773294|NCT00364611|364821594|FG000|Overall Study|Adverse Event|7|||
105773295|NCT00364611|364821595|FG001|Overall Study|Adverse Event|4|||
105773296|NCT00364611|364821594|FG000|Overall Study|Participant's Request|3|||
105773297|NCT00364611|364821595|FG001|Overall Study|Participant's Request|4|||
105773298|NCT00364611|364821594|FG000|Overall Study|Disease Progression|38|||
105773299|NCT00364611|364821595|FG001|Overall Study|Disease Progression|8|||
105773300|NCT00364611|364821594|FG000|Overall Study|Investigator decision|2|||
105773301|NCT00364611|364821595|FG001|Overall Study|Investigator decision|2|||
105773302|NCT00364611|364821594|FG000|Overall Study|Found Ineligible|1|||
105773303|NCT00364611|364821595|FG001|Overall Study|Found Ineligible|0|||
105773304|NCT00364611|364821594|FG000|Overall Study|Presumed CR on Study|0|||
105773305|NCT00364611|364821595|FG001|Overall Study|Presumed CR on Study|1|||
105773306|NCT00364611|364821594|FG000|Overall Study|Receiving Liver Ablation|0|||
105773307|NCT00364611|364821595|FG001|Overall Study|Receiving Liver Ablation|1|||
105773308|NCT02881151|364821602|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
105773309|NCT03225833|364821603|FG000|Overall Study|Adverse Event|0|||
105773310|NCT03225833|364821604|FG001|Overall Study|Adverse Event|1|||
105773311|NCT03225833|364821605|FG002|Overall Study|Adverse Event|2|||
105773312|NCT03225833|364821606|FG003|Overall Study|Adverse Event|0|||
105773313|NCT03225833|364821607|FG004|Overall Study|Adverse Event|0|||
105773314|NCT03225833|364821608|FG005|Overall Study|Adverse Event|2|||
105773315|NCT03225833|364821603|FG000|Overall Study|Withdrawal by Subject|1|||
105773316|NCT03225833|364821604|FG001|Overall Study|Withdrawal by Subject|0|||
105773317|NCT03225833|364821605|FG002|Overall Study|Withdrawal by Subject|0|||
105773318|NCT03225833|364821606|FG003|Overall Study|Withdrawal by Subject|0|||
105773319|NCT03225833|364821607|FG004|Overall Study|Withdrawal by Subject|1|||
105773320|NCT03225833|364821608|FG005|Overall Study|Withdrawal by Subject|0|||
105773321|NCT03225833|364821603|FG000|Overall Study|Termination of Study by Sponsor|4|||
105773322|NCT03225833|364821604|FG001|Overall Study|Termination of Study by Sponsor|0|||
105773323|NCT03225833|364821605|FG002|Overall Study|Termination of Study by Sponsor|0|||
105773324|NCT03225833|364821606|FG003|Overall Study|Termination of Study by Sponsor|0|||
105773325|NCT03225833|364821607|FG004|Overall Study|Termination of Study by Sponsor|0|||
105773326|NCT03225833|364821608|FG005|Overall Study|Termination of Study by Sponsor|7|||
105773327|NCT03225833|364821603|FG000|Overall Study|Sponsor Decision|0|||
105773328|NCT03225833|364821604|FG001|Overall Study|Sponsor Decision|0|||
105773329|NCT03225833|364821605|FG002|Overall Study|Sponsor Decision|0|||
105773330|NCT03225833|364821606|FG003|Overall Study|Sponsor Decision|0|||
105773331|NCT03225833|364821607|FG004|Overall Study|Sponsor Decision|0|||
105773332|NCT03225833|364821608|FG005|Overall Study|Sponsor Decision|1|||
105773333|NCT00723489|364821609|FG000|Overall Study|Physician Decision|0|||
105773334|NCT00723489|364821610|FG001|Overall Study|Physician Decision|1|||
105773335|NCT00723489|364821611|FG002|Overall Study|Physician Decision|0|||
105773336|NCT00723489|364821612|FG003|Overall Study|Physician Decision|0|||
105773337|NCT00723489|364821609|FG000|Overall Study|Pregnancy|0|||
105773338|NCT00723489|364821610|FG001|Overall Study|Pregnancy|0|||
105773339|NCT00723489|364821611|FG002|Overall Study|Pregnancy|0|||
105773340|NCT00723489|364821612|FG003|Overall Study|Pregnancy|1|||
105773341|NCT00723489|364821609|FG000|Overall Study|Withdrawal by Subject|0|||
105773342|NCT00723489|364821610|FG001|Overall Study|Withdrawal by Subject|0|||
105773343|NCT00723489|364821611|FG002|Overall Study|Withdrawal by Subject|0|||
105773344|NCT00723489|364821612|FG003|Overall Study|Withdrawal by Subject|1|||
105773345|NCT00723489|364821609|FG000|Overall Study|Seropositive at baseline|1|||
105773346|NCT00723489|364821610|FG001|Overall Study|Seropositive at baseline|0|||
105773347|NCT00723489|364821611|FG002|Overall Study|Seropositive at baseline|0|||
105773348|NCT00723489|364821612|FG003|Overall Study|Seropositive at baseline|0|||
105773349|NCT00723489|364821609|FG000|Overall Study|Prohibited Medication|0|||
105773350|NCT00723489|364821610|FG001|Overall Study|Prohibited Medication|0|||
105773351|NCT00723489|364821611|FG002|Overall Study|Prohibited Medication|0|||
105773352|NCT00723489|364821612|FG003|Overall Study|Prohibited Medication|1|||
105773353|NCT00723489|364821609|FG000|Overall Study|Samples Collected Out of Window|0|||
105773354|NCT00723489|364821610|FG001|Overall Study|Samples Collected Out of Window|3|||
105773355|NCT00723489|364821611|FG002|Overall Study|Samples Collected Out of Window|0|||
105773356|NCT00723489|364821612|FG003|Overall Study|Samples Collected Out of Window|0|||
105990730|NCT02881762|365624414|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105990731|NCT00774800|365624421|FG000|Intervention 4|Withdrawal by Subject|1|||
105773447|NCT05827978|364821623|FG000|Overall Study|Adverse Event|1|||
105773448|NCT05827978|364821624|FG001|Overall Study|Adverse Event|0|||
105773449|NCT05827978|364821625|FG002|Overall Study|Adverse Event|0|||
105773450|NCT05827978|364821626|FG003|Overall Study|Adverse Event|1|||
105773451|NCT05827978|364821627|FG004|Overall Study|Adverse Event|0|||
105773452|NCT05827978|364821628|FG005|Overall Study|Adverse Event|0|||
105773453|NCT05827978|364821623|FG000|Overall Study|Death|1|||
105773454|NCT05827978|364821624|FG001|Overall Study|Death|5|||
105773455|NCT05827978|364821625|FG002|Overall Study|Death|2|||
105773456|NCT05827978|364821626|FG003|Overall Study|Death|3|||
105773457|NCT05827978|364821627|FG004|Overall Study|Death|1|||
105773458|NCT05827978|364821628|FG005|Overall Study|Death|3|||
105773459|NCT05827978|364821623|FG000|Overall Study|Lost to Follow-up|57|||
105773460|NCT05827978|364821624|FG001|Overall Study|Lost to Follow-up|88|||
105773461|NCT05827978|364821625|FG002|Overall Study|Lost to Follow-up|54|||
105773462|NCT05827978|364821626|FG003|Overall Study|Lost to Follow-up|47|||
105773463|NCT05827978|364821627|FG004|Overall Study|Lost to Follow-up|25|||
105773464|NCT05827978|364821628|FG005|Overall Study|Lost to Follow-up|10|||
105773465|NCT05827978|364821623|FG000|Overall Study|Noncompliance with Study Procedures|0|||
105773466|NCT05827978|364821624|FG001|Overall Study|Noncompliance with Study Procedures|1|||
105773467|NCT05827978|364821625|FG002|Overall Study|Noncompliance with Study Procedures|1|||
105773468|NCT05827978|364821626|FG003|Overall Study|Noncompliance with Study Procedures|1|||
105773469|NCT05827978|364821627|FG004|Overall Study|Noncompliance with Study Procedures|1|||
105773470|NCT05827978|364821628|FG005|Overall Study|Noncompliance with Study Procedures|0|||
105773471|NCT05827978|364821623|FG000|Overall Study|Physician Decision|2|||
105773472|NCT05827978|364821624|FG001|Overall Study|Physician Decision|0|||
105773473|NCT05827978|364821625|FG002|Overall Study|Physician Decision|1|||
105773474|NCT05827978|364821626|FG003|Overall Study|Physician Decision|2|||
105773475|NCT05827978|364821627|FG004|Overall Study|Physician Decision|1|||
105773476|NCT05827978|364821628|FG005|Overall Study|Physician Decision|1|||
105773477|NCT05827978|364821623|FG000|Overall Study|Protocol Violation|5|||
105773478|NCT05827978|364821624|FG001|Overall Study|Protocol Violation|2|||
105773479|NCT05827978|364821625|FG002|Overall Study|Protocol Violation|0|||
105773480|NCT05827978|364821626|FG003|Overall Study|Protocol Violation|0|||
105773481|NCT05827978|364821627|FG004|Overall Study|Protocol Violation|0|||
105773482|NCT05827978|364821628|FG005|Overall Study|Protocol Violation|0|||
105773483|NCT05827978|364821623|FG000|Overall Study|Withdrawal by Subject|17|||
105773484|NCT05827978|364821624|FG001|Overall Study|Withdrawal by Subject|16|||
105773485|NCT05827978|364821625|FG002|Overall Study|Withdrawal by Subject|10|||
105773486|NCT05827978|364821626|FG003|Overall Study|Withdrawal by Subject|12|||
105773487|NCT05827978|364821627|FG004|Overall Study|Withdrawal by Subject|10|||
105773488|NCT05827978|364821628|FG005|Overall Study|Withdrawal by Subject|9|||
105773489|NCT05827978|364821623|FG000|Overall Study|Other Than Specified|0|||
105773490|NCT05827978|364821624|FG001|Overall Study|Other Than Specified|0|||
105773491|NCT05827978|364821625|FG002|Overall Study|Other Than Specified|1|||
105773492|NCT05827978|364821626|FG003|Overall Study|Other Than Specified|0|||
105773493|NCT05827978|364821627|FG004|Overall Study|Other Than Specified|2|||
105773494|NCT05827978|364821628|FG005|Overall Study|Other Than Specified|0|||
105773495|NCT01108263|364821629|FG000|Overall Study|Adverse Event|0|||
105773496|NCT01108263|364821630|FG001|Overall Study|Adverse Event|1|||
105773497|NCT01023516|364821631|FG000|Overall Study|Voluntary discontinuation|7|||
105773498|NCT01023516|364821632|FG001|Overall Study|Voluntary discontinuation|5|||
105773499|NCT01023516|364821631|FG000|Overall Study|Adverse Event|9|||
105773500|NCT01023516|364821632|FG001|Overall Study|Adverse Event|6|||
105773501|NCT01023516|364821631|FG000|Overall Study|Safety reason|0|||
105773502|NCT01023516|364821632|FG001|Overall Study|Safety reason|3|||
105773503|NCT01023516|364821631|FG000|Overall Study|Study-specific criteria|4|||
105773504|NCT01023516|364821632|FG001|Overall Study|Study-specific criteria|2|||
105773505|NCT01023516|364821631|FG000|Overall Study|Incorrect enrolment|4|||
105773506|NCT01023516|364821632|FG001|Overall Study|Incorrect enrolment|2|||
105773507|NCT01266876|364821633|FG000|Overall Study|Adverse Event|0|||
105773508|NCT01266876|364821634|FG001|Overall Study|Adverse Event|0|||
105773509|NCT01266876|364821635|FG002|Overall Study|Adverse Event|0|||
106099748|NCT04546581|366022615|FG000|Overall Study|Protocol Violation|1|||
105773510|NCT01266876|364821636|FG003|Overall Study|Adverse Event|1|||
105773511|NCT01266876|364821637|FG004|Overall Study|Adverse Event|0|||
105773512|NCT05180721|364821638|FG000|Overall Study|Lost to Follow-up|4|||
105773513|NCT01996865|364821639|FG000|Induction Period|Protocol Violation|1|||
105773514|NCT01996865|364821640|FG001|Induction Period|Protocol Violation|0|||
105773515|NCT01996865|364821641|FG002|Induction Period|Protocol Violation|0|||
105773516|NCT01996865|364821639|FG000|Induction Period|Progressive Disease|4|||
105773517|NCT01996865|364821640|FG001|Induction Period|Progressive Disease|0|||
105773518|NCT01996865|364821641|FG002|Induction Period|Progressive Disease|0|||
105773519|NCT01996865|364821639|FG000|Induction Period|Lost to Follow-up|10|||
105773520|NCT01996865|364821640|FG001|Induction Period|Lost to Follow-up|0|||
105773521|NCT01996865|364821641|FG002|Induction Period|Lost to Follow-up|0|||
105773522|NCT01996865|364821639|FG000|Induction Period|Other Reasons|13|||
105773523|NCT01996865|364821640|FG001|Induction Period|Other Reasons|0|||
105773524|NCT01996865|364821641|FG002|Induction Period|Other Reasons|0|||
105773525|NCT01996865|364821639|FG000|Induction Period|Adverse Event|20|||
105773526|NCT01996865|364821640|FG001|Induction Period|Adverse Event|0|||
105773527|NCT01996865|364821641|FG002|Induction Period|Adverse Event|0|||
105773528|NCT01996865|364821639|FG000|Induction Period|Withdrawal by Subject|60|||
105773529|NCT01996865|364821640|FG001|Induction Period|Withdrawal by Subject|0|||
105773530|NCT01996865|364821641|FG002|Induction Period|Withdrawal by Subject|0|||
105773531|NCT01996865|364821639|FG000|Induction Period|Death|111|||
105773532|NCT01996865|364821640|FG001|Induction Period|Death|0|||
105773533|NCT01996865|364821641|FG002|Induction Period|Death|0|||
105773534|NCT01996865|364821639|FG000|Maintenance Period|Protocol Violation|0|||
105773535|NCT01996865|364821640|FG001|Maintenance Period|Protocol Violation|1|||
105773536|NCT01996865|364821641|FG002|Maintenance Period|Protocol Violation|1|||
105773537|NCT01996865|364821639|FG000|Maintenance Period|Other reasons|0|||
105773538|NCT01996865|364821640|FG001|Maintenance Period|Other reasons|8|||
105773539|NCT01996865|364821641|FG002|Maintenance Period|Other reasons|5|||
105773540|NCT01996865|364821639|FG000|Maintenance Period|Progressive Disease|0|||
105773541|NCT01996865|364821640|FG001|Maintenance Period|Progressive Disease|6|||
105773542|NCT01996865|364821641|FG002|Maintenance Period|Progressive Disease|23|||
105773543|NCT01996865|364821639|FG000|Maintenance Period|Withdrawal by Subject|0|||
105773544|NCT01996865|364821640|FG001|Maintenance Period|Withdrawal by Subject|18|||
105773545|NCT01996865|364821641|FG002|Maintenance Period|Withdrawal by Subject|4|||
105773546|NCT01996865|364821639|FG000|Maintenance Period|Adverse Event|0|||
105773547|NCT01996865|364821640|FG001|Maintenance Period|Adverse Event|7|||
105773548|NCT01996865|364821641|FG002|Maintenance Period|Adverse Event|7|||
105773549|NCT01996865|364821639|FG000|Maintenance Period|Death|0|||
105773550|NCT01996865|364821640|FG001|Maintenance Period|Death|15|||
105773551|NCT01996865|364821641|FG002|Maintenance Period|Death|3|||
105773552|NCT01996865|364821639|FG000|Maintenance Period|Lost to Follow-up|0|||
105773553|NCT01996865|364821640|FG001|Maintenance Period|Lost to Follow-up|2|||
105773554|NCT01996865|364821641|FG002|Maintenance Period|Lost to Follow-up|0|||
105773555|NCT05304611|364821644|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773556|NCT05304611|364821645|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773557|NCT05304611|364821646|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773558|NCT05304611|364821647|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773559|NCT05304611|364821648|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773560|NCT05304611|364821649|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773561|NCT05304611|364821650|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
105773562|NCT05304611|364821651|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773563|NCT05304611|364821652|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
105773564|NCT05304611|364821653|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773565|NCT05304611|364821654|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773566|NCT05304611|364821655|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
105773567|NCT05304611|364821644|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
105773568|NCT05304611|364821645|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
105773569|NCT05304611|364821646|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
105773570|NCT05304611|364821647|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
105773571|NCT05304611|364821648|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
105773572|NCT05304611|364821649|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
105773573|NCT05304611|364821650|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
105773574|NCT05304611|364821651|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
105773575|NCT05304611|364821652|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
105773576|NCT05304611|364821653|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
105773577|NCT05304611|364821654|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
105773578|NCT05304611|364821655|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
105773579|NCT05304611|364821644|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
105773580|NCT05304611|364821645|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
105773581|NCT05304611|364821646|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
105773582|NCT05304611|364821647|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
105773583|NCT05304611|364821648|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
105773584|NCT05304611|364821649|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
105773585|NCT05304611|364821650|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
105773586|NCT05304611|364821651|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
105773587|NCT05304611|364821652|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
106099749|NCT04546581|366022616|FG001|Overall Study|Protocol Violation|2|||
105773588|NCT05304611|364821653|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
105773589|NCT05304611|364821654|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
105773590|NCT05304611|364821655|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
105773591|NCT03442595|364821656|FG000|Overall Study|Lost to Follow-up|94|||
105773592|NCT03442595|364821657|FG001|Overall Study|Lost to Follow-up|0|||
105773593|NCT00515099|364821658|FG000|Overall Study|Lost to Follow-up|0|||
105773594|NCT00515099|364821659|FG001|Overall Study|Lost to Follow-up|4|||
105806443|NCT01464827|364948982|FG001|Overall Study|Other|3|||
105773595|NCT00515099|364821658|FG000|Overall Study|Withdrawal by Subject|2|||
105773596|NCT00515099|364821659|FG001|Overall Study|Withdrawal by Subject|0|||
105773597|NCT00515099|364821658|FG000|Overall Study|IRB Recommendation|1|||
105773598|NCT00515099|364821659|FG001|Overall Study|IRB Recommendation|0|||
105773599|NCT02607865|364821662|FG000|Overall Study|Lost to Follow-up|9|||
105773600|NCT02607865|364821663|FG001|Overall Study|Lost to Follow-up|7|||
105773601|NCT02607865|364821664|FG002|Overall Study|Lost to Follow-up|7|||
105773602|NCT02607865|364821665|FG003|Overall Study|Lost to Follow-up|5|||
105773603|NCT02607865|364821662|FG000|Overall Study|Withdrawal by Subject|18|||
105773604|NCT02607865|364821663|FG001|Overall Study|Withdrawal by Subject|18|||
105773605|NCT02607865|364821664|FG002|Overall Study|Withdrawal by Subject|17|||
105773606|NCT02607865|364821665|FG003|Overall Study|Withdrawal by Subject|8|||
105773607|NCT02607865|364821662|FG000|Overall Study|Death|5|||
105773608|NCT02607865|364821663|FG001|Overall Study|Death|4|||
105773609|NCT02607865|364821664|FG002|Overall Study|Death|1|||
105773610|NCT02607865|364821665|FG003|Overall Study|Death|3|||
105773611|NCT02607865|364821662|FG000|Overall Study|Unclassified|1|||
105773612|NCT02607865|364821663|FG001|Overall Study|Unclassified|1|||
105773613|NCT02607865|364821664|FG002|Overall Study|Unclassified|2|||
105773614|NCT02607865|364821665|FG003|Overall Study|Unclassified|0|||
105773615|NCT03227692|364821666|FG000|Overall Study|Protocol Violation|1|||
105773616|NCT03227692|364821667|FG001|Overall Study|Protocol Violation|1|||
105773617|NCT03227692|364821666|FG000|Overall Study|Lost to Follow-up|4|||
105773618|NCT03227692|364821667|FG001|Overall Study|Lost to Follow-up|2|||
105773619|NCT03227692|364821666|FG000|Overall Study|Adverse Event|0|||
105773620|NCT03227692|364821667|FG001|Overall Study|Adverse Event|2|||
105773621|NCT00528840|364821668|FG000|Overall Study|Lost to Follow-up|10|||
105773622|NCT00528840|364821668|FG000|Overall Study|Adverse Event|1|||
105773623|NCT00528840|364821668|FG000|Overall Study|Withdrawal by Subject|17|||
105773624|NCT00528840|364821668|FG000|Overall Study|Death|2|||
105773625|NCT00528840|364821668|FG000|Overall Study|Administrative Reasons|1|||
105773626|NCT00528840|364821668|FG000|Overall Study|Other|2|||
105773627|NCT01657253|364821669|FG000|Overall Study|Lost to Follow-up|6|||
105773628|NCT01657253|364821670|FG001|Overall Study|Lost to Follow-up|5|||
105773629|NCT01657253|364821669|FG000|Overall Study|Withdrawal by Subject|11|||
105773630|NCT01657253|364821670|FG001|Overall Study|Withdrawal by Subject|12|||
105773631|NCT01657253|364821669|FG000|Overall Study|Adverse Event|0|||
105773632|NCT01657253|364821670|FG001|Overall Study|Adverse Event|1|||
105773633|NCT00397631|364821672|FG000|Overall Study|Adverse Event|5|||
105773634|NCT00397631|364821673|FG001|Overall Study|Adverse Event|6|||
105773635|NCT00397631|364821672|FG000|Overall Study|Lack of Efficacy|7|||
105773636|NCT00397631|364821673|FG001|Overall Study|Lack of Efficacy|10|||
105773637|NCT00397631|364821672|FG000|Overall Study|Lost to Follow-up|8|||
105773638|NCT00397631|364821673|FG001|Overall Study|Lost to Follow-up|9|||
105773639|NCT00397631|364821672|FG000|Overall Study|Physician Decision|2|||
105773640|NCT00397631|364821673|FG001|Overall Study|Physician Decision|0|||
105773641|NCT00397631|364821672|FG000|Overall Study|Protocol Violation|0|||
105773642|NCT00397631|364821673|FG001|Overall Study|Protocol Violation|1|||
105773643|NCT00397631|364821672|FG000|Overall Study|Withdrawal by Subject|7|||
105773644|NCT00397631|364821673|FG001|Overall Study|Withdrawal by Subject|14|||
105773645|NCT00397631|364821672|FG000|Overall Study|protocol discontinuation criteria|1|||
105773646|NCT00397631|364821673|FG001|Overall Study|protocol discontinuation criteria|4|||
105773647|NCT00355615|364821676|FG000|Randomized Double Blind Period|Adverse Event|1|||
105773648|NCT00355615|364821677|FG001|Randomized Double Blind Period|Adverse Event|0|||
105773649|NCT00355615|364821678|FG002|Randomized Double Blind Period|Adverse Event|0|||
105773650|NCT00355615|364821679|FG003|Randomized Double Blind Period|Adverse Event|0|||
105773651|NCT00355615|364821680|FG004|Randomized Double Blind Period|Adverse Event|0|||
105773652|NCT00355615|364821676|FG000|Randomized Double Blind Period|Protocol Violation|0|||
105773653|NCT00355615|364821677|FG001|Randomized Double Blind Period|Protocol Violation|0|||
105773654|NCT00355615|364821678|FG002|Randomized Double Blind Period|Protocol Violation|1|||
105773655|NCT00355615|364821679|FG003|Randomized Double Blind Period|Protocol Violation|1|||
105773656|NCT00355615|364821680|FG004|Randomized Double Blind Period|Protocol Violation|0|||
105773657|NCT00355615|364821676|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
105773658|NCT00355615|364821677|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
105773659|NCT00355615|364821678|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
105773660|NCT00355615|364821679|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
105773661|NCT00355615|364821680|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
105773662|NCT00355615|364821676|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
105773663|NCT00355615|364821677|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
105773664|NCT00355615|364821678|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
105773665|NCT00355615|364821679|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
105773666|NCT00355615|364821680|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
105773667|NCT00355615|364821676|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
105773668|NCT00355615|364821677|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
105773669|NCT00355615|364821678|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
105773670|NCT00355615|364821679|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
105773671|NCT00355615|364821680|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
105773672|NCT00355615|364821676|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
105773673|NCT00355615|364821677|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
105773674|NCT00355615|364821678|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
105773675|NCT00355615|364821679|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
105773676|NCT00355615|364821680|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
105773677|NCT03685643|364821681|FG000|Overall Study|Lost to Follow-up|14|||
105773678|NCT03685643|364821682|FG001|Overall Study|Lost to Follow-up|22|||
105773679|NCT02750501|364821683|FG000|Overall Study|Adverse Event|4|||
105773680|NCT02750501|364821683|FG000|Overall Study|Physician Decision|1|||
105773681|NCT02750501|364821683|FG000|Overall Study|Protocol Violation|1|||
105773682|NCT02750501|364821683|FG000|Overall Study|G-tube came out|1|||
105773683|NCT02750501|364821683|FG000|Overall Study|Non-compliant use of PERT|1|||
105773684|NCT01347840|364821685|FG000|Overall Study|Withdrawal by Subject|1|||
105773685|NCT00415623|364821687|FG000|Overall Study|Adverse Event|3|||
105773686|NCT00415623|364821688|FG001|Overall Study|Adverse Event|4|||
105773687|NCT00415623|364821687|FG000|Overall Study|Death|1|||
105773688|NCT00415623|364821688|FG001|Overall Study|Death|0|||
105773689|NCT00415623|364821687|FG000|Overall Study|Withdrawal by Subject|1|||
105773690|NCT00415623|364821688|FG001|Overall Study|Withdrawal by Subject|1|||
105773691|NCT01708915|364821689|FG000|Overall Study|Adverse Event|1|||
105773692|NCT01708915|364821690|FG001|Overall Study|Adverse Event|0|||
105773693|NCT01708915|364821691|FG002|Overall Study|Adverse Event|9|||
105773694|NCT01708915|364821692|FG003|Overall Study|Adverse Event|13|||
105773695|NCT01708915|364821689|FG000|Overall Study|Lack of Efficacy|84|||
105773696|NCT01708915|364821690|FG001|Overall Study|Lack of Efficacy|60|||
105773697|NCT01708915|364821691|FG002|Overall Study|Lack of Efficacy|35|||
105773698|NCT01708915|364821692|FG003|Overall Study|Lack of Efficacy|15|||
105773699|NCT01708915|364821689|FG000|Overall Study|Protocol Violation|0|||
105773700|NCT01708915|364821690|FG001|Overall Study|Protocol Violation|0|||
105773701|NCT01708915|364821691|FG002|Overall Study|Protocol Violation|0|||
105773702|NCT01708915|364821692|FG003|Overall Study|Protocol Violation|1|||
105773703|NCT01708915|364821689|FG000|Overall Study|Withdrawal by Subject|0|||
105773704|NCT01708915|364821690|FG001|Overall Study|Withdrawal by Subject|1|||
105773705|NCT01708915|364821691|FG002|Overall Study|Withdrawal by Subject|2|||
105773706|NCT01708915|364821692|FG003|Overall Study|Withdrawal by Subject|2|||
105773707|NCT01708915|364821689|FG000|Overall Study|Other reasons than stated above|1|||
105773708|NCT01708915|364821690|FG001|Overall Study|Other reasons than stated above|1|||
105773709|NCT01708915|364821691|FG002|Overall Study|Other reasons than stated above|0|||
105773710|NCT01708915|364821692|FG003|Overall Study|Other reasons than stated above|2|||
105773711|NCT00882362|364821693|FG000|Overall Study|Adverse Event|13|||
105773712|NCT00882362|364821694|FG001|Overall Study|Adverse Event|10|||
105773713|NCT00882362|364821693|FG000|Overall Study|Withdrawal by Subject|13|||
105773714|NCT00882362|364821694|FG001|Overall Study|Withdrawal by Subject|10|||
105773715|NCT00882362|364821693|FG000|Overall Study|Lack of Efficacy|3|||
105773716|NCT00882362|364821694|FG001|Overall Study|Lack of Efficacy|0|||
105773717|NCT00882362|364821693|FG000|Overall Study|Protocol Violation|7|||
105773718|NCT00882362|364821694|FG001|Overall Study|Protocol Violation|2|||
105773719|NCT00882362|364821693|FG000|Overall Study|Pregnancy|1|||
105773720|NCT00882362|364821694|FG001|Overall Study|Pregnancy|0|||
105773721|NCT00882362|364821693|FG000|Overall Study|Physician Decision|5|||
105773722|NCT00882362|364821694|FG001|Overall Study|Physician Decision|1|||
105773723|NCT00882362|364821693|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
105773724|NCT00882362|364821694|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
105773725|NCT00882362|364821693|FG000|Overall Study|change of residence or other commitments|5|||
105773726|NCT00882362|364821694|FG001|Overall Study|change of residence or other commitments|0|||
105773727|NCT01268514|364821695|FG000|Overall Study|Adverse Event|20|||
105773728|NCT01268514|364821695|FG000|Overall Study|Death|8|||
105773729|NCT01268514|364821695|FG000|Overall Study|Lost to Follow-up|5|||
105773730|NCT01268514|364821695|FG000|Overall Study|Withdrawal by Subject|3|||
105773731|NCT01268514|364821695|FG000|Overall Study|Withdrawal by Surgeon|5|||
105773732|NCT01424306|364821696|FG000|Overall Study|Protocol Violation|0|||
105773733|NCT01424306|364821697|FG001|Overall Study|Protocol Violation|0|||
105773734|NCT01424306|364821698|FG002|Overall Study|Protocol Violation|0|||
105773735|NCT01424306|364821699|FG003|Overall Study|Protocol Violation|0|||
105773736|NCT01424306|364821700|FG004|Overall Study|Protocol Violation|1|||
105773737|NCT01424306|364821701|FG005|Overall Study|Protocol Violation|0|||
105773738|NCT01601873|364821704|FG000|Overall Study|Lost to Follow-up|2|||
105773739|NCT01601873|364821705|FG001|Overall Study|Lost to Follow-up|3|||
105773740|NCT00590031|364821706|FG000|Overall Study|Adverse Event|3|||
105773741|NCT00590031|364821706|FG000|Overall Study|Withdrawal by Subject|1|||
105773742|NCT00590031|364821706|FG000|Overall Study|Metastatic Disease|1|||
105773743|NCT00590031|364821706|FG000|Overall Study|Admin Hold|1|||
105773744|NCT00826540|364821707|FG000|Overall Study|ineligible|3|||
105773745|NCT00826540|364821707|FG000|Overall Study|Withdrawal by Subject|1|||
105773746|NCT02483611|364821708|FG000|Overall Study|Protocol Violation|0|||
105773747|NCT02483611|364821709|FG001|Overall Study|Protocol Violation|0|||
105773748|NCT02483611|364821710|FG002|Overall Study|Protocol Violation|1|||
105773749|NCT06334055|364821713|FG000|Overall Study|Adverse Event|4|||
105773750|NCT06334055|364821713|FG000|Overall Study|Disqualified|72|||
105773751|NCT04097925|364823247|FG000|Overall Study|Withdrawal by Subject|1|||
105773752|NCT03763942|364823265|FG000|Overall Study|Lost to Follow-up|114|||
105773753|NCT03763942|364823266|FG001|Overall Study|Lost to Follow-up|54|||
105773754|NCT03763942|364823265|FG000|Overall Study|Protocol Violation|1|||
105773755|NCT03763942|364823266|FG001|Overall Study|Protocol Violation|0|||
105773756|NCT03763942|364823265|FG000|Overall Study|Withdrawal by Subject|2|||
105773757|NCT03763942|364823266|FG001|Overall Study|Withdrawal by Subject|0|||
105773758|NCT03763942|364823265|FG000|Overall Study|Other|2|||
105773759|NCT03763942|364823266|FG001|Overall Study|Other|3|||
105773760|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
105773761|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
105773762|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
105773763|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
105773764|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
105773765|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
105773766|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
105773767|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
105773768|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
105773769|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
105773770|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
105773771|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
105773772|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
105773773|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
105773774|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
105773775|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
105773776|NCT03345849|364823267|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
105773777|NCT03345849|364823268|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
105773778|NCT03345849|364823269|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
105773779|NCT03345849|364823270|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
105773780|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
105773781|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
105773782|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
105773783|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
105773784|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
105773785|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
105773786|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
105773787|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
105773788|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
105773789|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
105773790|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
105773791|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
105773792|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105773793|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105773794|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105773795|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
105773796|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
105773797|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
105773798|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
105773799|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
105773800|NCT03345849|364823267|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
105773801|NCT03345849|364823268|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
105773802|NCT03345849|364823269|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
105773803|NCT03345849|364823270|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
105773804|NCT03261037|364823271|FG000|Overall Study|Withdrawal by Subject|2|||
105773805|NCT03261037|364823272|FG001|Overall Study|Withdrawal by Subject|13|||
105773806|NCT03261037|364823273|FG002|Overall Study|Withdrawal by Subject|0|||
105773807|NCT03261037|364823274|FG003|Overall Study|Withdrawal by Subject|18|||
105773808|NCT03261037|364823271|FG000|Overall Study|Non-compliance with study procedures|0|||
105773809|NCT03261037|364823272|FG001|Overall Study|Non-compliance with study procedures|2|||
105773810|NCT03261037|364823273|FG002|Overall Study|Non-compliance with study procedures|0|||
105773811|NCT03261037|364823274|FG003|Overall Study|Non-compliance with study procedures|6|||
105773812|NCT03261037|364823271|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
106099750|NCT04546581|366022615|FG000|Overall Study|Withdrawal by Subject|3|||
105773813|NCT03261037|364823272|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
105773814|NCT03261037|364823273|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
105773815|NCT03261037|364823274|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
105773816|NCT03261037|364823271|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
105773817|NCT03261037|364823272|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
105773818|NCT03261037|364823273|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
105773819|NCT03261037|364823274|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
105773820|NCT03261037|364823271|FG000|Overall Study|Diagnosed but protocol deviation|1|||
105773821|NCT03261037|364823272|FG001|Overall Study|Diagnosed but protocol deviation|0|||
105773822|NCT03261037|364823273|FG002|Overall Study|Diagnosed but protocol deviation|0|||
105773823|NCT03261037|364823274|FG003|Overall Study|Diagnosed but protocol deviation|0|||
105773824|NCT03261037|364823271|FG000|Overall Study|Participant did not want to continue the study|0|||
105773825|NCT03261037|364823272|FG001|Overall Study|Participant did not want to continue the study|1|||
105773826|NCT03261037|364823273|FG002|Overall Study|Participant did not want to continue the study|0|||
105773827|NCT03261037|364823274|FG003|Overall Study|Participant did not want to continue the study|0|||
105773828|NCT03261037|364823271|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
105773829|NCT03261037|364823272|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
105773830|NCT03261037|364823273|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
105773831|NCT03261037|364823274|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
105773832|NCT03261037|364823271|FG000|Overall Study|Participant presented clinical improvement|0|||
105773833|NCT03261037|364823272|FG001|Overall Study|Participant presented clinical improvement|2|||
105773834|NCT03261037|364823273|FG002|Overall Study|Participant presented clinical improvement|0|||
105773835|NCT03261037|364823274|FG003|Overall Study|Participant presented clinical improvement|0|||
105773836|NCT03261037|364823271|FG000|Overall Study|Technical difficulties|0|||
105773837|NCT03261037|364823272|FG001|Overall Study|Technical difficulties|0|||
105773838|NCT03261037|364823273|FG002|Overall Study|Technical difficulties|0|||
105773839|NCT03261037|364823274|FG003|Overall Study|Technical difficulties|1|||
105773840|NCT03261037|364823271|FG000|Overall Study|Equipment failed to work|0|||
105773841|NCT03261037|364823272|FG001|Overall Study|Equipment failed to work|0|||
105773842|NCT03261037|364823273|FG002|Overall Study|Equipment failed to work|0|||
105773843|NCT03261037|364823274|FG003|Overall Study|Equipment failed to work|1|||
105773844|NCT03261037|364823271|FG000|Overall Study|End of study for participant and no follow up|0|||
105773845|NCT03261037|364823272|FG001|Overall Study|End of study for participant and no follow up|0|||
105773846|NCT03261037|364823273|FG002|Overall Study|End of study for participant and no follow up|0|||
105773847|NCT03261037|364823274|FG003|Overall Study|End of study for participant and no follow up|1|||
105773848|NCT03261037|364823271|FG000|Overall Study|Participant was too weak to continue in study|1|||
105773849|NCT03261037|364823272|FG001|Overall Study|Participant was too weak to continue in study|0|||
105773850|NCT03261037|364823273|FG002|Overall Study|Participant was too weak to continue in study|0|||
105773851|NCT03261037|364823274|FG003|Overall Study|Participant was too weak to continue in study|0|||
105773852|NCT00103207|364823277|FG000|Overall Study|Adverse Event|3|||
105773853|NCT00103207|364823277|FG000|Overall Study|Death|1|||
105773854|NCT00103207|364823277|FG000|Overall Study|Withdrawal by Subject|2|||
105773855|NCT00103207|364823277|FG000|Overall Study|Other complicating disease|1|||
105773856|NCT00103207|364823277|FG000|Overall Study|Ineligible|4|||
105773857|NCT00103207|364823277|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
105773858|NCT03662789|364823278|FG000|Overall Study|Lost to Follow-up|1|||
105773859|NCT03662789|364823279|FG001|Overall Study|Lost to Follow-up|2|||
105773860|NCT03662789|364823278|FG000|Overall Study|Could not perform treadmill test|4|||
105773861|NCT03662789|364823279|FG001|Overall Study|Could not perform treadmill test|4|||
105773862|NCT03662789|364823278|FG000|Overall Study|Death|0|||
105773863|NCT03662789|364823279|FG001|Overall Study|Death|1|||
105773864|NCT01029691|364823280|FG000|Continued APAP to Delivery|Death|0|||
105773865|NCT01029691|364823281|FG001|Continued APAP to Delivery|Death|0|||
105773866|NCT01029691|364823282|FG002|Continued APAP to Delivery|Death|1|||
105773867|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
105773868|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
105773869|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
105773870|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
105773871|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
105773872|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
105773873|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
105773874|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
105773875|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
105773876|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
105773877|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
105773878|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
105773879|NCT03659916|364823283|FG000|Treatment Period (72 Weeks)|Other|1|||
105773880|NCT03659916|364823284|FG001|Treatment Period (72 Weeks)|Other|3|||
105773881|NCT03659916|364823285|FG002|Treatment Period (72 Weeks)|Other|9|||
105773882|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
105773883|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
105773884|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
105773885|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
105773886|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
105773887|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
105773888|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
105773889|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
105773890|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
105773891|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
105773892|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
105773893|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
105773894|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
105773895|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
105773896|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
105773897|NCT03659916|364823283|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
105773898|NCT03659916|364823284|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
105773899|NCT03659916|364823285|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
105773900|NCT00170846|364823292|FG000|Overall Study|Subject withdrew Informed Consent|5|||
105773901|NCT00170846|364823293|FG001|Overall Study|Subject withdrew Informed Consent|12|||
105773902|NCT00170846|364823294|FG002|Overall Study|Subject withdrew Informed Consent|8|||
105773903|NCT00170846|364823292|FG000|Overall Study|Lost to Follow-up|6|||
105773904|NCT00170846|364823293|FG001|Overall Study|Lost to Follow-up|3|||
105773905|NCT00170846|364823294|FG002|Overall Study|Lost to Follow-up|2|||
105773906|NCT00170846|364823292|FG000|Overall Study|Death|0|||
105773907|NCT00170846|364823293|FG001|Overall Study|Death|3|||
105773908|NCT00170846|364823294|FG002|Overall Study|Death|3|||
105773909|NCT00170846|364823292|FG000|Overall Study|Reason Missing|0|||
105773910|NCT00170846|364823293|FG001|Overall Study|Reason Missing|1|||
105773911|NCT00170846|364823294|FG002|Overall Study|Reason Missing|0|||
105773912|NCT01738594|364823295|FG000|Registration and Treatment Start|Adverse Event|0|||
105773913|NCT01738594|364823296|FG001|Registration and Treatment Start|Adverse Event|1|||
105773914|NCT01738594|364823297|FG002|Registration and Treatment Start|Adverse Event|0|||
105773915|NCT01738594|364823298|FG003|Registration and Treatment Start|Adverse Event|0|||
105773916|NCT01738594|364823299|FG004|Registration and Treatment Start|Adverse Event|0|||
105773917|NCT01738594|364823300|FG005|Registration and Treatment Start|Adverse Event|0|||
105773918|NCT01738594|364823301|FG006|Registration and Treatment Start|Adverse Event|0|||
105773919|NCT01738594|364823302|FG007|Registration and Treatment Start|Adverse Event|0|||
105773920|NCT01738594|364823295|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773921|NCT01738594|364823296|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773922|NCT01738594|364823297|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773923|NCT01738594|364823298|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773924|NCT01738594|364823299|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773925|NCT01738594|364823300|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
105773926|NCT01738594|364823301|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773927|NCT01738594|364823302|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
105773928|NCT01738594|364823295|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773929|NCT01738594|364823296|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
105773930|NCT01738594|364823297|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773931|NCT01738594|364823298|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773932|NCT01738594|364823299|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773933|NCT01738594|364823300|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773934|NCT01738594|364823301|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773935|NCT01738594|364823302|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
105773936|NCT01738594|364823295|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773937|NCT01738594|364823296|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773938|NCT01738594|364823297|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773939|NCT01738594|364823298|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773940|NCT01738594|364823299|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773941|NCT01738594|364823300|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
105773942|NCT01738594|364823301|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773943|NCT01738594|364823302|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
105773944|NCT01738594|364823295|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773945|NCT01738594|364823296|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773946|NCT01738594|364823297|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773947|NCT01738594|364823298|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773948|NCT01738594|364823299|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773949|NCT01738594|364823300|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
105773950|NCT01738594|364823301|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773951|NCT01738594|364823302|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
105773952|NCT01738594|364823295|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773953|NCT01738594|364823296|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773954|NCT01738594|364823297|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773955|NCT01738594|364823298|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773956|NCT01738594|364823299|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
105773957|NCT01738594|364823300|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773958|NCT01738594|364823301|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773959|NCT01738594|364823302|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
105773960|NCT01738594|364823295|FG000|Follow up for 1 Year|Death|0|||
105773961|NCT01738594|364823296|FG001|Follow up for 1 Year|Death|0|||
105773962|NCT01738594|364823297|FG002|Follow up for 1 Year|Death|0|||
105773963|NCT01738594|364823298|FG003|Follow up for 1 Year|Death|0|||
105773964|NCT01738594|364823299|FG004|Follow up for 1 Year|Death|0|||
105773965|NCT01738594|364823300|FG005|Follow up for 1 Year|Death|1|||
105773966|NCT01738594|364823301|FG006|Follow up for 1 Year|Death|0|||
105773967|NCT01738594|364823302|FG007|Follow up for 1 Year|Death|0|||
105773968|NCT01738594|364823295|FG000|Follow up for 1 Year|Other|0|||
105773969|NCT01738594|364823296|FG001|Follow up for 1 Year|Other|0|||
105773970|NCT01738594|364823297|FG002|Follow up for 1 Year|Other|0|||
105773971|NCT01738594|364823298|FG003|Follow up for 1 Year|Other|0|||
105773972|NCT01738594|364823299|FG004|Follow up for 1 Year|Other|0|||
105773973|NCT01738594|364823300|FG005|Follow up for 1 Year|Other|2|||
105773974|NCT01738594|364823301|FG006|Follow up for 1 Year|Other|0|||
105773975|NCT01738594|364823302|FG007|Follow up for 1 Year|Other|0|||
105773976|NCT04430036|364823303|FG000|Safety Run in Phase|Progression of disease|2|||
105773977|NCT00942422|364823304|FG000|Overall Study|Withdrawal by Subject|1|||
105773978|NCT00942422|364823304|FG000|Overall Study|Death|1|||
105773979|NCT00942422|364823304|FG000|Overall Study|Progressive diease|1|||
105773980|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
105773981|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
105773982|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
105773983|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
105773984|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
105773985|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
105773986|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
105773987|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
105773988|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Death|0|||
105773989|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Death|0|||
105773990|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Death|0|||
105773991|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Death|1|||
105773992|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Death|1|||
105773993|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Death|0|||
105773994|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Death|2|||
105773995|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Death|0|||
105773996|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105773997|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105773998|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105773999|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
105774000|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105774001|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105774002|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105774003|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
105774004|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774005|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774006|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774007|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
105774008|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774009|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774010|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774011|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
105774012|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774013|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774014|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774015|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
105774016|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774017|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
105774018|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
105774019|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
105774020|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774021|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774022|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774023|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
105774024|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774025|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
105774026|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
105774027|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
105774028|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774029|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774030|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774031|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774032|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
105774033|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
105774034|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
105774035|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
105774036|NCT02442765|364823305|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774037|NCT02442765|364823306|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774038|NCT02442765|364823307|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774039|NCT02442765|364823308|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774040|NCT02442765|364823309|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
105774041|NCT02442765|364823310|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774042|NCT02442765|364823311|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
105774043|NCT02442765|364823312|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
105774044|NCT03117309|364823315|FG000|Overall Study|Not meeting inclusion criteria|0|||
105774045|NCT03117309|364823316|FG001|Overall Study|Not meeting inclusion criteria|1|||
105774046|NCT02120469|364823317|FG000|Overall Study|HER-2/neu-amplified|1|||
105774047|NCT02120469|364823318|FG001|Overall Study|HER-2/neu-amplified|0|||
105774048|NCT02120469|364823319|FG002|Overall Study|HER-2/neu-amplified|1|||
105774049|NCT02774291|364823323|FG000|Overall Study|Lost to Follow-up|1|||
105774050|NCT01012037|364823324|FG000|Overall Study|Adverse Event|0|||
105774051|NCT01012037|364823325|FG001|Overall Study|Adverse Event|8|||
105774052|NCT01012037|364823326|FG002|Overall Study|Adverse Event|3|||
105774053|NCT01012037|364823324|FG000|Overall Study|Protocol Violation|0|||
105774054|NCT01012037|364823325|FG001|Overall Study|Protocol Violation|3|||
105774055|NCT01012037|364823326|FG002|Overall Study|Protocol Violation|5|||
105774056|NCT01012037|364823324|FG000|Overall Study|Withdrawal by Subject|0|||
105774057|NCT01012037|364823325|FG001|Overall Study|Withdrawal by Subject|4|||
105774058|NCT01012037|364823326|FG002|Overall Study|Withdrawal by Subject|1|||
105774059|NCT01012037|364823324|FG000|Overall Study|Other reason (not specified)|1|||
105774060|NCT01012037|364823325|FG001|Overall Study|Other reason (not specified)|1|||
105774061|NCT01012037|364823326|FG002|Overall Study|Other reason (not specified)|1|||
105774062|NCT01700140|364823328|FG000|Overall Study|Use of rescue drugs|3|||
105774063|NCT01700140|364823329|FG001|Overall Study|Use of rescue drugs|3|||
105774064|NCT01700140|364823330|FG002|Overall Study|Use of rescue drugs|1|||
105774065|NCT01700140|364823328|FG000|Overall Study|Discontinuation of radiotherapy|1|||
105774066|NCT01700140|364823329|FG001|Overall Study|Discontinuation of radiotherapy|0|||
105774067|NCT01700140|364823330|FG002|Overall Study|Discontinuation of radiotherapy|0|||
105774068|NCT01700140|364823328|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
105774069|NCT01700140|364823329|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
105774070|NCT01700140|364823330|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
105774071|NCT01700140|364823328|FG000|Overall Study|Aggravation of symptoms|1|||
105774072|NCT01700140|364823329|FG001|Overall Study|Aggravation of symptoms|0|||
105774073|NCT01700140|364823330|FG002|Overall Study|Aggravation of symptoms|0|||
105774074|NCT01700140|364823328|FG000|Overall Study|Adverse Event|0|||
105774075|NCT01700140|364823329|FG001|Overall Study|Adverse Event|1|||
105774076|NCT01700140|364823330|FG002|Overall Study|Adverse Event|0|||
105774077|NCT01700140|364823328|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
105774078|NCT01700140|364823329|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
105774079|NCT01700140|364823330|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
105774080|NCT05307523|364823332|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
105774081|NCT05307523|364823333|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
105774082|NCT05307523|364823332|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
105774083|NCT05307523|364823333|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
105774084|NCT03231228|364823339|FG000|Overall Study|Lost to Follow-up|2|||
105774085|NCT03231228|364823340|FG001|Overall Study|Lost to Follow-up|0|||
105774086|NCT03231228|364823339|FG000|Overall Study|Physician Decision|1|||
105774087|NCT03231228|364823340|FG001|Overall Study|Physician Decision|0|||
105774088|NCT02096471|364823343|FG000|Overall Study|Adverse Event|1|||
105774089|NCT02096471|364823343|FG000|Overall Study|Lack of Efficacy|7|||
105806444|NCT01464827|364948983|FG002|Overall Study|Other|0|||
105774090|NCT02096471|364823343|FG000|Overall Study|Withdrawal by Subject|3|||
105774091|NCT02096471|364823343|FG000|Overall Study|Non-Compliant|2|||
105774092|NCT03196973|364823344|FG000|Overall Study|Adverse Event|1|||
105774093|NCT03196973|364823345|FG001|Overall Study|Adverse Event|1|||
105774094|NCT03196973|364823346|FG002|Overall Study|Adverse Event|2|||
105774095|NCT03196973|364823344|FG000|Overall Study|Lack of Efficacy|2|||
105774096|NCT03196973|364823345|FG001|Overall Study|Lack of Efficacy|6|||
105774097|NCT03196973|364823346|FG002|Overall Study|Lack of Efficacy|1|||
105774098|NCT03196973|364823344|FG000|Overall Study|Lost to Follow-up|4|||
105774099|NCT03196973|364823345|FG001|Overall Study|Lost to Follow-up|3|||
105774100|NCT03196973|364823346|FG002|Overall Study|Lost to Follow-up|2|||
105774101|NCT03196973|364823344|FG000|Overall Study|Consent withdrawn|2|||
105774102|NCT03196973|364823345|FG001|Overall Study|Consent withdrawn|1|||
105774103|NCT03196973|364823346|FG002|Overall Study|Consent withdrawn|0|||
105774104|NCT03196973|364823344|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
105774105|NCT03196973|364823345|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
105774106|NCT03196973|364823346|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
105774107|NCT01809327|364823347|FG000|Overall Study|Lost to Follow-up|5|||
105774108|NCT01809327|364823348|FG001|Overall Study|Lost to Follow-up|2|||
105774109|NCT01809327|364823349|FG002|Overall Study|Lost to Follow-up|4|||
105774110|NCT01809327|364823350|FG003|Overall Study|Lost to Follow-up|2|||
105774111|NCT01809327|364823351|FG004|Overall Study|Lost to Follow-up|3|||
105774112|NCT01809327|364823347|FG000|Overall Study|Withdrawal by Subject|6|||
105774113|NCT01809327|364823348|FG001|Overall Study|Withdrawal by Subject|4|||
105774114|NCT01809327|364823349|FG002|Overall Study|Withdrawal by Subject|4|||
105774115|NCT01809327|364823350|FG003|Overall Study|Withdrawal by Subject|2|||
105774116|NCT01809327|364823351|FG004|Overall Study|Withdrawal by Subject|5|||
105774117|NCT01809327|364823347|FG000|Overall Study|Adverse Event|4|||
105774118|NCT01809327|364823348|FG001|Overall Study|Adverse Event|3|||
105774119|NCT01809327|364823349|FG002|Overall Study|Adverse Event|7|||
105774120|NCT01809327|364823350|FG003|Overall Study|Adverse Event|4|||
105774121|NCT01809327|364823351|FG004|Overall Study|Adverse Event|8|||
105774122|NCT01809327|364823347|FG000|Overall Study|Death|1|||
105774123|NCT01809327|364823348|FG001|Overall Study|Death|0|||
105774124|NCT01809327|364823349|FG002|Overall Study|Death|0|||
105774125|NCT01809327|364823350|FG003|Overall Study|Death|0|||
105774126|NCT01809327|364823351|FG004|Overall Study|Death|0|||
105774127|NCT01809327|364823347|FG000|Overall Study|Protocol Violation|0|||
105774128|NCT01809327|364823348|FG001|Overall Study|Protocol Violation|1|||
105774129|NCT01809327|364823349|FG002|Overall Study|Protocol Violation|0|||
105774130|NCT01809327|364823350|FG003|Overall Study|Protocol Violation|0|||
105774131|NCT01809327|364823351|FG004|Overall Study|Protocol Violation|0|||
105774132|NCT01809327|364823347|FG000|Overall Study|Physician Decision|1|||
105774133|NCT01809327|364823348|FG001|Overall Study|Physician Decision|1|||
105774134|NCT01809327|364823349|FG002|Overall Study|Physician Decision|0|||
105774135|NCT01809327|364823350|FG003|Overall Study|Physician Decision|0|||
105774136|NCT01809327|364823351|FG004|Overall Study|Physician Decision|0|||
105774137|NCT01809327|364823347|FG000|Overall Study|Pregnancy|1|||
105774138|NCT01809327|364823348|FG001|Overall Study|Pregnancy|0|||
105774139|NCT01809327|364823349|FG002|Overall Study|Pregnancy|0|||
105774140|NCT01809327|364823350|FG003|Overall Study|Pregnancy|0|||
105774141|NCT01809327|364823351|FG004|Overall Study|Pregnancy|0|||
105774142|NCT01809327|364823347|FG000|Overall Study|Other|14|||
105774143|NCT01809327|364823348|FG001|Overall Study|Other|15|||
105774144|NCT01809327|364823349|FG002|Overall Study|Other|7|||
105774145|NCT01809327|364823350|FG003|Overall Study|Other|4|||
105774146|NCT01809327|364823351|FG004|Overall Study|Other|9|||
105774147|NCT01610414|364823356|FG000|Study Start - Month 13|Serious Adverse Event|65|||
105774148|NCT01610414|364823357|FG001|Study Start - Month 13|Serious Adverse Event|67|||
105774149|NCT01610414|364823356|FG000|Study Start - Month 13|Adverse Event|14|||
105774150|NCT01610414|364823357|FG001|Study Start - Month 13|Adverse Event|14|||
105774151|NCT01610414|364823356|FG000|Study Start - Month 13|Protocol Violation|3|||
105774152|NCT01610414|364823357|FG001|Study Start - Month 13|Protocol Violation|1|||
105774153|NCT01610414|364823356|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
105774154|NCT01610414|364823357|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
105774155|NCT01610414|364823356|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
105774156|NCT01610414|364823357|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
105774157|NCT01610414|364823356|FG000|Study Start - Month 13|Lost to Follow-up|4|||
105774158|NCT01610414|364823357|FG001|Study Start - Month 13|Lost to Follow-up|6|||
105774159|NCT01610414|364823356|FG000|Study Start - Month 13|Suspected HZ episode|1|||
105774160|NCT01610414|364823357|FG001|Study Start - Month 13|Suspected HZ episode|3|||
105774161|NCT01610414|364823356|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
105774162|NCT01610414|364823357|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
105774163|NCT01610414|364823356|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
105774164|NCT01610414|364823357|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
105774165|NCT01610414|364823356|FG000|Month 13 - Month 25|Adverse Event|8|||
105774166|NCT01610414|364823357|FG001|Month 13 - Month 25|Adverse Event|4|||
105774167|NCT01610414|364823356|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
105774168|NCT01610414|364823357|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
105774169|NCT01610414|364823356|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
105774170|NCT01610414|364823357|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
105774171|NCT01610414|364823356|FG000|Month 13 - Month 25|Protocol Violation|0|||
105774172|NCT01610414|364823357|FG001|Month 13 - Month 25|Protocol Violation|2|||
105774173|NCT01610414|364823356|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
105774174|NCT01610414|364823357|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
105774175|NCT01610414|364823356|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
105774176|NCT01610414|364823357|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
105774177|NCT01610414|364823356|FG000|After Month 25|Study end not reached|48|||
105774178|NCT01610414|364823357|FG001|After Month 25|Study end not reached|53|||
105774179|NCT00518336|364823360|FG000|Year 7|Lost to Follow-up|2|||
105774180|NCT00518336|364823361|FG001|Year 7|Lost to Follow-up|0|||
105774181|NCT00518336|364823360|FG000|Year 7|Could not attend in time|0|||
105774182|NCT00518336|364823361|FG001|Year 7|Could not attend in time|3|||
105774183|NCT00518336|364823360|FG000|Year 8|Lost to Follow-up|1|||
105774184|NCT00518336|364823361|FG001|Year 8|Lost to Follow-up|1|||
105774185|NCT00518336|364823360|FG000|Year 8|Could not attend in time|0|||
105774186|NCT00518336|364823361|FG001|Year 8|Could not attend in time|1|||
105774187|NCT00518336|364823360|FG000|Year 9|Migrated/moved from study area|1|||
105774188|NCT00518336|364823361|FG001|Year 9|Migrated/moved from study area|1|||
105774189|NCT00518336|364823360|FG000|Year 9|Lost to Follow-up|3|||
105774190|NCT00518336|364823361|FG001|Year 9|Lost to Follow-up|0|||
105774191|NCT00518336|364823360|FG000|Year 9|Personal reasons|1|||
105774192|NCT00518336|364823361|FG001|Year 9|Personal reasons|0|||
105774193|NCT00125268|364823362|FG000|Overall Study|Withdrawal by Subject|1|||
105774194|NCT00125268|364823363|FG001|Overall Study|Withdrawal by Subject|1|||
105774195|NCT02985684|364823368|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
105774196|NCT02985684|364823368|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
105774197|NCT02985684|364823368|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
105774198|NCT04303780|364823371|FG000|Overall Study|Death|104|||
105774199|NCT04303780|364823372|FG001|Overall Study|Death|85|||
105774200|NCT04303780|364823371|FG000|Overall Study|Lost to Follow-up|5|||
105774201|NCT04303780|364823372|FG001|Overall Study|Lost to Follow-up|2|||
105774202|NCT04303780|364823371|FG000|Overall Study|Withdrawal by Subject|12|||
105774203|NCT04303780|364823372|FG001|Overall Study|Withdrawal by Subject|39|||
105774204|NCT04303780|364823371|FG000|Overall Study|Ongoing in study|50|||
105774205|NCT04303780|364823372|FG001|Overall Study|Ongoing in study|45|||
105774206|NCT03455530|364824907|FG000|Overall Study|Withdrawal by Subject|9|||
105774207|NCT03455530|364824908|FG001|Overall Study|Withdrawal by Subject|1|||
105774208|NCT03455530|364824909|FG002|Overall Study|Withdrawal by Subject|3|||
105774209|NCT03455530|364824910|FG003|Overall Study|Withdrawal by Subject|3|||
105774210|NCT00740116|364824914|FG000|Overall Study|Withdrawal by Subject|1|||
105774211|NCT00740116|364824915|FG001|Overall Study|Withdrawal by Subject|1|||
105774212|NCT00740116|364824914|FG000|Overall Study|Protocol Violation|1|||
105774213|NCT00740116|364824915|FG001|Overall Study|Protocol Violation|4|||
105774214|NCT03958149|364824916|FG000|Overall Study|Withdrawal by Subject|0|||
105774215|NCT03958149|364824917|FG001|Overall Study|Withdrawal by Subject|1|||
105774216|NCT00621764|364824918|FG000|Overall Study|Protocol Violation|0|||
105774217|NCT00621764|364824919|FG001|Overall Study|Protocol Violation|0|||
105774218|NCT00621764|364824920|FG002|Overall Study|Protocol Violation|0|||
105774219|NCT00621764|364824921|FG003|Overall Study|Protocol Violation|1|||
105774220|NCT00121485|364824922|FG000|Overall Study|Not implanted|1|||
105774221|NCT00121485|364824923|FG001|Overall Study|Not implanted|5|||
105774222|NCT00121485|364824922|FG000|Overall Study|Crossover|0|||
105774223|NCT00121485|364824923|FG001|Overall Study|Crossover|2|||
105774224|NCT00669240|364824924|FG000|Overall Study|Lack of Efficacy|33|||
105774225|NCT00669240|364824924|FG000|Overall Study|Withdrawal by Subject|42|||
105774226|NCT00669240|364824924|FG000|Overall Study|Lost to Follow-up|34|||
105774227|NCT00669240|364824924|FG000|Overall Study|Adverse Event|21|||
105774228|NCT00669240|364824924|FG000|Overall Study|Other|19|||
105774229|NCT00669240|364824924|FG000|Overall Study|Enrolled but not treated|15|||
105774230|NCT00669240|364824924|FG000|Overall Study|Enrolled but no dosing record|1|||
105774231|NCT02583399|364824925|FG000|Overall Study|Able to be discharged|3|||
105774232|NCT02583399|364824925|FG000|Overall Study|Wanted to use a restricted medication|3|||
105774233|NCT01004861|364824926|FG000|Overall Study|Disease progression|3|||
105774234|NCT01004861|364824927|FG001|Overall Study|Disease progression|4|||
105774235|NCT01004861|364824928|FG002|Overall Study|Disease progression|5|||
105774236|NCT01004861|364824929|FG003|Overall Study|Disease progression|4|||
105774237|NCT01004861|364824930|FG004|Overall Study|Disease progression|4|||
105774238|NCT01004861|364824931|FG005|Overall Study|Disease progression|4|||
105774239|NCT01004861|364824932|FG006|Overall Study|Disease progression|5|||
105774240|NCT01004861|364824933|FG007|Overall Study|Disease progression|1|||
105774241|NCT01004861|364824934|FG008|Overall Study|Disease progression|4|||
105774242|NCT01004861|364824935|FG009|Overall Study|Disease progression|7|||
105774243|NCT01004861|364824936|FG010|Overall Study|Disease progression|6|||
105774244|NCT01004861|364824937|FG011|Overall Study|Disease progression|3|||
105774245|NCT01004861|364824938|FG012|Overall Study|Disease progression|8|||
105774246|NCT01004861|364824926|FG000|Overall Study|Physician Decision|0|||
105774247|NCT01004861|364824927|FG001|Overall Study|Physician Decision|2|||
105774248|NCT01004861|364824928|FG002|Overall Study|Physician Decision|1|||
105774249|NCT01004861|364824929|FG003|Overall Study|Physician Decision|1|||
105774250|NCT01004861|364824930|FG004|Overall Study|Physician Decision|1|||
105774251|NCT01004861|364824931|FG005|Overall Study|Physician Decision|0|||
105774252|NCT01004861|364824932|FG006|Overall Study|Physician Decision|0|||
105774253|NCT01004861|364824933|FG007|Overall Study|Physician Decision|1|||
105774254|NCT01004861|364824934|FG008|Overall Study|Physician Decision|0|||
105774255|NCT01004861|364824935|FG009|Overall Study|Physician Decision|0|||
105774256|NCT01004861|364824936|FG010|Overall Study|Physician Decision|0|||
105774257|NCT01004861|364824937|FG011|Overall Study|Physician Decision|0|||
105774258|NCT01004861|364824938|FG012|Overall Study|Physician Decision|3|||
105774259|NCT01004861|364824926|FG000|Overall Study|Adverse Event|0|||
105774260|NCT01004861|364824927|FG001|Overall Study|Adverse Event|0|||
105774261|NCT01004861|364824928|FG002|Overall Study|Adverse Event|0|||
105774262|NCT01004861|364824929|FG003|Overall Study|Adverse Event|1|||
105774263|NCT01004861|364824930|FG004|Overall Study|Adverse Event|0|||
105774264|NCT01004861|364824931|FG005|Overall Study|Adverse Event|2|||
105774265|NCT01004861|364824932|FG006|Overall Study|Adverse Event|1|||
105774266|NCT01004861|364824933|FG007|Overall Study|Adverse Event|1|||
105774267|NCT01004861|364824934|FG008|Overall Study|Adverse Event|13|||
105774268|NCT01004861|364824935|FG009|Overall Study|Adverse Event|1|||
105774269|NCT01004861|364824936|FG010|Overall Study|Adverse Event|1|||
105774270|NCT01004861|364824937|FG011|Overall Study|Adverse Event|0|||
105774271|NCT01004861|364824938|FG012|Overall Study|Adverse Event|2|||
105774272|NCT01004861|364824926|FG000|Overall Study|Protocol Violation|0|||
105774273|NCT01004861|364824927|FG001|Overall Study|Protocol Violation|0|||
105774274|NCT01004861|364824928|FG002|Overall Study|Protocol Violation|0|||
105774275|NCT01004861|364824929|FG003|Overall Study|Protocol Violation|0|||
105774276|NCT01004861|364824930|FG004|Overall Study|Protocol Violation|1|||
105774277|NCT01004861|364824931|FG005|Overall Study|Protocol Violation|0|||
105774278|NCT01004861|364824932|FG006|Overall Study|Protocol Violation|0|||
105774279|NCT01004861|364824933|FG007|Overall Study|Protocol Violation|0|||
105774280|NCT01004861|364824934|FG008|Overall Study|Protocol Violation|0|||
105774281|NCT01004861|364824935|FG009|Overall Study|Protocol Violation|0|||
105774282|NCT01004861|364824936|FG010|Overall Study|Protocol Violation|0|||
105774283|NCT01004861|364824937|FG011|Overall Study|Protocol Violation|0|||
105774284|NCT01004861|364824938|FG012|Overall Study|Protocol Violation|0|||
105774285|NCT01004861|364824926|FG000|Overall Study|Lost to Follow-up|0|||
105774286|NCT01004861|364824927|FG001|Overall Study|Lost to Follow-up|0|||
105774287|NCT01004861|364824928|FG002|Overall Study|Lost to Follow-up|0|||
105774288|NCT01004861|364824929|FG003|Overall Study|Lost to Follow-up|0|||
105774289|NCT01004861|364824930|FG004|Overall Study|Lost to Follow-up|0|||
105774290|NCT01004861|364824931|FG005|Overall Study|Lost to Follow-up|0|||
105774291|NCT01004861|364824932|FG006|Overall Study|Lost to Follow-up|0|||
105774292|NCT01004861|364824933|FG007|Overall Study|Lost to Follow-up|1|||
105774293|NCT01004861|364824934|FG008|Overall Study|Lost to Follow-up|3|||
105774294|NCT01004861|364824935|FG009|Overall Study|Lost to Follow-up|0|||
105774295|NCT01004861|364824936|FG010|Overall Study|Lost to Follow-up|0|||
105774296|NCT01004861|364824937|FG011|Overall Study|Lost to Follow-up|1|||
105774297|NCT01004861|364824938|FG012|Overall Study|Lost to Follow-up|0|||
105774298|NCT01004861|364824926|FG000|Overall Study|Non-compliance|0|||
105774299|NCT01004861|364824927|FG001|Overall Study|Non-compliance|0|||
105774300|NCT01004861|364824928|FG002|Overall Study|Non-compliance|0|||
105774301|NCT01004861|364824929|FG003|Overall Study|Non-compliance|0|||
105774302|NCT01004861|364824930|FG004|Overall Study|Non-compliance|0|||
105774303|NCT01004861|364824931|FG005|Overall Study|Non-compliance|0|||
105774304|NCT01004861|364824932|FG006|Overall Study|Non-compliance|0|||
105774305|NCT01004861|364824933|FG007|Overall Study|Non-compliance|0|||
105774306|NCT01004861|364824934|FG008|Overall Study|Non-compliance|5|||
105774307|NCT01004861|364824935|FG009|Overall Study|Non-compliance|0|||
105774308|NCT01004861|364824936|FG010|Overall Study|Non-compliance|0|||
105774309|NCT01004861|364824937|FG011|Overall Study|Non-compliance|0|||
105774310|NCT01004861|364824938|FG012|Overall Study|Non-compliance|1|||
105774311|NCT01004861|364824926|FG000|Overall Study|Other|0|||
105774312|NCT01004861|364824927|FG001|Overall Study|Other|0|||
105774313|NCT01004861|364824928|FG002|Overall Study|Other|0|||
105774314|NCT01004861|364824929|FG003|Overall Study|Other|0|||
105774315|NCT01004861|364824930|FG004|Overall Study|Other|0|||
105774316|NCT01004861|364824931|FG005|Overall Study|Other|0|||
105774317|NCT01004861|364824932|FG006|Overall Study|Other|0|||
105774318|NCT01004861|364824933|FG007|Overall Study|Other|0|||
105774319|NCT01004861|364824934|FG008|Overall Study|Other|0|||
105774320|NCT01004861|364824935|FG009|Overall Study|Other|2|||
105774321|NCT01004861|364824936|FG010|Overall Study|Other|1|||
105774322|NCT01004861|364824937|FG011|Overall Study|Other|2|||
105774323|NCT01004861|364824938|FG012|Overall Study|Other|3|||
105774324|NCT01004861|364824926|FG000|Overall Study|Patient decision|0|||
105774325|NCT01004861|364824927|FG001|Overall Study|Patient decision|0|||
105774326|NCT01004861|364824928|FG002|Overall Study|Patient decision|0|||
105774327|NCT01004861|364824929|FG003|Overall Study|Patient decision|0|||
105774328|NCT01004861|364824930|FG004|Overall Study|Patient decision|1|||
105774329|NCT01004861|364824931|FG005|Overall Study|Patient decision|0|||
105774330|NCT01004861|364824932|FG006|Overall Study|Patient decision|1|||
105774331|NCT01004861|364824933|FG007|Overall Study|Patient decision|0|||
105774332|NCT01004861|364824934|FG008|Overall Study|Patient decision|7|||
105774333|NCT01004861|364824935|FG009|Overall Study|Patient decision|1|||
105774334|NCT01004861|364824936|FG010|Overall Study|Patient decision|1|||
105774335|NCT01004861|364824937|FG011|Overall Study|Patient decision|2|||
105774336|NCT01004861|364824938|FG012|Overall Study|Patient decision|3|||
105774337|NCT01004861|364824926|FG000|Overall Study|Transitioned to Phase 4 study|0|||
105774338|NCT01004861|364824927|FG001|Overall Study|Transitioned to Phase 4 study|0|||
105774339|NCT01004861|364824928|FG002|Overall Study|Transitioned to Phase 4 study|0|||
105774340|NCT01004861|364824929|FG003|Overall Study|Transitioned to Phase 4 study|0|||
105774341|NCT01004861|364824930|FG004|Overall Study|Transitioned to Phase 4 study|0|||
105774342|NCT01004861|364824931|FG005|Overall Study|Transitioned to Phase 4 study|0|||
105774343|NCT01004861|364824932|FG006|Overall Study|Transitioned to Phase 4 study|0|||
105774344|NCT01004861|364824933|FG007|Overall Study|Transitioned to Phase 4 study|0|||
105774345|NCT01004861|364824934|FG008|Overall Study|Transitioned to Phase 4 study|2|||
105774346|NCT01004861|364824935|FG009|Overall Study|Transitioned to Phase 4 study|0|||
105774347|NCT01004861|364824936|FG010|Overall Study|Transitioned to Phase 4 study|0|||
105774348|NCT01004861|364824937|FG011|Overall Study|Transitioned to Phase 4 study|0|||
105774349|NCT01004861|364824938|FG012|Overall Study|Transitioned to Phase 4 study|0|||
105774350|NCT01004861|364824926|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774351|NCT01004861|364824927|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774352|NCT01004861|364824928|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774353|NCT01004861|364824929|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774354|NCT01004861|364824930|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774355|NCT01004861|364824931|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774356|NCT01004861|364824932|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774357|NCT01004861|364824933|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774358|NCT01004861|364824934|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
105774359|NCT01004861|364824935|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774360|NCT01004861|364824936|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774361|NCT01004861|364824937|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774362|NCT01004861|364824938|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
105774363|NCT01004861|364824926|FG000|Overall Study|Patient withdrew|0|||
105774364|NCT01004861|364824927|FG001|Overall Study|Patient withdrew|0|||
105774365|NCT01004861|364824928|FG002|Overall Study|Patient withdrew|0|||
105774366|NCT01004861|364824929|FG003|Overall Study|Patient withdrew|0|||
105774367|NCT01004861|364824930|FG004|Overall Study|Patient withdrew|0|||
105774368|NCT01004861|364824931|FG005|Overall Study|Patient withdrew|0|||
105774369|NCT01004861|364824932|FG006|Overall Study|Patient withdrew|0|||
105774370|NCT01004861|364824933|FG007|Overall Study|Patient withdrew|0|||
105774371|NCT01004861|364824934|FG008|Overall Study|Patient withdrew|1|||
105774372|NCT01004861|364824935|FG009|Overall Study|Patient withdrew|0|||
105774373|NCT01004861|364824936|FG010|Overall Study|Patient withdrew|0|||
105774374|NCT01004861|364824937|FG011|Overall Study|Patient withdrew|0|||
105774375|NCT01004861|364824938|FG012|Overall Study|Patient withdrew|0|||
105774376|NCT01004861|364824926|FG000|Overall Study|Surgical resection|0|||
105774377|NCT01004861|364824927|FG001|Overall Study|Surgical resection|0|||
105774378|NCT01004861|364824928|FG002|Overall Study|Surgical resection|0|||
105774379|NCT01004861|364824929|FG003|Overall Study|Surgical resection|0|||
105774380|NCT01004861|364824930|FG004|Overall Study|Surgical resection|0|||
105774381|NCT01004861|364824931|FG005|Overall Study|Surgical resection|0|||
105774382|NCT01004861|364824932|FG006|Overall Study|Surgical resection|0|||
105774383|NCT01004861|364824933|FG007|Overall Study|Surgical resection|0|||
105774384|NCT01004861|364824934|FG008|Overall Study|Surgical resection|1|||
105774385|NCT01004861|364824935|FG009|Overall Study|Surgical resection|0|||
105774386|NCT01004861|364824936|FG010|Overall Study|Surgical resection|0|||
105774387|NCT01004861|364824937|FG011|Overall Study|Surgical resection|0|||
105774388|NCT01004861|364824938|FG012|Overall Study|Surgical resection|0|||
105774389|NCT01004861|364824926|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774390|NCT01004861|364824927|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774391|NCT01004861|364824928|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774392|NCT01004861|364824929|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105990732|NCT01677858|365624426|FG000|Overall Study|Adverse Event|0|||
105774393|NCT01004861|364824930|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774394|NCT01004861|364824931|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774395|NCT01004861|364824932|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774396|NCT01004861|364824933|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774397|NCT01004861|364824934|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
105774398|NCT01004861|364824935|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774399|NCT01004861|364824936|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774400|NCT01004861|364824937|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774401|NCT01004861|364824938|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
105774402|NCT01004861|364824926|FG000|Overall Study|Study termination by Sponsor|0|||
105774403|NCT01004861|364824927|FG001|Overall Study|Study termination by Sponsor|0|||
105774404|NCT01004861|364824928|FG002|Overall Study|Study termination by Sponsor|0|||
105774405|NCT01004861|364824929|FG003|Overall Study|Study termination by Sponsor|0|||
105774406|NCT01004861|364824930|FG004|Overall Study|Study termination by Sponsor|0|||
105774407|NCT01004861|364824931|FG005|Overall Study|Study termination by Sponsor|0|||
105774408|NCT01004861|364824932|FG006|Overall Study|Study termination by Sponsor|0|||
105774409|NCT01004861|364824933|FG007|Overall Study|Study termination by Sponsor|0|||
105774410|NCT01004861|364824934|FG008|Overall Study|Study termination by Sponsor|1|||
105774411|NCT01004861|364824935|FG009|Overall Study|Study termination by Sponsor|0|||
105774412|NCT01004861|364824936|FG010|Overall Study|Study termination by Sponsor|0|||
105774413|NCT01004861|364824937|FG011|Overall Study|Study termination by Sponsor|0|||
105774414|NCT01004861|364824938|FG012|Overall Study|Study termination by Sponsor|0|||
105774415|NCT00003389|364824939|FG000|Overall Study|Disease progression|6|||
105774416|NCT00003389|364824940|FG001|Overall Study|Disease progression|1|||
105774417|NCT00003389|364824939|FG000|Overall Study|Adverse Event|13|||
105774418|NCT00003389|364824940|FG001|Overall Study|Adverse Event|2|||
105774419|NCT00003389|364824939|FG000|Overall Study|Death|0|||
105774420|NCT00003389|364824940|FG001|Overall Study|Death|3|||
105774421|NCT00003389|364824939|FG000|Overall Study|Withdrawal by Subject|12|||
105774422|NCT00003389|364824940|FG001|Overall Study|Withdrawal by Subject|5|||
105774423|NCT00003389|364824939|FG000|Overall Study|Alternative therapy|2|||
105774424|NCT00003389|364824940|FG001|Overall Study|Alternative therapy|1|||
105774425|NCT00003389|364824939|FG000|Overall Study|Complicating disease|1|||
105774426|NCT00003389|364824940|FG001|Overall Study|Complicating disease|0|||
105774427|NCT00003389|364824939|FG000|Overall Study|Off-treatment reason missing|31|||
105774428|NCT00003389|364824940|FG001|Overall Study|Off-treatment reason missing|21|||
105774429|NCT00003389|364824939|FG000|Overall Study|Ineligible|33|||
105774430|NCT00003389|364824940|FG001|Overall Study|Ineligible|27|||
105774431|NCT00686699|364824942|FG000|Treatment Period 1|Adverse Event|0|||
105774432|NCT00686699|364824943|FG001|Treatment Period 1|Adverse Event|2|||
105774433|NCT01997892|364824946|FG000|Overall Study|Physician Decision|2|||
105774434|NCT01997892|364824946|FG000|Overall Study|Lost to Follow-up|6|||
105774435|NCT01997892|364824946|FG000|Overall Study|Death|14|||
105774436|NCT01997892|364824946|FG000|Overall Study|Renal transplant|8|||
105774437|NCT01997892|364824946|FG000|Overall Study|Other|3|||
105774438|NCT01997892|364824946|FG000|Overall Study|Study completion data not recorded|35|||
105774439|NCT02710422|364824947|FG000|Overall Study|Termination of study|9|||
105774440|NCT02710422|364824948|FG001|Overall Study|Termination of study|9|||
105774441|NCT02306148|364824958|FG000|Overall Study|Adverse Event|12|||
105774442|NCT02306148|364824959|FG001|Overall Study|Adverse Event|6|||
105774443|NCT02306148|364824958|FG000|Overall Study|Lost to Follow-up|1|||
105774444|NCT02306148|364824959|FG001|Overall Study|Lost to Follow-up|4|||
105774445|NCT04657003|364824960|FG000|Overall Study|Adverse Event|5|||
105774446|NCT04657003|364824961|FG001|Overall Study|Adverse Event|1|||
105774447|NCT04657003|364824962|FG002|Overall Study|Adverse Event|5|||
105774448|NCT04657003|364824960|FG000|Overall Study|Death|0|||
105774449|NCT04657003|364824961|FG001|Overall Study|Death|2|||
105774450|NCT04657003|364824962|FG002|Overall Study|Death|0|||
105774451|NCT04657003|364824960|FG000|Overall Study|Lost to Follow-up|8|||
105774452|NCT04657003|364824961|FG001|Overall Study|Lost to Follow-up|4|||
105774453|NCT04657003|364824962|FG002|Overall Study|Lost to Follow-up|10|||
105774454|NCT04657003|364824960|FG000|Overall Study|Other - As Reported by Investigator|3|||
105774455|NCT04657003|364824961|FG001|Overall Study|Other - As Reported by Investigator|2|||
105774456|NCT04657003|364824962|FG002|Overall Study|Other - As Reported by Investigator|2|||
105774457|NCT04657003|364824960|FG000|Overall Study|Pregnancy|2|||
105774458|NCT04657003|364824961|FG001|Overall Study|Pregnancy|0|||
105774459|NCT04657003|364824962|FG002|Overall Study|Pregnancy|2|||
105774460|NCT04657003|364824960|FG000|Overall Study|Withdrawal by Subject|16|||
105774461|NCT04657003|364824961|FG001|Overall Study|Withdrawal by Subject|7|||
105774462|NCT04657003|364824962|FG002|Overall Study|Withdrawal by Subject|10|||
105774463|NCT01736176|364824965|FG000|Overall Study|Adverse Event|3|||
105774464|NCT01736176|364824965|FG000|Overall Study|Withdrawal by Subject|4|||
105774465|NCT01736176|364824965|FG000|Overall Study|Lack of Efficacy|3|||
105774466|NCT01736176|364824965|FG000|Overall Study|Unable to Complete PEG Placement|1|||
105774467|NCT00186121|364824968|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
105774468|NCT00186121|364824968|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
105774469|NCT00186121|364824968|FG000|Overall Study|Not eligible (no treatment)|1|||
105774470|NCT03650387|364824969|FG000|Overall Study|Withdrawal by Subject|13|||
105774471|NCT03650387|364824969|FG000|Overall Study|Lost to Follow-up|12|||
105774472|NCT03650387|364824969|FG000|Overall Study|Adverse Event (Not related)|1|||
105774473|NCT03650387|364824969|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
105774474|NCT01569568|364824970|FG000|Overall Study|Physician Decision|0|||
105774475|NCT01569568|364824971|FG001|Overall Study|Physician Decision|2|||
105774476|NCT03347279|364824972|FG000|Overall Study|Withdrawal by Subject|8|||
105774477|NCT03347279|364824973|FG001|Overall Study|Withdrawal by Subject|15|||
105774478|NCT03347279|364824972|FG000|Overall Study|Death|0|||
105774479|NCT03347279|364824973|FG001|Overall Study|Death|2|||
105774480|NCT03347279|364824972|FG000|Overall Study|Lost to Follow-up|5|||
105774481|NCT03347279|364824973|FG001|Overall Study|Lost to Follow-up|2|||
105774482|NCT03347279|364824972|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
105774483|NCT03347279|364824973|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
105774484|NCT03818399|364824974|FG000|Overall Study|Lost to Follow-up|11|||
105774485|NCT03818399|364824974|FG000|Overall Study|Withdrawal by Subject|1|||
105774486|NCT03818399|364824974|FG000|Overall Study|Protocol Violation|2|||
105774487|NCT00934791|364824975|FG000|Overall Study|Withdrawal by Subject|1|||
105774488|NCT00934791|364824976|FG001|Overall Study|Withdrawal by Subject|0|||
105774489|NCT02045979|364824980|FG000|Overall Study|Informed Consent Withdrawn|2|||
105774490|NCT02045979|364824981|FG001|Overall Study|Informed Consent Withdrawn|0|||
105774491|NCT02045979|364824982|FG002|Overall Study|Informed Consent Withdrawn|1|||
105774492|NCT02045979|364824980|FG000|Overall Study|not specified above|0|||
105774493|NCT02045979|364824981|FG001|Overall Study|not specified above|1|||
105774494|NCT02045979|364824982|FG002|Overall Study|not specified above|0|||
105774495|NCT02425891|364824983|FG000|Overall Study|Death|333|||
105774496|NCT02425891|364824984|FG001|Overall Study|Death|314|||
105774497|NCT02425891|364824983|FG000|Overall Study|Lost to Follow-up|4|||
105774498|NCT02425891|364824984|FG001|Overall Study|Lost to Follow-up|6|||
105774499|NCT02425891|364824983|FG000|Overall Study|Non-Compliance|1|||
105774500|NCT02425891|364824984|FG001|Overall Study|Non-Compliance|1|||
105774501|NCT02425891|364824983|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
105774502|NCT02425891|364824984|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
105774503|NCT02425891|364824983|FG000|Overall Study|Physician Decision|0|||
105774504|NCT02425891|364824984|FG001|Overall Study|Physician Decision|1|||
105774505|NCT02425891|364824983|FG000|Overall Study|Protocol Violation|1|||
105774506|NCT02425891|364824984|FG001|Overall Study|Protocol Violation|1|||
105774507|NCT02425891|364824983|FG000|Overall Study|Study Terminated By Sponsor|85|||
105774508|NCT02425891|364824984|FG001|Overall Study|Study Terminated By Sponsor|95|||
105774509|NCT02425891|364824983|FG000|Overall Study|Withdrawal by Subject|27|||
105774510|NCT02425891|364824984|FG001|Overall Study|Withdrawal by Subject|32|||
105774511|NCT00535236|364824985|FG000|Overall Study|Adverse Event|1|||
105774512|NCT00535236|364824986|FG001|Overall Study|Adverse Event|0|||
105774513|NCT00535236|364824987|FG002|Overall Study|Adverse Event|9|||
105774514|NCT00535236|364824988|FG003|Overall Study|Adverse Event|3|||
105774515|NCT00535236|364824989|FG004|Overall Study|Adverse Event|3|||
105774516|NCT00535236|364824990|FG005|Overall Study|Adverse Event|0|||
105774517|NCT00535236|364824991|FG006|Overall Study|Adverse Event|5|||
105774518|NCT00535236|364824992|FG007|Overall Study|Adverse Event|1|||
105774519|NCT00535236|364824993|FG008|Overall Study|Adverse Event|2|||
105774520|NCT00535236|364824994|FG009|Overall Study|Adverse Event|1|||
105774521|NCT00535236|364824985|FG000|Overall Study|Lost to Follow-up|1|||
105774522|NCT00535236|364824986|FG001|Overall Study|Lost to Follow-up|2|||
105774523|NCT00535236|364824987|FG002|Overall Study|Lost to Follow-up|0|||
105774524|NCT00535236|364824988|FG003|Overall Study|Lost to Follow-up|0|||
105774525|NCT00535236|364824989|FG004|Overall Study|Lost to Follow-up|2|||
105774526|NCT00535236|364824990|FG005|Overall Study|Lost to Follow-up|0|||
105774527|NCT00535236|364824991|FG006|Overall Study|Lost to Follow-up|0|||
105774528|NCT00535236|364824992|FG007|Overall Study|Lost to Follow-up|0|||
105774529|NCT00535236|364824993|FG008|Overall Study|Lost to Follow-up|6|||
105774530|NCT00535236|364824994|FG009|Overall Study|Lost to Follow-up|1|||
105774531|NCT00535236|364824985|FG000|Overall Study|Physician Decision|0|||
105774532|NCT00535236|364824986|FG001|Overall Study|Physician Decision|0|||
105774533|NCT00535236|364824987|FG002|Overall Study|Physician Decision|0|||
105774534|NCT00535236|364824988|FG003|Overall Study|Physician Decision|0|||
105774535|NCT00535236|364824989|FG004|Overall Study|Physician Decision|1|||
105774536|NCT00535236|364824990|FG005|Overall Study|Physician Decision|0|||
105774537|NCT00535236|364824991|FG006|Overall Study|Physician Decision|1|||
105774538|NCT00535236|364824992|FG007|Overall Study|Physician Decision|0|||
105774539|NCT00535236|364824993|FG008|Overall Study|Physician Decision|0|||
105774540|NCT00535236|364824994|FG009|Overall Study|Physician Decision|0|||
105774541|NCT00535236|364824985|FG000|Overall Study|Protocol Violation|2|||
105774542|NCT00535236|364824986|FG001|Overall Study|Protocol Violation|0|||
105774543|NCT00535236|364824987|FG002|Overall Study|Protocol Violation|1|||
105774544|NCT00535236|364824988|FG003|Overall Study|Protocol Violation|0|||
105774545|NCT00535236|364824989|FG004|Overall Study|Protocol Violation|0|||
105774546|NCT00535236|364824990|FG005|Overall Study|Protocol Violation|0|||
105774547|NCT00535236|364824991|FG006|Overall Study|Protocol Violation|0|||
105774548|NCT00535236|364824992|FG007|Overall Study|Protocol Violation|0|||
105774549|NCT00535236|364824993|FG008|Overall Study|Protocol Violation|1|||
105774550|NCT00535236|364824994|FG009|Overall Study|Protocol Violation|0|||
105774551|NCT00535236|364824985|FG000|Overall Study|Withdrawal by Subject|3|||
105774552|NCT00535236|364824986|FG001|Overall Study|Withdrawal by Subject|0|||
105774553|NCT00535236|364824987|FG002|Overall Study|Withdrawal by Subject|2|||
105774554|NCT00535236|364824988|FG003|Overall Study|Withdrawal by Subject|1|||
105774555|NCT00535236|364824989|FG004|Overall Study|Withdrawal by Subject|6|||
105774556|NCT00535236|364824990|FG005|Overall Study|Withdrawal by Subject|1|||
105774557|NCT00535236|364824991|FG006|Overall Study|Withdrawal by Subject|5|||
105774558|NCT00535236|364824992|FG007|Overall Study|Withdrawal by Subject|0|||
105774559|NCT00535236|364824993|FG008|Overall Study|Withdrawal by Subject|4|||
105774560|NCT00535236|364824994|FG009|Overall Study|Withdrawal by Subject|2|||
105774561|NCT04124952|364824995|FG000|Overall Study|Lost to Follow-up|1|||
105774562|NCT01654224|364824999|FG000|Overall Study|Lost to Follow-up|2|||
105774563|NCT01654224|364825000|FG001|Overall Study|Lost to Follow-up|2|||
105774564|NCT01654224|364824999|FG000|Overall Study|Did not receive allocation|1|||
105774565|NCT01654224|364825000|FG001|Overall Study|Did not receive allocation|8|||
105774566|NCT01654224|364824999|FG000|Overall Study|Insufficient blood sample|3|||
105774567|NCT01654224|364825000|FG001|Overall Study|Insufficient blood sample|2|||
105774568|NCT00846027|364825003|FG000|Overall Study|Death|3|||
105774569|NCT00846027|364825003|FG000|Overall Study|Disease Progression|30|||
105774570|NCT00846027|364825003|FG000|Overall Study|Toxicity|12|||
105774571|NCT00846027|364825003|FG000|Overall Study|Patient Decision|7|||
105774572|NCT00846027|364825003|FG000|Overall Study|Investigator Discretion|29|||
105774573|NCT00846027|364825003|FG000|Overall Study|Protocol Violation|2|||
105774574|NCT00846027|364825003|FG000|Overall Study|Subject Not Treated|7|||
105774575|NCT02646891|364825004|FG000|Overall Study|Adverse Event|0|||
105774576|NCT02646891|364825005|FG001|Overall Study|Adverse Event|1|||
105774577|NCT02646891|364825006|FG002|Overall Study|Adverse Event|0|||
105774578|NCT02646891|364825007|FG003|Overall Study|Adverse Event|0|||
105774579|NCT02646891|364825008|FG004|Overall Study|Adverse Event|0|||
105774580|NCT02646891|364825009|FG005|Overall Study|Adverse Event|0|||
105774581|NCT02646891|364825010|FG006|Overall Study|Adverse Event|0|||
105774582|NCT02646891|364825011|FG007|Overall Study|Adverse Event|0|||
105774583|NCT02646891|364825012|FG008|Overall Study|Adverse Event|0|||
105774584|NCT02646891|364825013|FG009|Overall Study|Adverse Event|0|||
105774585|NCT02646891|364825004|FG000|Overall Study|Lost to Follow-up|0|||
105774586|NCT02646891|364825005|FG001|Overall Study|Lost to Follow-up|0|||
105774587|NCT02646891|364825006|FG002|Overall Study|Lost to Follow-up|0|||
105774588|NCT02646891|364825007|FG003|Overall Study|Lost to Follow-up|0|||
105774589|NCT02646891|364825008|FG004|Overall Study|Lost to Follow-up|0|||
105774590|NCT02646891|364825009|FG005|Overall Study|Lost to Follow-up|0|||
105774591|NCT02646891|364825010|FG006|Overall Study|Lost to Follow-up|2|||
105774592|NCT02646891|364825011|FG007|Overall Study|Lost to Follow-up|2|||
105774593|NCT02646891|364825012|FG008|Overall Study|Lost to Follow-up|2|||
105774594|NCT02646891|364825013|FG009|Overall Study|Lost to Follow-up|2|||
105774595|NCT02646891|364825004|FG000|Overall Study|Protocol Violation|0|||
105774596|NCT02646891|364825005|FG001|Overall Study|Protocol Violation|0|||
105774597|NCT02646891|364825006|FG002|Overall Study|Protocol Violation|0|||
105774598|NCT02646891|364825007|FG003|Overall Study|Protocol Violation|0|||
105774599|NCT02646891|364825008|FG004|Overall Study|Protocol Violation|0|||
105774600|NCT02646891|364825009|FG005|Overall Study|Protocol Violation|0|||
105774601|NCT02646891|364825010|FG006|Overall Study|Protocol Violation|1|||
105774602|NCT02646891|364825011|FG007|Overall Study|Protocol Violation|1|||
105774603|NCT02646891|364825012|FG008|Overall Study|Protocol Violation|0|||
105774604|NCT02646891|364825013|FG009|Overall Study|Protocol Violation|0|||
105774605|NCT02646891|364825004|FG000|Overall Study|Withdrawal by Subject|2|||
105774606|NCT02646891|364825005|FG001|Overall Study|Withdrawal by Subject|0|||
105774607|NCT02646891|364825006|FG002|Overall Study|Withdrawal by Subject|1|||
105774608|NCT02646891|364825007|FG003|Overall Study|Withdrawal by Subject|0|||
105774609|NCT02646891|364825008|FG004|Overall Study|Withdrawal by Subject|0|||
105774610|NCT02646891|364825009|FG005|Overall Study|Withdrawal by Subject|0|||
105774611|NCT02646891|364825010|FG006|Overall Study|Withdrawal by Subject|5|||
105774612|NCT02646891|364825011|FG007|Overall Study|Withdrawal by Subject|9|||
105774613|NCT02646891|364825012|FG008|Overall Study|Withdrawal by Subject|7|||
105774614|NCT02646891|364825013|FG009|Overall Study|Withdrawal by Subject|3|||
105774615|NCT02646891|364825004|FG000|Overall Study|Death|0|||
105774616|NCT02646891|364825005|FG001|Overall Study|Death|0|||
106099751|NCT04546581|366022616|FG001|Overall Study|Withdrawal by Subject|7|||
105774617|NCT02646891|364825006|FG002|Overall Study|Death|0|||
105774618|NCT02646891|364825007|FG003|Overall Study|Death|0|||
105774619|NCT02646891|364825008|FG004|Overall Study|Death|0|||
105774620|NCT02646891|364825009|FG005|Overall Study|Death|0|||
105774621|NCT02646891|364825010|FG006|Overall Study|Death|1|||
105774622|NCT02646891|364825011|FG007|Overall Study|Death|1|||
105774623|NCT02646891|364825012|FG008|Overall Study|Death|1|||
105774624|NCT02646891|364825013|FG009|Overall Study|Death|0|||
105774625|NCT00638989|364825014|FG000|Overall Study|Lost to Follow-up|0|||
105774626|NCT00638989|364825015|FG001|Overall Study|Lost to Follow-up|0|||
105774627|NCT00638989|364825016|FG002|Overall Study|Lost to Follow-up|1|||
105774628|NCT01058395|364825018|FG000|Overall Study|Death|2|||
105774629|NCT01058395|364825019|FG001|Overall Study|Death|1|||
106099752|NCT02526693|366022617|FG000|Overall Study|Physician Decision|3|||
106099753|NCT02526693|366022618|FG001|Overall Study|Physician Decision|1|||
106099754|NCT01983293|366022619|FG000|Overall Study|Withdrawal by Subject|29|||
106099755|NCT01983293|366022620|FG001|Overall Study|Withdrawal by Subject|15|||
106099756|NCT01983293|366022619|FG000|Overall Study|Missing 12-month visit|3|||
106099757|NCT01983293|366022620|FG001|Overall Study|Missing 12-month visit|3|||
106099758|NCT01983293|366022619|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
106099759|NCT01983293|366022620|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
106099760|NCT01349569|366022621|FG000|Overall Study|Lack of Efficacy|4|||
106099761|NCT03581305|366022622|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
106099762|NCT03581305|366022623|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
105774630|NCT01058395|364825018|FG000|Overall Study|Lost to Follow-up|1|||
105774631|NCT01058395|364825019|FG001|Overall Study|Lost to Follow-up|0|||
105774632|NCT00963820|364825020|FG000|Dose Escalation Phase|Progressive Disease|3|||
105774633|NCT00963820|364825021|FG001|Dose Escalation Phase|Progressive Disease|3|||
105774634|NCT00963820|364825022|FG002|Dose Escalation Phase|Progressive Disease|3|||
105774635|NCT00963820|364825023|FG003|Dose Escalation Phase|Progressive Disease|3|||
105774636|NCT00963820|364825024|FG004|Dose Escalation Phase|Progressive Disease|4|||
105774637|NCT00963820|364825025|FG005|Dose Escalation Phase|Progressive Disease|3|||
105774638|NCT00963820|364825026|FG006|Dose Escalation Phase|Progressive Disease|3|||
105774639|NCT00963820|364825027|FG007|Dose Escalation Phase|Progressive Disease|2|||
105774640|NCT00963820|364825028|FG008|Dose Escalation Phase|Progressive Disease|0|||
105774641|NCT00963820|364825029|FG009|Dose Escalation Phase|Progressive Disease|0|||
105774642|NCT00963820|364825030|FG010|Dose Escalation Phase|Progressive Disease|0|||
105774643|NCT00963820|364825031|FG011|Dose Escalation Phase|Progressive Disease|0|||
105774644|NCT00963820|364825020|FG000|Dose Escalation Phase|Adverse Event|0|||
105774645|NCT00963820|364825021|FG001|Dose Escalation Phase|Adverse Event|0|||
105774646|NCT00963820|364825022|FG002|Dose Escalation Phase|Adverse Event|0|||
105774647|NCT00963820|364825023|FG003|Dose Escalation Phase|Adverse Event|0|||
105774648|NCT00963820|364825024|FG004|Dose Escalation Phase|Adverse Event|0|||
105774649|NCT00963820|364825025|FG005|Dose Escalation Phase|Adverse Event|0|||
105774650|NCT00963820|364825026|FG006|Dose Escalation Phase|Adverse Event|3|||
105774651|NCT00963820|364825027|FG007|Dose Escalation Phase|Adverse Event|1|||
105774652|NCT00963820|364825028|FG008|Dose Escalation Phase|Adverse Event|0|||
105774653|NCT00963820|364825029|FG009|Dose Escalation Phase|Adverse Event|0|||
105774654|NCT00963820|364825030|FG010|Dose Escalation Phase|Adverse Event|0|||
105774655|NCT00963820|364825031|FG011|Dose Escalation Phase|Adverse Event|0|||
105774656|NCT00963820|364825020|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
105774657|NCT00963820|364825021|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
105774658|NCT00963820|364825022|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
105774659|NCT00963820|364825023|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105774660|NCT00963820|364825024|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
105774661|NCT00963820|364825025|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
105774662|NCT00963820|364825026|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
105774663|NCT00963820|364825027|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
105774664|NCT00963820|364825028|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
105774665|NCT00963820|364825029|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
105774666|NCT00963820|364825030|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
105774667|NCT00963820|364825031|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
105774668|NCT00963820|364825020|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774669|NCT00963820|364825021|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774670|NCT00963820|364825022|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774671|NCT00963820|364825023|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774672|NCT00963820|364825024|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774673|NCT00963820|364825025|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774674|NCT00963820|364825026|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
105774675|NCT00963820|364825027|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774676|NCT00963820|364825028|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774677|NCT00963820|364825029|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774678|NCT00963820|364825030|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774679|NCT00963820|364825031|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105774680|NCT00963820|364825020|FG000|Expansion Phase|Progressive Disease|0|||
105774681|NCT00963820|364825021|FG001|Expansion Phase|Progressive Disease|0|||
105774682|NCT00963820|364825022|FG002|Expansion Phase|Progressive Disease|0|||
105774683|NCT00963820|364825023|FG003|Expansion Phase|Progressive Disease|0|||
105774684|NCT00963820|364825024|FG004|Expansion Phase|Progressive Disease|0|||
105774685|NCT00963820|364825025|FG005|Expansion Phase|Progressive Disease|0|||
106099763|NCT03581305|366022622|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
106099764|NCT03581305|366022623|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
105774686|NCT00963820|364825026|FG006|Expansion Phase|Progressive Disease|0|||
105774687|NCT00963820|364825027|FG007|Expansion Phase|Progressive Disease|0|||
105774688|NCT00963820|364825028|FG008|Expansion Phase|Progressive Disease|8|||
105774689|NCT00963820|364825029|FG009|Expansion Phase|Progressive Disease|6|||
105774690|NCT00963820|364825030|FG010|Expansion Phase|Progressive Disease|4|||
105774691|NCT00963820|364825031|FG011|Expansion Phase|Progressive Disease|2|||
105774692|NCT00963820|364825020|FG000|Expansion Phase|Adverse Event|0|||
105774693|NCT00963820|364825021|FG001|Expansion Phase|Adverse Event|0|||
105774694|NCT00963820|364825022|FG002|Expansion Phase|Adverse Event|0|||
105774695|NCT00963820|364825023|FG003|Expansion Phase|Adverse Event|0|||
105774696|NCT00963820|364825024|FG004|Expansion Phase|Adverse Event|0|||
105774697|NCT00963820|364825025|FG005|Expansion Phase|Adverse Event|0|||
105774698|NCT00963820|364825026|FG006|Expansion Phase|Adverse Event|0|||
105774699|NCT00963820|364825027|FG007|Expansion Phase|Adverse Event|0|||
105774700|NCT00963820|364825028|FG008|Expansion Phase|Adverse Event|1|||
105774701|NCT00963820|364825029|FG009|Expansion Phase|Adverse Event|3|||
105774702|NCT00963820|364825030|FG010|Expansion Phase|Adverse Event|0|||
105774703|NCT00963820|364825031|FG011|Expansion Phase|Adverse Event|0|||
105774704|NCT00963820|364825020|FG000|Expansion Phase|Withdrawal by Subject|0|||
105774705|NCT00963820|364825021|FG001|Expansion Phase|Withdrawal by Subject|0|||
105774706|NCT00963820|364825022|FG002|Expansion Phase|Withdrawal by Subject|0|||
105774707|NCT00963820|364825023|FG003|Expansion Phase|Withdrawal by Subject|0|||
105774708|NCT00963820|364825024|FG004|Expansion Phase|Withdrawal by Subject|0|||
105774709|NCT00963820|364825025|FG005|Expansion Phase|Withdrawal by Subject|0|||
105774710|NCT00963820|364825026|FG006|Expansion Phase|Withdrawal by Subject|0|||
105774711|NCT00963820|364825027|FG007|Expansion Phase|Withdrawal by Subject|0|||
105774712|NCT00963820|364825028|FG008|Expansion Phase|Withdrawal by Subject|1|||
105774713|NCT00963820|364825029|FG009|Expansion Phase|Withdrawal by Subject|0|||
105774714|NCT00963820|364825030|FG010|Expansion Phase|Withdrawal by Subject|1|||
105774715|NCT00963820|364825031|FG011|Expansion Phase|Withdrawal by Subject|1|||
105774716|NCT00963820|364825020|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774717|NCT00963820|364825021|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774718|NCT00963820|364825022|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774719|NCT00963820|364825023|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774720|NCT00963820|364825024|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774721|NCT00963820|364825025|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774722|NCT00963820|364825026|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774723|NCT00963820|364825027|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774724|NCT00963820|364825028|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774725|NCT00963820|364825029|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774726|NCT00963820|364825030|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105774727|NCT00963820|364825031|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
105774728|NCT02477800|364825032|FG000|Placebo-Controlled Period|Adverse Event|16|||
105774729|NCT02477800|364825033|FG001|Placebo-Controlled Period|Adverse Event|25|||
105774730|NCT02477800|364825034|FG002|Placebo-Controlled Period|Adverse Event|28|||
105774731|NCT02477800|364825035|FG003|Placebo-Controlled Period|Adverse Event|0|||
105774732|NCT02477800|364825036|FG004|Placebo-Controlled Period|Adverse Event|0|||
105774733|NCT02477800|364825037|FG005|Placebo-Controlled Period|Adverse Event|0|||
105774734|NCT02477800|364825038|FG006|Placebo-Controlled Period|Adverse Event|0|||
105774735|NCT02477800|364825032|FG000|Placebo-Controlled Period|Change of Treatment|1|||
105774736|NCT02477800|364825033|FG001|Placebo-Controlled Period|Change of Treatment|2|||
105774737|NCT02477800|364825034|FG002|Placebo-Controlled Period|Change of Treatment|1|||
105774738|NCT02477800|364825035|FG003|Placebo-Controlled Period|Change of Treatment|0|||
105774739|NCT02477800|364825036|FG004|Placebo-Controlled Period|Change of Treatment|0|||
105774740|NCT02477800|364825037|FG005|Placebo-Controlled Period|Change of Treatment|0|||
105774741|NCT02477800|364825038|FG006|Placebo-Controlled Period|Change of Treatment|0|||
105774742|NCT02477800|364825032|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
105774743|NCT02477800|364825033|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
105774744|NCT02477800|364825034|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
105774745|NCT02477800|364825035|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
105774746|NCT02477800|364825036|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
105774747|NCT02477800|364825037|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
105774748|NCT02477800|364825038|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
105774749|NCT02477800|364825032|FG000|Placebo-Controlled Period|Death|0|||
105774750|NCT02477800|364825033|FG001|Placebo-Controlled Period|Death|3|||
105774751|NCT02477800|364825034|FG002|Placebo-Controlled Period|Death|2|||
105774752|NCT02477800|364825035|FG003|Placebo-Controlled Period|Death|0|||
105774753|NCT02477800|364825036|FG004|Placebo-Controlled Period|Death|0|||
105774754|NCT02477800|364825037|FG005|Placebo-Controlled Period|Death|0|||
105774755|NCT02477800|364825038|FG006|Placebo-Controlled Period|Death|0|||
105774756|NCT02477800|364825032|FG000|Placebo-Controlled Period|Disease Progression|1|||
105774757|NCT02477800|364825033|FG001|Placebo-Controlled Period|Disease Progression|0|||
105774758|NCT02477800|364825034|FG002|Placebo-Controlled Period|Disease Progression|1|||
105806445|NCT01464827|364948984|FG003|Overall Study|Other|2|||
105774759|NCT02477800|364825035|FG003|Placebo-Controlled Period|Disease Progression|0|||
105774760|NCT02477800|364825036|FG004|Placebo-Controlled Period|Disease Progression|0|||
105774761|NCT02477800|364825037|FG005|Placebo-Controlled Period|Disease Progression|0|||
105774762|NCT02477800|364825038|FG006|Placebo-Controlled Period|Disease Progression|0|||
105774763|NCT02477800|364825032|FG000|Placebo-Controlled Period|Investigator Decision|3|||
105774764|NCT02477800|364825033|FG001|Placebo-Controlled Period|Investigator Decision|2|||
105774765|NCT02477800|364825034|FG002|Placebo-Controlled Period|Investigator Decision|1|||
105774766|NCT02477800|364825035|FG003|Placebo-Controlled Period|Investigator Decision|0|||
105774767|NCT02477800|364825036|FG004|Placebo-Controlled Period|Investigator Decision|0|||
105774768|NCT02477800|364825037|FG005|Placebo-Controlled Period|Investigator Decision|0|||
105774769|NCT02477800|364825038|FG006|Placebo-Controlled Period|Investigator Decision|0|||
105774770|NCT02477800|364825032|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
105774771|NCT02477800|364825033|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
105774772|NCT02477800|364825034|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
105774773|NCT02477800|364825035|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
105774774|NCT02477800|364825036|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
105774775|NCT02477800|364825037|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
105774776|NCT02477800|364825038|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
105774777|NCT02477800|364825032|FG000|Placebo-Controlled Period|Relocation|2|||
105774778|NCT02477800|364825033|FG001|Placebo-Controlled Period|Relocation|0|||
105774779|NCT02477800|364825034|FG002|Placebo-Controlled Period|Relocation|0|||
105774780|NCT02477800|364825035|FG003|Placebo-Controlled Period|Relocation|0|||
105774781|NCT02477800|364825036|FG004|Placebo-Controlled Period|Relocation|0|||
105774782|NCT02477800|364825037|FG005|Placebo-Controlled Period|Relocation|0|||
105774783|NCT02477800|364825038|FG006|Placebo-Controlled Period|Relocation|0|||
105774784|NCT02477800|364825032|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
105774785|NCT02477800|364825033|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
105774786|NCT02477800|364825034|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
105774787|NCT02477800|364825035|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
105774788|NCT02477800|364825036|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
105774789|NCT02477800|364825037|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
105774790|NCT02477800|364825038|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
105774791|NCT02477800|364825032|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
105774792|NCT02477800|364825033|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
105774793|NCT02477800|364825034|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774794|NCT02477800|364825035|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774795|NCT02477800|364825036|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774796|NCT02477800|364825037|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774797|NCT02477800|364825038|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
105774798|NCT02477800|364825032|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
105774799|NCT02477800|364825033|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
105774800|NCT02477800|364825034|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
105774801|NCT02477800|364825035|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
105774802|NCT02477800|364825036|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
105774803|NCT02477800|364825037|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
105774804|NCT02477800|364825038|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
105774805|NCT02477800|364825032|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
105774806|NCT02477800|364825033|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
105774807|NCT02477800|364825034|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
105774808|NCT02477800|364825035|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105774809|NCT02477800|364825036|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105774810|NCT02477800|364825037|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105774811|NCT02477800|364825038|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105774812|NCT02477800|364825032|FG000|Placebo-Controlled Period|Reason not Specified|161|||
105774813|NCT02477800|364825033|FG001|Placebo-Controlled Period|Reason not Specified|161|||
105774814|NCT02477800|364825034|FG002|Placebo-Controlled Period|Reason not Specified|189|||
105774815|NCT02477800|364825035|FG003|Placebo-Controlled Period|Reason not Specified|0|||
105774816|NCT02477800|364825036|FG004|Placebo-Controlled Period|Reason not Specified|0|||
105774817|NCT02477800|364825037|FG005|Placebo-Controlled Period|Reason not Specified|0|||
105774818|NCT02477800|364825038|FG006|Placebo-Controlled Period|Reason not Specified|0|||
105774819|NCT02477800|364825032|FG000|Long Term Extension Period|Adverse Event|0|||
105774820|NCT02477800|364825033|FG001|Long Term Extension Period|Adverse Event|0|||
105774821|NCT02477800|364825034|FG002|Long Term Extension Period|Adverse Event|0|||
105774822|NCT02477800|364825035|FG003|Long Term Extension Period|Adverse Event|6|||
105774823|NCT02477800|364825036|FG004|Long Term Extension Period|Adverse Event|2|||
105774824|NCT02477800|364825037|FG005|Long Term Extension Period|Adverse Event|4|||
105774825|NCT02477800|364825038|FG006|Long Term Extension Period|Adverse Event|3|||
105774826|NCT02477800|364825032|FG000|Long Term Extension Period|Death|0|||
106099765|NCT03581305|366022622|FG000|Serotonergic Study|Withdrawal by Subject|5|||
105774827|NCT02477800|364825033|FG001|Long Term Extension Period|Death|0|||
105774828|NCT02477800|364825034|FG002|Long Term Extension Period|Death|0|||
105774829|NCT02477800|364825035|FG003|Long Term Extension Period|Death|1|||
105774830|NCT02477800|364825036|FG004|Long Term Extension Period|Death|1|||
105774831|NCT02477800|364825037|FG005|Long Term Extension Period|Death|1|||
105774832|NCT02477800|364825038|FG006|Long Term Extension Period|Death|2|||
105774833|NCT02477800|364825032|FG000|Long Term Extension Period|Consent Withdrawn|0|||
105774834|NCT02477800|364825033|FG001|Long Term Extension Period|Consent Withdrawn|0|||
105774835|NCT02477800|364825034|FG002|Long Term Extension Period|Consent Withdrawn|0|||
105774836|NCT02477800|364825035|FG003|Long Term Extension Period|Consent Withdrawn|10|||
105774837|NCT02477800|364825036|FG004|Long Term Extension Period|Consent Withdrawn|4|||
105774838|NCT02477800|364825037|FG005|Long Term Extension Period|Consent Withdrawn|13|||
105774839|NCT02477800|364825038|FG006|Long Term Extension Period|Consent Withdrawn|16|||
105774840|NCT02477800|364825032|FG000|Long Term Extension Period|Disease Progression|0|||
105774841|NCT02477800|364825033|FG001|Long Term Extension Period|Disease Progression|0|||
105774842|NCT02477800|364825034|FG002|Long Term Extension Period|Disease Progression|0|||
105774843|NCT02477800|364825035|FG003|Long Term Extension Period|Disease Progression|3|||
105774844|NCT02477800|364825036|FG004|Long Term Extension Period|Disease Progression|1|||
105774845|NCT02477800|364825037|FG005|Long Term Extension Period|Disease Progression|1|||
105774846|NCT02477800|364825038|FG006|Long Term Extension Period|Disease Progression|0|||
105774847|NCT02477800|364825032|FG000|Long Term Extension Period|Investigator Decision|0|||
105774848|NCT02477800|364825033|FG001|Long Term Extension Period|Investigator Decision|0|||
105774849|NCT02477800|364825034|FG002|Long Term Extension Period|Investigator Decision|0|||
105774850|NCT02477800|364825035|FG003|Long Term Extension Period|Investigator Decision|0|||
105774851|NCT02477800|364825036|FG004|Long Term Extension Period|Investigator Decision|0|||
105774852|NCT02477800|364825037|FG005|Long Term Extension Period|Investigator Decision|0|||
105774853|NCT02477800|364825038|FG006|Long Term Extension Period|Investigator Decision|2|||
105774854|NCT02477800|364825032|FG000|Long Term Extension Period|Lost to Follow-up|0|||
105774855|NCT02477800|364825033|FG001|Long Term Extension Period|Lost to Follow-up|0|||
105774856|NCT02477800|364825034|FG002|Long Term Extension Period|Lost to Follow-up|0|||
105774857|NCT02477800|364825035|FG003|Long Term Extension Period|Lost to Follow-up|0|||
105774858|NCT02477800|364825036|FG004|Long Term Extension Period|Lost to Follow-up|1|||
105774859|NCT02477800|364825037|FG005|Long Term Extension Period|Lost to Follow-up|3|||
105774860|NCT02477800|364825038|FG006|Long Term Extension Period|Lost to Follow-up|0|||
105774861|NCT02477800|364825032|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774862|NCT02477800|364825033|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774863|NCT02477800|364825034|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774864|NCT02477800|364825035|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774865|NCT02477800|364825036|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
105774866|NCT02477800|364825037|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
105774867|NCT02477800|364825038|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
105774868|NCT02477800|364825032|FG000|Long Term Extension Period|Study Visit Burden|0|||
105774869|NCT02477800|364825033|FG001|Long Term Extension Period|Study Visit Burden|0|||
105774870|NCT02477800|364825034|FG002|Long Term Extension Period|Study Visit Burden|0|||
105774871|NCT02477800|364825035|FG003|Long Term Extension Period|Study Visit Burden|3|||
105774872|NCT02477800|364825036|FG004|Long Term Extension Period|Study Visit Burden|0|||
105774873|NCT02477800|364825037|FG005|Long Term Extension Period|Study Visit Burden|2|||
105774874|NCT02477800|364825038|FG006|Long Term Extension Period|Study Visit Burden|2|||
105774875|NCT02477800|364825032|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
105774876|NCT02477800|364825033|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
105774877|NCT02477800|364825034|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
105774878|NCT02477800|364825035|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
105774879|NCT02477800|364825036|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
105774880|NCT02477800|364825037|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
105774881|NCT02477800|364825038|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
105774882|NCT02477800|364825032|FG000|Long Term Extension Period|Reason not Specified|0|||
105774883|NCT02477800|364825033|FG001|Long Term Extension Period|Reason not Specified|0|||
105774884|NCT02477800|364825034|FG002|Long Term Extension Period|Reason not Specified|0|||
105774885|NCT02477800|364825035|FG003|Long Term Extension Period|Reason not Specified|126|||
105774886|NCT02477800|364825036|FG004|Long Term Extension Period|Reason not Specified|140|||
105774887|NCT02477800|364825037|FG005|Long Term Extension Period|Reason not Specified|270|||
105774888|NCT02477800|364825038|FG006|Long Term Extension Period|Reason not Specified|224|||
105774889|NCT00474539|364825041|FG000|Infant Series|Withdrawal by Subject|3|||
105774890|NCT00474539|364825042|FG001|Infant Series|Withdrawal by Subject|4|||
105774891|NCT00474539|364825041|FG000|Infant Series|Randomization error|5|||
105774892|NCT00474539|364825042|FG001|Infant Series|Randomization error|0|||
105774893|NCT00474539|364825041|FG000|Infant Series|Lost to Follow-up|2|||
105774894|NCT00474539|364825042|FG001|Infant Series|Lost to Follow-up|1|||
105774895|NCT00474539|364825041|FG000|Infant Series|Protocol Violation|0|||
105774896|NCT00474539|364825042|FG001|Infant Series|Protocol Violation|1|||
105774897|NCT00474539|364825041|FG000|After Infant Series|Lost to Follow-up|3|||
105774898|NCT00474539|364825042|FG001|After Infant Series|Lost to Follow-up|0|||
105774899|NCT00474539|364825041|FG000|After Infant Series|Withdrawal by Subject|1|||
105774900|NCT00474539|364825042|FG001|After Infant Series|Withdrawal by Subject|0|||
105774901|NCT00474539|364825041|FG000|Toddler Dose|Protocol Violation|1|||
105774902|NCT00474539|364825042|FG001|Toddler Dose|Protocol Violation|0|||
105774903|NCT01117428|364825043|FG000|Overall Study|Lack of Efficacy|1|||
105774904|NCT01117428|364825044|FG001|Overall Study|Lack of Efficacy|0|||
105774905|NCT01117428|364825045|FG002|Overall Study|Lack of Efficacy|0|||
105774906|NCT01117428|364825046|FG003|Overall Study|Lack of Efficacy|0|||
105774907|NCT01117428|364825047|FG004|Overall Study|Lack of Efficacy|0|||
105774908|NCT01117428|364825048|FG005|Overall Study|Lack of Efficacy|0|||
105774909|NCT01117428|364825043|FG000|Overall Study|Adverse Event|4|||
105774910|NCT01117428|364825044|FG001|Overall Study|Adverse Event|0|||
105774911|NCT01117428|364825045|FG002|Overall Study|Adverse Event|0|||
105774912|NCT01117428|364825046|FG003|Overall Study|Adverse Event|0|||
105774913|NCT01117428|364825047|FG004|Overall Study|Adverse Event|1|||
105774914|NCT01117428|364825048|FG005|Overall Study|Adverse Event|2|||
105774915|NCT01117428|364825043|FG000|Overall Study|Death|0|||
105774916|NCT01117428|364825044|FG001|Overall Study|Death|1|||
105774917|NCT01117428|364825045|FG002|Overall Study|Death|2|||
105774918|NCT01117428|364825046|FG003|Overall Study|Death|0|||
105774919|NCT01117428|364825047|FG004|Overall Study|Death|0|||
105774920|NCT01117428|364825048|FG005|Overall Study|Death|1|||
105774921|NCT01117428|364825043|FG000|Overall Study|Physician Decision|0|||
105774922|NCT01117428|364825044|FG001|Overall Study|Physician Decision|1|||
105774923|NCT01117428|364825045|FG002|Overall Study|Physician Decision|0|||
105774924|NCT01117428|364825046|FG003|Overall Study|Physician Decision|0|||
105774925|NCT01117428|364825047|FG004|Overall Study|Physician Decision|0|||
105774926|NCT01117428|364825048|FG005|Overall Study|Physician Decision|0|||
105774927|NCT01117428|364825043|FG000|Overall Study|Withdrawal by Subject|0|||
105774928|NCT01117428|364825044|FG001|Overall Study|Withdrawal by Subject|0|||
105774929|NCT01117428|364825045|FG002|Overall Study|Withdrawal by Subject|1|||
105774930|NCT01117428|364825046|FG003|Overall Study|Withdrawal by Subject|0|||
105774931|NCT01117428|364825047|FG004|Overall Study|Withdrawal by Subject|0|||
105774932|NCT01117428|364825048|FG005|Overall Study|Withdrawal by Subject|0|||
105774933|NCT01117428|364825043|FG000|Overall Study|Progressive disease|15|||
105774934|NCT01117428|364825044|FG001|Overall Study|Progressive disease|27|||
105774935|NCT01117428|364825045|FG002|Overall Study|Progressive disease|10|||
105774936|NCT01117428|364825046|FG003|Overall Study|Progressive disease|12|||
105774937|NCT01117428|364825047|FG004|Overall Study|Progressive disease|16|||
105774938|NCT01117428|364825048|FG005|Overall Study|Progressive disease|17|||
105774939|NCT02289833|364825051|FG000|Overall Study|Study discontinuation|0|||
105774940|NCT02289833|364825052|FG001|Overall Study|Study discontinuation|1|||
105774941|NCT02289833|364825051|FG000|Overall Study|Lost to Follow-up|4|||
105774942|NCT02289833|364825052|FG001|Overall Study|Lost to Follow-up|0|||
105774943|NCT02289833|364825051|FG000|Overall Study|Death|23|||
105774944|NCT02289833|364825052|FG001|Overall Study|Death|16|||
105774945|NCT02449915|364825053|FG000|Overall Study|Exclusion criteria - drug use|1|||
105774946|NCT02449915|364825054|FG001|Overall Study|Exclusion criteria - drug use|0|||
105774947|NCT02449915|364825053|FG000|Overall Study|Withdrawal by Subject|0|||
105774948|NCT02449915|364825054|FG001|Overall Study|Withdrawal by Subject|2|||
105774949|NCT02449915|364825053|FG000|Overall Study|Intraoperative surgical findings|1|||
105774950|NCT02449915|364825054|FG001|Overall Study|Intraoperative surgical findings|1|||
105774951|NCT02449915|364825053|FG000|Overall Study|Abnormal preop lab|0|||
105774952|NCT02449915|364825054|FG001|Overall Study|Abnormal preop lab|1|||
105774953|NCT02561273|364825055|FG000|Overall Study|Protocol Violation|1|||
105774954|NCT02561273|364825056|FG001|Overall Study|Protocol Violation|0|||
105774955|NCT01603628|364825059|FG000|Overall Study|Personal Reasons|1|||
105774956|NCT01603628|364825060|FG001|Overall Study|Personal Reasons|1|||
105774957|NCT01603628|364825061|FG002|Overall Study|Personal Reasons|2|||
105774958|NCT01603628|364825059|FG000|Overall Study|Protocol Violation|1|||
105774959|NCT01603628|364825060|FG001|Overall Study|Protocol Violation|1|||
105774960|NCT01603628|364825061|FG002|Overall Study|Protocol Violation|0|||
105774961|NCT01603628|364825059|FG000|Overall Study|Lost to Follow-up|0|||
105774962|NCT01603628|364825060|FG001|Overall Study|Lost to Follow-up|1|||
105774963|NCT01603628|364825061|FG002|Overall Study|Lost to Follow-up|0|||
105774964|NCT01603628|364825059|FG000|Overall Study|Other Miscellaneous Reason|1|||
105774965|NCT01603628|364825060|FG001|Overall Study|Other Miscellaneous Reason|0|||
105774966|NCT01603628|364825061|FG002|Overall Study|Other Miscellaneous Reason|0|||
105774967|NCT00403390|364825066|FG000|Overall Study|Withdrawal by Subject|1|||
105774968|NCT00403390|364825067|FG001|Overall Study|Withdrawal by Subject|0|||
105774969|NCT00403390|364825066|FG000|Overall Study|samples lost|1|||
105774970|NCT00403390|364825067|FG001|Overall Study|samples lost|0|||
105774971|NCT00403390|364825066|FG000|Overall Study|non-compliant|1|||
105774972|NCT00403390|364825067|FG001|Overall Study|non-compliant|0|||
105774973|NCT00935701|364825068|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
105774974|NCT02087241|364825069|FG000|Overall Study|Death|2|||
105774975|NCT02087241|364825070|FG001|Overall Study|Death|1|||
105774976|NCT02087241|364825071|FG002|Overall Study|Death|1|||
105774977|NCT02087241|364825072|FG003|Overall Study|Death|1|||
105774978|NCT02087241|364825069|FG000|Overall Study|Withdrawal by Subject|1|||
105774979|NCT02087241|364825070|FG001|Overall Study|Withdrawal by Subject|0|||
105774980|NCT02087241|364825071|FG002|Overall Study|Withdrawal by Subject|0|||
105774981|NCT02087241|364825072|FG003|Overall Study|Withdrawal by Subject|1|||
105774982|NCT02087241|364825069|FG000|Overall Study|Progressive Disease|0|||
105774983|NCT02087241|364825070|FG001|Overall Study|Progressive Disease|0|||
105774984|NCT02087241|364825071|FG002|Overall Study|Progressive Disease|0|||
105774985|NCT02087241|364825072|FG003|Overall Study|Progressive Disease|1|||
105774986|NCT02087241|364825069|FG000|Overall Study|Study Terminated by Sponsor|0|||
105774987|NCT02087241|364825070|FG001|Overall Study|Study Terminated by Sponsor|2|||
105774988|NCT02087241|364825071|FG002|Overall Study|Study Terminated by Sponsor|0|||
105774989|NCT02087241|364825072|FG003|Overall Study|Study Terminated by Sponsor|4|||
105806446|NCT01464827|364948985|FG004|Overall Study|Other|3|||
105806447|NCT01464827|364948986|FG005|Overall Study|Other|0|||
105806448|NCT01464827|364948987|FG006|Overall Study|Other|1|||
105806449|NCT01464827|364948988|FG007|Overall Study|Other|0|||
105806450|NCT01464827|364948989|FG008|Overall Study|Other|3|||
105806451|NCT01464827|364948990|FG009|Overall Study|Other|1|||
105806452|NCT01464827|364948991|FG010|Overall Study|Other|2|||
105806453|NCT01464827|364948992|FG011|Overall Study|Other|0|||
105806454|NCT01464827|364948993|FG012|Overall Study|Other|1|||
105806455|NCT01464827|364948994|FG013|Overall Study|Other|0|||
105806456|NCT01464827|364948981|FG000|Overall Study|Not Treated|0|||
105806457|NCT01464827|364948982|FG001|Overall Study|Not Treated|2|||
105806458|NCT01464827|364948983|FG002|Overall Study|Not Treated|0|||
105806459|NCT01464827|364948984|FG003|Overall Study|Not Treated|0|||
105806460|NCT01464827|364948985|FG004|Overall Study|Not Treated|1|||
105806461|NCT01464827|364948986|FG005|Overall Study|Not Treated|0|||
105806462|NCT01464827|364948987|FG006|Overall Study|Not Treated|1|||
105806463|NCT01464827|364948988|FG007|Overall Study|Not Treated|0|||
105806464|NCT01464827|364948989|FG008|Overall Study|Not Treated|0|||
105806465|NCT01464827|364948990|FG009|Overall Study|Not Treated|2|||
105806466|NCT01464827|364948991|FG010|Overall Study|Not Treated|0|||
105806467|NCT01464827|364948992|FG011|Overall Study|Not Treated|1|||
105806468|NCT01464827|364948993|FG012|Overall Study|Not Treated|0|||
105806469|NCT01464827|364948994|FG013|Overall Study|Not Treated|2|||
105806470|NCT00294723|364948997|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
105806471|NCT00294723|364948998|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
105806472|NCT00294723|364948999|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
105806473|NCT00294723|364948997|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
105806474|NCT00294723|364948998|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
105806475|NCT00294723|364948999|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
105806476|NCT00294723|364948997|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
105806477|NCT00294723|364948998|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
105806478|NCT00294723|364948999|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
105806479|NCT00294723|364948997|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
105806480|NCT00294723|364948998|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
105806481|NCT00294723|364948999|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
105806482|NCT00294723|364948997|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
105806483|NCT00294723|364948998|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
105806484|NCT00294723|364948999|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
105806485|NCT00294723|364948997|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
105806486|NCT00294723|364948998|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
105806487|NCT00294723|364948999|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
105806488|NCT00294723|364948997|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
105806489|NCT00294723|364948998|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
105806490|NCT00294723|364948999|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
105806491|NCT00294723|364948997|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
105806492|NCT00294723|364948998|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
105806493|NCT00294723|364948999|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
105806494|NCT00294723|364948997|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
105806495|NCT00294723|364948998|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
105806496|NCT00294723|364948999|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
105806497|NCT00294723|364948997|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
105806498|NCT00294723|364948998|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
105806499|NCT00294723|364948999|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
105806500|NCT00294723|364948997|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
105806501|NCT00294723|364948998|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
105806502|NCT00294723|364948999|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
105806503|NCT00294723|364948997|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
105806504|NCT00294723|364948998|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
105806505|NCT00294723|364948999|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
105806506|NCT03038113|364949000|FG000|Overall Study|Withdrawal by Subject|0|||
105806507|NCT03038113|364949001|FG001|Overall Study|Withdrawal by Subject|0|||
105806508|NCT03038113|364949002|FG002|Overall Study|Withdrawal by Subject|1|||
105774990|NCT00211536|364826730|FG000|Overall Study|Withdrawal by Subject|2|||
105774991|NCT00211536|364826731|FG001|Overall Study|Withdrawal by Subject|2|||
105774992|NCT00211536|364826730|FG000|Overall Study|Physician Decision|0|||
105774993|NCT00211536|364826731|FG001|Overall Study|Physician Decision|5|||
105774994|NCT00211536|364826730|FG000|Overall Study|Adverse Event|2|||
105774995|NCT00211536|364826731|FG001|Overall Study|Adverse Event|0|||
105774996|NCT00305773|364826734|FG000|Overall Study|Death|3|||
105774997|NCT00305773|364826735|FG001|Overall Study|Death|2|||
105774998|NCT00305773|364826734|FG000|Overall Study|Adverse Event|1|||
105774999|NCT00305773|364826735|FG001|Overall Study|Adverse Event|2|||
105775000|NCT00305773|364826734|FG000|Overall Study|Alternative Treatment|4|||
105775001|NCT00305773|364826735|FG001|Overall Study|Alternative Treatment|4|||
105775002|NCT00305773|364826734|FG000|Overall Study|Physician Decision|1|||
105775003|NCT00305773|364826735|FG001|Overall Study|Physician Decision|1|||
105775004|NCT00305773|364826734|FG000|Overall Study|Withdrawal by Subject|1|||
105775005|NCT00305773|364826735|FG001|Overall Study|Withdrawal by Subject|4|||
105775006|NCT00305773|364826734|FG000|Overall Study|Disease Progression|1|||
105775007|NCT00305773|364826735|FG001|Overall Study|Disease Progression|3|||
105775008|NCT00305773|364826734|FG000|Overall Study|All other reasons|3|||
105775009|NCT00305773|364826735|FG001|Overall Study|All other reasons|2|||
105775010|NCT02059174|364826737|FG000|Period 1|Withdrawal by Subject|0|||
105775011|NCT02059174|364826738|FG001|Period 1|Withdrawal by Subject|2|||
105775012|NCT02059174|364826737|FG000|Period 2|Withdrawal by Subject|0|||
105775013|NCT02059174|364826738|FG001|Period 2|Withdrawal by Subject|2|||
105775014|NCT02059174|364826737|FG000|Period 2|Protocol Violation|1|||
105775015|NCT02059174|364826738|FG001|Period 2|Protocol Violation|0|||
105775016|NCT02059174|364826737|FG000|Period 3|Physician Decision|1|||
105775017|NCT02059174|364826738|FG001|Period 3|Physician Decision|0|||
105775018|NCT02608099|364826739|FG000|Overall Study|Ablation procedure not initiated|3|||
105775019|NCT02608099|364826740|FG001|Overall Study|Ablation procedure not initiated|2|||
105775020|NCT00087594|364826741|FG000|Overall Study|Adverse Event|2|||
105775021|NCT00087594|364826742|FG001|Overall Study|Adverse Event|3|||
105775022|NCT00087594|364826741|FG000|Overall Study|Lost to Follow-up|0|||
105775023|NCT00087594|364826742|FG001|Overall Study|Lost to Follow-up|2|||
105775024|NCT00087594|364826741|FG000|Overall Study|Withdrawal by Subject|4|||
105775025|NCT00087594|364826742|FG001|Overall Study|Withdrawal by Subject|2|||
105775026|NCT00087594|364826741|FG000|Overall Study|Lack of Efficacy|2|||
105775027|NCT00087594|364826742|FG001|Overall Study|Lack of Efficacy|5|||
105775028|NCT00768040|364826748|FG000|Overall Study|Adverse Event|3|||
105775029|NCT00768040|364826749|FG001|Overall Study|Adverse Event|2|||
105775030|NCT00768040|364826748|FG000|Overall Study|Abnormal laboratory value|1|||
105775031|NCT00768040|364826749|FG001|Overall Study|Abnormal laboratory value|1|||
105775032|NCT01823991|364826750|FG000|Overall Study|Withdrawal by Subject|8|||
105775033|NCT01823991|364826751|FG001|Overall Study|Withdrawal by Subject|5|||
105775034|NCT00417248|364826754|FG000|Overall Study|Study Terminated|6|||
105775035|NCT00417248|364826754|FG000|Overall Study|Death|1|||
105775036|NCT00417248|364826754|FG000|Overall Study|Lack of Efficacy|1|||
105775037|NCT01370499|364826755|FG000|Overall Study|Adverse Event|38|||
105775038|NCT01370499|364826756|FG001|Overall Study|Adverse Event|12|||
105775039|NCT01370499|364826755|FG000|Overall Study|Lack of Efficacy|4|||
105775040|NCT01370499|364826756|FG001|Overall Study|Lack of Efficacy|2|||
105775041|NCT01370499|364826755|FG000|Overall Study|Lost to Follow-up|2|||
105775042|NCT01370499|364826756|FG001|Overall Study|Lost to Follow-up|1|||
105775043|NCT01370499|364826755|FG000|Overall Study|Physician Decision|3|||
105775044|NCT01370499|364826756|FG001|Overall Study|Physician Decision|3|||
105775045|NCT01370499|364826755|FG000|Overall Study|Protocol Violation|5|||
105775046|NCT01370499|364826756|FG001|Overall Study|Protocol Violation|4|||
105775047|NCT01370499|364826755|FG000|Overall Study|Withdrawal by Subject|18|||
105775048|NCT01370499|364826756|FG001|Overall Study|Withdrawal by Subject|7|||
105775049|NCT01370499|364826755|FG000|Overall Study|Sponsor Decision|41|||
105775050|NCT01370499|364826756|FG001|Overall Study|Sponsor Decision|15|||
105775051|NCT02185040|364826757|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
105775052|NCT02185040|364826758|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
105775053|NCT02185040|364826759|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
105775054|NCT02185040|364826760|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
105775055|NCT02185040|364826761|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
105775056|NCT02185040|364826762|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
105775057|NCT02185040|364826763|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
105775058|NCT02185040|364826757|FG000|Part 1 Treatment Phase|Adverse Event|1|||
105775059|NCT02185040|364826758|FG001|Part 1 Treatment Phase|Adverse Event|0|||
105775060|NCT02185040|364826759|FG002|Part 1 Treatment Phase|Adverse Event|0|||
105775061|NCT02185040|364826760|FG003|Part 1 Treatment Phase|Adverse Event|2|||
105775062|NCT02185040|364826761|FG004|Part 1 Treatment Phase|Adverse Event|3|||
105661687|NCT02165826|364425104|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
105775063|NCT02185040|364826762|FG005|Part 1 Treatment Phase|Adverse Event|0|||
105775064|NCT02185040|364826763|FG006|Part 1 Treatment Phase|Adverse Event|0|||
105775065|NCT02185040|364826757|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775066|NCT02185040|364826758|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
105775067|NCT02185040|364826759|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775068|NCT02185040|364826760|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775069|NCT02185040|364826761|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775070|NCT02185040|364826762|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775071|NCT02185040|364826763|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
105775072|NCT02185040|364826757|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775073|NCT02185040|364826758|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
105775074|NCT02185040|364826759|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775075|NCT02185040|364826760|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775076|NCT02185040|364826761|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775077|NCT02185040|364826762|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775078|NCT02185040|364826763|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
105775079|NCT02185040|364826757|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
105775080|NCT02185040|364826758|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
105775081|NCT02185040|364826759|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
105775082|NCT02185040|364826760|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
105775083|NCT02185040|364826761|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
105775084|NCT02185040|364826762|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
105775085|NCT02185040|364826763|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
105775086|NCT02185040|364826757|FG000|Active Treatment Extension Phase|Adverse Event|0|||
105775087|NCT02185040|364826758|FG001|Active Treatment Extension Phase|Adverse Event|0|||
105661688|NCT02165826|364425105|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
105661689|NCT02165826|364425103|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
105661690|NCT02165826|364425104|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
105661691|NCT02165826|364425105|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
105661692|NCT02165826|364425103|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
105661693|NCT02165826|364425104|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
105661694|NCT02165826|364425105|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
105661695|NCT02165826|364425103|FG000|Down-Titration Period|Reason Not Specified|1|||
105661696|NCT02165826|364425104|FG001|Down-Titration Period|Reason Not Specified|0|||
105661697|NCT02165826|364425105|FG002|Down-Titration Period|Reason Not Specified|2|||
105661698|NCT02392104|364425106|FG000|Overall Study|discontinuation of warfarin|3|||
105661699|NCT02392104|364425106|FG000|Overall Study|bleeding event|1|||
105661700|NCT02392104|364425106|FG000|Overall Study|transferred care to another doctor|2|||
105661701|NCT02392104|364425106|FG000|Overall Study|INR goal range changed|1|||
105661702|NCT02392104|364425106|FG000|Overall Study|admitted to skilled nursing facility|3|||
105661703|NCT02392104|364425106|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
105661704|NCT02581059|364425107|FG000|Study Treatment|Disease Progression|1|||
105661705|NCT02581059|364425108|FG001|Study Treatment|Disease Progression|1|||
105661706|NCT02581059|364425107|FG000|Study Treatment|Adverse Event|2|||
105661707|NCT02581059|364425108|FG001|Study Treatment|Adverse Event|1|||
105661708|NCT02581059|364425107|FG000|Study Treatment|Death|1|||
105661709|NCT02581059|364425108|FG001|Study Treatment|Death|1|||
105661710|NCT02581059|364425107|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
105661711|NCT02581059|364425108|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
105661712|NCT02581059|364425107|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
105661713|NCT02581059|364425108|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
105661714|NCT02581059|364425107|FG000|Follow up|Death|1|||
105661715|NCT02581059|364425108|FG001|Follow up|Death|3|||
105661716|NCT02581059|364425107|FG000|Follow up|study terminated|1|||
105661717|NCT02581059|364425108|FG001|Follow up|study terminated|1|||
105661718|NCT02581059|364425107|FG000|Follow up|screen failure|0|||
105661719|NCT02581059|364425108|FG001|Follow up|screen failure|1|||
105661720|NCT02581059|364425107|FG000|Follow up|Patient started new clinical trial|1|||
105661721|NCT02581059|364425108|FG001|Follow up|Patient started new clinical trial|0|||
105661722|NCT04547023|364425109|FG000|Overall Study|Did Not Receive Intervention|3|||
105661723|NCT04547023|364425110|FG001|Overall Study|Did Not Receive Intervention|2|||
105661724|NCT04547023|364425109|FG000|Overall Study|Lost to Follow-up|1|||
105661725|NCT04547023|364425110|FG001|Overall Study|Lost to Follow-up|1|||
105661726|NCT02394665|364425111|FG000|Overall Study|Physician Decision|1|||
105661727|NCT02394665|364425112|FG001|Overall Study|Physician Decision|0|||
105661728|NCT02394665|364425113|FG002|Overall Study|Physician Decision|0|||
105661729|NCT04147858|364425116|FG000|Overall Study|Adverse Event|6|||
105661730|NCT04147858|364425117|FG001|Overall Study|Adverse Event|6|||
105661731|NCT04147858|364425118|FG002|Overall Study|Adverse Event|6|||
105661732|NCT04147858|364425116|FG000|Overall Study|Lack of Efficacy|3|||
105661733|NCT04147858|364425117|FG001|Overall Study|Lack of Efficacy|3|||
105661734|NCT04147858|364425118|FG002|Overall Study|Lack of Efficacy|1|||
105661735|NCT04147858|364425116|FG000|Overall Study|Lost to Follow-up|1|||
105661736|NCT04147858|364425117|FG001|Overall Study|Lost to Follow-up|6|||
105661737|NCT04147858|364425118|FG002|Overall Study|Lost to Follow-up|2|||
105661738|NCT04147858|364425116|FG000|Overall Study|Withdrawal by Subject|3|||
105661739|NCT04147858|364425117|FG001|Overall Study|Withdrawal by Subject|4|||
105775088|NCT02185040|364826759|FG002|Active Treatment Extension Phase|Adverse Event|0|||
105775089|NCT02185040|364826760|FG003|Active Treatment Extension Phase|Adverse Event|0|||
105775090|NCT02185040|364826761|FG004|Active Treatment Extension Phase|Adverse Event|0|||
105775091|NCT02185040|364826762|FG005|Active Treatment Extension Phase|Adverse Event|1|||
105775092|NCT02185040|364826763|FG006|Active Treatment Extension Phase|Adverse Event|4|||
105775093|NCT02185040|364826757|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775094|NCT02185040|364826758|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775095|NCT02185040|364826759|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775096|NCT02185040|364826760|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775097|NCT02185040|364826761|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
105775098|NCT02185040|364826762|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
105775099|NCT02185040|364826763|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
105775100|NCT02185040|364826757|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775101|NCT02185040|364826758|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775102|NCT02185040|364826759|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775103|NCT02185040|364826760|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775104|NCT02185040|364826761|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775105|NCT02185040|364826762|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
105775106|NCT02185040|364826763|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
105775107|NCT00887822|364826764|FG000|Overall Study|Insufficient therapeutic response|53|||
105775108|NCT00887822|364826765|FG001|Overall Study|Insufficient therapeutic response|55|||
105775109|NCT00887822|364826764|FG000|Overall Study|Adverse Event|14|||
105775110|NCT00887822|364826765|FG001|Overall Study|Adverse Event|17|||
105775111|NCT00887822|364826764|FG000|Overall Study|Failure to return|11|||
105775112|NCT00887822|364826765|FG001|Overall Study|Failure to return|11|||
105775113|NCT00887822|364826764|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
105775114|NCT00887822|364826765|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
105775115|NCT00887822|364826764|FG000|Overall Study|Administrative/Other than specified|5|||
105775116|NCT00887822|364826765|FG001|Overall Study|Administrative/Other than specified|4|||
105775117|NCT00887822|364826764|FG000|Overall Study|Death|2|||
105775118|NCT00887822|364826765|FG001|Overall Study|Death|3|||
105775119|NCT00887822|364826764|FG000|Overall Study|Protocol Violation|0|||
105775120|NCT00887822|364826765|FG001|Overall Study|Protocol Violation|1|||
105775121|NCT00887822|364826764|FG000|Overall Study|Randomized but not treated|0|||
105775122|NCT00887822|364826765|FG001|Overall Study|Randomized but not treated|1|||
105775123|NCT00141297|364826767|FG000|Overall Study|Adverse Event|0|||
105775124|NCT00141297|364826768|FG001|Overall Study|Adverse Event|0|||
105775125|NCT00141297|364826769|FG002|Overall Study|Adverse Event|1|||
105775126|NCT00141297|364826770|FG003|Overall Study|Adverse Event|0|||
105775127|NCT00141297|364826771|FG004|Overall Study|Adverse Event|1|||
105775128|NCT00141297|364826772|FG005|Overall Study|Adverse Event|1|||
105775129|NCT00141297|364826773|FG006|Overall Study|Adverse Event|0|||
105775130|NCT00141297|364826774|FG007|Overall Study|Adverse Event|1|||
105775131|NCT00141297|364826775|FG008|Overall Study|Adverse Event|1|||
105775132|NCT00141297|364826776|FG009|Overall Study|Adverse Event|0|||
105775133|NCT00141297|364826767|FG000|Overall Study|Death|1|||
105775134|NCT00141297|364826768|FG001|Overall Study|Death|0|||
105775135|NCT00141297|364826769|FG002|Overall Study|Death|0|||
105775136|NCT00141297|364826770|FG003|Overall Study|Death|0|||
105775137|NCT00141297|364826771|FG004|Overall Study|Death|0|||
105775138|NCT00141297|364826772|FG005|Overall Study|Death|0|||
105775139|NCT00141297|364826773|FG006|Overall Study|Death|0|||
105775140|NCT00141297|364826774|FG007|Overall Study|Death|0|||
105775141|NCT00141297|364826775|FG008|Overall Study|Death|1|||
105775142|NCT00141297|364826776|FG009|Overall Study|Death|0|||
105775143|NCT00141297|364826767|FG000|Overall Study|Withdrawal by Subject|0|||
105775144|NCT00141297|364826768|FG001|Overall Study|Withdrawal by Subject|0|||
105775145|NCT00141297|364826769|FG002|Overall Study|Withdrawal by Subject|0|||
105775146|NCT00141297|364826770|FG003|Overall Study|Withdrawal by Subject|0|||
105775147|NCT00141297|364826771|FG004|Overall Study|Withdrawal by Subject|0|||
105775148|NCT00141297|364826772|FG005|Overall Study|Withdrawal by Subject|0|||
105775149|NCT00141297|364826773|FG006|Overall Study|Withdrawal by Subject|0|||
105775150|NCT00141297|364826774|FG007|Overall Study|Withdrawal by Subject|0|||
105775151|NCT00141297|364826775|FG008|Overall Study|Withdrawal by Subject|1|||
105775152|NCT00141297|364826776|FG009|Overall Study|Withdrawal by Subject|0|||
105775153|NCT00141297|364826767|FG000|Overall Study|Other|0|||
105775154|NCT00141297|364826768|FG001|Overall Study|Other|0|||
105775155|NCT00141297|364826769|FG002|Overall Study|Other|0|||
105775156|NCT00141297|364826770|FG003|Overall Study|Other|1|||
105775157|NCT00141297|364826771|FG004|Overall Study|Other|5|||
105775158|NCT00141297|364826772|FG005|Overall Study|Other|0|||
105775159|NCT00141297|364826773|FG006|Overall Study|Other|0|||
105775160|NCT00141297|364826774|FG007|Overall Study|Other|0|||
105775161|NCT00141297|364826775|FG008|Overall Study|Other|2|||
105775162|NCT00141297|364826776|FG009|Overall Study|Other|0|||
105775163|NCT00141297|364826767|FG000|Overall Study|Progressive Disease|2|||
105775164|NCT00141297|364826768|FG001|Overall Study|Progressive Disease|3|||
105775165|NCT00141297|364826769|FG002|Overall Study|Progressive Disease|6|||
105775166|NCT00141297|364826770|FG003|Overall Study|Progressive Disease|2|||
105775167|NCT00141297|364826771|FG004|Overall Study|Progressive Disease|15|||
105775168|NCT00141297|364826772|FG005|Overall Study|Progressive Disease|2|||
105775169|NCT00141297|364826773|FG006|Overall Study|Progressive Disease|3|||
105775170|NCT00141297|364826774|FG007|Overall Study|Progressive Disease|3|||
105775171|NCT00141297|364826775|FG008|Overall Study|Progressive Disease|15|||
105775172|NCT00141297|364826776|FG009|Overall Study|Progressive Disease|6|||
105775173|NCT00141297|364826767|FG000|Overall Study|Transitioned|0|||
105775174|NCT00141297|364826768|FG001|Overall Study|Transitioned|0|||
105775175|NCT00141297|364826769|FG002|Overall Study|Transitioned|0|||
105775176|NCT00141297|364826770|FG003|Overall Study|Transitioned|0|||
105775177|NCT00141297|364826771|FG004|Overall Study|Transitioned|1|||
105775178|NCT00141297|364826772|FG005|Overall Study|Transitioned|0|||
105775179|NCT00141297|364826773|FG006|Overall Study|Transitioned|0|||
105775180|NCT00141297|364826774|FG007|Overall Study|Transitioned|0|||
105775181|NCT00141297|364826775|FG008|Overall Study|Transitioned|0|||
105775182|NCT00141297|364826776|FG009|Overall Study|Transitioned|0|||
105775183|NCT00166504|364826777|FG000|Overall Study|Adverse Event|3|||
105775184|NCT00166504|364826778|FG001|Overall Study|Adverse Event|3|||
105775185|NCT00166504|364826777|FG000|Overall Study|Lost to Follow-up|1|||
105775186|NCT00166504|364826778|FG001|Overall Study|Lost to Follow-up|1|||
105775187|NCT00166504|364826777|FG000|Overall Study|Withdrawal by Subject|1|||
105775188|NCT00166504|364826778|FG001|Overall Study|Withdrawal by Subject|0|||
105775189|NCT03558503|364826779|FG000|Overall Study|Adverse Event|1|||
105775190|NCT03558503|364826779|FG000|Overall Study|Death|1|||
105775191|NCT03558503|364826779|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
105775192|NCT02200510|364826780|FG000|Overall Study|Death|1|||
105775193|NCT02200510|364826781|FG001|Overall Study|Death|1|||
105775194|NCT02200510|364826780|FG000|Overall Study|Protocol Violation|0|||
105775195|NCT02200510|364826781|FG001|Overall Study|Protocol Violation|1|||
105775196|NCT02200510|364826780|FG000|Overall Study|Lost to Follow-up|7|||
105775197|NCT02200510|364826781|FG001|Overall Study|Lost to Follow-up|1|||
105775198|NCT02200510|364826780|FG000|Overall Study|potential COI - joined study team|1|||
105775199|NCT02200510|364826781|FG001|Overall Study|potential COI - joined study team|0|||
105775200|NCT03288987|364826782|FG000|Overall Study|Protocol Violation|10|||
105775201|NCT03288987|364826783|FG001|Overall Study|Protocol Violation|4|||
105775202|NCT02807376|364826784|FG000|Overall Study|Intra-operative exclusion criteria|3|||
105775203|NCT02807376|364826785|FG001|Overall Study|Intra-operative exclusion criteria|0|||
105775204|NCT02807376|364826784|FG000|Overall Study|Lost to Follow-up|0|||
105775205|NCT02807376|364826785|FG001|Overall Study|Lost to Follow-up|1|||
105775206|NCT01542632|364826786|FG000|Overall Study|Withdrawal of Consent|0|||
105775207|NCT01542632|364826787|FG001|Overall Study|Withdrawal of Consent|0|||
105775208|NCT01542632|364826788|FG002|Overall Study|Withdrawal of Consent|0|||
105775209|NCT01542632|364826789|FG003|Overall Study|Withdrawal of Consent|2|||
105775210|NCT01542632|364826790|FG004|Overall Study|Withdrawal of Consent|3|||
105775211|NCT01542632|364826791|FG005|Overall Study|Withdrawal of Consent|0|||
105775212|NCT01542632|364826786|FG000|Overall Study|Adverse Event|0|||
105775213|NCT01542632|364826787|FG001|Overall Study|Adverse Event|0|||
105775214|NCT01542632|364826788|FG002|Overall Study|Adverse Event|1|||
105775215|NCT01542632|364826789|FG003|Overall Study|Adverse Event|0|||
105775216|NCT01542632|364826790|FG004|Overall Study|Adverse Event|0|||
105775217|NCT01542632|364826791|FG005|Overall Study|Adverse Event|0|||
105775218|NCT01542632|364826786|FG000|Overall Study|Lost to Follow-up|0|||
105775219|NCT01542632|364826787|FG001|Overall Study|Lost to Follow-up|1|||
105775220|NCT01542632|364826788|FG002|Overall Study|Lost to Follow-up|0|||
105775221|NCT01542632|364826789|FG003|Overall Study|Lost to Follow-up|0|||
105775222|NCT01542632|364826790|FG004|Overall Study|Lost to Follow-up|0|||
105775223|NCT01542632|364826791|FG005|Overall Study|Lost to Follow-up|0|||
105775224|NCT01542632|364826786|FG000|Overall Study|Sponsor/Investigator Decision|0|||
105775225|NCT01542632|364826787|FG001|Overall Study|Sponsor/Investigator Decision|0|||
105775226|NCT01542632|364826788|FG002|Overall Study|Sponsor/Investigator Decision|0|||
105775227|NCT01542632|364826789|FG003|Overall Study|Sponsor/Investigator Decision|0|||
105775228|NCT01542632|364826790|FG004|Overall Study|Sponsor/Investigator Decision|1|||
105775229|NCT01542632|364826791|FG005|Overall Study|Sponsor/Investigator Decision|0|||
105775230|NCT01944462|364826799|FG000|PPPP Educational Program|Lost to Follow-up|60|||
105775231|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
105775232|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
105775233|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
105775234|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
105775235|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Other|1|||
105775236|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Other|0|||
105775237|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Other|2|||
105775238|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Other|4|||
105775239|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
105775240|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
105775241|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
105775242|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
105775243|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Adverse Event|0|||
105775244|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Adverse Event|0|||
105775245|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Adverse Event|1|||
105775246|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Adverse Event|2|||
105775247|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
105775248|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
105775249|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
105775250|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
105775251|NCT00808028|364826800|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
105775252|NCT00808028|364826801|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
105775253|NCT00808028|364826802|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
105775254|NCT00808028|364826803|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
105775255|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
105775256|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
105775257|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
105775258|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
105775259|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
105775260|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
105775261|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
105775262|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
105775263|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
105775264|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
105775265|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
105775266|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
105775267|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
105775268|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
105775269|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
105775270|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
105775271|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
105775272|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
105775273|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
105775274|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
105775275|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
105775276|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
105775277|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
105775278|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
105775279|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
105775280|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
105775281|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
105775282|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
105775283|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
105775284|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
105775285|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
105775286|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
105775287|NCT00808028|364826800|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
105775288|NCT00808028|364826801|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
105775289|NCT00808028|364826802|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
105775290|NCT00808028|364826803|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
105775291|NCT01222767|364826808|FG000|Overall Study|Progressive disease|13|||
105775292|NCT01222767|364826808|FG000|Overall Study|Adverse Event|2|||
105775293|NCT01222767|364826808|FG000|Overall Study|Surgical resection|1|||
105775294|NCT01222767|364826808|FG000|Overall Study|Never treated|1|||
105775295|NCT02274311|364826809|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
105775296|NCT00081263|364826810|FG000|Overall Study|clerical error|1|||
105775297|NCT00081263|364826811|FG001|Overall Study|clerical error|0|||
105775298|NCT00081263|364826810|FG000|Overall Study|wrong cell type|7|||
105775299|NCT00081263|364826811|FG001|Overall Study|wrong cell type|5|||
105775300|NCT00081263|364826810|FG000|Overall Study|improper pre-protocol therapy|0|||
105775301|NCT00081263|364826811|FG001|Overall Study|improper pre-protocol therapy|1|||
105775302|NCT00081263|364826810|FG000|Overall Study|Inadequate pathology|0|||
105775303|NCT00081263|364826811|FG001|Overall Study|Inadequate pathology|1|||
105775304|NCT00081263|364826810|FG000|Overall Study|Never treated|4|||
105775305|NCT00081263|364826811|FG001|Overall Study|Never treated|5|||
105775306|NCT00081263|364826810|FG000|Overall Study|Inadequate data|5|||
105775307|NCT00081263|364826811|FG001|Overall Study|Inadequate data|10|||
105775308|NCT00106626|364826812|FG000|Overall Study|Adverse Event|5|||
105775309|NCT00106626|364826813|FG001|Overall Study|Adverse Event|4|||
105775310|NCT00106626|364826814|FG002|Overall Study|Adverse Event|3|||
105775311|NCT00106626|364826815|FG003|Overall Study|Adverse Event|3|||
105775312|NCT00106626|364826812|FG000|Overall Study|Progressive Disease|4|||
105775313|NCT00106626|364826813|FG001|Overall Study|Progressive Disease|1|||
105775314|NCT00106626|364826814|FG002|Overall Study|Progressive Disease|9|||
105775315|NCT00106626|364826815|FG003|Overall Study|Progressive Disease|10|||
105775316|NCT00106626|364826812|FG000|Overall Study|Received radiation on new therapy|1|||
105775317|NCT00106626|364826813|FG001|Overall Study|Received radiation on new therapy|0|||
105775318|NCT00106626|364826814|FG002|Overall Study|Received radiation on new therapy|0|||
105775319|NCT00106626|364826815|FG003|Overall Study|Received radiation on new therapy|0|||
105775320|NCT00106626|364826812|FG000|Overall Study|> 14 day delay in therapy start|0|||
105775321|NCT00106626|364826813|FG001|Overall Study|> 14 day delay in therapy start|1|||
105775322|NCT00106626|364826814|FG002|Overall Study|> 14 day delay in therapy start|0|||
105775323|NCT00106626|364826815|FG003|Overall Study|> 14 day delay in therapy start|0|||
105775324|NCT00672139|364826816|FG000|Overall Study|Death|14|||
105775325|NCT00672139|364826817|FG001|Overall Study|Death|23|||
105775326|NCT00672139|364826816|FG000|Overall Study|Withdrawal by Subject|2|||
105775327|NCT00672139|364826817|FG001|Overall Study|Withdrawal by Subject|11|||
105775328|NCT00672139|364826816|FG000|Overall Study|Adverse Event|4|||
105775329|NCT00672139|364826817|FG001|Overall Study|Adverse Event|7|||
105775330|NCT00672139|364826816|FG000|Overall Study|Physician Decision|2|||
105775331|NCT00672139|364826817|FG001|Overall Study|Physician Decision|0|||
105775332|NCT00672139|364826816|FG000|Overall Study|Lack of Efficacy|4|||
105775333|NCT00672139|364826817|FG001|Overall Study|Lack of Efficacy|1|||
105775334|NCT00672139|364826816|FG000|Overall Study|Protocol Violation|1|||
105775335|NCT00672139|364826817|FG001|Overall Study|Protocol Violation|1|||
105775336|NCT00672139|364826816|FG000|Overall Study|hospice discharge, caregiver requests|3|||
105775337|NCT00672139|364826817|FG001|Overall Study|hospice discharge, caregiver requests|2|||
105775338|NCT02176226|364826821|FG000|Overall Study|Lost to Follow-up|3|||
105775339|NCT02176226|364826821|FG000|Overall Study|Withdrew prior to treatment|6|||
105775340|NCT03798366|364826824|FG000|Overall Study|Lost to Follow-up|0|||
105775341|NCT03798366|364826825|FG001|Overall Study|Lost to Follow-up|1|||
105775342|NCT02061540|364826827|FG000|Overall Study|Adverse Event|2|||
105775343|NCT02061540|364826827|FG000|Overall Study|Withdrawal by Subject|2|||
105775344|NCT01642004|364826836|FG000|Randomization|Adverse Event unrelated to study drug|1|||
105775345|NCT01642004|364826837|FG001|Randomization|Adverse Event unrelated to study drug|0|||
105775346|NCT01642004|364826836|FG000|Randomization|Participant withdrew consent|1|||
105775347|NCT01642004|364826837|FG001|Randomization|Participant withdrew consent|6|||
105775348|NCT01642004|364826836|FG000|Randomization|No longer meets study criteria|2|||
105775349|NCT01642004|364826837|FG001|Randomization|No longer meets study criteria|2|||
105775350|NCT01642004|364826836|FG000|Treatment|Disease progression|95|||
105775351|NCT01642004|364826837|FG001|Treatment|Disease progression|79|||
105775352|NCT01642004|364826836|FG000|Treatment|Study drug toxicity|10|||
105775353|NCT01642004|364826837|FG001|Treatment|Study drug toxicity|13|||
105775354|NCT01642004|364826836|FG000|Treatment|Death|1|||
105775355|NCT01642004|364826837|FG001|Treatment|Death|1|||
105775356|NCT01642004|364826836|FG000|Treatment|Adverse event unrelated to study drug|9|||
105775357|NCT01642004|364826837|FG001|Treatment|Adverse event unrelated to study drug|13|||
105775358|NCT01642004|364826836|FG000|Treatment|Maximum clinical benefit|1|||
105775359|NCT01642004|364826837|FG001|Treatment|Maximum clinical benefit|9|||
105775360|NCT01642004|364826836|FG000|Treatment|Poor/non-compliance|1|||
105775361|NCT01642004|364826837|FG001|Treatment|Poor/non-compliance|0|||
105775362|NCT01642004|364826836|FG000|Treatment|No longer meets study criteria|1|||
105775363|NCT01642004|364826837|FG001|Treatment|No longer meets study criteria|2|||
105775364|NCT01642004|364826836|FG000|Treatment|Other reasons|2|||
105775365|NCT01642004|364826837|FG001|Treatment|Other reasons|0|||
105775366|NCT01642004|364826836|FG000|Treatment|Not reported|0|||
105775367|NCT01642004|364826837|FG001|Treatment|Not reported|3|||
105775368|NCT01642004|364826836|FG000|Treatment|Participant request to discontinue study treatment|6|||
105775369|NCT01642004|364826837|FG001|Treatment|Participant request to discontinue study treatment|4|||
105775370|NCT01642004|364826836|FG000|Treatment|Participant withdrew consent|5|||
105775371|NCT01642004|364826837|FG001|Treatment|Participant withdrew consent|5|||
105775372|NCT00811395|364826838|FG000|Extension Treatment|Adverse Event|1|||
105775373|NCT00811395|364826839|FG001|Extension Treatment|Adverse Event|2|||
105775374|NCT00811395|364826840|FG002|Extension Treatment|Adverse Event|2|||
105775375|NCT00811395|364826841|FG003|Extension Treatment|Adverse Event|2|||
105775376|NCT00811395|364826842|FG004|Extension Treatment|Adverse Event|0|||
105775377|NCT00811395|364826843|FG005|Extension Treatment|Adverse Event|1|||
105775378|NCT00811395|364826838|FG000|Extension Treatment|Progressive disease|1|||
105775379|NCT00811395|364826839|FG001|Extension Treatment|Progressive disease|1|||
105775380|NCT00811395|364826840|FG002|Extension Treatment|Progressive disease|0|||
105775381|NCT00811395|364826841|FG003|Extension Treatment|Progressive disease|0|||
105775382|NCT00811395|364826842|FG004|Extension Treatment|Progressive disease|0|||
105775383|NCT00811395|364826843|FG005|Extension Treatment|Progressive disease|0|||
105775384|NCT00811395|364826838|FG000|Extension Treatment|Participant did not wish to continue|0|||
105775385|NCT00811395|364826839|FG001|Extension Treatment|Participant did not wish to continue|3|||
105775386|NCT00811395|364826840|FG002|Extension Treatment|Participant did not wish to continue|0|||
105775387|NCT00811395|364826841|FG003|Extension Treatment|Participant did not wish to continue|1|||
105775388|NCT00811395|364826842|FG004|Extension Treatment|Participant did not wish to continue|0|||
105775389|NCT00811395|364826843|FG005|Extension Treatment|Participant did not wish to continue|1|||
105775390|NCT00811395|364826838|FG000|Extension Treatment|Other than above|0|||
105775391|NCT00811395|364826839|FG001|Extension Treatment|Other than above|0|||
105775392|NCT00811395|364826840|FG002|Extension Treatment|Other than above|1|||
105775393|NCT00811395|364826841|FG003|Extension Treatment|Other than above|0|||
105775394|NCT00811395|364826842|FG004|Extension Treatment|Other than above|0|||
105775395|NCT00811395|364826843|FG005|Extension Treatment|Other than above|0|||
105775396|NCT02795182|364826846|FG000|Overall Study|Death|5|||
105775397|NCT02795182|364826847|FG001|Overall Study|Death|4|||
105775398|NCT02795182|364826848|FG002|Overall Study|Death|4|||
105775399|NCT02795182|364826849|FG003|Overall Study|Death|18|||
105775400|NCT02795182|364826846|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
105775401|NCT02795182|364826847|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
105775402|NCT02795182|364826848|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
105775403|NCT02795182|364826849|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
105775404|NCT02795182|364826846|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
105775405|NCT02795182|364826847|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
105775406|NCT02795182|364826848|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
105775407|NCT02795182|364826849|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
105775408|NCT02795182|364826846|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
105775409|NCT02795182|364826847|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
105775410|NCT02795182|364826848|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
105775411|NCT02795182|364826849|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
105775412|NCT02795182|364826846|FG000|Overall Study|Withdrawal by Subject|4|||
105775413|NCT02795182|364826847|FG001|Overall Study|Withdrawal by Subject|0|||
105775414|NCT02795182|364826848|FG002|Overall Study|Withdrawal by Subject|0|||
105775415|NCT02795182|364826849|FG003|Overall Study|Withdrawal by Subject|3|||
105775416|NCT02795182|364826846|FG000|Overall Study|Lost to Follow-up|0|||
105775417|NCT02795182|364826847|FG001|Overall Study|Lost to Follow-up|0|||
105775418|NCT02795182|364826848|FG002|Overall Study|Lost to Follow-up|1|||
105775419|NCT02795182|364826849|FG003|Overall Study|Lost to Follow-up|1|||
105775420|NCT02795182|364826846|FG000|Overall Study|Roll Over to Long Term Extension|3|||
105775421|NCT02795182|364826847|FG001|Overall Study|Roll Over to Long Term Extension|3|||
105775422|NCT02795182|364826848|FG002|Overall Study|Roll Over to Long Term Extension|2|||
105775423|NCT02795182|364826849|FG003|Overall Study|Roll Over to Long Term Extension|5|||
105775424|NCT02795182|364826846|FG000|Overall Study|Progressive Disease|0|||
105775425|NCT02795182|364826847|FG001|Overall Study|Progressive Disease|1|||
105775426|NCT02795182|364826848|FG002|Overall Study|Progressive Disease|0|||
105775427|NCT02795182|364826849|FG003|Overall Study|Progressive Disease|4|||
105775428|NCT02795182|364826846|FG000|Overall Study|Physician Decision|0|||
105775429|NCT02795182|364826847|FG001|Overall Study|Physician Decision|0|||
105775430|NCT02795182|364826848|FG002|Overall Study|Physician Decision|0|||
105775431|NCT02795182|364826849|FG003|Overall Study|Physician Decision|1|||
105775432|NCT03267576|364826857|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
105775433|NCT03267576|364826858|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
105775434|NCT03267576|364826857|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
105775435|NCT03267576|364826858|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
105775436|NCT01369069|364826859|FG000|Overall Study|Lost to Follow-up|8|||
105775437|NCT01369069|364826860|FG001|Overall Study|Lost to Follow-up|9|||
105775438|NCT01369069|364826859|FG000|Overall Study|Withdrawal by Subject|9|||
105775439|NCT01369069|364826860|FG001|Overall Study|Withdrawal by Subject|7|||
105775440|NCT02692560|364826861|FG000|Overall Study|Withdrawal by Subject|0|||
105775441|NCT02692560|364826862|FG001|Overall Study|Withdrawal by Subject|6|||
105775442|NCT03344562|364826863|FG000|Overall Study|Withdrawal by Subject|2|||
105775443|NCT03344562|364826864|FG001|Overall Study|Withdrawal by Subject|0|||
105775444|NCT03032523|364826865|FG000|Overall Study|Withdrawal by Subject|2|||
105775445|NCT03032523|364826866|FG001|Overall Study|Withdrawal by Subject|2|||
105775446|NCT03032523|364826865|FG000|Overall Study|Physician Decision|1|||
105775447|NCT03032523|364826866|FG001|Overall Study|Physician Decision|0|||
105775448|NCT01646255|364826867|FG000|Overall Study|Adverse Event|7|||
105775449|NCT01646255|364826868|FG001|Overall Study|Adverse Event|8|||
105775450|NCT01646255|364826867|FG000|Overall Study|Lack of Efficacy|2|||
105775451|NCT01646255|364826868|FG001|Overall Study|Lack of Efficacy|0|||
105775452|NCT01646255|364826867|FG000|Overall Study|Withdrawal by Subject|10|||
105775453|NCT01646255|364826868|FG001|Overall Study|Withdrawal by Subject|6|||
105775454|NCT01646255|364826867|FG000|Overall Study|Compliance is not well|1|||
105775455|NCT01646255|364826868|FG001|Overall Study|Compliance is not well|0|||
105775456|NCT01646255|364826867|FG000|Overall Study|Inclusion Criteria Deviation|1|||
105775457|NCT01646255|364826868|FG001|Overall Study|Inclusion Criteria Deviation|0|||
105775458|NCT02168816|364826869|FG000|Overall Study|Lost to Follow-up|2|||
105775459|NCT02168816|364826870|FG001|Overall Study|Lost to Follow-up|2|||
105775460|NCT01987609|364826873|FG000|Overall Study|Adverse Event|1|||
105775461|NCT02417935|364826874|FG000|Treatment Period|Adverse Event|12|||
105775462|NCT02417935|364826875|FG001|Treatment Period|Adverse Event|10|||
105775463|NCT02417935|364826874|FG000|Treatment Period|Lost to Follow-up|1|||
105775464|NCT02417935|364826875|FG001|Treatment Period|Lost to Follow-up|0|||
105775465|NCT02417935|364826874|FG000|Treatment Period|Entry Criteria not met|0|||
105775466|NCT02417935|364826875|FG001|Treatment Period|Entry Criteria not met|1|||
105775467|NCT02417935|364826874|FG000|Treatment Period|Protocol Violation|2|||
105775468|NCT02417935|364826875|FG001|Treatment Period|Protocol Violation|1|||
105775469|NCT02417935|364826874|FG000|Treatment Period|Withdrawal by Subject|3|||
105775470|NCT02417935|364826875|FG001|Treatment Period|Withdrawal by Subject|3|||
105775471|NCT02417935|364826874|FG000|Treatment Period|Physician Decision|3|||
105775472|NCT02417935|364826875|FG001|Treatment Period|Physician Decision|1|||
105775473|NCT03258762|364826876|FG000|Overall Study|Lost to Follow-up|0|||
105775474|NCT03258762|364826877|FG001|Overall Study|Lost to Follow-up|1|||
105775475|NCT02698176|364826878|FG000|Overall Study|Progressive disease|4|||
105775476|NCT02698176|364826879|FG001|Overall Study|Progressive disease|3|||
105775477|NCT02698176|364826880|FG002|Overall Study|Progressive disease|1|||
105775478|NCT02698176|364826881|FG003|Overall Study|Progressive disease|0|||
105775479|NCT02698176|364826878|FG000|Overall Study|Adverse Event|2|||
105775480|NCT02698176|364826879|FG001|Overall Study|Adverse Event|0|||
105775481|NCT02698176|364826880|FG002|Overall Study|Adverse Event|0|||
105775482|NCT02698176|364826881|FG003|Overall Study|Adverse Event|0|||
105775483|NCT02698176|364826878|FG000|Overall Study|Clinical progression|3|||
105775484|NCT02698176|364826879|FG001|Overall Study|Clinical progression|0|||
105775485|NCT02698176|364826880|FG002|Overall Study|Clinical progression|0|||
105775486|NCT02698176|364826881|FG003|Overall Study|Clinical progression|0|||
105775487|NCT00410514|364826882|FG000|Overall Study|Adverse Event|2|||
105775488|NCT00410514|364826883|FG001|Overall Study|Adverse Event|2|||
105775489|NCT00410514|364826884|FG002|Overall Study|Adverse Event|2|||
105775490|NCT00410514|364826882|FG000|Overall Study|Protocol Violation|0|||
105775491|NCT00410514|364826883|FG001|Overall Study|Protocol Violation|1|||
105775492|NCT00410514|364826884|FG002|Overall Study|Protocol Violation|1|||
105775493|NCT00410514|364826882|FG000|Overall Study|Lost to Follow-up|0|||
105775494|NCT00410514|364826883|FG001|Overall Study|Lost to Follow-up|0|||
105775495|NCT00410514|364826884|FG002|Overall Study|Lost to Follow-up|2|||
105775496|NCT00410514|364826882|FG000|Overall Study|Non-compliant with study procedures|0|||
105775497|NCT00410514|364826883|FG001|Overall Study|Non-compliant with study procedures|0|||
105775498|NCT00410514|364826884|FG002|Overall Study|Non-compliant with study procedures|2|||
105775499|NCT03756285|364826887|FG000|Overall Study|Lost to Follow-up|0|||
105775500|NCT03756285|364826888|FG001|Overall Study|Lost to Follow-up|1|||
105775501|NCT03756285|364826887|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
105775502|NCT03756285|364826888|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
105775503|NCT03756285|364826887|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
105775504|NCT03756285|364826888|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
105775505|NCT02098733|364826889|FG000|Overall Study|Data Not Available|5|||
105775506|NCT02098733|364826889|FG000|Overall Study|Lost to Follow-up|5|||
105775507|NCT02545049|364826890|FG000|Overall Study|Withdrawal by Subject|1|||
105775508|NCT02545049|364826891|FG001|Overall Study|Withdrawal by Subject|7|||
105775509|NCT02545049|364826890|FG000|Overall Study|Lost to Follow-up|4|||
105775510|NCT02545049|364826891|FG001|Overall Study|Lost to Follow-up|6|||
105775511|NCT02545049|364826890|FG000|Overall Study|GCP violations|37|||
105775512|NCT02545049|364826891|FG001|Overall Study|GCP violations|48|||
105775513|NCT03458234|364826892|FG000|Overall Study|Withdrawal by Subject|1|||
105775514|NCT01855919|364828879|FG000|Overall Study|Adverse Event|16|||
105775515|NCT01855919|364828880|FG001|Overall Study|Adverse Event|8|||
105775516|NCT01855919|364828879|FG000|Overall Study|Lack of Efficacy|1|||
105775517|NCT01855919|364828880|FG001|Overall Study|Lack of Efficacy|3|||
105775518|NCT01855919|364828879|FG000|Overall Study|Withdrawal by Subject|4|||
105775519|NCT01855919|364828880|FG001|Overall Study|Withdrawal by Subject|10|||
105775520|NCT01855919|364828879|FG000|Overall Study|Entry Criteria Not Met|1|||
105775521|NCT01855919|364828880|FG001|Overall Study|Entry Criteria Not Met|1|||
105775522|NCT01855919|364828879|FG000|Overall Study|Protocol Violation|1|||
105775523|NCT01855919|364828880|FG001|Overall Study|Protocol Violation|4|||
105775524|NCT01592773|364828881|FG000|Overall Study|Study Terminated by Sponsor|582|||
105775525|NCT01592773|364828881|FG000|Overall Study|Withdrawal by Subject|35|||
105775526|NCT01592773|364828881|FG000|Overall Study|Lost to Follow-up|19|||
105775527|NCT01592773|364828881|FG000|Overall Study|Adverse Event|17|||
105775528|NCT01592773|364828881|FG000|Overall Study|Lack of Efficacy|9|||
105775529|NCT01592773|364828881|FG000|Overall Study|Protocol Violation|2|||
105775530|NCT01592773|364828881|FG000|Overall Study|Inclusion/exclusion not meet|1|||
105775531|NCT01592773|364828881|FG000|Overall Study|Other Reason|1|||
105775532|NCT02972658|364828882|FG000|Overall Study|Adverse Event|0|||
105775533|NCT02972658|364828883|FG001|Overall Study|Adverse Event|3|||
105775534|NCT02972658|364828884|FG002|Overall Study|Adverse Event|0|||
105775535|NCT02972658|364828885|FG003|Overall Study|Adverse Event|2|||
105775536|NCT02972658|364828882|FG000|Overall Study|Other-determined by Investigator|1|||
105775537|NCT02972658|364828883|FG001|Overall Study|Other-determined by Investigator|1|||
105775538|NCT02972658|364828884|FG002|Overall Study|Other-determined by Investigator|0|||
105775539|NCT02972658|364828885|FG003|Overall Study|Other-determined by Investigator|0|||
105775540|NCT02972658|364828882|FG000|Overall Study|Death|0|||
105775541|NCT02972658|364828883|FG001|Overall Study|Death|0|||
105775542|NCT02972658|364828884|FG002|Overall Study|Death|0|||
105775543|NCT02972658|364828885|FG003|Overall Study|Death|1|||
105775544|NCT02972658|364828882|FG000|Overall Study|Lost to Follow-up|0|||
105775545|NCT02972658|364828883|FG001|Overall Study|Lost to Follow-up|1|||
105775546|NCT02972658|364828884|FG002|Overall Study|Lost to Follow-up|1|||
105775547|NCT02972658|364828885|FG003|Overall Study|Lost to Follow-up|2|||
105775548|NCT02972658|364828882|FG000|Overall Study|Progressive Disease|0|||
105775549|NCT02972658|364828883|FG001|Overall Study|Progressive Disease|1|||
105775550|NCT02972658|364828884|FG002|Overall Study|Progressive Disease|0|||
105775551|NCT02972658|364828885|FG003|Overall Study|Progressive Disease|1|||
105775552|NCT02972658|364828882|FG000|Overall Study|Withdrawal by Subject|4|||
105775553|NCT02972658|364828883|FG001|Overall Study|Withdrawal by Subject|4|||
105775554|NCT02972658|364828884|FG002|Overall Study|Withdrawal by Subject|1|||
105775555|NCT02972658|364828885|FG003|Overall Study|Withdrawal by Subject|6|||
105775556|NCT02972658|364828882|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
105775557|NCT02972658|364828883|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
105775558|NCT02972658|364828884|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
105775559|NCT02972658|364828885|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
105775560|NCT02972658|364828882|FG000|Overall Study|Sponsor Decision|70|||
105775561|NCT02972658|364828883|FG001|Overall Study|Sponsor Decision|127|||
105775562|NCT02972658|364828884|FG002|Overall Study|Sponsor Decision|72|||
105775563|NCT02972658|364828885|FG003|Overall Study|Sponsor Decision|119|||
105775564|NCT02785588|364828887|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
105775565|NCT02785588|364828887|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
105775566|NCT03037489|364828888|FG000|Overall Study|Adverse Event|4|||
105775567|NCT03037489|364828889|FG001|Overall Study|Adverse Event|0|||
105775568|NCT03037489|364828888|FG000|Overall Study|Withdrawal by Subject|3|||
105775569|NCT03037489|364828889|FG001|Overall Study|Withdrawal by Subject|0|||
105775570|NCT02499172|364828891|FG000|Overall Study|Financial reason|0|||
105775571|NCT02499172|364828892|FG001|Overall Study|Financial reason|0|||
105775572|NCT02499172|364828893|FG002|Overall Study|Financial reason|523|||
105775573|NCT02499172|364828894|FG003|Overall Study|Financial reason|436|||
105775574|NCT02499172|364828891|FG000|Overall Study|Lost to Follow-up|65|||
105775575|NCT02499172|364828892|FG001|Overall Study|Lost to Follow-up|64|||
105775576|NCT02499172|364828893|FG002|Overall Study|Lost to Follow-up|0|||
105775577|NCT02499172|364828894|FG003|Overall Study|Lost to Follow-up|0|||
105775578|NCT01293123|364828895|FG000|Overall Study|Lost to Follow-up|0|||
105775579|NCT01293123|364828896|FG001|Overall Study|Lost to Follow-up|1|||
105775580|NCT00724243|364828899|FG000|Overall Study|Lack of Efficacy|10|||
105775581|NCT00724243|364828899|FG000|Overall Study|Adverse Event|5|||
105775582|NCT03031327|364828902|FG000|Overall Study|Withdrawal by Subject|0|||
105775583|NCT03031327|364828903|FG001|Overall Study|Withdrawal by Subject|1|||
105775584|NCT03031327|364828904|FG002|Overall Study|Withdrawal by Subject|1|||
105775585|NCT03557801|364828906|FG000|Overall Study|Protocol Violation|1|||
105775586|NCT03557801|364828907|FG001|Overall Study|Protocol Violation|0|||
105775587|NCT03557801|364828908|FG002|Overall Study|Protocol Violation|0|||
105775588|NCT03557801|364828906|FG000|Overall Study|Withdrawal by Subject|1|||
105775589|NCT03557801|364828907|FG001|Overall Study|Withdrawal by Subject|0|||
105775590|NCT03557801|364828908|FG002|Overall Study|Withdrawal by Subject|3|||
105775591|NCT03557801|364828906|FG000|Overall Study|Lost to Follow-up|0|||
105775592|NCT03557801|364828907|FG001|Overall Study|Lost to Follow-up|1|||
105775593|NCT03557801|364828908|FG002|Overall Study|Lost to Follow-up|0|||
105775594|NCT02145429|364828909|FG000|Overall Study|Death|4|||
105775595|NCT02145429|364828910|FG001|Overall Study|Death|5|||
105775596|NCT02145429|364828909|FG000|Overall Study|Lost to Follow-up|4|||
105775597|NCT02145429|364828910|FG001|Overall Study|Lost to Follow-up|3|||
105775598|NCT02145429|364828909|FG000|Overall Study|Withdrawal by Subject|8|||
105775599|NCT02145429|364828910|FG001|Overall Study|Withdrawal by Subject|3|||
105775600|NCT02516306|364828911|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
105775601|NCT02516306|364828912|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
105775602|NCT04652102|364828913|FG000|Overall Study|Adverse Event|14|||
105775603|NCT04652102|364828914|FG001|Overall Study|Adverse Event|13|||
105775604|NCT04652102|364828913|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
105775605|NCT04652102|364828914|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
105775606|NCT04652102|364828913|FG000|Overall Study|Physician Decision|78|||
105775607|NCT04652102|364828914|FG001|Overall Study|Physician Decision|40|||
105775608|NCT04652102|364828913|FG000|Overall Study|Study Ended by Sponsor|64|||
105775609|NCT04652102|364828914|FG001|Overall Study|Study Ended by Sponsor|17|||
105775610|NCT04652102|364828913|FG000|Overall Study|Withdrawal by Subject|4625|||
105775611|NCT04652102|364828914|FG001|Overall Study|Withdrawal by Subject|5594|||
105775612|NCT04652102|364828913|FG000|Overall Study|Lost to Follow-up|2019|||
105775613|NCT04652102|364828914|FG001|Overall Study|Lost to Follow-up|1082|||
105775614|NCT04652102|364828913|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
105775615|NCT04652102|364828914|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
105775616|NCT04652102|364828913|FG000|Overall Study|Miscellaneous|80|||
105775617|NCT04652102|364828914|FG001|Overall Study|Miscellaneous|64|||
105775618|NCT01970540|364828915|FG000|Overall Study|Non-treatment-related AE|0|||
105775619|NCT01970540|364828916|FG001|Overall Study|Non-treatment-related AE|0|||
105775620|NCT01970540|364828917|FG002|Overall Study|Non-treatment-related AE|1|||
105775621|NCT01970540|364828915|FG000|Overall Study|Progressive disease|55|||
105775622|NCT01970540|364828916|FG001|Overall Study|Progressive disease|23|||
105775623|NCT01970540|364828917|FG002|Overall Study|Progressive disease|10|||
105775624|NCT01970540|364828915|FG000|Overall Study|Treatment delay over protocol|0|||
105775625|NCT01970540|364828916|FG001|Overall Study|Treatment delay over protocol|0|||
105775626|NCT01970540|364828917|FG002|Overall Study|Treatment delay over protocol|1|||
105775627|NCT01970540|364828915|FG000|Overall Study|Physician Decision|7|||
105775628|NCT01970540|364828916|FG001|Overall Study|Physician Decision|2|||
105775629|NCT01970540|364828917|FG002|Overall Study|Physician Decision|0|||
105775630|NCT01970540|364828915|FG000|Overall Study|Clinical progression|0|||
105775631|NCT01970540|364828916|FG001|Overall Study|Clinical progression|1|||
105775632|NCT01970540|364828917|FG002|Overall Study|Clinical progression|1|||
105775633|NCT01970540|364828915|FG000|Overall Study|End of study|2|||
105775634|NCT01970540|364828916|FG001|Overall Study|End of study|0|||
105775635|NCT01970540|364828917|FG002|Overall Study|End of study|2|||
105775636|NCT01970540|364828915|FG000|Overall Study|Adverse Event|0|||
105775637|NCT01970540|364828916|FG001|Overall Study|Adverse Event|2|||
105775638|NCT01970540|364828917|FG002|Overall Study|Adverse Event|1|||
105775639|NCT01970540|364828915|FG000|Overall Study|Treatment-related AE|4|||
105775640|NCT01970540|364828916|FG001|Overall Study|Treatment-related AE|0|||
105775641|NCT01970540|364828917|FG002|Overall Study|Treatment-related AE|2|||
105775642|NCT01970540|364828915|FG000|Overall Study|Withdrawal by Subject|4|||
105775643|NCT01970540|364828916|FG001|Overall Study|Withdrawal by Subject|0|||
105775644|NCT01970540|364828917|FG002|Overall Study|Withdrawal by Subject|1|||
105775645|NCT01970540|364828915|FG000|Overall Study|Clinical deterioration|1|||
105775646|NCT01970540|364828916|FG001|Overall Study|Clinical deterioration|0|||
105775647|NCT01970540|364828917|FG002|Overall Study|Clinical deterioration|0|||
105775648|NCT01057394|364828921|FG000|Overall Study|Not eligible|0|||
105775649|NCT01057394|364828922|FG001|Overall Study|Not eligible|2|||
105775650|NCT03961529|364828923|FG000|Overall Study|Adverse Event|13|||
105775651|NCT03961529|364828924|FG001|Overall Study|Adverse Event|5|||
105775652|NCT03961529|364828925|FG002|Overall Study|Adverse Event|2|||
105775653|NCT03961529|364828923|FG000|Overall Study|Withdrawal by Subject|17|||
105775654|NCT03961529|364828924|FG001|Overall Study|Withdrawal by Subject|2|||
105775655|NCT03961529|364828925|FG002|Overall Study|Withdrawal by Subject|1|||
105775656|NCT03961529|364828923|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105775657|NCT03961529|364828924|FG001|Overall Study|Withdrawal by parent/guardian|7|||
105775658|NCT03961529|364828925|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105775659|NCT03961529|364828923|FG000|Overall Study|Physician Decision|2|||
105775660|NCT03961529|364828924|FG001|Overall Study|Physician Decision|1|||
105775661|NCT03961529|364828925|FG002|Overall Study|Physician Decision|1|||
105775662|NCT03961529|364828923|FG000|Overall Study|Lost to Follow-up|2|||
105775663|NCT03961529|364828924|FG001|Overall Study|Lost to Follow-up|1|||
105775664|NCT03961529|364828925|FG002|Overall Study|Lost to Follow-up|0|||
105775665|NCT03961529|364828923|FG000|Overall Study|Lack of Efficacy|2|||
105775666|NCT03961529|364828924|FG001|Overall Study|Lack of Efficacy|0|||
105775667|NCT03961529|364828925|FG002|Overall Study|Lack of Efficacy|1|||
105775668|NCT03961529|364828923|FG000|Overall Study|Other|6|||
105775669|NCT03961529|364828924|FG001|Overall Study|Other|1|||
105775670|NCT03961529|364828925|FG002|Overall Study|Other|0|||
106099766|NCT03581305|366022623|FG001|Serotonergic Study|Withdrawal by Subject|1|||
105775671|NCT03500419|364828926|FG000|Overall Study|Withdrawal by Subject|2|||
105775672|NCT03500419|364828927|FG001|Overall Study|Withdrawal by Subject|25|||
105775673|NCT01566981|364828928|FG000|Overall Study|Lost to Follow-up|5|||
105775674|NCT01566981|364828929|FG001|Overall Study|Lost to Follow-up|8|||
105775675|NCT01766401|364828930|FG000|Overall Study|Adverse Event|7|||
105775676|NCT01766401|364828931|FG001|Overall Study|Adverse Event|22|||
105775677|NCT01766401|364828930|FG000|Overall Study|Lack of Efficacy|1|||
105775678|NCT01766401|364828931|FG001|Overall Study|Lack of Efficacy|2|||
105775679|NCT01766401|364828930|FG000|Overall Study|Protocol Violation|3|||
105775680|NCT01766401|364828931|FG001|Overall Study|Protocol Violation|8|||
106099767|NCT01747772|366022624|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
105775681|NCT01766401|364828930|FG000|Overall Study|Withdrawal by Subject|15|||
105775682|NCT01766401|364828931|FG001|Overall Study|Withdrawal by Subject|12|||
105775683|NCT01766401|364828930|FG000|Overall Study|Lost to Follow-up|10|||
105775684|NCT01766401|364828931|FG001|Overall Study|Lost to Follow-up|11|||
105775685|NCT01766401|364828930|FG000|Overall Study|Pregnancy|1|||
105775686|NCT01766401|364828931|FG001|Overall Study|Pregnancy|1|||
105775687|NCT02177942|364828932|FG000|Overall Study|Adverse Event|1|||
105775688|NCT02177942|364828933|FG001|Overall Study|Adverse Event|0|||
105775689|NCT02177942|364828932|FG000|Overall Study|Lost to Follow-up|1|||
105775690|NCT02177942|364828933|FG001|Overall Study|Lost to Follow-up|1|||
105775691|NCT02177942|364828932|FG000|Overall Study|Protocol Violation|4|||
105775692|NCT02177942|364828933|FG001|Overall Study|Protocol Violation|6|||
105775693|NCT02177942|364828932|FG000|Overall Study|Withdrawal by Subject|71|||
105775694|NCT02177942|364828933|FG001|Overall Study|Withdrawal by Subject|81|||
105775695|NCT00886587|364828934|FG000|Overall Study|Adverse Event|2|||
105775696|NCT00886587|364828935|FG001|Overall Study|Adverse Event|1|||
105775697|NCT00886587|364828934|FG000|Overall Study|Protocol Violation|2|||
105775698|NCT00886587|364828935|FG001|Overall Study|Protocol Violation|0|||
105775699|NCT00886587|364828934|FG000|Overall Study|Withdrawal by Subject|0|||
105775700|NCT00886587|364828935|FG001|Overall Study|Withdrawal by Subject|1|||
105775701|NCT04107935|364828940|FG000|Overall Study|Death|1|||
105775702|NCT04107935|364828941|FG001|Overall Study|Death|0|||
105775703|NCT00398086|364828944|FG000|Overall Study|Unacceptable Toxicity|2|||
105775704|NCT00398086|364828945|FG001|Overall Study|Unacceptable Toxicity|8|||
105775705|NCT00398086|364828946|FG002|Overall Study|Unacceptable Toxicity|2|||
105775706|NCT00398086|364828944|FG000|Overall Study|Adverse Event|1|||
105775707|NCT00398086|364828945|FG001|Overall Study|Adverse Event|4|||
105775708|NCT00398086|364828946|FG002|Overall Study|Adverse Event|0|||
105775709|NCT00398086|364828944|FG000|Overall Study|Physician Decision|1|||
105775710|NCT00398086|364828945|FG001|Overall Study|Physician Decision|4|||
105775711|NCT00398086|364828946|FG002|Overall Study|Physician Decision|0|||
105775712|NCT00398086|364828944|FG000|Overall Study|Withdrawal by Subject|5|||
105775713|NCT00398086|364828945|FG001|Overall Study|Withdrawal by Subject|7|||
105775714|NCT00398086|364828946|FG002|Overall Study|Withdrawal by Subject|0|||
105775715|NCT01948791|364828953|FG000|Overall Study|Adverse Event|12|||
105775716|NCT01948791|364828953|FG000|Overall Study|Lack of Efficacy|3|||
105775717|NCT01948791|364828953|FG000|Overall Study|Protocol Violation|2|||
105775718|NCT01948791|364828953|FG000|Overall Study|Withdrawal by Subject|5|||
105775719|NCT01948791|364828953|FG000|Overall Study|Lost to Follow-up|6|||
105775720|NCT01948791|364828953|FG000|Overall Study|Management issues|1|||
105775721|NCT01948791|364828953|FG000|Overall Study|Others|7|||
105775722|NCT01948791|364828953|FG000|Overall Study|Screening failure|35|||
105775723|NCT00887913|364828954|FG000|Overall Study|Withdrawal by Subject|6|||
105775724|NCT01371721|364828955|FG000|Overall Study|Adverse Event|5|||
105775725|NCT01371721|364828956|FG001|Overall Study|Adverse Event|4|||
105775726|NCT01371721|364828957|FG002|Overall Study|Adverse Event|5|||
105775727|NCT01371721|364828955|FG000|Overall Study|Protocol Violation|6|||
105775728|NCT01371721|364828956|FG001|Overall Study|Protocol Violation|4|||
105775729|NCT01371721|364828957|FG002|Overall Study|Protocol Violation|5|||
105775730|NCT01371721|364828955|FG000|Overall Study|Lost to Follow-up|8|||
105775731|NCT01371721|364828956|FG001|Overall Study|Lost to Follow-up|2|||
105775732|NCT01371721|364828957|FG002|Overall Study|Lost to Follow-up|6|||
105775733|NCT01371721|364828955|FG000|Overall Study|Withdrawal by Subject|5|||
105775734|NCT01371721|364828956|FG001|Overall Study|Withdrawal by Subject|7|||
105775735|NCT01371721|364828957|FG002|Overall Study|Withdrawal by Subject|11|||
105775736|NCT01371721|364828955|FG000|Overall Study|Other|2|||
105775737|NCT01371721|364828956|FG001|Overall Study|Other|3|||
105775738|NCT01371721|364828957|FG002|Overall Study|Other|0|||
105775739|NCT01371721|364828955|FG000|Overall Study|Lack of Efficacy|2|||
105775740|NCT01371721|364828956|FG001|Overall Study|Lack of Efficacy|4|||
105775741|NCT01371721|364828957|FG002|Overall Study|Lack of Efficacy|3|||
105775742|NCT01371721|364828955|FG000|Overall Study|Randomized but not treated|1|||
105775743|NCT01371721|364828956|FG001|Overall Study|Randomized but not treated|0|||
105775744|NCT01371721|364828957|FG002|Overall Study|Randomized but not treated|0|||
105775745|NCT01200758|364828958|FG000|Stage I|Death|0|||
105775746|NCT01200758|364828959|FG001|Stage I|Death|1|||
105775747|NCT01200758|364828960|FG002|Stage I|Death|0|||
105775748|NCT01200758|364828961|FG003|Stage I|Death|0|||
105775749|NCT01200758|364828958|FG000|Stage I|Physician Decision|1|||
105775750|NCT01200758|364828959|FG001|Stage I|Physician Decision|1|||
105775751|NCT01200758|364828960|FG002|Stage I|Physician Decision|0|||
105775752|NCT01200758|364828961|FG003|Stage I|Physician Decision|0|||
105775753|NCT01200758|364828958|FG000|Stage I|Lack of Efficacy|2|||
105775754|NCT01200758|364828959|FG001|Stage I|Lack of Efficacy|1|||
105775755|NCT01200758|364828960|FG002|Stage I|Lack of Efficacy|0|||
105775756|NCT01200758|364828961|FG003|Stage I|Lack of Efficacy|0|||
105775757|NCT01200758|364828958|FG000|Stage I|Adverse Event|5|||
105775758|NCT01200758|364828959|FG001|Stage I|Adverse Event|5|||
105775759|NCT01200758|364828960|FG002|Stage I|Adverse Event|0|||
105775760|NCT01200758|364828961|FG003|Stage I|Adverse Event|0|||
105775761|NCT01200758|364828958|FG000|Stage I|Withdrawal by Subject|1|||
105775762|NCT01200758|364828959|FG001|Stage I|Withdrawal by Subject|2|||
105775763|NCT01200758|364828960|FG002|Stage I|Withdrawal by Subject|0|||
105775764|NCT01200758|364828961|FG003|Stage I|Withdrawal by Subject|0|||
105775765|NCT01200758|364828958|FG000|Stage I|Disease Progression|9|||
105775766|NCT01200758|364828959|FG001|Stage I|Disease Progression|7|||
105775767|NCT01200758|364828960|FG002|Stage I|Disease Progression|0|||
105775768|NCT01200758|364828961|FG003|Stage I|Disease Progression|0|||
105775769|NCT01200758|364828958|FG000|Stage 2|Disease Progression|0|||
105775770|NCT01200758|364828959|FG001|Stage 2|Disease Progression|0|||
105775771|NCT01200758|364828960|FG002|Stage 2|Disease Progression|16|||
105775772|NCT01200758|364828961|FG003|Stage 2|Disease Progression|21|||
105775773|NCT01200758|364828958|FG000|Stage 2|Lack of Efficacy|0|||
105775774|NCT01200758|364828959|FG001|Stage 2|Lack of Efficacy|0|||
105775775|NCT01200758|364828960|FG002|Stage 2|Lack of Efficacy|4|||
105775776|NCT01200758|364828961|FG003|Stage 2|Lack of Efficacy|2|||
105775777|NCT01200758|364828958|FG000|Stage 2|Physician Decision|0|||
105775778|NCT01200758|364828959|FG001|Stage 2|Physician Decision|0|||
105775779|NCT01200758|364828960|FG002|Stage 2|Physician Decision|5|||
105775780|NCT01200758|364828961|FG003|Stage 2|Physician Decision|7|||
105775781|NCT01200758|364828958|FG000|Stage 2|Adverse Event|0|||
105775782|NCT01200758|364828959|FG001|Stage 2|Adverse Event|0|||
105775783|NCT01200758|364828960|FG002|Stage 2|Adverse Event|5|||
105775784|NCT01200758|364828961|FG003|Stage 2|Adverse Event|9|||
105775785|NCT01200758|364828958|FG000|Stage 2|Withdrawal by Subject|0|||
105775786|NCT01200758|364828959|FG001|Stage 2|Withdrawal by Subject|0|||
105775787|NCT01200758|364828960|FG002|Stage 2|Withdrawal by Subject|4|||
105775788|NCT01200758|364828961|FG003|Stage 2|Withdrawal by Subject|1|||
105775789|NCT01200758|364828958|FG000|Stage 2|Lost to Follow-up|0|||
105775790|NCT01200758|364828959|FG001|Stage 2|Lost to Follow-up|0|||
105775791|NCT01200758|364828960|FG002|Stage 2|Lost to Follow-up|3|||
105775792|NCT01200758|364828961|FG003|Stage 2|Lost to Follow-up|1|||
105775793|NCT01200758|364828958|FG000|Stage 2|Protocol Violation|0|||
105775794|NCT01200758|364828959|FG001|Stage 2|Protocol Violation|0|||
105775795|NCT01200758|364828960|FG002|Stage 2|Protocol Violation|1|||
105775796|NCT01200758|364828961|FG003|Stage 2|Protocol Violation|4|||
105775797|NCT01200758|364828958|FG000|Stage 2|Death|0|||
105775798|NCT01200758|364828959|FG001|Stage 2|Death|0|||
105775799|NCT01200758|364828960|FG002|Stage 2|Death|3|||
105775800|NCT01200758|364828961|FG003|Stage 2|Death|5|||
105775801|NCT00545584|364828962|FG000|Overall Study|Only one reason for discontinuation|62|||
105775802|NCT00545584|364828963|FG001|Overall Study|Only one reason for discontinuation|61|||
105775803|NCT00545584|364828964|FG002|Overall Study|Only one reason for discontinuation|48|||
105775804|NCT00545584|364828962|FG000|Overall Study|Two or more reasons for discontinuation|17|||
105775805|NCT00545584|364828963|FG001|Overall Study|Two or more reasons for discontinuation|19|||
105775806|NCT00545584|364828964|FG002|Overall Study|Two or more reasons for discontinuation|8|||
105775807|NCT03525613|364828967|FG000|Overall Study|Adverse Event|11|||
105775808|NCT03525613|364828968|FG001|Overall Study|Adverse Event|8|||
105775809|NCT03525613|364828969|FG002|Overall Study|Adverse Event|3|||
105775810|NCT03525613|364828970|FG003|Overall Study|Adverse Event|3|||
105775811|NCT03525613|364828967|FG000|Overall Study|Lost to Follow-up|4|||
105775812|NCT03525613|364828968|FG001|Overall Study|Lost to Follow-up|5|||
105775813|NCT03525613|364828969|FG002|Overall Study|Lost to Follow-up|3|||
105775814|NCT03525613|364828970|FG003|Overall Study|Lost to Follow-up|2|||
105775815|NCT03525613|364828967|FG000|Overall Study|Physician Decision|0|||
105775816|NCT03525613|364828968|FG001|Overall Study|Physician Decision|1|||
105775817|NCT03525613|364828969|FG002|Overall Study|Physician Decision|0|||
105775818|NCT03525613|364828970|FG003|Overall Study|Physician Decision|1|||
105775819|NCT03525613|364828967|FG000|Overall Study|Consent Withdrawal|25|||
105775820|NCT03525613|364828968|FG001|Overall Study|Consent Withdrawal|16|||
105775821|NCT03525613|364828969|FG002|Overall Study|Consent Withdrawal|12|||
105775822|NCT03525613|364828970|FG003|Overall Study|Consent Withdrawal|9|||
105775823|NCT03525613|364828967|FG000|Overall Study|Death|20|||
105775824|NCT03525613|364828968|FG001|Overall Study|Death|9|||
105775825|NCT03525613|364828969|FG002|Overall Study|Death|7|||
105775826|NCT03525613|364828970|FG003|Overall Study|Death|1|||
105775827|NCT03525613|364828967|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
105775828|NCT03525613|364828968|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
105775829|NCT03525613|364828969|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
105775830|NCT03525613|364828970|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
105775831|NCT02584660|364828974|FG000|Overall Study|Adverse Event|4|||
105775832|NCT02584660|364828975|FG001|Overall Study|Adverse Event|0|||
105775833|NCT02584660|364828974|FG000|Overall Study|Lost to Follow-up|3|||
105775834|NCT02584660|364828975|FG001|Overall Study|Lost to Follow-up|4|||
105775835|NCT02584660|364828974|FG000|Overall Study|Protocol Violation|0|||
105775836|NCT02584660|364828975|FG001|Overall Study|Protocol Violation|1|||
105775837|NCT02584660|364828974|FG000|Overall Study|Withdrawal by Subject|0|||
106099768|NCT01798927|366022625|FG000|Overall Study|Withdrawal by Subject|1|||
106099769|NCT00626522|366022628|FG000|Overall Study|Protocol Violation|0|||
106099770|NCT00626522|366022629|FG001|Overall Study|Protocol Violation|0|||
105775838|NCT02584660|364828975|FG001|Overall Study|Withdrawal by Subject|2|||
105775839|NCT02584660|364828974|FG000|Overall Study|Other|0|||
105775840|NCT02584660|364828975|FG001|Overall Study|Other|1|||
105775841|NCT00461552|364828978|FG000|Overall Study|Drug Dispensing error|0|||
105775842|NCT00461552|364828979|FG001|Overall Study|Drug Dispensing error|2|||
105775843|NCT02463331|364828989|FG000|Overall Study|Adverse Event|4|||
105775844|NCT02463331|364828990|FG001|Overall Study|Adverse Event|2|||
105775845|NCT02463331|364828989|FG000|Overall Study|Lost to Follow-up|1|||
105775846|NCT02463331|364828990|FG001|Overall Study|Lost to Follow-up|1|||
105775847|NCT02463331|364828989|FG000|Overall Study|Pregnancy|2|||
105775848|NCT02463331|364828990|FG001|Overall Study|Pregnancy|3|||
105775849|NCT02463331|364828989|FG000|Overall Study|Lack of Efficacy|6|||
105775850|NCT02463331|364828990|FG001|Overall Study|Lack of Efficacy|0|||
105775851|NCT02463331|364828989|FG000|Overall Study|Physician Decision|3|||
105775852|NCT02463331|364828990|FG001|Overall Study|Physician Decision|0|||
105775853|NCT01166386|364828991|FG000|Overall Study|Withdrawal by Subject|3|||
105775854|NCT01166386|364828992|FG001|Overall Study|Withdrawal by Subject|5|||
105775855|NCT03922711|364828995|FG000|Overall Study|Adverse Event|3|||
105775856|NCT03922711|364828996|FG001|Overall Study|Adverse Event|2|||
105775857|NCT03922711|364828997|FG002|Overall Study|Adverse Event|2|||
105775858|NCT03922711|364828995|FG000|Overall Study|Protocol Violation|1|||
105775859|NCT03922711|364828996|FG001|Overall Study|Protocol Violation|0|||
105775860|NCT03922711|364828997|FG002|Overall Study|Protocol Violation|0|||
105775861|NCT03922711|364828995|FG000|Overall Study|Withdrawal by Subject|0|||
105775862|NCT03922711|364828996|FG001|Overall Study|Withdrawal by Subject|3|||
105775863|NCT03922711|364828997|FG002|Overall Study|Withdrawal by Subject|1|||
105775864|NCT03922711|364828995|FG000|Overall Study|Not further specified|0|||
105775865|NCT03922711|364828996|FG001|Overall Study|Not further specified|0|||
105775866|NCT03922711|364828997|FG002|Overall Study|Not further specified|1|||
105775867|NCT04009824|364828998|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
105775868|NCT04009824|364828999|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
105775869|NCT04009824|364829000|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
105775870|NCT04009824|364829001|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
105775871|NCT04009824|364829002|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
105775872|NCT03147495|364829003|FG000|Overall Study|Physician Decision|0|||
105775873|NCT03147495|364829004|FG001|Overall Study|Physician Decision|6|||
105775874|NCT01024946|364829005|FG000|Overall Study|Screen Failure|3|||
105775875|NCT01024946|364829005|FG000|Overall Study|Withdrawal by Subject|1|||
105775876|NCT01024946|364829005|FG000|Overall Study|Adverse Event|1|||
105775877|NCT02274766|364829008|FG000|Overall Study|Withdrawal by Subject|3|||
105775878|NCT02274766|364829009|FG001|Overall Study|Withdrawal by Subject|6|||
105775879|NCT02274766|364829008|FG000|Overall Study|Did Not Receive Study Drug|1|||
105775880|NCT02274766|364829009|FG001|Overall Study|Did Not Receive Study Drug|1|||
105775881|NCT02274766|364829008|FG000|Overall Study|Subject Unwilling to Proceed|0|||
105775882|NCT02274766|364829009|FG001|Overall Study|Subject Unwilling to Proceed|1|||
105775883|NCT02274766|364829008|FG000|Overall Study|Adverse Event|0|||
105775884|NCT02274766|364829009|FG001|Overall Study|Adverse Event|1|||
105775885|NCT01142791|364829019|FG000|Overall Study|Alternative Treatment|1|||
105775886|NCT01142791|364829020|FG001|Overall Study|Alternative Treatment|0|||
105775887|NCT01142791|364829019|FG000|Overall Study|Lost to Follow-up|1|||
105775888|NCT01142791|364829020|FG001|Overall Study|Lost to Follow-up|0|||
105775889|NCT01142791|364829019|FG000|Overall Study|Withdrawal by Subject|5|||
105775890|NCT01142791|364829020|FG001|Overall Study|Withdrawal by Subject|0|||
105775891|NCT01142791|364829019|FG000|Overall Study|Received only 1 sonication|0|||
105775892|NCT01142791|364829020|FG001|Overall Study|Received only 1 sonication|6|||
105775893|NCT02608892|364829021|FG000|Overall Study|Lost to Follow-up|1|||
105775894|NCT02608892|364829022|FG001|Overall Study|Lost to Follow-up|0|||
105775895|NCT01681836|364829023|FG000|Second Intervention|Withdrawal by Subject|0|||
105775896|NCT01681836|364829024|FG001|Second Intervention|Withdrawal by Subject|1|||
105775897|NCT00742391|364829025|FG000|Overall Study|Adverse Event|2|||
105775898|NCT00742391|364829026|FG001|Overall Study|Adverse Event|1|||
105775899|NCT00742391|364829025|FG000|Overall Study|Lost to Follow-up|1|||
105775900|NCT00742391|364829026|FG001|Overall Study|Lost to Follow-up|0|||
105775901|NCT00742391|364829025|FG000|Overall Study|Protocol Violation|1|||
105775902|NCT00742391|364829026|FG001|Overall Study|Protocol Violation|0|||
105775903|NCT02975206|364829031|FG000|Overall Study|Withdrawal by Subject|14|||
105775904|NCT02975206|364829032|FG001|Overall Study|Withdrawal by Subject|11|||
105775905|NCT02975206|364829033|FG002|Overall Study|Withdrawal by Subject|11|||
105775906|NCT02975206|364829031|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
105775907|NCT02975206|364829032|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
105775908|NCT02975206|364829033|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
105775909|NCT01984294|364829044|FG000|Overall Study|Randomized but Never Treated|0|||
105775910|NCT01984294|364829045|FG001|Overall Study|Randomized but Never Treated|0|||
105775911|NCT01984294|364829046|FG002|Overall Study|Randomized but Never Treated|1|||
105775912|NCT01984294|364829044|FG000|Overall Study|Lack of Efficacy|4|||
105775913|NCT01984294|364829045|FG001|Overall Study|Lack of Efficacy|2|||
105775914|NCT01984294|364829046|FG002|Overall Study|Lack of Efficacy|6|||
105775915|NCT01984294|364829044|FG000|Overall Study|Adverse Event|0|||
105775916|NCT01984294|364829045|FG001|Overall Study|Adverse Event|1|||
105775917|NCT01984294|364829046|FG002|Overall Study|Adverse Event|0|||
105775918|NCT02355665|364829047|FG000|Overall Study|Adverse Event|16|||
105775919|NCT02355665|364829048|FG001|Overall Study|Adverse Event|24|||
105775920|NCT02355665|364829047|FG000|Overall Study|Protocol Violation|2|||
105775921|NCT02355665|364829048|FG001|Overall Study|Protocol Violation|0|||
105775922|NCT02355665|364829047|FG000|Overall Study|Withdrawal by Subject|90|||
105775923|NCT02355665|364829048|FG001|Overall Study|Withdrawal by Subject|100|||
105775924|NCT02355665|364829047|FG000|Overall Study|Lost to Follow-up|131|||
105775925|NCT02355665|364829048|FG001|Overall Study|Lost to Follow-up|103|||
105775926|NCT02355665|364829047|FG000|Overall Study|Death|4|||
105775927|NCT02355665|364829048|FG001|Overall Study|Death|2|||
105775928|NCT02355665|364829047|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
105775929|NCT02355665|364829048|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
105775930|NCT01058356|364829051|FG000|Overall Study|Adverse Event|5|||
105775931|NCT01058356|364829051|FG000|Overall Study|Administration of contraindicated drugs|12|||
105775932|NCT01058356|364829051|FG000|Overall Study|Withdrawal by Subject|21|||
105775933|NCT01058356|364829051|FG000|Overall Study|Lost to Follow-up|4|||
105775934|NCT02993783|364829054|FG000|Overall Study|Reason not Specified|6|||
105775935|NCT02993783|364829055|FG001|Overall Study|Reason not Specified|9|||
105775936|NCT01066546|364829056|FG000|Overall Study|Study terminated by sponsor|5|||
105775937|NCT02679222|364831406|FG000|Overall Study|No time for project|1|||
105775938|NCT00303329|364831407|FG000|Overall Study|Adverse Event|7|||
105775939|NCT00303329|364831408|FG001|Overall Study|Adverse Event|14|||
105775940|NCT00303329|364831407|FG000|Overall Study|Abnormal Laboratory Values|0|||
105775941|NCT00303329|364831408|FG001|Overall Study|Abnormal Laboratory Values|1|||
105775942|NCT00303329|364831407|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
105775943|NCT00303329|364831408|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105775944|NCT00303329|364831407|FG000|Overall Study|Condition no longer requires study drug|0|||
105775945|NCT00303329|364831408|FG001|Overall Study|Condition no longer requires study drug|8|||
105775946|NCT00303329|364831407|FG000|Overall Study|Protocol Violation|3|||
105775947|NCT00303329|364831408|FG001|Overall Study|Protocol Violation|0|||
105775948|NCT00303329|364831407|FG000|Overall Study|Withdrawal by Subject|9|||
105775949|NCT00303329|364831408|FG001|Overall Study|Withdrawal by Subject|15|||
105775950|NCT00303329|364831407|FG000|Overall Study|Lost to Follow-up|0|||
105775951|NCT00303329|364831408|FG001|Overall Study|Lost to Follow-up|1|||
105775952|NCT00303329|364831407|FG000|Overall Study|Administrative problems|1|||
105775953|NCT00303329|364831408|FG001|Overall Study|Administrative problems|0|||
105775954|NCT00303329|364831407|FG000|Overall Study|Death|2|||
105775955|NCT00303329|364831408|FG001|Overall Study|Death|12|||
105775956|NCT00303329|364831407|FG000|Overall Study|Stopped at end of core|3|||
105775957|NCT00303329|364831408|FG001|Overall Study|Stopped at end of core|9|||
105775958|NCT00303329|364831407|FG000|Overall Study|Stopped at end of extension 1|1|||
105775959|NCT00303329|364831408|FG001|Overall Study|Stopped at end of extension 1|0|||
105775960|NCT04397757|364831409|FG000|Overall Study|Death|3|||
105775961|NCT04397757|364831410|FG001|Overall Study|Death|11|||
105775962|NCT04397757|364831409|FG000|Overall Study|Withdrawal by Subject|2|||
105775963|NCT04397757|364831410|FG001|Overall Study|Withdrawal by Subject|0|||
105775964|NCT04397757|364831409|FG000|Overall Study|Lost to Follow-up|4|||
105775965|NCT04397757|364831410|FG001|Overall Study|Lost to Follow-up|3|||
105775966|NCT03384316|364831411|FG000|Overall Study|Screen failure|0|||
105775967|NCT03384316|364831412|FG001|Overall Study|Screen failure|1|||
105775968|NCT01952041|364831417|FG000|Overall Study|Lost to Follow-up|9|||
105775969|NCT01952041|364831418|FG001|Overall Study|Lost to Follow-up|16|||
105775970|NCT01952041|364831417|FG000|Overall Study|Withdrawal by Subject|7|||
105775971|NCT01952041|364831418|FG001|Overall Study|Withdrawal by Subject|5|||
105775972|NCT01952041|364831417|FG000|Overall Study|Death|1|||
105775973|NCT01952041|364831418|FG001|Overall Study|Death|0|||
105775974|NCT00626327|364831419|FG000|Overall Study|Withdrawal by Subject|21|||
105775975|NCT00626327|364831420|FG001|Overall Study|Withdrawal by Subject|29|||
105775976|NCT00626327|364831421|FG002|Overall Study|Withdrawal by Subject|30|||
105775977|NCT00626327|364831419|FG000|Overall Study|Adverse Event|1|||
105775978|NCT00626327|364831420|FG001|Overall Study|Adverse Event|0|||
105775979|NCT00626327|364831421|FG002|Overall Study|Adverse Event|0|||
105775980|NCT00626327|364831419|FG000|Overall Study|Lost to Follow-up|24|||
105775981|NCT00626327|364831420|FG001|Overall Study|Lost to Follow-up|21|||
105775982|NCT00626327|364831421|FG002|Overall Study|Lost to Follow-up|23|||
105775983|NCT00626327|364831419|FG000|Overall Study|Inappropriate enrollment|4|||
105775984|NCT00626327|364831420|FG001|Overall Study|Inappropriate enrollment|5|||
105775985|NCT00626327|364831421|FG002|Overall Study|Inappropriate enrollment|3|||
105775986|NCT00626327|364831419|FG000|Overall Study|Administrative Reason|2|||
105775987|NCT00626327|364831420|FG001|Overall Study|Administrative Reason|0|||
105775988|NCT00626327|364831421|FG002|Overall Study|Administrative Reason|6|||
105775989|NCT00626327|364831419|FG000|Overall Study|Protocol Violation|26|||
105775990|NCT00626327|364831420|FG001|Overall Study|Protocol Violation|4|||
105775991|NCT00626327|364831421|FG002|Overall Study|Protocol Violation|26|||
105775992|NCT00945945|364831422|FG000|Overall Study|Adverse Event|15|||
105775993|NCT00945945|364831423|FG001|Overall Study|Adverse Event|35|||
105775994|NCT00945945|364831422|FG000|Overall Study|Withdrawal by Subject|7|||
105775995|NCT00945945|364831423|FG001|Overall Study|Withdrawal by Subject|10|||
105775996|NCT00945945|364831422|FG000|Overall Study|Lost to Follow-up|4|||
105775997|NCT00945945|364831423|FG001|Overall Study|Lost to Follow-up|5|||
105775998|NCT00945945|364831422|FG000|Overall Study|Lack of Efficacy|6|||
105775999|NCT00945945|364831423|FG001|Overall Study|Lack of Efficacy|2|||
105776000|NCT00945945|364831422|FG000|Overall Study|Protocol Violation|4|||
105776001|NCT00945945|364831423|FG001|Overall Study|Protocol Violation|2|||
105776002|NCT00945945|364831422|FG000|Overall Study|Entry Criteria Not Met|0|||
105776003|NCT00945945|364831423|FG001|Overall Study|Entry Criteria Not Met|1|||
105776004|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105776005|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105776006|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105776007|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105776008|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
105776009|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
105776010|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
105776011|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
105776012|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
105776013|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
105776014|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105776015|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105776016|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
105776017|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
105776018|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
105776019|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
105776020|NCT02275052|364831425|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
105776021|NCT02275052|364831426|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
105776022|NCT02275052|364831427|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
105776023|NCT02275052|364831428|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
105776024|NCT02275052|364831425|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
105776025|NCT02275052|364831426|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
105776026|NCT02275052|364831427|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
105776027|NCT02275052|364831428|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
105776028|NCT02275052|364831425|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
105776029|NCT02275052|364831426|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
105776030|NCT02275052|364831427|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
105776031|NCT02275052|364831428|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
105776032|NCT02275052|364831425|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
105776033|NCT02275052|364831426|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
105776034|NCT02275052|364831427|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
105776035|NCT02275052|364831428|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
105776036|NCT02275052|364831425|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105776037|NCT02275052|364831426|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105776038|NCT02275052|364831427|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105776039|NCT02275052|364831428|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
105776040|NCT02275052|364831425|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105776041|NCT02275052|364831426|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105776042|NCT02275052|364831427|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
105776043|NCT02275052|364831428|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
105776044|NCT02275052|364831425|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105776045|NCT02275052|364831426|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105776046|NCT02275052|364831427|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
105776047|NCT02275052|364831428|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
105776048|NCT00290355|364831431|FG000|Overall Study|Serious adverse event|7|||
105776049|NCT00290355|364831432|FG001|Overall Study|Serious adverse event|4|||
105776050|NCT00290355|364831431|FG000|Overall Study|Study product reactogenicity|1|||
105776051|NCT00290355|364831432|FG001|Overall Study|Study product reactogenicity|0|||
105776052|NCT00290355|364831431|FG000|Overall Study|Protocol Violation|1|||
105776053|NCT00290355|364831432|FG001|Overall Study|Protocol Violation|0|||
105776054|NCT00290355|364831431|FG000|Overall Study|Withdrawal by Subject|2|||
105776055|NCT00290355|364831432|FG001|Overall Study|Withdrawal by Subject|0|||
105776056|NCT00290355|364831431|FG000|Overall Study|Migrated / moved from the study area|1|||
105776057|NCT00290355|364831432|FG001|Overall Study|Migrated / moved from the study area|0|||
105776058|NCT00290355|364831431|FG000|Overall Study|Lost to Follow-up|3|||
105776059|NCT00290355|364831432|FG001|Overall Study|Lost to Follow-up|1|||
105776060|NCT00290355|364831431|FG000|Overall Study|Other|2|||
105776061|NCT00290355|364831432|FG001|Overall Study|Other|0|||
105776062|NCT01797302|364831435|FG000|Overall Study|Lost to Follow-up|16|||
105776063|NCT01797302|364831436|FG001|Overall Study|Lost to Follow-up|23|||
105776064|NCT01797302|364831437|FG002|Overall Study|Lost to Follow-up|22|||
105776065|NCT01797302|364831435|FG000|Overall Study|Withdrawal by Subject|1|||
105776066|NCT01797302|364831436|FG001|Overall Study|Withdrawal by Subject|3|||
105776067|NCT01797302|364831437|FG002|Overall Study|Withdrawal by Subject|4|||
105776068|NCT02773849|364831438|FG000|Overall Study|Lost to Follow-up|11|||
105776069|NCT02773849|364831438|FG000|Overall Study|Death|26|||
105776070|NCT02773849|364831438|FG000|Overall Study|Withdrawal by Subject|5|||
105776071|NCT02773849|364831438|FG000|Overall Study|Withdrawal of Consent|9|||
105776072|NCT02773849|364831438|FG000|Overall Study|Other: not due to lack of tolerability|11|||
105776073|NCT00948389|364831439|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
105776074|NCT00948389|364831440|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
105776075|NCT00948389|364831441|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
105776076|NCT00948389|364831442|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
105776077|NCT00948389|364831443|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
105776078|NCT00948389|364831439|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
105776079|NCT00948389|364831440|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
105776080|NCT00948389|364831441|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
105776081|NCT00948389|364831442|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
105776082|NCT00948389|364831443|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
105776083|NCT00948389|364831439|FG000|Overall Study|Both Progression and Toxicity|1|||
105776084|NCT00948389|364831440|FG001|Overall Study|Both Progression and Toxicity|0|||
105776085|NCT00948389|364831441|FG002|Overall Study|Both Progression and Toxicity|0|||
105776086|NCT00948389|364831442|FG003|Overall Study|Both Progression and Toxicity|0|||
105776087|NCT00948389|364831443|FG004|Overall Study|Both Progression and Toxicity|0|||
105776088|NCT04249076|364831450|FG000|Overall Study|Adverse Event|1|||
105776089|NCT04249076|364831451|FG001|Overall Study|Adverse Event|1|||
105776090|NCT04249076|364831450|FG000|Overall Study|Protocol Violation|1|||
105776091|NCT04249076|364831451|FG001|Overall Study|Protocol Violation|2|||
105776092|NCT04249076|364831450|FG000|Overall Study|Lack of Efficacy|0|||
105776093|NCT04249076|364831451|FG001|Overall Study|Lack of Efficacy|1|||
105776094|NCT04249076|364831450|FG000|Overall Study|Withdrawal by Subject|0|||
105776095|NCT04249076|364831451|FG001|Overall Study|Withdrawal by Subject|1|||
105776096|NCT00783263|364831452|FG000|Overall Study|Adverse Event|3|||
105776097|NCT00783263|364831453|FG001|Overall Study|Adverse Event|0|||
105776098|NCT00783263|364831454|FG002|Overall Study|Adverse Event|2|||
105776099|NCT00783263|364831455|FG003|Overall Study|Adverse Event|1|||
105776100|NCT00783263|364831452|FG000|Overall Study|Lost to Follow-up|1|||
105776101|NCT00783263|364831453|FG001|Overall Study|Lost to Follow-up|1|||
105776102|NCT00783263|364831454|FG002|Overall Study|Lost to Follow-up|0|||
105776103|NCT00783263|364831455|FG003|Overall Study|Lost to Follow-up|0|||
105776104|NCT00783263|364831452|FG000|Overall Study|Withdrawal by Subject|0|||
105776105|NCT00783263|364831453|FG001|Overall Study|Withdrawal by Subject|1|||
105776106|NCT00783263|364831454|FG002|Overall Study|Withdrawal by Subject|1|||
105776107|NCT00783263|364831455|FG003|Overall Study|Withdrawal by Subject|2|||
105776108|NCT02381795|364831459|FG000|Overall Study|Withdrawal by Subject|1|||
105776109|NCT02381795|364831459|FG000|Overall Study|Study Terminated|2|||
105776110|NCT01072500|364831462|FG000|Overall Study|Death|2|||
105776111|NCT01072500|364831463|FG001|Overall Study|Death|2|||
105776112|NCT01072500|364831462|FG000|Overall Study|Lost to Follow-up|5|||
105776113|NCT01072500|364831463|FG001|Overall Study|Lost to Follow-up|2|||
105776114|NCT01072500|364831462|FG000|Overall Study|Withdrawal by Subject|17|||
105776115|NCT01072500|364831463|FG001|Overall Study|Withdrawal by Subject|10|||
105776116|NCT02908841|364831464|FG000|Overall Study|Physician Decision|4|||
105776117|NCT02908841|364831465|FG001|Overall Study|Physician Decision|0|||
105776118|NCT01227252|364831466|FG000|Overall Study|Sponsor Decision|0|||
105776119|NCT01227252|364831467|FG001|Overall Study|Sponsor Decision|1|||
105776120|NCT01227252|364831468|FG002|Overall Study|Sponsor Decision|0|||
105776121|NCT01227252|364831469|FG003|Overall Study|Sponsor Decision|0|||
105776122|NCT01227252|364831466|FG000|Overall Study|Lost to Follow-up|0|||
105776123|NCT01227252|364831467|FG001|Overall Study|Lost to Follow-up|1|||
105776124|NCT01227252|364831468|FG002|Overall Study|Lost to Follow-up|0|||
105776125|NCT01227252|364831469|FG003|Overall Study|Lost to Follow-up|0|||
105776126|NCT01227252|364831466|FG000|Overall Study|Withdrawal by Subject|0|||
105776127|NCT01227252|364831467|FG001|Overall Study|Withdrawal by Subject|1|||
105776128|NCT01227252|364831468|FG002|Overall Study|Withdrawal by Subject|0|||
105776129|NCT01227252|364831469|FG003|Overall Study|Withdrawal by Subject|0|||
105776130|NCT04062240|364831472|FG000|Overall Study|equipment malfunction|1|||
105776131|NCT00579527|364831473|FG000|Overall Study|Death|4|||
105776132|NCT00952588|364831474|FG000|Overall Study|Death|28|||
105776133|NCT00952588|364831475|FG001|Overall Study|Death|13|||
105776134|NCT00952588|364831474|FG000|Overall Study|Withdrawal by Subject|2|||
105776135|NCT00952588|364831475|FG001|Overall Study|Withdrawal by Subject|5|||
105776136|NCT00952588|364831474|FG000|Overall Study|Adverse Event|2|||
105776137|NCT00952588|364831475|FG001|Overall Study|Adverse Event|3|||
105776138|NCT00952588|364831474|FG000|Overall Study|Lost to Follow-up|2|||
105776139|NCT00952588|364831475|FG001|Overall Study|Lost to Follow-up|0|||
105776140|NCT00952588|364831474|FG000|Overall Study|Physician Decision|0|||
105776141|NCT00952588|364831475|FG001|Overall Study|Physician Decision|1|||
105776142|NCT00952588|364831474|FG000|Overall Study|Lack of Efficacy|2|||
105776143|NCT00952588|364831475|FG001|Overall Study|Lack of Efficacy|2|||
105776144|NCT04554394|364831476|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
105776145|NCT04554394|364831477|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
105776146|NCT04554394|364831476|FG000|Overall Study|Withdrawal by Subject|2|||
105776147|NCT04554394|364831477|FG001|Overall Study|Withdrawal by Subject|2|||
105776148|NCT04554394|364831476|FG000|Overall Study|Lost to Follow-up|2|||
105776149|NCT04554394|364831477|FG001|Overall Study|Lost to Follow-up|2|||
105776150|NCT04554394|364831476|FG000|Overall Study|Physician Decision|1|||
105776151|NCT04554394|364831477|FG001|Overall Study|Physician Decision|1|||
105776152|NCT00256204|364831481|FG000|Overall Study|Adverse Event|10|||
105776153|NCT00256204|364831482|FG001|Overall Study|Adverse Event|14|||
105776154|NCT00256204|364831483|FG002|Overall Study|Adverse Event|16|||
105776155|NCT00256204|364831484|FG003|Overall Study|Adverse Event|14|||
105776156|NCT00256204|364831481|FG000|Overall Study|Death|0|||
105776157|NCT00256204|364831482|FG001|Overall Study|Death|1|||
105776158|NCT00256204|364831483|FG002|Overall Study|Death|0|||
105776159|NCT00256204|364831484|FG003|Overall Study|Death|0|||
105776160|NCT00256204|364831481|FG000|Overall Study|Lost to Follow-up|1|||
105776161|NCT00256204|364831482|FG001|Overall Study|Lost to Follow-up|1|||
105776162|NCT00256204|364831483|FG002|Overall Study|Lost to Follow-up|1|||
105776163|NCT00256204|364831484|FG003|Overall Study|Lost to Follow-up|2|||
105776164|NCT00256204|364831481|FG000|Overall Study|Protocol Violation|1|||
105776165|NCT00256204|364831482|FG001|Overall Study|Protocol Violation|0|||
105776166|NCT00256204|364831483|FG002|Overall Study|Protocol Violation|2|||
105776167|NCT00256204|364831484|FG003|Overall Study|Protocol Violation|1|||
105776168|NCT00256204|364831481|FG000|Overall Study|Physician Decision|0|||
105776169|NCT00256204|364831482|FG001|Overall Study|Physician Decision|0|||
105776170|NCT00256204|364831483|FG002|Overall Study|Physician Decision|1|||
105776171|NCT00256204|364831484|FG003|Overall Study|Physician Decision|2|||
105776172|NCT00256204|364831481|FG000|Overall Study|Withdrawal by Subject|17|||
105776173|NCT00256204|364831482|FG001|Overall Study|Withdrawal by Subject|6|||
105776174|NCT00256204|364831483|FG002|Overall Study|Withdrawal by Subject|7|||
105776175|NCT00256204|364831484|FG003|Overall Study|Withdrawal by Subject|5|||
105776176|NCT00256204|364831481|FG000|Overall Study|Need for additional prohibited treatment|38|||
105776177|NCT00256204|364831482|FG001|Overall Study|Need for additional prohibited treatment|28|||
105776178|NCT00256204|364831483|FG002|Overall Study|Need for additional prohibited treatment|27|||
105776179|NCT00256204|364831484|FG003|Overall Study|Need for additional prohibited treatment|25|||
105776180|NCT02364999|364831485|FG000|Overall Study|Death|136|||
105776181|NCT02364999|364831486|FG001|Overall Study|Death|138|||
105776182|NCT02364999|364831485|FG000|Overall Study|Lost to Follow-up|10|||
105776183|NCT02364999|364831486|FG001|Overall Study|Lost to Follow-up|15|||
105776184|NCT02364999|364831485|FG000|Overall Study|Protocol Violation|3|||
105776185|NCT02364999|364831486|FG001|Overall Study|Protocol Violation|2|||
105776186|NCT02364999|364831485|FG000|Overall Study|Withdrawal by Subject|14|||
105776187|NCT02364999|364831486|FG001|Overall Study|Withdrawal by Subject|14|||
105776188|NCT02364999|364831485|FG000|Overall Study|Other|0|||
105776189|NCT02364999|364831486|FG001|Overall Study|Other|1|||
105776190|NCT02364999|364831485|FG000|Overall Study|Randomized but did not receive treatment|2|||
105776191|NCT02364999|364831486|FG001|Overall Study|Randomized but did not receive treatment|3|||
105776192|NCT00696774|364831490|FG000|Period II|Adverse Event|0|||
105776193|NCT00696774|364831491|FG001|Period II|Adverse Event|0|||
105776194|NCT00696774|364831492|FG002|Period II|Adverse Event|15|||
105776195|NCT00696774|364831490|FG000|Period II|Lost to Follow-up|0|||
105776196|NCT00696774|364831491|FG001|Period II|Lost to Follow-up|0|||
105776197|NCT00696774|364831492|FG002|Period II|Lost to Follow-up|4|||
105776198|NCT00696774|364831490|FG000|Period II|Protocol Violation|0|||
105776199|NCT00696774|364831491|FG001|Period II|Protocol Violation|0|||
105776200|NCT00696774|364831492|FG002|Period II|Protocol Violation|11|||
105776201|NCT00696774|364831490|FG000|Period II|Withdrawal by Subject|0|||
105776202|NCT00696774|364831491|FG001|Period II|Withdrawal by Subject|0|||
105776203|NCT00696774|364831492|FG002|Period II|Withdrawal by Subject|4|||
105776204|NCT00696774|364831490|FG000|Period II|Sponsor Decision|0|||
105776205|NCT00696774|364831491|FG001|Period II|Sponsor Decision|0|||
105776206|NCT00696774|364831492|FG002|Period II|Sponsor Decision|0|||
105776207|NCT00696774|364831490|FG000|Period II|Lack of Efficacy|0|||
105776208|NCT00696774|364831491|FG001|Period II|Lack of Efficacy|0|||
105776209|NCT00696774|364831492|FG002|Period II|Lack of Efficacy|2|||
105776210|NCT00696774|364831490|FG000|Period III|Adverse Event|1|||
105776211|NCT00696774|364831491|FG001|Period III|Adverse Event|1|||
105776212|NCT00696774|364831492|FG002|Period III|Adverse Event|0|||
105776213|NCT00696774|364831490|FG000|Period III|Lost to Follow-up|2|||
105776214|NCT00696774|364831491|FG001|Period III|Lost to Follow-up|1|||
105776215|NCT00696774|364831492|FG002|Period III|Lost to Follow-up|0|||
105776216|NCT00696774|364831490|FG000|Period III|Protocol Violation|1|||
105776217|NCT00696774|364831491|FG001|Period III|Protocol Violation|1|||
105776218|NCT00696774|364831492|FG002|Period III|Protocol Violation|0|||
105776219|NCT00696774|364831490|FG000|Period III|Withdrawal by Subject|1|||
105776220|NCT00696774|364831491|FG001|Period III|Withdrawal by Subject|2|||
105776221|NCT00696774|364831492|FG002|Period III|Withdrawal by Subject|0|||
105776222|NCT00696774|364831490|FG000|Period III|Sponsor Decision|2|||
105776223|NCT00696774|364831491|FG001|Period III|Sponsor Decision|0|||
105776224|NCT00696774|364831492|FG002|Period III|Sponsor Decision|0|||
105776225|NCT00696774|364831490|FG000|Period III|Lack of Efficacy|0|||
105776226|NCT00696774|364831491|FG001|Period III|Lack of Efficacy|2|||
105776227|NCT00696774|364831492|FG002|Period III|Lack of Efficacy|0|||
105776228|NCT03490734|364831502|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
105776229|NCT03490734|364831503|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
105776230|NCT03490734|364831504|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
105776231|NCT03490734|364831505|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
105776232|NCT03490734|364831502|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
105776233|NCT03490734|364831503|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
105776234|NCT03490734|364831504|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
105776235|NCT03490734|364831505|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
105776236|NCT03490734|364831502|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
105776237|NCT03490734|364831503|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
105776238|NCT03490734|364831504|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
105776239|NCT03490734|364831505|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
105776240|NCT03490734|364831502|FG000|Post-intervention Scan Visit|Adverse Event|2|||
105776241|NCT03490734|364831503|FG001|Post-intervention Scan Visit|Adverse Event|0|||
105776242|NCT03490734|364831504|FG002|Post-intervention Scan Visit|Adverse Event|0|||
105776243|NCT03490734|364831505|FG003|Post-intervention Scan Visit|Adverse Event|0|||
105776244|NCT03490734|364831502|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
105776245|NCT03490734|364831503|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
105776246|NCT03490734|364831504|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
105776247|NCT03490734|364831505|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
105776248|NCT03490734|364831502|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
105776249|NCT03490734|364831503|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
105776250|NCT03490734|364831504|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
105776251|NCT03490734|364831505|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
105776252|NCT00890201|364831508|FG000|Overall Study|Protocol Violation|5|||
105776253|NCT00890201|364831509|FG001|Overall Study|Protocol Violation|56|||
105776254|NCT01289028|364831510|FG000|Overall Study|Progressive Disease|49|||
105776255|NCT01289028|364831510|FG000|Overall Study|Adverse Event|14|||
105776256|NCT01289028|364831510|FG000|Overall Study|Withdrawal by Subject|6|||
105776257|NCT01289028|364831510|FG000|Overall Study|Death|4|||
105776258|NCT01289028|364831510|FG000|Overall Study|Lack of Efficacy|2|||
105776259|NCT01289028|364831510|FG000|Overall Study|No longer required|2|||
105776260|NCT01289028|364831510|FG000|Overall Study|Lost to Follow-up|2|||
105776261|NCT01289028|364831510|FG000|Overall Study|New Cancer Therapy|2|||
105776262|NCT01289028|364831510|FG000|Overall Study|Abnormal Lab Value|1|||
105776263|NCT01289028|364831510|FG000|Overall Study|Missing reason for discon|1|||
105776264|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
106099771|NCT00626522|366022630|FG002|Overall Study|Protocol Violation|0|||
106099772|NCT00626522|366022631|FG003|Overall Study|Protocol Violation|0|||
105776265|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
105776266|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
105776267|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
105776268|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
105776269|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
105776270|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
105776271|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
105776272|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
105776273|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
105776274|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
105776275|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
105776276|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776277|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776278|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776279|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
105776280|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776281|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
105776282|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
105776283|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
105776284|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
105776285|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
105776286|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
105776287|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
105776288|NCT03099304|364831512|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
105776289|NCT03099304|364831513|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
105776290|NCT03099304|364831514|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
105776291|NCT03099304|364831515|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
105776292|NCT03099304|364831516|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
105776293|NCT03099304|364831517|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
105776294|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776295|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776296|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
105776297|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776298|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776299|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
105776300|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
105776301|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
105776302|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
105776303|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
105776304|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
105776305|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
105776306|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
105776307|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
105776308|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
105776309|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
105776310|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
105776311|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
105776312|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
105776313|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
105776314|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
105776315|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
105776316|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
105776317|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
105776318|NCT03099304|364831512|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776319|NCT03099304|364831513|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776320|NCT03099304|364831514|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776321|NCT03099304|364831515|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
105776322|NCT03099304|364831516|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776323|NCT03099304|364831517|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
105776324|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
105776325|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
105776326|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
105776327|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
105776328|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
105776329|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
105776330|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
105776331|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
105776332|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
105776333|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
105776334|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
105776335|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
105776336|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
105776337|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
105776338|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
105776339|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
105776340|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
105776341|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
105776342|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
105776343|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
105776344|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
105776345|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
105776346|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
105776347|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
105776348|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
105776349|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
105776350|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
105776351|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
105776352|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
105776353|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
105776354|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
105776355|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
105776356|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
105776357|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
105776358|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
105776359|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
105776360|NCT03099304|364831512|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
105776361|NCT03099304|364831513|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
105776362|NCT03099304|364831514|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
105776363|NCT03099304|364831515|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
105776364|NCT03099304|364831516|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
105776365|NCT03099304|364831517|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
105776366|NCT00472043|364831518|FG000|Overall Study|Withdrawal by Subject|1|||
105776367|NCT00472043|364831519|FG001|Overall Study|Withdrawal by Subject|0|||
105776368|NCT00472043|364831518|FG000|Overall Study|Death|1|||
105776369|NCT00472043|364831519|FG001|Overall Study|Death|0|||
105776370|NCT00715949|364831522|FG000|Overall Study|could not finish first test|4|||
105776371|NCT02590406|364831525|FG000|Overall Study|Adverse Event|1|||
105776372|NCT02590406|364831526|FG001|Overall Study|Adverse Event|0|||
105776373|NCT02590406|364831525|FG000|Overall Study|Saturometer malfunction|0|||
105776374|NCT02590406|364831526|FG001|Overall Study|Saturometer malfunction|1|||
105776375|NCT02363322|364831542|FG000|Overall Study|Lost to Follow-up|1|||
105776376|NCT02363322|364831543|FG001|Overall Study|Lost to Follow-up|0|||
105776377|NCT01843933|364831544|FG000|Overall Study|Data lost|6|||
105776378|NCT01843933|364831545|FG001|Overall Study|Data lost|4|||
105776379|NCT02055976|364831546|FG000|Overall Study|Other|0|||
105776380|NCT02055976|364831547|FG001|Overall Study|Other|0|||
105776381|NCT02055976|364831548|FG002|Overall Study|Other|1|||
105776382|NCT02055976|364831549|FG003|Overall Study|Other|0|||
105776383|NCT02055976|364831550|FG004|Overall Study|Other|0|||
105776384|NCT02055976|364831551|FG005|Overall Study|Other|0|||
105776385|NCT02055976|364831552|FG006|Overall Study|Other|0|||
105776386|NCT02055976|364831553|FG007|Overall Study|Other|0|||
105776387|NCT02055976|364831554|FG008|Overall Study|Other|0|||
105776388|NCT02055976|364831546|FG000|Overall Study|Adverse Event|0|||
105776389|NCT02055976|364831547|FG001|Overall Study|Adverse Event|0|||
105776390|NCT02055976|364831548|FG002|Overall Study|Adverse Event|0|||
105776391|NCT02055976|364831549|FG003|Overall Study|Adverse Event|0|||
105776392|NCT02055976|364831550|FG004|Overall Study|Adverse Event|0|||
105776393|NCT02055976|364831551|FG005|Overall Study|Adverse Event|1|||
105776394|NCT02055976|364831552|FG006|Overall Study|Adverse Event|1|||
105776395|NCT02055976|364831553|FG007|Overall Study|Adverse Event|0|||
105776396|NCT02055976|364831554|FG008|Overall Study|Adverse Event|0|||
105776397|NCT02055976|364831546|FG000|Overall Study|Does not meet entrance criteria|0|||
105776398|NCT02055976|364831547|FG001|Overall Study|Does not meet entrance criteria|0|||
105776399|NCT02055976|364831548|FG002|Overall Study|Does not meet entrance criteria|0|||
105776400|NCT02055976|364831549|FG003|Overall Study|Does not meet entrance criteria|0|||
105776401|NCT02055976|364831550|FG004|Overall Study|Does not meet entrance criteria|0|||
105776402|NCT02055976|364831551|FG005|Overall Study|Does not meet entrance criteria|0|||
105776403|NCT02055976|364831552|FG006|Overall Study|Does not meet entrance criteria|1|||
105776404|NCT02055976|364831553|FG007|Overall Study|Does not meet entrance criteria|0|||
105776405|NCT02055976|364831554|FG008|Overall Study|Does not meet entrance criteria|0|||
105776406|NCT02055976|364831546|FG000|Overall Study|Lost to Follow-up|0|||
105776407|NCT02055976|364831547|FG001|Overall Study|Lost to Follow-up|0|||
105776408|NCT02055976|364831548|FG002|Overall Study|Lost to Follow-up|0|||
105776409|NCT02055976|364831549|FG003|Overall Study|Lost to Follow-up|1|||
105776410|NCT02055976|364831550|FG004|Overall Study|Lost to Follow-up|0|||
105776411|NCT02055976|364831551|FG005|Overall Study|Lost to Follow-up|0|||
105776412|NCT02055976|364831552|FG006|Overall Study|Lost to Follow-up|0|||
105776413|NCT02055976|364831553|FG007|Overall Study|Lost to Follow-up|0|||
105776414|NCT02055976|364831554|FG008|Overall Study|Lost to Follow-up|0|||
105776415|NCT02504424|364831555|FG000|Overall Study|Withdrawal by Subject|2|||
105776416|NCT02146352|364831557|FG000|Overall Study|Death|1|||
105776417|NCT02146352|364831557|FG000|Overall Study|Patient entered hospice care|1|||
105776418|NCT02561572|364831562|FG000|Overall Study|Inadequate time before surgery|2|||
105776419|NCT02561572|364831563|FG001|Overall Study|Inadequate time before surgery|1|||
105776420|NCT02561572|364831562|FG000|Overall Study|Protocol Violation|0|||
105776421|NCT02561572|364831563|FG001|Overall Study|Protocol Violation|1|||
105776422|NCT01021423|364831565|FG000|Overall Study|Study terminated|4|||
105776423|NCT01021423|364831566|FG001|Overall Study|Study terminated|5|||
105776424|NCT02475564|364831568|FG000|Overall Study|Withdrawal by Subject|1|||
105776425|NCT02475564|364831569|FG001|Overall Study|Withdrawal by Subject|0|||
105776426|NCT02475564|364831568|FG000|Overall Study|Lost to Follow-up|2|||
105776427|NCT02475564|364831569|FG001|Overall Study|Lost to Follow-up|1|||
105776428|NCT02475564|364831568|FG000|Overall Study|Intense Menstrual bleeding|1|||
105776429|NCT02475564|364831569|FG001|Overall Study|Intense Menstrual bleeding|0|||
105776430|NCT01156012|364831570|FG000|Overall Study|Adverse Event|3|||
105776431|NCT01156012|364831571|FG001|Overall Study|Adverse Event|1|||
105776432|NCT01156012|364831570|FG000|Overall Study|Lost to Follow-up|1|||
105776433|NCT01156012|364831571|FG001|Overall Study|Lost to Follow-up|0|||
105776434|NCT01156012|364831570|FG000|Overall Study|Withdrawal by Subject|1|||
105776435|NCT01156012|364831571|FG001|Overall Study|Withdrawal by Subject|0|||
105776436|NCT01156012|364831570|FG000|Overall Study|use of commercial drug instead of study|0|||
105776437|NCT01156012|364831571|FG001|Overall Study|use of commercial drug instead of study|1|||
105776438|NCT01156012|364831570|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
105776439|NCT01156012|364831571|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
105776440|NCT03619902|364831572|FG000|Overall Study|Termination of Study by Investigator|1|||
105776441|NCT03619902|364831572|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
105776442|NCT00939094|364831573|FG000|Overall Study|Adverse Event|9|||
105776443|NCT00939094|364831574|FG001|Overall Study|Adverse Event|0|||
105776444|NCT00939094|364831573|FG000|Overall Study|Withdrawal by Subject|1|||
105776445|NCT00939094|364831574|FG001|Overall Study|Withdrawal by Subject|6|||
105776446|NCT00939094|364831573|FG000|Overall Study|Lost to Follow-up|1|||
105776447|NCT00939094|364831574|FG001|Overall Study|Lost to Follow-up|1|||
105776448|NCT00939094|364831573|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105776449|NCT00939094|364831574|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105776450|NCT00939094|364831573|FG000|Overall Study|Severe non-compliance to protocol|0|||
105776451|NCT00939094|364831574|FG001|Overall Study|Severe non-compliance to protocol|1|||
105776452|NCT00939094|364831573|FG000|Overall Study|Study stopped by sponsor|0|||
105776453|NCT00939094|364831574|FG001|Overall Study|Study stopped by sponsor|2|||
105776454|NCT00939094|364831573|FG000|Overall Study|Abnormal ECG findings|1|||
105776455|NCT00939094|364831574|FG001|Overall Study|Abnormal ECG findings|0|||
105776456|NCT02705755|364831575|FG000|Part A (6 Days)|Adverse Event|1|||
105776457|NCT02705755|364831576|FG001|Part A (6 Days)|Adverse Event|0|||
105776458|NCT02705755|364831577|FG002|Part A (6 Days)|Adverse Event|0|||
105776459|NCT02705755|364831578|FG003|Part A (6 Days)|Adverse Event|0|||
105776460|NCT02705755|364831575|FG000|Part A (6 Days)|Physician Decision|3|||
105776461|NCT02705755|364831576|FG001|Part A (6 Days)|Physician Decision|0|||
105776462|NCT02705755|364831577|FG002|Part A (6 Days)|Physician Decision|0|||
105776463|NCT02705755|364831578|FG003|Part A (6 Days)|Physician Decision|0|||
105776464|NCT02705755|364831575|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
105776465|NCT02705755|364831576|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
105776466|NCT02705755|364831577|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
105776467|NCT02705755|364831578|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
105776468|NCT02705755|364831575|FG000|Part C (20 Weeks)|Physician Decision|0|||
105776469|NCT02705755|364831576|FG001|Part C (20 Weeks)|Physician Decision|0|||
105776470|NCT02705755|364831577|FG002|Part C (20 Weeks)|Physician Decision|0|||
105776471|NCT02705755|364831578|FG003|Part C (20 Weeks)|Physician Decision|2|||
105776472|NCT02705755|364831575|FG000|Part C (20 Weeks)|Adverse Event|0|||
105776473|NCT02705755|364831576|FG001|Part C (20 Weeks)|Adverse Event|0|||
105776474|NCT02705755|364831577|FG002|Part C (20 Weeks)|Adverse Event|0|||
105776475|NCT02705755|364831578|FG003|Part C (20 Weeks)|Adverse Event|6|||
105776476|NCT02705755|364831575|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
105776477|NCT02705755|364831576|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
105776478|NCT02705755|364831577|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
105776479|NCT02705755|364831578|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
105776480|NCT00424463|364831579|FG000|Overall Study|Adverse Event|2|||
105776481|NCT00424463|364831580|FG001|Overall Study|Adverse Event|3|||
105776482|NCT00424463|364831581|FG002|Overall Study|Adverse Event|2|||
105776483|NCT00424463|364831579|FG000|Overall Study|Physician Decision|0|||
105776484|NCT00424463|364831580|FG001|Overall Study|Physician Decision|2|||
105776485|NCT00424463|364831581|FG002|Overall Study|Physician Decision|2|||
105776486|NCT00424463|364831579|FG000|Overall Study|Withdrawal by Subject|4|||
105776487|NCT00424463|364831580|FG001|Overall Study|Withdrawal by Subject|2|||
105776488|NCT00424463|364831581|FG002|Overall Study|Withdrawal by Subject|5|||
105776489|NCT00424463|364831579|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
105776490|NCT00424463|364831580|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
105776491|NCT00424463|364831581|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
105776492|NCT00424463|364831579|FG000|Overall Study|Patient's convenience|0|||
105776493|NCT00424463|364831580|FG001|Overall Study|Patient's convenience|0|||
105776494|NCT00424463|364831581|FG002|Overall Study|Patient's convenience|1|||
105776495|NCT01906489|364831582|FG000|Overall Study|Adverse Event|10|||
105776496|NCT01906489|364831583|FG001|Overall Study|Adverse Event|3|||
105776497|NCT01906489|364831582|FG000|Overall Study|Worsening of CKD|6|||
105776498|NCT01906489|364831583|FG001|Overall Study|Worsening of CKD|4|||
105776499|NCT01906489|364831582|FG000|Overall Study|Withdrawal by Subject|5|||
105776500|NCT01906489|364831583|FG001|Overall Study|Withdrawal by Subject|0|||
105776501|NCT01906489|364831582|FG000|Overall Study|Worsening of Anemia|1|||
105776502|NCT01906489|364831583|FG001|Overall Study|Worsening of Anemia|0|||
105776503|NCT01906489|364831582|FG000|Overall Study|Protocol Violation|0|||
105776504|NCT01906489|364831583|FG001|Overall Study|Protocol Violation|1|||
105776505|NCT01906489|364831582|FG000|Overall Study|Non- Compliance|1|||
105776506|NCT01906489|364831583|FG001|Overall Study|Non- Compliance|0|||
105776507|NCT01906489|364831582|FG000|Overall Study|Sponsor Decision|1|||
105776508|NCT01906489|364831583|FG001|Overall Study|Sponsor Decision|0|||
105776509|NCT01906489|364831582|FG000|Overall Study|Lost to Follow-up|1|||
105776510|NCT01906489|364831583|FG001|Overall Study|Lost to Follow-up|1|||
105776511|NCT01906489|364831582|FG000|Overall Study|Other|1|||
105776512|NCT01906489|364831583|FG001|Overall Study|Other|0|||
105776513|NCT01021293|364831584|FG000|Overall Study|Serious Adverse Event|2|||
105776514|NCT01021293|364831585|FG001|Overall Study|Serious Adverse Event|1|||
105776515|NCT01021293|364831584|FG000|Overall Study|Adverse Event|2|||
105776516|NCT01021293|364831585|FG001|Overall Study|Adverse Event|1|||
105776517|NCT01021293|364831584|FG000|Overall Study|Withdrawal by Subject|1|||
105776518|NCT01021293|364831585|FG001|Overall Study|Withdrawal by Subject|3|||
105776519|NCT01021293|364831584|FG000|Overall Study|Migrated/moved from study area|6|||
105776520|NCT01021293|364831585|FG001|Overall Study|Migrated/moved from study area|18|||
105776521|NCT01021293|364831584|FG000|Overall Study|Lost to Follow-up|1|||
105776522|NCT01021293|364831585|FG001|Overall Study|Lost to Follow-up|1|||
105776523|NCT04728815|364831586|FG000|Overall Study|Lost to Follow-up|3|||
105776524|NCT04728815|364831587|FG001|Overall Study|Lost to Follow-up|0|||
105776525|NCT04728815|364831588|FG002|Overall Study|Lost to Follow-up|0|||
105776526|NCT04728815|364831589|FG003|Overall Study|Lost to Follow-up|1|||
105776527|NCT04728815|364831590|FG004|Overall Study|Lost to Follow-up|1|||
105776528|NCT04728815|364831591|FG005|Overall Study|Lost to Follow-up|0|||
105776529|NCT04728815|364831592|FG006|Overall Study|Lost to Follow-up|2|||
105776530|NCT04728815|364831593|FG007|Overall Study|Lost to Follow-up|0|||
105776531|NCT04728815|364831586|FG000|Overall Study|Physician Decision|0|||
105776532|NCT04728815|364831587|FG001|Overall Study|Physician Decision|0|||
105776533|NCT04728815|364831588|FG002|Overall Study|Physician Decision|1|||
105776534|NCT04728815|364831589|FG003|Overall Study|Physician Decision|0|||
105776535|NCT04728815|364831590|FG004|Overall Study|Physician Decision|0|||
105776536|NCT04728815|364831591|FG005|Overall Study|Physician Decision|0|||
105776537|NCT04728815|364831592|FG006|Overall Study|Physician Decision|0|||
105776538|NCT04728815|364831593|FG007|Overall Study|Physician Decision|0|||
105776539|NCT04728815|364831586|FG000|Overall Study|Treatment drop|0|||
105776540|NCT04728815|364831587|FG001|Overall Study|Treatment drop|2|||
105776541|NCT04728815|364831588|FG002|Overall Study|Treatment drop|1|||
105776542|NCT04728815|364831589|FG003|Overall Study|Treatment drop|0|||
105776543|NCT04728815|364831590|FG004|Overall Study|Treatment drop|3|||
105776544|NCT04728815|364831591|FG005|Overall Study|Treatment drop|1|||
105776545|NCT04728815|364831592|FG006|Overall Study|Treatment drop|3|||
105776546|NCT04728815|364831593|FG007|Overall Study|Treatment drop|0|||
105776547|NCT04728815|364831586|FG000|Overall Study|Study drop|0|||
105776548|NCT04728815|364831587|FG001|Overall Study|Study drop|3|||
105776549|NCT04728815|364831588|FG002|Overall Study|Study drop|3|||
105776550|NCT04728815|364831589|FG003|Overall Study|Study drop|0|||
105776551|NCT04728815|364831590|FG004|Overall Study|Study drop|0|||
105776552|NCT04728815|364831591|FG005|Overall Study|Study drop|0|||
105776553|NCT04728815|364831592|FG006|Overall Study|Study drop|7|||
105776554|NCT04728815|364831593|FG007|Overall Study|Study drop|0|||
105776555|NCT00631969|364831594|FG000|Overall Study|Adverse Event|3|||
105776556|NCT00631969|364831595|FG001|Overall Study|Adverse Event|1|||
105776557|NCT00631969|364831594|FG000|Overall Study|Lack of Efficacy|2|||
105776558|NCT00631969|364831595|FG001|Overall Study|Lack of Efficacy|8|||
105776559|NCT00631969|364831594|FG000|Overall Study|Lost to Follow-up|2|||
105776560|NCT00631969|364831595|FG001|Overall Study|Lost to Follow-up|1|||
105776561|NCT00631969|364831594|FG000|Overall Study|Protocol Violation|1|||
105776562|NCT00631969|364831595|FG001|Overall Study|Protocol Violation|1|||
105776563|NCT00631969|364831594|FG000|Overall Study|Consent Withdrawn|5|||
105776564|NCT00631969|364831595|FG001|Overall Study|Consent Withdrawn|7|||
105776565|NCT00631969|364831594|FG000|Overall Study|Noncompliant With Study Medication|0|||
105776566|NCT00631969|364831595|FG001|Overall Study|Noncompliant With Study Medication|1|||
105776567|NCT00631969|364831594|FG000|Overall Study|No Drug Exposure|2|||
105776568|NCT00631969|364831595|FG001|Overall Study|No Drug Exposure|2|||
105776569|NCT03053180|364833260|FG000|Overall Study|Failure to Return|1|||
105776570|NCT00959192|364833265|FG000|Overall Study|Adverse Event|1|||
105776571|NCT00959192|364833266|FG001|Overall Study|Adverse Event|1|||
105776572|NCT00959192|364833267|FG002|Overall Study|Adverse Event|1|||
105776573|NCT00959192|364833268|FG003|Overall Study|Adverse Event|0|||
105776574|NCT00959192|364833265|FG000|Overall Study|Investigator Request|1|||
105776575|NCT00959192|364833266|FG001|Overall Study|Investigator Request|0|||
105776576|NCT00959192|364833267|FG002|Overall Study|Investigator Request|0|||
105776577|NCT00959192|364833268|FG003|Overall Study|Investigator Request|0|||
105776578|NCT00959192|364833265|FG000|Overall Study|Caregiver Request|0|||
105776579|NCT00959192|364833266|FG001|Overall Study|Caregiver Request|0|||
105776580|NCT00959192|364833267|FG002|Overall Study|Caregiver Request|2|||
105776581|NCT00959192|364833268|FG003|Overall Study|Caregiver Request|1|||
105776582|NCT00532441|364833269|FG000|Overall Study|Death|1|||
105776583|NCT00532441|364833270|FG001|Overall Study|Death|0|||
105776584|NCT05466240|364833271|FG000|Overall Study|Adverse Event|1|||
105776585|NCT05466240|364833272|FG001|Overall Study|Adverse Event|0|||
105776586|NCT05466240|364833271|FG000|Overall Study|Withdrawal by Subject|1|||
105776587|NCT05466240|364833272|FG001|Overall Study|Withdrawal by Subject|0|||
105776588|NCT01603615|364833274|FG000|Overall Study|Did not Receive Treatment|7|||
105776589|NCT01603615|364833274|FG000|Overall Study|Lost to Follow-up|9|||
105776590|NCT01603615|364833274|FG000|Overall Study|Personal Reasons|17|||
105776591|NCT01603615|364833274|FG000|Overall Study|Other Miscellaneous|1|||
105776592|NCT02759939|364833275|FG000|Overall Study|Missing data on first outcome assessed|11|||
105776593|NCT02759939|364833276|FG001|Overall Study|Missing data on first outcome assessed|2|||
105776594|NCT02759939|364833277|FG002|Overall Study|Missing data on first outcome assessed|5|||
105776595|NCT02759939|364833278|FG003|Overall Study|Missing data on first outcome assessed|2|||
105776596|NCT02759939|364833275|FG000|Overall Study|Ineligible for T2 and T3|310|||
105776597|NCT02759939|364833276|FG001|Overall Study|Ineligible for T2 and T3|179|||
105776598|NCT02759939|364833277|FG002|Overall Study|Ineligible for T2 and T3|366|||
105776599|NCT02759939|364833278|FG003|Overall Study|Ineligible for T2 and T3|391|||
105776600|NCT02759939|364833275|FG000|Overall Study|Lost to Follow-up|735|||
105776601|NCT02759939|364833276|FG001|Overall Study|Lost to Follow-up|791|||
105776602|NCT02759939|364833277|FG002|Overall Study|Lost to Follow-up|783|||
105776603|NCT02759939|364833278|FG003|Overall Study|Lost to Follow-up|650|||
105776604|NCT04735432|364833279|FG000|Overall Study|Other - due to personal reason|1|||
105776605|NCT04735432|364833280|FG001|Overall Study|Other - due to personal reason|0|||
105776606|NCT04735432|364833279|FG000|Overall Study|Adverse Event|2|||
105776607|NCT04735432|364833280|FG001|Overall Study|Adverse Event|0|||
105776608|NCT00413231|364833281|FG000|0 to 30-day Post Treatment|Death|5|||
105776609|NCT00413231|364833281|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
105776610|NCT00413231|364833281|FG000|30-day to 365-day Post Treatment|Death|13|||
105776611|NCT00413231|364833281|FG000|365-day to 60-month Post Treatment|Death|36|||
105776612|NCT00413231|364833281|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
105776613|NCT00413231|364833281|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
105776614|NCT00413231|364833281|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
105776615|NCT03228836|364833286|FG000|Overall Study|Adverse Event|3|||
105776616|NCT03228836|364833286|FG000|Overall Study|Withdrawal by Subject|1|||
105776617|NCT03228836|364833286|FG000|Overall Study|Death|1|||
105776618|NCT03228836|364833286|FG000|Overall Study|Physician Decision|1|||
105776619|NCT03228836|364833286|FG000|Overall Study|Disease Progression|7|||
105776620|NCT03228836|364833286|FG000|Overall Study|Other|4|||
105776621|NCT02870348|364833292|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
105776622|NCT00829010|364833295|FG000|Overall Study|Adverse Event|1|||
105776623|NCT00829010|364833296|FG001|Overall Study|Adverse Event|0|||
105776624|NCT00829010|364833297|FG002|Overall Study|Adverse Event|0|||
105776625|NCT00829010|364833298|FG003|Overall Study|Adverse Event|0|||
105776626|NCT00829010|364833299|FG004|Overall Study|Adverse Event|0|||
105776627|NCT00829010|364833295|FG000|Overall Study|Withdrawal by Subject|0|||
105776628|NCT00829010|364833296|FG001|Overall Study|Withdrawal by Subject|1|||
105776629|NCT00829010|364833297|FG002|Overall Study|Withdrawal by Subject|1|||
105776630|NCT00829010|364833298|FG003|Overall Study|Withdrawal by Subject|0|||
105776631|NCT00829010|364833299|FG004|Overall Study|Withdrawal by Subject|2|||
105776632|NCT00829010|364833295|FG000|Overall Study|Lost to Follow-up|1|||
105776633|NCT00829010|364833296|FG001|Overall Study|Lost to Follow-up|0|||
105776634|NCT00829010|364833297|FG002|Overall Study|Lost to Follow-up|2|||
105776635|NCT00829010|364833298|FG003|Overall Study|Lost to Follow-up|0|||
105776636|NCT00829010|364833299|FG004|Overall Study|Lost to Follow-up|0|||
105776637|NCT00829010|364833295|FG000|Overall Study|Fatality|5|||
105776638|NCT00829010|364833296|FG001|Overall Study|Fatality|4|||
105776639|NCT00829010|364833297|FG002|Overall Study|Fatality|0|||
105776640|NCT00829010|364833298|FG003|Overall Study|Fatality|3|||
105776641|NCT00829010|364833299|FG004|Overall Study|Fatality|0|||
105776642|NCT00829010|364833295|FG000|Overall Study|Migrated/Moved from study area|3|||
105776643|NCT00829010|364833296|FG001|Overall Study|Migrated/Moved from study area|4|||
105776644|NCT00829010|364833297|FG002|Overall Study|Migrated/Moved from study area|0|||
105776645|NCT00829010|364833298|FG003|Overall Study|Migrated/Moved from study area|5|||
105776646|NCT00829010|364833299|FG004|Overall Study|Migrated/Moved from study area|0|||
105776647|NCT04005885|364833313|FG000|First Intervention|Withdrawal by Subject|1|||
105776648|NCT04005885|364833314|FG001|First Intervention|Withdrawal by Subject|1|||
105776649|NCT04005885|364833313|FG000|Second Intervention|Withdrawal by Subject|0|||
105776650|NCT04005885|364833314|FG001|Second Intervention|Withdrawal by Subject|2|||
105776651|NCT02718625|364833319|FG000|Overall Study|Adverse Event|0|||
105776652|NCT02718625|364833320|FG001|Overall Study|Adverse Event|1|||
105776653|NCT02718625|364833319|FG000|Overall Study|Termination of Study by Sponsor|0|||
105776654|NCT02718625|364833320|FG001|Overall Study|Termination of Study by Sponsor|1|||
105776655|NCT00381706|364833321|FG000|Overall Study|Never treated|7|||
105776656|NCT00381706|364833322|FG001|Overall Study|Never treated|2|||
105776657|NCT00381706|364833323|FG002|Overall Study|Never treated|1|||
105776658|NCT01796106|364833325|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
105776659|NCT01796106|364833326|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
105776660|NCT01234337|364833333|FG000|Overall Study|Adverse Event|58|||
105776661|NCT01234337|364833334|FG001|Overall Study|Adverse Event|21|||
105776662|NCT01234337|364833333|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
105776663|NCT01234337|364833334|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
105776664|NCT01234337|364833333|FG000|Overall Study|Investi. decision not protocol driven|5|||
105776665|NCT01234337|364833334|FG001|Overall Study|Investi. decision not protocol driven|6|||
105776666|NCT01234337|364833333|FG000|Overall Study|Non-compliant with study medication|3|||
105776667|NCT01234337|364833334|FG001|Overall Study|Non-compliant with study medication|2|||
105776668|NCT01234337|364833333|FG000|Overall Study|Randomized but not treated|6|||
105776669|NCT01234337|364833334|FG001|Overall Study|Randomized but not treated|4|||
105776670|NCT01234337|364833333|FG000|Overall Study|Lost to Follow-up|0|||
105776671|NCT01234337|364833334|FG001|Overall Study|Lost to Follow-up|1|||
105776672|NCT01234337|364833333|FG000|Overall Study|Protocol Violation|2|||
105776673|NCT01234337|364833334|FG001|Overall Study|Protocol Violation|3|||
105776674|NCT01234337|364833333|FG000|Overall Study|Withdrawal by Subject|11|||
105776675|NCT01234337|364833334|FG001|Overall Study|Withdrawal by Subject|9|||
105776676|NCT01234337|364833333|FG000|Overall Study|Death|0|||
105776677|NCT01234337|364833334|FG001|Overall Study|Death|1|||
105776678|NCT01234337|364833333|FG000|Overall Study|Switch to commercial drug|0|||
105776679|NCT01234337|364833334|FG001|Overall Study|Switch to commercial drug|1|||
105776680|NCT03481634|364833335|FG000|Overall Study|Withdrawal by Subject|16|||
105776681|NCT03481634|364833336|FG001|Overall Study|Withdrawal by Subject|19|||
105776682|NCT03481634|364833337|FG002|Overall Study|Withdrawal by Subject|14|||
105776683|NCT03481634|364833335|FG000|Overall Study|Protocol Violation|1|||
105776684|NCT03481634|364833336|FG001|Overall Study|Protocol Violation|0|||
105776685|NCT03481634|364833337|FG002|Overall Study|Protocol Violation|1|||
105776686|NCT03481634|364833335|FG000|Overall Study|Progressive disease|0|||
105776687|NCT03481634|364833336|FG001|Overall Study|Progressive disease|1|||
105776688|NCT03481634|364833337|FG002|Overall Study|Progressive disease|0|||
105776689|NCT03481634|364833335|FG000|Overall Study|Physician Decision|3|||
105776690|NCT03481634|364833336|FG001|Overall Study|Physician Decision|0|||
105776691|NCT03481634|364833337|FG002|Overall Study|Physician Decision|1|||
105776692|NCT03481634|364833335|FG000|Overall Study|Lost to Follow-up|3|||
105776693|NCT03481634|364833336|FG001|Overall Study|Lost to Follow-up|4|||
105776694|NCT03481634|364833337|FG002|Overall Study|Lost to Follow-up|4|||
105776695|NCT03481634|364833335|FG000|Overall Study|Death|4|||
105776696|NCT03481634|364833336|FG001|Overall Study|Death|8|||
105776697|NCT03481634|364833337|FG002|Overall Study|Death|7|||
105776698|NCT03481634|364833335|FG000|Overall Study|Adverse Event|6|||
105776699|NCT03481634|364833336|FG001|Overall Study|Adverse Event|3|||
105776700|NCT03481634|364833337|FG002|Overall Study|Adverse Event|7|||
105776701|NCT03323385|364833345|FG000|Overall Study|Withdrawal by Subject|1|||
105776702|NCT03323385|364833346|FG001|Overall Study|Withdrawal by Subject|2|||
105776703|NCT03323385|364833345|FG000|Overall Study|Noncompliance|0|||
105776704|NCT03323385|364833346|FG001|Overall Study|Noncompliance|1|||
105776705|NCT00033293|364833347|FG000|Overall Study|Death|0|||
105776706|NCT00033293|364833348|FG001|Overall Study|Death|1|||
105776707|NCT00033293|364833347|FG000|Overall Study|Lack of Efficacy|5|||
105776708|NCT00033293|364833348|FG001|Overall Study|Lack of Efficacy|8|||
105776709|NCT00033293|364833347|FG000|Overall Study|Lost to Follow-up|0|||
105776710|NCT00033293|364833348|FG001|Overall Study|Lost to Follow-up|1|||
105776711|NCT00033293|364833347|FG000|Overall Study|Physician Decision|3|||
105776712|NCT00033293|364833348|FG001|Overall Study|Physician Decision|1|||
105776713|NCT00033293|364833347|FG000|Overall Study|Withdrawal by Subject|1|||
105776714|NCT00033293|364833348|FG001|Overall Study|Withdrawal by Subject|0|||
105776715|NCT00033293|364833347|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
105776716|NCT00033293|364833348|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
105776717|NCT00033293|364833347|FG000|Overall Study|Treatment refused|0|||
105776718|NCT00033293|364833348|FG001|Overall Study|Treatment refused|6|||
105776719|NCT02555722|364833349|FG000|Week 2|Adverse Event|0|||
105776720|NCT02555722|364833350|FG001|Week 2|Adverse Event|1|||
105776721|NCT02555722|364833349|FG000|Week 2|Withdrawal by Subject|1|||
105776722|NCT02555722|364833350|FG001|Week 2|Withdrawal by Subject|0|||
105776723|NCT02555722|364833349|FG000|Month 1|Lens Discomfort|1|||
105776724|NCT02555722|364833350|FG001|Month 1|Lens Discomfort|0|||
105776725|NCT02555722|364833349|FG000|Month 2|Withdrawal by Subject|3|||
105776726|NCT02555722|364833350|FG001|Month 2|Withdrawal by Subject|0|||
105776727|NCT02555722|364833349|FG000|Month 2|Lost to Follow-up|1|||
105776728|NCT02555722|364833350|FG001|Month 2|Lost to Follow-up|0|||
105776729|NCT00374452|364833351|FG000|Overall Study|Left clinic before intervention started|4|||
105776730|NCT00374452|364833352|FG001|Overall Study|Left clinic before intervention started|1|||
105776731|NCT00374452|364833351|FG000|Overall Study|Change in job role before intervention|0|||
105776732|NCT00374452|364833352|FG001|Overall Study|Change in job role before intervention|1|||
105776733|NCT00374452|364833351|FG000|Overall Study|Left clinic after intervention started|1|||
105776734|NCT00374452|364833352|FG001|Overall Study|Left clinic after intervention started|1|||
105776735|NCT00374452|364833351|FG000|Overall Study|Withdrawal by Subject|0|||
105776736|NCT00374452|364833352|FG001|Overall Study|Withdrawal by Subject|2|||
105776737|NCT02802735|364833355|FG000|Overall Study|Withdrawal by Subject|0|||
105776738|NCT02802735|364833356|FG001|Overall Study|Withdrawal by Subject|1|||
105776739|NCT02802735|364833357|FG002|Overall Study|Withdrawal by Subject|0|||
105776740|NCT02802735|364833358|FG003|Overall Study|Withdrawal by Subject|0|||
105776741|NCT02802735|364833359|FG004|Overall Study|Withdrawal by Subject|0|||
105776742|NCT01326910|364833360|FG000|Overall Study|Withdrawal by Subject|3|||
105776743|NCT01326910|364833361|FG001|Overall Study|Withdrawal by Subject|2|||
105776744|NCT01326910|364833360|FG000|Overall Study|Protocol Violation|1|||
105776745|NCT01326910|364833361|FG001|Overall Study|Protocol Violation|1|||
105776746|NCT02036476|364833370|FG000|Overall Study|Withdrawal by Subject|2|||
105776747|NCT02036476|364833370|FG000|Overall Study|Progressive Disease|4|||
106099773|NCT00626522|366022632|FG004|Overall Study|Protocol Violation|1|||
105776748|NCT02036476|364833370|FG000|Overall Study|Unacceptable Toxicity|2|||
105776749|NCT01241318|364833374|FG000|Overall Study|Woman: false pregnancies|27|||
105776750|NCT01241318|364833375|FG001|Overall Study|Woman: false pregnancies|15|||
105776751|NCT01241318|364833374|FG000|Overall Study|Woman: miscarriage/abortion|46|||
105776752|NCT01241318|364833375|FG001|Overall Study|Woman: miscarriage/abortion|38|||
105776753|NCT01241318|364833374|FG000|Overall Study|Withdrawal by Subject|175|||
105776754|NCT01241318|364833375|FG001|Overall Study|Withdrawal by Subject|46|||
105776755|NCT01241318|364833374|FG000|Overall Study|Lost to Follow-up|740|||
105776756|NCT01241318|364833375|FG001|Overall Study|Lost to Follow-up|455|||
105776757|NCT01241318|364833374|FG000|Overall Study|Death|2|||
105776758|NCT01241318|364833375|FG001|Overall Study|Death|4|||
105776759|NCT01241318|364833374|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
105776760|NCT01241318|364833375|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
105776761|NCT01241318|364833374|FG000|Overall Study|Woman: Stillborn infant|129|||
105776762|NCT01241318|364833375|FG001|Overall Study|Woman: Stillborn infant|146|||
105776763|NCT00606021|364833378|FG000|Induction Phase|Death|73|||
105776764|NCT00606021|364833379|FG001|Induction Phase|Death|0|||
105776765|NCT00606021|364833380|FG002|Induction Phase|Death|0|||
105776766|NCT00606021|364833378|FG000|Induction Phase|Physician Decision|2|||
105776767|NCT00606021|364833379|FG001|Induction Phase|Physician Decision|0|||
105776768|NCT00606021|364833380|FG002|Induction Phase|Physician Decision|0|||
105776769|NCT00606021|364833378|FG000|Induction Phase|Withdrawal by Subject|2|||
105776770|NCT00606021|364833379|FG001|Induction Phase|Withdrawal by Subject|0|||
105776771|NCT00606021|364833380|FG002|Induction Phase|Withdrawal by Subject|0|||
105776772|NCT00606021|364833378|FG000|Induction Phase|Lost to Follow-up|10|||
105776773|NCT00606021|364833379|FG001|Induction Phase|Lost to Follow-up|0|||
105776774|NCT00606021|364833380|FG002|Induction Phase|Lost to Follow-up|0|||
105776775|NCT00606021|364833378|FG000|Maintenance Phase|Death|0|||
105776776|NCT00606021|364833379|FG001|Maintenance Phase|Death|17|||
105776777|NCT00606021|364833380|FG002|Maintenance Phase|Death|15|||
105776778|NCT00606021|364833378|FG000|Maintenance Phase|Physician Decision|0|||
105776779|NCT00606021|364833379|FG001|Maintenance Phase|Physician Decision|1|||
105776780|NCT00606021|364833380|FG002|Maintenance Phase|Physician Decision|0|||
105776781|NCT00606021|364833378|FG000|Maintenance Phase|Lost to Follow-up|0|||
105776782|NCT00606021|364833379|FG001|Maintenance Phase|Lost to Follow-up|5|||
105776783|NCT00606021|364833380|FG002|Maintenance Phase|Lost to Follow-up|2|||
105776784|NCT01362049|364833381|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
105776785|NCT01362049|364833382|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
105776786|NCT01362049|364833383|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
105776787|NCT01362049|364833384|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
105776788|NCT01362049|364833381|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
105776789|NCT01362049|364833382|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
105776790|NCT01362049|364833383|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
105776791|NCT01362049|364833384|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
105776792|NCT02853318|364833389|FG000|Overall Study|Withdrawal by Subject|1|||
105776793|NCT00252499|364833390|FG000|Overall Study|Lost to Follow-up|1|||
105776794|NCT00252499|364833391|FG001|Overall Study|Lost to Follow-up|0|||
105776795|NCT00252499|364833392|FG002|Overall Study|Lost to Follow-up|0|||
105776796|NCT00554840|364833397|FG000|Overall Study|Physician Decision|0|||
105776797|NCT00554840|364833398|FG001|Overall Study|Physician Decision|1|||
105776798|NCT01385098|364833399|FG000|Overall Study|Adverse Event|10|||
105776799|NCT01385098|364833399|FG000|Overall Study|Lost to Follow-up|4|||
105776800|NCT01230827|364833400|FG000|Overall Study|Lost to Follow-up|0|||
105776801|NCT01230827|364833401|FG001|Overall Study|Lost to Follow-up|0|||
105776802|NCT01230827|364833402|FG002|Overall Study|Lost to Follow-up|1|||
105776803|NCT01230827|364833403|FG003|Overall Study|Lost to Follow-up|3|||
105776804|NCT01230827|364833400|FG000|Overall Study|Withdrawal by Subject|1|||
105776805|NCT01230827|364833401|FG001|Overall Study|Withdrawal by Subject|0|||
105776806|NCT01230827|364833402|FG002|Overall Study|Withdrawal by Subject|3|||
105776807|NCT01230827|364833403|FG003|Overall Study|Withdrawal by Subject|2|||
105776808|NCT01230827|364833400|FG000|Overall Study|Lack of Efficacy|14|||
105776809|NCT01230827|364833401|FG001|Overall Study|Lack of Efficacy|1|||
105776810|NCT01230827|364833402|FG002|Overall Study|Lack of Efficacy|2|||
105776811|NCT01230827|364833403|FG003|Overall Study|Lack of Efficacy|3|||
105776812|NCT01230827|364833400|FG000|Overall Study|Adverse Event|4|||
105776813|NCT01230827|364833401|FG001|Overall Study|Adverse Event|2|||
105776814|NCT01230827|364833402|FG002|Overall Study|Adverse Event|3|||
105776815|NCT01230827|364833403|FG003|Overall Study|Adverse Event|7|||
105776816|NCT01230827|364833400|FG000|Overall Study|Recovery|0|||
105776817|NCT01230827|364833401|FG001|Overall Study|Recovery|6|||
105776818|NCT01230827|364833402|FG002|Overall Study|Recovery|0|||
105776819|NCT01230827|364833403|FG003|Overall Study|Recovery|0|||
105776820|NCT01230827|364833400|FG000|Overall Study|Study terminated by Sponsor|0|||
105776821|NCT01230827|364833401|FG001|Overall Study|Study terminated by Sponsor|2|||
105776822|NCT01230827|364833402|FG002|Overall Study|Study terminated by Sponsor|56|||
105776823|NCT01230827|364833403|FG003|Overall Study|Study terminated by Sponsor|63|||
105776824|NCT00925522|364833411|FG000|Overall Study|study closed -- business decision|20|||
105776825|NCT01854918|364833414|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
105776826|NCT01854918|364833415|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
105776827|NCT01854918|364833414|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
105776828|NCT01854918|364833415|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
106099774|NCT00626522|366022633|FG005|Overall Study|Protocol Violation|0|||
105776829|NCT01854918|364833414|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
105776830|NCT01854918|364833415|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
105776831|NCT01854918|364833414|FG000|SOC-controlled Period (Year 1)|Death|5|||
105776832|NCT01854918|364833415|FG001|SOC-controlled Period (Year 1)|Death|5|||
105776833|NCT01854918|364833414|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
105776834|NCT01854918|364833415|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
105776835|NCT01854918|364833414|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
105776836|NCT01854918|364833415|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
105776837|NCT01854918|364833414|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
105776838|NCT01854918|364833415|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
105776839|NCT01854918|364833414|FG000|All-IP Period (Years 2 and 3)|Death|5|||
105776840|NCT01854918|364833415|FG001|All-IP Period (Years 2 and 3)|Death|16|||
105776841|NCT02918006|364833417|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
105776842|NCT02918006|364833418|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
105776843|NCT02918006|364833419|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
105776844|NCT02918006|364833417|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
105776845|NCT02918006|364833418|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
105776846|NCT02918006|364833419|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
105776847|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
105776848|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
105776849|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
105776850|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
105776851|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
105776852|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
105776853|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
105776854|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
105776855|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
105776856|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
105776857|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
105776858|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
105776859|NCT02918006|364833417|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
105776860|NCT02918006|364833418|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
105776861|NCT02918006|364833419|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
105776862|NCT02918006|364833417|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
105776863|NCT02918006|364833418|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
105776864|NCT02918006|364833419|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
105776865|NCT02918006|364833417|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
105776866|NCT02918006|364833418|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
105776867|NCT02918006|364833419|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
105776868|NCT00122317|364833420|FG000|Overall Study|Death|3|||
105776869|NCT00122317|364833420|FG000|Overall Study|Adverse Event|4|||
105776870|NCT00122317|364833420|FG000|Overall Study|Physician Decision|2|||
105776871|NCT00122317|364833420|FG000|Overall Study|patient non-compliance|1|||
105776872|NCT00122317|364833420|FG000|Overall Study|Withdrawal by Subject|1|||
105776873|NCT02886338|364833421|FG000|Overall Study|Withdrawal by Subject|1|||
105776874|NCT00394654|364833422|FG000|Overall Study|Lost to Follow-up|1|||
105776875|NCT00394654|364833423|FG001|Overall Study|Lost to Follow-up|0|||
105776876|NCT00394654|364833422|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
105776877|NCT00394654|364833423|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
105776878|NCT00656799|364833424|FG000|Overall Study|Death|2|||
105776879|NCT00027027|364835692|FG000|Overall Study|Adverse Event|0|||
105776880|NCT00027027|364835693|FG001|Overall Study|Adverse Event|0|||
105776881|NCT00027027|364835694|FG002|Overall Study|Adverse Event|1|||
105776882|NCT00027027|364835695|FG003|Overall Study|Adverse Event|0|||
105776883|NCT00027027|364835696|FG004|Overall Study|Adverse Event|1|||
105776884|NCT00027027|364835692|FG000|Overall Study|Admitted for Signs of PD|0|||
105776885|NCT00027027|364835693|FG001|Overall Study|Admitted for Signs of PD|0|||
105776886|NCT00027027|364835694|FG002|Overall Study|Admitted for Signs of PD|0|||
105776887|NCT00027027|364835695|FG003|Overall Study|Admitted for Signs of PD|0|||
105776888|NCT00027027|364835696|FG004|Overall Study|Admitted for Signs of PD|1|||
105776889|NCT00027027|364835692|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
105776890|NCT00027027|364835693|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
105776891|NCT00027027|364835694|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
105776892|NCT00027027|364835695|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
105776893|NCT00027027|364835696|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
105776894|NCT00027027|364835692|FG000|Overall Study|PD Requiring Surgery|0|||
105776895|NCT00027027|364835693|FG001|Overall Study|PD Requiring Surgery|0|||
105776896|NCT00027027|364835694|FG002|Overall Study|PD Requiring Surgery|1|||
105776897|NCT00027027|364835695|FG003|Overall Study|PD Requiring Surgery|0|||
105776898|NCT00027027|364835696|FG004|Overall Study|PD Requiring Surgery|0|||
105776899|NCT00027027|364835692|FG000|Overall Study|Physician Decision Due To PD|2|||
105776900|NCT00027027|364835693|FG001|Overall Study|Physician Decision Due To PD|3|||
105776901|NCT00027027|364835694|FG002|Overall Study|Physician Decision Due To PD|2|||
105776902|NCT00027027|364835695|FG003|Overall Study|Physician Decision Due To PD|3|||
105776903|NCT00027027|364835696|FG004|Overall Study|Physician Decision Due To PD|5|||
105776904|NCT00027027|364835692|FG000|Overall Study|Withdrawal by Subject|0|||
105776905|NCT00027027|364835693|FG001|Overall Study|Withdrawal by Subject|0|||
105776906|NCT00027027|364835694|FG002|Overall Study|Withdrawal by Subject|0|||
105776907|NCT00027027|364835695|FG003|Overall Study|Withdrawal by Subject|0|||
105776908|NCT00027027|364835696|FG004|Overall Study|Withdrawal by Subject|1|||
105776909|NCT03758612|364835699|FG000|Washout Period|Withdrawal by Subject|0|||
105776910|NCT03758612|364835700|FG001|Washout Period|Withdrawal by Subject|0|||
105776911|NCT03758612|364835701|FG002|Washout Period|Withdrawal by Subject|2|||
105776912|NCT03758612|364835702|FG003|Washout Period|Withdrawal by Subject|0|||
105776913|NCT03758612|364835703|FG004|Washout Period|Withdrawal by Subject|0|||
105776914|NCT03758612|364835704|FG005|Washout Period|Withdrawal by Subject|0|||
105776915|NCT03758612|364835705|FG006|Washout Period|Withdrawal by Subject|0|||
105776916|NCT03758612|364835706|FG007|Washout Period|Withdrawal by Subject|0|||
105776917|NCT03758612|364835707|FG008|Washout Period|Withdrawal by Subject|0|||
105776918|NCT03758612|364835708|FG009|Washout Period|Withdrawal by Subject|0|||
105776919|NCT03758612|364835709|FG010|Washout Period|Withdrawal by Subject|0|||
105776920|NCT03758612|364835710|FG011|Washout Period|Withdrawal by Subject|0|||
105776921|NCT03758612|364835699|FG000|Period 2|Protocol Violation|0|||
105776922|NCT03758612|364835700|FG001|Period 2|Protocol Violation|0|||
105776923|NCT03758612|364835701|FG002|Period 2|Protocol Violation|0|||
105776924|NCT03758612|364835702|FG003|Period 2|Protocol Violation|0|||
105776925|NCT03758612|364835703|FG004|Period 2|Protocol Violation|1|||
105776926|NCT03758612|364835704|FG005|Period 2|Protocol Violation|0|||
105776927|NCT03758612|364835705|FG006|Period 2|Protocol Violation|0|||
105776928|NCT03758612|364835706|FG007|Period 2|Protocol Violation|0|||
105776929|NCT03758612|364835707|FG008|Period 2|Protocol Violation|0|||
105776930|NCT03758612|364835708|FG009|Period 2|Protocol Violation|0|||
105776931|NCT03758612|364835709|FG010|Period 2|Protocol Violation|0|||
105776932|NCT03758612|364835710|FG011|Period 2|Protocol Violation|0|||
105776933|NCT01967134|364835711|FG000|Overall Study|Lost to Follow-up|0|||
105776934|NCT01967134|364835712|FG001|Overall Study|Lost to Follow-up|1|||
105776935|NCT01967134|364835713|FG002|Overall Study|Lost to Follow-up|0|||
105776936|NCT05158244|364835718|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
105776937|NCT05158244|364835719|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
105776938|NCT05158244|364835720|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
105776939|NCT05158244|364835721|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
105776940|NCT05158244|364835722|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
105776941|NCT05158244|364835718|FG000|Overall Study|Withdrawal by Subject|0|||
105776942|NCT05158244|364835719|FG001|Overall Study|Withdrawal by Subject|0|||
105776943|NCT05158244|364835720|FG002|Overall Study|Withdrawal by Subject|1|||
105776944|NCT05158244|364835721|FG003|Overall Study|Withdrawal by Subject|0|||
105776945|NCT05158244|364835722|FG004|Overall Study|Withdrawal by Subject|0|||
105776946|NCT00125138|364835723|FG000|Overall Study|Adverse Event|1|||
105776947|NCT00125138|364835724|FG001|Overall Study|Adverse Event|0|||
105776948|NCT00125138|364835725|FG002|Overall Study|Adverse Event|3|||
105776949|NCT00125138|364835726|FG003|Overall Study|Adverse Event|2|||
105776950|NCT00125138|364835723|FG000|Overall Study|Withdrawal by Subject|2|||
105776951|NCT00125138|364835724|FG001|Overall Study|Withdrawal by Subject|3|||
105776952|NCT00125138|364835725|FG002|Overall Study|Withdrawal by Subject|1|||
105776953|NCT00125138|364835726|FG003|Overall Study|Withdrawal by Subject|1|||
105776954|NCT00125138|364835723|FG000|Overall Study|Lack of Efficacy|0|||
105776955|NCT00125138|364835724|FG001|Overall Study|Lack of Efficacy|0|||
105776956|NCT00125138|364835725|FG002|Overall Study|Lack of Efficacy|0|||
105776957|NCT00125138|364835726|FG003|Overall Study|Lack of Efficacy|1|||
105776958|NCT00125138|364835723|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
105776959|NCT00125138|364835724|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
105776960|NCT00125138|364835725|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
105776961|NCT00125138|364835726|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
105776962|NCT02630459|364835727|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776963|NCT02630459|364835728|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
105776964|NCT02630459|364835729|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776965|NCT02630459|364835730|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
105776966|NCT02630459|364835731|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776967|NCT02630459|364835732|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776968|NCT02630459|364835733|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776969|NCT02630459|364835734|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
105776970|NCT02630459|364835727|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776971|NCT02630459|364835728|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776972|NCT02630459|364835729|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
105776973|NCT02630459|364835730|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776974|NCT02630459|364835731|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776975|NCT02630459|364835732|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776976|NCT02630459|364835733|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776977|NCT02630459|364835734|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
105776978|NCT02630459|364835727|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
105776979|NCT02630459|364835728|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
105776980|NCT02630459|364835729|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
105776981|NCT02630459|364835730|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
105776982|NCT02630459|364835731|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
105776983|NCT02630459|364835732|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
105776984|NCT02630459|364835733|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
105776985|NCT02630459|364835734|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
105776986|NCT02630459|364835727|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
105776987|NCT02630459|364835728|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776988|NCT02630459|364835729|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776989|NCT02630459|364835730|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776990|NCT02630459|364835731|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776991|NCT02630459|364835732|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776992|NCT02630459|364835733|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776993|NCT02630459|364835734|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
105776994|NCT02630459|364835727|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105776995|NCT02630459|364835728|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105776996|NCT02630459|364835729|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105776997|NCT02630459|364835730|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105776998|NCT02630459|364835731|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
105776999|NCT02630459|364835732|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
105777000|NCT02630459|364835733|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105777001|NCT02630459|364835734|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
105777002|NCT02630459|364835727|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777003|NCT02630459|364835728|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777004|NCT02630459|364835729|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777005|NCT02630459|364835730|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777006|NCT02630459|364835731|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
105777007|NCT02630459|364835732|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
105777008|NCT02630459|364835733|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777009|NCT02630459|364835734|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
105777010|NCT02630459|364835727|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777011|NCT02630459|364835728|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777012|NCT02630459|364835729|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777013|NCT02630459|364835730|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777014|NCT02630459|364835731|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
105777015|NCT02630459|364835732|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777016|NCT02630459|364835733|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777017|NCT02630459|364835734|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
105777018|NCT01453439|364835735|FG000|Treatment Phase|Withdrawal by Subject|13|||
105777019|NCT01453439|364835736|FG001|Treatment Phase|Withdrawal by Subject|10|||
105777020|NCT01453439|364835735|FG000|Treatment Phase|Suicidal Ideation|2|||
105777021|NCT01453439|364835736|FG001|Treatment Phase|Suicidal Ideation|0|||
105777022|NCT01453439|364835735|FG000|Treatment Phase|Need for higher level of care|1|||
105777023|NCT01453439|364835736|FG001|Treatment Phase|Need for higher level of care|1|||
105777024|NCT01453439|364835735|FG000|Treatment Phase|Therapist conflict of interest|1|||
105777025|NCT01453439|364835736|FG001|Treatment Phase|Therapist conflict of interest|0|||
105777026|NCT01453439|364835735|FG000|Follow-up|Withdrawal by Subject|0|||
105777027|NCT01453439|364835736|FG001|Follow-up|Withdrawal by Subject|1|||
105777028|NCT01453439|364835735|FG000|Follow-up|Lost to Follow-up|5|||
105777029|NCT01453439|364835736|FG001|Follow-up|Lost to Follow-up|10|||
105777030|NCT00568399|364835743|FG000|Overall Study|Death|2|||
105777031|NCT00568399|364835743|FG000|Overall Study|Adverse Event|5|||
105777032|NCT00568399|364835743|FG000|Overall Study|Withdrawal by Subject|8|||
105777033|NCT02967562|364835750|FG000|Overall Study|Consent not obtained|1|||
105777034|NCT02967562|364835751|FG001|Overall Study|Consent not obtained|0|||
105777035|NCT02967562|364835750|FG000|Overall Study|High leak precluding analysis|1|||
105777036|NCT02967562|364835751|FG001|Overall Study|High leak precluding analysis|1|||
105777037|NCT00089505|364835752|FG000|Overall Study|Death|4|||
105777038|NCT00089505|364835753|FG001|Overall Study|Death|1|||
105777039|NCT00089505|364835754|FG002|Overall Study|Death|5|||
105777040|NCT00089505|364835755|FG003|Overall Study|Death|8|||
105777041|NCT00089505|364835752|FG000|Overall Study|Withdrawal by Subject|3|||
105777042|NCT00089505|364835753|FG001|Overall Study|Withdrawal by Subject|0|||
105777043|NCT00089505|364835754|FG002|Overall Study|Withdrawal by Subject|6|||
105777044|NCT00089505|364835755|FG003|Overall Study|Withdrawal by Subject|6|||
105777045|NCT00089505|364835752|FG000|Overall Study|Lost to Follow-up|1|||
105777046|NCT00089505|364835753|FG001|Overall Study|Lost to Follow-up|1|||
105777047|NCT00089505|364835754|FG002|Overall Study|Lost to Follow-up|9|||
105777048|NCT00089505|364835755|FG003|Overall Study|Lost to Follow-up|7|||
105777049|NCT00089505|364835752|FG000|Overall Study|Physician Decision|1|||
105777050|NCT00089505|364835753|FG001|Overall Study|Physician Decision|0|||
105777051|NCT00089505|364835754|FG002|Overall Study|Physician Decision|0|||
105777052|NCT00089505|364835755|FG003|Overall Study|Physician Decision|0|||
105777053|NCT00089505|364835752|FG000|Overall Study|Protocol Violation|0|||
105777054|NCT00089505|364835753|FG001|Overall Study|Protocol Violation|0|||
105777055|NCT00089505|364835754|FG002|Overall Study|Protocol Violation|1|||
105777056|NCT00089505|364835755|FG003|Overall Study|Protocol Violation|0|||
105777057|NCT02519777|364835756|FG000|Overall Study|Death|1|||
105777058|NCT02519777|364835757|FG001|Overall Study|Death|0|||
105777059|NCT02519777|364835758|FG002|Overall Study|Death|0|||
105777060|NCT02519777|364835756|FG000|Overall Study|Lost to Follow-up|0|||
105777061|NCT02519777|364835757|FG001|Overall Study|Lost to Follow-up|4|||
105777062|NCT02519777|364835758|FG002|Overall Study|Lost to Follow-up|2|||
105777063|NCT02519777|364835756|FG000|Overall Study|Withdrawal by Subject|3|||
105777064|NCT02519777|364835757|FG001|Overall Study|Withdrawal by Subject|1|||
105777065|NCT02519777|364835758|FG002|Overall Study|Withdrawal by Subject|0|||
105777066|NCT02519777|364835756|FG000|Overall Study|Severe Debilitation|1|||
105777067|NCT02519777|364835757|FG001|Overall Study|Severe Debilitation|1|||
105777068|NCT02519777|364835758|FG002|Overall Study|Severe Debilitation|1|||
105777069|NCT02519777|364835756|FG000|Overall Study|Not able to get to clinic|1|||
105777070|NCT02519777|364835757|FG001|Overall Study|Not able to get to clinic|2|||
105777071|NCT02519777|364835758|FG002|Overall Study|Not able to get to clinic|1|||
105777072|NCT02195531|364835759|FG000|Overall Study|Withdrawal by Subject|1|||
105777073|NCT02195531|364835760|FG001|Overall Study|Withdrawal by Subject|1|||
105777074|NCT02195531|364835761|FG002|Overall Study|Withdrawal by Subject|1|||
105777075|NCT01038635|364835762|FG000|Overall Study|Disease Progression|2|||
105777076|NCT01038635|364835763|FG001|Overall Study|Disease Progression|0|||
105777077|NCT01038635|364835764|FG002|Overall Study|Disease Progression|0|||
105777078|NCT01038635|364835765|FG003|Overall Study|Disease Progression|0|||
105777079|NCT01038635|364835766|FG004|Overall Study|Disease Progression|0|||
105777080|NCT01038635|364835767|FG005|Overall Study|Disease Progression|0|||
105777081|NCT01038635|364835768|FG006|Overall Study|Disease Progression|1|||
105777082|NCT01038635|364835769|FG007|Overall Study|Disease Progression|4|||
105777083|NCT01038635|364835770|FG008|Overall Study|Disease Progression|0|||
105777084|NCT01038635|364835762|FG000|Overall Study|Death|0|||
105777085|NCT01038635|364835763|FG001|Overall Study|Death|0|||
105777086|NCT01038635|364835764|FG002|Overall Study|Death|0|||
105777087|NCT01038635|364835765|FG003|Overall Study|Death|0|||
105777088|NCT01038635|364835766|FG004|Overall Study|Death|1|||
105777089|NCT01038635|364835767|FG005|Overall Study|Death|0|||
105777090|NCT01038635|364835768|FG006|Overall Study|Death|1|||
105777091|NCT01038635|364835769|FG007|Overall Study|Death|1|||
105777092|NCT01038635|364835770|FG008|Overall Study|Death|2|||
105777093|NCT01562327|364835771|FG000|Overall Study|Adverse Event|2|||
105777094|NCT01562327|364835771|FG000|Overall Study|Lack of Efficacy|1|||
105777095|NCT01562327|364835771|FG000|Overall Study|Participant drop-out|1|||
105777096|NCT01562327|364835771|FG000|Overall Study|Infusion not received at 6 month window|4|||
105777097|NCT01836549|364835772|FG000|Overall Study|Did not receive study drug|0|||
105777098|NCT01836549|364835773|FG001|Overall Study|Did not receive study drug|0|||
105777099|NCT01836549|364835774|FG002|Overall Study|Did not receive study drug|1|||
105777100|NCT01836549|364835775|FG003|Overall Study|Did not receive study drug|0|||
105777101|NCT01836549|364835776|FG004|Overall Study|Did not receive study drug|0|||
105777102|NCT01836549|364835777|FG005|Overall Study|Did not receive study drug|0|||
105777103|NCT01836549|364835778|FG006|Overall Study|Did not receive study drug|0|||
105777104|NCT01836549|364835772|FG000|Overall Study|Patient declared ineligible|0|||
105777105|NCT01836549|364835773|FG001|Overall Study|Patient declared ineligible|0|||
105777106|NCT01836549|364835774|FG002|Overall Study|Patient declared ineligible|0|||
105777107|NCT01836549|364835775|FG003|Overall Study|Patient declared ineligible|1|||
105777108|NCT01836549|364835776|FG004|Overall Study|Patient declared ineligible|0|||
105777109|NCT01836549|364835777|FG005|Overall Study|Patient declared ineligible|0|||
105777110|NCT01836549|364835778|FG006|Overall Study|Patient declared ineligible|0|||
105777111|NCT01836549|364835772|FG000|Overall Study|Patient inevaluable to start therapy|0|||
105777112|NCT01836549|364835773|FG001|Overall Study|Patient inevaluable to start therapy|0|||
105777113|NCT01836549|364835774|FG002|Overall Study|Patient inevaluable to start therapy|0|||
105777114|NCT01836549|364835775|FG003|Overall Study|Patient inevaluable to start therapy|0|||
105777115|NCT01836549|364835776|FG004|Overall Study|Patient inevaluable to start therapy|0|||
105777116|NCT01836549|364835777|FG005|Overall Study|Patient inevaluable to start therapy|0|||
105777117|NCT01836549|364835778|FG006|Overall Study|Patient inevaluable to start therapy|1|||
105777118|NCT01969565|364835781|FG000|Overall Study|Withdrawal by Subject|1|||
105777119|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Adverse Event|30|||
105777120|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Adverse Event|25|||
105777121|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Adverse Event|23|||
105777122|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Adverse Event|14|||
105777123|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Death|0|||
105777124|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Death|0|||
105777125|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Death|1|||
105777126|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Death|0|||
105777127|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Physician Decision|0|||
105777128|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Physician Decision|1|||
105777129|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Physician Decision|0|||
105777130|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Physician Decision|1|||
105777131|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
105777132|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
105777133|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
105777134|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
105777135|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Other|6|||
105777136|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Other|1|||
105777137|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Other|0|||
105777138|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Other|2|||
105777139|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
105777140|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
105777141|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
105777142|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
105777143|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
105777144|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
105777145|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
105777146|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
105777147|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
105777148|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
105777149|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
105777150|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
105777151|NCT00242710|364835782|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
105777152|NCT00242710|364835783|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
105777153|NCT00242710|364835784|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
105777154|NCT00242710|364835785|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
105777155|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Adverse Event|2|||
105777156|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Adverse Event|3|||
105777157|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Adverse Event|5|||
105777158|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Adverse Event|2|||
105777159|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Physician Decision|1|||
105777160|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Physician Decision|1|||
105777161|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Physician Decision|0|||
105777162|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Physician Decision|0|||
105777163|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Other|24|||
105777164|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Other|24|||
105777165|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Other|9|||
105777166|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Other|11|||
105777167|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Extension not Available|17|||
105777168|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Extension not Available|21|||
105777169|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Extension not Available|8|||
105777170|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Extension not Available|7|||
105777171|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
105777172|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
105777173|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
105777174|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
105777175|NCT00242710|364835782|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
105777176|NCT00242710|364835783|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
105777177|NCT00242710|364835784|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
105777178|NCT00242710|364835785|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
105777179|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
105777180|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
105777181|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
105777182|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
105777183|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Death|0|||
105777184|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Death|0|||
105777185|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Death|0|||
105777186|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Death|1|||
105777187|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
105777188|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
105777189|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
105777190|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
105777191|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Other|3|||
105777192|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Other|5|||
105777193|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Other|4|||
105777194|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Other|3|||
105777195|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
105777196|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
105777197|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
105777198|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
105777199|NCT00242710|364835782|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
105777200|NCT00242710|364835783|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
105777201|NCT00242710|364835784|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
105777202|NCT00242710|364835785|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
105777203|NCT01683058|364835789|FG000|Overall Study|Lost to Follow-up|9|||
105777204|NCT01683058|364835789|FG000|Overall Study|Adverse Event|6|||
105777205|NCT01683058|364835789|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
105777206|NCT01683058|364835789|FG000|Overall Study|Withdrawal by Subject|7|||
105777207|NCT01683058|364835789|FG000|Overall Study|Lack of Efficacy|2|||
105777208|NCT01957111|364835790|FG000|Overall Study|Withdrawal by Subject|1|||
105777209|NCT01957111|364835791|FG001|Overall Study|Withdrawal by Subject|1|||
105777210|NCT00203294|364835794|FG000|Overall Study|Withdrawal by Subject|8|||
105777211|NCT00203294|364835795|FG001|Overall Study|Withdrawal by Subject|13|||
105777212|NCT00082628|364835796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
105777213|NCT00082628|364835797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
105777214|NCT00082628|364835798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
105777215|NCT00082628|364835799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
105777216|NCT00082628|364835800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
105777217|NCT00082628|364835796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
105777218|NCT00082628|364835797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
105777219|NCT00082628|364835798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
105777220|NCT00082628|364835799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
105777221|NCT00082628|364835800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
105777222|NCT00082628|364835796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
105777223|NCT00082628|364835797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
105777224|NCT00082628|364835798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
105777225|NCT00082628|364835799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
105777226|NCT00082628|364835800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
105777227|NCT00082628|364835796|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
105777228|NCT00082628|364835797|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
105777229|NCT00082628|364835798|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
105777230|NCT00082628|364835799|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
105777231|NCT00082628|364835800|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
105777232|NCT00082628|364835796|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
105777233|NCT00082628|364835797|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
105777234|NCT00082628|364835798|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
105777235|NCT00082628|364835799|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
105777236|NCT00082628|364835800|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
105777237|NCT00082628|364835796|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
105777238|NCT00082628|364835797|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
105777239|NCT00082628|364835798|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
105777240|NCT00082628|364835799|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
105777241|NCT00082628|364835800|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
105777242|NCT00082628|364835796|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
105777243|NCT00082628|364835797|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
105777244|NCT00082628|364835798|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
105777245|NCT00082628|364835799|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
105777246|NCT00082628|364835800|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
105777247|NCT00550615|364835801|FG000|Overall Study|Withdrawal by Subject|0|||
105777248|NCT00550615|364835802|FG001|Overall Study|Withdrawal by Subject|0|||
106099775|NCT00626522|366022628|FG000|Overall Study|Adverse Event|2|||
106099776|NCT00626522|366022629|FG001|Overall Study|Adverse Event|1|||
105777249|NCT00550615|364835803|FG002|Overall Study|Withdrawal by Subject|2|||
105777250|NCT00550615|364835804|FG003|Overall Study|Withdrawal by Subject|3|||
105777251|NCT00550615|364835801|FG000|Overall Study|Not evaluable|0|||
105777252|NCT00550615|364835802|FG001|Overall Study|Not evaluable|0|||
105777253|NCT00550615|364835803|FG002|Overall Study|Not evaluable|2|||
105777254|NCT00550615|364835804|FG003|Overall Study|Not evaluable|7|||
105777255|NCT02405091|364835805|FG000|Overall Study|Adverse Event|16|||
105777256|NCT02405091|364835806|FG001|Overall Study|Adverse Event|10|||
105777257|NCT02405091|364835807|FG002|Overall Study|Adverse Event|0|||
105777258|NCT02405091|364835805|FG000|Overall Study|Protocol Violation|1|||
105777259|NCT02405091|364835806|FG001|Overall Study|Protocol Violation|0|||
105777260|NCT02405091|364835807|FG002|Overall Study|Protocol Violation|0|||
105777261|NCT02405091|364835805|FG000|Overall Study|Noncompliance|1|||
105777262|NCT02405091|364835806|FG001|Overall Study|Noncompliance|6|||
105777263|NCT02405091|364835807|FG002|Overall Study|Noncompliance|2|||
105777264|NCT02405091|364835805|FG000|Overall Study|Withdrawal by Subject|4|||
105777265|NCT02405091|364835806|FG001|Overall Study|Withdrawal by Subject|8|||
105777266|NCT02405091|364835807|FG002|Overall Study|Withdrawal by Subject|0|||
105777267|NCT02405091|364835805|FG000|Overall Study|Death|0|||
105777268|NCT02405091|364835806|FG001|Overall Study|Death|1|||
105777269|NCT02405091|364835807|FG002|Overall Study|Death|0|||
105777270|NCT02405091|364835805|FG000|Overall Study|Lost to Follow-up|5|||
105777271|NCT02405091|364835806|FG001|Overall Study|Lost to Follow-up|6|||
105777272|NCT02405091|364835807|FG002|Overall Study|Lost to Follow-up|0|||
105777273|NCT02405091|364835805|FG000|Overall Study|Physician Decision|2|||
105777274|NCT02405091|364835806|FG001|Overall Study|Physician Decision|2|||
105777275|NCT02405091|364835807|FG002|Overall Study|Physician Decision|0|||
105777276|NCT04491591|364835808|FG000|Overall Study|Accidently randomized|3|||
105777277|NCT04491591|364835809|FG001|Overall Study|Accidently randomized|1|||
105777278|NCT04491591|364835810|FG002|Overall Study|Accidently randomized|0|||
105777279|NCT04491591|364835808|FG000|Overall Study|Did not complete survey|28|||
105777280|NCT04491591|364835809|FG001|Overall Study|Did not complete survey|20|||
105777281|NCT04491591|364835810|FG002|Overall Study|Did not complete survey|3|||
105777282|NCT03480360|364835811|FG000|Overall Study|Death|2|||
105777283|NCT00523744|364835815|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
105777284|NCT00523744|364835815|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
105777285|NCT00523744|364835815|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
105777286|NCT00523744|364835815|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
105777287|NCT00523744|364835815|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
105777288|NCT00523744|364835815|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
105777289|NCT00636506|364835816|FG000|Overall Study|Lost to Follow-up|8|||
105777290|NCT00636506|364835816|FG000|Overall Study|Explanted|1|||
105777291|NCT00636506|364835816|FG000|Overall Study|Withdrawal by Subject|6|||
105777292|NCT00636506|364835816|FG000|Overall Study|Procedure aborted|1|||
105777293|NCT03742271|364835817|FG000|Overall Study|Unsatisfactory Visual Response|1|||
105777294|NCT03742271|364835817|FG000|Overall Study|Withdrawal by Subject|3|||
105777295|NCT03742271|364835817|FG000|Overall Study|Lost to Follow-up|4|||
105777296|NCT03742271|364835817|FG000|Overall Study|Failed Insertion & removal|3|||
105777297|NCT03742271|364835817|FG000|Overall Study|Protocol Violation|1|||
105777298|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
105777299|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
105777300|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
105777301|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
105777302|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
105777303|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
105777304|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
105777305|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
105777306|NCT01624974|364835818|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
105777307|NCT01624974|364835819|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
105777308|NCT01624974|364835818|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
105777309|NCT01624974|364835819|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
105777310|NCT01624974|364835818|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
105777311|NCT01624974|364835819|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
105777312|NCT01624974|364835818|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
105777313|NCT01624974|364835819|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
105777314|NCT01624974|364835818|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
105777315|NCT01624974|364835819|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
105777316|NCT01624974|364835818|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
105990733|NCT01677858|365624427|FG001|Overall Study|Adverse Event|0|||
105990734|NCT01677858|365624428|FG002|Overall Study|Adverse Event|2|||
105777317|NCT01624974|364835819|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
105777318|NCT01624974|364835818|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
105777319|NCT01624974|364835819|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
105777320|NCT01624974|364835818|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
105777321|NCT01624974|364835819|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
105777322|NCT00957034|364835820|FG000|Overall Study|Adverse Event|0|||
105777323|NCT00957034|364835821|FG001|Overall Study|Adverse Event|1|||
105777324|NCT00957034|364835822|FG002|Overall Study|Adverse Event|1|||
105777325|NCT00957034|364835820|FG000|Overall Study|Sponsor Terminated Study|6|||
105777326|NCT00957034|364835821|FG001|Overall Study|Sponsor Terminated Study|1|||
105777327|NCT00957034|364835822|FG002|Overall Study|Sponsor Terminated Study|5|||
105777328|NCT00957034|364835820|FG000|Overall Study|Withdrawal by Subject|0|||
105777329|NCT00957034|364835821|FG001|Overall Study|Withdrawal by Subject|2|||
105777330|NCT00957034|364835822|FG002|Overall Study|Withdrawal by Subject|0|||
105777331|NCT02607735|364835823|FG000|Primary Study|Randomized but Never Treated|1|||
105777332|NCT02607735|364835824|FG001|Primary Study|Randomized but Never Treated|0|||
105777333|NCT02607735|364835825|FG002|Primary Study|Randomized but Never Treated|0|||
105777334|NCT02607735|364835823|FG000|Primary Study|Lost to Follow-up|4|||
105777335|NCT02607735|364835824|FG001|Primary Study|Lost to Follow-up|0|||
105777336|NCT02607735|364835825|FG002|Primary Study|Lost to Follow-up|0|||
105777337|NCT02607735|364835823|FG000|Primary Study|Withdrew Consent|2|||
105777338|NCT02607735|364835824|FG001|Primary Study|Withdrew Consent|0|||
105777339|NCT02607735|364835825|FG002|Primary Study|Withdrew Consent|0|||
105777340|NCT02607735|364835823|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
105777341|NCT02607735|364835824|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
105777342|NCT02607735|364835825|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
105777343|NCT02607735|364835823|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
105777344|NCT02607735|364835824|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
105777345|NCT02607735|364835825|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
105777346|NCT00957723|364835828|FG000|Overall Study|Death|3|||
105777347|NCT00957723|364835828|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
105777348|NCT00957723|364835828|FG000|Overall Study|Lost to Follow-up|8|||
105777349|NCT00957723|364835828|FG000|Overall Study|Withdrawal by Subject|24|||
105777350|NCT00957723|364835828|FG000|Overall Study|Investigative Site Terminated|61|||
105777351|NCT00957723|364835828|FG000|Overall Study|Intercurrent Illness|2|||
105777352|NCT00957723|364835828|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
105777353|NCT05375838|364835829|FG000|Overall Study|Other|0|||
105777354|NCT05375838|364835830|FG001|Overall Study|Other|0|||
105777355|NCT05375838|364835831|FG002|Overall Study|Other|0|||
105777356|NCT05375838|364835832|FG003|Overall Study|Other|1|||
105777357|NCT05375838|364835833|FG004|Overall Study|Other|1|||
105777358|NCT05375838|364835834|FG005|Overall Study|Other|0|||
105777359|NCT05375838|364835829|FG000|Overall Study|Withdrawal by Subject|2|||
105777360|NCT05375838|364835830|FG001|Overall Study|Withdrawal by Subject|1|||
105777361|NCT05375838|364835831|FG002|Overall Study|Withdrawal by Subject|3|||
105777362|NCT05375838|364835832|FG003|Overall Study|Withdrawal by Subject|2|||
105777363|NCT05375838|364835833|FG004|Overall Study|Withdrawal by Subject|2|||
105777364|NCT05375838|364835834|FG005|Overall Study|Withdrawal by Subject|0|||
105777365|NCT05375838|364835829|FG000|Overall Study|Protocol Violation|0|||
105777366|NCT05375838|364835830|FG001|Overall Study|Protocol Violation|0|||
105777367|NCT05375838|364835831|FG002|Overall Study|Protocol Violation|0|||
105777368|NCT05375838|364835832|FG003|Overall Study|Protocol Violation|0|||
105777369|NCT05375838|364835833|FG004|Overall Study|Protocol Violation|1|||
105777370|NCT05375838|364835834|FG005|Overall Study|Protocol Violation|0|||
105777371|NCT05375838|364835829|FG000|Overall Study|Physician Decision|0|||
105777372|NCT05375838|364835830|FG001|Overall Study|Physician Decision|1|||
105777373|NCT05375838|364835831|FG002|Overall Study|Physician Decision|0|||
105777374|NCT05375838|364835832|FG003|Overall Study|Physician Decision|0|||
105777375|NCT05375838|364835833|FG004|Overall Study|Physician Decision|0|||
105777376|NCT05375838|364835834|FG005|Overall Study|Physician Decision|1|||
105777377|NCT05375838|364835829|FG000|Overall Study|Lost to Follow-up|2|||
105777378|NCT05375838|364835830|FG001|Overall Study|Lost to Follow-up|7|||
105777379|NCT05375838|364835831|FG002|Overall Study|Lost to Follow-up|0|||
105777380|NCT05375838|364835832|FG003|Overall Study|Lost to Follow-up|4|||
105777381|NCT05375838|364835833|FG004|Overall Study|Lost to Follow-up|2|||
105777382|NCT05375838|364835834|FG005|Overall Study|Lost to Follow-up|3|||
105777383|NCT00877890|364835835|FG000|Overall Study|Adverse Event|6|||
105777384|NCT00877890|364835836|FG001|Overall Study|Adverse Event|6|||
105777385|NCT00877890|364835835|FG000|Overall Study|Lost to Follow-up|5|||
105777386|NCT00877890|364835836|FG001|Overall Study|Lost to Follow-up|5|||
105777387|NCT00877890|364835835|FG000|Overall Study|Protocol Violation|0|||
105777388|NCT00877890|364835836|FG001|Overall Study|Protocol Violation|1|||
105777389|NCT00877890|364835835|FG000|Overall Study|Withdrawal of Consent|6|||
105777390|NCT00877890|364835836|FG001|Overall Study|Withdrawal of Consent|12|||
105777391|NCT00877890|364835835|FG000|Overall Study|Investigator Decision|0|||
105777392|NCT00877890|364835836|FG001|Overall Study|Investigator Decision|2|||
105777393|NCT00877890|364835835|FG000|Overall Study|Loss of Glucose Control|3|||
105777394|NCT00877890|364835836|FG001|Overall Study|Loss of Glucose Control|4|||
105777395|NCT00984009|364835837|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
105777396|NCT00281528|364835838|FG000|Overall Study|Progressive Disease|28|||
105777397|NCT00281528|364835839|FG001|Overall Study|Progressive Disease|18|||
105777398|NCT00281528|364835840|FG002|Overall Study|Progressive Disease|27|||
105777399|NCT00281528|364835838|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
105777400|NCT00281528|364835839|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
105777401|NCT00281528|364835840|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
105777402|NCT00281528|364835838|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
105777403|NCT00281528|364835839|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
105777404|NCT00281528|364835840|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
105777405|NCT00281528|364835838|FG000|Overall Study|Physician Decision|11|||
105777406|NCT00281528|364835839|FG001|Overall Study|Physician Decision|4|||
105777407|NCT00281528|364835840|FG002|Overall Study|Physician Decision|5|||
105777408|NCT00281528|364835838|FG000|Overall Study|Protocol Violation|1|||
105777409|NCT00281528|364835839|FG001|Overall Study|Protocol Violation|0|||
105777410|NCT00281528|364835840|FG002|Overall Study|Protocol Violation|1|||
105777411|NCT00281528|364835838|FG000|Overall Study|Withdrawal by Subject|5|||
105777412|NCT00281528|364835839|FG001|Overall Study|Withdrawal by Subject|5|||
105777413|NCT00281528|364835840|FG002|Overall Study|Withdrawal by Subject|7|||
105777414|NCT00281528|364835838|FG000|Overall Study|Other|6|||
105777415|NCT00281528|364835839|FG001|Overall Study|Other|3|||
105777416|NCT00281528|364835840|FG002|Overall Study|Other|5|||
105777417|NCT02394028|364835841|FG000|Induction Phase|Adverse Event|2|||
105777418|NCT02394028|364835842|FG001|Induction Phase|Adverse Event|4|||
105777419|NCT02394028|364835843|FG002|Induction Phase|Adverse Event|1|||
105777420|NCT02394028|364835844|FG003|Induction Phase|Adverse Event|2|||
105777421|NCT02394028|364835845|FG004|Induction Phase|Adverse Event|5|||
105777422|NCT02394028|364835846|FG005|Induction Phase|Adverse Event|2|||
105777423|NCT02394028|364835847|FG006|Induction Phase|Adverse Event|0|||
105777424|NCT02394028|364835848|FG007|Induction Phase|Adverse Event|0|||
105777425|NCT02394028|364835849|FG008|Induction Phase|Adverse Event|0|||
105777426|NCT02394028|364835850|FG009|Induction Phase|Adverse Event|0|||
105777427|NCT02394028|364835851|FG010|Induction Phase|Adverse Event|0|||
105777428|NCT02394028|364835841|FG000|Induction Phase|Lack of Efficacy|3|||
105777429|NCT02394028|364835842|FG001|Induction Phase|Lack of Efficacy|6|||
105777430|NCT02394028|364835843|FG002|Induction Phase|Lack of Efficacy|2|||
105777431|NCT02394028|364835844|FG003|Induction Phase|Lack of Efficacy|17|||
105777432|NCT02394028|364835845|FG004|Induction Phase|Lack of Efficacy|14|||
105777433|NCT02394028|364835846|FG005|Induction Phase|Lack of Efficacy|8|||
105777434|NCT02394028|364835847|FG006|Induction Phase|Lack of Efficacy|17|||
105777435|NCT02394028|364835848|FG007|Induction Phase|Lack of Efficacy|23|||
105777436|NCT02394028|364835849|FG008|Induction Phase|Lack of Efficacy|0|||
105777437|NCT02394028|364835850|FG009|Induction Phase|Lack of Efficacy|0|||
105777438|NCT02394028|364835851|FG010|Induction Phase|Lack of Efficacy|0|||
105777439|NCT02394028|364835841|FG000|Induction Phase|Lost to Follow-up|1|||
105777440|NCT02394028|364835842|FG001|Induction Phase|Lost to Follow-up|0|||
105777441|NCT02394028|364835843|FG002|Induction Phase|Lost to Follow-up|0|||
105777442|NCT02394028|364835844|FG003|Induction Phase|Lost to Follow-up|1|||
105777443|NCT02394028|364835845|FG004|Induction Phase|Lost to Follow-up|0|||
105777444|NCT02394028|364835846|FG005|Induction Phase|Lost to Follow-up|0|||
105777445|NCT02394028|364835847|FG006|Induction Phase|Lost to Follow-up|1|||
105777446|NCT02394028|364835848|FG007|Induction Phase|Lost to Follow-up|0|||
105777447|NCT02394028|364835849|FG008|Induction Phase|Lost to Follow-up|0|||
105777448|NCT02394028|364835850|FG009|Induction Phase|Lost to Follow-up|0|||
105777449|NCT02394028|364835851|FG010|Induction Phase|Lost to Follow-up|0|||
105777450|NCT02394028|364835841|FG000|Induction Phase|Non-compliance|0|||
105777451|NCT02394028|364835842|FG001|Induction Phase|Non-compliance|1|||
105777452|NCT02394028|364835843|FG002|Induction Phase|Non-compliance|3|||
105777453|NCT02394028|364835844|FG003|Induction Phase|Non-compliance|1|||
105777454|NCT02394028|364835845|FG004|Induction Phase|Non-compliance|3|||
105777455|NCT02394028|364835846|FG005|Induction Phase|Non-compliance|0|||
105777456|NCT02394028|364835847|FG006|Induction Phase|Non-compliance|1|||
105777457|NCT02394028|364835848|FG007|Induction Phase|Non-compliance|1|||
105777458|NCT02394028|364835849|FG008|Induction Phase|Non-compliance|0|||
105777459|NCT02394028|364835850|FG009|Induction Phase|Non-compliance|0|||
105777460|NCT02394028|364835851|FG010|Induction Phase|Non-compliance|0|||
105777461|NCT02394028|364835841|FG000|Induction Phase|Physician Decision|0|||
105777462|NCT02394028|364835842|FG001|Induction Phase|Physician Decision|0|||
105777463|NCT02394028|364835843|FG002|Induction Phase|Physician Decision|1|||
105777464|NCT02394028|364835844|FG003|Induction Phase|Physician Decision|4|||
105777465|NCT02394028|364835845|FG004|Induction Phase|Physician Decision|0|||
105777466|NCT02394028|364835846|FG005|Induction Phase|Physician Decision|2|||
105777467|NCT02394028|364835847|FG006|Induction Phase|Physician Decision|1|||
105777468|NCT02394028|364835848|FG007|Induction Phase|Physician Decision|0|||
105777469|NCT02394028|364835849|FG008|Induction Phase|Physician Decision|0|||
105777470|NCT02394028|364835850|FG009|Induction Phase|Physician Decision|0|||
105777471|NCT02394028|364835851|FG010|Induction Phase|Physician Decision|0|||
105777472|NCT02394028|364835841|FG000|Induction Phase|Protocol Violation|0|||
105777473|NCT02394028|364835842|FG001|Induction Phase|Protocol Violation|2|||
105777474|NCT02394028|364835843|FG002|Induction Phase|Protocol Violation|0|||
105777475|NCT02394028|364835844|FG003|Induction Phase|Protocol Violation|3|||
105777476|NCT02394028|364835845|FG004|Induction Phase|Protocol Violation|0|||
105777477|NCT02394028|364835846|FG005|Induction Phase|Protocol Violation|1|||
105777478|NCT02394028|364835847|FG006|Induction Phase|Protocol Violation|1|||
105777479|NCT02394028|364835848|FG007|Induction Phase|Protocol Violation|0|||
105777480|NCT02394028|364835849|FG008|Induction Phase|Protocol Violation|0|||
105777481|NCT02394028|364835850|FG009|Induction Phase|Protocol Violation|0|||
105777482|NCT02394028|364835851|FG010|Induction Phase|Protocol Violation|0|||
105777483|NCT02394028|364835841|FG000|Induction Phase|Withdrawal by Subject|1|||
105777484|NCT02394028|364835842|FG001|Induction Phase|Withdrawal by Subject|2|||
105777485|NCT02394028|364835843|FG002|Induction Phase|Withdrawal by Subject|4|||
105777486|NCT02394028|364835844|FG003|Induction Phase|Withdrawal by Subject|6|||
105777487|NCT02394028|364835845|FG004|Induction Phase|Withdrawal by Subject|7|||
105777488|NCT02394028|364835846|FG005|Induction Phase|Withdrawal by Subject|4|||
105777489|NCT02394028|364835847|FG006|Induction Phase|Withdrawal by Subject|3|||
105777490|NCT02394028|364835848|FG007|Induction Phase|Withdrawal by Subject|6|||
105777491|NCT02394028|364835849|FG008|Induction Phase|Withdrawal by Subject|0|||
105777492|NCT02394028|364835850|FG009|Induction Phase|Withdrawal by Subject|0|||
105777493|NCT02394028|364835851|FG010|Induction Phase|Withdrawal by Subject|0|||
105777494|NCT02394028|364835841|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777495|NCT02394028|364835842|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777496|NCT02394028|364835843|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777497|NCT02394028|364835844|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777498|NCT02394028|364835845|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777499|NCT02394028|364835846|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777500|NCT02394028|364835847|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
105777501|NCT02394028|364835848|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777502|NCT02394028|364835849|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777503|NCT02394028|364835850|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777504|NCT02394028|364835851|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
105777505|NCT02394028|364835841|FG000|Induction Phase|Sponsor decision|0|||
105777506|NCT02394028|364835842|FG001|Induction Phase|Sponsor decision|1|||
105777507|NCT02394028|364835843|FG002|Induction Phase|Sponsor decision|2|||
105777508|NCT02394028|364835844|FG003|Induction Phase|Sponsor decision|0|||
105777509|NCT02394028|364835845|FG004|Induction Phase|Sponsor decision|0|||
105777510|NCT02394028|364835846|FG005|Induction Phase|Sponsor decision|0|||
105777511|NCT02394028|364835847|FG006|Induction Phase|Sponsor decision|0|||
105777512|NCT02394028|364835848|FG007|Induction Phase|Sponsor decision|0|||
105777513|NCT02394028|364835849|FG008|Induction Phase|Sponsor decision|0|||
105777514|NCT02394028|364835850|FG009|Induction Phase|Sponsor decision|0|||
105777515|NCT02394028|364835851|FG010|Induction Phase|Sponsor decision|0|||
105777516|NCT02394028|364835841|FG000|Induction Phase|Technical reason|0|||
105777517|NCT02394028|364835842|FG001|Induction Phase|Technical reason|0|||
105777518|NCT02394028|364835843|FG002|Induction Phase|Technical reason|0|||
105777519|NCT02394028|364835844|FG003|Induction Phase|Technical reason|1|||
105777520|NCT02394028|364835845|FG004|Induction Phase|Technical reason|0|||
105777521|NCT02394028|364835846|FG005|Induction Phase|Technical reason|0|||
105777522|NCT02394028|364835847|FG006|Induction Phase|Technical reason|0|||
105777523|NCT02394028|364835848|FG007|Induction Phase|Technical reason|0|||
105777524|NCT02394028|364835849|FG008|Induction Phase|Technical reason|0|||
105777525|NCT02394028|364835850|FG009|Induction Phase|Technical reason|0|||
105777526|NCT02394028|364835851|FG010|Induction Phase|Technical reason|0|||
105777527|NCT02394028|364835841|FG000|Induction Phase|:ack of calculation|0|||
105777528|NCT02394028|364835842|FG001|Induction Phase|:ack of calculation|0|||
105777529|NCT02394028|364835843|FG002|Induction Phase|:ack of calculation|0|||
105777530|NCT02394028|364835844|FG003|Induction Phase|:ack of calculation|0|||
105777531|NCT02394028|364835845|FG004|Induction Phase|:ack of calculation|0|||
105777532|NCT02394028|364835846|FG005|Induction Phase|:ack of calculation|0|||
105777533|NCT02394028|364835847|FG006|Induction Phase|:ack of calculation|0|||
105777534|NCT02394028|364835848|FG007|Induction Phase|:ack of calculation|1|||
105777535|NCT02394028|364835849|FG008|Induction Phase|:ack of calculation|0|||
105777536|NCT02394028|364835850|FG009|Induction Phase|:ack of calculation|0|||
105777537|NCT02394028|364835851|FG010|Induction Phase|:ack of calculation|0|||
105777538|NCT02394028|364835841|FG000|Maintenance Phase|Protocol Violation|0|||
105777539|NCT02394028|364835842|FG001|Maintenance Phase|Protocol Violation|0|||
105777540|NCT02394028|364835843|FG002|Maintenance Phase|Protocol Violation|0|||
105777541|NCT02394028|364835844|FG003|Maintenance Phase|Protocol Violation|0|||
105777542|NCT02394028|364835845|FG004|Maintenance Phase|Protocol Violation|0|||
105777543|NCT02394028|364835846|FG005|Maintenance Phase|Protocol Violation|0|||
105777544|NCT02394028|364835847|FG006|Maintenance Phase|Protocol Violation|0|||
105777545|NCT02394028|364835848|FG007|Maintenance Phase|Protocol Violation|0|||
105777546|NCT02394028|364835849|FG008|Maintenance Phase|Protocol Violation|0|||
105777547|NCT02394028|364835850|FG009|Maintenance Phase|Protocol Violation|0|||
105777548|NCT02394028|364835851|FG010|Maintenance Phase|Protocol Violation|1|||
105777549|NCT02394028|364835841|FG000|Maintenance Phase|Physician Decision|0|||
105777550|NCT02394028|364835842|FG001|Maintenance Phase|Physician Decision|0|||
105777551|NCT02394028|364835843|FG002|Maintenance Phase|Physician Decision|0|||
105777552|NCT02394028|364835844|FG003|Maintenance Phase|Physician Decision|0|||
105777553|NCT02394028|364835845|FG004|Maintenance Phase|Physician Decision|0|||
105777554|NCT02394028|364835846|FG005|Maintenance Phase|Physician Decision|0|||
105777555|NCT02394028|364835847|FG006|Maintenance Phase|Physician Decision|0|||
105777556|NCT02394028|364835848|FG007|Maintenance Phase|Physician Decision|0|||
105777557|NCT02394028|364835849|FG008|Maintenance Phase|Physician Decision|1|||
105777558|NCT02394028|364835850|FG009|Maintenance Phase|Physician Decision|3|||
105777559|NCT02394028|364835851|FG010|Maintenance Phase|Physician Decision|2|||
105777560|NCT02394028|364835841|FG000|Maintenance Phase|Lack of Efficacy|0|||
105777561|NCT02394028|364835842|FG001|Maintenance Phase|Lack of Efficacy|0|||
105777562|NCT02394028|364835843|FG002|Maintenance Phase|Lack of Efficacy|0|||
105777563|NCT02394028|364835844|FG003|Maintenance Phase|Lack of Efficacy|0|||
105777564|NCT02394028|364835845|FG004|Maintenance Phase|Lack of Efficacy|0|||
105777565|NCT02394028|364835846|FG005|Maintenance Phase|Lack of Efficacy|0|||
105777566|NCT02394028|364835847|FG006|Maintenance Phase|Lack of Efficacy|0|||
105777567|NCT02394028|364835848|FG007|Maintenance Phase|Lack of Efficacy|0|||
105777568|NCT02394028|364835849|FG008|Maintenance Phase|Lack of Efficacy|7|||
105777569|NCT02394028|364835850|FG009|Maintenance Phase|Lack of Efficacy|25|||
105777570|NCT02394028|364835851|FG010|Maintenance Phase|Lack of Efficacy|33|||
105777571|NCT02394028|364835841|FG000|Maintenance Phase|Death|0|||
105777572|NCT02394028|364835842|FG001|Maintenance Phase|Death|0|||
105777573|NCT02394028|364835843|FG002|Maintenance Phase|Death|0|||
105777574|NCT02394028|364835844|FG003|Maintenance Phase|Death|0|||
105777575|NCT02394028|364835845|FG004|Maintenance Phase|Death|0|||
105777576|NCT02394028|364835846|FG005|Maintenance Phase|Death|0|||
105777577|NCT02394028|364835847|FG006|Maintenance Phase|Death|0|||
105777578|NCT02394028|364835848|FG007|Maintenance Phase|Death|0|||
105777579|NCT02394028|364835849|FG008|Maintenance Phase|Death|0|||
105777580|NCT02394028|364835850|FG009|Maintenance Phase|Death|0|||
105777581|NCT02394028|364835851|FG010|Maintenance Phase|Death|1|||
105777582|NCT02394028|364835841|FG000|Maintenance Phase|Adverse Event|0|||
105777583|NCT02394028|364835842|FG001|Maintenance Phase|Adverse Event|0|||
105777584|NCT02394028|364835843|FG002|Maintenance Phase|Adverse Event|0|||
105777585|NCT02394028|364835844|FG003|Maintenance Phase|Adverse Event|0|||
105777586|NCT02394028|364835845|FG004|Maintenance Phase|Adverse Event|0|||
105777587|NCT02394028|364835846|FG005|Maintenance Phase|Adverse Event|0|||
105777588|NCT02394028|364835847|FG006|Maintenance Phase|Adverse Event|0|||
105777589|NCT02394028|364835848|FG007|Maintenance Phase|Adverse Event|0|||
105777590|NCT02394028|364835849|FG008|Maintenance Phase|Adverse Event|1|||
105777591|NCT02394028|364835850|FG009|Maintenance Phase|Adverse Event|1|||
105777592|NCT02394028|364835851|FG010|Maintenance Phase|Adverse Event|3|||
105777593|NCT02394028|364835841|FG000|Maintenance Phase|Site closure|0|||
105777594|NCT02394028|364835842|FG001|Maintenance Phase|Site closure|0|||
105777595|NCT02394028|364835843|FG002|Maintenance Phase|Site closure|0|||
105777596|NCT02394028|364835844|FG003|Maintenance Phase|Site closure|0|||
105777597|NCT02394028|364835845|FG004|Maintenance Phase|Site closure|0|||
105777598|NCT02394028|364835846|FG005|Maintenance Phase|Site closure|0|||
105777599|NCT02394028|364835847|FG006|Maintenance Phase|Site closure|0|||
105777600|NCT02394028|364835848|FG007|Maintenance Phase|Site closure|0|||
105777601|NCT02394028|364835849|FG008|Maintenance Phase|Site closure|0|||
105777602|NCT02394028|364835850|FG009|Maintenance Phase|Site closure|1|||
105777603|NCT02394028|364835851|FG010|Maintenance Phase|Site closure|0|||
105777604|NCT02394028|364835841|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105777605|NCT02394028|364835842|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105777606|NCT02394028|364835843|FG002|Maintenance Phase|Withdrawal by Subject|0|||
105777607|NCT02394028|364835844|FG003|Maintenance Phase|Withdrawal by Subject|0|||
105777608|NCT02394028|364835845|FG004|Maintenance Phase|Withdrawal by Subject|0|||
105777609|NCT02394028|364835846|FG005|Maintenance Phase|Withdrawal by Subject|0|||
105777610|NCT02394028|364835847|FG006|Maintenance Phase|Withdrawal by Subject|0|||
105777611|NCT02394028|364835848|FG007|Maintenance Phase|Withdrawal by Subject|0|||
105777612|NCT02394028|364835849|FG008|Maintenance Phase|Withdrawal by Subject|3|||
105777613|NCT02394028|364835850|FG009|Maintenance Phase|Withdrawal by Subject|12|||
105777614|NCT02394028|364835851|FG010|Maintenance Phase|Withdrawal by Subject|12|||
105777615|NCT01468844|364835854|FG000|Overall Study|Adverse Event|1|||
105777616|NCT01468844|364835855|FG001|Overall Study|Adverse Event|0|||
105777617|NCT01468844|364835854|FG000|Overall Study|Withdrawal by Subject|1|||
105777618|NCT01468844|364835855|FG001|Overall Study|Withdrawal by Subject|0|||
105777619|NCT02142712|364835856|FG000|Overall Study|Lost to Follow-up|1|||
105777620|NCT02142712|364835857|FG001|Overall Study|Lost to Follow-up|1|||
105777621|NCT02142712|364835858|FG002|Overall Study|Lost to Follow-up|1|||
105777622|NCT02142712|364835859|FG003|Overall Study|Lost to Follow-up|0|||
105777623|NCT00866606|364835860|FG000|Overall Study|Lost to Follow-up|3|||
105777624|NCT00866606|364835860|FG000|Overall Study|Adverse Event|1|||
105777625|NCT02067104|364835861|FG000|Overall Study|Study termination due to low accrual|4|||
105777626|NCT02067104|364835862|FG001|Overall Study|Study termination due to low accrual|5|||
105777627|NCT00806494|364835863|FG000|Overall Study|Adverse Event|29|||
105777628|NCT00806494|364835863|FG000|Overall Study|Lack of Efficacy|6|||
105777629|NCT00806494|364835863|FG000|Overall Study|Lost to Follow-up|10|||
105777630|NCT00806494|364835863|FG000|Overall Study|Other|30|||
105777631|NCT00806494|364835863|FG000|Overall Study|Withdrawal by Subject|5|||
105777632|NCT03607994|364835864|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
105777633|NCT03607994|364835865|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
105777634|NCT02610231|364835866|FG000|Overall Study|Withdrawal by Subject|27|||
105777635|NCT02610231|364835866|FG000|Overall Study|Adverse Event|20|||
105777636|NCT02610231|364835866|FG000|Overall Study|Death|5|||
105777637|NCT02610231|364835866|FG000|Overall Study|Surgery|2|||
105777638|NCT02610231|364835866|FG000|Overall Study|Physician Decision|1|||
105777639|NCT02610231|364835866|FG000|Overall Study|Non Compliance|2|||
105777640|NCT02610231|364835866|FG000|Overall Study|Other|3|||
105777641|NCT01279954|364835871|FG000|Overall Study|Lack of Efficacy|3|||
105777642|NCT01279954|364835872|FG001|Overall Study|Lack of Efficacy|4|||
105777643|NCT02140762|364835873|FG000|Overall Study|Adverse Event|1|||
105777644|NCT02140762|364835874|FG001|Overall Study|Adverse Event|1|||
105777645|NCT02140762|364835873|FG000|Overall Study|Lost to Follow-up|9|||
105777646|NCT02140762|364835874|FG001|Overall Study|Lost to Follow-up|5|||
105777647|NCT02140762|364835873|FG000|Overall Study|Protocol Violation|1|||
105777648|NCT02140762|364835874|FG001|Overall Study|Protocol Violation|1|||
105777649|NCT02140762|364835873|FG000|Overall Study|Withdrawal by Subject|6|||
105777650|NCT02140762|364835874|FG001|Overall Study|Withdrawal by Subject|4|||
105777651|NCT02140762|364835873|FG000|Overall Study|Other|0|||
105777652|NCT02140762|364835874|FG001|Overall Study|Other|1|||
105777653|NCT01454531|364835875|FG000|Overall Study|Adverse Event|14|||
105777654|NCT01454531|364835875|FG000|Overall Study|Withdrawal by Subject|5|||
105777655|NCT01454531|364835875|FG000|Overall Study|Lost to Follow-up|1|||
105777656|NCT01454531|364835875|FG000|Overall Study|Physician Decision|1|||
105777657|NCT01454531|364835875|FG000|Overall Study|Delay in IMP administration|1|||
105777658|NCT01454531|364835875|FG000|Overall Study|Other|1|||
105777659|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
105777660|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
105777661|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
105777662|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
105777663|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
105777664|NCT00989664|364835877|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
105777665|NCT00989664|364835877|FG000|Long-Term Follow-Up|Death|3|||
105777666|NCT03125902|364835885|FG000|Overall Study|Adverse Event|0|||
105777667|NCT03125902|364835886|FG001|Overall Study|Adverse Event|1|||
105777668|NCT03125902|364835885|FG000|Overall Study|Death|119|||
105777669|NCT03125902|364835886|FG001|Overall Study|Death|229|||
105777670|NCT03125902|364835885|FG000|Overall Study|Lost to Follow-up|4|||
105777671|NCT03125902|364835886|FG001|Overall Study|Lost to Follow-up|13|||
105777672|NCT03125902|364835885|FG000|Overall Study|Other|0|||
105777673|NCT03125902|364835886|FG001|Overall Study|Other|4|||
105777674|NCT03125902|364835885|FG000|Overall Study|Physician Decision|2|||
105777675|NCT03125902|364835886|FG001|Overall Study|Physician Decision|1|||
105777676|NCT03125902|364835885|FG000|Overall Study|Progressive Disease|0|||
105777677|NCT03125902|364835886|FG001|Overall Study|Progressive Disease|3|||
105777678|NCT03125902|364835885|FG000|Overall Study|Study Terminated By Sponsor|74|||
105777679|NCT03125902|364835886|FG001|Overall Study|Study Terminated By Sponsor|143|||
105777680|NCT03125902|364835885|FG000|Overall Study|Withdrawal by Subject|21|||
105777681|NCT03125902|364835886|FG001|Overall Study|Withdrawal by Subject|37|||
105777682|NCT01711359|364835887|FG000|Treatment Period|Withdrawal by Subject|18|||
105777683|NCT01711359|364835888|FG001|Treatment Period|Withdrawal by Subject|7|||
105777684|NCT01711359|364835889|FG002|Treatment Period|Withdrawal by Subject|13|||
105777685|NCT01711359|364835887|FG000|Treatment Period|Lack of Efficacy|13|||
105777686|NCT01711359|364835888|FG001|Treatment Period|Lack of Efficacy|2|||
105777687|NCT01711359|364835889|FG002|Treatment Period|Lack of Efficacy|2|||
105777688|NCT01711359|364835887|FG000|Treatment Period|Adverse Event|8|||
105777689|NCT01711359|364835888|FG001|Treatment Period|Adverse Event|10|||
105777690|NCT01711359|364835889|FG002|Treatment Period|Adverse Event|24|||
105777691|NCT01711359|364835887|FG000|Treatment Period|Physician Decision|4|||
105777692|NCT01711359|364835888|FG001|Treatment Period|Physician Decision|3|||
105777693|NCT01711359|364835889|FG002|Treatment Period|Physician Decision|2|||
105777694|NCT01711359|364835887|FG000|Treatment Period|Death|3|||
105777695|NCT01711359|364835888|FG001|Treatment Period|Death|0|||
105777696|NCT01711359|364835889|FG002|Treatment Period|Death|0|||
105777697|NCT01711359|364835887|FG000|Treatment Period|Entry Criteria Not Met|1|||
105777698|NCT01711359|364835888|FG001|Treatment Period|Entry Criteria Not Met|0|||
105777699|NCT01711359|364835889|FG002|Treatment Period|Entry Criteria Not Met|0|||
105777700|NCT01711359|364835887|FG000|Treatment Period|Sponsor Decision|1|||
105777701|NCT01711359|364835888|FG001|Treatment Period|Sponsor Decision|0|||
105777702|NCT01711359|364835889|FG002|Treatment Period|Sponsor Decision|0|||
105777703|NCT01711359|364835887|FG000|Treatment Period|Lost to Follow-up|1|||
105777704|NCT01711359|364835888|FG001|Treatment Period|Lost to Follow-up|1|||
105777705|NCT01711359|364835889|FG002|Treatment Period|Lost to Follow-up|1|||
105777706|NCT01711359|364835887|FG000|Treatment Period|Randomized, Not Treated|3|||
105777707|NCT01711359|364835888|FG001|Treatment Period|Randomized, Not Treated|1|||
105777708|NCT01711359|364835889|FG002|Treatment Period|Randomized, Not Treated|0|||
105777709|NCT00805142|364835890|FG000|Titration Period|Adverse Event|3|||
105777710|NCT00805142|364835891|FG001|Titration Period|Adverse Event|3|||
105777711|NCT00805142|364835890|FG000|Titration Period|Lack of Efficacy|1|||
105777712|NCT00805142|364835891|FG001|Titration Period|Lack of Efficacy|1|||
105777713|NCT00805142|364835890|FG000|Titration Period|Lost to Follow-up|0|||
105777714|NCT00805142|364835891|FG001|Titration Period|Lost to Follow-up|1|||
105777715|NCT00805142|364835890|FG000|Titration Period|Disease Progression|2|||
105777716|NCT00805142|364835891|FG001|Titration Period|Disease Progression|1|||
105777717|NCT00805142|364835890|FG000|Titration Period|Withdrawal of consent|0|||
105777718|NCT00805142|364835891|FG001|Titration Period|Withdrawal of consent|1|||
105777719|NCT00805142|364835890|FG000|Titration Period|Other|0|||
105777720|NCT00805142|364835891|FG001|Titration Period|Other|3|||
105777721|NCT00805142|364835890|FG000|Maintenance Period|Adverse Event|0|||
105777722|NCT00805142|364835891|FG001|Maintenance Period|Adverse Event|1|||
105777723|NCT00805142|364835890|FG000|Maintenance Period|Other|0|||
105777724|NCT00805142|364835891|FG001|Maintenance Period|Other|1|||
105777725|NCT02889861|364838126|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
105777726|NCT01640353|364838129|FG000|Overall Study|Withdrew prior to treatment|10|||
105777727|NCT01640353|364838129|FG000|Overall Study|Withdrawn from analysis at term site|12|||
105777728|NCT01640353|364838129|FG000|Overall Study|Withdrawal by Subject|5|||
105777729|NCT01640353|364838129|FG000|Overall Study|Death|2|||
105777730|NCT01640353|364838129|FG000|Overall Study|Early site termination|3|||
105777731|NCT01640353|364838129|FG000|Overall Study|Lost to Follow-up|12|||
105777732|NCT01640353|364838129|FG000|Overall Study|Physician Decision|1|||
105777733|NCT01524900|364838130|FG000|Overall Study|Lost to Follow-up|3|||
105777734|NCT01524900|364838131|FG001|Overall Study|Lost to Follow-up|12|||
105777735|NCT01524900|364838132|FG002|Overall Study|Lost to Follow-up|1|||
105777736|NCT01524900|364838133|FG003|Overall Study|Lost to Follow-up|0|||
105777737|NCT01524900|364838134|FG004|Overall Study|Lost to Follow-up|0|||
105777738|NCT01524900|364838130|FG000|Overall Study|Other reason than stated above|1|||
105777739|NCT01524900|364838131|FG001|Overall Study|Other reason than stated above|1|||
105777740|NCT01524900|364838132|FG002|Overall Study|Other reason than stated above|0|||
105777741|NCT01524900|364838133|FG003|Overall Study|Other reason than stated above|0|||
105777742|NCT01524900|364838134|FG004|Overall Study|Other reason than stated above|0|||
105777743|NCT01524900|364838130|FG000|Overall Study|No reason documented|2|||
105777744|NCT01524900|364838131|FG001|Overall Study|No reason documented|1|||
105777745|NCT01524900|364838132|FG002|Overall Study|No reason documented|0|||
105777746|NCT01524900|364838133|FG003|Overall Study|No reason documented|1|||
105777747|NCT01524900|364838134|FG004|Overall Study|No reason documented|0|||
105777748|NCT04354870|364838135|FG000|Overall Study|Lost to Follow-up|32|||
105777749|NCT04354870|364838136|FG001|Overall Study|Lost to Follow-up|12|||
105777750|NCT04354870|364838135|FG000|Overall Study|Withdrawal by Subject|10|||
105777751|NCT04354870|364838136|FG001|Overall Study|Withdrawal by Subject|16|||
105777752|NCT04354870|364838135|FG000|Overall Study|Did not complete all study visits|6|||
105777753|NCT04354870|364838136|FG001|Overall Study|Did not complete all study visits|5|||
105777754|NCT00298766|364838137|FG000|Overall Study|Adverse Event|18|||
105777755|NCT00298766|364838137|FG000|Overall Study|Death|2|||
105777756|NCT00298766|364838137|FG000|Overall Study|Withdrawal by Subject|9|||
105777757|NCT00298766|364838137|FG000|Overall Study|Treatment ongoing|4|||
105777758|NCT00298766|364838137|FG000|Overall Study|Progression of amyloid markers|4|||
105777759|NCT00298766|364838137|FG000|Overall Study|Deterioration in KPS and organ function|1|||
105777760|NCT00298766|364838137|FG000|Overall Study|Subjects overall condition deterioration|4|||
105777761|NCT00298766|364838137|FG000|Overall Study|Other|4|||
105777762|NCT02500901|364838138|FG000|Overall Study|Disease ProgressionDD|2|||
105777763|NCT03055806|364838141|FG000|Overall Study|Adverse Event|0|||
105777764|NCT03055806|364838142|FG001|Overall Study|Adverse Event|0|||
105777765|NCT03055806|364838143|FG002|Overall Study|Adverse Event|1|||
105777766|NCT03055806|364838144|FG003|Overall Study|Adverse Event|1|||
105777767|NCT03055806|364838141|FG000|Overall Study|Lost to Follow-up|0|||
105777768|NCT03055806|364838142|FG001|Overall Study|Lost to Follow-up|3|||
105777769|NCT03055806|364838143|FG002|Overall Study|Lost to Follow-up|6|||
105777770|NCT03055806|364838144|FG003|Overall Study|Lost to Follow-up|7|||
105777771|NCT03055806|364838141|FG000|Overall Study|Physician Decision|1|||
105777772|NCT03055806|364838142|FG001|Overall Study|Physician Decision|0|||
105777773|NCT03055806|364838143|FG002|Overall Study|Physician Decision|0|||
105777774|NCT03055806|364838144|FG003|Overall Study|Physician Decision|1|||
105777775|NCT03055806|364838141|FG000|Overall Study|Protocol Violation|1|||
105777776|NCT03055806|364838142|FG001|Overall Study|Protocol Violation|0|||
105777777|NCT03055806|364838143|FG002|Overall Study|Protocol Violation|0|||
105777778|NCT03055806|364838144|FG003|Overall Study|Protocol Violation|0|||
105777779|NCT03055806|364838141|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
105777780|NCT03055806|364838142|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
105777781|NCT03055806|364838143|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
105777782|NCT03055806|364838144|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
105777783|NCT03055806|364838141|FG000|Overall Study|Withdrawal of consent to continue study|2|||
105777784|NCT03055806|364838142|FG001|Overall Study|Withdrawal of consent to continue study|3|||
105777785|NCT03055806|364838143|FG002|Overall Study|Withdrawal of consent to continue study|4|||
105777786|NCT03055806|364838144|FG003|Overall Study|Withdrawal of consent to continue study|6|||
105777787|NCT03055806|364838141|FG000|Overall Study|Partner not willing to try intercourse|1|||
105777788|NCT03055806|364838142|FG001|Overall Study|Partner not willing to try intercourse|0|||
105777789|NCT03055806|364838143|FG002|Overall Study|Partner not willing to try intercourse|0|||
105777790|NCT03055806|364838144|FG003|Overall Study|Partner not willing to try intercourse|0|||
105777791|NCT00033514|364838145|FG000|Overall Study|Lost to Follow-up|1|||
105777792|NCT00033514|364838146|FG001|Overall Study|Lost to Follow-up|1|||
105777793|NCT00033514|364838145|FG000|Overall Study|Withdrawal by Subject|0|||
105777794|NCT00033514|364838146|FG001|Overall Study|Withdrawal by Subject|3|||
105777795|NCT00348686|364838147|FG000|Overall Study|Withdrawal by Subject|45|||
105777796|NCT00348686|364838147|FG000|Overall Study|Adverse Event|5|||
105777797|NCT00348686|364838147|FG000|Overall Study|Protocol Violation|6|||
105777798|NCT00348686|364838147|FG000|Overall Study|Lost to Follow-up|2|||
105777799|NCT00348686|364838147|FG000|Overall Study|Multiple Reasons|8|||
105777800|NCT01258738|364838148|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
105777801|NCT01258738|364838149|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
105777802|NCT01258738|364838148|FG000|Double-blind Period|Withdrawal by Subject|2|||
105777803|NCT01258738|364838149|FG001|Double-blind Period|Withdrawal by Subject|2|||
105777804|NCT01258738|364838148|FG000|Double-blind Period|Protocol Violation|1|||
105777805|NCT01258738|364838149|FG001|Double-blind Period|Protocol Violation|1|||
105777806|NCT01258738|364838148|FG000|Double-blind Period|Adverse Event|3|||
105777807|NCT01258738|364838149|FG001|Double-blind Period|Adverse Event|1|||
105777808|NCT01258738|364838148|FG000|Open-label Period|Did not meet inclusion criteria|0|||
105777809|NCT01258738|364838149|FG001|Open-label Period|Did not meet inclusion criteria|1|||
105777810|NCT01258738|364838148|FG000|Open-label Period|Insufficient clinical response|5|||
105777811|NCT01258738|364838149|FG001|Open-label Period|Insufficient clinical response|3|||
105777812|NCT01258738|364838148|FG000|Open-label Period|Lost to Follow-up|0|||
105777813|NCT01258738|364838149|FG001|Open-label Period|Lost to Follow-up|2|||
105777814|NCT01258738|364838148|FG000|Open-label Period|Withdrawal by Subject|5|||
105777815|NCT01258738|364838149|FG001|Open-label Period|Withdrawal by Subject|6|||
105777816|NCT01258738|364838148|FG000|Open-label Period|Protocol Violation|2|||
105777817|NCT01258738|364838149|FG001|Open-label Period|Protocol Violation|2|||
105777818|NCT01258738|364838148|FG000|Open-label Period|Adverse Event|4|||
105777819|NCT01258738|364838149|FG001|Open-label Period|Adverse Event|5|||
105777820|NCT01258738|364838148|FG000|Open-label Period|Other Reasons|0|||
105777821|NCT01258738|364838149|FG001|Open-label Period|Other Reasons|1|||
105777822|NCT01258738|364838148|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
105777823|NCT01258738|364838149|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
105777824|NCT00689611|364838150|FG000|Overall Study|Death|6|||
105777825|NCT00689611|364838151|FG001|Overall Study|Death|9|||
105777826|NCT00689611|364838150|FG000|Overall Study|Withdrawal by Subject|8|||
105777827|NCT00689611|364838151|FG001|Overall Study|Withdrawal by Subject|9|||
105777828|NCT00689611|364838150|FG000|Overall Study|Lost to Follow-up|27|||
105777829|NCT00689611|364838151|FG001|Overall Study|Lost to Follow-up|28|||
105777830|NCT01220024|364838154|FG000|Overall Study|Lost to Follow-up|1|||
105777831|NCT01220024|364838155|FG001|Overall Study|Lost to Follow-up|1|||
105777832|NCT00490815|364838156|FG000|Overall Study|Adverse Event|2|||
105777833|NCT00490815|364838157|FG001|Overall Study|Adverse Event|3|||
105777834|NCT00490815|364838156|FG000|Overall Study|Withdrawal by Subject|4|||
105777835|NCT00490815|364838157|FG001|Overall Study|Withdrawal by Subject|0|||
105777836|NCT00490815|364838156|FG000|Overall Study|Lost to Follow-up|1|||
105777837|NCT00490815|364838157|FG001|Overall Study|Lost to Follow-up|3|||
105777838|NCT00490815|364838156|FG000|Overall Study|Death|1|||
105777839|NCT00490815|364838157|FG001|Overall Study|Death|3|||
105777840|NCT00732199|364838165|FG000|Overall Study|Withdrawal by Subject|25|||
105777841|NCT00732199|364838166|FG001|Overall Study|Withdrawal by Subject|18|||
105777842|NCT00732199|364838165|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
105777843|NCT00732199|364838166|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
105777844|NCT01488994|364838180|FG000|Overall Study|Withdrawal by Subject|0|||
105777845|NCT01488994|364838181|FG001|Overall Study|Withdrawal by Subject|1|||
105777846|NCT03018028|364838184|FG000|Overall Study|Withdrawal by Subject|3|||
105777847|NCT03018028|364838185|FG001|Overall Study|Withdrawal by Subject|0|||
105777848|NCT03018028|364838186|FG002|Overall Study|Withdrawal by Subject|1|||
105777849|NCT03018028|364838187|FG003|Overall Study|Withdrawal by Subject|2|||
105777850|NCT03018028|364838188|FG004|Overall Study|Withdrawal by Subject|0|||
105777851|NCT00545740|364838192|FG000|Overall Study|Lack of Efficacy|34|||
105777852|NCT00545740|364838193|FG001|Overall Study|Lack of Efficacy|35|||
105777853|NCT00545740|364838194|FG002|Overall Study|Lack of Efficacy|47|||
105777854|NCT00545740|364838195|FG003|Overall Study|Lack of Efficacy|36|||
105777855|NCT00545740|364838192|FG000|Overall Study|Withdrawal by Subject|17|||
105777856|NCT00545740|364838193|FG001|Overall Study|Withdrawal by Subject|15|||
105777857|NCT00545740|364838194|FG002|Overall Study|Withdrawal by Subject|16|||
106099777|NCT00626522|366022630|FG002|Overall Study|Adverse Event|2|||
106099778|NCT00626522|366022631|FG003|Overall Study|Adverse Event|0|||
105777858|NCT00545740|364838195|FG003|Overall Study|Withdrawal by Subject|18|||
105777859|NCT00545740|364838192|FG000|Overall Study|Adverse Event|10|||
105777860|NCT00545740|364838193|FG001|Overall Study|Adverse Event|18|||
105777861|NCT00545740|364838194|FG002|Overall Study|Adverse Event|19|||
105777862|NCT00545740|364838195|FG003|Overall Study|Adverse Event|9|||
105777863|NCT00545740|364838192|FG000|Overall Study|Lost to Follow-up|7|||
105777864|NCT00545740|364838193|FG001|Overall Study|Lost to Follow-up|5|||
105777865|NCT00545740|364838194|FG002|Overall Study|Lost to Follow-up|5|||
105777866|NCT00545740|364838195|FG003|Overall Study|Lost to Follow-up|6|||
105777867|NCT00545740|364838192|FG000|Overall Study|Protocol Violation|1|||
105777868|NCT00545740|364838193|FG001|Overall Study|Protocol Violation|3|||
105777869|NCT00545740|364838194|FG002|Overall Study|Protocol Violation|1|||
105777870|NCT00545740|364838195|FG003|Overall Study|Protocol Violation|0|||
105777871|NCT00545740|364838192|FG000|Overall Study|Non-compliance|0|||
105777872|NCT00545740|364838193|FG001|Overall Study|Non-compliance|2|||
105777873|NCT00545740|364838194|FG002|Overall Study|Non-compliance|1|||
105777874|NCT00545740|364838195|FG003|Overall Study|Non-compliance|0|||
105777875|NCT00545740|364838192|FG000|Overall Study|Moved|2|||
105777876|NCT00545740|364838193|FG001|Overall Study|Moved|0|||
105777877|NCT00545740|364838194|FG002|Overall Study|Moved|1|||
105777878|NCT00545740|364838195|FG003|Overall Study|Moved|0|||
105777879|NCT00545740|364838192|FG000|Overall Study|Diverticulitis attack|0|||
105777880|NCT00545740|364838193|FG001|Overall Study|Diverticulitis attack|0|||
105777881|NCT00545740|364838194|FG002|Overall Study|Diverticulitis attack|1|||
105777882|NCT00545740|364838195|FG003|Overall Study|Diverticulitis attack|1|||
105777883|NCT00545740|364838192|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
105777884|NCT00545740|364838193|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
105777885|NCT00545740|364838194|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
105777886|NCT00545740|364838195|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
105777887|NCT00545740|364838192|FG000|Overall Study|Site closure|1|||
105777888|NCT00545740|364838193|FG001|Overall Study|Site closure|0|||
105777889|NCT00545740|364838194|FG002|Overall Study|Site closure|0|||
105777890|NCT00545740|364838195|FG003|Overall Study|Site closure|0|||
105777891|NCT00545740|364838192|FG000|Overall Study|Missed visit|1|||
105777892|NCT00545740|364838193|FG001|Overall Study|Missed visit|0|||
105777893|NCT00545740|364838194|FG002|Overall Study|Missed visit|0|||
105777894|NCT00545740|364838195|FG003|Overall Study|Missed visit|0|||
105777895|NCT00545740|364838192|FG000|Overall Study|Physician Decision|0|||
105777896|NCT00545740|364838193|FG001|Overall Study|Physician Decision|0|||
105777897|NCT00545740|364838194|FG002|Overall Study|Physician Decision|3|||
105777898|NCT00545740|364838195|FG003|Overall Study|Physician Decision|0|||
105777899|NCT00545740|364838192|FG000|Overall Study|Accepted only monthly telephone calls|1|||
105777900|NCT00545740|364838193|FG001|Overall Study|Accepted only monthly telephone calls|0|||
105777901|NCT00545740|364838194|FG002|Overall Study|Accepted only monthly telephone calls|0|||
105777902|NCT00545740|364838195|FG003|Overall Study|Accepted only monthly telephone calls|0|||
105777903|NCT00545740|364838192|FG000|Overall Study|Sponsor decision|0|||
105777904|NCT00545740|364838193|FG001|Overall Study|Sponsor decision|1|||
105777905|NCT00545740|364838194|FG002|Overall Study|Sponsor decision|0|||
105777906|NCT00545740|364838195|FG003|Overall Study|Sponsor decision|0|||
105777907|NCT00545740|364838192|FG000|Overall Study|Lack of time|0|||
105777908|NCT00545740|364838193|FG001|Overall Study|Lack of time|1|||
105777909|NCT00545740|364838194|FG002|Overall Study|Lack of time|0|||
105777910|NCT00545740|364838195|FG003|Overall Study|Lack of time|0|||
105777911|NCT00545740|364838192|FG000|Overall Study|Non-adherence to visits|0|||
105777912|NCT00545740|364838193|FG001|Overall Study|Non-adherence to visits|1|||
105777913|NCT00545740|364838194|FG002|Overall Study|Non-adherence to visits|0|||
105777914|NCT00545740|364838195|FG003|Overall Study|Non-adherence to visits|0|||
105777915|NCT00545740|364838192|FG000|Overall Study|Patient difficulties|0|||
105777916|NCT00545740|364838193|FG001|Overall Study|Patient difficulties|1|||
105777917|NCT00545740|364838194|FG002|Overall Study|Patient difficulties|0|||
105777918|NCT00545740|364838195|FG003|Overall Study|Patient difficulties|0|||
105777919|NCT00545740|364838192|FG000|Overall Study|Husband against study|0|||
105777920|NCT00545740|364838193|FG001|Overall Study|Husband against study|0|||
105777921|NCT00545740|364838194|FG002|Overall Study|Husband against study|1|||
105777922|NCT00545740|364838195|FG003|Overall Study|Husband against study|0|||
105777923|NCT01947127|364838196|FG000|Overall Study|Protocol Violation|18|||
105777924|NCT01947127|364838197|FG001|Overall Study|Protocol Violation|38|||
105777925|NCT01947127|364838196|FG000|Overall Study|Withdrawal by Subject|1|||
105777926|NCT01947127|364838197|FG001|Overall Study|Withdrawal by Subject|1|||
105777927|NCT01947127|364838196|FG000|Overall Study|Data loss|4|||
105777928|NCT01947127|364838197|FG001|Overall Study|Data loss|4|||
105777929|NCT03018340|364838198|FG000|Overall Study|Adverse Event|1|||
105777930|NCT03018340|364838199|FG001|Overall Study|Adverse Event|2|||
105777931|NCT03018340|364838198|FG000|Overall Study|Withdrawal by Subject|0|||
105777932|NCT03018340|364838199|FG001|Overall Study|Withdrawal by Subject|8|||
105777933|NCT03018340|364838198|FG000|Overall Study|Lack of Efficacy|0|||
105777934|NCT03018340|364838199|FG001|Overall Study|Lack of Efficacy|1|||
105777935|NCT03018340|364838198|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
105777936|NCT03018340|364838199|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
105777937|NCT03018340|364838198|FG000|Overall Study|Lost to Follow-up|1|||
105777938|NCT03018340|364838199|FG001|Overall Study|Lost to Follow-up|7|||
105777939|NCT03018340|364838198|FG000|Overall Study|Protocol Violation|3|||
105777940|NCT03018340|364838199|FG001|Overall Study|Protocol Violation|7|||
105777941|NCT03018340|364838198|FG000|Overall Study|Not further specified|0|||
105777942|NCT03018340|364838199|FG001|Overall Study|Not further specified|1|||
105777943|NCT00994890|364838213|FG000|Overall Study|Adverse Event|13|||
105777944|NCT00994890|364838214|FG001|Overall Study|Adverse Event|9|||
105777945|NCT00994890|364838215|FG002|Overall Study|Adverse Event|11|||
105777946|NCT00994890|364838213|FG000|Overall Study|Lack of Efficacy|0|||
105777947|NCT00994890|364838214|FG001|Overall Study|Lack of Efficacy|0|||
105777948|NCT00994890|364838215|FG002|Overall Study|Lack of Efficacy|1|||
105777949|NCT00994890|364838213|FG000|Overall Study|Lost to Follow-up|6|||
105777950|NCT00994890|364838214|FG001|Overall Study|Lost to Follow-up|1|||
105777951|NCT00994890|364838215|FG002|Overall Study|Lost to Follow-up|3|||
105777952|NCT00994890|364838213|FG000|Overall Study|No longer willing to participate|8|||
105777953|NCT00994890|364838214|FG001|Overall Study|No longer willing to participate|5|||
105777954|NCT00994890|364838215|FG002|Overall Study|No longer willing to participate|13|||
105777955|NCT00994890|364838213|FG000|Overall Study|Protocol Violation|2|||
105777956|NCT00994890|364838214|FG001|Overall Study|Protocol Violation|4|||
105777957|NCT00994890|364838215|FG002|Overall Study|Protocol Violation|0|||
105777958|NCT00994890|364838213|FG000|Overall Study|Study terminated by sponsor|199|||
105777959|NCT00994890|364838214|FG001|Overall Study|Study terminated by sponsor|201|||
105777960|NCT00994890|364838215|FG002|Overall Study|Study terminated by sponsor|197|||
105777961|NCT00994890|364838213|FG000|Overall Study|Randomized, but not treated|1|||
105777962|NCT00994890|364838214|FG001|Overall Study|Randomized, but not treated|0|||
105777963|NCT00994890|364838215|FG002|Overall Study|Randomized, but not treated|0|||
105777964|NCT00994890|364838213|FG000|Overall Study|Other|2|||
105777965|NCT00994890|364838214|FG001|Overall Study|Other|2|||
105777966|NCT00994890|364838215|FG002|Overall Study|Other|1|||
105777967|NCT01849289|364838218|FG000|Overall Study|Adverse Event|3|||
105777968|NCT01849289|364838219|FG001|Overall Study|Adverse Event|3|||
105777969|NCT01849289|364838218|FG000|Overall Study|Protocol Violation|3|||
105777970|NCT01849289|364838219|FG001|Overall Study|Protocol Violation|3|||
105777971|NCT01849289|364838218|FG000|Overall Study|Withdrawal criteria|1|||
105777972|NCT01849289|364838219|FG001|Overall Study|Withdrawal criteria|0|||
105777973|NCT01849289|364838218|FG000|Overall Study|Unclassified|25|||
105777974|NCT01849289|364838219|FG001|Overall Study|Unclassified|18|||
105777975|NCT00352027|364838224|FG000|Overall Study|Progressive disease|3|||
105777976|NCT00702949|364838225|FG000|Overall Study|Refusal|3|||
105777977|NCT00702949|364838226|FG001|Overall Study|Refusal|2|||
105777978|NCT00702949|364838227|FG002|Overall Study|Refusal|2|||
105777979|NCT00702949|364838225|FG000|Overall Study|Adverse Event|1|||
105777980|NCT00702949|364838226|FG001|Overall Study|Adverse Event|6|||
105777981|NCT00702949|364838227|FG002|Overall Study|Adverse Event|3|||
105777982|NCT00702949|364838225|FG000|Overall Study|Other Medical Reason/unknown|1|||
105777983|NCT00702949|364838226|FG001|Overall Study|Other Medical Reason/unknown|1|||
105777984|NCT00702949|364838227|FG002|Overall Study|Other Medical Reason/unknown|3|||
105777985|NCT01469637|364838228|FG000|First Intervention|Unacceptable behavior|0|||
105777986|NCT01469637|364838229|FG001|First Intervention|Unacceptable behavior|1|||
105777987|NCT01469637|364838228|FG000|Second Intervention|Incarcerated|1|||
105777988|NCT01469637|364838229|FG001|Second Intervention|Incarcerated|0|||
105777989|NCT00420212|364838237|FG000|Overall Study|Adverse Event|22|||
105777990|NCT00420212|364838238|FG001|Overall Study|Adverse Event|40|||
105777991|NCT00420212|364838239|FG002|Overall Study|Adverse Event|36|||
105777992|NCT00420212|364838237|FG000|Overall Study|Lost to Follow-up|9|||
105777993|NCT00420212|364838238|FG001|Overall Study|Lost to Follow-up|11|||
105777994|NCT00420212|364838239|FG002|Overall Study|Lost to Follow-up|11|||
105777995|NCT00420212|364838237|FG000|Overall Study|Withdrawal by Subject|31|||
105777996|NCT00420212|364838238|FG001|Overall Study|Withdrawal by Subject|22|||
105777997|NCT00420212|364838239|FG002|Overall Study|Withdrawal by Subject|19|||
105777998|NCT00420212|364838237|FG000|Overall Study|Physician Decision|4|||
105777999|NCT00420212|364838238|FG001|Overall Study|Physician Decision|4|||
105778000|NCT00420212|364838239|FG002|Overall Study|Physician Decision|3|||
105778001|NCT00420212|364838237|FG000|Overall Study|Protocol Violation|4|||
105778002|NCT00420212|364838238|FG001|Overall Study|Protocol Violation|4|||
105778003|NCT00420212|364838239|FG002|Overall Study|Protocol Violation|8|||
105778004|NCT00420212|364838237|FG000|Overall Study|Death|0|||
105778005|NCT00420212|364838238|FG001|Overall Study|Death|0|||
105778006|NCT00420212|364838239|FG002|Overall Study|Death|1|||
105778007|NCT00420212|364838237|FG000|Overall Study|Other-Unspecified|21|||
105778008|NCT00420212|364838238|FG001|Overall Study|Other-Unspecified|14|||
105778009|NCT00420212|364838239|FG002|Overall Study|Other-Unspecified|18|||
105778010|NCT02390362|364838240|FG000|Overall Study|Withdrawal by Subject|0|||
105778011|NCT02390362|364838241|FG001|Overall Study|Withdrawal by Subject|1|||
105778012|NCT01376908|364838242|FG000|Overall Study|Protocol Violation|1|||
105778013|NCT01376908|364838243|FG001|Overall Study|Protocol Violation|1|||
105778014|NCT01376908|364838242|FG000|Overall Study|Withdrawal by Subject|1|||
105778015|NCT01376908|364838243|FG001|Overall Study|Withdrawal by Subject|2|||
105778016|NCT00392210|364838244|FG000|First Voiding Trial|Physician Decision|2|||
105778017|NCT00392210|364838245|FG001|First Voiding Trial|Physician Decision|2|||
105778018|NCT03049852|364838249|FG000|Overall Study|Lost to Follow-up|0|||
105778019|NCT03049852|364838250|FG001|Overall Study|Lost to Follow-up|1|||
105778020|NCT03049852|364838251|FG002|Overall Study|Lost to Follow-up|0|||
105778021|NCT00434876|364838252|FG000|Overall Study|Lost to Follow-up|1|||
105778022|NCT00434876|364838253|FG001|Overall Study|Lost to Follow-up|1|||
105778023|NCT04815291|364838254|FG000|Overall Study|Lost to Follow-up|1|||
105778024|NCT04815291|364838254|FG000|Overall Study|Physician Decision|4|||
105778025|NCT04815291|364838254|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
105778026|NCT01899729|364838257|FG000|Overall Study|Adverse Event|1|||
105778027|NCT01899729|364838258|FG001|Overall Study|Adverse Event|0|||
105778028|NCT01899729|364838259|FG002|Overall Study|Adverse Event|0|||
105778029|NCT01899729|364838260|FG003|Overall Study|Adverse Event|0|||
105778030|NCT01899729|364838261|FG004|Overall Study|Adverse Event|1|||
105778031|NCT01899729|364838257|FG000|Overall Study|Withdrawal by Subject|1|||
105778032|NCT01899729|364838258|FG001|Overall Study|Withdrawal by Subject|2|||
105778033|NCT01899729|364838259|FG002|Overall Study|Withdrawal by Subject|0|||
105778034|NCT01899729|364838260|FG003|Overall Study|Withdrawal by Subject|0|||
105778035|NCT01899729|364838261|FG004|Overall Study|Withdrawal by Subject|0|||
105778036|NCT01899729|364838257|FG000|Overall Study|Lack of Efficacy|0|||
105778037|NCT01899729|364838258|FG001|Overall Study|Lack of Efficacy|0|||
105778038|NCT01899729|364838259|FG002|Overall Study|Lack of Efficacy|2|||
105778039|NCT01899729|364838260|FG003|Overall Study|Lack of Efficacy|0|||
105778040|NCT01899729|364838261|FG004|Overall Study|Lack of Efficacy|1|||
105778041|NCT00095836|364838262|FG000|Overall Study|Lost to Follow-up|1|||
105778042|NCT00095836|364838262|FG000|Overall Study|Adverse Event|1|||
105778043|NCT00095836|364838262|FG000|Overall Study|Death|2|||
105778044|NCT00982111|364838265|FG000|Overall Study|Adverse Event|1|||
105778045|NCT00982111|364838266|FG001|Overall Study|Adverse Event|1|||
105778046|NCT00982111|364838265|FG000|Overall Study|Progressive Disease|46|||
105778047|NCT00982111|364838266|FG001|Overall Study|Progressive Disease|39|||
105778048|NCT00982111|364838265|FG000|Overall Study|Lost to Follow-up|9|||
105778049|NCT00982111|364838266|FG001|Overall Study|Lost to Follow-up|6|||
105778050|NCT00982111|364838265|FG000|Overall Study|New Anti-Cancer Therapy|5|||
105778051|NCT00982111|364838266|FG001|Overall Study|New Anti-Cancer Therapy|5|||
105778052|NCT00982111|364838265|FG000|Overall Study|Medical Decision|1|||
105778053|NCT00982111|364838266|FG001|Overall Study|Medical Decision|0|||
105778054|NCT00982111|364838265|FG000|Overall Study|Withdrawal by Subject|17|||
105778055|NCT00982111|364838266|FG001|Overall Study|Withdrawal by Subject|19|||
105778056|NCT00982111|364838265|FG000|Overall Study|Global Study End|0|||
105778057|NCT00982111|364838266|FG001|Overall Study|Global Study End|1|||
105778058|NCT00982111|364838265|FG000|Overall Study|Sponsor's Decision|0|||
105778059|NCT00982111|364838266|FG001|Overall Study|Sponsor's Decision|1|||
105778060|NCT01070381|364838267|FG000|Period 2, 1 Week of Wear|Handling|0|||
105778061|NCT01070381|364838268|FG001|Period 2, 1 Week of Wear|Handling|1|||
105778062|NCT01070381|364838267|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
105778063|NCT01070381|364838268|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
105778064|NCT00620815|364838269|FG000|Overall Study|Adverse Event|1|||
105778065|NCT00620815|364838270|FG001|Overall Study|Adverse Event|1|||
105778066|NCT00620815|364838271|FG002|Overall Study|Adverse Event|2|||
105778067|NCT00620815|364838269|FG000|Overall Study|Withdrawal by Subject|1|||
105778068|NCT00620815|364838270|FG001|Overall Study|Withdrawal by Subject|2|||
105778069|NCT00620815|364838271|FG002|Overall Study|Withdrawal by Subject|0|||
105778070|NCT00620815|364838269|FG000|Overall Study|Lost to Follow-up|1|||
105778071|NCT00620815|364838270|FG001|Overall Study|Lost to Follow-up|6|||
105778072|NCT00620815|364838271|FG002|Overall Study|Lost to Follow-up|3|||
105778073|NCT00620815|364838269|FG000|Overall Study|Inappropriate enrolment|0|||
105778074|NCT00620815|364838270|FG001|Overall Study|Inappropriate enrolment|0|||
105778075|NCT00620815|364838271|FG002|Overall Study|Inappropriate enrolment|1|||
105778076|NCT00620815|364838269|FG000|Overall Study|Protocol Violation|1|||
105778077|NCT00620815|364838270|FG001|Overall Study|Protocol Violation|2|||
105778078|NCT00620815|364838271|FG002|Overall Study|Protocol Violation|1|||
105778079|NCT00983827|364838272|FG000|Overall Study|Withdrawal by Subject|1|||
105778080|NCT00795717|364838273|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
105778081|NCT00795717|364838274|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
105778082|NCT00795717|364838273|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
105778083|NCT00795717|364838274|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
105778084|NCT00795717|364838273|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
105778085|NCT00795717|364838274|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
105778086|NCT00795717|364838273|FG000|Phase II|too busy|0|||
105778087|NCT00795717|364838274|FG001|Phase II|too busy|1|||
105778088|NCT00695318|364838275|FG000|Overall Study|Lost to Follow-up|1|||
105778089|NCT00695318|364838276|FG001|Overall Study|Lost to Follow-up|0|||
105778090|NCT00695318|364838275|FG000|Overall Study|Withdrawal by Subject|2|||
105778091|NCT00695318|364838276|FG001|Overall Study|Withdrawal by Subject|0|||
105778092|NCT00695318|364838275|FG000|Overall Study|Death|1|||
105778093|NCT00695318|364838276|FG001|Overall Study|Death|1|||
105778094|NCT00695318|364838275|FG000|Overall Study|Study Terminated|1|||
105778095|NCT00695318|364838276|FG001|Overall Study|Study Terminated|0|||
105778096|NCT02390167|364840243|FG000|Overall Study|Lost to Follow-up|1|||
105778097|NCT04335929|364840247|FG000|Overall Study|Lost to Follow-up|10|||
105778098|NCT01005966|364840248|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
105778099|NCT01005966|364840249|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
105778100|NCT01005966|364840250|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
105778101|NCT01005966|364840251|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
105778102|NCT01005966|364840252|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
105778103|NCT01005966|364840248|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
105778104|NCT01005966|364840249|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
105778105|NCT01005966|364840250|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
105778106|NCT01005966|364840251|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
105778107|NCT01005966|364840252|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
105778108|NCT01005966|364840248|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
105778109|NCT01005966|364840249|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
105778110|NCT01005966|364840250|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
105778111|NCT01005966|364840251|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
105778112|NCT01005966|364840252|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
105778113|NCT01005966|364840248|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
105778114|NCT01005966|364840249|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
105778115|NCT01005966|364840250|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
105778116|NCT01005966|364840251|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
105778117|NCT01005966|364840252|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
105778118|NCT01005966|364840248|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105778119|NCT01005966|364840249|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105778120|NCT01005966|364840250|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105778121|NCT01005966|364840251|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105778122|NCT01005966|364840252|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105778123|NCT01005966|364840248|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105778124|NCT01005966|364840249|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105778125|NCT01005966|364840250|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
105778126|NCT01005966|364840251|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105778127|NCT01005966|364840252|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105778128|NCT01005966|364840248|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
105778129|NCT01005966|364840249|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
105778130|NCT01005966|364840250|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
105778131|NCT01005966|364840251|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
105778132|NCT01005966|364840252|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
105778133|NCT01005966|364840248|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
105778134|NCT01005966|364840249|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
105778135|NCT01005966|364840250|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
105778136|NCT01005966|364840251|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
105778137|NCT01005966|364840252|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
105778138|NCT01005966|364840248|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
105778139|NCT01005966|364840249|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
105778140|NCT01005966|364840250|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
105778141|NCT01005966|364840251|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
105778142|NCT01005966|364840252|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
105778143|NCT03419741|364840257|FG000|Overall Study|Adverse Event|1|||
105778144|NCT03419741|364840258|FG001|Overall Study|Adverse Event|0|||
105778145|NCT03419741|364840257|FG000|Overall Study|Withdrawal by Subject|1|||
105778146|NCT03419741|364840258|FG001|Overall Study|Withdrawal by Subject|2|||
105778147|NCT00577382|364840267|FG000|Overall Study|Adverse Event|0|||
105778148|NCT00577382|364840268|FG001|Overall Study|Adverse Event|6|||
105778149|NCT00577382|364840267|FG000|Overall Study|Withdrawal by Subject|0|||
105778150|NCT00577382|364840268|FG001|Overall Study|Withdrawal by Subject|1|||
105778151|NCT00577382|364840267|FG000|Overall Study|Progressive Disease|17|||
105778152|NCT00577382|364840268|FG001|Overall Study|Progressive Disease|19|||
105778153|NCT00577382|364840267|FG000|Overall Study|Intercurrent Illness|1|||
106099779|NCT00626522|366022632|FG004|Overall Study|Adverse Event|1|||
106099780|NCT00626522|366022633|FG005|Overall Study|Adverse Event|1|||
105778154|NCT00577382|364840268|FG001|Overall Study|Intercurrent Illness|2|||
105778155|NCT00577382|364840267|FG000|Overall Study|Death|1|||
105778156|NCT00577382|364840268|FG001|Overall Study|Death|1|||
105778157|NCT00577382|364840267|FG000|Overall Study|Lost to Follow-up|2|||
105778158|NCT00577382|364840268|FG001|Overall Study|Lost to Follow-up|2|||
105778159|NCT00253747|364840269|FG000|Overall Study|Lost to Follow-up|13|||
105778160|NCT00253747|364840270|FG001|Overall Study|Lost to Follow-up|14|||
105778161|NCT00253747|364840269|FG000|Overall Study|Withdrawal by Subject|10|||
105778162|NCT00253747|364840270|FG001|Overall Study|Withdrawal by Subject|11|||
105778163|NCT00253747|364840269|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
105778164|NCT00253747|364840270|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
105778165|NCT00661362|364840271|FG000|Overall Study|Adverse Event|5|||
105778166|NCT00661362|364840272|FG001|Overall Study|Adverse Event|4|||
105778167|NCT00661362|364840271|FG000|Overall Study|Incorrect enrollment|2|||
105778168|NCT00661362|364840272|FG001|Overall Study|Incorrect enrollment|0|||
105778169|NCT00661362|364840271|FG000|Overall Study|Study specific discontinuation criteria|4|||
105778170|NCT00661362|364840272|FG001|Overall Study|Study specific discontinuation criteria|11|||
105778171|NCT00661362|364840271|FG000|Overall Study|Withdrawal by Subject|13|||
105778172|NCT00661362|364840272|FG001|Overall Study|Withdrawal by Subject|23|||
105778173|NCT00661362|364840271|FG000|Overall Study|Lost to Follow-up|3|||
105778174|NCT00661362|364840272|FG001|Overall Study|Lost to Follow-up|1|||
105778175|NCT00661362|364840271|FG000|Overall Study|Severe non-compliance to protocol|0|||
105778176|NCT00661362|364840272|FG001|Overall Study|Severe non-compliance to protocol|1|||
105778177|NCT00661362|364840271|FG000|Overall Study|Safety reasons|1|||
105778178|NCT00661362|364840272|FG001|Overall Study|Safety reasons|0|||
105778179|NCT00661362|364840271|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
105778180|NCT00661362|364840272|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
105778181|NCT00718887|364840273|FG000|Overall Study|Withdrawal by Subject|3|||
105778182|NCT00718887|364840274|FG001|Overall Study|Withdrawal by Subject|2|||
105778183|NCT00718887|364840273|FG000|Overall Study|Not identified|2|||
105778184|NCT00718887|364840274|FG001|Overall Study|Not identified|7|||
105778185|NCT00775138|364840275|FG000|Overall Study|Withdrawal by Subject|0|||
105778186|NCT00775138|364840276|FG001|Overall Study|Withdrawal by Subject|0|||
105778187|NCT00775138|364840277|FG002|Overall Study|Withdrawal by Subject|2|||
105778188|NCT00775138|364840278|FG003|Overall Study|Withdrawal by Subject|2|||
105778189|NCT00775138|364840275|FG000|Overall Study|Adverse Event|0|||
105778190|NCT00775138|364840276|FG001|Overall Study|Adverse Event|0|||
105778191|NCT00775138|364840277|FG002|Overall Study|Adverse Event|1|||
105778192|NCT00775138|364840278|FG003|Overall Study|Adverse Event|0|||
105778193|NCT04880642|364840279|FG000|Randomization|Withdrawal by Subject|2|||
105778194|NCT04880642|364840280|FG001|Randomization|Withdrawal by Subject|3|||
105778195|NCT04880642|364840279|FG000|Treatment Period|Adverse Event|0|||
105778196|NCT04880642|364840280|FG001|Treatment Period|Adverse Event|1|||
105778197|NCT04880642|364840279|FG000|Treatment Period|Death|6|||
105778198|NCT04880642|364840280|FG001|Treatment Period|Death|6|||
105778199|NCT04880642|364840279|FG000|Treatment Period|Lost to Follow-up|1|||
105778200|NCT04880642|364840280|FG001|Treatment Period|Lost to Follow-up|0|||
105778201|NCT04880642|364840279|FG000|Treatment Period|Protocol Violation|0|||
105778202|NCT04880642|364840280|FG001|Treatment Period|Protocol Violation|1|||
105778203|NCT04880642|364840279|FG000|Treatment Period|Withdrawal by Subject|5|||
105778204|NCT04880642|364840280|FG001|Treatment Period|Withdrawal by Subject|3|||
105778205|NCT04880642|364840279|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
105778206|NCT04880642|364840280|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
105778207|NCT04880642|364840279|FG000|Follow-up|Death|4|||
105778208|NCT04880642|364840280|FG001|Follow-up|Death|3|||
105778209|NCT04880642|364840279|FG000|Follow-up|Withdrawal by Subject|1|||
105778210|NCT04880642|364840280|FG001|Follow-up|Withdrawal by Subject|0|||
105778211|NCT00104299|364840281|FG000|Overall Study|Adverse Event|3|||
105778212|NCT00104299|364840282|FG001|Overall Study|Adverse Event|1|||
105778213|NCT00104299|364840281|FG000|Overall Study|Death|2|||
105778214|NCT00104299|364840282|FG001|Overall Study|Death|2|||
105778215|NCT00104299|364840281|FG000|Overall Study|Withdrawal by Subject|2|||
105778216|NCT00104299|364840282|FG001|Overall Study|Withdrawal by Subject|6|||
105778217|NCT00104299|364840281|FG000|Overall Study|Physician Decision|1|||
105778218|NCT00104299|364840282|FG001|Overall Study|Physician Decision|1|||
105778219|NCT00104299|364840281|FG000|Overall Study|To have renal transplant|1|||
105778220|NCT00104299|364840282|FG001|Overall Study|To have renal transplant|0|||
105778221|NCT04601194|364840283|FG000|Overall Study|Lost to Follow-up|7|||
105778222|NCT04905563|364840284|FG000|Overall Study|Withdrawal by Subject|1|||
105778223|NCT04905563|364840285|FG001|Overall Study|Withdrawal by Subject|0|||
105778224|NCT04905563|364840284|FG000|Overall Study|Standard of care orders entered by resident|1|||
105778225|NCT04905563|364840285|FG001|Overall Study|Standard of care orders entered by resident|0|||
105778226|NCT04905563|364840284|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
105778227|NCT04905563|364840285|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
105778228|NCT04905563|364840284|FG000|Overall Study|Withdrawal by Subject|0|||
105778229|NCT04905563|364840285|FG001|Overall Study|Withdrawal by Subject|1|||
105778230|NCT00508001|364840288|FG000|Overall Study|Adverse Event|2|||
105778231|NCT00508001|364840289|FG001|Overall Study|Adverse Event|0|||
105778232|NCT00508001|364840290|FG002|Overall Study|Adverse Event|4|||
105778233|NCT00508001|364840288|FG000|Overall Study|condition under investigation worsened|13|||
105778234|NCT00508001|364840289|FG001|Overall Study|condition under investigation worsened|7|||
105778235|NCT00508001|364840290|FG002|Overall Study|condition under investigation worsened|1|||
105778236|NCT00508001|364840288|FG000|Overall Study|Death|0|||
105778237|NCT00508001|364840289|FG001|Overall Study|Death|1|||
105778238|NCT00508001|364840290|FG002|Overall Study|Death|1|||
105778239|NCT00508001|364840288|FG000|Overall Study|Withdrawal by Subject|4|||
105778240|NCT00508001|364840289|FG001|Overall Study|Withdrawal by Subject|4|||
105778241|NCT00508001|364840290|FG002|Overall Study|Withdrawal by Subject|1|||
105778242|NCT01051856|364840291|FG000|Overall Study|Withdrawal by Subject|1|||
105778243|NCT01051856|364840292|FG001|Overall Study|Withdrawal by Subject|0|||
105778244|NCT01611558|364840293|FG000|Induction Phase|Study drug toxicity|15|||
105778245|NCT01611558|364840293|FG000|Induction Phase|Disease progression|18|||
105778246|NCT01611558|364840293|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
105778247|NCT01611558|364840293|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
105778248|NCT01611558|364840293|FG000|Induction Phase|Death|1|||
105778249|NCT01611558|364840293|FG000|Maintenance Phase|Withdrawal by Subject|1|||
105778250|NCT01611558|364840293|FG000|Maintenance Phase|Elevated Uric acid|1|||
105778251|NCT01412333|364840294|FG000|Overall Study|Adverse Event|40|||
105778252|NCT01412333|364840295|FG001|Overall Study|Adverse Event|42|||
105778253|NCT01412333|364840294|FG000|Overall Study|Death|5|||
105778254|NCT01412333|364840295|FG001|Overall Study|Death|6|||
105778255|NCT01412333|364840294|FG000|Overall Study|Lack of Efficacy|22|||
105778256|NCT01412333|364840295|FG001|Overall Study|Lack of Efficacy|10|||
105778257|NCT01412333|364840294|FG000|Overall Study|Lost to Follow-up|15|||
105778258|NCT01412333|364840295|FG001|Overall Study|Lost to Follow-up|12|||
105778259|NCT01412333|364840294|FG000|Overall Study|Non-Compliance|3|||
105778260|NCT01412333|364840295|FG001|Overall Study|Non-Compliance|7|||
105778261|NCT01412333|364840294|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105778262|NCT01412333|364840295|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105778263|NCT01412333|364840294|FG000|Overall Study|Other|30|||
105778264|NCT01412333|364840295|FG001|Overall Study|Other|33|||
105778265|NCT01412333|364840294|FG000|Overall Study|Physician Decision|11|||
105778266|NCT01412333|364840295|FG001|Overall Study|Physician Decision|16|||
105778267|NCT01412333|364840294|FG000|Overall Study|Pregnancy|6|||
105778268|NCT01412333|364840295|FG001|Overall Study|Pregnancy|4|||
105778269|NCT01412333|364840294|FG000|Overall Study|Protocol Violation|1|||
105778270|NCT01412333|364840295|FG001|Overall Study|Protocol Violation|2|||
105778271|NCT01412333|364840294|FG000|Overall Study|Study Terminated By Sponsor|3|||
105778272|NCT01412333|364840295|FG001|Overall Study|Study Terminated By Sponsor|2|||
105778273|NCT01412333|364840294|FG000|Overall Study|Withdrawal by Subject|51|||
105778274|NCT01412333|364840295|FG001|Overall Study|Withdrawal by Subject|54|||
105778275|NCT01412333|364840294|FG000|Overall Study|Missing|1|||
105778276|NCT01412333|364840295|FG001|Overall Study|Missing|3|||
105778277|NCT00750867|364840296|FG000|Overall Study|Adverse Event|2|||
105778278|NCT02543801|364840297|FG000|Overall Study|Protocol Violation|1|||
105778279|NCT02543801|364840298|FG001|Overall Study|Protocol Violation|2|||
105778280|NCT02543801|364840299|FG002|Overall Study|Protocol Violation|0|||
105778281|NCT02543801|364840300|FG003|Overall Study|Protocol Violation|0|||
105778282|NCT01981096|364840304|FG000|Overall Study|Parent illness|1|||
105778283|NCT01981096|364840305|FG001|Overall Study|Parent illness|0|||
105778284|NCT01981096|364840304|FG000|Overall Study|Withdrawal by Subject|0|||
105778285|NCT01981096|364840305|FG001|Overall Study|Withdrawal by Subject|1|||
105778286|NCT01981096|364840304|FG000|Overall Study|Lost to Follow-up|2|||
105778287|NCT01981096|364840305|FG001|Overall Study|Lost to Follow-up|0|||
105778288|NCT01225211|364840306|FG000|Overall Study|Adverse Event|0|||
105778289|NCT01225211|364840307|FG001|Overall Study|Adverse Event|0|||
105778290|NCT01225211|364840308|FG002|Overall Study|Adverse Event|1|||
105778291|NCT01225211|364840309|FG003|Overall Study|Adverse Event|0|||
105778292|NCT01225211|364840310|FG004|Overall Study|Adverse Event|0|||
105778293|NCT01225211|364840311|FG005|Overall Study|Adverse Event|0|||
105778294|NCT01225211|364840312|FG006|Overall Study|Adverse Event|0|||
105778295|NCT01225211|364840313|FG007|Overall Study|Adverse Event|0|||
105778296|NCT01225211|364840314|FG008|Overall Study|Adverse Event|0|||
105778297|NCT01225211|364840315|FG009|Overall Study|Adverse Event|1|||
105778298|NCT01225211|364840306|FG000|Overall Study|Withdrawal by Subject|0|||
105778299|NCT01225211|364840307|FG001|Overall Study|Withdrawal by Subject|0|||
105778300|NCT01225211|364840308|FG002|Overall Study|Withdrawal by Subject|0|||
105778301|NCT01225211|364840309|FG003|Overall Study|Withdrawal by Subject|0|||
105778302|NCT01225211|364840310|FG004|Overall Study|Withdrawal by Subject|0|||
105778303|NCT01225211|364840311|FG005|Overall Study|Withdrawal by Subject|0|||
105778304|NCT01225211|364840312|FG006|Overall Study|Withdrawal by Subject|1|||
105778305|NCT01225211|364840313|FG007|Overall Study|Withdrawal by Subject|0|||
105778306|NCT01225211|364840314|FG008|Overall Study|Withdrawal by Subject|1|||
105778307|NCT01225211|364840315|FG009|Overall Study|Withdrawal by Subject|3|||
105778308|NCT01225211|364840306|FG000|Overall Study|Other|0|||
105778309|NCT01225211|364840307|FG001|Overall Study|Other|0|||
105778310|NCT01225211|364840308|FG002|Overall Study|Other|0|||
105778311|NCT01225211|364840309|FG003|Overall Study|Other|0|||
105778312|NCT01225211|364840310|FG004|Overall Study|Other|0|||
105778313|NCT01225211|364840311|FG005|Overall Study|Other|0|||
105778314|NCT01225211|364840312|FG006|Overall Study|Other|0|||
105778315|NCT01225211|364840313|FG007|Overall Study|Other|0|||
105778316|NCT01225211|364840314|FG008|Overall Study|Other|0|||
105778317|NCT01225211|364840315|FG009|Overall Study|Other|1|||
105778318|NCT04129242|364840320|FG000|Overall Study|Physician Decision|1|||
105778319|NCT04129242|364840321|FG001|Overall Study|Physician Decision|1|||
105778320|NCT04129242|364840320|FG000|Overall Study|Protocol Violation|0|||
105778321|NCT04129242|364840321|FG001|Overall Study|Protocol Violation|1|||
105778322|NCT02380703|364840324|FG000|Overall Study|Withdrawal by Subject|12|||
105778323|NCT02380703|364840325|FG001|Overall Study|Withdrawal by Subject|9|||
105778324|NCT02380703|364840324|FG000|Overall Study|Lost to Follow-up|12|||
105778325|NCT02380703|364840325|FG001|Overall Study|Lost to Follow-up|12|||
105778326|NCT02380703|364840324|FG000|Overall Study|Caregiver death|1|||
105778327|NCT02380703|364840325|FG001|Overall Study|Caregiver death|0|||
105778328|NCT02380703|364840324|FG000|Overall Study|Person with dementia (PWD) death|7|||
105778329|NCT02380703|364840325|FG001|Overall Study|Person with dementia (PWD) death|8|||
105778330|NCT02380703|364840324|FG000|Overall Study|Entered Long-term Care|4|||
105778331|NCT02380703|364840325|FG001|Overall Study|Entered Long-term Care|7|||
105778332|NCT02709889|364840333|FG000|Overall Study|Withdrawal by Subject|11|||
105778333|NCT02709889|364840334|FG001|Overall Study|Withdrawal by Subject|10|||
105778334|NCT02709889|364840335|FG002|Overall Study|Withdrawal by Subject|2|||
105778335|NCT02709889|364840336|FG003|Overall Study|Withdrawal by Subject|12|||
105778336|NCT02709889|364840333|FG000|Overall Study|Death|25|||
105778337|NCT02709889|364840334|FG001|Overall Study|Death|38|||
105778338|NCT02709889|364840335|FG002|Overall Study|Death|4|||
105778339|NCT02709889|364840336|FG003|Overall Study|Death|44|||
105778340|NCT02709889|364840333|FG000|Overall Study|Physician Decision|1|||
105778341|NCT02709889|364840334|FG001|Overall Study|Physician Decision|2|||
105778342|NCT02709889|364840335|FG002|Overall Study|Physician Decision|3|||
105778343|NCT02709889|364840336|FG003|Overall Study|Physician Decision|5|||
105778344|NCT02709889|364840333|FG000|Overall Study|Lost to Follow-up|2|||
105778345|NCT02709889|364840334|FG001|Overall Study|Lost to Follow-up|0|||
105778346|NCT02709889|364840335|FG002|Overall Study|Lost to Follow-up|0|||
105778347|NCT02709889|364840336|FG003|Overall Study|Lost to Follow-up|4|||
105778348|NCT02709889|364840333|FG000|Overall Study|Study Terminated by Sponsor|4|||
105778349|NCT02709889|364840334|FG001|Overall Study|Study Terminated by Sponsor|6|||
105778350|NCT02709889|364840335|FG002|Overall Study|Study Terminated by Sponsor|2|||
105778351|NCT02709889|364840336|FG003|Overall Study|Study Terminated by Sponsor|17|||
105778352|NCT02709889|364840333|FG000|Overall Study|Other, Not Specified|0|||
105778353|NCT02709889|364840334|FG001|Overall Study|Other, Not Specified|1|||
105778354|NCT02709889|364840335|FG002|Overall Study|Other, Not Specified|1|||
105778355|NCT02709889|364840336|FG003|Overall Study|Other, Not Specified|6|||
105778356|NCT00537810|364840338|FG000|Overall Study|Withdrawal by Subject|4|||
105778357|NCT00537810|364840339|FG001|Overall Study|Withdrawal by Subject|11|||
105778358|NCT00537810|364840340|FG002|Overall Study|Withdrawal by Subject|4|||
105778359|NCT00537810|364840341|FG003|Overall Study|Withdrawal by Subject|3|||
105778360|NCT00537810|364840338|FG000|Overall Study|Medically withdrawn|2|||
105778361|NCT00537810|364840339|FG001|Overall Study|Medically withdrawn|2|||
105778362|NCT00537810|364840340|FG002|Overall Study|Medically withdrawn|0|||
105778363|NCT00537810|364840341|FG003|Overall Study|Medically withdrawn|1|||
105778364|NCT00962780|364840343|FG000|Overall Study|Death|0|||
105778365|NCT00962780|364840344|FG001|Overall Study|Death|1|||
105778366|NCT00962780|364840343|FG000|Overall Study|Protocol Violation|9|||
105778367|NCT00962780|364840344|FG001|Overall Study|Protocol Violation|4|||
105778368|NCT00962780|364840343|FG000|Overall Study|Withdrawal by Subject|1|||
105778369|NCT00962780|364840344|FG001|Overall Study|Withdrawal by Subject|8|||
105778370|NCT00962780|364840343|FG000|Overall Study|Other|0|||
105778371|NCT00962780|364840344|FG001|Overall Study|Other|1|||
105778372|NCT01775995|364840348|FG000|Overall Study|Lost to Follow-up|1|||
105778373|NCT01775995|364840349|FG001|Overall Study|Lost to Follow-up|1|||
105778374|NCT02269709|364840350|FG000|Time of Enrollment|Withdrawal by Subject|3|||
105778375|NCT02269709|364840350|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
105778376|NCT02269709|364840350|FG000|Six Month Follow-up|Lost to Follow-up|12|||
105778377|NCT01657903|364840353|FG000|Overall Study|Lost to Follow-up|1|||
105778378|NCT01657903|364840353|FG000|Overall Study|Withdrawal by Subject|1|||
105778379|NCT01259388|364840356|FG000|Overall Study|Adverse Event|3|||
105778380|NCT01259388|364840357|FG001|Overall Study|Adverse Event|0|||
105778381|NCT01259388|364840356|FG000|Overall Study|Withdrawal by Subject|1|||
105778382|NCT01259388|364840357|FG001|Overall Study|Withdrawal by Subject|1|||
105778383|NCT01259388|364840356|FG000|Overall Study|Physician Decision|1|||
105778384|NCT01259388|364840357|FG001|Overall Study|Physician Decision|0|||
105778385|NCT03512028|364840358|FG000|Overall Study|Withdrawal by Subject|2|||
105778386|NCT03512028|364840359|FG001|Overall Study|Withdrawal by Subject|0|||
105778387|NCT03512028|364840358|FG000|Overall Study|Protocol Violation|2|||
105778388|NCT03512028|364840359|FG001|Overall Study|Protocol Violation|0|||
105778389|NCT01475214|364840360|FG000|Overall Study|Lost to Follow-up|1|||
105778390|NCT01475214|364840361|FG001|Overall Study|Lost to Follow-up|0|||
105778391|NCT01475214|364840362|FG002|Overall Study|Lost to Follow-up|1|||
105778392|NCT01475214|364840360|FG000|Overall Study|Physician Decision|2|||
105778393|NCT01475214|364840361|FG001|Overall Study|Physician Decision|0|||
105778394|NCT01475214|364840362|FG002|Overall Study|Physician Decision|0|||
105778395|NCT01475214|364840360|FG000|Overall Study|Withdrawal by Subject|2|||
105778396|NCT01475214|364840361|FG001|Overall Study|Withdrawal by Subject|4|||
105778397|NCT01475214|364840362|FG002|Overall Study|Withdrawal by Subject|1|||
105878752|NCT01120184|365209744|FG002|Overall Study|Adverse Event|0|||
105778398|NCT02743494|364840363|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
105778399|NCT02743494|364840364|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
105778400|NCT02743494|364840363|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
105778401|NCT02743494|364840364|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
105778402|NCT02743494|364840363|FG000|Treatment Period|Completed treatment|229|||
105778403|NCT02743494|364840364|FG001|Treatment Period|Completed treatment|99|||
105778404|NCT02743494|364840363|FG000|Treatment Period|Disease recurrence|149|||
105778405|NCT02743494|364840364|FG001|Treatment Period|Disease recurrence|113|||
105778406|NCT02743494|364840363|FG000|Treatment Period|Study drug toxicity|57|||
105778407|NCT02743494|364840364|FG001|Treatment Period|Study drug toxicity|8|||
105778408|NCT02743494|364840363|FG000|Treatment Period|Death|1|||
105778409|NCT02743494|364840364|FG001|Treatment Period|Death|0|||
105778410|NCT02743494|364840363|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
105778411|NCT02743494|364840364|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
105778412|NCT02743494|364840363|FG000|Treatment Period|Participant request to discontinue treatment|30|||
105778413|NCT02743494|364840364|FG001|Treatment Period|Participant request to discontinue treatment|5|||
105778414|NCT02743494|364840363|FG000|Treatment Period|Participant withdrew consent|12|||
105778415|NCT02743494|364840364|FG001|Treatment Period|Participant withdrew consent|4|||
105778416|NCT02743494|364840363|FG000|Treatment Period|Lost to Follow-up|0|||
105778417|NCT02743494|364840364|FG001|Treatment Period|Lost to Follow-up|1|||
105778418|NCT02743494|364840363|FG000|Treatment Period|Poor/Non-compliance|1|||
105778419|NCT02743494|364840364|FG001|Treatment Period|Poor/Non-compliance|0|||
105778420|NCT02743494|364840363|FG000|Treatment Period|Other reasons|7|||
105778421|NCT02743494|364840364|FG001|Treatment Period|Other reasons|2|||
105778422|NCT00643851|364840367|FG000|Overall Study|Death|0|||
105778423|NCT00643851|364840368|FG001|Overall Study|Death|1|||
105778424|NCT00643851|364840369|FG002|Overall Study|Death|0|||
105778425|NCT00643851|364840367|FG000|Overall Study|Lack of Efficacy|0|||
105778426|NCT00643851|364840368|FG001|Overall Study|Lack of Efficacy|1|||
105778427|NCT00643851|364840369|FG002|Overall Study|Lack of Efficacy|0|||
105778428|NCT00643851|364840367|FG000|Overall Study|Adverse Event|2|||
105778429|NCT00643851|364840368|FG001|Overall Study|Adverse Event|6|||
105778430|NCT00643851|364840369|FG002|Overall Study|Adverse Event|6|||
105778431|NCT00643851|364840367|FG000|Overall Study|Lost to Follow-up|4|||
105778432|NCT00643851|364840368|FG001|Overall Study|Lost to Follow-up|6|||
105778433|NCT00643851|364840369|FG002|Overall Study|Lost to Follow-up|9|||
105778434|NCT00643851|364840367|FG000|Overall Study|Withdrawal by Subject|8|||
105778435|NCT00643851|364840368|FG001|Overall Study|Withdrawal by Subject|15|||
105778436|NCT00643851|364840369|FG002|Overall Study|Withdrawal by Subject|9|||
105778437|NCT00643851|364840367|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
105778438|NCT00643851|364840368|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
105778439|NCT00643851|364840369|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
105778440|NCT03529162|364840370|FG000|Overall Study|Lost to Follow-up|2|||
105778441|NCT03529162|364840371|FG001|Overall Study|Lost to Follow-up|2|||
105778442|NCT01521494|364840372|FG000|Overall Study|Adverse Event|1|||
105778443|NCT01521494|364840373|FG001|Overall Study|Adverse Event|2|||
105778444|NCT01521494|364840374|FG002|Overall Study|Adverse Event|9|||
105778445|NCT01521494|364840375|FG003|Overall Study|Adverse Event|6|||
105778446|NCT01521494|364840376|FG004|Overall Study|Adverse Event|2|||
105778447|NCT01521494|364840372|FG000|Overall Study|Lack of Efficacy|0|||
105778448|NCT01521494|364840373|FG001|Overall Study|Lack of Efficacy|0|||
105778449|NCT01521494|364840374|FG002|Overall Study|Lack of Efficacy|0|||
105778450|NCT01521494|364840375|FG003|Overall Study|Lack of Efficacy|0|||
105778451|NCT01521494|364840376|FG004|Overall Study|Lack of Efficacy|2|||
105778452|NCT01521494|364840372|FG000|Overall Study|Withdrawal by Subject|1|||
105778453|NCT01521494|364840373|FG001|Overall Study|Withdrawal by Subject|1|||
105778454|NCT01521494|364840374|FG002|Overall Study|Withdrawal by Subject|0|||
105778455|NCT01521494|364840375|FG003|Overall Study|Withdrawal by Subject|2|||
105778456|NCT01521494|364840376|FG004|Overall Study|Withdrawal by Subject|0|||
105778457|NCT01521494|364840372|FG000|Overall Study|Decrease in serum phosphate|0|||
105778458|NCT01521494|364840373|FG001|Overall Study|Decrease in serum phosphate|2|||
105778459|NCT01521494|364840374|FG002|Overall Study|Decrease in serum phosphate|3|||
105778460|NCT01521494|364840375|FG003|Overall Study|Decrease in serum phosphate|12|||
105778461|NCT01521494|364840376|FG004|Overall Study|Decrease in serum phosphate|0|||
105778462|NCT01521494|364840372|FG000|Overall Study|Decrease in serum calcium|0|||
105778463|NCT01521494|364840373|FG001|Overall Study|Decrease in serum calcium|0|||
105778464|NCT01521494|364840374|FG002|Overall Study|Decrease in serum calcium|0|||
105778465|NCT01521494|364840375|FG003|Overall Study|Decrease in serum calcium|1|||
105778466|NCT01521494|364840376|FG004|Overall Study|Decrease in serum calcium|1|||
105778467|NCT01521494|364840372|FG000|Overall Study|Physician Decision|0|||
105778468|NCT01521494|364840373|FG001|Overall Study|Physician Decision|0|||
105778469|NCT01521494|364840374|FG002|Overall Study|Physician Decision|0|||
105778470|NCT01521494|364840375|FG003|Overall Study|Physician Decision|0|||
105778471|NCT01521494|364840376|FG004|Overall Study|Physician Decision|2|||
105778472|NCT02728804|364840379|FG000|Overall Study|Ineligible|3|||
105778473|NCT02728804|364840379|FG000|Overall Study|Did not complete baseline questionnaire|9|||
105778474|NCT02728804|364840379|FG000|Overall Study|Death|99|||
105778475|NCT00591786|364840380|FG000|Overall Study|Withdrawal of Informed Consent|0|||
105778476|NCT00591786|364840381|FG001|Overall Study|Withdrawal of Informed Consent|0|||
105778477|NCT00591786|364840382|FG002|Overall Study|Withdrawal of Informed Consent|1|||
105778478|NCT00591786|364840383|FG003|Overall Study|Withdrawal of Informed Consent|0|||
105778479|NCT00591786|364840384|FG004|Overall Study|Withdrawal of Informed Consent|0|||
105778480|NCT00591786|364840385|FG005|Overall Study|Withdrawal of Informed Consent|0|||
105778481|NCT00591786|364840386|FG006|Overall Study|Withdrawal of Informed Consent|0|||
105778482|NCT00591786|364840387|FG007|Overall Study|Withdrawal of Informed Consent|0|||
105778483|NCT00591786|364840388|FG008|Overall Study|Withdrawal of Informed Consent|0|||
105778484|NCT00591786|364840389|FG009|Overall Study|Withdrawal of Informed Consent|0|||
105778485|NCT01920061|364840393|FG000|Overall Study|Death|1|||
105778486|NCT01920061|364840394|FG001|Overall Study|Death|1|||
105778487|NCT01920061|364840395|FG002|Overall Study|Death|0|||
105778488|NCT01920061|364840396|FG003|Overall Study|Death|1|||
105778489|NCT01920061|364840397|FG004|Overall Study|Death|1|||
105778490|NCT01920061|364840398|FG005|Overall Study|Death|0|||
105778491|NCT01920061|364840399|FG006|Overall Study|Death|0|||
105778492|NCT01920061|364840400|FG007|Overall Study|Death|1|||
105778493|NCT01920061|364840401|FG008|Overall Study|Death|0|||
105778494|NCT01920061|364840402|FG009|Overall Study|Death|1|||
105778495|NCT01920061|364840403|FG010|Overall Study|Death|0|||
105778496|NCT01920061|364840404|FG011|Overall Study|Death|1|||
105778497|NCT01920061|364840405|FG012|Overall Study|Death|0|||
105778498|NCT01920061|364840406|FG013|Overall Study|Death|2|||
105778499|NCT01920061|364840407|FG014|Overall Study|Death|0|||
105778500|NCT01920061|364840408|FG015|Overall Study|Death|0|||
105778501|NCT01920061|364840409|FG016|Overall Study|Death|0|||
105778502|NCT01920061|364840410|FG017|Overall Study|Death|0|||
105778503|NCT01920061|364840411|FG018|Overall Study|Death|1|||
105778504|NCT01920061|364840412|FG019|Overall Study|Death|0|||
105778505|NCT01920061|364840393|FG000|Overall Study|Lost to Follow-up|0|||
105778506|NCT01920061|364840394|FG001|Overall Study|Lost to Follow-up|2|||
105778507|NCT01920061|364840395|FG002|Overall Study|Lost to Follow-up|0|||
105778508|NCT01920061|364840396|FG003|Overall Study|Lost to Follow-up|0|||
105778509|NCT01920061|364840397|FG004|Overall Study|Lost to Follow-up|0|||
105778510|NCT01920061|364840398|FG005|Overall Study|Lost to Follow-up|0|||
105778511|NCT01920061|364840399|FG006|Overall Study|Lost to Follow-up|1|||
105778512|NCT01920061|364840400|FG007|Overall Study|Lost to Follow-up|0|||
105778513|NCT01920061|364840401|FG008|Overall Study|Lost to Follow-up|0|||
105778514|NCT01920061|364840402|FG009|Overall Study|Lost to Follow-up|0|||
105778515|NCT01920061|364840403|FG010|Overall Study|Lost to Follow-up|3|||
105778516|NCT01920061|364840404|FG011|Overall Study|Lost to Follow-up|0|||
105778517|NCT01920061|364840405|FG012|Overall Study|Lost to Follow-up|0|||
105778518|NCT01920061|364840406|FG013|Overall Study|Lost to Follow-up|0|||
105778519|NCT01920061|364840407|FG014|Overall Study|Lost to Follow-up|0|||
105778520|NCT01920061|364840408|FG015|Overall Study|Lost to Follow-up|0|||
105778521|NCT01920061|364840409|FG016|Overall Study|Lost to Follow-up|0|||
105778522|NCT01920061|364840410|FG017|Overall Study|Lost to Follow-up|1|||
105778523|NCT01920061|364840411|FG018|Overall Study|Lost to Follow-up|4|||
105778524|NCT01920061|364840412|FG019|Overall Study|Lost to Follow-up|3|||
105778525|NCT01920061|364840393|FG000|Overall Study|Other|1|||
105778526|NCT01920061|364840394|FG001|Overall Study|Other|1|||
105778527|NCT01920061|364840395|FG002|Overall Study|Other|2|||
105778528|NCT01920061|364840396|FG003|Overall Study|Other|1|||
105778529|NCT01920061|364840397|FG004|Overall Study|Other|0|||
105778530|NCT01920061|364840398|FG005|Overall Study|Other|1|||
105778531|NCT01920061|364840399|FG006|Overall Study|Other|0|||
105778532|NCT01920061|364840400|FG007|Overall Study|Other|0|||
105778533|NCT01920061|364840401|FG008|Overall Study|Other|0|||
105778534|NCT01920061|364840402|FG009|Overall Study|Other|1|||
105778535|NCT01920061|364840403|FG010|Overall Study|Other|1|||
105778536|NCT01920061|364840404|FG011|Overall Study|Other|2|||
105778537|NCT01920061|364840405|FG012|Overall Study|Other|1|||
105778538|NCT01920061|364840406|FG013|Overall Study|Other|4|||
105778539|NCT01920061|364840407|FG014|Overall Study|Other|0|||
105778540|NCT01920061|364840408|FG015|Overall Study|Other|1|||
105778541|NCT01920061|364840409|FG016|Overall Study|Other|1|||
105778542|NCT01920061|364840410|FG017|Overall Study|Other|0|||
105778543|NCT01920061|364840411|FG018|Overall Study|Other|1|||
105778544|NCT01920061|364840412|FG019|Overall Study|Other|1|||
105778545|NCT01920061|364840393|FG000|Overall Study|Participant refused further follow-up|0|||
105778546|NCT01920061|364840394|FG001|Overall Study|Participant refused further follow-up|0|||
105778547|NCT01920061|364840395|FG002|Overall Study|Participant refused further follow-up|0|||
105778548|NCT01920061|364840396|FG003|Overall Study|Participant refused further follow-up|0|||
105778549|NCT01920061|364840397|FG004|Overall Study|Participant refused further follow-up|1|||
105778550|NCT01920061|364840398|FG005|Overall Study|Participant refused further follow-up|1|||
105778551|NCT01920061|364840399|FG006|Overall Study|Participant refused further follow-up|0|||
105778552|NCT01920061|364840400|FG007|Overall Study|Participant refused further follow-up|0|||
105778553|NCT01920061|364840401|FG008|Overall Study|Participant refused further follow-up|1|||
105878753|NCT01120184|365209742|FG000|Overall Study|Lost to Follow-up|13|||
105778554|NCT01920061|364840402|FG009|Overall Study|Participant refused further follow-up|0|||
105778555|NCT01920061|364840403|FG010|Overall Study|Participant refused further follow-up|1|||
105778556|NCT01920061|364840404|FG011|Overall Study|Participant refused further follow-up|0|||
105990735|NCT01677858|365624429|FG003|Overall Study|Adverse Event|3|||
105990736|NCT01677858|365624430|FG004|Overall Study|Adverse Event|13|||
105990737|NCT01677858|365624426|FG000|Overall Study|Death|0|||
105990738|NCT01677858|365624427|FG001|Overall Study|Death|0|||
105990739|NCT01677858|365624428|FG002|Overall Study|Death|0|||
105990740|NCT01677858|365624429|FG003|Overall Study|Death|0|||
105990741|NCT01677858|365624430|FG004|Overall Study|Death|1|||
105990742|NCT01677858|365624426|FG000|Overall Study|Physician Decision|1|||
105990743|NCT01677858|365624427|FG001|Overall Study|Physician Decision|0|||
105990744|NCT01677858|365624428|FG002|Overall Study|Physician Decision|2|||
105990745|NCT01677858|365624429|FG003|Overall Study|Physician Decision|0|||
105990746|NCT01677858|365624430|FG004|Overall Study|Physician Decision|12|||
105990747|NCT01677858|365624426|FG000|Overall Study|Progressive Disease|2|||
105990748|NCT01677858|365624427|FG001|Overall Study|Progressive Disease|1|||
105990749|NCT01677858|365624428|FG002|Overall Study|Progressive Disease|9|||
105990750|NCT01677858|365624429|FG003|Overall Study|Progressive Disease|3|||
105778557|NCT01920061|364840405|FG012|Overall Study|Participant refused further follow-up|1|||
105778558|NCT01920061|364840406|FG013|Overall Study|Participant refused further follow-up|0|||
105778559|NCT01920061|364840407|FG014|Overall Study|Participant refused further follow-up|1|||
105778560|NCT01920061|364840408|FG015|Overall Study|Participant refused further follow-up|2|||
105778561|NCT01920061|364840409|FG016|Overall Study|Participant refused further follow-up|1|||
105778562|NCT01920061|364840410|FG017|Overall Study|Participant refused further follow-up|1|||
105778563|NCT01920061|364840411|FG018|Overall Study|Participant refused further follow-up|0|||
105778564|NCT01920061|364840412|FG019|Overall Study|Participant refused further follow-up|0|||
105778565|NCT00554229|364840413|FG000|Overall Study|Lost to Follow-up|3|||
105778566|NCT00554229|364840414|FG001|Overall Study|Lost to Follow-up|6|||
105778567|NCT00554229|364840413|FG000|Overall Study|Withdrawal by Subject|29|||
105778568|NCT00554229|364840414|FG001|Overall Study|Withdrawal by Subject|37|||
105778569|NCT00554229|364840413|FG000|Overall Study|Adverse Event|71|||
105778570|NCT00554229|364840414|FG001|Overall Study|Adverse Event|39|||
105778571|NCT00554229|364840413|FG000|Overall Study|Protocol Violation|3|||
105778572|NCT00554229|364840414|FG001|Overall Study|Protocol Violation|3|||
105778573|NCT00554229|364840413|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
105778574|NCT00554229|364840414|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
105778575|NCT00554229|364840413|FG000|Overall Study|Randomised but no treatment received|1|||
105778576|NCT00554229|364840414|FG001|Overall Study|Randomised but no treatment received|0|||
105778577|NCT01140646|364840415|FG000|Overall Study|Adverse Event|4|||
105778578|NCT01140646|364840415|FG000|Overall Study|Refused Further Treatment|5|||
105778579|NCT04557189|364840419|FG000|Overall Study|Adverse Event|0|||
105778580|NCT04557189|364840420|FG001|Overall Study|Adverse Event|1|||
105778581|NCT04557189|364840419|FG000|Overall Study|Lost to Follow-up|1|||
105778582|NCT04557189|364840420|FG001|Overall Study|Lost to Follow-up|1|||
105778583|NCT04557189|364840419|FG000|Overall Study|Withdrawal by Subject|2|||
105778584|NCT04557189|364840420|FG001|Overall Study|Withdrawal by Subject|1|||
105778585|NCT04557189|364840419|FG000|Overall Study|Reason not Specified|3|||
105778586|NCT04557189|364840420|FG001|Overall Study|Reason not Specified|6|||
105778587|NCT01636076|364840424|FG000|Overall Study|Terminated by sponsor|1|||
105778588|NCT01636076|364840425|FG001|Overall Study|Terminated by sponsor|1|||
105778589|NCT01636076|364840424|FG000|Overall Study|Lack of Efficacy|0|||
105778590|NCT01636076|364840425|FG001|Overall Study|Lack of Efficacy|1|||
105778591|NCT01636076|364840424|FG000|Overall Study|Lost to Follow-up|1|||
105778592|NCT01636076|364840425|FG001|Overall Study|Lost to Follow-up|0|||
105778593|NCT01636076|364840424|FG000|Overall Study|Physician Decision|1|||
105778594|NCT01636076|364840425|FG001|Overall Study|Physician Decision|1|||
105778595|NCT01636076|364840424|FG000|Overall Study|Non-compliance with study treatment|1|||
105778596|NCT01636076|364840425|FG001|Overall Study|Non-compliance with study treatment|1|||
105778597|NCT01636076|364840424|FG000|Overall Study|Adverse Event|6|||
105778598|NCT01636076|364840425|FG001|Overall Study|Adverse Event|11|||
105778599|NCT01636076|364840424|FG000|Overall Study|Withdrawal by Subject|7|||
105778600|NCT01636076|364840425|FG001|Overall Study|Withdrawal by Subject|10|||
105778601|NCT01681004|364840428|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
105778602|NCT01681004|364840429|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
105778603|NCT01681004|364840428|FG000|Study Completion|Lost to Follow-up|8|||
105778604|NCT01681004|364840429|FG001|Study Completion|Lost to Follow-up|3|||
105778605|NCT01681004|364840428|FG000|Study Completion|Physician Decision|1|||
105778606|NCT01681004|364840429|FG001|Study Completion|Physician Decision|3|||
105778607|NCT01681004|364840428|FG000|Study Completion|Site Termination|2|||
105778608|NCT01681004|364840429|FG001|Study Completion|Site Termination|1|||
105990751|NCT01677858|365624430|FG004|Overall Study|Progressive Disease|43|||
105990752|NCT01677858|365624426|FG000|Overall Study|Withdrawal by Subject|0|||
105990753|NCT01677858|365624427|FG001|Overall Study|Withdrawal by Subject|1|||
105990754|NCT01677858|365624428|FG002|Overall Study|Withdrawal by Subject|1|||
105990755|NCT01677858|365624429|FG003|Overall Study|Withdrawal by Subject|0|||
105990756|NCT01677858|365624430|FG004|Overall Study|Withdrawal by Subject|15|||
105990757|NCT01677858|365624426|FG000|Overall Study|Lost to Follow-up|0|||
105990758|NCT01677858|365624427|FG001|Overall Study|Lost to Follow-up|0|||
105990759|NCT01677858|365624428|FG002|Overall Study|Lost to Follow-up|0|||
105990760|NCT01677858|365624429|FG003|Overall Study|Lost to Follow-up|0|||
105990761|NCT01677858|365624430|FG004|Overall Study|Lost to Follow-up|1|||
105990762|NCT01529034|365624433|FG000|Overall Study|Discontinued prior to study treatment|14|||
105990763|NCT01529034|365624433|FG000|Overall Study|Site closure|62|||
105990764|NCT01529034|365624433|FG000|Overall Study|Study termination|29|||
105990765|NCT01529034|365624433|FG000|Overall Study|Withdrawal by Subject|25|||
105990766|NCT01529034|365624433|FG000|Overall Study|No treated SCs within protocol window|13|||
105990767|NCT01529034|365624433|FG000|Overall Study|Noncompliance|8|||
105990768|NCT01529034|365624433|FG000|Overall Study|Caregiver no longer available|7|||
105990769|NCT01529034|365624433|FG000|Overall Study|Adverse Event|4|||
105990770|NCT01529034|365624433|FG000|Overall Study|Protocol Violation|4|||
105990771|NCT01529034|365624433|FG000|Overall Study|Lack of Efficacy|4|||
105990772|NCT01529034|365624433|FG000|Overall Study|Investigator no longer available|2|||
105990773|NCT01529034|365624433|FG000|Overall Study|Study drug not available|2|||
105990774|NCT03549104|365624434|FG000|Overall Study|Withdrawal by Subject|5|||
105990775|NCT03549104|365624435|FG001|Overall Study|Withdrawal by Subject|2|||
105990776|NCT03549104|365624434|FG000|Overall Study|Covid shelter in place|1|||
105990777|NCT03549104|365624435|FG001|Overall Study|Covid shelter in place|2|||
105990778|NCT03422536|365624438|FG000|Randomized|Physician Decision|1|||
105990779|NCT03422536|365624439|FG001|Randomized|Physician Decision|1|||
105990780|NCT03422536|365624438|FG000|Allocation - Received Intervention|Disease progression|19|||
105990781|NCT03422536|365624439|FG001|Allocation - Received Intervention|Disease progression|25|||
105990782|NCT03422536|365624438|FG000|Allocation - Received Intervention|Death|1|||
105990783|NCT03422536|365624439|FG001|Allocation - Received Intervention|Death|3|||
105990784|NCT03422536|365624438|FG000|Allocation - Received Intervention|Adverse Event|1|||
105990785|NCT03422536|365624439|FG001|Allocation - Received Intervention|Adverse Event|0|||
105990786|NCT03422536|365624438|FG000|Allocation - Received Intervention|Physician Decision|1|||
105990787|NCT03422536|365624439|FG001|Allocation - Received Intervention|Physician Decision|1|||
105990788|NCT03422536|365624438|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
105990789|NCT03422536|365624439|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
105990790|NCT03422536|365624438|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
105990791|NCT03422536|365624439|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
105990792|NCT00532298|365624440|FG000|Overall Study|Adverse Event|1|||
105990793|NCT00532298|365624441|FG001|Overall Study|Adverse Event|0|||
105990794|NCT00532298|365624442|FG002|Overall Study|Adverse Event|0|||
105990795|NCT00532298|365624443|FG003|Overall Study|Adverse Event|0|||
105990796|NCT00532298|365624444|FG004|Overall Study|Adverse Event|1|||
105990797|NCT00532298|365624445|FG005|Overall Study|Adverse Event|1|||
105990798|NCT00532298|365624440|FG000|Overall Study|Lost to Follow-up|1|||
105990799|NCT00532298|365624441|FG001|Overall Study|Lost to Follow-up|1|||
105990800|NCT00532298|365624442|FG002|Overall Study|Lost to Follow-up|1|||
105990801|NCT00532298|365624443|FG003|Overall Study|Lost to Follow-up|0|||
105990802|NCT00532298|365624444|FG004|Overall Study|Lost to Follow-up|0|||
105990803|NCT00532298|365624445|FG005|Overall Study|Lost to Follow-up|1|||
105990804|NCT00479856|365624446|FG000|Overall Study|Adverse Event|1|||
105990805|NCT00479856|365624446|FG000|Overall Study|Withdrawal by Subject|1|||
105990806|NCT00479856|365624446|FG000|Overall Study|Physician Decision|1|||
105990807|NCT04869358|365624449|FG000|Overall Study|Wish to have children.|1|||
105990808|NCT04869358|365624450|FG001|Overall Study|Wish to have children.|0|||
105990809|NCT04869358|365624451|FG002|Overall Study|Wish to have children.|0|||
105990810|NCT04869358|365624452|FG003|Overall Study|Wish to have children.|0|||
105990811|NCT00661622|365624453|FG000|Overall Study|Protocol Violation|1|||
105990812|NCT00661622|365624454|FG001|Overall Study|Protocol Violation|0|||
105990813|NCT01620762|365624459|FG000|Overall Study|Protocol Violation|1|||
105990814|NCT01620762|365624460|FG001|Overall Study|Protocol Violation|1|||
105990815|NCT01620762|365624461|FG002|Overall Study|Protocol Violation|1|||
105990816|NCT01620762|365624459|FG000|Overall Study|Adverse Event|9|||
105990817|NCT01620762|365624460|FG001|Overall Study|Adverse Event|5|||
105990818|NCT01620762|365624461|FG002|Overall Study|Adverse Event|2|||
105990819|NCT01620762|365624459|FG000|Overall Study|Withdrawal by Subject|23|||
105990820|NCT01620762|365624460|FG001|Overall Study|Withdrawal by Subject|26|||
105990821|NCT01620762|365624461|FG002|Overall Study|Withdrawal by Subject|27|||
105990822|NCT01620762|365624459|FG000|Overall Study|Lost to Follow-up|11|||
105990823|NCT01620762|365624460|FG001|Overall Study|Lost to Follow-up|17|||
105990824|NCT01620762|365624461|FG002|Overall Study|Lost to Follow-up|10|||
106099781|NCT00626522|366022628|FG000|Overall Study|Withdrawal by Subject|2|||
105778609|NCT01681004|364840428|FG000|Study Completion|Death|1|||
105990825|NCT01620762|365624459|FG000|Overall Study|Protocol deviation|1|||
105990826|NCT01620762|365624460|FG001|Overall Study|Protocol deviation|1|||
105990827|NCT01620762|365624461|FG002|Overall Study|Protocol deviation|6|||
105990828|NCT01620762|365624459|FG000|Overall Study|Subject deterioration|0|||
105990829|NCT01620762|365624460|FG001|Overall Study|Subject deterioration|1|||
106099782|NCT00626522|366022629|FG001|Overall Study|Withdrawal by Subject|5|||
105990830|NCT01620762|365624461|FG002|Overall Study|Subject deterioration|1|||
105990831|NCT01620762|365624459|FG000|Overall Study|Non-specified|3|||
105990832|NCT01620762|365624460|FG001|Overall Study|Non-specified|6|||
105990833|NCT01620762|365624461|FG002|Overall Study|Non-specified|5|||
105990834|NCT01620762|365624459|FG000|Overall Study|Use of prohibted therapies|0|||
105990835|NCT01620762|365624460|FG001|Overall Study|Use of prohibted therapies|1|||
105990836|NCT01620762|365624461|FG002|Overall Study|Use of prohibted therapies|1|||
105990837|NCT00705146|365624466|FG000|Overall Study|Lost to Follow-up|1|||
105990838|NCT00705146|365624467|FG001|Overall Study|Lost to Follow-up|1|||
105990839|NCT00835341|365624469|FG000|Overall Study|Lost to Follow-up|3|||
105990840|NCT00835341|365624470|FG001|Overall Study|Lost to Follow-up|12|||
105990841|NCT00106353|365624471|FG000|Part 1|Disease progression|3|||
105990842|NCT00106353|365624472|FG001|Part 1|Disease progression|4|||
105990843|NCT00106353|365624473|FG002|Part 1|Disease progression|1|||
105990844|NCT00106353|365624474|FG003|Part 1|Disease progression|3|||
105990845|NCT00106353|365624475|FG004|Part 1|Disease progression|0|||
105990846|NCT00106353|365624476|FG005|Part 1|Disease progression|0|||
105990847|NCT00106353|365624477|FG006|Part 1|Disease progression|0|||
105990848|NCT00106353|365624471|FG000|Part 1|Withdrawal by Subject|0|||
105990849|NCT00106353|365624472|FG001|Part 1|Withdrawal by Subject|0|||
105990850|NCT00106353|365624473|FG002|Part 1|Withdrawal by Subject|1|||
105990851|NCT00106353|365624474|FG003|Part 1|Withdrawal by Subject|2|||
105990852|NCT00106353|365624475|FG004|Part 1|Withdrawal by Subject|0|||
105990853|NCT00106353|365624476|FG005|Part 1|Withdrawal by Subject|0|||
105990854|NCT00106353|365624477|FG006|Part 1|Withdrawal by Subject|0|||
105990855|NCT00106353|365624471|FG000|Part 1|Symptomatic deterioration|0|||
105990856|NCT00106353|365624472|FG001|Part 1|Symptomatic deterioration|0|||
105990857|NCT00106353|365624473|FG002|Part 1|Symptomatic deterioration|1|||
105990858|NCT00106353|365624474|FG003|Part 1|Symptomatic deterioration|0|||
105990859|NCT00106353|365624475|FG004|Part 1|Symptomatic deterioration|0|||
105990860|NCT00106353|365624476|FG005|Part 1|Symptomatic deterioration|0|||
105990861|NCT00106353|365624477|FG006|Part 1|Symptomatic deterioration|0|||
105990862|NCT00106353|365624471|FG000|Part 1|Entered follow-up phase|1|||
105990863|NCT00106353|365624472|FG001|Part 1|Entered follow-up phase|1|||
105990864|NCT00106353|365624473|FG002|Part 1|Entered follow-up phase|0|||
105990865|NCT00106353|365624474|FG003|Part 1|Entered follow-up phase|1|||
105990866|NCT00106353|365624475|FG004|Part 1|Entered follow-up phase|0|||
105990867|NCT00106353|365624476|FG005|Part 1|Entered follow-up phase|0|||
105990868|NCT00106353|365624477|FG006|Part 1|Entered follow-up phase|0|||
105990869|NCT00106353|365624471|FG000|Part 1|Adverse Event|0|||
105990870|NCT00106353|365624472|FG001|Part 1|Adverse Event|0|||
105990871|NCT00106353|365624473|FG002|Part 1|Adverse Event|0|||
105990872|NCT00106353|365624474|FG003|Part 1|Adverse Event|1|||
105990873|NCT00106353|365624475|FG004|Part 1|Adverse Event|0|||
105990874|NCT00106353|365624476|FG005|Part 1|Adverse Event|0|||
105990875|NCT00106353|365624477|FG006|Part 1|Adverse Event|0|||
105990876|NCT00106353|365624471|FG000|Part 2|Disease progression|0|||
105990877|NCT00106353|365624472|FG001|Part 2|Disease progression|0|||
105990878|NCT00106353|365624473|FG002|Part 2|Disease progression|0|||
105990879|NCT00106353|365624474|FG003|Part 2|Disease progression|0|||
105990880|NCT00106353|365624475|FG004|Part 2|Disease progression|8|||
105990881|NCT00106353|365624476|FG005|Part 2|Disease progression|14|||
105990882|NCT00106353|365624477|FG006|Part 2|Disease progression|13|||
105990883|NCT00106353|365624471|FG000|Part 2|Death|0|||
105990884|NCT00106353|365624472|FG001|Part 2|Death|0|||
105990885|NCT00106353|365624473|FG002|Part 2|Death|0|||
105990886|NCT00106353|365624474|FG003|Part 2|Death|0|||
105990887|NCT00106353|365624475|FG004|Part 2|Death|3|||
105990888|NCT00106353|365624476|FG005|Part 2|Death|0|||
105990889|NCT00106353|365624477|FG006|Part 2|Death|1|||
105990890|NCT00106353|365624471|FG000|Part 2|Symptomatic deterioration|0|||
105990891|NCT00106353|365624472|FG001|Part 2|Symptomatic deterioration|0|||
105990892|NCT00106353|365624473|FG002|Part 2|Symptomatic deterioration|0|||
105990893|NCT00106353|365624474|FG003|Part 2|Symptomatic deterioration|0|||
105990894|NCT00106353|365624475|FG004|Part 2|Symptomatic deterioration|3|||
105990895|NCT00106353|365624476|FG005|Part 2|Symptomatic deterioration|0|||
105990896|NCT00106353|365624477|FG006|Part 2|Symptomatic deterioration|0|||
105990897|NCT00106353|365624471|FG000|Part 2|Adverse Event|0|||
105990898|NCT00106353|365624472|FG001|Part 2|Adverse Event|0|||
105990899|NCT00106353|365624473|FG002|Part 2|Adverse Event|0|||
105990900|NCT00106353|365624474|FG003|Part 2|Adverse Event|0|||
105990901|NCT00106353|365624475|FG004|Part 2|Adverse Event|0|||
105990902|NCT00106353|365624476|FG005|Part 2|Adverse Event|2|||
105990903|NCT00106353|365624477|FG006|Part 2|Adverse Event|1|||
105990904|NCT00106353|365624471|FG000|Part 2|Other|0|||
105990905|NCT00106353|365624472|FG001|Part 2|Other|0|||
105990906|NCT00106353|365624473|FG002|Part 2|Other|0|||
105990907|NCT00106353|365624474|FG003|Part 2|Other|0|||
105990908|NCT00106353|365624475|FG004|Part 2|Other|1|||
105990909|NCT00106353|365624476|FG005|Part 2|Other|1|||
105990910|NCT00106353|365624477|FG006|Part 2|Other|1|||
105990911|NCT00106353|365624471|FG000|Part 2|Withdrawal by Subject|0|||
105990912|NCT00106353|365624472|FG001|Part 2|Withdrawal by Subject|0|||
105990913|NCT00106353|365624473|FG002|Part 2|Withdrawal by Subject|0|||
105778610|NCT01681004|364840429|FG001|Study Completion|Death|1|||
105778611|NCT03395704|364840430|FG000|Overall Study|Adverse Event|2|||
105778612|NCT03395704|364840431|FG001|Overall Study|Adverse Event|1|||
105778613|NCT03395704|364840430|FG000|Overall Study|Withdrawal by Subject|2|||
105778614|NCT03395704|364840431|FG001|Overall Study|Withdrawal by Subject|1|||
105778615|NCT03395704|364840430|FG000|Overall Study|Physician Decision|0|||
105778616|NCT03395704|364840431|FG001|Overall Study|Physician Decision|1|||
105778617|NCT01084096|364842374|FG000|Overall Study|Lost to Follow-up|1501|||
105778618|NCT01084096|364842375|FG001|Overall Study|Lost to Follow-up|1833|||
105778619|NCT01084096|364842374|FG000|Overall Study|Withdrawal by Subject|3|||
105778620|NCT01084096|364842375|FG001|Overall Study|Withdrawal by Subject|0|||
105778621|NCT01084096|364842374|FG000|Overall Study|Woman had a miscarriage|21|||
105778622|NCT01084096|364842375|FG001|Overall Study|Woman had a miscarriage|17|||
105778623|NCT00027846|364842376|FG000|Overall Study|Lost to Follow-up|0|||
105778624|NCT00027846|364842377|FG001|Overall Study|Lost to Follow-up|41|||
105778625|NCT00027846|364842378|FG002|Overall Study|Lost to Follow-up|9|||
105778626|NCT00027846|364842376|FG000|Overall Study|Withdrawal by Subject|0|||
105778627|NCT00027846|364842377|FG001|Overall Study|Withdrawal by Subject|14|||
105778628|NCT00027846|364842378|FG002|Overall Study|Withdrawal by Subject|7|||
105778629|NCT00027846|364842376|FG000|Overall Study|Ineligible for study|2|||
105778630|NCT00027846|364842377|FG001|Overall Study|Ineligible for study|6|||
105778631|NCT00027846|364842378|FG002|Overall Study|Ineligible for study|14|||
105778632|NCT00027846|364842376|FG000|Overall Study|Entry into another COG therapeutic study|0|||
105778633|NCT00027846|364842377|FG001|Overall Study|Entry into another COG therapeutic study|5|||
105778634|NCT00027846|364842378|FG002|Overall Study|Entry into another COG therapeutic study|2|||
105778635|NCT00027846|364842376|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
105778636|NCT00027846|364842377|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
105778637|NCT00027846|364842378|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
105778638|NCT02033369|364842379|FG000|Overall Study|Physician Decision|1|||
105778639|NCT02033369|364842380|FG001|Overall Study|Physician Decision|2|||
105778640|NCT02033369|364842379|FG000|Overall Study|Not a good demographic match|0|||
105778641|NCT02033369|364842380|FG001|Overall Study|Not a good demographic match|2|||
105778642|NCT02033369|364842379|FG000|Overall Study|Withdrawal by Subject|1|||
105778643|NCT02033369|364842380|FG001|Overall Study|Withdrawal by Subject|1|||
105778644|NCT02033369|364842379|FG000|Overall Study|Lost to Follow-up|1|||
105778645|NCT02033369|364842380|FG001|Overall Study|Lost to Follow-up|0|||
105778646|NCT02033369|364842379|FG000|Overall Study|Protocol Violation|2|||
105778647|NCT02033369|364842380|FG001|Overall Study|Protocol Violation|0|||
105778648|NCT01354964|364842381|FG000|Overall Study|Lost to Follow-up|2|||
105778649|NCT01354964|364842382|FG001|Overall Study|Lost to Follow-up|0|||
105778650|NCT01354964|364842381|FG000|Overall Study|IV access issues|1|||
105778651|NCT01354964|364842382|FG001|Overall Study|IV access issues|1|||
105778652|NCT01354964|364842381|FG000|Overall Study|Physician Decision|1|||
105778653|NCT01354964|364842382|FG001|Overall Study|Physician Decision|0|||
105778654|NCT01265719|364842384|FG000|Overall Study|Does not meet entrance criteria|0|||
105778655|NCT01265719|364842385|FG001|Overall Study|Does not meet entrance criteria|3|||
105778656|NCT01265719|364842384|FG000|Overall Study|Other reasons|2|||
105778657|NCT01265719|364842385|FG001|Overall Study|Other reasons|0|||
105778658|NCT01265719|364842384|FG000|Overall Study|Withdrawal by Subject|8|||
105778659|NCT01265719|364842385|FG001|Overall Study|Withdrawal by Subject|3|||
105778660|NCT01265719|364842384|FG000|Overall Study|Lost to Follow-up|2|||
105778661|NCT01265719|364842385|FG001|Overall Study|Lost to Follow-up|7|||
105778662|NCT01265719|364842384|FG000|Overall Study|Adverse Event|2|||
105778663|NCT01265719|364842385|FG001|Overall Study|Adverse Event|0|||
105778664|NCT05604781|364842388|FG000|Overall Study|Lost to Follow-up|3|||
105778665|NCT05604781|364842388|FG000|Overall Study|Adverse Event|1|||
105778666|NCT01451203|364842389|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
105778667|NCT01451203|364842390|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
105778668|NCT01451203|364842389|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
105778669|NCT01451203|364842390|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
105778670|NCT01451203|364842389|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
105778671|NCT01451203|364842390|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
105778672|NCT01451203|364842389|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
105778673|NCT01451203|364842390|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
105778674|NCT01451203|364842389|FG000|Double-blind Treatment Period|Adverse Event|6|||
105778675|NCT01451203|364842390|FG001|Double-blind Treatment Period|Adverse Event|9|||
105778676|NCT01451203|364842389|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
105778677|NCT01451203|364842390|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
105778678|NCT01451203|364842389|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
105778679|NCT01451203|364842390|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
105778680|NCT01451203|364842389|FG000|Double-blind Treatment Period|Investigator decision|2|||
105778681|NCT01451203|364842390|FG001|Double-blind Treatment Period|Investigator decision|0|||
105778682|NCT01451203|364842389|FG000|Post-treatment Period|Consent withdrawn|2|||
105778683|NCT01451203|364842390|FG001|Post-treatment Period|Consent withdrawn|4|||
105778684|NCT01451203|364842389|FG000|Post-treatment Period|Lack of Efficacy|12|||
105778685|NCT01451203|364842390|FG001|Post-treatment Period|Lack of Efficacy|28|||
105778686|NCT01451203|364842389|FG000|Post-treatment Period|Adverse Event|0|||
105778687|NCT01451203|364842390|FG001|Post-treatment Period|Adverse Event|1|||
105778688|NCT01451203|364842389|FG000|Post-treatment Period|Investigator decision|0|||
105778689|NCT01451203|364842390|FG001|Post-treatment Period|Investigator decision|1|||
105778690|NCT03890731|364842391|FG000|Overall Study|Progressive disease|1|||
105778691|NCT03890731|364842391|FG000|Overall Study|Patient's decision|1|||
105778692|NCT03890731|364842391|FG000|Overall Study|Adverse Event|4|||
105778693|NCT00960323|364842395|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
105778694|NCT04450394|364842398|FG000|Overall Study|Adverse Event|2|||
105778695|NCT04450394|364842399|FG001|Overall Study|Adverse Event|0|||
105778696|NCT04450394|364842400|FG002|Overall Study|Adverse Event|0|||
105778697|NCT04450394|364842398|FG000|Overall Study|Death|0|||
105778698|NCT04450394|364842399|FG001|Overall Study|Death|1|||
105778699|NCT04450394|364842400|FG002|Overall Study|Death|0|||
105778700|NCT04450394|364842398|FG000|Overall Study|Lost to Follow-up|0|||
105778701|NCT04450394|364842399|FG001|Overall Study|Lost to Follow-up|3|||
105778702|NCT04450394|364842400|FG002|Overall Study|Lost to Follow-up|0|||
105778703|NCT04450394|364842398|FG000|Overall Study|Physician Decision|0|||
105778704|NCT04450394|364842399|FG001|Overall Study|Physician Decision|1|||
105778705|NCT04450394|364842400|FG002|Overall Study|Physician Decision|0|||
105778706|NCT04450394|364842398|FG000|Overall Study|Protocol Violation|2|||
105778707|NCT04450394|364842399|FG001|Overall Study|Protocol Violation|0|||
105778708|NCT04450394|364842400|FG002|Overall Study|Protocol Violation|0|||
105778709|NCT04450394|364842398|FG000|Overall Study|Withdrawal by Subject|6|||
105778710|NCT04450394|364842399|FG001|Overall Study|Withdrawal by Subject|9|||
105778711|NCT04450394|364842400|FG002|Overall Study|Withdrawal by Subject|0|||
105778712|NCT01066819|364842405|FG000|Overall Study|Adverse Event|18|||
105778713|NCT01066819|364842406|FG001|Overall Study|Adverse Event|1|||
105778714|NCT01066819|364842407|FG002|Overall Study|Adverse Event|6|||
105778715|NCT01066819|364842408|FG003|Overall Study|Adverse Event|0|||
105778716|NCT01066819|364842409|FG004|Overall Study|Adverse Event|0|||
105778717|NCT01066819|364842410|FG005|Overall Study|Adverse Event|0|||
105778718|NCT01066819|364842405|FG000|Overall Study|Death|5|||
105778719|NCT01066819|364842406|FG001|Overall Study|Death|0|||
105778720|NCT01066819|364842407|FG002|Overall Study|Death|1|||
105778721|NCT01066819|364842408|FG003|Overall Study|Death|0|||
105778722|NCT01066819|364842409|FG004|Overall Study|Death|0|||
105778723|NCT01066819|364842410|FG005|Overall Study|Death|0|||
105778724|NCT01066819|364842405|FG000|Overall Study|Lack of Efficacy|22|||
105778725|NCT01066819|364842406|FG001|Overall Study|Lack of Efficacy|1|||
105778726|NCT01066819|364842407|FG002|Overall Study|Lack of Efficacy|2|||
105778727|NCT01066819|364842408|FG003|Overall Study|Lack of Efficacy|1|||
105778728|NCT01066819|364842409|FG004|Overall Study|Lack of Efficacy|0|||
105778729|NCT01066819|364842410|FG005|Overall Study|Lack of Efficacy|0|||
105778730|NCT01066819|364842405|FG000|Overall Study|Physician Decision|6|||
105778731|NCT01066819|364842406|FG001|Overall Study|Physician Decision|2|||
105778732|NCT01066819|364842407|FG002|Overall Study|Physician Decision|3|||
105778733|NCT01066819|364842408|FG003|Overall Study|Physician Decision|0|||
105778734|NCT01066819|364842409|FG004|Overall Study|Physician Decision|0|||
105778735|NCT01066819|364842410|FG005|Overall Study|Physician Decision|0|||
105778736|NCT01066819|364842405|FG000|Overall Study|Protocol Violation|12|||
105778737|NCT01066819|364842406|FG001|Overall Study|Protocol Violation|6|||
105778738|NCT01066819|364842407|FG002|Overall Study|Protocol Violation|0|||
105778739|NCT01066819|364842408|FG003|Overall Study|Protocol Violation|0|||
105778740|NCT01066819|364842409|FG004|Overall Study|Protocol Violation|0|||
105778741|NCT01066819|364842410|FG005|Overall Study|Protocol Violation|0|||
105778742|NCT01066819|364842405|FG000|Overall Study|Withdrawal by Subject|29|||
105778743|NCT01066819|364842406|FG001|Overall Study|Withdrawal by Subject|11|||
105778744|NCT01066819|364842407|FG002|Overall Study|Withdrawal by Subject|6|||
105778745|NCT01066819|364842408|FG003|Overall Study|Withdrawal by Subject|0|||
105778746|NCT01066819|364842409|FG004|Overall Study|Withdrawal by Subject|0|||
105778747|NCT01066819|364842410|FG005|Overall Study|Withdrawal by Subject|0|||
105778748|NCT01066819|364842405|FG000|Overall Study|Administrative|6|||
105778749|NCT01066819|364842406|FG001|Overall Study|Administrative|4|||
105778750|NCT01066819|364842407|FG002|Overall Study|Administrative|2|||
105778751|NCT01066819|364842408|FG003|Overall Study|Administrative|0|||
105778752|NCT01066819|364842409|FG004|Overall Study|Administrative|0|||
105778753|NCT01066819|364842410|FG005|Overall Study|Administrative|0|||
105778754|NCT01066819|364842405|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
105778755|NCT01066819|364842406|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
105778756|NCT01066819|364842407|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
105778757|NCT01066819|364842408|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
105778758|NCT01066819|364842409|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
105778759|NCT01066819|364842410|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
105778760|NCT01066819|364842405|FG000|Overall Study|Early termination|2|||
105778761|NCT01066819|364842406|FG001|Overall Study|Early termination|0|||
105778762|NCT01066819|364842407|FG002|Overall Study|Early termination|0|||
105778763|NCT01066819|364842408|FG003|Overall Study|Early termination|0|||
105778764|NCT01066819|364842409|FG004|Overall Study|Early termination|0|||
105778765|NCT01066819|364842410|FG005|Overall Study|Early termination|0|||
105778766|NCT01066819|364842405|FG000|Overall Study|Failed to return|298|||
105778767|NCT01066819|364842406|FG001|Overall Study|Failed to return|107|||
105778768|NCT01066819|364842407|FG002|Overall Study|Failed to return|68|||
105778769|NCT01066819|364842408|FG003|Overall Study|Failed to return|7|||
105778770|NCT01066819|364842409|FG004|Overall Study|Failed to return|2|||
105778771|NCT01066819|364842410|FG005|Overall Study|Failed to return|3|||
105990914|NCT00106353|365624474|FG003|Part 2|Withdrawal by Subject|0|||
105990915|NCT00106353|365624475|FG004|Part 2|Withdrawal by Subject|1|||
105990916|NCT00106353|365624476|FG005|Part 2|Withdrawal by Subject|0|||
105990917|NCT00106353|365624477|FG006|Part 2|Withdrawal by Subject|0|||
105990918|NCT00106353|365624471|FG000|Part 2|Physician Decision|0|||
105990919|NCT00106353|365624472|FG001|Part 2|Physician Decision|0|||
105990920|NCT00106353|365624473|FG002|Part 2|Physician Decision|0|||
105990921|NCT00106353|365624474|FG003|Part 2|Physician Decision|0|||
105990922|NCT00106353|365624475|FG004|Part 2|Physician Decision|0|||
105990923|NCT00106353|365624476|FG005|Part 2|Physician Decision|1|||
105990924|NCT00106353|365624477|FG006|Part 2|Physician Decision|0|||
105990925|NCT01278797|365624478|FG000|Period 1|Adverse Event|0|||
105990926|NCT01278797|365624479|FG001|Period 1|Adverse Event|1|||
105990927|NCT01278797|365624478|FG000|Period 1|Protocol Violation|1|||
105990928|NCT01278797|365624479|FG001|Period 1|Protocol Violation|0|||
105990929|NCT01370265|365626854|FG000|First Intervention|Adverse Event|1|||
105990930|NCT01370265|365626855|FG001|First Intervention|Adverse Event|1|||
105990931|NCT02611817|365626860|FG000|Open-label Induction Phase|Reason not Specified|9|||
105990932|NCT02611817|365626861|FG001|Open-label Induction Phase|Reason not Specified|0|||
105990933|NCT02611817|365626862|FG002|Open-label Induction Phase|Reason not Specified|0|||
105990934|NCT02611817|365626860|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
105990935|NCT02611817|365626861|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
105990936|NCT02611817|365626862|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
105990937|NCT02611817|365626860|FG000|Open-label Induction Phase|Pregnancy|1|||
105990938|NCT02611817|365626861|FG001|Open-label Induction Phase|Pregnancy|0|||
105990939|NCT02611817|365626862|FG002|Open-label Induction Phase|Pregnancy|0|||
105990940|NCT02611817|365626860|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
105990941|NCT02611817|365626861|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
105990942|NCT02611817|365626862|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
105990943|NCT02611817|365626860|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
105990944|NCT02611817|365626861|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
105778772|NCT01066819|364842405|FG000|Overall Study|Lab test not done|9|||
105778773|NCT01066819|364842406|FG001|Overall Study|Lab test not done|0|||
105778774|NCT01066819|364842407|FG002|Overall Study|Lab test not done|2|||
105778775|NCT01066819|364842408|FG003|Overall Study|Lab test not done|1|||
105778776|NCT01066819|364842409|FG004|Overall Study|Lab test not done|0|||
105778777|NCT01066819|364842410|FG005|Overall Study|Lab test not done|0|||
105778778|NCT01066819|364842405|FG000|Overall Study|Miscellaneous|28|||
105778779|NCT01066819|364842406|FG001|Overall Study|Miscellaneous|10|||
105778780|NCT01066819|364842407|FG002|Overall Study|Miscellaneous|18|||
105778781|NCT01066819|364842408|FG003|Overall Study|Miscellaneous|1|||
105990945|NCT02611817|365626862|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
105990946|NCT02611817|365626860|FG000|Open-label Induction Phase|Protocol Violation|5|||
105990947|NCT02611817|365626861|FG001|Open-label Induction Phase|Protocol Violation|0|||
105990948|NCT02611817|365626862|FG002|Open-label Induction Phase|Protocol Violation|0|||
105990949|NCT02611817|365626860|FG000|Open-label Induction Phase|Adverse Event|16|||
105990950|NCT02611817|365626861|FG001|Open-label Induction Phase|Adverse Event|0|||
105990951|NCT02611817|365626862|FG002|Open-label Induction Phase|Adverse Event|0|||
105990952|NCT02611817|365626860|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
105778782|NCT01066819|364842409|FG004|Overall Study|Miscellaneous|0|||
105778783|NCT01066819|364842410|FG005|Overall Study|Miscellaneous|0|||
105778784|NCT01066819|364842405|FG000|Overall Study|Non responders|123|||
105778785|NCT01066819|364842406|FG001|Overall Study|Non responders|2|||
105778786|NCT01066819|364842407|FG002|Overall Study|Non responders|7|||
105778787|NCT01066819|364842408|FG003|Overall Study|Non responders|2|||
105778788|NCT01066819|364842409|FG004|Overall Study|Non responders|0|||
105778789|NCT01066819|364842410|FG005|Overall Study|Non responders|1|||
105990953|NCT02611817|365626861|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
105778790|NCT01066819|364842405|FG000|Overall Study|Not categorised|9|||
105778791|NCT01066819|364842406|FG001|Overall Study|Not categorised|2|||
105778792|NCT01066819|364842407|FG002|Overall Study|Not categorised|6|||
105778793|NCT01066819|364842408|FG003|Overall Study|Not categorised|1|||
105778794|NCT01066819|364842409|FG004|Overall Study|Not categorised|0|||
105778795|NCT01066819|364842410|FG005|Overall Study|Not categorised|0|||
105778796|NCT01066819|364842405|FG000|Overall Study|Relapse|16|||
105778797|NCT01066819|364842406|FG001|Overall Study|Relapse|4|||
105778798|NCT01066819|364842407|FG002|Overall Study|Relapse|3|||
105778799|NCT01066819|364842408|FG003|Overall Study|Relapse|0|||
105990954|NCT02611817|365626862|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
105990955|NCT02611817|365626860|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
105778800|NCT01066819|364842409|FG004|Overall Study|Relapse|0|||
105778801|NCT01066819|364842410|FG005|Overall Study|Relapse|0|||
105778802|NCT01066819|364842405|FG000|Overall Study|Results not available|1|||
105778803|NCT01066819|364842406|FG001|Overall Study|Results not available|0|||
105778804|NCT01066819|364842407|FG002|Overall Study|Results not available|0|||
105778805|NCT01066819|364842408|FG003|Overall Study|Results not available|0|||
105778806|NCT01066819|364842409|FG004|Overall Study|Results not available|0|||
105778807|NCT01066819|364842410|FG005|Overall Study|Results not available|0|||
105778808|NCT01066819|364842405|FG000|Overall Study|Screen failure|1|||
105778809|NCT01066819|364842406|FG001|Overall Study|Screen failure|0|||
105778810|NCT01066819|364842407|FG002|Overall Study|Screen failure|0|||
105778811|NCT01066819|364842408|FG003|Overall Study|Screen failure|0|||
105778812|NCT01066819|364842409|FG004|Overall Study|Screen failure|0|||
105778813|NCT01066819|364842410|FG005|Overall Study|Screen failure|0|||
105778814|NCT01066819|364842405|FG000|Overall Study|Spontaneous cure|1|||
105778815|NCT01066819|364842406|FG001|Overall Study|Spontaneous cure|0|||
105778816|NCT01066819|364842407|FG002|Overall Study|Spontaneous cure|0|||
105778817|NCT01066819|364842408|FG003|Overall Study|Spontaneous cure|0|||
105778818|NCT01066819|364842409|FG004|Overall Study|Spontaneous cure|0|||
105778819|NCT01066819|364842410|FG005|Overall Study|Spontaneous cure|0|||
105778820|NCT01066819|364842405|FG000|Overall Study|Treatment never started|85|||
105778821|NCT01066819|364842406|FG001|Overall Study|Treatment never started|19|||
105778822|NCT01066819|364842407|FG002|Overall Study|Treatment never started|19|||
105778823|NCT01066819|364842408|FG003|Overall Study|Treatment never started|3|||
105778824|NCT01066819|364842409|FG004|Overall Study|Treatment never started|2|||
105778825|NCT01066819|364842410|FG005|Overall Study|Treatment never started|2|||
105778826|NCT01066819|364842405|FG000|Overall Study|Treatment stopped|12|||
105778827|NCT01066819|364842406|FG001|Overall Study|Treatment stopped|1|||
105778828|NCT01066819|364842407|FG002|Overall Study|Treatment stopped|2|||
105778829|NCT01066819|364842408|FG003|Overall Study|Treatment stopped|1|||
105778830|NCT01066819|364842409|FG004|Overall Study|Treatment stopped|0|||
105778831|NCT01066819|364842410|FG005|Overall Study|Treatment stopped|0|||
105778832|NCT01066819|364842405|FG000|Overall Study|Other|5|||
105778833|NCT01066819|364842406|FG001|Overall Study|Other|1|||
105778834|NCT01066819|364842407|FG002|Overall Study|Other|1|||
105778835|NCT01066819|364842408|FG003|Overall Study|Other|0|||
105778836|NCT01066819|364842409|FG004|Overall Study|Other|0|||
105778837|NCT01066819|364842410|FG005|Overall Study|Other|0|||
105778838|NCT03322540|364842411|FG000|Overall Study|Death|21|||
105778839|NCT03322540|364842412|FG001|Overall Study|Death|28|||
105778840|NCT03322540|364842411|FG000|Overall Study|Lost to Follow-up|0|||
105778841|NCT03322540|364842412|FG001|Overall Study|Lost to Follow-up|1|||
105778842|NCT03322540|364842411|FG000|Overall Study|Physician Decision|7|||
105778843|NCT03322540|364842412|FG001|Overall Study|Physician Decision|6|||
105778844|NCT03322540|364842411|FG000|Overall Study|Withdrawal by Subject|3|||
105778845|NCT03322540|364842412|FG001|Overall Study|Withdrawal by Subject|1|||
105778846|NCT03322540|364842411|FG000|Overall Study|Study terminated by sponsor|0|||
105778847|NCT03322540|364842412|FG001|Overall Study|Study terminated by sponsor|1|||
105778848|NCT03287960|364842416|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
105778849|NCT03287960|364842416|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
105778850|NCT01014442|364842420|FG000|Overall Study|Adverse Event|0|||
105778851|NCT01014442|364842421|FG001|Overall Study|Adverse Event|8|||
105778852|NCT01014442|364842420|FG000|Overall Study|Withdrawal by Subject|4|||
105778853|NCT01014442|364842421|FG001|Overall Study|Withdrawal by Subject|4|||
105778854|NCT01014442|364842420|FG000|Overall Study|Protocol Violation|2|||
105778855|NCT01014442|364842421|FG001|Overall Study|Protocol Violation|5|||
105778856|NCT01014442|364842420|FG000|Overall Study|Lack of Compliance|0|||
105778857|NCT01014442|364842421|FG001|Overall Study|Lack of Compliance|1|||
105778858|NCT01014442|364842420|FG000|Overall Study|Unspecified Reason|1|||
105778859|NCT01014442|364842421|FG001|Overall Study|Unspecified Reason|1|||
105778860|NCT01904760|364842427|FG000|Overall Study|Protocol Violation|1|||
105778861|NCT01904760|364842428|FG001|Overall Study|Protocol Violation|0|||
105778862|NCT04047472|364842429|FG000|Overall Study|Adverse Event|3|||
105778863|NCT04047472|364842430|FG001|Overall Study|Adverse Event|3|||
105778864|NCT04047472|364842429|FG000|Overall Study|Death|0|||
105778865|NCT04047472|364842430|FG001|Overall Study|Death|1|||
105778866|NCT04047472|364842429|FG000|Overall Study|Lost to Follow-up|1|||
105778867|NCT04047472|364842430|FG001|Overall Study|Lost to Follow-up|0|||
105778868|NCT04047472|364842429|FG000|Overall Study|Physician Decision|1|||
105778869|NCT04047472|364842430|FG001|Overall Study|Physician Decision|2|||
105778870|NCT04047472|364842429|FG000|Overall Study|Protocol Violation|1|||
105778871|NCT04047472|364842430|FG001|Overall Study|Protocol Violation|0|||
105778872|NCT04047472|364842429|FG000|Overall Study|Withdrawal by Subject|10|||
105778873|NCT04047472|364842430|FG001|Overall Study|Withdrawal by Subject|10|||
105778874|NCT02243306|364842431|FG000|Overall Study|Adverse Event|0|||
105778875|NCT02243306|364842432|FG001|Overall Study|Adverse Event|1|||
105778876|NCT02243306|364842431|FG000|Overall Study|Other: Reached stopping criteria|0|||
105778877|NCT02243306|364842432|FG001|Overall Study|Other: Reached stopping criteria|1|||
105778878|NCT02243306|364842431|FG000|Overall Study|Physician Decision|0|||
105778879|NCT02243306|364842432|FG001|Overall Study|Physician Decision|1|||
105778880|NCT01034709|364842437|FG000|Overall Study|Protocol Violation|9|||
105778881|NCT01034709|364842438|FG001|Overall Study|Protocol Violation|16|||
105778882|NCT01060150|364842439|FG000|Overall Study|Adverse Event|6|||
105778883|NCT01060150|364842439|FG000|Overall Study|Lost to Follow-up|1|||
105778884|NCT01060150|364842439|FG000|Overall Study|Protocol Violation|6|||
105778885|NCT01060150|364842439|FG000|Overall Study|Withdrawal by Subject|8|||
105778886|NCT01060150|364842439|FG000|Overall Study|Enrolled, but not treated|2|||
105778887|NCT01195636|364842440|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
105778888|NCT01195636|364842441|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
105778889|NCT01195636|364842440|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
105778890|NCT01195636|364842441|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
105778891|NCT01195636|364842440|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105778892|NCT01195636|364842441|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
105778893|NCT01195636|364842440|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
105778894|NCT01195636|364842441|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
105778895|NCT01195636|364842440|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
105778896|NCT01195636|364842441|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
105778897|NCT01195636|364842440|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
105778898|NCT01195636|364842441|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
105778899|NCT01195636|364842440|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
105778900|NCT01195636|364842441|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
105778901|NCT01195636|364842440|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105778902|NCT01195636|364842441|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
105778903|NCT03644173|364842442|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
105778904|NCT03644173|364842442|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
105778905|NCT03644173|364842442|FG000|Participants at the 1-month Follow up|Death|2|||
105778906|NCT03644173|364842442|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
105778907|NCT00808132|364842445|FG000|Overall Study|Adverse Event|34|||
105778908|NCT00808132|364842446|FG001|Overall Study|Adverse Event|33|||
105778909|NCT00808132|364842447|FG002|Overall Study|Adverse Event|16|||
105778910|NCT00808132|364842448|FG003|Overall Study|Adverse Event|31|||
105778911|NCT00808132|364842449|FG004|Overall Study|Adverse Event|33|||
105778912|NCT00808132|364842445|FG000|Overall Study|Death|0|||
105778913|NCT00808132|364842446|FG001|Overall Study|Death|0|||
105778914|NCT00808132|364842447|FG002|Overall Study|Death|0|||
105778915|NCT00808132|364842448|FG003|Overall Study|Death|0|||
105778916|NCT00808132|364842449|FG004|Overall Study|Death|1|||
105778917|NCT00808132|364842445|FG000|Overall Study|Physician Decision|0|||
105778918|NCT00808132|364842446|FG001|Overall Study|Physician Decision|1|||
105778919|NCT00808132|364842447|FG002|Overall Study|Physician Decision|0|||
105778920|NCT00808132|364842448|FG003|Overall Study|Physician Decision|0|||
105778921|NCT00808132|364842449|FG004|Overall Study|Physician Decision|0|||
105778922|NCT00808132|364842445|FG000|Overall Study|Lost to Follow-up|8|||
105778923|NCT00808132|364842446|FG001|Overall Study|Lost to Follow-up|10|||
105778924|NCT00808132|364842447|FG002|Overall Study|Lost to Follow-up|11|||
105778925|NCT00808132|364842448|FG003|Overall Study|Lost to Follow-up|8|||
105778926|NCT00808132|364842449|FG004|Overall Study|Lost to Follow-up|9|||
105778927|NCT00808132|364842445|FG000|Overall Study|Protocol Violation|8|||
105778928|NCT00808132|364842446|FG001|Overall Study|Protocol Violation|9|||
105778929|NCT00808132|364842447|FG002|Overall Study|Protocol Violation|4|||
105778930|NCT00808132|364842448|FG003|Overall Study|Protocol Violation|9|||
105778931|NCT00808132|364842449|FG004|Overall Study|Protocol Violation|5|||
105778932|NCT00808132|364842445|FG000|Overall Study|Withdrawal by Subject|27|||
105778933|NCT00808132|364842446|FG001|Overall Study|Withdrawal by Subject|18|||
105778934|NCT00808132|364842447|FG002|Overall Study|Withdrawal by Subject|2|||
105778935|NCT00808132|364842448|FG003|Overall Study|Withdrawal by Subject|7|||
105778936|NCT00808132|364842449|FG004|Overall Study|Withdrawal by Subject|16|||
105778937|NCT00808132|364842445|FG000|Overall Study|Other|6|||
105778938|NCT00808132|364842446|FG001|Overall Study|Other|4|||
105778939|NCT00808132|364842447|FG002|Overall Study|Other|6|||
105778940|NCT00808132|364842448|FG003|Overall Study|Other|2|||
105778941|NCT00808132|364842449|FG004|Overall Study|Other|15|||
105778942|NCT00808132|364842445|FG000|Overall Study|Randomized, but not treated|10|||
105778943|NCT00808132|364842446|FG001|Overall Study|Randomized, but not treated|7|||
105778944|NCT00808132|364842447|FG002|Overall Study|Randomized, but not treated|9|||
105778945|NCT00808132|364842448|FG003|Overall Study|Randomized, but not treated|8|||
105778946|NCT00808132|364842449|FG004|Overall Study|Randomized, but not treated|9|||
105778947|NCT00808132|364842445|FG000|Overall Study|Unsatisfactory response|5|||
105778948|NCT00808132|364842446|FG001|Overall Study|Unsatisfactory response|6|||
105778949|NCT00808132|364842447|FG002|Overall Study|Unsatisfactory response|6|||
105778950|NCT00808132|364842448|FG003|Overall Study|Unsatisfactory response|4|||
105778951|NCT00808132|364842449|FG004|Overall Study|Unsatisfactory response|12|||
105778952|NCT01351415|364842450|FG000|Overall Study|Withdrawal by Subject|15|||
105778953|NCT01351415|364842451|FG001|Overall Study|Withdrawal by Subject|17|||
105778954|NCT01351415|364842450|FG000|Overall Study|Trial termination by the Sponsor|28|||
105778955|NCT01351415|364842451|FG001|Overall Study|Trial termination by the Sponsor|19|||
106099783|NCT00626522|366022630|FG002|Overall Study|Withdrawal by Subject|5|||
105778956|NCT01351415|364842450|FG000|Overall Study|Lost to Follow-up|5|||
105778957|NCT01351415|364842451|FG001|Overall Study|Lost to Follow-up|7|||
105778958|NCT01351415|364842450|FG000|Overall Study|Death|190|||
105778959|NCT01351415|364842451|FG001|Overall Study|Death|187|||
105778960|NCT01351415|364842450|FG000|Overall Study|Physician Decision|2|||
105778961|NCT01351415|364842451|FG001|Overall Study|Physician Decision|3|||
105778962|NCT01351415|364842450|FG000|Overall Study|Reason unknown|0|||
105778963|NCT01351415|364842451|FG001|Overall Study|Reason unknown|2|||
105778964|NCT01351415|364842450|FG000|Overall Study|Never Started|5|||
105778965|NCT01351415|364842451|FG001|Overall Study|Never Started|5|||
105778966|NCT00247962|364842460|FG000|Overall Study|Adverse Event|15|||
105778967|NCT00247962|364842461|FG001|Overall Study|Adverse Event|12|||
105778968|NCT00247962|364842460|FG000|Overall Study|Lost to Follow-up|3|||
105778969|NCT00247962|364842461|FG001|Overall Study|Lost to Follow-up|1|||
105778970|NCT00247962|364842460|FG000|Overall Study|Physician Decision|0|||
105778971|NCT00247962|364842461|FG001|Overall Study|Physician Decision|1|||
105778972|NCT00247962|364842460|FG000|Overall Study|Protocol Violation|1|||
105778973|NCT00247962|364842461|FG001|Overall Study|Protocol Violation|1|||
105778974|NCT00247962|364842460|FG000|Overall Study|Withdrawal by Subject|3|||
105778975|NCT00247962|364842461|FG001|Overall Study|Withdrawal by Subject|2|||
105778976|NCT00247962|364842460|FG000|Overall Study|Lack of Efficacy|4|||
105778977|NCT00247962|364842461|FG001|Overall Study|Lack of Efficacy|2|||
105778978|NCT01955005|364842462|FG000|Overall Study|Withdrawal by Subject|3|||
105778979|NCT01955005|364842463|FG001|Overall Study|Withdrawal by Subject|5|||
105778980|NCT00598585|364842465|FG000|Overall Study|Lost to Follow-up|1|||
105778981|NCT00598585|364842466|FG001|Overall Study|Lost to Follow-up|0|||
105778982|NCT03480841|364842469|FG000|Overall Study|Lost to Follow-up|2|||
105778983|NCT04490499|364842477|FG000|Overall Study|Withdrawal by Subject|2|||
105778984|NCT02646332|364842478|FG000|Overall Study|Lost to Follow-up|0|||
105778985|NCT02646332|364842479|FG001|Overall Study|Lost to Follow-up|3|||
105778986|NCT01882439|364842480|FG000|Overall Study|Adverse event related to study drug|3|||
105778987|NCT01882439|364842481|FG001|Overall Study|Adverse event related to study drug|8|||
105778988|NCT01882439|364842482|FG002|Overall Study|Adverse event related to study drug|1|||
105778989|NCT01882439|364842483|FG003|Overall Study|Adverse event related to study drug|2|||
105778990|NCT01882439|364842480|FG000|Overall Study|Pregnancy|0|||
105778991|NCT01882439|364842481|FG001|Overall Study|Pregnancy|1|||
105778992|NCT01882439|364842482|FG002|Overall Study|Pregnancy|0|||
105778993|NCT01882439|364842483|FG003|Overall Study|Pregnancy|0|||
105778994|NCT01882439|364842480|FG000|Overall Study|Protocol Violation|2|||
105778995|NCT01882439|364842481|FG001|Overall Study|Protocol Violation|2|||
105778996|NCT01882439|364842482|FG002|Overall Study|Protocol Violation|0|||
105778997|NCT01882439|364842483|FG003|Overall Study|Protocol Violation|1|||
105778998|NCT01882439|364842480|FG000|Overall Study|No longer willing to participate|1|||
105778999|NCT01882439|364842481|FG001|Overall Study|No longer willing to participate|4|||
105779000|NCT01882439|364842482|FG002|Overall Study|No longer willing to participate|2|||
105779001|NCT01882439|364842483|FG003|Overall Study|No longer willing to participate|3|||
105779002|NCT01882439|364842480|FG000|Overall Study|Medication error with no associated AE|0|||
105779003|NCT01882439|364842481|FG001|Overall Study|Medication error with no associated AE|0|||
105779004|NCT01882439|364842482|FG002|Overall Study|Medication error with no associated AE|2|||
105779005|NCT01882439|364842483|FG003|Overall Study|Medication error with no associated AE|0|||
105779006|NCT01882439|364842480|FG000|Overall Study|Insufficient clinical response|1|||
105779007|NCT01882439|364842481|FG001|Overall Study|Insufficient clinical response|4|||
105779008|NCT01882439|364842482|FG002|Overall Study|Insufficient clinical response|4|||
105779009|NCT01882439|364842483|FG003|Overall Study|Insufficient clinical response|2|||
105779010|NCT01882439|364842480|FG000|Overall Study|Adverse event unrelated to study drug|2|||
105779011|NCT01882439|364842481|FG001|Overall Study|Adverse event unrelated to study drug|2|||
105779012|NCT01882439|364842482|FG002|Overall Study|Adverse event unrelated to study drug|1|||
105779013|NCT01882439|364842483|FG003|Overall Study|Adverse event unrelated to study drug|1|||
105779014|NCT01997333|364842486|FG000|Randomization and Treatment|Disease Progression|70|||
105779015|NCT01997333|364842487|FG001|Randomization and Treatment|Disease Progression|159|||
105779016|NCT01997333|364842486|FG000|Randomization and Treatment|Adverse Event|10|||
105779017|NCT01997333|364842487|FG001|Randomization and Treatment|Adverse Event|32|||
105779018|NCT01997333|364842486|FG000|Randomization and Treatment|Physician Decision|0|||
105779019|NCT01997333|364842487|FG001|Randomization and Treatment|Physician Decision|4|||
105779020|NCT01997333|364842486|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
105779021|NCT01997333|364842487|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
105779022|NCT01997333|364842486|FG000|Randomization and Treatment|Did not receive treatment|17|||
105779023|NCT01997333|364842487|FG001|Randomization and Treatment|Did not receive treatment|5|||
105779024|NCT01997333|364842486|FG000|Survival Follow up|Withdrawal by Subject|15|||
105779025|NCT01997333|364842487|FG001|Survival Follow up|Withdrawal by Subject|6|||
105779026|NCT01997333|364842486|FG000|Survival Follow up|Lost to Follow-up|0|||
105779027|NCT01997333|364842487|FG001|Survival Follow up|Lost to Follow-up|6|||
105779028|NCT01997333|364842486|FG000|Survival Follow up|Various|1|||
105779029|NCT01997333|364842487|FG001|Survival Follow up|Various|2|||
105779030|NCT02909504|364842488|FG000|Overall Study|Adverse Event|2|||
105779031|NCT02909504|364842488|FG000|Overall Study|Lack of Efficacy|3|||
105779032|NCT02909504|364842488|FG000|Overall Study|Withdrawal by Subject|4|||
105779033|NCT02909504|364842488|FG000|Overall Study|Pregnancy|1|||
105779034|NCT02909504|364842488|FG000|Overall Study|Subject moved|1|||
105779035|NCT02909504|364842488|FG000|Overall Study|Lost to Follow-up|1|||
105779036|NCT04411472|364842489|FG000|Overall Study|Adverse Event|5|||
105779037|NCT04411472|364842490|FG001|Overall Study|Adverse Event|10|||
105779038|NCT04411472|364842491|FG002|Overall Study|Adverse Event|1|||
105779039|NCT04411472|364842492|FG003|Overall Study|Adverse Event|0|||
105779040|NCT04411472|364842493|FG004|Overall Study|Adverse Event|0|||
105779041|NCT04411472|364842494|FG005|Overall Study|Adverse Event|0|||
105779042|NCT04411472|364842489|FG000|Overall Study|Protocol Violation|1|||
105779043|NCT04411472|364842490|FG001|Overall Study|Protocol Violation|0|||
105779044|NCT04411472|364842491|FG002|Overall Study|Protocol Violation|0|||
105779045|NCT04411472|364842492|FG003|Overall Study|Protocol Violation|0|||
105779046|NCT04411472|364842493|FG004|Overall Study|Protocol Violation|0|||
105779047|NCT04411472|364842494|FG005|Overall Study|Protocol Violation|0|||
105779048|NCT04411472|364842489|FG000|Overall Study|Withdrawal by Subject|0|||
105779049|NCT04411472|364842490|FG001|Overall Study|Withdrawal by Subject|1|||
105779050|NCT04411472|364842491|FG002|Overall Study|Withdrawal by Subject|0|||
105779051|NCT04411472|364842492|FG003|Overall Study|Withdrawal by Subject|1|||
105779052|NCT04411472|364842493|FG004|Overall Study|Withdrawal by Subject|0|||
105779053|NCT04411472|364842494|FG005|Overall Study|Withdrawal by Subject|0|||
105779054|NCT04411472|364842489|FG000|Overall Study|Physician Decision|1|||
105779055|NCT04411472|364842490|FG001|Overall Study|Physician Decision|0|||
105779056|NCT04411472|364842491|FG002|Overall Study|Physician Decision|0|||
105779057|NCT04411472|364842492|FG003|Overall Study|Physician Decision|0|||
105779058|NCT04411472|364842493|FG004|Overall Study|Physician Decision|0|||
105779059|NCT04411472|364842494|FG005|Overall Study|Physician Decision|0|||
105779060|NCT04411472|364842489|FG000|Overall Study|Study terminated by sponsor|17|||
105779061|NCT04411472|364842490|FG001|Overall Study|Study terminated by sponsor|20|||
105779062|NCT04411472|364842491|FG002|Overall Study|Study terminated by sponsor|3|||
105779063|NCT04411472|364842492|FG003|Overall Study|Study terminated by sponsor|0|||
105779064|NCT04411472|364842493|FG004|Overall Study|Study terminated by sponsor|0|||
105779065|NCT04411472|364842494|FG005|Overall Study|Study terminated by sponsor|0|||
105779066|NCT00440232|364842495|FG000|Overall Study|Lost to Follow-up|1|||
105779067|NCT00440232|364842496|FG001|Overall Study|Lost to Follow-up|1|||
105779068|NCT00440232|364842495|FG000|Overall Study|Unable to treat within allowed time|0|||
105779069|NCT00440232|364842496|FG001|Overall Study|Unable to treat within allowed time|1|||
105779070|NCT00440232|364842495|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
105779071|NCT00440232|364842496|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
105779072|NCT05060003|364842497|FG000|Overall Study|ctDNA negative|7|||
105779073|NCT01535638|364842498|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779074|NCT01535638|364842499|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779075|NCT01535638|364842500|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779076|NCT01535638|364842501|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779077|NCT01535638|364842502|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
105779078|NCT01535638|364842503|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
105779079|NCT01535638|364842498|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779080|NCT01535638|364842499|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779081|NCT01535638|364842500|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779082|NCT01535638|364842501|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
105779083|NCT01535638|364842502|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779084|NCT01535638|364842503|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
105779085|NCT00426842|364842504|FG000|Overall Study|Lost to Follow-up|1|||
105779086|NCT01277666|364842505|FG000|Overall Study|Adverse Event|26|||
105779087|NCT01277666|364842506|FG001|Overall Study|Adverse Event|25|||
105779088|NCT01277666|364842507|FG002|Overall Study|Adverse Event|20|||
105779089|NCT01277666|364842505|FG000|Overall Study|Lack of Efficacy|8|||
105779090|NCT01277666|364842506|FG001|Overall Study|Lack of Efficacy|20|||
105779091|NCT01277666|364842507|FG002|Overall Study|Lack of Efficacy|12|||
105779092|NCT01277666|364842505|FG000|Overall Study|Protocol Violation|2|||
105779093|NCT01277666|364842506|FG001|Overall Study|Protocol Violation|3|||
105779094|NCT01277666|364842507|FG002|Overall Study|Protocol Violation|2|||
105779095|NCT01277666|364842505|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
105779096|NCT01277666|364842506|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
105779097|NCT01277666|364842507|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
105779098|NCT01277666|364842505|FG000|Overall Study|Lost to Follow-up|1|||
105779099|NCT01277666|364842506|FG001|Overall Study|Lost to Follow-up|1|||
105779100|NCT01277666|364842507|FG002|Overall Study|Lost to Follow-up|2|||
105779101|NCT01277666|364842505|FG000|Overall Study|Withdrawal by Subject|7|||
105779102|NCT01277666|364842506|FG001|Overall Study|Withdrawal by Subject|8|||
105990956|NCT02611817|365626861|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
105779103|NCT01277666|364842507|FG002|Overall Study|Withdrawal by Subject|6|||
105779104|NCT01277666|364842505|FG000|Overall Study|Death|0|||
105779105|NCT01277666|364842506|FG001|Overall Study|Death|0|||
105779106|NCT01277666|364842507|FG002|Overall Study|Death|1|||
105779107|NCT01747655|364842508|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
105779108|NCT01747655|364842509|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
105779109|NCT01747655|364842508|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
105779110|NCT01747655|364842509|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
105779111|NCT01747655|364842508|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
105779112|NCT01747655|364842509|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
105779113|NCT01373294|364842510|FG000|Overall Study|Adverse Event|1|||
105779114|NCT01373294|364842511|FG001|Overall Study|Adverse Event|0|||
105779115|NCT00423267|364842512|FG000|Period A|Withdrawal by Subject|0|||
105779116|NCT00423267|364842513|FG001|Period A|Withdrawal by Subject|1|||
105779117|NCT00423267|364842512|FG000|Period A|Non-compliance with protocol|1|||
105779118|NCT00423267|364842513|FG001|Period A|Non-compliance with protocol|0|||
105779119|NCT00423267|364842512|FG000|Period A|Administrative|1|||
105779120|NCT00423267|364842513|FG001|Period A|Administrative|0|||
105779121|NCT00827112|364842514|FG000|Overall Study|Adverse Event|2|||
105779122|NCT00827112|364842515|FG001|Overall Study|Adverse Event|0|||
105779123|NCT00827112|364842514|FG000|Overall Study|Lack of Efficacy|2|||
105779124|NCT00827112|364842515|FG001|Overall Study|Lack of Efficacy|0|||
105779125|NCT00827112|364842514|FG000|Overall Study|Lost to Follow-up|3|||
105779126|NCT00827112|364842515|FG001|Overall Study|Lost to Follow-up|2|||
105779127|NCT00827112|364842514|FG000|Overall Study|Pregnancy|0|||
105779128|NCT00827112|364842515|FG001|Overall Study|Pregnancy|1|||
105779129|NCT00827112|364842514|FG000|Overall Study|Protocol Violation|0|||
105779130|NCT00827112|364842515|FG001|Overall Study|Protocol Violation|2|||
105779131|NCT00827112|364842514|FG000|Overall Study|Withdrawal by Subject|2|||
105779132|NCT00827112|364842515|FG001|Overall Study|Withdrawal by Subject|1|||
105779133|NCT00827112|364842514|FG000|Overall Study|Randomized but not treated|5|||
105779134|NCT00827112|364842515|FG001|Overall Study|Randomized but not treated|3|||
105779135|NCT00827112|364842514|FG000|Overall Study|Other|1|||
105779136|NCT00827112|364842515|FG001|Overall Study|Other|3|||
105779137|NCT03702166|364842516|FG000|Overall Study|Lost to Follow-up|1|||
105779138|NCT03702166|364842516|FG000|Overall Study|Withdrawal by Subject|1|||
105779139|NCT01333865|364842517|FG000|Overall Study|Adverse Event|2|||
105779140|NCT00684073|364842518|FG000|Selection|Selection/non-selection criteria|3|||
105779141|NCT00684073|364842518|FG000|Selection|Death|1|||
105779142|NCT00684073|364842518|FG000|Selection|noncompliance|1|||
105779143|NCT00684073|364842518|FG000|Selection|Lost to Follow-up|1|||
105779144|NCT00684073|364842518|FG000|Selection|request of the sponsor|1|||
105779145|NCT00684073|364842518|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
105779146|NCT00842829|364842519|FG000|Dose Titration Period|Adverse Event|11|||
105779147|NCT00842829|364842520|FG001|Dose Titration Period|Adverse Event|10|||
105779148|NCT00842829|364842521|FG002|Dose Titration Period|Adverse Event|0|||
105779149|NCT00842829|364842519|FG000|Dose Titration Period|Lack of Efficacy|4|||
105779150|NCT00842829|364842520|FG001|Dose Titration Period|Lack of Efficacy|1|||
105779151|NCT00842829|364842521|FG002|Dose Titration Period|Lack of Efficacy|0|||
105779152|NCT00842829|364842519|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
105779153|NCT00842829|364842520|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
105779154|NCT00842829|364842521|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
105779155|NCT00842829|364842519|FG000|Dose Titration Period|Withdrawal by Subject|2|||
105779156|NCT00842829|364842520|FG001|Dose Titration Period|Withdrawal by Subject|6|||
105779157|NCT00842829|364842521|FG002|Dose Titration Period|Withdrawal by Subject|0|||
105779158|NCT00842829|364842519|FG000|Dose Titration Period|Other|5|||
105779159|NCT00842829|364842520|FG001|Dose Titration Period|Other|4|||
105779160|NCT00842829|364842521|FG002|Dose Titration Period|Other|0|||
105779161|NCT00842829|364842519|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
105779162|NCT00842829|364842520|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
105779163|NCT00842829|364842521|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
105779164|NCT00842829|364842519|FG000|Dose Titration Period|Non-compliance to study drug|2|||
105779165|NCT00842829|364842520|FG001|Dose Titration Period|Non-compliance to study drug|1|||
105779166|NCT00842829|364842521|FG002|Dose Titration Period|Non-compliance to study drug|0|||
105779167|NCT00842829|364842519|FG000|Treatment Period|Adverse Event|0|||
105779168|NCT00842829|364842520|FG001|Treatment Period|Adverse Event|0|||
105779169|NCT00842829|364842521|FG002|Treatment Period|Adverse Event|15|||
105779170|NCT00842829|364842519|FG000|Treatment Period|Lack of Efficacy|0|||
105779171|NCT00842829|364842520|FG001|Treatment Period|Lack of Efficacy|0|||
105779172|NCT00842829|364842521|FG002|Treatment Period|Lack of Efficacy|6|||
105779173|NCT00842829|364842519|FG000|Treatment Period|Unstable persistent cancer pain|0|||
105779174|NCT00842829|364842520|FG001|Treatment Period|Unstable persistent cancer pain|0|||
105779175|NCT00842829|364842521|FG002|Treatment Period|Unstable persistent cancer pain|5|||
105779176|NCT00842829|364842519|FG000|Treatment Period|Withdrawal by Subject|0|||
105779177|NCT00842829|364842520|FG001|Treatment Period|Withdrawal by Subject|0|||
105779178|NCT00842829|364842521|FG002|Treatment Period|Withdrawal by Subject|11|||
105779179|NCT00842829|364842519|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
106099784|NCT00626522|366022631|FG003|Overall Study|Withdrawal by Subject|0|||
105779180|NCT00842829|364842520|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
105779181|NCT00842829|364842521|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
105779182|NCT00842829|364842519|FG000|Treatment Period|Protocol Violation|0|||
105779183|NCT00842829|364842520|FG001|Treatment Period|Protocol Violation|0|||
105779184|NCT00842829|364842521|FG002|Treatment Period|Protocol Violation|2|||
105779185|NCT00842829|364842519|FG000|Treatment Period|Other|0|||
105779186|NCT00842829|364842520|FG001|Treatment Period|Other|0|||
105779187|NCT00842829|364842521|FG002|Treatment Period|Other|18|||
105779188|NCT00842829|364842519|FG000|Treatment Period|Non-compliance to study procedures|0|||
105779189|NCT00842829|364842520|FG001|Treatment Period|Non-compliance to study procedures|0|||
105779190|NCT00842829|364842521|FG002|Treatment Period|Non-compliance to study procedures|4|||
105779191|NCT00842829|364842519|FG000|Treatment Period|Unclear completion status|0|||
105779192|NCT00842829|364842520|FG001|Treatment Period|Unclear completion status|0|||
105779193|NCT00842829|364842521|FG002|Treatment Period|Unclear completion status|1|||
105779194|NCT00842829|364842519|FG000|Continuation Period|Adverse Event|0|||
105779195|NCT00842829|364842520|FG001|Continuation Period|Adverse Event|0|||
105779196|NCT00842829|364842521|FG002|Continuation Period|Adverse Event|32|||
105779197|NCT00842829|364842519|FG000|Continuation Period|Lack of Efficacy|0|||
105779198|NCT00842829|364842520|FG001|Continuation Period|Lack of Efficacy|0|||
105779199|NCT00842829|364842521|FG002|Continuation Period|Lack of Efficacy|6|||
105779200|NCT00842829|364842519|FG000|Continuation Period|Unstable persistent cancer pain|0|||
105779201|NCT00842829|364842520|FG001|Continuation Period|Unstable persistent cancer pain|0|||
105779202|NCT00842829|364842521|FG002|Continuation Period|Unstable persistent cancer pain|3|||
105779203|NCT00842829|364842519|FG000|Continuation Period|Withdrawal by Subject|0|||
105779204|NCT00842829|364842520|FG001|Continuation Period|Withdrawal by Subject|0|||
105779205|NCT00842829|364842521|FG002|Continuation Period|Withdrawal by Subject|10|||
105779206|NCT00842829|364842519|FG000|Continuation Period|Other|0|||
105779207|NCT00842829|364842520|FG001|Continuation Period|Other|0|||
105779208|NCT00842829|364842521|FG002|Continuation Period|Other|7|||
105779209|NCT00842829|364842519|FG000|Continuation Period|Non-compliance to study procedures|0|||
105779210|NCT00842829|364842520|FG001|Continuation Period|Non-compliance to study procedures|0|||
105779211|NCT00842829|364842521|FG002|Continuation Period|Non-compliance to study procedures|2|||
105779212|NCT00842829|364842519|FG000|Continuation Period|Non-compliance to study drug|0|||
105779213|NCT00842829|364842520|FG001|Continuation Period|Non-compliance to study drug|0|||
105779214|NCT00842829|364842521|FG002|Continuation Period|Non-compliance to study drug|1|||
105779215|NCT03091920|364842524|FG000|Overall Study|Adverse Event|0|||
105779216|NCT03091920|364842525|FG001|Overall Study|Adverse Event|1|||
105779217|NCT03091920|364842526|FG002|Overall Study|Adverse Event|0|||
105779218|NCT03143855|364842527|FG000|Overall Study|Withdrawal by Subject|4|||
105779219|NCT03143855|364842528|FG001|Overall Study|Withdrawal by Subject|3|||
105779220|NCT03143855|364842527|FG000|Overall Study|Protocol Violation|1|||
105779221|NCT03143855|364842528|FG001|Overall Study|Protocol Violation|0|||
105779222|NCT03143855|364842527|FG000|Overall Study|Participant experienced withdrawal|0|||
105779223|NCT03143855|364842528|FG001|Overall Study|Participant experienced withdrawal|1|||
105779224|NCT00453349|364842529|FG000|Randomized|Adverse Event|12|||
105779225|NCT00453349|364842530|FG001|Randomized|Adverse Event|11|||
105779226|NCT00453349|364842529|FG000|Randomized|Lack of Efficacy|2|||
105779227|NCT00453349|364842530|FG001|Randomized|Lack of Efficacy|1|||
105779228|NCT00453349|364842529|FG000|Randomized|Lost to Follow-up|7|||
105779229|NCT00453349|364842530|FG001|Randomized|Lost to Follow-up|5|||
105779230|NCT00453349|364842529|FG000|Randomized|Protocol Violation|1|||
105779231|NCT00453349|364842530|FG001|Randomized|Protocol Violation|1|||
105779232|NCT00453349|364842529|FG000|Randomized|Withdrawal by Subject|3|||
105779233|NCT00453349|364842530|FG001|Randomized|Withdrawal by Subject|5|||
105779234|NCT00453349|364842529|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
105779235|NCT00453349|364842530|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
105779236|NCT00453349|364842529|FG000|Completed Study|Adverse Event|12|||
105779237|NCT00453349|364842530|FG001|Completed Study|Adverse Event|11|||
105779238|NCT00453349|364842529|FG000|Completed Study|Lack of Efficacy|2|||
105779239|NCT00453349|364842530|FG001|Completed Study|Lack of Efficacy|1|||
105779240|NCT00453349|364842529|FG000|Completed Study|Lost to Follow-up|7|||
105779241|NCT00453349|364842530|FG001|Completed Study|Lost to Follow-up|5|||
105779242|NCT00453349|364842529|FG000|Completed Study|Protocol Violation|1|||
105779243|NCT00453349|364842530|FG001|Completed Study|Protocol Violation|1|||
105779244|NCT00453349|364842529|FG000|Completed Study|Withdrawal by Subject|3|||
105779245|NCT00453349|364842530|FG001|Completed Study|Withdrawal by Subject|5|||
105779246|NCT00453349|364842529|FG000|Completed Study|Lost to follow up after study treatment|2|||
105779247|NCT00453349|364842530|FG001|Completed Study|Lost to follow up after study treatment|11|||
105779248|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Death|2|||
105779249|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Death|0|||
105779250|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Adverse Event|33|||
105779251|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Adverse Event|31|||
105779252|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
105779253|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
105779254|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
105779255|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
105779256|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
105779257|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
105779258|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Other|7|||
105990957|NCT02611817|365626862|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
105990958|NCT02611817|365626860|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
105990959|NCT02611817|365626861|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
105990960|NCT02611817|365626862|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
105990961|NCT02611817|365626860|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
105990962|NCT02611817|365626861|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
105990963|NCT02611817|365626862|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
105990964|NCT02611817|365626860|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
105990965|NCT02611817|365626861|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
105990966|NCT02611817|365626862|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
105990967|NCT02611817|365626860|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
105990968|NCT02611817|365626861|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
105990969|NCT02611817|365626862|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
105990970|NCT02611817|365626860|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
105990971|NCT02611817|365626861|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
105990972|NCT02611817|365626862|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
105990973|NCT01959841|365626863|FG000|Overall Study|Adverse Event|1|||
105990974|NCT01959841|365626864|FG001|Overall Study|Adverse Event|3|||
105990975|NCT01959841|365626865|FG002|Overall Study|Adverse Event|2|||
105990976|NCT01959841|365626863|FG000|Overall Study|Lack of Efficacy|5|||
105990977|NCT01959841|365626864|FG001|Overall Study|Lack of Efficacy|0|||
105990978|NCT01959841|365626865|FG002|Overall Study|Lack of Efficacy|0|||
105990979|NCT01959841|365626863|FG000|Overall Study|Lost to Follow-up|1|||
105990980|NCT01959841|365626864|FG001|Overall Study|Lost to Follow-up|1|||
105990981|NCT01959841|365626865|FG002|Overall Study|Lost to Follow-up|0|||
105779259|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Other|8|||
105779260|NCT00280059|364842531|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
105779261|NCT00280059|364842532|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
105779262|NCT04369742|364842533|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
105779263|NCT04369742|364842534|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
105779264|NCT04369742|364842533|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
105779265|NCT04369742|364842534|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
105779266|NCT01864746|364844685|FG000|Overall Study|Disease recurrence|25|||
105779267|NCT01864746|364844686|FG001|Overall Study|Disease recurrence|40|||
105779268|NCT01864746|364844685|FG000|Overall Study|Second primary invasive nonbreast|2|||
105779269|NCT01864746|364844686|FG001|Overall Study|Second primary invasive nonbreast|3|||
105779270|NCT01864746|364844685|FG000|Overall Study|Death|2|||
105779271|NCT01864746|364844686|FG001|Overall Study|Death|1|||
105779272|NCT01864746|364844685|FG000|Overall Study|Adverse Event|33|||
105779273|NCT01864746|364844686|FG001|Overall Study|Adverse Event|5|||
105779274|NCT01864746|364844685|FG000|Overall Study|Withdrawal by Subject|56|||
105779275|NCT01864746|364844686|FG001|Overall Study|Withdrawal by Subject|41|||
105779276|NCT01864746|364844685|FG000|Overall Study|Physician Decision|5|||
105779277|NCT01864746|364844686|FG001|Overall Study|Physician Decision|6|||
105779278|NCT04144140|364844687|FG000|Overall Study|Other|0|||
105779279|NCT04144140|364844688|FG001|Overall Study|Other|0|||
105779280|NCT04144140|364844689|FG002|Overall Study|Other|0|||
105779281|NCT04144140|364844690|FG003|Overall Study|Other|0|||
105779282|NCT04144140|364844691|FG004|Overall Study|Other|0|||
105779283|NCT04144140|364844692|FG005|Overall Study|Other|1|||
105779284|NCT04144140|364844693|FG006|Overall Study|Other|0|||
105779285|NCT01465958|364844694|FG000|Run-in Phase|Protocol Violation|1|||
105779286|NCT01465958|364844695|FG001|Run-in Phase|Protocol Violation|0|||
105779287|NCT01465958|364844694|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
105779288|NCT01465958|364844695|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
105779289|NCT02039687|364844699|FG000|Overall Study|Adverse Event|0|||
105779290|NCT02039687|364844700|FG001|Overall Study|Adverse Event|0|||
105779291|NCT02039687|364844701|FG002|Overall Study|Adverse Event|1|||
105779292|NCT02039687|364844702|FG003|Overall Study|Adverse Event|0|||
105779293|NCT02039687|364844699|FG000|Overall Study|Withdrawal by Subject|0|||
105779294|NCT02039687|364844700|FG001|Overall Study|Withdrawal by Subject|1|||
105779295|NCT02039687|364844701|FG002|Overall Study|Withdrawal by Subject|0|||
105779296|NCT02039687|364844702|FG003|Overall Study|Withdrawal by Subject|0|||
105779297|NCT02039687|364844699|FG000|Overall Study|treatment assignment could not be confir|0|||
105779298|NCT02039687|364844700|FG001|Overall Study|treatment assignment could not be confir|0|||
105779299|NCT02039687|364844701|FG002|Overall Study|treatment assignment could not be confir|2|||
105779300|NCT02039687|364844702|FG003|Overall Study|treatment assignment could not be confir|0|||
105779301|NCT03824704|364844718|FG000|Overall Study|Study Terminated by Sponsor|1|||
105779302|NCT02194699|364844720|FG000|Randomised|Did not receive treatment|1|||
105878754|NCT01120184|365209743|FG001|Overall Study|Lost to Follow-up|13|||
105990982|NCT01959841|365626863|FG000|Overall Study|Physician Decision|0|||
105990983|NCT01959841|365626864|FG001|Overall Study|Physician Decision|2|||
105990984|NCT01959841|365626865|FG002|Overall Study|Physician Decision|3|||
105990985|NCT01959841|365626863|FG000|Overall Study|Protocol Violation|16|||
105990986|NCT01959841|365626864|FG001|Overall Study|Protocol Violation|23|||
105990987|NCT01959841|365626865|FG002|Overall Study|Protocol Violation|16|||
105990988|NCT01959841|365626863|FG000|Overall Study|Withdrawal by Subject|7|||
105990989|NCT01959841|365626864|FG001|Overall Study|Withdrawal by Subject|7|||
105990990|NCT01959841|365626865|FG002|Overall Study|Withdrawal by Subject|5|||
105990991|NCT01959841|365626863|FG000|Overall Study|Clinical laboratory value|2|||
105990992|NCT01959841|365626864|FG001|Overall Study|Clinical laboratory value|6|||
105990993|NCT01959841|365626865|FG002|Overall Study|Clinical laboratory value|6|||
105990994|NCT01959841|365626863|FG000|Overall Study|Platelet count below on day1 or 4|11|||
105990995|NCT01959841|365626864|FG001|Overall Study|Platelet count below on day1 or 4|15|||
105990996|NCT01959841|365626865|FG002|Overall Study|Platelet count below on day1 or 4|11|||
105990997|NCT01271725|365626868|FG000|Part A|Progressive disease according to RECIST|8|||
105990998|NCT01271725|365626869|FG001|Part A|Progressive disease according to RECIST|0|||
105990999|NCT01271725|365626868|FG000|Part A|Clinical signs/symptoms of progression|2|||
105991000|NCT01271725|365626869|FG001|Part A|Clinical signs/symptoms of progression|0|||
105991001|NCT01271725|365626868|FG000|Part A|Other Adverse Event|8|||
105991002|NCT01271725|365626869|FG001|Part A|Other Adverse Event|0|||
105991003|NCT01271725|365626868|FG000|Part A|Lost to Follow-up|1|||
105991004|NCT01271725|365626869|FG001|Part A|Lost to Follow-up|0|||
105991005|NCT01271725|365626868|FG000|Part A|Withdrawal by Subject|12|||
105991006|NCT01271725|365626869|FG001|Part A|Withdrawal by Subject|0|||
105991007|NCT01271725|365626868|FG000|Part A|Other than specified|3|||
105991008|NCT01271725|365626869|FG001|Part A|Other than specified|0|||
105991009|NCT01271725|365626868|FG000|Part A|Protocol Violation|1|||
105991010|NCT01271725|365626869|FG001|Part A|Protocol Violation|0|||
105991011|NCT01271725|365626868|FG000|Part B|Other than specified|0|||
105991012|NCT01271725|365626869|FG001|Part B|Other than specified|2|||
105991013|NCT01271725|365626868|FG000|Part B|Clinical signs/symptoms of progression|0|||
105991014|NCT01271725|365626869|FG001|Part B|Clinical signs/symptoms of progression|2|||
105991015|NCT01271725|365626868|FG000|Part B|Other Adverse Event|0|||
105991016|NCT01271725|365626869|FG001|Part B|Other Adverse Event|1|||
105991017|NCT01271725|365626868|FG000|Part B|Protocol Violation|0|||
105991018|NCT01271725|365626869|FG001|Part B|Protocol Violation|1|||
105991019|NCT01271725|365626868|FG000|Part B|Withdrawal by Subject|0|||
105991020|NCT01271725|365626869|FG001|Part B|Withdrawal by Subject|6|||
105991021|NCT00801229|365626870|FG000|Signed Consent|Withdrawal by Subject|2|||
105991022|NCT00801229|365626871|FG001|Signed Consent|Withdrawal by Subject|2|||
105991023|NCT00801229|365626870|FG000|Signed Consent|Found Ineligible|1|||
105991024|NCT00801229|365626871|FG001|Signed Consent|Found Ineligible|1|||
105991025|NCT00801229|365626870|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
105991026|NCT00801229|365626871|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
105991027|NCT00801229|365626870|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
105991028|NCT00801229|365626871|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
105991029|NCT00801229|365626870|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
105991030|NCT00801229|365626871|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
105991031|NCT00801229|365626870|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
105991032|NCT00801229|365626871|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
105991033|NCT00801229|365626870|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
105991034|NCT00801229|365626871|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
105991035|NCT00801229|365626870|FG000|Received Study Drug/Placebo|Adverse Event|1|||
105991036|NCT00801229|365626871|FG001|Received Study Drug/Placebo|Adverse Event|1|||
105991037|NCT01980095|365626876|FG000|Overall Study|Lost to Follow-up|6|||
105991038|NCT01980095|365626877|FG001|Overall Study|Lost to Follow-up|7|||
105991039|NCT01980095|365626876|FG000|Overall Study|Withdrawal by Subject|2|||
105991040|NCT01980095|365626877|FG001|Overall Study|Withdrawal by Subject|3|||
105991041|NCT01980095|365626876|FG000|Overall Study|Poor compliance|5|||
105991042|NCT01980095|365626877|FG001|Overall Study|Poor compliance|0|||
105991043|NCT01980095|365626876|FG000|Overall Study|Safety issue|0|||
105991044|NCT01980095|365626877|FG001|Overall Study|Safety issue|1|||
105991045|NCT01980095|365626876|FG000|Overall Study|Study drug discontinued|1|||
105991046|NCT01980095|365626877|FG001|Overall Study|Study drug discontinued|0|||
105991047|NCT01980095|365626876|FG000|Overall Study|Randomized by mistake|1|||
105991048|NCT01980095|365626877|FG001|Overall Study|Randomized by mistake|0|||
105991049|NCT02737475|365626878|FG000|Overall Study|Other reasons|0|||
105991050|NCT02737475|365626879|FG001|Overall Study|Other reasons|0|||
105991051|NCT02737475|365626880|FG002|Overall Study|Other reasons|0|||
105991052|NCT02737475|365626881|FG003|Overall Study|Other reasons|0|||
105779303|NCT02194699|364844721|FG001|Randomised|Did not receive treatment|5|||
105991053|NCT02737475|365626882|FG004|Overall Study|Other reasons|1|||
105991054|NCT02737475|365626883|FG005|Overall Study|Other reasons|1|||
105991055|NCT02737475|365626884|FG006|Overall Study|Other reasons|0|||
105991056|NCT02737475|365626885|FG007|Overall Study|Other reasons|0|||
105991057|NCT02737475|365626886|FG008|Overall Study|Other reasons|1|||
106099785|NCT00626522|366022632|FG004|Overall Study|Withdrawal by Subject|4|||
105779304|NCT02194699|364844720|FG000|Randomised|Without potential for 52 weeks of IP|5|||
105991058|NCT02737475|365626887|FG009|Overall Study|Other reasons|0|||
105991059|NCT02737475|365626888|FG010|Overall Study|Other reasons|1|||
105991060|NCT02737475|365626889|FG011|Overall Study|Other reasons|0|||
105991061|NCT02737475|365626890|FG012|Overall Study|Other reasons|0|||
105991062|NCT02737475|365626891|FG013|Overall Study|Other reasons|0|||
105991063|NCT02737475|365626892|FG014|Overall Study|Other reasons|0|||
105991064|NCT02737475|365626893|FG015|Overall Study|Other reasons|0|||
105991065|NCT02737475|365626894|FG016|Overall Study|Other reasons|0|||
105991066|NCT02737475|365626895|FG017|Overall Study|Other reasons|0|||
105991067|NCT02737475|365626896|FG018|Overall Study|Other reasons|0|||
105991068|NCT02737475|365626897|FG019|Overall Study|Other reasons|0|||
105991069|NCT02737475|365626898|FG020|Overall Study|Other reasons|0|||
105991070|NCT02737475|365626899|FG021|Overall Study|Other reasons|1|||
105991071|NCT02737475|365626900|FG022|Overall Study|Other reasons|0|||
105991072|NCT02737475|365626901|FG023|Overall Study|Other reasons|1|||
105991073|NCT02737475|365626902|FG024|Overall Study|Other reasons|1|||
105991074|NCT02737475|365626903|FG025|Overall Study|Other reasons|1|||
105991075|NCT02737475|365626904|FG026|Overall Study|Other reasons|0|||
105991076|NCT02737475|365626878|FG000|Overall Study|Death|1|||
105991077|NCT02737475|365626879|FG001|Overall Study|Death|0|||
105991078|NCT02737475|365626880|FG002|Overall Study|Death|0|||
105991079|NCT02737475|365626881|FG003|Overall Study|Death|1|||
105991080|NCT02737475|365626882|FG004|Overall Study|Death|0|||
105991081|NCT02737475|365626883|FG005|Overall Study|Death|0|||
105991082|NCT02737475|365626884|FG006|Overall Study|Death|0|||
105991083|NCT02737475|365626885|FG007|Overall Study|Death|2|||
105991084|NCT02737475|365626886|FG008|Overall Study|Death|0|||
105991085|NCT02737475|365626887|FG009|Overall Study|Death|0|||
105991086|NCT02737475|365626888|FG010|Overall Study|Death|0|||
105991087|NCT02737475|365626889|FG011|Overall Study|Death|4|||
105991088|NCT02737475|365626890|FG012|Overall Study|Death|2|||
105991089|NCT02737475|365626891|FG013|Overall Study|Death|2|||
105991090|NCT02737475|365626892|FG014|Overall Study|Death|0|||
105991091|NCT02737475|365626893|FG015|Overall Study|Death|2|||
105991092|NCT02737475|365626894|FG016|Overall Study|Death|2|||
105991093|NCT02737475|365626895|FG017|Overall Study|Death|2|||
105991094|NCT02737475|365626896|FG018|Overall Study|Death|1|||
105991095|NCT02737475|365626897|FG019|Overall Study|Death|0|||
105991096|NCT02737475|365626898|FG020|Overall Study|Death|0|||
105991097|NCT02737475|365626899|FG021|Overall Study|Death|0|||
105991098|NCT02737475|365626900|FG022|Overall Study|Death|0|||
105991099|NCT02737475|365626901|FG023|Overall Study|Death|0|||
105991100|NCT02737475|365626902|FG024|Overall Study|Death|0|||
105991101|NCT02737475|365626903|FG025|Overall Study|Death|0|||
105991102|NCT02737475|365626904|FG026|Overall Study|Death|0|||
105991103|NCT02737475|365626878|FG000|Overall Study|Participant withdrew consent|0|||
105991104|NCT02737475|365626879|FG001|Overall Study|Participant withdrew consent|0|||
105991105|NCT02737475|365626880|FG002|Overall Study|Participant withdrew consent|0|||
105991106|NCT02737475|365626881|FG003|Overall Study|Participant withdrew consent|0|||
105991107|NCT02737475|365626882|FG004|Overall Study|Participant withdrew consent|0|||
105991108|NCT02737475|365626883|FG005|Overall Study|Participant withdrew consent|2|||
105991109|NCT02737475|365626884|FG006|Overall Study|Participant withdrew consent|0|||
105991110|NCT02737475|365626885|FG007|Overall Study|Participant withdrew consent|0|||
105991111|NCT02737475|365626886|FG008|Overall Study|Participant withdrew consent|0|||
105991112|NCT02737475|365626887|FG009|Overall Study|Participant withdrew consent|0|||
105991113|NCT02737475|365626888|FG010|Overall Study|Participant withdrew consent|0|||
105991114|NCT02737475|365626889|FG011|Overall Study|Participant withdrew consent|0|||
105991115|NCT02737475|365626890|FG012|Overall Study|Participant withdrew consent|0|||
105991116|NCT02737475|365626891|FG013|Overall Study|Participant withdrew consent|0|||
105991117|NCT02737475|365626892|FG014|Overall Study|Participant withdrew consent|1|||
105991118|NCT02737475|365626893|FG015|Overall Study|Participant withdrew consent|0|||
105991119|NCT02737475|365626894|FG016|Overall Study|Participant withdrew consent|0|||
105991120|NCT02737475|365626895|FG017|Overall Study|Participant withdrew consent|2|||
105991121|NCT02737475|365626896|FG018|Overall Study|Participant withdrew consent|1|||
105991122|NCT02737475|365626897|FG019|Overall Study|Participant withdrew consent|0|||
105991123|NCT02737475|365626898|FG020|Overall Study|Participant withdrew consent|2|||
105991124|NCT02737475|365626899|FG021|Overall Study|Participant withdrew consent|0|||
105991125|NCT02737475|365626900|FG022|Overall Study|Participant withdrew consent|0|||
105991126|NCT02737475|365626901|FG023|Overall Study|Participant withdrew consent|0|||
105991127|NCT02737475|365626902|FG024|Overall Study|Participant withdrew consent|0|||
105991128|NCT02737475|365626903|FG025|Overall Study|Participant withdrew consent|0|||
105991129|NCT02737475|365626904|FG026|Overall Study|Participant withdrew consent|0|||
105991130|NCT02737475|365626878|FG000|Overall Study|Lost to Follow-up|0|||
105991131|NCT02737475|365626879|FG001|Overall Study|Lost to Follow-up|0|||
105991132|NCT02737475|365626880|FG002|Overall Study|Lost to Follow-up|0|||
105991133|NCT02737475|365626881|FG003|Overall Study|Lost to Follow-up|0|||
105991134|NCT02737475|365626882|FG004|Overall Study|Lost to Follow-up|0|||
105991135|NCT02737475|365626883|FG005|Overall Study|Lost to Follow-up|0|||
105991136|NCT02737475|365626884|FG006|Overall Study|Lost to Follow-up|0|||
105779305|NCT02194699|364844721|FG001|Randomised|Without potential for 52 weeks of IP|5|||
105779306|NCT02194699|364844720|FG000|Randomised|Duplicate patient|2|||
105779307|NCT02194699|364844721|FG001|Randomised|Duplicate patient|1|||
105779308|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
105779309|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
105779310|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
105779311|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
105779312|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
105779313|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
105779314|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
105779315|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
105779316|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
105779317|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
105779318|NCT02194699|364844720|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
105779319|NCT02194699|364844721|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
105779320|NCT02408016|364844722|FG000|Overall Study|Death|6|||
105779321|NCT02408016|364844723|FG001|Overall Study|Death|1|||
105779322|NCT02408016|364844724|FG002|Overall Study|Death|0|||
105779323|NCT02408016|364844722|FG000|Overall Study|Physician Decision|0|||
105779324|NCT02408016|364844723|FG001|Overall Study|Physician Decision|2|||
105779325|NCT02408016|364844724|FG002|Overall Study|Physician Decision|0|||
105779326|NCT00805194|364844725|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
105779327|NCT00805194|364844726|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
105779328|NCT00805194|364844725|FG000|Overall Study|Worsening or AE of underlying disease|64|||
105779329|NCT00805194|364844726|FG001|Overall Study|Worsening or AE of underlying disease|70|||
105779330|NCT00805194|364844725|FG000|Overall Study|Other AE|84|||
105779331|NCT00805194|364844726|FG001|Overall Study|Other AE|73|||
105779332|NCT00805194|364844725|FG000|Overall Study|Protocol Violation|9|||
105779333|NCT00805194|364844726|FG001|Overall Study|Protocol Violation|9|||
105779334|NCT00805194|364844725|FG000|Overall Study|Lost to Follow-up|5|||
105779335|NCT00805194|364844726|FG001|Overall Study|Lost to Follow-up|5|||
105779336|NCT00805194|364844725|FG000|Overall Study|Withdrawal by Subject|60|||
105779337|NCT00805194|364844726|FG001|Overall Study|Withdrawal by Subject|42|||
105779338|NCT00805194|364844725|FG000|Overall Study|Not treated|3|||
105779339|NCT00805194|364844726|FG001|Overall Study|Not treated|4|||
105779340|NCT00805194|364844725|FG000|Overall Study|Reasons other than stated above|20|||
105779341|NCT00805194|364844726|FG001|Overall Study|Reasons other than stated above|16|||
105779342|NCT02155660|364844727|FG000|Overall Study|Other Reason|8|||
105779343|NCT02155660|364844728|FG001|Overall Study|Other Reason|6|||
105779344|NCT02155660|364844729|FG002|Overall Study|Other Reason|10|||
105779345|NCT02155660|364844730|FG003|Overall Study|Other Reason|10|||
105779346|NCT02155660|364844727|FG000|Overall Study|Study-specific withdrawal criteria|0|||
105779347|NCT02155660|364844728|FG001|Overall Study|Study-specific withdrawal criteria|1|||
105779348|NCT02155660|364844729|FG002|Overall Study|Study-specific withdrawal criteria|1|||
105779349|NCT02155660|364844730|FG003|Overall Study|Study-specific withdrawal criteria|1|||
105779350|NCT02155660|364844727|FG000|Overall Study|Severe non-compliance|0|||
105779351|NCT02155660|364844728|FG001|Overall Study|Severe non-compliance|4|||
105779352|NCT02155660|364844729|FG002|Overall Study|Severe non-compliance|0|||
105779353|NCT02155660|364844730|FG003|Overall Study|Severe non-compliance|1|||
105779354|NCT02155660|364844727|FG000|Overall Study|Adverse Event|2|||
105779355|NCT02155660|364844728|FG001|Overall Study|Adverse Event|6|||
105779356|NCT02155660|364844729|FG002|Overall Study|Adverse Event|3|||
105779357|NCT02155660|364844730|FG003|Overall Study|Adverse Event|1|||
105779358|NCT02155660|364844727|FG000|Overall Study|Lost to Follow-up|3|||
105779359|NCT02155660|364844728|FG001|Overall Study|Lost to Follow-up|6|||
105779360|NCT02155660|364844729|FG002|Overall Study|Lost to Follow-up|5|||
105779361|NCT02155660|364844730|FG003|Overall Study|Lost to Follow-up|8|||
105779362|NCT02155660|364844727|FG000|Overall Study|Death|17|||
105779363|NCT02155660|364844728|FG001|Overall Study|Death|19|||
105779364|NCT02155660|364844729|FG002|Overall Study|Death|17|||
105779365|NCT02155660|364844730|FG003|Overall Study|Death|19|||
105779366|NCT02155660|364844727|FG000|Overall Study|Withdrawal by Subject|28|||
105779367|NCT02155660|364844728|FG001|Overall Study|Withdrawal by Subject|31|||
105779368|NCT02155660|364844729|FG002|Overall Study|Withdrawal by Subject|24|||
105779369|NCT02155660|364844730|FG003|Overall Study|Withdrawal by Subject|21|||
105779370|NCT03812224|364844737|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
105779371|NCT03812224|364844738|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105779372|NCT03812224|364844737|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
105779373|NCT03812224|364844738|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
105779374|NCT03812224|364844737|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
105779375|NCT03812224|364844738|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
105779376|NCT03812224|364844737|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
105779377|NCT03812224|364844738|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
105779378|NCT01641952|364844739|FG000|Overall Study|Lost to Follow-up|28|||
105779379|NCT01641952|364844739|FG000|Overall Study|Adverse Event|6|||
105991137|NCT02737475|365626885|FG007|Overall Study|Lost to Follow-up|0|||
105991138|NCT02737475|365626886|FG008|Overall Study|Lost to Follow-up|0|||
105991139|NCT02737475|365626887|FG009|Overall Study|Lost to Follow-up|0|||
105991140|NCT02737475|365626888|FG010|Overall Study|Lost to Follow-up|0|||
105991141|NCT02737475|365626889|FG011|Overall Study|Lost to Follow-up|0|||
105991142|NCT02737475|365626890|FG012|Overall Study|Lost to Follow-up|0|||
105991143|NCT02737475|365626891|FG013|Overall Study|Lost to Follow-up|0|||
105991144|NCT02737475|365626892|FG014|Overall Study|Lost to Follow-up|0|||
105991145|NCT02737475|365626893|FG015|Overall Study|Lost to Follow-up|1|||
105991146|NCT02737475|365626894|FG016|Overall Study|Lost to Follow-up|0|||
105991147|NCT02737475|365626895|FG017|Overall Study|Lost to Follow-up|0|||
105991148|NCT02737475|365626896|FG018|Overall Study|Lost to Follow-up|0|||
105991149|NCT02737475|365626897|FG019|Overall Study|Lost to Follow-up|0|||
105991150|NCT02737475|365626898|FG020|Overall Study|Lost to Follow-up|0|||
105991151|NCT02737475|365626899|FG021|Overall Study|Lost to Follow-up|0|||
105991152|NCT02737475|365626900|FG022|Overall Study|Lost to Follow-up|0|||
105991153|NCT02737475|365626901|FG023|Overall Study|Lost to Follow-up|0|||
105991154|NCT02737475|365626902|FG024|Overall Study|Lost to Follow-up|0|||
105991155|NCT02737475|365626903|FG025|Overall Study|Lost to Follow-up|0|||
105991156|NCT02737475|365626904|FG026|Overall Study|Lost to Follow-up|0|||
105991157|NCT02737475|365626878|FG000|Overall Study|Disease Progression|0|||
105991158|NCT02737475|365626879|FG001|Overall Study|Disease Progression|0|||
105991159|NCT02737475|365626880|FG002|Overall Study|Disease Progression|0|||
105991160|NCT02737475|365626881|FG003|Overall Study|Disease Progression|0|||
105991161|NCT02737475|365626882|FG004|Overall Study|Disease Progression|0|||
105991162|NCT02737475|365626883|FG005|Overall Study|Disease Progression|0|||
105991163|NCT02737475|365626884|FG006|Overall Study|Disease Progression|0|||
105991164|NCT02737475|365626885|FG007|Overall Study|Disease Progression|0|||
105991165|NCT02737475|365626886|FG008|Overall Study|Disease Progression|0|||
105991166|NCT02737475|365626887|FG009|Overall Study|Disease Progression|0|||
105991167|NCT02737475|365626888|FG010|Overall Study|Disease Progression|0|||
105991168|NCT02737475|365626889|FG011|Overall Study|Disease Progression|0|||
105991169|NCT02737475|365626890|FG012|Overall Study|Disease Progression|0|||
105991170|NCT02737475|365626891|FG013|Overall Study|Disease Progression|0|||
105991171|NCT02737475|365626892|FG014|Overall Study|Disease Progression|0|||
105991172|NCT02737475|365626893|FG015|Overall Study|Disease Progression|0|||
105991173|NCT02737475|365626894|FG016|Overall Study|Disease Progression|0|||
105991174|NCT02737475|365626895|FG017|Overall Study|Disease Progression|0|||
105991175|NCT02737475|365626896|FG018|Overall Study|Disease Progression|0|||
105991176|NCT02737475|365626897|FG019|Overall Study|Disease Progression|0|||
105991177|NCT02737475|365626898|FG020|Overall Study|Disease Progression|0|||
105991178|NCT02737475|365626899|FG021|Overall Study|Disease Progression|0|||
105991179|NCT02737475|365626900|FG022|Overall Study|Disease Progression|0|||
105991180|NCT02737475|365626901|FG023|Overall Study|Disease Progression|0|||
105991181|NCT02737475|365626902|FG024|Overall Study|Disease Progression|0|||
105991182|NCT02737475|365626903|FG025|Overall Study|Disease Progression|0|||
105991183|NCT02737475|365626904|FG026|Overall Study|Disease Progression|1|||
105991184|NCT02510001|365626905|FG000|Overall Study|Early disease progression|0|||
105991185|NCT02510001|365626906|FG001|Overall Study|Early disease progression|0|||
105991186|NCT02510001|365626907|FG002|Overall Study|Early disease progression|0|||
105991187|NCT02510001|365626908|FG003|Overall Study|Early disease progression|1|||
105991188|NCT02510001|365626909|FG004|Overall Study|Early disease progression|1|||
105991189|NCT02510001|365626910|FG005|Overall Study|Early disease progression|1|||
105991190|NCT02510001|365626911|FG006|Overall Study|Early disease progression|0|||
105991191|NCT02510001|365626912|FG007|Overall Study|Early disease progression|0|||
105991192|NCT02510001|365626905|FG000|Overall Study|Adverse Event|0|||
105991193|NCT02510001|365626906|FG001|Overall Study|Adverse Event|0|||
105991194|NCT02510001|365626907|FG002|Overall Study|Adverse Event|0|||
105991195|NCT02510001|365626908|FG003|Overall Study|Adverse Event|1|||
105991196|NCT02510001|365626909|FG004|Overall Study|Adverse Event|2|||
105991197|NCT02510001|365626910|FG005|Overall Study|Adverse Event|1|||
105991198|NCT02510001|365626911|FG006|Overall Study|Adverse Event|2|||
105991199|NCT02510001|365626912|FG007|Overall Study|Adverse Event|5|||
105991200|NCT02510001|365626905|FG000|Overall Study|Physician Decision|0|||
105991201|NCT02510001|365626906|FG001|Overall Study|Physician Decision|0|||
105991202|NCT02510001|365626907|FG002|Overall Study|Physician Decision|0|||
105991203|NCT02510001|365626908|FG003|Overall Study|Physician Decision|0|||
106099786|NCT00626522|366022633|FG005|Overall Study|Withdrawal by Subject|1|||
105991204|NCT02510001|365626909|FG004|Overall Study|Physician Decision|1|||
105991205|NCT02510001|365626910|FG005|Overall Study|Physician Decision|0|||
105991206|NCT02510001|365626911|FG006|Overall Study|Physician Decision|0|||
105991207|NCT02510001|365626912|FG007|Overall Study|Physician Decision|0|||
105991208|NCT02510001|365626905|FG000|Overall Study|Withdrawal by Subject|0|||
105991209|NCT02510001|365626906|FG001|Overall Study|Withdrawal by Subject|0|||
105991210|NCT02510001|365626907|FG002|Overall Study|Withdrawal by Subject|0|||
105991211|NCT02510001|365626908|FG003|Overall Study|Withdrawal by Subject|0|||
105991212|NCT02510001|365626909|FG004|Overall Study|Withdrawal by Subject|0|||
105991213|NCT02510001|365626910|FG005|Overall Study|Withdrawal by Subject|0|||
105991214|NCT02510001|365626911|FG006|Overall Study|Withdrawal by Subject|0|||
105991215|NCT02510001|365626912|FG007|Overall Study|Withdrawal by Subject|2|||
105991216|NCT02950480|365626913|FG000|Overall Study|Withdrawal by Subject|1|||
105991217|NCT02950480|365626914|FG001|Overall Study|Withdrawal by Subject|0|||
105991218|NCT00536471|365626929|FG000|Overall Study|Lost to Follow-up|48|||
105991219|NCT00536471|365626930|FG001|Overall Study|Lost to Follow-up|23|||
105991220|NCT00536471|365626931|FG002|Overall Study|Lost to Follow-up|48|||
105991221|NCT00536471|365626932|FG003|Overall Study|Lost to Follow-up|22|||
105991222|NCT00536471|365626929|FG000|Overall Study|Adverse Event|32|||
105991223|NCT00536471|365626930|FG001|Overall Study|Adverse Event|16|||
105991224|NCT00536471|365626931|FG002|Overall Study|Adverse Event|28|||
105991225|NCT00536471|365626932|FG003|Overall Study|Adverse Event|13|||
105991226|NCT00536471|365626929|FG000|Overall Study|Withdrawal by Subject|40|||
105991227|NCT00536471|365626930|FG001|Overall Study|Withdrawal by Subject|24|||
105991228|NCT00536471|365626931|FG002|Overall Study|Withdrawal by Subject|43|||
105991229|NCT00536471|365626932|FG003|Overall Study|Withdrawal by Subject|21|||
105991230|NCT00536471|365626929|FG000|Overall Study|Lack of Efficacy|17|||
105991231|NCT00536471|365626930|FG001|Overall Study|Lack of Efficacy|18|||
105991232|NCT00536471|365626931|FG002|Overall Study|Lack of Efficacy|11|||
105991233|NCT00536471|365626932|FG003|Overall Study|Lack of Efficacy|9|||
105991234|NCT00536471|365626929|FG000|Overall Study|Protocol Violation|8|||
105991235|NCT00536471|365626930|FG001|Overall Study|Protocol Violation|1|||
105991236|NCT00536471|365626931|FG002|Overall Study|Protocol Violation|2|||
105991237|NCT00536471|365626932|FG003|Overall Study|Protocol Violation|3|||
105991238|NCT00536471|365626929|FG000|Overall Study|Physician Decision|11|||
105991239|NCT00536471|365626930|FG001|Overall Study|Physician Decision|1|||
105991240|NCT00536471|365626931|FG002|Overall Study|Physician Decision|3|||
105991241|NCT00536471|365626932|FG003|Overall Study|Physician Decision|2|||
105991242|NCT00536471|365626929|FG000|Overall Study|Death|0|||
105991243|NCT00536471|365626930|FG001|Overall Study|Death|0|||
105991244|NCT00536471|365626931|FG002|Overall Study|Death|1|||
105991245|NCT00536471|365626932|FG003|Overall Study|Death|2|||
105991246|NCT00536471|365626929|FG000|Overall Study|Sponsor Decision|0|||
105991247|NCT00536471|365626930|FG001|Overall Study|Sponsor Decision|1|||
105991248|NCT00536471|365626931|FG002|Overall Study|Sponsor Decision|3|||
105991249|NCT00536471|365626932|FG003|Overall Study|Sponsor Decision|2|||
105991250|NCT03668613|365626933|FG000|Overall Study|Adverse Event|1|||
105991251|NCT03668613|365626934|FG001|Overall Study|Adverse Event|2|||
105991252|NCT03668613|365626933|FG000|Overall Study|Lack of Efficacy|5|||
105991253|NCT03668613|365626934|FG001|Overall Study|Lack of Efficacy|1|||
105991254|NCT03668613|365626933|FG000|Overall Study|Pregnancy|0|||
105991255|NCT03668613|365626934|FG001|Overall Study|Pregnancy|2|||
105991256|NCT03668613|365626933|FG000|Overall Study|Protocol Violation|1|||
105991257|NCT03668613|365626934|FG001|Overall Study|Protocol Violation|0|||
105991258|NCT03668613|365626933|FG000|Overall Study|Physician Decision|1|||
105991259|NCT03668613|365626934|FG001|Overall Study|Physician Decision|0|||
105991260|NCT03668613|365626933|FG000|Overall Study|Withdrawal by Subject|2|||
105991261|NCT03668613|365626934|FG001|Overall Study|Withdrawal by Subject|1|||
105991262|NCT03668613|365626933|FG000|Overall Study|Guardian decision|1|||
105991263|NCT03668613|365626934|FG001|Overall Study|Guardian decision|0|||
105991264|NCT00709618|365626935|FG000|Overall Study|Withdrawal by Subject|4|||
105991265|NCT00709618|365626935|FG000|Overall Study|Lost to Follow-up|1|||
105991266|NCT00709618|365626935|FG000|Overall Study|Study Closed/Terminated|25|||
105991267|NCT02703324|365626936|FG000|Period Two|Withdrawal by Subject|0|||
105991268|NCT02703324|365626937|FG001|Period Two|Withdrawal by Subject|0|||
105991269|NCT02703324|365626938|FG002|Period Two|Withdrawal by Subject|1|||
105991270|NCT02703324|365626939|FG003|Period Two|Withdrawal by Subject|0|||
105991271|NCT02703324|365626940|FG004|Period Two|Withdrawal by Subject|0|||
105991272|NCT02703324|365626941|FG005|Period Two|Withdrawal by Subject|0|||
105991273|NCT02221674|365626942|FG000|Overall Study|Lost to Follow-up|1|||
105991274|NCT02221674|365626943|FG001|Overall Study|Lost to Follow-up|0|||
105991275|NCT02221674|365626944|FG002|Overall Study|Lost to Follow-up|0|||
105991276|NCT04042909|365626945|FG000|Overall Study|Withdrawal by Subject|1|||
105991277|NCT04042909|365626946|FG001|Overall Study|Withdrawal by Subject|0|||
105991278|NCT04042909|365626947|FG002|Overall Study|Withdrawal by Subject|0|||
105991279|NCT04042909|365626945|FG000|Overall Study|duplicate cases|2|||
105991280|NCT04042909|365626946|FG001|Overall Study|duplicate cases|0|||
105991281|NCT04042909|365626947|FG002|Overall Study|duplicate cases|0|||
105991282|NCT04042909|365626945|FG000|Overall Study|technical problem|0|||
105991283|NCT04042909|365626946|FG001|Overall Study|technical problem|1|||
105991284|NCT04042909|365626947|FG002|Overall Study|technical problem|0|||
105991285|NCT01948063|365626948|FG000|Overall Study|Boston MCI halted research protocol|0|||
105991286|NCT01948063|365626949|FG001|Overall Study|Boston MCI halted research protocol|1|||
105991287|NCT01948063|365626948|FG000|Overall Study|Discovered an enrollment in other study|0|||
105991288|NCT01948063|365626949|FG001|Overall Study|Discovered an enrollment in other study|1|||
105991289|NCT01948063|365626948|FG000|Overall Study|Blood samples were accidentally thawed|1|||
105991290|NCT01948063|365626949|FG001|Overall Study|Blood samples were accidentally thawed|0|||
105991291|NCT00894361|365626950|FG000|Overall Study|deaths and less than 2 years followup|24|||
105991292|NCT00894361|365626951|FG001|Overall Study|deaths and less than 2 years followup|64|||
105991293|NCT05438576|365626952|FG000|Overall Study|Death|1|||
105991294|NCT05438576|365626953|FG001|Overall Study|Death|1|||
105991295|NCT05438576|365626952|FG000|Overall Study|Withdrawal by Subject|4|||
105991296|NCT05438576|365626953|FG001|Overall Study|Withdrawal by Subject|2|||
105991297|NCT05438576|365626952|FG000|Overall Study|Not Eligible|2|||
105991298|NCT05438576|365626953|FG001|Overall Study|Not Eligible|1|||
105991299|NCT05438576|365626952|FG000|Overall Study|Did not complete baseline testing|22|||
105991300|NCT05438576|365626953|FG001|Overall Study|Did not complete baseline testing|4|||
105991301|NCT02524158|365626954|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
105991302|NCT02524158|365626955|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
105991303|NCT02524158|365626954|FG000|12-weeks Assessment|Lost to Follow-up|18|||
105991304|NCT02524158|365626955|FG001|12-weeks Assessment|Lost to Follow-up|12|||
105991305|NCT02524158|365626954|FG000|6-month Assessment|Withdrawal by Subject|1|||
105991306|NCT02524158|365626955|FG001|6-month Assessment|Withdrawal by Subject|1|||
105991307|NCT02524158|365626954|FG000|6-month Assessment|Lost to Follow-up|21|||
105991308|NCT02524158|365626955|FG001|6-month Assessment|Lost to Follow-up|20|||
105991309|NCT00719355|365626961|FG000|Overall Study|Death|0|||
105991310|NCT00719355|365626962|FG001|Overall Study|Death|1|||
105991311|NCT00719355|365626961|FG000|Overall Study|Medical|14|||
105991312|NCT00719355|365626962|FG001|Overall Study|Medical|5|||
105991313|NCT00719355|365626961|FG000|Overall Study|Compliance|4|||
105991314|NCT00719355|365626962|FG001|Overall Study|Compliance|6|||
105991315|NCT00719355|365626961|FG000|Overall Study|Moved|0|||
105991316|NCT00719355|365626962|FG001|Overall Study|Moved|1|||
105991317|NCT03364738|365626963|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
105991318|NCT03364738|365626963|FG000|Overall Study|Withdrawal by Subject|1|||
105991319|NCT03364738|365626963|FG000|Overall Study|Adverse Event|1|||
105991320|NCT02669212|365626971|FG000|Overall Study|Lost to Follow-up|1|||
105991321|NCT02669212|365626972|FG001|Overall Study|Lost to Follow-up|0|||
105991322|NCT02669212|365626971|FG000|Overall Study|Medical Condition|3|||
105991323|NCT02669212|365626972|FG001|Overall Study|Medical Condition|4|||
105991324|NCT02669212|365626971|FG000|Overall Study|Withdrawal by Subject|0|||
105991325|NCT02669212|365626972|FG001|Overall Study|Withdrawal by Subject|2|||
105991326|NCT02669212|365626971|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
105991327|NCT02669212|365626972|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
105991328|NCT00391027|365626973|FG000|Overall Study|Adverse Event|8|||
105991329|NCT00391027|365626974|FG001|Overall Study|Adverse Event|8|||
105991330|NCT00391027|365626973|FG000|Overall Study|Lack of Efficacy|3|||
105991331|NCT00391027|365626974|FG001|Overall Study|Lack of Efficacy|0|||
105991332|NCT00391027|365626973|FG000|Overall Study|Withdrawal by Subject|10|||
105991333|NCT00391027|365626974|FG001|Overall Study|Withdrawal by Subject|1|||
105991334|NCT00391027|365626973|FG000|Overall Study|Other|4|||
105991335|NCT00391027|365626974|FG001|Overall Study|Other|3|||
105991336|NCT04124705|365626975|FG000|Titration Period|Adverse Event|9|||
105991337|NCT04124705|365626976|FG001|Titration Period|Adverse Event|5|||
105991338|NCT04124705|365626975|FG000|Titration Period|Withdrawal by Subject|6|||
105991339|NCT04124705|365626976|FG001|Titration Period|Withdrawal by Subject|3|||
105991340|NCT04124705|365626975|FG000|Titration Period|Lost to Follow-up|0|||
105991341|NCT04124705|365626976|FG001|Titration Period|Lost to Follow-up|1|||
105991342|NCT04124705|365626975|FG000|Titration Period|Death|1|||
105991343|NCT04124705|365626976|FG001|Titration Period|Death|1|||
105991344|NCT04124705|365626975|FG000|Titration Period|Lack of Efficacy|2|||
105991345|NCT04124705|365626976|FG001|Titration Period|Lack of Efficacy|0|||
105991346|NCT04124705|365626975|FG000|Titration Period|Physician Decision|2|||
105991347|NCT04124705|365626976|FG001|Titration Period|Physician Decision|0|||
105991348|NCT04124705|365626975|FG000|Titration Period|Non-compliance with Study Drug|2|||
105991349|NCT04124705|365626976|FG001|Titration Period|Non-compliance with Study Drug|0|||
105991350|NCT04124705|365626975|FG000|Titration Period|Other|4|||
105991351|NCT04124705|365626976|FG001|Titration Period|Other|9|||
105991352|NCT04124705|365626975|FG000|Stabilization Period|Adverse Event|4|||
105991353|NCT04124705|365626976|FG001|Stabilization Period|Adverse Event|2|||
105991354|NCT04124705|365626975|FG000|Stabilization Period|Withdrawal by Subject|1|||
105991355|NCT04124705|365626976|FG001|Stabilization Period|Withdrawal by Subject|1|||
105991356|NCT04124705|365626975|FG000|Stabilization Period|Lost to Follow-up|0|||
105991357|NCT04124705|365626976|FG001|Stabilization Period|Lost to Follow-up|1|||
105991358|NCT04124705|365626975|FG000|Stabilization Period|Lack of Efficacy|4|||
105991359|NCT04124705|365626976|FG001|Stabilization Period|Lack of Efficacy|2|||
105991360|NCT04124705|365626975|FG000|Stabilization Period|Protocol Deviation|0|||
105991361|NCT04124705|365626976|FG001|Stabilization Period|Protocol Deviation|2|||
105991362|NCT04124705|365626975|FG000|Stabilization Period|Other|2|||
105991363|NCT04124705|365626976|FG001|Stabilization Period|Other|2|||
105661740|NCT04147858|364425118|FG002|Overall Study|Withdrawal by Subject|10|||
105661741|NCT04147858|364425116|FG000|Overall Study|Subject Noncompliance, Other|4|||
105991364|NCT04164732|365626977|FG000|Treatment run-in Period|Adverse Event|4|||
106099787|NCT00626522|366022628|FG000|Overall Study|COPD exacerbation|0|||
105991365|NCT04164732|365626978|FG001|Treatment run-in Period|Adverse Event|0|||
105991366|NCT04164732|365626979|FG002|Treatment run-in Period|Adverse Event|0|||
105991367|NCT04164732|365626977|FG000|Treatment run-in Period|Physician Decision|1|||
105991368|NCT04164732|365626978|FG001|Treatment run-in Period|Physician Decision|0|||
105991369|NCT04164732|365626979|FG002|Treatment run-in Period|Physician Decision|0|||
105991370|NCT04164732|365626977|FG000|Treatment run-in Period|Screen Failure|1|||
105991371|NCT04164732|365626978|FG001|Treatment run-in Period|Screen Failure|0|||
105991372|NCT04164732|365626979|FG002|Treatment run-in Period|Screen Failure|0|||
105991373|NCT04164732|365626977|FG000|Randomized Treatment Period|Adverse Event|0|||
105991374|NCT04164732|365626978|FG001|Randomized Treatment Period|Adverse Event|1|||
105991375|NCT04164732|365626979|FG002|Randomized Treatment Period|Adverse Event|0|||
105991376|NCT04164732|365626977|FG000|Randomized Treatment Period|Protocol Deviation|0|||
105991377|NCT04164732|365626978|FG001|Randomized Treatment Period|Protocol Deviation|1|||
105991378|NCT04164732|365626979|FG002|Randomized Treatment Period|Protocol Deviation|1|||
105991379|NCT04164732|365626977|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
105991380|NCT04164732|365626978|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
105991381|NCT04164732|365626979|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
105991382|NCT01846741|365626980|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
105991383|NCT03664765|365626981|FG000|Overall Study|Withdrawal by Subject|4|||
105991384|NCT03664765|365626982|FG001|Overall Study|Withdrawal by Subject|1|||
105991385|NCT03664765|365626981|FG000|Overall Study|Lost to Follow-up|0|||
105991386|NCT03664765|365626982|FG001|Overall Study|Lost to Follow-up|1|||
105991387|NCT01153698|365626983|FG000|Overall Study|Adverse Event|12|||
105991388|NCT01153698|365626983|FG000|Overall Study|Lost to Follow-up|4|||
105991389|NCT01153698|365626983|FG000|Overall Study|Withdrawal by Subject|2|||
105991390|NCT01153698|365626983|FG000|Overall Study|Switch to other anticoagulants|4|||
105991391|NCT01153698|365626983|FG000|Overall Study|Other|2|||
105991392|NCT01153698|365626983|FG000|Overall Study|Not treated with Pradaxa|5|||
105991393|NCT04698993|365626984|FG000|Overall Study|PCR results not accessible|2|||
105991394|NCT04698993|365626985|FG001|Overall Study|PCR results not accessible|7|||
105991395|NCT04698993|365626984|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
105991396|NCT04698993|365626985|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
105991397|NCT00527904|365626986|FG000|Overall Study|Adverse Event|45|||
105991398|NCT00527904|365626986|FG000|Overall Study|Withdrawal by Subject|21|||
105991399|NCT00527904|365626986|FG000|Overall Study|Lost to Follow-up|8|||
105991400|NCT00527904|365626986|FG000|Overall Study|misc|22|||
105991401|NCT04006392|365626990|FG000|Overall Study|Lost to Follow-up|0|||
105991402|NCT04006392|365626991|FG001|Overall Study|Lost to Follow-up|1|||
105991403|NCT01832532|365626994|FG000|Overall Study|Withdrawal by Subject|5|||
105991404|NCT01832532|365626995|FG001|Overall Study|Withdrawal by Subject|2|||
105991405|NCT01534195|365626996|FG000|Overall Study|Withdrawal by Subject|1|||
105991406|NCT01534195|365626997|FG001|Overall Study|Withdrawal by Subject|1|||
105991407|NCT03302247|365626998|FG000|Overall Study|the study has closed prematurely|2|||
105991408|NCT03302247|365626998|FG000|Overall Study|Death|1|||
105991409|NCT03216746|365626999|FG000|Overall Study|Lost to Follow-up|6|||
105991410|NCT03216746|365627000|FG001|Overall Study|Lost to Follow-up|8|||
105991411|NCT03216746|365627001|FG002|Overall Study|Lost to Follow-up|5|||
105991412|NCT03216746|365627002|FG003|Overall Study|Lost to Follow-up|6|||
105991413|NCT04384523|365627003|FG000|Overall Study|Lost to Follow-up|0|||
105991414|NCT04384523|365627004|FG001|Overall Study|Lost to Follow-up|0|||
105991415|NCT04384523|365627005|FG002|Overall Study|Lost to Follow-up|0|||
105991416|NCT04384523|365627006|FG003|Overall Study|Lost to Follow-up|0|||
105991417|NCT04384523|365627007|FG004|Overall Study|Lost to Follow-up|0|||
105991418|NCT04384523|365627008|FG005|Overall Study|Lost to Follow-up|1|||
105991419|NCT04384523|365627003|FG000|Overall Study|Protocol Violation|0|||
105991420|NCT04384523|365627004|FG001|Overall Study|Protocol Violation|1|||
105991421|NCT04384523|365627005|FG002|Overall Study|Protocol Violation|0|||
105991422|NCT04384523|365627006|FG003|Overall Study|Protocol Violation|0|||
105991423|NCT04384523|365627007|FG004|Overall Study|Protocol Violation|0|||
105991424|NCT04384523|365627008|FG005|Overall Study|Protocol Violation|0|||
105991425|NCT04384523|365627003|FG000|Overall Study|Withdrawal by Subject|1|||
105991426|NCT04384523|365627004|FG001|Overall Study|Withdrawal by Subject|0|||
105991427|NCT04384523|365627005|FG002|Overall Study|Withdrawal by Subject|0|||
105991428|NCT04384523|365627006|FG003|Overall Study|Withdrawal by Subject|0|||
105991429|NCT04384523|365627007|FG004|Overall Study|Withdrawal by Subject|0|||
105991430|NCT04384523|365627008|FG005|Overall Study|Withdrawal by Subject|0|||
105991431|NCT02305238|365627009|FG000|Overall Study|Death|2|||
105991432|NCT02305238|365627010|FG001|Overall Study|Death|1|||
105991433|NCT02305238|365627011|FG002|Overall Study|Death|0|||
105991434|NCT02305238|365627009|FG000|Overall Study|Progressive disease|4|||
105991435|NCT02305238|365627010|FG001|Overall Study|Progressive disease|4|||
105991436|NCT02305238|365627011|FG002|Overall Study|Progressive disease|0|||
105991437|NCT02305238|365627009|FG000|Overall Study|Logistical difficulties|1|||
105991438|NCT02305238|365627010|FG001|Overall Study|Logistical difficulties|3|||
105991439|NCT02305238|365627011|FG002|Overall Study|Logistical difficulties|0|||
105991440|NCT02305238|365627009|FG000|Overall Study|Protocol Violation|0|||
105991441|NCT02305238|365627010|FG001|Overall Study|Protocol Violation|3|||
105991442|NCT02305238|365627011|FG002|Overall Study|Protocol Violation|0|||
105991443|NCT02305238|365627009|FG000|Overall Study|Physician Decision|2|||
105991444|NCT02305238|365627010|FG001|Overall Study|Physician Decision|1|||
105991445|NCT02305238|365627011|FG002|Overall Study|Physician Decision|0|||
105991446|NCT02305238|365627009|FG000|Overall Study|Adverse Event|4|||
105991447|NCT02305238|365627010|FG001|Overall Study|Adverse Event|2|||
105991448|NCT02305238|365627011|FG002|Overall Study|Adverse Event|0|||
105991449|NCT02305238|365627009|FG000|Overall Study|Withdrawal by Subject|3|||
105991450|NCT02305238|365627010|FG001|Overall Study|Withdrawal by Subject|4|||
105991451|NCT02305238|365627011|FG002|Overall Study|Withdrawal by Subject|0|||
105991452|NCT02305238|365627009|FG000|Overall Study|Randomized failure|0|||
105991453|NCT02305238|365627010|FG001|Overall Study|Randomized failure|0|||
105991454|NCT02305238|365627011|FG002|Overall Study|Randomized failure|8|||
105991455|NCT02305238|365627009|FG000|Overall Study|Required procedure failed|0|||
105991456|NCT02305238|365627010|FG001|Overall Study|Required procedure failed|1|||
105991457|NCT02305238|365627011|FG002|Overall Study|Required procedure failed|0|||
105991458|NCT01380834|365627012|FG000|Overall Study|Physician Decision|1|||
105991459|NCT01380834|365627013|FG001|Overall Study|Physician Decision|0|||
105991460|NCT04565951|365627018|FG000|Overall Study|Lost to Follow-up|66|||
105991461|NCT04565951|365627019|FG001|Overall Study|Lost to Follow-up|38|||
105991462|NCT04565951|365627018|FG000|Overall Study|Withdrawal by Subject|14|||
105991463|NCT04565951|365627019|FG001|Overall Study|Withdrawal by Subject|7|||
105991464|NCT04565951|365627018|FG000|Overall Study|Death|0|||
105991465|NCT04565951|365627019|FG001|Overall Study|Death|1|||
105991466|NCT03182907|365627020|FG000|Overall Study|Death|3|||
105991467|NCT03182907|365627021|FG001|Overall Study|Death|0|||
105991468|NCT03182907|365627020|FG000|Overall Study|Protocol Violation|4|||
105991469|NCT03182907|365627021|FG001|Overall Study|Protocol Violation|0|||
105991470|NCT03182907|365627020|FG000|Overall Study|Lost to Follow-up|1|||
105991471|NCT03182907|365627021|FG001|Overall Study|Lost to Follow-up|0|||
105991472|NCT03182907|365627020|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105991473|NCT03182907|365627021|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105991474|NCT00172042|365627026|FG000|Overall Study|Adverse Event|27|||
105991475|NCT00172042|365627027|FG001|Overall Study|Adverse Event|13|||
105991476|NCT00172042|365627026|FG000|Overall Study|Abnormal laboratory value(s)|5|||
105991477|NCT00172042|365627027|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105991478|NCT00172042|365627026|FG000|Overall Study|Abnormal test procedure(s)|0|||
105991479|NCT00172042|365627027|FG001|Overall Study|Abnormal test procedure(s)|3|||
105991480|NCT00172042|365627026|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
105991481|NCT00172042|365627027|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
105991482|NCT00172042|365627026|FG000|Overall Study|Patient no longer requires study drug|10|||
105991483|NCT00172042|365627027|FG001|Overall Study|Patient no longer requires study drug|8|||
105991484|NCT00172042|365627026|FG000|Overall Study|Protocol Violation|8|||
105991485|NCT00172042|365627027|FG001|Overall Study|Protocol Violation|7|||
105991486|NCT00172042|365627026|FG000|Overall Study|Withdrawal by Subject|37|||
105991487|NCT00172042|365627027|FG001|Overall Study|Withdrawal by Subject|25|||
105991488|NCT00172042|365627026|FG000|Overall Study|Lost to Follow-up|3|||
105991489|NCT00172042|365627027|FG001|Overall Study|Lost to Follow-up|5|||
105991490|NCT00172042|365627026|FG000|Overall Study|Administrative problems|13|||
105991491|NCT00172042|365627027|FG001|Overall Study|Administrative problems|10|||
105991492|NCT00172042|365627026|FG000|Overall Study|Death|42|||
105991493|NCT00172042|365627027|FG001|Overall Study|Death|42|||
105991494|NCT01368081|365627028|FG000|Overall Study|Adverse Event|4|||
105991495|NCT01368081|365627029|FG001|Overall Study|Adverse Event|4|||
105991496|NCT01368081|365627030|FG002|Overall Study|Adverse Event|3|||
105991497|NCT01368081|365627031|FG003|Overall Study|Adverse Event|2|||
105991498|NCT01368081|365627032|FG004|Overall Study|Adverse Event|2|||
105991499|NCT01368081|365627033|FG005|Overall Study|Adverse Event|5|||
105991500|NCT01368081|365627034|FG006|Overall Study|Adverse Event|6|||
105991501|NCT01368081|365627035|FG007|Overall Study|Adverse Event|2|||
105991502|NCT01368081|365627036|FG008|Overall Study|Adverse Event|3|||
105991503|NCT01368081|365627037|FG009|Overall Study|Adverse Event|5|||
105991504|NCT01368081|365627038|FG010|Overall Study|Adverse Event|6|||
105991505|NCT01368081|365627039|FG011|Overall Study|Adverse Event|1|||
105991506|NCT01368081|365627040|FG012|Overall Study|Adverse Event|3|||
105991507|NCT01368081|365627028|FG000|Overall Study|Lack of Efficacy|0|||
105991508|NCT01368081|365627029|FG001|Overall Study|Lack of Efficacy|1|||
105991509|NCT01368081|365627030|FG002|Overall Study|Lack of Efficacy|0|||
105991510|NCT01368081|365627031|FG003|Overall Study|Lack of Efficacy|1|||
105991511|NCT01368081|365627032|FG004|Overall Study|Lack of Efficacy|0|||
105991512|NCT01368081|365627033|FG005|Overall Study|Lack of Efficacy|0|||
105991513|NCT01368081|365627034|FG006|Overall Study|Lack of Efficacy|0|||
105991514|NCT01368081|365627035|FG007|Overall Study|Lack of Efficacy|2|||
105991515|NCT01368081|365627036|FG008|Overall Study|Lack of Efficacy|0|||
105991516|NCT01368081|365627037|FG009|Overall Study|Lack of Efficacy|0|||
105991517|NCT01368081|365627038|FG010|Overall Study|Lack of Efficacy|0|||
105991518|NCT01368081|365627039|FG011|Overall Study|Lack of Efficacy|0|||
105991519|NCT01368081|365627040|FG012|Overall Study|Lack of Efficacy|0|||
105991520|NCT01368081|365627028|FG000|Overall Study|Protocol Violation|0|||
106099788|NCT00626522|366022629|FG001|Overall Study|COPD exacerbation|0|||
105991521|NCT01368081|365627029|FG001|Overall Study|Protocol Violation|0|||
105991522|NCT01368081|365627030|FG002|Overall Study|Protocol Violation|0|||
105991523|NCT01368081|365627031|FG003|Overall Study|Protocol Violation|0|||
105991524|NCT01368081|365627032|FG004|Overall Study|Protocol Violation|0|||
105991525|NCT01368081|365627033|FG005|Overall Study|Protocol Violation|1|||
105991526|NCT01368081|365627034|FG006|Overall Study|Protocol Violation|0|||
105991527|NCT01368081|365627035|FG007|Overall Study|Protocol Violation|1|||
105991528|NCT01368081|365627036|FG008|Overall Study|Protocol Violation|0|||
105991529|NCT01368081|365627037|FG009|Overall Study|Protocol Violation|0|||
105991530|NCT01368081|365627038|FG010|Overall Study|Protocol Violation|0|||
105991531|NCT01368081|365627039|FG011|Overall Study|Protocol Violation|0|||
105991532|NCT01368081|365627040|FG012|Overall Study|Protocol Violation|0|||
105991533|NCT01368081|365627028|FG000|Overall Study|Lost to Follow-up|0|||
105991534|NCT01368081|365627029|FG001|Overall Study|Lost to Follow-up|0|||
105991535|NCT01368081|365627030|FG002|Overall Study|Lost to Follow-up|0|||
105991536|NCT01368081|365627031|FG003|Overall Study|Lost to Follow-up|0|||
105991537|NCT01368081|365627032|FG004|Overall Study|Lost to Follow-up|0|||
105991538|NCT01368081|365627033|FG005|Overall Study|Lost to Follow-up|0|||
105991539|NCT01368081|365627034|FG006|Overall Study|Lost to Follow-up|0|||
105991540|NCT01368081|365627035|FG007|Overall Study|Lost to Follow-up|0|||
105991541|NCT01368081|365627036|FG008|Overall Study|Lost to Follow-up|0|||
105991542|NCT01368081|365627037|FG009|Overall Study|Lost to Follow-up|0|||
105991543|NCT01368081|365627038|FG010|Overall Study|Lost to Follow-up|0|||
105991544|NCT01368081|365627039|FG011|Overall Study|Lost to Follow-up|0|||
105991545|NCT01368081|365627040|FG012|Overall Study|Lost to Follow-up|1|||
105991546|NCT01368081|365627028|FG000|Overall Study|Withdrawal by Subject|4|||
105991547|NCT01368081|365627029|FG001|Overall Study|Withdrawal by Subject|4|||
105991548|NCT01368081|365627030|FG002|Overall Study|Withdrawal by Subject|1|||
105991549|NCT01368081|365627031|FG003|Overall Study|Withdrawal by Subject|1|||
105991550|NCT01368081|365627032|FG004|Overall Study|Withdrawal by Subject|0|||
105991551|NCT01368081|365627033|FG005|Overall Study|Withdrawal by Subject|3|||
105991552|NCT01368081|365627034|FG006|Overall Study|Withdrawal by Subject|4|||
105991553|NCT01368081|365627035|FG007|Overall Study|Withdrawal by Subject|2|||
105991554|NCT01368081|365627036|FG008|Overall Study|Withdrawal by Subject|5|||
105991555|NCT01368081|365627037|FG009|Overall Study|Withdrawal by Subject|4|||
105991556|NCT01368081|365627038|FG010|Overall Study|Withdrawal by Subject|3|||
105991557|NCT01368081|365627039|FG011|Overall Study|Withdrawal by Subject|2|||
105991558|NCT01368081|365627040|FG012|Overall Study|Withdrawal by Subject|0|||
105991559|NCT01368081|365627028|FG000|Overall Study|Other reason not defined above|2|||
105991560|NCT01368081|365627029|FG001|Overall Study|Other reason not defined above|0|||
105991561|NCT01368081|365627030|FG002|Overall Study|Other reason not defined above|0|||
105991562|NCT01368081|365627031|FG003|Overall Study|Other reason not defined above|1|||
105991563|NCT01368081|365627032|FG004|Overall Study|Other reason not defined above|0|||
105991564|NCT01368081|365627033|FG005|Overall Study|Other reason not defined above|1|||
105991565|NCT01368081|365627034|FG006|Overall Study|Other reason not defined above|2|||
105991566|NCT01368081|365627035|FG007|Overall Study|Other reason not defined above|0|||
105991567|NCT01368081|365627036|FG008|Overall Study|Other reason not defined above|0|||
105991568|NCT01368081|365627037|FG009|Overall Study|Other reason not defined above|1|||
105991569|NCT01368081|365627038|FG010|Overall Study|Other reason not defined above|0|||
105991570|NCT01368081|365627039|FG011|Overall Study|Other reason not defined above|0|||
105991571|NCT01368081|365627040|FG012|Overall Study|Other reason not defined above|3|||
105991572|NCT00782483|365627041|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
105991573|NCT02123576|365627042|FG000|Overall Study|Adverse Event|1|||
105991574|NCT02123576|365627043|FG001|Overall Study|Adverse Event|0|||
105991575|NCT02475278|365629615|FG000|Overall Study|Lost to Follow-up|1|||
105991576|NCT02475278|365629615|FG000|Overall Study|Reason Not Specified|1|||
105991577|NCT00826618|365629618|FG000|Overall Study|Withdrawal by Subject|1|||
105991578|NCT01487265|365629619|FG000|Overall Study|Adverse Event|8|||
105991579|NCT01487265|365629619|FG000|Overall Study|Withdrawal by Subject|5|||
105991580|NCT01487265|365629619|FG000|Overall Study|Disease Progression|21|||
105991581|NCT01487265|365629619|FG000|Overall Study|Death|2|||
105991582|NCT01487265|365629619|FG000|Overall Study|Still on Treatment|1|||
105991583|NCT05111249|365629620|FG000|Overall Study|Lost to Follow-up|0|||
105991584|NCT05111249|365629621|FG001|Overall Study|Lost to Follow-up|2|||
105991585|NCT05111249|365629620|FG000|Overall Study|Physician Decision|0|||
105991586|NCT05111249|365629621|FG001|Overall Study|Physician Decision|1|||
105991587|NCT05111249|365629620|FG000|Overall Study|Participant decision|1|||
105991588|NCT05111249|365629621|FG001|Overall Study|Participant decision|5|||
105991589|NCT05128578|365629622|FG000|Overall Study|Withdrawal by Subject|9|||
105991590|NCT05128578|365629622|FG000|Overall Study|Lost to Follow-up|5|||
105991591|NCT03412812|365629623|FG000|Level 1|Death|3|||
105991592|NCT03412812|365629624|FG001|Level 1|Death|0|||
105991593|NCT03412812|365629623|FG000|Level 1|Adverse Event|0|||
105991594|NCT03412812|365629624|FG001|Level 1|Adverse Event|1|||
106099789|NCT00626522|366022630|FG002|Overall Study|COPD exacerbation|0|||
106099790|NCT00626522|366022631|FG003|Overall Study|COPD exacerbation|1|||
105991595|NCT00871338|365629631|FG000|Prior to Booster|Withdrawal by Subject|1|||
105991596|NCT00871338|365629632|FG001|Prior to Booster|Withdrawal by Subject|3|||
105991597|NCT00871338|365629631|FG000|Prior to Booster|Lost to Follow-up|1|||
105991598|NCT00871338|365629632|FG001|Prior to Booster|Lost to Follow-up|0|||
105991599|NCT02391363|365629633|FG000|Overall Study|Lost to Follow-up|5|||
105991600|NCT02391363|365629634|FG001|Overall Study|Lost to Follow-up|5|||
105991601|NCT02391363|365629633|FG000|Overall Study|Withdrawal by Subject|6|||
105991602|NCT02391363|365629634|FG001|Overall Study|Withdrawal by Subject|3|||
105991603|NCT03828617|365629635|FG000|Overall Study|Lost to Follow-up|22|||
105991604|NCT03828617|365629636|FG001|Overall Study|Lost to Follow-up|12|||
105991605|NCT03828617|365629637|FG002|Overall Study|Lost to Follow-up|23|||
105991606|NCT03828617|365629638|FG003|Overall Study|Lost to Follow-up|7|||
105991607|NCT03828617|365629635|FG000|Overall Study|No longer met eligibility criteria|0|||
105991608|NCT03828617|365629636|FG001|Overall Study|No longer met eligibility criteria|1|||
105991609|NCT03828617|365629637|FG002|Overall Study|No longer met eligibility criteria|1|||
105991610|NCT03828617|365629638|FG003|Overall Study|No longer met eligibility criteria|3|||
105991611|NCT03828617|365629635|FG000|Overall Study|Protocol Violation|0|||
105991612|NCT03828617|365629636|FG001|Overall Study|Protocol Violation|2|||
105991613|NCT03828617|365629637|FG002|Overall Study|Protocol Violation|0|||
106099791|NCT00626522|366022632|FG004|Overall Study|COPD exacerbation|1|||
106099792|NCT00626522|366022633|FG005|Overall Study|COPD exacerbation|0|||
106099793|NCT00626522|366022628|FG000|Overall Study|Lost to Follow-up|0|||
106099794|NCT00626522|366022629|FG001|Overall Study|Lost to Follow-up|1|||
106099795|NCT00626522|366022630|FG002|Overall Study|Lost to Follow-up|0|||
106099796|NCT00626522|366022631|FG003|Overall Study|Lost to Follow-up|0|||
106099797|NCT00626522|366022632|FG004|Overall Study|Lost to Follow-up|0|||
106099798|NCT00626522|366022633|FG005|Overall Study|Lost to Follow-up|0|||
106099799|NCT00626522|366022628|FG000|Overall Study|Inconsistent reason reported|1|||
106099800|NCT00626522|366022629|FG001|Overall Study|Inconsistent reason reported|0|||
106099801|NCT00626522|366022630|FG002|Overall Study|Inconsistent reason reported|0|||
106099802|NCT00626522|366022631|FG003|Overall Study|Inconsistent reason reported|0|||
106099803|NCT00626522|366022632|FG004|Overall Study|Inconsistent reason reported|0|||
106099804|NCT00626522|366022633|FG005|Overall Study|Inconsistent reason reported|0|||
106099805|NCT00626522|366022628|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
106099806|NCT00626522|366022629|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
106099807|NCT00626522|366022630|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
106099808|NCT00626522|366022631|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
106099809|NCT00626522|366022632|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
106099810|NCT00626522|366022633|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
106099811|NCT02280044|366022634|FG000|Overall Study|Planned alternate|0|||
106099812|NCT02280044|366022635|FG001|Overall Study|Planned alternate|2|||
106099813|NCT00263666|366022637|FG000|Overall Study|Adverse Event|6|||
106099814|NCT00263666|366022638|FG001|Overall Study|Adverse Event|8|||
106099815|NCT00263666|366022637|FG000|Overall Study|Lost to Follow-up|1|||
106099816|NCT00263666|366022638|FG001|Overall Study|Lost to Follow-up|2|||
106099817|NCT00263666|366022637|FG000|Overall Study|Withdrawal by Subject|0|||
106099818|NCT00263666|366022638|FG001|Overall Study|Withdrawal by Subject|1|||
106099819|NCT02489500|366022641|FG000|Overall Study|Death|1|||
106099820|NCT02489500|366022642|FG001|Overall Study|Death|1|||
106099821|NCT00686166|366022643|FG000|Overall Study|Adverse Event|7|||
106099822|NCT00686166|366022643|FG000|Overall Study|Withdrawal by Subject|1|||
106099823|NCT00686166|366022643|FG000|Overall Study|Progression/Relapse|1|||
106099824|NCT00686166|366022643|FG000|Overall Study|Death|1|||
106099825|NCT00686166|366022643|FG000|Overall Study|Not Protocol Specified|1|||
106099826|NCT00686166|366022643|FG000|Overall Study|Ineligible|5|||
106099827|NCT00686166|366022643|FG000|Overall Study|Did not begin protocol therapy|4|||
106099828|NCT01990950|366022645|FG000|Overall Study|Death|3|||
106099829|NCT01990950|366022645|FG000|Overall Study|Lost to Follow-up|2|||
106099830|NCT01990950|366022645|FG000|Overall Study|Withdrawal by Subject|6|||
106099831|NCT02349295|366022646|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
106099832|NCT02349295|366022647|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
105991614|NCT03828617|365629638|FG003|Overall Study|Protocol Violation|0|||
105991615|NCT03828617|365629635|FG000|Overall Study|Withdrawal by Subject|2|||
105991616|NCT03828617|365629636|FG001|Overall Study|Withdrawal by Subject|0|||
105991617|NCT03828617|365629637|FG002|Overall Study|Withdrawal by Subject|2|||
105991618|NCT03828617|365629638|FG003|Overall Study|Withdrawal by Subject|0|||
105991619|NCT01016600|365629639|FG000|Overall Study|Did not start treatment|1|||
105991620|NCT01016600|365629640|FG001|Overall Study|Did not start treatment|0|||
105991621|NCT01016600|365629641|FG002|Overall Study|Did not start treatment|0|||
105991622|NCT01016600|365629642|FG003|Overall Study|Did not start treatment|0|||
105991623|NCT00265317|365629645|FG000|Lead-In|Objective progression or relapse|6|||
106099833|NCT02349295|366022648|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
106099834|NCT02349295|366022649|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099835|NCT02349295|366022650|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099836|NCT02349295|366022651|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099837|NCT02349295|366022652|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099838|NCT02349295|366022653|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099839|NCT02349295|366022654|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105991624|NCT00265317|365629646|FG001|Lead-In|Objective progression or relapse|11|||
105991625|NCT00265317|365629647|FG002|Lead-In|Objective progression or relapse|0|||
105991626|NCT00265317|365629648|FG003|Lead-In|Objective progression or relapse|0|||
105991627|NCT00265317|365629645|FG000|Lead-In|Adverse Event|2|||
105991628|NCT00265317|365629646|FG001|Lead-In|Adverse Event|1|||
105991629|NCT00265317|365629647|FG002|Lead-In|Adverse Event|0|||
105991630|NCT00265317|365629648|FG003|Lead-In|Adverse Event|0|||
105991631|NCT00265317|365629645|FG000|Lead-In|Death|3|||
105991632|NCT00265317|365629646|FG001|Lead-In|Death|5|||
105991633|NCT00265317|365629647|FG002|Lead-In|Death|0|||
105991634|NCT00265317|365629648|FG003|Lead-In|Death|0|||
105991635|NCT00265317|365629645|FG000|Lead-In|Withdrawal/other than adverse event|1|||
105991636|NCT00265317|365629646|FG001|Lead-In|Withdrawal/other than adverse event|0|||
105991637|NCT00265317|365629647|FG002|Lead-In|Withdrawal/other than adverse event|0|||
105991638|NCT00265317|365629648|FG003|Lead-In|Withdrawal/other than adverse event|0|||
105991639|NCT00265317|365629645|FG000|Phase 2|Objective progression or relapse|0|||
105991640|NCT00265317|365629646|FG001|Phase 2|Objective progression or relapse|0|||
105991641|NCT00265317|365629647|FG002|Phase 2|Objective progression or relapse|37|||
105991642|NCT00265317|365629648|FG003|Phase 2|Objective progression or relapse|38|||
105991643|NCT00265317|365629645|FG000|Phase 2|Global deterioration of health status|0|||
105991644|NCT00265317|365629646|FG001|Phase 2|Global deterioration of health status|0|||
105991645|NCT00265317|365629647|FG002|Phase 2|Global deterioration of health status|3|||
105991646|NCT00265317|365629648|FG003|Phase 2|Global deterioration of health status|0|||
105991647|NCT00265317|365629645|FG000|Phase 2|Adverse Event|0|||
105991648|NCT00265317|365629646|FG001|Phase 2|Adverse Event|0|||
105991649|NCT00265317|365629647|FG002|Phase 2|Adverse Event|7|||
105991650|NCT00265317|365629648|FG003|Phase 2|Adverse Event|5|||
105991651|NCT00265317|365629645|FG000|Phase 2|Death|0|||
105991652|NCT00265317|365629646|FG001|Phase 2|Death|0|||
105991653|NCT00265317|365629647|FG002|Phase 2|Death|12|||
105991654|NCT00265317|365629648|FG003|Phase 2|Death|15|||
105991655|NCT00265317|365629645|FG000|Phase 2|Protocol Violation|0|||
105991656|NCT00265317|365629646|FG001|Phase 2|Protocol Violation|0|||
105991657|NCT00265317|365629647|FG002|Phase 2|Protocol Violation|1|||
105991658|NCT00265317|365629648|FG003|Phase 2|Protocol Violation|4|||
105991659|NCT00265317|365629645|FG000|Phase 2|Lost to Follow-up|0|||
105991660|NCT00265317|365629646|FG001|Phase 2|Lost to Follow-up|0|||
105991661|NCT00265317|365629647|FG002|Phase 2|Lost to Follow-up|0|||
105991662|NCT00265317|365629648|FG003|Phase 2|Lost to Follow-up|1|||
105991663|NCT00265317|365629645|FG000|Phase 2|Withdrawal/other than adverse event|0|||
105991664|NCT00265317|365629646|FG001|Phase 2|Withdrawal/other than adverse event|0|||
105991665|NCT00265317|365629647|FG002|Phase 2|Withdrawal/other than adverse event|2|||
105991666|NCT00265317|365629648|FG003|Phase 2|Withdrawal/other than adverse event|1|||
105991667|NCT00265317|365629645|FG000|Phase 2|Study terminated by sponsor|0|||
105991668|NCT00265317|365629646|FG001|Phase 2|Study terminated by sponsor|0|||
105991669|NCT00265317|365629647|FG002|Phase 2|Study terminated by sponsor|1|||
105991670|NCT00265317|365629648|FG003|Phase 2|Study terminated by sponsor|0|||
105991671|NCT00265317|365629645|FG000|Phase 2|Other|0|||
105991672|NCT00265317|365629646|FG001|Phase 2|Other|0|||
105991673|NCT00265317|365629647|FG002|Phase 2|Other|1|||
105991674|NCT00265317|365629648|FG003|Phase 2|Other|1|||
105991675|NCT03826186|365629651|FG000|Overall Study|Protocol Violation|2|||
105991676|NCT03826186|365629652|FG001|Overall Study|Protocol Violation|0|||
105991677|NCT03826186|365629651|FG000|Overall Study|Withdrawal by Subject|1|||
105991678|NCT03826186|365629652|FG001|Overall Study|Withdrawal by Subject|0|||
105991679|NCT01424501|365629653|FG000|Overall Study|Withdrawal by Subject|1|||
105991680|NCT01424501|365629654|FG001|Overall Study|Withdrawal by Subject|0|||
105991681|NCT01424501|365629655|FG002|Overall Study|Withdrawal by Subject|1|||
105991682|NCT01424501|365629656|FG003|Overall Study|Withdrawal by Subject|0|||
105991683|NCT01424501|365629657|FG004|Overall Study|Withdrawal by Subject|0|||
105991684|NCT01424501|365629658|FG005|Overall Study|Withdrawal by Subject|0|||
105991685|NCT01424501|365629653|FG000|Overall Study|Lost to Follow-up|0|||
105991686|NCT01424501|365629654|FG001|Overall Study|Lost to Follow-up|1|||
105991687|NCT01424501|365629655|FG002|Overall Study|Lost to Follow-up|1|||
105991688|NCT01424501|365629656|FG003|Overall Study|Lost to Follow-up|0|||
105991689|NCT01424501|365629657|FG004|Overall Study|Lost to Follow-up|0|||
105991690|NCT01424501|365629658|FG005|Overall Study|Lost to Follow-up|0|||
105991691|NCT03688074|365629660|FG000|Overall Study|Adverse Event|0|||
105991692|NCT03688074|365629661|FG001|Overall Study|Adverse Event|1|||
105991693|NCT03688074|365629660|FG000|Overall Study|Other|1|||
105991694|NCT03688074|365629661|FG001|Overall Study|Other|0|||
105991695|NCT00660179|365629668|FG000|Overall Study|Death|44|||
105991696|NCT00660179|365629669|FG001|Overall Study|Death|47|||
105991697|NCT00660179|365629670|FG002|Overall Study|Death|34|||
105991698|NCT00660179|365629668|FG000|Overall Study|Withdrawal of consent|4|||
105991699|NCT00660179|365629669|FG001|Overall Study|Withdrawal of consent|6|||
105991700|NCT00660179|365629670|FG002|Overall Study|Withdrawal of consent|4|||
105991701|NCT00660179|365629668|FG000|Overall Study|Lost to Follow-up|7|||
105991702|NCT00660179|365629669|FG001|Overall Study|Lost to Follow-up|5|||
105991703|NCT00660179|365629670|FG002|Overall Study|Lost to Follow-up|2|||
105991704|NCT00660179|365629668|FG000|Overall Study|Administrative reason|0|||
105991705|NCT00660179|365629669|FG001|Overall Study|Administrative reason|0|||
105991706|NCT00660179|365629670|FG002|Overall Study|Administrative reason|1|||
105991707|NCT00660179|365629668|FG000|Overall Study|Incorrect randomization|1|||
105991708|NCT00660179|365629669|FG001|Overall Study|Incorrect randomization|0|||
105991709|NCT00660179|365629670|FG002|Overall Study|Incorrect randomization|0|||
105991710|NCT02255461|365629671|FG000|Overall Study|Adverse Event|0|||
105991711|NCT02255461|365629672|FG001|Overall Study|Adverse Event|1|||
105991712|NCT02255461|365629673|FG002|Overall Study|Adverse Event|0|||
105991713|NCT02255461|365629674|FG003|Overall Study|Adverse Event|0|||
105991714|NCT02255461|365629675|FG004|Overall Study|Adverse Event|1|||
105991715|NCT02255461|365629671|FG000|Overall Study|Withdrawal by Subject|0|||
105991716|NCT02255461|365629672|FG001|Overall Study|Withdrawal by Subject|0|||
105991717|NCT02255461|365629673|FG002|Overall Study|Withdrawal by Subject|1|||
105991718|NCT02255461|365629674|FG003|Overall Study|Withdrawal by Subject|0|||
105991719|NCT02255461|365629675|FG004|Overall Study|Withdrawal by Subject|1|||
105991720|NCT02255461|365629671|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
105991721|NCT02255461|365629672|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
105991722|NCT02255461|365629673|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
105991723|NCT02255461|365629674|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
105991724|NCT02255461|365629675|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
105991725|NCT04838626|365629678|FG000|Overall Study|Adverse Event|2|||
105991726|NCT04838626|365629678|FG000|Overall Study|Physician Decision|6|||
105991727|NCT04838626|365629678|FG000|Overall Study|Protocol Violation|3|||
105991728|NCT04838626|365629678|FG000|Overall Study|Withdrawal by Subject|9|||
105991729|NCT04838626|365629678|FG000|Overall Study|Technical Problems|2|||
105991730|NCT01726582|365629679|FG000|Overall Study|Physician Decision|99|||
105991731|NCT01726582|365629679|FG000|Overall Study|Death|85|||
105991732|NCT02034877|365629680|FG000|Overall Study|Lost to Follow-up|0|||
105991733|NCT02034877|365629681|FG001|Overall Study|Lost to Follow-up|3|||
105991734|NCT02034877|365629680|FG000|Overall Study|No Longer Willing to Participate|0|||
105991735|NCT02034877|365629681|FG001|Overall Study|No Longer Willing to Participate|3|||
105991736|NCT04878211|365629683|FG000|Overall Study|Lost to Follow-up|0|||
105991737|NCT04878211|365629684|FG001|Overall Study|Lost to Follow-up|0|||
105991738|NCT04878211|365629685|FG002|Overall Study|Lost to Follow-up|0|||
105991739|NCT04878211|365629686|FG003|Overall Study|Lost to Follow-up|1|||
105991740|NCT04878211|365629687|FG004|Overall Study|Lost to Follow-up|0|||
105991741|NCT04878211|365629688|FG005|Overall Study|Lost to Follow-up|1|||
105991742|NCT04878211|365629683|FG000|Overall Study|Protocol deviation|1|||
105991743|NCT04878211|365629684|FG001|Overall Study|Protocol deviation|0|||
105991744|NCT04878211|365629685|FG002|Overall Study|Protocol deviation|0|||
105991745|NCT04878211|365629686|FG003|Overall Study|Protocol deviation|0|||
105991746|NCT04878211|365629687|FG004|Overall Study|Protocol deviation|0|||
105991747|NCT04878211|365629688|FG005|Overall Study|Protocol deviation|0|||
105991748|NCT04878211|365629683|FG000|Overall Study|Study terminated by sponsor|0|||
105991749|NCT04878211|365629684|FG001|Overall Study|Study terminated by sponsor|0|||
105991750|NCT04878211|365629685|FG002|Overall Study|Study terminated by sponsor|0|||
105991751|NCT04878211|365629686|FG003|Overall Study|Study terminated by sponsor|0|||
105991752|NCT04878211|365629687|FG004|Overall Study|Study terminated by sponsor|9|||
105991753|NCT04878211|365629688|FG005|Overall Study|Study terminated by sponsor|4|||
105991754|NCT04878211|365629683|FG000|Overall Study|Subject decision|0|||
105991755|NCT04878211|365629684|FG001|Overall Study|Subject decision|0|||
105991756|NCT04878211|365629685|FG002|Overall Study|Subject decision|0|||
105991757|NCT04878211|365629686|FG003|Overall Study|Subject decision|0|||
105991758|NCT04878211|365629687|FG004|Overall Study|Subject decision|1|||
105991759|NCT04878211|365629688|FG005|Overall Study|Subject decision|0|||
105991760|NCT01564732|365629695|FG000|Overall Study|Early termination by the study sponsor|6|||
105991761|NCT01564732|365629696|FG001|Overall Study|Early termination by the study sponsor|5|||
105991762|NCT01957202|365629697|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991763|NCT01957202|365629698|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
105991764|NCT01957202|365629699|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991765|NCT01957202|365629700|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991766|NCT01957202|365629701|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991767|NCT01957202|365629702|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991768|NCT01957202|365629703|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991769|NCT01957202|365629704|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991770|NCT01957202|365629705|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991771|NCT01957202|365629706|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991772|NCT01957202|365629707|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991773|NCT01957202|365629708|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991774|NCT01957202|365629709|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991775|NCT01957202|365629710|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991776|NCT01957202|365629711|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991777|NCT01957202|365629712|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991778|NCT01957202|365629713|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
105991779|NCT01957202|365629714|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
105991780|NCT01957202|365629697|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991781|NCT01957202|365629698|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991782|NCT01957202|365629699|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991783|NCT01957202|365629700|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991784|NCT01957202|365629701|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991785|NCT01957202|365629702|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991786|NCT01957202|365629703|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991787|NCT01957202|365629704|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991788|NCT01957202|365629705|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991789|NCT01957202|365629706|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991790|NCT01957202|365629707|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991791|NCT01957202|365629708|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991792|NCT01957202|365629709|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991793|NCT01957202|365629710|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991794|NCT01957202|365629711|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991795|NCT01957202|365629712|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991796|NCT01957202|365629713|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
105991797|NCT01957202|365629714|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
105991798|NCT00413036|365629717|FG000|Overall Study|Adverse Event|44|||
105991799|NCT00413036|365629717|FG000|Overall Study|Lack of Efficacy|129|||
105991800|NCT00413036|365629717|FG000|Overall Study|Withdrawal by Subject|7|||
105991801|NCT00413036|365629717|FG000|Overall Study|Death|9|||
105991802|NCT00413036|365629717|FG000|Overall Study|Other|26|||
105991803|NCT00413036|365629717|FG000|Overall Study|Missing|2|||
105991804|NCT02652156|365629720|FG000|Overall Study|Physician Decision|1|||
105991805|NCT02652156|365629721|FG001|Overall Study|Physician Decision|0|||
105991806|NCT02652156|365629722|FG002|Overall Study|Physician Decision|0|||
105991807|NCT03040674|365629723|FG000|Overall Study|Lost to Follow-up|225|||
105991808|NCT03040674|365629723|FG000|Overall Study|Death|23|||
105991809|NCT05173012|365629724|FG000|Overall Study|Adverse Event|2|||
105991810|NCT05173012|365629725|FG001|Overall Study|Adverse Event|3|||
105991811|NCT05173012|365629726|FG002|Overall Study|Adverse Event|4|||
105991812|NCT05173012|365629727|FG003|Overall Study|Adverse Event|13|||
105991813|NCT05173012|365629728|FG004|Overall Study|Adverse Event|0|||
105991814|NCT05173012|365629729|FG005|Overall Study|Adverse Event|0|||
105991815|NCT05173012|365629730|FG006|Overall Study|Adverse Event|2|||
105991816|NCT05173012|365629731|FG007|Overall Study|Adverse Event|4|||
105991817|NCT05173012|365629724|FG000|Overall Study|Lost to Follow-up|0|||
105991818|NCT05173012|365629725|FG001|Overall Study|Lost to Follow-up|0|||
105991819|NCT05173012|365629726|FG002|Overall Study|Lost to Follow-up|0|||
105991820|NCT05173012|365629727|FG003|Overall Study|Lost to Follow-up|1|||
105991821|NCT05173012|365629728|FG004|Overall Study|Lost to Follow-up|0|||
105991822|NCT05173012|365629729|FG005|Overall Study|Lost to Follow-up|0|||
105991823|NCT05173012|365629730|FG006|Overall Study|Lost to Follow-up|0|||
105991824|NCT05173012|365629731|FG007|Overall Study|Lost to Follow-up|0|||
105991825|NCT05173012|365629724|FG000|Overall Study|Withdrawal by Subject|1|||
105991826|NCT05173012|365629725|FG001|Overall Study|Withdrawal by Subject|0|||
105991827|NCT05173012|365629726|FG002|Overall Study|Withdrawal by Subject|1|||
105991828|NCT05173012|365629727|FG003|Overall Study|Withdrawal by Subject|3|||
105991829|NCT05173012|365629728|FG004|Overall Study|Withdrawal by Subject|1|||
105991830|NCT05173012|365629729|FG005|Overall Study|Withdrawal by Subject|0|||
105991831|NCT05173012|365629730|FG006|Overall Study|Withdrawal by Subject|1|||
105991832|NCT05173012|365629731|FG007|Overall Study|Withdrawal by Subject|0|||
105991833|NCT05173012|365629724|FG000|Overall Study|Protocol Deviation|0|||
105991834|NCT05173012|365629725|FG001|Overall Study|Protocol Deviation|0|||
105991835|NCT05173012|365629726|FG002|Overall Study|Protocol Deviation|0|||
105991836|NCT05173012|365629727|FG003|Overall Study|Protocol Deviation|1|||
105991837|NCT05173012|365629728|FG004|Overall Study|Protocol Deviation|0|||
105991838|NCT05173012|365629729|FG005|Overall Study|Protocol Deviation|0|||
105991839|NCT05173012|365629730|FG006|Overall Study|Protocol Deviation|0|||
105991840|NCT05173012|365629731|FG007|Overall Study|Protocol Deviation|0|||
105991841|NCT05173012|365629724|FG000|Overall Study|Other|0|||
105991842|NCT05173012|365629725|FG001|Overall Study|Other|0|||
105991843|NCT05173012|365629726|FG002|Overall Study|Other|0|||
105991844|NCT05173012|365629727|FG003|Overall Study|Other|2|||
105991845|NCT05173012|365629728|FG004|Overall Study|Other|0|||
105991846|NCT05173012|365629729|FG005|Overall Study|Other|0|||
105991847|NCT05173012|365629730|FG006|Overall Study|Other|0|||
105991848|NCT05173012|365629731|FG007|Overall Study|Other|0|||
105991849|NCT02936843|365629732|FG000|Overall Study|Lost to Follow-up|3|||
105991850|NCT02936843|365629733|FG001|Overall Study|Lost to Follow-up|1|||
105991851|NCT02936843|365629732|FG000|Overall Study|Withdrawal by Subject|1|||
105991852|NCT02936843|365629733|FG001|Overall Study|Withdrawal by Subject|1|||
105991853|NCT04034004|365629738|FG000|Overall Study|Withdrawal by Subject|1|||
105991854|NCT04034004|365629739|FG001|Overall Study|Withdrawal by Subject|2|||
105991855|NCT04034004|365629740|FG002|Overall Study|Withdrawal by Subject|2|||
105991856|NCT04034004|365629741|FG003|Overall Study|Withdrawal by Subject|3|||
105991857|NCT04034004|365629738|FG000|Overall Study|could not find vein to administer IV|2|||
105991858|NCT04034004|365629739|FG001|Overall Study|could not find vein to administer IV|1|||
105991859|NCT04034004|365629740|FG002|Overall Study|could not find vein to administer IV|0|||
105991860|NCT04034004|365629741|FG003|Overall Study|could not find vein to administer IV|0|||
105991861|NCT04034004|365629738|FG000|Overall Study|nurse accidentally unblinded subject|0|||
105991862|NCT04034004|365629739|FG001|Overall Study|nurse accidentally unblinded subject|0|||
105991863|NCT04034004|365629740|FG002|Overall Study|nurse accidentally unblinded subject|0|||
105991864|NCT04034004|365629741|FG003|Overall Study|nurse accidentally unblinded subject|1|||
105991865|NCT04776317|365629742|FG000|Overall Study|Physician Decision|0|||
105991866|NCT04776317|365629743|FG001|Overall Study|Physician Decision|1|||
105991867|NCT04776317|365629744|FG002|Overall Study|Physician Decision|0|||
105991868|NCT04776317|365629745|FG003|Overall Study|Physician Decision|0|||
105991869|NCT04776317|365629746|FG004|Overall Study|Physician Decision|0|||
105991870|NCT04776317|365629747|FG005|Overall Study|Physician Decision|0|||
105991871|NCT04776317|365629748|FG006|Overall Study|Physician Decision|0|||
105991872|NCT04776317|365629749|FG007|Overall Study|Physician Decision|0|||
105991873|NCT04776317|365629750|FG008|Overall Study|Physician Decision|0|||
105991874|NCT04776317|365629751|FG009|Overall Study|Physician Decision|0|||
105991875|NCT04776317|365629752|FG010|Overall Study|Physician Decision|0|||
105991876|NCT04776317|365629753|FG011|Overall Study|Physician Decision|0|||
105991877|NCT04776317|365629754|FG012|Overall Study|Physician Decision|0|||
105991878|NCT04776317|365629755|FG013|Overall Study|Physician Decision|0|||
105991879|NCT04776317|365629756|FG014|Overall Study|Physician Decision|0|||
105991880|NCT04776317|365629742|FG000|Overall Study|Protocol Violation|0|||
105991881|NCT04776317|365629743|FG001|Overall Study|Protocol Violation|0|||
105991882|NCT04776317|365629744|FG002|Overall Study|Protocol Violation|1|||
105991883|NCT04776317|365629745|FG003|Overall Study|Protocol Violation|0|||
105991884|NCT04776317|365629746|FG004|Overall Study|Protocol Violation|0|||
105991885|NCT04776317|365629747|FG005|Overall Study|Protocol Violation|0|||
105991886|NCT04776317|365629748|FG006|Overall Study|Protocol Violation|0|||
105991887|NCT04776317|365629749|FG007|Overall Study|Protocol Violation|0|||
105991888|NCT04776317|365629750|FG008|Overall Study|Protocol Violation|0|||
105991889|NCT04776317|365629751|FG009|Overall Study|Protocol Violation|0|||
105991890|NCT04776317|365629752|FG010|Overall Study|Protocol Violation|0|||
105991891|NCT04776317|365629753|FG011|Overall Study|Protocol Violation|0|||
105991892|NCT04776317|365629754|FG012|Overall Study|Protocol Violation|0|||
105991893|NCT04776317|365629755|FG013|Overall Study|Protocol Violation|0|||
105991894|NCT04776317|365629756|FG014|Overall Study|Protocol Violation|0|||
105991895|NCT04776317|365629742|FG000|Overall Study|Withdrawal by Subject|0|||
105991896|NCT04776317|365629743|FG001|Overall Study|Withdrawal by Subject|0|||
105991897|NCT04776317|365629744|FG002|Overall Study|Withdrawal by Subject|0|||
105991898|NCT04776317|365629745|FG003|Overall Study|Withdrawal by Subject|0|||
105991899|NCT04776317|365629746|FG004|Overall Study|Withdrawal by Subject|1|||
105991900|NCT04776317|365629747|FG005|Overall Study|Withdrawal by Subject|0|||
105991901|NCT04776317|365629748|FG006|Overall Study|Withdrawal by Subject|0|||
105991902|NCT04776317|365629749|FG007|Overall Study|Withdrawal by Subject|0|||
105991903|NCT04776317|365629750|FG008|Overall Study|Withdrawal by Subject|0|||
105991904|NCT04776317|365629751|FG009|Overall Study|Withdrawal by Subject|0|||
105991905|NCT04776317|365629752|FG010|Overall Study|Withdrawal by Subject|0|||
105991906|NCT04776317|365629753|FG011|Overall Study|Withdrawal by Subject|0|||
105991907|NCT04776317|365629754|FG012|Overall Study|Withdrawal by Subject|0|||
105991908|NCT04776317|365629755|FG013|Overall Study|Withdrawal by Subject|0|||
105991909|NCT04776317|365629756|FG014|Overall Study|Withdrawal by Subject|0|||
105991910|NCT04207060|365629757|FG000|Overall Study|Lost to Follow-up|2|||
105991911|NCT04207060|365629758|FG001|Overall Study|Lost to Follow-up|0|||
105991912|NCT01835158|365629764|FG000|Overall Study|Withdrawal by Subject|1|||
105991913|NCT01835158|365629765|FG001|Overall Study|Withdrawal by Subject|6|||
105991914|NCT01856582|365629766|FG000|Overall Study|Died prior to Boost infusion|1|||
105991915|NCT00773747|365629767|FG000|Overall Study|Lack of Efficacy|112|||
105991916|NCT00773747|365629768|FG001|Overall Study|Lack of Efficacy|144|||
105991917|NCT00773747|365629767|FG000|Overall Study|Physician Decision|26|||
105991918|NCT00773747|365629768|FG001|Overall Study|Physician Decision|18|||
105991919|NCT00773747|365629767|FG000|Overall Study|Lost to Follow-up|0|||
105991920|NCT00773747|365629768|FG001|Overall Study|Lost to Follow-up|1|||
105991921|NCT00773747|365629767|FG000|Overall Study|Protocol Violation|2|||
105991922|NCT00773747|365629768|FG001|Overall Study|Protocol Violation|2|||
105991923|NCT00773747|365629767|FG000|Overall Study|Withdrawal by Subject|89|||
105991924|NCT00773747|365629768|FG001|Overall Study|Withdrawal by Subject|61|||
105991925|NCT00773747|365629767|FG000|Overall Study|Adverse Event|61|||
105991926|NCT00773747|365629768|FG001|Overall Study|Adverse Event|62|||
105991927|NCT00773747|365629767|FG000|Overall Study|Death|5|||
105991928|NCT00773747|365629768|FG001|Overall Study|Death|8|||
105991929|NCT00773747|365629767|FG000|Overall Study|Not Treated|2|||
105991930|NCT00773747|365629768|FG001|Overall Study|Not Treated|0|||
105991931|NCT01973998|365629777|FG000|Overall Study|Death|2|||
105991932|NCT01973998|365629778|FG001|Overall Study|Death|2|||
105991933|NCT01636986|365629779|FG000|Overall Study|Withdrawal by Subject|0|||
105991934|NCT01636986|365629780|FG001|Overall Study|Withdrawal by Subject|1|||
105991935|NCT01636986|365629779|FG000|Overall Study|Corneal Staining|0|||
105991936|NCT01636986|365629780|FG001|Overall Study|Corneal Staining|1|||
105991937|NCT01320202|365629783|FG000|Overall Study|Adverse Event|5|||
105991938|NCT01320202|365629784|FG001|Overall Study|Adverse Event|5|||
105991939|NCT01320202|365629783|FG000|Overall Study|Death|5|||
105991940|NCT01320202|365629784|FG001|Overall Study|Death|3|||
105991941|NCT01320202|365629783|FG000|Overall Study|Lost to Follow-up|1|||
105991942|NCT01320202|365629784|FG001|Overall Study|Lost to Follow-up|0|||
105991943|NCT01320202|365629783|FG000|Overall Study|Physician Decision|3|||
105991944|NCT01320202|365629784|FG001|Overall Study|Physician Decision|1|||
105991945|NCT01320202|365629783|FG000|Overall Study|Protocol Violation|2|||
105991946|NCT01320202|365629784|FG001|Overall Study|Protocol Violation|1|||
105991947|NCT01320202|365629783|FG000|Overall Study|Withdrawal by Subject|10|||
105991948|NCT01320202|365629784|FG001|Overall Study|Withdrawal by Subject|3|||
105991949|NCT01320202|365629783|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
105991950|NCT01320202|365629784|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
105991951|NCT01320202|365629783|FG000|Overall Study|kidney transplant|1|||
105991952|NCT01320202|365629784|FG001|Overall Study|kidney transplant|2|||
105991953|NCT01320202|365629783|FG000|Overall Study|blood transfusion|1|||
105991954|NCT01320202|365629784|FG001|Overall Study|blood transfusion|7|||
105991955|NCT01320202|365629783|FG000|Overall Study|moved/changed dialysis|5|||
105991956|NCT01320202|365629784|FG001|Overall Study|moved/changed dialysis|2|||
105991957|NCT01320202|365629783|FG000|Overall Study|sponsor request|2|||
105991958|NCT01320202|365629784|FG001|Overall Study|sponsor request|0|||
105991959|NCT01320202|365629783|FG000|Overall Study|ineligible|3|||
105991960|NCT01320202|365629784|FG001|Overall Study|ineligible|0|||
105991961|NCT01320202|365629783|FG000|Overall Study|regained renal function|1|||
105991962|NCT01320202|365629784|FG001|Overall Study|regained renal function|0|||
105991963|NCT02513472|365629786|FG000|Overall Study|Radiological Disease Progression|45|||
105991964|NCT02513472|365629787|FG001|Overall Study|Radiological Disease Progression|57|||
105991965|NCT02513472|365629786|FG000|Overall Study|Clinical Disease Progression|5|||
105991966|NCT02513472|365629787|FG001|Overall Study|Clinical Disease Progression|13|||
105991967|NCT02513472|365629786|FG000|Overall Study|Adverse Event|8|||
105991968|NCT02513472|365629787|FG001|Overall Study|Adverse Event|11|||
105991969|NCT02513472|365629786|FG000|Overall Study|Withdrawal by Subject|0|||
105991970|NCT02513472|365629787|FG001|Overall Study|Withdrawal by Subject|4|||
105991971|NCT02513472|365629786|FG000|Overall Study|Subject Choice|2|||
105991972|NCT02513472|365629787|FG001|Overall Study|Subject Choice|7|||
105991973|NCT02513472|365629786|FG000|Overall Study|Treatment Completed as per Protocol|3|||
105991974|NCT02513472|365629787|FG001|Overall Study|Treatment Completed as per Protocol|3|||
105991975|NCT02513472|365629786|FG000|Overall Study|Other|3|||
105991976|NCT02513472|365629787|FG001|Overall Study|Other|6|||
105991977|NCT03214406|365629788|FG000|Overall Study|did not meet enrollment criteria|9|||
105991978|NCT03214406|365629789|FG001|Overall Study|did not meet enrollment criteria|13|||
105991979|NCT03214406|365629788|FG000|Overall Study|Withdrawal by Subject|1|||
105991980|NCT03214406|365629789|FG001|Overall Study|Withdrawal by Subject|0|||
105991981|NCT03214406|365629788|FG000|Overall Study|Lost to Follow-up|0|||
105991982|NCT03214406|365629789|FG001|Overall Study|Lost to Follow-up|2|||
105991983|NCT01098305|365629792|FG000|Overall Study|Lost to Follow-up|31|||
105991984|NCT01098305|365629793|FG001|Overall Study|Lost to Follow-up|33|||
105991985|NCT00392990|365629794|FG000|Treatment on Study|Adverse Event|3|||
105991986|NCT00392990|365629795|FG001|Treatment on Study|Adverse Event|1|||
105991987|NCT00392990|365629794|FG000|Follow up for 2 Years|Death|4|||
105991988|NCT00392990|365629795|FG001|Follow up for 2 Years|Death|0|||
105991989|NCT00429169|365629800|FG000|Overall Study|Lost to Follow-up|0|||
105991990|NCT00429169|365629801|FG001|Overall Study|Lost to Follow-up|1|||
105991991|NCT00429169|365629800|FG000|Overall Study|Ineligibility discovered after entry|2|||
105991992|NCT00429169|365629801|FG001|Overall Study|Ineligibility discovered after entry|1|||
105991993|NCT03052049|365629804|FG000|Overall Study|Withdrawal by Subject|2|||
105991994|NCT01036321|365631460|FG000|Overall Study|Ineligible after randomization|0|||
105991995|NCT01036321|365631461|FG001|Overall Study|Ineligible after randomization|1|||
105991996|NCT01036321|365631460|FG000|Overall Study|Withdrawal by Subject|3|||
105991997|NCT01036321|365631461|FG001|Overall Study|Withdrawal by Subject|2|||
105991998|NCT01036321|365631460|FG000|Overall Study|Adverse Event|2|||
105991999|NCT01036321|365631461|FG001|Overall Study|Adverse Event|1|||
105992000|NCT00847886|365631462|FG000|Overall Study|Adverse Event|0|||
105992001|NCT00847886|365631463|FG001|Overall Study|Adverse Event|1|||
105992002|NCT01687101|365631464|FG000|Overall Study|Lost to Follow-up|7|||
105992003|NCT01979952|365631469|FG000|Overall Study|Adverse Event|4|||
105992004|NCT01979952|365631470|FG001|Overall Study|Adverse Event|5|||
105992005|NCT01979952|365631469|FG000|Overall Study|Protocol Violation|1|||
105992006|NCT01979952|365631470|FG001|Overall Study|Protocol Violation|0|||
105992007|NCT01979952|365631469|FG000|Overall Study|Withdrawal by Subject|2|||
105992008|NCT01979952|365631470|FG001|Overall Study|Withdrawal by Subject|1|||
105992009|NCT01979952|365631469|FG000|Overall Study|Other than specified above|1|||
105992010|NCT01979952|365631470|FG001|Overall Study|Other than specified above|0|||
105992011|NCT00286494|365631471|FG000|Overall Study|Hyperglycemic rescue|12|||
105992012|NCT00286494|365631472|FG001|Overall Study|Hyperglycemic rescue|19|||
105992013|NCT00286494|365631473|FG002|Overall Study|Hyperglycemic rescue|18|||
105992014|NCT00286494|365631471|FG000|Overall Study|Withdrawal by Subject|2|||
105992015|NCT00286494|365631472|FG001|Overall Study|Withdrawal by Subject|10|||
105992016|NCT00286494|365631473|FG002|Overall Study|Withdrawal by Subject|9|||
105992017|NCT00286494|365631471|FG000|Overall Study|Adverse Event|3|||
105992018|NCT00286494|365631472|FG001|Overall Study|Adverse Event|8|||
105992019|NCT00286494|365631473|FG002|Overall Study|Adverse Event|6|||
105992020|NCT00286494|365631471|FG000|Overall Study|Physician Decision|5|||
105992021|NCT00286494|365631472|FG001|Overall Study|Physician Decision|5|||
105992022|NCT00286494|365631473|FG002|Overall Study|Physician Decision|1|||
105992023|NCT00286494|365631471|FG000|Overall Study|Lost to Follow-up|3|||
105992024|NCT00286494|365631472|FG001|Overall Study|Lost to Follow-up|1|||
105992025|NCT00286494|365631473|FG002|Overall Study|Lost to Follow-up|3|||
105992026|NCT00286494|365631471|FG000|Overall Study|Protocol Violation|1|||
105992027|NCT00286494|365631472|FG001|Overall Study|Protocol Violation|1|||
105992028|NCT00286494|365631473|FG002|Overall Study|Protocol Violation|2|||
105992029|NCT00475709|365631476|FG000|Overall Study|Did not meet eligibility criteria|8|||
105992030|NCT00475709|365631476|FG000|Overall Study|Death|41|||
105992031|NCT00475709|365631476|FG000|Overall Study|Device Explant|6|||
105992032|NCT00475709|365631476|FG000|Overall Study|Lost to Follow-up|21|||
105992033|NCT02735343|365631477|FG000|Overall Study|screen fail|0|||
105992034|NCT02735343|365631478|FG001|Overall Study|screen fail|2|||
105992035|NCT03078855|365631479|FG000|Overall Study|Lack of Efficacy|62|||
105992036|NCT03078855|365631480|FG001|Overall Study|Lack of Efficacy|31|||
105992037|NCT03078855|365631479|FG000|Overall Study|Death|1|||
105992038|NCT03078855|365631480|FG001|Overall Study|Death|0|||
105992039|NCT03078855|365631479|FG000|Overall Study|Withdrawal by Subject|12|||
105992040|NCT03078855|365631480|FG001|Overall Study|Withdrawal by Subject|6|||
105992041|NCT03078855|365631479|FG000|Overall Study|Physician Decision|3|||
105992042|NCT03078855|365631480|FG001|Overall Study|Physician Decision|2|||
105992043|NCT03078855|365631479|FG000|Overall Study|Second Malignancy|4|||
105992044|NCT03078855|365631480|FG001|Overall Study|Second Malignancy|0|||
105992045|NCT03078855|365631479|FG000|Overall Study|Ineligible|2|||
105992046|NCT03078855|365631480|FG001|Overall Study|Ineligible|0|||
105992047|NCT03078855|365631479|FG000|Overall Study|Withdrew before day 1 treatment|2|||
105992048|NCT03078855|365631480|FG001|Overall Study|Withdrew before day 1 treatment|1|||
105992049|NCT02023996|365631481|FG000|Overall Study|Protocol Violation|6|||
105992050|NCT03400176|365631485|FG000|Dose Escalation|Progressive disease|1|||
105992051|NCT03400176|365631486|FG001|Dose Escalation|Progressive disease|1|||
105992052|NCT03400176|365631487|FG002|Dose Escalation|Progressive disease|0|||
105992053|NCT03400176|365631488|FG003|Dose Escalation|Progressive disease|0|||
105992054|NCT03400176|365631489|FG004|Dose Escalation|Progressive disease|1|||
105992055|NCT03400176|365631485|FG000|Dose Escalation|Patient decision|0|||
105992056|NCT03400176|365631486|FG001|Dose Escalation|Patient decision|0|||
105992057|NCT03400176|365631487|FG002|Dose Escalation|Patient decision|0|||
105992058|NCT03400176|365631488|FG003|Dose Escalation|Patient decision|0|||
105992059|NCT03400176|365631489|FG004|Dose Escalation|Patient decision|1|||
105992060|NCT03400176|365631485|FG000|Dose Expansion|Patient decision|0|||
105992061|NCT03400176|365631486|FG001|Dose Expansion|Patient decision|0|||
105992062|NCT03400176|365631487|FG002|Dose Expansion|Patient decision|0|||
105992063|NCT03400176|365631488|FG003|Dose Expansion|Patient decision|1|||
105992064|NCT03400176|365631489|FG004|Dose Expansion|Patient decision|0|||
105992065|NCT03400176|365631485|FG000|Dose Expansion|Adverse Event|0|||
105992066|NCT03400176|365631486|FG001|Dose Expansion|Adverse Event|0|||
105992067|NCT03400176|365631487|FG002|Dose Expansion|Adverse Event|0|||
105992068|NCT03400176|365631488|FG003|Dose Expansion|Adverse Event|1|||
105992069|NCT03400176|365631489|FG004|Dose Expansion|Adverse Event|0|||
105992070|NCT03400176|365631485|FG000|Dose Expansion|Physician Decision|0|||
105992071|NCT03400176|365631486|FG001|Dose Expansion|Physician Decision|0|||
105992072|NCT03400176|365631487|FG002|Dose Expansion|Physician Decision|0|||
105992073|NCT03400176|365631488|FG003|Dose Expansion|Physician Decision|1|||
105992074|NCT03400176|365631489|FG004|Dose Expansion|Physician Decision|0|||
105992075|NCT03400176|365631485|FG000|Dose Expansion|Progressive disease|0|||
105992076|NCT03400176|365631486|FG001|Dose Expansion|Progressive disease|0|||
105992077|NCT03400176|365631487|FG002|Dose Expansion|Progressive disease|1|||
105992078|NCT03400176|365631488|FG003|Dose Expansion|Progressive disease|1|||
105992079|NCT03400176|365631489|FG004|Dose Expansion|Progressive disease|0|||
105992080|NCT00206440|365631490|FG000|Overall Study|Protocol Violation|1|||
105992081|NCT00206440|365631491|FG001|Overall Study|Protocol Violation|2|||
105992082|NCT00206440|365631490|FG000|Overall Study|Adverse Event|4|||
105992083|NCT00206440|365631491|FG001|Overall Study|Adverse Event|2|||
105992084|NCT01298765|365631492|FG000|Titration Period|Adverse Event|26|||
105992085|NCT01298765|365631492|FG000|Titration Period|Death|1|||
105992086|NCT01298765|365631492|FG000|Titration Period|Lack of Efficacy|21|||
105992087|NCT01298765|365631492|FG000|Titration Period|Lost to Follow-up|9|||
105992088|NCT01298765|365631492|FG000|Titration Period|Physician Decision|1|||
105992089|NCT01298765|365631492|FG000|Titration Period|Withdrawal by Subject|10|||
105992090|NCT01298765|365631492|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
105992091|NCT01298765|365631492|FG000|Long-Term Treatment Period|Adverse Event|19|||
105992092|NCT01298765|365631492|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
105992093|NCT01298765|365631492|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
105992094|NCT01298765|365631492|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
105992095|NCT01298765|365631492|FG000|Long-Term Treatment Period|Physician Decision|1|||
105992096|NCT01298765|365631492|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
105992097|NCT00828750|365631493|FG000|Overall Study|Lack of Efficacy|3|||
105992098|NCT00828750|365631493|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
105992099|NCT00766051|365631494|FG000|Overall Study|Withdrawal by Subject|2|||
105992100|NCT00766051|365631495|FG001|Overall Study|Withdrawal by Subject|0|||
105992101|NCT02669121|365631497|FG000|Overall Study|Adverse Event|4|||
105992102|NCT02669121|365631498|FG001|Overall Study|Adverse Event|5|||
105992103|NCT02669121|365631497|FG000|Overall Study|Lost to Follow-up|15|||
105992104|NCT02669121|365631498|FG001|Overall Study|Lost to Follow-up|27|||
105992105|NCT02669121|365631497|FG000|Overall Study|Withdrawal by Subject|132|||
105992106|NCT02669121|365631498|FG001|Overall Study|Withdrawal by Subject|140|||
105992107|NCT02669121|365631497|FG000|Overall Study|Pregnancy|0|||
105992108|NCT02669121|365631498|FG001|Overall Study|Pregnancy|1|||
105992109|NCT02669121|365631497|FG000|Overall Study|Discharged from US Military Active Service|117|||
105992110|NCT02669121|365631498|FG001|Overall Study|Discharged from US Military Active Service|91|||
105992111|NCT02669121|365631497|FG000|Overall Study|Reason not Specified|22|||
105992112|NCT02669121|365631498|FG001|Overall Study|Reason not Specified|18|||
105992113|NCT02708355|365631499|FG000|Overall Study|Adverse Event|1|||
105992114|NCT02708355|365631500|FG001|Overall Study|Adverse Event|0|||
105992115|NCT02708355|365631501|FG002|Overall Study|Adverse Event|0|||
105992116|NCT00635882|365631502|FG000|Overall Study|Protocol Violation|1|||
105992117|NCT00635882|365631503|FG001|Overall Study|Protocol Violation|0|||
105992118|NCT00635882|365631504|FG002|Overall Study|Protocol Violation|0|||
105992119|NCT00635882|365631505|FG003|Overall Study|Protocol Violation|0|||
105992120|NCT00635882|365631506|FG004|Overall Study|Protocol Violation|0|||
105992121|NCT00635882|365631507|FG005|Overall Study|Protocol Violation|0|||
105992122|NCT00858637|365631508|FG000|Active Comparison Phase|Adverse Event|14|||
105992123|NCT00858637|365631509|FG001|Active Comparison Phase|Adverse Event|0|||
105992124|NCT00858637|365631510|FG002|Active Comparison Phase|Adverse Event|0|||
105992125|NCT00858637|365631511|FG003|Active Comparison Phase|Adverse Event|9|||
105992126|NCT00858637|365631512|FG004|Active Comparison Phase|Adverse Event|0|||
105992127|NCT00858637|365631513|FG005|Active Comparison Phase|Adverse Event|0|||
105992128|NCT00858637|365631508|FG000|Active Comparison Phase|Death|1|||
105992129|NCT00858637|365631509|FG001|Active Comparison Phase|Death|0|||
105992130|NCT00858637|365631510|FG002|Active Comparison Phase|Death|0|||
105992131|NCT00858637|365631511|FG003|Active Comparison Phase|Death|1|||
105992132|NCT00858637|365631512|FG004|Active Comparison Phase|Death|0|||
105992133|NCT00858637|365631513|FG005|Active Comparison Phase|Death|0|||
105992134|NCT00858637|365631508|FG000|Active Comparison Phase|Physician Decision|1|||
105992135|NCT00858637|365631509|FG001|Active Comparison Phase|Physician Decision|0|||
105992136|NCT00858637|365631510|FG002|Active Comparison Phase|Physician Decision|0|||
105992137|NCT00858637|365631511|FG003|Active Comparison Phase|Physician Decision|1|||
105992138|NCT00858637|365631512|FG004|Active Comparison Phase|Physician Decision|0|||
105992139|NCT00858637|365631513|FG005|Active Comparison Phase|Physician Decision|0|||
105992140|NCT00858637|365631508|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
105992141|NCT00858637|365631509|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
105992142|NCT00858637|365631510|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
105992143|NCT00858637|365631511|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
105992144|NCT00858637|365631512|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
105992145|NCT00858637|365631513|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
105992146|NCT00858637|365631508|FG000|Active Comparison Phase|Other Reasons|1|||
105992147|NCT00858637|365631509|FG001|Active Comparison Phase|Other Reasons|0|||
105992148|NCT00858637|365631510|FG002|Active Comparison Phase|Other Reasons|0|||
105992149|NCT00858637|365631511|FG003|Active Comparison Phase|Other Reasons|1|||
105992150|NCT00858637|365631512|FG004|Active Comparison Phase|Other Reasons|0|||
105992151|NCT00858637|365631513|FG005|Active Comparison Phase|Other Reasons|0|||
105992152|NCT00858637|365631508|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
105992153|NCT00858637|365631509|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
105992154|NCT00858637|365631510|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
105992155|NCT00858637|365631511|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
105992156|NCT00858637|365631512|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
105992157|NCT00858637|365631513|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
105992158|NCT00858637|365631508|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105992159|NCT00858637|365631509|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105992160|NCT00858637|365631510|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105992161|NCT00858637|365631511|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105992162|NCT00858637|365631512|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
105992163|NCT00858637|365631513|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
105992164|NCT04310566|365631518|FG000|Period 1|Study Termination due to COVID-19|15|||
105992165|NCT04310566|365631519|FG001|Period 1|Study Termination due to COVID-19|17|||
105992166|NCT04310566|365631518|FG000|Period 1|Protocol Violation|0|||
105992167|NCT04310566|365631519|FG001|Period 1|Protocol Violation|1|||
106099840|NCT02349295|366022655|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
105992168|NCT04310566|365631518|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
105992169|NCT04310566|365631519|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
105992170|NCT04310566|365631518|FG000|Period 1|Lost to Follow-up|1|||
105992171|NCT04310566|365631519|FG001|Period 1|Lost to Follow-up|0|||
105992172|NCT04310566|365631518|FG000|Period 1|Withdrawal by Subject|0|||
105992173|NCT04310566|365631519|FG001|Period 1|Withdrawal by Subject|1|||
105992174|NCT04310566|365631518|FG000|Period 2|Study Termination|7|||
105992175|NCT04310566|365631519|FG001|Period 2|Study Termination|5|||
105992176|NCT02396589|365631520|FG000|Intervention|Lost to Follow-up|1|||
105992177|NCT02396589|365631521|FG001|Intervention|Lost to Follow-up|0|||
105992178|NCT02396589|365631520|FG000|6 Month Follow-up|change in health status|0|||
105992179|NCT02396589|365631521|FG001|6 Month Follow-up|change in health status|1|||
105992180|NCT02396589|365631520|FG000|9 Month Follow-up|Death|0|||
105992181|NCT02396589|365631521|FG001|9 Month Follow-up|Death|1|||
105992182|NCT02396589|365631520|FG000|12 Month Follow up|Lost to Follow-up|0|||
105992183|NCT02396589|365631521|FG001|12 Month Follow up|Lost to Follow-up|2|||
105992184|NCT00825812|365631522|FG000|Overall Study|Never entered follow up|0|||
105992185|NCT00825812|365631523|FG001|Overall Study|Never entered follow up|0|||
105992186|NCT00825812|365631524|FG002|Overall Study|Never entered follow up|0|||
105992187|NCT00825812|365631525|FG003|Overall Study|Never entered follow up|1|||
105992188|NCT00825812|365631522|FG000|Overall Study|Adverse Event|0|||
105992189|NCT00825812|365631523|FG001|Overall Study|Adverse Event|0|||
105992190|NCT00825812|365631524|FG002|Overall Study|Adverse Event|0|||
105992191|NCT00825812|365631525|FG003|Overall Study|Adverse Event|1|||
105992192|NCT00825812|365631522|FG000|Overall Study|Subject withdrew consent|0|||
105992193|NCT00825812|365631523|FG001|Overall Study|Subject withdrew consent|0|||
105992194|NCT00825812|365631524|FG002|Overall Study|Subject withdrew consent|3|||
105992195|NCT00825812|365631525|FG003|Overall Study|Subject withdrew consent|2|||
105992196|NCT00825812|365631522|FG000|Overall Study|Non-compliance with protocol|0|||
105992197|NCT00825812|365631523|FG001|Overall Study|Non-compliance with protocol|0|||
105992198|NCT00825812|365631524|FG002|Overall Study|Non-compliance with protocol|0|||
105992199|NCT00825812|365631525|FG003|Overall Study|Non-compliance with protocol|1|||
105992200|NCT00825812|365631522|FG000|Overall Study|Administrative|0|||
105992201|NCT00825812|365631523|FG001|Overall Study|Administrative|1|||
105992202|NCT00825812|365631524|FG002|Overall Study|Administrative|3|||
105992203|NCT00825812|365631525|FG003|Overall Study|Administrative|5|||
105992204|NCT01746173|365631528|FG000|Overall Study|Disease Progression|2|||
105992205|NCT01771250|365631531|FG000|Period 1|Met exclusion criteria|1|||
105992206|NCT01771250|365631532|FG001|Period 1|Met exclusion criteria|0|||
105992207|NCT00483938|365631533|FG000|Overall Study|Protocol Violation|0|||
105992208|NCT00483938|365631534|FG001|Overall Study|Protocol Violation|0|||
105992209|NCT00483938|365631535|FG002|Overall Study|Protocol Violation|0|||
105992210|NCT00483938|365631536|FG003|Overall Study|Protocol Violation|0|||
105992211|NCT00483938|365631537|FG004|Overall Study|Protocol Violation|0|||
105992212|NCT00483938|365631538|FG005|Overall Study|Protocol Violation|0|||
105992213|NCT00483938|365631539|FG006|Overall Study|Protocol Violation|3|||
105992214|NCT00483938|365631533|FG000|Overall Study|Withdrawal by Subject|1|||
105992215|NCT00483938|365631534|FG001|Overall Study|Withdrawal by Subject|6|||
105992216|NCT00483938|365631535|FG002|Overall Study|Withdrawal by Subject|0|||
105992217|NCT00483938|365631536|FG003|Overall Study|Withdrawal by Subject|0|||
105992218|NCT00483938|365631537|FG004|Overall Study|Withdrawal by Subject|1|||
105992219|NCT00483938|365631538|FG005|Overall Study|Withdrawal by Subject|3|||
105992220|NCT00483938|365631539|FG006|Overall Study|Withdrawal by Subject|2|||
105992221|NCT00483938|365631533|FG000|Overall Study|Lost to Follow-up|1|||
105992222|NCT00483938|365631534|FG001|Overall Study|Lost to Follow-up|2|||
105992223|NCT00483938|365631535|FG002|Overall Study|Lost to Follow-up|0|||
105992224|NCT00483938|365631536|FG003|Overall Study|Lost to Follow-up|2|||
105992225|NCT00483938|365631537|FG004|Overall Study|Lost to Follow-up|1|||
106099841|NCT02349295|366022656|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099842|NCT02349295|366022657|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099843|NCT02349295|366022658|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099844|NCT02349295|366022659|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
106099845|NCT02349295|366022646|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
106099846|NCT02349295|366022647|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
106099847|NCT02349295|366022648|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
106099848|NCT02349295|366022649|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099849|NCT02349295|366022650|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099850|NCT02349295|366022651|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099851|NCT02349295|366022652|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099852|NCT02349295|366022653|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
105992226|NCT00483938|365631538|FG005|Overall Study|Lost to Follow-up|1|||
105992227|NCT00483938|365631539|FG006|Overall Study|Lost to Follow-up|3|||
105992228|NCT00483938|365631533|FG000|Overall Study|Death|0|||
105992229|NCT00483938|365631534|FG001|Overall Study|Death|2|||
105992230|NCT00483938|365631535|FG002|Overall Study|Death|0|||
105992231|NCT00483938|365631536|FG003|Overall Study|Death|0|||
105992232|NCT00483938|365631537|FG004|Overall Study|Death|0|||
106099853|NCT02349295|366022654|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099854|NCT02349295|366022655|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099855|NCT02349295|366022656|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099856|NCT02349295|366022657|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099857|NCT02349295|366022658|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099858|NCT02349295|366022659|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
106099859|NCT02349295|366022646|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
106099860|NCT02349295|366022647|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
106099861|NCT02349295|366022648|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
106099862|NCT02349295|366022649|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099863|NCT02349295|366022650|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099864|NCT02349295|366022651|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099865|NCT02349295|366022652|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099866|NCT02349295|366022653|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099867|NCT02349295|366022654|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099868|NCT02349295|366022655|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099869|NCT02349295|366022656|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099870|NCT02349295|366022657|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099871|NCT02349295|366022658|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099872|NCT02349295|366022659|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
106099873|NCT02349295|366022646|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
106099874|NCT02349295|366022647|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
106099875|NCT02349295|366022648|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
106099876|NCT02349295|366022649|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099877|NCT02349295|366022650|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099878|NCT02349295|366022651|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099879|NCT02349295|366022652|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099880|NCT02349295|366022653|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099881|NCT02349295|366022654|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099882|NCT02349295|366022655|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099883|NCT02349295|366022656|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099884|NCT02349295|366022657|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099885|NCT02349295|366022658|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099886|NCT02349295|366022659|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
106099887|NCT02349295|366022646|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099888|NCT02349295|366022647|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
106099889|NCT02349295|366022648|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
106099890|NCT02349295|366022649|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099891|NCT02349295|366022650|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099892|NCT02349295|366022651|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099893|NCT02349295|366022652|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099894|NCT02349295|366022653|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099895|NCT02349295|366022654|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099896|NCT02349295|366022655|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099897|NCT02349295|366022656|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099898|NCT02349295|366022657|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099899|NCT02349295|366022658|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099900|NCT02349295|366022659|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
106099901|NCT02349295|366022646|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
106099902|NCT02349295|366022647|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
106099903|NCT02349295|366022648|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
106099904|NCT02349295|366022649|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
106099905|NCT02349295|366022650|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
106099906|NCT02349295|366022651|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
106099907|NCT02349295|366022652|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
106099908|NCT02349295|366022653|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
106099909|NCT02349295|366022654|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
106099910|NCT02349295|366022655|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
106099911|NCT02349295|366022656|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
106099912|NCT02349295|366022657|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
106099913|NCT02349295|366022658|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
106099914|NCT02349295|366022659|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
106099915|NCT02349295|366022646|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099916|NCT02349295|366022647|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099917|NCT02349295|366022648|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099918|NCT02349295|366022649|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099919|NCT02349295|366022650|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099920|NCT02349295|366022651|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099921|NCT02349295|366022652|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099922|NCT02349295|366022653|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
106099923|NCT02349295|366022654|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
106099924|NCT02349295|366022655|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
106099925|NCT02349295|366022656|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
106099926|NCT02349295|366022657|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099927|NCT02349295|366022658|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099928|NCT02349295|366022659|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
106099929|NCT02349295|366022646|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099930|NCT02349295|366022647|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099931|NCT02349295|366022648|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099932|NCT02349295|366022649|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099933|NCT02349295|366022650|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099934|NCT02349295|366022651|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099935|NCT02349295|366022652|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099936|NCT02349295|366022653|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
106099937|NCT02349295|366022654|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
106099938|NCT02349295|366022655|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
106099939|NCT02349295|366022656|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
106099940|NCT02349295|366022657|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099941|NCT02349295|366022658|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099942|NCT02349295|366022659|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
106099943|NCT02349295|366022646|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099944|NCT02349295|366022647|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099945|NCT02349295|366022648|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099946|NCT02349295|366022649|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099947|NCT02349295|366022650|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099948|NCT02349295|366022651|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099949|NCT02349295|366022652|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099950|NCT02349295|366022653|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
106099951|NCT02349295|366022654|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099952|NCT02349295|366022655|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
106099953|NCT02349295|366022656|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099954|NCT02349295|366022657|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099955|NCT02349295|366022658|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099956|NCT02349295|366022659|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
106099957|NCT02349295|366022646|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
106099958|NCT02349295|366022647|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
106099959|NCT02349295|366022648|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
106099960|NCT02349295|366022649|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
106099961|NCT02349295|366022650|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
106099962|NCT02349295|366022651|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
106099963|NCT02349295|366022652|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
106099964|NCT02349295|366022653|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
106099965|NCT02349295|366022654|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
106099966|NCT02349295|366022655|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
106099967|NCT02349295|366022656|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
106099968|NCT02349295|366022657|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
106099969|NCT02349295|366022658|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
106099970|NCT02349295|366022659|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
106099971|NCT02349295|366022646|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099972|NCT02349295|366022647|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099973|NCT02349295|366022648|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099974|NCT02349295|366022649|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099975|NCT02349295|366022650|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099976|NCT02349295|366022651|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099977|NCT02349295|366022652|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099978|NCT02349295|366022653|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
106099979|NCT02349295|366022654|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
106099980|NCT02349295|366022655|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
106099981|NCT02349295|366022656|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
105779380|NCT00386152|364844740|FG000|Overall Study|Adverse Event|6|||
106099982|NCT02349295|366022657|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099983|NCT02349295|366022658|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
105779381|NCT00386152|364844741|FG001|Overall Study|Adverse Event|5|||
106099984|NCT02349295|366022659|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
106099985|NCT02349295|366022646|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099986|NCT02349295|366022647|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099987|NCT02349295|366022648|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099988|NCT02349295|366022649|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099989|NCT02349295|366022650|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099990|NCT02349295|366022651|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099991|NCT02349295|366022652|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099992|NCT02349295|366022653|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
106099993|NCT02349295|366022654|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
106099994|NCT02349295|366022655|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099995|NCT02349295|366022656|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099996|NCT02349295|366022657|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099997|NCT02349295|366022658|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099998|NCT02349295|366022659|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
106099999|NCT02349295|366022646|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100000|NCT02349295|366022647|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100001|NCT02349295|366022648|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100002|NCT02349295|366022649|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100003|NCT02349295|366022650|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100004|NCT02349295|366022651|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100005|NCT02349295|366022652|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100006|NCT02349295|366022653|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
106100007|NCT02349295|366022654|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
106100008|NCT02349295|366022655|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100009|NCT02349295|366022656|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100010|NCT02349295|366022657|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100011|NCT02349295|366022658|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100012|NCT02349295|366022659|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
106100013|NCT02349295|366022646|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100014|NCT02349295|366022647|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100015|NCT02349295|366022648|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100016|NCT02349295|366022649|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100017|NCT02349295|366022650|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100018|NCT02349295|366022651|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100019|NCT02349295|366022652|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100020|NCT02349295|366022653|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100021|NCT02349295|366022654|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100022|NCT02349295|366022655|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100023|NCT02349295|366022656|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
106100024|NCT02349295|366022657|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
106100025|NCT02349295|366022658|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
106100026|NCT02349295|366022659|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
106100027|NCT02349295|366022646|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100028|NCT02349295|366022647|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100029|NCT02349295|366022648|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100030|NCT02349295|366022649|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100031|NCT02349295|366022650|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100032|NCT02349295|366022651|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100033|NCT02349295|366022652|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100034|NCT02349295|366022653|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100035|NCT02349295|366022654|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100036|NCT02349295|366022655|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100037|NCT02349295|366022656|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100038|NCT02349295|366022657|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
106100039|NCT02349295|366022658|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
106100040|NCT02349295|366022659|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
106100041|NCT02349295|366022646|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100042|NCT02349295|366022647|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100043|NCT02349295|366022648|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100044|NCT02349295|366022649|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
105779382|NCT00386152|364844742|FG002|Overall Study|Adverse Event|4|||
106100045|NCT02349295|366022650|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100046|NCT02349295|366022651|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100047|NCT02349295|366022652|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100048|NCT02349295|366022653|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100049|NCT02349295|366022654|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100050|NCT02349295|366022655|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100051|NCT02349295|366022656|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100052|NCT02349295|366022657|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
106100053|NCT02349295|366022658|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
106100054|NCT02349295|366022659|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
106100055|NCT02349295|366022646|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100056|NCT02349295|366022647|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100057|NCT02349295|366022648|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100058|NCT02349295|366022649|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100059|NCT02349295|366022650|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100060|NCT02349295|366022651|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100061|NCT02349295|366022652|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100062|NCT02349295|366022653|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100063|NCT02349295|366022654|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100064|NCT02349295|366022655|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100065|NCT02349295|366022656|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100066|NCT02349295|366022657|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
106100067|NCT02349295|366022658|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100068|NCT02349295|366022659|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
106100069|NCT02349295|366022646|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100070|NCT02349295|366022647|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100071|NCT02349295|366022648|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100072|NCT02349295|366022649|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100073|NCT02349295|366022650|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100074|NCT02349295|366022651|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100075|NCT02349295|366022652|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100076|NCT02349295|366022653|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100077|NCT02349295|366022654|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100078|NCT02349295|366022655|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100079|NCT02349295|366022656|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100080|NCT02349295|366022657|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
106100081|NCT02349295|366022658|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100082|NCT02349295|366022659|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
106100083|NCT02863926|366022660|FG000|Overall Study|Physician Decision|1|||
106100084|NCT02863926|366022661|FG001|Overall Study|Physician Decision|0|||
106100085|NCT02863926|366022660|FG000|Overall Study|Lost to Follow-up|1|||
106100086|NCT02863926|366022661|FG001|Overall Study|Lost to Follow-up|1|||
106100087|NCT03240588|366022662|FG000|Overall Study|Death|3|||
106100088|NCT03240588|366022663|FG001|Overall Study|Death|0|||
106100089|NCT03240588|366022664|FG002|Overall Study|Death|0|||
106100090|NCT03240588|366022662|FG000|Overall Study|Adverse Event|5|||
106100091|NCT03240588|366022663|FG001|Overall Study|Adverse Event|4|||
106100092|NCT03240588|366022664|FG002|Overall Study|Adverse Event|0|||
106100093|NCT03240588|366022662|FG000|Overall Study|Lost to Follow-up|9|||
106100094|NCT03240588|366022663|FG001|Overall Study|Lost to Follow-up|4|||
106100095|NCT03240588|366022664|FG002|Overall Study|Lost to Follow-up|0|||
106100096|NCT03240588|366022662|FG000|Overall Study|Physician Decision|3|||
106100097|NCT03240588|366022663|FG001|Overall Study|Physician Decision|2|||
106100098|NCT03240588|366022664|FG002|Overall Study|Physician Decision|0|||
106100099|NCT03240588|366022662|FG000|Overall Study|Did not meet eligibility criteria|0|||
106100100|NCT03240588|366022663|FG001|Overall Study|Did not meet eligibility criteria|6|||
106100101|NCT03240588|366022664|FG002|Overall Study|Did not meet eligibility criteria|0|||
106100102|NCT03240588|366022662|FG000|Overall Study|No longer meets protocol criteria|12|||
106100103|NCT03240588|366022663|FG001|Overall Study|No longer meets protocol criteria|7|||
106100104|NCT03240588|366022664|FG002|Overall Study|No longer meets protocol criteria|0|||
106100105|NCT03240588|366022662|FG000|Overall Study|Withdrawal by Subject|60|||
106100106|NCT03240588|366022663|FG001|Overall Study|Withdrawal by Subject|52|||
106100107|NCT03240588|366022664|FG002|Overall Study|Withdrawal by Subject|7|||
106100108|NCT03240588|366022662|FG000|Overall Study|Other, additional details not available.|0|||
106100109|NCT03240588|366022663|FG001|Overall Study|Other, additional details not available.|12|||
106100110|NCT03240588|366022664|FG002|Overall Study|Other, additional details not available.|1|||
106100111|NCT03240588|366022662|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
106100112|NCT03240588|366022663|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
106100113|NCT03240588|366022664|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
106100114|NCT03240588|366022662|FG000|Overall Study|Closure of study|55|||
106100115|NCT03240588|366022663|FG001|Overall Study|Closure of study|3|||
106100116|NCT03240588|366022664|FG002|Overall Study|Closure of study|0|||
106100117|NCT03240588|366022662|FG000|Overall Study|Subject non-compliance|23|||
106100118|NCT03240588|366022663|FG001|Overall Study|Subject non-compliance|2|||
106100119|NCT03240588|366022664|FG002|Overall Study|Subject non-compliance|1|||
106100120|NCT03240588|366022662|FG000|Overall Study|Device Deficiency|1|||
106100121|NCT03240588|366022663|FG001|Overall Study|Device Deficiency|0|||
106100122|NCT03240588|366022664|FG002|Overall Study|Device Deficiency|0|||
106100123|NCT03240588|366022662|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
106100124|NCT03240588|366022663|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
105992233|NCT00483938|365631538|FG005|Overall Study|Death|0|||
105992234|NCT00483938|365631539|FG006|Overall Study|Death|0|||
105992235|NCT00483938|365631533|FG000|Overall Study|Other|3|||
105992236|NCT00483938|365631534|FG001|Overall Study|Other|9|||
105992237|NCT00483938|365631535|FG002|Overall Study|Other|0|||
105992238|NCT00483938|365631536|FG003|Overall Study|Other|4|||
105992239|NCT00483938|365631537|FG004|Overall Study|Other|0|||
105992240|NCT00483938|365631538|FG005|Overall Study|Other|4|||
105992241|NCT00483938|365631539|FG006|Overall Study|Other|32|||
105992242|NCT02038075|365631544|FG000|Overall Study|Withdrawal by Subject|3|||
105992243|NCT02038075|365631545|FG001|Overall Study|Withdrawal by Subject|0|||
105992244|NCT04039217|365631546|FG000|Overall Study|Lost to Follow-up|1|||
105992245|NCT04000581|365631547|FG000|Overall Study|Withdrawal by Subject|0|||
105992246|NCT04000581|365631548|FG001|Overall Study|Withdrawal by Subject|1|||
105992247|NCT01371552|365631549|FG000|Part 1, First 3 Days|Inconvenience|0|||
105992248|NCT01371552|365631550|FG001|Part 1, First 3 Days|Inconvenience|0|||
105992249|NCT01371552|365631551|FG002|Part 1, First 3 Days|Inconvenience|1|||
105992250|NCT01371552|365631552|FG003|Part 1, First 3 Days|Inconvenience|0|||
105992251|NCT01371552|365631553|FG004|Part 1, First 3 Days|Inconvenience|0|||
105992252|NCT01371552|365631554|FG005|Part 1, First 3 Days|Inconvenience|0|||
105992253|NCT03364309|365631555|FG000|Induction Period|Adverse Event|4|||
105992254|NCT03364309|365631556|FG001|Induction Period|Adverse Event|0|||
105992255|NCT03364309|365631557|FG002|Induction Period|Adverse Event|1|||
105992256|NCT03364309|365631558|FG003|Induction Period|Adverse Event|0|||
105992257|NCT03364309|365631559|FG004|Induction Period|Adverse Event|0|||
105992258|NCT03364309|365631560|FG005|Induction Period|Adverse Event|0|||
105992259|NCT03364309|365631561|FG006|Induction Period|Adverse Event|0|||
105992260|NCT03364309|365631562|FG007|Induction Period|Adverse Event|0|||
105992261|NCT03364309|365631563|FG008|Induction Period|Adverse Event|0|||
105992262|NCT03364309|365631564|FG009|Induction Period|Adverse Event|0|||
105992263|NCT03364309|365631565|FG010|Induction Period|Adverse Event|0|||
105992264|NCT03364309|365631566|FG011|Induction Period|Adverse Event|0|||
105992265|NCT03364309|365631567|FG012|Induction Period|Adverse Event|0|||
105992266|NCT03364309|365631568|FG013|Induction Period|Adverse Event|0|||
105992267|NCT03364309|365631569|FG014|Induction Period|Adverse Event|0|||
105992268|NCT03364309|365631570|FG015|Induction Period|Adverse Event|0|||
105992269|NCT03364309|365631571|FG016|Induction Period|Adverse Event|0|||
105992270|NCT03364309|365631572|FG017|Induction Period|Adverse Event|0|||
105992271|NCT03364309|365631573|FG018|Induction Period|Adverse Event|0|||
105992272|NCT03364309|365631555|FG000|Induction Period|Withdrawal by Subject|1|||
105992273|NCT03364309|365631556|FG001|Induction Period|Withdrawal by Subject|3|||
105992274|NCT03364309|365631557|FG002|Induction Period|Withdrawal by Subject|0|||
105992275|NCT03364309|365631558|FG003|Induction Period|Withdrawal by Subject|0|||
105992276|NCT03364309|365631559|FG004|Induction Period|Withdrawal by Subject|0|||
105992277|NCT03364309|365631560|FG005|Induction Period|Withdrawal by Subject|0|||
105992278|NCT03364309|365631561|FG006|Induction Period|Withdrawal by Subject|0|||
105992279|NCT03364309|365631562|FG007|Induction Period|Withdrawal by Subject|0|||
105992280|NCT03364309|365631563|FG008|Induction Period|Withdrawal by Subject|0|||
105992281|NCT03364309|365631564|FG009|Induction Period|Withdrawal by Subject|0|||
105992282|NCT03364309|365631565|FG010|Induction Period|Withdrawal by Subject|0|||
105992283|NCT03364309|365631566|FG011|Induction Period|Withdrawal by Subject|0|||
105992284|NCT03364309|365631567|FG012|Induction Period|Withdrawal by Subject|0|||
105992285|NCT03364309|365631568|FG013|Induction Period|Withdrawal by Subject|0|||
105992286|NCT03364309|365631569|FG014|Induction Period|Withdrawal by Subject|0|||
105992287|NCT03364309|365631570|FG015|Induction Period|Withdrawal by Subject|0|||
105992288|NCT03364309|365631571|FG016|Induction Period|Withdrawal by Subject|0|||
105992289|NCT03364309|365631572|FG017|Induction Period|Withdrawal by Subject|0|||
105992290|NCT03364309|365631573|FG018|Induction Period|Withdrawal by Subject|0|||
105992291|NCT03364309|365631555|FG000|Induction Period|Lost to Follow-up|1|||
105992292|NCT03364309|365631556|FG001|Induction Period|Lost to Follow-up|0|||
105992293|NCT03364309|365631557|FG002|Induction Period|Lost to Follow-up|0|||
105992294|NCT03364309|365631558|FG003|Induction Period|Lost to Follow-up|0|||
105992295|NCT03364309|365631559|FG004|Induction Period|Lost to Follow-up|0|||
105992296|NCT03364309|365631560|FG005|Induction Period|Lost to Follow-up|0|||
105992297|NCT03364309|365631561|FG006|Induction Period|Lost to Follow-up|0|||
106100125|NCT03240588|366022664|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
106100126|NCT03912259|366022667|FG000|Overall Study|Adverse Event (AE)|2|||
106100127|NCT03912259|366022668|FG001|Overall Study|Adverse Event (AE)|4|||
106100128|NCT03912259|366022667|FG000|Overall Study|Lack of Efficacy|4|||
106100129|NCT03912259|366022668|FG001|Overall Study|Lack of Efficacy|1|||
106100130|NCT03912259|366022667|FG000|Overall Study|Withdrawal by Subject|11|||
106100131|NCT03912259|366022668|FG001|Overall Study|Withdrawal by Subject|1|||
106100132|NCT01259713|366022669|FG000|Overall Study|Adverse Event|54|||
106100133|NCT01259713|366022670|FG001|Overall Study|Adverse Event|23|||
106100134|NCT01259713|366022669|FG000|Overall Study|Death Not Related to IFI|8|||
106100135|NCT01259713|366022670|FG001|Overall Study|Death Not Related to IFI|1|||
106100136|NCT01259713|366022669|FG000|Overall Study|Investigators Discretion|14|||
106100137|NCT01259713|366022670|FG001|Overall Study|Investigators Discretion|6|||
106100138|NCT01259713|366022669|FG000|Overall Study|Lack of Efficacy|2|||
106100139|NCT01259713|366022670|FG001|Overall Study|Lack of Efficacy|0|||
106100140|NCT01259713|366022669|FG000|Overall Study|Protocol Violation|5|||
106100141|NCT01259713|366022670|FG001|Overall Study|Protocol Violation|4|||
106100142|NCT01259713|366022669|FG000|Overall Study|Subject Withdrew Consent|12|||
106100143|NCT01259713|366022670|FG001|Overall Study|Subject Withdrew Consent|7|||
106100144|NCT03461003|366022671|FG000|Overall Study|Lost to Follow-up|2|||
106100145|NCT03461003|366022672|FG001|Overall Study|Lost to Follow-up|2|||
106100146|NCT03461003|366022671|FG000|Overall Study|Withdrawal by Subject|3|||
106100147|NCT03461003|366022672|FG001|Overall Study|Withdrawal by Subject|1|||
106100148|NCT04955639|366022684|FG000|Overall Study|Withdrawal by Subject|2|||
106100149|NCT04955639|366022685|FG001|Overall Study|Withdrawal by Subject|2|||
106100150|NCT04955639|366022684|FG000|Overall Study|Week 26 survey not completed|2|||
106100151|NCT04955639|366022685|FG001|Overall Study|Week 26 survey not completed|2|||
106100152|NCT00413153|366022686|FG000|Overall Study|Withdrawal by Subject|1|||
106100153|NCT00413153|366022687|FG001|Overall Study|Withdrawal by Subject|1|||
106100154|NCT00413153|366022686|FG000|Overall Study|Adverse Event|1|||
106100155|NCT00413153|366022687|FG001|Overall Study|Adverse Event|0|||
106100156|NCT01221597|366022688|FG000|Overall Study|Adverse Event|4|||
106100157|NCT01221597|366022689|FG001|Overall Study|Adverse Event|1|||
106100158|NCT01221597|366022688|FG000|Overall Study|Withdrawal by Subject|20|||
106100159|NCT01221597|366022689|FG001|Overall Study|Withdrawal by Subject|6|||
106100160|NCT01221597|366022688|FG000|Overall Study|Lost to Follow-up|6|||
106100161|NCT01221597|366022689|FG001|Overall Study|Lost to Follow-up|5|||
106100162|NCT01221597|366022688|FG000|Overall Study|Protocol Violation|1|||
106100163|NCT01221597|366022689|FG001|Overall Study|Protocol Violation|0|||
106100164|NCT01221597|366022688|FG000|Overall Study|Other|3|||
106100165|NCT01221597|366022689|FG001|Overall Study|Other|4|||
106100166|NCT01221597|366022688|FG000|Overall Study|Death|2|||
106100167|NCT01221597|366022689|FG001|Overall Study|Death|0|||
105992298|NCT03364309|365631562|FG007|Induction Period|Lost to Follow-up|0|||
105992299|NCT03364309|365631563|FG008|Induction Period|Lost to Follow-up|0|||
105992300|NCT03364309|365631564|FG009|Induction Period|Lost to Follow-up|0|||
105992301|NCT03364309|365631565|FG010|Induction Period|Lost to Follow-up|0|||
105992302|NCT03364309|365631566|FG011|Induction Period|Lost to Follow-up|0|||
105992303|NCT03364309|365631567|FG012|Induction Period|Lost to Follow-up|0|||
105992304|NCT03364309|365631568|FG013|Induction Period|Lost to Follow-up|0|||
105992305|NCT03364309|365631569|FG014|Induction Period|Lost to Follow-up|0|||
105992306|NCT03364309|365631570|FG015|Induction Period|Lost to Follow-up|0|||
105992307|NCT03364309|365631571|FG016|Induction Period|Lost to Follow-up|0|||
105992308|NCT03364309|365631572|FG017|Induction Period|Lost to Follow-up|0|||
105992309|NCT03364309|365631573|FG018|Induction Period|Lost to Follow-up|0|||
105992310|NCT03364309|365631555|FG000|Induction Period|Physician Decision|0|||
105992311|NCT03364309|365631556|FG001|Induction Period|Physician Decision|1|||
105992312|NCT03364309|365631557|FG002|Induction Period|Physician Decision|0|||
105992313|NCT03364309|365631558|FG003|Induction Period|Physician Decision|0|||
105992314|NCT03364309|365631559|FG004|Induction Period|Physician Decision|0|||
105992315|NCT03364309|365631560|FG005|Induction Period|Physician Decision|0|||
105992316|NCT03364309|365631561|FG006|Induction Period|Physician Decision|0|||
105992317|NCT03364309|365631562|FG007|Induction Period|Physician Decision|0|||
105992318|NCT03364309|365631563|FG008|Induction Period|Physician Decision|0|||
105992319|NCT03364309|365631564|FG009|Induction Period|Physician Decision|0|||
105992320|NCT03364309|365631565|FG010|Induction Period|Physician Decision|0|||
105992321|NCT03364309|365631566|FG011|Induction Period|Physician Decision|0|||
105992322|NCT03364309|365631567|FG012|Induction Period|Physician Decision|0|||
105992323|NCT03364309|365631568|FG013|Induction Period|Physician Decision|0|||
105992324|NCT03364309|365631569|FG014|Induction Period|Physician Decision|0|||
105992325|NCT03364309|365631570|FG015|Induction Period|Physician Decision|0|||
106100168|NCT02119416|366022690|FG000|Overall Study|Protocol Violation|1|||
106100169|NCT02119416|366022691|FG001|Overall Study|Protocol Violation|1|||
106100170|NCT02119416|366022692|FG002|Overall Study|Protocol Violation|1|||
106100171|NCT02119416|366022690|FG000|Overall Study|wrong pubertal stage|1|||
106100172|NCT02119416|366022691|FG001|Overall Study|wrong pubertal stage|0|||
106100173|NCT02119416|366022692|FG002|Overall Study|wrong pubertal stage|1|||
106100174|NCT03834779|366022698|FG000|Overall Study|Death|1|||
106100175|NCT03834779|366022699|FG001|Overall Study|Death|2|||
106100176|NCT03834779|366022698|FG000|Overall Study|Lost to Follow-up|6|||
106100177|NCT03834779|366022699|FG001|Overall Study|Lost to Follow-up|4|||
106100178|NCT03593655|366022711|FG000|First Product Use Period|Withdrawal by Subject|1|||
106100179|NCT03593655|366022712|FG001|First Product Use Period|Withdrawal by Subject|1|||
106100180|NCT03593655|366022711|FG000|First Product Use Period|Lost to Follow-up|1|||
106100181|NCT03593655|366022712|FG001|First Product Use Period|Lost to Follow-up|3|||
106100182|NCT03593655|366022711|FG000|Second Product Use Period|Withdrawal by Subject|1|||
106100183|NCT03593655|366022712|FG001|Second Product Use Period|Withdrawal by Subject|1|||
106100184|NCT03593655|366022711|FG000|Second Product Use Period|Lost to Follow-up|1|||
106100185|NCT03593655|366022712|FG001|Second Product Use Period|Lost to Follow-up|0|||
106100186|NCT03593655|366022711|FG000|Third Product Use Period|Lost to Follow-up|1|||
106100187|NCT03593655|366022712|FG001|Third Product Use Period|Lost to Follow-up|2|||
106100188|NCT03593655|366022711|FG000|Third Product Use Period|Physician Decision|0|||
106100189|NCT03593655|366022712|FG001|Third Product Use Period|Physician Decision|1|||
106100190|NCT03593655|366022711|FG000|Third Product Use Period|Withdrawal by Subject|0|||
106100191|NCT03593655|366022712|FG001|Third Product Use Period|Withdrawal by Subject|1|||
106100192|NCT04420221|366022720|FG000|Overall Study|Withdrawal by Subject|0|||
106100193|NCT04420221|366022721|FG001|Overall Study|Withdrawal by Subject|0|||
106100194|NCT04420221|366022722|FG002|Overall Study|Withdrawal by Subject|0|||
106100195|NCT04420221|366022723|FG003|Overall Study|Withdrawal by Subject|0|||
106100196|NCT04420221|366022724|FG004|Overall Study|Withdrawal by Subject|0|||
106100197|NCT04420221|366022725|FG005|Overall Study|Withdrawal by Subject|20|||
106100198|NCT04420221|366022726|FG006|Overall Study|Withdrawal by Subject|5|||
106100199|NCT04420221|366022720|FG000|Overall Study|Other|0|||
106100200|NCT04420221|366022721|FG001|Overall Study|Other|0|||
106100201|NCT04420221|366022722|FG002|Overall Study|Other|0|||
106100202|NCT04420221|366022723|FG003|Overall Study|Other|0|||
106100203|NCT04420221|366022724|FG004|Overall Study|Other|0|||
106100204|NCT04420221|366022725|FG005|Overall Study|Other|1|||
106100205|NCT04420221|366022726|FG006|Overall Study|Other|1|||
106100206|NCT04420221|366022720|FG000|Overall Study|Lost to Follow-up|0|||
106100207|NCT04420221|366022721|FG001|Overall Study|Lost to Follow-up|0|||
106100208|NCT04420221|366022722|FG002|Overall Study|Lost to Follow-up|0|||
106100209|NCT04420221|366022723|FG003|Overall Study|Lost to Follow-up|0|||
106100210|NCT04420221|366022724|FG004|Overall Study|Lost to Follow-up|0|||
106100211|NCT04420221|366022725|FG005|Overall Study|Lost to Follow-up|3|||
106100212|NCT04420221|366022726|FG006|Overall Study|Lost to Follow-up|2|||
106100213|NCT04420221|366022720|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
106100214|NCT04420221|366022721|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
106100215|NCT04420221|366022722|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
106100216|NCT04420221|366022723|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
106100217|NCT04420221|366022724|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
106100218|NCT04420221|366022725|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
106100219|NCT04420221|366022726|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
106100220|NCT02363738|366022727|FG000|Overall Study|Adverse Event|5|||
106100221|NCT02363738|366022728|FG001|Overall Study|Adverse Event|2|||
106100222|NCT02363738|366022727|FG000|Overall Study|Lack of Efficacy|1|||
106100223|NCT02363738|366022728|FG001|Overall Study|Lack of Efficacy|2|||
106100224|NCT02363738|366022727|FG000|Overall Study|Lost to Follow-up|2|||
106100225|NCT02363738|366022728|FG001|Overall Study|Lost to Follow-up|1|||
106100226|NCT01300546|366022730|FG000|Overall Study|Withdrawal by Subject|1|||
106100227|NCT01300546|366022731|FG001|Overall Study|Withdrawal by Subject|0|||
106100228|NCT01300546|366022730|FG000|Overall Study|Lost to Follow-up|0|||
106100229|NCT01300546|366022731|FG001|Overall Study|Lost to Follow-up|2|||
106100230|NCT01300546|366022730|FG000|Overall Study|Lack of Efficacy|0|||
106100231|NCT01300546|366022731|FG001|Overall Study|Lack of Efficacy|3|||
106100232|NCT01300546|366022730|FG000|Overall Study|Adverse Event|0|||
106100233|NCT01300546|366022731|FG001|Overall Study|Adverse Event|1|||
106100234|NCT02715765|366022732|FG000|Overall Study|Study Termination|3|||
106100235|NCT02715765|366022733|FG001|Overall Study|Study Termination|0|||
106100236|NCT02715765|366022734|FG002|Overall Study|Study Termination|0|||
106100237|NCT00435370|366022741|FG000|Overall Study|Adverse Event|8|||
106100238|NCT00435370|366022742|FG001|Overall Study|Adverse Event|8|||
106100239|NCT00435370|366022741|FG000|Overall Study|Withdrawal by Subject|10|||
106100240|NCT00435370|366022742|FG001|Overall Study|Withdrawal by Subject|10|||
106100241|NCT00435370|366022741|FG000|Overall Study|Antipsychotic medication changed|4|||
106100242|NCT00435370|366022742|FG001|Overall Study|Antipsychotic medication changed|2|||
106100243|NCT01965834|366022743|FG000|Overall Study|Lack of Efficacy|4|||
106100244|NCT00744653|366022746|FG000|Overall Study|antineoplastic treatment|11|||
106100245|NCT00744653|366022746|FG000|Overall Study|Death|1|||
106100246|NCT00744653|366022746|FG000|Overall Study|Lost to Follow-up|1|||
106100247|NCT00744653|366022746|FG000|Overall Study|Physician Decision|3|||
106100248|NCT03826667|366022747|FG000|Overall Study|Protocol deviation|21|||
106100249|NCT02298192|366022748|FG000|Overall Study|Unclassified|3|||
106100250|NCT02298192|366022749|FG001|Overall Study|Unclassified|2|||
106100251|NCT02298192|366022748|FG000|Overall Study|Withdrawal criteria|2|||
106100252|NCT02298192|366022749|FG001|Overall Study|Withdrawal criteria|0|||
106100253|NCT02298192|366022748|FG000|Overall Study|Withdrawal by Subject|6|||
106100254|NCT02298192|366022749|FG001|Overall Study|Withdrawal by Subject|1|||
106100255|NCT02298192|366022748|FG000|Overall Study|Lost to Follow-up|2|||
106100256|NCT02298192|366022749|FG001|Overall Study|Lost to Follow-up|1|||
106100257|NCT02298192|366022748|FG000|Overall Study|Adverse Event|6|||
106100258|NCT02298192|366022749|FG001|Overall Study|Adverse Event|2|||
106100259|NCT02352948|366022754|FG000|Overall Study|Death|47|||
106100260|NCT02352948|366022755|FG001|Overall Study|Death|48|||
106100261|NCT02352948|366022756|FG002|Overall Study|Death|114|||
106100262|NCT02352948|366022757|FG003|Overall Study|Death|74|||
106100263|NCT02352948|366022758|FG004|Overall Study|Death|77|||
106100264|NCT02352948|366022759|FG005|Overall Study|Death|44|||
106100265|NCT02352948|366022754|FG000|Overall Study|Lost to Follow-up|1|||
106100266|NCT02352948|366022755|FG001|Overall Study|Lost to Follow-up|0|||
106100267|NCT02352948|366022756|FG002|Overall Study|Lost to Follow-up|2|||
106100268|NCT02352948|366022757|FG003|Overall Study|Lost to Follow-up|1|||
106100269|NCT02352948|366022758|FG004|Overall Study|Lost to Follow-up|2|||
106100270|NCT02352948|366022759|FG005|Overall Study|Lost to Follow-up|1|||
106100271|NCT02352948|366022754|FG000|Overall Study|Withdrawal by Subject|1|||
106100272|NCT02352948|366022755|FG001|Overall Study|Withdrawal by Subject|10|||
106100273|NCT02352948|366022756|FG002|Overall Study|Withdrawal by Subject|11|||
106100274|NCT02352948|366022757|FG003|Overall Study|Withdrawal by Subject|23|||
106100275|NCT02352948|366022758|FG004|Overall Study|Withdrawal by Subject|9|||
106100276|NCT02352948|366022759|FG005|Overall Study|Withdrawal by Subject|4|||
106100277|NCT02352948|366022754|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
106100278|NCT02352948|366022755|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
106100279|NCT02352948|366022756|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
106100280|NCT02352948|366022757|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
106100281|NCT02352948|366022758|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
106100282|NCT02352948|366022759|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
106100283|NCT02352948|366022754|FG000|Overall Study|Other|0|||
106100284|NCT02352948|366022755|FG001|Overall Study|Other|0|||
106100285|NCT02352948|366022756|FG002|Overall Study|Other|2|||
106100286|NCT02352948|366022757|FG003|Overall Study|Other|0|||
106100287|NCT02352948|366022758|FG004|Overall Study|Other|0|||
106100288|NCT02352948|366022759|FG005|Overall Study|Other|0|||
106100289|NCT02653482|366022760|FG000|Overall Study|Death|1|||
106100290|NCT02653482|366022761|FG001|Overall Study|Death|1|||
106100291|NCT03230916|366022762|FG000|Overall Study|Withdrawal by Subject|0|||
106100292|NCT03230916|366022763|FG001|Overall Study|Withdrawal by Subject|0|||
106100293|NCT03230916|366022764|FG002|Overall Study|Withdrawal by Subject|0|||
106100294|NCT03230916|366022765|FG003|Overall Study|Withdrawal by Subject|0|||
106100295|NCT03230916|366022766|FG004|Overall Study|Withdrawal by Subject|0|||
106100296|NCT03230916|366022767|FG005|Overall Study|Withdrawal by Subject|1|||
106100297|NCT03230916|366022768|FG006|Overall Study|Withdrawal by Subject|0|||
106100298|NCT03230916|366022769|FG007|Overall Study|Withdrawal by Subject|0|||
106100299|NCT03230916|366022770|FG008|Overall Study|Withdrawal by Subject|0|||
106100300|NCT03230916|366022771|FG009|Overall Study|Withdrawal by Subject|0|||
106100301|NCT03230916|366022772|FG010|Overall Study|Withdrawal by Subject|0|||
106100302|NCT01669122|366022773|FG000|Period I|Lost to Follow-up|1|||
106100303|NCT01669122|366022773|FG000|Washout Period II|Protocol Violation|2|||
106100304|NCT05132699|366022774|FG000|Overall Study|Withdrawal by Subject|3|||
106100305|NCT05132699|366022775|FG001|Overall Study|Withdrawal by Subject|0|||
106100306|NCT02899728|366022776|FG000|Overall Study|Withdrawal by Subject|1|||
106100307|NCT02899728|366022777|FG001|Overall Study|Withdrawal by Subject|1|||
106100308|NCT03972488|366022784|FG000|Overall Study|Progressive disease|42|||
106100309|NCT03972488|366022785|FG001|Overall Study|Progressive disease|44|||
106100310|NCT03972488|366022784|FG000|Overall Study|Physician Decision|13|||
106100311|NCT03972488|366022785|FG001|Overall Study|Physician Decision|7|||
106100312|NCT03972488|366022784|FG000|Overall Study|Adverse Event|8|||
106100313|NCT03972488|366022785|FG001|Overall Study|Adverse Event|1|||
106100314|NCT03972488|366022784|FG000|Overall Study|Death|4|||
106100315|NCT03972488|366022785|FG001|Overall Study|Death|4|||
106100316|NCT03972488|366022784|FG000|Overall Study|Withdrawal by Subject|3|||
106100317|NCT03972488|366022785|FG001|Overall Study|Withdrawal by Subject|4|||
106100318|NCT03972488|366022784|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
106100319|NCT03972488|366022785|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
106100320|NCT05245864|366022788|FG000|Overall Study|Withdrawal by Subject|1|||
106100321|NCT05245864|366022789|FG001|Overall Study|Withdrawal by Subject|1|||
106100322|NCT01275625|366024493|FG000|Overall Study|Death|1|||
106100323|NCT01275625|366024493|FG000|Overall Study|Lack of Efficacy|2|||
106100324|NCT01275625|366024493|FG000|Overall Study|Lost to Follow-up|1|||
106100325|NCT01275625|366024493|FG000|Overall Study|Withdrawal by Subject|3|||
106100326|NCT01275625|366024493|FG000|Overall Study|Protocol Violation|1|||
106100327|NCT01275625|366024493|FG000|Overall Study|Adverse Event|4|||
106100328|NCT01275625|366024493|FG000|Overall Study|Other|1|||
105779383|NCT00386152|364844740|FG000|Overall Study|Chang from original chemo stratification|4|||
105992326|NCT03364309|365631571|FG016|Induction Period|Physician Decision|0|||
105992327|NCT03364309|365631572|FG017|Induction Period|Physician Decision|0|||
105992328|NCT03364309|365631573|FG018|Induction Period|Physician Decision|0|||
105992329|NCT03364309|365631555|FG000|Maintenance Period|Withdrawal by Subject|0|||
105992330|NCT03364309|365631556|FG001|Maintenance Period|Withdrawal by Subject|0|||
105992331|NCT03364309|365631557|FG002|Maintenance Period|Withdrawal by Subject|0|||
105992332|NCT03364309|365631558|FG003|Maintenance Period|Withdrawal by Subject|1|||
105992333|NCT03364309|365631559|FG004|Maintenance Period|Withdrawal by Subject|3|||
105992334|NCT03364309|365631560|FG005|Maintenance Period|Withdrawal by Subject|1|||
105992335|NCT03364309|365631561|FG006|Maintenance Period|Withdrawal by Subject|3|||
105992336|NCT03364309|365631562|FG007|Maintenance Period|Withdrawal by Subject|0|||
105992337|NCT03364309|365631563|FG008|Maintenance Period|Withdrawal by Subject|1|||
105992338|NCT03364309|365631564|FG009|Maintenance Period|Withdrawal by Subject|1|||
105992339|NCT03364309|365631565|FG010|Maintenance Period|Withdrawal by Subject|2|||
105992340|NCT03364309|365631566|FG011|Maintenance Period|Withdrawal by Subject|0|||
105992341|NCT03364309|365631567|FG012|Maintenance Period|Withdrawal by Subject|0|||
105992342|NCT03364309|365631568|FG013|Maintenance Period|Withdrawal by Subject|0|||
105992343|NCT03364309|365631569|FG014|Maintenance Period|Withdrawal by Subject|0|||
105992344|NCT03364309|365631570|FG015|Maintenance Period|Withdrawal by Subject|0|||
105992345|NCT03364309|365631571|FG016|Maintenance Period|Withdrawal by Subject|0|||
105992346|NCT03364309|365631572|FG017|Maintenance Period|Withdrawal by Subject|0|||
105992347|NCT03364309|365631573|FG018|Maintenance Period|Withdrawal by Subject|0|||
105992348|NCT03364309|365631555|FG000|Maintenance Period|Adverse Event|0|||
105992349|NCT03364309|365631556|FG001|Maintenance Period|Adverse Event|0|||
105992350|NCT03364309|365631557|FG002|Maintenance Period|Adverse Event|0|||
105992351|NCT03364309|365631558|FG003|Maintenance Period|Adverse Event|0|||
105992352|NCT03364309|365631559|FG004|Maintenance Period|Adverse Event|2|||
105992353|NCT03364309|365631560|FG005|Maintenance Period|Adverse Event|0|||
105992354|NCT03364309|365631561|FG006|Maintenance Period|Adverse Event|3|||
105992355|NCT03364309|365631562|FG007|Maintenance Period|Adverse Event|0|||
105992356|NCT03364309|365631563|FG008|Maintenance Period|Adverse Event|1|||
105992357|NCT03364309|365631564|FG009|Maintenance Period|Adverse Event|0|||
105992358|NCT03364309|365631565|FG010|Maintenance Period|Adverse Event|2|||
105992359|NCT03364309|365631566|FG011|Maintenance Period|Adverse Event|0|||
105992360|NCT03364309|365631567|FG012|Maintenance Period|Adverse Event|0|||
105992361|NCT03364309|365631568|FG013|Maintenance Period|Adverse Event|0|||
105992362|NCT03364309|365631569|FG014|Maintenance Period|Adverse Event|0|||
105992363|NCT03364309|365631570|FG015|Maintenance Period|Adverse Event|0|||
105992364|NCT03364309|365631571|FG016|Maintenance Period|Adverse Event|0|||
105992365|NCT03364309|365631572|FG017|Maintenance Period|Adverse Event|0|||
105992366|NCT03364309|365631573|FG018|Maintenance Period|Adverse Event|0|||
105992367|NCT03364309|365631555|FG000|Maintenance Period|Relapsed|0|||
105992368|NCT03364309|365631556|FG001|Maintenance Period|Relapsed|0|||
105992369|NCT03364309|365631557|FG002|Maintenance Period|Relapsed|0|||
105992370|NCT03364309|365631558|FG003|Maintenance Period|Relapsed|43|||
105992371|NCT03364309|365631559|FG004|Maintenance Period|Relapsed|7|||
105992372|NCT03364309|365631560|FG005|Maintenance Period|Relapsed|45|||
105992373|NCT03364309|365631561|FG006|Maintenance Period|Relapsed|10|||
105992374|NCT03364309|365631562|FG007|Maintenance Period|Relapsed|2|||
105992375|NCT03364309|365631563|FG008|Maintenance Period|Relapsed|0|||
105992376|NCT03364309|365631564|FG009|Maintenance Period|Relapsed|0|||
105992377|NCT03364309|365631565|FG010|Maintenance Period|Relapsed|0|||
105992378|NCT03364309|365631566|FG011|Maintenance Period|Relapsed|0|||
105992379|NCT03364309|365631567|FG012|Maintenance Period|Relapsed|0|||
105992380|NCT03364309|365631568|FG013|Maintenance Period|Relapsed|0|||
105992381|NCT03364309|365631569|FG014|Maintenance Period|Relapsed|0|||
105992382|NCT03364309|365631570|FG015|Maintenance Period|Relapsed|0|||
105992383|NCT03364309|365631571|FG016|Maintenance Period|Relapsed|0|||
105992384|NCT03364309|365631572|FG017|Maintenance Period|Relapsed|0|||
105992385|NCT03364309|365631573|FG018|Maintenance Period|Relapsed|0|||
105992386|NCT03364309|365631555|FG000|Maintenance Period|Lack of Efficacy|0|||
105992387|NCT03364309|365631556|FG001|Maintenance Period|Lack of Efficacy|0|||
105992388|NCT03364309|365631557|FG002|Maintenance Period|Lack of Efficacy|0|||
105992389|NCT03364309|365631558|FG003|Maintenance Period|Lack of Efficacy|0|||
105992390|NCT03364309|365631559|FG004|Maintenance Period|Lack of Efficacy|0|||
105992391|NCT03364309|365631560|FG005|Maintenance Period|Lack of Efficacy|0|||
105992392|NCT03364309|365631561|FG006|Maintenance Period|Lack of Efficacy|0|||
105992393|NCT03364309|365631562|FG007|Maintenance Period|Lack of Efficacy|0|||
105992394|NCT03364309|365631563|FG008|Maintenance Period|Lack of Efficacy|1|||
105992395|NCT03364309|365631564|FG009|Maintenance Period|Lack of Efficacy|3|||
105992396|NCT03364309|365631565|FG010|Maintenance Period|Lack of Efficacy|2|||
105992397|NCT03364309|365631566|FG011|Maintenance Period|Lack of Efficacy|0|||
105992398|NCT03364309|365631567|FG012|Maintenance Period|Lack of Efficacy|0|||
105992399|NCT03364309|365631568|FG013|Maintenance Period|Lack of Efficacy|0|||
105992400|NCT03364309|365631569|FG014|Maintenance Period|Lack of Efficacy|0|||
105992401|NCT03364309|365631570|FG015|Maintenance Period|Lack of Efficacy|0|||
105992402|NCT03364309|365631571|FG016|Maintenance Period|Lack of Efficacy|0|||
106100329|NCT01585103|366024495|FG000|Overall Study|Unable to swallow Cytosponge|6|||
106100330|NCT03147248|366024499|FG000|Overall Study|Adverse Event|0|||
106100331|NCT03147248|366024500|FG001|Overall Study|Adverse Event|2|||
106100332|NCT03147248|366024501|FG002|Overall Study|Adverse Event|2|||
106100333|NCT03147248|366024502|FG003|Overall Study|Adverse Event|2|||
106100334|NCT03147248|366024503|FG004|Overall Study|Adverse Event|6|||
106100335|NCT03147248|366024504|FG005|Overall Study|Adverse Event|11|||
106100336|NCT03147248|366024499|FG000|Overall Study|Disease progression|1|||
106100337|NCT03147248|366024500|FG001|Overall Study|Disease progression|0|||
106100338|NCT03147248|366024501|FG002|Overall Study|Disease progression|0|||
106100339|NCT03147248|366024502|FG003|Overall Study|Disease progression|0|||
106100340|NCT03147248|366024503|FG004|Overall Study|Disease progression|0|||
106100341|NCT03147248|366024504|FG005|Overall Study|Disease progression|2|||
106100342|NCT03147248|366024499|FG000|Overall Study|Withdrawal by Subject|0|||
106100343|NCT03147248|366024500|FG001|Overall Study|Withdrawal by Subject|0|||
106100344|NCT03147248|366024501|FG002|Overall Study|Withdrawal by Subject|0|||
106100345|NCT03147248|366024502|FG003|Overall Study|Withdrawal by Subject|0|||
106100346|NCT03147248|366024503|FG004|Overall Study|Withdrawal by Subject|12|||
106100347|NCT03147248|366024504|FG005|Overall Study|Withdrawal by Subject|9|||
106100348|NCT03147248|366024499|FG000|Overall Study|Protocol Violation|0|||
106100349|NCT03147248|366024500|FG001|Overall Study|Protocol Violation|0|||
106100350|NCT03147248|366024501|FG002|Overall Study|Protocol Violation|0|||
106100351|NCT03147248|366024502|FG003|Overall Study|Protocol Violation|0|||
106100352|NCT03147248|366024503|FG004|Overall Study|Protocol Violation|2|||
106100353|NCT03147248|366024504|FG005|Overall Study|Protocol Violation|0|||
106100354|NCT03147248|366024499|FG000|Overall Study|Lost to Follow-up|0|||
106100355|NCT03147248|366024500|FG001|Overall Study|Lost to Follow-up|0|||
106100356|NCT03147248|366024501|FG002|Overall Study|Lost to Follow-up|0|||
106100357|NCT03147248|366024502|FG003|Overall Study|Lost to Follow-up|0|||
106100358|NCT03147248|366024503|FG004|Overall Study|Lost to Follow-up|2|||
106100359|NCT03147248|366024504|FG005|Overall Study|Lost to Follow-up|0|||
106100360|NCT03147248|366024499|FG000|Overall Study|Pregnancy|0|||
106100361|NCT03147248|366024500|FG001|Overall Study|Pregnancy|0|||
106100362|NCT03147248|366024501|FG002|Overall Study|Pregnancy|0|||
106100363|NCT03147248|366024502|FG003|Overall Study|Pregnancy|0|||
106100364|NCT03147248|366024503|FG004|Overall Study|Pregnancy|1|||
106100365|NCT03147248|366024504|FG005|Overall Study|Pregnancy|0|||
106100366|NCT03147248|366024499|FG000|Overall Study|Death|0|||
106100367|NCT03147248|366024500|FG001|Overall Study|Death|0|||
106100368|NCT03147248|366024501|FG002|Overall Study|Death|0|||
106100369|NCT03147248|366024502|FG003|Overall Study|Death|0|||
106100370|NCT03147248|366024503|FG004|Overall Study|Death|0|||
106100371|NCT03147248|366024504|FG005|Overall Study|Death|4|||
106100372|NCT03147248|366024499|FG000|Overall Study|Physician Decision|0|||
106100373|NCT03147248|366024500|FG001|Overall Study|Physician Decision|0|||
106100374|NCT03147248|366024501|FG002|Overall Study|Physician Decision|0|||
106100375|NCT03147248|366024502|FG003|Overall Study|Physician Decision|0|||
106100376|NCT03147248|366024503|FG004|Overall Study|Physician Decision|2|||
106100377|NCT03147248|366024504|FG005|Overall Study|Physician Decision|4|||
106100378|NCT03147248|366024499|FG000|Overall Study|Prolonged Dosing Interval|0|||
106100379|NCT03147248|366024500|FG001|Overall Study|Prolonged Dosing Interval|0|||
106100380|NCT03147248|366024501|FG002|Overall Study|Prolonged Dosing Interval|0|||
106100381|NCT03147248|366024502|FG003|Overall Study|Prolonged Dosing Interval|0|||
106100382|NCT03147248|366024503|FG004|Overall Study|Prolonged Dosing Interval|1|||
106100383|NCT03147248|366024504|FG005|Overall Study|Prolonged Dosing Interval|1|||
106100384|NCT03750552|366024505|FG000|Overall Study|Adverse Event|5|||
106100385|NCT03750552|366024506|FG001|Overall Study|Adverse Event|1|||
106100386|NCT03750552|366024505|FG000|Overall Study|Withdrawal by Subject|1|||
106100387|NCT03750552|366024506|FG001|Overall Study|Withdrawal by Subject|1|||
106100388|NCT03750552|366024505|FG000|Overall Study|Other|2|||
106100389|NCT03750552|366024506|FG001|Overall Study|Other|0|||
106100390|NCT02062632|366024507|FG000|Overall Study|No treatment data|1|||
106100391|NCT02105116|366024509|FG000|Overall Study|not eligible for step 2 of trial|5|||
106100392|NCT02105116|366024509|FG000|Overall Study|Death|1|||
106100393|NCT03832010|366024515|FG000|Overall Study|Withdrawal by Subject|2|||
106100394|NCT03832010|366024516|FG001|Overall Study|Withdrawal by Subject|1|||
106100395|NCT03832010|366024517|FG002|Overall Study|Withdrawal by Subject|0|||
106100396|NCT03832010|366024515|FG000|Overall Study|Lost to Follow-up|2|||
106100397|NCT03832010|366024516|FG001|Overall Study|Lost to Follow-up|1|||
106100398|NCT03832010|366024517|FG002|Overall Study|Lost to Follow-up|1|||
106100399|NCT01944631|366024518|FG000|Overall Study|Adverse Event|1|||
106100400|NCT01944631|366024519|FG001|Overall Study|Adverse Event|0|||
106100401|NCT01944631|366024518|FG000|Overall Study|Lost to Follow-up|3|||
106100402|NCT01944631|366024519|FG001|Overall Study|Lost to Follow-up|1|||
106100403|NCT01944631|366024518|FG000|Overall Study|Withdrawal by Subject|0|||
106100404|NCT01944631|366024519|FG001|Overall Study|Withdrawal by Subject|1|||
106100405|NCT02522494|366024520|FG000|Overall Study|Lost to Follow-up|6|||
106100406|NCT02522494|366024521|FG001|Overall Study|Lost to Follow-up|2|||
106100407|NCT02522494|366024520|FG000|Overall Study|Withdrawal by Subject|1|||
106100408|NCT02522494|366024521|FG001|Overall Study|Withdrawal by Subject|0|||
106100409|NCT02522494|366024520|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
106100410|NCT02522494|366024521|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
106100411|NCT02522494|366024520|FG000|Overall Study|Participant did not watch the video|1|||
106100412|NCT02522494|366024521|FG001|Overall Study|Participant did not watch the video|0|||
106100413|NCT02522494|366024520|FG000|Overall Study|Death|0|||
106100414|NCT02522494|366024521|FG001|Overall Study|Death|1|||
106100415|NCT02811861|366024522|FG000|Overall Study|Radiological Disease Progression|123|||
106100416|NCT02811861|366024523|FG001|Overall Study|Radiological Disease Progression|97|||
106100417|NCT02811861|366024524|FG002|Overall Study|Radiological Disease Progression|174|||
106100418|NCT02811861|366024522|FG000|Overall Study|Clinical Disease Progression|20|||
106100419|NCT02811861|366024523|FG001|Overall Study|Clinical Disease Progression|19|||
106100420|NCT02811861|366024524|FG002|Overall Study|Clinical Disease Progression|22|||
106100421|NCT02811861|366024522|FG000|Overall Study|Adverse Event|63|||
106100422|NCT02811861|366024523|FG001|Overall Study|Adverse Event|60|||
106100423|NCT02811861|366024524|FG002|Overall Study|Adverse Event|41|||
106100424|NCT02811861|366024522|FG000|Overall Study|Lost to Follow-up|0|||
106100425|NCT02811861|366024523|FG001|Overall Study|Lost to Follow-up|0|||
106100426|NCT02811861|366024524|FG002|Overall Study|Lost to Follow-up|1|||
106100427|NCT02811861|366024522|FG000|Overall Study|Subject Choice|29|||
106100428|NCT02811861|366024523|FG001|Overall Study|Subject Choice|17|||
106100429|NCT02811861|366024524|FG002|Overall Study|Subject Choice|23|||
106100430|NCT02811861|366024522|FG000|Overall Study|Withdrawal by Subject|4|||
106100431|NCT02811861|366024523|FG001|Overall Study|Withdrawal by Subject|4|||
106100432|NCT02811861|366024524|FG002|Overall Study|Withdrawal by Subject|9|||
106100433|NCT02811861|366024522|FG000|Overall Study|Other|4|||
106100434|NCT02811861|366024523|FG001|Overall Study|Other|13|||
106100435|NCT02811861|366024524|FG002|Overall Study|Other|3|||
106100436|NCT02811861|366024522|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
106100437|NCT02811861|366024523|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
106100438|NCT02811861|366024524|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
106100439|NCT02811861|366024522|FG000|Overall Study|Randomized but not treated|2|||
106100440|NCT02811861|366024523|FG001|Overall Study|Randomized but not treated|3|||
106100441|NCT02811861|366024524|FG002|Overall Study|Randomized but not treated|17|||
106100442|NCT01412944|366024525|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
106100443|NCT01412944|366024526|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
106100444|NCT01412944|366024527|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
106100445|NCT01412944|366024528|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
106100446|NCT01412944|366024529|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
106100447|NCT01412944|366024530|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
106100448|NCT01412944|366024525|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
106100449|NCT01412944|366024526|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
106100450|NCT01412944|366024527|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
106100451|NCT01412944|366024528|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
106100452|NCT01412944|366024529|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
106100453|NCT01412944|366024530|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
106100454|NCT01412944|366024525|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
106100455|NCT01412944|366024526|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
106100456|NCT01412944|366024527|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
106100457|NCT01412944|366024528|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
106100458|NCT01412944|366024529|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
106100459|NCT01412944|366024530|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
106100460|NCT01412944|366024525|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
106100461|NCT01412944|366024526|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
106100462|NCT01412944|366024527|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
106100463|NCT01412944|366024528|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
106100464|NCT01412944|366024529|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
106100465|NCT01412944|366024530|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
106100466|NCT01412944|366024525|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
106100467|NCT01412944|366024526|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
106100468|NCT01412944|366024527|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
106100469|NCT01412944|366024528|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
106100470|NCT01412944|366024529|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
106100471|NCT01412944|366024530|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
106100472|NCT01412944|366024525|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
106100473|NCT01412944|366024526|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
106100474|NCT01412944|366024527|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
106100475|NCT01412944|366024528|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
106100476|NCT01412944|366024529|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
105779384|NCT00386152|364844741|FG001|Overall Study|Chang from original chemo stratification|5|||
106100477|NCT01412944|366024530|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
106100478|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
105992403|NCT03364309|365631572|FG017|Maintenance Period|Lack of Efficacy|0|||
105992404|NCT03364309|365631573|FG018|Maintenance Period|Lack of Efficacy|0|||
105992405|NCT03364309|365631555|FG000|Maintenance Period|Death|0|||
105992406|NCT03364309|365631556|FG001|Maintenance Period|Death|0|||
105992407|NCT03364309|365631557|FG002|Maintenance Period|Death|0|||
105992408|NCT03364309|365631558|FG003|Maintenance Period|Death|0|||
105992409|NCT03364309|365631559|FG004|Maintenance Period|Death|0|||
105992410|NCT03364309|365631560|FG005|Maintenance Period|Death|0|||
105992411|NCT03364309|365631561|FG006|Maintenance Period|Death|0|||
105992412|NCT03364309|365631562|FG007|Maintenance Period|Death|0|||
105992413|NCT03364309|365631563|FG008|Maintenance Period|Death|1|||
105992414|NCT03364309|365631564|FG009|Maintenance Period|Death|0|||
105992415|NCT03364309|365631565|FG010|Maintenance Period|Death|0|||
105992416|NCT03364309|365631566|FG011|Maintenance Period|Death|0|||
105992417|NCT03364309|365631567|FG012|Maintenance Period|Death|0|||
105992418|NCT03364309|365631568|FG013|Maintenance Period|Death|0|||
105992419|NCT03364309|365631569|FG014|Maintenance Period|Death|0|||
105992420|NCT03364309|365631570|FG015|Maintenance Period|Death|0|||
105992421|NCT03364309|365631571|FG016|Maintenance Period|Death|0|||
105992422|NCT03364309|365631572|FG017|Maintenance Period|Death|0|||
105992423|NCT03364309|365631573|FG018|Maintenance Period|Death|0|||
105992424|NCT03364309|365631555|FG000|Maintenance Period|Lost to Follow-up|0|||
105992425|NCT03364309|365631556|FG001|Maintenance Period|Lost to Follow-up|0|||
105992426|NCT03364309|365631557|FG002|Maintenance Period|Lost to Follow-up|0|||
105992427|NCT03364309|365631558|FG003|Maintenance Period|Lost to Follow-up|0|||
105992428|NCT03364309|365631559|FG004|Maintenance Period|Lost to Follow-up|0|||
105992429|NCT03364309|365631560|FG005|Maintenance Period|Lost to Follow-up|0|||
105992430|NCT03364309|365631561|FG006|Maintenance Period|Lost to Follow-up|0|||
105992431|NCT03364309|365631562|FG007|Maintenance Period|Lost to Follow-up|0|||
105992432|NCT03364309|365631563|FG008|Maintenance Period|Lost to Follow-up|1|||
105992433|NCT03364309|365631564|FG009|Maintenance Period|Lost to Follow-up|0|||
105992434|NCT03364309|365631565|FG010|Maintenance Period|Lost to Follow-up|0|||
105992435|NCT03364309|365631566|FG011|Maintenance Period|Lost to Follow-up|0|||
105992436|NCT03364309|365631567|FG012|Maintenance Period|Lost to Follow-up|0|||
105992437|NCT03364309|365631568|FG013|Maintenance Period|Lost to Follow-up|0|||
105992438|NCT03364309|365631569|FG014|Maintenance Period|Lost to Follow-up|0|||
105992439|NCT03364309|365631570|FG015|Maintenance Period|Lost to Follow-up|0|||
105992440|NCT03364309|365631571|FG016|Maintenance Period|Lost to Follow-up|0|||
105992441|NCT03364309|365631572|FG017|Maintenance Period|Lost to Follow-up|0|||
105992442|NCT03364309|365631573|FG018|Maintenance Period|Lost to Follow-up|0|||
105992443|NCT03364309|365631555|FG000|Maintenance Period|Miscellaneous|0|||
105992444|NCT03364309|365631556|FG001|Maintenance Period|Miscellaneous|0|||
105992445|NCT03364309|365631557|FG002|Maintenance Period|Miscellaneous|0|||
105992446|NCT03364309|365631558|FG003|Maintenance Period|Miscellaneous|0|||
105992447|NCT03364309|365631559|FG004|Maintenance Period|Miscellaneous|0|||
105992448|NCT03364309|365631560|FG005|Maintenance Period|Miscellaneous|0|||
105992449|NCT03364309|365631561|FG006|Maintenance Period|Miscellaneous|0|||
105992450|NCT03364309|365631562|FG007|Maintenance Period|Miscellaneous|0|||
105992451|NCT03364309|365631563|FG008|Maintenance Period|Miscellaneous|1|||
105992452|NCT03364309|365631564|FG009|Maintenance Period|Miscellaneous|0|||
105992453|NCT03364309|365631565|FG010|Maintenance Period|Miscellaneous|0|||
105992454|NCT03364309|365631566|FG011|Maintenance Period|Miscellaneous|0|||
105992455|NCT03364309|365631567|FG012|Maintenance Period|Miscellaneous|0|||
105992456|NCT03364309|365631568|FG013|Maintenance Period|Miscellaneous|0|||
105992457|NCT03364309|365631569|FG014|Maintenance Period|Miscellaneous|0|||
105992458|NCT03364309|365631570|FG015|Maintenance Period|Miscellaneous|0|||
105992459|NCT03364309|365631571|FG016|Maintenance Period|Miscellaneous|0|||
105992460|NCT03364309|365631572|FG017|Maintenance Period|Miscellaneous|0|||
105992461|NCT03364309|365631573|FG018|Maintenance Period|Miscellaneous|0|||
105992462|NCT03364309|365631555|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992463|NCT03364309|365631556|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992464|NCT03364309|365631557|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992465|NCT03364309|365631558|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992466|NCT03364309|365631559|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992467|NCT03364309|365631560|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992468|NCT03364309|365631561|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992469|NCT03364309|365631562|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992470|NCT03364309|365631563|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992471|NCT03364309|365631564|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992472|NCT03364309|365631565|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992473|NCT03364309|365631566|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992474|NCT03364309|365631567|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992475|NCT03364309|365631568|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
105992476|NCT03364309|365631569|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
105992477|NCT03364309|365631570|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
105992478|NCT03364309|365631571|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105992479|NCT03364309|365631572|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
106100479|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
106100480|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
106100481|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
106100482|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
106100483|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
106100484|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Adverse Event|0|||
106100485|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Adverse Event|0|||
106100486|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Adverse Event|0|||
106100487|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Adverse Event|0|||
106100488|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Adverse Event|1|||
106100489|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Adverse Event|0|||
106100490|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
106100491|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
106100492|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
106100493|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
106100494|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
106100495|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
106100496|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100497|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100498|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100499|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100500|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100501|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
106100502|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100503|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100504|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100505|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100506|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
106100507|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100508|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
106100509|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
106100510|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
106100511|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
106100512|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
106100513|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
106100514|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
106100515|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
106100516|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
106100517|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
106100518|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
106100519|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
106100520|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100521|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
106100522|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100523|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100524|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100525|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
106100526|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100527|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
106100528|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100529|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100530|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100531|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
106100532|NCT01412944|366024525|FG000|Entire: IV + Maintenance|Adverse Event|0|||
106100533|NCT01412944|366024526|FG001|Entire: IV + Maintenance|Adverse Event|1|||
106100534|NCT01412944|366024527|FG002|Entire: IV + Maintenance|Adverse Event|0|||
106100535|NCT01412944|366024528|FG003|Entire: IV + Maintenance|Adverse Event|0|||
106100536|NCT01412944|366024529|FG004|Entire: IV + Maintenance|Adverse Event|0|||
106100537|NCT01412944|366024530|FG005|Entire: IV + Maintenance|Adverse Event|0|||
106100538|NCT05545072|366024532|FG000|Overall Study|Lost to Follow-up|1|||
106100539|NCT05545072|366024533|FG001|Overall Study|Lost to Follow-up|0|||
106100540|NCT05545072|366024532|FG000|Overall Study|Study ended prematurely due to funding|2|||
106100541|NCT05545072|366024533|FG001|Overall Study|Study ended prematurely due to funding|2|||
106100542|NCT05585307|366024536|FG000|Overall Study|Lost to Follow-up|0|||
106100543|NCT05585307|366024537|FG001|Overall Study|Lost to Follow-up|0|||
106100544|NCT05585307|366024538|FG002|Overall Study|Lost to Follow-up|0|||
105779385|NCT00386152|364844742|FG002|Overall Study|Chang from original chemo stratification|6|||
106100545|NCT05585307|366024539|FG003|Overall Study|Lost to Follow-up|0|||
106100546|NCT05585307|366024540|FG004|Overall Study|Lost to Follow-up|0|||
106100547|NCT05585307|366024541|FG005|Overall Study|Lost to Follow-up|0|||
106100548|NCT05585307|366024542|FG006|Overall Study|Lost to Follow-up|1|||
106100549|NCT05585307|366024543|FG007|Overall Study|Lost to Follow-up|0|||
106100550|NCT03579563|366024544|FG000|Overall Study|Lost to Follow-up|0|||
106100551|NCT03579563|366024545|FG001|Overall Study|Lost to Follow-up|0|||
106100552|NCT03579563|366024546|FG002|Overall Study|Lost to Follow-up|0|||
106100553|NCT03579563|366024547|FG003|Overall Study|Lost to Follow-up|0|||
106100554|NCT03579563|366024548|FG004|Overall Study|Lost to Follow-up|1|||
106100555|NCT03579563|366024549|FG005|Overall Study|Lost to Follow-up|0|||
106100556|NCT03579563|366024544|FG000|Overall Study|Lack of Efficacy|1|||
106100557|NCT03579563|366024545|FG001|Overall Study|Lack of Efficacy|1|||
106100558|NCT03579563|366024546|FG002|Overall Study|Lack of Efficacy|4|||
106100559|NCT03579563|366024547|FG003|Overall Study|Lack of Efficacy|1|||
106100560|NCT03579563|366024548|FG004|Overall Study|Lack of Efficacy|2|||
106100561|NCT03579563|366024549|FG005|Overall Study|Lack of Efficacy|3|||
106100562|NCT03579563|366024544|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
106100563|NCT03579563|366024545|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
106100564|NCT03579563|366024546|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
106100565|NCT03579563|366024547|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
106100566|NCT03579563|366024548|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
106100567|NCT03579563|366024549|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
106100568|NCT03579563|366024544|FG000|Overall Study|Time/distance concern|0|||
106100569|NCT03579563|366024545|FG001|Overall Study|Time/distance concern|0|||
106100570|NCT03579563|366024546|FG002|Overall Study|Time/distance concern|1|||
106100571|NCT03579563|366024547|FG003|Overall Study|Time/distance concern|0|||
106100572|NCT03579563|366024548|FG004|Overall Study|Time/distance concern|0|||
106100573|NCT03579563|366024549|FG005|Overall Study|Time/distance concern|1|||
106100574|NCT03579563|366024544|FG000|Overall Study|COVID shutdown|2|||
106100575|NCT03579563|366024545|FG001|Overall Study|COVID shutdown|3|||
106100576|NCT03579563|366024546|FG002|Overall Study|COVID shutdown|4|||
106100577|NCT03579563|366024547|FG003|Overall Study|COVID shutdown|3|||
106100578|NCT03579563|366024548|FG004|Overall Study|COVID shutdown|1|||
106100579|NCT03579563|366024549|FG005|Overall Study|COVID shutdown|2|||
106100580|NCT03579563|366024544|FG000|Overall Study|Protocol administration error|1|||
106100581|NCT03579563|366024545|FG001|Overall Study|Protocol administration error|0|||
106100582|NCT03579563|366024546|FG002|Overall Study|Protocol administration error|1|||
106100583|NCT03579563|366024547|FG003|Overall Study|Protocol administration error|0|||
106100584|NCT03579563|366024548|FG004|Overall Study|Protocol administration error|1|||
106100585|NCT03579563|366024549|FG005|Overall Study|Protocol administration error|5|||
106100586|NCT04642638|366024552|FG000|Overall Study|Withdrawal by Subject|23|||
106100587|NCT04642638|366024553|FG001|Overall Study|Withdrawal by Subject|29|||
106100588|NCT04642638|366024554|FG002|Overall Study|Withdrawal by Subject|9|||
106100589|NCT04642638|366024555|FG003|Overall Study|Withdrawal by Subject|7|||
106100590|NCT04642638|366024556|FG004|Overall Study|Withdrawal by Subject|61|||
106100591|NCT04642638|366024557|FG005|Overall Study|Withdrawal by Subject|27|||
106100592|NCT04642638|366024552|FG000|Overall Study|Lost to Follow-up|17|||
106100593|NCT04642638|366024553|FG001|Overall Study|Lost to Follow-up|18|||
106100594|NCT04642638|366024554|FG002|Overall Study|Lost to Follow-up|5|||
106100595|NCT04642638|366024555|FG003|Overall Study|Lost to Follow-up|5|||
106100596|NCT04642638|366024556|FG004|Overall Study|Lost to Follow-up|6|||
106100597|NCT04642638|366024557|FG005|Overall Study|Lost to Follow-up|3|||
106100598|NCT04642638|366024552|FG000|Overall Study|Adverse Event|0|||
106100599|NCT04642638|366024553|FG001|Overall Study|Adverse Event|0|||
106100600|NCT04642638|366024554|FG002|Overall Study|Adverse Event|1|||
106100601|NCT04642638|366024555|FG003|Overall Study|Adverse Event|0|||
106100602|NCT04642638|366024556|FG004|Overall Study|Adverse Event|10|||
106100603|NCT04642638|366024557|FG005|Overall Study|Adverse Event|3|||
106100604|NCT04642638|366024552|FG000|Overall Study|Reason Not Specified|1|||
106100605|NCT04642638|366024553|FG001|Overall Study|Reason Not Specified|4|||
106100606|NCT04642638|366024554|FG002|Overall Study|Reason Not Specified|0|||
106100607|NCT04642638|366024555|FG003|Overall Study|Reason Not Specified|0|||
106100608|NCT04642638|366024556|FG004|Overall Study|Reason Not Specified|38|||
106100609|NCT04642638|366024557|FG005|Overall Study|Reason Not Specified|16|||
106100610|NCT04642638|366024552|FG000|Overall Study|Physician Decision|0|||
106100611|NCT04642638|366024553|FG001|Overall Study|Physician Decision|0|||
106100612|NCT04642638|366024554|FG002|Overall Study|Physician Decision|0|||
106100613|NCT04642638|366024555|FG003|Overall Study|Physician Decision|0|||
106100614|NCT04642638|366024556|FG004|Overall Study|Physician Decision|2|||
106100615|NCT04642638|366024557|FG005|Overall Study|Physician Decision|1|||
106100616|NCT04642638|366024552|FG000|Overall Study|Protocol Deviation|0|||
106100617|NCT04642638|366024553|FG001|Overall Study|Protocol Deviation|0|||
106100618|NCT04642638|366024554|FG002|Overall Study|Protocol Deviation|0|||
106100619|NCT04642638|366024555|FG003|Overall Study|Protocol Deviation|0|||
106100620|NCT04642638|366024556|FG004|Overall Study|Protocol Deviation|1|||
106100621|NCT04642638|366024557|FG005|Overall Study|Protocol Deviation|3|||
106100622|NCT04642638|366024552|FG000|Overall Study|Study Terminated|0|||
106100623|NCT04642638|366024553|FG001|Overall Study|Study Terminated|0|||
106100624|NCT04642638|366024554|FG002|Overall Study|Study Terminated|0|||
106100625|NCT04642638|366024555|FG003|Overall Study|Study Terminated|0|||
106100626|NCT04642638|366024556|FG004|Overall Study|Study Terminated|484|||
106100627|NCT04642638|366024557|FG005|Overall Study|Study Terminated|250|||
106100628|NCT04642638|366024552|FG000|Overall Study|Pregnancy|0|||
106100629|NCT04642638|366024553|FG001|Overall Study|Pregnancy|0|||
106100630|NCT04642638|366024554|FG002|Overall Study|Pregnancy|0|||
106100631|NCT04642638|366024555|FG003|Overall Study|Pregnancy|0|||
106100632|NCT04642638|366024556|FG004|Overall Study|Pregnancy|1|||
106100633|NCT04642638|366024557|FG005|Overall Study|Pregnancy|0|||
106100634|NCT02189798|366024560|FG000|Extended Use Phase|Withdrawal by Subject|0|||
106100635|NCT02189798|366024561|FG001|Extended Use Phase|Withdrawal by Subject|4|||
106100636|NCT02189798|366024560|FG000|Extended Use Phase|Physician Decision|1|||
106100637|NCT02189798|366024561|FG001|Extended Use Phase|Physician Decision|0|||
106100638|NCT02189798|366024560|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
106100639|NCT02189798|366024561|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
106100640|NCT02189798|366024560|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
106100641|NCT02189798|366024561|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
106100642|NCT02189798|366024560|FG000|Extended Use Phase|Travel Issues|2|||
106100643|NCT02189798|366024561|FG001|Extended Use Phase|Travel Issues|1|||
106100644|NCT02189798|366024560|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
106100645|NCT02189798|366024561|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
106100646|NCT01672801|366024562|FG000|Overall Study|Screen Failure|0|||
106100647|NCT01672801|366024563|FG001|Overall Study|Screen Failure|1|||
106100648|NCT01474681|366024564|FG000|Overall Study|Death|0|||
106100649|NCT01474681|366024565|FG001|Overall Study|Death|3|||
106100650|NCT01474681|366024566|FG002|Overall Study|Death|2|||
106100651|NCT01474681|366024567|FG003|Overall Study|Death|6|||
106100652|NCT02415400|366024568|FG000|Overall Study|Adverse Event|0|||
106100653|NCT02415400|366024569|FG001|Overall Study|Adverse Event|1|||
106100654|NCT02415400|366024570|FG002|Overall Study|Adverse Event|1|||
106100655|NCT02415400|366024571|FG003|Overall Study|Adverse Event|2|||
106100656|NCT02415400|366024568|FG000|Overall Study|Participant request to stop therapy|4|||
106100657|NCT02415400|366024569|FG001|Overall Study|Participant request to stop therapy|3|||
106100658|NCT02415400|366024570|FG002|Overall Study|Participant request to stop therapy|8|||
106100659|NCT02415400|366024571|FG003|Overall Study|Participant request to stop therapy|6|||
106100660|NCT02415400|366024568|FG000|Overall Study|Participant withdrew consent|14|||
106100661|NCT02415400|366024569|FG001|Overall Study|Participant withdrew consent|12|||
106100662|NCT02415400|366024570|FG002|Overall Study|Participant withdrew consent|30|||
106100663|NCT02415400|366024571|FG003|Overall Study|Participant withdrew consent|21|||
106100664|NCT02415400|366024568|FG000|Overall Study|Death|39|||
106100665|NCT02415400|366024569|FG001|Overall Study|Death|41|||
106100666|NCT02415400|366024570|FG002|Overall Study|Death|35|||
106100667|NCT02415400|366024571|FG003|Overall Study|Death|42|||
106100668|NCT02415400|366024568|FG000|Overall Study|Lost to Follow-up|3|||
106100669|NCT02415400|366024569|FG001|Overall Study|Lost to Follow-up|3|||
106100670|NCT02415400|366024570|FG002|Overall Study|Lost to Follow-up|2|||
106100671|NCT02415400|366024571|FG003|Overall Study|Lost to Follow-up|5|||
106100672|NCT02415400|366024568|FG000|Overall Study|Poor/Non-Compliance|0|||
106100673|NCT02415400|366024569|FG001|Overall Study|Poor/Non-Compliance|1|||
106100674|NCT02415400|366024570|FG002|Overall Study|Poor/Non-Compliance|3|||
106100675|NCT02415400|366024571|FG003|Overall Study|Poor/Non-Compliance|4|||
106100676|NCT02415400|366024568|FG000|Overall Study|Participant no longer meets criteria|2|||
106100677|NCT02415400|366024569|FG001|Overall Study|Participant no longer meets criteria|0|||
106100678|NCT02415400|366024570|FG002|Overall Study|Participant no longer meets criteria|0|||
106100679|NCT02415400|366024571|FG003|Overall Study|Participant no longer meets criteria|1|||
106100680|NCT02415400|366024568|FG000|Overall Study|Participant doesn't answer phone|1|||
106100681|NCT02415400|366024569|FG001|Overall Study|Participant doesn't answer phone|0|||
106100682|NCT02415400|366024570|FG002|Overall Study|Participant doesn't answer phone|0|||
106100683|NCT02415400|366024571|FG003|Overall Study|Participant doesn't answer phone|0|||
106100684|NCT02415400|366024568|FG000|Overall Study|Participant wanted home visits|1|||
106100685|NCT02415400|366024569|FG001|Overall Study|Participant wanted home visits|0|||
106100686|NCT02415400|366024570|FG002|Overall Study|Participant wanted home visits|0|||
106100687|NCT02415400|366024571|FG003|Overall Study|Participant wanted home visits|0|||
106100688|NCT02415400|366024568|FG000|Overall Study|Randomized in error|2|||
106100689|NCT02415400|366024569|FG001|Overall Study|Randomized in error|0|||
106100690|NCT02415400|366024570|FG002|Overall Study|Randomized in error|0|||
106100691|NCT02415400|366024571|FG003|Overall Study|Randomized in error|0|||
106100692|NCT02415400|366024568|FG000|Overall Study|No study drug on site|0|||
106100693|NCT02415400|366024569|FG001|Overall Study|No study drug on site|1|||
106100694|NCT02415400|366024570|FG002|Overall Study|No study drug on site|0|||
106100695|NCT02415400|366024571|FG003|Overall Study|No study drug on site|0|||
106100696|NCT02415400|366024568|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
106100697|NCT02415400|366024569|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
106100698|NCT02415400|366024570|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
106100699|NCT02415400|366024571|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
106100700|NCT02415400|366024568|FG000|Overall Study|Coagulation values cannot be set|0|||
105779386|NCT00386152|364844740|FG000|Overall Study|Death|3|||
106100701|NCT02415400|366024569|FG001|Overall Study|Coagulation values cannot be set|0|||
106100702|NCT02415400|366024570|FG002|Overall Study|Coagulation values cannot be set|1|||
106100703|NCT02415400|366024571|FG003|Overall Study|Coagulation values cannot be set|0|||
106100704|NCT02415400|366024568|FG000|Overall Study|State regulations prevent participation|0|||
106100705|NCT02415400|366024569|FG001|Overall Study|State regulations prevent participation|0|||
106100706|NCT02415400|366024570|FG002|Overall Study|State regulations prevent participation|1|||
106100707|NCT02415400|366024571|FG003|Overall Study|State regulations prevent participation|0|||
106100708|NCT02415400|366024568|FG000|Overall Study|Poor treatment monitoring|0|||
106100709|NCT02415400|366024569|FG001|Overall Study|Poor treatment monitoring|0|||
106100710|NCT02415400|366024570|FG002|Overall Study|Poor treatment monitoring|1|||
106100711|NCT02415400|366024571|FG003|Overall Study|Poor treatment monitoring|0|||
106100712|NCT02415400|366024568|FG000|Overall Study|Participant in jail|0|||
106100713|NCT02415400|366024569|FG001|Overall Study|Participant in jail|0|||
106100714|NCT02415400|366024570|FG002|Overall Study|Participant in jail|1|||
106100715|NCT02415400|366024571|FG003|Overall Study|Participant in jail|0|||
106100716|NCT02415400|366024568|FG000|Overall Study|Investigator decision|0|||
106100717|NCT02415400|366024569|FG001|Overall Study|Investigator decision|0|||
106100718|NCT02415400|366024570|FG002|Overall Study|Investigator decision|1|||
106100719|NCT02415400|366024571|FG003|Overall Study|Investigator decision|1|||
106100720|NCT02415400|366024568|FG000|Overall Study|Site closure; participant won't transfer|0|||
106100721|NCT02415400|366024569|FG001|Overall Study|Site closure; participant won't transfer|0|||
106100722|NCT02415400|366024570|FG002|Overall Study|Site closure; participant won't transfer|0|||
106100723|NCT02415400|366024571|FG003|Overall Study|Site closure; participant won't transfer|1|||
106100724|NCT03595904|366024578|FG000|Overall Study|Protocol Violation|3|||
106100725|NCT03595904|366024579|FG001|Overall Study|Protocol Violation|1|||
106100726|NCT03595904|366024578|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
106100727|NCT03595904|366024579|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
106100728|NCT03595904|366024578|FG000|Overall Study|Insurance complications|1|||
106100729|NCT03595904|366024579|FG001|Overall Study|Insurance complications|0|||
106100730|NCT03595904|366024578|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
106100731|NCT03595904|366024579|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
106100732|NCT01581281|366024580|FG000|Overall Study|Early Study Closure|15|||
106100733|NCT01581281|366024581|FG001|Overall Study|Early Study Closure|6|||
106100734|NCT01581281|366024582|FG002|Overall Study|Early Study Closure|12|||
106100735|NCT01392560|366024583|FG000|Overall Study|Adverse Event|2|||
106100736|NCT01392560|366024583|FG000|Overall Study|not entered|8|||
106100737|NCT01392560|366024583|FG000|Overall Study|discontinued during placebo run-in|2|||
106100738|NCT01934218|366024584|FG000|Double-blind Phase|Adverse Event|8|||
106100739|NCT01934218|366024585|FG001|Double-blind Phase|Adverse Event|8|||
106100740|NCT01934218|366024584|FG000|Double-blind Phase|Lack of Efficacy|6|||
106100741|NCT01934218|366024585|FG001|Double-blind Phase|Lack of Efficacy|7|||
106100742|NCT01934218|366024584|FG000|Double-blind Phase|Lost to Follow-up|7|||
106100743|NCT01934218|366024585|FG001|Double-blind Phase|Lost to Follow-up|14|||
106100744|NCT01934218|366024584|FG000|Double-blind Phase|Physician Decision|1|||
106100745|NCT01934218|366024585|FG001|Double-blind Phase|Physician Decision|2|||
106100746|NCT01934218|366024584|FG000|Double-blind Phase|Protocol Violation|4|||
106100747|NCT01934218|366024585|FG001|Double-blind Phase|Protocol Violation|0|||
106100748|NCT01934218|366024584|FG000|Double-blind Phase|Withdrawal by Subject|16|||
106100749|NCT01934218|366024585|FG001|Double-blind Phase|Withdrawal by Subject|13|||
106100750|NCT01934218|366024584|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
106100751|NCT01934218|366024585|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
106100752|NCT01934218|366024584|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
106100753|NCT01934218|366024585|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
106100754|NCT01934218|366024584|FG000|Open-Label Phase|Adverse Event|2|||
106100755|NCT01934218|366024585|FG001|Open-Label Phase|Adverse Event|4|||
106100756|NCT01934218|366024584|FG000|Open-Label Phase|Lack of Efficacy|1|||
106100757|NCT01934218|366024585|FG001|Open-Label Phase|Lack of Efficacy|4|||
106100758|NCT01934218|366024584|FG000|Open-Label Phase|Lost to Follow-up|4|||
106100759|NCT01934218|366024585|FG001|Open-Label Phase|Lost to Follow-up|2|||
106100760|NCT01934218|366024584|FG000|Open-Label Phase|Physician Decision|1|||
106100761|NCT01934218|366024585|FG001|Open-Label Phase|Physician Decision|0|||
106100762|NCT01934218|366024584|FG000|Open-Label Phase|Protocol Violation|1|||
106100763|NCT01934218|366024585|FG001|Open-Label Phase|Protocol Violation|0|||
106100764|NCT01934218|366024584|FG000|Open-Label Phase|Withdrawal by Subject|13|||
106100765|NCT01934218|366024585|FG001|Open-Label Phase|Withdrawal by Subject|11|||
106100766|NCT01934218|366024584|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
106100767|NCT01934218|366024585|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
106100768|NCT01934218|366024584|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
106100769|NCT01934218|366024585|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
106100770|NCT00700401|366024592|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
106100771|NCT00700401|366024592|FG000|Overall Study|Adverse Event|5|||
106100772|NCT00700401|366024592|FG000|Overall Study|Refused Treatment|2|||
106100773|NCT00700401|366024592|FG000|Overall Study|Lost to Follow-up|1|||
106100774|NCT00700401|366024592|FG000|Overall Study|Treatment never started|1|||
106100775|NCT00700401|366024592|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
106100776|NCT00700401|366024592|FG000|Overall Study|Withdrawal by Subject|2|||
106100777|NCT03273946|366024593|FG000|Overall Study|Withdrawal by Subject|5|||
106100778|NCT03273946|366024593|FG000|Overall Study|Unwillingness of the guardian|1|||
106100779|NCT03273946|366024593|FG000|Overall Study|Participant refused to use the drug|2|||
106100780|NCT03273946|366024593|FG000|Overall Study|Participant relative refused to use drug|1|||
106100781|NCT04330638|366024600|FG000|Overall Study|Adverse Event|9|||
106100782|NCT04330638|366024601|FG001|Overall Study|Adverse Event|10|||
106100783|NCT04330638|366024602|FG002|Overall Study|Adverse Event|15|||
106100784|NCT04330638|366024603|FG003|Overall Study|Adverse Event|6|||
106100785|NCT04330638|366024604|FG004|Overall Study|Adverse Event|10|||
106100786|NCT04330638|366024605|FG005|Overall Study|Adverse Event|5|||
106100787|NCT04330638|366024600|FG000|Overall Study|Other|2|||
106100788|NCT04330638|366024601|FG001|Overall Study|Other|2|||
106100789|NCT04330638|366024602|FG002|Overall Study|Other|5|||
106100790|NCT04330638|366024603|FG003|Overall Study|Other|1|||
106100791|NCT04330638|366024604|FG004|Overall Study|Other|3|||
106100792|NCT04330638|366024605|FG005|Overall Study|Other|2|||
106100793|NCT04330638|366024600|FG000|Overall Study|Withdrawal by Subject|4|||
106100794|NCT04330638|366024601|FG001|Overall Study|Withdrawal by Subject|0|||
106100795|NCT04330638|366024602|FG002|Overall Study|Withdrawal by Subject|0|||
106100796|NCT04330638|366024603|FG003|Overall Study|Withdrawal by Subject|0|||
106100797|NCT04330638|366024604|FG004|Overall Study|Withdrawal by Subject|0|||
106100798|NCT04330638|366024605|FG005|Overall Study|Withdrawal by Subject|0|||
106100799|NCT04330638|366024600|FG000|Overall Study|Lost to Follow-up|3|||
106100800|NCT04330638|366024601|FG001|Overall Study|Lost to Follow-up|2|||
106100801|NCT04330638|366024602|FG002|Overall Study|Lost to Follow-up|3|||
106100802|NCT04330638|366024603|FG003|Overall Study|Lost to Follow-up|2|||
106100803|NCT04330638|366024604|FG004|Overall Study|Lost to Follow-up|3|||
106100804|NCT04330638|366024605|FG005|Overall Study|Lost to Follow-up|0|||
106100805|NCT00295750|366024610|FG000|Overall Study|Adverse Event|19|||
106100806|NCT00295750|366024611|FG001|Overall Study|Adverse Event|15|||
106100807|NCT00295750|366024612|FG002|Overall Study|Adverse Event|12|||
106100808|NCT00295750|366024610|FG000|Overall Study|Lack of Efficacy|1|||
106100809|NCT00295750|366024611|FG001|Overall Study|Lack of Efficacy|1|||
106100810|NCT00295750|366024612|FG002|Overall Study|Lack of Efficacy|0|||
106100811|NCT00295750|366024610|FG000|Overall Study|Lost to Follow-up|1|||
106100812|NCT00295750|366024611|FG001|Overall Study|Lost to Follow-up|4|||
106100813|NCT00295750|366024612|FG002|Overall Study|Lost to Follow-up|1|||
106100814|NCT00295750|366024610|FG000|Overall Study|Taking prohibited therapy|2|||
106100815|NCT00295750|366024611|FG001|Overall Study|Taking prohibited therapy|3|||
106100816|NCT00295750|366024612|FG002|Overall Study|Taking prohibited therapy|2|||
106100817|NCT00295750|366024610|FG000|Overall Study|Administrative errors|2|||
106100818|NCT00295750|366024611|FG001|Overall Study|Administrative errors|4|||
106100819|NCT00295750|366024612|FG002|Overall Study|Administrative errors|5|||
106100820|NCT00295750|366024610|FG000|Overall Study|Trial drug errors|1|||
106100821|NCT00295750|366024611|FG001|Overall Study|Trial drug errors|1|||
106100822|NCT00295750|366024612|FG002|Overall Study|Trial drug errors|0|||
106100823|NCT00295750|366024610|FG000|Overall Study|Disease progression|2|||
106100824|NCT00295750|366024611|FG001|Overall Study|Disease progression|1|||
106100825|NCT00295750|366024612|FG002|Overall Study|Disease progression|0|||
106100826|NCT00295750|366024610|FG000|Overall Study|Personal reasons|0|||
106100827|NCT00295750|366024611|FG001|Overall Study|Personal reasons|1|||
106100828|NCT00295750|366024612|FG002|Overall Study|Personal reasons|0|||
106100829|NCT00295750|366024610|FG000|Overall Study|Randomized but never received trial drug|4|||
106100830|NCT00295750|366024611|FG001|Overall Study|Randomized but never received trial drug|3|||
106100831|NCT00295750|366024612|FG002|Overall Study|Randomized but never received trial drug|3|||
106100832|NCT00295750|366024610|FG000|Overall Study|Withdrawal by Subject|9|||
105779387|NCT00386152|364844741|FG001|Overall Study|Death|0|||
105779388|NCT00386152|364844742|FG002|Overall Study|Death|1|||
105779389|NCT00386152|364844740|FG000|Overall Study|Disease progression|7|||
106100833|NCT00295750|366024611|FG001|Overall Study|Withdrawal by Subject|4|||
106100834|NCT00295750|366024612|FG002|Overall Study|Withdrawal by Subject|7|||
106100835|NCT00295750|366024610|FG000|Overall Study|Protocol Violation|2|||
106100836|NCT00295750|366024611|FG001|Overall Study|Protocol Violation|4|||
106100837|NCT00295750|366024612|FG002|Overall Study|Protocol Violation|2|||
106100838|NCT00522275|366024615|FG000|Overall Study|Adverse Event|35|||
106100839|NCT00522275|366024615|FG000|Overall Study|Lack of Efficacy|80|||
106100840|NCT00522275|366024615|FG000|Overall Study|Subject withdrew consent|16|||
106100841|NCT00522275|366024615|FG000|Overall Study|Protocol deviation|1|||
106100842|NCT00522275|366024615|FG000|Overall Study|Unsatisfactory compliance|11|||
106100843|NCT00522275|366024615|FG000|Overall Study|Lost to Follow-up|8|||
106100844|NCT00522275|366024615|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
106100845|NCT00522275|366024615|FG000|Overall Study|Other: Subject is pregnant|2|||
106100846|NCT00522275|366024615|FG000|Overall Study|Other: Subject relocated|2|||
106100847|NCT00522275|366024615|FG000|Overall Study|Other: Subject arrested|1|||
106100848|NCT00522275|366024615|FG000|Overall Study|Other: Site / clinic closed|4|||
106100849|NCT00522275|366024615|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
106100850|NCT00522275|366024615|FG000|Overall Study|Other: Sponsor request|2|||
106100851|NCT00522275|366024615|FG000|Overall Study|Other: Subject ran out of medication|1|||
106100852|NCT00522275|366024615|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
106100853|NCT03152552|366024616|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
106100854|NCT03152552|366024617|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
106100855|NCT03152552|366024618|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
106100856|NCT03152552|366024619|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
106100857|NCT03152552|366024620|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
106100858|NCT03152552|366024616|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
106100859|NCT03152552|366024617|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
106100860|NCT03152552|366024618|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
106100861|NCT03152552|366024619|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
106100862|NCT03152552|366024620|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
106100863|NCT03152552|366024616|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
106100864|NCT03152552|366024617|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
106100865|NCT03152552|366024618|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
106100866|NCT03152552|366024619|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
106100867|NCT03152552|366024620|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
106100868|NCT03152552|366024616|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106100869|NCT03152552|366024617|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106100870|NCT03152552|366024618|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
106100871|NCT03152552|366024619|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106100872|NCT03152552|366024620|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106100873|NCT03152552|366024616|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
106100874|NCT03152552|366024617|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
106100875|NCT03152552|366024618|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
106100876|NCT03152552|366024619|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
106100877|NCT03152552|366024620|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
106100878|NCT03152552|366024616|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
106100879|NCT03152552|366024617|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
106100880|NCT03152552|366024618|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
106100881|NCT03152552|366024619|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
106100882|NCT03152552|366024620|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
106100883|NCT03152552|366024616|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
106100884|NCT03152552|366024617|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
106100885|NCT03152552|366024618|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
106100886|NCT03152552|366024619|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
106100887|NCT03152552|366024620|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
106100888|NCT04899349|366024621|FG000|Overall Study|Study terminated by Sponsor|2|||
106100889|NCT04899349|366024622|FG001|Overall Study|Study terminated by Sponsor|0|||
106100890|NCT04656847|366024625|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
106100891|NCT03301051|366024626|FG000|Overall Study|Adverse Event|0|||
106100892|NCT03301051|366024627|FG001|Overall Study|Adverse Event|4|||
106100893|NCT03301051|366024626|FG000|Overall Study|Withdrawal by Subject|59|||
106100894|NCT03301051|366024627|FG001|Overall Study|Withdrawal by Subject|65|||
106100895|NCT03301051|366024626|FG000|Overall Study|Lost to Follow-up|263|||
106100896|NCT03301051|366024627|FG001|Overall Study|Lost to Follow-up|282|||
106100897|NCT03301051|366024626|FG000|Overall Study|Protocol Violation|1|||
106100898|NCT03301051|366024627|FG001|Overall Study|Protocol Violation|3|||
106100899|NCT03301051|366024626|FG000|Overall Study|Physician Decision|1|||
106100900|NCT03301051|366024627|FG001|Overall Study|Physician Decision|3|||
106100901|NCT03301051|366024626|FG000|Overall Study|Death|1|||
106100902|NCT03301051|366024627|FG001|Overall Study|Death|1|||
106100903|NCT03301051|366024626|FG000|Overall Study|Miscellaneous|8|||
106100904|NCT03301051|366024627|FG001|Overall Study|Miscellaneous|4|||
106100905|NCT03301051|366024626|FG000|Overall Study|Randomized, not vaccinated|13|||
106100906|NCT03301051|366024627|FG001|Overall Study|Randomized, not vaccinated|10|||
106100907|NCT00617344|366024629|FG000|Overall Study|Serious adverse event|1|||
106100908|NCT00617344|366024630|FG001|Overall Study|Serious adverse event|0|||
106100909|NCT00617344|366024631|FG002|Overall Study|Serious adverse event|0|||
106100910|NCT00617344|366024629|FG000|Overall Study|Other Adverse Event|1|||
106100911|NCT00617344|366024630|FG001|Overall Study|Other Adverse Event|1|||
106100912|NCT00617344|366024631|FG002|Overall Study|Other Adverse Event|0|||
106100913|NCT00617344|366024629|FG000|Overall Study|Protocol Violation|10|||
106100914|NCT00617344|366024630|FG001|Overall Study|Protocol Violation|8|||
106100915|NCT00617344|366024631|FG002|Overall Study|Protocol Violation|5|||
106100916|NCT00617344|366024629|FG000|Overall Study|Lost to Follow-up|5|||
106100917|NCT00617344|366024630|FG001|Overall Study|Lost to Follow-up|4|||
106100918|NCT00617344|366024631|FG002|Overall Study|Lost to Follow-up|1|||
106100919|NCT00617344|366024629|FG000|Overall Study|Withdrawal by Subject|8|||
105779390|NCT00386152|364844741|FG001|Overall Study|Disease progression|4|||
106100920|NCT00617344|366024630|FG001|Overall Study|Withdrawal by Subject|9|||
106100921|NCT00617344|366024631|FG002|Overall Study|Withdrawal by Subject|2|||
106100922|NCT00679939|366024632|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
106100923|NCT00679939|366024633|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
106100924|NCT00679939|366024632|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
106100925|NCT00679939|366024633|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
106100926|NCT00679939|366024632|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
106100927|NCT00679939|366024633|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
106100928|NCT00679939|366024632|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
106100929|NCT00679939|366024633|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
106100930|NCT00679939|366024632|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
106100931|NCT00679939|366024633|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
106100932|NCT00679939|366024632|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
106100933|NCT00679939|366024633|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
106100934|NCT00679939|366024632|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
106100935|NCT00679939|366024633|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
106100936|NCT00679939|366024632|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
106100937|NCT00679939|366024633|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
106100938|NCT00679939|366024632|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
106100939|NCT00679939|366024633|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
106100940|NCT00679939|366024632|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
106100941|NCT00679939|366024633|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
106100942|NCT00722761|366024634|FG000|Overall Study|Lost to Follow-up|1|||
106100943|NCT00722761|366024635|FG001|Overall Study|Lost to Follow-up|4|||
106100944|NCT00722761|366024634|FG000|Overall Study|Withdrawal by Subject|5|||
106100945|NCT00722761|366024635|FG001|Overall Study|Withdrawal by Subject|2|||
106100946|NCT02611037|366024636|FG000|Overall Study|Withdrawal prior to treatment|2|||
106100947|NCT02611037|366024637|FG001|Overall Study|Withdrawal prior to treatment|0|||
106100948|NCT04439110|366024638|FG000|Overall Study|Ineligible|2|||
106100949|NCT04439110|366024638|FG000|Overall Study|Adverse Event|4|||
106100950|NCT04439110|366024638|FG000|Overall Study|Death|2|||
106100951|NCT04439110|366024638|FG000|Overall Study|Disease proression|25|||
106100952|NCT04439110|366024638|FG000|Overall Study|Withdrawal by Subject|1|||
106100953|NCT04439110|366024638|FG000|Overall Study|Alternative therapy|1|||
106100954|NCT04439110|366024638|FG000|Overall Study|Other complicating disease|1|||
106100955|NCT04439110|366024638|FG000|Overall Study|Personal reasons|1|||
106100956|NCT04439110|366024638|FG000|Overall Study|Still on treatment|1|||
106100957|NCT00127608|366024639|FG000|Overall Study|VZV DNA negative|1|||
106100958|NCT00680407|366024651|FG000|Overall Study|Lost to Follow-up|3|||
106100959|NCT00680407|366024652|FG001|Overall Study|Lost to Follow-up|3|||
106100960|NCT00680407|366024653|FG002|Overall Study|Lost to Follow-up|1|||
106100961|NCT00680407|366024651|FG000|Overall Study|Withdrawal by Subject|5|||
106100962|NCT00680407|366024652|FG001|Overall Study|Withdrawal by Subject|2|||
106100963|NCT00680407|366024653|FG002|Overall Study|Withdrawal by Subject|2|||
106100964|NCT00506493|366024657|FG000|Overall Study|Death|6|||
106100965|NCT00506493|366024657|FG000|Overall Study|Withdrawal by Subject|5|||
106100966|NCT02277444|366024658|FG000|Overall Study|Adverse Event|10|||
106100967|NCT02277444|366024658|FG000|Overall Study|Withdrawal by Subject|3|||
106100968|NCT02277444|366024658|FG000|Overall Study|Other|1|||
106100969|NCT02277444|366024658|FG000|Overall Study|Enrolled and not Treated|3|||
106100970|NCT02277444|366024658|FG000|Overall Study|Ongoing|113|||
106100971|NCT00924287|366026607|FG000|Overall Study|Death|1|||
106100972|NCT01877408|366026608|FG000|Overall Study|Lost to Follow-up|0|||
106100973|NCT01877408|366026609|FG001|Overall Study|Lost to Follow-up|2|||
106100974|NCT01625897|366026610|FG000|Overall Study|Adverse Event|27|||
106100975|NCT01625897|366026611|FG001|Overall Study|Adverse Event|10|||
106100976|NCT01625897|366026610|FG000|Overall Study|Physician Decision|0|||
106100977|NCT01625897|366026611|FG001|Overall Study|Physician Decision|1|||
106100978|NCT01625897|366026610|FG000|Overall Study|Withdrawal by Subject|25|||
106100979|NCT01625897|366026611|FG001|Overall Study|Withdrawal by Subject|3|||
106100980|NCT02621931|366026613|FG000|Overall Study|Death|0|||
106100981|NCT02621931|366026614|FG001|Overall Study|Death|1|||
106100982|NCT02621931|366026615|FG002|Overall Study|Death|0|||
106100983|NCT02621931|366026613|FG000|Overall Study|Adverse Event|8|||
106100984|NCT02621931|366026614|FG001|Overall Study|Adverse Event|5|||
106100985|NCT02621931|366026615|FG002|Overall Study|Adverse Event|7|||
106100986|NCT02621931|366026613|FG000|Overall Study|Withdrawal by Subject|12|||
106100987|NCT02621931|366026614|FG001|Overall Study|Withdrawal by Subject|10|||
106100988|NCT02621931|366026615|FG002|Overall Study|Withdrawal by Subject|11|||
106100989|NCT02621931|366026613|FG000|Overall Study|Protocol Violation|2|||
106100990|NCT02621931|366026614|FG001|Overall Study|Protocol Violation|2|||
106100991|NCT02621931|366026615|FG002|Overall Study|Protocol Violation|2|||
106100992|NCT02621931|366026613|FG000|Overall Study|Pregnancy|2|||
106100993|NCT02621931|366026614|FG001|Overall Study|Pregnancy|0|||
106100994|NCT02621931|366026615|FG002|Overall Study|Pregnancy|0|||
106100995|NCT02621931|366026613|FG000|Overall Study|Noncompliance to study procedures|0|||
105779391|NCT00386152|364844742|FG002|Overall Study|Disease progression|5|||
105779392|NCT00386152|364844740|FG000|Overall Study|Physician Decision|13|||
105779393|NCT00386152|364844741|FG001|Overall Study|Physician Decision|10|||
105779394|NCT00386152|364844742|FG002|Overall Study|Physician Decision|4|||
105779395|NCT00386152|364844740|FG000|Overall Study|Lost to Follow-up|1|||
105779396|NCT00386152|364844741|FG001|Overall Study|Lost to Follow-up|0|||
105779397|NCT00386152|364844742|FG002|Overall Study|Lost to Follow-up|0|||
105779398|NCT00386152|364844740|FG000|Overall Study|Completed chemotherapy|4|||
105779399|NCT00386152|364844741|FG001|Overall Study|Completed chemotherapy|5|||
105779400|NCT00386152|364844742|FG002|Overall Study|Completed chemotherapy|1|||
105779401|NCT00386152|364844740|FG000|Overall Study|Protocol Violation|3|||
105779402|NCT00386152|364844741|FG001|Overall Study|Protocol Violation|5|||
105779403|NCT00386152|364844742|FG002|Overall Study|Protocol Violation|2|||
105779404|NCT00386152|364844740|FG000|Overall Study|Withdrawal by Subject|3|||
105779405|NCT00386152|364844741|FG001|Overall Study|Withdrawal by Subject|6|||
105779406|NCT00386152|364844742|FG002|Overall Study|Withdrawal by Subject|10|||
105779407|NCT00561912|364844755|FG000|Overall Study|ineligible|1|||
105779408|NCT02643420|364844756|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
105779409|NCT02643420|364844757|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
105779410|NCT02643420|364844756|FG000|Overall Study|Withdrawal by Subject|25|||
105779411|NCT02643420|364844757|FG001|Overall Study|Withdrawal by Subject|19|||
105779412|NCT02643420|364844756|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
105779413|NCT02643420|364844757|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
105779414|NCT02643420|364844756|FG000|Overall Study|Lost to Follow-up|6|||
105779415|NCT02643420|364844757|FG001|Overall Study|Lost to Follow-up|10|||
105779416|NCT02643420|364844756|FG000|Overall Study|Investigator Decision|2|||
105779417|NCT02643420|364844757|FG001|Overall Study|Investigator Decision|4|||
105779418|NCT02643420|364844756|FG000|Overall Study|Sponsor decision|1|||
105779419|NCT02643420|364844757|FG001|Overall Study|Sponsor decision|1|||
105779420|NCT02643420|364844756|FG000|Overall Study|Death|0|||
105779421|NCT02643420|364844757|FG001|Overall Study|Death|2|||
105779422|NCT02643420|364844756|FG000|Overall Study|Reason not Specified|8|||
105779423|NCT02643420|364844757|FG001|Overall Study|Reason not Specified|7|||
105779424|NCT02127970|364844758|FG000|Overall Study|Adverse Event|2|||
105779425|NCT02127970|364844759|FG001|Overall Study|Adverse Event|1|||
105779426|NCT02127970|364844758|FG000|Overall Study|Death|1|||
105779427|NCT02127970|364844759|FG001|Overall Study|Death|1|||
105779428|NCT02127970|364844758|FG000|Overall Study|Lost to Follow-up|14|||
105779429|NCT02127970|364844759|FG001|Overall Study|Lost to Follow-up|14|||
105779430|NCT02127970|364844758|FG000|Overall Study|Reason not Specified|4|||
105779431|NCT02127970|364844759|FG001|Overall Study|Reason not Specified|7|||
105779432|NCT02127970|364844758|FG000|Overall Study|Pregnancy|0|||
105779433|NCT02127970|364844759|FG001|Overall Study|Pregnancy|1|||
105779434|NCT02127970|364844758|FG000|Overall Study|Subject Withdrew Consent|5|||
105779435|NCT02127970|364844759|FG001|Overall Study|Subject Withdrew Consent|3|||
105779436|NCT04052425|364844760|FG000|24-Week Double-blind Period|Adverse Event|0|||
105779437|NCT04052425|364844761|FG001|24-Week Double-blind Period|Adverse Event|1|||
105779438|NCT04052425|364844762|FG002|24-Week Double-blind Period|Adverse Event|0|||
105779439|NCT04052425|364844763|FG003|24-Week Double-blind Period|Adverse Event|0|||
105779440|NCT04052425|364844760|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
105779441|NCT04052425|364844761|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
105779442|NCT04052425|364844762|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
105779443|NCT04052425|364844763|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
105779444|NCT04052425|364844760|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
105779445|NCT04052425|364844761|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
105779446|NCT04052425|364844762|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
105779447|NCT04052425|364844763|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
105779448|NCT04052425|364844760|FG000|24-Week Double-blind Period|Physician Decision|1|||
105779449|NCT04052425|364844761|FG001|24-Week Double-blind Period|Physician Decision|0|||
105779450|NCT04052425|364844762|FG002|24-Week Double-blind Period|Physician Decision|0|||
105779451|NCT04052425|364844763|FG003|24-Week Double-blind Period|Physician Decision|0|||
105779452|NCT04052425|364844760|FG000|24-Week Double-blind Period|Protocol Violation|1|||
105779453|NCT04052425|364844761|FG001|24-Week Double-blind Period|Protocol Violation|0|||
105779454|NCT04052425|364844762|FG002|24-Week Double-blind Period|Protocol Violation|0|||
105779455|NCT04052425|364844763|FG003|24-Week Double-blind Period|Protocol Violation|0|||
105779456|NCT04052425|364844760|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
105779457|NCT04052425|364844761|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
105779458|NCT04052425|364844762|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
105779459|NCT04052425|364844763|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
105779460|NCT04052425|364844760|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
105779461|NCT04052425|364844761|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
105779462|NCT04052425|364844762|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
105779463|NCT04052425|364844763|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
106100996|NCT02621931|366026614|FG001|Overall Study|Noncompliance to study procedures|1|||
106100997|NCT02621931|366026615|FG002|Overall Study|Noncompliance to study procedures|2|||
106100998|NCT02621931|366026613|FG000|Overall Study|Lost to Follow-up|8|||
106100999|NCT02621931|366026614|FG001|Overall Study|Lost to Follow-up|7|||
106101000|NCT02621931|366026615|FG002|Overall Study|Lost to Follow-up|10|||
106101001|NCT02621931|366026613|FG000|Overall Study|Lack of Efficacy|0|||
106101002|NCT02621931|366026614|FG001|Overall Study|Lack of Efficacy|0|||
106101003|NCT02621931|366026615|FG002|Overall Study|Lack of Efficacy|1|||
106101004|NCT02621931|366026613|FG000|Overall Study|Other|1|||
106101005|NCT02621931|366026614|FG001|Overall Study|Other|1|||
106101006|NCT02621931|366026615|FG002|Overall Study|Other|3|||
106101007|NCT01292603|366026616|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
106101008|NCT01292603|366026617|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
106101009|NCT01292603|366026618|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
106101010|NCT01292603|366026619|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
106101011|NCT01292603|366026620|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
106101012|NCT01292603|366026621|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
106101013|NCT01292603|366026616|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
106101014|NCT01292603|366026617|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
106101015|NCT01292603|366026618|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
106101016|NCT01292603|366026619|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
106101017|NCT01292603|366026620|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
106101018|NCT01292603|366026621|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
106101019|NCT01292603|366026616|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
106101020|NCT01292603|366026617|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
106101021|NCT01292603|366026618|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
106101022|NCT01292603|366026619|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
106101023|NCT01292603|366026620|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
106101024|NCT01292603|366026621|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
106101025|NCT01292603|366026616|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
106101026|NCT01292603|366026617|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
106101027|NCT01292603|366026618|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
106101028|NCT01292603|366026619|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
106101029|NCT01292603|366026620|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
106101030|NCT01292603|366026621|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
106101031|NCT01292603|366026616|FG000|Part 1: Regular Follow-Up Period|Death|3|||
106101032|NCT01292603|366026617|FG001|Part 1: Regular Follow-Up Period|Death|1|||
106101033|NCT01292603|366026618|FG002|Part 1: Regular Follow-Up Period|Death|3|||
106101034|NCT01292603|366026619|FG003|Part 1: Regular Follow-Up Period|Death|1|||
106101035|NCT01292603|366026620|FG004|Part 1: Regular Follow-Up Period|Death|0|||
106101036|NCT01292603|366026621|FG005|Part 1: Regular Follow-Up Period|Death|0|||
106101037|NCT01292603|366026616|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
106101038|NCT01292603|366026617|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
106101039|NCT01292603|366026618|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
106101040|NCT01292603|366026619|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
106101041|NCT01292603|366026620|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
106101042|NCT01292603|366026621|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
106101043|NCT01292603|366026616|FG000|Part 2: Dose Confirmation Period|Death|0|||
106101044|NCT01292603|366026617|FG001|Part 2: Dose Confirmation Period|Death|0|||
106101045|NCT01292603|366026618|FG002|Part 2: Dose Confirmation Period|Death|0|||
106101046|NCT01292603|366026619|FG003|Part 2: Dose Confirmation Period|Death|0|||
106101047|NCT01292603|366026620|FG004|Part 2: Dose Confirmation Period|Death|1|||
106101048|NCT01292603|366026621|FG005|Part 2: Dose Confirmation Period|Death|0|||
106101049|NCT01292603|366026616|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
106101050|NCT01292603|366026617|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
106101051|NCT01292603|366026618|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
106101052|NCT01292603|366026619|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
106101053|NCT01292603|366026620|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
106101054|NCT01292603|366026621|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
106101055|NCT01292603|366026616|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
106101056|NCT01292603|366026617|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
106101057|NCT01292603|366026618|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
106101058|NCT01292603|366026619|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
106101059|NCT01292603|366026620|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
106101060|NCT01292603|366026621|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
106101061|NCT01292603|366026616|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
106101062|NCT01292603|366026617|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
106101063|NCT01292603|366026618|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
106101064|NCT01292603|366026619|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
106101065|NCT01292603|366026620|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
106101066|NCT01292603|366026621|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
106101067|NCT01292603|366026616|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
106101068|NCT01292603|366026617|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
106101069|NCT01292603|366026618|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
106101070|NCT01292603|366026619|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
106101071|NCT01292603|366026620|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
106101072|NCT01292603|366026621|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
106101073|NCT01292603|366026616|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
106101074|NCT01292603|366026617|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
106101075|NCT01292603|366026618|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
106101076|NCT01292603|366026619|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
106101077|NCT01292603|366026620|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
106101078|NCT01292603|366026621|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
106101079|NCT01292603|366026616|FG000|Part 2: Regular Follow-Up|Death|0|||
106101080|NCT01292603|366026617|FG001|Part 2: Regular Follow-Up|Death|0|||
106101081|NCT01292603|366026618|FG002|Part 2: Regular Follow-Up|Death|0|||
106101082|NCT01292603|366026619|FG003|Part 2: Regular Follow-Up|Death|0|||
106101083|NCT01292603|366026620|FG004|Part 2: Regular Follow-Up|Death|6|||
106101084|NCT01292603|366026621|FG005|Part 2: Regular Follow-Up|Death|3|||
106101085|NCT01292603|366026616|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
106101086|NCT01292603|366026617|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
106101087|NCT01292603|366026618|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
106101088|NCT01292603|366026619|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
106101089|NCT01292603|366026620|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
106101090|NCT01292603|366026621|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
106101091|NCT01292603|366026616|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
106101092|NCT01292603|366026617|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
106101093|NCT01292603|366026618|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
106101094|NCT01292603|366026619|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
106101095|NCT01292603|366026620|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
106101096|NCT01292603|366026621|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
106101097|NCT01292603|366026616|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
106101098|NCT01292603|366026617|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
106101099|NCT01292603|366026618|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
106101100|NCT01292603|366026619|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
106101101|NCT01292603|366026620|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
106101102|NCT01292603|366026621|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
106101103|NCT01292603|366026616|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
106101104|NCT01292603|366026617|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
106101105|NCT01292603|366026618|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
106101106|NCT01292603|366026619|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
106101107|NCT01292603|366026620|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
106101108|NCT01292603|366026621|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
106101109|NCT01292603|366026616|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
106101110|NCT01292603|366026617|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
106101111|NCT01292603|366026618|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
106101112|NCT01292603|366026619|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
106101113|NCT01292603|366026620|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
106101114|NCT01292603|366026621|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
106101115|NCT01292603|366026616|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
106101116|NCT01292603|366026617|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
106101117|NCT01292603|366026618|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
106101118|NCT01292603|366026619|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
106101119|NCT01292603|366026620|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
106101120|NCT01292603|366026621|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
106101121|NCT01292603|366026616|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
106101122|NCT01292603|366026617|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
106101123|NCT01292603|366026618|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
106101124|NCT01292603|366026619|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
106101125|NCT01292603|366026620|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
106101126|NCT01292603|366026621|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
106101127|NCT01292603|366026616|FG000|Overall Survival Status|Death|3|||
106101128|NCT01292603|366026617|FG001|Overall Survival Status|Death|1|||
106101129|NCT01292603|366026618|FG002|Overall Survival Status|Death|3|||
106101130|NCT01292603|366026619|FG003|Overall Survival Status|Death|1|||
106101131|NCT01292603|366026620|FG004|Overall Survival Status|Death|16|||
106101132|NCT01292603|366026621|FG005|Overall Survival Status|Death|10|||
106101133|NCT03586648|366026622|FG000|Period 1|Withdrawal by Subject|0|||
106101134|NCT03586648|366026623|FG001|Period 1|Withdrawal by Subject|1|||
106101135|NCT03586648|366026622|FG000|Period 1|Lost to Follow-up|1|||
106101136|NCT03586648|366026623|FG001|Period 1|Lost to Follow-up|1|||
106101137|NCT03586648|366026622|FG000|Period 1|Adverse Event|1|||
106101138|NCT03586648|366026623|FG001|Period 1|Adverse Event|0|||
106101139|NCT03586648|366026622|FG000|Period 1|Study related symptoms or complaints|2|||
106101140|NCT03586648|366026623|FG001|Period 1|Study related symptoms or complaints|1|||
106101141|NCT03586648|366026622|FG000|Period 1|Physician Decision|0|||
106101142|NCT03586648|366026623|FG001|Period 1|Physician Decision|1|||
106101143|NCT03586648|366026622|FG000|Period 2|Adverse Event|1|||
106101144|NCT03586648|366026623|FG001|Period 2|Adverse Event|0|||
106101145|NCT00674986|366026624|FG000|Overall Study|Adverse Event|2|||
106101146|NCT00674986|366026625|FG001|Overall Study|Adverse Event|1|||
106101147|NCT00674986|366026624|FG000|Overall Study|Subject withdrew consent|12|||
106101148|NCT00674986|366026625|FG001|Overall Study|Subject withdrew consent|19|||
106101149|NCT00674986|366026624|FG000|Overall Study|Lost to Follow-up|25|||
106101150|NCT00674986|366026625|FG001|Overall Study|Lost to Follow-up|53|||
106101151|NCT00674986|366026624|FG000|Overall Study|Other reasons|4|||
106101152|NCT00674986|366026625|FG001|Overall Study|Other reasons|8|||
106101153|NCT00377234|366026626|FG000|Overall Study|Adverse Event|14|||
106101154|NCT00377234|366026627|FG001|Overall Study|Adverse Event|17|||
106101155|NCT00377234|366026626|FG000|Overall Study|Withdrawal by Subject|11|||
106101156|NCT00377234|366026627|FG001|Overall Study|Withdrawal by Subject|9|||
106101157|NCT00377234|366026626|FG000|Overall Study|Lost to Follow-up|4|||
106101158|NCT00377234|366026627|FG001|Overall Study|Lost to Follow-up|2|||
106101159|NCT00377234|366026626|FG000|Overall Study|Administrative|2|||
106101160|NCT00377234|366026627|FG001|Overall Study|Administrative|1|||
106101161|NCT00377234|366026626|FG000|Overall Study|Not assigned|3|||
106101162|NCT00377234|366026627|FG001|Overall Study|Not assigned|2|||
106101163|NCT01880424|366026628|FG000|Overall Study|Adverse Event|7|||
106101164|NCT01880424|366026629|FG001|Overall Study|Adverse Event|6|||
106101165|NCT01880424|366026628|FG000|Overall Study|Lack of Efficacy|1|||
106101166|NCT01880424|366026629|FG001|Overall Study|Lack of Efficacy|4|||
106101167|NCT01880424|366026628|FG000|Overall Study|Lost to Follow-up|3|||
106101168|NCT01880424|366026629|FG001|Overall Study|Lost to Follow-up|2|||
106101169|NCT01880424|366026628|FG000|Overall Study|Protocol Violation|11|||
106101170|NCT01880424|366026629|FG001|Overall Study|Protocol Violation|13|||
106101171|NCT01880424|366026628|FG000|Overall Study|Withdrawal by Subject|10|||
106101172|NCT01880424|366026629|FG001|Overall Study|Withdrawal by Subject|30|||
106101173|NCT01880424|366026628|FG000|Overall Study|Other|1|||
106101174|NCT01880424|366026629|FG001|Overall Study|Other|0|||
106101175|NCT01588184|366026635|FG000|Overall Study|Death|1|||
106101176|NCT01588184|366026636|FG001|Overall Study|Death|0|||
106101177|NCT01588184|366026637|FG002|Overall Study|Death|0|||
106101178|NCT01588184|366026638|FG003|Overall Study|Death|1|||
106101179|NCT01588184|366026639|FG004|Overall Study|Death|1|||
106101180|NCT01588184|366026640|FG005|Overall Study|Death|1|||
106101181|NCT01588184|366026635|FG000|Overall Study|Withdrawal by Subject|2|||
106101182|NCT01588184|366026636|FG001|Overall Study|Withdrawal by Subject|4|||
106101183|NCT01588184|366026637|FG002|Overall Study|Withdrawal by Subject|0|||
106101184|NCT01588184|366026638|FG003|Overall Study|Withdrawal by Subject|1|||
106101185|NCT01588184|366026639|FG004|Overall Study|Withdrawal by Subject|0|||
106101186|NCT01588184|366026640|FG005|Overall Study|Withdrawal by Subject|0|||
106101187|NCT01588184|366026635|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
106101188|NCT01588184|366026636|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
106101189|NCT01588184|366026637|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
106101190|NCT01588184|366026638|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
106101191|NCT01588184|366026639|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
106101192|NCT01588184|366026640|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
106101193|NCT01588184|366026635|FG000|Overall Study|multiple reasons|0|||
106101194|NCT01588184|366026636|FG001|Overall Study|multiple reasons|3|||
106101195|NCT01588184|366026637|FG002|Overall Study|multiple reasons|0|||
106101196|NCT01588184|366026638|FG003|Overall Study|multiple reasons|1|||
106101197|NCT01588184|366026639|FG004|Overall Study|multiple reasons|0|||
106101198|NCT01588184|366026640|FG005|Overall Study|multiple reasons|0|||
106101199|NCT00360308|366026642|FG000|Overall Study|Adverse Event|15|||
106101200|NCT00360308|366026643|FG001|Overall Study|Adverse Event|14|||
106101201|NCT00360308|366026644|FG002|Overall Study|Adverse Event|25|||
106101202|NCT00360308|366026642|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
106101203|NCT00360308|366026643|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
106101204|NCT00360308|366026644|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
106101205|NCT00360308|366026642|FG000|Overall Study|Protocol Violation|2|||
106101206|NCT00360308|366026643|FG001|Overall Study|Protocol Violation|1|||
106101207|NCT00360308|366026644|FG002|Overall Study|Protocol Violation|2|||
106101208|NCT00360308|366026642|FG000|Overall Study|Withdrawal by Subject|11|||
106101209|NCT00360308|366026643|FG001|Overall Study|Withdrawal by Subject|7|||
106101210|NCT00360308|366026644|FG002|Overall Study|Withdrawal by Subject|14|||
106101211|NCT00360308|366026642|FG000|Overall Study|Lack of Efficacy|3|||
105878755|NCT01120184|365209744|FG002|Overall Study|Lost to Follow-up|11|||
106101212|NCT00360308|366026643|FG001|Overall Study|Lack of Efficacy|0|||
106101213|NCT00360308|366026644|FG002|Overall Study|Lack of Efficacy|2|||
106101214|NCT00360308|366026642|FG000|Overall Study|Other|2|||
106101215|NCT00360308|366026643|FG001|Overall Study|Other|1|||
106101216|NCT00360308|366026644|FG002|Overall Study|Other|1|||
106101217|NCT00360308|366026642|FG000|Overall Study|Study termination by sponsor|43|||
106101218|NCT00360308|366026643|FG001|Overall Study|Study termination by sponsor|55|||
106101219|NCT00360308|366026644|FG002|Overall Study|Study termination by sponsor|44|||
106101220|NCT03422250|366026645|FG000|Intervention|Adverse Event|0|||
106101221|NCT03422250|366026646|FG001|Intervention|Adverse Event|1|||
106101222|NCT03422250|366026647|FG002|Intervention|Adverse Event|0|||
106101223|NCT03422250|366026648|FG003|Intervention|Adverse Event|1|||
106101224|NCT03422250|366026645|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
106101225|NCT03422250|366026646|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
106101226|NCT03422250|366026647|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
106101227|NCT03422250|366026648|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
106101228|NCT03422250|366026645|FG000|Follow-up|Withdrawal by Subject|0|||
106101229|NCT03422250|366026646|FG001|Follow-up|Withdrawal by Subject|0|||
106101230|NCT03422250|366026647|FG002|Follow-up|Withdrawal by Subject|0|||
106101231|NCT03422250|366026648|FG003|Follow-up|Withdrawal by Subject|1|||
106101232|NCT03422250|366026645|FG000|Follow-up|Adverse Event|0|||
106101233|NCT03422250|366026646|FG001|Follow-up|Adverse Event|0|||
106101234|NCT03422250|366026647|FG002|Follow-up|Adverse Event|0|||
106101235|NCT03422250|366026648|FG003|Follow-up|Adverse Event|1|||
106101236|NCT04786444|366026649|FG000|Overall Study|Withdrawal by Subject|4|||
106101237|NCT04786444|366026650|FG001|Overall Study|Withdrawal by Subject|7|||
106101238|NCT04786444|366026651|FG002|Overall Study|Withdrawal by Subject|2|||
106101239|NCT04786444|366026649|FG000|Overall Study|Lost to Follow-up|11|||
106101240|NCT04786444|366026650|FG001|Overall Study|Lost to Follow-up|9|||
106101241|NCT04786444|366026651|FG002|Overall Study|Lost to Follow-up|10|||
106101242|NCT04786444|366026649|FG000|Overall Study|Subject would like to become pregnant|0|||
106101243|NCT04786444|366026650|FG001|Overall Study|Subject would like to become pregnant|1|||
106101244|NCT04786444|366026651|FG002|Overall Study|Subject would like to become pregnant|0|||
106101245|NCT02388724|366026652|FG000|Overall Study|Reason not Specified|0|||
106101246|NCT02388724|366026653|FG001|Overall Study|Reason not Specified|1|||
106101247|NCT02388724|366026652|FG000|Overall Study|Major Protocol Deviation|3|||
106101248|NCT02388724|366026653|FG001|Overall Study|Major Protocol Deviation|3|||
106101249|NCT02388724|366026652|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
106101250|NCT02388724|366026653|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
106101251|NCT02388724|366026652|FG000|Overall Study|Voluntary Withdrawal|6|||
106101252|NCT02388724|366026653|FG001|Overall Study|Voluntary Withdrawal|5|||
106101253|NCT02388724|366026652|FG000|Overall Study|Randomized but not Treated|0|||
106101254|NCT02388724|366026653|FG001|Overall Study|Randomized but not Treated|2|||
106101255|NCT02239679|366026654|FG000|Overall Study|Lost to Follow-up|1|||
106101256|NCT02239679|366026655|FG001|Overall Study|Lost to Follow-up|0|||
106101257|NCT02239679|366026656|FG002|Overall Study|Lost to Follow-up|0|||
106101258|NCT02239679|366026654|FG000|Overall Study|Withdrawal by Subject|2|||
106101259|NCT02239679|366026655|FG001|Overall Study|Withdrawal by Subject|3|||
106101260|NCT02239679|366026656|FG002|Overall Study|Withdrawal by Subject|1|||
106101261|NCT02462876|366026660|FG000|Overall Study|Death|3|||
106101262|NCT02462876|366026660|FG000|Overall Study|Lost to Follow-up|7|||
106101263|NCT02462876|366026660|FG000|Overall Study|Surgical Bypass|9|||
106101264|NCT02462876|366026660|FG000|Overall Study|Amputation Above the Metatarsals|1|||
106101265|NCT02462876|366026660|FG000|Overall Study|36 months follow-up visit missed|1|||
106101266|NCT02462876|366026660|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
106101267|NCT02462876|366026660|FG000|Overall Study|Patient did not come back to the vascular department|1|||
106101268|NCT02462876|366026660|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
106101269|NCT02462876|366026660|FG000|Overall Study|Patient refused to come back|1|||
106101270|NCT02462876|366026660|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
106101271|NCT02462876|366026660|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
106101272|NCT01217073|366026664|FG000|Base Period|Adverse Event|1|||
106101273|NCT01217073|366026665|FG001|Base Period|Adverse Event|0|||
106101274|NCT01217073|366026666|FG002|Base Period|Adverse Event|1|||
106101275|NCT01217073|366026667|FG003|Base Period|Adverse Event|0|||
106101276|NCT01217073|366026668|FG004|Base Period|Adverse Event|4|||
106101277|NCT01217073|366026669|FG005|Base Period|Adverse Event|1|||
106101278|NCT01217073|366026670|FG006|Base Period|Adverse Event|0|||
106101279|NCT01217073|366026671|FG007|Base Period|Adverse Event|0|||
106101280|NCT01217073|366026664|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
106101281|NCT01217073|366026665|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
106101282|NCT01217073|366026666|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
106101283|NCT01217073|366026667|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105779464|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
106101284|NCT01217073|366026668|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
106101285|NCT01217073|366026669|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
106101286|NCT01217073|366026670|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
106101287|NCT01217073|366026671|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
105878756|NCT01120184|365209742|FG000|Overall Study|Physician Decision|9|||
106101288|NCT01217073|366026664|FG000|Base Period|Excluded medication|0|||
106101289|NCT01217073|366026665|FG001|Base Period|Excluded medication|0|||
106101290|NCT01217073|366026666|FG002|Base Period|Excluded medication|0|||
106101291|NCT01217073|366026667|FG003|Base Period|Excluded medication|0|||
106101292|NCT01217073|366026668|FG004|Base Period|Excluded medication|1|||
106101293|NCT01217073|366026669|FG005|Base Period|Excluded medication|0|||
106101294|NCT01217073|366026670|FG006|Base Period|Excluded medication|0|||
106101295|NCT01217073|366026671|FG007|Base Period|Excluded medication|0|||
106101296|NCT01217073|366026664|FG000|Base Period|Lack of Efficacy|0|||
106101297|NCT01217073|366026665|FG001|Base Period|Lack of Efficacy|0|||
106101298|NCT01217073|366026666|FG002|Base Period|Lack of Efficacy|0|||
106101299|NCT01217073|366026667|FG003|Base Period|Lack of Efficacy|0|||
106101300|NCT01217073|366026668|FG004|Base Period|Lack of Efficacy|0|||
106101301|NCT01217073|366026669|FG005|Base Period|Lack of Efficacy|1|||
106101302|NCT01217073|366026670|FG006|Base Period|Lack of Efficacy|0|||
106101303|NCT01217073|366026671|FG007|Base Period|Lack of Efficacy|0|||
106101304|NCT01217073|366026664|FG000|Base Period|Lost to Follow-up|0|||
106101305|NCT01217073|366026665|FG001|Base Period|Lost to Follow-up|0|||
106101306|NCT01217073|366026666|FG002|Base Period|Lost to Follow-up|1|||
106101307|NCT01217073|366026667|FG003|Base Period|Lost to Follow-up|1|||
106101308|NCT01217073|366026668|FG004|Base Period|Lost to Follow-up|3|||
106101309|NCT01217073|366026669|FG005|Base Period|Lost to Follow-up|0|||
106101310|NCT01217073|366026670|FG006|Base Period|Lost to Follow-up|0|||
106101311|NCT01217073|366026671|FG007|Base Period|Lost to Follow-up|0|||
106101312|NCT01217073|366026664|FG000|Base Period|Physician Decision|0|||
106101313|NCT01217073|366026665|FG001|Base Period|Physician Decision|0|||
106101314|NCT01217073|366026666|FG002|Base Period|Physician Decision|0|||
106101315|NCT01217073|366026667|FG003|Base Period|Physician Decision|0|||
106101316|NCT01217073|366026668|FG004|Base Period|Physician Decision|1|||
106101317|NCT01217073|366026669|FG005|Base Period|Physician Decision|0|||
106101318|NCT01217073|366026670|FG006|Base Period|Physician Decision|0|||
106101319|NCT01217073|366026671|FG007|Base Period|Physician Decision|0|||
106101320|NCT01217073|366026664|FG000|Base Period|Protocol Violation|1|||
106101321|NCT01217073|366026665|FG001|Base Period|Protocol Violation|0|||
106101322|NCT01217073|366026666|FG002|Base Period|Protocol Violation|0|||
106101323|NCT01217073|366026667|FG003|Base Period|Protocol Violation|0|||
106101324|NCT01217073|366026668|FG004|Base Period|Protocol Violation|1|||
106101325|NCT01217073|366026669|FG005|Base Period|Protocol Violation|2|||
106101326|NCT01217073|366026670|FG006|Base Period|Protocol Violation|0|||
106101327|NCT01217073|366026671|FG007|Base Period|Protocol Violation|0|||
106101328|NCT01217073|366026664|FG000|Base Period|Withdrawal by Subject|4|||
106101329|NCT01217073|366026665|FG001|Base Period|Withdrawal by Subject|5|||
106101330|NCT01217073|366026666|FG002|Base Period|Withdrawal by Subject|5|||
106101331|NCT01217073|366026667|FG003|Base Period|Withdrawal by Subject|1|||
106101332|NCT01217073|366026668|FG004|Base Period|Withdrawal by Subject|5|||
106101333|NCT01217073|366026669|FG005|Base Period|Withdrawal by Subject|5|||
106101334|NCT01217073|366026670|FG006|Base Period|Withdrawal by Subject|0|||
106101335|NCT01217073|366026671|FG007|Base Period|Withdrawal by Subject|0|||
106101336|NCT01217073|366026664|FG000|Extension Period|Adverse Event|0|||
106101337|NCT01217073|366026665|FG001|Extension Period|Adverse Event|0|||
106101338|NCT01217073|366026666|FG002|Extension Period|Adverse Event|0|||
106101339|NCT01217073|366026667|FG003|Extension Period|Adverse Event|0|||
106101340|NCT01217073|366026668|FG004|Extension Period|Adverse Event|0|||
106101341|NCT01217073|366026669|FG005|Extension Period|Adverse Event|0|||
106101342|NCT01217073|366026670|FG006|Extension Period|Adverse Event|19|||
106101343|NCT01217073|366026671|FG007|Extension Period|Adverse Event|5|||
106101344|NCT01217073|366026664|FG000|Extension Period|ALT/AST|0|||
106101345|NCT01217073|366026665|FG001|Extension Period|ALT/AST|0|||
106101346|NCT01217073|366026666|FG002|Extension Period|ALT/AST|0|||
106101347|NCT01217073|366026667|FG003|Extension Period|ALT/AST|0|||
106101348|NCT01217073|366026668|FG004|Extension Period|ALT/AST|0|||
106101349|NCT01217073|366026669|FG005|Extension Period|ALT/AST|0|||
106101350|NCT01217073|366026670|FG006|Extension Period|ALT/AST|2|||
106101351|NCT01217073|366026671|FG007|Extension Period|ALT/AST|0|||
106101352|NCT01217073|366026664|FG000|Extension Period|Contraindication to study medication|0|||
106101353|NCT01217073|366026665|FG001|Extension Period|Contraindication to study medication|0|||
106101354|NCT01217073|366026666|FG002|Extension Period|Contraindication to study medication|0|||
106101355|NCT01217073|366026667|FG003|Extension Period|Contraindication to study medication|0|||
106101356|NCT01217073|366026668|FG004|Extension Period|Contraindication to study medication|0|||
106101357|NCT01217073|366026669|FG005|Extension Period|Contraindication to study medication|0|||
106101358|NCT01217073|366026670|FG006|Extension Period|Contraindication to study medication|1|||
106101359|NCT01217073|366026671|FG007|Extension Period|Contraindication to study medication|0|||
106101360|NCT01217073|366026664|FG000|Extension Period|Creatinine/eGFR|0|||
106101361|NCT01217073|366026665|FG001|Extension Period|Creatinine/eGFR|0|||
106101362|NCT01217073|366026666|FG002|Extension Period|Creatinine/eGFR|0|||
106101363|NCT01217073|366026667|FG003|Extension Period|Creatinine/eGFR|0|||
106101364|NCT01217073|366026668|FG004|Extension Period|Creatinine/eGFR|0|||
106101365|NCT01217073|366026669|FG005|Extension Period|Creatinine/eGFR|0|||
106101366|NCT01217073|366026670|FG006|Extension Period|Creatinine/eGFR|11|||
106101367|NCT01217073|366026671|FG007|Extension Period|Creatinine/eGFR|1|||
106101368|NCT01217073|366026664|FG000|Extension Period|Death|0|||
106101369|NCT01217073|366026665|FG001|Extension Period|Death|0|||
106101370|NCT01217073|366026666|FG002|Extension Period|Death|0|||
106101371|NCT01217073|366026667|FG003|Extension Period|Death|0|||
106101372|NCT01217073|366026668|FG004|Extension Period|Death|0|||
106101373|NCT01217073|366026669|FG005|Extension Period|Death|0|||
106101374|NCT01217073|366026670|FG006|Extension Period|Death|1|||
106101375|NCT01217073|366026671|FG007|Extension Period|Death|0|||
106101376|NCT01217073|366026664|FG000|Extension Period|Excluded medication|0|||
106101377|NCT01217073|366026665|FG001|Extension Period|Excluded medication|0|||
106101378|NCT01217073|366026666|FG002|Extension Period|Excluded medication|0|||
106101379|NCT01217073|366026667|FG003|Extension Period|Excluded medication|0|||
106101380|NCT01217073|366026668|FG004|Extension Period|Excluded medication|0|||
106101381|NCT01217073|366026669|FG005|Extension Period|Excluded medication|0|||
106101382|NCT01217073|366026670|FG006|Extension Period|Excluded medication|2|||
106101383|NCT01217073|366026671|FG007|Extension Period|Excluded medication|0|||
106101384|NCT01217073|366026664|FG000|Extension Period|Lack of Efficacy|0|||
106101385|NCT01217073|366026665|FG001|Extension Period|Lack of Efficacy|0|||
106101386|NCT01217073|366026666|FG002|Extension Period|Lack of Efficacy|0|||
106101387|NCT01217073|366026667|FG003|Extension Period|Lack of Efficacy|0|||
106101388|NCT01217073|366026668|FG004|Extension Period|Lack of Efficacy|0|||
106101389|NCT01217073|366026669|FG005|Extension Period|Lack of Efficacy|0|||
106101390|NCT01217073|366026670|FG006|Extension Period|Lack of Efficacy|3|||
106101391|NCT01217073|366026671|FG007|Extension Period|Lack of Efficacy|0|||
106101392|NCT01217073|366026664|FG000|Extension Period|Lost to Follow-up|0|||
106101393|NCT01217073|366026665|FG001|Extension Period|Lost to Follow-up|0|||
106101394|NCT01217073|366026666|FG002|Extension Period|Lost to Follow-up|0|||
106101395|NCT01217073|366026667|FG003|Extension Period|Lost to Follow-up|0|||
106101396|NCT01217073|366026668|FG004|Extension Period|Lost to Follow-up|0|||
106101397|NCT01217073|366026669|FG005|Extension Period|Lost to Follow-up|0|||
106101398|NCT01217073|366026670|FG006|Extension Period|Lost to Follow-up|9|||
106101399|NCT01217073|366026671|FG007|Extension Period|Lost to Follow-up|1|||
106101400|NCT01217073|366026664|FG000|Extension Period|Non-compliance with study drug|0|||
106101401|NCT01217073|366026665|FG001|Extension Period|Non-compliance with study drug|0|||
106101402|NCT01217073|366026666|FG002|Extension Period|Non-compliance with study drug|0|||
106101403|NCT01217073|366026667|FG003|Extension Period|Non-compliance with study drug|0|||
106101404|NCT01217073|366026668|FG004|Extension Period|Non-compliance with study drug|0|||
106101405|NCT01217073|366026669|FG005|Extension Period|Non-compliance with study drug|0|||
106101406|NCT01217073|366026670|FG006|Extension Period|Non-compliance with study drug|0|||
106101407|NCT01217073|366026671|FG007|Extension Period|Non-compliance with study drug|1|||
106101408|NCT01217073|366026664|FG000|Extension Period|Physician Decision|0|||
106101409|NCT01217073|366026665|FG001|Extension Period|Physician Decision|0|||
106101410|NCT01217073|366026666|FG002|Extension Period|Physician Decision|0|||
106101411|NCT01217073|366026667|FG003|Extension Period|Physician Decision|0|||
106101412|NCT01217073|366026668|FG004|Extension Period|Physician Decision|0|||
106101413|NCT01217073|366026669|FG005|Extension Period|Physician Decision|0|||
106101414|NCT01217073|366026670|FG006|Extension Period|Physician Decision|4|||
106101415|NCT01217073|366026671|FG007|Extension Period|Physician Decision|1|||
106101416|NCT01217073|366026664|FG000|Extension Period|Protocol Violation|0|||
106101417|NCT01217073|366026665|FG001|Extension Period|Protocol Violation|0|||
106101418|NCT01217073|366026666|FG002|Extension Period|Protocol Violation|0|||
106101419|NCT01217073|366026667|FG003|Extension Period|Protocol Violation|0|||
106101420|NCT01217073|366026668|FG004|Extension Period|Protocol Violation|0|||
106101421|NCT01217073|366026669|FG005|Extension Period|Protocol Violation|0|||
106101422|NCT01217073|366026670|FG006|Extension Period|Protocol Violation|2|||
106101423|NCT01217073|366026671|FG007|Extension Period|Protocol Violation|1|||
106101424|NCT01217073|366026664|FG000|Extension Period|Site discontinued study participation|0|||
106101425|NCT01217073|366026665|FG001|Extension Period|Site discontinued study participation|0|||
106101426|NCT01217073|366026666|FG002|Extension Period|Site discontinued study participation|0|||
106101427|NCT01217073|366026667|FG003|Extension Period|Site discontinued study participation|0|||
106101428|NCT01217073|366026668|FG004|Extension Period|Site discontinued study participation|0|||
106101429|NCT01217073|366026669|FG005|Extension Period|Site discontinued study participation|0|||
106101430|NCT01217073|366026670|FG006|Extension Period|Site discontinued study participation|7|||
106101431|NCT01217073|366026671|FG007|Extension Period|Site discontinued study participation|2|||
106101432|NCT01217073|366026664|FG000|Extension Period|Withdrawal by Subject|0|||
106101433|NCT01217073|366026665|FG001|Extension Period|Withdrawal by Subject|0|||
106101434|NCT01217073|366026666|FG002|Extension Period|Withdrawal by Subject|0|||
106101435|NCT01217073|366026667|FG003|Extension Period|Withdrawal by Subject|0|||
106101436|NCT01217073|366026668|FG004|Extension Period|Withdrawal by Subject|0|||
106101437|NCT01217073|366026669|FG005|Extension Period|Withdrawal by Subject|0|||
106101438|NCT01217073|366026670|FG006|Extension Period|Withdrawal by Subject|30|||
106101439|NCT01217073|366026671|FG007|Extension Period|Withdrawal by Subject|8|||
105878757|NCT01120184|365209743|FG001|Overall Study|Physician Decision|1|||
106101440|NCT02479412|366026672|FG000|Overall Study|Adverse Event|0|||
106101441|NCT02479412|366026673|FG001|Overall Study|Adverse Event|0|||
106101442|NCT02479412|366026674|FG002|Overall Study|Adverse Event|1|||
106101443|NCT02479412|366026675|FG003|Overall Study|Adverse Event|0|||
106101444|NCT02479412|366026676|FG004|Overall Study|Adverse Event|0|||
106101445|NCT02479412|366026677|FG005|Overall Study|Adverse Event|0|||
106101446|NCT02479412|366026678|FG006|Overall Study|Adverse Event|0|||
106101447|NCT02479412|366026679|FG007|Overall Study|Adverse Event|0|||
106101448|NCT02479412|366026680|FG008|Overall Study|Adverse Event|0|||
106101449|NCT02479412|366026672|FG000|Overall Study|Study-specific withdrawal criteria|0|||
106101450|NCT02479412|366026673|FG001|Overall Study|Study-specific withdrawal criteria|0|||
106101451|NCT02479412|366026674|FG002|Overall Study|Study-specific withdrawal criteria|1|||
106101452|NCT02479412|366026675|FG003|Overall Study|Study-specific withdrawal criteria|1|||
106101453|NCT02479412|366026676|FG004|Overall Study|Study-specific withdrawal criteria|0|||
106101454|NCT02479412|366026677|FG005|Overall Study|Study-specific withdrawal criteria|0|||
106101455|NCT02479412|366026678|FG006|Overall Study|Study-specific withdrawal criteria|0|||
106101456|NCT02479412|366026679|FG007|Overall Study|Study-specific withdrawal criteria|1|||
106101457|NCT02479412|366026680|FG008|Overall Study|Study-specific withdrawal criteria|1|||
106101458|NCT02479412|366026672|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
106101459|NCT02479412|366026673|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
106101460|NCT02479412|366026674|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
106101461|NCT02479412|366026675|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
106101462|NCT02479412|366026676|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
106101463|NCT02479412|366026677|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
106101464|NCT02479412|366026678|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
106101465|NCT02479412|366026679|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
106101466|NCT02479412|366026680|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
106101467|NCT03117738|366026684|FG000|Overall Study|Withdrawal by Subject|3|||
106101468|NCT03117738|366026685|FG001|Overall Study|Withdrawal by Subject|1|||
106101469|NCT03117738|366026684|FG000|Overall Study|Lost to Follow-up|1|||
106101470|NCT03117738|366026685|FG001|Overall Study|Lost to Follow-up|4|||
106101471|NCT03667053|366026686|FG000|Overall Study|Withdrawal by Subject|1|||
106101472|NCT03667053|366026687|FG001|Overall Study|Withdrawal by Subject|0|||
106101473|NCT03667053|366026688|FG002|Overall Study|Withdrawal by Subject|0|||
106101474|NCT00487162|366026692|FG000|Overall Study|Adverse Event|0|||
106101475|NCT00487162|366026693|FG001|Overall Study|Adverse Event|1|||
106101476|NCT00487162|366026692|FG000|Overall Study|Physician Decision|0|||
106101477|NCT00487162|366026693|FG001|Overall Study|Physician Decision|1|||
106101478|NCT00487162|366026692|FG000|Overall Study|Withdrawal by Subject|2|||
106101479|NCT00487162|366026693|FG001|Overall Study|Withdrawal by Subject|3|||
106101480|NCT01292928|366026696|FG000|Overall Study|Death|8|||
106101481|NCT01292928|366026696|FG000|Overall Study|Withdrawal by Subject|8|||
106101482|NCT01292928|366026696|FG000|Overall Study|Lost to Follow-up|6|||
106101483|NCT01292928|366026696|FG000|Overall Study|Physician Decision|2|||
106101484|NCT00130533|366026697|FG000|Overall Study|Withdrawal by Subject|33|||
106101485|NCT00130533|366026698|FG001|Overall Study|Withdrawal by Subject|6|||
106101486|NCT00130533|366026697|FG000|Overall Study|Adverse Event|34|||
106101487|NCT00130533|366026698|FG001|Overall Study|Adverse Event|1|||
106101488|NCT00130533|366026697|FG000|Overall Study|Disease relapse|9|||
106101489|NCT00130533|366026698|FG001|Overall Study|Disease relapse|13|||
106101490|NCT00130533|366026697|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
106101491|NCT00130533|366026698|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
106101492|NCT00130533|366026697|FG000|Overall Study|Death|4|||
106101493|NCT00130533|366026698|FG001|Overall Study|Death|2|||
106101494|NCT00130533|366026697|FG000|Overall Study|Protocol Violation|5|||
106101495|NCT00130533|366026698|FG001|Overall Study|Protocol Violation|1|||
106101496|NCT00130533|366026697|FG000|Overall Study|Lost to Follow-up|1|||
106101497|NCT00130533|366026698|FG001|Overall Study|Lost to Follow-up|1|||
106101498|NCT00130533|366026697|FG000|Overall Study|Sponsor´s decision|2|||
106101499|NCT00130533|366026698|FG001|Overall Study|Sponsor´s decision|0|||
106101500|NCT00130533|366026697|FG000|Overall Study|Second Primary Malignancy|0|||
106101501|NCT00130533|366026698|FG001|Overall Study|Second Primary Malignancy|1|||
106101502|NCT00130533|366026697|FG000|Overall Study|Other|12|||
106101503|NCT00130533|366026698|FG001|Overall Study|Other|5|||
105779465|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
106101504|NCT01059565|366026699|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
106101505|NCT01059565|366026700|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
106101506|NCT01059565|366026699|FG000|24-Week Randomized Phase|Adverse Event|5|||
106101507|NCT01059565|366026700|FG001|24-Week Randomized Phase|Adverse Event|0|||
106101508|NCT01059565|366026699|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
106101509|NCT01059565|366026700|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
106101510|NCT01059565|366026699|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
106101511|NCT01059565|366026700|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
106101512|NCT01059565|366026699|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
106101513|NCT01059565|366026700|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
106101514|NCT01059565|366026699|FG000|24-Week Open-Label Phase|Adverse Event|2|||
105779466|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
106101515|NCT01059565|366026700|FG001|24-Week Open-Label Phase|Adverse Event|0|||
106101516|NCT01059565|366026699|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
106101517|NCT01059565|366026700|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
106101518|NCT01059565|366026699|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
106101519|NCT01059565|366026700|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
106101520|NCT01059565|366026699|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
106101521|NCT01059565|366026700|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
106101522|NCT01059565|366026699|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
106101523|NCT01059565|366026700|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
106101524|NCT01059565|366026699|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
106101525|NCT01059565|366026700|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
106101526|NCT01605617|366026701|FG000|First Intervention|Adverse Event|0|||
106101527|NCT01605617|366026702|FG001|First Intervention|Adverse Event|1|||
106101528|NCT01605617|366026701|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
106101529|NCT01605617|366026702|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
106101530|NCT01613248|366026703|FG000|Overall Study|Adverse Event|0|||
106101531|NCT01613248|366026704|FG001|Overall Study|Adverse Event|0|||
106101532|NCT01613248|366026705|FG002|Overall Study|Adverse Event|0|||
106101533|NCT01613248|366026706|FG003|Overall Study|Adverse Event|1|||
106101534|NCT01613248|366026707|FG004|Overall Study|Adverse Event|0|||
106101535|NCT01613248|366026708|FG005|Overall Study|Adverse Event|0|||
106101536|NCT01613248|366026703|FG000|Overall Study|Withdrawal by Subject|3|||
106101537|NCT01613248|366026704|FG001|Overall Study|Withdrawal by Subject|2|||
106101538|NCT01613248|366026705|FG002|Overall Study|Withdrawal by Subject|2|||
106101539|NCT01613248|366026706|FG003|Overall Study|Withdrawal by Subject|5|||
106101540|NCT01613248|366026707|FG004|Overall Study|Withdrawal by Subject|0|||
106101541|NCT01613248|366026708|FG005|Overall Study|Withdrawal by Subject|1|||
106101542|NCT01613248|366026703|FG000|Overall Study|Lost to Follow-up|5|||
106101543|NCT01613248|366026704|FG001|Overall Study|Lost to Follow-up|7|||
106101544|NCT01613248|366026705|FG002|Overall Study|Lost to Follow-up|4|||
106101545|NCT01613248|366026706|FG003|Overall Study|Lost to Follow-up|8|||
106101546|NCT01613248|366026707|FG004|Overall Study|Lost to Follow-up|4|||
106101547|NCT01613248|366026708|FG005|Overall Study|Lost to Follow-up|2|||
106101548|NCT01613248|366026703|FG000|Overall Study|Study Terminated by Sponsor|4|||
106101549|NCT01613248|366026704|FG001|Overall Study|Study Terminated by Sponsor|6|||
106101550|NCT01613248|366026705|FG002|Overall Study|Study Terminated by Sponsor|8|||
106101551|NCT01613248|366026706|FG003|Overall Study|Study Terminated by Sponsor|8|||
106101552|NCT01613248|366026707|FG004|Overall Study|Study Terminated by Sponsor|9|||
106101553|NCT01613248|366026708|FG005|Overall Study|Study Terminated by Sponsor|11|||
106101554|NCT01613248|366026703|FG000|Overall Study|Physician Decision|8|||
106101555|NCT01613248|366026704|FG001|Overall Study|Physician Decision|8|||
106101556|NCT01613248|366026705|FG002|Overall Study|Physician Decision|9|||
106101557|NCT01613248|366026706|FG003|Overall Study|Physician Decision|4|||
106101558|NCT01613248|366026707|FG004|Overall Study|Physician Decision|7|||
106101559|NCT01613248|366026708|FG005|Overall Study|Physician Decision|6|||
106101560|NCT01613248|366026703|FG000|Overall Study|Lack of Qualifying Event|9|||
106101561|NCT01613248|366026704|FG001|Overall Study|Lack of Qualifying Event|11|||
106101562|NCT01613248|366026705|FG002|Overall Study|Lack of Qualifying Event|10|||
106101563|NCT01613248|366026706|FG003|Overall Study|Lack of Qualifying Event|11|||
106101564|NCT01613248|366026707|FG004|Overall Study|Lack of Qualifying Event|15|||
106101565|NCT01613248|366026708|FG005|Overall Study|Lack of Qualifying Event|18|||
106101566|NCT01613248|366026703|FG000|Overall Study|Pregnancy|0|||
106101567|NCT01613248|366026704|FG001|Overall Study|Pregnancy|0|||
106101568|NCT01613248|366026705|FG002|Overall Study|Pregnancy|0|||
106101569|NCT01613248|366026706|FG003|Overall Study|Pregnancy|1|||
105779467|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
106101570|NCT01613248|366026707|FG004|Overall Study|Pregnancy|0|||
105779468|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
105779469|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
105779470|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
105779471|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
106101571|NCT01613248|366026708|FG005|Overall Study|Pregnancy|0|||
105779472|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
105779473|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
106101572|NCT01491854|366026709|FG000|Overall Study|mainly due to premature termination|93|||
106101573|NCT01491854|366026709|FG000|Overall Study|Death|1|||
106101574|NCT01491854|366026709|FG000|Overall Study|Withdrawal by Subject|3|||
106101575|NCT01491854|366026709|FG000|Overall Study|Lost to Follow-up|33|||
106101576|NCT00121238|366026710|FG000|Overall Study|disease progression before intervention|1|||
106101577|NCT00121238|366026710|FG000|Overall Study|Protocol Violation|2|||
106101578|NCT00868439|366026711|FG000|Overall Study|Adverse Event|4|||
106101579|NCT00868439|366026712|FG001|Overall Study|Adverse Event|3|||
106101580|NCT00868439|366026711|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
105779474|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
106101581|NCT00868439|366026712|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
106101582|NCT00868439|366026711|FG000|Overall Study|Death|0|||
106101583|NCT00868439|366026712|FG001|Overall Study|Death|1|||
105779475|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
105779476|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
105779477|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
105779478|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
105779479|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
105779480|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
105779481|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
105779482|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
105779483|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
105779484|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
105779485|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
105779486|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
105779487|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
105779488|NCT04052425|364844760|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
105779489|NCT04052425|364844761|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
105779490|NCT04052425|364844762|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
105779491|NCT04052425|364844763|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
105779492|NCT02452034|364844764|FG000|Overall Study|Adverse Event|0|||
105779493|NCT02452034|364844765|FG001|Overall Study|Adverse Event|0|||
105779494|NCT02452034|364844766|FG002|Overall Study|Adverse Event|0|||
105779495|NCT02452034|364844767|FG003|Overall Study|Adverse Event|0|||
105779496|NCT02452034|364844768|FG004|Overall Study|Adverse Event|0|||
105779497|NCT02452034|364844769|FG005|Overall Study|Adverse Event|1|||
105779498|NCT02452034|364844764|FG000|Overall Study|Death|0|||
105779499|NCT02452034|364844765|FG001|Overall Study|Death|0|||
105779500|NCT02452034|364844766|FG002|Overall Study|Death|0|||
105779501|NCT02452034|364844767|FG003|Overall Study|Death|0|||
105779502|NCT02452034|364844768|FG004|Overall Study|Death|1|||
105779503|NCT02452034|364844769|FG005|Overall Study|Death|1|||
105779504|NCT02452034|364844764|FG000|Overall Study|Physician Decision|0|||
105779505|NCT02452034|364844765|FG001|Overall Study|Physician Decision|1|||
106101584|NCT00868439|366026711|FG000|Overall Study|Protocol Violation|1|||
106101585|NCT00868439|366026712|FG001|Overall Study|Protocol Violation|1|||
106101586|NCT00868439|366026711|FG000|Overall Study|Physician Decision|1|||
106101587|NCT00868439|366026712|FG001|Overall Study|Physician Decision|0|||
106101588|NCT00868439|366026711|FG000|Overall Study|Withdrawal by Subject|0|||
106101589|NCT00868439|366026712|FG001|Overall Study|Withdrawal by Subject|1|||
106101590|NCT03526250|366026718|FG000|Overall Study|Adverse Event|4|||
106101591|NCT03526250|366026718|FG000|Overall Study|Progressive Disease|16|||
106101592|NCT03526250|366026718|FG000|Overall Study|No Treatment|3|||
106101593|NCT00511004|366026719|FG000|Overall Study|Lost to Follow-up|0|||
106101594|NCT00511004|366026720|FG001|Overall Study|Lost to Follow-up|0|||
106101595|NCT00511004|366026721|FG002|Overall Study|Lost to Follow-up|4|||
105779506|NCT02452034|364844766|FG002|Overall Study|Physician Decision|1|||
105779507|NCT02452034|364844767|FG003|Overall Study|Physician Decision|0|||
105779508|NCT02452034|364844768|FG004|Overall Study|Physician Decision|0|||
105779509|NCT02452034|364844769|FG005|Overall Study|Physician Decision|0|||
105779510|NCT02452034|364844764|FG000|Overall Study|Protocol Violation|0|||
105779511|NCT02452034|364844765|FG001|Overall Study|Protocol Violation|0|||
105779512|NCT02452034|364844766|FG002|Overall Study|Protocol Violation|0|||
105779513|NCT02452034|364844767|FG003|Overall Study|Protocol Violation|0|||
105779514|NCT02452034|364844768|FG004|Overall Study|Protocol Violation|0|||
105779515|NCT02452034|364844769|FG005|Overall Study|Protocol Violation|1|||
105779516|NCT02452034|364844764|FG000|Overall Study|Screen Failure|1|||
105779517|NCT02452034|364844765|FG001|Overall Study|Screen Failure|0|||
105779518|NCT02452034|364844766|FG002|Overall Study|Screen Failure|0|||
105779519|NCT02452034|364844767|FG003|Overall Study|Screen Failure|1|||
105779520|NCT02452034|364844768|FG004|Overall Study|Screen Failure|0|||
105779521|NCT02452034|364844769|FG005|Overall Study|Screen Failure|0|||
105779522|NCT02452034|364844764|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
105779523|NCT02452034|364844765|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
105779524|NCT02452034|364844766|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
105779525|NCT02452034|364844767|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
105779526|NCT02452034|364844768|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
105779527|NCT02452034|364844769|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
105779528|NCT05102734|364844773|FG000|Overall Study|Did not require vasopressors|1|||
105779529|NCT05102734|364844774|FG001|Overall Study|Did not require vasopressors|0|||
105779530|NCT05102734|364844773|FG000|Overall Study|Did not have functioning PA catheter|1|||
105779531|NCT05102734|364844774|FG001|Overall Study|Did not have functioning PA catheter|0|||
105779532|NCT05102734|364844773|FG000|Overall Study|Inadequate video quality|2|||
105779533|NCT05102734|364844774|FG001|Overall Study|Inadequate video quality|0|||
106101596|NCT01869491|366026722|FG000|Overall Study|Adverse Event|3|||
105779534|NCT02074059|364844776|FG000|Overall Study|Death|0|||
105779535|NCT02074059|364844777|FG001|Overall Study|Death|0|||
105779536|NCT02074059|364844778|FG002|Overall Study|Death|0|||
105779537|NCT02074059|364844779|FG003|Overall Study|Death|0|||
105779538|NCT02074059|364844780|FG004|Overall Study|Death|1|||
105779539|NCT02074059|364844781|FG005|Overall Study|Death|1|||
105779540|NCT00917553|364844783|FG000|Overall Study|Lost to Follow-up|2|||
105779541|NCT00917553|364844784|FG001|Overall Study|Lost to Follow-up|1|||
105779542|NCT03432819|364844786|FG000|Overall Study|Lost to Follow-up|2|||
105779543|NCT03432819|364844787|FG001|Overall Study|Lost to Follow-up|2|||
105779544|NCT03432819|364844786|FG000|Overall Study|Withdrawal by Subject|5|||
105779545|NCT03432819|364844787|FG001|Overall Study|Withdrawal by Subject|3|||
105779546|NCT02418000|364844788|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
105779547|NCT02418000|364844789|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779548|NCT02418000|364844790|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779549|NCT02418000|364844791|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779550|NCT02418000|364844792|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779551|NCT02418000|364844788|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
105779552|NCT02418000|364844789|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
105779553|NCT02418000|364844790|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
105779554|NCT02418000|364844791|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
105779555|NCT02418000|364844792|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
105779556|NCT02418000|364844788|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
105779557|NCT02418000|364844789|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
105779558|NCT02418000|364844790|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
105779559|NCT02418000|364844791|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
105779560|NCT02418000|364844792|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
105779561|NCT02418000|364844788|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779562|NCT02418000|364844789|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
105779563|NCT02418000|364844790|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779564|NCT02418000|364844791|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779565|NCT02418000|364844792|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
105779566|NCT02418000|364844788|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
105779567|NCT02418000|364844789|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
105779568|NCT02418000|364844790|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
105779569|NCT02418000|364844791|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
105779570|NCT02418000|364844792|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
105779571|NCT02418000|364844788|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779572|NCT02418000|364844789|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779573|NCT02418000|364844790|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
105779574|NCT02418000|364844791|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779575|NCT02418000|364844792|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779576|NCT02418000|364844788|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779577|NCT02418000|364844789|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779578|NCT02418000|364844790|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779579|NCT02418000|364844791|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
105779580|NCT02418000|364844792|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779581|NCT02418000|364844788|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
105779582|NCT02418000|364844789|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
105779583|NCT02418000|364844790|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
105779584|NCT02418000|364844791|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
105779585|NCT02418000|364844792|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
105779586|NCT02418000|364844788|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779587|NCT02418000|364844789|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779588|NCT02418000|364844790|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779589|NCT02418000|364844791|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
105779590|NCT02418000|364844792|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
105779591|NCT02030067|364844793|FG000|Overall Study|Disease Progression|1|||
105779592|NCT02030067|364844794|FG001|Overall Study|Disease Progression|1|||
105779593|NCT02030067|364844795|FG002|Overall Study|Disease Progression|2|||
105779594|NCT02030067|364844796|FG003|Overall Study|Disease Progression|2|||
105779595|NCT02030067|364844797|FG004|Overall Study|Disease Progression|3|||
106101597|NCT01869491|366026723|FG001|Overall Study|Adverse Event|5|||
105779596|NCT02030067|364844798|FG005|Overall Study|Disease Progression|2|||
105779597|NCT02030067|364844799|FG006|Overall Study|Disease Progression|3|||
105779598|NCT02030067|364844800|FG007|Overall Study|Disease Progression|3|||
105779599|NCT02030067|364844801|FG008|Overall Study|Disease Progression|4|||
105779600|NCT02030067|364844802|FG009|Overall Study|Disease Progression|3|||
105779601|NCT02030067|364844803|FG010|Overall Study|Disease Progression|7|||
106101598|NCT01869491|366026722|FG000|Overall Study|Lack of Efficacy|0|||
106101599|NCT01869491|366026723|FG001|Overall Study|Lack of Efficacy|3|||
105779602|NCT02030067|364844804|FG011|Overall Study|Disease Progression|2|||
105779603|NCT02030067|364844805|FG012|Overall Study|Disease Progression|59|||
105779604|NCT02030067|364844793|FG000|Overall Study|Withdrawal by Subject|0|||
105779605|NCT02030067|364844794|FG001|Overall Study|Withdrawal by Subject|0|||
105779606|NCT02030067|364844795|FG002|Overall Study|Withdrawal by Subject|0|||
105779607|NCT02030067|364844796|FG003|Overall Study|Withdrawal by Subject|1|||
105779608|NCT02030067|364844797|FG004|Overall Study|Withdrawal by Subject|0|||
105779609|NCT02030067|364844798|FG005|Overall Study|Withdrawal by Subject|0|||
105779610|NCT02030067|364844799|FG006|Overall Study|Withdrawal by Subject|0|||
105779611|NCT02030067|364844800|FG007|Overall Study|Withdrawal by Subject|1|||
105779612|NCT02030067|364844801|FG008|Overall Study|Withdrawal by Subject|0|||
105779613|NCT02030067|364844802|FG009|Overall Study|Withdrawal by Subject|0|||
105779614|NCT02030067|364844803|FG010|Overall Study|Withdrawal by Subject|3|||
105779615|NCT02030067|364844804|FG011|Overall Study|Withdrawal by Subject|0|||
105779616|NCT02030067|364844805|FG012|Overall Study|Withdrawal by Subject|6|||
105779617|NCT02030067|364844793|FG000|Overall Study|Physician Decision|0|||
105779618|NCT02030067|364844794|FG001|Overall Study|Physician Decision|0|||
105779619|NCT02030067|364844795|FG002|Overall Study|Physician Decision|0|||
105779620|NCT02030067|364844796|FG003|Overall Study|Physician Decision|0|||
105779621|NCT02030067|364844797|FG004|Overall Study|Physician Decision|0|||
105779622|NCT02030067|364844798|FG005|Overall Study|Physician Decision|0|||
105779623|NCT02030067|364844799|FG006|Overall Study|Physician Decision|0|||
105779624|NCT02030067|364844800|FG007|Overall Study|Physician Decision|0|||
105779625|NCT02030067|364844801|FG008|Overall Study|Physician Decision|0|||
105779626|NCT02030067|364844802|FG009|Overall Study|Physician Decision|0|||
105779627|NCT02030067|364844803|FG010|Overall Study|Physician Decision|1|||
105779628|NCT02030067|364844804|FG011|Overall Study|Physician Decision|0|||
105779629|NCT02030067|364844805|FG012|Overall Study|Physician Decision|3|||
105779630|NCT02030067|364844793|FG000|Overall Study|other reasons|0|||
105779631|NCT02030067|364844794|FG001|Overall Study|other reasons|0|||
105779632|NCT02030067|364844795|FG002|Overall Study|other reasons|0|||
105779633|NCT02030067|364844796|FG003|Overall Study|other reasons|0|||
105779634|NCT02030067|364844797|FG004|Overall Study|other reasons|0|||
105779635|NCT02030067|364844798|FG005|Overall Study|other reasons|1|||
105779636|NCT02030067|364844799|FG006|Overall Study|other reasons|0|||
105779637|NCT02030067|364844800|FG007|Overall Study|other reasons|0|||
105779638|NCT02030067|364844801|FG008|Overall Study|other reasons|2|||
105779639|NCT02030067|364844802|FG009|Overall Study|other reasons|0|||
105779640|NCT02030067|364844803|FG010|Overall Study|other reasons|0|||
105779641|NCT02030067|364844804|FG011|Overall Study|other reasons|0|||
105779642|NCT02030067|364844805|FG012|Overall Study|other reasons|4|||
105779643|NCT02030067|364844793|FG000|Overall Study|Adverse Event|0|||
105779644|NCT02030067|364844794|FG001|Overall Study|Adverse Event|0|||
105779645|NCT02030067|364844795|FG002|Overall Study|Adverse Event|0|||
105779646|NCT02030067|364844796|FG003|Overall Study|Adverse Event|0|||
105779647|NCT02030067|364844797|FG004|Overall Study|Adverse Event|0|||
105779648|NCT02030067|364844798|FG005|Overall Study|Adverse Event|0|||
105779649|NCT02030067|364844799|FG006|Overall Study|Adverse Event|0|||
105779650|NCT02030067|364844800|FG007|Overall Study|Adverse Event|0|||
105779651|NCT02030067|364844801|FG008|Overall Study|Adverse Event|0|||
105779652|NCT02030067|364844802|FG009|Overall Study|Adverse Event|0|||
105779653|NCT02030067|364844803|FG010|Overall Study|Adverse Event|0|||
105779654|NCT02030067|364844804|FG011|Overall Study|Adverse Event|1|||
105779655|NCT02030067|364844805|FG012|Overall Study|Adverse Event|8|||
105779656|NCT00496782|364844806|FG000|Overall Study|Protocol Violation|1|||
105779657|NCT00496782|364844807|FG001|Overall Study|Protocol Violation|2|||
105779658|NCT00760994|364844808|FG000|Overall Study|Lost to Follow-up|4|||
105779659|NCT00760994|364844809|FG001|Overall Study|Lost to Follow-up|4|||
105779660|NCT00760994|364844810|FG002|Overall Study|Lost to Follow-up|3|||
105779661|NCT00660816|364844811|FG000|Overall Study|Adverse Event|1|||
105779662|NCT00660816|364844812|FG001|Overall Study|Adverse Event|2|||
105779663|NCT00660816|364844811|FG000|Overall Study|Withdrawal by Subject|1|||
105779664|NCT00660816|364844812|FG001|Overall Study|Withdrawal by Subject|0|||
105779665|NCT00660816|364844811|FG000|Overall Study|Death|0|||
105779666|NCT00660816|364844812|FG001|Overall Study|Death|2|||
105779667|NCT00660816|364844811|FG000|Overall Study|Lack of Efficacy|1|||
105779668|NCT00660816|364844812|FG001|Overall Study|Lack of Efficacy|0|||
105779669|NCT00660816|364844811|FG000|Overall Study|Physician Decision|0|||
105779670|NCT00660816|364844812|FG001|Overall Study|Physician Decision|2|||
105779671|NCT00660816|364844811|FG000|Overall Study|Protocol Violation|1|||
105779672|NCT00660816|364844812|FG001|Overall Study|Protocol Violation|0|||
105779673|NCT00660816|364844811|FG000|Overall Study|Disease Progression|16|||
105779674|NCT00660816|364844812|FG001|Overall Study|Disease Progression|12|||
105779675|NCT00660816|364844811|FG000|Overall Study|Complicating Disease|0|||
105779676|NCT00660816|364844812|FG001|Overall Study|Complicating Disease|1|||
105779677|NCT04212221|364844813|FG000|Overall Study|Remained on Treatment|0|||
105779678|NCT04212221|364844814|FG001|Overall Study|Remained on Treatment|0|||
105779679|NCT04212221|364844815|FG002|Overall Study|Remained on Treatment|0|||
105779680|NCT04212221|364844816|FG003|Overall Study|Remained on Treatment|1|||
105779681|NCT04212221|364844817|FG004|Overall Study|Remained on Treatment|0|||
105779682|NCT04212221|364844818|FG005|Overall Study|Remained on Treatment|0|||
105779683|NCT04212221|364844819|FG006|Overall Study|Remained on Treatment|3|||
105779684|NCT04212221|364844820|FG007|Overall Study|Remained on Treatment|9|||
105779685|NCT04212221|364844813|FG000|Overall Study|Adverse Event|0|||
105779686|NCT04212221|364844814|FG001|Overall Study|Adverse Event|0|||
105779687|NCT04212221|364844815|FG002|Overall Study|Adverse Event|0|||
105779688|NCT04212221|364844816|FG003|Overall Study|Adverse Event|0|||
105779689|NCT04212221|364844817|FG004|Overall Study|Adverse Event|0|||
105779690|NCT04212221|364844818|FG005|Overall Study|Adverse Event|0|||
105779691|NCT04212221|364844819|FG006|Overall Study|Adverse Event|2|||
105779692|NCT04212221|364844820|FG007|Overall Study|Adverse Event|3|||
105779693|NCT04212221|364844813|FG000|Overall Study|Death|0|||
105779694|NCT04212221|364844814|FG001|Overall Study|Death|0|||
105779695|NCT04212221|364844815|FG002|Overall Study|Death|0|||
105779696|NCT04212221|364844816|FG003|Overall Study|Death|0|||
105779697|NCT04212221|364844817|FG004|Overall Study|Death|0|||
105779698|NCT04212221|364844818|FG005|Overall Study|Death|0|||
105779699|NCT04212221|364844819|FG006|Overall Study|Death|0|||
105779700|NCT04212221|364844820|FG007|Overall Study|Death|2|||
105779701|NCT04212221|364844813|FG000|Overall Study|Disease progression according to irRECIST|1|||
105779702|NCT04212221|364844814|FG001|Overall Study|Disease progression according to irRECIST|2|||
105779703|NCT04212221|364844815|FG002|Overall Study|Disease progression according to irRECIST|3|||
105779704|NCT04212221|364844816|FG003|Overall Study|Disease progression according to irRECIST|3|||
105779705|NCT04212221|364844817|FG004|Overall Study|Disease progression according to irRECIST|2|||
105779706|NCT04212221|364844818|FG005|Overall Study|Disease progression according to irRECIST|2|||
105779707|NCT04212221|364844819|FG006|Overall Study|Disease progression according to irRECIST|21|||
105779708|NCT04212221|364844820|FG007|Overall Study|Disease progression according to irRECIST|17|||
105779709|NCT04212221|364844813|FG000|Overall Study|Global Deterioration of Health Status|0|||
105779710|NCT04212221|364844814|FG001|Overall Study|Global Deterioration of Health Status|0|||
105779711|NCT04212221|364844815|FG002|Overall Study|Global Deterioration of Health Status|0|||
105779712|NCT04212221|364844816|FG003|Overall Study|Global Deterioration of Health Status|0|||
105779713|NCT04212221|364844817|FG004|Overall Study|Global Deterioration of Health Status|0|||
105779714|NCT04212221|364844818|FG005|Overall Study|Global Deterioration of Health Status|0|||
105779715|NCT04212221|364844819|FG006|Overall Study|Global Deterioration of Health Status|0|||
105779716|NCT04212221|364844820|FG007|Overall Study|Global Deterioration of Health Status|2|||
105779717|NCT04212221|364844813|FG000|Overall Study|Investigator's Decision|0|||
105779718|NCT04212221|364844814|FG001|Overall Study|Investigator's Decision|0|||
105779719|NCT04212221|364844815|FG002|Overall Study|Investigator's Decision|0|||
105779720|NCT04212221|364844816|FG003|Overall Study|Investigator's Decision|1|||
105779721|NCT04212221|364844817|FG004|Overall Study|Investigator's Decision|0|||
105779722|NCT04212221|364844818|FG005|Overall Study|Investigator's Decision|0|||
105779723|NCT04212221|364844819|FG006|Overall Study|Investigator's Decision|3|||
105779724|NCT04212221|364844820|FG007|Overall Study|Investigator's Decision|0|||
105779725|NCT04212221|364844813|FG000|Overall Study|Participant refused to continue treatment|0|||
105779726|NCT04212221|364844814|FG001|Overall Study|Participant refused to continue treatment|1|||
105779727|NCT04212221|364844815|FG002|Overall Study|Participant refused to continue treatment|0|||
105779728|NCT04212221|364844816|FG003|Overall Study|Participant refused to continue treatment|1|||
105779729|NCT04212221|364844817|FG004|Overall Study|Participant refused to continue treatment|1|||
105779730|NCT04212221|364844818|FG005|Overall Study|Participant refused to continue treatment|2|||
105779731|NCT04212221|364844819|FG006|Overall Study|Participant refused to continue treatment|4|||
105779732|NCT04212221|364844820|FG007|Overall Study|Participant refused to continue treatment|2|||
105779733|NCT04212221|364844813|FG000|Overall Study|Protocol Violation|0|||
105779734|NCT04212221|364844814|FG001|Overall Study|Protocol Violation|0|||
105779735|NCT04212221|364844815|FG002|Overall Study|Protocol Violation|0|||
105779736|NCT04212221|364844816|FG003|Overall Study|Protocol Violation|0|||
105779737|NCT04212221|364844817|FG004|Overall Study|Protocol Violation|0|||
105779738|NCT04212221|364844818|FG005|Overall Study|Protocol Violation|0|||
105779739|NCT04212221|364844819|FG006|Overall Study|Protocol Violation|0|||
105779740|NCT04212221|364844820|FG007|Overall Study|Protocol Violation|1|||
105779741|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
105779742|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
105779743|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
105779744|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
105779745|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
105779746|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
105779747|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Death|1|||
105779748|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Death|1|||
105779749|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Death|1|||
105779750|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Death|0|||
105779751|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Death|0|||
105779752|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Death|0|||
105779753|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
105779754|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
105779755|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
105779756|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
105779757|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
105779758|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
105779759|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779760|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779761|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
105779762|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779763|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779764|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
105779765|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779766|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
105779767|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779768|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779769|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779770|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
105779771|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
105779772|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
105779773|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
105779774|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
105779775|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
105779776|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
105779777|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779778|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
105779779|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779780|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779781|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779782|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
105779783|NCT03370133|364844825|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
105779784|NCT03370133|364844826|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
105779785|NCT03370133|364844827|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
105779786|NCT03370133|364844828|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
105779787|NCT03370133|364844829|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
105779788|NCT03370133|364844830|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
105779789|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
105779790|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
105779791|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
105779792|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
105779793|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
105779794|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
105779795|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
105779796|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
105779797|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
105779798|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
105779799|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
105779800|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
105779801|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
105779802|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
105779803|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
105779804|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
105779805|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
105779806|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
105779807|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
105779808|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
105779809|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
105779810|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
105779811|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
105779812|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
105779813|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
105779814|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
105779815|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
105779816|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
105779817|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
105779818|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
105779819|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779820|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779821|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779822|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779823|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
105779824|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
105779825|NCT03370133|364844825|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779826|NCT03370133|364844826|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779827|NCT03370133|364844827|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779828|NCT03370133|364844828|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779829|NCT03370133|364844829|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
105779830|NCT03370133|364844830|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
105779831|NCT00266695|364844837|FG000|Overall Study|Adverse Event|1|||
105779832|NCT00266695|364844837|FG000|Overall Study|Death|9|||
105779833|NCT00266695|364844837|FG000|Overall Study|Physician Decision|1|||
105779834|NCT00266695|364844837|FG000|Overall Study|Lost to Follow-up|3|||
105779835|NCT00266695|364844837|FG000|Overall Study|Withdrawal by Subject|15|||
105779836|NCT00819052|364844839|FG000|Overall Study|Adverse Event|0|||
105779837|NCT00819052|364844840|FG001|Overall Study|Adverse Event|5|||
105779838|NCT00819052|364844839|FG000|Overall Study|Protocol Violation|1|||
105779839|NCT00819052|364844840|FG001|Overall Study|Protocol Violation|2|||
105779840|NCT00819052|364844839|FG000|Overall Study|Lost to Follow-up|1|||
105779841|NCT00819052|364844840|FG001|Overall Study|Lost to Follow-up|2|||
105779842|NCT00819052|364844839|FG000|Overall Study|Withdrawal by Subject|1|||
105779843|NCT00819052|364844840|FG001|Overall Study|Withdrawal by Subject|2|||
105779844|NCT00819052|364844839|FG000|Overall Study|Lack of Efficacy|1|||
105779845|NCT00819052|364844840|FG001|Overall Study|Lack of Efficacy|1|||
105779846|NCT00819052|364844839|FG000|Overall Study|Pregnancy|1|||
105779847|NCT00819052|364844840|FG001|Overall Study|Pregnancy|2|||
105779848|NCT00819052|364844839|FG000|Overall Study|Death or events leading to death|1|||
105779849|NCT00819052|364844840|FG001|Overall Study|Death or events leading to death|0|||
105779850|NCT00362297|364844841|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
105779851|NCT00362297|364844842|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
105779852|NCT01365468|364844847|FG000|Overall Study|Physician Decision|1|||
105779853|NCT01365468|364844848|FG001|Overall Study|Physician Decision|0|||
105779854|NCT01365468|364844847|FG000|Overall Study|Disease progression|1|||
105779855|NCT01365468|364844848|FG001|Overall Study|Disease progression|0|||
105779856|NCT01365468|364844847|FG000|Overall Study|Lost to Follow-up|2|||
105779857|NCT01365468|364844848|FG001|Overall Study|Lost to Follow-up|0|||
105779858|NCT03524664|364844849|FG000|Overall Study|Withdrawal by Subject|1|||
105779859|NCT03524664|364844850|FG001|Overall Study|Withdrawal by Subject|2|||
105779860|NCT03524664|364844849|FG000|Overall Study|Lost to Follow-up|4|||
105779861|NCT03524664|364844850|FG001|Overall Study|Lost to Follow-up|13|||
105779862|NCT01815099|364844851|FG000|Overall Study|Lack of Efficacy|1|||
105779863|NCT01815099|364844851|FG000|Overall Study|unable to attend study visits|1|||
105779864|NCT03769753|364844854|FG000|Overall Study|Not Treated|6|||
105779865|NCT03769753|364844854|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
105779866|NCT02694562|364844855|FG000|Overall Study|Death|8|||
105779867|NCT02694562|364844855|FG000|Overall Study|Protocol Violation|4|||
105779868|NCT02694562|364844855|FG000|Overall Study|Lost to Follow-up|3|||
105779869|NCT02694562|364844855|FG000|Overall Study|Screen Failure|2|||
105779870|NCT02694562|364844855|FG000|Overall Study|Physician Decision|1|||
105779871|NCT01888367|364844858|FG000|Overall Study|Physician Decision|3|||
105779872|NCT01888367|364844859|FG001|Overall Study|Physician Decision|4|||
105779873|NCT01888367|364844860|FG002|Overall Study|Physician Decision|2|||
105779874|NCT01888367|364844858|FG000|Overall Study|Death|2|||
105779875|NCT01888367|364844859|FG001|Overall Study|Death|0|||
105779876|NCT01888367|364844860|FG002|Overall Study|Death|1|||
105779877|NCT01888367|364844858|FG000|Overall Study|Withdrawal by Subject|1|||
105779878|NCT01888367|364844859|FG001|Overall Study|Withdrawal by Subject|0|||
105779879|NCT01888367|364844860|FG002|Overall Study|Withdrawal by Subject|1|||
105779880|NCT01888367|364844858|FG000|Overall Study|Lost to Follow-up|1|||
105779881|NCT01888367|364844859|FG001|Overall Study|Lost to Follow-up|1|||
105779882|NCT01888367|364844860|FG002|Overall Study|Lost to Follow-up|0|||
105779883|NCT01888367|364844858|FG000|Overall Study|Protocol Violation|0|||
105779884|NCT01888367|364844859|FG001|Overall Study|Protocol Violation|0|||
105779885|NCT01888367|364844860|FG002|Overall Study|Protocol Violation|1|||
105779886|NCT01888367|364844858|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
105779887|NCT01888367|364844859|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
105779888|NCT01888367|364844860|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
105779889|NCT00877929|364844861|FG000|Overall Study|Adverse Event|11|||
105779890|NCT00877929|364844862|FG001|Overall Study|Adverse Event|20|||
105992480|NCT03364309|365631573|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
105779891|NCT00877929|364844861|FG000|Overall Study|Protocol Violation|3|||
105779892|NCT00877929|364844862|FG001|Overall Study|Protocol Violation|3|||
105779893|NCT00877929|364844861|FG000|Overall Study|Lost to Follow-up|0|||
105779894|NCT00877929|364844862|FG001|Overall Study|Lost to Follow-up|1|||
105779895|NCT00877929|364844861|FG000|Overall Study|Withdrawal by Subject|4|||
105779896|NCT00877929|364844862|FG001|Overall Study|Withdrawal by Subject|4|||
105779897|NCT00877929|364844861|FG000|Overall Study|Lack of Efficacy|0|||
105779898|NCT00877929|364844862|FG001|Overall Study|Lack of Efficacy|1|||
105779899|NCT00877929|364844861|FG000|Overall Study|Other reason (not specified)|2|||
105779900|NCT00877929|364844862|FG001|Overall Study|Other reason (not specified)|6|||
105779901|NCT00784836|364844865|FG000|Overall Study|Early Study Termination|3|||
105779902|NCT00660829|364844866|FG000|Overall Study|Adverse Event|3|||
105779903|NCT00660829|364844867|FG001|Overall Study|Adverse Event|4|||
105779904|NCT00660829|364844866|FG000|Overall Study|Lack of Efficacy|2|||
105779905|NCT00660829|364844867|FG001|Overall Study|Lack of Efficacy|3|||
105779906|NCT00660829|364844866|FG000|Overall Study|Non-Compliance|0|||
105779907|NCT00660829|364844867|FG001|Overall Study|Non-Compliance|4|||
105779908|NCT00660829|364844866|FG000|Overall Study|Withdrawal by Subject|1|||
105779909|NCT00660829|364844867|FG001|Overall Study|Withdrawal by Subject|2|||
105779910|NCT00660829|364844866|FG000|Overall Study|Lost to Follow-up|3|||
105779911|NCT00660829|364844867|FG001|Overall Study|Lost to Follow-up|2|||
105779912|NCT00660829|364844866|FG000|Overall Study|Other|9|||
105779913|NCT00660829|364844867|FG001|Overall Study|Other|4|||
105779914|NCT00967343|364844874|FG000|Overall Study|Study termination by sponsor|12|||
105779915|NCT00967343|364844874|FG000|Overall Study|Death|24|||
105779916|NCT00967343|364844874|FG000|Overall Study|Relapse|1|||
105779917|NCT00967343|364844874|FG000|Overall Study|Lost to Follow-up|1|||
105779918|NCT00758394|364844875|FG000|2nd Intervention Order|Lost to Follow-up|0|||
105779919|NCT00758394|364844876|FG001|2nd Intervention Order|Lost to Follow-up|1|||
105779920|NCT00758394|364844877|FG002|2nd Intervention Order|Lost to Follow-up|0|||
105779921|NCT00758394|364844878|FG003|2nd Intervention Order|Lost to Follow-up|0|||
105779922|NCT00758394|364844875|FG000|3rd Intervention|Lost to Follow-up|1|||
105779923|NCT00758394|364844876|FG001|3rd Intervention|Lost to Follow-up|0|||
105779924|NCT00758394|364844877|FG002|3rd Intervention|Lost to Follow-up|0|||
105779925|NCT00758394|364844878|FG003|3rd Intervention|Lost to Follow-up|1|||
105779926|NCT03044730|364844886|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
105779927|NCT03044730|364844886|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
105779928|NCT03044730|364844886|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
105779929|NCT03044730|364844886|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
105779930|NCT03044730|364844886|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
105779931|NCT03044730|364844886|FG000|Cycles 4 and Beyond|Adverse Event|1|||
105779932|NCT03044730|364844886|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
105779933|NCT03044730|364844886|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
105779934|NCT03044730|364844886|FG000|On Follow-up for 2 Years|Death|17|||
105779935|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
105779936|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
105779937|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
105779938|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
105779939|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
105779940|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
106101600|NCT01869491|366026722|FG000|Overall Study|Withdrawal by Subject|6|||
105779941|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
105779942|NCT00950755|364844887|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
105779943|NCT00950755|364844887|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
105779944|NCT00950755|364844887|FG000|Long-Term Follow-Up|Death|8|||
105779945|NCT00508820|364844888|FG000|Overall Study|Adverse Event|6|||
105779946|NCT00508820|364844889|FG001|Overall Study|Adverse Event|10|||
105779947|NCT00508820|364844888|FG000|Overall Study|Death|6|||
105779948|NCT00508820|364844889|FG001|Overall Study|Death|8|||
105779949|NCT00508820|364844888|FG000|Overall Study|Lost to Follow-up|1|||
105779950|NCT00508820|364844889|FG001|Overall Study|Lost to Follow-up|1|||
105779951|NCT00508820|364844888|FG000|Overall Study|Physician Decision|8|||
105779952|NCT00508820|364844889|FG001|Overall Study|Physician Decision|2|||
105779953|NCT00508820|364844888|FG000|Overall Study|Pregnancy|0|||
105779954|NCT00508820|364844889|FG001|Overall Study|Pregnancy|2|||
105779955|NCT00508820|364844888|FG000|Overall Study|Protocol Violation|2|||
105779956|NCT00508820|364844889|FG001|Overall Study|Protocol Violation|0|||
105779957|NCT00508820|364844888|FG000|Overall Study|Withdrawal by Subject|10|||
105779958|NCT00508820|364844889|FG001|Overall Study|Withdrawal by Subject|12|||
105779959|NCT00508820|364844888|FG000|Overall Study|Other|11|||
105779960|NCT00508820|364844889|FG001|Overall Study|Other|2|||
105779961|NCT00508820|364844888|FG000|Overall Study|Noncompliance|1|||
105779962|NCT00508820|364844889|FG001|Overall Study|Noncompliance|0|||
105779963|NCT00508820|364844888|FG000|Overall Study|Requirement for alternative therapy|7|||
105779964|NCT00508820|364844889|FG001|Overall Study|Requirement for alternative therapy|15|||
105779965|NCT00508820|364844888|FG000|Overall Study|Protocol-specified Criteria|3|||
105779966|NCT00508820|364844889|FG001|Overall Study|Protocol-specified Criteria|12|||
105779967|NCT04563845|364846493|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779968|NCT04563845|364846494|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779969|NCT04563845|364846495|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779970|NCT04563845|364846496|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779971|NCT04563845|364846497|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779972|NCT04563845|364846498|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779973|NCT04563845|364846499|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779974|NCT04563845|364846500|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
105779975|NCT04563845|364846501|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779976|NCT04563845|364846502|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779977|NCT04563845|364846503|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779978|NCT04563845|364846504|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779979|NCT04563845|364846505|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779980|NCT04563845|364846506|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
105779981|NCT04563845|364846493|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779982|NCT04563845|364846494|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779983|NCT04563845|364846495|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779984|NCT04563845|364846496|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
106101601|NCT01869491|366026723|FG001|Overall Study|Withdrawal by Subject|7|||
106101602|NCT01869491|366026722|FG000|Overall Study|Lost to Follow-up|11|||
106101603|NCT01869491|366026723|FG001|Overall Study|Lost to Follow-up|9|||
106101604|NCT01869491|366026722|FG000|Overall Study|No further need of investigational product|1|||
106101605|NCT01869491|366026723|FG001|Overall Study|No further need of investigational product|0|||
106101606|NCT01295944|366026728|FG000|Overall Study|Switched to alternative treatment|1|||
106101607|NCT01295944|366026728|FG000|Overall Study|Ineligible|9|||
106101608|NCT01295944|366026728|FG000|Overall Study|Withdrawal by Subject|1|||
105779985|NCT04563845|364846497|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
105779986|NCT04563845|364846498|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779987|NCT04563845|364846499|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779988|NCT04563845|364846500|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779989|NCT04563845|364846501|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779990|NCT04563845|364846502|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779991|NCT04563845|364846503|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779992|NCT04563845|364846504|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779993|NCT04563845|364846505|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779994|NCT04563845|364846506|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
105779995|NCT01020812|364846507|FG000|Overall Study|Physician Decision|1|||
105779996|NCT01020812|364846507|FG000|Overall Study|Withdrawal by Subject|1|||
105779997|NCT01020812|364846507|FG000|Overall Study|Protocol Violation|1|||
105779998|NCT02146274|364846508|FG000|Overall Study|Protocol Violation|73|||
105779999|NCT00303719|364846514|FG000|Overall Study|Not evaluable, prior therapies|0|||
105780000|NCT00303719|364846515|FG001|Overall Study|Not evaluable, prior therapies|30|||
105780001|NCT00303719|364846514|FG000|Overall Study|Lost to Follow-up|0|||
105780002|NCT00303719|364846515|FG001|Overall Study|Lost to Follow-up|7|||
105780003|NCT01097057|364846519|FG000|Overall Study|Physician Decision|3|||
105780004|NCT00134563|364846523|FG000|Overall Study|Not treated due to protocol violation|0|||
105780005|NCT00134563|364846524|FG001|Overall Study|Not treated due to protocol violation|1|||
105780006|NCT00134563|364846525|FG002|Overall Study|Not treated due to protocol violation|1|||
105780007|NCT00134563|364846523|FG000|Overall Study|Adverse Event|29|||
105780008|NCT00134563|364846524|FG001|Overall Study|Adverse Event|37|||
105780009|NCT00134563|364846525|FG002|Overall Study|Adverse Event|38|||
105780010|NCT00134563|364846523|FG000|Overall Study|Lack of Efficacy|24|||
105780011|NCT00134563|364846524|FG001|Overall Study|Lack of Efficacy|14|||
105780012|NCT00134563|364846525|FG002|Overall Study|Lack of Efficacy|17|||
105780013|NCT00134563|364846523|FG000|Overall Study|Protocol Violation|3|||
105780014|NCT00134563|364846524|FG001|Overall Study|Protocol Violation|2|||
105780015|NCT00134563|364846525|FG002|Overall Study|Protocol Violation|5|||
105780016|NCT00134563|364846523|FG000|Overall Study|Lost to Follow-up|4|||
105780017|NCT00134563|364846524|FG001|Overall Study|Lost to Follow-up|0|||
105780018|NCT00134563|364846525|FG002|Overall Study|Lost to Follow-up|2|||
105780019|NCT00134563|364846523|FG000|Overall Study|progressive disease|11|||
105780020|NCT00134563|364846524|FG001|Overall Study|progressive disease|4|||
105780021|NCT00134563|364846525|FG002|Overall Study|progressive disease|2|||
105780022|NCT00134563|364846523|FG000|Overall Study|did not wish to continue|33|||
105780023|NCT00134563|364846524|FG001|Overall Study|did not wish to continue|32|||
105780024|NCT00134563|364846525|FG002|Overall Study|did not wish to continue|26|||
105780025|NCT00134563|364846523|FG000|Overall Study|Reason other than above|0|||
105780026|NCT00134563|364846524|FG001|Overall Study|Reason other than above|2|||
105780027|NCT00134563|364846525|FG002|Overall Study|Reason other than above|5|||
105780028|NCT03802331|364846526|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
106101609|NCT01295944|366026728|FG000|Overall Study|Participant chose to be treated in Peru|1|||
106144067|NCT01317420|366186951|FG002|Overall Study|Progressive disease according to RECIST|3|||
105780029|NCT03802331|364846527|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
105780030|NCT04738123|364846542|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
105780031|NCT04738123|364846543|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
105780032|NCT04738123|364846542|FG000|Overall Study|Progressive Disease|0|||
105780033|NCT04738123|364846543|FG001|Overall Study|Progressive Disease|4|||
105780034|NCT04738123|364846542|FG000|Overall Study|Adverse Event|8|||
105780035|NCT04738123|364846543|FG001|Overall Study|Adverse Event|7|||
105780036|NCT04738123|364846542|FG000|Overall Study|Other Reasons|0|||
105780037|NCT04738123|364846543|FG001|Overall Study|Other Reasons|1|||
105780038|NCT04738123|364846542|FG000|Overall Study|Suicidal or assaultive behavior|0|||
105780039|NCT04738123|364846543|FG001|Overall Study|Suicidal or assaultive behavior|2|||
105780040|NCT04738123|364846542|FG000|Overall Study|Protocol Violation|2|||
105780041|NCT04738123|364846543|FG001|Overall Study|Protocol Violation|2|||
105780042|NCT04738123|364846542|FG000|Overall Study|Consent Withdrawn|35|||
105780043|NCT04738123|364846543|FG001|Overall Study|Consent Withdrawn|22|||
105780044|NCT00405756|364846544|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
105780045|NCT00405756|364846545|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
105780046|NCT00405756|364846546|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
105780047|NCT00405756|364846544|FG000|Double-blind Treatment|Adverse Event|31|||
105780048|NCT00405756|364846545|FG001|Double-blind Treatment|Adverse Event|27|||
105780049|NCT00405756|364846546|FG002|Double-blind Treatment|Adverse Event|12|||
105780050|NCT00405756|364846544|FG000|Double-blind Treatment|Disease Progression|47|||
105780051|NCT00405756|364846545|FG001|Double-blind Treatment|Disease Progression|81|||
105780052|NCT00405756|364846546|FG002|Double-blind Treatment|Disease Progression|102|||
105780053|NCT00405756|364846544|FG000|Double-blind Treatment|Lack of Efficacy|1|||
105780054|NCT00405756|364846545|FG001|Double-blind Treatment|Lack of Efficacy|4|||
105780055|NCT00405756|364846546|FG002|Double-blind Treatment|Lack of Efficacy|2|||
105780056|NCT00405756|364846544|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
105780057|NCT00405756|364846545|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
105780058|NCT00405756|364846546|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
105780059|NCT00405756|364846544|FG000|Double-blind Treatment|Lost to Follow-up|1|||
105780060|NCT00405756|364846545|FG001|Double-blind Treatment|Lost to Follow-up|0|||
105780061|NCT00405756|364846546|FG002|Double-blind Treatment|Lost to Follow-up|0|||
105780062|NCT00405756|364846544|FG000|Double-blind Treatment|Death|4|||
105780063|NCT00405756|364846545|FG001|Double-blind Treatment|Death|4|||
105780064|NCT00405756|364846546|FG002|Double-blind Treatment|Death|4|||
105780065|NCT00405756|364846544|FG000|Double-blind Treatment|Protocol Violation|1|||
105780066|NCT00405756|364846545|FG001|Double-blind Treatment|Protocol Violation|0|||
105780067|NCT00405756|364846546|FG002|Double-blind Treatment|Protocol Violation|2|||
105780068|NCT00405756|364846544|FG000|Double-blind Treatment|Other|7|||
105780069|NCT00405756|364846545|FG001|Double-blind Treatment|Other|4|||
105780070|NCT00405756|364846546|FG002|Double-blind Treatment|Other|4|||
105780071|NCT00405756|364846544|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
105780072|NCT00405756|364846545|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
105780073|NCT00405756|364846546|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
105780074|NCT00405756|364846544|FG000|Open-label Extension|Adverse Event|1|||
105780075|NCT00405756|364846545|FG001|Open-label Extension|Adverse Event|3|||
105780076|NCT00405756|364846546|FG002|Open-label Extension|Adverse Event|7|||
105780077|NCT00405756|364846544|FG000|Open-label Extension|Disease Progression|8|||
105780078|NCT00405756|364846545|FG001|Open-label Extension|Disease Progression|23|||
105780079|NCT00405756|364846546|FG002|Open-label Extension|Disease Progression|26|||
105780080|NCT00405756|364846544|FG000|Open-label Extension|Withdrawal by Subject|2|||
105780081|NCT00405756|364846545|FG001|Open-label Extension|Withdrawal by Subject|3|||
105780082|NCT00405756|364846546|FG002|Open-label Extension|Withdrawal by Subject|3|||
105780083|NCT00405756|364846544|FG000|Open-label Extension|Death|1|||
105780084|NCT00405756|364846545|FG001|Open-label Extension|Death|2|||
105780085|NCT00405756|364846546|FG002|Open-label Extension|Death|4|||
105780086|NCT00405756|364846544|FG000|Open-label Extension|Other|0|||
105780087|NCT00405756|364846545|FG001|Open-label Extension|Other|1|||
105780088|NCT00405756|364846546|FG002|Open-label Extension|Other|7|||
105780089|NCT00405756|364846544|FG000|Follow-up|Ongoing in Follow-up Period|52|||
105780090|NCT00405756|364846545|FG001|Follow-up|Ongoing in Follow-up Period|51|||
105780091|NCT00405756|364846546|FG002|Follow-up|Ongoing in Follow-up Period|60|||
105780092|NCT00405756|364846544|FG000|Follow-up|Death|21|||
105780093|NCT00405756|364846545|FG001|Follow-up|Death|31|||
105780094|NCT00405756|364846546|FG002|Follow-up|Death|24|||
105780095|NCT00405756|364846544|FG000|Follow-up|Lost to Follow-up|2|||
105780096|NCT00405756|364846545|FG001|Follow-up|Lost to Follow-up|8|||
105780097|NCT00405756|364846546|FG002|Follow-up|Lost to Follow-up|4|||
105780098|NCT00851721|364846547|FG000|Overall Study|planned surgery|1|||
105780099|NCT00851721|364846548|FG001|Overall Study|planned surgery|0|||
105780100|NCT00851721|364846547|FG000|Overall Study|Death|1|||
105780101|NCT00851721|364846548|FG001|Overall Study|Death|0|||
105780102|NCT00851721|364846547|FG000|Overall Study|Adverse Event|0|||
105780103|NCT00851721|364846548|FG001|Overall Study|Adverse Event|1|||
105780104|NCT03982069|364846549|FG000|Overall Study|Lost to Follow-up|5|||
105780105|NCT03982069|364846550|FG001|Overall Study|Lost to Follow-up|5|||
105780106|NCT03982069|364846551|FG002|Overall Study|Lost to Follow-up|3|||
105780107|NCT03982069|364846552|FG003|Overall Study|Lost to Follow-up|5|||
105780108|NCT03982069|364846549|FG000|Overall Study|Physician Decision|0|||
105780109|NCT03982069|364846550|FG001|Overall Study|Physician Decision|1|||
105780110|NCT03982069|364846551|FG002|Overall Study|Physician Decision|0|||
105780111|NCT03982069|364846552|FG003|Overall Study|Physician Decision|0|||
105780112|NCT03982069|364846549|FG000|Overall Study|Withdrawal by Subject|2|||
105780113|NCT03982069|364846550|FG001|Overall Study|Withdrawal by Subject|1|||
105780114|NCT03982069|364846551|FG002|Overall Study|Withdrawal by Subject|5|||
105780115|NCT03982069|364846552|FG003|Overall Study|Withdrawal by Subject|2|||
105780116|NCT03982069|364846549|FG000|Overall Study|Specimen loss|3|||
105780117|NCT03982069|364846550|FG001|Overall Study|Specimen loss|3|||
105780118|NCT03982069|364846551|FG002|Overall Study|Specimen loss|1|||
105780119|NCT03982069|364846552|FG003|Overall Study|Specimen loss|1|||
105780120|NCT01218477|364846553|FG000|Overall Study|Disease progression|2|||
105780121|NCT01218477|364846554|FG001|Overall Study|Disease progression|3|||
105780122|NCT01218477|364846555|FG002|Overall Study|Disease progression|6|||
105780123|NCT01218477|364846556|FG003|Overall Study|Disease progression|2|||
105780124|NCT01218477|364846553|FG000|Overall Study|Study drug toxicity|0|||
105780125|NCT01218477|364846554|FG001|Overall Study|Study drug toxicity|2|||
105780126|NCT01218477|364846555|FG002|Overall Study|Study drug toxicity|5|||
105780127|NCT01218477|364846556|FG003|Overall Study|Study drug toxicity|0|||
105780128|NCT01218477|364846553|FG000|Overall Study|No longer meets study criteria|1|||
105780129|NCT01218477|364846554|FG001|Overall Study|No longer meets study criteria|0|||
105780130|NCT01218477|364846555|FG002|Overall Study|No longer meets study criteria|0|||
105780131|NCT01218477|364846556|FG003|Overall Study|No longer meets study criteria|0|||
105780132|NCT01218477|364846553|FG000|Overall Study|Withdrawal by Subject|0|||
105780133|NCT01218477|364846554|FG001|Overall Study|Withdrawal by Subject|0|||
105780134|NCT01218477|364846555|FG002|Overall Study|Withdrawal by Subject|1|||
105780135|NCT01218477|364846556|FG003|Overall Study|Withdrawal by Subject|0|||
105780136|NCT01218477|364846553|FG000|Overall Study|Prepared for cell transplantation|0|||
105780137|NCT01218477|364846554|FG001|Overall Study|Prepared for cell transplantation|1|||
105780138|NCT01218477|364846555|FG002|Overall Study|Prepared for cell transplantation|1|||
105780139|NCT01218477|364846556|FG003|Overall Study|Prepared for cell transplantation|0|||
105780140|NCT01218477|364846553|FG000|Overall Study|Administrative reason by sponsor|0|||
105780141|NCT01218477|364846554|FG001|Overall Study|Administrative reason by sponsor|0|||
105780142|NCT01218477|364846555|FG002|Overall Study|Administrative reason by sponsor|1|||
105780143|NCT01218477|364846556|FG003|Overall Study|Administrative reason by sponsor|0|||
105780144|NCT01218477|364846553|FG000|Overall Study|Maximum clinical benefit|0|||
105780145|NCT01218477|364846554|FG001|Overall Study|Maximum clinical benefit|2|||
105780146|NCT01218477|364846555|FG002|Overall Study|Maximum clinical benefit|0|||
105780147|NCT01218477|364846556|FG003|Overall Study|Maximum clinical benefit|0|||
105780148|NCT02135848|364846557|FG000|Overall Study|Adverse Event|2|||
105780149|NCT02135848|364846558|FG001|Overall Study|Adverse Event|0|||
105780150|NCT02135848|364846557|FG000|Overall Study|Withdrawal by Subject|1|||
105780151|NCT02135848|364846558|FG001|Overall Study|Withdrawal by Subject|1|||
105780152|NCT03137433|364846561|FG000|Overall Study|Withdrawal by Subject|11|||
105780153|NCT03137433|364846562|FG001|Overall Study|Withdrawal by Subject|11|||
105780154|NCT03137433|364846561|FG000|Overall Study|Lost to Follow-up|5|||
105780155|NCT03137433|364846562|FG001|Overall Study|Lost to Follow-up|6|||
105780156|NCT03137433|364846561|FG000|Overall Study|Physician Decision|2|||
105780157|NCT03137433|364846562|FG001|Overall Study|Physician Decision|0|||
105780158|NCT03137433|364846561|FG000|Overall Study|Moved out of study area|1|||
105780159|NCT03137433|364846562|FG001|Overall Study|Moved out of study area|0|||
105780160|NCT03137433|364846561|FG000|Overall Study|Too far out of window due to COVID|0|||
105780161|NCT03137433|364846562|FG001|Overall Study|Too far out of window due to COVID|1|||
105780162|NCT00083616|364846563|FG000|Overall Study|Disease Progression|16|||
105780163|NCT00083616|364846563|FG000|Overall Study|Lost to Follow-up|1|||
105780164|NCT00083616|364846563|FG000|Overall Study|Physician Decision|2|||
105780165|NCT00083616|364846563|FG000|Overall Study|Withdrawal by Subject|3|||
105780166|NCT00083616|364846563|FG000|Overall Study|Ineligibility determined|2|||
105780167|NCT00083616|364846563|FG000|Overall Study|Non-compliance|1|||
105780168|NCT00083616|364846563|FG000|Overall Study|Other|6|||
106101610|NCT01295944|366026728|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
106101611|NCT01295944|366026728|FG000|Overall Study|Physician Decision|1|||
105780169|NCT00265382|364846567|FG000|Overall Study|Adverse Event|21|||
105780170|NCT00265382|364846567|FG000|Overall Study|Laboratory Abnormality|1|||
105780171|NCT00265382|364846567|FG000|Overall Study|Lost to Follow-up|3|||
105780172|NCT00265382|364846567|FG000|Overall Study|Lack of Efficacy|6|||
105780173|NCT00265382|364846567|FG000|Overall Study|Miscellaneous|6|||
105780174|NCT00265382|364846567|FG000|Overall Study|Withdrawal by Subject|13|||
105780175|NCT00265382|364846567|FG000|Overall Study|Study terminated by sponsor|94|||
105780176|NCT00265382|364846567|FG000|Overall Study|Death|1|||
105780177|NCT01474993|364846571|FG000|Overall Study|Lost to Follow-up|1|||
105780178|NCT01474993|364846572|FG001|Overall Study|Lost to Follow-up|2|||
105780179|NCT01474993|364846571|FG000|Overall Study|Adverse Event|0|||
105780180|NCT01474993|364846572|FG001|Overall Study|Adverse Event|1|||
105780181|NCT01632345|364846573|FG000|Treatment: Part I|Adverse Event|1|||
105780182|NCT01632345|364846574|FG001|Treatment: Part I|Adverse Event|4|||
105780183|NCT01632345|364846575|FG002|Treatment: Part I|Adverse Event|2|||
105780184|NCT01632345|364846576|FG003|Treatment: Part I|Adverse Event|1|||
105780185|NCT01632345|364846577|FG004|Treatment: Part I|Adverse Event|3|||
105780186|NCT01632345|364846578|FG005|Treatment: Part I|Adverse Event|0|||
105780187|NCT01632345|364846579|FG006|Treatment: Part I|Adverse Event|0|||
105780188|NCT01632345|364846573|FG000|Treatment: Part I|Lack of Efficacy|0|||
105780189|NCT01632345|364846574|FG001|Treatment: Part I|Lack of Efficacy|1|||
105780190|NCT01632345|364846575|FG002|Treatment: Part I|Lack of Efficacy|0|||
105780191|NCT01632345|364846576|FG003|Treatment: Part I|Lack of Efficacy|1|||
105780192|NCT01632345|364846577|FG004|Treatment: Part I|Lack of Efficacy|1|||
105780193|NCT01632345|364846578|FG005|Treatment: Part I|Lack of Efficacy|0|||
105780194|NCT01632345|364846579|FG006|Treatment: Part I|Lack of Efficacy|0|||
105780195|NCT01632345|364846573|FG000|Treatment: Part I|Lost to Follow-up|3|||
105780196|NCT01632345|364846574|FG001|Treatment: Part I|Lost to Follow-up|2|||
105780197|NCT01632345|364846575|FG002|Treatment: Part I|Lost to Follow-up|1|||
105780198|NCT01632345|364846576|FG003|Treatment: Part I|Lost to Follow-up|3|||
105780199|NCT01632345|364846577|FG004|Treatment: Part I|Lost to Follow-up|4|||
105780200|NCT01632345|364846578|FG005|Treatment: Part I|Lost to Follow-up|0|||
105780201|NCT01632345|364846579|FG006|Treatment: Part I|Lost to Follow-up|0|||
105780202|NCT01632345|364846573|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
105780203|NCT01632345|364846574|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
105780204|NCT01632345|364846575|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
105780205|NCT01632345|364846576|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
105780206|NCT01632345|364846577|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
105780207|NCT01632345|364846578|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
105780208|NCT01632345|364846579|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
105780209|NCT01632345|364846573|FG000|Treatment: Part I|Physician Decision|2|||
105780210|NCT01632345|364846574|FG001|Treatment: Part I|Physician Decision|1|||
105780211|NCT01632345|364846575|FG002|Treatment: Part I|Physician Decision|0|||
105780212|NCT01632345|364846576|FG003|Treatment: Part I|Physician Decision|0|||
105780213|NCT01632345|364846577|FG004|Treatment: Part I|Physician Decision|1|||
105780214|NCT01632345|364846578|FG005|Treatment: Part I|Physician Decision|0|||
105780215|NCT01632345|364846579|FG006|Treatment: Part I|Physician Decision|0|||
105780216|NCT01632345|364846573|FG000|Treatment: Part I|Pregnancy|0|||
105780217|NCT01632345|364846574|FG001|Treatment: Part I|Pregnancy|1|||
105780218|NCT01632345|364846575|FG002|Treatment: Part I|Pregnancy|0|||
105780219|NCT01632345|364846576|FG003|Treatment: Part I|Pregnancy|0|||
105780220|NCT01632345|364846577|FG004|Treatment: Part I|Pregnancy|0|||
105780221|NCT01632345|364846578|FG005|Treatment: Part I|Pregnancy|0|||
105780222|NCT01632345|364846579|FG006|Treatment: Part I|Pregnancy|0|||
105780223|NCT01632345|364846573|FG000|Treatment: Part I|Protocol Deviation|0|||
105780224|NCT01632345|364846574|FG001|Treatment: Part I|Protocol Deviation|0|||
105780225|NCT01632345|364846575|FG002|Treatment: Part I|Protocol Deviation|1|||
105780226|NCT01632345|364846576|FG003|Treatment: Part I|Protocol Deviation|1|||
105780227|NCT01632345|364846577|FG004|Treatment: Part I|Protocol Deviation|0|||
105780228|NCT01632345|364846578|FG005|Treatment: Part I|Protocol Deviation|0|||
105780229|NCT01632345|364846579|FG006|Treatment: Part I|Protocol Deviation|0|||
105780230|NCT01632345|364846573|FG000|Treatment: Part I|Withdrawal by Subject|3|||
105780231|NCT01632345|364846574|FG001|Treatment: Part I|Withdrawal by Subject|4|||
105780232|NCT01632345|364846575|FG002|Treatment: Part I|Withdrawal by Subject|4|||
105780233|NCT01632345|364846576|FG003|Treatment: Part I|Withdrawal by Subject|1|||
105780234|NCT01632345|364846577|FG004|Treatment: Part I|Withdrawal by Subject|4|||
105780235|NCT01632345|364846578|FG005|Treatment: Part I|Withdrawal by Subject|0|||
105780236|NCT01632345|364846579|FG006|Treatment: Part I|Withdrawal by Subject|0|||
105780237|NCT01632345|364846573|FG000|Treatment: Part II|Adverse Event|0|||
105780238|NCT01632345|364846574|FG001|Treatment: Part II|Adverse Event|0|||
105780239|NCT01632345|364846575|FG002|Treatment: Part II|Adverse Event|0|||
105780240|NCT01632345|364846576|FG003|Treatment: Part II|Adverse Event|0|||
105780241|NCT01632345|364846577|FG004|Treatment: Part II|Adverse Event|0|||
105780242|NCT01632345|364846578|FG005|Treatment: Part II|Adverse Event|3|||
105780243|NCT01632345|364846579|FG006|Treatment: Part II|Adverse Event|8|||
105780244|NCT01632345|364846573|FG000|Treatment: Part II|Lost to Follow-up|0|||
105780245|NCT01632345|364846574|FG001|Treatment: Part II|Lost to Follow-up|0|||
105780246|NCT01632345|364846575|FG002|Treatment: Part II|Lost to Follow-up|0|||
105780247|NCT01632345|364846576|FG003|Treatment: Part II|Lost to Follow-up|0|||
105780248|NCT01632345|364846577|FG004|Treatment: Part II|Lost to Follow-up|0|||
105780249|NCT01632345|364846578|FG005|Treatment: Part II|Lost to Follow-up|3|||
105780250|NCT01632345|364846579|FG006|Treatment: Part II|Lost to Follow-up|1|||
105780251|NCT01632345|364846573|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780252|NCT01632345|364846574|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780253|NCT01632345|364846575|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780254|NCT01632345|364846576|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780255|NCT01632345|364846577|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780256|NCT01632345|364846578|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
105780257|NCT01632345|364846579|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
105780258|NCT01632345|364846573|FG000|Treatment: Part II|Withdrawal by Subject|0|||
105780259|NCT01632345|364846574|FG001|Treatment: Part II|Withdrawal by Subject|0|||
105780260|NCT01632345|364846575|FG002|Treatment: Part II|Withdrawal by Subject|0|||
105780261|NCT01632345|364846576|FG003|Treatment: Part II|Withdrawal by Subject|0|||
105780262|NCT01632345|364846577|FG004|Treatment: Part II|Withdrawal by Subject|0|||
105780263|NCT01632345|364846578|FG005|Treatment: Part II|Withdrawal by Subject|2|||
105780264|NCT01632345|364846579|FG006|Treatment: Part II|Withdrawal by Subject|2|||
105780265|NCT01284127|364846582|FG000|Overall Study|Adverse Event|2|||
105780266|NCT01284127|364846582|FG000|Overall Study|Withdrawal by Subject|4|||
105780267|NCT01284127|364846582|FG000|Overall Study|Physician Decision|1|||
105780268|NCT04118127|364846592|FG000|Overall Study|Trial terminated by sponsor|0|||
105780269|NCT04118127|364846593|FG001|Overall Study|Trial terminated by sponsor|12|||
105780270|NCT04118127|364846592|FG000|Overall Study|Adverse Event|1|||
105780271|NCT04118127|364846593|FG001|Overall Study|Adverse Event|2|||
105780272|NCT04118127|364846592|FG000|Overall Study|Physician Decision|0|||
105780273|NCT04118127|364846593|FG001|Overall Study|Physician Decision|1|||
105780274|NCT04118127|364846592|FG000|Overall Study|Withdrawal by Subject|2|||
105780275|NCT04118127|364846593|FG001|Overall Study|Withdrawal by Subject|1|||
105780276|NCT00135694|364846595|FG000|Overall Study|Adverse Event|17|||
105780277|NCT00135694|364846596|FG001|Overall Study|Adverse Event|4|||
105780278|NCT00135694|364846597|FG002|Overall Study|Adverse Event|0|||
105780279|NCT00135694|364846595|FG000|Overall Study|Death|14|||
105780280|NCT00135694|364846596|FG001|Overall Study|Death|1|||
105780281|NCT00135694|364846597|FG002|Overall Study|Death|2|||
105780282|NCT00135694|364846595|FG000|Overall Study|Lost to Follow-up|8|||
105780283|NCT00135694|364846596|FG001|Overall Study|Lost to Follow-up|7|||
105780284|NCT00135694|364846597|FG002|Overall Study|Lost to Follow-up|1|||
105780285|NCT00135694|364846595|FG000|Overall Study|Withdrawal by Subject|41|||
105780286|NCT00135694|364846596|FG001|Overall Study|Withdrawal by Subject|7|||
105780287|NCT00135694|364846597|FG002|Overall Study|Withdrawal by Subject|4|||
105780288|NCT00135694|364846595|FG000|Overall Study|Protocol Violation|19|||
105780289|NCT00135694|364846596|FG001|Overall Study|Protocol Violation|1|||
105780290|NCT00135694|364846597|FG002|Overall Study|Protocol Violation|0|||
105780291|NCT00135694|364846595|FG000|Overall Study|Hepatitis C related reasons|39|||
105780292|NCT00135694|364846596|FG001|Overall Study|Hepatitis C related reasons|1|||
105780293|NCT00135694|364846597|FG002|Overall Study|Hepatitis C related reasons|0|||
105780294|NCT00135694|364846595|FG000|Overall Study|Ineligible for Random assignment|42|||
105780295|NCT00135694|364846596|FG001|Overall Study|Ineligible for Random assignment|0|||
105780296|NCT00135694|364846597|FG002|Overall Study|Ineligible for Random assignment|0|||
105780297|NCT02850276|364846602|FG000|Overall Study|screen failure|43|||
105780298|NCT02850276|364846602|FG000|Overall Study|Withdrawal by Subject|14|||
105780299|NCT02850276|364846602|FG000|Overall Study|Physician Decision|2|||
105780300|NCT02850276|364846602|FG000|Overall Study|Lost to Follow-up|2|||
105780301|NCT03137173|364846603|FG000|Overall Study|Withdrawal by Subject|8|||
105780302|NCT03137173|364846604|FG001|Overall Study|Withdrawal by Subject|13|||
105780303|NCT03137173|364846603|FG000|Overall Study|Death|1|||
105780304|NCT03137173|364846604|FG001|Overall Study|Death|3|||
105780305|NCT03137173|364846603|FG000|Overall Study|Physician Decision|1|||
105780306|NCT03137173|364846604|FG001|Overall Study|Physician Decision|0|||
105780307|NCT03137173|364846603|FG000|Overall Study|Lost to Follow-up|13|||
105780308|NCT03137173|364846604|FG001|Overall Study|Lost to Follow-up|18|||
105780309|NCT03137173|364846603|FG000|Overall Study|Other reasons|3|||
105780310|NCT03137173|364846604|FG001|Overall Study|Other reasons|2|||
105780311|NCT01482598|364846605|FG000|Overall Study|Death|7|||
105780312|NCT01482598|364846606|FG001|Overall Study|Death|10|||
105780313|NCT01482598|364846605|FG000|Overall Study|Physician Decision|0|||
105780314|NCT01482598|364846606|FG001|Overall Study|Physician Decision|3|||
105780315|NCT01482598|364846605|FG000|Overall Study|Withdrawal by Subject|4|||
105780316|NCT01482598|364846606|FG001|Overall Study|Withdrawal by Subject|5|||
105780317|NCT01482598|364846605|FG000|Overall Study|Lost to Follow-up|5|||
105780318|NCT01482598|364846606|FG001|Overall Study|Lost to Follow-up|4|||
105780319|NCT00951912|364846611|FG000|Overall Study|Lack of Efficacy|1|||
105780320|NCT00951912|364846612|FG001|Overall Study|Lack of Efficacy|0|||
105780321|NCT00951912|364846613|FG002|Overall Study|Lack of Efficacy|0|||
105780322|NCT00951912|364846611|FG000|Overall Study|Adverse Event|0|||
105780323|NCT00951912|364846612|FG001|Overall Study|Adverse Event|1|||
105780324|NCT00951912|364846613|FG002|Overall Study|Adverse Event|1|||
105780325|NCT00951912|364846611|FG000|Overall Study|Lost to Follow-up|2|||
105780326|NCT00951912|364846612|FG001|Overall Study|Lost to Follow-up|2|||
105780327|NCT00951912|364846613|FG002|Overall Study|Lost to Follow-up|0|||
105780328|NCT00951912|364846611|FG000|Overall Study|Physician Decision|1|||
105780329|NCT00951912|364846612|FG001|Overall Study|Physician Decision|0|||
105780330|NCT00951912|364846613|FG002|Overall Study|Physician Decision|1|||
105780331|NCT00951912|364846611|FG000|Overall Study|Withdrawal by Subject|1|||
105780332|NCT00951912|364846612|FG001|Overall Study|Withdrawal by Subject|1|||
105780333|NCT00951912|364846613|FG002|Overall Study|Withdrawal by Subject|0|||
105780334|NCT00951912|364846611|FG000|Overall Study|Other:Depression|1|||
105780335|NCT00951912|364846612|FG001|Overall Study|Other:Depression|0|||
105780336|NCT00951912|364846613|FG002|Overall Study|Other:Depression|0|||
105780337|NCT00951912|364846611|FG000|Overall Study|Other: Colon cancer|1|||
105780338|NCT00951912|364846612|FG001|Overall Study|Other: Colon cancer|0|||
105780339|NCT00951912|364846613|FG002|Overall Study|Other: Colon cancer|0|||
105780340|NCT00951912|364846611|FG000|Overall Study|Other: Stroke|0|||
105780341|NCT00951912|364846612|FG001|Overall Study|Other: Stroke|1|||
105780342|NCT00951912|364846613|FG002|Overall Study|Other: Stroke|0|||
105780343|NCT03417999|364846614|FG000|Overall Study|Withdrawal by Subject|1|||
105780344|NCT03417999|364846615|FG001|Overall Study|Withdrawal by Subject|0|||
105780345|NCT03417999|364846616|FG002|Overall Study|Withdrawal by Subject|0|||
105780346|NCT03417999|364846614|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
105780347|NCT03417999|364846615|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
105780348|NCT03417999|364846616|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
105780349|NCT03417999|364846614|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
105780350|NCT03417999|364846615|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
105780351|NCT03417999|364846616|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
105780352|NCT03417999|364846614|FG000|Overall Study|Inadequate study staff available to process samples|0|||
105780353|NCT03417999|364846615|FG001|Overall Study|Inadequate study staff available to process samples|0|||
105780354|NCT03417999|364846616|FG002|Overall Study|Inadequate study staff available to process samples|1|||
105780355|NCT03039699|364846621|FG000|Overall Study|Incorrect inclusion|5|||
105780356|NCT03039699|364846622|FG001|Overall Study|Incorrect inclusion|4|||
105780357|NCT03039699|364846621|FG000|Overall Study|Lack of data to assess study endpoint|5|||
105780358|NCT03039699|364846622|FG001|Overall Study|Lack of data to assess study endpoint|3|||
105780359|NCT03039699|364846621|FG000|Overall Study|Bacterial infection|12|||
105780360|NCT03039699|364846622|FG001|Overall Study|Bacterial infection|28|||
105780361|NCT02539160|364846623|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
105780362|NCT02539160|364846624|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
105780363|NCT02539160|364846625|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
105780364|NCT02539160|364846626|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
105780365|NCT02539160|364846623|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
105780366|NCT02539160|364846624|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
105780367|NCT02539160|364846625|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
105780368|NCT02539160|364846626|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
105780369|NCT02539160|364846623|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
105780370|NCT02539160|364846624|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
105780371|NCT02539160|364846625|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
105780372|NCT02539160|364846626|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
105780373|NCT02312934|364846630|FG000|Overall Study|Lost to Follow-up|1|||
105780374|NCT02312934|364846631|FG001|Overall Study|Lost to Follow-up|0|||
105780375|NCT02312934|364846630|FG000|Overall Study|Physician Decision|1|||
105780376|NCT02312934|364846631|FG001|Overall Study|Physician Decision|0|||
105780377|NCT00689299|364846632|FG000|Overall Study|Adverse Event|2|||
105780378|NCT00689299|364846633|FG001|Overall Study|Adverse Event|1|||
105780379|NCT00689299|364846634|FG002|Overall Study|Adverse Event|1|||
105780380|NCT00689299|364846632|FG000|Overall Study|Lost to Follow-up|0|||
105780381|NCT00689299|364846633|FG001|Overall Study|Lost to Follow-up|1|||
105780382|NCT00689299|364846634|FG002|Overall Study|Lost to Follow-up|1|||
105780383|NCT00689299|364846632|FG000|Overall Study|Withdrawal by Subject|4|||
105780384|NCT00689299|364846633|FG001|Overall Study|Withdrawal by Subject|1|||
105780385|NCT00689299|364846634|FG002|Overall Study|Withdrawal by Subject|3|||
105780386|NCT00689299|364846632|FG000|Overall Study|Protocol Violation|1|||
105780387|NCT00689299|364846633|FG001|Overall Study|Protocol Violation|0|||
105780388|NCT00689299|364846634|FG002|Overall Study|Protocol Violation|0|||
105780389|NCT01002573|364848564|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
105780390|NCT01002573|364848565|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
105780391|NCT04823494|364848566|FG000|Overall Study|Programming software malfunction.|1|||
105780392|NCT04823494|364848567|FG001|Overall Study|Programming software malfunction.|0|||
105780393|NCT04823494|364848566|FG000|Overall Study|Withdrawal by Subject|1|||
105780394|NCT04823494|364848567|FG001|Overall Study|Withdrawal by Subject|0|||
105780395|NCT04823494|364848566|FG000|Overall Study|Devices lost|0|||
105780396|NCT04823494|364848567|FG001|Overall Study|Devices lost|1|||
105780397|NCT04524663|364848570|FG000|Overall Study|Withdrawal by Subject|0|||
105780398|NCT04524663|364848571|FG001|Overall Study|Withdrawal by Subject|2|||
105780399|NCT00337935|364848572|FG000|Overall Study|Adverse Event|2|||
105780400|NCT00337935|364848573|FG001|Overall Study|Adverse Event|5|||
105780401|NCT00337935|364848572|FG000|Overall Study|Death|2|||
105780402|NCT00337935|364848573|FG001|Overall Study|Death|8|||
105780403|NCT00337935|364848572|FG000|Overall Study|Physician Decision|1|||
106144068|NCT01317420|366186952|FG003|Overall Study|Progressive disease according to RECIST|3|||
105780404|NCT00337935|364848573|FG001|Overall Study|Physician Decision|1|||
105780405|NCT00337935|364848572|FG000|Overall Study|Lost to Follow-up|0|||
105780406|NCT00337935|364848573|FG001|Overall Study|Lost to Follow-up|1|||
105780407|NCT00337935|364848572|FG000|Overall Study|Protocol Violation|4|||
105780408|NCT00337935|364848573|FG001|Overall Study|Protocol Violation|3|||
105780409|NCT00337935|364848572|FG000|Overall Study|Withdrawal by Subject|1|||
105780410|NCT00337935|364848573|FG001|Overall Study|Withdrawal by Subject|7|||
105780411|NCT00337935|364848572|FG000|Overall Study|Other|0|||
105780412|NCT00337935|364848573|FG001|Overall Study|Other|1|||
105780413|NCT00337935|364848572|FG000|Overall Study|Lack of Efficacy|0|||
105780414|NCT00337935|364848573|FG001|Overall Study|Lack of Efficacy|1|||
105780415|NCT01884675|364848574|FG000|Overall Study|Study closed/terminated|3|||
105780416|NCT01884675|364848575|FG001|Overall Study|Study closed/terminated|2|||
105780417|NCT03359811|364848576|FG000|Overall Study|Protocol Violation|2|||
105780418|NCT03359811|364848577|FG001|Overall Study|Protocol Violation|0|||
105780419|NCT02534324|364848578|FG000|Overall Study|Protocol Violation|4|||
105780420|NCT02534324|364848579|FG001|Overall Study|Protocol Violation|1|||
105780421|NCT02534324|364848578|FG000|Overall Study|Lost to Follow-up|20|||
105780422|NCT02534324|364848579|FG001|Overall Study|Lost to Follow-up|7|||
105780423|NCT02534324|364848578|FG000|Overall Study|Adverse Event|1|||
105780424|NCT02534324|364848579|FG001|Overall Study|Adverse Event|0|||
105780425|NCT00303602|364848583|FG000|Overall Study|Adverse Event|2|||
105780426|NCT00303602|364848584|FG001|Overall Study|Adverse Event|2|||
105780427|NCT00303602|364848583|FG000|Overall Study|Withdrawal by Subject|5|||
105780428|NCT00303602|364848584|FG001|Overall Study|Withdrawal by Subject|6|||
105780429|NCT00303602|364848583|FG000|Overall Study|Lost to Follow-up|5|||
105780430|NCT00303602|364848584|FG001|Overall Study|Lost to Follow-up|2|||
105780431|NCT00303602|364848583|FG000|Overall Study|Protocol entry criteria not met|2|||
105780432|NCT00303602|364848584|FG001|Overall Study|Protocol entry criteria not met|2|||
105780433|NCT00303602|364848583|FG000|Overall Study|Physician Decision|2|||
105780434|NCT00303602|364848584|FG001|Overall Study|Physician Decision|1|||
105780435|NCT00303602|364848583|FG000|Overall Study|Noncompliance|2|||
105780436|NCT00303602|364848584|FG001|Overall Study|Noncompliance|2|||
105780437|NCT00303602|364848583|FG000|Overall Study|Protocol Violation|1|||
105780438|NCT00303602|364848584|FG001|Overall Study|Protocol Violation|0|||
105780439|NCT01491802|364848595|FG000|Overall Study|Adverse Event|1|||
105780440|NCT01491802|364848596|FG001|Overall Study|Adverse Event|1|||
105780441|NCT01491802|364848595|FG000|Overall Study|Withdrawal by Subject|0|||
105780442|NCT01491802|364848596|FG001|Overall Study|Withdrawal by Subject|1|||
105780443|NCT00663208|364848597|FG000|Treatment Period|Lost to Follow-up|0|||
105780444|NCT00663208|364848598|FG001|Treatment Period|Lost to Follow-up|1|||
105780445|NCT00663208|364848599|FG002|Treatment Period|Lost to Follow-up|0|||
105780446|NCT00663208|364848600|FG003|Treatment Period|Lost to Follow-up|0|||
105780447|NCT00663208|364848601|FG004|Treatment Period|Lost to Follow-up|0|||
105780448|NCT00663208|364848602|FG005|Treatment Period|Lost to Follow-up|0|||
105780449|NCT00663208|364848603|FG006|Treatment Period|Lost to Follow-up|0|||
105780450|NCT00663208|364848597|FG000|Follow-up Period|Lost to Follow-up|2|||
105780451|NCT00663208|364848598|FG001|Follow-up Period|Lost to Follow-up|0|||
105780452|NCT00663208|364848599|FG002|Follow-up Period|Lost to Follow-up|3|||
105780453|NCT00663208|364848600|FG003|Follow-up Period|Lost to Follow-up|2|||
105780454|NCT00663208|364848601|FG004|Follow-up Period|Lost to Follow-up|0|||
105780455|NCT00663208|364848602|FG005|Follow-up Period|Lost to Follow-up|0|||
105780456|NCT00663208|364848603|FG006|Follow-up Period|Lost to Follow-up|0|||
105780457|NCT00663208|364848597|FG000|Follow-up Period|Other reason|1|||
105780458|NCT00663208|364848598|FG001|Follow-up Period|Other reason|0|||
105780459|NCT00663208|364848599|FG002|Follow-up Period|Other reason|0|||
105780460|NCT00663208|364848600|FG003|Follow-up Period|Other reason|0|||
105780461|NCT00663208|364848601|FG004|Follow-up Period|Other reason|0|||
105780462|NCT00663208|364848602|FG005|Follow-up Period|Other reason|0|||
105780463|NCT00663208|364848603|FG006|Follow-up Period|Other reason|1|||
105780464|NCT02927990|364848608|FG000|Overall Study|Protocol Violation|4|||
105780465|NCT02927990|364848608|FG000|Overall Study|Physician Decision|9|||
105780466|NCT02927990|364848608|FG000|Overall Study|Room switched and therefore no study device available|15|||
105780467|NCT02927990|364848608|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
105780468|NCT02839330|364848609|FG000|Overall Study|Adverse Event|0|||
105780469|NCT02839330|364848610|FG001|Overall Study|Adverse Event|1|||
105780470|NCT02839330|364848611|FG002|Overall Study|Adverse Event|2|||
105780471|NCT02839330|364848612|FG003|Overall Study|Adverse Event|2|||
105780472|NCT02839330|364848609|FG000|Overall Study|Death|4|||
105780473|NCT02839330|364848610|FG001|Overall Study|Death|6|||
105780474|NCT02839330|364848611|FG002|Overall Study|Death|1|||
105780475|NCT02839330|364848612|FG003|Overall Study|Death|1|||
105780476|NCT02839330|364848609|FG000|Overall Study|Withdrawal by Subject|27|||
105780477|NCT02839330|364848610|FG001|Overall Study|Withdrawal by Subject|19|||
105780478|NCT02839330|364848611|FG002|Overall Study|Withdrawal by Subject|11|||
105780479|NCT02839330|364848612|FG003|Overall Study|Withdrawal by Subject|13|||
105780480|NCT02839330|364848609|FG000|Overall Study|Lost to Follow-up|22|||
105780481|NCT02839330|364848610|FG001|Overall Study|Lost to Follow-up|27|||
105780482|NCT02839330|364848611|FG002|Overall Study|Lost to Follow-up|29|||
105780483|NCT02839330|364848612|FG003|Overall Study|Lost to Follow-up|25|||
105780484|NCT02839330|364848609|FG000|Overall Study|Administrative Reason|0|||
105780485|NCT02839330|364848610|FG001|Overall Study|Administrative Reason|0|||
105780486|NCT02839330|364848611|FG002|Overall Study|Administrative Reason|0|||
105780487|NCT02839330|364848612|FG003|Overall Study|Administrative Reason|1|||
105780488|NCT02839330|364848609|FG000|Overall Study|Protocol Violation|1|||
105780489|NCT02839330|364848610|FG001|Overall Study|Protocol Violation|2|||
105780490|NCT02839330|364848611|FG002|Overall Study|Protocol Violation|2|||
105780491|NCT02839330|364848612|FG003|Overall Study|Protocol Violation|3|||
105780492|NCT02839330|364848609|FG000|Overall Study|Other reason, not specified|4|||
105780493|NCT02839330|364848610|FG001|Overall Study|Other reason, not specified|3|||
105780494|NCT02839330|364848611|FG002|Overall Study|Other reason, not specified|3|||
105780495|NCT02839330|364848612|FG003|Overall Study|Other reason, not specified|6|||
105780496|NCT01710709|364848613|FG000|Overall Study|Lost to Follow-up|29|||
105780497|NCT01710709|364848613|FG000|Overall Study|Adverse Event|48|||
105780498|NCT01710709|364848613|FG000|Overall Study|Participant met withdrawal criteria|33|||
105780499|NCT01710709|364848613|FG000|Overall Study|Participant withdrawn by investigator|2|||
105780500|NCT01710709|364848613|FG000|Overall Study|Withdrawal by Subject|53|||
105780501|NCT01710709|364848613|FG000|Overall Study|Protocol Violation|5|||
105780502|NCT01710709|364848613|FG000|Overall Study|Lack of Efficacy|3|||
105780503|NCT01345162|364848618|FG000|Overall Study|Protocol Violation|2|||
105780504|NCT01345162|364848619|FG001|Overall Study|Protocol Violation|4|||
105780505|NCT01398176|364848620|FG000|Overall Study|Lost to Follow-up|1|||
105780506|NCT01398176|364848621|FG001|Overall Study|Lost to Follow-up|3|||
105780507|NCT01398176|364848620|FG000|Overall Study|Physician Decision|2|||
105780508|NCT01398176|364848621|FG001|Overall Study|Physician Decision|3|||
105780509|NCT00508872|364848622|FG000|Overall Study|Lost to Follow-up|1|||
105780510|NCT00508872|364848622|FG000|Overall Study|Physician Decision|1|||
105780511|NCT00542321|364848623|FG000|Overall Study|Death|0|||
105780512|NCT00542321|364848624|FG001|Overall Study|Death|1|||
105780513|NCT01871870|364848628|FG000|Overall Study|Hardware issues|7|||
105780514|NCT01871870|364848628|FG000|Overall Study|hyperglycemia|2|||
105780515|NCT03007472|364848629|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
105780516|NCT03007472|364848629|FG000|Overall Study|Death|2|||
105780517|NCT03007472|364848629|FG000|Overall Study|Loss to Follow Up|1|||
105780518|NCT00883896|364848630|FG000|Overall Study|Lost to Follow-up|0|||
105780519|NCT00883896|364848631|FG001|Overall Study|Lost to Follow-up|0|||
105780520|NCT00883896|364848632|FG002|Overall Study|Lost to Follow-up|0|||
105780521|NCT00883896|364848633|FG003|Overall Study|Lost to Follow-up|2|||
105780522|NCT00883896|364848630|FG000|Overall Study|Withdrawal by Subject|5|||
105780523|NCT00883896|364848631|FG001|Overall Study|Withdrawal by Subject|0|||
105780524|NCT00883896|364848632|FG002|Overall Study|Withdrawal by Subject|1|||
105780525|NCT00883896|364848633|FG003|Overall Study|Withdrawal by Subject|3|||
105780526|NCT00883896|364848630|FG000|Overall Study|Lack of Efficacy|0|||
105780527|NCT00883896|364848631|FG001|Overall Study|Lack of Efficacy|0|||
105780528|NCT00883896|364848632|FG002|Overall Study|Lack of Efficacy|0|||
105780529|NCT00883896|364848633|FG003|Overall Study|Lack of Efficacy|2|||
105780530|NCT00883896|364848630|FG000|Overall Study|Other|1|||
105780531|NCT00883896|364848631|FG001|Overall Study|Other|0|||
105780532|NCT00883896|364848632|FG002|Overall Study|Other|0|||
105780533|NCT00883896|364848633|FG003|Overall Study|Other|0|||
105780534|NCT00148109|364848639|FG000|Overall Study|Lack of Efficacy|10|||
105780535|NCT00148109|364848640|FG001|Overall Study|Lack of Efficacy|18|||
105780536|NCT00148109|364848639|FG000|Overall Study|Adverse Event|0|||
105780537|NCT00148109|364848640|FG001|Overall Study|Adverse Event|2|||
105780538|NCT00148109|364848639|FG000|Overall Study|Withdrawal by Subject|2|||
105780539|NCT00148109|364848640|FG001|Overall Study|Withdrawal by Subject|0|||
105780540|NCT02988115|364848641|FG000|Overall Study|Adverse Event|6|||
105780541|NCT02988115|364848642|FG001|Overall Study|Adverse Event|1|||
105780542|NCT02988115|364848641|FG000|Overall Study|Sponsor Decision|5|||
105780543|NCT02988115|364848642|FG001|Overall Study|Sponsor Decision|2|||
105780544|NCT02988115|364848641|FG000|Overall Study|Withdrawal by Subject|1|||
105780545|NCT02988115|364848642|FG001|Overall Study|Withdrawal by Subject|1|||
105780546|NCT02988115|364848641|FG000|Overall Study|Withdrawn by Mistake|1|||
105780547|NCT02988115|364848642|FG001|Overall Study|Withdrawn by Mistake|0|||
105780548|NCT02988115|364848641|FG000|Overall Study|Lost to Follow-up|1|||
105780549|NCT02988115|364848642|FG001|Overall Study|Lost to Follow-up|0|||
105780550|NCT01731951|364848643|FG000|Overall Study|Documented Disease Progression|1|||
105780551|NCT01731951|364848644|FG001|Overall Study|Documented Disease Progression|0|||
105780552|NCT01731951|364848645|FG002|Overall Study|Documented Disease Progression|0|||
105780553|NCT01731951|364848646|FG003|Overall Study|Documented Disease Progression|0|||
105780554|NCT01731951|364848647|FG004|Overall Study|Documented Disease Progression|0|||
105780555|NCT01731951|364848648|FG005|Overall Study|Documented Disease Progression|0|||
105780556|NCT01731951|364848643|FG000|Overall Study|Lost to Follow-up|2|||
105780557|NCT01731951|364848644|FG001|Overall Study|Lost to Follow-up|0|||
105780558|NCT01731951|364848645|FG002|Overall Study|Lost to Follow-up|0|||
105780559|NCT01731951|364848646|FG003|Overall Study|Lost to Follow-up|1|||
105780560|NCT01731951|364848647|FG004|Overall Study|Lost to Follow-up|3|||
105780561|NCT01731951|364848648|FG005|Overall Study|Lost to Follow-up|1|||
105780562|NCT01731951|364848643|FG000|Overall Study|Withdrawal of Consent|1|||
105780563|NCT01731951|364848644|FG001|Overall Study|Withdrawal of Consent|0|||
105992481|NCT03364309|365631555|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992482|NCT03364309|365631556|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992483|NCT03364309|365631557|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992484|NCT03364309|365631558|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992485|NCT03364309|365631559|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992486|NCT03364309|365631560|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992487|NCT03364309|365631561|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992488|NCT03364309|365631562|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992489|NCT03364309|365631563|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992490|NCT03364309|365631564|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992491|NCT03364309|365631565|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992492|NCT03364309|365631566|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992493|NCT03364309|365631567|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992494|NCT03364309|365631568|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992495|NCT03364309|365631569|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
105992496|NCT03364309|365631570|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992497|NCT03364309|365631571|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992498|NCT03364309|365631572|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992499|NCT03364309|365631573|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
105992500|NCT03364309|365631555|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
105992501|NCT03364309|365631556|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
105992502|NCT03364309|365631557|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
105992503|NCT03364309|365631558|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
105992504|NCT03364309|365631559|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
105992505|NCT03364309|365631560|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
105992506|NCT03364309|365631561|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
105992507|NCT03364309|365631562|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
105992508|NCT03364309|365631563|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
105992509|NCT03364309|365631564|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
105992510|NCT03364309|365631565|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
105992511|NCT03364309|365631566|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
105992512|NCT03364309|365631567|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
105992513|NCT03364309|365631568|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
105992514|NCT03364309|365631569|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
105992515|NCT03364309|365631570|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
105992516|NCT03364309|365631571|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
106101612|NCT01295944|366026728|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
106101613|NCT01295944|366026728|FG000|Overall Study|Disease progression|4|||
106101614|NCT01295944|366026728|FG000|Overall Study|Transferred care before starting new treatment|1|||
106101615|NCT01556438|366026731|FG000|Overall Study|Adverse Event|4|||
106101616|NCT01556438|366026732|FG001|Overall Study|Adverse Event|2|||
106101617|NCT01556438|366026731|FG000|Overall Study|Sponsor Decision|0|||
106101618|NCT01556438|366026732|FG001|Overall Study|Sponsor Decision|2|||
106101619|NCT01556438|366026731|FG000|Overall Study|Progressive Disease|0|||
106101620|NCT01556438|366026732|FG001|Overall Study|Progressive Disease|6|||
106101621|NCT01556438|366026731|FG000|Overall Study|Death|0|||
106101622|NCT01556438|366026732|FG001|Overall Study|Death|1|||
106101623|NCT00529399|366026733|FG000|Overall Study|Lost to Follow-up|1|||
106101624|NCT00529399|366026734|FG001|Overall Study|Lost to Follow-up|0|||
106101625|NCT00529399|366026735|FG002|Overall Study|Lost to Follow-up|1|||
105992517|NCT03364309|365631572|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
105992518|NCT03364309|365631573|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
105992519|NCT03364309|365631555|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992520|NCT03364309|365631556|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992521|NCT03364309|365631557|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992522|NCT03364309|365631558|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992523|NCT03364309|365631559|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992524|NCT03364309|365631560|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992525|NCT03364309|365631561|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992526|NCT03364309|365631562|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992527|NCT03364309|365631563|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992528|NCT03364309|365631564|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992529|NCT03364309|365631565|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992530|NCT03364309|365631566|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992531|NCT03364309|365631567|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992532|NCT03364309|365631568|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992533|NCT03364309|365631569|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992534|NCT03364309|365631570|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105992535|NCT03364309|365631571|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
105992536|NCT03364309|365631572|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
105992537|NCT03364309|365631573|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
105780564|NCT01731951|364848645|FG002|Overall Study|Withdrawal of Consent|0|||
105780565|NCT01731951|364848646|FG003|Overall Study|Withdrawal of Consent|0|||
105780566|NCT01731951|364848647|FG004|Overall Study|Withdrawal of Consent|0|||
105780567|NCT01731951|364848648|FG005|Overall Study|Withdrawal of Consent|2|||
105780568|NCT01731951|364848643|FG000|Overall Study|Death|13|||
105780569|NCT01731951|364848644|FG001|Overall Study|Death|15|||
105780570|NCT01731951|364848645|FG002|Overall Study|Death|9|||
105780571|NCT01731951|364848646|FG003|Overall Study|Death|8|||
105780572|NCT01731951|364848647|FG004|Overall Study|Death|9|||
105780573|NCT01731951|364848648|FG005|Overall Study|Death|6|||
105780574|NCT01977651|364848658|FG000|4 Month Treatment Period|Adverse Event|34|||
105780575|NCT01977651|364848658|FG000|4 Month Treatment Period|Death|3|||
105780576|NCT01977651|364848658|FG000|4 Month Treatment Period|Progressive Disease|43|||
105780577|NCT01977651|364848658|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
105780578|NCT01977651|364848658|FG000|4 Month Treatment Period|Physician Decision|4|||
105780579|NCT01977651|364848658|FG000|1 Year Extension Period|Adverse Event|14|||
105780580|NCT01977651|364848658|FG000|1 Year Extension Period|Death|10|||
105780581|NCT01977651|364848658|FG000|1 Year Extension Period|Lost to Follow-up|2|||
105780582|NCT01977651|364848658|FG000|1 Year Extension Period|Progressive Disease|86|||
105780583|NCT01977651|364848658|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
105780584|NCT01977651|364848658|FG000|1 Year Extension Period|Physician Decision|6|||
105780585|NCT01977651|364848658|FG000|1 Year Extension Period|Miscellaneous|1|||
105780586|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Adverse Event|5|||
105780587|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Death|13|||
105780588|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
105780589|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
105780590|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Physician Decision|4|||
105780591|NCT01977651|364848658|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
105780592|NCT01856920|364848659|FG000|Overall Study|Disease Progression On Study|3|||
105780593|NCT01856920|364848660|FG001|Overall Study|Disease Progression On Study|4|||
105780594|NCT01856920|364848659|FG000|Overall Study|Disease Progression before Treatment|1|||
105780595|NCT01856920|364848660|FG001|Overall Study|Disease Progression before Treatment|0|||
105780596|NCT01856920|364848659|FG000|Overall Study|Ineligible|0|||
105780597|NCT01856920|364848660|FG001|Overall Study|Ineligible|1|||
105780598|NCT01856920|364848659|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
105780599|NCT01856920|364848660|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
105780600|NCT01856920|364848659|FG000|Overall Study|Refused further Treatment|5|||
105780601|NCT01856920|364848660|FG001|Overall Study|Refused further Treatment|1|||
105780602|NCT01856920|364848659|FG000|Overall Study|Other Reasons|0|||
105780603|NCT01856920|364848660|FG001|Overall Study|Other Reasons|1|||
105780604|NCT01856920|364848659|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
105780605|NCT01856920|364848660|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
105780606|NCT03287089|364848662|FG000|Overall Study|Lost to Follow-up|0|||
105780607|NCT03287089|364848663|FG001|Overall Study|Lost to Follow-up|2|||
105780608|NCT03287089|364848662|FG000|Overall Study|Physician Decision|0|||
105780609|NCT03287089|364848663|FG001|Overall Study|Physician Decision|2|||
105780610|NCT03287089|364848662|FG000|Overall Study|Withdrawal by Subject|0|||
105780611|NCT03287089|364848663|FG001|Overall Study|Withdrawal by Subject|2|||
105780612|NCT02906644|364848664|FG000|First 2 Weeks|Withdrawal by Subject|0|||
105780613|NCT02906644|364848665|FG001|First 2 Weeks|Withdrawal by Subject|2|||
105780614|NCT02906644|364848664|FG000|First 2 Weeks|Physician Decision|1|||
105780615|NCT02906644|364848665|FG001|First 2 Weeks|Physician Decision|1|||
105780616|NCT02906644|364848664|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
105780617|NCT02906644|364848665|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
105780618|NCT02906644|364848664|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
105780619|NCT02906644|364848665|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
105780620|NCT00561795|364848666|FG000|Overall Study|Adverse Event|3|||
105780621|NCT00561795|364848667|FG001|Overall Study|Adverse Event|3|||
105780622|NCT00561795|364848668|FG002|Overall Study|Adverse Event|0|||
105780623|NCT00561795|364848669|FG003|Overall Study|Adverse Event|0|||
105780624|NCT00561795|364848666|FG000|Overall Study|Study Closed/Terminated|0|||
105780625|NCT00561795|364848667|FG001|Overall Study|Study Closed/Terminated|3|||
105780626|NCT00561795|364848668|FG002|Overall Study|Study Closed/Terminated|0|||
105780627|NCT00561795|364848669|FG003|Overall Study|Study Closed/Terminated|0|||
105780628|NCT00561795|364848666|FG000|Overall Study|Physician Decision|1|||
105780629|NCT00561795|364848667|FG001|Overall Study|Physician Decision|0|||
105780630|NCT00561795|364848668|FG002|Overall Study|Physician Decision|0|||
105780631|NCT00561795|364848669|FG003|Overall Study|Physician Decision|0|||
105780632|NCT03672006|364848670|FG000|Overall Study|exclusion criteria met|0|||
105780633|NCT03672006|364848671|FG001|Overall Study|exclusion criteria met|1|||
106101626|NCT00529399|366026733|FG000|Overall Study|Withdrawal by Subject|1|||
105780634|NCT04235959|364848672|FG000|Overall Study|Protocol Violation|0|||
105780635|NCT04235959|364848673|FG001|Overall Study|Protocol Violation|1|||
105780636|NCT04235959|364848674|FG002|Overall Study|Protocol Violation|0|||
105780637|NCT04235959|364848672|FG000|Overall Study|Adverse Event|1|||
105780638|NCT04235959|364848673|FG001|Overall Study|Adverse Event|0|||
105780639|NCT04235959|364848674|FG002|Overall Study|Adverse Event|0|||
105780640|NCT00608426|364848675|FG000|Overall Study|Death|32|||
105780641|NCT00608426|364848676|FG001|Overall Study|Death|36|||
105780642|NCT00608426|364848675|FG000|Overall Study|Lost to Follow-up|485|||
105780643|NCT00608426|364848676|FG001|Overall Study|Lost to Follow-up|521|||
105780644|NCT00608426|364848675|FG000|Overall Study|refused, health issues, wrong address|319|||
105780645|NCT00608426|364848676|FG001|Overall Study|refused, health issues, wrong address|348|||
105780646|NCT00761891|364848680|FG000|Overall Study|Withdrawal by Subject|10|||
105780647|NCT01707667|364848681|FG000|Period 1|expulsion of colonic sensor catheter|1|||
105780648|NCT01707667|364848682|FG001|Period 1|expulsion of colonic sensor catheter|0|||
105780649|NCT00579059|364848686|FG000|Overall Study|Study Canceled at 1 Year|21|||
105780650|NCT00579059|364848687|FG001|Overall Study|Study Canceled at 1 Year|10|||
105780651|NCT02764229|364848688|FG000|Overall Study|Withdrawal by Subject|15|||
105780652|NCT02764229|364848688|FG000|Overall Study|Adverse Event|9|||
105780653|NCT02764229|364848688|FG000|Overall Study|Physician Decision|5|||
105780654|NCT02764229|364848688|FG000|Overall Study|Lost to Follow-up|3|||
105780655|NCT02764229|364848688|FG000|Overall Study|Lack of Efficacy|1|||
105780656|NCT02764229|364848688|FG000|Overall Study|Study Stopped by Sponsor|69|||
105780657|NCT00779142|364848689|FG000|Overall Study|Screen Failures|3|||
105780658|NCT00672490|364848691|FG000|Overall Study|Withdrawal by Subject|8|||
105780659|NCT00672490|364848692|FG001|Overall Study|Withdrawal by Subject|8|||
105780660|NCT00672490|364848691|FG000|Overall Study|Lack of Compliance|2|||
105780661|NCT00672490|364848692|FG001|Overall Study|Lack of Compliance|7|||
105780662|NCT00672490|364848691|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
105780663|NCT00672490|364848692|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
105780664|NCT00672490|364848691|FG000|Overall Study|Adverse Event|5|||
105780665|NCT00672490|364848692|FG001|Overall Study|Adverse Event|8|||
105780666|NCT00672490|364848691|FG000|Overall Study|Violation of Concomitant Medicine|1|||
105780667|NCT00672490|364848692|FG001|Overall Study|Violation of Concomitant Medicine|0|||
105780668|NCT00672490|364848691|FG000|Overall Study|Intolerance|0|||
105780669|NCT00672490|364848692|FG001|Overall Study|Intolerance|2|||
105780670|NCT00672490|364848691|FG000|Overall Study|Lost to Follow-up|1|||
105780671|NCT00672490|364848692|FG001|Overall Study|Lost to Follow-up|5|||
105780672|NCT00672490|364848691|FG000|Overall Study|No reason was provided|6|||
105780673|NCT00672490|364848692|FG001|Overall Study|No reason was provided|2|||
105780674|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Adverse Event|6|||
105780675|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Adverse Event|6|||
105780676|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Death|14|||
105780677|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Death|11|||
105780678|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
105780679|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
105780680|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
105780681|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
106101627|NCT00529399|366026734|FG001|Overall Study|Withdrawal by Subject|0|||
106101628|NCT00529399|366026735|FG002|Overall Study|Withdrawal by Subject|1|||
106101629|NCT00529399|366026733|FG000|Overall Study|Non-compliant|0|||
106101630|NCT00529399|366026734|FG001|Overall Study|Non-compliant|1|||
106101631|NCT00529399|366026735|FG002|Overall Study|Non-compliant|0|||
106101632|NCT01572727|366026737|FG000|Overall Study|Adverse Event|43|||
106101633|NCT01572727|366026738|FG001|Overall Study|Adverse Event|15|||
106101634|NCT01572727|366026737|FG000|Overall Study|Lost to Follow-up|1|||
106101635|NCT01572727|366026738|FG001|Overall Study|Lost to Follow-up|1|||
106101636|NCT01572727|366026737|FG000|Overall Study|Physician Decision|23|||
106101637|NCT01572727|366026738|FG001|Overall Study|Physician Decision|9|||
106101638|NCT01572727|366026737|FG000|Overall Study|Progressive disease|59|||
106101639|NCT01572727|366026738|FG001|Overall Study|Progressive disease|82|||
106101640|NCT01572727|366026737|FG000|Overall Study|Protocol Violation|0|||
106101641|NCT01572727|366026738|FG001|Overall Study|Protocol Violation|1|||
106101642|NCT01572727|366026737|FG000|Overall Study|Study terminated by sponsor|61|||
106101643|NCT01572727|366026738|FG001|Overall Study|Study terminated by sponsor|83|||
106101644|NCT01572727|366026737|FG000|Overall Study|Parent/guardian decision|14|||
105780682|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
105780683|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
105780684|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Disease Progression|1|||
105780685|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Disease Progression|0|||
105780686|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
105780687|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
105780688|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
105780689|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
105780690|NCT04419558|364848695|FG000|DB Period (48 Weeks)|Participant Decision|4|||
105780691|NCT04419558|364848696|FG001|DB Period (48 Weeks)|Participant Decision|3|||
105780692|NCT04419558|364848695|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
105780693|NCT04419558|364848696|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
106101645|NCT01572727|366026738|FG001|Overall Study|Parent/guardian decision|9|||
106101646|NCT01572727|366026737|FG000|Overall Study|Death|2|||
106101647|NCT01572727|366026738|FG001|Overall Study|Death|2|||
105780694|NCT04419558|364848695|FG000|OLE Period (48 Weeks)|Death|4|||
105780695|NCT04419558|364848696|FG001|OLE Period (48 Weeks)|Death|6|||
105780696|NCT04419558|364848695|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
105780697|NCT04419558|364848696|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
105780698|NCT04419558|364848695|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
105780699|NCT04419558|364848696|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
105780700|NCT00697255|364848698|FG000|Stage 1a|Insufficient ovarian response|1|||
105780701|NCT00697255|364848699|FG001|Stage 1a|Insufficient ovarian response|0|||
105780702|NCT00697255|364848698|FG000|Stage 1a|Multifollicular growth|1|||
105780703|NCT00697255|364848699|FG001|Stage 1a|Multifollicular growth|0|||
105780704|NCT00697255|364848698|FG000|Stage 1a|Not growing of dominant follicle|1|||
105780705|NCT00697255|364848699|FG001|Stage 1a|Not growing of dominant follicle|0|||
105780706|NCT00697255|364848698|FG000|Stage 1b|Not growing of dominant follicle|0|||
105780707|NCT00697255|364848699|FG001|Stage 1b|Not growing of dominant follicle|1|||
106101648|NCT01572727|366026737|FG000|Overall Study|Untreated|4|||
106101649|NCT01572727|366026738|FG001|Overall Study|Untreated|7|||
106101650|NCT01328574|366026739|FG000|Overall Study|Refused further treatment|1|||
106101651|NCT03449030|366026747|FG000|Overall Study|Withdrawal by Subject|0|||
106101652|NCT03449030|366026748|FG001|Overall Study|Withdrawal by Subject|0|||
106101653|NCT03449030|366026749|FG002|Overall Study|Withdrawal by Subject|0|||
106101654|NCT03449030|366026750|FG003|Overall Study|Withdrawal by Subject|1|||
106101655|NCT03449030|366026751|FG004|Overall Study|Withdrawal by Subject|1|||
106101656|NCT03449030|366026752|FG005|Overall Study|Withdrawal by Subject|1|||
106101657|NCT03449030|366026753|FG006|Overall Study|Withdrawal by Subject|1|||
106101658|NCT03449030|366026754|FG007|Overall Study|Withdrawal by Subject|2|||
106101659|NCT03449030|366026755|FG008|Overall Study|Withdrawal by Subject|0|||
106101660|NCT03449030|366026756|FG009|Overall Study|Withdrawal by Subject|0|||
106101661|NCT03449030|366026747|FG000|Overall Study|Symptomatic Deterioration|0|||
106101662|NCT03449030|366026748|FG001|Overall Study|Symptomatic Deterioration|1|||
106101663|NCT03449030|366026749|FG002|Overall Study|Symptomatic Deterioration|0|||
106101664|NCT03449030|366026750|FG003|Overall Study|Symptomatic Deterioration|0|||
106101665|NCT03449030|366026751|FG004|Overall Study|Symptomatic Deterioration|0|||
106101666|NCT03449030|366026752|FG005|Overall Study|Symptomatic Deterioration|1|||
106101667|NCT03449030|366026753|FG006|Overall Study|Symptomatic Deterioration|1|||
106101668|NCT03449030|366026754|FG007|Overall Study|Symptomatic Deterioration|0|||
106101669|NCT03449030|366026755|FG008|Overall Study|Symptomatic Deterioration|2|||
106101670|NCT03449030|366026756|FG009|Overall Study|Symptomatic Deterioration|0|||
106101671|NCT03449030|366026747|FG000|Overall Study|Progressive Disease|1|||
106101672|NCT03449030|366026748|FG001|Overall Study|Progressive Disease|0|||
106101673|NCT03449030|366026749|FG002|Overall Study|Progressive Disease|1|||
106101674|NCT03449030|366026750|FG003|Overall Study|Progressive Disease|4|||
106101675|NCT03449030|366026751|FG004|Overall Study|Progressive Disease|5|||
106101676|NCT03449030|366026752|FG005|Overall Study|Progressive Disease|3|||
106101677|NCT03449030|366026753|FG006|Overall Study|Progressive Disease|0|||
106101678|NCT03449030|366026754|FG007|Overall Study|Progressive Disease|1|||
106101679|NCT03449030|366026755|FG008|Overall Study|Progressive Disease|1|||
106101680|NCT03449030|366026756|FG009|Overall Study|Progressive Disease|1|||
106101681|NCT03449030|366026747|FG000|Overall Study|Adverse Event|0|||
106101682|NCT03449030|366026748|FG001|Overall Study|Adverse Event|0|||
106101683|NCT03449030|366026749|FG002|Overall Study|Adverse Event|0|||
106101684|NCT03449030|366026750|FG003|Overall Study|Adverse Event|0|||
106101685|NCT03449030|366026751|FG004|Overall Study|Adverse Event|0|||
106101686|NCT03449030|366026752|FG005|Overall Study|Adverse Event|2|||
106101687|NCT03449030|366026753|FG006|Overall Study|Adverse Event|0|||
106101688|NCT03449030|366026754|FG007|Overall Study|Adverse Event|0|||
106101689|NCT03449030|366026755|FG008|Overall Study|Adverse Event|0|||
106101690|NCT03449030|366026756|FG009|Overall Study|Adverse Event|0|||
106101691|NCT03449030|366026747|FG000|Overall Study|Death|0|||
106101692|NCT03449030|366026748|FG001|Overall Study|Death|0|||
106101693|NCT03449030|366026749|FG002|Overall Study|Death|0|||
106101694|NCT03449030|366026750|FG003|Overall Study|Death|0|||
106101695|NCT03449030|366026751|FG004|Overall Study|Death|1|||
106101696|NCT03449030|366026752|FG005|Overall Study|Death|0|||
106101697|NCT03449030|366026753|FG006|Overall Study|Death|0|||
106101698|NCT03449030|366026754|FG007|Overall Study|Death|0|||
106101699|NCT03449030|366026755|FG008|Overall Study|Death|0|||
106101700|NCT03449030|366026756|FG009|Overall Study|Death|0|||
106101701|NCT00322348|366026758|FG000|Overall Study|Adverse Event|0|||
106101702|NCT00322348|366026759|FG001|Overall Study|Adverse Event|1|||
106101703|NCT00322348|366026758|FG000|Overall Study|Withdrawal by Subject|1|||
106101704|NCT00322348|366026759|FG001|Overall Study|Withdrawal by Subject|4|||
106101705|NCT00322348|366026758|FG000|Overall Study|Lost to Follow-up|1|||
105780708|NCT00697255|364848698|FG000|Stage 1b|Insufficient ovarian response|0|||
106101706|NCT00322348|366026759|FG001|Overall Study|Lost to Follow-up|0|||
106101707|NCT00322348|366026758|FG000|Overall Study|Death|0|||
106101708|NCT00322348|366026759|FG001|Overall Study|Death|2|||
106101709|NCT00322348|366026758|FG000|Overall Study|Disease Progression|30|||
106101710|NCT00322348|366026759|FG001|Overall Study|Disease Progression|25|||
106101711|NCT00322348|366026758|FG000|Overall Study|Reasons not specified|5|||
106101712|NCT00322348|366026759|FG001|Overall Study|Reasons not specified|1|||
106101713|NCT02341417|366026761|FG000|Overall Study|Withdrawal by Subject|0|||
106101714|NCT02341417|366026762|FG001|Overall Study|Withdrawal by Subject|2|||
106101715|NCT02341417|366026763|FG002|Overall Study|Withdrawal by Subject|0|||
106101716|NCT02341417|366026761|FG000|Overall Study|Decision by sponsor|2|||
106101717|NCT02341417|366026762|FG001|Overall Study|Decision by sponsor|0|||
106101718|NCT02341417|366026763|FG002|Overall Study|Decision by sponsor|0|||
106101719|NCT02341417|366026761|FG000|Overall Study|Death|0|||
106101720|NCT02341417|366026762|FG001|Overall Study|Death|0|||
106101721|NCT02341417|366026763|FG002|Overall Study|Death|1|||
105780709|NCT00697255|364848699|FG001|Stage 1b|Insufficient ovarian response|1|||
105780710|NCT01853397|364848710|FG000|Overall Study|Withdrawal by Subject|0|||
105780711|NCT01853397|364848711|FG001|Overall Study|Withdrawal by Subject|0|||
105780712|NCT01853397|364848712|FG002|Overall Study|Withdrawal by Subject|0|||
105780713|NCT01853397|364848713|FG003|Overall Study|Withdrawal by Subject|1|||
105780714|NCT01853397|364848710|FG000|Overall Study|Subject Noncompliance|0|||
105780715|NCT01853397|364848711|FG001|Overall Study|Subject Noncompliance|0|||
105780716|NCT01853397|364848712|FG002|Overall Study|Subject Noncompliance|0|||
105780717|NCT01853397|364848713|FG003|Overall Study|Subject Noncompliance|1|||
105780718|NCT02452892|364848714|FG000|Week 1 Initial Randommization|Adverse Event|1|||
105780719|NCT02452892|364848715|FG001|Week 1 Initial Randommization|Adverse Event|0|||
105780720|NCT02452892|364848716|FG002|Week 1 Initial Randommization|Adverse Event|0|||
105780721|NCT02452892|364848717|FG003|Week 1 Initial Randommization|Adverse Event|0|||
105780722|NCT02452892|364848714|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
105780723|NCT02452892|364848715|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
105780724|NCT02452892|364848716|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
105780725|NCT02452892|364848717|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
105780726|NCT02452892|364848714|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
105780727|NCT02452892|364848715|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
105780728|NCT02452892|364848716|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
105780729|NCT02452892|364848717|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
105780730|NCT02452892|364848714|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
105780731|NCT02452892|364848715|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
105780732|NCT02452892|364848716|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
105780733|NCT02452892|364848717|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
105780734|NCT02452892|364848714|FG000|Follow-up|Withdrawal by Subject|0|||
105780735|NCT02452892|364848715|FG001|Follow-up|Withdrawal by Subject|0|||
105780736|NCT02452892|364848716|FG002|Follow-up|Withdrawal by Subject|0|||
105780737|NCT02452892|364848717|FG003|Follow-up|Withdrawal by Subject|1|||
105780738|NCT02452892|364848714|FG000|Follow-up|Subject left town on Day 42|1|||
105780739|NCT02452892|364848715|FG001|Follow-up|Subject left town on Day 42|0|||
105780740|NCT02452892|364848716|FG002|Follow-up|Subject left town on Day 42|0|||
105780741|NCT02452892|364848717|FG003|Follow-up|Subject left town on Day 42|0|||
105780742|NCT00565721|364848722|FG000|Overall Study|Screen Failure|2|||
105780743|NCT00565721|364848722|FG000|Overall Study|Lost to Follow-up|6|||
105780744|NCT00565721|364848722|FG000|Overall Study|Technical Problems|1|||
105780745|NCT00565721|364848722|FG000|Overall Study|Physician Decision|2|||
105780746|NCT00565721|364848722|FG000|Overall Study|Other reasons|6|||
105780747|NCT05047601|364848723|FG000|Overall Study|Lost to Follow-up|9|||
105780748|NCT05047601|364848724|FG001|Overall Study|Lost to Follow-up|11|||
105780749|NCT05047601|364848725|FG002|Overall Study|Lost to Follow-up|7|||
105780750|NCT05047601|364848723|FG000|Overall Study|Withdrawal by Subject|25|||
105780751|NCT05047601|364848724|FG001|Overall Study|Withdrawal by Subject|36|||
105780752|NCT05047601|364848725|FG002|Overall Study|Withdrawal by Subject|23|||
105780753|NCT05047601|364848723|FG000|Overall Study|Other|10|||
105780754|NCT05047601|364848724|FG001|Overall Study|Other|6|||
105780755|NCT05047601|364848725|FG002|Overall Study|Other|5|||
105780756|NCT00286234|364848726|FG000|Overall Study|Protocol Violation|1|||
105780757|NCT00286234|364848727|FG001|Overall Study|Protocol Violation|2|||
105780758|NCT00286234|364848728|FG002|Overall Study|Protocol Violation|0|||
105780759|NCT00286234|364848729|FG003|Overall Study|Protocol Violation|1|||
105780760|NCT00286234|364848726|FG000|Overall Study|Physician Decision|1|||
105780761|NCT00286234|364848727|FG001|Overall Study|Physician Decision|0|||
105780762|NCT00286234|364848728|FG002|Overall Study|Physician Decision|0|||
105780763|NCT00286234|364848729|FG003|Overall Study|Physician Decision|1|||
105780764|NCT00286234|364848726|FG000|Overall Study|Adverse Event|0|||
105780765|NCT00286234|364848727|FG001|Overall Study|Adverse Event|0|||
105780766|NCT00286234|364848728|FG002|Overall Study|Adverse Event|0|||
105780767|NCT00286234|364848729|FG003|Overall Study|Adverse Event|1|||
105780768|NCT00286234|364848726|FG000|Overall Study|Adverse Event|0|||
105780769|NCT00286234|364848727|FG001|Overall Study|Adverse Event|0|||
105780770|NCT00286234|364848728|FG002|Overall Study|Adverse Event|0|||
105780771|NCT00286234|364848729|FG003|Overall Study|Adverse Event|1|||
105780772|NCT00699582|364848732|FG000|Overall Study|Adverse Event|4|||
106101722|NCT00833638|366026768|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
106101723|NCT00833638|366026769|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
105780773|NCT00699582|364848733|FG001|Overall Study|Adverse Event|11|||
105780774|NCT00699582|364848734|FG002|Overall Study|Adverse Event|23|||
105780775|NCT00699582|364848732|FG000|Overall Study|Withdrawal by Subject|6|||
105780776|NCT00699582|364848733|FG001|Overall Study|Withdrawal by Subject|7|||
105780777|NCT00699582|364848734|FG002|Overall Study|Withdrawal by Subject|4|||
105780778|NCT00699582|364848732|FG000|Overall Study|Lack of Efficacy|1|||
105780779|NCT00699582|364848733|FG001|Overall Study|Lack of Efficacy|0|||
105780780|NCT00699582|364848734|FG002|Overall Study|Lack of Efficacy|1|||
105780781|NCT00699582|364848732|FG000|Overall Study|Progressive Disease|1|||
105780782|NCT00699582|364848733|FG001|Overall Study|Progressive Disease|0|||
105780783|NCT00699582|364848734|FG002|Overall Study|Progressive Disease|0|||
105780784|NCT00699582|364848732|FG000|Overall Study|Administrative/Other|4|||
105780785|NCT00699582|364848733|FG001|Overall Study|Administrative/Other|3|||
105780786|NCT00699582|364848734|FG002|Overall Study|Administrative/Other|0|||
105780787|NCT00699582|364848732|FG000|Overall Study|Randomized, Not Treated|2|||
105780788|NCT00699582|364848733|FG001|Overall Study|Randomized, Not Treated|1|||
105780789|NCT00699582|364848734|FG002|Overall Study|Randomized, Not Treated|0|||
105780790|NCT00283062|364848736|FG000|Overall Study|Did not receive any study medication|5|||
105780791|NCT00283062|364848737|FG001|Overall Study|Did not receive any study medication|4|||
105780792|NCT00283062|364848738|FG002|Overall Study|Did not receive any study medication|36|||
105780793|NCT00283062|364848739|FG003|Overall Study|Did not receive any study medication|45|||
105780794|NCT00283062|364848736|FG000|Overall Study|Adverse Event|2|||
105780795|NCT00283062|364848737|FG001|Overall Study|Adverse Event|0|||
105780796|NCT00283062|364848738|FG002|Overall Study|Adverse Event|1|||
105780797|NCT00283062|364848739|FG003|Overall Study|Adverse Event|0|||
105780798|NCT00283062|364848736|FG000|Overall Study|Lost to Follow-up|1|||
105780799|NCT00283062|364848737|FG001|Overall Study|Lost to Follow-up|0|||
105780800|NCT00283062|364848738|FG002|Overall Study|Lost to Follow-up|1|||
105780801|NCT00283062|364848739|FG003|Overall Study|Lost to Follow-up|0|||
105780802|NCT00283062|364848736|FG000|Overall Study|Progressive disease|0|||
105780803|NCT00283062|364848737|FG001|Overall Study|Progressive disease|0|||
105780804|NCT00283062|364848738|FG002|Overall Study|Progressive disease|1|||
105780805|NCT00283062|364848739|FG003|Overall Study|Progressive disease|0|||
105780806|NCT00283062|364848736|FG000|Overall Study|Participant did not wish to continue|3|||
105780807|NCT00283062|364848737|FG001|Overall Study|Participant did not wish to continue|2|||
105780808|NCT00283062|364848738|FG002|Overall Study|Participant did not wish to continue|1|||
105780809|NCT00283062|364848739|FG003|Overall Study|Participant did not wish to continue|0|||
105780810|NCT00283062|364848736|FG000|Overall Study|Undefined|0|||
105780811|NCT00283062|364848737|FG001|Overall Study|Undefined|1|||
105780812|NCT00283062|364848738|FG002|Overall Study|Undefined|1|||
105780813|NCT00283062|364848739|FG003|Overall Study|Undefined|4|||
105780814|NCT00283062|364848736|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
105780815|NCT00283062|364848737|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
105780816|NCT00283062|364848738|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
106101724|NCT00833638|366026770|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
106101725|NCT00833638|366026768|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
106101726|NCT00833638|366026769|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
106101727|NCT00833638|366026770|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
106101728|NCT00833638|366026768|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
106101729|NCT00833638|366026769|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
106101730|NCT00833638|366026770|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
106101731|NCT00833638|366026768|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
106101732|NCT00833638|366026769|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
106101733|NCT00833638|366026770|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
106101734|NCT00833638|366026768|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
106101735|NCT00833638|366026769|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
106101736|NCT00833638|366026770|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
106101737|NCT00833638|366026768|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
105780817|NCT00283062|364848739|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
105780818|NCT00242658|364848740|FG000|Overall Study|Lost to Follow-up|22|||
105780819|NCT00242658|364848741|FG001|Overall Study|Lost to Follow-up|19|||
105780820|NCT00689728|364848742|FG000|Double-Blind Treatment|Adverse Event|1|||
105780821|NCT00689728|364848743|FG001|Double-Blind Treatment|Adverse Event|0|||
105780822|NCT00689728|364848744|FG002|Double-Blind Treatment|Adverse Event|0|||
105780823|NCT00689728|364848742|FG000|Double-Blind Treatment|Protocol Violation|0|||
105780824|NCT00689728|364848743|FG001|Double-Blind Treatment|Protocol Violation|0|||
105780825|NCT00689728|364848744|FG002|Double-Blind Treatment|Protocol Violation|1|||
105780826|NCT00689728|364848742|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
105780827|NCT00689728|364848743|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
105780828|NCT00689728|364848744|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
105780829|NCT00689728|364848742|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
106101738|NCT00833638|366026769|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
106101739|NCT00833638|366026770|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
105780830|NCT00689728|364848743|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
105780831|NCT00689728|364848744|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
105780832|NCT00689728|364848742|FG000|Rescue|Adverse Event|0|||
105780833|NCT00689728|364848743|FG001|Rescue|Adverse Event|1|||
105780834|NCT00689728|364848744|FG002|Rescue|Adverse Event|0|||
105780835|NCT00689728|364848742|FG000|Rescue|Withdrawal by Subject|1|||
105780836|NCT00689728|364848743|FG001|Rescue|Withdrawal by Subject|1|||
105780837|NCT00689728|364848744|FG002|Rescue|Withdrawal by Subject|1|||
105780838|NCT00689728|364848742|FG000|Optional Follow-Up|Adverse Event|1|||
105780839|NCT00689728|364848743|FG001|Optional Follow-Up|Adverse Event|0|||
105780840|NCT00689728|364848744|FG002|Optional Follow-Up|Adverse Event|0|||
105780841|NCT00689728|364848742|FG000|Optional Follow-Up|Lack of Efficacy|0|||
105780842|NCT00689728|364848743|FG001|Optional Follow-Up|Lack of Efficacy|1|||
105780843|NCT00689728|364848744|FG002|Optional Follow-Up|Lack of Efficacy|1|||
105780844|NCT00689728|364848742|FG000|Optional Follow-Up|Lost to Follow-up|0|||
105780845|NCT00689728|364848743|FG001|Optional Follow-Up|Lost to Follow-up|1|||
105780846|NCT00689728|364848744|FG002|Optional Follow-Up|Lost to Follow-up|1|||
105780847|NCT00689728|364848742|FG000|Optional Follow-Up|Protocol Violation|0|||
105780848|NCT00689728|364848743|FG001|Optional Follow-Up|Protocol Violation|0|||
105780849|NCT00689728|364848744|FG002|Optional Follow-Up|Protocol Violation|1|||
105780850|NCT00689728|364848742|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
105780851|NCT00689728|364848743|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
105780852|NCT00689728|364848744|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
105780853|NCT00517634|364848755|FG000|Second Treatment Period|Withdrawal by Subject|0|||
105780854|NCT00517634|364848756|FG001|Second Treatment Period|Withdrawal by Subject|0|||
105780855|NCT00517634|364848757|FG002|Second Treatment Period|Withdrawal by Subject|0|||
106101740|NCT00833638|366026768|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
106101741|NCT00833638|366026769|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
106101742|NCT00833638|366026770|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
106101743|NCT00833638|366026768|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
106101744|NCT00833638|366026769|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
106101745|NCT00833638|366026770|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
106101746|NCT00833638|366026768|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
106101747|NCT00833638|366026769|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
106101748|NCT00833638|366026770|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
106101749|NCT01864564|366026771|FG000|Overall Study|Lost to Follow-up|17|||
106101750|NCT01864564|366026772|FG001|Overall Study|Lost to Follow-up|23|||
106101751|NCT01864564|366026771|FG000|Overall Study|Withdrawal by Subject|20|||
106101752|NCT01864564|366026772|FG001|Overall Study|Withdrawal by Subject|11|||
106101753|NCT01864564|366026771|FG000|Overall Study|Protocol Violation|0|||
106101754|NCT01864564|366026772|FG001|Overall Study|Protocol Violation|27|||
106101755|NCT01864564|366026771|FG000|Overall Study|not reported|0|||
106101756|NCT01864564|366026772|FG001|Overall Study|not reported|34|||
106101757|NCT02269670|366026773|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
106101758|NCT00941330|366026774|FG000|Overall Study|Other|1|||
106101759|NCT00941330|366026775|FG001|Overall Study|Other|0|||
106101760|NCT00941330|366026774|FG000|Overall Study|Physician Decision|0|||
106101761|NCT00941330|366026775|FG001|Overall Study|Physician Decision|2|||
106101762|NCT02693665|366026776|FG000|Overall Study|Death|3|||
106101763|NCT02693665|366026777|FG001|Overall Study|Death|2|||
106101764|NCT02693665|366026776|FG000|Overall Study|Lost to Follow-up|7|||
106101765|NCT02693665|366026777|FG001|Overall Study|Lost to Follow-up|3|||
106101766|NCT02693665|366026776|FG000|Overall Study|Protocol Violation|1|||
106101767|NCT02693665|366026777|FG001|Overall Study|Protocol Violation|0|||
106101768|NCT02693665|366026776|FG000|Overall Study|Withdrawal by Subject|2|||
106101769|NCT02693665|366026777|FG001|Overall Study|Withdrawal by Subject|0|||
106101770|NCT02693665|366026776|FG000|Overall Study|patient wanted to leave it behind|1|||
106101771|NCT02693665|366026777|FG001|Overall Study|patient wanted to leave it behind|0|||
106101772|NCT02693665|366026776|FG000|Overall Study|anxiety|1|||
106101773|NCT02693665|366026777|FG001|Overall Study|anxiety|0|||
106101774|NCT02693665|366026776|FG000|Overall Study|family issues|1|||
106101775|NCT02693665|366026777|FG001|Overall Study|family issues|0|||
106101776|NCT02693665|366026776|FG000|Overall Study|no reason given|1|||
106101777|NCT02693665|366026777|FG001|Overall Study|no reason given|0|||
106101778|NCT01962493|366026780|FG000|Overall Study|Adverse Event|1|||
106101779|NCT01962493|366026781|FG001|Overall Study|Adverse Event|2|||
106101780|NCT01962493|366026780|FG000|Overall Study|Protocol Violation|0|||
105780856|NCT00517634|364848758|FG003|Second Treatment Period|Withdrawal by Subject|0|||
105780857|NCT00517634|364848759|FG004|Second Treatment Period|Withdrawal by Subject|1|||
105780858|NCT00517634|364848760|FG005|Second Treatment Period|Withdrawal by Subject|0|||
105780859|NCT03590613|364848761|FG000|Period 2, 4 Days|Physician Decision|0|||
105780860|NCT03590613|364848762|FG001|Period 2, 4 Days|Physician Decision|0|||
106101781|NCT01962493|366026781|FG001|Overall Study|Protocol Violation|1|||
106101782|NCT01962493|366026780|FG000|Overall Study|Withdrawal by Subject|4|||
106101783|NCT01962493|366026781|FG001|Overall Study|Withdrawal by Subject|2|||
106101784|NCT03776136|366026782|FG000|Overall Study|Death|85|||
106101785|NCT03776136|366026782|FG000|Overall Study|Withdrawal by Subject|3|||
106101786|NCT03776136|366026782|FG000|Overall Study|Sponsor Decision|15|||
106101787|NCT00655980|366026785|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
106101788|NCT00655980|366026786|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
106101789|NCT00655980|366026787|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
106101790|NCT01329029|366026788|FG000|Overall Study|Withdrawal by Subject|117|||
106101791|NCT01329029|366026789|FG001|Overall Study|Withdrawal by Subject|87|||
106101792|NCT01329029|366026788|FG000|Overall Study|Adverse Event|82|||
106101793|NCT01329029|366026789|FG001|Overall Study|Adverse Event|29|||
106101794|NCT01329029|366026788|FG000|Overall Study|Death|16|||
106101795|NCT01329029|366026789|FG001|Overall Study|Death|19|||
106101796|NCT01329029|366026788|FG000|Overall Study|Other|14|||
105780861|NCT03590613|364848763|FG002|Period 2, 4 Days|Physician Decision|0|||
105780862|NCT03590613|364848764|FG003|Period 2, 4 Days|Physician Decision|1|||
105780863|NCT02613910|364848766|FG000|Overall Study|Termination of study|1|||
105780864|NCT02993731|364848767|FG000|Overall Study|Study Termination|101|||
105780865|NCT02993731|364848768|FG001|Overall Study|Study Termination|105|||
105780866|NCT01503229|364850715|FG000|Overall Study|Withdrew consent|1|||
105780867|NCT01078389|364850716|FG000|Overall Study|Adverse Event|10|||
105780868|NCT01078389|364850717|FG001|Overall Study|Adverse Event|6|||
105780869|NCT01078389|364850716|FG000|Overall Study|Major Protocol Deviation|2|||
105780870|NCT01078389|364850717|FG001|Overall Study|Major Protocol Deviation|0|||
105780871|NCT01078389|364850716|FG000|Overall Study|Lost to Follow-up|23|||
105780872|NCT01078389|364850717|FG001|Overall Study|Lost to Follow-up|23|||
106101797|NCT01329029|366026789|FG001|Overall Study|Other|20|||
106101798|NCT01329029|366026788|FG000|Overall Study|COPD Exacerbation|11|||
105780873|NCT01078389|364850716|FG000|Overall Study|Voluntary Withdrawal|20|||
105780874|NCT01078389|364850717|FG001|Overall Study|Voluntary Withdrawal|36|||
105780875|NCT01078389|364850716|FG000|Overall Study|Other|9|||
105780876|NCT01078389|364850717|FG001|Overall Study|Other|2|||
105780877|NCT02028182|364850720|FG000|Overall Study|Protocol Violation|2|||
105780878|NCT02198040|364850721|FG000|Overall Study|Work reasons|0|||
105780879|NCT02198040|364850722|FG001|Overall Study|Work reasons|1|||
105780880|NCT02198040|364850723|FG002|Overall Study|Work reasons|0|||
105780881|NCT02198040|364850721|FG000|Overall Study|Withdrawal by Subject|0|||
105780882|NCT02198040|364850722|FG001|Overall Study|Withdrawal by Subject|0|||
105780883|NCT02198040|364850723|FG002|Overall Study|Withdrawal by Subject|1|||
105780884|NCT00711009|364850724|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
105780885|NCT00711009|364850725|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
105780886|NCT00711009|364850724|FG000|Overall Study|Withdrawal by Subject|4|||
105780887|NCT00711009|364850725|FG001|Overall Study|Withdrawal by Subject|2|||
105780888|NCT00711009|364850724|FG000|Overall Study|Lost to Follow-up|3|||
105780889|NCT00711009|364850725|FG001|Overall Study|Lost to Follow-up|9|||
105780890|NCT00711009|364850724|FG000|Overall Study|Participant Noncompliant|0|||
105780891|NCT00711009|364850725|FG001|Overall Study|Participant Noncompliant|1|||
105780892|NCT00711009|364850724|FG000|Overall Study|Virologic Failure|2|||
105780893|NCT00711009|364850725|FG001|Overall Study|Virologic Failure|1|||
105780894|NCT00711009|364850724|FG000|Overall Study|Pregnancy|1|||
105780895|NCT00711009|364850725|FG001|Overall Study|Pregnancy|0|||
105780896|NCT00711009|364850724|FG000|Overall Study|Site closing|0|||
105780897|NCT00711009|364850725|FG001|Overall Study|Site closing|1|||
105780898|NCT00711009|364850724|FG000|Overall Study|Dose adjustment|1|||
105780899|NCT00711009|364850725|FG001|Overall Study|Dose adjustment|0|||
105780900|NCT00911508|364850726|FG000|Overall Study|Lost to Follow-up|27|||
105780901|NCT00911508|364850727|FG001|Overall Study|Lost to Follow-up|18|||
106101799|NCT01329029|366026789|FG001|Overall Study|COPD Exacerbation|18|||
106101800|NCT01329029|366026788|FG000|Overall Study|Physician Decision|16|||
106101801|NCT01329029|366026789|FG001|Overall Study|Physician Decision|13|||
106101802|NCT01329029|366026788|FG000|Overall Study|Lost to Follow-up|8|||
106101803|NCT01329029|366026789|FG001|Overall Study|Lost to Follow-up|5|||
106101804|NCT01329029|366026788|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
106101805|NCT01329029|366026789|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
106101806|NCT00156065|366029110|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
106101807|NCT00156065|366029111|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
106101808|NCT00156065|366029112|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
106101809|NCT00156065|366029110|FG000|Overall Study|Adverse Event|8|||
106101810|NCT00156065|366029111|FG001|Overall Study|Adverse Event|11|||
106101811|NCT00156065|366029112|FG002|Overall Study|Adverse Event|4|||
106101812|NCT00156065|366029110|FG000|Overall Study|Lack of Efficacy|2|||
106101813|NCT00156065|366029111|FG001|Overall Study|Lack of Efficacy|9|||
106101814|NCT00156065|366029112|FG002|Overall Study|Lack of Efficacy|3|||
106101815|NCT00156065|366029110|FG000|Overall Study|Withdrawal by Subject|13|||
106101816|NCT00156065|366029111|FG001|Overall Study|Withdrawal by Subject|26|||
105780902|NCT00911508|364850726|FG000|Overall Study|Withdrawal by Subject|79|||
105780903|NCT00911508|364850727|FG001|Overall Study|Withdrawal by Subject|112|||
105780904|NCT00240331|364850728|FG000|Overall Study|Withdrawal by Subject|125|||
105780905|NCT00240331|364850729|FG001|Overall Study|Withdrawal by Subject|132|||
106101817|NCT00156065|366029112|FG002|Overall Study|Withdrawal by Subject|16|||
106101818|NCT00156065|366029110|FG000|Overall Study|Lost to Follow-up|5|||
106101819|NCT00156065|366029111|FG001|Overall Study|Lost to Follow-up|7|||
106101820|NCT00156065|366029112|FG002|Overall Study|Lost to Follow-up|1|||
106101821|NCT00156065|366029110|FG000|Overall Study|Other|2|||
106101822|NCT00156065|366029111|FG001|Overall Study|Other|9|||
106101823|NCT00156065|366029112|FG002|Overall Study|Other|3|||
105780906|NCT00240331|364850728|FG000|Overall Study|Option selected by investigator|1|||
105780907|NCT00240331|364850729|FG001|Overall Study|Option selected by investigator|2|||
106101824|NCT02985866|366029114|FG000|Overall Study|Poor CGM data|1|||
106101825|NCT02985866|366029115|FG001|Overall Study|Poor CGM data|1|||
106101826|NCT02008890|366029116|FG000|Period 1|Withdrawal by Subject|7|||
106101827|NCT02008890|366029117|FG001|Period 1|Withdrawal by Subject|7|||
105780908|NCT01409382|364850730|FG000|Overall Study|Lost to Follow-up|1|||
105780909|NCT01409382|364850731|FG001|Overall Study|Lost to Follow-up|1|||
105780910|NCT01409382|364850730|FG000|Overall Study|Protocol Violation|0|||
105780911|NCT01409382|364850731|FG001|Overall Study|Protocol Violation|3|||
105780912|NCT01409382|364850730|FG000|Overall Study|Multiple pregnancy|2|||
105780913|NCT01409382|364850731|FG001|Overall Study|Multiple pregnancy|4|||
105780914|NCT01409382|364850730|FG000|Overall Study|Still pregnant when study ended|13|||
105780915|NCT01409382|364850731|FG001|Overall Study|Still pregnant when study ended|2|||
105780916|NCT01409382|364850730|FG000|Overall Study|Did not manage to get pregnant|64|||
105780917|NCT01409382|364850731|FG001|Overall Study|Did not manage to get pregnant|70|||
105780918|NCT01409382|364850730|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
105780919|NCT01409382|364850731|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
105780920|NCT02491463|364850732|FG000|Overall Study|Withdrawal by Subject|1|||
105780921|NCT02491463|364850733|FG001|Overall Study|Withdrawal by Subject|2|||
105780922|NCT02491463|364850734|FG002|Overall Study|Withdrawal by Subject|0|||
105780923|NCT02491463|364850735|FG003|Overall Study|Withdrawal by Subject|0|||
105780924|NCT02491463|364850732|FG000|Overall Study|Migrated/moved from study area|1|||
105780925|NCT02491463|364850733|FG001|Overall Study|Migrated/moved from study area|5|||
105780926|NCT02491463|364850734|FG002|Overall Study|Migrated/moved from study area|1|||
105780927|NCT02491463|364850735|FG003|Overall Study|Migrated/moved from study area|1|||
105780928|NCT02491463|364850732|FG000|Overall Study|Lost to Follow-up|0|||
105780929|NCT02491463|364850733|FG001|Overall Study|Lost to Follow-up|3|||
105780930|NCT02491463|364850734|FG002|Overall Study|Lost to Follow-up|3|||
106101828|NCT02008890|366029118|FG002|Period 1|Withdrawal by Subject|5|||
106101829|NCT02008890|366029119|FG003|Period 1|Withdrawal by Subject|0|||
106101830|NCT02008890|366029120|FG004|Period 1|Withdrawal by Subject|0|||
106101831|NCT02008890|366029116|FG000|Period 1|Pregnancy|1|||
106101832|NCT02008890|366029117|FG001|Period 1|Pregnancy|0|||
106101833|NCT02008890|366029118|FG002|Period 1|Pregnancy|0|||
106101834|NCT02008890|366029119|FG003|Period 1|Pregnancy|0|||
106101835|NCT02008890|366029120|FG004|Period 1|Pregnancy|0|||
106101836|NCT02008890|366029116|FG000|Period 1|Physician Decision|1|||
106101837|NCT02008890|366029117|FG001|Period 1|Physician Decision|0|||
106101838|NCT02008890|366029118|FG002|Period 1|Physician Decision|1|||
106101839|NCT02008890|366029119|FG003|Period 1|Physician Decision|0|||
106101840|NCT02008890|366029120|FG004|Period 1|Physician Decision|0|||
106101841|NCT02008890|366029116|FG000|Period 1|Adverse Event|6|||
106101842|NCT02008890|366029117|FG001|Period 1|Adverse Event|8|||
106101843|NCT02008890|366029118|FG002|Period 1|Adverse Event|6|||
106101844|NCT02008890|366029119|FG003|Period 1|Adverse Event|0|||
106101845|NCT02008890|366029120|FG004|Period 1|Adverse Event|0|||
106101846|NCT02008890|366029116|FG000|Period 2|Adverse Event|12|||
106101847|NCT02008890|366029117|FG001|Period 2|Adverse Event|7|||
105780931|NCT02491463|364850735|FG003|Overall Study|Lost to Follow-up|0|||
105780932|NCT00039377|364850737|FG000|Initial Registration|Adverse Event|2|||
105780933|NCT00039377|364850738|FG001|Initial Registration|Adverse Event|0|||
105780934|NCT00039377|364850739|FG002|Initial Registration|Adverse Event|0|||
105780935|NCT00039377|364850740|FG003|Initial Registration|Adverse Event|0|||
105780936|NCT00039377|364850737|FG000|Initial Registration|Relapsed|6|||
105780937|NCT00039377|364850738|FG001|Initial Registration|Relapsed|0|||
105780938|NCT00039377|364850739|FG002|Initial Registration|Relapsed|0|||
105780939|NCT00039377|364850740|FG003|Initial Registration|Relapsed|0|||
105780940|NCT00039377|364850737|FG000|Initial Registration|Received non-protocol therapy|11|||
105780941|NCT00039377|364850738|FG001|Initial Registration|Received non-protocol therapy|0|||
106101848|NCT02008890|366029118|FG002|Period 2|Adverse Event|0|||
106101849|NCT02008890|366029119|FG003|Period 2|Adverse Event|5|||
106101850|NCT02008890|366029120|FG004|Period 2|Adverse Event|5|||
106101851|NCT02008890|366029116|FG000|Period 2|Withdrawal by Subject|11|||
106101852|NCT02008890|366029117|FG001|Period 2|Withdrawal by Subject|8|||
105780942|NCT00039377|364850739|FG002|Initial Registration|Received non-protocol therapy|0|||
105780943|NCT00039377|364850740|FG003|Initial Registration|Received non-protocol therapy|0|||
106101853|NCT02008890|366029118|FG002|Period 2|Withdrawal by Subject|0|||
106101854|NCT02008890|366029119|FG003|Period 2|Withdrawal by Subject|7|||
106101855|NCT02008890|366029120|FG004|Period 2|Withdrawal by Subject|2|||
106101856|NCT02008890|366029116|FG000|Period 2|Physician Decision|4|||
106101857|NCT02008890|366029117|FG001|Period 2|Physician Decision|0|||
106101858|NCT02008890|366029118|FG002|Period 2|Physician Decision|0|||
105780944|NCT00039377|364850737|FG000|Initial Registration|Withdrawal by Subject|3|||
105780945|NCT00039377|364850738|FG001|Initial Registration|Withdrawal by Subject|0|||
105780946|NCT00039377|364850739|FG002|Initial Registration|Withdrawal by Subject|0|||
105780947|NCT00039377|364850740|FG003|Initial Registration|Withdrawal by Subject|0|||
105780948|NCT01249404|364850744|FG000|Overall Study|Study treatment not received|0|||
105780949|NCT01249404|364850745|FG001|Overall Study|Study treatment not received|1|||
105780950|NCT01249404|364850746|FG002|Overall Study|Study treatment not received|2|||
105780951|NCT01249404|364850744|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
105780952|NCT01249404|364850745|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
105780953|NCT01249404|364850746|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
105780954|NCT01249404|364850744|FG000|Overall Study|Adverse Event|2|||
105780955|NCT01249404|364850745|FG001|Overall Study|Adverse Event|2|||
105780956|NCT01249404|364850746|FG002|Overall Study|Adverse Event|2|||
105780957|NCT01249404|364850744|FG000|Overall Study|Withdrawal by Subject|2|||
105780958|NCT01249404|364850745|FG001|Overall Study|Withdrawal by Subject|2|||
105780959|NCT01249404|364850746|FG002|Overall Study|Withdrawal by Subject|0|||
105780960|NCT01249404|364850744|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
105780961|NCT01249404|364850745|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
105780962|NCT01249404|364850746|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
105780963|NCT01249404|364850744|FG000|Overall Study|Non compliance to visit schedule|0|||
105780964|NCT01249404|364850745|FG001|Overall Study|Non compliance to visit schedule|1|||
105780965|NCT01249404|364850746|FG002|Overall Study|Non compliance to visit schedule|0|||
105780966|NCT01096017|364850752|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
105780967|NCT01096017|364850753|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
105780968|NCT02719028|364850759|FG000|Overall Study|Adverse Event|2|||
105780969|NCT02719028|364850760|FG001|Overall Study|Adverse Event|1|||
105780970|NCT02719028|364850761|FG002|Overall Study|Adverse Event|4|||
105780971|NCT02719028|364850762|FG003|Overall Study|Adverse Event|8|||
105780972|NCT02719028|364850759|FG000|Overall Study|Physician Decision|0|||
105780973|NCT02719028|364850760|FG001|Overall Study|Physician Decision|1|||
105780974|NCT02719028|364850761|FG002|Overall Study|Physician Decision|1|||
105780975|NCT02719028|364850762|FG003|Overall Study|Physician Decision|1|||
105780976|NCT02719028|364850759|FG000|Overall Study|Use of prohibited medication|0|||
105780977|NCT02719028|364850760|FG001|Overall Study|Use of prohibited medication|0|||
105780978|NCT02719028|364850761|FG002|Overall Study|Use of prohibited medication|1|||
105780979|NCT02719028|364850762|FG003|Overall Study|Use of prohibited medication|0|||
105780980|NCT02719028|364850759|FG000|Overall Study|Protocol Violation|0|||
105780981|NCT02719028|364850760|FG001|Overall Study|Protocol Violation|0|||
105780982|NCT02719028|364850761|FG002|Overall Study|Protocol Violation|0|||
105780983|NCT02719028|364850762|FG003|Overall Study|Protocol Violation|1|||
105780984|NCT01539720|364850763|FG000|Overall Study|Screen Fail|15|||
105780985|NCT01539720|364850764|FG001|Overall Study|Screen Fail|3|||
105780986|NCT01539720|364850763|FG000|Overall Study|Lost to Follow-up|14|||
105780987|NCT01539720|364850764|FG001|Overall Study|Lost to Follow-up|7|||
105780988|NCT00656136|364850773|FG000|Overall Study|Progressive disease|177|||
105780989|NCT00656136|364850774|FG001|Overall Study|Progressive disease|322|||
105780990|NCT00656136|364850773|FG000|Overall Study|Other Adverse Event|5|||
105780991|NCT00656136|364850774|FG001|Overall Study|Other Adverse Event|51|||
105780992|NCT00656136|364850773|FG000|Overall Study|Protocol Violation|2|||
105780993|NCT00656136|364850774|FG001|Overall Study|Protocol Violation|3|||
105780994|NCT00656136|364850773|FG000|Overall Study|Patient refused to take study medication|7|||
105780995|NCT00656136|364850774|FG001|Overall Study|Patient refused to take study medication|10|||
105780996|NCT00656136|364850773|FG000|Overall Study|Unknown and others|4|||
105780997|NCT00656136|364850774|FG001|Overall Study|Unknown and others|4|||
105780998|NCT02505945|364850775|FG000|Overall Study|Withdrawal by Subject|13|||
105780999|NCT02505945|364850776|FG001|Overall Study|Withdrawal by Subject|2|||
105781000|NCT02505945|364850775|FG000|Overall Study|Adverse Event|1|||
105781001|NCT02505945|364850776|FG001|Overall Study|Adverse Event|0|||
105781002|NCT02505945|364850775|FG000|Overall Study|Physician Decision|2|||
105781003|NCT02505945|364850776|FG001|Overall Study|Physician Decision|1|||
105781004|NCT02505945|364850775|FG000|Overall Study|Lost to Follow-up|6|||
105781005|NCT02505945|364850776|FG001|Overall Study|Lost to Follow-up|1|||
105781006|NCT01928758|364850777|FG000|Overall Study|Lost to Follow-up|14|||
105781007|NCT01928758|364850778|FG001|Overall Study|Lost to Follow-up|9|||
105781008|NCT01928758|364850777|FG000|Overall Study|Withdrawal by Subject|5|||
105781009|NCT01928758|364850778|FG001|Overall Study|Withdrawal by Subject|2|||
105781010|NCT01928758|364850777|FG000|Overall Study|Adverse Event|3|||
105781011|NCT01928758|364850778|FG001|Overall Study|Adverse Event|5|||
105781012|NCT01928758|364850777|FG000|Overall Study|Protocol Violation|3|||
105781013|NCT01928758|364850778|FG001|Overall Study|Protocol Violation|4|||
105781014|NCT01667731|364850779|FG000|Overall Study|Enrolled but not treated|0|||
105781015|NCT01667731|364850780|FG001|Overall Study|Enrolled but not treated|0|||
105781016|NCT01667731|364850781|FG002|Overall Study|Enrolled but not treated|0|||
105781017|NCT01667731|364850782|FG003|Overall Study|Enrolled but not treated|0|||
105781018|NCT01667731|364850783|FG004|Overall Study|Enrolled but not treated|1|||
105781019|NCT01667731|364850779|FG000|Overall Study|Efficacy Failure|1|||
105781020|NCT01667731|364850780|FG001|Overall Study|Efficacy Failure|12|||
105781021|NCT01667731|364850781|FG002|Overall Study|Efficacy Failure|0|||
105781022|NCT01667731|364850782|FG003|Overall Study|Efficacy Failure|1|||
105781023|NCT01667731|364850783|FG004|Overall Study|Efficacy Failure|24|||
105781024|NCT01667731|364850779|FG000|Overall Study|Lost to Follow-up|2|||
105781025|NCT01667731|364850780|FG001|Overall Study|Lost to Follow-up|3|||
105781026|NCT01667731|364850781|FG002|Overall Study|Lost to Follow-up|1|||
105781027|NCT01667731|364850782|FG003|Overall Study|Lost to Follow-up|1|||
105781028|NCT01667731|364850783|FG004|Overall Study|Lost to Follow-up|2|||
105781029|NCT01667731|364850779|FG000|Overall Study|Subject Withdrew Consent|2|||
105781030|NCT01667731|364850780|FG001|Overall Study|Subject Withdrew Consent|0|||
105781031|NCT01667731|364850781|FG002|Overall Study|Subject Withdrew Consent|1|||
105781032|NCT01667731|364850782|FG003|Overall Study|Subject Withdrew Consent|0|||
105781033|NCT01667731|364850783|FG004|Overall Study|Subject Withdrew Consent|1|||
105781034|NCT01667731|364850779|FG000|Overall Study|Death|0|||
105781035|NCT01667731|364850780|FG001|Overall Study|Death|1|||
105781036|NCT01667731|364850781|FG002|Overall Study|Death|0|||
105781037|NCT01667731|364850782|FG003|Overall Study|Death|0|||
105781038|NCT01667731|364850783|FG004|Overall Study|Death|0|||
105781039|NCT01425268|364850788|FG000|Overall Study|Withdrawal by Subject|2|||
105781040|NCT01425268|364850789|FG001|Overall Study|Withdrawal by Subject|0|||
105781041|NCT01425268|364850788|FG000|Overall Study|Sponsor Decision|5|||
105781042|NCT01425268|364850789|FG001|Overall Study|Sponsor Decision|0|||
105781043|NCT01425268|364850788|FG000|Overall Study|Physician Decision|1|||
105781044|NCT01425268|364850789|FG001|Overall Study|Physician Decision|0|||
105781045|NCT01101321|364850790|FG000|Period 1|Withdrawal by Subject|1|||
105781046|NCT01101321|364850791|FG001|Period 1|Withdrawal by Subject|1|||
105781047|NCT01101321|364850790|FG000|Period 1|Adverse Event|3|||
105781048|NCT01101321|364850791|FG001|Period 1|Adverse Event|3|||
105781049|NCT00719706|364850792|FG000|Overall Study|Adverse Event|5|||
105781050|NCT00719706|364850793|FG001|Overall Study|Adverse Event|4|||
105781051|NCT00719706|364850792|FG000|Overall Study|Withdrawal by Subject|1|||
105781052|NCT00719706|364850793|FG001|Overall Study|Withdrawal by Subject|2|||
105781053|NCT00719706|364850792|FG000|Overall Study|Protocol Violation|3|||
105781054|NCT00719706|364850793|FG001|Overall Study|Protocol Violation|0|||
105781055|NCT03633461|364850794|FG000|Overall Study|Lost to Follow-up|0|||
105781056|NCT03633461|364850795|FG001|Overall Study|Lost to Follow-up|1|||
105781057|NCT03938857|364850800|FG000|Overall Study|Physician Decision|1|||
105781058|NCT03938857|364850801|FG001|Overall Study|Physician Decision|0|||
105781059|NCT03938857|364850802|FG002|Overall Study|Physician Decision|0|||
105781060|NCT03938857|364850803|FG003|Overall Study|Physician Decision|0|||
105781061|NCT02406586|364850804|FG000|Overall Study|Lost to Follow-up|0|||
105781062|NCT02406586|364850805|FG001|Overall Study|Lost to Follow-up|4|||
105781063|NCT02406586|364850806|FG002|Overall Study|Lost to Follow-up|2|||
105781064|NCT02406586|364850804|FG000|Overall Study|Withdrawal by Subject|1|||
105781065|NCT02406586|364850805|FG001|Overall Study|Withdrawal by Subject|0|||
105781066|NCT02406586|364850806|FG002|Overall Study|Withdrawal by Subject|0|||
105781067|NCT03198559|364850807|FG000|Overall Study|Adverse Event|2|||
105781068|NCT02577107|364850808|FG000|Overall Study|Protocol deviation|0|||
105781069|NCT02577107|364850809|FG001|Overall Study|Protocol deviation|1|||
105781070|NCT02516605|364850810|FG000|Overall Study|Protocol Violation|0|||
105781071|NCT02516605|364850811|FG001|Overall Study|Protocol Violation|0|||
105781072|NCT02516605|364850812|FG002|Overall Study|Protocol Violation|0|||
105781073|NCT02516605|364850813|FG003|Overall Study|Protocol Violation|0|||
105781074|NCT02516605|364850814|FG004|Overall Study|Protocol Violation|1|||
105781075|NCT02516605|364850810|FG000|Overall Study|Withdrawal by Subject|0|||
105781076|NCT02516605|364850811|FG001|Overall Study|Withdrawal by Subject|0|||
105781077|NCT02516605|364850812|FG002|Overall Study|Withdrawal by Subject|0|||
105781078|NCT02516605|364850813|FG003|Overall Study|Withdrawal by Subject|1|||
105781079|NCT02516605|364850814|FG004|Overall Study|Withdrawal by Subject|0|||
105781080|NCT00682539|364850815|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
105781081|NCT00682539|364850816|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
105781082|NCT00682539|364850817|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
105781083|NCT00682539|364850815|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
105781084|NCT00682539|364850816|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
105781085|NCT00682539|364850817|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
105781086|NCT00679354|364850818|FG000|Overall Study|Death|3|||
105781087|NCT00679354|364850818|FG000|Overall Study|Lack of Efficacy|22|||
105781088|NCT00679354|364850818|FG000|Overall Study|Physician Decision|4|||
105781089|NCT00679354|364850818|FG000|Overall Study|Ineligible|1|||
105781090|NCT03764813|364850823|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
105781091|NCT03764813|364850824|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
105781092|NCT03764813|364850825|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
105781093|NCT03764813|364850826|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
105781094|NCT02898662|364850829|FG000|Overall Study|Adverse Event|1|||
105781095|NCT02898662|364850830|FG001|Overall Study|Adverse Event|0|||
105781096|NCT02898662|364850829|FG000|Overall Study|Loss of asthma control|23|||
105781097|NCT02898662|364850830|FG001|Overall Study|Loss of asthma control|24|||
106101859|NCT02008890|366029119|FG003|Period 2|Physician Decision|2|||
105781098|NCT02898662|364850829|FG000|Overall Study|Withdrawal by Subject|4|||
105781099|NCT02898662|364850830|FG001|Overall Study|Withdrawal by Subject|1|||
105781100|NCT02898662|364850829|FG000|Overall Study|Technical issue|0|||
105781101|NCT02898662|364850830|FG001|Overall Study|Technical issue|1|||
105781102|NCT02898662|364850829|FG000|Overall Study|Randomized in error|0|||
105781103|NCT02898662|364850830|FG001|Overall Study|Randomized in error|1|||
105781104|NCT02898662|364850829|FG000|Overall Study|Subject decision|1|||
105781105|NCT02898662|364850830|FG001|Overall Study|Subject decision|0|||
105781106|NCT02898662|364850829|FG000|Overall Study|Other|0|||
105781107|NCT02898662|364850830|FG001|Overall Study|Other|1|||
105781108|NCT00267202|364850831|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
105781109|NCT00267202|364850832|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105781110|NCT00267202|364850831|FG000|Overall Study|Withdrawal by Subject|12|||
105781111|NCT00267202|364850832|FG001|Overall Study|Withdrawal by Subject|15|||
105781112|NCT00267202|364850831|FG000|Overall Study|Adverse Event|13|||
105781113|NCT00267202|364850832|FG001|Overall Study|Adverse Event|7|||
105781114|NCT00267202|364850831|FG000|Overall Study|Protocol Violation|2|||
105781115|NCT00267202|364850832|FG001|Overall Study|Protocol Violation|3|||
105781116|NCT00267202|364850831|FG000|Overall Study|Administrative problems|2|||
105781117|NCT00267202|364850832|FG001|Overall Study|Administrative problems|1|||
105781118|NCT00267202|364850831|FG000|Overall Study|Lost to Follow-up|3|||
105781119|NCT00267202|364850832|FG001|Overall Study|Lost to Follow-up|0|||
105781120|NCT04382066|364850834|FG000|Overall Study|Adverse Event|1|||
105781121|NCT04382066|364850835|FG001|Overall Study|Adverse Event|0|||
105781122|NCT04382066|364850836|FG002|Overall Study|Adverse Event|0|||
105781123|NCT04382066|364850834|FG000|Overall Study|Death|1|||
105781124|NCT04382066|364850835|FG001|Overall Study|Death|0|||
105781125|NCT04382066|364850836|FG002|Overall Study|Death|1|||
105781126|NCT00174460|364850842|FG000|Overall Study|Withdrawal by Subject|0|||
105781127|NCT00174460|364850843|FG001|Overall Study|Withdrawal by Subject|1|||
105781128|NCT04225026|364850844|FG000|Overall Study|Withdrawal by Subject|4|||
105781129|NCT04225026|364850844|FG000|Overall Study|Adverse Event|1|||
105781130|NCT04225026|364850844|FG000|Overall Study|Other|1|||
105781131|NCT04225026|364850844|FG000|Overall Study|Death|11|||
105781132|NCT04225026|364850844|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
105781133|NCT00334893|364850845|FG000|Overall Study|Not Treated|1|||
105781134|NCT00334893|364850846|FG001|Overall Study|Not Treated|0|||
105781135|NCT00779506|364850849|FG000|Overall Study|Screening Failed|2|||
105781136|NCT00779506|364850849|FG000|Overall Study|Adverse Event|4|||
105781137|NCT00779506|364850849|FG000|Overall Study|Lack of Efficacy|11|||
105781138|NCT00779506|364850849|FG000|Overall Study|Protocol Violation|5|||
105781139|NCT00779506|364850849|FG000|Overall Study|Withdrawal by Subject|6|||
105781140|NCT00779506|364850849|FG000|Overall Study|Lost to Follow-up|1|||
105781141|NCT01303159|364850852|FG000|Overall Study|Death|16|||
105781142|NCT01303159|364850852|FG000|Overall Study|Study Termination|7|||
105781143|NCT03258710|364850857|FG000|Overall Study|Adverse Event|1|||
105781144|NCT03258710|364850857|FG000|Overall Study|Protocol-defined stopping criteria|1|||
105781145|NCT03258710|364850857|FG000|Overall Study|Physician Decision|1|||
105781146|NCT03451630|364850858|FG000|Overall Study|Death|15|||
105781147|NCT03451630|364850859|FG001|Overall Study|Death|16|||
105781148|NCT03451630|364850860|FG002|Overall Study|Death|11|||
105781149|NCT03451630|364850858|FG000|Overall Study|Lost to Follow-up|9|||
105781150|NCT03451630|364850859|FG001|Overall Study|Lost to Follow-up|0|||
105781151|NCT03451630|364850860|FG002|Overall Study|Lost to Follow-up|4|||
105781152|NCT03451630|364850858|FG000|Overall Study|Withdrawal by Subject|0|||
105781153|NCT03451630|364850859|FG001|Overall Study|Withdrawal by Subject|3|||
105781154|NCT03451630|364850860|FG002|Overall Study|Withdrawal by Subject|0|||
105781155|NCT03451630|364850858|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
105781156|NCT03451630|364850859|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
105781157|NCT03451630|364850860|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
105781158|NCT01724021|364850863|FG000|Overall Study|Adverse Event|11|||
105781159|NCT01724021|364850864|FG001|Overall Study|Adverse Event|6|||
105781160|NCT01724021|364850863|FG000|Overall Study|Death|46|||
105781161|NCT01724021|364850864|FG001|Overall Study|Death|58|||
105781162|NCT01724021|364850863|FG000|Overall Study|Participant request/ Withdrew consent|18|||
105781163|NCT01724021|364850864|FG001|Overall Study|Participant request/ Withdrew consent|14|||
105781164|NCT01724021|364850863|FG000|Overall Study|Lost to Follow-up|15|||
105781165|NCT01724021|364850864|FG001|Overall Study|Lost to Follow-up|15|||
105781166|NCT01724021|364850863|FG000|Overall Study|Reason Not Specified|36|||
105781167|NCT01724021|364850864|FG001|Overall Study|Reason Not Specified|39|||
105781168|NCT01724021|364850863|FG000|Overall Study|Missing|1|||
105781169|NCT01724021|364850864|FG001|Overall Study|Missing|1|||
105781170|NCT00486720|364850867|FG000|Overall Study|Adverse Event|1|||
105781171|NCT00486720|364850868|FG001|Overall Study|Adverse Event|2|||
105781172|NCT00486720|364850867|FG000|Overall Study|Lack of Efficacy|4|||
105781173|NCT00486720|364850868|FG001|Overall Study|Lack of Efficacy|6|||
105781174|NCT00486720|364850867|FG000|Overall Study|Physician Decision|1|||
105781175|NCT00486720|364850868|FG001|Overall Study|Physician Decision|2|||
105781176|NCT00486720|364850867|FG000|Overall Study|Protocol Violation|1|||
106101860|NCT02008890|366029120|FG004|Period 2|Physician Decision|1|||
106101861|NCT02008890|366029116|FG000|Period 2|Lost to Follow-up|0|||
106101862|NCT02008890|366029117|FG001|Period 2|Lost to Follow-up|0|||
106101863|NCT02008890|366029118|FG002|Period 2|Lost to Follow-up|1|||
106101864|NCT02008890|366029119|FG003|Period 2|Lost to Follow-up|0|||
106101865|NCT02008890|366029120|FG004|Period 2|Lost to Follow-up|0|||
106101866|NCT02008890|366029116|FG000|Extension Period|Withdrawal by Subject|3|||
106101867|NCT02008890|366029117|FG001|Extension Period|Withdrawal by Subject|2|||
106101868|NCT02008890|366029118|FG002|Extension Period|Withdrawal by Subject|0|||
106101869|NCT02008890|366029119|FG003|Extension Period|Withdrawal by Subject|4|||
106101870|NCT02008890|366029120|FG004|Extension Period|Withdrawal by Subject|2|||
106101871|NCT02008890|366029116|FG000|Extension Period|Lost to Follow-up|1|||
106101872|NCT02008890|366029117|FG001|Extension Period|Lost to Follow-up|0|||
106101873|NCT02008890|366029118|FG002|Extension Period|Lost to Follow-up|0|||
105781177|NCT00486720|364850868|FG001|Overall Study|Protocol Violation|0|||
105781178|NCT00486720|364850867|FG000|Overall Study|Withdrawal by Subject|3|||
105781179|NCT00486720|364850868|FG001|Overall Study|Withdrawal by Subject|1|||
105781180|NCT00486720|364850867|FG000|Overall Study|Progressive Disease|0|||
105781181|NCT00486720|364850868|FG001|Overall Study|Progressive Disease|1|||
105781182|NCT00955682|364850869|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
105781183|NCT00955682|364850870|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
105781184|NCT02041533|364850874|FG000|Pre-Treatment Period|Disease Progression|1|||
105781185|NCT02041533|364850875|FG001|Pre-Treatment Period|Disease Progression|1|||
105781186|NCT02041533|364850874|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
105781187|NCT02041533|364850875|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
105781188|NCT02041533|364850874|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
105781189|NCT02041533|364850875|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
105781190|NCT02041533|364850874|FG000|Treatment Period|Disease progression|189|||
105781191|NCT02041533|364850875|FG001|Treatment Period|Disease progression|146|||
105781192|NCT02041533|364850874|FG000|Treatment Period|Study drug toxicity|30|||
105781193|NCT02041533|364850875|FG001|Treatment Period|Study drug toxicity|34|||
105781194|NCT02041533|364850874|FG000|Treatment Period|Death|1|||
105781195|NCT02041533|364850875|FG001|Treatment Period|Death|0|||
105781196|NCT02041533|364850874|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
105781197|NCT02041533|364850875|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
105781198|NCT02041533|364850874|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
105781199|NCT02041533|364850875|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
105781200|NCT02041533|364850874|FG000|Treatment Period|Participant withdrew consent|2|||
105781201|NCT02041533|364850875|FG001|Treatment Period|Participant withdrew consent|2|||
105781202|NCT02041533|364850874|FG000|Treatment Period|Maximum clinical benefit|0|||
105781203|NCT02041533|364850875|FG001|Treatment Period|Maximum clinical benefit|18|||
105781204|NCT02041533|364850874|FG000|Treatment Period|Poor/Non-compliance|1|||
105781205|NCT02041533|364850875|FG001|Treatment Period|Poor/Non-compliance|0|||
105781206|NCT02041533|364850874|FG000|Treatment Period|Administrative reason by sponsor|1|||
105781207|NCT02041533|364850875|FG001|Treatment Period|Administrative reason by sponsor|0|||
105781208|NCT02041533|364850874|FG000|Treatment Period|Other reasons|9|||
105781209|NCT02041533|364850875|FG001|Treatment Period|Other reasons|2|||
105781210|NCT02041533|364850874|FG000|Treatment Period|Not Reported|0|||
105781211|NCT02041533|364850875|FG001|Treatment Period|Not Reported|1|||
105781212|NCT01756846|364850876|FG000|Overall Study|Lost to Follow-up|5|||
105781213|NCT01756846|364850877|FG001|Overall Study|Lost to Follow-up|10|||
105781214|NCT01756846|364850876|FG000|Overall Study|Withdrawal by Subject|1|||
106101874|NCT02008890|366029119|FG003|Extension Period|Lost to Follow-up|0|||
106101875|NCT02008890|366029120|FG004|Extension Period|Lost to Follow-up|0|||
106101876|NCT02008890|366029116|FG000|Extension Period|Adverse Event|1|||
106101877|NCT02008890|366029117|FG001|Extension Period|Adverse Event|3|||
106101878|NCT02008890|366029118|FG002|Extension Period|Adverse Event|0|||
106101879|NCT02008890|366029119|FG003|Extension Period|Adverse Event|0|||
106101880|NCT02008890|366029120|FG004|Extension Period|Adverse Event|2|||
106101881|NCT02216123|366029121|FG000|Overall Study|Lost to Follow-up|4|||
106101882|NCT02216123|366029122|FG001|Overall Study|Lost to Follow-up|2|||
106101883|NCT02216123|366029121|FG000|Overall Study|Withdrawal by Subject|2|||
106101884|NCT02216123|366029122|FG001|Overall Study|Withdrawal by Subject|0|||
106101885|NCT03166618|366029123|FG000|Overall Study|Study was Terminated|0|||
106101886|NCT03166618|366029124|FG001|Overall Study|Study was Terminated|1|||
105781215|NCT01756846|364850877|FG001|Overall Study|Withdrawal by Subject|2|||
105781216|NCT01497899|364850878|FG000|Double-Blind Phase|Randomized but not Treated|1|||
105781217|NCT01497899|364850879|FG001|Double-Blind Phase|Randomized but not Treated|0|||
105781218|NCT01497899|364850880|FG002|Double-Blind Phase|Randomized but not Treated|0|||
105781219|NCT01497899|364850881|FG003|Double-Blind Phase|Randomized but not Treated|0|||
106101887|NCT02502266|366029125|FG000|Overall Study|Adverse Event|0|||
106101888|NCT02502266|366029126|FG001|Overall Study|Adverse Event|0|||
106101889|NCT02502266|366029127|FG002|Overall Study|Adverse Event|0|||
105781220|NCT01497899|364850878|FG000|Double-Blind Phase|Adverse Event|1|||
105781221|NCT01497899|364850879|FG001|Double-Blind Phase|Adverse Event|0|||
105781222|NCT01497899|364850880|FG002|Double-Blind Phase|Adverse Event|0|||
105781223|NCT01497899|364850881|FG003|Double-Blind Phase|Adverse Event|0|||
105781224|NCT01497899|364850878|FG000|Double-Blind Phase|Lack of Efficacy|0|||
105781225|NCT01497899|364850879|FG001|Double-Blind Phase|Lack of Efficacy|1|||
105781226|NCT01497899|364850880|FG002|Double-Blind Phase|Lack of Efficacy|0|||
105781227|NCT01497899|364850881|FG003|Double-Blind Phase|Lack of Efficacy|0|||
105781228|NCT01497899|364850878|FG000|Double-Blind Phase|Investigator's Discretion|1|||
105781229|NCT01497899|364850879|FG001|Double-Blind Phase|Investigator's Discretion|0|||
105781230|NCT01497899|364850880|FG002|Double-Blind Phase|Investigator's Discretion|0|||
105781231|NCT01497899|364850881|FG003|Double-Blind Phase|Investigator's Discretion|0|||
105781232|NCT01497899|364850878|FG000|Double-Blind Phase|Withdrew Consent|0|||
105781233|NCT01497899|364850879|FG001|Double-Blind Phase|Withdrew Consent|1|||
105781234|NCT01497899|364850880|FG002|Double-Blind Phase|Withdrew Consent|0|||
105781235|NCT01497899|364850881|FG003|Double-Blind Phase|Withdrew Consent|0|||
105781236|NCT01497899|364850878|FG000|Double-Blind Phase|Lost to Follow-up|3|||
105781237|NCT01497899|364850879|FG001|Double-Blind Phase|Lost to Follow-up|2|||
105781238|NCT01497899|364850880|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105781239|NCT01497899|364850881|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105781240|NCT01497899|364850878|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
105781241|NCT01497899|364850879|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
105781242|NCT01497899|364850880|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
105781243|NCT01497899|364850881|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
105781244|NCT01497899|364850878|FG000|Open-Label Extension Phase|Adverse Event|1|||
105781245|NCT01497899|364850879|FG001|Open-Label Extension Phase|Adverse Event|0|||
105781246|NCT01497899|364850880|FG002|Open-Label Extension Phase|Adverse Event|0|||
105781247|NCT01497899|364850881|FG003|Open-Label Extension Phase|Adverse Event|0|||
105781248|NCT01497899|364850878|FG000|Open-Label Extension Phase|Death|1|||
105781249|NCT01497899|364850879|FG001|Open-Label Extension Phase|Death|0|||
105781250|NCT01497899|364850880|FG002|Open-Label Extension Phase|Death|0|||
105781251|NCT01497899|364850881|FG003|Open-Label Extension Phase|Death|0|||
105781252|NCT01497899|364850878|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
105781253|NCT01497899|364850879|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
105781254|NCT01497899|364850880|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
105781255|NCT01497899|364850881|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
105781256|NCT01497899|364850878|FG000|Open-Label Extension Phase|Pregnancy|0|||
105781257|NCT01497899|364850879|FG001|Open-Label Extension Phase|Pregnancy|1|||
105781258|NCT01497899|364850880|FG002|Open-Label Extension Phase|Pregnancy|1|||
105781259|NCT01497899|364850881|FG003|Open-Label Extension Phase|Pregnancy|0|||
105781260|NCT01497899|364850878|FG000|Open-Label Extension Phase|Protocol Violation|0|||
105781261|NCT01497899|364850879|FG001|Open-Label Extension Phase|Protocol Violation|0|||
105781262|NCT01497899|364850880|FG002|Open-Label Extension Phase|Protocol Violation|1|||
105781263|NCT01497899|364850881|FG003|Open-Label Extension Phase|Protocol Violation|0|||
105781264|NCT01497899|364850878|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
105781265|NCT01497899|364850879|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
105781266|NCT01497899|364850880|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
105781267|NCT01497899|364850881|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
105781268|NCT00701064|364850884|FG000|Overall Study|Protocol Violation|1|||
105781269|NCT00701064|364850885|FG001|Overall Study|Protocol Violation|1|||
105781270|NCT00701064|364850884|FG000|Overall Study|Withdrawal by Subject|1|||
105781271|NCT00701064|364850885|FG001|Overall Study|Withdrawal by Subject|1|||
105781272|NCT00701064|364850884|FG000|Overall Study|initiated other PTSD treatment|2|||
105781273|NCT00701064|364850885|FG001|Overall Study|initiated other PTSD treatment|2|||
105781274|NCT01791543|364850886|FG000|Overall Study|Lost to Follow-up|1|||
105781275|NCT01791543|364850886|FG000|Overall Study|Adverse Event|1|||
105781276|NCT00323479|364850890|FG000|Overall Study|Adverse Event|2|||
105781277|NCT00323479|364850890|FG000|Overall Study|Withdrawal by Subject|2|||
105781278|NCT00323479|364850890|FG000|Overall Study|Protocol Violation|3|||
105781279|NCT00323479|364850890|FG000|Overall Study|house moving|1|||
105781280|NCT02361307|364852873|FG000|Overall Study|Unstable medical condition.|0|||
105781281|NCT02361307|364852874|FG001|Overall Study|Unstable medical condition.|1|||
105781282|NCT01682876|364852875|FG000|Overall Study|Administrative reason|4|||
105781283|NCT01682876|364852876|FG001|Overall Study|Administrative reason|4|||
105781284|NCT01682876|364852877|FG002|Overall Study|Administrative reason|0|||
105781285|NCT01682876|364852878|FG003|Overall Study|Administrative reason|3|||
105781286|NCT01682876|364852875|FG000|Overall Study|Adverse Event|0|||
105781287|NCT01682876|364852876|FG001|Overall Study|Adverse Event|0|||
105781288|NCT01682876|364852877|FG002|Overall Study|Adverse Event|0|||
105781289|NCT01682876|364852878|FG003|Overall Study|Adverse Event|1|||
105781290|NCT01682876|364852875|FG000|Overall Study|Lost to Follow-up|11|||
105781291|NCT01682876|364852876|FG001|Overall Study|Lost to Follow-up|15|||
105781292|NCT01682876|364852877|FG002|Overall Study|Lost to Follow-up|9|||
105781293|NCT01682876|364852878|FG003|Overall Study|Lost to Follow-up|11|||
105781294|NCT01682876|364852875|FG000|Overall Study|Protocol Violation|1|||
105781295|NCT01682876|364852876|FG001|Overall Study|Protocol Violation|1|||
105781296|NCT01682876|364852877|FG002|Overall Study|Protocol Violation|1|||
105781297|NCT01682876|364852878|FG003|Overall Study|Protocol Violation|1|||
105781298|NCT01682876|364852875|FG000|Overall Study|Withdrawal by Subject|4|||
105781299|NCT01682876|364852876|FG001|Overall Study|Withdrawal by Subject|0|||
105781300|NCT01682876|364852877|FG002|Overall Study|Withdrawal by Subject|0|||
105781301|NCT01682876|364852878|FG003|Overall Study|Withdrawal by Subject|2|||
105781302|NCT01682876|364852875|FG000|Overall Study|Other|1|||
105781303|NCT01682876|364852876|FG001|Overall Study|Other|0|||
105781304|NCT01682876|364852877|FG002|Overall Study|Other|1|||
105781305|NCT01682876|364852878|FG003|Overall Study|Other|1|||
105781306|NCT02551874|364852887|FG000|Overall Study|Lost to Follow-up|0|||
105781307|NCT02551874|364852888|FG001|Overall Study|Lost to Follow-up|2|||
105781308|NCT02551874|364852887|FG000|Overall Study|Pregnancy|0|||
105781309|NCT02551874|364852888|FG001|Overall Study|Pregnancy|1|||
105781310|NCT02551874|364852887|FG000|Overall Study|Reason not reported|10|||
105781311|NCT02551874|364852888|FG001|Overall Study|Reason not reported|4|||
105781312|NCT02551874|364852887|FG000|Overall Study|Did not receive randomized treatment|0|||
105781313|NCT02551874|364852888|FG001|Overall Study|Did not receive randomized treatment|7|||
105781314|NCT02551874|364852887|FG000|Overall Study|Did not enter long-term study|18|||
105781315|NCT02551874|364852888|FG001|Overall Study|Did not enter long-term study|25|||
105781316|NCT03730987|364852891|FG000|Overall Study|Lost to Follow-up|2|||
105781317|NCT03730987|364852892|FG001|Overall Study|Lost to Follow-up|0|||
105781318|NCT03730987|364852893|FG002|Overall Study|Lost to Follow-up|2|||
105781319|NCT03730987|364852894|FG003|Overall Study|Lost to Follow-up|0|||
105781320|NCT02718131|364852895|FG000|Overall Study|Withdrawal by Subject|1|||
105781321|NCT02718131|364852896|FG001|Overall Study|Withdrawal by Subject|0|||
105781322|NCT02718131|364852895|FG000|Overall Study|Adverse Event|1|||
105781323|NCT02718131|364852896|FG001|Overall Study|Adverse Event|0|||
105781324|NCT02718131|364852895|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
105781325|NCT02718131|364852896|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
105781326|NCT01474291|364852903|FG000|Overall Study|Not Evaluable for Efficacy|26|||
105781327|NCT01474291|364852903|FG000|Overall Study|Lack of Treatment Efficacy|88|||
105781328|NCT01474291|364852903|FG000|Overall Study|Adverse Event|53|||
105781329|NCT01474291|364852903|FG000|Overall Study|Lost to Follow-up|29|||
105781330|NCT01474291|364852903|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
105781331|NCT01474291|364852903|FG000|Overall Study|No Reason Reported|10|||
105781332|NCT01474291|364852903|FG000|Overall Study|Death|2|||
105781333|NCT00310440|364852904|FG000|Overall Study|Lost to Follow-up|17|||
105781334|NCT00310440|364852905|FG001|Overall Study|Lost to Follow-up|8|||
105781335|NCT00310440|364852904|FG000|Overall Study|Withdrawal by Subject|2|||
105781336|NCT00310440|364852905|FG001|Overall Study|Withdrawal by Subject|1|||
105781337|NCT00310440|364852904|FG000|Overall Study|Missed 12 Month Visit|7|||
105781338|NCT00310440|364852905|FG001|Overall Study|Missed 12 Month Visit|4|||
105781339|NCT01098266|364852906|FG000|Overall Study|Physician Decision|1|||
105781340|NCT01098266|364852907|FG001|Overall Study|Physician Decision|0|||
105781341|NCT01098266|364852906|FG000|Overall Study|Death|3|||
105781342|NCT01098266|364852907|FG001|Overall Study|Death|2|||
105781343|NCT01098266|364852906|FG000|Overall Study|Withdrawal by Subject|3|||
105781344|NCT01098266|364852907|FG001|Overall Study|Withdrawal by Subject|5|||
105781345|NCT00525499|364852908|FG000|Overall Study|Lost to Follow-up|2|||
105781346|NCT00525499|364852909|FG001|Overall Study|Lost to Follow-up|4|||
105781347|NCT00525499|364852910|FG002|Overall Study|Lost to Follow-up|1|||
105781348|NCT00525499|364852911|FG003|Overall Study|Lost to Follow-up|4|||
105781349|NCT00525499|364852908|FG000|Overall Study|Adverse Event|0|||
105781350|NCT00525499|364852909|FG001|Overall Study|Adverse Event|1|||
105781351|NCT00525499|364852910|FG002|Overall Study|Adverse Event|0|||
105781352|NCT00525499|364852911|FG003|Overall Study|Adverse Event|1|||
105781353|NCT00525499|364852908|FG000|Overall Study|Withdrawal by Subject|5|||
105781354|NCT00525499|364852909|FG001|Overall Study|Withdrawal by Subject|1|||
105781355|NCT00525499|364852910|FG002|Overall Study|Withdrawal by Subject|5|||
105781356|NCT00525499|364852911|FG003|Overall Study|Withdrawal by Subject|2|||
105781357|NCT00525499|364852908|FG000|Overall Study|Protocol Violation|0|||
105781358|NCT00525499|364852909|FG001|Overall Study|Protocol Violation|1|||
105781359|NCT00525499|364852910|FG002|Overall Study|Protocol Violation|1|||
105781360|NCT00525499|364852911|FG003|Overall Study|Protocol Violation|0|||
105781361|NCT03339999|364852912|FG000|Overall Study|Adverse Event|1|||
105781362|NCT03339999|364852913|FG001|Overall Study|Adverse Event|2|||
105781363|NCT03339999|364852914|FG002|Overall Study|Adverse Event|2|||
105781364|NCT03339999|364852915|FG003|Overall Study|Adverse Event|1|||
105781365|NCT03339999|364852912|FG000|Overall Study|Lack of Efficacy|0|||
105781366|NCT03339999|364852913|FG001|Overall Study|Lack of Efficacy|1|||
105781367|NCT03339999|364852914|FG002|Overall Study|Lack of Efficacy|0|||
105781368|NCT03339999|364852915|FG003|Overall Study|Lack of Efficacy|0|||
105781369|NCT03339999|364852912|FG000|Overall Study|Lost to Follow-up|0|||
105781370|NCT03339999|364852913|FG001|Overall Study|Lost to Follow-up|0|||
105781371|NCT03339999|364852914|FG002|Overall Study|Lost to Follow-up|0|||
105781372|NCT03339999|364852915|FG003|Overall Study|Lost to Follow-up|1|||
105781373|NCT03339999|364852912|FG000|Overall Study|Study Terminated by Sponsor|6|||
105781374|NCT03339999|364852913|FG001|Overall Study|Study Terminated by Sponsor|3|||
105781375|NCT03339999|364852914|FG002|Overall Study|Study Terminated by Sponsor|4|||
105781376|NCT03339999|364852915|FG003|Overall Study|Study Terminated by Sponsor|3|||
105781377|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
105781378|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
106101890|NCT02502266|366029128|FG003|Overall Study|Adverse Event|0|||
106101891|NCT02502266|366029129|FG004|Overall Study|Adverse Event|1|||
106101892|NCT02502266|366029130|FG005|Overall Study|Adverse Event|1|||
106101893|NCT02502266|366029131|FG006|Overall Study|Adverse Event|1|||
106101894|NCT02502266|366029125|FG000|Overall Study|Withdrawal by Subject|30|||
106101895|NCT02502266|366029126|FG001|Overall Study|Withdrawal by Subject|15|||
106101896|NCT02502266|366029127|FG002|Overall Study|Withdrawal by Subject|16|||
106101897|NCT02502266|366029128|FG003|Overall Study|Withdrawal by Subject|0|||
106101898|NCT02502266|366029129|FG004|Overall Study|Withdrawal by Subject|0|||
106101899|NCT02502266|366029130|FG005|Overall Study|Withdrawal by Subject|0|||
106101900|NCT02502266|366029131|FG006|Overall Study|Withdrawal by Subject|0|||
106101901|NCT02502266|366029125|FG000|Overall Study|Still on Treatment|0|||
105781379|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
105781380|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
105781381|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
105781382|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
105781383|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
105781384|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
105781385|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
105781386|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
105781387|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
105781388|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
105781389|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
105781390|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
105781391|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781392|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781393|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781394|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781395|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781396|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781397|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781398|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781399|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781400|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
105781401|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
105781402|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781403|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781404|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781405|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781406|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781407|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781408|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781409|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781410|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781411|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781412|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
105781413|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Other|1|||
105781414|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Other|0|||
105781415|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Other|0|||
105781416|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Other|0|||
105781417|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Other|0|||
105781418|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Other|0|||
105781419|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Other|0|||
105781420|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Other|0|||
105781421|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Other|0|||
105781422|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Other|0|||
105781423|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Other|0|||
105781424|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Other|0|||
105781425|NCT05602818|364852920|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781426|NCT05602818|364852921|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
105781427|NCT05602818|364852922|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781428|NCT05602818|364852923|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
106101902|NCT02502266|366029126|FG001|Overall Study|Still on Treatment|0|||
106101903|NCT02502266|366029127|FG002|Overall Study|Still on Treatment|1|||
106101904|NCT02502266|366029128|FG003|Overall Study|Still on Treatment|0|||
105992538|NCT03364309|365631555|FG000|Post-Treatment Followup Period|Adverse Event|0|||
105992539|NCT03364309|365631556|FG001|Post-Treatment Followup Period|Adverse Event|0|||
105992540|NCT03364309|365631557|FG002|Post-Treatment Followup Period|Adverse Event|0|||
105992541|NCT03364309|365631558|FG003|Post-Treatment Followup Period|Adverse Event|0|||
105992542|NCT03364309|365631559|FG004|Post-Treatment Followup Period|Adverse Event|0|||
105992543|NCT03364309|365631560|FG005|Post-Treatment Followup Period|Adverse Event|0|||
105992544|NCT03364309|365631561|FG006|Post-Treatment Followup Period|Adverse Event|0|||
105992545|NCT03364309|365631562|FG007|Post-Treatment Followup Period|Adverse Event|0|||
105992546|NCT03364309|365631563|FG008|Post-Treatment Followup Period|Adverse Event|0|||
105992547|NCT03364309|365631564|FG009|Post-Treatment Followup Period|Adverse Event|0|||
105992548|NCT03364309|365631565|FG010|Post-Treatment Followup Period|Adverse Event|0|||
105992549|NCT03364309|365631566|FG011|Post-Treatment Followup Period|Adverse Event|0|||
105992550|NCT03364309|365631567|FG012|Post-Treatment Followup Period|Adverse Event|0|||
105992551|NCT03364309|365631568|FG013|Post-Treatment Followup Period|Adverse Event|0|||
105992552|NCT03364309|365631569|FG014|Post-Treatment Followup Period|Adverse Event|0|||
105992553|NCT03364309|365631570|FG015|Post-Treatment Followup Period|Adverse Event|0|||
105992554|NCT03364309|365631571|FG016|Post-Treatment Followup Period|Adverse Event|2|||
105992555|NCT03364309|365631572|FG017|Post-Treatment Followup Period|Adverse Event|6|||
105992556|NCT03364309|365631573|FG018|Post-Treatment Followup Period|Adverse Event|1|||
105992557|NCT03364309|365631555|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992558|NCT03364309|365631556|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992559|NCT03364309|365631557|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992560|NCT03364309|365631558|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992561|NCT03364309|365631559|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992562|NCT03364309|365631560|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992563|NCT03364309|365631561|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992564|NCT03364309|365631562|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992565|NCT03364309|365631563|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992566|NCT03364309|365631564|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992567|NCT03364309|365631565|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992568|NCT03364309|365631566|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992569|NCT03364309|365631567|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992570|NCT03364309|365631568|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992571|NCT03364309|365631569|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992572|NCT03364309|365631570|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992573|NCT03364309|365631571|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992574|NCT03364309|365631572|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
105992575|NCT03364309|365631573|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
105992576|NCT03364309|365631555|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
105992577|NCT03364309|365631556|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
105992578|NCT03364309|365631557|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
105992579|NCT03364309|365631558|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
105992580|NCT03364309|365631559|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
105992581|NCT03364309|365631560|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
105992582|NCT03364309|365631561|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
105992583|NCT03364309|365631562|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
105992584|NCT03364309|365631563|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
105992585|NCT03364309|365631564|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
105992586|NCT03364309|365631565|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
105992587|NCT03364309|365631566|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
105992588|NCT03364309|365631567|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
105992589|NCT03364309|365631568|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
105992590|NCT03364309|365631569|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
105992591|NCT03364309|365631570|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
105992592|NCT03364309|365631571|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
105992593|NCT03364309|365631572|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
105992594|NCT03364309|365631573|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
105992595|NCT03477838|365631574|FG000|Overall Study|Lost to Follow-up|14|||
105992596|NCT02519595|365631576|FG000|Overall Study|Protocol Violation|8|||
105992597|NCT02519595|365631577|FG001|Overall Study|Protocol Violation|22|||
105992598|NCT02519595|365631578|FG002|Overall Study|Protocol Violation|16|||
105992599|NCT00850538|365631581|FG000|Overall Study|unable/unwilling to complete MRI|13|||
105992600|NCT00850538|365631581|FG000|Overall Study|specimen missed due to scheduling error|14|||
105992601|NCT00850538|365631581|FG000|Overall Study|specimen unusable|7|||
105992602|NCT00850538|365631581|FG000|Overall Study|Withdrawal by Subject|3|||
105992603|NCT00850538|365631581|FG000|Overall Study|radiology error|2|||
105992604|NCT00850538|365631581|FG000|Overall Study|Protocol Violation|2|||
105992605|NCT00167310|365631582|FG000|Overall Study|Protocol Violation|5|||
105992606|NCT00167310|365631583|FG001|Overall Study|Protocol Violation|3|||
105992607|NCT00167310|365631582|FG000|Overall Study|Withdrawal by Subject|3|||
105992608|NCT00167310|365631583|FG001|Overall Study|Withdrawal by Subject|7|||
105781429|NCT05602818|364852924|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781430|NCT05602818|364852925|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781431|NCT05602818|364852926|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781432|NCT05602818|364852927|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781433|NCT05602818|364852928|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781434|NCT05602818|364852929|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781435|NCT05602818|364852930|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781436|NCT05602818|364852931|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
105781437|NCT05602818|364852920|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
105781438|NCT05602818|364852921|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
105781439|NCT05602818|364852922|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
105781440|NCT05602818|364852923|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
105781441|NCT05602818|364852924|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
105781442|NCT05602818|364852925|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
105781443|NCT05602818|364852926|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
105781444|NCT05602818|364852927|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
105781445|NCT05602818|364852928|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
105781446|NCT05602818|364852929|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
105781447|NCT05602818|364852930|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
105781448|NCT05602818|364852931|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
105781449|NCT05602818|364852920|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781450|NCT05602818|364852921|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781451|NCT05602818|364852922|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781452|NCT05602818|364852923|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781453|NCT05602818|364852924|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781454|NCT05602818|364852925|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781455|NCT05602818|364852926|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781456|NCT05602818|364852927|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781457|NCT05602818|364852928|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781458|NCT05602818|364852929|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
105781459|NCT05602818|364852930|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
105781460|NCT05602818|364852931|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
105781461|NCT05602818|364852920|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
105781462|NCT05602818|364852921|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
105781463|NCT05602818|364852922|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
105781464|NCT05602818|364852923|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
105781465|NCT05602818|364852924|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
105781466|NCT05602818|364852925|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
105781467|NCT05602818|364852926|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
105781468|NCT05602818|364852927|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
105781469|NCT05602818|364852928|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
105781470|NCT05602818|364852929|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
105781471|NCT05602818|364852930|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
105781472|NCT05602818|364852931|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
105781473|NCT04594213|364852932|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
105781474|NCT04594213|364852933|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
105781475|NCT04594213|364852934|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
105781476|NCT04594213|364852935|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105781477|NCT04594213|364852936|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105781478|NCT04594213|364852937|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
105781479|NCT04594213|364852932|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781480|NCT04594213|364852933|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
105781481|NCT04594213|364852934|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781482|NCT04594213|364852935|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781483|NCT04594213|364852936|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781484|NCT04594213|364852937|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
105781485|NCT04594213|364852932|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
105781486|NCT04594213|364852933|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105781487|NCT04594213|364852934|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
105781488|NCT04594213|364852935|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105781489|NCT04594213|364852936|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105781490|NCT04594213|364852937|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
105781491|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105781492|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105781493|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105781494|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
105781495|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
105781496|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
106101905|NCT02502266|366029129|FG004|Overall Study|Still on Treatment|0|||
106101906|NCT02502266|366029130|FG005|Overall Study|Still on Treatment|0|||
106101907|NCT02502266|366029131|FG006|Overall Study|Still on Treatment|0|||
106101908|NCT02502266|366029125|FG000|Overall Study|Other Reasons|19|||
106101909|NCT02502266|366029126|FG001|Overall Study|Other Reasons|6|||
106101910|NCT02502266|366029127|FG002|Overall Study|Other Reasons|14|||
106101911|NCT02502266|366029128|FG003|Overall Study|Other Reasons|0|||
106101912|NCT02502266|366029129|FG004|Overall Study|Other Reasons|1|||
106101913|NCT02502266|366029130|FG005|Overall Study|Other Reasons|1|||
106101914|NCT02502266|366029131|FG006|Overall Study|Other Reasons|0|||
106101915|NCT02502266|366029125|FG000|Overall Study|Arm 4 Discontinued|0|||
106101916|NCT02502266|366029126|FG001|Overall Study|Arm 4 Discontinued|0|||
106101917|NCT02502266|366029127|FG002|Overall Study|Arm 4 Discontinued|0|||
106101918|NCT02502266|366029128|FG003|Overall Study|Arm 4 Discontinued|52|||
106101919|NCT02502266|366029129|FG004|Overall Study|Arm 4 Discontinued|0|||
106101920|NCT02502266|366029130|FG005|Overall Study|Arm 4 Discontinued|0|||
106101921|NCT02502266|366029131|FG006|Overall Study|Arm 4 Discontinued|0|||
106101922|NCT02502266|366029125|FG000|Overall Study|Never treated|0|||
106101923|NCT02502266|366029126|FG001|Overall Study|Never treated|0|||
105781497|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105781498|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105781499|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
105781500|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
105781501|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
105781502|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
105781503|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781504|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781505|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781506|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781507|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
105781508|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
105781509|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781510|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781511|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781512|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
105781513|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781514|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
105781515|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781516|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781517|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781518|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
105781519|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781520|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
105781521|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105781522|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105781523|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
105781524|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
105781525|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
105781526|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
105781527|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105781528|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105781529|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
105781530|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
105781531|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
105781532|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
105781533|NCT04594213|364852932|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
105781534|NCT04594213|364852933|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
105781535|NCT04594213|364852934|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
105781536|NCT04594213|364852935|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
105781537|NCT04594213|364852936|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
105781538|NCT04594213|364852937|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
105781539|NCT01716585|364852938|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
105781540|NCT01716585|364852939|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
105781541|NCT01716585|364852938|FG000|Double-blind Treatment|Adverse Event|2|||
105781542|NCT01716585|364852939|FG001|Double-blind Treatment|Adverse Event|1|||
105781543|NCT01716585|364852938|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
105781544|NCT01716585|364852939|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
105781545|NCT01716585|364852938|FG000|Double-blind Treatment|Lost to Follow-up|2|||
105781546|NCT01716585|364852939|FG001|Double-blind Treatment|Lost to Follow-up|0|||
105781547|NCT01716585|364852938|FG000|Double-blind Treatment|Subject Noncompliant|1|||
105781548|NCT01716585|364852939|FG001|Double-blind Treatment|Subject Noncompliant|0|||
105992609|NCT03188510|365631584|FG000|Overall Study|Inappropriate behavior with site staff|0|||
105781549|NCT01716585|364852938|FG000|Double-blind Treatment|Other|1|||
105781550|NCT01716585|364852939|FG001|Double-blind Treatment|Other|0|||
105781551|NCT01716585|364852938|FG000|Open-label Treatment|Adverse Event|0|||
105781552|NCT01716585|364852939|FG001|Open-label Treatment|Adverse Event|2|||
105781553|NCT01716585|364852938|FG000|Open-label Treatment|Virologic Failure|0|||
105781554|NCT01716585|364852939|FG001|Open-label Treatment|Virologic Failure|2|||
105781555|NCT01716585|364852938|FG000|Open-label Treatment|Withdrawal by Subject|0|||
105781556|NCT01716585|364852939|FG001|Open-label Treatment|Withdrawal by Subject|3|||
105781557|NCT00408408|364852940|FG000|Overall Study|No follow up data|2|||
105781558|NCT00408408|364852941|FG001|Overall Study|No follow up data|3|||
105781559|NCT00408408|364852942|FG002|Overall Study|No follow up data|0|||
105781560|NCT00408408|364852943|FG003|Overall Study|No follow up data|7|||
105781561|NCT00408408|364852944|FG004|Overall Study|No follow up data|5|||
105781562|NCT00408408|364852945|FG005|Overall Study|No follow up data|3|||
105781563|NCT01616173|364852948|FG000|Overall Study|Lost to Follow-up|0|||
105781564|NCT01616173|364852949|FG001|Overall Study|Lost to Follow-up|2|||
105781565|NCT01616173|364852950|FG002|Overall Study|Lost to Follow-up|0|||
105781566|NCT00504595|364852954|FG000|Overall Study|Lack of Efficacy|1|||
105781567|NCT00504595|364852955|FG001|Overall Study|Lack of Efficacy|0|||
105781568|NCT00504595|364852956|FG002|Overall Study|Lack of Efficacy|0|||
105781569|NCT00504595|364852957|FG003|Overall Study|Lack of Efficacy|0|||
105781570|NCT00504595|364852954|FG000|Overall Study|Other|0|||
105781571|NCT00504595|364852955|FG001|Overall Study|Other|0|||
105781572|NCT00504595|364852956|FG002|Overall Study|Other|2|||
105781573|NCT00504595|364852957|FG003|Overall Study|Other|0|||
105781574|NCT00808665|364852960|FG000|Overall Study|Withdrawal by Subject|1|||
105781575|NCT00808665|364852961|FG001|Overall Study|Withdrawal by Subject|0|||
105781576|NCT00808665|364852960|FG000|Overall Study|only required minimally invasive surgery|1|||
105781577|NCT00808665|364852961|FG001|Overall Study|only required minimally invasive surgery|0|||
105781578|NCT00808665|364852960|FG000|Overall Study|surgery cancelled|1|||
105781579|NCT00808665|364852961|FG001|Overall Study|surgery cancelled|0|||
105781580|NCT00808665|364852960|FG000|Overall Study|required an additional procedure|0|||
105781581|NCT00808665|364852961|FG001|Overall Study|required an additional procedure|1|||
105781582|NCT00808665|364852960|FG000|Overall Study|Physician Decision|3|||
105781583|NCT00808665|364852961|FG001|Overall Study|Physician Decision|1|||
105781584|NCT00808665|364852960|FG000|Overall Study|Medication stopped by resident|0|||
105781585|NCT00808665|364852961|FG001|Overall Study|Medication stopped by resident|1|||
105781586|NCT03326323|364852962|FG000|Overall Study|Unable to receive ANH protocol|3|||
105781587|NCT01552408|364852966|FG000|Overall Study|Lost to Follow-up|2|||
105781588|NCT01552408|364852967|FG001|Overall Study|Lost to Follow-up|0|||
105781589|NCT01552408|364852966|FG000|Overall Study|Relocation|0|||
105781590|NCT01552408|364852967|FG001|Overall Study|Relocation|1|||
105781591|NCT01552408|364852966|FG000|Overall Study|Withdrawal by Subject|2|||
105781592|NCT01552408|364852967|FG001|Overall Study|Withdrawal by Subject|1|||
105781593|NCT03319160|364852968|FG000|Overall Study|Data not available.|7|||
105781594|NCT00665002|364852969|FG000|Overall Study|Progression/relapse during treatment|11|||
105781595|NCT00665002|364852969|FG000|Overall Study|Cytogenetic resistance|1|||
105781596|NCT03604159|364852970|FG000|Overall Study|Lost to Follow-up|6|||
105781597|NCT03604159|364852971|FG001|Overall Study|Lost to Follow-up|7|||
105781598|NCT04533204|364852975|FG000|Overall Study|Unable to understand training instructions|1|||
105781599|NCT04533204|364852976|FG001|Overall Study|Unable to understand training instructions|1|||
105781600|NCT00787527|364852977|FG000|Overall Study|Toxicity|3|||
105781601|NCT02242305|364852978|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
105781602|NCT02242305|364852979|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
105781603|NCT02242305|364852978|FG000|Overall Study|Adverse Event|1|||
105781604|NCT02242305|364852979|FG001|Overall Study|Adverse Event|0|||
105781605|NCT02242305|364852978|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
105781606|NCT02242305|364852979|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
105781607|NCT02242305|364852978|FG000|Overall Study|Subject withdraws inform consent|0|||
105781608|NCT02242305|364852979|FG001|Overall Study|Subject withdraws inform consent|4|||
105781609|NCT02242305|364852978|FG000|Overall Study|Lost to Follow-up|2|||
105781610|NCT02242305|364852979|FG001|Overall Study|Lost to Follow-up|0|||
105781611|NCT02543918|364852982|FG000|Overall Study|Never treated|0|||
105781612|NCT02543918|364852983|FG001|Overall Study|Never treated|1|||
105781613|NCT02543918|364852982|FG000|Overall Study|Lost to Follow-up|1|||
105781614|NCT02543918|364852983|FG001|Overall Study|Lost to Follow-up|1|||
105781615|NCT02543918|364852982|FG000|Overall Study|Withdrawal by Subject|1|||
105781616|NCT02543918|364852983|FG001|Overall Study|Withdrawal by Subject|1|||
105781617|NCT02543918|364852982|FG000|Overall Study|Adverse Event|1|||
105781618|NCT02543918|364852983|FG001|Overall Study|Adverse Event|1|||
105781619|NCT02117024|364852984|FG000|Overall Study|Progressive Disease|26|||
105781620|NCT02117024|364852985|FG001|Overall Study|Progressive Disease|9|||
105781621|NCT02117024|364852984|FG000|Overall Study|Significant Clinical Progression|7|||
105781622|NCT02117024|364852985|FG001|Overall Study|Significant Clinical Progression|4|||
105781623|NCT02117024|364852984|FG000|Overall Study|Death|5|||
105781624|NCT02117024|364852985|FG001|Overall Study|Death|0|||
105781625|NCT02117024|364852984|FG000|Overall Study|Withdrawal by Subject|3|||
105781626|NCT02117024|364852985|FG001|Overall Study|Withdrawal by Subject|1|||
105781627|NCT02117024|364852984|FG000|Overall Study|Protocol Violation|1|||
105781628|NCT02117024|364852985|FG001|Overall Study|Protocol Violation|0|||
105781629|NCT02117024|364852984|FG000|Overall Study|Adverse Event|1|||
105781630|NCT02117024|364852985|FG001|Overall Study|Adverse Event|2|||
105781631|NCT02117024|364852984|FG000|Overall Study|Randomized in Error|1|||
105781632|NCT02117024|364852985|FG001|Overall Study|Randomized in Error|0|||
105781633|NCT02117024|364852984|FG000|Overall Study|Patient returned to primary oncologist|0|||
105781634|NCT02117024|364852985|FG001|Overall Study|Patient returned to primary oncologist|1|||
105781635|NCT02117024|364852984|FG000|Overall Study|Patient took treatment break|0|||
105781636|NCT02117024|364852985|FG001|Overall Study|Patient took treatment break|1|||
105781637|NCT02117024|364852984|FG000|Overall Study|Physician Decision|0|||
105781638|NCT02117024|364852985|FG001|Overall Study|Physician Decision|2|||
105781639|NCT02500706|364852986|FG000|Overall Study|Adverse Event|0|||
105781640|NCT02500706|364852987|FG001|Overall Study|Adverse Event|0|||
105781641|NCT02500706|364852988|FG002|Overall Study|Adverse Event|1|||
105781642|NCT02500706|364852986|FG000|Overall Study|Lost to Follow-up|0|||
105781643|NCT02500706|364852987|FG001|Overall Study|Lost to Follow-up|1|||
105781644|NCT02500706|364852988|FG002|Overall Study|Lost to Follow-up|1|||
105781645|NCT02500706|364852986|FG000|Overall Study|Withdrawal by Subject|4|||
105781646|NCT02500706|364852987|FG001|Overall Study|Withdrawal by Subject|6|||
105781647|NCT02500706|364852988|FG002|Overall Study|Withdrawal by Subject|4|||
105781648|NCT02500706|364852986|FG000|Overall Study|Unclassified|0|||
105781649|NCT02500706|364852987|FG001|Overall Study|Unclassified|0|||
105781650|NCT02500706|364852988|FG002|Overall Study|Unclassified|1|||
105781651|NCT00529152|364852989|FG000|Overall Study|Adverse Event|2|||
105781652|NCT00529152|364852989|FG000|Overall Study|Withdrawal by Subject|2|||
105781653|NCT00529152|364852989|FG000|Overall Study|Lost to Follow-up|1|||
105781654|NCT01005875|364852992|FG000|Overall Study|Death|3|||
105781655|NCT02924129|364853007|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
105781656|NCT02924129|364853008|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
105781657|NCT02924129|364853007|FG000|Overall Study|Withdrawal by Subject|2|||
105781658|NCT02924129|364853008|FG001|Overall Study|Withdrawal by Subject|2|||
105781659|NCT02924129|364853007|FG000|Overall Study|Physician Decision|1|||
105781660|NCT02924129|364853008|FG001|Overall Study|Physician Decision|0|||
105781661|NCT02924129|364853007|FG000|Overall Study|Missed Visit|0|||
105781662|NCT02924129|364853008|FG001|Overall Study|Missed Visit|1|||
105781663|NCT01348828|364853014|FG000|Overall Study|Death|20|||
105781664|NCT01348828|364853014|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
105781665|NCT01348828|364853014|FG000|Overall Study|Conversion|2|||
105781666|NCT01348828|364853014|FG000|Overall Study|missed visit|1|||
105781667|NCT01365182|364853015|FG000|Overall Study|Withdrawal by Subject|10|||
105781668|NCT01365182|364853016|FG001|Overall Study|Withdrawal by Subject|13|||
105781669|NCT01365182|364853017|FG002|Overall Study|Withdrawal by Subject|12|||
105781670|NCT01990339|364853018|FG000|Overall Study|Data Not Available|49|||
105781671|NCT01990339|364853018|FG000|Overall Study|Voluntary Withdrawal|1402|||
105781672|NCT01990339|364853018|FG000|Overall Study|Lost to Follow-up|861|||
105781673|NCT01590810|364853019|FG000|Overall Study|Physician Decision|0|||
105781674|NCT01590810|364853020|FG001|Overall Study|Physician Decision|1|||
105781675|NCT01590810|364853021|FG002|Overall Study|Physician Decision|1|||
105781676|NCT01590810|364853022|FG003|Overall Study|Physician Decision|0|||
105781677|NCT01590810|364853023|FG004|Overall Study|Physician Decision|0|||
105781678|NCT01078974|364853027|FG000|Overall Study|Adverse Event|3|||
105781679|NCT00553319|364853028|FG000|Overall Study|Lost to Follow-up|10|||
105781680|NCT00553319|364853029|FG001|Overall Study|Lost to Follow-up|9|||
105781681|NCT00553319|364853030|FG002|Overall Study|Lost to Follow-up|5|||
105781682|NCT00553319|364853028|FG000|Overall Study|wanted treatment elsewhere|2|||
105781683|NCT00553319|364853029|FG001|Overall Study|wanted treatment elsewhere|1|||
105781684|NCT00553319|364853030|FG002|Overall Study|wanted treatment elsewhere|1|||
105781685|NCT00553319|364853028|FG000|Overall Study|non-compliance|0|||
105781686|NCT00553319|364853029|FG001|Overall Study|non-compliance|0|||
105781687|NCT00553319|364853030|FG002|Overall Study|non-compliance|2|||
105781688|NCT00553319|364853028|FG000|Overall Study|incarceration|1|||
105781689|NCT00553319|364853029|FG001|Overall Study|incarceration|0|||
105781690|NCT00553319|364853030|FG002|Overall Study|incarceration|0|||
105781691|NCT00553319|364853028|FG000|Overall Study|moved|1|||
105781692|NCT00553319|364853029|FG001|Overall Study|moved|0|||
105781693|NCT00553319|364853030|FG002|Overall Study|moved|1|||
105781694|NCT01159665|364853035|FG000|Overall Study|Withdrawal by Subject|0|||
105781695|NCT01159665|364853036|FG001|Overall Study|Withdrawal by Subject|1|||
105781696|NCT01159665|364853037|FG002|Overall Study|Withdrawal by Subject|0|||
105781697|NCT01159665|364853038|FG003|Overall Study|Withdrawal by Subject|0|||
105781698|NCT01159665|364853039|FG004|Overall Study|Withdrawal by Subject|0|||
105781699|NCT01159665|364853040|FG005|Overall Study|Withdrawal by Subject|0|||
105781700|NCT01130831|364853041|FG000|Overall Study|Withdrawal by Subject|7|||
105781701|NCT01130831|364853041|FG000|Overall Study|Death|4|||
105781702|NCT01130831|364853041|FG000|Overall Study|Information was missing|3|||
105781703|NCT00422942|364853042|FG000|Overall Study|Study terminated by Sponsor|3|||
105781704|NCT02173158|364853043|FG000|Efficacy Phase|Adverse Event|1|||
105781705|NCT01230489|364853055|FG000|Overall Study|Death|2|||
105781706|NCT01230489|364853055|FG000|Overall Study|Adverse Event|2|||
105781707|NCT01230489|364853055|FG000|Overall Study|Treatment modality changed|1|||
105781708|NCT03077646|364853056|FG000|Overall Study|Lost to Follow-up|29|||
105781709|NCT03077646|364853057|FG001|Overall Study|Lost to Follow-up|30|||
106101924|NCT02502266|366029127|FG002|Overall Study|Never treated|0|||
106101925|NCT02502266|366029128|FG003|Overall Study|Never treated|0|||
106101926|NCT02502266|366029129|FG004|Overall Study|Never treated|0|||
106101927|NCT02502266|366029130|FG005|Overall Study|Never treated|1|||
106101928|NCT02502266|366029131|FG006|Overall Study|Never treated|0|||
106101929|NCT04066114|366029132|FG000|Overall Study|Adverse Event|1|||
106101930|NCT04066114|366029133|FG001|Overall Study|Adverse Event|0|||
106101931|NCT04066114|366029134|FG002|Overall Study|Adverse Event|0|||
106101932|NCT04066114|366029132|FG000|Overall Study|Withdrawal by Subject|1|||
106101933|NCT04066114|366029133|FG001|Overall Study|Withdrawal by Subject|0|||
106101934|NCT04066114|366029134|FG002|Overall Study|Withdrawal by Subject|0|||
106101935|NCT04066114|366029132|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
106101936|NCT04066114|366029133|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
106101937|NCT04066114|366029134|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
106101938|NCT02103439|366029135|FG000|Overall Study|Adverse Event|0|||
106101939|NCT02103439|366029136|FG001|Overall Study|Adverse Event|2|||
106101940|NCT02103439|366029135|FG000|Overall Study|Withdrawal by Subject|3|||
106101941|NCT02103439|366029136|FG001|Overall Study|Withdrawal by Subject|1|||
106101942|NCT01816594|366029139|FG000|Overall Study|Local Progress|0|||
106101943|NCT01816594|366029140|FG001|Overall Study|Local Progress|2|||
106101944|NCT01816594|366029139|FG000|Overall Study|Adverse Event|9|||
106101945|NCT01816594|366029140|FG001|Overall Study|Adverse Event|0|||
106101946|NCT01816594|366029139|FG000|Overall Study|Withdrawal by Subject|1|||
106101947|NCT01816594|366029140|FG001|Overall Study|Withdrawal by Subject|0|||
106101948|NCT01816594|366029139|FG000|Overall Study|Physician Decision|1|||
106101949|NCT01816594|366029140|FG001|Overall Study|Physician Decision|0|||
106101950|NCT03905655|366029141|FG000|Overall Study|Adverse Event|1|||
106101951|NCT03905655|366029142|FG001|Overall Study|Adverse Event|0|||
106101952|NCT03905655|366029143|FG002|Overall Study|Adverse Event|1|||
106101953|NCT03905655|366029144|FG003|Overall Study|Adverse Event|1|||
106101954|NCT02566031|366029145|FG000|Overall Study|Patient/guardian decision|14|||
106101955|NCT02566031|366029146|FG001|Overall Study|Patient/guardian decision|7|||
106101956|NCT02566031|366029145|FG000|Overall Study|Protocol deviation|2|||
106101957|NCT02566031|366029146|FG001|Overall Study|Protocol deviation|3|||
106101958|NCT02566031|366029145|FG000|Overall Study|Adverse Event|3|||
106101959|NCT02566031|366029146|FG001|Overall Study|Adverse Event|1|||
106101960|NCT02566031|366029145|FG000|Overall Study|Lost to Follow-up|1|||
106101961|NCT02566031|366029146|FG001|Overall Study|Lost to Follow-up|1|||
106101962|NCT03204279|366029147|FG000|Overall Study|Withdrawal by Subject|0|||
106101963|NCT03204279|366029148|FG001|Overall Study|Withdrawal by Subject|1|||
106101964|NCT02277106|366029149|FG000|Stage 2|Adverse Event|0|||
106101965|NCT02277106|366029150|FG001|Stage 2|Adverse Event|0|||
106101966|NCT02277106|366029151|FG002|Stage 2|Adverse Event|1|||
106101967|NCT01064739|366029152|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
106101968|NCT03031938|366029153|FG000|Overall Study|Death|1|||
106101969|NCT03031938|366029154|FG001|Overall Study|Death|0|||
106101970|NCT01571362|366029157|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
106101971|NCT01571362|366029158|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
106101972|NCT01571362|366029159|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
106101973|NCT01571362|366029157|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
106101974|NCT01571362|366029158|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
106101975|NCT01571362|366029159|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
106101976|NCT01571362|366029157|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
106101977|NCT01571362|366029158|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
106101978|NCT01571362|366029159|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
105781710|NCT03077646|364853058|FG002|Overall Study|Lost to Follow-up|31|||
105781711|NCT00313716|364854823|FG000|Overall Study|Death|3|||
105781712|NCT00313716|364854824|FG001|Overall Study|Death|2|||
105781713|NCT00313716|364854825|FG002|Overall Study|Death|9|||
105781714|NCT00313716|364854826|FG003|Overall Study|Death|3|||
105781715|NCT00313716|364854827|FG004|Overall Study|Death|5|||
105781716|NCT00313716|364854828|FG005|Overall Study|Death|9|||
105781717|NCT00313716|364854823|FG000|Overall Study|Lost to Follow-up|2|||
105781718|NCT00313716|364854824|FG001|Overall Study|Lost to Follow-up|5|||
105781719|NCT00313716|364854825|FG002|Overall Study|Lost to Follow-up|2|||
105781720|NCT00313716|364854826|FG003|Overall Study|Lost to Follow-up|1|||
105781721|NCT00313716|364854827|FG004|Overall Study|Lost to Follow-up|0|||
105781722|NCT00313716|364854828|FG005|Overall Study|Lost to Follow-up|4|||
105781723|NCT00313716|364854823|FG000|Overall Study|Withdrawal by Subject|0|||
105781724|NCT00313716|364854824|FG001|Overall Study|Withdrawal by Subject|1|||
106101979|NCT01571362|366029157|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
106101980|NCT01571362|366029158|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
106101981|NCT01571362|366029159|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
106101982|NCT01571362|366029157|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
106101983|NCT01571362|366029158|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
106101984|NCT01571362|366029159|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
106101985|NCT01571362|366029157|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
106101986|NCT01571362|366029158|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
106101987|NCT01571362|366029159|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
106101988|NCT01571362|366029157|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106101989|NCT01571362|366029158|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
106101990|NCT01571362|366029159|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
106101991|NCT01571362|366029157|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
106101992|NCT01571362|366029158|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
106101993|NCT01571362|366029159|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
106101994|NCT01571362|366029157|FG000|Double-Blind Treatment Period|Adverse Event|0|||
106101995|NCT01571362|366029158|FG001|Double-Blind Treatment Period|Adverse Event|9|||
106101996|NCT01571362|366029159|FG002|Double-Blind Treatment Period|Adverse Event|14|||
106101997|NCT01571362|366029157|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
106101998|NCT01571362|366029158|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
106101999|NCT01571362|366029159|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
106102000|NCT01571362|366029157|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
106102001|NCT01571362|366029158|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
106102002|NCT01571362|366029159|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
106102003|NCT01571362|366029157|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
106102004|NCT01571362|366029158|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
106102005|NCT01571362|366029159|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
106102006|NCT03966157|366029160|FG000|Overall Study|Physician Decision|1|||
106102007|NCT03966157|366029161|FG001|Overall Study|Physician Decision|0|||
106102008|NCT03568318|366029162|FG000|Overall Study|Adverse Event|3|||
106102009|NCT03568318|366029163|FG001|Overall Study|Adverse Event|1|||
106102010|NCT03568318|366029164|FG002|Overall Study|Adverse Event|1|||
106102011|NCT03568318|366029165|FG003|Overall Study|Adverse Event|0|||
106102012|NCT03568318|366029166|FG004|Overall Study|Adverse Event|1|||
106102013|NCT03568318|366029167|FG005|Overall Study|Adverse Event|0|||
106102014|NCT03568318|366029162|FG000|Overall Study|Withdrawal by Subject|6|||
106102015|NCT03568318|366029163|FG001|Overall Study|Withdrawal by Subject|5|||
106102016|NCT03568318|366029164|FG002|Overall Study|Withdrawal by Subject|2|||
106102017|NCT03568318|366029165|FG003|Overall Study|Withdrawal by Subject|1|||
106102018|NCT03568318|366029166|FG004|Overall Study|Withdrawal by Subject|0|||
106102019|NCT03568318|366029167|FG005|Overall Study|Withdrawal by Subject|0|||
106102020|NCT03568318|366029162|FG000|Overall Study|Lost to Follow-up|3|||
106102021|NCT03568318|366029163|FG001|Overall Study|Lost to Follow-up|2|||
106102022|NCT03568318|366029164|FG002|Overall Study|Lost to Follow-up|2|||
106102023|NCT03568318|366029165|FG003|Overall Study|Lost to Follow-up|2|||
106102024|NCT03568318|366029166|FG004|Overall Study|Lost to Follow-up|1|||
106102025|NCT03568318|366029167|FG005|Overall Study|Lost to Follow-up|0|||
106102026|NCT03568318|366029162|FG000|Overall Study|Other|3|||
106102027|NCT03568318|366029163|FG001|Overall Study|Other|1|||
106102028|NCT03568318|366029164|FG002|Overall Study|Other|3|||
106102029|NCT03568318|366029165|FG003|Overall Study|Other|0|||
106102030|NCT03568318|366029166|FG004|Overall Study|Other|0|||
106102031|NCT03568318|366029167|FG005|Overall Study|Other|0|||
106102032|NCT03568318|366029162|FG000|Overall Study|Ongoing at Time of Analysis|5|||
106102033|NCT03568318|366029163|FG001|Overall Study|Ongoing at Time of Analysis|3|||
106102034|NCT03568318|366029164|FG002|Overall Study|Ongoing at Time of Analysis|2|||
106102035|NCT03568318|366029165|FG003|Overall Study|Ongoing at Time of Analysis|1|||
106102036|NCT03568318|366029166|FG004|Overall Study|Ongoing at Time of Analysis|0|||
106102037|NCT03568318|366029167|FG005|Overall Study|Ongoing at Time of Analysis|0|||
106102038|NCT04004611|366029168|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
106102039|NCT04004611|366029169|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
106102040|NCT04004611|366029170|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
106102041|NCT04004611|366029171|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
106102042|NCT04004611|366029172|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
106102043|NCT04004611|366029173|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
106102044|NCT04004611|366029174|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
106102045|NCT04004611|366029175|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
106102046|NCT04004611|366029176|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
106102047|NCT04004611|366029168|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
106102048|NCT04004611|366029169|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
106102049|NCT04004611|366029170|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
106102050|NCT04004611|366029171|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
106102051|NCT04004611|366029172|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
106102052|NCT04004611|366029173|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
106102053|NCT04004611|366029174|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
106102054|NCT04004611|366029175|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
106102055|NCT04004611|366029176|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
106102056|NCT04004611|366029168|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
106102057|NCT04004611|366029169|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
106102058|NCT04004611|366029170|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
106102059|NCT04004611|366029171|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
106102060|NCT04004611|366029172|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
106102061|NCT04004611|366029173|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
106102062|NCT04004611|366029174|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
106102063|NCT04004611|366029175|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
106102064|NCT04004611|366029176|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
106102065|NCT04004611|366029168|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
106102066|NCT04004611|366029169|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
106102067|NCT04004611|366029170|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
106102068|NCT04004611|366029171|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
106102069|NCT04004611|366029172|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
106102070|NCT04004611|366029173|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
106102071|NCT04004611|366029174|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
106102072|NCT04004611|366029175|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
106102073|NCT04004611|366029176|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
106102074|NCT04004611|366029168|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
106102075|NCT04004611|366029169|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
106102076|NCT04004611|366029170|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
106102077|NCT04004611|366029171|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
106102078|NCT04004611|366029172|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
106102079|NCT04004611|366029173|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
106102080|NCT04004611|366029174|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
106102081|NCT04004611|366029175|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
106102082|NCT04004611|366029176|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
106102083|NCT04004611|366029168|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
106102084|NCT04004611|366029169|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
106102085|NCT04004611|366029170|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
106102086|NCT04004611|366029171|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
106102087|NCT04004611|366029172|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
106102088|NCT04004611|366029173|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
106102089|NCT04004611|366029174|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
106102090|NCT04004611|366029175|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
106102091|NCT04004611|366029176|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
106102092|NCT00515502|366029183|FG000|Treatment Period 1|Adverse Event|0|||
106102093|NCT00515502|366029184|FG001|Treatment Period 1|Adverse Event|0|||
106102094|NCT00515502|366029185|FG002|Treatment Period 1|Adverse Event|0|||
106102095|NCT00515502|366029186|FG003|Treatment Period 1|Adverse Event|0|||
106102096|NCT00515502|366029187|FG004|Treatment Period 1|Adverse Event|0|||
106102097|NCT00515502|366029188|FG005|Treatment Period 1|Adverse Event|0|||
106102098|NCT00515502|366029189|FG006|Treatment Period 1|Adverse Event|1|||
106102099|NCT00515502|366029190|FG007|Treatment Period 1|Adverse Event|0|||
106102100|NCT00515502|366029191|FG008|Treatment Period 1|Adverse Event|1|||
106102101|NCT00515502|366029192|FG009|Treatment Period 1|Adverse Event|0|||
106102102|NCT00515502|366029193|FG010|Treatment Period 1|Adverse Event|0|||
106102103|NCT00515502|366029194|FG011|Treatment Period 1|Adverse Event|1|||
106102104|NCT00515502|366029183|FG000|Treatment Period 2|Adverse Event|0|||
106102105|NCT00515502|366029184|FG001|Treatment Period 2|Adverse Event|1|||
106102106|NCT00515502|366029185|FG002|Treatment Period 2|Adverse Event|0|||
106102107|NCT00515502|366029186|FG003|Treatment Period 2|Adverse Event|0|||
106102108|NCT00515502|366029187|FG004|Treatment Period 2|Adverse Event|0|||
106102109|NCT00515502|366029188|FG005|Treatment Period 2|Adverse Event|0|||
106102110|NCT00515502|366029189|FG006|Treatment Period 2|Adverse Event|0|||
106102111|NCT00515502|366029190|FG007|Treatment Period 2|Adverse Event|0|||
106102112|NCT00515502|366029191|FG008|Treatment Period 2|Adverse Event|0|||
106102113|NCT00515502|366029192|FG009|Treatment Period 2|Adverse Event|0|||
106102114|NCT00515502|366029193|FG010|Treatment Period 2|Adverse Event|0|||
106102115|NCT00515502|366029194|FG011|Treatment Period 2|Adverse Event|0|||
106102116|NCT01814371|366029198|FG000|Overall Study|Lost to Follow-up|30|||
106102117|NCT01814371|366029199|FG001|Overall Study|Lost to Follow-up|27|||
106102118|NCT03263429|366029200|FG000|Overall Study|Withdrawal by Subject|0|||
106102119|NCT03263429|366029201|FG001|Overall Study|Withdrawal by Subject|1|||
106102120|NCT03263429|366029202|FG002|Overall Study|Withdrawal by Subject|0|||
106102121|NCT03263429|366029200|FG000|Overall Study|Follow-Up Period Completed|0|||
106102122|NCT03263429|366029201|FG001|Overall Study|Follow-Up Period Completed|2|||
106102123|NCT03263429|366029202|FG002|Overall Study|Follow-Up Period Completed|0|||
106102124|NCT03263429|366029200|FG000|Overall Study|Death|3|||
106102125|NCT03263429|366029201|FG001|Overall Study|Death|5|||
106102126|NCT03263429|366029202|FG002|Overall Study|Death|16|||
106102127|NCT03263429|366029200|FG000|Overall Study|Participant unable to return|0|||
106102128|NCT03263429|366029201|FG001|Overall Study|Participant unable to return|0|||
106102129|NCT03263429|366029202|FG002|Overall Study|Participant unable to return|1|||
106102130|NCT03263429|366029200|FG000|Overall Study|Study Closed|0|||
106102131|NCT03263429|366029201|FG001|Overall Study|Study Closed|0|||
106102132|NCT03263429|366029202|FG002|Overall Study|Study Closed|1|||
106102133|NCT02384759|366029203|FG000|Overall Study|Patients not treated|3|||
106102134|NCT02384759|366029204|FG001|Overall Study|Patients not treated|2|||
106102135|NCT00325468|366029209|FG000|Overall Study|Adverse Event|1|||
106102136|NCT00325468|366029210|FG001|Overall Study|Adverse Event|1|||
106102137|NCT00325468|366029211|FG002|Overall Study|Adverse Event|0|||
106102138|NCT00325468|366029212|FG003|Overall Study|Adverse Event|5|||
106102139|NCT00325468|366029213|FG004|Overall Study|Adverse Event|1|||
106102140|NCT00325468|366029209|FG000|Overall Study|Death|2|||
106102141|NCT00325468|366029210|FG001|Overall Study|Death|0|||
106102142|NCT00325468|366029211|FG002|Overall Study|Death|2|||
106102143|NCT00325468|366029212|FG003|Overall Study|Death|4|||
106102144|NCT00325468|366029213|FG004|Overall Study|Death|0|||
106102145|NCT00325468|366029209|FG000|Overall Study|Lost to Follow-up|0|||
106102146|NCT00325468|366029210|FG001|Overall Study|Lost to Follow-up|0|||
106102147|NCT00325468|366029211|FG002|Overall Study|Lost to Follow-up|1|||
106102148|NCT00325468|366029212|FG003|Overall Study|Lost to Follow-up|2|||
106102149|NCT00325468|366029213|FG004|Overall Study|Lost to Follow-up|2|||
106102150|NCT00325468|366029209|FG000|Overall Study|Physician Decision|1|||
106102151|NCT00325468|366029210|FG001|Overall Study|Physician Decision|1|||
106102152|NCT00325468|366029211|FG002|Overall Study|Physician Decision|0|||
106102153|NCT00325468|366029212|FG003|Overall Study|Physician Decision|1|||
106102154|NCT00325468|366029213|FG004|Overall Study|Physician Decision|0|||
106102155|NCT00325468|366029209|FG000|Overall Study|Withdrawal by Subject|3|||
106102156|NCT00325468|366029210|FG001|Overall Study|Withdrawal by Subject|1|||
106102157|NCT00325468|366029211|FG002|Overall Study|Withdrawal by Subject|0|||
106102158|NCT00325468|366029212|FG003|Overall Study|Withdrawal by Subject|14|||
106102159|NCT00325468|366029213|FG004|Overall Study|Withdrawal by Subject|4|||
106102160|NCT00325468|366029209|FG000|Overall Study|site closure etc|4|||
106102161|NCT00325468|366029210|FG001|Overall Study|site closure etc|2|||
106102162|NCT00325468|366029211|FG002|Overall Study|site closure etc|1|||
106102163|NCT00325468|366029212|FG003|Overall Study|site closure etc|8|||
106102164|NCT00325468|366029213|FG004|Overall Study|site closure etc|1|||
106102165|NCT03280121|366029216|FG000|Overall Study|Physician Decision|1|||
106102166|NCT03280121|366029216|FG000|Overall Study|Lost to Follow-up|1|||
106102167|NCT03280121|366029216|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
106102168|NCT01933932|366029229|FG000|Overall Study|Death|173|||
106102169|NCT01933932|366029230|FG001|Overall Study|Death|163|||
106102170|NCT01933932|366029229|FG000|Overall Study|Withdrawal by Subject|11|||
106102171|NCT01933932|366029230|FG001|Overall Study|Withdrawal by Subject|14|||
106102172|NCT01933932|366029229|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
106102173|NCT01933932|366029230|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
106102174|NCT04969198|366029231|FG000|Overall Study|Withdrawal by Subject|20|||
106102175|NCT04969198|366029231|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
106102176|NCT04969198|366029231|FG000|Overall Study|Lost to Follow-up|20|||
106102177|NCT02085408|366029232|FG000|Step 1: Induction|Disease Progression|19|||
106102178|NCT02085408|366029233|FG001|Step 1: Induction|Disease Progression|19|||
106102179|NCT02085408|366029232|FG000|Step 1: Induction|Adverse Event|18|||
106102180|NCT02085408|366029233|FG001|Step 1: Induction|Adverse Event|17|||
106102181|NCT02085408|366029232|FG000|Step 1: Induction|Death|33|||
106102182|NCT02085408|366029233|FG001|Step 1: Induction|Death|30|||
106102183|NCT02085408|366029232|FG000|Step 1: Induction|Withdrawal by Subject|16|||
106102184|NCT02085408|366029233|FG001|Step 1: Induction|Withdrawal by Subject|8|||
106102185|NCT02085408|366029232|FG000|Step 1: Induction|Alternative Therapy|15|||
106102186|NCT02085408|366029233|FG001|Step 1: Induction|Alternative Therapy|19|||
106102187|NCT02085408|366029232|FG000|Step 1: Induction|Complicating Disease|2|||
106102188|NCT02085408|366029233|FG001|Step 1: Induction|Complicating Disease|3|||
105781725|NCT00313716|364854825|FG002|Overall Study|Withdrawal by Subject|1|||
106102189|NCT02085408|366029232|FG000|Step 1: Induction|Other|27|||
106102190|NCT02085408|366029233|FG001|Step 1: Induction|Other|39|||
106102191|NCT02085408|366029232|FG000|Step 1: Induction|Never started treatment|6|||
106102192|NCT02085408|366029233|FG001|Step 1: Induction|Never started treatment|4|||
106102193|NCT02085408|366029232|FG000|Step 2: Consolidation|Disease Progression|5|||
106102194|NCT02085408|366029233|FG001|Step 2: Consolidation|Disease Progression|20|||
106102195|NCT02085408|366029232|FG000|Step 2: Consolidation|Adverse Event|9|||
106102196|NCT02085408|366029233|FG001|Step 2: Consolidation|Adverse Event|8|||
106102197|NCT02085408|366029232|FG000|Step 2: Consolidation|Death|4|||
106102198|NCT02085408|366029233|FG001|Step 2: Consolidation|Death|3|||
106102199|NCT02085408|366029232|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
106102200|NCT02085408|366029233|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
106102201|NCT02085408|366029232|FG000|Step 2: Consolidation|Alternative Therapy|9|||
106102202|NCT02085408|366029233|FG001|Step 2: Consolidation|Alternative Therapy|3|||
106102203|NCT02085408|366029232|FG000|Step 2: Consolidation|Complicating Disease|0|||
106102204|NCT02085408|366029233|FG001|Step 2: Consolidation|Complicating Disease|2|||
106102205|NCT02085408|366029232|FG000|Step 2: Consolidation|Other|6|||
106102206|NCT02085408|366029233|FG001|Step 2: Consolidation|Other|6|||
106102207|NCT02085408|366029232|FG000|Step 2: Consolidation|Never started treatment|4|||
106102208|NCT02085408|366029233|FG001|Step 2: Consolidation|Never started treatment|3|||
106102209|NCT02085408|366029232|FG000|Step 3: Maintenance|Disease Progression|13|||
106102210|NCT02085408|366029233|FG001|Step 3: Maintenance|Disease Progression|11|||
106102211|NCT02085408|366029232|FG000|Step 3: Maintenance|Adverse Event|2|||
106102212|NCT02085408|366029233|FG001|Step 3: Maintenance|Adverse Event|4|||
106102213|NCT02085408|366029232|FG000|Step 3: Maintenance|Death|1|||
106102214|NCT02085408|366029233|FG001|Step 3: Maintenance|Death|2|||
106102215|NCT02085408|366029232|FG000|Step 3: Maintenance|Alternative Therapy|1|||
106102216|NCT02085408|366029233|FG001|Step 3: Maintenance|Alternative Therapy|1|||
106102217|NCT02085408|366029232|FG000|Step 3: Maintenance|Complicating Disease|0|||
106102218|NCT02085408|366029233|FG001|Step 3: Maintenance|Complicating Disease|1|||
106102219|NCT02085408|366029232|FG000|Step 3: Maintenance|Other|3|||
106102220|NCT02085408|366029233|FG001|Step 3: Maintenance|Other|2|||
106102221|NCT02085408|366029232|FG000|Step 3: Maintenance|Never started treatment|5|||
106102222|NCT02085408|366029233|FG001|Step 3: Maintenance|Never started treatment|1|||
106102223|NCT02273141|366029235|FG000|Overall Study|Adverse Event|0|||
106102224|NCT02273141|366029236|FG001|Overall Study|Adverse Event|1|||
106102225|NCT02273141|366029235|FG000|Overall Study|Lost to Follow-up|1|||
106102226|NCT02273141|366029236|FG001|Overall Study|Lost to Follow-up|3|||
106102227|NCT02273141|366029235|FG000|Overall Study|Withdrawal by Subject|10|||
106102228|NCT02273141|366029236|FG001|Overall Study|Withdrawal by Subject|15|||
106102229|NCT02273141|366029235|FG000|Overall Study|Various|6|||
106102230|NCT02273141|366029236|FG001|Overall Study|Various|6|||
106102231|NCT00688636|366029241|FG000|Overall Study|Adverse Event|2|||
106102232|NCT00688636|366029242|FG001|Overall Study|Adverse Event|1|||
106102233|NCT04053764|366029243|FG000|Overall Study|Withdrawal by Subject|6|||
106102234|NCT04053764|366029244|FG001|Overall Study|Withdrawal by Subject|2|||
106102235|NCT04053764|366029243|FG000|Overall Study|Physician Decision|2|||
106102236|NCT04053764|366029244|FG001|Overall Study|Physician Decision|1|||
106102237|NCT04053764|366029243|FG000|Overall Study|Adverse Event|1|||
106102238|NCT04053764|366029244|FG001|Overall Study|Adverse Event|0|||
106102239|NCT04053764|366029243|FG000|Overall Study|Pregnancy|1|||
106102240|NCT04053764|366029244|FG001|Overall Study|Pregnancy|0|||
106102241|NCT04732286|366029248|FG000|Overall Study|Progressive Disease|2|||
106102242|NCT04732286|366029248|FG000|Overall Study|Physician Decision|1|||
106102243|NCT04732286|366029248|FG000|Overall Study|Study Terminated by Sponsor|31|||
106102244|NCT04732286|366029248|FG000|Overall Study|Withdrawal by Subject|10|||
106102245|NCT04732286|366029248|FG000|Overall Study|Non-compliance With Study Drug|1|||
106102246|NCT04732286|366029248|FG000|Overall Study|Lost to Follow-up|4|||
106102247|NCT04732286|366029248|FG000|Overall Study|Death|51|||
106102248|NCT00319098|366029253|FG000|Overall Study|Serious adverse event|3|||
106102249|NCT00319098|366029254|FG001|Overall Study|Serious adverse event|0|||
106102250|NCT00319098|366029253|FG000|Overall Study|Adverse Event|20|||
106102251|NCT00319098|366029254|FG001|Overall Study|Adverse Event|1|||
106102252|NCT00319098|366029253|FG000|Overall Study|Withdrawal by Subject|37|||
106102253|NCT00319098|366029254|FG001|Overall Study|Withdrawal by Subject|8|||
106102254|NCT00319098|366029253|FG000|Overall Study|Migrated/moved from study area|2|||
106102255|NCT00319098|366029254|FG001|Overall Study|Migrated/moved from study area|1|||
106102256|NCT00319098|366029253|FG000|Overall Study|Lost to Follow-up|37|||
106102257|NCT00319098|366029254|FG001|Overall Study|Lost to Follow-up|13|||
106102258|NCT00319098|366029253|FG000|Overall Study|Others|33|||
106102259|NCT00319098|366029254|FG001|Overall Study|Others|8|||
106102260|NCT00319098|366029253|FG000|Overall Study|Protocol Violation|3|||
106102261|NCT00319098|366029254|FG001|Overall Study|Protocol Violation|1|||
106102262|NCT03282227|366029256|FG000|Overall Study|Exposure Goals Achieved|60|||
106102263|NCT03282227|366029256|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
106102264|NCT03282227|366029256|FG000|Overall Study|Adverse Event|15|||
106102265|NCT03282227|366029256|FG000|Overall Study|Lost to Follow-up|21|||
105992610|NCT03188510|365631585|FG001|Overall Study|Inappropriate behavior with site staff|1|||
106102266|NCT03282227|366029256|FG000|Overall Study|Withdrawal by Subject|20|||
106102267|NCT03282227|366029256|FG000|Overall Study|Lack of Efficacy|12|||
106102268|NCT03282227|366029256|FG000|Overall Study|Sponsor decision|3|||
106102269|NCT03282227|366029256|FG000|Overall Study|Physician Decision|2|||
106102270|NCT03282227|366029256|FG000|Overall Study|Pregnancy|2|||
106102271|NCT03282227|366029256|FG000|Overall Study|Other|1|||
106102272|NCT00535730|366029257|FG000|Overall Study|Adverse Event|1|||
106102273|NCT00535730|366029258|FG001|Overall Study|Adverse Event|1|||
106102274|NCT00535730|366029257|FG000|Overall Study|Lost to Follow-up|0|||
106102275|NCT00535730|366029258|FG001|Overall Study|Lost to Follow-up|1|||
106102276|NCT00535730|366029257|FG000|Overall Study|Physician Decision|0|||
106102277|NCT00535730|366029258|FG001|Overall Study|Physician Decision|1|||
106102278|NCT00535730|366029257|FG000|Overall Study|Protocol Violation|1|||
106102279|NCT00535730|366029258|FG001|Overall Study|Protocol Violation|0|||
106102280|NCT00535730|366029257|FG000|Overall Study|Withdrawal by Subject|0|||
106102281|NCT00535730|366029258|FG001|Overall Study|Withdrawal by Subject|4|||
106102282|NCT02293538|366029259|FG000|Overall Study|Adverse Event|0|||
106102283|NCT02293538|366029260|FG001|Overall Study|Adverse Event|1|||
106102284|NCT02293538|366029259|FG000|Overall Study|Lost to Follow-up|1|||
106102285|NCT02293538|366029260|FG001|Overall Study|Lost to Follow-up|0|||
106102286|NCT02293538|366029259|FG000|Overall Study|Withdrawal by Subject|0|||
106102287|NCT02293538|366029260|FG001|Overall Study|Withdrawal by Subject|1|||
106102288|NCT02363946|366029261|FG000|Overall Study|Lost to Follow-up|0|||
106102289|NCT02363946|366029262|FG001|Overall Study|Lost to Follow-up|0|||
106102290|NCT02363946|366029263|FG002|Overall Study|Lost to Follow-up|0|||
106102291|NCT02363946|366029264|FG003|Overall Study|Lost to Follow-up|0|||
106102292|NCT02363946|366029265|FG004|Overall Study|Lost to Follow-up|0|||
106102293|NCT02363946|366029266|FG005|Overall Study|Lost to Follow-up|0|||
106102294|NCT02363946|366029267|FG006|Overall Study|Lost to Follow-up|0|||
106102295|NCT02363946|366029268|FG007|Overall Study|Lost to Follow-up|1|||
106102296|NCT02363946|366029269|FG008|Overall Study|Lost to Follow-up|0|||
106102297|NCT02363946|366029270|FG009|Overall Study|Lost to Follow-up|0|||
106102298|NCT02363946|366029271|FG010|Overall Study|Lost to Follow-up|0|||
106102299|NCT02363946|366029272|FG011|Overall Study|Lost to Follow-up|0|||
106102300|NCT02363946|366029273|FG012|Overall Study|Lost to Follow-up|0|||
106102301|NCT01302119|366029284|FG000|Overall Study|Withdrawal by Subject|30|||
106102302|NCT01302119|366029285|FG001|Overall Study|Withdrawal by Subject|20|||
106102303|NCT01302119|366029284|FG000|Overall Study|Lost to Follow-up|10|||
106102304|NCT01302119|366029285|FG001|Overall Study|Lost to Follow-up|4|||
106102305|NCT01302119|366029284|FG000|Overall Study|Adverse Event|2|||
106102306|NCT01302119|366029285|FG001|Overall Study|Adverse Event|1|||
106102307|NCT01302119|366029284|FG000|Overall Study|Non-compliance|4|||
106102308|NCT01302119|366029285|FG001|Overall Study|Non-compliance|2|||
106102309|NCT01302119|366029284|FG000|Overall Study|Non-specific|4|||
106102310|NCT01302119|366029285|FG001|Overall Study|Non-specific|1|||
106102311|NCT00622167|366029286|FG000|Overall Study|Did not meet angiographic criteria|20|||
106102312|NCT03743038|366029287|FG000|Overall Study|Physician Decision|1|||
106102313|NCT05207813|366029288|FG000|Overall Study|Lost to Follow-up|2|||
106102314|NCT04988308|366029289|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
106102315|NCT04988308|366029290|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
106102316|NCT04988308|366029291|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
106102317|NCT04988308|366029292|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
106102318|NCT04988308|366029293|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
106102319|NCT04988308|366029294|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
106102320|NCT04988308|366029289|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
106102321|NCT04988308|366029290|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
106102322|NCT04988308|366029291|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
106102323|NCT04988308|366029292|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
106102324|NCT04988308|366029293|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
106102325|NCT04988308|366029294|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
106102326|NCT04988308|366029289|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
106102327|NCT04988308|366029290|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
106102328|NCT04988308|366029291|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
106102329|NCT04988308|366029292|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
106102330|NCT04988308|366029293|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
106102331|NCT04988308|366029294|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
106102332|NCT04988308|366029289|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
106102333|NCT04988308|366029290|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
106102334|NCT04988308|366029291|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
106102335|NCT04988308|366029292|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
106102336|NCT04988308|366029293|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
106102337|NCT04988308|366029294|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
106102338|NCT04988308|366029289|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
106102339|NCT04988308|366029290|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
106102340|NCT04988308|366029291|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
106102341|NCT04988308|366029292|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
106102342|NCT04988308|366029293|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
106102343|NCT04988308|366029294|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
106102344|NCT04988308|366029289|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
106102345|NCT04988308|366029290|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
106102346|NCT04988308|366029291|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
106102347|NCT04988308|366029292|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
106102348|NCT04988308|366029293|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
106102349|NCT04988308|366029294|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
106102350|NCT04988308|366029289|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
106102351|NCT04988308|366029290|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
106102352|NCT04988308|366029291|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
106102353|NCT04988308|366029292|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
106102354|NCT04988308|366029293|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
106102355|NCT04988308|366029294|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
106102356|NCT04988308|366029289|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
106102357|NCT04988308|366029290|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
106102358|NCT04988308|366029291|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
106102359|NCT04988308|366029292|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
106102360|NCT04988308|366029293|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
106102361|NCT04988308|366029294|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
106102362|NCT04988308|366029289|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
106102363|NCT04988308|366029290|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
106102364|NCT04988308|366029291|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
106102365|NCT04988308|366029292|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
106102366|NCT04988308|366029293|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
106102367|NCT04988308|366029294|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
106102368|NCT01371851|366029300|FG000|Overall Study|Lost to Follow-up|5|||
106102369|NCT01371851|366029301|FG001|Overall Study|Lost to Follow-up|8|||
106102370|NCT01371851|366029300|FG000|Overall Study|was arrested and put in jail|0|||
106102371|NCT01371851|366029301|FG001|Overall Study|was arrested and put in jail|1|||
106102372|NCT01371851|366029300|FG000|Overall Study|non study related adverse event|1|||
106102373|NCT01371851|366029301|FG001|Overall Study|non study related adverse event|0|||
106102374|NCT01371851|366029300|FG000|Overall Study|Blood Pressure outside study parameters|2|||
106102375|NCT01371851|366029301|FG001|Overall Study|Blood Pressure outside study parameters|0|||
106102376|NCT00234065|366029306|FG000|Overall Study|Adverse Event|268|||
106102377|NCT00234065|366029307|FG001|Overall Study|Adverse Event|166|||
106102378|NCT00234065|366029306|FG000|Overall Study|Withdrawal by Subject|73|||
106102379|NCT00234065|366029307|FG001|Overall Study|Withdrawal by Subject|56|||
106102380|NCT00234065|366029306|FG000|Overall Study|Physician Decision|23|||
106102381|NCT00234065|366029307|FG001|Overall Study|Physician Decision|22|||
106102382|NCT00234065|366029306|FG000|Overall Study|Not Classified|111|||
106102383|NCT00234065|366029307|FG001|Overall Study|Not Classified|112|||
106102384|NCT01738984|366030957|FG000|Overall Study|Pregnancy|4|||
106102385|NCT01738984|366030958|FG001|Overall Study|Pregnancy|0|||
106102386|NCT01738984|366030957|FG000|Overall Study|Withdrawal by Subject|1|||
106102387|NCT01738984|366030958|FG001|Overall Study|Withdrawal by Subject|0|||
106102388|NCT01738984|366030957|FG000|Overall Study|Lost to Follow-up|59|||
106102389|NCT01738984|366030958|FG001|Overall Study|Lost to Follow-up|39|||
106102390|NCT02207816|366030964|FG000|Overall Study|Serious Adverse Event|0|||
106102391|NCT02207816|366030965|FG001|Overall Study|Serious Adverse Event|5|||
106102392|NCT02207816|366030966|FG002|Overall Study|Serious Adverse Event|2|||
106102393|NCT02207816|366030964|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
106102394|NCT02207816|366030965|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
106102395|NCT02207816|366030966|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
106102396|NCT02207816|366030964|FG000|Overall Study|Withdrawal by Subject|4|||
106102397|NCT02207816|366030965|FG001|Overall Study|Withdrawal by Subject|9|||
106102398|NCT02207816|366030966|FG002|Overall Study|Withdrawal by Subject|7|||
106102399|NCT02207816|366030964|FG000|Overall Study|Migrated/Moved From Study Area|41|||
106102400|NCT02207816|366030965|FG001|Overall Study|Migrated/Moved From Study Area|60|||
106102401|NCT02207816|366030966|FG002|Overall Study|Migrated/Moved From Study Area|51|||
106102402|NCT02207816|366030964|FG000|Overall Study|Lost to Follow-up|3|||
106102403|NCT02207816|366030965|FG001|Overall Study|Lost to Follow-up|9|||
106102404|NCT02207816|366030966|FG002|Overall Study|Lost to Follow-up|1|||
106102405|NCT02207816|366030964|FG000|Overall Study|Other|1|||
106102406|NCT02207816|366030965|FG001|Overall Study|Other|2|||
106102407|NCT02207816|366030966|FG002|Overall Study|Other|4|||
106102408|NCT02925455|366030973|FG000|Overall Study|Withdrawal by Subject|2|||
106102409|NCT02925455|366030974|FG001|Overall Study|Withdrawal by Subject|0|||
106102410|NCT01549613|366030975|FG000|Overall Study|Lost to Follow-up|11|||
106102411|NCT01549613|366030976|FG001|Overall Study|Lost to Follow-up|11|||
106102412|NCT03489304|366030977|FG000|Overall Study|Lost to Follow-up|4|||
106102413|NCT00605293|366030978|FG000|Overall Study|Death|2|||
106102414|NCT00605293|366030979|FG001|Overall Study|Death|1|||
106102415|NCT00605293|366030978|FG000|Overall Study|Insufficient Therapeutic Response|2|||
106102416|NCT00605293|366030979|FG001|Overall Study|Insufficient Therapeutic Response|0|||
106102417|NCT00605293|366030978|FG000|Overall Study|Adverse Event|1|||
106102418|NCT00605293|366030979|FG001|Overall Study|Adverse Event|0|||
106102419|NCT00605293|366030978|FG000|Overall Study|Holidays Dialysis Out|1|||
106102420|NCT00605293|366030979|FG001|Overall Study|Holidays Dialysis Out|0|||
106102421|NCT00605293|366030978|FG000|Overall Study|Blood Transfusion|7|||
106102422|NCT00605293|366030979|FG001|Overall Study|Blood Transfusion|1|||
106102423|NCT00605293|366030978|FG000|Overall Study|Renal Transplantation|3|||
106102424|NCT00605293|366030979|FG001|Overall Study|Renal Transplantation|1|||
106102425|NCT00605293|366030978|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
106102426|NCT00605293|366030979|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
106102427|NCT00605293|366030978|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
106102428|NCT00605293|366030979|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
106102429|NCT00605293|366030978|FG000|Overall Study|Principal Investigator Decision|0|||
106102430|NCT00605293|366030979|FG001|Overall Study|Principal Investigator Decision|1|||
106102431|NCT03162224|366030980|FG000|Overall Study|Death|4|||
106102432|NCT03162224|366030981|FG001|Overall Study|Death|5|||
106102433|NCT03162224|366030982|FG002|Overall Study|Death|8|||
106102434|NCT03162224|366030980|FG000|Overall Study|Withdrawal by Subject|1|||
106102435|NCT03162224|366030981|FG001|Overall Study|Withdrawal by Subject|0|||
106102436|NCT03162224|366030982|FG002|Overall Study|Withdrawal by Subject|1|||
106102437|NCT03162224|366030980|FG000|Overall Study|Lost to Follow-up|0|||
106102438|NCT03162224|366030981|FG001|Overall Study|Lost to Follow-up|1|||
106102439|NCT03162224|366030982|FG002|Overall Study|Lost to Follow-up|0|||
106102440|NCT03162224|366030980|FG000|Overall Study|Other|6|||
106102441|NCT03162224|366030981|FG001|Overall Study|Other|2|||
106102442|NCT03162224|366030982|FG002|Overall Study|Other|1|||
106102443|NCT00713648|366030986|FG000|Overall Study|Adverse Event|1|||
106102444|NCT00713648|366030986|FG000|Overall Study|Unclassified|2|||
106102445|NCT00713648|366030986|FG000|Overall Study|According to Protocol|2|||
106102446|NCT00713648|366030986|FG000|Overall Study|Development of antibodies|3|||
106102447|NCT02047045|366030987|FG000|Baseline|Withdrawal by Subject|3|||
106102448|NCT02047045|366030988|FG001|Baseline|Withdrawal by Subject|2|||
106102449|NCT02047045|366030987|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
106102450|NCT02047045|366030988|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
106102451|NCT02047045|366030987|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
106102452|NCT02047045|366030988|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
106102453|NCT02047045|366030987|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
106102454|NCT02047045|366030988|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
106102455|NCT02047045|366030987|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
106102456|NCT02047045|366030988|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
106102457|NCT02047045|366030987|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
106102458|NCT02047045|366030988|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
106102459|NCT02047045|366030987|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
106102460|NCT02047045|366030988|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
106102461|NCT02047045|366030987|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
106102462|NCT02047045|366030988|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
106102463|NCT02047045|366030987|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
106102464|NCT02047045|366030988|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
106102465|NCT03214367|366030989|FG000|Lead-in Period|Withdrawal by Subject|50|||
106102466|NCT03214367|366030990|FG001|Lead-in Period|Withdrawal by Subject|0|||
106102467|NCT03214367|366030991|FG002|Lead-in Period|Withdrawal by Subject|0|||
106102468|NCT03214367|366030992|FG003|Lead-in Period|Withdrawal by Subject|0|||
106102469|NCT03214367|366030993|FG004|Lead-in Period|Withdrawal by Subject|2|||
106102470|NCT03214367|366030994|FG005|Lead-in Period|Withdrawal by Subject|0|||
106102471|NCT03214367|366030995|FG006|Lead-in Period|Withdrawal by Subject|0|||
106102472|NCT03214367|366030996|FG007|Lead-in Period|Withdrawal by Subject|0|||
106102473|NCT03214367|366030989|FG000|Lead-in Period|Adverse Event|3|||
106102474|NCT03214367|366030990|FG001|Lead-in Period|Adverse Event|0|||
106102475|NCT03214367|366030991|FG002|Lead-in Period|Adverse Event|0|||
106102476|NCT03214367|366030992|FG003|Lead-in Period|Adverse Event|0|||
106102477|NCT03214367|366030993|FG004|Lead-in Period|Adverse Event|0|||
106102478|NCT03214367|366030994|FG005|Lead-in Period|Adverse Event|0|||
106102479|NCT03214367|366030995|FG006|Lead-in Period|Adverse Event|0|||
106102480|NCT03214367|366030996|FG007|Lead-in Period|Adverse Event|0|||
106102481|NCT03214367|366030989|FG000|Lead-in Period|Lost to Follow-up|12|||
106102482|NCT03214367|366030990|FG001|Lead-in Period|Lost to Follow-up|0|||
106102483|NCT03214367|366030991|FG002|Lead-in Period|Lost to Follow-up|0|||
106102484|NCT03214367|366030992|FG003|Lead-in Period|Lost to Follow-up|0|||
106102485|NCT03214367|366030993|FG004|Lead-in Period|Lost to Follow-up|0|||
106102486|NCT03214367|366030994|FG005|Lead-in Period|Lost to Follow-up|0|||
106102487|NCT03214367|366030995|FG006|Lead-in Period|Lost to Follow-up|0|||
106102488|NCT03214367|366030996|FG007|Lead-in Period|Lost to Follow-up|0|||
106102489|NCT03214367|366030989|FG000|Lead-in Period|Sponsor Decision|11|||
106102490|NCT03214367|366030990|FG001|Lead-in Period|Sponsor Decision|0|||
106102491|NCT03214367|366030991|FG002|Lead-in Period|Sponsor Decision|0|||
106102492|NCT03214367|366030992|FG003|Lead-in Period|Sponsor Decision|0|||
106102493|NCT03214367|366030993|FG004|Lead-in Period|Sponsor Decision|0|||
106102494|NCT03214367|366030994|FG005|Lead-in Period|Sponsor Decision|0|||
106102495|NCT03214367|366030995|FG006|Lead-in Period|Sponsor Decision|0|||
106102496|NCT03214367|366030996|FG007|Lead-in Period|Sponsor Decision|0|||
106102497|NCT03214367|366030989|FG000|Lead-in Period|Physician Decision|12|||
106102498|NCT03214367|366030990|FG001|Lead-in Period|Physician Decision|0|||
106102499|NCT03214367|366030991|FG002|Lead-in Period|Physician Decision|0|||
106102500|NCT03214367|366030992|FG003|Lead-in Period|Physician Decision|0|||
106102501|NCT03214367|366030993|FG004|Lead-in Period|Physician Decision|0|||
106102502|NCT03214367|366030994|FG005|Lead-in Period|Physician Decision|0|||
106102503|NCT03214367|366030995|FG006|Lead-in Period|Physician Decision|0|||
106102504|NCT03214367|366030996|FG007|Lead-in Period|Physician Decision|0|||
106102505|NCT03214367|366030989|FG000|Lead-in Period|Protocol Violation|5|||
106102506|NCT03214367|366030990|FG001|Lead-in Period|Protocol Violation|0|||
106102507|NCT03214367|366030991|FG002|Lead-in Period|Protocol Violation|0|||
106102508|NCT03214367|366030992|FG003|Lead-in Period|Protocol Violation|0|||
106102509|NCT03214367|366030993|FG004|Lead-in Period|Protocol Violation|0|||
106102510|NCT03214367|366030994|FG005|Lead-in Period|Protocol Violation|0|||
106102511|NCT03214367|366030995|FG006|Lead-in Period|Protocol Violation|0|||
106102512|NCT03214367|366030996|FG007|Lead-in Period|Protocol Violation|0|||
106102513|NCT03214367|366030989|FG000|Lead-in Period|Treatment Interruption|1|||
106102514|NCT03214367|366030990|FG001|Lead-in Period|Treatment Interruption|0|||
106102515|NCT03214367|366030991|FG002|Lead-in Period|Treatment Interruption|0|||
106102516|NCT03214367|366030992|FG003|Lead-in Period|Treatment Interruption|0|||
106102517|NCT03214367|366030993|FG004|Lead-in Period|Treatment Interruption|0|||
106102518|NCT03214367|366030994|FG005|Lead-in Period|Treatment Interruption|0|||
106102519|NCT03214367|366030995|FG006|Lead-in Period|Treatment Interruption|0|||
106102520|NCT03214367|366030996|FG007|Lead-in Period|Treatment Interruption|0|||
106102521|NCT03214367|366030989|FG000|Treatment Period|Adverse Event|0|||
106102522|NCT03214367|366030990|FG001|Treatment Period|Adverse Event|1|||
106102523|NCT03214367|366030991|FG002|Treatment Period|Adverse Event|4|||
106102524|NCT03214367|366030992|FG003|Treatment Period|Adverse Event|2|||
106102525|NCT03214367|366030993|FG004|Treatment Period|Adverse Event|0|||
106102526|NCT03214367|366030994|FG005|Treatment Period|Adverse Event|0|||
106102527|NCT03214367|366030995|FG006|Treatment Period|Adverse Event|0|||
106102528|NCT03214367|366030996|FG007|Treatment Period|Adverse Event|0|||
106102529|NCT03214367|366030989|FG000|Treatment Period|Death|0|||
106102530|NCT03214367|366030990|FG001|Treatment Period|Death|1|||
106102531|NCT03214367|366030991|FG002|Treatment Period|Death|1|||
106102532|NCT03214367|366030992|FG003|Treatment Period|Death|1|||
106102533|NCT03214367|366030993|FG004|Treatment Period|Death|0|||
106102534|NCT03214367|366030994|FG005|Treatment Period|Death|0|||
106102535|NCT03214367|366030995|FG006|Treatment Period|Death|0|||
106102536|NCT03214367|366030996|FG007|Treatment Period|Death|0|||
106102537|NCT03214367|366030989|FG000|Treatment Period|Lost to Follow-up|0|||
106102538|NCT03214367|366030990|FG001|Treatment Period|Lost to Follow-up|5|||
106102539|NCT03214367|366030991|FG002|Treatment Period|Lost to Follow-up|3|||
106102540|NCT03214367|366030992|FG003|Treatment Period|Lost to Follow-up|2|||
106102541|NCT03214367|366030993|FG004|Treatment Period|Lost to Follow-up|0|||
106102542|NCT03214367|366030994|FG005|Treatment Period|Lost to Follow-up|2|||
106102543|NCT03214367|366030995|FG006|Treatment Period|Lost to Follow-up|1|||
106102544|NCT03214367|366030996|FG007|Treatment Period|Lost to Follow-up|0|||
106102545|NCT03214367|366030989|FG000|Treatment Period|Sponsor Decision|0|||
106102546|NCT03214367|366030990|FG001|Treatment Period|Sponsor Decision|3|||
106102547|NCT03214367|366030991|FG002|Treatment Period|Sponsor Decision|0|||
106102548|NCT03214367|366030992|FG003|Treatment Period|Sponsor Decision|0|||
106102549|NCT03214367|366030993|FG004|Treatment Period|Sponsor Decision|0|||
106102550|NCT03214367|366030994|FG005|Treatment Period|Sponsor Decision|0|||
106102551|NCT03214367|366030995|FG006|Treatment Period|Sponsor Decision|0|||
106102552|NCT03214367|366030996|FG007|Treatment Period|Sponsor Decision|0|||
106102553|NCT03214367|366030989|FG000|Treatment Period|Physician Decision|0|||
106102554|NCT03214367|366030990|FG001|Treatment Period|Physician Decision|1|||
106102555|NCT03214367|366030991|FG002|Treatment Period|Physician Decision|2|||
106102556|NCT03214367|366030992|FG003|Treatment Period|Physician Decision|0|||
106102557|NCT03214367|366030993|FG004|Treatment Period|Physician Decision|0|||
106102558|NCT03214367|366030994|FG005|Treatment Period|Physician Decision|0|||
106102559|NCT03214367|366030995|FG006|Treatment Period|Physician Decision|0|||
106102560|NCT03214367|366030996|FG007|Treatment Period|Physician Decision|0|||
106102561|NCT03214367|366030989|FG000|Treatment Period|Protocol Violation|0|||
106102562|NCT03214367|366030990|FG001|Treatment Period|Protocol Violation|3|||
106102563|NCT03214367|366030991|FG002|Treatment Period|Protocol Violation|0|||
106102564|NCT03214367|366030992|FG003|Treatment Period|Protocol Violation|0|||
106102565|NCT03214367|366030993|FG004|Treatment Period|Protocol Violation|0|||
106102566|NCT03214367|366030994|FG005|Treatment Period|Protocol Violation|0|||
106102567|NCT03214367|366030995|FG006|Treatment Period|Protocol Violation|0|||
106102568|NCT03214367|366030996|FG007|Treatment Period|Protocol Violation|0|||
106102569|NCT03214367|366030989|FG000|Treatment Period|Withdrawal by Subject|0|||
106102570|NCT03214367|366030990|FG001|Treatment Period|Withdrawal by Subject|20|||
106102571|NCT03214367|366030991|FG002|Treatment Period|Withdrawal by Subject|23|||
106102572|NCT03214367|366030992|FG003|Treatment Period|Withdrawal by Subject|14|||
106102573|NCT03214367|366030993|FG004|Treatment Period|Withdrawal by Subject|0|||
106102574|NCT03214367|366030994|FG005|Treatment Period|Withdrawal by Subject|1|||
106102575|NCT03214367|366030995|FG006|Treatment Period|Withdrawal by Subject|1|||
106102576|NCT03214367|366030996|FG007|Treatment Period|Withdrawal by Subject|1|||
106102577|NCT03508843|366030997|FG000|Overall Study|Withdrawal by Subject|1|||
106102578|NCT03508843|366030997|FG000|Overall Study|technical difficulties|2|||
106102579|NCT04154956|366030998|FG000|Overall Study|Death|109|||
106102580|NCT04154956|366030999|FG001|Overall Study|Death|110|||
106102581|NCT04154956|366030998|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
106102582|NCT04154956|366030999|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
106102583|NCT04154956|366030998|FG000|Overall Study|Withdrawal by Subject|1|||
106102584|NCT04154956|366030999|FG001|Overall Study|Withdrawal by Subject|7|||
106102585|NCT04154956|366030998|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
106102586|NCT04154956|366030999|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
106102587|NCT00254982|366031000|FG000|Overall Study|Other|2|||
106102588|NCT00254982|366031001|FG001|Overall Study|Other|1|||
106102589|NCT00254982|366031000|FG000|Overall Study|Lack of Efficacy|5|||
106102590|NCT00254982|366031001|FG001|Overall Study|Lack of Efficacy|3|||
106102591|NCT00254982|366031000|FG000|Overall Study|Lost to Follow-up|5|||
106102592|NCT00254982|366031001|FG001|Overall Study|Lost to Follow-up|3|||
106102593|NCT00254982|366031000|FG000|Overall Study|Adverse Event|18|||
106102594|NCT00254982|366031001|FG001|Overall Study|Adverse Event|16|||
106102595|NCT00254982|366031000|FG000|Overall Study|Withdrawal by Subject|1|||
106102596|NCT00254982|366031001|FG001|Overall Study|Withdrawal by Subject|1|||
106102597|NCT00254982|366031000|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
106102598|NCT00254982|366031001|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
106102599|NCT00254982|366031000|FG000|Overall Study|Protocol deviation|1|||
106102600|NCT00254982|366031001|FG001|Overall Study|Protocol deviation|1|||
106102601|NCT00254982|366031000|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
106102602|NCT00254982|366031001|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
106102603|NCT00254982|366031000|FG000|Overall Study|Malignancy|0|||
106102604|NCT00254982|366031001|FG001|Overall Study|Malignancy|2|||
106102605|NCT00254982|366031000|FG000|Overall Study|Opportunistic infection|1|||
106102606|NCT00254982|366031001|FG001|Overall Study|Opportunistic infection|0|||
106102607|NCT00254982|366031000|FG000|Overall Study|Abnormal liver function tests|2|||
106102608|NCT00254982|366031001|FG001|Overall Study|Abnormal liver function tests|1|||
106102609|NCT02564523|366031006|FG000|Overall Study|Withdrawal by Subject|3|||
106102610|NCT02564523|366031007|FG001|Overall Study|Withdrawal by Subject|0|||
106102611|NCT02564523|366031008|FG002|Overall Study|Withdrawal by Subject|1|||
106102612|NCT02564523|366031009|FG003|Overall Study|Withdrawal by Subject|0|||
106102613|NCT02564523|366031010|FG004|Overall Study|Withdrawal by Subject|1|||
106102614|NCT02564523|366031011|FG005|Overall Study|Withdrawal by Subject|0|||
106102615|NCT02564523|366031012|FG006|Overall Study|Withdrawal by Subject|1|||
106102616|NCT02564523|366031013|FG007|Overall Study|Withdrawal by Subject|0|||
106102617|NCT02564523|366031014|FG008|Overall Study|Withdrawal by Subject|0|||
106102618|NCT02564523|366031015|FG009|Overall Study|Withdrawal by Subject|0|||
106102619|NCT02564523|366031016|FG010|Overall Study|Withdrawal by Subject|1|||
106102620|NCT02564523|366031017|FG011|Overall Study|Withdrawal by Subject|0|||
106102621|NCT02564523|366031018|FG012|Overall Study|Withdrawal by Subject|1|||
106102622|NCT02564523|366031019|FG013|Overall Study|Withdrawal by Subject|0|||
106102623|NCT02564523|366031020|FG014|Overall Study|Withdrawal by Subject|0|||
106102624|NCT02564523|366031021|FG015|Overall Study|Withdrawal by Subject|0|||
106102625|NCT02564523|366031022|FG016|Overall Study|Withdrawal by Subject|0|||
106102626|NCT02564523|366031023|FG017|Overall Study|Withdrawal by Subject|0|||
106102627|NCT02564523|366031006|FG000|Overall Study|Adverse Event|0|||
106102628|NCT02564523|366031007|FG001|Overall Study|Adverse Event|0|||
106102629|NCT02564523|366031008|FG002|Overall Study|Adverse Event|0|||
105781726|NCT00313716|364854826|FG003|Overall Study|Withdrawal by Subject|0|||
106102630|NCT02564523|366031009|FG003|Overall Study|Adverse Event|0|||
106102631|NCT02564523|366031010|FG004|Overall Study|Adverse Event|0|||
106102632|NCT02564523|366031011|FG005|Overall Study|Adverse Event|0|||
106102633|NCT02564523|366031012|FG006|Overall Study|Adverse Event|0|||
106102634|NCT02564523|366031013|FG007|Overall Study|Adverse Event|0|||
106102635|NCT02564523|366031014|FG008|Overall Study|Adverse Event|0|||
106102636|NCT02564523|366031015|FG009|Overall Study|Adverse Event|0|||
106102637|NCT02564523|366031016|FG010|Overall Study|Adverse Event|0|||
106102638|NCT02564523|366031017|FG011|Overall Study|Adverse Event|0|||
106102639|NCT02564523|366031018|FG012|Overall Study|Adverse Event|0|||
106102640|NCT02564523|366031019|FG013|Overall Study|Adverse Event|0|||
106102641|NCT02564523|366031020|FG014|Overall Study|Adverse Event|0|||
106102642|NCT02564523|366031021|FG015|Overall Study|Adverse Event|0|||
106102643|NCT02564523|366031022|FG016|Overall Study|Adverse Event|0|||
106102644|NCT02564523|366031023|FG017|Overall Study|Adverse Event|1|||
106102645|NCT02564523|366031006|FG000|Overall Study|Death|0|||
106102646|NCT02564523|366031007|FG001|Overall Study|Death|0|||
106102647|NCT02564523|366031008|FG002|Overall Study|Death|0|||
106102648|NCT02564523|366031009|FG003|Overall Study|Death|0|||
106102649|NCT02564523|366031010|FG004|Overall Study|Death|0|||
106102650|NCT02564523|366031011|FG005|Overall Study|Death|0|||
106102651|NCT02564523|366031012|FG006|Overall Study|Death|1|||
106102652|NCT02564523|366031013|FG007|Overall Study|Death|0|||
106102653|NCT02564523|366031014|FG008|Overall Study|Death|0|||
106102654|NCT02564523|366031015|FG009|Overall Study|Death|0|||
106102655|NCT02564523|366031016|FG010|Overall Study|Death|1|||
106102656|NCT02564523|366031017|FG011|Overall Study|Death|0|||
106102657|NCT02564523|366031018|FG012|Overall Study|Death|0|||
106102658|NCT02564523|366031019|FG013|Overall Study|Death|0|||
106102659|NCT02564523|366031020|FG014|Overall Study|Death|0|||
106102660|NCT02564523|366031021|FG015|Overall Study|Death|0|||
106102661|NCT02564523|366031022|FG016|Overall Study|Death|0|||
106102662|NCT02564523|366031023|FG017|Overall Study|Death|0|||
106102663|NCT02564523|366031006|FG000|Overall Study|Lost to Follow-up|2|||
106102664|NCT02564523|366031007|FG001|Overall Study|Lost to Follow-up|1|||
106102665|NCT02564523|366031008|FG002|Overall Study|Lost to Follow-up|4|||
106102666|NCT02564523|366031009|FG003|Overall Study|Lost to Follow-up|0|||
106102667|NCT02564523|366031010|FG004|Overall Study|Lost to Follow-up|1|||
106102668|NCT02564523|366031011|FG005|Overall Study|Lost to Follow-up|0|||
106102669|NCT02564523|366031012|FG006|Overall Study|Lost to Follow-up|1|||
106102670|NCT02564523|366031013|FG007|Overall Study|Lost to Follow-up|0|||
106102671|NCT02564523|366031014|FG008|Overall Study|Lost to Follow-up|0|||
106102672|NCT02564523|366031015|FG009|Overall Study|Lost to Follow-up|0|||
106102673|NCT02564523|366031016|FG010|Overall Study|Lost to Follow-up|0|||
106102674|NCT02564523|366031017|FG011|Overall Study|Lost to Follow-up|1|||
106102675|NCT02564523|366031018|FG012|Overall Study|Lost to Follow-up|1|||
106102676|NCT02564523|366031019|FG013|Overall Study|Lost to Follow-up|0|||
106102677|NCT02564523|366031020|FG014|Overall Study|Lost to Follow-up|0|||
106102678|NCT02564523|366031021|FG015|Overall Study|Lost to Follow-up|0|||
106102679|NCT02564523|366031022|FG016|Overall Study|Lost to Follow-up|0|||
106102680|NCT02564523|366031023|FG017|Overall Study|Lost to Follow-up|0|||
106102681|NCT02564523|366031006|FG000|Overall Study|Physician Decision|0|||
106102682|NCT02564523|366031007|FG001|Overall Study|Physician Decision|0|||
106102683|NCT02564523|366031008|FG002|Overall Study|Physician Decision|0|||
106102684|NCT02564523|366031009|FG003|Overall Study|Physician Decision|0|||
106102685|NCT02564523|366031010|FG004|Overall Study|Physician Decision|1|||
106102686|NCT02564523|366031011|FG005|Overall Study|Physician Decision|0|||
106102687|NCT02564523|366031012|FG006|Overall Study|Physician Decision|0|||
106102688|NCT02564523|366031013|FG007|Overall Study|Physician Decision|0|||
106102689|NCT02564523|366031014|FG008|Overall Study|Physician Decision|0|||
106102690|NCT02564523|366031015|FG009|Overall Study|Physician Decision|0|||
106102691|NCT02564523|366031016|FG010|Overall Study|Physician Decision|1|||
106102692|NCT02564523|366031017|FG011|Overall Study|Physician Decision|0|||
106102693|NCT02564523|366031018|FG012|Overall Study|Physician Decision|0|||
106102694|NCT02564523|366031019|FG013|Overall Study|Physician Decision|0|||
106102695|NCT02564523|366031020|FG014|Overall Study|Physician Decision|0|||
106102696|NCT02564523|366031021|FG015|Overall Study|Physician Decision|0|||
106102697|NCT02564523|366031022|FG016|Overall Study|Physician Decision|0|||
106102698|NCT02564523|366031023|FG017|Overall Study|Physician Decision|0|||
106102699|NCT02564523|366031006|FG000|Overall Study|Protocol Violation|2|||
106102700|NCT02564523|366031007|FG001|Overall Study|Protocol Violation|2|||
106102701|NCT02564523|366031008|FG002|Overall Study|Protocol Violation|5|||
106102702|NCT02564523|366031009|FG003|Overall Study|Protocol Violation|0|||
106102703|NCT02564523|366031010|FG004|Overall Study|Protocol Violation|1|||
106102704|NCT02564523|366031011|FG005|Overall Study|Protocol Violation|0|||
106102705|NCT02564523|366031012|FG006|Overall Study|Protocol Violation|0|||
106102706|NCT02564523|366031013|FG007|Overall Study|Protocol Violation|0|||
106102707|NCT02564523|366031014|FG008|Overall Study|Protocol Violation|0|||
106102708|NCT02564523|366031015|FG009|Overall Study|Protocol Violation|0|||
106102709|NCT02564523|366031016|FG010|Overall Study|Protocol Violation|0|||
106102710|NCT02564523|366031017|FG011|Overall Study|Protocol Violation|0|||
106102711|NCT02564523|366031018|FG012|Overall Study|Protocol Violation|0|||
106102712|NCT02564523|366031019|FG013|Overall Study|Protocol Violation|0|||
106102713|NCT02564523|366031020|FG014|Overall Study|Protocol Violation|0|||
106102714|NCT02564523|366031021|FG015|Overall Study|Protocol Violation|0|||
106102715|NCT02564523|366031022|FG016|Overall Study|Protocol Violation|0|||
106102716|NCT02564523|366031023|FG017|Overall Study|Protocol Violation|0|||
106102717|NCT02564523|366031006|FG000|Overall Study|Other|3|||
106102718|NCT02564523|366031007|FG001|Overall Study|Other|0|||
106102719|NCT02564523|366031008|FG002|Overall Study|Other|0|||
106102720|NCT02564523|366031009|FG003|Overall Study|Other|1|||
106102721|NCT02564523|366031010|FG004|Overall Study|Other|0|||
106102722|NCT02564523|366031011|FG005|Overall Study|Other|0|||
106102723|NCT02564523|366031012|FG006|Overall Study|Other|0|||
106102724|NCT02564523|366031013|FG007|Overall Study|Other|0|||
106102725|NCT02564523|366031014|FG008|Overall Study|Other|0|||
106102726|NCT02564523|366031015|FG009|Overall Study|Other|0|||
106102727|NCT02564523|366031016|FG010|Overall Study|Other|0|||
106102728|NCT02564523|366031017|FG011|Overall Study|Other|0|||
106102729|NCT02564523|366031018|FG012|Overall Study|Other|0|||
106102730|NCT02564523|366031019|FG013|Overall Study|Other|0|||
106102731|NCT02564523|366031020|FG014|Overall Study|Other|0|||
106102732|NCT02564523|366031021|FG015|Overall Study|Other|0|||
106102733|NCT02564523|366031022|FG016|Overall Study|Other|0|||
106102734|NCT02564523|366031023|FG017|Overall Study|Other|0|||
106102735|NCT00448539|366031027|FG000|Overall Study|Medication non-compliance|4|||
106102736|NCT00448539|366031028|FG001|Overall Study|Medication non-compliance|1|||
106102737|NCT00448539|366031027|FG000|Overall Study|Protocol Violation|1|||
106102738|NCT00448539|366031028|FG001|Overall Study|Protocol Violation|0|||
106102739|NCT00448539|366031027|FG000|Overall Study|Request of the investigator or sponsor|67|||
106102740|NCT00448539|366031028|FG001|Overall Study|Request of the investigator or sponsor|54|||
106102741|NCT00448539|366031027|FG000|Overall Study|Withdrawal by Subject|20|||
106102742|NCT00448539|366031028|FG001|Overall Study|Withdrawal by Subject|24|||
106102743|NCT00448539|366031027|FG000|Overall Study|Diary non-compliance|1|||
106102744|NCT00448539|366031028|FG001|Overall Study|Diary non-compliance|0|||
106102745|NCT00448539|366031027|FG000|Overall Study|Adverse Event|9|||
106102746|NCT00448539|366031028|FG001|Overall Study|Adverse Event|26|||
106102747|NCT00448539|366031027|FG000|Overall Study|Lack of Efficacy|27|||
106102748|NCT00448539|366031028|FG001|Overall Study|Lack of Efficacy|40|||
106102749|NCT00448539|366031027|FG000|Overall Study|Miscellaneous|2|||
106102750|NCT00448539|366031028|FG001|Overall Study|Miscellaneous|1|||
106102751|NCT00448539|366031027|FG000|Overall Study|Change of meds|2|||
106102752|NCT00448539|366031028|FG001|Overall Study|Change of meds|3|||
106102753|NCT00448539|366031027|FG000|Overall Study|Lost to Follow-up|1|||
106102754|NCT00448539|366031028|FG001|Overall Study|Lost to Follow-up|3|||
106102755|NCT04862143|366031029|FG000|Overall Study|Adverse Event|1|||
106102756|NCT04862143|366031029|FG000|Overall Study|Study terminated by sponsor|1|||
106102757|NCT04447404|366031034|FG000|Overall Study|Death|2|||
106102758|NCT04447404|366031035|FG001|Overall Study|Death|0|||
106102759|NCT01669629|366031038|FG000|Period 1|protocol deviation|1|||
106102760|NCT01669629|366031039|FG001|Period 1|protocol deviation|2|||
106102761|NCT04420689|366031041|FG000|Overall Study|COVID-19 related hospitalization|0|||
106102762|NCT04420689|366031042|FG001|Overall Study|COVID-19 related hospitalization|0|||
106102763|NCT04420689|366031043|FG002|Overall Study|COVID-19 related hospitalization|0|||
106102764|NCT04420689|366031044|FG003|Overall Study|COVID-19 related hospitalization|0|||
106102765|NCT04420689|366031045|FG004|Overall Study|COVID-19 related hospitalization|1|||
106102766|NCT04420689|366031046|FG005|Overall Study|COVID-19 related hospitalization|0|||
106102767|NCT04420689|366031047|FG006|Overall Study|COVID-19 related hospitalization|0|||
106102768|NCT04420689|366031041|FG000|Overall Study|Physician Decision|0|||
106102769|NCT04420689|366031042|FG001|Overall Study|Physician Decision|0|||
106102770|NCT04420689|366031043|FG002|Overall Study|Physician Decision|0|||
106102771|NCT04420689|366031044|FG003|Overall Study|Physician Decision|0|||
106102772|NCT04420689|366031045|FG004|Overall Study|Physician Decision|0|||
106102773|NCT04420689|366031046|FG005|Overall Study|Physician Decision|1|||
106102774|NCT04420689|366031047|FG006|Overall Study|Physician Decision|0|||
106102775|NCT05224050|366031050|FG000|Overall Study|Withdrawal by Subject|9|||
106102776|NCT05224050|366031050|FG000|Overall Study|Lost to Follow-up|3|||
106102777|NCT02278328|366031051|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
106102778|NCT02278328|366031052|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
106102779|NCT02278328|366031053|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
106102780|NCT02278328|366031051|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
106102781|NCT02278328|366031052|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
106102782|NCT02278328|366031053|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
106102783|NCT02278328|366031051|FG000|Neuropsych Screening|incomplete consent|0|||
106102784|NCT02278328|366031052|FG001|Neuropsych Screening|incomplete consent|0|||
106102785|NCT02278328|366031053|FG002|Neuropsych Screening|incomplete consent|2|||
106102786|NCT03927950|366031054|FG000|Overall Study|Adverse Event|9|||
106102787|NCT04307004|366031057|FG000|Randomization 1|Withdrawal by Subject|25|||
106102788|NCT04307004|366031058|FG001|Randomization 1|Withdrawal by Subject|26|||
106102789|NCT04307004|366031059|FG002|Randomization 1|Withdrawal by Subject|0|||
106102790|NCT04307004|366031060|FG003|Randomization 1|Withdrawal by Subject|0|||
106102791|NCT04307004|366031057|FG000|Randomization 2|Withdrawal by Subject|0|||
106102792|NCT04307004|366031058|FG001|Randomization 2|Withdrawal by Subject|0|||
106102793|NCT04307004|366031059|FG002|Randomization 2|Withdrawal by Subject|28|||
106102794|NCT04307004|366031060|FG003|Randomization 2|Withdrawal by Subject|23|||
106102795|NCT06390839|366031064|FG000|Overall Study|Ineligible|2|||
106102796|NCT06390839|366031064|FG000|Overall Study|Never start protocol therapy|3|||
106102797|NCT06390839|366031064|FG000|Overall Study|Adverse Event|1|||
106102798|NCT06390839|366031064|FG000|Overall Study|Alternative therapy|2|||
106102799|NCT06390839|366031064|FG000|Overall Study|Death|3|||
106102800|NCT06390839|366031064|FG000|Overall Study|Disease progression|28|||
106102801|NCT06390839|366031064|FG000|Overall Study|Withdrawal by Subject|2|||
106102802|NCT06390839|366031064|FG000|Overall Study|Complicating disease|1|||
106102803|NCT06390839|366031064|FG000|Overall Study|Noncompliance|1|||
106102804|NCT03695172|366031065|FG000|Overall Study|Withdrawal by Subject|1|||
106102805|NCT03695172|366031066|FG001|Overall Study|Withdrawal by Subject|1|||
106102806|NCT03695172|366031067|FG002|Overall Study|Withdrawal by Subject|0|||
106102807|NCT00490646|366031070|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
106102808|NCT00490646|366031071|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
106102809|NCT00490646|366031070|FG000|Overall Study|Never Treated (had an adverse event)|1|||
106102810|NCT00490646|366031071|FG001|Overall Study|Never Treated (had an adverse event)|0|||
106102811|NCT00490646|366031070|FG000|Overall Study|Never Treated (withdrew consent)|0|||
106102812|NCT00490646|366031071|FG001|Overall Study|Never Treated (withdrew consent)|1|||
106102813|NCT02012491|366031072|FG000|Overall Study|Lost to Follow-up|1|||
106102814|NCT02012491|366031073|FG001|Overall Study|Lost to Follow-up|0|||
106102815|NCT02012491|366031072|FG000|Overall Study|Protocol Violation|0|||
106102816|NCT02012491|366031073|FG001|Overall Study|Protocol Violation|1|||
106102817|NCT02012491|366031072|FG000|Overall Study|Withdrawal by Subject|1|||
106102818|NCT02012491|366031073|FG001|Overall Study|Withdrawal by Subject|0|||
106102819|NCT01178086|366031074|FG000|Overall Study|Participant refusal|7|||
106102820|NCT01178086|366031074|FG000|Overall Study|Physician Decision|44|||
106102821|NCT01178086|366031074|FG000|Overall Study|Switch to other CLL therapy|113|||
106102822|NCT01178086|366031074|FG000|Overall Study|Death|59|||
106102823|NCT01178086|366031074|FG000|Overall Study|Other unspecified|89|||
106102824|NCT01178086|366031074|FG000|Overall Study|Excluded from EAS|20|||
106102825|NCT02137369|366031075|FG000|Overall Study|Withdrawal by Subject|3|||
106102826|NCT02137369|366031076|FG001|Overall Study|Withdrawal by Subject|2|||
106102827|NCT02137369|366031075|FG000|Overall Study|Adverse Event|2|||
106102828|NCT02137369|366031076|FG001|Overall Study|Adverse Event|0|||
106102829|NCT02137369|366031075|FG000|Overall Study|Lost to Follow-up|1|||
106102830|NCT02137369|366031076|FG001|Overall Study|Lost to Follow-up|0|||
106102831|NCT02137369|366031075|FG000|Overall Study|Moved away|2|||
106102832|NCT02137369|366031076|FG001|Overall Study|Moved away|0|||
106102833|NCT05608629|366031078|FG000|Overall Study|Lost to Follow-up|2|||
106102834|NCT01453595|366031079|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
106102835|NCT01453595|366031080|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
106102836|NCT01453595|366031081|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
106102837|NCT00983073|366031082|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
106102838|NCT00983073|366031082|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
106102839|NCT00983073|366031082|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
106102840|NCT00983073|366031082|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
106102841|NCT00983073|366031082|FG000|Titration and Optimal Dose Period|Other reason|4|||
106102842|NCT00983073|366031082|FG000|Maintenance Period|Adverse Event|5|||
106102843|NCT00983073|366031082|FG000|Maintenance Period|Withdrawal by Subject|2|||
106102844|NCT00983073|366031082|FG000|Maintenance Period|Lack of Efficacy|2|||
106102845|NCT00983073|366031082|FG000|Maintenance Period|Other Reason|7|||
106102846|NCT01261338|366031085|FG000|Overall Study|Withdrawal by Subject|3|||
106102847|NCT01261338|366031086|FG001|Overall Study|Withdrawal by Subject|2|||
106102848|NCT02313428|366031087|FG000|Overall Study|Lost to Follow-up|1|||
106102849|NCT02313428|366031088|FG001|Overall Study|Lost to Follow-up|1|||
106102850|NCT05374421|366031089|FG000|Overall Study|Withdrawal by Subject|3|||
106102851|NCT05374421|366031090|FG001|Overall Study|Withdrawal by Subject|4|||
106102852|NCT05557942|366031093|FG000|Overall Study|Death|0|||
106102853|NCT05557942|366031094|FG001|Overall Study|Death|0|||
106102854|NCT05557942|366031095|FG002|Overall Study|Death|0|||
106102855|NCT05557942|366031096|FG003|Overall Study|Death|2|||
106102856|NCT05557942|366031097|FG004|Overall Study|Death|1|||
106102857|NCT05557942|366031098|FG005|Overall Study|Death|1|||
106102858|NCT05557942|366031093|FG000|Overall Study|Physician Decision|1|||
106102859|NCT05557942|366031094|FG001|Overall Study|Physician Decision|1|||
106102860|NCT05557942|366031095|FG002|Overall Study|Physician Decision|2|||
106102861|NCT05557942|366031096|FG003|Overall Study|Physician Decision|3|||
106102862|NCT05557942|366031097|FG004|Overall Study|Physician Decision|0|||
106102863|NCT05557942|366031098|FG005|Overall Study|Physician Decision|2|||
106102864|NCT05557942|366031093|FG000|Overall Study|Study terminated by sponsor|17|||
106102865|NCT05557942|366031094|FG001|Overall Study|Study terminated by sponsor|17|||
106102866|NCT05557942|366031095|FG002|Overall Study|Study terminated by sponsor|14|||
106102867|NCT05557942|366031096|FG003|Overall Study|Study terminated by sponsor|40|||
106102868|NCT05557942|366031097|FG004|Overall Study|Study terminated by sponsor|45|||
106102869|NCT05557942|366031098|FG005|Overall Study|Study terminated by sponsor|37|||
106102870|NCT05557942|366031093|FG000|Overall Study|Protocol Violation|0|||
106102871|NCT05557942|366031094|FG001|Overall Study|Protocol Violation|0|||
106102872|NCT05557942|366031095|FG002|Overall Study|Protocol Violation|0|||
106102873|NCT05557942|366031096|FG003|Overall Study|Protocol Violation|0|||
106102874|NCT05557942|366031097|FG004|Overall Study|Protocol Violation|0|||
106102875|NCT05557942|366031098|FG005|Overall Study|Protocol Violation|1|||
106102876|NCT05557942|366031093|FG000|Overall Study|Withdrawal by Subject|0|||
106102877|NCT05557942|366031094|FG001|Overall Study|Withdrawal by Subject|0|||
106102878|NCT05557942|366031095|FG002|Overall Study|Withdrawal by Subject|0|||
106102879|NCT05557942|366031096|FG003|Overall Study|Withdrawal by Subject|0|||
106102880|NCT05557942|366031097|FG004|Overall Study|Withdrawal by Subject|2|||
106102881|NCT05557942|366031098|FG005|Overall Study|Withdrawal by Subject|0|||
106102882|NCT02477618|366031099|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
106102883|NCT02477618|366031100|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
106102884|NCT02477618|366031099|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
106102885|NCT02477618|366031100|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
106102886|NCT02477618|366031099|FG000|Overall Study|Adverse Event|1|||
106102887|NCT02477618|366031100|FG001|Overall Study|Adverse Event|1|||
106102888|NCT02477618|366031099|FG000|Overall Study|Transferred Away from Study Site|1|||
106102889|NCT02477618|366031100|FG001|Overall Study|Transferred Away from Study Site|0|||
106102890|NCT02477618|366031099|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
106102891|NCT02477618|366031100|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
106102892|NCT01389973|366031101|FG000|Overall Study|Lost to Follow-up|1|||
106102893|NCT01389973|366031101|FG000|Overall Study|Trial Stopped by Sponsor|9|||
106102894|NCT01389973|366031101|FG000|Overall Study|Other|10|||
106102895|NCT04304833|366031102|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
106102896|NCT04304833|366031103|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
106102897|NCT03456700|366031104|FG000|Overall Study|Withdrawal by Subject|1|||
106102898|NCT05540522|366031109|FG000|Overall Study|Adverse Event|1|||
106102899|NCT05540522|366031110|FG001|Overall Study|Adverse Event|0|||
106102900|NCT05540522|366031111|FG002|Overall Study|Adverse Event|2|||
106102901|NCT05540522|366031112|FG003|Overall Study|Adverse Event|5|||
106102902|NCT05540522|366031109|FG000|Overall Study|Lost to Follow-up|487|||
106102903|NCT05540522|366031110|FG001|Overall Study|Lost to Follow-up|427|||
106102904|NCT05540522|366031111|FG002|Overall Study|Lost to Follow-up|146|||
106102905|NCT05540522|366031112|FG003|Overall Study|Lost to Follow-up|166|||
106102906|NCT05540522|366031109|FG000|Overall Study|Physician Decision|11|||
106102907|NCT05540522|366031110|FG001|Overall Study|Physician Decision|19|||
106102908|NCT05540522|366031111|FG002|Overall Study|Physician Decision|8|||
106102909|NCT05540522|366031112|FG003|Overall Study|Physician Decision|13|||
106102910|NCT05540522|366031109|FG000|Overall Study|Pregnancy|1|||
106102911|NCT05540522|366031110|FG001|Overall Study|Pregnancy|0|||
106102912|NCT05540522|366031111|FG002|Overall Study|Pregnancy|0|||
106102913|NCT05540522|366031112|FG003|Overall Study|Pregnancy|0|||
106102914|NCT05540522|366031109|FG000|Overall Study|Protocol Violation|3|||
106102915|NCT05540522|366031110|FG001|Overall Study|Protocol Violation|1|||
106102916|NCT05540522|366031111|FG002|Overall Study|Protocol Violation|9|||
106102917|NCT05540522|366031112|FG003|Overall Study|Protocol Violation|7|||
106102918|NCT05540522|366031109|FG000|Overall Study|Withdrawal by Subject|168|||
106102919|NCT05540522|366031110|FG001|Overall Study|Withdrawal by Subject|134|||
106102920|NCT05540522|366031111|FG002|Overall Study|Withdrawal by Subject|331|||
106102921|NCT05540522|366031112|FG003|Overall Study|Withdrawal by Subject|322|||
106102922|NCT05540522|366031109|FG000|Overall Study|Death|7|||
106102923|NCT05540522|366031110|FG001|Overall Study|Death|9|||
106102924|NCT05540522|366031111|FG002|Overall Study|Death|49|||
106102925|NCT05540522|366031112|FG003|Overall Study|Death|46|||
106102926|NCT05540522|366031109|FG000|Overall Study|Not vaccinated|34|||
106102927|NCT05540522|366031110|FG001|Overall Study|Not vaccinated|53|||
106102928|NCT05540522|366031111|FG002|Overall Study|Not vaccinated|57|||
106102929|NCT05540522|366031112|FG003|Overall Study|Not vaccinated|50|||
106102930|NCT05540522|366031109|FG000|Overall Study|No longer meets eligibility criteria|0|||
106102931|NCT05540522|366031110|FG001|Overall Study|No longer meets eligibility criteria|0|||
106102932|NCT05540522|366031111|FG002|Overall Study|No longer meets eligibility criteria|3|||
106102933|NCT05540522|366031112|FG003|Overall Study|No longer meets eligibility criteria|2|||
106102934|NCT05540522|366031109|FG000|Overall Study|Other (Unspecified)|8|||
106102935|NCT05540522|366031110|FG001|Overall Study|Other (Unspecified)|10|||
106102936|NCT05540522|366031111|FG002|Overall Study|Other (Unspecified)|4|||
106102937|NCT05540522|366031112|FG003|Overall Study|Other (Unspecified)|2|||
106102938|NCT05239039|366031115|FG000|Overall Study|Withdrawal by Subject|0|||
106102939|NCT05239039|366031116|FG001|Overall Study|Withdrawal by Subject|1|||
106102940|NCT00936390|366031117|FG000|Overall Study|Protocol Violation|21|||
106102941|NCT00936390|366031118|FG001|Overall Study|Protocol Violation|25|||
106102942|NCT04348604|366031119|FG000|Week 8|Withdrawal by Subject|1|||
106102943|NCT04348604|366031120|FG001|Week 8|Withdrawal by Subject|1|||
106102944|NCT04348604|366031119|FG000|Week 8|Lost to Follow-up|1|||
106102945|NCT04348604|366031120|FG001|Week 8|Lost to Follow-up|2|||
106102946|NCT04348604|366031119|FG000|Week 8|Suspended|0|||
106102947|NCT04348604|366031120|FG001|Week 8|Suspended|1|||
106102948|NCT04348604|366031119|FG000|Week 12|Lost to Follow-up|1|||
106102949|NCT04348604|366031120|FG001|Week 12|Lost to Follow-up|2|||
106102950|NCT04348604|366031119|FG000|Week 12|Withdrawal by Subject|1|||
106102951|NCT04348604|366031120|FG001|Week 12|Withdrawal by Subject|0|||
106102952|NCT04348604|366031119|FG000|Week 24|Lost to Follow-up|2|||
106102953|NCT04348604|366031120|FG001|Week 24|Lost to Follow-up|1|||
106102954|NCT02097108|366031121|FG000|Overall Study|Adverse Event|1|||
106102955|NCT02097108|366031121|FG000|Overall Study|patient was abroad for 6 months|1|||
106144069|NCT01317420|366186953|FG004|Overall Study|Progressive disease according to RECIST|3|||
106144070|NCT01317420|366186954|FG005|Overall Study|Progressive disease according to RECIST|3|||
106144071|NCT01317420|366186955|FG006|Overall Study|Progressive disease according to RECIST|3|||
106144072|NCT01317420|366186956|FG007|Overall Study|Progressive disease according to RECIST|3|||
106144073|NCT01317420|366186957|FG008|Overall Study|Progressive disease according to RECIST|3|||
106144074|NCT01317420|366186958|FG009|Overall Study|Progressive disease according to RECIST|2|||
106144075|NCT01317420|366186959|FG010|Overall Study|Progressive disease according to RECIST|3|||
106144076|NCT01317420|366186960|FG011|Overall Study|Progressive disease according to RECIST|11|||
106144077|NCT01317420|366186961|FG012|Overall Study|Progressive disease according to RECIST|16|||
106144078|NCT01317420|366186949|FG000|Overall Study|Other adverse event|1|||
106144079|NCT01317420|366186950|FG001|Overall Study|Other adverse event|0|||
106102956|NCT00857207|366032851|FG000|Overall Study|Withdrawal by Subject|13|||
106102957|NCT00857207|366032852|FG001|Overall Study|Withdrawal by Subject|0|||
106102958|NCT00857207|366032851|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
106102959|NCT00857207|366032852|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
106102960|NCT00857207|366032851|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
106102961|NCT00857207|366032852|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
106102962|NCT03252587|366032862|FG000|Overall Study|Adverse Event|3|||
106102963|NCT03252587|366032863|FG001|Overall Study|Adverse Event|8|||
106102964|NCT03252587|366032864|FG002|Overall Study|Adverse Event|6|||
106102965|NCT03252587|366032865|FG003|Overall Study|Adverse Event|12|||
106102966|NCT03252587|366032862|FG000|Overall Study|Lack of Efficacy|7|||
106102967|NCT03252587|366032863|FG001|Overall Study|Lack of Efficacy|2|||
106102968|NCT03252587|366032864|FG002|Overall Study|Lack of Efficacy|2|||
106102969|NCT03252587|366032865|FG003|Overall Study|Lack of Efficacy|4|||
106102970|NCT03252587|366032862|FG000|Overall Study|Lost to Follow-up|2|||
106102971|NCT03252587|366032863|FG001|Overall Study|Lost to Follow-up|0|||
106102972|NCT03252587|366032864|FG002|Overall Study|Lost to Follow-up|0|||
106102973|NCT03252587|366032865|FG003|Overall Study|Lost to Follow-up|2|||
106102974|NCT03252587|366032862|FG000|Overall Study|Pregnancy|2|||
106102975|NCT03252587|366032863|FG001|Overall Study|Pregnancy|1|||
106102976|NCT03252587|366032864|FG002|Overall Study|Pregnancy|0|||
106102977|NCT03252587|366032865|FG003|Overall Study|Pregnancy|1|||
106102978|NCT03252587|366032862|FG000|Overall Study|Withdrawal by Subject|8|||
106102979|NCT03252587|366032863|FG001|Overall Study|Withdrawal by Subject|4|||
106102980|NCT03252587|366032864|FG002|Overall Study|Withdrawal by Subject|4|||
106102981|NCT03252587|366032865|FG003|Overall Study|Withdrawal by Subject|4|||
106102982|NCT03252587|366032862|FG000|Overall Study|Other Reasons|2|||
106102983|NCT03252587|366032863|FG001|Overall Study|Other Reasons|5|||
106102984|NCT03252587|366032864|FG002|Overall Study|Other Reasons|5|||
106102985|NCT03252587|366032865|FG003|Overall Study|Other Reasons|4|||
106102986|NCT04052204|366032866|FG000|Overall Study|Death|1|||
106102987|NCT04052204|366032867|FG001|Overall Study|Death|0|||
106102988|NCT04052204|366032868|FG002|Overall Study|Death|0|||
106102989|NCT04052204|366032866|FG000|Overall Study|Progressive disease|1|||
106102990|NCT04052204|366032867|FG001|Overall Study|Progressive disease|0|||
106102991|NCT04052204|366032868|FG002|Overall Study|Progressive disease|0|||
106102992|NCT04052204|366032866|FG000|Overall Study|Other|1|||
106102993|NCT04052204|366032867|FG001|Overall Study|Other|0|||
106102994|NCT04052204|366032868|FG002|Overall Study|Other|0|||
106102995|NCT03647501|366032870|FG000|Overall Study|Lost to Follow-up|1|||
106102996|NCT03647501|366032871|FG001|Overall Study|Lost to Follow-up|1|||
106102997|NCT03647501|366032870|FG000|Overall Study|Withdrawal by Subject|0|||
106102998|NCT03647501|366032871|FG001|Overall Study|Withdrawal by Subject|1|||
106102999|NCT03945188|366032872|FG000|Overall Study|Protocol Violation|1|||
106103000|NCT03945188|366032873|FG001|Overall Study|Protocol Violation|0|||
106103001|NCT03945188|366032872|FG000|Overall Study|Disease worsening|79|||
106103002|NCT03945188|366032873|FG001|Overall Study|Disease worsening|73|||
106103003|NCT03945188|366032872|FG000|Overall Study|Physician Decision|2|||
106103004|NCT03945188|366032873|FG001|Overall Study|Physician Decision|2|||
106103005|NCT03945188|366032872|FG000|Overall Study|Lack of Efficacy|7|||
106103006|NCT03945188|366032873|FG001|Overall Study|Lack of Efficacy|4|||
106103007|NCT03945188|366032872|FG000|Overall Study|Pregnancy|2|||
106103008|NCT03945188|366032873|FG001|Overall Study|Pregnancy|0|||
106103009|NCT03945188|366032872|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
106103010|NCT03945188|366032873|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
106103011|NCT03945188|366032872|FG000|Overall Study|Adverse Event|10|||
106103012|NCT03945188|366032873|FG001|Overall Study|Adverse Event|5|||
106103013|NCT03945188|366032872|FG000|Overall Study|Other|2|||
106103014|NCT03945188|366032873|FG001|Overall Study|Other|2|||
106103015|NCT03945188|366032872|FG000|Overall Study|Lost to Follow-up|1|||
106103016|NCT03945188|366032873|FG001|Overall Study|Lost to Follow-up|2|||
106103017|NCT04530448|366032876|FG000|Overall Study|Physician Decision|3|||
106103018|NCT04530448|366032877|FG001|Overall Study|Physician Decision|0|||
106103019|NCT02015676|366032894|FG000|Overall Study|Adverse Event|2|||
106103020|NCT02015676|366032895|FG001|Overall Study|Adverse Event|18|||
106103021|NCT02015676|366032896|FG002|Overall Study|Adverse Event|0|||
106103022|NCT02015676|366032894|FG000|Overall Study|Lack of Efficacy|2|||
106103023|NCT02015676|366032895|FG001|Overall Study|Lack of Efficacy|4|||
106103024|NCT02015676|366032896|FG002|Overall Study|Lack of Efficacy|0|||
106103025|NCT02015676|366032894|FG000|Overall Study|Protocol Violation|1|||
106103026|NCT02015676|366032895|FG001|Overall Study|Protocol Violation|0|||
106103027|NCT02015676|366032896|FG002|Overall Study|Protocol Violation|0|||
106103028|NCT02015676|366032894|FG000|Overall Study|Withdrawal by Subject|1|||
106103029|NCT02015676|366032895|FG001|Overall Study|Withdrawal by Subject|7|||
106103030|NCT02015676|366032896|FG002|Overall Study|Withdrawal by Subject|1|||
106103031|NCT02015676|366032894|FG000|Overall Study|Administrative reasons|0|||
106103032|NCT02015676|366032895|FG001|Overall Study|Administrative reasons|3|||
106103033|NCT02015676|366032896|FG002|Overall Study|Administrative reasons|1|||
106103034|NCT02015676|366032894|FG000|Overall Study|Death|0|||
105992611|NCT03188510|365631586|FG002|Overall Study|Inappropriate behavior with site staff|0|||
105992612|NCT00615992|365631592|FG000|Overall Study|Protocol Violation|67|||
105992613|NCT02328027|365631594|FG000|Overall Study|Withdrawal by Subject|0|||
105992614|NCT02328027|365631595|FG001|Overall Study|Withdrawal by Subject|1|||
105992615|NCT03319212|365631596|FG000|Overall Study|Discontinued as moving out of local area|0|||
105992616|NCT03319212|365631597|FG001|Overall Study|Discontinued as moving out of local area|1|||
105992617|NCT03319212|365631596|FG000|Overall Study|Adverse Event|2|||
105992618|NCT03319212|365631597|FG001|Overall Study|Adverse Event|2|||
105992619|NCT03319212|365631596|FG000|Overall Study|Withdrawal by Subject|0|||
105992620|NCT03319212|365631597|FG001|Overall Study|Withdrawal by Subject|1|||
105992621|NCT03319212|365631596|FG000|Overall Study|Lost to Follow-up|0|||
105992622|NCT03319212|365631597|FG001|Overall Study|Lost to Follow-up|1|||
105992623|NCT03319212|365631596|FG000|Overall Study|Physician Decision|1|||
105992624|NCT03319212|365631597|FG001|Overall Study|Physician Decision|0|||
105992625|NCT00250276|365631598|FG000|Overall Study|Serious Adverse Event|0|||
105992626|NCT00250276|365631599|FG001|Overall Study|Serious Adverse Event|0|||
105992627|NCT00250276|365631600|FG002|Overall Study|Serious Adverse Event|1|||
105992628|NCT00250276|365631601|FG003|Overall Study|Serious Adverse Event|0|||
105992629|NCT00250276|365631598|FG000|Overall Study|Non-serious Adverse Event|2|||
105992630|NCT00250276|365631599|FG001|Overall Study|Non-serious Adverse Event|0|||
105992631|NCT00250276|365631600|FG002|Overall Study|Non-serious Adverse Event|0|||
105992632|NCT00250276|365631601|FG003|Overall Study|Non-serious Adverse Event|2|||
105992633|NCT00250276|365631598|FG000|Overall Study|Protocol Violation|0|||
105992634|NCT00250276|365631599|FG001|Overall Study|Protocol Violation|1|||
105992635|NCT00250276|365631600|FG002|Overall Study|Protocol Violation|0|||
105992636|NCT00250276|365631601|FG003|Overall Study|Protocol Violation|0|||
105992637|NCT00250276|365631598|FG000|Overall Study|Withdrawal by Subject|1|||
105992638|NCT00250276|365631599|FG001|Overall Study|Withdrawal by Subject|2|||
105992639|NCT00250276|365631600|FG002|Overall Study|Withdrawal by Subject|3|||
105992640|NCT00250276|365631601|FG003|Overall Study|Withdrawal by Subject|2|||
105992641|NCT00250276|365631598|FG000|Overall Study|Migrated/moved from study area|3|||
105992642|NCT00250276|365631599|FG001|Overall Study|Migrated/moved from study area|0|||
105992643|NCT00250276|365631600|FG002|Overall Study|Migrated/moved from study area|2|||
105992644|NCT00250276|365631601|FG003|Overall Study|Migrated/moved from study area|7|||
105992645|NCT00250276|365631598|FG000|Overall Study|Lost to Follow-up|11|||
105992646|NCT00250276|365631599|FG001|Overall Study|Lost to Follow-up|18|||
105992647|NCT00250276|365631600|FG002|Overall Study|Lost to Follow-up|13|||
105992648|NCT00250276|365631601|FG003|Overall Study|Lost to Follow-up|8|||
105992649|NCT01088399|365631602|FG000|Overall Study|Adverse Event|211|||
105992650|NCT01088399|365631603|FG001|Overall Study|Adverse Event|16|||
105992651|NCT01088399|365631604|FG002|Overall Study|Adverse Event|0|||
105992652|NCT01088399|365631602|FG000|Overall Study|Death|204|||
105992653|NCT01088399|365631603|FG001|Overall Study|Death|45|||
105992654|NCT01088399|365631604|FG002|Overall Study|Death|0|||
105992655|NCT01088399|365631602|FG000|Overall Study|Lack of Efficacy|298|||
105992656|NCT01088399|365631603|FG001|Overall Study|Lack of Efficacy|7|||
105992657|NCT01088399|365631604|FG002|Overall Study|Lack of Efficacy|5|||
105992658|NCT01088399|365631602|FG000|Overall Study|Lost to Follow-up|1070|||
105992659|NCT01088399|365631603|FG001|Overall Study|Lost to Follow-up|278|||
105992660|NCT01088399|365631604|FG002|Overall Study|Lost to Follow-up|58|||
105992661|NCT01088399|365631602|FG000|Overall Study|Physician Decision|531|||
105992662|NCT01088399|365631603|FG001|Overall Study|Physician Decision|88|||
105992663|NCT01088399|365631604|FG002|Overall Study|Physician Decision|16|||
105992664|NCT01088399|365631602|FG000|Overall Study|Withdrawal by Subject|544|||
105992665|NCT01088399|365631603|FG001|Overall Study|Withdrawal by Subject|195|||
105992666|NCT01088399|365631604|FG002|Overall Study|Withdrawal by Subject|33|||
105992667|NCT01088399|365631602|FG000|Overall Study|Change to or start of somatropin therapy|234|||
105992668|NCT01088399|365631603|FG001|Overall Study|Change to or start of somatropin therapy|17|||
105992669|NCT01088399|365631604|FG002|Overall Study|Change to or start of somatropin therapy|12|||
105992670|NCT01088399|365631602|FG000|Overall Study|Sponsor decision|1573|||
105992671|NCT01088399|365631603|FG001|Overall Study|Sponsor decision|298|||
105992672|NCT01088399|365631604|FG002|Overall Study|Sponsor decision|7|||
105992673|NCT01088399|365631602|FG000|Overall Study|Protocol Violation|10|||
105992674|NCT01088399|365631603|FG001|Overall Study|Protocol Violation|1|||
105992675|NCT01088399|365631604|FG002|Overall Study|Protocol Violation|0|||
105992676|NCT01088399|365631602|FG000|Overall Study|Enrollment criteria not met|48|||
105992677|NCT01088399|365631603|FG001|Overall Study|Enrollment criteria not met|119|||
105992678|NCT01088399|365631604|FG002|Overall Study|Enrollment criteria not met|70|||
105992679|NCT01088399|365631602|FG000|Overall Study|Study summary visit not completed|2398|||
105992680|NCT01088399|365631603|FG001|Overall Study|Study summary visit not completed|283|||
105992681|NCT01088399|365631604|FG002|Overall Study|Study summary visit not completed|80|||
105992682|NCT00042991|365631607|FG000|Overall Study|Adverse Event|1|||
105992683|NCT00042991|365631608|FG001|Overall Study|Adverse Event|4|||
105992684|NCT00042991|365631609|FG002|Overall Study|Adverse Event|2|||
105992685|NCT00042991|365631610|FG003|Overall Study|Adverse Event|0|||
105992686|NCT00042991|365631611|FG004|Overall Study|Adverse Event|0|||
105992687|NCT00042991|365631612|FG005|Overall Study|Adverse Event|1|||
106103035|NCT02015676|366032895|FG001|Overall Study|Death|1|||
106103036|NCT02015676|366032896|FG002|Overall Study|Death|0|||
106103037|NCT02015676|366032894|FG000|Overall Study|Disease progression|3|||
106103038|NCT02015676|366032895|FG001|Overall Study|Disease progression|1|||
106103039|NCT02015676|366032896|FG002|Overall Study|Disease progression|1|||
106103040|NCT01540851|366032903|FG000|Overall Study|Lost to Follow-up|14|||
106103041|NCT01540851|366032904|FG001|Overall Study|Lost to Follow-up|15|||
106103042|NCT01540851|366032903|FG000|Overall Study|Withdrawal by Subject|7|||
106103043|NCT01540851|366032904|FG001|Overall Study|Withdrawal by Subject|3|||
106103044|NCT01654549|366032905|FG000|Overall Study|H.pylori eradication not successful|0|||
106103045|NCT01654549|366032906|FG001|Overall Study|H.pylori eradication not successful|1|||
106103046|NCT00937924|366032907|FG000|Overall Study|Lost to Follow-up|44|||
106103047|NCT00937924|366032908|FG001|Overall Study|Lost to Follow-up|44|||
106103048|NCT00937924|366032909|FG002|Overall Study|Lost to Follow-up|41|||
106103049|NCT00224874|366032910|FG000|Overall Study|Withdrawal by Subject|0|||
106103050|NCT00224874|366032911|FG001|Overall Study|Withdrawal by Subject|0|||
106103051|NCT00224874|366032912|FG002|Overall Study|Withdrawal by Subject|1|||
106103052|NCT00224874|366032913|FG003|Overall Study|Withdrawal by Subject|0|||
106103053|NCT02807558|366032914|FG000|Overall Study|Consent withdrawn by participant|4|||
106103054|NCT02807558|366032915|FG001|Overall Study|Consent withdrawn by participant|0|||
106103055|NCT02807558|366032916|FG002|Overall Study|Consent withdrawn by participant|4|||
106103056|NCT02807558|366032917|FG003|Overall Study|Consent withdrawn by participant|2|||
106103057|NCT02807558|366032918|FG004|Overall Study|Consent withdrawn by participant|1|||
106103058|NCT02807558|366032919|FG005|Overall Study|Consent withdrawn by participant|0|||
106103059|NCT02807558|366032914|FG000|Overall Study|Non-compliance with Study Drug|0|||
106103060|NCT02807558|366032915|FG001|Overall Study|Non-compliance with Study Drug|0|||
106103061|NCT02807558|366032916|FG002|Overall Study|Non-compliance with Study Drug|1|||
106103062|NCT02807558|366032917|FG003|Overall Study|Non-compliance with Study Drug|0|||
106103063|NCT02807558|366032918|FG004|Overall Study|Non-compliance with Study Drug|0|||
106103064|NCT02807558|366032919|FG005|Overall Study|Non-compliance with Study Drug|0|||
106103065|NCT02807558|366032914|FG000|Overall Study|Adverse Event|0|||
106103066|NCT02807558|366032915|FG001|Overall Study|Adverse Event|0|||
106103067|NCT02807558|366032916|FG002|Overall Study|Adverse Event|9|||
106103068|NCT02807558|366032917|FG003|Overall Study|Adverse Event|0|||
106103069|NCT02807558|366032918|FG004|Overall Study|Adverse Event|0|||
106103070|NCT02807558|366032919|FG005|Overall Study|Adverse Event|0|||
106103071|NCT02807558|366032914|FG000|Overall Study|Death|23|||
106103072|NCT02807558|366032915|FG001|Overall Study|Death|2|||
106103073|NCT02807558|366032916|FG002|Overall Study|Death|3|||
106103074|NCT02807558|366032917|FG003|Overall Study|Death|43|||
106103075|NCT02807558|366032918|FG004|Overall Study|Death|24|||
106103076|NCT02807558|366032919|FG005|Overall Study|Death|15|||
106103077|NCT02807558|366032914|FG000|Overall Study|Progressive Disease|0|||
106103078|NCT02807558|366032915|FG001|Overall Study|Progressive Disease|0|||
106103079|NCT02807558|366032916|FG002|Overall Study|Progressive Disease|1|||
106103080|NCT02807558|366032917|FG003|Overall Study|Progressive Disease|0|||
106103081|NCT02807558|366032918|FG004|Overall Study|Progressive Disease|0|||
106103082|NCT02807558|366032919|FG005|Overall Study|Progressive Disease|0|||
106103083|NCT02807558|366032914|FG000|Overall Study|Other than specified|1|||
106103084|NCT02807558|366032915|FG001|Overall Study|Other than specified|0|||
106103085|NCT02807558|366032916|FG002|Overall Study|Other than specified|2|||
106103086|NCT02807558|366032917|FG003|Overall Study|Other than specified|0|||
106103087|NCT02807558|366032918|FG004|Overall Study|Other than specified|1|||
106103088|NCT02807558|366032919|FG005|Overall Study|Other than specified|1|||
106103089|NCT02807558|366032914|FG000|Overall Study|Lack of Efficacy|0|||
106103090|NCT02807558|366032915|FG001|Overall Study|Lack of Efficacy|0|||
106103091|NCT02807558|366032916|FG002|Overall Study|Lack of Efficacy|9|||
106103092|NCT02807558|366032917|FG003|Overall Study|Lack of Efficacy|0|||
106103093|NCT02807558|366032918|FG004|Overall Study|Lack of Efficacy|0|||
106103094|NCT02807558|366032919|FG005|Overall Study|Lack of Efficacy|0|||
106103095|NCT03644186|366032920|FG000|Overall Study|Withdrawal by Subject|1|||
106103096|NCT03644186|366032921|FG001|Overall Study|Withdrawal by Subject|1|||
106103097|NCT02701985|366032922|FG000|Overall Study|Withdrawal by Subject|1|||
106103098|NCT02701985|366032923|FG001|Overall Study|Withdrawal by Subject|1|||
106103099|NCT02701985|366032922|FG000|Overall Study|Lost to Follow-up|1|||
106103100|NCT02701985|366032923|FG001|Overall Study|Lost to Follow-up|0|||
106103101|NCT02701985|366032922|FG000|Overall Study|Death|1|||
106103102|NCT02701985|366032923|FG001|Overall Study|Death|0|||
106103103|NCT02701985|366032922|FG000|Overall Study|Adverse Event|0|||
106103104|NCT02701985|366032923|FG001|Overall Study|Adverse Event|5|||
106103105|NCT01618864|366032925|FG000|Overall Study|Withdrawal by Subject|2|||
106103106|NCT01618864|366032925|FG000|Overall Study|Lost to Follow-up|2|||
106103107|NCT02734212|366032942|FG000|Overall Study|Lost to Follow-up|5|||
106103108|NCT02734212|366032943|FG001|Overall Study|Lost to Follow-up|10|||
106103109|NCT04313881|366032947|FG000|Overall Study|Death|138|||
106103110|NCT04313881|366032948|FG001|Overall Study|Death|126|||
106103111|NCT04313881|366032947|FG000|Overall Study|Study terminated by sponsor|108|||
106103112|NCT04313881|366032948|FG001|Overall Study|Study terminated by sponsor|129|||
106103113|NCT04313881|366032947|FG000|Overall Study|Consent withdrawn|19|||
106103114|NCT04313881|366032948|FG001|Overall Study|Consent withdrawn|15|||
106103115|NCT04313881|366032947|FG000|Overall Study|Reason not Specified|3|||
106103116|NCT04313881|366032948|FG001|Overall Study|Reason not Specified|1|||
106103117|NCT00727272|366032949|FG000|Washout Period A|Adverse Event|0|||
106103118|NCT00727272|366032950|FG001|Washout Period A|Adverse Event|0|||
106103119|NCT00727272|366032951|FG002|Washout Period A|Adverse Event|1|||
106103120|NCT00727272|366032949|FG000|Washout Period B|Withdrawal by Subject|0|||
106103121|NCT00727272|366032950|FG001|Washout Period B|Withdrawal by Subject|0|||
106103122|NCT00727272|366032951|FG002|Washout Period B|Withdrawal by Subject|1|||
106103123|NCT00651664|366032952|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
106103124|NCT00651664|366032953|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
106103125|NCT00651664|366032954|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
106103126|NCT00651664|366032955|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
106103127|NCT00651664|366032956|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
106103128|NCT00651664|366032957|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
106103129|NCT00651664|366032958|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
106103130|NCT00651664|366032959|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
106103131|NCT00651664|366032960|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
106103132|NCT00651664|366032961|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
106103133|NCT00651664|366032952|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
106103134|NCT00651664|366032953|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
106103135|NCT00651664|366032954|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
106103136|NCT00651664|366032955|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
106103137|NCT00651664|366032956|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
106103138|NCT00651664|366032957|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
106103139|NCT00651664|366032958|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
106103140|NCT00651664|366032959|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
106103141|NCT00651664|366032960|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
106103142|NCT00651664|366032961|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
106103143|NCT00651664|366032952|FG000|Overall Study|Progressive Disease|3|||
106103144|NCT00651664|366032953|FG001|Overall Study|Progressive Disease|3|||
106103145|NCT00651664|366032954|FG002|Overall Study|Progressive Disease|3|||
106103146|NCT00651664|366032955|FG003|Overall Study|Progressive Disease|12|||
106103147|NCT00651664|366032956|FG004|Overall Study|Progressive Disease|4|||
106103148|NCT00651664|366032957|FG005|Overall Study|Progressive Disease|1|||
106103149|NCT00651664|366032958|FG006|Overall Study|Progressive Disease|3|||
106103150|NCT00651664|366032959|FG007|Overall Study|Progressive Disease|6|||
106103151|NCT00651664|366032960|FG008|Overall Study|Progressive Disease|5|||
106103152|NCT00651664|366032961|FG009|Overall Study|Progressive Disease|5|||
106103153|NCT00651664|366032952|FG000|Overall Study|Patient Declined Further Treatment|0|||
106103154|NCT00651664|366032953|FG001|Overall Study|Patient Declined Further Treatment|0|||
106103155|NCT00651664|366032954|FG002|Overall Study|Patient Declined Further Treatment|0|||
106103156|NCT00651664|366032955|FG003|Overall Study|Patient Declined Further Treatment|1|||
106103157|NCT00651664|366032956|FG004|Overall Study|Patient Declined Further Treatment|1|||
106103158|NCT00651664|366032957|FG005|Overall Study|Patient Declined Further Treatment|1|||
106103159|NCT00651664|366032958|FG006|Overall Study|Patient Declined Further Treatment|0|||
106103160|NCT00651664|366032959|FG007|Overall Study|Patient Declined Further Treatment|0|||
106103161|NCT00651664|366032960|FG008|Overall Study|Patient Declined Further Treatment|0|||
106103162|NCT00651664|366032961|FG009|Overall Study|Patient Declined Further Treatment|1|||
106103163|NCT00651664|366032952|FG000|Overall Study|Symptomatic Deterioration|0|||
106103164|NCT00651664|366032953|FG001|Overall Study|Symptomatic Deterioration|0|||
106103165|NCT00651664|366032954|FG002|Overall Study|Symptomatic Deterioration|0|||
106103166|NCT00651664|366032955|FG003|Overall Study|Symptomatic Deterioration|1|||
106103167|NCT00651664|366032956|FG004|Overall Study|Symptomatic Deterioration|0|||
106103168|NCT00651664|366032957|FG005|Overall Study|Symptomatic Deterioration|0|||
106103169|NCT00651664|366032958|FG006|Overall Study|Symptomatic Deterioration|1|||
106103170|NCT00651664|366032959|FG007|Overall Study|Symptomatic Deterioration|0|||
106103171|NCT00651664|366032960|FG008|Overall Study|Symptomatic Deterioration|1|||
106103172|NCT00651664|366032961|FG009|Overall Study|Symptomatic Deterioration|0|||
106103173|NCT00651664|366032952|FG000|Overall Study|Reason not Specified|0|||
106103174|NCT00651664|366032953|FG001|Overall Study|Reason not Specified|0|||
106103175|NCT00651664|366032954|FG002|Overall Study|Reason not Specified|0|||
106103176|NCT00651664|366032955|FG003|Overall Study|Reason not Specified|0|||
106103177|NCT00651664|366032956|FG004|Overall Study|Reason not Specified|0|||
106103178|NCT00651664|366032957|FG005|Overall Study|Reason not Specified|0|||
106103179|NCT00651664|366032958|FG006|Overall Study|Reason not Specified|1|||
106103180|NCT00651664|366032959|FG007|Overall Study|Reason not Specified|0|||
106103181|NCT00651664|366032960|FG008|Overall Study|Reason not Specified|0|||
106103182|NCT00651664|366032961|FG009|Overall Study|Reason not Specified|0|||
106103183|NCT02576678|366032967|FG000|Overall Study|Adverse Event|0|||
106103184|NCT02576678|366032968|FG001|Overall Study|Adverse Event|0|||
106103185|NCT02576678|366032969|FG002|Overall Study|Adverse Event|2|||
106103186|NCT02576678|366032967|FG000|Overall Study|Withdrawal by Subject|3|||
106103187|NCT02576678|366032968|FG001|Overall Study|Withdrawal by Subject|1|||
106103188|NCT02576678|366032969|FG002|Overall Study|Withdrawal by Subject|2|||
106103189|NCT02576678|366032967|FG000|Overall Study|Lost to Follow-up|0|||
106103190|NCT02576678|366032968|FG001|Overall Study|Lost to Follow-up|0|||
106103191|NCT02576678|366032969|FG002|Overall Study|Lost to Follow-up|1|||
106103192|NCT02576678|366032967|FG000|Overall Study|Miscellaneous|2|||
106103193|NCT02576678|366032968|FG001|Overall Study|Miscellaneous|0|||
106103194|NCT02576678|366032969|FG002|Overall Study|Miscellaneous|0|||
106103195|NCT02677116|366032974|FG000|Overall Study|Adverse Event|0|||
106103196|NCT02677116|366032975|FG001|Overall Study|Adverse Event|1|||
106103197|NCT02677116|366032976|FG002|Overall Study|Adverse Event|0|||
106103198|NCT02677116|366032977|FG003|Overall Study|Adverse Event|0|||
106103199|NCT02677116|366032978|FG004|Overall Study|Adverse Event|0|||
106103200|NCT02677116|366032979|FG005|Overall Study|Adverse Event|1|||
106103201|NCT02677116|366032980|FG006|Overall Study|Adverse Event|1|||
106103202|NCT02677116|366032981|FG007|Overall Study|Adverse Event|0|||
106103203|NCT02677116|366032982|FG008|Overall Study|Adverse Event|0|||
106103204|NCT02677116|366032974|FG000|Overall Study|Physician Decision|0|||
106103205|NCT02677116|366032975|FG001|Overall Study|Physician Decision|2|||
106103206|NCT02677116|366032976|FG002|Overall Study|Physician Decision|3|||
106103207|NCT02677116|366032977|FG003|Overall Study|Physician Decision|2|||
106103208|NCT02677116|366032978|FG004|Overall Study|Physician Decision|1|||
106103209|NCT02677116|366032979|FG005|Overall Study|Physician Decision|3|||
106103210|NCT02677116|366032980|FG006|Overall Study|Physician Decision|1|||
106103211|NCT02677116|366032981|FG007|Overall Study|Physician Decision|1|||
106103212|NCT02677116|366032982|FG008|Overall Study|Physician Decision|2|||
106103213|NCT02677116|366032974|FG000|Overall Study|Withdrawal by parent or guardian|2|||
106103214|NCT02677116|366032975|FG001|Overall Study|Withdrawal by parent or guardian|1|||
106103215|NCT02677116|366032976|FG002|Overall Study|Withdrawal by parent or guardian|0|||
106103216|NCT02677116|366032977|FG003|Overall Study|Withdrawal by parent or guardian|1|||
106103217|NCT02677116|366032978|FG004|Overall Study|Withdrawal by parent or guardian|0|||
106103218|NCT02677116|366032979|FG005|Overall Study|Withdrawal by parent or guardian|0|||
106103219|NCT02677116|366032980|FG006|Overall Study|Withdrawal by parent or guardian|2|||
106103220|NCT02677116|366032981|FG007|Overall Study|Withdrawal by parent or guardian|1|||
106103221|NCT02677116|366032982|FG008|Overall Study|Withdrawal by parent or guardian|0|||
106103222|NCT02677116|366032974|FG000|Overall Study|Withdrawal by Subject|1|||
106103223|NCT02677116|366032975|FG001|Overall Study|Withdrawal by Subject|0|||
106103224|NCT02677116|366032976|FG002|Overall Study|Withdrawal by Subject|0|||
106103225|NCT02677116|366032977|FG003|Overall Study|Withdrawal by Subject|0|||
106103226|NCT02677116|366032978|FG004|Overall Study|Withdrawal by Subject|0|||
106103227|NCT02677116|366032979|FG005|Overall Study|Withdrawal by Subject|0|||
106103228|NCT02677116|366032980|FG006|Overall Study|Withdrawal by Subject|0|||
106103229|NCT02677116|366032981|FG007|Overall Study|Withdrawal by Subject|0|||
106103230|NCT02677116|366032982|FG008|Overall Study|Withdrawal by Subject|0|||
106103231|NCT03342638|366032983|FG000|Overall Study|Withdrawal by Subject|1|||
106103232|NCT03342638|366032984|FG001|Overall Study|Withdrawal by Subject|0|||
106103233|NCT03342638|366032983|FG000|Overall Study|Physician Decision|0|||
106103234|NCT03342638|366032984|FG001|Overall Study|Physician Decision|1|||
106103235|NCT00113568|366032989|FG000|Overall Study|Adverse Event|97|||
106103236|NCT00113568|366032989|FG000|Overall Study|Death|1|||
106103237|NCT00113568|366032989|FG000|Overall Study|Lack of Efficacy|30|||
106103238|NCT00113568|366032989|FG000|Overall Study|Lost to Follow-up|156|||
106103239|NCT00113568|366032989|FG000|Overall Study|Protocol Violation|32|||
106103240|NCT00113568|366032989|FG000|Overall Study|Withdrawal by Subject|117|||
106103241|NCT00113568|366032989|FG000|Overall Study|Other|112|||
106103242|NCT00262821|366032990|FG000|Overall Study|Ineligible - wrong stage|0|||
106103243|NCT00262821|366032991|FG001|Overall Study|Ineligible - wrong stage|3|||
106103244|NCT00262821|366032990|FG000|Overall Study|Ineligible - wrong cell type|2|||
106103245|NCT00262821|366032991|FG001|Overall Study|Ineligible - wrong cell type|2|||
106103246|NCT00262821|366032990|FG000|Overall Study|Ineligible - wrong primary|0|||
106103247|NCT00262821|366032991|FG001|Overall Study|Ineligible - wrong primary|1|||
106103248|NCT00262821|366032990|FG000|Overall Study|Ineligible - inadequate pathology|1|||
106103249|NCT00262821|366032991|FG001|Overall Study|Ineligible - inadequate pathology|3|||
106103250|NCT00262821|366032990|FG000|Overall Study|Ineligible - elevated creatinine|0|||
106103251|NCT00262821|366032991|FG001|Overall Study|Ineligible - elevated creatinine|2|||
106103252|NCT00262821|366032990|FG000|Overall Study|Ineligible - required test not done|1|||
106103253|NCT00262821|366032991|FG001|Overall Study|Ineligible - required test not done|4|||
106103254|NCT00262821|366032990|FG000|Overall Study|Inevaluable - inadequate data|0|||
106103255|NCT00262821|366032991|FG001|Overall Study|Inevaluable - inadequate data|4|||
106103256|NCT00695669|366032992|FG000|Overall Study|Adverse Event|0|||
106103257|NCT00695669|366032993|FG001|Overall Study|Adverse Event|0|||
106103258|NCT00695669|366032994|FG002|Overall Study|Adverse Event|2|||
105781727|NCT00313716|364854827|FG004|Overall Study|Withdrawal by Subject|1|||
105781728|NCT00313716|364854828|FG005|Overall Study|Withdrawal by Subject|0|||
106103259|NCT00695669|366032995|FG003|Overall Study|Adverse Event|0|||
106103260|NCT00695669|366032992|FG000|Overall Study|Lost to Follow-up|4|||
106103261|NCT00695669|366032993|FG001|Overall Study|Lost to Follow-up|4|||
106103262|NCT00695669|366032994|FG002|Overall Study|Lost to Follow-up|1|||
106103263|NCT00695669|366032995|FG003|Overall Study|Lost to Follow-up|4|||
106103264|NCT00417079|366032996|FG000|Overall Study|Disease progression|267|||
106103265|NCT00417079|366032997|FG001|Overall Study|Disease progression|180|||
106103266|NCT00417079|366032996|FG000|Overall Study|Adverse Event|32|||
106103267|NCT00417079|366032997|FG001|Overall Study|Adverse Event|67|||
106103268|NCT00417079|366032996|FG000|Overall Study|Non-compliance to protocol|0|||
106103269|NCT00417079|366032997|FG001|Overall Study|Non-compliance to protocol|1|||
106103270|NCT00417079|366032996|FG000|Overall Study|Lost to Follow-up|2|||
106103271|NCT00417079|366032997|FG001|Overall Study|Lost to Follow-up|0|||
106103272|NCT00417079|366032996|FG000|Overall Study|Withdrawal by Subject|17|||
106103273|NCT00417079|366032997|FG001|Overall Study|Withdrawal by Subject|8|||
106103274|NCT00417079|366032996|FG000|Overall Study|Not treated|6|||
106103275|NCT00417079|366032997|FG001|Overall Study|Not treated|7|||
106103276|NCT00417079|366032996|FG000|Overall Study|Screened failure|2|||
106103277|NCT00417079|366032997|FG001|Overall Study|Screened failure|1|||
106103278|NCT00417079|366032996|FG000|Overall Study|Investigator's decision|1|||
106103279|NCT00417079|366032997|FG001|Overall Study|Investigator's decision|4|||
106103280|NCT00417079|366032996|FG000|Overall Study|Non-confirmed Disease progression|1|||
106103281|NCT00417079|366032997|FG001|Overall Study|Non-confirmed Disease progression|1|||
106103282|NCT00417079|366032996|FG000|Overall Study|Clinical deterioration|1|||
106103283|NCT00417079|366032997|FG001|Overall Study|Clinical deterioration|0|||
106103284|NCT00417079|366032996|FG000|Overall Study|Screening error|2|||
106103285|NCT00417079|366032997|FG001|Overall Study|Screening error|1|||
106103286|NCT00417079|366032996|FG000|Overall Study|Withdrawal by subject's family|0|||
106103287|NCT00417079|366032997|FG001|Overall Study|Withdrawal by subject's family|1|||
106103288|NCT00417079|366032996|FG000|Overall Study|Patient unable to come to the clinic|0|||
106103289|NCT00417079|366032997|FG001|Overall Study|Patient unable to come to the clinic|1|||
106103290|NCT00417079|366032996|FG000|Overall Study|abnormal liver function tests|0|||
106103291|NCT00417079|366032997|FG001|Overall Study|abnormal liver function tests|1|||
106103292|NCT01995461|366033009|FG000|Overall Study|Death|1|||
106103293|NCT01995461|366033009|FG000|Overall Study|Lost to Follow-up|2|||
106103294|NCT01995461|366033009|FG000|Overall Study|Withdrawal by Subject|2|||
106103295|NCT02625623|366033013|FG000|Overall Study|Participants randomized but not treated|9|||
106103296|NCT02625623|366033014|FG001|Overall Study|Participants randomized but not treated|1|||
106103297|NCT00808808|366033015|FG000|Overall Study|Vaccinated; survey not completed|131|||
106103298|NCT00808808|366033016|FG001|Overall Study|Vaccinated; survey not completed|169|||
106103299|NCT00808808|366033017|FG002|Overall Study|Vaccinated; survey not completed|302|||
106103300|NCT00808808|366033015|FG000|Overall Study|Employee was not vaccinated.|2686|||
106103301|NCT00808808|366033016|FG001|Overall Study|Employee was not vaccinated.|2268|||
106103302|NCT00808808|366033017|FG002|Overall Study|Employee was not vaccinated.|2255|||
106103303|NCT02962908|366033020|FG000|Overall Study|Lost to Follow-up|0|||
106103304|NCT02962908|366033021|FG001|Overall Study|Lost to Follow-up|3|||
106103305|NCT02962908|366033022|FG002|Overall Study|Lost to Follow-up|0|||
106103306|NCT02962908|366033023|FG003|Overall Study|Lost to Follow-up|1|||
106103307|NCT02962908|366033020|FG000|Overall Study|Withdrawal by Subject|0|||
106103308|NCT02962908|366033021|FG001|Overall Study|Withdrawal by Subject|3|||
106103309|NCT02962908|366033022|FG002|Overall Study|Withdrawal by Subject|0|||
106103310|NCT02962908|366033023|FG003|Overall Study|Withdrawal by Subject|2|||
106103311|NCT02962908|366033020|FG000|Overall Study|Protocol Violation|0|||
106103312|NCT02962908|366033021|FG001|Overall Study|Protocol Violation|1|||
106103313|NCT02962908|366033022|FG002|Overall Study|Protocol Violation|0|||
106103314|NCT02962908|366033023|FG003|Overall Study|Protocol Violation|0|||
106103315|NCT02962908|366033020|FG000|Overall Study|Physician Decision|0|||
106103316|NCT02962908|366033021|FG001|Overall Study|Physician Decision|1|||
106103317|NCT02962908|366033022|FG002|Overall Study|Physician Decision|0|||
106103318|NCT02962908|366033023|FG003|Overall Study|Physician Decision|0|||
106103319|NCT03543254|366033024|FG000|Overall Study|Lost to Follow-up|1|||
106103320|NCT00126438|366033025|FG000|Overall Study|Withdrawal due to adverse event|1|||
106103321|NCT00126438|366033026|FG001|Overall Study|Withdrawal due to adverse event|0|||
106103322|NCT00126438|366033025|FG000|Overall Study|Lost to Follow-up|22|||
106103323|NCT00126438|366033026|FG001|Overall Study|Lost to Follow-up|0|||
106103324|NCT00126438|366033025|FG000|Overall Study|Protocol Violation|8|||
106103325|NCT00126438|366033026|FG001|Overall Study|Protocol Violation|8|||
106103326|NCT00126438|366033025|FG000|Overall Study|Withdrawal by Subject|3|||
106103327|NCT00126438|366033026|FG001|Overall Study|Withdrawal by Subject|2|||
106103328|NCT04154787|366033029|FG000|Overall Study|Adverse Event|0|||
106103329|NCT04154787|366033030|FG001|Overall Study|Adverse Event|1|||
106103330|NCT04154787|366033031|FG002|Overall Study|Adverse Event|0|||
106103331|NCT04154787|366033029|FG000|Overall Study|Patient Requires Other Treatment|0|||
106103332|NCT04154787|366033030|FG001|Overall Study|Patient Requires Other Treatment|1|||
106103333|NCT04154787|366033031|FG002|Overall Study|Patient Requires Other Treatment|0|||
106103334|NCT04154787|366033029|FG000|Overall Study|Study Terminated By Sponsor|0|||
106103335|NCT04154787|366033030|FG001|Overall Study|Study Terminated By Sponsor|6|||
106103336|NCT04154787|366033031|FG002|Overall Study|Study Terminated By Sponsor|1|||
106103337|NCT04154787|366033029|FG000|Overall Study|Subject Decision|0|||
106103338|NCT04154787|366033030|FG001|Overall Study|Subject Decision|1|||
106103339|NCT04154787|366033031|FG002|Overall Study|Subject Decision|0|||
106103340|NCT04154787|366033029|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
106103341|NCT04154787|366033030|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
106103342|NCT04154787|366033031|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
106103343|NCT02858895|366033032|FG000|Overall Study|Disease progression|31|||
106103344|NCT02858895|366033032|FG000|Overall Study|Death|2|||
106103345|NCT02858895|366033032|FG000|Overall Study|Adverse Event|1|||
106103346|NCT02858895|366033032|FG000|Overall Study|Withdrawal by Subject|3|||
106103347|NCT02858895|366033032|FG000|Overall Study|hospice,|1|||
106103348|NCT02858895|366033032|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
106103349|NCT04918784|366034703|FG000|Overall Study|Amputation - no longer eligible|1|||
106103350|NCT04918784|366034704|FG001|Overall Study|Amputation - no longer eligible|2|||
106103351|NCT04918784|366034703|FG000|Overall Study|Death|1|||
106103352|NCT04918784|366034704|FG001|Overall Study|Death|0|||
106103353|NCT04918784|366034703|FG000|Overall Study|patient non-compliance|3|||
106103354|NCT04918784|366034704|FG001|Overall Study|patient non-compliance|1|||
106103355|NCT04918784|366034703|FG000|Overall Study|Adverse Event|1|||
106103356|NCT04918784|366034704|FG001|Overall Study|Adverse Event|0|||
106103357|NCT00955357|366034705|FG000|Titration Phase|Adverse Event|9|||
106103358|NCT00955357|366034706|FG001|Titration Phase|Adverse Event|46|||
106103359|NCT00955357|366034705|FG000|Titration Phase|Lack of Efficacy|0|||
106103360|NCT00955357|366034706|FG001|Titration Phase|Lack of Efficacy|2|||
106103361|NCT00955357|366034705|FG000|Titration Phase|Protocol Violation|3|||
106103362|NCT00955357|366034706|FG001|Titration Phase|Protocol Violation|7|||
106103363|NCT00955357|366034705|FG000|Titration Phase|Lost to Follow-up|1|||
106103364|NCT00955357|366034706|FG001|Titration Phase|Lost to Follow-up|3|||
106103365|NCT00955357|366034705|FG000|Titration Phase|Withdrawal by Subject|3|||
106103366|NCT00955357|366034706|FG001|Titration Phase|Withdrawal by Subject|5|||
106103367|NCT00955357|366034705|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
106103368|NCT00955357|366034706|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
106103369|NCT00955357|366034705|FG000|Titration Phase|Study medication not tolerated|0|||
106103370|NCT00955357|366034706|FG001|Titration Phase|Study medication not tolerated|1|||
106103371|NCT00955357|366034705|FG000|Titration Phase|Non compliance to study procedures|0|||
106103372|NCT00955357|366034706|FG001|Titration Phase|Non compliance to study procedures|1|||
106103373|NCT00955357|366034705|FG000|Maintenance Phase|Adverse Event|3|||
106103374|NCT00955357|366034706|FG001|Maintenance Phase|Adverse Event|23|||
106103375|NCT00955357|366034705|FG000|Maintenance Phase|Lack of Efficacy|0|||
106103376|NCT00955357|366034706|FG001|Maintenance Phase|Lack of Efficacy|4|||
106103377|NCT00955357|366034705|FG000|Maintenance Phase|Protocol Violation|2|||
106103378|NCT00955357|366034706|FG001|Maintenance Phase|Protocol Violation|6|||
106103379|NCT00955357|366034705|FG000|Maintenance Phase|Lost to Follow-up|2|||
106103380|NCT00955357|366034706|FG001|Maintenance Phase|Lost to Follow-up|7|||
106103381|NCT00955357|366034705|FG000|Maintenance Phase|Withdrawal by Subject|4|||
106103382|NCT00955357|366034706|FG001|Maintenance Phase|Withdrawal by Subject|4|||
106103383|NCT00955357|366034705|FG000|Maintenance Phase|Patient moving out of area|0|||
106103384|NCT00955357|366034706|FG001|Maintenance Phase|Patient moving out of area|1|||
106103385|NCT00955357|366034705|FG000|Maintenance Phase|Non compliance to study procedures|1|||
106103386|NCT00955357|366034706|FG001|Maintenance Phase|Non compliance to study procedures|0|||
106103387|NCT01258608|366034707|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
106103388|NCT01258608|366034708|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
106103389|NCT01258608|366034707|FG000|Overall Study|Clinical progression|1|||
106103390|NCT01258608|366034708|FG001|Overall Study|Clinical progression|0|||
106103391|NCT01258608|366034707|FG000|Overall Study|Sponsor decision|0|||
106103392|NCT01258608|366034708|FG001|Overall Study|Sponsor decision|1|||
106103393|NCT01258608|366034707|FG000|Overall Study|Physician Decision|6|||
106103394|NCT01258608|366034708|FG001|Overall Study|Physician Decision|1|||
106103395|NCT01258608|366034707|FG000|Overall Study|Lost to Follow-up|0|||
106103396|NCT01258608|366034708|FG001|Overall Study|Lost to Follow-up|1|||
106103397|NCT01258608|366034707|FG000|Overall Study|Lack of compliance|1|||
106103398|NCT01258608|366034708|FG001|Overall Study|Lack of compliance|0|||
106103399|NCT01258608|366034707|FG000|Overall Study|Lack of Efficacy|0|||
106103400|NCT01258608|366034708|FG001|Overall Study|Lack of Efficacy|1|||
106103401|NCT01258608|366034707|FG000|Overall Study|Adverse Event|6|||
106103402|NCT01258608|366034708|FG001|Overall Study|Adverse Event|10|||
106103403|NCT01258608|366034707|FG000|Overall Study|Withdrawal by Subject|6|||
106103404|NCT01258608|366034708|FG001|Overall Study|Withdrawal by Subject|5|||
106103405|NCT04205630|366034712|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
106103406|NCT04205630|366034712|FG000|Overall Study|Disease clinical progression|7|||
106103407|NCT04205630|366034712|FG000|Overall Study|Withdrawal by Subject|2|||
106103408|NCT04205630|366034712|FG000|Overall Study|Adverse Event|17|||
106103409|NCT04205630|366034712|FG000|Overall Study|Other|1|||
106103410|NCT01471054|366034714|FG000|Overall Study|Study terminated prematurely|4|||
106103411|NCT01471054|366034715|FG001|Overall Study|Study terminated prematurely|0|||
106103412|NCT01843192|366034716|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
106103413|NCT01843192|366034717|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
106103414|NCT01843192|366034718|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
106103415|NCT04493216|366034719|FG000|Overall Study|Study terminated by sponsor|30|||
106103416|NCT04493216|366034720|FG001|Overall Study|Study terminated by sponsor|33|||
106103417|NCT04493216|366034721|FG002|Overall Study|Study terminated by sponsor|28|||
106103418|NCT04493216|366034722|FG003|Overall Study|Study terminated by sponsor|27|||
106103419|NCT04493216|366034719|FG000|Overall Study|Withdrawal by Subject|2|||
106103420|NCT04493216|366034720|FG001|Overall Study|Withdrawal by Subject|1|||
106103421|NCT04493216|366034721|FG002|Overall Study|Withdrawal by Subject|1|||
106103422|NCT04493216|366034722|FG003|Overall Study|Withdrawal by Subject|2|||
106103423|NCT04493216|366034719|FG000|Overall Study|Protocol Violation|1|||
106103424|NCT04493216|366034720|FG001|Overall Study|Protocol Violation|2|||
106103425|NCT04493216|366034721|FG002|Overall Study|Protocol Violation|0|||
106103426|NCT04493216|366034722|FG003|Overall Study|Protocol Violation|2|||
106103427|NCT04493216|366034719|FG000|Overall Study|Physician Decision|0|||
106103428|NCT04493216|366034720|FG001|Overall Study|Physician Decision|0|||
106103429|NCT04493216|366034721|FG002|Overall Study|Physician Decision|1|||
106103430|NCT04493216|366034722|FG003|Overall Study|Physician Decision|0|||
106103431|NCT04493216|366034719|FG000|Overall Study|Lost to Follow-up|2|||
106103432|NCT04493216|366034720|FG001|Overall Study|Lost to Follow-up|1|||
106103433|NCT04493216|366034721|FG002|Overall Study|Lost to Follow-up|0|||
106103434|NCT04493216|366034722|FG003|Overall Study|Lost to Follow-up|1|||
106103435|NCT04493216|366034719|FG000|Overall Study|Adverse Event|1|||
106103436|NCT04493216|366034720|FG001|Overall Study|Adverse Event|4|||
106103437|NCT04493216|366034721|FG002|Overall Study|Adverse Event|5|||
106103438|NCT04493216|366034722|FG003|Overall Study|Adverse Event|2|||
106103439|NCT04493216|366034719|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
106103440|NCT04493216|366034720|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
106103441|NCT04493216|366034721|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
106103442|NCT04493216|366034722|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
106103443|NCT02181803|366034725|FG000|Overall Study|Withdrawal by Subject|0|||
106103444|NCT02181803|366034726|FG001|Overall Study|Withdrawal by Subject|2|||
106103445|NCT02181803|366034727|FG002|Overall Study|Withdrawal by Subject|0|||
106103446|NCT02181803|366034728|FG003|Overall Study|Withdrawal by Subject|0|||
106103447|NCT02181803|366034729|FG004|Overall Study|Withdrawal by Subject|0|||
106103448|NCT02181803|366034730|FG005|Overall Study|Withdrawal by Subject|0|||
106103449|NCT02181803|366034731|FG006|Overall Study|Withdrawal by Subject|0|||
106103450|NCT02181803|366034732|FG007|Overall Study|Withdrawal by Subject|0|||
106103451|NCT02181803|366034733|FG008|Overall Study|Withdrawal by Subject|0|||
106103452|NCT02181803|366034725|FG000|Overall Study|Physician Decision|0|||
106103453|NCT02181803|366034726|FG001|Overall Study|Physician Decision|0|||
106103454|NCT02181803|366034727|FG002|Overall Study|Physician Decision|0|||
106103455|NCT02181803|366034728|FG003|Overall Study|Physician Decision|1|||
106103456|NCT02181803|366034729|FG004|Overall Study|Physician Decision|0|||
106103457|NCT02181803|366034730|FG005|Overall Study|Physician Decision|0|||
106103458|NCT02181803|366034731|FG006|Overall Study|Physician Decision|0|||
106103459|NCT02181803|366034732|FG007|Overall Study|Physician Decision|1|||
106103460|NCT02181803|366034733|FG008|Overall Study|Physician Decision|0|||
106103461|NCT02181803|366034725|FG000|Overall Study|Adverse Event|0|||
106103462|NCT02181803|366034726|FG001|Overall Study|Adverse Event|2|||
106103463|NCT02181803|366034727|FG002|Overall Study|Adverse Event|0|||
106103464|NCT02181803|366034728|FG003|Overall Study|Adverse Event|1|||
106103465|NCT02181803|366034729|FG004|Overall Study|Adverse Event|0|||
106103466|NCT02181803|366034730|FG005|Overall Study|Adverse Event|0|||
106103467|NCT02181803|366034731|FG006|Overall Study|Adverse Event|1|||
106103468|NCT02181803|366034732|FG007|Overall Study|Adverse Event|0|||
106103469|NCT02181803|366034733|FG008|Overall Study|Adverse Event|0|||
106103470|NCT00765843|366034738|FG000|Overall Study|Lost to Follow-up|1|||
106103471|NCT00765843|366034739|FG001|Overall Study|Lost to Follow-up|3|||
106103472|NCT00765843|366034740|FG002|Overall Study|Lost to Follow-up|2|||
106103473|NCT00765843|366034738|FG000|Overall Study|did not return to receive intervention|0|||
106103474|NCT00765843|366034739|FG001|Overall Study|did not return to receive intervention|1|||
106103475|NCT00765843|366034740|FG002|Overall Study|did not return to receive intervention|0|||
106103476|NCT00765843|366034738|FG000|Overall Study|Adverse Event|0|||
106103477|NCT00765843|366034739|FG001|Overall Study|Adverse Event|0|||
106103478|NCT00765843|366034740|FG002|Overall Study|Adverse Event|1|||
106103479|NCT00454051|366034745|FG000|Overall Study|Adverse Event|1|||
106103480|NCT00454051|366034746|FG001|Overall Study|Adverse Event|2|||
106103481|NCT00454051|366034745|FG000|Overall Study|Withdrawal by Subject|1|||
106103482|NCT00454051|366034746|FG001|Overall Study|Withdrawal by Subject|0|||
106103483|NCT00454051|366034745|FG000|Overall Study|Protocol Violation|1|||
106103484|NCT00454051|366034746|FG001|Overall Study|Protocol Violation|1|||
106103485|NCT01260350|366034749|FG000|Overall Study|Lack of Efficacy|0|||
106103486|NCT01260350|366034750|FG001|Overall Study|Lack of Efficacy|0|||
106103487|NCT01260350|366034751|FG002|Overall Study|Lack of Efficacy|0|||
106103488|NCT01260350|366034752|FG003|Overall Study|Lack of Efficacy|0|||
106103489|NCT01260350|366034753|FG004|Overall Study|Lack of Efficacy|0|||
106103490|NCT01260350|366034754|FG005|Overall Study|Lack of Efficacy|0|||
106103491|NCT01260350|366034755|FG006|Overall Study|Lack of Efficacy|0|||
106103492|NCT01260350|366034756|FG007|Overall Study|Lack of Efficacy|0|||
106103493|NCT01260350|366034757|FG008|Overall Study|Lack of Efficacy|0|||
106103494|NCT01260350|366034758|FG009|Overall Study|Lack of Efficacy|0|||
106103495|NCT01260350|366034759|FG010|Overall Study|Lack of Efficacy|0|||
106103496|NCT01260350|366034760|FG011|Overall Study|Lack of Efficacy|0|||
106103497|NCT01260350|366034761|FG012|Overall Study|Lack of Efficacy|0|||
106103498|NCT01260350|366034762|FG013|Overall Study|Lack of Efficacy|0|||
106103499|NCT01260350|366034763|FG014|Overall Study|Lack of Efficacy|0|||
106103500|NCT01260350|366034764|FG015|Overall Study|Lack of Efficacy|0|||
106103501|NCT01260350|366034765|FG016|Overall Study|Lack of Efficacy|0|||
106103502|NCT01260350|366034766|FG017|Overall Study|Lack of Efficacy|1|||
106103503|NCT01260350|366034767|FG018|Overall Study|Lack of Efficacy|0|||
106103504|NCT01260350|366034768|FG019|Overall Study|Lack of Efficacy|0|||
106103505|NCT01260350|366034769|FG020|Overall Study|Lack of Efficacy|3|||
106103506|NCT01260350|366034770|FG021|Overall Study|Lack of Efficacy|0|||
106103507|NCT01260350|366034749|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103508|NCT01260350|366034750|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103509|NCT01260350|366034751|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103510|NCT01260350|366034752|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103511|NCT01260350|366034753|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103512|NCT01260350|366034754|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103513|NCT01260350|366034755|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103514|NCT01260350|366034756|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103515|NCT01260350|366034757|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
106103516|NCT01260350|366034758|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103517|NCT01260350|366034759|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103518|NCT01260350|366034760|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103519|NCT01260350|366034761|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103520|NCT01260350|366034762|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103521|NCT01260350|366034763|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103522|NCT01260350|366034764|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103523|NCT01260350|366034765|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103524|NCT01260350|366034766|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103525|NCT01260350|366034767|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103526|NCT01260350|366034768|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103527|NCT01260350|366034769|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103528|NCT01260350|366034770|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
106103529|NCT00558428|366034773|FG000|Overall Study|Adverse Event|6|||
106103530|NCT00558428|366034774|FG001|Overall Study|Adverse Event|22|||
106103531|NCT00558428|366034775|FG002|Overall Study|Adverse Event|3|||
106103532|NCT00558428|366034776|FG003|Overall Study|Adverse Event|4|||
106103533|NCT00558428|366034773|FG000|Overall Study|Lost to Follow-up|0|||
106103534|NCT00558428|366034774|FG001|Overall Study|Lost to Follow-up|1|||
106103535|NCT00558428|366034775|FG002|Overall Study|Lost to Follow-up|0|||
106103536|NCT00558428|366034776|FG003|Overall Study|Lost to Follow-up|0|||
106103537|NCT00558428|366034773|FG000|Overall Study|Lack of Efficacy|0|||
106103538|NCT00558428|366034774|FG001|Overall Study|Lack of Efficacy|0|||
106103539|NCT00558428|366034775|FG002|Overall Study|Lack of Efficacy|1|||
106103540|NCT00558428|366034776|FG003|Overall Study|Lack of Efficacy|2|||
106103541|NCT00558428|366034773|FG000|Overall Study|Non compliant with protocol|1|||
106103542|NCT00558428|366034774|FG001|Overall Study|Non compliant with protocol|0|||
106103543|NCT00558428|366034775|FG002|Overall Study|Non compliant with protocol|0|||
106103544|NCT00558428|366034776|FG003|Overall Study|Non compliant with protocol|3|||
106103545|NCT00558428|366034773|FG000|Overall Study|Consent withdrawn|2|||
106103546|NCT00558428|366034774|FG001|Overall Study|Consent withdrawn|1|||
106103547|NCT00558428|366034775|FG002|Overall Study|Consent withdrawn|0|||
106103548|NCT00558428|366034776|FG003|Overall Study|Consent withdrawn|1|||
106103549|NCT00558428|366034773|FG000|Overall Study|Other|3|||
106103550|NCT00558428|366034774|FG001|Overall Study|Other|0|||
106103551|NCT00558428|366034775|FG002|Overall Study|Other|0|||
106103552|NCT00558428|366034776|FG003|Overall Study|Other|1|||
106103553|NCT02525874|366034787|FG000|Overall Study|Other|1|||
106103554|NCT02525874|366034787|FG000|Overall Study|Investigator Decision|1|||
106103555|NCT02525874|366034787|FG000|Overall Study|Consent withdrawn|22|||
106103556|NCT02525874|366034787|FG000|Overall Study|Non-compliance with study drug|3|||
106103557|NCT02525874|366034787|FG000|Overall Study|Adverse Event|17|||
106103558|NCT02525874|366034787|FG000|Overall Study|Lost to Follow-up|7|||
106103559|NCT02525874|366034787|FG000|Overall Study|Disease progression, defined by protocol|2|||
106103560|NCT02525874|366034787|FG000|Overall Study|Disease relapse|4|||
106103561|NCT02525874|366034787|FG000|Overall Study|Alternative Treatment for MS|2|||
106103562|NCT02525874|366034787|FG000|Overall Study|New lesions in Brain|1|||
106103563|NCT01692782|366034789|FG000|Overall Study|Adverse Event|12|||
106103564|NCT01692782|366034790|FG001|Overall Study|Adverse Event|32|||
106103565|NCT01692782|366034791|FG002|Overall Study|Adverse Event|2|||
106103566|NCT01692782|366034789|FG000|Overall Study|Lack of Efficacy|1|||
106103567|NCT01692782|366034790|FG001|Overall Study|Lack of Efficacy|2|||
106103568|NCT01692782|366034791|FG002|Overall Study|Lack of Efficacy|0|||
106103569|NCT01692782|366034789|FG000|Overall Study|Lost to Follow-up|2|||
106103570|NCT01692782|366034790|FG001|Overall Study|Lost to Follow-up|7|||
106103571|NCT01692782|366034791|FG002|Overall Study|Lost to Follow-up|1|||
106103572|NCT01692782|366034789|FG000|Overall Study|Pregnancy|1|||
106103573|NCT01692782|366034790|FG001|Overall Study|Pregnancy|0|||
106103574|NCT01692782|366034791|FG002|Overall Study|Pregnancy|0|||
106103575|NCT01692782|366034789|FG000|Overall Study|Protocol Violation|1|||
106103576|NCT01692782|366034790|FG001|Overall Study|Protocol Violation|0|||
106103577|NCT01692782|366034791|FG002|Overall Study|Protocol Violation|2|||
106103578|NCT01692782|366034789|FG000|Overall Study|Non-complance with study drug|0|||
106103579|NCT01692782|366034790|FG001|Overall Study|Non-complance with study drug|4|||
106103580|NCT01692782|366034791|FG002|Overall Study|Non-complance with study drug|1|||
106103581|NCT01692782|366034789|FG000|Overall Study|Non-compliant with study visits|0|||
106103582|NCT01692782|366034790|FG001|Overall Study|Non-compliant with study visits|0|||
106103583|NCT01692782|366034791|FG002|Overall Study|Non-compliant with study visits|1|||
106103584|NCT01692782|366034789|FG000|Overall Study|SAE not related to study drug|0|||
106103585|NCT01692782|366034790|FG001|Overall Study|SAE not related to study drug|1|||
106103586|NCT01692782|366034791|FG002|Overall Study|SAE not related to study drug|0|||
106103587|NCT01692782|366034789|FG000|Overall Study|Withdrawal by Subject|3|||
106103588|NCT01692782|366034790|FG001|Overall Study|Withdrawal by Subject|10|||
106103589|NCT01692782|366034791|FG002|Overall Study|Withdrawal by Subject|3|||
106103590|NCT02794285|366034792|FG000|Overall Study|Adverse Event|11|||
106103591|NCT02794285|366034793|FG001|Overall Study|Adverse Event|4|||
106103592|NCT02794285|366034794|FG002|Overall Study|Adverse Event|5|||
106103593|NCT02794285|366034795|FG003|Overall Study|Adverse Event|8|||
106103594|NCT02794285|366034792|FG000|Overall Study|Condition Under Investigation Improved|1|||
106103595|NCT02794285|366034793|FG001|Overall Study|Condition Under Investigation Improved|0|||
106103596|NCT02794285|366034794|FG002|Overall Study|Condition Under Investigation Improved|0|||
106103597|NCT02794285|366034795|FG003|Overall Study|Condition Under Investigation Improved|0|||
106103598|NCT02794285|366034792|FG000|Overall Study|Condition Under Investigation Worsened|0|||
106103599|NCT02794285|366034793|FG001|Overall Study|Condition Under Investigation Worsened|2|||
106103600|NCT02794285|366034794|FG002|Overall Study|Condition Under Investigation Worsened|1|||
106103601|NCT02794285|366034795|FG003|Overall Study|Condition Under Investigation Worsened|0|||
106103602|NCT02794285|366034792|FG000|Overall Study|Death|2|||
106103603|NCT02794285|366034793|FG001|Overall Study|Death|1|||
106103604|NCT02794285|366034794|FG002|Overall Study|Death|2|||
106103605|NCT02794285|366034795|FG003|Overall Study|Death|0|||
106103606|NCT02794285|366034792|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
106103607|NCT02794285|366034793|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
106103608|NCT02794285|366034794|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
106103609|NCT02794285|366034795|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
106103610|NCT02794285|366034792|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
106103611|NCT02794285|366034793|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
106103612|NCT02794285|366034794|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
106103613|NCT02794285|366034795|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
106103614|NCT02794285|366034792|FG000|Overall Study|Lack of Efficacy|10|||
106103615|NCT02794285|366034793|FG001|Overall Study|Lack of Efficacy|6|||
106103616|NCT02794285|366034794|FG002|Overall Study|Lack of Efficacy|3|||
106103617|NCT02794285|366034795|FG003|Overall Study|Lack of Efficacy|3|||
106103618|NCT02794285|366034792|FG000|Overall Study|Lost to Follow-up|5|||
106103619|NCT02794285|366034793|FG001|Overall Study|Lost to Follow-up|6|||
106103620|NCT02794285|366034794|FG002|Overall Study|Lost to Follow-up|3|||
106103621|NCT02794285|366034795|FG003|Overall Study|Lost to Follow-up|1|||
106103622|NCT02794285|366034792|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
106103623|NCT02794285|366034793|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
106103624|NCT02794285|366034794|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
106103625|NCT02794285|366034795|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
106103626|NCT02794285|366034792|FG000|Overall Study|Withdrawal by Subject|38|||
106103627|NCT02794285|366034793|FG001|Overall Study|Withdrawal by Subject|29|||
106103628|NCT02794285|366034794|FG002|Overall Study|Withdrawal by Subject|20|||
106103629|NCT02794285|366034795|FG003|Overall Study|Withdrawal by Subject|12|||
106103630|NCT02794285|366034792|FG000|Overall Study|Missing|1|||
106103631|NCT02794285|366034793|FG001|Overall Study|Missing|0|||
106103632|NCT02794285|366034794|FG002|Overall Study|Missing|0|||
106103633|NCT02794285|366034795|FG003|Overall Study|Missing|0|||
106103634|NCT02794285|366034792|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
105781729|NCT01347931|364854829|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
106103635|NCT02794285|366034793|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
106103636|NCT02794285|366034794|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
106103637|NCT02794285|366034795|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
106103638|NCT02794285|366034792|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
106103639|NCT02794285|366034793|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
106103640|NCT02794285|366034794|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
106103641|NCT02794285|366034795|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
106103642|NCT02732938|366034796|FG000|Overall Study|Death|0|||
106103643|NCT02732938|366034797|FG001|Overall Study|Death|11|||
106103644|NCT02732938|366034798|FG002|Overall Study|Death|0|||
106103645|NCT02732938|366034796|FG000|Overall Study|Randomized but did not receive treatment|0|||
106103646|NCT02732938|366034797|FG001|Overall Study|Randomized but did not receive treatment|1|||
106103647|NCT02732938|366034798|FG002|Overall Study|Randomized but did not receive treatment|0|||
106103648|NCT02732938|366034796|FG000|Overall Study|Refused further follow-up|1|||
106103649|NCT02732938|366034797|FG001|Overall Study|Refused further follow-up|0|||
106103650|NCT02732938|366034798|FG002|Overall Study|Refused further follow-up|0|||
106103651|NCT02732938|366034796|FG000|Overall Study|Study terminated by sponsor|3|||
106103652|NCT02732938|366034797|FG001|Overall Study|Study terminated by sponsor|6|||
106103653|NCT02732938|366034798|FG002|Overall Study|Study terminated by sponsor|0|||
106103654|NCT01640808|366034807|FG000|Overall Study|Unable to continue dynamic CT|14|||
106103655|NCT01640808|366034808|FG001|Overall Study|Unable to continue dynamic CT|4|||
106103656|NCT01640808|366034807|FG000|Overall Study|Withdrawal by Subject|12|||
106103657|NCT01640808|366034808|FG001|Overall Study|Withdrawal by Subject|4|||
106103658|NCT01640808|366034807|FG000|Overall Study|Lost to Follow-up|4|||
106103659|NCT01640808|366034808|FG001|Overall Study|Lost to Follow-up|0|||
106103660|NCT01640808|366034807|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
106103661|NCT01640808|366034808|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
106103662|NCT01640808|366034807|FG000|Overall Study|Administration of anticancer drugs|2|||
106103663|NCT01640808|366034808|FG001|Overall Study|Administration of anticancer drugs|1|||
106103664|NCT01640808|366034807|FG000|Overall Study|Physician Decision|19|||
106103665|NCT01640808|366034808|FG001|Overall Study|Physician Decision|5|||
106103666|NCT01640808|366034807|FG000|Overall Study|Randomized but not treated|4|||
106103667|NCT01640808|366034808|FG001|Overall Study|Randomized but not treated|2|||
106103668|NCT04391023|366034809|FG000|Overall Study|Withdrawal by Subject|2|||
106103669|NCT04391023|366034810|FG001|Overall Study|Withdrawal by Subject|2|||
106103670|NCT05553808|366034811|FG000|Overall Study|Death|25|||
106103671|NCT05553808|366034812|FG001|Overall Study|Death|62|||
106103672|NCT05553808|366034811|FG000|Overall Study|Site Closed|6|||
106103673|NCT05553808|366034812|FG001|Overall Study|Site Closed|6|||
106103674|NCT05553808|366034811|FG000|Overall Study|Lost to Follow-up|1|||
106103675|NCT05553808|366034812|FG001|Overall Study|Lost to Follow-up|0|||
106103676|NCT05553808|366034811|FG000|Overall Study|Withdrawal by Subject|3|||
106103677|NCT05553808|366034812|FG001|Overall Study|Withdrawal by Subject|2|||
106103678|NCT04575467|366034813|FG000|Overall Study|Adverse Event|0|||
106103679|NCT04575467|366034814|FG001|Overall Study|Adverse Event|1|||
106103680|NCT04575467|366034815|FG002|Overall Study|Adverse Event|0|||
106103681|NCT04575467|366034816|FG003|Overall Study|Adverse Event|0|||
106103682|NCT02384954|366034817|FG000|Phase 1|Progressive Disease|2|||
106103683|NCT02384954|366034818|FG001|Phase 1|Progressive Disease|0|||
106103684|NCT02384954|366034819|FG002|Phase 1|Progressive Disease|1|||
106103685|NCT02384954|366034820|FG003|Phase 1|Progressive Disease|1|||
106103686|NCT02384954|366034821|FG004|Phase 1|Progressive Disease|0|||
106103687|NCT02384954|366034822|FG005|Phase 1|Progressive Disease|0|||
106103688|NCT02384954|366034823|FG006|Phase 1|Progressive Disease|0|||
106103689|NCT02384954|366034824|FG007|Phase 1|Progressive Disease|0|||
106103690|NCT02384954|366034825|FG008|Phase 1|Progressive Disease|0|||
106103691|NCT02384954|366034817|FG000|Phase 1|Adverse Event|0|||
106103692|NCT02384954|366034818|FG001|Phase 1|Adverse Event|0|||
106103693|NCT02384954|366034819|FG002|Phase 1|Adverse Event|1|||
106103694|NCT02384954|366034820|FG003|Phase 1|Adverse Event|0|||
106103695|NCT02384954|366034821|FG004|Phase 1|Adverse Event|0|||
106103696|NCT02384954|366034822|FG005|Phase 1|Adverse Event|0|||
106103697|NCT02384954|366034823|FG006|Phase 1|Adverse Event|0|||
106103698|NCT02384954|366034824|FG007|Phase 1|Adverse Event|0|||
106103699|NCT02384954|366034825|FG008|Phase 1|Adverse Event|0|||
106103700|NCT02384954|366034817|FG000|Phase 2|Progressive Disease|0|||
106103701|NCT02384954|366034818|FG001|Phase 2|Progressive Disease|0|||
106103702|NCT02384954|366034819|FG002|Phase 2|Progressive Disease|0|||
106103703|NCT02384954|366034820|FG003|Phase 2|Progressive Disease|0|||
106103704|NCT02384954|366034821|FG004|Phase 2|Progressive Disease|0|||
106103705|NCT02384954|366034822|FG005|Phase 2|Progressive Disease|0|||
106103706|NCT02384954|366034823|FG006|Phase 2|Progressive Disease|0|||
106103707|NCT02384954|366034824|FG007|Phase 2|Progressive Disease|1|||
106103708|NCT02384954|366034825|FG008|Phase 2|Progressive Disease|2|||
106103709|NCT02384954|366034817|FG000|Phase 2|Adverse Event|0|||
106103710|NCT02384954|366034818|FG001|Phase 2|Adverse Event|0|||
106103711|NCT02384954|366034819|FG002|Phase 2|Adverse Event|0|||
106103712|NCT02384954|366034820|FG003|Phase 2|Adverse Event|0|||
106103713|NCT02384954|366034821|FG004|Phase 2|Adverse Event|0|||
106103714|NCT02384954|366034822|FG005|Phase 2|Adverse Event|0|||
106103715|NCT02384954|366034823|FG006|Phase 2|Adverse Event|0|||
106103716|NCT02384954|366034824|FG007|Phase 2|Adverse Event|1|||
106103717|NCT02384954|366034825|FG008|Phase 2|Adverse Event|1|||
106103718|NCT02384954|366034817|FG000|Phase 2|Failure to meet continuation criteria|0|||
106103719|NCT02384954|366034818|FG001|Phase 2|Failure to meet continuation criteria|0|||
106103720|NCT02384954|366034819|FG002|Phase 2|Failure to meet continuation criteria|0|||
106103721|NCT02384954|366034820|FG003|Phase 2|Failure to meet continuation criteria|0|||
106103722|NCT02384954|366034821|FG004|Phase 2|Failure to meet continuation criteria|0|||
106103723|NCT02384954|366034822|FG005|Phase 2|Failure to meet continuation criteria|0|||
106103724|NCT02384954|366034823|FG006|Phase 2|Failure to meet continuation criteria|0|||
106103725|NCT02384954|366034824|FG007|Phase 2|Failure to meet continuation criteria|1|||
106103726|NCT02384954|366034825|FG008|Phase 2|Failure to meet continuation criteria|0|||
106103727|NCT00003298|366034829|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
106103728|NCT00003298|366034829|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
106103729|NCT00003298|366034829|FG000|Surgery|Unresectable at surgery|3|||
106103730|NCT00003298|366034829|FG000|Surgery|Progression before surgery|2|||
106103731|NCT00003298|366034829|FG000|Surgery|Unevaluable and off study|2|||
106103732|NCT00003298|366034829|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
106103733|NCT00003298|366034829|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
106103734|NCT00003298|366034829|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
106103735|NCT00003298|366034829|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
106103736|NCT00003298|366034829|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
106103737|NCT00003298|366034829|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
106103738|NCT00003298|366034829|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
106103739|NCT00003298|366034829|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
106103740|NCT00003298|366034829|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
106103741|NCT00003298|366034829|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
106103742|NCT02195986|366034830|FG000|Overall Study|Adverse Event|3|||
106103743|NCT02195986|366034831|FG001|Overall Study|Adverse Event|0|||
106103744|NCT02195986|366034832|FG002|Overall Study|Adverse Event|0|||
106103745|NCT02195986|366034830|FG000|Overall Study|Withdrawal by Subject|0|||
106103746|NCT02195986|366034831|FG001|Overall Study|Withdrawal by Subject|3|||
106103747|NCT02195986|366034832|FG002|Overall Study|Withdrawal by Subject|0|||
106103748|NCT02195986|366034830|FG000|Overall Study|Family Emergency|0|||
106103749|NCT02195986|366034831|FG001|Overall Study|Family Emergency|0|||
106103750|NCT02195986|366034832|FG002|Overall Study|Family Emergency|1|||
106103751|NCT02195986|366034830|FG000|Overall Study|Protocol Violation|0|||
106103752|NCT02195986|366034831|FG001|Overall Study|Protocol Violation|1|||
106103753|NCT02195986|366034832|FG002|Overall Study|Protocol Violation|1|||
106103754|NCT02195986|366034830|FG000|Overall Study|Non-compliance|0|||
106103755|NCT02195986|366034831|FG001|Overall Study|Non-compliance|1|||
106103756|NCT02195986|366034832|FG002|Overall Study|Non-compliance|0|||
106103757|NCT02308748|366034833|FG000|Period 1|Withdrawal by Subject|0|||
106103758|NCT02308748|366034834|FG001|Period 1|Withdrawal by Subject|0|||
106103759|NCT02308748|366034835|FG002|Period 1|Withdrawal by Subject|1|||
106103760|NCT02308748|366034836|FG003|Period 1|Withdrawal by Subject|0|||
106103761|NCT02308748|366034837|FG004|Period 1|Withdrawal by Subject|0|||
106103762|NCT02308748|366034838|FG005|Period 1|Withdrawal by Subject|0|||
106103763|NCT02308748|366034839|FG006|Period 1|Withdrawal by Subject|0|||
106103764|NCT02308748|366034840|FG007|Period 1|Withdrawal by Subject|0|||
106103765|NCT02308748|366034841|FG008|Period 1|Withdrawal by Subject|0|||
106103766|NCT02308748|366034842|FG009|Period 1|Withdrawal by Subject|0|||
106103767|NCT02308748|366034833|FG000|Period 2|Adverse Event|0|||
106103768|NCT02308748|366034834|FG001|Period 2|Adverse Event|0|||
106103769|NCT02308748|366034835|FG002|Period 2|Adverse Event|0|||
106103770|NCT02308748|366034836|FG003|Period 2|Adverse Event|0|||
106103771|NCT02308748|366034837|FG004|Period 2|Adverse Event|0|||
106103772|NCT02308748|366034838|FG005|Period 2|Adverse Event|0|||
106103773|NCT02308748|366034839|FG006|Period 2|Adverse Event|0|||
106103774|NCT02308748|366034840|FG007|Period 2|Adverse Event|1|||
106103775|NCT02308748|366034841|FG008|Period 2|Adverse Event|0|||
106103776|NCT02308748|366034842|FG009|Period 2|Adverse Event|0|||
106103777|NCT02308748|366034833|FG000|Period 3|Protocol Violation|0|||
106103778|NCT02308748|366034834|FG001|Period 3|Protocol Violation|0|||
106103779|NCT02308748|366034835|FG002|Period 3|Protocol Violation|0|||
106103780|NCT02308748|366034836|FG003|Period 3|Protocol Violation|0|||
106103781|NCT02308748|366034837|FG004|Period 3|Protocol Violation|0|||
106103782|NCT02308748|366034838|FG005|Period 3|Protocol Violation|0|||
106103783|NCT02308748|366034839|FG006|Period 3|Protocol Violation|0|||
106103784|NCT02308748|366034840|FG007|Period 3|Protocol Violation|0|||
106103785|NCT02308748|366034841|FG008|Period 3|Protocol Violation|0|||
106103786|NCT02308748|366034842|FG009|Period 3|Protocol Violation|1|||
106103787|NCT02308748|366034833|FG000|Period 5|Adverse Event|1|||
106103788|NCT02308748|366034834|FG001|Period 5|Adverse Event|0|||
106103789|NCT02308748|366034835|FG002|Period 5|Adverse Event|0|||
106103790|NCT02308748|366034836|FG003|Period 5|Adverse Event|0|||
106103791|NCT02308748|366034837|FG004|Period 5|Adverse Event|0|||
106103792|NCT02308748|366034838|FG005|Period 5|Adverse Event|0|||
106103793|NCT02308748|366034839|FG006|Period 5|Adverse Event|0|||
106103794|NCT02308748|366034840|FG007|Period 5|Adverse Event|0|||
106103795|NCT02308748|366034841|FG008|Period 5|Adverse Event|1|||
106103796|NCT02308748|366034842|FG009|Period 5|Adverse Event|0|||
106103797|NCT02270450|366034843|FG000|Overall Study|Refusal unrelated to adverse event|3|||
106103798|NCT02270450|366034844|FG001|Overall Study|Refusal unrelated to adverse event|1|||
106144080|NCT01317420|366186951|FG002|Overall Study|Other adverse event|0|||
106103799|NCT02270450|366034845|FG002|Overall Study|Refusal unrelated to adverse event|5|||
106103800|NCT02270450|366034846|FG003|Overall Study|Refusal unrelated to adverse event|14|||
106103801|NCT02270450|366034843|FG000|Overall Study|Progression/relapse|1|||
106103802|NCT02270450|366034844|FG001|Overall Study|Progression/relapse|2|||
106103803|NCT02270450|366034845|FG002|Overall Study|Progression/relapse|4|||
106103804|NCT02270450|366034846|FG003|Overall Study|Progression/relapse|9|||
106103805|NCT02270450|366034843|FG000|Overall Study|Death|19|||
106103806|NCT02270450|366034844|FG001|Overall Study|Death|19|||
106103807|NCT02270450|366034845|FG002|Overall Study|Death|31|||
106103808|NCT02270450|366034846|FG003|Overall Study|Death|59|||
106103809|NCT02081846|366034848|FG000|Overall Study|Withdrawal by Subject|1|||
106103810|NCT02081846|366034849|FG001|Overall Study|Withdrawal by Subject|0|||
106103811|NCT02081846|366034848|FG000|Overall Study|invalid consent|1|||
106103812|NCT02081846|366034849|FG001|Overall Study|invalid consent|0|||
106103813|NCT02199028|366034851|FG000|Week 1|Adverse Event|1|||
106103814|NCT02199028|366034852|FG001|Week 1|Adverse Event|0|||
106103815|NCT02199028|366034851|FG000|Week 3|Adverse Event|1|||
106103816|NCT02199028|366034852|FG001|Week 3|Adverse Event|0|||
106103817|NCT01090453|366034853|FG000|Overall Study|Withdrawal by Subject|1|||
106103818|NCT01090453|366034854|FG001|Overall Study|Withdrawal by Subject|2|||
106103819|NCT01090453|366034853|FG000|Overall Study|Lost to Follow-up|7|||
106103820|NCT01090453|366034854|FG001|Overall Study|Lost to Follow-up|7|||
106103821|NCT01090453|366034853|FG000|Overall Study|Non serious AEs|1|||
106103822|NCT01090453|366034854|FG001|Overall Study|Non serious AEs|0|||
106103823|NCT01090453|366034853|FG000|Overall Study|Protocol Violation|2|||
106103824|NCT01090453|366034854|FG001|Overall Study|Protocol Violation|0|||
106103825|NCT01090453|366034853|FG000|Overall Study|Other|2|||
106103826|NCT01090453|366034854|FG001|Overall Study|Other|4|||
106103827|NCT01090453|366034853|FG000|Overall Study|Eligibility Criteria|0|||
106103828|NCT01090453|366034854|FG001|Overall Study|Eligibility Criteria|1|||
106103829|NCT05045625|366034855|FG000|Overall Study|Lost to Follow-up|3|||
106103830|NCT03570619|366034860|FG000|Overall Study|Adverse Event|2|||
106103831|NCT03570619|366034861|FG001|Overall Study|Adverse Event|0|||
106103832|NCT03570619|366034862|FG002|Overall Study|Adverse Event|1|||
106103833|NCT03570619|366034860|FG000|Overall Study|new diagnosis of new malignancy|1|||
106103834|NCT03570619|366034861|FG001|Overall Study|new diagnosis of new malignancy|0|||
106103835|NCT03570619|366034862|FG002|Overall Study|new diagnosis of new malignancy|0|||
106103836|NCT03570619|366034860|FG000|Overall Study|Physician Decision|1|||
106103837|NCT03570619|366034861|FG001|Overall Study|Physician Decision|1|||
106103838|NCT03570619|366034862|FG002|Overall Study|Physician Decision|0|||
106103839|NCT03570619|366034860|FG000|Overall Study|Withdrawal by Subject|0|||
106103840|NCT03570619|366034861|FG001|Overall Study|Withdrawal by Subject|2|||
106103841|NCT03570619|366034862|FG002|Overall Study|Withdrawal by Subject|0|||
106103842|NCT00802074|366034865|FG000|Overall Study|Adverse Event|1|||
106103843|NCT00802074|366034866|FG001|Overall Study|Adverse Event|1|||
106103844|NCT00802074|366034867|FG002|Overall Study|Adverse Event|1|||
106103845|NCT00802074|366034868|FG003|Overall Study|Adverse Event|0|||
106103846|NCT00802074|366034869|FG004|Overall Study|Adverse Event|0|||
106103847|NCT00802074|366034870|FG005|Overall Study|Adverse Event|0|||
106103848|NCT00802074|366034865|FG000|Overall Study|Withdrawal by Subject|1|||
106103849|NCT00802074|366034866|FG001|Overall Study|Withdrawal by Subject|0|||
106103850|NCT00802074|366034867|FG002|Overall Study|Withdrawal by Subject|0|||
106103851|NCT00802074|366034868|FG003|Overall Study|Withdrawal by Subject|0|||
106103852|NCT00802074|366034869|FG004|Overall Study|Withdrawal by Subject|0|||
106103853|NCT00802074|366034870|FG005|Overall Study|Withdrawal by Subject|0|||
106103854|NCT00843167|366034873|FG000|Treatment Period|Adverse Event|1|||
106103855|NCT00843167|366034874|FG001|Treatment Period|Adverse Event|5|||
106103856|NCT00843167|366034873|FG000|Treatment Period|Withdrawal by Subject|2|||
106103857|NCT00843167|366034874|FG001|Treatment Period|Withdrawal by Subject|3|||
106103858|NCT00127101|366034875|FG000|Base Protocol|Adverse Event|0|||
106103859|NCT00127101|366034876|FG001|Base Protocol|Adverse Event|2|||
106103860|NCT00127101|366034877|FG002|Base Protocol|Adverse Event|1|||
106103861|NCT00127101|366034878|FG003|Base Protocol|Adverse Event|0|||
106103862|NCT00127101|366034879|FG004|Base Protocol|Adverse Event|0|||
106103863|NCT00127101|366034880|FG005|Base Protocol|Adverse Event|0|||
106103864|NCT00127101|366034875|FG000|Base Protocol|Lack of Efficacy|1|||
106103865|NCT00127101|366034876|FG001|Base Protocol|Lack of Efficacy|0|||
106103866|NCT00127101|366034877|FG002|Base Protocol|Lack of Efficacy|0|||
106103867|NCT00127101|366034878|FG003|Base Protocol|Lack of Efficacy|0|||
106103868|NCT00127101|366034879|FG004|Base Protocol|Lack of Efficacy|2|||
106103869|NCT00127101|366034880|FG005|Base Protocol|Lack of Efficacy|0|||
106103870|NCT00127101|366034875|FG000|Base Protocol|Withdrawal by Subject|1|||
106103871|NCT00127101|366034876|FG001|Base Protocol|Withdrawal by Subject|2|||
106103872|NCT00127101|366034877|FG002|Base Protocol|Withdrawal by Subject|1|||
106103873|NCT00127101|366034878|FG003|Base Protocol|Withdrawal by Subject|0|||
106103874|NCT00127101|366034879|FG004|Base Protocol|Withdrawal by Subject|0|||
106103875|NCT00127101|366034880|FG005|Base Protocol|Withdrawal by Subject|1|||
106103876|NCT00127101|366034875|FG000|Continuation Phase|Adverse Event|0|||
106103877|NCT00127101|366034876|FG001|Continuation Phase|Adverse Event|0|||
106103878|NCT00127101|366034877|FG002|Continuation Phase|Adverse Event|0|||
106103879|NCT00127101|366034878|FG003|Continuation Phase|Adverse Event|0|||
106103880|NCT00127101|366034879|FG004|Continuation Phase|Adverse Event|1|||
106103881|NCT00127101|366034880|FG005|Continuation Phase|Adverse Event|1|||
106103882|NCT00127101|366034875|FG000|Continuation Phase|Lack of Efficacy|0|||
106103883|NCT00127101|366034876|FG001|Continuation Phase|Lack of Efficacy|0|||
106103884|NCT00127101|366034877|FG002|Continuation Phase|Lack of Efficacy|0|||
106103885|NCT00127101|366034878|FG003|Continuation Phase|Lack of Efficacy|0|||
106103886|NCT00127101|366034879|FG004|Continuation Phase|Lack of Efficacy|0|||
106103887|NCT00127101|366034880|FG005|Continuation Phase|Lack of Efficacy|1|||
106103888|NCT00127101|366034875|FG000|Continuation Phase|Withdrawal by Subject|0|||
106103889|NCT00127101|366034876|FG001|Continuation Phase|Withdrawal by Subject|0|||
106103890|NCT00127101|366034877|FG002|Continuation Phase|Withdrawal by Subject|1|||
106103891|NCT00127101|366034878|FG003|Continuation Phase|Withdrawal by Subject|0|||
106103892|NCT00127101|366034879|FG004|Continuation Phase|Withdrawal by Subject|2|||
106103893|NCT00127101|366034880|FG005|Continuation Phase|Withdrawal by Subject|1|||
106103894|NCT03336619|366034881|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
106103895|NCT03336619|366034882|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
106103896|NCT03336619|366034881|FG000|Overall Study|Withdrawal by Subject|17|||
106103897|NCT03336619|366034882|FG001|Overall Study|Withdrawal by Subject|16|||
106103898|NCT03336619|366034881|FG000|Overall Study|Adverse Event|2|||
106103899|NCT03336619|366034882|FG001|Overall Study|Adverse Event|5|||
106103900|NCT03336619|366034881|FG000|Overall Study|Physician Decision|3|||
106103901|NCT03336619|366034882|FG001|Overall Study|Physician Decision|0|||
106103902|NCT02820623|366034883|FG000|Overall Study|Withdrawal by Subject|1|||
106103903|NCT02820623|366034884|FG001|Overall Study|Withdrawal by Subject|3|||
106103904|NCT02820623|366034885|FG002|Overall Study|Withdrawal by Subject|3|||
106103905|NCT02820623|366034883|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
106103906|NCT02820623|366034884|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
106103907|NCT02820623|366034885|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
106103908|NCT02820623|366034883|FG000|Overall Study|Therapist unable to enroll clients|1|||
106103909|NCT02820623|366034884|FG001|Overall Study|Therapist unable to enroll clients|1|||
106103910|NCT02820623|366034885|FG002|Overall Study|Therapist unable to enroll clients|3|||
106103911|NCT02820623|366034883|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
106103912|NCT02820623|366034884|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
106103913|NCT02820623|366034885|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
106103914|NCT01565707|366034886|FG000|Overall Study|Adverse Event|1|||
106103915|NCT01565707|366034887|FG001|Overall Study|Adverse Event|6|||
106103916|NCT01565707|366034888|FG002|Overall Study|Adverse Event|2|||
106103917|NCT01565707|366034889|FG003|Overall Study|Adverse Event|1|||
106103918|NCT01565707|366034886|FG000|Overall Study|Lost to Follow-up|1|||
106103919|NCT01565707|366034887|FG001|Overall Study|Lost to Follow-up|0|||
106103920|NCT01565707|366034888|FG002|Overall Study|Lost to Follow-up|0|||
106103921|NCT01565707|366034889|FG003|Overall Study|Lost to Follow-up|0|||
106103922|NCT01565707|366034886|FG000|Overall Study|Protocol Violation|1|||
106103923|NCT01565707|366034887|FG001|Overall Study|Protocol Violation|0|||
106103924|NCT01565707|366034888|FG002|Overall Study|Protocol Violation|0|||
106103925|NCT01565707|366034889|FG003|Overall Study|Protocol Violation|1|||
106103926|NCT01565707|366034886|FG000|Overall Study|Withdrawal by Subject|3|||
106103927|NCT01565707|366034887|FG001|Overall Study|Withdrawal by Subject|1|||
106103928|NCT01565707|366034888|FG002|Overall Study|Withdrawal by Subject|1|||
106103929|NCT01565707|366034889|FG003|Overall Study|Withdrawal by Subject|1|||
106103930|NCT01565707|366034886|FG000|Overall Study|Randomized but not evaluable|2|||
106103931|NCT01565707|366034887|FG001|Overall Study|Randomized but not evaluable|0|||
106103932|NCT01565707|366034888|FG002|Overall Study|Randomized but not evaluable|0|||
106103933|NCT01565707|366034889|FG003|Overall Study|Randomized but not evaluable|0|||
106103934|NCT01565707|366034886|FG000|Overall Study|Miscellaneous|1|||
106103935|NCT01565707|366034887|FG001|Overall Study|Miscellaneous|1|||
106103936|NCT01565707|366034888|FG002|Overall Study|Miscellaneous|0|||
106103937|NCT01565707|366034889|FG003|Overall Study|Miscellaneous|2|||
106103938|NCT00251745|366034891|FG000|Overall Study|Adverse Event|7|||
106103939|NCT00251745|366034892|FG001|Overall Study|Adverse Event|9|||
106103940|NCT00251745|366034893|FG002|Overall Study|Adverse Event|11|||
106103941|NCT00251745|366034891|FG000|Overall Study|Lost to Follow-up|4|||
106103942|NCT00251745|366034892|FG001|Overall Study|Lost to Follow-up|2|||
106103943|NCT00251745|366034893|FG002|Overall Study|Lost to Follow-up|5|||
106103944|NCT00251745|366034891|FG000|Overall Study|Withdrawal by Subject|13|||
106103945|NCT00251745|366034892|FG001|Overall Study|Withdrawal by Subject|7|||
106103946|NCT00251745|366034893|FG002|Overall Study|Withdrawal by Subject|3|||
106103947|NCT00251745|366034891|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
106103948|NCT00251745|366034892|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
106103949|NCT00251745|366034893|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
106103950|NCT00251745|366034891|FG000|Overall Study|Lack of Efficacy|3|||
106103951|NCT00251745|366034892|FG001|Overall Study|Lack of Efficacy|0|||
106103952|NCT00251745|366034893|FG002|Overall Study|Lack of Efficacy|0|||
106103953|NCT00251745|366034891|FG000|Overall Study|Noncompliant|0|||
106103954|NCT00251745|366034892|FG001|Overall Study|Noncompliant|2|||
106103955|NCT00251745|366034893|FG002|Overall Study|Noncompliant|2|||
106103956|NCT00251745|366034891|FG000|Overall Study|Pregnancy|0|||
106103957|NCT00251745|366034892|FG001|Overall Study|Pregnancy|1|||
106103958|NCT00251745|366034893|FG002|Overall Study|Pregnancy|0|||
106103959|NCT00251745|366034891|FG000|Overall Study|Per Subject Request|0|||
106103960|NCT00251745|366034892|FG001|Overall Study|Per Subject Request|0|||
106103961|NCT00251745|366034893|FG002|Overall Study|Per Subject Request|1|||
106103962|NCT00251745|366034891|FG000|Overall Study|Per Investigator Request|1|||
106103963|NCT00251745|366034892|FG001|Overall Study|Per Investigator Request|0|||
106103964|NCT00251745|366034893|FG002|Overall Study|Per Investigator Request|0|||
106103965|NCT02119260|366036564|FG000|Overall Study|Adverse Event|1|||
106103966|NCT02119260|366036565|FG001|Overall Study|Adverse Event|0|||
106103967|NCT02119260|366036566|FG002|Overall Study|Adverse Event|0|||
106103968|NCT02119260|366036567|FG003|Overall Study|Adverse Event|0|||
106103969|NCT02119260|366036568|FG004|Overall Study|Adverse Event|0|||
106103970|NCT02119260|366036569|FG005|Overall Study|Adverse Event|0|||
106103971|NCT02119260|366036570|FG006|Overall Study|Adverse Event|0|||
106103972|NCT02119260|366036564|FG000|Overall Study|Withdrew consent|0|||
106103973|NCT02119260|366036565|FG001|Overall Study|Withdrew consent|1|||
106103974|NCT02119260|366036566|FG002|Overall Study|Withdrew consent|1|||
106103975|NCT02119260|366036567|FG003|Overall Study|Withdrew consent|0|||
106103976|NCT02119260|366036568|FG004|Overall Study|Withdrew consent|0|||
106103977|NCT02119260|366036569|FG005|Overall Study|Withdrew consent|0|||
106103978|NCT02119260|366036570|FG006|Overall Study|Withdrew consent|0|||
106103979|NCT00447057|366036579|FG000|Overall Study|Adverse Event|4|||
106103980|NCT00447057|366036580|FG001|Overall Study|Adverse Event|10|||
106103981|NCT00447057|366036581|FG002|Overall Study|Adverse Event|0|||
106103982|NCT00447057|366036582|FG003|Overall Study|Adverse Event|3|||
106103983|NCT00447057|366036579|FG000|Overall Study|Death due to study disease|6|||
106103984|NCT00447057|366036580|FG001|Overall Study|Death due to study disease|4|||
106103985|NCT00447057|366036581|FG002|Overall Study|Death due to study disease|1|||
106103986|NCT00447057|366036582|FG003|Overall Study|Death due to study disease|1|||
106103987|NCT00447057|366036579|FG000|Overall Study|Lost to Follow-up|0|||
106103988|NCT00447057|366036580|FG001|Overall Study|Lost to Follow-up|1|||
106103989|NCT00447057|366036581|FG002|Overall Study|Lost to Follow-up|0|||
106103990|NCT00447057|366036582|FG003|Overall Study|Lost to Follow-up|0|||
106103991|NCT00447057|366036579|FG000|Overall Study|Entry criteria not met|1|||
106103992|NCT00447057|366036580|FG001|Overall Study|Entry criteria not met|1|||
106103993|NCT00447057|366036581|FG002|Overall Study|Entry criteria not met|0|||
106103994|NCT00447057|366036582|FG003|Overall Study|Entry criteria not met|0|||
106103995|NCT00447057|366036579|FG000|Overall Study|Protocol Violation|0|||
106103996|NCT00447057|366036580|FG001|Overall Study|Protocol Violation|1|||
106103997|NCT00447057|366036581|FG002|Overall Study|Protocol Violation|0|||
106103998|NCT00447057|366036582|FG003|Overall Study|Protocol Violation|0|||
106103999|NCT00447057|366036579|FG000|Overall Study|Withdrawal by Subject|4|||
106104000|NCT00447057|366036580|FG001|Overall Study|Withdrawal by Subject|5|||
106104001|NCT00447057|366036581|FG002|Overall Study|Withdrawal by Subject|1|||
106104002|NCT00447057|366036582|FG003|Overall Study|Withdrawal by Subject|1|||
106104003|NCT00447057|366036579|FG000|Overall Study|Physician Decision|9|||
106104004|NCT00447057|366036580|FG001|Overall Study|Physician Decision|6|||
106104005|NCT00447057|366036581|FG002|Overall Study|Physician Decision|3|||
106104006|NCT00447057|366036582|FG003|Overall Study|Physician Decision|1|||
106104007|NCT00447057|366036579|FG000|Overall Study|Sponsor decision|1|||
106104008|NCT00447057|366036580|FG001|Overall Study|Sponsor decision|1|||
106104009|NCT00447057|366036581|FG002|Overall Study|Sponsor decision|0|||
106104010|NCT00447057|366036582|FG003|Overall Study|Sponsor decision|0|||
106104011|NCT00447057|366036579|FG000|Overall Study|Progressive disease|58|||
106104012|NCT00447057|366036580|FG001|Overall Study|Progressive disease|43|||
106104013|NCT00447057|366036581|FG002|Overall Study|Progressive disease|13|||
106104014|NCT00447057|366036582|FG003|Overall Study|Progressive disease|18|||
106104015|NCT00447057|366036579|FG000|Overall Study|Death due to adverse event|0|||
106104016|NCT00447057|366036580|FG001|Overall Study|Death due to adverse event|0|||
106104017|NCT00447057|366036581|FG002|Overall Study|Death due to adverse event|1|||
106104018|NCT00447057|366036582|FG003|Overall Study|Death due to adverse event|2|||
106104019|NCT00447057|366036579|FG000|Overall Study|Death, study drug related|0|||
106104020|NCT00447057|366036580|FG001|Overall Study|Death, study drug related|1|||
106104021|NCT00447057|366036581|FG002|Overall Study|Death, study drug related|0|||
106104022|NCT00447057|366036582|FG003|Overall Study|Death, study drug related|0|||
106104023|NCT00440531|366036583|FG000|Overall Study|Adverse Event|1|||
106104024|NCT00440531|366036584|FG001|Overall Study|Adverse Event|0|||
106104025|NCT00440531|366036585|FG002|Overall Study|Adverse Event|2|||
106104026|NCT00440531|366036583|FG000|Overall Study|Withdrawal by Subject|2|||
106104027|NCT00440531|366036584|FG001|Overall Study|Withdrawal by Subject|0|||
106104028|NCT00440531|366036585|FG002|Overall Study|Withdrawal by Subject|0|||
106104029|NCT00440531|366036583|FG000|Overall Study|Protocol Violation|1|||
106104030|NCT00440531|366036584|FG001|Overall Study|Protocol Violation|2|||
106104031|NCT00440531|366036585|FG002|Overall Study|Protocol Violation|0|||
106104032|NCT00440531|366036583|FG000|Overall Study|Lost to Follow-up|4|||
106104033|NCT00440531|366036584|FG001|Overall Study|Lost to Follow-up|3|||
106104034|NCT00440531|366036585|FG002|Overall Study|Lost to Follow-up|5|||
106104035|NCT00440531|366036583|FG000|Overall Study|see pre-assignment details|2|||
106104036|NCT00440531|366036584|FG001|Overall Study|see pre-assignment details|0|||
106104037|NCT00440531|366036585|FG002|Overall Study|see pre-assignment details|0|||
106104038|NCT01791725|366036586|FG000|Overall Study|Withdrawal by Subject|0|||
106104039|NCT01791725|366036587|FG001|Overall Study|Withdrawal by Subject|1|||
106104040|NCT01791725|366036588|FG002|Overall Study|Withdrawal by Subject|0|||
106104041|NCT00160680|366036589|FG000|Overall Study|Adverse Event|0|||
106104042|NCT00160680|366036590|FG001|Overall Study|Adverse Event|1|||
106104043|NCT00160680|366036589|FG000|Overall Study|Lack of Efficacy|2|||
106104044|NCT00160680|366036590|FG001|Overall Study|Lack of Efficacy|1|||
106104045|NCT00160680|366036589|FG000|Overall Study|Lost to Follow-up|3|||
106104046|NCT00160680|366036590|FG001|Overall Study|Lost to Follow-up|2|||
106104047|NCT00160680|366036589|FG000|Overall Study|Withdrawal by Subject|4|||
106104048|NCT00160680|366036590|FG001|Overall Study|Withdrawal by Subject|9|||
106104049|NCT01786512|366036593|FG000|Overall Study|Lost to Follow-up|0|||
106104050|NCT01786512|366036594|FG001|Overall Study|Lost to Follow-up|0|||
106104051|NCT01786512|366036595|FG002|Overall Study|Lost to Follow-up|0|||
106104052|NCT01786512|366036596|FG003|Overall Study|Lost to Follow-up|0|||
106104053|NCT01786512|366036597|FG004|Overall Study|Lost to Follow-up|0|||
106104054|NCT01786512|366036598|FG005|Overall Study|Lost to Follow-up|0|||
106104055|NCT01786512|366036599|FG006|Overall Study|Lost to Follow-up|0|||
106104056|NCT01786512|366036600|FG007|Overall Study|Lost to Follow-up|0|||
106104057|NCT01786512|366036601|FG008|Overall Study|Lost to Follow-up|0|||
106104058|NCT01786512|366036602|FG009|Overall Study|Lost to Follow-up|1|||
106104059|NCT01786512|366036603|FG010|Overall Study|Lost to Follow-up|0|||
106104060|NCT01786512|366036593|FG000|Overall Study|Decision by sponsor|0|||
106104061|NCT01786512|366036594|FG001|Overall Study|Decision by sponsor|0|||
106104062|NCT01786512|366036595|FG002|Overall Study|Decision by sponsor|0|||
106104063|NCT01786512|366036596|FG003|Overall Study|Decision by sponsor|0|||
106104064|NCT01786512|366036597|FG004|Overall Study|Decision by sponsor|0|||
106104065|NCT01786512|366036598|FG005|Overall Study|Decision by sponsor|0|||
106104066|NCT01786512|366036599|FG006|Overall Study|Decision by sponsor|0|||
106104067|NCT01786512|366036600|FG007|Overall Study|Decision by sponsor|0|||
106104068|NCT01786512|366036601|FG008|Overall Study|Decision by sponsor|0|||
106104069|NCT01786512|366036602|FG009|Overall Study|Decision by sponsor|0|||
106104070|NCT01786512|366036603|FG010|Overall Study|Decision by sponsor|2|||
106104071|NCT01786512|366036593|FG000|Overall Study|Withdrawal by Subject|0|||
106104072|NCT01786512|366036594|FG001|Overall Study|Withdrawal by Subject|1|||
106104073|NCT01786512|366036595|FG002|Overall Study|Withdrawal by Subject|0|||
106104074|NCT01786512|366036596|FG003|Overall Study|Withdrawal by Subject|0|||
106104075|NCT01786512|366036597|FG004|Overall Study|Withdrawal by Subject|0|||
106104076|NCT01786512|366036598|FG005|Overall Study|Withdrawal by Subject|0|||
106104077|NCT01786512|366036599|FG006|Overall Study|Withdrawal by Subject|1|||
106104078|NCT01786512|366036600|FG007|Overall Study|Withdrawal by Subject|0|||
106104079|NCT01786512|366036601|FG008|Overall Study|Withdrawal by Subject|0|||
106104080|NCT01786512|366036602|FG009|Overall Study|Withdrawal by Subject|3|||
106104081|NCT01786512|366036603|FG010|Overall Study|Withdrawal by Subject|7|||
106104082|NCT01786512|366036593|FG000|Overall Study|Death|0|||
106104083|NCT01786512|366036594|FG001|Overall Study|Death|0|||
106104084|NCT01786512|366036595|FG002|Overall Study|Death|0|||
106104085|NCT01786512|366036596|FG003|Overall Study|Death|0|||
106104086|NCT01786512|366036597|FG004|Overall Study|Death|0|||
106104087|NCT01786512|366036598|FG005|Overall Study|Death|0|||
106104088|NCT01786512|366036599|FG006|Overall Study|Death|0|||
106104089|NCT01786512|366036600|FG007|Overall Study|Death|0|||
106104090|NCT01786512|366036601|FG008|Overall Study|Death|4|||
106104091|NCT01786512|366036602|FG009|Overall Study|Death|1|||
106104092|NCT01786512|366036603|FG010|Overall Study|Death|3|||
106104093|NCT03561090|366036604|FG000|Overall Study|Adverse Event|11|||
106104094|NCT03561090|366036605|FG001|Overall Study|Adverse Event|7|||
106104095|NCT03561090|366036604|FG000|Overall Study|Non-Compliance With Study Drug|2|||
106104096|NCT03561090|366036605|FG001|Overall Study|Non-Compliance With Study Drug|0|||
106104097|NCT03561090|366036604|FG000|Overall Study|Protocol Violation|2|||
106104098|NCT03561090|366036605|FG001|Overall Study|Protocol Violation|2|||
105781730|NCT02493712|364854830|FG000|Overall Study|Withdrawal by Subject|1|||
106104099|NCT03561090|366036604|FG000|Overall Study|Withdrawal by Subject|7|||
106104100|NCT03561090|366036605|FG001|Overall Study|Withdrawal by Subject|7|||
105781731|NCT02493712|364854831|FG001|Overall Study|Withdrawal by Subject|0|||
105781732|NCT02493712|364854832|FG002|Overall Study|Withdrawal by Subject|2|||
106104101|NCT03561090|366036604|FG000|Overall Study|Lost to Follow-up|7|||
106104102|NCT03561090|366036605|FG001|Overall Study|Lost to Follow-up|2|||
106104103|NCT03561090|366036604|FG000|Overall Study|Study Terminated by Sponsor|10|||
106104104|NCT03561090|366036605|FG001|Overall Study|Study Terminated by Sponsor|15|||
106104105|NCT03561090|366036604|FG000|Overall Study|Randomized by Mistake|1|||
106104106|NCT03561090|366036605|FG001|Overall Study|Randomized by Mistake|1|||
106104107|NCT03561090|366036604|FG000|Overall Study|Other Not Specified|0|||
106104108|NCT03561090|366036605|FG001|Overall Study|Other Not Specified|2|||
106104109|NCT04162769|366036612|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
106104110|NCT04162769|366036613|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
106104111|NCT04162769|366036614|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
106104112|NCT04162769|366036615|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
106104113|NCT04162769|366036612|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
106104114|NCT04162769|366036613|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
106104115|NCT04162769|366036614|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
106104116|NCT04162769|366036615|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
106104117|NCT04162769|366036612|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
106104118|NCT04162769|366036613|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
106104119|NCT04162769|366036614|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
106104120|NCT04162769|366036615|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
106104121|NCT04162769|366036612|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
106104122|NCT04162769|366036613|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
106104123|NCT04162769|366036614|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
106104124|NCT04162769|366036615|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
106104125|NCT04162769|366036612|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
106104126|NCT04162769|366036613|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
106104127|NCT04162769|366036614|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
106104128|NCT04162769|366036615|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
106104129|NCT04162769|366036612|FG000|Double-blind Treatment (12-Week)|Other|0|||
106104130|NCT04162769|366036613|FG001|Double-blind Treatment (12-Week)|Other|1|||
106104131|NCT04162769|366036614|FG002|Double-blind Treatment (12-Week)|Other|1|||
106104132|NCT04162769|366036615|FG003|Double-blind Treatment (12-Week)|Other|0|||
106104133|NCT04162769|366036612|FG000|OLE Period (52-Week)|Adverse Event|0|||
106104134|NCT04162769|366036613|FG001|OLE Period (52-Week)|Adverse Event|0|||
106104135|NCT04162769|366036614|FG002|OLE Period (52-Week)|Adverse Event|0|||
106104136|NCT04162769|366036615|FG003|OLE Period (52-Week)|Adverse Event|5|||
106104137|NCT04162769|366036612|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
106104138|NCT04162769|366036613|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
106104139|NCT04162769|366036614|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
106104140|NCT04162769|366036615|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
106104141|NCT04162769|366036612|FG000|OLE Period (52-Week)|Physician Decision|0|||
106104142|NCT04162769|366036613|FG001|OLE Period (52-Week)|Physician Decision|0|||
106104143|NCT04162769|366036614|FG002|OLE Period (52-Week)|Physician Decision|0|||
106104144|NCT04162769|366036615|FG003|OLE Period (52-Week)|Physician Decision|1|||
106104145|NCT04162769|366036612|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
106104146|NCT04162769|366036613|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
106104147|NCT04162769|366036614|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
106104148|NCT04162769|366036615|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
106104149|NCT04162769|366036612|FG000|OLE Period (52-Week)|Protocol deviation|0|||
106104150|NCT04162769|366036613|FG001|OLE Period (52-Week)|Protocol deviation|0|||
106104151|NCT04162769|366036614|FG002|OLE Period (52-Week)|Protocol deviation|0|||
106104152|NCT04162769|366036615|FG003|OLE Period (52-Week)|Protocol deviation|2|||
106104153|NCT02163733|366036616|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
106104154|NCT02163733|366036617|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
106104155|NCT02163733|366036618|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
106104156|NCT02163733|366036616|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
106104157|NCT02163733|366036617|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
106104158|NCT02163733|366036618|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
106104159|NCT03643952|366036621|FG000|Overall Study|Lack of Efficacy|1|||
106104160|NCT01358968|366036622|FG000|Period 2|Adverse Event|0|||
106104161|NCT01358968|366036623|FG001|Period 2|Adverse Event|1|||
106104162|NCT01358968|366036624|FG002|Period 2|Adverse Event|0|||
106104163|NCT01358968|366036625|FG003|Period 2|Adverse Event|0|||
106104164|NCT01358968|366036622|FG000|Continued Access Phase|Progression of Disease|0|||
106104165|NCT01358968|366036623|FG001|Continued Access Phase|Progression of Disease|0|||
106104166|NCT01358968|366036624|FG002|Continued Access Phase|Progression of Disease|8|||
106104167|NCT01358968|366036625|FG003|Continued Access Phase|Progression of Disease|4|||
106104168|NCT01358968|366036622|FG000|Continued Access Phase|Protocol Violation|0|||
106104169|NCT01358968|366036623|FG001|Continued Access Phase|Protocol Violation|0|||
106104170|NCT01358968|366036624|FG002|Continued Access Phase|Protocol Violation|0|||
106104171|NCT01358968|366036625|FG003|Continued Access Phase|Protocol Violation|2|||
106104172|NCT01358968|366036622|FG000|Continued Access Phase|Withdrawal by Subject|0|||
106104173|NCT01358968|366036623|FG001|Continued Access Phase|Withdrawal by Subject|0|||
106104174|NCT01358968|366036624|FG002|Continued Access Phase|Withdrawal by Subject|3|||
106104175|NCT01358968|366036625|FG003|Continued Access Phase|Withdrawal by Subject|0|||
106104176|NCT01358968|366036622|FG000|Continued Access Phase|Death|0|||
106104177|NCT01358968|366036623|FG001|Continued Access Phase|Death|0|||
106104178|NCT01358968|366036624|FG002|Continued Access Phase|Death|1|||
106104179|NCT01358968|366036625|FG003|Continued Access Phase|Death|1|||
106104180|NCT01597050|366036626|FG000|Overall Study|Withdrawal by Subject|1|||
106104181|NCT01597050|366036627|FG001|Overall Study|Withdrawal by Subject|0|||
106104182|NCT00483184|366036628|FG000|Overall Study|Withdrawal by Subject|2|||
106104183|NCT00483184|366036629|FG001|Overall Study|Withdrawal by Subject|2|||
106104184|NCT00483184|366036630|FG002|Overall Study|Withdrawal by Subject|0|||
106104185|NCT00483184|366036628|FG000|Overall Study|Lost to Follow-up|1|||
106104186|NCT00483184|366036629|FG001|Overall Study|Lost to Follow-up|0|||
106104187|NCT00483184|366036630|FG002|Overall Study|Lost to Follow-up|0|||
106104188|NCT00483184|366036628|FG000|Overall Study|Adverse Event|1|||
106104189|NCT00483184|366036629|FG001|Overall Study|Adverse Event|2|||
106104190|NCT00483184|366036630|FG002|Overall Study|Adverse Event|2|||
106104191|NCT00483184|366036628|FG000|Overall Study|Protocol Violation|1|||
106104192|NCT00483184|366036629|FG001|Overall Study|Protocol Violation|0|||
106104193|NCT00483184|366036630|FG002|Overall Study|Protocol Violation|1|||
106104194|NCT03321396|366036631|FG000|Overall Study|Physician Decision|1|||
106104195|NCT00423176|366036632|FG000|Overall Study|Adverse Event|4|||
106104196|NCT00423176|366036633|FG001|Overall Study|Adverse Event|6|||
106104197|NCT00423176|366036632|FG000|Overall Study|Treatment Failure|1|||
106104198|NCT00423176|366036633|FG001|Overall Study|Treatment Failure|6|||
106104199|NCT00423176|366036632|FG000|Overall Study|Lost to Follow-up|4|||
106104200|NCT00423176|366036633|FG001|Overall Study|Lost to Follow-up|7|||
106104201|NCT00423176|366036632|FG000|Overall Study|Withdrawal by Subject|4|||
106104202|NCT00423176|366036633|FG001|Overall Study|Withdrawal by Subject|3|||
106104203|NCT00423176|366036632|FG000|Overall Study|Protocol Violation|1|||
106104204|NCT00423176|366036633|FG001|Overall Study|Protocol Violation|3|||
106104205|NCT00423176|366036632|FG000|Overall Study|Did not meet protocol eligibility|2|||
106104206|NCT00423176|366036633|FG001|Overall Study|Did not meet protocol eligibility|4|||
106104207|NCT02013622|366036634|FG000|Overall Study|Lost to Follow-up|10|||
106104208|NCT02013622|366036634|FG000|Overall Study|Adverse Event|3|||
106104209|NCT02013622|366036634|FG000|Overall Study|Met Withdrawal Criteria|3|||
106104210|NCT02013622|366036634|FG000|Overall Study|Withdrawal by Subject|6|||
106104211|NCT02013622|366036634|FG000|Overall Study|Protocol Deviation|1|||
106104212|NCT02013622|366036634|FG000|Overall Study|Lack of Efficacy|1|||
106104213|NCT05072080|366036635|FG000|Overall Study|Death|0|||
106104214|NCT05072080|366036636|FG001|Overall Study|Death|0|||
106104215|NCT05072080|366036637|FG002|Overall Study|Death|1|||
106104216|NCT05072080|366036638|FG003|Overall Study|Death|0|||
106104217|NCT05072080|366036635|FG000|Overall Study|Lost to Follow-up|65|||
106104218|NCT05072080|366036636|FG001|Overall Study|Lost to Follow-up|70|||
106104219|NCT05072080|366036637|FG002|Overall Study|Lost to Follow-up|58|||
106104220|NCT05072080|366036638|FG003|Overall Study|Lost to Follow-up|23|||
106104221|NCT05072080|366036635|FG000|Overall Study|Physician Decision|2|||
106104222|NCT05072080|366036636|FG001|Overall Study|Physician Decision|1|||
106104223|NCT05072080|366036637|FG002|Overall Study|Physician Decision|1|||
106104224|NCT05072080|366036638|FG003|Overall Study|Physician Decision|0|||
106104225|NCT05072080|366036635|FG000|Overall Study|Withdrawal by Subject|45|||
106104226|NCT05072080|366036636|FG001|Overall Study|Withdrawal by Subject|30|||
106104227|NCT05072080|366036637|FG002|Overall Study|Withdrawal by Subject|27|||
106104228|NCT05072080|366036638|FG003|Overall Study|Withdrawal by Subject|7|||
106104229|NCT05072080|366036635|FG000|Overall Study|Sponsor Decision|0|||
106104230|NCT05072080|366036636|FG001|Overall Study|Sponsor Decision|1|||
106104231|NCT05072080|366036637|FG002|Overall Study|Sponsor Decision|0|||
106104232|NCT05072080|366036638|FG003|Overall Study|Sponsor Decision|0|||
106104233|NCT05072080|366036635|FG000|Overall Study|Subject moved|1|||
106104234|NCT05072080|366036636|FG001|Overall Study|Subject moved|3|||
106104235|NCT05072080|366036637|FG002|Overall Study|Subject moved|5|||
106104236|NCT05072080|366036638|FG003|Overall Study|Subject moved|2|||
106104237|NCT05072080|366036635|FG000|Overall Study|Withdrawal by parent|0|||
106104238|NCT05072080|366036636|FG001|Overall Study|Withdrawal by parent|0|||
106104239|NCT05072080|366036637|FG002|Overall Study|Withdrawal by parent|1|||
106104240|NCT05072080|366036638|FG003|Overall Study|Withdrawal by parent|0|||
106104241|NCT05072080|366036635|FG000|Overall Study|Subject was deployed|0|||
106104242|NCT05072080|366036636|FG001|Overall Study|Subject was deployed|1|||
106104243|NCT05072080|366036637|FG002|Overall Study|Subject was deployed|0|||
106104244|NCT05072080|366036638|FG003|Overall Study|Subject was deployed|0|||
106104245|NCT05072080|366036635|FG000|Overall Study|Subject left site without receiving dose|0|||
106104246|NCT05072080|366036636|FG001|Overall Study|Subject left site without receiving dose|1|||
106104247|NCT05072080|366036637|FG002|Overall Study|Subject left site without receiving dose|0|||
106104248|NCT05072080|366036638|FG003|Overall Study|Subject left site without receiving dose|0|||
106104249|NCT05072080|366036635|FG000|Overall Study|Subject incarcerated|0|||
106104250|NCT05072080|366036636|FG001|Overall Study|Subject incarcerated|1|||
106104251|NCT05072080|366036637|FG002|Overall Study|Subject incarcerated|0|||
106104252|NCT05072080|366036638|FG003|Overall Study|Subject incarcerated|1|||
106104253|NCT05072080|366036635|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
106104254|NCT05072080|366036636|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
106104255|NCT05072080|366036637|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
106104256|NCT05072080|366036638|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
106104257|NCT05072080|366036635|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
106104258|NCT05072080|366036636|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
106104259|NCT05072080|366036637|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
106104260|NCT05072080|366036638|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
106104261|NCT01984684|366036639|FG000|Overall Study|Lost to Follow-up|25|||
106104262|NCT01984684|366036640|FG001|Overall Study|Lost to Follow-up|24|||
106104263|NCT01984684|366036639|FG000|Overall Study|Adverse Event|8|||
106104264|NCT01984684|366036640|FG001|Overall Study|Adverse Event|12|||
106104265|NCT01984684|366036639|FG000|Overall Study|Withdrawal by Subject|9|||
106104266|NCT01984684|366036640|FG001|Overall Study|Withdrawal by Subject|9|||
106104267|NCT01984684|366036639|FG000|Overall Study|Lack of Efficacy|3|||
106104268|NCT01984684|366036640|FG001|Overall Study|Lack of Efficacy|6|||
106104269|NCT01984684|366036639|FG000|Overall Study|Physician Decision|4|||
106104270|NCT01984684|366036640|FG001|Overall Study|Physician Decision|2|||
106104271|NCT01984684|366036639|FG000|Overall Study|Protocol Violation|4|||
106104272|NCT01984684|366036640|FG001|Overall Study|Protocol Violation|2|||
106104273|NCT01984684|366036639|FG000|Overall Study|Death|0|||
106104274|NCT01984684|366036640|FG001|Overall Study|Death|1|||
106104275|NCT01984684|366036639|FG000|Overall Study|Noncompliance with study drug|2|||
106104276|NCT01984684|366036640|FG001|Overall Study|Noncompliance with study drug|1|||
106104277|NCT01984684|366036639|FG000|Overall Study|Subject incarcerated|1|||
106104278|NCT01984684|366036640|FG001|Overall Study|Subject incarcerated|0|||
106104279|NCT01984684|366036639|FG000|Overall Study|Study drug not available at site|1|||
106104280|NCT01984684|366036640|FG001|Overall Study|Study drug not available at site|1|||
106104281|NCT01984684|366036639|FG000|Overall Study|Subject had inadequate IV access|0|||
106104282|NCT01984684|366036640|FG001|Overall Study|Subject had inadequate IV access|1|||
106104283|NCT03923959|366036645|FG000|Overall Study|Death|16|||
106104284|NCT03923959|366036646|FG001|Overall Study|Death|12|||
106104285|NCT03923959|366036645|FG000|Overall Study|Lost to Follow-up|56|||
106104286|NCT03923959|366036646|FG001|Overall Study|Lost to Follow-up|56|||
106104287|NCT03923959|366036645|FG000|Overall Study|Withdrawal by Subject|1|||
106104288|NCT03923959|366036646|FG001|Overall Study|Withdrawal by Subject|1|||
106104289|NCT03923959|366036645|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
106104290|NCT03923959|366036646|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
106104291|NCT05554237|366036647|FG000|Part 2 (7 Days)|Adverse Event|0|||
106104292|NCT05554237|366036648|FG001|Part 2 (7 Days)|Adverse Event|0|||
106104293|NCT05554237|366036649|FG002|Part 2 (7 Days)|Adverse Event|0|||
106104294|NCT05554237|366036650|FG003|Part 2 (7 Days)|Adverse Event|0|||
106104295|NCT05554237|366036651|FG004|Part 2 (7 Days)|Adverse Event|2|||
106104296|NCT05554237|366036652|FG005|Part 2 (7 Days)|Adverse Event|0|||
106104297|NCT05554237|366036653|FG006|Part 2 (7 Days)|Adverse Event|0|||
106104298|NCT05554237|366036654|FG007|Part 2 (7 Days)|Adverse Event|0|||
106104299|NCT05554237|366036655|FG008|Part 2 (7 Days)|Adverse Event|0|||
106104300|NCT05554237|366036656|FG009|Part 2 (7 Days)|Adverse Event|1|||
106104301|NCT05554237|366036657|FG010|Part 2 (7 Days)|Adverse Event|0|||
106104302|NCT05554237|366036658|FG011|Part 2 (7 Days)|Adverse Event|0|||
106104303|NCT05554237|366036659|FG012|Part 2 (7 Days)|Adverse Event|1|||
106104304|NCT05554237|366036660|FG013|Part 2 (7 Days)|Adverse Event|0|||
106104305|NCT02395042|366036663|FG000|Treatment 1 Period|Adverse Event|1|||
106104306|NCT02395042|366036664|FG001|Treatment 1 Period|Adverse Event|3|||
106104307|NCT02395042|366036665|FG002|Treatment 1 Period|Adverse Event|1|||
106104308|NCT02395042|366036663|FG000|Treatment 1 Period|Lack of Efficacy|1|||
106104309|NCT02395042|366036664|FG001|Treatment 1 Period|Lack of Efficacy|1|||
106104310|NCT02395042|366036665|FG002|Treatment 1 Period|Lack of Efficacy|0|||
106104311|NCT02395042|366036663|FG000|Treatment 1 Period|Lost to Follow-up|1|||
106104312|NCT02395042|366036664|FG001|Treatment 1 Period|Lost to Follow-up|0|||
106104313|NCT02395042|366036665|FG002|Treatment 1 Period|Lost to Follow-up|0|||
106104314|NCT02395042|366036663|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
106104315|NCT02395042|366036664|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
106104316|NCT02395042|366036665|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
106104317|NCT02395042|366036663|FG000|Treatment 2 Period|Lack of Efficacy|1|||
106104318|NCT02395042|366036664|FG001|Treatment 2 Period|Lack of Efficacy|1|||
106104319|NCT02395042|366036665|FG002|Treatment 2 Period|Lack of Efficacy|0|||
106104320|NCT01324271|366036666|FG000|Overall Study|Lost to Follow-up|3|||
106104321|NCT01324271|366036667|FG001|Overall Study|Lost to Follow-up|0|||
106104322|NCT01324271|366036666|FG000|Overall Study|Physician Decision|1|||
106104323|NCT01324271|366036667|FG001|Overall Study|Physician Decision|0|||
106104324|NCT05130970|366036668|FG000|Overall Study|Adverse Event|1|||
106104325|NCT05130970|366036669|FG001|Overall Study|Adverse Event|1|||
106104326|NCT05130970|366036668|FG000|Overall Study|Death|0|||
106104327|NCT05130970|366036669|FG001|Overall Study|Death|1|||
106104328|NCT05130970|366036668|FG000|Overall Study|Lost to Follow-up|0|||
106104329|NCT05130970|366036669|FG001|Overall Study|Lost to Follow-up|1|||
106104330|NCT05130970|366036668|FG000|Overall Study|Physician Decision|0|||
106104331|NCT05130970|366036669|FG001|Overall Study|Physician Decision|1|||
106104332|NCT05130970|366036668|FG000|Overall Study|Withdrawal by Subject|1|||
106104333|NCT05130970|366036669|FG001|Overall Study|Withdrawal by Subject|1|||
106104334|NCT03996473|366036670|FG000|Treatment Assignment|Withdrawal by Subject|1|||
106104335|NCT03996473|366036670|FG000|Treatment Assignment|Progressive disease|6|||
106104336|NCT03996473|366036670|FG000|Treatment Assignment|Study drug never administered|1|||
106104337|NCT03996473|366036670|FG000|Active Follow-up|Death|1|||
106104338|NCT03996473|366036670|FG000|Long-term Follow-up|Death|5|||
106104339|NCT06116591|366036671|FG000|Overall Study|No longer met eligibility criteria|0|||
106104340|NCT06116591|366036672|FG001|Overall Study|No longer met eligibility criteria|1|||
106104341|NCT06116591|366036671|FG000|Overall Study|Other: Change in life situation|0|||
106104342|NCT06116591|366036672|FG001|Overall Study|Other: Change in life situation|1|||
106104343|NCT01381692|366036673|FG000|Overall Study|Adverse Event|1|||
106104344|NCT01381692|366036674|FG001|Overall Study|Adverse Event|0|||
106104345|NCT01381692|366036675|FG002|Overall Study|Adverse Event|0|||
106104346|NCT01381692|366036676|FG003|Overall Study|Adverse Event|0|||
106104347|NCT01381692|366036677|FG004|Overall Study|Adverse Event|0|||
106104348|NCT01381692|366036678|FG005|Overall Study|Adverse Event|0|||
106104349|NCT01152580|366036679|FG000|Overall Study|Withdrawal by Subject|0|||
106104350|NCT01152580|366036680|FG001|Overall Study|Withdrawal by Subject|1|||
106104351|NCT02834780|366036681|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
106104352|NCT02834780|366036682|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
106104353|NCT02834780|366036683|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
106104354|NCT02834780|366036684|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
106104355|NCT02834780|366036685|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
106104356|NCT02834780|366036686|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
106104357|NCT02834780|366036687|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
106104358|NCT02834780|366036688|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
106104359|NCT02834780|366036689|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
106104360|NCT02834780|366036690|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
106104361|NCT02834780|366036691|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
106104362|NCT02834780|366036692|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
106104363|NCT02834780|366036693|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
106104364|NCT02834780|366036681|FG000|Overall Study|Withdrawal by Subject|0|||
106104365|NCT02834780|366036682|FG001|Overall Study|Withdrawal by Subject|0|||
106104366|NCT02834780|366036683|FG002|Overall Study|Withdrawal by Subject|1|||
106104367|NCT02834780|366036684|FG003|Overall Study|Withdrawal by Subject|0|||
106104368|NCT02834780|366036685|FG004|Overall Study|Withdrawal by Subject|0|||
106104369|NCT02834780|366036686|FG005|Overall Study|Withdrawal by Subject|0|||
106104370|NCT02834780|366036687|FG006|Overall Study|Withdrawal by Subject|0|||
106104371|NCT02834780|366036688|FG007|Overall Study|Withdrawal by Subject|0|||
106104372|NCT02834780|366036689|FG008|Overall Study|Withdrawal by Subject|0|||
106104373|NCT02834780|366036690|FG009|Overall Study|Withdrawal by Subject|0|||
106104374|NCT02834780|366036691|FG010|Overall Study|Withdrawal by Subject|1|||
106104375|NCT02834780|366036692|FG011|Overall Study|Withdrawal by Subject|0|||
106104376|NCT02834780|366036693|FG012|Overall Study|Withdrawal by Subject|0|||
106104377|NCT02834780|366036681|FG000|Overall Study|Adverse Event|0|||
106104378|NCT02834780|366036682|FG001|Overall Study|Adverse Event|0|||
106104379|NCT02834780|366036683|FG002|Overall Study|Adverse Event|0|||
106104380|NCT02834780|366036684|FG003|Overall Study|Adverse Event|0|||
106104381|NCT02834780|366036685|FG004|Overall Study|Adverse Event|1|||
106104382|NCT02834780|366036686|FG005|Overall Study|Adverse Event|0|||
106104383|NCT02834780|366036687|FG006|Overall Study|Adverse Event|1|||
106104384|NCT02834780|366036688|FG007|Overall Study|Adverse Event|1|||
106104385|NCT02834780|366036689|FG008|Overall Study|Adverse Event|0|||
106104386|NCT02834780|366036690|FG009|Overall Study|Adverse Event|2|||
106104387|NCT02834780|366036691|FG010|Overall Study|Adverse Event|0|||
106104388|NCT02834780|366036692|FG011|Overall Study|Adverse Event|3|||
106104389|NCT02834780|366036693|FG012|Overall Study|Adverse Event|2|||
106104390|NCT02834780|366036681|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
106104391|NCT02834780|366036682|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
106104392|NCT02834780|366036683|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
106104393|NCT02834780|366036684|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
106104394|NCT02834780|366036685|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
106104395|NCT02834780|366036686|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
106104396|NCT02834780|366036687|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
106104397|NCT02834780|366036688|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
106104398|NCT02834780|366036689|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
106104399|NCT02834780|366036690|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
106104400|NCT02834780|366036691|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
106104401|NCT02834780|366036692|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
106104402|NCT02834780|366036693|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
106104403|NCT02834780|366036681|FG000|Overall Study|Other|1|||
105781733|NCT02493712|364854830|FG000|Overall Study|Protocol Violation|0|||
105781734|NCT02493712|364854831|FG001|Overall Study|Protocol Violation|0|||
106104404|NCT02834780|366036682|FG001|Overall Study|Other|0|||
106104405|NCT02834780|366036683|FG002|Overall Study|Other|1|||
106104406|NCT02834780|366036684|FG003|Overall Study|Other|2|||
106104407|NCT02834780|366036685|FG004|Overall Study|Other|0|||
106104408|NCT02834780|366036686|FG005|Overall Study|Other|0|||
106104409|NCT02834780|366036687|FG006|Overall Study|Other|0|||
106104410|NCT02834780|366036688|FG007|Overall Study|Other|0|||
106104411|NCT02834780|366036689|FG008|Overall Study|Other|0|||
106104412|NCT02834780|366036690|FG009|Overall Study|Other|0|||
106104413|NCT02834780|366036691|FG010|Overall Study|Other|0|||
106104414|NCT02834780|366036692|FG011|Overall Study|Other|0|||
106104415|NCT02834780|366036693|FG012|Overall Study|Other|1|||
106104416|NCT02491671|366036703|FG000|Overall Study|Adverse Event|6|||
106104417|NCT02491671|366036704|FG001|Overall Study|Adverse Event|8|||
106104418|NCT02491671|366036703|FG000|Overall Study|Death|0|||
106104419|NCT02491671|366036704|FG001|Overall Study|Death|2|||
106104420|NCT02491671|366036703|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
106104421|NCT02491671|366036704|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
106104422|NCT01881126|366036711|FG000|Overall Study|Non-compliance|1|||
106104423|NCT01881126|366036712|FG001|Overall Study|Non-compliance|1|||
106104424|NCT01881126|366036711|FG000|Overall Study|Adverse Event|0|||
106104425|NCT01881126|366036712|FG001|Overall Study|Adverse Event|1|||
106104426|NCT01041638|366036717|FG000|Overall Study|Adverse Event|4|||
106104427|NCT01041638|366036717|FG000|Overall Study|Death|1|||
106104428|NCT01041638|366036717|FG000|Overall Study|Lack of Efficacy|7|||
106104429|NCT01041638|366036717|FG000|Overall Study|Physician Decision|4|||
106104430|NCT01041638|366036717|FG000|Overall Study|Withdrawal by Subject|11|||
106104431|NCT01777854|366036718|FG000|Overall Study|Physician Decision|3|||
106104432|NCT01777854|366036719|FG001|Overall Study|Physician Decision|3|||
106104433|NCT01239030|366036720|FG000|Double Blind|Adverse Event|0|||
106104434|NCT01239030|366036721|FG001|Double Blind|Adverse Event|1|||
106104435|NCT01239030|366036722|FG002|Double Blind|Adverse Event|0|||
106104436|NCT01239030|366036723|FG003|Double Blind|Adverse Event|2|||
106104437|NCT01239030|366036724|FG004|Double Blind|Adverse Event|0|||
106104438|NCT01239030|366036720|FG000|Double Blind|Withdrawal by Subject|0|||
106104439|NCT01239030|366036721|FG001|Double Blind|Withdrawal by Subject|1|||
106104440|NCT01239030|366036722|FG002|Double Blind|Withdrawal by Subject|1|||
106104441|NCT01239030|366036723|FG003|Double Blind|Withdrawal by Subject|0|||
106104442|NCT01239030|366036724|FG004|Double Blind|Withdrawal by Subject|1|||
106104443|NCT01239030|366036720|FG000|Double Blind|Lost to Follow-up|1|||
106104444|NCT01239030|366036721|FG001|Double Blind|Lost to Follow-up|1|||
106104445|NCT01239030|366036722|FG002|Double Blind|Lost to Follow-up|0|||
106104446|NCT01239030|366036723|FG003|Double Blind|Lost to Follow-up|0|||
106104447|NCT01239030|366036724|FG004|Double Blind|Lost to Follow-up|0|||
106104448|NCT01239030|366036720|FG000|Double Blind|Physician Decision|0|||
106104449|NCT01239030|366036721|FG001|Double Blind|Physician Decision|1|||
106104450|NCT01239030|366036722|FG002|Double Blind|Physician Decision|0|||
106104451|NCT01239030|366036723|FG003|Double Blind|Physician Decision|0|||
106104452|NCT01239030|366036724|FG004|Double Blind|Physician Decision|0|||
106104453|NCT01239030|366036720|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
106104454|NCT01239030|366036721|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
106104455|NCT01239030|366036722|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
106104456|NCT01239030|366036723|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
106104457|NCT01239030|366036724|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
106104458|NCT01239030|366036720|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
106104459|NCT01239030|366036721|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
106104460|NCT01239030|366036722|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
106104461|NCT01239030|366036723|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
106104462|NCT01239030|366036724|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
106104463|NCT01239030|366036720|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
106104464|NCT01239030|366036721|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
106104465|NCT01239030|366036722|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
106104466|NCT01239030|366036723|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
106104467|NCT01239030|366036724|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
106104468|NCT01239030|366036720|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
106104469|NCT01239030|366036721|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
106104470|NCT01239030|366036722|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
106104471|NCT01239030|366036723|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
106104472|NCT01239030|366036724|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
106104473|NCT04123067|366036725|FG000|Overall Study|Lost to Follow-up|0|||
106104474|NCT04123067|366036726|FG001|Overall Study|Lost to Follow-up|1|||
106104475|NCT03085485|366036728|FG000|Overall Study|Death|1|||
106104476|NCT03085485|366036729|FG001|Overall Study|Death|0|||
106104477|NCT03085485|366036728|FG000|Overall Study|Lost to Follow-up|1|||
106104478|NCT03085485|366036729|FG001|Overall Study|Lost to Follow-up|0|||
106104479|NCT01022762|366036730|FG000|Overall Study|Adverse Event|3|||
106104480|NCT01022762|366036731|FG001|Overall Study|Adverse Event|1|||
106104481|NCT01022762|366036730|FG000|Overall Study|Lack of Efficacy|0|||
106104482|NCT01022762|366036731|FG001|Overall Study|Lack of Efficacy|1|||
106104483|NCT01022762|366036730|FG000|Overall Study|Protocol Violation|7|||
106104484|NCT01022762|366036731|FG001|Overall Study|Protocol Violation|6|||
106104485|NCT01022762|366036730|FG000|Overall Study|Unclassified|12|||
106104486|NCT01022762|366036731|FG001|Overall Study|Unclassified|20|||
106104487|NCT04302350|366036733|FG000|Overall Study|Physician Decision|1|||
106104488|NCT04302350|366036734|FG001|Overall Study|Physician Decision|1|||
106104489|NCT04302350|366036735|FG002|Overall Study|Physician Decision|2|||
106104490|NCT04302350|366036733|FG000|Overall Study|Lack of Efficacy|1|||
106104491|NCT04302350|366036734|FG001|Overall Study|Lack of Efficacy|1|||
106104492|NCT04302350|366036735|FG002|Overall Study|Lack of Efficacy|4|||
106104493|NCT04302350|366036733|FG000|Overall Study|Adverse Event|0|||
106104494|NCT04302350|366036734|FG001|Overall Study|Adverse Event|1|||
106104495|NCT04302350|366036735|FG002|Overall Study|Adverse Event|2|||
106104496|NCT00374322|366036736|FG000|Overall Study|Lost to Follow-up|92|||
106104497|NCT00374322|366036737|FG001|Overall Study|Lost to Follow-up|90|||
106104498|NCT00374322|366036736|FG000|Overall Study|Protocol Violation|8|||
106104499|NCT00374322|366036737|FG001|Overall Study|Protocol Violation|3|||
106104500|NCT00374322|366036736|FG000|Overall Study|Withdrawal by Subject|235|||
106104501|NCT00374322|366036737|FG001|Overall Study|Withdrawal by Subject|167|||
106104502|NCT00374322|366036736|FG000|Overall Study|Sponsor Terminated Study|866|||
106104503|NCT00374322|366036737|FG001|Overall Study|Sponsor Terminated Study|990|||
106104504|NCT00374322|366036736|FG000|Overall Study|Physician Decision|36|||
106104505|NCT00374322|366036737|FG001|Overall Study|Physician Decision|32|||
106104506|NCT00374322|366036736|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
106104507|NCT00374322|366036737|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
106104508|NCT00374322|366036736|FG000|Overall Study|Sponsor Decision|2|||
106104509|NCT00374322|366036737|FG001|Overall Study|Sponsor Decision|3|||
106104510|NCT00374322|366036736|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
106104511|NCT00374322|366036737|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
106104512|NCT00374322|366036736|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
106104513|NCT00374322|366036737|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
106104514|NCT00374322|366036736|FG000|Overall Study|Severe Toxicity|1|||
106104515|NCT00374322|366036737|FG001|Overall Study|Severe Toxicity|0|||
106104516|NCT00374322|366036736|FG000|Overall Study|Site Closed|2|||
106104517|NCT00374322|366036737|FG001|Overall Study|Site Closed|2|||
106104518|NCT00374322|366036736|FG000|Overall Study|Participant Changed Physician|1|||
106104519|NCT00374322|366036737|FG001|Overall Study|Participant Changed Physician|0|||
106104520|NCT00374322|366036736|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
106104521|NCT00374322|366036737|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
106104522|NCT00374322|366036736|FG000|Overall Study|Noncompliance with Study Requirements|0|||
106104523|NCT00374322|366036737|FG001|Overall Study|Noncompliance with Study Requirements|1|||
106104524|NCT00374322|366036736|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
106104525|NCT00374322|366036737|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
106104526|NCT00374322|366036736|FG000|Overall Study|Did Not Receive Study Medication|8|||
106104527|NCT00374322|366036737|FG001|Overall Study|Did Not Receive Study Medication|6|||
106104528|NCT01400503|366036738|FG000|Overall Study|Withdrawal by Subject|1|||
106104529|NCT01400503|366036738|FG000|Overall Study|Study Terminated by Sponsor|58|||
106104530|NCT01400503|366036738|FG000|Overall Study|Other|1|||
106104531|NCT02626780|366036742|FG000|Overall Study|Withdrawal by Subject|3|||
106104532|NCT02459574|366036743|FG000|Overall Study|Withdrawal by Subject|6|||
106104533|NCT02459574|366036744|FG001|Overall Study|Withdrawal by Subject|6|||
106104534|NCT02459574|366036745|FG002|Overall Study|Withdrawal by Subject|2|||
106104535|NCT02459574|366036743|FG000|Overall Study|Lost to Follow-up|1|||
106104536|NCT02459574|366036744|FG001|Overall Study|Lost to Follow-up|1|||
106104537|NCT02459574|366036745|FG002|Overall Study|Lost to Follow-up|0|||
106104538|NCT02459574|366036743|FG000|Overall Study|Death|0|||
106104539|NCT02459574|366036744|FG001|Overall Study|Death|1|||
106104540|NCT02459574|366036745|FG002|Overall Study|Death|0|||
106104541|NCT02057874|366039228|FG000|Overall Study|participant did not return for scan|1|||
106104542|NCT02586025|366039229|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
106104543|NCT02586025|366039230|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
106104544|NCT02586025|366039229|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
106104545|NCT02586025|366039230|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
105781735|NCT02493712|364854832|FG002|Overall Study|Protocol Violation|1|||
106104546|NCT02586025|366039229|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
106104547|NCT02586025|366039230|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
106104548|NCT02586025|366039229|FG000|Neoadjuvant Treatment|Death|1|||
106104549|NCT02586025|366039230|FG001|Neoadjuvant Treatment|Death|0|||
106104550|NCT02586025|366039229|FG000|Neoadjuvant Treatment|Adverse Event|1|||
106104551|NCT02586025|366039230|FG001|Neoadjuvant Treatment|Adverse Event|0|||
106104552|NCT02586025|366039229|FG000|Neoadjuvant Treatment|Physician Decision|2|||
106104553|NCT02586025|366039230|FG001|Neoadjuvant Treatment|Physician Decision|1|||
106104554|NCT02586025|366039229|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
106104555|NCT02586025|366039230|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
106104556|NCT02586025|366039229|FG000|Adjuvant Treatment|Recurrent Disease|4|||
106104557|NCT02586025|366039230|FG001|Adjuvant Treatment|Recurrent Disease|5|||
106104558|NCT02586025|366039229|FG000|Adjuvant Treatment|Physician Decision|0|||
106104559|NCT02586025|366039230|FG001|Adjuvant Treatment|Physician Decision|1|||
106104560|NCT02586025|366039229|FG000|Adjuvant Treatment|Pregnancy|1|||
106104561|NCT02586025|366039230|FG001|Adjuvant Treatment|Pregnancy|0|||
106104562|NCT02586025|366039229|FG000|Treatment-Free Follow-Up|Death|11|||
106104563|NCT02586025|366039230|FG001|Treatment-Free Follow-Up|Death|11|||
106104564|NCT02586025|366039229|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
106104565|NCT02586025|366039230|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
106104566|NCT02586025|366039229|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
106104567|NCT02586025|366039230|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
106104568|NCT02586025|366039229|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
106104569|NCT02586025|366039230|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
106104570|NCT02586025|366039229|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
106104571|NCT02586025|366039230|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
106104572|NCT03432364|366039233|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
106104573|NCT03393000|366039234|FG000|Overall Study|Death|11|||
106104574|NCT03393000|366039234|FG000|Overall Study|Withdrawal by Subject|2|||
106104575|NCT03393000|366039234|FG000|Overall Study|Physician Decision|1|||
106104576|NCT01773070|366039235|FG000|Overall Study|Withdrawal by Subject|24|||
106104577|NCT01773070|366039235|FG000|Overall Study|Lost to Follow-up|39|||
106104578|NCT01773070|366039235|FG000|Overall Study|Other|15|||
106104579|NCT01773070|366039235|FG000|Overall Study|Death (unrelated to study procedures)|3|||
106104580|NCT00951041|366039236|FG000|Overall Study|Withdrawal by Subject|1|||
106104581|NCT00951041|366039237|FG001|Overall Study|Withdrawal by Subject|1|||
106104582|NCT00951041|366039236|FG000|Overall Study|Lost to Follow-up|1|||
106104583|NCT00951041|366039237|FG001|Overall Study|Lost to Follow-up|0|||
106104584|NCT00951041|366039236|FG000|Overall Study|Other|3|||
106104585|NCT00951041|366039237|FG001|Overall Study|Other|0|||
106104586|NCT03151005|366039240|FG000|Overall Study|Lost to Follow-up|5|||
106104587|NCT03151005|366039241|FG001|Overall Study|Lost to Follow-up|5|||
106104588|NCT02633800|366039242|FG000|Overall Study|Death|3|||
106104589|NCT02633800|366039243|FG001|Overall Study|Death|3|||
106104590|NCT02633800|366039242|FG000|Overall Study|Reason not provided|1|||
106104591|NCT02633800|366039243|FG001|Overall Study|Reason not provided|0|||
106104592|NCT02633800|366039242|FG000|Overall Study|Radiologic(al) progression|23|||
106104593|NCT02633800|366039243|FG001|Overall Study|Radiologic(al) progression|23|||
106104594|NCT02633800|366039242|FG000|Overall Study|Clinical progression|3|||
106104595|NCT02633800|366039243|FG001|Overall Study|Clinical progression|6|||
106104596|NCT02633800|366039242|FG000|Overall Study|Study terminated by sponsor|6|||
106104597|NCT02633800|366039243|FG001|Overall Study|Study terminated by sponsor|5|||
106104598|NCT02633800|366039242|FG000|Overall Study|Adverse event, non-fatal|7|||
106104599|NCT02633800|366039243|FG001|Overall Study|Adverse event, non-fatal|2|||
106104600|NCT02633800|366039242|FG000|Overall Study|Withdrawal by Subject|0|||
106104601|NCT02633800|366039243|FG001|Overall Study|Withdrawal by Subject|3|||
106104602|NCT02633800|366039242|FG000|Overall Study|Patient Request|1|||
106104603|NCT02633800|366039243|FG001|Overall Study|Patient Request|1|||
106104604|NCT00082173|366039244|FG000|Overall Study|Withdrawal by Subject|3|||
106104605|NCT00082173|366039245|FG001|Overall Study|Withdrawal by Subject|5|||
106104606|NCT00082173|366039244|FG000|Overall Study|Lost to Follow-up|1|||
106104607|NCT00082173|366039245|FG001|Overall Study|Lost to Follow-up|0|||
106104608|NCT00082173|366039244|FG000|Overall Study|Adverse Event|1|||
106104609|NCT00082173|366039245|FG001|Overall Study|Adverse Event|0|||
106104610|NCT00082173|366039244|FG000|Overall Study|Culture negative or resistant at baselin|5|||
106104611|NCT00082173|366039245|FG001|Overall Study|Culture negative or resistant at baselin|6|||
106104612|NCT00746590|366039246|FG000|Overall Study|Death|1|||
106104613|NCT02261493|366039250|FG000|Overall Study|Noncompliance|0|||
106104614|NCT02261493|366039251|FG001|Overall Study|Noncompliance|0|||
106104615|NCT02261493|366039252|FG002|Overall Study|Noncompliance|2|||
106104616|NCT02261493|366039250|FG000|Overall Study|Physician Decision|0|||
106104617|NCT02261493|366039251|FG001|Overall Study|Physician Decision|1|||
106104618|NCT02261493|366039252|FG002|Overall Study|Physician Decision|0|||
106104619|NCT02261493|366039250|FG000|Overall Study|Undisclosed alcohol abuse|0|||
106104620|NCT02261493|366039251|FG001|Overall Study|Undisclosed alcohol abuse|1|||
106104621|NCT02261493|366039252|FG002|Overall Study|Undisclosed alcohol abuse|0|||
106104622|NCT02261493|366039250|FG000|Overall Study|Protocol Violation|1|||
106104623|NCT02261493|366039251|FG001|Overall Study|Protocol Violation|0|||
106104624|NCT02261493|366039252|FG002|Overall Study|Protocol Violation|0|||
106104625|NCT02261493|366039250|FG000|Overall Study|Personal Reasons|14|||
106104626|NCT02261493|366039251|FG001|Overall Study|Personal Reasons|14|||
106104627|NCT02261493|366039252|FG002|Overall Study|Personal Reasons|16|||
106104628|NCT02261493|366039250|FG000|Overall Study|Lost to Follow-up|14|||
106104629|NCT02261493|366039251|FG001|Overall Study|Lost to Follow-up|27|||
106104630|NCT02261493|366039252|FG002|Overall Study|Lost to Follow-up|8|||
106104631|NCT02261493|366039250|FG000|Overall Study|Pregnancy|1|||
106104632|NCT02261493|366039251|FG001|Overall Study|Pregnancy|2|||
106104633|NCT02261493|366039252|FG002|Overall Study|Pregnancy|0|||
106104634|NCT02261493|366039250|FG000|Overall Study|Lack of Efficacy|0|||
106104635|NCT02261493|366039251|FG001|Overall Study|Lack of Efficacy|1|||
106104636|NCT02261493|366039252|FG002|Overall Study|Lack of Efficacy|0|||
106104637|NCT02261493|366039250|FG000|Overall Study|Adverse Event|0|||
106104638|NCT02261493|366039251|FG001|Overall Study|Adverse Event|1|||
106104639|NCT02261493|366039252|FG002|Overall Study|Adverse Event|0|||
106104640|NCT04402866|366039255|FG000|Overall Study|Discontinued Prior to Treatment|0|||
106104641|NCT04402866|366039256|FG001|Overall Study|Discontinued Prior to Treatment|0|||
106104642|NCT04402866|366039257|FG002|Overall Study|Discontinued Prior to Treatment|0|||
106104643|NCT04402866|366039258|FG003|Overall Study|Discontinued Prior to Treatment|0|||
106104644|NCT04402866|366039259|FG004|Overall Study|Discontinued Prior to Treatment|2|||
106104645|NCT04402866|366039260|FG005|Overall Study|Discontinued Prior to Treatment|3|||
106104646|NCT04402866|366039255|FG000|Overall Study|Adverse Event|2|||
106104647|NCT04402866|366039256|FG001|Overall Study|Adverse Event|1|||
106104648|NCT04402866|366039257|FG002|Overall Study|Adverse Event|0|||
106104649|NCT04402866|366039258|FG003|Overall Study|Adverse Event|0|||
106104650|NCT04402866|366039259|FG004|Overall Study|Adverse Event|13|||
106104651|NCT04402866|366039260|FG005|Overall Study|Adverse Event|8|||
106104652|NCT04402866|366039255|FG000|Overall Study|Miscellaneous|0|||
106104653|NCT04402866|366039256|FG001|Overall Study|Miscellaneous|0|||
106104654|NCT04402866|366039257|FG002|Overall Study|Miscellaneous|1|||
106104655|NCT04402866|366039258|FG003|Overall Study|Miscellaneous|0|||
106104656|NCT04402866|366039259|FG004|Overall Study|Miscellaneous|0|||
106104657|NCT04402866|366039260|FG005|Overall Study|Miscellaneous|0|||
106104658|NCT04402866|366039255|FG000|Overall Study|Lost to Follow-up|0|||
106104659|NCT04402866|366039256|FG001|Overall Study|Lost to Follow-up|0|||
106104660|NCT04402866|366039257|FG002|Overall Study|Lost to Follow-up|0|||
106104661|NCT04402866|366039258|FG003|Overall Study|Lost to Follow-up|0|||
106104662|NCT04402866|366039259|FG004|Overall Study|Lost to Follow-up|0|||
106104663|NCT04402866|366039260|FG005|Overall Study|Lost to Follow-up|1|||
106104664|NCT04402866|366039255|FG000|Overall Study|Withdrawal by Subject|0|||
106104665|NCT04402866|366039256|FG001|Overall Study|Withdrawal by Subject|0|||
106104666|NCT04402866|366039257|FG002|Overall Study|Withdrawal by Subject|0|||
106104667|NCT04402866|366039258|FG003|Overall Study|Withdrawal by Subject|0|||
106104668|NCT04402866|366039259|FG004|Overall Study|Withdrawal by Subject|0|||
106104669|NCT04402866|366039260|FG005|Overall Study|Withdrawal by Subject|2|||
106104670|NCT01754467|366039261|FG000|Overall Study|Lost to Follow-up|1|||
106104671|NCT02065336|366039262|FG000|Extension Phase|Study Terminated by Sponsor|0|||
106104672|NCT02065336|366039263|FG001|Extension Phase|Study Terminated by Sponsor|0|||
106104673|NCT02065336|366039264|FG002|Extension Phase|Study Terminated by Sponsor|0|||
106104674|NCT02065336|366039265|FG003|Extension Phase|Study Terminated by Sponsor|0|||
106104675|NCT02065336|366039266|FG004|Extension Phase|Study Terminated by Sponsor|0|||
106104676|NCT02065336|366039267|FG005|Extension Phase|Study Terminated by Sponsor|0|||
106104677|NCT02065336|366039268|FG006|Extension Phase|Study Terminated by Sponsor|0|||
106104678|NCT02065336|366039269|FG007|Extension Phase|Study Terminated by Sponsor|0|||
106104679|NCT02065336|366039270|FG008|Extension Phase|Study Terminated by Sponsor|2|||
106104680|NCT02065336|366039271|FG009|Extension Phase|Study Terminated by Sponsor|8|||
106104681|NCT00530855|366039272|FG000|Overall Study|Lack of Efficacy|20|||
106104682|NCT00530855|366039272|FG000|Overall Study|Withdrawal by Subject|30|||
106104683|NCT00530855|366039272|FG000|Overall Study|Fatal Serious AE|3|||
106104684|NCT00530855|366039272|FG000|Overall Study|Non Fatal Serious AE|7|||
106104685|NCT00530855|366039272|FG000|Overall Study|Non Fatal Non Serious AE|12|||
106104686|NCT00530855|366039272|FG000|Overall Study|Protocol Violation|3|||
106104687|NCT00530855|366039272|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
106104688|NCT00530855|366039272|FG000|Overall Study|Lost to Follow-up|9|||
106104689|NCT00530855|366039272|FG000|Overall Study|Other reason for premature termination|17|||
106104690|NCT00626028|366039273|FG000|Overall Study|Adverse Event|1|||
106104691|NCT00626028|366039274|FG001|Overall Study|Adverse Event|1|||
106104692|NCT00626028|366039273|FG000|Overall Study|Device Failure|0|||
106104693|NCT00626028|366039274|FG001|Overall Study|Device Failure|1|||
106104694|NCT00626028|366039273|FG000|Overall Study|Physician Decision|2|||
106104695|NCT00626028|366039274|FG001|Overall Study|Physician Decision|1|||
106104696|NCT00626028|366039273|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
106104697|NCT00626028|366039274|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
106104698|NCT01970462|366039275|FG000|Overall Study|Lost to Follow-up|0|||
106104699|NCT01970462|366039276|FG001|Overall Study|Lost to Follow-up|2|||
106104700|NCT01292876|366039277|FG000|Overall Study|Physician Decision|4|||
106104701|NCT01627327|366039278|FG000|Overall Study|Adverse Event|6|||
106104702|NCT01627327|366039279|FG001|Overall Study|Adverse Event|12|||
106104703|NCT01627327|366039278|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
106104704|NCT01627327|366039279|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
106104705|NCT01627327|366039278|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
106104706|NCT01627327|366039279|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
106104707|NCT01627327|366039278|FG000|Overall Study|Protocol Violation|4|||
106104708|NCT01627327|366039279|FG001|Overall Study|Protocol Violation|10|||
106104709|NCT01627327|366039278|FG000|Overall Study|Lost to Follow-up|1|||
106104710|NCT01627327|366039279|FG001|Overall Study|Lost to Follow-up|3|||
106104711|NCT01627327|366039278|FG000|Overall Study|Physician Decision|1|||
106104712|NCT01627327|366039279|FG001|Overall Study|Physician Decision|0|||
106104713|NCT01627327|366039278|FG000|Overall Study|Withdrawal by Subject|3|||
106104714|NCT01627327|366039279|FG001|Overall Study|Withdrawal by Subject|3|||
106104715|NCT01433354|366039294|FG000|Overall Study|Adverse Event|6|||
106104716|NCT01433354|366039294|FG000|Overall Study|Lost to Follow-up|1|||
106104717|NCT01433354|366039294|FG000|Overall Study|Administrative problems|90|||
106104718|NCT01433354|366039294|FG000|Overall Study|Protocol Violation|2|||
106104719|NCT01433354|366039294|FG000|Overall Study|Lack of Efficacy|17|||
106104720|NCT01433354|366039294|FG000|Overall Study|Subject Withdrew Consent|3|||
106104721|NCT01618162|366039295|FG000|Overall Study|Protocol Violation|13|||
106104722|NCT01618162|366039296|FG001|Overall Study|Protocol Violation|10|||
106104723|NCT01618162|366039295|FG000|Overall Study|Adverse Event|9|||
106104724|NCT01618162|366039296|FG001|Overall Study|Adverse Event|2|||
106104725|NCT01618162|366039295|FG000|Overall Study|Withdrawal Criteria|2|||
106104726|NCT01618162|366039296|FG001|Overall Study|Withdrawal Criteria|10|||
106104727|NCT01618162|366039295|FG000|Overall Study|Unclassified|14|||
106104728|NCT01618162|366039296|FG001|Overall Study|Unclassified|13|||
106104729|NCT02633137|366039301|FG000|Overall Study|Adverse Event|1|||
106104730|NCT02633137|366039301|FG000|Overall Study|Lack of Efficacy|2|||
106104731|NCT02633137|366039301|FG000|Overall Study|Withdrawal by Subject|1|||
106104732|NCT04867369|366039302|FG000|Overall Study|Withdrawal by Subject|1|||
106104733|NCT04867369|366039303|FG001|Overall Study|Withdrawal by Subject|0|||
106104734|NCT01972841|366039304|FG000|Overall Study|Randomized but Never Received Treatment|2|||
106104735|NCT01972841|366039305|FG001|Overall Study|Randomized but Never Received Treatment|5|||
106104736|NCT01972841|366039306|FG002|Overall Study|Randomized but Never Received Treatment|4|||
106104737|NCT01972841|366039307|FG003|Overall Study|Randomized but Never Received Treatment|2|||
106104738|NCT01972841|366039308|FG004|Overall Study|Randomized but Never Received Treatment|6|||
106104739|NCT01972841|366039309|FG005|Overall Study|Randomized but Never Received Treatment|13|||
106104740|NCT01972841|366039304|FG000|Overall Study|Adverse Event|13|||
106104741|NCT01972841|366039305|FG001|Overall Study|Adverse Event|8|||
106104742|NCT01972841|366039306|FG002|Overall Study|Adverse Event|12|||
106104743|NCT01972841|366039307|FG003|Overall Study|Adverse Event|9|||
106104744|NCT01972841|366039308|FG004|Overall Study|Adverse Event|21|||
106104745|NCT01972841|366039309|FG005|Overall Study|Adverse Event|26|||
106104746|NCT01972841|366039304|FG000|Overall Study|Lack of Efficacy|1|||
106104747|NCT01972841|366039305|FG001|Overall Study|Lack of Efficacy|0|||
106104748|NCT01972841|366039306|FG002|Overall Study|Lack of Efficacy|0|||
106104749|NCT01972841|366039307|FG003|Overall Study|Lack of Efficacy|2|||
106104750|NCT01972841|366039308|FG004|Overall Study|Lack of Efficacy|4|||
106104751|NCT01972841|366039309|FG005|Overall Study|Lack of Efficacy|1|||
106104752|NCT01972841|366039304|FG000|Overall Study|Lost to Follow-up|4|||
106104753|NCT01972841|366039305|FG001|Overall Study|Lost to Follow-up|2|||
106104754|NCT01972841|366039306|FG002|Overall Study|Lost to Follow-up|4|||
106104755|NCT01972841|366039307|FG003|Overall Study|Lost to Follow-up|2|||
106104756|NCT01972841|366039308|FG004|Overall Study|Lost to Follow-up|9|||
106104757|NCT01972841|366039309|FG005|Overall Study|Lost to Follow-up|3|||
106104758|NCT01972841|366039304|FG000|Overall Study|Protocol Violation|2|||
106104759|NCT01972841|366039305|FG001|Overall Study|Protocol Violation|2|||
106104760|NCT01972841|366039306|FG002|Overall Study|Protocol Violation|3|||
106104761|NCT01972841|366039307|FG003|Overall Study|Protocol Violation|5|||
106104762|NCT01972841|366039308|FG004|Overall Study|Protocol Violation|9|||
106104763|NCT01972841|366039309|FG005|Overall Study|Protocol Violation|4|||
105781736|NCT02493712|364854830|FG000|Overall Study|Lost to Follow-up|1|||
105781737|NCT02493712|364854831|FG001|Overall Study|Lost to Follow-up|0|||
106104764|NCT01972841|366039304|FG000|Overall Study|Withdrawal by participants|21|||
106104765|NCT01972841|366039305|FG001|Overall Study|Withdrawal by participants|27|||
106104766|NCT01972841|366039306|FG002|Overall Study|Withdrawal by participants|23|||
106104767|NCT01972841|366039307|FG003|Overall Study|Withdrawal by participants|16|||
106104768|NCT01972841|366039308|FG004|Overall Study|Withdrawal by participants|33|||
106104769|NCT01972841|366039309|FG005|Overall Study|Withdrawal by participants|34|||
106104770|NCT01972841|366039304|FG000|Overall Study|Miscellaneous|0|||
106104771|NCT01972841|366039305|FG001|Overall Study|Miscellaneous|0|||
106104772|NCT01972841|366039306|FG002|Overall Study|Miscellaneous|4|||
106104773|NCT01972841|366039307|FG003|Overall Study|Miscellaneous|1|||
106104774|NCT01972841|366039308|FG004|Overall Study|Miscellaneous|0|||
106104775|NCT01972841|366039309|FG005|Overall Study|Miscellaneous|4|||
106104776|NCT01972841|366039304|FG000|Overall Study|Did not have end of treatment page|0|||
106104777|NCT01972841|366039305|FG001|Overall Study|Did not have end of treatment page|0|||
106104778|NCT01972841|366039306|FG002|Overall Study|Did not have end of treatment page|0|||
106104779|NCT01972841|366039307|FG003|Overall Study|Did not have end of treatment page|0|||
106104780|NCT01972841|366039308|FG004|Overall Study|Did not have end of treatment page|1|||
106104781|NCT01972841|366039309|FG005|Overall Study|Did not have end of treatment page|0|||
106104782|NCT04435366|366039310|FG000|Year 1 (12 Months)|Adverse Event|3|||
106104783|NCT04435366|366039311|FG001|Year 1 (12 Months)|Adverse Event|0|||
106104784|NCT04435366|366039312|FG002|Year 1 (12 Months)|Adverse Event|2|||
106104785|NCT04435366|366039310|FG000|Year 1 (12 Months)|Death|2|||
106104786|NCT04435366|366039311|FG001|Year 1 (12 Months)|Death|0|||
106104787|NCT04435366|366039312|FG002|Year 1 (12 Months)|Death|1|||
106104788|NCT04435366|366039310|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
106104789|NCT04435366|366039311|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
106104790|NCT04435366|366039312|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
106104791|NCT04435366|366039310|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
106104792|NCT04435366|366039311|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
106104793|NCT04435366|366039312|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
106104794|NCT04435366|366039310|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
106104795|NCT04435366|366039311|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
106104796|NCT04435366|366039312|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
106104797|NCT04435366|366039310|FG000|Year 1 (12 Months)|Not treated|0|||
106104798|NCT04435366|366039311|FG001|Year 1 (12 Months)|Not treated|0|||
106104799|NCT04435366|366039312|FG002|Year 1 (12 Months)|Not treated|1|||
106104800|NCT04435366|366039310|FG000|Year 2 (12 Months)|Death|1|||
106104801|NCT04435366|366039311|FG001|Year 2 (12 Months)|Death|4|||
106104802|NCT04435366|366039312|FG002|Year 2 (12 Months)|Death|6|||
106104803|NCT04435366|366039310|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
106104804|NCT04435366|366039311|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
106104805|NCT04435366|366039312|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
106104806|NCT04435366|366039310|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
106104807|NCT04435366|366039311|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
106104808|NCT04435366|366039312|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
106104809|NCT04435366|366039310|FG000|Year 2 (12 Months)|Adverse Event|2|||
106104810|NCT04435366|366039311|FG001|Year 2 (12 Months)|Adverse Event|1|||
106104811|NCT04435366|366039312|FG002|Year 2 (12 Months)|Adverse Event|6|||
106104812|NCT02192502|366039317|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
106104813|NCT02192502|366039318|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
106104814|NCT02192502|366039317|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
106104815|NCT02192502|366039318|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
106104816|NCT02192502|366039317|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
106104817|NCT02192502|366039318|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
106104818|NCT01270347|366039319|FG000|Core Phase|Adverse Event|1|||
106104819|NCT01270347|366039320|FG001|Core Phase|Adverse Event|6|||
106104820|NCT01270347|366039319|FG000|Core Phase|Withdrawal by Subject|1|||
106104821|NCT01270347|366039320|FG001|Core Phase|Withdrawal by Subject|2|||
106104822|NCT01270347|366039319|FG000|Core Phase|Lost to Follow-up|0|||
106104823|NCT01270347|366039320|FG001|Core Phase|Lost to Follow-up|1|||
106104824|NCT01270347|366039319|FG000|Core Phase|Miscellaneous|8|||
106104825|NCT01270347|366039320|FG001|Core Phase|Miscellaneous|14|||
106104826|NCT01270347|366039319|FG000|Extension Phase|Adverse Event|1|||
106104827|NCT01270347|366039320|FG001|Extension Phase|Adverse Event|3|||
106104828|NCT01270347|366039319|FG000|Extension Phase|Withdrawal by Subject|3|||
106104829|NCT01270347|366039320|FG001|Extension Phase|Withdrawal by Subject|4|||
106104830|NCT01270347|366039319|FG000|Extension Phase|Miscellaneous|2|||
106104831|NCT01270347|366039320|FG001|Extension Phase|Miscellaneous|2|||
106104832|NCT03624504|366039324|FG000|Overall Study|Unsuccessful Implant|1|||
106104833|NCT02862457|366039325|FG000|Overall Study|Death|1|||
106104834|NCT02862457|366039326|FG001|Overall Study|Death|3|||
106104835|NCT02862457|366039327|FG002|Overall Study|Death|2|||
106104836|NCT02862457|366039328|FG003|Overall Study|Death|3|||
106104837|NCT02862457|366039329|FG004|Overall Study|Death|0|||
106104838|NCT02862457|366039330|FG005|Overall Study|Death|2|||
106104839|NCT02862457|366039331|FG006|Overall Study|Death|1|||
106104840|NCT02862457|366039325|FG000|Overall Study|Lost to Follow-up|1|||
106104841|NCT02862457|366039326|FG001|Overall Study|Lost to Follow-up|0|||
106104842|NCT02862457|366039327|FG002|Overall Study|Lost to Follow-up|0|||
106104843|NCT02862457|366039328|FG003|Overall Study|Lost to Follow-up|1|||
106104844|NCT02862457|366039329|FG004|Overall Study|Lost to Follow-up|0|||
106104845|NCT02862457|366039330|FG005|Overall Study|Lost to Follow-up|0|||
106104846|NCT02862457|366039331|FG006|Overall Study|Lost to Follow-up|0|||
106104847|NCT02862457|366039325|FG000|Overall Study|Withdrawal by Subject|0|||
106104848|NCT02862457|366039326|FG001|Overall Study|Withdrawal by Subject|0|||
106104849|NCT02862457|366039327|FG002|Overall Study|Withdrawal by Subject|1|||
106104850|NCT02862457|366039328|FG003|Overall Study|Withdrawal by Subject|0|||
106104851|NCT02862457|366039329|FG004|Overall Study|Withdrawal by Subject|0|||
106104852|NCT02862457|366039330|FG005|Overall Study|Withdrawal by Subject|1|||
106104853|NCT02862457|366039331|FG006|Overall Study|Withdrawal by Subject|0|||
106104854|NCT01388816|366039332|FG000|Overall Study|Adverse Event|0|||
106104855|NCT01388816|366039333|FG001|Overall Study|Adverse Event|2|||
106104856|NCT01388816|366039334|FG002|Overall Study|Adverse Event|0|||
106104857|NCT01388816|366039335|FG003|Overall Study|Adverse Event|0|||
106104858|NCT01388816|366039332|FG000|Overall Study|Lost to Follow-up|0|||
106104859|NCT01388816|366039333|FG001|Overall Study|Lost to Follow-up|1|||
106104860|NCT01388816|366039334|FG002|Overall Study|Lost to Follow-up|0|||
106104861|NCT01388816|366039335|FG003|Overall Study|Lost to Follow-up|0|||
106104862|NCT01388816|366039332|FG000|Overall Study|Withdrawal by Subject|2|||
106104863|NCT01388816|366039333|FG001|Overall Study|Withdrawal by Subject|1|||
106104864|NCT01388816|366039334|FG002|Overall Study|Withdrawal by Subject|1|||
106104865|NCT01388816|366039335|FG003|Overall Study|Withdrawal by Subject|0|||
106104866|NCT01388816|366039332|FG000|Overall Study|Protocol Violation|0|||
106104867|NCT01388816|366039333|FG001|Overall Study|Protocol Violation|0|||
106104868|NCT01388816|366039334|FG002|Overall Study|Protocol Violation|2|||
106104869|NCT01388816|366039335|FG003|Overall Study|Protocol Violation|0|||
106104870|NCT03206203|366039336|FG000|Treatment|Death|38|||
106104871|NCT03206203|366039337|FG001|Treatment|Death|26|||
106104872|NCT03206203|366039338|FG002|Treatment|Death|0|||
106104873|NCT03206203|366039336|FG000|Treatment|Withdrawal by Subject|1|||
106104874|NCT03206203|366039337|FG001|Treatment|Withdrawal by Subject|0|||
106104875|NCT03206203|366039338|FG002|Treatment|Withdrawal by Subject|0|||
106104876|NCT03206203|366039336|FG000|Treatment|Lost to Follow-up|4|||
106104877|NCT03206203|366039337|FG001|Treatment|Lost to Follow-up|0|||
106104878|NCT03206203|366039338|FG002|Treatment|Lost to Follow-up|0|||
106104879|NCT03206203|366039336|FG000|Treatment|N/A in Follow-Up|8|||
106104880|NCT03206203|366039337|FG001|Treatment|N/A in Follow-Up|1|||
106104881|NCT03206203|366039338|FG002|Treatment|N/A in Follow-Up|0|||
106104882|NCT03206203|366039336|FG000|Treatment|Disease progression|0|||
106104883|NCT03206203|366039337|FG001|Treatment|Disease progression|1|||
106104884|NCT03206203|366039338|FG002|Treatment|Disease progression|0|||
106104885|NCT03206203|366039336|FG000|Treatment|Refused follow-up|0|||
106104886|NCT03206203|366039337|FG001|Treatment|Refused follow-up|1|||
106104887|NCT03206203|366039338|FG002|Treatment|Refused follow-up|0|||
106104888|NCT03206203|366039336|FG000|Treatment|Cross over to Arm 1|0|||
106104889|NCT03206203|366039337|FG001|Treatment|Cross over to Arm 1|19|||
106104890|NCT03206203|366039338|FG002|Treatment|Cross over to Arm 1|0|||
106104891|NCT03206203|366039336|FG000|Optional Cross-Over|Death|0|||
106104892|NCT03206203|366039337|FG001|Optional Cross-Over|Death|0|||
106104893|NCT03206203|366039338|FG002|Optional Cross-Over|Death|14|||
106104894|NCT03206203|366039336|FG000|Optional Cross-Over|Refused follow-up|0|||
106104895|NCT03206203|366039337|FG001|Optional Cross-Over|Refused follow-up|0|||
106104896|NCT03206203|366039338|FG002|Optional Cross-Over|Refused follow-up|2|||
106104897|NCT01483924|366039339|FG000|Overall Study|Withdrawal by Subject|2|||
106104898|NCT01483924|366039340|FG001|Overall Study|Withdrawal by Subject|0|||
106104899|NCT01483924|366039341|FG002|Overall Study|Withdrawal by Subject|0|||
106104900|NCT01483924|366039342|FG003|Overall Study|Withdrawal by Subject|1|||
106104901|NCT01483924|366039343|FG004|Overall Study|Withdrawal by Subject|1|||
106104902|NCT01483924|366039339|FG000|Overall Study|Adverse Event|0|||
106104903|NCT01483924|366039340|FG001|Overall Study|Adverse Event|0|||
106104904|NCT01483924|366039341|FG002|Overall Study|Adverse Event|1|||
106104905|NCT01483924|366039342|FG003|Overall Study|Adverse Event|1|||
106104906|NCT01483924|366039343|FG004|Overall Study|Adverse Event|0|||
106104907|NCT01483924|366039339|FG000|Overall Study|Non-compliance|0|||
106104908|NCT01483924|366039340|FG001|Overall Study|Non-compliance|0|||
106104909|NCT01483924|366039341|FG002|Overall Study|Non-compliance|0|||
106104910|NCT01483924|366039342|FG003|Overall Study|Non-compliance|1|||
106104911|NCT01483924|366039343|FG004|Overall Study|Non-compliance|1|||
106104912|NCT01483924|366039339|FG000|Overall Study|Sponsor concern over ECG result|0|||
106104913|NCT01483924|366039340|FG001|Overall Study|Sponsor concern over ECG result|0|||
106104914|NCT01483924|366039341|FG002|Overall Study|Sponsor concern over ECG result|0|||
106104915|NCT01483924|366039342|FG003|Overall Study|Sponsor concern over ECG result|1|||
106104916|NCT01483924|366039343|FG004|Overall Study|Sponsor concern over ECG result|0|||
106104917|NCT03565887|366039347|FG000|Overall Study|Adverse Event|1|||
106104918|NCT03565887|366039348|FG001|Overall Study|Adverse Event|0|||
106104919|NCT03565887|366039347|FG000|Overall Study|Withdrawal by Subject|0|||
106104920|NCT03565887|366039348|FG001|Overall Study|Withdrawal by Subject|2|||
106104921|NCT01454583|366039351|FG000|1st Year|Lost to Follow-up|1057|||
106104922|NCT01454583|366039352|FG001|1st Year|Lost to Follow-up|318|||
106104923|NCT01454583|366039353|FG002|1st Year|Lost to Follow-up|180|||
106104924|NCT01454583|366039351|FG000|2nd Year|Lost to Follow-up|3965|||
106104925|NCT01454583|366039352|FG001|2nd Year|Lost to Follow-up|1049|||
106104926|NCT01454583|366039353|FG002|2nd Year|Lost to Follow-up|737|||
106104927|NCT01454583|366039351|FG000|3rd Year|Lost to Follow-up|1959|||
106104928|NCT01454583|366039352|FG001|3rd Year|Lost to Follow-up|512|||
106104929|NCT01454583|366039353|FG002|3rd Year|Lost to Follow-up|297|||
106104930|NCT03265600|366039354|FG000|Overall Study|Lost to Follow-up|17|||
106104931|NCT03265600|366039355|FG001|Overall Study|Lost to Follow-up|5|||
106104932|NCT03265600|366039354|FG000|Overall Study|Withdrawal by Subject|4|||
106104933|NCT03265600|366039355|FG001|Overall Study|Withdrawal by Subject|2|||
106104934|NCT03265600|366039354|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
106104935|NCT03265600|366039355|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
106104936|NCT01292239|366039368|FG000|Overall Study|Other|1|||
106104937|NCT01292239|366039369|FG001|Overall Study|Other|1|||
106104938|NCT01292239|366039368|FG000|Overall Study|Withdrawal by Subject|3|||
106104939|NCT01292239|366039369|FG001|Overall Study|Withdrawal by Subject|6|||
106104940|NCT00528775|366039371|FG000|Overall Study|Other not specified|1|||
106104941|NCT00295022|366039374|FG000|Overall Study|Adverse Event|1|||
106104942|NCT00295022|366039375|FG001|Overall Study|Adverse Event|1|||
106104943|NCT00295022|366039376|FG002|Overall Study|Adverse Event|2|||
106104944|NCT00295022|366039374|FG000|Overall Study|Lost to Follow-up|0|||
106104945|NCT00295022|366039375|FG001|Overall Study|Lost to Follow-up|0|||
106104946|NCT00295022|366039376|FG002|Overall Study|Lost to Follow-up|1|||
106104947|NCT00295022|366039374|FG000|Overall Study|Withdrawal by Subject|0|||
106104948|NCT00295022|366039375|FG001|Overall Study|Withdrawal by Subject|0|||
106104949|NCT00295022|366039376|FG002|Overall Study|Withdrawal by Subject|2|||
106104950|NCT00734630|366039378|FG000|Overall Study|Lack of Efficacy|4|||
106104951|NCT00734630|366039379|FG001|Overall Study|Lack of Efficacy|4|||
106104952|NCT00734630|366039378|FG000|Overall Study|Withdrawal by Subject|7|||
106104953|NCT00734630|366039379|FG001|Overall Study|Withdrawal by Subject|9|||
106104954|NCT00734630|366039378|FG000|Overall Study|Lost to Follow-up|13|||
106104955|NCT00734630|366039379|FG001|Overall Study|Lost to Follow-up|7|||
106104956|NCT00734630|366039378|FG000|Overall Study|Protocol Violation|0|||
106104957|NCT00734630|366039379|FG001|Overall Study|Protocol Violation|3|||
106104958|NCT00734630|366039378|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
106104959|NCT00734630|366039379|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
106104960|NCT00734630|366039378|FG000|Overall Study|Adverse Event|3|||
106104961|NCT00734630|366039379|FG001|Overall Study|Adverse Event|6|||
106104962|NCT00734630|366039378|FG000|Overall Study|Randomized in Error|0|||
106104963|NCT00734630|366039379|FG001|Overall Study|Randomized in Error|1|||
106104964|NCT00734630|366039378|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
106104965|NCT00734630|366039379|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
106104966|NCT00734630|366039378|FG000|Overall Study|Poor Compliance|1|||
106104967|NCT00734630|366039379|FG001|Overall Study|Poor Compliance|1|||
106104968|NCT01922076|366039380|FG000|Overall Study|Adverse Event|0|||
106104969|NCT01922076|366039381|FG001|Overall Study|Adverse Event|0|||
106104970|NCT01922076|366039382|FG002|Overall Study|Adverse Event|0|||
106104971|NCT01922076|366039383|FG003|Overall Study|Adverse Event|0|||
106104972|NCT01922076|366039384|FG004|Overall Study|Adverse Event|1|||
106104973|NCT01922076|366039385|FG005|Overall Study|Adverse Event|0|||
106104974|NCT01922076|366039386|FG006|Overall Study|Adverse Event|0|||
106104975|NCT01922076|366039380|FG000|Overall Study|Physician Decision|0|||
106104976|NCT01922076|366039381|FG001|Overall Study|Physician Decision|0|||
106104977|NCT01922076|366039382|FG002|Overall Study|Physician Decision|1|||
106104978|NCT01922076|366039383|FG003|Overall Study|Physician Decision|0|||
106104979|NCT01922076|366039384|FG004|Overall Study|Physician Decision|0|||
106104980|NCT01922076|366039385|FG005|Overall Study|Physician Decision|0|||
106104981|NCT01922076|366039386|FG006|Overall Study|Physician Decision|0|||
106104982|NCT01922076|366039380|FG000|Overall Study|Withdrawal by Subject|0|||
106104983|NCT01922076|366039381|FG001|Overall Study|Withdrawal by Subject|0|||
106104984|NCT01922076|366039382|FG002|Overall Study|Withdrawal by Subject|0|||
106104985|NCT01922076|366039383|FG003|Overall Study|Withdrawal by Subject|1|||
106104986|NCT01922076|366039384|FG004|Overall Study|Withdrawal by Subject|0|||
106104987|NCT01922076|366039385|FG005|Overall Study|Withdrawal by Subject|1|||
106104988|NCT01922076|366039386|FG006|Overall Study|Withdrawal by Subject|1|||
106104989|NCT01018394|366039392|FG000|Overall Study|Withdrawal by Subject|5|||
106104990|NCT01018394|366039393|FG001|Overall Study|Withdrawal by Subject|5|||
106104991|NCT01018394|366039392|FG000|Overall Study|Lost to Follow-up|4|||
106104992|NCT01018394|366039393|FG001|Overall Study|Lost to Follow-up|3|||
106104993|NCT03792126|366039394|FG000|Overall Study|Adverse Event|1|||
106104994|NCT03792126|366039395|FG001|Overall Study|Adverse Event|2|||
106104995|NCT03792126|366039394|FG000|Overall Study|Death|0|||
106104996|NCT03792126|366039395|FG001|Overall Study|Death|1|||
106104997|NCT03792126|366039394|FG000|Overall Study|Lost to Follow-up|1|||
106104998|NCT03792126|366039395|FG001|Overall Study|Lost to Follow-up|0|||
106104999|NCT03792126|366039394|FG000|Overall Study|Withdrawal by Subject|0|||
106105000|NCT03792126|366039395|FG001|Overall Study|Withdrawal by Subject|1|||
106105001|NCT03792126|366039394|FG000|Overall Study|COVID-19 Restrictions|1|||
106105002|NCT03792126|366039395|FG001|Overall Study|COVID-19 Restrictions|3|||
106105003|NCT03792126|366039394|FG000|Overall Study|Symptoms resolved|0|||
106105004|NCT03792126|366039395|FG001|Overall Study|Symptoms resolved|3|||
106105005|NCT00683644|366039396|FG000|Overall Study|Withdrawal by Subject|4|||
106105006|NCT00683644|366039397|FG001|Overall Study|Withdrawal by Subject|2|||
106105007|NCT00683644|366039396|FG000|Overall Study|Lost to Follow-up|1|||
106105008|NCT00683644|366039397|FG001|Overall Study|Lost to Follow-up|4|||
106105009|NCT00683644|366039396|FG000|Overall Study|Adverse Event|1|||
106105010|NCT00683644|366039397|FG001|Overall Study|Adverse Event|2|||
106105011|NCT00683644|366039396|FG000|Overall Study|Low copper, other health problems,|7|||
106105012|NCT00683644|366039397|FG001|Overall Study|Low copper, other health problems,|6|||
106105013|NCT03240692|366039398|FG000|Overall Study|Physician Decision|1|||
106105014|NCT03240692|366039398|FG000|Overall Study|Withdrawal by Subject|1|||
106105015|NCT01857531|366039399|FG000|Overall Study|Withdrawal by Subject|4|||
106105016|NCT01775904|366039403|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
106105017|NCT01775904|366039403|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
106105018|NCT00518115|366039404|FG000|Overall Study|Adverse Event|6|||
106105019|NCT00518115|366039405|FG001|Overall Study|Adverse Event|1|||
106105020|NCT00518115|366039406|FG002|Overall Study|Adverse Event|5|||
106105021|NCT00518115|366039407|FG003|Overall Study|Adverse Event|6|||
106105022|NCT00518115|366039408|FG004|Overall Study|Adverse Event|5|||
106105023|NCT00518115|366039409|FG005|Overall Study|Adverse Event|5|||
106105024|NCT00518115|366039410|FG006|Overall Study|Adverse Event|5|||
106105025|NCT00518115|366039411|FG007|Overall Study|Adverse Event|10|||
106105026|NCT00518115|366039412|FG008|Overall Study|Adverse Event|2|||
106105027|NCT00518115|366039413|FG009|Overall Study|Adverse Event|9|||
106105028|NCT00518115|366039404|FG000|Overall Study|Lost to Follow-up|0|||
106105029|NCT00518115|366039405|FG001|Overall Study|Lost to Follow-up|0|||
106105030|NCT00518115|366039406|FG002|Overall Study|Lost to Follow-up|2|||
106105031|NCT00518115|366039407|FG003|Overall Study|Lost to Follow-up|3|||
106105032|NCT00518115|366039408|FG004|Overall Study|Lost to Follow-up|1|||
106105033|NCT00518115|366039409|FG005|Overall Study|Lost to Follow-up|3|||
106105034|NCT00518115|366039410|FG006|Overall Study|Lost to Follow-up|0|||
106105035|NCT00518115|366039411|FG007|Overall Study|Lost to Follow-up|1|||
106105036|NCT00518115|366039412|FG008|Overall Study|Lost to Follow-up|1|||
106105037|NCT00518115|366039413|FG009|Overall Study|Lost to Follow-up|1|||
106105038|NCT00518115|366039404|FG000|Overall Study|Protocol Violation|1|||
106105039|NCT00518115|366039405|FG001|Overall Study|Protocol Violation|3|||
106105040|NCT00518115|366039406|FG002|Overall Study|Protocol Violation|1|||
106105041|NCT00518115|366039407|FG003|Overall Study|Protocol Violation|0|||
106105042|NCT00518115|366039408|FG004|Overall Study|Protocol Violation|0|||
106105043|NCT00518115|366039409|FG005|Overall Study|Protocol Violation|0|||
106105044|NCT00518115|366039410|FG006|Overall Study|Protocol Violation|0|||
106105045|NCT00518115|366039411|FG007|Overall Study|Protocol Violation|0|||
106105046|NCT00518115|366039412|FG008|Overall Study|Protocol Violation|0|||
106105047|NCT00518115|366039413|FG009|Overall Study|Protocol Violation|0|||
106105048|NCT00518115|366039404|FG000|Overall Study|Withdrawal by Subject|1|||
105781738|NCT02493712|364854832|FG002|Overall Study|Lost to Follow-up|0|||
105781739|NCT02493712|364854830|FG000|Overall Study|Physician Decision|0|||
105781740|NCT02493712|364854831|FG001|Overall Study|Physician Decision|1|||
105781741|NCT02493712|364854832|FG002|Overall Study|Physician Decision|0|||
105781742|NCT02493712|364854830|FG000|Overall Study|Lack of Efficacy|0|||
105781743|NCT02493712|364854831|FG001|Overall Study|Lack of Efficacy|5|||
105781744|NCT02493712|364854832|FG002|Overall Study|Lack of Efficacy|3|||
105781745|NCT03808298|364854833|FG000|Overall Study|Adverse Event|3|||
105781746|NCT03808298|364854833|FG000|Overall Study|Physician Decision|1|||
105781747|NCT03808298|364854833|FG000|Overall Study|Withdrawal by Subject|1|||
106105049|NCT00518115|366039405|FG001|Overall Study|Withdrawal by Subject|1|||
106105050|NCT00518115|366039406|FG002|Overall Study|Withdrawal by Subject|5|||
106105051|NCT00518115|366039407|FG003|Overall Study|Withdrawal by Subject|0|||
105781748|NCT03808298|364854833|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
106105052|NCT00518115|366039408|FG004|Overall Study|Withdrawal by Subject|2|||
106105053|NCT00518115|366039409|FG005|Overall Study|Withdrawal by Subject|1|||
106105054|NCT00518115|366039410|FG006|Overall Study|Withdrawal by Subject|0|||
106105055|NCT00518115|366039411|FG007|Overall Study|Withdrawal by Subject|2|||
106105056|NCT00518115|366039412|FG008|Overall Study|Withdrawal by Subject|1|||
106105057|NCT00518115|366039413|FG009|Overall Study|Withdrawal by Subject|3|||
106105058|NCT00518115|366039404|FG000|Overall Study|Lack of Efficacy|1|||
106105059|NCT00518115|366039405|FG001|Overall Study|Lack of Efficacy|0|||
106105060|NCT00518115|366039406|FG002|Overall Study|Lack of Efficacy|1|||
106105061|NCT00518115|366039407|FG003|Overall Study|Lack of Efficacy|1|||
106105062|NCT00518115|366039408|FG004|Overall Study|Lack of Efficacy|0|||
106105063|NCT00518115|366039409|FG005|Overall Study|Lack of Efficacy|0|||
106105064|NCT00518115|366039410|FG006|Overall Study|Lack of Efficacy|0|||
106105065|NCT00518115|366039411|FG007|Overall Study|Lack of Efficacy|1|||
106105066|NCT00518115|366039412|FG008|Overall Study|Lack of Efficacy|0|||
106105067|NCT00518115|366039413|FG009|Overall Study|Lack of Efficacy|0|||
106105068|NCT00518115|366039404|FG000|Overall Study|Non-Compliance|1|||
106105069|NCT00518115|366039405|FG001|Overall Study|Non-Compliance|0|||
106105070|NCT00518115|366039406|FG002|Overall Study|Non-Compliance|1|||
106105071|NCT00518115|366039407|FG003|Overall Study|Non-Compliance|0|||
106105072|NCT00518115|366039408|FG004|Overall Study|Non-Compliance|1|||
106105073|NCT00518115|366039409|FG005|Overall Study|Non-Compliance|1|||
106105074|NCT00518115|366039410|FG006|Overall Study|Non-Compliance|1|||
106105075|NCT00518115|366039411|FG007|Overall Study|Non-Compliance|1|||
106105076|NCT00518115|366039412|FG008|Overall Study|Non-Compliance|0|||
106105077|NCT00518115|366039413|FG009|Overall Study|Non-Compliance|1|||
105781749|NCT01858701|364854834|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
106105078|NCT00518115|366039404|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
106105079|NCT00518115|366039405|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
106105080|NCT00518115|366039406|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
106105081|NCT00518115|366039407|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105781750|NCT01858701|364854835|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
106105082|NCT00518115|366039408|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
106105083|NCT00518115|366039409|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
106105084|NCT00518115|366039410|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
106105085|NCT00518115|366039411|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
106105086|NCT00518115|366039412|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
106105087|NCT00518115|366039413|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
106105088|NCT00518115|366039404|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
106105089|NCT00518115|366039405|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105090|NCT00518115|366039406|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105091|NCT00518115|366039407|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105092|NCT00518115|366039408|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105093|NCT00518115|366039409|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105094|NCT00518115|366039410|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105095|NCT00518115|366039411|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105096|NCT00518115|366039412|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105097|NCT00518115|366039413|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
106105098|NCT00518115|366039404|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
106105099|NCT00518115|366039405|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
106105100|NCT00518115|366039406|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
106105101|NCT00518115|366039407|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
106105102|NCT00518115|366039408|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
106105103|NCT00518115|366039409|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
106105104|NCT00518115|366039410|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
106105105|NCT00518115|366039411|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
106105106|NCT00518115|366039412|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
106105107|NCT00518115|366039413|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
106105108|NCT00518115|366039404|FG000|Overall Study|Wrong Monotherapy Administered|0|||
106105109|NCT00518115|366039405|FG001|Overall Study|Wrong Monotherapy Administered|0|||
106105110|NCT00518115|366039406|FG002|Overall Study|Wrong Monotherapy Administered|1|||
106105111|NCT00518115|366039407|FG003|Overall Study|Wrong Monotherapy Administered|0|||
106105112|NCT00518115|366039408|FG004|Overall Study|Wrong Monotherapy Administered|0|||
106105113|NCT00518115|366039409|FG005|Overall Study|Wrong Monotherapy Administered|0|||
106105114|NCT00518115|366039410|FG006|Overall Study|Wrong Monotherapy Administered|1|||
106105115|NCT00518115|366039411|FG007|Overall Study|Wrong Monotherapy Administered|0|||
106105116|NCT00518115|366039412|FG008|Overall Study|Wrong Monotherapy Administered|0|||
106105117|NCT00518115|366039413|FG009|Overall Study|Wrong Monotherapy Administered|0|||
106105118|NCT00518115|366039404|FG000|Overall Study|Violation of Exclusion Criteria|0|||
106105119|NCT00518115|366039405|FG001|Overall Study|Violation of Exclusion Criteria|0|||
106105120|NCT00518115|366039406|FG002|Overall Study|Violation of Exclusion Criteria|0|||
106105121|NCT00518115|366039407|FG003|Overall Study|Violation of Exclusion Criteria|1|||
106105122|NCT00518115|366039408|FG004|Overall Study|Violation of Exclusion Criteria|0|||
106105123|NCT00518115|366039409|FG005|Overall Study|Violation of Exclusion Criteria|0|||
106105124|NCT00518115|366039410|FG006|Overall Study|Violation of Exclusion Criteria|1|||
106105125|NCT00518115|366039411|FG007|Overall Study|Violation of Exclusion Criteria|0|||
106105126|NCT00518115|366039412|FG008|Overall Study|Violation of Exclusion Criteria|0|||
106105127|NCT00518115|366039413|FG009|Overall Study|Violation of Exclusion Criteria|0|||
106105128|NCT00518115|366039404|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
106105129|NCT00518115|366039405|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
106105130|NCT00518115|366039406|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
106105131|NCT00518115|366039407|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
106105132|NCT00518115|366039408|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
106105133|NCT00518115|366039409|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
106105134|NCT00518115|366039410|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
106105135|NCT00518115|366039411|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
106105136|NCT00518115|366039412|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
106105137|NCT00518115|366039413|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
106105138|NCT00518115|366039404|FG000|Overall Study|Withdrew Consent|0|||
106105139|NCT00518115|366039405|FG001|Overall Study|Withdrew Consent|0|||
106105140|NCT00518115|366039406|FG002|Overall Study|Withdrew Consent|0|||
106105141|NCT00518115|366039407|FG003|Overall Study|Withdrew Consent|0|||
106105142|NCT00518115|366039408|FG004|Overall Study|Withdrew Consent|0|||
106105143|NCT00518115|366039409|FG005|Overall Study|Withdrew Consent|1|||
106105144|NCT00518115|366039410|FG006|Overall Study|Withdrew Consent|0|||
106105145|NCT00518115|366039411|FG007|Overall Study|Withdrew Consent|0|||
106105146|NCT00518115|366039412|FG008|Overall Study|Withdrew Consent|0|||
106105147|NCT00518115|366039413|FG009|Overall Study|Withdrew Consent|0|||
106105148|NCT00518115|366039404|FG000|Overall Study|Moved Out of State|0|||
106105149|NCT00518115|366039405|FG001|Overall Study|Moved Out of State|0|||
106105150|NCT00518115|366039406|FG002|Overall Study|Moved Out of State|0|||
106105151|NCT00518115|366039407|FG003|Overall Study|Moved Out of State|0|||
106105152|NCT00518115|366039408|FG004|Overall Study|Moved Out of State|0|||
106105153|NCT00518115|366039409|FG005|Overall Study|Moved Out of State|0|||
106105154|NCT00518115|366039410|FG006|Overall Study|Moved Out of State|0|||
106105155|NCT00518115|366039411|FG007|Overall Study|Moved Out of State|0|||
106105156|NCT00518115|366039412|FG008|Overall Study|Moved Out of State|0|||
106105157|NCT00518115|366039413|FG009|Overall Study|Moved Out of State|1|||
106105158|NCT04891419|366039414|FG000|Overall Study|Withdrawal by Subject|4|||
106105159|NCT04891419|366039415|FG001|Overall Study|Withdrawal by Subject|0|||
106105160|NCT04891419|366039414|FG000|Overall Study|Lost to Follow-up|1|||
106105161|NCT04891419|366039415|FG001|Overall Study|Lost to Follow-up|3|||
106105162|NCT04084314|366039416|FG000|Overall Study|Subject/guardian decision|91|||
106105163|NCT04084314|366039416|FG000|Overall Study|Adverse Event|24|||
106105164|NCT04084314|366039416|FG000|Overall Study|Lost to Follow-up|19|||
106105165|NCT04084314|366039416|FG000|Overall Study|New therapy for study indication|9|||
106105166|NCT04084314|366039416|FG000|Overall Study|Pregnancy|9|||
106105167|NCT04084314|366039416|FG000|Overall Study|Withdrawal of informed consent|8|||
106105168|NCT04084314|366039416|FG000|Overall Study|Physician Decision|4|||
106105169|NCT04084314|366039416|FG000|Overall Study|Protocol Deviation|3|||
106105170|NCT01297959|366039417|FG000|Overall Study|Adverse Event|0|||
106105171|NCT01297959|366039418|FG001|Overall Study|Adverse Event|1|||
106105172|NCT01297959|366039417|FG000|Overall Study|Protocol Violation|2|||
106105173|NCT01297959|366039418|FG001|Overall Study|Protocol Violation|1|||
106105174|NCT01297959|366039417|FG000|Overall Study|Withdrawal by Subject|5|||
106105175|NCT01297959|366039418|FG001|Overall Study|Withdrawal by Subject|4|||
106105176|NCT01297959|366039417|FG000|Overall Study|Physician Decision|0|||
106105177|NCT01297959|366039418|FG001|Overall Study|Physician Decision|1|||
106105178|NCT01297959|366039417|FG000|Overall Study|Unrelated medical illness / complication|0|||
106105179|NCT01297959|366039418|FG001|Overall Study|Unrelated medical illness / complication|2|||
106105180|NCT01297959|366039417|FG000|Overall Study|Other|13|||
106105181|NCT01297959|366039418|FG001|Overall Study|Other|7|||
106105182|NCT03519854|366039419|FG000|Overall Study|Technical Error|0|||
106105183|NCT03519854|366039420|FG001|Overall Study|Technical Error|0|||
106105184|NCT03519854|366039421|FG002|Overall Study|Technical Error|1|||
106105185|NCT03519854|366039422|FG003|Overall Study|Technical Error|0|||
106105186|NCT03519854|366039423|FG004|Overall Study|Technical Error|0|||
106105187|NCT03519854|366039424|FG005|Overall Study|Technical Error|0|||
106105188|NCT03519854|366039425|FG006|Overall Study|Technical Error|0|||
106105189|NCT03519854|366039426|FG007|Overall Study|Technical Error|0|||
106105190|NCT03519854|366039427|FG008|Overall Study|Technical Error|0|||
106105191|NCT03519854|366039428|FG009|Overall Study|Technical Error|0|||
106105192|NCT03519854|366039429|FG010|Overall Study|Technical Error|0|||
106105193|NCT03519854|366039430|FG011|Overall Study|Technical Error|0|||
106105194|NCT03519854|366039431|FG012|Overall Study|Technical Error|0|||
106105195|NCT03519854|366039432|FG013|Overall Study|Technical Error|0|||
106105196|NCT03519854|366039433|FG014|Overall Study|Technical Error|0|||
106105197|NCT03519854|366039434|FG015|Overall Study|Technical Error|0|||
106105198|NCT03519854|366039435|FG016|Overall Study|Technical Error|0|||
106105199|NCT03519854|366039436|FG017|Overall Study|Technical Error|0|||
106105200|NCT00818753|366039440|FG000|Overall Study|Protocol Violation|1|||
106105201|NCT00818753|366039441|FG001|Overall Study|Protocol Violation|0|||
106105202|NCT00818753|366039442|FG002|Overall Study|Protocol Violation|0|||
106105203|NCT00818753|366039440|FG000|Overall Study|Other reason (not specified)|0|||
106105204|NCT00818753|366039441|FG001|Overall Study|Other reason (not specified)|0|||
106105205|NCT00818753|366039442|FG002|Overall Study|Other reason (not specified)|1|||
106105206|NCT00818753|366039440|FG000|Overall Study|Randomised and not treated|2|||
106105207|NCT00818753|366039441|FG001|Overall Study|Randomised and not treated|0|||
106105208|NCT00818753|366039442|FG002|Overall Study|Randomised and not treated|0|||
106105209|NCT00608582|366041194|FG000|Overall Study|Lost to Follow-up|2|||
106105210|NCT00608582|366041195|FG001|Overall Study|Lost to Follow-up|0|||
106105211|NCT00608582|366041194|FG000|Overall Study|No Best Response in Phase 1 located|1|||
106105212|NCT00608582|366041195|FG001|Overall Study|No Best Response in Phase 1 located|1|||
106105213|NCT00608582|366041194|FG000|Overall Study|Illicit Drug Use|1|||
106105214|NCT00608582|366041195|FG001|Overall Study|Illicit Drug Use|0|||
106105215|NCT00608582|366041194|FG000|Overall Study|Early stage Design Change|0|||
106105216|NCT00608582|366041195|FG001|Overall Study|Early stage Design Change|3|||
106105217|NCT02943408|366041196|FG000|Overall Study|Lost to Follow-up|7|||
106105218|NCT02943408|366041197|FG001|Overall Study|Lost to Follow-up|1|||
106105219|NCT02943408|366041196|FG000|Overall Study|Withdrawal by Subject|0|||
106105220|NCT02943408|366041197|FG001|Overall Study|Withdrawal by Subject|1|||
106105221|NCT00886340|366041202|FG000|Overall Study|Withdrawal by Subject|0|||
106105222|NCT00886340|366041203|FG001|Overall Study|Withdrawal by Subject|7|||
106105223|NCT02338154|366041204|FG000|Overall Study|Death|46|||
106105224|NCT02338154|366041204|FG000|Overall Study|Valve Implant Failure|17|||
106105225|NCT02338154|366041204|FG000|Overall Study|Valve Explant|11|||
106105226|NCT02338154|366041204|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
106105227|NCT02338154|366041204|FG000|Overall Study|Lost to Follow-up|8|||
106105228|NCT02338154|366041204|FG000|Overall Study|Other Reason|3|||
106105229|NCT02338154|366041204|FG000|Overall Study|Patients Without Exit Form|47|||
106105230|NCT02338154|366041204|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
106105231|NCT02120027|366041205|FG000|Overall Study|Adverse Event|4|||
106105232|NCT02120027|366041206|FG001|Overall Study|Adverse Event|5|||
106105233|NCT02120027|366041205|FG000|Overall Study|Lack of Efficacy|3|||
106105234|NCT02120027|366041206|FG001|Overall Study|Lack of Efficacy|5|||
106105235|NCT02120027|366041205|FG000|Overall Study|Lost to Follow-up|5|||
106105236|NCT02120027|366041206|FG001|Overall Study|Lost to Follow-up|13|||
106105237|NCT02120027|366041205|FG000|Overall Study|Other|4|||
106105238|NCT02120027|366041206|FG001|Overall Study|Other|0|||
106105239|NCT02120027|366041205|FG000|Overall Study|Physician Decision|4|||
106105240|NCT02120027|366041206|FG001|Overall Study|Physician Decision|3|||
106105241|NCT02120027|366041205|FG000|Overall Study|Protocol Violation|18|||
106105242|NCT02120027|366041206|FG001|Overall Study|Protocol Violation|21|||
106105243|NCT02120027|366041205|FG000|Overall Study|Study terminated by Sponsor|45|||
106105244|NCT02120027|366041206|FG001|Overall Study|Study terminated by Sponsor|47|||
106105245|NCT02120027|366041205|FG000|Overall Study|Withdrawal by Subject|33|||
106105246|NCT02120027|366041206|FG001|Overall Study|Withdrawal by Subject|25|||
106105247|NCT01559844|366041213|FG000|Overall Study|Consent Withdrawn|7|||
106105248|NCT01559844|366041213|FG000|Overall Study|Death|5|||
106105249|NCT01559844|366041213|FG000|Overall Study|Efficacy Failure|10|||
106105250|NCT01559844|366041213|FG000|Overall Study|No Longer A Transplant Candidate|3|||
106105251|NCT01514448|366041214|FG000|Overall Study|Death|7|||
106105252|NCT01514448|366041215|FG001|Overall Study|Death|8|||
106105253|NCT01514448|366041214|FG000|Overall Study|Withdrawal by Subject|2|||
106105254|NCT01514448|366041215|FG001|Overall Study|Withdrawal by Subject|0|||
106105255|NCT01514448|366041214|FG000|Overall Study|Lost to Follow-up|2|||
106105256|NCT01514448|366041215|FG001|Overall Study|Lost to Follow-up|0|||
106105257|NCT01514448|366041214|FG000|Overall Study|New Cancer Therapy|1|||
106105258|NCT01514448|366041215|FG001|Overall Study|New Cancer Therapy|0|||
106105259|NCT02314624|366041219|FG000|Overall Study|No participating patient|16|||
106105260|NCT02314624|366041220|FG001|Overall Study|No participating patient|13|||
106105261|NCT02314624|366041219|FG000|Overall Study|Participant withdrew|7|||
106105262|NCT02314624|366041220|FG001|Overall Study|Participant withdrew|2|||
106105263|NCT02314624|366041219|FG000|Overall Study|Lost to Follow-up|2|||
106105264|NCT02314624|366041220|FG001|Overall Study|Lost to Follow-up|5|||
106105265|NCT02314624|366041219|FG000|Overall Study|Dropped/Excluded by PI|6|||
106105266|NCT02314624|366041220|FG001|Overall Study|Dropped/Excluded by PI|6|||
106105267|NCT02131272|366041221|FG000|Overall Study|Withdrawal by parent|0|||
106105268|NCT02131272|366041222|FG001|Overall Study|Withdrawal by parent|1|||
106105269|NCT02131272|366041221|FG000|Overall Study|Withdrawal by Subject|0|||
106105270|NCT02131272|366041222|FG001|Overall Study|Withdrawal by Subject|1|||
106105271|NCT02131272|366041221|FG000|Overall Study|Withdrawal Criteria|1|||
106105272|NCT02131272|366041222|FG001|Overall Study|Withdrawal Criteria|0|||
106105273|NCT01925950|366041223|FG000|Part 2|Withdrawal by Subject|1|||
106105274|NCT01925950|366041224|FG001|Part 2|Withdrawal by Subject|0|||
106105275|NCT00381940|366041227|FG000|Overall Study|Lack of Efficacy|3|||
106105276|NCT00381940|366041227|FG000|Overall Study|Protocol Violation|1|||
106105277|NCT00381940|366041227|FG000|Overall Study|Ineligible|1|||
106105278|NCT03137303|366041229|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
106105279|NCT03137303|366041230|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
106105280|NCT03137303|366041229|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
106105281|NCT03137303|366041230|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
106105282|NCT03137303|366041229|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
106105283|NCT03137303|366041230|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
106105284|NCT03137303|366041229|FG000|T3: 9-month Follow-up|Death|1|||
106105285|NCT03137303|366041230|FG001|T3: 9-month Follow-up|Death|0|||
106105286|NCT03137303|366041229|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
106105287|NCT03137303|366041230|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
106105288|NCT03137303|366041229|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
106105289|NCT03137303|366041230|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
106105290|NCT03137303|366041229|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
106105291|NCT03137303|366041230|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
106105292|NCT03318523|366041231|FG000|PC Period: Up to Year 1|Adverse Event|1|||
106105293|NCT03318523|366041232|FG001|PC Period: Up to Year 1|Adverse Event|0|||
106105294|NCT03318523|366041233|FG002|PC Period: Up to Year 1|Adverse Event|2|||
106105295|NCT03318523|366041234|FG003|PC Period: Up to Year 1|Adverse Event|0|||
106105296|NCT03318523|366041235|FG004|PC Period: Up to Year 1|Adverse Event|0|||
106105297|NCT03318523|366041236|FG005|PC Period: Up to Year 1|Adverse Event|0|||
106105298|NCT03318523|366041237|FG006|PC Period: Up to Year 1|Adverse Event|0|||
106105299|NCT03318523|366041238|FG007|PC Period: Up to Year 1|Adverse Event|0|||
106105300|NCT03318523|366041239|FG008|PC Period: Up to Year 1|Adverse Event|0|||
106105301|NCT03318523|366041240|FG009|PC Period: Up to Year 1|Adverse Event|0|||
106105302|NCT03318523|366041231|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
106105303|NCT03318523|366041232|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
106105304|NCT03318523|366041233|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
106105305|NCT03318523|366041234|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
106105306|NCT03318523|366041235|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
106105307|NCT03318523|366041236|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
106105308|NCT03318523|366041237|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
106105309|NCT03318523|366041238|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
106105310|NCT03318523|366041239|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
106105311|NCT03318523|366041240|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
106105312|NCT03318523|366041231|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
106105313|NCT03318523|366041232|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
106105314|NCT03318523|366041233|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
106105315|NCT03318523|366041234|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
106105316|NCT03318523|366041235|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
106105317|NCT03318523|366041236|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
106105318|NCT03318523|366041237|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
106105319|NCT03318523|366041238|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
106105320|NCT03318523|366041239|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
106105321|NCT03318523|366041240|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
106105322|NCT03318523|366041231|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
106105323|NCT03318523|366041232|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
106105324|NCT03318523|366041233|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
106105325|NCT03318523|366041234|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
106105326|NCT03318523|366041235|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
106105327|NCT03318523|366041236|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
106105328|NCT03318523|366041237|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
106105329|NCT03318523|366041238|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
106105330|NCT03318523|366041239|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
106105331|NCT03318523|366041240|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
106105332|NCT03318523|366041231|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105333|NCT03318523|366041232|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105334|NCT03318523|366041233|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105335|NCT03318523|366041234|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105336|NCT03318523|366041235|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105337|NCT03318523|366041236|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
106105338|NCT03318523|366041237|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105339|NCT03318523|366041238|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105340|NCT03318523|366041239|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105341|NCT03318523|366041240|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
106105342|NCT03318523|366041231|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105343|NCT03318523|366041232|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105344|NCT03318523|366041233|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105345|NCT03318523|366041234|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105346|NCT03318523|366041235|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105347|NCT03318523|366041236|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105348|NCT03318523|366041237|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105349|NCT03318523|366041238|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105350|NCT03318523|366041239|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
106105351|NCT03318523|366041240|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
106105352|NCT03318523|366041231|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
106105353|NCT03318523|366041232|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
106105354|NCT03318523|366041233|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
106105355|NCT03318523|366041234|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
106105356|NCT03318523|366041235|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
106105357|NCT03318523|366041236|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
106105358|NCT03318523|366041237|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
106105359|NCT03318523|366041238|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
106105360|NCT03318523|366041239|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
106105361|NCT03318523|366041240|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
106105362|NCT03318523|366041231|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
106105363|NCT03318523|366041232|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
106105364|NCT03318523|366041233|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
106105365|NCT03318523|366041234|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
106105366|NCT03318523|366041235|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
106105367|NCT03318523|366041236|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
106105368|NCT03318523|366041237|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
106105369|NCT03318523|366041238|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
106105370|NCT03318523|366041239|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
106105371|NCT03318523|366041240|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
106105372|NCT00725452|366041241|FG000|Overall Study|Adverse Event|3|||
106105373|NCT00725452|366041241|FG000|Overall Study|Lack of Efficacy|2|||
106105374|NCT00725452|366041241|FG000|Overall Study|Reason not specified|1|||
106105375|NCT00725452|366041241|FG000|Overall Study|Physician Decision|1|||
106105376|NCT00725452|366041241|FG000|Overall Study|Withdrawal by Subject|3|||
105781751|NCT01858701|364854834|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
106105377|NCT00725452|366041241|FG000|Overall Study|Lost to Follow-up|1|||
106105378|NCT02723864|366041242|FG000|Overall Study|Refused further treatment|1|||
106105379|NCT02723864|366041243|FG001|Overall Study|Refused further treatment|0|||
106105380|NCT02723864|366041244|FG002|Overall Study|Refused further treatment|0|||
106105381|NCT02723864|366041245|FG003|Overall Study|Refused further treatment|0|||
106105382|NCT02723864|366041246|FG004|Overall Study|Refused further treatment|1|||
106105383|NCT02723864|366041247|FG005|Overall Study|Refused further treatment|2|||
106105384|NCT02723864|366041248|FG006|Overall Study|Refused further treatment|0|||
106105385|NCT02723864|366041242|FG000|Overall Study|Exceed treatment hold time|0|||
106105386|NCT02723864|366041243|FG001|Overall Study|Exceed treatment hold time|1|||
106105387|NCT02723864|366041244|FG002|Overall Study|Exceed treatment hold time|0|||
106105388|NCT02723864|366041245|FG003|Overall Study|Exceed treatment hold time|0|||
106105389|NCT02723864|366041246|FG004|Overall Study|Exceed treatment hold time|0|||
106105390|NCT02723864|366041247|FG005|Overall Study|Exceed treatment hold time|0|||
106105391|NCT02723864|366041248|FG006|Overall Study|Exceed treatment hold time|0|||
106105392|NCT02723864|366041242|FG000|Overall Study|Clinical progression|0|||
106105393|NCT02723864|366041243|FG001|Overall Study|Clinical progression|0|||
106105394|NCT02723864|366041244|FG002|Overall Study|Clinical progression|1|||
106105395|NCT02723864|366041245|FG003|Overall Study|Clinical progression|0|||
106105396|NCT02723864|366041246|FG004|Overall Study|Clinical progression|0|||
106105397|NCT02723864|366041247|FG005|Overall Study|Clinical progression|3|||
106105398|NCT02723864|366041248|FG006|Overall Study|Clinical progression|1|||
106105399|NCT02723864|366041242|FG000|Overall Study|Physician Decision|0|||
106105400|NCT02723864|366041243|FG001|Overall Study|Physician Decision|0|||
106105401|NCT02723864|366041244|FG002|Overall Study|Physician Decision|0|||
106105402|NCT02723864|366041245|FG003|Overall Study|Physician Decision|0|||
106105403|NCT02723864|366041246|FG004|Overall Study|Physician Decision|0|||
106105404|NCT02723864|366041247|FG005|Overall Study|Physician Decision|0|||
106105405|NCT02723864|366041248|FG006|Overall Study|Physician Decision|1|||
106105406|NCT02723864|366041242|FG000|Overall Study|Changes in patient condition|0|||
106105407|NCT02723864|366041243|FG001|Overall Study|Changes in patient condition|0|||
106105408|NCT02723864|366041244|FG002|Overall Study|Changes in patient condition|0|||
106105409|NCT02723864|366041245|FG003|Overall Study|Changes in patient condition|0|||
106105410|NCT02723864|366041246|FG004|Overall Study|Changes in patient condition|0|||
106105411|NCT02723864|366041247|FG005|Overall Study|Changes in patient condition|1|||
106105412|NCT02723864|366041248|FG006|Overall Study|Changes in patient condition|0|||
106105413|NCT02723864|366041242|FG000|Overall Study|Patient choice|0|||
106105414|NCT02723864|366041243|FG001|Overall Study|Patient choice|0|||
106105415|NCT02723864|366041244|FG002|Overall Study|Patient choice|0|||
106105416|NCT02723864|366041245|FG003|Overall Study|Patient choice|0|||
106105417|NCT02723864|366041246|FG004|Overall Study|Patient choice|0|||
106105418|NCT02723864|366041247|FG005|Overall Study|Patient choice|1|||
106105419|NCT02723864|366041248|FG006|Overall Study|Patient choice|0|||
106105420|NCT02723864|366041242|FG000|Overall Study|Adverse Event|0|||
106105421|NCT02723864|366041243|FG001|Overall Study|Adverse Event|0|||
106105422|NCT02723864|366041244|FG002|Overall Study|Adverse Event|0|||
106105423|NCT02723864|366041245|FG003|Overall Study|Adverse Event|0|||
106105424|NCT02723864|366041246|FG004|Overall Study|Adverse Event|0|||
106105425|NCT02723864|366041247|FG005|Overall Study|Adverse Event|1|||
106105426|NCT02723864|366041248|FG006|Overall Study|Adverse Event|0|||
106105427|NCT02723864|366041242|FG000|Overall Study|Started new treatment|0|||
106105428|NCT02723864|366041243|FG001|Overall Study|Started new treatment|0|||
106105429|NCT02723864|366041244|FG002|Overall Study|Started new treatment|0|||
106105430|NCT02723864|366041245|FG003|Overall Study|Started new treatment|0|||
106105431|NCT02723864|366041246|FG004|Overall Study|Started new treatment|0|||
106105432|NCT02723864|366041247|FG005|Overall Study|Started new treatment|1|||
106105433|NCT02723864|366041248|FG006|Overall Study|Started new treatment|0|||
106105434|NCT02723864|366041242|FG000|Overall Study|Switched to alternative treatment|0|||
106105435|NCT02723864|366041243|FG001|Overall Study|Switched to alternative treatment|0|||
106105436|NCT02723864|366041244|FG002|Overall Study|Switched to alternative treatment|0|||
106105437|NCT02723864|366041245|FG003|Overall Study|Switched to alternative treatment|0|||
106105438|NCT02723864|366041246|FG004|Overall Study|Switched to alternative treatment|0|||
106105439|NCT02723864|366041247|FG005|Overall Study|Switched to alternative treatment|1|||
106105440|NCT02723864|366041248|FG006|Overall Study|Switched to alternative treatment|0|||
106105441|NCT02723864|366041242|FG000|Overall Study|Late determination of ineligibility|0|||
106105442|NCT02723864|366041243|FG001|Overall Study|Late determination of ineligibility|0|||
106105443|NCT02723864|366041244|FG002|Overall Study|Late determination of ineligibility|0|||
106105444|NCT02723864|366041245|FG003|Overall Study|Late determination of ineligibility|0|||
106105445|NCT02723864|366041246|FG004|Overall Study|Late determination of ineligibility|0|||
106105446|NCT02723864|366041247|FG005|Overall Study|Late determination of ineligibility|1|||
106105447|NCT02723864|366041248|FG006|Overall Study|Late determination of ineligibility|0|||
106105448|NCT04465357|366041249|FG000|Overall Study|Adverse Event|2|||
106105449|NCT04465357|366041249|FG000|Overall Study|Lack of Efficacy|1|||
106105450|NCT04465357|366041249|FG000|Overall Study|Lost to Follow-up|2|||
106105451|NCT04465357|366041249|FG000|Overall Study|Withdrawal by Subject|6|||
106144081|NCT01317420|366186952|FG003|Overall Study|Other adverse event|0|||
105781752|NCT01858701|364854835|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
105781753|NCT01858701|364854834|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
105781754|NCT01858701|364854835|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
105781755|NCT01858701|364854834|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
105781756|NCT01858701|364854835|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
105781757|NCT02079077|364854837|FG000|Overall Study|Lost to Follow-up|5|||
105781758|NCT02079077|364854838|FG001|Overall Study|Lost to Follow-up|7|||
105781759|NCT02079077|364854837|FG000|Overall Study|Became STIs Positive|1|||
105781760|NCT02079077|364854838|FG001|Overall Study|Became STIs Positive|2|||
105781761|NCT01270139|364854840|FG000|Overall Study|Adverse Event|8|||
106105452|NCT04465357|366041249|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
105781762|NCT01270139|364854841|FG001|Overall Study|Adverse Event|17|||
105781763|NCT01270139|364854842|FG002|Overall Study|Adverse Event|18|||
105781764|NCT01270139|364854840|FG000|Overall Study|Lost to Follow-up|10|||
105781765|NCT01270139|364854841|FG001|Overall Study|Lost to Follow-up|9|||
105781766|NCT01270139|364854842|FG002|Overall Study|Lost to Follow-up|2|||
105781767|NCT03704194|364854845|FG000|Overall Study|Withdrawal by Subject|0|||
105781768|NCT03704194|364854846|FG001|Overall Study|Withdrawal by Subject|1|||
105781769|NCT01072175|364854847|FG000|Part A (Drug-Drug Interaction)|Death|1|||
105781770|NCT01072175|364854848|FG001|Part A (Drug-Drug Interaction)|Death|0|||
105781771|NCT01072175|364854849|FG002|Part A (Drug-Drug Interaction)|Death|0|||
105781772|NCT01072175|364854850|FG003|Part A (Drug-Drug Interaction)|Death|0|||
105781773|NCT01072175|364854851|FG004|Part A (Drug-Drug Interaction)|Death|0|||
105781774|NCT01072175|364854852|FG005|Part A (Drug-Drug Interaction)|Death|0|||
105781775|NCT01072175|364854853|FG006|Part A (Drug-Drug Interaction)|Death|0|||
105781776|NCT01072175|364854854|FG007|Part A (Drug-Drug Interaction)|Death|0|||
105781777|NCT01072175|364854855|FG008|Part A (Drug-Drug Interaction)|Death|0|||
105781778|NCT01072175|364854856|FG009|Part A (Drug-Drug Interaction)|Death|0|||
105781779|NCT01072175|364854857|FG010|Part A (Drug-Drug Interaction)|Death|0|||
105781780|NCT01072175|364854858|FG011|Part A (Drug-Drug Interaction)|Death|0|||
105781781|NCT01072175|364854859|FG012|Part A (Drug-Drug Interaction)|Death|0|||
105781782|NCT01072175|364854847|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
105781783|NCT01072175|364854848|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781784|NCT01072175|364854849|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781785|NCT01072175|364854850|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781786|NCT01072175|364854851|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781787|NCT01072175|364854852|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781788|NCT01072175|364854853|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781789|NCT01072175|364854854|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781790|NCT01072175|364854855|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781791|NCT01072175|364854856|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781792|NCT01072175|364854857|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781793|NCT01072175|364854858|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781794|NCT01072175|364854859|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
105781795|NCT01072175|364854847|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
105781796|NCT01072175|364854848|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781797|NCT01072175|364854849|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781798|NCT01072175|364854850|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781799|NCT01072175|364854851|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781800|NCT01072175|364854852|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781801|NCT01072175|364854853|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781802|NCT01072175|364854854|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781803|NCT01072175|364854855|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781804|NCT01072175|364854856|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781805|NCT01072175|364854857|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781806|NCT01072175|364854858|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781807|NCT01072175|364854859|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
105781808|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
105781809|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
105992688|NCT00042991|365631613|FG006|Overall Study|Adverse Event|0|||
106105453|NCT00464815|366041250|FG000|Overall Study|Withdrawal by Subject|6|||
106105454|NCT00464815|366041251|FG001|Overall Study|Withdrawal by Subject|3|||
106105455|NCT00831779|366041256|FG000|Overall Study|Lost to Follow-up|1|||
106105456|NCT00831779|366041257|FG001|Overall Study|Lost to Follow-up|0|||
106105457|NCT00831779|366041256|FG000|Overall Study|No longer met criteria|0|||
106105458|NCT00831779|366041257|FG001|Overall Study|No longer met criteria|1|||
106105459|NCT02219048|366041266|FG000|Overall Study|Adverse Event|2|||
106105460|NCT02219048|366041267|FG001|Overall Study|Adverse Event|5|||
106105461|NCT02219048|366041266|FG000|Overall Study|No longer meets eligibility criteria|1|||
106105462|NCT02219048|366041267|FG001|Overall Study|No longer meets eligibility criteria|0|||
106105463|NCT02219048|366041266|FG000|Overall Study|Study terminated by sponsor|16|||
105992689|NCT00042991|365631607|FG000|Overall Study|Withdrawal by Subject|0|||
106105464|NCT02219048|366041267|FG001|Overall Study|Study terminated by sponsor|15|||
106105465|NCT02219048|366041266|FG000|Overall Study|Withdrawal by Subject|2|||
106105466|NCT02219048|366041267|FG001|Overall Study|Withdrawal by Subject|0|||
106105467|NCT02219048|366041266|FG000|Overall Study|Other|0|||
106105468|NCT02219048|366041267|FG001|Overall Study|Other|1|||
106105469|NCT04794803|366041268|FG000|Overall Study|Death|1|||
106105470|NCT04794803|366041269|FG001|Overall Study|Death|3|||
106105471|NCT04794803|366041268|FG000|Overall Study|Lost to Follow-up|2|||
106105472|NCT04794803|366041269|FG001|Overall Study|Lost to Follow-up|2|||
106105473|NCT04794803|366041268|FG000|Overall Study|Withdrawal by Subject|1|||
106105474|NCT04794803|366041269|FG001|Overall Study|Withdrawal by Subject|0|||
106105475|NCT04794803|366041268|FG000|Overall Study|Physician Decision|1|||
106105476|NCT04794803|366041269|FG001|Overall Study|Physician Decision|1|||
106105477|NCT04794803|366041268|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
106105478|NCT04794803|366041269|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
106105479|NCT04794803|366041268|FG000|Overall Study|Refused to continue the treatment|1|||
106105480|NCT04794803|366041269|FG001|Overall Study|Refused to continue the treatment|0|||
106105481|NCT04794803|366041268|FG000|Overall Study|Patient admitted to ICU|0|||
106105482|NCT04794803|366041269|FG001|Overall Study|Patient admitted to ICU|1|||
106105483|NCT04124926|366041270|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
106105484|NCT04124926|366041271|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
106105485|NCT04124926|366041272|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
106105486|NCT04124926|366041273|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
106105487|NCT04124926|366041274|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
106105488|NCT04124926|366041270|FG000|Healing Phase|Protocol Violation|0|||
106105489|NCT04124926|366041271|FG001|Healing Phase|Protocol Violation|1|||
106105490|NCT04124926|366041272|FG002|Healing Phase|Protocol Violation|0|||
106105491|NCT04124926|366041273|FG003|Healing Phase|Protocol Violation|0|||
106105492|NCT04124926|366041274|FG004|Healing Phase|Protocol Violation|0|||
106105493|NCT04124926|366041270|FG000|Healing Phase|Lost to Follow-up|5|||
106105494|NCT04124926|366041271|FG001|Healing Phase|Lost to Follow-up|4|||
106105495|NCT04124926|366041272|FG002|Healing Phase|Lost to Follow-up|0|||
106105496|NCT04124926|366041273|FG003|Healing Phase|Lost to Follow-up|0|||
106105497|NCT04124926|366041274|FG004|Healing Phase|Lost to Follow-up|0|||
106105498|NCT04124926|366041270|FG000|Healing Phase|Voluntary Withdrawal|10|||
106105499|NCT04124926|366041271|FG001|Healing Phase|Voluntary Withdrawal|7|||
106105500|NCT04124926|366041272|FG002|Healing Phase|Voluntary Withdrawal|0|||
106105501|NCT04124926|366041273|FG003|Healing Phase|Voluntary Withdrawal|0|||
106105502|NCT04124926|366041274|FG004|Healing Phase|Voluntary Withdrawal|0|||
106105503|NCT04124926|366041270|FG000|Healing Phase|Withdrawal of Consent|5|||
106105504|NCT04124926|366041271|FG001|Healing Phase|Withdrawal of Consent|3|||
106105505|NCT04124926|366041272|FG002|Healing Phase|Withdrawal of Consent|0|||
106105506|NCT04124926|366041273|FG003|Healing Phase|Withdrawal of Consent|0|||
106105507|NCT04124926|366041274|FG004|Healing Phase|Withdrawal of Consent|0|||
106105508|NCT04124926|366041270|FG000|Healing Phase|Miscellaneous|8|||
106105509|NCT04124926|366041271|FG001|Healing Phase|Miscellaneous|7|||
106105510|NCT04124926|366041272|FG002|Healing Phase|Miscellaneous|0|||
106105511|NCT04124926|366041273|FG003|Healing Phase|Miscellaneous|0|||
106105512|NCT04124926|366041274|FG004|Healing Phase|Miscellaneous|0|||
106105513|NCT04124926|366041270|FG000|Healing Phase|Randomized but not Treated|0|||
106105514|NCT04124926|366041271|FG001|Healing Phase|Randomized but not Treated|3|||
106105515|NCT04124926|366041272|FG002|Healing Phase|Randomized but not Treated|0|||
106105516|NCT04124926|366041273|FG003|Healing Phase|Randomized but not Treated|0|||
106105517|NCT04124926|366041274|FG004|Healing Phase|Randomized but not Treated|0|||
106105518|NCT04124926|366041270|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
106105519|NCT04124926|366041271|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
106105520|NCT04124926|366041272|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
106105521|NCT04124926|366041273|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
106105522|NCT04124926|366041274|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
106105523|NCT04124926|366041270|FG000|Maintenance Phase|Protocol Violation|0|||
106105524|NCT04124926|366041271|FG001|Maintenance Phase|Protocol Violation|0|||
106105525|NCT04124926|366041272|FG002|Maintenance Phase|Protocol Violation|3|||
106105526|NCT04124926|366041273|FG003|Maintenance Phase|Protocol Violation|0|||
106105527|NCT04124926|366041274|FG004|Maintenance Phase|Protocol Violation|0|||
106105528|NCT04124926|366041270|FG000|Maintenance Phase|Lost to Follow-up|0|||
106105529|NCT04124926|366041271|FG001|Maintenance Phase|Lost to Follow-up|0|||
106105530|NCT04124926|366041272|FG002|Maintenance Phase|Lost to Follow-up|7|||
106105531|NCT04124926|366041273|FG003|Maintenance Phase|Lost to Follow-up|8|||
106105532|NCT04124926|366041274|FG004|Maintenance Phase|Lost to Follow-up|9|||
106105533|NCT04124926|366041270|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
106105534|NCT04124926|366041271|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
106105535|NCT04124926|366041272|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
106105536|NCT04124926|366041273|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
106105537|NCT04124926|366041274|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
106105538|NCT04124926|366041270|FG000|Maintenance Phase|Pregnancy|0|||
106105539|NCT04124926|366041271|FG001|Maintenance Phase|Pregnancy|0|||
106105540|NCT04124926|366041272|FG002|Maintenance Phase|Pregnancy|0|||
106105541|NCT04124926|366041273|FG003|Maintenance Phase|Pregnancy|1|||
106105542|NCT04124926|366041274|FG004|Maintenance Phase|Pregnancy|0|||
106105543|NCT04124926|366041270|FG000|Maintenance Phase|Lack of Efficacy|0|||
106105544|NCT04124926|366041271|FG001|Maintenance Phase|Lack of Efficacy|0|||
106105545|NCT04124926|366041272|FG002|Maintenance Phase|Lack of Efficacy|0|||
105781810|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
105781811|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
105781812|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
105781813|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
105781814|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
105781815|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
105781816|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
105781817|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
105781818|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
105781819|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
105781820|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
105781821|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781822|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781823|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
105781824|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781825|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
105781826|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781827|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781828|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781829|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781830|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781831|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781832|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781833|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
105781834|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781835|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
105781836|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781837|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
105781838|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
105781839|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781840|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781841|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781842|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781843|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781844|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781845|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781846|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
105781847|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781848|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781849|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
105781850|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
105781851|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
105781852|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781853|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781854|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781855|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105878758|NCT01120184|365209744|FG002|Overall Study|Physician Decision|3|||
106105546|NCT04124926|366041273|FG003|Maintenance Phase|Lack of Efficacy|0|||
106105547|NCT04124926|366041274|FG004|Maintenance Phase|Lack of Efficacy|1|||
106105548|NCT04124926|366041270|FG000|Maintenance Phase|Withdrawal of Consent|0|||
106105549|NCT04124926|366041271|FG001|Maintenance Phase|Withdrawal of Consent|0|||
106105550|NCT04124926|366041272|FG002|Maintenance Phase|Withdrawal of Consent|5|||
106105551|NCT04124926|366041273|FG003|Maintenance Phase|Withdrawal of Consent|5|||
106105552|NCT04124926|366041274|FG004|Maintenance Phase|Withdrawal of Consent|5|||
106105553|NCT04124926|366041270|FG000|Maintenance Phase|Miscellaneous|0|||
106105554|NCT04124926|366041271|FG001|Maintenance Phase|Miscellaneous|0|||
106105555|NCT04124926|366041272|FG002|Maintenance Phase|Miscellaneous|1|||
106105556|NCT04124926|366041273|FG003|Maintenance Phase|Miscellaneous|2|||
106105557|NCT04124926|366041274|FG004|Maintenance Phase|Miscellaneous|4|||
106105558|NCT04124926|366041270|FG000|Maintenance Phase|Randomized but not Treated|0|||
106105559|NCT04124926|366041271|FG001|Maintenance Phase|Randomized but not Treated|0|||
106105560|NCT04124926|366041272|FG002|Maintenance Phase|Randomized but not Treated|2|||
106105561|NCT04124926|366041273|FG003|Maintenance Phase|Randomized but not Treated|2|||
106105562|NCT04124926|366041274|FG004|Maintenance Phase|Randomized but not Treated|0|||
106105563|NCT00338884|366041275|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
106105564|NCT00338884|366041275|FG000|Overall Study|Adverse Event|14|||
106105565|NCT00338884|366041275|FG000|Overall Study|Death|8|||
106105566|NCT00338884|366041275|FG000|Overall Study|Other|4|||
106105567|NCT00338884|366041275|FG000|Overall Study|Global Deterioration of Health Status|3|||
106105568|NCT00338884|366041275|FG000|Overall Study|Withdrawal by Subject|3|||
106105569|NCT00338884|366041275|FG000|Overall Study|Lost to Follow-up|1|||
106105570|NCT00338884|366041275|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
106105571|NCT00911534|366041277|FG000|Overall Study|Adverse Event|4|||
106105572|NCT00911534|366041278|FG001|Overall Study|Adverse Event|4|||
106105573|NCT00911534|366041277|FG000|Overall Study|Lost to Follow-up|2|||
106105574|NCT00911534|366041278|FG001|Overall Study|Lost to Follow-up|4|||
106105575|NCT00911534|366041277|FG000|Overall Study|Withdrawal by Subject|2|||
106105576|NCT00911534|366041278|FG001|Overall Study|Withdrawal by Subject|1|||
106105577|NCT00911534|366041277|FG000|Overall Study|Lack of Efficacy|4|||
106105578|NCT00911534|366041278|FG001|Overall Study|Lack of Efficacy|1|||
106105579|NCT00911534|366041277|FG000|Overall Study|Withdrawal of consent|1|||
106105580|NCT00911534|366041278|FG001|Overall Study|Withdrawal of consent|4|||
106105581|NCT00911534|366041277|FG000|Overall Study|Other|2|||
106105582|NCT00911534|366041278|FG001|Overall Study|Other|2|||
106105583|NCT01970982|366041279|FG000|Overall Study|Withdrawal by Subject|0|||
106105584|NCT01970982|366041280|FG001|Overall Study|Withdrawal by Subject|0|||
106105585|NCT01970982|366041281|FG002|Overall Study|Withdrawal by Subject|2|||
106105586|NCT03896035|366041282|FG000|Overall Study|Lost to Follow-up|2|||
106105587|NCT03896035|366041283|FG001|Overall Study|Lost to Follow-up|6|||
106105588|NCT03896035|366041282|FG000|Overall Study|Withdrawal by Subject|0|||
106105589|NCT03896035|366041283|FG001|Overall Study|Withdrawal by Subject|1|||
106105590|NCT03896035|366041282|FG000|Overall Study|Health/family health issues during COVID|0|||
106105591|NCT03896035|366041283|FG001|Overall Study|Health/family health issues during COVID|4|||
106105592|NCT00743366|366041284|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
106105593|NCT00743366|366041285|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
106105594|NCT00335322|366041286|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
106105595|NCT00335322|366041287|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
106105596|NCT00335322|366041288|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
106105597|NCT00951483|366041289|FG000|Overall Study|Physician Decision|4|||
106105598|NCT00951483|366041290|FG001|Overall Study|Physician Decision|0|||
106105599|NCT00951483|366041289|FG000|Overall Study|Withdrawal by Subject|15|||
106105600|NCT00951483|366041290|FG001|Overall Study|Withdrawal by Subject|0|||
106105601|NCT04393441|366041291|FG000|Overall Study|Adverse Event|0|||
106105602|NCT04393441|366041292|FG001|Overall Study|Adverse Event|3|||
106105603|NCT04393441|366041291|FG000|Overall Study|Withdrawal by Subject|5|||
106105604|NCT04393441|366041292|FG001|Overall Study|Withdrawal by Subject|7|||
106105605|NCT04393441|366041291|FG000|Overall Study|Lost to Follow-up|0|||
106105606|NCT04393441|366041292|FG001|Overall Study|Lost to Follow-up|2|||
106105607|NCT04393441|366041291|FG000|Overall Study|Protocol Deviation|2|||
106105608|NCT04393441|366041292|FG001|Overall Study|Protocol Deviation|1|||
106105609|NCT04393441|366041291|FG000|Overall Study|Reason not Specified|1|||
106105610|NCT04393441|366041292|FG001|Overall Study|Reason not Specified|1|||
106105611|NCT03364751|366041293|FG000|Overall Study|Withdrawal by Subject|1|||
106105612|NCT03364751|366041294|FG001|Overall Study|Withdrawal by Subject|0|||
106105613|NCT03364751|366041295|FG002|Overall Study|Withdrawal by Subject|0|||
106105614|NCT03364751|366041296|FG003|Overall Study|Withdrawal by Subject|0|||
106105615|NCT03364751|366041293|FG000|Overall Study|Lost to Follow-up|0|||
106105616|NCT03364751|366041294|FG001|Overall Study|Lost to Follow-up|1|||
106105617|NCT03364751|366041295|FG002|Overall Study|Lost to Follow-up|0|||
106105618|NCT03364751|366041296|FG003|Overall Study|Lost to Follow-up|0|||
106105619|NCT01994954|366041297|FG000|Overall Study|Death|1|||
106105620|NCT01994954|366041298|FG001|Overall Study|Death|0|||
106105621|NCT01994954|366041297|FG000|Overall Study|Withdrawal by Subject|9|||
106105622|NCT01994954|366041298|FG001|Overall Study|Withdrawal by Subject|14|||
106105623|NCT01994954|366041297|FG000|Overall Study|Physician Decision|2|||
106105624|NCT01994954|366041298|FG001|Overall Study|Physician Decision|2|||
106105625|NCT01994954|366041297|FG000|Overall Study|Lost to Follow-up|8|||
106105626|NCT01994954|366041298|FG001|Overall Study|Lost to Follow-up|10|||
106105627|NCT01994954|366041297|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
106105628|NCT01994954|366041298|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
106105629|NCT00449176|366041299|FG000|Overall Study|Withdrawal by Subject|39|||
106105630|NCT00449176|366041300|FG001|Overall Study|Withdrawal by Subject|43|||
106105631|NCT00449176|366041301|FG002|Overall Study|Withdrawal by Subject|59|||
106105632|NCT00449176|366041299|FG000|Overall Study|Lost to Follow-up|13|||
106105633|NCT00449176|366041300|FG001|Overall Study|Lost to Follow-up|8|||
106105634|NCT00449176|366041301|FG002|Overall Study|Lost to Follow-up|12|||
106105635|NCT00449176|366041299|FG000|Overall Study|Adverse Event|51|||
106105636|NCT00449176|366041300|FG001|Overall Study|Adverse Event|107|||
106105637|NCT00449176|366041301|FG002|Overall Study|Adverse Event|15|||
106105638|NCT00449176|366041299|FG000|Overall Study|Lack of Efficacy|13|||
106105639|NCT00449176|366041300|FG001|Overall Study|Lack of Efficacy|7|||
106105640|NCT00449176|366041301|FG002|Overall Study|Lack of Efficacy|50|||
106105641|NCT00449176|366041299|FG000|Overall Study|Study drug non-compliant|14|||
106105642|NCT00449176|366041300|FG001|Overall Study|Study drug non-compliant|11|||
106105643|NCT00449176|366041301|FG002|Overall Study|Study drug non-compliant|11|||
106105644|NCT00449176|366041299|FG000|Overall Study|all other|22|||
106105645|NCT00449176|366041300|FG001|Overall Study|all other|19|||
106105646|NCT00449176|366041301|FG002|Overall Study|all other|20|||
106105647|NCT03182868|366041302|FG000|Overall Study|Protocol Violation|3|||
106105648|NCT03182868|366041303|FG001|Overall Study|Protocol Violation|0|||
106105649|NCT03182868|366041304|FG002|Overall Study|Protocol Violation|4|||
106105650|NCT03182868|366041305|FG003|Overall Study|Protocol Violation|1|||
106105651|NCT03182868|366041306|FG004|Overall Study|Protocol Violation|8|||
106105652|NCT01596582|366041307|FG000|Overall Study|Deemed ineligible after study visit|3|||
106105653|NCT01596582|366041308|FG001|Overall Study|Deemed ineligible after study visit|6|||
106105654|NCT01596582|366041307|FG000|Overall Study|Missing all outcome data|1|||
106105655|NCT01596582|366041308|FG001|Overall Study|Missing all outcome data|1|||
106105656|NCT01967732|366041309|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
106105657|NCT01967732|366041310|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
106105658|NCT01967732|366041311|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
106105659|NCT01967732|366041312|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
106105660|NCT01967732|366041309|FG000|First Intervention (Day 1)|Poor venous access|0|||
106105661|NCT01967732|366041310|FG001|First Intervention (Day 1)|Poor venous access|1|||
106105662|NCT01967732|366041311|FG002|First Intervention (Day 1)|Poor venous access|0|||
106105663|NCT01967732|366041312|FG003|First Intervention (Day 1)|Poor venous access|0|||
106105664|NCT04435665|366041315|FG000|Overall Study|Lost to Follow-up|0|||
106105665|NCT04435665|366041316|FG001|Overall Study|Lost to Follow-up|0|||
106105666|NCT04435665|366041317|FG002|Overall Study|Lost to Follow-up|0|||
106105667|NCT04435665|366041318|FG003|Overall Study|Lost to Follow-up|1|||
106105668|NCT01988779|366041319|FG000|Overall Study|Withdrawal by Subject|2|||
106105669|NCT01988779|366041320|FG001|Overall Study|Withdrawal by Subject|2|||
106105670|NCT01988779|366041319|FG000|Overall Study|Protocol Violation|1|||
106105671|NCT01988779|366041320|FG001|Overall Study|Protocol Violation|0|||
106105672|NCT04072159|366041321|FG000|Overall Study|Lost to Follow-up|6|||
106105673|NCT04072159|366041322|FG001|Overall Study|Lost to Follow-up|6|||
106105674|NCT04072159|366041321|FG000|Overall Study|Withdrawal by Subject|2|||
106105675|NCT04072159|366041322|FG001|Overall Study|Withdrawal by Subject|0|||
106105676|NCT00377403|366041327|FG000|Overall Study|Unable to contact for telephone intervie|4|||
106105677|NCT00377403|366041328|FG001|Overall Study|Unable to contact for telephone intervie|7|||
106105678|NCT02275065|366041329|FG000|Overall Study|Randomized but not treated|1|||
106105679|NCT02275065|366041330|FG001|Overall Study|Randomized but not treated|0|||
106105680|NCT02275065|366041331|FG002|Overall Study|Randomized but not treated|1|||
106105681|NCT02275065|366041332|FG003|Overall Study|Randomized but not treated|1|||
106105682|NCT02275065|366041333|FG004|Overall Study|Randomized but not treated|0|||
106105683|NCT00989287|366041334|FG000|Overall Study|Adverse Event|1|||
106105684|NCT00989287|366041335|FG001|Overall Study|Adverse Event|0|||
106105685|NCT00989287|366041334|FG000|Overall Study|Lost to Follow-up|0|||
106105686|NCT00989287|366041335|FG001|Overall Study|Lost to Follow-up|1|||
106105687|NCT00729833|366041336|FG000|Overall Study|Death|5|||
106105688|NCT00729833|366041337|FG001|Overall Study|Death|1|||
106105689|NCT00729833|366041338|FG002|Overall Study|Death|3|||
106105690|NCT00729833|366041339|FG003|Overall Study|Death|5|||
106105691|NCT00729833|366041336|FG000|Overall Study|Study Terminated by Sponsor|0|||
106105692|NCT00729833|366041337|FG001|Overall Study|Study Terminated by Sponsor|0|||
106105693|NCT00729833|366041338|FG002|Overall Study|Study Terminated by Sponsor|1|||
106105694|NCT00729833|366041339|FG003|Overall Study|Study Terminated by Sponsor|0|||
106105695|NCT00729833|366041336|FG000|Overall Study|Lost to Follow-up|1|||
106105696|NCT00729833|366041337|FG001|Overall Study|Lost to Follow-up|0|||
106105697|NCT00729833|366041338|FG002|Overall Study|Lost to Follow-up|0|||
106105698|NCT00729833|366041339|FG003|Overall Study|Lost to Follow-up|0|||
106105699|NCT00729833|366041336|FG000|Overall Study|Withdrawal by Subject|3|||
106105700|NCT00729833|366041337|FG001|Overall Study|Withdrawal by Subject|1|||
106105701|NCT00729833|366041338|FG002|Overall Study|Withdrawal by Subject|3|||
106105702|NCT00729833|366041339|FG003|Overall Study|Withdrawal by Subject|0|||
106105703|NCT00729833|366041336|FG000|Overall Study|Unspecified Reasons|11|||
106105704|NCT00729833|366041337|FG001|Overall Study|Unspecified Reasons|5|||
106105705|NCT00729833|366041338|FG002|Overall Study|Unspecified Reasons|5|||
106105706|NCT00729833|366041339|FG003|Overall Study|Unspecified Reasons|1|||
106105707|NCT03015402|366041341|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
106105708|NCT03015402|366041342|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
106105709|NCT03015402|366041341|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
106105710|NCT03015402|366041342|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
106105711|NCT03213158|366041347|FG000|Overall Study|Withdrawal by Subject|1|||
106105712|NCT03213158|366041347|FG000|Overall Study|Physician Decision|2|||
106144082|NCT01317420|366186953|FG004|Overall Study|Other adverse event|0|||
106105713|NCT00587964|366041353|FG000|Overall Study|Withdrawal by Subject|1|||
106105714|NCT00587964|366041353|FG000|Overall Study|Lost to Follow-up|1|||
106105715|NCT00587964|366041353|FG000|Overall Study|Patient found to be ineligible|1|||
106105716|NCT00587964|366041353|FG000|Overall Study|Patient did not receive intervention|5|||
106105717|NCT00587964|366041353|FG000|Overall Study|Progression of Disease|4|||
106105718|NCT00540124|366041354|FG000|Overall Study|Adverse Event|0|||
106105719|NCT00540124|366041355|FG001|Overall Study|Adverse Event|2|||
106105720|NCT00540124|366041356|FG002|Overall Study|Adverse Event|1|||
106105721|NCT00540124|366041354|FG000|Overall Study|Entry Criteria Not Met|2|||
106105722|NCT00540124|366041355|FG001|Overall Study|Entry Criteria Not Met|0|||
106105723|NCT00540124|366041356|FG002|Overall Study|Entry Criteria Not Met|0|||
106105724|NCT00540124|366041354|FG000|Overall Study|Lack of Efficacy|1|||
106105725|NCT00540124|366041355|FG001|Overall Study|Lack of Efficacy|0|||
106105726|NCT00540124|366041356|FG002|Overall Study|Lack of Efficacy|0|||
106105727|NCT00540124|366041354|FG000|Overall Study|Withdrawal by Subject|1|||
106105728|NCT00540124|366041355|FG001|Overall Study|Withdrawal by Subject|1|||
106105729|NCT00540124|366041356|FG002|Overall Study|Withdrawal by Subject|0|||
106105730|NCT01569438|366041359|FG000|Overall Study|Lack of Efficacy|1|||
106105731|NCT01569438|366041360|FG001|Overall Study|Lack of Efficacy|2|||
106105732|NCT01569438|366041359|FG000|Overall Study|Withdrawal by Subject|0|||
106105733|NCT01569438|366041360|FG001|Overall Study|Withdrawal by Subject|3|||
106105734|NCT01569438|366041359|FG000|Overall Study|Adverse Event|2|||
106105735|NCT01569438|366041360|FG001|Overall Study|Adverse Event|15|||
106105736|NCT01569438|366041359|FG000|Overall Study|Protocol Violation|2|||
106105737|NCT01569438|366041360|FG001|Overall Study|Protocol Violation|0|||
106105738|NCT01569438|366041359|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
106105739|NCT01569438|366041360|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
106105740|NCT01569438|366041359|FG000|Overall Study|Sponsor/Physician decision|1|||
106105741|NCT01569438|366041360|FG001|Overall Study|Sponsor/Physician decision|1|||
106105742|NCT01569438|366041359|FG000|Overall Study|Unable to adhere to study schedule|0|||
106105743|NCT01569438|366041360|FG001|Overall Study|Unable to adhere to study schedule|1|||
106105744|NCT01936857|366041363|FG000|Overall Study|Sent to prison or 06 center|11|||
106105745|NCT01936857|366041364|FG001|Overall Study|Sent to prison or 06 center|12|||
106105746|NCT01936857|366041363|FG000|Overall Study|Lost to Follow-up|10|||
106105747|NCT01936857|366041364|FG001|Overall Study|Lost to Follow-up|7|||
106105748|NCT01936857|366041363|FG000|Overall Study|Death|7|||
106105749|NCT01936857|366041364|FG001|Overall Study|Death|3|||
106105750|NCT01936857|366041363|FG000|Overall Study|Moved|2|||
106105751|NCT01936857|366041364|FG001|Overall Study|Moved|1|||
106105752|NCT01936857|366041363|FG000|Overall Study|Withdrawal by Subject|1|||
106105753|NCT01936857|366041364|FG001|Overall Study|Withdrawal by Subject|0|||
106105754|NCT01936857|366041363|FG000|Overall Study|Side effect of medication|1|||
106105755|NCT01936857|366041364|FG001|Overall Study|Side effect of medication|0|||
106105756|NCT01936857|366041363|FG000|Overall Study|Other|2|||
106105757|NCT01936857|366041364|FG001|Overall Study|Other|2|||
106105758|NCT01207102|366041365|FG000|Overall Study|Withdrawal by Subject|5|||
106105759|NCT01207102|366041365|FG000|Overall Study|Adverse Event|2|||
106105760|NCT01207102|366041365|FG000|Overall Study|progression|2|||
106105761|NCT01207102|366041365|FG000|Overall Study|Withdrawal by Treating Physician|1|||
106105762|NCT00736645|366041368|FG000|Overall Study|Adverse Event|0|||
106105763|NCT00736645|366041369|FG001|Overall Study|Adverse Event|2|||
106105764|NCT00736645|366041370|FG002|Overall Study|Adverse Event|0|||
106105765|NCT00736645|366041371|FG003|Overall Study|Adverse Event|0|||
106105766|NCT02300220|366041376|FG000|Overall Study|Lost to Follow-up|1|||
106105767|NCT02300220|366041377|FG001|Overall Study|Lost to Follow-up|2|||
106105768|NCT02300220|366041376|FG000|Overall Study|Death|1|||
106105769|NCT02300220|366041377|FG001|Overall Study|Death|1|||
106105770|NCT02300220|366041376|FG000|Overall Study|Adverse Event|1|||
106105771|NCT02300220|366041377|FG001|Overall Study|Adverse Event|1|||
106105772|NCT02300220|366041376|FG000|Overall Study|Protocol Violation|1|||
106105773|NCT02300220|366041377|FG001|Overall Study|Protocol Violation|0|||
106105774|NCT02300220|366041376|FG000|Overall Study|Withdrawal by Subject|0|||
106105775|NCT02300220|366041377|FG001|Overall Study|Withdrawal by Subject|2|||
106105776|NCT02300220|366041376|FG000|Overall Study|Did not tolerate IMP|0|||
106105777|NCT02300220|366041377|FG001|Overall Study|Did not tolerate IMP|1|||
106105778|NCT04322682|366041378|FG000|Overall Study|Withdrawal by Subject|33|||
106105779|NCT04322682|366041379|FG001|Overall Study|Withdrawal by Subject|47|||
106105780|NCT04322682|366041378|FG000|Overall Study|Death|5|||
106105781|NCT04322682|366041379|FG001|Overall Study|Death|9|||
106105782|NCT04322682|366041378|FG000|Overall Study|Lost to Follow-up|4|||
106105783|NCT04322682|366041379|FG001|Overall Study|Lost to Follow-up|8|||
106105784|NCT04322682|366041378|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
106105785|NCT04322682|366041379|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
106105786|NCT00003508|366043881|FG000|Overall Study|Not evaluable|5|||
106105787|NCT01712009|366043882|FG000|Overall Study|Withdrawal by Subject|24|||
106105788|NCT01712009|366043883|FG001|Overall Study|Withdrawal by Subject|15|||
106105789|NCT01712009|366043884|FG002|Overall Study|Withdrawal by Subject|8|||
106105790|NCT01712009|366043882|FG000|Overall Study|Lost to Follow-up|2|||
106105791|NCT01712009|366043883|FG001|Overall Study|Lost to Follow-up|0|||
106105792|NCT01712009|366043884|FG002|Overall Study|Lost to Follow-up|1|||
106105793|NCT01712009|366043882|FG000|Overall Study|Decision by Sponsor|12|||
106105794|NCT01712009|366043883|FG001|Overall Study|Decision by Sponsor|14|||
106105795|NCT01712009|366043884|FG002|Overall Study|Decision by Sponsor|12|||
105781856|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781857|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781858|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781859|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
105781860|NCT01072175|364854847|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
106105796|NCT02160314|366043885|FG000|Overall Study|Adverse Event|0|||
106105797|NCT02160314|366043886|FG001|Overall Study|Adverse Event|6|||
106105798|NCT02160314|366043885|FG000|Overall Study|Protocol Violation|0|||
106105799|NCT02160314|366043886|FG001|Overall Study|Protocol Violation|4|||
106105800|NCT02160314|366043885|FG000|Overall Study|Withdrawal by Subject|1|||
106105801|NCT02160314|366043886|FG001|Overall Study|Withdrawal by Subject|2|||
106105802|NCT02160314|366043885|FG000|Overall Study|Lost to Follow-up|0|||
106105803|NCT02160314|366043886|FG001|Overall Study|Lost to Follow-up|1|||
106105804|NCT01986881|366043887|FG000|Overall Study|Death|228|||
106105805|NCT01986881|366043888|FG001|Overall Study|Death|233|||
106105806|NCT01986881|366043889|FG002|Overall Study|Death|247|||
106105807|NCT01986881|366043887|FG000|Overall Study|Lost to Follow-up|51|||
106105808|NCT01986881|366043888|FG001|Overall Study|Lost to Follow-up|44|||
106105809|NCT01986881|366043889|FG002|Overall Study|Lost to Follow-up|55|||
106105810|NCT01986881|366043887|FG000|Overall Study|Physician Decision|7|||
106105811|NCT01986881|366043888|FG001|Overall Study|Physician Decision|4|||
106105812|NCT01986881|366043889|FG002|Overall Study|Physician Decision|6|||
106105813|NCT01986881|366043887|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
106105814|NCT01986881|366043888|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
106105815|NCT01986881|366043889|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
106105816|NCT01986881|366043887|FG000|Overall Study|Withdrawal by Subject|41|||
106105817|NCT01986881|366043888|FG001|Overall Study|Withdrawal by Subject|60|||
106105818|NCT01986881|366043889|FG002|Overall Study|Withdrawal by Subject|45|||
106105819|NCT01986881|366043887|FG000|Overall Study|Subject Moved|0|||
106105820|NCT01986881|366043888|FG001|Overall Study|Subject Moved|1|||
106105821|NCT01986881|366043889|FG002|Overall Study|Subject Moved|0|||
106105822|NCT01986881|366043887|FG000|Overall Study|Other|1|||
106105823|NCT01986881|366043888|FG001|Overall Study|Other|2|||
106105824|NCT01986881|366043889|FG002|Overall Study|Other|2|||
106105825|NCT00844857|366043890|FG000|Overall Study|Adverse Event|24|||
105781861|NCT01072175|364854848|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
105781862|NCT01072175|364854849|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781863|NCT01072175|364854850|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
105781864|NCT01072175|364854851|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
105781865|NCT01072175|364854852|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781866|NCT01072175|364854853|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781867|NCT01072175|364854854|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781868|NCT01072175|364854855|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781869|NCT01072175|364854856|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781870|NCT01072175|364854857|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781871|NCT01072175|364854858|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
105781872|NCT01072175|364854859|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
106105826|NCT00844857|366043891|FG001|Overall Study|Adverse Event|5|||
106105827|NCT00844857|366043890|FG000|Overall Study|Sponsor Decision|1|||
106105828|NCT00844857|366043891|FG001|Overall Study|Sponsor Decision|1|||
106105829|NCT00844857|366043890|FG000|Overall Study|Physician Decision|2|||
106105830|NCT00844857|366043891|FG001|Overall Study|Physician Decision|0|||
106105831|NCT00844857|366043890|FG000|Overall Study|Parent/Caregiver Decision|6|||
106105832|NCT00844857|366043891|FG001|Overall Study|Parent/Caregiver Decision|2|||
105781873|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
105781874|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
105781875|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
106105833|NCT00844857|366043890|FG000|Overall Study|Withdrawal by Subject|8|||
106105834|NCT00844857|366043891|FG001|Overall Study|Withdrawal by Subject|7|||
106105835|NCT00844857|366043890|FG000|Overall Study|Protocol Violation|6|||
106105836|NCT00844857|366043891|FG001|Overall Study|Protocol Violation|0|||
106105837|NCT00844857|366043890|FG000|Overall Study|Lack of Efficacy|5|||
106105838|NCT00844857|366043891|FG001|Overall Study|Lack of Efficacy|5|||
106105839|NCT00844857|366043890|FG000|Overall Study|Clinical Relapse|0|||
106105840|NCT00844857|366043891|FG001|Overall Study|Clinical Relapse|1|||
106105841|NCT00844857|366043890|FG000|Overall Study|Entry Criteria Not Met|0|||
106105842|NCT00844857|366043891|FG001|Overall Study|Entry Criteria Not Met|1|||
106105843|NCT00844857|366043890|FG000|Overall Study|Lost to Follow-up|2|||
106105844|NCT00844857|366043891|FG001|Overall Study|Lost to Follow-up|3|||
106105845|NCT00844857|366043890|FG000|Overall Study|Did Not Take Study Drug|3|||
105781876|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
105781877|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
105781878|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
105781879|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
105781880|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
105781881|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
105781882|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
105781883|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
106105846|NCT00844857|366043891|FG001|Overall Study|Did Not Take Study Drug|1|||
106105847|NCT00844857|366043890|FG000|Overall Study|Good Clinical Practice Violations|21|||
106105848|NCT00844857|366043891|FG001|Overall Study|Good Clinical Practice Violations|11|||
106105849|NCT00570674|366043892|FG000|Overall Study|Withdrawal by Subject|0|||
106105850|NCT00570674|366043893|FG001|Overall Study|Withdrawal by Subject|0|||
106105851|NCT00570674|366043894|FG002|Overall Study|Withdrawal by Subject|1|||
106105852|NCT00570674|366043895|FG003|Overall Study|Withdrawal by Subject|0|||
106105853|NCT00570674|366043896|FG004|Overall Study|Withdrawal by Subject|0|||
106105854|NCT00570674|366043897|FG005|Overall Study|Withdrawal by Subject|0|||
106105855|NCT00570674|366043898|FG006|Overall Study|Withdrawal by Subject|0|||
106105856|NCT02822222|366043908|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
106105857|NCT02822222|366043909|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
105781884|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
105781885|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
105781886|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781887|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781888|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781889|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781890|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781891|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
105781892|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
105781893|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
105781894|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781895|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781896|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781897|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781898|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
105781899|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781900|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781901|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781902|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781903|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781904|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781905|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
105781906|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
105781907|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781908|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781909|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781910|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781911|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
105781912|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781913|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781914|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781915|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781916|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781917|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
105781918|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
105781919|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
105781920|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781921|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781922|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781923|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781924|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
105781925|NCT01072175|364854847|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781926|NCT01072175|364854848|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781927|NCT01072175|364854849|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781928|NCT01072175|364854850|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781929|NCT01072175|364854851|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781930|NCT01072175|364854852|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
106105858|NCT00643916|366043910|FG000|Overall Study|Protocol Violation|0|||
106105859|NCT00643916|366043911|FG001|Overall Study|Protocol Violation|1|||
106105860|NCT00643916|366043912|FG002|Overall Study|Protocol Violation|1|||
106105861|NCT00643916|366043913|FG003|Overall Study|Protocol Violation|1|||
106105862|NCT00643916|366043914|FG004|Overall Study|Protocol Violation|0|||
106105863|NCT00643916|366043915|FG005|Overall Study|Protocol Violation|0|||
106105864|NCT00643916|366043910|FG000|Overall Study|Lost to Follow-up|0|||
106105865|NCT00643916|366043911|FG001|Overall Study|Lost to Follow-up|1|||
106105866|NCT00643916|366043912|FG002|Overall Study|Lost to Follow-up|0|||
105781931|NCT01072175|364854853|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
105781932|NCT01072175|364854854|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781933|NCT01072175|364854855|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781934|NCT01072175|364854856|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781935|NCT01072175|364854857|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781936|NCT01072175|364854858|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781937|NCT01072175|364854859|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
105781938|NCT01072175|364854847|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781939|NCT01072175|364854848|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781940|NCT01072175|364854849|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781941|NCT01072175|364854850|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781942|NCT01072175|364854851|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781943|NCT01072175|364854852|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781944|NCT01072175|364854853|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781945|NCT01072175|364854854|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781946|NCT01072175|364854855|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
106105867|NCT00643916|366043913|FG003|Overall Study|Lost to Follow-up|0|||
106105868|NCT00643916|366043914|FG004|Overall Study|Lost to Follow-up|0|||
106105869|NCT00643916|366043915|FG005|Overall Study|Lost to Follow-up|0|||
106105870|NCT00643916|366043910|FG000|Overall Study|Withdrawal by Subject|2|||
106105871|NCT00643916|366043911|FG001|Overall Study|Withdrawal by Subject|2|||
106105872|NCT00643916|366043912|FG002|Overall Study|Withdrawal by Subject|2|||
106105873|NCT00643916|366043913|FG003|Overall Study|Withdrawal by Subject|1|||
106105874|NCT00643916|366043914|FG004|Overall Study|Withdrawal by Subject|0|||
106105875|NCT00643916|366043915|FG005|Overall Study|Withdrawal by Subject|1|||
106105876|NCT00643916|366043910|FG000|Overall Study|Not Vaccinated|2|||
106105877|NCT00643916|366043911|FG001|Overall Study|Not Vaccinated|2|||
106105878|NCT00643916|366043912|FG002|Overall Study|Not Vaccinated|3|||
106105879|NCT00643916|366043913|FG003|Overall Study|Not Vaccinated|0|||
106105880|NCT00643916|366043914|FG004|Overall Study|Not Vaccinated|2|||
105781947|NCT01072175|364854856|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781948|NCT01072175|364854857|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781949|NCT01072175|364854858|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781950|NCT01072175|364854859|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
105781951|NCT01072175|364854847|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781952|NCT01072175|364854848|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781953|NCT01072175|364854849|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781954|NCT01072175|364854850|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781955|NCT01072175|364854851|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781956|NCT01072175|364854852|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781957|NCT01072175|364854853|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781958|NCT01072175|364854854|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781959|NCT01072175|364854855|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
105781960|NCT01072175|364854856|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781961|NCT01072175|364854857|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
106105881|NCT00643916|366043915|FG005|Overall Study|Not Vaccinated|0|||
106105882|NCT02450331|366043922|FG000|Overall Study|Death|162|||
106105883|NCT02450331|366043923|FG001|Overall Study|Death|171|||
105781962|NCT01072175|364854858|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781963|NCT01072175|364854859|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
105781964|NCT01072175|364854847|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
106105884|NCT02450331|366043922|FG000|Overall Study|Lost to Follow-up|14|||
106105885|NCT02450331|366043923|FG001|Overall Study|Lost to Follow-up|12|||
106105886|NCT02450331|366043922|FG000|Overall Study|Withdrawal by Subject|55|||
106105887|NCT02450331|366043923|FG001|Overall Study|Withdrawal by Subject|44|||
105781965|NCT01072175|364854848|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781966|NCT01072175|364854849|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
106105888|NCT02450331|366043922|FG000|Overall Study|Non-specified other|1|||
106105889|NCT02450331|366043923|FG001|Overall Study|Non-specified other|1|||
106105890|NCT00828984|366043924|FG000|Overall Study|Adverse Event|2|||
106105891|NCT00828984|366043925|FG001|Overall Study|Adverse Event|3|||
106105892|NCT00828984|366043926|FG002|Overall Study|Adverse Event|0|||
106105893|NCT00828984|366043924|FG000|Overall Study|Lost to Follow-up|5|||
105781967|NCT01072175|364854850|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781968|NCT01072175|364854851|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781969|NCT01072175|364854852|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781970|NCT01072175|364854853|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781971|NCT01072175|364854854|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781972|NCT01072175|364854855|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
105781973|NCT01072175|364854856|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781974|NCT01072175|364854857|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781975|NCT01072175|364854858|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781976|NCT01072175|364854859|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
105781977|NCT01072175|364854847|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781978|NCT01072175|364854848|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781979|NCT01072175|364854849|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781980|NCT01072175|364854850|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781981|NCT01072175|364854851|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781982|NCT01072175|364854852|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781983|NCT01072175|364854853|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781984|NCT01072175|364854854|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781985|NCT01072175|364854855|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
105781986|NCT01072175|364854856|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781987|NCT01072175|364854857|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781988|NCT01072175|364854858|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781989|NCT01072175|364854859|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
105781990|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Death|0|||
105781991|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Death|0|||
105781992|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Death|0|||
105781993|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Death|0|||
105781994|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Death|0|||
105781995|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Death|0|||
105781996|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Death|0|||
105781997|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Death|0|||
105781998|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Death|0|||
105781999|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Death|10|||
105782000|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Death|12|||
105782001|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Death|28|||
105782002|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Death|26|||
105782003|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
105782004|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
106105894|NCT00828984|366043925|FG001|Overall Study|Lost to Follow-up|3|||
106105895|NCT00828984|366043926|FG002|Overall Study|Lost to Follow-up|1|||
105782005|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
106105896|NCT00828984|366043924|FG000|Overall Study|Withdrawal by Subject|4|||
106105897|NCT00828984|366043925|FG001|Overall Study|Withdrawal by Subject|4|||
106105898|NCT00828984|366043926|FG002|Overall Study|Withdrawal by Subject|4|||
106105899|NCT00828984|366043924|FG000|Overall Study|Ineligable|1|||
106105900|NCT00828984|366043925|FG001|Overall Study|Ineligable|2|||
106105901|NCT00828984|366043926|FG002|Overall Study|Ineligable|0|||
106105902|NCT00828984|366043924|FG000|Overall Study|Medical Contraindication|0|||
106105903|NCT00828984|366043925|FG001|Overall Study|Medical Contraindication|1|||
106105904|NCT00828984|366043926|FG002|Overall Study|Medical Contraindication|0|||
106105905|NCT00828984|366043924|FG000|Overall Study|Noncompliant|1|||
106105906|NCT00828984|366043925|FG001|Overall Study|Noncompliant|2|||
106105907|NCT00828984|366043926|FG002|Overall Study|Noncompliant|3|||
106105908|NCT00828984|366043924|FG000|Overall Study|ConMed|1|||
106105909|NCT00828984|366043925|FG001|Overall Study|ConMed|1|||
106105910|NCT00828984|366043926|FG002|Overall Study|ConMed|1|||
106105911|NCT01733732|366043927|FG000|Overall Study|Adverse Event|1|||
106105912|NCT01733732|366043928|FG001|Overall Study|Adverse Event|0|||
105782006|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
106105913|NCT01733732|366043927|FG000|Overall Study|Did not attend all study visits|1|||
106105914|NCT01733732|366043928|FG001|Overall Study|Did not attend all study visits|0|||
106105915|NCT00754338|366043930|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
106105916|NCT00754338|366043931|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
105782007|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
105782008|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
105782009|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
105782010|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
105782011|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
106105917|NCT00754338|366043932|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
106105918|NCT00754338|366043933|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
106105919|NCT00754338|366043930|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
105782012|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
105782013|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
105782014|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
105782015|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
105782016|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782017|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782018|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782019|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782020|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782021|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782022|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782023|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782024|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782025|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
105782026|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
105782027|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
105782028|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
105782029|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782030|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782031|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782032|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782033|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782034|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782035|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782036|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782037|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
105782038|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
105782039|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
105782040|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
105782041|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
105782042|NCT01072175|364854847|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782043|NCT01072175|364854848|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782044|NCT01072175|364854849|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782045|NCT01072175|364854850|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782046|NCT01072175|364854851|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782047|NCT01072175|364854852|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782048|NCT01072175|364854853|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782049|NCT01072175|364854854|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782050|NCT01072175|364854855|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782051|NCT01072175|364854856|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782052|NCT01072175|364854857|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
105782053|NCT01072175|364854858|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
105782054|NCT01072175|364854859|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
105782055|NCT02477215|364854864|FG000|Dose Escalation Phase|Physician Decision|1|||
105782056|NCT02477215|364854865|FG001|Dose Escalation Phase|Physician Decision|2|||
105782057|NCT02477215|364854866|FG002|Dose Escalation Phase|Physician Decision|0|||
105782058|NCT02477215|364854864|FG000|Fixed Dose Phase|Physician Decision|0|||
105782059|NCT02477215|364854865|FG001|Fixed Dose Phase|Physician Decision|7|||
105782060|NCT02477215|364854866|FG002|Fixed Dose Phase|Physician Decision|0|||
105782061|NCT01161173|364854870|FG000|Overall Study|Protocol Violation|13|||
105782062|NCT01161173|364854870|FG000|Overall Study|Lost to Follow-up|7|||
105782063|NCT01161173|364854870|FG000|Overall Study|Progressive Disease|82|||
105782064|NCT01161173|364854870|FG000|Overall Study|Withdrawal of Consent|5|||
105782065|NCT01161173|364854870|FG000|Overall Study|Unacceptable Toxicity|21|||
105782066|NCT01161173|364854870|FG000|Overall Study|Death|194|||
105782067|NCT01161173|364854870|FG000|Overall Study|End of Study|2|||
105782068|NCT01161173|364854870|FG000|Overall Study|Reasons Not Specified|23|||
105782069|NCT01911546|364854871|FG000|Overall Study|Lost to Follow-up|1|||
105782070|NCT01911546|364854871|FG000|Overall Study|Everolimus was discontinued|5|||
105782071|NCT02210559|364854872|FG000|Overall Study|Progressive Disease|3|||
105782072|NCT02210559|364854873|FG001|Overall Study|Progressive Disease|2|||
105782073|NCT02210559|364854872|FG000|Overall Study|Adverse Event|2|||
105782074|NCT02210559|364854873|FG001|Overall Study|Adverse Event|2|||
105782075|NCT02210559|364854872|FG000|Overall Study|Physician Decision|1|||
105782076|NCT02210559|364854873|FG001|Overall Study|Physician Decision|0|||
105782077|NCT02210559|364854872|FG000|Overall Study|Withdrawal by Subject|0|||
105782078|NCT02210559|364854873|FG001|Overall Study|Withdrawal by Subject|1|||
105782079|NCT02210559|364854872|FG000|Overall Study|Other than specified|0|||
105782080|NCT02210559|364854873|FG001|Overall Study|Other than specified|1|||
105782081|NCT03172026|364854881|FG000|Overall Study|Withdrawal by Subject|1|||
105782082|NCT03172026|364854882|FG001|Overall Study|Withdrawal by Subject|0|||
105782083|NCT03172026|364854881|FG000|Overall Study|COVID restrictions|1|||
105782084|NCT03172026|364854882|FG001|Overall Study|COVID restrictions|0|||
105782085|NCT01430559|364854886|FG000|Overall Study|Adverse Event|7|||
105782086|NCT01430559|364854887|FG001|Overall Study|Adverse Event|3|||
105782087|NCT01430559|364854886|FG000|Overall Study|Entry criteria not met|1|||
105782088|NCT01430559|364854887|FG001|Overall Study|Entry criteria not met|1|||
105782089|NCT01430559|364854886|FG000|Overall Study|Lost to Follow-up|1|||
105782090|NCT01430559|364854887|FG001|Overall Study|Lost to Follow-up|0|||
105782091|NCT01430559|364854886|FG000|Overall Study|Medication error|1|||
105782092|NCT01430559|364854887|FG001|Overall Study|Medication error|0|||
105782093|NCT01430559|364854886|FG000|Overall Study|Withdrawal by Subject|3|||
105782094|NCT01430559|364854887|FG001|Overall Study|Withdrawal by Subject|2|||
105782095|NCT01430559|364854886|FG000|Overall Study|Protocol Violation|1|||
105782096|NCT01430559|364854887|FG001|Overall Study|Protocol Violation|0|||
105782097|NCT01430559|364854886|FG000|Overall Study|Other|3|||
105782098|NCT01430559|364854887|FG001|Overall Study|Other|3|||
105782099|NCT01430559|364854886|FG000|Overall Study|Randomized, Not Treated|3|||
105782100|NCT01430559|364854887|FG001|Overall Study|Randomized, Not Treated|3|||
105782101|NCT02132312|364854891|FG000|Overall Study|Adverse Event|2|||
105782102|NCT02132312|364854892|FG001|Overall Study|Adverse Event|0|||
105782103|NCT02132312|364854891|FG000|Overall Study|Physician Decision|1|||
105782104|NCT02132312|364854892|FG001|Overall Study|Physician Decision|1|||
105782105|NCT02132312|364854891|FG000|Overall Study|Protocol Violation|0|||
105782106|NCT02132312|364854892|FG001|Overall Study|Protocol Violation|1|||
105782107|NCT02132312|364854891|FG000|Overall Study|Withdrawal by Subject|1|||
105782108|NCT02132312|364854892|FG001|Overall Study|Withdrawal by Subject|0|||
105782109|NCT02132312|364854891|FG000|Overall Study|Lost to Follow-up|2|||
105782110|NCT02132312|364854892|FG001|Overall Study|Lost to Follow-up|1|||
105782111|NCT02813681|364854893|FG000|Overall Study|Physician Decision|5|||
105782112|NCT02813681|364854894|FG001|Overall Study|Physician Decision|5|||
105782113|NCT02813681|364854895|FG002|Overall Study|Physician Decision|0|||
105782114|NCT02813681|364854893|FG000|Overall Study|Lost to Follow-up|0|||
105782115|NCT02813681|364854894|FG001|Overall Study|Lost to Follow-up|1|||
105782116|NCT02813681|364854895|FG002|Overall Study|Lost to Follow-up|0|||
105782117|NCT01326481|364854896|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
105782118|NCT00307736|364854897|FG000|Overall Study|Adverse Event|0|||
105782119|NCT00307736|364854898|FG001|Overall Study|Adverse Event|0|||
105782120|NCT00307736|364854899|FG002|Overall Study|Adverse Event|1|||
105782121|NCT00307736|364854900|FG003|Overall Study|Adverse Event|3|||
105782122|NCT00307736|364854897|FG000|Overall Study|Withdrawal by Subject|0|||
105782123|NCT00307736|364854898|FG001|Overall Study|Withdrawal by Subject|0|||
105782124|NCT00307736|364854899|FG002|Overall Study|Withdrawal by Subject|2|||
105782125|NCT00307736|364854900|FG003|Overall Study|Withdrawal by Subject|0|||
105782126|NCT01411917|364854905|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
105782127|NCT01411917|364854906|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
105782128|NCT01874288|364854910|FG000|Overall Study|Withdrawal by Subject|1|||
105782129|NCT01874288|364854911|FG001|Overall Study|Withdrawal by Subject|0|||
105782130|NCT01874288|364854912|FG002|Overall Study|Withdrawal by Subject|2|||
105782131|NCT01874288|364854913|FG003|Overall Study|Withdrawal by Subject|1|||
105782132|NCT01874288|364854914|FG004|Overall Study|Withdrawal by Subject|1|||
105782133|NCT01874288|364854910|FG000|Overall Study|Physician Decision|0|||
105782134|NCT01874288|364854911|FG001|Overall Study|Physician Decision|0|||
105782135|NCT01874288|364854912|FG002|Overall Study|Physician Decision|0|||
105782136|NCT01874288|364854913|FG003|Overall Study|Physician Decision|1|||
105782137|NCT01874288|364854914|FG004|Overall Study|Physician Decision|0|||
105782138|NCT01874288|364854910|FG000|Overall Study|Progressive disease|2|||
105782139|NCT01874288|364854911|FG001|Overall Study|Progressive disease|0|||
105782140|NCT01874288|364854912|FG002|Overall Study|Progressive disease|3|||
105782141|NCT01874288|364854913|FG003|Overall Study|Progressive disease|5|||
105782142|NCT01874288|364854914|FG004|Overall Study|Progressive disease|1|||
105782143|NCT02309372|364854915|FG000|Overall Study|Lost to Follow-up|3|||
105782144|NCT02309372|364854916|FG001|Overall Study|Lost to Follow-up|2|||
105782145|NCT02354599|364854925|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105782146|NCT02354599|364854926|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
105782147|NCT02354599|364854927|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105782148|NCT02354599|364854928|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
105782149|NCT02354599|364854929|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
105782150|NCT02354599|364854930|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
105782151|NCT02354599|364854925|FG000|Overall Study|Withdrawal by Subject|1|||
105782152|NCT02354599|364854926|FG001|Overall Study|Withdrawal by Subject|1|||
105782153|NCT02354599|364854927|FG002|Overall Study|Withdrawal by Subject|0|||
105782154|NCT02354599|364854928|FG003|Overall Study|Withdrawal by Subject|0|||
105782155|NCT02354599|364854929|FG004|Overall Study|Withdrawal by Subject|0|||
105782156|NCT02354599|364854930|FG005|Overall Study|Withdrawal by Subject|0|||
105782157|NCT04806334|364854935|FG000|Overall Study|Withdrawal by Subject|1|||
105782158|NCT02811640|364854936|FG000|Overall Study|Technology malfunction|2|||
105782159|NCT03969589|364854943|FG000|Overall Study|Lost to Follow-up|3|||
105782160|NCT03969589|364854944|FG001|Overall Study|Lost to Follow-up|2|||
105782161|NCT03969589|364854943|FG000|Overall Study|Declined Follow-Up|0|||
105782162|NCT03969589|364854944|FG001|Overall Study|Declined Follow-Up|1|||
105782163|NCT01731600|364854946|FG000|Overall Study|Adverse Event|2|||
105782164|NCT01731600|364854947|FG001|Overall Study|Adverse Event|0|||
105782165|NCT01731600|364854946|FG000|Overall Study|Withdrawal criteria|1|||
105782166|NCT01731600|364854947|FG001|Overall Study|Withdrawal criteria|0|||
105782167|NCT01731600|364854946|FG000|Overall Study|Other reasons|3|||
105782168|NCT01731600|364854947|FG001|Overall Study|Other reasons|0|||
105782169|NCT00465894|364854948|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
105782170|NCT00465894|364854949|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
105782171|NCT00465894|364854948|FG000|Treatment For 12 Weeks|Family Issues|1|||
105782172|NCT00465894|364854949|FG001|Treatment For 12 Weeks|Family Issues|1|||
105782173|NCT00465894|364854948|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
105782174|NCT00465894|364854949|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
105782175|NCT02127931|364854950|FG000|Overall Study|Glitch in Game|1|||
105782176|NCT02441517|364854951|FG000|Overall Study|Lost to Follow-up|1|||
105782177|NCT02441517|364854951|FG000|Overall Study|Withdrawal by Subject|2|||
105782178|NCT02441517|364854951|FG000|Overall Study|Study Terminated by Sponsor|1|||
105782179|NCT01513460|364854952|FG000|Overall Study|Death|0|||
105782180|NCT01513460|364854953|FG001|Overall Study|Death|0|||
105782181|NCT01513460|364854954|FG002|Overall Study|Death|1|||
105782182|NCT01513460|364854952|FG000|Overall Study|Lost to Follow-up|0|||
105782183|NCT01513460|364854953|FG001|Overall Study|Lost to Follow-up|0|||
105782184|NCT01513460|364854954|FG002|Overall Study|Lost to Follow-up|2|||
105782185|NCT01513460|364854952|FG000|Overall Study|Abnormal laboratory value|1|||
105782186|NCT01513460|364854953|FG001|Overall Study|Abnormal laboratory value|0|||
105782187|NCT01513460|364854954|FG002|Overall Study|Abnormal laboratory value|1|||
105782188|NCT01513460|364854952|FG000|Overall Study|Lack of Efficacy|1|||
105782189|NCT01513460|364854953|FG001|Overall Study|Lack of Efficacy|2|||
105782190|NCT01513460|364854954|FG002|Overall Study|Lack of Efficacy|5|||
105782191|NCT01513460|364854952|FG000|Overall Study|Protocol deviations|3|||
105782192|NCT01513460|364854953|FG001|Overall Study|Protocol deviations|4|||
105782193|NCT01513460|364854954|FG002|Overall Study|Protocol deviations|3|||
105782194|NCT01513460|364854952|FG000|Overall Study|Withdrawal by Subject|7|||
105782195|NCT01513460|364854953|FG001|Overall Study|Withdrawal by Subject|8|||
105782196|NCT01513460|364854954|FG002|Overall Study|Withdrawal by Subject|21|||
105782197|NCT01513460|364854952|FG000|Overall Study|Adverse Event|16|||
105782198|NCT01513460|364854953|FG001|Overall Study|Adverse Event|18|||
105782199|NCT01513460|364854954|FG002|Overall Study|Adverse Event|23|||
105782200|NCT01513460|364854952|FG000|Overall Study|Abnormal test procedure|1|||
105782201|NCT01513460|364854953|FG001|Overall Study|Abnormal test procedure|0|||
105782202|NCT01513460|364854954|FG002|Overall Study|Abnormal test procedure|0|||
105782203|NCT00489216|364854955|FG000|Overall Study|Adverse Event|1|||
105782204|NCT02612194|364854957|FG000|Overall Study|Death|5|||
105782205|NCT02612194|364854958|FG001|Overall Study|Death|0|||
105782206|NCT02612194|364854959|FG002|Overall Study|Death|2|||
105782207|NCT02612194|364854957|FG000|Overall Study|Early Study Termination|1|||
105782208|NCT02612194|364854958|FG001|Overall Study|Early Study Termination|0|||
105782209|NCT02612194|364854959|FG002|Overall Study|Early Study Termination|0|||
105782210|NCT00540228|364854960|FG000|Overall Study|Adverse Event|2|||
105782211|NCT00540228|364854961|FG001|Overall Study|Adverse Event|0|||
105782212|NCT00540228|364854962|FG002|Overall Study|Adverse Event|0|||
105782213|NCT00540228|364854963|FG003|Overall Study|Adverse Event|0|||
105782214|NCT00540228|364854964|FG004|Overall Study|Adverse Event|0|||
105782215|NCT00540228|364854960|FG000|Overall Study|Lost to Follow-up|1|||
105782216|NCT00540228|364854961|FG001|Overall Study|Lost to Follow-up|1|||
105782217|NCT00540228|364854962|FG002|Overall Study|Lost to Follow-up|0|||
105782218|NCT00540228|364854963|FG003|Overall Study|Lost to Follow-up|0|||
105782219|NCT00540228|364854964|FG004|Overall Study|Lost to Follow-up|0|||
105782220|NCT02828982|364854965|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
106105920|NCT00754338|366043931|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
106105921|NCT00754338|366043932|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
105782221|NCT02828982|364854966|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105782222|NCT01349816|364854968|FG000|Overall Study|Withdrawal by Subject|4|||
106105922|NCT00754338|366043933|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
105782223|NCT01349816|364854968|FG000|Overall Study|Physician Decision|1|||
105782224|NCT01349816|364854968|FG000|Overall Study|Adverse Event|14|||
105782225|NCT01349816|364854968|FG000|Overall Study|Lost to Follow-up|2|||
106105923|NCT04528069|366043934|FG000|Overall Study|Adverse Event|1|||
105782226|NCT01349816|364854968|FG000|Overall Study|Protocol Violation|1|||
105782227|NCT01349816|364854968|FG000|Overall Study|Protocol-specified criteria|8|||
105782228|NCT01190839|364854969|FG000|Overall Study|Adverse Event|32|||
105782229|NCT01190839|364854970|FG001|Overall Study|Adverse Event|41|||
105782230|NCT01190839|364854969|FG000|Overall Study|Protocol Violation|2|||
105782231|NCT01190839|364854970|FG001|Overall Study|Protocol Violation|2|||
105782232|NCT01190839|364854969|FG000|Overall Study|Lost to Follow-up|7|||
105782233|NCT01190839|364854970|FG001|Overall Study|Lost to Follow-up|1|||
105782234|NCT01190839|364854969|FG000|Overall Study|Death|1|||
105782235|NCT01190839|364854970|FG001|Overall Study|Death|0|||
105782236|NCT01190839|364854969|FG000|Overall Study|Trial stopped by Sponsor|71|||
105782237|NCT01190839|364854970|FG001|Overall Study|Trial stopped by Sponsor|68|||
105782238|NCT01190839|364854969|FG000|Overall Study|Undefined|35|||
106105924|NCT04528069|366043934|FG000|Overall Study|Lost to Follow-up|1|||
106105925|NCT04528069|366043934|FG000|Overall Study|Patient Unable to Come|1|||
106105926|NCT04528069|366043934|FG000|Overall Study|Patient Unable to Attend|1|||
106105927|NCT03152526|366043935|FG000|Overall Study|Withdrawal by Subject|0|||
106105928|NCT03152526|366043936|FG001|Overall Study|Withdrawal by Subject|1|||
106105929|NCT04040751|366043937|FG000|Overall Study|Withdrawal by Subject|2|||
106105930|NCT04040751|366043938|FG001|Overall Study|Withdrawal by Subject|0|||
106105931|NCT04040751|366043939|FG002|Overall Study|Withdrawal by Subject|2|||
106105932|NCT04040751|366043940|FG003|Overall Study|Withdrawal by Subject|0|||
106105933|NCT03492281|366043941|FG000|Overall Study|Withdrawal by Subject|21|||
106105934|NCT03492281|366043942|FG001|Overall Study|Withdrawal by Subject|14|||
106105935|NCT03492281|366043943|FG002|Overall Study|Withdrawal by Subject|13|||
106105936|NCT03492281|366043941|FG000|Overall Study|Lost to Follow-up|14|||
106105937|NCT03492281|366043942|FG001|Overall Study|Lost to Follow-up|15|||
106105938|NCT03492281|366043943|FG002|Overall Study|Lost to Follow-up|10|||
106105939|NCT03492281|366043941|FG000|Overall Study|Adverse Event|6|||
106105940|NCT03492281|366043942|FG001|Overall Study|Adverse Event|8|||
106105941|NCT03492281|366043943|FG002|Overall Study|Adverse Event|13|||
106105942|NCT03492281|366043941|FG000|Overall Study|Lack of Efficacy|3|||
106105943|NCT03492281|366043942|FG001|Overall Study|Lack of Efficacy|0|||
106105944|NCT03492281|366043943|FG002|Overall Study|Lack of Efficacy|1|||
106105945|NCT03492281|366043941|FG000|Overall Study|Physician Decision|1|||
106105946|NCT03492281|366043942|FG001|Overall Study|Physician Decision|0|||
106105947|NCT03492281|366043943|FG002|Overall Study|Physician Decision|3|||
106105948|NCT03492281|366043941|FG000|Overall Study|Protocol Violation|0|||
106105949|NCT03492281|366043942|FG001|Overall Study|Protocol Violation|2|||
106105950|NCT03492281|366043943|FG002|Overall Study|Protocol Violation|1|||
106105951|NCT03492281|366043941|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
106105952|NCT03492281|366043942|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
106105953|NCT03492281|366043943|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
106105954|NCT03492281|366043941|FG000|Overall Study|Death|0|||
106105955|NCT03492281|366043942|FG001|Overall Study|Death|0|||
106105956|NCT03492281|366043943|FG002|Overall Study|Death|1|||
106105957|NCT03492281|366043941|FG000|Overall Study|Captured as Other in Database|8|||
106105958|NCT03492281|366043942|FG001|Overall Study|Captured as Other in Database|6|||
106105959|NCT03492281|366043943|FG002|Overall Study|Captured as Other in Database|3|||
106105960|NCT01506193|366043944|FG000|Overall Study|Protocol Violation|1|||
106105961|NCT01506193|366043945|FG001|Overall Study|Protocol Violation|0|||
106105962|NCT01506193|366043946|FG002|Overall Study|Protocol Violation|1|||
106105963|NCT01506193|366043944|FG000|Overall Study|Migrated/moved from study area|0|||
106105964|NCT01506193|366043945|FG001|Overall Study|Migrated/moved from study area|0|||
106105965|NCT01506193|366043946|FG002|Overall Study|Migrated/moved from study area|1|||
106105966|NCT01506193|366043944|FG000|Overall Study|Adverse event, non-fatal|0|||
106105967|NCT01506193|366043945|FG001|Overall Study|Adverse event, non-fatal|0|||
106105968|NCT01506193|366043946|FG002|Overall Study|Adverse event, non-fatal|1|||
106105969|NCT01506193|366043944|FG000|Overall Study|Withdrawal by Subject|5|||
106105970|NCT01506193|366043945|FG001|Overall Study|Withdrawal by Subject|1|||
106105971|NCT01506193|366043946|FG002|Overall Study|Withdrawal by Subject|8|||
106105972|NCT01506193|366043944|FG000|Overall Study|Lost to Follow-up|8|||
106105973|NCT01506193|366043945|FG001|Overall Study|Lost to Follow-up|3|||
106105974|NCT01506193|366043946|FG002|Overall Study|Lost to Follow-up|3|||
106105975|NCT00675766|366043948|FG000|Overall Study|Lost to Follow-up|6|||
106105976|NCT00675766|366043949|FG001|Overall Study|Lost to Follow-up|5|||
106105977|NCT00675766|366043950|FG002|Overall Study|Lost to Follow-up|21|||
106105978|NCT00675766|366043951|FG003|Overall Study|Lost to Follow-up|26|||
106105979|NCT02251990|366043957|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
106105980|NCT02251990|366043958|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
106105981|NCT02251990|366043957|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
106105982|NCT02251990|366043958|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
106105983|NCT02251990|366043957|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
106105984|NCT02251990|366043958|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
106105985|NCT02251990|366043957|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
106105986|NCT02251990|366043958|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
106105987|NCT02251990|366043957|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
106105988|NCT02251990|366043958|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
106105989|NCT02251990|366043957|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
106105990|NCT02251990|366043958|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
106105991|NCT01749982|366043959|FG000|Overall Study|Physician Decision|0|||
105782239|NCT01190839|364854970|FG001|Overall Study|Undefined|31|||
105782240|NCT01190839|364854969|FG000|Overall Study|Randomized but not treated|2|||
106105992|NCT01749982|366043960|FG001|Overall Study|Physician Decision|0|||
106105993|NCT01749982|366043961|FG002|Overall Study|Physician Decision|0|||
106105994|NCT01749982|366043962|FG003|Overall Study|Physician Decision|1|||
106105995|NCT01749982|366043959|FG000|Overall Study|Lost to Follow-up|0|||
106105996|NCT01749982|366043960|FG001|Overall Study|Lost to Follow-up|0|||
105782241|NCT01190839|364854970|FG001|Overall Study|Randomized but not treated|4|||
106105997|NCT01749982|366043961|FG002|Overall Study|Lost to Follow-up|0|||
106105998|NCT01749982|366043962|FG003|Overall Study|Lost to Follow-up|1|||
106105999|NCT01749982|366043959|FG000|Overall Study|Withdrawal by Subject|0|||
106106000|NCT01749982|366043960|FG001|Overall Study|Withdrawal by Subject|0|||
106106001|NCT01749982|366043961|FG002|Overall Study|Withdrawal by Subject|0|||
106106002|NCT01749982|366043962|FG003|Overall Study|Withdrawal by Subject|1|||
106106003|NCT04672941|366043964|FG000|Overall Study|Investigator decision|1|||
106106004|NCT04672941|366043964|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
106106005|NCT04672941|366043964|FG000|Overall Study|COVID-19 related but no adverse event|1|||
106106006|NCT04672941|366043964|FG000|Overall Study|Adverse Event|2|||
106106007|NCT04672941|366043964|FG000|Overall Study|Lost to Follow-up|2|||
106106008|NCT00765388|366043967|FG000|Period 1|Lack of Efficacy|1|||
106106009|NCT00765388|366043968|FG001|Period 1|Lack of Efficacy|2|||
106106010|NCT00765388|366043967|FG000|Period 1|Lost to Follow-up|0|||
106106011|NCT00765388|366043968|FG001|Period 1|Lost to Follow-up|1|||
106106012|NCT00765388|366043967|FG000|Period 1|Herpes Zoster|0|||
106106013|NCT00765388|366043968|FG001|Period 1|Herpes Zoster|1|||
106106014|NCT00765388|366043967|FG000|Period 1|Hip operation|0|||
106106015|NCT00765388|366043968|FG001|Period 1|Hip operation|1|||
106106016|NCT00765674|366043972|FG000|Overall Study|Adverse Event|7|||
106106017|NCT00765674|366043973|FG001|Overall Study|Adverse Event|2|||
106106018|NCT00765674|366043974|FG002|Overall Study|Adverse Event|8|||
106106019|NCT00765674|366043975|FG003|Overall Study|Adverse Event|11|||
106106020|NCT00765674|366043972|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
106106021|NCT00765674|366043973|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
106106022|NCT00765674|366043974|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
106106023|NCT00765674|366043975|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
106106024|NCT00765674|366043972|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
106106025|NCT00765674|366043973|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
106106026|NCT00765674|366043974|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
106106027|NCT00765674|366043975|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
106106028|NCT00765674|366043972|FG000|Overall Study|Lack of Efficacy|2|||
106106029|NCT00765674|366043973|FG001|Overall Study|Lack of Efficacy|3|||
106106030|NCT00765674|366043974|FG002|Overall Study|Lack of Efficacy|1|||
106106031|NCT00765674|366043975|FG003|Overall Study|Lack of Efficacy|2|||
106106032|NCT00765674|366043972|FG000|Overall Study|Protocol Violation|2|||
106106033|NCT00765674|366043973|FG001|Overall Study|Protocol Violation|0|||
106106034|NCT00765674|366043974|FG002|Overall Study|Protocol Violation|1|||
106106035|NCT00765674|366043975|FG003|Overall Study|Protocol Violation|0|||
106106036|NCT00765674|366043972|FG000|Overall Study|Withdrawal by Subject|5|||
106106037|NCT00765674|366043973|FG001|Overall Study|Withdrawal by Subject|7|||
106106038|NCT00765674|366043974|FG002|Overall Study|Withdrawal by Subject|3|||
106106039|NCT00765674|366043975|FG003|Overall Study|Withdrawal by Subject|8|||
106106040|NCT00765674|366043972|FG000|Overall Study|Lost to Follow-up|4|||
106106041|NCT00765674|366043973|FG001|Overall Study|Lost to Follow-up|6|||
106106042|NCT00765674|366043974|FG002|Overall Study|Lost to Follow-up|2|||
106106043|NCT00765674|366043975|FG003|Overall Study|Lost to Follow-up|1|||
106106044|NCT00765674|366043972|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
106106045|NCT00765674|366043973|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
106106046|NCT00765674|366043974|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
106106047|NCT00765674|366043975|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
106106048|NCT01813474|366043976|FG000|Overall Study|Withdrawal by Subject|0|||
106106049|NCT01813474|366043977|FG001|Overall Study|Withdrawal by Subject|0|||
106106050|NCT01813474|366043978|FG002|Overall Study|Withdrawal by Subject|1|||
106106051|NCT01813474|366043976|FG000|Overall Study|Adverse Event|1|||
106106052|NCT01813474|366043977|FG001|Overall Study|Adverse Event|1|||
106106053|NCT01813474|366043978|FG002|Overall Study|Adverse Event|0|||
106106054|NCT01813474|366043976|FG000|Overall Study|Lack of Efficacy|2|||
106106055|NCT01813474|366043977|FG001|Overall Study|Lack of Efficacy|6|||
106106056|NCT01813474|366043978|FG002|Overall Study|Lack of Efficacy|9|||
106106057|NCT01813474|366043976|FG000|Overall Study|Death|0|||
106106058|NCT01813474|366043977|FG001|Overall Study|Death|0|||
106106059|NCT01813474|366043978|FG002|Overall Study|Death|1|||
106106060|NCT01441102|366043979|FG000|Overall Study|Adverse Event|1|||
106106061|NCT01441102|366043979|FG000|Overall Study|Withdrawal by Subject|2|||
106106062|NCT00827918|366043980|FG000|Overall Study|Adverse Event|4|||
106106063|NCT00827918|366043981|FG001|Overall Study|Adverse Event|0|||
106106064|NCT00827918|366043982|FG002|Overall Study|Adverse Event|0|||
106106065|NCT00827918|366043980|FG000|Overall Study|Lack of Efficacy|16|||
106106066|NCT00827918|366043981|FG001|Overall Study|Lack of Efficacy|4|||
106106067|NCT00827918|366043982|FG002|Overall Study|Lack of Efficacy|15|||
106106068|NCT00827918|366043980|FG000|Overall Study|Physician Decision|1|||
106106069|NCT00827918|366043981|FG001|Overall Study|Physician Decision|0|||
106106070|NCT00827918|366043982|FG002|Overall Study|Physician Decision|0|||
106106071|NCT00827918|366043980|FG000|Overall Study|Pregnancy|0|||
106106072|NCT00827918|366043981|FG001|Overall Study|Pregnancy|1|||
106106073|NCT00827918|366043982|FG002|Overall Study|Pregnancy|0|||
106106074|NCT00827918|366043980|FG000|Overall Study|Progressive Disease|1|||
106106075|NCT00827918|366043981|FG001|Overall Study|Progressive Disease|1|||
105782242|NCT01362062|364854971|FG000|Overall Study|Adverse Event|1|||
105782243|NCT01362062|364854972|FG001|Overall Study|Adverse Event|0|||
105782244|NCT01362062|364854971|FG000|Overall Study|Lost to Follow-up|11|||
105782245|NCT01362062|364854972|FG001|Overall Study|Lost to Follow-up|0|||
105782246|NCT01362062|364854971|FG000|Overall Study|Withdrawal by Subject|2|||
105782247|NCT01362062|364854972|FG001|Overall Study|Withdrawal by Subject|0|||
106106076|NCT00827918|366043982|FG002|Overall Study|Progressive Disease|0|||
106106077|NCT00827918|366043980|FG000|Overall Study|Protocol Violation|0|||
106106078|NCT00827918|366043981|FG001|Overall Study|Protocol Violation|1|||
106106079|NCT00827918|366043982|FG002|Overall Study|Protocol Violation|0|||
106106080|NCT00827918|366043980|FG000|Overall Study|Withdrawal by Subject|6|||
106106081|NCT00827918|366043981|FG001|Overall Study|Withdrawal by Subject|2|||
106106082|NCT00827918|366043982|FG002|Overall Study|Withdrawal by Subject|6|||
106106083|NCT02291614|366043984|FG000|Overall Study|Lost to Follow-up|0|||
106106084|NCT02291614|366043985|FG001|Overall Study|Lost to Follow-up|0|||
106106085|NCT02291614|366043986|FG002|Overall Study|Lost to Follow-up|0|||
106106086|NCT02291614|366043987|FG003|Overall Study|Lost to Follow-up|0|||
106106087|NCT02291614|366043988|FG004|Overall Study|Lost to Follow-up|0|||
106106088|NCT02291614|366043989|FG005|Overall Study|Lost to Follow-up|0|||
106106089|NCT02291614|366043990|FG006|Overall Study|Lost to Follow-up|0|||
106106090|NCT02291614|366043991|FG007|Overall Study|Lost to Follow-up|1|||
106106091|NCT02291614|366043992|FG008|Overall Study|Lost to Follow-up|0|||
106106092|NCT02291614|366043993|FG009|Overall Study|Lost to Follow-up|0|||
106106093|NCT02291614|366043994|FG010|Overall Study|Lost to Follow-up|0|||
106106094|NCT02291614|366043984|FG000|Overall Study|Withdrawal by Subject|0|||
106106095|NCT02291614|366043985|FG001|Overall Study|Withdrawal by Subject|1|||
106106096|NCT02291614|366043986|FG002|Overall Study|Withdrawal by Subject|0|||
106106097|NCT02291614|366043987|FG003|Overall Study|Withdrawal by Subject|0|||
106106098|NCT02291614|366043988|FG004|Overall Study|Withdrawal by Subject|0|||
106106099|NCT02291614|366043989|FG005|Overall Study|Withdrawal by Subject|0|||
106106100|NCT02291614|366043990|FG006|Overall Study|Withdrawal by Subject|0|||
106106101|NCT02291614|366043991|FG007|Overall Study|Withdrawal by Subject|0|||
106106102|NCT02291614|366043992|FG008|Overall Study|Withdrawal by Subject|0|||
106106103|NCT02291614|366043993|FG009|Overall Study|Withdrawal by Subject|2|||
106106104|NCT02291614|366043994|FG010|Overall Study|Withdrawal by Subject|2|||
106106105|NCT02291614|366043984|FG000|Overall Study|Decision by sponsor|0|||
106106106|NCT02291614|366043985|FG001|Overall Study|Decision by sponsor|0|||
106106107|NCT02291614|366043986|FG002|Overall Study|Decision by sponsor|0|||
106106108|NCT02291614|366043987|FG003|Overall Study|Decision by sponsor|1|||
106106109|NCT02291614|366043988|FG004|Overall Study|Decision by sponsor|0|||
106106110|NCT02291614|366043989|FG005|Overall Study|Decision by sponsor|0|||
106106111|NCT02291614|366043990|FG006|Overall Study|Decision by sponsor|0|||
106106112|NCT02291614|366043991|FG007|Overall Study|Decision by sponsor|0|||
106106113|NCT02291614|366043992|FG008|Overall Study|Decision by sponsor|0|||
106106114|NCT02291614|366043993|FG009|Overall Study|Decision by sponsor|0|||
106106115|NCT02291614|366043994|FG010|Overall Study|Decision by sponsor|0|||
106106116|NCT02291614|366043984|FG000|Overall Study|Death|0|||
106106117|NCT02291614|366043985|FG001|Overall Study|Death|0|||
106106118|NCT02291614|366043986|FG002|Overall Study|Death|1|||
106106119|NCT02291614|366043987|FG003|Overall Study|Death|0|||
106106120|NCT02291614|366043988|FG004|Overall Study|Death|1|||
106106121|NCT02291614|366043989|FG005|Overall Study|Death|1|||
106106122|NCT02291614|366043990|FG006|Overall Study|Death|1|||
106106123|NCT02291614|366043991|FG007|Overall Study|Death|0|||
106106124|NCT02291614|366043992|FG008|Overall Study|Death|0|||
106106125|NCT02291614|366043993|FG009|Overall Study|Death|0|||
106106126|NCT02291614|366043994|FG010|Overall Study|Death|0|||
106106127|NCT01662310|366043997|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
106106128|NCT01662310|366043998|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
106106129|NCT01662310|366043999|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
106106130|NCT01662310|366044000|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
106106131|NCT01662310|366044001|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
106106132|NCT01662310|366043997|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
106106133|NCT01662310|366043998|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
106106134|NCT01662310|366043999|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
106106135|NCT01662310|366044000|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
106106136|NCT01662310|366044001|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
106106137|NCT01662310|366043997|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
106106138|NCT01662310|366043998|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
106106139|NCT01662310|366043999|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
106106140|NCT01662310|366044000|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
106106141|NCT01662310|366044001|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
106106142|NCT01662310|366043997|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
105782248|NCT01362062|364854971|FG000|Overall Study|Non-compliant participant|2|||
106106143|NCT01662310|366043998|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
105782249|NCT01362062|364854972|FG001|Overall Study|Non-compliant participant|0|||
106106144|NCT01662310|366043999|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
106106145|NCT01662310|366044000|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
106106146|NCT01662310|366044001|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
106106147|NCT01662310|366043997|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
106106148|NCT01662310|366043998|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
106106149|NCT01662310|366043999|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
106106150|NCT01662310|366044000|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
106106151|NCT01662310|366044001|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
106106152|NCT01662310|366043997|FG000|Run-In or Stabilization Phase|Other|1|||
106106153|NCT01662310|366043998|FG001|Run-In or Stabilization Phase|Other|0|||
106106154|NCT01662310|366043999|FG002|Run-In or Stabilization Phase|Other|0|||
106106155|NCT01662310|366044000|FG003|Run-In or Stabilization Phase|Other|0|||
106106156|NCT01662310|366044001|FG004|Run-In or Stabilization Phase|Other|0|||
106106157|NCT01662310|366043997|FG000|Double-Blind Phase|Adverse Event|0|||
106106158|NCT01662310|366043998|FG001|Double-Blind Phase|Adverse Event|0|||
106106159|NCT01662310|366043999|FG002|Double-Blind Phase|Adverse Event|1|||
106106160|NCT01662310|366044000|FG003|Double-Blind Phase|Adverse Event|0|||
106106161|NCT01662310|366044001|FG004|Double-Blind Phase|Adverse Event|0|||
106106162|NCT01662310|366043997|FG000|Double-Blind Phase|Lost to Follow-up|0|||
106106163|NCT01662310|366043998|FG001|Double-Blind Phase|Lost to Follow-up|3|||
106106164|NCT01662310|366043999|FG002|Double-Blind Phase|Lost to Follow-up|0|||
106106165|NCT01662310|366044000|FG003|Double-Blind Phase|Lost to Follow-up|0|||
106106166|NCT01662310|366044001|FG004|Double-Blind Phase|Lost to Follow-up|0|||
106106167|NCT01662310|366043997|FG000|Double-Blind Phase|Pregnancy|0|||
106106168|NCT01662310|366043998|FG001|Double-Blind Phase|Pregnancy|2|||
106106169|NCT01662310|366043999|FG002|Double-Blind Phase|Pregnancy|0|||
106106170|NCT01662310|366044000|FG003|Double-Blind Phase|Pregnancy|0|||
106106171|NCT01662310|366044001|FG004|Double-Blind Phase|Pregnancy|0|||
106106172|NCT01662310|366043997|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
106106173|NCT01662310|366043998|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
106106174|NCT01662310|366043999|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
106106175|NCT01662310|366044000|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
106106176|NCT01662310|366044001|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
106106177|NCT01662310|366043997|FG000|Double-Blind Phase|Other|0|||
106106178|NCT01662310|366043998|FG001|Double-Blind Phase|Other|0|||
106106179|NCT01662310|366043999|FG002|Double-Blind Phase|Other|1|||
106106180|NCT01662310|366044000|FG003|Double-Blind Phase|Other|0|||
106106181|NCT01662310|366044001|FG004|Double-Blind Phase|Other|0|||
106106182|NCT01662310|366043997|FG000|Double-Blind Phase|Randomized but not treated|0|||
106106183|NCT01662310|366043998|FG001|Double-Blind Phase|Randomized but not treated|1|||
105782250|NCT01362062|364854971|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
105782251|NCT01362062|364854972|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
105782252|NCT01362062|364854971|FG000|Overall Study|Had significant improvement|9|||
106106184|NCT01662310|366043999|FG002|Double-Blind Phase|Randomized but not treated|0|||
106106185|NCT01662310|366044000|FG003|Double-Blind Phase|Randomized but not treated|0|||
105782253|NCT01362062|364854972|FG001|Overall Study|Had significant improvement|0|||
105782254|NCT02545504|364854973|FG000|Overall Study|Death|174|||
106106186|NCT01662310|366044001|FG004|Double-Blind Phase|Randomized but not treated|0|||
106106187|NCT01662310|366043997|FG000|Open-Label Extension Phase|Adverse Event|0|||
106106188|NCT01662310|366043998|FG001|Open-Label Extension Phase|Adverse Event|0|||
106106189|NCT01662310|366043999|FG002|Open-Label Extension Phase|Adverse Event|0|||
106106190|NCT01662310|366044000|FG003|Open-Label Extension Phase|Adverse Event|3|||
106106191|NCT01662310|366044001|FG004|Open-Label Extension Phase|Adverse Event|0|||
106106192|NCT01662310|366043997|FG000|Open-Label Extension Phase|Death|0|||
106106193|NCT01662310|366043998|FG001|Open-Label Extension Phase|Death|0|||
106106194|NCT01662310|366043999|FG002|Open-Label Extension Phase|Death|0|||
106106195|NCT01662310|366044000|FG003|Open-Label Extension Phase|Death|1|||
106106196|NCT01662310|366044001|FG004|Open-Label Extension Phase|Death|0|||
106106197|NCT01662310|366043997|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
106106198|NCT01662310|366043998|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
106106199|NCT01662310|366043999|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
106106200|NCT01662310|366044000|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
106106201|NCT01662310|366044001|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
106106202|NCT01662310|366043997|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
106106203|NCT01662310|366043998|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105782255|NCT02545504|364854974|FG001|Overall Study|Death|168|||
106106204|NCT01662310|366043999|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
106106205|NCT01662310|366044000|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
106106206|NCT01662310|366044001|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
106106207|NCT01662310|366043997|FG000|Open-Label Extension Phase|Pregnancy|0|||
105782256|NCT02545504|364854973|FG000|Overall Study|Unknown reason|30|||
106106208|NCT01662310|366043998|FG001|Open-Label Extension Phase|Pregnancy|0|||
106106209|NCT01662310|366043999|FG002|Open-Label Extension Phase|Pregnancy|0|||
106106210|NCT01662310|366044000|FG003|Open-Label Extension Phase|Pregnancy|1|||
106106211|NCT01662310|366044001|FG004|Open-Label Extension Phase|Pregnancy|0|||
105782257|NCT02545504|364854974|FG001|Overall Study|Unknown reason|32|||
105782258|NCT02545504|364854973|FG000|Overall Study|Withdrew consent|9|||
106144083|NCT01317420|366186954|FG005|Overall Study|Other adverse event|0|||
105782259|NCT02545504|364854974|FG001|Overall Study|Withdrew consent|11|||
105782260|NCT02545504|364854973|FG000|Overall Study|Investigator's discretion|3|||
105782261|NCT02545504|364854974|FG001|Overall Study|Investigator's discretion|1|||
105782262|NCT02545504|364854973|FG000|Overall Study|Lost to Follow-up|2|||
105782263|NCT02545504|364854974|FG001|Overall Study|Lost to Follow-up|2|||
105782264|NCT01459016|364856135|FG000|Overall Study|Withdrawal by Subject|11|||
105782265|NCT01459016|364856135|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
105782266|NCT03922945|364856136|FG000|Overall Study|Adverse Event|1|||
105782267|NCT03922945|364856137|FG001|Overall Study|Adverse Event|1|||
105782268|NCT03922945|364856138|FG002|Overall Study|Adverse Event|2|||
105782269|NCT03922945|364856136|FG000|Overall Study|Lost to Follow-up|13|||
105782270|NCT03922945|364856137|FG001|Overall Study|Lost to Follow-up|9|||
105782271|NCT03922945|364856138|FG002|Overall Study|Lost to Follow-up|20|||
105782272|NCT03922945|364856136|FG000|Overall Study|Lack of Efficacy|2|||
105782273|NCT03922945|364856137|FG001|Overall Study|Lack of Efficacy|0|||
105782274|NCT03922945|364856138|FG002|Overall Study|Lack of Efficacy|1|||
105782275|NCT03922945|364856136|FG000|Overall Study|Protocol Non-Compliance|0|||
105782276|NCT03922945|364856137|FG001|Overall Study|Protocol Non-Compliance|0|||
105782277|NCT03922945|364856138|FG002|Overall Study|Protocol Non-Compliance|1|||
105782278|NCT03922945|364856136|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
105782279|NCT03922945|364856137|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
105782280|NCT03922945|364856138|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
105782281|NCT03922945|364856136|FG000|Overall Study|All Other Personal Reasons|1|||
105782282|NCT03922945|364856137|FG001|Overall Study|All Other Personal Reasons|1|||
105782283|NCT03922945|364856138|FG002|Overall Study|All Other Personal Reasons|2|||
105782284|NCT04067310|364856140|FG000|Overall Study|Physician Decision|2|||
105782285|NCT04067310|364856141|FG001|Overall Study|Physician Decision|6|||
105782286|NCT04067310|364856140|FG000|Overall Study|Lost to Follow-up|0|||
105782287|NCT04067310|364856141|FG001|Overall Study|Lost to Follow-up|1|||
105782288|NCT04067310|364856140|FG000|Overall Study|Withdrawal by Subject|3|||
105782289|NCT04067310|364856141|FG001|Overall Study|Withdrawal by Subject|0|||
105782290|NCT01041027|364856142|FG000|Overall Study|Withdrawal by Subject|2|||
105782291|NCT01041027|364856142|FG000|Overall Study|Protocol Violation|1|||
105782292|NCT01041027|364856142|FG000|Overall Study|Delayed Radiation Therapy|1|||
105782293|NCT01041027|364856142|FG000|Overall Study|Adverse Event|4|||
105782294|NCT04308668|364856143|FG000|Overall Study|Lost to Follow-up|32|||
106106212|NCT01662310|366043997|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
106106213|NCT01662310|366043998|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
106106214|NCT01662310|366043999|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
106106215|NCT01662310|366044000|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
106106216|NCT01662310|366044001|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
106106217|NCT02432105|366044010|FG000|Overall Study|Lost to Follow-up|1|||
106106218|NCT02432105|366044011|FG001|Overall Study|Lost to Follow-up|1|||
106106219|NCT02432105|366044012|FG002|Overall Study|Lost to Follow-up|0|||
106106220|NCT02432105|366044010|FG000|Overall Study|Withdrawal by Subject|1|||
106106221|NCT02432105|366044011|FG001|Overall Study|Withdrawal by Subject|0|||
106106222|NCT02432105|366044012|FG002|Overall Study|Withdrawal by Subject|1|||
106106223|NCT02432105|366044010|FG000|Overall Study|Culture positive for yeast|0|||
106106224|NCT02432105|366044011|FG001|Overall Study|Culture positive for yeast|1|||
105782295|NCT04308668|364856144|FG001|Overall Study|Lost to Follow-up|38|||
105782296|NCT04308668|364856143|FG000|Overall Study|Withdrawal by Subject|4|||
105782297|NCT04308668|364856144|FG001|Overall Study|Withdrawal by Subject|4|||
105782298|NCT01801475|364856145|FG000|Overall Study|Withdrawal by Subject|0|||
106106225|NCT02432105|366044012|FG002|Overall Study|Culture positive for yeast|0|||
106106226|NCT02432105|366044010|FG000|Overall Study|Randomized in error|0|||
106106227|NCT02432105|366044011|FG001|Overall Study|Randomized in error|0|||
106106228|NCT02432105|366044012|FG002|Overall Study|Randomized in error|2|||
106106229|NCT01302847|366044013|FG000|Overall Study|Death|0|||
106106230|NCT01302847|366044014|FG001|Overall Study|Death|1|||
106106231|NCT01302847|366044015|FG002|Overall Study|Death|0|||
106106232|NCT01302847|366044016|FG003|Overall Study|Death|0|||
106106233|NCT01302847|366044017|FG004|Overall Study|Death|0|||
106106234|NCT01302847|366044018|FG005|Overall Study|Death|1|||
106106235|NCT01302847|366044019|FG006|Overall Study|Death|1|||
106106236|NCT01302847|366044020|FG007|Overall Study|Death|0|||
106106237|NCT01302847|366044013|FG000|Overall Study|Pregnancy|2|||
106106238|NCT01302847|366044014|FG001|Overall Study|Pregnancy|0|||
106106239|NCT01302847|366044015|FG002|Overall Study|Pregnancy|0|||
106106240|NCT01302847|366044016|FG003|Overall Study|Pregnancy|0|||
106106241|NCT01302847|366044017|FG004|Overall Study|Pregnancy|0|||
106106242|NCT01302847|366044018|FG005|Overall Study|Pregnancy|0|||
106106243|NCT01302847|366044019|FG006|Overall Study|Pregnancy|0|||
106106244|NCT01302847|366044020|FG007|Overall Study|Pregnancy|0|||
106106245|NCT01302847|366044013|FG000|Overall Study|Virologic failure|0|||
106106246|NCT01302847|366044014|FG001|Overall Study|Virologic failure|2|||
105782299|NCT01801475|364856146|FG001|Overall Study|Withdrawal by Subject|0|||
105782300|NCT01801475|364856147|FG002|Overall Study|Withdrawal by Subject|0|||
105782301|NCT01801475|364856148|FG003|Overall Study|Withdrawal by Subject|0|||
106106247|NCT01302847|366044015|FG002|Overall Study|Virologic failure|0|||
106106248|NCT01302847|366044016|FG003|Overall Study|Virologic failure|2|||
106106249|NCT01302847|366044017|FG004|Overall Study|Virologic failure|1|||
106106250|NCT01302847|366044018|FG005|Overall Study|Virologic failure|3|||
106106251|NCT01302847|366044019|FG006|Overall Study|Virologic failure|1|||
106106252|NCT01302847|366044020|FG007|Overall Study|Virologic failure|2|||
106106253|NCT01302847|366044013|FG000|Overall Study|Severe debilitation, unable to continue|0|||
106106254|NCT01302847|366044014|FG001|Overall Study|Severe debilitation, unable to continue|0|||
106106255|NCT01302847|366044015|FG002|Overall Study|Severe debilitation, unable to continue|0|||
106106256|NCT01302847|366044016|FG003|Overall Study|Severe debilitation, unable to continue|0|||
106106257|NCT01302847|366044017|FG004|Overall Study|Severe debilitation, unable to continue|0|||
106106258|NCT01302847|366044018|FG005|Overall Study|Severe debilitation, unable to continue|1|||
106106259|NCT01302847|366044019|FG006|Overall Study|Severe debilitation, unable to continue|1|||
106106260|NCT01302847|366044020|FG007|Overall Study|Severe debilitation, unable to continue|0|||
106106261|NCT01302847|366044013|FG000|Overall Study|Not able to get to clinic|1|||
106106262|NCT01302847|366044014|FG001|Overall Study|Not able to get to clinic|1|||
106106263|NCT01302847|366044015|FG002|Overall Study|Not able to get to clinic|0|||
106106264|NCT01302847|366044016|FG003|Overall Study|Not able to get to clinic|0|||
106106265|NCT01302847|366044017|FG004|Overall Study|Not able to get to clinic|0|||
106106266|NCT01302847|366044018|FG005|Overall Study|Not able to get to clinic|0|||
106106267|NCT01302847|366044019|FG006|Overall Study|Not able to get to clinic|0|||
106106268|NCT01302847|366044020|FG007|Overall Study|Not able to get to clinic|0|||
106106269|NCT01302847|366044013|FG000|Overall Study|Site closing|2|||
106106270|NCT01302847|366044014|FG001|Overall Study|Site closing|2|||
106106271|NCT01302847|366044015|FG002|Overall Study|Site closing|0|||
106106272|NCT01302847|366044016|FG003|Overall Study|Site closing|0|||
106106273|NCT01302847|366044017|FG004|Overall Study|Site closing|0|||
106106274|NCT01302847|366044018|FG005|Overall Study|Site closing|0|||
106106275|NCT01302847|366044019|FG006|Overall Study|Site closing|0|||
106106276|NCT01302847|366044020|FG007|Overall Study|Site closing|0|||
106106277|NCT01302847|366044013|FG000|Overall Study|Withdrawal by Subject|1|||
106106278|NCT01302847|366044014|FG001|Overall Study|Withdrawal by Subject|0|||
106106279|NCT01302847|366044015|FG002|Overall Study|Withdrawal by Subject|0|||
106106280|NCT01302847|366044016|FG003|Overall Study|Withdrawal by Subject|0|||
106106281|NCT01302847|366044017|FG004|Overall Study|Withdrawal by Subject|1|||
106106282|NCT01302847|366044018|FG005|Overall Study|Withdrawal by Subject|0|||
106106283|NCT01302847|366044019|FG006|Overall Study|Withdrawal by Subject|0|||
106106284|NCT01302847|366044020|FG007|Overall Study|Withdrawal by Subject|1|||
106106285|NCT01302847|366044013|FG000|Overall Study|Not willing to adhere to requirements|5|||
106106286|NCT01302847|366044014|FG001|Overall Study|Not willing to adhere to requirements|0|||
106106287|NCT01302847|366044015|FG002|Overall Study|Not willing to adhere to requirements|1|||
106106288|NCT01302847|366044016|FG003|Overall Study|Not willing to adhere to requirements|0|||
106106289|NCT01302847|366044017|FG004|Overall Study|Not willing to adhere to requirements|0|||
106106290|NCT01302847|366044018|FG005|Overall Study|Not willing to adhere to requirements|0|||
106106291|NCT01302847|366044019|FG006|Overall Study|Not willing to adhere to requirements|0|||
106106292|NCT01302847|366044020|FG007|Overall Study|Not willing to adhere to requirements|2|||
106106293|NCT01302847|366044013|FG000|Overall Study|Site unable to contact participant|2|||
106106294|NCT01302847|366044014|FG001|Overall Study|Site unable to contact participant|1|||
106106295|NCT01302847|366044015|FG002|Overall Study|Site unable to contact participant|0|||
106106296|NCT01302847|366044016|FG003|Overall Study|Site unable to contact participant|0|||
106106297|NCT01302847|366044017|FG004|Overall Study|Site unable to contact participant|0|||
106106298|NCT01302847|366044018|FG005|Overall Study|Site unable to contact participant|0|||
106106299|NCT01302847|366044019|FG006|Overall Study|Site unable to contact participant|2|||
106106300|NCT01302847|366044020|FG007|Overall Study|Site unable to contact participant|0|||
106106301|NCT03969719|366044033|FG000|Overall Study|Other reasons not specified|1|||
106106302|NCT03969719|366044034|FG001|Overall Study|Other reasons not specified|1|||
106106303|NCT03969719|366044035|FG002|Overall Study|Other reasons not specified|3|||
106106304|NCT03969719|366044033|FG000|Overall Study|Withdrawal by Subject|2|||
106106305|NCT03969719|366044034|FG001|Overall Study|Withdrawal by Subject|3|||
106106306|NCT03969719|366044035|FG002|Overall Study|Withdrawal by Subject|2|||
106106307|NCT03969719|366044033|FG000|Overall Study|Protocol Violation|1|||
106106308|NCT03969719|366044034|FG001|Overall Study|Protocol Violation|2|||
106106309|NCT03969719|366044035|FG002|Overall Study|Protocol Violation|0|||
106106310|NCT03969719|366044033|FG000|Overall Study|Adverse Event|0|||
106106311|NCT03969719|366044034|FG001|Overall Study|Adverse Event|2|||
106106312|NCT03969719|366044035|FG002|Overall Study|Adverse Event|0|||
106106313|NCT03969719|366044033|FG000|Overall Study|Lost to Follow-up|0|||
106106314|NCT03969719|366044034|FG001|Overall Study|Lost to Follow-up|1|||
106106315|NCT03969719|366044035|FG002|Overall Study|Lost to Follow-up|0|||
106106316|NCT00058123|366044039|FG000|Overall Study|Wrong histology|9|||
106106317|NCT00058123|366044039|FG000|Overall Study|Received >3 prior treatments|1|||
106106318|NCT02130193|366044040|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
106106319|NCT02130193|366044041|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
106106320|NCT02130193|366044042|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
106144084|NCT01317420|366186955|FG006|Overall Study|Other adverse event|0|||
105782302|NCT01801475|364856149|FG004|Overall Study|Withdrawal by Subject|1|||
105782303|NCT05056311|364856150|FG000|Overall Study|Lost to Follow-up|14|||
105782304|NCT05056311|364856150|FG000|Overall Study|Withdrawal by Subject|1|||
105782305|NCT05056311|364856150|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
105782306|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
105782307|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
105782308|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
105782309|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
106106321|NCT02130193|366044040|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
106106322|NCT02130193|366044041|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
106106323|NCT02130193|366044042|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
106106324|NCT02130193|366044040|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
106106325|NCT02130193|366044041|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
106106326|NCT02130193|366044042|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
106106327|NCT02130193|366044040|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
106106328|NCT02130193|366044041|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
106106329|NCT02130193|366044042|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
106106330|NCT01212770|366044043|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
106106331|NCT01212770|366044044|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
106106332|NCT01212770|366044045|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
106106333|NCT01212770|366044046|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106106334|NCT01212770|366044047|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106106335|NCT01212770|366044048|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106106336|NCT01212770|366044049|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106106337|NCT01212770|366044050|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106106338|NCT01212770|366044051|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106106339|NCT01212770|366044043|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
106106340|NCT01212770|366044044|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
106106341|NCT01212770|366044045|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
106106342|NCT01212770|366044046|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106106343|NCT01212770|366044047|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106106344|NCT01212770|366044048|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106106345|NCT01212770|366044049|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106106346|NCT01212770|366044050|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106106347|NCT01212770|366044051|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106106348|NCT01212770|366044043|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
106106349|NCT01212770|366044044|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
106106350|NCT01212770|366044045|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
106106351|NCT01212770|366044046|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106106352|NCT01212770|366044047|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106106353|NCT01212770|366044048|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106106354|NCT01212770|366044049|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106106355|NCT01212770|366044050|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106106356|NCT01212770|366044051|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106106357|NCT01212770|366044043|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
106106358|NCT01212770|366044044|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106106359|NCT01212770|366044045|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
106106360|NCT01212770|366044046|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106106361|NCT01212770|366044047|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106106362|NCT01212770|366044048|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106106363|NCT01212770|366044049|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106106364|NCT01212770|366044050|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106106365|NCT01212770|366044051|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106106366|NCT01212770|366044043|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106106367|NCT01212770|366044044|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106106368|NCT01212770|366044045|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
106106369|NCT01212770|366044046|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106106370|NCT01212770|366044047|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106106371|NCT01212770|366044048|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106106372|NCT01212770|366044049|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106106373|NCT01212770|366044050|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106106374|NCT01212770|366044051|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106106375|NCT01212770|366044043|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
106106376|NCT01212770|366044044|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
106106377|NCT01212770|366044045|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
106144085|NCT01317420|366186956|FG007|Overall Study|Other adverse event|0|||
105782310|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
106106378|NCT01212770|366044046|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
106106379|NCT01212770|366044047|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
106106380|NCT01212770|366044048|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
106106381|NCT01212770|366044049|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
106106382|NCT01212770|366044050|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
106106383|NCT01212770|366044051|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
106106384|NCT01212770|366044043|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
106106385|NCT01212770|366044044|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
106106386|NCT01212770|366044045|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
106106387|NCT01212770|366044046|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
106106388|NCT01212770|366044047|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
106106389|NCT01212770|366044048|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
106106390|NCT01212770|366044049|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
106106391|NCT01212770|366044050|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
106106392|NCT01212770|366044051|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
106106393|NCT01212770|366044043|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
106106394|NCT01212770|366044044|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
106106395|NCT01212770|366044045|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
106106396|NCT01212770|366044046|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
106106397|NCT01212770|366044047|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
106106398|NCT01212770|366044048|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
106106399|NCT01212770|366044049|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
106106400|NCT01212770|366044050|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
106106401|NCT01212770|366044051|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
106106402|NCT01212770|366044043|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
106106403|NCT01212770|366044044|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
106106404|NCT01212770|366044045|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
106106405|NCT01212770|366044046|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
106106406|NCT01212770|366044047|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
106106407|NCT01212770|366044048|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
106106408|NCT01212770|366044049|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
106106409|NCT01212770|366044050|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
106106410|NCT01212770|366044051|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
106106411|NCT01212770|366044043|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
106106412|NCT01212770|366044044|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
106106413|NCT01212770|366044045|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
106106414|NCT01212770|366044046|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
106106415|NCT01212770|366044047|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
106106416|NCT01212770|366044048|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
106106417|NCT01212770|366044049|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
106106418|NCT01212770|366044050|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
106106419|NCT01212770|366044051|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
106106420|NCT01212770|366044043|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
106106421|NCT01212770|366044044|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
106106422|NCT01212770|366044045|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
106106423|NCT01212770|366044046|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
106106424|NCT01212770|366044047|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
106106425|NCT01212770|366044048|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
106106426|NCT01212770|366044049|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
106106427|NCT01212770|366044050|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
106106428|NCT01212770|366044051|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
106106429|NCT01212770|366044043|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
106106430|NCT01212770|366044044|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
106106431|NCT01212770|366044045|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
106106432|NCT01212770|366044046|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
106106433|NCT01212770|366044047|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
106106434|NCT01212770|366044048|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
106106435|NCT01212770|366044049|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105782311|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
105782312|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
105782313|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
106106436|NCT01212770|366044050|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
105782314|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
106106437|NCT01212770|366044051|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
106106438|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
106106439|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
106106440|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
106106441|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
106106442|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
106106443|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
106106444|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
106106445|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
106106446|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
106106447|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
106106448|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
106106449|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
106106450|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
106106451|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
106106452|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
106106453|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
106106454|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
106106455|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
106106456|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
106106457|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
106106458|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
106106459|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
106106460|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
106106461|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
106106462|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
106106463|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
106106464|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
106106465|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106106466|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
106106467|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
106106468|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106106469|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106106470|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106106471|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106106472|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
106106473|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
106106474|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
106106475|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
106106476|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
106106477|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
106106478|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
106106479|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
106106480|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
106106481|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
106106482|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
106106483|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
106106484|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
106106485|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
106106486|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
106106487|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
106106488|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
106106489|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
106106490|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
106106491|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
106106492|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
106106493|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
106106494|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
106106495|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
106106496|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
106106497|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
106106498|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
106106499|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
106106500|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
106106501|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
106106502|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
106106503|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
106106504|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
106106505|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
106106506|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
106106507|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
106106508|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
106106509|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
106106510|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106106511|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
106106512|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
106106513|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106106514|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106106515|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106106516|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106106517|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
106106518|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
106106519|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
106106520|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
106106521|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
106106522|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
106106523|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
106106524|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
106106525|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
106106526|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
106106527|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
106106528|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
106106529|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
106106530|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
106106531|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
106106532|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
106106533|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
106106534|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
106106535|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
106106536|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
106106537|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
106106538|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
106106539|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
106106540|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
106106541|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
106106542|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
106106543|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
106106544|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
106106545|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
106106546|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
106106547|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
106106548|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
106106549|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
106106550|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
106106551|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
106106552|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
106106553|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
106106554|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
106106555|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
106106556|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
106106557|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
106106558|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
106106559|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
106106560|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
106106561|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
106106562|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
106106563|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
106106564|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
106106565|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
106106566|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
106106567|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
106106568|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
106106569|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
106106570|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
106106571|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
106144086|NCT01317420|366186957|FG008|Overall Study|Other adverse event|0|||
106106572|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
106106573|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106106574|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
106106575|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
106106576|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106106577|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106106578|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106106579|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106106580|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106106581|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106106582|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
106106583|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
106106584|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
106106585|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
106106586|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
106106587|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
106106588|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
106106589|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
106106590|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
106106591|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
106106592|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
106106593|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
106106594|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
106106595|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
106106596|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
106106597|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
106106598|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
106106599|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
106106600|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
106106601|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
106106602|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
106106603|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
106106604|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
106106605|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
106106606|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
106106607|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
106106608|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
106106609|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
106106610|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
106106611|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
106106612|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
106106613|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
106106614|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
106106615|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
106106616|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
106106617|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
106106618|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
106106619|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
106106620|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
106106621|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
106106622|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
106106623|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
106106624|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
106106625|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
106106626|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
106106627|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
106106628|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
106106629|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
106106630|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
106106631|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
106106632|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
106106633|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
106106634|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
106106635|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
106106636|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106106637|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
106106638|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
106106639|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106106640|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106144087|NCT01317420|366186958|FG009|Overall Study|Other adverse event|0|||
105782315|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
105782316|NCT02528643|364856151|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
105782317|NCT02528643|364856152|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
105782318|NCT02528643|364856151|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
105782319|NCT02528643|364856152|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
105782320|NCT00438815|364856153|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
105782321|NCT00438815|364856153|FG000|Overall Study|3-month follow-up no longer required|12|||
105782322|NCT00438815|364856153|FG000|Overall Study|Noncompliance with protocol requirements|9|||
105782323|NCT00438815|364856153|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
105782324|NCT00438815|364856153|FG000|Overall Study|Lost to Follow-up|6|||
105782325|NCT00438815|364856153|FG000|Overall Study|Withdrawal by Subject|6|||
105782326|NCT00438815|364856153|FG000|Overall Study|Death|1|||
105782327|NCT01399619|364856154|FG000|Overall Study|Adverse Event|10|||
105782328|NCT01399619|364856155|FG001|Overall Study|Adverse Event|0|||
105782329|NCT01399619|364856156|FG002|Overall Study|Adverse Event|4|||
105782330|NCT01399619|364856157|FG003|Overall Study|Adverse Event|10|||
105782331|NCT01399619|364856154|FG000|Overall Study|Lack of Efficacy|9|||
105782332|NCT01399619|364856155|FG001|Overall Study|Lack of Efficacy|0|||
105782333|NCT01399619|364856156|FG002|Overall Study|Lack of Efficacy|5|||
105782334|NCT01399619|364856157|FG003|Overall Study|Lack of Efficacy|0|||
105782335|NCT01399619|364856154|FG000|Overall Study|Withdrawal by Subject|6|||
105782336|NCT01399619|364856155|FG001|Overall Study|Withdrawal by Subject|0|||
105782337|NCT01399619|364856156|FG002|Overall Study|Withdrawal by Subject|3|||
105782338|NCT01399619|364856157|FG003|Overall Study|Withdrawal by Subject|4|||
105782339|NCT01399619|364856154|FG000|Overall Study|Protocol Violation|0|||
105782340|NCT01399619|364856155|FG001|Overall Study|Protocol Violation|0|||
105782341|NCT01399619|364856156|FG002|Overall Study|Protocol Violation|0|||
105782342|NCT01399619|364856157|FG003|Overall Study|Protocol Violation|1|||
105782343|NCT01399619|364856154|FG000|Overall Study|Not treated|0|||
105782344|NCT01399619|364856155|FG001|Overall Study|Not treated|0|||
105782345|NCT01399619|364856156|FG002|Overall Study|Not treated|0|||
105782346|NCT01399619|364856157|FG003|Overall Study|Not treated|2|||
105782347|NCT02545270|364856161|FG000|Overall Study|technical difficulties|0|||
105782348|NCT02545270|364856162|FG001|Overall Study|technical difficulties|1|||
105782349|NCT02545270|364856163|FG002|Overall Study|technical difficulties|0|||
105782350|NCT02545270|364856161|FG000|Overall Study|Videos being too similar to other|0|||
105782351|NCT02545270|364856162|FG001|Overall Study|Videos being too similar to other|0|||
105782352|NCT02545270|364856163|FG002|Overall Study|Videos being too similar to other|2|||
105782353|NCT03814499|364856173|FG000|Overall Study|Lost to Follow-up|3|||
106106641|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106106642|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106106643|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
106106644|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106106645|NCT01212770|366044043|FG000|Long-term Safety Phase (Year 5)|Death|0|||
106106646|NCT01212770|366044044|FG001|Long-term Safety Phase (Year 5)|Death|0|||
106106647|NCT01212770|366044045|FG002|Long-term Safety Phase (Year 5)|Death|0|||
106106648|NCT01212770|366044046|FG003|Long-term Safety Phase (Year 5)|Death|0|||
106106649|NCT01212770|366044047|FG004|Long-term Safety Phase (Year 5)|Death|0|||
106106650|NCT01212770|366044048|FG005|Long-term Safety Phase (Year 5)|Death|0|||
106106651|NCT01212770|366044049|FG006|Long-term Safety Phase (Year 5)|Death|0|||
106106652|NCT01212770|366044050|FG007|Long-term Safety Phase (Year 5)|Death|1|||
106106653|NCT01212770|366044051|FG008|Long-term Safety Phase (Year 5)|Death|0|||
106106654|NCT01667432|366044054|FG000|Overall Study|Premature Study Termination|26|||
106106655|NCT01667432|366044054|FG000|Overall Study|Failure to Return|10|||
106106656|NCT01667432|366044054|FG000|Overall Study|Moved to Another Center|3|||
106106657|NCT01667432|366044054|FG000|Overall Study|Lost to Follow-up|3|||
106106658|NCT01667432|366044054|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
106106659|NCT01667432|366044054|FG000|Overall Study|Insufficient Therapeutic Response|4|||
106106660|NCT01667432|366044054|FG000|Overall Study|Adverse Event|1|||
106106661|NCT01667432|366044054|FG000|Overall Study|Protocol Deviation|2|||
106106662|NCT01667432|366044054|FG000|Overall Study|Principal Investigator Decision|1|||
106106663|NCT01667432|366044054|FG000|Overall Study|Reason Not Specified|2|||
106106664|NCT01667432|366044054|FG000|Overall Study|Missing Information|4|||
106106665|NCT03762473|366044055|FG000|Overall Study|Death|1|||
106106666|NCT03762473|366044056|FG001|Overall Study|Death|0|||
106106667|NCT00829387|366044057|FG000|Overall Study|Withdrawal by Subject|2|||
106106668|NCT00829387|366044058|FG001|Overall Study|Withdrawal by Subject|3|||
106106669|NCT00829387|366044057|FG000|Overall Study|Disqualified by PI|1|||
105782354|NCT01980056|364856174|FG000|Overall Study|Death|1|||
105782355|NCT01980056|364856175|FG001|Overall Study|Death|1|||
105782356|NCT01980056|364856176|FG002|Overall Study|Death|0|||
105782357|NCT00351611|364856177|FG000|Overall Study|Adverse Event|11|||
105782358|NCT00351611|364856178|FG001|Overall Study|Adverse Event|3|||
105782359|NCT00351611|364856177|FG000|Overall Study|Death|1|||
105782360|NCT00351611|364856178|FG001|Overall Study|Death|0|||
105782361|NCT00351611|364856177|FG000|Overall Study|Lost to Follow-up|1|||
105782362|NCT00351611|364856178|FG001|Overall Study|Lost to Follow-up|0|||
105782363|NCT00351611|364856177|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
105782364|NCT00351611|364856178|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
105782365|NCT00351611|364856177|FG000|Overall Study|Other|1|||
105782366|NCT00351611|364856178|FG001|Overall Study|Other|0|||
105782367|NCT00351611|364856177|FG000|Overall Study|Protocol Violation|0|||
105782368|NCT00351611|364856178|FG001|Overall Study|Protocol Violation|2|||
105782369|NCT02046993|364856179|FG000|Overall Study|Withdrawal by Subject|2|||
105782370|NCT02046993|364856180|FG001|Overall Study|Withdrawal by Subject|10|||
105782371|NCT02046993|364856179|FG000|Overall Study|Lost to Follow-up|1|||
105782372|NCT02046993|364856180|FG001|Overall Study|Lost to Follow-up|1|||
105782373|NCT01589185|364856181|FG000|Overall Study|Death|1|||
105782374|NCT01589185|364856182|FG001|Overall Study|Death|2|||
105782375|NCT01589185|364856183|FG002|Overall Study|Death|2|||
105782376|NCT01589185|364856184|FG003|Overall Study|Death|0|||
105782377|NCT01589185|364856185|FG004|Overall Study|Death|1|||
105782378|NCT01589185|364856181|FG000|Overall Study|Lost to Follow-up|1|||
105782379|NCT01589185|364856182|FG001|Overall Study|Lost to Follow-up|0|||
105782380|NCT01589185|364856183|FG002|Overall Study|Lost to Follow-up|2|||
105782381|NCT01589185|364856184|FG003|Overall Study|Lost to Follow-up|3|||
105782382|NCT01589185|364856185|FG004|Overall Study|Lost to Follow-up|0|||
105782383|NCT00598442|364856188|FG000|Overall Study|Adverse Event|3|||
106106670|NCT00829387|366044058|FG001|Overall Study|Disqualified by PI|0|||
106106671|NCT02077166|366044068|FG000|Overall Study|Death|6|||
106106672|NCT02077166|366044069|FG001|Overall Study|Death|7|||
106106673|NCT02077166|366044070|FG002|Overall Study|Death|5|||
106106674|NCT02077166|366044071|FG003|Overall Study|Death|6|||
106106675|NCT02077166|366044072|FG004|Overall Study|Death|4|||
106106676|NCT02077166|366044073|FG005|Overall Study|Death|32|||
106106677|NCT02077166|366044074|FG006|Overall Study|Death|22|||
106106678|NCT02077166|366044068|FG000|Overall Study|Study Closure by Sponsor|3|||
106106679|NCT02077166|366044069|FG001|Overall Study|Study Closure by Sponsor|0|||
106106680|NCT02077166|366044070|FG002|Overall Study|Study Closure by Sponsor|2|||
106106681|NCT02077166|366044071|FG003|Overall Study|Study Closure by Sponsor|2|||
106106682|NCT02077166|366044072|FG004|Overall Study|Study Closure by Sponsor|2|||
106106683|NCT02077166|366044073|FG005|Overall Study|Study Closure by Sponsor|12|||
106106684|NCT02077166|366044074|FG006|Overall Study|Study Closure by Sponsor|4|||
106106685|NCT02077166|366044068|FG000|Overall Study|Lost to Follow-up|0|||
106106686|NCT02077166|366044069|FG001|Overall Study|Lost to Follow-up|0|||
106106687|NCT02077166|366044070|FG002|Overall Study|Lost to Follow-up|0|||
106106688|NCT02077166|366044071|FG003|Overall Study|Lost to Follow-up|0|||
106106689|NCT02077166|366044072|FG004|Overall Study|Lost to Follow-up|0|||
106106690|NCT02077166|366044073|FG005|Overall Study|Lost to Follow-up|1|||
106106691|NCT02077166|366044074|FG006|Overall Study|Lost to Follow-up|0|||
106106692|NCT02077166|366044068|FG000|Overall Study|Withdrawal by Subject|3|||
106106693|NCT02077166|366044069|FG001|Overall Study|Withdrawal by Subject|0|||
106106694|NCT02077166|366044070|FG002|Overall Study|Withdrawal by Subject|1|||
106106695|NCT02077166|366044071|FG003|Overall Study|Withdrawal by Subject|1|||
106106696|NCT02077166|366044072|FG004|Overall Study|Withdrawal by Subject|1|||
106106697|NCT02077166|366044073|FG005|Overall Study|Withdrawal by Subject|3|||
106106698|NCT02077166|366044074|FG006|Overall Study|Withdrawal by Subject|0|||
106106699|NCT02077166|366044068|FG000|Overall Study|Other, Not Specified|0|||
106106700|NCT02077166|366044069|FG001|Overall Study|Other, Not Specified|0|||
106106701|NCT02077166|366044070|FG002|Overall Study|Other, Not Specified|1|||
106106702|NCT02077166|366044071|FG003|Overall Study|Other, Not Specified|0|||
106106703|NCT02077166|366044072|FG004|Overall Study|Other, Not Specified|1|||
106106704|NCT02077166|366044073|FG005|Overall Study|Other, Not Specified|7|||
106106705|NCT02077166|366044074|FG006|Overall Study|Other, Not Specified|8|||
106106706|NCT00707031|366044075|FG000|Overall Study|Adverse Event|45|||
106106707|NCT00707031|366044076|FG001|Overall Study|Adverse Event|45|||
106106708|NCT00707031|366044075|FG000|Overall Study|Lack of Efficacy|19|||
106106709|NCT00707031|366044076|FG001|Overall Study|Lack of Efficacy|6|||
106106710|NCT00707031|366044075|FG000|Overall Study|Lost to Follow-up|2|||
106106711|NCT00707031|366044076|FG001|Overall Study|Lost to Follow-up|1|||
105782384|NCT00598442|364856189|FG001|Overall Study|Adverse Event|0|||
105782385|NCT00598442|364856190|FG002|Overall Study|Adverse Event|0|||
105782386|NCT00598442|364856188|FG000|Overall Study|Death|19|||
106106712|NCT00707031|366044075|FG000|Overall Study|Protocol Violation|1|||
106106713|NCT00707031|366044076|FG001|Overall Study|Protocol Violation|0|||
106106714|NCT00707031|366044075|FG000|Overall Study|Withdrawal by Subject|7|||
106106715|NCT00707031|366044076|FG001|Overall Study|Withdrawal by Subject|8|||
105782387|NCT00598442|364856189|FG001|Overall Study|Death|11|||
105782388|NCT00598442|364856190|FG002|Overall Study|Death|11|||
105782389|NCT00598442|364856188|FG000|Overall Study|Lost to Follow-up|4|||
105782390|NCT00598442|364856189|FG001|Overall Study|Lost to Follow-up|3|||
105782391|NCT00598442|364856190|FG002|Overall Study|Lost to Follow-up|3|||
105782392|NCT00598442|364856188|FG000|Overall Study|Physician Decision|2|||
105782393|NCT00598442|364856189|FG001|Overall Study|Physician Decision|1|||
105782394|NCT00598442|364856190|FG002|Overall Study|Physician Decision|1|||
105782395|NCT00598442|364856188|FG000|Overall Study|Withdrawal by Subject|8|||
106106716|NCT00707031|366044075|FG000|Overall Study|Poor Compliance to Protocol|7|||
106106717|NCT00707031|366044076|FG001|Overall Study|Poor Compliance to Protocol|13|||
106106718|NCT00707031|366044075|FG000|Overall Study|Familial or Personal Reasons|12|||
106106719|NCT00707031|366044076|FG001|Overall Study|Familial or Personal Reasons|15|||
106106720|NCT00707031|366044075|FG000|Overall Study|Serious Noncompliance|2|||
106106721|NCT00707031|366044076|FG001|Overall Study|Serious Noncompliance|3|||
106106722|NCT00707031|366044075|FG000|Overall Study|Sponsor Decision|9|||
106106723|NCT00707031|366044076|FG001|Overall Study|Sponsor Decision|8|||
106106724|NCT02747238|366044083|FG000|Overall Study|Lack of Efficacy|0|||
106106725|NCT02747238|366044084|FG001|Overall Study|Lack of Efficacy|1|||
106106726|NCT02747238|366044083|FG000|Overall Study|Data lost|3|||
106106727|NCT02747238|366044084|FG001|Overall Study|Data lost|5|||
106106728|NCT02085252|366044085|FG000|Overall Study|Withdrawal of Consent|1|||
106106729|NCT02085252|366044086|FG001|Overall Study|Withdrawal of Consent|0|||
106106730|NCT02085252|366044085|FG000|Overall Study|Adverse Event|0|||
106106731|NCT02085252|366044086|FG001|Overall Study|Adverse Event|1|||
106106732|NCT02085252|366044085|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
106106733|NCT02085252|366044086|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
106106734|NCT02085252|366044085|FG000|Overall Study|Reason Not Specified|0|||
106106735|NCT02085252|366044086|FG001|Overall Study|Reason Not Specified|1|||
106106736|NCT02085252|366044085|FG000|Overall Study|Reason Unknown|0|||
106106737|NCT02085252|366044086|FG001|Overall Study|Reason Unknown|1|||
106106738|NCT03832595|366044087|FG000|Overall Study|Death|142|||
106106739|NCT03832595|366044088|FG001|Overall Study|Death|130|||
106106740|NCT03832595|366044087|FG000|Overall Study|Medical management without dialysis|37|||
106106741|NCT03832595|366044088|FG001|Overall Study|Medical management without dialysis|1|||
106106742|NCT02979639|366045871|FG000|Overall Study|Withdrawal based on medical judgement|1|||
106106743|NCT02979639|366045871|FG000|Overall Study|Lost to Follow-up|8|||
106106744|NCT02979639|366045871|FG000|Overall Study|Withdrawal by Subject|3|||
106106745|NCT02979639|366045871|FG000|Overall Study|Adverse Event|2|||
106106746|NCT00175825|366045878|FG000|Overall Study|Adverse Event|3|||
106106747|NCT00175825|366045879|FG001|Overall Study|Adverse Event|2|||
106106748|NCT00175825|366045880|FG002|Overall Study|Adverse Event|1|||
106106749|NCT00175825|366045881|FG003|Overall Study|Adverse Event|1|||
106106750|NCT00175825|366045878|FG000|Overall Study|Lost to Follow-up|1|||
106106751|NCT00175825|366045879|FG001|Overall Study|Lost to Follow-up|2|||
106106752|NCT00175825|366045880|FG002|Overall Study|Lost to Follow-up|0|||
106106753|NCT00175825|366045881|FG003|Overall Study|Lost to Follow-up|0|||
106106754|NCT00175825|366045878|FG000|Overall Study|Withdrawal by Subject|1|||
106106755|NCT00175825|366045879|FG001|Overall Study|Withdrawal by Subject|0|||
106106756|NCT00175825|366045880|FG002|Overall Study|Withdrawal by Subject|0|||
106106757|NCT00175825|366045881|FG003|Overall Study|Withdrawal by Subject|0|||
106106758|NCT02030015|366045882|FG000|Overall Study|Withdrawal by Subject|3|||
106106759|NCT02030015|366045882|FG000|Overall Study|Death|13|||
106106760|NCT03014674|366045883|FG000|Overall Study|Withdrawal by Subject|1|||
106106761|NCT03014674|366045884|FG001|Overall Study|Withdrawal by Subject|0|||
106106762|NCT03014674|366045885|FG002|Overall Study|Withdrawal by Subject|0|||
106106763|NCT01332227|366045886|FG000|Overall Study|Adverse Event|4|||
106106764|NCT01332227|366045887|FG001|Overall Study|Adverse Event|1|||
106106765|NCT01332227|366045886|FG000|Overall Study|Withdrawal by Subject|5|||
106106766|NCT01332227|366045887|FG001|Overall Study|Withdrawal by Subject|1|||
106106767|NCT01332227|366045886|FG000|Overall Study|Lost to Follow-up|2|||
106106768|NCT01332227|366045887|FG001|Overall Study|Lost to Follow-up|0|||
106106769|NCT01332227|366045886|FG000|Overall Study|Lack of Efficacy|3|||
106106770|NCT01332227|366045887|FG001|Overall Study|Lack of Efficacy|1|||
106106771|NCT01332227|366045886|FG000|Overall Study|Poor compliance/noncompliance|1|||
106106772|NCT01332227|366045887|FG001|Overall Study|Poor compliance/noncompliance|1|||
106106773|NCT01332227|366045886|FG000|Overall Study|Patient moved from area|1|||
106106774|NCT01332227|366045887|FG001|Overall Study|Patient moved from area|0|||
106106775|NCT01332227|366045886|FG000|Overall Study|Patient began prohibited medication|0|||
106106776|NCT01332227|366045887|FG001|Overall Study|Patient began prohibited medication|1|||
106106777|NCT02173548|366045893|FG000|Overall Study|Lost to Follow-up|0|||
106106778|NCT02173548|366045894|FG001|Overall Study|Lost to Follow-up|2|||
106106779|NCT02173548|366045893|FG000|Overall Study|Withdrawal by Subject|1|||
106106780|NCT02173548|366045894|FG001|Overall Study|Withdrawal by Subject|0|||
106106781|NCT03597568|366045898|FG000|Overall Study|Withdrawal by Subject|1|||
106106782|NCT03597568|366045899|FG001|Overall Study|Withdrawal by Subject|1|||
106106783|NCT03597568|366045898|FG000|Overall Study|Unable to analyze vascular data|1|||
106106784|NCT03597568|366045899|FG001|Overall Study|Unable to analyze vascular data|1|||
106106785|NCT01621126|366045900|FG000|Overall Study|Physician Decision|6|||
106106786|NCT01949311|366045901|FG000|Overall Study|Lost to Follow-up|73|||
106106787|NCT01949311|366045901|FG000|Overall Study|Terminated by Sponsor|708|||
106106788|NCT01949311|366045901|FG000|Overall Study|Withdrawal by Subject|375|||
106106789|NCT01949311|366045901|FG000|Overall Study|Lack of Efficacy|50|||
106106790|NCT01949311|366045901|FG000|Overall Study|Protocol Deviation|34|||
106106791|NCT01949311|366045901|FG000|Overall Study|Pregnancy|20|||
106106792|NCT01949311|366045901|FG000|Overall Study|Physician Decision|9|||
106106793|NCT01949311|366045901|FG000|Overall Study|Other|4|||
106106794|NCT01949311|366045901|FG000|Overall Study|Adverse Event|107|||
106106795|NCT03751631|366045902|FG000|Overall Study|Withdrawal by Subject|0|||
106106796|NCT03751631|366045903|FG001|Overall Study|Withdrawal by Subject|0|||
106106797|NCT03751631|366045904|FG002|Overall Study|Withdrawal by Subject|1|||
106106798|NCT03751631|366045905|FG003|Overall Study|Withdrawal by Subject|1|||
106106799|NCT03751631|366045906|FG004|Overall Study|Withdrawal by Subject|0|||
106106800|NCT03751631|366045907|FG005|Overall Study|Withdrawal by Subject|0|||
106106801|NCT03224182|366045908|FG000|Overall Study|Study Drug Not Instilled|6|||
106106802|NCT03224182|366045909|FG001|Overall Study|Study Drug Not Instilled|1|||
106106803|NCT03224182|366045908|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
106106804|NCT03224182|366045909|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
106106805|NCT03224182|366045908|FG000|Overall Study|Withdrew of Consent|4|||
106106806|NCT03224182|366045909|FG001|Overall Study|Withdrew of Consent|2|||
106106807|NCT03224182|366045908|FG000|Overall Study|Investigator Decision|3|||
106106808|NCT03224182|366045909|FG001|Overall Study|Investigator Decision|1|||
106106809|NCT03224182|366045908|FG000|Overall Study|Sponsor Decision|26|||
105782396|NCT00598442|364856189|FG001|Overall Study|Withdrawal by Subject|16|||
106106810|NCT03224182|366045909|FG001|Overall Study|Sponsor Decision|12|||
106106811|NCT03224182|366045908|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
106106812|NCT03224182|366045909|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
106106813|NCT03224182|366045908|FG000|Overall Study|Lost to Follow-up|1|||
106106814|NCT03224182|366045909|FG001|Overall Study|Lost to Follow-up|0|||
106106815|NCT03224182|366045908|FG000|Overall Study|Participant Had Recurrence|11|||
106106816|NCT03224182|366045909|FG001|Overall Study|Participant Had Recurrence|5|||
106106817|NCT03224182|366045908|FG000|Overall Study|Death|0|||
106106818|NCT03224182|366045909|FG001|Overall Study|Death|1|||
106106819|NCT03224182|366045908|FG000|Overall Study|Reason not Specified|3|||
106106820|NCT03224182|366045909|FG001|Overall Study|Reason not Specified|3|||
106106821|NCT03224182|366045908|FG000|Overall Study|Other|1|||
106106822|NCT03224182|366045909|FG001|Overall Study|Other|0|||
106106823|NCT02481310|366045910|FG000|Follow up|Still in follow up|0|||
106106824|NCT02481310|366045911|FG001|Follow up|Still in follow up|3|||
106106825|NCT02481310|366045912|FG002|Follow up|Still in follow up|0|||
106106826|NCT00833560|366045913|FG000|Overall Study|Toxicity|13|||
106106827|NCT00833560|366045913|FG000|Overall Study|Adverse Event|11|||
106106828|NCT00833560|366045913|FG000|Overall Study|Protocol Violation|6|||
106106829|NCT00833560|366045913|FG000|Overall Study|Lack of Efficacy|4|||
106106830|NCT00833560|366045913|FG000|Overall Study|Death|2|||
106106831|NCT00833560|366045913|FG000|Overall Study|Pregression of other disease|1|||
106106832|NCT00833560|366045913|FG000|Overall Study|Other|5|||
106106833|NCT02184611|366045916|FG000|Overall Study|Lack of Efficacy|11|||
106106834|NCT02184611|366045917|FG001|Overall Study|Lack of Efficacy|15|||
106106835|NCT02184611|366045916|FG000|Overall Study|Withdrawal by Subject|5|||
106106836|NCT02184611|366045917|FG001|Overall Study|Withdrawal by Subject|6|||
106106837|NCT02184611|366045916|FG000|Overall Study|Adverse Event|4|||
106106838|NCT02184611|366045917|FG001|Overall Study|Adverse Event|5|||
106106839|NCT02184611|366045916|FG000|Overall Study|Protocol Violation|1|||
106106840|NCT02184611|366045917|FG001|Overall Study|Protocol Violation|1|||
106106841|NCT02184611|366045916|FG000|Overall Study|Protocol defined stopping criteria|0|||
106106842|NCT02184611|366045917|FG001|Overall Study|Protocol defined stopping criteria|1|||
106106843|NCT02366910|366045924|FG000|Overall Study|Withdrawal by Subject|2|||
106106844|NCT02366910|366045924|FG000|Overall Study|Screen Failure|3|||
106106845|NCT00985725|366045925|FG000|Overall Study|Adverse Event|4|||
106106846|NCT00985725|366045926|FG001|Overall Study|Adverse Event|1|||
106106847|NCT00985725|366045925|FG000|Overall Study|Protocol Violation|1|||
106106848|NCT00985725|366045926|FG001|Overall Study|Protocol Violation|3|||
105782397|NCT00598442|364856190|FG002|Overall Study|Withdrawal by Subject|6|||
105782398|NCT00598442|364856188|FG000|Overall Study|Noncompliance|0|||
105782399|NCT00598442|364856189|FG001|Overall Study|Noncompliance|2|||
105782400|NCT00598442|364856190|FG002|Overall Study|Noncompliance|1|||
105782401|NCT00598442|364856188|FG000|Overall Study|Relocation|1|||
105782402|NCT00598442|364856189|FG001|Overall Study|Relocation|4|||
105782403|NCT00598442|364856190|FG002|Overall Study|Relocation|0|||
105782404|NCT00598442|364856188|FG000|Overall Study|Renal transplant|0|||
105782405|NCT00598442|364856189|FG001|Overall Study|Renal transplant|0|||
105782406|NCT00598442|364856190|FG002|Overall Study|Renal transplant|1|||
105782407|NCT00598442|364856188|FG000|Overall Study|Site closed by sponsor|5|||
105782408|NCT00598442|364856189|FG001|Overall Study|Site closed by sponsor|2|||
105782409|NCT00598442|364856190|FG002|Overall Study|Site closed by sponsor|1|||
105782410|NCT00598442|364856188|FG000|Overall Study|Started dialysis|1|||
105782411|NCT00598442|364856189|FG001|Overall Study|Started dialysis|0|||
105782412|NCT00598442|364856190|FG002|Overall Study|Started dialysis|0|||
106106849|NCT00985725|366045925|FG000|Overall Study|Withdrawal by Subject|4|||
106106850|NCT00985725|366045926|FG001|Overall Study|Withdrawal by Subject|4|||
106106851|NCT00985725|366045925|FG000|Overall Study|Lost to Follow-up|1|||
106106852|NCT00985725|366045926|FG001|Overall Study|Lost to Follow-up|1|||
106106853|NCT00985725|366045925|FG000|Overall Study|Lack of Efficacy|0|||
106106854|NCT00985725|366045926|FG001|Overall Study|Lack of Efficacy|1|||
106106855|NCT00985725|366045925|FG000|Overall Study|Non-compliance|1|||
106106856|NCT00985725|366045926|FG001|Overall Study|Non-compliance|2|||
106106857|NCT00985725|366045925|FG000|Overall Study|Out-of-window visits|0|||
106106858|NCT00985725|366045926|FG001|Overall Study|Out-of-window visits|1|||
106106859|NCT02623322|366045927|FG000|Overall Study|Lost to Follow-up|2|||
106106860|NCT02623322|366045928|FG001|Overall Study|Lost to Follow-up|1|||
106106861|NCT02623322|366045929|FG002|Overall Study|Lost to Follow-up|0|||
106106862|NCT03813238|366045933|FG000|Overall Study|Adverse Event|0|||
106106863|NCT03813238|366045934|FG001|Overall Study|Adverse Event|6|||
106106864|NCT03813238|366045933|FG000|Overall Study|Withdrawal by parent/guardian|0|||
106106865|NCT03813238|366045934|FG001|Overall Study|Withdrawal by parent/guardian|2|||
106106866|NCT03813238|366045933|FG000|Overall Study|Lost to Follow-up|0|||
106106867|NCT03813238|366045934|FG001|Overall Study|Lost to Follow-up|1|||
106106868|NCT03813238|366045933|FG000|Overall Study|Other than specified|1|||
106106869|NCT03813238|366045934|FG001|Overall Study|Other than specified|2|||
106106870|NCT03581981|366045935|FG000|Overall Study|Withdrawal by Subject|12|||
106106871|NCT03581981|366045936|FG001|Overall Study|Withdrawal by Subject|13|||
106106872|NCT03581981|366045935|FG000|Overall Study|Physician Decision|1|||
106106873|NCT03581981|366045936|FG001|Overall Study|Physician Decision|2|||
106106874|NCT03581981|366045935|FG000|Overall Study|Lost to Follow-up|0|||
106106875|NCT03581981|366045936|FG001|Overall Study|Lost to Follow-up|4|||
106106876|NCT02080871|366045937|FG000|Overall Study|Death|1|||
106106877|NCT02080871|366045937|FG000|Overall Study|Lost to Follow-up|1|||
106106878|NCT00234052|366045938|FG000|Treatment|Withdrawal by Subject|3|||
106106879|NCT00234052|366045938|FG000|Treatment|Adverse Event|5|||
106106880|NCT00234052|366045938|FG000|Treatment|Death|2|||
105782413|NCT01729559|364856196|FG000|Overall Study|Protocol Violation|31|||
105782414|NCT01729559|364856197|FG001|Overall Study|Protocol Violation|28|||
105782415|NCT01654666|364856201|FG000|Overall Study|Protocol Violation|7|||
105782416|NCT01654666|364856202|FG001|Overall Study|Protocol Violation|4|||
105782417|NCT01654666|364856203|FG002|Overall Study|Protocol Violation|8|||
105782418|NCT01654666|364856201|FG000|Overall Study|Lost to Follow-up|4|||
105782419|NCT01654666|364856202|FG001|Overall Study|Lost to Follow-up|5|||
105782420|NCT01654666|364856203|FG002|Overall Study|Lost to Follow-up|5|||
105782421|NCT01654666|364856201|FG000|Overall Study|Withdrawal by Subject|4|||
105782422|NCT01654666|364856202|FG001|Overall Study|Withdrawal by Subject|4|||
105782423|NCT01654666|364856203|FG002|Overall Study|Withdrawal by Subject|1|||
105782424|NCT00535262|364856204|FG000|Overall Study|No funding|3|||
106106881|NCT00234052|366045938|FG000|Treatment|Progressive Disease|11|||
106106882|NCT00234052|366045938|FG000|Follow-up for 5 Years|Death|41|||
106106883|NCT00234052|366045938|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
106106884|NCT00234052|366045938|FG000|Follow-up for 5 Years|Other|7|||
106106885|NCT05763628|366045939|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
106106886|NCT05763628|366045940|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
106106887|NCT05763628|366045939|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
106106888|NCT05763628|366045940|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
106106889|NCT05763628|366045939|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
106106890|NCT05763628|366045940|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
106106891|NCT04385368|366045941|FG000|Overall Study|Death|5|||
106106892|NCT04385368|366045942|FG001|Overall Study|Death|5|||
106106893|NCT04385368|366045941|FG000|Overall Study|Physician Decision|3|||
106106894|NCT04385368|366045942|FG001|Overall Study|Physician Decision|0|||
106106895|NCT04385368|366045941|FG000|Overall Study|Withdrawal by Subject|4|||
106106896|NCT04385368|366045942|FG001|Overall Study|Withdrawal by Subject|3|||
106106897|NCT03575325|366045948|FG000|Overall Study|Death|1|||
106106898|NCT04495179|366045949|FG000|Overall Study|Lost to Follow-up|0|||
106106899|NCT04495179|366045950|FG001|Overall Study|Lost to Follow-up|1|||
106106900|NCT04495179|366045949|FG000|Overall Study|Withdrawal by Subject|2|||
106106901|NCT04495179|366045950|FG001|Overall Study|Withdrawal by Subject|4|||
106106902|NCT04495179|366045949|FG000|Overall Study|Study terminated by sponsor|0|||
106106903|NCT04495179|366045950|FG001|Overall Study|Study terminated by sponsor|18|||
106106904|NCT04495179|366045949|FG000|Overall Study|Death|0|||
106106905|NCT04495179|366045950|FG001|Overall Study|Death|4|||
106106906|NCT04495179|366045949|FG000|Overall Study|Adverse Event|0|||
106106907|NCT04495179|366045950|FG001|Overall Study|Adverse Event|1|||
106106908|NCT02477111|366045951|FG000|Overall Study|Death|28|||
106106909|NCT02477111|366045951|FG000|Overall Study|Withdrawal by Subject|19|||
106106910|NCT02477111|366045951|FG000|Overall Study|Lost to Follow-up|4|||
106106911|NCT00162370|366045953|FG000|Efficacy Population|Lost to Follow-up|51|||
106106912|NCT02612311|366045954|FG000|Overall Study|Adverse Event|16|||
105782425|NCT00612456|364856210|FG000|Overall Study|Adverse Event|1|||
105782426|NCT00612456|364856211|FG001|Overall Study|Adverse Event|0|||
105782427|NCT00612456|364856212|FG002|Overall Study|Adverse Event|0|||
106106913|NCT02612311|366045955|FG001|Overall Study|Adverse Event|12|||
106106914|NCT02612311|366045956|FG002|Overall Study|Adverse Event|7|||
106106915|NCT02612311|366045957|FG003|Overall Study|Adverse Event|13|||
106106916|NCT02612311|366045954|FG000|Overall Study|Death|29|||
106106917|NCT02612311|366045955|FG001|Overall Study|Death|10|||
106106918|NCT02612311|366045956|FG002|Overall Study|Death|11|||
106106919|NCT02612311|366045957|FG003|Overall Study|Death|11|||
106106920|NCT02612311|366045954|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
106106921|NCT02612311|366045955|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
106106922|NCT02612311|366045956|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
106106923|NCT02612311|366045957|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
106106924|NCT02612311|366045954|FG000|Overall Study|Investigator's Decision|11|||
106106925|NCT02612311|366045955|FG001|Overall Study|Investigator's Decision|15|||
106106926|NCT02612311|366045956|FG002|Overall Study|Investigator's Decision|6|||
106106927|NCT02612311|366045957|FG003|Overall Study|Investigator's Decision|6|||
106106928|NCT02612311|366045954|FG000|Overall Study|Lack of Efficacy|0|||
106106929|NCT02612311|366045955|FG001|Overall Study|Lack of Efficacy|0|||
106106930|NCT02612311|366045956|FG002|Overall Study|Lack of Efficacy|1|||
106106931|NCT02612311|366045957|FG003|Overall Study|Lack of Efficacy|1|||
106106932|NCT02612311|366045954|FG000|Overall Study|Lost to Follow-up|2|||
106106933|NCT02612311|366045955|FG001|Overall Study|Lost to Follow-up|2|||
106106934|NCT02612311|366045956|FG002|Overall Study|Lost to Follow-up|1|||
106106935|NCT02612311|366045957|FG003|Overall Study|Lost to Follow-up|2|||
106106936|NCT02612311|366045954|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
106106937|NCT02612311|366045955|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
106106938|NCT02612311|366045956|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
106106939|NCT02612311|366045957|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
106106940|NCT02612311|366045954|FG000|Overall Study|Site Terminated by Sponsor|29|||
106106941|NCT02612311|366045955|FG001|Overall Study|Site Terminated by Sponsor|12|||
106106942|NCT02612311|366045956|FG002|Overall Study|Site Terminated by Sponsor|13|||
106106943|NCT02612311|366045957|FG003|Overall Study|Site Terminated by Sponsor|5|||
106106944|NCT02612311|366045954|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
106106945|NCT02612311|366045955|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
106106946|NCT02612311|366045956|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
106106947|NCT02612311|366045957|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
106106948|NCT02612311|366045954|FG000|Overall Study|Reason Not Specified|3|||
106106949|NCT02612311|366045955|FG001|Overall Study|Reason Not Specified|7|||
106106950|NCT02612311|366045956|FG002|Overall Study|Reason Not Specified|4|||
106106951|NCT02612311|366045957|FG003|Overall Study|Reason Not Specified|5|||
106106952|NCT02612311|366045954|FG000|Overall Study|Unknown/Missing|10|||
106106953|NCT02612311|366045955|FG001|Overall Study|Unknown/Missing|13|||
106106954|NCT02612311|366045956|FG002|Overall Study|Unknown/Missing|4|||
106106955|NCT02612311|366045957|FG003|Overall Study|Unknown/Missing|0|||
106106956|NCT02612311|366045954|FG000|Overall Study|Non-Compliance with Study|1|||
106106957|NCT02612311|366045955|FG001|Overall Study|Non-Compliance with Study|0|||
106106958|NCT02612311|366045956|FG002|Overall Study|Non-Compliance with Study|0|||
106106959|NCT02612311|366045957|FG003|Overall Study|Non-Compliance with Study|0|||
106106960|NCT04575051|366045958|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
106106961|NCT04575051|366045959|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
106106962|NCT04575051|366045960|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
106106963|NCT04575051|366045961|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
106106964|NCT04575051|366045962|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
106106965|NCT04575051|366045958|FG000|Time Period 1|Missing follow up|1|||
105992690|NCT00042991|365631608|FG001|Overall Study|Withdrawal by Subject|7|||
105992691|NCT00042991|365631609|FG002|Overall Study|Withdrawal by Subject|2|||
105992692|NCT00042991|365631610|FG003|Overall Study|Withdrawal by Subject|0|||
105992693|NCT00042991|365631611|FG004|Overall Study|Withdrawal by Subject|1|||
105992694|NCT00042991|365631612|FG005|Overall Study|Withdrawal by Subject|0|||
105992695|NCT00042991|365631613|FG006|Overall Study|Withdrawal by Subject|0|||
105992696|NCT00042991|365631607|FG000|Overall Study|Disease Progression|5|||
105992697|NCT00042991|365631608|FG001|Overall Study|Disease Progression|29|||
105992698|NCT00042991|365631609|FG002|Overall Study|Disease Progression|2|||
105992699|NCT00042991|365631610|FG003|Overall Study|Disease Progression|2|||
105992700|NCT00042991|365631611|FG004|Overall Study|Disease Progression|1|||
105992701|NCT00042991|365631612|FG005|Overall Study|Disease Progression|4|||
105992702|NCT00042991|365631613|FG006|Overall Study|Disease Progression|2|||
105992703|NCT00042991|365631607|FG000|Overall Study|Alternative Therapy|0|||
105992704|NCT00042991|365631608|FG001|Overall Study|Alternative Therapy|0|||
105992705|NCT00042991|365631609|FG002|Overall Study|Alternative Therapy|0|||
105992706|NCT00042991|365631610|FG003|Overall Study|Alternative Therapy|0|||
106106966|NCT04575051|366045959|FG001|Time Period 1|Missing follow up|3|||
106106967|NCT04575051|366045960|FG002|Time Period 1|Missing follow up|1|||
106106968|NCT04575051|366045961|FG003|Time Period 1|Missing follow up|3|||
106106969|NCT04575051|366045962|FG004|Time Period 1|Missing follow up|2|||
106106970|NCT04575051|366045958|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
105992707|NCT00042991|365631611|FG004|Overall Study|Alternative Therapy|1|||
105992708|NCT00042991|365631612|FG005|Overall Study|Alternative Therapy|0|||
105992709|NCT00042991|365631613|FG006|Overall Study|Alternative Therapy|0|||
105992710|NCT01153724|365631614|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105992711|NCT01153724|365631614|FG000|Treatment Period 2|Adverse Event|1|||
105992712|NCT01153724|365631614|FG000|Treatment Period 2|Other reason not defined above|1|||
105992713|NCT02697435|365631619|FG000|Overall Study|Withdrawal by Subject|1|||
105992714|NCT02697435|365631620|FG001|Overall Study|Withdrawal by Subject|0|||
105992715|NCT02697435|365631619|FG000|Overall Study|Physician Decision|0|||
105992716|NCT02697435|365631620|FG001|Overall Study|Physician Decision|4|||
105992717|NCT04371666|365631627|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
105992718|NCT04371666|365631628|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
105992719|NCT04371666|365631627|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
105992720|NCT04371666|365631628|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
105992721|NCT04371666|365631627|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
105992722|NCT04371666|365631628|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
105992723|NCT04371666|365631627|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
105992724|NCT04371666|365631628|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
105992725|NCT04371666|365631627|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
105992726|NCT04371666|365631628|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
105992727|NCT04371666|365631627|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
105992728|NCT04371666|365631628|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
105992729|NCT01445080|365631641|FG000|Overall Study|Adverse Event|5|||
105992730|NCT01445080|365631642|FG001|Overall Study|Adverse Event|3|||
105992731|NCT01445080|365631643|FG002|Overall Study|Adverse Event|11|||
105992732|NCT01445080|365631644|FG003|Overall Study|Adverse Event|6|||
105992733|NCT01445080|365631645|FG004|Overall Study|Adverse Event|2|||
105992734|NCT01445080|365631646|FG005|Overall Study|Adverse Event|3|||
105992735|NCT01445080|365631647|FG006|Overall Study|Adverse Event|0|||
105992736|NCT01445080|365631648|FG007|Overall Study|Adverse Event|3|||
105992737|NCT01445080|365631649|FG008|Overall Study|Adverse Event|10|||
105992738|NCT01445080|365631641|FG000|Overall Study|Physician Decision|0|||
105992739|NCT01445080|365631642|FG001|Overall Study|Physician Decision|0|||
105992740|NCT01445080|365631643|FG002|Overall Study|Physician Decision|1|||
105992741|NCT01445080|365631644|FG003|Overall Study|Physician Decision|0|||
105992742|NCT01445080|365631645|FG004|Overall Study|Physician Decision|0|||
105992743|NCT01445080|365631646|FG005|Overall Study|Physician Decision|3|||
105992744|NCT01445080|365631647|FG006|Overall Study|Physician Decision|2|||
105992745|NCT01445080|365631648|FG007|Overall Study|Physician Decision|2|||
105992746|NCT01445080|365631649|FG008|Overall Study|Physician Decision|0|||
105992747|NCT01445080|365631641|FG000|Overall Study|Withdrawal by Subject|1|||
105992748|NCT01445080|365631642|FG001|Overall Study|Withdrawal by Subject|0|||
105992749|NCT01445080|365631643|FG002|Overall Study|Withdrawal by Subject|0|||
105992750|NCT01445080|365631644|FG003|Overall Study|Withdrawal by Subject|1|||
105992751|NCT01445080|365631645|FG004|Overall Study|Withdrawal by Subject|0|||
105992752|NCT01445080|365631646|FG005|Overall Study|Withdrawal by Subject|0|||
105992753|NCT01445080|365631647|FG006|Overall Study|Withdrawal by Subject|0|||
105992754|NCT01445080|365631648|FG007|Overall Study|Withdrawal by Subject|0|||
105992755|NCT01445080|365631649|FG008|Overall Study|Withdrawal by Subject|2|||
105992756|NCT01445080|365631641|FG000|Overall Study|Ineligible/Inevaluable|1|||
105992757|NCT01445080|365631642|FG001|Overall Study|Ineligible/Inevaluable|2|||
105992758|NCT01445080|365631643|FG002|Overall Study|Ineligible/Inevaluable|0|||
105992759|NCT01445080|365631644|FG003|Overall Study|Ineligible/Inevaluable|1|||
105992760|NCT01445080|365631645|FG004|Overall Study|Ineligible/Inevaluable|2|||
105992761|NCT01445080|365631646|FG005|Overall Study|Ineligible/Inevaluable|3|||
105992762|NCT01445080|365631647|FG006|Overall Study|Ineligible/Inevaluable|0|||
105992763|NCT01445080|365631648|FG007|Overall Study|Ineligible/Inevaluable|0|||
105992764|NCT01445080|365631649|FG008|Overall Study|Ineligible/Inevaluable|6|||
105992765|NCT03887221|365631650|FG000|Overall Study|Protocol Violation|1|||
105992766|NCT03887221|365631651|FG001|Overall Study|Protocol Violation|0|||
105992767|NCT00934128|365631653|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
105992768|NCT00934128|365631654|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
105992769|NCT00934128|365631653|FG000|First Intervention (2 Hours)|Adverse Event|4|||
105992770|NCT00934128|365631654|FG001|First Intervention (2 Hours)|Adverse Event|1|||
105992771|NCT00934128|365631653|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
105992772|NCT00934128|365631654|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
105992773|NCT00934128|365631653|FG000|Washout Period (1 Hour)|Patient preference|1|||
105992774|NCT00934128|365631654|FG001|Washout Period (1 Hour)|Patient preference|3|||
105992775|NCT00934128|365631653|FG000|Washout Period (1 Hour)|Pain|1|||
105992776|NCT00934128|365631654|FG001|Washout Period (1 Hour)|Pain|0|||
105992777|NCT00934128|365631653|FG000|Washout Period (1 Hour)|Too tired|1|||
105992778|NCT00934128|365631654|FG001|Washout Period (1 Hour)|Too tired|0|||
105992779|NCT00934128|365631653|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
105992780|NCT00934128|365631654|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
105992781|NCT00934128|365631653|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
105992782|NCT00934128|365631654|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
105992783|NCT00872599|365633004|FG000|Second Washout Period|Adverse Event|1|||
105992784|NCT00872599|365633005|FG001|Second Washout Period|Adverse Event|1|||
105992785|NCT00732875|365633008|FG000|Overall Study|Adverse Event|16|||
105992786|NCT00732875|365633008|FG000|Overall Study|Withdrawal by Subject|6|||
105992787|NCT00732875|365633008|FG000|Overall Study|Lack of Efficacy|13|||
105992788|NCT00546000|365633010|FG000|Overall Study|Adverse Event|1|||
105992789|NCT00546000|365633010|FG000|Overall Study|Lost to Follow-up|1|||
105992790|NCT00546000|365633010|FG000|Overall Study|Baseline HPA Axis Supression|2|||
105992791|NCT02828436|365633011|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
105992792|NCT02828436|365633012|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
105992793|NCT02828436|365633011|FG000|Period 1|Lost to Follow-up|0|||
105992794|NCT02828436|365633012|FG001|Period 1|Lost to Follow-up|1|||
105992795|NCT02828436|365633011|FG000|Period 2|Withdrawal by Subject|4|||
105992796|NCT02828436|365633012|FG001|Period 2|Withdrawal by Subject|0|||
105992797|NCT02828436|365633011|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
105992798|NCT02828436|365633012|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
105992799|NCT02828436|365633011|FG000|Period 2|Lost to Follow-up|1|||
105992800|NCT02828436|365633012|FG001|Period 2|Lost to Follow-up|0|||
105992801|NCT04426318|365633019|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
106106971|NCT04575051|366045959|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
106106972|NCT04575051|366045960|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
106106973|NCT04575051|366045961|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
106106974|NCT04575051|366045962|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
106106975|NCT04575051|366045958|FG000|Time Period 2|Missing follow up|1|||
106106976|NCT04575051|366045959|FG001|Time Period 2|Missing follow up|8|||
106106977|NCT04575051|366045960|FG002|Time Period 2|Missing follow up|7|||
106106978|NCT04575051|366045961|FG003|Time Period 2|Missing follow up|0|||
106106979|NCT04575051|366045962|FG004|Time Period 2|Missing follow up|1|||
106106980|NCT04575051|366045958|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
106106981|NCT04575051|366045959|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
106106982|NCT04575051|366045960|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
106106983|NCT04575051|366045961|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
106106984|NCT04575051|366045962|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
106106985|NCT04575051|366045958|FG000|Time Period 3|Missing follow up|8|||
106106986|NCT04575051|366045959|FG001|Time Period 3|Missing follow up|6|||
106106987|NCT04575051|366045960|FG002|Time Period 3|Missing follow up|4|||
106106988|NCT04575051|366045961|FG003|Time Period 3|Missing follow up|3|||
106106989|NCT04575051|366045962|FG004|Time Period 3|Missing follow up|0|||
106106990|NCT04575051|366045958|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
106106991|NCT04575051|366045959|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
106106992|NCT04575051|366045960|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
106106993|NCT04575051|366045961|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
106106994|NCT04575051|366045962|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
106106995|NCT04575051|366045958|FG000|Time Period 4|Missing follow up|17|||
106106996|NCT04575051|366045959|FG001|Time Period 4|Missing follow up|3|||
106106997|NCT04575051|366045960|FG002|Time Period 4|Missing follow up|4|||
106106998|NCT04575051|366045961|FG003|Time Period 4|Missing follow up|2|||
106106999|NCT04575051|366045962|FG004|Time Period 4|Missing follow up|1|||
106107000|NCT04575051|366045958|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
106107001|NCT04575051|366045959|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
106107002|NCT04575051|366045960|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
106107003|NCT04575051|366045961|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
106107004|NCT04575051|366045962|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
106107005|NCT04575051|366045958|FG000|Time Period 5|Missing follow up|11|||
106107006|NCT04575051|366045959|FG001|Time Period 5|Missing follow up|8|||
106107007|NCT04575051|366045960|FG002|Time Period 5|Missing follow up|12|||
106107008|NCT04575051|366045961|FG003|Time Period 5|Missing follow up|3|||
106107009|NCT04575051|366045962|FG004|Time Period 5|Missing follow up|11|||
106107010|NCT00715429|366045963|FG000|Overall Study|Did not complete the study diary|0|||
106107011|NCT00715429|366045964|FG001|Overall Study|Did not complete the study diary|1|||
106107012|NCT00514735|366045970|FG000|Overall Study|Withdrawal by Subject|13|||
106107013|NCT00514735|366045971|FG001|Overall Study|Withdrawal by Subject|5|||
106107014|NCT00514735|366045970|FG000|Overall Study|Death|1|||
106107015|NCT00514735|366045971|FG001|Overall Study|Death|0|||
106107016|NCT00514735|366045970|FG000|Overall Study|Lost to Follow-up|0|||
106107017|NCT00514735|366045971|FG001|Overall Study|Lost to Follow-up|1|||
106107018|NCT03178266|366045972|FG000|Overall Study|Death|0|||
105992802|NCT04426318|365633020|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
105992803|NCT02287467|365633025|FG000|Overall Study|Protocol Violation|12|||
105992804|NCT02287467|365633026|FG001|Overall Study|Protocol Violation|9|||
105992805|NCT03781778|365633027|FG000|Overall Study|Withdrawal by Subject|2|||
106107019|NCT03178266|366045973|FG001|Overall Study|Death|1|||
105782428|NCT00612456|364856210|FG000|Overall Study|Lack of Efficacy|1|||
105782429|NCT00612456|364856211|FG001|Overall Study|Lack of Efficacy|1|||
105782430|NCT00612456|364856212|FG002|Overall Study|Lack of Efficacy|0|||
105782431|NCT00612456|364856210|FG000|Overall Study|Withdrawal by Subject|0|||
106107020|NCT03178266|366045972|FG000|Overall Study|Disont. Early|0|||
106107021|NCT03178266|366045973|FG001|Overall Study|Disont. Early|1|||
106107022|NCT03178266|366045972|FG000|Overall Study|Withdrawal by Subject|0|||
106107023|NCT03178266|366045973|FG001|Overall Study|Withdrawal by Subject|2|||
106107024|NCT02472964|366045974|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
106107025|NCT02472964|366045975|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
106107026|NCT02472964|366045974|FG000|Part 1 (up to Week 24)|disease progression|58|||
106107027|NCT02472964|366045975|FG001|Part 1 (up to Week 24)|disease progression|47|||
106107028|NCT02472964|366045974|FG000|Part 1 (up to Week 24)|Death|3|||
106107029|NCT02472964|366045975|FG001|Part 1 (up to Week 24)|Death|6|||
106107030|NCT02472964|366045974|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
106107031|NCT02472964|366045975|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
106107032|NCT02472964|366045974|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
106107033|NCT02472964|366045975|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
106107034|NCT02472964|366045974|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
106107035|NCT02472964|366045975|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
106107036|NCT02472964|366045974|FG000|Part 1 (up to Week 24)|Other|2|||
106107037|NCT02472964|366045975|FG001|Part 1 (up to Week 24)|Other|1|||
106107038|NCT02472964|366045974|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
106107039|NCT02472964|366045975|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
106107040|NCT02472964|366045974|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
106107041|NCT02472964|366045975|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
106107042|NCT02472964|366045974|FG000|Part 2 (Week 24-week 48)|Death|0|||
106107043|NCT02472964|366045975|FG001|Part 2 (Week 24-week 48)|Death|1|||
106107044|NCT02472964|366045974|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
106107045|NCT02472964|366045975|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
106107046|NCT02472964|366045974|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
106107047|NCT02472964|366045975|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
106107048|NCT02472964|366045974|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
106107049|NCT02472964|366045975|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
106107050|NCT02472964|366045974|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
106107051|NCT02472964|366045975|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
106107052|NCT03311373|366045981|FG000|Overall Study|Adverse Event|1|||
106107053|NCT03311373|366045981|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
106107054|NCT03311373|366045981|FG000|Overall Study|Lost to Follow-up|1|||
106107055|NCT03311373|366045981|FG000|Overall Study|Physician Decision|1|||
106107056|NCT03311373|366045981|FG000|Overall Study|Withdrawal by Subject|3|||
106107057|NCT01687257|366045982|FG000|Overall Study|Efficacy Failure|6|||
106107058|NCT01687257|366045983|FG001|Overall Study|Efficacy Failure|0|||
106107059|NCT01687257|366045984|FG002|Overall Study|Efficacy Failure|5|||
106107060|NCT01687257|366045982|FG000|Overall Study|Subject Withdrew Consent|1|||
106107061|NCT01687257|366045983|FG001|Overall Study|Subject Withdrew Consent|1|||
106107062|NCT01687257|366045984|FG002|Overall Study|Subject Withdrew Consent|1|||
106107063|NCT01687257|366045982|FG000|Overall Study|Adverse Event|1|||
106107064|NCT01687257|366045983|FG001|Overall Study|Adverse Event|0|||
106107065|NCT01687257|366045984|FG002|Overall Study|Adverse Event|0|||
106107066|NCT01687257|366045982|FG000|Overall Study|Investigator's Discretion|0|||
105782432|NCT00612456|364856211|FG001|Overall Study|Withdrawal by Subject|1|||
105782433|NCT00612456|364856212|FG002|Overall Study|Withdrawal by Subject|0|||
105782434|NCT03907072|364856213|FG000|Overall Study|Study Terminated by Sponsor|2|||
105782435|NCT03907072|364856214|FG001|Overall Study|Study Terminated by Sponsor|2|||
105782436|NCT03907072|364856215|FG002|Overall Study|Study Terminated by Sponsor|2|||
105782437|NCT03205605|364856222|FG000|Overall Study|Withdrawal by Subject|1|||
105782438|NCT04246996|364856227|FG000|Overall Study|Physician Decision|1|||
105782439|NCT04246996|364856228|FG001|Overall Study|Physician Decision|1|||
105782440|NCT04246996|364856227|FG000|Overall Study|Did not meet eligibility criteria|1|||
105782441|NCT04246996|364856228|FG001|Overall Study|Did not meet eligibility criteria|4|||
105782442|NCT04604015|364856229|FG000|Overall Study|Incomplete Data Collection|33|||
105782443|NCT03289676|364856230|FG000|Overall Study|Withdrawal by Subject|2|||
105782444|NCT03289676|364856231|FG001|Overall Study|Withdrawal by Subject|0|||
105782445|NCT03289676|364856230|FG000|Overall Study|Protocol Violation|2|||
106107067|NCT01687257|366045983|FG001|Overall Study|Investigator's Discretion|3|||
106107068|NCT01687257|366045984|FG002|Overall Study|Investigator's Discretion|0|||
106107069|NCT02238379|366045986|FG000|Overall Study|Lost to Follow-up|1|||
106107070|NCT02238379|366045987|FG001|Overall Study|Lost to Follow-up|0|||
106107071|NCT00441090|366045990|FG000|Overall Study|Adverse Event|0|||
106107072|NCT00441090|366045991|FG001|Overall Study|Adverse Event|1|||
106107073|NCT00441090|366045992|FG002|Overall Study|Adverse Event|1|||
106107074|NCT00441090|366045993|FG003|Overall Study|Adverse Event|0|||
105782446|NCT03289676|364856231|FG001|Overall Study|Protocol Violation|0|||
105782447|NCT03289676|364856230|FG000|Overall Study|Lost to Follow-up|0|||
105782448|NCT03289676|364856231|FG001|Overall Study|Lost to Follow-up|1|||
105782449|NCT00372905|364856232|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
105782450|NCT00372905|364856233|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
105782451|NCT00372905|364856234|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
105782452|NCT00372905|364856235|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
105782453|NCT00372905|364856232|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
105782454|NCT00372905|364856233|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
105782455|NCT00372905|364856234|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
105782456|NCT00372905|364856235|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
105782457|NCT00372905|364856232|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
105782458|NCT00372905|364856233|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
105782459|NCT00372905|364856234|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
105782460|NCT00372905|364856235|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
105782461|NCT00372905|364856232|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
105782462|NCT00372905|364856233|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
105782463|NCT00372905|364856234|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
105782464|NCT00372905|364856235|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
105782465|NCT00372905|364856232|FG000|Follow up Until Relapse or Progression|Study closed|0|||
105782466|NCT00372905|364856233|FG001|Follow up Until Relapse or Progression|Study closed|0|||
105782467|NCT00372905|364856234|FG002|Follow up Until Relapse or Progression|Study closed|0|||
105782468|NCT00372905|364856235|FG003|Follow up Until Relapse or Progression|Study closed|3|||
105782469|NCT00372905|364856232|FG000|Follow up Until Relapse or Progression|Other|0|||
105782470|NCT00372905|364856233|FG001|Follow up Until Relapse or Progression|Other|1|||
105782471|NCT00372905|364856234|FG002|Follow up Until Relapse or Progression|Other|0|||
105782472|NCT00372905|364856235|FG003|Follow up Until Relapse or Progression|Other|0|||
105782473|NCT01728454|364856236|FG000|Stage 1 and 2|Pregnancy|1|||
105782474|NCT01728454|364856237|FG001|Stage 1 and 2|Pregnancy|0|||
105782475|NCT01728454|364856238|FG002|Stage 1 and 2|Pregnancy|0|||
105782476|NCT01728454|364856236|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
105782477|NCT01728454|364856237|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
105782478|NCT01728454|364856238|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
105782479|NCT01728454|364856236|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
105782480|NCT01728454|364856237|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
105782481|NCT01728454|364856238|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
105992806|NCT03781778|365633028|FG001|Overall Study|Withdrawal by Subject|2|||
105992807|NCT03755882|365633031|FG000|Period 1|Protocol Violation|1|||
105992808|NCT03755882|365633032|FG001|Period 1|Protocol Violation|0|||
106107075|NCT00441090|366045994|FG004|Overall Study|Adverse Event|0|||
106107076|NCT00441090|366045990|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
106107077|NCT00441090|366045991|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
106107078|NCT00441090|366045992|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
106107079|NCT00441090|366045993|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
106107080|NCT00441090|366045994|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
106107081|NCT00441090|366045990|FG000|Overall Study|Withdrawal by Subject|1|||
106107082|NCT00441090|366045991|FG001|Overall Study|Withdrawal by Subject|0|||
106107083|NCT00441090|366045992|FG002|Overall Study|Withdrawal by Subject|1|||
106107084|NCT00441090|366045993|FG003|Overall Study|Withdrawal by Subject|0|||
106107085|NCT00441090|366045994|FG004|Overall Study|Withdrawal by Subject|0|||
106107086|NCT00441090|366045990|FG000|Overall Study|Lack of Efficacy|1|||
106107087|NCT00441090|366045991|FG001|Overall Study|Lack of Efficacy|0|||
106107088|NCT00441090|366045992|FG002|Overall Study|Lack of Efficacy|0|||
106107089|NCT00441090|366045993|FG003|Overall Study|Lack of Efficacy|0|||
106107090|NCT00441090|366045994|FG004|Overall Study|Lack of Efficacy|0|||
106107091|NCT00605280|366045995|FG000|Year 1|Protocol Violation|0|||
106107092|NCT00605280|366045996|FG001|Year 1|Protocol Violation|0|||
106107093|NCT00605280|366045997|FG002|Year 1|Protocol Violation|0|||
106107094|NCT00605280|366045998|FG003|Year 1|Protocol Violation|1|||
106107095|NCT00605280|366045995|FG000|Year 1|Adverse Event|3|||
106107096|NCT00605280|366045996|FG001|Year 1|Adverse Event|1|||
105992809|NCT03755882|365633031|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
105992810|NCT03755882|365633032|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
105992811|NCT02292446|365633033|FG000|Overall Study|Adverse Event|12|||
105992812|NCT02292446|365633033|FG000|Overall Study|Death|1|||
105992813|NCT02292446|365633033|FG000|Overall Study|Disease progression|2|||
105992814|NCT02292446|365633033|FG000|Overall Study|Subject/guardian decision|2|||
105992815|NCT02292446|365633033|FG000|Overall Study|Withdrawal by Subject|3|||
105992816|NCT03386487|365633038|FG000|Overall Study|Lost to Follow-up|5|||
106107097|NCT00605280|366045997|FG002|Year 1|Adverse Event|1|||
106107098|NCT00605280|366045998|FG003|Year 1|Adverse Event|5|||
105782482|NCT01728454|364856236|FG000|Stage 1 and 2|Lost to Follow-up|1|||
105782483|NCT01728454|364856237|FG001|Stage 1 and 2|Lost to Follow-up|1|||
105782484|NCT01728454|364856238|FG002|Stage 1 and 2|Lost to Follow-up|0|||
105992817|NCT03386487|365633039|FG001|Overall Study|Lost to Follow-up|6|||
106107099|NCT00605280|366045995|FG000|Year 1|Physician Decision|7|||
106107100|NCT00605280|366045996|FG001|Year 1|Physician Decision|4|||
106107101|NCT00605280|366045997|FG002|Year 1|Physician Decision|0|||
106107102|NCT00605280|366045998|FG003|Year 1|Physician Decision|6|||
106107103|NCT00605280|366045995|FG000|Year 1|Withdrawal by Subject|2|||
106107104|NCT00605280|366045996|FG001|Year 1|Withdrawal by Subject|4|||
106107105|NCT00605280|366045997|FG002|Year 1|Withdrawal by Subject|0|||
106107106|NCT00605280|366045998|FG003|Year 1|Withdrawal by Subject|4|||
106107107|NCT00605280|366045995|FG000|Year 1|Other|2|||
106107108|NCT00605280|366045996|FG001|Year 1|Other|1|||
106107109|NCT00605280|366045997|FG002|Year 1|Other|0|||
106107110|NCT00605280|366045998|FG003|Year 1|Other|1|||
106107111|NCT00605280|366045995|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
106107112|NCT00605280|366045996|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
106107113|NCT00605280|366045997|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
106107114|NCT00605280|366045998|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
106107115|NCT00605280|366045995|FG000|Year 2|Adverse Event|4|||
106107116|NCT00605280|366045996|FG001|Year 2|Adverse Event|0|||
106107117|NCT00605280|366045997|FG002|Year 2|Adverse Event|2|||
106107118|NCT00605280|366045998|FG003|Year 2|Adverse Event|4|||
106107119|NCT00605280|366045995|FG000|Year 2|Physician Decision|11|||
106107120|NCT00605280|366045996|FG001|Year 2|Physician Decision|6|||
106107121|NCT00605280|366045997|FG002|Year 2|Physician Decision|4|||
106107122|NCT00605280|366045998|FG003|Year 2|Physician Decision|11|||
106107123|NCT00605280|366045995|FG000|Year 2|Withdrawal by Subject|4|||
106107124|NCT00605280|366045996|FG001|Year 2|Withdrawal by Subject|0|||
106107125|NCT00605280|366045997|FG002|Year 2|Withdrawal by Subject|0|||
106107126|NCT00605280|366045998|FG003|Year 2|Withdrawal by Subject|4|||
106107127|NCT00605280|366045995|FG000|Year 2|Other|1|||
106107128|NCT00605280|366045996|FG001|Year 2|Other|0|||
106107129|NCT00605280|366045997|FG002|Year 2|Other|0|||
106107130|NCT00605280|366045998|FG003|Year 2|Other|1|||
106107131|NCT00605280|366045995|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
106107132|NCT00605280|366045996|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
106107133|NCT00605280|366045997|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
106107134|NCT00605280|366045998|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
106107135|NCT00605280|366045995|FG000|Year 3 Extension|Adverse Event|2|||
106107136|NCT00605280|366045996|FG001|Year 3 Extension|Adverse Event|0|||
106107137|NCT00605280|366045997|FG002|Year 3 Extension|Adverse Event|0|||
106107138|NCT00605280|366045998|FG003|Year 3 Extension|Adverse Event|2|||
106107139|NCT00605280|366045995|FG000|Year 3 Extension|Physician Decision|0|||
106107140|NCT00605280|366045996|FG001|Year 3 Extension|Physician Decision|0|||
106107141|NCT00605280|366045997|FG002|Year 3 Extension|Physician Decision|0|||
106107142|NCT00605280|366045998|FG003|Year 3 Extension|Physician Decision|2|||
106107143|NCT00605280|366045995|FG000|Year 3 Extension|Withdrawal by Subject|2|||
106107144|NCT00605280|366045996|FG001|Year 3 Extension|Withdrawal by Subject|0|||
106107145|NCT00605280|366045997|FG002|Year 3 Extension|Withdrawal by Subject|0|||
106107146|NCT00605280|366045998|FG003|Year 3 Extension|Withdrawal by Subject|5|||
106107147|NCT00605280|366045995|FG000|Year 3 Extension|Other|2|||
106107148|NCT00605280|366045996|FG001|Year 3 Extension|Other|0|||
106107149|NCT00605280|366045997|FG002|Year 3 Extension|Other|0|||
106107150|NCT00605280|366045998|FG003|Year 3 Extension|Other|0|||
106107151|NCT00605280|366045995|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
106107152|NCT00605280|366045996|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
106107153|NCT00605280|366045997|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
106107154|NCT00605280|366045998|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
106107155|NCT00810264|366045999|FG000|Overall Study|Lost to Follow-up|191|||
106107156|NCT00810264|366045999|FG000|Overall Study|Withdrawal by subject or physician|721|||
106107157|NCT00810264|366045999|FG000|Overall Study|Death|641|||
106107158|NCT01256567|366046000|FG000|Overall Study|Withdrawal by Subject|1|||
106107159|NCT00951275|366046008|FG000|Overall Study|Administrative Reason|1|||
106107160|NCT00951275|366046008|FG000|Overall Study|Adverse Event|7|||
106107161|NCT00951275|366046008|FG000|Overall Study|Withdrawal by Subject|4|||
106107162|NCT00951275|366046008|FG000|Overall Study|Protocol Violation|1|||
106107163|NCT01112579|366046009|FG000|Overall Study|Missed Visit|1|||
106107164|NCT01112579|366046010|FG001|Overall Study|Missed Visit|1|||
106107165|NCT01112579|366046009|FG000|Overall Study|Death|0|||
106107166|NCT01112579|366046010|FG001|Overall Study|Death|2|||
106107167|NCT01971723|366046011|FG000|Overall Study|Withdrawal by Subject|1|||
106107168|NCT01971723|366046012|FG001|Overall Study|Withdrawal by Subject|1|||
106107169|NCT01971723|366046011|FG000|Overall Study|Protocol Violation|1|||
106107170|NCT01971723|366046012|FG001|Overall Study|Protocol Violation|2|||
106107171|NCT00725296|366046013|FG000|Overall Study|Adverse Event|11|||
106107172|NCT00725296|366046013|FG000|Overall Study|Lack of Efficacy|7|||
106107173|NCT00725296|366046013|FG000|Overall Study|Withdrawal by Subject|3|||
106107174|NCT00725296|366046013|FG000|Overall Study|Non-Compliance|2|||
106107175|NCT00725296|366046013|FG000|Overall Study|Lost to Follow-up|1|||
106107176|NCT00725296|366046013|FG000|Overall Study|Other|38|||
106107177|NCT02693743|366046014|FG000|Overall Study|Physician Decision|1|||
106107178|NCT02693743|366046015|FG001|Overall Study|Physician Decision|0|||
106107179|NCT03053050|366046019|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
106107180|NCT03053050|366046020|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
106107181|NCT03053050|366046021|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
106107182|NCT03053050|366046022|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
106107183|NCT03053050|366046019|FG000|Randomized Phase|Withdrew Consent|16|||
106107184|NCT03053050|366046020|FG001|Randomized Phase|Withdrew Consent|8|||
106107185|NCT03053050|366046021|FG002|Randomized Phase|Withdrew Consent|9|||
106107186|NCT03053050|366046022|FG003|Randomized Phase|Withdrew Consent|0|||
106107187|NCT03053050|366046019|FG000|Randomized Phase|Investigator's Discretion|6|||
105992818|NCT03386487|365633038|FG000|Overall Study|Withdrawal by Subject|11|||
105992819|NCT03386487|365633039|FG001|Overall Study|Withdrawal by Subject|7|||
105992820|NCT03386487|365633038|FG000|Overall Study|Physician Decision|11|||
105992821|NCT03386487|365633039|FG001|Overall Study|Physician Decision|8|||
105992822|NCT03534141|365633040|FG000|Overall Study|Enrolled in other clinical trial|1|||
105992823|NCT03534141|365633041|FG001|Overall Study|Enrolled in other clinical trial|0|||
105992824|NCT03534141|365633040|FG000|Overall Study|Liver transplant aborted after randomization|0|||
105992825|NCT03534141|365633041|FG001|Overall Study|Liver transplant aborted after randomization|2|||
105992826|NCT03534141|365633040|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
105992827|NCT03534141|365633041|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
105992828|NCT06136897|365633044|FG000|Overall Study|Ineligible|3|||
105992829|NCT06136897|365633044|FG000|Overall Study|Mutation status not confirmed|7|||
105992830|NCT06136897|365633044|FG000|Overall Study|Adverse Event|2|||
105992831|NCT06136897|365633044|FG000|Overall Study|Death|1|||
105992832|NCT06136897|365633044|FG000|Overall Study|Disease progression|18|||
105992833|NCT06136897|365633044|FG000|Overall Study|Other complicating disease|1|||
105992834|NCT06136897|365633044|FG000|Overall Study|Withdrawal by Subject|1|||
105992835|NCT06136897|365633044|FG000|Overall Study|Still on treatment|1|||
105992836|NCT06136897|365633044|FG000|Overall Study|Lost to Follow-up|1|||
105992837|NCT00195091|365633045|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
105992838|NCT00239928|365633046|FG000|Overall Study|Lack of Efficacy|1|||
105992839|NCT00239928|365633046|FG000|Overall Study|Adverse Event|4|||
105992840|NCT00239928|365633046|FG000|Overall Study|Not need to continue study|3|||
105992841|NCT00239928|365633046|FG000|Overall Study|Withdrawal by Subject|2|||
105992842|NCT00245037|365633049|FG000|Overall Study|Death|17|||
105992843|NCT01067144|365633050|FG000|Treatment|Did not receive allocated intervention|4|||
105992844|NCT01067144|365633051|FG001|Treatment|Did not receive allocated intervention|7|||
105992845|NCT01067144|365633050|FG000|Follow-up|Lost to Follow-up|22|||
105992846|NCT01067144|365633051|FG001|Follow-up|Lost to Follow-up|12|||
105992847|NCT01067144|365633050|FG000|Follow-up|Censored owing to second surgery|19|||
105992848|NCT01067144|365633051|FG001|Follow-up|Censored owing to second surgery|28|||
105992849|NCT01067144|365633050|FG000|Follow-up|Withdrawal by Subject|18|||
105992850|NCT01067144|365633051|FG001|Follow-up|Withdrawal by Subject|14|||
105992851|NCT01067144|365633050|FG000|Follow-up|Surgery cancelled|0|||
105992852|NCT01067144|365633051|FG001|Follow-up|Surgery cancelled|1|||
105992853|NCT01067144|365633050|FG000|Follow-up|Death|0|||
105992854|NCT01067144|365633051|FG001|Follow-up|Death|1|||
105992855|NCT00203424|365633053|FG000|Treatment Period|Withdrawal by Subject|4|||
105992856|NCT00203424|365633053|FG000|Treatment Period|Adverse Event|5|||
105992857|NCT00203424|365633053|FG000|Treatment Period|progressive disease|2|||
105992858|NCT00203424|365633053|FG000|Follow-up Period|Withdrawal by Subject|1|||
105992859|NCT00203424|365633053|FG000|Follow-up Period|progressive disease|4|||
105992860|NCT00203424|365633053|FG000|Follow-up Period|Lost to Follow-up|1|||
105992861|NCT00555672|365633054|FG000|Overall Study|Death|0|||
105992862|NCT00555672|365633055|FG001|Overall Study|Death|2|||
105992863|NCT00555672|365633054|FG000|Overall Study|Adverse Event|8|||
105992864|NCT00555672|365633055|FG001|Overall Study|Adverse Event|2|||
105992865|NCT00555672|365633054|FG000|Overall Study|Objective progression or relapse|11|||
105992866|NCT00555672|365633055|FG001|Overall Study|Objective progression or relapse|5|||
105992867|NCT00555672|365633054|FG000|Overall Study|Other|3|||
105992868|NCT00555672|365633055|FG001|Overall Study|Other|1|||
105992869|NCT00555672|365633054|FG000|Overall Study|Participant refused|2|||
105992870|NCT00555672|365633055|FG001|Overall Study|Participant refused|0|||
105992871|NCT01053988|365633056|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
105992872|NCT01053988|365633057|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105992873|NCT01053988|365633058|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105992874|NCT01053988|365633059|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105992875|NCT01053988|365633060|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105992876|NCT01053988|365633061|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
106107188|NCT03053050|366046020|FG001|Randomized Phase|Investigator's Discretion|6|||
105992877|NCT01053988|365633056|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
105992878|NCT01053988|365633057|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105992879|NCT01053988|365633058|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105992880|NCT01053988|365633059|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105992881|NCT01053988|365633060|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
106144088|NCT01317420|366186959|FG010|Overall Study|Other adverse event|0|||
105992882|NCT01053988|365633061|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
105992883|NCT01053988|365633056|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
105992884|NCT01053988|365633057|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
106107189|NCT03053050|366046021|FG002|Randomized Phase|Investigator's Discretion|3|||
106107190|NCT03053050|366046022|FG003|Randomized Phase|Investigator's Discretion|0|||
106107191|NCT03053050|366046019|FG000|Randomized Phase|Lost to Follow-up|5|||
106107192|NCT03053050|366046020|FG001|Randomized Phase|Lost to Follow-up|1|||
105992885|NCT01053988|365633058|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105992886|NCT01053988|365633059|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105992887|NCT01053988|365633060|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105992888|NCT01053988|365633061|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105992889|NCT01053988|365633056|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
105992890|NCT01053988|365633057|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
105992891|NCT01053988|365633058|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
105992892|NCT01053988|365633059|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
105992893|NCT01053988|365633060|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
105992894|NCT01053988|365633061|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
105992895|NCT01053988|365633056|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
105992896|NCT01053988|365633057|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
105992897|NCT01053988|365633058|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
105992898|NCT01053988|365633059|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
105992899|NCT01053988|365633060|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
105992900|NCT01053988|365633061|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
106107193|NCT03053050|366046021|FG002|Randomized Phase|Lost to Follow-up|1|||
106107194|NCT03053050|366046022|FG003|Randomized Phase|Lost to Follow-up|0|||
106107195|NCT03053050|366046019|FG000|Randomized Phase|Adverse Event|0|||
106107196|NCT03053050|366046020|FG001|Randomized Phase|Adverse Event|1|||
106107197|NCT03053050|366046021|FG002|Randomized Phase|Adverse Event|0|||
106107198|NCT03053050|366046022|FG003|Randomized Phase|Adverse Event|0|||
106107199|NCT03053050|366046019|FG000|Randomized Phase|Randomized but Never Treated|2|||
106107200|NCT03053050|366046020|FG001|Randomized Phase|Randomized but Never Treated|2|||
106107201|NCT03053050|366046021|FG002|Randomized Phase|Randomized but Never Treated|2|||
106107202|NCT03053050|366046022|FG003|Randomized Phase|Randomized but Never Treated|0|||
106107203|NCT03053050|366046019|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
106107204|NCT03053050|366046020|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
106107205|NCT03053050|366046021|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
106107206|NCT03053050|366046022|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
106107207|NCT03053050|366046019|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
106107208|NCT03053050|366046020|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
106107209|NCT03053050|366046021|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
106107210|NCT03053050|366046022|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
106107211|NCT03053050|366046019|FG000|Open-label Phase|Withdrew Consent|0|||
106107212|NCT03053050|366046020|FG001|Open-label Phase|Withdrew Consent|0|||
106107213|NCT03053050|366046021|FG002|Open-label Phase|Withdrew Consent|0|||
106107214|NCT03053050|366046022|FG003|Open-label Phase|Withdrew Consent|6|||
106107215|NCT03053050|366046019|FG000|Open-label Phase|Investigator's Discretion|0|||
106107216|NCT03053050|366046020|FG001|Open-label Phase|Investigator's Discretion|0|||
106107217|NCT03053050|366046021|FG002|Open-label Phase|Investigator's Discretion|0|||
106107218|NCT03053050|366046022|FG003|Open-label Phase|Investigator's Discretion|4|||
106107219|NCT03703466|366046025|FG000|Overall Study|Death|2|||
106107220|NCT03703466|366046026|FG001|Overall Study|Death|1|||
106107221|NCT03703466|366046027|FG002|Overall Study|Death|0|||
106107222|NCT03703466|366046025|FG000|Overall Study|Withdrawal by Subject|0|||
106107223|NCT03703466|366046026|FG001|Overall Study|Withdrawal by Subject|3|||
106107224|NCT03703466|366046027|FG002|Overall Study|Withdrawal by Subject|0|||
106107225|NCT03703466|366046025|FG000|Overall Study|Completed < 3 Cycles|2|||
106107226|NCT03703466|366046026|FG001|Overall Study|Completed < 3 Cycles|2|||
106107227|NCT03703466|366046027|FG002|Overall Study|Completed < 3 Cycles|2|||
106107228|NCT05338333|366046028|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
106107229|NCT05338333|366046029|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
106107230|NCT05073133|366046033|FG000|Overall Study|Death|2|||
106107231|NCT04508699|366046040|FG000|Overall Study|Lack of Efficacy|2|||
106107232|NCT04508699|366046041|FG001|Overall Study|Lack of Efficacy|15|||
106107233|NCT04508699|366046040|FG000|Overall Study|Withdrawal by Subject|0|||
106107234|NCT04508699|366046041|FG001|Overall Study|Withdrawal by Subject|2|||
106107235|NCT04866017|366046042|FG000|Overall Study|Study Terminated by Sponsor|13|||
106107236|NCT04866017|366046043|FG001|Overall Study|Study Terminated by Sponsor|14|||
106107237|NCT04866017|366046044|FG002|Overall Study|Study Terminated by Sponsor|13|||
106107238|NCT04866017|366046042|FG000|Overall Study|Death|8|||
106107239|NCT04866017|366046043|FG001|Overall Study|Death|4|||
106107240|NCT04866017|366046044|FG002|Overall Study|Death|8|||
106107241|NCT04866017|366046042|FG000|Overall Study|Withdrawal by Subject|1|||
106107242|NCT04866017|366046043|FG001|Overall Study|Withdrawal by Subject|0|||
106107243|NCT04866017|366046044|FG002|Overall Study|Withdrawal by Subject|1|||
106107244|NCT04866017|366046042|FG000|Overall Study|Physician Decision|0|||
106107245|NCT04866017|366046043|FG001|Overall Study|Physician Decision|1|||
106107246|NCT04866017|366046044|FG002|Overall Study|Physician Decision|0|||
106107247|NCT01475136|366046045|FG000|Overall Study|Sponsor Decision|0|||
106107248|NCT01475136|366046046|FG001|Overall Study|Sponsor Decision|1|||
106107249|NCT01475136|366046047|FG002|Overall Study|Sponsor Decision|0|||
106107250|NCT01475136|366046048|FG003|Overall Study|Sponsor Decision|0|||
106107251|NCT01475136|366046045|FG000|Overall Study|Entry Criteria Not Met|0|||
106107252|NCT01475136|366046046|FG001|Overall Study|Entry Criteria Not Met|2|||
106107253|NCT01475136|366046047|FG002|Overall Study|Entry Criteria Not Met|3|||
106107254|NCT01475136|366046048|FG003|Overall Study|Entry Criteria Not Met|1|||
106107255|NCT01475136|366046045|FG000|Overall Study|Withdrawal by Subject|0|||
106107256|NCT01475136|366046046|FG001|Overall Study|Withdrawal by Subject|0|||
106107257|NCT01475136|366046047|FG002|Overall Study|Withdrawal by Subject|0|||
106107258|NCT01475136|366046048|FG003|Overall Study|Withdrawal by Subject|2|||
106107259|NCT01475136|366046045|FG000|Overall Study|Adverse Event|1|||
106107260|NCT01475136|366046046|FG001|Overall Study|Adverse Event|0|||
106107261|NCT01475136|366046047|FG002|Overall Study|Adverse Event|0|||
106107262|NCT01475136|366046048|FG003|Overall Study|Adverse Event|1|||
105782485|NCT01728454|364856236|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
105782486|NCT01728454|364856237|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
105782487|NCT01728454|364856238|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
105782488|NCT01728454|364856236|FG000|Stage 3|Reason Missing|0|||
105782489|NCT01728454|364856237|FG001|Stage 3|Reason Missing|0|||
105782490|NCT01728454|364856238|FG002|Stage 3|Reason Missing|1|||
105782491|NCT01728454|364856236|FG000|Stage 3|Subject Required Other Treatment|0|||
105782492|NCT01728454|364856237|FG001|Stage 3|Subject Required Other Treatment|1|||
105782493|NCT01728454|364856238|FG002|Stage 3|Subject Required Other Treatment|0|||
105782494|NCT01728454|364856236|FG000|Stage 3|Pregnancy|1|||
105782495|NCT01728454|364856237|FG001|Stage 3|Pregnancy|0|||
105782496|NCT01728454|364856238|FG002|Stage 3|Pregnancy|0|||
105782497|NCT01728454|364856236|FG000|Stage 3|Withdrew Consent|1|||
105782498|NCT01728454|364856237|FG001|Stage 3|Withdrew Consent|0|||
105782499|NCT01728454|364856238|FG002|Stage 3|Withdrew Consent|1|||
105782500|NCT01728454|364856236|FG000|Stage 3|Non-compliance with Protocol|0|||
105782501|NCT01728454|364856237|FG001|Stage 3|Non-compliance with Protocol|0|||
105782502|NCT01728454|364856238|FG002|Stage 3|Non-compliance with Protocol|1|||
105782503|NCT01728454|364856236|FG000|Stage 3|Lost to Follow-up|0|||
105782504|NCT01728454|364856237|FG001|Stage 3|Lost to Follow-up|3|||
105782505|NCT01728454|364856238|FG002|Stage 3|Lost to Follow-up|1|||
105782506|NCT01728454|364856236|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
105782507|NCT01728454|364856237|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
105782508|NCT01728454|364856238|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
105782509|NCT02058966|364856239|FG000|Open-Label Methamphetamine|Adverse Event|1|||
105782510|NCT02058966|364856239|FG000|First Intervention|Withdrawal by Subject|1|||
105782511|NCT01396434|364856242|FG000|Overall Study|Lost to Follow-up|1|||
105782512|NCT01396434|364856243|FG001|Overall Study|Lost to Follow-up|0|||
105782513|NCT01396434|364856244|FG002|Overall Study|Lost to Follow-up|0|||
105782514|NCT01396434|364856242|FG000|Overall Study|Other|10|||
105782515|NCT01396434|364856243|FG001|Overall Study|Other|0|||
105782516|NCT01396434|364856244|FG002|Overall Study|Other|0|||
105782517|NCT00157157|364856246|FG000|Overall Study|Withdrawal by Subject|6|||
105782518|NCT00157157|364856246|FG000|Overall Study|Physician Decision|1|||
105782519|NCT00157157|364856246|FG000|Overall Study|Lost to Follow-up|1|||
105782520|NCT00157157|364856246|FG000|Overall Study|Enrolled in another study|1|||
105782521|NCT00157157|364856246|FG000|Overall Study|Met exclusion criteria|1|||
105782522|NCT00157157|364856246|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
105782523|NCT02260804|364856249|FG000|Induction Study Period|Protocol Violation|2|||
105782524|NCT02260804|364856250|FG001|Induction Study Period|Protocol Violation|0|||
105782525|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
105782526|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
105782527|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
105782528|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
105782529|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
105782530|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
105782531|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
105782532|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
105782533|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
105782534|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
105782535|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
105782536|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
105782537|NCT02260804|364856249|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
106107263|NCT01475136|366046045|FG000|Overall Study|Death|0|||
106107264|NCT01475136|366046046|FG001|Overall Study|Death|0|||
106107265|NCT01475136|366046047|FG002|Overall Study|Death|0|||
106107266|NCT01475136|366046048|FG003|Overall Study|Death|1|||
106107267|NCT01377480|366047637|FG000|Overall Study|Protocol Violation|0|||
106107268|NCT01377480|366047638|FG001|Overall Study|Protocol Violation|0|||
106107269|NCT01377480|366047639|FG002|Overall Study|Protocol Violation|0|||
106107270|NCT01377480|366047640|FG003|Overall Study|Protocol Violation|4|||
106107271|NCT01377480|366047637|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
106107272|NCT01377480|366047638|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
106107273|NCT01377480|366047639|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
106107274|NCT01377480|366047640|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
106107275|NCT01377480|366047637|FG000|Overall Study|Withdrawal by Subject|0|||
106107276|NCT01377480|366047638|FG001|Overall Study|Withdrawal by Subject|0|||
106107277|NCT01377480|366047639|FG002|Overall Study|Withdrawal by Subject|1|||
106107278|NCT01377480|366047640|FG003|Overall Study|Withdrawal by Subject|0|||
106107279|NCT01377480|366047637|FG000|Overall Study|Serious adverse event|0|||
106107280|NCT01377480|366047638|FG001|Overall Study|Serious adverse event|0|||
106107281|NCT01377480|366047639|FG002|Overall Study|Serious adverse event|1|||
106107282|NCT01377480|366047640|FG003|Overall Study|Serious adverse event|1|||
106107283|NCT01377480|366047637|FG000|Overall Study|Other|0|||
106107284|NCT01377480|366047638|FG001|Overall Study|Other|0|||
106107285|NCT01377480|366047639|FG002|Overall Study|Other|7|||
106107286|NCT01377480|366047640|FG003|Overall Study|Other|6|||
106107287|NCT00593567|366047641|FG000|Overall Study|Adverse Event|2|||
106107288|NCT00593567|366047642|FG001|Overall Study|Adverse Event|0|||
106107289|NCT00593567|366047641|FG000|Overall Study|Physician Decision|2|||
106107290|NCT00593567|366047642|FG001|Overall Study|Physician Decision|0|||
106107291|NCT00593567|366047641|FG000|Overall Study|Protocol Violation|13|||
106107292|NCT00593567|366047642|FG001|Overall Study|Protocol Violation|7|||
106107293|NCT00593567|366047641|FG000|Overall Study|Lack of Efficacy|2|||
106107294|NCT00593567|366047642|FG001|Overall Study|Lack of Efficacy|1|||
106107295|NCT00593567|366047641|FG000|Overall Study|Withdrawal by Subject|1|||
106107296|NCT00593567|366047642|FG001|Overall Study|Withdrawal by Subject|2|||
106107297|NCT03576768|366047645|FG000|Overall Study|Lost to Follow-up|3|||
106107298|NCT03576768|366047646|FG001|Overall Study|Lost to Follow-up|3|||
106107299|NCT03576768|366047647|FG002|Overall Study|Lost to Follow-up|0|||
106107300|NCT03576768|366047648|FG003|Overall Study|Lost to Follow-up|0|||
106107301|NCT00590902|366047649|FG000|Overall Study|Death|1|||
106107302|NCT00785291|366047653|FG000|Overall Study|Never began treatment|8|||
106107303|NCT00785291|366047654|FG001|Overall Study|Never began treatment|4|||
106107304|NCT00785291|366047655|FG002|Overall Study|Never began treatment|4|||
106107305|NCT00785291|366047653|FG000|Overall Study|Adverse Event|39|||
106107306|NCT00785291|366047654|FG001|Overall Study|Adverse Event|70|||
106107307|NCT00785291|366047655|FG002|Overall Study|Adverse Event|56|||
106107308|NCT00785291|366047653|FG000|Overall Study|Death|7|||
106107309|NCT00785291|366047654|FG001|Overall Study|Death|4|||
106107310|NCT00785291|366047655|FG002|Overall Study|Death|3|||
106107311|NCT00785291|366047653|FG000|Overall Study|Withdrawal by Subject|35|||
106107312|NCT00785291|366047654|FG001|Overall Study|Withdrawal by Subject|36|||
106107313|NCT00785291|366047655|FG002|Overall Study|Withdrawal by Subject|17|||
106107314|NCT00785291|366047653|FG000|Overall Study|Alternative Therapy|12|||
106107315|NCT00785291|366047654|FG001|Overall Study|Alternative Therapy|6|||
106107316|NCT00785291|366047655|FG002|Overall Study|Alternative Therapy|7|||
106107317|NCT00785291|366047653|FG000|Overall Study|Complicating illness|6|||
106107318|NCT00785291|366047654|FG001|Overall Study|Complicating illness|4|||
106107319|NCT00785291|366047655|FG002|Overall Study|Complicating illness|4|||
106107320|NCT00785291|366047653|FG000|Overall Study|Other Medical Reasons|29|||
106107321|NCT00785291|366047654|FG001|Overall Study|Other Medical Reasons|25|||
106107322|NCT00785291|366047655|FG002|Overall Study|Other Medical Reasons|15|||
106107323|NCT04050865|366047656|FG000|Overall Study|Adverse Event|1|||
106107324|NCT04050865|366047657|FG001|Overall Study|Adverse Event|0|||
106107325|NCT04050865|366047656|FG000|Overall Study|no insert|1|||
106107326|NCT04050865|366047657|FG001|Overall Study|no insert|0|||
106107327|NCT04050865|366047656|FG000|Overall Study|Only 1 insert|2|||
106107328|NCT04050865|366047657|FG001|Overall Study|Only 1 insert|3|||
106107329|NCT04050865|366047656|FG000|Overall Study|Physician Decision|0|||
106107330|NCT04050865|366047657|FG001|Overall Study|Physician Decision|1|||
106107331|NCT04050865|366047656|FG000|Overall Study|Withdrawal by Subject|0|||
106107332|NCT04050865|366047657|FG001|Overall Study|Withdrawal by Subject|1|||
106107333|NCT00428090|366047668|FG000|Overall Study|Adverse Event|10|||
106107334|NCT00428090|366047669|FG001|Overall Study|Adverse Event|8|||
106107335|NCT00428090|366047670|FG002|Overall Study|Adverse Event|10|||
106107336|NCT00428090|366047671|FG003|Overall Study|Adverse Event|11|||
106107337|NCT00428090|366047668|FG000|Overall Study|Lost to Follow-up|3|||
106107338|NCT00428090|366047669|FG001|Overall Study|Lost to Follow-up|6|||
106107339|NCT00428090|366047670|FG002|Overall Study|Lost to Follow-up|1|||
106107340|NCT00428090|366047671|FG003|Overall Study|Lost to Follow-up|4|||
106107341|NCT00428090|366047668|FG000|Overall Study|Protocol Violation|3|||
106107342|NCT00428090|366047669|FG001|Overall Study|Protocol Violation|1|||
106107343|NCT00428090|366047670|FG002|Overall Study|Protocol Violation|3|||
106107344|NCT00428090|366047671|FG003|Overall Study|Protocol Violation|3|||
105992901|NCT01053988|365633056|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
105992902|NCT01053988|365633057|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105992903|NCT01053988|365633058|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105992904|NCT01053988|365633059|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105992905|NCT01053988|365633060|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105992906|NCT01053988|365633061|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105992907|NCT01053988|365633056|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
105992908|NCT01053988|365633057|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
105992909|NCT01053988|365633058|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
105992910|NCT01053988|365633059|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
105992911|NCT01053988|365633060|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
105992912|NCT01053988|365633061|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
105992913|NCT01053988|365633056|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105992914|NCT01053988|365633057|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
105992915|NCT01053988|365633058|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
105992916|NCT01053988|365633059|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
105992917|NCT01053988|365633060|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
105992918|NCT01053988|365633061|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105992919|NCT01053988|365633056|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
105992920|NCT01053988|365633057|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
105992921|NCT01053988|365633058|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
105992922|NCT01053988|365633059|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
105992923|NCT01053988|365633060|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
105992924|NCT01053988|365633061|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
105992925|NCT01053988|365633056|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105992926|NCT01053988|365633057|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
105992927|NCT01053988|365633058|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
105992928|NCT01053988|365633059|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
105992929|NCT01053988|365633060|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
105992930|NCT01053988|365633061|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
105992931|NCT01053988|365633056|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105992932|NCT01053988|365633057|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
105992933|NCT01053988|365633058|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
105992934|NCT01053988|365633059|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
105992935|NCT01053988|365633060|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
105992936|NCT01053988|365633061|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
105992937|NCT01053988|365633056|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105992938|NCT01053988|365633057|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
105992939|NCT01053988|365633058|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105992940|NCT01053988|365633059|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
105992941|NCT01053988|365633060|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105992942|NCT01053988|365633061|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
105992943|NCT01053988|365633056|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
105992944|NCT01053988|365633057|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
105992945|NCT01053988|365633058|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
105992946|NCT01053988|365633059|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
105992947|NCT01053988|365633060|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
105992948|NCT01053988|365633061|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
105992949|NCT01053988|365633056|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105992950|NCT01053988|365633057|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
105992951|NCT01053988|365633058|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
105992952|NCT01053988|365633059|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
105992953|NCT01053988|365633060|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
105992954|NCT01053988|365633061|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
105992955|NCT01415401|365633068|FG000|Overall Study|Adverse Event|5|||
105992956|NCT01415401|365633068|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
105992957|NCT01415401|365633068|FG000|Overall Study|Terminated by Sponsor|1|||
105992958|NCT01824355|365633069|FG000|Overall Study|Adverse Event|2|||
105992959|NCT01824355|365633069|FG000|Overall Study|unevaluable reference method results per|1|||
105992960|NCT02097030|365633071|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
105992961|NCT02097030|365633072|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
105992962|NCT02097030|365633071|FG000|First Intervention (3 Days)|Visual Acuity|0|||
105782538|NCT02260804|364856250|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
105992963|NCT02097030|365633072|FG001|First Intervention (3 Days)|Visual Acuity|1|||
105992964|NCT01919801|365633073|FG000|Overall Study|Withdrawal by Subject|1|||
105992965|NCT01919801|365633074|FG001|Overall Study|Withdrawal by Subject|0|||
105992966|NCT01919801|365633073|FG000|Overall Study|Physician Decision|0|||
105992967|NCT01919801|365633074|FG001|Overall Study|Physician Decision|1|||
105992968|NCT01919801|365633073|FG000|Overall Study|Lost to Follow-up|0|||
105992969|NCT01919801|365633074|FG001|Overall Study|Lost to Follow-up|1|||
105992970|NCT01919801|365633073|FG000|Overall Study|Other|0|||
105992971|NCT01919801|365633074|FG001|Overall Study|Other|1|||
105992972|NCT01843062|365633075|FG000|Overall Study|Protocol Violation|1|||
105992973|NCT01843062|365633076|FG001|Overall Study|Protocol Violation|0|||
105992974|NCT01843062|365633075|FG000|Overall Study|New treatment following progression|2|||
105992975|NCT01843062|365633076|FG001|Overall Study|New treatment following progression|0|||
105992976|NCT01843062|365633075|FG000|Overall Study|Pregnancy|1|||
105992977|NCT01843062|365633076|FG001|Overall Study|Pregnancy|0|||
105992978|NCT01843062|365633075|FG000|Overall Study|Adverse Event|2|||
105992979|NCT01843062|365633076|FG001|Overall Study|Adverse Event|0|||
105992980|NCT01843062|365633075|FG000|Overall Study|Incorrect randomisation|1|||
105992981|NCT01843062|365633076|FG001|Overall Study|Incorrect randomisation|0|||
105992982|NCT01843062|365633075|FG000|Overall Study|Withdrawal by Subject|12|||
105992983|NCT01843062|365633076|FG001|Overall Study|Withdrawal by Subject|3|||
105992984|NCT01843062|365633075|FG000|Overall Study|Death|1|||
105992985|NCT01843062|365633076|FG001|Overall Study|Death|2|||
105992986|NCT01843062|365633075|FG000|Overall Study|Lost to Follow-up|2|||
105992987|NCT01843062|365633076|FG001|Overall Study|Lost to Follow-up|4|||
105992988|NCT00994422|365633077|FG000|Overall Study|Lost to Follow-up|7|||
105992989|NCT00994422|365633078|FG001|Overall Study|Lost to Follow-up|1|||
105992990|NCT01625000|365633079|FG000|Overall Study|Physician Decision|15|||
105992991|NCT01625000|365633080|FG001|Overall Study|Physician Decision|7|||
105992992|NCT01625000|365633081|FG002|Overall Study|Physician Decision|7|||
105992993|NCT01625000|365633082|FG003|Overall Study|Physician Decision|2|||
105992994|NCT01625000|365633083|FG004|Overall Study|Physician Decision|15|||
105992995|NCT01625000|365633079|FG000|Overall Study|Protocol Violation|3|||
105992996|NCT01625000|365633080|FG001|Overall Study|Protocol Violation|10|||
105992997|NCT01625000|365633081|FG002|Overall Study|Protocol Violation|4|||
105992998|NCT01625000|365633082|FG003|Overall Study|Protocol Violation|1|||
105992999|NCT01625000|365633083|FG004|Overall Study|Protocol Violation|2|||
105993000|NCT01625000|365633079|FG000|Overall Study|Withdrawal by Subject|19|||
105993001|NCT01625000|365633080|FG001|Overall Study|Withdrawal by Subject|16|||
105993002|NCT01625000|365633081|FG002|Overall Study|Withdrawal by Subject|11|||
105993003|NCT01625000|365633082|FG003|Overall Study|Withdrawal by Subject|9|||
105993004|NCT01625000|365633083|FG004|Overall Study|Withdrawal by Subject|17|||
105993005|NCT01625000|365633079|FG000|Overall Study|Adverse Event (including Death)|15|||
105993006|NCT01625000|365633080|FG001|Overall Study|Adverse Event (including Death)|19|||
105993007|NCT01625000|365633081|FG002|Overall Study|Adverse Event (including Death)|11|||
105993008|NCT01625000|365633082|FG003|Overall Study|Adverse Event (including Death)|7|||
105993009|NCT01625000|365633083|FG004|Overall Study|Adverse Event (including Death)|21|||
105993010|NCT04346654|365633085|FG000|Overall Study|Adverse Event|2|||
105993011|NCT04346654|365633086|FG001|Overall Study|Adverse Event|0|||
105993012|NCT04346654|365633085|FG000|Overall Study|Non-response|1|||
105993013|NCT04346654|365633086|FG001|Overall Study|Non-response|1|||
105993014|NCT04346654|365633085|FG000|Overall Study|Withdrawal by Subject|2|||
105993015|NCT04346654|365633086|FG001|Overall Study|Withdrawal by Subject|0|||
105993016|NCT04346654|365633085|FG000|Overall Study|Lost to Follow-up|0|||
105993017|NCT04346654|365633086|FG001|Overall Study|Lost to Follow-up|1|||
105993018|NCT04346654|365633085|FG000|Overall Study|Pregnancy|0|||
105993019|NCT04346654|365633086|FG001|Overall Study|Pregnancy|1|||
105993020|NCT04929249|365633087|FG000|Overall Study|Adverse Event|2|||
105993021|NCT04929249|365633088|FG001|Overall Study|Adverse Event|1|||
105993022|NCT04929249|365633087|FG000|Overall Study|Death|2|||
105993023|NCT04929249|365633088|FG001|Overall Study|Death|1|||
105993024|NCT04929249|365633087|FG000|Overall Study|Lost to Follow-up|3|||
105993025|NCT04929249|365633088|FG001|Overall Study|Lost to Follow-up|11|||
105993026|NCT04929249|365633087|FG000|Overall Study|Technical problems|0|||
105993027|NCT04929249|365633088|FG001|Overall Study|Technical problems|1|||
105993028|NCT04929249|365633087|FG000|Overall Study|Subject decision|6|||
105993029|NCT04929249|365633088|FG001|Overall Study|Subject decision|8|||
105993030|NCT04929249|365633087|FG000|Overall Study|Withdrew consent|0|||
105993031|NCT04929249|365633088|FG001|Overall Study|Withdrew consent|8|||
105993032|NCT04677504|365633092|FG000|Overall Study|Death|51|||
105993033|NCT04677504|365633093|FG001|Overall Study|Death|49|||
105993034|NCT04677504|365633092|FG000|Overall Study|Progressive Disease|1|||
105993035|NCT04677504|365633093|FG001|Overall Study|Progressive Disease|0|||
105993036|NCT04677504|365633092|FG000|Overall Study|Symptomatic Deterioration|1|||
105993037|NCT04677504|365633093|FG001|Overall Study|Symptomatic Deterioration|0|||
105993038|NCT04677504|365633092|FG000|Overall Study|Withdrawal by Subject|2|||
105993039|NCT04677504|365633093|FG001|Overall Study|Withdrawal by Subject|5|||
105993040|NCT04677504|365633092|FG000|Overall Study|Study Terminated By Sponsor|28|||
105993041|NCT04677504|365633093|FG001|Overall Study|Study Terminated By Sponsor|24|||
106107345|NCT00428090|366047668|FG000|Overall Study|Withdrawal by Subject|10|||
106107346|NCT00428090|366047669|FG001|Overall Study|Withdrawal by Subject|12|||
106107347|NCT00428090|366047670|FG002|Overall Study|Withdrawal by Subject|15|||
106107348|NCT00428090|366047671|FG003|Overall Study|Withdrawal by Subject|5|||
106107349|NCT00428090|366047668|FG000|Overall Study|Sponsor terminated study|0|||
106107350|NCT00428090|366047669|FG001|Overall Study|Sponsor terminated study|1|||
106107351|NCT00428090|366047670|FG002|Overall Study|Sponsor terminated study|0|||
106107352|NCT00428090|366047671|FG003|Overall Study|Sponsor terminated study|0|||
106107353|NCT00428090|366047668|FG000|Overall Study|Non-compliance|4|||
106107354|NCT00428090|366047669|FG001|Overall Study|Non-compliance|0|||
106107355|NCT00428090|366047670|FG002|Overall Study|Non-compliance|1|||
106107356|NCT00428090|366047671|FG003|Overall Study|Non-compliance|3|||
106107357|NCT00428090|366047668|FG000|Overall Study|Par. did not returned to visit|1|||
106107358|NCT00428090|366047669|FG001|Overall Study|Par. did not returned to visit|0|||
106107359|NCT00428090|366047670|FG002|Overall Study|Par. did not returned to visit|0|||
105782539|NCT02260804|364856249|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
105782540|NCT02260804|364856250|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
105782541|NCT02260804|364856249|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
106107360|NCT00428090|366047671|FG003|Overall Study|Par. did not returned to visit|1|||
106107361|NCT00428090|366047668|FG000|Overall Study|Follow-Up visit not possible|1|||
106107362|NCT00428090|366047669|FG001|Overall Study|Follow-Up visit not possible|0|||
106107363|NCT00428090|366047670|FG002|Overall Study|Follow-Up visit not possible|0|||
106107364|NCT00428090|366047671|FG003|Overall Study|Follow-Up visit not possible|0|||
106107365|NCT00428090|366047668|FG000|Overall Study|Prohibited medication used for SAE|1|||
106107366|NCT00428090|366047669|FG001|Overall Study|Prohibited medication used for SAE|0|||
106107367|NCT00428090|366047670|FG002|Overall Study|Prohibited medication used for SAE|0|||
106107368|NCT00428090|366047671|FG003|Overall Study|Prohibited medication used for SAE|0|||
106107369|NCT00428090|366047668|FG000|Overall Study|Death of par.|1|||
106107370|NCT00428090|366047669|FG001|Overall Study|Death of par.|0|||
106107371|NCT00428090|366047670|FG002|Overall Study|Death of par.|1|||
106107372|NCT00428090|366047671|FG003|Overall Study|Death of par.|0|||
106107373|NCT00428090|366047668|FG000|Overall Study|Visit 7 exceed the visit window|0|||
106107374|NCT00428090|366047669|FG001|Overall Study|Visit 7 exceed the visit window|1|||
106107375|NCT00428090|366047670|FG002|Overall Study|Visit 7 exceed the visit window|0|||
106107376|NCT00428090|366047671|FG003|Overall Study|Visit 7 exceed the visit window|0|||
106107377|NCT00428090|366047668|FG000|Overall Study|Medical monitor terminated par.|0|||
106107378|NCT00428090|366047669|FG001|Overall Study|Medical monitor terminated par.|1|||
106107379|NCT00428090|366047670|FG002|Overall Study|Medical monitor terminated par.|0|||
106107380|NCT00428090|366047671|FG003|Overall Study|Medical monitor terminated par.|0|||
106107381|NCT00428090|366047668|FG000|Overall Study|Mental status of par. was|0|||
106107382|NCT00428090|366047669|FG001|Overall Study|Mental status of par. was|1|||
106107383|NCT00428090|366047670|FG002|Overall Study|Mental status of par. was|0|||
106107384|NCT00428090|366047671|FG003|Overall Study|Mental status of par. was|0|||
106107385|NCT00428090|366047668|FG000|Overall Study|Worsening of AD|0|||
106107386|NCT00428090|366047669|FG001|Overall Study|Worsening of AD|0|||
106107387|NCT00428090|366047670|FG002|Overall Study|Worsening of AD|1|||
106107388|NCT00428090|366047671|FG003|Overall Study|Worsening of AD|0|||
106107389|NCT00428090|366047668|FG000|Overall Study|Excluded for concerning QTc value|0|||
106107390|NCT00428090|366047669|FG001|Overall Study|Excluded for concerning QTc value|0|||
106107391|NCT00428090|366047670|FG002|Overall Study|Excluded for concerning QTc value|1|||
106107392|NCT00428090|366047671|FG003|Overall Study|Excluded for concerning QTc value|0|||
106107393|NCT00428090|366047668|FG000|Overall Study|Insufficient AD documentation|0|||
106107394|NCT00428090|366047669|FG001|Overall Study|Insufficient AD documentation|0|||
106107395|NCT00428090|366047670|FG002|Overall Study|Insufficient AD documentation|1|||
106107396|NCT00428090|366047671|FG003|Overall Study|Insufficient AD documentation|0|||
106107397|NCT00428090|366047668|FG000|Overall Study|High MMSE scores|0|||
106107398|NCT00428090|366047669|FG001|Overall Study|High MMSE scores|0|||
106107399|NCT00428090|366047670|FG002|Overall Study|High MMSE scores|1|||
105782542|NCT02260804|364856250|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
105782543|NCT02260804|364856249|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
105782544|NCT02260804|364856250|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
105782545|NCT02207413|364856253|FG000|Overall Study|Withdrawal by Subject|1|||
105782546|NCT02207413|364856254|FG001|Overall Study|Withdrawal by Subject|0|||
105782547|NCT02207413|364856255|FG002|Overall Study|Withdrawal by Subject|0|||
105782548|NCT02207413|364856256|FG003|Overall Study|Withdrawal by Subject|0|||
105782549|NCT02207413|364856257|FG004|Overall Study|Withdrawal by Subject|3|||
105782550|NCT02207413|364856258|FG005|Overall Study|Withdrawal by Subject|7|||
105782551|NCT02207413|364856253|FG000|Overall Study|Lost to Follow-up|0|||
105782552|NCT02207413|364856254|FG001|Overall Study|Lost to Follow-up|0|||
105782553|NCT02207413|364856255|FG002|Overall Study|Lost to Follow-up|0|||
105782554|NCT02207413|364856256|FG003|Overall Study|Lost to Follow-up|1|||
105782555|NCT02207413|364856257|FG004|Overall Study|Lost to Follow-up|1|||
105782556|NCT02207413|364856258|FG005|Overall Study|Lost to Follow-up|5|||
105782557|NCT02207413|364856253|FG000|Overall Study|Adverse Event|0|||
106107400|NCT00428090|366047671|FG003|Overall Study|High MMSE scores|0|||
106107401|NCT00428090|366047668|FG000|Overall Study|Deterioration of cognitive status|0|||
106107402|NCT00428090|366047669|FG001|Overall Study|Deterioration of cognitive status|0|||
105782558|NCT02207413|364856254|FG001|Overall Study|Adverse Event|0|||
105782559|NCT02207413|364856255|FG002|Overall Study|Adverse Event|0|||
105782560|NCT02207413|364856256|FG003|Overall Study|Adverse Event|0|||
105782561|NCT02207413|364856257|FG004|Overall Study|Adverse Event|2|||
105782562|NCT02207413|364856258|FG005|Overall Study|Adverse Event|1|||
106107403|NCT00428090|366047670|FG002|Overall Study|Deterioration of cognitive status|1|||
106107404|NCT00428090|366047671|FG003|Overall Study|Deterioration of cognitive status|0|||
106107405|NCT00428090|366047668|FG000|Overall Study|Serious adverse event|0|||
106107406|NCT00428090|366047669|FG001|Overall Study|Serious adverse event|0|||
106107407|NCT00428090|366047670|FG002|Overall Study|Serious adverse event|1|||
106107408|NCT00428090|366047671|FG003|Overall Study|Serious adverse event|0|||
106107409|NCT00428090|366047668|FG000|Overall Study|Excluded for heart insufficiency|0|||
106107410|NCT00428090|366047669|FG001|Overall Study|Excluded for heart insufficiency|0|||
106107411|NCT00428090|366047670|FG002|Overall Study|Excluded for heart insufficiency|1|||
106107412|NCT00428090|366047671|FG003|Overall Study|Excluded for heart insufficiency|0|||
106107413|NCT00428090|366047668|FG000|Overall Study|Raised Creatinine Value|0|||
106107414|NCT00428090|366047669|FG001|Overall Study|Raised Creatinine Value|0|||
106107415|NCT00428090|366047670|FG002|Overall Study|Raised Creatinine Value|0|||
106107416|NCT00428090|366047671|FG003|Overall Study|Raised Creatinine Value|1|||
106107417|NCT03409666|366047672|FG000|Overall Study|Physician Decision|0|||
106107418|NCT03409666|366047673|FG001|Overall Study|Physician Decision|1|||
106107419|NCT03409666|366047672|FG000|Overall Study|Protocol Violation|0|||
106107420|NCT03409666|366047673|FG001|Overall Study|Protocol Violation|3|||
106107421|NCT00512148|366047674|FG000|Primay Study Period|Withdrawal by Subject|1|||
106107422|NCT00677833|366047677|FG000|Overall Study|Withdrawal by Subject|4|||
106107423|NCT00677833|366047678|FG001|Overall Study|Withdrawal by Subject|0|||
106107424|NCT00677833|366047679|FG002|Overall Study|Withdrawal by Subject|1|||
106107425|NCT00677833|366047680|FG003|Overall Study|Withdrawal by Subject|3|||
106107426|NCT00677833|366047677|FG000|Overall Study|Lost to Follow-up|0|||
106107427|NCT00677833|366047678|FG001|Overall Study|Lost to Follow-up|0|||
106107428|NCT00677833|366047679|FG002|Overall Study|Lost to Follow-up|1|||
106107429|NCT00677833|366047680|FG003|Overall Study|Lost to Follow-up|0|||
106107430|NCT02001194|366047682|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
106107431|NCT02001194|366047683|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
106107432|NCT02001194|366047684|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
106107433|NCT02001194|366047685|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
106107434|NCT02001194|366047682|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
106107435|NCT02001194|366047683|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
106107436|NCT02001194|366047684|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
106107437|NCT02001194|366047685|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
106107438|NCT02606279|366047692|FG000|Overall Study|Lost to Follow-up|0|||
106107439|NCT02606279|366047693|FG001|Overall Study|Lost to Follow-up|1|||
106107440|NCT02690974|366047694|FG000|Overall Study|Adverse Event|16|||
106107441|NCT02690974|366047694|FG000|Overall Study|Death|9|||
106107442|NCT02690974|366047694|FG000|Overall Study|Subject/guardian decision|4|||
106107443|NCT02690974|366047694|FG000|Overall Study|Lost to Follow-up|3|||
106107444|NCT02690974|366047694|FG000|Overall Study|Withdrawal of Informed Consent|3|||
106107445|NCT02690974|366047694|FG000|Overall Study|Physician Decision|2|||
106107446|NCT02690974|366047694|FG000|Overall Study|Non-compliance with study treatment|1|||
106107447|NCT02690974|366047694|FG000|Overall Study|Protocol-defined stopping criteria|1|||
106107448|NCT02690974|366047694|FG000|Overall Study|Protocol Deviation|1|||
106107449|NCT00522301|366047699|FG000|Overall Study|Withdrawal by Subject|1|||
106107450|NCT00522301|366047699|FG000|Overall Study|Adverse Event|5|||
106107451|NCT01666951|366047700|FG000|Overall Study|Not dosed|1|||
106107452|NCT01666951|366047701|FG001|Overall Study|Not dosed|1|||
106107453|NCT02052310|366047704|FG000|Overall Study|Death|64|||
106107454|NCT02052310|366047705|FG001|Overall Study|Death|54|||
106107455|NCT02052310|366047704|FG000|Overall Study|Withdrawal by Subject|37|||
106107456|NCT02052310|366047705|FG001|Overall Study|Withdrawal by Subject|49|||
106107457|NCT02052310|366047704|FG000|Overall Study|Other than specified|32|||
106107458|NCT02052310|366047705|FG001|Overall Study|Other than specified|29|||
106107459|NCT02052310|366047704|FG000|Overall Study|Adverse Event|29|||
106107460|NCT02052310|366047705|FG001|Overall Study|Adverse Event|22|||
106107461|NCT02052310|366047704|FG000|Overall Study|Kidney Transplant|23|||
106107462|NCT02052310|366047705|FG001|Overall Study|Kidney Transplant|29|||
106107463|NCT02052310|366047704|FG000|Overall Study|Physician Decision|14|||
106107464|NCT02052310|366047705|FG001|Overall Study|Physician Decision|7|||
106107465|NCT02052310|366047704|FG000|Overall Study|Lack of Efficacy|6|||
106107466|NCT02052310|366047705|FG001|Overall Study|Lack of Efficacy|1|||
105782563|NCT02207413|364856253|FG000|Overall Study|Migrated/moved from study area|0|||
105782564|NCT02207413|364856254|FG001|Overall Study|Migrated/moved from study area|0|||
106107467|NCT02052310|366047704|FG000|Overall Study|Site Terminated by Sponsor|5|||
105782565|NCT02207413|364856255|FG002|Overall Study|Migrated/moved from study area|0|||
105993042|NCT04677504|365633092|FG000|Overall Study|Adverse Event|0|||
105993043|NCT04677504|365633093|FG001|Overall Study|Adverse Event|1|||
105993044|NCT05513053|365633095|FG000|Overall Study|Lost to Follow-up|9|||
105993045|NCT05513053|365633096|FG001|Overall Study|Lost to Follow-up|11|||
105993046|NCT05513053|365633095|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105993047|NCT05513053|365633096|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105993048|NCT05513053|365633095|FG000|Overall Study|Withdrawal by Subject|2|||
105993049|NCT05513053|365633096|FG001|Overall Study|Withdrawal by Subject|9|||
105993050|NCT05513053|365633095|FG000|Overall Study|Protocol Violation|6|||
105993051|NCT05513053|365633096|FG001|Overall Study|Protocol Violation|3|||
105993052|NCT05513053|365633095|FG000|Overall Study|Adverse Event|0|||
105993053|NCT05513053|365633096|FG001|Overall Study|Adverse Event|2|||
105993054|NCT01180296|365633097|FG000|Overall Study|Protocol Violation|1|||
105993055|NCT01180296|365633098|FG001|Overall Study|Protocol Violation|2|||
105993056|NCT03304873|365633099|FG000|Overall Study|Lost to Follow-up|1|||
105993057|NCT03304873|365633100|FG001|Overall Study|Lost to Follow-up|8|||
105993058|NCT01546688|365633101|FG000|Overall Study|Adverse Event|0|||
105993059|NCT01546688|365633102|FG001|Overall Study|Adverse Event|4|||
105993060|NCT01546688|365633101|FG000|Overall Study|Withdrawal by Subject|2|||
105993061|NCT01546688|365633102|FG001|Overall Study|Withdrawal by Subject|1|||
105993062|NCT01546688|365633101|FG000|Overall Study|Lack of Efficacy|1|||
105993063|NCT01546688|365633102|FG001|Overall Study|Lack of Efficacy|0|||
105993064|NCT03543137|365633105|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
105993065|NCT03543137|365633106|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
105993066|NCT03543137|365633105|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
105993067|NCT03543137|365633106|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
105993068|NCT03543137|365633105|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
105993069|NCT03543137|365633106|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
105993070|NCT01868477|365633107|FG000|Overall Study|Adverse Event|2|||
105993071|NCT01868477|365633108|FG001|Overall Study|Adverse Event|4|||
106107468|NCT02052310|366047705|FG001|Overall Study|Site Terminated by Sponsor|13|||
106107469|NCT02052310|366047704|FG000|Overall Study|Lost to Follow-up|4|||
106107470|NCT02052310|366047705|FG001|Overall Study|Lost to Follow-up|2|||
106107471|NCT02052310|366047704|FG000|Overall Study|Protocol Violation|1|||
106107472|NCT02052310|366047705|FG001|Overall Study|Protocol Violation|6|||
106107473|NCT00152464|366047706|FG000|Overall Study|Adverse Event|3|||
106107474|NCT00152464|366047707|FG001|Overall Study|Adverse Event|6|||
106107475|NCT00152464|366047706|FG000|Overall Study|Lost to Follow-up|8|||
105993072|NCT01868477|365633107|FG000|Overall Study|Disease progression|1|||
105993073|NCT01868477|365633108|FG001|Overall Study|Disease progression|1|||
105993074|NCT01868477|365633107|FG000|Overall Study|Withdrawal by Subject|1|||
105993075|NCT01868477|365633108|FG001|Overall Study|Withdrawal by Subject|0|||
105993076|NCT01052077|365633109|FG000|Phase A|Lost to Follow-up|22|||
105993077|NCT01052077|365633110|FG001|Phase A|Lost to Follow-up|0|||
105993078|NCT01052077|365633111|FG002|Phase A|Lost to Follow-up|0|||
105993079|NCT01052077|365633112|FG003|Phase A|Lost to Follow-up|0|||
105993080|NCT01052077|365633109|FG000|Phase A|Adverse Event|32|||
105993081|NCT01052077|365633110|FG001|Phase A|Adverse Event|0|||
105993082|NCT01052077|365633111|FG002|Phase A|Adverse Event|0|||
105993083|NCT01052077|365633112|FG003|Phase A|Adverse Event|0|||
105993084|NCT01052077|365633109|FG000|Phase A|Met Withdrawal Criteria|26|||
105993085|NCT01052077|365633110|FG001|Phase A|Met Withdrawal Criteria|0|||
105993086|NCT01052077|365633111|FG002|Phase A|Met Withdrawal Criteria|0|||
105993087|NCT01052077|365633112|FG003|Phase A|Met Withdrawal Criteria|0|||
105993088|NCT01052077|365633109|FG000|Phase A|Physician Decision|10|||
105993089|NCT01052077|365633110|FG001|Phase A|Physician Decision|0|||
105993090|NCT01052077|365633111|FG002|Phase A|Physician Decision|0|||
105993091|NCT01052077|365633112|FG003|Phase A|Physician Decision|0|||
105993092|NCT01052077|365633109|FG000|Phase A|Withdrawal by Subject|29|||
105993093|NCT01052077|365633110|FG001|Phase A|Withdrawal by Subject|0|||
105993094|NCT01052077|365633111|FG002|Phase A|Withdrawal by Subject|0|||
105993095|NCT01052077|365633112|FG003|Phase A|Withdrawal by Subject|0|||
105993096|NCT01052077|365633109|FG000|Phase A|Protocol Deviation|27|||
105993097|NCT01052077|365633110|FG001|Phase A|Protocol Deviation|0|||
105993098|NCT01052077|365633111|FG002|Phase A|Protocol Deviation|0|||
105993099|NCT01052077|365633112|FG003|Phase A|Protocol Deviation|0|||
105993100|NCT01052077|365633109|FG000|Phase B|Lost to Follow-up|0|||
105993101|NCT01052077|365633110|FG001|Phase B|Lost to Follow-up|2|||
105993102|NCT01052077|365633111|FG002|Phase B|Lost to Follow-up|3|||
106107476|NCT00152464|366047707|FG001|Overall Study|Lost to Follow-up|4|||
105993103|NCT01052077|365633112|FG003|Phase B|Lost to Follow-up|0|||
105993104|NCT01052077|365633109|FG000|Phase B|Adverse Event|0|||
105993105|NCT01052077|365633110|FG001|Phase B|Adverse Event|9|||
105993106|NCT01052077|365633111|FG002|Phase B|Adverse Event|2|||
105993107|NCT01052077|365633112|FG003|Phase B|Adverse Event|0|||
105993108|NCT01052077|365633109|FG000|Phase B|Met Withdrawal Criteria|0|||
105993109|NCT01052077|365633110|FG001|Phase B|Met Withdrawal Criteria|2|||
106107477|NCT00152464|366047706|FG000|Overall Study|Protocol Violation|3|||
105993110|NCT01052077|365633111|FG002|Phase B|Met Withdrawal Criteria|1|||
105993111|NCT01052077|365633112|FG003|Phase B|Met Withdrawal Criteria|0|||
106107478|NCT00152464|366047707|FG001|Overall Study|Protocol Violation|1|||
105993112|NCT01052077|365633109|FG000|Phase B|Physician Decision|0|||
105993113|NCT01052077|365633110|FG001|Phase B|Physician Decision|1|||
105993114|NCT01052077|365633111|FG002|Phase B|Physician Decision|1|||
106107479|NCT00152464|366047706|FG000|Overall Study|Withdrawal by Subject|21|||
106107480|NCT00152464|366047707|FG001|Overall Study|Withdrawal by Subject|22|||
106107481|NCT00152464|366047706|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
106107482|NCT00152464|366047707|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
106107483|NCT00152464|366047706|FG000|Overall Study|Eczema deterioration|0|||
106107484|NCT00152464|366047707|FG001|Overall Study|Eczema deterioration|1|||
106107485|NCT00152464|366047706|FG000|Overall Study|Parent decision|1|||
106107486|NCT00152464|366047707|FG001|Overall Study|Parent decision|1|||
106107487|NCT00152464|366047706|FG000|Overall Study|Investigator decision|1|||
106107488|NCT00152464|366047707|FG001|Overall Study|Investigator decision|0|||
106107489|NCT00152464|366047706|FG000|Overall Study|Lack of Efficacy|1|||
105782566|NCT02207413|364856256|FG003|Overall Study|Migrated/moved from study area|0|||
105782567|NCT02207413|364856257|FG004|Overall Study|Migrated/moved from study area|1|||
106107490|NCT00152464|366047707|FG001|Overall Study|Lack of Efficacy|0|||
106107491|NCT00152464|366047706|FG000|Overall Study|Eczema poorly controlled|1|||
106107492|NCT00152464|366047707|FG001|Overall Study|Eczema poorly controlled|0|||
106107493|NCT00152464|366047706|FG000|Overall Study|Patient relocated|1|||
106107494|NCT00152464|366047707|FG001|Overall Study|Patient relocated|0|||
106107495|NCT01644734|366047708|FG000|Overall Study|Adverse Event|4|||
106107496|NCT01644734|366047708|FG000|Overall Study|Lost to Follow-up|17|||
106107497|NCT01644734|366047708|FG000|Overall Study|Reasons other than stated above|7|||
106107498|NCT01644734|366047708|FG000|Overall Study|Missing documentation|238|||
106107499|NCT01410474|366047709|FG000|Overall Study|Withdrawal by Subject|0|||
106107500|NCT01410474|366047710|FG001|Overall Study|Withdrawal by Subject|1|||
106107501|NCT02428296|366047711|FG000|Overall Study|Adverse Event|7|||
106107502|NCT02428296|366047711|FG000|Overall Study|Withdrawal by Subject|2|||
106107503|NCT00620750|366047712|FG000|Overall Study|Lost to Follow-up|25|||
106107504|NCT04477187|366047713|FG000|Overall Study|Lost to Follow-up|2|||
106107505|NCT03232983|366047717|FG000|Period 1|Physician Decision|0|||
106107506|NCT03232983|366047718|FG001|Period 1|Physician Decision|0|||
106107507|NCT03232983|366047719|FG002|Period 1|Physician Decision|1|||
106107508|NCT03232983|366047720|FG003|Period 1|Physician Decision|0|||
106107509|NCT03232983|366047717|FG000|Washout Period 2|Physician Decision|0|||
106107510|NCT03232983|366047718|FG001|Washout Period 2|Physician Decision|0|||
106107511|NCT03232983|366047719|FG002|Washout Period 2|Physician Decision|1|||
106107512|NCT03232983|366047720|FG003|Washout Period 2|Physician Decision|0|||
106107513|NCT03232983|366047717|FG000|Washout Period 2|Withdrawal by Subject|0|||
106107514|NCT03232983|366047718|FG001|Washout Period 2|Withdrawal by Subject|0|||
106107515|NCT03232983|366047719|FG002|Washout Period 2|Withdrawal by Subject|0|||
106107516|NCT03232983|366047720|FG003|Washout Period 2|Withdrawal by Subject|1|||
106107517|NCT03232983|366047717|FG000|Period 4|Withdrawal by Subject|1|||
106107518|NCT03232983|366047718|FG001|Period 4|Withdrawal by Subject|0|||
106107519|NCT03232983|366047719|FG002|Period 4|Withdrawal by Subject|0|||
106107520|NCT03232983|366047720|FG003|Period 4|Withdrawal by Subject|0|||
106107521|NCT01615328|366047721|FG000|Overall Study|Lost to Follow-up|3|||
106107522|NCT01615328|366047722|FG001|Overall Study|Lost to Follow-up|5|||
106107523|NCT00430248|366047725|FG000|Overall Study|Adverse Event|49|||
106107524|NCT00430248|366047726|FG001|Overall Study|Adverse Event|61|||
106107525|NCT00430248|366047727|FG002|Overall Study|Adverse Event|64|||
106107526|NCT00430248|366047725|FG000|Overall Study|Protocol Violation|10|||
106107527|NCT00430248|366047726|FG001|Overall Study|Protocol Violation|2|||
106107528|NCT00430248|366047727|FG002|Overall Study|Protocol Violation|4|||
106107529|NCT00430248|366047725|FG000|Overall Study|Personal Reasons|12|||
106107530|NCT00430248|366047726|FG001|Overall Study|Personal Reasons|24|||
106107531|NCT00430248|366047727|FG002|Overall Study|Personal Reasons|9|||
106107532|NCT00430248|366047725|FG000|Overall Study|Lost to Follow-up|28|||
106107533|NCT00430248|366047726|FG001|Overall Study|Lost to Follow-up|33|||
105782568|NCT02207413|364856258|FG005|Overall Study|Migrated/moved from study area|0|||
105782569|NCT03726320|364857924|FG000|Overall Study|Lost to Follow-up|2|||
105782570|NCT03726320|364857925|FG001|Overall Study|Lost to Follow-up|4|||
105782571|NCT03726320|364857926|FG002|Overall Study|Lost to Follow-up|0|||
105782572|NCT03726320|364857924|FG000|Overall Study|Time Constraints|4|||
105782573|NCT03726320|364857925|FG001|Overall Study|Time Constraints|1|||
105782574|NCT03726320|364857926|FG002|Overall Study|Time Constraints|0|||
105782575|NCT03726320|364857924|FG000|Overall Study|Ineligible after enrollment|3|||
105782576|NCT03726320|364857925|FG001|Overall Study|Ineligible after enrollment|3|||
105782577|NCT03726320|364857926|FG002|Overall Study|Ineligible after enrollment|0|||
106107534|NCT00430248|366047727|FG002|Overall Study|Lost to Follow-up|28|||
106107535|NCT00430248|366047725|FG000|Overall Study|Therapeutic Failure|1|||
106107536|NCT00430248|366047726|FG001|Overall Study|Therapeutic Failure|1|||
106107537|NCT00430248|366047727|FG002|Overall Study|Therapeutic Failure|1|||
106107538|NCT00430248|366047725|FG000|Overall Study|Withdrawal by Subject|14|||
105782578|NCT03726320|364857924|FG000|Overall Study|Clinic / insurance issue|2|||
105993115|NCT01052077|365633112|FG003|Phase B|Physician Decision|0|||
105993116|NCT01052077|365633109|FG000|Phase B|Withdrawal by Subject|0|||
105993117|NCT01052077|365633110|FG001|Phase B|Withdrawal by Subject|0|||
105993118|NCT01052077|365633111|FG002|Phase B|Withdrawal by Subject|5|||
105993119|NCT01052077|365633112|FG003|Phase B|Withdrawal by Subject|0|||
105993120|NCT01052077|365633109|FG000|Phase B|Protocol Deviation|0|||
105993121|NCT01052077|365633110|FG001|Phase B|Protocol Deviation|3|||
105993122|NCT01052077|365633111|FG002|Phase B|Protocol Deviation|4|||
105993123|NCT01052077|365633112|FG003|Phase B|Protocol Deviation|0|||
105993124|NCT01052077|365633109|FG000|Phase B|Lack of Efficacy|0|||
105993125|NCT01052077|365633110|FG001|Phase B|Lack of Efficacy|1|||
105993126|NCT01052077|365633111|FG002|Phase B|Lack of Efficacy|0|||
105993127|NCT01052077|365633112|FG003|Phase B|Lack of Efficacy|0|||
105993128|NCT01052077|365633109|FG000|Phase A+|Lost to Follow-up|0|||
105993129|NCT01052077|365633110|FG001|Phase A+|Lost to Follow-up|0|||
105993130|NCT01052077|365633111|FG002|Phase A+|Lost to Follow-up|0|||
105993131|NCT01052077|365633112|FG003|Phase A+|Lost to Follow-up|8|||
105993132|NCT01052077|365633109|FG000|Phase A+|Adverse Event|0|||
105993133|NCT01052077|365633110|FG001|Phase A+|Adverse Event|0|||
105993134|NCT01052077|365633111|FG002|Phase A+|Adverse Event|0|||
105993135|NCT01052077|365633112|FG003|Phase A+|Adverse Event|4|||
105993136|NCT01052077|365633109|FG000|Phase A+|Met Withdrawal Criteria|0|||
105993137|NCT01052077|365633110|FG001|Phase A+|Met Withdrawal Criteria|0|||
105993138|NCT01052077|365633111|FG002|Phase A+|Met Withdrawal Criteria|0|||
105993139|NCT01052077|365633112|FG003|Phase A+|Met Withdrawal Criteria|2|||
105993140|NCT01052077|365633109|FG000|Phase A+|Withdrawal by Subject|0|||
105993141|NCT01052077|365633110|FG001|Phase A+|Withdrawal by Subject|0|||
105993142|NCT01052077|365633111|FG002|Phase A+|Withdrawal by Subject|0|||
105993143|NCT01052077|365633112|FG003|Phase A+|Withdrawal by Subject|7|||
106107539|NCT00430248|366047726|FG001|Overall Study|Withdrawal by Subject|20|||
106107540|NCT00430248|366047727|FG002|Overall Study|Withdrawal by Subject|16|||
106107541|NCT00430248|366047725|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
106107542|NCT00430248|366047726|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
106107543|NCT00430248|366047727|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
106107544|NCT00430248|366047725|FG000|Overall Study|Gout Flare|3|||
106107545|NCT00430248|366047726|FG001|Overall Study|Gout Flare|7|||
106107546|NCT00430248|366047727|FG002|Overall Study|Gout Flare|2|||
106107547|NCT00430248|366047725|FG000|Overall Study|Reason Not Specified|8|||
106107548|NCT00430248|366047726|FG001|Overall Study|Reason Not Specified|8|||
106107549|NCT00430248|366047727|FG002|Overall Study|Reason Not Specified|11|||
106107550|NCT00002558|366047730|FG000|Overall Study|Withdrawal by Subject|0|||
106107551|NCT00002558|366047731|FG001|Overall Study|Withdrawal by Subject|1|||
106107552|NCT01949870|366047732|FG000|Overall Study|Lack of Efficacy|2|||
106107553|NCT01949870|366047732|FG000|Overall Study|Adverse Event|1|||
106107554|NCT01949870|366047732|FG000|Overall Study|Study termination|1|||
106107555|NCT01949870|366047732|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
106107556|NCT02316769|366047734|FG000|Overall Study|Physician Decision|1|||
106107557|NCT02316769|366047735|FG001|Overall Study|Physician Decision|0|||
106107558|NCT02316769|366047734|FG000|Overall Study|Withdrawal by Subject|1|||
106107559|NCT02316769|366047735|FG001|Overall Study|Withdrawal by Subject|0|||
106107560|NCT02436330|366047736|FG000|Cohort 1|Lost to Follow-up|5|||
106107561|NCT02436330|366047737|FG001|Cohort 1|Lost to Follow-up|2|||
106107562|NCT02436330|366047736|FG000|Cohort 1|Withdrawal by Subject|0|||
106107563|NCT02436330|366047737|FG001|Cohort 1|Withdrawal by Subject|1|||
106107564|NCT02436330|366047736|FG000|Cohort 2|Lost to Follow-up|2|||
106107565|NCT02436330|366047737|FG001|Cohort 2|Lost to Follow-up|0|||
106107566|NCT02436330|366047736|FG000|Cohort 2|Withdrawal by Subject|2|||
106107567|NCT02436330|366047737|FG001|Cohort 2|Withdrawal by Subject|3|||
106107568|NCT02436330|366047736|FG000|Cohort 3|Lost to Follow-up|1|||
106107569|NCT02436330|366047737|FG001|Cohort 3|Lost to Follow-up|0|||
106107570|NCT02436330|366047736|FG000|Cohort 3|Withdrawal by Subject|4|||
106107571|NCT02436330|366047737|FG001|Cohort 3|Withdrawal by Subject|0|||
106107572|NCT02436330|366047736|FG000|Cohort 4|Lost to Follow-up|1|||
106107573|NCT02436330|366047737|FG001|Cohort 4|Lost to Follow-up|0|||
106107574|NCT02436330|366047736|FG000|Cohort 4|Withdrawal by Subject|1|||
106107575|NCT02436330|366047737|FG001|Cohort 4|Withdrawal by Subject|0|||
106107576|NCT02436330|366047736|FG000|Cohort 5|Lost to Follow-up|3|||
106107577|NCT02436330|366047737|FG001|Cohort 5|Lost to Follow-up|2|||
106107578|NCT02436330|366047736|FG000|Cohort 5|Withdrawal by Subject|3|||
106107579|NCT02436330|366047737|FG001|Cohort 5|Withdrawal by Subject|2|||
106107580|NCT02436330|366047736|FG000|Cohort 6|Lost to Follow-up|2|||
106107581|NCT02436330|366047737|FG001|Cohort 6|Lost to Follow-up|0|||
106107582|NCT02436330|366047736|FG000|Cohort 6|Withdrawal by Subject|1|||
105993144|NCT02465203|365633113|FG000|Overall Study|Protocol Violation|1|||
105993145|NCT02465203|365633114|FG001|Overall Study|Protocol Violation|1|||
105993146|NCT02465203|365633115|FG002|Overall Study|Protocol Violation|1|||
105993147|NCT02465203|365633113|FG000|Overall Study|Study terminated by sponsor|50|||
105993148|NCT02465203|365633114|FG001|Overall Study|Study terminated by sponsor|34|||
105993149|NCT02465203|365633115|FG002|Overall Study|Study terminated by sponsor|11|||
105993150|NCT02465203|365633113|FG000|Overall Study|New therapy for study indication|4|||
106107583|NCT02436330|366047737|FG001|Cohort 6|Withdrawal by Subject|1|||
106107584|NCT00677235|366047738|FG000|Overall Study|Withdrawal by Subject|1|||
106107585|NCT00677235|366047739|FG001|Overall Study|Withdrawal by Subject|1|||
106107586|NCT00677235|366047738|FG000|Overall Study|Lost to Follow-up|2|||
106107587|NCT00677235|366047739|FG001|Overall Study|Lost to Follow-up|1|||
106107588|NCT00677235|366047738|FG000|Overall Study|Death|37|||
106107589|NCT00677235|366047739|FG001|Overall Study|Death|36|||
106107590|NCT00677235|366047738|FG000|Overall Study|Adverse Experience|1|||
106107591|NCT00677235|366047739|FG001|Overall Study|Adverse Experience|0|||
106107592|NCT01040260|366047740|FG000|Overall Study|Withdrawal by Subject|12|||
106107593|NCT01040260|366047741|FG001|Overall Study|Withdrawal by Subject|6|||
106107594|NCT01040260|366047740|FG000|Overall Study|Lost to Follow-up|3|||
106107595|NCT01040260|366047741|FG001|Overall Study|Lost to Follow-up|5|||
106107596|NCT02230956|366047742|FG000|Overall Study|Adverse Event|1|||
106107597|NCT02230956|366047743|FG001|Overall Study|Adverse Event|1|||
106107598|NCT02230956|366047744|FG002|Overall Study|Adverse Event|0|||
106107599|NCT02230956|366047742|FG000|Overall Study|Lack of Efficacy|1|||
106107600|NCT02230956|366047743|FG001|Overall Study|Lack of Efficacy|1|||
106107601|NCT02230956|366047744|FG002|Overall Study|Lack of Efficacy|1|||
106107602|NCT02230956|366047742|FG000|Overall Study|Lost to Follow-up|1|||
106107603|NCT02230956|366047743|FG001|Overall Study|Lost to Follow-up|1|||
106107604|NCT02230956|366047744|FG002|Overall Study|Lost to Follow-up|2|||
106107605|NCT02230956|366047742|FG000|Overall Study|Personal Reasons|2|||
106107606|NCT02230956|366047743|FG001|Overall Study|Personal Reasons|1|||
106107607|NCT02230956|366047744|FG002|Overall Study|Personal Reasons|1|||
106107608|NCT02230956|366047742|FG000|Overall Study|Protocol Violation|0|||
106107609|NCT02230956|366047743|FG001|Overall Study|Protocol Violation|1|||
106107610|NCT02230956|366047744|FG002|Overall Study|Protocol Violation|1|||
106107611|NCT02230956|366047742|FG000|Overall Study|Other Miscellaneous Reason|0|||
106107612|NCT02230956|366047743|FG001|Overall Study|Other Miscellaneous Reason|1|||
106107613|NCT02230956|366047744|FG002|Overall Study|Other Miscellaneous Reason|2|||
106107614|NCT04570436|366047745|FG000|Overall Study|Adverse Event|0|||
106107615|NCT04570436|366047746|FG001|Overall Study|Adverse Event|0|||
106107616|NCT04570436|366047747|FG002|Overall Study|Adverse Event|1|||
106107617|NCT04570436|366047748|FG003|Overall Study|Adverse Event|0|||
106107618|NCT04570436|366047749|FG004|Overall Study|Adverse Event|0|||
106107619|NCT04570436|366047750|FG005|Overall Study|Adverse Event|0|||
106107620|NCT04570436|366047751|FG006|Overall Study|Adverse Event|0|||
106107621|NCT04570436|366047752|FG007|Overall Study|Adverse Event|0|||
106107622|NCT04570436|366047753|FG008|Overall Study|Adverse Event|0|||
106107623|NCT04570436|366047754|FG009|Overall Study|Adverse Event|0|||
106107624|NCT04570436|366047745|FG000|Overall Study|Physician Decision|1|||
106107625|NCT04570436|366047746|FG001|Overall Study|Physician Decision|0|||
106107626|NCT04570436|366047747|FG002|Overall Study|Physician Decision|0|||
106107627|NCT04570436|366047748|FG003|Overall Study|Physician Decision|0|||
106107628|NCT04570436|366047749|FG004|Overall Study|Physician Decision|0|||
106107629|NCT04570436|366047750|FG005|Overall Study|Physician Decision|0|||
106107630|NCT04570436|366047751|FG006|Overall Study|Physician Decision|0|||
106107631|NCT04570436|366047752|FG007|Overall Study|Physician Decision|0|||
106107632|NCT04570436|366047753|FG008|Overall Study|Physician Decision|0|||
106107633|NCT04570436|366047754|FG009|Overall Study|Physician Decision|0|||
106107634|NCT00658567|366047759|FG000|Overall Study|Adverse Event|5|||
106107635|NCT00658567|366047760|FG001|Overall Study|Adverse Event|2|||
106107636|NCT00658567|366047761|FG002|Overall Study|Adverse Event|3|||
106107637|NCT00658567|366047759|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
106107638|NCT00658567|366047760|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
106107639|NCT00658567|366047761|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
106107640|NCT00658567|366047759|FG000|Overall Study|Physician Decision|0|||
106107641|NCT00658567|366047760|FG001|Overall Study|Physician Decision|1|||
106107642|NCT00658567|366047761|FG002|Overall Study|Physician Decision|0|||
106107643|NCT00658567|366047759|FG000|Overall Study|At Discretion of Sponsor|1|||
106107644|NCT00658567|366047760|FG001|Overall Study|At Discretion of Sponsor|1|||
106107645|NCT00658567|366047761|FG002|Overall Study|At Discretion of Sponsor|1|||
106107646|NCT00611858|366047765|FG000|Overall Study|Adverse Event|2|||
106107647|NCT00611858|366047765|FG000|Overall Study|Withdrawal by Subject|2|||
106107648|NCT05711641|366047767|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
106107649|NCT05711641|366047768|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
106107650|NCT05711641|366047767|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
106107651|NCT05711641|366047768|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
106107652|NCT00538590|366047774|FG000|Overall Study|Death|1|||
106107653|NCT00538590|366047775|FG001|Overall Study|Death|0|||
106107654|NCT00671931|366047778|FG000|Overall Study|Physician Decision|1|||
106107655|NCT00671931|366047779|FG001|Overall Study|Physician Decision|0|||
106107656|NCT00671931|366047780|FG002|Overall Study|Physician Decision|0|||
106107657|NCT00671931|366047781|FG003|Overall Study|Physician Decision|2|||
106107658|NCT00671931|366047782|FG004|Overall Study|Physician Decision|1|||
106107659|NCT02151266|366047783|FG000|Overall Study|Lost to Follow-up|1|||
106107660|NCT02151266|366047784|FG001|Overall Study|Lost to Follow-up|4|||
106107661|NCT02151266|366047785|FG002|Overall Study|Lost to Follow-up|1|||
106107662|NCT02151266|366047783|FG000|Overall Study|Did NOT receive intervention|3|||
106107663|NCT02151266|366047784|FG001|Overall Study|Did NOT receive intervention|6|||
106107664|NCT02151266|366047785|FG002|Overall Study|Did NOT receive intervention|2|||
106107665|NCT02151266|366047783|FG000|Overall Study|Not able to exercise|4|||
106107666|NCT02151266|366047784|FG001|Overall Study|Not able to exercise|5|||
106107667|NCT02151266|366047785|FG002|Overall Study|Not able to exercise|4|||
106107668|NCT01169675|366047786|FG000|Overall Study|Progressive disease|13|||
106107669|NCT01169675|366047787|FG001|Overall Study|Progressive disease|2|||
106107670|NCT01169675|366047788|FG002|Overall Study|Progressive disease|5|||
106107671|NCT01169675|366047789|FG003|Overall Study|Progressive disease|15|||
106107672|NCT01169675|366047790|FG004|Overall Study|Progressive disease|1|||
106107673|NCT01169675|366047786|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
106107674|NCT01169675|366047787|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
106107675|NCT01169675|366047788|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
106107676|NCT01169675|366047789|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
106107677|NCT01169675|366047790|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
106107678|NCT01169675|366047786|FG000|Overall Study|Adverse Event|5|||
106107679|NCT01169675|366047787|FG001|Overall Study|Adverse Event|1|||
106107680|NCT01169675|366047788|FG002|Overall Study|Adverse Event|2|||
106107681|NCT01169675|366047789|FG003|Overall Study|Adverse Event|0|||
106107682|NCT01169675|366047790|FG004|Overall Study|Adverse Event|0|||
106107683|NCT01169675|366047786|FG000|Overall Study|Withdrawal by Subject|1|||
106107684|NCT01169675|366047787|FG001|Overall Study|Withdrawal by Subject|0|||
106107685|NCT01169675|366047788|FG002|Overall Study|Withdrawal by Subject|0|||
106107686|NCT01169675|366047789|FG003|Overall Study|Withdrawal by Subject|1|||
106107687|NCT01169675|366047790|FG004|Overall Study|Withdrawal by Subject|2|||
106107688|NCT01169675|366047786|FG000|Overall Study|Other Reason Not Defined Above|0|||
106107689|NCT01169675|366047787|FG001|Overall Study|Other Reason Not Defined Above|0|||
106107690|NCT01169675|366047788|FG002|Overall Study|Other Reason Not Defined Above|0|||
106107691|NCT01169675|366047789|FG003|Overall Study|Other Reason Not Defined Above|1|||
106107692|NCT01169675|366047790|FG004|Overall Study|Other Reason Not Defined Above|1|||
106107693|NCT02816138|366047791|FG000|Overall Study|Adverse Event|1|||
106107694|NCT02291679|366047792|FG000|Overall Study|Adverse Event|2|||
106107695|NCT02291679|366047793|FG001|Overall Study|Adverse Event|12|||
106107696|NCT02291679|366047794|FG002|Overall Study|Adverse Event|19|||
106107697|NCT02291679|366047792|FG000|Overall Study|Protocol Violation|5|||
106107698|NCT02291679|366047793|FG001|Overall Study|Protocol Violation|1|||
106107699|NCT02291679|366047794|FG002|Overall Study|Protocol Violation|7|||
106107700|NCT02291679|366047792|FG000|Overall Study|Withdrew Consent|18|||
106107701|NCT02291679|366047793|FG001|Overall Study|Withdrew Consent|10|||
106107702|NCT02291679|366047794|FG002|Overall Study|Withdrew Consent|15|||
106107703|NCT02291679|366047792|FG000|Overall Study|Lost to Follow-up|12|||
106107704|NCT02291679|366047793|FG001|Overall Study|Lost to Follow-up|10|||
106107705|NCT02291679|366047794|FG002|Overall Study|Lost to Follow-up|9|||
106107706|NCT02291679|366047792|FG000|Overall Study|Insufficient Therapeutic Response|5|||
106107707|NCT02291679|366047793|FG001|Overall Study|Insufficient Therapeutic Response|5|||
106107708|NCT02291679|366047794|FG002|Overall Study|Insufficient Therapeutic Response|7|||
106107709|NCT02291679|366047792|FG000|Overall Study|Other|2|||
106107710|NCT02291679|366047793|FG001|Overall Study|Other|4|||
106107711|NCT02291679|366047794|FG002|Overall Study|Other|2|||
106107712|NCT03657277|366047795|FG000|Overall Study|Physician Decision|2|||
106107713|NCT03657277|366047795|FG000|Overall Study|Lost to Follow-up|1|||
106107714|NCT03657277|366047795|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
106107715|NCT01024608|366047796|FG000|Overall Study|Adverse Event|1|||
106107716|NCT01024608|366047797|FG001|Overall Study|Adverse Event|0|||
106107717|NCT01024608|366047796|FG000|Overall Study|Withdrawal by Subject|1|||
106107718|NCT01024608|366047797|FG001|Overall Study|Withdrawal by Subject|0|||
106107719|NCT01024608|366047796|FG000|Overall Study|Lost to Follow-up|0|||
106107720|NCT01024608|366047797|FG001|Overall Study|Lost to Follow-up|1|||
106107721|NCT01024608|366047796|FG000|Overall Study|Protocol Violation|0|||
106107722|NCT01024608|366047797|FG001|Overall Study|Protocol Violation|3|||
106107723|NCT01024608|366047796|FG000|Overall Study|Never received study treatment|2|||
106107724|NCT01024608|366047797|FG001|Overall Study|Never received study treatment|0|||
106107725|NCT01951625|366047798|FG000|Treatment Period|Protocol Violation|2|||
106107726|NCT01951625|366047799|FG001|Treatment Period|Protocol Violation|0|||
106107727|NCT01951625|366047800|FG002|Treatment Period|Protocol Violation|1|||
106107728|NCT01951625|366047801|FG003|Treatment Period|Protocol Violation|3|||
106107729|NCT01951625|366047802|FG004|Treatment Period|Protocol Violation|2|||
106107730|NCT01951625|366047798|FG000|Treatment Period|Physician Decision|0|||
106107731|NCT01951625|366047799|FG001|Treatment Period|Physician Decision|0|||
106107732|NCT01951625|366047800|FG002|Treatment Period|Physician Decision|0|||
106107733|NCT01951625|366047801|FG003|Treatment Period|Physician Decision|0|||
106107734|NCT01951625|366047802|FG004|Treatment Period|Physician Decision|1|||
106107735|NCT01951625|366047798|FG000|Treatment Period|Protocol driven decision point|0|||
106107736|NCT01951625|366047799|FG001|Treatment Period|Protocol driven decision point|5|||
106107737|NCT01951625|366047800|FG002|Treatment Period|Protocol driven decision point|0|||
106107738|NCT01951625|366047801|FG003|Treatment Period|Protocol driven decision point|2|||
106107739|NCT01951625|366047802|FG004|Treatment Period|Protocol driven decision point|1|||
105782579|NCT03726320|364857925|FG001|Overall Study|Clinic / insurance issue|0|||
105782580|NCT03726320|364857926|FG002|Overall Study|Clinic / insurance issue|0|||
105782581|NCT03726320|364857924|FG000|Overall Study|Language barrier|1|||
105782582|NCT03726320|364857925|FG001|Overall Study|Language barrier|0|||
105782583|NCT03726320|364857926|FG002|Overall Study|Language barrier|0|||
105782584|NCT03726320|364857924|FG000|Overall Study|Provider left the clinic|0|||
105782585|NCT03726320|364857925|FG001|Overall Study|Provider left the clinic|0|||
105782586|NCT03726320|364857926|FG002|Overall Study|Provider left the clinic|1|||
105782587|NCT03691831|364857932|FG000|Overall Study|Lost to Follow-up|16|||
105782588|NCT03691831|364857933|FG001|Overall Study|Lost to Follow-up|12|||
105782589|NCT03691831|364857932|FG000|Overall Study|Withdrawal by Subject|9|||
105782590|NCT03691831|364857933|FG001|Overall Study|Withdrawal by Subject|17|||
105782591|NCT03691831|364857932|FG000|Overall Study|Investigator Decision|2|||
105782592|NCT03691831|364857933|FG001|Overall Study|Investigator Decision|2|||
105782593|NCT01684930|364857934|FG000|Overall Study|Withdrawal by Subject|3|||
105782594|NCT01684930|364857935|FG001|Overall Study|Withdrawal by Subject|1|||
105782595|NCT00690612|364857936|FG000|Overall Study|Adverse Event|1|||
105782596|NCT00690612|364857936|FG000|Overall Study|Withdrawal by Subject|2|||
105782597|NCT02926833|364857937|FG000|Overall Study|Death|1|||
105782598|NCT02926833|364857938|FG001|Overall Study|Death|1|||
105782599|NCT02926833|364857939|FG002|Overall Study|Death|2|||
105782600|NCT02926833|364857940|FG003|Overall Study|Death|13|||
105782601|NCT02926833|364857937|FG000|Overall Study|Lost to Follow-up|1|||
105782602|NCT02926833|364857938|FG001|Overall Study|Lost to Follow-up|2|||
105782603|NCT02926833|364857939|FG002|Overall Study|Lost to Follow-up|0|||
105782604|NCT02926833|364857940|FG003|Overall Study|Lost to Follow-up|3|||
105782605|NCT02926833|364857937|FG000|Overall Study|Full Consent Withdrawal|0|||
105782606|NCT02926833|364857938|FG001|Overall Study|Full Consent Withdrawal|0|||
105782607|NCT02926833|364857939|FG002|Overall Study|Full Consent Withdrawal|0|||
106107740|NCT01951625|366047798|FG000|Treatment Period|Non compliance with study drug|1|||
106107741|NCT01951625|366047799|FG001|Treatment Period|Non compliance with study drug|2|||
106107742|NCT01951625|366047800|FG002|Treatment Period|Non compliance with study drug|2|||
106107743|NCT01951625|366047801|FG003|Treatment Period|Non compliance with study drug|0|||
106107744|NCT01951625|366047802|FG004|Treatment Period|Non compliance with study drug|0|||
106107745|NCT01951625|366047798|FG000|Treatment Period|Death|3|||
106107746|NCT01951625|366047799|FG001|Treatment Period|Death|2|||
105782608|NCT02926833|364857940|FG003|Overall Study|Full Consent Withdrawal|2|||
106107747|NCT01951625|366047800|FG002|Treatment Period|Death|2|||
106107748|NCT01951625|366047801|FG003|Treatment Period|Death|1|||
106107749|NCT01951625|366047802|FG004|Treatment Period|Death|2|||
106107750|NCT01951625|366047798|FG000|Treatment Period|Adverse Event|7|||
106107751|NCT01951625|366047799|FG001|Treatment Period|Adverse Event|10|||
106107752|NCT01951625|366047800|FG002|Treatment Period|Adverse Event|9|||
106107753|NCT01951625|366047801|FG003|Treatment Period|Adverse Event|8|||
106107754|NCT01951625|366047802|FG004|Treatment Period|Adverse Event|8|||
106107755|NCT01951625|366047798|FG000|Treatment Period|Withdrawal by Subject|5|||
106107756|NCT01951625|366047799|FG001|Treatment Period|Withdrawal by Subject|2|||
106107757|NCT01951625|366047800|FG002|Treatment Period|Withdrawal by Subject|1|||
106107758|NCT01951625|366047801|FG003|Treatment Period|Withdrawal by Subject|7|||
106107759|NCT01951625|366047802|FG004|Treatment Period|Withdrawal by Subject|3|||
106107760|NCT01951625|366047798|FG000|Treatment Period|Lost to Follow-up|1|||
106107761|NCT01951625|366047799|FG001|Treatment Period|Lost to Follow-up|0|||
106107762|NCT01951625|366047800|FG002|Treatment Period|Lost to Follow-up|0|||
106107763|NCT01951625|366047801|FG003|Treatment Period|Lost to Follow-up|1|||
106107764|NCT01951625|366047802|FG004|Treatment Period|Lost to Follow-up|0|||
106107765|NCT01951625|366047798|FG000|Follow Up Period|Non-compliance with study drug|1|||
106107766|NCT01951625|366047799|FG001|Follow Up Period|Non-compliance with study drug|0|||
106107767|NCT01951625|366047800|FG002|Follow Up Period|Non-compliance with study drug|0|||
105782609|NCT02926833|364857937|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
105782610|NCT02926833|364857938|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
105782611|NCT02926833|364857939|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
105782612|NCT02926833|364857940|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
105782613|NCT02926833|364857937|FG000|Overall Study|Investigator Decision|0|||
106107768|NCT01951625|366047801|FG003|Follow Up Period|Non-compliance with study drug|0|||
106107769|NCT01951625|366047802|FG004|Follow Up Period|Non-compliance with study drug|0|||
106107770|NCT01951625|366047798|FG000|Follow Up Period|Death|1|||
106107771|NCT01951625|366047799|FG001|Follow Up Period|Death|3|||
105782614|NCT02926833|364857938|FG001|Overall Study|Investigator Decision|1|||
105782615|NCT02926833|364857939|FG002|Overall Study|Investigator Decision|0|||
105782616|NCT02926833|364857940|FG003|Overall Study|Investigator Decision|0|||
105782617|NCT02926833|364857937|FG000|Overall Study|Adverse Event|0|||
105782618|NCT02926833|364857938|FG001|Overall Study|Adverse Event|0|||
106107772|NCT01951625|366047800|FG002|Follow Up Period|Death|2|||
106107773|NCT01951625|366047801|FG003|Follow Up Period|Death|2|||
106107774|NCT01951625|366047802|FG004|Follow Up Period|Death|1|||
106107775|NCT01951625|366047798|FG000|Follow Up Period|Logistical difficulties|1|||
106107776|NCT01951625|366047799|FG001|Follow Up Period|Logistical difficulties|2|||
106107777|NCT01951625|366047800|FG002|Follow Up Period|Logistical difficulties|0|||
106107778|NCT01951625|366047801|FG003|Follow Up Period|Logistical difficulties|0|||
106107779|NCT01951625|366047802|FG004|Follow Up Period|Logistical difficulties|0|||
106107780|NCT01951625|366047798|FG000|Follow Up Period|Adverse Event|0|||
106107781|NCT01951625|366047799|FG001|Follow Up Period|Adverse Event|3|||
106107782|NCT01951625|366047800|FG002|Follow Up Period|Adverse Event|2|||
106107783|NCT01951625|366047801|FG003|Follow Up Period|Adverse Event|3|||
106107784|NCT01951625|366047802|FG004|Follow Up Period|Adverse Event|5|||
106107785|NCT01951625|366047798|FG000|Follow Up Period|Withdrawal by Subject|4|||
106107786|NCT01951625|366047799|FG001|Follow Up Period|Withdrawal by Subject|1|||
106107787|NCT01951625|366047800|FG002|Follow Up Period|Withdrawal by Subject|0|||
106107788|NCT01951625|366047801|FG003|Follow Up Period|Withdrawal by Subject|5|||
106107789|NCT01951625|366047802|FG004|Follow Up Period|Withdrawal by Subject|3|||
106107790|NCT01951625|366047798|FG000|Follow Up Period|Lost to Follow-up|1|||
106107791|NCT01951625|366047799|FG001|Follow Up Period|Lost to Follow-up|0|||
106107792|NCT01951625|366047800|FG002|Follow Up Period|Lost to Follow-up|0|||
106107793|NCT01951625|366047801|FG003|Follow Up Period|Lost to Follow-up|1|||
106107794|NCT01951625|366047802|FG004|Follow Up Period|Lost to Follow-up|1|||
106107795|NCT01323530|366049581|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
106107796|NCT01323530|366049582|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106107797|NCT01323530|366049583|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106107798|NCT01323530|366049584|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106107799|NCT01323530|366049585|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106107800|NCT01323530|366049586|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
106107801|NCT01323530|366049587|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106107802|NCT01323530|366049581|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
106107803|NCT01323530|366049582|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
106107804|NCT01323530|366049583|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
106107805|NCT01323530|366049584|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
106107806|NCT01323530|366049585|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
106107807|NCT01323530|366049586|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
106107808|NCT01323530|366049587|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
106107809|NCT01323530|366049581|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
106107810|NCT01323530|366049582|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
106107811|NCT01323530|366049583|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
106107812|NCT01323530|366049584|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
106107813|NCT01323530|366049585|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
106107814|NCT01323530|366049586|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
106107815|NCT01323530|366049587|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
106107816|NCT01323530|366049581|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
106107817|NCT01323530|366049582|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
106107818|NCT01323530|366049583|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
106107819|NCT01323530|366049584|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
106107820|NCT01323530|366049585|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
106107821|NCT01323530|366049586|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
106107822|NCT01323530|366049587|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
106107823|NCT01323530|366049581|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
106107824|NCT01323530|366049582|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
106107825|NCT01323530|366049583|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
106107826|NCT01323530|366049584|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
106107827|NCT01323530|366049585|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
106107828|NCT01323530|366049586|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
106107829|NCT01323530|366049587|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
106107830|NCT01323530|366049581|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
106107831|NCT01323530|366049582|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
106107832|NCT01323530|366049583|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
106107833|NCT01323530|366049584|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
106107834|NCT01323530|366049585|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
106107835|NCT01323530|366049586|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
106107836|NCT01323530|366049587|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
106107837|NCT01323530|366049581|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
106107838|NCT01323530|366049582|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
106107839|NCT01323530|366049583|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
106107840|NCT01323530|366049584|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
106107841|NCT01323530|366049585|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
106107842|NCT01323530|366049586|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
106107843|NCT01323530|366049587|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
106107844|NCT01323530|366049581|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
106107845|NCT01323530|366049582|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
106107846|NCT01323530|366049583|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
106107847|NCT01323530|366049584|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
106107848|NCT01323530|366049585|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
106107849|NCT01323530|366049586|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
106107850|NCT01323530|366049587|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
106107851|NCT00437645|366049590|FG000|Overall Study|Adverse Event|15|||
106107852|NCT00437645|366049591|FG001|Overall Study|Adverse Event|84|||
106107853|NCT00437645|366049590|FG000|Overall Study|Withdrawal by Subject|10|||
106107854|NCT00437645|366049591|FG001|Overall Study|Withdrawal by Subject|22|||
106107855|NCT00437645|366049590|FG000|Overall Study|Protocol Violation|3|||
106107856|NCT00437645|366049591|FG001|Overall Study|Protocol Violation|3|||
106107857|NCT00437645|366049590|FG000|Overall Study|Lost to Follow-up|2|||
106107858|NCT00437645|366049591|FG001|Overall Study|Lost to Follow-up|3|||
106107859|NCT00437645|366049590|FG000|Overall Study|Administrative problems|2|||
106107860|NCT00437645|366049591|FG001|Overall Study|Administrative problems|1|||
106107861|NCT00437645|366049590|FG000|Overall Study|Lack of Efficacy|2|||
106107862|NCT00437645|366049591|FG001|Overall Study|Lack of Efficacy|1|||
106107863|NCT00437645|366049590|FG000|Overall Study|Condition no longer requires study drug|1|||
106107864|NCT00437645|366049591|FG001|Overall Study|Condition no longer requires study drug|1|||
106107865|NCT04791761|366049594|FG000|Overall Study|Lost to Follow-up|8|||
106107866|NCT04791761|366049595|FG001|Overall Study|Lost to Follow-up|6|||
106107867|NCT04791761|366049596|FG002|Overall Study|Lost to Follow-up|10|||
106107868|NCT04791761|366049594|FG000|Overall Study|Withdrawal by Subject|0|||
106107869|NCT04791761|366049595|FG001|Overall Study|Withdrawal by Subject|1|||
106107870|NCT04791761|366049596|FG002|Overall Study|Withdrawal by Subject|1|||
105782619|NCT02926833|364857939|FG002|Overall Study|Adverse Event|1|||
105782620|NCT02926833|364857940|FG003|Overall Study|Adverse Event|0|||
105782621|NCT02926833|364857937|FG000|Overall Study|Partial Withdrawal of Consent|0|||
105782622|NCT02926833|364857938|FG001|Overall Study|Partial Withdrawal of Consent|0|||
105782623|NCT02926833|364857939|FG002|Overall Study|Partial Withdrawal of Consent|0|||
106107871|NCT04791761|366049594|FG000|Overall Study|Protocol Violation|0|||
106107872|NCT04791761|366049595|FG001|Overall Study|Protocol Violation|1|||
106107873|NCT04791761|366049596|FG002|Overall Study|Protocol Violation|1|||
105782624|NCT02926833|364857940|FG003|Overall Study|Partial Withdrawal of Consent|1|||
105782625|NCT01189201|364857948|FG000|Overall Study|Adverse Event|1|||
105782626|NCT01277757|364857949|FG000|Overall Study|Disease Progression|1|||
105782627|NCT01277757|364857949|FG000|Overall Study|Withdrawal by Subject|1|||
105782628|NCT01266967|364857952|FG000|Overall Study|Death|69|||
105782629|NCT01266967|364857953|FG001|Overall Study|Death|61|||
105782630|NCT01266967|364857952|FG000|Overall Study|Study Closed/Terminated|15|||
105782631|NCT01266967|364857953|FG001|Overall Study|Study Closed/Terminated|17|||
105782632|NCT01266967|364857952|FG000|Overall Study|Lost to Follow-up|2|||
105782633|NCT01266967|364857953|FG001|Overall Study|Lost to Follow-up|1|||
105782634|NCT01266967|364857952|FG000|Overall Study|Physician Decision|0|||
105782635|NCT01266967|364857953|FG001|Overall Study|Physician Decision|1|||
105782636|NCT01266967|364857952|FG000|Overall Study|Withdrawal by Subject|3|||
105782637|NCT01266967|364857953|FG001|Overall Study|Withdrawal by Subject|3|||
105782638|NCT01945866|364857954|FG000|Overall Study|Eyes did not complete or were dropped|2|||
105782639|NCT01945866|364857955|FG001|Overall Study|Eyes did not complete or were dropped|0|||
105782640|NCT03799198|364857957|FG000|Overall Study|Lost to Follow-up|4|||
105782641|NCT03799198|364857958|FG001|Overall Study|Lost to Follow-up|8|||
105782642|NCT03799198|364857957|FG000|Overall Study|Death|0|||
105782643|NCT03799198|364857958|FG001|Overall Study|Death|1|||
105782644|NCT00960869|364857959|FG000|Overall Study|Adverse Event|17|||
105782645|NCT00960869|364857960|FG001|Overall Study|Adverse Event|26|||
105782646|NCT00960869|364857959|FG000|Overall Study|Withdrawal by Subject|16|||
105782647|NCT00960869|364857960|FG001|Overall Study|Withdrawal by Subject|14|||
105782648|NCT00960869|364857959|FG000|Overall Study|Lost to Follow-up|1|||
105782649|NCT00960869|364857960|FG001|Overall Study|Lost to Follow-up|4|||
105782650|NCT00960869|364857959|FG000|Overall Study|Misc|19|||
105782651|NCT00960869|364857960|FG001|Overall Study|Misc|18|||
105782652|NCT02501642|364857961|FG000|Overall Study|Lost to Follow-up|7|||
105782653|NCT02501642|364857962|FG001|Overall Study|Lost to Follow-up|11|||
105782654|NCT00548340|364857965|FG000|Overall Study|Protocol Violation|2|||
105782655|NCT00548340|364857966|FG001|Overall Study|Protocol Violation|3|||
105782656|NCT00548340|364857967|FG002|Overall Study|Protocol Violation|3|||
105782657|NCT00548340|364857965|FG000|Overall Study|Adverse Event|2|||
105782658|NCT00548340|364857966|FG001|Overall Study|Adverse Event|2|||
105782659|NCT00548340|364857967|FG002|Overall Study|Adverse Event|2|||
105782660|NCT00548340|364857965|FG000|Overall Study|Lost to Follow-up|1|||
105782661|NCT00548340|364857966|FG001|Overall Study|Lost to Follow-up|1|||
106107874|NCT01756352|366049598|FG000|Overall Study|moved away and lost to followup|1|||
105782662|NCT00548340|364857967|FG002|Overall Study|Lost to Follow-up|0|||
105782663|NCT00548340|364857965|FG000|Overall Study|Withdrawal by Subject|2|||
105782664|NCT00548340|364857966|FG001|Overall Study|Withdrawal by Subject|4|||
105782665|NCT00548340|364857967|FG002|Overall Study|Withdrawal by Subject|3|||
106107875|NCT04279314|366049599|FG000|Overall Study|Adverse Event|55|||
105993151|NCT02465203|365633114|FG001|Overall Study|New therapy for study indication|0|||
105993152|NCT02465203|365633115|FG002|Overall Study|New therapy for study indication|0|||
105993153|NCT02465203|365633113|FG000|Overall Study|Patient/guardian decision|1|||
105993154|NCT02465203|365633114|FG001|Overall Study|Patient/guardian decision|1|||
105993155|NCT02465203|365633115|FG002|Overall Study|Patient/guardian decision|1|||
105993156|NCT04072887|365633120|FG000|Overall Study|Withdrawal by Subject|3|||
105993157|NCT04072887|365633121|FG001|Overall Study|Withdrawal by Subject|8|||
105993158|NCT04072887|365633122|FG002|Overall Study|Withdrawal by Subject|1|||
105993159|NCT04072887|365633123|FG003|Overall Study|Withdrawal by Subject|3|||
105993160|NCT04072887|365633124|FG004|Overall Study|Withdrawal by Subject|3|||
105993161|NCT04072887|365633125|FG005|Overall Study|Withdrawal by Subject|13|||
105993162|NCT04072887|365633120|FG000|Overall Study|Adverse Event|2|||
105993163|NCT04072887|365633121|FG001|Overall Study|Adverse Event|4|||
105993164|NCT04072887|365633122|FG002|Overall Study|Adverse Event|1|||
105993165|NCT04072887|365633123|FG003|Overall Study|Adverse Event|4|||
105993166|NCT04072887|365633124|FG004|Overall Study|Adverse Event|0|||
105993167|NCT04072887|365633125|FG005|Overall Study|Adverse Event|1|||
105993168|NCT04072887|365633120|FG000|Overall Study|Physician Decision|2|||
105993169|NCT04072887|365633121|FG001|Overall Study|Physician Decision|0|||
105993170|NCT04072887|365633122|FG002|Overall Study|Physician Decision|0|||
105993171|NCT04072887|365633123|FG003|Overall Study|Physician Decision|0|||
105993172|NCT04072887|365633124|FG004|Overall Study|Physician Decision|0|||
105993173|NCT04072887|365633125|FG005|Overall Study|Physician Decision|1|||
105993174|NCT04072887|365633120|FG000|Overall Study|Lost to Follow-up|1|||
105993175|NCT04072887|365633121|FG001|Overall Study|Lost to Follow-up|3|||
105993176|NCT04072887|365633122|FG002|Overall Study|Lost to Follow-up|0|||
105993177|NCT04072887|365633123|FG003|Overall Study|Lost to Follow-up|0|||
105993178|NCT04072887|365633124|FG004|Overall Study|Lost to Follow-up|0|||
105993179|NCT04072887|365633125|FG005|Overall Study|Lost to Follow-up|0|||
105993180|NCT04072887|365633120|FG000|Overall Study|Death|0|||
105993181|NCT04072887|365633121|FG001|Overall Study|Death|2|||
105993182|NCT04072887|365633122|FG002|Overall Study|Death|0|||
105993183|NCT04072887|365633123|FG003|Overall Study|Death|2|||
105993184|NCT04072887|365633124|FG004|Overall Study|Death|3|||
105993185|NCT04072887|365633125|FG005|Overall Study|Death|0|||
105993186|NCT00856297|365633126|FG000|Overall Study|Unable to classify|2|||
105993187|NCT00856297|365633127|FG001|Overall Study|Unable to classify|0|||
105993188|NCT00856297|365633128|FG002|Overall Study|Unable to classify|0|||
105993189|NCT00856297|365633129|FG003|Overall Study|Unable to classify|0|||
105993190|NCT00856297|365633130|FG004|Overall Study|Unable to classify|0|||
105993191|NCT00367835|365633131|FG000|Overall Study|Adverse Event|14|||
105993192|NCT00367835|365633132|FG001|Overall Study|Adverse Event|1|||
105993193|NCT00367835|365633131|FG000|Overall Study|Protocol Violation|1|||
105993194|NCT00367835|365633132|FG001|Overall Study|Protocol Violation|7|||
105993195|NCT00367835|365633131|FG000|Overall Study|Withdrawal by Subject|7|||
105993196|NCT00367835|365633132|FG001|Overall Study|Withdrawal by Subject|6|||
105993197|NCT00367835|365633131|FG000|Overall Study|Lost to Follow-up|1|||
105782666|NCT00548340|364857965|FG000|Overall Study|Other|1|||
105993198|NCT00367835|365633132|FG001|Overall Study|Lost to Follow-up|4|||
105993199|NCT00367835|365633131|FG000|Overall Study|Lack of Efficacy|3|||
105993200|NCT00367835|365633132|FG001|Overall Study|Lack of Efficacy|12|||
105993201|NCT00367835|365633131|FG000|Overall Study|Subject in juvenile detention center|1|||
105993202|NCT00367835|365633132|FG001|Overall Study|Subject in juvenile detention center|0|||
105993203|NCT00367835|365633131|FG000|Overall Study|refused blood collection|1|||
105993204|NCT00367835|365633132|FG001|Overall Study|refused blood collection|0|||
105993205|NCT00367835|365633131|FG000|Overall Study|Did not respond to calls|1|||
105993206|NCT00367835|365633132|FG001|Overall Study|Did not respond to calls|0|||
105993207|NCT00367835|365633131|FG000|Overall Study|History of lead poisoning|0|||
105993208|NCT00367835|365633132|FG001|Overall Study|History of lead poisoning|1|||
105993209|NCT02508428|365633138|FG000|Overall Study|Death|32|||
105993210|NCT02508428|365633139|FG001|Overall Study|Death|33|||
105993211|NCT02508428|365633138|FG000|Overall Study|Liner revised|3|||
105993212|NCT02508428|365633139|FG001|Overall Study|Liner revised|19|||
105993213|NCT02508428|365633138|FG000|Overall Study|Incomplete follow-up|17|||
105993214|NCT02508428|365633139|FG001|Overall Study|Incomplete follow-up|15|||
105993215|NCT03228212|365633140|FG000|Period 1|Adverse Event|1|||
105993216|NCT03228212|365633141|FG001|Period 1|Adverse Event|0|||
105993217|NCT03228212|365633140|FG000|Period 1|no longer meets eligibility criteria|0|||
105993218|NCT03228212|365633141|FG001|Period 1|no longer meets eligibility criteria|1|||
105993219|NCT03228212|365633140|FG000|Period 2|Lost to Follow-up|1|||
105993220|NCT03228212|365633141|FG001|Period 2|Lost to Follow-up|0|||
105993221|NCT01959139|365634443|FG000|Phase II|Disease progression|0|||
105993222|NCT01959139|365634444|FG001|Phase II|Disease progression|0|||
105993223|NCT01959139|365634445|FG002|Phase II|Disease progression|26|||
105993224|NCT01959139|365634446|FG003|Phase II|Disease progression|34|||
105993225|NCT01959139|365634443|FG000|Phase II|Adverse Event|0|||
105993226|NCT01959139|365634444|FG001|Phase II|Adverse Event|0|||
105993227|NCT01959139|365634445|FG002|Phase II|Adverse Event|10|||
105993228|NCT01959139|365634446|FG003|Phase II|Adverse Event|11|||
105993229|NCT01959139|365634443|FG000|Phase II|Patient Refusal|0|||
106107876|NCT04279314|366049599|FG000|Overall Study|Withdrawal by Subject|5|||
106107877|NCT04279314|366049599|FG000|Overall Study|Lack of Efficacy|5|||
106107878|NCT04279314|366049599|FG000|Overall Study|Protocol Violation|3|||
106107879|NCT04279314|366049599|FG000|Overall Study|Other (not COVID-19 related)|2|||
106107880|NCT00999466|366049602|FG000|Main Part|Withdrawal by Subject|0|||
106107881|NCT00999466|366049603|FG001|Main Part|Withdrawal by Subject|0|||
106107882|NCT00999466|366049604|FG002|Main Part|Withdrawal by Subject|2|||
106107883|NCT00999466|366049602|FG000|Main Part|Adverse Event|0|||
106107884|NCT00999466|366049603|FG001|Main Part|Adverse Event|4|||
106107885|NCT00999466|366049604|FG002|Main Part|Adverse Event|2|||
105993230|NCT01959139|365634444|FG001|Phase II|Patient Refusal|0|||
105993231|NCT01959139|365634445|FG002|Phase II|Patient Refusal|5|||
105993232|NCT01959139|365634446|FG003|Phase II|Patient Refusal|4|||
105993233|NCT01959139|365634443|FG000|Phase II|Death|0|||
105993234|NCT01959139|365634444|FG001|Phase II|Death|0|||
105993235|NCT01959139|365634445|FG002|Phase II|Death|3|||
105993236|NCT01959139|365634446|FG003|Phase II|Death|1|||
105993237|NCT01959139|365634443|FG000|Phase II|Other/Unknown|0|||
105993238|NCT01959139|365634444|FG001|Phase II|Other/Unknown|0|||
105993239|NCT01959139|365634445|FG002|Phase II|Other/Unknown|8|||
105993240|NCT01959139|365634446|FG003|Phase II|Other/Unknown|5|||
105993241|NCT01959139|365634443|FG000|Phase II|On treatment|0|||
105993242|NCT01959139|365634444|FG001|Phase II|On treatment|0|||
105993243|NCT01959139|365634445|FG002|Phase II|On treatment|4|||
105993244|NCT01959139|365634446|FG003|Phase II|On treatment|0|||
105993245|NCT01559675|365634447|FG000|Overall Study|Protocol Violation|1|||
105993246|NCT01559675|365634448|FG001|Overall Study|Protocol Violation|2|||
105993247|NCT01559675|365634447|FG000|Overall Study|2nd operation on same patient excluded|14|||
105993248|NCT01559675|365634448|FG001|Overall Study|2nd operation on same patient excluded|12|||
105993249|NCT01504412|365634449|FG000|Overall Study|Adverse Event|1|||
105993250|NCT01504412|365634450|FG001|Overall Study|Adverse Event|8|||
105993251|NCT01504412|365634451|FG002|Overall Study|Adverse Event|1|||
105993252|NCT01504412|365634452|FG003|Overall Study|Adverse Event|7|||
105993253|NCT01504412|365634453|FG004|Overall Study|Adverse Event|10|||
105993254|NCT01504412|365634449|FG000|Overall Study|Withdrawal by Subject|2|||
105993255|NCT01504412|365634450|FG001|Overall Study|Withdrawal by Subject|1|||
105993256|NCT01504412|365634451|FG002|Overall Study|Withdrawal by Subject|1|||
105993257|NCT01504412|365634452|FG003|Overall Study|Withdrawal by Subject|5|||
105993258|NCT01504412|365634453|FG004|Overall Study|Withdrawal by Subject|1|||
105993259|NCT01504412|365634449|FG000|Overall Study|Other|2|||
105993260|NCT01504412|365634450|FG001|Overall Study|Other|1|||
105993261|NCT01504412|365634451|FG002|Overall Study|Other|1|||
105993262|NCT01504412|365634452|FG003|Overall Study|Other|6|||
105993263|NCT01504412|365634453|FG004|Overall Study|Other|1|||
105993264|NCT01504412|365634449|FG000|Overall Study|Lost to Follow-up|0|||
105993265|NCT01504412|365634450|FG001|Overall Study|Lost to Follow-up|2|||
105993266|NCT01504412|365634451|FG002|Overall Study|Lost to Follow-up|0|||
105993267|NCT01504412|365634452|FG003|Overall Study|Lost to Follow-up|0|||
105993268|NCT01504412|365634453|FG004|Overall Study|Lost to Follow-up|0|||
105993269|NCT01504412|365634449|FG000|Overall Study|Lack of Efficacy|0|||
106107886|NCT00499031|366049605|FG000|Overall Study|Improper pre-protocol treatment|1|||
106107887|NCT00499031|366049605|FG000|Overall Study|Required test not done|1|||
106107888|NCT00499031|366049605|FG000|Overall Study|Never treated|1|||
106107889|NCT01357616|366049608|FG000|Overall Study|Adverse Event|1|||
106107890|NCT01357616|366049609|FG001|Overall Study|Adverse Event|1|||
106107891|NCT01357616|366049608|FG000|Overall Study|Lost to Follow-up|4|||
106107892|NCT01357616|366049609|FG001|Overall Study|Lost to Follow-up|3|||
106107893|NCT01357616|366049608|FG000|Overall Study|Protocol Violation|0|||
106107894|NCT01357616|366049609|FG001|Overall Study|Protocol Violation|2|||
106107895|NCT01357616|366049608|FG000|Overall Study|Inadequate Control of IOP|1|||
105993270|NCT01504412|365634450|FG001|Overall Study|Lack of Efficacy|0|||
105993271|NCT01504412|365634451|FG002|Overall Study|Lack of Efficacy|1|||
105993272|NCT01504412|365634452|FG003|Overall Study|Lack of Efficacy|0|||
106107896|NCT01357616|366049609|FG001|Overall Study|Inadequate Control of IOP|2|||
106107897|NCT01357616|366049608|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
106107898|NCT01357616|366049609|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
106107899|NCT01357616|366049608|FG000|Overall Study|Withdrawal by Subject|1|||
106107900|NCT01357616|366049609|FG001|Overall Study|Withdrawal by Subject|0|||
105993273|NCT01504412|365634453|FG004|Overall Study|Lack of Efficacy|1|||
105993274|NCT01504412|365634449|FG000|Overall Study|Death|0|||
105993275|NCT01504412|365634450|FG001|Overall Study|Death|0|||
105993276|NCT01504412|365634451|FG002|Overall Study|Death|0|||
105993277|NCT01504412|365634452|FG003|Overall Study|Death|1|||
105993278|NCT01504412|365634453|FG004|Overall Study|Death|0|||
105993279|NCT02219334|365634456|FG000|Overall Study|Withdrawal by Subject|1|||
105993280|NCT02219334|365634457|FG001|Overall Study|Withdrawal by Subject|0|||
105993281|NCT02219334|365634456|FG000|Overall Study|Protocol Violation|7|||
105993282|NCT02219334|365634457|FG001|Overall Study|Protocol Violation|3|||
105993283|NCT02630472|365634459|FG000|Overall Study|Physician Decision|10|||
105993284|NCT02630472|365634460|FG001|Overall Study|Physician Decision|0|||
105993285|NCT03329092|365634463|FG000|Overall Study|Other|2|||
106107901|NCT03255824|366049612|FG000|Overall Study|Under-sedation|2|||
105782667|NCT00548340|364857966|FG001|Overall Study|Other|1|||
105782668|NCT00548340|364857967|FG002|Overall Study|Other|1|||
105782669|NCT02600559|364857970|FG000|Overall Study|Withdrawal by Subject|3|||
105782670|NCT02600559|364857970|FG000|Overall Study|Lost to Follow-up|20|||
105782671|NCT01153971|364857971|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
105782672|NCT01153971|364857971|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
105782673|NCT01153971|364857971|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
105782674|NCT01153971|364857971|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
105782675|NCT01153971|364857971|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
105782676|NCT01153971|364857971|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
105782677|NCT01153971|364857971|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
105782678|NCT00953576|364857972|FG000|Overall Study|Adverse Event|0|||
105782679|NCT00953576|364857973|FG001|Overall Study|Adverse Event|1|||
105782680|NCT00953576|364857972|FG000|Overall Study|Ineligible after Consent|2|||
105782681|NCT00953576|364857973|FG001|Overall Study|Ineligible after Consent|0|||
105782682|NCT00594958|364857974|FG000|Overall Study|Withdrawal by Subject|1|||
105782683|NCT00594958|364857975|FG001|Overall Study|Withdrawal by Subject|0|||
105782684|NCT00594958|364857976|FG002|Overall Study|Withdrawal by Subject|1|||
105782685|NCT00594958|364857974|FG000|Overall Study|Adverse Event|4|||
105782686|NCT00594958|364857975|FG001|Overall Study|Adverse Event|1|||
105782687|NCT00594958|364857976|FG002|Overall Study|Adverse Event|2|||
105782688|NCT00594958|364857974|FG000|Overall Study|Pregnancy|0|||
105782689|NCT00594958|364857975|FG001|Overall Study|Pregnancy|2|||
105782690|NCT00594958|364857976|FG002|Overall Study|Pregnancy|0|||
105782691|NCT00594958|364857974|FG000|Overall Study|Protocol Violation|1|||
105782692|NCT00594958|364857975|FG001|Overall Study|Protocol Violation|0|||
105782693|NCT00594958|364857976|FG002|Overall Study|Protocol Violation|2|||
105782694|NCT00594958|364857974|FG000|Overall Study|Lost to Follow-up|5|||
105782695|NCT00594958|364857975|FG001|Overall Study|Lost to Follow-up|0|||
105782696|NCT00594958|364857976|FG002|Overall Study|Lost to Follow-up|3|||
105782697|NCT00594958|364857974|FG000|Overall Study|administrative|3|||
105782698|NCT00594958|364857975|FG001|Overall Study|administrative|0|||
105782699|NCT00594958|364857976|FG002|Overall Study|administrative|2|||
105782700|NCT02087085|364857978|FG000|Overall Study|Adverse Event|10|||
105782701|NCT02087085|364857979|FG001|Overall Study|Adverse Event|14|||
105782702|NCT02087085|364857978|FG000|Overall Study|Lack of Efficacy|4|||
105782703|NCT02087085|364857979|FG001|Overall Study|Lack of Efficacy|3|||
105782704|NCT02087085|364857978|FG000|Overall Study|Lost to Follow-up|6|||
105782705|NCT02087085|364857979|FG001|Overall Study|Lost to Follow-up|4|||
105782706|NCT02087085|364857978|FG000|Overall Study|Withdrawal by Subject|9|||
105782707|NCT02087085|364857979|FG001|Overall Study|Withdrawal by Subject|11|||
105782708|NCT02087085|364857978|FG000|Overall Study|Protocol Violation|1|||
105782709|NCT02087085|364857979|FG001|Overall Study|Protocol Violation|0|||
105782710|NCT02087085|364857978|FG000|Overall Study|Study Terminated by Sponsor|87|||
105782711|NCT02087085|364857979|FG001|Overall Study|Study Terminated by Sponsor|80|||
105782712|NCT02087085|364857978|FG000|Overall Study|Other Miscellaneous Reasons|3|||
105782713|NCT02087085|364857979|FG001|Overall Study|Other Miscellaneous Reasons|4|||
105782714|NCT01191190|364857980|FG000|Overall Study|Withdrawal by Subject|1|||
105782715|NCT01982942|364857981|FG000|Overall Study|Adverse Event|10|||
105782716|NCT01982942|364857982|FG001|Overall Study|Adverse Event|5|||
105782717|NCT01982942|364857981|FG000|Overall Study|Lost to Follow-up|4|||
105782718|NCT01982942|364857982|FG001|Overall Study|Lost to Follow-up|3|||
105782719|NCT01982942|364857981|FG000|Overall Study|Multiple sclerosis progression|3|||
105782720|NCT01982942|364857982|FG001|Overall Study|Multiple sclerosis progression|2|||
105782721|NCT01982942|364857981|FG000|Overall Study|Wanted to try therapy not permitted|1|||
105782722|NCT01982942|364857982|FG001|Overall Study|Wanted to try therapy not permitted|0|||
106107902|NCT03255824|366049613|FG001|Overall Study|Under-sedation|1|||
106107903|NCT03284788|366049614|FG000|Overall Study|Withdrawal by Subject|2|||
106107904|NCT01690130|366049618|FG000|Overall Study|Subject have cancelled visit.|1|||
106107905|NCT01690130|366049619|FG001|Overall Study|Subject have cancelled visit.|0|||
106107906|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
106107907|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
106107908|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
106107909|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
106107910|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
105782723|NCT01982942|364857981|FG000|Overall Study|Subject declined future visits|0|||
105782724|NCT01982942|364857982|FG001|Overall Study|Subject declined future visits|1|||
105782725|NCT01982942|364857981|FG000|Overall Study|Left geographical area|2|||
105782726|NCT01982942|364857982|FG001|Overall Study|Left geographical area|0|||
105782727|NCT01982942|364857981|FG000|Overall Study|Too many pills|1|||
105782728|NCT01982942|364857982|FG001|Overall Study|Too many pills|0|||
105782729|NCT01982942|364857981|FG000|Overall Study|MS Relapse|0|||
105782730|NCT01982942|364857982|FG001|Overall Study|MS Relapse|1|||
105782731|NCT01982942|364857981|FG000|Overall Study|Chose to join a stem cell trial|0|||
105782732|NCT01982942|364857982|FG001|Overall Study|Chose to join a stem cell trial|1|||
105782733|NCT01982942|364857981|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
105993286|NCT03329092|365634464|FG001|Overall Study|Other|2|||
105993287|NCT03329092|365634463|FG000|Overall Study|Withdrawal by Subject|16|||
105993288|NCT03329092|365634464|FG001|Overall Study|Withdrawal by Subject|3|||
105993289|NCT03329092|365634463|FG000|Overall Study|Physician Decision|1|||
105993290|NCT03329092|365634464|FG001|Overall Study|Physician Decision|0|||
105993291|NCT03329092|365634463|FG000|Overall Study|Death|17|||
105993292|NCT03329092|365634464|FG001|Overall Study|Death|11|||
105993293|NCT03329092|365634463|FG000|Overall Study|Adverse Event|3|||
105993294|NCT03329092|365634464|FG001|Overall Study|Adverse Event|1|||
105993295|NCT03329092|365634463|FG000|Overall Study|Lost to Follow-up|1|||
105993296|NCT03329092|365634464|FG001|Overall Study|Lost to Follow-up|1|||
105993297|NCT02588261|365634467|FG000|Overall Study|Study Terminated by Sponsor|157|||
105993298|NCT02588261|365634468|FG001|Overall Study|Study Terminated by Sponsor|142|||
105993299|NCT02588261|365634467|FG000|Overall Study|Protocol Deviation|1|||
105993300|NCT02588261|365634468|FG001|Overall Study|Protocol Deviation|0|||
105993301|NCT02588261|365634467|FG000|Overall Study|Death|1|||
105993302|NCT02588261|365634468|FG001|Overall Study|Death|2|||
105993303|NCT02588261|365634467|FG000|Overall Study|Withdrawal by Subject|12|||
105993304|NCT02588261|365634468|FG001|Overall Study|Withdrawal by Subject|8|||
105993305|NCT02588261|365634467|FG000|Overall Study|Noncompliance with Study Drug|0|||
105993306|NCT02588261|365634468|FG001|Overall Study|Noncompliance with Study Drug|1|||
105993307|NCT02588261|365634467|FG000|Overall Study|Miscellaneous|5|||
105993308|NCT02588261|365634468|FG001|Overall Study|Miscellaneous|4|||
105993309|NCT02588261|365634467|FG000|Overall Study|Progressive Disease|61|||
105993310|NCT02588261|365634468|FG001|Overall Study|Progressive Disease|82|||
105993311|NCT02588261|365634467|FG000|Overall Study|Adverse Event|29|||
105993312|NCT02588261|365634468|FG001|Overall Study|Adverse Event|24|||
105993313|NCT02588261|365634467|FG000|Overall Study|Lost to Follow-up|1|||
105993314|NCT02588261|365634468|FG001|Overall Study|Lost to Follow-up|0|||
105993315|NCT02152761|365634476|FG000|Epoch: Treatment Epoch|Technical problems|0|||
105993316|NCT02152761|365634477|FG001|Epoch: Treatment Epoch|Technical problems|0|||
105993317|NCT02152761|365634478|FG002|Epoch: Treatment Epoch|Technical problems|0|||
105993318|NCT02152761|365634479|FG003|Epoch: Treatment Epoch|Technical problems|1|||
105993319|NCT02152761|365634476|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
105993320|NCT02152761|365634477|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
105993321|NCT02152761|365634478|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
105993322|NCT02152761|365634479|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
105993323|NCT02152761|365634476|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
105993324|NCT02152761|365634477|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
105993325|NCT02152761|365634478|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
105993326|NCT02152761|365634479|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
105993327|NCT02152761|365634476|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
105993328|NCT02152761|365634477|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
105993329|NCT02152761|365634478|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
105993330|NCT02152761|365634479|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
105993331|NCT02152761|365634476|FG000|Epoch: Treatment Epoch|Death|0|||
105993332|NCT02152761|365634477|FG001|Epoch: Treatment Epoch|Death|3|||
105993333|NCT02152761|365634478|FG002|Epoch: Treatment Epoch|Death|1|||
105993334|NCT02152761|365634479|FG003|Epoch: Treatment Epoch|Death|0|||
106107911|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
106107912|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
106107913|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
106107914|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Other|18|||
106107915|NCT02565914|366049620|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
106107916|NCT02565914|366049620|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
106107917|NCT02565914|366049620|FG000|Part B (Up to 96 Weeks)|Other|1|||
106107918|NCT02565914|366049620|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
106107919|NCT02565914|366049620|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
106107920|NCT02565914|366049620|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
106107921|NCT02565914|366049620|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
106107922|NCT02565914|366049620|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
106107923|NCT02565914|366049620|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
106107924|NCT02565914|366049620|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
106107925|NCT02565914|366049620|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
106107926|NCT02565914|366049620|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
106107927|NCT02565914|366049620|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
106107928|NCT02565914|366049620|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
105993335|NCT02152761|365634476|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
105993336|NCT02152761|365634477|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
105993337|NCT02152761|365634478|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
105993338|NCT02152761|365634479|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
105993339|NCT02152761|365634476|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
105993340|NCT02152761|365634477|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
105993341|NCT02152761|365634478|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
106107929|NCT02565914|366049620|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
106107930|NCT05159622|366049621|FG000|Overall Study|Lost to Follow-up|4|||
106107931|NCT05159622|366049622|FG001|Overall Study|Lost to Follow-up|5|||
106107932|NCT03338894|366049625|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
106107933|NCT00863655|366049626|FG000|Overall Study|Protocol Violation|4|||
106107934|NCT00863655|366049627|FG001|Overall Study|Protocol Violation|0|||
106107935|NCT00863655|366049626|FG000|Overall Study|Adverse Event|52|||
106107936|NCT00863655|366049627|FG001|Overall Study|Adverse Event|8|||
106107937|NCT00863655|366049626|FG000|Overall Study|Withdrawal by Subject|47|||
106107938|NCT00863655|366049627|FG001|Overall Study|Withdrawal by Subject|7|||
106107939|NCT00863655|366049626|FG000|Overall Study|Administrative problems|1|||
106107940|NCT00863655|366049627|FG001|Overall Study|Administrative problems|0|||
106107941|NCT00863655|366049626|FG000|Overall Study|Death|7|||
106107942|NCT00863655|366049627|FG001|Overall Study|Death|1|||
106107943|NCT00863655|366049626|FG000|Overall Study|New cancer therapy|5|||
106107944|NCT00863655|366049627|FG001|Overall Study|New cancer therapy|1|||
106107945|NCT00863655|366049626|FG000|Overall Study|Disease progression|364|||
106107946|NCT00863655|366049627|FG001|Overall Study|Disease progression|221|||
106107947|NCT00863655|366049626|FG000|Overall Study|Treatment completed as per protocol|5|||
106107948|NCT00863655|366049627|FG001|Overall Study|Treatment completed as per protocol|1|||
106107949|NCT02157779|366049630|FG000|Overall Study|Logistical|9|||
106107950|NCT02157779|366049631|FG001|Overall Study|Logistical|3|||
106107951|NCT02157779|366049630|FG000|Overall Study|Stopped attending, reason unknown|11|||
106107952|NCT02157779|366049631|FG001|Overall Study|Stopped attending, reason unknown|7|||
106107953|NCT02157779|366049630|FG000|Overall Study|No response to outreach after Baseline|1|||
106107954|NCT02157779|366049631|FG001|Overall Study|No response to outreach after Baseline|1|||
106107955|NCT02157779|366049630|FG000|Overall Study|Moved|1|||
106107956|NCT02157779|366049631|FG001|Overall Study|Moved|0|||
106107957|NCT02157779|366049630|FG000|Overall Study|Medical|1|||
106107958|NCT02157779|366049631|FG001|Overall Study|Medical|0|||
106107959|NCT02157779|366049630|FG000|Overall Study|Legal issue|1|||
106107960|NCT02157779|366049631|FG001|Overall Study|Legal issue|0|||
106107961|NCT02570126|366049640|FG000|Overall Study|Lost to Follow-up|2|||
106107962|NCT02570126|366049641|FG001|Overall Study|Lost to Follow-up|0|||
106107963|NCT02570126|366049640|FG000|Overall Study|Unable To Arrange Visit 3|1|||
106107964|NCT02570126|366049641|FG001|Overall Study|Unable To Arrange Visit 3|0|||
106107965|NCT02570126|366049640|FG000|Overall Study|Violation Of Procedures GSK|0|||
106107966|NCT02570126|366049641|FG001|Overall Study|Violation Of Procedures GSK|1|||
106107967|NCT02570126|366049640|FG000|Overall Study|Protocol Violation|0|||
106107968|NCT02570126|366049641|FG001|Overall Study|Protocol Violation|1|||
106107969|NCT02570126|366049640|FG000|Overall Study|Withdrawal by Subject|3|||
106107970|NCT02570126|366049641|FG001|Overall Study|Withdrawal by Subject|7|||
106107971|NCT00815295|366049642|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
106107972|NCT00815295|366049643|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
106107973|NCT00815295|366049644|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
106107974|NCT00917579|366049645|FG000|Washout >= 2 Weeks|Adverse Event|1|||
106107975|NCT00917579|366049646|FG001|Washout >= 2 Weeks|Adverse Event|0|||
106107976|NCT00917579|366049645|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
106107977|NCT00917579|366049646|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
106107978|NCT01137474|366049649|FG000|Overall Study|Adverse Event|3|||
106107979|NCT01137474|366049650|FG001|Overall Study|Adverse Event|5|||
106107980|NCT01137474|366049651|FG002|Overall Study|Adverse Event|1|||
106107981|NCT01137474|366049652|FG003|Overall Study|Adverse Event|3|||
106107982|NCT01137474|366049649|FG000|Overall Study|Withdrawal by Subject|7|||
106107983|NCT01137474|366049650|FG001|Overall Study|Withdrawal by Subject|2|||
106107984|NCT01137474|366049651|FG002|Overall Study|Withdrawal by Subject|6|||
106107985|NCT01137474|366049652|FG003|Overall Study|Withdrawal by Subject|9|||
106107986|NCT01137474|366049649|FG000|Overall Study|No longer met study criteria|6|||
106107987|NCT01137474|366049650|FG001|Overall Study|No longer met study criteria|1|||
106107988|NCT01137474|366049651|FG002|Overall Study|No longer met study criteria|0|||
106107989|NCT01137474|366049652|FG003|Overall Study|No longer met study criteria|5|||
106107990|NCT01137474|366049649|FG000|Overall Study|Lost to Follow-up|5|||
106107991|NCT01137474|366049650|FG001|Overall Study|Lost to Follow-up|1|||
106107992|NCT01137474|366049651|FG002|Overall Study|Lost to Follow-up|0|||
106107993|NCT01137474|366049652|FG003|Overall Study|Lost to Follow-up|2|||
106107994|NCT01137474|366049649|FG000|Overall Study|Lack of Efficacy|0|||
106107995|NCT01137474|366049650|FG001|Overall Study|Lack of Efficacy|0|||
106107996|NCT01137474|366049651|FG002|Overall Study|Lack of Efficacy|0|||
106107997|NCT01137474|366049652|FG003|Overall Study|Lack of Efficacy|2|||
106107998|NCT01137474|366049649|FG000|Overall Study|Other|3|||
106107999|NCT01137474|366049650|FG001|Overall Study|Other|1|||
106108000|NCT01137474|366049651|FG002|Overall Study|Other|0|||
106108001|NCT01137474|366049652|FG003|Overall Study|Other|0|||
106108002|NCT01137474|366049649|FG000|Overall Study|Pregnancy|0|||
106108003|NCT01137474|366049650|FG001|Overall Study|Pregnancy|1|||
106108004|NCT01137474|366049651|FG002|Overall Study|Pregnancy|0|||
106108005|NCT01137474|366049652|FG003|Overall Study|Pregnancy|0|||
106108006|NCT01137474|366049649|FG000|Overall Study|Administrative reason by sponsor|0|||
105782734|NCT01982942|364857982|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
105782735|NCT00635804|364857983|FG000|Overall Study|Adverse Event|0|||
105782736|NCT00635804|364857984|FG001|Overall Study|Adverse Event|0|||
105782737|NCT00635804|364857985|FG002|Overall Study|Adverse Event|0|||
106108007|NCT01137474|366049650|FG001|Overall Study|Administrative reason by sponsor|1|||
106108008|NCT01137474|366049651|FG002|Overall Study|Administrative reason by sponsor|0|||
106108009|NCT01137474|366049652|FG003|Overall Study|Administrative reason by sponsor|0|||
106108010|NCT04683926|366049653|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
105782738|NCT00635804|364857986|FG003|Overall Study|Adverse Event|0|||
105782739|NCT00635804|364857987|FG004|Overall Study|Adverse Event|0|||
105782740|NCT00635804|364857988|FG005|Overall Study|Adverse Event|1|||
105782741|NCT00635804|364857989|FG006|Overall Study|Adverse Event|0|||
105782742|NCT00635804|364857990|FG007|Overall Study|Adverse Event|0|||
105782743|NCT00635804|364857983|FG000|Overall Study|Withdrawal by Subject|1|||
105782744|NCT00635804|364857984|FG001|Overall Study|Withdrawal by Subject|0|||
105782745|NCT00635804|364857985|FG002|Overall Study|Withdrawal by Subject|0|||
105782746|NCT00635804|364857986|FG003|Overall Study|Withdrawal by Subject|0|||
105782747|NCT00635804|364857987|FG004|Overall Study|Withdrawal by Subject|0|||
105782748|NCT00635804|364857988|FG005|Overall Study|Withdrawal by Subject|0|||
105782749|NCT00635804|364857989|FG006|Overall Study|Withdrawal by Subject|0|||
105782750|NCT00635804|364857990|FG007|Overall Study|Withdrawal by Subject|0|||
105782751|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
105782752|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
105782753|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
105782754|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
105782755|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
106108011|NCT04683926|366049654|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
106108012|NCT04683926|366049655|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
106108013|NCT04683926|366049656|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
106108014|NCT02740049|366049657|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
106108015|NCT01256411|366049658|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
106108016|NCT01256411|366049659|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
106108017|NCT01256411|366049660|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
106108018|NCT01256411|366049661|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
106108019|NCT01256411|366049662|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
106108020|NCT01256411|366049663|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
106108021|NCT01256411|366049658|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
106108022|NCT01256411|366049659|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
106108023|NCT01256411|366049660|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
106108024|NCT01256411|366049661|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
105782756|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
105782757|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
105782758|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
105782759|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
105782760|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
105782761|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
105782762|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
105782763|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
105782764|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
105782765|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
105782766|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|Other|6|||
105782767|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|Other|6|||
105782768|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|Other|7|||
105782769|NCT02681094|364857997|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
105782770|NCT02681094|364857998|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
105782771|NCT02681094|364857999|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
105782772|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Participant decision|7|||
105782773|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Participant decision|10|||
105782774|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Participant decision|9|||
105782775|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
105782776|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
105782777|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
105782778|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
105782779|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
105782780|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
105782781|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
106108025|NCT01256411|366049662|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
106108026|NCT01256411|366049663|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
106108027|NCT01256411|366049658|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
106108028|NCT01256411|366049659|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
106108029|NCT01256411|366049660|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
106108030|NCT01256411|366049661|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
106108031|NCT01256411|366049662|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
106108032|NCT01256411|366049663|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
106108033|NCT01256411|366049658|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
106108034|NCT01256411|366049659|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
106108035|NCT01256411|366049660|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
106108036|NCT01256411|366049661|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
106108037|NCT01256411|366049662|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
106108038|NCT01256411|366049663|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
106108039|NCT01256411|366049658|FG000|Extension by Maximum Treatment|Adverse Event|4|||
106108040|NCT01256411|366049659|FG001|Extension by Maximum Treatment|Adverse Event|2|||
106108041|NCT01256411|366049660|FG002|Extension by Maximum Treatment|Adverse Event|1|||
106108042|NCT01256411|366049661|FG003|Extension by Maximum Treatment|Adverse Event|0|||
106108043|NCT01256411|366049662|FG004|Extension by Maximum Treatment|Adverse Event|0|||
106108044|NCT01256411|366049663|FG005|Extension by Maximum Treatment|Adverse Event|0|||
106108045|NCT01256411|366049658|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
106108046|NCT01256411|366049659|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
106108047|NCT01256411|366049660|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
106108048|NCT01256411|366049661|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
106108049|NCT01256411|366049662|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
106108050|NCT01256411|366049663|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
106108051|NCT01256411|366049658|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
106108052|NCT01256411|366049659|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
106108053|NCT01256411|366049660|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
106108054|NCT01256411|366049661|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
106108055|NCT01256411|366049662|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
106108056|NCT01256411|366049663|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
106108057|NCT01256411|366049658|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
106108058|NCT01256411|366049659|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
106108059|NCT01256411|366049660|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
106108060|NCT01256411|366049661|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
106108061|NCT01256411|366049662|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
106108062|NCT01256411|366049663|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
106108063|NCT01256411|366049658|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
106108064|NCT01256411|366049659|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
106108065|NCT01256411|366049660|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
106108066|NCT01256411|366049661|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
106108067|NCT01256411|366049662|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
106108068|NCT01256411|366049663|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
106108069|NCT01256411|366049658|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
106108070|NCT01256411|366049659|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
106108071|NCT01256411|366049660|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
106108072|NCT01256411|366049661|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
106108073|NCT01256411|366049662|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
106108074|NCT01256411|366049663|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
106108075|NCT03583554|366049665|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
106108076|NCT03583554|366049666|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
106108077|NCT03583554|366049667|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
106108078|NCT00689221|366049669|FG000|Overall Study|Ongoing at cut-off date|39|||
106108079|NCT00689221|366049670|FG001|Overall Study|Ongoing at cut-off date|36|||
106108080|NCT00584727|366049671|FG000|First Intervention|Discontinuation|0|||
106108081|NCT00584727|366049672|FG001|First Intervention|Discontinuation|0|||
106108082|NCT00584727|366049673|FG002|First Intervention|Discontinuation|1|||
106108083|NCT00584727|366049674|FG003|First Intervention|Discontinuation|0|||
106108084|NCT00584727|366049675|FG004|First Intervention|Discontinuation|0|||
106108085|NCT00584727|366049676|FG005|First Intervention|Discontinuation|0|||
106108086|NCT00584727|366049671|FG000|Third Intervention|Protocol Violation|0|||
106108087|NCT00584727|366049672|FG001|Third Intervention|Protocol Violation|0|||
106108088|NCT00584727|366049673|FG002|Third Intervention|Protocol Violation|1|||
106108089|NCT00584727|366049674|FG003|Third Intervention|Protocol Violation|0|||
106108090|NCT00584727|366049675|FG004|Third Intervention|Protocol Violation|4|||
106108091|NCT00584727|366049676|FG005|Third Intervention|Protocol Violation|2|||
106108092|NCT03923933|366049677|FG000|Overall Study|Lost to Follow-up|1|||
106108093|NCT03923933|366049678|FG001|Overall Study|Lost to Follow-up|0|||
105993342|NCT02152761|365634479|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
105993343|NCT02152761|365634476|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
105993344|NCT02152761|365634477|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
105993345|NCT02152761|365634478|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
105993346|NCT02152761|365634479|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
105993347|NCT02152761|365634476|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
105993348|NCT02152761|365634477|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
105993349|NCT02152761|365634478|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
105993350|NCT02152761|365634479|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
105993351|NCT02152761|365634476|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
105993352|NCT02152761|365634477|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
105993353|NCT02152761|365634478|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
105993354|NCT02152761|365634479|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
105993355|NCT02506192|365634480|FG000|Overall Study|Withdrawal by Subject|1|||
105993356|NCT02506192|365634481|FG001|Overall Study|Withdrawal by Subject|1|||
105993357|NCT01685697|365634482|FG000|Overall Study|Protocol Violation|3|||
105993358|NCT01685697|365634483|FG001|Overall Study|Protocol Violation|3|||
105993359|NCT05292131|365634488|FG000|Overall Study|Lost to Follow-up|1|||
105993360|NCT05292131|365634489|FG001|Overall Study|Lost to Follow-up|1|||
105993361|NCT05292131|365634488|FG000|Overall Study|Withdrawal by Subject|0|||
105993362|NCT05292131|365634489|FG001|Overall Study|Withdrawal by Subject|1|||
105993363|NCT04390880|365634491|FG000|Overall Study|Withdrawal by Subject|1|||
105993364|NCT02557542|365634492|FG000|Overall Study|Poor recruitment|3|||
105993365|NCT02557542|365634493|FG001|Overall Study|Poor recruitment|0|||
105993366|NCT03785405|365634494|FG000|Overall Study|Adverse Event|16|||
105993367|NCT03785405|365634495|FG001|Overall Study|Adverse Event|1|||
105993368|NCT03785405|365634494|FG000|Overall Study|Death|6|||
105993369|NCT03785405|365634495|FG001|Overall Study|Death|4|||
105993370|NCT03785405|365634494|FG000|Overall Study|Guardian decision|4|||
105993371|NCT03785405|365634495|FG001|Overall Study|Guardian decision|1|||
105993372|NCT03785405|365634494|FG000|Overall Study|Lost to Follow-up|1|||
105993373|NCT03785405|365634495|FG001|Overall Study|Lost to Follow-up|0|||
105993374|NCT03785405|365634494|FG000|Overall Study|Physician Decision|8|||
105993375|NCT03785405|365634495|FG001|Overall Study|Physician Decision|5|||
105993376|NCT03785405|365634494|FG000|Overall Study|Participant decision|2|||
105993377|NCT03785405|365634495|FG001|Overall Study|Participant decision|0|||
105993378|NCT03785405|365634494|FG000|Overall Study|Other|1|||
105993379|NCT03785405|365634495|FG001|Overall Study|Other|0|||
105993380|NCT03785405|365634494|FG000|Overall Study|No treatment was received|0|||
105993381|NCT03785405|365634495|FG001|Overall Study|No treatment was received|1|||
105993382|NCT03705559|365634496|FG000|Overall Study|COVID Shut down|1|||
105993383|NCT03517228|365634497|FG000|Overall Study|Withdrawal by Subject|2|||
105993384|NCT03517228|365634497|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
105993385|NCT03517228|365634497|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
105993386|NCT03517228|365634497|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
105993387|NCT03517228|365634497|FG000|Overall Study|Canceled due to device being updated|1|||
105993388|NCT03517228|365634497|FG000|Overall Study|No V Cares in stock|1|||
105993389|NCT03517228|365634497|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
105993390|NCT01345188|365634498|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
105993391|NCT01345188|365634498|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
105993392|NCT01922271|365634499|FG000|WASHOUT Period|Withdrawal by Subject|1|||
105993393|NCT01922271|365634500|FG001|WASHOUT Period|Withdrawal by Subject|0|||
105993394|NCT02534909|365634519|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
105993395|NCT04079816|365634520|FG000|Overall Study|Request of Subject|2|||
105993396|NCT04079816|365634520|FG000|Overall Study|Unable to draw samples|1|||
105993397|NCT01702246|365634521|FG000|Overall Study|Lost to Follow-up|2|||
105993398|NCT01702246|365634521|FG000|Overall Study|Withdrawal by Subject|2|||
105993399|NCT01702246|365634521|FG000|Overall Study|Physician Decision|1|||
105993400|NCT04300309|365634524|FG000|Overall Study|Lost to Follow-up|1|||
105993401|NCT04300309|365634525|FG001|Overall Study|Lost to Follow-up|0|||
105993402|NCT04427072|365634528|FG000|Randomized Treatment Phase|Progressive disease|9|||
105993403|NCT04427072|365634529|FG001|Randomized Treatment Phase|Progressive disease|4|||
105993404|NCT04427072|365634528|FG000|Randomized Treatment Phase|Adverse Event|3|||
105993405|NCT04427072|365634529|FG001|Randomized Treatment Phase|Adverse Event|1|||
105993406|NCT04427072|365634528|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
105993407|NCT04427072|365634529|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
105993408|NCT04427072|365634528|FG000|Randomized Treatment Phase|Death|0|||
105993409|NCT04427072|365634529|FG001|Randomized Treatment Phase|Death|1|||
105993410|NCT04427072|365634528|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
105993411|NCT04427072|365634529|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
105993412|NCT04427072|365634528|FG000|Extension Treatment Phase|Progressive disease|0|||
105993413|NCT04427072|365634529|FG001|Extension Treatment Phase|Progressive disease|5|||
106108094|NCT03923933|366049677|FG000|Overall Study|Withdrawal by Subject|0|||
105782782|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
105782783|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
105782784|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
105782785|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
105782786|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
105782787|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|Other|6|||
105782788|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|Other|6|||
105782789|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|Other|7|||
105782790|NCT02681094|364857997|FG000|2 - Enrolled Participants Set|No treatment given|0|||
105782791|NCT02681094|364857998|FG001|2 - Enrolled Participants Set|No treatment given|1|||
105782792|NCT02681094|364857999|FG002|2 - Enrolled Participants Set|No treatment given|1|||
105782793|NCT02452320|364858000|FG000|Overall Study|Adverse Event|0|||
105782794|NCT02452320|364858001|FG001|Overall Study|Adverse Event|1|||
105782795|NCT00285857|364858002|FG000|Overall Study|Withdrawal by Subject|2|||
105782796|NCT00285857|364858002|FG000|Overall Study|Inadequate initial breast cytology|1|||
105782797|NCT00285857|364858002|FG000|Overall Study|Adverse Event|1|||
105782798|NCT00649220|364858003|FG000|Overall Study|Adverse Event|2|||
105782799|NCT00649220|364858003|FG000|Overall Study|Withdrawal by Subject|1|||
105782800|NCT01733758|364858004|FG000|Overall Study|Adverse Event|5|||
105782801|NCT01733758|364858005|FG001|Overall Study|Adverse Event|7|||
105782802|NCT01733758|364858006|FG002|Overall Study|Adverse Event|8|||
105782803|NCT01733758|364858007|FG003|Overall Study|Adverse Event|1|||
105782804|NCT01733758|364858004|FG000|Overall Study|Withdrawal by Subject|1|||
105782805|NCT01733758|364858005|FG001|Overall Study|Withdrawal by Subject|1|||
105782806|NCT01733758|364858006|FG002|Overall Study|Withdrawal by Subject|5|||
105782807|NCT01733758|364858007|FG003|Overall Study|Withdrawal by Subject|3|||
105782808|NCT01733758|364858004|FG000|Overall Study|Persistent Hyperglycemia|3|||
105782809|NCT01733758|364858005|FG001|Overall Study|Persistent Hyperglycemia|2|||
105782810|NCT01733758|364858006|FG002|Overall Study|Persistent Hyperglycemia|0|||
105782811|NCT01733758|364858007|FG003|Overall Study|Persistent Hyperglycemia|0|||
105782812|NCT01733758|364858004|FG000|Overall Study|Protocol Violation|0|||
105782813|NCT01733758|364858005|FG001|Overall Study|Protocol Violation|1|||
105782814|NCT01733758|364858006|FG002|Overall Study|Protocol Violation|2|||
105782815|NCT01733758|364858007|FG003|Overall Study|Protocol Violation|2|||
105782816|NCT01733758|364858004|FG000|Overall Study|Non-compliance|1|||
105782817|NCT01733758|364858005|FG001|Overall Study|Non-compliance|0|||
105782818|NCT01733758|364858006|FG002|Overall Study|Non-compliance|0|||
105782819|NCT01733758|364858007|FG003|Overall Study|Non-compliance|0|||
105782820|NCT01733758|364858004|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
105782821|NCT01733758|364858005|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
105782822|NCT01733758|364858006|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
105782823|NCT01733758|364858007|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
105782824|NCT01733758|364858004|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
105782825|NCT01733758|364858005|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
105782826|NCT01733758|364858006|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
105782827|NCT01733758|364858007|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
105782828|NCT02557308|364858010|FG000|Overall Study|Withdrawal by Subject|11|||
105782829|NCT02557308|364858011|FG001|Overall Study|Withdrawal by Subject|3|||
105782830|NCT02557308|364858012|FG002|Overall Study|Withdrawal by Subject|2|||
105993414|NCT05870865|365634540|FG000|Randomized|Did not receive study treatment|2|||
105993415|NCT05870865|365634541|FG001|Randomized|Did not receive study treatment|4|||
105993416|NCT05870865|365634542|FG002|Randomized|Did not receive study treatment|4|||
105993417|NCT05870865|365634543|FG003|Randomized|Did not receive study treatment|3|||
105993418|NCT05870865|365634540|FG000|Treatment Period|Adverse Event|1|||
105993419|NCT05870865|365634541|FG001|Treatment Period|Adverse Event|1|||
105993420|NCT05870865|365634542|FG002|Treatment Period|Adverse Event|1|||
105993421|NCT05870865|365634543|FG003|Treatment Period|Adverse Event|1|||
105993422|NCT05870865|365634540|FG000|Treatment Period|Lost to Follow-up|0|||
105993423|NCT05870865|365634541|FG001|Treatment Period|Lost to Follow-up|1|||
105993424|NCT05870865|365634542|FG002|Treatment Period|Lost to Follow-up|2|||
105993425|NCT05870865|365634543|FG003|Treatment Period|Lost to Follow-up|0|||
105993426|NCT05870865|365634540|FG000|Treatment Period|Protocol Violation|0|||
105993427|NCT05870865|365634541|FG001|Treatment Period|Protocol Violation|0|||
105993428|NCT05870865|365634542|FG002|Treatment Period|Protocol Violation|0|||
105993429|NCT05870865|365634543|FG003|Treatment Period|Protocol Violation|1|||
105993430|NCT05870865|365634540|FG000|Treatment Period|Withdrawal by Subject|0|||
105993431|NCT05870865|365634541|FG001|Treatment Period|Withdrawal by Subject|1|||
106108095|NCT03923933|366049678|FG001|Overall Study|Withdrawal by Subject|1|||
106108096|NCT00419263|366049679|FG000|Overall Study|Lost to Follow-up|2|||
105782831|NCT02557308|364858013|FG003|Overall Study|Withdrawal by Subject|0|||
105782832|NCT02557308|364858014|FG004|Overall Study|Withdrawal by Subject|1|||
105782833|NCT02557308|364858015|FG005|Overall Study|Withdrawal by Subject|0|||
105993432|NCT05870865|365634542|FG002|Treatment Period|Withdrawal by Subject|1|||
106108097|NCT00419263|366049680|FG001|Overall Study|Lost to Follow-up|1|||
105993433|NCT05870865|365634543|FG003|Treatment Period|Withdrawal by Subject|1|||
105993434|NCT04739761|365634544|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
105993435|NCT04739761|365634545|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
105993436|NCT04739761|365634544|FG000|Overall Study|By complete response from the participant|1|||
105993437|NCT04739761|365634545|FG001|Overall Study|By complete response from the participant|0|||
105993438|NCT04739761|365634544|FG000|Overall Study|Lost to Follow-up|3|||
105993439|NCT04739761|365634545|FG001|Overall Study|Lost to Follow-up|3|||
105993440|NCT04739761|365634544|FG000|Overall Study|Death|13|||
105993441|NCT04739761|365634545|FG001|Overall Study|Death|13|||
105993442|NCT04739761|365634544|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
105993443|NCT04739761|365634545|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
105993444|NCT04739761|365634544|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
105993445|NCT04739761|365634545|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
105993446|NCT04739761|365634544|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
105993447|NCT04739761|365634545|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
105993448|NCT04739761|365634544|FG000|Overall Study|Adverse Event|0|||
105993449|NCT04739761|365634545|FG001|Overall Study|Adverse Event|3|||
105993450|NCT04739761|365634544|FG000|Overall Study|Participant decision|1|||
105993451|NCT04739761|365634545|FG001|Overall Study|Participant decision|0|||
105993452|NCT04739761|365634544|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
105993453|NCT04739761|365634545|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
105993454|NCT04739761|365634544|FG000|Overall Study|Participant immediately started next line of treatment|1|||
105993455|NCT04739761|365634545|FG001|Overall Study|Participant immediately started next line of treatment|0|||
105993456|NCT04739761|365634544|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
105993457|NCT04739761|365634545|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
105993458|NCT04739761|365634544|FG000|Overall Study|Lack of clinical benefit|1|||
105993459|NCT04739761|365634545|FG001|Overall Study|Lack of clinical benefit|0|||
105993460|NCT04739761|365634544|FG000|Overall Study|Disease progression|5|||
105993461|NCT04739761|365634545|FG001|Overall Study|Disease progression|5|||
105993462|NCT04739761|365634544|FG000|Overall Study|Withdrawal by Subject|14|||
105993463|NCT04739761|365634545|FG001|Overall Study|Withdrawal by Subject|13|||
105993464|NCT04739761|365634544|FG000|Overall Study|Protocol Violation|1|||
105993465|NCT04739761|365634545|FG001|Overall Study|Protocol Violation|0|||
105993466|NCT04739761|365634544|FG000|Overall Study|Physician Decision|2|||
105993467|NCT04739761|365634545|FG001|Overall Study|Physician Decision|0|||
105993468|NCT01711645|365634553|FG000|Overall Study|Withdrawal by Subject|8|||
105993469|NCT01711645|365634553|FG000|Overall Study|Lost to Follow-up|6|||
105993470|NCT01711645|365634553|FG000|Overall Study|Physician Decision|5|||
105993471|NCT02058563|365634556|FG000|Overall Study|Lost to Follow-up|26|||
105993472|NCT02058563|365634557|FG001|Overall Study|Lost to Follow-up|22|||
105993473|NCT02058563|365634556|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
105993474|NCT02058563|365634557|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
105993475|NCT02058563|365634556|FG000|Overall Study|Consent Withdrawal|1|||
105993476|NCT02058563|365634557|FG001|Overall Study|Consent Withdrawal|1|||
105993477|NCT02058563|365634556|FG000|Overall Study|Other (patient incarcerated)|0|||
105993478|NCT02058563|365634557|FG001|Overall Study|Other (patient incarcerated)|1|||
105993479|NCT00166439|365634558|FG000|Overall Study|Ineligible|5|||
105993480|NCT04522141|365634559|FG000|Overall Study|Withdrawal by Subject|1|||
105993481|NCT04522141|365634560|FG001|Overall Study|Withdrawal by Subject|0|||
105993482|NCT00186901|365634561|FG000|Overall Study|Pregnancy|6|||
105993483|NCT00186901|365634562|FG001|Overall Study|Pregnancy|3|||
105993484|NCT00186901|365634563|FG002|Overall Study|Pregnancy|0|||
105993485|NCT00186901|365634561|FG000|Overall Study|Lost to Follow-up|6|||
105993486|NCT00186901|365634562|FG001|Overall Study|Lost to Follow-up|3|||
105993487|NCT00186901|365634563|FG002|Overall Study|Lost to Follow-up|0|||
105993488|NCT00186901|365634561|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
105993489|NCT00186901|365634562|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
105993490|NCT00186901|365634563|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
105993491|NCT00186901|365634561|FG000|Overall Study|ALL relapse or second malignancy|1|||
105993492|NCT00186901|365634562|FG001|Overall Study|ALL relapse or second malignancy|2|||
105993493|NCT00186901|365634563|FG002|Overall Study|ALL relapse or second malignancy|0|||
105993494|NCT00186901|365634561|FG000|Overall Study|Withdrawal by Subject|4|||
105993495|NCT00186901|365634562|FG001|Overall Study|Withdrawal by Subject|5|||
105993496|NCT00186901|365634563|FG002|Overall Study|Withdrawal by Subject|0|||
105993497|NCT00186901|365634561|FG000|Overall Study|Open label|3|||
105993498|NCT00186901|365634562|FG001|Overall Study|Open label|2|||
105993499|NCT00186901|365634563|FG002|Overall Study|Open label|0|||
105993500|NCT00186901|365634561|FG000|Overall Study|Limited adherence to study requirements|20|||
105993501|NCT00186901|365634562|FG001|Overall Study|Limited adherence to study requirements|23|||
105993502|NCT00186901|365634563|FG002|Overall Study|Limited adherence to study requirements|0|||
105993503|NCT00186901|365634561|FG000|Overall Study|Bone Mineral Density > 0|0|||
105993504|NCT00186901|365634562|FG001|Overall Study|Bone Mineral Density > 0|0|||
105993505|NCT00186901|365634563|FG002|Overall Study|Bone Mineral Density > 0|149|||
105993506|NCT03193736|365634565|FG000|Overall Study|Death|2|||
105993507|NCT03193736|365634565|FG000|Overall Study|Withdrawal by Subject|1|||
105993508|NCT03193736|365634565|FG000|Overall Study|Lost to Follow-up|1|||
105993509|NCT03193736|365634565|FG000|Overall Study|implant not received|1|||
105993510|NCT00003199|365634569|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
105993511|NCT00003199|365634569|FG000|Overall Study|Lack of insurance clearance|2|||
105993512|NCT00003199|365634569|FG000|Overall Study|Screen fail|15|||
105993513|NCT03761810|365634570|FG000|Overall Study|Adverse Event|12|||
105993514|NCT03761810|365634571|FG001|Overall Study|Adverse Event|0|||
105993515|NCT03761810|365634570|FG000|Overall Study|Lost to Follow-up|15|||
105993516|NCT03761810|365634571|FG001|Overall Study|Lost to Follow-up|7|||
105993517|NCT03761810|365634570|FG000|Overall Study|Pregnancy|1|||
105993518|NCT03761810|365634571|FG001|Overall Study|Pregnancy|0|||
105993519|NCT03761810|365634570|FG000|Overall Study|Withdrawal by Subject|14|||
105993520|NCT03761810|365634571|FG001|Overall Study|Withdrawal by Subject|5|||
105993521|NCT03761810|365634570|FG000|Overall Study|Physician Decision|1|||
105993522|NCT03761810|365634571|FG001|Overall Study|Physician Decision|0|||
105993523|NCT03761810|365634570|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
105993524|NCT03761810|365634571|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105993525|NCT03761810|365634570|FG000|Overall Study|Other Than Specified|1|||
105993526|NCT03761810|365634571|FG001|Overall Study|Other Than Specified|0|||
105993527|NCT00264537|365634572|FG000|Overall Study|Death|0|||
105993528|NCT00264537|365634573|FG001|Overall Study|Death|3|||
105993529|NCT00264537|365634574|FG002|Overall Study|Death|3|||
105993530|NCT00264537|365634575|FG003|Overall Study|Death|2|||
105993531|NCT00264537|365634572|FG000|Overall Study|Lost to Follow-up|3|||
105993532|NCT00264537|365634573|FG001|Overall Study|Lost to Follow-up|4|||
105993533|NCT00264537|365634574|FG002|Overall Study|Lost to Follow-up|7|||
105993534|NCT00264537|365634575|FG003|Overall Study|Lost to Follow-up|6|||
105993535|NCT00264537|365634572|FG000|Overall Study|Adverse Event|21|||
106108098|NCT00419263|366049681|FG002|Overall Study|Lost to Follow-up|1|||
106108099|NCT00419263|366049679|FG000|Overall Study|Randomized in Error, Not Treated|1|||
106108100|NCT00419263|366049680|FG001|Overall Study|Randomized in Error, Not Treated|1|||
106108101|NCT00419263|366049681|FG002|Overall Study|Randomized in Error, Not Treated|0|||
105993536|NCT00264537|365634573|FG001|Overall Study|Adverse Event|32|||
105993537|NCT00264537|365634574|FG002|Overall Study|Adverse Event|24|||
105993538|NCT00264537|365634575|FG003|Overall Study|Adverse Event|34|||
106108102|NCT00419263|366049679|FG000|Overall Study|Adverse Event|0|||
106108103|NCT00419263|366049680|FG001|Overall Study|Adverse Event|0|||
106108104|NCT00419263|366049681|FG002|Overall Study|Adverse Event|1|||
106108105|NCT00419263|366049679|FG000|Overall Study|Withdrawal by Subject|0|||
106108106|NCT00419263|366049680|FG001|Overall Study|Withdrawal by Subject|0|||
106108107|NCT00419263|366049681|FG002|Overall Study|Withdrawal by Subject|1|||
106108108|NCT01328080|366049682|FG000|Overall Study|Lost to Follow-up|5|||
106108109|NCT00862134|366049683|FG000|Overall Study|Death|1|||
106108110|NCT00862134|366049684|FG001|Overall Study|Death|0|||
106108111|NCT00862134|366049683|FG000|Overall Study|Physician Decision|0|||
106108112|NCT00862134|366049684|FG001|Overall Study|Physician Decision|1|||
106108113|NCT00862134|366049683|FG000|Overall Study|Withdrawal by Subject|1|||
106108114|NCT00862134|366049684|FG001|Overall Study|Withdrawal by Subject|2|||
106108115|NCT00862134|366049683|FG000|Overall Study|Sponsor terminated study|5|||
106108116|NCT00862134|366049684|FG001|Overall Study|Sponsor terminated study|7|||
106108117|NCT00862134|366049683|FG000|Overall Study|Adverse Event|2|||
106108118|NCT00862134|366049684|FG001|Overall Study|Adverse Event|2|||
106108119|NCT00862134|366049683|FG000|Overall Study|Withdrew prior to dosing|2|||
106108120|NCT00862134|366049684|FG001|Overall Study|Withdrew prior to dosing|0|||
106108121|NCT02191267|366049685|FG000|Overall Study|Withdrawal by Subject|1|||
106108122|NCT02191267|366049686|FG001|Overall Study|Withdrawal by Subject|0|||
106108123|NCT02191267|366049687|FG002|Overall Study|Withdrawal by Subject|0|||
106108124|NCT00316082|366049688|FG000|Overall Study|Lack of Efficacy|2|||
106108125|NCT00316082|366049689|FG001|Overall Study|Lack of Efficacy|3|||
106108126|NCT00316082|366049690|FG002|Overall Study|Lack of Efficacy|3|||
106108127|NCT00316082|366049691|FG003|Overall Study|Lack of Efficacy|4|||
106108128|NCT00316082|366049692|FG004|Overall Study|Lack of Efficacy|6|||
106108129|NCT00316082|366049688|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
106108130|NCT00316082|366049689|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
106108131|NCT00316082|366049690|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
106108132|NCT00316082|366049691|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
106108133|NCT00316082|366049692|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
106108134|NCT00316082|366049688|FG000|Overall Study|Lost to Follow-up|7|||
106108135|NCT00316082|366049689|FG001|Overall Study|Lost to Follow-up|6|||
106108136|NCT00316082|366049690|FG002|Overall Study|Lost to Follow-up|7|||
106108137|NCT00316082|366049691|FG003|Overall Study|Lost to Follow-up|8|||
105993539|NCT00264537|365634572|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
105993540|NCT00264537|365634573|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
105993541|NCT00264537|365634574|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
105993542|NCT00264537|365634575|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
106108138|NCT00316082|366049692|FG004|Overall Study|Lost to Follow-up|6|||
106108139|NCT00316082|366049688|FG000|Overall Study|Poor/noncompliance|6|||
106108140|NCT00316082|366049689|FG001|Overall Study|Poor/noncompliance|1|||
106108141|NCT00316082|366049690|FG002|Overall Study|Poor/noncompliance|4|||
106108142|NCT00316082|366049691|FG003|Overall Study|Poor/noncompliance|1|||
106108143|NCT00316082|366049692|FG004|Overall Study|Poor/noncompliance|4|||
106108144|NCT00316082|366049688|FG000|Overall Study|Adverse Event|4|||
106108145|NCT00316082|366049689|FG001|Overall Study|Adverse Event|2|||
106108146|NCT00316082|366049690|FG002|Overall Study|Adverse Event|5|||
106108147|NCT00316082|366049691|FG003|Overall Study|Adverse Event|1|||
106108148|NCT00316082|366049692|FG004|Overall Study|Adverse Event|3|||
106108149|NCT00316082|366049688|FG000|Overall Study|Subject no longer meets study criteria|3|||
106108150|NCT00316082|366049689|FG001|Overall Study|Subject no longer meets study criteria|1|||
106108151|NCT00316082|366049690|FG002|Overall Study|Subject no longer meets study criteria|2|||
106108152|NCT00316082|366049691|FG003|Overall Study|Subject no longer meets study criteria|2|||
106108153|NCT00316082|366049692|FG004|Overall Study|Subject no longer meets study criteria|1|||
106108154|NCT00316082|366049688|FG000|Overall Study|Physician Decision|1|||
106108155|NCT00316082|366049689|FG001|Overall Study|Physician Decision|1|||
106108156|NCT00316082|366049690|FG002|Overall Study|Physician Decision|2|||
106108157|NCT00316082|366049691|FG003|Overall Study|Physician Decision|1|||
106108158|NCT00316082|366049692|FG004|Overall Study|Physician Decision|1|||
106108159|NCT00316082|366049688|FG000|Overall Study|Death|0|||
106108160|NCT00316082|366049689|FG001|Overall Study|Death|0|||
106108161|NCT00316082|366049690|FG002|Overall Study|Death|1|||
106108162|NCT00316082|366049691|FG003|Overall Study|Death|0|||
106108163|NCT00316082|366049692|FG004|Overall Study|Death|0|||
106108164|NCT00316082|366049688|FG000|Overall Study|Administrative reason by sponsor|0|||
106108165|NCT00316082|366049689|FG001|Overall Study|Administrative reason by sponsor|0|||
106108166|NCT00316082|366049690|FG002|Overall Study|Administrative reason by sponsor|1|||
106108167|NCT00316082|366049691|FG003|Overall Study|Administrative reason by sponsor|0|||
106108168|NCT00316082|366049692|FG004|Overall Study|Administrative reason by sponsor|0|||
106108169|NCT01693068|366049697|FG000|Randomization Period|On-study|2|||
106108170|NCT01693068|366049698|FG001|Randomization Period|On-study|5|||
106108171|NCT01693068|366049699|FG002|Randomization Period|On-study|0|||
106108172|NCT01693068|366049697|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
105782834|NCT02557308|364858016|FG006|Overall Study|Withdrawal by Subject|10|||
105782835|NCT02557308|364858017|FG007|Overall Study|Withdrawal by Subject|1|||
105782836|NCT02557308|364858010|FG000|Overall Study|Disease Progression|0|||
105782837|NCT02557308|364858011|FG001|Overall Study|Disease Progression|1|||
105782838|NCT02557308|364858012|FG002|Overall Study|Disease Progression|0|||
105782839|NCT02557308|364858013|FG003|Overall Study|Disease Progression|0|||
105782840|NCT02557308|364858014|FG004|Overall Study|Disease Progression|0|||
105993543|NCT00264537|365634572|FG000|Overall Study|Other|21|||
105993544|NCT00264537|365634573|FG001|Overall Study|Other|11|||
105993545|NCT00264537|365634574|FG002|Overall Study|Other|10|||
105993546|NCT00264537|365634575|FG003|Overall Study|Other|11|||
105993547|NCT00264537|365634572|FG000|Overall Study|Not treated|0|||
105993548|NCT00264537|365634573|FG001|Overall Study|Not treated|2|||
105993549|NCT00264537|365634574|FG002|Overall Study|Not treated|1|||
105993550|NCT00264537|365634575|FG003|Overall Study|Not treated|0|||
105993551|NCT00811174|365634576|FG000|Overall Study|Protocol Violation|2|||
105993552|NCT00811174|365634576|FG000|Overall Study|Sponsors Decision|1|||
106016817|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Death|3|||
106016818|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Death|0|||
106016819|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Death|0|||
106016820|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
106016821|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
106016822|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
106016823|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
106016824|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
106016825|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
106016826|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
106016827|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
106016828|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
106016829|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
106016830|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
106016831|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
106108173|NCT01693068|366049698|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
106108174|NCT01693068|366049699|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
106108175|NCT01939548|366049700|FG000|Overall Study|Non compliance|0|||
106108176|NCT01939548|366049701|FG001|Overall Study|Non compliance|2|||
106108177|NCT01939548|366049702|FG002|Overall Study|Non compliance|0|||
106108178|NCT01939548|366049700|FG000|Overall Study|Study Terminated by Sponsor|17|||
105782841|NCT02557308|364858015|FG005|Overall Study|Disease Progression|0|||
105782842|NCT02557308|364858016|FG006|Overall Study|Disease Progression|0|||
105993553|NCT03058692|365636032|FG000|Overall Study|Lost to Follow-up|2|||
105993554|NCT03058692|365636033|FG001|Overall Study|Lost to Follow-up|1|||
105993555|NCT03058692|365636032|FG000|Overall Study|Withdrawal by Subject|1|||
105993556|NCT03058692|365636033|FG001|Overall Study|Withdrawal by Subject|1|||
105993557|NCT00615017|365636034|FG000|Overall Study|Adverse Event|0|||
105993558|NCT00615017|365636035|FG001|Overall Study|Adverse Event|1|||
105993559|NCT00615017|365636036|FG002|Overall Study|Adverse Event|2|||
105993560|NCT00615017|365636037|FG003|Overall Study|Adverse Event|0|||
105993561|NCT00615017|365636038|FG004|Overall Study|Adverse Event|0|||
105993562|NCT00615017|365636039|FG005|Overall Study|Adverse Event|1|||
105993563|NCT00615017|365636034|FG000|Overall Study|Death|0|||
105993564|NCT00615017|365636035|FG001|Overall Study|Death|0|||
105993565|NCT00615017|365636036|FG002|Overall Study|Death|2|||
105993566|NCT00615017|365636037|FG003|Overall Study|Death|0|||
105993567|NCT00615017|365636038|FG004|Overall Study|Death|1|||
105993568|NCT00615017|365636039|FG005|Overall Study|Death|1|||
105993569|NCT00615017|365636034|FG000|Overall Study|Sepsis resolved|0|||
105993570|NCT00615017|365636035|FG001|Overall Study|Sepsis resolved|0|||
105993571|NCT00615017|365636036|FG002|Overall Study|Sepsis resolved|1|||
105993572|NCT00615017|365636037|FG003|Overall Study|Sepsis resolved|0|||
105993573|NCT00615017|365636038|FG004|Overall Study|Sepsis resolved|0|||
105993574|NCT00615017|365636039|FG005|Overall Study|Sepsis resolved|0|||
105993575|NCT00615017|365636034|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
105993576|NCT00615017|365636035|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
105993577|NCT00615017|365636036|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
105993578|NCT00615017|365636037|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
105993579|NCT00615017|365636038|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
105993580|NCT00615017|365636039|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
105993581|NCT00615017|365636034|FG000|Overall Study|Physician discontinued drug|0|||
105993582|NCT00615017|365636035|FG001|Overall Study|Physician discontinued drug|0|||
105993583|NCT00615017|365636036|FG002|Overall Study|Physician discontinued drug|0|||
105993584|NCT00615017|365636037|FG003|Overall Study|Physician discontinued drug|0|||
105993585|NCT00615017|365636038|FG004|Overall Study|Physician discontinued drug|0|||
105993586|NCT00615017|365636039|FG005|Overall Study|Physician discontinued drug|1|||
105993587|NCT01525615|365636040|FG000|Overall Study|Adverse Event|11|||
105993588|NCT01525615|365636041|FG001|Overall Study|Adverse Event|7|||
105993589|NCT01525615|365636042|FG002|Overall Study|Adverse Event|5|||
105993590|NCT01525615|365636040|FG000|Overall Study|Lost to Follow-up|1|||
105993591|NCT01525615|365636041|FG001|Overall Study|Lost to Follow-up|0|||
105993592|NCT01525615|365636042|FG002|Overall Study|Lost to Follow-up|0|||
105993593|NCT01525615|365636040|FG000|Overall Study|Withdrawal by Subject|1|||
105993594|NCT01525615|365636041|FG001|Overall Study|Withdrawal by Subject|0|||
105993595|NCT01525615|365636042|FG002|Overall Study|Withdrawal by Subject|0|||
105993596|NCT01525615|365636040|FG000|Overall Study|Other reason not described above|1|||
105993597|NCT01525615|365636041|FG001|Overall Study|Other reason not described above|0|||
105993598|NCT01525615|365636042|FG002|Overall Study|Other reason not described above|1|||
105993599|NCT01946152|365636043|FG000|Overall Study|Adverse Event|1|||
105993600|NCT01946152|365636044|FG001|Overall Study|Adverse Event|0|||
105993601|NCT01946152|365636045|FG002|Overall Study|Adverse Event|0|||
105993602|NCT01946152|365636046|FG003|Overall Study|Adverse Event|0|||
105993603|NCT01946152|365636043|FG000|Overall Study|Withdrawal by Subject|0|||
105993604|NCT01946152|365636044|FG001|Overall Study|Withdrawal by Subject|2|||
105993605|NCT01946152|365636045|FG002|Overall Study|Withdrawal by Subject|0|||
105993606|NCT01946152|365636046|FG003|Overall Study|Withdrawal by Subject|0|||
105993607|NCT01946152|365636043|FG000|Overall Study|Progression|0|||
105993608|NCT01946152|365636044|FG001|Overall Study|Progression|1|||
105993609|NCT01946152|365636045|FG002|Overall Study|Progression|4|||
105993610|NCT01946152|365636046|FG003|Overall Study|Progression|7|||
105993611|NCT01946152|365636043|FG000|Overall Study|Physician Decision|0|||
105993612|NCT01946152|365636044|FG001|Overall Study|Physician Decision|0|||
105993613|NCT01946152|365636045|FG002|Overall Study|Physician Decision|1|||
105993614|NCT01946152|365636046|FG003|Overall Study|Physician Decision|0|||
105993615|NCT01946152|365636043|FG000|Overall Study|Second malignancy|0|||
105993616|NCT01946152|365636044|FG001|Overall Study|Second malignancy|0|||
105993617|NCT01946152|365636045|FG002|Overall Study|Second malignancy|1|||
105993618|NCT01946152|365636046|FG003|Overall Study|Second malignancy|0|||
105993619|NCT01946152|365636043|FG000|Overall Study|Adverse Event|0|||
105993620|NCT01946152|365636044|FG001|Overall Study|Adverse Event|0|||
105993621|NCT01946152|365636045|FG002|Overall Study|Adverse Event|0|||
105993622|NCT01946152|365636046|FG003|Overall Study|Adverse Event|1|||
105993623|NCT03712787|365636047|FG000|Overall Study|Adverse Event|2|||
105993624|NCT03712787|365636048|FG001|Overall Study|Adverse Event|3|||
105993625|NCT03712787|365636049|FG002|Overall Study|Adverse Event|0|||
105993626|NCT03712787|365636050|FG003|Overall Study|Adverse Event|4|||
105993627|NCT03712787|365636047|FG000|Overall Study|Withdrawal by Subject|4|||
105993628|NCT03712787|365636048|FG001|Overall Study|Withdrawal by Subject|14|||
105993629|NCT03712787|365636049|FG002|Overall Study|Withdrawal by Subject|12|||
105993630|NCT03712787|365636050|FG003|Overall Study|Withdrawal by Subject|8|||
105993631|NCT03712787|365636047|FG000|Overall Study|Lost to Follow-up|1|||
106108179|NCT01939548|366049701|FG001|Overall Study|Study Terminated by Sponsor|19|||
106108180|NCT01939548|366049702|FG002|Overall Study|Study Terminated by Sponsor|12|||
105782843|NCT02557308|364858017|FG007|Overall Study|Disease Progression|0|||
105782844|NCT02557308|364858010|FG000|Overall Study|Lack of Efficacy|3|||
105782845|NCT02557308|364858011|FG001|Overall Study|Lack of Efficacy|0|||
105782846|NCT02557308|364858012|FG002|Overall Study|Lack of Efficacy|0|||
105782847|NCT02557308|364858013|FG003|Overall Study|Lack of Efficacy|0|||
105782848|NCT02557308|364858014|FG004|Overall Study|Lack of Efficacy|0|||
105782849|NCT02557308|364858015|FG005|Overall Study|Lack of Efficacy|0|||
105782850|NCT02557308|364858016|FG006|Overall Study|Lack of Efficacy|1|||
105782851|NCT02557308|364858017|FG007|Overall Study|Lack of Efficacy|0|||
105782852|NCT02557308|364858010|FG000|Overall Study|Adverse Event|4|||
105782853|NCT02557308|364858011|FG001|Overall Study|Adverse Event|1|||
105782854|NCT02557308|364858012|FG002|Overall Study|Adverse Event|2|||
105782855|NCT02557308|364858013|FG003|Overall Study|Adverse Event|0|||
105782856|NCT02557308|364858014|FG004|Overall Study|Adverse Event|0|||
105782857|NCT02557308|364858015|FG005|Overall Study|Adverse Event|0|||
105782858|NCT02557308|364858016|FG006|Overall Study|Adverse Event|4|||
105782859|NCT02557308|364858017|FG007|Overall Study|Adverse Event|1|||
105782860|NCT02557308|364858010|FG000|Overall Study|Lost to Follow-up|2|||
105782861|NCT02557308|364858011|FG001|Overall Study|Lost to Follow-up|0|||
105782862|NCT02557308|364858012|FG002|Overall Study|Lost to Follow-up|1|||
105782863|NCT02557308|364858013|FG003|Overall Study|Lost to Follow-up|0|||
105782864|NCT02557308|364858014|FG004|Overall Study|Lost to Follow-up|0|||
105782865|NCT02557308|364858015|FG005|Overall Study|Lost to Follow-up|0|||
105782866|NCT02557308|364858016|FG006|Overall Study|Lost to Follow-up|2|||
105782867|NCT02557308|364858017|FG007|Overall Study|Lost to Follow-up|0|||
105782868|NCT02557308|364858010|FG000|Overall Study|Death|1|||
105782869|NCT02557308|364858011|FG001|Overall Study|Death|0|||
105782870|NCT02557308|364858012|FG002|Overall Study|Death|0|||
105782871|NCT02557308|364858013|FG003|Overall Study|Death|0|||
105782872|NCT02557308|364858014|FG004|Overall Study|Death|0|||
105782873|NCT02557308|364858015|FG005|Overall Study|Death|0|||
105782874|NCT02557308|364858016|FG006|Overall Study|Death|0|||
105782875|NCT02557308|364858017|FG007|Overall Study|Death|0|||
105782876|NCT02557308|364858010|FG000|Overall Study|Study Close|98|||
105782877|NCT02557308|364858011|FG001|Overall Study|Study Close|18|||
105782878|NCT02557308|364858012|FG002|Overall Study|Study Close|5|||
105782879|NCT02557308|364858013|FG003|Overall Study|Study Close|3|||
105782880|NCT02557308|364858014|FG004|Overall Study|Study Close|1|||
105782881|NCT02557308|364858015|FG005|Overall Study|Study Close|0|||
105782882|NCT02557308|364858016|FG006|Overall Study|Study Close|123|||
105782883|NCT02557308|364858017|FG007|Overall Study|Study Close|5|||
105782884|NCT02557308|364858010|FG000|Overall Study|Except for study close|5|||
105782885|NCT02557308|364858011|FG001|Overall Study|Except for study close|0|||
105782886|NCT02557308|364858012|FG002|Overall Study|Except for study close|0|||
105782887|NCT02557308|364858013|FG003|Overall Study|Except for study close|0|||
105782888|NCT02557308|364858014|FG004|Overall Study|Except for study close|3|||
105782889|NCT02557308|364858015|FG005|Overall Study|Except for study close|0|||
105782890|NCT02557308|364858016|FG006|Overall Study|Except for study close|6|||
105782891|NCT02557308|364858017|FG007|Overall Study|Except for study close|10|||
105782892|NCT03380091|364858018|FG000|Overall Study|Withdrawal by Subject|2|||
105782893|NCT03380091|364858019|FG001|Overall Study|Withdrawal by Subject|1|||
105782894|NCT02918968|364858020|FG000|1st Line AAT|Progressive disease|9|||
105782895|NCT02918968|364858021|FG001|1st Line AAT|Progressive disease|4|||
105782896|NCT02918968|364858020|FG000|1st Line AAT|Adverse Event|12|||
105782897|NCT02918968|364858021|FG001|1st Line AAT|Adverse Event|3|||
105782898|NCT02918968|364858020|FG000|1st Line AAT|Physician Decision|4|||
105782899|NCT02918968|364858021|FG001|1st Line AAT|Physician Decision|2|||
105782900|NCT02918968|364858020|FG000|1st Line AAT|Withdrawal by Subject|2|||
105782901|NCT02918968|364858021|FG001|1st Line AAT|Withdrawal by Subject|1|||
105782902|NCT02918968|364858020|FG000|1st Line AAT|Lost to Follow-up|0|||
105782903|NCT02918968|364858021|FG001|1st Line AAT|Lost to Follow-up|1|||
105782904|NCT02918968|364858020|FG000|1st Line AAT|Death|1|||
105782905|NCT02918968|364858021|FG001|1st Line AAT|Death|0|||
105782906|NCT02918968|364858020|FG000|1st Line AAT|Miscellaneous|1|||
105782907|NCT02918968|364858021|FG001|1st Line AAT|Miscellaneous|0|||
105782908|NCT02918968|364858020|FG000|2nd Line AAT|Progressive disease|21|||
105782909|NCT02918968|364858021|FG001|2nd Line AAT|Progressive disease|3|||
105782910|NCT02918968|364858020|FG000|2nd Line AAT|Adverse Event|2|||
105782911|NCT02918968|364858021|FG001|2nd Line AAT|Adverse Event|5|||
105782912|NCT02918968|364858020|FG000|2nd Line AAT|Physician Decision|0|||
105782913|NCT02918968|364858021|FG001|2nd Line AAT|Physician Decision|1|||
105782914|NCT02918968|364858020|FG000|2nd Line AAT|Withdrawal by Subject|2|||
105782915|NCT02918968|364858021|FG001|2nd Line AAT|Withdrawal by Subject|2|||
105782916|NCT02918968|364858020|FG000|2nd Line AAT|Death|0|||
105782917|NCT02918968|364858021|FG001|2nd Line AAT|Death|1|||
105782918|NCT00265109|364858033|FG000|Overall Study|Withdrawal by Subject|5|||
105782919|NCT00265109|364858033|FG000|Overall Study|Adverse Event|1|||
105782920|NCT02463097|364858034|FG000|Overall Study|Withdrawal by Subject|1|||
105782921|NCT01177943|364858035|FG000|First Intervention|Withdrawal by Subject|2|||
105782922|NCT01177943|364858036|FG001|First Intervention|Withdrawal by Subject|0|||
105782923|NCT01757821|364858037|FG000|Overall Study|Adverse Event|1|||
105782924|NCT04652245|364858038|FG000|Wash-Out Period|Adverse Event|0|||
105782925|NCT04652245|364858039|FG001|Wash-Out Period|Adverse Event|2|||
105782926|NCT04652245|364858038|FG000|Wash-Out Period|Withdrawal by Subject|0|||
105782927|NCT04652245|364858039|FG001|Wash-Out Period|Withdrawal by Subject|2|||
105782928|NCT00764465|364858042|FG000|Overall Study|Adverse Event|2|||
105782929|NCT00764465|364858043|FG001|Overall Study|Adverse Event|0|||
105782930|NCT00764465|364858044|FG002|Overall Study|Adverse Event|0|||
105782931|NCT00764465|364858045|FG003|Overall Study|Adverse Event|1|||
105782932|NCT00764465|364858046|FG004|Overall Study|Adverse Event|1|||
105782933|NCT00764465|364858047|FG005|Overall Study|Adverse Event|1|||
105782934|NCT00764465|364858042|FG000|Overall Study|Withdrawal by Subject|0|||
106108181|NCT01939548|366049700|FG000|Overall Study|Insufficient Clinical Response|1|||
106108182|NCT01939548|366049701|FG001|Overall Study|Insufficient Clinical Response|0|||
106108183|NCT01939548|366049702|FG002|Overall Study|Insufficient Clinical Response|0|||
106108184|NCT01939548|366049700|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
106108185|NCT01939548|366049701|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
106108186|NCT01939548|366049702|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
106108187|NCT01939548|366049700|FG000|Overall Study|Withdrawal by Subject|4|||
106108188|NCT01939548|366049701|FG001|Overall Study|Withdrawal by Subject|4|||
106108189|NCT01939548|366049702|FG002|Overall Study|Withdrawal by Subject|1|||
106108190|NCT01939548|366049700|FG000|Overall Study|Protocol Violation|7|||
106108191|NCT01939548|366049701|FG001|Overall Study|Protocol Violation|6|||
106108192|NCT01939548|366049702|FG002|Overall Study|Protocol Violation|5|||
106108193|NCT01939548|366049700|FG000|Overall Study|Lost to Follow-up|5|||
106108194|NCT01939548|366049701|FG001|Overall Study|Lost to Follow-up|5|||
106108195|NCT01939548|366049702|FG002|Overall Study|Lost to Follow-up|3|||
106108196|NCT01939548|366049700|FG000|Overall Study|Adverse Event|2|||
106108197|NCT01939548|366049701|FG001|Overall Study|Adverse Event|9|||
106108198|NCT01939548|366049702|FG002|Overall Study|Adverse Event|7|||
106108199|NCT01939548|366049700|FG000|Overall Study|Death|0|||
106108200|NCT01939548|366049701|FG001|Overall Study|Death|0|||
106108201|NCT01939548|366049702|FG002|Overall Study|Death|1|||
106108202|NCT01939548|366049700|FG000|Overall Study|Participant dropped|0|||
106108203|NCT01939548|366049701|FG001|Overall Study|Participant dropped|0|||
106108204|NCT01939548|366049702|FG002|Overall Study|Participant dropped|1|||
106108205|NCT01939548|366049700|FG000|Overall Study|Participant unwilling to continue|0|||
106108206|NCT01939548|366049701|FG001|Overall Study|Participant unwilling to continue|1|||
106108207|NCT01939548|366049702|FG002|Overall Study|Participant unwilling to continue|0|||
106108208|NCT01939548|366049700|FG000|Overall Study|Participant withdrew consent|0|||
106108209|NCT01939548|366049701|FG001|Overall Study|Participant withdrew consent|2|||
106108210|NCT01939548|366049702|FG002|Overall Study|Participant withdrew consent|0|||
106108211|NCT01939548|366049700|FG000|Overall Study|Did not complete follow-up|0|||
106108212|NCT01939548|366049701|FG001|Overall Study|Did not complete follow-up|1|||
106108213|NCT01939548|366049702|FG002|Overall Study|Did not complete follow-up|0|||
106108214|NCT01563536|366049703|FG000|Overall Study|Withdrawal by Subject|0|||
106108215|NCT01563536|366049704|FG001|Overall Study|Withdrawal by Subject|2|||
105993632|NCT03712787|365636048|FG001|Overall Study|Lost to Follow-up|1|||
105993633|NCT03712787|365636049|FG002|Overall Study|Lost to Follow-up|2|||
105993634|NCT03712787|365636050|FG003|Overall Study|Lost to Follow-up|1|||
105993635|NCT03712787|365636047|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
105993636|NCT03712787|365636048|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
105993637|NCT03712787|365636049|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
105993638|NCT03712787|365636050|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
105993639|NCT03712787|365636047|FG000|Overall Study|COVID-19 Infection|0|||
105993640|NCT03712787|365636048|FG001|Overall Study|COVID-19 Infection|1|||
105993641|NCT03712787|365636049|FG002|Overall Study|COVID-19 Infection|0|||
105993642|NCT03712787|365636050|FG003|Overall Study|COVID-19 Infection|0|||
105782935|NCT00764465|364858043|FG001|Overall Study|Withdrawal by Subject|1|||
105993643|NCT03712787|365636047|FG000|Overall Study|Other, Not Specified|79|||
105993644|NCT03712787|365636048|FG001|Overall Study|Other, Not Specified|77|||
105993645|NCT03712787|365636049|FG002|Overall Study|Other, Not Specified|74|||
106108216|NCT01563536|366049703|FG000|Overall Study|Lost to Follow-up|1|||
105993646|NCT03712787|365636050|FG003|Overall Study|Other, Not Specified|78|||
105993647|NCT04794270|365636058|FG000|Period 1|Non Compliance|1|||
105993648|NCT04794270|365636059|FG001|Period 1|Non Compliance|0|||
106108217|NCT01563536|366049704|FG001|Overall Study|Lost to Follow-up|0|||
105782936|NCT00764465|364858044|FG002|Overall Study|Withdrawal by Subject|1|||
105782937|NCT00764465|364858045|FG003|Overall Study|Withdrawal by Subject|0|||
105782938|NCT00764465|364858046|FG004|Overall Study|Withdrawal by Subject|0|||
105782939|NCT00764465|364858047|FG005|Overall Study|Withdrawal by Subject|0|||
105806509|NCT03038113|364949003|FG003|Overall Study|Withdrawal by Subject|0|||
105993649|NCT04794270|365636058|FG000|Period 1|Adverse Event|1|||
105993650|NCT04794270|365636059|FG001|Period 1|Adverse Event|0|||
105993651|NCT04794270|365636058|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
106108218|NCT00450411|366049706|FG000|Overall Study|Protocol Violation|6|||
105782940|NCT03457701|364858048|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
105782941|NCT03457701|364858049|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
105782942|NCT03457701|364858048|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
105782943|NCT03457701|364858049|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
105782944|NCT05664672|364858050|FG000|Overall Study|Adverse Event|0|||
105782945|NCT05664672|364858051|FG001|Overall Study|Adverse Event|0|||
105782946|NCT05664672|364858052|FG002|Overall Study|Adverse Event|0|||
105782947|NCT05664672|364858053|FG003|Overall Study|Adverse Event|0|||
105782948|NCT05664672|364858054|FG004|Overall Study|Adverse Event|0|||
105782949|NCT05664672|364858055|FG005|Overall Study|Adverse Event|1|||
105782950|NCT05664672|364858050|FG000|Overall Study|Withdrawal by Subject|0|||
105782951|NCT05664672|364858051|FG001|Overall Study|Withdrawal by Subject|1|||
105782952|NCT05664672|364858052|FG002|Overall Study|Withdrawal by Subject|3|||
105782953|NCT05664672|364858053|FG003|Overall Study|Withdrawal by Subject|0|||
105782954|NCT05664672|364858054|FG004|Overall Study|Withdrawal by Subject|5|||
105782955|NCT05664672|364858055|FG005|Overall Study|Withdrawal by Subject|6|||
105782956|NCT05664672|364858050|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
105782957|NCT05664672|364858051|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
105782958|NCT05664672|364858052|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
105782959|NCT05664672|364858053|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
105782960|NCT05664672|364858054|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
105782961|NCT05664672|364858055|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
105782962|NCT05664672|364858050|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
105782963|NCT05664672|364858051|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782964|NCT05664672|364858052|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782965|NCT05664672|364858053|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782966|NCT05664672|364858054|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782967|NCT05664672|364858055|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
105782968|NCT01000311|364858058|FG000|Overall Study|Adverse Event|2|||
105782969|NCT01000311|364858059|FG001|Overall Study|Adverse Event|5|||
105782970|NCT01000311|364858058|FG000|Overall Study|Withdrawal by Subject|16|||
105782971|NCT01000311|364858059|FG001|Overall Study|Withdrawal by Subject|24|||
105782972|NCT01000311|364858058|FG000|Overall Study|Lost to Follow-up|15|||
105782973|NCT01000311|364858059|FG001|Overall Study|Lost to Follow-up|24|||
105782974|NCT01000311|364858058|FG000|Overall Study|Protocol Violation|1|||
105782975|NCT01000311|364858059|FG001|Overall Study|Protocol Violation|2|||
105782976|NCT01000311|364858058|FG000|Overall Study|Inappropriate enrollment|2|||
105782977|NCT01000311|364858059|FG001|Overall Study|Inappropriate enrollment|0|||
105782978|NCT01000311|364858058|FG000|Overall Study|Administrative reason|9|||
105782979|NCT01000311|364858059|FG001|Overall Study|Administrative reason|15|||
105782980|NCT02815670|364858060|FG000|Overall Study|Prematurely discontinued of the trial|1|||
105782981|NCT01314261|364858065|FG000|Overall Study|Adverse Event|1|||
105782982|NCT01314261|364858066|FG001|Overall Study|Adverse Event|0|||
105782983|NCT01314261|364858067|FG002|Overall Study|Adverse Event|0|||
105782984|NCT01314261|364858068|FG003|Overall Study|Adverse Event|0|||
105782985|NCT01314261|364858065|FG000|Overall Study|Withdrawal by Subject|0|||
105782986|NCT01314261|364858066|FG001|Overall Study|Withdrawal by Subject|3|||
105782987|NCT01314261|364858067|FG002|Overall Study|Withdrawal by Subject|1|||
105782988|NCT01314261|364858068|FG003|Overall Study|Withdrawal by Subject|0|||
105782989|NCT01314261|364858065|FG000|Overall Study|Lost to Follow-up|1|||
105782990|NCT01314261|364858066|FG001|Overall Study|Lost to Follow-up|0|||
105782991|NCT01314261|364858067|FG002|Overall Study|Lost to Follow-up|2|||
105782992|NCT01314261|364858068|FG003|Overall Study|Lost to Follow-up|2|||
105782993|NCT01314261|364858065|FG000|Overall Study|Virologic Failure|0|||
105782994|NCT01314261|364858066|FG001|Overall Study|Virologic Failure|1|||
105782995|NCT01314261|364858067|FG002|Overall Study|Virologic Failure|0|||
105782996|NCT01314261|364858068|FG003|Overall Study|Virologic Failure|1|||
105782997|NCT04524507|364858069|FG000|Overall Study|Lost to Follow-up|2|||
105782998|NCT04524507|364858070|FG001|Overall Study|Lost to Follow-up|4|||
105782999|NCT04524507|364858069|FG000|Overall Study|Withdrawal by Subject|2|||
105783000|NCT04524507|364858070|FG001|Overall Study|Withdrawal by Subject|9|||
105783001|NCT04524507|364858069|FG000|Overall Study|Death|2|||
105783002|NCT04524507|364858070|FG001|Overall Study|Death|10|||
105783003|NCT00412360|364858071|FG000|Overall Study|Lost to Follow-up|0|||
105783004|NCT00412360|364858072|FG001|Overall Study|Lost to Follow-up|1|||
105783005|NCT00412360|364858071|FG000|Overall Study|Not Transplanted|1|||
105783006|NCT00412360|364858072|FG001|Overall Study|Not Transplanted|2|||
105783007|NCT02711306|364858074|FG000|Overall Study|Withdrawal by Subject|2|||
105783008|NCT02711306|364858075|FG001|Overall Study|Withdrawal by Subject|2|||
105783009|NCT03655951|364858077|FG000|Overall Study|Lost to Follow-up|39|||
105783010|NCT03655951|364858078|FG001|Overall Study|Lost to Follow-up|20|||
105783011|NCT03655951|364858077|FG000|Overall Study|Withdrawal by Subject|0|||
105993652|NCT04794270|365636059|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
105783012|NCT03655951|364858078|FG001|Overall Study|Withdrawal by Subject|1|||
106108219|NCT00450411|366049706|FG000|Overall Study|No protocol treatment|2|||
106108220|NCT00344461|366049707|FG000|Overall Study|Adverse Event|6|||
106108221|NCT00344461|366049707|FG000|Overall Study|Death|1|||
106108222|NCT00344461|366049707|FG000|Overall Study|Lack of Efficacy|2|||
106108223|NCT00344461|366049707|FG000|Overall Study|Lost to Follow-up|2|||
106108224|NCT00344461|366049707|FG000|Overall Study|Physician Decision|2|||
106108225|NCT00344461|366049707|FG000|Overall Study|Protocol Violation|6|||
106108226|NCT00344461|366049707|FG000|Overall Study|Withdrawal by Subject|2|||
106108227|NCT00636610|366049708|FG000|Overall Study|Adverse Event|4|||
105783013|NCT01233076|364859440|FG000|Period 2, One Week|Lost to Follow-up|1|||
106108228|NCT00636610|366049709|FG001|Overall Study|Adverse Event|4|||
106108229|NCT00636610|366049708|FG000|Overall Study|Death|6|||
106108230|NCT00636610|366049709|FG001|Overall Study|Death|3|||
106108231|NCT00636610|366049708|FG000|Overall Study|Physician decision to withdraw patient|15|||
106108232|NCT00636610|366049709|FG001|Overall Study|Physician decision to withdraw patient|9|||
106108233|NCT00636610|366049708|FG000|Overall Study|Subject decision to withdraw|15|||
106108234|NCT00636610|366049709|FG001|Overall Study|Subject decision to withdraw|11|||
106108235|NCT00636610|366049708|FG000|Overall Study|Disease progression - radiographic|41|||
106108236|NCT00636610|366049709|FG001|Overall Study|Disease progression - radiographic|51|||
106108237|NCT00636610|366049708|FG000|Overall Study|Disease progression - clinical|8|||
106108238|NCT00636610|366049709|FG001|Overall Study|Disease progression - clinical|3|||
106108239|NCT00636610|366049708|FG000|Overall Study|Reason for discontinuation not available|3|||
106108240|NCT00636610|366049709|FG001|Overall Study|Reason for discontinuation not available|2|||
106108241|NCT00313820|366049711|FG000|Assigned to Treatment|Other|1|||
106108242|NCT00313820|366049712|FG001|Assigned to Treatment|Other|0|||
106108243|NCT00313820|366049711|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
106108244|NCT00313820|366049712|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
106108245|NCT00313820|366049711|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
105783014|NCT01233076|364859441|FG001|Period 2, One Week|Lost to Follow-up|0|||
105783015|NCT01674010|364859442|FG000|Open Treatment Phase 1|Adverse Event|10|||
105783016|NCT01674010|364859443|FG001|Open Treatment Phase 1|Adverse Event|0|||
105783017|NCT01674010|364859444|FG002|Open Treatment Phase 1|Adverse Event|0|||
105783018|NCT01674010|364859442|FG000|Open Treatment Phase 1|Death|1|||
105783019|NCT01674010|364859443|FG001|Open Treatment Phase 1|Death|0|||
105783020|NCT01674010|364859444|FG002|Open Treatment Phase 1|Death|0|||
105783021|NCT01674010|364859442|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
105783022|NCT01674010|364859443|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
105783023|NCT01674010|364859444|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
105783024|NCT01674010|364859442|FG000|Open Treatment Phase 1|Physician Decision|9|||
105783025|NCT01674010|364859443|FG001|Open Treatment Phase 1|Physician Decision|0|||
105783026|NCT01674010|364859444|FG002|Open Treatment Phase 1|Physician Decision|0|||
105783027|NCT01674010|364859442|FG000|Open Treatment Phase 1|Protocol Violation|7|||
105783028|NCT01674010|364859443|FG001|Open Treatment Phase 1|Protocol Violation|0|||
105783029|NCT01674010|364859444|FG002|Open Treatment Phase 1|Protocol Violation|0|||
105783030|NCT01674010|364859442|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
105783031|NCT01674010|364859443|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
105783032|NCT01674010|364859444|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
105783033|NCT01674010|364859442|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
105783034|NCT01674010|364859443|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
105783035|NCT01674010|364859444|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
105783036|NCT01674010|364859442|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
105783037|NCT01674010|364859443|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
105783038|NCT01674010|364859444|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
105783039|NCT01674010|364859442|FG000|Randomization Phase 2|Adverse Event|0|||
105783040|NCT01674010|364859443|FG001|Randomization Phase 2|Adverse Event|1|||
105783041|NCT01674010|364859444|FG002|Randomization Phase 2|Adverse Event|1|||
105783042|NCT01674010|364859442|FG000|Randomization Phase 2|Lost to Follow-up|0|||
105783043|NCT01674010|364859443|FG001|Randomization Phase 2|Lost to Follow-up|1|||
105783044|NCT01674010|364859444|FG002|Randomization Phase 2|Lost to Follow-up|2|||
105783045|NCT01674010|364859442|FG000|Randomization Phase 2|Mood episode recurrence|0|||
105783046|NCT01674010|364859443|FG001|Randomization Phase 2|Mood episode recurrence|8|||
105783047|NCT01674010|364859444|FG002|Randomization Phase 2|Mood episode recurrence|2|||
105783048|NCT01674010|364859442|FG000|Randomization Phase 2|Physician Decision|0|||
105783049|NCT01674010|364859443|FG001|Randomization Phase 2|Physician Decision|0|||
105783050|NCT01674010|364859444|FG002|Randomization Phase 2|Physician Decision|2|||
105783051|NCT01674010|364859442|FG000|Randomization Phase 2|Pregnancy|0|||
105783052|NCT01674010|364859443|FG001|Randomization Phase 2|Pregnancy|1|||
105783053|NCT01674010|364859444|FG002|Randomization Phase 2|Pregnancy|1|||
105783054|NCT01674010|364859442|FG000|Randomization Phase 2|Protocol Violation|0|||
105783055|NCT01674010|364859443|FG001|Randomization Phase 2|Protocol Violation|1|||
105783056|NCT01674010|364859444|FG002|Randomization Phase 2|Protocol Violation|1|||
106108246|NCT00313820|366049712|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
105783057|NCT01674010|364859442|FG000|Randomization Phase 2|Sponsor Decision|0|||
105783058|NCT01674010|364859443|FG001|Randomization Phase 2|Sponsor Decision|42|||
105993653|NCT02679755|365636060|FG000|Overall Study|Death|0|||
105993654|NCT02679755|365636061|FG001|Overall Study|Death|3|||
105993655|NCT02679755|365636060|FG000|Overall Study|Global deterioration of health status|1|||
105993656|NCT02679755|365636061|FG001|Overall Study|Global deterioration of health status|8|||
105993657|NCT02679755|365636060|FG000|Overall Study|Lost to Follow-up|1|||
105993658|NCT02679755|365636061|FG001|Overall Study|Lost to Follow-up|0|||
105993659|NCT02679755|365636060|FG000|Overall Study|Objective progression or relapse|24|||
105993660|NCT02679755|365636061|FG001|Overall Study|Objective progression or relapse|83|||
105993661|NCT02679755|365636060|FG000|Overall Study|Not defined|0|||
105993662|NCT02679755|365636061|FG001|Overall Study|Not defined|2|||
105993663|NCT02679755|365636060|FG000|Overall Study|Withdrawal by participant|6|||
105993664|NCT02679755|365636061|FG001|Overall Study|Withdrawal by participant|3|||
105993665|NCT02679755|365636060|FG000|Overall Study|Adverse Event|1|||
106108247|NCT00313820|366049711|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
106108248|NCT00313820|366049712|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
106108249|NCT00313820|366049711|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
106108250|NCT00313820|366049712|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
106108251|NCT00313820|366049711|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
106108252|NCT00313820|366049712|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
106108253|NCT01515748|366049713|FG000|Overall Study|Withdrawal by Subject|32|||
106108254|NCT01515748|366049714|FG001|Overall Study|Withdrawal by Subject|41|||
105783059|NCT01674010|364859444|FG002|Randomization Phase 2|Sponsor Decision|45|||
105993666|NCT02679755|365636061|FG001|Overall Study|Adverse Event|4|||
105993667|NCT02679755|365636060|FG000|Overall Study|Adverse events not related to study drug|1|||
105993668|NCT02679755|365636061|FG001|Overall Study|Adverse events not related to study drug|2|||
105993669|NCT01061359|365636062|FG000|Overall Study|Death|32|||
105993670|NCT01061359|365636062|FG000|Overall Study|Lost to Follow-up|1072|||
105993671|NCT01061359|365636062|FG000|Overall Study|Relapse|187|||
105993672|NCT01061359|365636062|FG000|Overall Study|Secondary neoplasm|11|||
105993673|NCT03038126|365636063|FG000|Overall Study|Death|1|||
105993674|NCT03038126|365636064|FG001|Overall Study|Death|1|||
105993675|NCT03038126|365636063|FG000|Overall Study|Withdrawal by Subject|5|||
105993676|NCT03038126|365636064|FG001|Overall Study|Withdrawal by Subject|0|||
105993677|NCT03038126|365636063|FG000|Overall Study|Lost to Follow-up|0|||
105993678|NCT03038126|365636064|FG001|Overall Study|Lost to Follow-up|1|||
105993679|NCT03038126|365636063|FG000|Overall Study|Long Term Hospitalization|2|||
105993680|NCT03038126|365636064|FG001|Overall Study|Long Term Hospitalization|0|||
105783060|NCT01674010|364859442|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
105783061|NCT01674010|364859443|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
105783062|NCT01674010|364859444|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
105783063|NCT03159455|364859446|FG000|Overall Study|Adverse Event|0|||
105783064|NCT03159455|364859447|FG001|Overall Study|Adverse Event|0|||
105783065|NCT03159455|364859448|FG002|Overall Study|Adverse Event|0|||
105783066|NCT03159455|364859449|FG003|Overall Study|Adverse Event|0|||
105783067|NCT03159455|364859450|FG004|Overall Study|Adverse Event|0|||
105783068|NCT03159455|364859451|FG005|Overall Study|Adverse Event|1|||
105783069|NCT02058940|364859454|FG000|Overall Study|Discharged from Critical Care Unit|1|||
105783070|NCT02713490|364859455|FG000|Overall Study|Withdrawal by Subject|2|||
105783071|NCT02713490|364859456|FG001|Overall Study|Withdrawal by Subject|1|||
105783072|NCT02713490|364859455|FG000|Overall Study|Did not receive study drug|1|||
105783073|NCT02713490|364859456|FG001|Overall Study|Did not receive study drug|0|||
105783074|NCT02713490|364859455|FG000|Overall Study|Met exclusion criteria|0|||
105783075|NCT02713490|364859456|FG001|Overall Study|Met exclusion criteria|1|||
105783076|NCT02985541|364859464|FG000|Overall Study|Withdrawal by Subject|33|||
105783077|NCT02985541|364859464|FG000|Overall Study|Lost to Follow-up|26|||
105783078|NCT02985541|364859464|FG000|Overall Study|Adverse Event|27|||
105783079|NCT02985541|364859464|FG000|Overall Study|Physician Decision|2|||
105783080|NCT02985541|364859464|FG000|Overall Study|Pregnancy|2|||
105783081|NCT02985541|364859464|FG000|Overall Study|Wish for pregnancy|44|||
105783082|NCT02985541|364859464|FG000|Overall Study|Other reason|5|||
105783083|NCT02985541|364859464|FG000|Overall Study|Not valid for analysis|2|||
105783084|NCT04120116|364859472|FG000|Overall Study|Lost to Follow-up|0|||
105783085|NCT04120116|364859473|FG001|Overall Study|Lost to Follow-up|1|||
105783086|NCT04120116|364859474|FG002|Overall Study|Lost to Follow-up|0|||
105783087|NCT04120116|364859475|FG003|Overall Study|Lost to Follow-up|2|||
105783088|NCT04120116|364859472|FG000|Overall Study|Withdrawal by Subject|1|||
105783089|NCT04120116|364859473|FG001|Overall Study|Withdrawal by Subject|0|||
105783090|NCT04120116|364859474|FG002|Overall Study|Withdrawal by Subject|1|||
105783091|NCT04120116|364859475|FG003|Overall Study|Withdrawal by Subject|1|||
105783092|NCT04120116|364859472|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
105783093|NCT04120116|364859473|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
105993681|NCT03038126|365636063|FG000|Overall Study|Too Ill to Participate|1|||
105993682|NCT03038126|365636064|FG001|Overall Study|Too Ill to Participate|2|||
105993683|NCT02610777|365636065|FG000|Overall Study|Lost to Follow-up|1|||
105993684|NCT02610777|365636066|FG001|Overall Study|Lost to Follow-up|0|||
106108255|NCT01515748|366049713|FG000|Overall Study|Lost to Follow-up|2|||
106108256|NCT01515748|366049714|FG001|Overall Study|Lost to Follow-up|4|||
106108257|NCT01515748|366049713|FG000|Overall Study|Other than specified above|5|||
106108258|NCT01515748|366049714|FG001|Overall Study|Other than specified above|10|||
105783094|NCT04120116|364859474|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
106108259|NCT03221387|366049717|FG000|Overall Study|Lost to Follow-up|1|||
106108260|NCT03221387|366049717|FG000|Overall Study|Lung transplant|1|||
106108261|NCT03260868|366049718|FG000|Overall Study|Poor Compliance to Protocol|0|||
106108262|NCT03260868|366049719|FG001|Overall Study|Poor Compliance to Protocol|2|||
106108263|NCT03260868|366049718|FG000|Overall Study|Study Terminated By Sponsor|2|||
106108264|NCT03260868|366049719|FG001|Overall Study|Study Terminated By Sponsor|1|||
106108265|NCT03260868|366049718|FG000|Overall Study|Other than specified above|1|||
106108266|NCT03260868|366049719|FG001|Overall Study|Other than specified above|0|||
106108267|NCT04839965|366049720|FG000|Overall Study|Death|6|||
106108268|NCT04839965|366049721|FG001|Overall Study|Death|6|||
106108269|NCT04839965|366049720|FG000|Overall Study|Lost to Follow-up|1|||
106108270|NCT04839965|366049721|FG001|Overall Study|Lost to Follow-up|0|||
106108271|NCT00981084|366049722|FG000|Post Intervention (Data Analysis)|poor effort|1|||
106108272|NCT00981084|366049723|FG001|Post Intervention (Data Analysis)|poor effort|1|||
106108273|NCT00981084|366049722|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
106108274|NCT00981084|366049723|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
106108275|NCT02048072|366049724|FG000|Overall Study|Adverse Event|3|||
106108276|NCT02048072|366049724|FG000|Overall Study|Lost to Follow-up|1|||
106108277|NCT02276222|366049725|FG000|Overall Study|Adverse Event|62|||
106108278|NCT02276222|366049726|FG001|Overall Study|Adverse Event|11|||
106108279|NCT02276222|366049725|FG000|Overall Study|Death|3|||
106108280|NCT02276222|366049726|FG001|Overall Study|Death|4|||
106108281|NCT02276222|366049725|FG000|Overall Study|Lack of Efficacy|13|||
106108282|NCT02276222|366049726|FG001|Overall Study|Lack of Efficacy|3|||
106108283|NCT02276222|366049725|FG000|Overall Study|Protocol Violation|3|||
106108284|NCT02276222|366049726|FG001|Overall Study|Protocol Violation|2|||
106108285|NCT02276222|366049725|FG000|Overall Study|Withdrawal by Subject|79|||
106108286|NCT02276222|366049726|FG001|Overall Study|Withdrawal by Subject|33|||
106108287|NCT02276222|366049725|FG000|Overall Study|non compliance with study medication|6|||
106108288|NCT02276222|366049726|FG001|Overall Study|non compliance with study medication|2|||
106108289|NCT02276222|366049725|FG000|Overall Study|sponsor decision|0|||
106108290|NCT02276222|366049726|FG001|Overall Study|sponsor decision|3|||
106108291|NCT02276222|366049725|FG000|Overall Study|Lost to Follow-up|15|||
106108292|NCT02276222|366049726|FG001|Overall Study|Lost to Follow-up|5|||
106108293|NCT02276222|366049725|FG000|Overall Study|Physician Decision|2|||
106108294|NCT02276222|366049726|FG001|Overall Study|Physician Decision|1|||
106108295|NCT02276222|366049725|FG000|Overall Study|sheduling conflict|1|||
106108296|NCT02276222|366049726|FG001|Overall Study|sheduling conflict|0|||
105661742|NCT04147858|364425117|FG001|Overall Study|Subject Noncompliance, Other|3|||
105783095|NCT04120116|364859475|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
105783096|NCT03410693|364859476|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
105783097|NCT03410693|364859477|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
105783098|NCT03410693|364859476|FG000|Overall Study|Disc trt: Lost to follow up|0|||
105783099|NCT03410693|364859477|FG001|Overall Study|Disc trt: Lost to follow up|1|||
105783100|NCT03410693|364859476|FG000|Overall Study|Disc trt: radiological progression|58|||
105783101|NCT03410693|364859477|FG001|Overall Study|Disc trt: radiological progression|50|||
105783102|NCT03410693|364859476|FG000|Overall Study|Disc trt: Other|1|||
105783103|NCT03410693|364859477|FG001|Overall Study|Disc trt: Other|0|||
105783104|NCT03410693|364859476|FG000|Overall Study|Study drug never administered|1|||
105783105|NCT03410693|364859477|FG001|Overall Study|Study drug never administered|6|||
105783106|NCT03410693|364859476|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
105783107|NCT03410693|364859477|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
105783108|NCT03410693|364859476|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
105783109|NCT03410693|364859477|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
105783110|NCT03410693|364859476|FG000|Overall Study|Disc trt: Physician decision|0|||
105783111|NCT03410693|364859477|FG001|Overall Study|Disc trt: Physician decision|5|||
105783112|NCT03410693|364859476|FG000|Overall Study|Disc trt: clinical progression|1|||
105783113|NCT03410693|364859477|FG001|Overall Study|Disc trt: clinical progression|5|||
105783114|NCT03410693|364859476|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
105783115|NCT03410693|364859477|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
105783116|NCT01789476|364859478|FG000|Overall Study|Lack of Efficacy|6|||
105783117|NCT01789476|364859479|FG001|Overall Study|Lack of Efficacy|2|||
105783118|NCT01789476|364859478|FG000|Overall Study|Adverse Event|1|||
105783119|NCT01789476|364859479|FG001|Overall Study|Adverse Event|0|||
105783120|NCT01789476|364859478|FG000|Overall Study|Unable to get IV access|1|||
105783121|NCT01789476|364859479|FG001|Overall Study|Unable to get IV access|0|||
105783122|NCT00501969|364859480|FG000|Overall Study|Major Protocol Violation|4|||
105783123|NCT00501969|364859480|FG000|Overall Study|Lack of Efficacy|29|||
105783124|NCT00501969|364859480|FG000|Overall Study|Adverse Event|76|||
106108297|NCT02276222|366049725|FG000|Overall Study|subject withdrew after randomization|1|||
106108298|NCT02276222|366049726|FG001|Overall Study|subject withdrew after randomization|0|||
106108299|NCT04102579|366049727|FG000|Overall Study|Withdrawal by Subject|3|||
106108300|NCT04102579|366049728|FG001|Overall Study|Withdrawal by Subject|4|||
106108301|NCT04102579|366049727|FG000|Overall Study|Lost to Follow-up|0|||
106108302|NCT04102579|366049728|FG001|Overall Study|Lost to Follow-up|1|||
106108303|NCT04102579|366049727|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
106108304|NCT04102579|366049728|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
106108305|NCT04102579|366049727|FG000|Overall Study|Other than Specified|1|||
106108306|NCT04102579|366049728|FG001|Overall Study|Other than Specified|0|||
106108307|NCT04102579|366049727|FG000|Overall Study|Not Dosed with Study Drug|0|||
106108308|NCT04102579|366049728|FG001|Overall Study|Not Dosed with Study Drug|1|||
106108309|NCT05899686|366049729|FG000|Overall Study|Protocol Violation|1|||
106108310|NCT03645759|366049730|FG000|Overall Study|Lost to Follow-up|3|||
106108311|NCT03645759|366049731|FG001|Overall Study|Lost to Follow-up|2|||
106108312|NCT02412137|366049732|FG000|Overall Study|Withdrawal by Subject|2|||
106108313|NCT02412137|366049733|FG001|Overall Study|Withdrawal by Subject|0|||
106108314|NCT02412137|366049732|FG000|Overall Study|Lost to Follow-up|21|||
106108315|NCT02412137|366049733|FG001|Overall Study|Lost to Follow-up|14|||
106108316|NCT02412137|366049732|FG000|Overall Study|Physician Decision|28|||
106108317|NCT02412137|366049733|FG001|Overall Study|Physician Decision|9|||
106108318|NCT04981678|366049740|FG000|Overall Study|Lost to Follow-up|0|||
106108319|NCT04981678|366049741|FG001|Overall Study|Lost to Follow-up|1|||
106108320|NCT03355326|366049742|FG000|Overall Study|Protocol Violation|3|||
105783125|NCT00501969|364859480|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
105783126|NCT00501969|364859480|FG000|Overall Study|Subject withdrew consent|51|||
105783127|NCT00501969|364859480|FG000|Overall Study|Lost to Follow-up|4|||
105783128|NCT00501969|364859480|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
105783129|NCT00501969|364859480|FG000|Overall Study|Other: Sponsors Request|10|||
105783130|NCT00501969|364859480|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
105783131|NCT00501969|364859480|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
105783132|NCT00501969|364859480|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
105783133|NCT00501969|364859480|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
105783134|NCT00501969|364859480|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
105783135|NCT00501969|364859480|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
105783136|NCT00501969|364859480|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
105783137|NCT00501969|364859480|FG000|Overall Study|Other: As Required by Local EC|2|||
105783138|NCT00501969|364859480|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
105783139|NCT00501969|364859480|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
105783140|NCT00965458|364859483|FG000|Overall Study|Adverse Event|1|||
105783141|NCT00965458|364859484|FG001|Overall Study|Adverse Event|0|||
105783142|NCT00965458|364859483|FG000|Overall Study|Lost to Follow-up|1|||
105783143|NCT00965458|364859484|FG001|Overall Study|Lost to Follow-up|3|||
105783144|NCT00965458|364859483|FG000|Overall Study|Withdrawal by Subject|0|||
105783145|NCT00965458|364859484|FG001|Overall Study|Withdrawal by Subject|1|||
105783146|NCT00656669|364859485|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
105783147|NCT00656669|364859485|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
105783148|NCT00656669|364859485|FG000|AC (Cycles 6-9)|Adverse Event|1|||
105783149|NCT00656669|364859485|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
105783150|NCT00679042|364859491|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
105783151|NCT00679042|364859491|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
105783152|NCT00679042|364859491|FG000|5-Year Follow Up|Death|1|||
105783153|NCT00679042|364859491|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
105783154|NCT00679042|364859491|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
105783155|NCT04511533|364859494|FG000|Treatment|Other|2|||
105783156|NCT04511533|364859494|FG000|Treatment|Withdrawal by Subject|11|||
105783157|NCT04511533|364859494|FG000|Treatment|Death|5|||
105783158|NCT04511533|364859494|FG000|Treatment|Physician Decision|1|||
105783159|NCT04511533|364859494|FG000|Treatment|Progressive Disease|61|||
105783160|NCT04511533|364859494|FG000|Follow-Up|Other|7|||
105783161|NCT04511533|364859494|FG000|Follow-Up|Withdrawal by Subject|5|||
105783162|NCT04511533|364859494|FG000|Follow-Up|Lost to Follow-up|2|||
105783163|NCT04511533|364859494|FG000|Follow-Up|Death|4|||
105993685|NCT02610777|365636065|FG000|Overall Study|Site Terminated by Sponsor|9|||
106108321|NCT03355326|366049743|FG001|Overall Study|Protocol Violation|3|||
106108322|NCT03382782|366051172|FG000|Cohort 1|Withdrawal by Subject|11|||
106108323|NCT03382782|366051173|FG001|Cohort 1|Withdrawal by Subject|5|||
106108324|NCT03382782|366051174|FG002|Cohort 1|Withdrawal by Subject|0|||
105783164|NCT03382639|364859495|FG000|Overall Study|Adverse Event|2|||
105783165|NCT03382639|364859496|FG001|Overall Study|Adverse Event|0|||
105783166|NCT03382639|364859497|FG002|Overall Study|Adverse Event|1|||
105783167|NCT03382639|364859498|FG003|Overall Study|Adverse Event|1|||
105783168|NCT03382639|364859495|FG000|Overall Study|Lost to Follow-up|1|||
105783169|NCT03382639|364859496|FG001|Overall Study|Lost to Follow-up|0|||
105783170|NCT03382639|364859497|FG002|Overall Study|Lost to Follow-up|0|||
105783171|NCT03382639|364859498|FG003|Overall Study|Lost to Follow-up|0|||
106108325|NCT03382782|366051172|FG000|Cohort 2|Withdrawal by Subject|1|||
106108326|NCT03382782|366051173|FG001|Cohort 2|Withdrawal by Subject|1|||
106108327|NCT03382782|366051174|FG002|Cohort 2|Withdrawal by Subject|0|||
106108328|NCT03382782|366051172|FG000|Cohort 3|Withdrawal by Subject|1|||
106108329|NCT03382782|366051173|FG001|Cohort 3|Withdrawal by Subject|2|||
106108330|NCT03382782|366051174|FG002|Cohort 3|Withdrawal by Subject|0|||
106108331|NCT03320018|366051180|FG000|Treatment Period|Withdrawal by Subject|1|||
106108332|NCT03320018|366051181|FG001|Treatment Period|Withdrawal by Subject|0|||
106108333|NCT03320018|366051180|FG000|Day 90 Follow up|Death|0|||
106108334|NCT03320018|366051181|FG001|Day 90 Follow up|Death|1|||
106108335|NCT01699022|366051182|FG000|Overall Study|Early discontinuation from the study|3|||
106108336|NCT04721925|366051183|FG000|2-Month Assessment|Lost to Follow-up|5|||
106108337|NCT04721925|366051184|FG001|2-Month Assessment|Lost to Follow-up|3|||
106108338|NCT04721925|366051183|FG000|4-Month Assessment|Lost to Follow-up|3|||
106108339|NCT04721925|366051184|FG001|4-Month Assessment|Lost to Follow-up|6|||
106108340|NCT00929162|366051185|FG000|Overall Study|Adverse Event|8|||
106108341|NCT00929162|366051186|FG001|Overall Study|Adverse Event|5|||
106108342|NCT00929162|366051185|FG000|Overall Study|Withdrawal by Subject|3|||
106108343|NCT00929162|366051186|FG001|Overall Study|Withdrawal by Subject|1|||
106108344|NCT00929162|366051185|FG000|Overall Study|Protocol Violation|32|||
106108345|NCT00929162|366051186|FG001|Overall Study|Protocol Violation|30|||
106108346|NCT00929162|366051185|FG000|Overall Study|Other termination reason|5|||
106108347|NCT00929162|366051186|FG001|Overall Study|Other termination reason|6|||
106108348|NCT01362439|366051189|FG000|Overall Study|Adverse Event|1|||
106108349|NCT01362439|366051189|FG000|Overall Study|Lack of Efficacy|3|||
106108350|NCT01362439|366051189|FG000|Overall Study|Lost to Follow-up|2|||
106108351|NCT01362439|366051189|FG000|Overall Study|Study medication non-compliant|1|||
106108352|NCT01362439|366051189|FG000|Overall Study|Participant who withdrew consent|8|||
106108353|NCT00594854|366051191|FG000|Overall Study|Study terminated|7|||
106108354|NCT00594854|366051192|FG001|Overall Study|Study terminated|10|||
106108355|NCT04212091|366051193|FG000|Overall Study|Lost to Follow-up|0|||
106108356|NCT04212091|366051194|FG001|Overall Study|Lost to Follow-up|0|||
106108357|NCT04212091|366051195|FG002|Overall Study|Lost to Follow-up|0|||
106108358|NCT04212091|366051196|FG003|Overall Study|Lost to Follow-up|0|||
106108359|NCT04212091|366051197|FG004|Overall Study|Lost to Follow-up|1|||
106108360|NCT04212091|366051198|FG005|Overall Study|Lost to Follow-up|1|||
106108361|NCT04212091|366051193|FG000|Overall Study|Participant unable to adhere to visit|0|||
106108362|NCT04212091|366051194|FG001|Overall Study|Participant unable to adhere to visit|0|||
106108363|NCT04212091|366051195|FG002|Overall Study|Participant unable to adhere to visit|0|||
106108364|NCT04212091|366051196|FG003|Overall Study|Participant unable to adhere to visit|0|||
106108365|NCT04212091|366051197|FG004|Overall Study|Participant unable to adhere to visit|1|||
106108366|NCT04212091|366051198|FG005|Overall Study|Participant unable to adhere to visit|0|||
106108367|NCT02660827|366051202|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
106108368|NCT02660827|366051202|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
106108369|NCT02660827|366051202|FG000|From Study to End of Continued Access|Adverse Event|3|||
106108370|NCT02660827|366051202|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
106108371|NCT02660827|366051202|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
106108372|NCT02660827|366051202|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
106108373|NCT02660827|366051202|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
106108374|NCT02660827|366051202|FG000|Period 2: Continued Access Period|Adverse Event|3|||
106108375|NCT01812655|366051203|FG000|Overall Study|Protocol Violation|1|||
106108376|NCT01812655|366051204|FG001|Overall Study|Protocol Violation|1|||
106108377|NCT01812655|366051205|FG002|Overall Study|Protocol Violation|0|||
106108378|NCT01428076|366051207|FG000|Overall Study|Adverse Event|0|||
106108379|NCT01428076|366051208|FG001|Overall Study|Adverse Event|1|||
106108380|NCT02454101|366051209|FG000|Overall Study|Adverse Event|2|||
106108381|NCT02454101|366051210|FG001|Overall Study|Adverse Event|3|||
106108382|NCT02454101|366051209|FG000|Overall Study|Lost to Follow-up|3|||
106108383|NCT02454101|366051210|FG001|Overall Study|Lost to Follow-up|4|||
106108384|NCT02342886|366051211|FG000|Overall Study|Treatment non-compliance|1|||
106108385|NCT02342886|366051212|FG001|Overall Study|Treatment non-compliance|0|||
106108386|NCT02342886|366051213|FG002|Overall Study|Treatment non-compliance|0|||
106108387|NCT02342886|366051214|FG003|Overall Study|Treatment non-compliance|1|||
106108388|NCT02342886|366051215|FG004|Overall Study|Treatment non-compliance|0|||
106108389|NCT02342886|366051211|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
106108390|NCT02342886|366051212|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
106108391|NCT02342886|366051213|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
106108392|NCT02342886|366051214|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
106108393|NCT02342886|366051215|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
106108394|NCT02342886|366051211|FG000|Overall Study|Adverse event/specific toxicity|4|||
106108395|NCT02342886|366051212|FG001|Overall Study|Adverse event/specific toxicity|3|||
106108396|NCT02342886|366051213|FG002|Overall Study|Adverse event/specific toxicity|11|||
106108397|NCT02342886|366051214|FG003|Overall Study|Adverse event/specific toxicity|2|||
106108398|NCT02342886|366051215|FG004|Overall Study|Adverse event/specific toxicity|1|||
105783172|NCT03382639|364859495|FG000|Overall Study|Withdrawal by Subject|4|||
105993686|NCT02610777|365636066|FG001|Overall Study|Site Terminated by Sponsor|8|||
106108399|NCT02342886|366051211|FG000|Overall Study|Lost to Follow-up|1|||
106108400|NCT02342886|366051212|FG001|Overall Study|Lost to Follow-up|0|||
106108401|NCT02342886|366051213|FG002|Overall Study|Lost to Follow-up|0|||
106108402|NCT02342886|366051214|FG003|Overall Study|Lost to Follow-up|0|||
106108403|NCT02342886|366051215|FG004|Overall Study|Lost to Follow-up|0|||
106108404|NCT02342886|366051211|FG000|Overall Study|Death|1|||
106108405|NCT02342886|366051212|FG001|Overall Study|Death|2|||
106108406|NCT02342886|366051213|FG002|Overall Study|Death|1|||
106108407|NCT02342886|366051214|FG003|Overall Study|Death|0|||
106108408|NCT02342886|366051215|FG004|Overall Study|Death|1|||
106108409|NCT02342886|366051211|FG000|Overall Study|Withdrawal by Subject|0|||
106108410|NCT02342886|366051212|FG001|Overall Study|Withdrawal by Subject|1|||
106108411|NCT02342886|366051213|FG002|Overall Study|Withdrawal by Subject|0|||
106108412|NCT02342886|366051214|FG003|Overall Study|Withdrawal by Subject|1|||
106108413|NCT02342886|366051215|FG004|Overall Study|Withdrawal by Subject|0|||
106108414|NCT02342886|366051211|FG000|Overall Study|Investigator/sponsor decision|0|||
106108415|NCT02342886|366051212|FG001|Overall Study|Investigator/sponsor decision|2|||
106108416|NCT02342886|366051213|FG002|Overall Study|Investigator/sponsor decision|0|||
106108417|NCT02342886|366051214|FG003|Overall Study|Investigator/sponsor decision|3|||
106108418|NCT02342886|366051215|FG004|Overall Study|Investigator/sponsor decision|1|||
106108419|NCT02342886|366051211|FG000|Overall Study|Pregnancy|0|||
106108420|NCT02342886|366051212|FG001|Overall Study|Pregnancy|0|||
106108421|NCT02342886|366051213|FG002|Overall Study|Pregnancy|2|||
106108422|NCT02342886|366051214|FG003|Overall Study|Pregnancy|0|||
106108423|NCT02342886|366051215|FG004|Overall Study|Pregnancy|0|||
106108424|NCT02342886|366051211|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
106108425|NCT02342886|366051212|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
106108426|NCT02342886|366051213|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
106108427|NCT02342886|366051214|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
106108428|NCT02342886|366051215|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
106108429|NCT02342886|366051211|FG000|Overall Study|Protocol Violation|0|||
106108430|NCT02342886|366051212|FG001|Overall Study|Protocol Violation|0|||
106108431|NCT02342886|366051213|FG002|Overall Study|Protocol Violation|0|||
106108432|NCT02342886|366051214|FG003|Overall Study|Protocol Violation|2|||
106108433|NCT02342886|366051215|FG004|Overall Study|Protocol Violation|0|||
106108434|NCT00045305|366051216|FG000|Overall Study|Lack of Efficacy|6|||
106108435|NCT00045305|366051216|FG000|Overall Study|Adverse Event|3|||
106108436|NCT00045305|366051216|FG000|Overall Study|Death|3|||
106108437|NCT00045305|366051216|FG000|Overall Study|site error|2|||
106108438|NCT02216773|366051222|FG000|Overall Study|Disease progression|4|||
106108439|NCT02216773|366051223|FG001|Overall Study|Disease progression|2|||
106108440|NCT02216773|366051222|FG000|Overall Study|Insufficient FLRV|4|||
106108441|NCT02216773|366051223|FG001|Overall Study|Insufficient FLRV|0|||
106108442|NCT02216773|366051222|FG000|Overall Study|Abandoned|4|||
106108443|NCT02216773|366051223|FG001|Overall Study|Abandoned|3|||
106108444|NCT04274894|366051224|FG000|Overall Study|Adverse Event|7|||
106108445|NCT04274894|366051224|FG000|Overall Study|Withdrew consent|5|||
106108446|NCT04274894|366051224|FG000|Overall Study|Lost to Follow-up|9|||
106108447|NCT04274894|366051224|FG000|Overall Study|COVID-19 infection|1|||
106108448|NCT04274894|366051224|FG000|Overall Study|Other, not specified|20|||
106108449|NCT03649230|366051228|FG000|Overall Study|Adverse Event|12|||
106108450|NCT03649230|366051228|FG000|Overall Study|Death|8|||
106108451|NCT03649230|366051228|FG000|Overall Study|Withdrawal by Subject|6|||
106108452|NCT03649230|366051228|FG000|Overall Study|Physician Decision|5|||
106108453|NCT03649230|366051228|FG000|Overall Study|Disease progression|5|||
106108454|NCT03649230|366051228|FG000|Overall Study|Switched to non-HEC|5|||
106108455|NCT03649230|366051228|FG000|Overall Study|Chemotherapy discontinued|4|||
106108456|NCT03649230|366051228|FG000|Overall Study|Received only 3 HEC cycles|4|||
106108457|NCT03649230|366051228|FG000|Overall Study|Screen Failure|3|||
106108458|NCT03649230|366051228|FG000|Overall Study|Patient stopped treatment|2|||
106108459|NCT03649230|366051228|FG000|Overall Study|Protocol Violation|1|||
106108460|NCT03649230|366051228|FG000|Overall Study|Non-compliance|1|||
106108461|NCT03649230|366051228|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
106108462|NCT04510675|366051229|FG000|Overall Study|Withdrawal by Subject|5|||
106108463|NCT04198805|366051230|FG000|Overall Study|Death|0|||
106108464|NCT04198805|366051231|FG001|Overall Study|Death|0|||
106108465|NCT04198805|366051232|FG002|Overall Study|Death|0|||
106108466|NCT04198805|366051233|FG003|Overall Study|Death|1|||
106108467|NCT04198805|366051230|FG000|Overall Study|Early Termination|8|||
106108468|NCT04198805|366051231|FG001|Overall Study|Early Termination|4|||
106108469|NCT04198805|366051232|FG002|Overall Study|Early Termination|6|||
106108470|NCT04198805|366051233|FG003|Overall Study|Early Termination|9|||
106108471|NCT02114151|366051234|FG000|Overall Study|Death|1|||
106108472|NCT02114151|366051234|FG000|Overall Study|Lost to Follow-up|1|||
106108473|NCT02114151|366051234|FG000|Overall Study|Withdrawal by Subject|5|||
106108474|NCT01666808|366051235|FG000|Overall Study|Lost to Follow-up|9|||
106108475|NCT01666808|366051236|FG001|Overall Study|Lost to Follow-up|15|||
106108476|NCT01666808|366051235|FG000|Overall Study|Withdrawal by Subject|3|||
106108477|NCT01666808|366051236|FG001|Overall Study|Withdrawal by Subject|1|||
106108478|NCT01666808|366051235|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
106108479|NCT01666808|366051236|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
106108480|NCT02638948|366051239|FG000|Overall Study|Withdrawal by Subject|4|||
106108481|NCT02638948|366051240|FG001|Overall Study|Withdrawal by Subject|5|||
106108482|NCT02638948|366051241|FG002|Overall Study|Withdrawal by Subject|3|||
106108483|NCT02638948|366051242|FG003|Overall Study|Withdrawal by Subject|1|||
106108484|NCT02638948|366051239|FG000|Overall Study|Administrative Reason by Sponsor|0|||
106108485|NCT02638948|366051240|FG001|Overall Study|Administrative Reason by Sponsor|1|||
106108486|NCT02638948|366051241|FG002|Overall Study|Administrative Reason by Sponsor|0|||
106108487|NCT02638948|366051242|FG003|Overall Study|Administrative Reason by Sponsor|4|||
106108488|NCT02638948|366051239|FG000|Overall Study|Adverse Event|0|||
106108489|NCT02638948|366051240|FG001|Overall Study|Adverse Event|0|||
106108490|NCT02638948|366051241|FG002|Overall Study|Adverse Event|1|||
106108491|NCT02638948|366051242|FG003|Overall Study|Adverse Event|1|||
106108492|NCT02638948|366051239|FG000|Overall Study|Lack of Efficacy|1|||
106108493|NCT02638948|366051240|FG001|Overall Study|Lack of Efficacy|1|||
106108494|NCT02638948|366051241|FG002|Overall Study|Lack of Efficacy|0|||
106108495|NCT02638948|366051242|FG003|Overall Study|Lack of Efficacy|0|||
106108496|NCT02638948|366051239|FG000|Overall Study|Lost to Follow-up|0|||
106108497|NCT02638948|366051240|FG001|Overall Study|Lost to Follow-up|0|||
106108498|NCT02638948|366051241|FG002|Overall Study|Lost to Follow-up|1|||
106108499|NCT02638948|366051242|FG003|Overall Study|Lost to Follow-up|1|||
106108500|NCT02638948|366051239|FG000|Overall Study|Poor/Non-Compliance|0|||
106108501|NCT02638948|366051240|FG001|Overall Study|Poor/Non-Compliance|2|||
106108502|NCT02638948|366051241|FG002|Overall Study|Poor/Non-Compliance|1|||
106108503|NCT02638948|366051242|FG003|Overall Study|Poor/Non-Compliance|0|||
106108504|NCT02638948|366051239|FG000|Overall Study|Participant no longer met study criteria|0|||
106108505|NCT02638948|366051240|FG001|Overall Study|Participant no longer met study criteria|1|||
106108506|NCT02638948|366051241|FG002|Overall Study|Participant no longer met study criteria|0|||
106108507|NCT02638948|366051242|FG003|Overall Study|Participant no longer met study criteria|0|||
106108508|NCT02638948|366051239|FG000|Overall Study|Other than specified above|4|||
106108509|NCT02638948|366051240|FG001|Overall Study|Other than specified above|1|||
106108510|NCT02638948|366051241|FG002|Overall Study|Other than specified above|1|||
106108511|NCT02638948|366051242|FG003|Overall Study|Other than specified above|1|||
106108512|NCT01830127|366051246|FG000|Overall Study|Adverse Event|1|||
106108513|NCT01830127|366051247|FG001|Overall Study|Adverse Event|6|||
106108514|NCT01830127|366051246|FG000|Overall Study|Lack of Efficacy|3|||
106108515|NCT01830127|366051247|FG001|Overall Study|Lack of Efficacy|0|||
106108516|NCT01830127|366051246|FG000|Overall Study|Withdrawal by Subject|1|||
106108517|NCT01830127|366051247|FG001|Overall Study|Withdrawal by Subject|1|||
106108518|NCT01830127|366051246|FG000|Overall Study|Other reason not defined above|0|||
106108519|NCT01830127|366051247|FG001|Overall Study|Other reason not defined above|2|||
106108520|NCT01860703|366051258|FG000|Overall Study|Adverse Event|1|||
106108521|NCT01860703|366051259|FG001|Overall Study|Adverse Event|4|||
106108522|NCT01860703|366051260|FG002|Overall Study|Adverse Event|0|||
106108523|NCT01860703|366051261|FG003|Overall Study|Adverse Event|2|||
106108524|NCT01860703|366051258|FG000|Overall Study|Withdrawal by Subject|0|||
106108525|NCT01860703|366051259|FG001|Overall Study|Withdrawal by Subject|1|||
106108526|NCT01860703|366051260|FG002|Overall Study|Withdrawal by Subject|0|||
106108527|NCT01860703|366051261|FG003|Overall Study|Withdrawal by Subject|0|||
106108528|NCT01860703|366051258|FG000|Overall Study|Personal reason|1|||
106108529|NCT01860703|366051259|FG001|Overall Study|Personal reason|0|||
106108530|NCT01860703|366051260|FG002|Overall Study|Personal reason|1|||
106108531|NCT01860703|366051261|FG003|Overall Study|Personal reason|0|||
106108532|NCT00567190|366051262|FG000|Overall Study|Death|235|||
106108533|NCT00567190|366051263|FG001|Overall Study|Death|280|||
106108534|NCT00567190|366051262|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
106108535|NCT00567190|366051263|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
106108536|NCT00553696|366051277|FG000|Overall Study|Adverse Event|2|||
106108537|NCT00553696|366051278|FG001|Overall Study|Adverse Event|4|||
106108538|NCT00553696|366051279|FG002|Overall Study|Adverse Event|0|||
106108539|NCT00553696|366051280|FG003|Overall Study|Adverse Event|1|||
106108540|NCT00553696|366051277|FG000|Overall Study|Global deterioration of health status|0|||
106108541|NCT00553696|366051278|FG001|Overall Study|Global deterioration of health status|2|||
106108542|NCT00553696|366051279|FG002|Overall Study|Global deterioration of health status|0|||
106108543|NCT00553696|366051280|FG003|Overall Study|Global deterioration of health status|0|||
106108544|NCT00553696|366051277|FG000|Overall Study|Objective progression or relapse|2|||
106108545|NCT00553696|366051278|FG001|Overall Study|Objective progression or relapse|9|||
106108546|NCT00553696|366051279|FG002|Overall Study|Objective progression or relapse|6|||
106108547|NCT00553696|366051280|FG003|Overall Study|Objective progression or relapse|0|||
106108548|NCT00553696|366051277|FG000|Overall Study|Withdrawal by Subject|0|||
106108549|NCT00553696|366051278|FG001|Overall Study|Withdrawal by Subject|1|||
106108550|NCT00553696|366051279|FG002|Overall Study|Withdrawal by Subject|0|||
105783173|NCT03382639|364859496|FG001|Overall Study|Withdrawal by Subject|3|||
105783174|NCT03382639|364859497|FG002|Overall Study|Withdrawal by Subject|2|||
105783175|NCT03382639|364859498|FG003|Overall Study|Withdrawal by Subject|3|||
105783176|NCT03382639|364859495|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
105783177|NCT03382639|364859496|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
106108551|NCT00553696|366051280|FG003|Overall Study|Withdrawal by Subject|0|||
106108552|NCT00686881|366051281|FG000|Overall Study|Withdrawal by Subject|11|||
106108553|NCT00686881|366051282|FG001|Overall Study|Withdrawal by Subject|18|||
106108554|NCT00686881|366051281|FG000|Overall Study|Lost to Follow-up|0|||
106108555|NCT00686881|366051282|FG001|Overall Study|Lost to Follow-up|1|||
106108556|NCT00686881|366051281|FG000|Overall Study|Treatment-related adverse event|10|||
106108557|NCT00686881|366051282|FG001|Overall Study|Treatment-related adverse event|9|||
106108558|NCT00686881|366051281|FG000|Overall Study|Met discontinuation criteria|5|||
106108559|NCT00686881|366051282|FG001|Overall Study|Met discontinuation criteria|0|||
106108560|NCT00686881|366051281|FG000|Overall Study|Onset of malignant tumor|11|||
106108561|NCT00686881|366051282|FG001|Overall Study|Onset of malignant tumor|11|||
106108562|NCT00686881|366051281|FG000|Overall Study|Lack of Efficacy|4|||
106108563|NCT00686881|366051282|FG001|Overall Study|Lack of Efficacy|3|||
106108564|NCT00686881|366051281|FG000|Overall Study|Physician Decision|1|||
106108565|NCT00686881|366051282|FG001|Overall Study|Physician Decision|0|||
106108566|NCT00686881|366051281|FG000|Overall Study|Circumstances of site|1|||
106108567|NCT00686881|366051282|FG001|Overall Study|Circumstances of site|1|||
106108568|NCT00686881|366051281|FG000|Overall Study|Did not meet protocol eligibility|1|||
106108569|NCT00686881|366051282|FG001|Overall Study|Did not meet protocol eligibility|0|||
106108570|NCT00686881|366051281|FG000|Overall Study|Irregular visits|1|||
106108571|NCT00686881|366051282|FG001|Overall Study|Irregular visits|0|||
106108572|NCT00686881|366051281|FG000|Overall Study|Study discontinuation|35|||
106108573|NCT00686881|366051282|FG001|Overall Study|Study discontinuation|32|||
106108574|NCT00686881|366051281|FG000|Overall Study|Never received study drug|2|||
106108575|NCT00686881|366051282|FG001|Overall Study|Never received study drug|6|||
106108576|NCT02925676|366051283|FG000|Overall Study|Withdrawal by Subject|1|||
106108577|NCT00541450|366051287|FG000|Phase A|Adverse Event|3|||
106108578|NCT00541450|366051288|FG001|Phase A|Adverse Event|0|||
106108579|NCT00541450|366051287|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
106108580|NCT00541450|366051288|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
106108581|NCT00541450|366051287|FG000|Phase A|Hyperglycemia|0|||
106108582|NCT00541450|366051288|FG001|Phase A|Hyperglycemia|1|||
106108583|NCT00541450|366051287|FG000|Phase A|Lost to Follow-up|6|||
106108584|NCT00541450|366051288|FG001|Phase A|Lost to Follow-up|4|||
106108585|NCT00541450|366051287|FG000|Phase A|Physician Decision|2|||
106108586|NCT00541450|366051288|FG001|Phase A|Physician Decision|0|||
106108587|NCT00541450|366051287|FG000|Phase A|Protocol Violation|2|||
106108588|NCT00541450|366051288|FG001|Phase A|Protocol Violation|3|||
106108589|NCT00541450|366051287|FG000|Phase A|Withdrawal by Subject|7|||
106108590|NCT00541450|366051288|FG001|Phase A|Withdrawal by Subject|7|||
106108591|NCT00541450|366051287|FG000|Phase B|Adverse Event|6|||
106108592|NCT00541450|366051288|FG001|Phase B|Adverse Event|6|||
106108593|NCT00541450|366051287|FG000|Phase B|Hyperglycemia|10|||
106108594|NCT00541450|366051288|FG001|Phase B|Hyperglycemia|9|||
106108595|NCT00541450|366051287|FG000|Phase B|Lost to Follow-up|6|||
106108596|NCT00541450|366051288|FG001|Phase B|Lost to Follow-up|4|||
106108597|NCT00541450|366051287|FG000|Phase B|Physician Decision|4|||
106108598|NCT00541450|366051288|FG001|Phase B|Physician Decision|2|||
106108599|NCT00541450|366051287|FG000|Phase B|Pregnancy|0|||
106108600|NCT00541450|366051288|FG001|Phase B|Pregnancy|1|||
106108601|NCT00541450|366051287|FG000|Phase B|Protocol Violation|3|||
106108602|NCT00541450|366051288|FG001|Phase B|Protocol Violation|3|||
106108603|NCT00541450|366051287|FG000|Phase B|Withdrawal by Subject|8|||
106108604|NCT00541450|366051288|FG001|Phase B|Withdrawal by Subject|6|||
106108605|NCT01298999|366051289|FG000|Overall Study|Physician Decision|0|||
106108606|NCT01298999|366051290|FG001|Overall Study|Physician Decision|1|||
106108607|NCT01298999|366051289|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
106108608|NCT01298999|366051290|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
106108609|NCT00803452|366051294|FG000|Overall Study|Adverse Event|0|||
106108610|NCT00803452|366051295|FG001|Overall Study|Adverse Event|2|||
106108611|NCT00803452|366051294|FG000|Overall Study|Lost to Follow-up|0|||
106108612|NCT00803452|366051295|FG001|Overall Study|Lost to Follow-up|3|||
106108613|NCT02365519|366051299|FG000|Randomized and Treated|Adverse Event|0|||
106108614|NCT02365519|366051300|FG001|Randomized and Treated|Adverse Event|1|||
106108615|NCT02365519|366051301|FG002|Randomized and Treated|Adverse Event|0|||
106108616|NCT02365519|366051299|FG000|Randomized and Treated|Withdrawal by Subject|0|||
105783178|NCT03382639|364859497|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
106108617|NCT02365519|366051300|FG001|Randomized and Treated|Withdrawal by Subject|1|||
106108618|NCT02365519|366051301|FG002|Randomized and Treated|Withdrawal by Subject|1|||
106108619|NCT02355028|366051302|FG000|Overall Study|Adverse Event|2|||
106108620|NCT02355028|366051303|FG001|Overall Study|Adverse Event|0|||
106108621|NCT02355028|366051302|FG000|Overall Study|Withdrawal by Subject|1|||
106108622|NCT02355028|366051303|FG001|Overall Study|Withdrawal by Subject|1|||
106108623|NCT02355028|366051302|FG000|Overall Study|Deemed ineligible after randomization|8|||
106108624|NCT02355028|366051303|FG001|Overall Study|Deemed ineligible after randomization|4|||
106108625|NCT03419364|366051304|FG000|Overall Study|Delivery due to maternal condition|2|||
106108626|NCT03419364|366051305|FG001|Overall Study|Delivery due to maternal condition|0|||
106108627|NCT03419364|366051306|FG002|Overall Study|Delivery due to maternal condition|0|||
106108628|NCT01648270|366051307|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
106108629|NCT02170025|366051308|FG000|Overall Study|Adverse Event|2|||
106108630|NCT02170025|366051309|FG001|Overall Study|Adverse Event|0|||
106108631|NCT00572195|366051310|FG000|Overall Study|Withdrawal by Subject|50|||
106108632|NCT00572195|366051310|FG000|Overall Study|Death|9|||
106108633|NCT00572195|366051310|FG000|Overall Study|Adverse Event|4|||
106108634|NCT00572195|366051310|FG000|Overall Study|Lost to Follow-up|5|||
106108635|NCT03360942|366051315|FG000|Overall Study|Device explanted|2|||
106108636|NCT03360942|366051315|FG000|Overall Study|Study closure|1|||
106108637|NCT03360942|366051315|FG000|Overall Study|Withdrawal by Subject|2|||
106108638|NCT00657618|366051318|FG000|Overall Study|Adverse Event|32|||
106108639|NCT00657618|366051318|FG000|Overall Study|Withdrawal by Subject|8|||
106108640|NCT00657618|366051318|FG000|Overall Study|negative for leishmaniasis|2|||
106108641|NCT00657618|366051318|FG000|Overall Study|didn't start due to schedule conflicts|1|||
106108642|NCT00289887|366052821|FG000|Overall Study|Adverse Event|3|||
106108643|NCT00289887|366052822|FG001|Overall Study|Adverse Event|3|||
106108644|NCT00289887|366052821|FG000|Overall Study|Lack of Efficacy|3|||
106108645|NCT00289887|366052822|FG001|Overall Study|Lack of Efficacy|11|||
106108646|NCT00289887|366052821|FG000|Overall Study|Lost to Follow-up|3|||
106108647|NCT00289887|366052822|FG001|Overall Study|Lost to Follow-up|3|||
106108648|NCT00289887|366052821|FG000|Overall Study|Protocol Violation|3|||
106108649|NCT00289887|366052822|FG001|Overall Study|Protocol Violation|1|||
106108650|NCT00289887|366052821|FG000|Overall Study|Withdrawal by Subject|3|||
106108651|NCT00289887|366052822|FG001|Overall Study|Withdrawal by Subject|8|||
106108652|NCT00289887|366052821|FG000|Overall Study|Other|7|||
106108653|NCT00289887|366052822|FG001|Overall Study|Other|3|||
106108654|NCT04128293|366052826|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
106108655|NCT04128293|366052827|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
106108656|NCT04128293|366052828|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
106108657|NCT04128293|366052829|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
106108658|NCT04605978|366052838|FG000|Overall Study|Adverse Event|2|||
106108659|NCT04605978|366052839|FG001|Overall Study|Adverse Event|1|||
106108660|NCT04605978|366052838|FG000|Overall Study|Withdrawal nonmedical reason|1|||
106108661|NCT04605978|366052839|FG001|Overall Study|Withdrawal nonmedical reason|1|||
106108662|NCT02583425|366052840|FG000|Screening|Did not meet entry criteria|12|||
106108663|NCT02583425|366052840|FG000|Baseline|Did not meet continued criteria|5|||
106108664|NCT02583425|366052840|FG000|Treatment Period|Adverse Event|1|||
106108665|NCT02548455|366052847|FG000|Overall Study|Withdrawal by Subject|27|||
106108666|NCT02548455|366052847|FG000|Overall Study|Death|26|||
106108667|NCT02548455|366052847|FG000|Overall Study|Lost to Follow-up|14|||
106108668|NCT02548455|366052847|FG000|Overall Study|Visit not completed|173|||
106108669|NCT03466086|366052850|FG000|Period 1|Sponsor decision due to study timeline|1|||
106108670|NCT03466086|366052851|FG001|Period 1|Sponsor decision due to study timeline|0|||
106108671|NCT03466086|366052850|FG000|Period 1|Withdrawal by Subject|1|||
106108672|NCT03466086|366052851|FG001|Period 1|Withdrawal by Subject|0|||
106108673|NCT02123108|366052855|FG000|Overall Study|Death|2|||
106108674|NCT02123108|366052856|FG001|Overall Study|Death|3|||
106108675|NCT02054806|366052857|FG000|Overall Study|Sponsor Decision|31|||
106108676|NCT02054806|366052857|FG000|Overall Study|Withdrawal by Subject|43|||
106108677|NCT02054806|366052857|FG000|Overall Study|Protocol Violation|2|||
106108678|NCT02054806|366052857|FG000|Overall Study|Lost to Follow-up|10|||
106108679|NCT02054806|366052857|FG000|Overall Study|Death|391|||
106108680|NCT01132326|366052858|FG000|Overall Study|Lack of Efficacy|25|||
106108681|NCT01132326|366052858|FG000|Overall Study|Adverse Event|37|||
106108682|NCT01132326|366052858|FG000|Overall Study|Protocol Violation|1|||
106108683|NCT01132326|366052858|FG000|Overall Study|Lost to Follow-up|16|||
106108684|NCT01132326|366052858|FG000|Overall Study|Withdrawal by Subject|40|||
106108685|NCT01132326|366052858|FG000|Overall Study|Physician Decision|10|||
106108686|NCT01132326|366052858|FG000|Overall Study|Study Termination|80|||
106108687|NCT01132326|366052858|FG000|Overall Study|Declining Health|1|||
106108688|NCT01132326|366052858|FG000|Overall Study|Pregnancy|1|||
106108689|NCT01132326|366052858|FG000|Overall Study|Caregiver Withdrew Consent|1|||
106108690|NCT01132326|366052858|FG000|Overall Study|Death|5|||
106108691|NCT01132326|366052858|FG000|Overall Study|Subject Unable to Come To Visits|1|||
106108692|NCT00952367|366052859|FG000|Overall Study|Withdrawal by Subject|2|||
106108693|NCT00952367|366052859|FG000|Overall Study|Noncoordination|1|||
106108694|NCT00952367|366052859|FG000|Overall Study|Protocol Violation|3|||
106108695|NCT00781391|366052862|FG000|Overall Study|never received study drug|24|||
106108696|NCT00781391|366052863|FG001|Overall Study|never received study drug|23|||
106108697|NCT00781391|366052864|FG002|Overall Study|never received study drug|32|||
106108698|NCT00781391|366052862|FG000|Overall Study|Protocol Violation|19|||
106108699|NCT00781391|366052863|FG001|Overall Study|Protocol Violation|17|||
106108700|NCT00781391|366052864|FG002|Overall Study|Protocol Violation|20|||
106108701|NCT00781391|366052862|FG000|Overall Study|Death|789|||
106108702|NCT00781391|366052863|FG001|Overall Study|Death|730|||
106108703|NCT00781391|366052864|FG002|Overall Study|Death|706|||
106108704|NCT00781391|366052862|FG000|Overall Study|Withdrawal by Subject|47|||
106108705|NCT00781391|366052863|FG001|Overall Study|Withdrawal by Subject|37|||
106108706|NCT00781391|366052864|FG002|Overall Study|Withdrawal by Subject|25|||
106108707|NCT00781391|366052862|FG000|Overall Study|Lost to Follow-up|0|||
106108708|NCT00781391|366052863|FG001|Overall Study|Lost to Follow-up|0|||
106108709|NCT00781391|366052864|FG002|Overall Study|Lost to Follow-up|1|||
106108710|NCT04535947|366052865|FG000|Overall Study|Adverse Event|1|||
106108711|NCT04535947|366052866|FG001|Overall Study|Adverse Event|4|||
106108712|NCT04535947|366052865|FG000|Overall Study|Other reasons not specified|2|||
106108713|NCT04535947|366052866|FG001|Overall Study|Other reasons not specified|0|||
106108714|NCT04535947|366052865|FG000|Overall Study|Withdrawal by Subject|1|||
106108715|NCT04535947|366052866|FG001|Overall Study|Withdrawal by Subject|1|||
106108716|NCT03802123|366052867|FG000|Overall Study|Withdrawal by Subject|3|||
106108717|NCT03802123|366052867|FG000|Overall Study|Physician Decision|1|||
106108718|NCT03802123|366052867|FG000|Overall Study|Subject moved to hospice care|1|||
106108719|NCT03802123|366052867|FG000|Overall Study|technician error|1|||
106108720|NCT03802123|366052867|FG000|Overall Study|Death|3|||
106108721|NCT00645164|366052868|FG000|Overall Study|Lost to Follow-up|2|||
106108722|NCT00645164|366052868|FG000|Overall Study|Withdrawal by Subject|4|||
106108723|NCT00645164|366052868|FG000|Overall Study|Protocol Violation|1|||
106108724|NCT01822587|366052869|FG000|Overall Study|Lost to Follow-up|7|||
106108725|NCT01822587|366052870|FG001|Overall Study|Lost to Follow-up|9|||
106108726|NCT01822587|366052871|FG002|Overall Study|Lost to Follow-up|12|||
106108727|NCT01822587|366052869|FG000|Overall Study|Physician Decision|9|||
106108728|NCT01822587|366052870|FG001|Overall Study|Physician Decision|6|||
106108729|NCT01822587|366052871|FG002|Overall Study|Physician Decision|6|||
106108730|NCT01274182|366052872|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
106108731|NCT01274182|366052873|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
106108732|NCT01274182|366052874|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
106108733|NCT01274182|366052872|FG000|Overall Study|Adverse Event|4|||
106108734|NCT01274182|366052873|FG001|Overall Study|Adverse Event|5|||
106108735|NCT01274182|366052874|FG002|Overall Study|Adverse Event|3|||
106108736|NCT01274182|366052872|FG000|Overall Study|Withdrawal by Subject|5|||
106108737|NCT01274182|366052873|FG001|Overall Study|Withdrawal by Subject|5|||
106108738|NCT01274182|366052874|FG002|Overall Study|Withdrawal by Subject|3|||
106108739|NCT01274182|366052872|FG000|Overall Study|Lost to Follow-up|2|||
106108740|NCT01274182|366052873|FG001|Overall Study|Lost to Follow-up|3|||
106108741|NCT01274182|366052874|FG002|Overall Study|Lost to Follow-up|1|||
106108742|NCT01274182|366052872|FG000|Overall Study|Protocol Violation|3|||
106108743|NCT01274182|366052873|FG001|Overall Study|Protocol Violation|2|||
106108744|NCT01274182|366052874|FG002|Overall Study|Protocol Violation|0|||
106108745|NCT01274182|366052872|FG000|Overall Study|Death|1|||
106108746|NCT01274182|366052873|FG001|Overall Study|Death|0|||
106108747|NCT01274182|366052874|FG002|Overall Study|Death|1|||
106108748|NCT02355002|366052875|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
106108749|NCT02355002|366052876|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
106108750|NCT02355002|366052875|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
106108751|NCT02355002|366052876|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
106108752|NCT02355002|366052875|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
106108753|NCT02355002|366052876|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
106108754|NCT02355002|366052875|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
106108755|NCT02355002|366052876|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
106108756|NCT02355002|366052875|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
106108757|NCT02355002|366052876|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
106108758|NCT02355002|366052875|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
106108759|NCT02355002|366052876|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
106108760|NCT02355002|366052875|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
106108761|NCT02355002|366052876|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
106108762|NCT00708916|366052877|FG000|Overall Study|Subject Noncompliance|2|||
106108763|NCT00708916|366052877|FG000|Overall Study|Adverse Event|2|||
106108764|NCT00952822|366052879|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
106108765|NCT00952822|366052880|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
106108766|NCT00952822|366052881|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
106108767|NCT00952822|366052882|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
106108768|NCT00952822|366052879|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
106108769|NCT00952822|366052880|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
106108770|NCT00952822|366052881|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
106108771|NCT00952822|366052882|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
106108772|NCT04860518|366052887|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
106108773|NCT04860518|366052888|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
106108774|NCT02835339|366052889|FG000|Overall Study|Did not receive allocated intervention|13|||
106108775|NCT02835339|366052890|FG001|Overall Study|Did not receive allocated intervention|16|||
105783179|NCT03382639|364859498|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
106108776|NCT01077544|366052891|FG000|Overall Study|New Cancer Therapy|3|||
106108777|NCT01077544|366052892|FG001|Overall Study|New Cancer Therapy|3|||
106108778|NCT01077544|366052891|FG000|Overall Study|Adverse Event|0|||
106108779|NCT01077544|366052892|FG001|Overall Study|Adverse Event|1|||
106108780|NCT01077544|366052891|FG000|Overall Study|Disease Progression|0|||
106108781|NCT01077544|366052892|FG001|Overall Study|Disease Progression|1|||
106108782|NCT04085328|366052895|FG000|Overall Study|Witihdrew Consent|16|||
106108783|NCT04085328|366052896|FG001|Overall Study|Witihdrew Consent|16|||
106108784|NCT04085328|366052895|FG000|Overall Study|Adverse Event|8|||
106108785|NCT04085328|366052896|FG001|Overall Study|Adverse Event|7|||
106108786|NCT04085328|366052895|FG000|Overall Study|Lost to Follow-up|7|||
106108787|NCT04085328|366052896|FG001|Overall Study|Lost to Follow-up|2|||
106108788|NCT04085328|366052895|FG000|Overall Study|Physician Decision|0|||
106108789|NCT04085328|366052896|FG001|Overall Study|Physician Decision|1|||
106108790|NCT04085328|366052895|FG000|Overall Study|Pregnancy|0|||
106108791|NCT04085328|366052896|FG001|Overall Study|Pregnancy|1|||
106108792|NCT04085328|366052895|FG000|Overall Study|Reasons Related to COVID-19|5|||
106108793|NCT04085328|366052896|FG001|Overall Study|Reasons Related to COVID-19|8|||
106108794|NCT04085328|366052895|FG000|Overall Study|Did not meet inclusion criteria|1|||
106108795|NCT04085328|366052896|FG001|Overall Study|Did not meet inclusion criteria|1|||
106108796|NCT04085328|366052895|FG000|Overall Study|Early termination|1|||
106108797|NCT04085328|366052896|FG001|Overall Study|Early termination|0|||
106108798|NCT02753595|366052897|FG000|Overall Study|Sponsor termination|2|||
106108799|NCT02753595|366052898|FG001|Overall Study|Sponsor termination|2|||
106108800|NCT02782169|366052901|FG000|Overall Study|Lost to Follow-up|1|||
106108801|NCT02782169|366052902|FG001|Overall Study|Lost to Follow-up|2|||
106108802|NCT03266770|366052905|FG000|Overall Study|Physician Decision|3|||
106108803|NCT03266770|366052905|FG000|Overall Study|Insufficient study supplies|1|||
106108804|NCT03266770|366052905|FG000|Overall Study|Adverse Event|1|||
106108805|NCT02279043|366052906|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
106108806|NCT02279043|366052907|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
106108807|NCT02279043|366052908|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
106108808|NCT02279043|366052906|FG000|Overall Study|Lost to Follow-up|46|||
106108809|NCT02279043|366052907|FG001|Overall Study|Lost to Follow-up|88|||
106108810|NCT02279043|366052908|FG002|Overall Study|Lost to Follow-up|0|||
106108811|NCT00490282|366052909|FG000|Overall Study|Withdrawal by Subject|3|||
106108812|NCT02657031|366052913|FG000|Overall Study|Adverse Event|1|||
106108813|NCT02657031|366052914|FG001|Overall Study|Adverse Event|2|||
106108814|NCT00977665|366052917|FG000|Overall Study|Withdrawal by Subject|1|||
106108815|NCT00977665|366052918|FG001|Overall Study|Withdrawal by Subject|3|||
106108816|NCT00977665|366052917|FG000|Overall Study|Physician Decision|2|||
106108817|NCT00977665|366052918|FG001|Overall Study|Physician Decision|1|||
106108818|NCT00977665|366052917|FG000|Overall Study|Sponsor requested withdrawal|0|||
106108819|NCT00977665|366052918|FG001|Overall Study|Sponsor requested withdrawal|1|||
106108820|NCT00977665|366052917|FG000|Overall Study|Lost to Follow-up|1|||
106108821|NCT00977665|366052918|FG001|Overall Study|Lost to Follow-up|0|||
106108822|NCT00977665|366052917|FG000|Overall Study|Death|3|||
106108823|NCT00977665|366052918|FG001|Overall Study|Death|2|||
106108824|NCT00977665|366052917|FG000|Overall Study|Adverse Event|14|||
106108825|NCT00977665|366052918|FG001|Overall Study|Adverse Event|7|||
106108826|NCT00977665|366052917|FG000|Overall Study|Treatment failure|0|||
106108827|NCT00977665|366052918|FG001|Overall Study|Treatment failure|1|||
106108828|NCT01330433|366052919|FG000|Overall Study|Death|1|||
106108829|NCT01330433|366052920|FG001|Overall Study|Death|3|||
106108830|NCT01330433|366052919|FG000|Overall Study|Lost to Follow-up|1|||
106108831|NCT01330433|366052920|FG001|Overall Study|Lost to Follow-up|0|||
106108832|NCT03078816|366052924|FG000|Overall Study|Withdrawal by Subject|1|||
106108833|NCT01494584|366052925|FG000|Overall Study|Study Closed/Terminated|1|||
106108834|NCT01499082|366052926|FG000|Overall Study|Randomized but not Treated|0|||
106108835|NCT01499082|366052927|FG001|Overall Study|Randomized but not Treated|1|||
106108836|NCT01499082|366052926|FG000|Overall Study|Adverse Event|12|||
106108837|NCT01499082|366052927|FG001|Overall Study|Adverse Event|16|||
106108838|NCT01499082|366052926|FG000|Overall Study|Lack of Efficacy|1|||
106108839|NCT01499082|366052927|FG001|Overall Study|Lack of Efficacy|1|||
106108840|NCT01499082|366052926|FG000|Overall Study|Protocol Violation|6|||
106108841|NCT01499082|366052927|FG001|Overall Study|Protocol Violation|8|||
106108842|NCT01499082|366052926|FG000|Overall Study|Diverse Reasons|18|||
106108843|NCT01499082|366052927|FG001|Overall Study|Diverse Reasons|14|||
106108844|NCT01499082|366052926|FG000|Overall Study|Site Closure for Noncompliance|5|||
106108845|NCT01499082|366052927|FG001|Overall Study|Site Closure for Noncompliance|2|||
106108846|NCT01499082|366052926|FG000|Overall Study|Hypoglycemia|2|||
106108847|NCT01499082|366052927|FG001|Overall Study|Hypoglycemia|3|||
106108848|NCT01499082|366052926|FG000|Overall Study|Lost to Follow-up|1|||
106108849|NCT01499082|366052927|FG001|Overall Study|Lost to Follow-up|3|||
106108850|NCT03599349|366052928|FG000|Overall Study|Lost to Follow-up|1|||
106108851|NCT02495025|366052931|FG000|Overall Study|Lost to Follow-up|21|||
106108852|NCT02495025|366052932|FG001|Overall Study|Lost to Follow-up|14|||
106108853|NCT02495025|366052931|FG000|Overall Study|Withdrawal by Subject|5|||
106108854|NCT02495025|366052932|FG001|Overall Study|Withdrawal by Subject|0|||
106108855|NCT01592370|366052938|FG000|Overall Study|Disease Progression|62|||
106108856|NCT01592370|366052939|FG001|Overall Study|Disease Progression|16|||
106108857|NCT01592370|366052940|FG002|Overall Study|Disease Progression|52|||
106108858|NCT01592370|366052941|FG003|Overall Study|Disease Progression|3|||
106108859|NCT01592370|366052942|FG004|Overall Study|Disease Progression|3|||
106108860|NCT01592370|366052943|FG005|Overall Study|Disease Progression|31|||
106108861|NCT01592370|366052944|FG006|Overall Study|Disease Progression|14|||
106108862|NCT01592370|366052938|FG000|Overall Study|Study Drug Toxicity|14|||
106108863|NCT01592370|366052939|FG001|Overall Study|Study Drug Toxicity|3|||
106108864|NCT01592370|366052940|FG002|Overall Study|Study Drug Toxicity|0|||
106108865|NCT01592370|366052941|FG003|Overall Study|Study Drug Toxicity|0|||
106108866|NCT01592370|366052942|FG004|Overall Study|Study Drug Toxicity|0|||
106108867|NCT01592370|366052943|FG005|Overall Study|Study Drug Toxicity|0|||
106108868|NCT01592370|366052944|FG006|Overall Study|Study Drug Toxicity|1|||
106108869|NCT01592370|366052938|FG000|Overall Study|AE unrelated to study drug|4|||
106108870|NCT01592370|366052939|FG001|Overall Study|AE unrelated to study drug|3|||
106108871|NCT01592370|366052940|FG002|Overall Study|AE unrelated to study drug|0|||
106108872|NCT01592370|366052941|FG003|Overall Study|AE unrelated to study drug|0|||
106108873|NCT01592370|366052942|FG004|Overall Study|AE unrelated to study drug|0|||
106108874|NCT01592370|366052943|FG005|Overall Study|AE unrelated to study drug|0|||
106108875|NCT01592370|366052944|FG006|Overall Study|AE unrelated to study drug|1|||
106108876|NCT01592370|366052938|FG000|Overall Study|Request to discontinue study treatment|5|||
106108877|NCT01592370|366052939|FG001|Overall Study|Request to discontinue study treatment|0|||
106108878|NCT01592370|366052940|FG002|Overall Study|Request to discontinue study treatment|2|||
106108879|NCT01592370|366052941|FG003|Overall Study|Request to discontinue study treatment|0|||
106108880|NCT01592370|366052942|FG004|Overall Study|Request to discontinue study treatment|1|||
106108881|NCT01592370|366052943|FG005|Overall Study|Request to discontinue study treatment|2|||
106108882|NCT01592370|366052944|FG006|Overall Study|Request to discontinue study treatment|0|||
106108883|NCT01592370|366052938|FG000|Overall Study|Withdrew consent|1|||
106108884|NCT01592370|366052939|FG001|Overall Study|Withdrew consent|2|||
106108885|NCT01592370|366052940|FG002|Overall Study|Withdrew consent|1|||
106108886|NCT01592370|366052941|FG003|Overall Study|Withdrew consent|1|||
106108887|NCT01592370|366052942|FG004|Overall Study|Withdrew consent|0|||
106108888|NCT01592370|366052943|FG005|Overall Study|Withdrew consent|0|||
106108889|NCT01592370|366052944|FG006|Overall Study|Withdrew consent|0|||
106108890|NCT01592370|366052938|FG000|Overall Study|Maximum clinical benefit|11|||
106108891|NCT01592370|366052939|FG001|Overall Study|Maximum clinical benefit|1|||
106108892|NCT01592370|366052940|FG002|Overall Study|Maximum clinical benefit|7|||
106108893|NCT01592370|366052941|FG003|Overall Study|Maximum clinical benefit|1|||
106108894|NCT01592370|366052942|FG004|Overall Study|Maximum clinical benefit|0|||
106108895|NCT01592370|366052943|FG005|Overall Study|Maximum clinical benefit|0|||
106108896|NCT01592370|366052944|FG006|Overall Study|Maximum clinical benefit|0|||
106108897|NCT01592370|366052938|FG000|Overall Study|No longer meets study criteria|1|||
106108898|NCT01592370|366052939|FG001|Overall Study|No longer meets study criteria|0|||
106108899|NCT01592370|366052940|FG002|Overall Study|No longer meets study criteria|0|||
106108900|NCT01592370|366052941|FG003|Overall Study|No longer meets study criteria|0|||
106108901|NCT01592370|366052942|FG004|Overall Study|No longer meets study criteria|0|||
106108902|NCT01592370|366052943|FG005|Overall Study|No longer meets study criteria|0|||
106108903|NCT01592370|366052944|FG006|Overall Study|No longer meets study criteria|0|||
106108904|NCT01592370|366052938|FG000|Overall Study|Other Reasons|6|||
106108905|NCT01592370|366052939|FG001|Overall Study|Other Reasons|0|||
106108906|NCT01592370|366052940|FG002|Overall Study|Other Reasons|10|||
106108907|NCT01592370|366052941|FG003|Overall Study|Other Reasons|0|||
106108908|NCT01592370|366052942|FG004|Overall Study|Other Reasons|0|||
106108909|NCT01592370|366052943|FG005|Overall Study|Other Reasons|1|||
105783180|NCT03382639|364859495|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
105783181|NCT03382639|364859496|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
105783182|NCT03382639|364859497|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
105783183|NCT03382639|364859498|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
105783184|NCT03382639|364859495|FG000|Overall Study|Other|2|||
105783185|NCT03382639|364859496|FG001|Overall Study|Other|0|||
106108910|NCT01592370|366052944|FG006|Overall Study|Other Reasons|0|||
106108911|NCT03538951|366052945|FG000|Overall Study|Withdrawal by Subject|1|||
106108912|NCT03538951|366052946|FG001|Overall Study|Withdrawal by Subject|2|||
106108913|NCT01111123|366054840|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
106108914|NCT01111123|366054841|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
106108915|NCT01111123|366054840|FG000|Maintenance Phase|Lost to Follow-up|0|||
106108916|NCT01111123|366054841|FG001|Maintenance Phase|Lost to Follow-up|2|||
106108917|NCT03092375|366054846|FG000|Overall Study|Lack of Efficacy|0|||
105783186|NCT03382639|364859497|FG002|Overall Study|Other|0|||
105783187|NCT03382639|364859498|FG003|Overall Study|Other|3|||
105783188|NCT00399542|364859507|FG000|Overall Study|Adverse Event|18|||
105783189|NCT00399542|364859508|FG001|Overall Study|Adverse Event|15|||
105783190|NCT00399542|364859507|FG000|Overall Study|Protocol Violation|13|||
105783191|NCT00399542|364859508|FG001|Overall Study|Protocol Violation|3|||
105783192|NCT00399542|364859507|FG000|Overall Study|Withdrawal by Subject|28|||
105783193|NCT00399542|364859508|FG001|Overall Study|Withdrawal by Subject|10|||
105783194|NCT00399542|364859507|FG000|Overall Study|Lack of Efficacy|18|||
105783195|NCT00399542|364859508|FG001|Overall Study|Lack of Efficacy|8|||
105783196|NCT00399542|364859507|FG000|Overall Study|Lost to Follow-up|6|||
105783197|NCT00399542|364859508|FG001|Overall Study|Lost to Follow-up|6|||
105783198|NCT00399542|364859507|FG000|Overall Study|Other|1|||
105783199|NCT00399542|364859508|FG001|Overall Study|Other|0|||
105783200|NCT00399542|364859507|FG000|Overall Study|Physician Decision|0|||
105783201|NCT00399542|364859508|FG001|Overall Study|Physician Decision|1|||
105783202|NCT02260791|364859515|FG000|Overall Study|Lost to Follow-up|4|||
105783203|NCT02260791|364859516|FG001|Overall Study|Lost to Follow-up|4|||
105783204|NCT02260791|364859515|FG000|Overall Study|Lack of Efficacy|2|||
105783205|NCT02260791|364859516|FG001|Overall Study|Lack of Efficacy|1|||
105783206|NCT02260791|364859515|FG000|Overall Study|Adverse Event|13|||
105783207|NCT02260791|364859516|FG001|Overall Study|Adverse Event|9|||
105783208|NCT02260791|364859515|FG000|Overall Study|Death|1|||
105783209|NCT02260791|364859516|FG001|Overall Study|Death|0|||
105783210|NCT02260791|364859515|FG000|Overall Study|Withdrawal by Subject|11|||
105783211|NCT02260791|364859516|FG001|Overall Study|Withdrawal by Subject|16|||
105783212|NCT02260791|364859515|FG000|Overall Study|Screen failure|0|||
105783213|NCT02260791|364859516|FG001|Overall Study|Screen failure|1|||
105783214|NCT02260791|364859515|FG000|Overall Study|Protocol deviation|2|||
105783215|NCT02260791|364859516|FG001|Overall Study|Protocol deviation|3|||
105783216|NCT00606931|364859517|FG000|Overall Study|Withdrawal by Subject|3|||
105783217|NCT02442284|364859527|FG000|Overall Study|Adverse Event|1|||
105783218|NCT02442284|364859527|FG000|Overall Study|Withdrew Consent|2|||
105783219|NCT02442284|364859527|FG000|Overall Study|Lost to Follow-up|3|||
105783220|NCT02442284|364859527|FG000|Overall Study|Other|1|||
105783221|NCT00302731|364859528|FG000|Overall Study|Lost to Follow-up|1|||
105783222|NCT00302731|364859529|FG001|Overall Study|Lost to Follow-up|2|||
105783223|NCT00302731|364859530|FG002|Overall Study|Lost to Follow-up|0|||
105783224|NCT00302731|364859531|FG003|Overall Study|Lost to Follow-up|0|||
105783225|NCT00302731|364859528|FG000|Overall Study|Adverse Event|0|||
105783226|NCT00302731|364859529|FG001|Overall Study|Adverse Event|2|||
105783227|NCT00302731|364859530|FG002|Overall Study|Adverse Event|2|||
105783228|NCT00302731|364859531|FG003|Overall Study|Adverse Event|0|||
105783229|NCT00302731|364859528|FG000|Overall Study|Withdrawal by Subject|1|||
105783230|NCT00302731|364859529|FG001|Overall Study|Withdrawal by Subject|1|||
105783231|NCT00302731|364859530|FG002|Overall Study|Withdrawal by Subject|0|||
105993687|NCT02610777|365636065|FG000|Overall Study|Withdrawal by Subject|2|||
106108918|NCT03092375|366054847|FG001|Overall Study|Lack of Efficacy|1|||
106108919|NCT03092375|366054848|FG002|Overall Study|Lack of Efficacy|1|||
106108920|NCT03092375|366054849|FG003|Overall Study|Lack of Efficacy|0|||
106108921|NCT00553501|366054851|FG000|Overall Study|Adverse Event|2|||
106108922|NCT00553501|366054851|FG000|Overall Study|Death|1|||
106108923|NCT00553501|366054851|FG000|Overall Study|Progression|1|||
106108924|NCT01266850|366054852|FG000|Overall Study|Lost to Follow-up|19|||
106108925|NCT01266850|366054853|FG001|Overall Study|Lost to Follow-up|19|||
106108926|NCT01266850|366054854|FG002|Overall Study|Lost to Follow-up|13|||
106108927|NCT01266850|366054855|FG003|Overall Study|Lost to Follow-up|13|||
106108928|NCT01266850|366054856|FG004|Overall Study|Lost to Follow-up|12|||
106108929|NCT01266850|366054852|FG000|Overall Study|Withdrawal by Subject|8|||
106108930|NCT01266850|366054853|FG001|Overall Study|Withdrawal by Subject|9|||
106108931|NCT01266850|366054854|FG002|Overall Study|Withdrawal by Subject|6|||
106108932|NCT01266850|366054855|FG003|Overall Study|Withdrawal by Subject|9|||
106108933|NCT01266850|366054856|FG004|Overall Study|Withdrawal by Subject|12|||
106108934|NCT01266850|366054852|FG000|Overall Study|Physician Decision|3|||
106108935|NCT01266850|366054853|FG001|Overall Study|Physician Decision|6|||
106108936|NCT01266850|366054854|FG002|Overall Study|Physician Decision|4|||
106108937|NCT01266850|366054855|FG003|Overall Study|Physician Decision|4|||
106108938|NCT01266850|366054856|FG004|Overall Study|Physician Decision|3|||
106108939|NCT01266850|366054852|FG000|Overall Study|Protocol Violation|0|||
106108940|NCT01266850|366054853|FG001|Overall Study|Protocol Violation|1|||
106108941|NCT01266850|366054854|FG002|Overall Study|Protocol Violation|0|||
106108942|NCT01266850|366054855|FG003|Overall Study|Protocol Violation|1|||
106108943|NCT01266850|366054856|FG004|Overall Study|Protocol Violation|2|||
106108944|NCT01266850|366054852|FG000|Overall Study|Adverse Event|0|||
106108945|NCT01266850|366054853|FG001|Overall Study|Adverse Event|0|||
106108946|NCT01266850|366054854|FG002|Overall Study|Adverse Event|0|||
106108947|NCT01266850|366054855|FG003|Overall Study|Adverse Event|0|||
105783232|NCT00302731|364859531|FG003|Overall Study|Withdrawal by Subject|0|||
105783233|NCT00302731|364859528|FG000|Overall Study|Protocol Violation|1|||
105783234|NCT00302731|364859529|FG001|Overall Study|Protocol Violation|0|||
105783235|NCT00302731|364859530|FG002|Overall Study|Protocol Violation|0|||
105783236|NCT00302731|364859531|FG003|Overall Study|Protocol Violation|0|||
106108948|NCT01266850|366054856|FG004|Overall Study|Adverse Event|1|||
106108949|NCT01266850|366054852|FG000|Overall Study|Site Closure|0|||
106108950|NCT01266850|366054853|FG001|Overall Study|Site Closure|1|||
106108951|NCT01266850|366054854|FG002|Overall Study|Site Closure|1|||
106108952|NCT01266850|366054855|FG003|Overall Study|Site Closure|1|||
106108953|NCT01266850|366054856|FG004|Overall Study|Site Closure|0|||
106108954|NCT00224770|366054860|FG000|Overall Study|Lost to Follow-up|4|||
106108955|NCT00224770|366054861|FG001|Overall Study|Lost to Follow-up|2|||
106108956|NCT00224770|366054862|FG002|Overall Study|Lost to Follow-up|0|||
106108957|NCT00662857|366054863|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
106108958|NCT00662857|366054864|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
106108959|NCT00662857|366054863|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
106108960|NCT00662857|366054864|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
106108961|NCT00662857|366054863|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
106108962|NCT00662857|366054864|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
106108963|NCT03315143|366054865|FG000|Overall Study|Death|240|||
106108964|NCT03315143|366054866|FG001|Overall Study|Death|246|||
106108965|NCT03315143|366054865|FG000|Overall Study|Withdrawal by Subject|57|||
106108966|NCT03315143|366054866|FG001|Overall Study|Withdrawal by Subject|68|||
106108967|NCT03315143|366054865|FG000|Overall Study|Site Terminated by Sponsor|256|||
106108968|NCT03315143|366054866|FG001|Overall Study|Site Terminated by Sponsor|282|||
106108969|NCT03315143|366054865|FG000|Overall Study|Study Terminated by Sponsor|4723|||
106108970|NCT03315143|366054866|FG001|Overall Study|Study Terminated by Sponsor|4664|||
106108971|NCT03315143|366054865|FG000|Overall Study|Reason not Specified|16|||
106108972|NCT03315143|366054866|FG001|Overall Study|Reason not Specified|32|||
106108973|NCT03040713|366054867|FG000|Overall Study|Positive amyloid scan|3|||
106108974|NCT00337272|366054868|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
106108975|NCT00337272|366054869|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
106108976|NCT00337272|366054868|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
106108977|NCT00337272|366054869|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
106108978|NCT00337272|366054868|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
106108979|NCT00337272|366054869|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
106108980|NCT00337272|366054868|FG000|Treatment Period|Non-compliance|1|||
106108981|NCT00337272|366054869|FG001|Treatment Period|Non-compliance|1|||
106108982|NCT00337272|366054868|FG000|Treatment Period|Withdrawal by Subject|0|||
106108983|NCT00337272|366054869|FG001|Treatment Period|Withdrawal by Subject|1|||
106108984|NCT00337272|366054868|FG000|Withdrawal Period|Non-compliance|0|||
106108985|NCT00337272|366054869|FG001|Withdrawal Period|Non-compliance|1|||
106108986|NCT01662063|366054872|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
106108987|NCT01662063|366054873|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
106108988|NCT01662063|366054874|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
106108989|NCT01662063|366054872|FG000|Overall Study|Lack of Efficacy|1|||
106108990|NCT01662063|366054873|FG001|Overall Study|Lack of Efficacy|6|||
106108991|NCT01662063|366054874|FG002|Overall Study|Lack of Efficacy|0|||
106108992|NCT01662063|366054872|FG000|Overall Study|Lost to Follow-up|0|||
106108993|NCT01662063|366054873|FG001|Overall Study|Lost to Follow-up|4|||
106108994|NCT01662063|366054874|FG002|Overall Study|Lost to Follow-up|0|||
106108995|NCT01662063|366054872|FG000|Overall Study|Protocol Violation|1|||
106108996|NCT01662063|366054873|FG001|Overall Study|Protocol Violation|0|||
106108997|NCT01662063|366054874|FG002|Overall Study|Protocol Violation|0|||
106108998|NCT01662063|366054872|FG000|Overall Study|Withdrawal by Subject|2|||
106108999|NCT01662063|366054873|FG001|Overall Study|Withdrawal by Subject|4|||
106109000|NCT01662063|366054874|FG002|Overall Study|Withdrawal by Subject|1|||
106109001|NCT01662063|366054872|FG000|Overall Study|Physician Decision|0|||
106109002|NCT01662063|366054873|FG001|Overall Study|Physician Decision|2|||
106109003|NCT01662063|366054874|FG002|Overall Study|Physician Decision|0|||
106109004|NCT01662063|366054872|FG000|Overall Study|Other|0|||
106109005|NCT01662063|366054873|FG001|Overall Study|Other|1|||
106109006|NCT01662063|366054874|FG002|Overall Study|Other|0|||
106109007|NCT00716092|366054881|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
106109008|NCT00716092|366054882|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
106109009|NCT00716092|366054883|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
106109010|NCT00117676|366054887|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
106109011|NCT00117676|366054888|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
106109012|NCT00117676|366054887|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
106109013|NCT00117676|366054888|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
106109014|NCT00117676|366054887|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
106109015|NCT00117676|366054888|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
106109016|NCT00117676|366054887|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
106109017|NCT00117676|366054888|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
106109018|NCT00117676|366054887|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
106109019|NCT00117676|366054888|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
106109020|NCT00117676|366054887|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
106109021|NCT00117676|366054888|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
106109022|NCT00117676|366054887|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
106109023|NCT00117676|366054888|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
106109024|NCT00117676|366054887|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
106109025|NCT00117676|366054888|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
106109026|NCT00117676|366054887|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
106109027|NCT00117676|366054888|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
106109028|NCT00117676|366054887|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
106109029|NCT00117676|366054888|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
106109030|NCT00117676|366054887|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
106109031|NCT00117676|366054888|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
106109032|NCT00117676|366054887|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
106109033|NCT00117676|366054888|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
106109034|NCT00117676|366054887|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
106109035|NCT00117676|366054888|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
106109036|NCT00117676|366054887|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
106109037|NCT00117676|366054888|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
106109038|NCT00117676|366054887|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
106109039|NCT00117676|366054888|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
106109040|NCT00117676|366054887|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
106109041|NCT00117676|366054888|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
106109042|NCT00117676|366054887|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
106109043|NCT00117676|366054888|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
106109044|NCT00117676|366054887|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
106109045|NCT00117676|366054888|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
106109046|NCT00117676|366054887|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
106109047|NCT00117676|366054888|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
106109048|NCT00117676|366054887|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
106109049|NCT00117676|366054888|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
106109050|NCT00117676|366054887|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
106109051|NCT00117676|366054888|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
106109052|NCT00117676|366054887|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
106109053|NCT00117676|366054888|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
106109054|NCT00117676|366054887|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
106109055|NCT00117676|366054888|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
106109056|NCT00117676|366054887|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
106109057|NCT00117676|366054888|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
106109058|NCT00117676|366054887|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
106109059|NCT00117676|366054888|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
106109060|NCT00117676|366054887|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
106109061|NCT00117676|366054888|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
106109062|NCT00117676|366054887|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
106109063|NCT00117676|366054888|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
106109064|NCT00117676|366054887|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
106109065|NCT00117676|366054888|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
106109066|NCT00117676|366054887|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
106109067|NCT00117676|366054888|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
106109068|NCT00117676|366054887|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
106109069|NCT00117676|366054888|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
106109070|NCT00117676|366054887|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
106109071|NCT00117676|366054888|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
106109072|NCT00117676|366054887|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
106109073|NCT00117676|366054888|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
106109074|NCT00117676|366054887|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
106109075|NCT00117676|366054888|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
106109076|NCT00117676|366054887|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
106109077|NCT00117676|366054888|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
106109078|NCT00117676|366054887|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
106109079|NCT00117676|366054888|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
106109080|NCT01281644|366054889|FG000|Overall Study|Lost to Follow-up|3|||
106109081|NCT01281644|366054889|FG000|Overall Study|Withdrawal by Subject|2|||
106109082|NCT02110901|366054890|FG000|Overall Study|Death|6|||
106109083|NCT02110901|366054891|FG001|Overall Study|Death|3|||
106109084|NCT02110901|366054890|FG000|Overall Study|Lost to Follow-up|12|||
106109085|NCT02110901|366054891|FG001|Overall Study|Lost to Follow-up|8|||
106109086|NCT02110901|366054890|FG000|Overall Study|Withdrawal by Subject|7|||
106109087|NCT02110901|366054891|FG001|Overall Study|Withdrawal by Subject|3|||
106109088|NCT02110901|366054890|FG000|Overall Study|received a kidney transplant|5|||
106109089|NCT02110901|366054891|FG001|Overall Study|received a kidney transplant|0|||
106109090|NCT02831257|366054892|FG000|Overall Study|Lack of Efficacy|3|||
106109091|NCT02831257|366054892|FG000|Overall Study|Adverse Event|2|||
106109092|NCT02831257|366054892|FG000|Overall Study|Physician Decision|1|||
106109093|NCT02831257|366054892|FG000|Overall Study|Withdrawal by Subject|6|||
106109094|NCT01058304|366054893|FG000|Overall Study|Withdrawal by Subject|8|||
106109095|NCT01058304|366054894|FG001|Overall Study|Withdrawal by Subject|5|||
106109096|NCT01058304|366054893|FG000|Overall Study|Lost to Follow-up|13|||
106109097|NCT01058304|366054894|FG001|Overall Study|Lost to Follow-up|16|||
106109098|NCT01058304|366054893|FG000|Overall Study|Developed exclusion criterion|6|||
106109099|NCT01058304|366054894|FG001|Overall Study|Developed exclusion criterion|12|||
106109100|NCT01820559|366054895|FG000|Overall Study|Adverse Event|4|||
106109101|NCT01820559|366054896|FG001|Overall Study|Adverse Event|6|||
106109102|NCT01820559|366054897|FG002|Overall Study|Adverse Event|13|||
106109103|NCT01820559|366054895|FG000|Overall Study|Withdrawal by Subject|1|||
106109104|NCT01820559|366054896|FG001|Overall Study|Withdrawal by Subject|2|||
106109105|NCT01820559|366054897|FG002|Overall Study|Withdrawal by Subject|5|||
106109106|NCT01820559|366054895|FG000|Overall Study|Protocol Violation|2|||
106109107|NCT01820559|366054896|FG001|Overall Study|Protocol Violation|1|||
106109108|NCT01820559|366054897|FG002|Overall Study|Protocol Violation|3|||
106109109|NCT01820559|366054895|FG000|Overall Study|Subject's non-compliance|1|||
106109110|NCT01820559|366054896|FG001|Overall Study|Subject's non-compliance|0|||
106109111|NCT01820559|366054897|FG002|Overall Study|Subject's non-compliance|2|||
106109112|NCT01820559|366054895|FG000|Overall Study|Lost to Follow-up|3|||
106109113|NCT01820559|366054896|FG001|Overall Study|Lost to Follow-up|2|||
106109114|NCT01820559|366054897|FG002|Overall Study|Lost to Follow-up|2|||
106109115|NCT01820559|366054895|FG000|Overall Study|At sponsor request|0|||
106109116|NCT01820559|366054896|FG001|Overall Study|At sponsor request|0|||
106109117|NCT01820559|366054897|FG002|Overall Study|At sponsor request|1|||
106109118|NCT01820559|366054895|FG000|Overall Study|Lack of Efficacy|3|||
106109119|NCT01820559|366054896|FG001|Overall Study|Lack of Efficacy|2|||
106109120|NCT01820559|366054897|FG002|Overall Study|Lack of Efficacy|3|||
106109121|NCT03205371|366054898|FG000|Overall Study|Withdrawal by Subject|4|||
106109122|NCT03205371|366054899|FG001|Overall Study|Withdrawal by Subject|1|||
106109123|NCT03205371|366054900|FG002|Overall Study|Withdrawal by Subject|0|||
106109124|NCT03205371|366054901|FG003|Overall Study|Withdrawal by Subject|0|||
106109125|NCT03205371|366054902|FG004|Overall Study|Withdrawal by Subject|0|||
106109126|NCT03205371|366054903|FG005|Overall Study|Withdrawal by Subject|0|||
106109127|NCT03205371|366054904|FG006|Overall Study|Withdrawal by Subject|4|||
106109128|NCT03205371|366054905|FG007|Overall Study|Withdrawal by Subject|0|||
106109129|NCT03205371|366054906|FG008|Overall Study|Withdrawal by Subject|2|||
106109130|NCT03205371|366054907|FG009|Overall Study|Withdrawal by Subject|0|||
106109131|NCT03205371|366054908|FG010|Overall Study|Withdrawal by Subject|0|||
106109132|NCT03205371|366054909|FG011|Overall Study|Withdrawal by Subject|1|||
106109133|NCT03205371|366054898|FG000|Overall Study|Lost to Follow-up|0|||
106109134|NCT03205371|366054899|FG001|Overall Study|Lost to Follow-up|0|||
106109135|NCT03205371|366054900|FG002|Overall Study|Lost to Follow-up|0|||
106109136|NCT03205371|366054901|FG003|Overall Study|Lost to Follow-up|0|||
106109137|NCT03205371|366054902|FG004|Overall Study|Lost to Follow-up|0|||
106109138|NCT03205371|366054903|FG005|Overall Study|Lost to Follow-up|0|||
106109139|NCT03205371|366054904|FG006|Overall Study|Lost to Follow-up|5|||
106109140|NCT03205371|366054905|FG007|Overall Study|Lost to Follow-up|2|||
106109141|NCT03205371|366054906|FG008|Overall Study|Lost to Follow-up|3|||
106109142|NCT03205371|366054907|FG009|Overall Study|Lost to Follow-up|0|||
106109143|NCT03205371|366054908|FG010|Overall Study|Lost to Follow-up|0|||
106109144|NCT03205371|366054909|FG011|Overall Study|Lost to Follow-up|0|||
106109145|NCT03205371|366054898|FG000|Overall Study|Protocol Violation|0|||
106109146|NCT03205371|366054899|FG001|Overall Study|Protocol Violation|0|||
106109147|NCT03205371|366054900|FG002|Overall Study|Protocol Violation|0|||
106109148|NCT03205371|366054901|FG003|Overall Study|Protocol Violation|0|||
106109149|NCT03205371|366054902|FG004|Overall Study|Protocol Violation|0|||
106109150|NCT03205371|366054903|FG005|Overall Study|Protocol Violation|0|||
106109151|NCT03205371|366054904|FG006|Overall Study|Protocol Violation|1|||
106109152|NCT03205371|366054905|FG007|Overall Study|Protocol Violation|0|||
106109153|NCT03205371|366054906|FG008|Overall Study|Protocol Violation|0|||
106109154|NCT03205371|366054907|FG009|Overall Study|Protocol Violation|0|||
106109155|NCT03205371|366054908|FG010|Overall Study|Protocol Violation|0|||
106109156|NCT03205371|366054909|FG011|Overall Study|Protocol Violation|0|||
106109157|NCT03205371|366054898|FG000|Overall Study|Adverse Event|0|||
106109158|NCT03205371|366054899|FG001|Overall Study|Adverse Event|0|||
106109159|NCT03205371|366054900|FG002|Overall Study|Adverse Event|0|||
106109160|NCT03205371|366054901|FG003|Overall Study|Adverse Event|0|||
106109161|NCT03205371|366054902|FG004|Overall Study|Adverse Event|0|||
106109162|NCT03205371|366054903|FG005|Overall Study|Adverse Event|0|||
106109163|NCT03205371|366054904|FG006|Overall Study|Adverse Event|0|||
106109164|NCT03205371|366054905|FG007|Overall Study|Adverse Event|1|||
106109165|NCT03205371|366054906|FG008|Overall Study|Adverse Event|0|||
106109166|NCT03205371|366054907|FG009|Overall Study|Adverse Event|0|||
106109167|NCT03205371|366054908|FG010|Overall Study|Adverse Event|0|||
106109168|NCT03205371|366054909|FG011|Overall Study|Adverse Event|0|||
106109169|NCT03172702|366054912|FG000|Overall Study|Adverse Event|9|||
106109170|NCT03172702|366054912|FG000|Overall Study|Death|2|||
106109171|NCT03172702|366054912|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
106109172|NCT03172702|366054912|FG000|Overall Study|Withdrawal by Subject|5|||
106109173|NCT03172702|366054912|FG000|Overall Study|Other|2|||
106109174|NCT02954354|366054921|FG000|Overall Study|Adverse Event|2|||
106109175|NCT02954354|366054922|FG001|Overall Study|Adverse Event|2|||
106109176|NCT02954354|366054923|FG002|Overall Study|Adverse Event|4|||
106109177|NCT02954354|366054921|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
106109178|NCT02954354|366054922|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
106109179|NCT02954354|366054923|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
106109180|NCT02954354|366054921|FG000|Overall Study|Lack of Efficacy|0|||
106109181|NCT02954354|366054922|FG001|Overall Study|Lack of Efficacy|2|||
106109182|NCT02954354|366054923|FG002|Overall Study|Lack of Efficacy|0|||
106109183|NCT02954354|366054921|FG000|Overall Study|Withdrawal by Subject|17|||
106109184|NCT02954354|366054922|FG001|Overall Study|Withdrawal by Subject|9|||
106109185|NCT02954354|366054923|FG002|Overall Study|Withdrawal by Subject|11|||
106109186|NCT02954354|366054921|FG000|Overall Study|Lost to Follow-up|12|||
106109187|NCT02954354|366054922|FG001|Overall Study|Lost to Follow-up|5|||
106109188|NCT02954354|366054923|FG002|Overall Study|Lost to Follow-up|0|||
106109189|NCT02954354|366054921|FG000|Overall Study|Miscellaneous|2|||
106109190|NCT02954354|366054922|FG001|Overall Study|Miscellaneous|2|||
106109191|NCT02954354|366054923|FG002|Overall Study|Miscellaneous|1|||
106109192|NCT03574597|366054926|FG000|Overall Study|Withdrawal by Subject|67|||
106109193|NCT03574597|366054927|FG001|Overall Study|Withdrawal by Subject|96|||
106109194|NCT03574597|366054926|FG000|Overall Study|Lost to Follow-up|192|||
106109195|NCT03574597|366054927|FG001|Overall Study|Lost to Follow-up|188|||
106109196|NCT02618967|366054928|FG000|Overall Study|Lost to Follow-up|0|||
106109197|NCT02618967|366054929|FG001|Overall Study|Lost to Follow-up|0|||
106109198|NCT02618967|366054930|FG002|Overall Study|Lost to Follow-up|1|||
106109199|NCT02618967|366054931|FG003|Overall Study|Lost to Follow-up|0|||
106109200|NCT02618967|366054932|FG004|Overall Study|Lost to Follow-up|2|||
106109201|NCT02618967|366054933|FG005|Overall Study|Lost to Follow-up|0|||
106109202|NCT02618967|366054934|FG006|Overall Study|Lost to Follow-up|0|||
106109203|NCT02618967|366054935|FG007|Overall Study|Lost to Follow-up|0|||
106109204|NCT02618967|366054928|FG000|Overall Study|Withdrawal by Subject|1|||
106109205|NCT02618967|366054929|FG001|Overall Study|Withdrawal by Subject|0|||
106109206|NCT02618967|366054930|FG002|Overall Study|Withdrawal by Subject|0|||
106109207|NCT02618967|366054931|FG003|Overall Study|Withdrawal by Subject|0|||
106109208|NCT02618967|366054932|FG004|Overall Study|Withdrawal by Subject|0|||
106109209|NCT02618967|366054933|FG005|Overall Study|Withdrawal by Subject|0|||
106109210|NCT02618967|366054934|FG006|Overall Study|Withdrawal by Subject|0|||
106109211|NCT02618967|366054935|FG007|Overall Study|Withdrawal by Subject|0|||
106109212|NCT01368965|366054936|FG000|Overall Study|Lost to Follow-up|12|||
106109213|NCT02061202|366054937|FG000|Overall Study|Lost to Follow-up|1|||
106109214|NCT02061202|366054938|FG001|Overall Study|Lost to Follow-up|1|||
106109215|NCT00569582|366054949|FG000|Overall Study|Withdrawal by Subject|5|||
106109216|NCT00569582|366054949|FG000|Overall Study|Death|2|||
106109217|NCT00569582|366054949|FG000|Overall Study|Adverse Event|7|||
106109218|NCT00569582|366054949|FG000|Overall Study|Subject was too ill to travel.|1|||
106109219|NCT00569582|366054949|FG000|Overall Study|Subject was non-compliant.|1|||
106109220|NCT01533493|366054953|FG000|Overall Study|Adverse Event|2|||
106109221|NCT01533493|366054954|FG001|Overall Study|Adverse Event|1|||
106109222|NCT01533493|366054953|FG000|Overall Study|Withdrawal by Subject|1|||
106109223|NCT01533493|366054954|FG001|Overall Study|Withdrawal by Subject|2|||
106109224|NCT01533493|366054953|FG000|Overall Study|Lost to Follow-up|2|||
106109225|NCT01533493|366054954|FG001|Overall Study|Lost to Follow-up|0|||
106109226|NCT02355743|366054955|FG000|Overall Study|Withdrawal by Subject|1|||
106109227|NCT02355743|366054955|FG000|Overall Study|Lost to Follow-up|1|||
106109228|NCT00771810|366054969|FG000|Overall Study|Adverse Event|3|||
106109229|NCT00771810|366054970|FG001|Overall Study|Adverse Event|0|||
106109230|NCT00771810|366054971|FG002|Overall Study|Adverse Event|2|||
106109231|NCT00771810|366054969|FG000|Overall Study|Lost to Follow-up|0|||
106109232|NCT00771810|366054970|FG001|Overall Study|Lost to Follow-up|0|||
106109233|NCT00771810|366054971|FG002|Overall Study|Lost to Follow-up|1|||
106109234|NCT00771810|366054969|FG000|Overall Study|Physician Decision|1|||
106109235|NCT00771810|366054970|FG001|Overall Study|Physician Decision|2|||
106109236|NCT00771810|366054971|FG002|Overall Study|Physician Decision|2|||
106109237|NCT00771810|366054969|FG000|Overall Study|Protocol Violation|0|||
106109238|NCT00771810|366054970|FG001|Overall Study|Protocol Violation|1|||
106109239|NCT00771810|366054971|FG002|Overall Study|Protocol Violation|1|||
106109240|NCT00771810|366054969|FG000|Overall Study|Withdrawal by Subject|1|||
106109241|NCT00771810|366054970|FG001|Overall Study|Withdrawal by Subject|2|||
106109242|NCT00771810|366054971|FG002|Overall Study|Withdrawal by Subject|0|||
106109243|NCT00771810|366054969|FG000|Overall Study|Other|0|||
106109244|NCT00771810|366054970|FG001|Overall Study|Other|0|||
106109245|NCT00771810|366054971|FG002|Overall Study|Other|1|||
106109246|NCT03804710|366054974|FG000|Overall Study|Adverse Event|0|||
106109247|NCT03804710|366054975|FG001|Overall Study|Adverse Event|3|||
106109248|NCT03804710|366054974|FG000|Overall Study|Withdrawal by Subject|2|||
106109249|NCT03804710|366054975|FG001|Overall Study|Withdrawal by Subject|1|||
106109250|NCT03804710|366054974|FG000|Overall Study|Other|0|||
106109251|NCT03804710|366054975|FG001|Overall Study|Other|1|||
106109252|NCT02515279|366054976|FG000|Overall Study|Adverse Event|7|||
106109253|NCT02515279|366054976|FG000|Overall Study|Lack of Efficacy|31|||
106109254|NCT02515279|366054976|FG000|Overall Study|Lost to Follow-up|9|||
106109255|NCT02515279|366054976|FG000|Overall Study|Withdrawal by Subject|18|||
106109256|NCT02515279|366054976|FG000|Overall Study|End-of-treatment visit not attended|17|||
106109257|NCT02515279|366054976|FG000|Overall Study|Other|22|||
106109258|NCT01800968|366054977|FG000|Overall Study|Death|23|||
106109259|NCT01800968|366054978|FG001|Overall Study|Death|16|||
106109260|NCT01800968|366054977|FG000|Overall Study|Lost to Follow-up|5|||
106109261|NCT01800968|366054978|FG001|Overall Study|Lost to Follow-up|7|||
106109262|NCT01800968|366054977|FG000|Overall Study|Withdrawal by Subject|7|||
106109263|NCT01800968|366054978|FG001|Overall Study|Withdrawal by Subject|9|||
106109264|NCT01800968|366054977|FG000|Overall Study|Physician Decision|1|||
106109265|NCT01800968|366054978|FG001|Overall Study|Physician Decision|0|||
106109266|NCT02953938|366054981|FG000|Overall Study|Adverse Event|0|||
106109267|NCT02953938|366054982|FG001|Overall Study|Adverse Event|1|||
106109268|NCT02953938|366054981|FG000|Overall Study|Withdrawal by Subject|1|||
106109269|NCT02953938|366054982|FG001|Overall Study|Withdrawal by Subject|1|||
106109270|NCT00696410|366054985|FG000|Overall Study|Lost to Follow-up|2|||
106109271|NCT00696410|366054986|FG001|Overall Study|Lost to Follow-up|0|||
106109272|NCT00696410|366054985|FG000|Overall Study|Withdrawal by Subject|8|||
106109273|NCT00696410|366054986|FG001|Overall Study|Withdrawal by Subject|0|||
106109274|NCT00696410|366054985|FG000|Overall Study|Physician Decision|3|||
106109275|NCT00696410|366054986|FG001|Overall Study|Physician Decision|0|||
106109276|NCT01338025|366055003|FG000|Overall Study|Unexpected closure of study|10|||
106109277|NCT01338025|366055004|FG001|Overall Study|Unexpected closure of study|9|||
106109278|NCT01338025|366055003|FG000|Overall Study|Withdrawal by Subject|0|||
106109279|NCT01338025|366055004|FG001|Overall Study|Withdrawal by Subject|2|||
106109280|NCT01338025|366055003|FG000|Overall Study|Found ineligible after starting|1|||
106109281|NCT01338025|366055004|FG001|Overall Study|Found ineligible after starting|0|||
106109282|NCT04349280|366055005|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
106109283|NCT04349280|366055006|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
106109284|NCT04349280|366055005|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
106109285|NCT04349280|366055006|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
106109286|NCT04349280|366055005|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
106109287|NCT04349280|366055006|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
106109288|NCT03076970|366056619|FG000|Washout Period 2|Adverse Event|0|||
106109289|NCT03076970|366056620|FG001|Washout Period 2|Adverse Event|0|||
106109290|NCT03076970|366056621|FG002|Washout Period 2|Adverse Event|0|||
106109291|NCT03076970|366056622|FG003|Washout Period 2|Adverse Event|0|||
106109292|NCT03076970|366056623|FG004|Washout Period 2|Adverse Event|1|||
106109293|NCT03076970|366056624|FG005|Washout Period 2|Adverse Event|0|||
106109294|NCT03076970|366056619|FG000|Period 3|Withdrawal by Subject|0|||
106109295|NCT03076970|366056620|FG001|Period 3|Withdrawal by Subject|0|||
106109296|NCT03076970|366056621|FG002|Period 3|Withdrawal by Subject|0|||
106109297|NCT03076970|366056622|FG003|Period 3|Withdrawal by Subject|0|||
106109298|NCT03076970|366056623|FG004|Period 3|Withdrawal by Subject|0|||
106109299|NCT03076970|366056624|FG005|Period 3|Withdrawal by Subject|1|||
106109300|NCT03076970|366056619|FG000|Period 3|Failure to meet I/E criteria|0|||
106109301|NCT03076970|366056620|FG001|Period 3|Failure to meet I/E criteria|0|||
106109302|NCT03076970|366056621|FG002|Period 3|Failure to meet I/E criteria|0|||
106109303|NCT03076970|366056622|FG003|Period 3|Failure to meet I/E criteria|0|||
106109304|NCT03076970|366056623|FG004|Period 3|Failure to meet I/E criteria|1|||
106109305|NCT03076970|366056624|FG005|Period 3|Failure to meet I/E criteria|0|||
106109306|NCT01345630|366056625|FG000|Overall Study|Adverse Event|22|||
106109307|NCT01345630|366056626|FG001|Overall Study|Adverse Event|23|||
106109308|NCT01345630|366056625|FG000|Overall Study|Lost to Follow-up|17|||
106109309|NCT01345630|366056626|FG001|Overall Study|Lost to Follow-up|16|||
106109310|NCT01345630|366056625|FG000|Overall Study|Protocol Violation|4|||
106109311|NCT01345630|366056626|FG001|Overall Study|Protocol Violation|1|||
106109312|NCT01345630|366056625|FG000|Overall Study|Medication error without associated AE|0|||
106109313|NCT01345630|366056626|FG001|Overall Study|Medication error without associated AE|1|||
106109314|NCT01345630|366056625|FG000|Overall Study|Study terminated by sponsor|254|||
106109315|NCT01345630|366056626|FG001|Overall Study|Study terminated by sponsor|285|||
106109316|NCT01345630|366056625|FG000|Overall Study|Other reasons|6|||
106109317|NCT01345630|366056626|FG001|Overall Study|Other reasons|8|||
106109318|NCT01345630|366056625|FG000|Overall Study|Withdrawn due to pregnancy|1|||
106109319|NCT01345630|366056626|FG001|Overall Study|Withdrawn due to pregnancy|2|||
106109320|NCT01345630|366056625|FG000|Overall Study|No longer willing to participate|9|||
106109321|NCT01345630|366056626|FG001|Overall Study|No longer willing to participate|12|||
106109322|NCT01345630|366056625|FG000|Overall Study|Insufficient clinical response|48|||
106109323|NCT01345630|366056626|FG001|Overall Study|Insufficient clinical response|11|||
106109324|NCT02543658|366056627|FG000|Overall Study|Lack of Efficacy|0|||
106109325|NCT02543658|366056628|FG001|Overall Study|Lack of Efficacy|4|||
106109326|NCT00789815|366056629|FG000|Overall Study|Protocol Violation|6|||
106109327|NCT00789815|366056630|FG001|Overall Study|Protocol Violation|1|||
106109328|NCT00789815|366056629|FG000|Overall Study|Intubation due to massive bleeding|1|||
106109329|NCT00789815|366056630|FG001|Overall Study|Intubation due to massive bleeding|0|||
106109330|NCT00119405|366056633|FG000|Overall Study|Withdrawal by Subject|1|||
106109331|NCT01735201|366056634|FG000|Overall Study|Adverse Event|1|||
106109332|NCT01735201|366056635|FG001|Overall Study|Adverse Event|1|||
106109333|NCT01735201|366056636|FG002|Overall Study|Adverse Event|0|||
106109334|NCT01735201|366056637|FG003|Overall Study|Adverse Event|1|||
106109335|NCT01735201|366056638|FG004|Overall Study|Adverse Event|1|||
106109336|NCT01735201|366056639|FG005|Overall Study|Adverse Event|3|||
106109337|NCT01735201|366056640|FG006|Overall Study|Adverse Event|2|||
106109338|NCT01735201|366056641|FG007|Overall Study|Adverse Event|1|||
106109339|NCT01735201|366056634|FG000|Overall Study|Personal Reasons|1|||
106109340|NCT01735201|366056635|FG001|Overall Study|Personal Reasons|0|||
106109341|NCT01735201|366056636|FG002|Overall Study|Personal Reasons|0|||
106109342|NCT01735201|366056637|FG003|Overall Study|Personal Reasons|0|||
106109343|NCT01735201|366056638|FG004|Overall Study|Personal Reasons|0|||
106109344|NCT01735201|366056639|FG005|Overall Study|Personal Reasons|0|||
106109345|NCT01735201|366056640|FG006|Overall Study|Personal Reasons|0|||
106109346|NCT01735201|366056641|FG007|Overall Study|Personal Reasons|0|||
106109347|NCT01735201|366056634|FG000|Overall Study|Protocol Violation|1|||
106109348|NCT01735201|366056635|FG001|Overall Study|Protocol Violation|0|||
106109349|NCT01735201|366056636|FG002|Overall Study|Protocol Violation|0|||
106109350|NCT01735201|366056637|FG003|Overall Study|Protocol Violation|0|||
106109351|NCT01735201|366056638|FG004|Overall Study|Protocol Violation|0|||
106109352|NCT01735201|366056639|FG005|Overall Study|Protocol Violation|0|||
106109353|NCT01735201|366056640|FG006|Overall Study|Protocol Violation|0|||
106109354|NCT01735201|366056641|FG007|Overall Study|Protocol Violation|0|||
106109355|NCT01735201|366056634|FG000|Overall Study|Other Miscellaneous Reasons|0|||
106109356|NCT01735201|366056635|FG001|Overall Study|Other Miscellaneous Reasons|0|||
106109357|NCT01735201|366056636|FG002|Overall Study|Other Miscellaneous Reasons|0|||
106109358|NCT01735201|366056637|FG003|Overall Study|Other Miscellaneous Reasons|1|||
106109359|NCT01735201|366056638|FG004|Overall Study|Other Miscellaneous Reasons|0|||
106109360|NCT01735201|366056639|FG005|Overall Study|Other Miscellaneous Reasons|2|||
106109361|NCT01735201|366056640|FG006|Overall Study|Other Miscellaneous Reasons|1|||
106109362|NCT01735201|366056641|FG007|Overall Study|Other Miscellaneous Reasons|1|||
106109363|NCT01553318|366056644|FG000|Overall Study|Protocol Violation|3|||
106109364|NCT01553318|366056645|FG001|Overall Study|Protocol Violation|2|||
106109365|NCT00939484|366056650|FG000|Overall Study|Progression/Relapse|8|||
106109366|NCT00939484|366056651|FG001|Overall Study|Progression/Relapse|20|||
106109367|NCT00939484|366056652|FG002|Overall Study|Progression/Relapse|3|||
106109368|NCT04493931|366056662|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
106109369|NCT04493931|366056663|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
106109370|NCT04493931|366056664|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
106109371|NCT04493931|366056665|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
106109372|NCT04493931|366056666|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
106109373|NCT04493931|366056667|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
106109374|NCT04493931|366056668|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
106109375|NCT04493931|366056662|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
106109376|NCT04493931|366056663|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
106109377|NCT04493931|366056664|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
106109378|NCT04493931|366056665|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
106109379|NCT04493931|366056666|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
106109380|NCT04493931|366056667|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
106109381|NCT04493931|366056668|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
106109382|NCT04493931|366056662|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
106109383|NCT04493931|366056663|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
106109384|NCT04493931|366056664|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
106109385|NCT04493931|366056665|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
106109386|NCT04493931|366056666|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
106109387|NCT04493931|366056667|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
106109388|NCT04493931|366056668|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
106109389|NCT04493931|366056662|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
106109390|NCT04493931|366056663|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
106109391|NCT04493931|366056664|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
106109392|NCT04493931|366056665|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
106109393|NCT04493931|366056666|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
105783237|NCT00302731|364859528|FG000|Overall Study|cancer unrelated to study discovered|1|||
105783238|NCT00302731|364859529|FG001|Overall Study|cancer unrelated to study discovered|0|||
105783239|NCT00302731|364859530|FG002|Overall Study|cancer unrelated to study discovered|1|||
105783240|NCT00302731|364859531|FG003|Overall Study|cancer unrelated to study discovered|0|||
105783241|NCT01610752|364859534|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
105783242|NCT01610752|364859535|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
105783243|NCT01610752|364859536|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
105783244|NCT00736840|364859537|FG000|Overall Study|Lost to Follow-up|13|||
105783245|NCT00945815|364859538|FG000|Overall Study|Death|3|||
106109394|NCT04493931|366056667|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
106109395|NCT04493931|366056668|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
105783246|NCT00945815|364859538|FG000|Overall Study|Not protocol specified|1|||
105783247|NCT00945815|364859538|FG000|Overall Study|Ineligible|3|||
106109396|NCT00293267|366056669|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
106109397|NCT00293267|366056670|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
106109398|NCT00293267|366056669|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
106109399|NCT00293267|366056670|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
106109400|NCT00293267|366056669|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
106109401|NCT00293267|366056670|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
106109402|NCT00293267|366056669|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
106109403|NCT00293267|366056670|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
106109404|NCT00293267|366056669|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
106109405|NCT00293267|366056670|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
106109406|NCT00293267|366056669|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
106109407|NCT00293267|366056670|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
106109408|NCT00293267|366056669|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
106109409|NCT00293267|366056670|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
106109410|NCT00293267|366056669|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
106109411|NCT00293267|366056670|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
106109412|NCT00293267|366056669|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
106109413|NCT00293267|366056670|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
106109414|NCT00293267|366056669|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
106109415|NCT00293267|366056670|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
106109416|NCT00293267|366056669|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
106109417|NCT00293267|366056670|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
106109418|NCT00293267|366056669|FG000|Extension - Double-Blind Week 49-156|Death|3|||
106109419|NCT00293267|366056670|FG001|Extension - Double-Blind Week 49-156|Death|0|||
106109420|NCT00293267|366056669|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
106109421|NCT00293267|366056670|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
106109422|NCT00293267|366056669|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
106109423|NCT00293267|366056670|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
106109424|NCT00293267|366056669|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
106109425|NCT00293267|366056670|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
106109426|NCT00293267|366056669|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
106109427|NCT00293267|366056670|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
106109428|NCT00293267|366056669|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
106109429|NCT00293267|366056670|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
106109430|NCT00293267|366056669|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
106109431|NCT00293267|366056670|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
106109432|NCT00293267|366056669|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
106109433|NCT00293267|366056670|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
106109434|NCT00293267|366056669|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
106109435|NCT00293267|366056670|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
106109436|NCT00293267|366056669|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
106109437|NCT00293267|366056670|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
106109438|NCT00293267|366056669|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
106109439|NCT00293267|366056670|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
106109440|NCT00293267|366056669|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
106109441|NCT00293267|366056670|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
106109442|NCT00293267|366056669|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
106109443|NCT00293267|366056670|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
106109444|NCT00293267|366056669|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
106109445|NCT00293267|366056670|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
105661743|NCT04147858|364425118|FG002|Overall Study|Subject Noncompliance, Other|1|||
105783248|NCT00945815|364859538|FG000|Overall Study|Did not begin protocol therapy|1|||
106109446|NCT00293267|366056669|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
106109447|NCT00293267|366056670|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
106109448|NCT00293267|366056669|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
106109449|NCT00293267|366056670|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
106109450|NCT00293267|366056669|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
106109451|NCT00293267|366056670|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
105783249|NCT01728194|364859539|FG000|Overall Study|Lost to Follow-up|4|||
105783250|NCT01728194|364859540|FG001|Overall Study|Lost to Follow-up|3|||
106109452|NCT01050816|366056671|FG000|Overall Study|Lost to Follow-up|2|||
106109453|NCT01050816|366056671|FG000|Overall Study|patient's refusal|2|||
106109454|NCT00677352|366056674|FG000|Treatment Phase|Adverse Event|14|||
105783251|NCT01728194|364859539|FG000|Overall Study|Physician Decision|4|||
105783252|NCT01728194|364859540|FG001|Overall Study|Physician Decision|0|||
105783253|NCT01728194|364859539|FG000|Overall Study|Withdrawal by Subject|7|||
105783254|NCT01728194|364859540|FG001|Overall Study|Withdrawal by Subject|3|||
105783255|NCT01728194|364859539|FG000|Overall Study|Perceived Medication Side Effects|4|||
105783256|NCT01728194|364859540|FG001|Overall Study|Perceived Medication Side Effects|0|||
105783257|NCT01728194|364859539|FG000|Overall Study|Family Member Request|1|||
105783258|NCT01728194|364859540|FG001|Overall Study|Family Member Request|0|||
105783259|NCT02129192|364859543|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
106109455|NCT00677352|366056675|FG001|Treatment Phase|Adverse Event|22|||
106109456|NCT00677352|366056674|FG000|Treatment Phase|Lack of Efficacy|2|||
106109457|NCT00677352|366056675|FG001|Treatment Phase|Lack of Efficacy|3|||
106109458|NCT00677352|366056674|FG000|Treatment Phase|Lost to Follow-up|0|||
106109459|NCT00677352|366056675|FG001|Treatment Phase|Lost to Follow-up|1|||
106109460|NCT00677352|366056674|FG000|Treatment Phase|Withdrawal by Subject|7|||
106109461|NCT00677352|366056675|FG001|Treatment Phase|Withdrawal by Subject|7|||
106109462|NCT00677352|366056674|FG000|Treatment Phase|Physician Decision|1|||
105783260|NCT02129192|364859544|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
105783261|NCT01231620|364859545|FG000|Overall Study|Physician Decision|3|||
105783262|NCT01231620|364859546|FG001|Overall Study|Physician Decision|5|||
105783263|NCT01231620|364859547|FG002|Overall Study|Physician Decision|10|||
105783264|NCT01231620|364859545|FG000|Overall Study|Death|12|||
105783265|NCT01231620|364859546|FG001|Overall Study|Death|14|||
105783266|NCT01231620|364859547|FG002|Overall Study|Death|11|||
105783267|NCT01231620|364859545|FG000|Overall Study|Adverse Event|2|||
105783268|NCT01231620|364859546|FG001|Overall Study|Adverse Event|2|||
105783269|NCT01231620|364859547|FG002|Overall Study|Adverse Event|1|||
105783270|NCT01231620|364859545|FG000|Overall Study|Withdrawal by Subject|6|||
105783271|NCT01231620|364859546|FG001|Overall Study|Withdrawal by Subject|6|||
105783272|NCT01231620|364859547|FG002|Overall Study|Withdrawal by Subject|8|||
105783273|NCT01231620|364859545|FG000|Overall Study|Lost to Follow-up|3|||
105783274|NCT01231620|364859546|FG001|Overall Study|Lost to Follow-up|4|||
105783275|NCT01231620|364859547|FG002|Overall Study|Lost to Follow-up|9|||
105783276|NCT02400281|364859548|FG000|Overall Study|Adverse Event|0|||
105783277|NCT02400281|364859549|FG001|Overall Study|Adverse Event|0|||
105783278|NCT02400281|364859550|FG002|Overall Study|Adverse Event|1|||
106109463|NCT00677352|366056675|FG001|Treatment Phase|Physician Decision|0|||
106109464|NCT00677352|366056674|FG000|Treatment Phase|Pregnancy|0|||
106109465|NCT00677352|366056675|FG001|Treatment Phase|Pregnancy|1|||
106109466|NCT00677352|366056674|FG000|Treatment Phase|Protocol Violation|1|||
106109467|NCT00677352|366056675|FG001|Treatment Phase|Protocol Violation|1|||
106109468|NCT00677352|366056674|FG000|Treatment Phase|Transference or work related matter|0|||
106109469|NCT00677352|366056675|FG001|Treatment Phase|Transference or work related matter|5|||
106109470|NCT00677352|366056674|FG000|Treatment Phase|Not treated|0|||
106109471|NCT00677352|366056675|FG001|Treatment Phase|Not treated|2|||
106109472|NCT00677352|366056674|FG000|Tapering Phase|Adverse Event|1|||
106109473|NCT00677352|366056675|FG001|Tapering Phase|Adverse Event|5|||
106109474|NCT00677352|366056674|FG000|Tapering Phase|Withdrawal by Subject|5|||
106109475|NCT00677352|366056675|FG001|Tapering Phase|Withdrawal by Subject|3|||
106109476|NCT00677352|366056674|FG000|Tapering Phase|Pregnancy|0|||
106109477|NCT00677352|366056675|FG001|Tapering Phase|Pregnancy|1|||
106109478|NCT00677352|366056674|FG000|Tapering Phase|Job transfer|0|||
106109479|NCT00677352|366056675|FG001|Tapering Phase|Job transfer|1|||
106109480|NCT02182973|366056676|FG000|Overall Study|Withdrawal by Subject|3|||
105783279|NCT02400281|364859551|FG003|Overall Study|Adverse Event|0|||
105783280|NCT02400281|364859552|FG004|Overall Study|Adverse Event|1|||
105783281|NCT02400281|364859553|FG005|Overall Study|Adverse Event|0|||
105783282|NCT02400281|364859548|FG000|Overall Study|Physician Decision|0|||
106109481|NCT02182973|366056677|FG001|Overall Study|Withdrawal by Subject|0|||
106109482|NCT01235546|366056678|FG000|Overall Study|Staff error, medication not administered|1|||
106109483|NCT01235546|366056679|FG001|Overall Study|Staff error, medication not administered|0|||
106109484|NCT01235546|366056678|FG000|Overall Study|Protocol Violation|1|||
106109485|NCT01235546|366056679|FG001|Overall Study|Protocol Violation|1|||
106109486|NCT01123382|366056680|FG000|Overall Study|Withdrawal by Subject|1|||
106109487|NCT01123382|366056681|FG001|Overall Study|Withdrawal by Subject|4|||
105783283|NCT02400281|364859549|FG001|Overall Study|Physician Decision|0|||
105783284|NCT02400281|364859550|FG002|Overall Study|Physician Decision|1|||
106109488|NCT01123382|366056680|FG000|Overall Study|Lost to Follow-up|1|||
106109489|NCT01123382|366056681|FG001|Overall Study|Lost to Follow-up|2|||
106109490|NCT00238433|366056682|FG000|Overall Study|Screen failure|1|||
106109491|NCT00238433|366056682|FG000|Overall Study|Lost to Follow-up|1|||
106109492|NCT00238433|366056682|FG000|Overall Study|Death|1|||
106109493|NCT02274857|366056683|FG000|Overall Study|Adverse Event|1|||
106109494|NCT02274857|366056684|FG001|Overall Study|Adverse Event|0|||
106109495|NCT02274857|366056683|FG000|Overall Study|Death|1|||
106109496|NCT02274857|366056684|FG001|Overall Study|Death|2|||
106109497|NCT02274857|366056683|FG000|Overall Study|Lost to Follow-up|3|||
106109498|NCT02274857|366056684|FG001|Overall Study|Lost to Follow-up|0|||
106109499|NCT02274857|366056683|FG000|Overall Study|Physician Decision|2|||
106109500|NCT02274857|366056684|FG001|Overall Study|Physician Decision|0|||
106109501|NCT02274857|366056683|FG000|Overall Study|Trial screen failure|0|||
106109502|NCT02274857|366056684|FG001|Overall Study|Trial screen failure|2|||
106109503|NCT02274857|366056683|FG000|Overall Study|Withdrawal by Subject|11|||
106109504|NCT02274857|366056684|FG001|Overall Study|Withdrawal by Subject|2|||
106109505|NCT02274857|366056683|FG000|Overall Study|Other|2|||
106109506|NCT02274857|366056684|FG001|Overall Study|Other|0|||
106109507|NCT00330174|366056685|FG000|Overall Study|Withdrawal by Subject|7|||
106109508|NCT00330174|366056686|FG001|Overall Study|Withdrawal by Subject|7|||
106109509|NCT00330174|366056685|FG000|Overall Study|Lost to Follow-up|4|||
106109510|NCT00330174|366056686|FG001|Overall Study|Lost to Follow-up|1|||
106109511|NCT00330174|366056685|FG000|Overall Study|Clinical deterioration|1|||
106109512|NCT00330174|366056686|FG001|Overall Study|Clinical deterioration|2|||
106109513|NCT00330174|366056685|FG000|Overall Study|Excessive missed visits|3|||
106109514|NCT00330174|366056686|FG001|Overall Study|Excessive missed visits|8|||
106109515|NCT00330174|366056685|FG000|Overall Study|Miscellaneous reasons|7|||
106109516|NCT00330174|366056686|FG001|Overall Study|Miscellaneous reasons|1|||
106109517|NCT00409682|366056687|FG000|Open-label Induction Period|Adverse Event|1|||
106109518|NCT00409682|366056688|FG001|Open-label Induction Period|Adverse Event|0|||
106109519|NCT00409682|366056689|FG002|Open-label Induction Period|Adverse Event|0|||
106109520|NCT00409682|366056687|FG000|Open-label Induction Period|Lack of Efficacy|1|||
106109521|NCT00409682|366056688|FG001|Open-label Induction Period|Lack of Efficacy|0|||
106109522|NCT00409682|366056689|FG002|Open-label Induction Period|Lack of Efficacy|0|||
106109523|NCT00409682|366056687|FG000|Open-label Induction Period|Protocol Violation|1|||
106109524|NCT00409682|366056688|FG001|Open-label Induction Period|Protocol Violation|0|||
106109525|NCT00409682|366056689|FG002|Open-label Induction Period|Protocol Violation|0|||
106109526|NCT00409682|366056687|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
106109527|NCT00409682|366056688|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
106109528|NCT00409682|366056689|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
106109529|NCT00409682|366056687|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
106109530|NCT00409682|366056688|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
106109531|NCT00409682|366056689|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
106109532|NCT00409682|366056687|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
106109533|NCT00409682|366056688|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
106109534|NCT00409682|366056689|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
106109535|NCT00409682|366056687|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
106109536|NCT00409682|366056688|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
106109537|NCT00409682|366056689|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
106109538|NCT00409682|366056687|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
106109539|NCT00409682|366056688|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
106109540|NCT00409682|366056689|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
106109541|NCT00409682|366056687|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
106109542|NCT00409682|366056688|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
106109543|NCT00409682|366056689|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
106109544|NCT00409682|366056687|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
106109545|NCT00409682|366056688|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
106109546|NCT00409682|366056689|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
106109547|NCT01896869|366056690|FG000|Overall Study|Withdrawal by Subject|0|||
106109548|NCT01896869|366056691|FG001|Overall Study|Withdrawal by Subject|6|||
106109549|NCT01896869|366056690|FG000|Overall Study|Lost to Follow-up|1|||
105661744|NCT01191008|364425119|FG000|Overall Study|Protocol Violation|7|||
106109550|NCT01896869|366056691|FG001|Overall Study|Lost to Follow-up|0|||
106109551|NCT01755702|366056700|FG000|Wash Out Period I|Other Reason|3|||
106109552|NCT01755702|366056700|FG000|Washout Period II|Other Reason|5|||
106109553|NCT00691938|366056701|FG000|Overall Study|QTc prolongation|1|||
106109554|NCT00691938|366056702|FG001|Overall Study|QTc prolongation|0|||
106109555|NCT00691938|366056703|FG002|Overall Study|QTc prolongation|0|||
106109556|NCT00691938|366056704|FG003|Overall Study|QTc prolongation|0|||
106109557|NCT00691938|366056705|FG004|Overall Study|QTc prolongation|0|||
106109558|NCT00691938|366056706|FG005|Overall Study|QTc prolongation|0|||
106109559|NCT00691938|366056707|FG006|Overall Study|QTc prolongation|0|||
106109560|NCT01780935|366056713|FG000|Overall Study|Admin problems due to early termination|321|||
106109561|NCT01780935|366056714|FG001|Overall Study|Admin problems due to early termination|309|||
106109562|NCT01780935|366056713|FG000|Overall Study|Adverse Event|2|||
106109563|NCT01780935|366056714|FG001|Overall Study|Adverse Event|4|||
106109564|NCT01780935|366056713|FG000|Overall Study|Death|1|||
106109565|NCT01780935|366056714|FG001|Overall Study|Death|6|||
106109566|NCT01780935|366056713|FG000|Overall Study|Lost to Follow-up|2|||
106109567|NCT01780935|366056714|FG001|Overall Study|Lost to Follow-up|6|||
106109568|NCT01780935|366056713|FG000|Overall Study|Physician Decision|1|||
106109569|NCT01780935|366056714|FG001|Overall Study|Physician Decision|1|||
106109570|NCT01780935|366056713|FG000|Overall Study|Protocol deviation|0|||
106109571|NCT01780935|366056714|FG001|Overall Study|Protocol deviation|1|||
106109572|NCT01780935|366056713|FG000|Overall Study|Patient withdrew consent|8|||
106109573|NCT01780935|366056714|FG001|Overall Study|Patient withdrew consent|9|||
106109574|NCT01844284|366056715|FG000|Overall Study|Lost to Follow-up|12|||
106109575|NCT01844284|366056716|FG001|Overall Study|Lost to Follow-up|7|||
106109576|NCT02975973|366056728|FG000|Overall Study|Adverse Event|1|||
106109577|NCT02975973|366056729|FG001|Overall Study|Adverse Event|1|||
106109578|NCT02975973|366056730|FG002|Overall Study|Adverse Event|1|||
106109579|NCT02975973|366056731|FG003|Overall Study|Adverse Event|0|||
106109580|NCT02686034|366056736|FG000|Run-In Period 1|Eligibility|12|||
106109581|NCT02686034|366056737|FG001|Run-In Period 1|Eligibility|10|||
106109582|NCT02686034|366056736|FG000|Run-In Period 1|Withdrawal by Subject|4|||
106109583|NCT02686034|366056737|FG001|Run-In Period 1|Withdrawal by Subject|3|||
106109584|NCT02686034|366056736|FG000|Run-In Period 1|Lost to Follow-up|4|||
106109585|NCT02686034|366056737|FG001|Run-In Period 1|Lost to Follow-up|4|||
106109586|NCT02686034|366056736|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
106109587|NCT02686034|366056737|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
106109588|NCT02686034|366056736|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
106109589|NCT02686034|366056737|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
106109590|NCT02686034|366056736|FG000|Randomized Controlled Period 2|Adverse Event|0|||
106109591|NCT02686034|366056737|FG001|Randomized Controlled Period 2|Adverse Event|2|||
106109592|NCT02686034|366056736|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
106109593|NCT02686034|366056737|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
106109594|NCT02686034|366056736|FG000|Open Label Period 3|Lost to Follow-up|0|||
106109595|NCT02686034|366056737|FG001|Open Label Period 3|Lost to Follow-up|1|||
106109596|NCT00552084|366056738|FG000|Overall Study|Adverse Event|2|||
106109597|NCT00552084|366056739|FG001|Overall Study|Adverse Event|3|||
106109598|NCT00552084|366056738|FG000|Overall Study|Withdrawal by Subject|4|||
106109599|NCT00552084|366056739|FG001|Overall Study|Withdrawal by Subject|5|||
106109600|NCT00552084|366056738|FG000|Overall Study|Protocol Violation|1|||
106109601|NCT00552084|366056739|FG001|Overall Study|Protocol Violation|0|||
106109602|NCT00552084|366056738|FG000|Overall Study|change in anti-arrythmic drug|1|||
106109603|NCT00552084|366056739|FG001|Overall Study|change in anti-arrythmic drug|1|||
106109604|NCT04225988|366056740|FG000|Overall Study|Withdrawal by Subject|2|||
106109605|NCT04225988|366056741|FG001|Overall Study|Withdrawal by Subject|0|||
106109606|NCT01525602|366056742|FG000|Overall Study|Adverse Event|1|||
106109607|NCT01525602|366056743|FG001|Overall Study|Adverse Event|0|||
106109608|NCT01525602|366056744|FG002|Overall Study|Adverse Event|1|||
106109609|NCT01525602|366056745|FG003|Overall Study|Adverse Event|1|||
106109610|NCT01525602|366056746|FG004|Overall Study|Adverse Event|3|||
106109611|NCT01525602|366056747|FG005|Overall Study|Adverse Event|3|||
106109612|NCT01525602|366056748|FG006|Overall Study|Adverse Event|0|||
106109613|NCT01525602|366056749|FG007|Overall Study|Adverse Event|1|||
106109614|NCT01525602|366056742|FG000|Overall Study|Disease progression|6|||
106109615|NCT01525602|366056743|FG001|Overall Study|Disease progression|3|||
106109616|NCT01525602|366056744|FG002|Overall Study|Disease progression|2|||
106109617|NCT01525602|366056745|FG003|Overall Study|Disease progression|5|||
106109618|NCT01525602|366056746|FG004|Overall Study|Disease progression|22|||
106109619|NCT01525602|366056747|FG005|Overall Study|Disease progression|2|||
106109620|NCT01525602|366056748|FG006|Overall Study|Disease progression|3|||
106109621|NCT01525602|366056749|FG007|Overall Study|Disease progression|3|||
106109622|NCT01525602|366056742|FG000|Overall Study|Clinical progression|2|||
106109623|NCT01525602|366056743|FG001|Overall Study|Clinical progression|0|||
106109624|NCT01525602|366056744|FG002|Overall Study|Clinical progression|0|||
106109625|NCT01525602|366056745|FG003|Overall Study|Clinical progression|0|||
106109626|NCT01525602|366056746|FG004|Overall Study|Clinical progression|0|||
106109627|NCT01525602|366056747|FG005|Overall Study|Clinical progression|0|||
106109628|NCT01525602|366056748|FG006|Overall Study|Clinical progression|1|||
106109629|NCT01525602|366056749|FG007|Overall Study|Clinical progression|1|||
106109630|NCT01525602|366056742|FG000|Overall Study|Non-compliance|0|||
106109631|NCT01525602|366056743|FG001|Overall Study|Non-compliance|0|||
106109632|NCT01525602|366056744|FG002|Overall Study|Non-compliance|0|||
106109633|NCT01525602|366056745|FG003|Overall Study|Non-compliance|0|||
106109634|NCT01525602|366056746|FG004|Overall Study|Non-compliance|1|||
106109635|NCT01525602|366056747|FG005|Overall Study|Non-compliance|0|||
106109636|NCT01525602|366056748|FG006|Overall Study|Non-compliance|0|||
106109637|NCT01525602|366056749|FG007|Overall Study|Non-compliance|0|||
106109638|NCT01525602|366056742|FG000|Overall Study|Withdrawal by Subject|0|||
105783285|NCT02400281|364859551|FG003|Overall Study|Physician Decision|0|||
105783286|NCT02400281|364859552|FG004|Overall Study|Physician Decision|0|||
105783287|NCT02400281|364859553|FG005|Overall Study|Physician Decision|0|||
105783288|NCT02576652|364859554|FG000|Overall Study|Withdrawal by Subject|2|||
105783289|NCT01087944|364859558|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
105783290|NCT01087944|364859559|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
105783291|NCT01087944|364859558|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
105783292|NCT01087944|364859559|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
106109639|NCT01525602|366056743|FG001|Overall Study|Withdrawal by Subject|0|||
106109640|NCT01525602|366056744|FG002|Overall Study|Withdrawal by Subject|0|||
106109641|NCT01525602|366056745|FG003|Overall Study|Withdrawal by Subject|0|||
106109642|NCT01525602|366056746|FG004|Overall Study|Withdrawal by Subject|3|||
106109643|NCT01525602|366056747|FG005|Overall Study|Withdrawal by Subject|1|||
106109644|NCT01525602|366056748|FG006|Overall Study|Withdrawal by Subject|0|||
106109645|NCT01525602|366056749|FG007|Overall Study|Withdrawal by Subject|1|||
106109646|NCT01525602|366056742|FG000|Overall Study|Physician Decision|0|||
106109647|NCT01525602|366056743|FG001|Overall Study|Physician Decision|0|||
106109648|NCT01525602|366056744|FG002|Overall Study|Physician Decision|0|||
106109649|NCT01525602|366056745|FG003|Overall Study|Physician Decision|0|||
106109650|NCT01525602|366056746|FG004|Overall Study|Physician Decision|3|||
106109651|NCT01525602|366056747|FG005|Overall Study|Physician Decision|0|||
106109652|NCT01525602|366056748|FG006|Overall Study|Physician Decision|1|||
106109653|NCT01525602|366056749|FG007|Overall Study|Physician Decision|0|||
106109654|NCT01525602|366056742|FG000|Overall Study|Death|0|||
106109655|NCT01525602|366056743|FG001|Overall Study|Death|0|||
106109656|NCT01525602|366056744|FG002|Overall Study|Death|0|||
106109657|NCT01525602|366056745|FG003|Overall Study|Death|0|||
106109658|NCT01525602|366056746|FG004|Overall Study|Death|1|||
106109659|NCT01525602|366056747|FG005|Overall Study|Death|1|||
106109660|NCT01525602|366056748|FG006|Overall Study|Death|0|||
106109661|NCT01525602|366056749|FG007|Overall Study|Death|0|||
106109662|NCT01525602|366056742|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
106109663|NCT01525602|366056743|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
106109664|NCT01525602|366056744|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
106109665|NCT01525602|366056745|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
106109666|NCT01525602|366056746|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
106109667|NCT01525602|366056747|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
106109668|NCT01525602|366056748|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
106109669|NCT01525602|366056749|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
106109670|NCT03017079|366056753|FG000|Overall Study|Physician Decision|1|||
106109671|NCT03017079|366056754|FG001|Overall Study|Physician Decision|1|||
106109672|NCT03017079|366056753|FG000|Overall Study|Death|3|||
106109673|NCT03017079|366056754|FG001|Overall Study|Death|2|||
106109674|NCT03017079|366056753|FG000|Overall Study|Lack of Efficacy|2|||
106109675|NCT03017079|366056754|FG001|Overall Study|Lack of Efficacy|2|||
106109676|NCT03017079|366056753|FG000|Overall Study|Protocol Violation|0|||
106109677|NCT03017079|366056754|FG001|Overall Study|Protocol Violation|1|||
106109678|NCT04120233|366056759|FG000|Overall Study|Adverse Event|0|||
106109679|NCT04120233|366056760|FG001|Overall Study|Adverse Event|0|||
106109680|NCT04120233|366056761|FG002|Overall Study|Adverse Event|0|||
106109681|NCT04120233|366056762|FG003|Overall Study|Adverse Event|0|||
106109682|NCT04120233|366056763|FG004|Overall Study|Adverse Event|1|||
106109683|NCT04120233|366056764|FG005|Overall Study|Adverse Event|0|||
106109684|NCT02532179|366058595|FG000|Overall Study|Lost to Follow-up|1|||
106109685|NCT02532179|366058595|FG000|Overall Study|Pregnancy|1|||
106109686|NCT02532179|366058595|FG000|Overall Study|Subject received depot steroid injection|1|||
106109687|NCT01194570|366058596|FG000|Overall Study|Adverse Event|22|||
106109688|NCT01194570|366058597|FG001|Overall Study|Adverse Event|40|||
106109689|NCT01194570|366058596|FG000|Overall Study|Death|6|||
106109690|NCT01194570|366058597|FG001|Overall Study|Death|20|||
106109691|NCT01194570|366058596|FG000|Overall Study|Lack of Efficacy|32|||
106109692|NCT01194570|366058597|FG001|Overall Study|Lack of Efficacy|33|||
106109693|NCT01194570|366058596|FG000|Overall Study|Lost to Follow-up|4|||
106109694|NCT01194570|366058597|FG001|Overall Study|Lost to Follow-up|15|||
106109695|NCT01194570|366058596|FG000|Overall Study|Non-Compliance|2|||
105783293|NCT02451137|364859566|FG000|Overall Study|Randomized but not treated|19|||
106109696|NCT01194570|366058597|FG001|Overall Study|Non-Compliance|2|||
106109697|NCT01194570|366058596|FG000|Overall Study|Non-Compliance With Study Drug|2|||
106109698|NCT01194570|366058597|FG001|Overall Study|Non-Compliance With Study Drug|2|||
105783294|NCT02451137|364859567|FG001|Overall Study|Randomized but not treated|27|||
106109699|NCT01194570|366058596|FG000|Overall Study|Other|18|||
106109700|NCT01194570|366058597|FG001|Overall Study|Other|47|||
106109701|NCT01194570|366058596|FG000|Overall Study|Physician Decision|10|||
106109702|NCT01194570|366058597|FG001|Overall Study|Physician Decision|25|||
106109703|NCT01194570|366058596|FG000|Overall Study|Protocol Violation|1|||
106109704|NCT01194570|366058597|FG001|Overall Study|Protocol Violation|2|||
106109705|NCT01194570|366058596|FG000|Overall Study|Study Terminated By Sponsor|0|||
106109706|NCT01194570|366058597|FG001|Overall Study|Study Terminated By Sponsor|1|||
105783295|NCT02451137|364859566|FG000|Overall Study|Adverse Event|43|||
106109707|NCT01194570|366058596|FG000|Overall Study|Withdrawal by Subject|57|||
106109708|NCT01194570|366058597|FG001|Overall Study|Withdrawal by Subject|82|||
106109709|NCT01194570|366058596|FG000|Overall Study|Pregnancy|1|||
106109710|NCT01194570|366058597|FG001|Overall Study|Pregnancy|1|||
106109711|NCT01337674|366058598|FG000|Treatment Period 1|Adverse Event|0|||
106109712|NCT01337674|366058599|FG001|Treatment Period 1|Adverse Event|1|||
106109713|NCT01337674|366058600|FG002|Treatment Period 1|Adverse Event|0|||
106109714|NCT01337674|366058601|FG003|Treatment Period 1|Adverse Event|0|||
106109715|NCT01337674|366058598|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
106109716|NCT01337674|366058599|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
106109717|NCT01337674|366058600|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
106109718|NCT01337674|366058601|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
106109719|NCT01337674|366058598|FG000|Treatment Period 2|Withdrawal by Subject|0|||
106109720|NCT01337674|366058599|FG001|Treatment Period 2|Withdrawal by Subject|0|||
106109721|NCT01337674|366058600|FG002|Treatment Period 2|Withdrawal by Subject|1|||
106109722|NCT01337674|366058601|FG003|Treatment Period 2|Withdrawal by Subject|0|||
106109723|NCT01224925|366058602|FG000|Overall Study|Lost to Follow-up|3|||
106109724|NCT01224925|366058603|FG001|Overall Study|Lost to Follow-up|2|||
106109725|NCT00989092|366058608|FG000|Overall Study|Physician Decision|9|||
106109726|NCT00989092|366058609|FG001|Overall Study|Physician Decision|6|||
106109727|NCT00989092|366058608|FG000|Overall Study|Adverse Event|20|||
106109728|NCT00989092|366058609|FG001|Overall Study|Adverse Event|1|||
106109729|NCT00989092|366058608|FG000|Overall Study|Chemotherapy initiated|12|||
106109730|NCT00989092|366058609|FG001|Overall Study|Chemotherapy initiated|4|||
106109731|NCT00989092|366058608|FG000|Overall Study|Withdrawal by Subject|17|||
106109732|NCT00989092|366058609|FG001|Overall Study|Withdrawal by Subject|9|||
106109733|NCT00989092|366058608|FG000|Overall Study|Death|14|||
106109734|NCT00989092|366058609|FG001|Overall Study|Death|2|||
106109735|NCT00989092|366058608|FG000|Overall Study|Ineligibility determined|3|||
106109736|NCT00989092|366058609|FG001|Overall Study|Ineligibility determined|3|||
106109737|NCT00989092|366058608|FG000|Overall Study|Lost to Follow-up|6|||
106109738|NCT00989092|366058609|FG001|Overall Study|Lost to Follow-up|2|||
106109739|NCT00989092|366058608|FG000|Overall Study|Other|3|||
106109740|NCT00989092|366058609|FG001|Overall Study|Other|1|||
106109741|NCT00989092|366058608|FG000|Overall Study|Protocol deviation|2|||
106109742|NCT00989092|366058609|FG001|Overall Study|Protocol deviation|0|||
106109743|NCT00989092|366058608|FG000|Overall Study|Erythropoietin therapy initiated|2|||
106109744|NCT00989092|366058609|FG001|Overall Study|Erythropoietin therapy initiated|0|||
106109745|NCT00989092|366058608|FG000|Overall Study|Did not receive study drug|2|||
106109746|NCT00989092|366058609|FG001|Overall Study|Did not receive study drug|0|||
106109747|NCT00415610|366058612|FG000|Overall Study|Death|3|||
106109748|NCT00415610|366058613|FG001|Overall Study|Death|2|||
106109749|NCT00415610|366058614|FG002|Overall Study|Death|5|||
106109750|NCT01301391|366058615|FG000|Overall Study|Death|13|||
106109751|NCT01301391|366058615|FG000|Overall Study|Lost to Follow-up|3|||
106109752|NCT01301391|366058615|FG000|Overall Study|Physician Decision|2|||
106109753|NCT01301391|366058615|FG000|Overall Study|Sponsor's decision|8|||
106109754|NCT04020341|366058617|FG000|Overall Study|Adverse Event|8|||
106109755|NCT04020341|366058618|FG001|Overall Study|Adverse Event|6|||
106109756|NCT04020341|366058617|FG000|Overall Study|Lost to Follow-up|8|||
106109757|NCT04020341|366058618|FG001|Overall Study|Lost to Follow-up|2|||
106109758|NCT04020341|366058617|FG000|Overall Study|Withdrawal by Subject|16|||
106109759|NCT04020341|366058618|FG001|Overall Study|Withdrawal by Subject|16|||
106109760|NCT04020341|366058617|FG000|Overall Study|Participant not able to swallow the tablet|1|||
106109761|NCT04020341|366058618|FG001|Overall Study|Participant not able to swallow the tablet|0|||
106109762|NCT04020341|366058617|FG000|Overall Study|Physician Decision|0|||
106109763|NCT04020341|366058618|FG001|Overall Study|Physician Decision|2|||
106109764|NCT04020341|366058617|FG000|Overall Study|Protocol Deviation|0|||
106109765|NCT04020341|366058618|FG001|Overall Study|Protocol Deviation|2|||
106109766|NCT01814748|366058621|FG000|Overall Study|Lost to Follow-up|1|||
106109767|NCT01814748|366058622|FG001|Overall Study|Lost to Follow-up|2|||
106109768|NCT01814748|366058621|FG000|Overall Study|Study site terminated by sponsor|1|||
106109769|NCT01814748|366058622|FG001|Overall Study|Study site terminated by sponsor|1|||
106109770|NCT01814748|366058621|FG000|Overall Study|Withdrawal by Subject|6|||
106109771|NCT01814748|366058622|FG001|Overall Study|Withdrawal by Subject|4|||
106109772|NCT04044456|366058623|FG000|Overall Study|Lost to Follow-up|4|||
106109773|NCT04044456|366058624|FG001|Overall Study|Lost to Follow-up|1|||
106109774|NCT04044456|366058623|FG000|Overall Study|Withdrawal by Subject|1|||
106109775|NCT04044456|366058624|FG001|Overall Study|Withdrawal by Subject|0|||
106109776|NCT01972529|366058625|FG000|Overall Study|Adverse Event|0|||
106109777|NCT01972529|366058626|FG001|Overall Study|Adverse Event|1|||
106109778|NCT01972529|366058627|FG002|Overall Study|Adverse Event|0|||
106109779|NCT01972529|366058628|FG003|Overall Study|Adverse Event|0|||
106109780|NCT01972529|366058625|FG000|Overall Study|Lost to Follow-up|1|||
106109781|NCT01972529|366058626|FG001|Overall Study|Lost to Follow-up|0|||
106109782|NCT01972529|366058627|FG002|Overall Study|Lost to Follow-up|0|||
106109783|NCT01972529|366058628|FG003|Overall Study|Lost to Follow-up|0|||
106109784|NCT01972529|366058625|FG000|Overall Study|Participant Choice|0|||
105783296|NCT02451137|364859567|FG001|Overall Study|Adverse Event|42|||
105783297|NCT02451137|364859566|FG000|Overall Study|Lack of Efficacy|4|||
105783298|NCT02451137|364859567|FG001|Overall Study|Lack of Efficacy|9|||
105783299|NCT02451137|364859566|FG000|Overall Study|Participant decision:discontinue insulin|41|||
105783300|NCT02451137|364859567|FG001|Overall Study|Participant decision:discontinue insulin|43|||
106109785|NCT01972529|366058626|FG001|Overall Study|Participant Choice|1|||
106109786|NCT01972529|366058627|FG002|Overall Study|Participant Choice|0|||
106109787|NCT01972529|366058628|FG003|Overall Study|Participant Choice|0|||
106109788|NCT01972529|366058625|FG000|Overall Study|Withdrawl of Consent|1|||
105783301|NCT02451137|364859566|FG000|Overall Study|Hypoglycemia|2|||
105783302|NCT02451137|364859567|FG001|Overall Study|Hypoglycemia|1|||
106109789|NCT01972529|366058626|FG001|Overall Study|Withdrawl of Consent|2|||
106109790|NCT01972529|366058627|FG002|Overall Study|Withdrawl of Consent|0|||
106109791|NCT01972529|366058628|FG003|Overall Study|Withdrawl of Consent|1|||
106109792|NCT01972529|366058625|FG000|Overall Study|Other|0|||
106109793|NCT01972529|366058626|FG001|Overall Study|Other|0|||
106109794|NCT01972529|366058627|FG002|Overall Study|Other|0|||
106109795|NCT01972529|366058628|FG003|Overall Study|Other|2|||
106109796|NCT01972529|366058625|FG000|Overall Study|Not treated|0|||
106109797|NCT01972529|366058626|FG001|Overall Study|Not treated|1|||
106109798|NCT01972529|366058627|FG002|Overall Study|Not treated|2|||
106109799|NCT01972529|366058628|FG003|Overall Study|Not treated|1|||
106109800|NCT01591382|366058629|FG000|Overall Study|Discharged Prior to Study Completion|2|||
106109801|NCT01591382|366058630|FG001|Overall Study|Discharged Prior to Study Completion|1|||
106109802|NCT01591382|366058629|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
106109803|NCT01591382|366058630|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
106109804|NCT01059630|366058641|FG000|Overall Study|Death|100|||
106109805|NCT01059630|366058642|FG001|Overall Study|Death|84|||
106109806|NCT01059630|366058641|FG000|Overall Study|Lost to Follow-up|4|||
106109807|NCT01059630|366058642|FG001|Overall Study|Lost to Follow-up|1|||
106109808|NCT01059630|366058641|FG000|Overall Study|Physician Decision|2|||
106109809|NCT01059630|366058642|FG001|Overall Study|Physician Decision|4|||
106109810|NCT01059630|366058641|FG000|Overall Study|Withdrawal by Subject|21|||
106109811|NCT01059630|366058642|FG001|Overall Study|Withdrawal by Subject|14|||
106109812|NCT02403180|366058643|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
106109813|NCT02403180|366058644|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
106109814|NCT02403180|366058643|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
106109815|NCT02403180|366058644|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
106109816|NCT03002610|366058651|FG000|Overall Study|Withdrawal by Subject|6|||
106109817|NCT03002610|366058652|FG001|Overall Study|Withdrawal by Subject|25|||
106109818|NCT03002610|366058653|FG002|Overall Study|Withdrawal by Subject|13|||
106109819|NCT02436811|366058654|FG000|Overall Study|Lost to Follow-up|2|||
106109820|NCT02436811|366058655|FG001|Overall Study|Lost to Follow-up|9|||
106109821|NCT02436811|366058656|FG002|Overall Study|Lost to Follow-up|7|||
106109822|NCT02657317|366058661|FG000|Overall Study|Withdrawal by Subject|2|||
106109823|NCT02657317|366058662|FG001|Overall Study|Withdrawal by Subject|0|||
106109824|NCT02657317|366058661|FG000|Overall Study|Lost to Follow-up|3|||
106109825|NCT02657317|366058662|FG001|Overall Study|Lost to Follow-up|3|||
106109826|NCT01089374|366058663|FG000|Overall Study|Lost to Follow-up|3|||
106109827|NCT01089374|366058664|FG001|Overall Study|Lost to Follow-up|0|||
106109828|NCT01089374|366058663|FG000|Overall Study|Withdrawal by Subject|1|||
106109829|NCT01089374|366058664|FG001|Overall Study|Withdrawal by Subject|0|||
106109830|NCT01089374|366058663|FG000|Overall Study|Study closed early - low accrual|6|||
105783303|NCT02451137|364859566|FG000|Overall Study|Investigator's decision|23|||
105783304|NCT02451137|364859567|FG001|Overall Study|Investigator's decision|19|||
105783305|NCT02451137|364859566|FG000|Overall Study|Lost to Follow-up|53|||
105783306|NCT02451137|364859567|FG001|Overall Study|Lost to Follow-up|61|||
105783307|NCT02451137|364859566|FG000|Overall Study|Physician Decision|6|||
105783308|NCT02451137|364859567|FG001|Overall Study|Physician Decision|5|||
105783309|NCT02451137|364859566|FG000|Overall Study|Sponsor decision|13|||
105783310|NCT02451137|364859567|FG001|Overall Study|Sponsor decision|25|||
106109831|NCT01089374|366058664|FG001|Overall Study|Study closed early - low accrual|0|||
105783311|NCT02451137|364859566|FG000|Overall Study|Withdrawal by Subject|40|||
105783312|NCT02451137|364859567|FG001|Overall Study|Withdrawal by Subject|63|||
105783313|NCT02451137|364859566|FG000|Overall Study|Other than specified above|2|||
106109832|NCT01201811|366058665|FG000|Overall Study|Adverse Event|6|||
106109833|NCT01201811|366058665|FG000|Overall Study|Disease progression|3|||
106109834|NCT01201811|366058665|FG000|Overall Study|Withdrawal by Subject|3|||
106109835|NCT01201811|366058665|FG000|Overall Study|Death|4|||
106109836|NCT01201811|366058665|FG000|Overall Study|Treatment Failure|2|||
106109837|NCT01201811|366058665|FG000|Overall Study|Physician Decision|1|||
105783314|NCT02451137|364859567|FG001|Overall Study|Other than specified above|3|||
106109838|NCT03494166|366058666|FG000|Overall Study|Death|0|||
106109839|NCT03494166|366058667|FG001|Overall Study|Death|0|||
106109840|NCT03494166|366058668|FG002|Overall Study|Death|0|||
106109841|NCT03494166|366058669|FG003|Overall Study|Death|1|||
106109842|NCT03494166|366058670|FG004|Overall Study|Death|3|||
106109843|NCT03494166|366058671|FG005|Overall Study|Death|0|||
105783315|NCT01977573|364859568|FG000|Overall Study|Adverse Event|7|||
105783316|NCT01977573|364859569|FG001|Overall Study|Adverse Event|0|||
105783317|NCT01977573|364859570|FG002|Overall Study|Adverse Event|2|||
105783318|NCT01977573|364859571|FG003|Overall Study|Adverse Event|1|||
105783319|NCT01977573|364859568|FG000|Overall Study|Lost to Follow-up|1|||
105783320|NCT01977573|364859569|FG001|Overall Study|Lost to Follow-up|0|||
105783321|NCT01977573|364859570|FG002|Overall Study|Lost to Follow-up|0|||
105783322|NCT01977573|364859571|FG003|Overall Study|Lost to Follow-up|1|||
105783323|NCT01977573|364859568|FG000|Overall Study|Physician Decision|1|||
105783324|NCT01977573|364859569|FG001|Overall Study|Physician Decision|0|||
105783325|NCT01977573|364859570|FG002|Overall Study|Physician Decision|0|||
105783326|NCT01977573|364859571|FG003|Overall Study|Physician Decision|0|||
105783327|NCT01977573|364859568|FG000|Overall Study|Protocol Violation|3|||
105783328|NCT01977573|364859569|FG001|Overall Study|Protocol Violation|1|||
105783329|NCT01977573|364859570|FG002|Overall Study|Protocol Violation|0|||
105783330|NCT01977573|364859571|FG003|Overall Study|Protocol Violation|0|||
105783331|NCT01977573|364859568|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
105783332|NCT01977573|364859569|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
105783333|NCT01977573|364859570|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
105783334|NCT01977573|364859571|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
105783335|NCT01977573|364859568|FG000|Overall Study|Withdrawal by Subject|6|||
105783336|NCT01977573|364859569|FG001|Overall Study|Withdrawal by Subject|1|||
105783337|NCT01977573|364859570|FG002|Overall Study|Withdrawal by Subject|1|||
105783338|NCT01977573|364859571|FG003|Overall Study|Withdrawal by Subject|1|||
105783339|NCT00765726|364859575|FG000|Overall Study|Withdrawal by Subject|1|||
105783340|NCT00765726|364859575|FG000|Overall Study|Discontinuation of study by sponsor|8|||
105783341|NCT01265511|364859576|FG000|Overall Study|Lack of Efficacy|2|||
105783342|NCT01265511|364859577|FG001|Overall Study|Lack of Efficacy|1|||
105783343|NCT01265511|364859576|FG000|Overall Study|Met stopping rules|0|||
105783344|NCT01265511|364859577|FG001|Overall Study|Met stopping rules|2|||
105783345|NCT01790633|364859578|FG000|Overall Study|Protocol Violation|1|||
105783346|NCT01790633|364859579|FG001|Overall Study|Protocol Violation|2|||
105783347|NCT01790633|364859578|FG000|Overall Study|Did not have serology performed|47|||
105783348|NCT01790633|364859579|FG001|Overall Study|Did not have serology performed|0|||
105783349|NCT01790633|364859578|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
105783350|NCT01790633|364859579|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
105783351|NCT00223990|364859580|FG000|Overall Study|Moved from area|2|||
105783352|NCT00223990|364859581|FG001|Overall Study|Moved from area|1|||
105783353|NCT00223990|364859580|FG000|Overall Study|Withdrawal by Subject|4|||
105783354|NCT00223990|364859581|FG001|Overall Study|Withdrawal by Subject|8|||
105783355|NCT00223990|364859580|FG000|Overall Study|Lost to Follow-up|1|||
105783356|NCT00223990|364859581|FG001|Overall Study|Lost to Follow-up|0|||
105783357|NCT01519700|364860717|FG000|Overall Study|Death|1|||
105783358|NCT01519700|364860718|FG001|Overall Study|Death|0|||
105783359|NCT01519700|364860719|FG002|Overall Study|Death|0|||
105783360|NCT01519700|364860720|FG003|Overall Study|Death|0|||
105783361|NCT01519700|364860717|FG000|Overall Study|Lost to Follow-up|0|||
105783362|NCT01519700|364860718|FG001|Overall Study|Lost to Follow-up|0|||
105783363|NCT01519700|364860719|FG002|Overall Study|Lost to Follow-up|1|||
105783364|NCT01519700|364860720|FG003|Overall Study|Lost to Follow-up|1|||
105783365|NCT01519700|364860717|FG000|Overall Study|Physician Decision|1|||
105783366|NCT01519700|364860718|FG001|Overall Study|Physician Decision|1|||
105783367|NCT01519700|364860719|FG002|Overall Study|Physician Decision|3|||
105783368|NCT01519700|364860720|FG003|Overall Study|Physician Decision|0|||
106109844|NCT03494166|366058666|FG000|Overall Study|Lost to Follow-up|2|||
106109845|NCT03494166|366058667|FG001|Overall Study|Lost to Follow-up|2|||
106109846|NCT03494166|366058668|FG002|Overall Study|Lost to Follow-up|2|||
106109847|NCT03494166|366058669|FG003|Overall Study|Lost to Follow-up|2|||
106109848|NCT03494166|366058670|FG004|Overall Study|Lost to Follow-up|14|||
106109849|NCT03494166|366058671|FG005|Overall Study|Lost to Follow-up|0|||
106109850|NCT03494166|366058666|FG000|Overall Study|Withdrawal by Subject|10|||
106109851|NCT03494166|366058667|FG001|Overall Study|Withdrawal by Subject|7|||
106109852|NCT03494166|366058668|FG002|Overall Study|Withdrawal by Subject|0|||
106109853|NCT03494166|366058669|FG003|Overall Study|Withdrawal by Subject|5|||
106109854|NCT03494166|366058670|FG004|Overall Study|Withdrawal by Subject|3|||
106109855|NCT03494166|366058671|FG005|Overall Study|Withdrawal by Subject|17|||
106109856|NCT03494166|366058666|FG000|Overall Study|Screen failure|1|||
106109857|NCT03494166|366058667|FG001|Overall Study|Screen failure|0|||
105783369|NCT01519700|364860717|FG000|Overall Study|Withdrawal by Subject|5|||
106109858|NCT03494166|366058668|FG002|Overall Study|Screen failure|0|||
106109859|NCT03494166|366058669|FG003|Overall Study|Screen failure|0|||
105783370|NCT01519700|364860718|FG001|Overall Study|Withdrawal by Subject|3|||
105783371|NCT01519700|364860719|FG002|Overall Study|Withdrawal by Subject|3|||
105783372|NCT01519700|364860720|FG003|Overall Study|Withdrawal by Subject|2|||
105783373|NCT01519700|364860717|FG000|Overall Study|Other Reason|2|||
105783374|NCT01519700|364860718|FG001|Overall Study|Other Reason|2|||
105783375|NCT01519700|364860719|FG002|Overall Study|Other Reason|0|||
105783376|NCT01519700|364860720|FG003|Overall Study|Other Reason|4|||
105783377|NCT00346775|364860721|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
106109860|NCT03494166|366058670|FG004|Overall Study|Screen failure|1|||
105783378|NCT00346775|364860722|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
105783379|NCT00346775|364860721|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
105783380|NCT00346775|364860722|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
105783381|NCT00346775|364860721|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
105783382|NCT00346775|364860722|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
105783383|NCT02946515|364860723|FG000|Overall Study|Lost to Follow-up|2|||
105783384|NCT02946515|364860724|FG001|Overall Study|Lost to Follow-up|1|||
105783385|NCT01714726|364860725|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
105783386|NCT01714726|364860726|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
105783387|NCT01714726|364860727|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
105783388|NCT01714726|364860728|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
105783389|NCT01714726|364860725|FG000|Double-Blinded Induction Period|Adverse Event|0|||
105783390|NCT01714726|364860726|FG001|Double-Blinded Induction Period|Adverse Event|1|||
105783391|NCT01714726|364860727|FG002|Double-Blinded Induction Period|Adverse Event|0|||
105783392|NCT01714726|364860728|FG003|Double-Blinded Induction Period|Adverse Event|0|||
105783393|NCT01714726|364860725|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
105783394|NCT01714726|364860726|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
105783395|NCT01714726|364860727|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
105783396|NCT01714726|364860728|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
105783397|NCT01714726|364860725|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
105783398|NCT01714726|364860726|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
106109861|NCT03494166|366058671|FG005|Overall Study|Screen failure|0|||
106109862|NCT02755597|366058672|FG000|Overall Study|Withdrew consent|27|||
106109863|NCT02755597|366058673|FG001|Overall Study|Withdrew consent|11|||
106109864|NCT02755597|366058672|FG000|Overall Study|Lost to Follow-up|1|||
106109865|NCT02755597|366058673|FG001|Overall Study|Lost to Follow-up|0|||
106109866|NCT02755597|366058672|FG000|Overall Study|Death|78|||
106109867|NCT02755597|366058673|FG001|Overall Study|Death|36|||
106109868|NCT02755597|366058672|FG000|Overall Study|Study terminated by Sponsor|67|||
106109869|NCT02755597|366058673|FG001|Overall Study|Study terminated by Sponsor|47|||
106109870|NCT02755597|366058672|FG000|Overall Study|Other, not specified|20|||
106109871|NCT02755597|366058673|FG001|Overall Study|Other, not specified|3|||
106109872|NCT02755597|366058672|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
106109873|NCT02755597|366058673|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
106109874|NCT01422408|366058688|FG000|Overall Study|Adverse Event|1|||
105783399|NCT01714726|364860727|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
105783400|NCT01714726|364860728|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
105783401|NCT01714726|364860725|FG000|Open-Label Period|Other|0|||
105783402|NCT01714726|364860726|FG001|Open-Label Period|Other|0|||
105783403|NCT01714726|364860727|FG002|Open-Label Period|Other|1|||
105783404|NCT01714726|364860728|FG003|Open-Label Period|Other|3|||
106109875|NCT01422408|366058688|FG000|Overall Study|Withdrawal by Subject|3|||
106109876|NCT00701038|366058692|FG000|Overall Study|study amended pilot group of patients|4|||
106109877|NCT00701038|366058693|FG001|Overall Study|study amended pilot group of patients|4|||
106109878|NCT03371940|366058697|FG000|Overall Study|Withdrawal by Subject|8|||
106109879|NCT03371940|366058698|FG001|Overall Study|Withdrawal by Subject|1|||
106109880|NCT03371940|366058699|FG002|Overall Study|Withdrawal by Subject|3|||
106109881|NCT03371940|366058700|FG003|Overall Study|Withdrawal by Subject|4|||
106109882|NCT05099926|366058706|FG000|Overall Study|Lost to Follow-up|1|||
106109883|NCT03685591|366058716|FG000|Overall Study|Global Deterioration of Health Status|0|||
106109884|NCT03685591|366058717|FG001|Overall Study|Global Deterioration of Health Status|0|||
106109885|NCT03685591|366058718|FG002|Overall Study|Global Deterioration of Health Status|0|||
106109886|NCT03685591|366058719|FG003|Overall Study|Global Deterioration of Health Status|1|||
106109887|NCT03685591|366058720|FG004|Overall Study|Global Deterioration of Health Status|2|||
106109888|NCT03685591|366058721|FG005|Overall Study|Global Deterioration of Health Status|4|||
106109889|NCT03685591|366058722|FG006|Overall Study|Global Deterioration of Health Status|1|||
106109890|NCT03685591|366058723|FG007|Overall Study|Global Deterioration of Health Status|1|||
106109891|NCT03685591|366058724|FG008|Overall Study|Global Deterioration of Health Status|0|||
106109892|NCT03685591|366058716|FG000|Overall Study|Progressive Disease|1|||
106109893|NCT03685591|366058717|FG001|Overall Study|Progressive Disease|1|||
106109894|NCT03685591|366058718|FG002|Overall Study|Progressive Disease|0|||
105783405|NCT01714726|364860725|FG000|Open-Label Period|Adverse Event|0|||
105783406|NCT01714726|364860726|FG001|Open-Label Period|Adverse Event|0|||
105783407|NCT01714726|364860727|FG002|Open-Label Period|Adverse Event|1|||
106109895|NCT03685591|366058719|FG003|Overall Study|Progressive Disease|3|||
106109896|NCT03685591|366058720|FG004|Overall Study|Progressive Disease|5|||
106109897|NCT03685591|366058721|FG005|Overall Study|Progressive Disease|4|||
106109898|NCT03685591|366058722|FG006|Overall Study|Progressive Disease|3|||
105783408|NCT01714726|364860728|FG003|Open-Label Period|Adverse Event|0|||
106109899|NCT03685591|366058723|FG007|Overall Study|Progressive Disease|2|||
106109900|NCT03685591|366058724|FG008|Overall Study|Progressive Disease|1|||
106109901|NCT03685591|366058716|FG000|Overall Study|Other|0|||
106109902|NCT03685591|366058717|FG001|Overall Study|Other|0|||
106109903|NCT03685591|366058718|FG002|Overall Study|Other|1|||
106109904|NCT03685591|366058719|FG003|Overall Study|Other|0|||
106109905|NCT03685591|366058720|FG004|Overall Study|Other|2|||
106109906|NCT03685591|366058721|FG005|Overall Study|Other|3|||
106109907|NCT03685591|366058722|FG006|Overall Study|Other|0|||
106109908|NCT03685591|366058723|FG007|Overall Study|Other|0|||
106109909|NCT03685591|366058724|FG008|Overall Study|Other|0|||
106109910|NCT03685591|366058716|FG000|Overall Study|Withdrawal by Subject|0|||
106109911|NCT03685591|366058717|FG001|Overall Study|Withdrawal by Subject|0|||
106109912|NCT03685591|366058718|FG002|Overall Study|Withdrawal by Subject|0|||
106109913|NCT03685591|366058719|FG003|Overall Study|Withdrawal by Subject|0|||
106109914|NCT03685591|366058720|FG004|Overall Study|Withdrawal by Subject|3|||
106109915|NCT03685591|366058721|FG005|Overall Study|Withdrawal by Subject|2|||
106109916|NCT03685591|366058722|FG006|Overall Study|Withdrawal by Subject|0|||
106109917|NCT03685591|366058723|FG007|Overall Study|Withdrawal by Subject|0|||
106109918|NCT03685591|366058724|FG008|Overall Study|Withdrawal by Subject|1|||
106109919|NCT03685591|366058716|FG000|Overall Study|Adverse Event|0|||
106109920|NCT03685591|366058717|FG001|Overall Study|Adverse Event|0|||
106109921|NCT03685591|366058718|FG002|Overall Study|Adverse Event|0|||
106109922|NCT03685591|366058719|FG003|Overall Study|Adverse Event|1|||
106109923|NCT03685591|366058720|FG004|Overall Study|Adverse Event|1|||
106109924|NCT03685591|366058721|FG005|Overall Study|Adverse Event|4|||
106109925|NCT03685591|366058722|FG006|Overall Study|Adverse Event|0|||
106109926|NCT03685591|366058723|FG007|Overall Study|Adverse Event|1|||
106109927|NCT03685591|366058724|FG008|Overall Study|Adverse Event|1|||
106109928|NCT01218126|366058725|FG000|Overall Study|Adverse Event|8|||
106109929|NCT01218126|366058726|FG001|Overall Study|Adverse Event|10|||
106109930|NCT01218126|366058727|FG002|Overall Study|Adverse Event|12|||
106109931|NCT01218126|366058728|FG003|Overall Study|Adverse Event|16|||
106109932|NCT01218126|366058725|FG000|Overall Study|Lack of Efficacy|7|||
106109933|NCT01218126|366058726|FG001|Overall Study|Lack of Efficacy|2|||
106109934|NCT01218126|366058727|FG002|Overall Study|Lack of Efficacy|2|||
106109935|NCT01218126|366058728|FG003|Overall Study|Lack of Efficacy|6|||
106109936|NCT01218126|366058725|FG000|Overall Study|Protocol Violation|5|||
106109937|NCT01218126|366058726|FG001|Overall Study|Protocol Violation|2|||
106109938|NCT01218126|366058727|FG002|Overall Study|Protocol Violation|2|||
106109939|NCT01218126|366058728|FG003|Overall Study|Protocol Violation|3|||
106109940|NCT01218126|366058725|FG000|Overall Study|Protocol-defined stopping criteria|1|||
106109941|NCT01218126|366058726|FG001|Overall Study|Protocol-defined stopping criteria|1|||
106109942|NCT01218126|366058727|FG002|Overall Study|Protocol-defined stopping criteria|0|||
106109943|NCT01218126|366058728|FG003|Overall Study|Protocol-defined stopping criteria|0|||
106109944|NCT01218126|366058725|FG000|Overall Study|Lost to Follow-up|0|||
106109945|NCT01218126|366058726|FG001|Overall Study|Lost to Follow-up|0|||
106109946|NCT01218126|366058727|FG002|Overall Study|Lost to Follow-up|0|||
106109947|NCT01218126|366058728|FG003|Overall Study|Lost to Follow-up|2|||
106109948|NCT01218126|366058725|FG000|Overall Study|Physician Decision|1|||
106109949|NCT01218126|366058726|FG001|Overall Study|Physician Decision|2|||
106109950|NCT01218126|366058727|FG002|Overall Study|Physician Decision|4|||
106109951|NCT01218126|366058728|FG003|Overall Study|Physician Decision|2|||
106109952|NCT01218126|366058725|FG000|Overall Study|Withdrawal by Subject|2|||
106109953|NCT01218126|366058726|FG001|Overall Study|Withdrawal by Subject|5|||
106109954|NCT01218126|366058727|FG002|Overall Study|Withdrawal by Subject|4|||
106109955|NCT01218126|366058728|FG003|Overall Study|Withdrawal by Subject|6|||
106109956|NCT00500903|366058729|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
106109957|NCT00500903|366058730|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
106109958|NCT00500903|366058731|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
106109959|NCT00500903|366058729|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
106109960|NCT00500903|366058730|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
106109961|NCT00500903|366058731|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
106109962|NCT00500903|366058729|FG000|Overall Study|Progressive Disease|41|||
106109963|NCT00500903|366058730|FG001|Overall Study|Progressive Disease|2|||
106109964|NCT00500903|366058731|FG002|Overall Study|Progressive Disease|15|||
106109965|NCT00500903|366058729|FG000|Overall Study|Patient Declined Further Treatment|0|||
106109966|NCT00500903|366058730|FG001|Overall Study|Patient Declined Further Treatment|0|||
106109967|NCT00500903|366058731|FG002|Overall Study|Patient Declined Further Treatment|3|||
106109968|NCT00500903|366058729|FG000|Overall Study|Symptomatic Deterioration|2|||
106109969|NCT00500903|366058730|FG001|Overall Study|Symptomatic Deterioration|0|||
106109970|NCT00500903|366058731|FG002|Overall Study|Symptomatic Deterioration|0|||
106109971|NCT00500903|366058729|FG000|Overall Study|Reason Not Specified|10|||
106109972|NCT00500903|366058730|FG001|Overall Study|Reason Not Specified|0|||
106109973|NCT00500903|366058731|FG002|Overall Study|Reason Not Specified|2|||
106109974|NCT00698646|366058735|FG000|Overall Study|Adverse Event|8|||
106109975|NCT00698646|366058736|FG001|Overall Study|Adverse Event|7|||
106109976|NCT00698646|366058737|FG002|Overall Study|Adverse Event|8|||
106109977|NCT00698646|366058735|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
106109978|NCT00698646|366058736|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
106109979|NCT00698646|366058737|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
106109980|NCT00698646|366058735|FG000|Overall Study|Protocol Deviation|6|||
105783409|NCT01714726|364860725|FG000|Open-Label Period|Withdrawal by Subject|0|||
105783410|NCT01714726|364860726|FG001|Open-Label Period|Withdrawal by Subject|0|||
105783411|NCT01714726|364860727|FG002|Open-Label Period|Withdrawal by Subject|9|||
105783412|NCT01714726|364860728|FG003|Open-Label Period|Withdrawal by Subject|19|||
105783413|NCT01714726|364860725|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
105783414|NCT01714726|364860726|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
105783415|NCT01714726|364860727|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
105783416|NCT01714726|364860728|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
105783417|NCT01714726|364860725|FG000|Open-Label Period|Lost to Follow-up|0|||
105783418|NCT01714726|364860726|FG001|Open-Label Period|Lost to Follow-up|0|||
105783419|NCT01714726|364860727|FG002|Open-Label Period|Lost to Follow-up|3|||
105783420|NCT01714726|364860728|FG003|Open-Label Period|Lost to Follow-up|4|||
105783421|NCT03778021|364860735|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
105783422|NCT03778021|364860736|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
105783423|NCT01545375|364860737|FG000|Overall Study|Adverse Event|2|||
105783424|NCT01545375|364860738|FG001|Overall Study|Adverse Event|1|||
105783425|NCT01545375|364860737|FG000|Overall Study|Lost to Follow-up|34|||
105783426|NCT01545375|364860738|FG001|Overall Study|Lost to Follow-up|31|||
105783427|NCT01545375|364860737|FG000|Overall Study|Protocol Violation|3|||
105783428|NCT01545375|364860738|FG001|Overall Study|Protocol Violation|3|||
105783429|NCT01545375|364860737|FG000|Overall Study|Withdrawal by Subject|58|||
105783430|NCT01545375|364860738|FG001|Overall Study|Withdrawal by Subject|55|||
105783431|NCT05111548|364860740|FG000|Overall Study|Withdrawal by Subject|2|||
105783432|NCT05111548|364860741|FG001|Overall Study|Withdrawal by Subject|1|||
105783433|NCT05111548|364860740|FG000|Overall Study|Adverse Event|1|||
105783434|NCT05111548|364860741|FG001|Overall Study|Adverse Event|0|||
105783435|NCT00379639|364860742|FG000|Overall Study|Disease Progression|3|||
105783436|NCT00379639|364860743|FG001|Overall Study|Disease Progression|3|||
105783437|NCT00379639|364860744|FG002|Overall Study|Disease Progression|3|||
105783438|NCT00379639|364860745|FG003|Overall Study|Disease Progression|4|||
105783439|NCT00379639|364860746|FG004|Overall Study|Disease Progression|4|||
105783440|NCT00379639|364860742|FG000|Overall Study|Physician Decision|0|||
105783441|NCT00379639|364860743|FG001|Overall Study|Physician Decision|2|||
105783442|NCT00379639|364860744|FG002|Overall Study|Physician Decision|1|||
105783443|NCT00379639|364860745|FG003|Overall Study|Physician Decision|1|||
105783444|NCT00379639|364860746|FG004|Overall Study|Physician Decision|0|||
105783445|NCT00379639|364860742|FG000|Overall Study|Symptomatic Deterioration|0|||
105783446|NCT00379639|364860743|FG001|Overall Study|Symptomatic Deterioration|0|||
105783447|NCT00379639|364860744|FG002|Overall Study|Symptomatic Deterioration|1|||
105783448|NCT00379639|364860745|FG003|Overall Study|Symptomatic Deterioration|0|||
105783449|NCT00379639|364860746|FG004|Overall Study|Symptomatic Deterioration|1|||
105783450|NCT00379639|364860742|FG000|Overall Study|Adverse Event|0|||
105783451|NCT00379639|364860743|FG001|Overall Study|Adverse Event|0|||
105783452|NCT00379639|364860744|FG002|Overall Study|Adverse Event|1|||
105783453|NCT00379639|364860745|FG003|Overall Study|Adverse Event|0|||
105783454|NCT00379639|364860746|FG004|Overall Study|Adverse Event|1|||
105783455|NCT00379639|364860742|FG000|Overall Study|Lost to Follow-up|0|||
105783456|NCT00379639|364860743|FG001|Overall Study|Lost to Follow-up|0|||
105783457|NCT00379639|364860744|FG002|Overall Study|Lost to Follow-up|0|||
105783458|NCT00379639|364860745|FG003|Overall Study|Lost to Follow-up|1|||
105783459|NCT00379639|364860746|FG004|Overall Study|Lost to Follow-up|0|||
105783460|NCT00379639|364860742|FG000|Overall Study|Other|0|||
105783461|NCT00379639|364860743|FG001|Overall Study|Other|0|||
105783462|NCT00379639|364860744|FG002|Overall Study|Other|3|||
105783463|NCT00379639|364860745|FG003|Overall Study|Other|0|||
105783464|NCT00379639|364860746|FG004|Overall Study|Other|0|||
105783465|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
105783466|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
105783467|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783468|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783469|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783470|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783471|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105661745|NCT01191008|364425119|FG000|Overall Study|Lost to Follow-up|8|||
105783472|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783473|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783474|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783475|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783476|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
105783477|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
105783478|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783479|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783480|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783481|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
106109981|NCT00698646|366058736|FG001|Overall Study|Protocol Deviation|2|||
105783482|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783483|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
105783484|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783485|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783486|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783487|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
105783488|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
105783489|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783490|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
105783491|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783492|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783493|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783494|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783495|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783496|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783497|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783498|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783499|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783500|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
105783501|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
105783502|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
105783503|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
105783504|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
106109982|NCT00698646|366058737|FG002|Overall Study|Protocol Deviation|3|||
106109983|NCT00698646|366058735|FG000|Overall Study|Withdrawal by Subject|10|||
106109984|NCT00698646|366058736|FG001|Overall Study|Withdrawal by Subject|11|||
106109985|NCT00698646|366058737|FG002|Overall Study|Withdrawal by Subject|8|||
106109986|NCT00698646|366058735|FG000|Overall Study|Lost to Follow-up|0|||
106109987|NCT00698646|366058736|FG001|Overall Study|Lost to Follow-up|0|||
106109988|NCT00698646|366058737|FG002|Overall Study|Lost to Follow-up|2|||
106109989|NCT00698646|366058735|FG000|Overall Study|Administrative problems|1|||
106109990|NCT00698646|366058736|FG001|Overall Study|Administrative problems|0|||
106109991|NCT00698646|366058737|FG002|Overall Study|Administrative problems|1|||
106109992|NCT00279201|366058738|FG000|Initiation|Death|1|||
106109993|NCT00279201|366058739|FG001|Initiation|Death|5|||
106109994|NCT00279201|366058740|FG002|Initiation|Death|0|||
106109995|NCT00279201|366058741|FG003|Initiation|Death|0|||
106109996|NCT00279201|366058742|FG004|Initiation|Death|0|||
106109997|NCT00279201|366058743|FG005|Initiation|Death|0|||
106109998|NCT00279201|366058738|FG000|Initiation|Adverse Event|6|||
106109999|NCT00279201|366058739|FG001|Initiation|Adverse Event|15|||
106110000|NCT00279201|366058740|FG002|Initiation|Adverse Event|0|||
106110001|NCT00279201|366058741|FG003|Initiation|Adverse Event|0|||
106110002|NCT00279201|366058742|FG004|Initiation|Adverse Event|0|||
106110003|NCT00279201|366058743|FG005|Initiation|Adverse Event|0|||
106110004|NCT00279201|366058738|FG000|Initiation|Lost to Follow-up|42|||
106110005|NCT00279201|366058739|FG001|Initiation|Lost to Follow-up|41|||
106110006|NCT00279201|366058740|FG002|Initiation|Lost to Follow-up|0|||
106110007|NCT00279201|366058741|FG003|Initiation|Lost to Follow-up|0|||
106110008|NCT00279201|366058742|FG004|Initiation|Lost to Follow-up|0|||
106110009|NCT00279201|366058743|FG005|Initiation|Lost to Follow-up|0|||
106110010|NCT00279201|366058738|FG000|Initiation|Entry Criteria Exclusion|7|||
106110011|NCT00279201|366058739|FG001|Initiation|Entry Criteria Exclusion|9|||
106110012|NCT00279201|366058740|FG002|Initiation|Entry Criteria Exclusion|0|||
106110013|NCT00279201|366058741|FG003|Initiation|Entry Criteria Exclusion|0|||
106110014|NCT00279201|366058742|FG004|Initiation|Entry Criteria Exclusion|0|||
105783505|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
105783506|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
105783507|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
105783508|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
105783509|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
106110015|NCT00279201|366058743|FG005|Initiation|Entry Criteria Exclusion|0|||
106110016|NCT00279201|366058738|FG000|Initiation|Protocol Violation|9|||
106110017|NCT00279201|366058739|FG001|Initiation|Protocol Violation|10|||
106110018|NCT00279201|366058740|FG002|Initiation|Protocol Violation|0|||
106110019|NCT00279201|366058741|FG003|Initiation|Protocol Violation|0|||
106110020|NCT00279201|366058742|FG004|Initiation|Protocol Violation|0|||
106110021|NCT00279201|366058743|FG005|Initiation|Protocol Violation|0|||
106110022|NCT00279201|366058738|FG000|Initiation|Withdrawal by Subject|35|||
106110023|NCT00279201|366058739|FG001|Initiation|Withdrawal by Subject|41|||
106110024|NCT00279201|366058740|FG002|Initiation|Withdrawal by Subject|0|||
106110025|NCT00279201|366058741|FG003|Initiation|Withdrawal by Subject|0|||
106110026|NCT00279201|366058742|FG004|Initiation|Withdrawal by Subject|0|||
106110027|NCT00279201|366058743|FG005|Initiation|Withdrawal by Subject|0|||
106110028|NCT00279201|366058738|FG000|Initiation|Physician Decision|15|||
106110029|NCT00279201|366058739|FG001|Initiation|Physician Decision|18|||
105783510|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
105783511|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
105783512|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
105783513|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783514|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783515|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783516|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783517|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783518|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
105783519|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783520|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783521|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783522|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783523|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783524|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
105783525|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783526|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783527|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783528|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783529|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783530|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
105783531|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783532|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783533|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783534|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783535|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783536|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
105783537|NCT00151775|364860759|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783538|NCT00151775|364860760|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783539|NCT00151775|364860761|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783540|NCT00151775|364860762|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783541|NCT00151775|364860763|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783542|NCT00151775|364860764|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783543|NCT00151775|364860765|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
105783544|NCT00151775|364860766|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783545|NCT00151775|364860767|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783546|NCT00151775|364860768|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783547|NCT00151775|364860769|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783548|NCT00151775|364860770|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
105783549|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783550|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783551|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783552|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783553|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783554|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
105783555|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783556|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783557|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783558|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783559|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783560|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
105783561|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
105783562|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
105783563|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
105783564|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
105783565|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
105783566|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
105783567|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
105783568|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
105783569|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
105783570|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
105783571|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
105783572|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
105783573|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783574|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
106110030|NCT00279201|366058740|FG002|Initiation|Physician Decision|0|||
105783575|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783576|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783577|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783578|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783579|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
105783580|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783581|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783582|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783583|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783584|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
105783585|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783586|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783587|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
105783588|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783589|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783590|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783591|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783592|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783593|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783594|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783595|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783596|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
105783597|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783598|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783599|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
105783600|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783601|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783602|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783603|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783604|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783605|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783606|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783607|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783608|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
105783609|NCT00151775|364860759|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783610|NCT00151775|364860760|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783611|NCT00151775|364860761|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783612|NCT00151775|364860762|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783613|NCT00151775|364860763|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783614|NCT00151775|364860764|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783615|NCT00151775|364860765|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783616|NCT00151775|364860766|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783617|NCT00151775|364860767|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783618|NCT00151775|364860768|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783619|NCT00151775|364860769|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
105783620|NCT00151775|364860770|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
105783621|NCT00151775|364860759|FG000|Period 4: Open Label|Increased blood pressure|0|||
105783622|NCT00151775|364860760|FG001|Period 4: Open Label|Increased blood pressure|0|||
105783623|NCT00151775|364860761|FG002|Period 4: Open Label|Increased blood pressure|0|||
105783624|NCT00151775|364860762|FG003|Period 4: Open Label|Increased blood pressure|0|||
105783625|NCT00151775|364860763|FG004|Period 4: Open Label|Increased blood pressure|1|||
105783626|NCT00151775|364860764|FG005|Period 4: Open Label|Increased blood pressure|0|||
105783627|NCT00151775|364860765|FG006|Period 4: Open Label|Increased blood pressure|0|||
106110031|NCT00279201|366058741|FG003|Initiation|Physician Decision|0|||
106110032|NCT00279201|366058742|FG004|Initiation|Physician Decision|0|||
106110033|NCT00279201|366058743|FG005|Initiation|Physician Decision|0|||
106110034|NCT00279201|366058738|FG000|Initiation|Sponsor Decision|13|||
106110035|NCT00279201|366058739|FG001|Initiation|Sponsor Decision|5|||
106110036|NCT00279201|366058740|FG002|Initiation|Sponsor Decision|0|||
106110037|NCT00279201|366058741|FG003|Initiation|Sponsor Decision|0|||
106110038|NCT00279201|366058742|FG004|Initiation|Sponsor Decision|0|||
106110039|NCT00279201|366058743|FG005|Initiation|Sponsor Decision|0|||
106110040|NCT00279201|366058738|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
106110041|NCT00279201|366058739|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
106110042|NCT00279201|366058740|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
105783628|NCT00151775|364860766|FG007|Period 4: Open Label|Increased blood pressure|0|||
105783629|NCT00151775|364860767|FG008|Period 4: Open Label|Increased blood pressure|0|||
105783630|NCT00151775|364860768|FG009|Period 4: Open Label|Increased blood pressure|1|||
106110043|NCT00279201|366058741|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
106110044|NCT00279201|366058742|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
106110045|NCT00279201|366058743|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
106110046|NCT00279201|366058738|FG000|Maintenance|Lack of Efficacy|32|||
106110047|NCT00279201|366058739|FG001|Maintenance|Lack of Efficacy|30|||
106110048|NCT00279201|366058740|FG002|Maintenance|Lack of Efficacy|0|||
106110049|NCT00279201|366058741|FG003|Maintenance|Lack of Efficacy|0|||
106110050|NCT00279201|366058742|FG004|Maintenance|Lack of Efficacy|0|||
106110051|NCT00279201|366058743|FG005|Maintenance|Lack of Efficacy|0|||
106110052|NCT00279201|366058738|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
106110053|NCT00279201|366058739|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
106110054|NCT00279201|366058740|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
106110055|NCT00279201|366058741|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
106110056|NCT00279201|366058742|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
106110057|NCT00279201|366058743|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
106110058|NCT00279201|366058738|FG000|Maintenance|Adverse Event|4|||
106110059|NCT00279201|366058739|FG001|Maintenance|Adverse Event|4|||
106110060|NCT00279201|366058740|FG002|Maintenance|Adverse Event|0|||
106110061|NCT00279201|366058741|FG003|Maintenance|Adverse Event|0|||
106110062|NCT00279201|366058742|FG004|Maintenance|Adverse Event|0|||
106110063|NCT00279201|366058743|FG005|Maintenance|Adverse Event|0|||
106110064|NCT00279201|366058738|FG000|Maintenance|Death|4|||
106110065|NCT00279201|366058739|FG001|Maintenance|Death|4|||
106110066|NCT00279201|366058740|FG002|Maintenance|Death|0|||
106110067|NCT00279201|366058741|FG003|Maintenance|Death|0|||
106110068|NCT00279201|366058742|FG004|Maintenance|Death|0|||
106110069|NCT00279201|366058743|FG005|Maintenance|Death|0|||
106110070|NCT00279201|366058738|FG000|Maintenance|Lost to Follow-up|17|||
106110071|NCT00279201|366058739|FG001|Maintenance|Lost to Follow-up|13|||
106110072|NCT00279201|366058740|FG002|Maintenance|Lost to Follow-up|0|||
106110073|NCT00279201|366058741|FG003|Maintenance|Lost to Follow-up|0|||
106110074|NCT00279201|366058742|FG004|Maintenance|Lost to Follow-up|0|||
106110075|NCT00279201|366058743|FG005|Maintenance|Lost to Follow-up|0|||
106110076|NCT00279201|366058738|FG000|Maintenance|Entry Criteria Exclusion|1|||
106110077|NCT00279201|366058739|FG001|Maintenance|Entry Criteria Exclusion|4|||
106110078|NCT00279201|366058740|FG002|Maintenance|Entry Criteria Exclusion|0|||
106110079|NCT00279201|366058741|FG003|Maintenance|Entry Criteria Exclusion|0|||
106110080|NCT00279201|366058742|FG004|Maintenance|Entry Criteria Exclusion|0|||
106110081|NCT00279201|366058743|FG005|Maintenance|Entry Criteria Exclusion|0|||
106110082|NCT00279201|366058738|FG000|Maintenance|Protocol Violation|16|||
106110083|NCT00279201|366058739|FG001|Maintenance|Protocol Violation|24|||
106110084|NCT00279201|366058740|FG002|Maintenance|Protocol Violation|0|||
106110085|NCT00279201|366058741|FG003|Maintenance|Protocol Violation|0|||
106110086|NCT00279201|366058742|FG004|Maintenance|Protocol Violation|0|||
106110087|NCT00279201|366058743|FG005|Maintenance|Protocol Violation|0|||
106110088|NCT00279201|366058738|FG000|Maintenance|Withdrawal by Subject|18|||
106110089|NCT00279201|366058739|FG001|Maintenance|Withdrawal by Subject|18|||
106110090|NCT00279201|366058740|FG002|Maintenance|Withdrawal by Subject|0|||
106110091|NCT00279201|366058741|FG003|Maintenance|Withdrawal by Subject|0|||
106110092|NCT00279201|366058742|FG004|Maintenance|Withdrawal by Subject|0|||
106110093|NCT00279201|366058743|FG005|Maintenance|Withdrawal by Subject|0|||
106110094|NCT00279201|366058738|FG000|Maintenance|Physician Decision|9|||
106110095|NCT00279201|366058739|FG001|Maintenance|Physician Decision|9|||
106110096|NCT00279201|366058740|FG002|Maintenance|Physician Decision|0|||
106110097|NCT00279201|366058741|FG003|Maintenance|Physician Decision|0|||
106110098|NCT00279201|366058742|FG004|Maintenance|Physician Decision|0|||
106110099|NCT00279201|366058743|FG005|Maintenance|Physician Decision|0|||
106110100|NCT00279201|366058738|FG000|Maintenance|Sponsor Decision|4|||
106110101|NCT00279201|366058739|FG001|Maintenance|Sponsor Decision|0|||
106110102|NCT00279201|366058740|FG002|Maintenance|Sponsor Decision|0|||
106110103|NCT00279201|366058741|FG003|Maintenance|Sponsor Decision|0|||
106110104|NCT00279201|366058742|FG004|Maintenance|Sponsor Decision|0|||
106110105|NCT00279201|366058743|FG005|Maintenance|Sponsor Decision|0|||
106110106|NCT00279201|366058738|FG000|Maintenance|HbA1c>7.5%|123|||
106110107|NCT00279201|366058739|FG001|Maintenance|HbA1c>7.5%|126|||
106110108|NCT00279201|366058740|FG002|Maintenance|HbA1c>7.5%|0|||
106110109|NCT00279201|366058741|FG003|Maintenance|HbA1c>7.5%|0|||
106110110|NCT00279201|366058742|FG004|Maintenance|HbA1c>7.5%|0|||
106110111|NCT00279201|366058743|FG005|Maintenance|HbA1c>7.5%|0|||
106110112|NCT00279201|366058738|FG000|Intensification Addendum|Withdrawal by Subject|0|||
106110113|NCT00279201|366058739|FG001|Intensification Addendum|Withdrawal by Subject|0|||
106110114|NCT00279201|366058740|FG002|Intensification Addendum|Withdrawal by Subject|12|||
106110115|NCT00279201|366058741|FG003|Intensification Addendum|Withdrawal by Subject|14|||
106110116|NCT00279201|366058742|FG004|Intensification Addendum|Withdrawal by Subject|9|||
106110117|NCT00279201|366058743|FG005|Intensification Addendum|Withdrawal by Subject|18|||
106110118|NCT00279201|366058738|FG000|Intensification Addendum|Lost to Follow-up|0|||
106110119|NCT00279201|366058739|FG001|Intensification Addendum|Lost to Follow-up|0|||
106110120|NCT00279201|366058740|FG002|Intensification Addendum|Lost to Follow-up|4|||
106110121|NCT00279201|366058741|FG003|Intensification Addendum|Lost to Follow-up|6|||
105783631|NCT00151775|364860769|FG010|Period 4: Open Label|Increased blood pressure|0|||
105783632|NCT00151775|364860770|FG011|Period 4: Open Label|Increased blood pressure|0|||
105783633|NCT00151775|364860759|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
105783634|NCT00151775|364860760|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
105783635|NCT00151775|364860761|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
105783636|NCT00151775|364860762|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
105783637|NCT00151775|364860763|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
105783638|NCT00151775|364860764|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
105783639|NCT00151775|364860765|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
105783640|NCT00151775|364860766|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
105783641|NCT00151775|364860767|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
105783642|NCT00151775|364860768|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
105783643|NCT00151775|364860769|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
105783644|NCT00151775|364860770|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
105783645|NCT00151775|364860759|FG000|Period 4: Open Label|Adverse Event|0|||
105783646|NCT00151775|364860760|FG001|Period 4: Open Label|Adverse Event|0|||
105783647|NCT00151775|364860761|FG002|Period 4: Open Label|Adverse Event|0|||
105783648|NCT00151775|364860762|FG003|Period 4: Open Label|Adverse Event|0|||
105783649|NCT00151775|364860763|FG004|Period 4: Open Label|Adverse Event|1|||
105783650|NCT00151775|364860764|FG005|Period 4: Open Label|Adverse Event|0|||
105783651|NCT00151775|364860765|FG006|Period 4: Open Label|Adverse Event|0|||
105783652|NCT00151775|364860766|FG007|Period 4: Open Label|Adverse Event|0|||
105783653|NCT00151775|364860767|FG008|Period 4: Open Label|Adverse Event|0|||
105783654|NCT00151775|364860768|FG009|Period 4: Open Label|Adverse Event|2|||
105783655|NCT00151775|364860769|FG010|Period 4: Open Label|Adverse Event|0|||
105783656|NCT00151775|364860770|FG011|Period 4: Open Label|Adverse Event|0|||
105783657|NCT00151775|364860759|FG000|Period 4: Open Label|Lost to Follow-up|0|||
105783658|NCT00151775|364860760|FG001|Period 4: Open Label|Lost to Follow-up|0|||
105783659|NCT00151775|364860761|FG002|Period 4: Open Label|Lost to Follow-up|0|||
105783660|NCT00151775|364860762|FG003|Period 4: Open Label|Lost to Follow-up|0|||
105783661|NCT00151775|364860763|FG004|Period 4: Open Label|Lost to Follow-up|17|||
105783662|NCT00151775|364860764|FG005|Period 4: Open Label|Lost to Follow-up|0|||
105783663|NCT00151775|364860765|FG006|Period 4: Open Label|Lost to Follow-up|0|||
105783664|NCT00151775|364860766|FG007|Period 4: Open Label|Lost to Follow-up|0|||
105783665|NCT00151775|364860767|FG008|Period 4: Open Label|Lost to Follow-up|0|||
105783666|NCT00151775|364860768|FG009|Period 4: Open Label|Lost to Follow-up|7|||
105783667|NCT00151775|364860769|FG010|Period 4: Open Label|Lost to Follow-up|0|||
105783668|NCT00151775|364860770|FG011|Period 4: Open Label|Lost to Follow-up|0|||
105783669|NCT00151775|364860759|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
105783670|NCT00151775|364860760|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
105783671|NCT00151775|364860761|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
105783672|NCT00151775|364860762|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
105783673|NCT00151775|364860763|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
105783674|NCT00151775|364860764|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
105783675|NCT00151775|364860765|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
105783676|NCT00151775|364860766|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
105783677|NCT00151775|364860767|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
105783678|NCT00151775|364860768|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
105783679|NCT00151775|364860769|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
105783680|NCT00151775|364860770|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
105783681|NCT00151775|364860759|FG000|Period 4: Open Label|Other|0|||
105783682|NCT00151775|364860760|FG001|Period 4: Open Label|Other|0|||
105783683|NCT00151775|364860761|FG002|Period 4: Open Label|Other|0|||
105783684|NCT00151775|364860762|FG003|Period 4: Open Label|Other|0|||
105783685|NCT00151775|364860763|FG004|Period 4: Open Label|Other|1|||
106110122|NCT00279201|366058742|FG004|Intensification Addendum|Lost to Follow-up|7|||
106110123|NCT00279201|366058743|FG005|Intensification Addendum|Lost to Follow-up|7|||
106110124|NCT00279201|366058738|FG000|Intensification Addendum|Protocol Violation|0|||
106110125|NCT00279201|366058739|FG001|Intensification Addendum|Protocol Violation|0|||
106110126|NCT00279201|366058740|FG002|Intensification Addendum|Protocol Violation|2|||
106110127|NCT00279201|366058741|FG003|Intensification Addendum|Protocol Violation|2|||
106110128|NCT00279201|366058742|FG004|Intensification Addendum|Protocol Violation|6|||
106110129|NCT00279201|366058743|FG005|Intensification Addendum|Protocol Violation|6|||
106110130|NCT00279201|366058738|FG000|Intensification Addendum|Adverse Event|0|||
105783686|NCT00151775|364860764|FG005|Period 4: Open Label|Other|0|||
106110131|NCT00279201|366058739|FG001|Intensification Addendum|Adverse Event|0|||
106144089|NCT01317420|366186960|FG011|Overall Study|Other adverse event|0|||
105783687|NCT00151775|364860765|FG006|Period 4: Open Label|Other|0|||
105783688|NCT00151775|364860766|FG007|Period 4: Open Label|Other|0|||
105783689|NCT00151775|364860767|FG008|Period 4: Open Label|Other|0|||
105783690|NCT00151775|364860768|FG009|Period 4: Open Label|Other|3|||
105783691|NCT00151775|364860769|FG010|Period 4: Open Label|Other|0|||
105783692|NCT00151775|364860770|FG011|Period 4: Open Label|Other|0|||
105783693|NCT00151775|364860759|FG000|Period 4: Open Label|Physician Decision|0|||
105783694|NCT00151775|364860760|FG001|Period 4: Open Label|Physician Decision|0|||
105783695|NCT00151775|364860761|FG002|Period 4: Open Label|Physician Decision|0|||
105783696|NCT00151775|364860762|FG003|Period 4: Open Label|Physician Decision|0|||
105783697|NCT00151775|364860763|FG004|Period 4: Open Label|Physician Decision|0|||
105783698|NCT00151775|364860764|FG005|Period 4: Open Label|Physician Decision|0|||
105783699|NCT00151775|364860765|FG006|Period 4: Open Label|Physician Decision|0|||
105783700|NCT00151775|364860766|FG007|Period 4: Open Label|Physician Decision|0|||
105783701|NCT00151775|364860767|FG008|Period 4: Open Label|Physician Decision|0|||
105783702|NCT00151775|364860768|FG009|Period 4: Open Label|Physician Decision|2|||
105783703|NCT00151775|364860769|FG010|Period 4: Open Label|Physician Decision|0|||
105783704|NCT00151775|364860770|FG011|Period 4: Open Label|Physician Decision|0|||
105783705|NCT00151775|364860759|FG000|Period 4: Open Label|Protocol Violation|0|||
105783706|NCT00151775|364860760|FG001|Period 4: Open Label|Protocol Violation|0|||
105783707|NCT00151775|364860761|FG002|Period 4: Open Label|Protocol Violation|0|||
105783708|NCT00151775|364860762|FG003|Period 4: Open Label|Protocol Violation|0|||
105783709|NCT00151775|364860763|FG004|Period 4: Open Label|Protocol Violation|1|||
105783710|NCT00151775|364860764|FG005|Period 4: Open Label|Protocol Violation|0|||
105783711|NCT00151775|364860765|FG006|Period 4: Open Label|Protocol Violation|0|||
105783712|NCT00151775|364860766|FG007|Period 4: Open Label|Protocol Violation|0|||
105783713|NCT00151775|364860767|FG008|Period 4: Open Label|Protocol Violation|0|||
105783714|NCT00151775|364860768|FG009|Period 4: Open Label|Protocol Violation|0|||
105783715|NCT00151775|364860769|FG010|Period 4: Open Label|Protocol Violation|0|||
105783716|NCT00151775|364860770|FG011|Period 4: Open Label|Protocol Violation|0|||
105783717|NCT03971422|364860785|FG000|Overall Study|Lost to Follow-up|0|||
105783718|NCT03971422|364860786|FG001|Overall Study|Lost to Follow-up|1|||
105783719|NCT03971422|364860787|FG002|Overall Study|Lost to Follow-up|0|||
105783720|NCT03971422|364860785|FG000|Overall Study|Lack of Efficacy|5|||
105783721|NCT03971422|364860786|FG001|Overall Study|Lack of Efficacy|1|||
105783722|NCT03971422|364860787|FG002|Overall Study|Lack of Efficacy|1|||
105783723|NCT03971422|364860785|FG000|Overall Study|Adverse event, not fatal|2|||
105783724|NCT03971422|364860786|FG001|Overall Study|Adverse event, not fatal|2|||
105783725|NCT03971422|364860787|FG002|Overall Study|Adverse event, not fatal|5|||
105783726|NCT03971422|364860785|FG000|Overall Study|Worsening of MG Symptoms|1|||
105783727|NCT03971422|364860786|FG001|Overall Study|Worsening of MG Symptoms|4|||
105783728|NCT03971422|364860787|FG002|Overall Study|Worsening of MG Symptoms|2|||
105783729|NCT03971422|364860785|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
105783730|NCT03971422|364860786|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
105783731|NCT03971422|364860787|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
105783732|NCT03971422|364860785|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
105783733|NCT03971422|364860786|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
105783734|NCT03971422|364860787|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
105783735|NCT03971422|364860785|FG000|Overall Study|Due to COVID-19 pandemic|0|||
105783736|NCT03971422|364860786|FG001|Overall Study|Due to COVID-19 pandemic|1|||
105783737|NCT03971422|364860787|FG002|Overall Study|Due to COVID-19 pandemic|1|||
105783738|NCT02706327|364860788|FG000|Overall Study|Lost to Follow-up|1|||
105783739|NCT02706327|364860789|FG001|Overall Study|Lost to Follow-up|1|||
105783740|NCT02706327|364860790|FG002|Overall Study|Lost to Follow-up|2|||
105783741|NCT00772031|364860793|FG000|Overall Study|Early termination of trial|12|||
105783742|NCT00772031|364860794|FG001|Overall Study|Early termination of trial|10|||
105783743|NCT00772031|364860793|FG000|Overall Study|Lost to Follow-up|20|||
105783744|NCT00772031|364860794|FG001|Overall Study|Lost to Follow-up|33|||
105783745|NCT06045026|364860795|FG000|Overall Study|Lost to Follow-up|60|||
105783746|NCT06045026|364860795|FG000|Overall Study|Adverse Event|12|||
105783747|NCT06045026|364860795|FG000|Overall Study|Withdrawal by Subject|3|||
105783748|NCT06045026|364860795|FG000|Overall Study|Enrollment closed|1|||
106110132|NCT00279201|366058740|FG002|Intensification Addendum|Adverse Event|0|||
106110133|NCT00279201|366058741|FG003|Intensification Addendum|Adverse Event|4|||
106110134|NCT00279201|366058742|FG004|Intensification Addendum|Adverse Event|1|||
106110135|NCT00279201|366058743|FG005|Intensification Addendum|Adverse Event|3|||
106110136|NCT00279201|366058738|FG000|Intensification Addendum|Physician Decision|0|||
106110137|NCT00279201|366058739|FG001|Intensification Addendum|Physician Decision|0|||
106110138|NCT00279201|366058740|FG002|Intensification Addendum|Physician Decision|4|||
106110139|NCT00279201|366058741|FG003|Intensification Addendum|Physician Decision|1|||
105783749|NCT01224171|364860796|FG000|Overall Study|Adverse Event|8|||
105783750|NCT01224171|364860797|FG001|Overall Study|Adverse Event|4|||
105783751|NCT01224171|364860796|FG000|Overall Study|Protocol Violation|0|||
105783752|NCT01224171|364860797|FG001|Overall Study|Protocol Violation|1|||
105783753|NCT01224171|364860796|FG000|Overall Study|Lack of Efficacy|5|||
105783754|NCT01224171|364860797|FG001|Overall Study|Lack of Efficacy|1|||
105783755|NCT01224171|364860796|FG000|Overall Study|Withdrawal of Consent|2|||
106110140|NCT00279201|366058742|FG004|Intensification Addendum|Physician Decision|3|||
106110141|NCT00279201|366058743|FG005|Intensification Addendum|Physician Decision|2|||
105783756|NCT01224171|364860797|FG001|Overall Study|Withdrawal of Consent|4|||
105783757|NCT01224171|364860796|FG000|Overall Study|Lost to Follow-up|0|||
105783758|NCT01224171|364860797|FG001|Overall Study|Lost to Follow-up|3|||
105783759|NCT02624713|364860800|FG000|Overall Study|Lost to Follow-up|14|||
106110142|NCT00279201|366058738|FG000|Intensification Addendum|Sponsor Decision|0|||
106110143|NCT00279201|366058739|FG001|Intensification Addendum|Sponsor Decision|0|||
106110144|NCT00279201|366058740|FG002|Intensification Addendum|Sponsor Decision|0|||
106110145|NCT00279201|366058741|FG003|Intensification Addendum|Sponsor Decision|0|||
106110146|NCT00279201|366058742|FG004|Intensification Addendum|Sponsor Decision|1|||
106110147|NCT00279201|366058743|FG005|Intensification Addendum|Sponsor Decision|1|||
106110148|NCT00279201|366058738|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
106110149|NCT00279201|366058739|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
106110150|NCT00279201|366058740|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
106110151|NCT00279201|366058741|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
106110152|NCT00279201|366058742|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
106110153|NCT00279201|366058743|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
106110154|NCT00279201|366058738|FG000|Intensification Addendum|Lack of Efficacy|0|||
106110155|NCT00279201|366058739|FG001|Intensification Addendum|Lack of Efficacy|0|||
106110156|NCT00279201|366058740|FG002|Intensification Addendum|Lack of Efficacy|0|||
106110157|NCT00279201|366058741|FG003|Intensification Addendum|Lack of Efficacy|1|||
106110158|NCT00279201|366058742|FG004|Intensification Addendum|Lack of Efficacy|1|||
106110159|NCT00279201|366058743|FG005|Intensification Addendum|Lack of Efficacy|0|||
106110160|NCT00279201|366058738|FG000|Intensification Addendum|Death|0|||
106110161|NCT00279201|366058739|FG001|Intensification Addendum|Death|0|||
106110162|NCT00279201|366058740|FG002|Intensification Addendum|Death|0|||
106110163|NCT00279201|366058741|FG003|Intensification Addendum|Death|0|||
106110164|NCT00279201|366058742|FG004|Intensification Addendum|Death|1|||
106110165|NCT00279201|366058743|FG005|Intensification Addendum|Death|0|||
106110166|NCT00265889|366058744|FG000|Overall Study|Physician Decision|1|||
106110167|NCT00265889|366058744|FG000|Overall Study|Protocol Violation|1|||
106110168|NCT00265889|366058744|FG000|Overall Study|Insurance denied the request|3|||
106110169|NCT02453685|366058745|FG000|Overall Study|Adverse Event|0|||
106110170|NCT02453685|366058746|FG001|Overall Study|Adverse Event|1|||
106110171|NCT02453685|366058745|FG000|Overall Study|Protocol Violation|7|||
106110172|NCT02453685|366058746|FG001|Overall Study|Protocol Violation|4|||
106110173|NCT02453685|366058745|FG000|Overall Study|Lost to Follow-up|0|||
106110174|NCT02453685|366058746|FG001|Overall Study|Lost to Follow-up|1|||
106110175|NCT02453685|366058745|FG000|Overall Study|Withdrawal by Subject|8|||
106110176|NCT02453685|366058746|FG001|Overall Study|Withdrawal by Subject|4|||
106110177|NCT02453685|366058745|FG000|Overall Study|Unclassified|4|||
106110178|NCT02453685|366058746|FG001|Overall Study|Unclassified|2|||
105783760|NCT02624713|364860801|FG001|Overall Study|Lost to Follow-up|0|||
105783761|NCT00792467|364860809|FG000|Overall Study|progression of disease|17|||
105783762|NCT00792467|364860809|FG000|Overall Study|Adverse Event|1|||
105783763|NCT00792467|364860809|FG000|Overall Study|patient request|1|||
105783764|NCT00792467|364860809|FG000|Overall Study|Lost to Follow-up|1|||
105783765|NCT00792467|364860809|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
105783766|NCT00792467|364860809|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
105783767|NCT01287403|364860810|FG000|1st Intervention (1 Day)|Adverse Event|1|||
105783768|NCT03911401|364860811|FG000|Overall Study|Adverse Event|1|||
105783769|NCT03911401|364860812|FG001|Overall Study|Adverse Event|2|||
105783770|NCT03911401|364860813|FG002|Overall Study|Adverse Event|5|||
105783771|NCT03911401|364860811|FG000|Overall Study|Lack of Efficacy|1|||
105783772|NCT03911401|364860812|FG001|Overall Study|Lack of Efficacy|1|||
105783773|NCT03911401|364860813|FG002|Overall Study|Lack of Efficacy|8|||
105783774|NCT03911401|364860811|FG000|Overall Study|Physician Decision|0|||
105783775|NCT03911401|364860812|FG001|Overall Study|Physician Decision|0|||
105783776|NCT03911401|364860813|FG002|Overall Study|Physician Decision|1|||
105783777|NCT03911401|364860811|FG000|Overall Study|Withdrawal by Subject|1|||
105783778|NCT03911401|364860812|FG001|Overall Study|Withdrawal by Subject|2|||
105783779|NCT03911401|364860813|FG002|Overall Study|Withdrawal by Subject|0|||
105783780|NCT03911401|364860811|FG000|Overall Study|Withdrawal by parent/guardian|4|||
105783781|NCT03911401|364860812|FG001|Overall Study|Withdrawal by parent/guardian|4|||
105783782|NCT03911401|364860813|FG002|Overall Study|Withdrawal by parent/guardian|11|||
105783783|NCT04165824|364860818|FG000|Overall Study|Adverse Event|23|||
105783784|NCT04165824|364860818|FG000|Overall Study|Physician Decision|1|||
105783785|NCT04165824|364860818|FG000|Overall Study|Withdrawal by Subject|17|||
105783786|NCT04165824|364860818|FG000|Overall Study|Other|5|||
105783787|NCT00368069|364860819|FG000|Overall Study|Adverse Event|5|||
105783788|NCT00368069|364860820|FG001|Overall Study|Adverse Event|2|||
106110179|NCT02134587|366058747|FG000|Overall Study|Did not completed all meetings|30|||
106110180|NCT00453986|366058749|FG000|Overall Study|Lost to Follow-up|6|||
106110181|NCT00453986|366058750|FG001|Overall Study|Lost to Follow-up|5|||
106110182|NCT00453986|366058751|FG002|Overall Study|Lost to Follow-up|6|||
106110183|NCT00453986|366058752|FG003|Overall Study|Lost to Follow-up|2|||
106110184|NCT00453986|366058753|FG004|Overall Study|Lost to Follow-up|0|||
105783789|NCT00368069|364860819|FG000|Overall Study|Lack of Efficacy|0|||
105783790|NCT00368069|364860820|FG001|Overall Study|Lack of Efficacy|1|||
105783791|NCT00368069|364860819|FG000|Overall Study|Lost to Follow-up|1|||
105783792|NCT00368069|364860820|FG001|Overall Study|Lost to Follow-up|0|||
105783793|NCT00368069|364860819|FG000|Overall Study|Protocol Violation|0|||
105783794|NCT00368069|364860820|FG001|Overall Study|Protocol Violation|2|||
105783795|NCT00368069|364860819|FG000|Overall Study|Withdrawal of Consent|2|||
105783796|NCT00368069|364860820|FG001|Overall Study|Withdrawal of Consent|1|||
105783797|NCT00368069|364860819|FG000|Overall Study|no blood sampling possible|0|||
105783798|NCT00368069|364860820|FG001|Overall Study|no blood sampling possible|1|||
105783799|NCT00914940|364860823|FG000|D0 to D100 Post-transplant|Death|2|||
105783800|NCT00914940|364860823|FG000|D101 to 2 Years Post-transplant|Death|8|||
105783801|NCT00914940|364860823|FG000|2 Years to 5 Years Post-transplant|Death|3|||
105783802|NCT02221882|364860824|FG000|Overall Study|Withdrawal by Subject|0|||
105783803|NCT02221882|364860825|FG001|Overall Study|Withdrawal by Subject|0|||
105783804|NCT02221882|364860826|FG002|Overall Study|Withdrawal by Subject|4|||
105783805|NCT02221882|364860827|FG003|Overall Study|Withdrawal by Subject|2|||
105783806|NCT02221882|364860828|FG004|Overall Study|Withdrawal by Subject|2|||
105783807|NCT02221882|364860829|FG005|Overall Study|Withdrawal by Subject|2|||
105783808|NCT02221882|364860824|FG000|Overall Study|Death|0|||
105783809|NCT02221882|364860825|FG001|Overall Study|Death|1|||
105783810|NCT02221882|364860826|FG002|Overall Study|Death|0|||
105783811|NCT02221882|364860827|FG003|Overall Study|Death|0|||
105783812|NCT02221882|364860828|FG004|Overall Study|Death|0|||
105783813|NCT02221882|364860829|FG005|Overall Study|Death|0|||
105783814|NCT02431559|364860830|FG000|Overall Study|Adverse Event|0|||
105783815|NCT02431559|364860831|FG001|Overall Study|Adverse Event|1|||
105783816|NCT02431559|364860832|FG002|Overall Study|Adverse Event|0|||
105783817|NCT02431559|364860833|FG003|Overall Study|Adverse Event|4|||
105783818|NCT02431559|364860830|FG000|Overall Study|Progressive disease|2|||
105783819|NCT02431559|364860831|FG001|Overall Study|Progressive disease|1|||
105783820|NCT02431559|364860832|FG002|Overall Study|Progressive disease|4|||
105783821|NCT02431559|364860833|FG003|Overall Study|Progressive disease|22|||
105783822|NCT02431559|364860830|FG000|Overall Study|Withdrawal by Subject|0|||
105783823|NCT02431559|364860831|FG001|Overall Study|Withdrawal by Subject|1|||
105783824|NCT02431559|364860832|FG002|Overall Study|Withdrawal by Subject|0|||
105783825|NCT02431559|364860833|FG003|Overall Study|Withdrawal by Subject|4|||
105783826|NCT02431559|364860830|FG000|Overall Study|Physician Decision|0|||
105783827|NCT02431559|364860831|FG001|Overall Study|Physician Decision|0|||
105783828|NCT02431559|364860832|FG002|Overall Study|Physician Decision|0|||
105783829|NCT02431559|364860833|FG003|Overall Study|Physician Decision|1|||
105783830|NCT04236986|364860834|FG000|Overall Study|Withdrawal by Subject|3|||
105783831|NCT04236986|364860835|FG001|Overall Study|Withdrawal by Subject|1|||
105783832|NCT03328325|364860836|FG000|Overall Study|Lost to Follow-up|4|||
105783833|NCT03328325|364860836|FG000|Overall Study|Physician Decision|1|||
105783834|NCT03328325|364860836|FG000|Overall Study|Withdrawal by Subject|3|||
105783835|NCT03328325|364860836|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
105783836|NCT03575975|364860842|FG000|Overall Study|Lost to Follow-up|1|||
105783837|NCT03575975|364860843|FG001|Overall Study|Lost to Follow-up|0|||
105783838|NCT03575975|364860844|FG002|Overall Study|Lost to Follow-up|0|||
105783839|NCT00129220|364860845|FG000|Study Period II|Adverse Event|9|||
105783840|NCT00129220|364860846|FG001|Study Period II|Adverse Event|5|||
105783841|NCT00129220|364860847|FG002|Study Period II|Adverse Event|7|||
105783842|NCT00129220|364860845|FG000|Study Period II|Lack of Efficacy|15|||
105783843|NCT00129220|364860846|FG001|Study Period II|Lack of Efficacy|1|||
105783844|NCT00129220|364860847|FG002|Study Period II|Lack of Efficacy|28|||
105783845|NCT00129220|364860845|FG000|Study Period II|Entry Criteria Not Met|2|||
105783846|NCT00129220|364860846|FG001|Study Period II|Entry Criteria Not Met|0|||
105783847|NCT00129220|364860847|FG002|Study Period II|Entry Criteria Not Met|2|||
105783848|NCT00129220|364860845|FG000|Study Period II|Protocol Violation|4|||
105783849|NCT00129220|364860846|FG001|Study Period II|Protocol Violation|2|||
105783850|NCT00129220|364860847|FG002|Study Period II|Protocol Violation|1|||
105783851|NCT00129220|364860845|FG000|Study Period II|Physician Decision|0|||
105783852|NCT00129220|364860846|FG001|Study Period II|Physician Decision|1|||
105783853|NCT00129220|364860847|FG002|Study Period II|Physician Decision|0|||
105783854|NCT00129220|364860845|FG000|Study Period II|Withdrawal by Subject|1|||
105783855|NCT00129220|364860846|FG001|Study Period II|Withdrawal by Subject|3|||
105783856|NCT00129220|364860847|FG002|Study Period II|Withdrawal by Subject|4|||
106110185|NCT02778100|366058756|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
105783857|NCT00129220|364860845|FG000|Study Period II|Reason Not Specified|2|||
105783858|NCT00129220|364860846|FG001|Study Period II|Reason Not Specified|0|||
105783859|NCT00129220|364860847|FG002|Study Period II|Reason Not Specified|5|||
105783860|NCT00129220|364860845|FG000|Study Period III|Adverse Event|1|||
105783861|NCT00129220|364860846|FG001|Study Period III|Adverse Event|0|||
105783862|NCT00129220|364860847|FG002|Study Period III|Adverse Event|3|||
105783863|NCT00129220|364860845|FG000|Study Period III|Protocol Violation|1|||
105783864|NCT00129220|364860846|FG001|Study Period III|Protocol Violation|1|||
105783865|NCT00129220|364860847|FG002|Study Period III|Protocol Violation|2|||
105783866|NCT00129220|364860845|FG000|Study Period III|Withdrawal by Subject|1|||
105783867|NCT00129220|364860846|FG001|Study Period III|Withdrawal by Subject|0|||
105783868|NCT00129220|364860847|FG002|Study Period III|Withdrawal by Subject|3|||
105783869|NCT00129220|364860845|FG000|Study Period III|Sponsor Decision|1|||
105783870|NCT00129220|364860846|FG001|Study Period III|Sponsor Decision|0|||
105783871|NCT00129220|364860847|FG002|Study Period III|Sponsor Decision|0|||
105783872|NCT00129220|364860845|FG000|Study Period III|Reason Not Specified|9|||
105783873|NCT00129220|364860846|FG001|Study Period III|Reason Not Specified|0|||
105783874|NCT00129220|364860847|FG002|Study Period III|Reason Not Specified|2|||
105783875|NCT02569996|364860851|FG000|Overall Study|Adverse Event|6|||
105783876|NCT02569996|364860851|FG000|Overall Study|Physician Decision|3|||
105783877|NCT02569996|364860851|FG000|Overall Study|Progression of the disease|18|||
105783878|NCT02569996|364860851|FG000|Overall Study|New anti-lymphoma treatment|1|||
105783879|NCT02569996|364860851|FG000|Overall Study|Non-compliance|9|||
105783880|NCT02569996|364860851|FG000|Overall Study|Withdrawal by Subject|5|||
105783881|NCT02569996|364860851|FG000|Overall Study|Lost to Follow-up|5|||
105783882|NCT02569996|364860851|FG000|Overall Study|Complete remission|7|||
105783883|NCT02569996|364860851|FG000|Overall Study|Unknown reason|1|||
105783884|NCT01383317|364860852|FG000|Overall Study|Lost to Follow-up|2|||
105783885|NCT01383317|364860853|FG001|Overall Study|Lost to Follow-up|1|||
105783886|NCT01383317|364860852|FG000|Overall Study|Death|1|||
105783887|NCT01383317|364860853|FG001|Overall Study|Death|0|||
105783888|NCT01383317|364860852|FG000|Overall Study|Adverse Event|0|||
105783889|NCT01383317|364860853|FG001|Overall Study|Adverse Event|1|||
105783890|NCT01377194|364860856|FG000|Overall Study|Adverse Event|3|||
105783891|NCT01377194|364860857|FG001|Overall Study|Adverse Event|12|||
105783892|NCT01377194|364860858|FG002|Overall Study|Adverse Event|19|||
105783893|NCT01377194|364860856|FG000|Overall Study|Lack of Efficacy|3|||
105783894|NCT01377194|364860857|FG001|Overall Study|Lack of Efficacy|3|||
105783895|NCT01377194|364860858|FG002|Overall Study|Lack of Efficacy|3|||
105783896|NCT01377194|364860856|FG000|Overall Study|Protocol Violation|4|||
105783897|NCT01377194|364860857|FG001|Overall Study|Protocol Violation|10|||
105783898|NCT01377194|364860858|FG002|Overall Study|Protocol Violation|6|||
105783899|NCT01377194|364860856|FG000|Overall Study|Withdrawal by Subject|8|||
105783900|NCT01377194|364860857|FG001|Overall Study|Withdrawal by Subject|10|||
105783901|NCT01377194|364860858|FG002|Overall Study|Withdrawal by Subject|7|||
105783902|NCT01377194|364860856|FG000|Overall Study|Lost to Follow-up|14|||
105783903|NCT01377194|364860857|FG001|Overall Study|Lost to Follow-up|8|||
105783904|NCT01377194|364860858|FG002|Overall Study|Lost to Follow-up|11|||
105783905|NCT02911285|364860859|FG000|Overall Study|Lost to Follow-up|8|||
105783906|NCT02911285|364860860|FG001|Overall Study|Lost to Follow-up|5|||
105783907|NCT02911285|364860859|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
105783908|NCT02911285|364860860|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
105783909|NCT01397409|364860861|FG000|Stage 2|Adverse Event|0|||
105783910|NCT01397409|364860862|FG001|Stage 2|Adverse Event|0|||
105783911|NCT01397409|364860863|FG002|Stage 2|Adverse Event|0|||
105783912|NCT01397409|364860864|FG003|Stage 2|Adverse Event|0|||
105783913|NCT01397409|364860865|FG004|Stage 2|Adverse Event|6|||
105783914|NCT01397409|364860866|FG005|Stage 2|Adverse Event|3|||
105783915|NCT01397409|364860867|FG006|Stage 2|Adverse Event|0|||
105783916|NCT01397409|364860868|FG007|Stage 2|Adverse Event|0|||
105783917|NCT01397409|364860869|FG008|Stage 2|Adverse Event|0|||
105783918|NCT01397409|364860870|FG009|Stage 2|Adverse Event|0|||
105783919|NCT01397409|364860861|FG000|Stage 2|Personal Reasons|0|||
105783920|NCT01397409|364860862|FG001|Stage 2|Personal Reasons|0|||
105783921|NCT01397409|364860863|FG002|Stage 2|Personal Reasons|0|||
105783922|NCT01397409|364860864|FG003|Stage 2|Personal Reasons|0|||
105783923|NCT01397409|364860865|FG004|Stage 2|Personal Reasons|1|||
105783924|NCT01397409|364860866|FG005|Stage 2|Personal Reasons|0|||
105783925|NCT01397409|364860867|FG006|Stage 2|Personal Reasons|0|||
105783926|NCT01397409|364860868|FG007|Stage 2|Personal Reasons|0|||
105783927|NCT01397409|364860869|FG008|Stage 2|Personal Reasons|0|||
105783928|NCT01397409|364860870|FG009|Stage 2|Personal Reasons|0|||
105783929|NCT01397409|364860861|FG000|Stage 2|Other Miscellaneous Reasons|0|||
105783930|NCT01397409|364860862|FG001|Stage 2|Other Miscellaneous Reasons|0|||
106110186|NCT02778100|366058757|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
106110187|NCT00522626|366058760|FG000|Overall Study|Lost to Follow-up|7|||
106110188|NCT02618616|366058763|FG000|Overall Study|Lack of Efficacy|4|||
106110189|NCT02618616|366058764|FG001|Overall Study|Lack of Efficacy|0|||
106110190|NCT02618616|366058763|FG000|Overall Study|Pregnancy|0|||
105783931|NCT01397409|364860863|FG002|Stage 2|Other Miscellaneous Reasons|0|||
105783932|NCT01397409|364860864|FG003|Stage 2|Other Miscellaneous Reasons|0|||
105783933|NCT01397409|364860865|FG004|Stage 2|Other Miscellaneous Reasons|1|||
105783934|NCT01397409|364860866|FG005|Stage 2|Other Miscellaneous Reasons|1|||
105783935|NCT01397409|364860867|FG006|Stage 2|Other Miscellaneous Reasons|0|||
105783936|NCT01397409|364860868|FG007|Stage 2|Other Miscellaneous Reasons|0|||
105783937|NCT01397409|364860869|FG008|Stage 2|Other Miscellaneous Reasons|0|||
105783938|NCT01397409|364860870|FG009|Stage 2|Other Miscellaneous Reasons|0|||
106110191|NCT02618616|366058764|FG001|Overall Study|Pregnancy|1|||
105783939|NCT01397409|364860861|FG000|Stage 3|Adverse Event|0|||
105783940|NCT01397409|364860862|FG001|Stage 3|Adverse Event|0|||
105783941|NCT01397409|364860863|FG002|Stage 3|Adverse Event|0|||
105783942|NCT01397409|364860864|FG003|Stage 3|Adverse Event|0|||
105783943|NCT01397409|364860865|FG004|Stage 3|Adverse Event|0|||
105783944|NCT01397409|364860866|FG005|Stage 3|Adverse Event|0|||
105783945|NCT01397409|364860867|FG006|Stage 3|Adverse Event|0|||
105783946|NCT01397409|364860868|FG007|Stage 3|Adverse Event|1|||
105783947|NCT01397409|364860869|FG008|Stage 3|Adverse Event|0|||
105783948|NCT01397409|364860870|FG009|Stage 3|Adverse Event|0|||
105783949|NCT01397409|364860861|FG000|Stage 3|Other Miscellaneous Reasons|0|||
105783950|NCT01397409|364860862|FG001|Stage 3|Other Miscellaneous Reasons|0|||
105783951|NCT01397409|364860863|FG002|Stage 3|Other Miscellaneous Reasons|0|||
105783952|NCT01397409|364860864|FG003|Stage 3|Other Miscellaneous Reasons|0|||
105783953|NCT01397409|364860865|FG004|Stage 3|Other Miscellaneous Reasons|0|||
105783954|NCT01397409|364860866|FG005|Stage 3|Other Miscellaneous Reasons|0|||
105783955|NCT01397409|364860867|FG006|Stage 3|Other Miscellaneous Reasons|0|||
105783956|NCT01397409|364860868|FG007|Stage 3|Other Miscellaneous Reasons|1|||
105783957|NCT01397409|364860869|FG008|Stage 3|Other Miscellaneous Reasons|0|||
105783958|NCT01397409|364860870|FG009|Stage 3|Other Miscellaneous Reasons|0|||
105783959|NCT01207427|364860871|FG000|Double-blind Treatment Period|Adverse Event|0|||
105783960|NCT01207427|364860872|FG001|Double-blind Treatment Period|Adverse Event|1|||
105783961|NCT01207427|364860873|FG002|Double-blind Treatment Period|Adverse Event|0|||
105783962|NCT01207427|364860871|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105783963|NCT01207427|364860872|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105783964|NCT01207427|364860873|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
106110192|NCT02618616|366058763|FG000|Overall Study|Adverse Event|8|||
106110193|NCT02618616|366058764|FG001|Overall Study|Adverse Event|0|||
106110194|NCT02618616|366058763|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
106110195|NCT02618616|366058764|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
106110196|NCT02618616|366058763|FG000|Overall Study|Consent withdrawn by subject|8|||
106110197|NCT02618616|366058764|FG001|Overall Study|Consent withdrawn by subject|5|||
106110198|NCT02618616|366058763|FG000|Overall Study|Lost to Follow-up|0|||
106110199|NCT02618616|366058764|FG001|Overall Study|Lost to Follow-up|1|||
106110200|NCT01951638|366058765|FG000|Treatment Period|Protocol Violation|0|||
106110201|NCT01951638|366058766|FG001|Treatment Period|Protocol Violation|0|||
106110202|NCT01951638|366058767|FG002|Treatment Period|Protocol Violation|0|||
106110203|NCT01951638|366058768|FG003|Treatment Period|Protocol Violation|2|||
106110204|NCT01951638|366058769|FG004|Treatment Period|Protocol Violation|0|||
106110205|NCT01951638|366058765|FG000|Treatment Period|Protocol-driven decision point|1|||
106110206|NCT01951638|366058766|FG001|Treatment Period|Protocol-driven decision point|3|||
106110207|NCT01951638|366058767|FG002|Treatment Period|Protocol-driven decision point|0|||
106110208|NCT01951638|366058768|FG003|Treatment Period|Protocol-driven decision point|0|||
106110209|NCT01951638|366058769|FG004|Treatment Period|Protocol-driven decision point|0|||
106110210|NCT01951638|366058765|FG000|Treatment Period|Logistical difficulties|0|||
106110211|NCT01951638|366058766|FG001|Treatment Period|Logistical difficulties|1|||
106110212|NCT01951638|366058767|FG002|Treatment Period|Logistical difficulties|1|||
106110213|NCT01951638|366058768|FG003|Treatment Period|Logistical difficulties|0|||
106110214|NCT01951638|366058769|FG004|Treatment Period|Logistical difficulties|0|||
106110215|NCT01951638|366058765|FG000|Treatment Period|Withdrawal by Subject|9|||
106110216|NCT01951638|366058766|FG001|Treatment Period|Withdrawal by Subject|6|||
106110217|NCT01951638|366058767|FG002|Treatment Period|Withdrawal by Subject|4|||
106110218|NCT01951638|366058768|FG003|Treatment Period|Withdrawal by Subject|5|||
106110219|NCT01951638|366058769|FG004|Treatment Period|Withdrawal by Subject|4|||
106110220|NCT01951638|366058765|FG000|Treatment Period|Death|0|||
106110221|NCT01951638|366058766|FG001|Treatment Period|Death|0|||
106110222|NCT01951638|366058767|FG002|Treatment Period|Death|0|||
106110223|NCT01951638|366058768|FG003|Treatment Period|Death|3|||
106110224|NCT01951638|366058769|FG004|Treatment Period|Death|1|||
106110225|NCT01951638|366058765|FG000|Treatment Period|Adverse Event|3|||
106110226|NCT01951638|366058766|FG001|Treatment Period|Adverse Event|4|||
106110227|NCT01951638|366058767|FG002|Treatment Period|Adverse Event|8|||
106110228|NCT01951638|366058768|FG003|Treatment Period|Adverse Event|6|||
106110229|NCT01951638|366058769|FG004|Treatment Period|Adverse Event|5|||
106110230|NCT01951638|366058765|FG000|Follow-up Period|Protocol Violation|0|||
106110231|NCT01951638|366058766|FG001|Follow-up Period|Protocol Violation|0|||
106110232|NCT01951638|366058767|FG002|Follow-up Period|Protocol Violation|0|||
106110233|NCT01951638|366058768|FG003|Follow-up Period|Protocol Violation|1|||
105783965|NCT01207427|364860871|FG000|Double-blind Treatment Period|Protocol Violation|2|||
106110234|NCT01951638|366058769|FG004|Follow-up Period|Protocol Violation|0|||
106110235|NCT01951638|366058765|FG000|Follow-up Period|Logistical difficulties|0|||
106110236|NCT01951638|366058766|FG001|Follow-up Period|Logistical difficulties|2|||
106110237|NCT01951638|366058767|FG002|Follow-up Period|Logistical difficulties|0|||
106110238|NCT01951638|366058768|FG003|Follow-up Period|Logistical difficulties|0|||
106110239|NCT01951638|366058769|FG004|Follow-up Period|Logistical difficulties|1|||
105783966|NCT01207427|364860872|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105783967|NCT01207427|364860873|FG002|Double-blind Treatment Period|Protocol Violation|1|||
105783968|NCT01207427|364860871|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
106110240|NCT01951638|366058765|FG000|Follow-up Period|Withdrawal by Subject|1|||
106110241|NCT01951638|366058766|FG001|Follow-up Period|Withdrawal by Subject|5|||
106110242|NCT01951638|366058767|FG002|Follow-up Period|Withdrawal by Subject|2|||
106110243|NCT01951638|366058768|FG003|Follow-up Period|Withdrawal by Subject|1|||
105783969|NCT01207427|364860872|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105783970|NCT01207427|364860873|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105783971|NCT00422227|364860874|FG000|Overall Study|Adverse Event|3|||
105783972|NCT00422227|364860875|FG001|Overall Study|Adverse Event|8|||
105783973|NCT00422227|364860874|FG000|Overall Study|Lost to Follow-up|1|||
105783974|NCT00422227|364860875|FG001|Overall Study|Lost to Follow-up|3|||
105783975|NCT00422227|364860874|FG000|Overall Study|Withdrawal by Subject|0|||
105783976|NCT00422227|364860875|FG001|Overall Study|Withdrawal by Subject|4|||
105783977|NCT00686894|364860876|FG000|Overall Study|Relapse|2|||
105783978|NCT00686894|364860876|FG000|Overall Study|Protocol Violation|4|||
105783979|NCT01336647|364862712|FG000|Overall Study|Lost to Follow-up|4|||
105783980|NCT01336647|364862713|FG001|Overall Study|Lost to Follow-up|1|||
105783981|NCT01336647|364862714|FG002|Overall Study|Lost to Follow-up|3|||
105783982|NCT04398030|364862715|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
105783983|NCT04398030|364862716|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
105783984|NCT04398030|364862715|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
105783985|NCT04398030|364862716|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
105783986|NCT01004822|364862717|FG000|Overall Study|Objective progression or relapse|3|||
105783987|NCT01004822|364862718|FG001|Overall Study|Objective progression or relapse|3|||
105783988|NCT01004822|364862719|FG002|Overall Study|Objective progression or relapse|0|||
105783989|NCT01004822|364862720|FG003|Overall Study|Objective progression or relapse|1|||
105783990|NCT01004822|364862721|FG004|Overall Study|Objective progression or relapse|2|||
105783991|NCT01004822|364862722|FG005|Overall Study|Objective progression or relapse|2|||
105783992|NCT01004822|364862723|FG006|Overall Study|Objective progression or relapse|1|||
105783993|NCT01004822|364862724|FG007|Overall Study|Objective progression or relapse|4|||
105783994|NCT01004822|364862717|FG000|Overall Study|Global deterioration of health status|0|||
105783995|NCT01004822|364862718|FG001|Overall Study|Global deterioration of health status|0|||
105783996|NCT01004822|364862719|FG002|Overall Study|Global deterioration of health status|0|||
105783997|NCT01004822|364862720|FG003|Overall Study|Global deterioration of health status|1|||
105783998|NCT01004822|364862721|FG004|Overall Study|Global deterioration of health status|0|||
105783999|NCT01004822|364862722|FG005|Overall Study|Global deterioration of health status|0|||
105784000|NCT01004822|364862723|FG006|Overall Study|Global deterioration of health status|1|||
105784001|NCT01004822|364862724|FG007|Overall Study|Global deterioration of health status|0|||
105784002|NCT01004822|364862717|FG000|Overall Study|No longer willing to continue|0|||
105784003|NCT01004822|364862718|FG001|Overall Study|No longer willing to continue|0|||
105784004|NCT01004822|364862719|FG002|Overall Study|No longer willing to continue|0|||
105784005|NCT01004822|364862720|FG003|Overall Study|No longer willing to continue|1|||
105784006|NCT01004822|364862721|FG004|Overall Study|No longer willing to continue|2|||
105784007|NCT01004822|364862722|FG005|Overall Study|No longer willing to continue|1|||
105784008|NCT01004822|364862723|FG006|Overall Study|No longer willing to continue|1|||
105784009|NCT01004822|364862724|FG007|Overall Study|No longer willing to continue|0|||
105784010|NCT01004822|364862717|FG000|Overall Study|Adverse Event|0|||
105784011|NCT01004822|364862718|FG001|Overall Study|Adverse Event|0|||
105784012|NCT01004822|364862719|FG002|Overall Study|Adverse Event|0|||
105784013|NCT01004822|364862720|FG003|Overall Study|Adverse Event|0|||
105784014|NCT01004822|364862721|FG004|Overall Study|Adverse Event|0|||
105784015|NCT01004822|364862722|FG005|Overall Study|Adverse Event|0|||
105784016|NCT01004822|364862723|FG006|Overall Study|Adverse Event|1|||
105784017|NCT01004822|364862724|FG007|Overall Study|Adverse Event|1|||
105784018|NCT01004822|364862717|FG000|Overall Study|Other|0|||
105784019|NCT01004822|364862718|FG001|Overall Study|Other|0|||
105784020|NCT01004822|364862719|FG002|Overall Study|Other|4|||
105784021|NCT01004822|364862720|FG003|Overall Study|Other|1|||
105784022|NCT01004822|364862721|FG004|Overall Study|Other|0|||
105784023|NCT01004822|364862722|FG005|Overall Study|Other|1|||
105784024|NCT01004822|364862723|FG006|Overall Study|Other|0|||
105784025|NCT01004822|364862724|FG007|Overall Study|Other|0|||
105784026|NCT02181634|364862726|FG000|Overall Study|Lack of Efficacy|33|||
105784027|NCT02181634|364862726|FG000|Overall Study|Adverse Event|17|||
105993688|NCT02610777|365636066|FG001|Overall Study|Withdrawal by Subject|2|||
105993689|NCT02610777|365636065|FG000|Overall Study|Reason not Specified|0|||
105993690|NCT02610777|365636066|FG001|Overall Study|Reason not Specified|1|||
105993691|NCT02610777|365636065|FG000|Overall Study|Death|50|||
105993692|NCT02610777|365636066|FG001|Overall Study|Death|47|||
105993693|NCT01362608|365636072|FG000|Overall Study|Protocol Violation|0|||
105993694|NCT01362608|365636073|FG001|Overall Study|Protocol Violation|1|||
105993695|NCT01362608|365636072|FG000|Overall Study|Lost to Follow-up|3|||
105993696|NCT01362608|365636073|FG001|Overall Study|Lost to Follow-up|1|||
105993697|NCT01362608|365636072|FG000|Overall Study|Withdrawal by Subject|1|||
105993698|NCT01362608|365636073|FG001|Overall Study|Withdrawal by Subject|2|||
105993699|NCT01362608|365636072|FG000|Overall Study|Lack of Efficacy|0|||
105993700|NCT01362608|365636073|FG001|Overall Study|Lack of Efficacy|2|||
105993701|NCT01362608|365636072|FG000|Overall Study|Adverse Event|0|||
105993702|NCT01362608|365636073|FG001|Overall Study|Adverse Event|2|||
105784028|NCT02181634|364862726|FG000|Overall Study|Physician Decision|8|||
105993703|NCT01510158|365636075|FG000|Overall Study|Adverse Event|7|||
105784029|NCT02181634|364862726|FG000|Overall Study|Withdrawal by Subject|5|||
105784030|NCT02181634|364862726|FG000|Overall Study|Death|2|||
105784031|NCT02181634|364862726|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
105784032|NCT02181634|364862726|FG000|Overall Study|Ineligible|1|||
105784033|NCT02181634|364862726|FG000|Overall Study|Max number of dose reduction|1|||
105784034|NCT02181634|364862726|FG000|Overall Study|Symptomatic progression|1|||
105784035|NCT02181634|364862726|FG000|Overall Study|Patient opted to proceed to surgery|1|||
105784036|NCT04001790|364862730|FG000|Overall Study|Withdrawal by Subject|1|||
105784037|NCT04001790|364862731|FG001|Overall Study|Withdrawal by Subject|2|||
105784038|NCT03737812|364862735|FG000|Overall Study|Withdrawal by Subject|1|||
105784039|NCT03737812|364862736|FG001|Overall Study|Withdrawal by Subject|2|||
105784040|NCT03737812|364862737|FG002|Overall Study|Withdrawal by Subject|1|||
105784041|NCT03737812|364862735|FG000|Overall Study|Sponsor Discontinued the Study|4|||
105784042|NCT03737812|364862736|FG001|Overall Study|Sponsor Discontinued the Study|3|||
105784043|NCT03737812|364862737|FG002|Overall Study|Sponsor Discontinued the Study|2|||
105784044|NCT03737812|364862735|FG000|Overall Study|Adverse Event|0|||
105784045|NCT03737812|364862736|FG001|Overall Study|Adverse Event|1|||
105784046|NCT03737812|364862737|FG002|Overall Study|Adverse Event|0|||
105784047|NCT03737812|364862735|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
105784048|NCT03737812|364862736|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
105784049|NCT03737812|364862737|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
105784050|NCT02546193|364862741|FG000|Overall Study|Withdrawal by Subject|2|||
105784051|NCT02546193|364862742|FG001|Overall Study|Withdrawal by Subject|0|||
105784052|NCT02546193|364862743|FG002|Overall Study|Withdrawal by Subject|1|||
105784053|NCT02546193|364862744|FG003|Overall Study|Withdrawal by Subject|0|||
105784054|NCT02546193|364862741|FG000|Overall Study|Not eligible at time of induction|4|||
105784055|NCT02546193|364862742|FG001|Overall Study|Not eligible at time of induction|6|||
105784056|NCT02546193|364862743|FG002|Overall Study|Not eligible at time of induction|1|||
105784057|NCT02546193|364862744|FG003|Overall Study|Not eligible at time of induction|0|||
105784058|NCT01151085|364862745|FG000|Overall Study|Lost to Follow-up|31|||
105784059|NCT01151085|364862745|FG000|Overall Study|Protocol Violation|25|||
105784060|NCT01319422|364862746|FG000|Overall Study|Withdrawal by Subject|1|||
105784061|NCT01319422|364862747|FG001|Overall Study|Withdrawal by Subject|0|||
105784062|NCT01308476|364862749|FG000|Overall Study|Lost to Follow-up|2|||
105784063|NCT01308476|364862750|FG001|Overall Study|Lost to Follow-up|2|||
105784064|NCT01308476|364862749|FG000|Overall Study|Other|1|||
105784065|NCT01308476|364862750|FG001|Overall Study|Other|0|||
105784066|NCT03781167|364862756|FG000|Overall Study|Adverse Event|23|||
105784067|NCT03781167|364862757|FG001|Overall Study|Adverse Event|25|||
105784068|NCT03781167|364862756|FG000|Overall Study|Withdrew consent|16|||
105784069|NCT03781167|364862757|FG001|Overall Study|Withdrew consent|12|||
105784070|NCT03781167|364862756|FG000|Overall Study|Lost to Follow-up|0|||
105784071|NCT03781167|364862757|FG001|Overall Study|Lost to Follow-up|1|||
105784072|NCT03781167|364862756|FG000|Overall Study|Lack of Efficacy|4|||
105784073|NCT03781167|364862757|FG001|Overall Study|Lack of Efficacy|5|||
105784074|NCT03781167|364862756|FG000|Overall Study|Difficulty with drug delivery system|2|||
105784075|NCT03781167|364862757|FG001|Overall Study|Difficulty with drug delivery system|3|||
105784076|NCT03781167|364862756|FG000|Overall Study|Other, not specified|2|||
105784077|NCT03781167|364862757|FG001|Overall Study|Other, not specified|2|||
105784078|NCT00462501|364862758|FG000|Overall Study|Not treated|3|||
105784079|NCT00462501|364862758|FG000|Overall Study|Adverse Event|2|||
105784080|NCT03246152|364862759|FG000|Overall Study|Lost to Follow-up|2|||
105784081|NCT03246152|364862759|FG000|Overall Study|Protocol Violation|1|||
105784082|NCT01590628|364862767|FG000|Overall Study|Death|2|||
105784083|NCT01590628|364862768|FG001|Overall Study|Death|0|||
105784084|NCT00475657|364862773|FG000|Overall Study|Death|1|||
105784085|NCT00475657|364862773|FG000|Overall Study|Sponsor's Decision|3|||
105784086|NCT02992743|364862774|FG000|Overall Study|Withdrawal by Subject|1|||
105784087|NCT02992743|364862775|FG001|Overall Study|Withdrawal by Subject|1|||
105784088|NCT02992743|364862774|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
105784089|NCT02992743|364862775|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
105784090|NCT02992743|364862774|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
105784091|NCT02992743|364862775|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
105784092|NCT02992743|364862774|FG000|Overall Study|No measurable disease|1|||
105784093|NCT02992743|364862775|FG001|Overall Study|No measurable disease|0|||
105784094|NCT02992743|364862774|FG000|Overall Study|Lost to Follow-up|0|||
105784095|NCT02992743|364862775|FG001|Overall Study|Lost to Follow-up|1|||
105784096|NCT00361504|364862776|FG000|Overall Study|Withdrawal by Subject|94|||
105784097|NCT00361504|364862777|FG001|Overall Study|Withdrawal by Subject|31|||
105784098|NCT00361504|364862776|FG000|Overall Study|Lost to Follow-up|40|||
105784099|NCT00361504|364862777|FG001|Overall Study|Lost to Follow-up|7|||
105784100|NCT00361504|364862776|FG000|Overall Study|Adverse Event|203|||
105784101|NCT00361504|364862777|FG001|Overall Study|Adverse Event|82|||
105784102|NCT00361504|364862776|FG000|Overall Study|Lack of Efficacy|72|||
105784103|NCT00361504|364862777|FG001|Overall Study|Lack of Efficacy|7|||
105784104|NCT00361504|364862776|FG000|Overall Study|Resolution of Pain|2|||
105784105|NCT00361504|364862777|FG001|Overall Study|Resolution of Pain|0|||
105784106|NCT00361504|364862776|FG000|Overall Study|Study medication non compliant|42|||
105784107|NCT00361504|364862777|FG001|Overall Study|Study medication non compliant|15|||
105784108|NCT00361504|364862776|FG000|Overall Study|All other|28|||
105784109|NCT00361504|364862777|FG001|Overall Study|All other|3|||
105784110|NCT00450814|364862778|FG000|Overall Study|Failed to complete the initial therapy|0|||
105784111|NCT00450814|364862779|FG001|Overall Study|Failed to complete the initial therapy|0|||
105784112|NCT00450814|364862780|FG002|Overall Study|Failed to complete the initial therapy|0|||
105784113|NCT00450814|364862781|FG003|Overall Study|Failed to complete the initial therapy|1|||
105784114|NCT00450814|364862782|FG004|Overall Study|Failed to complete the initial therapy|1|||
105784115|NCT00450814|364862783|FG005|Overall Study|Failed to complete the initial therapy|1|||
105784116|NCT00450814|364862784|FG006|Overall Study|Failed to complete the initial therapy|0|||
105784117|NCT00450814|364862785|FG007|Overall Study|Failed to complete the initial therapy|0|||
105784118|NCT00450814|364862786|FG008|Overall Study|Failed to complete the initial therapy|0|||
105784119|NCT00450814|364862787|FG009|Overall Study|Failed to complete the initial therapy|0|||
105784120|NCT00450814|364862788|FG010|Overall Study|Failed to complete the initial therapy|0|||
105784121|NCT00450814|364862778|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
105784122|NCT00450814|364862779|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
105784123|NCT00450814|364862780|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
105784124|NCT00450814|364862781|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
105784125|NCT00450814|364862782|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
105784126|NCT00450814|364862783|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
105784127|NCT00450814|364862784|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
105784128|NCT00450814|364862785|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
105784129|NCT00450814|364862786|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
105784130|NCT00450814|364862787|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
105784131|NCT00450814|364862788|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
105784132|NCT00401726|364862789|FG000|Overall Study|Adverse Event|34|||
105784133|NCT00401726|364862790|FG001|Overall Study|Adverse Event|45|||
105784134|NCT00401726|364862789|FG000|Overall Study|Death|0|||
105784135|NCT00401726|364862790|FG001|Overall Study|Death|3|||
105784136|NCT00401726|364862789|FG000|Overall Study|Sponsor Request|0|||
105784137|NCT00401726|364862790|FG001|Overall Study|Sponsor Request|1|||
105784138|NCT00401726|364862789|FG000|Overall Study|Physician Decision|3|||
105784139|NCT00401726|364862790|FG001|Overall Study|Physician Decision|6|||
105784140|NCT00401726|364862789|FG000|Overall Study|Lost to Follow-up|23|||
105784141|NCT00401726|364862790|FG001|Overall Study|Lost to Follow-up|20|||
105784142|NCT00401726|364862789|FG000|Overall Study|Protocol Violation|6|||
105784143|NCT00401726|364862790|FG001|Overall Study|Protocol Violation|3|||
105784144|NCT00401726|364862789|FG000|Overall Study|Withdrawal by Subject|18|||
105784145|NCT00401726|364862790|FG001|Overall Study|Withdrawal by Subject|24|||
105784146|NCT00401726|364862789|FG000|Overall Study|Lack of Efficacy|4|||
105784147|NCT00401726|364862790|FG001|Overall Study|Lack of Efficacy|6|||
105784148|NCT00401726|364862789|FG000|Overall Study|Protocol Deviation|9|||
105784149|NCT00401726|364862790|FG001|Overall Study|Protocol Deviation|4|||
105784150|NCT02067728|364862791|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
105784151|NCT02067728|364862792|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
105784152|NCT02067728|364862791|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
105784153|NCT02067728|364862792|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
106110244|NCT01951638|366058769|FG004|Follow-up Period|Withdrawal by Subject|2|||
106110245|NCT01951638|366058765|FG000|Follow-up Period|Lost to Follow-up|0|||
106110246|NCT01951638|366058766|FG001|Follow-up Period|Lost to Follow-up|1|||
106110247|NCT01951638|366058767|FG002|Follow-up Period|Lost to Follow-up|0|||
106110248|NCT01951638|366058768|FG003|Follow-up Period|Lost to Follow-up|1|||
106110249|NCT01951638|366058769|FG004|Follow-up Period|Lost to Follow-up|0|||
106110250|NCT01951638|366058765|FG000|Follow-up Period|Death|1|||
106110251|NCT01951638|366058766|FG001|Follow-up Period|Death|0|||
106110252|NCT01951638|366058767|FG002|Follow-up Period|Death|1|||
106110253|NCT01951638|366058768|FG003|Follow-up Period|Death|4|||
106110254|NCT01951638|366058769|FG004|Follow-up Period|Death|1|||
106110255|NCT01951638|366058765|FG000|Follow-up Period|Adverse Event|0|||
105784154|NCT02067728|364862791|FG000|6 Month Measurements|Unable to attend|114|||
105784155|NCT02067728|364862792|FG001|6 Month Measurements|Unable to attend|97|||
105784156|NCT00933543|364862793|FG000|Overall Study|Adverse Event|2|||
105784157|NCT00933543|364862794|FG001|Overall Study|Adverse Event|1|||
105784158|NCT00933543|364862793|FG000|Overall Study|Lost to Follow-up|0|||
105784159|NCT00933543|364862794|FG001|Overall Study|Lost to Follow-up|1|||
105784160|NCT00933543|364862793|FG000|Overall Study|Withdrawal by Subject|0|||
105784161|NCT00933543|364862794|FG001|Overall Study|Withdrawal by Subject|1|||
106110256|NCT01951638|366058766|FG001|Follow-up Period|Adverse Event|1|||
106110257|NCT01951638|366058767|FG002|Follow-up Period|Adverse Event|2|||
105784162|NCT00933543|364862793|FG000|Overall Study|Lack of Efficacy|0|||
106110258|NCT01951638|366058768|FG003|Follow-up Period|Adverse Event|1|||
106110259|NCT01951638|366058769|FG004|Follow-up Period|Adverse Event|1|||
106110260|NCT00459342|366058773|FG000|Overall Study|Not eligible|1|||
106110261|NCT00696384|366058774|FG000|Open Label Phase|Adverse Event|27|||
105784163|NCT00933543|364862794|FG001|Overall Study|Lack of Efficacy|3|||
105784164|NCT00933543|364862793|FG000|Overall Study|Other|1|||
105784165|NCT00933543|364862794|FG001|Overall Study|Other|1|||
105784166|NCT01050998|364862800|FG000|Overall Study|Adverse Event|1|||
105784167|NCT01050998|364862801|FG001|Overall Study|Adverse Event|0|||
105784168|NCT01050998|364862802|FG002|Overall Study|Adverse Event|1|||
105784169|NCT01050998|364862803|FG003|Overall Study|Adverse Event|0|||
105784170|NCT01050998|364862804|FG004|Overall Study|Adverse Event|2|||
105784171|NCT01050998|364862800|FG000|Overall Study|Withdrawal by Subject|0|||
105784172|NCT01050998|364862801|FG001|Overall Study|Withdrawal by Subject|0|||
105784173|NCT01050998|364862802|FG002|Overall Study|Withdrawal by Subject|0|||
105784174|NCT01050998|364862803|FG003|Overall Study|Withdrawal by Subject|1|||
105784175|NCT01050998|364862804|FG004|Overall Study|Withdrawal by Subject|3|||
105784176|NCT01050998|364862800|FG000|Overall Study|Other|3|||
105784177|NCT01050998|364862801|FG001|Overall Study|Other|2|||
105784178|NCT01050998|364862802|FG002|Overall Study|Other|1|||
105784179|NCT01050998|364862803|FG003|Overall Study|Other|1|||
105784180|NCT01050998|364862804|FG004|Overall Study|Other|5|||
105784181|NCT01050998|364862800|FG000|Overall Study|Data integrity issues|0|||
105784182|NCT01050998|364862801|FG001|Overall Study|Data integrity issues|0|||
105784183|NCT01050998|364862802|FG002|Overall Study|Data integrity issues|1|||
105784184|NCT01050998|364862803|FG003|Overall Study|Data integrity issues|1|||
105784185|NCT01050998|364862804|FG004|Overall Study|Data integrity issues|4|||
105784186|NCT01428882|364862807|FG000|Overall Study|Lack of Efficacy|2|||
105784187|NCT01428882|364862808|FG001|Overall Study|Lack of Efficacy|7|||
105784188|NCT01428882|364862807|FG000|Overall Study|Protocol Violation|4|||
105784189|NCT01428882|364862808|FG001|Overall Study|Protocol Violation|3|||
105784190|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
105784191|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
105784192|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
105784193|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
105784194|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
105784195|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Death|1|||
105784196|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Death|0|||
105784197|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Death|0|||
105784198|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Death|0|||
105784199|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Death|0|||
105784200|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
105784201|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
105784202|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
105784203|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
105784204|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
105784205|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
105784206|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
105784207|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
105784208|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
105784209|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
105784210|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
105784211|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
105784212|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
105784213|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
105784214|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
105784215|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
105784216|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
105784217|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
105784218|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
105784219|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
105784220|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
106110262|NCT00696384|366058775|FG001|Open Label Phase|Adverse Event|0|||
106110263|NCT00696384|366058776|FG002|Open Label Phase|Adverse Event|0|||
105784221|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
105784222|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
105784223|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
105784224|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
106110264|NCT00696384|366058774|FG000|Open Label Phase|Protocol Violation|18|||
106110265|NCT00696384|366058775|FG001|Open Label Phase|Protocol Violation|0|||
106110266|NCT00696384|366058776|FG002|Open Label Phase|Protocol Violation|0|||
105784225|NCT00634933|364862810|FG000|Part A: Baseline to Week 24|Other|1|||
105784226|NCT00634933|364862811|FG001|Part A: Baseline to Week 24|Other|8|||
105784227|NCT00634933|364862812|FG002|Part A: Baseline to Week 24|Other|5|||
105784228|NCT00634933|364862813|FG003|Part A: Baseline to Week 24|Other|0|||
105784229|NCT00634933|364862814|FG004|Part A: Baseline to Week 24|Other|0|||
106110267|NCT00696384|366058774|FG000|Open Label Phase|Lost to Follow-up|24|||
105784230|NCT00634933|364862810|FG000|Between Part A and Part B|Physician Decision|0|||
105784231|NCT00634933|364862811|FG001|Between Part A and Part B|Physician Decision|1|||
106110268|NCT00696384|366058775|FG001|Open Label Phase|Lost to Follow-up|0|||
105784232|NCT00634933|364862812|FG002|Between Part A and Part B|Physician Decision|0|||
105784233|NCT00634933|364862813|FG003|Between Part A and Part B|Physician Decision|0|||
105784234|NCT00634933|364862814|FG004|Between Part A and Part B|Physician Decision|0|||
105784235|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
105784236|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
105784237|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
105784238|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
105784239|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
105784240|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
105784241|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
105784242|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
105784243|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
105784244|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
105784245|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
105784246|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
105784247|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
105784248|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
105784249|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
105784250|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
105784251|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
105784252|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
105784253|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
105784254|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
105784255|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
105784256|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
105784257|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
105784258|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
105784259|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
105784260|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
105784261|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
105784262|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
105784263|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
105784264|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
105784265|NCT00634933|364862810|FG000|Part B: Week 24 to Week 52|Other|0|||
105784266|NCT00634933|364862811|FG001|Part B: Week 24 to Week 52|Other|0|||
105784267|NCT00634933|364862812|FG002|Part B: Week 24 to Week 52|Other|5|||
105784268|NCT00634933|364862813|FG003|Part B: Week 24 to Week 52|Other|0|||
105784269|NCT00634933|364862814|FG004|Part B: Week 24 to Week 52|Other|1|||
105784270|NCT03831282|364862815|FG000|Overall Study|Could not place sensor|1|||
105784271|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
105784272|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
105784273|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
105784274|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
105784275|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
105784276|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
105784277|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
105784278|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
105784279|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
105784280|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
105784281|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
105784282|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
105784283|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
105784284|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
105784285|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
105784286|NCT01694849|364862816|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
105784287|NCT01694849|364862817|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
106110269|NCT00696384|366058776|FG002|Open Label Phase|Lost to Follow-up|0|||
106110270|NCT00696384|366058774|FG000|Open Label Phase|Withdrawal by Subject|37|||
105784288|NCT01694849|364862818|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
105784289|NCT01694849|364862816|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
106110271|NCT00696384|366058775|FG001|Open Label Phase|Withdrawal by Subject|0|||
106110272|NCT00696384|366058776|FG002|Open Label Phase|Withdrawal by Subject|0|||
106110273|NCT00696384|366058774|FG000|Open Label Phase|Other|6|||
105784290|NCT01694849|364862817|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
105784291|NCT01694849|364862818|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
105784292|NCT01694849|364862816|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
105784293|NCT01694849|364862817|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
105784294|NCT01694849|364862818|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
106110274|NCT00696384|366058775|FG001|Open Label Phase|Other|0|||
105784295|NCT01258803|364862819|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
105784296|NCT01258803|364862820|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
105784297|NCT01258803|364862821|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
105784298|NCT01258803|364862822|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
105784299|NCT01258803|364862823|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
105784300|NCT01258803|364862824|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
105784301|NCT01258803|364862819|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784302|NCT01258803|364862820|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
105784303|NCT01258803|364862821|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784304|NCT01258803|364862822|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784305|NCT01258803|364862823|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784306|NCT01258803|364862824|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
105784307|NCT01258803|364862819|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784308|NCT01258803|364862820|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784309|NCT01258803|364862821|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
105784310|NCT01258803|364862822|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784311|NCT01258803|364862823|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784312|NCT01258803|364862824|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
105784313|NCT01326312|364862825|FG000|Overall Study|Adverse Event|11|||
105784314|NCT01326312|364862826|FG001|Overall Study|Adverse Event|11|||
105784315|NCT01326312|364862827|FG002|Overall Study|Adverse Event|1|||
105784316|NCT01326312|364862825|FG000|Overall Study|Withdrawal by Subject|1|||
105784317|NCT01326312|364862826|FG001|Overall Study|Withdrawal by Subject|2|||
105784318|NCT01326312|364862827|FG002|Overall Study|Withdrawal by Subject|1|||
105784319|NCT01326312|364862825|FG000|Overall Study|Protocol Violation|0|||
105784320|NCT01326312|364862826|FG001|Overall Study|Protocol Violation|1|||
105784321|NCT01326312|364862827|FG002|Overall Study|Protocol Violation|0|||
105784322|NCT01326312|364862825|FG000|Overall Study|Lack of Efficacy|13|||
105784323|NCT01326312|364862826|FG001|Overall Study|Lack of Efficacy|7|||
105784324|NCT01326312|364862827|FG002|Overall Study|Lack of Efficacy|1|||
105784325|NCT01326312|364862825|FG000|Overall Study|Death|1|||
105784326|NCT01326312|364862826|FG001|Overall Study|Death|0|||
105784327|NCT01326312|364862827|FG002|Overall Study|Death|1|||
105784328|NCT01326312|364862825|FG000|Overall Study|progressive disease|0|||
105784329|NCT01326312|364862826|FG001|Overall Study|progressive disease|1|||
105784330|NCT01326312|364862827|FG002|Overall Study|progressive disease|1|||
105784331|NCT01326312|364862825|FG000|Overall Study|Study terminated by Sponsor|8|||
105784332|NCT01326312|364862826|FG001|Overall Study|Study terminated by Sponsor|32|||
105784333|NCT01326312|364862827|FG002|Overall Study|Study terminated by Sponsor|46|||
105784334|NCT01326312|364862825|FG000|Overall Study|Treatment arm terminated|19|||
105784335|NCT01326312|364862826|FG001|Overall Study|Treatment arm terminated|0|||
105784336|NCT01326312|364862827|FG002|Overall Study|Treatment arm terminated|0|||
105784337|NCT01326312|364862825|FG000|Overall Study|QTc > 500|0|||
105784338|NCT01326312|364862826|FG001|Overall Study|QTc > 500|1|||
105784339|NCT01326312|364862827|FG002|Overall Study|QTc > 500|0|||
105878759|NCT01120184|365209742|FG000|Overall Study|Reason not Specified|8|||
105878760|NCT01120184|365209743|FG001|Overall Study|Reason not Specified|3|||
105878761|NCT01120184|365209744|FG002|Overall Study|Reason not Specified|12|||
105878762|NCT01120184|365209742|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
105784340|NCT02370173|364862833|FG000|Overall Study|Protocol Violation|1|||
105784341|NCT02370173|364862834|FG001|Overall Study|Protocol Violation|1|||
105784342|NCT02370173|364862833|FG000|Overall Study|Withdrawal by Subject|2|||
105878763|NCT01120184|365209743|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
105878764|NCT01120184|365209744|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
105878765|NCT01120184|365209742|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
105878766|NCT01120184|365209743|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
105878767|NCT01120184|365209744|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
105878768|NCT01120184|365209742|FG000|Overall Study|Death|170|||
105878769|NCT01120184|365209743|FG001|Overall Study|Death|176|||
105878770|NCT01120184|365209744|FG002|Overall Study|Death|169|||
105878771|NCT02525783|365209745|FG000|Overall Study|Lost to Follow-up|10|||
105878772|NCT04003636|365209746|FG000|Overall Study|Death|409|||
105878773|NCT04003636|365209747|FG001|Overall Study|Death|443|||
105878774|NCT04003636|365209746|FG000|Overall Study|Lost to Follow-up|0|||
105878775|NCT04003636|365209747|FG001|Overall Study|Lost to Follow-up|1|||
105878776|NCT04003636|365209746|FG000|Overall Study|Withdrawal by Subject|5|||
105878777|NCT04003636|365209747|FG001|Overall Study|Withdrawal by Subject|2|||
105878778|NCT04003636|365209746|FG000|Overall Study|Participant On-going|119|||
105878779|NCT04003636|365209747|FG001|Overall Study|Participant On-going|90|||
105878780|NCT00449865|365209748|FG000|Overall Study|Withdrawal by Subject|110|||
105878781|NCT00449865|365209749|FG001|Overall Study|Withdrawal by Subject|110|||
105878782|NCT00449865|365209748|FG000|Overall Study|Lost to Follow-up|36|||
105878783|NCT00449865|365209749|FG001|Overall Study|Lost to Follow-up|37|||
105878784|NCT00449865|365209748|FG000|Overall Study|Physician Decision|13|||
105878785|NCT00449865|365209749|FG001|Overall Study|Physician Decision|12|||
106110275|NCT00696384|366058776|FG002|Open Label Phase|Other|0|||
106110276|NCT00696384|366058774|FG000|Open Label Phase|Lack of Efficacy|3|||
105878786|NCT00449865|365209748|FG000|Overall Study|Death|31|||
105878787|NCT00449865|365209749|FG001|Overall Study|Death|40|||
105878788|NCT00449865|365209748|FG000|Overall Study|Protocol Violation|8|||
105878789|NCT00449865|365209749|FG001|Overall Study|Protocol Violation|7|||
105878790|NCT00449865|365209748|FG000|Overall Study|Study was stopped|324|||
105878791|NCT00449865|365209749|FG001|Overall Study|Study was stopped|328|||
105878792|NCT01778855|365209750|FG000|Overall Study|Death|0|||
105878793|NCT01778855|365209751|FG001|Overall Study|Death|1|||
105878794|NCT00444535|365209752|FG000|Overall Study|Withdrawal by Subject|5|||
105878795|NCT00444535|365209752|FG000|Overall Study|Physician Decision|5|||
105878796|NCT00444535|365209752|FG000|Overall Study|progressive disease|1|||
105878797|NCT00444535|365209752|FG000|Overall Study|Adverse Event|2|||
105878798|NCT00171210|365209760|FG000|Overall Study|Adverse Event|16|||
105878799|NCT00171210|365209761|FG001|Overall Study|Adverse Event|27|||
105878800|NCT00171210|365209760|FG000|Overall Study|Abnormal laboratory value(s)|6|||
105878801|NCT00171210|365209761|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105878802|NCT00171210|365209760|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105878803|NCT00171210|365209761|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105878804|NCT00171210|365209760|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
105878805|NCT00171210|365209761|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
105878806|NCT00171210|365209760|FG000|Overall Study|Protocol Violation|0|||
105878807|NCT00171210|365209761|FG001|Overall Study|Protocol Violation|2|||
105878808|NCT00171210|365209760|FG000|Overall Study|Withdrawal by Subject|32|||
105878809|NCT00171210|365209761|FG001|Overall Study|Withdrawal by Subject|30|||
105878810|NCT00171210|365209760|FG000|Overall Study|Lost to Follow-up|1|||
105878811|NCT00171210|365209761|FG001|Overall Study|Lost to Follow-up|0|||
105878812|NCT00171210|365209760|FG000|Overall Study|Administrative problems|1|||
105878813|NCT00171210|365209761|FG001|Overall Study|Administrative problems|1|||
105878814|NCT00171210|365209760|FG000|Overall Study|Death|2|||
105878815|NCT00171210|365209761|FG001|Overall Study|Death|3|||
105878816|NCT00171210|365209760|FG000|Overall Study|Stopped at end of core|0|||
105878817|NCT00171210|365209761|FG001|Overall Study|Stopped at end of core|32|||
105878818|NCT00171210|365209760|FG000|Overall Study|Stopped at end of extension 1|0|||
105878819|NCT00171210|365209761|FG001|Overall Study|Stopped at end of extension 1|1|||
105878820|NCT00320710|365209770|FG000|Overall Study|Disease progression|24|||
105878821|NCT00320710|365209771|FG001|Overall Study|Disease progression|19|||
105878822|NCT00320710|365209772|FG002|Overall Study|Disease progression|2|||
105878823|NCT00320710|365209770|FG000|Overall Study|Death|10|||
105878824|NCT00320710|365209771|FG001|Overall Study|Death|7|||
105878825|NCT00320710|365209772|FG002|Overall Study|Death|1|||
105878826|NCT00320710|365209770|FG000|Overall Study|Administrative problems|1|||
105878827|NCT00320710|365209771|FG001|Overall Study|Administrative problems|2|||
105878828|NCT00320710|365209772|FG002|Overall Study|Administrative problems|0|||
105878829|NCT00320710|365209770|FG000|Overall Study|Withdrawal by Subject|20|||
105878830|NCT00320710|365209771|FG001|Overall Study|Withdrawal by Subject|26|||
105878831|NCT00320710|365209772|FG002|Overall Study|Withdrawal by Subject|1|||
105878832|NCT00320710|365209770|FG000|Overall Study|Protocol Violation|6|||
105878833|NCT00320710|365209771|FG001|Overall Study|Protocol Violation|5|||
105878834|NCT00320710|365209772|FG002|Overall Study|Protocol Violation|0|||
105878835|NCT00320710|365209770|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105878836|NCT00320710|365209771|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105878837|NCT00320710|365209772|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105878838|NCT00320710|365209770|FG000|Overall Study|Abnormal laboratory value(s)|12|||
105878839|NCT00320710|365209771|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105878840|NCT00320710|365209772|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105878841|NCT00320710|365209770|FG000|Overall Study|Adverse Event|18|||
105878842|NCT00320710|365209771|FG001|Overall Study|Adverse Event|14|||
105878843|NCT00320710|365209772|FG002|Overall Study|Adverse Event|1|||
105878844|NCT00320710|365209770|FG000|Overall Study|Lost to Follow-up|1|||
105878845|NCT00320710|365209771|FG001|Overall Study|Lost to Follow-up|0|||
105878846|NCT00320710|365209772|FG002|Overall Study|Lost to Follow-up|0|||
105878847|NCT03448419|365209773|FG000|Overall Study|Adverse Event|10|||
105878848|NCT03448419|365209774|FG001|Overall Study|Adverse Event|9|||
105878849|NCT03448419|365209773|FG000|Overall Study|Lost to Follow-up|0|||
105878850|NCT03448419|365209774|FG001|Overall Study|Lost to Follow-up|2|||
105878851|NCT03448419|365209773|FG000|Overall Study|Withdrawal by Subject|3|||
105878852|NCT03448419|365209774|FG001|Overall Study|Withdrawal by Subject|1|||
105878853|NCT03448419|365209773|FG000|Overall Study|Not treated|0|||
105878854|NCT03448419|365209774|FG001|Overall Study|Not treated|1|||
105878855|NCT03448419|365209773|FG000|Overall Study|Patient did not attend all visits|0|||
105878856|NCT03448419|365209774|FG001|Overall Study|Patient did not attend all visits|2|||
105878857|NCT03448419|365209773|FG000|Overall Study|Withdrawn by Sponsor|0|||
105878858|NCT03448419|365209774|FG001|Overall Study|Withdrawn by Sponsor|1|||
105878859|NCT04578457|365209775|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
105878860|NCT04578457|365209775|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
105878861|NCT04578457|365209775|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
105878862|NCT04578457|365209775|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
105878863|NCT03376789|365209782|FG000|Overall Study|Withdrawal by Subject|3|||
105878864|NCT03376789|365209783|FG001|Overall Study|Withdrawal by Subject|5|||
105878865|NCT03376789|365209782|FG000|Overall Study|Protocol Violation|0|||
105878866|NCT03376789|365209783|FG001|Overall Study|Protocol Violation|1|||
105878867|NCT03376789|365209782|FG000|Overall Study|Adverse Event|0|||
105878868|NCT03376789|365209783|FG001|Overall Study|Adverse Event|1|||
105878869|NCT03376789|365209782|FG000|Overall Study|Lost to Follow-up|1|||
105784343|NCT02370173|364862834|FG001|Overall Study|Withdrawal by Subject|2|||
105784344|NCT04034225|364862835|FG000|Overall Study|Death|3|||
105784345|NCT04034225|364862835|FG000|Overall Study|Withdrawal by Subject|2|||
105784346|NCT04034225|364862835|FG000|Overall Study|Study termination by Sponsor|18|||
105878870|NCT03376789|365209783|FG001|Overall Study|Lost to Follow-up|1|||
105878871|NCT03376789|365209782|FG000|Overall Study|Per sponsor due to noncompliance|1|||
105878872|NCT03376789|365209783|FG001|Overall Study|Per sponsor due to noncompliance|0|||
105878873|NCT03376789|365209782|FG000|Overall Study|Subject off study medication|0|||
105878874|NCT03376789|365209783|FG001|Overall Study|Subject off study medication|1|||
105878875|NCT02792062|365209790|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
105878876|NCT02792062|365209791|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105878877|NCT02792062|365209792|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105878878|NCT02792062|365209793|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105878879|NCT02792062|365209794|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105878880|NCT02792062|365209795|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
105878881|NCT00558467|365209796|FG000|Overall Study|Adverse Event|1|||
105878882|NCT00558467|365209797|FG001|Overall Study|Adverse Event|2|||
105878883|NCT00558467|365209796|FG000|Overall Study|Lack of Efficacy|0|||
105878884|NCT00558467|365209797|FG001|Overall Study|Lack of Efficacy|1|||
105878885|NCT00558467|365209796|FG000|Overall Study|Patient moving out of state|0|||
105878886|NCT00558467|365209797|FG001|Overall Study|Patient moving out of state|1|||
105878887|NCT03309943|365209798|FG000|Overall Study|Withdrawal by Subject|0|||
105878888|NCT03309943|365209799|FG001|Overall Study|Withdrawal by Subject|1|||
105878889|NCT03309943|365209798|FG000|Overall Study|Inappropriate behavior towards staff|0|||
105878890|NCT03309943|365209799|FG001|Overall Study|Inappropriate behavior towards staff|1|||
105878891|NCT01372995|365209800|FG000|Overall Study|Spouse withdrew participant from study|0|||
105878892|NCT01372995|365209801|FG001|Overall Study|Spouse withdrew participant from study|1|||
105878893|NCT01372995|365209802|FG002|Overall Study|Spouse withdrew participant from study|0|||
105878894|NCT01372995|365209800|FG000|Overall Study|Physician Decision|0|||
105878895|NCT01372995|365209801|FG001|Overall Study|Physician Decision|0|||
105878896|NCT01372995|365209802|FG002|Overall Study|Physician Decision|1|||
105878897|NCT02019264|365209803|FG000|Overall Study|Not treated|6|||
105878898|NCT02019264|365209804|FG001|Overall Study|Not treated|4|||
105878899|NCT02019264|365209803|FG000|Overall Study|Lost to Follow-up|50|||
105878900|NCT02019264|365209804|FG001|Overall Study|Lost to Follow-up|47|||
105878901|NCT02019264|365209803|FG000|Overall Study|Withdrawal by Subject|142|||
105878902|NCT02019264|365209804|FG001|Overall Study|Withdrawal by Subject|117|||
105878903|NCT02019264|365209803|FG000|Overall Study|Administrative reason|36|||
105878904|NCT02019264|365209804|FG001|Overall Study|Administrative reason|28|||
105878905|NCT02019264|365209803|FG000|Overall Study|Missing|14|||
105878906|NCT02019264|365209804|FG001|Overall Study|Missing|11|||
105878907|NCT03103152|365209805|FG000|Overall Study|Physician Decision|5|||
105878908|NCT03103152|365209806|FG001|Overall Study|Physician Decision|2|||
105878909|NCT03103152|365209807|FG002|Overall Study|Physician Decision|6|||
105878910|NCT03103152|365209808|FG003|Overall Study|Physician Decision|3|||
105878911|NCT03103152|365209809|FG004|Overall Study|Physician Decision|3|||
105878912|NCT03103152|365209810|FG005|Overall Study|Physician Decision|1|||
105878913|NCT03103152|365209805|FG000|Overall Study|Protocol Violation|2|||
105878914|NCT03103152|365209806|FG001|Overall Study|Protocol Violation|2|||
105878915|NCT03103152|365209807|FG002|Overall Study|Protocol Violation|1|||
105878916|NCT03103152|365209808|FG003|Overall Study|Protocol Violation|2|||
105784347|NCT04034225|364862835|FG000|Overall Study|Physician Decision|1|||
105784348|NCT04034225|364862835|FG000|Overall Study|Lack of Efficacy|1|||
105784349|NCT03759340|364862837|FG000|Overall Study|Adverse Event|2|||
105784350|NCT03759340|364862837|FG000|Overall Study|Lost to Follow-up|1|||
105784351|NCT03759340|364862837|FG000|Overall Study|Withdrawal by Subject|15|||
105784352|NCT03759340|364862837|FG000|Overall Study|Study Terminated by Sponsor|38|||
105784353|NCT00167414|364862839|FG000|Overall Study|Death|10|||
105784354|NCT01593761|364862840|FG000|Overall Study|Lost to Follow-up|1|||
105784355|NCT01593761|364862840|FG000|Overall Study|culture negative for MRSA at baseline|5|||
105784356|NCT01593761|364862840|FG000|Overall Study|positive for hepatitis C virus|1|||
105784357|NCT01593761|364862840|FG000|Overall Study|secondary cellulitis|1|||
105784358|NCT01038609|364862841|FG000|Overall Study|Adverse Event|0|||
105784359|NCT01038609|364862842|FG001|Overall Study|Adverse Event|0|||
105878917|NCT03103152|365209809|FG004|Overall Study|Protocol Violation|1|||
105878918|NCT03103152|365209810|FG005|Overall Study|Protocol Violation|1|||
105878919|NCT03103152|365209805|FG000|Overall Study|Inter-current illness|0|||
105878920|NCT03103152|365209806|FG001|Overall Study|Inter-current illness|0|||
105878921|NCT03103152|365209807|FG002|Overall Study|Inter-current illness|1|||
105878922|NCT03103152|365209808|FG003|Overall Study|Inter-current illness|0|||
105878923|NCT03103152|365209809|FG004|Overall Study|Inter-current illness|0|||
105878924|NCT03103152|365209810|FG005|Overall Study|Inter-current illness|0|||
105878925|NCT03103152|365209805|FG000|Overall Study|Death|0|||
105878926|NCT03103152|365209806|FG001|Overall Study|Death|1|||
105878927|NCT03103152|365209807|FG002|Overall Study|Death|0|||
105878928|NCT03103152|365209808|FG003|Overall Study|Death|0|||
105878929|NCT03103152|365209809|FG004|Overall Study|Death|0|||
105878930|NCT03103152|365209810|FG005|Overall Study|Death|0|||
105878931|NCT03103152|365209805|FG000|Overall Study|Adverse Event|0|||
105878932|NCT03103152|365209806|FG001|Overall Study|Adverse Event|0|||
105878933|NCT03103152|365209807|FG002|Overall Study|Adverse Event|1|||
105878934|NCT03103152|365209808|FG003|Overall Study|Adverse Event|0|||
105878935|NCT03103152|365209809|FG004|Overall Study|Adverse Event|0|||
105878936|NCT03103152|365209810|FG005|Overall Study|Adverse Event|1|||
105878937|NCT03103152|365209805|FG000|Overall Study|Withdrawal by Subject|1|||
105878938|NCT03103152|365209806|FG001|Overall Study|Withdrawal by Subject|0|||
105878939|NCT03103152|365209807|FG002|Overall Study|Withdrawal by Subject|1|||
105878940|NCT03103152|365209808|FG003|Overall Study|Withdrawal by Subject|1|||
105878941|NCT03103152|365209809|FG004|Overall Study|Withdrawal by Subject|1|||
105878942|NCT03103152|365209810|FG005|Overall Study|Withdrawal by Subject|1|||
105878943|NCT03103152|365209805|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
105878944|NCT03103152|365209806|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
105878945|NCT03103152|365209807|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
105878946|NCT03103152|365209808|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
105878947|NCT03103152|365209809|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
105878948|NCT03103152|365209810|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
105878949|NCT03103152|365209805|FG000|Overall Study|Unacceptable side effects|0|||
105878950|NCT03103152|365209806|FG001|Overall Study|Unacceptable side effects|0|||
105878951|NCT03103152|365209807|FG002|Overall Study|Unacceptable side effects|0|||
105878952|NCT03103152|365209808|FG003|Overall Study|Unacceptable side effects|0|||
105878953|NCT03103152|365209809|FG004|Overall Study|Unacceptable side effects|0|||
105878954|NCT03103152|365209810|FG005|Overall Study|Unacceptable side effects|1|||
105878955|NCT03103152|365209805|FG000|Overall Study|Lost to Follow-up|0|||
105878956|NCT03103152|365209806|FG001|Overall Study|Lost to Follow-up|1|||
105878957|NCT03103152|365209807|FG002|Overall Study|Lost to Follow-up|0|||
105878958|NCT03103152|365209808|FG003|Overall Study|Lost to Follow-up|1|||
105878959|NCT03103152|365209809|FG004|Overall Study|Lost to Follow-up|0|||
105878960|NCT03103152|365209810|FG005|Overall Study|Lost to Follow-up|1|||
105878961|NCT03103152|365209805|FG000|Overall Study|Testicular pain|0|||
105878962|NCT03103152|365209806|FG001|Overall Study|Testicular pain|0|||
105878963|NCT03103152|365209807|FG002|Overall Study|Testicular pain|0|||
105878964|NCT03103152|365209808|FG003|Overall Study|Testicular pain|1|||
105878965|NCT03103152|365209809|FG004|Overall Study|Testicular pain|0|||
105878966|NCT03103152|365209810|FG005|Overall Study|Testicular pain|0|||
105878967|NCT03123393|365209816|FG000|Overall Study|Study Terminated by Sponsor|6|||
105878968|NCT03123393|365209817|FG001|Overall Study|Study Terminated by Sponsor|9|||
105878969|NCT03123393|365209816|FG000|Overall Study|Withdrawal by Subject|2|||
105878970|NCT03123393|365209817|FG001|Overall Study|Withdrawal by Subject|1|||
105878971|NCT03123393|365209816|FG000|Overall Study|Reason not Specified|13|||
105878972|NCT03123393|365209817|FG001|Overall Study|Reason not Specified|13|||
105878973|NCT00558701|365209818|FG000|Overall Study|Protocol Deviations|1|||
105878974|NCT00558701|365209819|FG001|Overall Study|Protocol Deviations|4|||
105878975|NCT00427648|365209820|FG000|Overall Study|Protocol Violation|1|||
105878976|NCT00427648|365209821|FG001|Overall Study|Protocol Violation|2|||
105878977|NCT00427648|365209820|FG000|Overall Study|Adverse Event|0|||
105878978|NCT00427648|365209821|FG001|Overall Study|Adverse Event|1|||
105878979|NCT01297517|365209825|FG000|Overall Study|Adverse Event|21|||
105878980|NCT01297517|365209826|FG001|Overall Study|Adverse Event|7|||
105878981|NCT01297517|365209827|FG002|Overall Study|Adverse Event|16|||
105878982|NCT01297517|365209825|FG000|Overall Study|Lost to Follow-up|1|||
105878983|NCT01297517|365209826|FG001|Overall Study|Lost to Follow-up|0|||
105878984|NCT01297517|365209827|FG002|Overall Study|Lost to Follow-up|1|||
105878985|NCT01297517|365209825|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
105878986|NCT01297517|365209826|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
105878987|NCT01297517|365209827|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
105878988|NCT01297517|365209825|FG000|Overall Study|Noncompliance|1|||
105878989|NCT01297517|365209826|FG001|Overall Study|Noncompliance|0|||
105878990|NCT01297517|365209827|FG002|Overall Study|Noncompliance|0|||
105878991|NCT01297517|365209825|FG000|Overall Study|Protocol Violation|1|||
105878992|NCT01297517|365209826|FG001|Overall Study|Protocol Violation|1|||
105878993|NCT01297517|365209827|FG002|Overall Study|Protocol Violation|1|||
105878994|NCT01297517|365209825|FG000|Overall Study|Inadequate Control of IOP|1|||
105878995|NCT01297517|365209826|FG001|Overall Study|Inadequate Control of IOP|1|||
105878996|NCT01297517|365209827|FG002|Overall Study|Inadequate Control of IOP|2|||
105878997|NCT00386360|365209830|FG000|Overall Study|Adverse Event|4|||
105878998|NCT00386360|365209831|FG001|Overall Study|Adverse Event|2|||
105784360|NCT01038609|364862843|FG002|Overall Study|Adverse Event|1|||
105784361|NCT01038609|364862844|FG003|Overall Study|Adverse Event|0|||
105784362|NCT01038609|364862845|FG004|Overall Study|Adverse Event|0|||
105784363|NCT01038609|364862841|FG000|Overall Study|Dosing Error|0|||
105784364|NCT01038609|364862842|FG001|Overall Study|Dosing Error|0|||
105784365|NCT01038609|364862843|FG002|Overall Study|Dosing Error|0|||
105784366|NCT01038609|364862844|FG003|Overall Study|Dosing Error|1|||
105784367|NCT01038609|364862845|FG004|Overall Study|Dosing Error|1|||
105784368|NCT01038609|364862841|FG000|Overall Study|Death in the Family|1|||
105784369|NCT01038609|364862842|FG001|Overall Study|Death in the Family|0|||
105784370|NCT01038609|364862843|FG002|Overall Study|Death in the Family|0|||
105784371|NCT01038609|364862844|FG003|Overall Study|Death in the Family|0|||
105784372|NCT01038609|364862845|FG004|Overall Study|Death in the Family|0|||
105784373|NCT01038609|364862841|FG000|Overall Study|Refusal of Blood Draws|0|||
105784374|NCT01038609|364862842|FG001|Overall Study|Refusal of Blood Draws|1|||
105784375|NCT01038609|364862843|FG002|Overall Study|Refusal of Blood Draws|0|||
105784376|NCT01038609|364862844|FG003|Overall Study|Refusal of Blood Draws|0|||
105784377|NCT01038609|364862845|FG004|Overall Study|Refusal of Blood Draws|0|||
105784378|NCT00495794|364862849|FG000|Overall Study|Pharmacist did not activate patient|522|||
105784379|NCT00495794|364862850|FG001|Overall Study|Pharmacist did not activate patient|0|||
105784380|NCT01393444|364862851|FG000|Overall Study|Withdrawal by Subject|1|||
105784381|NCT01393444|364862851|FG000|Overall Study|Determined ineligible during screening.|2|||
105784382|NCT01883362|364862852|FG000|Treatment|Adverse Event|1|||
105784383|NCT01883362|364862853|FG001|Treatment|Adverse Event|8|||
105784384|NCT01883362|364862852|FG000|Treatment|Withdrawal by Subject|6|||
105784385|NCT01883362|364862853|FG001|Treatment|Withdrawal by Subject|2|||
105784386|NCT01883362|364862852|FG000|Treatment|Administrative problems|4|||
105784387|NCT01883362|364862853|FG001|Treatment|Administrative problems|1|||
105784388|NCT01883362|364862852|FG000|Treatment|Relapse|4|||
105784389|NCT01883362|364862853|FG001|Treatment|Relapse|2|||
105784390|NCT01883362|364862852|FG000|Treatment|Randomized, not treated|1|||
105784391|NCT01883362|364862853|FG001|Treatment|Randomized, not treated|1|||
105784392|NCT01883362|364862852|FG000|Post Treatment Follow-up|Protocol Violation|0|||
105784393|NCT01883362|364862853|FG001|Post Treatment Follow-up|Protocol Violation|1|||
105784394|NCT01883362|364862852|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
105784395|NCT01883362|364862853|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
105784396|NCT01883362|364862852|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
105784397|NCT01883362|364862853|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
105784398|NCT01883362|364862852|FG000|Post Treatment Follow-up|Administrative problems|2|||
105784399|NCT01883362|364862853|FG001|Post Treatment Follow-up|Administrative problems|0|||
105784400|NCT01883362|364862852|FG000|Post Treatment Follow-up|Death|8|||
105784401|NCT01883362|364862853|FG001|Post Treatment Follow-up|Death|4|||
105784402|NCT01883362|364862852|FG000|Post Treatment Follow-up|Relapse|1|||
105784403|NCT01883362|364862853|FG001|Post Treatment Follow-up|Relapse|2|||
105784404|NCT04678557|364862860|FG000|Overall Study|Withdrawal by Subject|1|||
105784405|NCT04678557|364862861|FG001|Overall Study|Withdrawal by Subject|0|||
105784406|NCT04678557|364862860|FG000|Overall Study|Lack of Efficacy|0|||
105784407|NCT04678557|364862861|FG001|Overall Study|Lack of Efficacy|13|||
105784408|NCT04678557|364862860|FG000|Overall Study|Safety Evaluation|0|||
105784409|NCT04678557|364862861|FG001|Overall Study|Safety Evaluation|1|||
105784410|NCT00421928|364864313|FG000|Overall Study|Adverse Event|61|||
105784411|NCT00421928|364864314|FG001|Overall Study|Adverse Event|140|||
105784412|NCT00421928|364864315|FG002|Overall Study|Adverse Event|22|||
105784413|NCT00421928|364864313|FG000|Overall Study|Lost to Follow-up|5|||
105784414|NCT00421928|364864314|FG001|Overall Study|Lost to Follow-up|0|||
105784415|NCT00421928|364864315|FG002|Overall Study|Lost to Follow-up|3|||
105784416|NCT00421928|364864313|FG000|Overall Study|Withdrawal by Subject|50|||
105784417|NCT00421928|364864314|FG001|Overall Study|Withdrawal by Subject|48|||
105784418|NCT00421928|364864315|FG002|Overall Study|Withdrawal by Subject|43|||
105784419|NCT00421928|364864313|FG000|Overall Study|Lack of Efficacy|15|||
105784420|NCT00421928|364864314|FG001|Overall Study|Lack of Efficacy|7|||
105784421|NCT00421928|364864315|FG002|Overall Study|Lack of Efficacy|35|||
105784422|NCT00421928|364864313|FG000|Overall Study|Study drug non-compliant|6|||
105784423|NCT00421928|364864314|FG001|Overall Study|Study drug non-compliant|7|||
105784424|NCT00421928|364864315|FG002|Overall Study|Study drug non-compliant|4|||
105784425|NCT00421928|364864313|FG000|Overall Study|All other|26|||
105784426|NCT00421928|364864314|FG001|Overall Study|All other|21|||
105784427|NCT00421928|364864315|FG002|Overall Study|All other|27|||
105784428|NCT00421928|364864313|FG000|Overall Study|Death|0|||
105784429|NCT00421928|364864314|FG001|Overall Study|Death|1|||
105784430|NCT00421928|364864315|FG002|Overall Study|Death|0|||
105784431|NCT01846442|364864321|FG000|Overall Study|Adverse Event|2|||
105784432|NCT01846442|364864322|FG001|Overall Study|Adverse Event|4|||
105784433|NCT01846442|364864323|FG002|Overall Study|Adverse Event|2|||
105784434|NCT01846442|364864324|FG003|Overall Study|Adverse Event|1|||
105784435|NCT01846442|364864321|FG000|Overall Study|Lost to Follow-up|0|||
105878999|NCT00386360|365209830|FG000|Overall Study|Physician Decision|2|||
105879000|NCT00386360|365209831|FG001|Overall Study|Physician Decision|2|||
105879001|NCT00386360|365209830|FG000|Overall Study|Lost to Follow-up|0|||
105879002|NCT00386360|365209831|FG001|Overall Study|Lost to Follow-up|2|||
105879003|NCT00386360|365209830|FG000|Overall Study|Protocol Violation|0|||
105879004|NCT00386360|365209831|FG001|Overall Study|Protocol Violation|3|||
105879005|NCT00386360|365209830|FG000|Overall Study|Withdrawal by Subject|3|||
105879006|NCT00386360|365209831|FG001|Overall Study|Withdrawal by Subject|6|||
105879007|NCT00386360|365209830|FG000|Overall Study|Did not take any study medication|0|||
105879008|NCT00386360|365209831|FG001|Overall Study|Did not take any study medication|2|||
105879009|NCT02025725|365209832|FG000|Overall Study|Adverse Event|5|||
105879010|NCT02025725|365209833|FG001|Overall Study|Adverse Event|0|||
105879011|NCT02025725|365209832|FG000|Overall Study|Lost to Follow-up|2|||
106110277|NCT00696384|366058775|FG001|Open Label Phase|Lack of Efficacy|0|||
105784436|NCT01846442|364864322|FG001|Overall Study|Lost to Follow-up|0|||
105784437|NCT01846442|364864323|FG002|Overall Study|Lost to Follow-up|1|||
105784438|NCT01846442|364864324|FG003|Overall Study|Lost to Follow-up|0|||
105784439|NCT01846442|364864321|FG000|Overall Study|Withdrawal by Subject|3|||
105784440|NCT01846442|364864322|FG001|Overall Study|Withdrawal by Subject|2|||
105784441|NCT01846442|364864323|FG002|Overall Study|Withdrawal by Subject|0|||
105784442|NCT01846442|364864324|FG003|Overall Study|Withdrawal by Subject|1|||
105784443|NCT01846442|364864321|FG000|Overall Study|Left the city/Lost medication|1|||
105784444|NCT01846442|364864322|FG001|Overall Study|Left the city/Lost medication|0|||
105784445|NCT01846442|364864323|FG002|Overall Study|Left the city/Lost medication|1|||
105784446|NCT01846442|364864324|FG003|Overall Study|Left the city/Lost medication|1|||
105784447|NCT00451191|364864325|FG000|Overall Study|withdrawal or received alternate tx|15|||
105784448|NCT00451191|364864326|FG001|Overall Study|withdrawal or received alternate tx|11|||
105784449|NCT02687815|364864327|FG000|Overall Study|Lost to Follow-up|2|||
105784450|NCT02687815|364864328|FG001|Overall Study|Lost to Follow-up|4|||
105784451|NCT02687815|364864327|FG000|Overall Study|Withdrawal by Subject|2|||
105784452|NCT02687815|364864328|FG001|Overall Study|Withdrawal by Subject|4|||
105784453|NCT02777554|364864329|FG000|Overall Study|Adverse Event|4|||
105784454|NCT02777554|364864330|FG001|Overall Study|Adverse Event|4|||
105784455|NCT02777554|364864331|FG002|Overall Study|Adverse Event|0|||
105784456|NCT02777554|364864332|FG003|Overall Study|Adverse Event|1|||
105784457|NCT02777554|364864333|FG004|Overall Study|Adverse Event|0|||
105784458|NCT02777554|364864334|FG005|Overall Study|Adverse Event|0|||
105784459|NCT02777554|364864329|FG000|Overall Study|Withdrawal by Subject|3|||
105784460|NCT02777554|364864330|FG001|Overall Study|Withdrawal by Subject|1|||
105784461|NCT02777554|364864331|FG002|Overall Study|Withdrawal by Subject|1|||
105784462|NCT02777554|364864332|FG003|Overall Study|Withdrawal by Subject|0|||
105784463|NCT02777554|364864333|FG004|Overall Study|Withdrawal by Subject|0|||
105784464|NCT02777554|364864334|FG005|Overall Study|Withdrawal by Subject|0|||
105784465|NCT02777554|364864329|FG000|Overall Study|Discharged early due to hurricane|22|||
105784466|NCT02777554|364864330|FG001|Overall Study|Discharged early due to hurricane|20|||
105784467|NCT02777554|364864331|FG002|Overall Study|Discharged early due to hurricane|0|||
105784468|NCT02777554|364864332|FG003|Overall Study|Discharged early due to hurricane|0|||
105784469|NCT02777554|364864333|FG004|Overall Study|Discharged early due to hurricane|0|||
105784470|NCT02777554|364864334|FG005|Overall Study|Discharged early due to hurricane|0|||
105784471|NCT02777554|364864329|FG000|Overall Study|Other - Miscellaneous|1|||
105784472|NCT02777554|364864330|FG001|Overall Study|Other - Miscellaneous|0|||
105784473|NCT02777554|364864331|FG002|Overall Study|Other - Miscellaneous|0|||
105784474|NCT02777554|364864332|FG003|Overall Study|Other - Miscellaneous|0|||
105784475|NCT02777554|364864333|FG004|Overall Study|Other - Miscellaneous|0|||
105784476|NCT02777554|364864334|FG005|Overall Study|Other - Miscellaneous|0|||
105784477|NCT04177862|364864335|FG000|Overall Study|Protocol Violation|2|||
105784478|NCT04177862|364864336|FG001|Overall Study|Protocol Violation|7|||
105784479|NCT01846039|364864337|FG000|Overall Study|Protocol Violation|1|||
105784480|NCT01846039|364864337|FG000|Overall Study|Subject Withdrew Consent|1|||
105784481|NCT03233009|364864340|FG000|Overall Study|Lost to Follow-up|1|||
105784482|NCT03039686|364864342|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
105784483|NCT03039686|364864343|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
105784484|NCT03039686|364864344|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
105784485|NCT03039686|364864342|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
105784486|NCT03039686|364864343|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
105784487|NCT03039686|364864344|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
105784488|NCT03039686|364864342|FG000|Double-blind Period|Withdrawal by Subject|2|||
105784489|NCT03039686|364864343|FG001|Double-blind Period|Withdrawal by Subject|2|||
105784490|NCT03039686|364864344|FG002|Double-blind Period|Withdrawal by Subject|1|||
105784491|NCT03039686|364864342|FG000|Double-blind Period|Death|0|||
105784492|NCT03039686|364864343|FG001|Double-blind Period|Death|0|||
105784493|NCT03039686|364864344|FG002|Double-blind Period|Death|1|||
105879012|NCT02025725|365209833|FG001|Overall Study|Lost to Follow-up|0|||
105879013|NCT02025725|365209832|FG000|Overall Study|Protocol Violation|1|||
105879014|NCT02025725|365209833|FG001|Overall Study|Protocol Violation|1|||
105879015|NCT02025725|365209832|FG000|Overall Study|Withdrawal by Subject|3|||
106110278|NCT00696384|366058776|FG002|Open Label Phase|Lack of Efficacy|0|||
106110279|NCT00696384|366058774|FG000|Open Label Phase|Physician Decision|4|||
106110280|NCT00696384|366058775|FG001|Open Label Phase|Physician Decision|0|||
106110281|NCT00696384|366058776|FG002|Open Label Phase|Physician Decision|0|||
106110282|NCT00696384|366058774|FG000|Double Blind Phase|Adverse Event|0|||
105784494|NCT03039686|364864342|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
105784495|NCT03039686|364864343|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
105784496|NCT03039686|364864344|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
105784497|NCT03039686|364864342|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
105784498|NCT03039686|364864343|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
105784499|NCT03039686|364864344|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
105784500|NCT03039686|364864342|FG000|Open Label Period|Withdrawal by Subject|0|||
105784501|NCT03039686|364864343|FG001|Open Label Period|Withdrawal by Subject|3|||
105784502|NCT03039686|364864344|FG002|Open Label Period|Withdrawal by Subject|1|||
105784503|NCT04854421|364864345|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
105784504|NCT04854421|364864346|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
105784505|NCT02158949|364864347|FG000|Overall Study|Withdrawal by Subject|1|||
105784506|NCT02158949|364864348|FG001|Overall Study|Withdrawal by Subject|0|||
105784507|NCT02158949|364864347|FG000|Overall Study|Lost to Follow-up|5|||
105784508|NCT02158949|364864348|FG001|Overall Study|Lost to Follow-up|11|||
105784509|NCT02322866|364864350|FG000|Overall Study|Adverse Event|6|||
105784510|NCT02322866|364864351|FG001|Overall Study|Adverse Event|11|||
105784511|NCT02322866|364864350|FG000|Overall Study|Withdrawal of Consent|16|||
105784512|NCT02322866|364864351|FG001|Overall Study|Withdrawal of Consent|25|||
105784513|NCT02322866|364864350|FG000|Overall Study|Lost to Follow-up|36|||
105784514|NCT02322866|364864351|FG001|Overall Study|Lost to Follow-up|39|||
105784515|NCT02322866|364864350|FG000|Overall Study|Protocol Violation|1|||
105784516|NCT02322866|364864351|FG001|Overall Study|Protocol Violation|0|||
105784517|NCT02322866|364864350|FG000|Overall Study|Noncompliance with Treatment|3|||
105784518|NCT02322866|364864351|FG001|Overall Study|Noncompliance with Treatment|4|||
105784519|NCT02322866|364864350|FG000|Overall Study|Lack of Efficacy|3|||
105784520|NCT02322866|364864351|FG001|Overall Study|Lack of Efficacy|1|||
105784521|NCT02322866|364864350|FG000|Overall Study|Other Miscellaneous Reasons|6|||
105784522|NCT02322866|364864351|FG001|Overall Study|Other Miscellaneous Reasons|6|||
105784523|NCT02708524|364864354|FG000|Overall Study|Adverse Event|0|||
105784524|NCT02708524|364864355|FG001|Overall Study|Adverse Event|1|||
105784525|NCT02708524|364864356|FG002|Overall Study|Adverse Event|0|||
105784526|NCT02708524|364864357|FG003|Overall Study|Adverse Event|0|||
105784527|NCT02708524|364864354|FG000|Overall Study|Lens Discomfort|1|||
105784528|NCT02708524|364864355|FG001|Overall Study|Lens Discomfort|0|||
105784529|NCT02708524|364864356|FG002|Overall Study|Lens Discomfort|1|||
105784530|NCT02708524|364864357|FG003|Overall Study|Lens Discomfort|0|||
105784531|NCT02708524|364864354|FG000|Overall Study|Lost to Follow-up|1|||
105784532|NCT02708524|364864355|FG001|Overall Study|Lost to Follow-up|1|||
105784533|NCT02708524|364864356|FG002|Overall Study|Lost to Follow-up|1|||
105784534|NCT02708524|364864357|FG003|Overall Study|Lost to Follow-up|0|||
105784535|NCT02708524|364864354|FG000|Overall Study|Protocol Violation|0|||
105784536|NCT02708524|364864355|FG001|Overall Study|Protocol Violation|1|||
105784537|NCT02708524|364864356|FG002|Overall Study|Protocol Violation|0|||
105784538|NCT02708524|364864357|FG003|Overall Study|Protocol Violation|0|||
105784539|NCT02708524|364864354|FG000|Overall Study|Withdrawal by Subject|1|||
105784540|NCT02708524|364864355|FG001|Overall Study|Withdrawal by Subject|1|||
105784541|NCT02708524|364864356|FG002|Overall Study|Withdrawal by Subject|0|||
105784542|NCT02708524|364864357|FG003|Overall Study|Withdrawal by Subject|0|||
105784543|NCT02708524|364864354|FG000|Overall Study|Dispensed incorrect study lens|0|||
105784544|NCT02708524|364864355|FG001|Overall Study|Dispensed incorrect study lens|1|||
105784545|NCT02708524|364864356|FG002|Overall Study|Dispensed incorrect study lens|1|||
105784546|NCT02708524|364864357|FG003|Overall Study|Dispensed incorrect study lens|0|||
105784547|NCT02708524|364864354|FG000|Overall Study|Did not wear lens at final visit|0|||
105784548|NCT02708524|364864355|FG001|Overall Study|Did not wear lens at final visit|1|||
105784549|NCT02708524|364864356|FG002|Overall Study|Did not wear lens at final visit|0|||
105784550|NCT02708524|364864357|FG003|Overall Study|Did not wear lens at final visit|0|||
105784551|NCT02708524|364864354|FG000|Overall Study|Subject lost study lens|1|||
105784552|NCT02708524|364864355|FG001|Overall Study|Subject lost study lens|0|||
105784553|NCT02708524|364864356|FG002|Overall Study|Subject lost study lens|0|||
105784554|NCT02708524|364864357|FG003|Overall Study|Subject lost study lens|0|||
105784555|NCT02059265|364864360|FG000|Overall Study|Ineligible|4|||
105784556|NCT00761735|364864361|FG000|Overall Study|Lost to Follow-up|6|||
105784557|NCT00761735|364864361|FG000|Overall Study|Withdrawal by Subject|6|||
105784558|NCT00761735|364864361|FG000|Overall Study|Non-compliance with protocol|1|||
105784559|NCT00761735|364864361|FG000|Overall Study|Administrative|1|||
105784560|NCT00381680|364864362|FG000|Overall Study|Adverse Event|9|||
105784561|NCT00381680|364864363|FG001|Overall Study|Adverse Event|3|||
106110283|NCT00696384|366058775|FG001|Double Blind Phase|Adverse Event|2|||
106110284|NCT00696384|366058776|FG002|Double Blind Phase|Adverse Event|2|||
105784562|NCT00381680|364864362|FG000|Overall Study|Death|10|||
105784563|NCT00381680|364864363|FG001|Overall Study|Death|7|||
105784564|NCT00381680|364864362|FG000|Overall Study|Lost to Follow-up|3|||
105784565|NCT00381680|364864363|FG001|Overall Study|Lost to Follow-up|2|||
105784566|NCT00381680|364864362|FG000|Overall Study|Physician Decision|25|||
105784567|NCT00381680|364864363|FG001|Overall Study|Physician Decision|6|||
105784568|NCT00381680|364864362|FG000|Overall Study|Withdrawal by Subject|3|||
105784569|NCT00381680|364864363|FG001|Overall Study|Withdrawal by Subject|1|||
105784570|NCT00381680|364864362|FG000|Overall Study|Entry onto another COG Trial|1|||
105784571|NCT00381680|364864363|FG001|Overall Study|Entry onto another COG Trial|2|||
105784572|NCT00381680|364864362|FG000|Overall Study|Alternative Therapy|11|||
105784573|NCT00381680|364864363|FG001|Overall Study|Alternative Therapy|5|||
105784574|NCT00381680|364864362|FG000|Overall Study|Secondary Malignancy|3|||
105784575|NCT00381680|364864363|FG001|Overall Study|Secondary Malignancy|0|||
105784576|NCT00381680|364864362|FG000|Overall Study|Delay initiation|1|||
105784577|NCT00381680|364864363|FG001|Overall Study|Delay initiation|0|||
105784578|NCT00381680|364864362|FG000|Overall Study|Stem Cell Transplant|26|||
105784579|NCT00381680|364864363|FG001|Overall Study|Stem Cell Transplant|10|||
105784580|NCT00381680|364864362|FG000|Overall Study|Relapse|18|||
105784581|NCT00381680|364864363|FG001|Overall Study|Relapse|9|||
105784582|NCT00381680|364864362|FG000|Overall Study|Induction Failure|4|||
105784583|NCT00381680|364864363|FG001|Overall Study|Induction Failure|1|||
105784584|NCT00381680|364864362|FG000|Overall Study|Progression|1|||
105784585|NCT00381680|364864363|FG001|Overall Study|Progression|1|||
105784586|NCT00381680|364864362|FG000|Overall Study|Other not otherwise specified|7|||
105784587|NCT00381680|364864363|FG001|Overall Study|Other not otherwise specified|2|||
105784588|NCT00381680|364864362|FG000|Overall Study|Ineligible|3|||
105784589|NCT00381680|364864363|FG001|Overall Study|Ineligible|1|||
105784590|NCT03290131|364864364|FG000|Overall Study|Adverse Event|22|||
105784591|NCT03290131|364864365|FG001|Overall Study|Adverse Event|57|||
105784592|NCT03290131|364864366|FG002|Overall Study|Adverse Event|11|||
105784593|NCT03290131|364864364|FG000|Overall Study|Withdrawal by Subject|18|||
105784594|NCT03290131|364864365|FG001|Overall Study|Withdrawal by Subject|13|||
105784595|NCT03290131|364864366|FG002|Overall Study|Withdrawal by Subject|8|||
105784596|NCT03290131|364864364|FG000|Overall Study|MS Relapse|2|||
105784597|NCT03290131|364864365|FG001|Overall Study|MS Relapse|1|||
105784598|NCT03290131|364864366|FG002|Overall Study|MS Relapse|0|||
105784599|NCT03290131|364864364|FG000|Overall Study|Unknown reason|0|||
105784600|NCT03290131|364864365|FG001|Overall Study|Unknown reason|1|||
105784601|NCT03290131|364864366|FG002|Overall Study|Unknown reason|0|||
105784602|NCT00465101|364864367|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
105784603|NCT00465101|364864367|FG000|Overall Study|Change in health precluded follow up|4|||
105784604|NCT00465101|364864367|FG000|Overall Study|Did not meet study criteria|4|||
105784605|NCT00465101|364864367|FG000|Overall Study|Lost to Follow-up|5|||
105784606|NCT00465101|364864367|FG000|Overall Study|Other|6|||
105784607|NCT00465101|364864367|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
105784608|NCT00465101|364864367|FG000|Overall Study|Patient postponed procedure|1|||
105784609|NCT00465101|364864367|FG000|Overall Study|Site closed due to IRB expiration|1|||
105784610|NCT00465101|364864367|FG000|Overall Study|Unable to obtain IRB approval|1|||
105784611|NCT00465101|364864367|FG000|Overall Study|Death|3|||
105784612|NCT00465101|364864367|FG000|Overall Study|Withdrawal by Subject|25|||
105784613|NCT00465101|364864367|FG000|Overall Study|Physician Decision|1|||
105784614|NCT00465101|364864367|FG000|Overall Study|Withdrew consent prior to procedure|3|||
105784615|NCT00483574|364864368|FG000|Overall Study|Adverse Event|6|||
105784616|NCT00483574|364864369|FG001|Overall Study|Adverse Event|0|||
105784617|NCT00483574|364864368|FG000|Overall Study|Protocol Violation|28|||
105784618|NCT00483574|364864369|FG001|Overall Study|Protocol Violation|9|||
105784619|NCT00483574|364864368|FG000|Overall Study|Lost to Follow-up|16|||
105784620|NCT00483574|364864369|FG001|Overall Study|Lost to Follow-up|4|||
105784621|NCT00483574|364864368|FG000|Overall Study|Withdrawal by Subject|52|||
105784622|NCT00483574|364864369|FG001|Overall Study|Withdrawal by Subject|0|||
105784623|NCT02369874|364864377|FG000|Overall Study|Lost to Follow-up|2|||
105784624|NCT02369874|364864378|FG001|Overall Study|Lost to Follow-up|2|||
105784625|NCT02369874|364864379|FG002|Overall Study|Lost to Follow-up|2|||
105784626|NCT02369874|364864377|FG000|Overall Study|Withdrawal by Subject|7|||
105784627|NCT02369874|364864378|FG001|Overall Study|Withdrawal by Subject|9|||
105784628|NCT02369874|364864379|FG002|Overall Study|Withdrawal by Subject|27|||
105784629|NCT02369874|364864377|FG000|Overall Study|Miscellaneous|1|||
105784630|NCT02369874|364864378|FG001|Overall Study|Miscellaneous|1|||
105784631|NCT02369874|364864379|FG002|Overall Study|Miscellaneous|0|||
105784632|NCT02369874|364864377|FG000|Overall Study|On Treatment/Off Study|34|||
105784633|NCT02369874|364864378|FG001|Overall Study|On Treatment/Off Study|45|||
105784634|NCT02369874|364864379|FG002|Overall Study|On Treatment/Off Study|32|||
105784635|NCT01049360|364864382|FG000|Period 1|Adverse Event|0|||
105784636|NCT01049360|364864383|FG001|Period 1|Adverse Event|1|||
105784637|NCT01049360|364864384|FG002|Period 1|Adverse Event|0|||
105784638|NCT01049360|364864385|FG003|Period 1|Adverse Event|1|||
105784639|NCT01049360|364864386|FG004|Period 1|Adverse Event|0|||
106110285|NCT00696384|366058774|FG000|Double Blind Phase|Lost to Follow-up|0|||
106110286|NCT00696384|366058775|FG001|Double Blind Phase|Lost to Follow-up|2|||
106110287|NCT00696384|366058776|FG002|Double Blind Phase|Lost to Follow-up|1|||
106110288|NCT00696384|366058774|FG000|Double Blind Phase|Withdrawal by Subject|0|||
106110289|NCT00696384|366058775|FG001|Double Blind Phase|Withdrawal by Subject|4|||
106110290|NCT00696384|366058776|FG002|Double Blind Phase|Withdrawal by Subject|3|||
106110291|NCT00696384|366058774|FG000|Double Blind Phase|Lack of Efficacy|0|||
106110292|NCT00696384|366058775|FG001|Double Blind Phase|Lack of Efficacy|1|||
106110293|NCT00696384|366058776|FG002|Double Blind Phase|Lack of Efficacy|0|||
106110294|NCT00696384|366058774|FG000|Double Blind Phase|Physician Decision|0|||
106110295|NCT00696384|366058775|FG001|Double Blind Phase|Physician Decision|2|||
106110296|NCT00696384|366058776|FG002|Double Blind Phase|Physician Decision|0|||
106110297|NCT02027402|366058777|FG000|Overall Study|Withdrawal by Subject|4|||
106110298|NCT02027402|366058778|FG001|Overall Study|Withdrawal by Subject|1|||
106110299|NCT04179721|366058779|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
106110300|NCT04179721|366058780|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
106110301|NCT04179721|366058779|FG000|Overall Study|Lost to Follow-up|0|||
106110302|NCT04179721|366058780|FG001|Overall Study|Lost to Follow-up|1|||
106110303|NCT02240108|366060306|FG000|Overall Study|Other than specified|8|||
106110304|NCT02240108|366060307|FG001|Overall Study|Other than specified|6|||
106110305|NCT02240108|366060306|FG000|Overall Study|Adverse Event|1|||
106110306|NCT02240108|366060307|FG001|Overall Study|Adverse Event|9|||
106110307|NCT02240108|366060306|FG000|Overall Study|Pregnancy|1|||
106110308|NCT02240108|366060307|FG001|Overall Study|Pregnancy|0|||
106110309|NCT02240108|366060306|FG000|Overall Study|Withdrawal by Subject|4|||
106110310|NCT02240108|366060307|FG001|Overall Study|Withdrawal by Subject|9|||
106110311|NCT02240108|366060306|FG000|Overall Study|StudyTerminated by Sponsor|0|||
106110312|NCT02240108|366060307|FG001|Overall Study|StudyTerminated by Sponsor|1|||
106110313|NCT00685945|366060308|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
106110314|NCT03183388|366060309|FG000|Overall Study|Lost to Follow-up|3|||
106110315|NCT03183388|366060310|FG001|Overall Study|Lost to Follow-up|5|||
106110316|NCT03183388|366060309|FG000|Overall Study|Physician Decision|1|||
106110317|NCT03183388|366060310|FG001|Overall Study|Physician Decision|4|||
106110318|NCT03183388|366060309|FG000|Overall Study|Withdrawal by Subject|4|||
106110319|NCT03183388|366060310|FG001|Overall Study|Withdrawal by Subject|1|||
106110320|NCT03183388|366060309|FG000|Overall Study|Moved|1|||
106110321|NCT03183388|366060310|FG001|Overall Study|Moved|0|||
106110322|NCT03183388|366060309|FG000|Overall Study|Met Exclusion Criteria|2|||
106110323|NCT03183388|366060310|FG001|Overall Study|Met Exclusion Criteria|2|||
106110324|NCT03183388|366060309|FG000|Overall Study|COVID Pandemic Related|2|||
106110325|NCT03183388|366060310|FG001|Overall Study|COVID Pandemic Related|4|||
106110326|NCT03938454|366060311|FG000|Overall Study|Protocol Violation|1|||
106110327|NCT03938454|366060311|FG000|Overall Study|Withdrawal by Subject|2|||
106110328|NCT03938454|366060311|FG000|Overall Study|Lost to Follow-up|3|||
106110329|NCT00847405|366060312|FG000|First Intervention|Adverse Event|0|||
106110330|NCT00847405|366060313|FG001|First Intervention|Adverse Event|1|||
106110331|NCT00847405|366060312|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
106110332|NCT00847405|366060313|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
106110333|NCT01203930|366060315|FG000|Overall Study|Disease Progression|0|||
106110334|NCT01203930|366060316|FG001|Overall Study|Disease Progression|4|||
106110335|NCT01203930|366060315|FG000|Overall Study|Death|3|||
106110336|NCT01203930|366060316|FG001|Overall Study|Death|1|||
106110337|NCT01203930|366060315|FG000|Overall Study|Withdrew Consent|1|||
106110338|NCT01203930|366060316|FG001|Overall Study|Withdrew Consent|10|||
106110339|NCT01203930|366060315|FG000|Overall Study|Investigator Request|0|||
106110340|NCT01203930|366060316|FG001|Overall Study|Investigator Request|8|||
106110341|NCT01203930|366060315|FG000|Overall Study|Study Terminated by Sponsor|0|||
106110342|NCT01203930|366060316|FG001|Overall Study|Study Terminated by Sponsor|12|||
106110343|NCT01203930|366060315|FG000|Overall Study|Poor tolerance of study drug|0|||
106110344|NCT01203930|366060316|FG001|Overall Study|Poor tolerance of study drug|1|||
106110345|NCT01203930|366060315|FG000|Overall Study|Adverse Event|17|||
106110346|NCT01203930|366060316|FG001|Overall Study|Adverse Event|5|||
106110347|NCT02178059|366060317|FG000|Washout|Physician Decision|1|||
106110348|NCT02178059|366060318|FG001|Washout|Physician Decision|0|||
106110349|NCT01787097|366060319|FG000|Overall Study|Withdrawal by Subject|1|||
106110350|NCT01787097|366060320|FG001|Overall Study|Withdrawal by Subject|0|||
106110351|NCT01787097|366060321|FG002|Overall Study|Withdrawal by Subject|0|||
106110352|NCT01787097|366060322|FG003|Overall Study|Withdrawal by Subject|0|||
106110353|NCT05178121|366060323|FG000|Overall Study|Other|4|||
106110354|NCT05178121|366060323|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
106110355|NCT00245102|366060324|FG000|Overall Study|Not Treated|1|||
106110356|NCT00245102|366060325|FG001|Overall Study|Not Treated|0|||
106110357|NCT00245102|366060326|FG002|Overall Study|Not Treated|1|||
106110358|NCT00245102|366060327|FG003|Overall Study|Not Treated|0|||
106110359|NCT00245102|366060328|FG004|Overall Study|Not Treated|0|||
106110360|NCT00245102|366060329|FG005|Overall Study|Not Treated|0|||
106110361|NCT00245102|366060324|FG000|Overall Study|Protocol Violation|1|||
106110362|NCT00245102|366060325|FG001|Overall Study|Protocol Violation|0|||
105879016|NCT02025725|365209833|FG001|Overall Study|Withdrawal by Subject|2|||
105879017|NCT02025725|365209832|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
105879018|NCT02025725|365209833|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
105879019|NCT02677922|365209842|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
105879020|NCT02677922|365209843|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
105879021|NCT02677922|365209844|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
105879022|NCT02677922|365209845|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
105879023|NCT02677922|365209846|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
105879024|NCT02677922|365209847|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
105879025|NCT02677922|365209842|FG000|Treatment Period|Adverse Event|0|||
105879026|NCT02677922|365209843|FG001|Treatment Period|Adverse Event|0|||
105879027|NCT02677922|365209844|FG002|Treatment Period|Adverse Event|1|||
105879028|NCT02677922|365209845|FG003|Treatment Period|Adverse Event|3|||
105879029|NCT02677922|365209846|FG004|Treatment Period|Adverse Event|5|||
105784640|NCT01049360|364864387|FG005|Period 1|Adverse Event|0|||
105784641|NCT01049360|364864388|FG006|Period 1|Adverse Event|0|||
105784642|NCT01049360|364864389|FG007|Period 1|Adverse Event|1|||
105784643|NCT01049360|364864390|FG008|Period 1|Adverse Event|0|||
105784644|NCT01049360|364864391|FG009|Period 1|Adverse Event|0|||
105784645|NCT01049360|364864392|FG010|Period 1|Adverse Event|0|||
105879030|NCT02677922|365209847|FG005|Treatment Period|Adverse Event|2|||
105879031|NCT02677922|365209842|FG000|Treatment Period|Progressive Disease|1|||
105879032|NCT02677922|365209843|FG001|Treatment Period|Progressive Disease|1|||
105879033|NCT02677922|365209844|FG002|Treatment Period|Progressive Disease|0|||
105879034|NCT02677922|365209845|FG003|Treatment Period|Progressive Disease|0|||
105879035|NCT02677922|365209846|FG004|Treatment Period|Progressive Disease|8|||
105879036|NCT02677922|365209847|FG005|Treatment Period|Progressive Disease|7|||
105879037|NCT02677922|365209842|FG000|Treatment Period|Lack of Efficacy|0|||
105879038|NCT02677922|365209843|FG001|Treatment Period|Lack of Efficacy|0|||
106110363|NCT00245102|366060326|FG002|Overall Study|Protocol Violation|0|||
106110364|NCT00245102|366060327|FG003|Overall Study|Protocol Violation|0|||
106110365|NCT00245102|366060328|FG004|Overall Study|Protocol Violation|0|||
105784646|NCT01049360|364864393|FG011|Period 1|Adverse Event|0|||
105784647|NCT01049360|364864394|FG012|Period 1|Adverse Event|1|||
105784648|NCT01049360|364864395|FG013|Period 1|Adverse Event|1|||
105784649|NCT01049360|364864396|FG014|Period 1|Adverse Event|0|||
105784650|NCT01049360|364864397|FG015|Period 1|Adverse Event|0|||
105784651|NCT01049360|364864398|FG016|Period 1|Adverse Event|1|||
105784652|NCT01049360|364864399|FG017|Period 1|Adverse Event|0|||
105784653|NCT01049360|364864400|FG018|Period 1|Adverse Event|1|||
105784654|NCT01049360|364864401|FG019|Period 1|Adverse Event|0|||
105784655|NCT01049360|364864382|FG000|Period 1|Did not meet inc/exc criteria|0|||
105784656|NCT01049360|364864383|FG001|Period 1|Did not meet inc/exc criteria|0|||
105784657|NCT01049360|364864384|FG002|Period 1|Did not meet inc/exc criteria|0|||
105784658|NCT01049360|364864385|FG003|Period 1|Did not meet inc/exc criteria|0|||
105784659|NCT01049360|364864386|FG004|Period 1|Did not meet inc/exc criteria|0|||
105784660|NCT01049360|364864387|FG005|Period 1|Did not meet inc/exc criteria|0|||
105784661|NCT01049360|364864388|FG006|Period 1|Did not meet inc/exc criteria|0|||
105784662|NCT01049360|364864389|FG007|Period 1|Did not meet inc/exc criteria|1|||
105784663|NCT01049360|364864390|FG008|Period 1|Did not meet inc/exc criteria|1|||
105784664|NCT01049360|364864391|FG009|Period 1|Did not meet inc/exc criteria|0|||
105784665|NCT01049360|364864392|FG010|Period 1|Did not meet inc/exc criteria|0|||
105784666|NCT01049360|364864393|FG011|Period 1|Did not meet inc/exc criteria|0|||
105784667|NCT01049360|364864394|FG012|Period 1|Did not meet inc/exc criteria|0|||
105784668|NCT01049360|364864395|FG013|Period 1|Did not meet inc/exc criteria|0|||
105784669|NCT01049360|364864396|FG014|Period 1|Did not meet inc/exc criteria|0|||
105784670|NCT01049360|364864397|FG015|Period 1|Did not meet inc/exc criteria|0|||
105784671|NCT01049360|364864398|FG016|Period 1|Did not meet inc/exc criteria|0|||
105784672|NCT01049360|364864399|FG017|Period 1|Did not meet inc/exc criteria|0|||
105784673|NCT01049360|364864400|FG018|Period 1|Did not meet inc/exc criteria|0|||
105784674|NCT01049360|364864401|FG019|Period 1|Did not meet inc/exc criteria|0|||
105784675|NCT01049360|364864382|FG000|Period 1|Withdrawal by Subject|0|||
105784676|NCT01049360|364864383|FG001|Period 1|Withdrawal by Subject|0|||
105784677|NCT01049360|364864384|FG002|Period 1|Withdrawal by Subject|0|||
105784678|NCT01049360|364864385|FG003|Period 1|Withdrawal by Subject|0|||
105784679|NCT01049360|364864386|FG004|Period 1|Withdrawal by Subject|0|||
105784680|NCT01049360|364864387|FG005|Period 1|Withdrawal by Subject|0|||
105784681|NCT01049360|364864388|FG006|Period 1|Withdrawal by Subject|0|||
105784682|NCT01049360|364864389|FG007|Period 1|Withdrawal by Subject|0|||
105784683|NCT01049360|364864390|FG008|Period 1|Withdrawal by Subject|1|||
105784684|NCT01049360|364864391|FG009|Period 1|Withdrawal by Subject|0|||
105784685|NCT01049360|364864392|FG010|Period 1|Withdrawal by Subject|1|||
105784686|NCT01049360|364864393|FG011|Period 1|Withdrawal by Subject|0|||
105784687|NCT01049360|364864394|FG012|Period 1|Withdrawal by Subject|1|||
105784688|NCT01049360|364864395|FG013|Period 1|Withdrawal by Subject|0|||
105784689|NCT01049360|364864396|FG014|Period 1|Withdrawal by Subject|0|||
105784690|NCT01049360|364864397|FG015|Period 1|Withdrawal by Subject|0|||
105879039|NCT02677922|365209844|FG002|Treatment Period|Lack of Efficacy|0|||
105879040|NCT02677922|365209845|FG003|Treatment Period|Lack of Efficacy|1|||
105879041|NCT02677922|365209846|FG004|Treatment Period|Lack of Efficacy|1|||
105879042|NCT02677922|365209847|FG005|Treatment Period|Lack of Efficacy|6|||
105879043|NCT02677922|365209842|FG000|Treatment Period|Withdrawal by Subject|0|||
105879044|NCT02677922|365209843|FG001|Treatment Period|Withdrawal by Subject|0|||
105879045|NCT02677922|365209844|FG002|Treatment Period|Withdrawal by Subject|1|||
105879046|NCT02677922|365209845|FG003|Treatment Period|Withdrawal by Subject|3|||
105879047|NCT02677922|365209846|FG004|Treatment Period|Withdrawal by Subject|5|||
105879048|NCT02677922|365209847|FG005|Treatment Period|Withdrawal by Subject|5|||
105879049|NCT02677922|365209842|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
105879050|NCT02677922|365209843|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
105879051|NCT02677922|365209844|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
105879052|NCT02677922|365209845|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
105879053|NCT02677922|365209846|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
105879054|NCT02677922|365209847|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
105879055|NCT02677922|365209842|FG000|Treatment Period|Disease Relapse|0|||
105879056|NCT02677922|365209843|FG001|Treatment Period|Disease Relapse|0|||
105879057|NCT02677922|365209844|FG002|Treatment Period|Disease Relapse|0|||
105879058|NCT02677922|365209845|FG003|Treatment Period|Disease Relapse|3|||
105879059|NCT02677922|365209846|FG004|Treatment Period|Disease Relapse|6|||
105879060|NCT02677922|365209847|FG005|Treatment Period|Disease Relapse|1|||
105879061|NCT02677922|365209842|FG000|Treatment Period|Allogeneic HSCT|1|||
105879062|NCT02677922|365209843|FG001|Treatment Period|Allogeneic HSCT|0|||
105879063|NCT02677922|365209844|FG002|Treatment Period|Allogeneic HSCT|0|||
105879064|NCT02677922|365209845|FG003|Treatment Period|Allogeneic HSCT|1|||
105879065|NCT02677922|365209846|FG004|Treatment Period|Allogeneic HSCT|4|||
105879066|NCT02677922|365209847|FG005|Treatment Period|Allogeneic HSCT|1|||
105879067|NCT02677922|365209842|FG000|Treatment Period|Other Reasons|0|||
105879068|NCT02677922|365209843|FG001|Treatment Period|Other Reasons|0|||
105879069|NCT02677922|365209844|FG002|Treatment Period|Other Reasons|0|||
105879070|NCT02677922|365209845|FG003|Treatment Period|Other Reasons|1|||
105879071|NCT02677922|365209846|FG004|Treatment Period|Other Reasons|3|||
105879072|NCT02677922|365209847|FG005|Treatment Period|Other Reasons|5|||
105879073|NCT02677922|365209842|FG000|Treatment Period|Death|0|||
105879074|NCT02677922|365209843|FG001|Treatment Period|Death|0|||
105879075|NCT02677922|365209844|FG002|Treatment Period|Death|0|||
105879076|NCT02677922|365209845|FG003|Treatment Period|Death|0|||
105879077|NCT02677922|365209846|FG004|Treatment Period|Death|12|||
105879078|NCT02677922|365209847|FG005|Treatment Period|Death|1|||
105879079|NCT02677922|365209842|FG000|Treatment Period|Non-compliance with Study Drug|0|||
105879080|NCT02677922|365209843|FG001|Treatment Period|Non-compliance with Study Drug|0|||
105879081|NCT02677922|365209844|FG002|Treatment Period|Non-compliance with Study Drug|0|||
105879082|NCT02677922|365209845|FG003|Treatment Period|Non-compliance with Study Drug|0|||
105879083|NCT02677922|365209846|FG004|Treatment Period|Non-compliance with Study Drug|1|||
105879084|NCT02677922|365209847|FG005|Treatment Period|Non-compliance with Study Drug|0|||
105879085|NCT02677922|365209842|FG000|Treatment Period|Physician Decision|0|||
105879086|NCT02677922|365209843|FG001|Treatment Period|Physician Decision|0|||
105879087|NCT02677922|365209844|FG002|Treatment Period|Physician Decision|0|||
105879088|NCT02677922|365209845|FG003|Treatment Period|Physician Decision|0|||
105879089|NCT02677922|365209846|FG004|Treatment Period|Physician Decision|0|||
105879090|NCT02677922|365209847|FG005|Treatment Period|Physician Decision|1|||
105879091|NCT02677922|365209842|FG000|Treatment Period|Symptomatic Deterioration|0|||
105879092|NCT02677922|365209843|FG001|Treatment Period|Symptomatic Deterioration|0|||
106110366|NCT00245102|366060329|FG005|Overall Study|Protocol Violation|0|||
105784691|NCT01049360|364864398|FG016|Period 1|Withdrawal by Subject|0|||
105784692|NCT01049360|364864399|FG017|Period 1|Withdrawal by Subject|0|||
105784693|NCT01049360|364864400|FG018|Period 1|Withdrawal by Subject|0|||
105784694|NCT01049360|364864401|FG019|Period 1|Withdrawal by Subject|0|||
105784695|NCT01049360|364864382|FG000|Period 2|Protocol Violation|0|||
105784696|NCT01049360|364864383|FG001|Period 2|Protocol Violation|0|||
105784697|NCT01049360|364864384|FG002|Period 2|Protocol Violation|0|||
105784698|NCT01049360|364864385|FG003|Period 2|Protocol Violation|1|||
105784699|NCT01049360|364864386|FG004|Period 2|Protocol Violation|0|||
105784700|NCT01049360|364864387|FG005|Period 2|Protocol Violation|0|||
105784701|NCT01049360|364864388|FG006|Period 2|Protocol Violation|0|||
105784702|NCT01049360|364864389|FG007|Period 2|Protocol Violation|0|||
105784703|NCT01049360|364864390|FG008|Period 2|Protocol Violation|0|||
105784704|NCT01049360|364864391|FG009|Period 2|Protocol Violation|0|||
105879093|NCT02677922|365209844|FG002|Treatment Period|Symptomatic Deterioration|0|||
105879094|NCT02677922|365209845|FG003|Treatment Period|Symptomatic Deterioration|0|||
105879095|NCT02677922|365209846|FG004|Treatment Period|Symptomatic Deterioration|1|||
105879096|NCT02677922|365209847|FG005|Treatment Period|Symptomatic Deterioration|0|||
105879097|NCT01791894|365209855|FG000|Overall Study|Adverse Event|1|||
105784705|NCT01049360|364864392|FG010|Period 2|Protocol Violation|0|||
105784706|NCT01049360|364864393|FG011|Period 2|Protocol Violation|0|||
105784707|NCT01049360|364864394|FG012|Period 2|Protocol Violation|0|||
105879098|NCT02268916|365209856|FG000|Overall Study|Lost to Follow-up|1|||
105879099|NCT02268916|365209857|FG001|Overall Study|Lost to Follow-up|1|||
105879100|NCT02268916|365209856|FG000|Overall Study|Withdrawal by Subject|6|||
105879101|NCT02268916|365209857|FG001|Overall Study|Withdrawal by Subject|5|||
105879102|NCT02268916|365209856|FG000|Overall Study|Participant did not have diabetes|1|||
105879103|NCT02268916|365209857|FG001|Overall Study|Participant did not have diabetes|0|||
105879104|NCT02268916|365209856|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
105879105|NCT02268916|365209857|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
105879106|NCT01420068|365209858|FG000|Overall Study|Administrative problems|1|||
105879107|NCT01420068|365209859|FG001|Overall Study|Administrative problems|3|||
105879108|NCT01420068|365209858|FG000|Overall Study|Withdrawal by Subject|1|||
105879109|NCT01420068|365209859|FG001|Overall Study|Withdrawal by Subject|2|||
105879110|NCT00365794|365209862|FG000|Overall Study|Withdrawal by Subject|2|||
105879111|NCT03926117|365209863|FG000|Overall Study|Unclassified|1|||
105879112|NCT03926117|365209864|FG001|Overall Study|Unclassified|4|||
105879113|NCT03926117|365209865|FG002|Overall Study|Unclassified|1|||
105879114|NCT03926117|365209866|FG003|Overall Study|Unclassified|4|||
105879115|NCT03926117|365209863|FG000|Overall Study|Withdrawal by Subject|3|||
105879116|NCT03926117|365209864|FG001|Overall Study|Withdrawal by Subject|0|||
105879117|NCT03926117|365209865|FG002|Overall Study|Withdrawal by Subject|1|||
105879118|NCT03926117|365209866|FG003|Overall Study|Withdrawal by Subject|1|||
105879119|NCT03926117|365209863|FG000|Overall Study|Lost to Follow-up|0|||
105879120|NCT03926117|365209864|FG001|Overall Study|Lost to Follow-up|2|||
105879121|NCT03926117|365209865|FG002|Overall Study|Lost to Follow-up|1|||
105879122|NCT03926117|365209866|FG003|Overall Study|Lost to Follow-up|0|||
105879123|NCT03926117|365209863|FG000|Overall Study|Adverse Event|1|||
105879124|NCT03926117|365209864|FG001|Overall Study|Adverse Event|2|||
105879125|NCT03926117|365209865|FG002|Overall Study|Adverse Event|3|||
105879126|NCT03926117|365209866|FG003|Overall Study|Adverse Event|1|||
105879127|NCT03926117|365209863|FG000|Overall Study|Randomized but not treated|1|||
105879128|NCT03926117|365209864|FG001|Overall Study|Randomized but not treated|1|||
105879129|NCT03926117|365209865|FG002|Overall Study|Randomized but not treated|0|||
105879130|NCT03926117|365209866|FG003|Overall Study|Randomized but not treated|1|||
105879131|NCT02554682|365209867|FG000|Overall Study|Lost to Follow-up|11|||
105879132|NCT02554682|365209868|FG001|Overall Study|Lost to Follow-up|9|||
105879133|NCT02554682|365209869|FG002|Overall Study|Lost to Follow-up|4|||
105879134|NCT02554682|365209870|FG003|Overall Study|Lost to Follow-up|3|||
105879135|NCT02554682|365209871|FG004|Overall Study|Lost to Follow-up|2|||
105879136|NCT02554682|365209872|FG005|Overall Study|Lost to Follow-up|1|||
105879137|NCT02554682|365209873|FG006|Overall Study|Lost to Follow-up|6|||
105879138|NCT02554682|365209874|FG007|Overall Study|Lost to Follow-up|6|||
105879139|NCT02554682|365209875|FG008|Overall Study|Lost to Follow-up|2|||
105879140|NCT02554682|365209876|FG009|Overall Study|Lost to Follow-up|2|||
105879141|NCT02554682|365209867|FG000|Overall Study|Withdrawal by Subject|2|||
105879142|NCT02554682|365209868|FG001|Overall Study|Withdrawal by Subject|1|||
105879143|NCT02554682|365209869|FG002|Overall Study|Withdrawal by Subject|0|||
105879144|NCT02554682|365209870|FG003|Overall Study|Withdrawal by Subject|0|||
105879145|NCT02554682|365209871|FG004|Overall Study|Withdrawal by Subject|0|||
105879146|NCT02554682|365209872|FG005|Overall Study|Withdrawal by Subject|0|||
105879147|NCT02554682|365209873|FG006|Overall Study|Withdrawal by Subject|0|||
105879148|NCT02554682|365209874|FG007|Overall Study|Withdrawal by Subject|0|||
105879149|NCT02554682|365209875|FG008|Overall Study|Withdrawal by Subject|0|||
105879150|NCT02554682|365209876|FG009|Overall Study|Withdrawal by Subject|0|||
105879151|NCT02554682|365209867|FG000|Overall Study|Physician Decision|2|||
105879152|NCT02554682|365209868|FG001|Overall Study|Physician Decision|2|||
105879153|NCT02554682|365209869|FG002|Overall Study|Physician Decision|0|||
105879154|NCT02554682|365209870|FG003|Overall Study|Physician Decision|0|||
105879155|NCT02554682|365209871|FG004|Overall Study|Physician Decision|0|||
105879156|NCT02554682|365209872|FG005|Overall Study|Physician Decision|0|||
105879157|NCT02554682|365209873|FG006|Overall Study|Physician Decision|0|||
105879158|NCT02554682|365209874|FG007|Overall Study|Physician Decision|0|||
105879159|NCT02554682|365209875|FG008|Overall Study|Physician Decision|0|||
105879160|NCT02554682|365209876|FG009|Overall Study|Physician Decision|0|||
105879161|NCT04830969|365209880|FG000|Overall Study|Withdrawal by Subject|6|||
105879162|NCT04830969|365209881|FG001|Overall Study|Withdrawal by Subject|2|||
105879163|NCT04830969|365209880|FG000|Overall Study|Protocol Violation|3|||
105879164|NCT04830969|365209881|FG001|Overall Study|Protocol Violation|9|||
105879165|NCT04830969|365209880|FG000|Overall Study|Lost to Follow-up|4|||
105879166|NCT04830969|365209881|FG001|Overall Study|Lost to Follow-up|4|||
105879167|NCT02929589|365209882|FG000|Overall Study|Withdrawal by Subject|1|||
105879168|NCT02929589|365209883|FG001|Overall Study|Withdrawal by Subject|0|||
105879169|NCT02929589|365209884|FG002|Overall Study|Withdrawal by Subject|0|||
105879170|NCT02929589|365209885|FG003|Overall Study|Withdrawal by Subject|0|||
105879171|NCT02929589|365209882|FG000|Overall Study|Physician Decision|2|||
105879172|NCT02929589|365209883|FG001|Overall Study|Physician Decision|0|||
105879173|NCT02929589|365209884|FG002|Overall Study|Physician Decision|0|||
105879174|NCT02929589|365209885|FG003|Overall Study|Physician Decision|0|||
105879175|NCT01786993|365209886|FG000|Overall Study|Death|6|||
105879176|NCT01786993|365209887|FG001|Overall Study|Death|7|||
105879177|NCT01786993|365209886|FG000|Overall Study|Withdrawal by Subject|3|||
105879178|NCT01786993|365209887|FG001|Overall Study|Withdrawal by Subject|2|||
105879179|NCT01786993|365209886|FG000|Overall Study|Lost to Follow-up|0|||
105879180|NCT01786993|365209887|FG001|Overall Study|Lost to Follow-up|1|||
105879181|NCT01786993|365209886|FG000|Overall Study|Subject Non-Compliance|1|||
105879182|NCT01786993|365209887|FG001|Overall Study|Subject Non-Compliance|0|||
105879183|NCT01786993|365209886|FG000|Overall Study|System Explant|1|||
105879184|NCT01786993|365209887|FG001|Overall Study|System Explant|0|||
105879185|NCT01786993|365209886|FG000|Overall Study|Hospice Admission|1|||
105879186|NCT01786993|365209887|FG001|Overall Study|Hospice Admission|0|||
105879187|NCT03564119|365209895|FG000|Overall Study|Adverse Event|4|||
105879188|NCT03564119|365209896|FG001|Overall Study|Adverse Event|0|||
105879189|NCT03564119|365209895|FG000|Overall Study|Lost to Follow-up|1|||
105879190|NCT03564119|365209896|FG001|Overall Study|Lost to Follow-up|4|||
105879191|NCT03564119|365209895|FG000|Overall Study|Protocol Violation|1|||
105879192|NCT03564119|365209896|FG001|Overall Study|Protocol Violation|0|||
105879193|NCT03564119|365209895|FG000|Overall Study|Withdrawal by Subject|9|||
105879194|NCT03564119|365209896|FG001|Overall Study|Withdrawal by Subject|4|||
105879195|NCT03564119|365209895|FG000|Overall Study|Other Than Specified|0|||
105879196|NCT03564119|365209896|FG001|Overall Study|Other Than Specified|1|||
105879197|NCT00634036|365209897|FG000|Overall Study|Lost to Follow-up|1|||
105879198|NCT00634036|365209898|FG001|Overall Study|Lost to Follow-up|1|||
105879199|NCT00634036|365209897|FG000|Overall Study|Withdrawal by Subject|1|||
105879200|NCT00634036|365209898|FG001|Overall Study|Withdrawal by Subject|1|||
105879201|NCT03896022|365209905|FG000|Overall Study|Withdrawal by Subject|1|||
105879202|NCT03896022|365209906|FG001|Overall Study|Withdrawal by Subject|0|||
105879203|NCT03896022|365209907|FG002|Overall Study|Withdrawal by Subject|0|||
105879204|NCT03896022|365209905|FG000|Overall Study|Did not have procedure|3|||
105879205|NCT03896022|365209906|FG001|Overall Study|Did not have procedure|0|||
105879206|NCT03896022|365209907|FG002|Overall Study|Did not have procedure|0|||
105879207|NCT03859427|365209913|FG000|Overall Study|Withdrawal by Subject|4|||
105879208|NCT03859427|365209914|FG001|Overall Study|Withdrawal by Subject|7|||
105879209|NCT03859427|365209913|FG000|Overall Study|Decision by sponsor|0|||
105879210|NCT03859427|365209914|FG001|Overall Study|Decision by sponsor|3|||
105879211|NCT03859427|365209913|FG000|Overall Study|Lost to Follow-up|3|||
105879212|NCT03859427|365209914|FG001|Overall Study|Lost to Follow-up|2|||
105879213|NCT03859427|365209913|FG000|Overall Study|Death|22|||
105879214|NCT03859427|365209914|FG001|Overall Study|Death|25|||
105879215|NCT02503540|365209915|FG000|Overall Study|Death|2|||
105879216|NCT02503540|365209915|FG000|Overall Study|Withdrawal by Subject|1|||
105879217|NCT00979654|365209918|FG000|Overall Study|Lost to Follow-up|1|||
105879218|NCT00979654|365209918|FG000|Overall Study|Withdrawal by Subject|22|||
106110367|NCT00245102|366060324|FG000|Overall Study|Death|0|||
105879219|NCT00979654|365209918|FG000|Overall Study|Death|1|||
105879220|NCT00979654|365209918|FG000|Overall Study|Lack of Efficacy|6|||
105879221|NCT00979654|365209918|FG000|Overall Study|Adverse Event|1|||
105879222|NCT00979654|365209918|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
105879223|NCT00979654|365209918|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
105879224|NCT00979654|365209918|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
105879225|NCT00979654|365209918|FG000|Overall Study|Serious Adverse Event|1|||
105879226|NCT00979654|365209918|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
105879227|NCT00734994|365209921|FG000|Overall Study|Withdrawal by Subject|1|||
105879228|NCT04509076|365211649|FG000|Overall Study|Withdrawal by Subject|1|||
105879229|NCT04509076|365211650|FG001|Overall Study|Withdrawal by Subject|2|||
105879230|NCT04509076|365211649|FG000|Overall Study|Lost to Follow-up|1|||
105879231|NCT04509076|365211650|FG001|Overall Study|Lost to Follow-up|2|||
105879232|NCT00391768|365211651|FG000|Overall Study|Withdrawal by Subject|0|||
105879233|NCT00391768|365211652|FG001|Overall Study|Withdrawal by Subject|0|||
105879234|NCT00391768|365211653|FG002|Overall Study|Withdrawal by Subject|1|||
105879235|NCT00391768|365211654|FG003|Overall Study|Withdrawal by Subject|0|||
106110368|NCT00245102|366060325|FG001|Overall Study|Death|0|||
106110369|NCT00245102|366060326|FG002|Overall Study|Death|0|||
105879236|NCT00391768|365211655|FG004|Overall Study|Withdrawal by Subject|0|||
105879237|NCT00391768|365211656|FG005|Overall Study|Withdrawal by Subject|1|||
105879238|NCT00391768|365211657|FG006|Overall Study|Withdrawal by Subject|1|||
105879239|NCT00391768|365211651|FG000|Overall Study|Lost to Follow-up|0|||
105993704|NCT01510158|365636076|FG001|Overall Study|Adverse Event|8|||
105993705|NCT01510158|365636077|FG002|Overall Study|Adverse Event|5|||
105879240|NCT00391768|365211652|FG001|Overall Study|Lost to Follow-up|0|||
105879241|NCT00391768|365211653|FG002|Overall Study|Lost to Follow-up|0|||
105879242|NCT00391768|365211654|FG003|Overall Study|Lost to Follow-up|1|||
105879243|NCT00391768|365211655|FG004|Overall Study|Lost to Follow-up|2|||
105879244|NCT00391768|365211656|FG005|Overall Study|Lost to Follow-up|2|||
105879245|NCT00391768|365211657|FG006|Overall Study|Lost to Follow-up|3|||
105879246|NCT00406367|365211658|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
105879247|NCT00406367|365211659|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
105993706|NCT01510158|365636075|FG000|Overall Study|Gout flare|1|||
106110370|NCT00245102|366060327|FG003|Overall Study|Death|1|||
106110371|NCT00245102|366060328|FG004|Overall Study|Death|0|||
106110372|NCT00245102|366060329|FG005|Overall Study|Death|0|||
105784708|NCT01049360|364864395|FG013|Period 2|Protocol Violation|0|||
105784709|NCT01049360|364864396|FG014|Period 2|Protocol Violation|1|||
105784710|NCT01049360|364864397|FG015|Period 2|Protocol Violation|1|||
105784711|NCT01049360|364864398|FG016|Period 2|Protocol Violation|0|||
105784712|NCT01049360|364864399|FG017|Period 2|Protocol Violation|0|||
105784713|NCT01049360|364864400|FG018|Period 2|Protocol Violation|0|||
105784714|NCT01049360|364864401|FG019|Period 2|Protocol Violation|0|||
105784715|NCT01049360|364864382|FG000|Period 2|Adverse Event|0|||
105784716|NCT01049360|364864383|FG001|Period 2|Adverse Event|1|||
105784717|NCT01049360|364864384|FG002|Period 2|Adverse Event|0|||
105784718|NCT01049360|364864385|FG003|Period 2|Adverse Event|0|||
105784719|NCT01049360|364864386|FG004|Period 2|Adverse Event|0|||
105784720|NCT01049360|364864387|FG005|Period 2|Adverse Event|0|||
105784721|NCT01049360|364864388|FG006|Period 2|Adverse Event|0|||
105784722|NCT01049360|364864389|FG007|Period 2|Adverse Event|0|||
105784723|NCT01049360|364864390|FG008|Period 2|Adverse Event|1|||
105784724|NCT01049360|364864391|FG009|Period 2|Adverse Event|0|||
105784725|NCT01049360|364864392|FG010|Period 2|Adverse Event|0|||
105784726|NCT01049360|364864393|FG011|Period 2|Adverse Event|0|||
105784727|NCT01049360|364864394|FG012|Period 2|Adverse Event|0|||
105784728|NCT01049360|364864395|FG013|Period 2|Adverse Event|0|||
105784729|NCT01049360|364864396|FG014|Period 2|Adverse Event|0|||
105784730|NCT01049360|364864397|FG015|Period 2|Adverse Event|0|||
105784731|NCT01049360|364864398|FG016|Period 2|Adverse Event|0|||
105784732|NCT01049360|364864399|FG017|Period 2|Adverse Event|0|||
105784733|NCT01049360|364864400|FG018|Period 2|Adverse Event|0|||
105784734|NCT01049360|364864401|FG019|Period 2|Adverse Event|1|||
105784735|NCT01049360|364864382|FG000|Period 2|Withdrawal by Subject|0|||
105784736|NCT01049360|364864383|FG001|Period 2|Withdrawal by Subject|0|||
105784737|NCT01049360|364864384|FG002|Period 2|Withdrawal by Subject|0|||
105784738|NCT01049360|364864385|FG003|Period 2|Withdrawal by Subject|1|||
105784739|NCT01049360|364864386|FG004|Period 2|Withdrawal by Subject|0|||
105784740|NCT01049360|364864387|FG005|Period 2|Withdrawal by Subject|0|||
105784741|NCT01049360|364864388|FG006|Period 2|Withdrawal by Subject|0|||
105784742|NCT01049360|364864389|FG007|Period 2|Withdrawal by Subject|0|||
105784743|NCT01049360|364864390|FG008|Period 2|Withdrawal by Subject|0|||
105784744|NCT01049360|364864391|FG009|Period 2|Withdrawal by Subject|0|||
105784745|NCT01049360|364864392|FG010|Period 2|Withdrawal by Subject|0|||
105784746|NCT01049360|364864393|FG011|Period 2|Withdrawal by Subject|0|||
105784747|NCT01049360|364864394|FG012|Period 2|Withdrawal by Subject|0|||
105784748|NCT01049360|364864395|FG013|Period 2|Withdrawal by Subject|0|||
105784749|NCT01049360|364864396|FG014|Period 2|Withdrawal by Subject|1|||
105784750|NCT01049360|364864397|FG015|Period 2|Withdrawal by Subject|0|||
105784751|NCT01049360|364864398|FG016|Period 2|Withdrawal by Subject|0|||
105784752|NCT01049360|364864399|FG017|Period 2|Withdrawal by Subject|0|||
105784753|NCT01049360|364864400|FG018|Period 2|Withdrawal by Subject|0|||
105784754|NCT01049360|364864401|FG019|Period 2|Withdrawal by Subject|1|||
105784755|NCT01049360|364864382|FG000|Period 2|Lack of Efficacy|0|||
105784756|NCT01049360|364864383|FG001|Period 2|Lack of Efficacy|0|||
105784757|NCT01049360|364864384|FG002|Period 2|Lack of Efficacy|0|||
105784758|NCT01049360|364864385|FG003|Period 2|Lack of Efficacy|0|||
105784759|NCT01049360|364864386|FG004|Period 2|Lack of Efficacy|0|||
105784760|NCT01049360|364864387|FG005|Period 2|Lack of Efficacy|1|||
105784761|NCT01049360|364864388|FG006|Period 2|Lack of Efficacy|0|||
105784762|NCT01049360|364864389|FG007|Period 2|Lack of Efficacy|0|||
105784763|NCT01049360|364864390|FG008|Period 2|Lack of Efficacy|0|||
105784764|NCT01049360|364864391|FG009|Period 2|Lack of Efficacy|0|||
105784765|NCT01049360|364864392|FG010|Period 2|Lack of Efficacy|0|||
105784766|NCT01049360|364864393|FG011|Period 2|Lack of Efficacy|0|||
105784767|NCT01049360|364864394|FG012|Period 2|Lack of Efficacy|0|||
105784768|NCT01049360|364864395|FG013|Period 2|Lack of Efficacy|0|||
105784769|NCT01049360|364864396|FG014|Period 2|Lack of Efficacy|0|||
105784770|NCT01049360|364864397|FG015|Period 2|Lack of Efficacy|0|||
105784771|NCT01049360|364864398|FG016|Period 2|Lack of Efficacy|0|||
105784772|NCT01049360|364864399|FG017|Period 2|Lack of Efficacy|0|||
105784773|NCT01049360|364864400|FG018|Period 2|Lack of Efficacy|0|||
105784774|NCT01049360|364864401|FG019|Period 2|Lack of Efficacy|0|||
105784775|NCT01049360|364864382|FG000|Period 4|Protocol Violation|0|||
105784776|NCT01049360|364864383|FG001|Period 4|Protocol Violation|0|||
105784777|NCT01049360|364864384|FG002|Period 4|Protocol Violation|0|||
105784778|NCT01049360|364864385|FG003|Period 4|Protocol Violation|0|||
105784779|NCT01049360|364864386|FG004|Period 4|Protocol Violation|0|||
105784780|NCT01049360|364864387|FG005|Period 4|Protocol Violation|0|||
105784781|NCT01049360|364864388|FG006|Period 4|Protocol Violation|0|||
105784782|NCT01049360|364864389|FG007|Period 4|Protocol Violation|0|||
105784783|NCT01049360|364864390|FG008|Period 4|Protocol Violation|0|||
105784784|NCT01049360|364864391|FG009|Period 4|Protocol Violation|0|||
105784785|NCT01049360|364864392|FG010|Period 4|Protocol Violation|0|||
105784786|NCT01049360|364864393|FG011|Period 4|Protocol Violation|0|||
105784787|NCT01049360|364864394|FG012|Period 4|Protocol Violation|0|||
105784788|NCT01049360|364864395|FG013|Period 4|Protocol Violation|0|||
106110373|NCT00245102|366060324|FG000|Overall Study|Adverse Event|4|||
105879248|NCT00406367|365211658|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
105879249|NCT00406367|365211659|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
105879250|NCT00406367|365211658|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
105879251|NCT00406367|365211659|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
105879252|NCT00406367|365211658|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
105879253|NCT00406367|365211659|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
105879254|NCT00406367|365211658|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
105879255|NCT00406367|365211659|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
105879256|NCT00406367|365211658|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
105879257|NCT00406367|365211659|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
105879258|NCT00406367|365211658|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
105879259|NCT00406367|365211659|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
105879260|NCT00406367|365211658|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
105879261|NCT00406367|365211659|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
105879262|NCT00406367|365211658|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
105879263|NCT00406367|365211659|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
105879264|NCT00406367|365211658|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
105879265|NCT00406367|365211659|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
105879266|NCT00406367|365211658|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
105879267|NCT00406367|365211659|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
105879268|NCT00406367|365211658|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
105879269|NCT00406367|365211659|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
105879270|NCT01812109|365211662|FG000|Overall Study|research personnel delay|16|||
105879271|NCT01812109|365211662|FG000|Overall Study|NIRS Unattainable|17|||
105879272|NCT03313180|365211663|FG000|Overall Study|Adverse Event|120|||
105879273|NCT03313180|365211663|FG000|Overall Study|Lost to Follow-up|3|||
105879274|NCT03313180|365211663|FG000|Overall Study|Withdrawal by Subject|39|||
105879275|NCT03313180|365211663|FG000|Overall Study|Other than listed above|15|||
105879276|NCT03313180|365211663|FG000|Overall Study|Covid-19 related|2|||
105879277|NCT04498182|365211666|FG000|Overall Study|Adverse Event|2|||
105879278|NCT04498182|365211667|FG001|Overall Study|Adverse Event|3|||
105879279|NCT04498182|365211668|FG002|Overall Study|Adverse Event|2|||
105879280|NCT04498182|365211666|FG000|Overall Study|Withdrawal of Consent|3|||
105879281|NCT04498182|365211667|FG001|Overall Study|Withdrawal of Consent|4|||
105879282|NCT04498182|365211668|FG002|Overall Study|Withdrawal of Consent|3|||
105879283|NCT04498182|365211666|FG000|Overall Study|Non-Compliant|1|||
105879284|NCT04498182|365211667|FG001|Overall Study|Non-Compliant|0|||
105879285|NCT04498182|365211668|FG002|Overall Study|Non-Compliant|1|||
105879286|NCT04498182|365211666|FG000|Overall Study|Lost to Follow-up|0|||
105879287|NCT04498182|365211667|FG001|Overall Study|Lost to Follow-up|0|||
105879288|NCT04498182|365211668|FG002|Overall Study|Lost to Follow-up|1|||
105879289|NCT04498182|365211666|FG000|Overall Study|Investigator Decision|0|||
105879290|NCT04498182|365211667|FG001|Overall Study|Investigator Decision|0|||
105879291|NCT04498182|365211668|FG002|Overall Study|Investigator Decision|1|||
105879292|NCT04498182|365211666|FG000|Overall Study|Protocol Violation|1|||
105879293|NCT04498182|365211667|FG001|Overall Study|Protocol Violation|0|||
105879294|NCT04498182|365211668|FG002|Overall Study|Protocol Violation|2|||
105879295|NCT00832455|365211677|FG000|Overall Study|Adverse Event|13|||
105879296|NCT00832455|365211677|FG000|Overall Study|Lost to Follow-up|26|||
105879297|NCT00832455|365211677|FG000|Overall Study|Protocol Violation|4|||
105879298|NCT00832455|365211677|FG000|Overall Study|Withdrawal by Subject|17|||
105879299|NCT00832455|365211677|FG000|Overall Study|Screening Failure|2|||
105879300|NCT00832455|365211677|FG000|Overall Study|Stopped Medication|4|||
105879301|NCT00832455|365211677|FG000|Overall Study|Parent misunderstood study|1|||
106110374|NCT00245102|366060325|FG001|Overall Study|Adverse Event|2|||
106110375|NCT00245102|366060326|FG002|Overall Study|Adverse Event|5|||
105879302|NCT00832455|365211677|FG000|Overall Study|Parent dissatisfied|1|||
105879303|NCT00832455|365211677|FG000|Overall Study|No improvement|3|||
105879304|NCT00832455|365211677|FG000|Overall Study|Patient moved|1|||
105879305|NCT03337113|365211679|FG000|Overall Study|Adverse Event|1|||
105879306|NCT03337113|365211680|FG001|Overall Study|Adverse Event|1|||
105879307|NCT03337113|365211681|FG002|Overall Study|Adverse Event|0|||
105879308|NCT03337113|365211682|FG003|Overall Study|Adverse Event|1|||
105879309|NCT03337113|365211679|FG000|Overall Study|Physician Decision|0|||
105879310|NCT03337113|365211680|FG001|Overall Study|Physician Decision|2|||
105879311|NCT03337113|365211681|FG002|Overall Study|Physician Decision|0|||
105879312|NCT03337113|365211682|FG003|Overall Study|Physician Decision|1|||
105879313|NCT03337113|365211679|FG000|Overall Study|Withdrawal by Subject|0|||
105879314|NCT03337113|365211680|FG001|Overall Study|Withdrawal by Subject|0|||
105879315|NCT03337113|365211681|FG002|Overall Study|Withdrawal by Subject|1|||
105879316|NCT03337113|365211682|FG003|Overall Study|Withdrawal by Subject|0|||
105879317|NCT02556775|365211684|FG000|Overall Study|Withdrawal by Subject|1|||
106110376|NCT00245102|366060327|FG003|Overall Study|Adverse Event|1|||
105879318|NCT02556775|365211685|FG001|Overall Study|Withdrawal by Subject|0|||
105879319|NCT02556775|365211686|FG002|Overall Study|Withdrawal by Subject|1|||
105879320|NCT02556775|365211687|FG003|Overall Study|Withdrawal by Subject|0|||
105879321|NCT02556775|365211684|FG000|Overall Study|Lost to Follow-up|1|||
105879322|NCT02556775|365211685|FG001|Overall Study|Lost to Follow-up|0|||
105879323|NCT02556775|365211686|FG002|Overall Study|Lost to Follow-up|0|||
105879324|NCT02556775|365211687|FG003|Overall Study|Lost to Follow-up|0|||
105879325|NCT03876743|365211688|FG000|Overall Study|Lost to Follow-up|6|||
105879326|NCT03876743|365211689|FG001|Overall Study|Lost to Follow-up|4|||
105879327|NCT03876743|365211690|FG002|Overall Study|Lost to Follow-up|4|||
105879328|NCT03876743|365211691|FG003|Overall Study|Lost to Follow-up|7|||
105879329|NCT01609296|365211694|FG000|Overall Study|Death|253|||
105879330|NCT01609296|365211694|FG000|Overall Study|Withdrawal by Subject|151|||
105879331|NCT01609296|365211694|FG000|Overall Study|Lost to Follow-up|21|||
105879332|NCT01609296|365211694|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
105879333|NCT01609296|365211694|FG000|Overall Study|missed visit but known to be alive|28|||
105879334|NCT01592786|365211697|FG000|Overall Study|Adverse Event|60|||
105879335|NCT01592786|365211697|FG000|Overall Study|Lack of Efficacy|19|||
105879336|NCT01592786|365211697|FG000|Overall Study|Protocol Violation|14|||
105879337|NCT01592786|365211697|FG000|Overall Study|Withdrawal by Subject|23|||
105879338|NCT01592786|365211697|FG000|Overall Study|Lost to Follow-up|19|||
105879339|NCT01592786|365211697|FG000|Overall Study|Other|3|||
105879340|NCT03321968|365211701|FG000|Overall Study|Withdrawal by Subject|1|||
105879341|NCT03321968|365211702|FG001|Overall Study|Withdrawal by Subject|2|||
105879342|NCT03321968|365211703|FG002|Overall Study|Withdrawal by Subject|1|||
105879343|NCT03321968|365211701|FG000|Overall Study|Lost to Follow-up|2|||
105879344|NCT03321968|365211702|FG001|Overall Study|Lost to Follow-up|0|||
105879345|NCT03321968|365211703|FG002|Overall Study|Lost to Follow-up|1|||
105879346|NCT03321968|365211701|FG000|Overall Study|Other than specified|0|||
105879347|NCT03321968|365211702|FG001|Overall Study|Other than specified|0|||
105879348|NCT03321968|365211703|FG002|Overall Study|Other than specified|1|||
105879349|NCT01737710|365211704|FG000|Overall Study|Lost to Follow-up|0|||
105879350|NCT01737710|365211705|FG001|Overall Study|Lost to Follow-up|2|||
105879351|NCT01737710|365211706|FG002|Overall Study|Lost to Follow-up|2|||
105879352|NCT01737710|365211707|FG003|Overall Study|Lost to Follow-up|0|||
105879353|NCT01737710|365211708|FG004|Overall Study|Lost to Follow-up|0|||
105879354|NCT01737710|365211704|FG000|Overall Study|Withdrawal by Subject|1|||
105879355|NCT01737710|365211705|FG001|Overall Study|Withdrawal by Subject|1|||
105879356|NCT01737710|365211706|FG002|Overall Study|Withdrawal by Subject|1|||
105879357|NCT01737710|365211707|FG003|Overall Study|Withdrawal by Subject|0|||
105879358|NCT01737710|365211708|FG004|Overall Study|Withdrawal by Subject|0|||
105879359|NCT01737710|365211704|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
105879360|NCT01737710|365211705|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
105879361|NCT01737710|365211706|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
105879362|NCT01737710|365211707|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
105879363|NCT01737710|365211708|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
105879364|NCT01575834|365211709|FG000|Overall Study|Withdrawal by Subject|352|||
105879365|NCT01575834|365211710|FG001|Overall Study|Withdrawal by Subject|390|||
105879366|NCT01575834|365211709|FG000|Overall Study|Death|81|||
105879367|NCT01575834|365211710|FG001|Overall Study|Death|74|||
105879368|NCT01575834|365211709|FG000|Overall Study|Other|70|||
105879369|NCT01575834|365211710|FG001|Overall Study|Other|70|||
105879370|NCT01575834|365211709|FG000|Overall Study|Adverse Event|63|||
105879371|NCT01575834|365211710|FG001|Overall Study|Adverse Event|61|||
105879372|NCT01575834|365211709|FG000|Overall Study|Lost to Follow-up|55|||
105879373|NCT01575834|365211710|FG001|Overall Study|Lost to Follow-up|68|||
105879374|NCT01575834|365211709|FG000|Overall Study|Noncompliance|52|||
105879375|NCT01575834|365211710|FG001|Overall Study|Noncompliance|27|||
105879376|NCT01575834|365211709|FG000|Overall Study|Administrative decision|15|||
105879377|NCT01575834|365211710|FG001|Overall Study|Administrative decision|33|||
106110377|NCT00245102|366060328|FG004|Overall Study|Adverse Event|0|||
105879378|NCT01575834|365211709|FG000|Overall Study|Ineligibility Determined|5|||
106110378|NCT00245102|366060329|FG005|Overall Study|Adverse Event|2|||
106110379|NCT00245102|366060324|FG000|Overall Study|Decline in performance|0|||
106110380|NCT00245102|366060325|FG001|Overall Study|Decline in performance|2|||
106110381|NCT00245102|366060326|FG002|Overall Study|Decline in performance|0|||
105879379|NCT01575834|365211710|FG001|Overall Study|Ineligibility Determined|8|||
105879380|NCT01575834|365211709|FG000|Overall Study|Protocol Deviation|4|||
105879381|NCT01575834|365211710|FG001|Overall Study|Protocol Deviation|3|||
105879382|NCT01575834|365211709|FG000|Overall Study|Requirement for Alternative Therapy|2|||
105879383|NCT01575834|365211710|FG001|Overall Study|Requirement for Alternative Therapy|4|||
105879384|NCT02155283|365211711|FG000|Overall Study|Lost to Follow-up|3|||
105879385|NCT02155283|365211711|FG000|Overall Study|Withdrawal by Subject|1|||
105879386|NCT02155283|365211711|FG000|Overall Study|Protocol Violation|3|||
105879387|NCT01741688|365211715|FG000|Overall Study|Lack of insurance coverage|2|||
105879388|NCT01741688|365211715|FG000|Overall Study|Withdrawal by Subject|1|||
105879389|NCT00463047|365211716|FG000|Titration Period 1|Adverse Event|10|||
105879390|NCT00463047|365211717|FG001|Titration Period 1|Adverse Event|8|||
105879391|NCT00463047|365211716|FG000|Titration Period 1|Lack of Efficacy|10|||
105879392|NCT00463047|365211717|FG001|Titration Period 1|Lack of Efficacy|4|||
105879393|NCT00463047|365211716|FG000|Titration Period 1|Lost to Follow-up|2|||
105879394|NCT00463047|365211717|FG001|Titration Period 1|Lost to Follow-up|0|||
105879395|NCT00463047|365211716|FG000|Titration Period 1|Non-compliance with study medication|3|||
105879396|NCT00463047|365211717|FG001|Titration Period 1|Non-compliance with study medication|5|||
105879397|NCT00463047|365211716|FG000|Titration Period 1|Protocol Violation|5|||
105879398|NCT00463047|365211717|FG001|Titration Period 1|Protocol Violation|5|||
105879399|NCT00463047|365211716|FG000|Titration Period 1|Withdrawal by Subject|3|||
105879400|NCT00463047|365211717|FG001|Titration Period 1|Withdrawal by Subject|5|||
105879401|NCT00463047|365211716|FG000|Titration Period 1|Non-compliance procedures|4|||
105879402|NCT00463047|365211717|FG001|Titration Period 1|Non-compliance procedures|10|||
105879403|NCT00463047|365211716|FG000|Titration Period 1|Other|0|||
105879404|NCT00463047|365211717|FG001|Titration Period 1|Other|2|||
105879405|NCT00463047|365211716|FG000|Titration Period 2|Adverse Event|9|||
105879406|NCT00463047|365211717|FG001|Titration Period 2|Adverse Event|9|||
105879407|NCT00463047|365211716|FG000|Titration Period 2|Lack of Efficacy|6|||
105879408|NCT00463047|365211717|FG001|Titration Period 2|Lack of Efficacy|4|||
105879409|NCT00463047|365211716|FG000|Titration Period 2|Withdrawal by Subject|1|||
105879410|NCT00463047|365211717|FG001|Titration Period 2|Withdrawal by Subject|0|||
105879411|NCT00463047|365211716|FG000|Titration Period 2|Protocol Violation|2|||
105879412|NCT00463047|365211717|FG001|Titration Period 2|Protocol Violation|3|||
105879413|NCT00463047|365211716|FG000|Titration Period 2|Lost to Follow-up|1|||
105879414|NCT00463047|365211717|FG001|Titration Period 2|Lost to Follow-up|2|||
105879415|NCT00463047|365211716|FG000|Titration Period 2|Non-compliance study medication|4|||
105879416|NCT00463047|365211717|FG001|Titration Period 2|Non-compliance study medication|2|||
105879417|NCT00463047|365211716|FG000|Titration Period 2|Non-compliance procedures|4|||
105879418|NCT00463047|365211717|FG001|Titration Period 2|Non-compliance procedures|1|||
105879419|NCT00463047|365211716|FG000|Titration Period 2|Other|3|||
105879420|NCT00463047|365211717|FG001|Titration Period 2|Other|2|||
105879421|NCT00463047|365211716|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
105879422|NCT00463047|365211717|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
105879423|NCT00463047|365211716|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
105879424|NCT00463047|365211717|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
105879425|NCT00463047|365211716|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
105879426|NCT00463047|365211717|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
105879427|NCT00463047|365211716|FG000|Double-Blind Treatment Period 1|Other|1|||
105879428|NCT00463047|365211717|FG001|Double-Blind Treatment Period 1|Other|0|||
105879429|NCT00463047|365211716|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
105879430|NCT00463047|365211717|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
105879431|NCT00463047|365211716|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
105879432|NCT00463047|365211717|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
105879433|NCT00463047|365211716|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
105879434|NCT00463047|365211717|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
105879435|NCT00954941|365211720|FG000|Overall Study|Received treatment at home|1|||
105879436|NCT00954941|365211721|FG001|Overall Study|Received treatment at home|0|||
105879437|NCT00954941|365211720|FG000|Overall Study|Withdrawal by Subject|1|||
105879438|NCT00954941|365211721|FG001|Overall Study|Withdrawal by Subject|0|||
105879439|NCT00954941|365211720|FG000|Overall Study|Insurance Denial|2|||
105879440|NCT00954941|365211721|FG001|Overall Study|Insurance Denial|2|||
105879441|NCT00954941|365211720|FG000|Overall Study|Physician Decision|2|||
105879442|NCT00954941|365211721|FG001|Overall Study|Physician Decision|2|||
105879443|NCT00954941|365211720|FG000|Overall Study|Ineligible|2|||
105879444|NCT00954941|365211721|FG001|Overall Study|Ineligible|2|||
105879445|NCT00954941|365211720|FG000|Overall Study|Adverse Event|0|||
105879446|NCT00954941|365211721|FG001|Overall Study|Adverse Event|1|||
105879447|NCT00529308|365211723|FG000|Overall Study|Withdrawal by Subject|1|||
105879448|NCT00529308|365211724|FG001|Overall Study|Withdrawal by Subject|1|||
105879449|NCT02418949|365211725|FG000|Overall Study|Withdrawal by Subject|1|||
105879450|NCT02418949|365211726|FG001|Overall Study|Withdrawal by Subject|0|||
105879451|NCT02418949|365211727|FG002|Overall Study|Withdrawal by Subject|1|||
105879452|NCT02418949|365211728|FG003|Overall Study|Withdrawal by Subject|1|||
105879453|NCT02418949|365211725|FG000|Overall Study|Lost to Follow-up|1|||
105879454|NCT02418949|365211726|FG001|Overall Study|Lost to Follow-up|0|||
105879455|NCT02418949|365211727|FG002|Overall Study|Lost to Follow-up|1|||
105879456|NCT02418949|365211728|FG003|Overall Study|Lost to Follow-up|0|||
105879457|NCT02418949|365211725|FG000|Overall Study|Physician Decision|1|||
105879458|NCT02418949|365211726|FG001|Overall Study|Physician Decision|1|||
105879459|NCT02418949|365211727|FG002|Overall Study|Physician Decision|1|||
105879460|NCT02418949|365211728|FG003|Overall Study|Physician Decision|0|||
105879461|NCT00745901|365211733|FG000|Overall Study|Adverse Event|3|||
105879462|NCT00745901|365211734|FG001|Overall Study|Adverse Event|4|||
105879463|NCT00745901|365211733|FG000|Overall Study|Protocol Violation|0|||
105879464|NCT00745901|365211734|FG001|Overall Study|Protocol Violation|1|||
105879465|NCT00745901|365211733|FG000|Overall Study|Withdrawal by Subject|1|||
105879466|NCT00745901|365211734|FG001|Overall Study|Withdrawal by Subject|0|||
105879467|NCT00745901|365211733|FG000|Overall Study|Lost to Follow-up|7|||
105879468|NCT00745901|365211734|FG001|Overall Study|Lost to Follow-up|4|||
105879469|NCT00745901|365211733|FG000|Overall Study|Pregnancy|2|||
105879470|NCT00745901|365211734|FG001|Overall Study|Pregnancy|4|||
105879471|NCT00745901|365211733|FG000|Overall Study|Lack of compliance|2|||
105879472|NCT00745901|365211734|FG001|Overall Study|Lack of compliance|2|||
105879473|NCT00745901|365211733|FG000|Overall Study|Patient's next menses did not start with|1|||
105879474|NCT00745901|365211734|FG001|Overall Study|Patient's next menses did not start with|0|||
105879475|NCT00745901|365211733|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
105879476|NCT00745901|365211734|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
105879477|NCT00745901|365211733|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
105879478|NCT00745901|365211734|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
105879479|NCT00745901|365211733|FG000|Overall Study|Patient didn't take any study medication|7|||
105879480|NCT00745901|365211734|FG001|Overall Study|Patient didn't take any study medication|3|||
105879481|NCT04526288|365211739|FG000|Overall Study|Disease Progression|1|||
105879482|NCT04526288|365211740|FG001|Overall Study|Disease Progression|0|||
105879483|NCT00984542|365211743|FG000|Overall Study|disease progression|19|||
105879484|NCT00984542|365211743|FG000|Overall Study|toxicity|7|||
105879485|NCT00984542|365211743|FG000|Overall Study|Death|7|||
105879486|NCT00984542|365211743|FG000|Overall Study|complicating disease|3|||
105879487|NCT00984542|365211743|FG000|Overall Study|Withdrawal by Subject|3|||
105879488|NCT00984542|365211743|FG000|Overall Study|clinical deterioration|2|||
105879489|NCT01422889|365211778|FG000|Overall Study|No Data Entered for Study Stent|9|||
105879490|NCT02343939|365211779|FG000|Overall Study|Death|0|||
105879491|NCT02343939|365211780|FG001|Overall Study|Death|15|||
105879492|NCT02343939|365211781|FG002|Overall Study|Death|4|||
105879493|NCT02343939|365211782|FG003|Overall Study|Death|2|||
105879494|NCT02343939|365211783|FG004|Overall Study|Death|5|||
105879495|NCT02343939|365211784|FG005|Overall Study|Death|11|||
105879496|NCT02343939|365211785|FG006|Overall Study|Death|8|||
105879497|NCT02343939|365211786|FG007|Overall Study|Death|22|||
105879498|NCT02343939|365211787|FG008|Overall Study|Death|1|||
105879499|NCT02343939|365211779|FG000|Overall Study|Study terminated by sponsor|0|||
105879500|NCT02343939|365211780|FG001|Overall Study|Study terminated by sponsor|27|||
105879501|NCT02343939|365211781|FG002|Overall Study|Study terminated by sponsor|0|||
105879502|NCT02343939|365211782|FG003|Overall Study|Study terminated by sponsor|1|||
105879503|NCT02343939|365211783|FG004|Overall Study|Study terminated by sponsor|1|||
105879504|NCT02343939|365211784|FG005|Overall Study|Study terminated by sponsor|5|||
105879505|NCT02343939|365211785|FG006|Overall Study|Study terminated by sponsor|3|||
105879506|NCT02343939|365211786|FG007|Overall Study|Study terminated by sponsor|4|||
105879507|NCT02343939|365211787|FG008|Overall Study|Study terminated by sponsor|0|||
105879508|NCT02343939|365211779|FG000|Overall Study|Withdrew consent|3|||
105879509|NCT02343939|365211780|FG001|Overall Study|Withdrew consent|6|||
105879510|NCT02343939|365211781|FG002|Overall Study|Withdrew consent|1|||
105879511|NCT02343939|365211782|FG003|Overall Study|Withdrew consent|2|||
105879512|NCT02343939|365211783|FG004|Overall Study|Withdrew consent|2|||
105879513|NCT02343939|365211784|FG005|Overall Study|Withdrew consent|0|||
105879514|NCT02343939|365211785|FG006|Overall Study|Withdrew consent|0|||
105879515|NCT02343939|365211786|FG007|Overall Study|Withdrew consent|8|||
105879516|NCT02343939|365211787|FG008|Overall Study|Withdrew consent|6|||
105879517|NCT02343939|365211779|FG000|Overall Study|Treatment failure|0|||
105879518|NCT02343939|365211780|FG001|Overall Study|Treatment failure|0|||
105879519|NCT02343939|365211781|FG002|Overall Study|Treatment failure|0|||
105879520|NCT02343939|365211782|FG003|Overall Study|Treatment failure|0|||
105879521|NCT02343939|365211783|FG004|Overall Study|Treatment failure|0|||
105879522|NCT02343939|365211784|FG005|Overall Study|Treatment failure|0|||
105879523|NCT02343939|365211785|FG006|Overall Study|Treatment failure|2|||
105879524|NCT02343939|365211786|FG007|Overall Study|Treatment failure|1|||
105879525|NCT02343939|365211787|FG008|Overall Study|Treatment failure|0|||
105879526|NCT02343939|365211779|FG000|Overall Study|Investigator's discretion|0|||
105879527|NCT02343939|365211780|FG001|Overall Study|Investigator's discretion|0|||
105879528|NCT02343939|365211781|FG002|Overall Study|Investigator's discretion|0|||
105879529|NCT02343939|365211782|FG003|Overall Study|Investigator's discretion|1|||
105879530|NCT02343939|365211783|FG004|Overall Study|Investigator's discretion|0|||
105879531|NCT02343939|365211784|FG005|Overall Study|Investigator's discretion|0|||
105879532|NCT02343939|365211785|FG006|Overall Study|Investigator's discretion|1|||
105879533|NCT02343939|365211786|FG007|Overall Study|Investigator's discretion|0|||
105879534|NCT02343939|365211787|FG008|Overall Study|Investigator's discretion|0|||
105879535|NCT02343939|365211779|FG000|Overall Study|Adverse Event|0|||
105879536|NCT02343939|365211780|FG001|Overall Study|Adverse Event|0|||
105879537|NCT02343939|365211781|FG002|Overall Study|Adverse Event|0|||
105879538|NCT02343939|365211782|FG003|Overall Study|Adverse Event|0|||
105879539|NCT02343939|365211783|FG004|Overall Study|Adverse Event|0|||
105879540|NCT02343939|365211784|FG005|Overall Study|Adverse Event|1|||
105879541|NCT02343939|365211785|FG006|Overall Study|Adverse Event|0|||
105879542|NCT02343939|365211786|FG007|Overall Study|Adverse Event|0|||
105879543|NCT02343939|365211787|FG008|Overall Study|Adverse Event|0|||
105879544|NCT02343939|365211779|FG000|Overall Study|Never Treated With ENTO|0|||
105879545|NCT02343939|365211780|FG001|Overall Study|Never Treated With ENTO|0|||
105879546|NCT02343939|365211781|FG002|Overall Study|Never Treated With ENTO|0|||
105879547|NCT02343939|365211782|FG003|Overall Study|Never Treated With ENTO|0|||
105879548|NCT02343939|365211783|FG004|Overall Study|Never Treated With ENTO|0|||
105879549|NCT02343939|365211784|FG005|Overall Study|Never Treated With ENTO|0|||
105879550|NCT02343939|365211785|FG006|Overall Study|Never Treated With ENTO|1|||
105879551|NCT02343939|365211786|FG007|Overall Study|Never Treated With ENTO|2|||
105879552|NCT02343939|365211787|FG008|Overall Study|Never Treated With ENTO|0|||
105879553|NCT01303172|365211792|FG000|Overall Study|Physician Decision|9|||
105879554|NCT01303172|365211793|FG001|Overall Study|Physician Decision|6|||
105879555|NCT01303172|365211792|FG000|Overall Study|Adverse Event|5|||
105879556|NCT01303172|365211793|FG001|Overall Study|Adverse Event|2|||
105879557|NCT01303172|365211792|FG000|Overall Study|Withdrawal by Subject|4|||
105879558|NCT01303172|365211793|FG001|Overall Study|Withdrawal by Subject|2|||
105879559|NCT01303172|365211792|FG000|Overall Study|Death|20|||
105879560|NCT01303172|365211793|FG001|Overall Study|Death|7|||
105879561|NCT01303172|365211792|FG000|Overall Study|Lack of Efficacy|25|||
105879562|NCT01303172|365211793|FG001|Overall Study|Lack of Efficacy|17|||
105879563|NCT01890122|365211798|FG000|Overall Study|Adverse Event|1|||
105879564|NCT01890122|365211799|FG001|Overall Study|Adverse Event|1|||
105879565|NCT01890122|365211800|FG002|Overall Study|Adverse Event|1|||
105879566|NCT01890122|365211801|FG003|Overall Study|Adverse Event|2|||
105879567|NCT01890122|365211798|FG000|Overall Study|Major Protocol Deviation|3|||
105879568|NCT01890122|365211799|FG001|Overall Study|Major Protocol Deviation|1|||
105879569|NCT01890122|365211800|FG002|Overall Study|Major Protocol Deviation|0|||
105879570|NCT01890122|365211801|FG003|Overall Study|Major Protocol Deviation|1|||
105879571|NCT01890122|365211798|FG000|Overall Study|Lost to Follow-up|0|||
105879572|NCT01890122|365211799|FG001|Overall Study|Lost to Follow-up|1|||
105879573|NCT01890122|365211800|FG002|Overall Study|Lost to Follow-up|2|||
105879574|NCT01890122|365211801|FG003|Overall Study|Lost to Follow-up|2|||
105879575|NCT01890122|365211798|FG000|Overall Study|Voluntary Withdrawal|8|||
105879576|NCT01890122|365211799|FG001|Overall Study|Voluntary Withdrawal|8|||
105879577|NCT01890122|365211800|FG002|Overall Study|Voluntary Withdrawal|2|||
105879578|NCT01890122|365211801|FG003|Overall Study|Voluntary Withdrawal|11|||
105879579|NCT01890122|365211798|FG000|Overall Study|Lack of Efficacy|14|||
105879580|NCT01890122|365211799|FG001|Overall Study|Lack of Efficacy|24|||
105879581|NCT01890122|365211800|FG002|Overall Study|Lack of Efficacy|7|||
105879582|NCT01890122|365211801|FG003|Overall Study|Lack of Efficacy|41|||
105879583|NCT01890122|365211798|FG000|Overall Study|Reason not Specified|0|||
105879584|NCT01890122|365211799|FG001|Overall Study|Reason not Specified|1|||
105879585|NCT01890122|365211800|FG002|Overall Study|Reason not Specified|1|||
105879586|NCT01890122|365211801|FG003|Overall Study|Reason not Specified|2|||
105879587|NCT01890122|365211798|FG000|Overall Study|Randomized but not Treated|1|||
105879588|NCT01890122|365211799|FG001|Overall Study|Randomized but not Treated|1|||
105879589|NCT01890122|365211800|FG002|Overall Study|Randomized but not Treated|0|||
105879590|NCT01890122|365211801|FG003|Overall Study|Randomized but not Treated|0|||
105879591|NCT02062450|365211802|FG000|Overall Study|No follow-up visit|124|||
105879592|NCT02593097|365211803|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
105879593|NCT02593097|365211804|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
105879594|NCT02593097|365211803|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105879595|NCT02593097|365211804|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
105879596|NCT02593097|365211803|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
105879597|NCT02593097|365211804|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
105879598|NCT02593097|365211803|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
105879599|NCT02593097|365211804|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
106110382|NCT00245102|366060327|FG003|Overall Study|Decline in performance|1|||
106110383|NCT00245102|366060328|FG004|Overall Study|Decline in performance|0|||
106110384|NCT00245102|366060329|FG005|Overall Study|Decline in performance|2|||
105879600|NCT02593097|365211803|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
105879601|NCT02593097|365211804|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
105879602|NCT03668119|365213836|FG000|Pre-treatment|Disease Progression|1|||
105879603|NCT03668119|365213837|FG001|Pre-treatment|Disease Progression|0|||
105879604|NCT03668119|365213836|FG000|Treatment|Disease Progression|76|||
105879605|NCT03668119|365213837|FG001|Treatment|Disease Progression|57|||
105879606|NCT03668119|365213836|FG000|Treatment|Study drug toxicity|19|||
106110385|NCT00245102|366060324|FG000|Overall Study|Participant needed surgery|0|||
105879607|NCT03668119|365213837|FG001|Treatment|Study drug toxicity|1|||
105879608|NCT03668119|365213836|FG000|Treatment|Death|3|||
105879609|NCT03668119|365213837|FG001|Treatment|Death|0|||
105879610|NCT03668119|365213836|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
105879611|NCT03668119|365213837|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
105879612|NCT03668119|365213836|FG000|Treatment|Withdrawal by Subject|1|||
105879613|NCT03668119|365213837|FG001|Treatment|Withdrawal by Subject|1|||
105879614|NCT03668119|365213836|FG000|Treatment|Participant request to discontinue study treatment|3|||
105879615|NCT03668119|365213837|FG001|Treatment|Participant request to discontinue study treatment|1|||
105784789|NCT01049360|364864396|FG014|Period 4|Protocol Violation|0|||
105784790|NCT01049360|364864397|FG015|Period 4|Protocol Violation|0|||
105784791|NCT01049360|364864398|FG016|Period 4|Protocol Violation|0|||
105784792|NCT01049360|364864399|FG017|Period 4|Protocol Violation|1|||
105784793|NCT01049360|364864400|FG018|Period 4|Protocol Violation|0|||
105784794|NCT01049360|364864401|FG019|Period 4|Protocol Violation|0|||
105784795|NCT01049360|364864382|FG000|Period 4|Withdrawal by Subject|0|||
105784796|NCT01049360|364864383|FG001|Period 4|Withdrawal by Subject|0|||
105784797|NCT01049360|364864384|FG002|Period 4|Withdrawal by Subject|0|||
105784798|NCT01049360|364864385|FG003|Period 4|Withdrawal by Subject|1|||
105784799|NCT01049360|364864386|FG004|Period 4|Withdrawal by Subject|0|||
105784800|NCT01049360|364864387|FG005|Period 4|Withdrawal by Subject|0|||
105784801|NCT01049360|364864388|FG006|Period 4|Withdrawal by Subject|0|||
105784802|NCT01049360|364864389|FG007|Period 4|Withdrawal by Subject|0|||
105784803|NCT01049360|364864390|FG008|Period 4|Withdrawal by Subject|0|||
105784804|NCT01049360|364864391|FG009|Period 4|Withdrawal by Subject|0|||
105784805|NCT01049360|364864392|FG010|Period 4|Withdrawal by Subject|0|||
105784806|NCT01049360|364864393|FG011|Period 4|Withdrawal by Subject|0|||
105784807|NCT01049360|364864394|FG012|Period 4|Withdrawal by Subject|0|||
105784808|NCT01049360|364864395|FG013|Period 4|Withdrawal by Subject|0|||
105784809|NCT01049360|364864396|FG014|Period 4|Withdrawal by Subject|0|||
105784810|NCT01049360|364864397|FG015|Period 4|Withdrawal by Subject|0|||
105784811|NCT01049360|364864398|FG016|Period 4|Withdrawal by Subject|0|||
105784812|NCT01049360|364864399|FG017|Period 4|Withdrawal by Subject|0|||
105784813|NCT01049360|364864400|FG018|Period 4|Withdrawal by Subject|0|||
105784814|NCT01049360|364864401|FG019|Period 4|Withdrawal by Subject|0|||
105784815|NCT00429026|364864402|FG000|Overall Study|Inevaluable for response.|40|||
105784816|NCT00920582|364864403|FG000|Overall Study|Lost to Follow-up|5|||
105784817|NCT00920582|364864404|FG001|Overall Study|Lost to Follow-up|1|||
105784818|NCT00920582|364864405|FG002|Overall Study|Lost to Follow-up|2|||
105784819|NCT00920582|364864406|FG003|Overall Study|Lost to Follow-up|0|||
105784820|NCT00920582|364864403|FG000|Overall Study|Withdrawal by Subject|5|||
105784821|NCT00920582|364864404|FG001|Overall Study|Withdrawal by Subject|4|||
105784822|NCT00920582|364864405|FG002|Overall Study|Withdrawal by Subject|6|||
105784823|NCT00920582|364864406|FG003|Overall Study|Withdrawal by Subject|3|||
105784824|NCT00920582|364864403|FG000|Overall Study|Protocol Violation|1|||
105784825|NCT00920582|364864404|FG001|Overall Study|Protocol Violation|0|||
105784826|NCT00920582|364864405|FG002|Overall Study|Protocol Violation|0|||
105784827|NCT00920582|364864406|FG003|Overall Study|Protocol Violation|0|||
105784828|NCT00920582|364864403|FG000|Overall Study|Other|2|||
105784829|NCT00920582|364864404|FG001|Overall Study|Other|1|||
105784830|NCT00920582|364864405|FG002|Overall Study|Other|3|||
105784831|NCT00920582|364864406|FG003|Overall Study|Other|2|||
105784832|NCT01012765|364864410|FG000|Treatment Period 1|Adverse Event|1|||
105784833|NCT01012765|364864411|FG001|Treatment Period 1|Adverse Event|0|||
105784834|NCT01012765|364864412|FG002|Treatment Period 1|Adverse Event|1|||
105784835|NCT01012765|364864413|FG003|Treatment Period 1|Adverse Event|0|||
105784836|NCT01012765|364864414|FG004|Treatment Period 1|Adverse Event|0|||
105784837|NCT01012765|364864415|FG005|Treatment Period 1|Adverse Event|0|||
105784838|NCT01012765|364864410|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105784839|NCT01012765|364864411|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105784840|NCT01012765|364864412|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105784841|NCT01012765|364864413|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105784842|NCT01012765|364864414|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105784843|NCT01012765|364864415|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105784844|NCT01012765|364864410|FG000|Treatment Period 1|Administrative problems|0|||
105784845|NCT01012765|364864411|FG001|Treatment Period 1|Administrative problems|0|||
105784846|NCT01012765|364864412|FG002|Treatment Period 1|Administrative problems|1|||
105784847|NCT01012765|364864413|FG003|Treatment Period 1|Administrative problems|1|||
105784848|NCT01012765|364864414|FG004|Treatment Period 1|Administrative problems|1|||
105784849|NCT01012765|364864415|FG005|Treatment Period 1|Administrative problems|0|||
105784850|NCT01012765|364864410|FG000|Treatment Period 1|Protocol Violation|0|||
105784851|NCT01012765|364864411|FG001|Treatment Period 1|Protocol Violation|0|||
105784852|NCT01012765|364864412|FG002|Treatment Period 1|Protocol Violation|0|||
105784853|NCT01012765|364864413|FG003|Treatment Period 1|Protocol Violation|2|||
105784854|NCT01012765|364864414|FG004|Treatment Period 1|Protocol Violation|1|||
105784855|NCT01012765|364864415|FG005|Treatment Period 1|Protocol Violation|0|||
105784856|NCT01012765|364864410|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784857|NCT01012765|364864411|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784858|NCT01012765|364864412|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784859|NCT01012765|364864413|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784860|NCT01012765|364864414|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
105784861|NCT01012765|364864415|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
105784862|NCT01012765|364864410|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105784863|NCT01012765|364864411|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105879616|NCT03668119|365213836|FG000|Treatment|Maximum Clinical Benefit|0|||
105879617|NCT03668119|365213837|FG001|Treatment|Maximum Clinical Benefit|1|||
105879618|NCT03668119|365213836|FG000|Treatment|Participants completed treatment|27|||
105879619|NCT03668119|365213837|FG001|Treatment|Participants completed treatment|11|||
105879620|NCT03668119|365213836|FG000|Treatment|Other reasons|2|||
105879621|NCT03668119|365213837|FG001|Treatment|Other reasons|1|||
105879622|NCT01068678|365213838|FG000|Overall Study|Lack of Efficacy|3|||
105879623|NCT01068678|365213839|FG001|Overall Study|Lack of Efficacy|2|||
105879624|NCT01068678|365213838|FG000|Overall Study|Protocol Violation|5|||
105879625|NCT01068678|365213839|FG001|Overall Study|Protocol Violation|1|||
105879626|NCT01068678|365213838|FG000|Overall Study|Withdrawal criteria|12|||
105879627|NCT01068678|365213839|FG001|Overall Study|Withdrawal criteria|6|||
105879628|NCT01068678|365213838|FG000|Overall Study|Unclassified|18|||
105879629|NCT01068678|365213839|FG001|Overall Study|Unclassified|15|||
105879630|NCT00347958|365213840|FG000|Overall Study|Adverse Event|1|||
105879631|NCT00347958|365213840|FG000|Overall Study|Protocol Violation|2|||
105879632|NCT00347958|365213840|FG000|Overall Study|Withdrawal by Subject|1|||
105879633|NCT00754234|365213841|FG000|Overall Study|Withdrawal by Subject|3|||
105879634|NCT00975611|365213844|FG000|Overall Study|Screen Fail|16|||
105879635|NCT00975611|365213844|FG000|Overall Study|Physician Decision|1|||
105879636|NCT01102257|365213848|FG000|Overall Study|Adverse Event|1|||
105879637|NCT01102257|365213849|FG001|Overall Study|Adverse Event|0|||
105879638|NCT01102257|365213848|FG000|Overall Study|Adverse Event|1|||
105879639|NCT01102257|365213849|FG001|Overall Study|Adverse Event|0|||
105879640|NCT00298272|365213850|FG000|Double-blind Phase|Adverse Event|2|||
105879641|NCT00298272|365213851|FG001|Double-blind Phase|Adverse Event|0|||
105879642|NCT00298272|365213850|FG000|Double-blind Phase|Failure to Return|2|||
105879643|NCT00298272|365213851|FG001|Double-blind Phase|Failure to Return|0|||
105879644|NCT00298272|365213850|FG000|Double-blind Phase|Protocol Violation|2|||
105879645|NCT00298272|365213851|FG001|Double-blind Phase|Protocol Violation|0|||
105879646|NCT00298272|365213850|FG000|Double-blind Phase|Withdrawal by Subject|2|||
105879647|NCT00298272|365213851|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105879648|NCT00298272|365213850|FG000|Open Label Retreatment Phase|Adverse Event|1|||
105879649|NCT00298272|365213851|FG001|Open Label Retreatment Phase|Adverse Event|2|||
105879650|NCT00298272|365213850|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
105879651|NCT00298272|365213851|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
105879652|NCT00298272|365213850|FG000|Open Label Retreatment Phase|Failure to Return|1|||
105879653|NCT00298272|365213851|FG001|Open Label Retreatment Phase|Failure to Return|0|||
105879654|NCT00298272|365213850|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
105879655|NCT00298272|365213851|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
105879656|NCT00298272|365213850|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
105879657|NCT00298272|365213851|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
105879658|NCT00298272|365213850|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
105879659|NCT00298272|365213851|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
105879660|NCT00298272|365213850|FG000|Safety Follow-up Phase|Failure to Return|1|||
105879661|NCT00298272|365213851|FG001|Safety Follow-up Phase|Failure to Return|1|||
105879662|NCT00298272|365213850|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
105879663|NCT00298272|365213851|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
105879664|NCT00298272|365213850|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
105879665|NCT00298272|365213851|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
105879666|NCT02898597|365213854|FG000|Overall Study|Protocol Violation|4|||
105879667|NCT02898597|365213855|FG001|Overall Study|Protocol Violation|2|||
105879668|NCT02898597|365213854|FG000|Overall Study|Lost to Follow-up|0|||
105879669|NCT02898597|365213855|FG001|Overall Study|Lost to Follow-up|9|||
105879670|NCT02898597|365213854|FG000|Overall Study|Death|0|||
105879671|NCT02898597|365213855|FG001|Overall Study|Death|1|||
105879672|NCT02530125|365213856|FG000|Completed Treatment|Early termination of study|1|||
105879673|NCT02530125|365213856|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
105993707|NCT01510158|365636076|FG001|Overall Study|Gout flare|0|||
105879674|NCT05326529|365213857|FG000|Overall Study|Lack of Efficacy|0|||
105879675|NCT05326529|365213858|FG001|Overall Study|Lack of Efficacy|1|||
105879676|NCT05326529|365213859|FG002|Overall Study|Lack of Efficacy|0|||
105879677|NCT05326529|365213857|FG000|Overall Study|Physician Decision|0|||
105879678|NCT05326529|365213858|FG001|Overall Study|Physician Decision|0|||
105879679|NCT05326529|365213859|FG002|Overall Study|Physician Decision|2|||
105879680|NCT01379768|365213860|FG000|Overall Study|Adverse Event|1|||
105879681|NCT01379768|365213861|FG001|Overall Study|Adverse Event|1|||
105879682|NCT01379768|365213862|FG002|Overall Study|Adverse Event|0|||
105879683|NCT01379768|365213860|FG000|Overall Study|Lost to Follow-up|2|||
105879684|NCT01379768|365213861|FG001|Overall Study|Lost to Follow-up|0|||
105879685|NCT01379768|365213862|FG002|Overall Study|Lost to Follow-up|0|||
105879686|NCT01344824|365213865|FG000|Overall Study|Adverse Event|15|||
105879687|NCT01344824|365213865|FG000|Overall Study|Withdrawal by Subject|6|||
105879688|NCT01344824|365213865|FG000|Overall Study|Other complicating disease|1|||
105879689|NCT01344824|365213865|FG000|Overall Study|Progression|15|||
105879690|NCT00566020|365213869|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
105879691|NCT00566020|365213870|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
105879692|NCT00566020|365213869|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
105879693|NCT00566020|365213870|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
105879694|NCT00566020|365213869|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
105879695|NCT00566020|365213870|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
105879696|NCT00566020|365213869|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
105879697|NCT00566020|365213870|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
105879698|NCT00566020|365213869|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
105879699|NCT00566020|365213870|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
105879700|NCT00566020|365213869|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
105879701|NCT00566020|365213870|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
105879702|NCT02393950|365213871|FG000|Overall Study|Adverse Event|1|||
105879703|NCT02393950|365213872|FG001|Overall Study|Adverse Event|0|||
105879704|NCT02393950|365213871|FG000|Overall Study|Withdrawal by Subject|0|||
105879705|NCT02393950|365213872|FG001|Overall Study|Withdrawal by Subject|1|||
105879706|NCT01295671|365213876|FG000|Overall Study|Lost to Follow-up|4|||
105879707|NCT01295671|365213877|FG001|Overall Study|Lost to Follow-up|6|||
105879708|NCT01295671|365213878|FG002|Overall Study|Lost to Follow-up|3|||
105879709|NCT01295671|365213876|FG000|Overall Study|Withdrawal by Subject|3|||
105879710|NCT01295671|365213877|FG001|Overall Study|Withdrawal by Subject|1|||
105879711|NCT01295671|365213878|FG002|Overall Study|Withdrawal by Subject|0|||
105879712|NCT01754129|365213879|FG000|Overall Study|Death|13|||
105879713|NCT01754129|365213879|FG000|Overall Study|Duodopa discontinuation|9|||
105879714|NCT01754129|365213879|FG000|Overall Study|Lost to Follow-up|7|||
105879715|NCT01754129|365213879|FG000|Overall Study|Withdrew consent|1|||
105879716|NCT01754129|365213879|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
105879717|NCT02058537|365213880|FG000|Overall Study|Withdrawal by Subject|1|||
105879718|NCT00708552|365213881|FG000|Overall Study|Adverse Event|10|||
105879719|NCT00708552|365213882|FG001|Overall Study|Adverse Event|3|||
105879720|NCT00708552|365213883|FG002|Overall Study|Adverse Event|4|||
105879721|NCT00708552|365213884|FG003|Overall Study|Adverse Event|6|||
105879722|NCT00708552|365213881|FG000|Overall Study|Lack of Efficacy|0|||
105879723|NCT00708552|365213882|FG001|Overall Study|Lack of Efficacy|4|||
105879724|NCT00708552|365213883|FG002|Overall Study|Lack of Efficacy|1|||
105879725|NCT00708552|365213884|FG003|Overall Study|Lack of Efficacy|0|||
105879726|NCT00708552|365213881|FG000|Overall Study|Protocol Violation|0|||
105879727|NCT00708552|365213882|FG001|Overall Study|Protocol Violation|0|||
105879728|NCT00708552|365213883|FG002|Overall Study|Protocol Violation|2|||
105879729|NCT00708552|365213884|FG003|Overall Study|Protocol Violation|4|||
105879730|NCT00708552|365213881|FG000|Overall Study|Lost to Follow-up|4|||
105879731|NCT00708552|365213882|FG001|Overall Study|Lost to Follow-up|2|||
105879732|NCT00708552|365213883|FG002|Overall Study|Lost to Follow-up|0|||
105879733|NCT00708552|365213884|FG003|Overall Study|Lost to Follow-up|1|||
105879734|NCT00708552|365213881|FG000|Overall Study|Physician Decision|1|||
105879735|NCT00708552|365213882|FG001|Overall Study|Physician Decision|2|||
105879736|NCT00708552|365213883|FG002|Overall Study|Physician Decision|0|||
105879737|NCT00708552|365213884|FG003|Overall Study|Physician Decision|0|||
105879738|NCT00708552|365213881|FG000|Overall Study|Withdrawal by Subject|12|||
105879739|NCT00708552|365213882|FG001|Overall Study|Withdrawal by Subject|7|||
105879740|NCT00708552|365213883|FG002|Overall Study|Withdrawal by Subject|8|||
105879741|NCT00708552|365213884|FG003|Overall Study|Withdrawal by Subject|10|||
105879742|NCT02126579|365213885|FG000|Overall Study|disease progression|0|||
105879743|NCT02126579|365213886|FG001|Overall Study|disease progression|0|||
105879744|NCT02126579|365213887|FG002|Overall Study|disease progression|0|||
105879745|NCT02126579|365213888|FG003|Overall Study|disease progression|1|||
105879746|NCT02126579|365213889|FG004|Overall Study|disease progression|0|||
105879747|NCT02126579|365213890|FG005|Overall Study|disease progression|0|||
105879748|NCT02126579|365213891|FG006|Overall Study|disease progression|1|||
105879749|NCT01085630|365213892|FG000|Overall Study|Insufficient data|1|||
105879750|NCT01085630|365213893|FG001|Overall Study|Insufficient data|0|||
105879751|NCT01085630|365213892|FG000|Overall Study|Ineligible|3|||
105879752|NCT01085630|365213893|FG001|Overall Study|Ineligible|0|||
105879753|NCT00808210|365213897|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
105879754|NCT00808210|365213898|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
105879755|NCT00808210|365213897|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
105879756|NCT00808210|365213898|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
105879757|NCT00808210|365213897|FG000|Double-Blind TX Period|Adverse Event|0|||
105879758|NCT00808210|365213898|FG001|Double-Blind TX Period|Adverse Event|1|||
105879759|NCT00808210|365213897|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
105879760|NCT00808210|365213898|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
105879761|NCT00808210|365213897|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
105879762|NCT00808210|365213898|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
105879763|NCT00808210|365213897|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
105951988|NCT02808429|365488170|FG000|Overall Study|Premature study termination by sponsor|2|||
105879764|NCT00808210|365213898|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
105879765|NCT02588612|365213903|FG000|Overall Study|Physician Decision|1|||
105879766|NCT02588612|365213903|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
105879767|NCT02588612|365213903|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
105879768|NCT02588612|365213903|FG000|Overall Study|Death prior to T-cell infusion|1|||
105879769|NCT00628212|365213904|FG000|Overall Study|Adverse Event|2|||
105879770|NCT00628212|365213905|FG001|Overall Study|Adverse Event|0|||
105879771|NCT00628212|365213906|FG002|Overall Study|Adverse Event|1|||
105879772|NCT00628212|365213907|FG003|Overall Study|Adverse Event|2|||
105879773|NCT00628212|365213904|FG000|Overall Study|Physician Decision|1|||
105879774|NCT00628212|365213905|FG001|Overall Study|Physician Decision|1|||
105879775|NCT00628212|365213906|FG002|Overall Study|Physician Decision|2|||
105879776|NCT00628212|365213907|FG003|Overall Study|Physician Decision|3|||
105879777|NCT05047211|365213908|FG000|Overall Study|Lost to Follow-up|8|||
105879778|NCT05047211|365213909|FG001|Overall Study|Lost to Follow-up|5|||
105879779|NCT03363776|365213916|FG000|Overall Study|Progressive disease|2|||
105879780|NCT03363776|365213917|FG001|Overall Study|Progressive disease|3|||
105879781|NCT03363776|365213918|FG002|Overall Study|Progressive disease|1|||
105879782|NCT03363776|365213916|FG000|Overall Study|Study drug toxicity|0|||
105879783|NCT03363776|365213917|FG001|Overall Study|Study drug toxicity|0|||
105879784|NCT03363776|365213918|FG002|Overall Study|Study drug toxicity|1|||
105879785|NCT03363776|365213916|FG000|Overall Study|Death|1|||
105879786|NCT03363776|365213917|FG001|Overall Study|Death|0|||
105879787|NCT03363776|365213918|FG002|Overall Study|Death|0|||
105879788|NCT02684097|365213927|FG000|Overall Study|Lack of Efficacy|13|||
105879789|NCT02684097|365213928|FG001|Overall Study|Lack of Efficacy|6|||
105879790|NCT02630251|365213929|FG000|Overall Study|Physician Decision|0|||
105879791|NCT02630251|365213930|FG001|Overall Study|Physician Decision|0|||
105879792|NCT02630251|365213931|FG002|Overall Study|Physician Decision|1|||
105879793|NCT02630251|365213932|FG003|Overall Study|Physician Decision|0|||
105879794|NCT00570063|365213935|FG000|Overall Study|Adverse Event|4|||
105879795|NCT00570063|365213936|FG001|Overall Study|Adverse Event|1|||
105879796|NCT00570063|365213935|FG000|Overall Study|Lack of Efficacy|0|||
105879797|NCT00570063|365213936|FG001|Overall Study|Lack of Efficacy|1|||
105879798|NCT00570063|365213935|FG000|Overall Study|Withdrawal by Subject|4|||
105879799|NCT00570063|365213936|FG001|Overall Study|Withdrawal by Subject|3|||
105879800|NCT00570063|365213935|FG000|Overall Study|Sponsor's Decision|7|||
105879801|NCT00570063|365213936|FG001|Overall Study|Sponsor's Decision|3|||
105879802|NCT00697463|365213937|FG000|Overall Study|Withdrawal by Subject|1|||
105879803|NCT03307252|365213938|FG000|Part 2, Period 1|Treatment not received|0|||
105879804|NCT03307252|365213939|FG001|Part 2, Period 1|Treatment not received|0|||
105879805|NCT03307252|365213940|FG002|Part 2, Period 1|Treatment not received|0|||
105879806|NCT03307252|365213941|FG003|Part 2, Period 1|Treatment not received|0|||
105879807|NCT03307252|365213942|FG004|Part 2, Period 1|Treatment not received|0|||
105879808|NCT03307252|365213943|FG005|Part 2, Period 1|Treatment not received|1|||
105879809|NCT03307252|365213944|FG006|Part 2, Period 1|Treatment not received|0|||
105879810|NCT03307252|365213945|FG007|Part 2, Period 1|Treatment not received|0|||
105879811|NCT03307252|365213946|FG008|Part 2, Period 1|Treatment not received|0|||
105879812|NCT03307252|365213947|FG009|Part 2, Period 1|Treatment not received|0|||
105879813|NCT03307252|365213948|FG010|Part 2, Period 1|Treatment not received|0|||
105879814|NCT03307252|365213938|FG000|Part 2, Period 3|Other than listed|0|||
105879815|NCT03307252|365213939|FG001|Part 2, Period 3|Other than listed|0|||
105879816|NCT03307252|365213940|FG002|Part 2, Period 3|Other than listed|0|||
105879817|NCT03307252|365213941|FG003|Part 2, Period 3|Other than listed|0|||
105879818|NCT03307252|365213942|FG004|Part 2, Period 3|Other than listed|1|||
105879819|NCT03307252|365213943|FG005|Part 2, Period 3|Other than listed|0|||
106110386|NCT00245102|366060325|FG001|Overall Study|Participant needed surgery|0|||
105879820|NCT03307252|365213944|FG006|Part 2, Period 3|Other than listed|0|||
105879821|NCT03307252|365213945|FG007|Part 2, Period 3|Other than listed|0|||
105879822|NCT03307252|365213946|FG008|Part 2, Period 3|Other than listed|0|||
105879823|NCT03307252|365213947|FG009|Part 2, Period 3|Other than listed|0|||
105879824|NCT03307252|365213948|FG010|Part 2, Period 3|Other than listed|0|||
105879825|NCT03307252|365213938|FG000|Part 2, Period 4|Other than listed|0|||
105879826|NCT03307252|365213939|FG001|Part 2, Period 4|Other than listed|0|||
105879827|NCT03307252|365213940|FG002|Part 2, Period 4|Other than listed|0|||
105879828|NCT03307252|365213941|FG003|Part 2, Period 4|Other than listed|0|||
105879829|NCT03307252|365213942|FG004|Part 2, Period 4|Other than listed|0|||
105879830|NCT03307252|365213943|FG005|Part 2, Period 4|Other than listed|0|||
105879831|NCT03307252|365213944|FG006|Part 2, Period 4|Other than listed|1|||
105879832|NCT03307252|365213945|FG007|Part 2, Period 4|Other than listed|0|||
105879833|NCT03307252|365213946|FG008|Part 2, Period 4|Other than listed|0|||
105879834|NCT03307252|365213947|FG009|Part 2, Period 4|Other than listed|0|||
105879835|NCT03307252|365213948|FG010|Part 2, Period 4|Other than listed|0|||
105879836|NCT03307252|365213938|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879837|NCT03307252|365213939|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879838|NCT03307252|365213940|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879839|NCT03307252|365213941|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879840|NCT03307252|365213942|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879841|NCT03307252|365213943|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879842|NCT03307252|365213944|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879843|NCT03307252|365213945|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879844|NCT03307252|365213946|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879845|NCT03307252|365213947|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
105879846|NCT03307252|365213948|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
105879847|NCT03517540|365213949|FG000|Overall Study|Protocol Violation|2|||
105879848|NCT03517540|365213950|FG001|Overall Study|Protocol Violation|0|||
105879849|NCT03517540|365213951|FG002|Overall Study|Protocol Violation|0|||
105879850|NCT03517540|365213952|FG003|Overall Study|Protocol Violation|1|||
105879851|NCT03517540|365213949|FG000|Overall Study|Adverse Event|9|||
105879852|NCT03517540|365213950|FG001|Overall Study|Adverse Event|3|||
105879853|NCT03517540|365213951|FG002|Overall Study|Adverse Event|8|||
105879854|NCT03517540|365213952|FG003|Overall Study|Adverse Event|1|||
105879855|NCT03517540|365213949|FG000|Overall Study|Withdrawal by Subject|3|||
105879856|NCT03517540|365213950|FG001|Overall Study|Withdrawal by Subject|4|||
105879857|NCT03517540|365213951|FG002|Overall Study|Withdrawal by Subject|1|||
105879858|NCT03517540|365213952|FG003|Overall Study|Withdrawal by Subject|3|||
105879859|NCT02568189|365213953|FG000|Overall Study|Protocol Violation|0|||
105879860|NCT02568189|365213954|FG001|Overall Study|Protocol Violation|0|||
105879861|NCT02568189|365213955|FG002|Overall Study|Protocol Violation|19|||
105879862|NCT02568189|365213956|FG003|Overall Study|Protocol Violation|18|||
105879863|NCT02712554|365213957|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
105879864|NCT02712554|365213958|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
105879865|NCT02712554|365213957|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
105879866|NCT02712554|365213958|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
105879867|NCT02712554|365213957|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
105879868|NCT02712554|365213958|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
105879869|NCT02712554|365213957|FG000|Part B: Qualification Phase|Adverse Event|0|||
105879870|NCT02712554|365213958|FG001|Part B: Qualification Phase|Adverse Event|1|||
105879871|NCT02712554|365213957|FG000|Part B: Treatment Phase|Adverse Event|0|||
105879872|NCT02712554|365213958|FG001|Part B: Treatment Phase|Adverse Event|1|||
105879873|NCT02712554|365213957|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
105879874|NCT02712554|365213958|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
105879875|NCT02712554|365213957|FG000|Part B: Treatment Phase|Other|0|||
105879876|NCT02712554|365213958|FG001|Part B: Treatment Phase|Other|1|||
105879877|NCT01554527|365213959|FG000|Overall Study|Withdrawal by Subject|1|||
105879878|NCT01554527|365213960|FG001|Overall Study|Withdrawal by Subject|0|||
105879879|NCT01554527|365213961|FG002|Overall Study|Withdrawal by Subject|3|||
105879880|NCT01554527|365213959|FG000|Overall Study|Lost to Follow-up|0|||
105879881|NCT01554527|365213960|FG001|Overall Study|Lost to Follow-up|0|||
105879882|NCT01554527|365213961|FG002|Overall Study|Lost to Follow-up|4|||
105879883|NCT01554527|365213959|FG000|Overall Study|Physician Decision|0|||
105879884|NCT01554527|365213960|FG001|Overall Study|Physician Decision|0|||
105879885|NCT01554527|365213961|FG002|Overall Study|Physician Decision|1|||
105879886|NCT01052480|365213962|FG000|Overall Study|Lost to Follow-up|3|||
105879887|NCT01052480|365213963|FG001|Overall Study|Lost to Follow-up|3|||
105879888|NCT01052480|365213962|FG000|Overall Study|Protocol Violation|1|||
105879889|NCT01052480|365213963|FG001|Overall Study|Protocol Violation|0|||
105879890|NCT01052480|365213962|FG000|Overall Study|Withdrawal by Subject|3|||
105879891|NCT01052480|365213963|FG001|Overall Study|Withdrawal by Subject|7|||
105879892|NCT01052480|365213962|FG000|Overall Study|Physician Decision|0|||
105879893|NCT01052480|365213963|FG001|Overall Study|Physician Decision|2|||
105879894|NCT01052480|365213962|FG000|Overall Study|Death|1|||
105879895|NCT01052480|365213963|FG001|Overall Study|Death|5|||
105879896|NCT02157376|365213964|FG000|Overall Study|Death|10|||
105879897|NCT02157376|365213965|FG001|Overall Study|Death|4|||
105879898|NCT02157376|365213964|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105879899|NCT02157376|365213965|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
106110387|NCT00245102|366060326|FG002|Overall Study|Participant needed surgery|1|||
106110388|NCT00245102|366060327|FG003|Overall Study|Participant needed surgery|0|||
106110389|NCT00245102|366060328|FG004|Overall Study|Participant needed surgery|0|||
106110390|NCT00245102|366060329|FG005|Overall Study|Participant needed surgery|0|||
106110391|NCT00245102|366060324|FG000|Overall Study|Clinical progression|1|||
105879900|NCT02157376|365213964|FG000|Overall Study|Withdrawal by Subject|3|||
105879901|NCT02157376|365213965|FG001|Overall Study|Withdrawal by Subject|8|||
105879902|NCT02157376|365213964|FG000|Overall Study|Not treated|8|||
105879903|NCT02157376|365213965|FG001|Overall Study|Not treated|3|||
105879904|NCT02157376|365213964|FG000|Overall Study|Investigator's misjudgement|1|||
105879905|NCT02157376|365213965|FG001|Overall Study|Investigator's misjudgement|2|||
105879906|NCT00529373|365213966|FG000|Base Study|Adverse Event|525|||
105879907|NCT00529373|365213967|FG001|Base Study|Adverse Event|470|||
105879908|NCT00529373|365213966|FG000|Base Study|Lack of Efficacy|16|||
105879909|NCT00529373|365213967|FG001|Base Study|Lack of Efficacy|75|||
105879910|NCT00529373|365213966|FG000|Base Study|Lost to Follow-up|221|||
105879911|NCT00529373|365213967|FG001|Base Study|Lost to Follow-up|208|||
105879912|NCT00529373|365213966|FG000|Base Study|Other Protocol Specified Criteria|19|||
105879913|NCT00529373|365213967|FG001|Base Study|Other Protocol Specified Criteria|20|||
105879914|NCT00529373|365213966|FG000|Base Study|Physician Decision|60|||
105879915|NCT00529373|365213967|FG001|Base Study|Physician Decision|52|||
105879916|NCT00529373|365213966|FG000|Base Study|Protocol Violation|48|||
105879917|NCT00529373|365213967|FG001|Base Study|Protocol Violation|38|||
105879918|NCT00529373|365213966|FG000|Base Study|Withdrawal by Subject|1062|||
105879919|NCT00529373|365213967|FG001|Base Study|Withdrawal by Subject|967|||
105879920|NCT00529373|365213966|FG000|Base Study|Did not continue into Extension|1795|||
105879921|NCT00529373|365213967|FG001|Base Study|Did not continue into Extension|2238|||
105879922|NCT00529373|365213966|FG000|First Extension Study|Adverse Event|162|||
105879923|NCT00529373|365213967|FG001|First Extension Study|Adverse Event|142|||
105879924|NCT00529373|365213966|FG000|First Extension Study|Lack of Efficacy|65|||
105879925|NCT00529373|365213967|FG001|First Extension Study|Lack of Efficacy|427|||
105879926|NCT00529373|365213966|FG000|First Extension Study|Lost to Follow-up|41|||
105879927|NCT00529373|365213967|FG001|First Extension Study|Lost to Follow-up|37|||
105879928|NCT00529373|365213966|FG000|First Extension Study|Other|27|||
105879929|NCT00529373|365213967|FG001|First Extension Study|Other|47|||
105879930|NCT00529373|365213966|FG000|First Extension Study|Physician Decision|50|||
105879931|NCT00529373|365213967|FG001|First Extension Study|Physician Decision|45|||
105879932|NCT00529373|365213966|FG000|First Extension Study|Protocol Violation|16|||
105879933|NCT00529373|365213967|FG001|First Extension Study|Protocol Violation|13|||
105879934|NCT00529373|365213966|FG000|First Extension Study|Withdrawal by Subject|296|||
105879935|NCT00529373|365213967|FG001|First Extension Study|Withdrawal by Subject|287|||
105879936|NCT00529373|365213966|FG000|First Extension Study|Disposition record non-existing|0|||
105879937|NCT00529373|365213967|FG001|First Extension Study|Disposition record non-existing|1|||
105879938|NCT00529373|365213966|FG000|First Extension Study|Discontinued after 5 years completion|208|||
105879939|NCT00529373|365213967|FG001|First Extension Study|Discontinued after 5 years completion|346|||
105879940|NCT00529373|365213966|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
105879941|NCT00529373|365213967|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
105879942|NCT00529373|365213966|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
105879943|NCT00529373|365213967|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
105879944|NCT00529373|365213966|FG000|Second Extension Study|Adverse Event|101|||
105879945|NCT00529373|365213967|FG001|Second Extension Study|Adverse Event|51|||
105879946|NCT00529373|365213966|FG000|Second Extension Study|Lack of Efficacy|7|||
105879947|NCT00529373|365213967|FG001|Second Extension Study|Lack of Efficacy|15|||
105879948|NCT00529373|365213966|FG000|Second Extension Study|Lost to Follow-up|18|||
105879949|NCT00529373|365213967|FG001|Second Extension Study|Lost to Follow-up|12|||
105879950|NCT00529373|365213966|FG000|Second Extension Study|Other|7|||
105879951|NCT00529373|365213967|FG001|Second Extension Study|Other|12|||
105879952|NCT00529373|365213966|FG000|Second Extension Study|Physician Decision|63|||
105879953|NCT00529373|365213967|FG001|Second Extension Study|Physician Decision|26|||
105879954|NCT00529373|365213966|FG000|Second Extension Study|Protocol Violation|2|||
105879955|NCT00529373|365213967|FG001|Second Extension Study|Protocol Violation|1|||
105879956|NCT00529373|365213966|FG000|Second Extension Study|Withdrawal by Subject|97|||
105879957|NCT00529373|365213967|FG001|Second Extension Study|Withdrawal by Subject|75|||
105879958|NCT00529373|365213966|FG000|Second Extension Study|Status Missing|5|||
105879959|NCT00529373|365213967|FG001|Second Extension Study|Status Missing|5|||
105879960|NCT01863667|365213974|FG000|Overall Study|Adverse Event|1|||
105879961|NCT01863667|365213975|FG001|Overall Study|Adverse Event|0|||
105879962|NCT01863667|365213974|FG000|Overall Study|Study terminated by Sponsor|30|||
105879963|NCT01863667|365213975|FG001|Overall Study|Study terminated by Sponsor|30|||
105879964|NCT01863667|365213974|FG000|Overall Study|Withdrawal by Subject|2|||
105879965|NCT01863667|365213975|FG001|Overall Study|Withdrawal by Subject|2|||
105879966|NCT00615550|365213976|FG000|Overall Study|Lost to Follow-up|6|||
105879967|NCT00615550|365213977|FG001|Overall Study|Lost to Follow-up|1|||
105879968|NCT02741076|365213978|FG000|Overall Study|Adverse Event|0|||
105879969|NCT02741076|365213979|FG001|Overall Study|Adverse Event|1|||
105879970|NCT02741076|365213980|FG002|Overall Study|Adverse Event|1|||
105879971|NCT02741076|365213981|FG003|Overall Study|Adverse Event|0|||
105879972|NCT02741076|365213978|FG000|Overall Study|Lack of Efficacy|1|||
105879973|NCT02741076|365213979|FG001|Overall Study|Lack of Efficacy|0|||
105879974|NCT02741076|365213980|FG002|Overall Study|Lack of Efficacy|0|||
105879975|NCT02741076|365213981|FG003|Overall Study|Lack of Efficacy|0|||
105879976|NCT02741076|365213978|FG000|Overall Study|Withdrawal by Subject|0|||
105879977|NCT02741076|365213979|FG001|Overall Study|Withdrawal by Subject|1|||
105879978|NCT02741076|365213980|FG002|Overall Study|Withdrawal by Subject|0|||
105879979|NCT02741076|365213981|FG003|Overall Study|Withdrawal by Subject|0|||
105879980|NCT02741076|365213978|FG000|Overall Study|Sponsor Request|2|||
105879981|NCT02741076|365213979|FG001|Overall Study|Sponsor Request|3|||
105879982|NCT02741076|365213980|FG002|Overall Study|Sponsor Request|0|||
105879983|NCT02741076|365213981|FG003|Overall Study|Sponsor Request|1|||
105879984|NCT02741076|365213978|FG000|Overall Study|No additional information available|0|||
105879985|NCT02741076|365213979|FG001|Overall Study|No additional information available|0|||
105879986|NCT02741076|365213980|FG002|Overall Study|No additional information available|1|||
105879987|NCT02741076|365213981|FG003|Overall Study|No additional information available|1|||
105879988|NCT00315458|365213982|FG000|Overall Study|Administrative|0|||
105879989|NCT00315458|365213983|FG001|Overall Study|Administrative|3|||
105879990|NCT00315458|365213984|FG002|Overall Study|Administrative|8|||
105879991|NCT00315458|365213985|FG003|Overall Study|Administrative|21|||
105879992|NCT00315458|365213982|FG000|Overall Study|Adverse Event|2|||
105879993|NCT00315458|365213983|FG001|Overall Study|Adverse Event|4|||
105879994|NCT00315458|365213984|FG002|Overall Study|Adverse Event|23|||
105879995|NCT00315458|365213985|FG003|Overall Study|Adverse Event|3|||
105879996|NCT00315458|365213982|FG000|Overall Study|Lost to Follow-up|1|||
105879997|NCT00315458|365213983|FG001|Overall Study|Lost to Follow-up|2|||
105879998|NCT00315458|365213984|FG002|Overall Study|Lost to Follow-up|0|||
105879999|NCT00315458|365213985|FG003|Overall Study|Lost to Follow-up|2|||
105880000|NCT00315458|365213982|FG000|Overall Study|Withdrawal by Subject|0|||
105880001|NCT00315458|365213983|FG001|Overall Study|Withdrawal by Subject|3|||
105880002|NCT00315458|365213984|FG002|Overall Study|Withdrawal by Subject|0|||
105880003|NCT00315458|365213985|FG003|Overall Study|Withdrawal by Subject|2|||
105880004|NCT00315458|365213982|FG000|Overall Study|Lack of Efficacy|0|||
105880005|NCT00315458|365213983|FG001|Overall Study|Lack of Efficacy|0|||
105880006|NCT00315458|365213984|FG002|Overall Study|Lack of Efficacy|20|||
105880007|NCT00315458|365213985|FG003|Overall Study|Lack of Efficacy|1|||
105880008|NCT00315458|365213982|FG000|Overall Study|Did not qualify|0|||
105880009|NCT00315458|365213983|FG001|Overall Study|Did not qualify|0|||
105880010|NCT00315458|365213984|FG002|Overall Study|Did not qualify|1|||
105880011|NCT00315458|365213985|FG003|Overall Study|Did not qualify|0|||
105880012|NCT02748213|365213986|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
105880013|NCT02748213|365213987|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
105880014|NCT02748213|365213986|FG000|Overall Study|Abnormal Laboratory Test|1|||
105880015|NCT02748213|365213987|FG001|Overall Study|Abnormal Laboratory Test|0|||
105880016|NCT02748213|365213986|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
105880017|NCT02748213|365213987|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
105880018|NCT02748213|365213986|FG000|Overall Study|Death|5|||
105880019|NCT02748213|365213987|FG001|Overall Study|Death|3|||
105880020|NCT02748213|365213986|FG000|Overall Study|Insufficient Therapeutic Response|56|||
105880021|NCT02748213|365213987|FG001|Overall Study|Insufficient Therapeutic Response|57|||
105880022|NCT02748213|365213986|FG000|Overall Study|Violation of Selection Criteria|2|||
105880023|NCT02748213|365213987|FG001|Overall Study|Violation of Selection Criteria|0|||
105880024|NCT02748213|365213986|FG000|Overall Study|Protocol Violation|6|||
105880025|NCT02748213|365213987|FG001|Overall Study|Protocol Violation|4|||
105880026|NCT02748213|365213986|FG000|Overall Study|Refused Treatment*|6|||
105880027|NCT02748213|365213987|FG001|Overall Study|Refused Treatment*|6|||
105880028|NCT02748213|365213986|FG000|Overall Study|Failure to Return|1|||
105880029|NCT02748213|365213987|FG001|Overall Study|Failure to Return|0|||
105880030|NCT02748213|365213986|FG000|Overall Study|Other|30|||
105880031|NCT02748213|365213987|FG001|Overall Study|Other|29|||
105880032|NCT02418182|365213993|FG000|Overall Study|Unable to re-consent|18|||
105880033|NCT02418182|365213994|FG001|Overall Study|Unable to re-consent|15|||
105880034|NCT02418182|365213993|FG000|Overall Study|Lost to Follow-up|0|||
105880035|NCT02418182|365213994|FG001|Overall Study|Lost to Follow-up|2|||
105880036|NCT03351608|365215346|FG000|Overall Study|Lost to Follow-up|0|||
105880037|NCT03351608|365215347|FG001|Overall Study|Lost to Follow-up|1|||
105880038|NCT03351608|365215348|FG002|Overall Study|Lost to Follow-up|1|||
105880039|NCT03351608|365215349|FG003|Overall Study|Lost to Follow-up|1|||
105880040|NCT03351608|365215350|FG004|Overall Study|Lost to Follow-up|1|||
105880041|NCT03351608|365215346|FG000|Overall Study|Physician Decision|1|||
105880042|NCT03351608|365215347|FG001|Overall Study|Physician Decision|0|||
105880043|NCT03351608|365215348|FG002|Overall Study|Physician Decision|0|||
106110392|NCT00245102|366060325|FG001|Overall Study|Clinical progression|0|||
106110393|NCT00245102|366060326|FG002|Overall Study|Clinical progression|0|||
106110394|NCT00245102|366060327|FG003|Overall Study|Clinical progression|0|||
106110395|NCT00245102|366060328|FG004|Overall Study|Clinical progression|0|||
105880044|NCT03351608|365215349|FG003|Overall Study|Physician Decision|2|||
105880045|NCT03351608|365215350|FG004|Overall Study|Physician Decision|1|||
105880046|NCT03351608|365215346|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
105880047|NCT03351608|365215347|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
105880048|NCT03351608|365215348|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
105880049|NCT03351608|365215349|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
105880050|NCT03351608|365215350|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
105880051|NCT03351608|365215346|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105880052|NCT03351608|365215347|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105880053|NCT03351608|365215348|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105880054|NCT03351608|365215349|FG003|Overall Study|Withdrawal by parent/guardian|1|||
106110396|NCT00245102|366060329|FG005|Overall Study|Clinical progression|0|||
106110397|NCT02293395|366060330|FG000|Overall Study|Lost to Follow-up|1|||
105880055|NCT03351608|365215350|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105880056|NCT03351608|365215346|FG000|Overall Study|Other|0|||
105880057|NCT03351608|365215347|FG001|Overall Study|Other|1|||
105880058|NCT03351608|365215348|FG002|Overall Study|Other|1|||
105880059|NCT03351608|365215349|FG003|Overall Study|Other|3|||
105880060|NCT03351608|365215350|FG004|Overall Study|Other|0|||
105880061|NCT03150719|365215351|FG000|Overall Study|Adverse Event|0|||
105880062|NCT03150719|365215352|FG001|Overall Study|Adverse Event|1|||
105880063|NCT03150719|365215351|FG000|Overall Study|Death|0|||
105880064|NCT03150719|365215352|FG001|Overall Study|Death|1|||
105880065|NCT03150719|365215351|FG000|Overall Study|Other|1|||
105880066|NCT03150719|365215352|FG001|Overall Study|Other|0|||
105880067|NCT01790984|365215353|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
105880068|NCT01790984|365215354|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
105880069|NCT01790984|365215355|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
105880070|NCT01790984|365215356|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
105880071|NCT03187301|365215357|FG000|Titration Period|Adverse Event|0|||
105880072|NCT03187301|365215358|FG001|Titration Period|Adverse Event|0|||
105880073|NCT03187301|365215359|FG002|Titration Period|Adverse Event|0|||
105880074|NCT03187301|365215360|FG003|Titration Period|Adverse Event|0|||
105880075|NCT03187301|365215361|FG004|Titration Period|Adverse Event|0|||
105880076|NCT03187301|365215362|FG005|Titration Period|Adverse Event|0|||
105880077|NCT03187301|365215363|FG006|Titration Period|Adverse Event|5|||
105880078|NCT03187301|365215357|FG000|Titration Period|Withdrawal by Subject|0|||
105880079|NCT03187301|365215358|FG001|Titration Period|Withdrawal by Subject|0|||
105880080|NCT03187301|365215359|FG002|Titration Period|Withdrawal by Subject|0|||
105880081|NCT03187301|365215360|FG003|Titration Period|Withdrawal by Subject|0|||
105880082|NCT03187301|365215361|FG004|Titration Period|Withdrawal by Subject|0|||
105880083|NCT03187301|365215362|FG005|Titration Period|Withdrawal by Subject|0|||
105880084|NCT03187301|365215363|FG006|Titration Period|Withdrawal by Subject|1|||
105880085|NCT03187301|365215357|FG000|Titration Period|Exclusion Criteria Met|0|||
105880086|NCT03187301|365215358|FG001|Titration Period|Exclusion Criteria Met|0|||
105880087|NCT03187301|365215359|FG002|Titration Period|Exclusion Criteria Met|0|||
105880088|NCT03187301|365215360|FG003|Titration Period|Exclusion Criteria Met|0|||
105880089|NCT03187301|365215361|FG004|Titration Period|Exclusion Criteria Met|0|||
105880090|NCT03187301|365215362|FG005|Titration Period|Exclusion Criteria Met|0|||
105880091|NCT03187301|365215363|FG006|Titration Period|Exclusion Criteria Met|1|||
105880092|NCT03187301|365215357|FG000|Pre-Intervention|Withdrawal by Subject|1|||
105880093|NCT03187301|365215358|FG001|Pre-Intervention|Withdrawal by Subject|0|||
105880094|NCT03187301|365215359|FG002|Pre-Intervention|Withdrawal by Subject|0|||
105880095|NCT03187301|365215360|FG003|Pre-Intervention|Withdrawal by Subject|0|||
105880096|NCT03187301|365215361|FG004|Pre-Intervention|Withdrawal by Subject|0|||
105880097|NCT03187301|365215362|FG005|Pre-Intervention|Withdrawal by Subject|0|||
105880098|NCT03187301|365215363|FG006|Pre-Intervention|Withdrawal by Subject|0|||
105880099|NCT01966120|365215364|FG000|Overall Study|Withdrawal by Subject|0|||
105880100|NCT01966120|365215365|FG001|Overall Study|Withdrawal by Subject|5|||
105880101|NCT01966120|365215364|FG000|Overall Study|Lost to Follow-up|1|||
105880102|NCT01966120|365215365|FG001|Overall Study|Lost to Follow-up|1|||
105880103|NCT01346696|365215366|FG000|Overall Study|Death|1|||
105880104|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
105880105|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105880106|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105880107|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105880108|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
105880109|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
105880110|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
105880111|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
105880112|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
105880113|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
105880114|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
105880115|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
105880116|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
106110398|NCT02293395|366060331|FG001|Overall Study|Lost to Follow-up|0|||
106110399|NCT02293395|366060330|FG000|Overall Study|Withdrawal by Subject|8|||
105880117|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105880118|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105880119|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105880120|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
105880121|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105880122|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105880123|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105880124|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
105880125|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105880126|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105880127|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105880128|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
105880129|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
105880130|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
105880131|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
105880132|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
105880133|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
105880134|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
105880135|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
105880136|NCT00506415|365215378|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
105880137|NCT00506415|365215379|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105880138|NCT00506415|365215380|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105880139|NCT00506415|365215381|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105880140|NCT00506415|365215378|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
105880141|NCT00506415|365215379|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
105880142|NCT00506415|365215380|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
105880143|NCT00506415|365215381|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
105880144|NCT00506415|365215378|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
105880145|NCT00506415|365215379|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
105880146|NCT00506415|365215380|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
105880147|NCT00506415|365215381|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
105880148|NCT00506415|365215378|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
105880149|NCT00506415|365215379|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
105880150|NCT00506415|365215380|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
105880151|NCT00506415|365215381|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
105880152|NCT00506415|365215378|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
105880153|NCT00506415|365215379|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
105880154|NCT00506415|365215380|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
105880155|NCT00506415|365215381|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
105880156|NCT00506415|365215378|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
105880157|NCT00506415|365215379|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
105880158|NCT00506415|365215380|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
105880159|NCT00506415|365215381|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
105880160|NCT00506415|365215378|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
105880161|NCT00506415|365215379|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
105880162|NCT00506415|365215380|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
105880163|NCT00506415|365215381|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
105880164|NCT00506415|365215378|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
105880165|NCT00506415|365215379|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
105880166|NCT00506415|365215380|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
105880167|NCT00506415|365215381|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
105880168|NCT00506415|365215378|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
105880169|NCT00506415|365215379|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
105880170|NCT00506415|365215380|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
105880171|NCT00506415|365215381|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
105880172|NCT00506415|365215378|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
105880173|NCT00506415|365215379|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
105880174|NCT00506415|365215380|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
105880175|NCT00506415|365215381|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
105880176|NCT00506415|365215378|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105880177|NCT00506415|365215379|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105880178|NCT00506415|365215380|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
105880179|NCT00506415|365215381|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
105880180|NCT00506415|365215378|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105880181|NCT00506415|365215379|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105880182|NCT00506415|365215380|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
105880183|NCT00506415|365215381|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
106110400|NCT02293395|366060331|FG001|Overall Study|Withdrawal by Subject|7|||
106110401|NCT01106430|366060334|FG000|Overall Study|Adverse Event|8|||
106110402|NCT01106430|366060335|FG001|Overall Study|Adverse Event|10|||
106110403|NCT01106430|366060334|FG000|Overall Study|Lack of Efficacy|2|||
106110404|NCT01106430|366060335|FG001|Overall Study|Lack of Efficacy|13|||
106110405|NCT01106430|366060334|FG000|Overall Study|Lost to Follow-up|5|||
106110406|NCT01106430|366060335|FG001|Overall Study|Lost to Follow-up|1|||
105880184|NCT00506415|365215378|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105880185|NCT00506415|365215379|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105880186|NCT00506415|365215380|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
105880187|NCT00506415|365215381|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
105880188|NCT00506415|365215378|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105880189|NCT00506415|365215379|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105880190|NCT00506415|365215380|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
105880191|NCT00506415|365215381|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
105880192|NCT00506415|365215378|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105880193|NCT00506415|365215379|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105880194|NCT00506415|365215380|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
105880195|NCT00506415|365215381|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
105880196|NCT00506415|365215378|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
105880197|NCT00506415|365215379|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
105880198|NCT00506415|365215380|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
105880199|NCT00506415|365215381|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
105880200|NCT01703260|365215387|FG000|Overall Study|Adverse Event|1|||
105880201|NCT01703260|365215388|FG001|Overall Study|Adverse Event|2|||
105880202|NCT01703260|365215389|FG002|Overall Study|Adverse Event|2|||
105880203|NCT01703260|365215387|FG000|Overall Study|Lost to Follow-up|1|||
105880204|NCT01703260|365215388|FG001|Overall Study|Lost to Follow-up|0|||
105880205|NCT01703260|365215389|FG002|Overall Study|Lost to Follow-up|0|||
105880206|NCT01703260|365215387|FG000|Overall Study|Withdrawal by Subject|0|||
105880207|NCT01703260|365215388|FG001|Overall Study|Withdrawal by Subject|0|||
105880208|NCT01703260|365215389|FG002|Overall Study|Withdrawal by Subject|1|||
105880209|NCT01703260|365215387|FG000|Overall Study|Study Termination|1|||
105880210|NCT01703260|365215388|FG001|Overall Study|Study Termination|2|||
105880211|NCT01703260|365215389|FG002|Overall Study|Study Termination|0|||
105880212|NCT01081769|365215394|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
105880213|NCT01081769|365215395|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
105880214|NCT01081769|365215394|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
105880215|NCT01081769|365215395|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
105880216|NCT01081769|365215394|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
105880217|NCT01081769|365215395|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
105880218|NCT01081769|365215394|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
105880219|NCT01081769|365215395|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
105880220|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Adverse Event|14|||
105880221|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Adverse Event|11|||
105880222|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Death|1|||
105880223|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Death|1|||
105880224|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
105880225|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
105880226|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
105880227|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
105880228|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Pregnancy|1|||
105880229|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Pregnancy|0|||
105880230|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
105880231|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
105880232|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
105880233|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
105880234|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Other|0|||
105880235|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Other|1|||
105880236|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Ineligibility|3|||
105880237|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Ineligibility|4|||
105880238|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
105880239|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
105880240|NCT01081769|365215394|FG000|CORE Intent-To-Treat|Patient Moved|2|||
105880241|NCT01081769|365215395|FG001|CORE Intent-To-Treat|Patient Moved|2|||
105880242|NCT00507455|365215396|FG000|Overall Study|Adverse Event|3|||
105880243|NCT00507455|365215397|FG001|Overall Study|Adverse Event|3|||
105880244|NCT00507455|365215398|FG002|Overall Study|Adverse Event|6|||
106110407|NCT01106430|366060334|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
106110408|NCT01106430|366060335|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
106110409|NCT01106430|366060334|FG000|Overall Study|Moved Out Of State|0|||
106110410|NCT01106430|366060335|FG001|Overall Study|Moved Out Of State|1|||
106110411|NCT01106430|366060334|FG000|Overall Study|Refused To Take Medication|0|||
106110412|NCT01106430|366060335|FG001|Overall Study|Refused To Take Medication|1|||
105880245|NCT00507455|365215396|FG000|Overall Study|Withdrawal by Subject|2|||
106110413|NCT01106430|366060334|FG000|Overall Study|Noncompliance|0|||
106110414|NCT01106430|366060335|FG001|Overall Study|Noncompliance|1|||
105880246|NCT00507455|365215397|FG001|Overall Study|Withdrawal by Subject|1|||
105880247|NCT00507455|365215398|FG002|Overall Study|Withdrawal by Subject|2|||
105880248|NCT00507455|365215396|FG000|Overall Study|Protocol Violation|4|||
105880249|NCT00507455|365215397|FG001|Overall Study|Protocol Violation|1|||
105880250|NCT00507455|365215398|FG002|Overall Study|Protocol Violation|1|||
105880251|NCT00507455|365215396|FG000|Overall Study|Lost to Follow-up|2|||
105880252|NCT00507455|365215397|FG001|Overall Study|Lost to Follow-up|0|||
105880253|NCT00507455|365215398|FG002|Overall Study|Lost to Follow-up|2|||
105880254|NCT00507455|365215396|FG000|Overall Study|Lack of Efficacy|0|||
105880255|NCT00507455|365215397|FG001|Overall Study|Lack of Efficacy|1|||
105880256|NCT00507455|365215398|FG002|Overall Study|Lack of Efficacy|0|||
105880257|NCT00507455|365215396|FG000|Overall Study|Other - miscellaneous reason|1|||
105880258|NCT00507455|365215397|FG001|Overall Study|Other - miscellaneous reason|0|||
105880259|NCT00507455|365215398|FG002|Overall Study|Other - miscellaneous reason|1|||
105880260|NCT02176655|365215399|FG000|Overall Study|Subjects did not treat|6|||
105880261|NCT00561392|365215403|FG000|Overall Study|Adverse Event|38|||
105880262|NCT00561392|365215403|FG000|Overall Study|Lack of Efficacy|2|||
105880263|NCT00561392|365215403|FG000|Overall Study|Protocol Violation|1|||
105880264|NCT00561392|365215403|FG000|Overall Study|Withdrawal by Subject|8|||
105880265|NCT00561392|365215403|FG000|Overall Study|Administrative problems|4|||
105880266|NCT02861807|365215404|FG000|Overall Study|Lost to Follow-up|7|||
105880267|NCT02861807|365215405|FG001|Overall Study|Lost to Follow-up|6|||
105880268|NCT02861807|365215404|FG000|Overall Study|Withdrawal by Subject|5|||
105880269|NCT02861807|365215405|FG001|Overall Study|Withdrawal by Subject|8|||
105880270|NCT00410813|365215406|FG000|Overall Study|Adverse Event|6|||
105880271|NCT00410813|365215407|FG001|Overall Study|Adverse Event|11|||
105880272|NCT00410813|365215406|FG000|Overall Study|Progression|32|||
105880273|NCT00410813|365215407|FG001|Overall Study|Progression|21|||
105880274|NCT00410813|365215406|FG000|Overall Study|Not protocol specified|3|||
105880275|NCT00410813|365215407|FG001|Overall Study|Not protocol specified|4|||
105880276|NCT00410813|365215406|FG000|Overall Study|Ineligible|2|||
105880277|NCT00410813|365215407|FG001|Overall Study|Ineligible|4|||
105880278|NCT00410813|365215406|FG000|Overall Study|Death|0|||
105880279|NCT00410813|365215407|FG001|Overall Study|Death|2|||
105880280|NCT05027451|365215408|FG000|Overall Study|Lost to Follow-up|1|||
105880281|NCT05027451|365215409|FG001|Overall Study|Lost to Follow-up|1|||
105880282|NCT05310071|365215410|FG000|Overall Study|Death|0|||
105880283|NCT05310071|365215411|FG001|Overall Study|Death|3|||
105880284|NCT05310071|365215410|FG000|Overall Study|Adverse Event|4|||
105880285|NCT05310071|365215411|FG001|Overall Study|Adverse Event|31|||
105880286|NCT05310071|365215410|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
105880287|NCT05310071|365215411|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
105880288|NCT05310071|365215410|FG000|Overall Study|Protocol Deviation|2|||
105880289|NCT05310071|365215411|FG001|Overall Study|Protocol Deviation|0|||
105880290|NCT05310071|365215410|FG000|Overall Study|Randomized by Mistake|0|||
105880291|NCT05310071|365215411|FG001|Overall Study|Randomized by Mistake|1|||
105880292|NCT05310071|365215410|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
105880293|NCT05310071|365215411|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
105880294|NCT05310071|365215410|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
105880295|NCT05310071|365215411|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
105880296|NCT05310071|365215410|FG000|Overall Study|Site Terminated by Sponsor|0|||
105880297|NCT05310071|365215411|FG001|Overall Study|Site Terminated by Sponsor|2|||
105880298|NCT05310071|365215410|FG000|Overall Study|Study Terminated by Sponsor|282|||
105880299|NCT05310071|365215411|FG001|Overall Study|Study Terminated by Sponsor|559|||
105880300|NCT05310071|365215410|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
105880301|NCT05310071|365215411|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
105880302|NCT05310071|365215410|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
105880303|NCT05310071|365215411|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
105880304|NCT05310071|365215410|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
105880305|NCT05310071|365215411|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
105880306|NCT05310071|365215410|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
105880307|NCT05310071|365215411|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
105880308|NCT05310071|365215410|FG000|Overall Study|Withdrawal by Participant - Other|25|||
105880309|NCT05310071|365215411|FG001|Overall Study|Withdrawal by Participant - Other|30|||
105880310|NCT05310071|365215410|FG000|Overall Study|Lost to Follow-up|2|||
105880311|NCT05310071|365215411|FG001|Overall Study|Lost to Follow-up|4|||
105880312|NCT05310071|365215410|FG000|Overall Study|Reason Not Specified|1|||
105880313|NCT05310071|365215411|FG001|Overall Study|Reason Not Specified|3|||
105880314|NCT02091089|365215414|FG000|Overall Study|Lost to Follow-up|2|||
106110415|NCT01106430|366060334|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
106110416|NCT01106430|366060335|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
105880315|NCT00462709|365215417|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
105880316|NCT00462709|365215417|FG000|Overall Study|Lost to Follow-up|10|||
105880317|NCT00462709|365215417|FG000|Overall Study|Withdrawal by Subject|8|||
105880318|NCT00462709|365215417|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
105880319|NCT00462709|365215417|FG000|Overall Study|Death|2|||
105880320|NCT00462709|365215417|FG000|Overall Study|Logistical reasons|2|||
105880321|NCT00462709|365215417|FG000|Overall Study|Physician Decision|1|||
105880322|NCT00462709|365215417|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
105880323|NCT02097745|365215418|FG000|Overall Study|Adverse Event|25|||
105880324|NCT02097745|365215418|FG000|Overall Study|Death|16|||
105880325|NCT02097745|365215418|FG000|Overall Study|Failure to Return|14|||
105880326|NCT02097745|365215418|FG000|Overall Study|Administrative/Other|27|||
105880327|NCT02097745|365215418|FG000|Overall Study|Reason Not Specified|96|||
105880328|NCT00425750|365215419|FG000|Overall Study|Death|1|||
105880329|NCT00425750|365215419|FG000|Overall Study|Withdrawal by Subject|3|||
105880330|NCT00425750|365215419|FG000|Overall Study|Adverse Event|3|||
105880331|NCT00425750|365215419|FG000|Overall Study|Progression of disease|18|||
105880332|NCT03515811|365215421|FG000|Overall Study|Lost to Follow-up|2|||
105880333|NCT03515811|365215422|FG001|Overall Study|Lost to Follow-up|1|||
105880334|NCT03515811|365215421|FG000|Overall Study|Protocol Violation|1|||
105880335|NCT03515811|365215422|FG001|Overall Study|Protocol Violation|1|||
105880336|NCT03515811|365215421|FG000|Overall Study|Death|1|||
105880337|NCT03515811|365215422|FG001|Overall Study|Death|1|||
105880338|NCT03515811|365215421|FG000|Overall Study|Withdrawal by Subject|0|||
105880339|NCT03515811|365215422|FG001|Overall Study|Withdrawal by Subject|2|||
105880340|NCT03515811|365215421|FG000|Overall Study|Technical Problems|1|||
105880341|NCT03515811|365215422|FG001|Overall Study|Technical Problems|0|||
105880342|NCT03515811|365215421|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
105880343|NCT03515811|365215422|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
105880344|NCT03515811|365215421|FG000|Overall Study|COVID-19|0|||
105880345|NCT03515811|365215422|FG001|Overall Study|COVID-19|1|||
105880346|NCT00237458|365215423|FG000|Overall Study|Lack of Efficacy|1|||
105880347|NCT00237458|365215423|FG000|Overall Study|Adverse Event|1|||
105880348|NCT00237458|365215423|FG000|Overall Study|Withdrawal by Subject|1|||
106110417|NCT01106430|366060334|FG000|Overall Study|Previous Use Of Marijuana|1|||
106110418|NCT01106430|366060335|FG001|Overall Study|Previous Use Of Marijuana|0|||
106110419|NCT01106430|366060334|FG000|Overall Study|Protocol Violation|7|||
106110420|NCT01106430|366060335|FG001|Overall Study|Protocol Violation|2|||
106110421|NCT01106430|366060334|FG000|Overall Study|Withdrawal by Subject|8|||
106110422|NCT01106430|366060335|FG001|Overall Study|Withdrawal by Subject|4|||
106110423|NCT00861614|366060338|FG000|Overall Study|Disease Progression|182|||
106110424|NCT00861614|366060339|FG001|Overall Study|Disease Progression|263|||
106110425|NCT00861614|366060338|FG000|Overall Study|Study Drug Toxicity|79|||
106110426|NCT00861614|366060339|FG001|Overall Study|Study Drug Toxicity|6|||
106110427|NCT00861614|366060338|FG000|Overall Study|Death|32|||
106110428|NCT00861614|366060339|FG001|Overall Study|Death|19|||
106110429|NCT00861614|366060338|FG000|Overall Study|Adverse Event|27|||
106110430|NCT00861614|366060339|FG001|Overall Study|Adverse Event|23|||
106110431|NCT00861614|366060338|FG000|Overall Study|Withdrawal by Subject|34|||
106110432|NCT00861614|366060339|FG001|Overall Study|Withdrawal by Subject|35|||
106110433|NCT00861614|366060338|FG000|Overall Study|Other|17|||
106110434|NCT00861614|366060339|FG001|Overall Study|Other|22|||
106110435|NCT00838682|366060340|FG000|Overall Study|Lost to Follow-up|21|||
106110436|NCT00838682|366060341|FG001|Overall Study|Lost to Follow-up|14|||
106110437|NCT00838682|366060340|FG000|Overall Study|detection of exclusion criteria|4|||
106110438|NCT00838682|366060341|FG001|Overall Study|detection of exclusion criteria|3|||
106110439|NCT00838682|366060340|FG000|Overall Study|Protocol Violation|0|||
106110440|NCT00838682|366060341|FG001|Overall Study|Protocol Violation|1|||
106110441|NCT00838682|366060340|FG000|Overall Study|Withdrawal by Subject|0|||
106110442|NCT00838682|366060341|FG001|Overall Study|Withdrawal by Subject|1|||
106110443|NCT03966053|366060342|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
106110444|NCT01807156|366060349|FG000|Overall Study|Physician Decision|1|||
106110445|NCT00514943|366060350|FG000|Stage 1|Progressive disease|4|||
106110446|NCT00514943|366060351|FG001|Stage 1|Progressive disease|8|||
106110447|NCT00514943|366060350|FG000|Stage 1|Other Adverse Event|16|||
106110448|NCT00514943|366060351|FG001|Stage 1|Other Adverse Event|6|||
106110449|NCT00514943|366060350|FG000|Stage 1|Not treated|1|||
106110450|NCT00514943|366060351|FG001|Stage 1|Not treated|2|||
106110451|NCT00514943|366060350|FG000|Stage 1|Patient refused to continue study meds|8|||
105880349|NCT04331067|365215425|FG000|Overall Study|Adverse Event|1|||
105880350|NCT04331067|365215426|FG001|Overall Study|Adverse Event|3|||
105880351|NCT04331067|365215427|FG002|Overall Study|Adverse Event|1|||
105880352|NCT04331067|365215425|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
105880353|NCT04331067|365215426|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
106110452|NCT00514943|366060351|FG001|Stage 1|Patient refused to continue study meds|3|||
105880354|NCT04331067|365215427|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
106110453|NCT00514943|366060350|FG000|Stage 1|Other than stated above|1|||
106110454|NCT00514943|366060351|FG001|Stage 1|Other than stated above|7|||
106110455|NCT00514943|366060350|FG000|Stage 2|Progressive disease|27|||
106110456|NCT00514943|366060351|FG001|Stage 2|Progressive disease|24|||
106110457|NCT00514943|366060350|FG000|Stage 2|Other Adverse Event|3|||
105880355|NCT04339062|365215428|FG000|Overall Study|Death|0|||
105880356|NCT04339062|365215429|FG001|Overall Study|Death|1|||
105880357|NCT05870371|365215430|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
105880358|NCT05870371|365215431|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
105880359|NCT01197534|365215432|FG000|Overall Study|Not reported|16|||
105880360|NCT01197534|365215433|FG001|Overall Study|Not reported|10|||
105880361|NCT01197534|365215434|FG002|Overall Study|Not reported|16|||
105880362|NCT01197534|365215432|FG000|Overall Study|Enrolment in long term extension|57|||
105880363|NCT01197534|365215433|FG001|Overall Study|Enrolment in long term extension|66|||
105880364|NCT01197534|365215434|FG002|Overall Study|Enrolment in long term extension|119|||
105880365|NCT01197534|365215432|FG000|Overall Study|Severe non-compliance to protocol|3|||
105880366|NCT01197534|365215433|FG001|Overall Study|Severe non-compliance to protocol|4|||
105880367|NCT01197534|365215434|FG002|Overall Study|Severe non-compliance to protocol|1|||
105880368|NCT01197534|365215432|FG000|Overall Study|Lack of therapeutic response|9|||
105880369|NCT01197534|365215433|FG001|Overall Study|Lack of therapeutic response|4|||
105880370|NCT01197534|365215434|FG002|Overall Study|Lack of therapeutic response|9|||
105880371|NCT01197534|365215432|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
105880372|NCT01197534|365215433|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
105880373|NCT01197534|365215434|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
105880374|NCT01197534|365215432|FG000|Overall Study|Lost to Follow-up|1|||
105880375|NCT01197534|365215433|FG001|Overall Study|Lost to Follow-up|4|||
105880376|NCT01197534|365215434|FG002|Overall Study|Lost to Follow-up|2|||
105880377|NCT01197534|365215432|FG000|Overall Study|Adverse Event|35|||
105880378|NCT01197534|365215433|FG001|Overall Study|Adverse Event|36|||
105880379|NCT01197534|365215434|FG002|Overall Study|Adverse Event|24|||
105880380|NCT01153815|365215437|FG000|Overall Study|Adverse Event|3|||
105880381|NCT01153815|365215438|FG001|Overall Study|Adverse Event|1|||
106110458|NCT00514943|366060351|FG001|Stage 2|Other Adverse Event|10|||
106110459|NCT00514943|366060350|FG000|Stage 2|Patient refused to continue study meds|2|||
106110460|NCT00514943|366060351|FG001|Stage 2|Patient refused to continue study meds|0|||
106110461|NCT00514943|366060350|FG000|Stage 2|Other than stated above|0|||
106110462|NCT00514943|366060351|FG001|Stage 2|Other than stated above|2|||
105880382|NCT01153815|365215437|FG000|Overall Study|Withdrawal by Subject|6|||
105880383|NCT01153815|365215438|FG001|Overall Study|Withdrawal by Subject|4|||
105880384|NCT00708461|365215443|FG000|Overall Study|Lost to Follow-up|18|||
105880385|NCT00708461|365215444|FG001|Overall Study|Lost to Follow-up|11|||
105880386|NCT00708461|365215443|FG000|Overall Study|Withdrawal by Subject|8|||
105880387|NCT00708461|365215444|FG001|Overall Study|Withdrawal by Subject|9|||
105880388|NCT00708461|365215443|FG000|Overall Study|left workforce|115|||
105880389|NCT00708461|365215444|FG001|Overall Study|left workforce|180|||
105880390|NCT02968173|365215445|FG000|Overall Study|Withdrawal by Subject|1|||
105880391|NCT02670525|365215446|FG000|Overall Study|Death|94|||
105880392|NCT02670525|365215447|FG001|Overall Study|Death|14|||
105880393|NCT02670525|365215446|FG000|Overall Study|Lost to Follow-up|4|||
105880394|NCT02670525|365215447|FG001|Overall Study|Lost to Follow-up|1|||
105880395|NCT02670525|365215446|FG000|Overall Study|Subject withdrew consent|1|||
105880396|NCT02670525|365215447|FG001|Overall Study|Subject withdrew consent|0|||
105880397|NCT02670525|365215446|FG000|Overall Study|Unknown, data entry delayed|123|||
105880398|NCT02670525|365215447|FG001|Overall Study|Unknown, data entry delayed|78|||
105880399|NCT01796392|365215448|FG000|Overall Study|Withdrawal by Subject|2|||
106110463|NCT02323646|366060358|FG000|Treatment Course 1|Adverse Event|1|||
106110464|NCT02323646|366060359|FG001|Treatment Course 1|Adverse Event|0|||
106110465|NCT02323646|366060360|FG002|Treatment Course 1|Adverse Event|1|||
106110466|NCT02323646|366060358|FG000|Treatment Course 1|Heavy Bleeding|1|||
106110467|NCT02323646|366060359|FG001|Treatment Course 1|Heavy Bleeding|1|||
106110468|NCT02323646|366060360|FG002|Treatment Course 1|Heavy Bleeding|0|||
106110469|NCT02323646|366060358|FG000|Treatment Course 1|Lost to Follow-up|1|||
106110470|NCT02323646|366060359|FG001|Treatment Course 1|Lost to Follow-up|0|||
106110471|NCT02323646|366060360|FG002|Treatment Course 1|Lost to Follow-up|2|||
106110472|NCT02323646|366060358|FG000|Treatment Course 1|Withdrawal by Subject|0|||
106110473|NCT02323646|366060359|FG001|Treatment Course 1|Withdrawal by Subject|2|||
106110474|NCT02323646|366060360|FG002|Treatment Course 1|Withdrawal by Subject|0|||
106110475|NCT02323646|366060358|FG000|Treatment Course 2|Adverse Event|1|||
106110476|NCT02323646|366060359|FG001|Treatment Course 2|Adverse Event|0|||
106110477|NCT02323646|366060360|FG002|Treatment Course 2|Adverse Event|1|||
105880400|NCT01796392|365215449|FG001|Overall Study|Withdrawal by Subject|0|||
105880401|NCT01796392|365215448|FG000|Overall Study|Death|5|||
105880402|NCT01796392|365215449|FG001|Overall Study|Death|1|||
105880403|NCT01796392|365215448|FG000|Overall Study|Excluded for medical reasons|1|||
105880404|NCT01796392|365215449|FG001|Overall Study|Excluded for medical reasons|2|||
105880405|NCT01796392|365215448|FG000|Overall Study|Lost to Follow-up|1|||
105880406|NCT01796392|365215449|FG001|Overall Study|Lost to Follow-up|0|||
105880407|NCT03627546|365215454|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
106110478|NCT02323646|366060358|FG000|Treatment Course 2|Lost to Follow-up|0|||
106110479|NCT02323646|366060359|FG001|Treatment Course 2|Lost to Follow-up|0|||
106110480|NCT02323646|366060360|FG002|Treatment Course 2|Lost to Follow-up|1|||
106110481|NCT02323646|366060358|FG000|Treatment Course 2|Non-compliance|0|||
106110482|NCT02323646|366060359|FG001|Treatment Course 2|Non-compliance|1|||
106110483|NCT02323646|366060360|FG002|Treatment Course 2|Non-compliance|1|||
106110484|NCT01783418|366060361|FG000|Overall Study|Withdrawal by Subject|1|||
106110485|NCT01783418|366060362|FG001|Overall Study|Withdrawal by Subject|0|||
106110486|NCT00526630|366060364|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
106110487|NCT00526630|366060365|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
106110488|NCT00526630|366060364|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
106110489|NCT00526630|366060365|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
106110490|NCT02459262|366060366|FG000|Overall Study|Withdrawal by Subject|0|||
106110491|NCT02459262|366060367|FG001|Overall Study|Withdrawal by Subject|0|||
106110492|NCT02459262|366060368|FG002|Overall Study|Withdrawal by Subject|0|||
106110493|NCT02459262|366060369|FG003|Overall Study|Withdrawal by Subject|0|||
106110494|NCT02459262|366060370|FG004|Overall Study|Withdrawal by Subject|0|||
106110495|NCT02459262|366060371|FG005|Overall Study|Withdrawal by Subject|0|||
106110496|NCT02459262|366060372|FG006|Overall Study|Withdrawal by Subject|0|||
106110497|NCT02459262|366060373|FG007|Overall Study|Withdrawal by Subject|0|||
106110498|NCT02459262|366060374|FG008|Overall Study|Withdrawal by Subject|0|||
106110499|NCT02459262|366060375|FG009|Overall Study|Withdrawal by Subject|1|||
106110500|NCT02459262|366060376|FG010|Overall Study|Withdrawal by Subject|0|||
106110501|NCT00840801|366060377|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
106110502|NCT00840801|366060378|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
106110503|NCT00840801|366060379|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
106110504|NCT00840801|366060377|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
106110505|NCT00840801|366060378|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
106110506|NCT00840801|366060379|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
106110507|NCT00840801|366060377|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
106110508|NCT00840801|366060378|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
106110509|NCT00840801|366060379|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
106110510|NCT00840801|366060377|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
106110511|NCT00840801|366060378|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
106110512|NCT00840801|366060379|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
106110513|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
106110514|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
106110515|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
106110516|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
106110517|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
106110518|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
106110519|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
106110520|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
106110521|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
106110522|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
106110523|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
106110524|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
106110525|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
106110526|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
106110527|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
106110528|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
106110529|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
106110530|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
106110531|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
106110532|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
106110533|NCT00549757|366060381|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
106110534|NCT00549757|366060382|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
106110535|NCT00549757|366060381|FG000|Extension Period (in Average 9 Months)|Death|143|||
106110536|NCT00549757|366060382|FG001|Extension Period (in Average 9 Months)|Death|136|||
106110537|NCT00549757|366060381|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
106110538|NCT00549757|366060382|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
106110539|NCT00549757|366060381|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
106110540|NCT00549757|366060382|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
106110541|NCT00549757|366060381|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
106110542|NCT00549757|366060382|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
106110543|NCT04539821|366060383|FG000|Overall Study|Withdrawal by Subject|2|||
105880408|NCT03627546|365215455|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
106110544|NCT04539821|366060383|FG000|Overall Study|continued care with their physician|20|||
106110545|NCT04539821|366060383|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
106110546|NCT02641392|366060384|FG000|Overall Study|Lost to Follow-up|0|||
106110547|NCT02641392|366060385|FG001|Overall Study|Lost to Follow-up|0|||
105880409|NCT03627546|365215456|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
105880410|NCT03627546|365215454|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
105880411|NCT03627546|365215455|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
105880412|NCT03627546|365215456|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
105880413|NCT01578239|365215457|FG000|Treatment Period|Progressive Disease|19|||
105880414|NCT01578239|365215458|FG001|Treatment Period|Progressive Disease|64|||
105880415|NCT01578239|365215457|FG000|Treatment Period|Physician Decision|17|||
105880416|NCT01578239|365215458|FG001|Treatment Period|Physician Decision|17|||
105880417|NCT01578239|365215457|FG000|Treatment Period|Adverse Event|13|||
105880418|NCT01578239|365215458|FG001|Treatment Period|Adverse Event|10|||
105880419|NCT01578239|365215457|FG000|Treatment Period|Non-compliance|2|||
105880420|NCT01578239|365215458|FG001|Treatment Period|Non-compliance|0|||
105880421|NCT01578239|365215457|FG000|Treatment Period|Withdrawal by Subject|10|||
105880422|NCT01578239|365215458|FG001|Treatment Period|Withdrawal by Subject|9|||
105880423|NCT01578239|365215457|FG000|Treatment Period|Other|6|||
105880424|NCT01578239|365215458|FG001|Treatment Period|Other|1|||
105880425|NCT01578239|365215457|FG000|Long-term Follow-Up Period|Death|69|||
105880426|NCT01578239|365215458|FG001|Long-term Follow-Up Period|Death|64|||
105880427|NCT01578239|365215457|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
105880428|NCT01578239|365215458|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
105880429|NCT01578239|365215457|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
105880430|NCT01578239|365215458|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
105880431|NCT01578239|365215457|FG000|Long-term Follow-Up Period|Other|2|||
105880432|NCT01578239|365215458|FG001|Long-term Follow-Up Period|Other|2|||
105880433|NCT03379727|365215460|FG000|Overall Study|Lack of Efficacy|73|||
105880434|NCT03379727|365215460|FG000|Overall Study|Adverse Event|32|||
105880435|NCT03379727|365215460|FG000|Overall Study|Death|18|||
105880436|NCT03379727|365215460|FG000|Overall Study|Patient/guardian decision|17|||
105880437|NCT03379727|365215460|FG000|Overall Study|Physician Decision|104|||
105880438|NCT03379727|365215460|FG000|Overall Study|Protocol Violation|4|||
105880439|NCT03379727|365215460|FG000|Overall Study|Lost to Follow-up|1|||
105880440|NCT01134939|365215464|FG000|Overall Study|Adverse Event|9|||
105880441|NCT01134939|365215465|FG001|Overall Study|Adverse Event|3|||
105880442|NCT01134939|365215466|FG002|Overall Study|Adverse Event|4|||
105880443|NCT01134939|365215467|FG003|Overall Study|Adverse Event|5|||
105880444|NCT01134939|365215468|FG004|Overall Study|Adverse Event|5|||
105880445|NCT01134939|365215469|FG005|Overall Study|Adverse Event|5|||
105880446|NCT01134939|365215470|FG006|Overall Study|Adverse Event|1|||
105880447|NCT01134939|365215471|FG007|Overall Study|Adverse Event|0|||
105880448|NCT01134939|365215464|FG000|Overall Study|Lack of Efficacy|2|||
105880449|NCT01134939|365215465|FG001|Overall Study|Lack of Efficacy|5|||
105880450|NCT01134939|365215466|FG002|Overall Study|Lack of Efficacy|1|||
105880451|NCT01134939|365215467|FG003|Overall Study|Lack of Efficacy|0|||
105880452|NCT01134939|365215468|FG004|Overall Study|Lack of Efficacy|3|||
105880453|NCT01134939|365215469|FG005|Overall Study|Lack of Efficacy|0|||
105880454|NCT01134939|365215470|FG006|Overall Study|Lack of Efficacy|1|||
105880455|NCT01134939|365215471|FG007|Overall Study|Lack of Efficacy|0|||
105880456|NCT01134939|365215464|FG000|Overall Study|Lost to Follow-up|2|||
105880457|NCT01134939|365215465|FG001|Overall Study|Lost to Follow-up|3|||
105880458|NCT01134939|365215466|FG002|Overall Study|Lost to Follow-up|0|||
105880459|NCT01134939|365215467|FG003|Overall Study|Lost to Follow-up|1|||
105880460|NCT01134939|365215468|FG004|Overall Study|Lost to Follow-up|2|||
105880461|NCT01134939|365215469|FG005|Overall Study|Lost to Follow-up|1|||
105880462|NCT01134939|365215470|FG006|Overall Study|Lost to Follow-up|0|||
105880463|NCT01134939|365215471|FG007|Overall Study|Lost to Follow-up|0|||
105880464|NCT01134939|365215464|FG000|Overall Study|Death|0|||
105880465|NCT01134939|365215465|FG001|Overall Study|Death|1|||
105880466|NCT01134939|365215466|FG002|Overall Study|Death|0|||
105880467|NCT01134939|365215467|FG003|Overall Study|Death|0|||
105880468|NCT01134939|365215468|FG004|Overall Study|Death|0|||
105880469|NCT01134939|365215469|FG005|Overall Study|Death|0|||
105880470|NCT01134939|365215470|FG006|Overall Study|Death|0|||
105880471|NCT01134939|365215471|FG007|Overall Study|Death|0|||
105880472|NCT01134939|365215464|FG000|Overall Study|Termination page not available|4|||
105880473|NCT01134939|365215465|FG001|Overall Study|Termination page not available|6|||
105880474|NCT01134939|365215466|FG002|Overall Study|Termination page not available|5|||
105880475|NCT01134939|365215467|FG003|Overall Study|Termination page not available|8|||
105880476|NCT01134939|365215468|FG004|Overall Study|Termination page not available|0|||
105880477|NCT01134939|365215469|FG005|Overall Study|Termination page not available|3|||
105880478|NCT01134939|365215470|FG006|Overall Study|Termination page not available|7|||
105880479|NCT01134939|365215471|FG007|Overall Study|Termination page not available|0|||
105880480|NCT02547220|365215474|FG000|Overall Study|Withdrawal by Subject|1|||
105880481|NCT02547220|365215475|FG001|Overall Study|Withdrawal by Subject|0|||
105880482|NCT02547220|365215474|FG000|Overall Study|Study terminated by sponsor|18|||
105880483|NCT02547220|365215475|FG001|Overall Study|Study terminated by sponsor|20|||
105880484|NCT02887183|365215476|FG000|Overall Study|Adverse Event|44|||
105880485|NCT02887183|365215476|FG000|Overall Study|Death|30|||
105880486|NCT02887183|365215476|FG000|Overall Study|Pregnancy|1|||
106110548|NCT02641392|366060386|FG002|Overall Study|Lost to Follow-up|2|||
106110549|NCT02641392|366060384|FG000|Overall Study|Withdrawal by Subject|0|||
106110550|NCT02641392|366060385|FG001|Overall Study|Withdrawal by Subject|0|||
106110551|NCT02641392|366060386|FG002|Overall Study|Withdrawal by Subject|17|||
106110552|NCT02641392|366060384|FG000|Overall Study|Adverse Event|0|||
106110553|NCT02641392|366060385|FG001|Overall Study|Adverse Event|1|||
106110554|NCT02641392|366060386|FG002|Overall Study|Adverse Event|25|||
106110555|NCT02641392|366060384|FG000|Overall Study|Study Terminated by Sponsor|4|||
106110556|NCT02641392|366060385|FG001|Overall Study|Study Terminated by Sponsor|12|||
106110557|NCT02641392|366060386|FG002|Overall Study|Study Terminated by Sponsor|144|||
106110558|NCT02641392|366060384|FG000|Overall Study|Lack of Efficacy|0|||
106110559|NCT02641392|366060385|FG001|Overall Study|Lack of Efficacy|0|||
106110560|NCT02641392|366060386|FG002|Overall Study|Lack of Efficacy|101|||
106110561|NCT02641392|366060384|FG000|Overall Study|Miscellaneous|0|||
106110562|NCT02641392|366060385|FG001|Overall Study|Miscellaneous|0|||
106110563|NCT02641392|366060386|FG002|Overall Study|Miscellaneous|3|||
106110564|NCT02641392|366060384|FG000|Overall Study|Death|0|||
106110565|NCT02641392|366060385|FG001|Overall Study|Death|0|||
106110566|NCT02641392|366060386|FG002|Overall Study|Death|1|||
105880487|NCT02887183|365215476|FG000|Overall Study|Protocol Violation|6|||
105880488|NCT02887183|365215476|FG000|Overall Study|Technical Problems|2|||
105880489|NCT02887183|365215476|FG000|Overall Study|Lost to Follow-up|13|||
105880490|NCT02887183|365215476|FG000|Overall Study|Physician Decision|10|||
105880491|NCT02887183|365215476|FG000|Overall Study|Withdrawal by Subject|35|||
105880492|NCT01031680|365215477|FG000|Overall Study|Adverse Event|8|||
105880493|NCT01031680|365215478|FG001|Overall Study|Adverse Event|3|||
106110567|NCT02563002|366060387|FG000|Overall Study|Death|72|||
106110568|NCT02563002|366060388|FG001|Overall Study|Death|87|||
105880494|NCT01031680|365215477|FG000|Overall Study|Lost to Follow-up|2|||
106110569|NCT02563002|366060387|FG000|Overall Study|Lost to Follow-up|5|||
106110570|NCT02563002|366060388|FG001|Overall Study|Lost to Follow-up|0|||
106110571|NCT02563002|366060387|FG000|Overall Study|Physician Decision|0|||
106110572|NCT02563002|366060388|FG001|Overall Study|Physician Decision|2|||
106110573|NCT02563002|366060387|FG000|Overall Study|Withdrawal by Subject|2|||
106110574|NCT02563002|366060388|FG001|Overall Study|Withdrawal by Subject|10|||
106110575|NCT02563002|366060387|FG000|Overall Study|Sponsor decision|74|||
106110576|NCT02563002|366060388|FG001|Overall Study|Sponsor decision|55|||
106110577|NCT01505387|366060391|FG000|Overall Study|Protocol Violation|1|||
106110578|NCT01505387|366060392|FG001|Overall Study|Protocol Violation|0|||
106110579|NCT01505387|366060391|FG000|Overall Study|Withdrawal by Subject|1|||
106110580|NCT01505387|366060392|FG001|Overall Study|Withdrawal by Subject|1|||
106110581|NCT01197508|366060394|FG000|Overall Study|Withdrawal by Subject|8|||
106110582|NCT01197508|366060395|FG001|Overall Study|Withdrawal by Subject|7|||
105880495|NCT01031680|365215478|FG001|Overall Study|Lost to Follow-up|10|||
105880496|NCT01031680|365215477|FG000|Overall Study|Withdrawal by Subject|12|||
105880497|NCT01031680|365215478|FG001|Overall Study|Withdrawal by Subject|16|||
105880498|NCT01031680|365215477|FG000|Overall Study|Death|2|||
105880499|NCT01031680|365215478|FG001|Overall Study|Death|1|||
105880500|NCT01031680|365215477|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
105880501|NCT01031680|365215478|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
105880502|NCT01031680|365215477|FG000|Overall Study|Poor/Non-compliance|5|||
105880503|NCT01031680|365215478|FG001|Overall Study|Poor/Non-compliance|6|||
105880504|NCT01031680|365215477|FG000|Overall Study|Safety|1|||
105880505|NCT01031680|365215478|FG001|Overall Study|Safety|0|||
105880506|NCT01031680|365215477|FG000|Overall Study|Incorrect Enrolment|1|||
105880507|NCT01031680|365215478|FG001|Overall Study|Incorrect Enrolment|2|||
105880508|NCT01031680|365215477|FG000|Overall Study|Administrative Reason by Sponsor|0|||
105880509|NCT01031680|365215478|FG001|Overall Study|Administrative Reason by Sponsor|1|||
105880510|NCT01031680|365215477|FG000|Overall Study|Various|0|||
105880511|NCT01031680|365215478|FG001|Overall Study|Various|2|||
105880512|NCT00961350|365215479|FG000|Overall Study|Adverse Event|18|||
105880513|NCT00961350|365215480|FG001|Overall Study|Adverse Event|33|||
105880514|NCT00961350|365215479|FG000|Overall Study|Withdrawal by Subject|10|||
105880515|NCT00961350|365215480|FG001|Overall Study|Withdrawal by Subject|10|||
106110583|NCT01197508|366060396|FG002|Overall Study|Withdrawal by Subject|15|||
106110584|NCT01197508|366060397|FG003|Overall Study|Withdrawal by Subject|4|||
106110585|NCT01197508|366060394|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
106110586|NCT01197508|366060395|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
105880516|NCT00961350|365215479|FG000|Overall Study|Lost to Follow-up|3|||
106110587|NCT01197508|366060396|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
105880517|NCT00961350|365215480|FG001|Overall Study|Lost to Follow-up|3|||
105880518|NCT00961350|365215479|FG000|Overall Study|Misc|16|||
105880519|NCT00961350|365215480|FG001|Overall Study|Misc|21|||
105880520|NCT02195869|365215484|FG000|Overall Study|cGVHD Progression|5|||
106110588|NCT01197508|366060397|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
106110589|NCT01197508|366060394|FG000|Overall Study|Adverse Event|10|||
106110590|NCT01197508|366060395|FG001|Overall Study|Adverse Event|13|||
106110591|NCT01197508|366060396|FG002|Overall Study|Adverse Event|23|||
106110592|NCT01197508|366060397|FG003|Overall Study|Adverse Event|3|||
105880521|NCT02195869|365215484|FG000|Overall Study|Malignancy Progression/relapse|2|||
105880522|NCT02195869|365215484|FG000|Overall Study|Adverse Event|15|||
105880523|NCT02195869|365215484|FG000|Overall Study|Withdrawal by Subject|7|||
105880524|NCT02195869|365215484|FG000|Overall Study|Physician Decision|4|||
106110593|NCT01197508|366060394|FG000|Overall Study|Severe non-compliance to protocol|0|||
105880525|NCT02195869|365215484|FG000|Overall Study|Study Terminated by Sponsor|7|||
105880526|NCT02195869|365215484|FG000|Overall Study|Noncompliance with study drug|2|||
105880527|NCT05336227|365217064|FG000|Overall Study|Adverse Event|1|||
105880528|NCT05336227|365217065|FG001|Overall Study|Adverse Event|0|||
105880529|NCT05336227|365217064|FG000|Overall Study|Lost to Follow-up|2|||
105880530|NCT05336227|365217065|FG001|Overall Study|Lost to Follow-up|0|||
105880531|NCT05336227|365217064|FG000|Overall Study|Withdrawal by Subject|1|||
105880532|NCT05336227|365217065|FG001|Overall Study|Withdrawal by Subject|0|||
105880533|NCT03058705|365217066|FG000|Overall Study|Withdrawal by Subject|2|||
105880534|NCT03058705|365217066|FG000|Overall Study|Physician Decision|2|||
105880535|NCT01682226|365217067|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
105880536|NCT01682226|365217067|FG000|Overall Study|Participants did not receive treatment|2|||
105880537|NCT01682226|365217067|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
105880538|NCT02640950|365217070|FG000|Overall Study|Adverse Event|1|||
105880539|NCT02640950|365217070|FG000|Overall Study|Withdrawal by Subject|1|||
105880540|NCT00356603|365217071|FG000|Overall Study|Other|6|||
105880541|NCT00356603|365217072|FG001|Overall Study|Other|3|||
105880542|NCT00154284|365217073|FG000|Overall Study|Adverse Event|6|||
105880543|NCT00154284|365217074|FG001|Overall Study|Adverse Event|9|||
105880544|NCT00154284|365217073|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105880545|NCT00154284|365217074|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105880546|NCT00154284|365217073|FG000|Overall Study|Lack of Efficacy|1|||
105880547|NCT00154284|365217074|FG001|Overall Study|Lack of Efficacy|2|||
105880548|NCT00154284|365217073|FG000|Overall Study|Protocol Violation|0|||
105880549|NCT00154284|365217074|FG001|Overall Study|Protocol Violation|1|||
105880550|NCT00326716|365217075|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
105880551|NCT00326716|365217076|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
105880552|NCT00326716|365217077|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
105880553|NCT00326716|365217078|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
105880554|NCT05253573|365217080|FG000|Overall Study|Death|1|||
105880555|NCT05253573|365217081|FG001|Overall Study|Death|0|||
105880556|NCT01568034|365217082|FG000|Overall Study|Withdrawal by Subject|1|||
105880557|NCT01568034|365217083|FG001|Overall Study|Withdrawal by Subject|0|||
105880558|NCT01568034|365217084|FG002|Overall Study|Withdrawal by Subject|0|||
105880559|NCT01568034|365217085|FG003|Overall Study|Withdrawal by Subject|0|||
105880560|NCT00728468|365217086|FG000|Overall Study|Enrolled but not treated|1|||
105880561|NCT00728468|365217086|FG000|Overall Study|Death|1|||
105880562|NCT00728468|365217086|FG000|Overall Study|Protocol Violation|4|||
105880563|NCT00728468|365217086|FG000|Overall Study|Objective progression or relapse|9|||
105880564|NCT00728468|365217086|FG000|Overall Study|Study terminated by sponsor|1|||
105880565|NCT01262287|365217087|FG000|Overall Study|Lost to Follow-up|2|||
105880566|NCT01262287|365217088|FG001|Overall Study|Lost to Follow-up|1|||
105880567|NCT06098339|365217089|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
105880568|NCT06098339|365217090|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
105880569|NCT06098339|365217089|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
105880570|NCT06098339|365217090|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
105880571|NCT01209949|365217091|FG000|Overall Study|Lost to Follow-up|3|||
105880572|NCT01436370|365217105|FG000|Overall Study|Lost to Follow-up|0|||
105880573|NCT01436370|365217106|FG001|Overall Study|Lost to Follow-up|0|||
106110594|NCT01197508|366060395|FG001|Overall Study|Severe non-compliance to protocol|3|||
106110595|NCT01197508|366060396|FG002|Overall Study|Severe non-compliance to protocol|1|||
106110596|NCT01197508|366060397|FG003|Overall Study|Severe non-compliance to protocol|3|||
106110597|NCT01197508|366060394|FG000|Overall Study|Condition under investigation worsened|1|||
106110598|NCT01197508|366060395|FG001|Overall Study|Condition under investigation worsened|1|||
106110599|NCT01197508|366060396|FG002|Overall Study|Condition under investigation worsened|1|||
106110600|NCT01197508|366060397|FG003|Overall Study|Condition under investigation worsened|1|||
106110601|NCT01197508|366060394|FG000|Overall Study|Lack of Efficacy|1|||
106110602|NCT01197508|366060395|FG001|Overall Study|Lack of Efficacy|2|||
106110603|NCT01197508|366060396|FG002|Overall Study|Lack of Efficacy|2|||
105880574|NCT01436370|365217107|FG002|Overall Study|Lost to Follow-up|0|||
105880575|NCT01436370|365217108|FG003|Overall Study|Lost to Follow-up|0|||
105880576|NCT01436370|365217109|FG004|Overall Study|Lost to Follow-up|1|||
105880577|NCT01436370|365217110|FG005|Overall Study|Lost to Follow-up|0|||
105880578|NCT01436370|365217111|FG006|Overall Study|Lost to Follow-up|0|||
105880579|NCT01436370|365217112|FG007|Overall Study|Lost to Follow-up|0|||
105880580|NCT02395848|365217113|FG000|Overall Study|Lost to Follow-up|2|||
106110604|NCT01197508|366060397|FG003|Overall Study|Lack of Efficacy|1|||
106110605|NCT01197508|366060394|FG000|Overall Study|Study-specific withdrawal criteria|0|||
106144090|NCT01317420|366186961|FG012|Overall Study|Other adverse event|2|||
105880581|NCT02276560|365217114|FG000|Overall Study|Adverse Event|1|||
105880582|NCT02276560|365217115|FG001|Overall Study|Adverse Event|0|||
105880583|NCT02276560|365217116|FG002|Overall Study|Adverse Event|0|||
105880584|NCT04134767|365217117|FG000|Overall Study|Death|0|||
105880585|NCT04134767|365217118|FG001|Overall Study|Death|1|||
105880586|NCT04134767|365217117|FG000|Overall Study|Removed for harassing staff|0|||
105880587|NCT04134767|365217118|FG001|Overall Study|Removed for harassing staff|1|||
105880588|NCT04134767|365217117|FG000|Overall Study|Lost to Follow-up|44|||
105880589|NCT04134767|365217118|FG001|Overall Study|Lost to Follow-up|40|||
105880590|NCT02582242|365217119|FG000|Overall Study|Adverse Event|4|||
105880591|NCT02582242|365217120|FG001|Overall Study|Adverse Event|3|||
105880592|NCT02582242|365217119|FG000|Overall Study|Protocol Violation|3|||
105880593|NCT02582242|365217120|FG001|Overall Study|Protocol Violation|1|||
105880594|NCT02582242|365217119|FG000|Overall Study|Lost to Follow-up|0|||
105880595|NCT02582242|365217120|FG001|Overall Study|Lost to Follow-up|1|||
105880596|NCT02582242|365217119|FG000|Overall Study|Withdrawal by Subject|11|||
105880597|NCT02582242|365217120|FG001|Overall Study|Withdrawal by Subject|11|||
105880598|NCT02582242|365217119|FG000|Overall Study|Unclassified|2|||
105880599|NCT02582242|365217120|FG001|Overall Study|Unclassified|1|||
105880600|NCT00300885|365217121|FG000|Treatment|Adverse Event|134|||
105880601|NCT00300885|365217122|FG001|Treatment|Adverse Event|82|||
105880602|NCT00300885|365217121|FG000|Treatment|Death|20|||
105880603|NCT00300885|365217122|FG001|Treatment|Death|7|||
105880604|NCT00300885|365217121|FG000|Treatment|Lack of Efficacy|1|||
105880605|NCT00300885|365217122|FG001|Treatment|Lack of Efficacy|1|||
105880606|NCT00300885|365217121|FG000|Treatment|Lost to Follow-up|3|||
105880607|NCT00300885|365217122|FG001|Treatment|Lost to Follow-up|2|||
105880608|NCT00300885|365217121|FG000|Treatment|Physician Decision|4|||
105880609|NCT00300885|365217122|FG001|Treatment|Physician Decision|5|||
105880610|NCT00300885|365217121|FG000|Treatment|Protocol Violation|11|||
105880611|NCT00300885|365217122|FG001|Treatment|Protocol Violation|11|||
105880612|NCT00300885|365217121|FG000|Treatment|Withdrawal by Subject|26|||
105880613|NCT00300885|365217122|FG001|Treatment|Withdrawal by Subject|23|||
105880614|NCT00300885|365217121|FG000|Treatment|Disease progression|171|||
105880615|NCT00300885|365217122|FG001|Treatment|Disease progression|238|||
105880616|NCT00300885|365217121|FG000|Treatment|Random code broken (subject died)|0|||
105880617|NCT00300885|365217122|FG001|Treatment|Random code broken (subject died)|1|||
105880618|NCT00300885|365217121|FG000|Treatment|Non-compliant with study medication|3|||
105880619|NCT00300885|365217122|FG001|Treatment|Non-compliant with study medication|4|||
105880620|NCT00300885|365217121|FG000|Follow-up|Death|141|||
105880621|NCT00300885|365217122|FG001|Follow-up|Death|163|||
105880622|NCT00300885|365217121|FG000|Follow-up|Lost to Follow-up|11|||
105880623|NCT00300885|365217122|FG001|Follow-up|Lost to Follow-up|7|||
105880624|NCT00300885|365217121|FG000|Follow-up|Withdrawal by Subject|26|||
105880625|NCT00300885|365217122|FG001|Follow-up|Withdrawal by Subject|25|||
105880626|NCT01780038|365217127|FG000|Overall Study|Lost to Follow-up|4|||
105880627|NCT01780038|365217128|FG001|Overall Study|Lost to Follow-up|1|||
106110606|NCT01197508|366060395|FG001|Overall Study|Study-specific withdrawal criteria|0|||
106110607|NCT01197508|366060396|FG002|Overall Study|Study-specific withdrawal criteria|1|||
106110608|NCT01197508|366060397|FG003|Overall Study|Study-specific withdrawal criteria|2|||
106110609|NCT01197508|366060394|FG000|Overall Study|Lost to Follow-up|1|||
106110610|NCT01197508|366060395|FG001|Overall Study|Lost to Follow-up|1|||
106110611|NCT01197508|366060396|FG002|Overall Study|Lost to Follow-up|2|||
106110612|NCT01197508|366060397|FG003|Overall Study|Lost to Follow-up|0|||
106110613|NCT01197508|366060394|FG000|Overall Study|Other|2|||
106110614|NCT01197508|366060395|FG001|Overall Study|Other|3|||
106110615|NCT01197508|366060396|FG002|Overall Study|Other|2|||
106110616|NCT01197508|366060397|FG003|Overall Study|Other|2|||
106110617|NCT04067401|366060401|FG000|Overall Study|Withdrawal by Subject|7|||
106110618|NCT04067401|366060402|FG001|Overall Study|Withdrawal by Subject|0|||
106110619|NCT04067401|366060401|FG000|Overall Study|no data provided|1|||
106110620|NCT04067401|366060402|FG001|Overall Study|no data provided|0|||
106110621|NCT00595504|366060403|FG000|Overall Study|Withdrawal by Subject|1|||
106110622|NCT00595504|366060404|FG001|Overall Study|Withdrawal by Subject|3|||
106110623|NCT00595504|366060403|FG000|Overall Study|Physician Decision|1|||
105880628|NCT03168711|365217134|FG000|Overall Study|Adverse Event|2|||
105880629|NCT03168711|365217135|FG001|Overall Study|Adverse Event|0|||
105880630|NCT03168711|365217134|FG000|Overall Study|Withdrawal by Subject|0|||
106110624|NCT00595504|366060404|FG001|Overall Study|Physician Decision|0|||
105880631|NCT03168711|365217135|FG001|Overall Study|Withdrawal by Subject|1|||
105880632|NCT03168711|365217134|FG000|Overall Study|Death|0|||
105880633|NCT03168711|365217135|FG001|Overall Study|Death|1|||
105880634|NCT00687271|365217136|FG000|Overall Study|Adverse Event|1|||
105880635|NCT00687271|365217137|FG001|Overall Study|Adverse Event|3|||
105880636|NCT00687271|365217138|FG002|Overall Study|Adverse Event|1|||
106110625|NCT01477853|366060406|FG000|Phase A|Adverse Event|1|||
105880637|NCT00687271|365217139|FG003|Overall Study|Adverse Event|0|||
105880638|NCT00687271|365217136|FG000|Overall Study|Lost to Follow-up|0|||
105880639|NCT00687271|365217137|FG001|Overall Study|Lost to Follow-up|1|||
105880640|NCT00687271|365217138|FG002|Overall Study|Lost to Follow-up|0|||
106110626|NCT01477853|366060407|FG001|Phase A|Adverse Event|2|||
105880641|NCT00687271|365217139|FG003|Overall Study|Lost to Follow-up|0|||
105880642|NCT00687271|365217136|FG000|Overall Study|Protocol Violation|2|||
105880643|NCT00687271|365217137|FG001|Overall Study|Protocol Violation|1|||
105880644|NCT00687271|365217138|FG002|Overall Study|Protocol Violation|1|||
105880645|NCT00687271|365217139|FG003|Overall Study|Protocol Violation|0|||
105880646|NCT00687271|365217136|FG000|Overall Study|Withdrawal by Subject|0|||
106110627|NCT01477853|366060408|FG002|Phase A|Adverse Event|2|||
106110628|NCT01477853|366060406|FG000|Phase A|Lost to Follow-up|4|||
106110629|NCT01477853|366060407|FG001|Phase A|Lost to Follow-up|3|||
106110630|NCT01477853|366060408|FG002|Phase A|Lost to Follow-up|2|||
106110631|NCT01477853|366060406|FG000|Phase A|Physician Decision|1|||
106110632|NCT01477853|366060407|FG001|Phase A|Physician Decision|0|||
106110633|NCT01477853|366060408|FG002|Phase A|Physician Decision|1|||
106110634|NCT01477853|366060406|FG000|Phase A|Study terminated by sponsor|37|||
106110635|NCT01477853|366060407|FG001|Phase A|Study terminated by sponsor|40|||
106110636|NCT01477853|366060408|FG002|Phase A|Study terminated by sponsor|39|||
106110637|NCT01477853|366060406|FG000|Phase B|Lost to Follow-up|0|||
106110638|NCT01477853|366060407|FG001|Phase B|Lost to Follow-up|1|||
106110639|NCT01477853|366060408|FG002|Phase B|Lost to Follow-up|0|||
106110640|NCT01477853|366060406|FG000|Phase B|Study terminated by sponsor|12|||
106110641|NCT01477853|366060407|FG001|Phase B|Study terminated by sponsor|10|||
106110642|NCT01477853|366060408|FG002|Phase B|Study terminated by sponsor|11|||
106110643|NCT00948974|366060420|FG000|Overall Study|Lost to Follow-up|23|||
106110644|NCT00948974|366060421|FG001|Overall Study|Lost to Follow-up|20|||
106110645|NCT01113502|366060425|FG000|Overall Study|Withdrawal by Subject|1|||
106110646|NCT01113502|366060426|FG001|Overall Study|Withdrawal by Subject|0|||
106110647|NCT01113502|366060427|FG002|Overall Study|Withdrawal by Subject|1|||
106110648|NCT01113502|366060428|FG003|Overall Study|Withdrawal by Subject|1|||
106110649|NCT01113502|366060429|FG004|Overall Study|Withdrawal by Subject|0|||
106110650|NCT01113502|366060425|FG000|Overall Study|Adverse Event|0|||
106110651|NCT01113502|366060426|FG001|Overall Study|Adverse Event|0|||
106110652|NCT01113502|366060427|FG002|Overall Study|Adverse Event|3|||
106110653|NCT01113502|366060428|FG003|Overall Study|Adverse Event|2|||
106110654|NCT01113502|366060429|FG004|Overall Study|Adverse Event|0|||
106110655|NCT00118716|366060430|FG000|Overall Study|Adverse Event|2|||
106110656|NCT00118716|366060431|FG001|Overall Study|Adverse Event|7|||
106110657|NCT00118716|366060430|FG000|Overall Study|Protocol Violation|5|||
106110658|NCT00118716|366060431|FG001|Overall Study|Protocol Violation|4|||
106110659|NCT00118716|366060430|FG000|Overall Study|Withdrawal by Subject|0|||
106110660|NCT00118716|366060431|FG001|Overall Study|Withdrawal by Subject|1|||
106110661|NCT00118716|366060430|FG000|Overall Study|Exacerbation|2|||
106110662|NCT00118716|366060431|FG001|Overall Study|Exacerbation|2|||
106110663|NCT00118716|366060430|FG000|Overall Study|Discontinued by sponsor|1|||
106110664|NCT00118716|366060431|FG001|Overall Study|Discontinued by sponsor|1|||
106110665|NCT00118716|366060430|FG000|Overall Study|Non-compliance|1|||
106110666|NCT00118716|366060431|FG001|Overall Study|Non-compliance|3|||
106110667|NCT00118716|366060430|FG000|Overall Study|misrandomized|1|||
106110668|NCT00118716|366060431|FG001|Overall Study|misrandomized|1|||
106110669|NCT00118716|366060430|FG000|Overall Study|Expired drug use|1|||
106110670|NCT00118716|366060431|FG001|Overall Study|Expired drug use|2|||
106110671|NCT00118716|366060430|FG000|Overall Study|Investigator discretion|0|||
106110672|NCT00118716|366060431|FG001|Overall Study|Investigator discretion|1|||
106110673|NCT01445652|366060432|FG000|Overall Study|Not comfortable in lenses|5|||
106110674|NCT01445652|366060433|FG001|Overall Study|Not comfortable in lenses|0|||
106110675|NCT01445652|366060432|FG000|Overall Study|Failed to attend scheduled visit|2|||
106110676|NCT01445652|366060433|FG001|Overall Study|Failed to attend scheduled visit|3|||
106110677|NCT01445652|366060432|FG000|Overall Study|Failed teach session|2|||
106110678|NCT01445652|366060433|FG001|Overall Study|Failed teach session|0|||
106110679|NCT01445652|366060432|FG000|Overall Study|Adverse Event|1|||
106110680|NCT01445652|366060433|FG001|Overall Study|Adverse Event|0|||
105880647|NCT00687271|365217137|FG001|Overall Study|Withdrawal by Subject|1|||
105880648|NCT00687271|365217138|FG002|Overall Study|Withdrawal by Subject|3|||
106110681|NCT00454571|366060442|FG000|Overall Study|Adverse Event|2|||
105880649|NCT00687271|365217139|FG003|Overall Study|Withdrawal by Subject|0|||
106110682|NCT00454571|366060443|FG001|Overall Study|Adverse Event|0|||
106110683|NCT00454571|366060442|FG000|Overall Study|Physician Decision|0|||
106110684|NCT00454571|366060443|FG001|Overall Study|Physician Decision|1|||
106110685|NCT00454571|366060442|FG000|Overall Study|Protocol Violation|1|||
106110686|NCT00454571|366060443|FG001|Overall Study|Protocol Violation|0|||
106110687|NCT00454571|366060442|FG000|Overall Study|Withdrawal by Subject|10|||
106110688|NCT00454571|366060443|FG001|Overall Study|Withdrawal by Subject|5|||
106110689|NCT03595332|366060444|FG000|Overall Study|Lost to Follow-up|16|||
106110690|NCT03595332|366060445|FG001|Overall Study|Lost to Follow-up|22|||
105880650|NCT01134107|365217140|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
106110691|NCT03595332|366060444|FG000|Overall Study|Unable to retrieve ID from school|0|||
105880651|NCT01134107|365217141|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
106110692|NCT03595332|366060445|FG001|Overall Study|Unable to retrieve ID from school|2|||
106110693|NCT02227875|366060446|FG000|Overall Study|Protocol Violation|10|||
106110694|NCT02227875|366060447|FG001|Overall Study|Protocol Violation|7|||
106110695|NCT02227875|366060446|FG000|Overall Study|Other|1|||
106110696|NCT02227875|366060447|FG001|Overall Study|Other|3|||
106110697|NCT02227875|366060446|FG000|Overall Study|Physician Decision|1|||
106110698|NCT02227875|366060447|FG001|Overall Study|Physician Decision|0|||
106110699|NCT02227875|366060446|FG000|Overall Study|Adverse Event|3|||
106110700|NCT02227875|366060447|FG001|Overall Study|Adverse Event|0|||
106110701|NCT02227875|366060446|FG000|Overall Study|Withdrawal by Subject|12|||
106110702|NCT02227875|366060447|FG001|Overall Study|Withdrawal by Subject|13|||
106110703|NCT02227875|366060446|FG000|Overall Study|Lost to Follow-up|10|||
106110704|NCT02227875|366060447|FG001|Overall Study|Lost to Follow-up|10|||
106110705|NCT04209725|366060448|FG000|Overall Study|Adverse Event|1|||
106110706|NCT02856113|366060449|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
106110707|NCT02856113|366060450|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
106110708|NCT02856113|366060449|FG000|Overall Study|Significant Protocol Deviation|1|||
106110709|NCT02856113|366060450|FG001|Overall Study|Significant Protocol Deviation|0|||
106110710|NCT02856113|366060449|FG000|Overall Study|Lost to Follow-up|3|||
106110711|NCT02856113|366060450|FG001|Overall Study|Lost to Follow-up|5|||
106110712|NCT02856113|366060449|FG000|Overall Study|Voluntary Withdrawal|3|||
106110713|NCT02856113|366060450|FG001|Overall Study|Voluntary Withdrawal|5|||
106110714|NCT02856113|366060449|FG000|Overall Study|Pregnancy|0|||
106110715|NCT02856113|366060450|FG001|Overall Study|Pregnancy|1|||
106110716|NCT02856113|366060449|FG000|Overall Study|Principal Investigator Discretion|2|||
106110717|NCT02856113|366060450|FG001|Overall Study|Principal Investigator Discretion|1|||
106110718|NCT02856113|366060449|FG000|Overall Study|Randomized but not Treated|1|||
106110719|NCT02856113|366060450|FG001|Overall Study|Randomized but not Treated|0|||
106110720|NCT02856113|366060449|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
106110721|NCT02856113|366060450|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
106110722|NCT02857426|366060451|FG000|Overall Study|Disease progression|34|||
106110723|NCT02857426|366060452|FG001|Overall Study|Disease progression|13|||
106110724|NCT02857426|366060451|FG000|Overall Study|Study drug toxicity|4|||
106110725|NCT02857426|366060452|FG001|Overall Study|Study drug toxicity|1|||
106110726|NCT02857426|366060451|FG000|Overall Study|Death|1|||
106110727|NCT02857426|366060452|FG001|Overall Study|Death|0|||
106110728|NCT02857426|366060451|FG000|Overall Study|Adverse event unrelated to study drug|6|||
106110729|NCT02857426|366060452|FG001|Overall Study|Adverse event unrelated to study drug|2|||
106110730|NCT02857426|366060451|FG000|Overall Study|Participant withdrew consent|1|||
106110731|NCT02857426|366060452|FG001|Overall Study|Participant withdrew consent|1|||
106110732|NCT02857426|366060451|FG000|Overall Study|Maximum clinical benefit|1|||
106110733|NCT02857426|366060452|FG001|Overall Study|Maximum clinical benefit|0|||
106110734|NCT02857426|366060451|FG000|Overall Study|Completed treatment|0|||
106110735|NCT02857426|366060452|FG001|Overall Study|Completed treatment|2|||
106110736|NCT04252742|366060455|FG000|Overall Study|Decision by sponsor|0|||
106110737|NCT04252742|366060456|FG001|Overall Study|Decision by sponsor|2|||
106110738|NCT04252742|366060455|FG000|Overall Study|Withdrawal by Subject|15|||
106110739|NCT04252742|366060456|FG001|Overall Study|Withdrawal by Subject|9|||
106110740|NCT04252742|366060455|FG000|Overall Study|Lost to Follow-up|0|||
106110741|NCT04252742|366060456|FG001|Overall Study|Lost to Follow-up|1|||
106110742|NCT03185481|366060457|FG000|Overall Study|Adverse Event|1|||
106110743|NCT03185481|366060457|FG000|Overall Study|Study Terminated by Sponsor|4|||
106110744|NCT00504426|366060460|FG000|Overall Study|Adverse Event|0|||
106110745|NCT00504426|366060461|FG001|Overall Study|Adverse Event|0|||
106110746|NCT00504426|366060462|FG002|Overall Study|Adverse Event|2|||
106110747|NCT00504426|366060463|FG003|Overall Study|Adverse Event|0|||
106110748|NCT00504426|366060460|FG000|Overall Study|Protocol Violation|1|||
106110749|NCT00504426|366060461|FG001|Overall Study|Protocol Violation|1|||
106110750|NCT00504426|366060462|FG002|Overall Study|Protocol Violation|2|||
106110751|NCT00504426|366060463|FG003|Overall Study|Protocol Violation|0|||
106110752|NCT00504426|366060460|FG000|Overall Study|Withdrawal by Subject|2|||
106110753|NCT00504426|366060461|FG001|Overall Study|Withdrawal by Subject|0|||
106110754|NCT00504426|366060462|FG002|Overall Study|Withdrawal by Subject|0|||
106110755|NCT00504426|366060463|FG003|Overall Study|Withdrawal by Subject|0|||
106110756|NCT00168038|366060467|FG000|Overall Study|Adverse Event|1|||
106110757|NCT00168038|366060467|FG000|Overall Study|Therapy failure|1|||
106110758|NCT02703922|366060476|FG000|Overall Study|Death|5|||
106110759|NCT02703922|366060477|FG001|Overall Study|Death|8|||
106110760|NCT02703922|366060476|FG000|Overall Study|Lost to Follow-up|10|||
106110761|NCT02703922|366060477|FG001|Overall Study|Lost to Follow-up|10|||
106110762|NCT00394355|366060478|FG000|Overall Study|Adverse Event|10|||
106110763|NCT00394355|366060479|FG001|Overall Study|Adverse Event|6|||
106110764|NCT00394355|366060480|FG002|Overall Study|Adverse Event|7|||
106110765|NCT00394355|366060481|FG003|Overall Study|Adverse Event|8|||
106110766|NCT00394355|366060478|FG000|Overall Study|Did not meet protocol eligibility|1|||
106110767|NCT00394355|366060479|FG001|Overall Study|Did not meet protocol eligibility|5|||
106110768|NCT00394355|366060480|FG002|Overall Study|Did not meet protocol eligibility|4|||
106110769|NCT00394355|366060481|FG003|Overall Study|Did not meet protocol eligibility|2|||
106110770|NCT00394355|366060478|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
105880652|NCT01134107|365217140|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
105880653|NCT01134107|365217141|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
105880654|NCT01134107|365217140|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
105880655|NCT01134107|365217141|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
105880656|NCT01134107|365217140|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
105880657|NCT01134107|365217141|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
105880658|NCT01134107|365217140|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
105880659|NCT01134107|365217141|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
105880660|NCT01134107|365217140|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
105880661|NCT01134107|365217141|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
105880662|NCT01134107|365217140|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
105880663|NCT01134107|365217141|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
105880664|NCT03656692|365217142|FG000|Overall Study|Worsening of disease activity|2|||
105880665|NCT03656692|365217142|FG000|Overall Study|Physician Decision|1|||
105880666|NCT02877004|365217152|FG000|Overall Study|Pregnancy|0|||
105880667|NCT02877004|365217153|FG001|Overall Study|Pregnancy|0|||
105880668|NCT02877004|365217154|FG002|Overall Study|Pregnancy|1|||
105880669|NCT02727478|365217155|FG000|Overall Study|Withdrawal by Subject|8|||
105880670|NCT02727478|365217156|FG001|Overall Study|Withdrawal by Subject|10|||
105880671|NCT02633293|365217157|FG000|Overall Study|Death|56|||
105880672|NCT02633293|365217157|FG000|Overall Study|Progressive Disease|12|||
105880673|NCT02633293|365217157|FG000|Overall Study|Adverse Event|29|||
105880674|NCT02633293|365217157|FG000|Overall Study|Withdrawal by Subject|41|||
105880675|NCT02633293|365217157|FG000|Overall Study|Protocol Violation|1|||
105880676|NCT02633293|365217157|FG000|Overall Study|Lost to Follow-up|1|||
105880677|NCT02633293|365217157|FG000|Overall Study|Study Terminated by Sponsor|24|||
105880678|NCT02633293|365217157|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
105880679|NCT02633293|365217157|FG000|Overall Study|Lung Transplant|5|||
105880680|NCT02633293|365217157|FG000|Overall Study|Lack of Efficacy|2|||
105880681|NCT02633293|365217157|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
105880682|NCT03877068|365217158|FG000|Overall Study|Physician Decision|9|||
105880683|NCT03877068|365217159|FG001|Overall Study|Physician Decision|3|||
105880684|NCT02509507|365217160|FG000|Overall Study|Death|21|||
105880685|NCT02509507|365217161|FG001|Overall Study|Death|3|||
105880686|NCT02509507|365217162|FG002|Overall Study|Death|22|||
105880687|NCT02509507|365217163|FG003|Overall Study|Death|14|||
105880688|NCT02509507|365217164|FG004|Overall Study|Death|8|||
105880689|NCT02509507|365217165|FG005|Overall Study|Death|12|||
105880690|NCT02509507|365217166|FG006|Overall Study|Death|5|||
105880691|NCT02509507|365217167|FG007|Overall Study|Death|4|||
105880692|NCT02509507|365217168|FG008|Overall Study|Death|8|||
105880693|NCT02509507|365217160|FG000|Overall Study|Lost to Follow-up|0|||
105880694|NCT02509507|365217161|FG001|Overall Study|Lost to Follow-up|1|||
105880695|NCT02509507|365217162|FG002|Overall Study|Lost to Follow-up|0|||
105880696|NCT02509507|365217163|FG003|Overall Study|Lost to Follow-up|0|||
106110771|NCT00394355|366060479|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
106110772|NCT00394355|366060480|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
106110773|NCT00394355|366060481|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
106110774|NCT00394355|366060478|FG000|Overall Study|Subject withdrawal - related to drug|1|||
106110775|NCT00394355|366060479|FG001|Overall Study|Subject withdrawal - related to drug|0|||
106110776|NCT00394355|366060480|FG002|Overall Study|Subject withdrawal - related to drug|0|||
106110777|NCT00394355|366060481|FG003|Overall Study|Subject withdrawal - related to drug|0|||
106110778|NCT00394355|366060478|FG000|Overall Study|Lost to Follow-up|7|||
106110779|NCT00394355|366060479|FG001|Overall Study|Lost to Follow-up|5|||
106110780|NCT00394355|366060480|FG002|Overall Study|Lost to Follow-up|4|||
106110781|NCT00394355|366060481|FG003|Overall Study|Lost to Follow-up|3|||
106110782|NCT00394355|366060478|FG000|Overall Study|Noncompliance with protocol|4|||
106110783|NCT00394355|366060479|FG001|Overall Study|Noncompliance with protocol|3|||
106110784|NCT00394355|366060480|FG002|Overall Study|Noncompliance with protocol|10|||
106110785|NCT00394355|366060481|FG003|Overall Study|Noncompliance with protocol|8|||
106110786|NCT00394355|366060478|FG000|Overall Study|Administrative|0|||
106110787|NCT00394355|366060479|FG001|Overall Study|Administrative|1|||
105880697|NCT02509507|365217164|FG004|Overall Study|Lost to Follow-up|0|||
105880698|NCT02509507|365217165|FG005|Overall Study|Lost to Follow-up|2|||
105880699|NCT02509507|365217166|FG006|Overall Study|Lost to Follow-up|0|||
105880700|NCT02509507|365217167|FG007|Overall Study|Lost to Follow-up|0|||
105880701|NCT02509507|365217168|FG008|Overall Study|Lost to Follow-up|0|||
105880702|NCT02509507|365217160|FG000|Overall Study|Withdrawal by Subject|2|||
105880703|NCT02509507|365217161|FG001|Overall Study|Withdrawal by Subject|0|||
105880704|NCT02509507|365217162|FG002|Overall Study|Withdrawal by Subject|1|||
105880705|NCT02509507|365217163|FG003|Overall Study|Withdrawal by Subject|4|||
105880706|NCT02509507|365217164|FG004|Overall Study|Withdrawal by Subject|1|||
105880707|NCT02509507|365217165|FG005|Overall Study|Withdrawal by Subject|3|||
105880708|NCT02509507|365217166|FG006|Overall Study|Withdrawal by Subject|4|||
106110788|NCT00394355|366060480|FG002|Overall Study|Administrative|1|||
106110789|NCT00394355|366060481|FG003|Overall Study|Administrative|1|||
106110790|NCT00394355|366060478|FG000|Overall Study|Lack of Efficacy|0|||
106110791|NCT00394355|366060479|FG001|Overall Study|Lack of Efficacy|0|||
106110792|NCT00394355|366060480|FG002|Overall Study|Lack of Efficacy|2|||
106110793|NCT00394355|366060481|FG003|Overall Study|Lack of Efficacy|3|||
106110794|NCT02612064|366060484|FG000|Overall Study|Withdrawal by Subject|1|||
106110795|NCT02612064|366060485|FG001|Overall Study|Withdrawal by Subject|1|||
106110796|NCT02612064|366060484|FG000|Overall Study|Other|0|||
106110797|NCT02612064|366060485|FG001|Overall Study|Other|2|||
106110798|NCT01648348|366060486|FG000|Overall Study|Cancel|1|||
106110799|NCT01648348|366060487|FG001|Overall Study|Cancel|0|||
106110800|NCT01648348|366060488|FG002|Overall Study|Cancel|0|||
106110801|NCT01648348|366060489|FG003|Overall Study|Cancel|0|||
106110802|NCT01648348|366060490|FG004|Overall Study|Cancel|3|||
106110803|NCT01648348|366060491|FG005|Overall Study|Cancel|6|||
106110804|NCT01648348|366060486|FG000|Overall Study|Replaced for MTD analysis|1|||
106110805|NCT01648348|366060487|FG001|Overall Study|Replaced for MTD analysis|0|||
106110806|NCT01648348|366060488|FG002|Overall Study|Replaced for MTD analysis|1|||
106110807|NCT01648348|366060489|FG003|Overall Study|Replaced for MTD analysis|0|||
106110808|NCT01648348|366060490|FG004|Overall Study|Replaced for MTD analysis|0|||
106110809|NCT01648348|366060491|FG005|Overall Study|Replaced for MTD analysis|0|||
106110810|NCT01669798|366060492|FG000|Overall Study|Physician Decision|5|||
106110811|NCT01120249|366060494|FG000|Overall Study|No protocol treatment received|21|||
106110812|NCT01120249|366060495|FG001|Overall Study|No protocol treatment received|15|||
106110813|NCT01120249|366060494|FG000|Overall Study|Disease recurrence|107|||
106110814|NCT01120249|366060495|FG001|Overall Study|Disease recurrence|57|||
106110815|NCT01120249|366060494|FG000|Overall Study|Death|1|||
106110816|NCT01120249|366060495|FG001|Overall Study|Death|0|||
106110817|NCT01120249|366060494|FG000|Overall Study|Adverse Event|40|||
106110818|NCT01120249|366060495|FG001|Overall Study|Adverse Event|276|||
106110819|NCT01120249|366060494|FG000|Overall Study|Participant refusal|34|||
106110820|NCT01120249|366060495|FG001|Overall Study|Participant refusal|42|||
106110821|NCT01120249|366060494|FG000|Overall Study|Other reasons, not protocol specified|29|||
106110822|NCT01120249|366060495|FG001|Overall Study|Other reasons, not protocol specified|22|||
106110823|NCT00717860|366060496|FG000|Overall Study|Clinical adverse experience|5|||
106110824|NCT00717860|366060497|FG001|Overall Study|Clinical adverse experience|9|||
106110825|NCT00717860|366060496|FG000|Overall Study|Laboratory adverse experience|2|||
106110826|NCT00717860|366060497|FG001|Overall Study|Laboratory adverse experience|2|||
106110827|NCT00717860|366060496|FG000|Overall Study|Lack of Efficacy|7|||
106110828|NCT00717860|366060497|FG001|Overall Study|Lack of Efficacy|13|||
106110829|NCT00717860|366060496|FG000|Overall Study|Discontinued for other reason|6|||
106110830|NCT00717860|366060497|FG001|Overall Study|Discontinued for other reason|1|||
106110831|NCT00717860|366060496|FG000|Overall Study|Withdrew consent|7|||
106110832|NCT00717860|366060497|FG001|Overall Study|Withdrew consent|3|||
106110833|NCT00558064|366060502|FG000|Overall Study|Adverse Event|3|||
106110834|NCT00558064|366060503|FG001|Overall Study|Adverse Event|2|||
106110835|NCT00558064|366060502|FG000|Overall Study|Lack of Efficacy|0|||
106110836|NCT00558064|366060503|FG001|Overall Study|Lack of Efficacy|1|||
106110837|NCT00558064|366060502|FG000|Overall Study|Protocol Violation|1|||
106110838|NCT00558064|366060503|FG001|Overall Study|Protocol Violation|0|||
106110839|NCT00558064|366060502|FG000|Overall Study|Lost to Follow-up|0|||
106110840|NCT00558064|366060503|FG001|Overall Study|Lost to Follow-up|1|||
106110841|NCT00558064|366060502|FG000|Overall Study|Withdrawal by Subject|0|||
106110842|NCT00558064|366060503|FG001|Overall Study|Withdrawal by Subject|1|||
106110843|NCT00558064|366060502|FG000|Overall Study|No visit within allowance period|1|||
106110844|NCT00558064|366060503|FG001|Overall Study|No visit within allowance period|0|||
106110845|NCT03391765|366061940|FG000|Overall Study|Adverse Event|2|||
106110846|NCT03391765|366061941|FG001|Overall Study|Adverse Event|0|||
106110847|NCT03391765|366061942|FG002|Overall Study|Adverse Event|0|||
106110848|NCT03391765|366061943|FG003|Overall Study|Adverse Event|2|||
106110849|NCT03391765|366061940|FG000|Overall Study|Withdrew consent|5|||
106110850|NCT03391765|366061941|FG001|Overall Study|Withdrew consent|7|||
106110851|NCT03391765|366061942|FG002|Overall Study|Withdrew consent|2|||
106110852|NCT03391765|366061943|FG003|Overall Study|Withdrew consent|5|||
106110853|NCT03391765|366061940|FG000|Overall Study|Other, not specified|44|||
106110854|NCT03391765|366061941|FG001|Overall Study|Other, not specified|38|||
106110855|NCT03391765|366061942|FG002|Overall Study|Other, not specified|21|||
106110856|NCT03391765|366061943|FG003|Overall Study|Other, not specified|16|||
106110857|NCT02832622|366061948|FG000|Overall Study|MPP not programmed|1259|||
106110858|NCT02832622|366061948|FG000|Overall Study|Withdrawal by Subject|123|||
106110859|NCT02832622|366061948|FG000|Overall Study|Death|119|||
106110860|NCT02832622|366061948|FG000|Overall Study|Unsuccessful CRT implant|93|||
106110861|NCT02832622|366061948|FG000|Overall Study|Lost to Follow-up|45|||
106110862|NCT02832622|366061948|FG000|Overall Study|Patient non-compliance|42|||
106110863|NCT02832622|366061948|FG000|Overall Study|Withdrawal by other reasons|25|||
106110864|NCT02832622|366061948|FG000|Overall Study|System explant|24|||
106110865|NCT02832622|366061948|FG000|Overall Study|Physician Decision|6|||
106110866|NCT02243280|366061949|FG000|Treated|Adverse Event|1|||
106110867|NCT02243280|366061950|FG001|Treated|Adverse Event|0|||
105880709|NCT02509507|365217167|FG007|Overall Study|Withdrawal by Subject|0|||
105880710|NCT02509507|365217168|FG008|Overall Study|Withdrawal by Subject|1|||
105880711|NCT02356588|365217169|FG000|Overall Study|Lack of Efficacy|4|||
105880712|NCT02356588|365217170|FG001|Overall Study|Lack of Efficacy|10|||
105880713|NCT02356588|365217169|FG000|Overall Study|Adverse Event|0|||
105880714|NCT02356588|365217170|FG001|Overall Study|Adverse Event|2|||
105880715|NCT02356588|365217169|FG000|Overall Study|Withdrawal by Subject|1|||
105880716|NCT02356588|365217170|FG001|Overall Study|Withdrawal by Subject|0|||
105880717|NCT02356588|365217169|FG000|Overall Study|Protocol Violation|0|||
105880718|NCT02356588|365217170|FG001|Overall Study|Protocol Violation|1|||
105880719|NCT01418378|365217171|FG000|Overall Study|Death|1|||
105880720|NCT01418378|365217172|FG001|Overall Study|Death|2|||
105880721|NCT01418378|365217171|FG000|Overall Study|Physician Decision|0|||
105880722|NCT01418378|365217172|FG001|Overall Study|Physician Decision|1|||
105880723|NCT01418378|365217171|FG000|Overall Study|ligament imbalance|0|||
105880724|NCT01418378|365217172|FG001|Overall Study|ligament imbalance|1|||
105880725|NCT01418378|365217171|FG000|Overall Study|developed chronic myopathy|0|||
105880726|NCT01418378|365217172|FG001|Overall Study|developed chronic myopathy|1|||
105880727|NCT00461630|365217178|FG000|Overall Study|Death|798|||
105880728|NCT00461630|365217179|FG001|Overall Study|Death|732|||
105880729|NCT00461630|365217178|FG000|Overall Study|Lost to Follow-up|108|||
105880730|NCT00461630|365217179|FG001|Overall Study|Lost to Follow-up|95|||
105880731|NCT00839800|365217181|FG000|Overall Study|Adverse Event|8|||
105880732|NCT00839800|365217182|FG001|Overall Study|Adverse Event|12|||
105880733|NCT00839800|365217181|FG000|Overall Study|Lost to Follow-up|31|||
105880734|NCT00839800|365217182|FG001|Overall Study|Lost to Follow-up|26|||
105880735|NCT00839800|365217181|FG000|Overall Study|Withdrawal by Subject|28|||
105880736|NCT00839800|365217182|FG001|Overall Study|Withdrawal by Subject|34|||
105880737|NCT00839800|365217181|FG000|Overall Study|Incorrect Enrolment|3|||
105880738|NCT00839800|365217182|FG001|Overall Study|Incorrect Enrolment|3|||
105880739|NCT00839800|365217181|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
105880740|NCT00839800|365217182|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
105880741|NCT00839800|365217181|FG000|Overall Study|Safety Reasons|2|||
105880742|NCT00839800|365217182|FG001|Overall Study|Safety Reasons|1|||
105880743|NCT00839800|365217181|FG000|Overall Study|Other|8|||
105880744|NCT00839800|365217182|FG001|Overall Study|Other|14|||
105880745|NCT00839800|365217181|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
105880746|NCT00839800|365217182|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
105880747|NCT02510664|365217183|FG000|Overall Study|Transferred Care|9|||
105880748|NCT02510664|365217184|FG001|Overall Study|Transferred Care|9|||
105880749|NCT02510664|365217185|FG002|Overall Study|Transferred Care|0|||
105880750|NCT02510664|365217183|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
105880751|NCT02510664|365217184|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
105880752|NCT02510664|365217185|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
105880753|NCT02510664|365217183|FG000|Overall Study|Time Constraints|1|||
105880754|NCT02510664|365217184|FG001|Overall Study|Time Constraints|1|||
105880755|NCT02510664|365217185|FG002|Overall Study|Time Constraints|0|||
105880756|NCT01051791|365217186|FG000|Overall Study|Failed screening|3|||
105880757|NCT01051791|365217186|FG000|Overall Study|Withdrawal by Subject|1|||
105880758|NCT00288626|365217187|FG000|Overall Study|Death|3|||
105880759|NCT00288626|365217187|FG000|Overall Study|Withdrawal by Subject|4|||
105880760|NCT00564850|365217198|FG000|Overall Study|Protocol Violation|2|||
105880761|NCT02640664|365217199|FG000|Epoch 1|Withdrawal of informed consent|1|||
105880762|NCT02640664|365217200|FG001|Epoch 1|Withdrawal of informed consent|0|||
105880763|NCT02640664|365217201|FG002|Epoch 1|Withdrawal of informed consent|0|||
105880764|NCT02640664|365217199|FG000|Epoch 1|Death|0|||
105880765|NCT02640664|365217200|FG001|Epoch 1|Death|0|||
105880766|NCT02640664|365217201|FG002|Epoch 1|Death|1|||
105880767|NCT02640664|365217199|FG000|Epoch 2|Withdrawal of informed consent|3|||
105880768|NCT02640664|365217200|FG001|Epoch 2|Withdrawal of informed consent|4|||
105880769|NCT02640664|365217201|FG002|Epoch 2|Withdrawal of informed consent|2|||
105880770|NCT02640664|365217199|FG000|Epoch 2|Subject/guardian decision|0|||
105880771|NCT02640664|365217200|FG001|Epoch 2|Subject/guardian decision|2|||
106110868|NCT02243280|366061951|FG002|Treated|Adverse Event|0|||
106110869|NCT02243280|366061952|FG003|Treated|Adverse Event|0|||
106110870|NCT02243280|366061953|FG004|Treated|Adverse Event|0|||
106110871|NCT02243280|366061954|FG005|Treated|Adverse Event|0|||
105880772|NCT02640664|365217201|FG002|Epoch 2|Subject/guardian decision|2|||
105880773|NCT02640664|365217199|FG000|Epoch 2|Lost to Follow-up|3|||
105880774|NCT02640664|365217200|FG001|Epoch 2|Lost to Follow-up|4|||
105880775|NCT02640664|365217201|FG002|Epoch 2|Lost to Follow-up|1|||
105880776|NCT02640664|365217199|FG000|Epoch 2|Death|0|||
105880777|NCT02640664|365217200|FG001|Epoch 2|Death|0|||
105880778|NCT02640664|365217201|FG002|Epoch 2|Death|1|||
105880779|NCT00987337|365217204|FG000|Overall Study|Adverse Event|10|||
105880780|NCT00987337|365217205|FG001|Overall Study|Adverse Event|9|||
105880781|NCT00987337|365217206|FG002|Overall Study|Adverse Event|8|||
106110872|NCT02243280|366061955|FG006|Treated|Adverse Event|0|||
105880782|NCT00987337|365217204|FG000|Overall Study|Insufficient Virologic Response|10|||
105993708|NCT01510158|365636077|FG002|Overall Study|Gout flare|0|||
106110873|NCT02243280|366061956|FG007|Treated|Adverse Event|0|||
105880783|NCT00987337|365217205|FG001|Overall Study|Insufficient Virologic Response|7|||
105880784|NCT00987337|365217206|FG002|Overall Study|Insufficient Virologic Response|12|||
105880785|NCT00987337|365217204|FG000|Overall Study|Virologic Breakthrough|2|||
105880786|NCT00987337|365217205|FG001|Overall Study|Virologic Breakthrough|2|||
105880787|NCT00987337|365217206|FG002|Overall Study|Virologic Breakthrough|8|||
105880788|NCT00987337|365217204|FG000|Overall Study|Lost to Follow-up|10|||
105880789|NCT00987337|365217205|FG001|Overall Study|Lost to Follow-up|6|||
105880790|NCT00987337|365217206|FG002|Overall Study|Lost to Follow-up|2|||
105880791|NCT00987337|365217204|FG000|Overall Study|Withdrawal by Subject|6|||
105880792|NCT00987337|365217205|FG001|Overall Study|Withdrawal by Subject|9|||
105880793|NCT00987337|365217206|FG002|Overall Study|Withdrawal by Subject|9|||
105880794|NCT00987337|365217204|FG000|Overall Study|Other|0|||
105880795|NCT00987337|365217205|FG001|Overall Study|Other|2|||
105880796|NCT00987337|365217206|FG002|Overall Study|Other|5|||
105880797|NCT00987337|365217204|FG000|Overall Study|Protocol Violation|1|||
105880798|NCT00987337|365217205|FG001|Overall Study|Protocol Violation|0|||
105880799|NCT00987337|365217206|FG002|Overall Study|Protocol Violation|2|||
105880800|NCT00987337|365217204|FG000|Overall Study|Participant Relapsed|18|||
105880801|NCT00987337|365217205|FG001|Overall Study|Participant Relapsed|20|||
105880802|NCT00987337|365217206|FG002|Overall Study|Participant Relapsed|5|||
105880803|NCT00489918|365217208|FG000|Overall Study|Withdrawal by Subject|2|||
105880804|NCT00489918|365217209|FG001|Overall Study|Withdrawal by Subject|1|||
105880805|NCT00489918|365217210|FG002|Overall Study|Withdrawal by Subject|1|||
105880806|NCT00489918|365217211|FG003|Overall Study|Withdrawal by Subject|0|||
105880807|NCT00489918|365217212|FG004|Overall Study|Withdrawal by Subject|1|||
105880808|NCT00489918|365217208|FG000|Overall Study|Adverse Event|0|||
105880809|NCT00489918|365217209|FG001|Overall Study|Adverse Event|1|||
105880810|NCT00489918|365217210|FG002|Overall Study|Adverse Event|1|||
105880811|NCT00489918|365217211|FG003|Overall Study|Adverse Event|0|||
105880812|NCT00489918|365217212|FG004|Overall Study|Adverse Event|0|||
105880813|NCT00489918|365217208|FG000|Overall Study|Lost to Follow-up|0|||
105880814|NCT00489918|365217209|FG001|Overall Study|Lost to Follow-up|0|||
105880815|NCT00489918|365217210|FG002|Overall Study|Lost to Follow-up|1|||
105880816|NCT00489918|365217211|FG003|Overall Study|Lost to Follow-up|1|||
105880817|NCT00489918|365217212|FG004|Overall Study|Lost to Follow-up|0|||
105880818|NCT00489918|365217208|FG000|Overall Study|Physician Decision|0|||
105880819|NCT00489918|365217209|FG001|Overall Study|Physician Decision|0|||
105880820|NCT00489918|365217210|FG002|Overall Study|Physician Decision|1|||
105880821|NCT00489918|365217211|FG003|Overall Study|Physician Decision|0|||
105880822|NCT00489918|365217212|FG004|Overall Study|Physician Decision|0|||
105880823|NCT00550043|365217213|FG000|Overall Study|Adverse Event|0|||
105880824|NCT00550043|365217214|FG001|Overall Study|Adverse Event|0|||
105880825|NCT00550043|365217215|FG002|Overall Study|Adverse Event|0|||
105880826|NCT00550043|365217216|FG003|Overall Study|Adverse Event|1|||
105880827|NCT00550043|365217217|FG004|Overall Study|Adverse Event|1|||
105880828|NCT00550043|365217213|FG000|Overall Study|Subject Withdrew Consent|0|||
105880829|NCT00550043|365217214|FG001|Overall Study|Subject Withdrew Consent|2|||
105880830|NCT00550043|365217215|FG002|Overall Study|Subject Withdrew Consent|1|||
105880831|NCT00550043|365217216|FG003|Overall Study|Subject Withdrew Consent|0|||
105880832|NCT00550043|365217217|FG004|Overall Study|Subject Withdrew Consent|0|||
105880833|NCT00550043|365217213|FG000|Overall Study|Other Reasons- Unspecified|0|||
105880834|NCT00550043|365217214|FG001|Overall Study|Other Reasons- Unspecified|1|||
105880835|NCT00550043|365217215|FG002|Overall Study|Other Reasons- Unspecified|0|||
105880836|NCT00550043|365217216|FG003|Overall Study|Other Reasons- Unspecified|1|||
105880837|NCT00550043|365217217|FG004|Overall Study|Other Reasons- Unspecified|0|||
105880838|NCT02654977|365217220|FG000|Overall Study|Death|1|||
105880839|NCT02654977|365217220|FG000|Overall Study|Lost to Follow-up|1|||
105880840|NCT02654977|365217220|FG000|Overall Study|Adverse Event|1|||
105880841|NCT02654977|365217220|FG000|Overall Study|Withdrawal by Subject|1|||
105880842|NCT02654977|365217220|FG000|Overall Study|Lack of Efficacy|3|||
105880843|NCT01921101|365217221|FG000|Overall Study|Death|16|||
105880844|NCT01921101|365217222|FG001|Overall Study|Death|6|||
105880845|NCT02134015|365217223|FG000|Overall Study|Protocol Violation|0|||
105880846|NCT02134015|365217224|FG001|Overall Study|Protocol Violation|1|||
105880847|NCT02134015|365217223|FG000|Overall Study|Death|2|||
106110874|NCT02243280|366061957|FG008|Treated|Adverse Event|0|||
106110875|NCT02243280|366061958|FG009|Treated|Adverse Event|0|||
105880848|NCT02134015|365217224|FG001|Overall Study|Death|1|||
105880849|NCT02134015|365217223|FG000|Overall Study|Reason not provided|1|||
105880850|NCT02134015|365217224|FG001|Overall Study|Reason not provided|2|||
105880851|NCT02134015|365217223|FG000|Overall Study|Clinical progression|14|||
105880852|NCT02134015|365217224|FG001|Overall Study|Clinical progression|7|||
105880853|NCT02134015|365217223|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
105880854|NCT02134015|365217224|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
105880855|NCT02134015|365217223|FG000|Overall Study|Study terminated by sponsor|2|||
105880856|NCT02134015|365217224|FG001|Overall Study|Study terminated by sponsor|3|||
105880857|NCT02134015|365217223|FG000|Overall Study|Adverse Event|9|||
105880858|NCT02134015|365217224|FG001|Overall Study|Adverse Event|10|||
106110876|NCT02243280|366061959|FG010|Treated|Adverse Event|1|||
105880859|NCT02134015|365217223|FG000|Overall Study|Withdrawal by Subject|3|||
105880860|NCT02134015|365217224|FG001|Overall Study|Withdrawal by Subject|7|||
105880861|NCT00617890|365218703|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
105880862|NCT00617890|365218704|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
105880863|NCT00617890|365218705|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
105880864|NCT00617890|365218706|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
105880865|NCT00617890|365218703|FG000|Overall Study|Lack of Efficacy|23|||
105880866|NCT00617890|365218704|FG001|Overall Study|Lack of Efficacy|26|||
105880867|NCT00617890|365218705|FG002|Overall Study|Lack of Efficacy|30|||
105880868|NCT00617890|365218706|FG003|Overall Study|Lack of Efficacy|97|||
105880869|NCT00617890|365218703|FG000|Overall Study|Lost to Follow-up|0|||
105880870|NCT00617890|365218704|FG001|Overall Study|Lost to Follow-up|0|||
106110877|NCT02243280|366061949|FG000|Treated|Lost to Follow-up|0|||
106110878|NCT02243280|366061950|FG001|Treated|Lost to Follow-up|0|||
106110879|NCT02243280|366061951|FG002|Treated|Lost to Follow-up|0|||
106110880|NCT02243280|366061952|FG003|Treated|Lost to Follow-up|0|||
106110881|NCT02243280|366061953|FG004|Treated|Lost to Follow-up|0|||
106110882|NCT02243280|366061954|FG005|Treated|Lost to Follow-up|0|||
106110883|NCT02243280|366061955|FG006|Treated|Lost to Follow-up|0|||
106110884|NCT02243280|366061956|FG007|Treated|Lost to Follow-up|0|||
106110885|NCT02243280|366061957|FG008|Treated|Lost to Follow-up|1|||
106110886|NCT02243280|366061958|FG009|Treated|Lost to Follow-up|0|||
106110887|NCT02243280|366061959|FG010|Treated|Lost to Follow-up|2|||
106110888|NCT04098406|366061964|FG000|Overall Study|Adverse Event|2|||
106110889|NCT04098406|366061965|FG001|Overall Study|Adverse Event|1|||
106110890|NCT04098406|366061964|FG000|Overall Study|Withdrawal by Subject|1|||
106110891|NCT04098406|366061965|FG001|Overall Study|Withdrawal by Subject|0|||
106110892|NCT02127372|366061966|FG000|Overall Study|Withdrawal by Subject|1|||
106110893|NCT02127372|366061967|FG001|Overall Study|Withdrawal by Subject|0|||
106110894|NCT02691182|366061981|FG000|Overall Study|Withdrawal by Subject|4|||
106110895|NCT02691182|366061982|FG001|Overall Study|Withdrawal by Subject|7|||
106110896|NCT02691182|366061983|FG002|Overall Study|Withdrawal by Subject|6|||
106110897|NCT02691182|366061984|FG003|Overall Study|Withdrawal by Subject|8|||
106110898|NCT02691182|366061981|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
106110899|NCT02691182|366061982|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
106110900|NCT02691182|366061983|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
106110901|NCT02691182|366061984|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
106110902|NCT02691182|366061981|FG000|Overall Study|Lost to Follow-up|8|||
106110903|NCT02691182|366061982|FG001|Overall Study|Lost to Follow-up|33|||
106110904|NCT02691182|366061983|FG002|Overall Study|Lost to Follow-up|19|||
106110905|NCT02691182|366061984|FG003|Overall Study|Lost to Follow-up|22|||
106110906|NCT02691182|366061981|FG000|Overall Study|Adverse Event|3|||
106110907|NCT02691182|366061982|FG001|Overall Study|Adverse Event|10|||
106110908|NCT02691182|366061983|FG002|Overall Study|Adverse Event|10|||
106110909|NCT02691182|366061984|FG003|Overall Study|Adverse Event|11|||
106110910|NCT02691182|366061981|FG000|Overall Study|Physician Decision|3|||
106110911|NCT02691182|366061982|FG001|Overall Study|Physician Decision|7|||
106110912|NCT02691182|366061983|FG002|Overall Study|Physician Decision|14|||
106110913|NCT02691182|366061984|FG003|Overall Study|Physician Decision|8|||
106110914|NCT02691182|366061981|FG000|Overall Study|Lack of Efficacy|0|||
106110915|NCT02691182|366061982|FG001|Overall Study|Lack of Efficacy|0|||
106110916|NCT02691182|366061983|FG002|Overall Study|Lack of Efficacy|0|||
106110917|NCT02691182|366061984|FG003|Overall Study|Lack of Efficacy|4|||
106110918|NCT02691182|366061981|FG000|Overall Study|Protocol Violation|2|||
106110919|NCT02691182|366061982|FG001|Overall Study|Protocol Violation|6|||
106110920|NCT02691182|366061983|FG002|Overall Study|Protocol Violation|6|||
106110921|NCT02691182|366061984|FG003|Overall Study|Protocol Violation|8|||
106110922|NCT02691182|366061981|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
106110923|NCT02691182|366061982|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
106110924|NCT02691182|366061983|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
106110925|NCT02691182|366061984|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
106110926|NCT02691182|366061981|FG000|Overall Study|Missing|0|||
106110927|NCT02691182|366061982|FG001|Overall Study|Missing|5|||
106110928|NCT02691182|366061983|FG002|Overall Study|Missing|1|||
106110929|NCT02691182|366061984|FG003|Overall Study|Missing|5|||
106110930|NCT00420199|366061985|FG000|Overall Study|Participant no longer met study criteria|1|||
106110931|NCT00420199|366061986|FG001|Overall Study|Participant no longer met study criteria|0|||
106110932|NCT01078155|366061988|FG000|Overall Study|Adverse Event|7|||
106110933|NCT01078155|366061988|FG000|Overall Study|Lack of Efficacy|16|||
106110934|NCT01078155|366061988|FG000|Overall Study|Participant's Decision|6|||
106110935|NCT01078155|366061988|FG000|Overall Study|Lost to Follow-up|15|||
106110936|NCT00266825|366061989|FG000|Completed Follow-Up|Lost to Follow-up|14|||
106110937|NCT00266825|366061990|FG001|Completed Follow-Up|Lost to Follow-up|19|||
105880871|NCT00617890|365218705|FG002|Overall Study|Lost to Follow-up|1|||
105880872|NCT00617890|365218706|FG003|Overall Study|Lost to Follow-up|2|||
105880873|NCT00617890|365218703|FG000|Overall Study|Withdrawal by Subject|4|||
105880874|NCT00617890|365218704|FG001|Overall Study|Withdrawal by Subject|1|||
105880875|NCT00617890|365218705|FG002|Overall Study|Withdrawal by Subject|0|||
105880876|NCT00617890|365218706|FG003|Overall Study|Withdrawal by Subject|2|||
105880877|NCT00617890|365218703|FG000|Overall Study|Protocol Violation|2|||
105880878|NCT00617890|365218704|FG001|Overall Study|Protocol Violation|1|||
105880879|NCT00617890|365218705|FG002|Overall Study|Protocol Violation|0|||
105880880|NCT00617890|365218706|FG003|Overall Study|Protocol Violation|0|||
105880881|NCT00617890|365218703|FG000|Overall Study|Adverse Event|1|||
105880882|NCT00617890|365218704|FG001|Overall Study|Adverse Event|0|||
105880883|NCT00617890|365218705|FG002|Overall Study|Adverse Event|3|||
105880884|NCT00617890|365218706|FG003|Overall Study|Adverse Event|8|||
105880885|NCT00617890|365218703|FG000|Overall Study|Not treated|1|||
105880886|NCT00617890|365218704|FG001|Overall Study|Not treated|0|||
105880887|NCT00617890|365218705|FG002|Overall Study|Not treated|1|||
105880888|NCT00617890|365218706|FG003|Overall Study|Not treated|1|||
105880889|NCT01623310|365218707|FG000|Overall Study|Adverse Event|21|||
105880890|NCT01623310|365218707|FG000|Overall Study|Lost to Follow-up|18|||
105880891|NCT01623310|365218707|FG000|Overall Study|Lack of Efficacy|6|||
105880892|NCT01623310|365218707|FG000|Overall Study|Protocol Violation|6|||
105880893|NCT01623310|365218707|FG000|Overall Study|Withdrawal by Subject|25|||
105880894|NCT01623310|365218707|FG000|Overall Study|Became potentially child-bearing|1|||
105880895|NCT01623310|365218707|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
105880896|NCT01623310|365218707|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
105880897|NCT00684411|365218708|FG000|Overall Study|New Primary Cancer|1|||
105880898|NCT00684411|365218708|FG000|Overall Study|Disease Progression|10|||
105880899|NCT00684411|365218708|FG000|Overall Study|Adverse Event|1|||
105880900|NCT02027545|365218710|FG000|Overall Study|Failed to sign HIPAA|0|||
105880901|NCT02027545|365218711|FG001|Overall Study|Failed to sign HIPAA|2|||
105880902|NCT02027545|365218710|FG000|Overall Study|Failed to attend study visit|2|||
105880903|NCT02027545|365218711|FG001|Overall Study|Failed to attend study visit|0|||
105880904|NCT02027545|365218710|FG000|Overall Study|Protocol Violation|1|||
105880905|NCT02027545|365218711|FG001|Overall Study|Protocol Violation|0|||
105880906|NCT02453334|365218712|FG000|Overall Study|Death|15|||
105880907|NCT02453334|365218713|FG001|Overall Study|Death|13|||
105880908|NCT02453334|365218712|FG000|Overall Study|Adverse Event|2|||
105880909|NCT02453334|365218713|FG001|Overall Study|Adverse Event|1|||
105880910|NCT02453334|365218712|FG000|Overall Study|Lost to Follow-up|5|||
105880911|NCT02453334|365218713|FG001|Overall Study|Lost to Follow-up|9|||
105880912|NCT02453334|365218712|FG000|Overall Study|Physician Decision|1|||
105880913|NCT02453334|365218713|FG001|Overall Study|Physician Decision|0|||
105880914|NCT02453334|365218712|FG000|Overall Study|Withdrawal by Subject|17|||
105880915|NCT02453334|365218713|FG001|Overall Study|Withdrawal by Subject|13|||
105880916|NCT02453334|365218712|FG000|Overall Study|Other reason|1|||
105880917|NCT02453334|365218713|FG001|Overall Study|Other reason|4|||
105880918|NCT01346059|365218721|FG000|Overall Study|Withdrawal by Subject|1|||
105880919|NCT01346059|365218722|FG001|Overall Study|Withdrawal by Subject|0|||
105880920|NCT06110494|365218725|FG000|Overall Study|Protocol Violation|2|||
105880921|NCT06110494|365218726|FG001|Overall Study|Protocol Violation|0|||
105880922|NCT06110494|365218727|FG002|Overall Study|Protocol Violation|1|||
105880923|NCT06110494|365218725|FG000|Overall Study|Dixon's test for outlier analysis|1|||
105880924|NCT06110494|365218726|FG001|Overall Study|Dixon's test for outlier analysis|1|||
105880925|NCT06110494|365218727|FG002|Overall Study|Dixon's test for outlier analysis|0|||
105880926|NCT00105079|365218730|FG000|Overall Study|Adverse Event|5|||
105880927|NCT00105079|365218731|FG001|Overall Study|Adverse Event|12|||
105880928|NCT00105079|365218730|FG000|Overall Study|Death|3|||
105880929|NCT00105079|365218731|FG001|Overall Study|Death|1|||
105880930|NCT00105079|365218730|FG000|Overall Study|Lost to Follow-up|12|||
105880931|NCT00105079|365218731|FG001|Overall Study|Lost to Follow-up|12|||
105880932|NCT00105079|365218730|FG000|Overall Study|Lack of Efficacy|9|||
105880933|NCT00105079|365218731|FG001|Overall Study|Lack of Efficacy|3|||
105880934|NCT00105079|365218730|FG000|Overall Study|Refused treatment|6|||
105880935|NCT00105079|365218731|FG001|Overall Study|Refused treatment|4|||
105880936|NCT00105079|365218730|FG000|Overall Study|Violation of selection criteria at entry|0|||
105880937|NCT00105079|365218731|FG001|Overall Study|Violation of selection criteria at entry|2|||
105880938|NCT00105079|365218730|FG000|Overall Study|Protocol Violation|1|||
105880939|NCT00105079|365218731|FG001|Overall Study|Protocol Violation|0|||
105880940|NCT00105079|365218730|FG000|Overall Study|Other|3|||
105880941|NCT00105079|365218731|FG001|Overall Study|Other|1|||
105880942|NCT01681212|365218734|FG000|Overall Study|No longer met study criteria|5|||
105993709|NCT01510158|365636075|FG000|Overall Study|Protocol Violation|17|||
105880943|NCT01681212|365218734|FG000|Overall Study|Administrative reason by sponsor|1|||
105880944|NCT01464424|365218735|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
105880945|NCT01464424|365218736|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
105880946|NCT01464333|365218739|FG000|Overall Study|Adverse Event|34|||
105880947|NCT01464333|365218739|FG000|Overall Study|Lack of Efficacy|72|||
105880948|NCT01464333|365218739|FG000|Overall Study|Withdrawal by Subject|11|||
105880949|NCT01464333|365218739|FG000|Overall Study|Other|4|||
105880950|NCT01464333|365218739|FG000|Overall Study|No Hospital Visit|42|||
105880951|NCT00789373|365218740|FG000|Induction|Adverse Event|64|||
105880952|NCT00789373|365218741|FG001|Induction|Adverse Event|0|||
105880953|NCT00789373|365218742|FG002|Induction|Adverse Event|0|||
105880954|NCT00789373|365218740|FG000|Induction|Death Due to study disease|24|||
105880955|NCT00789373|365218741|FG001|Induction|Death Due to study disease|0|||
105880956|NCT00789373|365218742|FG002|Induction|Death Due to study disease|0|||
105880957|NCT00789373|365218740|FG000|Induction|Death due to adverse event|19|||
105880958|NCT00789373|365218741|FG001|Induction|Death due to adverse event|0|||
105880959|NCT00789373|365218742|FG002|Induction|Death due to adverse event|0|||
105880960|NCT00789373|365218740|FG000|Induction|Death due to toxicity|11|||
105880961|NCT00789373|365218741|FG001|Induction|Death due to toxicity|0|||
105880962|NCT00789373|365218742|FG002|Induction|Death due to toxicity|0|||
105880963|NCT00789373|365218740|FG000|Induction|Death due to procedure|1|||
105880964|NCT00789373|365218741|FG001|Induction|Death due to procedure|0|||
105880965|NCT00789373|365218742|FG002|Induction|Death due to procedure|0|||
105880966|NCT00789373|365218740|FG000|Induction|Investigator decision|7|||
105880967|NCT00789373|365218741|FG001|Induction|Investigator decision|0|||
105880968|NCT00789373|365218742|FG002|Induction|Investigator decision|0|||
105880969|NCT00789373|365218740|FG000|Induction|Protocol entry criteria not met|9|||
105880970|NCT00789373|365218741|FG001|Induction|Protocol entry criteria not met|0|||
105880971|NCT00789373|365218742|FG002|Induction|Protocol entry criteria not met|0|||
105880972|NCT00789373|365218740|FG000|Induction|Lost to Follow-up|6|||
105880973|NCT00789373|365218741|FG001|Induction|Lost to Follow-up|0|||
105880974|NCT00789373|365218742|FG002|Induction|Lost to Follow-up|0|||
105880975|NCT00789373|365218740|FG000|Induction|Protocol Violation|1|||
105880976|NCT00789373|365218741|FG001|Induction|Protocol Violation|0|||
105880977|NCT00789373|365218742|FG002|Induction|Protocol Violation|0|||
105880978|NCT00789373|365218740|FG000|Induction|Progressive Disease|220|||
105880979|NCT00789373|365218741|FG001|Induction|Progressive Disease|0|||
105880980|NCT00789373|365218742|FG002|Induction|Progressive Disease|0|||
105880981|NCT00789373|365218740|FG000|Induction|Withdrawal by Subject|37|||
105880982|NCT00789373|365218741|FG001|Induction|Withdrawal by Subject|0|||
105880983|NCT00789373|365218742|FG002|Induction|Withdrawal by Subject|0|||
105880984|NCT00789373|365218740|FG000|Maintenance|Adverse Event|0|||
105880985|NCT00789373|365218741|FG001|Maintenance|Adverse Event|65|||
105880986|NCT00789373|365218742|FG002|Maintenance|Adverse Event|12|||
105880987|NCT00789373|365218740|FG000|Maintenance|Death due to study disease|0|||
105880988|NCT00789373|365218741|FG001|Maintenance|Death due to study disease|3|||
105880989|NCT00789373|365218742|FG002|Maintenance|Death due to study disease|1|||
105880990|NCT00789373|365218740|FG000|Maintenance|Death due to adverse event|0|||
105880991|NCT00789373|365218741|FG001|Maintenance|Death due to adverse event|4|||
105880992|NCT00789373|365218742|FG002|Maintenance|Death due to adverse event|1|||
105880993|NCT00789373|365218740|FG000|Maintenance|Death due to toxicity|0|||
105880994|NCT00789373|365218741|FG001|Maintenance|Death due to toxicity|1|||
105880995|NCT00789373|365218742|FG002|Maintenance|Death due to toxicity|2|||
105880996|NCT00789373|365218740|FG000|Maintenance|Investigator Decision|0|||
105880997|NCT00789373|365218741|FG001|Maintenance|Investigator Decision|4|||
105880998|NCT00789373|365218742|FG002|Maintenance|Investigator Decision|2|||
105880999|NCT00789373|365218740|FG000|Maintenance|Protocol entry criteria not met|0|||
105881000|NCT00789373|365218741|FG001|Maintenance|Protocol entry criteria not met|2|||
105881001|NCT00789373|365218742|FG002|Maintenance|Protocol entry criteria not met|0|||
105881002|NCT00789373|365218740|FG000|Maintenance|Lost to Follow-up|0|||
105881003|NCT00789373|365218741|FG001|Maintenance|Lost to Follow-up|2|||
105881004|NCT00789373|365218742|FG002|Maintenance|Lost to Follow-up|0|||
105881005|NCT00789373|365218740|FG000|Maintenance|Progressive Disease|0|||
105881006|NCT00789373|365218741|FG001|Maintenance|Progressive Disease|253|||
105881007|NCT00789373|365218742|FG002|Maintenance|Progressive Disease|152|||
105881008|NCT00789373|365218740|FG000|Maintenance|Withdrawal by Subject|0|||
105881009|NCT00789373|365218741|FG001|Maintenance|Withdrawal by Subject|21|||
105881010|NCT00789373|365218742|FG002|Maintenance|Withdrawal by Subject|8|||
105881011|NCT00789373|365218740|FG000|Maintenance|Sponsor Decision|0|||
105881012|NCT00789373|365218741|FG001|Maintenance|Sponsor Decision|0|||
106110938|NCT00266825|366061989|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
105881013|NCT00789373|365218742|FG002|Maintenance|Sponsor Decision|2|||
106110939|NCT00266825|366061990|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
106110940|NCT03286751|366061991|FG000|Washout Period 1|Withdrawal by Subject|0|||
105881014|NCT00789373|365218740|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
105881015|NCT00789373|365218741|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
105881016|NCT00789373|365218742|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
105881017|NCT02476578|365218746|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
105881018|NCT02476578|365218747|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
105881019|NCT02476578|365218746|FG000|Overall Study|Lost to Follow-up|6|||
105881020|NCT02476578|365218747|FG001|Overall Study|Lost to Follow-up|13|||
105881021|NCT02187198|365218748|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
105881022|NCT02187198|365218749|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
105881023|NCT02187198|365218748|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
105881024|NCT02187198|365218749|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
105881025|NCT00546377|365218750|FG000|Overall Study|Deemed ineligible|1|||
105881026|NCT00546377|365218750|FG000|Overall Study|Adverse Event|6|||
105881027|NCT02282813|365218756|FG000|Overall Study|Withdrawal by Subject|4|||
105881028|NCT02282813|365218757|FG001|Overall Study|Withdrawal by Subject|5|||
105881029|NCT02282813|365218758|FG002|Overall Study|Withdrawal by Subject|0|||
105881030|NCT02282813|365218756|FG000|Overall Study|Adverse Event|3|||
105881031|NCT02282813|365218757|FG001|Overall Study|Adverse Event|10|||
105881032|NCT02282813|365218758|FG002|Overall Study|Adverse Event|1|||
105881033|NCT02282813|365218756|FG000|Overall Study|Subject non-compliance|1|||
105881034|NCT02282813|365218757|FG001|Overall Study|Subject non-compliance|4|||
105881035|NCT02282813|365218758|FG002|Overall Study|Subject non-compliance|0|||
105881036|NCT02282813|365218756|FG000|Overall Study|Physician Decision|0|||
105881037|NCT02282813|365218757|FG001|Overall Study|Physician Decision|3|||
105881038|NCT02282813|365218758|FG002|Overall Study|Physician Decision|1|||
105881039|NCT02282813|365218756|FG000|Overall Study|Lost to Follow-up|2|||
105881040|NCT02282813|365218757|FG001|Overall Study|Lost to Follow-up|0|||
105881041|NCT02282813|365218758|FG002|Overall Study|Lost to Follow-up|1|||
105881042|NCT02282813|365218756|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
105881043|NCT02282813|365218757|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
105881044|NCT02282813|365218758|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
105881045|NCT02282813|365218756|FG000|Overall Study|Lack of Efficacy|1|||
105881046|NCT02282813|365218757|FG001|Overall Study|Lack of Efficacy|0|||
105881047|NCT02282813|365218758|FG002|Overall Study|Lack of Efficacy|0|||
105881048|NCT02282813|365218756|FG000|Overall Study|Administrative reasons|0|||
105881049|NCT02282813|365218757|FG001|Overall Study|Administrative reasons|1|||
105881050|NCT02282813|365218758|FG002|Overall Study|Administrative reasons|0|||
105881051|NCT03777436|365218759|FG000|Placebo-controlled Phase|Adverse Event|8|||
105881052|NCT03777436|365218760|FG001|Placebo-controlled Phase|Adverse Event|10|||
105881053|NCT03777436|365218761|FG002|Placebo-controlled Phase|Adverse Event|0|||
105881054|NCT03777436|365218759|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
105881055|NCT03777436|365218760|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
105881056|NCT03777436|365218761|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
105881057|NCT03777436|365218759|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
105881058|NCT03777436|365218760|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
105881059|NCT03777436|365218761|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
105881060|NCT03777436|365218759|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
105881061|NCT03777436|365218760|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
105881062|NCT03777436|365218761|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
105881063|NCT03777436|365218759|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
105881064|NCT03777436|365218760|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
105881065|NCT03777436|365218761|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
105881066|NCT03777436|365218759|FG000|Placebo-controlled Phase|Physician Decision|0|||
105881067|NCT03777436|365218760|FG001|Placebo-controlled Phase|Physician Decision|1|||
105881068|NCT03777436|365218761|FG002|Placebo-controlled Phase|Physician Decision|0|||
105881069|NCT03777436|365218759|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
105881070|NCT03777436|365218760|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
105881071|NCT03777436|365218761|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
105881072|NCT03777436|365218759|FG000|Apremilast Extension Phase|Adverse Event|0|||
105881073|NCT03777436|365218760|FG001|Apremilast Extension Phase|Adverse Event|0|||
105881074|NCT03777436|365218761|FG002|Apremilast Extension Phase|Adverse Event|6|||
105881075|NCT03777436|365218759|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
105881076|NCT03777436|365218760|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
105881077|NCT03777436|365218761|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
105881078|NCT03777436|365218759|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
105881079|NCT03777436|365218760|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
105881080|NCT03777436|365218761|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
105881081|NCT03777436|365218759|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
105881082|NCT03777436|365218760|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
105881083|NCT03777436|365218761|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
105881084|NCT03777436|365218759|FG000|Apremilast Extension Phase|Miscellaneous|0|||
105881085|NCT03777436|365218760|FG001|Apremilast Extension Phase|Miscellaneous|0|||
105881086|NCT03777436|365218761|FG002|Apremilast Extension Phase|Miscellaneous|1|||
105881087|NCT00921557|365218762|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
105881088|NCT00921557|365218763|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
105881089|NCT00921557|365218764|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
105881090|NCT00921557|365218762|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
105881091|NCT00921557|365218763|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
105881092|NCT00921557|365218764|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
105881093|NCT00921557|365218762|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
105881094|NCT00921557|365218763|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
105881095|NCT00921557|365218764|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
105881096|NCT00921557|365218762|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
105881097|NCT00921557|365218763|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
105881098|NCT00921557|365218764|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
105881099|NCT00921557|365218762|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
105881100|NCT00921557|365218763|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
105881101|NCT00921557|365218764|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
105881102|NCT04157296|365218765|FG000|Overall Study|Withdrawal by Subject|0|||
105881103|NCT04157296|365218766|FG001|Overall Study|Withdrawal by Subject|1|||
105881104|NCT04157296|365218765|FG000|Overall Study|Did not obtain second fMRI.|0|||
105881105|NCT04157296|365218766|FG001|Overall Study|Did not obtain second fMRI.|1|||
105881106|NCT04157296|365218765|FG000|Overall Study|MRI failed/no second fMRI|0|||
105881107|NCT04157296|365218766|FG001|Overall Study|MRI failed/no second fMRI|1|||
105881108|NCT00267969|365218769|FG000|Controlled Period|Adverse Event|6|||
105881109|NCT00267969|365218770|FG001|Controlled Period|Adverse Event|0|||
105881110|NCT00267969|365218771|FG002|Controlled Period|Adverse Event|2|||
106110941|NCT03286751|366061992|FG001|Washout Period 1|Withdrawal by Subject|0|||
106110942|NCT03286751|366061993|FG002|Washout Period 1|Withdrawal by Subject|0|||
106110943|NCT03286751|366061994|FG003|Washout Period 1|Withdrawal by Subject|0|||
106110944|NCT03286751|366061995|FG004|Washout Period 1|Withdrawal by Subject|1|||
106110945|NCT03286751|366061996|FG005|Washout Period 1|Withdrawal by Subject|0|||
106110946|NCT03286751|366061991|FG000|Washout Period 2|Personal Reasons|0|||
106110947|NCT03286751|366061992|FG001|Washout Period 2|Personal Reasons|1|||
106110948|NCT03286751|366061993|FG002|Washout Period 2|Personal Reasons|0|||
106110949|NCT03286751|366061994|FG003|Washout Period 2|Personal Reasons|0|||
106110950|NCT03286751|366061995|FG004|Washout Period 2|Personal Reasons|0|||
106110951|NCT03286751|366061996|FG005|Washout Period 2|Personal Reasons|0|||
106110952|NCT03286751|366061991|FG000|Washout Period 5|Adverse Event|0|||
106110953|NCT03286751|366061992|FG001|Washout Period 5|Adverse Event|0|||
106110954|NCT03286751|366061993|FG002|Washout Period 5|Adverse Event|0|||
106110955|NCT03286751|366061994|FG003|Washout Period 5|Adverse Event|0|||
106110956|NCT03286751|366061995|FG004|Washout Period 5|Adverse Event|1|||
106110957|NCT03286751|366061996|FG005|Washout Period 5|Adverse Event|0|||
106110958|NCT02799784|366061997|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
106110959|NCT02799784|366061998|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
106110960|NCT02799784|366061997|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
106110961|NCT02799784|366061998|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
106110962|NCT02799784|366061997|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
106110963|NCT02799784|366061998|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
106110964|NCT02799784|366061997|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
106110965|NCT02799784|366061998|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
106110966|NCT02799784|366061997|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
106110967|NCT02799784|366061998|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
106110968|NCT02799784|366061997|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
106110969|NCT02799784|366061998|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
106110970|NCT00855062|366062004|FG000|Step1|Early Study Closure|5|||
106110971|NCT00855062|366062005|FG001|Step1|Early Study Closure|7|||
106110972|NCT00855062|366062004|FG000|Step1|Adverse Event|1|||
106110973|NCT00855062|366062005|FG001|Step1|Adverse Event|1|||
106110974|NCT00855062|366062004|FG000|Step1|Protocol Violation|1|||
106110975|NCT00855062|366062005|FG001|Step1|Protocol Violation|0|||
106110976|NCT00855062|366062004|FG000|Step1|Pregnancy|1|||
106110977|NCT00855062|366062005|FG001|Step1|Pregnancy|0|||
106110978|NCT00855062|366062004|FG000|Step1|Withdrawal by Subject|2|||
106110979|NCT00855062|366062005|FG001|Step1|Withdrawal by Subject|3|||
106110980|NCT00855062|366062004|FG000|Step2|Early Study Closure|6|||
106110981|NCT00855062|366062005|FG001|Step2|Early Study Closure|2|||
106110982|NCT00855062|366062004|FG000|Step2|Adverse Event|0|||
106110983|NCT00855062|366062005|FG001|Step2|Adverse Event|3|||
106110984|NCT00855062|366062004|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
106110985|NCT00855062|366062005|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
106110986|NCT00763958|366062006|FG000|Overall Study|did not meet final criteria|4|||
106110987|NCT00763958|366062007|FG001|Overall Study|did not meet final criteria|4|||
106110988|NCT00763958|366062006|FG000|Overall Study|Lost to Follow-up|10|||
106110989|NCT00763958|366062007|FG001|Overall Study|Lost to Follow-up|2|||
106110990|NCT00763958|366062006|FG000|Overall Study|Believed they were receiving placebo|0|||
106110991|NCT00763958|366062007|FG001|Overall Study|Believed they were receiving placebo|5|||
106110992|NCT01376323|366062009|FG000|Overall Study|Adverse Event|1|||
106110993|NCT01376323|366062010|FG001|Overall Study|Adverse Event|0|||
106110994|NCT01376323|366062011|FG002|Overall Study|Adverse Event|0|||
105881111|NCT00267969|365218772|FG003|Controlled Period|Adverse Event|0|||
105881112|NCT00267969|365218773|FG004|Controlled Period|Adverse Event|0|||
106110995|NCT01376323|366062012|FG003|Overall Study|Adverse Event|2|||
106110996|NCT01376323|366062013|FG004|Overall Study|Adverse Event|0|||
106110997|NCT01376323|366062009|FG000|Overall Study|Lost to Follow-up|0|||
106110998|NCT01376323|366062010|FG001|Overall Study|Lost to Follow-up|0|||
106110999|NCT01376323|366062011|FG002|Overall Study|Lost to Follow-up|0|||
106111000|NCT01376323|366062012|FG003|Overall Study|Lost to Follow-up|2|||
105881113|NCT00267969|365218774|FG005|Controlled Period|Adverse Event|0|||
105881114|NCT00267969|365218775|FG006|Controlled Period|Adverse Event|0|||
105881115|NCT00267969|365218769|FG000|Controlled Period|Lack of Efficacy|3|||
105881116|NCT00267969|365218770|FG001|Controlled Period|Lack of Efficacy|0|||
105881117|NCT00267969|365218771|FG002|Controlled Period|Lack of Efficacy|1|||
105881118|NCT00267969|365218772|FG003|Controlled Period|Lack of Efficacy|0|||
105881119|NCT00267969|365218773|FG004|Controlled Period|Lack of Efficacy|0|||
105881120|NCT00267969|365218774|FG005|Controlled Period|Lack of Efficacy|0|||
105881121|NCT00267969|365218775|FG006|Controlled Period|Lack of Efficacy|0|||
105881122|NCT00267969|365218769|FG000|Controlled Period|Lost to Follow-up|1|||
105881123|NCT00267969|365218770|FG001|Controlled Period|Lost to Follow-up|0|||
105881124|NCT00267969|365218771|FG002|Controlled Period|Lost to Follow-up|1|||
105881125|NCT00267969|365218772|FG003|Controlled Period|Lost to Follow-up|0|||
105881126|NCT00267969|365218773|FG004|Controlled Period|Lost to Follow-up|0|||
105881127|NCT00267969|365218774|FG005|Controlled Period|Lost to Follow-up|0|||
105881128|NCT00267969|365218775|FG006|Controlled Period|Lost to Follow-up|0|||
105881129|NCT00267969|365218769|FG000|Controlled Period|Randomized but not treated|0|||
105881130|NCT00267969|365218770|FG001|Controlled Period|Randomized but not treated|0|||
105881131|NCT00267969|365218771|FG002|Controlled Period|Randomized but not treated|1|||
105881132|NCT00267969|365218772|FG003|Controlled Period|Randomized but not treated|0|||
105881133|NCT00267969|365218773|FG004|Controlled Period|Randomized but not treated|0|||
105881134|NCT00267969|365218774|FG005|Controlled Period|Randomized but not treated|0|||
105881135|NCT00267969|365218775|FG006|Controlled Period|Randomized but not treated|0|||
105881136|NCT00267969|365218769|FG000|Controlled Period|Other|2|||
105881137|NCT00267969|365218770|FG001|Controlled Period|Other|1|||
105881138|NCT00267969|365218771|FG002|Controlled Period|Other|6|||
105881139|NCT00267969|365218772|FG003|Controlled Period|Other|0|||
105881140|NCT00267969|365218773|FG004|Controlled Period|Other|0|||
105881141|NCT00267969|365218774|FG005|Controlled Period|Other|0|||
105881142|NCT00267969|365218775|FG006|Controlled Period|Other|0|||
105881143|NCT00267969|365218769|FG000|After Controlled Period|Adverse Event|0|||
105881144|NCT00267969|365218770|FG001|After Controlled Period|Adverse Event|0|||
105881145|NCT00267969|365218771|FG002|After Controlled Period|Adverse Event|0|||
105881146|NCT00267969|365218772|FG003|After Controlled Period|Adverse Event|7|||
105881147|NCT00267969|365218773|FG004|After Controlled Period|Adverse Event|8|||
105881148|NCT00267969|365218774|FG005|After Controlled Period|Adverse Event|23|||
105881149|NCT00267969|365218775|FG006|After Controlled Period|Adverse Event|21|||
105881150|NCT00267969|365218769|FG000|After Controlled Period|Death|0|||
105881151|NCT00267969|365218770|FG001|After Controlled Period|Death|0|||
105881152|NCT00267969|365218771|FG002|After Controlled Period|Death|0|||
105881153|NCT00267969|365218772|FG003|After Controlled Period|Death|1|||
105881154|NCT00267969|365218773|FG004|After Controlled Period|Death|2|||
105881155|NCT00267969|365218774|FG005|After Controlled Period|Death|0|||
105881156|NCT00267969|365218775|FG006|After Controlled Period|Death|1|||
105881157|NCT00267969|365218769|FG000|After Controlled Period|Lack of Efficacy|0|||
105881158|NCT00267969|365218770|FG001|After Controlled Period|Lack of Efficacy|0|||
105881159|NCT00267969|365218771|FG002|After Controlled Period|Lack of Efficacy|0|||
105881160|NCT00267969|365218772|FG003|After Controlled Period|Lack of Efficacy|10|||
105881161|NCT00267969|365218773|FG004|After Controlled Period|Lack of Efficacy|6|||
105881162|NCT00267969|365218774|FG005|After Controlled Period|Lack of Efficacy|28|||
105881163|NCT00267969|365218775|FG006|After Controlled Period|Lack of Efficacy|15|||
105881164|NCT00267969|365218769|FG000|After Controlled Period|Lost to Follow-up|0|||
105881165|NCT00267969|365218770|FG001|After Controlled Period|Lost to Follow-up|0|||
105881166|NCT00267969|365218771|FG002|After Controlled Period|Lost to Follow-up|0|||
105881167|NCT00267969|365218772|FG003|After Controlled Period|Lost to Follow-up|5|||
105881168|NCT00267969|365218773|FG004|After Controlled Period|Lost to Follow-up|8|||
105881169|NCT00267969|365218774|FG005|After Controlled Period|Lost to Follow-up|9|||
105881170|NCT00267969|365218775|FG006|After Controlled Period|Lost to Follow-up|10|||
105881171|NCT00267969|365218769|FG000|After Controlled Period|Other|0|||
105881172|NCT00267969|365218770|FG001|After Controlled Period|Other|0|||
105881173|NCT00267969|365218771|FG002|After Controlled Period|Other|0|||
105881174|NCT00267969|365218772|FG003|After Controlled Period|Other|13|||
105881175|NCT00267969|365218773|FG004|After Controlled Period|Other|11|||
105881176|NCT00267969|365218774|FG005|After Controlled Period|Other|22|||
105881177|NCT00267969|365218775|FG006|After Controlled Period|Other|25|||
105881178|NCT03674112|365218781|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
105881179|NCT03674112|365218782|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
105881180|NCT03674112|365218781|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
105881181|NCT03674112|365218782|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
105881182|NCT03674112|365218781|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
105881183|NCT03674112|365218782|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
105881184|NCT03674112|365218781|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
105881185|NCT03674112|365218782|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
105881186|NCT03674112|365218781|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
105881187|NCT03674112|365218782|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
105881188|NCT03674112|365218781|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
105881189|NCT03674112|365218782|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
105881190|NCT03674112|365218781|FG000|Follow-Up Period (≥3 Years)|Death|2|||
105881191|NCT03674112|365218782|FG001|Follow-Up Period (≥3 Years)|Death|0|||
105881192|NCT03674112|365218781|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
105881193|NCT03674112|365218782|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
105881194|NCT00862823|365218783|FG000|First Intervention|Withdrawal by Subject|1|||
105881195|NCT00862823|365218784|FG001|First Intervention|Withdrawal by Subject|1|||
105881196|NCT00887315|365218785|FG000|Overall Study|Study termination|7|||
105881197|NCT00887315|365218786|FG001|Overall Study|Study termination|4|||
105881198|NCT01106911|365218793|FG000|Overall Study|Physician Decision|2|||
105881199|NCT01106911|365218793|FG000|Overall Study|deemed ineligible after screening|3|||
105881200|NCT03020992|365218794|FG000|Overall Study|Adverse Event|5|||
105881201|NCT03020992|365218794|FG000|Overall Study|Withdrawal by Subject|1|||
105881202|NCT01431716|365218795|FG000|Overall Study|Withdrawal of consent|1|||
105881203|NCT01006122|365218796|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
105881204|NCT01006122|365218797|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
105881205|NCT01006122|365218796|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
105881206|NCT01006122|365218797|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
105881207|NCT01006122|365218796|FG000|First Double-blind Intervention Period|Pregnancy|0|||
105881208|NCT01006122|365218797|FG001|First Double-blind Intervention Period|Pregnancy|1|||
105881209|NCT01006122|365218796|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
105881210|NCT01006122|365218797|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
105881211|NCT01006122|365218796|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
105881212|NCT01006122|365218797|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
105881213|NCT01006122|365218796|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
105881214|NCT01006122|365218797|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
105881215|NCT01006122|365218796|FG000|First Double-blind Intervention Period|Other|3|||
105881216|NCT01006122|365218797|FG001|First Double-blind Intervention Period|Other|0|||
105881217|NCT01006122|365218796|FG000|First Double-blind Intervention Period|Adverse Event|0|||
105881218|NCT01006122|365218797|FG001|First Double-blind Intervention Period|Adverse Event|4|||
105881219|NCT01006122|365218796|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
105881220|NCT01006122|365218797|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
105881221|NCT01006122|365218796|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
105881222|NCT01006122|365218797|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
105881223|NCT01006122|365218796|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
105881224|NCT01006122|365218797|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
105881225|NCT01006122|365218796|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
105881226|NCT01006122|365218797|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
105881227|NCT01006122|365218796|FG000|Second Double-blind Intervention Period|Death|0|||
105881228|NCT01006122|365218797|FG001|Second Double-blind Intervention Period|Death|1|||
105881229|NCT00634803|365218800|FG000|Overall Study|Lost to Follow-up|6|||
105881230|NCT00634803|365218801|FG001|Overall Study|Lost to Follow-up|7|||
105881231|NCT00634803|365218802|FG002|Overall Study|Lost to Follow-up|7|||
105881232|NCT01580670|365218805|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
105881233|NCT01580670|365218805|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
105881234|NCT02748356|365218806|FG000|Overall Study|Withdrawal by Subject|1|||
105881235|NCT02821754|365218807|FG000|Overall Study|Procedure not required prior to amendment change|13|||
105881236|NCT02821754|365218808|FG001|Overall Study|Procedure not required prior to amendment change|11|||
105881237|NCT02821754|365218809|FG002|Overall Study|Procedure not required prior to amendment change|0|||
105881238|NCT02821754|365218807|FG000|Overall Study|Participant's Clinical status|2|||
105881239|NCT02821754|365218808|FG001|Overall Study|Participant's Clinical status|0|||
105881240|NCT02821754|365218809|FG002|Overall Study|Participant's Clinical status|0|||
105881241|NCT02821754|365218807|FG000|Overall Study|Participant removed for noncompliance|1|||
105881242|NCT02821754|365218808|FG001|Overall Study|Participant removed for noncompliance|0|||
105881243|NCT02821754|365218809|FG002|Overall Study|Participant removed for noncompliance|0|||
105881244|NCT02821754|365218807|FG000|Overall Study|Drug not available.|0|||
105881245|NCT02821754|365218808|FG001|Overall Study|Drug not available.|0|||
105881246|NCT02821754|365218809|FG002|Overall Study|Drug not available.|1|||
105881247|NCT02821754|365218807|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
105881248|NCT02821754|365218808|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
105881249|NCT02821754|365218809|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
105881250|NCT01757184|365218815|FG000|Double-blind Period|Adverse Event|1|||
105881251|NCT01757184|365218816|FG001|Double-blind Period|Adverse Event|0|||
105881252|NCT01757184|365218817|FG002|Double-blind Period|Adverse Event|0|||
105881253|NCT01757184|365218818|FG003|Double-blind Period|Adverse Event|0|||
105881254|NCT01757184|365218815|FG000|Open-label Period|Lost to Follow-up|0|||
105881255|NCT01757184|365218816|FG001|Open-label Period|Lost to Follow-up|0|||
105881256|NCT01757184|365218817|FG002|Open-label Period|Lost to Follow-up|2|||
105881257|NCT01757184|365218818|FG003|Open-label Period|Lost to Follow-up|0|||
105881258|NCT01757184|365218815|FG000|Open-label Period|Withdrawal by Subject|0|||
105881259|NCT01757184|365218816|FG001|Open-label Period|Withdrawal by Subject|0|||
105881260|NCT01757184|365218817|FG002|Open-label Period|Withdrawal by Subject|1|||
105881261|NCT01757184|365218818|FG003|Open-label Period|Withdrawal by Subject|1|||
105881262|NCT01757184|365218815|FG000|Open-label Period|Discontinued by Sponsor|0|||
105881263|NCT01757184|365218816|FG001|Open-label Period|Discontinued by Sponsor|0|||
105881264|NCT01757184|365218817|FG002|Open-label Period|Discontinued by Sponsor|1|||
105881265|NCT01757184|365218818|FG003|Open-label Period|Discontinued by Sponsor|2|||
105881266|NCT04468347|365218819|FG000|Overall Study|Withdrawal by Subject|0|||
105881267|NCT04468347|365218820|FG001|Overall Study|Withdrawal by Subject|1|||
105881268|NCT04468347|365218821|FG002|Overall Study|Withdrawal by Subject|3|||
105881269|NCT04468347|365218822|FG003|Overall Study|Withdrawal by Subject|3|||
106111001|NCT01376323|366062013|FG004|Overall Study|Lost to Follow-up|0|||
106111002|NCT01376323|366062009|FG000|Overall Study|Physician Decision|1|||
106111003|NCT01376323|366062010|FG001|Overall Study|Physician Decision|0|||
106111004|NCT01376323|366062011|FG002|Overall Study|Physician Decision|2|||
106111005|NCT01376323|366062012|FG003|Overall Study|Physician Decision|1|||
106111006|NCT01376323|366062013|FG004|Overall Study|Physician Decision|1|||
105881270|NCT04468347|365218819|FG000|Overall Study|Lost to Follow-up|0|||
106111007|NCT01376323|366062009|FG000|Overall Study|Withdrawal by Subject|0|||
106111008|NCT01376323|366062010|FG001|Overall Study|Withdrawal by Subject|1|||
106111009|NCT01376323|366062011|FG002|Overall Study|Withdrawal by Subject|1|||
106111010|NCT01376323|366062012|FG003|Overall Study|Withdrawal by Subject|0|||
106111011|NCT01376323|366062013|FG004|Overall Study|Withdrawal by Subject|0|||
106111012|NCT01960725|366062014|FG000|Overall Study|Lost to Follow-up|4|||
106111013|NCT01960725|366062015|FG001|Overall Study|Lost to Follow-up|3|||
105881271|NCT04468347|365218820|FG001|Overall Study|Lost to Follow-up|0|||
105881272|NCT04468347|365218821|FG002|Overall Study|Lost to Follow-up|1|||
105881273|NCT04468347|365218822|FG003|Overall Study|Lost to Follow-up|1|||
105881274|NCT04468347|365218819|FG000|Overall Study|Physician Decision|1|||
105881275|NCT04468347|365218820|FG001|Overall Study|Physician Decision|0|||
105881276|NCT04468347|365218821|FG002|Overall Study|Physician Decision|2|||
105881277|NCT04468347|365218822|FG003|Overall Study|Physician Decision|0|||
106111014|NCT01960725|366062014|FG000|Overall Study|Withdrawal by Subject|1|||
106111015|NCT01960725|366062015|FG001|Overall Study|Withdrawal by Subject|0|||
106111016|NCT01960725|366062014|FG000|Overall Study|unable to obtain blood sample|1|||
106111017|NCT01960725|366062015|FG001|Overall Study|unable to obtain blood sample|2|||
106111018|NCT00758459|366062017|FG000|Overall Study|Adverse Event|3|||
106111019|NCT00758459|366062018|FG001|Overall Study|Adverse Event|2|||
106111020|NCT00758459|366062017|FG000|Overall Study|Protocol Violation|0|||
106111021|NCT00758459|366062018|FG001|Overall Study|Protocol Violation|1|||
106111022|NCT00758459|366062017|FG000|Overall Study|Withdrawal by Subject|0|||
106111023|NCT00758459|366062018|FG001|Overall Study|Withdrawal by Subject|1|||
106111024|NCT04766086|366062020|FG000|Overall Study|Lost to Follow-up|3|||
106111025|NCT04766086|366062021|FG001|Overall Study|Lost to Follow-up|5|||
106111026|NCT04766086|366062022|FG002|Overall Study|Lost to Follow-up|3|||
106111027|NCT04766086|366062020|FG000|Overall Study|Withdrawal by Subject|1|||
106111028|NCT04766086|366062021|FG001|Overall Study|Withdrawal by Subject|1|||
106111029|NCT04766086|366062022|FG002|Overall Study|Withdrawal by Subject|2|||
106111030|NCT04766086|366062020|FG000|Overall Study|Other|0|||
106111031|NCT04766086|366062021|FG001|Overall Study|Other|0|||
106111032|NCT04766086|366062022|FG002|Overall Study|Other|1|||
106111033|NCT02496767|366062033|FG000|Open-label Lead-in Phase|Adverse Event|176|||
106111034|NCT02496767|366062034|FG001|Open-label Lead-in Phase|Adverse Event|0|||
106111035|NCT02496767|366062035|FG002|Open-label Lead-in Phase|Adverse Event|0|||
106111036|NCT02496767|366062036|FG003|Open-label Lead-in Phase|Adverse Event|0|||
106111037|NCT02496767|366062037|FG004|Open-label Lead-in Phase|Adverse Event|0|||
106111038|NCT02496767|366062038|FG005|Open-label Lead-in Phase|Adverse Event|0|||
106111039|NCT02496767|366062039|FG006|Open-label Lead-in Phase|Adverse Event|0|||
106111040|NCT02496767|366062040|FG007|Open-label Lead-in Phase|Adverse Event|0|||
106111041|NCT02496767|366062033|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
106111042|NCT02496767|366062034|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
106111043|NCT02496767|366062035|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
105661746|NCT04913948|364425129|FG000|Overall Study|Withdrawal by Subject|2|||
105881278|NCT04468347|365218819|FG000|Overall Study|Protocol Violation|1|||
106111044|NCT02496767|366062036|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
106111045|NCT02496767|366062037|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
106111046|NCT02496767|366062038|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
105661747|NCT04913948|364425129|FG000|Overall Study|Sample processing issues|1|||
105881279|NCT04468347|365218820|FG001|Overall Study|Protocol Violation|0|||
105881280|NCT04468347|365218821|FG002|Overall Study|Protocol Violation|0|||
106111047|NCT02496767|366062039|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
106111048|NCT02496767|366062040|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
106111049|NCT02496767|366062033|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
106111050|NCT02496767|366062034|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
106111051|NCT02496767|366062035|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
105881281|NCT04468347|365218822|FG003|Overall Study|Protocol Violation|0|||
105881282|NCT01732458|365218823|FG000|Overall Study|Lost to Follow-up|0|||
105881283|NCT01732458|365218824|FG001|Overall Study|Lost to Follow-up|2|||
105881284|NCT01732458|365218825|FG002|Overall Study|Lost to Follow-up|0|||
105881285|NCT01732458|365218826|FG003|Overall Study|Lost to Follow-up|0|||
105881286|NCT01732458|365218823|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105881287|NCT01732458|365218824|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105881288|NCT01732458|365218825|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105881289|NCT01732458|365218826|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105881290|NCT01732458|365218823|FG000|Overall Study|Physician Decision|1|||
105881291|NCT01732458|365218824|FG001|Overall Study|Physician Decision|2|||
105881292|NCT01732458|365218825|FG002|Overall Study|Physician Decision|2|||
105881293|NCT01732458|365218826|FG003|Overall Study|Physician Decision|0|||
105881294|NCT01732458|365218823|FG000|Overall Study|Protocol Violation|2|||
105881295|NCT01732458|365218824|FG001|Overall Study|Protocol Violation|0|||
105881296|NCT01732458|365218825|FG002|Overall Study|Protocol Violation|0|||
105881297|NCT01732458|365218826|FG003|Overall Study|Protocol Violation|2|||
105881298|NCT01732458|365218823|FG000|Overall Study|Screen Failure|0|||
105881299|NCT01732458|365218824|FG001|Overall Study|Screen Failure|1|||
105881300|NCT01732458|365218825|FG002|Overall Study|Screen Failure|0|||
105881301|NCT01732458|365218826|FG003|Overall Study|Screen Failure|0|||
105881302|NCT00554515|365218827|FG000|Overall Study|Withdrawal by Subject|3|||
105881303|NCT00554515|365218827|FG000|Overall Study|Disease progression|52|||
105881304|NCT00554515|365218827|FG000|Overall Study|Physician Decision|18|||
105881305|NCT00554515|365218827|FG000|Overall Study|Withdrawal by Subject|11|||
105881306|NCT00554515|365218827|FG000|Overall Study|Adverse Event|9|||
105881307|NCT00554515|365218827|FG000|Overall Study|Death|2|||
105881308|NCT00554515|365218827|FG000|Overall Study|Achieved Stable Disease|7|||
105881309|NCT00554515|365218827|FG000|Overall Study|Other|1|||
105881310|NCT00554515|365218827|FG000|Overall Study|Misc|15|||
105881311|NCT00488644|365218828|FG000|Overall Study|Not Eligible|1|||
105881312|NCT00488644|365218828|FG000|Overall Study|Not Evaluable|1|||
105881313|NCT00952068|365218829|FG000|Overall Study|Adverse Event|3|||
105881314|NCT00952068|365218829|FG000|Overall Study|Withdrawal by Subject|4|||
105881315|NCT01276756|365218837|FG000|Overall Study|Lost to Follow-up|2|||
105881316|NCT01276756|365218838|FG001|Overall Study|Lost to Follow-up|0|||
105881317|NCT01276756|365218837|FG000|Overall Study|Adverse Event|3|||
105881318|NCT01276756|365218838|FG001|Overall Study|Adverse Event|2|||
105881319|NCT02589639|365218839|FG000|Overall Study|Lost to Follow-up|1|||
105881320|NCT02589639|365218840|FG001|Overall Study|Lost to Follow-up|0|||
105881321|NCT02589639|365218841|FG002|Overall Study|Lost to Follow-up|0|||
105881322|NCT02589639|365218839|FG000|Overall Study|Protocol Violation|1|||
106111052|NCT02496767|366062036|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
106111053|NCT02496767|366062037|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
106111054|NCT02496767|366062038|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
106111055|NCT02496767|366062039|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
106111056|NCT02496767|366062040|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
106111057|NCT02496767|366062033|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
106111058|NCT02496767|366062034|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
106111059|NCT02496767|366062035|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
106111060|NCT02496767|366062036|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
106111061|NCT02496767|366062037|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
106111062|NCT02496767|366062038|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
106111063|NCT02496767|366062039|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
106111064|NCT02496767|366062040|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
106111065|NCT02496767|366062033|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
106111066|NCT02496767|366062034|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
106111067|NCT02496767|366062035|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
106111068|NCT02496767|366062036|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
106111069|NCT02496767|366062037|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
106111070|NCT02496767|366062038|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
106111071|NCT02496767|366062039|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
106111072|NCT02496767|366062040|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
106111073|NCT02496767|366062033|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
106111074|NCT02496767|366062034|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
105881323|NCT02589639|365218840|FG001|Overall Study|Protocol Violation|0|||
105881324|NCT02589639|365218841|FG002|Overall Study|Protocol Violation|0|||
105881325|NCT02589639|365218839|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
105881326|NCT02589639|365218840|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
105881327|NCT02589639|365218841|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
105881328|NCT02589639|365218839|FG000|Overall Study|Adverse Event|4|||
105881329|NCT02589639|365218840|FG001|Overall Study|Adverse Event|5|||
105881330|NCT02589639|365218841|FG002|Overall Study|Adverse Event|3|||
105881331|NCT02589639|365218839|FG000|Overall Study|Other reason than specified above|1|||
105881332|NCT02589639|365218840|FG001|Overall Study|Other reason than specified above|2|||
105881333|NCT02589639|365218841|FG002|Overall Study|Other reason than specified above|1|||
105881334|NCT02589639|365218839|FG000|Overall Study|Not Treated|0|||
105881335|NCT02589639|365218840|FG001|Overall Study|Not Treated|3|||
105881336|NCT02589639|365218841|FG002|Overall Study|Not Treated|0|||
105881337|NCT03759587|365218842|FG000|Overall Study|Adverse Event|5|||
105881338|NCT03759587|365218842|FG000|Overall Study|Progressive Disease|10|||
105881339|NCT03759587|365218842|FG000|Overall Study|Site Terminated by Sponsor|3|||
105881340|NCT03759587|365218842|FG000|Overall Study|Withdrawal by Subject|1|||
105881341|NCT04615403|365218843|FG000|Overall Study|Death|1|||
105881342|NCT00603473|365218846|FG000|Overall Study|Adverse Event|4|||
105881343|NCT00603473|365218846|FG000|Overall Study|Lack of Efficacy|4|||
105881344|NCT00603473|365218846|FG000|Overall Study|Protocol Violation|1|||
105881345|NCT01209520|365218847|FG000|Overall Study|Withdrawal by Subject|3|||
105881346|NCT02801617|365220362|FG000|Overall Study|Protocol Violation|2|||
105881347|NCT02801617|365220363|FG001|Overall Study|Protocol Violation|6|||
105881348|NCT01372618|365220364|FG000|Overall Study|PI Died. Study Terminated|9|||
105881349|NCT01954056|365220365|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
105881350|NCT01954056|365220366|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
105881351|NCT01464593|365220370|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
105881352|NCT01288937|365220375|FG000|Overall Study|Adverse Event|1|||
105881353|NCT01288937|365220376|FG001|Overall Study|Adverse Event|0|||
105881354|NCT02230904|365220377|FG000|Overall Study|Safety follow up could not take place|0|||
105881355|NCT02230904|365220378|FG001|Overall Study|Safety follow up could not take place|1|||
105881356|NCT01560234|365220379|FG000|Overall Study|Lost to Follow-up|3|||
105881357|NCT01560234|365220380|FG001|Overall Study|Lost to Follow-up|0|||
105881358|NCT01560234|365220381|FG002|Overall Study|Lost to Follow-up|1|||
105881359|NCT01560234|365220382|FG003|Overall Study|Lost to Follow-up|0|||
105881360|NCT01560234|365220383|FG004|Overall Study|Lost to Follow-up|0|||
105881361|NCT01560234|365220384|FG005|Overall Study|Lost to Follow-up|2|||
105881362|NCT01560234|365220385|FG006|Overall Study|Lost to Follow-up|0|||
105881363|NCT01560234|365220386|FG007|Overall Study|Lost to Follow-up|2|||
105881364|NCT02914613|365220387|FG000|Overall Study|Withdrawal by Subject|1|||
105881365|NCT02914613|365220388|FG001|Overall Study|Withdrawal by Subject|2|||
105881366|NCT02914613|365220387|FG000|Overall Study|Adverse Event|1|||
105881367|NCT02914613|365220388|FG001|Overall Study|Adverse Event|0|||
105881368|NCT01964222|365220393|FG000|Overall Study|Lost to Follow-up|7|||
105881369|NCT01964222|365220394|FG001|Overall Study|Lost to Follow-up|5|||
105881370|NCT01964222|365220393|FG000|Overall Study|Withdrawal by Subject|6|||
105881371|NCT01964222|365220394|FG001|Overall Study|Withdrawal by Subject|6|||
105881372|NCT01964222|365220393|FG000|Overall Study|Screening Failure|2|||
105881373|NCT01964222|365220394|FG001|Overall Study|Screening Failure|0|||
105881374|NCT01455597|365220397|FG000|Overall Study|Adverse Event|7|||
105881375|NCT01455597|365220398|FG001|Overall Study|Adverse Event|0|||
105881376|NCT01455597|365220399|FG002|Overall Study|Adverse Event|5|||
105881377|NCT01455597|365220400|FG003|Overall Study|Adverse Event|1|||
105881378|NCT01455597|365220397|FG000|Overall Study|Lack of Efficacy|0|||
105881379|NCT01455597|365220398|FG001|Overall Study|Lack of Efficacy|1|||
105881380|NCT01455597|365220399|FG002|Overall Study|Lack of Efficacy|2|||
105881381|NCT01455597|365220400|FG003|Overall Study|Lack of Efficacy|0|||
105881382|NCT01455597|365220397|FG000|Overall Study|Lost to Follow-up|3|||
105881383|NCT01455597|365220398|FG001|Overall Study|Lost to Follow-up|0|||
105881384|NCT01455597|365220399|FG002|Overall Study|Lost to Follow-up|2|||
105881385|NCT01455597|365220400|FG003|Overall Study|Lost to Follow-up|1|||
105881386|NCT01455597|365220397|FG000|Overall Study|Withdrew Consent|6|||
105881387|NCT01455597|365220398|FG001|Overall Study|Withdrew Consent|5|||
105881388|NCT01455597|365220399|FG002|Overall Study|Withdrew Consent|8|||
105881389|NCT01455597|365220400|FG003|Overall Study|Withdrew Consent|5|||
105881390|NCT01455597|365220397|FG000|Overall Study|Reason not Specified|1|||
105881391|NCT01455597|365220398|FG001|Overall Study|Reason not Specified|2|||
105881392|NCT01455597|365220399|FG002|Overall Study|Reason not Specified|3|||
105881393|NCT01455597|365220400|FG003|Overall Study|Reason not Specified|3|||
105881394|NCT03412734|365220401|FG000|Overall Study|Incorrect labeling of samples|2|||
105881395|NCT03412734|365220402|FG001|Overall Study|Incorrect labeling of samples|0|||
106111075|NCT02496767|366062035|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
105881396|NCT03412734|365220401|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
105881397|NCT03412734|365220402|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
105881398|NCT00758485|365220404|FG000|Overall Study|Lost to Follow-up|0|||
105881399|NCT00758485|365220405|FG001|Overall Study|Lost to Follow-up|1|||
105881400|NCT00758485|365220404|FG000|Overall Study|Not Treated|1|||
105881401|NCT00758485|365220405|FG001|Overall Study|Not Treated|2|||
105881402|NCT02347774|365220406|FG000|Study Participation|Lost to Follow-up|3|||
105881403|NCT02347774|365220407|FG001|Study Participation|Lost to Follow-up|6|||
105881404|NCT02347774|365220408|FG002|Study Participation|Lost to Follow-up|2|||
105881405|NCT02347774|365220406|FG000|Study Participation|Withdrawal by Subject|8|||
105881406|NCT02347774|365220407|FG001|Study Participation|Withdrawal by Subject|9|||
105881407|NCT02347774|365220408|FG002|Study Participation|Withdrawal by Subject|15|||
105881408|NCT02347774|365220406|FG000|Study Participation|Adverse Event|1|||
105881409|NCT02347774|365220407|FG001|Study Participation|Adverse Event|4|||
105881410|NCT02347774|365220408|FG002|Study Participation|Adverse Event|6|||
105881411|NCT02347774|365220406|FG000|Study Participation|withdrew consent|1|||
105881412|NCT02347774|365220407|FG001|Study Participation|withdrew consent|1|||
105881413|NCT02347774|365220408|FG002|Study Participation|withdrew consent|1|||
105881414|NCT02347774|365220406|FG000|Study Participation|Met Prolonged QT criteria|1|||
105881415|NCT02347774|365220407|FG001|Study Participation|Met Prolonged QT criteria|0|||
105881416|NCT02347774|365220408|FG002|Study Participation|Met Prolonged QT criteria|0|||
105881417|NCT02347774|365220406|FG000|Study Participation|non-compliance with study drug|0|||
105881418|NCT02347774|365220407|FG001|Study Participation|non-compliance with study drug|1|||
105881419|NCT02347774|365220408|FG002|Study Participation|non-compliance with study drug|0|||
105881420|NCT02347774|365220406|FG000|Study Participation|incarceration|1|||
105881421|NCT02347774|365220407|FG001|Study Participation|incarceration|0|||
105881422|NCT02347774|365220408|FG002|Study Participation|incarceration|0|||
105881423|NCT02347774|365220406|FG000|Study Participation|randomized in error|0|||
105881424|NCT02347774|365220407|FG001|Study Participation|randomized in error|0|||
105881425|NCT02347774|365220408|FG002|Study Participation|randomized in error|1|||
105881426|NCT02347774|365220406|FG000|On Study Treatment|Adverse Event|9|||
105881427|NCT02347774|365220407|FG001|On Study Treatment|Adverse Event|15|||
105881428|NCT02347774|365220408|FG002|On Study Treatment|Adverse Event|19|||
105881429|NCT02347774|365220406|FG000|On Study Treatment|Lack of Efficacy|3|||
105881430|NCT02347774|365220407|FG001|On Study Treatment|Lack of Efficacy|0|||
105881431|NCT02347774|365220408|FG002|On Study Treatment|Lack of Efficacy|2|||
105881432|NCT02347774|365220406|FG000|On Study Treatment|non-complicance with study medication|0|||
105881433|NCT02347774|365220407|FG001|On Study Treatment|non-complicance with study medication|2|||
105881434|NCT02347774|365220408|FG002|On Study Treatment|non-complicance with study medication|0|||
105881435|NCT02347774|365220406|FG000|On Study Treatment|Protocol Violation|0|||
105881436|NCT02347774|365220407|FG001|On Study Treatment|Protocol Violation|0|||
105881437|NCT02347774|365220408|FG002|On Study Treatment|Protocol Violation|1|||
105881438|NCT02347774|365220406|FG000|On Study Treatment|withdrew consent|9|||
105881439|NCT02347774|365220407|FG001|On Study Treatment|withdrew consent|8|||
105881440|NCT02347774|365220408|FG002|On Study Treatment|withdrew consent|12|||
105881441|NCT02347774|365220406|FG000|On Study Treatment|Lost to Follow-up|2|||
105881442|NCT02347774|365220407|FG001|On Study Treatment|Lost to Follow-up|6|||
105881443|NCT02347774|365220408|FG002|On Study Treatment|Lost to Follow-up|1|||
105881444|NCT02347774|365220406|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
105881445|NCT02347774|365220407|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
105881446|NCT02347774|365220408|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
105881447|NCT02347774|365220406|FG000|On Study Treatment|ranomized in error|0|||
105881448|NCT02347774|365220407|FG001|On Study Treatment|ranomized in error|0|||
105881449|NCT02347774|365220408|FG002|On Study Treatment|ranomized in error|1|||
105881450|NCT00820248|365220409|FG000|Overall Study|No treated|4|||
105881451|NCT00820248|365220410|FG001|Overall Study|No treated|1|||
105881452|NCT03259425|365220411|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
105881453|NCT01750697|365220412|FG000|Overall Study|Transferred Back to Local Hospital|1|||
105881454|NCT01750697|365220412|FG000|Overall Study|Physician and Family Decision|1|||
105881455|NCT01750697|365220412|FG000|Overall Study|Transferred to Adult Services|5|||
105881456|NCT01750697|365220412|FG000|Overall Study|Physician Decision|1|||
105881457|NCT01750697|365220412|FG000|Overall Study|Withdrawal by Subject|1|||
105881458|NCT01562782|365220414|FG000|Overall Study|Withdrawal by Subject|3|||
106111076|NCT02496767|366062036|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
106111077|NCT02496767|366062037|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
106111078|NCT02496767|366062038|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
106111079|NCT02496767|366062039|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
106111080|NCT02496767|366062040|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
106111081|NCT02496767|366062033|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
106111082|NCT02496767|366062034|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
106111083|NCT02496767|366062035|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
106111084|NCT02496767|366062036|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
106111085|NCT02496767|366062037|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
106111086|NCT02496767|366062038|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
106111087|NCT02496767|366062039|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
106111088|NCT02496767|366062040|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
106111089|NCT02496767|366062033|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105881459|NCT01562782|365220415|FG001|Overall Study|Withdrawal by Subject|3|||
105881460|NCT01562782|365220414|FG000|Overall Study|screen failure|1|||
105881461|NCT01562782|365220415|FG001|Overall Study|screen failure|2|||
105881462|NCT02285166|365220418|FG000|Overall Study|Case Report Forms Uncollected|564|||
105881463|NCT02285166|365220418|FG000|Overall Study|Protocol Deviation|402|||
105881464|NCT01421225|365220423|FG000|Overall Study|Withdrawal by Subject|0|||
105881465|NCT01421225|365220424|FG001|Overall Study|Withdrawal by Subject|1|||
106111090|NCT02496767|366062034|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
105881466|NCT01814696|365220432|FG000|Overall Study|Withdrawal by Subject|1|||
105881467|NCT01814696|365220433|FG001|Overall Study|Withdrawal by Subject|0|||
105881468|NCT01814696|365220432|FG000|Overall Study|Randomized to wrong group|1|||
105881469|NCT01814696|365220433|FG001|Overall Study|Randomized to wrong group|0|||
105881470|NCT00713258|365220434|FG000|Overall Study|Adverse Event|2|||
105881471|NCT00713258|365220435|FG001|Overall Study|Adverse Event|4|||
105881472|NCT00713258|365220434|FG000|Overall Study|Non-Compliance|2|||
105881473|NCT00713258|365220435|FG001|Overall Study|Non-Compliance|1|||
105881474|NCT00713258|365220434|FG000|Overall Study|Other|1|||
105881475|NCT00713258|365220435|FG001|Overall Study|Other|1|||
105881476|NCT00568061|365220436|FG000|Overall Study|Inclusion / exclusion criteria|5|||
105881477|NCT00568061|365220437|FG001|Overall Study|Inclusion / exclusion criteria|1|||
105881478|NCT00568061|365220436|FG000|Overall Study|Adverse Event|0|||
105881479|NCT00568061|365220437|FG001|Overall Study|Adverse Event|1|||
105881480|NCT01896128|365220438|FG000|Overall Study|Withdrawal by Subject|3|||
105881481|NCT01896128|365220439|FG001|Overall Study|Withdrawal by Subject|3|||
105881482|NCT00356148|365220440|FG000|Overall Study|Reoperation within 30 days|2|||
105881483|NCT00356148|365220441|FG001|Overall Study|Reoperation within 30 days|1|||
105881484|NCT00812981|365220444|FG000|Overall Study|Other|0|||
105881485|NCT00812981|365220445|FG001|Overall Study|Other|1|||
105881486|NCT00460811|365220457|FG000|Overall Study|Adverse Event|4|||
105881487|NCT00460811|365220458|FG001|Overall Study|Adverse Event|6|||
105881488|NCT00460811|365220459|FG002|Overall Study|Adverse Event|3|||
105881489|NCT00460811|365220460|FG003|Overall Study|Adverse Event|10|||
105881490|NCT00460811|365220461|FG004|Overall Study|Adverse Event|2|||
105881491|NCT00460811|365220457|FG000|Overall Study|Noncompliance|1|||
105881492|NCT00460811|365220458|FG001|Overall Study|Noncompliance|0|||
105881493|NCT00460811|365220459|FG002|Overall Study|Noncompliance|0|||
105881494|NCT00460811|365220460|FG003|Overall Study|Noncompliance|2|||
105881495|NCT00460811|365220461|FG004|Overall Study|Noncompliance|1|||
105881496|NCT00460811|365220457|FG000|Overall Study|Withdrawal by Subject|7|||
105881497|NCT00460811|365220458|FG001|Overall Study|Withdrawal by Subject|7|||
105881498|NCT00460811|365220459|FG002|Overall Study|Withdrawal by Subject|6|||
105881499|NCT00460811|365220460|FG003|Overall Study|Withdrawal by Subject|3|||
105881500|NCT00460811|365220461|FG004|Overall Study|Withdrawal by Subject|11|||
105881501|NCT00460811|365220457|FG000|Overall Study|Physician Decision|1|||
105881502|NCT00460811|365220458|FG001|Overall Study|Physician Decision|0|||
105881503|NCT00460811|365220459|FG002|Overall Study|Physician Decision|0|||
105881504|NCT00460811|365220460|FG003|Overall Study|Physician Decision|0|||
105881505|NCT00460811|365220461|FG004|Overall Study|Physician Decision|0|||
105881506|NCT00460811|365220457|FG000|Overall Study|Lost to Follow-up|3|||
105881507|NCT00460811|365220458|FG001|Overall Study|Lost to Follow-up|2|||
105881508|NCT00460811|365220459|FG002|Overall Study|Lost to Follow-up|5|||
105881509|NCT00460811|365220460|FG003|Overall Study|Lost to Follow-up|3|||
105881510|NCT00460811|365220461|FG004|Overall Study|Lost to Follow-up|6|||
105881511|NCT02099110|365220462|FG000|Overall Study|Protocol Violation|2|||
105881512|NCT02099110|365220463|FG001|Overall Study|Protocol Violation|1|||
105881513|NCT02099110|365220464|FG002|Overall Study|Protocol Violation|0|||
105881514|NCT02099110|365220465|FG003|Overall Study|Protocol Violation|3|||
105881515|NCT02099110|365220466|FG004|Overall Study|Protocol Violation|1|||
105881516|NCT02099110|365220462|FG000|Overall Study|Participant moved|1|||
105881517|NCT02099110|365220463|FG001|Overall Study|Participant moved|1|||
105881518|NCT02099110|365220464|FG002|Overall Study|Participant moved|1|||
105881519|NCT02099110|365220465|FG003|Overall Study|Participant moved|0|||
105881520|NCT02099110|365220466|FG004|Overall Study|Participant moved|2|||
105881521|NCT02099110|365220462|FG000|Overall Study|Withdrawal by Subject|7|||
105881522|NCT02099110|365220463|FG001|Overall Study|Withdrawal by Subject|11|||
105881523|NCT02099110|365220464|FG002|Overall Study|Withdrawal by Subject|13|||
105881524|NCT02099110|365220465|FG003|Overall Study|Withdrawal by Subject|9|||
105881525|NCT02099110|365220466|FG004|Overall Study|Withdrawal by Subject|13|||
106111091|NCT02496767|366062035|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
106111092|NCT02496767|366062036|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
105881526|NCT02099110|365220462|FG000|Overall Study|Adverse Event|3|||
106111093|NCT02496767|366062037|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
106111094|NCT02496767|366062038|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105881527|NCT02099110|365220463|FG001|Overall Study|Adverse Event|5|||
105881528|NCT02099110|365220464|FG002|Overall Study|Adverse Event|2|||
105881529|NCT02099110|365220465|FG003|Overall Study|Adverse Event|3|||
105881530|NCT02099110|365220466|FG004|Overall Study|Adverse Event|2|||
105881531|NCT02099110|365220462|FG000|Overall Study|Lost to Follow-up|6|||
105881532|NCT02099110|365220463|FG001|Overall Study|Lost to Follow-up|12|||
105881533|NCT02099110|365220464|FG002|Overall Study|Lost to Follow-up|11|||
105881534|NCT02099110|365220465|FG003|Overall Study|Lost to Follow-up|5|||
105881535|NCT02099110|365220466|FG004|Overall Study|Lost to Follow-up|6|||
105881536|NCT02099110|365220462|FG000|Overall Study|Death|0|||
105881537|NCT02099110|365220463|FG001|Overall Study|Death|1|||
105881538|NCT02099110|365220464|FG002|Overall Study|Death|0|||
105881539|NCT02099110|365220465|FG003|Overall Study|Death|0|||
105881540|NCT02099110|365220466|FG004|Overall Study|Death|0|||
105881541|NCT02099110|365220462|FG000|Overall Study|Screen failure|0|||
105881542|NCT02099110|365220463|FG001|Overall Study|Screen failure|0|||
105881543|NCT02099110|365220464|FG002|Overall Study|Screen failure|0|||
105881544|NCT02099110|365220465|FG003|Overall Study|Screen failure|0|||
105881545|NCT02099110|365220466|FG004|Overall Study|Screen failure|1|||
105881546|NCT02099110|365220462|FG000|Overall Study|Non-compliance with study drug|2|||
105881547|NCT02099110|365220463|FG001|Overall Study|Non-compliance with study drug|0|||
105881548|NCT02099110|365220464|FG002|Overall Study|Non-compliance with study drug|0|||
105881549|NCT02099110|365220465|FG003|Overall Study|Non-compliance with study drug|0|||
105881550|NCT02099110|365220466|FG004|Overall Study|Non-compliance with study drug|1|||
105881551|NCT02099110|365220462|FG000|Overall Study|Physician Decision|3|||
105881552|NCT02099110|365220463|FG001|Overall Study|Physician Decision|0|||
105881553|NCT02099110|365220464|FG002|Overall Study|Physician Decision|1|||
105881554|NCT02099110|365220465|FG003|Overall Study|Physician Decision|2|||
105881555|NCT02099110|365220466|FG004|Overall Study|Physician Decision|1|||
105881556|NCT02064816|365220467|FG000|Overall Study|Adverse Event|3|||
105881557|NCT02064816|365220468|FG001|Overall Study|Adverse Event|2|||
105881558|NCT02064816|365220467|FG000|Overall Study|Withdrawal by Subject|2|||
105881559|NCT02064816|365220468|FG001|Overall Study|Withdrawal by Subject|1|||
105881560|NCT02064816|365220467|FG000|Overall Study|Lost to Follow-up|2|||
105881561|NCT02064816|365220468|FG001|Overall Study|Lost to Follow-up|1|||
105881562|NCT02064816|365220467|FG000|Overall Study|Therapeutic failure|0|||
105881563|NCT02064816|365220468|FG001|Overall Study|Therapeutic failure|1|||
105881564|NCT02064816|365220467|FG000|Overall Study|Other|1|||
105881565|NCT02064816|365220468|FG001|Overall Study|Other|3|||
105881566|NCT00996125|365220469|FG000|Overall Study|Adverse Event|0|||
105881567|NCT00996125|365220470|FG001|Overall Study|Adverse Event|2|||
105881568|NCT00996125|365220469|FG000|Overall Study|Lost to Follow-up|1|||
105881569|NCT00996125|365220470|FG001|Overall Study|Lost to Follow-up|6|||
105881570|NCT00996125|365220469|FG000|Overall Study|Withdrawal by Subject|4|||
105881571|NCT00996125|365220470|FG001|Overall Study|Withdrawal by Subject|3|||
105881572|NCT02203721|365220482|FG000|Overall Study|Lost to Follow-up|1|||
105881573|NCT02203721|365220483|FG001|Overall Study|Lost to Follow-up|0|||
105881574|NCT02203721|365220482|FG000|Overall Study|Death|0|||
105881575|NCT02203721|365220483|FG001|Overall Study|Death|2|||
105881576|NCT02203721|365220482|FG000|Overall Study|Illness|0|||
105881577|NCT02203721|365220483|FG001|Overall Study|Illness|1|||
105881578|NCT02522884|365220491|FG000|Overall Study|Withdrawal by Subject|6|||
105881579|NCT02522884|365220491|FG000|Overall Study|Death|3|||
105881580|NCT02522884|365220491|FG000|Overall Study|Missed 12-month Follow-up|9|||
105881581|NCT03340454|365220492|FG000|Overall Study|Lost to Follow-up|0|||
105881582|NCT03340454|365220493|FG001|Overall Study|Lost to Follow-up|4|||
105881583|NCT03482453|365220494|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881584|NCT03482453|365220495|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881585|NCT03482453|365220496|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881586|NCT03482453|365220497|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881587|NCT03482453|365220498|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881588|NCT03482453|365220499|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881589|NCT03482453|365220500|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881590|NCT03482453|365220501|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881591|NCT03482453|365220502|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881592|NCT03482453|365220503|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881593|NCT03482453|365220504|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
105881594|NCT03482453|365220505|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
105881595|NCT01074268|365220506|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
105881596|NCT01074268|365220507|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
105881597|NCT01074268|365220506|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
106111095|NCT02496767|366062039|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
106111096|NCT02496767|366062040|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
106111097|NCT02496767|366062033|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
106111098|NCT02496767|366062034|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
106111099|NCT02496767|366062035|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
106111100|NCT02496767|366062036|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105881598|NCT01074268|365220507|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
105881599|NCT01074268|365220506|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
105881600|NCT01074268|365220507|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
105881601|NCT01074268|365220506|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
105881602|NCT01074268|365220507|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
105881603|NCT01074268|365220506|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
105881604|NCT01074268|365220507|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
105881605|NCT01074268|365220506|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
105881606|NCT01074268|365220507|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
105993710|NCT01510158|365636076|FG001|Overall Study|Protocol Violation|16|||
105881607|NCT01074268|365220506|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
105881608|NCT01074268|365220507|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
105881609|NCT01074268|365220506|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
105881610|NCT01074268|365220507|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
105881611|NCT01074268|365220506|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
105881612|NCT01074268|365220507|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
105881613|NCT00314327|365220512|FG000|Overall Study|Withdrawal by Subject|1|||
105881614|NCT02837731|365220513|FG000|Allocation|Admitted to General Floor|3|||
105881615|NCT02837731|365220514|FG001|Allocation|Admitted to General Floor|4|||
105881616|NCT02837731|365220513|FG000|Allocation|Immediate surgery/withdrew|2|||
105881617|NCT02837731|365220514|FG001|Allocation|Immediate surgery/withdrew|0|||
105881618|NCT02837731|365220513|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
105881619|NCT02837731|365220514|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
105881620|NCT02837731|365220513|FG000|Allocation|Withdrawal by Subject|2|||
105881621|NCT02837731|365220514|FG001|Allocation|Withdrawal by Subject|0|||
105881622|NCT02837731|365220513|FG000|Allocation|Device not available|1|||
105881623|NCT02837731|365220514|FG001|Allocation|Device not available|0|||
105881624|NCT02837731|365220513|FG000|Allocation|Protocol not implemented|7|||
105881625|NCT02837731|365220514|FG001|Allocation|Protocol not implemented|0|||
105881626|NCT02837731|365220513|FG000|Allocation|Moribund/Do not resuscitate|2|||
105881627|NCT02837731|365220514|FG001|Allocation|Moribund/Do not resuscitate|0|||
105881628|NCT02837731|365220513|FG000|Allocation|Did not meet sepsis criteria|1|||
105881629|NCT02837731|365220514|FG001|Allocation|Did not meet sepsis criteria|2|||
105881630|NCT02837731|365220513|FG000|Allocation|Known aortic abnormalities|0|||
105881631|NCT02837731|365220514|FG001|Allocation|Known aortic abnormalities|1|||
105881632|NCT02965573|365220518|FG000|Overall Study|Lack of Efficacy|1|||
105881633|NCT02965573|365220519|FG001|Overall Study|Lack of Efficacy|0|||
105881634|NCT01119859|365220520|FG000|Overall Study|Adverse Event|9|||
105881635|NCT01119859|365220521|FG001|Overall Study|Adverse Event|10|||
105881636|NCT01119859|365220520|FG000|Overall Study|Death|2|||
105881637|NCT01119859|365220521|FG001|Overall Study|Death|0|||
105881638|NCT01119859|365220520|FG000|Overall Study|Insufficient therapeutic response|7|||
105881639|NCT01119859|365220521|FG001|Overall Study|Insufficient therapeutic response|14|||
105881640|NCT01119859|365220520|FG000|Overall Study|Refused treatment|3|||
105881641|NCT01119859|365220521|FG001|Overall Study|Refused treatment|6|||
105881642|NCT01119859|365220520|FG000|Overall Study|Failure to return|3|||
105881643|NCT01119859|365220521|FG001|Overall Study|Failure to return|0|||
105881644|NCT00086619|365220522|FG000|Overall Study|Withdrawal by Subject|6|||
105881645|NCT00086619|365220523|FG001|Overall Study|Withdrawal by Subject|6|||
105881646|NCT00086619|365220522|FG000|Overall Study|Adverse Event|8|||
105881647|NCT00086619|365220523|FG001|Overall Study|Adverse Event|10|||
105881648|NCT00086619|365220522|FG000|Overall Study|Protocol Violation|1|||
105881649|NCT00086619|365220523|FG001|Overall Study|Protocol Violation|1|||
105881650|NCT00733421|365220525|FG000|Overall Study|Withdrawal by Subject|1|||
105881651|NCT00733421|365220526|FG001|Overall Study|Withdrawal by Subject|1|||
105881652|NCT01029782|365220527|FG000|Overall Study|Lost to Follow-up|2|||
105881653|NCT01029782|365220528|FG001|Overall Study|Lost to Follow-up|2|||
105881654|NCT01029782|365220527|FG000|Overall Study|Diagnosis changed|1|||
105881655|NCT01029782|365220528|FG001|Overall Study|Diagnosis changed|1|||
105881656|NCT01029782|365220527|FG000|Overall Study|Adverse Event|0|||
105881657|NCT01029782|365220528|FG001|Overall Study|Adverse Event|1|||
105881658|NCT01029782|365220527|FG000|Overall Study|Physician Decision|0|||
105881659|NCT01029782|365220528|FG001|Overall Study|Physician Decision|1|||
105881660|NCT01029782|365220527|FG000|Overall Study|Protocol Violation|0|||
105881661|NCT01029782|365220528|FG001|Overall Study|Protocol Violation|2|||
105881662|NCT01029782|365220527|FG000|Overall Study|Withdrawal by Subject|0|||
105881663|NCT01029782|365220528|FG001|Overall Study|Withdrawal by Subject|1|||
105881664|NCT01870973|365220532|FG000|Overall Study|Lost to Follow-up|10|||
105881665|NCT01870973|365220533|FG001|Overall Study|Lost to Follow-up|3|||
105881666|NCT00915018|365221854|FG000|Overall Study|Death|75|||
105993711|NCT01510158|365636077|FG002|Overall Study|Protocol Violation|24|||
105993712|NCT01510158|365636075|FG000|Overall Study|Sponsor terminated study.|2|||
105993713|NCT01510158|365636076|FG001|Overall Study|Sponsor terminated study.|0|||
105993714|NCT01510158|365636077|FG002|Overall Study|Sponsor terminated study.|2|||
105881667|NCT00915018|365221855|FG001|Overall Study|Death|70|||
105881668|NCT00915018|365221854|FG000|Overall Study|Lost to Follow-up|10|||
105881669|NCT00915018|365221855|FG001|Overall Study|Lost to Follow-up|5|||
105881670|NCT00915018|365221854|FG000|Overall Study|Withdrawal by Subject|38|||
105881671|NCT00915018|365221855|FG001|Overall Study|Withdrawal by Subject|27|||
105881672|NCT00915018|365221854|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
105881673|NCT00915018|365221855|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
105881674|NCT02101736|365221859|FG000|Overall Study|Protocol Violation|3|||
105881675|NCT02101736|365221860|FG001|Overall Study|Protocol Violation|0|||
105881676|NCT02101736|365221859|FG000|Overall Study|Withdrawal by Subject|1|||
105881677|NCT02101736|365221860|FG001|Overall Study|Withdrawal by Subject|1|||
105881678|NCT02609607|365221861|FG000|Overall Study|Lost to Follow-up|0|||
105993715|NCT01510158|365636075|FG000|Overall Study|Lost to Follow-up|13|||
105881679|NCT02609607|365221862|FG001|Overall Study|Lost to Follow-up|1|||
105881680|NCT00651261|365221863|FG000|Overall Study|Adverse Event|32|||
105881681|NCT00651261|365221864|FG001|Overall Study|Adverse Event|22|||
105881682|NCT00651261|365221863|FG000|Overall Study|Death|18|||
105881683|NCT00651261|365221864|FG001|Overall Study|Death|18|||
105881684|NCT00651261|365221863|FG000|Overall Study|Withdrawal by Subject|22|||
105881685|NCT00651261|365221864|FG001|Overall Study|Withdrawal by Subject|40|||
105881686|NCT00651261|365221863|FG000|Overall Study|Induction failure|24|||
105881687|NCT00651261|365221864|FG001|Overall Study|Induction failure|35|||
105881688|NCT00651261|365221863|FG000|Overall Study|Disease progression|58|||
105881689|NCT00651261|365221864|FG001|Overall Study|Disease progression|58|||
105881690|NCT00651261|365221863|FG000|Overall Study|Alternative therapy|109|||
105881691|NCT00651261|365221864|FG001|Overall Study|Alternative therapy|107|||
105881692|NCT00651261|365221863|FG000|Overall Study|Other disease or participant decisions|23|||
105881693|NCT00651261|365221864|FG001|Overall Study|Other disease or participant decisions|23|||
105881694|NCT00651261|365221863|FG000|Overall Study|Never treated|5|||
105881695|NCT00651261|365221864|FG001|Overall Study|Never treated|3|||
105881696|NCT00778817|365221867|FG000|Overall Study|Adverse Event|2|||
105881697|NCT00778817|365221867|FG000|Overall Study|Withdrawal by Subject|2|||
105881698|NCT04090060|365221869|FG000|Overall Study|Lost to Follow-up|76|||
105881699|NCT04090060|365221870|FG001|Overall Study|Lost to Follow-up|77|||
105881700|NCT01164579|365221877|FG000|Overall Study|Lack of Efficacy|0|||
105881701|NCT01164579|365221878|FG001|Overall Study|Lack of Efficacy|0|||
105881702|NCT01164579|365221879|FG002|Overall Study|Lack of Efficacy|6|||
105881703|NCT01164579|365221877|FG000|Overall Study|Lost to Follow-up|1|||
105881704|NCT01164579|365221878|FG001|Overall Study|Lost to Follow-up|1|||
105881705|NCT01164579|365221879|FG002|Overall Study|Lost to Follow-up|0|||
105881706|NCT01164579|365221877|FG000|Overall Study|Withdrawal by Subject|2|||
105881707|NCT01164579|365221878|FG001|Overall Study|Withdrawal by Subject|5|||
105881708|NCT01164579|365221879|FG002|Overall Study|Withdrawal by Subject|3|||
105881709|NCT01164579|365221877|FG000|Overall Study|Protocol Violation|0|||
105881710|NCT01164579|365221878|FG001|Overall Study|Protocol Violation|1|||
105881711|NCT01164579|365221879|FG002|Overall Study|Protocol Violation|2|||
105881712|NCT01164579|365221877|FG000|Overall Study|Adverse Event|4|||
105881713|NCT01164579|365221878|FG001|Overall Study|Adverse Event|2|||
105881714|NCT01164579|365221879|FG002|Overall Study|Adverse Event|5|||
105881715|NCT01164579|365221877|FG000|Overall Study|Reason not specified|1|||
105881716|NCT01164579|365221878|FG001|Overall Study|Reason not specified|0|||
105881717|NCT01164579|365221879|FG002|Overall Study|Reason not specified|0|||
105881718|NCT02490371|365221884|FG000|Overall Study|Lost to Follow-up|1|||
105881719|NCT02490371|365221885|FG001|Overall Study|Lost to Follow-up|1|||
105881720|NCT04938180|365221886|FG000|Overall Study|Adverse Event|1|||
105881721|NCT03018080|365221887|FG000|Overall Study|Death|12|||
105881722|NCT03018080|365221888|FG001|Overall Study|Death|19|||
105881723|NCT03491462|365221889|FG000|Overall Study|Lost to Follow-up|2|||
105881724|NCT03491462|365221890|FG001|Overall Study|Lost to Follow-up|0|||
105881725|NCT03491462|365221889|FG000|Overall Study|Adverse Event|11|||
105881726|NCT03491462|365221890|FG001|Overall Study|Adverse Event|1|||
105881727|NCT03491462|365221889|FG000|Overall Study|Physician Decision|3|||
105881728|NCT03491462|365221890|FG001|Overall Study|Physician Decision|0|||
105881729|NCT03491462|365221889|FG000|Overall Study|Withdrawal by Subject|22|||
105881730|NCT03491462|365221890|FG001|Overall Study|Withdrawal by Subject|15|||
105881731|NCT00740792|365221891|FG000|Overall Study|Adverse Event|3|||
105881732|NCT00740792|365221892|FG001|Overall Study|Adverse Event|1|||
105881733|NCT00740792|365221893|FG002|Overall Study|Adverse Event|1|||
105881734|NCT00740792|365221894|FG003|Overall Study|Adverse Event|3|||
105881735|NCT00740792|365221891|FG000|Overall Study|Lack of Efficacy|1|||
105881736|NCT00740792|365221892|FG001|Overall Study|Lack of Efficacy|1|||
105881737|NCT00740792|365221893|FG002|Overall Study|Lack of Efficacy|0|||
105881738|NCT00740792|365221894|FG003|Overall Study|Lack of Efficacy|3|||
105881739|NCT00740792|365221891|FG000|Overall Study|Lost to Follow-up|2|||
105881740|NCT00740792|365221892|FG001|Overall Study|Lost to Follow-up|1|||
105881741|NCT00740792|365221893|FG002|Overall Study|Lost to Follow-up|0|||
105881742|NCT00740792|365221894|FG003|Overall Study|Lost to Follow-up|0|||
105881743|NCT00740792|365221891|FG000|Overall Study|Protocol Violation|0|||
105881744|NCT00740792|365221892|FG001|Overall Study|Protocol Violation|1|||
105881745|NCT00740792|365221893|FG002|Overall Study|Protocol Violation|0|||
105881746|NCT00740792|365221894|FG003|Overall Study|Protocol Violation|2|||
105881747|NCT00740792|365221891|FG000|Overall Study|Withdrawal by Subject|1|||
105881748|NCT00740792|365221892|FG001|Overall Study|Withdrawal by Subject|1|||
105881749|NCT00740792|365221893|FG002|Overall Study|Withdrawal by Subject|0|||
105881750|NCT00740792|365221894|FG003|Overall Study|Withdrawal by Subject|0|||
105881751|NCT00740792|365221891|FG000|Overall Study|administrative|3|||
105881752|NCT00740792|365221892|FG001|Overall Study|administrative|3|||
105881753|NCT00740792|365221893|FG002|Overall Study|administrative|8|||
105881754|NCT00740792|365221894|FG003|Overall Study|administrative|2|||
105881755|NCT01532518|365221901|FG000|Overall Study|Withdrawal by Subject|0|||
105881756|NCT01532518|365221902|FG001|Overall Study|Withdrawal by Subject|0|||
105881757|NCT01532518|365221903|FG002|Overall Study|Withdrawal by Subject|1|||
105881758|NCT01019694|365221904|FG000|Overall Study|Adverse Event|12|||
106111101|NCT02496767|366062037|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105881759|NCT01019694|365221905|FG001|Overall Study|Adverse Event|16|||
105881760|NCT01019694|365221906|FG002|Overall Study|Adverse Event|19|||
105881761|NCT01019694|365221904|FG000|Overall Study|Protocol Violation|2|||
105881762|NCT01019694|365221905|FG001|Overall Study|Protocol Violation|6|||
105881763|NCT01019694|365221906|FG002|Overall Study|Protocol Violation|4|||
105881764|NCT01019694|365221904|FG000|Overall Study|Lost to Follow-up|5|||
105881765|NCT01019694|365221905|FG001|Overall Study|Lost to Follow-up|3|||
105881766|NCT01019694|365221906|FG002|Overall Study|Lost to Follow-up|3|||
105881767|NCT01019694|365221904|FG000|Overall Study|Withdrawal by Subject|4|||
105881768|NCT01019694|365221905|FG001|Overall Study|Withdrawal by Subject|6|||
105881769|NCT01019694|365221906|FG002|Overall Study|Withdrawal by Subject|12|||
105881770|NCT01019694|365221904|FG000|Overall Study|Not treated|0|||
105881771|NCT01019694|365221905|FG001|Overall Study|Not treated|2|||
105881772|NCT01019694|365221906|FG002|Overall Study|Not treated|3|||
105881773|NCT01019694|365221904|FG000|Overall Study|Other reason (not specified)|1|||
105881774|NCT01019694|365221905|FG001|Overall Study|Other reason (not specified)|5|||
105881775|NCT01019694|365221906|FG002|Overall Study|Other reason (not specified)|6|||
105881776|NCT00912743|365221914|FG000|Overall Study|Adverse Event|3|||
105881777|NCT00912743|365221915|FG001|Overall Study|Adverse Event|1|||
105881778|NCT00912743|365221914|FG000|Overall Study|Lack of Efficacy|9|||
105881779|NCT00912743|365221915|FG001|Overall Study|Lack of Efficacy|18|||
105881780|NCT00912743|365221914|FG000|Overall Study|Toxicity|0|||
105881781|NCT00912743|365221915|FG001|Overall Study|Toxicity|1|||
105881782|NCT00912743|365221914|FG000|Overall Study|End of treatment form was not collected|1|||
105881783|NCT00912743|365221915|FG001|Overall Study|End of treatment form was not collected|0|||
105881784|NCT00423332|365221916|FG000|Overall Study|Adverse Event|6|||
105881785|NCT00423332|365221917|FG001|Overall Study|Adverse Event|2|||
105881786|NCT00423332|365221916|FG000|Overall Study|Withdrawal by Subject|1|||
105881787|NCT00423332|365221917|FG001|Overall Study|Withdrawal by Subject|0|||
105881788|NCT00423332|365221916|FG000|Overall Study|Condition under investigation worsened|1|||
105881789|NCT00423332|365221917|FG001|Overall Study|Condition under investigation worsened|1|||
105881790|NCT00423332|365221916|FG000|Overall Study|Progressive at Week 6|0|||
105881791|NCT00423332|365221917|FG001|Overall Study|Progressive at Week 6|1|||
105881792|NCT00423332|365221916|FG000|Overall Study|Unblinded before 12 weeks|1|||
105881793|NCT00423332|365221917|FG001|Overall Study|Unblinded before 12 weeks|3|||
105881794|NCT04747886|365221918|FG000|Overall Study|Withdrawal by Subject|1|||
105881795|NCT04747886|365221919|FG001|Overall Study|Withdrawal by Subject|4|||
105881796|NCT00179660|365221920|FG000|Overall Study|Adverse Event|7|||
105881797|NCT00179660|365221920|FG000|Overall Study|Lack of therapeutic effect|28|||
105881798|NCT00179660|365221920|FG000|Overall Study|Withdrawal by Subject|2|||
105881799|NCT00179660|365221920|FG000|Overall Study|Lost to Follow-up|1|||
105881800|NCT00179660|365221920|FG000|Overall Study|Death|3|||
105881801|NCT00179660|365221920|FG000|Overall Study|Other - Unspecified|9|||
105881802|NCT03850496|365221923|FG000|Overall Study|Withdrawal by Subject|1|||
105881803|NCT03850496|365221924|FG001|Overall Study|Withdrawal by Subject|0|||
105881804|NCT03850496|365221925|FG002|Overall Study|Withdrawal by Subject|0|||
105881805|NCT03850496|365221923|FG000|Overall Study|Lost to Follow-up|0|||
105881806|NCT03850496|365221924|FG001|Overall Study|Lost to Follow-up|1|||
105881807|NCT03850496|365221925|FG002|Overall Study|Lost to Follow-up|4|||
105881808|NCT00869999|365221930|FG000|Overall Study|Withdrawal by Subject|1|||
105881809|NCT00869999|365221930|FG000|Overall Study|removed prior to starting therapy|1|||
105881810|NCT04478695|365221931|FG000|Overall Study|Death|1|||
105881811|NCT04478695|365221932|FG001|Overall Study|Death|0|||
105881812|NCT00927862|365221933|FG000|Overall Study|Missing data needed for endpt analyses|27|||
105881813|NCT00927862|365221934|FG001|Overall Study|Missing data needed for endpt analyses|45|||
105881814|NCT04112043|365221936|FG000|Overall Study|Withdrawal by Subject|1|||
105881815|NCT04112043|365221937|FG001|Overall Study|Withdrawal by Subject|1|||
105881816|NCT04112043|365221938|FG002|Overall Study|Withdrawal by Subject|1|||
105881817|NCT04112043|365221936|FG000|Overall Study|Taking NR supplement|1|||
105881818|NCT04112043|365221937|FG001|Overall Study|Taking NR supplement|0|||
105881819|NCT04112043|365221938|FG002|Overall Study|Taking NR supplement|0|||
105881820|NCT04112043|365221936|FG000|Overall Study|Adverse Event|0|||
105881821|NCT04112043|365221937|FG001|Overall Study|Adverse Event|1|||
105881822|NCT04112043|365221938|FG002|Overall Study|Adverse Event|0|||
105881823|NCT02237196|365221939|FG000|Overall Study|Adverse Event|0|||
105881824|NCT02237196|365221940|FG001|Overall Study|Adverse Event|1|||
105881825|NCT02237196|365221941|FG002|Overall Study|Adverse Event|1|||
105881826|NCT02237196|365221942|FG003|Overall Study|Adverse Event|0|||
105881827|NCT02237196|365221939|FG000|Overall Study|Lost to Follow-up|4|||
105881828|NCT02237196|365221940|FG001|Overall Study|Lost to Follow-up|2|||
105881829|NCT02237196|365221941|FG002|Overall Study|Lost to Follow-up|4|||
105881830|NCT02237196|365221942|FG003|Overall Study|Lost to Follow-up|6|||
105881831|NCT02237196|365221939|FG000|Overall Study|Physician Decision|2|||
105881832|NCT02237196|365221940|FG001|Overall Study|Physician Decision|0|||
105881833|NCT02237196|365221941|FG002|Overall Study|Physician Decision|0|||
105881834|NCT02237196|365221942|FG003|Overall Study|Physician Decision|1|||
105881835|NCT02237196|365221939|FG000|Overall Study|Pregnancy|0|||
105881836|NCT02237196|365221940|FG001|Overall Study|Pregnancy|0|||
105881837|NCT02237196|365221941|FG002|Overall Study|Pregnancy|1|||
105881838|NCT02237196|365221942|FG003|Overall Study|Pregnancy|1|||
105881839|NCT02237196|365221939|FG000|Overall Study|Withdrawal by Subject|1|||
105881840|NCT02237196|365221940|FG001|Overall Study|Withdrawal by Subject|1|||
105881841|NCT02237196|365221941|FG002|Overall Study|Withdrawal by Subject|4|||
106111102|NCT02496767|366062038|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
106111103|NCT02496767|366062039|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
106111104|NCT02496767|366062040|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
106111105|NCT02496767|366062033|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
106111106|NCT02496767|366062034|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
106111107|NCT02496767|366062035|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105881842|NCT02237196|365221942|FG003|Overall Study|Withdrawal by Subject|1|||
105881843|NCT02237196|365221939|FG000|Overall Study|Site Error|1|||
105881844|NCT02237196|365221940|FG001|Overall Study|Site Error|2|||
105881845|NCT02237196|365221941|FG002|Overall Study|Site Error|0|||
105881846|NCT02237196|365221942|FG003|Overall Study|Site Error|2|||
105881847|NCT02088905|365221945|FG000|Overall Study|Withdrawal by Subject|5|||
105881848|NCT02088905|365221946|FG001|Overall Study|Withdrawal by Subject|1|||
105881849|NCT00619892|365221949|FG000|Overall Study|Adverse Event|3|||
105881850|NCT00619892|365221950|FG001|Overall Study|Adverse Event|0|||
105881851|NCT00619892|365221949|FG000|Overall Study|Lost to Follow-up|0|||
105881852|NCT00619892|365221950|FG001|Overall Study|Lost to Follow-up|1|||
105881853|NCT00619892|365221949|FG000|Overall Study|Intercurrent illness|0|||
105881854|NCT00619892|365221950|FG001|Overall Study|Intercurrent illness|1|||
105881855|NCT00857896|365221958|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
105881856|NCT02308540|365221959|FG000|Overall Study|Lost to Follow-up|0|||
105881857|NCT02308540|365221960|FG001|Overall Study|Lost to Follow-up|0|||
105881858|NCT02308540|365221961|FG002|Overall Study|Lost to Follow-up|0|||
105881859|NCT02308540|365221962|FG003|Overall Study|Lost to Follow-up|0|||
105881860|NCT02308540|365221963|FG004|Overall Study|Lost to Follow-up|0|||
105881861|NCT02308540|365221964|FG005|Overall Study|Lost to Follow-up|1|||
105881862|NCT00703157|365221966|FG000|Overall Study|Lost to Follow-up|0|||
105881863|NCT00703157|365221967|FG001|Overall Study|Lost to Follow-up|1|||
105881864|NCT00703157|365221966|FG000|Overall Study|source data permanently lost/ other|4|||
105881865|NCT00703157|365221967|FG001|Overall Study|source data permanently lost/ other|1|||
105881866|NCT03170362|365221968|FG000|Overall Study|Death|2|||
105881867|NCT03170362|365221969|FG001|Overall Study|Death|2|||
105881868|NCT03170362|365221968|FG000|Overall Study|Withdrawal by Subject|23|||
105881869|NCT03170362|365221969|FG001|Overall Study|Withdrawal by Subject|22|||
106111108|NCT02496767|366062036|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
106111109|NCT02496767|366062037|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
106111110|NCT02496767|366062038|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
106111111|NCT02496767|366062039|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
106111112|NCT02496767|366062040|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
106111113|NCT02496767|366062033|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
106111114|NCT02496767|366062034|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
106111115|NCT02496767|366062035|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
106111116|NCT02496767|366062036|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
106111117|NCT02496767|366062037|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
106111118|NCT02496767|366062038|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
106111119|NCT02496767|366062039|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
106111120|NCT02496767|366062040|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
106111121|NCT02496767|366062033|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
106111122|NCT02496767|366062034|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
106111123|NCT02496767|366062035|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
106111124|NCT02496767|366062036|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
106111125|NCT02496767|366062037|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
106111126|NCT02496767|366062038|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
106111127|NCT02496767|366062039|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
106111128|NCT02496767|366062040|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
106111129|NCT02496767|366062033|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
105881870|NCT03170362|365221968|FG000|Overall Study|Lost to Follow-up|187|||
105881871|NCT03170362|365221969|FG001|Overall Study|Lost to Follow-up|167|||
105881872|NCT00665431|365221970|FG000|Overall Study|Adverse Event|16|||
105881873|NCT00665431|365221971|FG001|Overall Study|Adverse Event|22|||
105881874|NCT00665431|365221972|FG002|Overall Study|Adverse Event|6|||
105881875|NCT00665431|365221970|FG000|Overall Study|Withdrawal by Subject|17|||
105881876|NCT00665431|365221971|FG001|Overall Study|Withdrawal by Subject|25|||
105881877|NCT00665431|365221972|FG002|Overall Study|Withdrawal by Subject|15|||
105881878|NCT00665431|365221970|FG000|Overall Study|Lost to Follow-up|3|||
105881879|NCT00665431|365221971|FG001|Overall Study|Lost to Follow-up|3|||
106111130|NCT02496767|366062034|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
106111131|NCT02496767|366062035|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
106111132|NCT02496767|366062036|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
106111133|NCT02496767|366062037|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
106111134|NCT02496767|366062038|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
106111135|NCT02496767|366062039|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
105881880|NCT00665431|365221972|FG002|Overall Study|Lost to Follow-up|1|||
105881881|NCT00665431|365221970|FG000|Overall Study|Other|4|||
105881882|NCT00665431|365221971|FG001|Overall Study|Other|7|||
105881883|NCT00665431|365221972|FG002|Overall Study|Other|2|||
105881884|NCT02347813|365221973|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
105881885|NCT02347813|365221974|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
105881886|NCT02347813|365221973|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
105881887|NCT02347813|365221974|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
105881888|NCT04185220|365221975|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
105881889|NCT04185220|365221976|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
105881890|NCT04185220|365221975|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
105881891|NCT04185220|365221976|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
105881892|NCT02366637|365223451|FG000|First Intervention Period|Adverse Event|0|||
105881893|NCT02366637|365223452|FG001|First Intervention Period|Adverse Event|1|||
105881894|NCT02366637|365223451|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
105881895|NCT02366637|365223452|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
105881896|NCT02366637|365223451|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
105881897|NCT02366637|365223452|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
105881898|NCT03691207|365223453|FG000|Overall Study|Death|41|||
105881899|NCT03691207|365223454|FG001|Overall Study|Death|26|||
105881900|NCT03691207|365223453|FG000|Overall Study|Lost to Follow-up|1|||
105881901|NCT03691207|365223454|FG001|Overall Study|Lost to Follow-up|1|||
105881902|NCT03691207|365223453|FG000|Overall Study|Withdrawal by Subject|2|||
105881903|NCT03691207|365223454|FG001|Overall Study|Withdrawal by Subject|8|||
105881904|NCT03691207|365223453|FG000|Overall Study|Sponsor decision|1|||
105881905|NCT03691207|365223454|FG001|Overall Study|Sponsor decision|7|||
105881906|NCT02309411|365223455|FG000|Overall Study|Physician Decision|1|||
105881907|NCT02309411|365223456|FG001|Overall Study|Physician Decision|0|||
105881908|NCT02309411|365223457|FG002|Overall Study|Physician Decision|0|||
105881909|NCT02309411|365223455|FG000|Overall Study|Withdrawal by Subject|1|||
105881910|NCT02309411|365223456|FG001|Overall Study|Withdrawal by Subject|1|||
105881911|NCT02309411|365223457|FG002|Overall Study|Withdrawal by Subject|0|||
105881912|NCT02498444|365223458|FG000|Overall Study|Withdrawal by Subject|3|||
105881913|NCT02498444|365223459|FG001|Overall Study|Withdrawal by Subject|0|||
105881914|NCT02498444|365223458|FG000|Overall Study|Physician Decision|1|||
105881915|NCT02498444|365223459|FG001|Overall Study|Physician Decision|0|||
105881916|NCT00302328|365223460|FG000|Overall Study|Physician Decision|0|||
105881917|NCT00302328|365223461|FG001|Overall Study|Physician Decision|1|||
105881918|NCT00302328|365223462|FG002|Overall Study|Physician Decision|0|||
105881919|NCT04411810|365223463|FG000|Overall Study|Screen failure|1|||
105881920|NCT04411810|365223463|FG000|Overall Study|Withdrawal by Subject|1|||
106111136|NCT02496767|366062040|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
106111137|NCT02496767|366062033|FG000|Double-blind, Withdrawal Phase|Death|0|||
106111138|NCT02496767|366062034|FG001|Double-blind, Withdrawal Phase|Death|0|||
106111139|NCT02496767|366062035|FG002|Double-blind, Withdrawal Phase|Death|0|||
106111140|NCT02496767|366062036|FG003|Double-blind, Withdrawal Phase|Death|0|||
106111141|NCT02496767|366062037|FG004|Double-blind, Withdrawal Phase|Death|0|||
106111142|NCT02496767|366062038|FG005|Double-blind, Withdrawal Phase|Death|0|||
106111143|NCT02496767|366062039|FG006|Double-blind, Withdrawal Phase|Death|1|||
106111144|NCT02496767|366062040|FG007|Double-blind, Withdrawal Phase|Death|2|||
106111145|NCT02496767|366062033|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
106111146|NCT02496767|366062034|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
106111147|NCT02496767|366062035|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
106111148|NCT02496767|366062036|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
106111149|NCT02496767|366062037|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
106111150|NCT02496767|366062038|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
106111151|NCT02496767|366062039|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
106111152|NCT02496767|366062040|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
106111153|NCT00166296|366062041|FG000|Overall Study|Withdrawal by Subject|1|||
106111154|NCT00166296|366062042|FG001|Overall Study|Withdrawal by Subject|3|||
106111155|NCT00166296|366062041|FG000|Overall Study|Adverse Event|2|||
105881921|NCT01920958|365223466|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
105881922|NCT01718535|365223467|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
105881923|NCT01718535|365223468|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
105881924|NCT01718535|365223469|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
105881925|NCT01718535|365223470|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
106111156|NCT00166296|366062042|FG001|Overall Study|Adverse Event|4|||
106111157|NCT00166296|366062041|FG000|Overall Study|Lost to Follow-up|4|||
106111158|NCT00166296|366062042|FG001|Overall Study|Lost to Follow-up|2|||
106111159|NCT04899245|366062049|FG000|Overall Study|Withdrawal by Subject|3|||
106111160|NCT04899245|366062050|FG001|Overall Study|Withdrawal by Subject|5|||
106111161|NCT04899245|366062051|FG002|Overall Study|Withdrawal by Subject|2|||
106111162|NCT04899245|366062049|FG000|Overall Study|No longer eligible - Left staff position|0|||
106111163|NCT04899245|366062050|FG001|Overall Study|No longer eligible - Left staff position|0|||
106111164|NCT04899245|366062051|FG002|Overall Study|No longer eligible - Left staff position|1|||
106111165|NCT04899245|366062049|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
106111166|NCT04899245|366062050|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
106111167|NCT04899245|366062051|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
106111168|NCT04899245|366062049|FG000|Overall Study|No longer eligible - Moved away from area|2|||
106111169|NCT04899245|366062050|FG001|Overall Study|No longer eligible - Moved away from area|2|||
106111170|NCT04899245|366062051|FG002|Overall Study|No longer eligible - Moved away from area|0|||
106111171|NCT04987762|366062052|FG000|Overall Study|Study was Terminated by Sponsor|103|||
106111172|NCT00724152|366062059|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
106111173|NCT00724152|366062060|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
106111174|NCT00724152|366062061|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
106111175|NCT00724152|366062059|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
106111176|NCT00724152|366062060|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
106111177|NCT00724152|366062061|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
106111178|NCT01064297|366062062|FG000|Overall Study|Lost to Follow-up|791|||
106111179|NCT01064297|366062063|FG001|Overall Study|Lost to Follow-up|48|||
106111180|NCT01064297|366062064|FG002|Overall Study|Lost to Follow-up|133|||
106111181|NCT00031486|366062070|FG000|Overall Study|Adverse Event|1|||
106111182|NCT00031486|366062071|FG001|Overall Study|Adverse Event|0|||
106111183|NCT00031486|366062070|FG000|Overall Study|Lost to Follow-up|0|||
106111184|NCT00031486|366062071|FG001|Overall Study|Lost to Follow-up|1|||
106111185|NCT00031486|366062070|FG000|Overall Study|Withdrawal by Subject|3|||
105881926|NCT01718535|365223471|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
105881927|NCT01718535|365223472|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
105881928|NCT01718535|365223473|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
105881929|NCT01718535|365223474|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
105881930|NCT01718535|365223475|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
105881931|NCT01718535|365223476|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
105881932|NCT00026494|365223479|FG000|Overall Study|Withdrawal by Subject|1|||
105881933|NCT00026494|365223480|FG001|Overall Study|Withdrawal by Subject|0|||
105881934|NCT00026494|365223481|FG002|Overall Study|Withdrawal by Subject|1|||
105881935|NCT00026494|365223482|FG003|Overall Study|Withdrawal by Subject|0|||
105881936|NCT00026494|365223479|FG000|Overall Study|Patient non-compliance|1|||
105881937|NCT00026494|365223480|FG001|Overall Study|Patient non-compliance|0|||
105881938|NCT00026494|365223481|FG002|Overall Study|Patient non-compliance|0|||
105881939|NCT00026494|365223482|FG003|Overall Study|Patient non-compliance|0|||
105881940|NCT00026494|365223479|FG000|Overall Study|Patient not treated|0|||
105881941|NCT00026494|365223480|FG001|Overall Study|Patient not treated|0|||
105881942|NCT00026494|365223481|FG002|Overall Study|Patient not treated|2|||
105881943|NCT00026494|365223482|FG003|Overall Study|Patient not treated|0|||
105881944|NCT00026494|365223479|FG000|Overall Study|Clinical progression|0|||
105881945|NCT00026494|365223480|FG001|Overall Study|Clinical progression|0|||
105881946|NCT00026494|365223481|FG002|Overall Study|Clinical progression|3|||
105881947|NCT00026494|365223482|FG003|Overall Study|Clinical progression|0|||
105881948|NCT00644917|365223490|FG000|Overall Study|Withdrawal by Subject|2|||
105881949|NCT02875613|365223491|FG000|Overall Study|Withdrawal by Subject|1|||
105881950|NCT02875613|365223491|FG000|Overall Study|Screen Failure|1|||
105881951|NCT01136356|365223492|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
105881952|NCT01136356|365223493|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
105881953|NCT01136356|365223492|FG000|First 18-day Withdrawal|Physician Decision|1|||
105881954|NCT01136356|365223493|FG001|First 18-day Withdrawal|Physician Decision|0|||
105881955|NCT01136356|365223492|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
105881956|NCT01136356|365223493|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
105881957|NCT00402688|365223494|FG000|Overall Study|Adverse Event|12|||
105881958|NCT00402688|365223495|FG001|Overall Study|Adverse Event|9|||
105881959|NCT00402688|365223496|FG002|Overall Study|Adverse Event|3|||
105881960|NCT00402688|365223494|FG000|Overall Study|Withdrawal by Subject|3|||
105881961|NCT00402688|365223495|FG001|Overall Study|Withdrawal by Subject|1|||
106111186|NCT00031486|366062071|FG001|Overall Study|Withdrawal by Subject|2|||
106111187|NCT00031486|366062070|FG000|Overall Study|Death|0|||
105881962|NCT00402688|365223496|FG002|Overall Study|Withdrawal by Subject|1|||
105881963|NCT00402688|365223494|FG000|Overall Study|Physician Decision|0|||
105881964|NCT00402688|365223495|FG001|Overall Study|Physician Decision|0|||
105881965|NCT00402688|365223496|FG002|Overall Study|Physician Decision|1|||
106111188|NCT00031486|366062071|FG001|Overall Study|Death|3|||
106111189|NCT00031486|366062070|FG000|Overall Study|Non-compliant|0|||
105881966|NCT00402688|365223494|FG000|Overall Study|Lack of Efficacy|4|||
105881967|NCT00402688|365223495|FG001|Overall Study|Lack of Efficacy|4|||
105881968|NCT00402688|365223496|FG002|Overall Study|Lack of Efficacy|5|||
105881969|NCT00402688|365223494|FG000|Overall Study|Protocol Violation|1|||
105881970|NCT00402688|365223495|FG001|Overall Study|Protocol Violation|1|||
105881971|NCT00402688|365223496|FG002|Overall Study|Protocol Violation|1|||
105881972|NCT00402688|365223494|FG000|Overall Study|Lost to Follow-up|1|||
105881973|NCT00402688|365223495|FG001|Overall Study|Lost to Follow-up|0|||
105881974|NCT00402688|365223496|FG002|Overall Study|Lost to Follow-up|2|||
105881975|NCT00402688|365223494|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
105881976|NCT00402688|365223495|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
105881977|NCT00402688|365223496|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
105881978|NCT00402688|365223494|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
105881979|NCT00402688|365223495|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
105881980|NCT00402688|365223496|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
105881981|NCT00402688|365223494|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
105881982|NCT00402688|365223495|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
105881983|NCT00402688|365223496|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
105881984|NCT00178685|365223497|FG000|Overall Study|Death|3|||
105881985|NCT00178685|365223498|FG001|Overall Study|Death|3|||
105881986|NCT00178685|365223499|FG002|Overall Study|Death|6|||
105881987|NCT00178685|365223497|FG000|Overall Study|Lost to Follow-up|100|||
105881988|NCT00178685|365223498|FG001|Overall Study|Lost to Follow-up|187|||
105881989|NCT00178685|365223499|FG002|Overall Study|Lost to Follow-up|183|||
105881990|NCT00178685|365223497|FG000|Overall Study|Withdrawal by Subject|8|||
105881991|NCT00178685|365223498|FG001|Overall Study|Withdrawal by Subject|14|||
105881992|NCT00178685|365223499|FG002|Overall Study|Withdrawal by Subject|7|||
105881993|NCT00443079|365223500|FG000|Overall Study|Lost to Follow-up|0|||
105881994|NCT00443079|365223501|FG001|Overall Study|Lost to Follow-up|1|||
105881995|NCT02049814|365223504|FG000|Overall Study|Reason not Specified|4|||
105881996|NCT02049814|365223505|FG001|Overall Study|Reason not Specified|3|||
105881997|NCT02049814|365223504|FG000|Overall Study|Pregnancy|1|||
105881998|NCT02049814|365223505|FG001|Overall Study|Pregnancy|0|||
105881999|NCT02049814|365223504|FG000|Overall Study|Lost to Follow-up|2|||
105882000|NCT02049814|365223505|FG001|Overall Study|Lost to Follow-up|3|||
105882001|NCT02049814|365223504|FG000|Overall Study|Serious Protocol Violation|5|||
105882002|NCT02049814|365223505|FG001|Overall Study|Serious Protocol Violation|7|||
105882003|NCT02049814|365223504|FG000|Overall Study|Study Termination|0|||
105882004|NCT02049814|365223505|FG001|Overall Study|Study Termination|1|||
105882005|NCT02049814|365223504|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
105882006|NCT02049814|365223505|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
105882007|NCT02049814|365223504|FG000|Overall Study|Voluntary withdrawal|9|||
105882008|NCT02049814|365223505|FG001|Overall Study|Voluntary withdrawal|8|||
105882009|NCT02097238|365223506|FG000|Overall Study|Death|1|||
105882010|NCT02097238|365223506|FG000|Overall Study|Physician Decision|1|||
105882011|NCT02097238|365223506|FG000|Overall Study|Progressive Disease|17|||
105882012|NCT02993250|365223508|FG000|Overall Study|Lost to Follow-up|0|||
105882013|NCT02993250|365223509|FG001|Overall Study|Lost to Follow-up|1|||
105882014|NCT01996254|365223512|FG000|Overall Study|Change in Eligibility|0|||
105882015|NCT01996254|365223513|FG001|Overall Study|Change in Eligibility|2|||
105882016|NCT01996254|365223514|FG002|Overall Study|Change in Eligibility|0|||
105882017|NCT01996254|365223512|FG000|Overall Study|Withdrawal by Subject|0|||
105882018|NCT01996254|365223513|FG001|Overall Study|Withdrawal by Subject|3|||
105882019|NCT01996254|365223514|FG002|Overall Study|Withdrawal by Subject|4|||
105882020|NCT01996254|365223512|FG000|Overall Study|Lost to Follow-up|1|||
105882021|NCT01996254|365223513|FG001|Overall Study|Lost to Follow-up|0|||
105882022|NCT01996254|365223514|FG002|Overall Study|Lost to Follow-up|4|||
105882023|NCT02693002|365223515|FG000|Overall Study|Withdrawal by Subject|1|||
105882024|NCT02693002|365223516|FG001|Overall Study|Withdrawal by Subject|0|||
105882025|NCT02865499|365223519|FG000|Baseline|Adverse Event|1|||
105882026|NCT02865499|365223519|FG000|Baseline|Withdrawal by Subject|1|||
105882027|NCT00014495|365223522|FG000|Overall Study|Death|0|||
105882028|NCT00014495|365223523|FG001|Overall Study|Death|0|||
105882029|NCT00014495|365223524|FG002|Overall Study|Death|1|||
105882030|NCT00014495|365223525|FG003|Overall Study|Death|0|||
105882031|NCT00014495|365223522|FG000|Overall Study|Clinical deterioration|0|||
105882032|NCT00014495|365223523|FG001|Overall Study|Clinical deterioration|0|||
105882033|NCT00014495|365223524|FG002|Overall Study|Clinical deterioration|0|||
105882034|NCT00014495|365223525|FG003|Overall Study|Clinical deterioration|1|||
105882035|NCT00828568|365223527|FG000|Randomized|Withdrawal by Subject|1|||
105882036|NCT00828568|365223528|FG001|Randomized|Withdrawal by Subject|0|||
105882037|NCT00828568|365223529|FG002|Randomized|Withdrawal by Subject|2|||
105882038|NCT00828568|365223527|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
105882039|NCT00828568|365223528|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
105882040|NCT00828568|365223529|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
105882041|NCT00828568|365223527|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
105993716|NCT01510158|365636076|FG001|Overall Study|Lost to Follow-up|16|||
105882042|NCT00828568|365223528|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
105882043|NCT00828568|365223529|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
105882044|NCT00828568|365223527|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
105882045|NCT00828568|365223528|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
105882046|NCT00828568|365223529|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
105882047|NCT00828568|365223527|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
105882048|NCT00828568|365223528|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
105882049|NCT00828568|365223529|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
105882050|NCT00403481|365223530|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
105882051|NCT00403481|365223530|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
105882052|NCT00403481|365223530|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
105882053|NCT00403481|365223530|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
105882054|NCT00403481|365223530|FG000|Olm 40 mg|Adverse Event|2|||
105882055|NCT00403481|365223530|FG000|Olm 40 mg|Protocol Violation|1|||
105882056|NCT00403481|365223530|FG000|Olm 40 mg|Withdrawal by Subject|1|||
105882057|NCT00403481|365223530|FG000|Olm 40 mg|Other|1|||
105882058|NCT00403481|365223530|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
105882059|NCT00403481|365223530|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
105882060|NCT00403481|365223530|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
105882061|NCT00403481|365223530|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
105882062|NCT00403481|365223530|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
105882063|NCT00403481|365223530|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
105882064|NCT00396656|365223531|FG000|First Treatment Period|Withdrawal by Subject|0|||
105882065|NCT00396656|365223532|FG001|First Treatment Period|Withdrawal by Subject|2|||
105882066|NCT00396656|365223531|FG000|Second Treatment Period|Adverse Event|0|||
105882067|NCT00396656|365223532|FG001|Second Treatment Period|Adverse Event|1|||
105882068|NCT00994461|365223536|FG000|Overall Study|Adverse Event|2|||
105882069|NCT00994461|365223537|FG001|Overall Study|Adverse Event|1|||
105882070|NCT00994461|365223538|FG002|Overall Study|Adverse Event|0|||
105882071|NCT02477332|365223539|FG000|Overall Study|Adverse Event|0|||
105882072|NCT02477332|365223540|FG001|Overall Study|Adverse Event|1|||
105882073|NCT02477332|365223541|FG002|Overall Study|Adverse Event|1|||
105882074|NCT02477332|365223542|FG003|Overall Study|Adverse Event|2|||
105882075|NCT02477332|365223543|FG004|Overall Study|Adverse Event|1|||
105882076|NCT02477332|365223544|FG005|Overall Study|Adverse Event|2|||
105882077|NCT02477332|365223539|FG000|Overall Study|Lack of Efficacy|1|||
105882078|NCT02477332|365223540|FG001|Overall Study|Lack of Efficacy|2|||
105882079|NCT02477332|365223541|FG002|Overall Study|Lack of Efficacy|1|||
105882080|NCT02477332|365223542|FG003|Overall Study|Lack of Efficacy|2|||
105882081|NCT02477332|365223543|FG004|Overall Study|Lack of Efficacy|1|||
105882082|NCT02477332|365223544|FG005|Overall Study|Lack of Efficacy|1|||
105882083|NCT02477332|365223539|FG000|Overall Study|Non-compliance with study treatment|0|||
105882084|NCT02477332|365223540|FG001|Overall Study|Non-compliance with study treatment|1|||
105882085|NCT02477332|365223541|FG002|Overall Study|Non-compliance with study treatment|2|||
105882086|NCT02477332|365223542|FG003|Overall Study|Non-compliance with study treatment|0|||
105882087|NCT02477332|365223543|FG004|Overall Study|Non-compliance with study treatment|0|||
105882088|NCT02477332|365223544|FG005|Overall Study|Non-compliance with study treatment|0|||
105882089|NCT02477332|365223539|FG000|Overall Study|Pregnancy|0|||
105882090|NCT02477332|365223540|FG001|Overall Study|Pregnancy|0|||
105882091|NCT02477332|365223541|FG002|Overall Study|Pregnancy|0|||
105882092|NCT02477332|365223542|FG003|Overall Study|Pregnancy|1|||
105882093|NCT02477332|365223543|FG004|Overall Study|Pregnancy|0|||
105882094|NCT02477332|365223544|FG005|Overall Study|Pregnancy|0|||
105882095|NCT02477332|365223539|FG000|Overall Study|Protocol Violation|2|||
105882096|NCT02477332|365223540|FG001|Overall Study|Protocol Violation|0|||
105882097|NCT02477332|365223541|FG002|Overall Study|Protocol Violation|3|||
105882098|NCT02477332|365223542|FG003|Overall Study|Protocol Violation|3|||
105882099|NCT02477332|365223543|FG004|Overall Study|Protocol Violation|1|||
105882100|NCT02477332|365223544|FG005|Overall Study|Protocol Violation|1|||
105882101|NCT02477332|365223539|FG000|Overall Study|Technical problems|0|||
105882102|NCT02477332|365223540|FG001|Overall Study|Technical problems|0|||
105882103|NCT02477332|365223541|FG002|Overall Study|Technical problems|1|||
105882104|NCT02477332|365223542|FG003|Overall Study|Technical problems|0|||
105882105|NCT02477332|365223543|FG004|Overall Study|Technical problems|0|||
105882106|NCT02477332|365223544|FG005|Overall Study|Technical problems|0|||
105882107|NCT02477332|365223539|FG000|Overall Study|Lost to Follow-up|0|||
105882108|NCT02477332|365223540|FG001|Overall Study|Lost to Follow-up|0|||
105882109|NCT02477332|365223541|FG002|Overall Study|Lost to Follow-up|2|||
105882110|NCT02477332|365223542|FG003|Overall Study|Lost to Follow-up|0|||
105882111|NCT02477332|365223543|FG004|Overall Study|Lost to Follow-up|0|||
105882112|NCT02477332|365223544|FG005|Overall Study|Lost to Follow-up|0|||
105882113|NCT02477332|365223539|FG000|Overall Study|Physician Decision|0|||
105882114|NCT02477332|365223540|FG001|Overall Study|Physician Decision|0|||
105882115|NCT02477332|365223541|FG002|Overall Study|Physician Decision|1|||
105882116|NCT02477332|365223542|FG003|Overall Study|Physician Decision|3|||
105882117|NCT02477332|365223543|FG004|Overall Study|Physician Decision|0|||
105882118|NCT02477332|365223544|FG005|Overall Study|Physician Decision|1|||
105882119|NCT02477332|365223539|FG000|Overall Study|Withdrawal by Subject|0|||
105882120|NCT02477332|365223540|FG001|Overall Study|Withdrawal by Subject|3|||
105882121|NCT02477332|365223541|FG002|Overall Study|Withdrawal by Subject|1|||
105882122|NCT02477332|365223542|FG003|Overall Study|Withdrawal by Subject|2|||
105882123|NCT02477332|365223543|FG004|Overall Study|Withdrawal by Subject|1|||
105882124|NCT02477332|365223544|FG005|Overall Study|Withdrawal by Subject|0|||
105882125|NCT02549287|365223545|FG000|Overall Study|Lost to Follow-up|65|||
105882126|NCT02549287|365223546|FG001|Overall Study|Lost to Follow-up|26|||
105882127|NCT02549287|365223545|FG000|Overall Study|Withdrawal by Subject|15|||
105882128|NCT02549287|365223546|FG001|Overall Study|Withdrawal by Subject|6|||
105882129|NCT04657198|365223547|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
105882130|NCT04657198|365223548|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
105882131|NCT04657198|365223549|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
105882132|NCT02977572|365223550|FG000|Overall Study|Exclusion criterion|2|||
105882133|NCT02977572|365223551|FG001|Overall Study|Exclusion criterion|2|||
105882134|NCT05107492|365223552|FG000|Overall Study|Lost to Follow-up|1|||
105882135|NCT05107492|365223553|FG001|Overall Study|Lost to Follow-up|0|||
105882136|NCT02438826|365223554|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
105882137|NCT02438826|365223555|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
105882138|NCT02438826|365223556|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
105882139|NCT02438826|365223557|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105882140|NCT02438826|365223554|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
105882141|NCT02438826|365223555|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105882142|NCT02438826|365223556|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105882143|NCT02438826|365223557|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105882144|NCT02438826|365223554|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
105882145|NCT02438826|365223555|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
105882146|NCT02438826|365223556|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105882147|NCT02438826|365223557|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105882148|NCT02438826|365223554|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
106111190|NCT00031486|366062071|FG001|Overall Study|Non-compliant|4|||
106111191|NCT00031486|366062070|FG000|Overall Study|Did not meet eligibility requirement|2|||
106111192|NCT00031486|366062071|FG001|Overall Study|Did not meet eligibility requirement|1|||
106111193|NCT00031486|366062070|FG000|Overall Study|Other|1|||
106111194|NCT00031486|366062071|FG001|Overall Study|Other|1|||
106111195|NCT01685138|366062072|FG000|Overall Study|Lost to Follow-up|1|||
106111196|NCT01685138|366062072|FG000|Overall Study|Protocol Violation|1|||
106111197|NCT01685138|366062072|FG000|Overall Study|No longer requires treatment|1|||
106111198|NCT01685138|366062072|FG000|Overall Study|Subject/guardian decision|2|||
106111199|NCT01685138|366062072|FG000|Overall Study|Physician Decision|6|||
106111200|NCT01685138|366062072|FG000|Overall Study|Death|10|||
106111201|NCT01685138|366062072|FG000|Overall Study|Adverse Event|18|||
106111202|NCT01685138|366062072|FG000|Overall Study|Progressive disease|53|||
106111203|NCT02068495|366062073|FG000|Overall Study|Case Report Forms Uncollected|60|||
106111204|NCT02068495|366062073|FG000|Overall Study|Protocol Deviation|49|||
106111205|NCT00689026|366062074|FG000|Overall Study|Withdrawal by Subject|13|||
106111206|NCT00689026|366062075|FG001|Overall Study|Withdrawal by Subject|6|||
106111207|NCT02220894|366062076|FG000|Overall Study|Adverse Event|127|||
106111208|NCT02220894|366062077|FG001|Overall Study|Adverse Event|74|||
106111209|NCT02220894|366062076|FG000|Overall Study|Death|418|||
106111210|NCT02220894|366062077|FG001|Overall Study|Death|508|||
106111211|NCT02220894|366062076|FG000|Overall Study|Lost to Follow-up|0|||
106111212|NCT02220894|366062077|FG001|Overall Study|Lost to Follow-up|4|||
106111213|NCT02220894|366062076|FG000|Overall Study|Site Terminated by Sponsor|2|||
106111214|NCT02220894|366062077|FG001|Overall Study|Site Terminated by Sponsor|0|||
105882149|NCT02438826|365223555|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
105882150|NCT02438826|365223556|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
105882151|NCT02438826|365223557|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
105882152|NCT02438826|365223554|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
105882153|NCT02438826|365223555|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
105882154|NCT02438826|365223556|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
105882155|NCT02438826|365223557|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
105882156|NCT02438826|365223554|FG000|Open-Label Treatment Phase|Adverse Event|11|||
105882157|NCT02438826|365223555|FG001|Open-Label Treatment Phase|Adverse Event|6|||
105882158|NCT02438826|365223556|FG002|Open-Label Treatment Phase|Adverse Event|0|||
105882159|NCT02438826|365223557|FG003|Open-Label Treatment Phase|Adverse Event|0|||
105882160|NCT02438826|365223554|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
105882161|NCT02438826|365223555|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
105882162|NCT02438826|365223556|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
105882163|NCT02438826|365223557|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
105882164|NCT02438826|365223554|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
106111215|NCT02220894|366062076|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
106111216|NCT02220894|366062077|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
105882165|NCT02438826|365223555|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
105882166|NCT02438826|365223556|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
105882167|NCT02438826|365223557|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
105882168|NCT02438826|365223554|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
105882169|NCT02438826|365223555|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
105882170|NCT02438826|365223556|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
105882171|NCT02438826|365223557|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
105882172|NCT02438826|365223554|FG000|Post-Treatment Phase|Adverse Event|3|||
105882173|NCT02438826|365223555|FG001|Post-Treatment Phase|Adverse Event|0|||
105882174|NCT02438826|365223556|FG002|Post-Treatment Phase|Adverse Event|0|||
105882175|NCT02438826|365223557|FG003|Post-Treatment Phase|Adverse Event|0|||
105882176|NCT02438826|365223554|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
105882177|NCT02438826|365223555|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
105882178|NCT02438826|365223556|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
105882179|NCT02438826|365223557|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
105882180|NCT02438826|365223554|FG000|Post-Treatment Phase|Physician Decision|1|||
105882181|NCT02438826|365223555|FG001|Post-Treatment Phase|Physician Decision|0|||
105882182|NCT02438826|365223556|FG002|Post-Treatment Phase|Physician Decision|0|||
105882183|NCT02438826|365223557|FG003|Post-Treatment Phase|Physician Decision|0|||
105882184|NCT02438826|365223554|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
105882185|NCT02438826|365223555|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
105882186|NCT02438826|365223556|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
105882187|NCT02438826|365223557|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
105882188|NCT00591565|365223561|FG000|Overall Study|lost follow up, withdrawn|5|||
105882189|NCT01464164|365223562|FG000|Overall Study|Screen failure|0|||
105882190|NCT01464164|365223563|FG001|Overall Study|Screen failure|1|||
105882191|NCT01464164|365223564|FG002|Overall Study|Screen failure|2|||
105882192|NCT01464164|365223565|FG003|Overall Study|Screen failure|0|||
105882193|NCT01464164|365223566|FG004|Overall Study|Screen failure|0|||
105882194|NCT01464164|365223567|FG005|Overall Study|Screen failure|0|||
105882195|NCT01464164|365223568|FG006|Overall Study|Screen failure|0|||
105882196|NCT01464164|365223562|FG000|Overall Study|Physician Decision|0|||
105882197|NCT01464164|365223563|FG001|Overall Study|Physician Decision|1|||
105882198|NCT01464164|365223564|FG002|Overall Study|Physician Decision|0|||
105882199|NCT01464164|365223565|FG003|Overall Study|Physician Decision|0|||
105882200|NCT01464164|365223566|FG004|Overall Study|Physician Decision|0|||
105882201|NCT01464164|365223567|FG005|Overall Study|Physician Decision|0|||
105882202|NCT01464164|365223568|FG006|Overall Study|Physician Decision|2|||
105882203|NCT02644668|365223571|FG000|Overall Study|Adverse Event|2|||
105882204|NCT02644668|365223572|FG001|Overall Study|Adverse Event|0|||
105882205|NCT02644668|365223573|FG002|Overall Study|Adverse Event|1|||
105882206|NCT02644668|365223571|FG000|Overall Study|Protocol Violation|0|||
105882207|NCT02644668|365223572|FG001|Overall Study|Protocol Violation|0|||
105882208|NCT02644668|365223573|FG002|Overall Study|Protocol Violation|1|||
105882209|NCT02644668|365223571|FG000|Overall Study|Withdrawal by Subject|0|||
105882210|NCT02644668|365223572|FG001|Overall Study|Withdrawal by Subject|0|||
105882211|NCT02644668|365223573|FG002|Overall Study|Withdrawal by Subject|1|||
105882212|NCT00757042|365223579|FG000|Overall Study|Lost to Follow-up|0|||
105882213|NCT00757042|365223580|FG001|Overall Study|Lost to Follow-up|0|||
105882214|NCT00757042|365223581|FG002|Overall Study|Lost to Follow-up|0|||
105882215|NCT00757042|365223582|FG003|Overall Study|Lost to Follow-up|0|||
105882216|NCT00757042|365223583|FG004|Overall Study|Lost to Follow-up|0|||
105882217|NCT00757042|365223584|FG005|Overall Study|Lost to Follow-up|0|||
105882218|NCT00757042|365223585|FG006|Overall Study|Lost to Follow-up|0|||
105882219|NCT00757042|365223586|FG007|Overall Study|Lost to Follow-up|0|||
105882220|NCT00757042|365223587|FG008|Overall Study|Lost to Follow-up|1|||
105882221|NCT00757042|365223588|FG009|Overall Study|Lost to Follow-up|0|||
105882222|NCT00757042|365223589|FG010|Overall Study|Lost to Follow-up|0|||
105882223|NCT00757042|365223579|FG000|Overall Study|Ineligibility Determined|0|||
105882224|NCT00757042|365223580|FG001|Overall Study|Ineligibility Determined|0|||
105882225|NCT00757042|365223581|FG002|Overall Study|Ineligibility Determined|0|||
105882226|NCT00757042|365223582|FG003|Overall Study|Ineligibility Determined|0|||
105882227|NCT00757042|365223583|FG004|Overall Study|Ineligibility Determined|0|||
105882228|NCT00757042|365223584|FG005|Overall Study|Ineligibility Determined|0|||
105882229|NCT00757042|365223585|FG006|Overall Study|Ineligibility Determined|0|||
105882230|NCT00757042|365223586|FG007|Overall Study|Ineligibility Determined|0|||
105882231|NCT00757042|365223587|FG008|Overall Study|Ineligibility Determined|0|||
105882232|NCT00757042|365223588|FG009|Overall Study|Ineligibility Determined|0|||
105882233|NCT00757042|365223589|FG010|Overall Study|Ineligibility Determined|1|||
105882234|NCT00757042|365223579|FG000|Overall Study|Withdrawal by Subject|0|||
105882235|NCT00757042|365223580|FG001|Overall Study|Withdrawal by Subject|0|||
105882236|NCT00757042|365223581|FG002|Overall Study|Withdrawal by Subject|0|||
105882237|NCT00757042|365223582|FG003|Overall Study|Withdrawal by Subject|0|||
105882238|NCT00757042|365223583|FG004|Overall Study|Withdrawal by Subject|0|||
105882239|NCT00757042|365223584|FG005|Overall Study|Withdrawal by Subject|0|||
105882240|NCT00757042|365223585|FG006|Overall Study|Withdrawal by Subject|0|||
105882241|NCT00757042|365223586|FG007|Overall Study|Withdrawal by Subject|0|||
105882242|NCT00757042|365223587|FG008|Overall Study|Withdrawal by Subject|0|||
105882243|NCT00757042|365223588|FG009|Overall Study|Withdrawal by Subject|1|||
105882244|NCT00757042|365223589|FG010|Overall Study|Withdrawal by Subject|0|||
105882245|NCT00789698|365223590|FG000|Overall Study|Lack of Efficacy|10|||
105882246|NCT00789698|365223591|FG001|Overall Study|Lack of Efficacy|4|||
105882247|NCT00789698|365223592|FG002|Overall Study|Lack of Efficacy|5|||
105882248|NCT00789698|365223593|FG003|Overall Study|Lack of Efficacy|18|||
105882249|NCT00789698|365223590|FG000|Overall Study|Adverse Event|5|||
105882250|NCT00789698|365223591|FG001|Overall Study|Adverse Event|5|||
105882251|NCT00789698|365223592|FG002|Overall Study|Adverse Event|3|||
105882252|NCT00789698|365223593|FG003|Overall Study|Adverse Event|4|||
105882253|NCT00789698|365223590|FG000|Overall Study|Lost to Follow-up|5|||
105882254|NCT00789698|365223591|FG001|Overall Study|Lost to Follow-up|5|||
105882255|NCT00789698|365223592|FG002|Overall Study|Lost to Follow-up|2|||
105882256|NCT00789698|365223593|FG003|Overall Study|Lost to Follow-up|9|||
105882257|NCT00789698|365223590|FG000|Overall Study|Protocol Violation|6|||
105882258|NCT00789698|365223591|FG001|Overall Study|Protocol Violation|1|||
105882259|NCT00789698|365223592|FG002|Overall Study|Protocol Violation|2|||
105882260|NCT00789698|365223593|FG003|Overall Study|Protocol Violation|1|||
105882261|NCT00789698|365223590|FG000|Overall Study|Withdrawal by Subject|14|||
105882262|NCT00789698|365223591|FG001|Overall Study|Withdrawal by Subject|15|||
105882263|NCT00789698|365223592|FG002|Overall Study|Withdrawal by Subject|12|||
105882264|NCT00789698|365223593|FG003|Overall Study|Withdrawal by Subject|19|||
105882265|NCT00789698|365223590|FG000|Overall Study|Administrative|0|||
105882266|NCT00789698|365223591|FG001|Overall Study|Administrative|3|||
105882267|NCT00789698|365223592|FG002|Overall Study|Administrative|3|||
105882268|NCT00789698|365223593|FG003|Overall Study|Administrative|1|||
105882269|NCT01500382|365223595|FG000|Washout Period|Study site went out of business|0|||
105882270|NCT01500382|365223596|FG001|Washout Period|Study site went out of business|0|||
105882271|NCT01500382|365223597|FG002|Washout Period|Study site went out of business|1|||
105882272|NCT01500382|365223598|FG003|Washout Period|Study site went out of business|0|||
105882273|NCT01483027|365223599|FG000|Overall Study|Administrative Reasons|2|||
105882274|NCT01483027|365223600|FG001|Overall Study|Administrative Reasons|1|||
105882275|NCT01483027|365223599|FG000|Overall Study|Withdrawal by Subject|21|||
105882276|NCT01483027|365223600|FG001|Overall Study|Withdrawal by Subject|32|||
105882277|NCT01483027|365223599|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
105882278|NCT01483027|365223600|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
105882279|NCT01483027|365223599|FG000|Overall Study|Lost to Follow-up|1|||
105882280|NCT01483027|365223600|FG001|Overall Study|Lost to Follow-up|1|||
105882281|NCT01483027|365223599|FG000|Overall Study|Adverse Event|0|||
105882282|NCT01483027|365223600|FG001|Overall Study|Adverse Event|1|||
105882283|NCT01483027|365223599|FG000|Overall Study|Withdrawal by Subject|0|||
105882284|NCT01483027|365223600|FG001|Overall Study|Withdrawal by Subject|1|||
105882285|NCT04463251|365223602|FG000|Overall Study|Death|1|||
105882286|NCT04463251|365223603|FG001|Overall Study|Death|0|||
105882287|NCT04463251|365223604|FG002|Overall Study|Death|1|||
105882288|NCT04463251|365223602|FG000|Overall Study|Adverse Event|0|||
105882289|NCT04463251|365223603|FG001|Overall Study|Adverse Event|1|||
105882290|NCT04463251|365223604|FG002|Overall Study|Adverse Event|0|||
105882291|NCT04463251|365223602|FG000|Overall Study|Lost to Follow-up|0|||
105882292|NCT04463251|365223603|FG001|Overall Study|Lost to Follow-up|1|||
105882293|NCT04463251|365223604|FG002|Overall Study|Lost to Follow-up|0|||
105882294|NCT04463251|365223602|FG000|Overall Study|Withdrawal by Subject|0|||
105882295|NCT04463251|365223603|FG001|Overall Study|Withdrawal by Subject|2|||
105882296|NCT04463251|365223604|FG002|Overall Study|Withdrawal by Subject|2|||
105882297|NCT01266291|365223605|FG000|Overall Study|Adverse Event|1|||
105882298|NCT03291431|365223606|FG000|Overall Study|Protocol Violation|2|||
105882299|NCT03291431|365223607|FG001|Overall Study|Protocol Violation|1|||
105882300|NCT03291431|365223606|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
106111217|NCT02220894|366062076|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
106111218|NCT02220894|366062077|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
106111219|NCT02220894|366062076|FG000|Overall Study|Withdrawal by Subject|10|||
106111220|NCT02220894|366062077|FG001|Overall Study|Withdrawal by Subject|9|||
106111221|NCT03248375|366062078|FG000|Overall Study|Lost to Follow-up|5|||
106111222|NCT02390531|366062084|FG000|Overall Study|Death|0|||
106111223|NCT02390531|366062085|FG001|Overall Study|Death|2|||
106111224|NCT02390531|366062086|FG002|Overall Study|Death|0|||
106111225|NCT02390531|366062087|FG003|Overall Study|Death|1|||
106111226|NCT02390531|366062088|FG004|Overall Study|Death|0|||
106111227|NCT02390531|366062089|FG005|Overall Study|Death|0|||
106111228|NCT02390531|366062090|FG006|Overall Study|Death|0|||
105882301|NCT03291431|365223607|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
105951989|NCT02808429|365488171|FG001|Overall Study|Premature study termination by sponsor|0|||
106111229|NCT02390531|366062091|FG007|Overall Study|Death|1|||
106111230|NCT02390531|366062084|FG000|Overall Study|Protocol Violation|0|||
106111231|NCT02390531|366062085|FG001|Overall Study|Protocol Violation|0|||
106111232|NCT02390531|366062086|FG002|Overall Study|Protocol Violation|0|||
105882302|NCT03291431|365223606|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
105882303|NCT03291431|365223607|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
105882304|NCT00550745|365223610|FG000|Overall Study|Death|20|||
105882305|NCT00550745|365223611|FG001|Overall Study|Death|16|||
105882306|NCT00550745|365223610|FG000|Overall Study|Lost to Follow-up|45|||
105882307|NCT00550745|365223611|FG001|Overall Study|Lost to Follow-up|30|||
105882308|NCT00550745|365223610|FG000|Overall Study|Physician Decision|0|||
105882309|NCT00550745|365223611|FG001|Overall Study|Physician Decision|2|||
105882310|NCT00550745|365223610|FG000|Overall Study|Protocol Violation|4|||
105882311|NCT00550745|365223611|FG001|Overall Study|Protocol Violation|2|||
105882312|NCT00550745|365223610|FG000|Overall Study|Withdrawal by Subject|17|||
105882313|NCT00550745|365223611|FG001|Overall Study|Withdrawal by Subject|10|||
105882314|NCT00550745|365223610|FG000|Overall Study|Screen failure|1|||
105882315|NCT00550745|365223611|FG001|Overall Study|Screen failure|0|||
105882316|NCT03850483|365223612|FG000|Treatment for Stage 1|Adverse Event|1|||
105882317|NCT03850483|365223613|FG001|Treatment for Stage 1|Adverse Event|1|||
105882318|NCT03850483|365223614|FG002|Treatment for Stage 1|Adverse Event|3|||
105882319|NCT03850483|365223615|FG003|Treatment for Stage 1|Adverse Event|0|||
105882320|NCT03850483|365223616|FG004|Treatment for Stage 1|Adverse Event|2|||
105882321|NCT03850483|365223617|FG005|Treatment for Stage 1|Adverse Event|0|||
105882322|NCT03850483|365223618|FG006|Treatment for Stage 1|Adverse Event|2|||
105882323|NCT03850483|365223619|FG007|Treatment for Stage 1|Adverse Event|2|||
105882324|NCT03850483|365223620|FG008|Treatment for Stage 1|Adverse Event|0|||
105882325|NCT03850483|365223621|FG009|Treatment for Stage 1|Adverse Event|0|||
105882326|NCT03850483|365223612|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
105882327|NCT03850483|365223613|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
105882328|NCT03850483|365223614|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
105882329|NCT03850483|365223615|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
106111233|NCT02390531|366062087|FG003|Overall Study|Protocol Violation|0|||
106111234|NCT02390531|366062088|FG004|Overall Study|Protocol Violation|1|||
106111235|NCT02390531|366062089|FG005|Overall Study|Protocol Violation|0|||
106111236|NCT02390531|366062090|FG006|Overall Study|Protocol Violation|2|||
106111237|NCT02390531|366062091|FG007|Overall Study|Protocol Violation|0|||
106111238|NCT00542880|366062092|FG000|Period 1|Eligibility criteria not fulfilled|2|||
106111239|NCT00542880|366062093|FG001|Period 1|Eligibility criteria not fulfilled|6|||
106111240|NCT00542880|366062092|FG000|Period 1|Adverse Event|2|||
106111241|NCT00542880|366062093|FG001|Period 1|Adverse Event|2|||
106111242|NCT00542880|366062092|FG000|Period 1|Development of study-specific criteria|1|||
106111243|NCT00542880|366062093|FG001|Period 1|Development of study-specific criteria|2|||
106111244|NCT00542880|366062092|FG000|Period 1|Withdrawal by Subject|1|||
106111245|NCT00542880|366062093|FG001|Period 1|Withdrawal by Subject|1|||
106111246|NCT00542880|366062092|FG000|Period 1|Protocol Violation|0|||
106111247|NCT00542880|366062093|FG001|Period 1|Protocol Violation|1|||
106111248|NCT00542880|366062092|FG000|Period 2|Adverse Event|5|||
106111249|NCT00542880|366062093|FG001|Period 2|Adverse Event|7|||
106111250|NCT00542880|366062092|FG000|Period 2|Eligibility not fulfilled|0|||
106111251|NCT00542880|366062093|FG001|Period 2|Eligibility not fulfilled|1|||
106111252|NCT00542880|366062092|FG000|Period 2|Discontinuation criteria|2|||
106111253|NCT00542880|366062093|FG001|Period 2|Discontinuation criteria|0|||
106111254|NCT00542880|366062092|FG000|Period 2|Severe non-compliance|0|||
106111255|NCT00542880|366062093|FG001|Period 2|Severe non-compliance|1|||
106111256|NCT00542880|366062092|FG000|Period 2|Other|0|||
106111257|NCT00542880|366062093|FG001|Period 2|Other|1|||
106111258|NCT00542880|366062092|FG000|Period 3|Adverse Event|0|||
106111259|NCT00542880|366062093|FG001|Period 3|Adverse Event|2|||
106111260|NCT00982930|366062096|FG000|Overall Study|Adverse Event|1|||
106111261|NCT00982930|366062096|FG000|Overall Study|Withdrawal by Subject|1|||
106111262|NCT00982930|366062096|FG000|Overall Study|Administrative Problems|2|||
106111263|NCT00949884|366064034|FG000|Overall Study|Adverse Event|14|||
105882330|NCT03850483|365223616|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
106111264|NCT00949884|366064035|FG001|Overall Study|Adverse Event|3|||
106111265|NCT00949884|366064036|FG002|Overall Study|Adverse Event|12|||
106111266|NCT00949884|366064034|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
105882331|NCT03850483|365223617|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
105882332|NCT03850483|365223618|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
105882333|NCT03850483|365223619|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
105882334|NCT03850483|365223620|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
105882335|NCT03850483|365223621|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
105882336|NCT03850483|365223612|FG000|Treatment for Stage 1|Protocol Violation|1|||
105882337|NCT03850483|365223613|FG001|Treatment for Stage 1|Protocol Violation|0|||
105882338|NCT03850483|365223614|FG002|Treatment for Stage 1|Protocol Violation|0|||
105882339|NCT03850483|365223615|FG003|Treatment for Stage 1|Protocol Violation|0|||
106111267|NCT00949884|366064035|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
106111268|NCT00949884|366064036|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
106111269|NCT00949884|366064034|FG000|Overall Study|Lost to Follow-up|7|||
106111270|NCT00949884|366064035|FG001|Overall Study|Lost to Follow-up|5|||
105882340|NCT03850483|365223616|FG004|Treatment for Stage 1|Protocol Violation|0|||
105882341|NCT03850483|365223617|FG005|Treatment for Stage 1|Protocol Violation|0|||
105882342|NCT03850483|365223618|FG006|Treatment for Stage 1|Protocol Violation|1|||
105882343|NCT03850483|365223619|FG007|Treatment for Stage 1|Protocol Violation|0|||
105882344|NCT03850483|365223620|FG008|Treatment for Stage 1|Protocol Violation|0|||
105882345|NCT03850483|365223621|FG009|Treatment for Stage 1|Protocol Violation|0|||
105882346|NCT03850483|365223612|FG000|Treatment for Stage 1|Physician Decision|0|||
105882347|NCT03850483|365223613|FG001|Treatment for Stage 1|Physician Decision|0|||
105882348|NCT03850483|365223614|FG002|Treatment for Stage 1|Physician Decision|0|||
105882349|NCT03850483|365223615|FG003|Treatment for Stage 1|Physician Decision|0|||
105882350|NCT03850483|365223616|FG004|Treatment for Stage 1|Physician Decision|0|||
105882351|NCT03850483|365223617|FG005|Treatment for Stage 1|Physician Decision|1|||
105882352|NCT03850483|365223618|FG006|Treatment for Stage 1|Physician Decision|0|||
105882353|NCT03850483|365223619|FG007|Treatment for Stage 1|Physician Decision|0|||
105882354|NCT03850483|365223620|FG008|Treatment for Stage 1|Physician Decision|0|||
105882355|NCT03850483|365223621|FG009|Treatment for Stage 1|Physician Decision|0|||
105882356|NCT03850483|365223612|FG000|Treatment for Stage 1|Other|0|||
105882357|NCT03850483|365223613|FG001|Treatment for Stage 1|Other|0|||
105882358|NCT03850483|365223614|FG002|Treatment for Stage 1|Other|0|||
105882359|NCT03850483|365223615|FG003|Treatment for Stage 1|Other|0|||
105882360|NCT03850483|365223616|FG004|Treatment for Stage 1|Other|2|||
105882361|NCT03850483|365223617|FG005|Treatment for Stage 1|Other|1|||
105882362|NCT03850483|365223618|FG006|Treatment for Stage 1|Other|0|||
105882363|NCT03850483|365223619|FG007|Treatment for Stage 1|Other|0|||
105882364|NCT03850483|365223620|FG008|Treatment for Stage 1|Other|0|||
105882365|NCT03850483|365223621|FG009|Treatment for Stage 1|Other|0|||
105882366|NCT03850483|365223612|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882367|NCT03850483|365223613|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882368|NCT03850483|365223614|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
105882369|NCT03850483|365223615|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882370|NCT03850483|365223616|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882371|NCT03850483|365223617|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882372|NCT03850483|365223618|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882373|NCT03850483|365223619|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882374|NCT03850483|365223620|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882375|NCT03850483|365223621|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
105882376|NCT03850483|365223612|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882377|NCT03850483|365223613|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882378|NCT03850483|365223614|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882379|NCT03850483|365223615|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882380|NCT03850483|365223616|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882381|NCT03850483|365223617|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
105882382|NCT03850483|365223618|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882383|NCT03850483|365223619|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882384|NCT03850483|365223620|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882385|NCT03850483|365223621|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
105882386|NCT03850483|365223612|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
105882387|NCT03850483|365223613|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
105882388|NCT03850483|365223614|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
105882389|NCT03850483|365223615|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
105882390|NCT03850483|365223616|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
105882391|NCT03850483|365223617|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
105882392|NCT03850483|365223618|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
105882393|NCT03850483|365223619|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
105882394|NCT03850483|365223620|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
105882395|NCT03850483|365223621|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
105882396|NCT03850483|365223612|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
105882397|NCT03850483|365223613|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
105882398|NCT03850483|365223614|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
105882399|NCT03850483|365223615|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
105882400|NCT03850483|365223616|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
105882401|NCT03850483|365223617|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
105882402|NCT03850483|365223618|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
105882403|NCT03850483|365223619|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
105882404|NCT03850483|365223620|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
105882405|NCT03850483|365223621|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
105882406|NCT03850483|365223612|FG000|Treatment for Stage 1|Death|0|||
105882407|NCT03850483|365223613|FG001|Treatment for Stage 1|Death|0|||
105882408|NCT03850483|365223614|FG002|Treatment for Stage 1|Death|0|||
105882409|NCT03850483|365223615|FG003|Treatment for Stage 1|Death|0|||
105882410|NCT03850483|365223616|FG004|Treatment for Stage 1|Death|0|||
105882411|NCT03850483|365223617|FG005|Treatment for Stage 1|Death|1|||
105882412|NCT03850483|365223618|FG006|Treatment for Stage 1|Death|0|||
105882413|NCT03850483|365223619|FG007|Treatment for Stage 1|Death|0|||
105882414|NCT03850483|365223620|FG008|Treatment for Stage 1|Death|0|||
105882415|NCT03850483|365223621|FG009|Treatment for Stage 1|Death|0|||
105882416|NCT03850483|365223612|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
105882417|NCT03850483|365223613|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
105882418|NCT03850483|365223614|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
105882419|NCT03850483|365223615|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
105882420|NCT03850483|365223616|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
105882421|NCT03850483|365223617|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
105882422|NCT03850483|365223618|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
105882423|NCT03850483|365223619|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
105882424|NCT03850483|365223620|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
105882425|NCT03850483|365223621|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
105882426|NCT03850483|365223612|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
105882427|NCT03850483|365223613|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
105882428|NCT03850483|365223614|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
105882429|NCT03850483|365223615|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
105882430|NCT03850483|365223616|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
105882431|NCT03850483|365223617|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
105882432|NCT03850483|365223618|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
105882433|NCT03850483|365223619|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
105882434|NCT03850483|365223620|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
105882435|NCT03850483|365223621|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
105882436|NCT03850483|365223612|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
105882437|NCT03850483|365223613|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
105882438|NCT03850483|365223614|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
105882439|NCT03850483|365223615|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
105882440|NCT03850483|365223616|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
105882441|NCT03850483|365223617|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
105882442|NCT03850483|365223618|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
105882443|NCT03850483|365223619|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
105882444|NCT03850483|365223620|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
105882445|NCT03850483|365223621|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
105882446|NCT03850483|365223612|FG000|Follow-up for Stage 1|Physician Decision|0|||
105882447|NCT03850483|365223613|FG001|Follow-up for Stage 1|Physician Decision|0|||
105882448|NCT03850483|365223614|FG002|Follow-up for Stage 1|Physician Decision|0|||
105882449|NCT03850483|365223615|FG003|Follow-up for Stage 1|Physician Decision|0|||
105882450|NCT03850483|365223616|FG004|Follow-up for Stage 1|Physician Decision|1|||
105882451|NCT03850483|365223617|FG005|Follow-up for Stage 1|Physician Decision|0|||
105882452|NCT03850483|365223618|FG006|Follow-up for Stage 1|Physician Decision|1|||
105882453|NCT03850483|365223619|FG007|Follow-up for Stage 1|Physician Decision|0|||
105882454|NCT03850483|365223620|FG008|Follow-up for Stage 1|Physician Decision|0|||
105882455|NCT03850483|365223621|FG009|Follow-up for Stage 1|Physician Decision|0|||
105882456|NCT03850483|365223612|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
105882457|NCT03850483|365223613|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
105882458|NCT03850483|365223614|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
105882459|NCT03850483|365223615|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
105882460|NCT03850483|365223616|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
105882461|NCT03850483|365223617|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
105882462|NCT03850483|365223618|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
105882463|NCT03850483|365223619|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
105882464|NCT03850483|365223620|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
105882465|NCT03850483|365223621|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
105882466|NCT03850483|365223612|FG000|Follow-up for Stage 1|Adverse Event|0|||
105882467|NCT03850483|365223613|FG001|Follow-up for Stage 1|Adverse Event|0|||
105882468|NCT03850483|365223614|FG002|Follow-up for Stage 1|Adverse Event|1|||
105882469|NCT03850483|365223615|FG003|Follow-up for Stage 1|Adverse Event|0|||
105882470|NCT03850483|365223616|FG004|Follow-up for Stage 1|Adverse Event|0|||
105882471|NCT03850483|365223617|FG005|Follow-up for Stage 1|Adverse Event|1|||
105882472|NCT03850483|365223618|FG006|Follow-up for Stage 1|Adverse Event|0|||
105882473|NCT03850483|365223619|FG007|Follow-up for Stage 1|Adverse Event|0|||
105882474|NCT03850483|365223620|FG008|Follow-up for Stage 1|Adverse Event|0|||
105882475|NCT03850483|365223621|FG009|Follow-up for Stage 1|Adverse Event|0|||
105882476|NCT03850483|365223612|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105882477|NCT03850483|365223613|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
106111271|NCT00949884|366064036|FG002|Overall Study|Lost to Follow-up|5|||
106111272|NCT00949884|366064034|FG000|Overall Study|Physician Decision|5|||
106111273|NCT00949884|366064035|FG001|Overall Study|Physician Decision|0|||
106111274|NCT00949884|366064036|FG002|Overall Study|Physician Decision|6|||
106111275|NCT00949884|366064034|FG000|Overall Study|Treatment non-compliance|5|||
106111276|NCT00949884|366064035|FG001|Overall Study|Treatment non-compliance|0|||
106111277|NCT00949884|366064036|FG002|Overall Study|Treatment non-compliance|8|||
106111278|NCT00949884|366064034|FG000|Overall Study|Withdrawal by Subject|13|||
106111279|NCT00949884|366064035|FG001|Overall Study|Withdrawal by Subject|4|||
105882478|NCT03850483|365223614|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105882479|NCT03850483|365223615|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105882480|NCT03850483|365223616|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
105882481|NCT03850483|365223617|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
105882482|NCT03850483|365223618|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105882483|NCT03850483|365223619|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105882484|NCT03850483|365223620|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105882485|NCT03850483|365223621|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
105882486|NCT03850483|365223612|FG000|Follow-up for Stage 1|Other|0|||
105882487|NCT03850483|365223613|FG001|Follow-up for Stage 1|Other|2|||
105882488|NCT03850483|365223614|FG002|Follow-up for Stage 1|Other|0|||
105882489|NCT03850483|365223615|FG003|Follow-up for Stage 1|Other|2|||
105882490|NCT03850483|365223616|FG004|Follow-up for Stage 1|Other|0|||
105882491|NCT03850483|365223617|FG005|Follow-up for Stage 1|Other|1|||
105882492|NCT03850483|365223618|FG006|Follow-up for Stage 1|Other|0|||
105882493|NCT03850483|365223619|FG007|Follow-up for Stage 1|Other|0|||
105882494|NCT03850483|365223620|FG008|Follow-up for Stage 1|Other|0|||
105882495|NCT03850483|365223621|FG009|Follow-up for Stage 1|Other|0|||
106111280|NCT00949884|366064036|FG002|Overall Study|Withdrawal by Subject|16|||
106111281|NCT00949884|366064034|FG000|Overall Study|Lack of Efficacy|4|||
106111282|NCT00949884|366064035|FG001|Overall Study|Lack of Efficacy|2|||
106111283|NCT00949884|366064036|FG002|Overall Study|Lack of Efficacy|7|||
106111284|NCT00949884|366064034|FG000|Overall Study|Study terminated by sponsor|0|||
106111285|NCT00949884|366064035|FG001|Overall Study|Study terminated by sponsor|0|||
106111286|NCT00949884|366064036|FG002|Overall Study|Study terminated by sponsor|1|||
106111287|NCT01953003|366064037|FG000|Overall Study|Not treated|0|||
106111288|NCT01953003|366064038|FG001|Overall Study|Not treated|1|||
106111289|NCT01953003|366064037|FG000|Overall Study|Progressive disease|35|||
106111290|NCT01953003|366064038|FG001|Overall Study|Progressive disease|45|||
106111291|NCT01953003|366064037|FG000|Overall Study|Related Adverse events|7|||
106111292|NCT01953003|366064038|FG001|Overall Study|Related Adverse events|2|||
106111293|NCT01953003|366064037|FG000|Overall Study|Non-related adverse events|0|||
106111294|NCT01953003|366064038|FG001|Overall Study|Non-related adverse events|2|||
106111295|NCT01953003|366064037|FG000|Overall Study|Protocol Violation|0|||
106111296|NCT01953003|366064038|FG001|Overall Study|Protocol Violation|1|||
106111297|NCT01953003|366064037|FG000|Overall Study|Withdrawal by Subject|14|||
106111298|NCT01953003|366064038|FG001|Overall Study|Withdrawal by Subject|4|||
106111299|NCT04737109|366064039|FG000|Study Treatment|Disease Progression|5|||
106111300|NCT04737109|366064040|FG001|Study Treatment|Disease Progression|0|||
106111301|NCT04737109|366064041|FG002|Study Treatment|Disease Progression|0|||
106111302|NCT04737109|366064042|FG003|Study Treatment|Disease Progression|0|||
106111303|NCT04737109|366064039|FG000|Study Treatment|Death on study|1|||
106111304|NCT04737109|366064040|FG001|Study Treatment|Death on study|0|||
106111305|NCT04737109|366064041|FG002|Study Treatment|Death on study|0|||
106111306|NCT04737109|366064042|FG003|Study Treatment|Death on study|0|||
106111307|NCT01464021|366064047|FG000|Overall Study|Withdrawal by Subject|13|||
106111308|NCT01464021|366064047|FG000|Overall Study|Lost to Follow-up|1|||
106111309|NCT01464021|366064047|FG000|Overall Study|Lack of Efficacy|1|||
106111310|NCT01464021|366064047|FG000|Overall Study|various|11|||
106111311|NCT00949715|366064048|FG000|Overall Study|Physician Decision|1|||
106111312|NCT00949715|366064049|FG001|Overall Study|Physician Decision|0|||
106111313|NCT00949715|366064048|FG000|Overall Study|Lost to Follow-up|1|||
106111314|NCT00949715|366064049|FG001|Overall Study|Lost to Follow-up|0|||
106111315|NCT00949715|366064048|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
106111316|NCT00949715|366064049|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
106111317|NCT04858802|366064050|FG000|Overall Study|Lost to Follow-up|1|||
105882496|NCT03850483|365223612|FG000|Treatment for Stage 2|Adverse Event|0|||
105882497|NCT03850483|365223613|FG001|Treatment for Stage 2|Adverse Event|0|||
105882498|NCT03850483|365223614|FG002|Treatment for Stage 2|Adverse Event|0|||
105882499|NCT03850483|365223615|FG003|Treatment for Stage 2|Adverse Event|0|||
105882500|NCT03850483|365223616|FG004|Treatment for Stage 2|Adverse Event|0|||
105882501|NCT03850483|365223617|FG005|Treatment for Stage 2|Adverse Event|0|||
105882502|NCT03850483|365223618|FG006|Treatment for Stage 2|Adverse Event|0|||
105882503|NCT03850483|365223619|FG007|Treatment for Stage 2|Adverse Event|0|||
105882504|NCT03850483|365223620|FG008|Treatment for Stage 2|Adverse Event|0|||
105882505|NCT03850483|365223621|FG009|Treatment for Stage 2|Adverse Event|1|||
105882506|NCT03850483|365223612|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
105882507|NCT03850483|365223613|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
106111318|NCT04858802|366064051|FG001|Overall Study|Lost to Follow-up|1|||
106111319|NCT04858802|366064050|FG000|Overall Study|Withdrawal by Subject|1|||
106111320|NCT04858802|366064051|FG001|Overall Study|Withdrawal by Subject|1|||
106111321|NCT01352585|366064052|FG000|Overall Study|Adverse Event|2|||
105882508|NCT03850483|365223614|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
106111322|NCT01352585|366064053|FG001|Overall Study|Adverse Event|1|||
106111323|NCT01352585|366064052|FG000|Overall Study|Lost to Follow-up|1|||
106111324|NCT01352585|366064053|FG001|Overall Study|Lost to Follow-up|0|||
106111325|NCT01352585|366064052|FG000|Overall Study|Other|5|||
106111326|NCT01352585|366064053|FG001|Overall Study|Other|2|||
106111327|NCT00998400|366064054|FG000|Overall Study|Lack of interest/motivation|1|||
106111328|NCT00998400|366064055|FG001|Overall Study|Lack of interest/motivation|2|||
106111329|NCT00998400|366064054|FG000|Overall Study|Logistical problems|1|||
106111330|NCT00998400|366064055|FG001|Overall Study|Logistical problems|0|||
106111331|NCT03928028|366064059|FG000|Overall Study|Physician Decision|9|||
106111332|NCT03928028|366064060|FG001|Overall Study|Physician Decision|6|||
106111333|NCT03928028|366064061|FG002|Overall Study|Physician Decision|3|||
106111334|NCT03928028|366064059|FG000|Overall Study|Withdrawal by Subject|12|||
106111335|NCT03928028|366064060|FG001|Overall Study|Withdrawal by Subject|3|||
106111336|NCT03928028|366064061|FG002|Overall Study|Withdrawal by Subject|3|||
106111337|NCT02710292|366064066|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
106111338|NCT02710292|366064067|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
106111339|NCT02710292|366064066|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
106111340|NCT02710292|366064067|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
106111341|NCT00800202|366064068|FG000|Overall Study|Adverse Event|7|||
106111342|NCT00800202|366064069|FG001|Overall Study|Adverse Event|6|||
106111343|NCT00800202|366064068|FG000|Overall Study|Death|1|||
106111344|NCT00800202|366064069|FG001|Overall Study|Death|0|||
106111345|NCT00800202|366064068|FG000|Overall Study|Other|5|||
106111346|NCT00800202|366064069|FG001|Overall Study|Other|0|||
106111347|NCT00800202|366064068|FG000|Overall Study|Disease Progression|54|||
106111348|NCT00800202|366064069|FG001|Overall Study|Disease Progression|18|||
106111349|NCT01392300|366064075|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
106111350|NCT01392300|366064076|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
106111351|NCT01392300|366064077|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
106111352|NCT01392300|366064075|FG000|Main Period (MP)|Withdrawal by Subject|5|||
106111353|NCT01392300|366064076|FG001|Main Period (MP)|Withdrawal by Subject|1|||
106111354|NCT01392300|366064077|FG002|Main Period (MP)|Withdrawal by Subject|0|||
106111355|NCT01392300|366064075|FG000|Main Period (MP)|Lost to Follow-up|3|||
106111356|NCT01392300|366064076|FG001|Main Period (MP)|Lost to Follow-up|3|||
106111357|NCT01392300|366064077|FG002|Main Period (MP)|Lost to Follow-up|0|||
106111358|NCT01392300|366064075|FG000|Main Period (MP)|Non-compliance|1|||
106111359|NCT01392300|366064076|FG001|Main Period (MP)|Non-compliance|0|||
106111360|NCT01392300|366064077|FG002|Main Period (MP)|Non-compliance|0|||
106111361|NCT01392300|366064075|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
106111362|NCT01392300|366064076|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
106111363|NCT01392300|366064077|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
106111364|NCT01392300|366064075|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
106111365|NCT01392300|366064076|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
106111366|NCT01392300|366064077|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
106111367|NCT01392300|366064075|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
106111368|NCT01392300|366064076|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
106111369|NCT01392300|366064077|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
106111370|NCT01392300|366064075|FG000|Open Label Extension (OLEX) Period|Death|0|||
106111371|NCT01392300|366064076|FG001|Open Label Extension (OLEX) Period|Death|0|||
106111372|NCT01392300|366064077|FG002|Open Label Extension (OLEX) Period|Death|4|||
106111373|NCT01392300|366064075|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
106111374|NCT01392300|366064076|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
106111375|NCT01392300|366064077|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
106111376|NCT01392300|366064075|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
106111377|NCT01392300|366064076|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
106111378|NCT01392300|366064077|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
106111379|NCT01392300|366064075|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
106111380|NCT01392300|366064076|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
106111381|NCT01392300|366064077|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
106111382|NCT01493687|366064078|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
106111383|NCT01493687|366064079|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
106111384|NCT01493687|366064078|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
106111385|NCT01493687|366064079|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
106111386|NCT01493687|366064078|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
106111387|NCT01493687|366064079|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
106111388|NCT01493687|366064078|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
106111389|NCT01493687|366064079|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
106111390|NCT01493687|366064078|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
106111391|NCT01493687|366064079|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
106111392|NCT01493687|366064078|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
106111393|NCT01493687|366064079|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
106111394|NCT01493687|366064078|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
106111395|NCT01493687|366064079|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
106111396|NCT01493687|366064078|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
105882509|NCT03850483|365223615|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
105882510|NCT03850483|365223616|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
105882511|NCT03850483|365223617|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
105882512|NCT03850483|365223618|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
105882513|NCT03850483|365223619|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
105882514|NCT03850483|365223620|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
105882515|NCT03850483|365223621|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
105882516|NCT03850483|365223612|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
105882517|NCT03850483|365223613|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
105882518|NCT03850483|365223614|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
105882519|NCT03850483|365223615|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
105882520|NCT03850483|365223616|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
105882521|NCT03850483|365223617|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
105882522|NCT03850483|365223618|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
105882523|NCT03850483|365223619|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
105882524|NCT03850483|365223620|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
105882525|NCT03850483|365223621|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
105882526|NCT03850483|365223612|FG000|Treatment for Stage 2|Physician Decision|0|||
105882527|NCT03850483|365223613|FG001|Treatment for Stage 2|Physician Decision|0|||
105882528|NCT03850483|365223614|FG002|Treatment for Stage 2|Physician Decision|0|||
105882529|NCT03850483|365223615|FG003|Treatment for Stage 2|Physician Decision|0|||
105882530|NCT03850483|365223616|FG004|Treatment for Stage 2|Physician Decision|0|||
105882531|NCT03850483|365223617|FG005|Treatment for Stage 2|Physician Decision|0|||
105882532|NCT03850483|365223618|FG006|Treatment for Stage 2|Physician Decision|0|||
105882533|NCT03850483|365223619|FG007|Treatment for Stage 2|Physician Decision|0|||
105882534|NCT03850483|365223620|FG008|Treatment for Stage 2|Physician Decision|0|||
105882535|NCT03850483|365223621|FG009|Treatment for Stage 2|Physician Decision|1|||
105882536|NCT03850483|365223612|FG000|Treatment for Stage 2|Protocol Violation|0|||
105882537|NCT03850483|365223613|FG001|Treatment for Stage 2|Protocol Violation|0|||
105882538|NCT03850483|365223614|FG002|Treatment for Stage 2|Protocol Violation|0|||
105882539|NCT03850483|365223615|FG003|Treatment for Stage 2|Protocol Violation|0|||
106111397|NCT01493687|366064079|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
106111398|NCT01493687|366064078|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
106111399|NCT01493687|366064079|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
106111400|NCT01493687|366064078|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
106111401|NCT01493687|366064079|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
106111402|NCT01493687|366064078|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
106111403|NCT01493687|366064079|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
106111404|NCT01493687|366064078|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
106111405|NCT01493687|366064079|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
106111406|NCT01493687|366064078|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
106111407|NCT01493687|366064079|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
106111408|NCT01493687|366064078|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
106111409|NCT01493687|366064079|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
106111410|NCT01493687|366064078|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
106111411|NCT01493687|366064079|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
106111412|NCT02364180|366064081|FG000|Overall Study|Screen Fail|1|||
106111413|NCT00521144|366064082|FG000|Overall Study|Not Treated|0|||
106111414|NCT00521144|366064083|FG001|Overall Study|Not Treated|0|||
106111415|NCT00521144|366064084|FG002|Overall Study|Not Treated|0|||
106111416|NCT00521144|366064085|FG003|Overall Study|Not Treated|1|||
106111417|NCT00521144|366064086|FG004|Overall Study|Not Treated|0|||
106111418|NCT00521144|366064082|FG000|Overall Study|Adverse Event|0|||
106111419|NCT00521144|366064083|FG001|Overall Study|Adverse Event|1|||
106111420|NCT00521144|366064084|FG002|Overall Study|Adverse Event|0|||
106111421|NCT00521144|366064085|FG003|Overall Study|Adverse Event|0|||
106111422|NCT00521144|366064086|FG004|Overall Study|Adverse Event|1|||
106111423|NCT00521144|366064082|FG000|Overall Study|Progressive Disease|4|||
106111424|NCT00521144|366064083|FG001|Overall Study|Progressive Disease|2|||
106111425|NCT00521144|366064084|FG002|Overall Study|Progressive Disease|2|||
106111426|NCT00521144|366064085|FG003|Overall Study|Progressive Disease|0|||
106111427|NCT00521144|366064086|FG004|Overall Study|Progressive Disease|6|||
106111428|NCT01370525|366064087|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
106111429|NCT01370525|366064088|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
106111430|NCT01370525|366064087|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
106111431|NCT01370525|366064088|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
106111432|NCT01370525|366064087|FG000|Overall Study|Adverse Event|0|||
106111433|NCT01370525|366064088|FG001|Overall Study|Adverse Event|1|||
106111434|NCT01370525|366064087|FG000|Overall Study|Protocol Violation|2|||
105882540|NCT03850483|365223616|FG004|Treatment for Stage 2|Protocol Violation|0|||
105882541|NCT03850483|365223617|FG005|Treatment for Stage 2|Protocol Violation|0|||
106111435|NCT01370525|366064088|FG001|Overall Study|Protocol Violation|1|||
106111436|NCT01370525|366064087|FG000|Overall Study|Lost to follow up|2|||
106111437|NCT01370525|366064088|FG001|Overall Study|Lost to follow up|6|||
106111438|NCT00710606|366064091|FG000|Overall Study|Adverse Event|0|||
106111439|NCT00710606|366064092|FG001|Overall Study|Adverse Event|2|||
106111440|NCT05131165|366064093|FG000|Overall Study|Death|1|||
106111441|NCT05131165|366064094|FG001|Overall Study|Death|1|||
106111442|NCT05131165|366064095|FG002|Overall Study|Death|0|||
106111443|NCT05131165|366064093|FG000|Overall Study|Lost to Follow-up|2|||
106111444|NCT05131165|366064094|FG001|Overall Study|Lost to Follow-up|2|||
106111445|NCT05131165|366064095|FG002|Overall Study|Lost to Follow-up|5|||
106111446|NCT05131165|366064093|FG000|Overall Study|Transferred out of clinic|1|||
106111447|NCT05131165|366064094|FG001|Overall Study|Transferred out of clinic|0|||
106111448|NCT05131165|366064095|FG002|Overall Study|Transferred out of clinic|3|||
106111449|NCT05131165|366064093|FG000|Overall Study|Dropped out|1|||
106111450|NCT05131165|366064094|FG001|Overall Study|Dropped out|2|||
106111451|NCT05131165|366064095|FG002|Overall Study|Dropped out|0|||
106111452|NCT01964326|366064096|FG000|Overall Study|Adverse Event|48|||
106111453|NCT01964326|366064096|FG000|Overall Study|Death|2|||
106111454|NCT01964326|366064096|FG000|Overall Study|Protocol Violation|4|||
106111455|NCT01964326|366064096|FG000|Overall Study|Lost to Follow-up|88|||
106111456|NCT01964326|366064096|FG000|Overall Study|Withdrawal by Subject|87|||
106111457|NCT01964326|366064096|FG000|Overall Study|Pregnancy|1|||
106111458|NCT01964326|366064096|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
106111459|NCT01964326|366064096|FG000|Overall Study|Physician Decision|55|||
106111460|NCT01964326|366064096|FG000|Overall Study|Investigator Discretion|1|||
106111461|NCT01964326|366064096|FG000|Overall Study|Other|9|||
106111462|NCT01964326|366064096|FG000|Overall Study|Did not meet eligibility criteria|1|||
106111463|NCT01995539|366064097|FG000|Overall Study|Screening Failure|1|||
106111464|NCT01995539|366064097|FG000|Overall Study|Withdrawal by Investigator|15|||
106111465|NCT01995539|366064097|FG000|Overall Study|Withdrawal by Subject|11|||
106111466|NCT01995539|366064097|FG000|Overall Study|Lost to Follow-up|5|||
106111467|NCT01995539|366064097|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
106111468|NCT00261495|366064104|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
106111469|NCT00261495|366064105|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
106111470|NCT00261495|366064104|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
106111471|NCT00261495|366064105|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
106111472|NCT00261495|366064104|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
106111473|NCT00261495|366064105|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
106111474|NCT00261495|366064104|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
106111475|NCT00261495|366064105|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
106111476|NCT00261495|366064104|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
106111477|NCT00261495|366064105|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
106111478|NCT00261495|366064104|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
106111479|NCT00261495|366064105|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
106111480|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
106111481|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
106111482|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
106111483|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
106111484|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
106111485|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
106111486|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
106111487|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
106111488|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
106111489|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
106111490|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
106111491|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
106111492|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
106111493|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
106111494|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
106111495|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
106111496|NCT00261495|366064104|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
106111497|NCT00261495|366064105|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
106111498|NCT00261495|366064104|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
106111499|NCT00261495|366064105|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
106111500|NCT00261495|366064104|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
106111501|NCT00261495|366064105|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
106111502|NCT00261495|366064104|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
106111503|NCT00261495|366064105|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
106111504|NCT00261495|366064104|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
106111505|NCT00261495|366064105|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
106111506|NCT00261495|366064104|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
106111507|NCT00261495|366064105|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
106111508|NCT00261495|366064104|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
106111509|NCT00261495|366064105|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
106111510|NCT02066402|366064106|FG000|Overall Study|Adverse Event|1|||
106111511|NCT02066402|366064107|FG001|Overall Study|Adverse Event|2|||
106111512|NCT02066402|366064106|FG000|Overall Study|Lost to Follow-up|11|||
106111513|NCT02066402|366064107|FG001|Overall Study|Lost to Follow-up|8|||
106111514|NCT02066402|366064106|FG000|Overall Study|Withdrawal by Subject|14|||
106111515|NCT02066402|366064107|FG001|Overall Study|Withdrawal by Subject|11|||
106111516|NCT02066402|366064106|FG000|Overall Study|Progressive disease-clinical progression|0|||
106111517|NCT02066402|366064107|FG001|Overall Study|Progressive disease-clinical progression|1|||
106111518|NCT02066402|366064106|FG000|Overall Study|Protocol driven decision point|0|||
106111519|NCT02066402|366064107|FG001|Overall Study|Protocol driven decision point|1|||
105882542|NCT03850483|365223618|FG006|Treatment for Stage 2|Protocol Violation|0|||
105882543|NCT03850483|365223619|FG007|Treatment for Stage 2|Protocol Violation|0|||
105882544|NCT03850483|365223620|FG008|Treatment for Stage 2|Protocol Violation|1|||
105882545|NCT03850483|365223621|FG009|Treatment for Stage 2|Protocol Violation|0|||
105882546|NCT03850483|365223612|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
105882547|NCT03850483|365223613|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
105882548|NCT03850483|365223614|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
105882549|NCT03850483|365223615|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
105882550|NCT03850483|365223616|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
105882551|NCT03850483|365223617|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
105882552|NCT03850483|365223618|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
105882553|NCT03850483|365223619|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
105882554|NCT03850483|365223620|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
105882555|NCT03850483|365223621|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
105882556|NCT03850483|365223612|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105882557|NCT03850483|365223613|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105882558|NCT03850483|365223614|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105882559|NCT03850483|365223615|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105882560|NCT03850483|365223616|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105882561|NCT03850483|365223617|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
106111520|NCT03243422|366064108|FG000|Overall Study|Death|20|||
106111521|NCT03243422|366064109|FG001|Overall Study|Death|21|||
106111522|NCT03243422|366064108|FG000|Overall Study|Lost to Follow-up|9|||
106111523|NCT03243422|366064109|FG001|Overall Study|Lost to Follow-up|21|||
106111524|NCT03243422|366064108|FG000|Overall Study|Withdrawal by Subject|22|||
106111525|NCT03243422|366064109|FG001|Overall Study|Withdrawal by Subject|8|||
106111526|NCT01424930|366064111|FG000|Overall Study|Adverse Event|0|||
106111527|NCT01424930|366064112|FG001|Overall Study|Adverse Event|1|||
106111528|NCT01424930|366064111|FG000|Overall Study|Death|1|||
106111529|NCT01424930|366064112|FG001|Overall Study|Death|0|||
106111530|NCT01424930|366064111|FG000|Overall Study|Progressive Disease|3|||
106111531|NCT01424930|366064112|FG001|Overall Study|Progressive Disease|6|||
106111532|NCT01424930|366064111|FG000|Overall Study|Screen Failure|0|||
106111533|NCT01424930|366064112|FG001|Overall Study|Screen Failure|1|||
106111534|NCT01424930|366064111|FG000|Overall Study|Reason not specified|0|||
106111535|NCT01424930|366064112|FG001|Overall Study|Reason not specified|6|||
106111536|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
106111537|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
106111538|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
106111539|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
106111540|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
106111541|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
106111542|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
106111543|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
106111544|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
106111545|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
106111546|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
106111547|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
106111548|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
106111549|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
106111550|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
106111551|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
106111552|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
106111553|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
106111554|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
106111555|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
106111556|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Death|2|||
106111557|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Death|2|||
106111558|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Death|0|||
106111559|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Death|0|||
106111560|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Death|0|||
106111561|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
106111562|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
106111563|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
106111564|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
106111565|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
106111566|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
106111567|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
106111568|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
106111569|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
106111570|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
106111571|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
106111572|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
106111573|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
106111574|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
106111575|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
106111576|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
106111577|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
106111578|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
106111579|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
106111580|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
106111581|NCT03420781|366064117|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
106111582|NCT03420781|366064118|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
106111583|NCT03420781|366064119|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
106111584|NCT03420781|366064120|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
106111585|NCT03420781|366064121|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
106111586|NCT03420781|366064117|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
106111587|NCT03420781|366064118|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
106111588|NCT03420781|366064119|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
106111589|NCT03420781|366064120|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
106111590|NCT03420781|366064121|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
106111591|NCT03420781|366064117|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
106111592|NCT03420781|366064118|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
106111593|NCT03420781|366064119|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
106111594|NCT03420781|366064120|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
106111595|NCT03420781|366064121|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
106111596|NCT03420781|366064117|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
106111597|NCT03420781|366064118|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
106111598|NCT03420781|366064119|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
106111599|NCT03420781|366064120|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
106111600|NCT03420781|366064121|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
106111601|NCT01621880|366064122|FG000|Overall Study|Adverse Event|5|||
106111602|NCT01621880|366064123|FG001|Overall Study|Adverse Event|1|||
106111603|NCT01621880|366064122|FG000|Overall Study|Withdrawal by Subject|5|||
106111604|NCT01621880|366064123|FG001|Overall Study|Withdrawal by Subject|4|||
106111605|NCT01127646|366064124|FG000|Overall Study|Entry Criteria Not Met|1|||
106111606|NCT01127646|366064125|FG001|Overall Study|Entry Criteria Not Met|0|||
106111607|NCT01127646|366064124|FG000|Overall Study|Protocol Violation|0|||
106111608|NCT01127646|366064125|FG001|Overall Study|Protocol Violation|1|||
106111609|NCT02313909|366064128|FG000|Overall Study|Consent withdrawn by participant|33|||
106111610|NCT02313909|366064129|FG001|Overall Study|Consent withdrawn by participant|33|||
106111611|NCT02313909|366064128|FG000|Overall Study|Lost to Follow-up|24|||
106111612|NCT02313909|366064129|FG001|Overall Study|Lost to Follow-up|17|||
106111613|NCT00638235|366064130|FG000|Overall Study|Lost to Follow-up|31|||
106111614|NCT00638235|366064131|FG001|Overall Study|Lost to Follow-up|3|||
106111615|NCT00638235|366064132|FG002|Overall Study|Lost to Follow-up|18|||
106111616|NCT00638235|366064133|FG003|Overall Study|Lost to Follow-up|10|||
106111617|NCT00638235|366064134|FG004|Overall Study|Lost to Follow-up|13|||
106111618|NCT00638235|366064135|FG005|Overall Study|Lost to Follow-up|26|||
106111619|NCT00638235|366064136|FG006|Overall Study|Lost to Follow-up|0|||
106111620|NCT00638235|366064137|FG007|Overall Study|Lost to Follow-up|1|||
106111621|NCT00638235|366064138|FG008|Overall Study|Lost to Follow-up|18|||
106111622|NCT02923739|366064139|FG000|Overall Study|Withdrawal by Subject|2|||
106111623|NCT02923739|366064140|FG001|Overall Study|Withdrawal by Subject|0|||
106111624|NCT02923739|366064141|FG002|Overall Study|Withdrawal by Subject|0|||
106111625|NCT02923739|366064142|FG003|Overall Study|Withdrawal by Subject|0|||
106111626|NCT02923739|366064139|FG000|Overall Study|Failed Screening|3|||
106111627|NCT02923739|366064140|FG001|Overall Study|Failed Screening|0|||
106111628|NCT02923739|366064141|FG002|Overall Study|Failed Screening|0|||
106111629|NCT02923739|366064142|FG003|Overall Study|Failed Screening|0|||
106111630|NCT03086330|366064143|FG000|Overall Study|Withdrawal by Subject|3|||
106111631|NCT03086330|366064144|FG001|Overall Study|Withdrawal by Subject|2|||
106111632|NCT03086330|366064143|FG000|Overall Study|Lost to Follow-up|1|||
106111633|NCT03086330|366064144|FG001|Overall Study|Lost to Follow-up|2|||
106111634|NCT01281202|366064145|FG000|Overall Study|Adverse Event|2|||
106111635|NCT01281202|366064146|FG001|Overall Study|Adverse Event|0|||
106111636|NCT01281202|366064145|FG000|Overall Study|Withdrawal by Subject|2|||
106111637|NCT01281202|366064146|FG001|Overall Study|Withdrawal by Subject|2|||
106111638|NCT01281202|366064145|FG000|Overall Study|Protocol Violation|11|||
106111639|NCT01281202|366064146|FG001|Overall Study|Protocol Violation|10|||
106111640|NCT01281202|366064145|FG000|Overall Study|Administrative|2|||
106111641|NCT01281202|366064146|FG001|Overall Study|Administrative|8|||
106111642|NCT01281202|366064145|FG000|Overall Study|Lost to Follow-up|11|||
106111643|NCT01281202|366064146|FG001|Overall Study|Lost to Follow-up|13|||
106111644|NCT01281202|366064145|FG000|Overall Study|Incarceration|0|||
106111645|NCT01281202|366064146|FG001|Overall Study|Incarceration|3|||
106111646|NCT02889133|366064150|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
106111647|NCT02889133|366064151|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
106111648|NCT02889133|366064150|FG000|Completed Primary Outcome|Manufacturing error|3|||
106111649|NCT02889133|366064151|FG001|Completed Primary Outcome|Manufacturing error|8|||
106111650|NCT02889133|366064150|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
106111651|NCT02889133|366064151|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
106111652|NCT02889133|366064150|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
106111653|NCT02889133|366064151|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
106111654|NCT02889133|366064150|FG000|Completed Primary Outcome|Protocol Violation|1|||
106111655|NCT02889133|366064151|FG001|Completed Primary Outcome|Protocol Violation|0|||
106111656|NCT02889133|366064150|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
106111657|NCT02889133|366064151|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
106111658|NCT02889133|366064150|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
106111659|NCT02889133|366064151|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
106111660|NCT02889133|366064150|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
106111661|NCT02889133|366064151|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
106111662|NCT02889133|366064150|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
106111663|NCT02889133|366064151|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
106111664|NCT02889133|366064150|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
106111665|NCT02889133|366064151|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
106111666|NCT02277990|366064152|FG000|Overall Study|Death|170|||
106111667|NCT02277990|366064153|FG001|Overall Study|Death|188|||
106111668|NCT02277990|366064152|FG000|Overall Study|Withdrawal by Subject|64|||
106111669|NCT02277990|366064153|FG001|Overall Study|Withdrawal by Subject|53|||
106111670|NCT02277990|366064152|FG000|Overall Study|Physician Decision|40|||
106111671|NCT02277990|366064153|FG001|Overall Study|Physician Decision|34|||
106111672|NCT02277990|366064152|FG000|Overall Study|Lost to Follow-up|66|||
106111673|NCT02277990|366064153|FG001|Overall Study|Lost to Follow-up|69|||
106111674|NCT02277990|366064152|FG000|Overall Study|Had other reason|26|||
106111675|NCT02277990|366064153|FG001|Overall Study|Had other reason|32|||
106111676|NCT00386022|366064165|FG000|Plus Estrogen|Lost to Follow-up|2|||
106111677|NCT00386022|366064166|FG001|Plus Estrogen|Lost to Follow-up|0|||
106111678|NCT00386022|366064165|FG000|Plus Estrogen|Adverse Event|0|||
106111679|NCT00386022|366064166|FG001|Plus Estrogen|Adverse Event|1|||
106111680|NCT03848403|366064169|FG000|Period 2 (Day 8)|Adverse Event|1|||
106111681|NCT03848403|366064170|FG001|Period 2 (Day 8)|Adverse Event|2|||
106111682|NCT03848403|366064171|FG002|Period 2 (Day 8)|Adverse Event|2|||
106111683|NCT03848403|366064169|FG000|Period 2 (Day 8)|Physician Decision|0|||
106111684|NCT03848403|366064170|FG001|Period 2 (Day 8)|Physician Decision|1|||
106111685|NCT03848403|366064171|FG002|Period 2 (Day 8)|Physician Decision|0|||
106111686|NCT03848403|366064169|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
106111687|NCT03848403|366064170|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
106111688|NCT03848403|366064171|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
106111689|NCT02124265|366064174|FG000|Overall Study|Adverse Event|1|||
106111690|NCT04241094|366064176|FG000|Overall Study|Dropped out of treatment|4|||
106111691|NCT04241094|366064176|FG000|Overall Study|Ineligible after clinical assessment|2|||
106111692|NCT04241094|366064176|FG000|Overall Study|Lost to Follow-up|2|||
106111693|NCT04058353|366064177|FG000|Overall Study|Adverse Event|2|||
106111694|NCT04058353|366064178|FG001|Overall Study|Adverse Event|1|||
106111695|NCT04058353|366064177|FG000|Overall Study|Physician Decision|1|||
106111696|NCT04058353|366064178|FG001|Overall Study|Physician Decision|0|||
106111697|NCT04058353|366064177|FG000|Overall Study|Other|1|||
106111698|NCT04058353|366064178|FG001|Overall Study|Other|0|||
106111699|NCT00511875|366064181|FG000|Overall Study|Lost to Follow-up|4|||
106111700|NCT00511875|366064182|FG001|Overall Study|Lost to Follow-up|0|||
106111701|NCT00511875|366064181|FG000|Overall Study|Missing variables|1|||
106111702|NCT00511875|366064182|FG001|Overall Study|Missing variables|0|||
106111703|NCT01678131|366064185|FG000|Overall Study|Adverse Event|0|||
106111704|NCT01678131|366064186|FG001|Overall Study|Adverse Event|1|||
106111705|NCT01678131|366064187|FG002|Overall Study|Adverse Event|0|||
106111706|NCT01678131|366064185|FG000|Overall Study|Withdrawal by Subject|0|||
106111707|NCT01678131|366064186|FG001|Overall Study|Withdrawal by Subject|0|||
106111708|NCT01678131|366064187|FG002|Overall Study|Withdrawal by Subject|2|||
106111709|NCT00766675|366065648|FG000|Overall Study|Adverse Event|16|||
105882562|NCT03850483|365223618|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
106111710|NCT00766675|366065648|FG000|Overall Study|Lost to Follow-up|2|||
106111711|NCT00766675|366065648|FG000|Overall Study|Withdrawal by Subject|11|||
106111712|NCT00766675|366065648|FG000|Overall Study|Protocol Violation|8|||
106111713|NCT00766675|366065648|FG000|Overall Study|Participant took prohibited medication|1|||
106111714|NCT00766675|366065648|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
106111715|NCT00766675|366065648|FG000|Overall Study|Insufficient therapy|1|||
106111716|NCT01984697|366065652|FG000|Overall Study|Adverse Event|0|||
106111717|NCT01984697|366065653|FG001|Overall Study|Adverse Event|0|||
106111718|NCT01984697|366065654|FG002|Overall Study|Adverse Event|2|||
106111719|NCT01984697|366065655|FG003|Overall Study|Adverse Event|0|||
106111720|NCT01984697|366065656|FG004|Overall Study|Adverse Event|0|||
106111721|NCT01984697|366065652|FG000|Overall Study|Lost to Follow-up|14|||
106111722|NCT01984697|366065653|FG001|Overall Study|Lost to Follow-up|5|||
106111723|NCT01984697|366065654|FG002|Overall Study|Lost to Follow-up|10|||
106111724|NCT01984697|366065655|FG003|Overall Study|Lost to Follow-up|6|||
106111725|NCT01984697|366065656|FG004|Overall Study|Lost to Follow-up|21|||
106111726|NCT01984697|366065652|FG000|Overall Study|Physician Decision|3|||
106111727|NCT01984697|366065653|FG001|Overall Study|Physician Decision|0|||
106111728|NCT01984697|366065654|FG002|Overall Study|Physician Decision|0|||
106111729|NCT01984697|366065655|FG003|Overall Study|Physician Decision|1|||
106111730|NCT01984697|366065656|FG004|Overall Study|Physician Decision|0|||
106111731|NCT01984697|366065652|FG000|Overall Study|Protocol Violation|8|||
105882563|NCT03850483|365223619|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105882564|NCT03850483|365223620|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
105882565|NCT03850483|365223621|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
105882566|NCT03850483|365223612|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
105882567|NCT03850483|365223613|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
105882568|NCT03850483|365223614|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
105882569|NCT03850483|365223615|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
106111732|NCT01984697|366065653|FG001|Overall Study|Protocol Violation|5|||
105882570|NCT03850483|365223616|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
105882571|NCT03850483|365223617|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
105882572|NCT03850483|365223618|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
105882573|NCT03850483|365223619|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
105882574|NCT03850483|365223620|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
105882575|NCT03850483|365223621|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
105882576|NCT03850483|365223612|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
105882577|NCT03850483|365223613|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
105882578|NCT03850483|365223614|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
105882579|NCT03850483|365223615|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
105882580|NCT03850483|365223616|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
105882581|NCT03850483|365223617|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
105882582|NCT03850483|365223618|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
105882583|NCT03850483|365223619|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
105882584|NCT03850483|365223620|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
105882585|NCT03850483|365223621|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
105882586|NCT03850483|365223612|FG000|Follow-up For Stage 2|Other|0|||
105882587|NCT03850483|365223613|FG001|Follow-up For Stage 2|Other|0|||
105882588|NCT03850483|365223614|FG002|Follow-up For Stage 2|Other|0|||
105882589|NCT03850483|365223615|FG003|Follow-up For Stage 2|Other|0|||
105882590|NCT03850483|365223616|FG004|Follow-up For Stage 2|Other|0|||
105882591|NCT03850483|365223617|FG005|Follow-up For Stage 2|Other|0|||
105882592|NCT03850483|365223618|FG006|Follow-up For Stage 2|Other|0|||
105882593|NCT03850483|365223619|FG007|Follow-up For Stage 2|Other|0|||
105882594|NCT03850483|365223620|FG008|Follow-up For Stage 2|Other|0|||
105882595|NCT03850483|365223621|FG009|Follow-up For Stage 2|Other|1|||
105882596|NCT03274687|365225508|FG000|Overall Study|Protocol Violation|1|||
105882597|NCT03274687|365225509|FG001|Overall Study|Protocol Violation|1|||
105882598|NCT05119595|365225518|FG000|Overall Study|Death|1|||
105882599|NCT05119595|365225518|FG000|Overall Study|Lost to Follow-up|7|||
105882600|NCT03503370|365225519|FG000|Overall Study|Death|3|||
105882601|NCT03503370|365225520|FG001|Overall Study|Death|1|||
105882602|NCT00679029|365225521|FG000|Overall Study|Adverse Event|3|||
105882603|NCT00679029|365225521|FG000|Overall Study|Withdrawal by Subject|1|||
105882604|NCT00679029|365225521|FG000|Overall Study|Lost to Follow-up|1|||
105882605|NCT03056638|365225529|FG000|Overall Study|Death|1|||
105882606|NCT03056638|365225530|FG001|Overall Study|Death|0|||
105882607|NCT00596687|365225531|FG000|Overall Study|< 24 hours of insulin treatment|8|||
106111733|NCT01984697|366065654|FG002|Overall Study|Protocol Violation|3|||
106111734|NCT01984697|366065655|FG003|Overall Study|Protocol Violation|2|||
106111735|NCT01984697|366065656|FG004|Overall Study|Protocol Violation|0|||
106111736|NCT01984697|366065652|FG000|Overall Study|Withdrawal by Subject|15|||
106111737|NCT01984697|366065653|FG001|Overall Study|Withdrawal by Subject|21|||
105882608|NCT00596687|365225532|FG001|Overall Study|< 24 hours of insulin treatment|6|||
105882609|NCT00596687|365225531|FG000|Overall Study|continuous insulin infusion during TPN|2|||
105882610|NCT00596687|365225532|FG001|Overall Study|continuous insulin infusion during TPN|1|||
105882611|NCT00596687|365225531|FG000|Overall Study|Withdrawal by Subject|3|||
105882612|NCT00596687|365225532|FG001|Overall Study|Withdrawal by Subject|1|||
105882613|NCT00596687|365225531|FG000|Overall Study|cancelled surgery|1|||
105882614|NCT00596687|365225532|FG001|Overall Study|cancelled surgery|1|||
105882615|NCT00932373|365225533|FG000|Overall Study|Progressive disease|3|||
106111738|NCT01984697|366065654|FG002|Overall Study|Withdrawal by Subject|13|||
105882616|NCT00932373|365225534|FG001|Overall Study|Progressive disease|1|||
105882617|NCT00932373|365225535|FG002|Overall Study|Progressive disease|0|||
105882618|NCT00932373|365225536|FG003|Overall Study|Progressive disease|0|||
105882619|NCT00932373|365225537|FG004|Overall Study|Progressive disease|10|||
105882620|NCT00932373|365225538|FG005|Overall Study|Progressive disease|1|||
105882621|NCT00932373|365225539|FG006|Overall Study|Progressive disease|0|||
105882622|NCT00932373|365225540|FG007|Overall Study|Progressive disease|2|||
105882623|NCT00932373|365225541|FG008|Overall Study|Progressive disease|1|||
105882624|NCT00932373|365225542|FG009|Overall Study|Progressive disease|9|||
105882625|NCT00932373|365225543|FG010|Overall Study|Progressive disease|2|||
105882626|NCT00932373|365225533|FG000|Overall Study|Adverse Event|0|||
105882627|NCT00932373|365225534|FG001|Overall Study|Adverse Event|0|||
105882628|NCT00932373|365225535|FG002|Overall Study|Adverse Event|0|||
105882629|NCT00932373|365225536|FG003|Overall Study|Adverse Event|0|||
105882630|NCT00932373|365225537|FG004|Overall Study|Adverse Event|2|||
105882631|NCT00932373|365225538|FG005|Overall Study|Adverse Event|1|||
105882632|NCT00932373|365225539|FG006|Overall Study|Adverse Event|0|||
105882633|NCT00932373|365225540|FG007|Overall Study|Adverse Event|1|||
105882634|NCT00932373|365225541|FG008|Overall Study|Adverse Event|0|||
105882635|NCT00932373|365225542|FG009|Overall Study|Adverse Event|2|||
105882636|NCT00932373|365225543|FG010|Overall Study|Adverse Event|1|||
105882637|NCT00932373|365225533|FG000|Overall Study|Physician Decision|0|||
105882638|NCT00932373|365225534|FG001|Overall Study|Physician Decision|0|||
105882639|NCT00932373|365225535|FG002|Overall Study|Physician Decision|1|||
105882640|NCT00932373|365225536|FG003|Overall Study|Physician Decision|0|||
105882641|NCT00932373|365225537|FG004|Overall Study|Physician Decision|2|||
105882642|NCT00932373|365225538|FG005|Overall Study|Physician Decision|0|||
105882643|NCT00932373|365225539|FG006|Overall Study|Physician Decision|0|||
105882644|NCT00932373|365225540|FG007|Overall Study|Physician Decision|0|||
105882645|NCT00932373|365225541|FG008|Overall Study|Physician Decision|0|||
105882646|NCT00932373|365225542|FG009|Overall Study|Physician Decision|1|||
105882647|NCT00932373|365225543|FG010|Overall Study|Physician Decision|0|||
105882648|NCT00932373|365225533|FG000|Overall Study|Dose limiting toxicity|0|||
105882649|NCT00932373|365225534|FG001|Overall Study|Dose limiting toxicity|0|||
105882650|NCT00932373|365225535|FG002|Overall Study|Dose limiting toxicity|0|||
105882651|NCT00932373|365225536|FG003|Overall Study|Dose limiting toxicity|0|||
105882652|NCT00932373|365225537|FG004|Overall Study|Dose limiting toxicity|0|||
105882653|NCT00932373|365225538|FG005|Overall Study|Dose limiting toxicity|1|||
106111739|NCT01984697|366065655|FG003|Overall Study|Withdrawal by Subject|11|||
106111740|NCT01984697|366065656|FG004|Overall Study|Withdrawal by Subject|13|||
106111741|NCT01984697|366065652|FG000|Overall Study|Missed last follow-up visit|1|||
106111742|NCT01984697|366065653|FG001|Overall Study|Missed last follow-up visit|0|||
106111743|NCT01984697|366065654|FG002|Overall Study|Missed last follow-up visit|0|||
106111744|NCT01984697|366065655|FG003|Overall Study|Missed last follow-up visit|0|||
106111745|NCT01984697|366065656|FG004|Overall Study|Missed last follow-up visit|0|||
106111746|NCT01984697|366065652|FG000|Overall Study|Death|0|||
106111747|NCT01984697|366065653|FG001|Overall Study|Death|0|||
106111748|NCT01984697|366065654|FG002|Overall Study|Death|0|||
106111749|NCT01984697|366065655|FG003|Overall Study|Death|1|||
106111750|NCT01984697|366065656|FG004|Overall Study|Death|0|||
106111751|NCT01984697|366065652|FG000|Overall Study|Pregnancy|2|||
106111752|NCT01984697|366065653|FG001|Overall Study|Pregnancy|0|||
105882654|NCT00932373|365225539|FG006|Overall Study|Dose limiting toxicity|0|||
106111753|NCT01984697|366065654|FG002|Overall Study|Pregnancy|1|||
106111754|NCT01984697|366065655|FG003|Overall Study|Pregnancy|0|||
106111755|NCT01984697|366065656|FG004|Overall Study|Pregnancy|1|||
105882655|NCT00932373|365225540|FG007|Overall Study|Dose limiting toxicity|0|||
105882656|NCT00932373|365225541|FG008|Overall Study|Dose limiting toxicity|0|||
105882657|NCT00932373|365225542|FG009|Overall Study|Dose limiting toxicity|0|||
106111756|NCT03308825|366065657|FG000|Overall Study|Lost to Follow-up|2|||
105882658|NCT00932373|365225543|FG010|Overall Study|Dose limiting toxicity|0|||
105882659|NCT00932373|365225533|FG000|Overall Study|Withdrawal by Subject|0|||
106111757|NCT03308825|366065658|FG001|Overall Study|Lost to Follow-up|2|||
105882660|NCT00932373|365225534|FG001|Overall Study|Withdrawal by Subject|0|||
106111758|NCT03308825|366065659|FG002|Overall Study|Lost to Follow-up|1|||
106111759|NCT03308825|366065660|FG003|Overall Study|Lost to Follow-up|0|||
106111760|NCT03308825|366065657|FG000|Overall Study|Protocol Violation|0|||
106111761|NCT03308825|366065658|FG001|Overall Study|Protocol Violation|2|||
105882661|NCT00932373|365225535|FG002|Overall Study|Withdrawal by Subject|0|||
105882662|NCT00932373|365225536|FG003|Overall Study|Withdrawal by Subject|0|||
105882663|NCT00932373|365225537|FG004|Overall Study|Withdrawal by Subject|0|||
105882664|NCT00932373|365225538|FG005|Overall Study|Withdrawal by Subject|0|||
105882665|NCT00932373|365225539|FG006|Overall Study|Withdrawal by Subject|0|||
106111762|NCT03308825|366065659|FG002|Overall Study|Protocol Violation|0|||
106111763|NCT03308825|366065660|FG003|Overall Study|Protocol Violation|0|||
106111764|NCT02044848|366065661|FG000|Overall Study|Administrative Problems|2|||
106111765|NCT02044848|366065662|FG001|Overall Study|Administrative Problems|3|||
106111766|NCT00045708|366065663|FG000|Phase 1|early progressive disease|0|||
106111767|NCT00045708|366065664|FG001|Phase 1|early progressive disease|1|||
106111768|NCT00045708|366065665|FG002|Phase 1|early progressive disease|0|||
106111769|NCT01090310|366065666|FG000|Core Study|Adverse Event|2|||
106111770|NCT01090310|366065667|FG001|Core Study|Adverse Event|2|||
106111771|NCT01090310|366065668|FG002|Core Study|Adverse Event|1|||
106111772|NCT01090310|366065669|FG003|Core Study|Adverse Event|1|||
106111773|NCT01090310|366065666|FG000|Core Study|Subject withdrew consent|0|||
106111774|NCT01090310|366065667|FG001|Core Study|Subject withdrew consent|3|||
106111775|NCT01090310|366065668|FG002|Core Study|Subject withdrew consent|1|||
106111776|NCT01090310|366065669|FG003|Core Study|Subject withdrew consent|1|||
106111777|NCT01090310|366065666|FG000|Core Study|Abnormal test procedure result|0|||
106111778|NCT01090310|366065667|FG001|Core Study|Abnormal test procedure result|0|||
106111779|NCT01090310|366065668|FG002|Core Study|Abnormal test procedure result|1|||
106111780|NCT01090310|366065669|FG003|Core Study|Abnormal test procedure result|0|||
106111781|NCT01090310|366065666|FG000|Core Study|Administrative reasons|5|||
106111782|NCT01090310|366065667|FG001|Core Study|Administrative reasons|6|||
106111783|NCT01090310|366065668|FG002|Core Study|Administrative reasons|4|||
106111784|NCT01090310|366065669|FG003|Core Study|Administrative reasons|4|||
106111785|NCT01090310|366065666|FG000|Core Study|Protocol deviation|1|||
106111786|NCT01090310|366065667|FG001|Core Study|Protocol deviation|0|||
106111787|NCT01090310|366065668|FG002|Core Study|Protocol deviation|0|||
106111788|NCT01090310|366065669|FG003|Core Study|Protocol deviation|1|||
106111789|NCT01090310|366065666|FG000|Extension Study|Aministrative problems|13|||
106111790|NCT01090310|366065667|FG001|Extension Study|Aministrative problems|15|||
106111791|NCT01090310|366065668|FG002|Extension Study|Aministrative problems|14|||
106111792|NCT01090310|366065669|FG003|Extension Study|Aministrative problems|18|||
106111793|NCT01090310|366065666|FG000|Extension Study|Adverse Event|0|||
106111794|NCT01090310|366065667|FG001|Extension Study|Adverse Event|0|||
106111795|NCT01090310|366065668|FG002|Extension Study|Adverse Event|0|||
106111796|NCT01090310|366065669|FG003|Extension Study|Adverse Event|1|||
106111797|NCT01090310|366065666|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
106111798|NCT01090310|366065667|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
106111799|NCT01090310|366065668|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
106111800|NCT01090310|366065669|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
106111801|NCT01090310|366065666|FG000|Extension Study|Subject withdrew consent|0|||
106111802|NCT01090310|366065667|FG001|Extension Study|Subject withdrew consent|1|||
106111803|NCT01090310|366065668|FG002|Extension Study|Subject withdrew consent|0|||
106111804|NCT01090310|366065669|FG003|Extension Study|Subject withdrew consent|0|||
106111805|NCT00695786|366065670|FG000|Overall Study|Adverse Event|0|||
106111806|NCT00695786|366065671|FG001|Overall Study|Adverse Event|3|||
106111807|NCT00695786|366065672|FG002|Overall Study|Adverse Event|4|||
106111808|NCT00695786|366065673|FG003|Overall Study|Adverse Event|2|||
106111809|NCT00695786|366065670|FG000|Overall Study|Lost to Follow-up|0|||
106111810|NCT00695786|366065671|FG001|Overall Study|Lost to Follow-up|5|||
106111811|NCT00695786|366065672|FG002|Overall Study|Lost to Follow-up|1|||
106111812|NCT00695786|366065673|FG003|Overall Study|Lost to Follow-up|1|||
106111813|NCT00695786|366065670|FG000|Overall Study|Withdrawal by Subject|0|||
106111814|NCT00695786|366065671|FG001|Overall Study|Withdrawal by Subject|4|||
106111815|NCT00695786|366065672|FG002|Overall Study|Withdrawal by Subject|3|||
106111816|NCT00695786|366065673|FG003|Overall Study|Withdrawal by Subject|1|||
106111817|NCT00695786|366065670|FG000|Overall Study|Deemed Ineligible|1|||
106111818|NCT00695786|366065671|FG001|Overall Study|Deemed Ineligible|0|||
106111819|NCT00695786|366065672|FG002|Overall Study|Deemed Ineligible|0|||
106111820|NCT00695786|366065673|FG003|Overall Study|Deemed Ineligible|0|||
106111821|NCT00695786|366065670|FG000|Overall Study|Lack of Efficacy|0|||
106111822|NCT00695786|366065671|FG001|Overall Study|Lack of Efficacy|0|||
106111823|NCT00695786|366065672|FG002|Overall Study|Lack of Efficacy|0|||
106111824|NCT00695786|366065673|FG003|Overall Study|Lack of Efficacy|4|||
106111825|NCT01364922|366065674|FG000|Open-label (OL) Period|Adverse Event|7|||
106111826|NCT01364922|366065675|FG001|Open-label (OL) Period|Adverse Event|0|||
106111827|NCT01364922|366065676|FG002|Open-label (OL) Period|Adverse Event|0|||
106111828|NCT01364922|366065674|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
106111829|NCT01364922|366065675|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
106111830|NCT01364922|366065676|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
106111831|NCT01364922|366065674|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
106111832|NCT01364922|366065675|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
106111833|NCT01364922|366065676|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
106111834|NCT01364922|366065674|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
106111835|NCT01364922|366065675|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
106111836|NCT01364922|366065676|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
106111837|NCT01364922|366065674|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
106111838|NCT01364922|366065675|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
106111839|NCT01364922|366065676|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
106111840|NCT01364922|366065674|FG000|Open-label (OL) Period|Other, Unspecified|1|||
106111841|NCT01364922|366065675|FG001|Open-label (OL) Period|Other, Unspecified|0|||
106111842|NCT01364922|366065676|FG002|Open-label (OL) Period|Other, Unspecified|0|||
106111843|NCT01364922|366065674|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
106111844|NCT01364922|366065675|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
106111845|NCT01364922|366065676|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
106111846|NCT01364922|366065674|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
106111847|NCT01364922|366065675|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
106111848|NCT01364922|366065676|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
106111849|NCT01364922|366065674|FG000|Double-Blind (DB) Period|Adverse Event|0|||
106111850|NCT01364922|366065675|FG001|Double-Blind (DB) Period|Adverse Event|0|||
106111851|NCT01364922|366065676|FG002|Double-Blind (DB) Period|Adverse Event|1|||
106111852|NCT01364922|366065674|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
106111853|NCT01364922|366065675|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
106111854|NCT01364922|366065676|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
106111855|NCT03237858|366065681|FG000|Overall Study|Death|19|||
106111856|NCT03237858|366065681|FG000|Overall Study|Withdrawal by Subject|37|||
106111857|NCT01782742|366065682|FG000|Double-blind Treatment Phase|Adverse Event|1|||
106111858|NCT01782742|366065683|FG001|Double-blind Treatment Phase|Adverse Event|0|||
106111859|NCT01529008|366065690|FG000|Bone Marrow Harvesting|Physician Decision|1|||
106111860|NCT01529008|366065691|FG001|Bone Marrow Harvesting|Physician Decision|1|||
106111861|NCT01529008|366065690|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
106111862|NCT01529008|366065691|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
106111863|NCT01529008|366065690|FG000|Treatment|Adverse Event|6|||
106111864|NCT01529008|366065691|FG001|Treatment|Adverse Event|0|||
106111865|NCT01529008|366065690|FG000|Treatment|Other|3|||
106111866|NCT01529008|366065691|FG001|Treatment|Other|1|||
106111867|NCT01529008|366065690|FG000|Efficacy Analysis|Protocol Violation|2|||
106111868|NCT01529008|366065691|FG001|Efficacy Analysis|Protocol Violation|0|||
106111869|NCT01529008|366065690|FG000|Efficacy Analysis|Physician Decision|0|||
106111870|NCT01529008|366065691|FG001|Efficacy Analysis|Physician Decision|1|||
106111871|NCT01529008|366065690|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
106111872|NCT01529008|366065691|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
106111873|NCT00944658|366065695|FG000|Treatment 12 Weeks|Adverse Event|0|||
106111874|NCT00944658|366065696|FG001|Treatment 12 Weeks|Adverse Event|2|||
106111875|NCT01255592|366065697|FG000|Overall Study|Adverse Event|5|||
105882666|NCT00932373|365225540|FG007|Overall Study|Withdrawal by Subject|0|||
105882667|NCT00932373|365225541|FG008|Overall Study|Withdrawal by Subject|1|||
106111876|NCT01255592|366065698|FG001|Overall Study|Adverse Event|0|||
106111877|NCT01255592|366065697|FG000|Overall Study|Withdrawal by Subject|1|||
106111878|NCT01255592|366065698|FG001|Overall Study|Withdrawal by Subject|0|||
106111879|NCT01255592|366065697|FG000|Overall Study|Other|0|||
106111880|NCT01255592|366065698|FG001|Overall Study|Other|1|||
106111881|NCT02035332|366065699|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
106111882|NCT02259517|366065700|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
106111883|NCT02259517|366065701|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
106111884|NCT02259517|366065702|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
106111885|NCT02259517|366065700|FG000|Overall Study|Withdrawal by Subject|0|||
106111886|NCT02259517|366065701|FG001|Overall Study|Withdrawal by Subject|0|||
106111887|NCT02259517|366065702|FG002|Overall Study|Withdrawal by Subject|3|||
106111888|NCT01289418|366065705|FG000|Day 8 Survey|email address invalid|283|||
106111889|NCT01289418|366065705|FG000|Day 8 Survey|participants did not complete the survey|1935|||
106111890|NCT01289418|366065705|FG000|Day 29 Survey|email address invalid|283|||
106111891|NCT01289418|366065705|FG000|Day 29 Survey|participants did not complete the survey|2185|||
106111892|NCT03704584|366065708|FG000|Overall Study|Withdrawal by Subject|1|||
106111893|NCT03704584|366065709|FG001|Overall Study|Withdrawal by Subject|0|||
106111894|NCT03185832|366065710|FG000|Overall Study|Death|9|||
106111895|NCT03185832|366065711|FG001|Overall Study|Death|14|||
106111896|NCT03185832|366065712|FG002|Overall Study|Death|9|||
106111897|NCT03185832|366065713|FG003|Overall Study|Death|7|||
106111898|NCT03185832|366065710|FG000|Overall Study|Withdrawn - vital status available|0|||
106111899|NCT03185832|366065711|FG001|Overall Study|Withdrawn - vital status available|1|||
106111900|NCT03185832|366065712|FG002|Overall Study|Withdrawn - vital status available|1|||
106111901|NCT03185832|366065713|FG003|Overall Study|Withdrawn - vital status available|4|||
106111902|NCT01083641|366065715|FG000|Overall Study|Withdrawal by Subject|2|||
106111903|NCT03439189|366065716|FG000|Overall Study|Protocol Violation|19|||
106111904|NCT03439189|366065716|FG000|Overall Study|Lack of Efficacy|63|||
106111905|NCT01777321|366065717|FG000|Overall Study|Withdrawal by Subject|0|||
105882668|NCT00932373|365225542|FG009|Overall Study|Withdrawal by Subject|0|||
106111906|NCT01777321|366065718|FG001|Overall Study|Withdrawal by Subject|1|||
106111907|NCT03386032|366065719|FG000|Overall Study|Lack of Efficacy|6|||
106111908|NCT03386032|366065720|FG001|Overall Study|Lack of Efficacy|2|||
106111909|NCT03386032|366065721|FG002|Overall Study|Lack of Efficacy|0|||
106111910|NCT03386032|366065719|FG000|Overall Study|Adverse Event|2|||
106111911|NCT03386032|366065720|FG001|Overall Study|Adverse Event|2|||
105882669|NCT00932373|365225543|FG010|Overall Study|Withdrawal by Subject|0|||
106111912|NCT03386032|366065721|FG002|Overall Study|Adverse Event|0|||
106111913|NCT03386032|366065719|FG000|Overall Study|Withdrawal by Subject|1|||
106111914|NCT03386032|366065720|FG001|Overall Study|Withdrawal by Subject|0|||
106111915|NCT03386032|366065721|FG002|Overall Study|Withdrawal by Subject|0|||
106111916|NCT03386032|366065719|FG000|Overall Study|Lost to Follow-up|9|||
106111917|NCT03386032|366065720|FG001|Overall Study|Lost to Follow-up|3|||
106111918|NCT03386032|366065721|FG002|Overall Study|Lost to Follow-up|0|||
106111919|NCT03122119|366065728|FG000|Overall Study|Did not meet eligibility critria|1|||
106111920|NCT00790452|366065737|FG000|Overall Study|Drug supply issue|1|||
106111921|NCT00790452|366065738|FG001|Overall Study|Drug supply issue|0|||
106111922|NCT00742079|366065739|FG000|Overall Study|Lost to Follow-up|0|||
106111923|NCT00742079|366065740|FG001|Overall Study|Lost to Follow-up|1|||
106111924|NCT03518125|366065741|FG000|Overall Study|Lost to Follow-up|0|||
106111925|NCT03518125|366065742|FG001|Overall Study|Lost to Follow-up|2|||
106111926|NCT03518125|366065743|FG002|Overall Study|Lost to Follow-up|0|||
106111927|NCT03518125|366065744|FG003|Overall Study|Lost to Follow-up|0|||
106111928|NCT03518125|366065745|FG004|Overall Study|Lost to Follow-up|3|||
106111929|NCT03518125|366065746|FG005|Overall Study|Lost to Follow-up|5|||
106111930|NCT03518125|366065741|FG000|Overall Study|Physician Decision|0|||
106111931|NCT03518125|366065742|FG001|Overall Study|Physician Decision|1|||
106111932|NCT03518125|366065743|FG002|Overall Study|Physician Decision|0|||
106111933|NCT03518125|366065744|FG003|Overall Study|Physician Decision|0|||
106111934|NCT03518125|366065745|FG004|Overall Study|Physician Decision|0|||
106111935|NCT03518125|366065746|FG005|Overall Study|Physician Decision|0|||
106111936|NCT03518125|366065741|FG000|Overall Study|Withdrawal by Subject|1|||
106111937|NCT03518125|366065742|FG001|Overall Study|Withdrawal by Subject|1|||
106111938|NCT03518125|366065743|FG002|Overall Study|Withdrawal by Subject|0|||
106111939|NCT03518125|366065744|FG003|Overall Study|Withdrawal by Subject|1|||
106111940|NCT03518125|366065745|FG004|Overall Study|Withdrawal by Subject|1|||
106111941|NCT03518125|366065746|FG005|Overall Study|Withdrawal by Subject|3|||
106111942|NCT03518125|366065741|FG000|Overall Study|Missed Day 394 Visit|1|||
106111943|NCT03518125|366065742|FG001|Overall Study|Missed Day 394 Visit|0|||
106111944|NCT03518125|366065743|FG002|Overall Study|Missed Day 394 Visit|0|||
106111945|NCT03518125|366065744|FG003|Overall Study|Missed Day 394 Visit|0|||
106111946|NCT03518125|366065745|FG004|Overall Study|Missed Day 394 Visit|0|||
106111947|NCT03518125|366065746|FG005|Overall Study|Missed Day 394 Visit|0|||
106111948|NCT02093663|366065747|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
106111949|NCT02093663|366065748|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
106111950|NCT02093663|366065749|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
106111951|NCT02093663|366065750|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
106111952|NCT02093663|366065751|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
106111953|NCT02093663|366065747|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
106111954|NCT02093663|366065748|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
106111955|NCT02093663|366065749|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
106111956|NCT02093663|366065750|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
106111957|NCT02093663|366065751|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
106111958|NCT02093663|366065747|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
106111959|NCT02093663|366065748|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
106111960|NCT02093663|366065749|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
106111961|NCT02093663|366065750|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
106111962|NCT02093663|366065751|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
106111963|NCT02093663|366065747|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
106111964|NCT02093663|366065748|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
106111965|NCT02093663|366065749|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
106111966|NCT02093663|366065750|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
106111967|NCT02093663|366065751|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
106111968|NCT02093663|366065747|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
106111969|NCT02093663|366065748|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
106111970|NCT02093663|366065749|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
106111971|NCT02093663|366065750|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
106111972|NCT02093663|366065751|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
106111973|NCT02093663|366065747|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
106111974|NCT02093663|366065748|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
106111975|NCT02093663|366065749|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
105993717|NCT01510158|365636077|FG002|Overall Study|Lost to Follow-up|9|||
106111976|NCT02093663|366065750|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
106111977|NCT02093663|366065751|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
106111978|NCT02093663|366065747|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
106111979|NCT02093663|366065748|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
106111980|NCT02093663|366065749|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
106111981|NCT02093663|366065750|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
106111982|NCT02093663|366065751|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
106111983|NCT02093663|366065747|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
106111984|NCT02093663|366065748|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
106111985|NCT02093663|366065749|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
106111986|NCT02093663|366065750|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
106111987|NCT02093663|366065751|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
106111988|NCT02093663|366065747|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
106111989|NCT02093663|366065748|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
106111990|NCT02093663|366065749|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
106111991|NCT02093663|366065750|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
106111992|NCT02093663|366065751|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
106111993|NCT04207840|366065752|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
106111994|NCT04207840|366065753|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
106111995|NCT04207840|366065754|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
106111996|NCT04207840|366065752|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
106111997|NCT04207840|366065753|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
106111998|NCT04207840|366065754|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
106111999|NCT01966003|366065757|FG000|Overall Study|Death|43|||
106112000|NCT01966003|366065758|FG001|Overall Study|Death|36|||
106112001|NCT01966003|366065757|FG000|Overall Study|Protocol Violation|6|||
105882670|NCT00932373|365225533|FG000|Overall Study|Clinical progression|0|||
105882671|NCT00932373|365225534|FG001|Overall Study|Clinical progression|0|||
105882672|NCT00932373|365225535|FG002|Overall Study|Clinical progression|0|||
105882673|NCT00932373|365225536|FG003|Overall Study|Clinical progression|0|||
105882674|NCT00932373|365225537|FG004|Overall Study|Clinical progression|0|||
105882675|NCT00932373|365225538|FG005|Overall Study|Clinical progression|0|||
105882676|NCT00932373|365225539|FG006|Overall Study|Clinical progression|1|||
105882677|NCT00932373|365225540|FG007|Overall Study|Clinical progression|0|||
105882678|NCT00932373|365225541|FG008|Overall Study|Clinical progression|0|||
105882679|NCT00932373|365225542|FG009|Overall Study|Clinical progression|0|||
105882680|NCT00932373|365225543|FG010|Overall Study|Clinical progression|0|||
105882681|NCT00932373|365225533|FG000|Overall Study|Lack of Efficacy|0|||
105882682|NCT00932373|365225534|FG001|Overall Study|Lack of Efficacy|0|||
105882683|NCT00932373|365225535|FG002|Overall Study|Lack of Efficacy|0|||
105882684|NCT00932373|365225536|FG003|Overall Study|Lack of Efficacy|0|||
105882685|NCT00932373|365225537|FG004|Overall Study|Lack of Efficacy|0|||
105882686|NCT00932373|365225538|FG005|Overall Study|Lack of Efficacy|0|||
105882687|NCT00932373|365225539|FG006|Overall Study|Lack of Efficacy|0|||
105882688|NCT00932373|365225540|FG007|Overall Study|Lack of Efficacy|0|||
105882689|NCT00932373|365225541|FG008|Overall Study|Lack of Efficacy|0|||
106112002|NCT01966003|366065758|FG001|Overall Study|Protocol Violation|4|||
106112003|NCT01966003|366065757|FG000|Overall Study|Lost to Follow-up|4|||
106112004|NCT01966003|366065758|FG001|Overall Study|Lost to Follow-up|3|||
106112005|NCT01966003|366065757|FG000|Overall Study|Physician Decision|12|||
106112006|NCT01966003|366065758|FG001|Overall Study|Physician Decision|13|||
106112007|NCT01966003|366065757|FG000|Overall Study|Withdrawal by Subject|29|||
106112008|NCT01966003|366065758|FG001|Overall Study|Withdrawal by Subject|19|||
106112009|NCT01966003|366065757|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
106112010|NCT01966003|366065758|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
106112011|NCT01966003|366065757|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
106112012|NCT01966003|366065758|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
106112013|NCT01966003|366065757|FG000|Overall Study|Other|1|||
106112014|NCT01966003|366065758|FG001|Overall Study|Other|1|||
106112015|NCT01538472|366065761|FG000|Overall Study|Disease Progression|3|||
106112016|NCT01538472|366065761|FG000|Overall Study|Death|1|||
106112017|NCT02309112|366065762|FG000|Overall Study|Withdrawal by Subject|1|||
106112018|NCT02309112|366065763|FG001|Overall Study|Withdrawal by Subject|0|||
106112019|NCT02309112|366065764|FG002|Overall Study|Withdrawal by Subject|1|||
106112020|NCT02309112|366065762|FG000|Overall Study|Lost to Follow-up|0|||
106112021|NCT02309112|366065763|FG001|Overall Study|Lost to Follow-up|1|||
106112022|NCT02309112|366065764|FG002|Overall Study|Lost to Follow-up|0|||
106112023|NCT04555096|366065765|FG000|Overall Study|Death|4|||
106112024|NCT04555096|366065766|FG001|Overall Study|Death|4|||
106112025|NCT04555096|366065765|FG000|Overall Study|Withdrawal by Subject|1|||
106112026|NCT04555096|366065766|FG001|Overall Study|Withdrawal by Subject|0|||
106112027|NCT04555096|366065765|FG000|Overall Study|Other|0|||
106112028|NCT04555096|366065766|FG001|Overall Study|Other|1|||
105882690|NCT00932373|365225542|FG009|Overall Study|Lack of Efficacy|1|||
105882691|NCT00932373|365225543|FG010|Overall Study|Lack of Efficacy|0|||
105882692|NCT01637922|365225544|FG000|Overall Study|Adverse Event|0|||
105882693|NCT01637922|365225545|FG001|Overall Study|Adverse Event|1|||
105882694|NCT01637922|365225544|FG000|Overall Study|Protocol Violation|0|||
106112029|NCT03056534|366065768|FG000|Overall Study|Participant withdrew consent|8|||
106112030|NCT03056534|366065768|FG000|Overall Study|Participant not able to return|6|||
106112031|NCT03056534|366065768|FG000|Overall Study|Lost to Follow-up|37|||
106112032|NCT03056534|366065768|FG000|Overall Study|Investigator judgment|1|||
106112033|NCT03056534|366065768|FG000|Overall Study|Death|4|||
105882695|NCT01637922|365225545|FG001|Overall Study|Protocol Violation|1|||
105882696|NCT01637922|365225544|FG000|Overall Study|Withdrawal by Subject|0|||
105882697|NCT01637922|365225545|FG001|Overall Study|Withdrawal by Subject|3|||
105882698|NCT01637922|365225544|FG000|Overall Study|Lost to Follow-up|2|||
105882699|NCT01637922|365225545|FG001|Overall Study|Lost to Follow-up|0|||
105882700|NCT00638404|365225546|FG000|Overall Study|Physician Decision|8|||
105882701|NCT00638404|365225547|FG001|Overall Study|Physician Decision|0|||
105882702|NCT01068730|365225548|FG000|Period 3|Personal reason|1|||
105882703|NCT01068730|365225549|FG001|Period 3|Personal reason|0|||
105882704|NCT01068730|365225550|FG002|Period 3|Personal reason|0|||
105882705|NCT01068730|365225551|FG003|Period 3|Personal reason|0|||
105882706|NCT01068730|365225548|FG000|Period 4|Family emergency|0|||
105882707|NCT01068730|365225549|FG001|Period 4|Family emergency|1|||
105882708|NCT01068730|365225550|FG002|Period 4|Family emergency|0|||
105882709|NCT01068730|365225551|FG003|Period 4|Family emergency|0|||
105882710|NCT03508726|365225552|FG000|Overall Study|Withdrawal by Subject|0|||
105882711|NCT03508726|365225553|FG001|Overall Study|Withdrawal by Subject|1|||
105882712|NCT02492984|365225554|FG000|Overall Study|Adverse Event|1|||
105882713|NCT02492984|365225555|FG001|Overall Study|Adverse Event|0|||
105882714|NCT02492984|365225554|FG000|Overall Study|Protocol Violation|1|||
105882715|NCT02492984|365225555|FG001|Overall Study|Protocol Violation|0|||
105882716|NCT02492984|365225554|FG000|Overall Study|Withdrawal by Subject|1|||
105882717|NCT02492984|365225555|FG001|Overall Study|Withdrawal by Subject|0|||
105882718|NCT00459290|365225556|FG000|Overall Study|Adverse Event|3|||
105882719|NCT00459290|365225556|FG000|Overall Study|Ineligible|2|||
105882720|NCT02693106|365225558|FG000|Overall Study|No time|3|||
105882721|NCT03981926|365225567|FG000|Overall Study|Lost to Follow-up|5|||
105882722|NCT03981926|365225568|FG001|Overall Study|Lost to Follow-up|9|||
105882723|NCT00610155|365225569|FG000|Period 1|Withdrawal by Subject|0|||
105882724|NCT00610155|365225570|FG001|Period 1|Withdrawal by Subject|0|||
105882725|NCT00610155|365225571|FG002|Period 1|Withdrawal by Subject|1|||
105882726|NCT00610155|365225572|FG003|Period 1|Withdrawal by Subject|0|||
105882727|NCT00610155|365225573|FG004|Period 1|Withdrawal by Subject|0|||
105882728|NCT00610155|365225574|FG005|Period 1|Withdrawal by Subject|0|||
105882729|NCT00610155|365225569|FG000|Period 3|Adverse Event|1|||
105882730|NCT00610155|365225570|FG001|Period 3|Adverse Event|0|||
105882731|NCT00610155|365225571|FG002|Period 3|Adverse Event|0|||
105882732|NCT00610155|365225572|FG003|Period 3|Adverse Event|0|||
105882733|NCT00610155|365225573|FG004|Period 3|Adverse Event|0|||
105882734|NCT00610155|365225574|FG005|Period 3|Adverse Event|0|||
105882735|NCT01163851|365225575|FG000|Overall Study|Site Closure|0|||
105882736|NCT01163851|365225576|FG001|Overall Study|Site Closure|1|||
105882737|NCT01163851|365225575|FG000|Overall Study|Enrolled but not treated|1|||
105882738|NCT01163851|365225576|FG001|Overall Study|Enrolled but not treated|0|||
105882739|NCT01073605|365225580|FG000|Overall Study|Ongoing at Cutoff Date|1|||
105882740|NCT01073605|365225581|FG001|Overall Study|Ongoing at Cutoff Date|1|||
105882741|NCT01073605|365225582|FG002|Overall Study|Ongoing at Cutoff Date|0|||
105882742|NCT01073605|365225580|FG000|Overall Study|Adverse Event|2|||
105882743|NCT01073605|365225581|FG001|Overall Study|Adverse Event|1|||
105882744|NCT01073605|365225582|FG002|Overall Study|Adverse Event|0|||
105882745|NCT01073605|365225580|FG000|Overall Study|Lost to Follow-up|3|||
105882746|NCT01073605|365225581|FG001|Overall Study|Lost to Follow-up|4|||
105882747|NCT01073605|365225582|FG002|Overall Study|Lost to Follow-up|9|||
105882748|NCT01073605|365225580|FG000|Overall Study|Other|25|||
105882749|NCT01073605|365225581|FG001|Overall Study|Other|21|||
105882750|NCT01073605|365225582|FG002|Overall Study|Other|29|||
105882751|NCT01073605|365225580|FG000|Overall Study|Withdrawal by Subject|31|||
105882752|NCT01073605|365225581|FG001|Overall Study|Withdrawal by Subject|39|||
105882753|NCT01073605|365225582|FG002|Overall Study|Withdrawal by Subject|22|||
105882754|NCT01073605|365225580|FG000|Overall Study|Randomized But Not Treated|0|||
106112034|NCT03056534|366065768|FG000|Overall Study|Adverse Event|1|||
106112035|NCT03056534|366065768|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
105882755|NCT01073605|365225581|FG001|Overall Study|Randomized But Not Treated|1|||
105882756|NCT01073605|365225582|FG002|Overall Study|Randomized But Not Treated|1|||
105882757|NCT01284348|365225583|FG000|Overall Study|Death|1|||
105882758|NCT01284348|365225584|FG001|Overall Study|Death|1|||
105882759|NCT01284348|365225583|FG000|Overall Study|Withdrew consent|0|||
105882760|NCT01284348|365225584|FG001|Overall Study|Withdrew consent|1|||
105882761|NCT01284348|365225583|FG000|Overall Study|Status not recorded|9|||
106112036|NCT05375955|366065770|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
105882762|NCT01284348|365225584|FG001|Overall Study|Status not recorded|10|||
105882763|NCT01684423|365225589|FG000|Overall Study|Withdrawal by Subject|0|||
105882764|NCT01684423|365225590|FG001|Overall Study|Withdrawal by Subject|0|||
105882765|NCT01684423|365225591|FG002|Overall Study|Withdrawal by Subject|1|||
105882766|NCT01684423|365225592|FG003|Overall Study|Withdrawal by Subject|0|||
105882767|NCT01684423|365225593|FG004|Overall Study|Withdrawal by Subject|0|||
105882768|NCT03192306|365225594|FG000|Overall Study|Did not treat cold sore during study|149|||
105882769|NCT03192306|365225595|FG001|Overall Study|Did not treat cold sore during study|143|||
105882770|NCT03192306|365225594|FG000|Overall Study|Withdrawal by Subject|1|||
106112037|NCT05375955|366065771|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
106112038|NCT05375955|366065772|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
106112039|NCT05375955|366065773|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
106112040|NCT05375955|366065774|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
106112041|NCT05375955|366065775|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
105882771|NCT03192306|365225595|FG001|Overall Study|Withdrawal by Subject|1|||
105882772|NCT03192306|365225594|FG000|Overall Study|Lost to Follow-up|1|||
105882773|NCT03192306|365225595|FG001|Overall Study|Lost to Follow-up|0|||
105882774|NCT03192306|365225594|FG000|Overall Study|Protocol Violation|1|||
105882775|NCT03192306|365225595|FG001|Overall Study|Protocol Violation|1|||
105882776|NCT00441129|365225598|FG000|Overall Study|Withdrawal by Subject|6|||
105882777|NCT00441129|365225599|FG001|Overall Study|Withdrawal by Subject|14|||
105882778|NCT02035202|365225607|FG000|Overall Study|Lost to Follow-up|8|||
105882779|NCT02035202|365225608|FG001|Overall Study|Lost to Follow-up|16|||
105882780|NCT02035202|365225609|FG002|Overall Study|Lost to Follow-up|2|||
105882781|NCT00083759|365225611|FG000|Overall Study|Adverse Event|5|||
105882782|NCT00083759|365225612|FG001|Overall Study|Adverse Event|3|||
105882783|NCT00083759|365225611|FG000|Overall Study|Lost to Follow-up|1|||
105882784|NCT00083759|365225612|FG001|Overall Study|Lost to Follow-up|0|||
105882785|NCT00083759|365225611|FG000|Overall Study|Death|1|||
105882786|NCT00083759|365225612|FG001|Overall Study|Death|1|||
105882787|NCT00083759|365225611|FG000|Overall Study|Inadequate Therapeutic Response|32|||
105882788|NCT00083759|365225612|FG001|Overall Study|Inadequate Therapeutic Response|35|||
105882789|NCT00083759|365225611|FG000|Overall Study|Subject Withdrew Consent|2|||
105882790|NCT00083759|365225612|FG001|Overall Study|Subject Withdrew Consent|2|||
105882791|NCT00083759|365225611|FG000|Overall Study|Non-Compliance|1|||
105882792|NCT00083759|365225612|FG001|Overall Study|Non-Compliance|0|||
105882793|NCT00083759|365225611|FG000|Overall Study|Sponsor's Discretion|28|||
105882794|NCT00083759|365225612|FG001|Overall Study|Sponsor's Discretion|29|||
105882795|NCT00083759|365225611|FG000|Overall Study|Other|14|||
105882796|NCT00083759|365225612|FG001|Overall Study|Other|13|||
105882797|NCT00685399|365225613|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105882798|NCT00685399|365225614|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105882799|NCT00685399|365225615|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105882800|NCT00685399|365225616|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105882801|NCT00685399|365225617|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105882802|NCT00685399|365225618|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105882803|NCT00685399|365225619|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105882804|NCT00685399|365225620|FG007|Treatment Period 1|Withdrawal by Subject|0|||
105882805|NCT00685399|365225613|FG000|Treatment Period 1|Protocol Violation|1|||
105882806|NCT00685399|365225614|FG001|Treatment Period 1|Protocol Violation|0|||
105882807|NCT00685399|365225615|FG002|Treatment Period 1|Protocol Violation|0|||
105882808|NCT00685399|365225616|FG003|Treatment Period 1|Protocol Violation|0|||
105882809|NCT00685399|365225617|FG004|Treatment Period 1|Protocol Violation|0|||
105882810|NCT00685399|365225618|FG005|Treatment Period 1|Protocol Violation|0|||
106112042|NCT05375955|366065776|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
106112043|NCT05375955|366065770|FG000|Treatment (12 Weeks)|Physician Decision|4|||
105882811|NCT00685399|365225619|FG006|Treatment Period 1|Protocol Violation|0|||
105882812|NCT00685399|365225620|FG007|Treatment Period 1|Protocol Violation|0|||
105882813|NCT00685399|365225613|FG000|Treatment Period 1|Administrative|2|||
105882814|NCT00685399|365225614|FG001|Treatment Period 1|Administrative|0|||
105882815|NCT00685399|365225615|FG002|Treatment Period 1|Administrative|0|||
105882816|NCT00685399|365225616|FG003|Treatment Period 1|Administrative|0|||
105882817|NCT00685399|365225617|FG004|Treatment Period 1|Administrative|0|||
105882818|NCT00685399|365225618|FG005|Treatment Period 1|Administrative|0|||
105882819|NCT00685399|365225619|FG006|Treatment Period 1|Administrative|0|||
105882820|NCT00685399|365225620|FG007|Treatment Period 1|Administrative|0|||
106112044|NCT05375955|366065771|FG001|Treatment (12 Weeks)|Physician Decision|1|||
105882821|NCT00685399|365225613|FG000|Treatment Period 1|Lack of Efficacy|1|||
106112045|NCT05375955|366065772|FG002|Treatment (12 Weeks)|Physician Decision|3|||
106112046|NCT05375955|366065773|FG003|Treatment (12 Weeks)|Physician Decision|0|||
106112047|NCT05375955|366065774|FG004|Treatment (12 Weeks)|Physician Decision|0|||
106112048|NCT05375955|366065775|FG005|Treatment (12 Weeks)|Physician Decision|1|||
106112049|NCT05375955|366065776|FG006|Treatment (12 Weeks)|Physician Decision|0|||
106112050|NCT05375955|366065770|FG000|Treatment (12 Weeks)|Other|0|||
105882822|NCT00685399|365225614|FG001|Treatment Period 1|Lack of Efficacy|0|||
105882823|NCT00685399|365225615|FG002|Treatment Period 1|Lack of Efficacy|0|||
105882824|NCT00685399|365225616|FG003|Treatment Period 1|Lack of Efficacy|0|||
105882825|NCT00685399|365225617|FG004|Treatment Period 1|Lack of Efficacy|0|||
106112051|NCT05375955|366065771|FG001|Treatment (12 Weeks)|Other|1|||
105882826|NCT00685399|365225618|FG005|Treatment Period 1|Lack of Efficacy|0|||
105882827|NCT00685399|365225619|FG006|Treatment Period 1|Lack of Efficacy|0|||
105882828|NCT00685399|365225620|FG007|Treatment Period 1|Lack of Efficacy|0|||
105882829|NCT00685399|365225613|FG000|Treatment Period 2|Administrative Problems|0|||
105882830|NCT00685399|365225614|FG001|Treatment Period 2|Administrative Problems|2|||
105882831|NCT00685399|365225615|FG002|Treatment Period 2|Administrative Problems|1|||
106112052|NCT05375955|366065772|FG002|Treatment (12 Weeks)|Other|0|||
106112053|NCT05375955|366065773|FG003|Treatment (12 Weeks)|Other|0|||
105882832|NCT00685399|365225616|FG003|Treatment Period 2|Administrative Problems|0|||
105882833|NCT00685399|365225617|FG004|Treatment Period 2|Administrative Problems|0|||
105882834|NCT00685399|365225618|FG005|Treatment Period 2|Administrative Problems|0|||
105882835|NCT00685399|365225619|FG006|Treatment Period 2|Administrative Problems|0|||
105882836|NCT00685399|365225620|FG007|Treatment Period 2|Administrative Problems|0|||
105882837|NCT00685399|365225613|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105882838|NCT00685399|365225614|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105882839|NCT00685399|365225615|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105882840|NCT00685399|365225616|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105882841|NCT00685399|365225617|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105882842|NCT00685399|365225618|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105882843|NCT00685399|365225619|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105882844|NCT00685399|365225620|FG007|Treatment Period 2|Withdrawal by Subject|2|||
105882845|NCT00685399|365225613|FG000|Treatment Period 2|Adverse Event|0|||
105882846|NCT00685399|365225614|FG001|Treatment Period 2|Adverse Event|0|||
105882847|NCT00685399|365225615|FG002|Treatment Period 2|Adverse Event|0|||
105882848|NCT00685399|365225616|FG003|Treatment Period 2|Adverse Event|0|||
105882849|NCT00685399|365225617|FG004|Treatment Period 2|Adverse Event|0|||
105882850|NCT00685399|365225618|FG005|Treatment Period 2|Adverse Event|1|||
105882851|NCT00685399|365225619|FG006|Treatment Period 2|Adverse Event|0|||
105882852|NCT00685399|365225620|FG007|Treatment Period 2|Adverse Event|0|||
105882853|NCT00685399|365225613|FG000|Treatment Period 2|Lack of Efficacy|0|||
105882854|NCT00685399|365225614|FG001|Treatment Period 2|Lack of Efficacy|10|||
105882855|NCT00685399|365225615|FG002|Treatment Period 2|Lack of Efficacy|2|||
105882856|NCT00685399|365225616|FG003|Treatment Period 2|Lack of Efficacy|0|||
105882857|NCT00685399|365225617|FG004|Treatment Period 2|Lack of Efficacy|0|||
105882858|NCT00685399|365225618|FG005|Treatment Period 2|Lack of Efficacy|1|||
105882859|NCT00685399|365225619|FG006|Treatment Period 2|Lack of Efficacy|0|||
105882860|NCT00685399|365225620|FG007|Treatment Period 2|Lack of Efficacy|0|||
105882861|NCT00685399|365225613|FG000|Extension|Administrative Issues|0|||
105882862|NCT00685399|365225614|FG001|Extension|Administrative Issues|0|||
105882863|NCT00685399|365225615|FG002|Extension|Administrative Issues|0|||
105882864|NCT00685399|365225616|FG003|Extension|Administrative Issues|1|||
105882865|NCT00685399|365225617|FG004|Extension|Administrative Issues|0|||
105882866|NCT00685399|365225618|FG005|Extension|Administrative Issues|0|||
105882867|NCT00685399|365225619|FG006|Extension|Administrative Issues|0|||
105882868|NCT00685399|365225620|FG007|Extension|Administrative Issues|0|||
105882869|NCT00685399|365225613|FG000|Extension|Withdrawal by Subject|0|||
105882870|NCT00685399|365225614|FG001|Extension|Withdrawal by Subject|0|||
105882871|NCT00685399|365225615|FG002|Extension|Withdrawal by Subject|0|||
105882872|NCT00685399|365225616|FG003|Extension|Withdrawal by Subject|1|||
105882873|NCT00685399|365225617|FG004|Extension|Withdrawal by Subject|0|||
106112054|NCT05375955|366065774|FG004|Treatment (12 Weeks)|Other|0|||
106112055|NCT05375955|366065775|FG005|Treatment (12 Weeks)|Other|0|||
106112056|NCT05375955|366065776|FG006|Treatment (12 Weeks)|Other|0|||
106112057|NCT05375955|366065770|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
106112058|NCT05375955|366065771|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
106112059|NCT05375955|366065772|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
106112060|NCT05375955|366065773|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
106112061|NCT05375955|366065774|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
106112062|NCT05375955|366065775|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
106112063|NCT05375955|366065776|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
106112064|NCT05375955|366065770|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
106112065|NCT05375955|366065771|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
106112066|NCT05375955|366065772|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
106112067|NCT05375955|366065773|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
106112068|NCT05375955|366065774|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
106112069|NCT05375955|366065775|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
106112070|NCT05375955|366065776|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
106112071|NCT05375955|366065770|FG000|Treatment (12 Weeks)|Pregnancy|0|||
106112072|NCT05375955|366065771|FG001|Treatment (12 Weeks)|Pregnancy|0|||
106112073|NCT05375955|366065772|FG002|Treatment (12 Weeks)|Pregnancy|1|||
106112074|NCT05375955|366065773|FG003|Treatment (12 Weeks)|Pregnancy|0|||
106112075|NCT05375955|366065774|FG004|Treatment (12 Weeks)|Pregnancy|0|||
105882874|NCT00685399|365225618|FG005|Extension|Withdrawal by Subject|0|||
105882875|NCT00685399|365225619|FG006|Extension|Withdrawal by Subject|0|||
105882876|NCT00685399|365225620|FG007|Extension|Withdrawal by Subject|0|||
105882877|NCT00685399|365225613|FG000|Extension|Protocol Violation|0|||
105882878|NCT00685399|365225614|FG001|Extension|Protocol Violation|0|||
105882879|NCT00685399|365225615|FG002|Extension|Protocol Violation|0|||
105882880|NCT00685399|365225616|FG003|Extension|Protocol Violation|1|||
105882881|NCT00685399|365225617|FG004|Extension|Protocol Violation|0|||
105882882|NCT00685399|365225618|FG005|Extension|Protocol Violation|0|||
105882883|NCT00685399|365225619|FG006|Extension|Protocol Violation|0|||
105882884|NCT00685399|365225620|FG007|Extension|Protocol Violation|0|||
105882885|NCT00685399|365225613|FG000|Extension|Lack of Efficacy|0|||
105882886|NCT00685399|365225614|FG001|Extension|Lack of Efficacy|0|||
105882887|NCT00685399|365225615|FG002|Extension|Lack of Efficacy|0|||
105882888|NCT00685399|365225616|FG003|Extension|Lack of Efficacy|2|||
105882889|NCT00685399|365225617|FG004|Extension|Lack of Efficacy|0|||
105882890|NCT00685399|365225618|FG005|Extension|Lack of Efficacy|0|||
105882891|NCT00685399|365225619|FG006|Extension|Lack of Efficacy|0|||
105882892|NCT00685399|365225620|FG007|Extension|Lack of Efficacy|0|||
105882893|NCT00685399|365225613|FG000|Extension|Adverse Event|0|||
105882894|NCT00685399|365225614|FG001|Extension|Adverse Event|0|||
105882895|NCT00685399|365225615|FG002|Extension|Adverse Event|0|||
105882896|NCT00685399|365225616|FG003|Extension|Adverse Event|2|||
105882897|NCT00685399|365225617|FG004|Extension|Adverse Event|0|||
105882898|NCT00685399|365225618|FG005|Extension|Adverse Event|0|||
105882899|NCT00685399|365225619|FG006|Extension|Adverse Event|0|||
105882900|NCT00685399|365225620|FG007|Extension|Adverse Event|0|||
105882901|NCT00656292|365225622|FG000|Overall Study|Withdrawal by Subject|2|||
105882902|NCT00656292|365225623|FG001|Overall Study|Withdrawal by Subject|3|||
105882903|NCT00656292|365225622|FG000|Overall Study|Screen failure|1|||
105882904|NCT00656292|365225623|FG001|Overall Study|Screen failure|2|||
105882905|NCT03645395|365225637|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
105882906|NCT03645395|365225638|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
105882907|NCT03645395|365225639|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
105882908|NCT03645395|365225640|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
105882909|NCT03645395|365225637|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
105882910|NCT03645395|365225638|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
105882911|NCT03645395|365225639|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
105882912|NCT03645395|365225640|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
105882913|NCT03645395|365225637|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
105882914|NCT03645395|365225638|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
105882915|NCT03645395|365225639|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
105882916|NCT03645395|365225640|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
105882917|NCT03645395|365225637|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
105882918|NCT03645395|365225638|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
105882919|NCT03645395|365225639|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
105882920|NCT03645395|365225640|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
105882921|NCT00892151|365225641|FG000|Overall Study|Protocol Violation|1|||
105882922|NCT02714595|365225644|FG000|Overall Study|Lost to Follow-up|1|||
105882923|NCT02714595|365225645|FG001|Overall Study|Lost to Follow-up|0|||
105882924|NCT02714595|365225644|FG000|Overall Study|Withdrawal by Subject|1|||
105882925|NCT02714595|365225645|FG001|Overall Study|Withdrawal by Subject|2|||
105882926|NCT02714595|365225644|FG000|Overall Study|Lack of Efficacy|0|||
105882927|NCT02714595|365225645|FG001|Overall Study|Lack of Efficacy|1|||
105882928|NCT02714595|365225644|FG000|Overall Study|Death|30|||
105882929|NCT02714595|365225645|FG001|Overall Study|Death|9|||
105882930|NCT02714595|365225644|FG000|Overall Study|Other-Miscellaneous|0|||
105882931|NCT02714595|365225645|FG001|Overall Study|Other-Miscellaneous|1|||
105882932|NCT02527434|365225647|FG000|Overall Study|Lost to Follow-up|2|||
106112076|NCT05375955|366065775|FG005|Treatment (12 Weeks)|Pregnancy|0|||
105882933|NCT02527434|365225648|FG001|Overall Study|Lost to Follow-up|2|||
105882934|NCT02527434|365225649|FG002|Overall Study|Lost to Follow-up|0|||
106112077|NCT05375955|366065776|FG006|Treatment (12 Weeks)|Pregnancy|0|||
106112078|NCT05375955|366065770|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
106112079|NCT05375955|366065771|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
106112080|NCT05375955|366065772|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
106112081|NCT05375955|366065773|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
106112082|NCT05375955|366065774|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
106112083|NCT05375955|366065775|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
106112084|NCT05375955|366065776|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
106112085|NCT05375955|366065770|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
106112086|NCT05375955|366065771|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
106112087|NCT05375955|366065772|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
106112088|NCT05375955|366065773|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
106112089|NCT05375955|366065774|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
106112090|NCT05375955|366065775|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
106112091|NCT05375955|366065776|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
106112092|NCT05375955|366065770|FG000|Follow-up (up to 5 Weeks)|Other|0|||
106112093|NCT05375955|366065771|FG001|Follow-up (up to 5 Weeks)|Other|1|||
106112094|NCT05375955|366065772|FG002|Follow-up (up to 5 Weeks)|Other|0|||
106112095|NCT05375955|366065773|FG003|Follow-up (up to 5 Weeks)|Other|0|||
106112096|NCT05375955|366065774|FG004|Follow-up (up to 5 Weeks)|Other|0|||
106112097|NCT05375955|366065775|FG005|Follow-up (up to 5 Weeks)|Other|0|||
106112098|NCT05375955|366065776|FG006|Follow-up (up to 5 Weeks)|Other|0|||
106112099|NCT05375955|366065770|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
105882935|NCT02527434|365225647|FG000|Overall Study|Death|19|||
105882936|NCT02527434|365225648|FG001|Overall Study|Death|6|||
105882937|NCT02527434|365225649|FG002|Overall Study|Death|17|||
105882938|NCT02527434|365225647|FG000|Overall Study|Withdrawal by Subject|5|||
105882939|NCT02527434|365225648|FG001|Overall Study|Withdrawal by Subject|3|||
105882940|NCT02527434|365225649|FG002|Overall Study|Withdrawal by Subject|3|||
105882941|NCT02527434|365225647|FG000|Overall Study|Reason Not Specified|1|||
105882942|NCT02527434|365225648|FG001|Overall Study|Reason Not Specified|0|||
105882943|NCT02527434|365225649|FG002|Overall Study|Reason Not Specified|0|||
105882944|NCT02527434|365225647|FG000|Overall Study|Site closure|1|||
105882945|NCT02527434|365225648|FG001|Overall Study|Site closure|0|||
105882946|NCT02527434|365225649|FG002|Overall Study|Site closure|0|||
105882947|NCT03348930|365225652|FG000|Washout (1 Week)|Lost to Follow-up|1|||
105882948|NCT03348930|365225653|FG001|Washout (1 Week)|Lost to Follow-up|1|||
105882949|NCT02199795|365225655|FG000|Overall Study|no longer met inclusion criteria|1|||
105882950|NCT02199795|365225656|FG001|Overall Study|no longer met inclusion criteria|0|||
105882951|NCT02199795|365225655|FG000|Overall Study|withdrew due to shoulder pain|1|||
105882952|NCT02199795|365225656|FG001|Overall Study|withdrew due to shoulder pain|0|||
105882953|NCT02858583|365225670|FG000|Overall Study|Declined consent|1|||
105882954|NCT02858583|365225671|FG001|Overall Study|Declined consent|1|||
105882955|NCT01218087|365225673|FG000|Overall Study|Death|2|||
105882956|NCT01218087|365225674|FG001|Overall Study|Death|1|||
105882957|NCT01218087|365225673|FG000|Overall Study|Withdrawal by Subject|5|||
105882958|NCT01218087|365225674|FG001|Overall Study|Withdrawal by Subject|0|||
105882959|NCT01218087|365225673|FG000|Overall Study|Transferred|8|||
105882960|NCT01218087|365225674|FG001|Overall Study|Transferred|5|||
105882961|NCT03682848|365225678|FG000|Overall Study|Withdrawal by Subject|2|||
105882962|NCT03682848|365225678|FG000|Overall Study|Site closed|5|||
105882963|NCT03682848|365225678|FG000|Overall Study|Protocol Deviation|1|||
105882964|NCT03682848|365225678|FG000|Overall Study|Adverse Event|1|||
105882965|NCT00454363|365225679|FG000|Overall Study|Adverse Event|1|||
105882966|NCT00454363|365225680|FG001|Overall Study|Adverse Event|2|||
105882967|NCT00454363|365225679|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
105882968|NCT00454363|365225680|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
105882969|NCT00068393|365227656|FG000|Overall Study|Adverse Event|2|||
105882970|NCT00068393|365227656|FG000|Overall Study|Death|3|||
105882971|NCT00068393|365227656|FG000|Overall Study|Withdrawal by Subject|3|||
105882972|NCT00068393|365227656|FG000|Overall Study|Alternative treatment|1|||
105882973|NCT00068393|365227656|FG000|Overall Study|Quality of life worsening|1|||
105882974|NCT00078767|365227657|FG000|Overall Study|Withdrawal by Subject|1|||
105882975|NCT00078767|365227658|FG001|Overall Study|Withdrawal by Subject|1|||
105882976|NCT01091662|365227659|FG000|Overall Study|Adverse Event|1|||
105882977|NCT01091662|365227660|FG001|Overall Study|Adverse Event|9|||
105882978|NCT01091662|365227659|FG000|Overall Study|Physician Decision|1|||
105882979|NCT01091662|365227660|FG001|Overall Study|Physician Decision|1|||
105882980|NCT01091662|365227659|FG000|Overall Study|Withdrawal by Subject|7|||
105882981|NCT01091662|365227660|FG001|Overall Study|Withdrawal by Subject|6|||
105882982|NCT01091662|365227659|FG000|Overall Study|met exit criteria|7|||
105882983|NCT01091662|365227660|FG001|Overall Study|met exit criteria|13|||
105882984|NCT01091662|365227659|FG000|Overall Study|met exclusion criteria|1|||
105882985|NCT01091662|365227660|FG001|Overall Study|met exclusion criteria|0|||
105882986|NCT01091662|365227659|FG000|Overall Study|Lost to Follow-up|0|||
105882987|NCT01091662|365227660|FG001|Overall Study|Lost to Follow-up|1|||
105882988|NCT01091662|365227659|FG000|Overall Study|Pregnancy|0|||
105882989|NCT01091662|365227660|FG001|Overall Study|Pregnancy|1|||
105882990|NCT01091662|365227659|FG000|Overall Study|Protocol Violation|0|||
105882991|NCT01091662|365227660|FG001|Overall Study|Protocol Violation|2|||
105882992|NCT01091662|365227659|FG000|Overall Study|unable to swallow capsule|0|||
105882993|NCT01091662|365227660|FG001|Overall Study|unable to swallow capsule|1|||
105882994|NCT04109391|365227661|FG000|Overall Study|Adverse Event|2|||
105882995|NCT04109391|365227662|FG001|Overall Study|Adverse Event|2|||
105882996|NCT04109391|365227663|FG002|Overall Study|Adverse Event|0|||
105882997|NCT04109391|365227661|FG000|Overall Study|Withdrawal by Subject|2|||
105882998|NCT04109391|365227662|FG001|Overall Study|Withdrawal by Subject|0|||
106112100|NCT05375955|366065771|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
106112101|NCT05375955|366065772|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
106112102|NCT05375955|366065773|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
106112103|NCT05375955|366065774|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
106112104|NCT05375955|366065775|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
105882999|NCT04109391|365227663|FG002|Overall Study|Withdrawal by Subject|0|||
106112105|NCT05375955|366065776|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
106112106|NCT05375955|366065770|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
106112107|NCT05375955|366065771|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
106112108|NCT05375955|366065772|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
105883000|NCT04109391|365227661|FG000|Overall Study|Pregnancy|1|||
105883001|NCT04109391|365227662|FG001|Overall Study|Pregnancy|0|||
105883002|NCT04109391|365227663|FG002|Overall Study|Pregnancy|0|||
105883003|NCT04109391|365227661|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
105883004|NCT04109391|365227662|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
105883005|NCT04109391|365227663|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
105883006|NCT04109391|365227661|FG000|Overall Study|Lost to Follow-up|0|||
105883007|NCT04109391|365227662|FG001|Overall Study|Lost to Follow-up|0|||
105883008|NCT04109391|365227663|FG002|Overall Study|Lost to Follow-up|1|||
105883009|NCT04109391|365227661|FG000|Overall Study|Lack of Efficacy|2|||
105883010|NCT04109391|365227662|FG001|Overall Study|Lack of Efficacy|2|||
105883011|NCT04109391|365227663|FG002|Overall Study|Lack of Efficacy|3|||
105883012|NCT01222520|365227664|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
105883013|NCT01222520|365227665|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
105883014|NCT01222520|365227664|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
105883015|NCT01222520|365227665|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
105883016|NCT01222520|365227664|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
105883017|NCT01222520|365227665|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
105883018|NCT01222520|365227664|FG000|Double-blind Period|Adverse Event|0|||
105883019|NCT01222520|365227665|FG001|Double-blind Period|Adverse Event|1|||
105883020|NCT01222520|365227664|FG000|Double-blind Period|Lack of Efficacy|0|||
105883021|NCT01222520|365227665|FG001|Double-blind Period|Lack of Efficacy|1|||
105883022|NCT01222520|365227664|FG000|Double-blind Period|Study medication stolen|1|||
105883023|NCT01222520|365227665|FG001|Double-blind Period|Study medication stolen|0|||
105883024|NCT00596817|365227666|FG000|Open-label Period|Adverse Event|0|||
105883025|NCT00596817|365227667|FG001|Open-label Period|Adverse Event|49|||
105883026|NCT00596817|365227666|FG000|Open-label Period|Lack of Efficacy|0|||
105883027|NCT00596817|365227667|FG001|Open-label Period|Lack of Efficacy|33|||
105883028|NCT00596817|365227666|FG000|Open-label Period|Other Reasons|0|||
105883029|NCT00596817|365227667|FG001|Open-label Period|Other Reasons|65|||
105883030|NCT00596817|365227666|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
105883031|NCT00596817|365227667|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
105883032|NCT00596817|365227666|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
105883033|NCT00596817|365227667|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
105883034|NCT00596817|365227666|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
105883035|NCT00596817|365227667|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
105883036|NCT00596817|365227666|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
105883037|NCT00596817|365227667|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
105883038|NCT00596817|365227666|FG000|Double-blind Period|Adverse Event|5|||
105883039|NCT00596817|365227667|FG001|Double-blind Period|Adverse Event|16|||
105883040|NCT00596817|365227666|FG000|Double-blind Period|Lack of Efficacy|52|||
105883041|NCT00596817|365227667|FG001|Double-blind Period|Lack of Efficacy|28|||
105883042|NCT00596817|365227666|FG000|Double-blind Period|Non-compliance With Study Product|3|||
105883043|NCT00596817|365227667|FG001|Double-blind Period|Non-compliance With Study Product|4|||
105883044|NCT00596817|365227666|FG000|Double-blind Period|Protocol Violation|11|||
105883045|NCT00596817|365227667|FG001|Double-blind Period|Protocol Violation|8|||
105883046|NCT00596817|365227666|FG000|Double-blind Period|Withdrawal of Consent|7|||
105883047|NCT00596817|365227667|FG001|Double-blind Period|Withdrawal of Consent|3|||
106112109|NCT05375955|366065773|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
106112110|NCT05375955|366065774|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
106112111|NCT05375955|366065775|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
106112112|NCT05375955|366065776|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
106112113|NCT04027348|366065779|FG000|Overall Study|Adverse Event|2|||
106112114|NCT01313286|366065782|FG000|Period 1|Withdrawal by Subject|2|||
106112115|NCT01313286|366065783|FG001|Period 1|Withdrawal by Subject|0|||
106112116|NCT00633464|366065797|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
106112117|NCT00633464|366065798|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
106112118|NCT00633464|366065797|FG000|Overall Study|Never Treated (Randomized in error)|0|||
106112119|NCT00633464|366065798|FG001|Overall Study|Never Treated (Randomized in error)|1|||
106112120|NCT04512066|366065803|FG000|Double-blind Treatment Period|Adverse Event|6|||
106112121|NCT04512066|366065804|FG001|Double-blind Treatment Period|Adverse Event|4|||
106112122|NCT04512066|366065805|FG002|Double-blind Treatment Period|Adverse Event|5|||
106112123|NCT04512066|366065806|FG003|Double-blind Treatment Period|Adverse Event|1|||
106112124|NCT04512066|366065807|FG004|Double-blind Treatment Period|Adverse Event|0|||
106112125|NCT04512066|366065808|FG005|Double-blind Treatment Period|Adverse Event|0|||
106112126|NCT04512066|366065803|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
106112127|NCT04512066|366065804|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
106112128|NCT04512066|366065805|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
106112129|NCT04512066|366065806|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
106112130|NCT04512066|366065807|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
106112131|NCT04512066|366065808|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
105883048|NCT00596817|365227666|FG000|Double-blind Period|Lost to Follow-up|0|||
105883049|NCT00596817|365227667|FG001|Double-blind Period|Lost to Follow-up|2|||
105883050|NCT00596817|365227666|FG000|Double-blind Period|Other Reasons|10|||
105883051|NCT00596817|365227667|FG001|Double-blind Period|Other Reasons|18|||
105883052|NCT01089608|365227670|FG000|Overall Study|Adverse Event|0|||
105883053|NCT01089608|365227671|FG001|Overall Study|Adverse Event|4|||
106112132|NCT04512066|366065803|FG000|Double-blind Treatment Period|Physician Decision|1|||
106112133|NCT04512066|366065804|FG001|Double-blind Treatment Period|Physician Decision|0|||
106112134|NCT04512066|366065805|FG002|Double-blind Treatment Period|Physician Decision|1|||
106112135|NCT04512066|366065806|FG003|Double-blind Treatment Period|Physician Decision|0|||
106112136|NCT04512066|366065807|FG004|Double-blind Treatment Period|Physician Decision|0|||
106112137|NCT04512066|366065808|FG005|Double-blind Treatment Period|Physician Decision|0|||
106112138|NCT04512066|366065803|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
106112139|NCT04512066|366065804|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
106112140|NCT04512066|366065805|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
106112141|NCT04512066|366065806|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
106112142|NCT04512066|366065807|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
106112143|NCT04512066|366065808|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
106112144|NCT04512066|366065803|FG000|Extension Period|Adverse Event|0|||
106112145|NCT04512066|366065804|FG001|Extension Period|Adverse Event|1|||
106112146|NCT04512066|366065805|FG002|Extension Period|Adverse Event|4|||
106112147|NCT04512066|366065806|FG003|Extension Period|Adverse Event|3|||
106112148|NCT04512066|366065807|FG004|Extension Period|Adverse Event|1|||
106112149|NCT04512066|366065808|FG005|Extension Period|Adverse Event|3|||
106112150|NCT04512066|366065803|FG000|Extension Period|Death|0|||
106112151|NCT04512066|366065804|FG001|Extension Period|Death|0|||
106112152|NCT04512066|366065805|FG002|Extension Period|Death|0|||
106112153|NCT04512066|366065806|FG003|Extension Period|Death|0|||
106112154|NCT04512066|366065807|FG004|Extension Period|Death|0|||
106112155|NCT04512066|366065808|FG005|Extension Period|Death|1|||
106112156|NCT04512066|366065803|FG000|Extension Period|Lack of Efficacy|0|||
106112157|NCT04512066|366065804|FG001|Extension Period|Lack of Efficacy|4|||
106112158|NCT04512066|366065805|FG002|Extension Period|Lack of Efficacy|4|||
106112159|NCT04512066|366065806|FG003|Extension Period|Lack of Efficacy|1|||
106112160|NCT04512066|366065807|FG004|Extension Period|Lack of Efficacy|3|||
106112161|NCT04512066|366065808|FG005|Extension Period|Lack of Efficacy|3|||
106112162|NCT04512066|366065803|FG000|Extension Period|Lost to Follow-up|0|||
106112163|NCT04512066|366065804|FG001|Extension Period|Lost to Follow-up|1|||
106112164|NCT04512066|366065805|FG002|Extension Period|Lost to Follow-up|5|||
106112165|NCT04512066|366065806|FG003|Extension Period|Lost to Follow-up|2|||
106112166|NCT04512066|366065807|FG004|Extension Period|Lost to Follow-up|3|||
106112167|NCT04512066|366065808|FG005|Extension Period|Lost to Follow-up|2|||
106112168|NCT04512066|366065803|FG000|Extension Period|Non-compliance with study drug|0|||
106112169|NCT04512066|366065804|FG001|Extension Period|Non-compliance with study drug|1|||
106112170|NCT04512066|366065805|FG002|Extension Period|Non-compliance with study drug|0|||
106112171|NCT04512066|366065806|FG003|Extension Period|Non-compliance with study drug|0|||
106112172|NCT04512066|366065807|FG004|Extension Period|Non-compliance with study drug|0|||
106112173|NCT04512066|366065808|FG005|Extension Period|Non-compliance with study drug|1|||
106112174|NCT04512066|366065803|FG000|Extension Period|Other|0|||
106112175|NCT04512066|366065804|FG001|Extension Period|Other|2|||
106112176|NCT04512066|366065805|FG002|Extension Period|Other|0|||
106112177|NCT04512066|366065806|FG003|Extension Period|Other|0|||
106112178|NCT04512066|366065807|FG004|Extension Period|Other|0|||
106112179|NCT04512066|366065808|FG005|Extension Period|Other|0|||
106112180|NCT04512066|366065803|FG000|Extension Period|Physician Decision|0|||
106112181|NCT04512066|366065804|FG001|Extension Period|Physician Decision|2|||
106112182|NCT04512066|366065805|FG002|Extension Period|Physician Decision|0|||
106112183|NCT04512066|366065806|FG003|Extension Period|Physician Decision|1|||
106112184|NCT04512066|366065807|FG004|Extension Period|Physician Decision|1|||
106112185|NCT04512066|366065808|FG005|Extension Period|Physician Decision|0|||
106112186|NCT04512066|366065803|FG000|Extension Period|Withdrawal by Subject|0|||
106112187|NCT04512066|366065804|FG001|Extension Period|Withdrawal by Subject|3|||
106112188|NCT04512066|366065805|FG002|Extension Period|Withdrawal by Subject|7|||
106112189|NCT04512066|366065806|FG003|Extension Period|Withdrawal by Subject|11|||
106112190|NCT04512066|366065807|FG004|Extension Period|Withdrawal by Subject|8|||
106112191|NCT04512066|366065808|FG005|Extension Period|Withdrawal by Subject|4|||
106112192|NCT00316173|366065809|FG000|Run-in Phase|Adverse Event|1|||
106112193|NCT00316173|366065810|FG001|Run-in Phase|Adverse Event|0|||
106112194|NCT00316173|366065809|FG000|Run-in Phase|Protocol Violation|1|||
106112195|NCT00316173|366065810|FG001|Run-in Phase|Protocol Violation|0|||
106112196|NCT00316173|366065809|FG000|Run-in Phase|Study Follow-up Stopped|5|||
106112197|NCT00316173|366065810|FG001|Run-in Phase|Study Follow-up Stopped|0|||
106112198|NCT00316173|366065809|FG000|Treatment Phase|Adverse Event|0|||
106112199|NCT00316173|366065810|FG001|Treatment Phase|Adverse Event|1|||
106112200|NCT00316173|366065809|FG000|Treatment Phase|Lack of Efficacy|0|||
106112201|NCT00316173|366065810|FG001|Treatment Phase|Lack of Efficacy|3|||
106112202|NCT00316173|366065809|FG000|Treatment Phase|Lost to Follow-up|0|||
106112203|NCT00316173|366065810|FG001|Treatment Phase|Lost to Follow-up|3|||
106112204|NCT00316173|366065809|FG000|Treatment Phase|Withdrawal by Subject|0|||
106112205|NCT00316173|366065810|FG001|Treatment Phase|Withdrawal by Subject|1|||
106112206|NCT00316173|366065809|FG000|Treatment Phase|Study Follow-up Stopped|0|||
106112207|NCT00316173|366065810|FG001|Treatment Phase|Study Follow-up Stopped|34|||
106112208|NCT01489189|366065811|FG000|Overall Study|Withdrawal by Subject|20|||
106112209|NCT01489189|366065812|FG001|Overall Study|Withdrawal by Subject|23|||
106112210|NCT01489189|366065811|FG000|Overall Study|Death|10|||
106112211|NCT01489189|366065812|FG001|Overall Study|Death|8|||
106112212|NCT01489189|366065811|FG000|Overall Study|Missed Visit|1|||
106112213|NCT01489189|366065812|FG001|Overall Study|Missed Visit|4|||
106112214|NCT00112580|366065813|FG000|Overall Study|Adverse Event|1|||
106112215|NCT00112580|366065814|FG001|Overall Study|Adverse Event|2|||
106112216|NCT00112580|366065813|FG000|Overall Study|Disease progression|5|||
106112217|NCT00112580|366065814|FG001|Overall Study|Disease progression|16|||
106112218|NCT00112580|366065813|FG000|Overall Study|Participant withdrew consent|2|||
106112219|NCT00112580|366065814|FG001|Overall Study|Participant withdrew consent|1|||
106112220|NCT03181399|366068355|FG000|6 Months on Treatment|Protocol non-compliance|7|||
106112221|NCT03181399|366068355|FG000|6 Months on Treatment|Adverse Event|4|||
106112222|NCT03181399|366068355|FG000|6 Months on Treatment|Tried alternative treatment|2|||
106112223|NCT03181399|366068355|FG000|6 Months on Treatment|Lost to Follow-up|2|||
106112224|NCT03181399|366068355|FG000|6 Months on Treatment|Personal reasons|1|||
106112225|NCT03181399|366068355|FG000|3 Months Off-treatment|Parent unable to travel|1|||
106112226|NCT02276066|366068358|FG000|Overall Study|Lost to Follow-up|21|||
106112227|NCT02276066|366068359|FG001|Overall Study|Lost to Follow-up|11|||
106112228|NCT01061333|366068360|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
106112229|NCT01061333|366068361|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
106112230|NCT05050578|366068362|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
106112231|NCT05050578|366068363|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
106112232|NCT05050578|366068362|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
106112233|NCT05050578|366068363|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
106112234|NCT05050578|366068362|FG000|Period 2, 30 Days|Protocol Violation|0|||
106112235|NCT05050578|366068363|FG001|Period 2, 30 Days|Protocol Violation|1|||
106112236|NCT02472652|366068364|FG000|Overall Study|Lost to Follow-up|1|||
106112237|NCT04425902|366068365|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
106112238|NCT01191840|366068366|FG000|Overall Study|withdrew consent|2|||
106112239|NCT01191840|366068367|FG001|Overall Study|withdrew consent|1|||
106112240|NCT01191840|366068366|FG000|Overall Study|Subject discontinued treatment|1|||
105883054|NCT01089608|365227670|FG000|Overall Study|Lost to Follow-up|0|||
105883055|NCT01089608|365227671|FG001|Overall Study|Lost to Follow-up|2|||
105883056|NCT00384839|365227672|FG000|Overall Study|Adverse Event|4|||
105883057|NCT00384839|365227672|FG000|Overall Study|Investigator Request|1|||
105883058|NCT00384839|365227672|FG000|Overall Study|Patient Request|1|||
105883059|NCT00384839|365227672|FG000|Overall Study|Ineligible|2|||
106112241|NCT01191840|366068367|FG001|Overall Study|Subject discontinued treatment|2|||
106112242|NCT01191840|366068366|FG000|Overall Study|Lost to Follow-up|4|||
106112243|NCT01191840|366068367|FG001|Overall Study|Lost to Follow-up|6|||
106112244|NCT01191840|366068366|FG000|Overall Study|Non Staph Infection|4|||
106112245|NCT01191840|366068367|FG001|Overall Study|Non Staph Infection|3|||
106112246|NCT01191840|366068366|FG000|Overall Study|ineligible at enrollment|1|||
106112247|NCT01191840|366068367|FG001|Overall Study|ineligible at enrollment|0|||
106112248|NCT01191840|366068366|FG000|Overall Study|IRB approval lapse|0|||
106112249|NCT01191840|366068367|FG001|Overall Study|IRB approval lapse|2|||
106112250|NCT01191840|366068366|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
106112251|NCT01191840|366068367|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
106112252|NCT01191840|366068366|FG000|Overall Study|Withdrawal by Subject|2|||
106112253|NCT01191840|366068367|FG001|Overall Study|Withdrawal by Subject|0|||
106112254|NCT00089141|366068372|FG000|Overall Study|Termination of trial|18|||
106112255|NCT00089141|366068373|FG001|Overall Study|Termination of trial|24|||
106112256|NCT00180479|366068374|FG000|Overall Study|Death|4|||
106112257|NCT00180479|366068375|FG001|Overall Study|Death|2|||
106112258|NCT00180479|366068374|FG000|Overall Study|Lost to Follow-up|9|||
106112259|NCT00180479|366068375|FG001|Overall Study|Lost to Follow-up|7|||
106112260|NCT00180479|366068374|FG000|Overall Study|Withdrawal by Subject|3|||
106112261|NCT00180479|366068375|FG001|Overall Study|Withdrawal by Subject|3|||
106112262|NCT00180479|366068374|FG000|Overall Study|Informed consent not signed|0|||
106112263|NCT00180479|366068375|FG001|Overall Study|Informed consent not signed|1|||
105993718|NCT01510158|365636075|FG000|Overall Study|Withdrawal by Subject|10|||
106112264|NCT05168579|366068389|FG000|Overall Study|Lack of Consent|1|||
106112265|NCT05168579|366068390|FG001|Overall Study|Lack of Consent|0|||
106112266|NCT05168579|366068389|FG000|Overall Study|Conflicts with time|2|||
105883060|NCT02649439|365227673|FG000|Overall Study|Switched to alternative treatment|6|||
106112267|NCT05168579|366068390|FG001|Overall Study|Conflicts with time|0|||
106112268|NCT05168579|366068389|FG000|Overall Study|Time slots were full|3|||
106112269|NCT05168579|366068390|FG001|Overall Study|Time slots were full|0|||
106112270|NCT05168579|366068389|FG000|Overall Study|Lost to Follow-up|0|||
106112271|NCT05168579|366068390|FG001|Overall Study|Lost to Follow-up|15|||
106112272|NCT00514683|366068391|FG000|Overall Study|Not treated|2|||
106112273|NCT00514683|366068392|FG001|Overall Study|Not treated|1|||
106112274|NCT00514683|366068393|FG002|Overall Study|Not treated|0|||
106112275|NCT00514683|366068394|FG003|Overall Study|Not treated|0|||
106112276|NCT00514683|366068395|FG004|Overall Study|Not treated|1|||
106112277|NCT00514683|366068391|FG000|Overall Study|Adverse Event|21|||
106112278|NCT00514683|366068392|FG001|Overall Study|Adverse Event|20|||
105883061|NCT02649439|365227674|FG001|Overall Study|Switched to alternative treatment|4|||
105883062|NCT02649439|365227673|FG000|Overall Study|Patient decision|1|||
105883063|NCT02649439|365227674|FG001|Overall Study|Patient decision|0|||
105883064|NCT02649439|365227673|FG000|Overall Study|Patient going out of country|1|||
105883065|NCT02649439|365227674|FG001|Overall Study|Patient going out of country|0|||
105883066|NCT02649439|365227673|FG000|Overall Study|To start finasteride|1|||
105883067|NCT02649439|365227674|FG001|Overall Study|To start finasteride|0|||
105883068|NCT02649439|365227673|FG000|Overall Study|Physician Decision|1|||
105883069|NCT02649439|365227674|FG001|Overall Study|Physician Decision|0|||
105883070|NCT02649439|365227673|FG000|Overall Study|Disease progression on study|12|||
105883071|NCT02649439|365227674|FG001|Overall Study|Disease progression on study|13|||
105883072|NCT02649439|365227673|FG000|Overall Study|Refused further treatment|1|||
105883073|NCT02649439|365227674|FG001|Overall Study|Refused further treatment|0|||
105883074|NCT02649439|365227673|FG000|Overall Study|Refused further follow up|2|||
105883075|NCT02649439|365227674|FG001|Overall Study|Refused further follow up|7|||
105883076|NCT02649439|365227673|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
105883077|NCT02649439|365227674|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
105883078|NCT02649439|365227673|FG000|Overall Study|No treatment, per protocol|1|||
105883079|NCT02649439|365227674|FG001|Overall Study|No treatment, per protocol|0|||
105883080|NCT02649439|365227673|FG000|Overall Study|PSA DT makes ineligible|0|||
105883081|NCT02649439|365227674|FG001|Overall Study|PSA DT makes ineligible|1|||
105883082|NCT02649439|365227673|FG000|Overall Study|Rising PSA No Mets|0|||
105883083|NCT02649439|365227674|FG001|Overall Study|Rising PSA No Mets|1|||
105883084|NCT02649439|365227673|FG000|Overall Study|Rising PSA|0|||
105883085|NCT02649439|365227674|FG001|Overall Study|Rising PSA|1|||
105883086|NCT02649439|365227673|FG000|Overall Study|Signed follow up protocol|0|||
105883087|NCT02649439|365227674|FG001|Overall Study|Signed follow up protocol|1|||
105883088|NCT01282372|365227679|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
105883089|NCT01282372|365227679|FG000|Overall Study|Lost to Follow-up|23|||
105883090|NCT01282372|365227679|FG000|Overall Study|Withdrawal by Subject|11|||
105883091|NCT01282372|365227679|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
105883092|NCT01282372|365227679|FG000|Overall Study|Death|1|||
105883093|NCT01282372|365227679|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
105883094|NCT01282372|365227679|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
105883095|NCT01282372|365227679|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
105883096|NCT01282372|365227679|FG000|Overall Study|Adverse Event|12|||
105883097|NCT01322490|365227681|FG000|Treatment Period|Adverse Event|12|||
105883098|NCT01322490|365227682|FG001|Treatment Period|Adverse Event|18|||
105883099|NCT01322490|365227683|FG002|Treatment Period|Adverse Event|15|||
105883100|NCT01322490|365227681|FG000|Treatment Period|Death|5|||
105883101|NCT01322490|365227682|FG001|Treatment Period|Death|7|||
105883102|NCT01322490|365227683|FG002|Treatment Period|Death|3|||
105883103|NCT01322490|365227681|FG000|Treatment Period|Lack of Efficacy|89|||
105883104|NCT01322490|365227682|FG001|Treatment Period|Lack of Efficacy|100|||
105883105|NCT01322490|365227683|FG002|Treatment Period|Lack of Efficacy|112|||
105883106|NCT01322490|365227681|FG000|Treatment Period|Physician Decision|0|||
105883107|NCT01322490|365227682|FG001|Treatment Period|Physician Decision|2|||
105883108|NCT01322490|365227683|FG002|Treatment Period|Physician Decision|1|||
105883109|NCT01322490|365227681|FG000|Treatment Period|Protocol Violation|7|||
105883110|NCT01322490|365227682|FG001|Treatment Period|Protocol Violation|5|||
105883111|NCT01322490|365227683|FG002|Treatment Period|Protocol Violation|4|||
105883112|NCT01322490|365227681|FG000|Treatment Period|Withdrawal by Subject|14|||
105883113|NCT01322490|365227682|FG001|Treatment Period|Withdrawal by Subject|16|||
105883114|NCT01322490|365227683|FG002|Treatment Period|Withdrawal by Subject|11|||
105883115|NCT01322490|365227681|FG000|Treatment Period|Non-compliance with study drug|0|||
105883116|NCT01322490|365227682|FG001|Treatment Period|Non-compliance with study drug|0|||
105883117|NCT01322490|365227683|FG002|Treatment Period|Non-compliance with study drug|1|||
105883118|NCT01322490|365227681|FG000|Treatment Period|Other per report|2|||
105883119|NCT01322490|365227682|FG001|Treatment Period|Other per report|2|||
105883120|NCT01322490|365227683|FG002|Treatment Period|Other per report|1|||
105883121|NCT01322490|365227681|FG000|Treatment Period|Randomized but Not Treated|3|||
105883122|NCT01322490|365227682|FG001|Treatment Period|Randomized but Not Treated|3|||
105883123|NCT01322490|365227683|FG002|Treatment Period|Randomized but Not Treated|5|||
105883124|NCT01322490|365227681|FG000|Long Term Follow-up Period|Death|235|||
105883125|NCT01322490|365227682|FG001|Long Term Follow-up Period|Death|239|||
105883126|NCT01322490|365227683|FG002|Long Term Follow-up Period|Death|236|||
105883127|NCT01322490|365227681|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
105883128|NCT01322490|365227682|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
105883129|NCT01322490|365227683|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
105883130|NCT01322490|365227681|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
105883131|NCT01322490|365227682|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
105883132|NCT01322490|365227683|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
105883133|NCT01322490|365227681|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
105883134|NCT01322490|365227682|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
106112279|NCT00514683|366068393|FG002|Overall Study|Adverse Event|15|||
106112280|NCT00514683|366068394|FG003|Overall Study|Adverse Event|13|||
106112281|NCT00514683|366068395|FG004|Overall Study|Adverse Event|27|||
106112282|NCT00514683|366068391|FG000|Overall Study|Protocol Violation|1|||
106112283|NCT00514683|366068392|FG001|Overall Study|Protocol Violation|1|||
106112284|NCT00514683|366068393|FG002|Overall Study|Protocol Violation|0|||
105883135|NCT01322490|365227683|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
105883136|NCT01322490|365227681|FG000|Long Term Follow-up Period|Other per report|3|||
105883137|NCT01322490|365227682|FG001|Long Term Follow-up Period|Other per report|2|||
105883138|NCT01322490|365227683|FG002|Long Term Follow-up Period|Other per report|2|||
105883139|NCT01322490|365227681|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
105883140|NCT01322490|365227682|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
105883141|NCT01322490|365227683|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
105883142|NCT02257489|365227684|FG000|Overall Study|Withdrawal by Subject|0|||
105883143|NCT02257489|365227685|FG001|Overall Study|Withdrawal by Subject|0|||
105883144|NCT02257489|365227686|FG002|Overall Study|Withdrawal by Subject|0|||
105883145|NCT02257489|365227687|FG003|Overall Study|Withdrawal by Subject|1|||
105883146|NCT02257489|365227688|FG004|Overall Study|Withdrawal by Subject|0|||
105883147|NCT02257489|365227689|FG005|Overall Study|Withdrawal by Subject|0|||
105883148|NCT02257489|365227690|FG006|Overall Study|Withdrawal by Subject|0|||
105883149|NCT02257489|365227691|FG007|Overall Study|Withdrawal by Subject|0|||
105883150|NCT02257489|365227692|FG008|Overall Study|Withdrawal by Subject|0|||
105883151|NCT04606394|365227695|FG000|Overall Study|Withdrawal by Subject|3|||
105883152|NCT04606394|365227695|FG000|Overall Study|Exclusion criteria screen failure|12|||
105883153|NCT02484456|365227697|FG000|Washout Period|Withdrawal by Subject|0|||
105883154|NCT02484456|365227698|FG001|Washout Period|Withdrawal by Subject|1|||
105883155|NCT02484456|365227697|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
105883156|NCT02484456|365227698|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
105883157|NCT02484456|365227697|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
105883158|NCT02484456|365227698|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
105883159|NCT02484456|365227697|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
105883160|NCT02484456|365227698|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
105883161|NCT02920008|365227699|FG000|Overall Study|Death|117|||
105883162|NCT02920008|365227700|FG001|Overall Study|Death|127|||
105883163|NCT02920008|365227699|FG000|Overall Study|Withdrawal by Subject|3|||
105883164|NCT02920008|365227700|FG001|Overall Study|Withdrawal by Subject|6|||
105883165|NCT02920008|365227699|FG000|Overall Study|Lost to Follow-up|0|||
105883166|NCT02920008|365227700|FG001|Overall Study|Lost to Follow-up|1|||
105883167|NCT01053663|365227701|FG000|Overall Study|Death|2|||
105883168|NCT01053663|365227701|FG000|Overall Study|Lost to Follow-up|1|||
105883169|NCT01053663|365227701|FG000|Overall Study|Poor IV Access|1|||
105883170|NCT01053663|365227701|FG000|Overall Study|Transferred to Another Hospital|1|||
105883171|NCT01053663|365227701|FG000|Overall Study|Negative Influenza Diagnosis|1|||
105883172|NCT02737930|365227702|FG000|Overall Study|Withdrawal by Subject|0|||
105883173|NCT02737930|365227703|FG001|Overall Study|Withdrawal by Subject|1|||
105883174|NCT02411396|365227704|FG000|Overall Study|Lost to Follow-up|31|||
105883175|NCT02411396|365227704|FG000|Overall Study|Death|10|||
105883176|NCT02016105|365227705|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
105883177|NCT02016105|365227706|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
105883178|NCT02016105|365227707|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
105883179|NCT02016105|365227708|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
105883180|NCT02016105|365227709|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
105883181|NCT02016105|365227710|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
105883182|NCT02016105|365227705|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
105883183|NCT02016105|365227706|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
105883184|NCT02016105|365227707|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
105883185|NCT02016105|365227708|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
105883186|NCT02016105|365227709|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
105883187|NCT02016105|365227710|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
105883188|NCT02016105|365227705|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
105883189|NCT02016105|365227706|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
105883190|NCT02016105|365227707|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
105883191|NCT02016105|365227708|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
105883192|NCT02016105|365227709|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
105883193|NCT02016105|365227710|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
105883194|NCT02016105|365227705|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
105883195|NCT02016105|365227706|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
105883196|NCT02016105|365227707|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
106112285|NCT00514683|366068394|FG003|Overall Study|Protocol Violation|1|||
106112286|NCT00514683|366068395|FG004|Overall Study|Protocol Violation|0|||
105883197|NCT02016105|365227708|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
105993719|NCT01510158|365636076|FG001|Overall Study|Withdrawal by Subject|13|||
105883198|NCT02016105|365227709|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
105883199|NCT02016105|365227710|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
105883200|NCT02016105|365227705|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
105883201|NCT02016105|365227706|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
106112287|NCT00514683|366068391|FG000|Overall Study|Withdrawal by Subject|2|||
105883202|NCT02016105|365227707|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
105883203|NCT02016105|365227708|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
105883204|NCT02016105|365227709|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
105883205|NCT02016105|365227710|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
105883206|NCT02016105|365227705|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
105883207|NCT02016105|365227706|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
105883208|NCT02016105|365227707|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
105883209|NCT02016105|365227708|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
105883210|NCT02016105|365227709|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
105883211|NCT02016105|365227710|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
105883212|NCT02016105|365227705|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
105883213|NCT02016105|365227706|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
105883214|NCT02016105|365227707|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
105883215|NCT02016105|365227708|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
105883216|NCT02016105|365227709|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
105883217|NCT02016105|365227710|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
105883218|NCT02016105|365227705|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
105883219|NCT02016105|365227706|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
105883220|NCT02016105|365227707|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
105883221|NCT02016105|365227708|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
105883222|NCT02016105|365227709|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
105883223|NCT02016105|365227710|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
105883224|NCT02016105|365227705|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
105883225|NCT02016105|365227706|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
106112288|NCT00514683|366068392|FG001|Overall Study|Withdrawal by Subject|2|||
106112289|NCT00514683|366068393|FG002|Overall Study|Withdrawal by Subject|1|||
106112290|NCT00514683|366068394|FG003|Overall Study|Withdrawal by Subject|0|||
106112291|NCT00514683|366068395|FG004|Overall Study|Withdrawal by Subject|4|||
106112292|NCT00514683|366068391|FG000|Overall Study|Reason other than listed above|0|||
106112293|NCT00514683|366068392|FG001|Overall Study|Reason other than listed above|1|||
106112294|NCT00514683|366068393|FG002|Overall Study|Reason other than listed above|2|||
106112295|NCT00514683|366068394|FG003|Overall Study|Reason other than listed above|0|||
106112296|NCT00514683|366068395|FG004|Overall Study|Reason other than listed above|1|||
106112297|NCT00335452|366068396|FG000|Overall Study|Death|156|||
106112298|NCT00335452|366068397|FG001|Overall Study|Death|144|||
106112299|NCT00335452|366068398|FG002|Overall Study|Death|158|||
106112300|NCT00335452|366068399|FG003|Overall Study|Death|129|||
106112301|NCT00335452|366068396|FG000|Overall Study|Lost to Follow-up|2|||
106112302|NCT00335452|366068397|FG001|Overall Study|Lost to Follow-up|3|||
106112303|NCT00335452|366068398|FG002|Overall Study|Lost to Follow-up|1|||
106112304|NCT00335452|366068399|FG003|Overall Study|Lost to Follow-up|2|||
106112305|NCT02736825|366068400|FG000|Overall Study|Lost to Follow-up|10|||
106112306|NCT02736825|366068401|FG001|Overall Study|Lost to Follow-up|11|||
106112307|NCT02736825|366068400|FG000|Overall Study|Early Termination|0|||
106112308|NCT02736825|366068401|FG001|Overall Study|Early Termination|1|||
106112309|NCT05044325|366068404|FG000|Part A:Treatment Period 1|Adverse Event|0|||
106112310|NCT05044325|366068405|FG001|Part A:Treatment Period 1|Adverse Event|0|||
106112311|NCT05044325|366068406|FG002|Part A:Treatment Period 1|Adverse Event|0|||
106112312|NCT05044325|366068407|FG003|Part A:Treatment Period 1|Adverse Event|0|||
106112313|NCT05044325|366068408|FG004|Part A:Treatment Period 1|Adverse Event|0|||
106112314|NCT05044325|366068409|FG005|Part A:Treatment Period 1|Adverse Event|1|||
106112315|NCT05044325|366068410|FG006|Part A:Treatment Period 1|Adverse Event|0|||
106112316|NCT05044325|366068411|FG007|Part A:Treatment Period 1|Adverse Event|1|||
106112317|NCT05044325|366068412|FG008|Part A:Treatment Period 1|Adverse Event|0|||
106112318|NCT05044325|366068413|FG009|Part A:Treatment Period 1|Adverse Event|0|||
106112319|NCT05044325|366068404|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
106112320|NCT05044325|366068405|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
106112321|NCT05044325|366068406|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
106112322|NCT05044325|366068407|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
106112323|NCT05044325|366068408|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
106112324|NCT05044325|366068409|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
106112325|NCT05044325|366068410|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
106112326|NCT05044325|366068411|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
106112327|NCT05044325|366068412|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
105883226|NCT02016105|365227707|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
106112328|NCT05044325|366068413|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
106112329|NCT05044325|366068404|FG000|Part A:Treatment Period 1|Physician Decision|0|||
106112330|NCT05044325|366068405|FG001|Part A:Treatment Period 1|Physician Decision|0|||
106112331|NCT05044325|366068406|FG002|Part A:Treatment Period 1|Physician Decision|0|||
106112332|NCT05044325|366068407|FG003|Part A:Treatment Period 1|Physician Decision|0|||
106112333|NCT05044325|366068408|FG004|Part A:Treatment Period 1|Physician Decision|0|||
106112334|NCT05044325|366068409|FG005|Part A:Treatment Period 1|Physician Decision|0|||
106112335|NCT05044325|366068410|FG006|Part A:Treatment Period 1|Physician Decision|1|||
105883227|NCT02016105|365227708|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
105883228|NCT02016105|365227709|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
105883229|NCT02016105|365227710|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
105883230|NCT02016105|365227705|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
105883231|NCT02016105|365227706|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
105883232|NCT02016105|365227707|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
105883233|NCT02016105|365227708|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
105883234|NCT02016105|365227709|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
105883235|NCT02016105|365227710|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
105883236|NCT02016105|365227705|FG000|TREATMENT PERIOD 2|Death|0|||
105883237|NCT02016105|365227706|FG001|TREATMENT PERIOD 2|Death|0|||
105883238|NCT02016105|365227707|FG002|TREATMENT PERIOD 2|Death|0|||
105883239|NCT02016105|365227708|FG003|TREATMENT PERIOD 2|Death|0|||
105883240|NCT02016105|365227709|FG004|TREATMENT PERIOD 2|Death|0|||
105883241|NCT02016105|365227710|FG005|TREATMENT PERIOD 2|Death|1|||
105883242|NCT02016105|365227705|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
105883243|NCT02016105|365227706|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
105883244|NCT02016105|365227707|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
106112336|NCT05044325|366068411|FG007|Part A:Treatment Period 1|Physician Decision|0|||
106112337|NCT05044325|366068412|FG008|Part A:Treatment Period 1|Physician Decision|0|||
106112338|NCT05044325|366068413|FG009|Part A:Treatment Period 1|Physician Decision|0|||
106112339|NCT05044325|366068404|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112340|NCT05044325|366068405|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112341|NCT05044325|366068406|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
106112342|NCT05044325|366068407|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112343|NCT05044325|366068408|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112344|NCT05044325|366068409|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112345|NCT05044325|366068410|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112346|NCT05044325|366068411|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112347|NCT05044325|366068412|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112348|NCT05044325|366068413|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
106112349|NCT05044325|366068404|FG000|Part A:Treatment Period 2|Adverse Event|0|||
106112350|NCT05044325|366068405|FG001|Part A:Treatment Period 2|Adverse Event|1|||
106112351|NCT05044325|366068406|FG002|Part A:Treatment Period 2|Adverse Event|0|||
106112352|NCT05044325|366068407|FG003|Part A:Treatment Period 2|Adverse Event|0|||
106112353|NCT05044325|366068408|FG004|Part A:Treatment Period 2|Adverse Event|1|||
106112354|NCT05044325|366068409|FG005|Part A:Treatment Period 2|Adverse Event|1|||
106112355|NCT05044325|366068410|FG006|Part A:Treatment Period 2|Adverse Event|0|||
106112356|NCT05044325|366068411|FG007|Part A:Treatment Period 2|Adverse Event|0|||
106112357|NCT05044325|366068412|FG008|Part A:Treatment Period 2|Adverse Event|0|||
106112358|NCT05044325|366068413|FG009|Part A:Treatment Period 2|Adverse Event|0|||
106112359|NCT05044325|366068404|FG000|Part A:Treatment Period 2|Physician Decision|0|||
106112360|NCT05044325|366068405|FG001|Part A:Treatment Period 2|Physician Decision|0|||
106112361|NCT05044325|366068406|FG002|Part A:Treatment Period 2|Physician Decision|0|||
106112362|NCT05044325|366068407|FG003|Part A:Treatment Period 2|Physician Decision|0|||
106112363|NCT05044325|366068408|FG004|Part A:Treatment Period 2|Physician Decision|0|||
106112364|NCT05044325|366068409|FG005|Part A:Treatment Period 2|Physician Decision|1|||
106112365|NCT05044325|366068410|FG006|Part A:Treatment Period 2|Physician Decision|0|||
106112366|NCT05044325|366068411|FG007|Part A:Treatment Period 2|Physician Decision|0|||
106112367|NCT05044325|366068412|FG008|Part A:Treatment Period 2|Physician Decision|0|||
106112368|NCT05044325|366068413|FG009|Part A:Treatment Period 2|Physician Decision|0|||
106112369|NCT05044325|366068404|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
106112370|NCT05044325|366068405|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
106112371|NCT05044325|366068406|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
106112372|NCT05044325|366068407|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
106112373|NCT05044325|366068408|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
106112374|NCT05044325|366068409|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
106112375|NCT05044325|366068410|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
106112376|NCT05044325|366068411|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
106112377|NCT05044325|366068412|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
106112378|NCT05044325|366068413|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
106112379|NCT02901626|366068414|FG000|Overall Study|Lost to Follow-up|1|||
106112380|NCT02901626|366068415|FG001|Overall Study|Lost to Follow-up|1|||
106112381|NCT00429663|366068416|FG000|Overall Study|Lost to Follow-up|24|||
106112382|NCT00429663|366068417|FG001|Overall Study|Lost to Follow-up|31|||
106112383|NCT00429663|366068416|FG000|Overall Study|Physician Decision|6|||
106112384|NCT00429663|366068417|FG001|Overall Study|Physician Decision|3|||
106112385|NCT00429663|366068416|FG000|Overall Study|Withdrawal by Subject|2|||
106112386|NCT00429663|366068417|FG001|Overall Study|Withdrawal by Subject|5|||
106112387|NCT00429663|366068416|FG000|Overall Study|Death|4|||
106112388|NCT00429663|366068417|FG001|Overall Study|Death|0|||
105883245|NCT02016105|365227708|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
105883246|NCT02016105|365227709|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
105883247|NCT02016105|365227710|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
106112389|NCT00508404|366068423|FG000|Overall Study|Ongoing at Data Cut-off|12|||
106112390|NCT00508404|366068423|FG000|Overall Study|Adverse Event|2|||
106112391|NCT00508404|366068423|FG000|Overall Study|Death|16|||
106112392|NCT00508404|366068423|FG000|Overall Study|Physician Decision|2|||
106112393|NCT00508404|366068423|FG000|Overall Study|Withdrawal by Subject|3|||
106112394|NCT00508404|366068423|FG000|Overall Study|Protocol-specified Criteria|2|||
106112395|NCT00508404|366068423|FG000|Overall Study|Lost to Follow-up|2|||
105883248|NCT02016105|365227705|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
105883249|NCT02016105|365227706|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
105883250|NCT02016105|365227707|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
105883251|NCT02016105|365227708|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
105883252|NCT02016105|365227709|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
105883253|NCT02016105|365227710|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
105883254|NCT02016105|365227705|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
105883255|NCT02016105|365227706|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
105883256|NCT02016105|365227707|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
105883257|NCT02016105|365227708|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
105883258|NCT02016105|365227709|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
105883259|NCT02016105|365227710|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
105883260|NCT02016105|365227705|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
105883261|NCT02016105|365227706|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
105883262|NCT02016105|365227707|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
105883263|NCT02016105|365227708|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
105883264|NCT02016105|365227709|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
105883265|NCT02016105|365227710|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
105883266|NCT02016105|365227705|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
105883267|NCT02016105|365227706|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
105883268|NCT02016105|365227707|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
105883269|NCT02016105|365227708|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
105883270|NCT02016105|365227709|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
105883271|NCT02016105|365227710|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
105883272|NCT02016105|365227705|FG000|EXTENSION PERIOD|Adverse Event|0|||
105883273|NCT02016105|365227706|FG001|EXTENSION PERIOD|Adverse Event|0|||
105883274|NCT02016105|365227707|FG002|EXTENSION PERIOD|Adverse Event|2|||
105883275|NCT02016105|365227708|FG003|EXTENSION PERIOD|Adverse Event|0|||
105883276|NCT02016105|365227709|FG004|EXTENSION PERIOD|Adverse Event|1|||
105883277|NCT02016105|365227710|FG005|EXTENSION PERIOD|Adverse Event|0|||
105883278|NCT02016105|365227705|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
105883279|NCT02016105|365227706|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
105883280|NCT02016105|365227707|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
105883281|NCT02016105|365227708|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
105883282|NCT02016105|365227709|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
105883283|NCT02016105|365227710|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
105883284|NCT02016105|365227705|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
105883285|NCT02016105|365227706|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
105883286|NCT02016105|365227707|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
105883287|NCT02016105|365227708|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
105883288|NCT02016105|365227709|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
105883289|NCT02016105|365227710|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
105883290|NCT02016105|365227705|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
105883291|NCT02016105|365227706|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
105883292|NCT02016105|365227707|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
105883293|NCT02016105|365227708|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
105883294|NCT02016105|365227709|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
105883295|NCT02016105|365227710|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
105883296|NCT01680861|365227711|FG000|Early Post-transplant Period|Protocol Violation|1|||
105883297|NCT01680861|365227712|FG001|Early Post-transplant Period|Protocol Violation|1|||
105883298|NCT02792192|365227716|FG000|Overall Study|Death|1|||
105883299|NCT02792192|365227717|FG001|Overall Study|Death|0|||
105883300|NCT02792192|365227718|FG002|Overall Study|Death|0|||
105883301|NCT02792192|365227719|FG003|Overall Study|Death|0|||
105883302|NCT02792192|365227716|FG000|Overall Study|Informed Consent Withdrawn|4|||
106112396|NCT00508404|366068423|FG000|Overall Study|Other - Not Specified|3|||
106112397|NCT01559454|366068424|FG000|Overall Study|Lost to Follow-up|3|||
106112398|NCT01559454|366068425|FG001|Overall Study|Lost to Follow-up|2|||
105883303|NCT02792192|365227717|FG001|Overall Study|Informed Consent Withdrawn|0|||
105883304|NCT02792192|365227718|FG002|Overall Study|Informed Consent Withdrawn|0|||
105883305|NCT02792192|365227719|FG003|Overall Study|Informed Consent Withdrawn|0|||
105883306|NCT02792192|365227716|FG000|Overall Study|Physician Decision|1|||
105883307|NCT02792192|365227717|FG001|Overall Study|Physician Decision|0|||
105883308|NCT02792192|365227718|FG002|Overall Study|Physician Decision|0|||
105883309|NCT02792192|365227719|FG003|Overall Study|Physician Decision|0|||
105883310|NCT02792192|365227716|FG000|Overall Study|Progressive Disease|0|||
105883311|NCT02792192|365227717|FG001|Overall Study|Progressive Disease|1|||
106112399|NCT01559454|366068424|FG000|Overall Study|Withdrawal by Subject|0|||
105883312|NCT02792192|365227718|FG002|Overall Study|Progressive Disease|0|||
106112400|NCT01559454|366068425|FG001|Overall Study|Withdrawal by Subject|1|||
106112401|NCT01559454|366068424|FG000|Overall Study|Physician Decision|0|||
106112402|NCT01559454|366068425|FG001|Overall Study|Physician Decision|1|||
106112403|NCT01559454|366068424|FG000|Overall Study|Protocol Violation|0|||
106112404|NCT01559454|366068425|FG001|Overall Study|Protocol Violation|1|||
106112405|NCT01559454|366068424|FG000|Overall Study|Lack of Efficacy|0|||
106112406|NCT01559454|366068425|FG001|Overall Study|Lack of Efficacy|1|||
106112407|NCT01119768|366068426|FG000|Treatment Period|Lack of Efficacy|18|||
106112408|NCT01119768|366068427|FG001|Treatment Period|Lack of Efficacy|25|||
106112409|NCT00106184|366068431|FG000|Overall Study|Withdrawal by Subject|3|||
106112410|NCT00106184|366068432|FG001|Overall Study|Withdrawal by Subject|2|||
106112411|NCT00643123|366068434|FG000|Overall Study|Lost to Follow-up|4|||
106112412|NCT00643123|366068435|FG001|Overall Study|Lost to Follow-up|0|||
106112413|NCT00643123|366068434|FG000|Overall Study|Withdrawal by Subject|1|||
106112414|NCT00643123|366068435|FG001|Overall Study|Withdrawal by Subject|1|||
106112415|NCT00441701|366068445|FG000|Overall Study|Adverse Event|3|||
106112416|NCT00441701|366068446|FG001|Overall Study|Adverse Event|2|||
106112417|NCT00441701|366068447|FG002|Overall Study|Adverse Event|1|||
106112418|NCT00441701|366068448|FG003|Overall Study|Adverse Event|0|||
106112419|NCT00441701|366068449|FG004|Overall Study|Adverse Event|2|||
106112420|NCT00441701|366068450|FG005|Overall Study|Adverse Event|2|||
106112421|NCT00441701|366068451|FG006|Overall Study|Adverse Event|0|||
106112422|NCT00441701|366068452|FG007|Overall Study|Adverse Event|0|||
106112423|NCT00441701|366068453|FG008|Overall Study|Adverse Event|0|||
106112424|NCT00441701|366068454|FG009|Overall Study|Adverse Event|0|||
106112425|NCT00441701|366068445|FG000|Overall Study|Lack of Efficacy|2|||
106112426|NCT00441701|366068446|FG001|Overall Study|Lack of Efficacy|0|||
106112427|NCT00441701|366068447|FG002|Overall Study|Lack of Efficacy|2|||
106112428|NCT00441701|366068448|FG003|Overall Study|Lack of Efficacy|2|||
106112429|NCT00441701|366068449|FG004|Overall Study|Lack of Efficacy|0|||
106112430|NCT00441701|366068450|FG005|Overall Study|Lack of Efficacy|1|||
106112431|NCT00441701|366068451|FG006|Overall Study|Lack of Efficacy|0|||
106112432|NCT00441701|366068452|FG007|Overall Study|Lack of Efficacy|0|||
106112433|NCT00441701|366068453|FG008|Overall Study|Lack of Efficacy|0|||
106112434|NCT00441701|366068454|FG009|Overall Study|Lack of Efficacy|0|||
106112435|NCT00441701|366068445|FG000|Overall Study|Withdrawal by Subject|0|||
106112436|NCT00441701|366068446|FG001|Overall Study|Withdrawal by Subject|2|||
106112437|NCT00441701|366068447|FG002|Overall Study|Withdrawal by Subject|1|||
106112438|NCT00441701|366068448|FG003|Overall Study|Withdrawal by Subject|1|||
106112439|NCT00441701|366068449|FG004|Overall Study|Withdrawal by Subject|0|||
106112440|NCT00441701|366068450|FG005|Overall Study|Withdrawal by Subject|0|||
106112441|NCT00441701|366068451|FG006|Overall Study|Withdrawal by Subject|0|||
106112442|NCT00441701|366068452|FG007|Overall Study|Withdrawal by Subject|0|||
106112443|NCT00441701|366068453|FG008|Overall Study|Withdrawal by Subject|0|||
106112444|NCT00441701|366068454|FG009|Overall Study|Withdrawal by Subject|0|||
106112445|NCT00077064|366068455|FG000|Overall Study|Adverse Event|0|||
106112446|NCT00077064|366068456|FG001|Overall Study|Adverse Event|4|||
106112447|NCT00077064|366068455|FG000|Overall Study|Patient refusal|0|||
106112448|NCT00077064|366068456|FG001|Overall Study|Patient refusal|2|||
106112449|NCT02007434|366068460|FG000|Overall Study|Lost to Follow-up|0|||
106112450|NCT02007434|366068461|FG001|Overall Study|Lost to Follow-up|1|||
106112451|NCT02007434|366068462|FG002|Overall Study|Lost to Follow-up|0|||
106112452|NCT02007434|366068463|FG003|Overall Study|Lost to Follow-up|0|||
106112453|NCT02007434|366068464|FG004|Overall Study|Lost to Follow-up|0|||
106112454|NCT02007434|366068465|FG005|Overall Study|Lost to Follow-up|0|||
106112455|NCT02007434|366068466|FG006|Overall Study|Lost to Follow-up|0|||
106112456|NCT02007434|366068467|FG007|Overall Study|Lost to Follow-up|0|||
106112457|NCT02007434|366068460|FG000|Overall Study|Non-compliance|1|||
105883313|NCT02792192|365227719|FG003|Overall Study|Progressive Disease|0|||
105883314|NCT02792192|365227716|FG000|Overall Study|Study Terminated By Sponsor|6|||
105883315|NCT02792192|365227717|FG001|Overall Study|Study Terminated By Sponsor|10|||
105883316|NCT02792192|365227718|FG002|Overall Study|Study Terminated By Sponsor|0|||
105883317|NCT02792192|365227719|FG003|Overall Study|Study Terminated By Sponsor|0|||
105883318|NCT01339923|365227720|FG000|Overall Study|Adverse Event|1|||
106112458|NCT02007434|366068461|FG001|Overall Study|Non-compliance|0|||
106112459|NCT02007434|366068462|FG002|Overall Study|Non-compliance|1|||
106112460|NCT02007434|366068463|FG003|Overall Study|Non-compliance|0|||
106112461|NCT02007434|366068464|FG004|Overall Study|Non-compliance|0|||
106112462|NCT02007434|366068465|FG005|Overall Study|Non-compliance|0|||
106112463|NCT02007434|366068466|FG006|Overall Study|Non-compliance|0|||
105883319|NCT01339923|365227721|FG001|Overall Study|Adverse Event|1|||
105883320|NCT01339923|365227722|FG002|Overall Study|Adverse Event|1|||
106112464|NCT02007434|366068467|FG007|Overall Study|Non-compliance|0|||
106112465|NCT00509236|366068470|FG000|Overall Study|Adverse Event|7|||
106112466|NCT00509236|366068471|FG001|Overall Study|Adverse Event|9|||
106112467|NCT00509236|366068470|FG000|Overall Study|Withdrawal by Subject|5|||
106112468|NCT00509236|366068471|FG001|Overall Study|Withdrawal by Subject|10|||
106112469|NCT00509236|366068470|FG000|Overall Study|Protocol Violation|3|||
106112470|NCT00509236|366068471|FG001|Overall Study|Protocol Violation|0|||
106112471|NCT00509236|366068470|FG000|Overall Study|Excluded Medication|1|||
105883321|NCT01339923|365227723|FG003|Overall Study|Adverse Event|0|||
105883322|NCT01339923|365227724|FG004|Overall Study|Adverse Event|0|||
105883323|NCT01339923|365227725|FG005|Overall Study|Adverse Event|0|||
105883324|NCT01339923|365227726|FG006|Overall Study|Adverse Event|1|||
105883325|NCT01339923|365227720|FG000|Overall Study|Inappropriate Enrollment|1|||
105883326|NCT01339923|365227721|FG001|Overall Study|Inappropriate Enrollment|0|||
105883327|NCT01339923|365227722|FG002|Overall Study|Inappropriate Enrollment|0|||
105883328|NCT01339923|365227723|FG003|Overall Study|Inappropriate Enrollment|0|||
105883329|NCT01339923|365227724|FG004|Overall Study|Inappropriate Enrollment|0|||
105883330|NCT01339923|365227725|FG005|Overall Study|Inappropriate Enrollment|1|||
105883331|NCT01339923|365227726|FG006|Overall Study|Inappropriate Enrollment|0|||
105883332|NCT01339923|365227720|FG000|Overall Study|Lost to Follow-up|4|||
105883333|NCT01339923|365227721|FG001|Overall Study|Lost to Follow-up|4|||
105883334|NCT01339923|365227722|FG002|Overall Study|Lost to Follow-up|0|||
105883335|NCT01339923|365227723|FG003|Overall Study|Lost to Follow-up|3|||
105883336|NCT01339923|365227724|FG004|Overall Study|Lost to Follow-up|1|||
105883337|NCT01339923|365227725|FG005|Overall Study|Lost to Follow-up|1|||
105883338|NCT01339923|365227726|FG006|Overall Study|Lost to Follow-up|5|||
105883339|NCT01339923|365227720|FG000|Overall Study|Protocol Violation|0|||
105883340|NCT01339923|365227721|FG001|Overall Study|Protocol Violation|0|||
105883341|NCT01339923|365227722|FG002|Overall Study|Protocol Violation|0|||
105883342|NCT01339923|365227723|FG003|Overall Study|Protocol Violation|0|||
105883343|NCT01339923|365227724|FG004|Overall Study|Protocol Violation|0|||
105883344|NCT01339923|365227725|FG005|Overall Study|Protocol Violation|3|||
105883345|NCT01339923|365227726|FG006|Overall Study|Protocol Violation|1|||
105883346|NCT01339923|365227720|FG000|Overall Study|Unable to Classify|1|||
105883347|NCT01339923|365227721|FG001|Overall Study|Unable to Classify|0|||
105883348|NCT01339923|365227722|FG002|Overall Study|Unable to Classify|1|||
105883349|NCT01339923|365227723|FG003|Overall Study|Unable to Classify|0|||
105883350|NCT01339923|365227724|FG004|Overall Study|Unable to Classify|0|||
105883351|NCT01339923|365227725|FG005|Overall Study|Unable to Classify|1|||
105883352|NCT01339923|365227726|FG006|Overall Study|Unable to Classify|5|||
105883353|NCT01339923|365227720|FG000|Overall Study|Withdrawal by Subject|7|||
105883354|NCT01339923|365227721|FG001|Overall Study|Withdrawal by Subject|11|||
105883355|NCT01339923|365227722|FG002|Overall Study|Withdrawal by Subject|6|||
105883356|NCT01339923|365227723|FG003|Overall Study|Withdrawal by Subject|1|||
105883357|NCT01339923|365227724|FG004|Overall Study|Withdrawal by Subject|4|||
105883358|NCT01339923|365227725|FG005|Overall Study|Withdrawal by Subject|3|||
105883359|NCT01339923|365227726|FG006|Overall Study|Withdrawal by Subject|2|||
105883360|NCT03124407|365227727|FG000|Overall Study|Lost to Follow-up|1|||
105883361|NCT03124407|365227728|FG001|Overall Study|Lost to Follow-up|0|||
105883362|NCT03124407|365227729|FG002|Overall Study|Lost to Follow-up|0|||
105883363|NCT03124407|365227730|FG003|Overall Study|Lost to Follow-up|0|||
105883364|NCT03124407|365227727|FG000|Overall Study|Adverse Event|0|||
105883365|NCT03124407|365227728|FG001|Overall Study|Adverse Event|0|||
105883366|NCT03124407|365227729|FG002|Overall Study|Adverse Event|1|||
105883367|NCT03124407|365227730|FG003|Overall Study|Adverse Event|0|||
105883368|NCT00364923|365227731|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
105883369|NCT00364923|365227731|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
105883370|NCT00766636|365227736|FG000|Overall Study|Withdrawal by Subject|1|||
105883371|NCT00766636|365227737|FG001|Overall Study|Withdrawal by Subject|1|||
105883372|NCT00766636|365227736|FG000|Overall Study|Incomplete Treatment|0|||
105883373|NCT00766636|365227737|FG001|Overall Study|Incomplete Treatment|1|||
105883374|NCT00766636|365227736|FG000|Overall Study|Adverse Event|1|||
105883375|NCT00766636|365227737|FG001|Overall Study|Adverse Event|0|||
105883376|NCT00766636|365227736|FG000|Overall Study|Disease Progression|1|||
105883377|NCT00766636|365227737|FG001|Overall Study|Disease Progression|0|||
105883378|NCT02887248|365227741|FG000|Overall Study|Withdrawal by Subject|1|||
105883379|NCT02887248|365227741|FG000|Overall Study|Adverse Event|1|||
105883380|NCT02887248|365227741|FG000|Overall Study|Progressive Disease|1|||
105883381|NCT00900159|365227742|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
105883382|NCT00900159|365227743|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
105883383|NCT01166438|365227744|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
105883384|NCT01166438|365227745|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
105883385|NCT01166438|365227744|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
105883386|NCT01166438|365227745|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
105883387|NCT01166438|365227744|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
105883388|NCT01166438|365227745|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
105883389|NCT01166438|365227744|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
105883390|NCT01166438|365227745|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
105883391|NCT01166438|365227744|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
105883392|NCT01166438|365227745|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
105883393|NCT01166438|365227744|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
105883394|NCT01166438|365227745|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
105883395|NCT00765336|365227749|FG000|Overall Study|Protocol Violation|4|||
105883396|NCT00765336|365227750|FG001|Overall Study|Protocol Violation|2|||
106112472|NCT00509236|366068471|FG001|Overall Study|Excluded Medication|1|||
106112473|NCT00509236|366068470|FG000|Overall Study|Scheduled Kidney Transplant|1|||
106112474|NCT00509236|366068471|FG001|Overall Study|Scheduled Kidney Transplant|0|||
106112475|NCT03299686|366068472|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
105883397|NCT00765336|365227749|FG000|Overall Study|Withdrawal by Subject|6|||
105883398|NCT00765336|365227750|FG001|Overall Study|Withdrawal by Subject|4|||
105883399|NCT00765336|365227749|FG000|Overall Study|Lost to Follow-up|7|||
105883400|NCT00765336|365227750|FG001|Overall Study|Lost to Follow-up|9|||
105883401|NCT00765336|365227749|FG000|Overall Study|Adverse Event|2|||
105883402|NCT00765336|365227750|FG001|Overall Study|Adverse Event|1|||
105883403|NCT01435460|365227755|FG000|Overall Study|Adverse Event|2|||
105883404|NCT01435460|365227756|FG001|Overall Study|Adverse Event|1|||
105883405|NCT01435460|365227755|FG000|Overall Study|Lost to Follow-up|6|||
105883406|NCT01435460|365227756|FG001|Overall Study|Lost to Follow-up|1|||
105883407|NCT01435460|365227755|FG000|Overall Study|Withdrawal by Subject|1|||
105883408|NCT01435460|365227756|FG001|Overall Study|Withdrawal by Subject|3|||
105883409|NCT01435460|365227755|FG000|Overall Study|Protocol Violation|0|||
105883410|NCT01435460|365227756|FG001|Overall Study|Protocol Violation|1|||
105883411|NCT01435460|365227755|FG000|Overall Study|Did not meet eligibility criteria|2|||
105883412|NCT01435460|365227756|FG001|Overall Study|Did not meet eligibility criteria|0|||
105883413|NCT00347009|365227757|FG000|Overall Study|Death|1|||
105883414|NCT00347009|365227757|FG000|Overall Study|Adverse Event|6|||
105883415|NCT00347009|365227757|FG000|Overall Study|Withdrawal by Subject|3|||
105883416|NCT00347009|365227757|FG000|Overall Study|Physician Decision|5|||
105883417|NCT00347009|365227757|FG000|Overall Study|Lost to Follow-up|4|||
105883418|NCT00347009|365227757|FG000|Overall Study|Protocol Violation|2|||
105883419|NCT00347009|365227757|FG000|Overall Study|Adverse Laboratory Experience|1|||
105883420|NCT00347009|365227757|FG000|Overall Study|Insufficient Viral Suppression|3|||
105883421|NCT00347009|365227757|FG000|Overall Study|Increased ALT/HBV DNA|1|||
105883422|NCT00347009|365227757|FG000|Overall Study|Serious Adverse Event|1|||
105883423|NCT00552396|365227759|FG000|Overall Study|protocol withdrawal criteria|3|||
105883424|NCT00552396|365227760|FG001|Overall Study|protocol withdrawal criteria|3|||
105883425|NCT00552396|365227761|FG002|Overall Study|protocol withdrawal criteria|3|||
105883426|NCT00552396|365227762|FG003|Overall Study|protocol withdrawal criteria|6|||
105883427|NCT00552396|365227763|FG004|Overall Study|protocol withdrawal criteria|3|||
105883428|NCT00552396|365227764|FG005|Overall Study|protocol withdrawal criteria|3|||
105883429|NCT00552396|365227765|FG006|Overall Study|protocol withdrawal criteria|9|||
105883430|NCT04537234|365227766|FG000|Overall Study|Withdrawal by Subject|2|||
105883431|NCT04537234|365227767|FG001|Overall Study|Withdrawal by Subject|0|||
105883432|NCT01323387|365227768|FG000|Overall Study|Withdrawal by Subject|41|||
105883433|NCT01323387|365227768|FG000|Overall Study|Radiographic Data Unavailable|1|||
105883434|NCT01323387|365227768|FG000|Overall Study|Revision|14|||
105883435|NCT01323387|365227768|FG000|Overall Study|Protocol Violation|12|||
105883436|NCT01323387|365227768|FG000|Overall Study|Randomized but Never Treated|16|||
105883437|NCT01972438|365227769|FG000|Baseline-Month 3 Crossover Period|Death|1|||
105883438|NCT01972438|365227770|FG001|Baseline-Month 3 Crossover Period|Death|0|||
105883439|NCT01972438|365227769|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
105883440|NCT01972438|365227770|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
105883441|NCT01972438|365227769|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
105883442|NCT01972438|365227770|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
105883443|NCT01972438|365227769|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
105883444|NCT01972438|365227770|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
105883445|NCT01972438|365227769|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
105883446|NCT01972438|365227770|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
105883447|NCT01972438|365227769|FG000|Months 6-12 Study Period|Death|1|||
105883448|NCT01972438|365227770|FG001|Months 6-12 Study Period|Death|0|||
105883449|NCT01972438|365227769|FG000|Months 6-12 Study Period|Early Study Closure|2|||
105883450|NCT01972438|365227770|FG001|Months 6-12 Study Period|Early Study Closure|2|||
105883451|NCT01972438|365227769|FG000|Post Month 12 Study Period|Early Study Closure|3|||
105883452|NCT01972438|365227770|FG001|Post Month 12 Study Period|Early Study Closure|4|||
105883453|NCT03478644|365227773|FG000|Phase 2|Withdrawal by Subject|2|||
105883454|NCT03478644|365227774|FG001|Phase 2|Withdrawal by Subject|1|||
106112476|NCT03299686|366068473|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
105883455|NCT03478644|365227773|FG000|Phase 2|Lost to Follow-up|1|||
105883456|NCT03478644|365227774|FG001|Phase 2|Lost to Follow-up|0|||
105883457|NCT02073929|365227779|FG000|Overall Study|Lost to Follow-up|2|||
105883458|NCT02073929|365227780|FG001|Overall Study|Lost to Follow-up|1|||
105883459|NCT02073929|365227779|FG000|Overall Study|Adverse Event|2|||
105883460|NCT02073929|365227780|FG001|Overall Study|Adverse Event|1|||
105883461|NCT02073929|365227779|FG000|Overall Study|Withdrawal by Subject|0|||
105883462|NCT02073929|365227780|FG001|Overall Study|Withdrawal by Subject|1|||
105883463|NCT03887442|365227781|FG000|Overall Study|Adverse Event|1|||
105883464|NCT03887442|365227782|FG001|Overall Study|Adverse Event|0|||
105883465|NCT03319732|365227783|FG000|Overall Study|Adverse Event|40|||
105883466|NCT03319732|365227783|FG000|Overall Study|Withdrawal by Subject|50|||
105883467|NCT03319732|365227783|FG000|Overall Study|MS relapse|10|||
105883468|NCT03319732|365227783|FG000|Overall Study|reason not specified|5|||
105883469|NCT00767455|365227784|FG000|Overall Study|Investigator error|19|||
105883470|NCT01295827|365227785|FG000|Overall Study|Adverse Event|1|||
105883471|NCT01295827|365227786|FG001|Overall Study|Adverse Event|2|||
105883472|NCT01295827|365227787|FG002|Overall Study|Adverse Event|2|||
105883473|NCT01295827|365227788|FG003|Overall Study|Adverse Event|1|||
105883474|NCT01295827|365227789|FG004|Overall Study|Adverse Event|1|||
105883475|NCT01295827|365227790|FG005|Overall Study|Adverse Event|4|||
105883476|NCT01295827|365227791|FG006|Overall Study|Adverse Event|15|||
105883477|NCT01295827|365227792|FG007|Overall Study|Adverse Event|49|||
105883478|NCT01295827|365227793|FG008|Overall Study|Adverse Event|22|||
105883479|NCT01295827|365227794|FG009|Overall Study|Adverse Event|7|||
105883480|NCT01295827|365227795|FG010|Overall Study|Adverse Event|50|||
105883481|NCT01295827|365227796|FG011|Overall Study|Adverse Event|21|||
105883482|NCT01295827|365227797|FG012|Overall Study|Adverse Event|0|||
105883483|NCT01295827|365227798|FG013|Overall Study|Adverse Event|0|||
106112477|NCT03299686|366068472|FG000|Treatment Epoch|Physician Decision|1|||
106112478|NCT03299686|366068473|FG001|Treatment Epoch|Physician Decision|0|||
106112479|NCT03299686|366068472|FG000|Treatment Epoch|Adverse Event|8|||
106112480|NCT03299686|366068473|FG001|Treatment Epoch|Adverse Event|4|||
106112481|NCT03299686|366068472|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
106112482|NCT03299686|366068473|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
106112483|NCT02535364|366068478|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
106112484|NCT02535364|366068478|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
105883484|NCT01295827|365227799|FG014|Overall Study|Adverse Event|0|||
105883485|NCT01295827|365227785|FG000|Overall Study|Lost to Follow-up|0|||
105883486|NCT01295827|365227786|FG001|Overall Study|Lost to Follow-up|0|||
105883487|NCT01295827|365227787|FG002|Overall Study|Lost to Follow-up|3|||
106112485|NCT02535364|366068478|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
106112486|NCT02535364|366068478|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
106112487|NCT02535364|366068478|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
106112488|NCT02535364|366068478|FG000|Part B Screening|Death|2|||
106112489|NCT02535364|366068478|FG000|Part B Screening|Physician Decision|1|||
106112490|NCT02535364|366068478|FG000|Part B Screening|Withdrawal by Subject|1|||
106112491|NCT02535364|366068478|FG000|Part B Screening|Adverse Event|1|||
106112492|NCT02535364|366068478|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
106112493|NCT02535364|366068478|FG000|Study Treatment|Death|1|||
106112494|NCT02535364|366068478|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
106112495|NCT02535364|366068478|FG000|12-Month Follow-up Period|Disease progression|22|||
106112496|NCT02535364|366068478|FG000|12-Month Follow-up Period|Death|5|||
106112497|NCT02535364|366068478|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
106112498|NCT02535364|366068478|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
106112499|NCT02535364|366068478|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
106112500|NCT00571701|366068479|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
106112501|NCT00571701|366068480|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
106112502|NCT00571701|366068479|FG000|First Intervention 12 Months|Death|1|||
106112503|NCT00571701|366068480|FG001|First Intervention 12 Months|Death|0|||
106112504|NCT00571701|366068479|FG000|Second Intervention 12 Months|Adverse Event|0|||
106112505|NCT00571701|366068480|FG001|Second Intervention 12 Months|Adverse Event|1|||
106112506|NCT00571701|366068479|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
106112507|NCT00571701|366068480|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
106112508|NCT02634788|366068481|FG000|Overall Study|Adverse Event|0|||
106112509|NCT02634788|366068482|FG001|Overall Study|Adverse Event|8|||
106112510|NCT02634788|366068483|FG002|Overall Study|Adverse Event|3|||
106112511|NCT02634788|366068484|FG003|Overall Study|Adverse Event|1|||
106112512|NCT02634788|366068481|FG000|Overall Study|Lack of Efficacy|4|||
106112513|NCT02634788|366068482|FG001|Overall Study|Lack of Efficacy|0|||
106112514|NCT02634788|366068483|FG002|Overall Study|Lack of Efficacy|1|||
106112515|NCT02634788|366068484|FG003|Overall Study|Lack of Efficacy|4|||
106112516|NCT02634788|366068481|FG000|Overall Study|Lost to Follow-up|0|||
106112517|NCT02634788|366068482|FG001|Overall Study|Lost to Follow-up|1|||
106112518|NCT02634788|366068483|FG002|Overall Study|Lost to Follow-up|0|||
106112519|NCT02634788|366068484|FG003|Overall Study|Lost to Follow-up|0|||
105883488|NCT01295827|365227788|FG003|Overall Study|Lost to Follow-up|0|||
106112520|NCT02634788|366068481|FG000|Overall Study|Withdrawal by Subject|0|||
105883489|NCT01295827|365227789|FG004|Overall Study|Lost to Follow-up|1|||
105883490|NCT01295827|365227790|FG005|Overall Study|Lost to Follow-up|0|||
105883491|NCT01295827|365227791|FG006|Overall Study|Lost to Follow-up|4|||
105883492|NCT01295827|365227792|FG007|Overall Study|Lost to Follow-up|8|||
105883493|NCT01295827|365227793|FG008|Overall Study|Lost to Follow-up|7|||
105883494|NCT01295827|365227794|FG009|Overall Study|Lost to Follow-up|4|||
105883495|NCT01295827|365227795|FG010|Overall Study|Lost to Follow-up|7|||
105883496|NCT01295827|365227796|FG011|Overall Study|Lost to Follow-up|3|||
106112521|NCT02634788|366068482|FG001|Overall Study|Withdrawal by Subject|1|||
105883497|NCT01295827|365227797|FG012|Overall Study|Lost to Follow-up|0|||
105883498|NCT01295827|365227798|FG013|Overall Study|Lost to Follow-up|0|||
105883499|NCT01295827|365227799|FG014|Overall Study|Lost to Follow-up|0|||
105883500|NCT01295827|365227785|FG000|Overall Study|Not Reported|0|||
105883501|NCT01295827|365227786|FG001|Overall Study|Not Reported|0|||
105883502|NCT01295827|365227787|FG002|Overall Study|Not Reported|0|||
105883503|NCT01295827|365227788|FG003|Overall Study|Not Reported|1|||
105883504|NCT01295827|365227789|FG004|Overall Study|Not Reported|0|||
105883505|NCT01295827|365227790|FG005|Overall Study|Not Reported|0|||
105883506|NCT01295827|365227791|FG006|Overall Study|Not Reported|24|||
105883507|NCT01295827|365227792|FG007|Overall Study|Not Reported|58|||
105883508|NCT01295827|365227793|FG008|Overall Study|Not Reported|41|||
105883509|NCT01295827|365227794|FG009|Overall Study|Not Reported|2|||
105883510|NCT01295827|365227795|FG010|Overall Study|Not Reported|23|||
105883511|NCT01295827|365227796|FG011|Overall Study|Not Reported|13|||
105883512|NCT01295827|365227797|FG012|Overall Study|Not Reported|0|||
105883513|NCT01295827|365227798|FG013|Overall Study|Not Reported|0|||
105883514|NCT01295827|365227799|FG014|Overall Study|Not Reported|0|||
105883515|NCT01295827|365227785|FG000|Overall Study|Progressive Disease|2|||
105883516|NCT01295827|365227786|FG001|Overall Study|Progressive Disease|1|||
105883517|NCT01295827|365227787|FG002|Overall Study|Progressive Disease|5|||
105883518|NCT01295827|365227788|FG003|Overall Study|Progressive Disease|2|||
105883519|NCT01295827|365227789|FG004|Overall Study|Progressive Disease|0|||
105883520|NCT01295827|365227790|FG005|Overall Study|Progressive Disease|1|||
105883521|NCT01295827|365227791|FG006|Overall Study|Progressive Disease|87|||
105883522|NCT01295827|365227792|FG007|Overall Study|Progressive Disease|144|||
105883523|NCT01295827|365227793|FG008|Overall Study|Progressive Disease|85|||
105883524|NCT01295827|365227794|FG009|Overall Study|Progressive Disease|40|||
105883525|NCT01295827|365227795|FG010|Overall Study|Progressive Disease|175|||
105883526|NCT01295827|365227796|FG011|Overall Study|Progressive Disease|136|||
105883527|NCT01295827|365227797|FG012|Overall Study|Progressive Disease|0|||
105883528|NCT01295827|365227798|FG013|Overall Study|Progressive Disease|0|||
105883529|NCT01295827|365227799|FG014|Overall Study|Progressive Disease|0|||
105883530|NCT01295827|365227785|FG000|Overall Study|Screen Failure|0|||
105883531|NCT01295827|365227786|FG001|Overall Study|Screen Failure|0|||
105883532|NCT01295827|365227787|FG002|Overall Study|Screen Failure|0|||
105883533|NCT01295827|365227788|FG003|Overall Study|Screen Failure|0|||
105883534|NCT01295827|365227789|FG004|Overall Study|Screen Failure|0|||
105883535|NCT01295827|365227790|FG005|Overall Study|Screen Failure|0|||
105883536|NCT01295827|365227791|FG006|Overall Study|Screen Failure|2|||
105883537|NCT01295827|365227792|FG007|Overall Study|Screen Failure|2|||
105883538|NCT01295827|365227793|FG008|Overall Study|Screen Failure|2|||
105883539|NCT01295827|365227794|FG009|Overall Study|Screen Failure|0|||
105883540|NCT01295827|365227795|FG010|Overall Study|Screen Failure|1|||
105883541|NCT01295827|365227796|FG011|Overall Study|Screen Failure|0|||
105883542|NCT01295827|365227797|FG012|Overall Study|Screen Failure|0|||
105883543|NCT01295827|365227798|FG013|Overall Study|Screen Failure|0|||
105883544|NCT01295827|365227799|FG014|Overall Study|Screen Failure|0|||
105883545|NCT01295827|365227785|FG000|Overall Study|Withdrawal by Subject|1|||
105883546|NCT01295827|365227786|FG001|Overall Study|Withdrawal by Subject|0|||
105883547|NCT01295827|365227787|FG002|Overall Study|Withdrawal by Subject|2|||
105883548|NCT01295827|365227788|FG003|Overall Study|Withdrawal by Subject|0|||
105883549|NCT01295827|365227789|FG004|Overall Study|Withdrawal by Subject|0|||
105883550|NCT01295827|365227790|FG005|Overall Study|Withdrawal by Subject|1|||
105883551|NCT01295827|365227791|FG006|Overall Study|Withdrawal by Subject|13|||
105883552|NCT01295827|365227792|FG007|Overall Study|Withdrawal by Subject|35|||
105883553|NCT01295827|365227793|FG008|Overall Study|Withdrawal by Subject|11|||
105883554|NCT01295827|365227794|FG009|Overall Study|Withdrawal by Subject|2|||
105883555|NCT01295827|365227795|FG010|Overall Study|Withdrawal by Subject|18|||
105883556|NCT01295827|365227796|FG011|Overall Study|Withdrawal by Subject|13|||
105883557|NCT01295827|365227797|FG012|Overall Study|Withdrawal by Subject|0|||
105883558|NCT01295827|365227798|FG013|Overall Study|Withdrawal by Subject|0|||
105883559|NCT01295827|365227799|FG014|Overall Study|Withdrawal by Subject|0|||
105883560|NCT01295827|365227785|FG000|Overall Study|Other|0|||
106112522|NCT02634788|366068483|FG002|Overall Study|Withdrawal by Subject|1|||
105883561|NCT01295827|365227786|FG001|Overall Study|Other|0|||
105883562|NCT01295827|365227787|FG002|Overall Study|Other|0|||
105883563|NCT01295827|365227788|FG003|Overall Study|Other|0|||
105883564|NCT01295827|365227789|FG004|Overall Study|Other|0|||
105883565|NCT01295827|365227790|FG005|Overall Study|Other|0|||
105883566|NCT01295827|365227791|FG006|Overall Study|Other|1|||
105883567|NCT01295827|365227792|FG007|Overall Study|Other|1|||
105883568|NCT01295827|365227793|FG008|Overall Study|Other|1|||
105883569|NCT01295827|365227794|FG009|Overall Study|Other|0|||
105883570|NCT01295827|365227795|FG010|Overall Study|Other|2|||
105883571|NCT01295827|365227796|FG011|Overall Study|Other|0|||
105883572|NCT01295827|365227797|FG012|Overall Study|Other|0|||
105883573|NCT01295827|365227798|FG013|Overall Study|Other|0|||
105993720|NCT01510158|365636077|FG002|Overall Study|Withdrawal by Subject|10|||
105883574|NCT01295827|365227799|FG014|Overall Study|Other|0|||
105883575|NCT00072280|365227800|FG000|Treatment|Found ineligible|1|||
105883576|NCT00072280|365227801|FG001|Treatment|Found ineligible|2|||
106112523|NCT02634788|366068484|FG003|Overall Study|Withdrawal by Subject|0|||
106112524|NCT00855595|366068485|FG000|Overall Study|Withdrawal by Subject|1|||
106112525|NCT00855595|366068486|FG001|Overall Study|Withdrawal by Subject|2|||
106112526|NCT00855595|366068485|FG000|Overall Study|Lost to Follow-up|3|||
106112527|NCT00855595|366068486|FG001|Overall Study|Lost to Follow-up|3|||
106112528|NCT00855595|366068485|FG000|Overall Study|Adverse Event|1|||
106112529|NCT00855595|366068486|FG001|Overall Study|Adverse Event|1|||
106112530|NCT00855595|366068485|FG000|Overall Study|patient moved out of state|1|||
106112531|NCT00855595|366068486|FG001|Overall Study|patient moved out of state|0|||
106112532|NCT00855595|366068485|FG000|Overall Study|patient left country|0|||
106112533|NCT00855595|366068486|FG001|Overall Study|patient left country|1|||
106112534|NCT01060553|366068487|FG000|Overall Study|Lost to Follow-up|3|||
106112535|NCT01060553|366068488|FG001|Overall Study|Lost to Follow-up|5|||
106112536|NCT01060553|366068487|FG000|Overall Study|Withdrawal by Subject|5|||
106112537|NCT01060553|366068488|FG001|Overall Study|Withdrawal by Subject|5|||
106112538|NCT01060553|366068487|FG000|Overall Study|Lack of Efficacy|1|||
106112539|NCT01060553|366068488|FG001|Overall Study|Lack of Efficacy|0|||
106112540|NCT04035200|366068489|FG000|Overall Study|Lost to Follow-up|0|||
106112541|NCT04035200|366068490|FG001|Overall Study|Lost to Follow-up|1|||
106112542|NCT04035200|366068491|FG002|Overall Study|Lost to Follow-up|0|||
106112543|NCT04035200|366068489|FG000|Overall Study|Withdrawal by Subject|1|||
106112544|NCT04035200|366068490|FG001|Overall Study|Withdrawal by Subject|4|||
106112545|NCT04035200|366068491|FG002|Overall Study|Withdrawal by Subject|4|||
106112546|NCT04035200|366068489|FG000|Overall Study|COVID-19|1|||
106112547|NCT04035200|366068490|FG001|Overall Study|COVID-19|0|||
106112548|NCT04035200|366068491|FG002|Overall Study|COVID-19|0|||
106112549|NCT04035200|366068489|FG000|Overall Study|Early Termination|0|||
106112550|NCT04035200|366068490|FG001|Overall Study|Early Termination|1|||
106112551|NCT04035200|366068491|FG002|Overall Study|Early Termination|0|||
106112552|NCT04035200|366068489|FG000|Overall Study|Non-compliance|0|||
106112553|NCT04035200|366068490|FG001|Overall Study|Non-compliance|1|||
106112554|NCT04035200|366068491|FG002|Overall Study|Non-compliance|0|||
106112555|NCT03138733|366068493|FG000|Overall Study|Death|17|||
106112556|NCT03138733|366068494|FG001|Overall Study|Death|18|||
106112557|NCT03138733|366068493|FG000|Overall Study|Withdrawal by Subject|11|||
106112558|NCT03138733|366068494|FG001|Overall Study|Withdrawal by Subject|6|||
106112559|NCT03138733|366068493|FG000|Overall Study|Lost to Follow-up|3|||
106112560|NCT03138733|366068494|FG001|Overall Study|Lost to Follow-up|2|||
106112561|NCT03138733|366068493|FG000|Overall Study|Adverse Event|1|||
106112562|NCT03138733|366068494|FG001|Overall Study|Adverse Event|0|||
106112563|NCT03138733|366068493|FG000|Overall Study|Protocol Violation|1|||
106112564|NCT03138733|366068494|FG001|Overall Study|Protocol Violation|3|||
106112565|NCT03138733|366068493|FG000|Overall Study|Administrative or logistical reason|1|||
106112566|NCT03138733|366068494|FG001|Overall Study|Administrative or logistical reason|0|||
106112567|NCT03138733|366068493|FG000|Overall Study|The patient was transferred to another hospital|1|||
106112568|NCT03138733|366068494|FG001|Overall Study|The patient was transferred to another hospital|0|||
106112569|NCT02063828|366068495|FG000|Overall Study|Withdrawal by Subject|4|||
106112570|NCT02063828|366068496|FG001|Overall Study|Withdrawal by Subject|6|||
106112571|NCT02063828|366068497|FG002|Overall Study|Withdrawal by Subject|3|||
106112572|NCT02063828|366068495|FG000|Overall Study|Death|0|||
106112573|NCT02063828|366068496|FG001|Overall Study|Death|0|||
106112574|NCT02063828|366068497|FG002|Overall Study|Death|1|||
106112575|NCT00733980|366068500|FG000|Overall Study|Adverse Event|5|||
106112576|NCT00733980|366068501|FG001|Overall Study|Adverse Event|2|||
106112577|NCT00733980|366068500|FG000|Overall Study|Lack of Efficacy|0|||
105883577|NCT00072280|365227800|FG000|Follow-up|Early termination of study|2|||
105883578|NCT00072280|365227801|FG001|Follow-up|Early termination of study|2|||
105883579|NCT01628198|365227802|FG000|Overall Study|Lost to Follow-up|7|||
105883580|NCT01628198|365227802|FG000|Overall Study|Withdrawal by Subject|10|||
105883581|NCT01628198|365227802|FG000|Overall Study|Screen failure|1|||
105883582|NCT00022698|365227803|FG000|Overall Study|Adverse Event|5|||
105883583|NCT00022698|365227804|FG001|Overall Study|Adverse Event|9|||
105883584|NCT00022698|365227803|FG000|Overall Study|Death|0|||
105883585|NCT00022698|365227804|FG001|Overall Study|Death|2|||
105883586|NCT00022698|365227803|FG000|Overall Study|Failure to return|0|||
105883587|NCT00022698|365227804|FG001|Overall Study|Failure to return|1|||
105883588|NCT00022698|365227803|FG000|Overall Study|Refused treatment|0|||
105883589|NCT00022698|365227804|FG001|Overall Study|Refused treatment|2|||
105883590|NCT00022698|365227803|FG000|Overall Study|Insufficient therapeutic response|2|||
106112578|NCT00733980|366068501|FG001|Overall Study|Lack of Efficacy|1|||
105883591|NCT00022698|365227804|FG001|Overall Study|Insufficient therapeutic response|14|||
105883592|NCT00022698|365227803|FG000|Overall Study|Administrative /other|1|||
106112579|NCT00733980|366068500|FG000|Overall Study|Protocol Violation|2|||
106112580|NCT00733980|366068501|FG001|Overall Study|Protocol Violation|1|||
106112581|NCT00733980|366068500|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
106112582|NCT00733980|366068501|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
106112583|NCT00733980|366068500|FG000|Overall Study|Lost to Follow-up|6|||
106112584|NCT00733980|366068501|FG001|Overall Study|Lost to Follow-up|11|||
106112585|NCT00733980|366068500|FG000|Overall Study|Physician Decision|2|||
105883593|NCT00022698|365227804|FG001|Overall Study|Administrative /other|7|||
105883594|NCT02504827|365227808|FG000|Overall Study|Could not produce sputum|1|||
105883595|NCT00712543|365227822|FG000|Day 8-14|Lost to Follow-up|0|||
105883596|NCT00712543|365227823|FG001|Day 8-14|Lost to Follow-up|2|||
105883597|NCT02122887|365227824|FG000|Overall Study|Withdrawal by Subject|20|||
105883598|NCT02122887|365227825|FG001|Overall Study|Withdrawal by Subject|2|||
105883599|NCT01314872|365227826|FG000|Treatment Period 1|Protocol Violation|2|||
105883600|NCT01314872|365227827|FG001|Treatment Period 1|Protocol Violation|1|||
105883601|NCT01314872|365227828|FG002|Treatment Period 1|Protocol Violation|1|||
105883602|NCT01314872|365227829|FG003|Treatment Period 1|Protocol Violation|0|||
105883603|NCT01314872|365227830|FG004|Treatment Period 1|Protocol Violation|1|||
105883604|NCT01314872|365227831|FG005|Treatment Period 1|Protocol Violation|0|||
105883605|NCT01314872|365227832|FG006|Treatment Period 1|Protocol Violation|0|||
105883606|NCT01314872|365227833|FG007|Treatment Period 1|Protocol Violation|0|||
105883607|NCT01314872|365227834|FG008|Treatment Period 1|Protocol Violation|0|||
105883608|NCT01314872|365227835|FG009|Treatment Period 1|Protocol Violation|1|||
105883609|NCT01314872|365227836|FG010|Treatment Period 1|Protocol Violation|1|||
105883610|NCT01314872|365227837|FG011|Treatment Period 1|Protocol Violation|0|||
105883611|NCT01314872|365227838|FG012|Treatment Period 1|Protocol Violation|0|||
105883612|NCT01314872|365227839|FG013|Treatment Period 1|Protocol Violation|0|||
105883613|NCT01314872|365227840|FG014|Treatment Period 1|Protocol Violation|0|||
105883614|NCT01314872|365227826|FG000|Treatment Period 1|Physician Decision|0|||
105883615|NCT01314872|365227827|FG001|Treatment Period 1|Physician Decision|1|||
105883616|NCT01314872|365227828|FG002|Treatment Period 1|Physician Decision|0|||
105883617|NCT01314872|365227829|FG003|Treatment Period 1|Physician Decision|1|||
105883618|NCT01314872|365227830|FG004|Treatment Period 1|Physician Decision|0|||
105883619|NCT01314872|365227831|FG005|Treatment Period 1|Physician Decision|0|||
105883620|NCT01314872|365227832|FG006|Treatment Period 1|Physician Decision|0|||
105883621|NCT01314872|365227833|FG007|Treatment Period 1|Physician Decision|0|||
105883622|NCT01314872|365227834|FG008|Treatment Period 1|Physician Decision|0|||
105883623|NCT01314872|365227835|FG009|Treatment Period 1|Physician Decision|1|||
105883624|NCT01314872|365227836|FG010|Treatment Period 1|Physician Decision|0|||
105883625|NCT01314872|365227837|FG011|Treatment Period 1|Physician Decision|0|||
105883626|NCT01314872|365227838|FG012|Treatment Period 1|Physician Decision|0|||
105883627|NCT01314872|365227839|FG013|Treatment Period 1|Physician Decision|0|||
105883628|NCT01314872|365227840|FG014|Treatment Period 1|Physician Decision|0|||
105883629|NCT01314872|365227826|FG000|Treatment Period 1|Lack of Efficacy|1|||
105883630|NCT01314872|365227827|FG001|Treatment Period 1|Lack of Efficacy|0|||
105883631|NCT01314872|365227828|FG002|Treatment Period 1|Lack of Efficacy|0|||
105883632|NCT01314872|365227829|FG003|Treatment Period 1|Lack of Efficacy|0|||
105883633|NCT01314872|365227830|FG004|Treatment Period 1|Lack of Efficacy|0|||
105883634|NCT01314872|365227831|FG005|Treatment Period 1|Lack of Efficacy|1|||
105883635|NCT01314872|365227832|FG006|Treatment Period 1|Lack of Efficacy|0|||
105883636|NCT01314872|365227833|FG007|Treatment Period 1|Lack of Efficacy|2|||
105883637|NCT01314872|365227834|FG008|Treatment Period 1|Lack of Efficacy|0|||
105883638|NCT01314872|365227835|FG009|Treatment Period 1|Lack of Efficacy|0|||
105883639|NCT01314872|365227836|FG010|Treatment Period 1|Lack of Efficacy|0|||
105883640|NCT01314872|365227837|FG011|Treatment Period 1|Lack of Efficacy|0|||
105883641|NCT01314872|365227838|FG012|Treatment Period 1|Lack of Efficacy|0|||
105883642|NCT01314872|365227839|FG013|Treatment Period 1|Lack of Efficacy|0|||
105883643|NCT01314872|365227840|FG014|Treatment Period 1|Lack of Efficacy|0|||
105883644|NCT01314872|365227826|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
105883645|NCT01314872|365227827|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
105883646|NCT01314872|365227828|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
105883647|NCT01314872|365227829|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
105883648|NCT01314872|365227830|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
105883649|NCT01314872|365227831|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
105883650|NCT01314872|365227832|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
105883651|NCT01314872|365227833|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
105883652|NCT01314872|365227834|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
105883653|NCT01314872|365227835|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
105883654|NCT01314872|365227836|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
105883655|NCT01314872|365227837|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
105883656|NCT01314872|365227838|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
105883657|NCT01314872|365227839|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
105883658|NCT01314872|365227840|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
105883659|NCT01314872|365227826|FG000|Treatment Period 1|Withdrawal by Subject|3|||
105883660|NCT01314872|365227827|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105883661|NCT01314872|365227828|FG002|Treatment Period 1|Withdrawal by Subject|0|||
106112586|NCT00733980|366068501|FG001|Overall Study|Physician Decision|3|||
105883662|NCT01314872|365227829|FG003|Treatment Period 1|Withdrawal by Subject|2|||
105883663|NCT01314872|365227830|FG004|Treatment Period 1|Withdrawal by Subject|3|||
105883664|NCT01314872|365227831|FG005|Treatment Period 1|Withdrawal by Subject|1|||
105883665|NCT01314872|365227832|FG006|Treatment Period 1|Withdrawal by Subject|3|||
105883666|NCT01314872|365227833|FG007|Treatment Period 1|Withdrawal by Subject|2|||
105883667|NCT01314872|365227834|FG008|Treatment Period 1|Withdrawal by Subject|2|||
105883668|NCT01314872|365227835|FG009|Treatment Period 1|Withdrawal by Subject|2|||
105883669|NCT01314872|365227836|FG010|Treatment Period 1|Withdrawal by Subject|1|||
105883670|NCT01314872|365227837|FG011|Treatment Period 1|Withdrawal by Subject|0|||
105883671|NCT01314872|365227838|FG012|Treatment Period 1|Withdrawal by Subject|0|||
105883672|NCT01314872|365227839|FG013|Treatment Period 1|Withdrawal by Subject|0|||
105883673|NCT01314872|365227840|FG014|Treatment Period 1|Withdrawal by Subject|0|||
105883674|NCT01314872|365227826|FG000|Treatment Period 1|Lost to Follow-up|0|||
105883675|NCT01314872|365227827|FG001|Treatment Period 1|Lost to Follow-up|1|||
105883676|NCT01314872|365227828|FG002|Treatment Period 1|Lost to Follow-up|2|||
105883677|NCT01314872|365227829|FG003|Treatment Period 1|Lost to Follow-up|2|||
105883678|NCT01314872|365227830|FG004|Treatment Period 1|Lost to Follow-up|1|||
105883679|NCT01314872|365227831|FG005|Treatment Period 1|Lost to Follow-up|1|||
105883680|NCT01314872|365227832|FG006|Treatment Period 1|Lost to Follow-up|1|||
105883681|NCT01314872|365227833|FG007|Treatment Period 1|Lost to Follow-up|1|||
105883682|NCT01314872|365227834|FG008|Treatment Period 1|Lost to Follow-up|1|||
105883683|NCT01314872|365227835|FG009|Treatment Period 1|Lost to Follow-up|0|||
105883684|NCT01314872|365227836|FG010|Treatment Period 1|Lost to Follow-up|0|||
105883685|NCT01314872|365227837|FG011|Treatment Period 1|Lost to Follow-up|0|||
105883686|NCT01314872|365227838|FG012|Treatment Period 1|Lost to Follow-up|0|||
105883687|NCT01314872|365227839|FG013|Treatment Period 1|Lost to Follow-up|0|||
105883688|NCT01314872|365227840|FG014|Treatment Period 1|Lost to Follow-up|0|||
105883689|NCT01314872|365227826|FG000|Period 2|Protocol Violation|0|||
105883690|NCT01314872|365227827|FG001|Period 2|Protocol Violation|0|||
105883691|NCT01314872|365227828|FG002|Period 2|Protocol Violation|0|||
105883692|NCT01314872|365227829|FG003|Period 2|Protocol Violation|0|||
105883693|NCT01314872|365227830|FG004|Period 2|Protocol Violation|0|||
105883694|NCT01314872|365227831|FG005|Period 2|Protocol Violation|0|||
105883695|NCT01314872|365227832|FG006|Period 2|Protocol Violation|0|||
105883696|NCT01314872|365227833|FG007|Period 2|Protocol Violation|0|||
105883697|NCT01314872|365227834|FG008|Period 2|Protocol Violation|0|||
105883698|NCT01314872|365227835|FG009|Period 2|Protocol Violation|0|||
105883699|NCT01314872|365227836|FG010|Period 2|Protocol Violation|0|||
105883700|NCT01314872|365227837|FG011|Period 2|Protocol Violation|3|||
105883701|NCT01314872|365227838|FG012|Period 2|Protocol Violation|3|||
105883702|NCT01314872|365227839|FG013|Period 2|Protocol Violation|2|||
105883703|NCT01314872|365227840|FG014|Period 2|Protocol Violation|0|||
105883704|NCT01314872|365227826|FG000|Period 2|Non-compliance with study drug|0|||
105883705|NCT01314872|365227827|FG001|Period 2|Non-compliance with study drug|0|||
105883706|NCT01314872|365227828|FG002|Period 2|Non-compliance with study drug|0|||
105883707|NCT01314872|365227829|FG003|Period 2|Non-compliance with study drug|0|||
105883708|NCT01314872|365227830|FG004|Period 2|Non-compliance with study drug|0|||
105883709|NCT01314872|365227831|FG005|Period 2|Non-compliance with study drug|0|||
105883710|NCT01314872|365227832|FG006|Period 2|Non-compliance with study drug|0|||
105883711|NCT01314872|365227833|FG007|Period 2|Non-compliance with study drug|0|||
105883712|NCT01314872|365227834|FG008|Period 2|Non-compliance with study drug|0|||
105883713|NCT01314872|365227835|FG009|Period 2|Non-compliance with study drug|0|||
105883714|NCT01314872|365227836|FG010|Period 2|Non-compliance with study drug|0|||
105883715|NCT01314872|365227837|FG011|Period 2|Non-compliance with study drug|3|||
105883716|NCT01314872|365227838|FG012|Period 2|Non-compliance with study drug|3|||
105883717|NCT01314872|365227839|FG013|Period 2|Non-compliance with study drug|1|||
105883718|NCT01314872|365227840|FG014|Period 2|Non-compliance with study drug|2|||
105883719|NCT01314872|365227826|FG000|Period 2|Lack of Efficacy|0|||
105883720|NCT01314872|365227827|FG001|Period 2|Lack of Efficacy|0|||
105883721|NCT01314872|365227828|FG002|Period 2|Lack of Efficacy|0|||
105883722|NCT01314872|365227829|FG003|Period 2|Lack of Efficacy|0|||
105883723|NCT01314872|365227830|FG004|Period 2|Lack of Efficacy|0|||
105883724|NCT01314872|365227831|FG005|Period 2|Lack of Efficacy|0|||
105883725|NCT01314872|365227832|FG006|Period 2|Lack of Efficacy|0|||
105883726|NCT01314872|365227833|FG007|Period 2|Lack of Efficacy|0|||
105883727|NCT01314872|365227834|FG008|Period 2|Lack of Efficacy|0|||
105883728|NCT01314872|365227835|FG009|Period 2|Lack of Efficacy|0|||
105883729|NCT01314872|365227836|FG010|Period 2|Lack of Efficacy|0|||
105883730|NCT01314872|365227837|FG011|Period 2|Lack of Efficacy|7|||
105883731|NCT01314872|365227838|FG012|Period 2|Lack of Efficacy|12|||
105883732|NCT01314872|365227839|FG013|Period 2|Lack of Efficacy|9|||
105883733|NCT01314872|365227840|FG014|Period 2|Lack of Efficacy|2|||
105883734|NCT01314872|365227826|FG000|Period 2|Pregnancy|0|||
105883735|NCT01314872|365227827|FG001|Period 2|Pregnancy|0|||
105883736|NCT01314872|365227828|FG002|Period 2|Pregnancy|0|||
105883737|NCT01314872|365227829|FG003|Period 2|Pregnancy|0|||
105883738|NCT01314872|365227830|FG004|Period 2|Pregnancy|0|||
105883739|NCT01314872|365227831|FG005|Period 2|Pregnancy|0|||
105883740|NCT01314872|365227832|FG006|Period 2|Pregnancy|0|||
105883741|NCT01314872|365227833|FG007|Period 2|Pregnancy|0|||
105883742|NCT01314872|365227834|FG008|Period 2|Pregnancy|0|||
105883743|NCT01314872|365227835|FG009|Period 2|Pregnancy|0|||
105883744|NCT01314872|365227836|FG010|Period 2|Pregnancy|0|||
105883745|NCT01314872|365227837|FG011|Period 2|Pregnancy|0|||
105993721|NCT01510158|365636075|FG000|Overall Study|Death|1|||
105993722|NCT01510158|365636076|FG001|Overall Study|Death|0|||
105993723|NCT01510158|365636077|FG002|Overall Study|Death|0|||
105993724|NCT02837029|365636078|FG000|Screening|Failed to meet screening requirements.|7|||
105993725|NCT02837029|365636079|FG001|Screening|Failed to meet screening requirements.|3|||
105993726|NCT02837029|365636080|FG002|Screening|Failed to meet screening requirements.|0|||
105993727|NCT02837029|365636078|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
106112587|NCT00733980|366068500|FG000|Overall Study|Withdrawal by Subject|6|||
106112588|NCT00733980|366068501|FG001|Overall Study|Withdrawal by Subject|2|||
106112589|NCT04843930|366068502|FG000|Randomization|Withdrawal by Subject|6|||
106112590|NCT04843930|366068503|FG001|Randomization|Withdrawal by Subject|6|||
106112591|NCT04843930|366068504|FG002|Randomization|Withdrawal by Subject|0|||
106112592|NCT04843930|366068505|FG003|Randomization|Withdrawal by Subject|0|||
106112593|NCT04843930|366068502|FG000|Week 6 Assessment|Adverse Event|3|||
106112594|NCT04843930|366068503|FG001|Week 6 Assessment|Adverse Event|0|||
106112595|NCT04843930|366068504|FG002|Week 6 Assessment|Adverse Event|0|||
105883746|NCT01314872|365227838|FG012|Period 2|Pregnancy|0|||
105883747|NCT01314872|365227839|FG013|Period 2|Pregnancy|0|||
105883748|NCT01314872|365227840|FG014|Period 2|Pregnancy|1|||
105883749|NCT01314872|365227826|FG000|Period 2|Study terminated by Sponsor|0|||
105883750|NCT01314872|365227827|FG001|Period 2|Study terminated by Sponsor|0|||
105883751|NCT01314872|365227828|FG002|Period 2|Study terminated by Sponsor|0|||
105883752|NCT01314872|365227829|FG003|Period 2|Study terminated by Sponsor|0|||
105883753|NCT01314872|365227830|FG004|Period 2|Study terminated by Sponsor|0|||
105883754|NCT01314872|365227831|FG005|Period 2|Study terminated by Sponsor|0|||
105883755|NCT01314872|365227832|FG006|Period 2|Study terminated by Sponsor|0|||
105883756|NCT01314872|365227833|FG007|Period 2|Study terminated by Sponsor|0|||
105883757|NCT01314872|365227834|FG008|Period 2|Study terminated by Sponsor|0|||
105883758|NCT01314872|365227835|FG009|Period 2|Study terminated by Sponsor|0|||
105883759|NCT01314872|365227836|FG010|Period 2|Study terminated by Sponsor|0|||
105883760|NCT01314872|365227837|FG011|Period 2|Study terminated by Sponsor|2|||
105883761|NCT01314872|365227838|FG012|Period 2|Study terminated by Sponsor|2|||
105883762|NCT01314872|365227839|FG013|Period 2|Study terminated by Sponsor|3|||
105883763|NCT01314872|365227840|FG014|Period 2|Study terminated by Sponsor|0|||
105883764|NCT01314872|365227826|FG000|Period 2|Adverse event, non-fatal|0|||
105883765|NCT01314872|365227827|FG001|Period 2|Adverse event, non-fatal|0|||
105883766|NCT01314872|365227828|FG002|Period 2|Adverse event, non-fatal|0|||
105883767|NCT01314872|365227829|FG003|Period 2|Adverse event, non-fatal|0|||
105883768|NCT01314872|365227830|FG004|Period 2|Adverse event, non-fatal|0|||
105883769|NCT01314872|365227831|FG005|Period 2|Adverse event, non-fatal|0|||
105883770|NCT01314872|365227832|FG006|Period 2|Adverse event, non-fatal|0|||
105883771|NCT01314872|365227833|FG007|Period 2|Adverse event, non-fatal|0|||
105883772|NCT01314872|365227834|FG008|Period 2|Adverse event, non-fatal|0|||
105883773|NCT01314872|365227835|FG009|Period 2|Adverse event, non-fatal|0|||
105883774|NCT01314872|365227836|FG010|Period 2|Adverse event, non-fatal|0|||
105883775|NCT01314872|365227837|FG011|Period 2|Adverse event, non-fatal|13|||
105883776|NCT01314872|365227838|FG012|Period 2|Adverse event, non-fatal|16|||
105883777|NCT01314872|365227839|FG013|Period 2|Adverse event, non-fatal|24|||
105883778|NCT01314872|365227840|FG014|Period 2|Adverse event, non-fatal|9|||
105883779|NCT01314872|365227826|FG000|Period 2|Withdrawal by Subject|0|||
105883780|NCT01314872|365227827|FG001|Period 2|Withdrawal by Subject|0|||
105883781|NCT01314872|365227828|FG002|Period 2|Withdrawal by Subject|0|||
105883782|NCT01314872|365227829|FG003|Period 2|Withdrawal by Subject|0|||
105883783|NCT01314872|365227830|FG004|Period 2|Withdrawal by Subject|0|||
105883784|NCT01314872|365227831|FG005|Period 2|Withdrawal by Subject|0|||
105883785|NCT01314872|365227832|FG006|Period 2|Withdrawal by Subject|0|||
105883786|NCT01314872|365227833|FG007|Period 2|Withdrawal by Subject|0|||
105883787|NCT01314872|365227834|FG008|Period 2|Withdrawal by Subject|0|||
105883788|NCT01314872|365227835|FG009|Period 2|Withdrawal by Subject|0|||
105883789|NCT01314872|365227836|FG010|Period 2|Withdrawal by Subject|0|||
105883790|NCT01314872|365227837|FG011|Period 2|Withdrawal by Subject|14|||
105883791|NCT01314872|365227838|FG012|Period 2|Withdrawal by Subject|17|||
105883792|NCT01314872|365227839|FG013|Period 2|Withdrawal by Subject|12|||
105883793|NCT01314872|365227840|FG014|Period 2|Withdrawal by Subject|4|||
105883794|NCT01314872|365227826|FG000|Period 2|Lost to Follow-up|0|||
105883795|NCT01314872|365227827|FG001|Period 2|Lost to Follow-up|0|||
105883796|NCT01314872|365227828|FG002|Period 2|Lost to Follow-up|0|||
105883797|NCT01314872|365227829|FG003|Period 2|Lost to Follow-up|0|||
105993728|NCT02837029|365636079|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
105993729|NCT02837029|365636080|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
106112596|NCT04843930|366068505|FG003|Week 6 Assessment|Adverse Event|0|||
105883798|NCT01314872|365227830|FG004|Period 2|Lost to Follow-up|0|||
105883799|NCT01314872|365227831|FG005|Period 2|Lost to Follow-up|0|||
105883800|NCT01314872|365227832|FG006|Period 2|Lost to Follow-up|0|||
105883801|NCT01314872|365227833|FG007|Period 2|Lost to Follow-up|0|||
105883802|NCT01314872|365227834|FG008|Period 2|Lost to Follow-up|0|||
105883803|NCT01314872|365227835|FG009|Period 2|Lost to Follow-up|0|||
105883804|NCT01314872|365227836|FG010|Period 2|Lost to Follow-up|0|||
106112597|NCT04843930|366068502|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
105993730|NCT02837029|365636078|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
105993731|NCT02837029|365636079|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
105993732|NCT02837029|365636080|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
105993733|NCT02837029|365636078|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
105993734|NCT02837029|365636079|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
105993735|NCT02837029|365636080|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
105993736|NCT02837029|365636078|FG000|Cycle 2 and Beyond|Adverse Event|1|||
105993737|NCT02837029|365636079|FG001|Cycle 2 and Beyond|Adverse Event|0|||
105993738|NCT02837029|365636080|FG002|Cycle 2 and Beyond|Adverse Event|0|||
105993739|NCT02837029|365636078|FG000|2 Year Follow-up|Death|6|||
105993740|NCT02837029|365636079|FG001|2 Year Follow-up|Death|7|||
105993741|NCT02837029|365636080|FG002|2 Year Follow-up|Death|0|||
105993742|NCT02644343|365636081|FG000|Overall Study|Withdrawal by Subject|1|||
105993743|NCT00570310|365636089|FG000|Overall Study|Adverse Event|1|||
105993744|NCT00570310|365636090|FG001|Overall Study|Adverse Event|2|||
105993745|NCT00570310|365636089|FG000|Overall Study|Lack of Efficacy|1|||
105993746|NCT00570310|365636090|FG001|Overall Study|Lack of Efficacy|4|||
105993747|NCT03329846|365636091|FG000|Overall Study|Disease progression|4|||
105993748|NCT03329846|365636092|FG001|Overall Study|Disease progression|6|||
105993749|NCT03329846|365636091|FG000|Overall Study|Study drug toxicity|1|||
105993750|NCT03329846|365636092|FG001|Overall Study|Study drug toxicity|0|||
105993751|NCT03329846|365636091|FG000|Overall Study|Participant request to discontinue treatment|0|||
105993752|NCT03329846|365636092|FG001|Overall Study|Participant request to discontinue treatment|1|||
105993753|NCT03329846|365636091|FG000|Overall Study|Participant withdrew consent|1|||
105993754|NCT03329846|365636092|FG001|Overall Study|Participant withdrew consent|0|||
105993755|NCT03329846|365636091|FG000|Overall Study|Other reasons|2|||
105993756|NCT03329846|365636092|FG001|Overall Study|Other reasons|2|||
105993757|NCT00108862|365636093|FG000|Overall Study|Death|31|||
105883805|NCT01314872|365227837|FG011|Period 2|Lost to Follow-up|6|||
105883806|NCT01314872|365227838|FG012|Period 2|Lost to Follow-up|7|||
105883807|NCT01314872|365227839|FG013|Period 2|Lost to Follow-up|2|||
105883808|NCT01314872|365227840|FG014|Period 2|Lost to Follow-up|6|||
105883809|NCT05488470|365229617|FG000|Overall Study|Physician Decision|2|||
105883810|NCT05488470|365229617|FG000|Overall Study|Withdrawal by Subject|1|||
105883811|NCT05488470|365229617|FG000|Overall Study|Death|1|||
105883812|NCT02564900|365229630|FG000|Dose Escalation|Progressive disease per RECIST|2|||
105883813|NCT02564900|365229631|FG001|Dose Escalation|Progressive disease per RECIST|3|||
105883814|NCT02564900|365229632|FG002|Dose Escalation|Progressive disease per RECIST|3|||
105883815|NCT02564900|365229633|FG003|Dose Escalation|Progressive disease per RECIST|3|||
105883816|NCT02564900|365229634|FG004|Dose Escalation|Progressive disease per RECIST|3|||
106112598|NCT04843930|366068503|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
106112599|NCT04843930|366068504|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
106112600|NCT04843930|366068505|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
106112601|NCT04843930|366068502|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
106112602|NCT04843930|366068503|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
106112603|NCT04843930|366068504|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
106112604|NCT04843930|366068505|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
106112605|NCT00779779|366068506|FG000|Overall Study|Adverse Event|1|||
106112606|NCT00779779|366068506|FG000|Overall Study|Protocol Violation|14|||
106112607|NCT00779779|366068506|FG000|Overall Study|Withdrawal by Subject|4|||
106112608|NCT00779779|366068506|FG000|Overall Study|Lost to Follow-up|5|||
106112609|NCT05158296|366068507|FG000|Overall Study|Sponsor Decision|2|||
106112610|NCT05158296|366068508|FG001|Overall Study|Sponsor Decision|3|||
106112611|NCT05158296|366068509|FG002|Overall Study|Sponsor Decision|2|||
106112612|NCT00117156|366068510|FG000|Overall Study|Adverse Event|9|||
106112613|NCT00117156|366068510|FG000|Overall Study|Physician Decision|1|||
106112614|NCT00117156|366068510|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
106112615|NCT02178566|366068511|FG000|Overall Study|patient did not complete due to noncompliance|0|||
106112616|NCT02178566|366068512|FG001|Overall Study|patient did not complete due to noncompliance|1|||
106112617|NCT03764072|366068513|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
106112618|NCT03764072|366068514|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
106112619|NCT03764072|366068515|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
106112620|NCT03764072|366068516|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
106112621|NCT03764072|366068517|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
106112622|NCT03764072|366068518|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
105883817|NCT02564900|365229635|FG005|Dose Escalation|Progressive disease per RECIST|1|||
105883818|NCT02564900|365229636|FG006|Dose Escalation|Progressive disease per RECIST|0|||
105993758|NCT00108862|365636094|FG001|Overall Study|Death|37|||
105993759|NCT00108862|365636093|FG000|Overall Study|Withdrawal by Subject|10|||
105993760|NCT00108862|365636094|FG001|Overall Study|Withdrawal by Subject|6|||
106112623|NCT03764072|366068513|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
106112624|NCT03764072|366068514|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
105883819|NCT02564900|365229637|FG007|Dose Escalation|Progressive disease per RECIST|0|||
105993761|NCT00108862|365636093|FG000|Overall Study|Lost to Follow-up|27|||
105883820|NCT02564900|365229638|FG008|Dose Escalation|Progressive disease per RECIST|0|||
105883821|NCT02564900|365229639|FG009|Dose Escalation|Progressive disease per RECIST|0|||
105883822|NCT02564900|365229640|FG010|Dose Escalation|Progressive disease per RECIST|0|||
105883823|NCT02564900|365229641|FG011|Dose Escalation|Progressive disease per RECIST|0|||
105883824|NCT02564900|365229642|FG012|Dose Escalation|Progressive disease per RECIST|0|||
105883825|NCT02564900|365229643|FG013|Dose Escalation|Progressive disease per RECIST|0|||
105883826|NCT02564900|365229644|FG014|Dose Escalation|Progressive disease per RECIST|0|||
105883827|NCT02564900|365229630|FG000|Dose Escalation|Ongoing|1|||
105883828|NCT02564900|365229631|FG001|Dose Escalation|Ongoing|0|||
106112625|NCT03764072|366068515|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
106112626|NCT03764072|366068516|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
106112627|NCT03764072|366068517|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
106112628|NCT03764072|366068518|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
106112629|NCT03764072|366068513|FG000|Overall Study|Lost to Follow-up|0|||
106112630|NCT03764072|366068514|FG001|Overall Study|Lost to Follow-up|0|||
106112631|NCT03764072|366068515|FG002|Overall Study|Lost to Follow-up|0|||
106112632|NCT03764072|366068516|FG003|Overall Study|Lost to Follow-up|0|||
106112633|NCT03764072|366068517|FG004|Overall Study|Lost to Follow-up|1|||
106112634|NCT03764072|366068518|FG005|Overall Study|Lost to Follow-up|0|||
106112635|NCT01122381|366068521|FG000|Overall Study|study terminated early|0|||
106112636|NCT01122381|366068522|FG001|Overall Study|study terminated early|1|||
106112637|NCT05597722|366068525|FG000|Overall Study|Study was terminated|6|||
105883829|NCT02564900|365229632|FG002|Dose Escalation|Ongoing|0|||
105883830|NCT02564900|365229633|FG003|Dose Escalation|Ongoing|2|||
105883831|NCT02564900|365229634|FG004|Dose Escalation|Ongoing|2|||
105883832|NCT02564900|365229635|FG005|Dose Escalation|Ongoing|2|||
105883833|NCT02564900|365229636|FG006|Dose Escalation|Ongoing|0|||
105883834|NCT02564900|365229637|FG007|Dose Escalation|Ongoing|0|||
105883835|NCT02564900|365229638|FG008|Dose Escalation|Ongoing|0|||
105883836|NCT02564900|365229639|FG009|Dose Escalation|Ongoing|0|||
105883837|NCT02564900|365229640|FG010|Dose Escalation|Ongoing|0|||
105883838|NCT02564900|365229641|FG011|Dose Escalation|Ongoing|0|||
105883839|NCT02564900|365229642|FG012|Dose Escalation|Ongoing|0|||
106112638|NCT05597722|366068526|FG001|Overall Study|Study was terminated|1|||
106112639|NCT03445065|366068530|FG000|Overall Study|Withdrawal by Subject|3|||
106112640|NCT03445065|366068531|FG001|Overall Study|Withdrawal by Subject|6|||
106112641|NCT03445065|366068532|FG002|Overall Study|Withdrawal by Subject|2|||
106112642|NCT03445065|366068533|FG003|Overall Study|Withdrawal by Subject|2|||
106112643|NCT03445065|366068530|FG000|Overall Study|Other|4|||
106112644|NCT03445065|366068531|FG001|Overall Study|Other|3|||
106112645|NCT03445065|366068532|FG002|Overall Study|Other|3|||
106112646|NCT03445065|366068533|FG003|Overall Study|Other|1|||
106112647|NCT03750006|366068534|FG000|Overall Study|Withdrawal by Subject|8|||
106112648|NCT03750006|366068534|FG000|Overall Study|COVID PANDEMIC|11|||
106112649|NCT04244396|366070253|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
106112650|NCT04244396|366070253|FG000|Overall Study|Withdrawal by Subject|2|||
106112651|NCT04244396|366070253|FG000|Overall Study|Study termination|37|||
106112652|NCT01679301|366070256|FG000|Screening Period|screen failure|3|||
106112653|NCT01679301|366070257|FG001|Screening Period|screen failure|0|||
106112654|NCT01679301|366070258|FG002|Screening Period|screen failure|0|||
106112655|NCT01582789|366070260|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
106112656|NCT01582789|366070261|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
106112657|NCT04170686|366070262|FG000|Screening|Physician Decision|12|||
106112658|NCT04170686|366070263|FG001|Screening|Physician Decision|13|||
106112659|NCT04170686|366070262|FG000|Randomization and Treatment|Lost to Follow-up|26|||
106112660|NCT04170686|366070263|FG001|Randomization and Treatment|Lost to Follow-up|15|||
106112661|NCT04525547|366070264|FG000|Overall Study|Not treated with Ofev|2|||
106112662|NCT04525547|366070264|FG000|Overall Study|Off-label use|2|||
106112663|NCT04525547|366070264|FG000|Overall Study|Lost to Follow-up|1|||
106112664|NCT00508261|366070266|FG000|Overall Study|Other|0|||
106112665|NCT00508261|366070267|FG001|Overall Study|Other|1|||
106112666|NCT00508261|366070268|FG002|Overall Study|Other|1|||
106112667|NCT00508261|366070269|FG003|Overall Study|Other|0|||
106112668|NCT00508261|366070266|FG000|Overall Study|Serious Adverse Event|0|||
106112669|NCT00508261|366070267|FG001|Overall Study|Serious Adverse Event|1|||
106112670|NCT00508261|366070268|FG002|Overall Study|Serious Adverse Event|0|||
106112671|NCT00508261|366070269|FG003|Overall Study|Serious Adverse Event|0|||
106112672|NCT00508261|366070266|FG000|Overall Study|Withdrawal by Subject|3|||
106112673|NCT00508261|366070267|FG001|Overall Study|Withdrawal by Subject|4|||
106112674|NCT00508261|366070268|FG002|Overall Study|Withdrawal by Subject|4|||
106112675|NCT00508261|366070269|FG003|Overall Study|Withdrawal by Subject|0|||
106112676|NCT00508261|366070266|FG000|Overall Study|Migrated/ moved from study area|0|||
106112677|NCT00508261|366070267|FG001|Overall Study|Migrated/ moved from study area|1|||
106112678|NCT00508261|366070268|FG002|Overall Study|Migrated/ moved from study area|0|||
105883840|NCT02564900|365229643|FG013|Dose Escalation|Ongoing|0|||
105883841|NCT02564900|365229644|FG014|Dose Escalation|Ongoing|0|||
105883842|NCT02564900|365229630|FG000|Dose Escalation|Adverse Event|0|||
106112679|NCT00508261|366070269|FG003|Overall Study|Migrated/ moved from study area|0|||
106112680|NCT00508261|366070266|FG000|Overall Study|Lost to Follow-up|0|||
106112681|NCT00508261|366070267|FG001|Overall Study|Lost to Follow-up|1|||
106112682|NCT00508261|366070268|FG002|Overall Study|Lost to Follow-up|1|||
106112683|NCT00508261|366070269|FG003|Overall Study|Lost to Follow-up|1|||
106112684|NCT01242748|366070270|FG000|Overall Study|Adverse Event|10|||
106112685|NCT01242748|366070271|FG001|Overall Study|Adverse Event|5|||
106112686|NCT01242748|366070270|FG000|Overall Study|Lost to Follow-up|6|||
106112687|NCT01242748|366070271|FG001|Overall Study|Lost to Follow-up|2|||
106112688|NCT01242748|366070270|FG000|Overall Study|Physician Decision|3|||
106112689|NCT01242748|366070271|FG001|Overall Study|Physician Decision|2|||
106112690|NCT01242748|366070270|FG000|Overall Study|Protocol Violation|1|||
106112691|NCT01242748|366070271|FG001|Overall Study|Protocol Violation|0|||
106112692|NCT01242748|366070270|FG000|Overall Study|Withdrawal by Subject|10|||
106112693|NCT01242748|366070271|FG001|Overall Study|Withdrawal by Subject|2|||
106112694|NCT01242748|366070270|FG000|Overall Study|Miscellaneous reasons|8|||
106112695|NCT01242748|366070271|FG001|Overall Study|Miscellaneous reasons|3|||
106112696|NCT05056870|366070272|FG000|Period 1|Site COVID-19 Related|3|||
106112697|NCT05056870|366070273|FG001|Period 1|Site COVID-19 Related|3|||
106112698|NCT05056870|366070272|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
106112699|NCT05056870|366070273|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
106112700|NCT05056870|366070272|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
106112701|NCT05056870|366070273|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
106112702|NCT05056870|366070272|FG000|Period 2|COVID-19 Related|1|||
106112703|NCT05056870|366070273|FG001|Period 2|COVID-19 Related|0|||
106112704|NCT05056870|366070272|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
106112705|NCT05056870|366070273|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
106112706|NCT02487498|366070274|FG000|Period: Period 1|Adverse Event|2|||
106112707|NCT02487498|366070275|FG001|Period: Period 1|Adverse Event|4|||
106112708|NCT02487498|366070274|FG000|Period: Period 1|Subject/guardian decision|2|||
106112709|NCT02487498|366070275|FG001|Period: Period 1|Subject/guardian decision|4|||
106112710|NCT02487498|366070274|FG000|Period: Period 1|Lost to Follow-up|0|||
105784864|NCT01012765|364864412|FG002|Treatment Period 2|Withdrawal by Subject|1|||
106112711|NCT02487498|366070275|FG001|Period: Period 1|Lost to Follow-up|2|||
105784865|NCT01012765|364864413|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105784866|NCT01012765|364864414|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105784867|NCT01012765|364864415|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105784868|NCT01012765|364864410|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784869|NCT01012765|364864411|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784870|NCT01012765|364864412|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784871|NCT01012765|364864413|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784872|NCT01012765|364864414|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
105784873|NCT01012765|364864415|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
105784874|NCT01012765|364864410|FG000|Treatment Period 2|Adverse Event|0|||
105784875|NCT01012765|364864411|FG001|Treatment Period 2|Adverse Event|1|||
105784876|NCT01012765|364864412|FG002|Treatment Period 2|Adverse Event|1|||
105784877|NCT01012765|364864413|FG003|Treatment Period 2|Adverse Event|0|||
105784878|NCT01012765|364864414|FG004|Treatment Period 2|Adverse Event|0|||
105784879|NCT01012765|364864415|FG005|Treatment Period 2|Adverse Event|0|||
105784880|NCT01012765|364864410|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
105784881|NCT01012765|364864411|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
105784882|NCT01012765|364864412|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
105784883|NCT01012765|364864413|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
105784884|NCT01012765|364864414|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
105784885|NCT01012765|364864415|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
105784886|NCT02219477|364864416|FG000|Overall Study|Adverse Event|0|||
105784887|NCT02219477|364864417|FG001|Overall Study|Adverse Event|1|||
105784888|NCT02219477|364864418|FG002|Overall Study|Adverse Event|1|||
105784889|NCT02219477|364864416|FG000|Overall Study|Withdrawal by Subject|0|||
105784890|NCT02219477|364864417|FG001|Overall Study|Withdrawal by Subject|1|||
105784891|NCT02219477|364864418|FG002|Overall Study|Withdrawal by Subject|0|||
105784892|NCT05147311|364864419|FG000|Overall Study|Did not complete survey|2|||
105784893|NCT05147311|364864420|FG001|Overall Study|Did not complete survey|1|||
105784894|NCT05147311|364864419|FG000|Overall Study|Patient too sick|1|||
105784895|NCT05147311|364864420|FG001|Overall Study|Patient too sick|2|||
105784896|NCT05147311|364864419|FG000|Overall Study|Death|0|||
105784897|NCT05147311|364864420|FG001|Overall Study|Death|1|||
105784898|NCT05147311|364864419|FG000|Overall Study|Declined survey|1|||
105784899|NCT05147311|364864420|FG001|Overall Study|Declined survey|0|||
105784900|NCT00499694|364864423|FG000|Overall Study|Patient never received treatment.|1|||
105784901|NCT02304484|364864424|FG000|Overall Study|Death|9|||
105784902|NCT02304484|364864424|FG000|Overall Study|Withdrawal by Subject|14|||
105784903|NCT02304484|364864424|FG000|Overall Study|Lost to Follow-up|2|||
105784904|NCT02967055|364864425|FG000|Overall Study|Excluded|40|||
105784905|NCT02967055|364864425|FG000|Overall Study|Screen fail|3|||
105784906|NCT02967055|364864425|FG000|Overall Study|Lost to Follow-up|2|||
105784907|NCT02967055|364864425|FG000|Overall Study|Stopped due to side effects|3|||
106112712|NCT02487498|366070274|FG000|Period: Period 1|Lack of Efficacy|1|||
106112713|NCT02487498|366070275|FG001|Period: Period 1|Lack of Efficacy|0|||
106112714|NCT02487498|366070274|FG000|Period: Period 1|Physician Decision|0|||
106112715|NCT02487498|366070275|FG001|Period: Period 1|Physician Decision|1|||
106112716|NCT02487498|366070274|FG000|Period: Period 1|Protocol deviation|1|||
106112717|NCT02487498|366070275|FG001|Period: Period 1|Protocol deviation|0|||
105883843|NCT02564900|365229631|FG001|Dose Escalation|Adverse Event|0|||
105883844|NCT02564900|365229632|FG002|Dose Escalation|Adverse Event|0|||
105883845|NCT02564900|365229633|FG003|Dose Escalation|Adverse Event|1|||
105883846|NCT02564900|365229634|FG004|Dose Escalation|Adverse Event|1|||
105883847|NCT02564900|365229635|FG005|Dose Escalation|Adverse Event|3|||
105883848|NCT02564900|365229636|FG006|Dose Escalation|Adverse Event|0|||
105883849|NCT02564900|365229637|FG007|Dose Escalation|Adverse Event|0|||
105883850|NCT02564900|365229638|FG008|Dose Escalation|Adverse Event|0|||
105883851|NCT02564900|365229639|FG009|Dose Escalation|Adverse Event|0|||
105883852|NCT02564900|365229640|FG010|Dose Escalation|Adverse Event|0|||
105883853|NCT02564900|365229641|FG011|Dose Escalation|Adverse Event|0|||
105883854|NCT02564900|365229642|FG012|Dose Escalation|Adverse Event|0|||
105883855|NCT02564900|365229643|FG013|Dose Escalation|Adverse Event|0|||
105883856|NCT02564900|365229644|FG014|Dose Escalation|Adverse Event|0|||
105883857|NCT02564900|365229630|FG000|Dose Expansion|Progressive disease per RECIST|0|||
105883858|NCT02564900|365229631|FG001|Dose Expansion|Progressive disease per RECIST|0|||
105883859|NCT02564900|365229632|FG002|Dose Expansion|Progressive disease per RECIST|0|||
105883860|NCT02564900|365229633|FG003|Dose Expansion|Progressive disease per RECIST|0|||
105883861|NCT02564900|365229634|FG004|Dose Expansion|Progressive disease per RECIST|0|||
105883862|NCT02564900|365229635|FG005|Dose Expansion|Progressive disease per RECIST|0|||
105883863|NCT02564900|365229636|FG006|Dose Expansion|Progressive disease per RECIST|19|||
105883864|NCT02564900|365229637|FG007|Dose Expansion|Progressive disease per RECIST|17|||
105883865|NCT02564900|365229638|FG008|Dose Expansion|Progressive disease per RECIST|8|||
105883866|NCT02564900|365229639|FG009|Dose Expansion|Progressive disease per RECIST|16|||
105883867|NCT02564900|365229640|FG010|Dose Expansion|Progressive disease per RECIST|13|||
105883868|NCT02564900|365229641|FG011|Dose Expansion|Progressive disease per RECIST|19|||
106112718|NCT02487498|366070274|FG000|Period: Washout|Subject/guardian decision|0|||
106112719|NCT02487498|366070275|FG001|Period: Washout|Subject/guardian decision|5|||
106112720|NCT02487498|366070274|FG000|Period: Washout|Lack of Efficacy|1|||
106112721|NCT02487498|366070275|FG001|Period: Washout|Lack of Efficacy|1|||
106112722|NCT02487498|366070274|FG000|Period: Washout|Physician Decision|1|||
106112723|NCT02487498|366070275|FG001|Period: Washout|Physician Decision|0|||
106112724|NCT02487498|366070274|FG000|Period: Washout|Non-compliance with study treatment|0|||
106112725|NCT02487498|366070275|FG001|Period: Washout|Non-compliance with study treatment|1|||
106112726|NCT02487498|366070274|FG000|Period: Period 2|Adverse Event|2|||
106112727|NCT02487498|366070275|FG001|Period: Period 2|Adverse Event|2|||
106112728|NCT02487498|366070274|FG000|Period: Period 2|Subject/guardian decision|2|||
106112729|NCT02487498|366070275|FG001|Period: Period 2|Subject/guardian decision|1|||
106112730|NCT02487498|366070274|FG000|Period: Period 2|Lost to Follow-up|1|||
106112731|NCT02487498|366070275|FG001|Period: Period 2|Lost to Follow-up|1|||
106112732|NCT02487498|366070274|FG000|Period: Period 2|Death|0|||
106112733|NCT02487498|366070275|FG001|Period: Period 2|Death|1|||
106112734|NCT02487498|366070274|FG000|Period: Period 2|Physician Decision|1|||
106112735|NCT02487498|366070275|FG001|Period: Period 2|Physician Decision|0|||
106112736|NCT00676130|366070282|FG000|Overall Study|Lost to Follow-up|0|||
106112737|NCT00676130|366070283|FG001|Overall Study|Lost to Follow-up|1|||
106112738|NCT00676130|366070282|FG000|Overall Study|Found ineligible|3|||
106112739|NCT00676130|366070283|FG001|Overall Study|Found ineligible|2|||
106112740|NCT00676130|366070282|FG000|Overall Study|Withdrawal by Subject|0|||
106112741|NCT00676130|366070283|FG001|Overall Study|Withdrawal by Subject|1|||
106112742|NCT00755222|366070284|FG000|Overall Study|Withdrawal by Subject|4|||
106112743|NCT00755222|366070285|FG001|Overall Study|Withdrawal by Subject|2|||
106112744|NCT00755222|366070284|FG000|Overall Study|Adverse Event|2|||
106112745|NCT00755222|366070285|FG001|Overall Study|Adverse Event|0|||
106112746|NCT00755222|366070284|FG000|Overall Study|Protocol Violation|2|||
106112747|NCT00755222|366070285|FG001|Overall Study|Protocol Violation|0|||
106112748|NCT04082884|366070286|FG000|Overall Study|Withdrawal by Subject|1|||
105883869|NCT02564900|365229642|FG012|Dose Expansion|Progressive disease per RECIST|10|||
105883870|NCT02564900|365229643|FG013|Dose Expansion|Progressive disease per RECIST|13|||
105883871|NCT02564900|365229644|FG014|Dose Expansion|Progressive disease per RECIST|11|||
106112749|NCT01373931|366070294|FG000|Lead-in Period|Adverse Event|2|||
106112750|NCT01373931|366070295|FG001|Lead-in Period|Adverse Event|0|||
106112751|NCT01373931|366070294|FG000|Period 1|Adverse Event|2|||
106112752|NCT01373931|366070295|FG001|Period 1|Adverse Event|0|||
106112753|NCT01373931|366070294|FG000|Period 1|Withdrawal by Subject|0|||
105883872|NCT02564900|365229630|FG000|Dose Expansion|Clinical progression|0|||
105883873|NCT02564900|365229631|FG001|Dose Expansion|Clinical progression|0|||
106112754|NCT01373931|366070295|FG001|Period 1|Withdrawal by Subject|2|||
106112755|NCT02940574|366070296|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
106112756|NCT02940574|366070297|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
106112757|NCT02940574|366070296|FG000|1-year Follow-up|Lost to Follow-up|3|||
106112758|NCT02940574|366070297|FG001|1-year Follow-up|Lost to Follow-up|4|||
106112759|NCT00387894|366070298|FG000|Overall Study|Withdrawal by Subject|1|||
106112760|NCT00659490|366070299|FG000|Overall Study|Lost to Follow-up|2|||
106112761|NCT00659490|366070300|FG001|Overall Study|Lost to Follow-up|0|||
106112762|NCT00659490|366070301|FG002|Overall Study|Lost to Follow-up|1|||
106112763|NCT05674890|366070306|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
106112764|NCT05674890|366070307|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
106112765|NCT05674890|366070306|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
106112766|NCT05674890|366070307|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
106112767|NCT05674890|366070306|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
106112768|NCT05674890|366070307|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
106112769|NCT00827541|366070308|FG000|Overall Study|Exitus|1|||
106112770|NCT00827541|366070309|FG001|Overall Study|Exitus|8|||
106112771|NCT00827541|366070308|FG000|Overall Study|Other|1|||
106112772|NCT00827541|366070309|FG001|Overall Study|Other|3|||
106112773|NCT00827541|366070308|FG000|Overall Study|Pathogen not susceptible|1|||
106112774|NCT00827541|366070309|FG001|Overall Study|Pathogen not susceptible|0|||
106112775|NCT00827541|366070308|FG000|Overall Study|Lack of effectiveness|1|||
106112776|NCT00827541|366070309|FG001|Overall Study|Lack of effectiveness|0|||
106112777|NCT01750879|366070310|FG000|Overall Study|Adverse Event|8|||
106112778|NCT01750879|366070311|FG001|Overall Study|Adverse Event|0|||
106112779|NCT01750879|366070310|FG000|Overall Study|Lack of Efficacy|1|||
106112780|NCT01750879|366070311|FG001|Overall Study|Lack of Efficacy|0|||
106112781|NCT01750879|366070310|FG000|Overall Study|Withdrawal by Subject|1|||
106112782|NCT01750879|366070311|FG001|Overall Study|Withdrawal by Subject|0|||
106112783|NCT01750879|366070310|FG000|Overall Study|Did not complete per protocol|0|||
106112784|NCT01750879|366070311|FG001|Overall Study|Did not complete per protocol|3|||
106112785|NCT04810221|366070314|FG000|Overall Study|Physician Decision|3|||
106112786|NCT03642938|366070315|FG000|Overall Study|Withdrawal by Subject|0|||
106112787|NCT03642938|366070316|FG001|Overall Study|Withdrawal by Subject|0|||
106112788|NCT03642938|366070317|FG002|Overall Study|Withdrawal by Subject|0|||
106112789|NCT03642938|366070318|FG003|Overall Study|Withdrawal by Subject|1|||
106112790|NCT04439136|366070319|FG000|Overall Study|Ineligible|1|||
106112791|NCT04439136|366070319|FG000|Overall Study|Never Started Treatment|2|||
106112792|NCT04439136|366070319|FG000|Overall Study|Adverse Event|4|||
106112793|NCT04439136|366070319|FG000|Overall Study|Death|3|||
106112794|NCT04439136|366070319|FG000|Overall Study|Disease Progression|27|||
106112795|NCT04439136|366070319|FG000|Overall Study|Alternative Therapy|1|||
106112796|NCT04439136|366070319|FG000|Overall Study|Increased Tumor Burden|1|||
106112797|NCT04439136|366070319|FG000|Overall Study|Symptomatic Detrioration|1|||
106112798|NCT02347657|366070320|FG000|Overall Study|Physician Decision|0|||
106112799|NCT02347657|366070321|FG001|Overall Study|Physician Decision|1|||
106112800|NCT02347657|366070320|FG000|Overall Study|Adverse Event|8|||
106112801|NCT02347657|366070321|FG001|Overall Study|Adverse Event|4|||
106112802|NCT02347657|366070320|FG000|Overall Study|Withdrawal by Subject|6|||
106112803|NCT02347657|366070321|FG001|Overall Study|Withdrawal by Subject|7|||
106112804|NCT02347657|366070320|FG000|Overall Study|Randomized but not treated|1|||
106112805|NCT02347657|366070321|FG001|Overall Study|Randomized but not treated|0|||
106112806|NCT02347657|366070320|FG000|Overall Study|Other|3|||
106112807|NCT02347657|366070321|FG001|Overall Study|Other|3|||
106112808|NCT01264380|366070322|FG000|Period C|Disease Progression|0|||
106112809|NCT01264380|366070323|FG001|Period C|Disease Progression|0|||
106112810|NCT01264380|366070324|FG002|Period C|Disease Progression|4|||
106112811|NCT01264380|366070322|FG000|Period C|Death|0|||
106112812|NCT01264380|366070323|FG001|Period C|Death|0|||
106112813|NCT01264380|366070324|FG002|Period C|Death|2|||
106112814|NCT01264380|366070322|FG000|Period C|Follow-up for survival status|0|||
106112815|NCT01264380|366070323|FG001|Period C|Follow-up for survival status|0|||
106112816|NCT01264380|366070324|FG002|Period C|Follow-up for survival status|6|||
106112817|NCT01264380|366070322|FG000|Period C|Withdrawal by Subject|0|||
106112818|NCT01264380|366070323|FG001|Period C|Withdrawal by Subject|0|||
106112819|NCT01264380|366070324|FG002|Period C|Withdrawal by Subject|1|||
106112820|NCT01264380|366070322|FG000|Period C|Adverse Event|0|||
106112821|NCT01264380|366070323|FG001|Period C|Adverse Event|0|||
106112822|NCT01264380|366070324|FG002|Period C|Adverse Event|1|||
106112823|NCT02013388|366070330|FG000|Overall Study|work emergency|1|||
106112824|NCT02013388|366070331|FG001|Overall Study|work emergency|0|||
106112825|NCT02013388|366070332|FG002|Overall Study|work emergency|0|||
106112826|NCT02013388|366070333|FG003|Overall Study|work emergency|0|||
106112827|NCT02013388|366070334|FG004|Overall Study|work emergency|1|||
106112828|NCT02013388|366070335|FG005|Overall Study|work emergency|0|||
106112829|NCT02013388|366070336|FG006|Overall Study|work emergency|0|||
106112830|NCT02013388|366070337|FG007|Overall Study|work emergency|0|||
106112831|NCT01114204|366070338|FG000|Overall Study|Adverse Event|3|||
106112832|NCT01114204|366070339|FG001|Overall Study|Adverse Event|2|||
106112833|NCT01114204|366070338|FG000|Overall Study|Lost to Follow-up|1|||
106112834|NCT01114204|366070339|FG001|Overall Study|Lost to Follow-up|0|||
106112835|NCT01114204|366070338|FG000|Overall Study|Withdrawal by Subject|10|||
106112836|NCT01114204|366070339|FG001|Overall Study|Withdrawal by Subject|6|||
106112837|NCT01114204|366070338|FG000|Overall Study|Death|1|||
105993762|NCT00108862|365636094|FG001|Overall Study|Lost to Follow-up|19|||
105993763|NCT04854551|365636095|FG000|Overall Study|Withdrawal by Subject|1|||
105883874|NCT02564900|365229632|FG002|Dose Expansion|Clinical progression|0|||
105883875|NCT02564900|365229633|FG003|Dose Expansion|Clinical progression|0|||
105883876|NCT02564900|365229634|FG004|Dose Expansion|Clinical progression|0|||
105883877|NCT02564900|365229635|FG005|Dose Expansion|Clinical progression|0|||
105883878|NCT02564900|365229636|FG006|Dose Expansion|Clinical progression|5|||
105883879|NCT02564900|365229637|FG007|Dose Expansion|Clinical progression|12|||
105883880|NCT02564900|365229638|FG008|Dose Expansion|Clinical progression|0|||
105883881|NCT02564900|365229639|FG009|Dose Expansion|Clinical progression|3|||
105883882|NCT02564900|365229640|FG010|Dose Expansion|Clinical progression|2|||
106112838|NCT01114204|366070339|FG001|Overall Study|Death|0|||
106112839|NCT01114204|366070338|FG000|Overall Study|Other-Personal reasons|2|||
106112840|NCT01114204|366070339|FG001|Overall Study|Other-Personal reasons|0|||
106112841|NCT01114204|366070338|FG000|Overall Study|Other-Medical monitor request|1|||
106112842|NCT01114204|366070339|FG001|Overall Study|Other-Medical monitor request|0|||
106112843|NCT01114204|366070338|FG000|Overall Study|Other-Participant request|2|||
106112844|NCT01114204|366070339|FG001|Overall Study|Other-Participant request|0|||
106112845|NCT01114204|366070338|FG000|Overall Study|Other-Protocol Violation|1|||
106112846|NCT01114204|366070339|FG001|Overall Study|Other-Protocol Violation|0|||
106112847|NCT00674570|366070346|FG000|Overall Study|Withdrawal by Subject|0|||
106112848|NCT00674570|366070347|FG001|Overall Study|Withdrawal by Subject|2|||
106112849|NCT00674570|366070348|FG002|Overall Study|Withdrawal by Subject|0|||
106112850|NCT01337986|366070349|FG000|Overall Study|Adverse Event|2|||
106112851|NCT01337986|366070350|FG001|Overall Study|Adverse Event|2|||
106112852|NCT01337986|366070349|FG000|Overall Study|Lost to Follow-up|1|||
106112853|NCT01337986|366070350|FG001|Overall Study|Lost to Follow-up|0|||
106112854|NCT01337986|366070349|FG000|Overall Study|Protocol Violation|0|||
106112855|NCT01337986|366070350|FG001|Overall Study|Protocol Violation|3|||
106112856|NCT00058422|366070353|FG000|Overall Study|Not treated|2|||
106112857|NCT01520402|366070355|FG000|Overall Study|Withdrawal by Subject|2|||
105883883|NCT02564900|365229641|FG011|Dose Expansion|Clinical progression|0|||
105883884|NCT02564900|365229642|FG012|Dose Expansion|Clinical progression|1|||
105883885|NCT02564900|365229643|FG013|Dose Expansion|Clinical progression|3|||
105883886|NCT02564900|365229644|FG014|Dose Expansion|Clinical progression|1|||
105883887|NCT02564900|365229630|FG000|Dose Expansion|Adverse Event|0|||
105883888|NCT02564900|365229631|FG001|Dose Expansion|Adverse Event|0|||
105883889|NCT02564900|365229632|FG002|Dose Expansion|Adverse Event|0|||
105883890|NCT02564900|365229633|FG003|Dose Expansion|Adverse Event|0|||
105883891|NCT02564900|365229634|FG004|Dose Expansion|Adverse Event|0|||
105883892|NCT02564900|365229635|FG005|Dose Expansion|Adverse Event|0|||
105883893|NCT02564900|365229636|FG006|Dose Expansion|Adverse Event|9|||
105883894|NCT02564900|365229637|FG007|Dose Expansion|Adverse Event|22|||
105883895|NCT02564900|365229638|FG008|Dose Expansion|Adverse Event|0|||
105883896|NCT02564900|365229639|FG009|Dose Expansion|Adverse Event|11|||
105883897|NCT02564900|365229640|FG010|Dose Expansion|Adverse Event|0|||
105883898|NCT02564900|365229641|FG011|Dose Expansion|Adverse Event|5|||
105883899|NCT02564900|365229642|FG012|Dose Expansion|Adverse Event|2|||
105883900|NCT02564900|365229643|FG013|Dose Expansion|Adverse Event|2|||
105883901|NCT02564900|365229644|FG014|Dose Expansion|Adverse Event|1|||
105883902|NCT02564900|365229630|FG000|Dose Expansion|Ongoing|0|||
105883903|NCT02564900|365229631|FG001|Dose Expansion|Ongoing|0|||
105883904|NCT02564900|365229632|FG002|Dose Expansion|Ongoing|0|||
105883905|NCT02564900|365229633|FG003|Dose Expansion|Ongoing|0|||
105883906|NCT02564900|365229634|FG004|Dose Expansion|Ongoing|0|||
105883907|NCT02564900|365229635|FG005|Dose Expansion|Ongoing|0|||
105883908|NCT02564900|365229636|FG006|Dose Expansion|Ongoing|9|||
105883909|NCT02564900|365229637|FG007|Dose Expansion|Ongoing|10|||
105883910|NCT02564900|365229638|FG008|Dose Expansion|Ongoing|11|||
105883911|NCT02564900|365229639|FG009|Dose Expansion|Ongoing|3|||
105883912|NCT02564900|365229640|FG010|Dose Expansion|Ongoing|0|||
105883913|NCT02564900|365229641|FG011|Dose Expansion|Ongoing|0|||
105883914|NCT02564900|365229642|FG012|Dose Expansion|Ongoing|4|||
105883915|NCT02564900|365229643|FG013|Dose Expansion|Ongoing|0|||
105883916|NCT02564900|365229644|FG014|Dose Expansion|Ongoing|6|||
105883917|NCT02564900|365229630|FG000|Dose Expansion|Death|0|||
105883918|NCT02564900|365229631|FG001|Dose Expansion|Death|0|||
105883919|NCT02564900|365229632|FG002|Dose Expansion|Death|0|||
105883920|NCT02564900|365229633|FG003|Dose Expansion|Death|0|||
105993764|NCT04854551|365636096|FG001|Overall Study|Withdrawal by Subject|1|||
105883921|NCT02564900|365229634|FG004|Dose Expansion|Death|0|||
105883922|NCT02564900|365229635|FG005|Dose Expansion|Death|0|||
105883923|NCT02564900|365229636|FG006|Dose Expansion|Death|1|||
105993765|NCT03472950|365636097|FG000|Overall Study|Lost to Follow-up|0|||
106112858|NCT01520402|366070355|FG000|Overall Study|Physician Decision|3|||
105883924|NCT02564900|365229637|FG007|Dose Expansion|Death|0|||
106112859|NCT02569437|366070372|FG000|Overall Study|Lost to Follow-up|12|||
106112860|NCT02569437|366070373|FG001|Overall Study|Lost to Follow-up|14|||
106112861|NCT02487472|366070374|FG000|Overall Study|Did not complete telephonic interviews|9|||
106112862|NCT02487472|366070374|FG000|Overall Study|Other|2|||
106112863|NCT02034708|366070379|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
106112864|NCT02034708|366070380|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
106112865|NCT02034708|366070379|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
106112866|NCT02034708|366070380|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
106112867|NCT02034708|366070379|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
106112868|NCT02034708|366070380|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
106112869|NCT02034708|366070379|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
106112870|NCT02034708|366070380|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
106112871|NCT03988166|366070383|FG000|Overall Study|Lost to Follow-up|2|||
106112872|NCT03988166|366070383|FG000|Overall Study|Death|1|||
106112873|NCT02552238|366070384|FG000|Overall Study|Withdrawal by Subject|2|||
106112874|NCT02552238|366070384|FG000|Overall Study|Adverse Event|2|||
106112875|NCT05076149|366070385|FG000|Overall Study|Adverse Event|3|||
106112876|NCT05076149|366070386|FG001|Overall Study|Adverse Event|9|||
106112877|NCT05076149|366070385|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
105883925|NCT02564900|365229638|FG008|Dose Expansion|Death|0|||
105883926|NCT02564900|365229639|FG009|Dose Expansion|Death|0|||
105883927|NCT02564900|365229640|FG010|Dose Expansion|Death|1|||
105883928|NCT02564900|365229641|FG011|Dose Expansion|Death|0|||
105883929|NCT02564900|365229642|FG012|Dose Expansion|Death|1|||
105883930|NCT02564900|365229643|FG013|Dose Expansion|Death|1|||
105883931|NCT02564900|365229644|FG014|Dose Expansion|Death|0|||
105883932|NCT02564900|365229630|FG000|Dose Expansion|Withdrawal by Subject|0|||
105883933|NCT02564900|365229631|FG001|Dose Expansion|Withdrawal by Subject|0|||
105883934|NCT02564900|365229632|FG002|Dose Expansion|Withdrawal by Subject|0|||
105883935|NCT02564900|365229633|FG003|Dose Expansion|Withdrawal by Subject|0|||
105883936|NCT02564900|365229634|FG004|Dose Expansion|Withdrawal by Subject|0|||
105883937|NCT02564900|365229635|FG005|Dose Expansion|Withdrawal by Subject|0|||
105883938|NCT02564900|365229636|FG006|Dose Expansion|Withdrawal by Subject|4|||
105883939|NCT02564900|365229637|FG007|Dose Expansion|Withdrawal by Subject|0|||
105883940|NCT02564900|365229638|FG008|Dose Expansion|Withdrawal by Subject|0|||
105883941|NCT02564900|365229639|FG009|Dose Expansion|Withdrawal by Subject|0|||
105883942|NCT02564900|365229640|FG010|Dose Expansion|Withdrawal by Subject|1|||
105883943|NCT02564900|365229641|FG011|Dose Expansion|Withdrawal by Subject|0|||
105883944|NCT02564900|365229642|FG012|Dose Expansion|Withdrawal by Subject|0|||
105883945|NCT02564900|365229643|FG013|Dose Expansion|Withdrawal by Subject|1|||
105883946|NCT02564900|365229644|FG014|Dose Expansion|Withdrawal by Subject|1|||
106112878|NCT05076149|366070386|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
106112879|NCT05076149|366070385|FG000|Overall Study|Lost to Follow-up|0|||
106112880|NCT05076149|366070386|FG001|Overall Study|Lost to Follow-up|1|||
106112881|NCT05076149|366070385|FG000|Overall Study|Commercial drug is available for participant|0|||
106112882|NCT05076149|366070386|FG001|Overall Study|Commercial drug is available for participant|1|||
106112883|NCT05076149|366070385|FG000|Overall Study|Other non compliance|1|||
106112884|NCT05076149|366070386|FG001|Overall Study|Other non compliance|1|||
106112885|NCT05076149|366070385|FG000|Overall Study|Physician Decision|0|||
105883947|NCT02564900|365229630|FG000|Dose Expansion|Other|0|||
105883948|NCT02564900|365229631|FG001|Dose Expansion|Other|0|||
105883949|NCT02564900|365229632|FG002|Dose Expansion|Other|0|||
105883950|NCT02564900|365229633|FG003|Dose Expansion|Other|0|||
105883951|NCT02564900|365229634|FG004|Dose Expansion|Other|0|||
106112886|NCT05076149|366070386|FG001|Overall Study|Physician Decision|1|||
106112887|NCT05076149|366070385|FG000|Overall Study|Other|5|||
106112888|NCT05076149|366070386|FG001|Overall Study|Other|4|||
106112889|NCT00782496|366070387|FG000|Overall Study|Lost to Follow-up|14|||
106112890|NCT00782496|366070388|FG001|Overall Study|Lost to Follow-up|15|||
106112891|NCT02070484|366070393|FG000|Overall Study|Withdrawal by Subject|1|||
106112892|NCT02070484|366070394|FG001|Overall Study|Withdrawal by Subject|0|||
106112893|NCT00263328|366070395|FG000|Overall Study|Death|0|||
106112894|NCT00263328|366070396|FG001|Overall Study|Death|0|||
106112895|NCT00263328|366070397|FG002|Overall Study|Death|1|||
106112896|NCT00263328|366070395|FG000|Overall Study|Lost to Follow-up|1|||
106112897|NCT00263328|366070396|FG001|Overall Study|Lost to Follow-up|1|||
106112898|NCT00263328|366070397|FG002|Overall Study|Lost to Follow-up|0|||
106112899|NCT00263328|366070395|FG000|Overall Study|Withdrawal by Subject|3|||
106112900|NCT00263328|366070396|FG001|Overall Study|Withdrawal by Subject|0|||
106112901|NCT00263328|366070397|FG002|Overall Study|Withdrawal by Subject|1|||
106112902|NCT00263328|366070395|FG000|Overall Study|Other|3|||
105883952|NCT02564900|365229635|FG005|Dose Expansion|Other|0|||
105883953|NCT02564900|365229636|FG006|Dose Expansion|Other|1|||
105883954|NCT02564900|365229637|FG007|Dose Expansion|Other|0|||
105883955|NCT02564900|365229638|FG008|Dose Expansion|Other|1|||
105883956|NCT02564900|365229639|FG009|Dose Expansion|Other|0|||
105883957|NCT02564900|365229640|FG010|Dose Expansion|Other|0|||
106112903|NCT00263328|366070396|FG001|Overall Study|Other|0|||
106112904|NCT00263328|366070397|FG002|Overall Study|Other|1|||
105883958|NCT02564900|365229641|FG011|Dose Expansion|Other|0|||
105883959|NCT02564900|365229642|FG012|Dose Expansion|Other|0|||
105883960|NCT02564900|365229643|FG013|Dose Expansion|Other|0|||
105883961|NCT02564900|365229644|FG014|Dose Expansion|Other|1|||
105883962|NCT02564900|365229630|FG000|Dose Expansion|Did not receive treatment|0|||
105883963|NCT02564900|365229631|FG001|Dose Expansion|Did not receive treatment|0|||
105883964|NCT02564900|365229632|FG002|Dose Expansion|Did not receive treatment|0|||
105883965|NCT02564900|365229633|FG003|Dose Expansion|Did not receive treatment|0|||
105883966|NCT02564900|365229634|FG004|Dose Expansion|Did not receive treatment|0|||
105883967|NCT02564900|365229635|FG005|Dose Expansion|Did not receive treatment|0|||
105883968|NCT02564900|365229636|FG006|Dose Expansion|Did not receive treatment|1|||
106112905|NCT00263328|366070395|FG000|Overall Study|Adverse Event|1|||
106112906|NCT00263328|366070396|FG001|Overall Study|Adverse Event|1|||
106112907|NCT00263328|366070397|FG002|Overall Study|Adverse Event|4|||
106112908|NCT00622180|366070398|FG000|Overall Study|Lost to Follow-up|1|||
106112909|NCT00622180|366070399|FG001|Overall Study|Lost to Follow-up|2|||
106112910|NCT02332590|366070402|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
106112911|NCT02332590|366070403|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
106112912|NCT02332590|366070402|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
106112913|NCT02332590|366070403|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
106112914|NCT02332590|366070402|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
106112915|NCT02332590|366070403|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
106112916|NCT02332590|366070402|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
106112917|NCT02332590|366070403|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
106112918|NCT02332590|366070402|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
106112919|NCT02332590|366070403|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
106112920|NCT02332590|366070402|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
106112921|NCT02332590|366070403|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
106112922|NCT02332590|366070402|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
106112923|NCT02332590|366070403|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
106112924|NCT02332590|366070402|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
106112925|NCT02332590|366070403|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
106112926|NCT02332590|366070402|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
106112927|NCT02332590|366070403|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
106112928|NCT00445679|366070406|FG000|Overall Study|Adverse Event|22|||
106112929|NCT00445679|366070407|FG001|Overall Study|Adverse Event|12|||
106112930|NCT00445679|366070408|FG002|Overall Study|Adverse Event|30|||
106112931|NCT00445679|366070409|FG003|Overall Study|Adverse Event|19|||
106112932|NCT00445679|366070406|FG000|Overall Study|Failed to return|1|||
106112933|NCT00445679|366070407|FG001|Overall Study|Failed to return|3|||
106112934|NCT00445679|366070408|FG002|Overall Study|Failed to return|2|||
106112935|NCT00445679|366070409|FG003|Overall Study|Failed to return|2|||
106112936|NCT00445679|366070406|FG000|Overall Study|Physician Decision|0|||
106112937|NCT00445679|366070407|FG001|Overall Study|Physician Decision|0|||
106112938|NCT00445679|366070408|FG002|Overall Study|Physician Decision|1|||
106112939|NCT00445679|366070409|FG003|Overall Study|Physician Decision|0|||
106112940|NCT00445679|366070406|FG000|Overall Study|Lost to Follow-up|10|||
106112941|NCT00445679|366070407|FG001|Overall Study|Lost to Follow-up|6|||
106112942|NCT00445679|366070408|FG002|Overall Study|Lost to Follow-up|6|||
106112943|NCT00445679|366070409|FG003|Overall Study|Lost to Follow-up|5|||
106112944|NCT00445679|366070406|FG000|Overall Study|Compliance|3|||
106112945|NCT00445679|366070407|FG001|Overall Study|Compliance|2|||
106112946|NCT00445679|366070408|FG002|Overall Study|Compliance|1|||
106112947|NCT00445679|366070409|FG003|Overall Study|Compliance|2|||
106112948|NCT00445679|366070406|FG000|Overall Study|Withdrawal of Informed Consent|0|||
106112949|NCT00445679|366070407|FG001|Overall Study|Withdrawal of Informed Consent|0|||
106112950|NCT00445679|366070408|FG002|Overall Study|Withdrawal of Informed Consent|1|||
106112951|NCT00445679|366070409|FG003|Overall Study|Withdrawal of Informed Consent|0|||
106112952|NCT00445679|366070406|FG000|Overall Study|Protocol Violation|2|||
106112953|NCT00445679|366070407|FG001|Overall Study|Protocol Violation|3|||
106112954|NCT00445679|366070408|FG002|Overall Study|Protocol Violation|3|||
106112955|NCT00445679|366070409|FG003|Overall Study|Protocol Violation|1|||
106112956|NCT00445679|366070406|FG000|Overall Study|Withdrawal by Subject|8|||
106112957|NCT00445679|366070407|FG001|Overall Study|Withdrawal by Subject|14|||
106112958|NCT00445679|366070408|FG002|Overall Study|Withdrawal by Subject|20|||
106112959|NCT00445679|366070409|FG003|Overall Study|Withdrawal by Subject|18|||
106112960|NCT00445679|366070406|FG000|Overall Study|Lack of Efficacy|2|||
106112961|NCT00445679|366070407|FG001|Overall Study|Lack of Efficacy|6|||
106112962|NCT00445679|366070408|FG002|Overall Study|Lack of Efficacy|2|||
106112963|NCT00445679|366070409|FG003|Overall Study|Lack of Efficacy|0|||
106112964|NCT00941798|366070414|FG000|Overall Study|Withdrawal by Subject|72|||
106112965|NCT00941798|366070415|FG001|Overall Study|Withdrawal by Subject|74|||
106112966|NCT00941798|366070414|FG000|Overall Study|Adverse Event|43|||
105883969|NCT02564900|365229637|FG007|Dose Expansion|Did not receive treatment|1|||
105883970|NCT02564900|365229638|FG008|Dose Expansion|Did not receive treatment|0|||
106112967|NCT00941798|366070415|FG001|Overall Study|Adverse Event|23|||
105883971|NCT02564900|365229639|FG009|Dose Expansion|Did not receive treatment|0|||
105883972|NCT02564900|365229640|FG010|Dose Expansion|Did not receive treatment|0|||
105883973|NCT02564900|365229641|FG011|Dose Expansion|Did not receive treatment|0|||
105883974|NCT02564900|365229642|FG012|Dose Expansion|Did not receive treatment|0|||
105883975|NCT02564900|365229643|FG013|Dose Expansion|Did not receive treatment|0|||
105883976|NCT02564900|365229644|FG014|Dose Expansion|Did not receive treatment|1|||
105883977|NCT04075682|365229645|FG000|Overall Study|Lost to Follow-up|5|||
105883978|NCT04075682|365229646|FG001|Overall Study|Lost to Follow-up|5|||
105883979|NCT04075682|365229647|FG002|Overall Study|Lost to Follow-up|2|||
105883980|NCT04075682|365229648|FG003|Overall Study|Lost to Follow-up|2|||
105883981|NCT04075682|365229645|FG000|Overall Study|Withdrawal by Subject|1|||
105883982|NCT04075682|365229646|FG001|Overall Study|Withdrawal by Subject|0|||
105883983|NCT04075682|365229647|FG002|Overall Study|Withdrawal by Subject|1|||
105883984|NCT04075682|365229648|FG003|Overall Study|Withdrawal by Subject|0|||
105883985|NCT04075682|365229645|FG000|Overall Study|Protocol Violation|0|||
105883986|NCT04075682|365229646|FG001|Overall Study|Protocol Violation|1|||
105883987|NCT04075682|365229647|FG002|Overall Study|Protocol Violation|1|||
105883988|NCT04075682|365229648|FG003|Overall Study|Protocol Violation|0|||
105883989|NCT04075682|365229645|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
105883990|NCT04075682|365229646|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
105883991|NCT04075682|365229647|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
105883992|NCT04075682|365229648|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
105883993|NCT04075682|365229645|FG000|Overall Study|Lost study phone the first day of study participation|0|||
105883994|NCT04075682|365229646|FG001|Overall Study|Lost study phone the first day of study participation|1|||
105883995|NCT04075682|365229647|FG002|Overall Study|Lost study phone the first day of study participation|0|||
105883996|NCT04075682|365229648|FG003|Overall Study|Lost study phone the first day of study participation|0|||
105883997|NCT00379080|365229653|FG000|Overall Study|Withdrawal by Subject|0|||
105883998|NCT00379080|365229654|FG001|Overall Study|Withdrawal by Subject|4|||
105883999|NCT00379080|365229655|FG002|Overall Study|Withdrawal by Subject|0|||
105884000|NCT01289639|365229657|FG000|Overall Study|Lost to Follow-up|1|||
105884001|NCT01289639|365229658|FG001|Overall Study|Lost to Follow-up|0|||
105884002|NCT01289639|365229659|FG002|Overall Study|Lost to Follow-up|0|||
105884003|NCT02780713|365229660|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
105884004|NCT02780713|365229661|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
105884005|NCT02780713|365229662|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
106112968|NCT00941798|366070414|FG000|Overall Study|Lost to Follow-up|29|||
106112969|NCT00941798|366070415|FG001|Overall Study|Lost to Follow-up|23|||
106112970|NCT00941798|366070414|FG000|Overall Study|Protocol Violation|17|||
106112971|NCT00941798|366070415|FG001|Overall Study|Protocol Violation|20|||
106112972|NCT00941798|366070414|FG000|Overall Study|Administrative problems|13|||
106112973|NCT00941798|366070415|FG001|Overall Study|Administrative problems|23|||
106112974|NCT00941798|366070414|FG000|Overall Study|Lack of Efficacy|10|||
106112975|NCT00941798|366070415|FG001|Overall Study|Lack of Efficacy|17|||
106112976|NCT00941798|366070414|FG000|Overall Study|Patient's inability to use device|6|||
106112977|NCT00941798|366070415|FG001|Overall Study|Patient's inability to use device|1|||
106112978|NCT00941798|366070414|FG000|Overall Study|Abnormal test procedure results|3|||
106112979|NCT00941798|366070415|FG001|Overall Study|Abnormal test procedure results|1|||
106112980|NCT00941798|366070414|FG000|Overall Study|Abnormal laboratory values|1|||
106112981|NCT00941798|366070415|FG001|Overall Study|Abnormal laboratory values|2|||
106112982|NCT00941798|366070414|FG000|Overall Study|Death|0|||
106112983|NCT00941798|366070415|FG001|Overall Study|Death|1|||
106112984|NCT03474549|366070416|FG000|Overall Study|Death|31|||
106112985|NCT03474549|366070416|FG000|Overall Study|Lost to Follow-up|4|||
106112986|NCT03474549|366070416|FG000|Overall Study|Withdrawal by Subject|2|||
106112987|NCT00404495|366070420|FG000|Overall Study|Death|37|||
106112988|NCT00404495|366070421|FG001|Overall Study|Death|11|||
106112989|NCT00404495|366070420|FG000|Overall Study|Lost to Follow-up|5|||
106112990|NCT00404495|366070421|FG001|Overall Study|Lost to Follow-up|0|||
106112991|NCT00404495|366070420|FG000|Overall Study|Other|1|||
106112992|NCT00404495|366070421|FG001|Overall Study|Other|0|||
106112993|NCT00404495|366070420|FG000|Overall Study|Withdrawal by Subject|1|||
106112994|NCT00404495|366070421|FG001|Overall Study|Withdrawal by Subject|0|||
106112995|NCT04108000|366070422|FG000|Overall Study|Death of patient|1|||
106112996|NCT04108000|366070423|FG001|Overall Study|Death of patient|0|||
106112997|NCT04108000|366070424|FG002|Overall Study|Death of patient|1|||
106112998|NCT04108000|366070425|FG003|Overall Study|Death of patient|0|||
106112999|NCT04108000|366070422|FG000|Overall Study|Withdrawal by Subject|2|||
106113000|NCT04108000|366070423|FG001|Overall Study|Withdrawal by Subject|2|||
106113001|NCT04108000|366070424|FG002|Overall Study|Withdrawal by Subject|0|||
106113002|NCT04108000|366070425|FG003|Overall Study|Withdrawal by Subject|0|||
106113003|NCT04108000|366070422|FG000|Overall Study|Death of surrogate partner|0|||
106113004|NCT04108000|366070423|FG001|Overall Study|Death of surrogate partner|1|||
106113005|NCT04108000|366070424|FG002|Overall Study|Death of surrogate partner|0|||
106113006|NCT04108000|366070425|FG003|Overall Study|Death of surrogate partner|1|||
105884006|NCT02780713|365229663|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
105884007|NCT02780713|365229664|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
105884008|NCT01931475|365229666|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
105884009|NCT01931475|365229667|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
105884010|NCT01931475|365229666|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
105884011|NCT01931475|365229667|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
105884012|NCT01931475|365229666|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
105884013|NCT01931475|365229667|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
105884014|NCT01931475|365229666|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
105884015|NCT01931475|365229667|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
105884016|NCT01931475|365229666|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
105884017|NCT01931475|365229667|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
105884018|NCT01931475|365229666|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
105884019|NCT01931475|365229667|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
105884020|NCT01931475|365229666|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
105884021|NCT01931475|365229667|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
105884022|NCT01931475|365229666|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
105884023|NCT01931475|365229667|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
105884024|NCT01931475|365229666|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
105884025|NCT01931475|365229667|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
105884026|NCT01931475|365229666|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
105884027|NCT01931475|365229667|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
105884028|NCT01931475|365229666|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
105884029|NCT01931475|365229667|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
105884030|NCT00280397|365229668|FG000|Overall Study|Adverse Event|1|||
105884031|NCT00955955|365229669|FG000|Overall Study|Lost to Follow-up|2|||
105884032|NCT00955955|365229670|FG001|Overall Study|Lost to Follow-up|0|||
105884033|NCT00955955|365229671|FG002|Overall Study|Lost to Follow-up|0|||
105884034|NCT03423173|365229672|FG000|Overall Study|Randomized but not vaccinated|1|||
105884035|NCT03423173|365229673|FG001|Overall Study|Randomized but not vaccinated|0|||
105884036|NCT03423173|365229674|FG002|Overall Study|Randomized but not vaccinated|2|||
105884037|NCT03423173|365229675|FG003|Overall Study|Randomized but not vaccinated|1|||
105884038|NCT03423173|365229672|FG000|Overall Study|Adverse Event|1|||
105884039|NCT03423173|365229673|FG001|Overall Study|Adverse Event|1|||
105884040|NCT03423173|365229674|FG002|Overall Study|Adverse Event|1|||
105884041|NCT03423173|365229675|FG003|Overall Study|Adverse Event|1|||
105884042|NCT03423173|365229672|FG000|Overall Study|Lost to Follow-up|10|||
105884043|NCT03423173|365229673|FG001|Overall Study|Lost to Follow-up|19|||
105884044|NCT03423173|365229674|FG002|Overall Study|Lost to Follow-up|17|||
105884045|NCT03423173|365229675|FG003|Overall Study|Lost to Follow-up|22|||
105884046|NCT03423173|365229672|FG000|Overall Study|Withdrawal of consent|4|||
105884047|NCT03423173|365229673|FG001|Overall Study|Withdrawal of consent|10|||
105884048|NCT03423173|365229674|FG002|Overall Study|Withdrawal of consent|4|||
105884049|NCT03423173|365229675|FG003|Overall Study|Withdrawal of consent|5|||
105884050|NCT03423173|365229672|FG000|Overall Study|Death|1|||
105884051|NCT03423173|365229673|FG001|Overall Study|Death|0|||
105884052|NCT03423173|365229674|FG002|Overall Study|Death|0|||
105884053|NCT03423173|365229675|FG003|Overall Study|Death|0|||
105884054|NCT03423173|365229672|FG000|Overall Study|Reason not Specified|2|||
105884055|NCT03423173|365229673|FG001|Overall Study|Reason not Specified|5|||
105884056|NCT03423173|365229674|FG002|Overall Study|Reason not Specified|3|||
105884057|NCT03423173|365229675|FG003|Overall Study|Reason not Specified|1|||
105884058|NCT00708214|365229678|FG000|Overall Study|Other Adverse Event|3|||
105884059|NCT00708214|365229679|FG001|Overall Study|Other Adverse Event|6|||
105884060|NCT00708214|365229680|FG002|Overall Study|Other Adverse Event|2|||
105884061|NCT00708214|365229678|FG000|Overall Study|Other|0|||
105884062|NCT00708214|365229679|FG001|Overall Study|Other|1|||
105884063|NCT00708214|365229680|FG002|Overall Study|Other|1|||
105884064|NCT00708214|365229678|FG000|Overall Study|Progressive Disease|4|||
105884065|NCT00708214|365229679|FG001|Overall Study|Progressive Disease|6|||
105884066|NCT00708214|365229680|FG002|Overall Study|Progressive Disease|5|||
105884067|NCT03533114|365229681|FG000|Overall|Adverse Event|16|||
105884068|NCT03533114|365229682|FG001|Overall|Adverse Event|11|||
105884069|NCT03533114|365229681|FG000|Overall|Consent Withdrawal by Participant|7|||
105884070|NCT03533114|365229682|FG001|Overall|Consent Withdrawal by Participant|6|||
105884071|NCT03533114|365229681|FG000|Overall|Lack of Efficacy|5|||
105884072|NCT03533114|365229682|FG001|Overall|Lack of Efficacy|3|||
105884073|NCT03533114|365229681|FG000|Overall|Lost to Follow-up|1|||
105884074|NCT03533114|365229682|FG001|Overall|Lost to Follow-up|1|||
105884075|NCT03533114|365229681|FG000|Overall|Physician Decision|0|||
105884076|NCT03533114|365229682|FG001|Overall|Physician Decision|2|||
105884077|NCT03533114|365229681|FG000|Overall|Protocol deviation|1|||
105884078|NCT03533114|365229682|FG001|Overall|Protocol deviation|1|||
105884079|NCT03533114|365229681|FG000|Overall|Failure to meet randomization criteria|1|||
105884080|NCT03533114|365229682|FG001|Overall|Failure to meet randomization criteria|2|||
105884081|NCT03533114|365229681|FG000|Overall|Non-Compliance with study drug|0|||
106113007|NCT03535337|366070432|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
106113008|NCT03535337|366070433|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
106113009|NCT03535337|366070434|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
106113010|NCT03535337|366070435|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
106113011|NCT03535337|366070436|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
106113012|NCT03535337|366070437|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
106113013|NCT03535337|366070438|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
106113014|NCT03535337|366070439|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
106113015|NCT03535337|366070440|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
106113016|NCT03535337|366070441|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
106113017|NCT01728792|366072085|FG000|Overall Study|Withdrawal of Consent|1|||
106113018|NCT01728792|366072086|FG001|Overall Study|Withdrawal of Consent|1|||
106113019|NCT01728792|366072087|FG002|Overall Study|Withdrawal of Consent|0|||
106113020|NCT01728792|366072088|FG003|Overall Study|Withdrawal of Consent|1|||
106113021|NCT01728792|366072089|FG004|Overall Study|Withdrawal of Consent|0|||
106113022|NCT01728792|366072085|FG000|Overall Study|Lost to Follow-up|2|||
106113023|NCT01728792|366072086|FG001|Overall Study|Lost to Follow-up|1|||
106113024|NCT01728792|366072087|FG002|Overall Study|Lost to Follow-up|4|||
106113025|NCT01728792|366072088|FG003|Overall Study|Lost to Follow-up|2|||
106113026|NCT01728792|366072089|FG004|Overall Study|Lost to Follow-up|0|||
106113027|NCT02026232|366072092|FG000|Overall Study|incomplete visit/missing data|3|||
106113028|NCT02026232|366072093|FG001|Overall Study|incomplete visit/missing data|2|||
106113029|NCT01564368|366072095|FG000|Overall Study|Ineligible|18|||
106113030|NCT01564368|366072095|FG000|Overall Study|Not Randomized in Parent study|116|||
106113031|NCT01564368|366072095|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
106113032|NCT01564368|366072095|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
106113033|NCT01802437|366072096|FG000|Overall Study|Lost to Follow-up|1|||
106113034|NCT01802437|366072097|FG001|Overall Study|Lost to Follow-up|0|||
106113035|NCT01802437|366072096|FG000|Overall Study|Withdrawal by Subject|3|||
106113036|NCT01802437|366072097|FG001|Overall Study|Withdrawal by Subject|4|||
106113037|NCT00331344|366072098|FG000|Phase I|Adverse Event|0|||
106113038|NCT00331344|366072099|FG001|Phase I|Adverse Event|0|||
106113039|NCT00331344|366072100|FG002|Phase I|Adverse Event|0|||
106113040|NCT00331344|366072101|FG003|Phase I|Adverse Event|1|||
106113041|NCT00331344|366072102|FG004|Phase I|Adverse Event|2|||
106113042|NCT00331344|366072103|FG005|Phase I|Adverse Event|2|||
106113043|NCT00331344|366072104|FG006|Phase I|Adverse Event|0|||
106113044|NCT00331344|366072105|FG007|Phase I|Adverse Event|1|||
106113045|NCT00331344|366072106|FG008|Phase I|Adverse Event|0|||
106113046|NCT00331344|366072098|FG000|Phase II|Death|0|||
106113047|NCT00331344|366072099|FG001|Phase II|Death|0|||
106113048|NCT00331344|366072100|FG002|Phase II|Death|0|||
106113049|NCT00331344|366072101|FG003|Phase II|Death|0|||
106113050|NCT00331344|366072102|FG004|Phase II|Death|0|||
106113051|NCT00331344|366072103|FG005|Phase II|Death|0|||
106113052|NCT00331344|366072104|FG006|Phase II|Death|0|||
106113053|NCT00331344|366072105|FG007|Phase II|Death|0|||
106113054|NCT00331344|366072106|FG008|Phase II|Death|4|||
106113055|NCT01649232|366072107|FG000|Overall Study|Physician Decision|2|||
106113056|NCT01649232|366072108|FG001|Overall Study|Physician Decision|0|||
106113057|NCT02228967|366072109|FG000|Overall Study|Lost to Follow-up|146|||
106113058|NCT02228967|366072110|FG001|Overall Study|Lost to Follow-up|142|||
106113059|NCT02228967|366072109|FG000|Overall Study|Withdrawal by Subject|13|||
106113060|NCT02228967|366072110|FG001|Overall Study|Withdrawal by Subject|18|||
106113061|NCT00520975|366072111|FG000|Overall Study|Disease progression|31|||
106113062|NCT00520975|366072112|FG001|Overall Study|Disease progression|23|||
106113063|NCT00520975|366072111|FG000|Overall Study|Adverse Event|7|||
106113064|NCT00520975|366072112|FG001|Overall Study|Adverse Event|10|||
106113065|NCT00520975|366072111|FG000|Overall Study|Death|0|||
106113066|NCT00520975|366072112|FG001|Overall Study|Death|2|||
106113067|NCT00520975|366072111|FG000|Overall Study|Withdrawal by Subject|3|||
106113068|NCT00520975|366072112|FG001|Overall Study|Withdrawal by Subject|5|||
106113069|NCT00520975|366072111|FG000|Overall Study|Other therapy|2|||
106113070|NCT00520975|366072112|FG001|Overall Study|Other therapy|4|||
106113071|NCT00520975|366072111|FG000|Overall Study|Other reasons|4|||
106113072|NCT00520975|366072112|FG001|Overall Study|Other reasons|2|||
106113073|NCT00520975|366072111|FG000|Overall Study|Not start protocol therapy|1|||
106113074|NCT00520975|366072112|FG001|Overall Study|Not start protocol therapy|2|||
106113075|NCT01147822|366072113|FG000|Overall Study|Lost to Follow-up|14|||
106113076|NCT01147822|366072114|FG001|Overall Study|Lost to Follow-up|6|||
106113077|NCT01147822|366072113|FG000|Overall Study|Withdrawal by Subject|10|||
106113078|NCT01147822|366072114|FG001|Overall Study|Withdrawal by Subject|16|||
106113079|NCT01147822|366072113|FG000|Overall Study|Physician Decision|9|||
106113080|NCT01147822|366072114|FG001|Overall Study|Physician Decision|8|||
106113081|NCT01147822|366072113|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
106113082|NCT01147822|366072114|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
106113083|NCT01147822|366072113|FG000|Overall Study|Protocol Violation|1|||
106113084|NCT01147822|366072114|FG001|Overall Study|Protocol Violation|1|||
106113085|NCT04382924|366072116|FG000|Overall Study|Death|2|||
106113086|NCT04382924|366072117|FG001|Overall Study|Death|5|||
106113087|NCT04382924|366072118|FG002|Overall Study|Death|4|||
105884082|NCT03533114|365229682|FG001|Overall|Non-Compliance with study drug|1|||
105884083|NCT03533114|365229681|FG000|Overall|Other|0|||
105884084|NCT03533114|365229682|FG001|Overall|Other|1|||
105884085|NCT03533114|365229681|FG000|Open Label Titration and Optimization|Adverse Event|11|||
105884086|NCT03533114|365229682|FG001|Open Label Titration and Optimization|Adverse Event|8|||
105884087|NCT03533114|365229681|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
105884088|NCT03533114|365229682|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
105884089|NCT03533114|365229681|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
105884090|NCT03533114|365229682|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
105884091|NCT03533114|365229681|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
105884092|NCT03533114|365229682|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
105884093|NCT03533114|365229681|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
105884094|NCT03533114|365229682|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
105884095|NCT03533114|365229681|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
105884096|NCT03533114|365229682|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
105884097|NCT03533114|365229681|FG000|Stable Dose|Adverse Event|0|||
105884098|NCT03533114|365229682|FG001|Stable Dose|Adverse Event|2|||
105884099|NCT03533114|365229681|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
105884100|NCT03533114|365229682|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
105884101|NCT03533114|365229681|FG000|Stable Dose|Lack of Efficacy|1|||
105884102|NCT03533114|365229682|FG001|Stable Dose|Lack of Efficacy|0|||
105884103|NCT03533114|365229681|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
105884104|NCT03533114|365229682|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
105884105|NCT03533114|365229681|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
105884106|NCT03533114|365229682|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
105884107|NCT03533114|365229681|FG000|Open-Label Safety Extension|Adverse Event|3|||
105884108|NCT03533114|365229682|FG001|Open-Label Safety Extension|Adverse Event|0|||
105884109|NCT03533114|365229681|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
105884110|NCT03533114|365229682|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
105884111|NCT03533114|365229681|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
105884112|NCT03533114|365229682|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
105884113|NCT03533114|365229681|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
105884114|NCT03533114|365229682|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
105884115|NCT03533114|365229681|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
105884116|NCT03533114|365229682|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
105884117|NCT01862250|365229683|FG000|Overall Study|Adverse Event|4|||
105884118|NCT03852264|365229684|FG000|Third Research Visit|Lost to Follow-up|1|||
105884119|NCT03852264|365229685|FG001|Third Research Visit|Lost to Follow-up|0|||
105884120|NCT03169881|365229686|FG000|Overall Study|Incomplete Follow-up|10|||
105884121|NCT03169881|365229687|FG001|Overall Study|Incomplete Follow-up|15|||
105884122|NCT03169881|365229686|FG000|Overall Study|Lost to Follow-up|18|||
105884123|NCT03169881|365229687|FG001|Overall Study|Lost to Follow-up|20|||
105884124|NCT03169881|365229686|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
105884125|NCT03169881|365229687|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
105884126|NCT01028014|365229689|FG000|Overall Study|Lost to Follow-up|1|||
105884127|NCT01028014|365229690|FG001|Overall Study|Lost to Follow-up|2|||
105884128|NCT01028014|365229691|FG002|Overall Study|Lost to Follow-up|0|||
105884129|NCT01028014|365229692|FG003|Overall Study|Lost to Follow-up|1|||
105884130|NCT01028014|365229693|FG004|Overall Study|Lost to Follow-up|1|||
105884131|NCT01028014|365229694|FG005|Overall Study|Lost to Follow-up|2|||
105884132|NCT05338502|365229697|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
105884133|NCT05338502|365229698|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
105884134|NCT05338502|365229699|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
105884135|NCT05338502|365229697|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
105884136|NCT05338502|365229698|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
105884137|NCT05338502|365229699|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
105884138|NCT00090493|365229704|FG000|Overall Study|Physician Decision|2|||
105884139|NCT02111577|365229707|FG000|Overall Study|Protocol Violation|2|||
105884140|NCT02111577|365229708|FG001|Overall Study|Protocol Violation|0|||
106113088|NCT04382924|366072116|FG000|Overall Study|Protocol Violation|0|||
106113089|NCT04382924|366072117|FG001|Overall Study|Protocol Violation|1|||
106113090|NCT04382924|366072118|FG002|Overall Study|Protocol Violation|1|||
106113091|NCT04382924|366072116|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
105993766|NCT03472950|365636098|FG001|Overall Study|Lost to Follow-up|1|||
105993767|NCT03472950|365636097|FG000|Overall Study|Adverse Event|0|||
105993768|NCT03472950|365636098|FG001|Overall Study|Adverse Event|3|||
106113092|NCT04382924|366072117|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
105884141|NCT02111577|365229707|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
105993769|NCT00080301|365636099|FG000|Overall Study|Randomized but Never Treated|5|||
105993770|NCT00080301|365636100|FG001|Overall Study|Randomized but Never Treated|10|||
105884142|NCT02111577|365229708|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
106113093|NCT04382924|366072118|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
106113094|NCT04382924|366072116|FG000|Overall Study|Withdrawal by Subject|6|||
106113095|NCT04382924|366072117|FG001|Overall Study|Withdrawal by Subject|3|||
106113096|NCT04382924|366072118|FG002|Overall Study|Withdrawal by Subject|6|||
106113097|NCT00642902|366072121|FG000|Overall Study|Adverse Event|0|||
106113098|NCT00642902|366072122|FG001|Overall Study|Adverse Event|1|||
106113099|NCT00642902|366072123|FG002|Overall Study|Adverse Event|3|||
106113100|NCT00642902|366072124|FG003|Overall Study|Adverse Event|1|||
106113101|NCT00642902|366072121|FG000|Overall Study|Lost to Follow-up|1|||
106113102|NCT00642902|366072122|FG001|Overall Study|Lost to Follow-up|1|||
106113103|NCT00642902|366072123|FG002|Overall Study|Lost to Follow-up|0|||
105884143|NCT02111577|365229707|FG000|Overall Study|Failure to produce study treatment|6|||
105884144|NCT02111577|365229708|FG001|Overall Study|Failure to produce study treatment|0|||
105884145|NCT02111577|365229707|FG000|Overall Study|Death|518|||
105884146|NCT02111577|365229708|FG001|Overall Study|Death|254|||
105884147|NCT02111577|365229707|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
105884148|NCT02111577|365229708|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
105884149|NCT02111577|365229707|FG000|Overall Study|Adverse Event|1|||
105884150|NCT02111577|365229708|FG001|Overall Study|Adverse Event|1|||
105884151|NCT02111577|365229707|FG000|Overall Study|Withdrawal by Subject|51|||
105884152|NCT02111577|365229708|FG001|Overall Study|Withdrawal by Subject|23|||
105884153|NCT02111577|365229707|FG000|Overall Study|Disease progression|0|||
105884154|NCT02111577|365229708|FG001|Overall Study|Disease progression|1|||
105884155|NCT02111577|365229707|FG000|Overall Study|Lost to Follow-up|19|||
105884156|NCT02111577|365229708|FG001|Overall Study|Lost to Follow-up|10|||
105884157|NCT01014988|365229709|FG000|Overall Study|Adverse Event|20|||
105884158|NCT01014988|365229710|FG001|Overall Study|Adverse Event|0|||
105884159|NCT01014988|365229711|FG002|Overall Study|Adverse Event|1|||
105884160|NCT01014988|365229712|FG003|Overall Study|Adverse Event|0|||
105884161|NCT01014988|365229713|FG004|Overall Study|Adverse Event|1|||
105884162|NCT01014988|365229714|FG005|Overall Study|Adverse Event|3|||
105884163|NCT01014988|365229709|FG000|Overall Study|Lost to Follow-up|1|||
105884164|NCT01014988|365229710|FG001|Overall Study|Lost to Follow-up|0|||
105884165|NCT01014988|365229711|FG002|Overall Study|Lost to Follow-up|1|||
105884166|NCT01014988|365229712|FG003|Overall Study|Lost to Follow-up|0|||
105884167|NCT01014988|365229713|FG004|Overall Study|Lost to Follow-up|0|||
105884168|NCT01014988|365229714|FG005|Overall Study|Lost to Follow-up|0|||
105884169|NCT01014988|365229709|FG000|Overall Study|Physician Decision|1|||
105884170|NCT01014988|365229710|FG001|Overall Study|Physician Decision|0|||
105884171|NCT01014988|365229711|FG002|Overall Study|Physician Decision|0|||
105884172|NCT01014988|365229712|FG003|Overall Study|Physician Decision|0|||
105884173|NCT01014988|365229713|FG004|Overall Study|Physician Decision|0|||
105884174|NCT01014988|365229714|FG005|Overall Study|Physician Decision|0|||
105884175|NCT01014988|365229709|FG000|Overall Study|Withdrawal by Subject|1|||
105884176|NCT01014988|365229710|FG001|Overall Study|Withdrawal by Subject|0|||
105884177|NCT01014988|365229711|FG002|Overall Study|Withdrawal by Subject|0|||
105884178|NCT01014988|365229712|FG003|Overall Study|Withdrawal by Subject|0|||
105884179|NCT01014988|365229713|FG004|Overall Study|Withdrawal by Subject|0|||
105884180|NCT01014988|365229714|FG005|Overall Study|Withdrawal by Subject|0|||
105884181|NCT02217410|365229715|FG000|Overall Study|Graft Loss|0|||
105884182|NCT02217410|365229716|FG001|Overall Study|Graft Loss|0|||
105884183|NCT02217410|365229717|FG002|Overall Study|Graft Loss|2|||
105884184|NCT02217410|365229715|FG000|Overall Study|Withdrawal by Subject|0|||
105884185|NCT02217410|365229716|FG001|Overall Study|Withdrawal by Subject|0|||
105884186|NCT02217410|365229717|FG002|Overall Study|Withdrawal by Subject|2|||
105884187|NCT02217410|365229715|FG000|Overall Study|Lost to Follow-up|0|||
105884188|NCT02217410|365229716|FG001|Overall Study|Lost to Follow-up|0|||
105884189|NCT02217410|365229717|FG002|Overall Study|Lost to Follow-up|1|||
105884190|NCT02217410|365229715|FG000|Overall Study|Lack of Efficacy|0|||
105884191|NCT02217410|365229716|FG001|Overall Study|Lack of Efficacy|1|||
105884192|NCT02217410|365229717|FG002|Overall Study|Lack of Efficacy|0|||
105884193|NCT02217410|365229715|FG000|Overall Study|Physician Decision|1|||
105884194|NCT02217410|365229716|FG001|Overall Study|Physician Decision|3|||
105884195|NCT02217410|365229717|FG002|Overall Study|Physician Decision|0|||
105884196|NCT00492648|365229726|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
105884197|NCT00492648|365229727|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
105884198|NCT03474731|365229731|FG000|Overall Study|Withdrawal by Subject|36|||
105884199|NCT03474731|365229732|FG001|Overall Study|Withdrawal by Subject|29|||
105884200|NCT03474731|365229733|FG002|Overall Study|Withdrawal by Subject|11|||
105884201|NCT03474731|365229734|FG003|Overall Study|Withdrawal by Subject|27|||
105884202|NCT03474731|365229731|FG000|Overall Study|COVID|0|||
105884203|NCT03474731|365229732|FG001|Overall Study|COVID|23|||
105884204|NCT03474731|365229733|FG002|Overall Study|COVID|0|||
105884205|NCT03474731|365229734|FG003|Overall Study|COVID|0|||
105884206|NCT03474731|365229731|FG000|Overall Study|Participant moved from area|1|||
105884207|NCT03474731|365229732|FG001|Overall Study|Participant moved from area|0|||
106113104|NCT00642902|366072124|FG003|Overall Study|Lost to Follow-up|0|||
106113105|NCT00642902|366072121|FG000|Overall Study|Lack of Efficacy|0|||
106113106|NCT00642902|366072122|FG001|Overall Study|Lack of Efficacy|3|||
106113107|NCT00642902|366072123|FG002|Overall Study|Lack of Efficacy|3|||
106113108|NCT00642902|366072124|FG003|Overall Study|Lack of Efficacy|0|||
106113109|NCT00642902|366072121|FG000|Overall Study|Death|1|||
106113110|NCT00642902|366072122|FG001|Overall Study|Death|0|||
106113111|NCT00642902|366072123|FG002|Overall Study|Death|0|||
106113112|NCT00642902|366072124|FG003|Overall Study|Death|0|||
106113113|NCT00642902|366072121|FG000|Overall Study|Premature termination of clinical trial|37|||
106113114|NCT00642902|366072122|FG001|Overall Study|Premature termination of clinical trial|32|||
106113115|NCT00642902|366072123|FG002|Overall Study|Premature termination of clinical trial|35|||
106113116|NCT00642902|366072124|FG003|Overall Study|Premature termination of clinical trial|35|||
106113117|NCT00642902|366072121|FG000|Overall Study|Randomized, but not treated|0|||
106113118|NCT00642902|366072122|FG001|Overall Study|Randomized, but not treated|0|||
106113119|NCT00642902|366072123|FG002|Overall Study|Randomized, but not treated|1|||
106113120|NCT00642902|366072124|FG003|Overall Study|Randomized, but not treated|0|||
106113121|NCT00642902|366072121|FG000|Overall Study|Other|1|||
105884208|NCT03474731|365229733|FG002|Overall Study|Participant moved from area|0|||
105884209|NCT03474731|365229734|FG003|Overall Study|Participant moved from area|0|||
105884210|NCT03474731|365229731|FG000|Overall Study|Lost to Follow-up|11|||
105884211|NCT03474731|365229732|FG001|Overall Study|Lost to Follow-up|3|||
105884212|NCT03474731|365229733|FG002|Overall Study|Lost to Follow-up|18|||
105884213|NCT03474731|365229734|FG003|Overall Study|Lost to Follow-up|17|||
105884214|NCT03474731|365229731|FG000|Overall Study|Death|0|||
105884215|NCT03474731|365229732|FG001|Overall Study|Death|1|||
105884216|NCT03474731|365229733|FG002|Overall Study|Death|0|||
105884217|NCT03474731|365229734|FG003|Overall Study|Death|0|||
105884218|NCT03474731|365229731|FG000|Overall Study|Participant Removed|0|||
105884219|NCT03474731|365229732|FG001|Overall Study|Participant Removed|0|||
105884220|NCT03474731|365229733|FG002|Overall Study|Participant Removed|0|||
105884221|NCT03474731|365229734|FG003|Overall Study|Participant Removed|1|||
105884222|NCT00427921|365229735|FG000|Overall Study|Adverse Event|26|||
105884223|NCT00427921|365229735|FG000|Overall Study|Withdrawal by Subject|4|||
105884224|NCT00427921|365229735|FG000|Overall Study|Lost to Follow-up|2|||
105884225|NCT00427921|365229735|FG000|Overall Study|Other reason not specified|10|||
105884226|NCT00427921|365229735|FG000|Overall Study|Adverse Event + Hospitalization|1|||
105884227|NCT00427921|365229735|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
105884228|NCT00427921|365229735|FG000|Overall Study|Adverse Event + No Response|1|||
105884229|NCT00427921|365229735|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
105884230|NCT00427921|365229735|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
105884231|NCT00427921|365229735|FG000|Overall Study|Adverse Event + Lost Response|1|||
105884232|NCT00427921|365229735|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
105884233|NCT00427921|365229735|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
105884234|NCT03706430|365229736|FG000|Overall Study|No A-Line placed|5|||
105884235|NCT03706430|365229736|FG000|Overall Study|Subject had gel nail polish|1|||
105884236|NCT03706430|365229736|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
105884237|NCT03706430|365229736|FG000|Overall Study|Cancelled Case|6|||
105884238|NCT03706430|365229736|FG000|Overall Study|Physician Decision|2|||
105884239|NCT02294396|365229737|FG000|Overall Study|Adverse Event|26|||
105884240|NCT02294396|365229738|FG001|Overall Study|Adverse Event|25|||
105884241|NCT02294396|365229739|FG002|Overall Study|Adverse Event|21|||
105884242|NCT02294396|365229740|FG003|Overall Study|Adverse Event|24|||
105884243|NCT02294396|365229737|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
105884244|NCT02294396|365229738|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
105884245|NCT02294396|365229739|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
105884246|NCT02294396|365229740|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
105884247|NCT02294396|365229737|FG000|Overall Study|Withdrawal by Subject|8|||
105884248|NCT02294396|365229738|FG001|Overall Study|Withdrawal by Subject|6|||
105884249|NCT02294396|365229739|FG002|Overall Study|Withdrawal by Subject|6|||
105884250|NCT02294396|365229740|FG003|Overall Study|Withdrawal by Subject|8|||
105884251|NCT02294396|365229737|FG000|Overall Study|Lost to Follow-up|0|||
105884252|NCT02294396|365229738|FG001|Overall Study|Lost to Follow-up|0|||
105884253|NCT02294396|365229739|FG002|Overall Study|Lost to Follow-up|1|||
105884254|NCT02294396|365229740|FG003|Overall Study|Lost to Follow-up|1|||
105884255|NCT02294396|365229737|FG000|Overall Study|Protocol Deviation|3|||
105884256|NCT02294396|365229738|FG001|Overall Study|Protocol Deviation|2|||
105884257|NCT02294396|365229739|FG002|Overall Study|Protocol Deviation|2|||
105884258|NCT02294396|365229740|FG003|Overall Study|Protocol Deviation|1|||
105884259|NCT02294396|365229737|FG000|Overall Study|Miscellaneous|2|||
105884260|NCT02294396|365229738|FG001|Overall Study|Miscellaneous|0|||
105884261|NCT02294396|365229739|FG002|Overall Study|Miscellaneous|5|||
105884262|NCT02294396|365229740|FG003|Overall Study|Miscellaneous|2|||
105884263|NCT01075256|365229741|FG000|Overall Study|Withdrawal by Subject|1|||
106113122|NCT00642902|366072122|FG001|Overall Study|Other|5|||
106113123|NCT00642902|366072123|FG002|Overall Study|Other|1|||
106113124|NCT00642902|366072124|FG003|Overall Study|Other|4|||
106113125|NCT02173054|366072125|FG000|Overall Study|lack of compliance|1|||
106113126|NCT02173054|366072126|FG001|Overall Study|lack of compliance|0|||
106113127|NCT02173054|366072127|FG002|Overall Study|lack of compliance|0|||
106113128|NCT02173054|366072125|FG000|Overall Study|Withdrawal by Subject|0|||
106113129|NCT02173054|366072126|FG001|Overall Study|Withdrawal by Subject|0|||
106113130|NCT02173054|366072127|FG002|Overall Study|Withdrawal by Subject|1|||
106113131|NCT01330316|366072141|FG000|Overall Study|Adverse Event|2|||
105993771|NCT00080301|365636099|FG000|Overall Study|Still on Treatment as of CSR date|0|||
105884264|NCT01075256|365229742|FG001|Overall Study|Withdrawal by Subject|0|||
105884265|NCT01075256|365229743|FG002|Overall Study|Withdrawal by Subject|0|||
105884266|NCT00478777|365229748|FG000|Overall Study|Adverse Event|29|||
105884267|NCT00478777|365229748|FG000|Overall Study|Lack of Efficacy|23|||
105884268|NCT00478777|365229748|FG000|Overall Study|Withdrawal by Subject|4|||
105884269|NCT00478777|365229748|FG000|Overall Study|Death|3|||
106113132|NCT01330316|366072142|FG001|Overall Study|Adverse Event|2|||
105884270|NCT00478777|365229748|FG000|Overall Study|Protocol Violation|3|||
105993772|NCT00080301|365636100|FG001|Overall Study|Still on Treatment as of CSR date|1|||
105993773|NCT00726232|365636103|FG000|Initial Phase (Dose-finding)|Death|0|||
105993774|NCT00726232|365636104|FG001|Initial Phase (Dose-finding)|Death|0|||
105993775|NCT00726232|365636105|FG002|Initial Phase (Dose-finding)|Death|0|||
105993776|NCT00726232|365636106|FG003|Initial Phase (Dose-finding)|Death|0|||
105993777|NCT00726232|365636107|FG004|Initial Phase (Dose-finding)|Death|1|||
105993778|NCT00726232|365636108|FG005|Initial Phase (Dose-finding)|Death|0|||
105993779|NCT00726232|365636109|FG006|Initial Phase (Dose-finding)|Death|0|||
105993780|NCT00726232|365636110|FG007|Initial Phase (Dose-finding)|Death|0|||
105993781|NCT00726232|365636103|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
105993782|NCT00726232|365636104|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
106113133|NCT01330316|366072141|FG000|Overall Study|Lack of Efficacy|0|||
105884271|NCT00478777|365229748|FG000|Overall Study|Lost to Follow-up|3|||
105884272|NCT00478777|365229748|FG000|Overall Study|Physician Decision|1|||
105884273|NCT00478777|365229748|FG000|Overall Study|Intolerance of therapy|1|||
105884274|NCT00478777|365229748|FG000|Overall Study|Lack of compliance|1|||
105993783|NCT00726232|365636105|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
105993784|NCT00726232|365636106|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
105993785|NCT00726232|365636107|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
105993786|NCT00726232|365636108|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
105993787|NCT00726232|365636109|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
105993788|NCT00726232|365636110|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
105993789|NCT00726232|365636103|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
105993790|NCT00726232|365636104|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105993791|NCT00726232|365636105|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105993792|NCT00726232|365636106|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
105993793|NCT00726232|365636107|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105993794|NCT00726232|365636108|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
105993795|NCT00726232|365636109|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105993796|NCT00726232|365636110|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
105993797|NCT00726232|365636103|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
105993798|NCT00726232|365636104|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
105993799|NCT00726232|365636105|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
105993800|NCT00726232|365636106|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
105993801|NCT00726232|365636107|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
105993802|NCT00726232|365636108|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
105993803|NCT00726232|365636109|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
105993804|NCT00726232|365636110|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
105993805|NCT00726232|365636103|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
105993806|NCT00726232|365636104|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
105993807|NCT00726232|365636105|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
106113134|NCT01330316|366072142|FG001|Overall Study|Lack of Efficacy|10|||
106113135|NCT01330316|366072141|FG000|Overall Study|Lost to Follow-up|0|||
106113136|NCT01330316|366072142|FG001|Overall Study|Lost to Follow-up|1|||
106113137|NCT01330316|366072141|FG000|Overall Study|Withdrawal by Subject|0|||
105884275|NCT00478777|365229748|FG000|Overall Study|Lymphocytes infusion|1|||
105884276|NCT00478777|365229748|FG000|Overall Study|End of therapy|2|||
105884277|NCT00478777|365229748|FG000|Overall Study|Not treated with lenalidomide|6|||
105884278|NCT01377922|365229749|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
105993808|NCT00726232|365636106|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
105884279|NCT01377922|365229750|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
106113138|NCT01330316|366072142|FG001|Overall Study|Withdrawal by Subject|1|||
106113139|NCT01330316|366072141|FG000|Overall Study|other than above|0|||
106113140|NCT01330316|366072142|FG001|Overall Study|other than above|1|||
106113141|NCT00215540|366072143|FG000|Overall Study|Withdrew from study medication|1|||
106113142|NCT00215540|366072144|FG001|Overall Study|Withdrew from study medication|0|||
106113143|NCT00215540|366072145|FG002|Overall Study|Withdrew from study medication|0|||
106113144|NCT03010462|366072146|FG000|Overall Study|Withdrawal by Subject|3|||
106113145|NCT03010462|366072147|FG001|Overall Study|Withdrawal by Subject|1|||
105884280|NCT01706939|365229751|FG000|Pre Randomization|Screen Failure|1|||
105884281|NCT01706939|365229752|FG001|Pre Randomization|Screen Failure|0|||
105884282|NCT01706939|365229753|FG002|Pre Randomization|Screen Failure|0|||
105884283|NCT01706939|365229751|FG000|Pre Randomization|Ineligible for Randomization|1|||
105884284|NCT01706939|365229752|FG001|Pre Randomization|Ineligible for Randomization|0|||
105884285|NCT01706939|365229753|FG002|Pre Randomization|Ineligible for Randomization|0|||
105884286|NCT01706939|365229751|FG000|Pre Randomization|Withdrawal by Subject|1|||
105884287|NCT01706939|365229752|FG001|Pre Randomization|Withdrawal by Subject|0|||
105884288|NCT01706939|365229753|FG002|Pre Randomization|Withdrawal by Subject|0|||
105884289|NCT01706939|365229751|FG000|Randomization|Insufficient QoL survey compliance|0|||
105884290|NCT01706939|365229752|FG001|Randomization|Insufficient QoL survey compliance|1|||
105884291|NCT01706939|365229753|FG002|Randomization|Insufficient QoL survey compliance|1|||
105884292|NCT01706939|365229751|FG000|Randomization|Progression of disease|0|||
105884293|NCT01706939|365229752|FG001|Randomization|Progression of disease|2|||
105884294|NCT01706939|365229753|FG002|Randomization|Progression of disease|1|||
105884295|NCT05020665|365229763|FG000|Overall Study|Study terminated by Sponsor|5|||
105884296|NCT05020665|365229764|FG001|Overall Study|Study terminated by Sponsor|4|||
105884297|NCT05020665|365229763|FG000|Overall Study|Death|2|||
105884298|NCT05020665|365229764|FG001|Overall Study|Death|1|||
105884299|NCT05020665|365229763|FG000|Overall Study|Physician Decision|0|||
105884300|NCT05020665|365229764|FG001|Overall Study|Physician Decision|1|||
105884301|NCT05020665|365229763|FG000|Overall Study|Withdrawal by Subject|0|||
105884302|NCT05020665|365229764|FG001|Overall Study|Withdrawal by Subject|1|||
105884303|NCT05020665|365229763|FG000|Overall Study|Reason not specified|1|||
105884304|NCT05020665|365229764|FG001|Overall Study|Reason not specified|0|||
105884305|NCT00101166|365229765|FG000|Overall Study|progressive disease|10|||
105884306|NCT02729051|365229769|FG000|Overall Study|Adverse Event|21|||
105884307|NCT02729051|365229770|FG001|Overall Study|Adverse Event|11|||
105884308|NCT02729051|365229769|FG000|Overall Study|Lack of Efficacy|1|||
105884309|NCT02729051|365229770|FG001|Overall Study|Lack of Efficacy|1|||
105884310|NCT02729051|365229769|FG000|Overall Study|Lost to Follow-up|1|||
105884311|NCT02729051|365229770|FG001|Overall Study|Lost to Follow-up|2|||
105884312|NCT02729051|365229769|FG000|Overall Study|Physician Decision|1|||
105884313|NCT02729051|365229770|FG001|Overall Study|Physician Decision|1|||
105884314|NCT02729051|365229769|FG000|Overall Study|Withdrawal by Subject|6|||
105884315|NCT02729051|365229770|FG001|Overall Study|Withdrawal by Subject|17|||
105884316|NCT04390503|365231155|FG000|Overall Study|Physician Decision|2|||
105884317|NCT04390503|365231156|FG001|Overall Study|Physician Decision|1|||
105884318|NCT04390503|365231155|FG000|Overall Study|Adverse Event|1|||
105884319|NCT04390503|365231156|FG001|Overall Study|Adverse Event|0|||
105884320|NCT00593684|365231157|FG000|Overall Study|Death|2|||
105884321|NCT00593684|365231158|FG001|Overall Study|Death|1|||
105884322|NCT03625466|365231159|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
105884323|NCT03625466|365231160|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
105884324|NCT03625466|365231161|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
105884325|NCT03625466|365231159|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
105884326|NCT03625466|365231160|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
105884327|NCT03625466|365231161|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
105884328|NCT03625466|365231159|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
105884329|NCT03625466|365231160|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
105884330|NCT03625466|365231161|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
105884331|NCT01270464|365231165|FG000|Overall Study|Protocol Violation|4|||
105884332|NCT01270464|365231166|FG001|Overall Study|Protocol Violation|3|||
105884333|NCT01270464|365231167|FG002|Overall Study|Protocol Violation|2|||
105884334|NCT01270464|365231165|FG000|Overall Study|Lack of Efficacy|2|||
105884335|NCT01270464|365231166|FG001|Overall Study|Lack of Efficacy|3|||
105884336|NCT01270464|365231167|FG002|Overall Study|Lack of Efficacy|1|||
105884337|NCT01270464|365231165|FG000|Overall Study|Adverse Event|9|||
105884338|NCT01270464|365231166|FG001|Overall Study|Adverse Event|1|||
105884339|NCT01270464|365231167|FG002|Overall Study|Adverse Event|7|||
105884340|NCT01270464|365231165|FG000|Overall Study|Withdrawal by Subject|2|||
105884341|NCT01270464|365231166|FG001|Overall Study|Withdrawal by Subject|1|||
105884342|NCT01270464|365231167|FG002|Overall Study|Withdrawal by Subject|4|||
105884343|NCT01270464|365231165|FG000|Overall Study|Lost to Follow-up|2|||
105884344|NCT01270464|365231166|FG001|Overall Study|Lost to Follow-up|3|||
105884345|NCT01270464|365231167|FG002|Overall Study|Lost to Follow-up|1|||
105884346|NCT01270464|365231165|FG000|Overall Study|Other|1|||
105884347|NCT01270464|365231166|FG001|Overall Study|Other|1|||
105884348|NCT01270464|365231167|FG002|Overall Study|Other|3|||
105884349|NCT05483686|365231168|FG000|Overall Study|Lost to Follow-up|5|||
105884350|NCT05483686|365231169|FG001|Overall Study|Lost to Follow-up|7|||
105884351|NCT01250873|365231182|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
105884352|NCT01250873|365231182|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
105884353|NCT02423343|365231183|FG000|Overall Study|Withdrawal by Subject|0|||
106113146|NCT01059643|366072148|FG000|Overall Study|Adverse Event|3|||
105884354|NCT02423343|365231184|FG001|Overall Study|Withdrawal by Subject|1|||
105884355|NCT02423343|365231185|FG002|Overall Study|Withdrawal by Subject|0|||
105884356|NCT02423343|365231186|FG003|Overall Study|Withdrawal by Subject|0|||
105884357|NCT02423343|365231187|FG004|Overall Study|Withdrawal by Subject|0|||
105884358|NCT02423343|365231188|FG005|Overall Study|Withdrawal by Subject|0|||
105884359|NCT02423343|365231183|FG000|Overall Study|Progressive Disease|0|||
105884360|NCT02423343|365231184|FG001|Overall Study|Progressive Disease|0|||
105884361|NCT02423343|365231185|FG002|Overall Study|Progressive Disease|0|||
105884362|NCT02423343|365231186|FG003|Overall Study|Progressive Disease|0|||
105884363|NCT02423343|365231187|FG004|Overall Study|Progressive Disease|2|||
105884364|NCT02423343|365231188|FG005|Overall Study|Progressive Disease|0|||
105884365|NCT02423343|365231183|FG000|Overall Study|Adverse Event|0|||
105884366|NCT02423343|365231184|FG001|Overall Study|Adverse Event|0|||
105884367|NCT02423343|365231185|FG002|Overall Study|Adverse Event|0|||
105884368|NCT02423343|365231186|FG003|Overall Study|Adverse Event|0|||
105884369|NCT02423343|365231187|FG004|Overall Study|Adverse Event|2|||
105884370|NCT02423343|365231188|FG005|Overall Study|Adverse Event|0|||
105884371|NCT02423343|365231183|FG000|Overall Study|Death|0|||
105884372|NCT02423343|365231184|FG001|Overall Study|Death|0|||
105884373|NCT02423343|365231185|FG002|Overall Study|Death|0|||
105884374|NCT02423343|365231186|FG003|Overall Study|Death|0|||
105884375|NCT02423343|365231187|FG004|Overall Study|Death|1|||
105993809|NCT00726232|365636107|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
106113147|NCT01059643|366072148|FG000|Overall Study|Withdrawal by Subject|2|||
106113148|NCT01059643|366072148|FG000|Overall Study|Physician Decision|1|||
106113149|NCT02207725|366072149|FG000|Overall Study|Did Not Receive Treatment|0|||
106113150|NCT02207725|366072150|FG001|Overall Study|Did Not Receive Treatment|1|||
106113151|NCT02207725|366072151|FG002|Overall Study|Did Not Receive Treatment|1|||
106113152|NCT02207725|366072152|FG003|Overall Study|Did Not Receive Treatment|1|||
105884376|NCT02423343|365231188|FG005|Overall Study|Death|0|||
105884377|NCT01908829|365231189|FG000|Overall Study|Adverse Event|13|||
106113153|NCT00246337|366072155|FG000|Overall Study|Lost to Follow-up|3|||
106113154|NCT00246337|366072156|FG001|Overall Study|Lost to Follow-up|0|||
106113155|NCT00246337|366072157|FG002|Overall Study|Lost to Follow-up|0|||
106113156|NCT00246337|366072158|FG003|Overall Study|Lost to Follow-up|0|||
106113157|NCT00246337|366072159|FG004|Overall Study|Lost to Follow-up|2|||
106113158|NCT00246337|366072160|FG005|Overall Study|Lost to Follow-up|2|||
106113159|NCT00246337|366072161|FG006|Overall Study|Lost to Follow-up|1|||
106113160|NCT00246337|366072162|FG007|Overall Study|Lost to Follow-up|2|||
106113161|NCT00246337|366072163|FG008|Overall Study|Lost to Follow-up|0|||
106113162|NCT00246337|366072155|FG000|Overall Study|Protocol Violation|1|||
106113163|NCT00246337|366072156|FG001|Overall Study|Protocol Violation|0|||
106113164|NCT00246337|366072157|FG002|Overall Study|Protocol Violation|0|||
106113165|NCT00246337|366072158|FG003|Overall Study|Protocol Violation|0|||
106113166|NCT00246337|366072159|FG004|Overall Study|Protocol Violation|1|||
106113167|NCT00246337|366072160|FG005|Overall Study|Protocol Violation|0|||
106113168|NCT00246337|366072161|FG006|Overall Study|Protocol Violation|1|||
106113169|NCT00246337|366072162|FG007|Overall Study|Protocol Violation|1|||
106113170|NCT00246337|366072163|FG008|Overall Study|Protocol Violation|0|||
106113171|NCT00246337|366072155|FG000|Overall Study|Withdrawal by Subject|2|||
106113172|NCT00246337|366072156|FG001|Overall Study|Withdrawal by Subject|0|||
106113173|NCT00246337|366072157|FG002|Overall Study|Withdrawal by Subject|0|||
106113174|NCT00246337|366072158|FG003|Overall Study|Withdrawal by Subject|0|||
106113175|NCT00246337|366072159|FG004|Overall Study|Withdrawal by Subject|0|||
106113176|NCT00246337|366072160|FG005|Overall Study|Withdrawal by Subject|0|||
106113177|NCT00246337|366072161|FG006|Overall Study|Withdrawal by Subject|1|||
106113178|NCT00246337|366072162|FG007|Overall Study|Withdrawal by Subject|1|||
106113179|NCT00246337|366072163|FG008|Overall Study|Withdrawal by Subject|0|||
106113180|NCT00246337|366072155|FG000|Overall Study|Lack of Qualifying Event|8|||
106113181|NCT00246337|366072156|FG001|Overall Study|Lack of Qualifying Event|2|||
106113182|NCT00246337|366072157|FG002|Overall Study|Lack of Qualifying Event|1|||
106113183|NCT00246337|366072158|FG003|Overall Study|Lack of Qualifying Event|1|||
106113184|NCT00246337|366072159|FG004|Overall Study|Lack of Qualifying Event|1|||
106113185|NCT00246337|366072160|FG005|Overall Study|Lack of Qualifying Event|3|||
106113186|NCT00246337|366072161|FG006|Overall Study|Lack of Qualifying Event|3|||
105884378|NCT01908829|365231190|FG001|Overall Study|Adverse Event|11|||
105884379|NCT01908829|365231191|FG002|Overall Study|Adverse Event|13|||
106113187|NCT00246337|366072162|FG007|Overall Study|Lack of Qualifying Event|2|||
106113188|NCT00246337|366072163|FG008|Overall Study|Lack of Qualifying Event|5|||
106113189|NCT00246337|366072155|FG000|Overall Study|Site Terminated|10|||
106113190|NCT00246337|366072156|FG001|Overall Study|Site Terminated|0|||
106113191|NCT00246337|366072157|FG002|Overall Study|Site Terminated|0|||
106113192|NCT00246337|366072158|FG003|Overall Study|Site Terminated|0|||
106113193|NCT00246337|366072159|FG004|Overall Study|Site Terminated|0|||
105884380|NCT01908829|365231189|FG000|Overall Study|Lost to Follow-up|4|||
105884381|NCT01908829|365231190|FG001|Overall Study|Lost to Follow-up|2|||
105884382|NCT01908829|365231191|FG002|Overall Study|Lost to Follow-up|1|||
105884383|NCT01908829|365231189|FG000|Overall Study|Randomized no double-blind drug received|1|||
105884384|NCT01908829|365231190|FG001|Overall Study|Randomized no double-blind drug received|0|||
106113194|NCT00246337|366072160|FG005|Overall Study|Site Terminated|7|||
106113195|NCT00246337|366072161|FG006|Overall Study|Site Terminated|1|||
106113196|NCT00246337|366072162|FG007|Overall Study|Site Terminated|6|||
106113197|NCT00246337|366072163|FG008|Overall Study|Site Terminated|2|||
106113198|NCT00246337|366072155|FG000|Overall Study|Abnormal baseline lab values|7|||
106113199|NCT00246337|366072156|FG001|Overall Study|Abnormal baseline lab values|0|||
106113200|NCT00246337|366072157|FG002|Overall Study|Abnormal baseline lab values|2|||
106113201|NCT00246337|366072158|FG003|Overall Study|Abnormal baseline lab values|0|||
106113202|NCT00246337|366072159|FG004|Overall Study|Abnormal baseline lab values|0|||
106113203|NCT00246337|366072160|FG005|Overall Study|Abnormal baseline lab values|2|||
106113204|NCT00246337|366072161|FG006|Overall Study|Abnormal baseline lab values|2|||
106113205|NCT00246337|366072162|FG007|Overall Study|Abnormal baseline lab values|0|||
106113206|NCT00246337|366072163|FG008|Overall Study|Abnormal baseline lab values|4|||
106113207|NCT00246337|366072155|FG000|Overall Study|Overwhelmed|0|||
105884385|NCT01908829|365231191|FG002|Overall Study|Randomized no double-blind drug received|1|||
105884386|NCT01908829|365231189|FG000|Overall Study|Discontinued (no EoT page)|2|||
105884387|NCT01908829|365231190|FG001|Overall Study|Discontinued (no EoT page)|0|||
105884388|NCT01908829|365231191|FG002|Overall Study|Discontinued (no EoT page)|0|||
105884389|NCT01908829|365231189|FG000|Overall Study|Miscellaneous|0|||
105884390|NCT01908829|365231190|FG001|Overall Study|Miscellaneous|2|||
105884391|NCT01908829|365231191|FG002|Overall Study|Miscellaneous|0|||
105884392|NCT01908829|365231189|FG000|Overall Study|Protocol Violation|2|||
105884393|NCT01908829|365231190|FG001|Overall Study|Protocol Violation|2|||
105884394|NCT01908829|365231191|FG002|Overall Study|Protocol Violation|0|||
105884395|NCT01908829|365231189|FG000|Overall Study|Lack of Efficacy|1|||
105884396|NCT01908829|365231190|FG001|Overall Study|Lack of Efficacy|3|||
105884397|NCT01908829|365231191|FG002|Overall Study|Lack of Efficacy|2|||
105884398|NCT01908829|365231189|FG000|Overall Study|Withdrawal by Subject|26|||
105884399|NCT01908829|365231190|FG001|Overall Study|Withdrawal by Subject|29|||
105884400|NCT01908829|365231191|FG002|Overall Study|Withdrawal by Subject|22|||
105884401|NCT04967885|365231192|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
105884402|NCT04967885|365231193|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
105884403|NCT04967885|365231192|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
105884404|NCT04967885|365231193|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
105884405|NCT04967885|365231192|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
105884406|NCT04967885|365231193|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
105884407|NCT04967885|365231192|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
105884408|NCT04967885|365231193|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
105884409|NCT04967885|365231192|FG000|EMI-II Intervention|Lost to Follow-up|14|||
105884410|NCT04967885|365231193|FG001|EMI-II Intervention|Lost to Follow-up|10|||
105884411|NCT02320058|365231194|FG000|Overall Study|Death|25|||
105884412|NCT02320058|365231195|FG001|Overall Study|Death|10|||
105884413|NCT02320058|365231194|FG000|Overall Study|Lost to Follow-up|4|||
105884414|NCT02320058|365231195|FG001|Overall Study|Lost to Follow-up|0|||
105884415|NCT02320058|365231194|FG000|Overall Study|Other reasons|4|||
105884416|NCT02320058|365231195|FG001|Overall Study|Other reasons|1|||
105884417|NCT02320058|365231194|FG000|Overall Study|Withdrawal by Subject|8|||
105884418|NCT02320058|365231195|FG001|Overall Study|Withdrawal by Subject|2|||
105884419|NCT02320058|365231194|FG000|Overall Study|Not reported|1|||
105884420|NCT02320058|365231195|FG001|Overall Study|Not reported|0|||
105884421|NCT00729157|365231196|FG000|Overall Study|Withdrawal by Subject|1|||
105884422|NCT01940887|365231197|FG000|Year 1|Protocol Violation|0|||
105884423|NCT01940887|365231198|FG001|Year 1|Protocol Violation|1|||
105884424|NCT01940887|365231197|FG000|Year 1|Physician Decision|7|||
105884425|NCT01940887|365231198|FG001|Year 1|Physician Decision|3|||
105993810|NCT00726232|365636108|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
105993811|NCT00726232|365636109|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
105993812|NCT00726232|365636110|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
106113208|NCT00246337|366072156|FG001|Overall Study|Overwhelmed|0|||
106113209|NCT00246337|366072157|FG002|Overall Study|Overwhelmed|0|||
106113210|NCT00246337|366072158|FG003|Overall Study|Overwhelmed|0|||
106113211|NCT00246337|366072159|FG004|Overall Study|Overwhelmed|0|||
106113212|NCT00246337|366072160|FG005|Overall Study|Overwhelmed|1|||
106113213|NCT00246337|366072161|FG006|Overall Study|Overwhelmed|0|||
106113214|NCT00246337|366072162|FG007|Overall Study|Overwhelmed|0|||
106113215|NCT00246337|366072163|FG008|Overall Study|Overwhelmed|0|||
105884426|NCT01940887|365231197|FG000|Year 1|Death|5|||
105884427|NCT01940887|365231198|FG001|Year 1|Death|3|||
105884428|NCT01940887|365231197|FG000|Year 1|Adverse Event|7|||
105884429|NCT01940887|365231198|FG001|Year 1|Adverse Event|6|||
105884430|NCT01940887|365231197|FG000|Year 1|Withdrawal by Subject|18|||
105884431|NCT01940887|365231198|FG001|Year 1|Withdrawal by Subject|9|||
105884432|NCT01940887|365231197|FG000|Year 1|Lost to Follow-up|2|||
105884433|NCT01940887|365231198|FG001|Year 1|Lost to Follow-up|1|||
105884434|NCT01940887|365231197|FG000|Year 2|Physician Decision|8|||
105884435|NCT01940887|365231198|FG001|Year 2|Physician Decision|1|||
105884436|NCT01940887|365231197|FG000|Year 2|Death|0|||
105884437|NCT01940887|365231198|FG001|Year 2|Death|2|||
105884438|NCT01940887|365231197|FG000|Year 2|Sponsor Decision, early termination|192|||
106113216|NCT00246337|366072155|FG000|Overall Study|Protocol Violator|1|||
106113217|NCT00246337|366072156|FG001|Overall Study|Protocol Violator|0|||
106113218|NCT00246337|366072157|FG002|Overall Study|Protocol Violator|0|||
106113219|NCT00246337|366072158|FG003|Overall Study|Protocol Violator|0|||
106113220|NCT00246337|366072159|FG004|Overall Study|Protocol Violator|0|||
106113221|NCT00246337|366072160|FG005|Overall Study|Protocol Violator|0|||
106113222|NCT00246337|366072161|FG006|Overall Study|Protocol Violator|0|||
105884439|NCT01940887|365231198|FG001|Year 2|Sponsor Decision, early termination|203|||
105884440|NCT01940887|365231197|FG000|Year 2|Adverse Event|8|||
105884441|NCT01940887|365231198|FG001|Year 2|Adverse Event|2|||
105884442|NCT01940887|365231197|FG000|Year 2|Withdrawal by Subject|8|||
105884443|NCT01940887|365231198|FG001|Year 2|Withdrawal by Subject|8|||
105884444|NCT01940887|365231197|FG000|Year 2|Lost to Follow-up|1|||
105884445|NCT01940887|365231198|FG001|Year 2|Lost to Follow-up|6|||
105884446|NCT01430403|365231202|FG000|Overall Study|Lost to Follow-up|5|||
105884447|NCT01430403|365231203|FG001|Overall Study|Lost to Follow-up|5|||
105884448|NCT01430403|365231204|FG002|Overall Study|Lost to Follow-up|3|||
105884449|NCT01430403|365231202|FG000|Overall Study|Physician Decision|1|||
105884450|NCT01430403|365231203|FG001|Overall Study|Physician Decision|0|||
105884451|NCT01430403|365231204|FG002|Overall Study|Physician Decision|0|||
105884452|NCT01430403|365231202|FG000|Overall Study|Protocol Violation|2|||
105884453|NCT01430403|365231203|FG001|Overall Study|Protocol Violation|3|||
105884454|NCT01430403|365231204|FG002|Overall Study|Protocol Violation|2|||
105884455|NCT01430403|365231202|FG000|Overall Study|Withdrawal by Subject|9|||
105884456|NCT01430403|365231203|FG001|Overall Study|Withdrawal by Subject|1|||
105884457|NCT01430403|365231204|FG002|Overall Study|Withdrawal by Subject|3|||
105884458|NCT01290679|365231207|FG000|Overall Study|Adverse Event|2|||
105884459|NCT01290679|365231208|FG001|Overall Study|Adverse Event|0|||
105884460|NCT01290679|365231207|FG000|Overall Study|Lost to Follow-up|8|||
105884461|NCT01290679|365231208|FG001|Overall Study|Lost to Follow-up|10|||
105884462|NCT01290679|365231207|FG000|Overall Study|Protocol Violation|0|||
105884463|NCT01290679|365231208|FG001|Overall Study|Protocol Violation|1|||
105884464|NCT01290679|365231207|FG000|Overall Study|Withdrawal by Subject|6|||
105884465|NCT01290679|365231208|FG001|Overall Study|Withdrawal by Subject|5|||
105884466|NCT01290679|365231207|FG000|Overall Study|Subject Entered Another Trial|0|||
105884467|NCT01290679|365231208|FG001|Overall Study|Subject Entered Another Trial|5|||
105884468|NCT01855243|365231209|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
105884469|NCT01855243|365231210|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
105884470|NCT01855243|365231211|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
105884471|NCT01860040|365231214|FG000|Overall Study|Withdrawal by Subject|1|||
105884472|NCT01860040|365231215|FG001|Overall Study|Withdrawal by Subject|0|||
105884473|NCT03793842|365231219|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
105884474|NCT03793842|365231220|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
105884475|NCT03793842|365231219|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
105884476|NCT03793842|365231220|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
105884477|NCT04087720|365231221|FG000|Overall Study|Withdrawal by Subject|2|||
105884478|NCT04087720|365231221|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
105884479|NCT02120833|365231226|FG000|Overall Study|Adverse Event|1|||
105884480|NCT02120833|365231227|FG001|Overall Study|Adverse Event|0|||
105884481|NCT02120833|365231226|FG000|Overall Study|Withdrawal by Subject|2|||
105884482|NCT02120833|365231227|FG001|Overall Study|Withdrawal by Subject|0|||
105884483|NCT02120833|365231226|FG000|Overall Study|Lost to Follow-up|1|||
105884484|NCT02120833|365231227|FG001|Overall Study|Lost to Follow-up|1|||
105884485|NCT00520533|365231228|FG000|Overall Study|Death|1|||
105884486|NCT00520533|365231228|FG000|Overall Study|Suspension of the study for safety reasons|1|||
105884487|NCT00520533|365231228|FG000|Overall Study|Withdrawal by Subject|1|||
105884488|NCT00520533|365231228|FG000|Overall Study|Physician Decision|1|||
105884489|NCT04105218|365231229|FG000|Overall Study|Withdrawal by Subject|3|||
105884490|NCT04105218|365231230|FG001|Overall Study|Withdrawal by Subject|2|||
105884491|NCT04105218|365231229|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
105884492|NCT04105218|365231230|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
105884493|NCT04105218|365231229|FG000|Overall Study|Failed screening tests|2|||
106113223|NCT00246337|366072162|FG007|Overall Study|Protocol Violator|0|||
106113224|NCT00246337|366072163|FG008|Overall Study|Protocol Violator|0|||
106113225|NCT00246337|366072155|FG000|Overall Study|Reported as completing trial in error|0|||
106113226|NCT00246337|366072156|FG001|Overall Study|Reported as completing trial in error|0|||
105884494|NCT04105218|365231230|FG001|Overall Study|Failed screening tests|1|||
105884495|NCT01167881|365231231|FG000|Overall Study|Adverse Event|47|||
105884496|NCT01167881|365231232|FG001|Overall Study|Adverse Event|51|||
105884497|NCT01167881|365231231|FG000|Overall Study|Lack of Efficacy|4|||
105884498|NCT01167881|365231232|FG001|Overall Study|Lack of Efficacy|7|||
105884499|NCT01167881|365231231|FG000|Overall Study|Non compliant with protocol|9|||
105884500|NCT01167881|365231232|FG001|Overall Study|Non compliant with protocol|18|||
105884501|NCT01167881|365231231|FG000|Overall Study|Lost to Follow-up|19|||
105884502|NCT01167881|365231232|FG001|Overall Study|Lost to Follow-up|20|||
106113227|NCT00246337|366072157|FG002|Overall Study|Reported as completing trial in error|0|||
105993813|NCT00726232|365636103|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
105993814|NCT00726232|365636104|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
105993815|NCT00726232|365636105|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
105993816|NCT00726232|365636106|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
105993817|NCT00726232|365636107|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
105993818|NCT00726232|365636108|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
105993819|NCT00726232|365636109|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
105993820|NCT00726232|365636110|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
105993821|NCT00726232|365636103|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
105993822|NCT00726232|365636104|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
105993823|NCT00726232|365636105|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
105993824|NCT00726232|365636106|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
105993825|NCT00726232|365636107|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
105993826|NCT00726232|365636108|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
105993827|NCT00726232|365636109|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
105993828|NCT00726232|365636110|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
105993829|NCT00726232|365636103|FG000|Expansion Phase|Death|0|||
105993830|NCT00726232|365636104|FG001|Expansion Phase|Death|0|||
105993831|NCT00726232|365636105|FG002|Expansion Phase|Death|0|||
105993832|NCT00726232|365636106|FG003|Expansion Phase|Death|0|||
105993833|NCT00726232|365636107|FG004|Expansion Phase|Death|0|||
105993834|NCT00726232|365636108|FG005|Expansion Phase|Death|0|||
105993835|NCT00726232|365636109|FG006|Expansion Phase|Death|0|||
105993836|NCT00726232|365636110|FG007|Expansion Phase|Death|1|||
105993837|NCT00726232|365636103|FG000|Expansion Phase|Adverse Event|0|||
105993838|NCT00726232|365636104|FG001|Expansion Phase|Adverse Event|0|||
105993839|NCT00726232|365636105|FG002|Expansion Phase|Adverse Event|0|||
105993840|NCT00726232|365636106|FG003|Expansion Phase|Adverse Event|0|||
105993841|NCT00726232|365636107|FG004|Expansion Phase|Adverse Event|0|||
105993842|NCT00726232|365636108|FG005|Expansion Phase|Adverse Event|0|||
105993843|NCT00726232|365636109|FG006|Expansion Phase|Adverse Event|6|||
105993844|NCT00726232|365636110|FG007|Expansion Phase|Adverse Event|11|||
105993845|NCT00726232|365636103|FG000|Expansion Phase|Withdrawal by Subject|0|||
105993846|NCT00726232|365636104|FG001|Expansion Phase|Withdrawal by Subject|0|||
105993847|NCT00726232|365636105|FG002|Expansion Phase|Withdrawal by Subject|0|||
105993848|NCT00726232|365636106|FG003|Expansion Phase|Withdrawal by Subject|0|||
105993849|NCT00726232|365636107|FG004|Expansion Phase|Withdrawal by Subject|0|||
105993850|NCT00726232|365636108|FG005|Expansion Phase|Withdrawal by Subject|0|||
105993851|NCT00726232|365636109|FG006|Expansion Phase|Withdrawal by Subject|2|||
105993852|NCT00726232|365636110|FG007|Expansion Phase|Withdrawal by Subject|3|||
105993853|NCT00726232|365636103|FG000|Expansion Phase|Disease progression|0|||
105993854|NCT00726232|365636104|FG001|Expansion Phase|Disease progression|0|||
105993855|NCT00726232|365636105|FG002|Expansion Phase|Disease progression|0|||
105993856|NCT00726232|365636106|FG003|Expansion Phase|Disease progression|0|||
105993857|NCT00726232|365636107|FG004|Expansion Phase|Disease progression|0|||
105993858|NCT00726232|365636108|FG005|Expansion Phase|Disease progression|0|||
105993859|NCT00726232|365636109|FG006|Expansion Phase|Disease progression|4|||
105993860|NCT00726232|365636110|FG007|Expansion Phase|Disease progression|0|||
105993861|NCT00726232|365636103|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
105993862|NCT00726232|365636104|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
105993863|NCT00726232|365636105|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
105993864|NCT00726232|365636106|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
105993865|NCT00726232|365636107|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
105993866|NCT00726232|365636108|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
105993867|NCT00726232|365636109|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
105993868|NCT00726232|365636110|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
105993869|NCT00726232|365636103|FG000|Expansion Phase|Per Investigator: lack of response|0|||
105993870|NCT00726232|365636104|FG001|Expansion Phase|Per Investigator: lack of response|0|||
105993871|NCT00726232|365636105|FG002|Expansion Phase|Per Investigator: lack of response|0|||
105993872|NCT00726232|365636106|FG003|Expansion Phase|Per Investigator: lack of response|0|||
105993873|NCT00726232|365636107|FG004|Expansion Phase|Per Investigator: lack of response|0|||
105993874|NCT00726232|365636108|FG005|Expansion Phase|Per Investigator: lack of response|0|||
105993875|NCT00726232|365636109|FG006|Expansion Phase|Per Investigator: lack of response|1|||
105993876|NCT00726232|365636110|FG007|Expansion Phase|Per Investigator: lack of response|7|||
105993877|NCT00726232|365636103|FG000|Expansion Phase|Unspecified reason|0|||
106113228|NCT00246337|366072158|FG003|Overall Study|Reported as completing trial in error|0|||
105993878|NCT00726232|365636104|FG001|Expansion Phase|Unspecified reason|0|||
105993879|NCT00726232|365636105|FG002|Expansion Phase|Unspecified reason|0|||
105993880|NCT00726232|365636106|FG003|Expansion Phase|Unspecified reason|0|||
105993881|NCT00726232|365636107|FG004|Expansion Phase|Unspecified reason|0|||
105993882|NCT00726232|365636108|FG005|Expansion Phase|Unspecified reason|0|||
105993883|NCT00726232|365636109|FG006|Expansion Phase|Unspecified reason|1|||
106113229|NCT00246337|366072159|FG004|Overall Study|Reported as completing trial in error|0|||
106113230|NCT00246337|366072160|FG005|Overall Study|Reported as completing trial in error|0|||
106113231|NCT00246337|366072161|FG006|Overall Study|Reported as completing trial in error|0|||
106113232|NCT00246337|366072162|FG007|Overall Study|Reported as completing trial in error|1|||
106113233|NCT00246337|366072163|FG008|Overall Study|Reported as completing trial in error|0|||
106113234|NCT01226511|366072166|FG000|Acute Treatment Period|Adverse Event|7|||
106113235|NCT01226511|366072167|FG001|Acute Treatment Period|Adverse Event|6|||
106113236|NCT01226511|366072166|FG000|Acute Treatment Period|Lack of Efficacy|2|||
105884503|NCT01167881|365231231|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
105884504|NCT01167881|365231232|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
105884505|NCT01167881|365231231|FG000|Overall Study|Not treated|4|||
105884506|NCT01167881|365231232|FG001|Overall Study|Not treated|0|||
105884507|NCT01167881|365231231|FG000|Overall Study|Other not defined above|31|||
105884508|NCT01167881|365231232|FG001|Overall Study|Other not defined above|55|||
105884509|NCT00430573|365231250|FG000|Overall Study|Withdrawal by Subject|5|||
105884510|NCT01732640|365231253|FG000|Overall Study|Adverse Event|0|||
105884511|NCT01732640|365231254|FG001|Overall Study|Adverse Event|1|||
106113237|NCT01226511|366072167|FG001|Acute Treatment Period|Lack of Efficacy|1|||
106113238|NCT01226511|366072166|FG000|Acute Treatment Period|Lost to Follow-up|3|||
106113239|NCT01226511|366072167|FG001|Acute Treatment Period|Lost to Follow-up|6|||
106113240|NCT01226511|366072166|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
106113241|NCT01226511|366072167|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
106113242|NCT01226511|366072166|FG000|Acute Treatment Period|Protocol Violation|5|||
106113243|NCT01226511|366072167|FG001|Acute Treatment Period|Protocol Violation|5|||
106113244|NCT01226511|366072166|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
106113245|NCT01226511|366072167|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
106113246|NCT01226511|366072166|FG000|Extension Treatment Period|Adverse Event|8|||
106113247|NCT01226511|366072167|FG001|Extension Treatment Period|Adverse Event|8|||
106113248|NCT01226511|366072166|FG000|Extension Treatment Period|Lack of Efficacy|3|||
105884512|NCT01732640|365231253|FG000|Overall Study|Death|0|||
105884513|NCT01732640|365231254|FG001|Overall Study|Death|1|||
105884514|NCT01684943|365231257|FG000|Overall Study|Inadequate Venous Access|3|||
105884515|NCT01684943|365231258|FG001|Overall Study|Inadequate Venous Access|0|||
105884516|NCT01684943|365231259|FG002|Overall Study|Inadequate Venous Access|0|||
105884517|NCT01684943|365231257|FG000|Overall Study|Principal Investigator Determination|1|||
105884518|NCT01684943|365231258|FG001|Overall Study|Principal Investigator Determination|0|||
105884519|NCT01684943|365231259|FG002|Overall Study|Principal Investigator Determination|0|||
105884520|NCT01684943|365231257|FG000|Overall Study|Excluded from Analysis|1|||
105884521|NCT01684943|365231258|FG001|Overall Study|Excluded from Analysis|1|||
105884522|NCT01684943|365231259|FG002|Overall Study|Excluded from Analysis|1|||
105884523|NCT01684943|365231257|FG000|Overall Study|Lost to Follow-up|3|||
105884524|NCT01684943|365231258|FG001|Overall Study|Lost to Follow-up|0|||
105884525|NCT01684943|365231259|FG002|Overall Study|Lost to Follow-up|0|||
105884526|NCT01684943|365231257|FG000|Overall Study|Planning Pregnancy|1|||
105884527|NCT01684943|365231258|FG001|Overall Study|Planning Pregnancy|0|||
105884528|NCT01684943|365231259|FG002|Overall Study|Planning Pregnancy|0|||
105884529|NCT01516008|365231260|FG000|Overall Study|Adverse Event|0|||
105884530|NCT01516008|365231261|FG001|Overall Study|Adverse Event|2|||
105884531|NCT01516008|365231262|FG002|Overall Study|Adverse Event|7|||
105884532|NCT01516008|365231260|FG000|Overall Study|Lack of Efficacy|44|||
105884533|NCT01516008|365231261|FG001|Overall Study|Lack of Efficacy|14|||
105884534|NCT01516008|365231262|FG002|Overall Study|Lack of Efficacy|10|||
105884535|NCT01516008|365231260|FG000|Overall Study|Protocol Violation|1|||
105884536|NCT01516008|365231261|FG001|Overall Study|Protocol Violation|0|||
105884537|NCT01516008|365231262|FG002|Overall Study|Protocol Violation|0|||
105884538|NCT01516008|365231260|FG000|Overall Study|Reason not specified|0|||
105884539|NCT01516008|365231261|FG001|Overall Study|Reason not specified|0|||
105884540|NCT01516008|365231262|FG002|Overall Study|Reason not specified|1|||
105884541|NCT01441765|365231265|FG000|Overall Study|Death|1|||
105884542|NCT01441765|365231266|FG001|Overall Study|Death|0|||
105993884|NCT00726232|365636110|FG007|Expansion Phase|Unspecified reason|0|||
105993885|NCT00466921|365636111|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
105993886|NCT00466921|365636111|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
105993887|NCT00466921|365636111|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
106113249|NCT01226511|366072167|FG001|Extension Treatment Period|Lack of Efficacy|2|||
106113250|NCT01226511|366072166|FG000|Extension Treatment Period|Lost to Follow-up|4|||
105884543|NCT04520997|365231267|FG000|Overall Study|Lost to Follow-up|1|||
105884544|NCT04520997|365231268|FG001|Overall Study|Lost to Follow-up|1|||
105884545|NCT04520997|365231267|FG000|Overall Study|Withdrawal by Subject|1|||
105884546|NCT04520997|365231268|FG001|Overall Study|Withdrawal by Subject|0|||
105884547|NCT04520997|365231267|FG000|Overall Study|Not Treated|0|||
105884548|NCT04520997|365231268|FG001|Overall Study|Not Treated|1|||
105884549|NCT04925557|365232589|FG000|Overall Study|Study closed|5|||
105884550|NCT04925557|365232590|FG001|Overall Study|Study closed|3|||
105884551|NCT04432831|365232591|FG000|Overall Study|Withdrawal by Subject|24|||
105884552|NCT04432831|365232592|FG001|Overall Study|Withdrawal by Subject|28|||
105993888|NCT00466921|365636111|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
105993889|NCT00466921|365636111|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
105993890|NCT00466921|365636111|FG000|Follow up for a Minimum of 1 Year|Death|6|||
105993891|NCT01397461|365636112|FG000|Overall Study|Withdrawal by Subject|2|||
105993892|NCT01397461|365636113|FG001|Overall Study|Withdrawal by Subject|1|||
105993893|NCT01397461|365636114|FG002|Overall Study|Withdrawal by Subject|0|||
105993894|NCT01397461|365636112|FG000|Overall Study|Lost to Follow-up|0|||
105993895|NCT01397461|365636113|FG001|Overall Study|Lost to Follow-up|2|||
105993896|NCT01397461|365636114|FG002|Overall Study|Lost to Follow-up|1|||
105993897|NCT01397461|365636112|FG000|Overall Study|Lack of Efficacy|0|||
105993898|NCT01397461|365636113|FG001|Overall Study|Lack of Efficacy|3|||
105993899|NCT01397461|365636114|FG002|Overall Study|Lack of Efficacy|0|||
105993900|NCT01397461|365636112|FG000|Overall Study|Not treated|0|||
105993901|NCT01397461|365636113|FG001|Overall Study|Not treated|0|||
105993902|NCT01397461|365636114|FG002|Overall Study|Not treated|1|||
105993903|NCT04526145|365636115|FG000|Overall Study|Withdrawal by Subject|5|||
105993904|NCT01502228|365636118|FG000|Overall Study|Death|1|||
105993905|NCT01221350|365636119|FG000|Overall Study|Discontinued intervention (GERD)|1|||
105993906|NCT01221350|365636120|FG001|Overall Study|Discontinued intervention (GERD)|0|||
105993907|NCT01221350|365636119|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
105993908|NCT01221350|365636120|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
105993909|NCT01221350|365636119|FG000|Overall Study|Withdrawal by Subject|4|||
105993910|NCT01221350|365636120|FG001|Overall Study|Withdrawal by Subject|2|||
105993911|NCT02362464|365636127|FG000|Overall Study|Switched to alternative therapy|1|||
105993912|NCT02362464|365636127|FG000|Overall Study|Refused further treatment|1|||
105993913|NCT02362464|365636127|FG000|Overall Study|Physician Decision|4|||
105993914|NCT05232864|365636128|FG000|Overall Study|Adverse Event|0|||
105993915|NCT05232864|365636129|FG001|Overall Study|Adverse Event|1|||
105993916|NCT05232864|365636128|FG000|Overall Study|Study terminated by sponsor|16|||
105993917|NCT05232864|365636129|FG001|Overall Study|Study terminated by sponsor|14|||
105993918|NCT00465452|365636139|FG000|Overall Study|Adverse Event|1|||
105993919|NCT04209205|365636140|FG000|Overall Study|Adverse Event|2|||
105993920|NCT04209205|365636141|FG001|Overall Study|Adverse Event|3|||
105993921|NCT04209205|365636140|FG000|Overall Study|Lost to Follow-up|3|||
105993922|NCT04209205|365636141|FG001|Overall Study|Lost to Follow-up|1|||
105993923|NCT04209205|365636140|FG000|Overall Study|Physician Decision|1|||
105993924|NCT04209205|365636141|FG001|Overall Study|Physician Decision|1|||
105993925|NCT04209205|365636140|FG000|Overall Study|Subject decision|10|||
105993926|NCT04209205|365636141|FG001|Overall Study|Subject decision|10|||
105993927|NCT04209205|365636140|FG000|Overall Study|Progressive disease|1|||
105993928|NCT04209205|365636141|FG001|Overall Study|Progressive disease|0|||
105993929|NCT04209205|365636140|FG000|Overall Study|Protocol deviation|0|||
105993930|NCT04209205|365636141|FG001|Overall Study|Protocol deviation|1|||
105993931|NCT04209205|365636140|FG000|Overall Study|New therapy for study indication|1|||
105993932|NCT04209205|365636141|FG001|Overall Study|New therapy for study indication|0|||
105993933|NCT04209205|365636140|FG000|Overall Study|Adverse event - placebo not switched|0|||
105993934|NCT04209205|365636141|FG001|Overall Study|Adverse event - placebo not switched|1|||
106113251|NCT01226511|366072167|FG001|Extension Treatment Period|Lost to Follow-up|3|||
106113252|NCT01226511|366072166|FG000|Extension Treatment Period|Protocol Violation|2|||
106113253|NCT01226511|366072167|FG001|Extension Treatment Period|Protocol Violation|2|||
106113254|NCT01226511|366072166|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
106113255|NCT01226511|366072167|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
106113256|NCT01226511|366072166|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
106113257|NCT01226511|366072167|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
106113258|NCT01226511|366072166|FG000|Extension Treatment Period|Sponsor Decision|1|||
106113259|NCT01226511|366072167|FG001|Extension Treatment Period|Sponsor Decision|1|||
106113260|NCT01226511|366072166|FG000|Taper Period|Adverse Event|1|||
106113261|NCT01226511|366072167|FG001|Taper Period|Adverse Event|0|||
106113262|NCT01226511|366072166|FG000|Taper Period|Lost to Follow-up|2|||
106113263|NCT01226511|366072167|FG001|Taper Period|Lost to Follow-up|2|||
106113264|NCT01226511|366072166|FG000|Taper Period|Protocol Violation|1|||
106113265|NCT01226511|366072167|FG001|Taper Period|Protocol Violation|0|||
105993935|NCT04209205|365636140|FG000|Overall Study|Subject decision - placebo not switched|0|||
105993936|NCT04209205|365636141|FG001|Overall Study|Subject decision - placebo not switched|5|||
105993937|NCT04209205|365636140|FG000|Overall Study|Death - placebo not switched|0|||
105993938|NCT04209205|365636141|FG001|Overall Study|Death - placebo not switched|1|||
105993939|NCT01635855|365636142|FG000|Overall Study|Withdrawal by Subject|4|||
105993940|NCT05236257|365636143|FG000|Overall Study|Ongoing with study treatment|29|||
105993941|NCT05236257|365636144|FG001|Overall Study|Ongoing with study treatment|1|||
105993942|NCT05236257|365636143|FG000|Overall Study|Discontinued study treatment|22|||
105993943|NCT05236257|365636144|FG001|Overall Study|Discontinued study treatment|41|||
106113266|NCT01226511|366072166|FG000|Taper Period|Parent/Caregiver Decision|1|||
105993944|NCT00145574|365636146|FG000|Double Blind|Adverse Event|0|||
105993945|NCT00145574|365636147|FG001|Double Blind|Adverse Event|3|||
105993946|NCT00145574|365636148|FG002|Double Blind|Adverse Event|1|||
105884553|NCT04432831|365232593|FG002|Overall Study|Withdrawal by Subject|21|||
105884554|NCT04432831|365232591|FG000|Overall Study|Death|23|||
105884555|NCT04432831|365232592|FG001|Overall Study|Death|23|||
105884556|NCT04432831|365232593|FG002|Overall Study|Death|17|||
105884557|NCT04432831|365232591|FG000|Overall Study|Lost to Follow-up|15|||
105884558|NCT04432831|365232592|FG001|Overall Study|Lost to Follow-up|15|||
105884559|NCT04432831|365232593|FG002|Overall Study|Lost to Follow-up|12|||
105884560|NCT04432831|365232591|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
105884561|NCT04432831|365232592|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
105884562|NCT04432831|365232593|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
105884563|NCT04432831|365232591|FG000|Overall Study|Reason Not Specified|7|||
105884564|NCT04432831|365232592|FG001|Overall Study|Reason Not Specified|11|||
105884565|NCT04432831|365232593|FG002|Overall Study|Reason Not Specified|9|||
105884566|NCT04432831|365232591|FG000|Overall Study|Adverse Event|7|||
105884567|NCT04432831|365232592|FG001|Overall Study|Adverse Event|7|||
105884568|NCT04432831|365232593|FG002|Overall Study|Adverse Event|7|||
105884569|NCT04432831|365232591|FG000|Overall Study|Physician Decision|1|||
105884570|NCT04432831|365232592|FG001|Overall Study|Physician Decision|3|||
105884571|NCT04432831|365232593|FG002|Overall Study|Physician Decision|6|||
105884572|NCT04432831|365232591|FG000|Overall Study|Protocol Violation|1|||
105884573|NCT04432831|365232592|FG001|Overall Study|Protocol Violation|0|||
105884574|NCT04432831|365232593|FG002|Overall Study|Protocol Violation|2|||
105884575|NCT04432831|365232591|FG000|Overall Study|Pregnancy|0|||
105884576|NCT04432831|365232592|FG001|Overall Study|Pregnancy|1|||
105884577|NCT04432831|365232593|FG002|Overall Study|Pregnancy|0|||
105884578|NCT04432831|365232591|FG000|Overall Study|Lack of Efficacy|0|||
105884579|NCT04432831|365232592|FG001|Overall Study|Lack of Efficacy|0|||
105884580|NCT04432831|365232593|FG002|Overall Study|Lack of Efficacy|2|||
105884581|NCT03300505|365232595|FG000|Overall Study|Death|0|||
105884582|NCT03300505|365232596|FG001|Overall Study|Death|1|||
105884583|NCT03300505|365232597|FG002|Overall Study|Death|0|||
105884584|NCT03300505|365232595|FG000|Overall Study|Withdrawal by Subject|0|||
105884585|NCT03300505|365232596|FG001|Overall Study|Withdrawal by Subject|1|||
105884586|NCT03300505|365232597|FG002|Overall Study|Withdrawal by Subject|1|||
105884587|NCT03300505|365232595|FG000|Overall Study|Sponsor Termination|0|||
106113267|NCT01226511|366072167|FG001|Taper Period|Parent/Caregiver Decision|1|||
106113268|NCT03633929|366072169|FG000|Overall Study|Lost to Follow-up|1|||
105884588|NCT03300505|365232596|FG001|Overall Study|Sponsor Termination|1|||
105884589|NCT03300505|365232597|FG002|Overall Study|Sponsor Termination|0|||
105884590|NCT03300505|365232595|FG000|Overall Study|Adverse Event|0|||
106113269|NCT03633929|366072169|FG000|Overall Study|Did not login to software. Did not participate|3|||
106113270|NCT01287611|366072171|FG000|Overall Study|Lost to Follow-up|29|||
106113271|NCT01287611|366072172|FG001|Overall Study|Lost to Follow-up|16|||
106113272|NCT01287611|366072171|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
106113273|NCT01287611|366072172|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
106113274|NCT02255357|366072173|FG000|Overall Study|Physician Decision|10|||
106113275|NCT02255357|366072174|FG001|Overall Study|Physician Decision|24|||
106113276|NCT04074590|366072179|FG000|Overall Study|Adverse Event|1|||
106113277|NCT04074590|366072180|FG001|Overall Study|Adverse Event|0|||
106113278|NCT04074590|366072179|FG000|Overall Study|Physician Decision|1|||
106113279|NCT04074590|366072180|FG001|Overall Study|Physician Decision|0|||
106113280|NCT04074590|366072179|FG000|Overall Study|Withdrawal by Subject|2|||
106113281|NCT04074590|366072180|FG001|Overall Study|Withdrawal by Subject|0|||
106113282|NCT02709005|366072181|FG000|Overall Study|Lost to Follow-up|1|||
106113283|NCT02709005|366072182|FG001|Overall Study|Lost to Follow-up|1|||
106113284|NCT02709005|366072181|FG000|Overall Study|Withdrawal by Subject|3|||
106113285|NCT02709005|366072182|FG001|Overall Study|Withdrawal by Subject|0|||
106113286|NCT01282801|366072189|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
106113287|NCT01282801|366072190|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
106113288|NCT00946296|366072194|FG000|Overall Study|Physician Decision|3|||
106113289|NCT00946296|366072195|FG001|Overall Study|Physician Decision|0|||
106113290|NCT01320943|366072196|FG000|Overall Study|Lost to Follow-up|1|||
106113291|NCT01320943|366072197|FG001|Overall Study|Lost to Follow-up|0|||
106113292|NCT01320943|366072196|FG000|Overall Study|Physician Decision|0|||
106113293|NCT01320943|366072197|FG001|Overall Study|Physician Decision|1|||
106113294|NCT01320943|366072196|FG000|Overall Study|Randomized but not Treated|0|||
106113295|NCT01320943|366072197|FG001|Overall Study|Randomized but not Treated|1|||
106113296|NCT02036645|366072201|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
105884591|NCT03300505|365232596|FG001|Overall Study|Adverse Event|0|||
105884592|NCT03300505|365232597|FG002|Overall Study|Adverse Event|2|||
105884593|NCT03483961|365232598|FG000|Overall Study|Lost to Follow-up|7|||
105884594|NCT03483961|365232599|FG001|Overall Study|Lost to Follow-up|6|||
105884595|NCT03483961|365232600|FG002|Overall Study|Lost to Follow-up|6|||
105884596|NCT03483961|365232601|FG003|Overall Study|Lost to Follow-up|6|||
105884597|NCT03483961|365232602|FG004|Overall Study|Lost to Follow-up|6|||
105884598|NCT03483961|365232603|FG005|Overall Study|Lost to Follow-up|4|||
105884599|NCT03483961|365232604|FG006|Overall Study|Lost to Follow-up|4|||
105884600|NCT03483961|365232605|FG007|Overall Study|Lost to Follow-up|11|||
106113297|NCT02036645|366072202|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113298|NCT02036645|366072203|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113299|NCT02036645|366072204|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113300|NCT02036645|366072205|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113301|NCT02036645|366072206|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113302|NCT02036645|366072207|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
106113303|NCT02036645|366072208|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113304|NCT02036645|366072209|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113305|NCT02036645|366072210|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113306|NCT02036645|366072211|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113307|NCT02036645|366072212|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
106113308|NCT02036645|366072201|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
105884601|NCT03483961|365232606|FG008|Overall Study|Lost to Follow-up|1|||
105884602|NCT03483961|365232607|FG009|Overall Study|Lost to Follow-up|0|||
105884603|NCT03483961|365232598|FG000|Overall Study|Withdrawal by Subject|3|||
106113309|NCT02036645|366072202|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113310|NCT02036645|366072203|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113311|NCT02036645|366072204|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
106113312|NCT02036645|366072205|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113313|NCT02036645|366072206|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113314|NCT02036645|366072207|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113315|NCT02036645|366072208|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113316|NCT02036645|366072209|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113317|NCT02036645|366072210|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113318|NCT02036645|366072211|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113319|NCT02036645|366072212|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
106113320|NCT01693692|366072213|FG000|Overall Study|Withdrawal by Subject|12|||
106113321|NCT01693692|366072214|FG001|Overall Study|Withdrawal by Subject|10|||
106113322|NCT01693692|366072215|FG002|Overall Study|Withdrawal by Subject|11|||
106113323|NCT01693692|366072213|FG000|Overall Study|Adverse Event|7|||
106113324|NCT01693692|366072214|FG001|Overall Study|Adverse Event|14|||
106113325|NCT01693692|366072215|FG002|Overall Study|Adverse Event|9|||
106113326|NCT01693692|366072213|FG000|Overall Study|Physician Decision|0|||
106113327|NCT01693692|366072214|FG001|Overall Study|Physician Decision|0|||
106113328|NCT01693692|366072215|FG002|Overall Study|Physician Decision|1|||
106113329|NCT01693692|366072213|FG000|Overall Study|Protocol Violation|5|||
106113330|NCT01693692|366072214|FG001|Overall Study|Protocol Violation|4|||
106113331|NCT01693692|366072215|FG002|Overall Study|Protocol Violation|6|||
106113332|NCT01693692|366072213|FG000|Overall Study|Lost to Follow-up|2|||
106113333|NCT01693692|366072214|FG001|Overall Study|Lost to Follow-up|2|||
106113334|NCT01693692|366072215|FG002|Overall Study|Lost to Follow-up|3|||
106113335|NCT01693692|366072213|FG000|Overall Study|Other|4|||
106113336|NCT01693692|366072214|FG001|Overall Study|Other|4|||
106113337|NCT01693692|366072215|FG002|Overall Study|Other|6|||
106113338|NCT02719990|366072216|FG000|Overall Study|Physician Decision|2|||
106113339|NCT02719990|366072216|FG000|Overall Study|Withdrawal by Subject|2|||
106113340|NCT02719990|366072216|FG000|Overall Study|Study Terminated By Sponsor|32|||
106113341|NCT01778556|366072217|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
106113342|NCT01778556|366072218|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
106113343|NCT01778556|366072217|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
106113344|NCT01778556|366072218|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
106113345|NCT01778556|366072217|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
106113346|NCT01778556|366072218|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
106113347|NCT01778556|366072217|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
106113348|NCT01778556|366072218|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
106113349|NCT01412801|366072223|FG000|Overall Study|Death|0|||
105884604|NCT03483961|365232599|FG001|Overall Study|Withdrawal by Subject|4|||
105884605|NCT03483961|365232600|FG002|Overall Study|Withdrawal by Subject|5|||
106113350|NCT01412801|366072224|FG001|Overall Study|Death|1|||
106113351|NCT01412801|366072225|FG002|Overall Study|Death|0|||
106113352|NCT01412801|366072226|FG003|Overall Study|Death|4|||
106113353|NCT01412801|366072227|FG004|Overall Study|Death|2|||
106113354|NCT01412801|366072228|FG005|Overall Study|Death|2|||
106113355|NCT01412801|366072223|FG000|Overall Study|Lost to Follow-up|1|||
106113356|NCT01412801|366072224|FG001|Overall Study|Lost to Follow-up|2|||
106113357|NCT01412801|366072225|FG002|Overall Study|Lost to Follow-up|4|||
105884606|NCT03483961|365232601|FG003|Overall Study|Withdrawal by Subject|3|||
105884607|NCT03483961|365232602|FG004|Overall Study|Withdrawal by Subject|4|||
106113358|NCT01412801|366072226|FG003|Overall Study|Lost to Follow-up|0|||
106113359|NCT01412801|366072227|FG004|Overall Study|Lost to Follow-up|1|||
106113360|NCT01412801|366072228|FG005|Overall Study|Lost to Follow-up|1|||
106113361|NCT01412801|366072223|FG000|Overall Study|Withdrawal by Subject|3|||
105884608|NCT03483961|365232603|FG005|Overall Study|Withdrawal by Subject|2|||
106113362|NCT01412801|366072224|FG001|Overall Study|Withdrawal by Subject|2|||
106113363|NCT01412801|366072225|FG002|Overall Study|Withdrawal by Subject|1|||
106113364|NCT01412801|366072226|FG003|Overall Study|Withdrawal by Subject|0|||
106113365|NCT01412801|366072227|FG004|Overall Study|Withdrawal by Subject|0|||
106113366|NCT01412801|366072228|FG005|Overall Study|Withdrawal by Subject|0|||
106113367|NCT01412801|366072223|FG000|Overall Study|Relocated to another area|0|||
106113368|NCT01412801|366072224|FG001|Overall Study|Relocated to another area|0|||
106113369|NCT01412801|366072225|FG002|Overall Study|Relocated to another area|2|||
106113370|NCT01412801|366072226|FG003|Overall Study|Relocated to another area|0|||
106113371|NCT01412801|366072227|FG004|Overall Study|Relocated to another area|0|||
106113372|NCT01412801|366072228|FG005|Overall Study|Relocated to another area|0|||
106113373|NCT00116272|366072229|FG000|Overall Study|Lost to Follow-up|11|||
106113374|NCT00116272|366072230|FG001|Overall Study|Lost to Follow-up|6|||
106113375|NCT03188120|366072231|FG000|Overall Study|Adverse Event|4|||
106113376|NCT03188120|366072231|FG000|Overall Study|Insufficient Effectiveness|8|||
106113377|NCT03188120|366072231|FG000|Overall Study|Improved|12|||
106113378|NCT03188120|366072231|FG000|Overall Study|Lost to Follow-up|7|||
106113379|NCT03188120|366072231|FG000|Overall Study|Other than specified|3|||
106113380|NCT03188120|366072231|FG000|Overall Study|No visit after the first visit|13|||
106113381|NCT01235403|366072232|FG000|Overall Study|Adverse Event|14|||
106113382|NCT01235403|366072232|FG000|Overall Study|Lost to Follow-up|2|||
106113383|NCT01235403|366072232|FG000|Overall Study|Withdrawal by Subject|4|||
106113384|NCT01235403|366072232|FG000|Overall Study|Lack of Efficacy|2|||
106113385|NCT01235403|366072232|FG000|Overall Study|Other reasons for premature termination|4|||
106113386|NCT02296190|366072233|FG000|Overall Study|Lost to Follow-up|0|||
106113387|NCT02296190|366072234|FG001|Overall Study|Lost to Follow-up|0|||
106113388|NCT02296190|366072235|FG002|Overall Study|Lost to Follow-up|0|||
106113389|NCT02296190|366072236|FG003|Overall Study|Lost to Follow-up|0|||
106113390|NCT02296190|366072237|FG004|Overall Study|Lost to Follow-up|1|||
105884609|NCT03483961|365232604|FG006|Overall Study|Withdrawal by Subject|1|||
105884610|NCT03483961|365232605|FG007|Overall Study|Withdrawal by Subject|2|||
105884611|NCT03483961|365232606|FG008|Overall Study|Withdrawal by Subject|1|||
105884612|NCT03483961|365232607|FG009|Overall Study|Withdrawal by Subject|0|||
105884613|NCT03483961|365232598|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
105884614|NCT03483961|365232599|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884615|NCT03483961|365232600|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884616|NCT03483961|365232601|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884617|NCT03483961|365232602|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884618|NCT03483961|365232603|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884619|NCT03483961|365232604|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884620|NCT03483961|365232605|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884621|NCT03483961|365232606|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884622|NCT03483961|365232607|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
105884623|NCT03483961|365232598|FG000|Overall Study|Adverse Event|0|||
105884624|NCT03483961|365232599|FG001|Overall Study|Adverse Event|0|||
105884625|NCT03483961|365232600|FG002|Overall Study|Adverse Event|1|||
105884626|NCT03483961|365232601|FG003|Overall Study|Adverse Event|0|||
105884627|NCT03483961|365232602|FG004|Overall Study|Adverse Event|0|||
105884628|NCT03483961|365232603|FG005|Overall Study|Adverse Event|0|||
105884629|NCT03483961|365232604|FG006|Overall Study|Adverse Event|0|||
105884630|NCT03483961|365232605|FG007|Overall Study|Adverse Event|0|||
105884631|NCT03483961|365232606|FG008|Overall Study|Adverse Event|0|||
105884632|NCT03483961|365232607|FG009|Overall Study|Adverse Event|0|||
105884633|NCT01108341|365232608|FG000|Overall Study|Death|2|||
105884634|NCT01108341|365232608|FG000|Overall Study|Withdrawal by Subject|1|||
105884635|NCT01108341|365232608|FG000|Overall Study|Lost to Follow-up|1|||
105884636|NCT01108341|365232608|FG000|Overall Study|Other|1|||
105884637|NCT00652626|365232611|FG000|Initial Treatment Phase|Adverse Event|0|||
105884638|NCT00652626|365232612|FG001|Initial Treatment Phase|Adverse Event|0|||
105884639|NCT00652626|365232613|FG002|Initial Treatment Phase|Adverse Event|0|||
105884640|NCT00652626|365232614|FG003|Initial Treatment Phase|Adverse Event|0|||
105884641|NCT00652626|365232615|FG004|Initial Treatment Phase|Adverse Event|1|||
105884642|NCT00652626|365232616|FG005|Initial Treatment Phase|Adverse Event|0|||
105884643|NCT00652626|365232617|FG006|Initial Treatment Phase|Adverse Event|0|||
105884644|NCT00652626|365232611|FG000|Initial Treatment Phase|Protocol Violation|0|||
105884645|NCT00652626|365232612|FG001|Initial Treatment Phase|Protocol Violation|0|||
105993947|NCT00145574|365636146|FG000|Double Blind|Withdrawal by Subject|1|||
106113391|NCT02296190|366072238|FG005|Overall Study|Lost to Follow-up|0|||
106113392|NCT02296190|366072233|FG000|Overall Study|Failure to induce PSVT|6|||
106113393|NCT02296190|366072234|FG001|Overall Study|Failure to induce PSVT|10|||
106113394|NCT02296190|366072235|FG002|Overall Study|Failure to induce PSVT|5|||
106113395|NCT02296190|366072236|FG003|Overall Study|Failure to induce PSVT|13|||
106113396|NCT02296190|366072237|FG004|Overall Study|Failure to induce PSVT|8|||
105884646|NCT00652626|365232613|FG002|Initial Treatment Phase|Protocol Violation|0|||
105884647|NCT00652626|365232614|FG003|Initial Treatment Phase|Protocol Violation|1|||
105884648|NCT00652626|365232615|FG004|Initial Treatment Phase|Protocol Violation|0|||
105884649|NCT00652626|365232616|FG005|Initial Treatment Phase|Protocol Violation|0|||
105884650|NCT00652626|365232617|FG006|Initial Treatment Phase|Protocol Violation|0|||
105884651|NCT00652626|365232611|FG000|Initial Treatment Phase|Physician Decision|0|||
105884652|NCT00652626|365232612|FG001|Initial Treatment Phase|Physician Decision|0|||
105884653|NCT00652626|365232613|FG002|Initial Treatment Phase|Physician Decision|0|||
105884654|NCT00652626|365232614|FG003|Initial Treatment Phase|Physician Decision|0|||
105884655|NCT00652626|365232615|FG004|Initial Treatment Phase|Physician Decision|1|||
105884656|NCT00652626|365232616|FG005|Initial Treatment Phase|Physician Decision|0|||
105884657|NCT00652626|365232617|FG006|Initial Treatment Phase|Physician Decision|0|||
105884658|NCT00652626|365232611|FG000|Initial Treatment Phase|Sponsor Request|0|||
105884659|NCT00652626|365232612|FG001|Initial Treatment Phase|Sponsor Request|0|||
105884660|NCT00652626|365232613|FG002|Initial Treatment Phase|Sponsor Request|1|||
105884661|NCT00652626|365232614|FG003|Initial Treatment Phase|Sponsor Request|0|||
105884662|NCT00652626|365232615|FG004|Initial Treatment Phase|Sponsor Request|0|||
105884663|NCT00652626|365232616|FG005|Initial Treatment Phase|Sponsor Request|0|||
105884664|NCT00652626|365232617|FG006|Initial Treatment Phase|Sponsor Request|0|||
105884665|NCT00652626|365232611|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
105884666|NCT00652626|365232612|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
105884667|NCT00652626|365232613|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
105884668|NCT00652626|365232614|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
105884669|NCT00652626|365232615|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
105884670|NCT00652626|365232616|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
105884671|NCT00652626|365232617|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
105884672|NCT00652626|365232611|FG000|Extension Phase|Withdrawal by Subject|0|||
105884673|NCT00652626|365232612|FG001|Extension Phase|Withdrawal by Subject|0|||
105884674|NCT00652626|365232613|FG002|Extension Phase|Withdrawal by Subject|0|||
105884675|NCT00652626|365232614|FG003|Extension Phase|Withdrawal by Subject|0|||
105884676|NCT00652626|365232615|FG004|Extension Phase|Withdrawal by Subject|0|||
105884677|NCT00652626|365232616|FG005|Extension Phase|Withdrawal by Subject|2|||
105884678|NCT00652626|365232617|FG006|Extension Phase|Withdrawal by Subject|0|||
105884679|NCT00652626|365232611|FG000|Extension Phase|Adverse Event|0|||
105884680|NCT00652626|365232612|FG001|Extension Phase|Adverse Event|0|||
105884681|NCT00652626|365232613|FG002|Extension Phase|Adverse Event|0|||
105884682|NCT00652626|365232614|FG003|Extension Phase|Adverse Event|0|||
105884683|NCT00652626|365232615|FG004|Extension Phase|Adverse Event|0|||
105884684|NCT00652626|365232616|FG005|Extension Phase|Adverse Event|2|||
105884685|NCT00652626|365232617|FG006|Extension Phase|Adverse Event|1|||
105884686|NCT00652626|365232611|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105884687|NCT00652626|365232612|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105884688|NCT00652626|365232613|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105884689|NCT00652626|365232614|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105884690|NCT00652626|365232615|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105884691|NCT00652626|365232616|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
105993948|NCT00145574|365636147|FG001|Double Blind|Withdrawal by Subject|1|||
105993949|NCT00145574|365636148|FG002|Double Blind|Withdrawal by Subject|1|||
106113397|NCT02296190|366072238|FG005|Overall Study|Failure to induce PSVT|0|||
106113398|NCT02296190|366072233|FG000|Overall Study|Physician Decision|1|||
106113399|NCT02296190|366072234|FG001|Overall Study|Physician Decision|1|||
106113400|NCT02296190|366072235|FG002|Overall Study|Physician Decision|0|||
106113401|NCT02296190|366072236|FG003|Overall Study|Physician Decision|1|||
106113402|NCT02296190|366072237|FG004|Overall Study|Physician Decision|2|||
106113403|NCT02296190|366072238|FG005|Overall Study|Physician Decision|0|||
106113404|NCT02296190|366072233|FG000|Overall Study|Withdrawal by Subject|0|||
106113405|NCT02296190|366072234|FG001|Overall Study|Withdrawal by Subject|1|||
106113406|NCT02296190|366072235|FG002|Overall Study|Withdrawal by Subject|0|||
106113407|NCT02296190|366072236|FG003|Overall Study|Withdrawal by Subject|0|||
106113408|NCT02296190|366072237|FG004|Overall Study|Withdrawal by Subject|0|||
106113409|NCT02296190|366072238|FG005|Overall Study|Withdrawal by Subject|0|||
106113410|NCT02296190|366072233|FG000|Overall Study|PSVT < 5 minutes|5|||
106113411|NCT02296190|366072234|FG001|Overall Study|PSVT < 5 minutes|6|||
106113412|NCT02296190|366072235|FG002|Overall Study|PSVT < 5 minutes|6|||
106113413|NCT02296190|366072236|FG003|Overall Study|PSVT < 5 minutes|6|||
106113414|NCT02296190|366072237|FG004|Overall Study|PSVT < 5 minutes|5|||
106113415|NCT02296190|366072238|FG005|Overall Study|PSVT < 5 minutes|0|||
106113416|NCT02296190|366072233|FG000|Overall Study|Patient was given Propofol|0|||
105884692|NCT00652626|365232617|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
105884693|NCT00652626|365232611|FG000|Extension Phase|Physician Decision|0|||
105884694|NCT00652626|365232612|FG001|Extension Phase|Physician Decision|0|||
105884695|NCT00652626|365232613|FG002|Extension Phase|Physician Decision|0|||
105884696|NCT00652626|365232614|FG003|Extension Phase|Physician Decision|0|||
105884697|NCT00652626|365232615|FG004|Extension Phase|Physician Decision|0|||
106113417|NCT02296190|366072234|FG001|Overall Study|Patient was given Propofol|1|||
105993950|NCT00145574|365636146|FG000|Double Blind|required restricted medicine|0|||
105993951|NCT00145574|365636147|FG001|Double Blind|required restricted medicine|1|||
105993952|NCT00145574|365636148|FG002|Double Blind|required restricted medicine|0|||
105993953|NCT00145574|365636146|FG000|Open Label Long-term Extension|Adverse Event|0|||
105993954|NCT00145574|365636147|FG001|Open Label Long-term Extension|Adverse Event|0|||
105993955|NCT00145574|365636148|FG002|Open Label Long-term Extension|Adverse Event|5|||
105993956|NCT00145574|365636146|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
105993957|NCT00145574|365636147|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
105993958|NCT00145574|365636148|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
105993959|NCT00145574|365636146|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
105993960|NCT00145574|365636147|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
105993961|NCT00145574|365636148|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
105993962|NCT00145574|365636146|FG000|Open Label Long-term Extension|required restricted medicine|0|||
105993963|NCT00145574|365636147|FG001|Open Label Long-term Extension|required restricted medicine|0|||
105993964|NCT00145574|365636148|FG002|Open Label Long-term Extension|required restricted medicine|1|||
105993965|NCT03508609|365636150|FG000|Overall Study|Withdrawal by Subject|1|||
105993966|NCT00423449|365636153|FG000|Overall Study|Clinical Adverse Event|1|||
105993967|NCT00423449|365636154|FG001|Overall Study|Clinical Adverse Event|0|||
105993968|NCT00423449|365636155|FG002|Overall Study|Clinical Adverse Event|1|||
105993969|NCT00423449|365636156|FG003|Overall Study|Clinical Adverse Event|8|||
105993970|NCT00423449|365636157|FG004|Overall Study|Clinical Adverse Event|2|||
105993971|NCT00423449|365636153|FG000|Overall Study|Death|1|||
105993972|NCT00423449|365636154|FG001|Overall Study|Death|0|||
105993973|NCT00423449|365636155|FG002|Overall Study|Death|2|||
105993974|NCT00423449|365636156|FG003|Overall Study|Death|1|||
105993975|NCT00423449|365636157|FG004|Overall Study|Death|1|||
105993976|NCT00423449|365636153|FG000|Overall Study|Progressive Disease|1|||
105993977|NCT00423449|365636154|FG001|Overall Study|Progressive Disease|3|||
105993978|NCT00423449|365636155|FG002|Overall Study|Progressive Disease|8|||
105993979|NCT00423449|365636156|FG003|Overall Study|Progressive Disease|11|||
105993980|NCT00423449|365636157|FG004|Overall Study|Progressive Disease|4|||
105993981|NCT00423449|365636153|FG000|Overall Study|Laboratory Adverse Event|0|||
105993982|NCT00423449|365636154|FG001|Overall Study|Laboratory Adverse Event|1|||
105993983|NCT00423449|365636155|FG002|Overall Study|Laboratory Adverse Event|2|||
105993984|NCT00423449|365636156|FG003|Overall Study|Laboratory Adverse Event|0|||
105993985|NCT00423449|365636157|FG004|Overall Study|Laboratory Adverse Event|0|||
105993986|NCT00423449|365636153|FG000|Overall Study|Other|0|||
105993987|NCT00423449|365636154|FG001|Overall Study|Other|0|||
105993988|NCT00423449|365636155|FG002|Overall Study|Other|0|||
105993989|NCT00423449|365636156|FG003|Overall Study|Other|1|||
105993990|NCT00423449|365636157|FG004|Overall Study|Other|0|||
105993991|NCT00423449|365636153|FG000|Overall Study|Protocol Violation|0|||
105993992|NCT00423449|365636154|FG001|Overall Study|Protocol Violation|0|||
105993993|NCT00423449|365636155|FG002|Overall Study|Protocol Violation|2|||
105993994|NCT00423449|365636156|FG003|Overall Study|Protocol Violation|1|||
105993995|NCT00423449|365636157|FG004|Overall Study|Protocol Violation|0|||
105993996|NCT00869518|365636161|FG000|Overall Study|Lost to Follow-up|1|||
105993997|NCT00869518|365636162|FG001|Overall Study|Lost to Follow-up|1|||
105993998|NCT01574651|365636163|FG000|Overall Study|Lost to Follow-up|2|||
105993999|NCT01574651|365636164|FG001|Overall Study|Lost to Follow-up|4|||
105994000|NCT01574651|365636163|FG000|Overall Study|Administrative problems|0|||
105994001|NCT01574651|365636164|FG001|Overall Study|Administrative problems|1|||
105994002|NCT01574651|365636163|FG000|Overall Study|Death|3|||
105994003|NCT01574651|365636164|FG001|Overall Study|Death|3|||
105994004|NCT01574651|365636163|FG000|Overall Study|Patient's inability to use the device|0|||
105994005|NCT01574651|365636164|FG001|Overall Study|Patient's inability to use the device|1|||
106113418|NCT02296190|366072235|FG002|Overall Study|Patient was given Propofol|0|||
106113419|NCT02296190|366072236|FG003|Overall Study|Patient was given Propofol|1|||
106113420|NCT02296190|366072237|FG004|Overall Study|Patient was given Propofol|0|||
106113421|NCT02296190|366072238|FG005|Overall Study|Patient was given Propofol|0|||
106113422|NCT02296190|366072233|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
106113423|NCT02296190|366072234|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
106113424|NCT02296190|366072235|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
106113425|NCT02296190|366072236|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
106113426|NCT02296190|366072237|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
105994006|NCT01574651|365636163|FG000|Overall Study|Adverse Event|36|||
105994007|NCT01574651|365636164|FG001|Overall Study|Adverse Event|27|||
105994008|NCT01574651|365636163|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105994009|NCT01574651|365636164|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105994010|NCT01574651|365636163|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105994011|NCT01574651|365636164|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105994012|NCT01574651|365636163|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
105994013|NCT01574651|365636164|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105994014|NCT01574651|365636163|FG000|Overall Study|Protocol Violation|3|||
105994015|NCT01574651|365636164|FG001|Overall Study|Protocol Violation|5|||
105884698|NCT00652626|365232616|FG005|Extension Phase|Physician Decision|1|||
105884699|NCT00652626|365232617|FG006|Extension Phase|Physician Decision|1|||
105884700|NCT00652626|365232611|FG000|Extension Phase|Death|0|||
105884701|NCT00652626|365232612|FG001|Extension Phase|Death|0|||
105884702|NCT00652626|365232613|FG002|Extension Phase|Death|0|||
105884703|NCT00652626|365232614|FG003|Extension Phase|Death|0|||
105884704|NCT00652626|365232615|FG004|Extension Phase|Death|0|||
105884705|NCT00652626|365232616|FG005|Extension Phase|Death|1|||
105884706|NCT00652626|365232617|FG006|Extension Phase|Death|1|||
105884707|NCT04402138|365232618|FG000|Overall Study|Progressive Disease|2|||
105884708|NCT04402138|365232618|FG000|Overall Study|Adverse Event|1|||
105884709|NCT00468481|365232619|FG000|Overall Study|Adverse Event|13|||
105884710|NCT00468481|365232620|FG001|Overall Study|Adverse Event|3|||
105884711|NCT00468481|365232619|FG000|Overall Study|Lost to Follow-up|25|||
106113427|NCT02296190|366072238|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
106113428|NCT02296190|366072233|FG000|Overall Study|Blood pressure <100 after sedation|0|||
106113429|NCT02296190|366072234|FG001|Overall Study|Blood pressure <100 after sedation|0|||
106113430|NCT02296190|366072235|FG002|Overall Study|Blood pressure <100 after sedation|0|||
106113431|NCT02296190|366072236|FG003|Overall Study|Blood pressure <100 after sedation|1|||
106113432|NCT02296190|366072237|FG004|Overall Study|Blood pressure <100 after sedation|0|||
106113433|NCT02296190|366072238|FG005|Overall Study|Blood pressure <100 after sedation|0|||
106113434|NCT02296190|366072233|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
106113435|NCT02296190|366072234|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
106113436|NCT02296190|366072235|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
106113437|NCT02296190|366072236|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
106113438|NCT02296190|366072237|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
106113439|NCT02296190|366072238|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
106113440|NCT02296190|366072233|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
106113441|NCT02296190|366072234|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
106113442|NCT02296190|366072235|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
106113443|NCT02296190|366072236|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
106113444|NCT02296190|366072237|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
106113445|NCT02296190|366072238|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
106113446|NCT02296190|366072233|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
106113447|NCT02296190|366072234|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
106113448|NCT02296190|366072235|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
106113449|NCT02296190|366072236|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
106113450|NCT02296190|366072237|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
106113451|NCT02296190|366072238|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
106113452|NCT02296190|366072233|FG000|Overall Study|Lab result not available in time|1|||
106113453|NCT02296190|366072234|FG001|Overall Study|Lab result not available in time|0|||
106113454|NCT02296190|366072235|FG002|Overall Study|Lab result not available in time|0|||
106113455|NCT02296190|366072236|FG003|Overall Study|Lab result not available in time|0|||
106113456|NCT02296190|366072237|FG004|Overall Study|Lab result not available in time|0|||
106113457|NCT02296190|366072238|FG005|Overall Study|Lab result not available in time|0|||
106113458|NCT02978443|366072239|FG000|Overall Study|Withdrawal by Subject|1|||
106113459|NCT02978443|366072239|FG000|Overall Study|Adverse Event|3|||
106113460|NCT02978443|366072239|FG000|Overall Study|Disease Progression on study|6|||
106113461|NCT02978443|366072239|FG000|Overall Study|Death|1|||
106113462|NCT02978443|366072239|FG000|Overall Study|Physician Decision|1|||
106113463|NCT02978443|366072239|FG000|Overall Study|Switch to alternative therapy|1|||
106113464|NCT02978443|366072239|FG000|Overall Study|Refused further treatment|1|||
106113465|NCT01987817|366072240|FG000|Overall Study|Adverse Event|4|||
106113466|NCT01987817|366072241|FG001|Overall Study|Adverse Event|0|||
106113467|NCT01987817|366072240|FG000|Overall Study|Withdrawal by Subject|1|||
106113468|NCT01987817|366072241|FG001|Overall Study|Withdrawal by Subject|1|||
106113469|NCT01987817|366072240|FG000|Overall Study|Physician Decision|1|||
106113470|NCT01987817|366072241|FG001|Overall Study|Physician Decision|0|||
106113471|NCT02658630|366072243|FG000|Overall Study|Withdrawal by Subject|4|||
106113472|NCT00085202|366072244|FG000|Overall Study|Still on therapy|2|||
106113473|NCT00085202|366072245|FG001|Overall Study|Still on therapy|0|||
106113474|NCT00085202|366072244|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
106113475|NCT00085202|366072245|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
106113476|NCT00085202|366072244|FG000|Overall Study|Excessive toxicity|6|||
106113477|NCT00085202|366072245|FG001|Overall Study|Excessive toxicity|5|||
106113478|NCT00085202|366072244|FG000|Overall Study|Non-specified|3|||
106113479|NCT00085202|366072245|FG001|Overall Study|Non-specified|5|||
106113480|NCT00085202|366072244|FG000|Overall Study|Withdrawal by Subject|2|||
105884712|NCT00468481|365232620|FG001|Overall Study|Lost to Follow-up|8|||
106113481|NCT00085202|366072245|FG001|Overall Study|Withdrawal by Subject|1|||
106113482|NCT00085202|366072244|FG000|Overall Study|Physician Decision|4|||
106113483|NCT00085202|366072245|FG001|Overall Study|Physician Decision|1|||
106113484|NCT00085202|366072244|FG000|Overall Study|Progressive disease|1|||
106113485|NCT00085202|366072245|FG001|Overall Study|Progressive disease|11|||
105884713|NCT00468481|365232619|FG000|Overall Study|Pregnancy|2|||
105994016|NCT01574651|365636163|FG000|Overall Study|Withdrawal by Subject|9|||
105994017|NCT01574651|365636164|FG001|Overall Study|Withdrawal by Subject|10|||
105994018|NCT02092025|365636165|FG000|Overall Study|Case Report Forms Uncollected|44|||
105994019|NCT02092025|365636165|FG000|Overall Study|Protocol Deviation|24|||
105994020|NCT01223183|365636167|FG000|Imaging Day 1|Physician Decision|0|||
105994021|NCT01223183|365636168|FG001|Imaging Day 1|Physician Decision|1|||
105994022|NCT01223183|365636167|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
105994023|NCT01223183|365636168|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
105994024|NCT01223183|365636167|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
105994025|NCT01223183|365636168|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
105994026|NCT02709330|365636173|FG000|Overall Study|Death|5|||
105994027|NCT02709330|365636174|FG001|Overall Study|Death|0|||
105994028|NCT02709330|365636173|FG000|Overall Study|Lost to Follow-up|2|||
105994029|NCT02709330|365636174|FG001|Overall Study|Lost to Follow-up|0|||
105994030|NCT02709330|365636173|FG000|Overall Study|Physician Decision|2|||
105994031|NCT02709330|365636174|FG001|Overall Study|Physician Decision|0|||
105994032|NCT02709330|365636173|FG000|Overall Study|Withdrawal by Subject|4|||
105994033|NCT02709330|365636174|FG001|Overall Study|Withdrawal by Subject|0|||
105994034|NCT01807299|365636175|FG000|Overall Study|Protocol Violation|3|||
105994035|NCT01807299|365636176|FG001|Overall Study|Protocol Violation|1|||
105994036|NCT01807299|365636177|FG002|Overall Study|Protocol Violation|0|||
105994037|NCT01807299|365636178|FG003|Overall Study|Protocol Violation|2|||
105994038|NCT00511238|365636179|FG000|Overall Study|Adverse Event|13|||
105994039|NCT00511238|365636180|FG001|Overall Study|Adverse Event|33|||
105994040|NCT00511238|365636179|FG000|Overall Study|Withdrawal by Subject|2|||
105994041|NCT00511238|365636180|FG001|Overall Study|Withdrawal by Subject|22|||
105994042|NCT00511238|365636179|FG000|Overall Study|Progressive Disease|23|||
105994043|NCT00511238|365636180|FG001|Overall Study|Progressive Disease|157|||
105994044|NCT00511238|365636179|FG000|Overall Study|various reasons|4|||
105994045|NCT00511238|365636180|FG001|Overall Study|various reasons|14|||
105994046|NCT03772665|365636181|FG000|Overall Study|Protocol Violation|1|||
105994047|NCT03772665|365636182|FG001|Overall Study|Protocol Violation|0|||
105994048|NCT01478971|365637892|FG000|Standard of Care Period|Adverse Event|1|||
105994049|NCT01478971|365637892|FG000|Standard of Care Period|Withdrawal by Subject|3|||
105994050|NCT01478971|365637892|FG000|Standard of Care Period|Death|8|||
105994051|NCT01478971|365637892|FG000|Standard of Care Period|Lost to Follow-up|9|||
105994052|NCT01478971|365637892|FG000|Standard of Care Period|Other|4|||
105884714|NCT00468481|365232620|FG001|Overall Study|Pregnancy|0|||
105994053|NCT01478971|365637892|FG000|Peginesatide Treatment Period|Adverse Event|1|||
105994054|NCT01478971|365637892|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
105994055|NCT01478971|365637892|FG000|Peginesatide Treatment Period|Death|4|||
105994056|NCT01478971|365637892|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
105994057|NCT01478971|365637892|FG000|Peginesatide Treatment Period|Other|4|||
105994058|NCT01698814|365637893|FG000|Overall Study|Adverse Event|0|||
105994059|NCT01698814|365637894|FG001|Overall Study|Adverse Event|2|||
105994060|NCT01698814|365637893|FG000|Overall Study|Lost to Follow-up|0|||
105994061|NCT01698814|365637894|FG001|Overall Study|Lost to Follow-up|1|||
105994062|NCT01698814|365637893|FG000|Overall Study|Pregnancy|1|||
105994063|NCT01698814|365637894|FG001|Overall Study|Pregnancy|0|||
105994064|NCT01698814|365637893|FG000|Overall Study|Randomized in error|1|||
105994065|NCT01698814|365637894|FG001|Overall Study|Randomized in error|0|||
105994066|NCT04014062|365637897|FG000|Period I: Dosing|Medical Grounds|4|||
105994067|NCT04014062|365637898|FG001|Period I: Dosing|Medical Grounds|5|||
105994068|NCT04014062|365637897|FG000|Period I: Dosing|Withdrawal by Subject|3|||
105994069|NCT04014062|365637898|FG001|Period I: Dosing|Withdrawal by Subject|1|||
105994070|NCT02451917|365637899|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
105994071|NCT02451917|365637900|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
105994072|NCT02451917|365637899|FG000|First Intervention (24 Weeks)|Death|0|||
105994073|NCT02451917|365637900|FG001|First Intervention (24 Weeks)|Death|1|||
105994074|NCT02451917|365637899|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
105994075|NCT02451917|365637900|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
105994076|NCT01724866|365637901|FG000|Overall Study|Adverse Event|0|||
105994077|NCT01724866|365637902|FG001|Overall Study|Adverse Event|0|||
105994078|NCT01724866|365637903|FG002|Overall Study|Adverse Event|1|||
105994079|NCT01724866|365637904|FG003|Overall Study|Adverse Event|1|||
105994080|NCT01724866|365637901|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
105994081|NCT01724866|365637902|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
105994082|NCT01724866|365637903|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
105994083|NCT01724866|365637904|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
105994084|NCT01724866|365637901|FG000|Overall Study|Investigator's Discretion|0|||
105994085|NCT01724866|365637902|FG001|Overall Study|Investigator's Discretion|1|||
105994086|NCT01724866|365637903|FG002|Overall Study|Investigator's Discretion|1|||
105994087|NCT01724866|365637904|FG003|Overall Study|Investigator's Discretion|0|||
106113486|NCT03238300|366072246|FG000|Baseline (Before Intervention)|Physician Decision|0|||
105884715|NCT00468481|365232619|FG000|Overall Study|Protocol Violation|18|||
105884716|NCT00468481|365232620|FG001|Overall Study|Protocol Violation|8|||
105884717|NCT00468481|365232619|FG000|Overall Study|Withdrawal by Subject|12|||
105884718|NCT00468481|365232620|FG001|Overall Study|Withdrawal by Subject|3|||
105884719|NCT00468481|365232619|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
105884720|NCT00468481|365232620|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
105884721|NCT00468481|365232619|FG000|Overall Study|Prohibited Medication|1|||
105884722|NCT00468481|365232620|FG001|Overall Study|Prohibited Medication|1|||
105884723|NCT00468481|365232619|FG000|Overall Study|Egg Donor|1|||
105884724|NCT00468481|365232620|FG001|Overall Study|Egg Donor|0|||
105884725|NCT00468481|365232619|FG000|Overall Study|Moved out of area|4|||
105884726|NCT00468481|365232620|FG001|Overall Study|Moved out of area|1|||
105884727|NCT00468481|365232619|FG000|Overall Study|Non-Compliance|5|||
105884728|NCT00468481|365232620|FG001|Overall Study|Non-Compliance|0|||
105884729|NCT00468481|365232619|FG000|Overall Study|Other|6|||
105884730|NCT00468481|365232620|FG001|Overall Study|Other|0|||
105884731|NCT03806933|365232622|FG000|Main Period|Physician Decision|0|||
105884732|NCT03806933|365232623|FG001|Main Period|Physician Decision|0|||
105884733|NCT03806933|365232624|FG002|Main Period|Physician Decision|0|||
105884734|NCT03806933|365232625|FG003|Main Period|Physician Decision|1|||
105884735|NCT03806933|365232622|FG000|Main Period|Pregnancy|0|||
105884736|NCT03806933|365232623|FG001|Main Period|Pregnancy|0|||
105884737|NCT03806933|365232624|FG002|Main Period|Pregnancy|1|||
105884738|NCT03806933|365232625|FG003|Main Period|Pregnancy|0|||
105884739|NCT03806933|365232622|FG000|Main Period|Withdrawal by Subject|2|||
105884740|NCT03806933|365232623|FG001|Main Period|Withdrawal by Subject|1|||
105884741|NCT03806933|365232624|FG002|Main Period|Withdrawal by Subject|1|||
105884742|NCT03806933|365232625|FG003|Main Period|Withdrawal by Subject|2|||
105884743|NCT03806933|365232622|FG000|Main Period|Lost to Follow-up|2|||
105884744|NCT03806933|365232623|FG001|Main Period|Lost to Follow-up|2|||
105884745|NCT03806933|365232624|FG002|Main Period|Lost to Follow-up|0|||
105884746|NCT03806933|365232625|FG003|Main Period|Lost to Follow-up|0|||
105884747|NCT03806933|365232622|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
105884748|NCT03806933|365232623|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
105884749|NCT03806933|365232624|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
105884750|NCT03806933|365232625|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
105884751|NCT00734162|365232626|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
105884752|NCT00734162|365232627|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
105884753|NCT00734162|365232628|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
106113487|NCT03238300|366072247|FG001|Baseline (Before Intervention)|Physician Decision|1|||
106113488|NCT03238300|366072246|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
106113489|NCT03238300|366072247|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
106113490|NCT03238300|366072246|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
106113491|NCT03238300|366072247|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
106113492|NCT03238300|366072246|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
106113493|NCT03238300|366072247|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
106113494|NCT00661661|366072249|FG000|Overall Study|Adverse Event|99|||
106113495|NCT00661661|366072250|FG001|Overall Study|Adverse Event|24|||
106113496|NCT00661661|366072249|FG000|Overall Study|Lack of Efficacy|3|||
106113497|NCT00661661|366072250|FG001|Overall Study|Lack of Efficacy|2|||
105884754|NCT00734162|365232629|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
105884755|NCT00734162|365232626|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
105884756|NCT00734162|365232627|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
105884757|NCT00734162|365232628|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
105884758|NCT00734162|365232629|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
105884759|NCT00734162|365232626|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
105884760|NCT00734162|365232627|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
105884761|NCT00734162|365232628|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
105884762|NCT00734162|365232629|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
105884763|NCT00734162|365232626|FG000|Open-Label Phase|Withdrew Consent|1|||
105884764|NCT00734162|365232627|FG001|Open-Label Phase|Withdrew Consent|0|||
105884765|NCT00734162|365232628|FG002|Open-Label Phase|Withdrew Consent|1|||
105884766|NCT00734162|365232629|FG003|Open-Label Phase|Withdrew Consent|1|||
106113498|NCT00661661|366072249|FG000|Overall Study|Lost to Follow-up|0|||
106113499|NCT00661661|366072250|FG001|Overall Study|Lost to Follow-up|1|||
105884767|NCT00734162|365232626|FG000|Open-Label Phase|Lost to Follow-up|1|||
105884768|NCT00734162|365232627|FG001|Open-Label Phase|Lost to Follow-up|2|||
105884769|NCT00734162|365232628|FG002|Open-Label Phase|Lost to Follow-up|0|||
105884770|NCT00734162|365232629|FG003|Open-Label Phase|Lost to Follow-up|1|||
105884771|NCT00734162|365232626|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105884772|NCT00734162|365232627|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
106113500|NCT00661661|366072249|FG000|Overall Study|Withdrawal by Subject|15|||
106113501|NCT00661661|366072250|FG001|Overall Study|Withdrawal by Subject|5|||
106113502|NCT00661661|366072249|FG000|Overall Study|Other|22|||
105884773|NCT00734162|365232628|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105884774|NCT00734162|365232629|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
105884775|NCT03831113|365232630|FG000|Overall Study|Withdrawal by Subject|0|||
105884776|NCT03831113|365232631|FG001|Overall Study|Withdrawal by Subject|2|||
105884777|NCT03831113|365232630|FG000|Overall Study|Protocol Violation|0|||
105884778|NCT03831113|365232631|FG001|Overall Study|Protocol Violation|9|||
105884779|NCT01515865|365232633|FG000|Part A (Open-label)|Other|3|||
105884780|NCT01515865|365232634|FG001|Part A (Open-label)|Other|0|||
105884781|NCT01515865|365232635|FG002|Part A (Open-label)|Other|0|||
105884782|NCT01515865|365232633|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
105884783|NCT01515865|365232634|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
105884784|NCT01515865|365232635|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
105884785|NCT01515865|365232633|FG000|Part B (Open-label)|Other|1|||
105884786|NCT01515865|365232634|FG001|Part B (Open-label)|Other|0|||
105884787|NCT01515865|365232635|FG002|Part B (Open-label)|Other|0|||
105884788|NCT01868438|365232637|FG000|First Intervention|Withdrawal by Subject|5|||
105884789|NCT01868438|365232638|FG001|First Intervention|Withdrawal by Subject|1|||
105884790|NCT01868438|365232637|FG000|First Intervention|Lost to Follow-up|2|||
105884791|NCT01868438|365232638|FG001|First Intervention|Lost to Follow-up|3|||
105884792|NCT01868438|365232637|FG000|First Intervention|Meeting the non-redosing criteria|0|||
105884793|NCT01868438|365232638|FG001|First Intervention|Meeting the non-redosing criteria|1|||
105884794|NCT01868438|365232637|FG000|Second Intervention|Adverse Event|3|||
105884795|NCT01868438|365232638|FG001|Second Intervention|Adverse Event|3|||
105884796|NCT00956592|365232641|FG000|Overall Study|Protocol Violation|1|||
105884797|NCT00956592|365232642|FG001|Overall Study|Protocol Violation|3|||
105884798|NCT03981900|365232643|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
105884799|NCT03981900|365232643|FG000|Overall Study|Adverse Event|5|||
105884800|NCT03981900|365232643|FG000|Overall Study|Protocol Violation|1|||
105884801|NCT03981900|365232643|FG000|Overall Study|Withdrawal by Subject|7|||
105884802|NCT03981900|365232643|FG000|Overall Study|Lost to Follow-up|46|||
105884803|NCT03981900|365232643|FG000|Overall Study|Decision of the researcher|3|||
105884804|NCT03981900|365232643|FG000|Overall Study|Death|3|||
105884805|NCT03981900|365232643|FG000|Overall Study|Other|5|||
105884806|NCT02162719|365232644|FG000|Overall Study|Death|41|||
105884807|NCT02162719|365232645|FG001|Overall Study|Death|46|||
105884808|NCT02162719|365232644|FG000|Overall Study|Lost to Follow-up|1|||
105884809|NCT02162719|365232645|FG001|Overall Study|Lost to Follow-up|3|||
105884810|NCT02162719|365232644|FG000|Overall Study|Disease Progression|2|||
105884811|NCT02162719|365232645|FG001|Overall Study|Disease Progression|1|||
105884812|NCT02162719|365232644|FG000|Overall Study|Withdrawal by Subject|8|||
105884813|NCT02162719|365232645|FG001|Overall Study|Withdrawal by Subject|2|||
105884814|NCT02162719|365232644|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
105884815|NCT02162719|365232645|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
105884816|NCT00160706|365232646|FG000|Overall Study|Adverse Event|53|||
105994088|NCT01724866|365637901|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
105994089|NCT01724866|365637902|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
105994090|NCT01724866|365637903|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
105994091|NCT01724866|365637904|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
105994092|NCT01724866|365637901|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
105994093|NCT01724866|365637902|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
105994094|NCT01724866|365637903|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
105994095|NCT01724866|365637904|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
105994096|NCT02300259|365637907|FG000|Period 1|Adverse Event|0|||
105994097|NCT02300259|365637908|FG001|Period 1|Adverse Event|0|||
105994098|NCT02300259|365637909|FG002|Period 1|Adverse Event|1|||
105994099|NCT02300259|365637907|FG000|Period 1|Withdrawal by Subject|0|||
105994100|NCT02300259|365637908|FG001|Period 1|Withdrawal by Subject|0|||
105994101|NCT02300259|365637909|FG002|Period 1|Withdrawal by Subject|1|||
105994102|NCT02300259|365637907|FG000|Period 2|Adverse Event|1|||
105994103|NCT02300259|365637908|FG001|Period 2|Adverse Event|0|||
105994104|NCT02300259|365637909|FG002|Period 2|Adverse Event|0|||
105994105|NCT02300259|365637907|FG000|Period 2|Withdrawal by Subject|0|||
105994106|NCT02300259|365637908|FG001|Period 2|Withdrawal by Subject|0|||
105994107|NCT02300259|365637909|FG002|Period 2|Withdrawal by Subject|1|||
105994108|NCT04506502|365637912|FG000|Overall Study|Withdrawal by Subject|1|||
105994109|NCT04506502|365637912|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
105994110|NCT03526146|365637913|FG000|Overall Study|Lost to Follow-up|5|||
105994111|NCT03526146|365637913|FG000|Overall Study|Withdrawal by Subject|6|||
105994112|NCT03526146|365637913|FG000|Overall Study|class canceled due to COVID-19|4|||
105994113|NCT01136408|365637918|FG000|Overall Study|Adverse Event|4|||
105994114|NCT01136408|365637919|FG001|Overall Study|Adverse Event|8|||
105994115|NCT01136408|365637920|FG002|Overall Study|Adverse Event|4|||
105994116|NCT01136408|365637918|FG000|Overall Study|Protocol Violation|1|||
105994117|NCT01136408|365637919|FG001|Overall Study|Protocol Violation|1|||
106113503|NCT00661661|366072250|FG001|Overall Study|Other|7|||
106113504|NCT00661661|366072249|FG000|Overall Study|Not assigned treatment|1|||
106113505|NCT00661661|366072250|FG001|Overall Study|Not assigned treatment|0|||
106113506|NCT01353222|366072253|FG000|Overall Study|Death|30|||
106113507|NCT01353222|366072254|FG001|Overall Study|Death|30|||
106113508|NCT01353222|366072253|FG000|Overall Study|Withdrawal by Subject|8|||
106113509|NCT01353222|366072254|FG001|Overall Study|Withdrawal by Subject|5|||
106113510|NCT01353222|366072253|FG000|Overall Study|Study Terminated|31|||
106113511|NCT01353222|366072254|FG001|Overall Study|Study Terminated|37|||
106113512|NCT01353222|366072253|FG000|Overall Study|Site closed research department|1|||
106113513|NCT01353222|366072254|FG001|Overall Study|Site closed research department|0|||
106113514|NCT01654601|366072255|FG000|1st Administration|Withdrawal by Subject|2|||
106113515|NCT01654601|366072256|FG001|1st Administration|Withdrawal by Subject|0|||
106113516|NCT01654601|366072255|FG000|1st Administration|Protocol Violation|0|||
106113517|NCT01654601|366072256|FG001|1st Administration|Protocol Violation|2|||
106113518|NCT01654601|366072255|FG000|2nd Administration|Adverse Event|1|||
106113519|NCT01654601|366072256|FG001|2nd Administration|Adverse Event|0|||
106113520|NCT01654601|366072255|FG000|2nd Administration|Protocol Violation|0|||
106113521|NCT01654601|366072256|FG001|2nd Administration|Protocol Violation|1|||
106113522|NCT00116844|366072257|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
106113523|NCT00116844|366072258|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
106113524|NCT00116844|366072257|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
106113525|NCT00116844|366072258|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
106113526|NCT00116844|366072257|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
106113527|NCT00116844|366072258|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
106113528|NCT00116844|366072257|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
106113529|NCT00116844|366072258|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
106113530|NCT00116844|366072257|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
106113531|NCT00116844|366072258|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
106113532|NCT00116844|366072257|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
106113533|NCT00116844|366072258|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
106113534|NCT00116844|366072257|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
106113535|NCT00116844|366072258|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
106113536|NCT00116844|366072257|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
106113537|NCT00116844|366072258|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
106113538|NCT00116844|366072257|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
106113539|NCT00116844|366072258|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
106113540|NCT02969525|366072259|FG000|Double-Blind Period|Adverse Event|0|||
106113541|NCT02969525|366072260|FG001|Double-Blind Period|Adverse Event|0|||
106113542|NCT02969525|366072261|FG002|Double-Blind Period|Adverse Event|1|||
106113543|NCT02969525|366072262|FG003|Double-Blind Period|Adverse Event|1|||
105884817|NCT00160706|365232646|FG000|Overall Study|Adverse Event and Other Reason|105|||
105884818|NCT00160706|365232646|FG000|Overall Study|Protocol Violation|3|||
105884819|NCT00160706|365232646|FG000|Overall Study|Withdrawal by Subject|41|||
105884820|NCT00160706|365232646|FG000|Overall Study|Withdrawal by Subject and Other|12|||
105884821|NCT00160706|365232646|FG000|Overall Study|Physician Decision|10|||
105884822|NCT00160706|365232646|FG000|Overall Study|Physician Decision and Other|3|||
105884823|NCT00160706|365232646|FG000|Overall Study|Lost to Follow-up|4|||
105884824|NCT00160706|365232646|FG000|Overall Study|Lost to Follow-up and Other|1|||
105884825|NCT00160706|365232646|FG000|Overall Study|Lack of Efficacy|42|||
105884826|NCT00160706|365232646|FG000|Overall Study|Lack of Efficacy and Other|1|||
105884827|NCT00160706|365232646|FG000|Overall Study|Other Reason|11|||
105884828|NCT04696055|365232651|FG000|Overall Study|Adverse Event|10|||
105884829|NCT04696055|365232652|FG001|Overall Study|Adverse Event|2|||
105884830|NCT04696055|365232651|FG000|Overall Study|Death|4|||
105884831|NCT04696055|365232652|FG001|Overall Study|Death|0|||
105884832|NCT04696055|365232651|FG000|Overall Study|Other|7|||
105884833|NCT04696055|365232652|FG001|Overall Study|Other|2|||
105884834|NCT04696055|365232651|FG000|Overall Study|Physician Decision|3|||
105884835|NCT04696055|365232652|FG001|Overall Study|Physician Decision|0|||
105884836|NCT04696055|365232651|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
105884837|NCT04696055|365232652|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
106113544|NCT02969525|366072263|FG004|Double-Blind Period|Adverse Event|0|||
106113545|NCT02969525|366072264|FG005|Double-Blind Period|Adverse Event|0|||
105884838|NCT04696055|365232651|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
105884839|NCT04696055|365232652|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
105994118|NCT01136408|365637920|FG002|Overall Study|Protocol Violation|1|||
106113546|NCT02969525|366072265|FG006|Double-Blind Period|Adverse Event|0|||
106113547|NCT02969525|366072266|FG007|Double-Blind Period|Adverse Event|0|||
106113548|NCT02969525|366072267|FG008|Double-Blind Period|Adverse Event|0|||
106113549|NCT02969525|366072268|FG009|Double-Blind Period|Adverse Event|0|||
106113550|NCT02969525|366072269|FG010|Double-Blind Period|Adverse Event|0|||
106113551|NCT02969525|366072270|FG011|Double-Blind Period|Adverse Event|0|||
106113552|NCT02969525|366072259|FG000|Double-Blind Period|LOW EGFR|0|||
106113553|NCT02969525|366072260|FG001|Double-Blind Period|LOW EGFR|0|||
106113554|NCT02969525|366072261|FG002|Double-Blind Period|LOW EGFR|0|||
105994119|NCT00398567|365637921|FG000|Overall Study|Disease Progression|3|||
105994120|NCT00398567|365637922|FG001|Overall Study|Disease Progression|4|||
106113555|NCT02969525|366072262|FG003|Double-Blind Period|LOW EGFR|1|||
106113556|NCT02969525|366072263|FG004|Double-Blind Period|LOW EGFR|0|||
106113557|NCT02969525|366072264|FG005|Double-Blind Period|LOW EGFR|0|||
105884840|NCT04696055|365232651|FG000|Overall Study|Subject Decision|1|||
105884841|NCT04696055|365232652|FG001|Overall Study|Subject Decision|2|||
105884842|NCT02589626|365232655|FG000|Overall Study|Other than the reason specified|1|||
105884843|NCT02589626|365232656|FG001|Overall Study|Other than the reason specified|0|||
106113558|NCT02969525|366072265|FG006|Double-Blind Period|LOW EGFR|0|||
106113559|NCT02969525|366072266|FG007|Double-Blind Period|LOW EGFR|0|||
106113560|NCT02969525|366072267|FG008|Double-Blind Period|LOW EGFR|0|||
106113561|NCT02969525|366072268|FG009|Double-Blind Period|LOW EGFR|0|||
106113562|NCT02969525|366072269|FG010|Double-Blind Period|LOW EGFR|0|||
106113563|NCT02969525|366072270|FG011|Double-Blind Period|LOW EGFR|0|||
106113564|NCT02969525|366072259|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
105884844|NCT02589626|365232655|FG000|Overall Study|Withdrawal by Subject|1|||
105884845|NCT02589626|365232656|FG001|Overall Study|Withdrawal by Subject|1|||
105884846|NCT02589626|365232655|FG000|Overall Study|Adverse Event|1|||
105884847|NCT02589626|365232656|FG001|Overall Study|Adverse Event|1|||
105884848|NCT01057810|365232657|FG000|Overall Study|Disease progression|156|||
105884849|NCT01057810|365232658|FG001|Overall Study|Disease progression|197|||
105884850|NCT01057810|365232657|FG000|Overall Study|Study drug toxicity|5|||
105884851|NCT01057810|365232658|FG001|Overall Study|Study drug toxicity|114|||
105884852|NCT01057810|365232657|FG000|Overall Study|Adverse event unrelated to study drug|13|||
105884853|NCT01057810|365232658|FG001|Overall Study|Adverse event unrelated to study drug|29|||
105884854|NCT01057810|365232657|FG000|Overall Study|Withdrawal by Subject|10|||
105884855|NCT01057810|365232658|FG001|Overall Study|Withdrawal by Subject|25|||
105884856|NCT01057810|365232657|FG000|Overall Study|Death|2|||
105884857|NCT01057810|365232658|FG001|Overall Study|Death|12|||
105884858|NCT01057810|365232657|FG000|Overall Study|Maximum clinical benefit|5|||
105884859|NCT01057810|365232658|FG001|Overall Study|Maximum clinical benefit|5|||
105884860|NCT01057810|365232657|FG000|Overall Study|Poor/non-compliance|0|||
105884861|NCT01057810|365232658|FG001|Overall Study|Poor/non-compliance|1|||
105884862|NCT01057810|365232657|FG000|Overall Study|No longer met study criteria|0|||
105884863|NCT01057810|365232658|FG001|Overall Study|No longer met study criteria|1|||
105884864|NCT01057810|365232657|FG000|Overall Study|Other|7|||
105884865|NCT01057810|365232658|FG001|Overall Study|Other|14|||
105884866|NCT02278939|365232663|FG000|Overall Study|lack of time|1|||
105884867|NCT02278939|365232664|FG001|Overall Study|lack of time|0|||
105884868|NCT02278939|365232663|FG000|Overall Study|Lost to Follow-up|1|||
105884869|NCT02278939|365232664|FG001|Overall Study|Lost to Follow-up|1|||
105884870|NCT02278939|365232663|FG000|Overall Study|death in family|1|||
105884871|NCT02278939|365232664|FG001|Overall Study|death in family|0|||
105884872|NCT02278939|365232663|FG000|Overall Study|family emergency unable to commit|2|||
105884873|NCT02278939|365232664|FG001|Overall Study|family emergency unable to commit|0|||
105884874|NCT03728426|365232665|FG000|Overall Study|Death|3|||
105884875|NCT01127451|365232669|FG000|Overall Study|Other|2|||
105884876|NCT01127451|365232670|FG001|Overall Study|Other|1|||
105884877|NCT01127451|365232669|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
105884878|NCT01127451|365232670|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
105884879|NCT01127451|365232669|FG000|Overall Study|Death|22|||
105884880|NCT01127451|365232670|FG001|Overall Study|Death|17|||
105884881|NCT01127451|365232669|FG000|Overall Study|Lost to Follow-up|3|||
105884882|NCT01127451|365232670|FG001|Overall Study|Lost to Follow-up|0|||
105884883|NCT01127451|365232669|FG000|Overall Study|Administrative Reason by Sponsor|2|||
105884884|NCT01127451|365232670|FG001|Overall Study|Administrative Reason by Sponsor|2|||
105994121|NCT00398567|365637923|FG002|Overall Study|Disease Progression|27|||
105994122|NCT00398567|365637921|FG000|Overall Study|Withdrawal by Subject|1|||
105994123|NCT00398567|365637922|FG001|Overall Study|Withdrawal by Subject|0|||
105661748|NCT04913948|364425129|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
106113565|NCT02969525|366072260|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105884885|NCT00562302|365232674|FG000|Overall Study|Lost to Follow-up|3|||
105884886|NCT00562302|365232675|FG001|Overall Study|Lost to Follow-up|3|||
105884887|NCT00562302|365232674|FG000|Overall Study|Adverse Event|0|||
105884888|NCT00562302|365232675|FG001|Overall Study|Adverse Event|6|||
105884889|NCT00562302|365232674|FG000|Overall Study|Non-compliance|1|||
105884890|NCT00562302|365232675|FG001|Overall Study|Non-compliance|2|||
106113566|NCT02969525|366072261|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105884891|NCT00562302|365232674|FG000|Overall Study|Withdrawal by Subject|7|||
106113567|NCT02969525|366072262|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
106113568|NCT02969525|366072263|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105884892|NCT00562302|365232675|FG001|Overall Study|Withdrawal by Subject|8|||
105994124|NCT00398567|365637923|FG002|Overall Study|Withdrawal by Subject|4|||
106113569|NCT02969525|366072264|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
106113570|NCT02969525|366072265|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105884893|NCT00562302|365232674|FG000|Overall Study|Death|1|||
105884894|NCT00562302|365232675|FG001|Overall Study|Death|2|||
105884895|NCT00562302|365232674|FG000|Overall Study|Lung resection prior to study completion|7|||
105884896|NCT00562302|365232675|FG001|Overall Study|Lung resection prior to study completion|7|||
105884897|NCT00562302|365232674|FG000|Overall Study|Not stated|1|||
105884898|NCT00562302|365232675|FG001|Overall Study|Not stated|4|||
105884899|NCT03075891|365232678|FG000|Overall Study|Withdrawal by Subject|3|||
105884900|NCT03075891|365232679|FG001|Overall Study|Withdrawal by Subject|6|||
105884901|NCT03075891|365232678|FG000|Overall Study|Lost to Follow-up|1|||
105884902|NCT03075891|365232679|FG001|Overall Study|Lost to Follow-up|0|||
105884903|NCT03075891|365232678|FG000|Overall Study|Pregnancy|3|||
105884904|NCT03075891|365232679|FG001|Overall Study|Pregnancy|1|||
105884905|NCT03075891|365232678|FG000|Overall Study|visits not performed (no time)|1|||
105884906|NCT03075891|365232679|FG001|Overall Study|visits not performed (no time)|0|||
105884907|NCT03075891|365232678|FG000|Overall Study|Drug abuse relapse issue|0|||
105884908|NCT03075891|365232679|FG001|Overall Study|Drug abuse relapse issue|1|||
105884909|NCT03075891|365232678|FG000|Overall Study|Participant requiring study withdrawal|0|||
105884910|NCT03075891|365232679|FG001|Overall Study|Participant requiring study withdrawal|1|||
105884911|NCT03075891|365232678|FG000|Overall Study|Adverse event, non-fatal|1|||
105884912|NCT03075891|365232679|FG001|Overall Study|Adverse event, non-fatal|4|||
105884913|NCT01355575|365232680|FG000|Overall Study|Withdrawal by Subject|2|||
105884914|NCT03502070|365232682|FG000|Overall Study|Withdrawal by Subject|1|||
105884915|NCT03502070|365232682|FG000|Overall Study|Screen Failure|1|||
105884916|NCT01726270|365232686|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
105884917|NCT01726270|365232686|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
105884918|NCT01726270|365232686|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
105884919|NCT01726270|365232686|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
105884920|NCT01726270|365232686|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
105884921|NCT01726270|365232686|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
105884922|NCT04013672|365232687|FG000|Overall Study|Withdrawal by Subject|3|||
105884923|NCT04013672|365232688|FG001|Overall Study|Withdrawal by Subject|0|||
105884924|NCT04013672|365232687|FG000|Overall Study|Death|1|||
105884925|NCT04013672|365232688|FG001|Overall Study|Death|0|||
105884926|NCT04013672|365232687|FG000|Overall Study|Physician Decision|5|||
105884927|NCT04013672|365232688|FG001|Overall Study|Physician Decision|0|||
105884928|NCT04445714|365232690|FG000|Overall Study|Discontinuation of the study|14|||
105884929|NCT04445714|365232690|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
105884930|NCT04445714|365232690|FG000|Overall Study|Withdrawal of Informed Consent|8|||
105884931|NCT00833482|365232691|FG000|Days 11-20|Adverse Event|0|||
105884932|NCT00833482|365232692|FG001|Days 11-20|Adverse Event|2|||
105884933|NCT00833482|365232693|FG002|Days 11-20|Adverse Event|0|||
105884934|NCT00833482|365232694|FG003|Days 11-20|Adverse Event|0|||
105884935|NCT00833482|365232695|FG004|Days 11-20|Adverse Event|0|||
105884936|NCT00833482|365232696|FG005|Days 11-20|Adverse Event|0|||
105884937|NCT00833482|365232691|FG000|Days 11-20|Withdrawal by Subject|0|||
105884938|NCT00833482|365232692|FG001|Days 11-20|Withdrawal by Subject|1|||
105884939|NCT00833482|365232693|FG002|Days 11-20|Withdrawal by Subject|0|||
105884940|NCT00833482|365232694|FG003|Days 11-20|Withdrawal by Subject|0|||
105884941|NCT00833482|365232695|FG004|Days 11-20|Withdrawal by Subject|0|||
105884942|NCT00833482|365232696|FG005|Days 11-20|Withdrawal by Subject|0|||
105884943|NCT00833482|365232691|FG000|Days 21-30|Adverse Event|0|||
105884944|NCT00833482|365232692|FG001|Days 21-30|Adverse Event|0|||
105884945|NCT00833482|365232693|FG002|Days 21-30|Adverse Event|1|||
105884946|NCT00833482|365232694|FG003|Days 21-30|Adverse Event|0|||
105884947|NCT00833482|365232695|FG004|Days 21-30|Adverse Event|0|||
105884948|NCT00833482|365232696|FG005|Days 21-30|Adverse Event|0|||
105884949|NCT00833482|365232691|FG000|Days 21-30|Withdrawal by Subject|0|||
105884950|NCT00833482|365232692|FG001|Days 21-30|Withdrawal by Subject|0|||
105884951|NCT00833482|365232693|FG002|Days 21-30|Withdrawal by Subject|0|||
105884952|NCT00833482|365232694|FG003|Days 21-30|Withdrawal by Subject|0|||
105884953|NCT00833482|365232695|FG004|Days 21-30|Withdrawal by Subject|1|||
105884954|NCT00833482|365232696|FG005|Days 21-30|Withdrawal by Subject|0|||
105884955|NCT02805660|365232697|FG000|Overall Study|Death|5|||
105884956|NCT02805660|365232698|FG001|Overall Study|Death|2|||
105884957|NCT02805660|365232699|FG002|Overall Study|Death|9|||
105884958|NCT02805660|365232700|FG003|Overall Study|Death|5|||
105884959|NCT02805660|365232701|FG004|Overall Study|Death|0|||
105884960|NCT02805660|365232702|FG005|Overall Study|Death|14|||
105884961|NCT02805660|365232703|FG006|Overall Study|Death|12|||
105884962|NCT02805660|365232697|FG000|Overall Study|Lost to Follow-up|0|||
105884963|NCT02805660|365232698|FG001|Overall Study|Lost to Follow-up|1|||
105884964|NCT02805660|365232699|FG002|Overall Study|Lost to Follow-up|1|||
105884965|NCT02805660|365232700|FG003|Overall Study|Lost to Follow-up|2|||
105884966|NCT02805660|365232701|FG004|Overall Study|Lost to Follow-up|0|||
105884967|NCT02805660|365232702|FG005|Overall Study|Lost to Follow-up|0|||
105884968|NCT02805660|365232703|FG006|Overall Study|Lost to Follow-up|0|||
105884969|NCT02805660|365232697|FG000|Overall Study|Withdrawal by Subject|0|||
105884970|NCT02805660|365232698|FG001|Overall Study|Withdrawal by Subject|0|||
105884971|NCT02805660|365232699|FG002|Overall Study|Withdrawal by Subject|0|||
105884972|NCT02805660|365232700|FG003|Overall Study|Withdrawal by Subject|3|||
105884973|NCT02805660|365232701|FG004|Overall Study|Withdrawal by Subject|1|||
105884974|NCT02805660|365232702|FG005|Overall Study|Withdrawal by Subject|0|||
105884975|NCT02805660|365232703|FG006|Overall Study|Withdrawal by Subject|2|||
105884976|NCT02805660|365232697|FG000|Overall Study|Study terminated by Sponsor|0|||
105884977|NCT02805660|365232698|FG001|Overall Study|Study terminated by Sponsor|0|||
105884978|NCT02805660|365232699|FG002|Overall Study|Study terminated by Sponsor|1|||
105884979|NCT02805660|365232700|FG003|Overall Study|Study terminated by Sponsor|4|||
105884980|NCT02805660|365232701|FG004|Overall Study|Study terminated by Sponsor|2|||
105884981|NCT02805660|365232702|FG005|Overall Study|Study terminated by Sponsor|3|||
105884982|NCT02805660|365232703|FG006|Overall Study|Study terminated by Sponsor|1|||
105884983|NCT02805660|365232697|FG000|Overall Study|Miscellaneous|0|||
105884984|NCT02805660|365232698|FG001|Overall Study|Miscellaneous|1|||
105884985|NCT02805660|365232699|FG002|Overall Study|Miscellaneous|0|||
105884986|NCT02805660|365232700|FG003|Overall Study|Miscellaneous|4|||
105884987|NCT02805660|365232701|FG004|Overall Study|Miscellaneous|0|||
105884988|NCT02805660|365232702|FG005|Overall Study|Miscellaneous|6|||
105884989|NCT02805660|365232703|FG006|Overall Study|Miscellaneous|4|||
105884990|NCT01672710|365232704|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
105884991|NCT01672710|365232705|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
105884992|NCT01672710|365232704|FG000|3 Month Follow up|Lost to Follow-up|2|||
105884993|NCT01672710|365232705|FG001|3 Month Follow up|Lost to Follow-up|3|||
105884994|NCT01672710|365232704|FG000|3 Month Follow up|follow up due after termination date|4|||
105884995|NCT01672710|365232705|FG001|3 Month Follow up|follow up due after termination date|1|||
105884996|NCT03725761|365232706|FG000|Overall Study|still on study|1|||
105951990|NCT02808429|365488172|FG002|Overall Study|Premature study termination by sponsor|1|||
105951991|NCT02808429|365488170|FG000|Overall Study|Relocation|0|||
105951992|NCT02808429|365488171|FG001|Overall Study|Relocation|0|||
105951993|NCT02808429|365488172|FG002|Overall Study|Relocation|1|||
105951994|NCT01436110|365488173|FG000|Overall Study|Lack of Efficacy|23|||
105951995|NCT01436110|365488174|FG001|Overall Study|Lack of Efficacy|14|||
105951996|NCT01436110|365488175|FG002|Overall Study|Lack of Efficacy|9|||
105951997|NCT01436110|365488173|FG000|Overall Study|Withdrawal by Subject|6|||
105951998|NCT01436110|365488174|FG001|Overall Study|Withdrawal by Subject|8|||
105951999|NCT01436110|365488175|FG002|Overall Study|Withdrawal by Subject|4|||
105952000|NCT01436110|365488173|FG000|Overall Study|Adverse Event|2|||
105952001|NCT01436110|365488174|FG001|Overall Study|Adverse Event|1|||
105952002|NCT01436110|365488175|FG002|Overall Study|Adverse Event|2|||
105952003|NCT01436110|365488173|FG000|Overall Study|Physician Decision|3|||
105952004|NCT01436110|365488174|FG001|Overall Study|Physician Decision|1|||
105952005|NCT01436110|365488175|FG002|Overall Study|Physician Decision|1|||
105952006|NCT01436110|365488173|FG000|Overall Study|Lost to Follow-up|1|||
105952007|NCT01436110|365488174|FG001|Overall Study|Lost to Follow-up|1|||
105952008|NCT01436110|365488175|FG002|Overall Study|Lost to Follow-up|3|||
105952009|NCT01436110|365488173|FG000|Overall Study|Protocol Violation|3|||
105952010|NCT01436110|365488174|FG001|Overall Study|Protocol Violation|1|||
105952011|NCT01436110|365488175|FG002|Overall Study|Protocol Violation|1|||
105952012|NCT01436110|365488173|FG000|Overall Study|Did Not Receive Trial Medication|1|||
105952013|NCT01436110|365488174|FG001|Overall Study|Did Not Receive Trial Medication|0|||
105952014|NCT01436110|365488175|FG002|Overall Study|Did Not Receive Trial Medication|3|||
105952015|NCT03637491|365488176|FG000|Overall Study|Death|9|||
105952016|NCT03637491|365488177|FG001|Overall Study|Death|9|||
105952017|NCT03637491|365488178|FG002|Overall Study|Death|5|||
105952018|NCT03637491|365488179|FG003|Overall Study|Death|3|||
105952019|NCT03637491|365488176|FG000|Overall Study|Lost to Follow-up|0|||
105952020|NCT03637491|365488177|FG001|Overall Study|Lost to Follow-up|1|||
105952021|NCT03637491|365488178|FG002|Overall Study|Lost to Follow-up|0|||
105952022|NCT03637491|365488179|FG003|Overall Study|Lost to Follow-up|1|||
105952023|NCT03637491|365488176|FG000|Overall Study|Study Terminated By Sponsor|0|||
105952024|NCT03637491|365488177|FG001|Overall Study|Study Terminated By Sponsor|2|||
105952025|NCT03637491|365488178|FG002|Overall Study|Study Terminated By Sponsor|1|||
105952026|NCT03637491|365488179|FG003|Overall Study|Study Terminated By Sponsor|0|||
105952027|NCT03637491|365488176|FG000|Overall Study|Withdrawal by Subject|1|||
105952028|NCT03637491|365488177|FG001|Overall Study|Withdrawal by Subject|0|||
105952029|NCT03637491|365488178|FG002|Overall Study|Withdrawal by Subject|1|||
105952030|NCT03637491|365488179|FG003|Overall Study|Withdrawal by Subject|2|||
105952031|NCT00527618|365488180|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
105952032|NCT00527618|365488181|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
105952033|NCT00527618|365488180|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
105952034|NCT00527618|365488181|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
105952035|NCT00527618|365488180|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
105952036|NCT00527618|365488181|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
105952037|NCT00527618|365488180|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
105884997|NCT02218736|365234094|FG000|Overall Study|Withdrawal by Subject|10|||
105884998|NCT02218736|365234095|FG001|Overall Study|Withdrawal by Subject|9|||
105884999|NCT02218736|365234094|FG000|Overall Study|Protocol Violation|2|||
105885000|NCT02218736|365234095|FG001|Overall Study|Protocol Violation|0|||
105885001|NCT05481125|365234096|FG000|Overall Study|Adverse Event|1|||
105885002|NCT05481125|365234097|FG001|Overall Study|Adverse Event|0|||
105885003|NCT05481125|365234096|FG000|Overall Study|Lost to Follow-up|0|||
105885004|NCT05481125|365234097|FG001|Overall Study|Lost to Follow-up|1|||
105885005|NCT05481125|365234096|FG000|Overall Study|Withdrawal by Subject|0|||
105885006|NCT05481125|365234097|FG001|Overall Study|Withdrawal by Subject|1|||
105885007|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
105885008|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
105885009|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
105885010|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
105885011|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
105885012|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
105885013|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
105885014|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
105885015|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
105885016|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
105885017|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
105885018|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
105885019|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
105885020|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
105885021|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
105885022|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
105885023|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
105885024|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
105885025|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
105885026|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
105885027|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
105885028|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
105885029|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
105885030|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
105885031|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
105885032|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
105885033|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
105885034|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
105885035|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
105885036|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
105885037|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
105885038|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
105885039|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
105885040|NCT00839527|365234100|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
105885041|NCT00839527|365234101|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
105885042|NCT00839527|365234102|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
105885043|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
105885044|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
105885045|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
105885046|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
105885047|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
105885048|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
105885049|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
105885050|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
105885051|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
105885052|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
105885053|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
105885054|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
105885055|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
105885056|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
105885057|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
105885058|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
105885059|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
105885060|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
105885061|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
105885062|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
105952038|NCT00527618|365488181|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
106113571|NCT02969525|366072266|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
106113572|NCT02969525|366072267|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
106113573|NCT02969525|366072268|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105885063|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
105885064|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
105885065|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
105885066|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
105885067|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
105885068|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
105885069|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
105885070|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
105885071|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
105885072|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
105885073|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
105885074|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
105885075|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
105885076|NCT00839527|365234100|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
105885077|NCT00839527|365234101|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
105885078|NCT00839527|365234102|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
105885079|NCT02751450|365234103|FG000|Overall Study|Adverse Event|1|||
105885080|NCT02751450|365234104|FG001|Overall Study|Adverse Event|0|||
105885081|NCT03315286|365234111|FG000|Overall Study|Lost to Follow-up|0|||
105885082|NCT03315286|365234112|FG001|Overall Study|Lost to Follow-up|3|||
105885083|NCT03315286|365234111|FG000|Overall Study|Withdrawal by Subject|1|||
105885084|NCT03315286|365234112|FG001|Overall Study|Withdrawal by Subject|0|||
105885085|NCT03315286|365234111|FG000|Overall Study|Protocol Violation|0|||
105885086|NCT03315286|365234112|FG001|Overall Study|Protocol Violation|1|||
105885087|NCT01931995|365234113|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
105885088|NCT01931995|365234114|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
105885089|NCT01931995|365234113|FG000|First Intervention (1 Day)|Physician Decision|1|||
105885090|NCT01931995|365234114|FG001|First Intervention (1 Day)|Physician Decision|1|||
105885091|NCT01931995|365234113|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
105885092|NCT01931995|365234114|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
105885093|NCT01894100|365234126|FG000|Overall Study|Lost to Follow-up|0|||
105885094|NCT01894100|365234127|FG001|Overall Study|Lost to Follow-up|1|||
105885095|NCT01894100|365234126|FG000|Overall Study|Withdrawal by Subject|3|||
105885096|NCT01894100|365234127|FG001|Overall Study|Withdrawal by Subject|0|||
105885097|NCT01094301|365234128|FG000|Trial Stage|Withdrawal by Subject|1|||
105885098|NCT01094301|365234128|FG000|Implant Stage|Adverse Event|1|||
105885099|NCT01094301|365234128|FG000|Implant Stage|Protocol Violation|1|||
105885100|NCT01094301|365234128|FG000|Implant Stage|Withdrawal by Subject|2|||
105885101|NCT01094301|365234128|FG000|Implant Stage|No return of pain|4|||
105885102|NCT00135512|365234129|FG000|Overall Study|Adverse Event|56|||
105885103|NCT00135512|365234129|FG000|Overall Study|Lack of Efficacy|25|||
105885104|NCT00135512|365234129|FG000|Overall Study|Other|42|||
105885105|NCT02553499|365234130|FG000|Overall Study|Adverse Event|0|||
105885106|NCT02553499|365234131|FG001|Overall Study|Adverse Event|0|||
105885107|NCT02553499|365234132|FG002|Overall Study|Adverse Event|0|||
105885108|NCT02553499|365234133|FG003|Overall Study|Adverse Event|0|||
105885109|NCT02553499|365234134|FG004|Overall Study|Adverse Event|0|||
105885110|NCT02553499|365234135|FG005|Overall Study|Adverse Event|0|||
105885111|NCT02553499|365234136|FG006|Overall Study|Adverse Event|1|||
105885112|NCT02553499|365234137|FG007|Overall Study|Adverse Event|1|||
105885113|NCT02553499|365234138|FG008|Overall Study|Adverse Event|0|||
105885114|NCT02553499|365234139|FG009|Overall Study|Adverse Event|0|||
105885115|NCT02553499|365234140|FG010|Overall Study|Adverse Event|0|||
105885116|NCT02553499|365234141|FG011|Overall Study|Adverse Event|0|||
105885117|NCT02553499|365234142|FG012|Overall Study|Adverse Event|0|||
105885118|NCT02553499|365234143|FG013|Overall Study|Adverse Event|1|||
105885119|NCT02553499|365234130|FG000|Overall Study|Death|0|||
105885120|NCT02553499|365234131|FG001|Overall Study|Death|1|||
105885121|NCT02553499|365234132|FG002|Overall Study|Death|1|||
105885122|NCT02553499|365234133|FG003|Overall Study|Death|0|||
105885123|NCT02553499|365234134|FG004|Overall Study|Death|1|||
106113574|NCT02969525|366072269|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
106113575|NCT02969525|366072270|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
105885124|NCT02553499|365234135|FG005|Overall Study|Death|2|||
105885125|NCT02553499|365234136|FG006|Overall Study|Death|0|||
105885126|NCT02553499|365234137|FG007|Overall Study|Death|0|||
105885127|NCT02553499|365234138|FG008|Overall Study|Death|0|||
105885128|NCT02553499|365234139|FG009|Overall Study|Death|0|||
105885129|NCT02553499|365234140|FG010|Overall Study|Death|1|||
105885130|NCT02553499|365234141|FG011|Overall Study|Death|0|||
105885131|NCT02553499|365234142|FG012|Overall Study|Death|0|||
106113576|NCT02969525|366072259|FG000|Dose-Blind Period|Adverse Event|0|||
106113577|NCT02969525|366072260|FG001|Dose-Blind Period|Adverse Event|0|||
106113578|NCT02969525|366072261|FG002|Dose-Blind Period|Adverse Event|0|||
106113579|NCT02969525|366072262|FG003|Dose-Blind Period|Adverse Event|0|||
106113580|NCT02969525|366072263|FG004|Dose-Blind Period|Adverse Event|0|||
106113581|NCT02969525|366072264|FG005|Dose-Blind Period|Adverse Event|0|||
106113582|NCT02969525|366072265|FG006|Dose-Blind Period|Adverse Event|0|||
106113583|NCT02969525|366072266|FG007|Dose-Blind Period|Adverse Event|0|||
106113584|NCT02969525|366072267|FG008|Dose-Blind Period|Adverse Event|0|||
106113585|NCT02969525|366072268|FG009|Dose-Blind Period|Adverse Event|1|||
106113586|NCT02969525|366072269|FG010|Dose-Blind Period|Adverse Event|1|||
106113587|NCT02969525|366072270|FG011|Dose-Blind Period|Adverse Event|1|||
106113588|NCT02969525|366072259|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
106113589|NCT02969525|366072260|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
106113590|NCT02969525|366072261|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
106113591|NCT02969525|366072262|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
105885132|NCT02553499|365234143|FG013|Overall Study|Death|0|||
105885133|NCT02553499|365234130|FG000|Overall Study|Lost to Follow-up|0|||
105885134|NCT02553499|365234131|FG001|Overall Study|Lost to Follow-up|0|||
105885135|NCT02553499|365234132|FG002|Overall Study|Lost to Follow-up|0|||
105885136|NCT02553499|365234133|FG003|Overall Study|Lost to Follow-up|0|||
105885137|NCT02553499|365234134|FG004|Overall Study|Lost to Follow-up|0|||
105885138|NCT02553499|365234135|FG005|Overall Study|Lost to Follow-up|0|||
105885139|NCT02553499|365234136|FG006|Overall Study|Lost to Follow-up|1|||
105885140|NCT02553499|365234137|FG007|Overall Study|Lost to Follow-up|0|||
105885141|NCT02553499|365234138|FG008|Overall Study|Lost to Follow-up|0|||
105885142|NCT02553499|365234139|FG009|Overall Study|Lost to Follow-up|0|||
105885143|NCT02553499|365234140|FG010|Overall Study|Lost to Follow-up|0|||
105885144|NCT02553499|365234141|FG011|Overall Study|Lost to Follow-up|0|||
105885145|NCT02553499|365234142|FG012|Overall Study|Lost to Follow-up|0|||
105885146|NCT02553499|365234143|FG013|Overall Study|Lost to Follow-up|0|||
105885147|NCT02553499|365234130|FG000|Overall Study|Physician Decision|0|||
105885148|NCT02553499|365234131|FG001|Overall Study|Physician Decision|1|||
105885149|NCT02553499|365234132|FG002|Overall Study|Physician Decision|1|||
105885150|NCT02553499|365234133|FG003|Overall Study|Physician Decision|0|||
105885151|NCT02553499|365234134|FG004|Overall Study|Physician Decision|1|||
105885152|NCT02553499|365234135|FG005|Overall Study|Physician Decision|0|||
105885153|NCT02553499|365234136|FG006|Overall Study|Physician Decision|0|||
105885154|NCT02553499|365234137|FG007|Overall Study|Physician Decision|1|||
105885155|NCT02553499|365234138|FG008|Overall Study|Physician Decision|1|||
105885156|NCT02553499|365234139|FG009|Overall Study|Physician Decision|2|||
105885157|NCT02553499|365234140|FG010|Overall Study|Physician Decision|1|||
105885158|NCT02553499|365234141|FG011|Overall Study|Physician Decision|3|||
105885159|NCT02553499|365234142|FG012|Overall Study|Physician Decision|1|||
105885160|NCT02553499|365234143|FG013|Overall Study|Physician Decision|0|||
105885161|NCT02553499|365234130|FG000|Overall Study|Progressive Disease|0|||
105885162|NCT02553499|365234131|FG001|Overall Study|Progressive Disease|0|||
105885163|NCT02553499|365234132|FG002|Overall Study|Progressive Disease|0|||
105885164|NCT02553499|365234133|FG003|Overall Study|Progressive Disease|2|||
105885165|NCT02553499|365234134|FG004|Overall Study|Progressive Disease|1|||
105885166|NCT02553499|365234135|FG005|Overall Study|Progressive Disease|1|||
105885167|NCT02553499|365234136|FG006|Overall Study|Progressive Disease|1|||
105885168|NCT02553499|365234137|FG007|Overall Study|Progressive Disease|0|||
105885169|NCT02553499|365234138|FG008|Overall Study|Progressive Disease|0|||
105885170|NCT02553499|365234139|FG009|Overall Study|Progressive Disease|1|||
105885171|NCT02553499|365234140|FG010|Overall Study|Progressive Disease|0|||
105885172|NCT02553499|365234141|FG011|Overall Study|Progressive Disease|0|||
105885173|NCT02553499|365234142|FG012|Overall Study|Progressive Disease|2|||
105885174|NCT02553499|365234143|FG013|Overall Study|Progressive Disease|1|||
105885175|NCT02553499|365234130|FG000|Overall Study|Study Terminated by Sponsor|0|||
105885176|NCT02553499|365234131|FG001|Overall Study|Study Terminated by Sponsor|0|||
105885177|NCT02553499|365234132|FG002|Overall Study|Study Terminated by Sponsor|0|||
105885178|NCT02553499|365234133|FG003|Overall Study|Study Terminated by Sponsor|0|||
105885179|NCT02553499|365234134|FG004|Overall Study|Study Terminated by Sponsor|0|||
105885180|NCT02553499|365234135|FG005|Overall Study|Study Terminated by Sponsor|0|||
105885181|NCT02553499|365234136|FG006|Overall Study|Study Terminated by Sponsor|0|||
105885182|NCT02553499|365234137|FG007|Overall Study|Study Terminated by Sponsor|0|||
105885183|NCT02553499|365234138|FG008|Overall Study|Study Terminated by Sponsor|1|||
105885184|NCT02553499|365234139|FG009|Overall Study|Study Terminated by Sponsor|0|||
105885185|NCT02553499|365234140|FG010|Overall Study|Study Terminated by Sponsor|0|||
105885186|NCT02553499|365234141|FG011|Overall Study|Study Terminated by Sponsor|0|||
105885187|NCT02553499|365234142|FG012|Overall Study|Study Terminated by Sponsor|0|||
105885188|NCT02553499|365234143|FG013|Overall Study|Study Terminated by Sponsor|0|||
106113592|NCT02969525|366072263|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
106113593|NCT02969525|366072264|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
105885189|NCT02553499|365234130|FG000|Overall Study|Withdrawal by Subject|2|||
105885190|NCT02553499|365234131|FG001|Overall Study|Withdrawal by Subject|0|||
105885191|NCT02553499|365234132|FG002|Overall Study|Withdrawal by Subject|0|||
106113594|NCT02969525|366072265|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
105885192|NCT02553499|365234133|FG003|Overall Study|Withdrawal by Subject|0|||
105885193|NCT02553499|365234134|FG004|Overall Study|Withdrawal by Subject|0|||
105885194|NCT02553499|365234135|FG005|Overall Study|Withdrawal by Subject|0|||
105885195|NCT02553499|365234136|FG006|Overall Study|Withdrawal by Subject|0|||
105885196|NCT02553499|365234137|FG007|Overall Study|Withdrawal by Subject|1|||
105885197|NCT02553499|365234138|FG008|Overall Study|Withdrawal by Subject|1|||
105885198|NCT02553499|365234139|FG009|Overall Study|Withdrawal by Subject|0|||
105885199|NCT02553499|365234140|FG010|Overall Study|Withdrawal by Subject|1|||
105885200|NCT02553499|365234141|FG011|Overall Study|Withdrawal by Subject|0|||
105885201|NCT02553499|365234142|FG012|Overall Study|Withdrawal by Subject|0|||
105885202|NCT02553499|365234143|FG013|Overall Study|Withdrawal by Subject|0|||
105885203|NCT04439214|365234144|FG000|Overall Study|Adverse Event|13|||
105885204|NCT04439214|365234144|FG000|Overall Study|Disease progression|16|||
105885205|NCT04439214|365234144|FG000|Overall Study|Death|1|||
105885206|NCT04439214|365234144|FG000|Overall Study|Withdrawal by Subject|2|||
105885207|NCT04439214|365234144|FG000|Overall Study|Declining health|1|||
105885208|NCT04439214|365234144|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
105885209|NCT04439214|365234144|FG000|Overall Study|Ineligible|5|||
105885210|NCT02235077|365234145|FG000|Overall Study|Death|5|||
105885211|NCT02235077|365234146|FG001|Overall Study|Death|7|||
105885212|NCT02235077|365234145|FG000|Overall Study|Lost to Follow-up|5|||
105885213|NCT02235077|365234146|FG001|Overall Study|Lost to Follow-up|6|||
105885214|NCT02235077|365234145|FG000|Overall Study|Withdrawal by Subject|8|||
105885215|NCT02235077|365234146|FG001|Overall Study|Withdrawal by Subject|5|||
105885216|NCT02235077|365234145|FG000|Overall Study|Physician Decision|0|||
105885217|NCT02235077|365234146|FG001|Overall Study|Physician Decision|1|||
105885218|NCT00582608|365234147|FG000|Overall Study|Not Treated|7|||
105885219|NCT00582608|365234147|FG000|Overall Study|Patient Ineligible|1|||
105885220|NCT00582608|365234147|FG000|Overall Study|Lack of accrual|4|||
105885221|NCT04152837|365234148|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
105885222|NCT04152837|365234148|FG000|Maintenance Period|Adverse Event|1|||
105885223|NCT04152837|365234148|FG000|Maintenance Period|Withdrawal by Subject|1|||
105885224|NCT04152837|365234148|FG000|Maintenance Period|Sponsor Termination of Study|2|||
105885225|NCT01186692|365234149|FG000|Overall Study|Not Catheterized|11|||
105885226|NCT01186692|365234149|FG000|Overall Study|Futher testing contraindicated implant|19|||
105885227|NCT01186692|365234149|FG000|Overall Study|Adverse Event|2|||
105885228|NCT00556933|365234153|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
105885229|NCT00556933|365234154|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
105885230|NCT00556933|365234155|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
105885231|NCT00556933|365234156|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
105885232|NCT00556933|365234153|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
105885233|NCT00556933|365234154|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
105885234|NCT00556933|365234155|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
105885235|NCT00556933|365234156|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
105885236|NCT00556933|365234153|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
105885237|NCT00556933|365234154|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
105885238|NCT00556933|365234155|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
105885239|NCT00556933|365234156|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
105885240|NCT00556933|365234153|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
105885241|NCT00556933|365234154|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
105885242|NCT00556933|365234155|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
105885243|NCT00556933|365234156|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
105885244|NCT00556933|365234153|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
105885245|NCT00556933|365234154|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
105885246|NCT00556933|365234155|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
105885247|NCT00556933|365234156|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
105885248|NCT00556933|365234153|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
105885249|NCT00556933|365234154|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
105885250|NCT00556933|365234155|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
105885251|NCT00556933|365234156|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
105885252|NCT00556933|365234153|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
105885253|NCT00556933|365234154|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
105885254|NCT00556933|365234155|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
105885255|NCT00556933|365234156|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
105885256|NCT00556933|365234153|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
105885257|NCT00556933|365234154|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
106113595|NCT02969525|366072266|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
106113596|NCT02969525|366072267|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
106113597|NCT02969525|366072268|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
105885258|NCT00556933|365234155|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
105885259|NCT00556933|365234156|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
106113598|NCT02969525|366072269|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
106113599|NCT02969525|366072270|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
106113600|NCT02969525|366072259|FG000|Dose-Blind Period|Non-cooperating patient|0|||
106113601|NCT02969525|366072260|FG001|Dose-Blind Period|Non-cooperating patient|0|||
106113602|NCT02969525|366072261|FG002|Dose-Blind Period|Non-cooperating patient|0|||
106113603|NCT02969525|366072262|FG003|Dose-Blind Period|Non-cooperating patient|0|||
106113604|NCT02969525|366072263|FG004|Dose-Blind Period|Non-cooperating patient|0|||
106113605|NCT02969525|366072264|FG005|Dose-Blind Period|Non-cooperating patient|0|||
106113606|NCT02969525|366072265|FG006|Dose-Blind Period|Non-cooperating patient|0|||
106113607|NCT02969525|366072266|FG007|Dose-Blind Period|Non-cooperating patient|0|||
106113608|NCT02969525|366072267|FG008|Dose-Blind Period|Non-cooperating patient|0|||
106113609|NCT02969525|366072268|FG009|Dose-Blind Period|Non-cooperating patient|0|||
106113610|NCT02969525|366072269|FG010|Dose-Blind Period|Non-cooperating patient|0|||
106113611|NCT02969525|366072270|FG011|Dose-Blind Period|Non-cooperating patient|1|||
106113612|NCT02969525|366072259|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113613|NCT02969525|366072260|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113614|NCT02969525|366072261|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113615|NCT02969525|366072262|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113616|NCT02969525|366072263|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113617|NCT02969525|366072264|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113618|NCT02969525|366072265|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113619|NCT02969525|366072266|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113620|NCT02969525|366072267|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113621|NCT02969525|366072268|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113622|NCT02969525|366072269|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
106113623|NCT02969525|366072270|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
106113624|NCT04398537|366072271|FG000|Overall Study|Physician Decision|10|||
106113625|NCT04398537|366072272|FG001|Overall Study|Physician Decision|15|||
106113626|NCT02272725|366072273|FG000|Overall Study|equipment malfunction|2|||
106113627|NCT02272725|366072274|FG001|Overall Study|equipment malfunction|0|||
106113628|NCT01659658|366074272|FG000|Overall Study|Withdrawal by Patient|18|||
106113629|NCT01659658|366074273|FG001|Overall Study|Withdrawal by Patient|4|||
106113630|NCT01659658|366074274|FG002|Overall Study|Withdrawal by Patient|2|||
106113631|NCT01659658|366074275|FG003|Overall Study|Withdrawal by Patient|0|||
106113632|NCT01659658|366074276|FG004|Overall Study|Withdrawal by Patient|11|||
106113633|NCT01659658|366074272|FG000|Overall Study|Study Terminated by Sponsor|9|||
106113634|NCT01659658|366074273|FG001|Overall Study|Study Terminated by Sponsor|7|||
106113635|NCT01659658|366074274|FG002|Overall Study|Study Terminated by Sponsor|0|||
106113636|NCT01659658|366074275|FG003|Overall Study|Study Terminated by Sponsor|1|||
106113637|NCT01659658|366074276|FG004|Overall Study|Study Terminated by Sponsor|4|||
106113638|NCT01659658|366074272|FG000|Overall Study|Reason not Specified|61|||
106113639|NCT01659658|366074273|FG001|Overall Study|Reason not Specified|15|||
106113640|NCT01659658|366074274|FG002|Overall Study|Reason not Specified|8|||
106113641|NCT01659658|366074275|FG003|Overall Study|Reason not Specified|1|||
106113642|NCT01659658|366074276|FG004|Overall Study|Reason not Specified|34|||
106113643|NCT01659658|366074272|FG000|Overall Study|Lost to Follow-up|2|||
106113644|NCT01659658|366074273|FG001|Overall Study|Lost to Follow-up|0|||
106113645|NCT01659658|366074274|FG002|Overall Study|Lost to Follow-up|0|||
106113646|NCT01659658|366074275|FG003|Overall Study|Lost to Follow-up|0|||
106113647|NCT01659658|366074276|FG004|Overall Study|Lost to Follow-up|0|||
106113648|NCT02421666|366074277|FG000|6-month Follow-up|Lost to Follow-up|8|||
106113649|NCT02421666|366074278|FG001|6-month Follow-up|Lost to Follow-up|7|||
106113650|NCT02421666|366074277|FG000|6-month Follow-up|Withdrawal by Subject|5|||
106113651|NCT02421666|366074278|FG001|6-month Follow-up|Withdrawal by Subject|6|||
106113652|NCT02421666|366074277|FG000|12-month Follow-up|Lost to Follow-up|5|||
106113653|NCT02421666|366074278|FG001|12-month Follow-up|Lost to Follow-up|5|||
106113654|NCT02421666|366074277|FG000|12-month Follow-up|Withdrawal by Subject|6|||
106113655|NCT02421666|366074278|FG001|12-month Follow-up|Withdrawal by Subject|11|||
106113656|NCT00105235|366074281|FG000|Overall Study|Death|4|||
106113657|NCT00105235|366074281|FG000|Overall Study|Physician Decision|1|||
106113658|NCT00105235|366074281|FG000|Overall Study|Withdrawal by Subject|2|||
106113659|NCT03261271|366074283|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
106113660|NCT03261271|366074284|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
106113661|NCT00991341|366074289|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
106113662|NCT00991341|366074290|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
106113663|NCT00991341|366074289|FG000|Overall Study|Death|3|||
106113664|NCT00991341|366074290|FG001|Overall Study|Death|0|||
106113665|NCT00991341|366074289|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
106113666|NCT00991341|366074290|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
106113667|NCT00991341|366074289|FG000|Overall Study|Physician Decision|1|||
106113668|NCT00991341|366074290|FG001|Overall Study|Physician Decision|2|||
106113669|NCT00991341|366074289|FG000|Overall Study|Withdrawal by Subject|3|||
106113670|NCT00991341|366074290|FG001|Overall Study|Withdrawal by Subject|4|||
105885260|NCT00556933|365234153|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
105885261|NCT00556933|365234154|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
105885262|NCT00556933|365234155|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
106113671|NCT03145766|366074295|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
106113672|NCT03145766|366074296|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
106113673|NCT03145766|366074297|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
106113674|NCT03145766|366074298|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
106113675|NCT03145766|366074299|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
106113676|NCT03145766|366074295|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
106113677|NCT03145766|366074296|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
106113678|NCT03145766|366074297|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
106113679|NCT03145766|366074298|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
106113680|NCT03145766|366074299|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
106113681|NCT03145766|366074295|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
106113682|NCT03145766|366074296|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
106113683|NCT03145766|366074297|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
106113684|NCT03145766|366074298|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
106113685|NCT03145766|366074299|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
106113686|NCT03145766|366074295|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
106113687|NCT03145766|366074296|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
106113688|NCT03145766|366074297|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
106113689|NCT03145766|366074298|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
106113690|NCT03145766|366074299|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
106113691|NCT03145766|366074295|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
106113692|NCT03145766|366074296|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
106113693|NCT03145766|366074297|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
106113694|NCT03145766|366074298|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
106113695|NCT03145766|366074299|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
106113696|NCT03145766|366074295|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
106113697|NCT03145766|366074296|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
106113698|NCT03145766|366074297|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
106113699|NCT03145766|366074298|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
106113700|NCT03145766|366074299|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
106113701|NCT03145766|366074295|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
106113702|NCT03145766|366074296|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
106113703|NCT03145766|366074297|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
106113704|NCT03145766|366074298|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
106113705|NCT03145766|366074299|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
106113706|NCT01722162|366074302|FG000|Overall Study|Withdrawal by Subject|1|||
106113707|NCT01722162|366074303|FG001|Overall Study|Withdrawal by Subject|1|||
106113708|NCT01722162|366074302|FG000|Overall Study|Found ineligible|1|||
106113709|NCT01722162|366074303|FG001|Overall Study|Found ineligible|0|||
106113710|NCT01722162|366074302|FG000|Overall Study|Unrelated to study adverse event|2|||
106113711|NCT01722162|366074303|FG001|Overall Study|Unrelated to study adverse event|2|||
106113712|NCT01722162|366074302|FG000|Overall Study|Adverse Event|1|||
106113713|NCT01722162|366074303|FG001|Overall Study|Adverse Event|1|||
106113714|NCT01722162|366074302|FG000|Overall Study|Insurance denial post enrollment|0|||
106113715|NCT01722162|366074303|FG001|Overall Study|Insurance denial post enrollment|1|||
106113716|NCT01722162|366074302|FG000|Overall Study|Noncompliance|0|||
106113717|NCT01722162|366074303|FG001|Overall Study|Noncompliance|1|||
106113718|NCT03124199|366074305|FG000|Overall Study|Lost to Follow-up|4|||
106113719|NCT02798211|366074306|FG000|Period 1|Adverse Event|1|||
106113720|NCT02798211|366074307|FG001|Period 1|Adverse Event|1|||
106113721|NCT02798211|366074308|FG002|Period 1|Adverse Event|0|||
106113722|NCT02798211|366074309|FG003|Period 1|Adverse Event|0|||
106113723|NCT02798211|366074310|FG004|Period 1|Adverse Event|0|||
106113724|NCT02798211|366074311|FG005|Period 1|Adverse Event|0|||
106113725|NCT02798211|366074306|FG000|Period 1|Lost to Follow-up|2|||
106113726|NCT02798211|366074307|FG001|Period 1|Lost to Follow-up|1|||
106113727|NCT02798211|366074308|FG002|Period 1|Lost to Follow-up|0|||
106113728|NCT02798211|366074309|FG003|Period 1|Lost to Follow-up|0|||
106113729|NCT02798211|366074310|FG004|Period 1|Lost to Follow-up|0|||
106113730|NCT02798211|366074311|FG005|Period 1|Lost to Follow-up|0|||
106113731|NCT02798211|366074306|FG000|Period 1|Protocol Violation|0|||
106113732|NCT02798211|366074307|FG001|Period 1|Protocol Violation|0|||
106113733|NCT02798211|366074308|FG002|Period 1|Protocol Violation|2|||
106113734|NCT02798211|366074309|FG003|Period 1|Protocol Violation|0|||
106113735|NCT02798211|366074310|FG004|Period 1|Protocol Violation|0|||
106113736|NCT02798211|366074311|FG005|Period 1|Protocol Violation|0|||
106113737|NCT02798211|366074306|FG000|Period 1|Withdrawal by Subject|1|||
106113738|NCT02798211|366074307|FG001|Period 1|Withdrawal by Subject|1|||
106113739|NCT02798211|366074308|FG002|Period 1|Withdrawal by Subject|0|||
106113740|NCT02798211|366074309|FG003|Period 1|Withdrawal by Subject|0|||
106113741|NCT02798211|366074310|FG004|Period 1|Withdrawal by Subject|0|||
106113742|NCT02798211|366074311|FG005|Period 1|Withdrawal by Subject|0|||
106113743|NCT02798211|366074306|FG000|Period 1|Death|0|||
106113744|NCT02798211|366074307|FG001|Period 1|Death|0|||
106113745|NCT02798211|366074308|FG002|Period 1|Death|1|||
106113746|NCT02798211|366074309|FG003|Period 1|Death|0|||
106113747|NCT02798211|366074310|FG004|Period 1|Death|0|||
106113748|NCT02798211|366074311|FG005|Period 1|Death|0|||
106113749|NCT02798211|366074306|FG000|Period 1|Withdrawal of Informed Consent|2|||
106113750|NCT02798211|366074307|FG001|Period 1|Withdrawal of Informed Consent|7|||
106113751|NCT02798211|366074308|FG002|Period 1|Withdrawal of Informed Consent|3|||
105885263|NCT00556933|365234156|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
105885264|NCT00556933|365234153|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
105885265|NCT00556933|365234154|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
105885266|NCT00556933|365234155|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
105885267|NCT00556933|365234156|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
105885268|NCT00556933|365234153|FG000|CNI Withdrawal vs. Minimization|Death|0|||
105885269|NCT00556933|365234154|FG001|CNI Withdrawal vs. Minimization|Death|0|||
105885270|NCT00556933|365234155|FG002|CNI Withdrawal vs. Minimization|Death|0|||
105885271|NCT00556933|365234156|FG003|CNI Withdrawal vs. Minimization|Death|1|||
105885272|NCT01668173|365234161|FG000|Overall Study|Adverse Event|3|||
105885273|NCT01668173|365234161|FG000|Overall Study|Trial suspension|4|||
105885274|NCT03386994|365234162|FG000|Overall Study|Lung transplant|1|||
105885275|NCT03386994|365234162|FG000|Overall Study|Adverse Event|14|||
105885276|NCT03386994|365234162|FG000|Overall Study|Lost to Follow-up|4|||
105885277|NCT03386994|365234162|FG000|Overall Study|Withdrawal by Subject|3|||
105885278|NCT03386994|365234162|FG000|Overall Study|Death|16|||
105885279|NCT00686829|365234163|FG000|Overall Study|Adverse Event|5|||
105885280|NCT00686829|365234163|FG000|Overall Study|Lack of Efficacy|6|||
105885281|NCT00686829|365234163|FG000|Overall Study|Lost to Follow-up|4|||
105885282|NCT00686829|365234163|FG000|Overall Study|Withdrawal by Subject|14|||
105885283|NCT00686829|365234163|FG000|Overall Study|Protocol Violation|3|||
105885284|NCT00686829|365234163|FG000|Overall Study|Sponsor discontinued VCV|47|||
105885285|NCT03226769|365234164|FG000|Overall Study|Withdrawal by Subject|0|||
106113752|NCT02798211|366074309|FG003|Period 1|Withdrawal of Informed Consent|0|||
106113753|NCT02798211|366074310|FG004|Period 1|Withdrawal of Informed Consent|0|||
106113754|NCT02798211|366074311|FG005|Period 1|Withdrawal of Informed Consent|0|||
106113755|NCT02798211|366074306|FG000|Period 2|Withdrawal by Subject|2|||
106113756|NCT02798211|366074307|FG001|Period 2|Withdrawal by Subject|0|||
106113757|NCT02798211|366074308|FG002|Period 2|Withdrawal by Subject|0|||
106113758|NCT02798211|366074309|FG003|Period 2|Withdrawal by Subject|0|||
106113759|NCT02798211|366074310|FG004|Period 2|Withdrawal by Subject|2|||
106113760|NCT02798211|366074311|FG005|Period 2|Withdrawal by Subject|2|||
106113761|NCT02798211|366074306|FG000|Period 2|Adverse Event|5|||
106113762|NCT02798211|366074307|FG001|Period 2|Adverse Event|0|||
106113763|NCT02798211|366074308|FG002|Period 2|Adverse Event|0|||
106113764|NCT02798211|366074309|FG003|Period 2|Adverse Event|0|||
106113765|NCT02798211|366074310|FG004|Period 2|Adverse Event|1|||
106113766|NCT02798211|366074311|FG005|Period 2|Adverse Event|0|||
106113767|NCT02798211|366074306|FG000|Period 2|Lack of Efficacy|1|||
106113768|NCT02798211|366074307|FG001|Period 2|Lack of Efficacy|0|||
106113769|NCT02798211|366074308|FG002|Period 2|Lack of Efficacy|0|||
106113770|NCT02798211|366074309|FG003|Period 2|Lack of Efficacy|1|||
106113771|NCT02798211|366074310|FG004|Period 2|Lack of Efficacy|0|||
106113772|NCT02798211|366074311|FG005|Period 2|Lack of Efficacy|1|||
106113773|NCT02798211|366074306|FG000|Period 2|Lost to Follow-up|3|||
106113774|NCT02798211|366074307|FG001|Period 2|Lost to Follow-up|0|||
106113775|NCT02798211|366074308|FG002|Period 2|Lost to Follow-up|0|||
106113776|NCT02798211|366074309|FG003|Period 2|Lost to Follow-up|0|||
106113777|NCT02798211|366074310|FG004|Period 2|Lost to Follow-up|2|||
106113778|NCT02798211|366074311|FG005|Period 2|Lost to Follow-up|0|||
106113779|NCT02798211|366074306|FG000|Period 2|Physician Decision|1|||
106113780|NCT02798211|366074307|FG001|Period 2|Physician Decision|0|||
106113781|NCT02798211|366074308|FG002|Period 2|Physician Decision|0|||
106113782|NCT02798211|366074309|FG003|Period 2|Physician Decision|1|||
106113783|NCT02798211|366074310|FG004|Period 2|Physician Decision|1|||
105885286|NCT03226769|365234165|FG001|Overall Study|Withdrawal by Subject|1|||
106113784|NCT02798211|366074311|FG005|Period 2|Physician Decision|0|||
106113785|NCT02798211|366074306|FG000|Period 2|Pregnancy|0|||
106113786|NCT02798211|366074307|FG001|Period 2|Pregnancy|0|||
106113787|NCT02798211|366074308|FG002|Period 2|Pregnancy|0|||
106113788|NCT02798211|366074309|FG003|Period 2|Pregnancy|2|||
106113789|NCT02798211|366074310|FG004|Period 2|Pregnancy|0|||
106113790|NCT02798211|366074311|FG005|Period 2|Pregnancy|0|||
106113791|NCT02798211|366074306|FG000|Period 2|Technical problems|1|||
106113792|NCT02798211|366074307|FG001|Period 2|Technical problems|0|||
106113793|NCT02798211|366074308|FG002|Period 2|Technical problems|0|||
105885287|NCT01827267|365234166|FG000|Overall Study|Did not receive study drug|1|||
105885288|NCT01827267|365234167|FG001|Overall Study|Did not receive study drug|1|||
105885289|NCT01827267|365234166|FG000|Overall Study|Physician Decision|1|||
105885290|NCT01827267|365234167|FG001|Overall Study|Physician Decision|0|||
105885291|NCT01827267|365234166|FG000|Overall Study|Disease Progression|1|||
105885292|NCT01827267|365234167|FG001|Overall Study|Disease Progression|1|||
105885293|NCT01827267|365234166|FG000|Overall Study|Sponsor Discontinued Study|2|||
105885294|NCT01827267|365234167|FG001|Overall Study|Sponsor Discontinued Study|8|||
105885295|NCT01827267|365234166|FG000|Overall Study|Still on study|0|||
105885296|NCT01827267|365234167|FG001|Overall Study|Still on study|2|||
105885297|NCT00877487|365234170|FG000|Open-label Treatment Phase|Adverse Event|1|||
105885298|NCT00877487|365234171|FG001|Open-label Treatment Phase|Adverse Event|0|||
105885299|NCT00877487|365234170|FG000|Open-label Treatment Phase|Protocol Violation|3|||
105885300|NCT00877487|365234171|FG001|Open-label Treatment Phase|Protocol Violation|0|||
105885301|NCT00877487|365234170|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
105885302|NCT00877487|365234171|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
105885303|NCT00877487|365234170|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
105885304|NCT00877487|365234171|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
105885305|NCT00877487|365234170|FG000|Open-label Treatment Phase|Out of country for business|1|||
105885306|NCT00877487|365234171|FG001|Open-label Treatment Phase|Out of country for business|0|||
105885307|NCT00877487|365234170|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
105885308|NCT00877487|365234171|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
105885309|NCT00877487|365234170|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
105885310|NCT00877487|365234171|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
105885311|NCT00877487|365234170|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
105885312|NCT00877487|365234171|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
105885313|NCT00877487|365234170|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
105885314|NCT00877487|365234171|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
105885315|NCT02640677|365234172|FG000|Overall Study|Lost to Follow-up|1|||
105885316|NCT02640677|365234172|FG000|Overall Study|Withdrawal by Subject|1|||
105885317|NCT03070002|365234173|FG000|Follow up for 2 Years|Death|1|||
105885318|NCT04553471|365234176|FG000|Overall Study|Did not start treatment on protocol|3|||
105885319|NCT04553471|365234176|FG000|Overall Study|Death|1|||
105885320|NCT02702388|365234177|FG000|Overall Study|Disease Progression|18|||
105885321|NCT02702388|365234178|FG001|Overall Study|Disease Progression|25|||
105885322|NCT02702388|365234177|FG000|Overall Study|Withdrawal by Subject|9|||
105885323|NCT02702388|365234178|FG001|Overall Study|Withdrawal by Subject|7|||
105885324|NCT02702388|365234177|FG000|Overall Study|Adverse Event|11|||
105885325|NCT02702388|365234178|FG001|Overall Study|Adverse Event|15|||
105885326|NCT02702388|365234177|FG000|Overall Study|Other|2|||
105885327|NCT02702388|365234178|FG001|Overall Study|Other|4|||
105885328|NCT01217476|365234188|FG000|Overall Study|Adverse Event|6|||
105885329|NCT01217476|365234189|FG001|Overall Study|Adverse Event|1|||
105885330|NCT01217476|365234188|FG000|Overall Study|Physician Decision|0|||
105885331|NCT01217476|365234189|FG001|Overall Study|Physician Decision|1|||
105885332|NCT01217476|365234188|FG000|Overall Study|Withdrawal by Subject|3|||
105885333|NCT01217476|365234189|FG001|Overall Study|Withdrawal by Subject|3|||
105885334|NCT01217476|365234188|FG000|Overall Study|Surgery on the Target Limb|0|||
105885335|NCT01217476|365234189|FG001|Overall Study|Surgery on the Target Limb|2|||
105885336|NCT01217476|365234188|FG000|Overall Study|Protocol Deviation|1|||
105885337|NCT01217476|365234189|FG001|Overall Study|Protocol Deviation|0|||
105885338|NCT01217476|365234188|FG000|Overall Study|Other|2|||
105885339|NCT01217476|365234189|FG001|Overall Study|Other|0|||
105885340|NCT04740827|365234190|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
105885341|NCT04740827|365234191|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
105885342|NCT04740827|365234190|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
105885343|NCT04740827|365234191|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
105885344|NCT04740827|365234190|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
105885345|NCT04740827|365234191|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
105885346|NCT04740827|365234190|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
105885347|NCT04740827|365234191|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
105885348|NCT04740827|365234190|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
106113794|NCT02798211|366074309|FG003|Period 2|Technical problems|1|||
106113795|NCT02798211|366074310|FG004|Period 2|Technical problems|0|||
106113796|NCT02798211|366074311|FG005|Period 2|Technical problems|0|||
105885349|NCT04740827|365234191|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
105885350|NCT04740827|365234190|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
105885351|NCT04740827|365234191|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
105885352|NCT03033602|365234192|FG000|Overall Study|Withdrawal by Subject|11|||
105885353|NCT03033602|365234193|FG001|Overall Study|Withdrawal by Subject|21|||
105885354|NCT03033602|365234192|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
105885355|NCT03033602|365234193|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
105885356|NCT03425396|365234194|FG000|Overall Study|Lost to Follow-up|2|||
105885357|NCT03425396|365234195|FG001|Overall Study|Lost to Follow-up|5|||
105885358|NCT03425396|365234196|FG002|Overall Study|Lost to Follow-up|2|||
105885359|NCT03425396|365234197|FG003|Overall Study|Lost to Follow-up|0|||
105885360|NCT03425396|365234198|FG004|Overall Study|Lost to Follow-up|0|||
105885361|NCT03425396|365234194|FG000|Overall Study|Withdrawal by Subject|0|||
105885362|NCT03425396|365234195|FG001|Overall Study|Withdrawal by Subject|1|||
105885363|NCT03425396|365234196|FG002|Overall Study|Withdrawal by Subject|0|||
105885364|NCT03425396|365234197|FG003|Overall Study|Withdrawal by Subject|1|||
105885365|NCT03425396|365234198|FG004|Overall Study|Withdrawal by Subject|0|||
105885366|NCT03425396|365234194|FG000|Overall Study|Other|0|||
105885367|NCT03425396|365234195|FG001|Overall Study|Other|1|||
105885368|NCT03425396|365234196|FG002|Overall Study|Other|1|||
105885369|NCT03425396|365234197|FG003|Overall Study|Other|0|||
105885370|NCT03425396|365234198|FG004|Overall Study|Other|1|||
105885371|NCT00940823|365234199|FG000|Overall Study|Death|8|||
105885372|NCT00940823|365234200|FG001|Overall Study|Death|12|||
105885373|NCT00940823|365234199|FG000|Overall Study|Lost to Follow-up|27|||
105885374|NCT00940823|365234200|FG001|Overall Study|Lost to Follow-up|20|||
105885375|NCT02981082|365234203|FG000|Overall Study|Withdrawal by Subject|2|||
105885376|NCT02981082|365234204|FG001|Overall Study|Withdrawal by Subject|0|||
105885377|NCT02981082|365234203|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
105885378|NCT02981082|365234204|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
105885379|NCT02981082|365234203|FG000|Overall Study|Adverse Event|0|||
105885380|NCT02981082|365234204|FG001|Overall Study|Adverse Event|1|||
105885381|NCT03689374|365234205|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
105885382|NCT03689374|365234206|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
105885383|NCT03689374|365234207|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
105885384|NCT03689374|365234205|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
105885385|NCT03689374|365234206|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
105885386|NCT03689374|365234207|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
105885387|NCT03689374|365234205|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
105885388|NCT03689374|365234206|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
105885389|NCT03689374|365234207|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
105885390|NCT03689374|365234205|FG000|Treatment Period (Week 0 to 52)|Death|0|||
105885391|NCT03689374|365234206|FG001|Treatment Period (Week 0 to 52)|Death|11|||
105885392|NCT03689374|365234207|FG002|Treatment Period (Week 0 to 52)|Death|1|||
105885393|NCT05367973|365234209|FG000|Overall Study|Adverse Event|0|||
105885394|NCT05367973|365234210|FG001|Overall Study|Adverse Event|2|||
105885395|NCT00986921|365234212|FG000|Overall Study|Physician Decision|1|||
105885396|NCT00986921|365234213|FG001|Overall Study|Physician Decision|0|||
105885397|NCT00813813|365234214|FG000|Overall Study|Withdrawal by Subject|1|||
105885398|NCT00813813|365234215|FG001|Overall Study|Withdrawal by Subject|1|||
105885399|NCT00813813|365234214|FG000|Overall Study|Lost to Follow-up|2|||
105885400|NCT00813813|365234215|FG001|Overall Study|Lost to Follow-up|7|||
105885401|NCT00813813|365234214|FG000|Overall Study|Other|0|||
105885402|NCT00813813|365234215|FG001|Overall Study|Other|1|||
105885403|NCT03963232|365234218|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105885404|NCT03963232|365234219|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
105885405|NCT03963232|365234218|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
105885406|NCT03963232|365234219|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
105885407|NCT03963232|365234218|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
105885408|NCT03963232|365234219|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
105885409|NCT03963232|365234218|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
105885410|NCT03963232|365234219|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
105885411|NCT03963232|365234218|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
105885412|NCT03963232|365234219|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
105885413|NCT03963232|365234218|FG000|Open-Label Treatment Phase|Adverse Event|1|||
105885414|NCT03963232|365234219|FG001|Open-Label Treatment Phase|Adverse Event|2|||
105885415|NCT03963232|365234218|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
105885416|NCT03963232|365234219|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
105885417|NCT03963232|365234218|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
105885418|NCT03963232|365234219|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
105885419|NCT03963232|365234218|FG000|Open-Label Treatment Phase|Pregnancy|1|||
105885420|NCT03963232|365234219|FG001|Open-Label Treatment Phase|Pregnancy|0|||
105885421|NCT03963232|365234218|FG000|Follow-up Phase|Withdrawal by Subject|7|||
105885422|NCT03963232|365234219|FG001|Follow-up Phase|Withdrawal by Subject|5|||
105885423|NCT03963232|365234218|FG000|Follow-up Phase|Protocol Violation|0|||
105885424|NCT03963232|365234219|FG001|Follow-up Phase|Protocol Violation|2|||
105885425|NCT03963232|365234218|FG000|Follow-up Phase|Adverse Event|0|||
105885426|NCT03963232|365234219|FG001|Follow-up Phase|Adverse Event|1|||
105885427|NCT03963232|365234218|FG000|Follow-up Phase|Lost to Follow-up|0|||
105885428|NCT03963232|365234219|FG001|Follow-up Phase|Lost to Follow-up|1|||
105885429|NCT03617770|365234220|FG000|Overall Study|Lost to Follow-up|1|||
105885430|NCT03617770|365234221|FG001|Overall Study|Lost to Follow-up|0|||
105885431|NCT03512210|365234223|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
105885432|NCT03512210|365234223|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
105885433|NCT03512210|365234223|FG000|Step 2:Post-MINMON|Death|2|||
105885434|NCT03512210|365234223|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
105885435|NCT03512210|365234223|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
105885436|NCT04999163|365234231|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
105885437|NCT04999163|365234232|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
105885438|NCT04999163|365234231|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
105885439|NCT04999163|365234232|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
105885440|NCT04999163|365234231|FG000|Overall Study|Withdrawal by Subject|1|||
105885441|NCT04999163|365234232|FG001|Overall Study|Withdrawal by Subject|0|||
105885442|NCT03232931|365235573|FG000|Overall Study|Physician Decision|1|||
105885443|NCT03232931|365235574|FG001|Overall Study|Physician Decision|1|||
105885444|NCT03232931|365235573|FG000|Overall Study|Withdrawal by Subject|6|||
105885445|NCT03232931|365235574|FG001|Overall Study|Withdrawal by Subject|0|||
105885446|NCT03232931|365235573|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
105885447|NCT03232931|365235574|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
105885448|NCT03232931|365235573|FG000|Overall Study|Parent did not record voice|1|||
105885449|NCT03232931|365235574|FG001|Overall Study|Parent did not record voice|2|||
105885450|NCT03232931|365235573|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
105885451|NCT03232931|365235574|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
105885452|NCT00504725|365235576|FG000|Overall Study|Protocol Violation|1|||
105885453|NCT00504725|365235577|FG001|Overall Study|Protocol Violation|0|||
105885454|NCT04981470|365235580|FG000|Overall Study|Device failure in all 4 patients|4|||
105885455|NCT00809471|365235581|FG000|Overall Study|Protocol non-compliance|15|||
105885456|NCT00809471|365235582|FG001|Overall Study|Protocol non-compliance|15|||
105885457|NCT00809471|365235583|FG002|Overall Study|Protocol non-compliance|6|||
105885458|NCT00809471|365235581|FG000|Overall Study|Lost to Follow-up|4|||
105885459|NCT00809471|365235582|FG001|Overall Study|Lost to Follow-up|2|||
105885460|NCT00809471|365235583|FG002|Overall Study|Lost to Follow-up|9|||
105885461|NCT00809471|365235581|FG000|Overall Study|Adverse Event|0|||
105885462|NCT00809471|365235582|FG001|Overall Study|Adverse Event|2|||
105885463|NCT00809471|365235583|FG002|Overall Study|Adverse Event|2|||
105885464|NCT00809471|365235581|FG000|Overall Study|Requirement for restricted medication|1|||
105885465|NCT00809471|365235582|FG001|Overall Study|Requirement for restricted medication|1|||
105885466|NCT00809471|365235583|FG002|Overall Study|Requirement for restricted medication|0|||
105885467|NCT01736397|365235584|FG000|Overall Study|Lack of Efficacy|1|||
105885468|NCT01736397|365235585|FG001|Overall Study|Lack of Efficacy|11|||
105885469|NCT01736397|365235584|FG000|Overall Study|Withdrawal by Subject|6|||
105885470|NCT01736397|365235585|FG001|Overall Study|Withdrawal by Subject|5|||
105885471|NCT01736397|365235584|FG000|Overall Study|Lost to Follow-up|0|||
105885472|NCT01736397|365235585|FG001|Overall Study|Lost to Follow-up|1|||
105885473|NCT01736397|365235584|FG000|Overall Study|Adverse Event|6|||
105885474|NCT01736397|365235585|FG001|Overall Study|Adverse Event|3|||
105885475|NCT01736397|365235584|FG000|Overall Study|Not stated|1|||
105885476|NCT01736397|365235585|FG001|Overall Study|Not stated|4|||
105885477|NCT00831311|365235586|FG000|Overall Study|Definitive Contraindication|3|||
105885478|NCT00831311|365235587|FG001|Overall Study|Definitive Contraindication|3|||
105885479|NCT00831311|365235586|FG000|Overall Study|Lost to Follow-up|3|||
105885480|NCT00831311|365235587|FG001|Overall Study|Lost to Follow-up|0|||
105885481|NCT00831311|365235586|FG000|Overall Study|Physician Decision|0|||
105885482|NCT00831311|365235587|FG001|Overall Study|Physician Decision|1|||
105885483|NCT00831311|365235586|FG000|Overall Study|Withdrawal by Subject|6|||
105885484|NCT00831311|365235587|FG001|Overall Study|Withdrawal by Subject|4|||
105885485|NCT05088603|365235590|FG000|Overall Study|Protocol Violation|6|||
105885486|NCT05088603|365235591|FG001|Overall Study|Protocol Violation|1|||
105885487|NCT00594100|365235595|FG000|Procedure|Technical Failure|9|||
105885488|NCT00594100|365235595|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
105885489|NCT00594100|365235595|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
105885490|NCT00594100|365235595|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
105885491|NCT02448537|365235596|FG000|Overall Study|Withdrawal by Subject|1|||
105885492|NCT02448537|365235597|FG001|Overall Study|Withdrawal by Subject|1|||
105885493|NCT02448537|365235598|FG002|Overall Study|Withdrawal by Subject|1|||
105885494|NCT03555565|365235601|FG000|Overall Study|Case Report Forms Uncollected|2|||
105885495|NCT03555565|365235601|FG000|Overall Study|Protocol Deviation|13|||
105885496|NCT04292912|365235602|FG000|Overall Study|Physician Decision|1|||
105885497|NCT04292912|365235602|FG000|Overall Study|Protocol Violation|6|||
105885498|NCT00930774|365235605|FG000|Overall Study|Withdrawal by Subject|1|||
105885499|NCT00930774|365235606|FG001|Overall Study|Withdrawal by Subject|9|||
105885500|NCT00930774|365235607|FG002|Overall Study|Withdrawal by Subject|2|||
105885501|NCT00930774|365235608|FG003|Overall Study|Withdrawal by Subject|0|||
105994125|NCT00398567|365637921|FG000|Overall Study|Adverse Event|0|||
105994126|NCT00398567|365637922|FG001|Overall Study|Adverse Event|0|||
105885502|NCT04720911|365235611|FG000|Overall Study|Withdrawal by Subject|0|||
105885503|NCT04720911|365235612|FG001|Overall Study|Withdrawal by Subject|1|||
105885504|NCT04720911|365235613|FG002|Overall Study|Withdrawal by Subject|0|||
105885505|NCT00661609|365235614|FG000|Overall Study|Adverse Event|4|||
105885506|NCT00661609|365235614|FG000|Overall Study|Death|20|||
105885507|NCT00661609|365235614|FG000|Overall Study|Withdrawal by Subject|2|||
105885508|NCT00661609|365235614|FG000|Overall Study|PI Decision|1|||
105885509|NCT00661609|365235614|FG000|Overall Study|Survival follow up stage discontinued|11|||
105885510|NCT00661609|365235614|FG000|Overall Study|Disease progression|3|||
105885511|NCT01981954|365235621|FG000|Titration Period|Protocol Deviation|1|||
105885512|NCT01981954|365235621|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
105885513|NCT04590586|365235622|FG000|Overall Study|Death|7|||
105885514|NCT04590586|365235623|FG001|Overall Study|Death|1|||
105885515|NCT04590586|365235624|FG002|Overall Study|Death|37|||
105885516|NCT04590586|365235625|FG003|Overall Study|Death|34|||
105885517|NCT04590586|365235626|FG004|Overall Study|Death|19|||
105885518|NCT04590586|365235627|FG005|Overall Study|Death|3|||
105885519|NCT04590586|365235622|FG000|Overall Study|Lost to Follow-up|3|||
105885520|NCT04590586|365235623|FG001|Overall Study|Lost to Follow-up|0|||
105885521|NCT04590586|365235624|FG002|Overall Study|Lost to Follow-up|11|||
105885522|NCT04590586|365235625|FG003|Overall Study|Lost to Follow-up|11|||
105885523|NCT04590586|365235626|FG004|Overall Study|Lost to Follow-up|6|||
105885524|NCT04590586|365235627|FG005|Overall Study|Lost to Follow-up|0|||
105885525|NCT04590586|365235622|FG000|Overall Study|Withdrawal by Subject|0|||
105885526|NCT04590586|365235623|FG001|Overall Study|Withdrawal by Subject|0|||
105885527|NCT04590586|365235624|FG002|Overall Study|Withdrawal by Subject|6|||
105885528|NCT04590586|365235625|FG003|Overall Study|Withdrawal by Subject|0|||
105885529|NCT04590586|365235626|FG004|Overall Study|Withdrawal by Subject|3|||
105885530|NCT04590586|365235627|FG005|Overall Study|Withdrawal by Subject|0|||
105885531|NCT04590586|365235622|FG000|Overall Study|Other|3|||
105885532|NCT04590586|365235623|FG001|Overall Study|Other|0|||
105885533|NCT04590586|365235624|FG002|Overall Study|Other|1|||
105885534|NCT04590586|365235625|FG003|Overall Study|Other|1|||
105885535|NCT04590586|365235626|FG004|Overall Study|Other|2|||
105885536|NCT04590586|365235627|FG005|Overall Study|Other|1|||
105885537|NCT03063086|365235628|FG000|Overall Study|technical problems|1|||
105885538|NCT03063086|365235629|FG001|Overall Study|technical problems|0|||
105885539|NCT03063086|365235630|FG002|Overall Study|technical problems|0|||
105885540|NCT03063086|365235631|FG003|Overall Study|technical problems|0|||
105885541|NCT03063086|365235632|FG004|Overall Study|technical problems|0|||
105885542|NCT03063086|365235633|FG005|Overall Study|technical problems|0|||
105885543|NCT03063086|365235628|FG000|Overall Study|Adverse Event|1|||
105885544|NCT03063086|365235629|FG001|Overall Study|Adverse Event|1|||
105885545|NCT03063086|365235630|FG002|Overall Study|Adverse Event|1|||
105885546|NCT03063086|365235631|FG003|Overall Study|Adverse Event|1|||
105885547|NCT03063086|365235632|FG004|Overall Study|Adverse Event|0|||
105885548|NCT03063086|365235633|FG005|Overall Study|Adverse Event|0|||
105885549|NCT03063086|365235628|FG000|Overall Study|subject/guardian decision|1|||
105885550|NCT03063086|365235629|FG001|Overall Study|subject/guardian decision|0|||
105885551|NCT03063086|365235630|FG002|Overall Study|subject/guardian decision|0|||
105885552|NCT03063086|365235631|FG003|Overall Study|subject/guardian decision|0|||
105885553|NCT03063086|365235632|FG004|Overall Study|subject/guardian decision|0|||
105885554|NCT03063086|365235633|FG005|Overall Study|subject/guardian decision|0|||
105885555|NCT03063086|365235628|FG000|Overall Study|Non-compliance with study treatment|0|||
105885556|NCT03063086|365235629|FG001|Overall Study|Non-compliance with study treatment|0|||
105885557|NCT03063086|365235630|FG002|Overall Study|Non-compliance with study treatment|0|||
105885558|NCT03063086|365235631|FG003|Overall Study|Non-compliance with study treatment|1|||
105885559|NCT03063086|365235632|FG004|Overall Study|Non-compliance with study treatment|0|||
105885560|NCT03063086|365235633|FG005|Overall Study|Non-compliance with study treatment|1|||
105885561|NCT03063086|365235628|FG000|Overall Study|Physician Decision|0|||
105885562|NCT03063086|365235629|FG001|Overall Study|Physician Decision|0|||
105885563|NCT03063086|365235630|FG002|Overall Study|Physician Decision|0|||
105885564|NCT03063086|365235631|FG003|Overall Study|Physician Decision|1|||
105885565|NCT03063086|365235632|FG004|Overall Study|Physician Decision|0|||
105885566|NCT03063086|365235633|FG005|Overall Study|Physician Decision|0|||
105885567|NCT01893281|365235634|FG000|Overall Study|Adverse Event|1|||
106113797|NCT02798211|366074306|FG000|Period 2|Withdrawal of Informed Consent|1|||
105885568|NCT01893281|365235634|FG000|Overall Study|Protocol Violation|1|||
105885569|NCT01893281|365235634|FG000|Overall Study|Withdrawal by Subject|1|||
105885570|NCT00637000|365235635|FG000|Overall Study|Withdrawal by Subject|4|||
105885571|NCT00637000|365235636|FG001|Overall Study|Withdrawal by Subject|3|||
105885572|NCT02295020|365235639|FG000|Overall Study|Adverse Event|0|||
105885573|NCT02295020|365235640|FG001|Overall Study|Adverse Event|1|||
105885574|NCT02295020|365235639|FG000|Overall Study|Withdrawal by Subject|3|||
105885575|NCT02295020|365235640|FG001|Overall Study|Withdrawal by Subject|2|||
105885576|NCT04481789|365235641|FG000|Period 1|Withdrawal by Subject|1|||
105885577|NCT04481789|365235642|FG001|Period 1|Withdrawal by Subject|0|||
105885578|NCT04481789|365235643|FG002|Period 1|Withdrawal by Subject|0|||
105885579|NCT04481789|365235644|FG003|Period 1|Withdrawal by Subject|0|||
105885580|NCT04481789|365235645|FG004|Period 1|Withdrawal by Subject|0|||
105885581|NCT04481789|365235646|FG005|Period 1|Withdrawal by Subject|0|||
105885582|NCT01598090|365235647|FG000|Treatment Period|Poor/non-compliance|0|||
105885583|NCT01598090|365235648|FG001|Treatment Period|Poor/non-compliance|2|||
105885584|NCT01598090|365235649|FG002|Treatment Period|Poor/non-compliance|0|||
105885585|NCT01598090|365235647|FG000|Treatment Period|No longer meet study criteria|0|||
105885586|NCT01598090|365235648|FG001|Treatment Period|No longer meet study criteria|1|||
105885587|NCT01598090|365235649|FG002|Treatment Period|No longer meet study criteria|0|||
105885588|NCT01598090|365235647|FG000|Treatment Period|Lack of Efficacy|5|||
105885589|NCT01598090|365235648|FG001|Treatment Period|Lack of Efficacy|14|||
105885590|NCT01598090|365235649|FG002|Treatment Period|Lack of Efficacy|6|||
105885591|NCT01598090|365235647|FG000|Treatment Period|Adverse Event|2|||
105885592|NCT01598090|365235648|FG001|Treatment Period|Adverse Event|33|||
105885593|NCT01598090|365235649|FG002|Treatment Period|Adverse Event|17|||
105885594|NCT01598090|365235647|FG000|Treatment Period|Other reasons|0|||
105885595|NCT01598090|365235648|FG001|Treatment Period|Other reasons|4|||
105885596|NCT01598090|365235649|FG002|Treatment Period|Other reasons|1|||
105885597|NCT01598090|365235647|FG000|Treatment Period|Withdrawal by Subject|3|||
105885598|NCT01598090|365235648|FG001|Treatment Period|Withdrawal by Subject|13|||
105885599|NCT01598090|365235649|FG002|Treatment Period|Withdrawal by Subject|10|||
105885600|NCT01598090|365235647|FG000|Treatment Period|Lost to Follow-up|1|||
105885601|NCT01598090|365235648|FG001|Treatment Period|Lost to Follow-up|5|||
105885602|NCT01598090|365235649|FG002|Treatment Period|Lost to Follow-up|1|||
105885603|NCT01598090|365235647|FG000|Follow-up Period|Death|0|||
105885604|NCT01598090|365235648|FG001|Follow-up Period|Death|1|||
105885605|NCT01598090|365235649|FG002|Follow-up Period|Death|0|||
105885606|NCT01598090|365235647|FG000|Follow-up Period|No longer required per protocol|1|||
105885607|NCT01598090|365235648|FG001|Follow-up Period|No longer required per protocol|3|||
105885608|NCT01598090|365235649|FG002|Follow-up Period|No longer required per protocol|2|||
105885609|NCT01598090|365235647|FG000|Follow-up Period|Not reported|0|||
105885610|NCT01598090|365235648|FG001|Follow-up Period|Not reported|10|||
105885611|NCT01598090|365235649|FG002|Follow-up Period|Not reported|4|||
105885612|NCT01598090|365235647|FG000|Follow-up Period|Withdrawal by Subject|0|||
105885613|NCT01598090|365235648|FG001|Follow-up Period|Withdrawal by Subject|3|||
105885614|NCT01598090|365235649|FG002|Follow-up Period|Withdrawal by Subject|2|||
105885615|NCT01598090|365235647|FG000|Follow-up Period|Other reasons|2|||
105885616|NCT01598090|365235648|FG001|Follow-up Period|Other reasons|8|||
105885617|NCT01598090|365235649|FG002|Follow-up Period|Other reasons|8|||
105885618|NCT01598090|365235647|FG000|Follow-up Period|Lost to Follow-up|2|||
105885619|NCT01598090|365235648|FG001|Follow-up Period|Lost to Follow-up|10|||
105885620|NCT01598090|365235649|FG002|Follow-up Period|Lost to Follow-up|12|||
105885621|NCT03615144|365235650|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
105885622|NCT03615144|365235651|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
105885623|NCT04791319|365235652|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
105885624|NCT04791319|365235653|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
105885625|NCT04791319|365235654|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
105885626|NCT04791319|365235655|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
105885627|NCT04791319|365235656|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105885628|NCT04791319|365235657|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105885629|NCT04791319|365235658|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105885630|NCT04791319|365235659|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105885631|NCT04791319|365235660|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105885632|NCT04791319|365235661|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105885633|NCT04791319|365235662|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
105885634|NCT04791319|365235652|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
105885635|NCT04791319|365235653|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105885636|NCT04791319|365235654|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
105885637|NCT04791319|365235655|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
105885638|NCT04791319|365235656|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105885639|NCT04791319|365235657|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105885640|NCT04791319|365235658|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105885641|NCT04791319|365235659|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105885642|NCT04791319|365235660|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
106113798|NCT02798211|366074307|FG001|Period 2|Withdrawal of Informed Consent|0|||
105885643|NCT04791319|365235661|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
105885644|NCT04791319|365235662|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
106113799|NCT02798211|366074308|FG002|Period 2|Withdrawal of Informed Consent|0|||
105885645|NCT04791319|365235652|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
105885646|NCT04791319|365235653|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
105885647|NCT04791319|365235654|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
105885648|NCT04791319|365235655|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
105885649|NCT04791319|365235656|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105885650|NCT04791319|365235657|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105885651|NCT04791319|365235658|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105885652|NCT04791319|365235659|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105885653|NCT04791319|365235660|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105885654|NCT04791319|365235661|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105885655|NCT04791319|365235662|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
105885656|NCT04791319|365235652|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
105885657|NCT04791319|365235653|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
105885658|NCT04791319|365235654|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
105885659|NCT04791319|365235655|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
105885660|NCT04791319|365235656|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105885661|NCT04791319|365235657|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105885662|NCT04791319|365235658|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105885663|NCT04791319|365235659|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105885664|NCT04791319|365235660|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105885665|NCT04791319|365235661|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105885666|NCT04791319|365235662|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
105885667|NCT04791319|365235652|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885668|NCT04791319|365235653|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885669|NCT04791319|365235654|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885670|NCT04791319|365235655|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
105885671|NCT04791319|365235656|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885672|NCT04791319|365235657|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885673|NCT04791319|365235658|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885674|NCT04791319|365235659|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885675|NCT04791319|365235660|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885676|NCT04791319|365235661|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885677|NCT04791319|365235662|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
105885678|NCT04791319|365235652|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105885679|NCT04791319|365235653|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105885680|NCT04791319|365235654|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105885681|NCT04791319|365235655|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105885682|NCT04791319|365235656|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
105885683|NCT04791319|365235657|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
105885684|NCT04791319|365235658|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
105885685|NCT04791319|365235659|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
106113800|NCT02798211|366074309|FG003|Period 2|Withdrawal of Informed Consent|2|||
106113801|NCT02798211|366074310|FG004|Period 2|Withdrawal of Informed Consent|2|||
106113802|NCT02798211|366074311|FG005|Period 2|Withdrawal of Informed Consent|3|||
106113803|NCT05292534|366074312|FG000|Overall Study|Protocol Violation|3|||
106113804|NCT05292534|366074313|FG001|Overall Study|Protocol Violation|4|||
106113805|NCT05292534|366074312|FG000|Overall Study|Withdrawal by Subject|0|||
106113806|NCT05292534|366074313|FG001|Overall Study|Withdrawal by Subject|1|||
106113807|NCT01982435|366074314|FG000|Overall Study|Adverse Event|1|||
106113808|NCT01982435|366074315|FG001|Overall Study|Adverse Event|0|||
106113809|NCT04887948|366074316|FG000|Overall Study|Death|1|||
106113810|NCT04887948|366074317|FG001|Overall Study|Death|0|||
106113811|NCT04887948|366074318|FG002|Overall Study|Death|0|||
106113812|NCT04887948|366074316|FG000|Overall Study|Lost to Follow-up|1|||
106113813|NCT04887948|366074317|FG001|Overall Study|Lost to Follow-up|0|||
106113814|NCT04887948|366074318|FG002|Overall Study|Lost to Follow-up|3|||
106113815|NCT04887948|366074316|FG000|Overall Study|Physician Decision|0|||
106113816|NCT04887948|366074317|FG001|Overall Study|Physician Decision|4|||
106113817|NCT04887948|366074318|FG002|Overall Study|Physician Decision|1|||
105885686|NCT04791319|365235660|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105885687|NCT04791319|365235661|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
105885688|NCT04791319|365235662|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
105885689|NCT04791319|365235652|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885690|NCT04791319|365235653|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885691|NCT04791319|365235654|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885692|NCT04791319|365235655|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
106113818|NCT04887948|366074316|FG000|Overall Study|Protocol Violation|1|||
106113819|NCT04887948|366074317|FG001|Overall Study|Protocol Violation|1|||
106113820|NCT04887948|366074318|FG002|Overall Study|Protocol Violation|0|||
106113821|NCT04887948|366074316|FG000|Overall Study|Withdrawal by Subject|0|||
106113822|NCT04887948|366074317|FG001|Overall Study|Withdrawal by Subject|6|||
105885693|NCT04791319|365235656|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885694|NCT04791319|365235657|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885695|NCT04791319|365235658|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885696|NCT04791319|365235659|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885697|NCT04791319|365235660|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885698|NCT04791319|365235661|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
105885699|NCT04791319|365235662|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
105885700|NCT04791319|365235652|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105885701|NCT04791319|365235653|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105885702|NCT04791319|365235654|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105885703|NCT04791319|365235655|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105885704|NCT04791319|365235656|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
105885705|NCT04791319|365235657|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
105885706|NCT04791319|365235658|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
105885707|NCT04791319|365235659|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
105885708|NCT04791319|365235660|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
105885709|NCT04791319|365235661|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
105885710|NCT04791319|365235662|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
105885711|NCT04791319|365235652|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
105885712|NCT04791319|365235653|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
105885713|NCT04791319|365235654|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
105885714|NCT04791319|365235655|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
105885715|NCT04791319|365235656|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
105885716|NCT04791319|365235657|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
105885717|NCT04791319|365235658|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
105885718|NCT04791319|365235659|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
105885719|NCT04791319|365235660|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
105885720|NCT04791319|365235661|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
105885721|NCT04791319|365235662|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
105885722|NCT02587598|365235663|FG000|Overall Study|Death|4|||
105885723|NCT02587598|365235664|FG001|Overall Study|Death|8|||
105885724|NCT02587598|365235665|FG002|Overall Study|Death|4|||
106113823|NCT04887948|366074318|FG002|Overall Study|Withdrawal by Subject|1|||
106113824|NCT04887948|366074316|FG000|Overall Study|No longer met eligibility criteria|1|||
105885725|NCT02587598|365235666|FG003|Overall Study|Death|16|||
105885726|NCT02587598|365235667|FG004|Overall Study|Death|9|||
105885727|NCT02587598|365235668|FG005|Overall Study|Death|4|||
105885728|NCT02587598|365235669|FG006|Overall Study|Death|6|||
105885729|NCT02587598|365235670|FG007|Overall Study|Death|7|||
105885730|NCT02587598|365235671|FG008|Overall Study|Death|9|||
105885731|NCT02587598|365235672|FG009|Overall Study|Death|1|||
105885732|NCT02587598|365235673|FG010|Overall Study|Death|3|||
105885733|NCT02587598|365235663|FG000|Overall Study|Study Terminated by the Sponsor|0|||
105885734|NCT02587598|365235664|FG001|Overall Study|Study Terminated by the Sponsor|1|||
105885735|NCT02587598|365235665|FG002|Overall Study|Study Terminated by the Sponsor|0|||
105885736|NCT02587598|365235666|FG003|Overall Study|Study Terminated by the Sponsor|3|||
105885737|NCT02587598|365235667|FG004|Overall Study|Study Terminated by the Sponsor|0|||
105885738|NCT02587598|365235668|FG005|Overall Study|Study Terminated by the Sponsor|1|||
105885739|NCT02587598|365235669|FG006|Overall Study|Study Terminated by the Sponsor|0|||
105885740|NCT02587598|365235670|FG007|Overall Study|Study Terminated by the Sponsor|0|||
105885741|NCT02587598|365235671|FG008|Overall Study|Study Terminated by the Sponsor|0|||
105885742|NCT02587598|365235672|FG009|Overall Study|Study Terminated by the Sponsor|1|||
105885743|NCT02587598|365235673|FG010|Overall Study|Study Terminated by the Sponsor|6|||
105885744|NCT02587598|365235663|FG000|Overall Study|Reason for study withdrawal not specified|0|||
105885745|NCT02587598|365235664|FG001|Overall Study|Reason for study withdrawal not specified|1|||
105885746|NCT02587598|365235665|FG002|Overall Study|Reason for study withdrawal not specified|0|||
105885747|NCT02587598|365235666|FG003|Overall Study|Reason for study withdrawal not specified|0|||
105885748|NCT02587598|365235667|FG004|Overall Study|Reason for study withdrawal not specified|0|||
105885749|NCT02587598|365235668|FG005|Overall Study|Reason for study withdrawal not specified|0|||
105885750|NCT02587598|365235669|FG006|Overall Study|Reason for study withdrawal not specified|0|||
105885751|NCT02587598|365235670|FG007|Overall Study|Reason for study withdrawal not specified|0|||
105885752|NCT02587598|365235671|FG008|Overall Study|Reason for study withdrawal not specified|0|||
105885753|NCT02587598|365235672|FG009|Overall Study|Reason for study withdrawal not specified|0|||
105885754|NCT02587598|365235673|FG010|Overall Study|Reason for study withdrawal not specified|0|||
105885755|NCT02587598|365235663|FG000|Overall Study|Withdrawal by Subject|0|||
105885756|NCT02587598|365235664|FG001|Overall Study|Withdrawal by Subject|1|||
105885757|NCT02587598|365235665|FG002|Overall Study|Withdrawal by Subject|0|||
105885758|NCT02587598|365235666|FG003|Overall Study|Withdrawal by Subject|2|||
105885759|NCT02587598|365235667|FG004|Overall Study|Withdrawal by Subject|3|||
105885760|NCT02587598|365235668|FG005|Overall Study|Withdrawal by Subject|1|||
105885761|NCT02587598|365235669|FG006|Overall Study|Withdrawal by Subject|0|||
105885762|NCT02587598|365235670|FG007|Overall Study|Withdrawal by Subject|0|||
105885763|NCT02587598|365235671|FG008|Overall Study|Withdrawal by Subject|0|||
105885764|NCT02587598|365235672|FG009|Overall Study|Withdrawal by Subject|1|||
105885765|NCT02587598|365235673|FG010|Overall Study|Withdrawal by Subject|2|||
105885766|NCT02587598|365235663|FG000|Overall Study|Physician Decision|0|||
105885767|NCT02587598|365235664|FG001|Overall Study|Physician Decision|0|||
105885768|NCT02587598|365235665|FG002|Overall Study|Physician Decision|0|||
105885769|NCT02587598|365235666|FG003|Overall Study|Physician Decision|0|||
105885770|NCT02587598|365235667|FG004|Overall Study|Physician Decision|0|||
105885771|NCT02587598|365235668|FG005|Overall Study|Physician Decision|0|||
105885772|NCT02587598|365235669|FG006|Overall Study|Physician Decision|0|||
105885773|NCT02587598|365235670|FG007|Overall Study|Physician Decision|0|||
105885774|NCT02587598|365235671|FG008|Overall Study|Physician Decision|0|||
105885775|NCT02587598|365235672|FG009|Overall Study|Physician Decision|0|||
105885776|NCT02587598|365235673|FG010|Overall Study|Physician Decision|3|||
105885777|NCT01704651|365235676|FG000|Overall Study|Pre-op withdrawal by subject|1|||
105885778|NCT01704651|365235677|FG001|Overall Study|Pre-op withdrawal by subject|1|||
105885779|NCT01704651|365235676|FG000|Overall Study|Pre-op change in treatment plan|1|||
105885780|NCT01704651|365235677|FG001|Overall Study|Pre-op change in treatment plan|4|||
105885781|NCT01704651|365235676|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
105885782|NCT01704651|365235677|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
105885783|NCT01704651|365235676|FG000|Overall Study|Post-op did not have laparotomy|2|||
105885784|NCT01704651|365235677|FG001|Overall Study|Post-op did not have laparotomy|1|||
105885785|NCT00256854|365235678|FG000|Overall Study|Withdrawal by Subject|2|||
105885786|NCT00256854|365235679|FG001|Overall Study|Withdrawal by Subject|3|||
105885787|NCT00256854|365235680|FG002|Overall Study|Withdrawal by Subject|0|||
105885788|NCT00256854|365235681|FG003|Overall Study|Withdrawal by Subject|0|||
105885789|NCT00256854|365235682|FG004|Overall Study|Withdrawal by Subject|0|||
105885790|NCT00256854|365235683|FG005|Overall Study|Withdrawal by Subject|0|||
105885791|NCT00256854|365235678|FG000|Overall Study|Lack of Efficacy|1|||
105994127|NCT00398567|365637923|FG002|Overall Study|Adverse Event|2|||
105994128|NCT00398567|365637921|FG000|Overall Study|Protocol Violation|0|||
105994129|NCT00398567|365637922|FG001|Overall Study|Protocol Violation|0|||
105994130|NCT00398567|365637923|FG002|Overall Study|Protocol Violation|1|||
105994131|NCT01200368|365637930|FG000|Infant Series|Adverse Event|2|||
105994132|NCT01200368|365637931|FG001|Infant Series|Adverse Event|2|||
105994133|NCT01200368|365637932|FG002|Infant Series|Adverse Event|3|||
105994134|NCT01200368|365637930|FG000|Infant Series|Withdrawal by Subject|0|||
105994135|NCT01200368|365637931|FG001|Infant Series|Withdrawal by Subject|2|||
105994136|NCT01200368|365637932|FG002|Infant Series|Withdrawal by Subject|2|||
105994137|NCT01200368|365637930|FG000|Infant Series|Did not meet entrance criteria|0|||
105994138|NCT01200368|365637931|FG001|Infant Series|Did not meet entrance criteria|1|||
105994139|NCT01200368|365637932|FG002|Infant Series|Did not meet entrance criteria|0|||
105994140|NCT01200368|365637930|FG000|Infant Series|Randomized, not vaccinated|0|||
105994141|NCT01200368|365637931|FG001|Infant Series|Randomized, not vaccinated|1|||
105994142|NCT01200368|365637932|FG002|Infant Series|Randomized, not vaccinated|1|||
105994143|NCT01200368|365637930|FG000|Infant Series|Other|1|||
105994144|NCT01200368|365637931|FG001|Infant Series|Other|0|||
105994145|NCT01200368|365637932|FG002|Infant Series|Other|0|||
105994146|NCT01200368|365637930|FG000|After Infant Series|Adverse Event|6|||
105994147|NCT01200368|365637931|FG001|After Infant Series|Adverse Event|6|||
105994148|NCT01200368|365637932|FG002|After Infant Series|Adverse Event|3|||
105885792|NCT00256854|365235679|FG001|Overall Study|Lack of Efficacy|0|||
105885793|NCT00256854|365235680|FG002|Overall Study|Lack of Efficacy|0|||
105885794|NCT00256854|365235681|FG003|Overall Study|Lack of Efficacy|0|||
105885795|NCT00256854|365235682|FG004|Overall Study|Lack of Efficacy|0|||
105994149|NCT01200368|365637930|FG000|After Infant Series|Withdrawal by Subject|10|||
105994150|NCT01200368|365637931|FG001|After Infant Series|Withdrawal by Subject|8|||
105885796|NCT00256854|365235683|FG005|Overall Study|Lack of Efficacy|0|||
105994151|NCT01200368|365637932|FG002|After Infant Series|Withdrawal by Subject|4|||
105994152|NCT01200368|365637930|FG000|After Infant Series|Lost to Follow-up|1|||
105994153|NCT01200368|365637931|FG001|After Infant Series|Lost to Follow-up|0|||
105994154|NCT01200368|365637932|FG002|After Infant Series|Lost to Follow-up|0|||
105885797|NCT00256854|365235678|FG000|Overall Study|Protocol Violation|0|||
105885798|NCT00256854|365235679|FG001|Overall Study|Protocol Violation|1|||
105885799|NCT00256854|365235680|FG002|Overall Study|Protocol Violation|1|||
105885800|NCT00256854|365235681|FG003|Overall Study|Protocol Violation|1|||
105994155|NCT01200368|365637930|FG000|After Infant Series|Other|1|||
105994156|NCT01200368|365637931|FG001|After Infant Series|Other|2|||
105994157|NCT01200368|365637932|FG002|After Infant Series|Other|2|||
105994158|NCT01200368|365637930|FG000|Toddler Dose|Adverse Event|0|||
105994159|NCT01200368|365637931|FG001|Toddler Dose|Adverse Event|3|||
106113825|NCT04887948|366074317|FG001|Overall Study|No longer met eligibility criteria|2|||
106113826|NCT04887948|366074318|FG002|Overall Study|No longer met eligibility criteria|1|||
106113827|NCT04887948|366074316|FG000|Overall Study|Other|2|||
106113828|NCT04887948|366074317|FG001|Overall Study|Other|1|||
106113829|NCT04887948|366074318|FG002|Overall Study|Other|1|||
106113830|NCT03086018|366074320|FG000|Final Testing for End of Trial|Adverse Event|1|||
106113831|NCT03086018|366074320|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
106113832|NCT01782872|366074321|FG000|Overall Study|Protocol Violation|0|||
106113833|NCT01782872|366074322|FG001|Overall Study|Protocol Violation|0|||
106113834|NCT01782872|366074323|FG002|Overall Study|Protocol Violation|0|||
106113835|NCT01782872|366074324|FG003|Overall Study|Protocol Violation|1|||
106113836|NCT01782872|366074321|FG000|Overall Study|Withdrawal by Subject|0|||
106113837|NCT01782872|366074322|FG001|Overall Study|Withdrawal by Subject|1|||
106113838|NCT01782872|366074323|FG002|Overall Study|Withdrawal by Subject|0|||
106113839|NCT01782872|366074324|FG003|Overall Study|Withdrawal by Subject|0|||
106113840|NCT01892345|366074325|FG000|Overall Study|Adverse Event|0|||
106113841|NCT01892345|366074326|FG001|Overall Study|Adverse Event|2|||
106113842|NCT01892345|366074325|FG000|Overall Study|Death|1|||
106113843|NCT01892345|366074326|FG001|Overall Study|Death|0|||
106113844|NCT01892345|366074325|FG000|Overall Study|Lost to Follow-up|3|||
106113845|NCT01892345|366074326|FG001|Overall Study|Lost to Follow-up|0|||
106113846|NCT01892345|366074325|FG000|Overall Study|Withdrawal by Subject|12|||
106113847|NCT01892345|366074326|FG001|Overall Study|Withdrawal by Subject|1|||
106113848|NCT02748694|366074327|FG000|Overall Study|Voluntary Withdrawal|0|||
106113849|NCT02748694|366074328|FG001|Overall Study|Voluntary Withdrawal|0|||
106113850|NCT02748694|366074329|FG002|Overall Study|Voluntary Withdrawal|0|||
106113851|NCT02748694|366074330|FG003|Overall Study|Voluntary Withdrawal|0|||
106113852|NCT02748694|366074331|FG004|Overall Study|Voluntary Withdrawal|0|||
106113853|NCT02748694|366074332|FG005|Overall Study|Voluntary Withdrawal|0|||
106113854|NCT02748694|366074333|FG006|Overall Study|Voluntary Withdrawal|0|||
106113855|NCT02748694|366074334|FG007|Overall Study|Voluntary Withdrawal|0|||
106113856|NCT02748694|366074335|FG008|Overall Study|Voluntary Withdrawal|0|||
106113857|NCT02748694|366074336|FG009|Overall Study|Voluntary Withdrawal|0|||
106113858|NCT02748694|366074337|FG010|Overall Study|Voluntary Withdrawal|0|||
106113859|NCT02748694|366074338|FG011|Overall Study|Voluntary Withdrawal|0|||
106113860|NCT02748694|366074339|FG012|Overall Study|Voluntary Withdrawal|0|||
106113861|NCT02748694|366074340|FG013|Overall Study|Voluntary Withdrawal|0|||
106113862|NCT02748694|366074341|FG014|Overall Study|Voluntary Withdrawal|2|||
106113863|NCT01473381|366074342|FG000|Overall Study|Adverse Event|8|||
106113864|NCT01473381|366074343|FG001|Overall Study|Adverse Event|20|||
106113865|NCT01473381|366074344|FG002|Overall Study|Adverse Event|25|||
106113866|NCT01473381|366074345|FG003|Overall Study|Adverse Event|17|||
106113867|NCT01473381|366074342|FG000|Overall Study|Insufficient Therapeutic Response|10|||
106113868|NCT01473381|366074343|FG001|Overall Study|Insufficient Therapeutic Response|1|||
106113869|NCT01473381|366074344|FG002|Overall Study|Insufficient Therapeutic Response|2|||
106113870|NCT01473381|366074345|FG003|Overall Study|Insufficient Therapeutic Response|3|||
106113871|NCT01473381|366074342|FG000|Overall Study|Protocol Violation|17|||
106113872|NCT01473381|366074343|FG001|Overall Study|Protocol Violation|23|||
106113873|NCT01473381|366074344|FG002|Overall Study|Protocol Violation|19|||
106113874|NCT01473381|366074345|FG003|Overall Study|Protocol Violation|17|||
106113875|NCT01473381|366074342|FG000|Overall Study|Withdrawal of Consent|20|||
105885801|NCT00256854|365235682|FG004|Overall Study|Protocol Violation|0|||
105885802|NCT00256854|365235683|FG005|Overall Study|Protocol Violation|0|||
105885803|NCT00256854|365235678|FG000|Overall Study|Adverse Event|0|||
105885804|NCT00256854|365235679|FG001|Overall Study|Adverse Event|0|||
105885805|NCT00256854|365235680|FG002|Overall Study|Adverse Event|2|||
105885806|NCT00256854|365235681|FG003|Overall Study|Adverse Event|2|||
105885807|NCT00256854|365235682|FG004|Overall Study|Adverse Event|0|||
105885808|NCT00256854|365235683|FG005|Overall Study|Adverse Event|1|||
105885809|NCT00256854|365235678|FG000|Overall Study|Not compliant with the study drug|0|||
105885810|NCT00256854|365235679|FG001|Overall Study|Not compliant with the study drug|0|||
105885811|NCT00256854|365235680|FG002|Overall Study|Not compliant with the study drug|0|||
105885812|NCT00256854|365235681|FG003|Overall Study|Not compliant with the study drug|0|||
105885813|NCT00256854|365235682|FG004|Overall Study|Not compliant with the study drug|1|||
105885814|NCT00256854|365235683|FG005|Overall Study|Not compliant with the study drug|0|||
105885815|NCT00791661|365235685|FG000|7 Day Wash-out|Adverse Event|0|||
106113876|NCT01473381|366074343|FG001|Overall Study|Withdrawal of Consent|21|||
106113877|NCT01473381|366074344|FG002|Overall Study|Withdrawal of Consent|20|||
106113878|NCT01473381|366074345|FG003|Overall Study|Withdrawal of Consent|26|||
106113879|NCT01473381|366074342|FG000|Overall Study|Lost to Follow-up|25|||
106113880|NCT01473381|366074343|FG001|Overall Study|Lost to Follow-up|28|||
106113881|NCT01473381|366074344|FG002|Overall Study|Lost to Follow-up|35|||
106113882|NCT01473381|366074345|FG003|Overall Study|Lost to Follow-up|23|||
106113883|NCT01473381|366074342|FG000|Overall Study|Other Reasons|0|||
106113884|NCT01473381|366074343|FG001|Overall Study|Other Reasons|0|||
106113885|NCT01473381|366074344|FG002|Overall Study|Other Reasons|1|||
106113886|NCT01473381|366074345|FG003|Overall Study|Other Reasons|3|||
105994160|NCT01200368|365637932|FG002|Toddler Dose|Adverse Event|1|||
105994161|NCT03066193|365637933|FG000|Overall Study|Withdrawal by Subject|1|||
105994162|NCT00377858|365637944|FG000|Overall Study|Withdrawal by Subject|12|||
105994163|NCT00377858|365637945|FG001|Overall Study|Withdrawal by Subject|11|||
105994164|NCT00377858|365637944|FG000|Overall Study|Lost to Follow-up|6|||
105994165|NCT00377858|365637945|FG001|Overall Study|Lost to Follow-up|1|||
105994166|NCT00377858|365637944|FG000|Overall Study|Physician Decision|5|||
105994167|NCT00377858|365637945|FG001|Overall Study|Physician Decision|5|||
105994168|NCT00377858|365637944|FG000|Overall Study|Protocol Violation|3|||
105994169|NCT00377858|365637945|FG001|Overall Study|Protocol Violation|4|||
105994170|NCT00377858|365637944|FG000|Overall Study|Adverse Event|2|||
105994171|NCT00377858|365637945|FG001|Overall Study|Adverse Event|1|||
106113887|NCT00659984|366074346|FG000|Overall Study|Adverse Event|1|||
105885816|NCT00791661|365235686|FG001|7 Day Wash-out|Adverse Event|0|||
105885817|NCT00791661|365235687|FG002|7 Day Wash-out|Adverse Event|1|||
105885818|NCT00791661|365235685|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
105885819|NCT00791661|365235686|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
105885820|NCT00791661|365235687|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
106113888|NCT02228395|366074347|FG000|First Intervention Period|No longer willing to participate|1|||
106113889|NCT02228395|366074348|FG001|First Intervention Period|No longer willing to participate|0|||
106113890|NCT02228395|366074349|FG002|First Intervention Period|No longer willing to participate|0|||
106113891|NCT02228395|366074347|FG000|First Intervention Period|Unable to comply with study dates|0|||
105885821|NCT02691936|365235688|FG000|Overall Study|Withdrawal by Subject|2|||
105885822|NCT02691936|365235689|FG001|Overall Study|Withdrawal by Subject|5|||
105885823|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
105885824|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
105885825|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
105885826|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
105885827|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
105885828|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
105885829|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
105885830|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
105885831|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
105885832|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
105885833|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Death|1|||
105885834|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Death|0|||
105885835|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
105885836|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
105885837|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
105885838|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
105885839|NCT01876784|365235690|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
105885840|NCT01876784|365235691|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
105885841|NCT01876784|365235690|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
105885842|NCT01876784|365235691|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
105885843|NCT01876784|365235690|FG000|Open-label Period (31 Months)|Adverse Event|2|||
105885844|NCT01876784|365235691|FG001|Open-label Period (31 Months)|Adverse Event|6|||
105885845|NCT01876784|365235690|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
105885846|NCT01876784|365235691|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
105885847|NCT01876784|365235690|FG000|Open-label Period (31 Months)|Progressive disease|4|||
105885848|NCT01876784|365235691|FG001|Open-label Period (31 Months)|Progressive disease|35|||
105885849|NCT01876784|365235690|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
105885850|NCT01876784|365235691|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
105885851|NCT01876784|365235690|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
105994172|NCT00377858|365637944|FG000|Overall Study|Entry Criteria Not Met|2|||
105994173|NCT00377858|365637945|FG001|Overall Study|Entry Criteria Not Met|0|||
105994174|NCT00377858|365637944|FG000|Overall Study|Sponsor Decision|1|||
106113892|NCT02228395|366074348|FG001|First Intervention Period|Unable to comply with study dates|1|||
106113893|NCT02228395|366074349|FG002|First Intervention Period|Unable to comply with study dates|1|||
105885852|NCT01876784|365235691|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
105885853|NCT01876784|365235690|FG000|Open-label Period (31 Months)|Death|0|||
105885854|NCT01876784|365235691|FG001|Open-label Period (31 Months)|Death|1|||
105885855|NCT01876784|365235690|FG000|Open-label Period (31 Months)|Other than specified above|9|||
105994175|NCT00377858|365637945|FG001|Overall Study|Sponsor Decision|2|||
105994176|NCT00377858|365637944|FG000|Overall Study|Death|0|||
105994177|NCT00377858|365637945|FG001|Overall Study|Death|3|||
105994178|NCT00517361|365637946|FG000|Overall Study|Death|6|||
105994179|NCT00517361|365637946|FG000|Overall Study|The study was terminated|5|||
105994180|NCT03461146|365637950|FG000|Overall Study|Adverse Event|2|||
106113894|NCT04026165|366074355|FG000|Run-in Placebo Period|Enrollment Error|13|||
105885856|NCT01876784|365235691|FG001|Open-label Period (31 Months)|Other than specified above|18|||
105885857|NCT04603482|365235692|FG000|Overall Study|Lost to Follow-up|15|||
105885858|NCT04603482|365235693|FG001|Overall Study|Lost to Follow-up|15|||
105885859|NCT04603482|365235694|FG002|Overall Study|Lost to Follow-up|15|||
105885860|NCT02147158|365235699|FG000|Treatment Course 1|Adverse Event|1|||
105885861|NCT02147158|365235700|FG001|Treatment Course 1|Adverse Event|4|||
105885862|NCT02147158|365235701|FG002|Treatment Course 1|Adverse Event|3|||
105885863|NCT02147158|365235702|FG003|Treatment Course 1|Adverse Event|4|||
105885864|NCT02147158|365235703|FG004|Treatment Course 1|Adverse Event|1|||
105885865|NCT02147158|365235704|FG005|Treatment Course 1|Adverse Event|2|||
105885866|NCT02147158|365235699|FG000|Treatment Course 1|Lost to Follow-up|2|||
105885867|NCT02147158|365235700|FG001|Treatment Course 1|Lost to Follow-up|4|||
105885868|NCT02147158|365235701|FG002|Treatment Course 1|Lost to Follow-up|3|||
105885869|NCT02147158|365235702|FG003|Treatment Course 1|Lost to Follow-up|3|||
105885870|NCT02147158|365235703|FG004|Treatment Course 1|Lost to Follow-up|2|||
105885871|NCT02147158|365235704|FG005|Treatment Course 1|Lost to Follow-up|4|||
105885872|NCT02147158|365235699|FG000|Treatment Course 1|Protocol Violation|0|||
105885873|NCT02147158|365235700|FG001|Treatment Course 1|Protocol Violation|0|||
105885874|NCT02147158|365235701|FG002|Treatment Course 1|Protocol Violation|1|||
105885875|NCT02147158|365235702|FG003|Treatment Course 1|Protocol Violation|1|||
105885876|NCT02147158|365235703|FG004|Treatment Course 1|Protocol Violation|0|||
105885877|NCT02147158|365235704|FG005|Treatment Course 1|Protocol Violation|0|||
105885878|NCT02147158|365235699|FG000|Treatment Course 1|Withdrawal of Consent|1|||
105885879|NCT02147158|365235700|FG001|Treatment Course 1|Withdrawal of Consent|1|||
105885880|NCT02147158|365235701|FG002|Treatment Course 1|Withdrawal of Consent|1|||
105885881|NCT02147158|365235702|FG003|Treatment Course 1|Withdrawal of Consent|5|||
105885882|NCT02147158|365235703|FG004|Treatment Course 1|Withdrawal of Consent|3|||
105885883|NCT02147158|365235704|FG005|Treatment Course 1|Withdrawal of Consent|2|||
105885884|NCT02147158|365235699|FG000|Off-Treatment Interval 1|Adverse Event|1|||
105885885|NCT02147158|365235700|FG001|Off-Treatment Interval 1|Adverse Event|0|||
105885886|NCT02147158|365235701|FG002|Off-Treatment Interval 1|Adverse Event|0|||
105885887|NCT02147158|365235702|FG003|Off-Treatment Interval 1|Adverse Event|1|||
105885888|NCT02147158|365235703|FG004|Off-Treatment Interval 1|Adverse Event|0|||
105885889|NCT02147158|365235704|FG005|Off-Treatment Interval 1|Adverse Event|0|||
105885890|NCT02147158|365235699|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
105885891|NCT02147158|365235700|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
105885892|NCT02147158|365235701|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
105885893|NCT02147158|365235702|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
105885894|NCT02147158|365235703|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
105885895|NCT02147158|365235704|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
105994181|NCT03461146|365637950|FG000|Overall Study|Physician Decision|1|||
105994182|NCT02073682|365637951|FG000|Overall Study|Low Creatinine Clearance|1|||
105994183|NCT02073682|365637952|FG001|Overall Study|Low Creatinine Clearance|2|||
105994184|NCT02073682|365637951|FG000|Overall Study|Death|86|||
105994185|NCT02073682|365637952|FG001|Overall Study|Death|100|||
105885896|NCT02147158|365235699|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
105885897|NCT02147158|365235700|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
105885898|NCT02147158|365235701|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
105885899|NCT02147158|365235702|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
105885900|NCT02147158|365235703|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
105885901|NCT02147158|365235704|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
105885902|NCT02147158|365235699|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
105885903|NCT02147158|365235700|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
105885904|NCT02147158|365235701|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
105885905|NCT02147158|365235702|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
105885906|NCT02147158|365235703|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
105885907|NCT02147158|365235704|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
105885908|NCT02147158|365235699|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
105885909|NCT02147158|365235700|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
105885910|NCT02147158|365235701|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
105885911|NCT02147158|365235702|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
105885912|NCT02147158|365235703|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
105994186|NCT02073682|365637951|FG000|Overall Study|Cancer Cured|10|||
105994187|NCT02073682|365637952|FG001|Overall Study|Cancer Cured|15|||
105994188|NCT02073682|365637951|FG000|Overall Study|ID: Patient Noncompliance|1|||
105994189|NCT02073682|365637952|FG001|Overall Study|ID: Patient Noncompliance|2|||
106113895|NCT04026165|366074356|FG001|Run-in Placebo Period|Enrollment Error|0|||
105994190|NCT02073682|365637951|FG000|Overall Study|ID: Palliative Treatment Only|10|||
106113896|NCT04026165|366074357|FG002|Run-in Placebo Period|Enrollment Error|0|||
106113897|NCT04026165|366074358|FG003|Run-in Placebo Period|Enrollment Error|0|||
105885913|NCT02147158|365235704|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
105885914|NCT02147158|365235699|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
105885915|NCT02147158|365235700|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
105885916|NCT02147158|365235701|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
105885917|NCT02147158|365235702|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
105885918|NCT02147158|365235703|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
105885919|NCT02147158|365235704|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
105885920|NCT02147158|365235699|FG000|Treatment Course 2|Adverse Event|0|||
105885921|NCT02147158|365235700|FG001|Treatment Course 2|Adverse Event|4|||
105885922|NCT02147158|365235701|FG002|Treatment Course 2|Adverse Event|2|||
105885923|NCT02147158|365235702|FG003|Treatment Course 2|Adverse Event|1|||
105885924|NCT02147158|365235703|FG004|Treatment Course 2|Adverse Event|0|||
105885925|NCT02147158|365235704|FG005|Treatment Course 2|Adverse Event|1|||
105885926|NCT02147158|365235699|FG000|Treatment Course 2|Withdrawal of Consent|0|||
105885927|NCT02147158|365235700|FG001|Treatment Course 2|Withdrawal of Consent|1|||
105885928|NCT02147158|365235701|FG002|Treatment Course 2|Withdrawal of Consent|2|||
105885929|NCT02147158|365235702|FG003|Treatment Course 2|Withdrawal of Consent|3|||
105885930|NCT02147158|365235703|FG004|Treatment Course 2|Withdrawal of Consent|0|||
105885931|NCT02147158|365235704|FG005|Treatment Course 2|Withdrawal of Consent|0|||
105885932|NCT02147158|365235699|FG000|Treatment Course 2|Lost to Follow-up|1|||
105885933|NCT02147158|365235700|FG001|Treatment Course 2|Lost to Follow-up|0|||
105885934|NCT02147158|365235701|FG002|Treatment Course 2|Lost to Follow-up|1|||
105885935|NCT02147158|365235702|FG003|Treatment Course 2|Lost to Follow-up|1|||
105885936|NCT02147158|365235703|FG004|Treatment Course 2|Lost to Follow-up|0|||
105885937|NCT02147158|365235704|FG005|Treatment Course 2|Lost to Follow-up|1|||
105885938|NCT02147158|365235699|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
105885939|NCT02147158|365235700|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
105885940|NCT02147158|365235701|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
105885941|NCT02147158|365235702|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
105885942|NCT02147158|365235703|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
105885943|NCT02147158|365235704|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
105885944|NCT02147158|365235699|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
105885945|NCT02147158|365235700|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
105885946|NCT02147158|365235701|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
105885947|NCT02147158|365235702|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
105885948|NCT02147158|365235703|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
105885949|NCT02147158|365235704|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
105885950|NCT02147158|365235699|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
105885951|NCT02147158|365235700|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
105885952|NCT02147158|365235701|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
105885953|NCT02147158|365235702|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
105885954|NCT02147158|365235703|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
105885955|NCT02147158|365235704|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
105885956|NCT02147158|365235699|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
105885957|NCT02147158|365235700|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
105885958|NCT02147158|365235701|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
105885959|NCT02147158|365235702|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
105885960|NCT02147158|365235703|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
105885961|NCT02147158|365235704|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
105885962|NCT02147158|365235699|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
105885963|NCT02147158|365235700|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
105885964|NCT02147158|365235701|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
105885965|NCT02147158|365235702|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
105885966|NCT02147158|365235703|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
105885967|NCT02147158|365235704|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
105885968|NCT00915876|365235709|FG000|Overall Study|Adverse Event|0|||
105885969|NCT00915876|365235710|FG001|Overall Study|Adverse Event|1|||
105885970|NCT02778074|365235711|FG000|Overall Study|Lost to Follow-up|7|||
105885971|NCT02778074|365235712|FG001|Overall Study|Lost to Follow-up|10|||
105885972|NCT00356135|365235713|FG000|Overall Study|Protocol Violation|1|||
105885973|NCT00356135|365235714|FG001|Overall Study|Protocol Violation|0|||
105885974|NCT00356135|365235715|FG002|Overall Study|Protocol Violation|0|||
105885975|NCT00356135|365235713|FG000|Overall Study|Adverse Event|1|||
105885976|NCT00356135|365235714|FG001|Overall Study|Adverse Event|0|||
105885977|NCT00356135|365235715|FG002|Overall Study|Adverse Event|0|||
106113898|NCT04026165|366074355|FG000|Run-in Placebo Period|Run-in Failure|4|||
106113899|NCT04026165|366074356|FG001|Run-in Placebo Period|Run-in Failure|0|||
106113900|NCT04026165|366074357|FG002|Run-in Placebo Period|Run-in Failure|0|||
105885978|NCT00356135|365235713|FG000|Overall Study|Lost to Follow-up|0|||
105885979|NCT00356135|365235714|FG001|Overall Study|Lost to Follow-up|0|||
105885980|NCT00356135|365235715|FG002|Overall Study|Lost to Follow-up|1|||
105885981|NCT00356135|365235713|FG000|Overall Study|Physician Decision|1|||
105885982|NCT00356135|365235714|FG001|Overall Study|Physician Decision|1|||
105885983|NCT00356135|365235715|FG002|Overall Study|Physician Decision|1|||
105885984|NCT00356135|365235713|FG000|Overall Study|Subject non-compliance|1|||
105885985|NCT00356135|365235714|FG001|Overall Study|Subject non-compliance|1|||
105885986|NCT00356135|365235715|FG002|Overall Study|Subject non-compliance|3|||
106113901|NCT04026165|366074358|FG003|Run-in Placebo Period|Run-in Failure|0|||
105885987|NCT05270395|365235717|FG000|Overall Study|Lost to Follow-up|2|||
105885988|NCT05270395|365235718|FG001|Overall Study|Lost to Follow-up|2|||
105885989|NCT05270395|365235717|FG000|Overall Study|Death|1|||
105885990|NCT05270395|365235718|FG001|Overall Study|Death|2|||
105885991|NCT05270395|365235717|FG000|Overall Study|Study Team Withdrew|1|||
105885992|NCT05270395|365235718|FG001|Overall Study|Study Team Withdrew|0|||
105885993|NCT03260244|365237310|FG000|Overall Study|Death|19|||
105885994|NCT03260244|365237310|FG000|Overall Study|Lost to Follow-up|60|||
105885995|NCT03260244|365237310|FG000|Overall Study|Withdrawal by Subject|48|||
105885996|NCT03260244|365237310|FG000|Overall Study|Procedure Not Performed|21|||
105885997|NCT03260244|365237310|FG000|Overall Study|Enrollment Criteria Not Met|31|||
105885998|NCT03260244|365237310|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
105885999|NCT03260244|365237310|FG000|Overall Study|Subject Noncompliance|6|||
105886000|NCT03260244|365237310|FG000|Overall Study|No inducible Arrhythmia|2|||
105886001|NCT03260244|365237310|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
105886002|NCT03260244|365237310|FG000|Overall Study|Screen Failure|2|||
105886003|NCT03260244|365237310|FG000|Overall Study|Treated Off Label|69|||
105886004|NCT03260244|365237310|FG000|Overall Study|No Radiofrequency Ablation|14|||
105886005|NCT02028767|365237317|FG000|Treatment Period 2|Non compliant with protocol|1|||
105886006|NCT02028767|365237318|FG001|Treatment Period 2|Non compliant with protocol|0|||
105886007|NCT02028767|365237317|FG000|Treatment Period 2|Reason other than those specified above|1|||
105886008|NCT02028767|365237318|FG001|Treatment Period 2|Reason other than those specified above|0|||
105886009|NCT03575793|365237323|FG000|Overall Study|Withdrawal by Subject|0|||
105886010|NCT03575793|365237324|FG001|Overall Study|Withdrawal by Subject|1|||
105886011|NCT03575793|365237323|FG000|Overall Study|Never Treated|0|||
105886012|NCT03575793|365237324|FG001|Overall Study|Never Treated|2|||
105886013|NCT03200704|365237329|FG000|Overall Study|Withdrawal by Subject|1|||
105886014|NCT03436693|365237330|FG000|Overall Study|Adverse Event|22|||
105886015|NCT03436693|365237331|FG001|Overall Study|Adverse Event|10|||
105886016|NCT03436693|365237330|FG000|Overall Study|Physician Decision|3|||
105886017|NCT03436693|365237331|FG001|Overall Study|Physician Decision|3|||
105886018|NCT03436693|365237330|FG000|Overall Study|Withdrawal by Subject|4|||
105886019|NCT03436693|365237331|FG001|Overall Study|Withdrawal by Subject|13|||
105886020|NCT03436693|365237330|FG000|Overall Study|Progressive Disease|1|||
105886021|NCT03436693|365237331|FG001|Overall Study|Progressive Disease|1|||
105886022|NCT02071706|365237332|FG000|Overall Study|Adverse Event|1|||
105886023|NCT02071706|365237332|FG000|Overall Study|Withdrawal by Subject|2|||
105886024|NCT00654875|365237335|FG000|Overall Study|Adverse Event|5|||
105886025|NCT00654875|365237336|FG001|Overall Study|Adverse Event|5|||
105886026|NCT00654875|365237335|FG000|Overall Study|Withdrawal by Subject|4|||
105886027|NCT00654875|365237336|FG001|Overall Study|Withdrawal by Subject|4|||
105886028|NCT00654875|365237335|FG000|Overall Study|Protocol Violation|3|||
105886029|NCT00654875|365237336|FG001|Overall Study|Protocol Violation|3|||
105886030|NCT00654875|365237335|FG000|Overall Study|Lack of Efficacy|2|||
105886031|NCT00654875|365237336|FG001|Overall Study|Lack of Efficacy|2|||
105886032|NCT00654875|365237335|FG000|Overall Study|Lost to Follow-up|1|||
105886033|NCT00654875|365237336|FG001|Overall Study|Lost to Follow-up|3|||
105886034|NCT00654875|365237335|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
105886035|NCT00654875|365237336|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105886036|NCT00654875|365237335|FG000|Overall Study|Administrative Problems|1|||
105886037|NCT00654875|365237336|FG001|Overall Study|Administrative Problems|0|||
105886038|NCT01011465|365237337|FG000|Overall Study|Withdrawal by Subject|2|||
105886039|NCT01011465|365237338|FG001|Overall Study|Withdrawal by Subject|1|||
105886040|NCT01011465|365237339|FG002|Overall Study|Withdrawal by Subject|0|||
105886041|NCT01011465|365237340|FG003|Overall Study|Withdrawal by Subject|0|||
105886042|NCT01011465|365237341|FG004|Overall Study|Withdrawal by Subject|1|||
105886043|NCT01011465|365237342|FG005|Overall Study|Withdrawal by Subject|0|||
105886044|NCT01011465|365237343|FG006|Overall Study|Withdrawal by Subject|1|||
105886045|NCT01011465|365237344|FG007|Overall Study|Withdrawal by Subject|0|||
105994191|NCT02073682|365637952|FG001|Overall Study|ID: Palliative Treatment Only|7|||
105994192|NCT02073682|365637951|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
106113902|NCT04026165|366074355|FG000|Run-in Placebo Period|Protocol Violation|2|||
106113903|NCT04026165|366074356|FG001|Run-in Placebo Period|Protocol Violation|0|||
106113904|NCT04026165|366074357|FG002|Run-in Placebo Period|Protocol Violation|0|||
106113905|NCT04026165|366074358|FG003|Run-in Placebo Period|Protocol Violation|0|||
105886046|NCT02247440|365237347|FG000|Overall Study|Withdrawal by Subject|1|||
105886047|NCT02247440|365237347|FG000|Overall Study|Lack of Efficacy|3|||
105886048|NCT02042950|365237349|FG000|Overall Study|Progressive Disease|4|||
105886049|NCT00723008|365237350|FG000|Enrollment|Lost to Follow-up|1|||
105886050|NCT00723008|365237351|FG001|Enrollment|Lost to Follow-up|0|||
105886051|NCT00723008|365237350|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
105886052|NCT00723008|365237351|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
105886053|NCT00723008|365237350|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
105886054|NCT00723008|365237351|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
105886055|NCT00723008|365237350|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
105886056|NCT00723008|365237351|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
105994193|NCT02073682|365637952|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
105994194|NCT02073682|365637951|FG000|Overall Study|Platelet Count <50,000/mL|1|||
105994195|NCT02073682|365637952|FG001|Overall Study|Platelet Count <50,000/mL|2|||
105994196|NCT02073682|365637951|FG000|Overall Study|Surgery/Medical Procedure|3|||
105994197|NCT02073682|365637952|FG001|Overall Study|Surgery/Medical Procedure|1|||
105994198|NCT02073682|365637951|FG000|Overall Study|Withdrawal by Subject|6|||
105994199|NCT02073682|365637952|FG001|Overall Study|Withdrawal by Subject|8|||
105994200|NCT02073682|365637951|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
105994201|NCT02073682|365637952|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
105994202|NCT02073682|365637951|FG000|Overall Study|Cancer Progression|53|||
105994203|NCT02073682|365637952|FG001|Overall Study|Cancer Progression|33|||
105994204|NCT02073682|365637951|FG000|Overall Study|Protocol Violation|1|||
105994205|NCT02073682|365637952|FG001|Overall Study|Protocol Violation|0|||
105994206|NCT02073682|365637951|FG000|Overall Study|Adverse Event|79|||
106113906|NCT04026165|366074355|FG000|Run-in Placebo Period|Withdrew Consent|2|||
106113907|NCT04026165|366074356|FG001|Run-in Placebo Period|Withdrew Consent|0|||
106113908|NCT04026165|366074357|FG002|Run-in Placebo Period|Withdrew Consent|0|||
106113909|NCT04026165|366074358|FG003|Run-in Placebo Period|Withdrew Consent|0|||
106113910|NCT04026165|366074355|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
106113911|NCT04026165|366074356|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
106113912|NCT04026165|366074357|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
106113913|NCT04026165|366074358|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
106113914|NCT04026165|366074355|FG000|Run-in SEL Period|Run-in Failure|0|||
106113915|NCT04026165|366074356|FG001|Run-in SEL Period|Run-in Failure|26|||
106113916|NCT04026165|366074357|FG002|Run-in SEL Period|Run-in Failure|0|||
106113917|NCT04026165|366074358|FG003|Run-in SEL Period|Run-in Failure|0|||
106113918|NCT04026165|366074355|FG000|Run-in SEL Period|Withdrew Consent|0|||
106113919|NCT04026165|366074356|FG001|Run-in SEL Period|Withdrew Consent|10|||
106113920|NCT04026165|366074357|FG002|Run-in SEL Period|Withdrew Consent|0|||
106113921|NCT04026165|366074358|FG003|Run-in SEL Period|Withdrew Consent|0|||
106113922|NCT04026165|366074355|FG000|Run-in SEL Period|Enrollment Error|0|||
106113923|NCT04026165|366074356|FG001|Run-in SEL Period|Enrollment Error|4|||
106113924|NCT04026165|366074357|FG002|Run-in SEL Period|Enrollment Error|0|||
106113925|NCT04026165|366074358|FG003|Run-in SEL Period|Enrollment Error|0|||
106113926|NCT04026165|366074355|FG000|Run-in SEL Period|Protocol Violation|0|||
106113927|NCT04026165|366074356|FG001|Run-in SEL Period|Protocol Violation|3|||
106113928|NCT04026165|366074357|FG002|Run-in SEL Period|Protocol Violation|0|||
106113929|NCT04026165|366074358|FG003|Run-in SEL Period|Protocol Violation|0|||
106113930|NCT04026165|366074355|FG000|Run-in SEL Period|Investigator's Discretion|0|||
106113931|NCT04026165|366074356|FG001|Run-in SEL Period|Investigator's Discretion|2|||
106113932|NCT04026165|366074357|FG002|Run-in SEL Period|Investigator's Discretion|0|||
106113933|NCT04026165|366074358|FG003|Run-in SEL Period|Investigator's Discretion|0|||
106113934|NCT04026165|366074355|FG000|Run-in SEL Period|Death|0|||
106113935|NCT04026165|366074356|FG001|Run-in SEL Period|Death|1|||
106113936|NCT04026165|366074357|FG002|Run-in SEL Period|Death|0|||
106113937|NCT04026165|366074358|FG003|Run-in SEL Period|Death|0|||
106113938|NCT04026165|366074355|FG000|Randomized Period|Withdrew Consent|0|||
106113939|NCT04026165|366074356|FG001|Randomized Period|Withdrew Consent|0|||
106113940|NCT04026165|366074357|FG002|Randomized Period|Withdrew Consent|5|||
106113941|NCT04026165|366074358|FG003|Randomized Period|Withdrew Consent|8|||
106113942|NCT04026165|366074355|FG000|Randomized Period|Death|0|||
106113943|NCT04026165|366074356|FG001|Randomized Period|Death|0|||
106113944|NCT04026165|366074357|FG002|Randomized Period|Death|5|||
106113945|NCT04026165|366074358|FG003|Randomized Period|Death|7|||
106113946|NCT04026165|366074355|FG000|Randomized Period|Investigator's Discretion|0|||
106113947|NCT04026165|366074356|FG001|Randomized Period|Investigator's Discretion|0|||
106113948|NCT04026165|366074357|FG002|Randomized Period|Investigator's Discretion|2|||
106113949|NCT04026165|366074358|FG003|Randomized Period|Investigator's Discretion|2|||
106113950|NCT04026165|366074355|FG000|Randomized Period|Lost to Follow-up|0|||
106113951|NCT04026165|366074356|FG001|Randomized Period|Lost to Follow-up|0|||
106113952|NCT04026165|366074357|FG002|Randomized Period|Lost to Follow-up|2|||
106113953|NCT04026165|366074358|FG003|Randomized Period|Lost to Follow-up|2|||
106113954|NCT02487810|366074359|FG000|Overall Study|Withdrawal by Subject|1|||
106113955|NCT02487810|366074360|FG001|Overall Study|Withdrawal by Subject|0|||
106113956|NCT01889186|366074361|FG000|Overall Study|Adverse event- not related to progression|18|||
106113957|NCT01889186|366074362|FG001|Overall Study|Adverse event- not related to progression|5|||
106113958|NCT01889186|366074361|FG000|Overall Study|Adverse event- related to progression|7|||
106113959|NCT01889186|366074362|FG001|Overall Study|Adverse event- related to progression|2|||
106113960|NCT01889186|366074361|FG000|Overall Study|COVID-19 logistical restrictions|1|||
106113961|NCT01889186|366074362|FG001|Overall Study|COVID-19 logistical restrictions|0|||
106113962|NCT01889186|366074361|FG000|Overall Study|Investigator request|1|||
106113963|NCT01889186|366074362|FG001|Overall Study|Investigator request|1|||
105994207|NCT02073682|365637952|FG001|Overall Study|Adverse Event|62|||
105994208|NCT02073682|365637951|FG000|Overall Study|No reason provided|11|||
106113964|NCT01889186|366074361|FG000|Overall Study|Progressive disease- Richter's|12|||
106113965|NCT01889186|366074362|FG001|Overall Study|Progressive disease- Richter's|7|||
106113966|NCT01889186|366074361|FG000|Overall Study|Progressive disease per protocol|46|||
106113967|NCT01889186|366074362|FG001|Overall Study|Progressive disease per protocol|17|||
106113968|NCT01889186|366074361|FG000|Overall Study|Stem cell transplant|2|||
106113969|NCT01889186|366074362|FG001|Overall Study|Stem cell transplant|1|||
106113970|NCT01889186|366074361|FG000|Overall Study|Withdrew consent|2|||
106113971|NCT01889186|366074362|FG001|Overall Study|Withdrew consent|3|||
106113972|NCT01889186|366074361|FG000|Overall Study|Other, not specified|18|||
106113973|NCT01889186|366074362|FG001|Overall Study|Other, not specified|15|||
106113974|NCT04710927|366074363|FG000|Overall Study|Lost to Follow-up|7|||
106113975|NCT04710927|366074364|FG001|Overall Study|Lost to Follow-up|6|||
106113976|NCT04710927|366074365|FG002|Overall Study|Lost to Follow-up|5|||
106113977|NCT00985985|366074366|FG000|Overall Study|Adverse Event|4|||
106113978|NCT00985985|366074367|FG001|Overall Study|Adverse Event|2|||
106113979|NCT00985985|366074368|FG002|Overall Study|Adverse Event|2|||
106113980|NCT00985985|366074369|FG003|Overall Study|Adverse Event|2|||
106113981|NCT00985985|366074366|FG000|Overall Study|Lost to Follow-up|4|||
106113982|NCT00985985|366074367|FG001|Overall Study|Lost to Follow-up|11|||
106113983|NCT00985985|366074368|FG002|Overall Study|Lost to Follow-up|2|||
106113984|NCT00985985|366074369|FG003|Overall Study|Lost to Follow-up|3|||
106113985|NCT00985985|366074366|FG000|Overall Study|Protocol Violation|1|||
106113986|NCT00985985|366074367|FG001|Overall Study|Protocol Violation|2|||
106113987|NCT00985985|366074368|FG002|Overall Study|Protocol Violation|0|||
106113988|NCT00985985|366074369|FG003|Overall Study|Protocol Violation|1|||
106113989|NCT00985985|366074366|FG000|Overall Study|Lack of Efficacy|5|||
106113990|NCT00985985|366074367|FG001|Overall Study|Lack of Efficacy|6|||
106113991|NCT00985985|366074368|FG002|Overall Study|Lack of Efficacy|1|||
106113992|NCT00985985|366074369|FG003|Overall Study|Lack of Efficacy|3|||
106113993|NCT00985985|366074366|FG000|Overall Study|Withdrawal by Subject|4|||
106113994|NCT00985985|366074367|FG001|Overall Study|Withdrawal by Subject|2|||
106113995|NCT00985985|366074368|FG002|Overall Study|Withdrawal by Subject|2|||
106113996|NCT00985985|366074369|FG003|Overall Study|Withdrawal by Subject|2|||
106113997|NCT00985985|366074366|FG000|Overall Study|Other Reason|6|||
106113998|NCT00985985|366074367|FG001|Overall Study|Other Reason|1|||
106113999|NCT00985985|366074368|FG002|Overall Study|Other Reason|4|||
106114000|NCT00985985|366074369|FG003|Overall Study|Other Reason|2|||
106114001|NCT00621543|366074370|FG000|Overall Study|Lost to Follow-up|23|||
106114002|NCT02192970|366074373|FG000|Overall Study|Lost to Follow-up|6|||
106114003|NCT02192970|366074374|FG001|Overall Study|Lost to Follow-up|0|||
106114004|NCT01364597|366074377|FG000|Overall Study|Adverse Event|4|||
106114005|NCT01364597|366074378|FG001|Overall Study|Adverse Event|5|||
106114006|NCT01364597|366074379|FG002|Overall Study|Adverse Event|16|||
106114007|NCT01364597|366074380|FG003|Overall Study|Adverse Event|7|||
106114008|NCT01364597|366074377|FG000|Overall Study|Lack of Efficacy|4|||
106114009|NCT01364597|366074378|FG001|Overall Study|Lack of Efficacy|4|||
106114010|NCT01364597|366074379|FG002|Overall Study|Lack of Efficacy|23|||
106114011|NCT01364597|366074380|FG003|Overall Study|Lack of Efficacy|8|||
106114012|NCT01364597|366074377|FG000|Overall Study|Protocol Violation|0|||
106114013|NCT01364597|366074378|FG001|Overall Study|Protocol Violation|0|||
106114014|NCT01364597|366074379|FG002|Overall Study|Protocol Violation|2|||
106114015|NCT01364597|366074380|FG003|Overall Study|Protocol Violation|0|||
106114016|NCT01364597|366074377|FG000|Overall Study|Lost to Follow-up|0|||
106114017|NCT01364597|366074378|FG001|Overall Study|Lost to Follow-up|0|||
106114018|NCT01364597|366074379|FG002|Overall Study|Lost to Follow-up|5|||
105886057|NCT00723008|365237350|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
105886058|NCT00723008|365237351|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
105886059|NCT00723008|365237350|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
105886060|NCT00723008|365237351|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
105886061|NCT05835011|365237356|FG000|Overall Study|Study Terminated by the Sponsor|1|||
105886062|NCT05835011|365237356|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
105886063|NCT01683266|365237359|FG000|Overall Study|Adverse Event|5|||
105886064|NCT01683266|365237360|FG001|Overall Study|Adverse Event|4|||
106114019|NCT01364597|366074380|FG003|Overall Study|Lost to Follow-up|3|||
106114020|NCT01364597|366074377|FG000|Overall Study|Withdrawal by Subject|4|||
106114021|NCT01364597|366074378|FG001|Overall Study|Withdrawal by Subject|1|||
106114022|NCT01364597|366074379|FG002|Overall Study|Withdrawal by Subject|18|||
106114023|NCT01364597|366074380|FG003|Overall Study|Withdrawal by Subject|6|||
106114024|NCT01364597|366074377|FG000|Overall Study|Non compliance|1|||
106114025|NCT01364597|366074378|FG001|Overall Study|Non compliance|0|||
106114026|NCT01364597|366074379|FG002|Overall Study|Non compliance|1|||
106114027|NCT01364597|366074380|FG003|Overall Study|Non compliance|0|||
105886065|NCT01683266|365237359|FG000|Overall Study|Lack of Efficacy|5|||
106114028|NCT01364597|366074377|FG000|Overall Study|Lack of compliance|1|||
106114029|NCT01364597|366074378|FG001|Overall Study|Lack of compliance|0|||
106114030|NCT01364597|366074379|FG002|Overall Study|Lack of compliance|0|||
105886066|NCT01683266|365237360|FG001|Overall Study|Lack of Efficacy|2|||
106114031|NCT01364597|366074380|FG003|Overall Study|Lack of compliance|0|||
106114032|NCT01364597|366074377|FG000|Overall Study|End of treatment epilepsy|1|||
106114033|NCT01364597|366074378|FG001|Overall Study|End of treatment epilepsy|0|||
106114034|NCT01364597|366074379|FG002|Overall Study|End of treatment epilepsy|0|||
106114035|NCT01364597|366074380|FG003|Overall Study|End of treatment epilepsy|0|||
106114036|NCT01364597|366074377|FG000|Overall Study|No Seizures|1|||
106114037|NCT01364597|366074378|FG001|Overall Study|No Seizures|0|||
106114038|NCT01364597|366074379|FG002|Overall Study|No Seizures|0|||
106114039|NCT01364597|366074380|FG003|Overall Study|No Seizures|0|||
106114040|NCT01364597|366074377|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
106114041|NCT01364597|366074378|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
106114042|NCT01364597|366074379|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
106114043|NCT01364597|366074380|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
106114044|NCT01364597|366074377|FG000|Overall Study|Cure|1|||
106114045|NCT01364597|366074378|FG001|Overall Study|Cure|0|||
106114046|NCT01364597|366074379|FG002|Overall Study|Cure|0|||
106114047|NCT01364597|366074380|FG003|Overall Study|Cure|0|||
105994209|NCT02073682|365637952|FG001|Overall Study|No reason provided|9|||
105994210|NCT02073682|365637951|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
105994211|NCT02073682|365637952|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
105994212|NCT02073682|365637951|FG000|Overall Study|Lost to Follow-up|1|||
105994213|NCT02073682|365637952|FG001|Overall Study|Lost to Follow-up|1|||
105994214|NCT02073682|365637951|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
105994215|NCT02073682|365637952|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
105994216|NCT00855816|365637953|FG000|Overall Study|Withdrawal by Subject|22|||
105994217|NCT00855816|365637954|FG001|Overall Study|Withdrawal by Subject|15|||
105994218|NCT00855816|365637953|FG000|Overall Study|Lost to Follow-up|3|||
105994219|NCT00855816|365637954|FG001|Overall Study|Lost to Follow-up|5|||
105994220|NCT00855816|365637953|FG000|Overall Study|Death|1|||
105994221|NCT00855816|365637954|FG001|Overall Study|Death|0|||
105994222|NCT00855816|365637953|FG000|Overall Study|Became ineligible|0|||
105994223|NCT00855816|365637954|FG001|Overall Study|Became ineligible|1|||
105994224|NCT01076036|365637955|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
105994225|NCT00837213|365637956|FG000|Overall Study|Lost to Follow-up|3|||
105994226|NCT00837213|365637957|FG001|Overall Study|Lost to Follow-up|2|||
105994227|NCT00837213|365637956|FG000|Overall Study|Withdrawal by Subject|2|||
105994228|NCT00837213|365637957|FG001|Overall Study|Withdrawal by Subject|2|||
105994229|NCT00837213|365637956|FG000|Overall Study|not stated|1|||
105994230|NCT00837213|365637957|FG001|Overall Study|not stated|1|||
105994231|NCT02855268|365637958|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
105994232|NCT02855268|365637959|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
105994233|NCT02855268|365637958|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
105994234|NCT02855268|365637959|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
105994235|NCT02855268|365637958|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
105994236|NCT02855268|365637959|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
105994237|NCT02855268|365637958|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
105994238|NCT02855268|365637959|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
105994239|NCT02855268|365637958|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
105994240|NCT02855268|365637959|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
105994241|NCT02855268|365637958|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
105994242|NCT02855268|365637959|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
105994243|NCT04181762|365637967|FG000|Overall Study|Adverse Event|1|||
105994244|NCT04181762|365637968|FG001|Overall Study|Adverse Event|3|||
105994245|NCT04181762|365637967|FG000|Overall Study|Lost to Follow-up|1|||
105994246|NCT04181762|365637968|FG001|Overall Study|Lost to Follow-up|1|||
105994247|NCT04181762|365637967|FG000|Overall Study|Physician Decision|1|||
105994248|NCT04181762|365637968|FG001|Overall Study|Physician Decision|3|||
105994249|NCT04181762|365637967|FG000|Overall Study|Pregnancy|0|||
106114048|NCT01364597|366074377|FG000|Overall Study|Patient was moving|0|||
106114049|NCT01364597|366074378|FG001|Overall Study|Patient was moving|1|||
106114050|NCT01364597|366074379|FG002|Overall Study|Patient was moving|0|||
105994250|NCT04181762|365637968|FG001|Overall Study|Pregnancy|1|||
105994251|NCT04181762|365637967|FG000|Overall Study|Lack of Efficacy|2|||
105994252|NCT04181762|365637968|FG001|Overall Study|Lack of Efficacy|2|||
105994253|NCT04181762|365637967|FG000|Overall Study|Study terminated by sponsor|95|||
105994254|NCT04181762|365637968|FG001|Overall Study|Study terminated by sponsor|97|||
105994255|NCT04181762|365637967|FG000|Overall Study|Subject decision|11|||
105994256|NCT04181762|365637968|FG001|Overall Study|Subject decision|4|||
105994257|NCT04181762|365637967|FG000|Overall Study|Death|1|||
105994258|NCT04181762|365637968|FG001|Overall Study|Death|1|||
105994259|NCT04181762|365637967|FG000|Overall Study|Protocol deviation|1|||
105994260|NCT04181762|365637968|FG001|Overall Study|Protocol deviation|0|||
105994261|NCT04181762|365637967|FG000|Overall Study|Withdrawal of informed consent|1|||
105994262|NCT04181762|365637968|FG001|Overall Study|Withdrawal of informed consent|3|||
105994263|NCT05888181|365637970|FG000|Overall Study|Lost to Follow-up|1|||
105994264|NCT05888181|365637971|FG001|Overall Study|Lost to Follow-up|1|||
105994265|NCT05888181|365637972|FG002|Overall Study|Lost to Follow-up|0|||
105994266|NCT00577824|365637984|FG000|Overall Study|Adverse Event|6|||
105994267|NCT00577824|365637985|FG001|Overall Study|Adverse Event|18|||
105994268|NCT00577824|365637986|FG002|Overall Study|Adverse Event|1|||
105886067|NCT01683266|365237359|FG000|Overall Study|Protocol Violation|13|||
105886068|NCT01683266|365237360|FG001|Overall Study|Protocol Violation|6|||
105886069|NCT01683266|365237359|FG000|Overall Study|Personal Reason|17|||
105886070|NCT01683266|365237360|FG001|Overall Study|Personal Reason|25|||
105886071|NCT01683266|365237359|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
105886072|NCT01683266|365237360|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
105886073|NCT01683266|365237359|FG000|Overall Study|Lost to Follow-up|5|||
105886074|NCT01683266|365237360|FG001|Overall Study|Lost to Follow-up|0|||
105886075|NCT01683266|365237359|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
105886076|NCT01683266|365237360|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
105886077|NCT01683266|365237359|FG000|Overall Study|Nonserious Hypoglycemia|0|||
105886078|NCT01683266|365237360|FG001|Overall Study|Nonserious Hypoglycemia|3|||
105886079|NCT01683266|365237359|FG000|Overall Study|Perceived Lack of Efficacy|1|||
105886080|NCT01683266|365237360|FG001|Overall Study|Perceived Lack of Efficacy|1|||
105886081|NCT01683266|365237359|FG000|Overall Study|Possibly Hypoglycemia|1|||
105886082|NCT01683266|365237360|FG001|Overall Study|Possibly Hypoglycemia|0|||
105886083|NCT01683266|365237359|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
105886084|NCT01683266|365237360|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
105886085|NCT00886743|365237365|FG000|Overall Study|Adverse Event|3|||
105886086|NCT00886743|365237365|FG000|Overall Study|Other|1|||
105886087|NCT05217641|365237366|FG000|Overall Study|Lost to Follow-up|1|||
105886088|NCT05217641|365237367|FG001|Overall Study|Lost to Follow-up|1|||
105886089|NCT05217641|365237368|FG002|Overall Study|Lost to Follow-up|0|||
105886090|NCT05217641|365237369|FG003|Overall Study|Lost to Follow-up|1|||
105886091|NCT05217641|365237370|FG004|Overall Study|Lost to Follow-up|1|||
105886092|NCT05217641|365237371|FG005|Overall Study|Lost to Follow-up|0|||
105886093|NCT05217641|365237366|FG000|Overall Study|Withdrawal by Subject|0|||
105886094|NCT05217641|365237367|FG001|Overall Study|Withdrawal by Subject|0|||
105886095|NCT05217641|365237368|FG002|Overall Study|Withdrawal by Subject|0|||
105994269|NCT00577824|365637984|FG000|Overall Study|Patient decision|0|||
105994270|NCT00577824|365637985|FG001|Overall Study|Patient decision|1|||
105994271|NCT00577824|365637986|FG002|Overall Study|Patient decision|1|||
105994272|NCT00577824|365637984|FG000|Overall Study|Protocol Violation|1|||
105994273|NCT00577824|365637985|FG001|Overall Study|Protocol Violation|1|||
105994274|NCT00577824|365637986|FG002|Overall Study|Protocol Violation|0|||
105994275|NCT00836186|365637987|FG000|Overall Study|Blood could not be drawn|1|||
105994276|NCT04137731|365637988|FG000|Overall Study|Surgery Cancellation|1|||
105994277|NCT04137731|365637989|FG001|Overall Study|Surgery Cancellation|2|||
105994278|NCT04137731|365637988|FG000|Overall Study|Withdrawal by Subject|2|||
105886096|NCT05217641|365237369|FG003|Overall Study|Withdrawal by Subject|3|||
105886097|NCT05217641|365237370|FG004|Overall Study|Withdrawal by Subject|1|||
105886098|NCT05217641|365237371|FG005|Overall Study|Withdrawal by Subject|0|||
105886099|NCT05217641|365237366|FG000|Overall Study|Other: participant did not specify reason|0|||
105886100|NCT05217641|365237367|FG001|Overall Study|Other: participant did not specify reason|0|||
105886101|NCT05217641|365237368|FG002|Overall Study|Other: participant did not specify reason|0|||
105886102|NCT05217641|365237369|FG003|Overall Study|Other: participant did not specify reason|0|||
105886103|NCT05217641|365237370|FG004|Overall Study|Other: participant did not specify reason|1|||
105994279|NCT04137731|365637989|FG001|Overall Study|Withdrawal by Subject|0|||
105994280|NCT04137731|365637988|FG000|Overall Study|Protocol Violation|0|||
105994281|NCT04137731|365637989|FG001|Overall Study|Protocol Violation|1|||
105994282|NCT02717611|365638002|FG000|Overall Study|Death|13|||
105886104|NCT05217641|365237371|FG005|Overall Study|Other: participant did not specify reason|0|||
105886105|NCT05217641|365237366|FG000|Overall Study|Extended Follow up|1|||
105886106|NCT05217641|365237367|FG001|Overall Study|Extended Follow up|1|||
105886107|NCT05217641|365237368|FG002|Overall Study|Extended Follow up|0|||
105886108|NCT05217641|365237369|FG003|Overall Study|Extended Follow up|0|||
105886109|NCT05217641|365237370|FG004|Overall Study|Extended Follow up|1|||
105886110|NCT05217641|365237371|FG005|Overall Study|Extended Follow up|0|||
105886111|NCT00626821|365237375|FG000|Overall Study|Adverse Event|44|||
105886112|NCT00626821|365237375|FG000|Overall Study|Protocol Violation|33|||
105886113|NCT00626821|365237375|FG000|Overall Study|Withdrawal by Subject|10|||
105886114|NCT00626821|365237375|FG000|Overall Study|Physician Decision|9|||
106114051|NCT01364597|366074380|FG003|Overall Study|Patient was moving|0|||
106114052|NCT01364597|366074377|FG000|Overall Study|Seizures resolved|0|||
105886115|NCT00626821|365237375|FG000|Overall Study|Product dysfunction|21|||
105886116|NCT00626821|365237375|FG000|Overall Study|other/unknown reason|104|||
105886117|NCT02632409|365237380|FG000|Randomized|AE unrelated to study Drug|0|||
105886118|NCT02632409|365237381|FG001|Randomized|AE unrelated to study Drug|1|||
105886119|NCT02632409|365237380|FG000|Randomized|Participant withdrew consent|2|||
105886120|NCT02632409|365237381|FG001|Randomized|Participant withdrew consent|1|||
105886121|NCT02632409|365237380|FG000|Randomized|No Longer meets study criteria|5|||
105994283|NCT02717611|365638002|FG000|Overall Study|Withdrawal by Subject|6|||
105994284|NCT02717611|365638002|FG000|Overall Study|Active, not recruiting|40|||
105994285|NCT02717611|365638002|FG000|Overall Study|Complicating disease|1|||
105994286|NCT01587040|365638003|FG000|Overall Study|Protocol Violation|0|||
106114053|NCT01364597|366074378|FG001|Overall Study|Seizures resolved|0|||
105886122|NCT02632409|365237381|FG001|Randomized|No Longer meets study criteria|0|||
105886123|NCT02632409|365237380|FG000|Randomized|other reasons|1|||
105886124|NCT02632409|365237381|FG001|Randomized|other reasons|0|||
105886125|NCT02632409|365237380|FG000|Treatment Period|Ongoing Treatment|20|||
105886126|NCT02632409|365237381|FG001|Treatment Period|Ongoing Treatment|21|||
105886127|NCT02632409|365237380|FG000|Treatment Period|Disease Recurrence|147|||
105886128|NCT02632409|365237381|FG001|Treatment Period|Disease Recurrence|90|||
105886129|NCT02632409|365237380|FG000|Treatment Period|Study Drug Toxicity|8|||
105886130|NCT02632409|365237381|FG001|Treatment Period|Study Drug Toxicity|49|||
105886131|NCT02632409|365237380|FG000|Treatment Period|Death|1|||
105886132|NCT02632409|365237381|FG001|Treatment Period|Death|0|||
105886133|NCT02632409|365237380|FG000|Treatment Period|AE unrelated to study drug|15|||
105886134|NCT02632409|365237381|FG001|Treatment Period|AE unrelated to study drug|16|||
105886135|NCT02632409|365237380|FG000|Treatment Period|Request to discontinue treatment|4|||
105886136|NCT02632409|365237381|FG001|Treatment Period|Request to discontinue treatment|19|||
105886137|NCT02632409|365237380|FG000|Treatment Period|Participant withdrew consent|7|||
105886138|NCT02632409|365237381|FG001|Treatment Period|Participant withdrew consent|5|||
105886139|NCT02632409|365237380|FG000|Treatment Period|Lost to Follow-up|0|||
105886140|NCT02632409|365237381|FG001|Treatment Period|Lost to Follow-up|1|||
105886141|NCT02632409|365237380|FG000|Treatment Period|Maximum clinical benefit|1|||
105886142|NCT02632409|365237381|FG001|Treatment Period|Maximum clinical benefit|0|||
105886143|NCT02632409|365237380|FG000|Treatment Period|No longer meets study criteria|3|||
105886144|NCT02632409|365237381|FG001|Treatment Period|No longer meets study criteria|0|||
105886145|NCT02632409|365237380|FG000|Treatment Period|Administrative Reason by sponsor|0|||
105886146|NCT02632409|365237381|FG001|Treatment Period|Administrative Reason by sponsor|1|||
105886147|NCT02632409|365237380|FG000|Treatment Period|Other Reasons|10|||
105886148|NCT02632409|365237381|FG001|Treatment Period|Other Reasons|6|||
105886149|NCT00090220|365237383|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
105886150|NCT00090220|365237384|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
105886151|NCT00090220|365237385|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105886152|NCT00090220|365237386|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105886153|NCT00090220|365237387|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105886154|NCT00090220|365237388|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
105886155|NCT00090220|365237383|FG000|Base Study Vaccination Period|Adverse Event|6|||
105886156|NCT00090220|365237384|FG001|Base Study Vaccination Period|Adverse Event|1|||
105886157|NCT00090220|365237385|FG002|Base Study Vaccination Period|Adverse Event|0|||
105886158|NCT00090220|365237386|FG003|Base Study Vaccination Period|Adverse Event|0|||
105886159|NCT00090220|365237387|FG004|Base Study Vaccination Period|Adverse Event|0|||
105886160|NCT00090220|365237388|FG005|Base Study Vaccination Period|Adverse Event|0|||
105886161|NCT00090220|365237383|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
105886162|NCT00090220|365237384|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
105886163|NCT00090220|365237385|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
105886164|NCT00090220|365237386|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
105886165|NCT00090220|365237387|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
105886166|NCT00090220|365237388|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
105886167|NCT00090220|365237383|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
105886168|NCT00090220|365237384|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
105886169|NCT00090220|365237385|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
105886170|NCT00090220|365237386|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
105994287|NCT01587040|365638004|FG001|Overall Study|Protocol Violation|0|||
105994288|NCT01587040|365638005|FG002|Overall Study|Protocol Violation|1|||
105994289|NCT01587040|365638006|FG003|Overall Study|Protocol Violation|0|||
105994290|NCT01587040|365638003|FG000|Overall Study|Adverse Event|0|||
105994291|NCT01587040|365638004|FG001|Overall Study|Adverse Event|1|||
105994292|NCT01587040|365638005|FG002|Overall Study|Adverse Event|10|||
105994293|NCT01587040|365638006|FG003|Overall Study|Adverse Event|0|||
105994294|NCT01587040|365638003|FG000|Overall Study|Disease progression|12|||
105994295|NCT01587040|365638004|FG001|Overall Study|Disease progression|1|||
106114054|NCT01364597|366074379|FG002|Overall Study|Seizures resolved|1|||
105886171|NCT00090220|365237387|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
105886172|NCT00090220|365237388|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
105994296|NCT01587040|365638005|FG002|Overall Study|Disease progression|15|||
106114055|NCT01364597|366074380|FG003|Overall Study|Seizures resolved|0|||
106114056|NCT01364597|366074377|FG000|Overall Study|Patient became seizure-free after surgery|0|||
106114057|NCT01364597|366074378|FG001|Overall Study|Patient became seizure-free after surgery|0|||
105886173|NCT00090220|365237383|FG000|Base Study Vaccination Period|Patient Moved|6|||
105886174|NCT00090220|365237384|FG001|Base Study Vaccination Period|Patient Moved|2|||
105886175|NCT00090220|365237385|FG002|Base Study Vaccination Period|Patient Moved|0|||
105886176|NCT00090220|365237386|FG003|Base Study Vaccination Period|Patient Moved|0|||
105994297|NCT01587040|365638006|FG003|Overall Study|Disease progression|3|||
105994298|NCT01587040|365638003|FG000|Overall Study|Other than specified|5|||
105994299|NCT01587040|365638004|FG001|Overall Study|Other than specified|1|||
105994300|NCT01587040|365638005|FG002|Overall Study|Other than specified|11|||
105886177|NCT00090220|365237387|FG004|Base Study Vaccination Period|Patient Moved|0|||
105886178|NCT00090220|365237388|FG005|Base Study Vaccination Period|Patient Moved|0|||
105886179|NCT00090220|365237383|FG000|Base Study Vaccination Period|Other|4|||
105886180|NCT00090220|365237384|FG001|Base Study Vaccination Period|Other|4|||
105886181|NCT00090220|365237385|FG002|Base Study Vaccination Period|Other|0|||
105886182|NCT00090220|365237386|FG003|Base Study Vaccination Period|Other|0|||
105886183|NCT00090220|365237387|FG004|Base Study Vaccination Period|Other|0|||
105886184|NCT00090220|365237388|FG005|Base Study Vaccination Period|Other|0|||
105886185|NCT00090220|365237383|FG000|Base Study Follow-up Period|Adverse Event|6|||
105886186|NCT00090220|365237384|FG001|Base Study Follow-up Period|Adverse Event|1|||
105886187|NCT00090220|365237385|FG002|Base Study Follow-up Period|Adverse Event|0|||
105886188|NCT00090220|365237386|FG003|Base Study Follow-up Period|Adverse Event|0|||
105886189|NCT00090220|365237387|FG004|Base Study Follow-up Period|Adverse Event|0|||
105886190|NCT00090220|365237388|FG005|Base Study Follow-up Period|Adverse Event|0|||
105886191|NCT00090220|365237383|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
105886192|NCT00090220|365237384|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
105886193|NCT00090220|365237385|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
105886194|NCT00090220|365237386|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
105886195|NCT00090220|365237387|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
105886196|NCT00090220|365237388|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
105886197|NCT00090220|365237383|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
105886198|NCT00090220|365237384|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
105886199|NCT00090220|365237385|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
105886200|NCT00090220|365237386|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
105886201|NCT00090220|365237387|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
105886202|NCT00090220|365237388|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
105886203|NCT00090220|365237383|FG000|Base Study Follow-up Period|Patient Moved|20|||
105886204|NCT00090220|365237384|FG001|Base Study Follow-up Period|Patient Moved|28|||
105886205|NCT00090220|365237385|FG002|Base Study Follow-up Period|Patient Moved|0|||
105886206|NCT00090220|365237386|FG003|Base Study Follow-up Period|Patient Moved|0|||
105886207|NCT00090220|365237387|FG004|Base Study Follow-up Period|Patient Moved|0|||
105886208|NCT00090220|365237388|FG005|Base Study Follow-up Period|Patient Moved|0|||
105886209|NCT00090220|365237383|FG000|Base Study Follow-up Period|Other|19|||
105886210|NCT00090220|365237384|FG001|Base Study Follow-up Period|Other|21|||
105886211|NCT00090220|365237385|FG002|Base Study Follow-up Period|Other|0|||
105886212|NCT00090220|365237386|FG003|Base Study Follow-up Period|Other|0|||
105886213|NCT00090220|365237387|FG004|Base Study Follow-up Period|Other|0|||
105886214|NCT00090220|365237388|FG005|Base Study Follow-up Period|Other|0|||
105886215|NCT00090220|365237383|FG000|Extension 1 (EXT1)|Adverse Event|0|||
105886216|NCT00090220|365237384|FG001|Extension 1 (EXT1)|Adverse Event|0|||
105886217|NCT00090220|365237385|FG002|Extension 1 (EXT1)|Adverse Event|4|||
105886218|NCT00090220|365237386|FG003|Extension 1 (EXT1)|Adverse Event|0|||
105886219|NCT00090220|365237387|FG004|Extension 1 (EXT1)|Adverse Event|0|||
105886220|NCT00090220|365237388|FG005|Extension 1 (EXT1)|Adverse Event|0|||
105886221|NCT00090220|365237383|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
105886222|NCT00090220|365237384|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
105886223|NCT00090220|365237385|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
105886224|NCT00090220|365237386|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
105886225|NCT00090220|365237387|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
105886226|NCT00090220|365237388|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
105886227|NCT00090220|365237383|FG000|Extension 1 (EXT1)|Moved|0|||
105886228|NCT00090220|365237384|FG001|Extension 1 (EXT1)|Moved|0|||
105886229|NCT00090220|365237385|FG002|Extension 1 (EXT1)|Moved|2|||
105886230|NCT00090220|365237386|FG003|Extension 1 (EXT1)|Moved|1|||
105886231|NCT00090220|365237387|FG004|Extension 1 (EXT1)|Moved|0|||
105886232|NCT00090220|365237388|FG005|Extension 1 (EXT1)|Moved|0|||
105886233|NCT00090220|365237383|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105886234|NCT00090220|365237384|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105886235|NCT00090220|365237385|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
105886236|NCT00090220|365237386|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105886237|NCT00090220|365237387|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105886238|NCT00090220|365237388|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
105886239|NCT00090220|365237383|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
105886240|NCT00090220|365237384|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
105886241|NCT00090220|365237385|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
105886242|NCT00090220|365237386|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
105886243|NCT00090220|365237387|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
105886244|NCT00090220|365237388|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
105886245|NCT00090220|365237383|FG000|Extension 1 (EXT1)|Other reason|0|||
105886246|NCT00090220|365237384|FG001|Extension 1 (EXT1)|Other reason|0|||
105886247|NCT00090220|365237385|FG002|Extension 1 (EXT1)|Other reason|2|||
105886248|NCT00090220|365237386|FG003|Extension 1 (EXT1)|Other reason|0|||
105886249|NCT00090220|365237387|FG004|Extension 1 (EXT1)|Other reason|0|||
105886250|NCT00090220|365237388|FG005|Extension 1 (EXT1)|Other reason|0|||
105886251|NCT00090220|365237383|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105886252|NCT00090220|365237384|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105886253|NCT00090220|365237385|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105886254|NCT00090220|365237386|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105886255|NCT00090220|365237387|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
105886256|NCT00090220|365237388|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
105886257|NCT00090220|365237383|FG000|Long-term Follow-up (EXT2)|Death|0|||
105886258|NCT00090220|365237384|FG001|Long-term Follow-up (EXT2)|Death|0|||
105886259|NCT00090220|365237385|FG002|Long-term Follow-up (EXT2)|Death|0|||
105886260|NCT00090220|365237386|FG003|Long-term Follow-up (EXT2)|Death|0|||
105886261|NCT00090220|365237387|FG004|Long-term Follow-up (EXT2)|Death|1|||
105886262|NCT00090220|365237388|FG005|Long-term Follow-up (EXT2)|Death|1|||
105886263|NCT00090220|365237383|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105886264|NCT00090220|365237384|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105886265|NCT00090220|365237385|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105886266|NCT00090220|365237386|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105886267|NCT00090220|365237387|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
105886268|NCT00090220|365237388|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
105886269|NCT00090220|365237383|FG000|Long-term Follow-up (EXT2)|Other|0|||
105886270|NCT00090220|365237384|FG001|Long-term Follow-up (EXT2)|Other|0|||
105886271|NCT00090220|365237385|FG002|Long-term Follow-up (EXT2)|Other|0|||
105886272|NCT00090220|365237386|FG003|Long-term Follow-up (EXT2)|Other|0|||
105886273|NCT00090220|365237387|FG004|Long-term Follow-up (EXT2)|Other|1|||
105886274|NCT00090220|365237388|FG005|Long-term Follow-up (EXT2)|Other|0|||
105886275|NCT01062113|365237389|FG000|Overall Study|Adverse Event|1|||
105886276|NCT01062113|365237390|FG001|Overall Study|Adverse Event|0|||
105886277|NCT01062113|365237391|FG002|Overall Study|Adverse Event|0|||
105886278|NCT01062113|365237389|FG000|Overall Study|Lack of Efficacy|38|||
105886279|NCT01062113|365237390|FG001|Overall Study|Lack of Efficacy|22|||
105886280|NCT01062113|365237391|FG002|Overall Study|Lack of Efficacy|31|||
105886281|NCT01062113|365237389|FG000|Overall Study|Withdrawal by Subject|1|||
105886282|NCT01062113|365237390|FG001|Overall Study|Withdrawal by Subject|0|||
105886283|NCT01062113|365237391|FG002|Overall Study|Withdrawal by Subject|0|||
105886284|NCT03521115|365237392|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
105886285|NCT03521115|365237393|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
105886286|NCT03521115|365237392|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
105886287|NCT03521115|365237393|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
105886288|NCT01471340|365237395|FG000|Overall Study|Death|5|||
105886289|NCT01471340|365237396|FG001|Overall Study|Death|4|||
105886290|NCT01471340|365237395|FG000|Overall Study|Lost to Follow-up|0|||
105886291|NCT01471340|365237396|FG001|Overall Study|Lost to Follow-up|1|||
105886292|NCT01471340|365237395|FG000|Overall Study|Investigational site closure|0|||
105886293|NCT01471340|365237396|FG001|Overall Study|Investigational site closure|1|||
105886294|NCT01471340|365237395|FG000|Overall Study|Invalid informed consent|1|||
105886295|NCT01471340|365237396|FG001|Overall Study|Invalid informed consent|0|||
105886296|NCT02475265|365237397|FG000|Overall Study|Physician Decision|1|||
105886297|NCT02475265|365237397|FG000|Overall Study|Withdrawal by Subject|2|||
105886298|NCT00526669|365237398|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
105886299|NCT00526669|365237399|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
105886300|NCT00526669|365237398|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
105886301|NCT00526669|365237399|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
105886302|NCT00526669|365237398|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
105886303|NCT00526669|365237399|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
105886304|NCT00526669|365237398|FG000|Combined Treatment Phase|Death|0|||
105886305|NCT00526669|365237399|FG001|Combined Treatment Phase|Death|2|||
105886306|NCT03499899|365237400|FG000|Overall Study|Adverse Event|2|||
105886307|NCT03499899|365237401|FG001|Overall Study|Adverse Event|3|||
105886308|NCT03499899|365237402|FG002|Overall Study|Adverse Event|3|||
105886309|NCT03499899|365237400|FG000|Overall Study|Death|0|||
105886310|NCT03499899|365237401|FG001|Overall Study|Death|0|||
105886311|NCT03499899|365237402|FG002|Overall Study|Death|1|||
105886312|NCT03499899|365237400|FG000|Overall Study|Physician Decision|3|||
105886313|NCT03499899|365237401|FG001|Overall Study|Physician Decision|6|||
105886314|NCT03499899|365237402|FG002|Overall Study|Physician Decision|6|||
105994301|NCT01587040|365638006|FG003|Overall Study|Other than specified|1|||
105994302|NCT03724890|365638007|FG000|Overall Study|Death|2|||
106114058|NCT01364597|366074379|FG002|Overall Study|Patient became seizure-free after surgery|1|||
106114059|NCT01364597|366074380|FG003|Overall Study|Patient became seizure-free after surgery|0|||
105661749|NCT01068210|364425130|FG000|Overall Study|Lost to Follow-up|1|||
105886315|NCT03499899|365237400|FG000|Overall Study|Progressive disease|15|||
105886316|NCT03499899|365237401|FG001|Overall Study|Progressive disease|23|||
105886317|NCT03499899|365237402|FG002|Overall Study|Progressive disease|23|||
105886318|NCT03499899|365237400|FG000|Overall Study|Patient decision|0|||
105886319|NCT03499899|365237401|FG001|Overall Study|Patient decision|1|||
105886320|NCT03499899|365237402|FG002|Overall Study|Patient decision|1|||
105886321|NCT03499899|365237400|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
105886322|NCT03499899|365237401|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
105886323|NCT03499899|365237402|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
106114060|NCT01364597|366074377|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
106114061|NCT01364597|366074378|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
106114062|NCT01364597|366074379|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
106114063|NCT01364597|366074380|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
106114064|NCT01364597|366074377|FG000|Overall Study|Patient cured from Epilepsy|0|||
106114065|NCT01364597|366074378|FG001|Overall Study|Patient cured from Epilepsy|0|||
106114066|NCT01364597|366074379|FG002|Overall Study|Patient cured from Epilepsy|1|||
106114067|NCT01364597|366074380|FG003|Overall Study|Patient cured from Epilepsy|0|||
106114068|NCT01364597|366074377|FG000|Overall Study|Investigator decision|0|||
106114069|NCT01364597|366074378|FG001|Overall Study|Investigator decision|0|||
106114070|NCT01364597|366074379|FG002|Overall Study|Investigator decision|1|||
106114071|NCT01364597|366074380|FG003|Overall Study|Investigator decision|0|||
106114072|NCT01364597|366074377|FG000|Overall Study|Sponsor recommended discontinuation|0|||
106114073|NCT01364597|366074378|FG001|Overall Study|Sponsor recommended discontinuation|0|||
106114074|NCT01364597|366074379|FG002|Overall Study|Sponsor recommended discontinuation|0|||
106114075|NCT01364597|366074380|FG003|Overall Study|Sponsor recommended discontinuation|1|||
106114076|NCT01364597|366074377|FG000|Overall Study|Parents went abroad with the patient|0|||
106114077|NCT01364597|366074378|FG001|Overall Study|Parents went abroad with the patient|0|||
106114078|NCT01364597|366074379|FG002|Overall Study|Parents went abroad with the patient|1|||
106114079|NCT01364597|366074380|FG003|Overall Study|Parents went abroad with the patient|0|||
106114080|NCT01364597|366074377|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
106114081|NCT01364597|366074378|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
106114082|NCT01364597|366074379|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
106114083|NCT01364597|366074380|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
106114084|NCT01364597|366074377|FG000|Overall Study|BRV administration dropout|0|||
106114085|NCT01364597|366074378|FG001|Overall Study|BRV administration dropout|0|||
106114086|NCT01364597|366074379|FG002|Overall Study|BRV administration dropout|1|||
105886324|NCT03557931|365237415|FG000|Overall Study|Adverse Event|4|||
105886325|NCT03557931|365237416|FG001|Overall Study|Adverse Event|6|||
105886326|NCT03557931|365237417|FG002|Overall Study|Adverse Event|1|||
105886327|NCT03557931|365237415|FG000|Overall Study|Lost to Follow-up|4|||
105886328|NCT03557931|365237416|FG001|Overall Study|Lost to Follow-up|4|||
105886329|NCT03557931|365237417|FG002|Overall Study|Lost to Follow-up|1|||
105886330|NCT03557931|365237415|FG000|Overall Study|Protocol Violation|1|||
105886331|NCT03557931|365237416|FG001|Overall Study|Protocol Violation|4|||
105886332|NCT03557931|365237417|FG002|Overall Study|Protocol Violation|1|||
105886333|NCT03557931|365237415|FG000|Overall Study|Withdrawal by Subject|14|||
105886334|NCT03557931|365237416|FG001|Overall Study|Withdrawal by Subject|0|||
105886335|NCT03557931|365237417|FG002|Overall Study|Withdrawal by Subject|7|||
105886336|NCT03557931|365237415|FG000|Overall Study|Miscellaneous|8|||
105886337|NCT03557931|365237416|FG001|Overall Study|Miscellaneous|5|||
105886338|NCT03557931|365237417|FG002|Overall Study|Miscellaneous|3|||
105886339|NCT02353442|365237420|FG000|Overall Study|Withdrawal by Subject|3|||
105886340|NCT02353442|365237421|FG001|Overall Study|Withdrawal by Subject|4|||
105886341|NCT06586788|365237422|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
105886342|NCT03514485|365237423|FG000|Overall Study|Lost to Follow-up|5|||
105886343|NCT03514485|365237424|FG001|Overall Study|Lost to Follow-up|3|||
105886344|NCT03514485|365237425|FG002|Overall Study|Lost to Follow-up|2|||
105886345|NCT03514485|365237426|FG003|Overall Study|Lost to Follow-up|0|||
105886346|NCT03514485|365237427|FG004|Overall Study|Lost to Follow-up|1|||
105886347|NCT03514485|365237428|FG005|Overall Study|Lost to Follow-up|4|||
105886348|NCT03514485|365237423|FG000|Overall Study|Withdrawal by Subject|0|||
105886349|NCT03514485|365237424|FG001|Overall Study|Withdrawal by Subject|1|||
105886350|NCT03514485|365237425|FG002|Overall Study|Withdrawal by Subject|3|||
105886351|NCT03514485|365237426|FG003|Overall Study|Withdrawal by Subject|1|||
105886352|NCT03514485|365237427|FG004|Overall Study|Withdrawal by Subject|2|||
105886353|NCT03514485|365237428|FG005|Overall Study|Withdrawal by Subject|1|||
105886354|NCT01878084|365237431|FG000|Overall Study|Physician Decision|2|||
105886355|NCT03605862|365237432|FG000|Overall Study|Withdrawal by Subject|12|||
105886356|NCT03605862|365237433|FG001|Overall Study|Withdrawal by Subject|9|||
105886357|NCT03605862|365237432|FG000|Overall Study|Adverse Event|2|||
105886358|NCT03605862|365237433|FG001|Overall Study|Adverse Event|1|||
105886359|NCT03605862|365237432|FG000|Overall Study|Physician Decision|3|||
105886360|NCT03605862|365237433|FG001|Overall Study|Physician Decision|1|||
105886361|NCT03605862|365237432|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
105886362|NCT03605862|365237433|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
105886363|NCT03891862|365237434|FG000|Open-label Period|Adverse Event|2|||
105886364|NCT03891862|365237435|FG001|Open-label Period|Adverse Event|0|||
105886365|NCT03891862|365237436|FG002|Open-label Period|Adverse Event|0|||
105886366|NCT03891862|365237434|FG000|Open-label Period|Protocol Violation|5|||
106114087|NCT01364597|366074380|FG003|Overall Study|BRV administration dropout|0|||
106114088|NCT01364597|366074377|FG000|Overall Study|Dropout|0|||
106114089|NCT01364597|366074378|FG001|Overall Study|Dropout|0|||
105994303|NCT03724890|365638008|FG001|Overall Study|Death|6|||
105994304|NCT03724890|365638009|FG002|Overall Study|Death|3|||
105994305|NCT03724890|365638010|FG003|Overall Study|Death|5|||
105994306|NCT03724890|365638011|FG004|Overall Study|Death|2|||
105994307|NCT03724890|365638012|FG005|Overall Study|Death|0|||
105994308|NCT03724890|365638013|FG006|Overall Study|Death|2|||
105994309|NCT03724890|365638014|FG007|Overall Study|Death|3|||
105994310|NCT03724890|365638015|FG008|Overall Study|Death|4|||
105994311|NCT03724890|365638016|FG009|Overall Study|Death|2|||
105994312|NCT03724890|365638017|FG010|Overall Study|Death|2|||
105994313|NCT03724890|365638007|FG000|Overall Study|Lost to Follow-up|0|||
105994314|NCT03724890|365638008|FG001|Overall Study|Lost to Follow-up|3|||
105994315|NCT03724890|365638009|FG002|Overall Study|Lost to Follow-up|0|||
105994316|NCT03724890|365638010|FG003|Overall Study|Lost to Follow-up|1|||
105994317|NCT03724890|365638011|FG004|Overall Study|Lost to Follow-up|2|||
105994318|NCT03724890|365638012|FG005|Overall Study|Lost to Follow-up|2|||
105886367|NCT03891862|365237435|FG001|Open-label Period|Protocol Violation|0|||
105886368|NCT03891862|365237436|FG002|Open-label Period|Protocol Violation|0|||
105886369|NCT03891862|365237434|FG000|Open-label Period|Withdrawal by Subject|6|||
105886370|NCT03891862|365237435|FG001|Open-label Period|Withdrawal by Subject|0|||
105886371|NCT03891862|365237436|FG002|Open-label Period|Withdrawal by Subject|0|||
105886372|NCT03891862|365237434|FG000|Open-label Period|Death|1|||
105886373|NCT03891862|365237435|FG001|Open-label Period|Death|0|||
105886374|NCT03891862|365237436|FG002|Open-label Period|Death|0|||
105886375|NCT03891862|365237434|FG000|Open-label Period|Lost to Follow-up|2|||
105886376|NCT03891862|365237435|FG001|Open-label Period|Lost to Follow-up|0|||
105886377|NCT03891862|365237436|FG002|Open-label Period|Lost to Follow-up|0|||
105886378|NCT03891862|365237434|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
105886379|NCT03891862|365237435|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
105886380|NCT03891862|365237436|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
105886381|NCT03891862|365237434|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
105886382|NCT03891862|365237435|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
105886383|NCT03891862|365237436|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
105886384|NCT03891862|365237434|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
105886385|NCT03891862|365237435|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
105886386|NCT03891862|365237436|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
105886387|NCT03891862|365237434|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
105886388|NCT03891862|365237435|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
105886389|NCT03891862|365237436|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
105886390|NCT05239494|365237437|FG000|Overall Study|Lost to Follow-up|1|||
105886391|NCT01194531|365237438|FG000|Overall Study|Withdrawal by Subject|1|||
105886392|NCT01194531|365237439|FG001|Overall Study|Withdrawal by Subject|0|||
105886393|NCT01194531|365237438|FG000|Overall Study|Protocol Violation|4|||
105886394|NCT01194531|365237439|FG001|Overall Study|Protocol Violation|1|||
105886395|NCT01194531|365237438|FG000|Overall Study|Physician Decision|0|||
105886396|NCT01194531|365237439|FG001|Overall Study|Physician Decision|2|||
105886397|NCT04143594|365237442|FG000|Overall Study|Withdrew consent|3|||
105886398|NCT04143594|365237443|FG001|Overall Study|Withdrew consent|10|||
105886399|NCT04143594|365237444|FG002|Overall Study|Withdrew consent|3|||
105886400|NCT04143594|365237445|FG003|Overall Study|Withdrew consent|1|||
105886401|NCT04143594|365237442|FG000|Overall Study|Lost to Follow-up|3|||
105886402|NCT04143594|365237443|FG001|Overall Study|Lost to Follow-up|5|||
105886403|NCT04143594|365237444|FG002|Overall Study|Lost to Follow-up|11|||
105886404|NCT04143594|365237445|FG003|Overall Study|Lost to Follow-up|0|||
105886405|NCT04143594|365237442|FG000|Overall Study|Investigator's discretion|2|||
105886406|NCT04143594|365237443|FG001|Overall Study|Investigator's discretion|2|||
105886407|NCT04143594|365237444|FG002|Overall Study|Investigator's discretion|0|||
105886408|NCT04143594|365237445|FG003|Overall Study|Investigator's discretion|0|||
105886409|NCT04143594|365237442|FG000|Overall Study|Randomized but never treated|0|||
105886410|NCT04143594|365237443|FG001|Overall Study|Randomized but never treated|0|||
105994319|NCT03724890|365638013|FG006|Overall Study|Lost to Follow-up|1|||
105994320|NCT03724890|365638014|FG007|Overall Study|Lost to Follow-up|0|||
105994321|NCT03724890|365638015|FG008|Overall Study|Lost to Follow-up|2|||
105886411|NCT04143594|365237444|FG002|Overall Study|Randomized but never treated|0|||
105994322|NCT03724890|365638016|FG009|Overall Study|Lost to Follow-up|0|||
105994323|NCT03724890|365638017|FG010|Overall Study|Lost to Follow-up|0|||
105886412|NCT04143594|365237445|FG003|Overall Study|Randomized but never treated|1|||
105886413|NCT04143594|365237442|FG000|Overall Study|Death|1|||
105886414|NCT04143594|365237443|FG001|Overall Study|Death|0|||
105886415|NCT04143594|365237444|FG002|Overall Study|Death|1|||
105994324|NCT03724890|365638007|FG000|Overall Study|Withdrawal by Subject|1|||
105994325|NCT03724890|365638008|FG001|Overall Study|Withdrawal by Subject|2|||
105994326|NCT03724890|365638009|FG002|Overall Study|Withdrawal by Subject|1|||
105994327|NCT03724890|365638010|FG003|Overall Study|Withdrawal by Subject|0|||
105994328|NCT03724890|365638011|FG004|Overall Study|Withdrawal by Subject|0|||
105994329|NCT03724890|365638012|FG005|Overall Study|Withdrawal by Subject|1|||
106114090|NCT01364597|366074379|FG002|Overall Study|Dropout|3|||
105886416|NCT04143594|365237445|FG003|Overall Study|Death|0|||
105886417|NCT04143594|365237442|FG000|Overall Study|Adverse Event|1|||
105886418|NCT04143594|365237443|FG001|Overall Study|Adverse Event|0|||
105886419|NCT04143594|365237444|FG002|Overall Study|Adverse Event|0|||
105886420|NCT04143594|365237445|FG003|Overall Study|Adverse Event|0|||
105886421|NCT04143594|365237442|FG000|Overall Study|Pregnancy|0|||
105886422|NCT04143594|365237443|FG001|Overall Study|Pregnancy|0|||
106114091|NCT01364597|366074380|FG003|Overall Study|Dropout|1|||
106114092|NCT01364597|366074377|FG000|Overall Study|Unreliable subject|0|||
106114093|NCT01364597|366074378|FG001|Overall Study|Unreliable subject|0|||
106114094|NCT01364597|366074379|FG002|Overall Study|Unreliable subject|0|||
106114095|NCT01364597|366074380|FG003|Overall Study|Unreliable subject|1|||
106114096|NCT01364597|366074377|FG000|Overall Study|Other|0|||
106114097|NCT01364597|366074378|FG001|Overall Study|Other|0|||
106114098|NCT01364597|366074379|FG002|Overall Study|Other|0|||
105886423|NCT04143594|365237444|FG002|Overall Study|Pregnancy|1|||
105886424|NCT04143594|365237445|FG003|Overall Study|Pregnancy|0|||
105886425|NCT04143594|365237442|FG000|Overall Study|Lack of Efficacy|1|||
105886426|NCT04143594|365237443|FG001|Overall Study|Lack of Efficacy|1|||
105886427|NCT04143594|365237444|FG002|Overall Study|Lack of Efficacy|0|||
105886428|NCT04143594|365237445|FG003|Overall Study|Lack of Efficacy|0|||
105886429|NCT01054196|365237449|FG000|Overall Study|Physician Decision|0|||
105886430|NCT01054196|365237450|FG001|Overall Study|Physician Decision|0|||
106114099|NCT01364597|366074380|FG003|Overall Study|Other|1|||
105886431|NCT01054196|365237451|FG002|Overall Study|Physician Decision|0|||
105886432|NCT01054196|365237452|FG003|Overall Study|Physician Decision|1|||
105886433|NCT01054196|365237453|FG004|Overall Study|Physician Decision|0|||
105886434|NCT01054196|365237454|FG005|Overall Study|Physician Decision|0|||
105886435|NCT01054196|365237455|FG006|Overall Study|Physician Decision|1|||
105886436|NCT00179673|365237456|FG000|Overall Study|Adverse Event|7|||
105886437|NCT00179673|365237456|FG000|Overall Study|Lack of Efficacy|15|||
105886438|NCT00179673|365237456|FG000|Overall Study|Withdrawal by Subject|3|||
105886439|NCT00179673|365237456|FG000|Overall Study|Death|4|||
105886440|NCT00179673|365237456|FG000|Overall Study|Other Observations and options|14|||
105886441|NCT00282113|365237457|FG000|Overall Study|Removed at parents request|1|||
105886442|NCT00282113|365237458|FG001|Overall Study|Removed at parents request|0|||
105886443|NCT00282113|365237459|FG002|Overall Study|Removed at parents request|0|||
105886444|NCT03382834|365237460|FG000|Step 1|Lost to Follow-up|0|||
105886445|NCT03382834|365237461|FG001|Step 1|Lost to Follow-up|1|||
105886446|NCT03382834|365237460|FG000|Step 2|Death|1|||
106114100|NCT01498822|366074381|FG000|Overall Study|Protocol Violation|8|||
106114101|NCT01498822|366074382|FG001|Overall Study|Protocol Violation|4|||
106114102|NCT01498822|366074381|FG000|Overall Study|Other Reason|5|||
106114103|NCT01498822|366074382|FG001|Overall Study|Other Reason|2|||
106114104|NCT01498822|366074381|FG000|Overall Study|Lack of Efficacy|7|||
106114105|NCT01498822|366074382|FG001|Overall Study|Lack of Efficacy|2|||
106114106|NCT01498822|366074381|FG000|Overall Study|AE, non-serious non-fatal|8|||
106114107|NCT01498822|366074382|FG001|Overall Study|AE, non-serious non-fatal|17|||
106114108|NCT01498822|366074381|FG000|Overall Study|SAE, non-fatal|2|||
106114109|NCT01498822|366074382|FG001|Overall Study|SAE, non-fatal|2|||
106114110|NCT01498822|366074381|FG000|Overall Study|Adverse Event, serious fatal|1|||
106114111|NCT01498822|366074382|FG001|Overall Study|Adverse Event, serious fatal|1|||
106114112|NCT01498822|366074381|FG000|Overall Study|Withdrawal by Subject|15|||
106114113|NCT01498822|366074382|FG001|Overall Study|Withdrawal by Subject|25|||
105886447|NCT03382834|365237461|FG001|Step 2|Death|0|||
105886448|NCT03382834|365237460|FG000|Step 2|Lost to Follow-up|2|||
105886449|NCT03382834|365237461|FG001|Step 2|Lost to Follow-up|2|||
105886450|NCT03382834|365237460|FG000|Step 2|Site Terminated by Sponsor|1|||
105886451|NCT03382834|365237461|FG001|Step 2|Site Terminated by Sponsor|0|||
105886452|NCT02387957|365237462|FG000|Overall Study|The study was discontinued|21|||
105886453|NCT02387957|365237463|FG001|Overall Study|The study was discontinued|21|||
105886454|NCT02387957|365237464|FG002|Overall Study|The study was discontinued|20|||
105886455|NCT02949843|365237467|FG000|Overall Study|Withdrawal by Subject|0|||
105886456|NCT02949843|365237468|FG001|Overall Study|Withdrawal by Subject|1|||
105886457|NCT02949843|365237469|FG002|Overall Study|Withdrawal by Subject|1|||
105886458|NCT01680159|365237470|FG000|Screening Period|Not meet criteria for dose-up period|7|||
106114114|NCT01498822|366074381|FG000|Overall Study|Lost to Follow-up|8|||
106114115|NCT01498822|366074382|FG001|Overall Study|Lost to Follow-up|3|||
105886459|NCT01680159|365237470|FG000|Increased Dose Period|Adverse Event|6|||
106114116|NCT03131960|366074384|FG000|Overall Study|Adverse Event|0|||
106114117|NCT03131960|366074385|FG001|Overall Study|Adverse Event|1|||
106114118|NCT04707196|366074386|FG000|Overall Study|Withdrawal by Subject|9|||
106114119|NCT04707196|366074387|FG001|Overall Study|Withdrawal by Subject|6|||
106114120|NCT04707196|366074386|FG000|Overall Study|Lost to Follow-up|1|||
106114121|NCT04707196|366074387|FG001|Overall Study|Lost to Follow-up|0|||
105886460|NCT01680159|365237470|FG000|Increased Dose Period|Withdrawal by Subject|2|||
105886461|NCT00675428|365237473|FG000|Overall Study|Disease Progression|2|||
105886462|NCT00675428|365237474|FG001|Overall Study|Disease Progression|2|||
105886463|NCT00675428|365237473|FG000|Overall Study|No Disease Response After Cycle 6|0|||
105886464|NCT00675428|365237474|FG001|Overall Study|No Disease Response After Cycle 6|1|||
106114122|NCT04707196|366074386|FG000|Overall Study|Protocol Violation|4|||
106114123|NCT04707196|366074387|FG001|Overall Study|Protocol Violation|1|||
106114124|NCT04707196|366074386|FG000|Overall Study|Adverse Event|2|||
106114125|NCT04707196|366074387|FG001|Overall Study|Adverse Event|2|||
106114126|NCT04707196|366074386|FG000|Overall Study|Death|3|||
106114127|NCT04707196|366074387|FG001|Overall Study|Death|1|||
106114128|NCT04707196|366074386|FG000|Overall Study|Non-compliance with study drug|1|||
106114129|NCT04707196|366074387|FG001|Overall Study|Non-compliance with study drug|0|||
106114130|NCT04707196|366074386|FG000|Overall Study|Progressive disease|9|||
106114131|NCT04707196|366074387|FG001|Overall Study|Progressive disease|10|||
106114132|NCT01862796|366074388|FG000|Overall Study|Prohibited medications|0|||
105784908|NCT02967055|364864425|FG000|Overall Study|Stopped due to drug cost|1|||
106114133|NCT01862796|366074389|FG001|Overall Study|Prohibited medications|0|||
106114134|NCT01862796|366074390|FG002|Overall Study|Prohibited medications|1|||
106114135|NCT04404478|366074391|FG000|Overall Study|Withdrawal by Subject|1|||
106114136|NCT04404478|366074392|FG001|Overall Study|Withdrawal by Subject|3|||
106114137|NCT03002038|366074401|FG000|Overall Study|Adverse Event|3|||
106114138|NCT03002038|366074402|FG001|Overall Study|Adverse Event|1|||
106114139|NCT03002038|366074401|FG000|Overall Study|Withdrawal by Subject|8|||
106114140|NCT03002038|366074402|FG001|Overall Study|Withdrawal by Subject|4|||
106114141|NCT03002038|366074401|FG000|Overall Study|Immigration to another region|0|||
106114142|NCT03002038|366074402|FG001|Overall Study|Immigration to another region|2|||
106114143|NCT03351738|366074407|FG000|Overall Study|Withdrawal by Subject|0|||
106114144|NCT03351738|366074408|FG001|Overall Study|Withdrawal by Subject|1|||
106114145|NCT03351738|366074409|FG002|Overall Study|Withdrawal by Subject|0|||
106114146|NCT03351738|366074410|FG003|Overall Study|Withdrawal by Subject|1|||
106114147|NCT03351738|366074411|FG004|Overall Study|Withdrawal by Subject|0|||
106114148|NCT03351738|366074412|FG005|Overall Study|Withdrawal by Subject|0|||
106114149|NCT02904902|366074415|FG000|Overall Study|Withdrawal by Subject|1|||
106114150|NCT04000594|366074417|FG000|Overall Study|Withdrawal by Subject|1|||
106114151|NCT04000594|366074418|FG001|Overall Study|Withdrawal by Subject|0|||
106114152|NCT04000594|366074419|FG002|Overall Study|Withdrawal by Subject|0|||
106114153|NCT04522180|366074421|FG000|Overall Study|Investigator judgement|3|||
106114154|NCT04522180|366074422|FG001|Overall Study|Investigator judgement|4|||
106114155|NCT04522180|366074421|FG000|Overall Study|Voluntary withdrawal|1|||
106114156|NCT04522180|366074422|FG001|Overall Study|Voluntary withdrawal|0|||
106114157|NCT04522180|366074421|FG000|Overall Study|Pregnancy|0|||
106114158|NCT04522180|366074422|FG001|Overall Study|Pregnancy|1|||
106114159|NCT04522180|366074421|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
106114160|NCT04522180|366074422|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
106114161|NCT04522180|366074421|FG000|Overall Study|Reason not specified|8|||
106114162|NCT04522180|366074422|FG001|Overall Study|Reason not specified|5|||
106114163|NCT03489057|366074424|FG000|Overall Study|Lost to Follow-up|16|||
106114164|NCT03489057|366074425|FG001|Overall Study|Lost to Follow-up|16|||
106114165|NCT03489057|366074426|FG002|Overall Study|Lost to Follow-up|14|||
106114166|NCT03489057|366074427|FG003|Overall Study|Lost to Follow-up|14|||
106114167|NCT03489057|366074424|FG000|Overall Study|Withdrawal by Subject|12|||
106114168|NCT03489057|366074425|FG001|Overall Study|Withdrawal by Subject|12|||
106114169|NCT03489057|366074426|FG002|Overall Study|Withdrawal by Subject|8|||
106114170|NCT03489057|366074427|FG003|Overall Study|Withdrawal by Subject|8|||
106114171|NCT03489057|366074424|FG000|Overall Study|Protocol Violation|7|||
106114172|NCT03489057|366074425|FG001|Overall Study|Protocol Violation|7|||
106114173|NCT03489057|366074426|FG002|Overall Study|Protocol Violation|2|||
106114174|NCT03489057|366074427|FG003|Overall Study|Protocol Violation|2|||
106114175|NCT01368900|366074430|FG000|Overall Study|Lost to Follow-up|7|||
106114176|NCT02158884|366074431|FG000|Baseline Assessment|Missed performance assessment|3|||
106114177|NCT02158884|366074431|FG000|Baseline Assessment|Missed SMFA|1|||
106114178|NCT02158884|366074431|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
106114179|NCT02158884|366074431|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
106114180|NCT02158884|366074431|FG000|6 Month Assessment|Missed SMFA|20|||
106114181|NCT02158884|366074431|FG000|12 Month Assessment|Missed SMFA|17|||
106114182|NCT00654901|366074432|FG000|Overall Study|Lost to Follow-up|1|||
106114183|NCT00654901|366074433|FG001|Overall Study|Lost to Follow-up|0|||
106114184|NCT00654901|366074434|FG002|Overall Study|Lost to Follow-up|1|||
106114185|NCT00654901|366074435|FG003|Overall Study|Lost to Follow-up|0|||
105784909|NCT00903357|364864426|FG000|First Intervention|Withdrawal by Subject|5|||
105784910|NCT00903357|364864427|FG001|First Intervention|Withdrawal by Subject|3|||
105784911|NCT00903357|364864426|FG000|First Intervention|Flu|0|||
105784912|NCT00903357|364864427|FG001|First Intervention|Flu|1|||
105784913|NCT00903357|364864426|FG000|Wash Out Period of 2 Weeks|Flu|0|||
105784914|NCT00903357|364864427|FG001|Wash Out Period of 2 Weeks|Flu|1|||
105784915|NCT00903357|364864426|FG000|Second Intervention|Lost to Follow-up|1|||
105784916|NCT00903357|364864427|FG001|Second Intervention|Lost to Follow-up|0|||
105784917|NCT01484691|364864428|FG000|Overall Study|Withdrawal by Subject|1|||
105784918|NCT01484691|364864429|FG001|Overall Study|Withdrawal by Subject|1|||
105784919|NCT01484691|364864430|FG002|Overall Study|Withdrawal by Subject|1|||
105784920|NCT01484691|364864428|FG000|Overall Study|Physician Decision|0|||
105886465|NCT00675428|365237473|FG000|Overall Study|Physician Decision|1|||
105886466|NCT00675428|365237474|FG001|Overall Study|Physician Decision|0|||
105886467|NCT02653170|365239089|FG000|Overall Study|Withdrawal by Subject|3|||
105886468|NCT02653170|365239090|FG001|Overall Study|Withdrawal by Subject|8|||
105886469|NCT02653170|365239091|FG002|Overall Study|Withdrawal by Subject|3|||
105886470|NCT02653170|365239089|FG000|Overall Study|withdrawn by study team|2|||
105886471|NCT02653170|365239090|FG001|Overall Study|withdrawn by study team|4|||
105886472|NCT02653170|365239091|FG002|Overall Study|withdrawn by study team|5|||
105886473|NCT02653170|365239089|FG000|Overall Study|Lost to Follow-up|12|||
105886474|NCT02653170|365239090|FG001|Overall Study|Lost to Follow-up|4|||
105886475|NCT02653170|365239091|FG002|Overall Study|Lost to Follow-up|10|||
105886476|NCT03969901|365239096|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105886477|NCT03969901|365239097|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105886478|NCT03969901|365239098|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105886479|NCT03969901|365239099|FG003|Overall Study|Withdrawal by parent/guardian|0|||
105886480|NCT03969901|365239100|FG004|Overall Study|Withdrawal by parent/guardian|1|||
105886481|NCT03969901|365239101|FG005|Overall Study|Withdrawal by parent/guardian|0|||
105886482|NCT03969901|365239102|FG006|Overall Study|Withdrawal by parent/guardian|0|||
105886483|NCT03969901|365239103|FG007|Overall Study|Withdrawal by parent/guardian|1|||
105886484|NCT03969901|365239104|FG008|Overall Study|Withdrawal by parent/guardian|1|||
105886485|NCT03969901|365239105|FG009|Overall Study|Withdrawal by parent/guardian|0|||
105886486|NCT01194999|365239108|FG000|Overall Study|Lost to Follow-up|17|||
105886487|NCT01895270|365239109|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
105886488|NCT01895270|365239110|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
105886489|NCT01895270|365239109|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
105886490|NCT01895270|365239110|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
105886491|NCT01895270|365239109|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
105886492|NCT01895270|365239110|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
105886493|NCT01895270|365239109|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
105886494|NCT01895270|365239110|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
105886495|NCT01895270|365239109|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
105886496|NCT01895270|365239110|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
105886497|NCT01895270|365239109|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
105886498|NCT01895270|365239110|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
105886499|NCT01895270|365239109|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
105886500|NCT01895270|365239110|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
105886501|NCT02682823|365239112|FG000|Overall Study|Withdrawal by Subject|0|||
105886502|NCT02682823|365239113|FG001|Overall Study|Withdrawal by Subject|0|||
105886503|NCT02682823|365239114|FG002|Overall Study|Withdrawal by Subject|1|||
105886504|NCT02682823|365239115|FG003|Overall Study|Withdrawal by Subject|0|||
105886505|NCT02682823|365239116|FG004|Overall Study|Withdrawal by Subject|1|||
105886506|NCT02682823|365239112|FG000|Overall Study|Protocol Deviation|0|||
105886507|NCT02682823|365239113|FG001|Overall Study|Protocol Deviation|1|||
105886508|NCT02682823|365239114|FG002|Overall Study|Protocol Deviation|0|||
105886509|NCT02682823|365239115|FG003|Overall Study|Protocol Deviation|0|||
105886510|NCT02682823|365239116|FG004|Overall Study|Protocol Deviation|0|||
105886511|NCT02682823|365239112|FG000|Overall Study|Adverse Event|0|||
105886512|NCT02682823|365239113|FG001|Overall Study|Adverse Event|0|||
105886513|NCT02682823|365239114|FG002|Overall Study|Adverse Event|0|||
105886514|NCT02682823|365239115|FG003|Overall Study|Adverse Event|1|||
105886515|NCT02682823|365239116|FG004|Overall Study|Adverse Event|0|||
105886516|NCT02429778|365239117|FG000|Overall Study|Lost to Follow-up|2|||
105886517|NCT02429778|365239118|FG001|Overall Study|Lost to Follow-up|0|||
105886518|NCT02429778|365239117|FG000|Overall Study|Withdrawal by Subject|5|||
105886519|NCT02429778|365239118|FG001|Overall Study|Withdrawal by Subject|0|||
105886520|NCT03655470|365239119|FG000|Overall Study|Lost to Follow-up|6|||
105886521|NCT03655470|365239120|FG001|Overall Study|Lost to Follow-up|7|||
105886522|NCT01082211|365239125|FG000|Overall Study|Protocol Violation|4|||
105886523|NCT01082211|365239125|FG000|Overall Study|No protocol treatment received|3|||
105886524|NCT03702010|365239130|FG000|Follow-up (30days)|Lack of Efficacy|2|||
105886525|NCT03702010|365239131|FG001|Follow-up (30days)|Lack of Efficacy|2|||
105886526|NCT01254318|365239132|FG000|Overall Study|Lost to Follow-up|5|||
105886527|NCT01254318|365239132|FG000|Overall Study|Death|47|||
105886528|NCT04016779|365239143|FG000|Overall Study|Adverse Event|9|||
105886529|NCT04016779|365239144|FG001|Overall Study|Adverse Event|17|||
105886530|NCT04016779|365239143|FG000|Overall Study|Lack of Efficacy|4|||
105886531|NCT04016779|365239144|FG001|Overall Study|Lack of Efficacy|1|||
105886532|NCT04016779|365239143|FG000|Overall Study|Lost to Follow-up|5|||
105886533|NCT04016779|365239144|FG001|Overall Study|Lost to Follow-up|14|||
105886534|NCT04016779|365239143|FG000|Overall Study|Physician Decision|1|||
105886535|NCT04016779|365239144|FG001|Overall Study|Physician Decision|3|||
105886536|NCT04016779|365239143|FG000|Overall Study|Withdrawal by Subject|6|||
105886537|NCT04016779|365239144|FG001|Overall Study|Withdrawal by Subject|8|||
105886538|NCT04016779|365239143|FG000|Overall Study|Non-compliance with Study Drug|2|||
105886539|NCT04016779|365239144|FG001|Overall Study|Non-compliance with Study Drug|3|||
105886540|NCT04016779|365239143|FG000|Overall Study|Other, Multiple categories|17|||
105886541|NCT04016779|365239144|FG001|Overall Study|Other, Multiple categories|17|||
105886542|NCT01137110|365239150|FG000|Overall Study|Protocol Violation|1|||
105886543|NCT01137110|365239151|FG001|Overall Study|Protocol Violation|0|||
105886544|NCT02394340|365239152|FG000|Overall Study|Failed drug screen test|1|||
105886545|NCT02394340|365239152|FG000|Overall Study|Adverse Event|1|||
105886546|NCT02828124|365239153|FG000|Overall Study|Disease Progression|1|||
105886547|NCT02828124|365239154|FG001|Overall Study|Disease Progression|2|||
105886548|NCT02828124|365239155|FG002|Overall Study|Disease Progression|1|||
105886549|NCT02828124|365239156|FG003|Overall Study|Disease Progression|4|||
105886550|NCT02828124|365239153|FG000|Overall Study|AE Unrelated to Study Drug|0|||
105886551|NCT02828124|365239154|FG001|Overall Study|AE Unrelated to Study Drug|0|||
105886552|NCT02828124|365239155|FG002|Overall Study|AE Unrelated to Study Drug|0|||
105886553|NCT02828124|365239156|FG003|Overall Study|AE Unrelated to Study Drug|1|||
105886554|NCT02828124|365239153|FG000|Overall Study|Subject Withdrew Consent|0|||
105886555|NCT02828124|365239154|FG001|Overall Study|Subject Withdrew Consent|0|||
105886556|NCT02828124|365239155|FG002|Overall Study|Subject Withdrew Consent|0|||
105886557|NCT02828124|365239156|FG003|Overall Study|Subject Withdrew Consent|1|||
105886558|NCT03614078|365239166|FG000|Overall Study|Withdrawal by Subject|2|||
105886559|NCT03614078|365239167|FG001|Overall Study|Withdrawal by Subject|2|||
105886560|NCT03614078|365239168|FG002|Overall Study|Withdrawal by Subject|3|||
105886561|NCT03614078|365239166|FG000|Overall Study|Participant Did Not Return for Visit|0|||
105886562|NCT03614078|365239167|FG001|Overall Study|Participant Did Not Return for Visit|1|||
105886563|NCT03614078|365239168|FG002|Overall Study|Participant Did Not Return for Visit|0|||
105886564|NCT03614078|365239166|FG000|Overall Study|High Neutrophils|0|||
105886565|NCT03614078|365239167|FG001|Overall Study|High Neutrophils|0|||
105886566|NCT03614078|365239168|FG002|Overall Study|High Neutrophils|2|||
105886567|NCT03614078|365239166|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
105994330|NCT03724890|365638013|FG006|Overall Study|Withdrawal by Subject|0|||
105994331|NCT03724890|365638014|FG007|Overall Study|Withdrawal by Subject|0|||
105994332|NCT03724890|365638015|FG008|Overall Study|Withdrawal by Subject|2|||
105994333|NCT03724890|365638016|FG009|Overall Study|Withdrawal by Subject|2|||
105994334|NCT03724890|365638017|FG010|Overall Study|Withdrawal by Subject|1|||
105994335|NCT03724890|365638007|FG000|Overall Study|Other|1|||
105994336|NCT03724890|365638008|FG001|Overall Study|Other|0|||
105994337|NCT03724890|365638009|FG002|Overall Study|Other|0|||
105994338|NCT03724890|365638010|FG003|Overall Study|Other|0|||
105994339|NCT03724890|365638011|FG004|Overall Study|Other|0|||
105994340|NCT03724890|365638012|FG005|Overall Study|Other|0|||
105994341|NCT03724890|365638013|FG006|Overall Study|Other|0|||
105994342|NCT03724890|365638014|FG007|Overall Study|Other|1|||
105994343|NCT03724890|365638015|FG008|Overall Study|Other|1|||
105994344|NCT03724890|365638016|FG009|Overall Study|Other|0|||
105994345|NCT03724890|365638017|FG010|Overall Study|Other|2|||
105994346|NCT04765202|365638022|FG000|Overall Study|Lost to Follow-up|1|||
105994347|NCT04765202|365638023|FG001|Overall Study|Lost to Follow-up|1|||
105994348|NCT04765202|365638024|FG002|Overall Study|Lost to Follow-up|2|||
105994349|NCT04765202|365638025|FG003|Overall Study|Lost to Follow-up|2|||
105994350|NCT04765202|365638022|FG000|Overall Study|Physician Decision|0|||
105994351|NCT04765202|365638023|FG001|Overall Study|Physician Decision|0|||
105994352|NCT04765202|365638024|FG002|Overall Study|Physician Decision|1|||
105994353|NCT04765202|365638025|FG003|Overall Study|Physician Decision|1|||
105994354|NCT05715242|365638026|FG000|Overall Study|Lost to Follow-up|0|||
105994355|NCT05715242|365638027|FG001|Overall Study|Lost to Follow-up|0|||
106114186|NCT00654901|366074432|FG000|Overall Study|Withdrawal by Subject|3|||
106114187|NCT00654901|366074433|FG001|Overall Study|Withdrawal by Subject|0|||
106114188|NCT00654901|366074434|FG002|Overall Study|Withdrawal by Subject|1|||
105886568|NCT03614078|365239167|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
105994356|NCT05715242|365638028|FG002|Overall Study|Lost to Follow-up|1|||
105994357|NCT05715242|365638029|FG003|Overall Study|Lost to Follow-up|0|||
105994358|NCT05715242|365638030|FG004|Overall Study|Lost to Follow-up|0|||
105994359|NCT05715242|365638031|FG005|Overall Study|Lost to Follow-up|1|||
105994360|NCT05715242|365638032|FG006|Overall Study|Lost to Follow-up|0|||
106114189|NCT00654901|366074435|FG003|Overall Study|Withdrawal by Subject|0|||
106114190|NCT01552954|366074436|FG000|Overall Study|Adverse Event|1|||
106114191|NCT01552954|366074437|FG001|Overall Study|Adverse Event|2|||
105886569|NCT03614078|365239168|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
105886570|NCT03614078|365239166|FG000|Overall Study|Exacerbation of Psoriasis|0|||
105886571|NCT03614078|365239167|FG001|Overall Study|Exacerbation of Psoriasis|1|||
105994361|NCT05715242|365638033|FG007|Overall Study|Lost to Follow-up|0|||
105886572|NCT03614078|365239168|FG002|Overall Study|Exacerbation of Psoriasis|0|||
105994362|NCT05715242|365638034|FG008|Overall Study|Lost to Follow-up|0|||
105994363|NCT05715242|365638035|FG009|Overall Study|Lost to Follow-up|0|||
105994364|NCT05715242|365638036|FG010|Overall Study|Lost to Follow-up|0|||
105994365|NCT05715242|365638037|FG011|Overall Study|Lost to Follow-up|0|||
105994366|NCT05715242|365638038|FG012|Overall Study|Lost to Follow-up|0|||
105994367|NCT05715242|365638039|FG013|Overall Study|Lost to Follow-up|0|||
106114192|NCT01552954|366074436|FG000|Overall Study|Lost to Follow-up|1|||
106114193|NCT01552954|366074437|FG001|Overall Study|Lost to Follow-up|1|||
106114194|NCT01552954|366074436|FG000|Overall Study|Withdrawal by Subject|1|||
106114195|NCT01552954|366074437|FG001|Overall Study|Withdrawal by Subject|1|||
106114196|NCT01552954|366074436|FG000|Overall Study|Protocol Violation|1|||
106114197|NCT01552954|366074437|FG001|Overall Study|Protocol Violation|2|||
106114198|NCT01552954|366074436|FG000|Overall Study|diagnosed DM|1|||
106114199|NCT01552954|366074437|FG001|Overall Study|diagnosed DM|0|||
106114200|NCT02010632|366074438|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
106114201|NCT02010632|366074439|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
105661750|NCT01068210|364425131|FG001|Overall Study|Lost to Follow-up|2|||
105886573|NCT03614078|365239166|FG000|Overall Study|Adverse Event|0|||
105886574|NCT03614078|365239167|FG001|Overall Study|Adverse Event|2|||
106114202|NCT01852058|366074442|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
106114203|NCT01852058|366074443|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114204|NCT01852058|366074444|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114205|NCT01852058|366074445|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114206|NCT01852058|366074446|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114207|NCT01852058|366074447|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114208|NCT01852058|366074448|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114209|NCT01852058|366074449|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114210|NCT01852058|366074450|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114211|NCT01852058|366074451|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114212|NCT01852058|366074452|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114213|NCT01852058|366074453|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
106114214|NCT01852058|366074442|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114215|NCT01852058|366074443|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114216|NCT01852058|366074444|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114217|NCT01852058|366074445|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114218|NCT01852058|366074446|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
106114219|NCT01852058|366074447|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114220|NCT01852058|366074448|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114221|NCT01852058|366074449|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114222|NCT01852058|366074450|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114223|NCT01852058|366074451|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114224|NCT01852058|366074452|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114225|NCT01852058|366074453|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
106114226|NCT01852058|366074442|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114227|NCT01852058|366074443|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114228|NCT01852058|366074444|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114229|NCT01852058|366074445|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114230|NCT01852058|366074446|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
105886575|NCT03614078|365239168|FG002|Overall Study|Adverse Event|0|||
105886576|NCT03614078|365239166|FG000|Overall Study|Dizziness and Rash|0|||
105886577|NCT03614078|365239167|FG001|Overall Study|Dizziness and Rash|1|||
105886578|NCT03614078|365239168|FG002|Overall Study|Dizziness and Rash|0|||
105886579|NCT02004886|365239169|FG000|Overall Study|Adverse Event|0|||
105886580|NCT02004886|365239170|FG001|Overall Study|Adverse Event|1|||
105886581|NCT02004886|365239171|FG002|Overall Study|Adverse Event|0|||
105886582|NCT02004886|365239172|FG003|Overall Study|Adverse Event|0|||
105886583|NCT02004886|365239169|FG000|Overall Study|Unable to attend future visits|1|||
105886584|NCT02004886|365239170|FG001|Overall Study|Unable to attend future visits|0|||
105886585|NCT02004886|365239171|FG002|Overall Study|Unable to attend future visits|0|||
105886586|NCT02004886|365239172|FG003|Overall Study|Unable to attend future visits|0|||
105886587|NCT00749684|365239174|FG000|Overall Study|Death|1|||
105886588|NCT00749684|365239174|FG000|Overall Study|Adverse Event|27|||
106114231|NCT01852058|366074447|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
106114232|NCT01852058|366074448|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114233|NCT01852058|366074449|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114234|NCT01852058|366074450|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114235|NCT01852058|366074451|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114236|NCT01852058|366074452|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114237|NCT01852058|366074453|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
106114238|NCT01852058|366074442|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114239|NCT01852058|366074443|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114240|NCT01852058|366074444|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114241|NCT01852058|366074445|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
105661751|NCT01068210|364425132|FG002|Overall Study|Lost to Follow-up|2|||
105886589|NCT00749684|365239174|FG000|Overall Study|Participant's Wish|10|||
105886590|NCT00749684|365239174|FG000|Overall Study|Not Documented|1|||
106114242|NCT01852058|366074446|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
106114243|NCT01852058|366074447|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114244|NCT01852058|366074448|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114245|NCT01852058|366074449|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114246|NCT01852058|366074450|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114247|NCT01852058|366074451|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114248|NCT01852058|366074452|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114249|NCT01852058|366074453|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
106114250|NCT01852058|366074442|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114251|NCT01852058|366074443|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114252|NCT01852058|366074444|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114253|NCT01852058|366074445|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114254|NCT01852058|366074446|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
106114255|NCT01852058|366074447|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
106114256|NCT01852058|366074448|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114257|NCT01852058|366074449|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114258|NCT01852058|366074450|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114259|NCT01852058|366074451|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114260|NCT01852058|366074452|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114261|NCT01852058|366074453|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
106114262|NCT01852058|366074442|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
106114263|NCT01852058|366074443|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
106114264|NCT01852058|366074444|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105886591|NCT00749684|365239174|FG000|Overall Study|Progressive Desease|31|||
105886592|NCT00749684|365239174|FG000|Overall Study|Therapy according to protocol + AE|2|||
105886593|NCT00749684|365239174|FG000|Overall Study|AE+discontinuation on participants wish|1|||
105886594|NCT00749684|365239174|FG000|Overall Study|Missing|9|||
105886595|NCT00679289|365239175|FG000|Overall Study|Progressive disease|4|||
105886596|NCT00679289|365239176|FG001|Overall Study|Progressive disease|5|||
105886597|NCT00679289|365239177|FG002|Overall Study|Progressive disease|18|||
105886598|NCT00679289|365239175|FG000|Overall Study|Withdrawal by Subject|0|||
105886599|NCT00679289|365239176|FG001|Overall Study|Withdrawal by Subject|1|||
105886600|NCT00679289|365239177|FG002|Overall Study|Withdrawal by Subject|1|||
105886601|NCT00679289|365239175|FG000|Overall Study|Adverse Event|0|||
105886602|NCT00679289|365239176|FG001|Overall Study|Adverse Event|0|||
105886603|NCT00679289|365239177|FG002|Overall Study|Adverse Event|3|||
105886604|NCT00679289|365239175|FG000|Overall Study|Physician Decision|1|||
105886605|NCT00679289|365239176|FG001|Overall Study|Physician Decision|0|||
105886606|NCT00679289|365239177|FG002|Overall Study|Physician Decision|1|||
105886607|NCT01046903|365239184|FG000|Overall Study|Lost to Follow-up|16|||
105886608|NCT01046903|365239184|FG000|Overall Study|Adverse Event|4|||
105886609|NCT01046903|365239184|FG000|Overall Study|Withdrawal by Subject|3|||
105886610|NCT01046903|365239184|FG000|Overall Study|Other|5|||
105886611|NCT02107859|365239187|FG000|Overall Study|Withdrawal by Subject|14|||
105886612|NCT02107859|365239187|FG000|Overall Study|Adverse Event|3|||
105886613|NCT02107859|365239187|FG000|Overall Study|Study closure|41|||
105886614|NCT02107859|365239187|FG000|Overall Study|Other than specified|3|||
105886615|NCT02964208|365239191|FG000|Overall Study|Death|103|||
105886616|NCT02964208|365239191|FG000|Overall Study|Withdrawal by Subject|6|||
105886617|NCT02964208|365239191|FG000|Overall Study|Lost to Follow-up|6|||
105886618|NCT02964208|365239191|FG000|Overall Study|Unsuccessful Procedure|5|||
105886619|NCT02964208|365239191|FG000|Overall Study|Device Explant|1|||
105886620|NCT02964208|365239191|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
105886621|NCT00586820|365239195|FG000|Overall Study|Unsuccessful PCI|1|||
105886622|NCT00586820|365239196|FG001|Overall Study|Unsuccessful PCI|0|||
105886623|NCT01868022|365239199|FG000|Overall Study|Withdrawal by Subject|0|||
105886624|NCT01868022|365239200|FG001|Overall Study|Withdrawal by Subject|0|||
105886625|NCT01868022|365239201|FG002|Overall Study|Withdrawal by Subject|1|||
105886626|NCT01868022|365239202|FG003|Overall Study|Withdrawal by Subject|1|||
105886627|NCT01868022|365239203|FG004|Overall Study|Withdrawal by Subject|0|||
105886628|NCT01868022|365239204|FG005|Overall Study|Withdrawal by Subject|0|||
105886629|NCT01868022|365239205|FG006|Overall Study|Withdrawal by Subject|0|||
105886630|NCT01868022|365239206|FG007|Overall Study|Withdrawal by Subject|1|||
105886631|NCT01868022|365239207|FG008|Overall Study|Withdrawal by Subject|0|||
105886632|NCT01868022|365239199|FG000|Overall Study|Adverse Event|0|||
105994368|NCT05715242|365638040|FG014|Overall Study|Lost to Follow-up|0|||
105886633|NCT01868022|365239200|FG001|Overall Study|Adverse Event|0|||
105886634|NCT01868022|365239201|FG002|Overall Study|Adverse Event|0|||
105886635|NCT01868022|365239202|FG003|Overall Study|Adverse Event|0|||
105886636|NCT01868022|365239203|FG004|Overall Study|Adverse Event|2|||
105886637|NCT01868022|365239204|FG005|Overall Study|Adverse Event|0|||
105886638|NCT01868022|365239205|FG006|Overall Study|Adverse Event|0|||
105886639|NCT01868022|365239206|FG007|Overall Study|Adverse Event|2|||
105886640|NCT01868022|365239207|FG008|Overall Study|Adverse Event|2|||
105886641|NCT01868022|365239199|FG000|Overall Study|Physician Decision|0|||
105886642|NCT01868022|365239200|FG001|Overall Study|Physician Decision|0|||
105886643|NCT01868022|365239201|FG002|Overall Study|Physician Decision|0|||
105886644|NCT01868022|365239202|FG003|Overall Study|Physician Decision|0|||
105886645|NCT01868022|365239203|FG004|Overall Study|Physician Decision|0|||
105886646|NCT01868022|365239204|FG005|Overall Study|Physician Decision|1|||
105886647|NCT01868022|365239205|FG006|Overall Study|Physician Decision|0|||
105886648|NCT01868022|365239206|FG007|Overall Study|Physician Decision|2|||
105886649|NCT01868022|365239207|FG008|Overall Study|Physician Decision|0|||
105886650|NCT01868022|365239199|FG000|Overall Study|Study closed/terminated|0|||
105886651|NCT01868022|365239200|FG001|Overall Study|Study closed/terminated|0|||
105886652|NCT01868022|365239201|FG002|Overall Study|Study closed/terminated|0|||
105886653|NCT01868022|365239202|FG003|Overall Study|Study closed/terminated|0|||
105886654|NCT01868022|365239203|FG004|Overall Study|Study closed/terminated|0|||
105886655|NCT01868022|365239204|FG005|Overall Study|Study closed/terminated|0|||
105886656|NCT01868022|365239205|FG006|Overall Study|Study closed/terminated|0|||
105886657|NCT01868022|365239206|FG007|Overall Study|Study closed/terminated|1|||
105886658|NCT01868022|365239207|FG008|Overall Study|Study closed/terminated|0|||
105886659|NCT01868022|365239199|FG000|Overall Study|Ongoing|0|||
105886660|NCT01868022|365239200|FG001|Overall Study|Ongoing|0|||
105886661|NCT01868022|365239201|FG002|Overall Study|Ongoing|0|||
105886662|NCT01868022|365239202|FG003|Overall Study|Ongoing|0|||
105886663|NCT01868022|365239203|FG004|Overall Study|Ongoing|0|||
105886664|NCT01868022|365239204|FG005|Overall Study|Ongoing|0|||
105886665|NCT01868022|365239205|FG006|Overall Study|Ongoing|0|||
105886666|NCT01868022|365239206|FG007|Overall Study|Ongoing|3|||
105886667|NCT01868022|365239207|FG008|Overall Study|Ongoing|0|||
105886668|NCT00746564|365239208|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
105886669|NCT01743560|365239209|FG000|Overall Study|Disease progression|26|||
105886670|NCT01743560|365239209|FG000|Overall Study|Adverse Event|8|||
105886671|NCT01743560|365239209|FG000|Overall Study|Death|3|||
105886672|NCT01743560|365239209|FG000|Overall Study|Withdrawal by Subject|2|||
105886673|NCT01743560|365239209|FG000|Overall Study|Protocol Violation|1|||
105886674|NCT01743560|365239209|FG000|Overall Study|>1 dose of study drug|3|||
105886675|NCT02727777|365239212|FG000|Overall Study|Screen Failure|2|||
105886676|NCT02727777|365239213|FG001|Overall Study|Screen Failure|0|||
105886677|NCT02727777|365239214|FG002|Overall Study|Screen Failure|0|||
105886678|NCT02727777|365239212|FG000|Overall Study|Progressive disease|2|||
105886679|NCT02727777|365239213|FG001|Overall Study|Progressive disease|0|||
105886680|NCT02727777|365239214|FG002|Overall Study|Progressive disease|0|||
105886681|NCT01817582|365239219|FG000|Overall Study|Withdrawal by Subject|0|||
105886682|NCT01817582|365239220|FG001|Overall Study|Withdrawal by Subject|1|||
105886683|NCT01817582|365239221|FG002|Overall Study|Withdrawal by Subject|0|||
105886684|NCT01817582|365239219|FG000|Overall Study|Participant revealed masked treatment|1|||
105886685|NCT01817582|365239220|FG001|Overall Study|Participant revealed masked treatment|0|||
105886686|NCT01817582|365239221|FG002|Overall Study|Participant revealed masked treatment|0|||
105886687|NCT01817582|365239219|FG000|Overall Study|Randomized but exclusion criteria met|1|||
105886688|NCT01817582|365239220|FG001|Overall Study|Randomized but exclusion criteria met|0|||
105886689|NCT01817582|365239221|FG002|Overall Study|Randomized but exclusion criteria met|0|||
105886690|NCT01294696|365239224|FG000|Overall Study|Screening failures|7|||
105886691|NCT01294696|365239224|FG000|Overall Study|Protocol Violation|8|||
105886692|NCT01294696|365239224|FG000|Overall Study|Missing BPI Response|7|||
105886693|NCT01294696|365239224|FG000|Overall Study|Site closure|52|||
105886694|NCT01190410|365241704|FG000|Overall Study|Adverse Event|0|||
106114265|NCT01852058|366074445|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
105886695|NCT01190410|365241705|FG001|Overall Study|Adverse Event|3|||
105886696|NCT01190410|365241704|FG000|Overall Study|Lack of Efficacy|0|||
105886697|NCT01190410|365241705|FG001|Overall Study|Lack of Efficacy|2|||
105886698|NCT01190410|365241704|FG000|Overall Study|Withdrawal by Subject|0|||
105886699|NCT01190410|365241705|FG001|Overall Study|Withdrawal by Subject|2|||
106114266|NCT01852058|366074446|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
106114267|NCT01852058|366074447|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105886700|NCT01190410|365241704|FG000|Overall Study|Administrative decision|1|||
105886701|NCT01190410|365241705|FG001|Overall Study|Administrative decision|0|||
105886702|NCT01190410|365241704|FG000|Overall Study|PI discretion|0|||
105886703|NCT01190410|365241705|FG001|Overall Study|PI discretion|2|||
105886704|NCT01399047|365241706|FG000|Overall Study|Withdrawal by Subject|0|||
105886705|NCT01399047|365241707|FG001|Overall Study|Withdrawal by Subject|1|||
105886706|NCT03652636|365241716|FG000|Overall Study|Withdrawal by Subject|7|||
105886707|NCT01435018|365241717|FG000|Overall Study|Death|37|||
105886708|NCT01435018|365241718|FG001|Overall Study|Death|18|||
105886709|NCT01435018|365241719|FG002|Overall Study|Death|25|||
105886710|NCT01435018|365241717|FG000|Overall Study|Site is closing|4|||
105886711|NCT01435018|365241718|FG001|Overall Study|Site is closing|9|||
105886712|NCT01435018|365241719|FG002|Overall Study|Site is closing|7|||
105886713|NCT01435018|365241717|FG000|Overall Study|Withdrew consent|0|||
105886714|NCT01435018|365241718|FG001|Overall Study|Withdrew consent|3|||
105886715|NCT01435018|365241719|FG002|Overall Study|Withdrew consent|1|||
105886716|NCT01435018|365241717|FG000|Overall Study|Not willing to adhere to requirements|0|||
105886717|NCT01435018|365241718|FG001|Overall Study|Not willing to adhere to requirements|2|||
105886718|NCT01435018|365241719|FG002|Overall Study|Not willing to adhere to requirements|3|||
105886719|NCT01435018|365241717|FG000|Overall Study|Not able to get to clinic|2|||
105886720|NCT01435018|365241718|FG001|Overall Study|Not able to get to clinic|0|||
105886721|NCT01435018|365241719|FG002|Overall Study|Not able to get to clinic|2|||
105886722|NCT01435018|365241717|FG000|Overall Study|Severe debilitation, unable to continue|0|||
105886723|NCT01435018|365241718|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105886724|NCT01435018|365241719|FG002|Overall Study|Severe debilitation, unable to continue|1|||
105886725|NCT01435018|365241717|FG000|Overall Study|Unable to contact participant/parent|1|||
105886726|NCT01435018|365241718|FG001|Overall Study|Unable to contact participant/parent|1|||
105886727|NCT01435018|365241719|FG002|Overall Study|Unable to contact participant/parent|1|||
105886728|NCT01435018|365241717|FG000|Overall Study|Enrollment Violation|0|||
105886729|NCT01435018|365241718|FG001|Overall Study|Enrollment Violation|1|||
105886730|NCT01435018|365241719|FG002|Overall Study|Enrollment Violation|0|||
105886731|NCT01435018|365241717|FG000|Overall Study|Never started chemotherapy|3|||
105886732|NCT01435018|365241718|FG001|Overall Study|Never started chemotherapy|0|||
105886733|NCT01435018|365241719|FG002|Overall Study|Never started chemotherapy|1|||
105886734|NCT00378508|365241720|FG000|Overall Study|Withdrawal by Subject|1|||
105886735|NCT00378508|365241721|FG001|Overall Study|Withdrawal by Subject|3|||
105886736|NCT00378508|365241720|FG000|Overall Study|Lost to Follow-up|1|||
105886737|NCT00378508|365241721|FG001|Overall Study|Lost to Follow-up|0|||
105886738|NCT01841762|365241722|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
105886739|NCT01841762|365241722|FG000|Treatment Period|Adverse Event|16|||
105886740|NCT01841762|365241722|FG000|Treatment Period|Death|1|||
105886741|NCT01841762|365241722|FG000|Treatment Period|Withdrawal by Subject|7|||
105886742|NCT01841762|365241722|FG000|Treatment Period|Lost to Follow-up|1|||
105886743|NCT01841762|365241722|FG000|Treatment Period|Physician Decision|2|||
105886744|NCT01841762|365241722|FG000|Treatment Period|Other, including non-compliance|5|||
105886745|NCT01841762|365241722|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
105886746|NCT01841762|365241722|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
105886747|NCT01841762|365241722|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
105886748|NCT01841762|365241722|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
105886749|NCT01177293|365241723|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
105886750|NCT01177293|365241724|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
105886751|NCT03528369|365241725|FG000|Overall Study|Withdrawal by Subject|2|||
105886752|NCT03528369|365241726|FG001|Overall Study|Withdrawal by Subject|0|||
105886753|NCT03528369|365241727|FG002|Overall Study|Withdrawal by Subject|0|||
105886754|NCT03528369|365241725|FG000|Overall Study|Lost to Follow-up|1|||
105994369|NCT05715242|365638041|FG015|Overall Study|Lost to Follow-up|0|||
105994370|NCT02915978|365638042|FG000|Overall Study|Adverse Event|2|||
105994371|NCT02915978|365638043|FG001|Overall Study|Adverse Event|1|||
105994372|NCT02915978|365638044|FG002|Overall Study|Adverse Event|0|||
105994373|NCT00048347|365638050|FG000|Overall Study|Screen failure|2|||
105994374|NCT02343406|365638051|FG000|Overall Study|Progressive disease|72|||
105994375|NCT02343406|365638052|FG001|Overall Study|Progressive disease|70|||
105994376|NCT02343406|365638053|FG002|Overall Study|Progressive disease|43|||
105994377|NCT02343406|365638054|FG003|Overall Study|Progressive disease|15|||
105994378|NCT02343406|365638055|FG004|Overall Study|Progressive disease|5|||
105994379|NCT02343406|365638051|FG000|Overall Study|Adverse Event|6|||
105994380|NCT02343406|365638052|FG001|Overall Study|Adverse Event|8|||
105994381|NCT02343406|365638053|FG002|Overall Study|Adverse Event|6|||
105994382|NCT02343406|365638054|FG003|Overall Study|Adverse Event|3|||
105994383|NCT02343406|365638055|FG004|Overall Study|Adverse Event|0|||
105994384|NCT02343406|365638051|FG000|Overall Study|Withdrawal by Subject|6|||
105994385|NCT02343406|365638052|FG001|Overall Study|Withdrawal by Subject|4|||
105994386|NCT02343406|365638053|FG002|Overall Study|Withdrawal by Subject|8|||
105886755|NCT03528369|365241726|FG001|Overall Study|Lost to Follow-up|0|||
105994387|NCT02343406|365638054|FG003|Overall Study|Withdrawal by Subject|3|||
105994388|NCT02343406|365638055|FG004|Overall Study|Withdrawal by Subject|0|||
105994389|NCT02343406|365638051|FG000|Overall Study|Death|2|||
105886756|NCT03528369|365241727|FG002|Overall Study|Lost to Follow-up|0|||
105886757|NCT03528369|365241725|FG000|Overall Study|Adverse Event|0|||
105886758|NCT03528369|365241726|FG001|Overall Study|Adverse Event|1|||
105886759|NCT03528369|365241727|FG002|Overall Study|Adverse Event|0|||
105886760|NCT03214380|365241728|FG000|Lead-in|Adverse Event|3|||
106114268|NCT01852058|366074448|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
106114269|NCT01852058|366074449|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
106114270|NCT01852058|366074450|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
105994390|NCT02343406|365638052|FG001|Overall Study|Death|1|||
105994391|NCT02343406|365638053|FG002|Overall Study|Death|0|||
105994392|NCT02343406|365638054|FG003|Overall Study|Death|0|||
105886761|NCT03214380|365241729|FG001|Lead-in|Adverse Event|0|||
105886762|NCT03214380|365241730|FG002|Lead-in|Adverse Event|0|||
105886763|NCT03214380|365241731|FG003|Lead-in|Adverse Event|1|||
105886764|NCT03214380|365241732|FG004|Lead-in|Adverse Event|0|||
105886765|NCT03214380|365241733|FG005|Lead-in|Adverse Event|0|||
105886766|NCT03214380|365241728|FG000|Lead-in|Lost to Follow-up|4|||
105886767|NCT03214380|365241729|FG001|Lead-in|Lost to Follow-up|0|||
105886768|NCT03214380|365241730|FG002|Lead-in|Lost to Follow-up|0|||
105886769|NCT03214380|365241731|FG003|Lead-in|Lost to Follow-up|1|||
105886770|NCT03214380|365241732|FG004|Lead-in|Lost to Follow-up|0|||
105886771|NCT03214380|365241733|FG005|Lead-in|Lost to Follow-up|0|||
105886772|NCT03214380|365241728|FG000|Lead-in|Eligibility Criteria|3|||
105886773|NCT03214380|365241729|FG001|Lead-in|Eligibility Criteria|0|||
105886774|NCT03214380|365241730|FG002|Lead-in|Eligibility Criteria|0|||
105886775|NCT03214380|365241731|FG003|Lead-in|Eligibility Criteria|0|||
105886776|NCT03214380|365241732|FG004|Lead-in|Eligibility Criteria|0|||
105886777|NCT03214380|365241733|FG005|Lead-in|Eligibility Criteria|0|||
105886778|NCT03214380|365241728|FG000|Lead-in|Physician Decision|6|||
105886779|NCT03214380|365241729|FG001|Lead-in|Physician Decision|0|||
105886780|NCT03214380|365241730|FG002|Lead-in|Physician Decision|0|||
105886781|NCT03214380|365241731|FG003|Lead-in|Physician Decision|0|||
105886782|NCT03214380|365241732|FG004|Lead-in|Physician Decision|0|||
105886783|NCT03214380|365241733|FG005|Lead-in|Physician Decision|0|||
105886784|NCT03214380|365241728|FG000|Lead-in|Protocol Deviation|7|||
105886785|NCT03214380|365241729|FG001|Lead-in|Protocol Deviation|0|||
105886786|NCT03214380|365241730|FG002|Lead-in|Protocol Deviation|0|||
105886787|NCT03214380|365241731|FG003|Lead-in|Protocol Deviation|3|||
105886788|NCT03214380|365241732|FG004|Lead-in|Protocol Deviation|0|||
105886789|NCT03214380|365241733|FG005|Lead-in|Protocol Deviation|0|||
105886790|NCT03214380|365241728|FG000|Lead-in|Withdrawal by Subject|41|||
105886791|NCT03214380|365241729|FG001|Lead-in|Withdrawal by Subject|0|||
106114271|NCT01852058|366074451|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
106114272|NCT01852058|366074452|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
106114273|NCT01852058|366074453|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
106114274|NCT01852058|366074442|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114275|NCT01852058|366074443|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114276|NCT01852058|366074444|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114277|NCT01852058|366074445|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114278|NCT01852058|366074446|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
106114279|NCT01852058|366074447|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
106114280|NCT01852058|366074448|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114281|NCT01852058|366074449|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114282|NCT01852058|366074450|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114283|NCT01852058|366074451|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114284|NCT01852058|366074452|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114285|NCT01852058|366074453|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
106114286|NCT01852058|366074442|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114287|NCT01852058|366074443|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114288|NCT01852058|366074444|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114289|NCT01852058|366074445|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114290|NCT01852058|366074446|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114291|NCT01852058|366074447|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114292|NCT01852058|366074448|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114293|NCT01852058|366074449|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
106114294|NCT01852058|366074450|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114295|NCT01852058|366074451|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114296|NCT01852058|366074452|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114297|NCT01852058|366074453|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
106114298|NCT01852058|366074442|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114299|NCT01852058|366074443|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114300|NCT01852058|366074444|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
105886792|NCT03214380|365241730|FG002|Lead-in|Withdrawal by Subject|0|||
105886793|NCT03214380|365241731|FG003|Lead-in|Withdrawal by Subject|14|||
105886794|NCT03214380|365241732|FG004|Lead-in|Withdrawal by Subject|0|||
105886795|NCT03214380|365241733|FG005|Lead-in|Withdrawal by Subject|0|||
105886796|NCT03214380|365241728|FG000|Lead-in|Family Emergency|1|||
105886797|NCT03214380|365241729|FG001|Lead-in|Family Emergency|0|||
105886798|NCT03214380|365241730|FG002|Lead-in|Family Emergency|0|||
105886799|NCT03214380|365241731|FG003|Lead-in|Family Emergency|0|||
105886800|NCT03214380|365241732|FG004|Lead-in|Family Emergency|0|||
105886801|NCT03214380|365241733|FG005|Lead-in|Family Emergency|0|||
105886802|NCT03214380|365241728|FG000|Lead-in|Natural Disaster|9|||
105886803|NCT03214380|365241729|FG001|Lead-in|Natural Disaster|0|||
105886804|NCT03214380|365241730|FG002|Lead-in|Natural Disaster|0|||
105886805|NCT03214380|365241731|FG003|Lead-in|Natural Disaster|0|||
105886806|NCT03214380|365241732|FG004|Lead-in|Natural Disaster|0|||
105886807|NCT03214380|365241733|FG005|Lead-in|Natural Disaster|0|||
105886808|NCT03214380|365241728|FG000|Lead-in|Non Compliance|1|||
105886809|NCT03214380|365241729|FG001|Lead-in|Non Compliance|0|||
105886810|NCT03214380|365241730|FG002|Lead-in|Non Compliance|0|||
105886811|NCT03214380|365241731|FG003|Lead-in|Non Compliance|0|||
105886812|NCT03214380|365241732|FG004|Lead-in|Non Compliance|0|||
106114301|NCT01852058|366074445|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114302|NCT01852058|366074446|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114303|NCT01852058|366074447|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114304|NCT01852058|366074448|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114305|NCT01852058|366074449|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114306|NCT01852058|366074450|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
106114307|NCT01852058|366074451|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114308|NCT01852058|366074452|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114309|NCT01852058|366074453|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
106114310|NCT01301274|366074454|FG000|Overall Study|Physician Decision|2|||
106114311|NCT01301274|366074455|FG001|Overall Study|Physician Decision|1|||
106114312|NCT01119898|366074456|FG000|Overall Study|Adverse Event|4|||
106114313|NCT01119898|366074457|FG001|Overall Study|Adverse Event|5|||
106114314|NCT01119898|366074456|FG000|Overall Study|Withdrawal by Subject|1|||
106114315|NCT01119898|366074457|FG001|Overall Study|Withdrawal by Subject|4|||
106114316|NCT01119898|366074456|FG000|Overall Study|Lack of Efficacy|0|||
106114317|NCT01119898|366074457|FG001|Overall Study|Lack of Efficacy|2|||
106114318|NCT01119898|366074456|FG000|Overall Study|Protocol Violation|1|||
106114319|NCT01119898|366074457|FG001|Overall Study|Protocol Violation|1|||
106114320|NCT01119898|366074456|FG000|Overall Study|Medical procedure|1|||
106114321|NCT01119898|366074457|FG001|Overall Study|Medical procedure|0|||
106114322|NCT01119898|366074456|FG000|Overall Study|Randomized in error did not participate|1|||
106114323|NCT01119898|366074457|FG001|Overall Study|Randomized in error did not participate|0|||
106114324|NCT01833143|366074458|FG000|Overall Study|Not Treated|1|||
106114325|NCT03995784|366074459|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
106114326|NCT00069784|366074460|FG000|Overall Study|Adverse Event|105|||
106114327|NCT00069784|366074461|FG001|Overall Study|Adverse Event|0|||
106114328|NCT00069784|366074460|FG000|Overall Study|Withdrawal by Subject|1090|||
106114329|NCT00069784|366074461|FG001|Overall Study|Withdrawal by Subject|0|||
106114330|NCT00069784|366074460|FG000|Overall Study|Other|17|||
106114331|NCT00069784|366074461|FG001|Overall Study|Other|0|||
106114332|NCT00738101|366074462|FG000|Overall Study|Physician Decision|5|||
106114333|NCT00738101|366074462|FG000|Overall Study|Death|1|||
106114334|NCT00738101|366074462|FG000|Overall Study|Repeat enrollment|1|||
106114335|NCT01786330|366074464|FG000|Overall Study|Withdrawal by Subject|0|||
106114336|NCT01786330|366074465|FG001|Overall Study|Withdrawal by Subject|1|||
106114337|NCT01786330|366074464|FG000|Overall Study|Lost to Follow-up|0|||
106114338|NCT01786330|366074465|FG001|Overall Study|Lost to Follow-up|1|||
106114339|NCT01786330|366074464|FG000|Overall Study|Excluded intraoperatively|0|||
106114340|NCT01786330|366074465|FG001|Overall Study|Excluded intraoperatively|1|||
106114341|NCT01786330|366074464|FG000|Overall Study|Protocol Violation|1|||
106114342|NCT01786330|366074465|FG001|Overall Study|Protocol Violation|0|||
106114343|NCT02172625|366074468|FG000|Overall Study|Adverse Event|0|||
106114344|NCT02172625|366074469|FG001|Overall Study|Adverse Event|1|||
106114345|NCT02172625|366074468|FG000|Overall Study|Pregnancy|0|||
106114346|NCT02172625|366074469|FG001|Overall Study|Pregnancy|1|||
106114347|NCT02172625|366074468|FG000|Overall Study|car accident|0|||
106114348|NCT02172625|366074469|FG001|Overall Study|car accident|1|||
106114349|NCT03315130|366074470|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
106114350|NCT03315130|366074471|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
106114351|NCT03315130|366074472|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
106114352|NCT03315130|366074473|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
106114353|NCT03315130|366074470|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
106114354|NCT03315130|366074471|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
106114355|NCT03315130|366074472|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
106114356|NCT03315130|366074473|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
106114357|NCT03315130|366074470|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
106114358|NCT03315130|366074471|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
106114359|NCT03315130|366074472|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
106114360|NCT03315130|366074473|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
106114361|NCT03315130|366074470|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
106114362|NCT03315130|366074471|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
105886813|NCT03214380|365241733|FG005|Lead-in|Non Compliance|0|||
105886814|NCT03214380|365241728|FG000|Lead-in|Participant Schedule|2|||
105886815|NCT03214380|365241729|FG001|Lead-in|Participant Schedule|0|||
105886816|NCT03214380|365241730|FG002|Lead-in|Participant Schedule|0|||
105886817|NCT03214380|365241731|FG003|Lead-in|Participant Schedule|0|||
105886818|NCT03214380|365241732|FG004|Lead-in|Participant Schedule|0|||
105886819|NCT03214380|365241733|FG005|Lead-in|Participant Schedule|0|||
105886820|NCT03214380|365241728|FG000|Treatment Period|Adverse Event|0|||
105886821|NCT03214380|365241729|FG001|Treatment Period|Adverse Event|1|||
105886822|NCT03214380|365241730|FG002|Treatment Period|Adverse Event|1|||
105886823|NCT03214380|365241731|FG003|Treatment Period|Adverse Event|0|||
105886824|NCT03214380|365241732|FG004|Treatment Period|Adverse Event|1|||
105886825|NCT03214380|365241733|FG005|Treatment Period|Adverse Event|0|||
105886826|NCT03214380|365241728|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
105886827|NCT03214380|365241729|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
105886828|NCT03214380|365241730|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
105886829|NCT03214380|365241731|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
105886830|NCT03214380|365241732|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
105886831|NCT03214380|365241733|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
105886832|NCT03214380|365241728|FG000|Treatment Period|Withdrawal by Subject|0|||
105886833|NCT03214380|365241729|FG001|Treatment Period|Withdrawal by Subject|10|||
105886834|NCT03214380|365241730|FG002|Treatment Period|Withdrawal by Subject|8|||
105886835|NCT03214380|365241731|FG003|Treatment Period|Withdrawal by Subject|0|||
105886836|NCT03214380|365241732|FG004|Treatment Period|Withdrawal by Subject|7|||
105886837|NCT03214380|365241733|FG005|Treatment Period|Withdrawal by Subject|11|||
105886838|NCT03214380|365241728|FG000|Treatment Period|Death|0|||
105886839|NCT03214380|365241729|FG001|Treatment Period|Death|1|||
105886840|NCT03214380|365241730|FG002|Treatment Period|Death|2|||
105886841|NCT03214380|365241731|FG003|Treatment Period|Death|0|||
105886842|NCT03214380|365241732|FG004|Treatment Period|Death|0|||
105886843|NCT03214380|365241733|FG005|Treatment Period|Death|0|||
105886844|NCT03214380|365241728|FG000|Treatment Period|Lost to Follow-up|0|||
105886845|NCT03214380|365241729|FG001|Treatment Period|Lost to Follow-up|6|||
105886846|NCT03214380|365241730|FG002|Treatment Period|Lost to Follow-up|3|||
105886847|NCT03214380|365241731|FG003|Treatment Period|Lost to Follow-up|0|||
105886848|NCT03214380|365241732|FG004|Treatment Period|Lost to Follow-up|0|||
105886849|NCT03214380|365241733|FG005|Treatment Period|Lost to Follow-up|0|||
105886850|NCT03214380|365241728|FG000|Treatment Period|Participant schedule|0|||
105886851|NCT03214380|365241729|FG001|Treatment Period|Participant schedule|0|||
105886852|NCT03214380|365241730|FG002|Treatment Period|Participant schedule|1|||
105886853|NCT03214380|365241731|FG003|Treatment Period|Participant schedule|0|||
105886854|NCT03214380|365241732|FG004|Treatment Period|Participant schedule|0|||
105886855|NCT03214380|365241733|FG005|Treatment Period|Participant schedule|0|||
105886856|NCT03214380|365241728|FG000|Treatment Period|Treatment Interruption|0|||
105886857|NCT03214380|365241729|FG001|Treatment Period|Treatment Interruption|0|||
105886858|NCT03214380|365241730|FG002|Treatment Period|Treatment Interruption|1|||
105886859|NCT03214380|365241731|FG003|Treatment Period|Treatment Interruption|0|||
105886860|NCT03214380|365241732|FG004|Treatment Period|Treatment Interruption|0|||
105886861|NCT03214380|365241733|FG005|Treatment Period|Treatment Interruption|0|||
105886862|NCT03962790|365241741|FG000|Period 1|Adverse Event|0|||
105886863|NCT03962790|365241742|FG001|Period 1|Adverse Event|1|||
105886864|NCT03962790|365241741|FG000|Period 1|Failed to meet all eligibility criteria|1|||
106114363|NCT03315130|366074472|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
106114364|NCT03315130|366074473|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
106114365|NCT03315130|366074470|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
106114366|NCT03315130|366074471|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
106114367|NCT03315130|366074472|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
106114368|NCT03315130|366074473|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
106114369|NCT03315130|366074470|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
106114370|NCT03315130|366074471|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
106114371|NCT03315130|366074472|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
106114372|NCT03315130|366074473|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
106114373|NCT01679236|366076354|FG000|Overall Study|Lost to Follow-up|15|||
106114374|NCT01679236|366076355|FG001|Overall Study|Lost to Follow-up|15|||
106114375|NCT04277455|366076356|FG000|Overall Study|Lost to Follow-up|1|||
106114376|NCT02202434|366076359|FG000|Overall Study|Death|70|||
106114377|NCT02202434|366076360|FG001|Overall Study|Death|39|||
106114378|NCT02202434|366076361|FG002|Overall Study|Death|13|||
106114379|NCT02202434|366076362|FG003|Overall Study|Death|27|||
106114380|NCT02202434|366076359|FG000|Overall Study|Lost to Follow-up|1|||
106114381|NCT02202434|366076360|FG001|Overall Study|Lost to Follow-up|1|||
106114382|NCT02202434|366076361|FG002|Overall Study|Lost to Follow-up|1|||
106114383|NCT02202434|366076362|FG003|Overall Study|Lost to Follow-up|0|||
106114384|NCT02202434|366076359|FG000|Overall Study|Physician Decision|2|||
105886865|NCT03962790|365241742|FG001|Period 1|Failed to meet all eligibility criteria|1|||
105886866|NCT03962790|365241741|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
105886867|NCT03962790|365241742|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
105886868|NCT03962790|365241741|FG000|Period 1|Withdrawal by Subject|1|||
105886869|NCT03962790|365241742|FG001|Period 1|Withdrawal by Subject|0|||
105886870|NCT00076752|365241745|FG000|Overall Study|Death|2|||
105886871|NCT00076752|365241745|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
105886872|NCT00452673|365241746|FG000|Dose Escalation Period|Disease Progression|6|||
105886873|NCT00452673|365241747|FG001|Dose Escalation Period|Disease Progression|6|||
105886874|NCT00452673|365241748|FG002|Dose Escalation Period|Disease Progression|2|||
105886875|NCT00452673|365241749|FG003|Dose Escalation Period|Disease Progression|6|||
105886876|NCT00452673|365241750|FG004|Dose Escalation Period|Disease Progression|0|||
105886877|NCT00452673|365241746|FG000|Dose Escalation Period|study drug toxicity|1|||
105886878|NCT00452673|365241747|FG001|Dose Escalation Period|study drug toxicity|3|||
105886879|NCT00452673|365241748|FG002|Dose Escalation Period|study drug toxicity|3|||
105886880|NCT00452673|365241749|FG003|Dose Escalation Period|study drug toxicity|1|||
105886881|NCT00452673|365241750|FG004|Dose Escalation Period|study drug toxicity|0|||
105886882|NCT00452673|365241746|FG000|Dose Escalation Period|Other|0|||
105886883|NCT00452673|365241747|FG001|Dose Escalation Period|Other|0|||
105886884|NCT00452673|365241748|FG002|Dose Escalation Period|Other|1|||
105886885|NCT00452673|365241749|FG003|Dose Escalation Period|Other|0|||
105886886|NCT00452673|365241750|FG004|Dose Escalation Period|Other|0|||
105886887|NCT00452673|365241746|FG000|Dose Escalation Period|Adverse Event|0|||
105886888|NCT00452673|365241747|FG001|Dose Escalation Period|Adverse Event|0|||
105886889|NCT00452673|365241748|FG002|Dose Escalation Period|Adverse Event|0|||
105886890|NCT00452673|365241749|FG003|Dose Escalation Period|Adverse Event|1|||
105886891|NCT00452673|365241750|FG004|Dose Escalation Period|Adverse Event|0|||
105886892|NCT00452673|365241746|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
105886893|NCT00452673|365241747|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
105886894|NCT00452673|365241748|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
105886895|NCT00452673|365241749|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
105886896|NCT00452673|365241750|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
105886897|NCT00452673|365241746|FG000|Dose Expansion Period|Disease Progression|0|||
105886898|NCT00452673|365241747|FG001|Dose Expansion Period|Disease Progression|0|||
105886899|NCT00452673|365241748|FG002|Dose Expansion Period|Disease Progression|0|||
105886900|NCT00452673|365241749|FG003|Dose Expansion Period|Disease Progression|0|||
105886901|NCT00452673|365241750|FG004|Dose Expansion Period|Disease Progression|19|||
105886902|NCT00452673|365241746|FG000|Dose Expansion Period|Other|0|||
105886903|NCT00452673|365241747|FG001|Dose Expansion Period|Other|0|||
105886904|NCT00452673|365241748|FG002|Dose Expansion Period|Other|0|||
105886905|NCT00452673|365241749|FG003|Dose Expansion Period|Other|0|||
105886906|NCT00452673|365241750|FG004|Dose Expansion Period|Other|2|||
105886907|NCT02656290|365241751|FG000|Overall Study|Lost to Follow-up|1|||
105886908|NCT02656290|365241751|FG000|Overall Study|Reintervention|3|||
105886909|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
105886910|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
105886911|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
105886912|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
105886913|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
105886914|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
105886915|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
105886916|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
105886917|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Death|0|||
105886918|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Death|1|||
105994393|NCT02343406|365638055|FG004|Overall Study|Death|0|||
105994394|NCT02343406|365638051|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
105994395|NCT02343406|365638052|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
105994396|NCT02343406|365638053|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
105994397|NCT02343406|365638054|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
105994398|NCT02343406|365638055|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
105994399|NCT02343406|365638051|FG000|Overall Study|Other primary malignancy|0|||
105994400|NCT02343406|365638052|FG001|Overall Study|Other primary malignancy|1|||
105994401|NCT02343406|365638053|FG002|Overall Study|Other primary malignancy|0|||
105994402|NCT02343406|365638054|FG003|Overall Study|Other primary malignancy|0|||
105994403|NCT02343406|365638055|FG004|Overall Study|Other primary malignancy|0|||
105886919|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
105886920|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
105886921|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
105994404|NCT02343406|365638051|FG000|Overall Study|Other, not specified|2|||
105994405|NCT02343406|365638052|FG001|Overall Study|Other, not specified|1|||
105994406|NCT02343406|365638053|FG002|Overall Study|Other, not specified|1|||
105994407|NCT02343406|365638054|FG003|Overall Study|Other, not specified|4|||
105886922|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
105886923|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
105886924|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
105886925|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
105994408|NCT02343406|365638055|FG004|Overall Study|Other, not specified|0|||
105886926|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
105886927|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
105886928|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
105886929|NCT00394836|365241754|FG000|Teatment or Follow-up Phase|Non compliance|0|||
105886930|NCT00394836|365241755|FG001|Teatment or Follow-up Phase|Non compliance|1|||
105886931|NCT00394836|365241754|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
106114385|NCT02202434|366076360|FG001|Overall Study|Physician Decision|3|||
106114386|NCT02202434|366076361|FG002|Overall Study|Physician Decision|0|||
106114387|NCT02202434|366076362|FG003|Overall Study|Physician Decision|0|||
106114388|NCT02202434|366076359|FG000|Overall Study|Withdrawal by Subject|13|||
106114389|NCT02202434|366076360|FG001|Overall Study|Withdrawal by Subject|14|||
106114390|NCT02202434|366076361|FG002|Overall Study|Withdrawal by Subject|1|||
106114391|NCT02202434|366076362|FG003|Overall Study|Withdrawal by Subject|4|||
105886932|NCT00394836|365241755|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
105886933|NCT00394836|365241754|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
105886934|NCT00394836|365241755|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
105886935|NCT00394836|365241754|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
105886936|NCT00394836|365241755|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
105886937|NCT00394836|365241754|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
105886938|NCT00394836|365241755|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
105886939|NCT04725812|365241756|FG000|Overall Study|Withdrawal by Subject|1|||
105886940|NCT02461524|365241760|FG000|Overall Study|Death|16|||
105886941|NCT02461524|365241760|FG000|Overall Study|Withdrawal by Subject|4|||
105886942|NCT02461524|365241760|FG000|Overall Study|Device Explanted|5|||
105886943|NCT02461524|365241760|FG000|Overall Study|Missed Visit|6|||
105886944|NCT00231114|365241766|FG000|Randomized|Withdrawal by Subject|6|||
105886945|NCT00231114|365241767|FG001|Randomized|Withdrawal by Subject|3|||
105886946|NCT00231114|365241766|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
105886947|NCT00231114|365241767|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
105886948|NCT00231114|365241766|FG000|Post-Treatment Period|Lost to Follow-up|6|||
105886949|NCT00231114|365241767|FG001|Post-Treatment Period|Lost to Follow-up|1|||
105886950|NCT00231114|365241766|FG000|Post-Treatment Period|Physician Decision|1|||
105886951|NCT00231114|365241767|FG001|Post-Treatment Period|Physician Decision|0|||
105886952|NCT00231114|365241766|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
105886953|NCT00231114|365241767|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
105886954|NCT02048826|365241768|FG000|Overall Study|Withdrawal by Subject|1|||
105886955|NCT02048826|365241769|FG001|Overall Study|Withdrawal by Subject|0|||
105886956|NCT04470544|365241770|FG000|Overall Study|Withdrawal by Subject|4|||
105886957|NCT04470544|365241771|FG001|Overall Study|Withdrawal by Subject|6|||
105886958|NCT00712881|365241773|FG000|Overall Study|Adverse Event|3|||
105886959|NCT00712881|365241774|FG001|Overall Study|Adverse Event|3|||
105886960|NCT00712881|365241773|FG000|Overall Study|Withdrawal by Subject|1|||
105886961|NCT00712881|365241774|FG001|Overall Study|Withdrawal by Subject|1|||
105886962|NCT00712881|365241773|FG000|Overall Study|Disease Progression|2|||
105886963|NCT00712881|365241774|FG001|Overall Study|Disease Progression|1|||
105886964|NCT00712881|365241773|FG000|Overall Study|Lost to Follow-up|1|||
105886965|NCT00712881|365241774|FG001|Overall Study|Lost to Follow-up|1|||
105886966|NCT00712881|365241773|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
105886967|NCT00712881|365241774|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
105886968|NCT00712881|365241773|FG000|Overall Study|Protocol Violation|1|||
105886969|NCT00712881|365241774|FG001|Overall Study|Protocol Violation|1|||
105886970|NCT00712881|365241773|FG000|Overall Study|Randomized but not treated|1|||
105886971|NCT00712881|365241774|FG001|Overall Study|Randomized but not treated|0|||
105886972|NCT00507819|365241777|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
105886973|NCT00507819|365241778|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
105886974|NCT02244463|365241779|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
105886975|NCT02244463|365241780|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105886976|NCT02244463|365241781|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105886977|NCT02244463|365241782|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105886978|NCT02244463|365241783|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
106114392|NCT02202434|366076359|FG000|Overall Study|Completed Study|1|||
106114393|NCT02202434|366076360|FG001|Overall Study|Completed Study|0|||
106114394|NCT02202434|366076361|FG002|Overall Study|Completed Study|0|||
106114395|NCT02202434|366076362|FG003|Overall Study|Completed Study|0|||
105886979|NCT02244463|365241784|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
105886980|NCT02244463|365241779|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
105886981|NCT02244463|365241780|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
105886982|NCT02244463|365241781|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
105886983|NCT02244463|365241782|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
105886984|NCT02244463|365241783|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
106114396|NCT02202434|366076359|FG000|Overall Study|Visit Missed|21|||
106114397|NCT02202434|366076360|FG001|Overall Study|Visit Missed|12|||
106114398|NCT02202434|366076361|FG002|Overall Study|Visit Missed|0|||
106114399|NCT02202434|366076362|FG003|Overall Study|Visit Missed|5|||
106114400|NCT02202434|366076359|FG000|Overall Study|Other|1|||
106114401|NCT02202434|366076360|FG001|Overall Study|Other|0|||
106114402|NCT02202434|366076361|FG002|Overall Study|Other|0|||
106114403|NCT02202434|366076362|FG003|Overall Study|Other|1|||
106114404|NCT01160484|366076367|FG000|Overall Study|Lack of Efficacy|9|||
106114405|NCT01160484|366076367|FG000|Overall Study|Adverse Event|6|||
106114406|NCT01160484|366076367|FG000|Overall Study|Withdrawal by Subject|2|||
106114407|NCT01160484|366076367|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
106114408|NCT00803101|366076368|FG000|Overall Study|Death / Serious Adverse Event|4|||
106114409|NCT00803101|366076369|FG001|Overall Study|Death / Serious Adverse Event|6|||
106114410|NCT00803101|366076368|FG000|Overall Study|Withdrawal by Subject|6|||
106114411|NCT00803101|366076369|FG001|Overall Study|Withdrawal by Subject|4|||
106114412|NCT00803101|366076368|FG000|Overall Study|Lost to Follow-up|2|||
106114413|NCT00803101|366076369|FG001|Overall Study|Lost to Follow-up|2|||
106114414|NCT00803101|366076368|FG000|Overall Study|Protocol Violation|1|||
106114415|NCT00803101|366076369|FG001|Overall Study|Protocol Violation|7|||
106114416|NCT00803101|366076368|FG000|Overall Study|Surgery finished outside protocol window|1|||
106114417|NCT00803101|366076369|FG001|Overall Study|Surgery finished outside protocol window|1|||
106114418|NCT00803101|366076368|FG000|Overall Study|Patient died outside SAE report period|1|||
106114419|NCT00803101|366076369|FG001|Overall Study|Patient died outside SAE report period|0|||
106114420|NCT00803101|366076368|FG000|Overall Study|Patient did not attend scheduled visit|2|||
106114421|NCT00803101|366076369|FG001|Overall Study|Patient did not attend scheduled visit|1|||
106114422|NCT00803101|366076368|FG000|Overall Study|Patient did not have surgery|1|||
106114423|NCT00803101|366076369|FG001|Overall Study|Patient did not have surgery|1|||
106114424|NCT01108458|366076370|FG000|Overall Study|Withdrawal by Subject|1|||
106114425|NCT01382602|366076371|FG000|Overall Study|Protocol Violation|0|||
106114426|NCT01382602|366076372|FG001|Overall Study|Protocol Violation|3|||
106114427|NCT01382602|366076371|FG000|Overall Study|Withdrawal by Subject|0|||
106114428|NCT01382602|366076372|FG001|Overall Study|Withdrawal by Subject|1|||
106114429|NCT02790073|366076373|FG000|Overall Study|Death|1|||
106114430|NCT02790073|366076373|FG000|Overall Study|Withdrawal from HD|1|||
106114431|NCT02790073|366076373|FG000|Overall Study|Withdrawal by Subject|1|||
106114432|NCT03328143|366076374|FG000|Overall Study|Declined|3|||
106114433|NCT03328143|366076374|FG000|Overall Study|Required increased sedation|4|||
106114434|NCT03328143|366076374|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
106114435|NCT03328143|366076374|FG000|Overall Study|Surgery cancelled|1|||
106114436|NCT02494921|366076375|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
106114437|NCT02494921|366076376|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
106114438|NCT02494921|366076377|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
106114439|NCT02494921|366076378|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
106114440|NCT02494921|366076379|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
106114441|NCT02494921|366076375|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
106114442|NCT02494921|366076376|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
106114443|NCT02494921|366076377|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
106114444|NCT02494921|366076378|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
106114445|NCT02494921|366076379|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
106114446|NCT02494921|366076375|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
106114447|NCT02494921|366076376|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
106114448|NCT02494921|366076377|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
106114449|NCT02494921|366076378|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
106114450|NCT02494921|366076379|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
106114451|NCT04461795|366076380|FG000|Overall Study|Lost to Follow-up|2|||
106114452|NCT04461795|366076380|FG000|Overall Study|Withdrawal by Subject|2|||
106114453|NCT04461795|366076380|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
106114454|NCT00615264|366076382|FG000|Overall Study|Withdrawal by Subject|17|||
106114455|NCT00615264|366076383|FG001|Overall Study|Withdrawal by Subject|19|||
106114456|NCT00615264|366076382|FG000|Overall Study|Lost to Follow-up|6|||
106114457|NCT00615264|366076383|FG001|Overall Study|Lost to Follow-up|13|||
106114458|NCT00615264|366076382|FG000|Overall Study|Adverse Event|8|||
106114459|NCT00615264|366076383|FG001|Overall Study|Adverse Event|5|||
106114460|NCT00615264|366076382|FG000|Overall Study|Death|1|||
106114461|NCT00615264|366076383|FG001|Overall Study|Death|1|||
106114462|NCT00615264|366076382|FG000|Overall Study|Protocol Violation|11|||
106114463|NCT00615264|366076383|FG001|Overall Study|Protocol Violation|7|||
106114464|NCT00615264|366076382|FG000|Overall Study|Not defined|7|||
106114465|NCT00615264|366076383|FG001|Overall Study|Not defined|4|||
106114466|NCT00615264|366076382|FG000|Overall Study|Dermal Hypersensitivity|0|||
106114467|NCT00615264|366076383|FG001|Overall Study|Dermal Hypersensitivity|3|||
106114468|NCT01492686|366076384|FG000|Double-blind Phase|Adverse Event|0|||
106114469|NCT01492686|366076385|FG001|Double-blind Phase|Adverse Event|2|||
106114470|NCT01492686|366076384|FG000|Double-blind Phase|Physician Decision|0|||
106114471|NCT01492686|366076385|FG001|Double-blind Phase|Physician Decision|1|||
106114472|NCT01492686|366076384|FG000|Double-blind Phase|Withdrawal by Subject|0|||
106114473|NCT01492686|366076385|FG001|Double-blind Phase|Withdrawal by Subject|2|||
106114474|NCT01492686|366076384|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
106114475|NCT01492686|366076385|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
106114476|NCT01492686|366076384|FG000|Open-label Phase|Adverse Event|1|||
106114477|NCT01492686|366076385|FG001|Open-label Phase|Adverse Event|2|||
106114478|NCT01492686|366076384|FG000|Open-label Phase|Physician Decision|1|||
106114479|NCT01492686|366076385|FG001|Open-label Phase|Physician Decision|0|||
106114480|NCT01492686|366076384|FG000|Open-label Phase|Withdrawal by Subject|6|||
106114481|NCT01492686|366076385|FG001|Open-label Phase|Withdrawal by Subject|7|||
106114482|NCT01492686|366076384|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
106114483|NCT01492686|366076385|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
106114484|NCT03502616|366076388|FG000|Up to Week 16|Withdrawal by Subject|1|||
106114485|NCT03502616|366076389|FG001|Up to Week 16|Withdrawal by Subject|2|||
106114486|NCT03502616|366076388|FG000|Up to Week 16|Lost to Follow-up|0|||
106114487|NCT03502616|366076389|FG001|Up to Week 16|Lost to Follow-up|1|||
106114488|NCT03502616|366076388|FG000|Up to Week 16|Randomized, but not treated|1|||
106114489|NCT03502616|366076389|FG001|Up to Week 16|Randomized, but not treated|0|||
106114490|NCT03502616|366076388|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
106114491|NCT03502616|366076389|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
106114492|NCT03502616|366076388|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
106114493|NCT03502616|366076389|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
106114494|NCT01691521|366076390|FG000|Overall Study|Adverse Event|4|||
106114495|NCT01691521|366076391|FG001|Overall Study|Adverse Event|0|||
106114496|NCT01691521|366076392|FG002|Overall Study|Adverse Event|1|||
106114497|NCT01691521|366076390|FG000|Overall Study|Lack of Efficacy|1|||
106114498|NCT01691521|366076391|FG001|Overall Study|Lack of Efficacy|1|||
106114499|NCT01691521|366076392|FG002|Overall Study|Lack of Efficacy|2|||
106114500|NCT01691521|366076390|FG000|Overall Study|Protocol Violation|0|||
106114501|NCT01691521|366076391|FG001|Overall Study|Protocol Violation|3|||
106114502|NCT01691521|366076392|FG002|Overall Study|Protocol Violation|0|||
106114503|NCT01691521|366076390|FG000|Overall Study|Lost to Follow-up|0|||
106114504|NCT01691521|366076391|FG001|Overall Study|Lost to Follow-up|2|||
106114505|NCT01691521|366076392|FG002|Overall Study|Lost to Follow-up|2|||
106114506|NCT01691521|366076390|FG000|Overall Study|Physician Decision|2|||
106114507|NCT01691521|366076391|FG001|Overall Study|Physician Decision|1|||
106114508|NCT01691521|366076392|FG002|Overall Study|Physician Decision|0|||
106114509|NCT01691521|366076390|FG000|Overall Study|Withdrawal by Subject|5|||
106114510|NCT01691521|366076391|FG001|Overall Study|Withdrawal by Subject|9|||
106114511|NCT01691521|366076392|FG002|Overall Study|Withdrawal by Subject|4|||
106114512|NCT04503096|366076393|FG000|Overall Study|Withdrawal by Subject|3|||
106114513|NCT01480596|366076394|FG000|Overall Study|Adverse Event|3|||
106114514|NCT01480596|366076395|FG001|Overall Study|Adverse Event|0|||
106114515|NCT01480596|366076394|FG000|Overall Study|MG exacerbation or change in medication|2|||
106114516|NCT01480596|366076395|FG001|Overall Study|MG exacerbation or change in medication|2|||
106114517|NCT02343003|366076399|FG000|Overall Study|Withdrawal by Subject|9|||
106114518|NCT02343003|366076400|FG001|Overall Study|Withdrawal by Subject|4|||
106114519|NCT02343003|366076399|FG000|Overall Study|Lost to Follow-up|5|||
106114520|NCT02343003|366076400|FG001|Overall Study|Lost to Follow-up|1|||
106114521|NCT02343003|366076399|FG000|Overall Study|Protocol Violation|1|||
106114522|NCT02343003|366076400|FG001|Overall Study|Protocol Violation|0|||
106114523|NCT02343003|366076399|FG000|Overall Study|Death|0|||
106114524|NCT02343003|366076400|FG001|Overall Study|Death|1|||
106114525|NCT02343003|366076399|FG000|Overall Study|exclusion criteria met|1|||
106114526|NCT02343003|366076400|FG001|Overall Study|exclusion criteria met|1|||
106114527|NCT02343003|366076399|FG000|Overall Study|terminated by sponsor|2|||
106114528|NCT02343003|366076400|FG001|Overall Study|terminated by sponsor|0|||
106114529|NCT01785563|366076401|FG000|Overall Study|Physician Decision|10|||
106114530|NCT01785563|366076401|FG000|Overall Study|Withdrawal by Subject|1|||
106114531|NCT01785563|366076401|FG000|Overall Study|Protocol Violation|2|||
106114532|NCT03954743|366076403|FG000|Overall Study|Adverse Event|1|||
106114533|NCT03954743|366076404|FG001|Overall Study|Adverse Event|0|||
106114534|NCT03954743|366076403|FG000|Overall Study|Lost to Follow-up|6|||
106114535|NCT03954743|366076404|FG001|Overall Study|Lost to Follow-up|4|||
106114536|NCT03954743|366076403|FG000|Overall Study|Protocol Violation|1|||
106114537|NCT03954743|366076404|FG001|Overall Study|Protocol Violation|0|||
106114538|NCT03954743|366076403|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
106114539|NCT03954743|366076404|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
106114540|NCT03954743|366076403|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
106114541|NCT03954743|366076404|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
106114542|NCT00860067|366076407|FG000|Overall Study|Lost to Follow-up|46|||
106114543|NCT00860067|366076408|FG001|Overall Study|Lost to Follow-up|9|||
106114544|NCT00860067|366076409|FG002|Overall Study|Lost to Follow-up|9|||
106114545|NCT00860067|366076407|FG000|Overall Study|Withdrawal by Subject|4|||
106114546|NCT00860067|366076408|FG001|Overall Study|Withdrawal by Subject|0|||
105886985|NCT02244463|365241784|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
106114547|NCT00860067|366076409|FG002|Overall Study|Withdrawal by Subject|0|||
106114548|NCT00860067|366076407|FG000|Overall Study|Pregnancy|1|||
105661752|NCT01068210|364425133|FG003|Overall Study|Lost to Follow-up|1|||
106114549|NCT00860067|366076408|FG001|Overall Study|Pregnancy|0|||
106114550|NCT00860067|366076409|FG002|Overall Study|Pregnancy|0|||
106114551|NCT00770432|366076414|FG000|Overall Study|Other|4|||
105994409|NCT02119663|365638056|FG000|Overall Study|Disease progression|26|||
105994410|NCT02119663|365638057|FG001|Overall Study|Disease progression|27|||
105994411|NCT02119663|365638056|FG000|Overall Study|Adverse Event|5|||
105994412|NCT02119663|365638057|FG001|Overall Study|Adverse Event|5|||
105994413|NCT02119663|365638056|FG000|Overall Study|Death|3|||
105994414|NCT02119663|365638057|FG001|Overall Study|Death|2|||
105994415|NCT02119663|365638056|FG000|Overall Study|Physician Decision|1|||
105994416|NCT02119663|365638057|FG001|Overall Study|Physician Decision|2|||
105994417|NCT02119663|365638056|FG000|Overall Study|Other unspecified|2|||
105994418|NCT02119663|365638057|FG001|Overall Study|Other unspecified|0|||
105994419|NCT02119663|365638056|FG000|Overall Study|Subject decision|0|||
105994420|NCT02119663|365638057|FG001|Overall Study|Subject decision|1|||
105994421|NCT02119663|365638056|FG000|Overall Study|Study Terminated by the Sponsor|3|||
105994422|NCT02119663|365638057|FG001|Overall Study|Study Terminated by the Sponsor|4|||
105994423|NCT01123395|365638063|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
105994424|NCT01123395|365638064|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
105994425|NCT03691571|365638065|FG000|Overall Study|Withdrawal by Subject|9|||
105994426|NCT03691571|365638066|FG001|Overall Study|Withdrawal by Subject|2|||
105994427|NCT02487030|365638067|FG000|Overall Study|Lack of Efficacy|2|||
105994428|NCT02487030|365638068|FG001|Overall Study|Lack of Efficacy|4|||
105994429|NCT02487030|365638069|FG002|Overall Study|Lack of Efficacy|1|||
105994430|NCT02487030|365638070|FG003|Overall Study|Lack of Efficacy|0|||
106114552|NCT00770432|366076415|FG001|Overall Study|Other|6|||
106114553|NCT00770432|366076414|FG000|Overall Study|Non-compliance|0|||
106114554|NCT00770432|366076415|FG001|Overall Study|Non-compliance|1|||
106114555|NCT02756832|366076419|FG000|Overall Study|Lost for Observation after Baseline|6|||
106114556|NCT02756832|366076419|FG000|Overall Study|Lost for Observation|13|||
106114557|NCT02756832|366076419|FG000|Overall Study|Patient's Unwillingness|12|||
106114558|NCT02756832|366076419|FG000|Overall Study|Insufficient Efficacy|2|||
106114559|NCT02756832|366076419|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
106114560|NCT02756832|366076419|FG000|Overall Study|Reason not Specified|9|||
106114561|NCT02756832|366076419|FG000|Overall Study|Protocol Deviation|10|||
106114562|NCT03579290|366076420|FG000|Overall Study|Lost to Follow-up|9|||
106114563|NCT03485911|366076421|FG000|Part 1|Perceived lack of efficacy|1|||
106114564|NCT03485911|366076422|FG001|Part 1|Perceived lack of efficacy|1|||
106114565|NCT03485911|366076423|FG002|Part 1|Perceived lack of efficacy|2|||
106114566|NCT03485911|366076424|FG003|Part 1|Perceived lack of efficacy|0|||
106114567|NCT03485911|366076421|FG000|Part 1|Subject withdrew consent|0|||
106114568|NCT03485911|366076422|FG001|Part 1|Subject withdrew consent|1|||
106114569|NCT03485911|366076423|FG002|Part 1|Subject withdrew consent|0|||
106114570|NCT03485911|366076424|FG003|Part 1|Subject withdrew consent|1|||
106114571|NCT03485911|366076421|FG000|Part 1|Lab abnormalities/AEs|3|||
106114572|NCT03485911|366076422|FG001|Part 1|Lab abnormalities/AEs|1|||
106114573|NCT03485911|366076423|FG002|Part 1|Lab abnormalities/AEs|1|||
106114574|NCT03485911|366076424|FG003|Part 1|Lab abnormalities/AEs|0|||
106114575|NCT03485911|366076421|FG000|Part 1|Withdrew Consent prior to dosing|0|||
106114576|NCT03485911|366076422|FG001|Part 1|Withdrew Consent prior to dosing|0|||
106114577|NCT03485911|366076423|FG002|Part 1|Withdrew Consent prior to dosing|0|||
106114578|NCT03485911|366076424|FG003|Part 1|Withdrew Consent prior to dosing|1|||
106114579|NCT03485911|366076421|FG000|Part 1|Other NOS|0|||
106114580|NCT03485911|366076422|FG001|Part 1|Other NOS|0|||
106114581|NCT03485911|366076423|FG002|Part 1|Other NOS|0|||
106114582|NCT03485911|366076424|FG003|Part 1|Other NOS|1|||
106114583|NCT03485911|366076421|FG000|Part 2|Perceived lack of efficacy|5|||
106114584|NCT03485911|366076422|FG001|Part 2|Perceived lack of efficacy|3|||
106114585|NCT03485911|366076423|FG002|Part 2|Perceived lack of efficacy|0|||
106114586|NCT03485911|366076424|FG003|Part 2|Perceived lack of efficacy|2|||
106114587|NCT03485911|366076421|FG000|Part 2|Subject withdrew consent|1|||
106114588|NCT03485911|366076422|FG001|Part 2|Subject withdrew consent|0|||
106114589|NCT03485911|366076423|FG002|Part 2|Subject withdrew consent|2|||
106114590|NCT03485911|366076424|FG003|Part 2|Subject withdrew consent|1|||
106114591|NCT03485911|366076421|FG000|Part 2|Lab abnormalities/AEs|1|||
106114592|NCT03485911|366076422|FG001|Part 2|Lab abnormalities/AEs|2|||
106114593|NCT03485911|366076423|FG002|Part 2|Lab abnormalities/AEs|0|||
106114594|NCT03485911|366076424|FG003|Part 2|Lab abnormalities/AEs|0|||
106114595|NCT03485911|366076421|FG000|Part 2|Other NOS|0|||
106114596|NCT03485911|366076422|FG001|Part 2|Other NOS|1|||
106114597|NCT03485911|366076423|FG002|Part 2|Other NOS|0|||
106114598|NCT03485911|366076424|FG003|Part 2|Other NOS|0|||
106114599|NCT03485911|366076421|FG000|Part 2|Intercurrent illness/new medical condition|1|||
106114600|NCT03485911|366076422|FG001|Part 2|Intercurrent illness/new medical condition|0|||
106114601|NCT03485911|366076423|FG002|Part 2|Intercurrent illness/new medical condition|0|||
106114602|NCT03485911|366076424|FG003|Part 2|Intercurrent illness/new medical condition|0|||
105994431|NCT02487030|365638071|FG004|Overall Study|Lack of Efficacy|1|||
105994432|NCT02487030|365638072|FG005|Overall Study|Lack of Efficacy|0|||
105994433|NCT02487030|365638073|FG006|Overall Study|Lack of Efficacy|0|||
105994434|NCT02487030|365638067|FG000|Overall Study|Lost to Follow-up|0|||
106114603|NCT03485911|366076421|FG000|Part 2|Investigator judgement|1|||
106114604|NCT03485911|366076422|FG001|Part 2|Investigator judgement|0|||
106114605|NCT03485911|366076423|FG002|Part 2|Investigator judgement|0|||
106114606|NCT03485911|366076424|FG003|Part 2|Investigator judgement|0|||
106114607|NCT03485911|366076421|FG000|Part 3|Perceived lack of efficacy|2|||
106114608|NCT03485911|366076422|FG001|Part 3|Perceived lack of efficacy|2|||
106114609|NCT03485911|366076423|FG002|Part 3|Perceived lack of efficacy|2|||
106114610|NCT03485911|366076424|FG003|Part 3|Perceived lack of efficacy|0|||
106114611|NCT03485911|366076421|FG000|Part 3|Subject withdrew consent|1|||
106114612|NCT03485911|366076422|FG001|Part 3|Subject withdrew consent|4|||
106114613|NCT03485911|366076423|FG002|Part 3|Subject withdrew consent|0|||
106114614|NCT03485911|366076424|FG003|Part 3|Subject withdrew consent|1|||
106114615|NCT03485911|366076421|FG000|Part 3|Lab abnormalities/AEs|1|||
106114616|NCT03485911|366076422|FG001|Part 3|Lab abnormalities/AEs|1|||
106114617|NCT03485911|366076423|FG002|Part 3|Lab abnormalities/AEs|0|||
106114618|NCT03485911|366076424|FG003|Part 3|Lab abnormalities/AEs|2|||
106114619|NCT03485911|366076421|FG000|Part 3|Other NOS|1|||
106114620|NCT03485911|366076422|FG001|Part 3|Other NOS|1|||
106114621|NCT03485911|366076423|FG002|Part 3|Other NOS|0|||
106114622|NCT03485911|366076424|FG003|Part 3|Other NOS|0|||
106114623|NCT03485911|366076421|FG000|Part 3|Intercurrent illness/new medical condition|0|||
106114624|NCT03485911|366076422|FG001|Part 3|Intercurrent illness/new medical condition|1|||
106114625|NCT03485911|366076423|FG002|Part 3|Intercurrent illness/new medical condition|1|||
106114626|NCT03485911|366076424|FG003|Part 3|Intercurrent illness/new medical condition|0|||
106114627|NCT03485911|366076421|FG000|Part 3|Sponsor discontinuation|1|||
106114628|NCT03485911|366076422|FG001|Part 3|Sponsor discontinuation|0|||
106114629|NCT03485911|366076423|FG002|Part 3|Sponsor discontinuation|0|||
106114630|NCT03485911|366076424|FG003|Part 3|Sponsor discontinuation|0|||
106114631|NCT03485911|366076421|FG000|Part 3|Berotralstat provided by alternative means|13|||
106114632|NCT03485911|366076422|FG001|Part 3|Berotralstat provided by alternative means|13|||
106114633|NCT03485911|366076423|FG002|Part 3|Berotralstat provided by alternative means|7|||
106114634|NCT03485911|366076424|FG003|Part 3|Berotralstat provided by alternative means|7|||
106114635|NCT01375205|366076425|FG000|Overall Study|Lost to Follow-up|15|||
106114636|NCT01375205|366076426|FG001|Overall Study|Lost to Follow-up|12|||
106114637|NCT01375205|366076425|FG000|Overall Study|Withdrawal by Subject|6|||
106114638|NCT01375205|366076426|FG001|Overall Study|Withdrawal by Subject|1|||
106114639|NCT01674621|366076427|FG000|Overall Study|Adverse Event|3|||
106114640|NCT01674621|366076428|FG001|Overall Study|Adverse Event|2|||
106114641|NCT01674621|366076429|FG002|Overall Study|Adverse Event|5|||
106114642|NCT01674621|366076430|FG003|Overall Study|Adverse Event|5|||
106114643|NCT01674621|366076431|FG004|Overall Study|Adverse Event|1|||
106114644|NCT01674621|366076427|FG000|Overall Study|Inability to Complete Study Procedures|0|||
106114645|NCT01674621|366076428|FG001|Overall Study|Inability to Complete Study Procedures|0|||
106114646|NCT01674621|366076429|FG002|Overall Study|Inability to Complete Study Procedures|0|||
106114647|NCT01674621|366076430|FG003|Overall Study|Inability to Complete Study Procedures|0|||
106114648|NCT01674621|366076431|FG004|Overall Study|Inability to Complete Study Procedures|2|||
106114649|NCT01674621|366076427|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
106114650|NCT01674621|366076428|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
106114651|NCT01674621|366076429|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
106114652|NCT01674621|366076430|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
106114653|NCT01674621|366076431|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
106114654|NCT01674621|366076427|FG000|Overall Study|Withdrawal by Subject|2|||
106114655|NCT01674621|366076428|FG001|Overall Study|Withdrawal by Subject|5|||
106114656|NCT01674621|366076429|FG002|Overall Study|Withdrawal by Subject|2|||
106114657|NCT01674621|366076430|FG003|Overall Study|Withdrawal by Subject|0|||
106114658|NCT01674621|366076431|FG004|Overall Study|Withdrawal by Subject|1|||
106114659|NCT01674621|366076427|FG000|Overall Study|Other than specified|0|||
106114660|NCT01674621|366076428|FG001|Overall Study|Other than specified|1|||
106114661|NCT01674621|366076429|FG002|Overall Study|Other than specified|0|||
106114662|NCT01674621|366076430|FG003|Overall Study|Other than specified|0|||
106114663|NCT01674621|366076431|FG004|Overall Study|Other than specified|2|||
106114664|NCT01859793|366076434|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
106114665|NCT01859793|366076435|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
106114666|NCT01859793|366076434|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
106114667|NCT01859793|366076435|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
106114668|NCT01859793|366076434|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
106114669|NCT01859793|366076435|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
106114670|NCT01859793|366076434|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
106114671|NCT01859793|366076435|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
106114672|NCT01735396|366076436|FG000|Overall Study|not evaluable|1|||
106114673|NCT01148862|366076437|FG000|Second Intervention|Withdrawal by Subject|0|||
106114674|NCT01148862|366076438|FG001|Second Intervention|Withdrawal by Subject|2|||
106114675|NCT03724396|366076442|FG000|Overall Study|Lost to Follow-up|1|||
106114676|NCT03724396|366076443|FG001|Overall Study|Lost to Follow-up|1|||
106114677|NCT03724396|366076442|FG000|Overall Study|Withdrawal by Subject|1|||
106114678|NCT03724396|366076443|FG001|Overall Study|Withdrawal by Subject|0|||
106114679|NCT03879408|366076444|FG000|Overall Study|Lost to Follow-up|0|||
106114680|NCT03879408|366076445|FG001|Overall Study|Lost to Follow-up|3|||
106114681|NCT03879408|366076446|FG002|Overall Study|Lost to Follow-up|2|||
106114682|NCT03879408|366076447|FG003|Overall Study|Lost to Follow-up|1|||
106114683|NCT03879408|366076448|FG004|Overall Study|Lost to Follow-up|0|||
106114684|NCT03879408|366076444|FG000|Overall Study|Withdrawal by Subject|2|||
106114685|NCT03879408|366076445|FG001|Overall Study|Withdrawal by Subject|1|||
106114686|NCT03879408|366076446|FG002|Overall Study|Withdrawal by Subject|1|||
106114687|NCT03879408|366076447|FG003|Overall Study|Withdrawal by Subject|0|||
106114688|NCT03879408|366076448|FG004|Overall Study|Withdrawal by Subject|1|||
106114689|NCT01490125|366076449|FG000|Period I|Adverse Event|4|||
106114690|NCT01490125|366076450|FG001|Period I|Adverse Event|1|||
106114691|NCT01490125|366076451|FG002|Period I|Adverse Event|1|||
106114692|NCT01490125|366076452|FG003|Period I|Adverse Event|3|||
106114693|NCT01490125|366076453|FG004|Period I|Adverse Event|2|||
106114694|NCT01490125|366076454|FG005|Period I|Adverse Event|4|||
106114695|NCT01490125|366076449|FG000|Period I|Protocol Violation|1|||
106114696|NCT01490125|366076450|FG001|Period I|Protocol Violation|1|||
106114697|NCT01490125|366076451|FG002|Period I|Protocol Violation|1|||
106114698|NCT01490125|366076452|FG003|Period I|Protocol Violation|1|||
106114699|NCT01490125|366076453|FG004|Period I|Protocol Violation|0|||
106114700|NCT01490125|366076454|FG005|Period I|Protocol Violation|0|||
106114701|NCT01490125|366076449|FG000|Period I|Withdrawal by Subject|1|||
106114702|NCT01490125|366076450|FG001|Period I|Withdrawal by Subject|3|||
106114703|NCT01490125|366076451|FG002|Period I|Withdrawal by Subject|2|||
106114704|NCT01490125|366076452|FG003|Period I|Withdrawal by Subject|1|||
106114705|NCT01490125|366076453|FG004|Period I|Withdrawal by Subject|2|||
106114706|NCT01490125|366076454|FG005|Period I|Withdrawal by Subject|1|||
106114707|NCT01490125|366076449|FG000|Period II|Adverse Event|2|||
106114708|NCT01490125|366076450|FG001|Period II|Adverse Event|3|||
106114709|NCT01490125|366076451|FG002|Period II|Adverse Event|2|||
106114710|NCT01490125|366076452|FG003|Period II|Adverse Event|2|||
106114711|NCT01490125|366076453|FG004|Period II|Adverse Event|4|||
106114712|NCT01490125|366076454|FG005|Period II|Adverse Event|2|||
106114713|NCT01490125|366076449|FG000|Period II|Protocol Violation|0|||
106114714|NCT01490125|366076450|FG001|Period II|Protocol Violation|0|||
106114715|NCT01490125|366076451|FG002|Period II|Protocol Violation|1|||
106114716|NCT01490125|366076452|FG003|Period II|Protocol Violation|1|||
106114717|NCT01490125|366076453|FG004|Period II|Protocol Violation|0|||
106114718|NCT01490125|366076454|FG005|Period II|Protocol Violation|0|||
106114719|NCT01490125|366076449|FG000|Period II|Lost to Follow-up|0|||
106114720|NCT01490125|366076450|FG001|Period II|Lost to Follow-up|1|||
106114721|NCT01490125|366076451|FG002|Period II|Lost to Follow-up|0|||
106114722|NCT01490125|366076452|FG003|Period II|Lost to Follow-up|0|||
106114723|NCT01490125|366076453|FG004|Period II|Lost to Follow-up|0|||
106114724|NCT01490125|366076454|FG005|Period II|Lost to Follow-up|0|||
106114725|NCT01490125|366076449|FG000|Period II|Withdrawal by Subject|1|||
106114726|NCT01490125|366076450|FG001|Period II|Withdrawal by Subject|0|||
106114727|NCT01490125|366076451|FG002|Period II|Withdrawal by Subject|0|||
106114728|NCT01490125|366076452|FG003|Period II|Withdrawal by Subject|0|||
106114729|NCT01490125|366076453|FG004|Period II|Withdrawal by Subject|0|||
106114730|NCT01490125|366076454|FG005|Period II|Withdrawal by Subject|0|||
106114731|NCT01490125|366076449|FG000|Period III|Adverse Event|3|||
106114732|NCT01490125|366076450|FG001|Period III|Adverse Event|1|||
106114733|NCT01490125|366076451|FG002|Period III|Adverse Event|0|||
106114734|NCT01490125|366076452|FG003|Period III|Adverse Event|1|||
106114735|NCT01490125|366076453|FG004|Period III|Adverse Event|0|||
106114736|NCT01490125|366076454|FG005|Period III|Adverse Event|0|||
106114737|NCT01490125|366076449|FG000|Period III|Death|0|||
106114738|NCT01490125|366076450|FG001|Period III|Death|0|||
106114739|NCT01490125|366076451|FG002|Period III|Death|0|||
106114740|NCT01490125|366076452|FG003|Period III|Death|1|||
106114741|NCT01490125|366076453|FG004|Period III|Death|0|||
106114742|NCT01490125|366076454|FG005|Period III|Death|0|||
106114743|NCT01490125|366076449|FG000|Period III|Lack of Efficacy|0|||
106114744|NCT01490125|366076450|FG001|Period III|Lack of Efficacy|0|||
106114745|NCT01490125|366076451|FG002|Period III|Lack of Efficacy|0|||
106114746|NCT01490125|366076452|FG003|Period III|Lack of Efficacy|0|||
106114747|NCT01490125|366076453|FG004|Period III|Lack of Efficacy|1|||
106114748|NCT01490125|366076454|FG005|Period III|Lack of Efficacy|0|||
106114749|NCT02237508|366076456|FG000|Overall Study|Withdrawal by Subject|0|||
106114750|NCT02237508|366076457|FG001|Overall Study|Withdrawal by Subject|2|||
106114751|NCT02237508|366076458|FG002|Overall Study|Withdrawal by Subject|0|||
106114752|NCT02237508|366076459|FG003|Overall Study|Withdrawal by Subject|1|||
106114753|NCT02237508|366076460|FG004|Overall Study|Withdrawal by Subject|0|||
106114754|NCT02237508|366076461|FG005|Overall Study|Withdrawal by Subject|1|||
106114755|NCT02237508|366076462|FG006|Overall Study|Withdrawal by Subject|1|||
106114756|NCT02237508|366076463|FG007|Overall Study|Withdrawal by Subject|0|||
106114757|NCT02237508|366076464|FG008|Overall Study|Withdrawal by Subject|1|||
106114758|NCT02237508|366076465|FG009|Overall Study|Withdrawal by Subject|0|||
106114759|NCT02237508|366076456|FG000|Overall Study|Physician Decision|0|||
106114760|NCT02237508|366076457|FG001|Overall Study|Physician Decision|1|||
106114761|NCT02237508|366076458|FG002|Overall Study|Physician Decision|0|||
106114762|NCT02237508|366076459|FG003|Overall Study|Physician Decision|0|||
105994435|NCT02487030|365638068|FG001|Overall Study|Lost to Follow-up|0|||
105994436|NCT02487030|365638069|FG002|Overall Study|Lost to Follow-up|1|||
105994437|NCT02487030|365638070|FG003|Overall Study|Lost to Follow-up|1|||
105994438|NCT02487030|365638071|FG004|Overall Study|Lost to Follow-up|0|||
105994439|NCT02487030|365638072|FG005|Overall Study|Lost to Follow-up|1|||
105994440|NCT02487030|365638073|FG006|Overall Study|Lost to Follow-up|0|||
105994441|NCT02487030|365638067|FG000|Overall Study|Adverse Event|0|||
105994442|NCT02487030|365638068|FG001|Overall Study|Adverse Event|0|||
105994443|NCT02487030|365638069|FG002|Overall Study|Adverse Event|0|||
105994444|NCT02487030|365638070|FG003|Overall Study|Adverse Event|1|||
105994445|NCT02487030|365638071|FG004|Overall Study|Adverse Event|0|||
105994446|NCT02487030|365638072|FG005|Overall Study|Adverse Event|0|||
105994447|NCT02487030|365638073|FG006|Overall Study|Adverse Event|0|||
105994448|NCT02487030|365638067|FG000|Overall Study|Death|0|||
105994449|NCT02487030|365638068|FG001|Overall Study|Death|0|||
105994450|NCT02487030|365638069|FG002|Overall Study|Death|0|||
105994451|NCT02487030|365638070|FG003|Overall Study|Death|0|||
105994452|NCT02487030|365638071|FG004|Overall Study|Death|1|||
105994453|NCT02487030|365638072|FG005|Overall Study|Death|0|||
105994454|NCT02487030|365638073|FG006|Overall Study|Death|0|||
105994455|NCT00947115|365638074|FG000|Overall Study|Missed reporting interval|3|||
105994456|NCT00947115|365638075|FG001|Overall Study|Missed reporting interval|4|||
105994457|NCT00947115|365638076|FG002|Overall Study|Missed reporting interval|2|||
105994458|NCT00947115|365638074|FG000|Overall Study|Physician Decision|0|||
105994459|NCT00947115|365638075|FG001|Overall Study|Physician Decision|2|||
105994460|NCT00947115|365638076|FG002|Overall Study|Physician Decision|0|||
105994461|NCT00947115|365638074|FG000|Overall Study|Death|0|||
105994462|NCT00947115|365638075|FG001|Overall Study|Death|1|||
106114763|NCT02237508|366076460|FG004|Overall Study|Physician Decision|0|||
106114764|NCT02237508|366076461|FG005|Overall Study|Physician Decision|0|||
106114765|NCT02237508|366076462|FG006|Overall Study|Physician Decision|0|||
106114766|NCT02237508|366076463|FG007|Overall Study|Physician Decision|0|||
106114767|NCT02237508|366076464|FG008|Overall Study|Physician Decision|0|||
106114768|NCT02237508|366076465|FG009|Overall Study|Physician Decision|0|||
106114769|NCT02237508|366076456|FG000|Overall Study|Protocol Violation|0|||
106114770|NCT02237508|366076457|FG001|Overall Study|Protocol Violation|0|||
106114771|NCT02237508|366076458|FG002|Overall Study|Protocol Violation|1|||
106114772|NCT02237508|366076459|FG003|Overall Study|Protocol Violation|0|||
106114773|NCT02237508|366076460|FG004|Overall Study|Protocol Violation|0|||
106114774|NCT02237508|366076461|FG005|Overall Study|Protocol Violation|0|||
106114775|NCT02237508|366076462|FG006|Overall Study|Protocol Violation|0|||
106114776|NCT02237508|366076463|FG007|Overall Study|Protocol Violation|0|||
106114777|NCT02237508|366076464|FG008|Overall Study|Protocol Violation|0|||
106114778|NCT02237508|366076465|FG009|Overall Study|Protocol Violation|0|||
106114779|NCT04954586|366076466|FG000|Overall Study|Withdrawal by Subject|5|||
106114780|NCT02055157|366076469|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
106114781|NCT02055157|366076470|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
106114782|NCT02055157|366076471|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
106114783|NCT02055157|366076472|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
106114784|NCT02055157|366076469|FG000|Initial 6 Months|Adverse Event|0|||
106114785|NCT02055157|366076470|FG001|Initial 6 Months|Adverse Event|0|||
106114786|NCT02055157|366076471|FG002|Initial 6 Months|Adverse Event|0|||
106114787|NCT02055157|366076472|FG003|Initial 6 Months|Adverse Event|1|||
106114788|NCT02055157|366076469|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
106114789|NCT02055157|366076470|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
106114790|NCT02055157|366076471|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
106114791|NCT02055157|366076472|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
106114792|NCT02055157|366076469|FG000|18-month Extension|Investigator decision|0|||
106114793|NCT02055157|366076470|FG001|18-month Extension|Investigator decision|1|||
106114794|NCT02055157|366076471|FG002|18-month Extension|Investigator decision|0|||
106114795|NCT02055157|366076472|FG003|18-month Extension|Investigator decision|0|||
105994463|NCT00947115|365638076|FG002|Overall Study|Death|1|||
105994464|NCT00947115|365638074|FG000|Overall Study|Migrated from study area|2|||
106114796|NCT02055157|366076469|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
106114797|NCT02055157|366076470|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
106114798|NCT02055157|366076471|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
106114799|NCT02055157|366076472|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
105994465|NCT00947115|365638075|FG001|Overall Study|Migrated from study area|0|||
105994466|NCT00947115|365638076|FG002|Overall Study|Migrated from study area|0|||
106114800|NCT01395823|366076475|FG000|Overall Study|Death|4|||
106114801|NCT01395823|366076476|FG001|Overall Study|Death|4|||
105994467|NCT00947115|365638074|FG000|Overall Study|Withdrawal by Subject|1|||
105994468|NCT00947115|365638075|FG001|Overall Study|Withdrawal by Subject|3|||
105994469|NCT00947115|365638076|FG002|Overall Study|Withdrawal by Subject|4|||
105994470|NCT00947115|365638074|FG000|Overall Study|Lost to Follow-up|11|||
105994471|NCT00947115|365638075|FG001|Overall Study|Lost to Follow-up|12|||
105994472|NCT00947115|365638076|FG002|Overall Study|Lost to Follow-up|8|||
105994473|NCT00584012|365640232|FG000|Overall Study|Withdrawal by Subject|1|||
106114802|NCT01395823|366076475|FG000|Overall Study|Physician Decision|3|||
106114803|NCT01395823|366076476|FG001|Overall Study|Physician Decision|1|||
106114804|NCT01395823|366076475|FG000|Overall Study|Lost to Follow-up|1|||
106114805|NCT01395823|366076476|FG001|Overall Study|Lost to Follow-up|0|||
106114806|NCT01395823|366076475|FG000|Overall Study|Transplant|1|||
106114807|NCT01395823|366076476|FG001|Overall Study|Transplant|0|||
106114808|NCT01395823|366076475|FG000|Overall Study|GI symptoms|1|||
106114809|NCT01395823|366076476|FG001|Overall Study|GI symptoms|0|||
106114810|NCT01395823|366076475|FG000|Overall Study|Withdrawal by Subject|5|||
106114811|NCT01395823|366076476|FG001|Overall Study|Withdrawal by Subject|4|||
106114812|NCT00652938|366076482|FG000|Overall Study|Adverse Event|1|||
106114813|NCT00652938|366076483|FG001|Overall Study|Adverse Event|0|||
106114814|NCT00652938|366076484|FG002|Overall Study|Adverse Event|2|||
106114815|NCT00652938|366076482|FG000|Overall Study|Withdrawal by Subject|0|||
106114816|NCT00652938|366076483|FG001|Overall Study|Withdrawal by Subject|6|||
106114817|NCT00652938|366076484|FG002|Overall Study|Withdrawal by Subject|1|||
106114818|NCT00652938|366076482|FG000|Overall Study|Lost to Follow-up|0|||
106114819|NCT00652938|366076483|FG001|Overall Study|Lost to Follow-up|0|||
106114820|NCT00652938|366076484|FG002|Overall Study|Lost to Follow-up|2|||
106114821|NCT00652938|366076482|FG000|Overall Study|fear of blood sampling|0|||
106114822|NCT00652938|366076483|FG001|Overall Study|fear of blood sampling|1|||
106114823|NCT00652938|366076484|FG002|Overall Study|fear of blood sampling|0|||
106114824|NCT00717314|366076485|FG000|Overall Study|Adverse Event|3|||
106114825|NCT00717314|366076486|FG001|Overall Study|Adverse Event|2|||
106114826|NCT00717314|366076485|FG000|Overall Study|Protocol Violation|1|||
106114827|NCT00717314|366076486|FG001|Overall Study|Protocol Violation|0|||
106114828|NCT00717314|366076485|FG000|Overall Study|Lost to Follow-up|1|||
106114829|NCT00717314|366076486|FG001|Overall Study|Lost to Follow-up|5|||
106114830|NCT00717314|366076485|FG000|Overall Study|Withdrawal by Subject|1|||
106114831|NCT00717314|366076486|FG001|Overall Study|Withdrawal by Subject|3|||
106114832|NCT01919970|366076489|FG000|Overall Study|Withdrawal by Subject|3|||
106114833|NCT01919970|366076490|FG001|Overall Study|Withdrawal by Subject|0|||
106114834|NCT00682643|366076492|FG000|Overall Study|Adverse Event|12|||
106114835|NCT00682643|366076493|FG001|Overall Study|Adverse Event|23|||
106114836|NCT00682643|366076492|FG000|Overall Study|Lack of Efficacy|2|||
106114837|NCT00682643|366076493|FG001|Overall Study|Lack of Efficacy|0|||
106114838|NCT00682643|366076492|FG000|Overall Study|Protocol Violation|38|||
106114839|NCT00682643|366076493|FG001|Overall Study|Protocol Violation|76|||
106114840|NCT00682643|366076492|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
106114841|NCT00682643|366076493|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
106114842|NCT00682643|366076492|FG000|Overall Study|Lost to Follow-up|1|||
106114843|NCT00682643|366076493|FG001|Overall Study|Lost to Follow-up|6|||
106114844|NCT00682643|366076492|FG000|Overall Study|Physician Decision|2|||
106114845|NCT00682643|366076493|FG001|Overall Study|Physician Decision|6|||
106114846|NCT00682643|366076492|FG000|Overall Study|Withdrawal by Subject|19|||
106114847|NCT00682643|366076493|FG001|Overall Study|Withdrawal by Subject|53|||
106114848|NCT00682643|366076492|FG000|Overall Study|Did Not Receive Study Drug|1|||
106114849|NCT00682643|366076493|FG001|Overall Study|Did Not Receive Study Drug|1|||
106114850|NCT01521884|366076495|FG000|Overall Study|Non Responders|10|||
106114851|NCT01521884|366076495|FG000|Overall Study|Adverse Event|5|||
106114852|NCT01521884|366076495|FG000|Overall Study|Pregnancy|1|||
106114853|NCT01521884|366076495|FG000|Overall Study|Withdrawal by Subject|1|||
106114854|NCT01521884|366076495|FG000|Overall Study|Physician Decision|2|||
106114855|NCT01521884|366076495|FG000|Overall Study|Protocol Violation|3|||
106114856|NCT01521884|366076495|FG000|Overall Study|Participant non-eligible|1|||
106114857|NCT01521884|366076495|FG000|Overall Study|Lost to Follow-up|4|||
106114858|NCT03565068|366076496|FG000|Overall Study|Protocol Violation|0|||
106114859|NCT03565068|366076497|FG001|Overall Study|Protocol Violation|0|||
106114860|NCT03565068|366076498|FG002|Overall Study|Protocol Violation|0|||
106114861|NCT03565068|366076499|FG003|Overall Study|Protocol Violation|0|||
106114862|NCT03565068|366076500|FG004|Overall Study|Protocol Violation|1|||
106114863|NCT03565068|366076501|FG005|Overall Study|Protocol Violation|0|||
106114864|NCT03565068|366076502|FG006|Overall Study|Protocol Violation|0|||
105886986|NCT02244463|365241779|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105886987|NCT02244463|365241780|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
106114865|NCT03565068|366076503|FG007|Overall Study|Protocol Violation|1|||
106114866|NCT03565068|366076504|FG008|Overall Study|Protocol Violation|0|||
106114867|NCT03565068|366076496|FG000|Overall Study|Sponsor decision|0|||
106114868|NCT03565068|366076497|FG001|Overall Study|Sponsor decision|0|||
106114869|NCT03565068|366076498|FG002|Overall Study|Sponsor decision|0|||
106114870|NCT03565068|366076499|FG003|Overall Study|Sponsor decision|0|||
106114871|NCT03565068|366076500|FG004|Overall Study|Sponsor decision|1|||
106114872|NCT03565068|366076501|FG005|Overall Study|Sponsor decision|1|||
106114873|NCT03565068|366076502|FG006|Overall Study|Sponsor decision|0|||
106114874|NCT03565068|366076503|FG007|Overall Study|Sponsor decision|0|||
106114875|NCT03565068|366076504|FG008|Overall Study|Sponsor decision|0|||
106114876|NCT03565068|366076496|FG000|Overall Study|Withdrawal by Subject|0|||
106114877|NCT03565068|366076497|FG001|Overall Study|Withdrawal by Subject|0|||
106114878|NCT03565068|366076498|FG002|Overall Study|Withdrawal by Subject|1|||
106114879|NCT03565068|366076499|FG003|Overall Study|Withdrawal by Subject|0|||
106114880|NCT03565068|366076500|FG004|Overall Study|Withdrawal by Subject|2|||
106114881|NCT03565068|366076501|FG005|Overall Study|Withdrawal by Subject|0|||
106114882|NCT03565068|366076502|FG006|Overall Study|Withdrawal by Subject|1|||
106114883|NCT03565068|366076503|FG007|Overall Study|Withdrawal by Subject|5|||
106114884|NCT03565068|366076504|FG008|Overall Study|Withdrawal by Subject|1|||
106114885|NCT03565068|366076496|FG000|Overall Study|Physician Decision|0|||
106114886|NCT03565068|366076497|FG001|Overall Study|Physician Decision|0|||
106114887|NCT03565068|366076498|FG002|Overall Study|Physician Decision|0|||
106114888|NCT03565068|366076499|FG003|Overall Study|Physician Decision|0|||
106114889|NCT03565068|366076500|FG004|Overall Study|Physician Decision|0|||
106114890|NCT03565068|366076501|FG005|Overall Study|Physician Decision|0|||
106114891|NCT03565068|366076502|FG006|Overall Study|Physician Decision|0|||
106114892|NCT03565068|366076503|FG007|Overall Study|Physician Decision|1|||
106114893|NCT03565068|366076504|FG008|Overall Study|Physician Decision|0|||
106114894|NCT03565068|366076496|FG000|Overall Study|Lost to Follow-up|0|||
106114895|NCT03565068|366076497|FG001|Overall Study|Lost to Follow-up|0|||
106114896|NCT03565068|366076498|FG002|Overall Study|Lost to Follow-up|0|||
106114897|NCT03565068|366076499|FG003|Overall Study|Lost to Follow-up|0|||
106114898|NCT03565068|366076500|FG004|Overall Study|Lost to Follow-up|0|||
106114899|NCT03565068|366076501|FG005|Overall Study|Lost to Follow-up|0|||
106114900|NCT03565068|366076502|FG006|Overall Study|Lost to Follow-up|0|||
106114901|NCT03565068|366076503|FG007|Overall Study|Lost to Follow-up|1|||
106114902|NCT03565068|366076504|FG008|Overall Study|Lost to Follow-up|0|||
106114903|NCT01436201|366076511|FG000|Overall Study|Adverse Event|2|||
106114904|NCT01436201|366076511|FG000|Overall Study|Withdrawal by Subject|1|||
106114905|NCT01436201|366076511|FG000|Overall Study|Protocol Violation|1|||
106114906|NCT01435655|366076512|FG000|Overall Study|Death|2|||
106114907|NCT01435655|366076512|FG000|Overall Study|Other|1|||
106114908|NCT00110890|366076513|FG000|Overall Study|Adverse Event|30|||
106114909|NCT00110890|366076514|FG001|Overall Study|Adverse Event|7|||
106114910|NCT00110890|366076513|FG000|Overall Study|Death|16|||
106114911|NCT00110890|366076514|FG001|Overall Study|Death|9|||
106114912|NCT00110890|366076513|FG000|Overall Study|Lost to Follow-up|3|||
106114913|NCT00110890|366076514|FG001|Overall Study|Lost to Follow-up|1|||
106114914|NCT00110890|366076513|FG000|Overall Study|Physician Decision|4|||
106114915|NCT00110890|366076514|FG001|Overall Study|Physician Decision|5|||
106114916|NCT00110890|366076513|FG000|Overall Study|Withdrawal by Subject|17|||
106114917|NCT00110890|366076514|FG001|Overall Study|Withdrawal by Subject|5|||
106114918|NCT00110890|366076513|FG000|Overall Study|Protocol Deviation|1|||
106114919|NCT00110890|366076514|FG001|Overall Study|Protocol Deviation|0|||
106114920|NCT00110890|366076513|FG000|Overall Study|Noncompliance|10|||
106114921|NCT00110890|366076514|FG001|Overall Study|Noncompliance|0|||
106114922|NCT00110890|366076513|FG000|Overall Study|Kidney Transplant|16|||
106114923|NCT00110890|366076514|FG001|Overall Study|Kidney Transplant|12|||
106114924|NCT00110890|366076513|FG000|Overall Study|Invest. Product Commercially Available|217|||
106114925|NCT00110890|366076514|FG001|Overall Study|Invest. Product Commercially Available|110|||
106114926|NCT00110890|366076513|FG000|Overall Study|Other|34|||
106114927|NCT00110890|366076514|FG001|Overall Study|Other|23|||
106114928|NCT00110890|366076513|FG000|Overall Study|Ineligibility determined|3|||
106114929|NCT00110890|366076514|FG001|Overall Study|Ineligibility determined|0|||
106114930|NCT00110890|366076513|FG000|Overall Study|Requirement for alternative therapy|0|||
106114931|NCT00110890|366076514|FG001|Overall Study|Requirement for alternative therapy|1|||
106114932|NCT00110890|366076513|FG000|Overall Study|Disease progression|0|||
106114933|NCT00110890|366076514|FG001|Overall Study|Disease progression|1|||
106114934|NCT00110890|366076513|FG000|Overall Study|Parathyroidectomy|0|||
106114935|NCT00110890|366076514|FG001|Overall Study|Parathyroidectomy|1|||
106114936|NCT00110890|366076513|FG000|Overall Study|Did not enter follow-up phase|10|||
106114937|NCT00110890|366076514|FG001|Overall Study|Did not enter follow-up phase|4|||
106114938|NCT02839343|366076515|FG000|Overall Study|Withdrawal by Subject|3|||
106114939|NCT02839343|366076516|FG001|Overall Study|Withdrawal by Subject|1|||
106114940|NCT02839343|366076515|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
106114941|NCT02839343|366076516|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
106114942|NCT02839343|366076515|FG000|Overall Study|Adverse Event|1|||
106114943|NCT02839343|366076516|FG001|Overall Study|Adverse Event|0|||
106114944|NCT02636270|366076517|FG000|Overall Study|Adverse Event|1|||
106114945|NCT02636270|366076518|FG001|Overall Study|Adverse Event|0|||
106114946|NCT02636270|366076519|FG002|Overall Study|Adverse Event|0|||
106114947|NCT02636270|366076517|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
106114948|NCT02636270|366076518|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
106114949|NCT02636270|366076519|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
106114950|NCT02946918|366076522|FG000|Overall Study|Patient unblinded himself|1|||
106114951|NCT02946918|366076523|FG001|Overall Study|Patient unblinded himself|0|||
106114952|NCT02946918|366076522|FG000|Overall Study|Physician Decision|0|||
106114953|NCT02946918|366076523|FG001|Overall Study|Physician Decision|2|||
106114954|NCT02946918|366076522|FG000|Overall Study|Ran out of study medication|0|||
106114955|NCT02946918|366076523|FG001|Overall Study|Ran out of study medication|1|||
106114956|NCT00709059|366076524|FG000|Overall Study|Lost to Follow-up|34|||
106114957|NCT00709059|366076524|FG000|Overall Study|Withdrawal by Subject|19|||
106114958|NCT00709059|366076524|FG000|Overall Study|Physician Decision|7|||
106114959|NCT00709059|366076524|FG000|Overall Study|Disease complication|3|||
106114960|NCT00709059|366076524|FG000|Overall Study|Side effects|20|||
106114961|NCT00709059|366076524|FG000|Overall Study|Serious side effects|11|||
106114962|NCT02089230|366076525|FG000|Overall Study|Death|0|||
106114963|NCT02089230|366076526|FG001|Overall Study|Death|0|||
106114964|NCT02089230|366076527|FG002|Overall Study|Death|2|||
106114965|NCT02089230|366076525|FG000|Overall Study|Seeking Alternative Therapy|0|||
106114966|NCT02089230|366076526|FG001|Overall Study|Seeking Alternative Therapy|0|||
106114967|NCT02089230|366076527|FG002|Overall Study|Seeking Alternative Therapy|4|||
106114968|NCT02799472|366078198|FG000|Overall Study|Withdrawal by Subject|2|||
106114969|NCT02799472|366078199|FG001|Overall Study|Withdrawal by Subject|4|||
106114970|NCT02799472|366078198|FG000|Overall Study|Lack of Efficacy|2|||
106114971|NCT02799472|366078199|FG001|Overall Study|Lack of Efficacy|0|||
106114972|NCT02799472|366078198|FG000|Overall Study|Lost to Follow-up|0|||
106114973|NCT02799472|366078199|FG001|Overall Study|Lost to Follow-up|1|||
106114974|NCT02801669|366078200|FG000|Overall Study|Death|66|||
106114975|NCT02801669|366078201|FG001|Overall Study|Death|69|||
106114976|NCT02801669|366078200|FG000|Overall Study|Withdrawal by Subject|81|||
106114977|NCT02801669|366078201|FG001|Overall Study|Withdrawal by Subject|77|||
106114978|NCT02801669|366078200|FG000|Overall Study|Other|4|||
106114979|NCT02801669|366078201|FG001|Overall Study|Other|6|||
106114980|NCT02696564|366078202|FG000|Overall Study|Death|1|||
106114981|NCT02696564|366078203|FG001|Overall Study|Death|2|||
106114982|NCT02696564|366078202|FG000|Overall Study|Withdrawal by Subject|3|||
106114983|NCT02696564|366078203|FG001|Overall Study|Withdrawal by Subject|2|||
106114984|NCT02696564|366078202|FG000|Overall Study|Lost to Follow-up|3|||
106114985|NCT02696564|366078203|FG001|Overall Study|Lost to Follow-up|3|||
106114986|NCT02696564|366078202|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
106114987|NCT02696564|366078203|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
106114988|NCT02696564|366078202|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
106114989|NCT02696564|366078203|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
106114990|NCT02696564|366078202|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
106114991|NCT02696564|366078203|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
106114992|NCT02696564|366078202|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
106114993|NCT02696564|366078203|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
106114994|NCT02696564|366078202|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
106114995|NCT02696564|366078203|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
106114996|NCT00185640|366078204|FG000|Overall Study|Not Eligible|4|||
106114997|NCT00185640|366078204|FG000|Overall Study|Withdrawal by Subject|3|||
106114998|NCT00185640|366078204|FG000|Overall Study|Death|138|||
106114999|NCT02312856|366078208|FG000|Overall Study|Death|1|||
106115000|NCT02312856|366078208|FG000|Overall Study|Lost to Follow-up|3|||
106115001|NCT02508532|366078215|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
106115002|NCT02508532|366078216|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
106115003|NCT02508532|366078217|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
106115004|NCT02508532|366078218|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
105994474|NCT04404556|365640233|FG000|Intervention|Withdrawal by Subject|15|||
105994475|NCT04404556|365640234|FG001|Intervention|Withdrawal by Subject|3|||
105994476|NCT04404556|365640233|FG000|Intervention|Did not complete all intervention sessions|2|||
105994477|NCT04404556|365640234|FG001|Intervention|Did not complete all intervention sessions|1|||
105994478|NCT04404556|365640233|FG000|Post-Intervention|Missing Data|1|||
105994479|NCT04404556|365640234|FG001|Post-Intervention|Missing Data|2|||
105994480|NCT04404556|365640233|FG000|Follow-up 1|Withdrawal by Subject|5|||
105994481|NCT04404556|365640234|FG001|Follow-up 1|Withdrawal by Subject|1|||
105994482|NCT04404556|365640233|FG000|Follow-up 1|Missing Data|4|||
105994483|NCT04404556|365640234|FG001|Follow-up 1|Missing Data|7|||
105994484|NCT04404556|365640233|FG000|Follow-up 2|Withdrawal by Subject|1|||
105994485|NCT04404556|365640234|FG001|Follow-up 2|Withdrawal by Subject|1|||
105994486|NCT04404556|365640233|FG000|Follow-up 2|Missing Data|6|||
105994487|NCT04404556|365640234|FG001|Follow-up 2|Missing Data|5|||
105994488|NCT01865448|365640235|FG000|Overall Study|Adverse Event|1|||
106115005|NCT02508532|366078219|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
106115006|NCT02508532|366078220|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
106115007|NCT02508532|366078221|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
106115008|NCT02508532|366078222|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
106115009|NCT02508532|366078223|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
106115010|NCT02508532|366078215|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
105994489|NCT01865448|365640236|FG001|Overall Study|Adverse Event|1|||
105994490|NCT01865448|365640235|FG000|Overall Study|Pregnancy|0|||
106115011|NCT02508532|366078216|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
106115012|NCT02508532|366078217|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
106115013|NCT02508532|366078218|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
106115014|NCT02508532|366078219|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
106115015|NCT02508532|366078220|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
106115016|NCT02508532|366078221|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
106115017|NCT02508532|366078222|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
106115018|NCT02508532|366078223|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
106115019|NCT02508532|366078215|FG000|Part 2 - Treatment|Disease Progression|0|||
106115020|NCT02508532|366078216|FG001|Part 2 - Treatment|Disease Progression|0|||
106115021|NCT02508532|366078217|FG002|Part 2 - Treatment|Disease Progression|0|||
106115022|NCT02508532|366078218|FG003|Part 2 - Treatment|Disease Progression|0|||
105994491|NCT01865448|365640236|FG001|Overall Study|Pregnancy|1|||
105994492|NCT01865448|365640235|FG000|Overall Study|dropout unrelated to study|1|||
105994493|NCT01865448|365640236|FG001|Overall Study|dropout unrelated to study|1|||
105994494|NCT02333799|365640237|FG000|Treatment Period|Withdrawal by Subject|1|||
105994495|NCT02333799|365640237|FG000|Treatment Period|Death|6|||
105994496|NCT02333799|365640237|FG000|6 Month Follow Up Period|Physician Decision|1|||
105994497|NCT02333799|365640237|FG000|6 Month Follow Up Period|Death|1|||
105994498|NCT02333799|365640237|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
105994499|NCT02333799|365640237|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
105994500|NCT02451943|365640239|FG000|Overall Study|Withdrawal by Subject|13|||
105994501|NCT02451943|365640240|FG001|Overall Study|Withdrawal by Subject|16|||
105994502|NCT02451943|365640239|FG000|Overall Study|Lost to Follow-up|3|||
105994503|NCT02451943|365640240|FG001|Overall Study|Lost to Follow-up|4|||
105994504|NCT02451943|365640239|FG000|Overall Study|Sponsor Decision|0|||
105994505|NCT02451943|365640240|FG001|Overall Study|Sponsor Decision|4|||
105994506|NCT00368641|365640241|FG000|Overall Study|Adverse Event|2|||
105994507|NCT00368641|365640242|FG001|Overall Study|Adverse Event|1|||
105994508|NCT00368641|365640241|FG000|Overall Study|Death|1|||
105994509|NCT00368641|365640242|FG001|Overall Study|Death|0|||
105994510|NCT00368641|365640241|FG000|Overall Study|Withdrawal by Subject|1|||
105994511|NCT00368641|365640242|FG001|Overall Study|Withdrawal by Subject|0|||
105994512|NCT00368641|365640241|FG000|Overall Study|Sponsor decision to terminate study|2|||
105994513|NCT00368641|365640242|FG001|Overall Study|Sponsor decision to terminate study|5|||
105994514|NCT00799266|365640245|FG000|Overall Study|Adverse Event|0|||
105994515|NCT00799266|365640246|FG001|Overall Study|Adverse Event|1|||
105994516|NCT00799266|365640245|FG000|Overall Study|Subject withdrew consent|3|||
106115023|NCT02508532|366078219|FG004|Part 2 - Treatment|Disease Progression|0|||
106115024|NCT02508532|366078220|FG005|Part 2 - Treatment|Disease Progression|0|||
106115025|NCT02508532|366078221|FG006|Part 2 - Treatment|Disease Progression|0|||
106115026|NCT02508532|366078222|FG007|Part 2 - Treatment|Disease Progression|0|||
106115027|NCT02508532|366078223|FG008|Part 2 - Treatment|Disease Progression|118|||
106115028|NCT02508532|366078215|FG000|Part 2 - Treatment|Adverse Event|0|||
106115029|NCT02508532|366078216|FG001|Part 2 - Treatment|Adverse Event|0|||
106115030|NCT02508532|366078217|FG002|Part 2 - Treatment|Adverse Event|0|||
106115031|NCT02508532|366078218|FG003|Part 2 - Treatment|Adverse Event|0|||
106115032|NCT02508532|366078219|FG004|Part 2 - Treatment|Adverse Event|0|||
106115033|NCT02508532|366078220|FG005|Part 2 - Treatment|Adverse Event|0|||
106115034|NCT02508532|366078221|FG006|Part 2 - Treatment|Adverse Event|0|||
106115035|NCT02508532|366078222|FG007|Part 2 - Treatment|Adverse Event|0|||
106115036|NCT02508532|366078223|FG008|Part 2 - Treatment|Adverse Event|49|||
106115037|NCT02508532|366078215|FG000|Part 2 - Treatment|Physician Decision|0|||
106115038|NCT02508532|366078216|FG001|Part 2 - Treatment|Physician Decision|0|||
106115039|NCT02508532|366078217|FG002|Part 2 - Treatment|Physician Decision|0|||
106115040|NCT02508532|366078218|FG003|Part 2 - Treatment|Physician Decision|0|||
106115041|NCT02508532|366078219|FG004|Part 2 - Treatment|Physician Decision|0|||
106115042|NCT02508532|366078220|FG005|Part 2 - Treatment|Physician Decision|0|||
106115043|NCT02508532|366078221|FG006|Part 2 - Treatment|Physician Decision|0|||
106115044|NCT02508532|366078222|FG007|Part 2 - Treatment|Physician Decision|0|||
106115045|NCT02508532|366078223|FG008|Part 2 - Treatment|Physician Decision|12|||
106115046|NCT02508532|366078215|FG000|Part 2 - Treatment|Administrative|0|||
106115047|NCT02508532|366078216|FG001|Part 2 - Treatment|Administrative|0|||
106115048|NCT02508532|366078217|FG002|Part 2 - Treatment|Administrative|0|||
105994517|NCT00799266|365640246|FG001|Overall Study|Subject withdrew consent|0|||
105994518|NCT04809285|365640252|FG000|Phase 1|Lost to Follow-up|6|||
105994519|NCT04809285|365640252|FG000|Phase 1|Protocol Violation|2|||
105994520|NCT04809285|365640252|FG000|Phase 1|Physician Decision|3|||
105994521|NCT04809285|365640252|FG000|Phase 1|Withdrawal by Subject|29|||
105994522|NCT04809285|365640252|FG000|Phase 2|Protocol Violation|3|||
105994523|NCT04809285|365640252|FG000|Phase 2|Withdrawal by Subject|4|||
105994524|NCT02974257|365640255|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
105994525|NCT02974257|365640256|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
106115049|NCT02508532|366078218|FG003|Part 2 - Treatment|Administrative|0|||
106115050|NCT02508532|366078219|FG004|Part 2 - Treatment|Administrative|0|||
106115051|NCT02508532|366078220|FG005|Part 2 - Treatment|Administrative|0|||
106115052|NCT02508532|366078221|FG006|Part 2 - Treatment|Administrative|0|||
106115053|NCT02508532|366078222|FG007|Part 2 - Treatment|Administrative|0|||
106115054|NCT02508532|366078223|FG008|Part 2 - Treatment|Administrative|3|||
106115055|NCT02508532|366078215|FG000|Part 2 - Treatment|Sponsor Decision|0|||
106115056|NCT02508532|366078216|FG001|Part 2 - Treatment|Sponsor Decision|0|||
106115057|NCT02508532|366078217|FG002|Part 2 - Treatment|Sponsor Decision|0|||
106115058|NCT02508532|366078218|FG003|Part 2 - Treatment|Sponsor Decision|0|||
106115059|NCT02508532|366078219|FG004|Part 2 - Treatment|Sponsor Decision|0|||
106115060|NCT02508532|366078220|FG005|Part 2 - Treatment|Sponsor Decision|0|||
106115061|NCT02508532|366078221|FG006|Part 2 - Treatment|Sponsor Decision|0|||
106115062|NCT02508532|366078222|FG007|Part 2 - Treatment|Sponsor Decision|0|||
106115063|NCT02508532|366078223|FG008|Part 2 - Treatment|Sponsor Decision|28|||
106115064|NCT02508532|366078215|FG000|Part 2 - Treatment|Death|0|||
106115065|NCT02508532|366078216|FG001|Part 2 - Treatment|Death|0|||
106115066|NCT02508532|366078217|FG002|Part 2 - Treatment|Death|0|||
106115067|NCT02508532|366078218|FG003|Part 2 - Treatment|Death|0|||
106115068|NCT02508532|366078219|FG004|Part 2 - Treatment|Death|0|||
106115069|NCT02508532|366078220|FG005|Part 2 - Treatment|Death|0|||
106115070|NCT02508532|366078221|FG006|Part 2 - Treatment|Death|0|||
106115071|NCT02508532|366078222|FG007|Part 2 - Treatment|Death|0|||
106115072|NCT02508532|366078223|FG008|Part 2 - Treatment|Death|1|||
106115073|NCT02508532|366078215|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
106115074|NCT02508532|366078216|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
106115075|NCT02508532|366078217|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
106115076|NCT02508532|366078218|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
106115077|NCT02508532|366078219|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
106115078|NCT02508532|366078220|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
106115079|NCT02508532|366078221|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
106115080|NCT02508532|366078222|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
106115081|NCT02508532|366078223|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
106115082|NCT02508532|366078215|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
106115083|NCT02508532|366078216|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
106115084|NCT02508532|366078217|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
106115085|NCT02508532|366078218|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
106115086|NCT02508532|366078219|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
106115087|NCT02508532|366078220|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
106115088|NCT02508532|366078221|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
106115089|NCT02508532|366078222|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
106115090|NCT02508532|366078223|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
106115091|NCT02508532|366078215|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
106115092|NCT02508532|366078216|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
105886988|NCT02244463|365241781|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105886989|NCT02244463|365241782|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105886990|NCT02244463|365241783|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105886991|NCT02244463|365241784|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
105886992|NCT02244463|365241779|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105886993|NCT02244463|365241780|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105886994|NCT02244463|365241781|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
105886995|NCT02244463|365241782|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105886996|NCT02244463|365241783|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105886997|NCT02244463|365241784|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
105886998|NCT02244463|365241779|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105886999|NCT02244463|365241780|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105887000|NCT02244463|365241781|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105887001|NCT02244463|365241782|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
105887002|NCT02244463|365241783|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105887003|NCT02244463|365241784|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
105887004|NCT02244463|365241779|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105887005|NCT02244463|365241780|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105887006|NCT02244463|365241781|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105887007|NCT02244463|365241782|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
105887008|NCT02244463|365241783|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105887009|NCT02244463|365241784|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
105887010|NCT02244463|365241779|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105887011|NCT02244463|365241780|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105887012|NCT02244463|365241781|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105887013|NCT02244463|365241782|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
105887014|NCT02244463|365241783|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
106115093|NCT02508532|366078217|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
106115094|NCT02508532|366078218|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
106115095|NCT02508532|366078219|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
106115096|NCT02508532|366078220|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
106115097|NCT02508532|366078221|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
106115098|NCT02508532|366078222|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
106115099|NCT02508532|366078223|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
106115100|NCT02508532|366078215|FG000|Part 1 and Part 2 End of Study|Death|0|||
106115101|NCT02508532|366078216|FG001|Part 1 and Part 2 End of Study|Death|4|||
106115102|NCT02508532|366078217|FG002|Part 1 and Part 2 End of Study|Death|2|||
106115103|NCT02508532|366078218|FG003|Part 1 and Part 2 End of Study|Death|4|||
106115104|NCT02508532|366078219|FG004|Part 1 and Part 2 End of Study|Death|3|||
106115105|NCT02508532|366078220|FG005|Part 1 and Part 2 End of Study|Death|0|||
106115106|NCT02508532|366078221|FG006|Part 1 and Part 2 End of Study|Death|0|||
106115107|NCT02508532|366078222|FG007|Part 1 and Part 2 End of Study|Death|1|||
106115108|NCT02508532|366078223|FG008|Part 1 and Part 2 End of Study|Death|111|||
106115109|NCT02508532|366078215|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
106115110|NCT02508532|366078216|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
106115111|NCT02508532|366078217|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
106115112|NCT02508532|366078218|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
106115113|NCT02508532|366078219|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
106115114|NCT02508532|366078220|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
106115115|NCT02508532|366078221|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
106115116|NCT02508532|366078222|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
106115117|NCT02508532|366078223|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
106115118|NCT02508532|366078215|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
106115119|NCT02508532|366078216|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
106115120|NCT02508532|366078217|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
106115121|NCT02508532|366078218|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
106115122|NCT02508532|366078219|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
106115123|NCT02508532|366078220|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
106115124|NCT02508532|366078221|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
106115125|NCT02508532|366078222|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
106115126|NCT02508532|366078223|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
106115127|NCT02508532|366078215|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
106115128|NCT02508532|366078216|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
106115129|NCT02508532|366078217|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
106115130|NCT02508532|366078218|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
106115131|NCT02508532|366078219|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
106115132|NCT02508532|366078220|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
106115133|NCT02508532|366078221|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
106115134|NCT02508532|366078222|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
106115135|NCT02508532|366078223|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
106115136|NCT02508532|366078215|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
106115137|NCT02508532|366078216|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
106115138|NCT02508532|366078217|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
106115139|NCT02508532|366078218|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
106115140|NCT02508532|366078219|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
106115141|NCT02508532|366078220|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
106115142|NCT02508532|366078221|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
106115143|NCT02508532|366078222|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
106115144|NCT02508532|366078223|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
106115145|NCT02508532|366078215|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
106115146|NCT02508532|366078216|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
106115147|NCT02508532|366078217|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
106115148|NCT02508532|366078218|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
106115149|NCT02508532|366078219|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
106115150|NCT02508532|366078220|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
106115151|NCT02508532|366078221|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
106115152|NCT02508532|366078222|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
106115153|NCT02508532|366078223|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
106115154|NCT03745222|366078237|FG000|Overall Study|Withdrawal by Subject|0|||
106115155|NCT03745222|366078238|FG001|Overall Study|Withdrawal by Subject|1|||
106115156|NCT03745222|366078239|FG002|Overall Study|Withdrawal by Subject|0|||
106115157|NCT00792103|366078240|FG000|Overall Study|Enrolled, not treated|15|||
106115158|NCT00792103|366078240|FG000|Overall Study|Lost to Follow-up|17|||
106115159|NCT00792103|366078240|FG000|Overall Study|Adverse Event|25|||
106115160|NCT00792103|366078240|FG000|Overall Study|Withdrawal by Subject|52|||
106115161|NCT00792103|366078240|FG000|Overall Study|Protocol Violation|10|||
106115162|NCT00792103|366078240|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
106115163|NCT01572389|366078241|FG000|Overall Study|Death|1|||
106115164|NCT01572389|366078242|FG001|Overall Study|Death|3|||
105661753|NCT01068210|364425130|FG000|Overall Study|Second cancer|0|||
105994526|NCT02974257|365640255|FG000|Overall Study|Clinical indication for thiamine|1|||
105994527|NCT02974257|365640256|FG001|Overall Study|Clinical indication for thiamine|0|||
105994528|NCT02974257|365640255|FG000|Overall Study|Already on thiamine|1|||
105994529|NCT02974257|365640256|FG001|Overall Study|Already on thiamine|0|||
105994530|NCT02974257|365640255|FG000|Overall Study|Extubated prior to study drug|0|||
105994531|NCT02974257|365640256|FG001|Overall Study|Extubated prior to study drug|1|||
105994532|NCT02974257|365640255|FG000|Overall Study|Death|0|||
105994533|NCT02974257|365640256|FG001|Overall Study|Death|1|||
105994534|NCT01449006|365640257|FG000|Overall Study|Lost to Follow-up|1|||
105994535|NCT01449006|365640258|FG001|Overall Study|Lost to Follow-up|0|||
105994536|NCT01449006|365640257|FG000|Overall Study|Withdrawal by Subject|1|||
105994537|NCT01449006|365640258|FG001|Overall Study|Withdrawal by Subject|0|||
105994538|NCT01449006|365640257|FG000|Overall Study|Protocol Violation|1|||
105994539|NCT01449006|365640258|FG001|Overall Study|Protocol Violation|0|||
105994540|NCT02114606|365640259|FG000|Overall Study|Unable to swallow Cytosponge|6|||
105994541|NCT04421482|365640260|FG000|Overall Study|Physician Decision|1|||
105994542|NCT02128724|365640263|FG000|Overall Study|Death|1|||
105994543|NCT02128724|365640264|FG001|Overall Study|Death|0|||
105994544|NCT02128724|365640265|FG002|Overall Study|Death|0|||
105994545|NCT02128724|365640266|FG003|Overall Study|Death|0|||
105994546|NCT02128724|365640263|FG000|Overall Study|Adverse Event|0|||
105994547|NCT02128724|365640264|FG001|Overall Study|Adverse Event|1|||
105994548|NCT02128724|365640265|FG002|Overall Study|Adverse Event|0|||
105994549|NCT02128724|365640266|FG003|Overall Study|Adverse Event|0|||
105994550|NCT02128724|365640263|FG000|Overall Study|Physician Decision|0|||
105994551|NCT02128724|365640264|FG001|Overall Study|Physician Decision|0|||
105994552|NCT02128724|365640265|FG002|Overall Study|Physician Decision|0|||
105994553|NCT02128724|365640266|FG003|Overall Study|Physician Decision|2|||
105994554|NCT02128724|365640263|FG000|Overall Study|Withdrawal by Subject|0|||
105994555|NCT02128724|365640264|FG001|Overall Study|Withdrawal by Subject|0|||
105994556|NCT02128724|365640265|FG002|Overall Study|Withdrawal by Subject|0|||
105994557|NCT02128724|365640266|FG003|Overall Study|Withdrawal by Subject|1|||
105994558|NCT04720417|365640269|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
105994559|NCT04273893|365640270|FG000|Overall Study|Withdrawal by Subject|0|||
106115165|NCT01572389|366078241|FG000|Overall Study|Withdrawal by Subject|14|||
106115166|NCT01572389|366078242|FG001|Overall Study|Withdrawal by Subject|2|||
106115167|NCT01572389|366078241|FG000|Overall Study|Lost to Follow-up|25|||
106115168|NCT01572389|366078242|FG001|Overall Study|Lost to Follow-up|14|||
106115169|NCT01572389|366078241|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
106115170|NCT01572389|366078242|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
106115171|NCT01111838|366078243|FG000|Overall Study|Patient Ineligible|2|||
106115172|NCT01111838|366078243|FG000|Overall Study|Not Treated|3|||
106115173|NCT01111838|366078243|FG000|Overall Study|Clinical deterioration|1|||
106115174|NCT01111838|366078243|FG000|Overall Study|Other Complicating Disease|1|||
106115175|NCT01287520|366078244|FG000|Overall Study|Adverse Event|2|||
106115176|NCT01287520|366078245|FG001|Overall Study|Adverse Event|2|||
106115177|NCT01287520|366078246|FG002|Overall Study|Adverse Event|2|||
106115178|NCT01287520|366078247|FG003|Overall Study|Adverse Event|1|||
106115179|NCT01287520|366078248|FG004|Overall Study|Adverse Event|1|||
106115180|NCT01287520|366078249|FG005|Overall Study|Adverse Event|2|||
106115181|NCT01287520|366078250|FG006|Overall Study|Adverse Event|0|||
106115182|NCT01287520|366078251|FG007|Overall Study|Adverse Event|2|||
106115183|NCT01287520|366078252|FG008|Overall Study|Adverse Event|0|||
105994560|NCT04273893|365640271|FG001|Overall Study|Withdrawal by Subject|2|||
105994561|NCT04273893|365640270|FG000|Overall Study|Treatment of Disease Progression|0|||
105994562|NCT04273893|365640271|FG001|Overall Study|Treatment of Disease Progression|2|||
105994563|NCT04273893|365640270|FG000|Overall Study|Death|1|||
105994564|NCT04273893|365640271|FG001|Overall Study|Death|2|||
105994565|NCT04273893|365640270|FG000|Overall Study|Lost to Follow-up|0|||
105994566|NCT04273893|365640271|FG001|Overall Study|Lost to Follow-up|2|||
106115184|NCT01287520|366078244|FG000|Overall Study|Physician Decision|1|||
106115185|NCT01287520|366078245|FG001|Overall Study|Physician Decision|1|||
105994567|NCT04273893|365640270|FG000|Overall Study|Physician Decision|1|||
105994568|NCT04273893|365640271|FG001|Overall Study|Physician Decision|0|||
105994569|NCT03906071|365640272|FG000|Overall Study|Death|180|||
105994570|NCT03906071|365640273|FG001|Overall Study|Death|185|||
105994571|NCT03906071|365640272|FG000|Overall Study|Lost to Follow-up|3|||
105994572|NCT03906071|365640273|FG001|Overall Study|Lost to Follow-up|3|||
105994573|NCT03906071|365640272|FG000|Overall Study|Withdrawal by Subject|15|||
105994574|NCT03906071|365640273|FG001|Overall Study|Withdrawal by Subject|27|||
106115186|NCT01287520|366078246|FG002|Overall Study|Physician Decision|2|||
106115187|NCT01287520|366078247|FG003|Overall Study|Physician Decision|0|||
106115188|NCT01287520|366078248|FG004|Overall Study|Physician Decision|1|||
105994575|NCT03906071|365640272|FG000|Overall Study|Other|2|||
105994576|NCT03906071|365640273|FG001|Overall Study|Other|1|||
106115189|NCT01287520|366078249|FG005|Overall Study|Physician Decision|1|||
106115190|NCT01287520|366078250|FG006|Overall Study|Physician Decision|0|||
106115191|NCT01287520|366078251|FG007|Overall Study|Physician Decision|1|||
105994577|NCT03574779|365640274|FG000|Overall Study|Screening failure|13|||
105994578|NCT03574779|365640275|FG001|Overall Study|Screening failure|83|||
105994579|NCT00381693|365640277|FG000|Overall Study|Death|1|||
106115192|NCT01287520|366078252|FG008|Overall Study|Physician Decision|0|||
106115193|NCT01287520|366078244|FG000|Overall Study|Progressive disease|0|||
106115194|NCT01287520|366078245|FG001|Overall Study|Progressive disease|4|||
106115195|NCT01287520|366078246|FG002|Overall Study|Progressive disease|1|||
106115196|NCT01287520|366078247|FG003|Overall Study|Progressive disease|6|||
106115197|NCT01287520|366078248|FG004|Overall Study|Progressive disease|1|||
106115198|NCT01287520|366078249|FG005|Overall Study|Progressive disease|0|||
106115199|NCT01287520|366078250|FG006|Overall Study|Progressive disease|2|||
106115200|NCT01287520|366078251|FG007|Overall Study|Progressive disease|2|||
106115201|NCT01287520|366078252|FG008|Overall Study|Progressive disease|4|||
106115202|NCT01287520|366078244|FG000|Overall Study|Withdrawal by Subject|0|||
106115203|NCT01287520|366078245|FG001|Overall Study|Withdrawal by Subject|0|||
106115204|NCT01287520|366078246|FG002|Overall Study|Withdrawal by Subject|0|||
106115205|NCT01287520|366078247|FG003|Overall Study|Withdrawal by Subject|0|||
106115206|NCT01287520|366078248|FG004|Overall Study|Withdrawal by Subject|0|||
106115207|NCT01287520|366078249|FG005|Overall Study|Withdrawal by Subject|1|||
106115208|NCT01287520|366078250|FG006|Overall Study|Withdrawal by Subject|0|||
106115209|NCT01287520|366078251|FG007|Overall Study|Withdrawal by Subject|0|||
106115210|NCT01287520|366078252|FG008|Overall Study|Withdrawal by Subject|1|||
106115211|NCT03587142|366078253|FG000|Overall Study|Lost to Follow-up|5|||
106115212|NCT03587142|366078254|FG001|Overall Study|Lost to Follow-up|3|||
105994580|NCT00381693|365640277|FG000|Overall Study|Adverse Event|4|||
105994581|NCT00381693|365640277|FG000|Overall Study|Patient Choice|1|||
105994582|NCT00381693|365640277|FG000|Overall Study|Progression|2|||
105994583|NCT01219985|365640278|FG000|Overall Study|Physician Decision|20|||
105994584|NCT04669301|365640279|FG000|Overall Study|Lost to Follow-up|0|||
105994585|NCT04669301|365640280|FG001|Overall Study|Lost to Follow-up|1|||
105994586|NCT04669301|365640281|FG002|Overall Study|Lost to Follow-up|0|||
105994587|NCT04669301|365640279|FG000|Overall Study|Withdrawal by Subject|3|||
105994588|NCT04669301|365640280|FG001|Overall Study|Withdrawal by Subject|2|||
105994589|NCT04669301|365640281|FG002|Overall Study|Withdrawal by Subject|0|||
105994590|NCT01514201|365640286|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
105994591|NCT01514201|365640287|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105994592|NCT01514201|365640288|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105994593|NCT01514201|365640289|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105994594|NCT01514201|365640286|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105994595|NCT01514201|365640287|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
105994596|NCT01514201|365640288|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
105994597|NCT01514201|365640289|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105994598|NCT01514201|365640286|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
105994599|NCT01514201|365640287|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
105994600|NCT01514201|365640288|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
105994601|NCT01514201|365640289|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
105994602|NCT01514201|365640286|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
105994603|NCT01514201|365640287|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
105994604|NCT01514201|365640288|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105994605|NCT01514201|365640289|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105994606|NCT01514201|365640286|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
105994607|NCT01514201|365640287|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
106115213|NCT03587142|366078253|FG000|Overall Study|Did not complete the f4 visit|3|||
106115214|NCT03587142|366078254|FG001|Overall Study|Did not complete the f4 visit|7|||
106115215|NCT02768662|366078255|FG000|Overall Study|Adverse Event|1|||
106115216|NCT02768662|366078255|FG000|Overall Study|Lost to Follow-up|4|||
106115217|NCT02768662|366078255|FG000|Overall Study|Withdrawal by Subject|3|||
106115218|NCT02768662|366078255|FG000|Overall Study|Study terminated by Sponsor|78|||
106115219|NCT00499863|366078258|FG000|Overall Study|Lack of Efficacy|21|||
106115220|NCT00499863|366078259|FG001|Overall Study|Lack of Efficacy|27|||
106115221|NCT00499863|366078258|FG000|Overall Study|Protocol Violation|12|||
106115222|NCT00499863|366078259|FG001|Overall Study|Protocol Violation|7|||
106115223|NCT00499863|366078258|FG000|Overall Study|Withdrawal by Subject|6|||
106115224|NCT00499863|366078259|FG001|Overall Study|Withdrawal by Subject|4|||
106115225|NCT00499863|366078258|FG000|Overall Study|Adverse Event|8|||
106115226|NCT00499863|366078259|FG001|Overall Study|Adverse Event|2|||
106115227|NCT00499863|366078258|FG000|Overall Study|Sponsor decision|2|||
106115228|NCT00499863|366078259|FG001|Overall Study|Sponsor decision|2|||
106115229|NCT00499863|366078258|FG000|Overall Study|Lost to Follow-up|1|||
105994608|NCT01514201|365640288|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
105994609|NCT01514201|365640289|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
106115230|NCT00499863|366078259|FG001|Overall Study|Lost to Follow-up|1|||
106115231|NCT01800201|366078260|FG000|Overall Study|Withdrawal by Subject|2|||
106115232|NCT01800201|366078261|FG001|Overall Study|Withdrawal by Subject|0|||
106115233|NCT01800201|366078260|FG000|Overall Study|patient privacy concerns|1|||
106115234|NCT01800201|366078261|FG001|Overall Study|patient privacy concerns|1|||
106115235|NCT01800201|366078260|FG000|Overall Study|did not want to use device|0|||
106115236|NCT01800201|366078261|FG001|Overall Study|did not want to use device|1|||
106115237|NCT01800201|366078260|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
106115238|NCT01800201|366078261|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
106115239|NCT03303469|366078262|FG000|Overall Study|Lost to Follow-up|2|||
106115240|NCT00708435|366078265|FG000|Overall Study|Death / Serious Adverse Event|10|||
106115241|NCT00708435|366078266|FG001|Overall Study|Death / Serious Adverse Event|5|||
106115242|NCT00708435|366078265|FG000|Overall Study|Lost to Follow-up|9|||
106115243|NCT00708435|366078266|FG001|Overall Study|Lost to Follow-up|4|||
106115244|NCT00708435|366078265|FG000|Overall Study|Withdrawal by Subject|3|||
106115245|NCT00708435|366078266|FG001|Overall Study|Withdrawal by Subject|7|||
106115246|NCT00708435|366078265|FG000|Overall Study|Adverse Event|1|||
106115247|NCT00708435|366078266|FG001|Overall Study|Adverse Event|0|||
106115248|NCT00708435|366078265|FG000|Overall Study|Protocol Violation|0|||
106115249|NCT00708435|366078266|FG001|Overall Study|Protocol Violation|1|||
106115250|NCT00708435|366078265|FG000|Overall Study|Intervention by primary care physician|1|||
106115251|NCT00708435|366078266|FG001|Overall Study|Intervention by primary care physician|0|||
106115252|NCT00708435|366078265|FG000|Overall Study|Refused hospitalization|1|||
106115253|NCT00708435|366078266|FG001|Overall Study|Refused hospitalization|0|||
106115254|NCT00691132|366078268|FG000|Overall Study|Adverse Event|2|||
106115255|NCT00691132|366078269|FG001|Overall Study|Adverse Event|3|||
106115256|NCT00691132|366078268|FG000|Overall Study|Withdrawal by Subject|10|||
106115257|NCT00691132|366078269|FG001|Overall Study|Withdrawal by Subject|10|||
106115258|NCT01959347|366078273|FG000|Overall Study|Protocol Violation|9|||
106115259|NCT01959347|366078274|FG001|Overall Study|Protocol Violation|7|||
106115260|NCT05061537|366078277|FG000|Treatment Phase|Progressive disease|0|||
106115261|NCT05061537|366078278|FG001|Treatment Phase|Progressive disease|1|||
106115262|NCT05061537|366078279|FG002|Treatment Phase|Progressive disease|2|||
106115263|NCT05061537|366078280|FG003|Treatment Phase|Progressive disease|0|||
106115264|NCT05061537|366078281|FG004|Treatment Phase|Progressive disease|0|||
106115265|NCT05061537|366078277|FG000|Treatment Phase|Adverse Event|0|||
106115266|NCT05061537|366078278|FG001|Treatment Phase|Adverse Event|0|||
106115267|NCT05061537|366078279|FG002|Treatment Phase|Adverse Event|2|||
106115268|NCT05061537|366078280|FG003|Treatment Phase|Adverse Event|0|||
106115269|NCT05061537|366078281|FG004|Treatment Phase|Adverse Event|0|||
106115270|NCT05061537|366078277|FG000|Treatment Phase|Global deterioration of health status|0|||
106115271|NCT05061537|366078278|FG001|Treatment Phase|Global deterioration of health status|1|||
106115272|NCT05061537|366078279|FG002|Treatment Phase|Global deterioration of health status|0|||
106115273|NCT05061537|366078280|FG003|Treatment Phase|Global deterioration of health status|0|||
106115274|NCT05061537|366078281|FG004|Treatment Phase|Global deterioration of health status|0|||
106115275|NCT05061537|366078277|FG000|Follow up|Other|2|||
106115276|NCT05061537|366078278|FG001|Follow up|Other|0|||
106115277|NCT05061537|366078279|FG002|Follow up|Other|2|||
106115278|NCT05061537|366078280|FG003|Follow up|Other|0|||
106115279|NCT05061537|366078281|FG004|Follow up|Other|0|||
106115280|NCT05061537|366078277|FG000|Follow up|Study terminated by sponsor|0|||
106115281|NCT05061537|366078278|FG001|Follow up|Study terminated by sponsor|0|||
106115282|NCT05061537|366078279|FG002|Follow up|Study terminated by sponsor|2|||
106115283|NCT05061537|366078280|FG003|Follow up|Study terminated by sponsor|0|||
106115284|NCT05061537|366078281|FG004|Follow up|Study terminated by sponsor|0|||
106115285|NCT05061537|366078277|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
106115286|NCT05061537|366078278|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
106115287|NCT05061537|366078279|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
106115288|NCT05061537|366078280|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
106115289|NCT05061537|366078281|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
106115290|NCT05061537|366078277|FG000|Long-term Follow-up|Death|0|||
106115291|NCT05061537|366078278|FG001|Long-term Follow-up|Death|1|||
106115292|NCT05061537|366078279|FG002|Long-term Follow-up|Death|0|||
106115293|NCT05061537|366078280|FG003|Long-term Follow-up|Death|0|||
106115294|NCT05061537|366078281|FG004|Long-term Follow-up|Death|0|||
106115295|NCT02635724|366078292|FG000|Overall Study|Withdrawal by Subject|0|||
106115296|NCT02635724|366078293|FG001|Overall Study|Withdrawal by Subject|1|||
106115297|NCT02635724|366078294|FG002|Overall Study|Withdrawal by Subject|0|||
106115298|NCT02387996|366078297|FG000|Overall Study|Disease Progression|167|||
106115299|NCT02387996|366078297|FG000|Overall Study|Study Drug Toxicity|31|||
106115300|NCT02387996|366078297|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
106115301|NCT02387996|366078297|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
106115302|NCT02387996|366078297|FG000|Overall Study|Subject Withdrew Consent|5|||
106115303|NCT02387996|366078297|FG000|Overall Study|Lost to Follow-up|1|||
106115304|NCT02387996|366078297|FG000|Overall Study|Poor/Non-Compliance|1|||
106115305|NCT02387996|366078297|FG000|Overall Study|Other Reasons|5|||
106115306|NCT02387996|366078297|FG000|Overall Study|Death|1|||
106115307|NCT01453348|366078298|FG000|Overall Study|Death|0|||
106115308|NCT01453348|366078299|FG001|Overall Study|Death|0|||
106115309|NCT01453348|366078300|FG002|Overall Study|Death|1|||
106115310|NCT01453348|366078298|FG000|Overall Study|Withdrawal by Subject|0|||
105994610|NCT01514201|365640286|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
105994611|NCT01514201|365640287|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
105994612|NCT01514201|365640288|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
105994613|NCT01514201|365640289|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
105994614|NCT01514201|365640286|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
105994615|NCT01514201|365640287|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
105994616|NCT01514201|365640288|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
105994617|NCT01514201|365640289|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
105994618|NCT01514201|365640286|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105994619|NCT01514201|365640287|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105994620|NCT01514201|365640288|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
105994621|NCT01514201|365640289|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
105994622|NCT01514201|365640286|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
105994623|NCT01514201|365640287|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
105994624|NCT01514201|365640288|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
105994625|NCT01514201|365640289|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
105994626|NCT01514201|365640286|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105994627|NCT01514201|365640287|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105994628|NCT01514201|365640288|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
105994629|NCT01514201|365640289|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
105994630|NCT01514201|365640286|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105994631|NCT01514201|365640287|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105994632|NCT01514201|365640288|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
105994633|NCT01514201|365640289|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
105994634|NCT01514201|365640286|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
106115311|NCT01453348|366078299|FG001|Overall Study|Withdrawal by Subject|1|||
106115312|NCT01453348|366078300|FG002|Overall Study|Withdrawal by Subject|0|||
106115313|NCT01453348|366078298|FG000|Overall Study|Protocol Violation|1|||
106115314|NCT01453348|366078299|FG001|Overall Study|Protocol Violation|0|||
106115315|NCT01453348|366078300|FG002|Overall Study|Protocol Violation|0|||
106115316|NCT00909480|366078310|FG000|Overall Study|Adverse Event|5|||
106115317|NCT00909480|366078311|FG001|Overall Study|Adverse Event|3|||
106115318|NCT00909480|366078310|FG000|Overall Study|Protocol Violation|6|||
106115319|NCT00909480|366078311|FG001|Overall Study|Protocol Violation|8|||
106115320|NCT00909480|366078310|FG000|Overall Study|Withdrawal criteria|9|||
106115321|NCT00909480|366078311|FG001|Overall Study|Withdrawal criteria|11|||
106115322|NCT00909480|366078310|FG000|Overall Study|Unclassified|18|||
106115323|NCT00909480|366078311|FG001|Overall Study|Unclassified|19|||
106115324|NCT00744263|366078314|FG000|Overall Study|Death|3006|||
106115325|NCT00744263|366078315|FG001|Overall Study|Death|3005|||
106115326|NCT00744263|366078314|FG000|Overall Study|Lost to Follow-up|2038|||
106115327|NCT00744263|366078315|FG001|Overall Study|Lost to Follow-up|2135|||
106115328|NCT00744263|366078314|FG000|Overall Study|Withdrawal by Subject|166|||
106115329|NCT00744263|366078315|FG001|Overall Study|Withdrawal by Subject|150|||
106115330|NCT00744263|366078314|FG000|Overall Study|Physician Decision|20|||
106115331|NCT00744263|366078315|FG001|Overall Study|Physician Decision|23|||
106115332|NCT00744263|366078314|FG000|Overall Study|Protocol Violation|3|||
106115333|NCT00744263|366078315|FG001|Overall Study|Protocol Violation|5|||
106115334|NCT00744263|366078314|FG000|Overall Study|Adverse Event|1|||
106115335|NCT00744263|366078315|FG001|Overall Study|Adverse Event|0|||
105661754|NCT01068210|364425131|FG001|Overall Study|Second cancer|1|||
105994635|NCT01514201|365640287|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
106115336|NCT00744263|366078314|FG000|Overall Study|Other|2|||
106115337|NCT00744263|366078315|FG001|Overall Study|Other|2|||
106115338|NCT05004688|366078325|FG000|Overall Study|Protocol Violation|7|||
106115339|NCT05004688|366078325|FG000|Overall Study|Physician Decision|2|||
106115340|NCT05004688|366078325|FG000|Overall Study|Withdrawal by Subject|2|||
106115341|NCT00895622|366078326|FG000|Overall Study|Protocol Violation|5|||
106115342|NCT00895622|366078327|FG001|Overall Study|Protocol Violation|4|||
106115343|NCT00895622|366078328|FG002|Overall Study|Protocol Violation|4|||
106115344|NCT02277743|366078333|FG000|Overall Study|Protocol Violation|1|||
106115345|NCT02277743|366078334|FG001|Overall Study|Protocol Violation|1|||
106115346|NCT02277743|366078335|FG002|Overall Study|Protocol Violation|1|||
106115347|NCT02277743|366078333|FG000|Overall Study|Adverse Event|10|||
106115348|NCT02277743|366078334|FG001|Overall Study|Adverse Event|6|||
106115349|NCT02277743|366078335|FG002|Overall Study|Adverse Event|6|||
106115350|NCT02277743|366078333|FG000|Overall Study|Lack of Efficacy|11|||
106115351|NCT02277743|366078334|FG001|Overall Study|Lack of Efficacy|4|||
106115352|NCT02277743|366078335|FG002|Overall Study|Lack of Efficacy|3|||
106115353|NCT02277743|366078333|FG000|Overall Study|Other than specified above|18|||
106115354|NCT02277743|366078334|FG001|Overall Study|Other than specified above|5|||
106115355|NCT02277743|366078335|FG002|Overall Study|Other than specified above|16|||
106115356|NCT01224158|366078336|FG000|Overall Study|Withdrawal by Subject|1|||
106115357|NCT01224158|366078337|FG001|Overall Study|Withdrawal by Subject|0|||
106115358|NCT03976466|366078338|FG000|Overall Study|Lost to Follow-up|1|||
106115359|NCT03976466|366078339|FG001|Overall Study|Lost to Follow-up|3|||
106115360|NCT01931735|366078340|FG000|Randomized Phase|Lost to Follow-up|2|||
106115361|NCT01931735|366078341|FG001|Randomized Phase|Lost to Follow-up|2|||
106115362|NCT01931735|366078342|FG002|Randomized Phase|Lost to Follow-up|5|||
106115363|NCT01931735|366078343|FG003|Randomized Phase|Lost to Follow-up|0|||
106115364|NCT01931735|366078340|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
106115365|NCT01931735|366078341|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
106115366|NCT01931735|366078342|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
106115367|NCT01931735|366078343|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
106115368|NCT01931735|366078340|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
106115369|NCT01931735|366078341|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
106115370|NCT01931735|366078342|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
106115371|NCT01931735|366078343|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
106115372|NCT03520400|366078349|FG000|Overall Study|Physician Decision|15|||
106115373|NCT03520400|366078350|FG001|Overall Study|Physician Decision|7|||
106115374|NCT00909428|366078353|FG000|Overall Study|Lost to Follow-up|13|||
106115375|NCT00909428|366078354|FG001|Overall Study|Lost to Follow-up|10|||
106115376|NCT00909428|366078355|FG002|Overall Study|Lost to Follow-up|9|||
106115377|NCT02234063|366078356|FG000|Overall Study|Lost to Follow-up|235|||
106115378|NCT02234063|366078357|FG001|Overall Study|Lost to Follow-up|42|||
106115379|NCT02234063|366078356|FG000|Overall Study|Withdrawal by Subject|20|||
106115380|NCT02234063|366078357|FG001|Overall Study|Withdrawal by Subject|1|||
106115381|NCT01338012|366078358|FG000|Overall Study|Death|4|||
106115382|NCT01338012|366078358|FG000|Overall Study|Study terminated|4|||
106115383|NCT03559218|366080143|FG000|Overall Study|Withdrawal by Subject|1|||
106115384|NCT03559218|366080144|FG001|Overall Study|Withdrawal by Subject|0|||
106115385|NCT01062763|366080145|FG000|Overall Study|Adverse Event|3|||
106115386|NCT01062763|366080146|FG001|Overall Study|Adverse Event|4|||
106115387|NCT02305381|366080147|FG000|Overall Study|Unclassified|5|||
106115388|NCT02305381|366080148|FG001|Overall Study|Unclassified|5|||
106115389|NCT02305381|366080149|FG002|Overall Study|Unclassified|7|||
106115390|NCT01682213|366080155|FG000|Overall Study|Withdrawal by Subject|2|||
106115391|NCT01181726|366080156|FG000|First Intervention|Adverse Event|1|||
106115392|NCT01181726|366080157|FG001|First Intervention|Adverse Event|0|||
106115393|NCT04836858|366080158|FG000|Overall Study|Adverse Event|0|||
106115394|NCT04836858|366080159|FG001|Overall Study|Adverse Event|0|||
106115395|NCT04836858|366080160|FG002|Overall Study|Adverse Event|0|||
106115396|NCT04836858|366080161|FG003|Overall Study|Adverse Event|1|||
106115397|NCT04836858|366080158|FG000|Overall Study|Lost to Follow-up|1|||
106115398|NCT04836858|366080159|FG001|Overall Study|Lost to Follow-up|0|||
106115399|NCT04836858|366080160|FG002|Overall Study|Lost to Follow-up|0|||
106115400|NCT04836858|366080161|FG003|Overall Study|Lost to Follow-up|0|||
106115401|NCT04836858|366080158|FG000|Overall Study|Subject/Guardian decision|3|||
106115402|NCT04836858|366080159|FG001|Overall Study|Subject/Guardian decision|0|||
106115403|NCT04836858|366080160|FG002|Overall Study|Subject/Guardian decision|0|||
106115404|NCT04836858|366080161|FG003|Overall Study|Subject/Guardian decision|1|||
106115405|NCT04836858|366080158|FG000|Overall Study|Randomized but not treated|4|||
106115406|NCT04836858|366080159|FG001|Overall Study|Randomized but not treated|0|||
106115407|NCT04836858|366080160|FG002|Overall Study|Randomized but not treated|0|||
106115408|NCT04836858|366080161|FG003|Overall Study|Randomized but not treated|0|||
106115409|NCT04359771|366080166|FG000|Overall Study|Lack of Efficacy|2|||
106115410|NCT04359771|366080167|FG001|Overall Study|Lack of Efficacy|2|||
106115411|NCT00622713|366080170|FG000|Overall Study|Adverse Event|35|||
106115412|NCT00622713|366080170|FG000|Overall Study|Administrative problems|4|||
106115413|NCT00622713|366080170|FG000|Overall Study|Withdrawal by Subject|11|||
106115414|NCT00622713|366080170|FG000|Overall Study|Lost to Follow-up|5|||
106115415|NCT00622713|366080170|FG000|Overall Study|Death|2|||
106115416|NCT00622713|366080170|FG000|Overall Study|Subject no longer required study drug|1|||
106115417|NCT00622713|366080170|FG000|Overall Study|Did not meet eligibility criteria|1|||
106115418|NCT01462162|366080172|FG000|Overall Study|Adverse Event|5|||
106115419|NCT01462162|366080172|FG000|Overall Study|Lack of Efficacy|4|||
106115420|NCT01462162|366080172|FG000|Overall Study|Abnormal laboratory parameters|1|||
106115421|NCT01462162|366080172|FG000|Overall Study|Other|2|||
106115422|NCT01013792|366080179|FG000|Overall Study|Study suspended|2|||
106115423|NCT01013792|366080180|FG001|Overall Study|Study suspended|1|||
106115424|NCT01013792|366080179|FG000|Overall Study|Adverse Event|0|||
106115425|NCT01013792|366080180|FG001|Overall Study|Adverse Event|3|||
106115426|NCT01013792|366080179|FG000|Overall Study|Lost to Follow-up|0|||
106115427|NCT01013792|366080180|FG001|Overall Study|Lost to Follow-up|1|||
106115428|NCT05807919|366080184|FG000|Overall Study|Received antibiotics - excluded|0|||
106115429|NCT05807919|366080185|FG001|Overall Study|Received antibiotics - excluded|1|||
106115430|NCT05807919|366080184|FG000|Overall Study|Withdrawal by Subject|0|||
106115431|NCT05807919|366080185|FG001|Overall Study|Withdrawal by Subject|3|||
106115432|NCT05807919|366080184|FG000|Overall Study|Adverse Event|1|||
106115433|NCT05807919|366080185|FG001|Overall Study|Adverse Event|1|||
106115434|NCT01905046|366080186|FG000|Months 13-24|Withdrawal by Subject|10|||
106115435|NCT01905046|366080187|FG001|Months 13-24|Withdrawal by Subject|10|||
106115436|NCT01905046|366080186|FG000|Months 13-24|Adverse Event|3|||
106115437|NCT01905046|366080187|FG001|Months 13-24|Adverse Event|2|||
106115438|NCT01905046|366080186|FG000|Months 13-24|Protocol Violation|3|||
106115439|NCT01905046|366080187|FG001|Months 13-24|Protocol Violation|3|||
106115440|NCT01905046|366080186|FG000|Months 13-24|Physician Decision|1|||
106115441|NCT01905046|366080187|FG001|Months 13-24|Physician Decision|0|||
106115442|NCT03635489|366080191|FG000|Overall Study|Death|19|||
106115443|NCT03635489|366080192|FG001|Overall Study|Death|13|||
106115444|NCT03635489|366080191|FG000|Overall Study|Lost to Follow-up|1|||
106115445|NCT03635489|366080192|FG001|Overall Study|Lost to Follow-up|2|||
106115446|NCT03635489|366080191|FG000|Overall Study|Withdrawal by Subject|1|||
106115447|NCT03635489|366080192|FG001|Overall Study|Withdrawal by Subject|2|||
106115448|NCT03635489|366080191|FG000|Overall Study|Study Ended by Sponsor|28|||
106115449|NCT03635489|366080192|FG001|Overall Study|Study Ended by Sponsor|34|||
106115450|NCT02421939|366080195|FG000|Overall Study|Progressive disease|70|||
106115451|NCT02421939|366080196|FG001|Overall Study|Progressive disease|16|||
106115452|NCT02421939|366080195|FG000|Overall Study|Lack of Efficacy|21|||
106115453|NCT02421939|366080196|FG001|Overall Study|Lack of Efficacy|31|||
106115454|NCT02421939|366080195|FG000|Overall Study|Death|36|||
106115455|NCT02421939|366080196|FG001|Overall Study|Death|10|||
106115456|NCT02421939|366080195|FG000|Overall Study|Disease relapse|33|||
106115457|NCT02421939|366080196|FG001|Overall Study|Disease relapse|2|||
106115458|NCT02421939|366080195|FG000|Overall Study|Adverse Event|28|||
106115459|NCT02421939|366080196|FG001|Overall Study|Adverse Event|5|||
105994636|NCT01514201|365640288|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
105994637|NCT01514201|365640289|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
105994638|NCT00637416|365640290|FG000|Overall Study|Lost to Follow-up|1|||
105994639|NCT00637416|365640291|FG001|Overall Study|Lost to Follow-up|1|||
106115460|NCT02421939|366080195|FG000|Overall Study|Withdrawal by Subject|5|||
106115461|NCT02421939|366080196|FG001|Overall Study|Withdrawal by Subject|24|||
106115462|NCT02421939|366080195|FG000|Overall Study|Physician Decision|11|||
105994640|NCT00637416|365640290|FG000|Overall Study|Unable to take study drug|0|||
105994641|NCT00637416|365640291|FG001|Overall Study|Unable to take study drug|1|||
105994642|NCT04531241|365640296|FG000|Period 1|Withdrawal by Subject|2|||
106115463|NCT02421939|366080196|FG001|Overall Study|Physician Decision|11|||
106115464|NCT02421939|366080195|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
106115465|NCT02421939|366080196|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
106115466|NCT02421939|366080195|FG000|Overall Study|Miscellaneous|4|||
106115467|NCT02421939|366080196|FG001|Overall Study|Miscellaneous|5|||
106115468|NCT02421939|366080195|FG000|Overall Study|Protocol deviation|1|||
106115469|NCT02421939|366080196|FG001|Overall Study|Protocol deviation|1|||
106115470|NCT04043962|366080197|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
106115471|NCT04043962|366080197|FG000|Post-Treatment|Withdrawal by Subject|5|||
106115472|NCT04043962|366080197|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
106115473|NCT00990340|366080198|FG000|First 14-day Treatment|Not Compliant|2|||
106115474|NCT00990340|366080199|FG001|First 14-day Treatment|Not Compliant|1|||
106115475|NCT00990340|366080198|FG000|First 14-day Treatment|Lost to Follow-up|2|||
106115476|NCT00990340|366080199|FG001|First 14-day Treatment|Lost to Follow-up|1|||
106115477|NCT00990340|366080198|FG000|First 14-day Treatment|Protocol Violation|2|||
106115478|NCT00990340|366080199|FG001|First 14-day Treatment|Protocol Violation|2|||
106115479|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
106115480|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
106115481|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
106115482|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
106115483|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
106115484|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
106115485|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
106115486|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
106115487|NCT01336621|366080200|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
106115488|NCT01336621|366080200|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
106115489|NCT01336621|366080200|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
106115490|NCT01336621|366080200|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
106115491|NCT01336621|366080200|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
106115492|NCT01336621|366080200|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
106115493|NCT01576718|366080201|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
106115494|NCT01576718|366080202|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106115495|NCT01576718|366080203|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106115496|NCT01576718|366080204|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106115497|NCT01576718|366080205|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
105994643|NCT04531241|365640297|FG001|Period 1|Withdrawal by Subject|0|||
105994644|NCT04531241|365640296|FG000|Period 1|Dispesed incorrect lens power|1|||
105994645|NCT04531241|365640297|FG001|Period 1|Dispesed incorrect lens power|0|||
105994646|NCT04531241|365640296|FG000|Period 1|Protocol Violation|1|||
105994647|NCT04531241|365640297|FG001|Period 1|Protocol Violation|0|||
105994648|NCT04531241|365640296|FG000|Period 1|No longer eligible|0|||
105994649|NCT04531241|365640297|FG001|Period 1|No longer eligible|1|||
105994650|NCT04531241|365640296|FG000|Period 1|Lens Discomfort|0|||
105994651|NCT04531241|365640297|FG001|Period 1|Lens Discomfort|1|||
105994652|NCT04531241|365640296|FG000|Period 2|Covid-19 Related|1|||
105994653|NCT04531241|365640297|FG001|Period 2|Covid-19 Related|1|||
105994654|NCT00310817|365640298|FG000|Overall Study|AE or Death|3|||
105994655|NCT00310817|365640299|FG001|Overall Study|AE or Death|1|||
105994656|NCT00310817|365640300|FG002|Overall Study|AE or Death|0|||
105994657|NCT00310817|365640301|FG003|Overall Study|AE or Death|0|||
105994658|NCT00310817|365640298|FG000|Overall Study|Withdrawal by Subject|1|||
105994659|NCT00310817|365640299|FG001|Overall Study|Withdrawal by Subject|4|||
105994660|NCT00310817|365640300|FG002|Overall Study|Withdrawal by Subject|6|||
105994661|NCT00310817|365640301|FG003|Overall Study|Withdrawal by Subject|7|||
105994662|NCT00310817|365640298|FG000|Overall Study|Lost to Follow-up|2|||
105994663|NCT00310817|365640299|FG001|Overall Study|Lost to Follow-up|1|||
105994664|NCT00310817|365640300|FG002|Overall Study|Lost to Follow-up|0|||
105994665|NCT00310817|365640301|FG003|Overall Study|Lost to Follow-up|0|||
105994666|NCT00310817|365640298|FG000|Overall Study|Inappropriate Enrollment|1|||
105994667|NCT00310817|365640299|FG001|Overall Study|Inappropriate Enrollment|0|||
105994668|NCT00310817|365640300|FG002|Overall Study|Inappropriate Enrollment|1|||
105994669|NCT00310817|365640301|FG003|Overall Study|Inappropriate Enrollment|0|||
105994670|NCT00310817|365640298|FG000|Overall Study|Protocol Violation|1|||
105994671|NCT00310817|365640299|FG001|Overall Study|Protocol Violation|1|||
105994672|NCT00310817|365640300|FG002|Overall Study|Protocol Violation|1|||
105994673|NCT00310817|365640301|FG003|Overall Study|Protocol Violation|1|||
105994674|NCT00310817|365640298|FG000|Overall Study|Unable to classify|3|||
106115498|NCT01576718|366080206|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106115499|NCT01576718|366080207|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106115500|NCT01576718|366080201|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
106115501|NCT01576718|366080202|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106115502|NCT01576718|366080203|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106115503|NCT01576718|366080204|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
105994675|NCT00310817|365640299|FG001|Overall Study|Unable to classify|1|||
105994676|NCT00310817|365640300|FG002|Overall Study|Unable to classify|0|||
105994677|NCT00310817|365640301|FG003|Overall Study|Unable to classify|0|||
105994678|NCT01518374|365640302|FG000|Overall Study|Withdrawal by Subject|2|||
105994679|NCT01518374|365640302|FG000|Overall Study|Protocol Violation|3|||
105994680|NCT01518374|365640302|FG000|Overall Study|Lost to Follow-up|2|||
105994681|NCT04607837|365640304|FG000|Overall Study|Adverse Event|8|||
105994682|NCT04607837|365640305|FG001|Overall Study|Adverse Event|2|||
105994683|NCT04607837|365640304|FG000|Overall Study|Withdrawal by Subject|8|||
105994684|NCT04607837|365640305|FG001|Overall Study|Withdrawal by Subject|7|||
105994685|NCT04607837|365640304|FG000|Overall Study|Physician Decision|2|||
105994686|NCT04607837|365640305|FG001|Overall Study|Physician Decision|0|||
105994687|NCT04607837|365640304|FG000|Overall Study|Lack of Efficacy|2|||
105994688|NCT04607837|365640305|FG001|Overall Study|Lack of Efficacy|0|||
105994689|NCT04607837|365640304|FG000|Overall Study|Participant terminated by sponsor|1|||
105994690|NCT04607837|365640305|FG001|Overall Study|Participant terminated by sponsor|0|||
105994691|NCT04607837|365640304|FG000|Overall Study|Disease worsening|36|||
106115504|NCT01576718|366080205|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106115505|NCT01576718|366080206|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106115506|NCT01576718|366080207|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106115507|NCT01576718|366080201|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
106115508|NCT01576718|366080202|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106115509|NCT01576718|366080203|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106115510|NCT01576718|366080204|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106115511|NCT01576718|366080205|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106115512|NCT01576718|366080206|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106115513|NCT01576718|366080207|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
105994692|NCT04607837|365640305|FG001|Overall Study|Disease worsening|36|||
105994693|NCT04607837|365640304|FG000|Overall Study|Other|1|||
105994694|NCT04607837|365640305|FG001|Overall Study|Other|0|||
105994695|NCT02123823|365640307|FG000|Overall Study|Lack of Efficacy|0|||
105994696|NCT02123823|365640308|FG001|Overall Study|Lack of Efficacy|2|||
105994697|NCT02123823|365640309|FG002|Overall Study|Lack of Efficacy|8|||
105994698|NCT02123823|365640310|FG003|Overall Study|Lack of Efficacy|10|||
105994699|NCT02123823|365640307|FG000|Overall Study|Progressive disease|3|||
105994700|NCT02123823|365640308|FG001|Overall Study|Progressive disease|19|||
105994701|NCT02123823|365640309|FG002|Overall Study|Progressive disease|52|||
105994702|NCT02123823|365640310|FG003|Overall Study|Progressive disease|53|||
106115514|NCT01576718|366080201|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
106115515|NCT01576718|366080202|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106115516|NCT01576718|366080203|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106115517|NCT01576718|366080204|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106115518|NCT01576718|366080205|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106115519|NCT01576718|366080206|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106115520|NCT01576718|366080207|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106115521|NCT01576718|366080201|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
106115522|NCT01576718|366080202|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106115523|NCT01576718|366080203|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106115524|NCT01576718|366080204|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106115525|NCT01576718|366080205|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106115526|NCT01576718|366080206|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106115527|NCT01576718|366080207|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106115528|NCT01576718|366080201|FG000|Treatment Period|Adverse Event|0|||
106115529|NCT01576718|366080202|FG001|Treatment Period|Adverse Event|1|||
106115530|NCT01576718|366080203|FG002|Treatment Period|Adverse Event|1|||
106115531|NCT01576718|366080204|FG003|Treatment Period|Adverse Event|1|||
106115532|NCT01576718|366080205|FG004|Treatment Period|Adverse Event|1|||
106115533|NCT01576718|366080206|FG005|Treatment Period|Adverse Event|1|||
106115534|NCT01576718|366080207|FG006|Treatment Period|Adverse Event|0|||
106115535|NCT01576718|366080201|FG000|Treatment Period|Withdrawal by Subject|0|||
106115536|NCT01576718|366080202|FG001|Treatment Period|Withdrawal by Subject|1|||
106115537|NCT01576718|366080203|FG002|Treatment Period|Withdrawal by Subject|1|||
106115538|NCT01576718|366080204|FG003|Treatment Period|Withdrawal by Subject|0|||
106115539|NCT01576718|366080205|FG004|Treatment Period|Withdrawal by Subject|2|||
106115540|NCT01576718|366080206|FG005|Treatment Period|Withdrawal by Subject|4|||
106115541|NCT01576718|366080207|FG006|Treatment Period|Withdrawal by Subject|2|||
106115542|NCT01576718|366080201|FG000|Treatment Period|Physician Decision|0|||
106115543|NCT01576718|366080202|FG001|Treatment Period|Physician Decision|1|||
106115544|NCT01576718|366080203|FG002|Treatment Period|Physician Decision|1|||
106115545|NCT01576718|366080204|FG003|Treatment Period|Physician Decision|1|||
106115546|NCT01576718|366080205|FG004|Treatment Period|Physician Decision|1|||
106115547|NCT01576718|366080206|FG005|Treatment Period|Physician Decision|0|||
106115548|NCT01576718|366080207|FG006|Treatment Period|Physician Decision|0|||
106115549|NCT01576718|366080201|FG000|Treatment Period|Protocol Violation|0|||
106115550|NCT01576718|366080202|FG001|Treatment Period|Protocol Violation|5|||
106115551|NCT01576718|366080203|FG002|Treatment Period|Protocol Violation|4|||
106115552|NCT01576718|366080204|FG003|Treatment Period|Protocol Violation|10|||
106115553|NCT01576718|366080205|FG004|Treatment Period|Protocol Violation|6|||
106115554|NCT01576718|366080206|FG005|Treatment Period|Protocol Violation|8|||
106115555|NCT01576718|366080207|FG006|Treatment Period|Protocol Violation|12|||
106115556|NCT01576718|366080201|FG000|Treatment Period|Sponsor request|0|||
106115557|NCT01576718|366080202|FG001|Treatment Period|Sponsor request|1|||
106115558|NCT01576718|366080203|FG002|Treatment Period|Sponsor request|0|||
106115559|NCT01576718|366080204|FG003|Treatment Period|Sponsor request|0|||
106115560|NCT01576718|366080205|FG004|Treatment Period|Sponsor request|0|||
106115561|NCT01576718|366080206|FG005|Treatment Period|Sponsor request|1|||
106115562|NCT01576718|366080207|FG006|Treatment Period|Sponsor request|0|||
106115563|NCT01576718|366080201|FG000|Treatment Period|Met stopping criteria|0|||
106115564|NCT01576718|366080202|FG001|Treatment Period|Met stopping criteria|16|||
106115565|NCT01576718|366080203|FG002|Treatment Period|Met stopping criteria|13|||
106115566|NCT01576718|366080204|FG003|Treatment Period|Met stopping criteria|19|||
106115567|NCT01576718|366080205|FG004|Treatment Period|Met stopping criteria|16|||
106115568|NCT01576718|366080206|FG005|Treatment Period|Met stopping criteria|33|||
106115569|NCT01576718|366080207|FG006|Treatment Period|Met stopping criteria|15|||
106115570|NCT01576718|366080201|FG000|Treatment Period|Lost to Follow-up|0|||
106115571|NCT01576718|366080202|FG001|Treatment Period|Lost to Follow-up|0|||
106115572|NCT01576718|366080203|FG002|Treatment Period|Lost to Follow-up|0|||
106115573|NCT01576718|366080204|FG003|Treatment Period|Lost to Follow-up|0|||
106115574|NCT01576718|366080205|FG004|Treatment Period|Lost to Follow-up|1|||
106115575|NCT01576718|366080206|FG005|Treatment Period|Lost to Follow-up|0|||
106115576|NCT01576718|366080207|FG006|Treatment Period|Lost to Follow-up|0|||
106115577|NCT01576718|366080201|FG000|Treatment Period|Noncompliance to study medication|0|||
106115578|NCT01576718|366080202|FG001|Treatment Period|Noncompliance to study medication|0|||
106115579|NCT01576718|366080203|FG002|Treatment Period|Noncompliance to study medication|0|||
106115580|NCT01576718|366080204|FG003|Treatment Period|Noncompliance to study medication|0|||
106115581|NCT01576718|366080205|FG004|Treatment Period|Noncompliance to study medication|0|||
106115582|NCT01576718|366080206|FG005|Treatment Period|Noncompliance to study medication|1|||
106115583|NCT01576718|366080207|FG006|Treatment Period|Noncompliance to study medication|1|||
106115584|NCT01874145|366080209|FG000|Core Period|Non-compliance|1|||
106115585|NCT01874145|366080210|FG001|Core Period|Non-compliance|0|||
106115586|NCT01874145|366080209|FG000|Core Period|Protocol Violation|1|||
106115587|NCT01874145|366080210|FG001|Core Period|Protocol Violation|1|||
106115588|NCT01874145|366080209|FG000|Core Period|Physician Decision|1|||
106115589|NCT01874145|366080210|FG001|Core Period|Physician Decision|1|||
106115590|NCT01874145|366080209|FG000|Core Period|Adverse Event|0|||
106115591|NCT01874145|366080210|FG001|Core Period|Adverse Event|1|||
106115592|NCT01874145|366080209|FG000|Core Period|Withdrawal by Subject|0|||
106115593|NCT01874145|366080210|FG001|Core Period|Withdrawal by Subject|4|||
106115594|NCT01874145|366080209|FG000|Extension Period|Adverse Event|3|||
106115595|NCT01874145|366080210|FG001|Extension Period|Adverse Event|2|||
106115596|NCT01874145|366080209|FG000|Extension Period|Withdrawal by Subject|2|||
106115597|NCT01874145|366080210|FG001|Extension Period|Withdrawal by Subject|1|||
106115598|NCT01874145|366080209|FG000|Extension Period|Lost to Follow-up|1|||
106115599|NCT01874145|366080210|FG001|Extension Period|Lost to Follow-up|1|||
106115600|NCT02487095|366080211|FG000|Dose Expansion|Unable to scan/restage participant|0|||
106115601|NCT02487095|366080212|FG001|Dose Expansion|Unable to scan/restage participant|0|||
106115602|NCT02487095|366080213|FG002|Dose Expansion|Unable to scan/restage participant|0|||
106115603|NCT02487095|366080214|FG003|Dose Expansion|Unable to scan/restage participant|0|||
106115604|NCT02487095|366080215|FG004|Dose Expansion|Unable to scan/restage participant|1|||
106115605|NCT04631705|366080216|FG000|Overall Study|Withdrawal by Subject|0|||
106115606|NCT04631705|366080217|FG001|Overall Study|Withdrawal by Subject|0|||
106115607|NCT04631705|366080218|FG002|Overall Study|Withdrawal by Subject|0|||
105994703|NCT02123823|365640307|FG000|Overall Study|Withdrawal by Subject|0|||
105994704|NCT02123823|365640308|FG001|Overall Study|Withdrawal by Subject|0|||
106115608|NCT04631705|366080219|FG003|Overall Study|Withdrawal by Subject|0|||
106115609|NCT04631705|366080220|FG004|Overall Study|Withdrawal by Subject|0|||
106115610|NCT04631705|366080221|FG005|Overall Study|Withdrawal by Subject|0|||
106115611|NCT04631705|366080222|FG006|Overall Study|Withdrawal by Subject|1|||
106115612|NCT04631705|366080223|FG007|Overall Study|Withdrawal by Subject|0|||
106115613|NCT04631705|366080224|FG008|Overall Study|Withdrawal by Subject|0|||
106115614|NCT02130284|366080225|FG000|Overall Study|Withdrawal by Subject|3|||
106115615|NCT02130284|366080225|FG000|Overall Study|Subject Withdrew Consent|1|||
106115616|NCT02130284|366080225|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
106115617|NCT02130284|366080225|FG000|Overall Study|Subject was screened as backup for study|3|||
106115618|NCT02130284|366080225|FG000|Overall Study|Screen Failure|1|||
106115619|NCT01875185|366080226|FG000|Overall Study|study was terminated|52|||
106115620|NCT01875185|366080227|FG001|Overall Study|study was terminated|48|||
106115621|NCT04838613|366080230|FG000|Overall Study|Withdrawal by Subject|3|||
106115622|NCT04838613|366080231|FG001|Overall Study|Withdrawal by Subject|6|||
106115623|NCT04838613|366080230|FG000|Overall Study|Protocol Deviation|3|||
106115624|NCT04838613|366080231|FG001|Overall Study|Protocol Deviation|2|||
106115625|NCT04838613|366080230|FG000|Overall Study|Technical Problems|0|||
106115626|NCT04838613|366080231|FG001|Overall Study|Technical Problems|5|||
106115627|NCT04838613|366080230|FG000|Overall Study|Physician Decision|2|||
106115628|NCT04838613|366080231|FG001|Overall Study|Physician Decision|0|||
106115629|NCT02613221|366080236|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
106115630|NCT02613221|366080236|FG000|Overall Study|Adverse Event|2|||
106115631|NCT02613221|366080236|FG000|Overall Study|Voluntary Discontinuation|1|||
106115632|NCT02613221|366080236|FG000|Overall Study|Delayed Treatment|1|||
106115633|NCT02613221|366080236|FG000|Overall Study|Enrolled but Not Treated|1|||
106115634|NCT01893827|366080240|FG000|Overall Study|Lost to Follow-up|19|||
106115635|NCT01893827|366080241|FG001|Overall Study|Lost to Follow-up|26|||
106115636|NCT03389477|366080244|FG000|Step 1|Withdrawal by Subject|1|||
106115637|NCT03389477|366080245|FG001|Step 1|Withdrawal by Subject|0|||
106115638|NCT03389477|366080244|FG000|Step 2|Withdrawal by Subject|1|||
106115639|NCT03389477|366080245|FG001|Step 2|Withdrawal by Subject|2|||
105994705|NCT02123823|365640309|FG002|Overall Study|Withdrawal by Subject|7|||
105994706|NCT02123823|365640310|FG003|Overall Study|Withdrawal by Subject|2|||
105994707|NCT02123823|365640307|FG000|Overall Study|Adverse Event|0|||
105994708|NCT02123823|365640308|FG001|Overall Study|Adverse Event|0|||
105994709|NCT02123823|365640309|FG002|Overall Study|Adverse Event|3|||
106115640|NCT03389477|366080244|FG000|Step 2|Disease progression|1|||
106115641|NCT03389477|366080245|FG001|Step 2|Disease progression|0|||
106115642|NCT03389477|366080244|FG000|Step 2|Death|0|||
106115643|NCT03389477|366080245|FG001|Step 2|Death|1|||
106115644|NCT03389477|366080244|FG000|Step 2|Poor performance status and nutrition|0|||
106115645|NCT03389477|366080245|FG001|Step 2|Poor performance status and nutrition|1|||
106115646|NCT03389477|366080244|FG000|Step 3|Withdrawal after 3 cycles|0|||
106115647|NCT03389477|366080245|FG001|Step 3|Withdrawal after 3 cycles|1|||
105661755|NCT01068210|364425132|FG002|Overall Study|Second cancer|0|||
105994710|NCT02123823|365640310|FG003|Overall Study|Adverse Event|5|||
106115648|NCT03389477|366080244|FG000|Step 3|Still receiving active treatment|4|||
106115649|NCT03389477|366080245|FG001|Step 3|Still receiving active treatment|0|||
106115650|NCT03389477|366080244|FG000|Step 3|Progressive disease after 2 cycles|1|||
106115651|NCT03389477|366080245|FG001|Step 3|Progressive disease after 2 cycles|0|||
105661756|NCT01068210|364425133|FG003|Overall Study|Second cancer|0|||
106115652|NCT01065350|366080246|FG000|Overall Study|Received incorrect drug allocation|0|||
106115653|NCT01065350|366080247|FG001|Overall Study|Received incorrect drug allocation|1|||
106115654|NCT01807650|366080255|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
105994711|NCT03828019|365640313|FG000|Overall Study|Withdrawal by Subject|3|||
105994712|NCT03828019|365640314|FG001|Overall Study|Withdrawal by Subject|8|||
105994713|NCT03828019|365640313|FG000|Overall Study|Lost to Follow-up|1|||
105994714|NCT03828019|365640314|FG001|Overall Study|Lost to Follow-up|6|||
105994715|NCT03828019|365640313|FG000|Overall Study|Incarcerated|1|||
105994716|NCT03828019|365640314|FG001|Overall Study|Incarcerated|0|||
105994717|NCT03828019|365640313|FG000|Overall Study|Adverse Event|0|||
105994718|NCT03828019|365640314|FG001|Overall Study|Adverse Event|1|||
105994719|NCT00924443|365640315|FG000|Overall Study|Physician Decision|2|||
105994720|NCT00924443|365640315|FG000|Overall Study|Protocol Violation|1|||
105994721|NCT02863328|365640318|FG000|Overall Study|Lost to Follow-up|4|||
105994722|NCT02863328|365640319|FG001|Overall Study|Lost to Follow-up|10|||
105994723|NCT02863328|365640318|FG000|Overall Study|Withdrawal by Subject|7|||
106115655|NCT01807650|366080255|FG000|Overall Study|Adverse Event|5|||
106115656|NCT01807650|366080255|FG000|Overall Study|Other|2|||
106115657|NCT02217280|366080256|FG000|Overall Study|Withdrawal by Subject|2|||
106115658|NCT02217280|366080256|FG000|Overall Study|Post-consent sceen fail|2|||
106115659|NCT00736489|366080259|FG000|Period 1|Lost to Follow-up|1|||
106115660|NCT00736489|366080260|FG001|Period 1|Lost to Follow-up|0|||
106115661|NCT00736489|366080261|FG002|Period 1|Lost to Follow-up|0|||
106115662|NCT00736489|366080262|FG003|Period 1|Lost to Follow-up|0|||
106115663|NCT00736489|366080263|FG004|Period 1|Lost to Follow-up|0|||
106115664|NCT00736489|366080264|FG005|Period 1|Lost to Follow-up|0|||
106115665|NCT00736489|366080259|FG000|Period 1|Withdrawal by Subject|0|||
106115666|NCT00736489|366080260|FG001|Period 1|Withdrawal by Subject|0|||
106115667|NCT00736489|366080261|FG002|Period 1|Withdrawal by Subject|0|||
106115668|NCT00736489|366080262|FG003|Period 1|Withdrawal by Subject|0|||
106115669|NCT00736489|366080263|FG004|Period 1|Withdrawal by Subject|0|||
106115670|NCT00736489|366080264|FG005|Period 1|Withdrawal by Subject|1|||
106115671|NCT01933880|366080265|FG000|Overall Study|Withdrawal by Subject|5|||
106115672|NCT01933880|366080266|FG001|Overall Study|Withdrawal by Subject|0|||
106115673|NCT01933880|366080265|FG000|Overall Study|Lack of Efficacy|1|||
106115674|NCT01933880|366080266|FG001|Overall Study|Lack of Efficacy|0|||
106115675|NCT01933880|366080265|FG000|Overall Study|Concomitant medication Interference|0|||
106115676|NCT01933880|366080266|FG001|Overall Study|Concomitant medication Interference|1|||
106115677|NCT01933880|366080265|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
106115678|NCT01933880|366080266|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
106115679|NCT01933880|366080265|FG000|Overall Study|Other|4|||
106115680|NCT01933880|366080266|FG001|Overall Study|Other|0|||
106115681|NCT01933880|366080265|FG000|Overall Study|Protocol Violation|1|||
106115682|NCT01933880|366080266|FG001|Overall Study|Protocol Violation|0|||
106115683|NCT01125722|366080267|FG000|Overall Study|Withdrawal by Subject|2|||
106115684|NCT01125722|366080268|FG001|Overall Study|Withdrawal by Subject|1|||
106115685|NCT01125722|366080267|FG000|Overall Study|Lost to Follow-up|1|||
106115686|NCT01125722|366080268|FG001|Overall Study|Lost to Follow-up|0|||
106115687|NCT02090634|366080269|FG000|Overall Study|Lost to Follow-up|0|||
106115688|NCT02090634|366080270|FG001|Overall Study|Lost to Follow-up|1|||
106115689|NCT02090634|366080269|FG000|Overall Study|Death|0|||
106115690|NCT02090634|366080270|FG001|Overall Study|Death|1|||
106115691|NCT02090634|366080269|FG000|Overall Study|Protocol Violation|3|||
106115692|NCT02090634|366080270|FG001|Overall Study|Protocol Violation|1|||
106115693|NCT02090634|366080269|FG000|Overall Study|Adverse Event|2|||
106115694|NCT02090634|366080270|FG001|Overall Study|Adverse Event|0|||
106115695|NCT01518946|366080279|FG000|Open-label Phase|Other|4|||
106115696|NCT01518946|366080280|FG001|Open-label Phase|Other|0|||
106115697|NCT01518946|366080281|FG002|Open-label Phase|Other|0|||
106115698|NCT01518946|366080279|FG000|Randomized Phase (First Intervention)|Other|0|||
106115699|NCT01518946|366080280|FG001|Randomized Phase (First Intervention)|Other|1|||
106115700|NCT01518946|366080281|FG002|Randomized Phase (First Intervention)|Other|0|||
106115701|NCT00118898|366080282|FG000|Overall Study|Death|6|||
106115702|NCT00118898|366080283|FG001|Overall Study|Death|11|||
106115703|NCT00118898|366080284|FG002|Overall Study|Death|6|||
106115704|NCT00118898|366080285|FG003|Overall Study|Death|8|||
106115705|NCT00118898|366080282|FG000|Overall Study|Lost to Follow-up|26|||
106115706|NCT00118898|366080283|FG001|Overall Study|Lost to Follow-up|34|||
106115707|NCT00118898|366080284|FG002|Overall Study|Lost to Follow-up|33|||
106115708|NCT00118898|366080285|FG003|Overall Study|Lost to Follow-up|33|||
106115709|NCT00118898|366080282|FG000|Overall Study|Withdrawal by Subject|10|||
106115710|NCT00118898|366080283|FG001|Overall Study|Withdrawal by Subject|5|||
106115711|NCT00118898|366080284|FG002|Overall Study|Withdrawal by Subject|8|||
106115712|NCT00118898|366080285|FG003|Overall Study|Withdrawal by Subject|8|||
106115713|NCT00118898|366080282|FG000|Overall Study|Site Closure|33|||
106115714|NCT00118898|366080283|FG001|Overall Study|Site Closure|31|||
106115715|NCT00118898|366080284|FG002|Overall Study|Site Closure|28|||
106115716|NCT00118898|366080285|FG003|Overall Study|Site Closure|37|||
105994724|NCT02863328|365640319|FG001|Overall Study|Withdrawal by Subject|12|||
105994725|NCT02863328|365640318|FG000|Overall Study|Died|0|||
105994726|NCT02863328|365640319|FG001|Overall Study|Died|1|||
106115717|NCT00118898|366080282|FG000|Overall Study|Severe debilitation|1|||
106115718|NCT00118898|366080283|FG001|Overall Study|Severe debilitation|4|||
106115719|NCT00118898|366080284|FG002|Overall Study|Severe debilitation|6|||
106115720|NCT00118898|366080285|FG003|Overall Study|Severe debilitation|4|||
106115721|NCT00118898|366080282|FG000|Overall Study|Not compliant with requirements|11|||
106115722|NCT00118898|366080283|FG001|Overall Study|Not compliant with requirements|13|||
106115723|NCT00118898|366080284|FG002|Overall Study|Not compliant with requirements|11|||
106115724|NCT00118898|366080285|FG003|Overall Study|Not compliant with requirements|11|||
106115725|NCT00118898|366080282|FG000|Overall Study|Not able to get to clinic|34|||
106115726|NCT00118898|366080283|FG001|Overall Study|Not able to get to clinic|43|||
106115727|NCT00118898|366080284|FG002|Overall Study|Not able to get to clinic|31|||
106115728|NCT00118898|366080285|FG003|Overall Study|Not able to get to clinic|40|||
106115729|NCT00384059|366080286|FG000|Infant Series|Not consented|2|||
106115730|NCT00384059|366080287|FG001|Infant Series|Not consented|6|||
106115731|NCT00384059|366080286|FG000|Infant Series|Withdrawal by Subject|2|||
106115732|NCT00384059|366080287|FG001|Infant Series|Withdrawal by Subject|2|||
106115733|NCT00384059|366080286|FG000|Infant Series|Adverse Event|1|||
106115734|NCT00384059|366080287|FG001|Infant Series|Adverse Event|2|||
106115735|NCT00384059|366080286|FG000|Infant Series|Protocol Violation|1|||
106115736|NCT00384059|366080287|FG001|Infant Series|Protocol Violation|2|||
106115737|NCT00384059|366080286|FG000|Infant Series|Lost to Follow-up|0|||
106115738|NCT00384059|366080287|FG001|Infant Series|Lost to Follow-up|1|||
106115739|NCT00384059|366080286|FG000|After Infant Series|Protocol Violation|2|||
106115740|NCT00384059|366080287|FG001|After Infant Series|Protocol Violation|3|||
106115741|NCT00384059|366080286|FG000|After Infant Series|Withdrawal by Subject|2|||
106115742|NCT00384059|366080287|FG001|After Infant Series|Withdrawal by Subject|2|||
106115743|NCT00384059|366080286|FG000|After Infant Series|Failed to Return|0|||
106115744|NCT00384059|366080287|FG001|After Infant Series|Failed to Return|2|||
106115745|NCT00384059|366080286|FG000|After Infant Series|Adverse Event|0|||
106115746|NCT00384059|366080287|FG001|After Infant Series|Adverse Event|1|||
106115747|NCT00384059|366080286|FG000|After Infant Series|Physician Decision|0|||
106115748|NCT00384059|366080287|FG001|After Infant Series|Physician Decision|1|||
106115749|NCT00384059|366080286|FG000|After Infant Series|Lost to Follow-up|0|||
105994727|NCT00699660|365640320|FG000|Overall Study|Lost to Follow-up|4|||
105994728|NCT00699660|365640321|FG001|Overall Study|Lost to Follow-up|2|||
105994729|NCT00699660|365640320|FG000|Overall Study|missing reports and recording failures|10|||
105994730|NCT00699660|365640321|FG001|Overall Study|missing reports and recording failures|6|||
105994731|NCT00398320|365640322|FG000|Overall Study|Death|1|||
105994732|NCT00398320|365640322|FG000|Overall Study|Adverse Event|4|||
105994733|NCT00398320|365640322|FG000|Overall Study|Physician Decision|1|||
105994734|NCT01870726|365640323|FG000|Overall Study|Withdrawal of informed consent|0|||
105994735|NCT01870726|365640324|FG001|Overall Study|Withdrawal of informed consent|0|||
105994736|NCT01870726|365640325|FG002|Overall Study|Withdrawal of informed consent|0|||
105994737|NCT01870726|365640326|FG003|Overall Study|Withdrawal of informed consent|1|||
105994738|NCT01870726|365640327|FG004|Overall Study|Withdrawal of informed consent|0|||
105994739|NCT01870726|365640328|FG005|Overall Study|Withdrawal of informed consent|0|||
105994740|NCT01870726|365640329|FG006|Overall Study|Withdrawal of informed consent|0|||
105994741|NCT01870726|365640323|FG000|Overall Study|Withdrawal by Subject|0|||
105994742|NCT01870726|365640324|FG001|Overall Study|Withdrawal by Subject|1|||
105994743|NCT01870726|365640325|FG002|Overall Study|Withdrawal by Subject|0|||
105994744|NCT01870726|365640326|FG003|Overall Study|Withdrawal by Subject|0|||
105994745|NCT01870726|365640327|FG004|Overall Study|Withdrawal by Subject|0|||
105994746|NCT01870726|365640328|FG005|Overall Study|Withdrawal by Subject|0|||
105994747|NCT01870726|365640329|FG006|Overall Study|Withdrawal by Subject|0|||
105994748|NCT01870726|365640323|FG000|Overall Study|Adverse Event|0|||
105994749|NCT01870726|365640324|FG001|Overall Study|Adverse Event|0|||
105994750|NCT01870726|365640325|FG002|Overall Study|Adverse Event|0|||
105994751|NCT01870726|365640326|FG003|Overall Study|Adverse Event|0|||
105994752|NCT01870726|365640327|FG004|Overall Study|Adverse Event|1|||
105994753|NCT01870726|365640328|FG005|Overall Study|Adverse Event|1|||
105994754|NCT01870726|365640329|FG006|Overall Study|Adverse Event|0|||
105994755|NCT01870726|365640323|FG000|Overall Study|Progressive disease|5|||
105994756|NCT01870726|365640324|FG001|Overall Study|Progressive disease|5|||
105994757|NCT01870726|365640325|FG002|Overall Study|Progressive disease|4|||
105994758|NCT01870726|365640326|FG003|Overall Study|Progressive disease|5|||
105994759|NCT01870726|365640327|FG004|Overall Study|Progressive disease|6|||
106115750|NCT00384059|366080287|FG001|After Infant Series|Lost to Follow-up|1|||
106115751|NCT00384059|366080286|FG000|Toddler Dose|Lost to Follow-up|1|||
106115752|NCT00384059|366080287|FG001|Toddler Dose|Lost to Follow-up|1|||
105994760|NCT01870726|365640328|FG005|Overall Study|Progressive disease|4|||
105994761|NCT01870726|365640329|FG006|Overall Study|Progressive disease|10|||
106115753|NCT00384059|366080286|FG000|Toddler Dose|Failed to return|0|||
105994762|NCT01248949|365640330|FG000|Overall Study|Lost to Follow-up|2|||
105994763|NCT01248949|365640331|FG001|Overall Study|Lost to Follow-up|2|||
105994764|NCT01248949|365640332|FG002|Overall Study|Lost to Follow-up|2|||
105994765|NCT01248949|365640333|FG003|Overall Study|Lost to Follow-up|1|||
105994766|NCT01248949|365640334|FG004|Overall Study|Lost to Follow-up|0|||
105994767|NCT01248949|365640330|FG000|Overall Study|Withdrawal by Subject|5|||
106115754|NCT00384059|366080287|FG001|Toddler Dose|Failed to return|1|||
106115755|NCT01493960|366082607|FG000|Overall Study|Adverse Event|0|||
106115756|NCT01493960|366082608|FG001|Overall Study|Adverse Event|1|||
106115757|NCT01493960|366082607|FG000|Overall Study|Lack of Efficacy|15|||
106115758|NCT01493960|366082608|FG001|Overall Study|Lack of Efficacy|9|||
106115759|NCT01493960|366082607|FG000|Overall Study|Protocol Violation|3|||
106115760|NCT01493960|366082608|FG001|Overall Study|Protocol Violation|0|||
106115761|NCT01493960|366082607|FG000|Overall Study|Withdrawal by Subject|10|||
106115762|NCT01493960|366082608|FG001|Overall Study|Withdrawal by Subject|4|||
106115763|NCT01493960|366082607|FG000|Overall Study|Non-specified|4|||
106115764|NCT01493960|366082608|FG001|Overall Study|Non-specified|4|||
106115765|NCT00284141|366082609|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
106115766|NCT00284141|366082609|FG000|Overall Study|Adverse Event|19|||
106115767|NCT00284141|366082609|FG000|Overall Study|Participant's request|9|||
106115768|NCT00284141|366082609|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
106115769|NCT00284141|366082609|FG000|Overall Study|Clinical deterioration / death|2|||
106115770|NCT00284141|366082609|FG000|Overall Study|General decline|1|||
106115771|NCT00284141|366082609|FG000|Overall Study|Pneumonia|1|||
106115772|NCT00284141|366082609|FG000|Overall Study|Did not take study medication|2|||
106115773|NCT00284141|366082609|FG000|Overall Study|Ongoing treatment|2|||
106115774|NCT02714868|366082614|FG000|Overall Study|Withdrawal by Subject|3|||
106115775|NCT02714868|366082615|FG001|Overall Study|Withdrawal by Subject|0|||
106115776|NCT02714868|366082614|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
106115777|NCT02714868|366082615|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
106115778|NCT02714868|366082614|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
106115779|NCT02714868|366082615|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
106115780|NCT00369681|366082616|FG000|Overall Study|Death|1|||
106115781|NCT04439253|366082619|FG000|Overall Study|Adverse Event|1|||
106115782|NCT04439253|366082619|FG000|Overall Study|Disease progression|2|||
106115783|NCT04439253|366082619|FG000|Overall Study|Complicating disease|1|||
106115784|NCT02991482|366082620|FG000|Overall Study|Disease progression|56|||
106115785|NCT02991482|366082621|FG001|Overall Study|Disease progression|47|||
106115786|NCT02991482|366082620|FG000|Overall Study|Death|4|||
106115787|NCT02991482|366082621|FG001|Overall Study|Death|4|||
106115788|NCT02991482|366082620|FG000|Overall Study|Adverse Event|1|||
106115789|NCT02991482|366082621|FG001|Overall Study|Adverse Event|6|||
106115790|NCT02991482|366082620|FG000|Overall Study|Patient decision|1|||
106115791|NCT02991482|366082621|FG001|Overall Study|Patient decision|1|||
106115792|NCT02991482|366082620|FG000|Overall Study|Physician Decision|0|||
106115793|NCT02991482|366082621|FG001|Overall Study|Physician Decision|6|||
106115794|NCT02991482|366082620|FG000|Overall Study|Clinical deterioration|1|||
106115795|NCT02991482|366082621|FG001|Overall Study|Clinical deterioration|0|||
106115796|NCT02991482|366082620|FG000|Overall Study|Patient feeling too unwell|1|||
106115797|NCT02991482|366082621|FG001|Overall Study|Patient feeling too unwell|0|||
106115798|NCT02991482|366082620|FG000|Overall Study|Worsening of performance status|0|||
106115799|NCT02991482|366082621|FG001|Overall Study|Worsening of performance status|1|||
106115800|NCT02991482|366082620|FG000|Overall Study|Death prior to study drug initiation|1|||
106115801|NCT02991482|366082621|FG001|Overall Study|Death prior to study drug initiation|0|||
106115802|NCT02991482|366082620|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
106115803|NCT02991482|366082621|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
106115804|NCT01250119|366082624|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
106115805|NCT01250119|366082625|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
106115806|NCT01250119|366082624|FG000|Diagnostic Phase|Participants Not Tested|44|||
106115807|NCT01250119|366082625|FG001|Diagnostic Phase|Participants Not Tested|0|||
106115808|NCT01250119|366082624|FG000|Treatment Phase|Progressive Disease|0|||
106115809|NCT01250119|366082625|FG001|Treatment Phase|Progressive Disease|32|||
106115810|NCT01250119|366082624|FG000|Treatment Phase|Death|0|||
106115811|NCT01250119|366082625|FG001|Treatment Phase|Death|2|||
106115812|NCT01250119|366082624|FG000|Treatment Phase|Withdrawal by Subject|0|||
106115813|NCT01250119|366082625|FG001|Treatment Phase|Withdrawal by Subject|1|||
106115814|NCT01250119|366082624|FG000|Treatment Phase|Adverse Event|0|||
106115815|NCT01250119|366082625|FG001|Treatment Phase|Adverse Event|2|||
106115816|NCT01250119|366082624|FG000|Treatment Phase|Unknown reason|0|||
106115817|NCT01250119|366082625|FG001|Treatment Phase|Unknown reason|4|||
106115818|NCT02243202|366082626|FG000|Overall Study|Adverse Event|5|||
106115819|NCT02243202|366082627|FG001|Overall Study|Adverse Event|6|||
106115820|NCT02243202|366082628|FG002|Overall Study|Adverse Event|10|||
106115821|NCT02243202|366082629|FG003|Overall Study|Adverse Event|4|||
106115822|NCT02243202|366082626|FG000|Overall Study|Lost to Follow-up|9|||
106115823|NCT02243202|366082627|FG001|Overall Study|Lost to Follow-up|9|||
106115824|NCT02243202|366082628|FG002|Overall Study|Lost to Follow-up|14|||
106115825|NCT02243202|366082629|FG003|Overall Study|Lost to Follow-up|11|||
106115826|NCT02243202|366082626|FG000|Overall Study|Protocol Violation|3|||
106115827|NCT02243202|366082627|FG001|Overall Study|Protocol Violation|1|||
106115828|NCT02243202|366082628|FG002|Overall Study|Protocol Violation|2|||
106115829|NCT02243202|366082629|FG003|Overall Study|Protocol Violation|1|||
106115830|NCT02243202|366082626|FG000|Overall Study|Withdrawal by Subject|7|||
106115831|NCT02243202|366082627|FG001|Overall Study|Withdrawal by Subject|6|||
105994768|NCT01248949|365640331|FG001|Overall Study|Withdrawal by Subject|3|||
105994769|NCT01248949|365640332|FG002|Overall Study|Withdrawal by Subject|11|||
105994770|NCT01248949|365640333|FG003|Overall Study|Withdrawal by Subject|3|||
105994771|NCT01248949|365640334|FG004|Overall Study|Withdrawal by Subject|1|||
105994772|NCT01248949|365640330|FG000|Overall Study|Death|22|||
105994773|NCT01248949|365640331|FG001|Overall Study|Death|7|||
105994774|NCT01248949|365640332|FG002|Overall Study|Death|21|||
105994775|NCT01248949|365640333|FG003|Overall Study|Death|6|||
105994776|NCT01248949|365640334|FG004|Overall Study|Death|2|||
105994777|NCT01248949|365640330|FG000|Overall Study|Alternative Therapy|1|||
105994778|NCT01248949|365640331|FG001|Overall Study|Alternative Therapy|0|||
105994779|NCT01248949|365640332|FG002|Overall Study|Alternative Therapy|0|||
105994780|NCT01248949|365640333|FG003|Overall Study|Alternative Therapy|0|||
105994781|NCT01248949|365640334|FG004|Overall Study|Alternative Therapy|0|||
105994782|NCT01248949|365640330|FG000|Overall Study|Alternative Therapy.|1|||
105994783|NCT01248949|365640331|FG001|Overall Study|Alternative Therapy.|0|||
105994784|NCT01248949|365640332|FG002|Overall Study|Alternative Therapy.|0|||
105994785|NCT01248949|365640333|FG003|Overall Study|Alternative Therapy.|0|||
105994786|NCT01248949|365640334|FG004|Overall Study|Alternative Therapy.|0|||
105994787|NCT01248949|365640330|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
105994788|NCT01248949|365640331|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
105994789|NCT01248949|365640332|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
105994790|NCT01248949|365640333|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
105994791|NCT01248949|365640334|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
105994792|NCT01248949|365640330|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
105994793|NCT01248949|365640331|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
105994794|NCT01248949|365640332|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
105994795|NCT01248949|365640333|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
105994796|NCT01248949|365640334|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
105994797|NCT01248949|365640330|FG000|Overall Study|Participant Went To Hospice|0|||
105994798|NCT01248949|365640331|FG001|Overall Study|Participant Went To Hospice|0|||
105994799|NCT01248949|365640332|FG002|Overall Study|Participant Went To Hospice|1|||
105994800|NCT01248949|365640333|FG003|Overall Study|Participant Went To Hospice|0|||
105994801|NCT01248949|365640334|FG004|Overall Study|Participant Went To Hospice|0|||
105994802|NCT01248949|365640330|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
105994803|NCT01248949|365640331|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
105994804|NCT01248949|365640332|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
105994805|NCT01248949|365640333|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
105994806|NCT01248949|365640334|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
105994807|NCT01248949|365640330|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
105994808|NCT01248949|365640331|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
105994809|NCT01248949|365640332|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
105994810|NCT01248949|365640333|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
105994811|NCT01248949|365640334|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
105994812|NCT01248949|365640330|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
105994813|NCT01248949|365640331|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
105994814|NCT01248949|365640332|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
105994815|NCT01248949|365640333|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
105994816|NCT01248949|365640334|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
105994817|NCT01248949|365640330|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
105994818|NCT01248949|365640331|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
105994819|NCT01248949|365640332|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
105994820|NCT01248949|365640333|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
105994821|NCT01248949|365640334|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
105994822|NCT00286429|365640335|FG000|Overall Study|Adverse Event|4|||
105994823|NCT00286429|365640336|FG001|Overall Study|Adverse Event|1|||
105994824|NCT00286429|365640337|FG002|Overall Study|Adverse Event|6|||
105994825|NCT00286429|365640335|FG000|Overall Study|Lack of Efficacy|52|||
105994826|NCT00286429|365640336|FG001|Overall Study|Lack of Efficacy|27|||
105994827|NCT00286429|365640337|FG002|Overall Study|Lack of Efficacy|25|||
105994828|NCT00286429|365640335|FG000|Overall Study|Lost to Follow-up|2|||
105994829|NCT00286429|365640336|FG001|Overall Study|Lost to Follow-up|4|||
105994830|NCT00286429|365640337|FG002|Overall Study|Lost to Follow-up|3|||
105994831|NCT00286429|365640335|FG000|Overall Study|Physician Decision|10|||
105994832|NCT00286429|365640336|FG001|Overall Study|Physician Decision|7|||
105994833|NCT00286429|365640337|FG002|Overall Study|Physician Decision|7|||
105994834|NCT00286429|365640335|FG000|Overall Study|Protocol Violation|3|||
105994835|NCT00286429|365640336|FG001|Overall Study|Protocol Violation|5|||
106115832|NCT02243202|366082628|FG002|Overall Study|Withdrawal by Subject|4|||
106115833|NCT02243202|366082629|FG003|Overall Study|Withdrawal by Subject|4|||
106115834|NCT02243202|366082626|FG000|Overall Study|Other|1|||
106115835|NCT02243202|366082627|FG001|Overall Study|Other|3|||
106115836|NCT02243202|366082628|FG002|Overall Study|Other|1|||
106115837|NCT02243202|366082629|FG003|Overall Study|Other|2|||
106115838|NCT02243202|366082626|FG000|Overall Study|Randomized but not received treatment|0|||
106115839|NCT02243202|366082627|FG001|Overall Study|Randomized but not received treatment|0|||
106115840|NCT02243202|366082628|FG002|Overall Study|Randomized but not received treatment|0|||
106115841|NCT02243202|366082629|FG003|Overall Study|Randomized but not received treatment|1|||
106115842|NCT02287584|366082633|FG000|the Double-blind Phase|Adverse Event|17|||
106115843|NCT02287584|366082634|FG001|the Double-blind Phase|Adverse Event|17|||
106115844|NCT02287584|366082635|FG002|the Double-blind Phase|Adverse Event|12|||
106115845|NCT02287584|366082636|FG003|the Double-blind Phase|Adverse Event|0|||
106115846|NCT02287584|366082637|FG004|the Double-blind Phase|Adverse Event|0|||
106115847|NCT02287584|366082638|FG005|the Double-blind Phase|Adverse Event|0|||
106115848|NCT02287584|366082633|FG000|the Double-blind Phase|Lack of Efficacy|18|||
106115849|NCT02287584|366082634|FG001|the Double-blind Phase|Lack of Efficacy|8|||
106115850|NCT02287584|366082635|FG002|the Double-blind Phase|Lack of Efficacy|8|||
106115851|NCT02287584|366082636|FG003|the Double-blind Phase|Lack of Efficacy|0|||
106115852|NCT02287584|366082637|FG004|the Double-blind Phase|Lack of Efficacy|0|||
106115853|NCT02287584|366082638|FG005|the Double-blind Phase|Lack of Efficacy|0|||
106115854|NCT02287584|366082633|FG000|the Double-blind Phase|Lost to Follow-up|0|||
106115855|NCT02287584|366082634|FG001|the Double-blind Phase|Lost to Follow-up|1|||
106115856|NCT02287584|366082635|FG002|the Double-blind Phase|Lost to Follow-up|1|||
106115857|NCT02287584|366082636|FG003|the Double-blind Phase|Lost to Follow-up|0|||
106115858|NCT02287584|366082637|FG004|the Double-blind Phase|Lost to Follow-up|0|||
106115859|NCT02287584|366082638|FG005|the Double-blind Phase|Lost to Follow-up|0|||
106115860|NCT02287584|366082633|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
106115861|NCT02287584|366082634|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
106115862|NCT02287584|366082635|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
106115863|NCT02287584|366082636|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
106115864|NCT02287584|366082637|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
106115865|NCT02287584|366082638|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
106115866|NCT02287584|366082633|FG000|the Double-blind Phase|Pregnancy|0|||
106115867|NCT02287584|366082634|FG001|the Double-blind Phase|Pregnancy|1|||
106115868|NCT02287584|366082635|FG002|the Double-blind Phase|Pregnancy|0|||
106115869|NCT02287584|366082636|FG003|the Double-blind Phase|Pregnancy|0|||
106115870|NCT02287584|366082637|FG004|the Double-blind Phase|Pregnancy|0|||
106115871|NCT02287584|366082638|FG005|the Double-blind Phase|Pregnancy|0|||
106115872|NCT02287584|366082633|FG000|the Double-blind Phase|Protocol Violation|0|||
106115873|NCT02287584|366082634|FG001|the Double-blind Phase|Protocol Violation|3|||
106115874|NCT02287584|366082635|FG002|the Double-blind Phase|Protocol Violation|0|||
106115875|NCT02287584|366082636|FG003|the Double-blind Phase|Protocol Violation|0|||
106115876|NCT02287584|366082637|FG004|the Double-blind Phase|Protocol Violation|0|||
106115877|NCT02287584|366082638|FG005|the Double-blind Phase|Protocol Violation|0|||
106115878|NCT02287584|366082633|FG000|the Double-blind Phase|other reasons|0|||
106115879|NCT02287584|366082634|FG001|the Double-blind Phase|other reasons|0|||
106115880|NCT02287584|366082635|FG002|the Double-blind Phase|other reasons|1|||
106115881|NCT02287584|366082636|FG003|the Double-blind Phase|other reasons|0|||
106115882|NCT02287584|366082637|FG004|the Double-blind Phase|other reasons|0|||
106115883|NCT02287584|366082638|FG005|the Double-blind Phase|other reasons|0|||
106115884|NCT02287584|366082633|FG000|the Open-label Phase|Did not receive drug|0|||
106115885|NCT02287584|366082634|FG001|the Open-label Phase|Did not receive drug|0|||
106115886|NCT02287584|366082635|FG002|the Open-label Phase|Did not receive drug|0|||
106115887|NCT02287584|366082636|FG003|the Open-label Phase|Did not receive drug|7|||
106115888|NCT02287584|366082637|FG004|the Open-label Phase|Did not receive drug|6|||
106115889|NCT02287584|366082638|FG005|the Open-label Phase|Did not receive drug|4|||
106115890|NCT02287584|366082633|FG000|the Open-label Phase|Adverse Event|0|||
106115891|NCT02287584|366082634|FG001|the Open-label Phase|Adverse Event|0|||
106115892|NCT02287584|366082635|FG002|the Open-label Phase|Adverse Event|0|||
106115893|NCT02287584|366082636|FG003|the Open-label Phase|Adverse Event|15|||
106115894|NCT02287584|366082637|FG004|the Open-label Phase|Adverse Event|12|||
106115895|NCT02287584|366082638|FG005|the Open-label Phase|Adverse Event|16|||
106115896|NCT02287584|366082633|FG000|the Open-label Phase|Lack of Efficacy|0|||
106115897|NCT02287584|366082634|FG001|the Open-label Phase|Lack of Efficacy|0|||
106115898|NCT02287584|366082635|FG002|the Open-label Phase|Lack of Efficacy|0|||
106115899|NCT02287584|366082636|FG003|the Open-label Phase|Lack of Efficacy|8|||
106115900|NCT02287584|366082637|FG004|the Open-label Phase|Lack of Efficacy|3|||
106115901|NCT02287584|366082638|FG005|the Open-label Phase|Lack of Efficacy|7|||
106115902|NCT02287584|366082633|FG000|the Open-label Phase|Lost to Follow-up|0|||
106115903|NCT02287584|366082634|FG001|the Open-label Phase|Lost to Follow-up|0|||
106115904|NCT02287584|366082635|FG002|the Open-label Phase|Lost to Follow-up|0|||
106115905|NCT02287584|366082636|FG003|the Open-label Phase|Lost to Follow-up|4|||
106115906|NCT02287584|366082637|FG004|the Open-label Phase|Lost to Follow-up|1|||
106115907|NCT02287584|366082638|FG005|the Open-label Phase|Lost to Follow-up|2|||
106115908|NCT02287584|366082633|FG000|the Open-label Phase|Withdrawal by Subject|0|||
106115909|NCT02287584|366082634|FG001|the Open-label Phase|Withdrawal by Subject|0|||
106115910|NCT02287584|366082635|FG002|the Open-label Phase|Withdrawal by Subject|0|||
106115911|NCT02287584|366082636|FG003|the Open-label Phase|Withdrawal by Subject|18|||
106115912|NCT02287584|366082637|FG004|the Open-label Phase|Withdrawal by Subject|29|||
106115913|NCT02287584|366082638|FG005|the Open-label Phase|Withdrawal by Subject|21|||
106115914|NCT02287584|366082633|FG000|the Open-label Phase|non-compliance|0|||
106115915|NCT02287584|366082634|FG001|the Open-label Phase|non-compliance|0|||
106115916|NCT02287584|366082635|FG002|the Open-label Phase|non-compliance|0|||
106115917|NCT02287584|366082636|FG003|the Open-label Phase|non-compliance|2|||
106115918|NCT02287584|366082637|FG004|the Open-label Phase|non-compliance|5|||
106115919|NCT02287584|366082638|FG005|the Open-label Phase|non-compliance|1|||
106115920|NCT02287584|366082633|FG000|the Open-label Phase|other reasons|0|||
106115921|NCT02287584|366082634|FG001|the Open-label Phase|other reasons|0|||
106115922|NCT02287584|366082635|FG002|the Open-label Phase|other reasons|0|||
106115923|NCT02287584|366082636|FG003|the Open-label Phase|other reasons|3|||
106115924|NCT02287584|366082637|FG004|the Open-label Phase|other reasons|6|||
106115925|NCT02287584|366082638|FG005|the Open-label Phase|other reasons|6|||
106115926|NCT03430063|366082644|FG000|Overall Study|Adverse Event|0|||
106115927|NCT03430063|366082645|FG001|Overall Study|Adverse Event|1|||
106115928|NCT03430063|366082646|FG002|Overall Study|Adverse Event|0|||
106115929|NCT03430063|366082644|FG000|Overall Study|Death|3|||
106115930|NCT03430063|366082645|FG001|Overall Study|Death|2|||
106115931|NCT03430063|366082646|FG002|Overall Study|Death|3|||
106115932|NCT03430063|366082644|FG000|Overall Study|Lost to Follow-up|0|||
106115933|NCT03430063|366082645|FG001|Overall Study|Lost to Follow-up|1|||
106115934|NCT03430063|366082646|FG002|Overall Study|Lost to Follow-up|0|||
106115935|NCT03430063|366082644|FG000|Overall Study|Withdrawal by Subject|0|||
106115936|NCT03430063|366082645|FG001|Overall Study|Withdrawal by Subject|0|||
106115937|NCT03430063|366082646|FG002|Overall Study|Withdrawal by Subject|1|||
106115938|NCT03430063|366082644|FG000|Overall Study|Withdrawal of consent|3|||
106115939|NCT03430063|366082645|FG001|Overall Study|Withdrawal of consent|1|||
106115940|NCT03430063|366082646|FG002|Overall Study|Withdrawal of consent|2|||
106115941|NCT03430063|366082644|FG000|Overall Study|Progressive disease|1|||
106115942|NCT03430063|366082645|FG001|Overall Study|Progressive disease|2|||
106115943|NCT03430063|366082646|FG002|Overall Study|Progressive disease|1|||
106115944|NCT03430063|366082644|FG000|Overall Study|Other un-specified|1|||
106115945|NCT03430063|366082645|FG001|Overall Study|Other un-specified|1|||
106115946|NCT03430063|366082646|FG002|Overall Study|Other un-specified|0|||
106115947|NCT03430063|366082644|FG000|Overall Study|Randomized, but never treated|0|||
106115948|NCT03430063|366082645|FG001|Overall Study|Randomized, but never treated|0|||
105887015|NCT02244463|365241784|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
105887016|NCT02244463|365241779|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105887017|NCT02244463|365241780|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105887018|NCT02244463|365241781|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105887019|NCT02244463|365241782|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
105887020|NCT02244463|365241783|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105887021|NCT02244463|365241784|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
105887022|NCT02244463|365241779|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105887023|NCT02244463|365241780|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105887024|NCT02244463|365241781|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105887025|NCT02244463|365241782|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
105887026|NCT02244463|365241783|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105887027|NCT02244463|365241784|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
105887028|NCT02244463|365241779|FG000|Period 5: Phase II|Disease Progression|0|||
105887029|NCT02244463|365241780|FG001|Period 5: Phase II|Disease Progression|0|||
105887030|NCT02244463|365241781|FG002|Period 5: Phase II|Disease Progression|0|||
105887031|NCT02244463|365241782|FG003|Period 5: Phase II|Disease Progression|0|||
105887032|NCT02244463|365241783|FG004|Period 5: Phase II|Disease Progression|10|||
105887033|NCT02244463|365241784|FG005|Period 5: Phase II|Disease Progression|11|||
105887034|NCT02244463|365241779|FG000|Period 5: Phase II|Physician Decision|0|||
105887035|NCT02244463|365241780|FG001|Period 5: Phase II|Physician Decision|0|||
105887036|NCT02244463|365241781|FG002|Period 5: Phase II|Physician Decision|0|||
105887037|NCT02244463|365241782|FG003|Period 5: Phase II|Physician Decision|0|||
105887038|NCT02244463|365241783|FG004|Period 5: Phase II|Physician Decision|3|||
105887039|NCT02244463|365241784|FG005|Period 5: Phase II|Physician Decision|2|||
105887040|NCT02244463|365241779|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
105887041|NCT02244463|365241780|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
105887042|NCT02244463|365241781|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
105887043|NCT02244463|365241782|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
105887044|NCT02244463|365241783|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
105887045|NCT02244463|365241784|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
105887046|NCT02244463|365241779|FG000|Period 5: Phase II|Intercurrent Illness|0|||
105887047|NCT02244463|365241780|FG001|Period 5: Phase II|Intercurrent Illness|0|||
105887048|NCT02244463|365241781|FG002|Period 5: Phase II|Intercurrent Illness|0|||
106115949|NCT03430063|366082646|FG002|Overall Study|Randomized, but never treated|1|||
106115950|NCT00787319|366082650|FG000|Overall Study|Lost to Follow-up|2|||
106115951|NCT00787319|366082650|FG000|Overall Study|Withdrawal by Subject|15|||
106115952|NCT00787319|366082650|FG000|Overall Study|Adverse Event|3|||
106115953|NCT00787319|366082650|FG000|Overall Study|Objective progression or relapse|30|||
106115954|NCT00787319|366082650|FG000|Overall Study|Lack of Efficacy|1|||
106115955|NCT00787319|366082650|FG000|Overall Study|Budget exhausted/exceeded|1|||
106115956|NCT00787319|366082650|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
106115957|NCT00787319|366082650|FG000|Overall Study|No health insurance reimbursement|2|||
106115958|NCT00787319|366082650|FG000|Overall Study|Stabilized disease findings|3|||
106115959|NCT00787319|366082650|FG000|Overall Study|Inactive disease|5|||
106115960|NCT04415151|366082651|FG000|Overall Study|Death|1|||
106115961|NCT04415151|366082652|FG001|Overall Study|Death|1|||
106115962|NCT04415151|366082651|FG000|Overall Study|Withdrawal by Subject|1|||
106115963|NCT04415151|366082652|FG001|Overall Study|Withdrawal by Subject|0|||
106115964|NCT03505476|366082655|FG000|Overall Study|Physician Decision|18|||
106115965|NCT03505476|366082655|FG000|Overall Study|Device Malfunctioned|101|||
106115966|NCT03505476|366082655|FG000|Overall Study|Data Corrupt|6|||
106115967|NCT03505476|366082655|FG000|Overall Study|Device application insufficiant|3|||
106115968|NCT01350141|366082656|FG000|Overall Study|Lost to Follow-up|1|||
106115969|NCT01350141|366082657|FG001|Overall Study|Lost to Follow-up|0|||
106115970|NCT01350141|366082658|FG002|Overall Study|Lost to Follow-up|1|||
106115971|NCT01350141|366082656|FG000|Overall Study|Withdrawal by Subject|1|||
106115972|NCT01350141|366082657|FG001|Overall Study|Withdrawal by Subject|0|||
106115973|NCT01350141|366082658|FG002|Overall Study|Withdrawal by Subject|0|||
106115974|NCT01350141|366082656|FG000|Overall Study|Randomized but not treated|1|||
106115975|NCT01350141|366082657|FG001|Overall Study|Randomized but not treated|0|||
106115976|NCT01350141|366082658|FG002|Overall Study|Randomized but not treated|0|||
106115977|NCT01641926|366082659|FG000|Overall Study|Adverse Event|5|||
106115978|NCT01641926|366082660|FG001|Overall Study|Adverse Event|2|||
106115979|NCT01641926|366082661|FG002|Overall Study|Adverse Event|3|||
106115980|NCT01641926|366082662|FG003|Overall Study|Adverse Event|1|||
106115981|NCT01641926|366082659|FG000|Overall Study|Lost to Follow-up|2|||
106115982|NCT01641926|366082660|FG001|Overall Study|Lost to Follow-up|2|||
106115983|NCT01641926|366082661|FG002|Overall Study|Lost to Follow-up|1|||
106115984|NCT01641926|366082662|FG003|Overall Study|Lost to Follow-up|0|||
106115985|NCT01641926|366082659|FG000|Overall Study|Physician Decision|6|||
106115986|NCT01641926|366082660|FG001|Overall Study|Physician Decision|5|||
106115987|NCT01641926|366082661|FG002|Overall Study|Physician Decision|0|||
106115988|NCT01641926|366082662|FG003|Overall Study|Physician Decision|1|||
105994836|NCT00286429|365640337|FG002|Overall Study|Protocol Violation|4|||
106115989|NCT01641926|366082659|FG000|Overall Study|Protocol Violation|1|||
106115990|NCT01641926|366082660|FG001|Overall Study|Protocol Violation|0|||
106115991|NCT01641926|366082661|FG002|Overall Study|Protocol Violation|0|||
106115992|NCT01641926|366082662|FG003|Overall Study|Protocol Violation|1|||
106115993|NCT01641926|366082659|FG000|Overall Study|Withdrawal by Subject|13|||
106115994|NCT01641926|366082660|FG001|Overall Study|Withdrawal by Subject|5|||
106115995|NCT01641926|366082661|FG002|Overall Study|Withdrawal by Subject|6|||
106115996|NCT01641926|366082662|FG003|Overall Study|Withdrawal by Subject|1|||
106115997|NCT01641926|366082659|FG000|Overall Study|Not Treated|1|||
106115998|NCT01641926|366082660|FG001|Overall Study|Not Treated|1|||
106115999|NCT01641926|366082661|FG002|Overall Study|Not Treated|1|||
106116000|NCT01641926|366082662|FG003|Overall Study|Not Treated|0|||
106116001|NCT02424591|366082668|FG000|Overall Study|Protocol Violation|2|||
106116002|NCT02424591|366082669|FG001|Overall Study|Protocol Violation|3|||
106116003|NCT01576367|366082670|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106116004|NCT01576367|366082670|FG000|Overall Study|Moved to commercial use after 6 months|1|||
106116005|NCT01446796|366082671|FG000|Overall Study|Withdrawal by Subject|1|||
106116006|NCT01446796|366082672|FG001|Overall Study|Withdrawal by Subject|0|||
106116007|NCT00312702|366082673|FG000|Immunization Phase|Lost to Follow-up|0|||
106116008|NCT00312702|366082674|FG001|Immunization Phase|Lost to Follow-up|1|||
106116009|NCT00312702|366082675|FG002|Immunization Phase|Lost to Follow-up|0|||
106116010|NCT03812536|366082682|FG000|Overall Study|Protocol Violation|2|||
106116011|NCT03812536|366082683|FG001|Overall Study|Protocol Violation|0|||
106116012|NCT03812536|366082682|FG000|Overall Study|Withdrawal by Subject|1|||
106116013|NCT03812536|366082683|FG001|Overall Study|Withdrawal by Subject|1|||
106116014|NCT01216163|366082684|FG000|Overall Study|Withdrawal by Subject|1|||
106116015|NCT01216163|366082685|FG001|Overall Study|Withdrawal by Subject|1|||
106116016|NCT01216163|366082686|FG002|Overall Study|Withdrawal by Subject|0|||
106116017|NCT02914314|366082687|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
106116018|NCT02914314|366082688|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
106116019|NCT02914314|366082689|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
106116020|NCT02914314|366082690|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
106116021|NCT02914314|366082687|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
106116022|NCT02914314|366082688|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
106116023|NCT02914314|366082689|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
106116024|NCT02914314|366082690|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
106116025|NCT02914314|366082687|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
106116026|NCT02914314|366082688|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
106116027|NCT02914314|366082689|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
105994837|NCT00286429|365640335|FG000|Overall Study|Withdrawal by Subject|3|||
105994838|NCT00286429|365640336|FG001|Overall Study|Withdrawal by Subject|2|||
105994839|NCT00286429|365640337|FG002|Overall Study|Withdrawal by Subject|6|||
105994840|NCT00286429|365640335|FG000|Overall Study|Administrative Error|1|||
106116028|NCT02914314|366082690|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
106116029|NCT02914314|366082687|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
105994841|NCT00286429|365640336|FG001|Overall Study|Administrative Error|1|||
105994842|NCT00286429|365640337|FG002|Overall Study|Administrative Error|1|||
105994843|NCT00286429|365640335|FG000|Overall Study|Administrative Decision|0|||
105994844|NCT00286429|365640336|FG001|Overall Study|Administrative Decision|1|||
105994845|NCT00286429|365640337|FG002|Overall Study|Administrative Decision|0|||
105994846|NCT00958165|365640338|FG000|Overall Study|Lost to Follow-up|5|||
105994847|NCT00958165|365640338|FG000|Overall Study|Not eligible|9|||
105994848|NCT01746225|365640341|FG000|Overall Study|Death|1|||
105994849|NCT01746225|365640342|FG001|Overall Study|Death|0|||
105994850|NCT01746225|365640343|FG002|Overall Study|Death|1|||
105994851|NCT01746225|365640341|FG000|Overall Study|Withdrawal by Subject|5|||
105994852|NCT01746225|365640342|FG001|Overall Study|Withdrawal by Subject|15|||
105994853|NCT01746225|365640343|FG002|Overall Study|Withdrawal by Subject|19|||
105994854|NCT01746225|365640341|FG000|Overall Study|Physician Decision|14|||
105994855|NCT01746225|365640342|FG001|Overall Study|Physician Decision|11|||
105994856|NCT01746225|365640343|FG002|Overall Study|Physician Decision|3|||
105994857|NCT01746225|365640341|FG000|Overall Study|Adverse Event|15|||
105994858|NCT01746225|365640342|FG001|Overall Study|Adverse Event|12|||
105994859|NCT01746225|365640343|FG002|Overall Study|Adverse Event|17|||
105994860|NCT01746225|365640341|FG000|Overall Study|Continuing Treatment|5|||
105994861|NCT01746225|365640342|FG001|Overall Study|Continuing Treatment|8|||
106116030|NCT02914314|366082688|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
105994862|NCT01746225|365640343|FG002|Overall Study|Continuing Treatment|3|||
105994863|NCT03915470|365640346|FG000|Overall Study|Death|3|||
105994864|NCT03915470|365640347|FG001|Overall Study|Death|1|||
105994865|NCT03915470|365640346|FG000|Overall Study|Adverse Event|1|||
105994866|NCT03915470|365640347|FG001|Overall Study|Adverse Event|0|||
105994867|NCT03915470|365640346|FG000|Overall Study|Physician Decision|1|||
105994868|NCT03915470|365640347|FG001|Overall Study|Physician Decision|0|||
105994869|NCT03915470|365640346|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
105994870|NCT03915470|365640347|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
106116031|NCT02914314|366082689|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
106116032|NCT02914314|366082690|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
106116033|NCT02914314|366082687|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
106116034|NCT02914314|366082688|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
106116035|NCT02914314|366082689|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
106116036|NCT02914314|366082690|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
106116037|NCT04702568|366082691|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
106116038|NCT04702568|366082692|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
106116039|NCT04702568|366082691|FG000|Overall Study|Pregnancy|1|||
106116040|NCT04702568|366082692|FG001|Overall Study|Pregnancy|0|||
106116041|NCT04702568|366082691|FG000|Overall Study|Bone marrow transplant|1|||
106116042|NCT04702568|366082692|FG001|Overall Study|Bone marrow transplant|0|||
105994871|NCT00595478|365640348|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
105994872|NCT00595478|365640349|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
106116043|NCT04702568|366082691|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
106116044|NCT04702568|366082692|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
106116045|NCT04702568|366082691|FG000|Overall Study|Withdrawal by Subject|0|||
106116046|NCT04702568|366082692|FG001|Overall Study|Withdrawal by Subject|2|||
106116047|NCT02002182|366082700|FG000|Overall Study|Withdraw from study|3|||
106116048|NCT02002182|366082701|FG001|Overall Study|Withdraw from study|1|||
106116049|NCT02002182|366082700|FG000|Overall Study|Health Reasons|1|||
106116050|NCT02002182|366082701|FG001|Overall Study|Health Reasons|0|||
106116051|NCT02002182|366082700|FG000|Overall Study|Death|1|||
106116052|NCT02002182|366082701|FG001|Overall Study|Death|0|||
106116053|NCT00423852|366082702|FG000|Overall Study|Removed pior to the high-dose portion|3|||
106116054|NCT04145037|366082707|FG000|Overall Study|Study terminated|2|||
106116055|NCT04145037|366082708|FG001|Overall Study|Study terminated|0|||
106116056|NCT04145037|366082707|FG000|Overall Study|Withdrawal by Subject|1|||
106116057|NCT04145037|366082708|FG001|Overall Study|Withdrawal by Subject|0|||
106116058|NCT04145037|366082707|FG000|Overall Study|Lost to Follow-up|1|||
106116059|NCT04145037|366082708|FG001|Overall Study|Lost to Follow-up|0|||
106116060|NCT04772053|366082709|FG000|Overall Study|Physician Decision|2|||
106116061|NCT04772053|366082709|FG000|Overall Study|Withdrawal by Subject|3|||
106116062|NCT04772053|366082709|FG000|Overall Study|Study Terminated by Sponsor|1|||
105994873|NCT00595478|365640348|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
105994874|NCT00595478|365640349|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
105994875|NCT03245775|365640352|FG000|Overall Study|Lost to Follow-up|25|||
105994876|NCT03245775|365640353|FG001|Overall Study|Lost to Follow-up|26|||
106116063|NCT04599101|366082710|FG000|Overall Study|Lost to Follow-up|5|||
106116064|NCT04599101|366082711|FG001|Overall Study|Lost to Follow-up|5|||
106116065|NCT00525265|366082714|FG000|Overall Study|Protocol Violation|1|||
106116066|NCT00525265|366082715|FG001|Overall Study|Protocol Violation|0|||
106116067|NCT04146896|366082718|FG000|Overall Study|Adverse Event|5|||
106116068|NCT04146896|366082719|FG001|Overall Study|Adverse Event|8|||
106116069|NCT04146896|366082718|FG000|Overall Study|Lack of Efficacy|3|||
106116070|NCT04146896|366082719|FG001|Overall Study|Lack of Efficacy|2|||
106116071|NCT04146896|366082718|FG000|Overall Study|Lost to Follow-up|0|||
106116072|NCT04146896|366082719|FG001|Overall Study|Lost to Follow-up|1|||
106116073|NCT04146896|366082718|FG000|Overall Study|Non-compliance|5|||
106116074|NCT04146896|366082719|FG001|Overall Study|Non-compliance|4|||
106116075|NCT04146896|366082718|FG000|Overall Study|Withdrawal by Subject|3|||
106116076|NCT04146896|366082719|FG001|Overall Study|Withdrawal by Subject|5|||
106116077|NCT04146896|366082718|FG000|Overall Study|Randomized in error|1|||
106116078|NCT04146896|366082719|FG001|Overall Study|Randomized in error|2|||
106116079|NCT01597505|366082720|FG000|Overall Study|Physician Decision|5|||
106116080|NCT01597505|366082721|FG001|Overall Study|Physician Decision|0|||
106116081|NCT01597505|366082720|FG000|Overall Study|Adverse Event|19|||
106116082|NCT01597505|366082721|FG001|Overall Study|Adverse Event|7|||
106116083|NCT01597505|366082720|FG000|Overall Study|Lost to Follow-up|4|||
106116084|NCT01597505|366082721|FG001|Overall Study|Lost to Follow-up|2|||
106116085|NCT01597505|366082720|FG000|Overall Study|Withdrawal by Subject|10|||
106116086|NCT01597505|366082721|FG001|Overall Study|Withdrawal by Subject|18|||
106116087|NCT01597505|366082720|FG000|Overall Study|Other|5|||
106116088|NCT01597505|366082721|FG001|Overall Study|Other|6|||
106116089|NCT01597505|366082720|FG000|Overall Study|Missing|1|||
106116090|NCT01597505|366082721|FG001|Overall Study|Missing|0|||
106116091|NCT01515189|366082723|FG000|Induction|Disease Progression|109|||
106116092|NCT01515189|366082724|FG001|Induction|Disease Progression|155|||
106116093|NCT01515189|366082723|FG000|Induction|Study drug toxicity|86|||
106116094|NCT01515189|366082724|FG001|Induction|Study drug toxicity|36|||
106116095|NCT01515189|366082723|FG000|Induction|Death|24|||
106116096|NCT01515189|366082724|FG001|Induction|Death|17|||
106116097|NCT01515189|366082723|FG000|Induction|Adverse Event|14|||
106116098|NCT01515189|366082724|FG001|Induction|Adverse Event|9|||
106116099|NCT01515189|366082723|FG000|Induction|Withdrawal by Subject|3|||
106116100|NCT01515189|366082724|FG001|Induction|Withdrawal by Subject|9|||
106116101|NCT01515189|366082723|FG000|Induction|No longer meets study criteria|0|||
106116102|NCT01515189|366082724|FG001|Induction|No longer meets study criteria|2|||
106116103|NCT01515189|366082723|FG000|Induction|Lost to Follow-up|1|||
106116104|NCT01515189|366082724|FG001|Induction|Lost to Follow-up|0|||
106116105|NCT01515189|366082723|FG000|Induction|Other|0|||
106116106|NCT01515189|366082724|FG001|Induction|Other|4|||
106116107|NCT01515189|366082723|FG000|First Re-Induction Phase|Disease progression|6|||
106116108|NCT01515189|366082724|FG001|First Re-Induction Phase|Disease progression|14|||
106116109|NCT01515189|366082723|FG000|First Re-Induction Phase|Study drug toxicity|5|||
106116110|NCT01515189|366082724|FG001|First Re-Induction Phase|Study drug toxicity|0|||
106116111|NCT01515189|366082723|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
106116112|NCT01515189|366082724|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
106116113|NCT01515189|366082723|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
106116114|NCT01515189|366082724|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
106116115|NCT01515189|366082723|FG000|First Re-Induction Phase|Other|1|||
106116116|NCT01515189|366082724|FG001|First Re-Induction Phase|Other|0|||
106116117|NCT05400746|366082725|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
106116118|NCT05400746|366082726|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
106116119|NCT05400746|366082727|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
106116120|NCT05454410|366082728|FG000|Overall Study|Withdrawal by Subject|0|||
106116121|NCT05454410|366082729|FG001|Overall Study|Withdrawal by Subject|0|||
106116122|NCT05454410|366082730|FG002|Overall Study|Withdrawal by Subject|1|||
106116123|NCT05454410|366082731|FG003|Overall Study|Withdrawal by Subject|1|||
106116124|NCT05014412|366082732|FG000|Overall Study|Death|11|||
106116125|NCT05014412|366082733|FG001|Overall Study|Death|7|||
106116126|NCT05014412|366082734|FG002|Overall Study|Death|4|||
106116127|NCT05014412|366082735|FG003|Overall Study|Death|7|||
106116128|NCT05014412|366082732|FG000|Overall Study|Withdrawal by Subject|1|||
106116129|NCT05014412|366082733|FG001|Overall Study|Withdrawal by Subject|1|||
106116130|NCT05014412|366082734|FG002|Overall Study|Withdrawal by Subject|1|||
106116131|NCT05014412|366082735|FG003|Overall Study|Withdrawal by Subject|2|||
106116132|NCT05014412|366082732|FG000|Overall Study|Ongoing|21|||
106116133|NCT05014412|366082733|FG001|Overall Study|Ongoing|4|||
106116134|NCT05014412|366082734|FG002|Overall Study|Ongoing|6|||
106116135|NCT05014412|366082735|FG003|Overall Study|Ongoing|20|||
106116136|NCT00943306|366082741|FG000|Overall Study|Physician Decision|1|||
106116137|NCT00943306|366082741|FG000|Overall Study|Death|1|||
106116138|NCT00943306|366082741|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
106116139|NCT00733499|366082742|FG000|Pre-operative|Protocol Violation|0|||
106116140|NCT00733499|366082743|FG001|Pre-operative|Protocol Violation|1|||
106116141|NCT00733499|366082742|FG000|3 Months Follow-up|Death|1|||
106116142|NCT00733499|366082743|FG001|3 Months Follow-up|Death|2|||
106116143|NCT00733499|366082742|FG000|6 Months Follow-up|Death|0|||
106116144|NCT00733499|366082743|FG001|6 Months Follow-up|Death|2|||
106116145|NCT00733499|366082742|FG000|6 Months Follow-up|Adverse Event|0|||
106116146|NCT00733499|366082743|FG001|6 Months Follow-up|Adverse Event|1|||
106116147|NCT00733499|366082742|FG000|12 Months Follow-up|Death|2|||
106116148|NCT00733499|366082743|FG001|12 Months Follow-up|Death|1|||
106116149|NCT00733499|366082742|FG000|24 Months Follow-up|Death|0|||
106116150|NCT00733499|366082743|FG001|24 Months Follow-up|Death|1|||
106116151|NCT00733499|366082742|FG000|5 Year Followup|Adverse Event|2|||
106116152|NCT00733499|366082743|FG001|5 Year Followup|Adverse Event|2|||
106116153|NCT00733499|366082742|FG000|5 Year Followup|Non device related AE|0|||
106116154|NCT00733499|366082743|FG001|5 Year Followup|Non device related AE|1|||
106116155|NCT00733499|366082742|FG000|5 Year Followup|Revision of Study Implant|0|||
106116156|NCT00733499|366082743|FG001|5 Year Followup|Revision of Study Implant|1|||
106116157|NCT00733499|366082742|FG000|5 Year Followup|Lost to Follow-up|2|||
106116158|NCT00733499|366082743|FG001|5 Year Followup|Lost to Follow-up|0|||
106116159|NCT00733499|366082742|FG000|5 Year Followup|Death|13|||
106116160|NCT00733499|366082743|FG001|5 Year Followup|Death|19|||
106116161|NCT00733499|366082742|FG000|5 Year Followup|missing, unable to locate|0|||
106116162|NCT00733499|366082743|FG001|5 Year Followup|missing, unable to locate|1|||
106116163|NCT00733499|366082742|FG000|5 Year Followup|Withdrawal by Subject|4|||
106116164|NCT00733499|366082743|FG001|5 Year Followup|Withdrawal by Subject|1|||
106116165|NCT00733499|366082742|FG000|10 Year Followup|Death|9|||
106116166|NCT00733499|366082743|FG001|10 Year Followup|Death|7|||
106116167|NCT00733499|366082742|FG000|10 Year Followup|Adverse Event|3|||
106116168|NCT00733499|366082743|FG001|10 Year Followup|Adverse Event|3|||
106116169|NCT00733499|366082742|FG000|10 Year Followup|Lost to Follow-up|3|||
106116170|NCT00733499|366082743|FG001|10 Year Followup|Lost to Follow-up|2|||
106116171|NCT00733499|366082742|FG000|10 Year Followup|Withdrawal by Subject|5|||
106116172|NCT00733499|366082743|FG001|10 Year Followup|Withdrawal by Subject|5|||
106116173|NCT00733499|366082742|FG000|10 Year Followup|missing, unable to locate|0|||
106116174|NCT00733499|366082743|FG001|10 Year Followup|missing, unable to locate|2|||
106116175|NCT02739347|366082744|FG000|Overall Study|Adverse Event|3|||
106116176|NCT02739347|366082745|FG001|Overall Study|Adverse Event|0|||
106116177|NCT02739347|366082744|FG000|Overall Study|Protocol Violation|0|||
106116178|NCT02739347|366082745|FG001|Overall Study|Protocol Violation|1|||
106116179|NCT02739347|366082744|FG000|Overall Study|Lost to Follow-up|0|||
106116180|NCT02739347|366082745|FG001|Overall Study|Lost to Follow-up|2|||
106116181|NCT03929562|366082746|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
106116182|NCT03929562|366082747|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
106116183|NCT03929562|366082746|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
106116184|NCT03929562|366082747|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
106116185|NCT03929562|366082746|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
106116186|NCT03929562|366082747|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
106116187|NCT02404389|366082748|FG000|Overall Study|Adverse Event|1|||
106116188|NCT02404389|366082749|FG001|Overall Study|Adverse Event|0|||
106116189|NCT02404389|366082750|FG002|Overall Study|Adverse Event|1|||
106116190|NCT02404389|366082751|FG003|Overall Study|Adverse Event|0|||
106116191|NCT02404389|366082752|FG004|Overall Study|Adverse Event|2|||
106116192|NCT02404389|366082748|FG000|Overall Study|Subject/guardian decision|1|||
106116193|NCT02404389|366082749|FG001|Overall Study|Subject/guardian decision|0|||
106116194|NCT02404389|366082750|FG002|Overall Study|Subject/guardian decision|0|||
106116195|NCT02404389|366082751|FG003|Overall Study|Subject/guardian decision|1|||
106116196|NCT02404389|366082752|FG004|Overall Study|Subject/guardian decision|1|||
106116197|NCT03324880|366082753|FG000|Overall Study|Adverse Event|0|||
106116198|NCT03324880|366082754|FG001|Overall Study|Adverse Event|2|||
106116199|NCT03324880|366082753|FG000|Overall Study|Withdrawal by Subject|2|||
106116200|NCT03324880|366082754|FG001|Overall Study|Withdrawal by Subject|2|||
106116201|NCT03324880|366082753|FG000|Overall Study|Lost to Follow-up|0|||
106116202|NCT03324880|366082754|FG001|Overall Study|Lost to Follow-up|1|||
106116203|NCT03324880|366082753|FG000|Overall Study|Product Recall|0|||
105994877|NCT03245775|365640354|FG002|Overall Study|Lost to Follow-up|16|||
106116204|NCT03324880|366082754|FG001|Overall Study|Product Recall|1|||
106116205|NCT01036022|366082755|FG000|Overall Study|Adverse Event|1|||
106116206|NCT01036022|366082756|FG001|Overall Study|Adverse Event|3|||
106116207|NCT01036022|366082757|FG002|Overall Study|Adverse Event|2|||
106116208|NCT01036022|366082758|FG003|Overall Study|Adverse Event|1|||
106116209|NCT01036022|366082759|FG004|Overall Study|Adverse Event|0|||
106116210|NCT01036022|366082760|FG005|Overall Study|Adverse Event|2|||
106116211|NCT01036022|366082755|FG000|Overall Study|Lack of Efficacy|1|||
106116212|NCT01036022|366082756|FG001|Overall Study|Lack of Efficacy|1|||
105994878|NCT03245775|365640355|FG003|Overall Study|Lost to Follow-up|16|||
106116213|NCT01036022|366082757|FG002|Overall Study|Lack of Efficacy|1|||
106116214|NCT01036022|366082758|FG003|Overall Study|Lack of Efficacy|0|||
106116215|NCT01036022|366082759|FG004|Overall Study|Lack of Efficacy|1|||
106116216|NCT01036022|366082760|FG005|Overall Study|Lack of Efficacy|1|||
106116217|NCT01036022|366082755|FG000|Overall Study|Physician Decision|0|||
106116218|NCT01036022|366082756|FG001|Overall Study|Physician Decision|0|||
106116219|NCT01036022|366082757|FG002|Overall Study|Physician Decision|1|||
106116220|NCT01036022|366082758|FG003|Overall Study|Physician Decision|0|||
106116221|NCT01036022|366082759|FG004|Overall Study|Physician Decision|0|||
106116222|NCT01036022|366082760|FG005|Overall Study|Physician Decision|0|||
106116223|NCT01036022|366082755|FG000|Overall Study|Withdrawal by Subject|0|||
106116224|NCT01036022|366082756|FG001|Overall Study|Withdrawal by Subject|0|||
106116225|NCT01036022|366082757|FG002|Overall Study|Withdrawal by Subject|0|||
106116226|NCT01036022|366082758|FG003|Overall Study|Withdrawal by Subject|1|||
106116227|NCT01036022|366082759|FG004|Overall Study|Withdrawal by Subject|2|||
106116228|NCT01036022|366082760|FG005|Overall Study|Withdrawal by Subject|0|||
106116229|NCT03300570|366082761|FG000|Overall Study|Adverse Event|0|||
106116230|NCT03300570|366082762|FG001|Overall Study|Adverse Event|1|||
106116231|NCT03300570|366082761|FG000|Overall Study|Withdrawal by Subject|1|||
106116232|NCT03300570|366082762|FG001|Overall Study|Withdrawal by Subject|0|||
106116233|NCT03300570|366082761|FG000|Overall Study|Inadequate bowel prep|1|||
106116234|NCT03300570|366082762|FG001|Overall Study|Inadequate bowel prep|0|||
106116235|NCT00576732|366082764|FG000|DOUBLE BLIND|Adverse Event|0|||
106116236|NCT00576732|366082765|FG001|DOUBLE BLIND|Adverse Event|0|||
106116237|NCT00576732|366082766|FG002|DOUBLE BLIND|Adverse Event|1|||
106116238|NCT00576732|366082767|FG003|DOUBLE BLIND|Adverse Event|0|||
106116239|NCT00576732|366082768|FG004|DOUBLE BLIND|Adverse Event|0|||
106116240|NCT00576732|366082769|FG005|DOUBLE BLIND|Adverse Event|0|||
106116241|NCT00576732|366082764|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
106116242|NCT00576732|366082765|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
106116243|NCT00576732|366082766|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
106116244|NCT00576732|366082767|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
106116245|NCT00576732|366082768|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
106116246|NCT00576732|366082769|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
106116247|NCT00576732|366082764|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
106116248|NCT00576732|366082765|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
106116249|NCT00576732|366082766|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
106116250|NCT00576732|366082767|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
106116251|NCT00576732|366082768|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
106116252|NCT00576732|366082769|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
106116253|NCT00576732|366082764|FG000|DOUBLE BLIND|OTHER|0|||
106116254|NCT00576732|366082765|FG001|DOUBLE BLIND|OTHER|2|||
106116255|NCT00576732|366082766|FG002|DOUBLE BLIND|OTHER|1|||
106116256|NCT00576732|366082767|FG003|DOUBLE BLIND|OTHER|0|||
106116257|NCT00576732|366082768|FG004|DOUBLE BLIND|OTHER|0|||
106116258|NCT00576732|366082769|FG005|DOUBLE BLIND|OTHER|0|||
106116259|NCT00576732|366082764|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
106116260|NCT00576732|366082765|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
106116261|NCT00576732|366082766|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
106116262|NCT00576732|366082767|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
106116263|NCT00576732|366082768|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
106116264|NCT00576732|366082769|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
106116265|NCT00576732|366082764|FG000|DOUBLE BLIND|Protocol Violation|1|||
106116266|NCT00576732|366082765|FG001|DOUBLE BLIND|Protocol Violation|0|||
106116267|NCT00576732|366082766|FG002|DOUBLE BLIND|Protocol Violation|0|||
106116268|NCT00576732|366082767|FG003|DOUBLE BLIND|Protocol Violation|0|||
106116269|NCT00576732|366082768|FG004|DOUBLE BLIND|Protocol Violation|0|||
106116270|NCT00576732|366082769|FG005|DOUBLE BLIND|Protocol Violation|0|||
106116271|NCT00576732|366082764|FG000|OPEN LABEL|Adverse Event|0|||
106116272|NCT00576732|366082765|FG001|OPEN LABEL|Adverse Event|0|||
106116273|NCT00576732|366082766|FG002|OPEN LABEL|Adverse Event|0|||
106116274|NCT00576732|366082767|FG003|OPEN LABEL|Adverse Event|4|||
106116275|NCT00576732|366082768|FG004|OPEN LABEL|Adverse Event|0|||
106116276|NCT00576732|366082769|FG005|OPEN LABEL|Adverse Event|1|||
106116277|NCT00576732|366082764|FG000|OPEN LABEL|Lost to Follow-up|0|||
106116278|NCT00576732|366082765|FG001|OPEN LABEL|Lost to Follow-up|0|||
106116279|NCT00576732|366082766|FG002|OPEN LABEL|Lost to Follow-up|0|||
106116280|NCT00576732|366082767|FG003|OPEN LABEL|Lost to Follow-up|2|||
106116281|NCT00576732|366082768|FG004|OPEN LABEL|Lost to Follow-up|1|||
106116282|NCT00576732|366082769|FG005|OPEN LABEL|Lost to Follow-up|1|||
106116283|NCT00576732|366082764|FG000|OPEN LABEL|Withdrawal by Subject|0|||
105661757|NCT01068210|364425130|FG000|Overall Study|Disease progression|0|||
106116284|NCT00576732|366082765|FG001|OPEN LABEL|Withdrawal by Subject|0|||
106116285|NCT00576732|366082766|FG002|OPEN LABEL|Withdrawal by Subject|0|||
106116286|NCT00576732|366082767|FG003|OPEN LABEL|Withdrawal by Subject|1|||
106116287|NCT00576732|366082768|FG004|OPEN LABEL|Withdrawal by Subject|0|||
106116288|NCT00576732|366082769|FG005|OPEN LABEL|Withdrawal by Subject|1|||
106116289|NCT00576732|366082764|FG000|OPEN LABEL|OTHER|0|||
106116290|NCT00576732|366082765|FG001|OPEN LABEL|OTHER|0|||
106116291|NCT00576732|366082766|FG002|OPEN LABEL|OTHER|0|||
106116292|NCT00576732|366082767|FG003|OPEN LABEL|OTHER|0|||
106116293|NCT00576732|366082768|FG004|OPEN LABEL|OTHER|0|||
106116294|NCT00576732|366082769|FG005|OPEN LABEL|OTHER|2|||
106116295|NCT00576732|366082764|FG000|OPEN LABEL|Lack of Efficacy|0|||
106116296|NCT00576732|366082765|FG001|OPEN LABEL|Lack of Efficacy|0|||
106116297|NCT00576732|366082766|FG002|OPEN LABEL|Lack of Efficacy|0|||
106116298|NCT00576732|366082767|FG003|OPEN LABEL|Lack of Efficacy|2|||
106116299|NCT00576732|366082768|FG004|OPEN LABEL|Lack of Efficacy|2|||
106116300|NCT00576732|366082769|FG005|OPEN LABEL|Lack of Efficacy|3|||
106116301|NCT00576732|366082764|FG000|OPEN LABEL|Protocol Violation|0|||
106116302|NCT00576732|366082765|FG001|OPEN LABEL|Protocol Violation|0|||
106116303|NCT00576732|366082766|FG002|OPEN LABEL|Protocol Violation|0|||
106116304|NCT00576732|366082767|FG003|OPEN LABEL|Protocol Violation|2|||
106116305|NCT00576732|366082768|FG004|OPEN LABEL|Protocol Violation|1|||
106116306|NCT00576732|366082769|FG005|OPEN LABEL|Protocol Violation|0|||
106116307|NCT01547299|366082772|FG000|Overall Study|Withdrawal by Subject|2|||
106116308|NCT01547299|366082773|FG001|Overall Study|Withdrawal by Subject|2|||
106116309|NCT02087501|366082775|FG000|Overall Study|Death|7|||
106116310|NCT02087501|366082775|FG000|Overall Study|Open repair of aneurysm|1|||
106116311|NCT02087501|366082775|FG000|Overall Study|Lost to Follow-up|2|||
106116312|NCT03682705|366082776|FG000|Overall Study|Adverse Event|1|||
106116313|NCT03682705|366082777|FG001|Overall Study|Adverse Event|1|||
106116314|NCT03682705|366082778|FG002|Overall Study|Adverse Event|1|||
106116315|NCT03682705|366082779|FG003|Overall Study|Adverse Event|0|||
106116316|NCT03682705|366082780|FG004|Overall Study|Adverse Event|1|||
106116317|NCT03682705|366082781|FG005|Overall Study|Adverse Event|1|||
106116318|NCT03682705|366082776|FG000|Overall Study|Withdrawal by Subject|1|||
106116319|NCT03682705|366082777|FG001|Overall Study|Withdrawal by Subject|3|||
106116320|NCT03682705|366082778|FG002|Overall Study|Withdrawal by Subject|2|||
106116321|NCT03682705|366082779|FG003|Overall Study|Withdrawal by Subject|4|||
106116322|NCT03682705|366082780|FG004|Overall Study|Withdrawal by Subject|0|||
106116323|NCT03682705|366082781|FG005|Overall Study|Withdrawal by Subject|1|||
106116324|NCT03682705|366082776|FG000|Overall Study|Other, not specified|0|||
106116325|NCT03682705|366082777|FG001|Overall Study|Other, not specified|0|||
106116326|NCT03682705|366082778|FG002|Overall Study|Other, not specified|0|||
106116327|NCT03682705|366082779|FG003|Overall Study|Other, not specified|1|||
106116328|NCT03682705|366082780|FG004|Overall Study|Other, not specified|2|||
106116329|NCT03682705|366082781|FG005|Overall Study|Other, not specified|0|||
106116330|NCT03682705|366082776|FG000|Overall Study|Lost to Follow-up|0|||
106116331|NCT03682705|366082777|FG001|Overall Study|Lost to Follow-up|0|||
106116332|NCT03682705|366082778|FG002|Overall Study|Lost to Follow-up|0|||
106116333|NCT03682705|366082779|FG003|Overall Study|Lost to Follow-up|0|||
106116334|NCT03682705|366082780|FG004|Overall Study|Lost to Follow-up|3|||
106116335|NCT03682705|366082781|FG005|Overall Study|Lost to Follow-up|0|||
106116336|NCT00402337|366082782|FG000|Overall Study|Adverse Event|0|||
106116337|NCT00402337|366082783|FG001|Overall Study|Adverse Event|2|||
106116338|NCT00402337|366082784|FG002|Overall Study|Adverse Event|2|||
106116339|NCT00402337|366082785|FG003|Overall Study|Adverse Event|3|||
106116340|NCT00402337|366082786|FG004|Overall Study|Adverse Event|2|||
106116341|NCT00402337|366082782|FG000|Overall Study|Noncompliance|0|||
106116342|NCT00402337|366082783|FG001|Overall Study|Noncompliance|0|||
106116343|NCT00402337|366082784|FG002|Overall Study|Noncompliance|0|||
106116344|NCT00402337|366082785|FG003|Overall Study|Noncompliance|0|||
106116345|NCT00402337|366082786|FG004|Overall Study|Noncompliance|2|||
106116346|NCT00402337|366082782|FG000|Overall Study|Withdrawal by Subject|5|||
106116347|NCT00402337|366082783|FG001|Overall Study|Withdrawal by Subject|3|||
106116348|NCT00402337|366082784|FG002|Overall Study|Withdrawal by Subject|1|||
106116349|NCT00402337|366082785|FG003|Overall Study|Withdrawal by Subject|6|||
106116350|NCT00402337|366082786|FG004|Overall Study|Withdrawal by Subject|4|||
106116351|NCT00402337|366082782|FG000|Overall Study|Lost to Follow-up|0|||
106116352|NCT00402337|366082783|FG001|Overall Study|Lost to Follow-up|0|||
106116353|NCT00402337|366082784|FG002|Overall Study|Lost to Follow-up|1|||
106116354|NCT00402337|366082785|FG003|Overall Study|Lost to Follow-up|2|||
106116355|NCT00402337|366082786|FG004|Overall Study|Lost to Follow-up|0|||
106116356|NCT00402337|366082782|FG000|Overall Study|Physician Decision|0|||
106116357|NCT00402337|366082783|FG001|Overall Study|Physician Decision|0|||
106116358|NCT00402337|366082784|FG002|Overall Study|Physician Decision|0|||
106116359|NCT00402337|366082785|FG003|Overall Study|Physician Decision|1|||
106116360|NCT00402337|366082786|FG004|Overall Study|Physician Decision|0|||
106116361|NCT00402337|366082782|FG000|Overall Study|Other Reason|0|||
106116362|NCT00402337|366082783|FG001|Overall Study|Other Reason|1|||
106116363|NCT00402337|366082784|FG002|Overall Study|Other Reason|0|||
106116364|NCT00402337|366082785|FG003|Overall Study|Other Reason|0|||
106116365|NCT00402337|366082786|FG004|Overall Study|Other Reason|0|||
106116366|NCT03108157|366082787|FG000|Overall Study|Protocol Violation|15|||
106116367|NCT03108157|366082788|FG001|Overall Study|Protocol Violation|4|||
106116368|NCT03287414|366082789|FG000|Treatment Epoch|Adverse Event|0|||
106116369|NCT03287414|366082790|FG001|Treatment Epoch|Adverse Event|1|||
106116370|NCT03287414|366082789|FG000|Treatment Epoch|Study terminated by sponsor|2|||
106116371|NCT03287414|366082790|FG001|Treatment Epoch|Study terminated by sponsor|2|||
106116372|NCT03287414|366082789|FG000|Treatment Epoch|Subject/Guardian decision|4|||
106116373|NCT03287414|366082790|FG001|Treatment Epoch|Subject/Guardian decision|0|||
106116374|NCT03287414|366082789|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
106116375|NCT03287414|366082790|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
106116376|NCT03287414|366082789|FG000|Treatment Epoch|Withdrawal by Subject|1|||
106116377|NCT03287414|366082790|FG001|Treatment Epoch|Withdrawal by Subject|0|||
105994879|NCT02713828|365640356|FG000|Overall Study|Death|2|||
105994880|NCT02713828|365640357|FG001|Overall Study|Death|0|||
105994881|NCT02713828|365640356|FG000|Overall Study|Withdrawal by Subject|1|||
105994882|NCT02713828|365640357|FG001|Overall Study|Withdrawal by Subject|0|||
105994883|NCT02713828|365640356|FG000|Overall Study|study terminated but patient allowed to|2|||
105994884|NCT02713828|365640357|FG001|Overall Study|study terminated but patient allowed to|0|||
105994885|NCT03197376|365640361|FG000|Primary and Booster Phase|Adverse Event|0|||
105994886|NCT03197376|365640362|FG001|Primary and Booster Phase|Adverse Event|0|||
105994887|NCT03197376|365640363|FG002|Primary and Booster Phase|Adverse Event|0|||
105994888|NCT03197376|365640364|FG003|Primary and Booster Phase|Adverse Event|1|||
105994889|NCT03197376|365640361|FG000|Primary and Booster Phase|Death|1|||
105994890|NCT03197376|365640362|FG001|Primary and Booster Phase|Death|0|||
105994891|NCT03197376|365640363|FG002|Primary and Booster Phase|Death|0|||
105994892|NCT03197376|365640364|FG003|Primary and Booster Phase|Death|2|||
105994893|NCT03197376|365640361|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
105994894|NCT03197376|365640362|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
105994895|NCT03197376|365640363|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
105994896|NCT03197376|365640364|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
105994897|NCT03197376|365640361|FG000|Primary and Booster Phase|Physician Decision|1|||
105994898|NCT03197376|365640362|FG001|Primary and Booster Phase|Physician Decision|0|||
105994899|NCT03197376|365640363|FG002|Primary and Booster Phase|Physician Decision|1|||
105994900|NCT03197376|365640364|FG003|Primary and Booster Phase|Physician Decision|3|||
105994901|NCT03197376|365640361|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
105994902|NCT03197376|365640362|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
105994903|NCT03197376|365640363|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
105994904|NCT03197376|365640364|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
105994905|NCT03197376|365640361|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
105994906|NCT03197376|365640362|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
105994907|NCT03197376|365640363|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
105994908|NCT03197376|365640364|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
105994909|NCT03197376|365640361|FG000|Primary and Booster Phase|Not vaccine related|1|||
105994910|NCT03197376|365640362|FG001|Primary and Booster Phase|Not vaccine related|2|||
105994911|NCT03197376|365640363|FG002|Primary and Booster Phase|Not vaccine related|0|||
106116378|NCT03287414|366082789|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
106116379|NCT03287414|366082790|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
106116380|NCT03287414|366082789|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
106116381|NCT03287414|366082790|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
106116382|NCT01396317|366082798|FG000|Overall Study|Adverse Event|1|||
106116383|NCT01396317|366082799|FG001|Overall Study|Adverse Event|0|||
106116384|NCT02073097|366082800|FG000|Overall Study|Adverse Event|0|||
106116385|NCT02073097|366082801|FG001|Overall Study|Adverse Event|0|||
106116386|NCT02073097|366082802|FG002|Overall Study|Adverse Event|0|||
106116387|NCT02073097|366082803|FG003|Overall Study|Adverse Event|0|||
106116388|NCT02073097|366082804|FG004|Overall Study|Adverse Event|0|||
106116389|NCT02073097|366082805|FG005|Overall Study|Adverse Event|0|||
106116390|NCT02073097|366082806|FG006|Overall Study|Adverse Event|0|||
106116391|NCT02073097|366082807|FG007|Overall Study|Adverse Event|2|||
106116392|NCT02073097|366082800|FG000|Overall Study|Withdrawal by Subject|0|||
106116393|NCT02073097|366082801|FG001|Overall Study|Withdrawal by Subject|0|||
106116394|NCT02073097|366082802|FG002|Overall Study|Withdrawal by Subject|0|||
106116395|NCT02073097|366082803|FG003|Overall Study|Withdrawal by Subject|0|||
106116396|NCT02073097|366082804|FG004|Overall Study|Withdrawal by Subject|0|||
106116397|NCT02073097|366082805|FG005|Overall Study|Withdrawal by Subject|0|||
106116398|NCT02073097|366082806|FG006|Overall Study|Withdrawal by Subject|0|||
106116399|NCT02073097|366082807|FG007|Overall Study|Withdrawal by Subject|2|||
106116400|NCT02073097|366082800|FG000|Overall Study|Death|0|||
106116401|NCT02073097|366082801|FG001|Overall Study|Death|0|||
106116402|NCT02073097|366082802|FG002|Overall Study|Death|0|||
106116403|NCT02073097|366082803|FG003|Overall Study|Death|0|||
106116404|NCT02073097|366082804|FG004|Overall Study|Death|0|||
106116405|NCT02073097|366082805|FG005|Overall Study|Death|0|||
106116406|NCT02073097|366082806|FG006|Overall Study|Death|0|||
106116407|NCT02073097|366082807|FG007|Overall Study|Death|1|||
106116408|NCT02073097|366082800|FG000|Overall Study|Physician Decision|0|||
106116409|NCT02073097|366082801|FG001|Overall Study|Physician Decision|0|||
106116410|NCT02073097|366082802|FG002|Overall Study|Physician Decision|0|||
106116411|NCT02073097|366082803|FG003|Overall Study|Physician Decision|0|||
106116412|NCT02073097|366082804|FG004|Overall Study|Physician Decision|0|||
106116413|NCT02073097|366082805|FG005|Overall Study|Physician Decision|0|||
105994912|NCT03197376|365640364|FG003|Primary and Booster Phase|Not vaccine related|6|||
106116414|NCT02073097|366082806|FG006|Overall Study|Physician Decision|0|||
106116415|NCT02073097|366082807|FG007|Overall Study|Physician Decision|1|||
106116416|NCT01862991|366084164|FG000|Overall Study|Lost to Follow-up|2|||
106116417|NCT01862991|366084165|FG001|Overall Study|Lost to Follow-up|1|||
106116418|NCT01862991|366084166|FG002|Overall Study|Lost to Follow-up|1|||
106116419|NCT01862991|366084164|FG000|Overall Study|Protocol Violation|1|||
105994913|NCT03197376|365640361|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
106116420|NCT01862991|366084165|FG001|Overall Study|Protocol Violation|0|||
106116421|NCT01862991|366084166|FG002|Overall Study|Protocol Violation|0|||
106116422|NCT05648357|366084178|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
106116423|NCT03585296|366084180|FG000|Overall Study|Adverse Event|1|||
106116424|NCT03585296|366084180|FG000|Overall Study|Lost to Follow-up|2|||
106116425|NCT03585296|366084180|FG000|Overall Study|Withdrawal by Subject|2|||
106116426|NCT00539643|366084181|FG000|Overall Study|Adverse Event|1|||
106116427|NCT00539643|366084182|FG001|Overall Study|Adverse Event|0|||
106116428|NCT00539643|366084181|FG000|Overall Study|Death|2|||
106116429|NCT00539643|366084182|FG001|Overall Study|Death|1|||
106116430|NCT00539643|366084181|FG000|Overall Study|Physician Decision|3|||
106116431|NCT00539643|366084182|FG001|Overall Study|Physician Decision|1|||
106116432|NCT00539643|366084181|FG000|Overall Study|Withdrawal by Subject|0|||
106116433|NCT00539643|366084182|FG001|Overall Study|Withdrawal by Subject|1|||
106116434|NCT03673462|366084183|FG000|Overall Study|Adverse Event|11|||
106116435|NCT03673462|366084184|FG001|Overall Study|Adverse Event|1|||
106116436|NCT03673462|366084183|FG000|Overall Study|Protocol Violation|25|||
106116437|NCT03673462|366084184|FG001|Overall Study|Protocol Violation|11|||
106116438|NCT03673462|366084183|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
106116439|NCT03673462|366084184|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
106116440|NCT03673462|366084183|FG000|Overall Study|Lost to Follow-up|102|||
106116441|NCT03673462|366084184|FG001|Overall Study|Lost to Follow-up|19|||
106116442|NCT03097861|366084185|FG000|Overall Study|Adverse Event|3|||
106116443|NCT03097861|366084186|FG001|Overall Study|Adverse Event|8|||
106116444|NCT03097861|366084187|FG002|Overall Study|Adverse Event|4|||
106116445|NCT03097861|366084185|FG000|Overall Study|Investigator Decision|0|||
106116446|NCT03097861|366084186|FG001|Overall Study|Investigator Decision|1|||
106116447|NCT03097861|366084187|FG002|Overall Study|Investigator Decision|0|||
106116448|NCT03097861|366084185|FG000|Overall Study|Lost to Follow-up|0|||
106116449|NCT03097861|366084186|FG001|Overall Study|Lost to Follow-up|7|||
106116450|NCT03097861|366084187|FG002|Overall Study|Lost to Follow-up|1|||
105994914|NCT03197376|365640362|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
105994915|NCT03197376|365640363|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
105994916|NCT03197376|365640364|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
106116451|NCT03097861|366084185|FG000|Overall Study|Withdrawal by Subject|1|||
106116452|NCT03097861|366084186|FG001|Overall Study|Withdrawal by Subject|5|||
106116453|NCT03097861|366084187|FG002|Overall Study|Withdrawal by Subject|3|||
105994917|NCT03197376|365640361|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
105994918|NCT03197376|365640362|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
105994919|NCT03197376|365640363|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
105994920|NCT03197376|365640364|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
105994921|NCT03197376|365640361|FG000|Immune Persistence Phase|Not vaccine related|1|||
105994922|NCT03197376|365640362|FG001|Immune Persistence Phase|Not vaccine related|0|||
105994923|NCT03197376|365640363|FG002|Immune Persistence Phase|Not vaccine related|1|||
105994924|NCT03197376|365640364|FG003|Immune Persistence Phase|Not vaccine related|1|||
105994925|NCT04090242|365640365|FG000|Overall Study|Withdrawal by Subject|1|||
105994926|NCT04090242|365640366|FG001|Overall Study|Withdrawal by Subject|0|||
105994927|NCT00604695|365640368|FG000|Overall Study|Did not receive first bolus.|0|||
105994928|NCT00604695|365640369|FG001|Overall Study|Did not receive first bolus.|4|||
105994929|NCT00434109|365640370|FG000|Overall Study|Physician Decision|9|||
106116454|NCT03097861|366084185|FG000|Overall Study|Reason not provided|3|||
106116455|NCT03097861|366084186|FG001|Overall Study|Reason not provided|1|||
106116456|NCT03097861|366084187|FG002|Overall Study|Reason not provided|1|||
105994930|NCT00434109|365640370|FG000|Overall Study|Adverse Event|5|||
105994931|NCT00434109|365640370|FG000|Overall Study|Protocol Violation|1|||
106116457|NCT01153269|366084189|FG000|Overall Study|Withdrawal by Subject|1|||
106116458|NCT01153269|366084189|FG000|Overall Study|Antiretroviral therapy break|1|||
106116459|NCT03541044|366084190|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
106116460|NCT03541044|366084191|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
106116461|NCT03541044|366084190|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
106116462|NCT03541044|366084191|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
106116463|NCT00988221|366084196|FG000|Part I|Adverse Event|0|||
106116464|NCT00988221|366084197|FG001|Part I|Adverse Event|1|||
106116465|NCT00988221|366084198|FG002|Part I|Adverse Event|2|||
106116466|NCT00988221|366084199|FG003|Part I|Adverse Event|0|||
106116467|NCT00988221|366084196|FG000|Part I|Insufficient Therapeutic Response|4|||
106116468|NCT00988221|366084197|FG001|Part I|Insufficient Therapeutic Response|6|||
106116469|NCT00988221|366084198|FG002|Part I|Insufficient Therapeutic Response|5|||
106116470|NCT00988221|366084199|FG003|Part I|Insufficient Therapeutic Response|0|||
106116471|NCT00988221|366084196|FG000|Part I|Refused Treatment|0|||
106116472|NCT00988221|366084197|FG001|Part I|Refused Treatment|2|||
106116473|NCT00988221|366084198|FG002|Part I|Refused Treatment|1|||
106116474|NCT00988221|366084199|FG003|Part I|Refused Treatment|0|||
106116475|NCT00988221|366084196|FG000|Part I|Lost to Follow-up|0|||
106116476|NCT00988221|366084197|FG001|Part I|Lost to Follow-up|1|||
105994932|NCT00434109|365640370|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
106116477|NCT00988221|366084198|FG002|Part I|Lost to Follow-up|0|||
106116478|NCT00988221|366084199|FG003|Part I|Lost to Follow-up|0|||
106116479|NCT00988221|366084196|FG000|Part II|Adverse Event|1|||
106116480|NCT00988221|366084197|FG001|Part II|Adverse Event|0|||
106116481|NCT00988221|366084198|FG002|Part II|Adverse Event|0|||
106116482|NCT00988221|366084199|FG003|Part II|Adverse Event|1|||
106116483|NCT00988221|366084196|FG000|Part II|Withdrawal by Subject|0|||
106116484|NCT00988221|366084197|FG001|Part II|Withdrawal by Subject|0|||
106116485|NCT00988221|366084198|FG002|Part II|Withdrawal by Subject|2|||
106116486|NCT00988221|366084199|FG003|Part II|Withdrawal by Subject|2|||
106116487|NCT00988221|366084196|FG000|Part II|Reason not Specified|0|||
106116488|NCT00988221|366084197|FG001|Part II|Reason not Specified|0|||
106116489|NCT00988221|366084198|FG002|Part II|Reason not Specified|1|||
106116490|NCT00988221|366084199|FG003|Part II|Reason not Specified|0|||
106116491|NCT00988221|366084196|FG000|Part III|Adverse Event|1|||
106116492|NCT00988221|366084197|FG001|Part III|Adverse Event|0|||
106116493|NCT00988221|366084198|FG002|Part III|Adverse Event|1|||
106116494|NCT00988221|366084199|FG003|Part III|Adverse Event|0|||
106116495|NCT00988221|366084196|FG000|Part III|Insufficient Therapeutic Response|0|||
106116496|NCT00988221|366084197|FG001|Part III|Insufficient Therapeutic Response|1|||
106116497|NCT00988221|366084198|FG002|Part III|Insufficient Therapeutic Response|1|||
106116498|NCT00988221|366084199|FG003|Part III|Insufficient Therapeutic Response|0|||
106116499|NCT00988221|366084196|FG000|Part III|Refused Treatment|0|||
106116500|NCT00988221|366084197|FG001|Part III|Refused Treatment|0|||
106116501|NCT00988221|366084198|FG002|Part III|Refused Treatment|1|||
106116502|NCT00988221|366084199|FG003|Part III|Refused Treatment|0|||
106116503|NCT01540565|366084202|FG000|Overall Study|Ineligible|2|||
106116504|NCT04399356|366084203|FG000|Overall Study|Lost to Follow-up|1|||
106116505|NCT04399356|366084204|FG001|Overall Study|Lost to Follow-up|1|||
106116506|NCT04399356|366084203|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
106116507|NCT04399356|366084204|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
106116508|NCT04399356|366084203|FG000|Overall Study|Withdrawal by Subject|1|||
106116509|NCT04399356|366084204|FG001|Overall Study|Withdrawal by Subject|0|||
106116510|NCT03528174|366084205|FG000|Overall Study|Adverse Event|1|||
106116511|NCT03528174|366084205|FG000|Overall Study|sensors dislodged|1|||
106116512|NCT04251065|366084211|FG000|Overall Study|Death|2|||
106116513|NCT04251065|366084211|FG000|Overall Study|Lack of Efficacy|3|||
106116514|NCT04251065|366084211|FG000|Overall Study|Death|1|||
106116515|NCT01054573|366084212|FG000|Overall Study|Adverse Event|1|||
106116516|NCT01054573|366084213|FG001|Overall Study|Adverse Event|0|||
106116517|NCT01054573|366084214|FG002|Overall Study|Adverse Event|1|||
106116518|NCT01054573|366084215|FG003|Overall Study|Adverse Event|1|||
106116519|NCT01054573|366084212|FG000|Overall Study|Lost to Follow-up|0|||
106116520|NCT01054573|366084213|FG001|Overall Study|Lost to Follow-up|2|||
106116521|NCT01054573|366084214|FG002|Overall Study|Lost to Follow-up|0|||
106116522|NCT01054573|366084215|FG003|Overall Study|Lost to Follow-up|0|||
106116523|NCT01054573|366084212|FG000|Overall Study|Withdrawal by Subject|0|||
106116524|NCT01054573|366084213|FG001|Overall Study|Withdrawal by Subject|2|||
106116525|NCT01054573|366084214|FG002|Overall Study|Withdrawal by Subject|2|||
106116526|NCT01054573|366084215|FG003|Overall Study|Withdrawal by Subject|1|||
106116527|NCT01719237|366084219|FG000|Overall Study|Physician Decision|0|||
106116528|NCT01719237|366084220|FG001|Overall Study|Physician Decision|1|||
106116529|NCT01725386|366084221|FG000|Overall Study|Death|84|||
106116530|NCT01725386|366084222|FG001|Overall Study|Death|40|||
106116531|NCT01725386|366084221|FG000|Overall Study|Lost to Follow-up|81|||
106116532|NCT01725386|366084222|FG001|Overall Study|Lost to Follow-up|6|||
106116533|NCT01725386|366084221|FG000|Overall Study|Withdrawal by Subject|10|||
106116534|NCT01725386|366084222|FG001|Overall Study|Withdrawal by Subject|0|||
106116535|NCT00152009|366084230|FG000|Overall Study|Adverse Event|9|||
106116536|NCT00152009|366084231|FG001|Overall Study|Adverse Event|13|||
106116537|NCT00152009|366084232|FG002|Overall Study|Adverse Event|20|||
106116538|NCT00152009|366084233|FG003|Overall Study|Adverse Event|1|||
106116539|NCT00152009|366084230|FG000|Overall Study|Protocol Violation|3|||
106116540|NCT00152009|366084231|FG001|Overall Study|Protocol Violation|0|||
105661758|NCT01068210|364425131|FG001|Overall Study|Disease progression|0|||
105661759|NCT01068210|364425132|FG002|Overall Study|Disease progression|0|||
106116541|NCT00152009|366084232|FG002|Overall Study|Protocol Violation|0|||
106116542|NCT00152009|366084233|FG003|Overall Study|Protocol Violation|1|||
106116543|NCT00152009|366084230|FG000|Overall Study|Withdrawal by Subject|2|||
106116544|NCT00152009|366084231|FG001|Overall Study|Withdrawal by Subject|3|||
106116545|NCT00152009|366084232|FG002|Overall Study|Withdrawal by Subject|4|||
105661760|NCT01068210|364425133|FG003|Overall Study|Disease progression|2|||
106116546|NCT00152009|366084233|FG003|Overall Study|Withdrawal by Subject|9|||
106116547|NCT00152009|366084230|FG000|Overall Study|Lost to Follow-up|2|||
106116548|NCT00152009|366084231|FG001|Overall Study|Lost to Follow-up|4|||
106116549|NCT00152009|366084232|FG002|Overall Study|Lost to Follow-up|3|||
106116550|NCT00152009|366084233|FG003|Overall Study|Lost to Follow-up|3|||
106116551|NCT00152009|366084230|FG000|Overall Study|Lack of Efficacy|8|||
106116552|NCT00152009|366084231|FG001|Overall Study|Lack of Efficacy|6|||
106116553|NCT00152009|366084232|FG002|Overall Study|Lack of Efficacy|7|||
105994933|NCT01059318|365640371|FG000|Core Study (26 Week)|Adverse Event|3|||
105994934|NCT01059318|365640371|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
105994935|NCT01059318|365640371|FG000|Extension (36 Week)|Adverse Event|3|||
105994936|NCT03790917|365640372|FG000|Overall Study|Death|1|||
105994937|NCT04186871|365640373|FG000|Overall Study|Lack of Efficacy|0|||
105994938|NCT04186871|365640374|FG001|Overall Study|Lack of Efficacy|1|||
105994939|NCT04186871|365640375|FG002|Overall Study|Lack of Efficacy|0|||
105994940|NCT04186871|365640376|FG003|Overall Study|Lack of Efficacy|0|||
105994941|NCT04186871|365640377|FG004|Overall Study|Lack of Efficacy|1|||
105994942|NCT04186871|365640378|FG005|Overall Study|Lack of Efficacy|1|||
105994943|NCT04186871|365640373|FG000|Overall Study|Adverse Event|1|||
105994944|NCT04186871|365640374|FG001|Overall Study|Adverse Event|1|||
105994945|NCT04186871|365640375|FG002|Overall Study|Adverse Event|0|||
105994946|NCT04186871|365640376|FG003|Overall Study|Adverse Event|0|||
105994947|NCT04186871|365640377|FG004|Overall Study|Adverse Event|0|||
105994948|NCT04186871|365640378|FG005|Overall Study|Adverse Event|2|||
106116554|NCT00152009|366084233|FG003|Overall Study|Lack of Efficacy|15|||
106116555|NCT00152009|366084230|FG000|Overall Study|ECG abnormalities|2|||
106116556|NCT00152009|366084231|FG001|Overall Study|ECG abnormalities|2|||
106116557|NCT00152009|366084232|FG002|Overall Study|ECG abnormalities|2|||
106116558|NCT00152009|366084233|FG003|Overall Study|ECG abnormalities|1|||
106116559|NCT00152009|366084230|FG000|Overall Study|Sponsor's decision|3|||
106116560|NCT00152009|366084231|FG001|Overall Study|Sponsor's decision|3|||
106116561|NCT00152009|366084232|FG002|Overall Study|Sponsor's decision|1|||
106116562|NCT00152009|366084233|FG003|Overall Study|Sponsor's decision|3|||
106116563|NCT01306201|366084236|FG000|Overall Study|Arrhythmia|4|||
106116564|NCT01306201|366084236|FG000|Overall Study|Files could not be processed|3|||
106116565|NCT01306201|366084236|FG000|Overall Study|Files unreadable|3|||
106116566|NCT04296890|366084247|FG000|Overall Study|Withdrawal by Subject|1|||
106116567|NCT04296890|366084247|FG000|Overall Study|Death|62|||
106116568|NCT04296890|366084247|FG000|Overall Study|Lost to Follow-up|3|||
106116569|NCT04296890|366084247|FG000|Overall Study|Other than specified|2|||
106116570|NCT02541383|366084248|FG000|Overall Study|Death|50|||
106116571|NCT02541383|366084249|FG001|Overall Study|Death|37|||
106116572|NCT02541383|366084250|FG002|Overall Study|Death|48|||
106116573|NCT02541383|366084251|FG003|Overall Study|Death|41|||
106116574|NCT02541383|366084252|FG004|Overall Study|Death|21|||
106116575|NCT02541383|366084253|FG005|Overall Study|Death|25|||
106116576|NCT02541383|366084248|FG000|Overall Study|Lost to Follow-up|5|||
106116577|NCT02541383|366084249|FG001|Overall Study|Lost to Follow-up|3|||
106116578|NCT02541383|366084250|FG002|Overall Study|Lost to Follow-up|1|||
106116579|NCT02541383|366084251|FG003|Overall Study|Lost to Follow-up|1|||
106116580|NCT02541383|366084252|FG004|Overall Study|Lost to Follow-up|3|||
106116581|NCT02541383|366084253|FG005|Overall Study|Lost to Follow-up|0|||
106116582|NCT02541383|366084248|FG000|Overall Study|Consent withdrawn|5|||
106116583|NCT02541383|366084249|FG001|Overall Study|Consent withdrawn|6|||
106116584|NCT02541383|366084250|FG002|Overall Study|Consent withdrawn|1|||
106116585|NCT02541383|366084251|FG003|Overall Study|Consent withdrawn|1|||
106116586|NCT02541383|366084252|FG004|Overall Study|Consent withdrawn|0|||
106116587|NCT02541383|366084253|FG005|Overall Study|Consent withdrawn|0|||
106116588|NCT02541383|366084248|FG000|Overall Study|Sponsor's decision|1|||
106116589|NCT02541383|366084249|FG001|Overall Study|Sponsor's decision|1|||
106116590|NCT02541383|366084250|FG002|Overall Study|Sponsor's decision|0|||
106116591|NCT02541383|366084251|FG003|Overall Study|Sponsor's decision|0|||
106116592|NCT02541383|366084252|FG004|Overall Study|Sponsor's decision|0|||
106116593|NCT02541383|366084253|FG005|Overall Study|Sponsor's decision|0|||
106116594|NCT00728962|366084254|FG000|Implant Placement Surgery|Adverse Event|8|||
106116595|NCT00728962|366084254|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
106116596|NCT00728962|366084254|FG000|Implant Placement Surgery|Protocol Violation|1|||
106116597|NCT00728962|366084254|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
106116598|NCT00728962|366084254|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
106116599|NCT00405639|366084265|FG000|Overall Study|Withdrawal by Subject|1|||
106116600|NCT00405639|366084266|FG001|Overall Study|Withdrawal by Subject|0|||
106116601|NCT00405639|366084265|FG000|Overall Study|Adverse Event|1|||
105994949|NCT04186871|365640373|FG000|Overall Study|Study terminated by sponsor|1|||
105994950|NCT04186871|365640374|FG001|Overall Study|Study terminated by sponsor|2|||
105994951|NCT04186871|365640375|FG002|Overall Study|Study terminated by sponsor|0|||
105994952|NCT04186871|365640376|FG003|Overall Study|Study terminated by sponsor|1|||
106116602|NCT00405639|366084266|FG001|Overall Study|Adverse Event|0|||
106116603|NCT00405639|366084265|FG000|Overall Study|Seizure prior to receiving BNP|1|||
106116604|NCT00405639|366084266|FG001|Overall Study|Seizure prior to receiving BNP|0|||
106116605|NCT05096208|366084267|FG000|Overall Study|Lost to Follow-up|3|||
106116606|NCT05096208|366084268|FG001|Overall Study|Lost to Follow-up|5|||
106116607|NCT05096208|366084269|FG002|Overall Study|Lost to Follow-up|5|||
106116608|NCT05096208|366084270|FG003|Overall Study|Lost to Follow-up|2|||
106116609|NCT05096208|366084267|FG000|Overall Study|Withdrawal by Subject|0|||
106116610|NCT05096208|366084268|FG001|Overall Study|Withdrawal by Subject|1|||
106116611|NCT05096208|366084269|FG002|Overall Study|Withdrawal by Subject|2|||
106116612|NCT05096208|366084270|FG003|Overall Study|Withdrawal by Subject|3|||
106116613|NCT05096208|366084267|FG000|Overall Study|No longer met eligibility criteria|1|||
106116614|NCT05096208|366084268|FG001|Overall Study|No longer met eligibility criteria|0|||
106116615|NCT05096208|366084269|FG002|Overall Study|No longer met eligibility criteria|0|||
106116616|NCT05096208|366084270|FG003|Overall Study|No longer met eligibility criteria|0|||
106116617|NCT05096208|366084267|FG000|Overall Study|Other|0|||
106116618|NCT05096208|366084268|FG001|Overall Study|Other|0|||
106116619|NCT05096208|366084269|FG002|Overall Study|Other|1|||
106116620|NCT05096208|366084270|FG003|Overall Study|Other|0|||
106116621|NCT00094328|366084272|FG000|Overall Study|Lost to Follow-up|1|||
106116622|NCT00612534|366084274|FG000|Overall Study|Adverse Event|0|||
106116623|NCT00612534|366084275|FG001|Overall Study|Adverse Event|4|||
106116624|NCT00612534|366084276|FG002|Overall Study|Adverse Event|2|||
106116625|NCT00612534|366084277|FG003|Overall Study|Adverse Event|1|||
106116626|NCT00612534|366084274|FG000|Overall Study|Lack of Efficacy|13|||
106116627|NCT00612534|366084275|FG001|Overall Study|Lack of Efficacy|12|||
106116628|NCT00612534|366084276|FG002|Overall Study|Lack of Efficacy|5|||
106116629|NCT00612534|366084277|FG003|Overall Study|Lack of Efficacy|16|||
106116630|NCT00612534|366084274|FG000|Overall Study|Other Reason|0|||
106116631|NCT00612534|366084275|FG001|Overall Study|Other Reason|1|||
106116632|NCT00612534|366084276|FG002|Overall Study|Other Reason|0|||
106116633|NCT00612534|366084277|FG003|Overall Study|Other Reason|0|||
106116634|NCT04615182|366084278|FG000|Overall Study|Re-transplanted|2|||
106116635|NCT04615182|366084278|FG000|Overall Study|Protocol Violation|6|||
106116636|NCT04615182|366084278|FG000|Overall Study|Death|6|||
106116637|NCT04615182|366084278|FG000|Overall Study|Death and protocol violation|1|||
106116638|NCT02821819|366084283|FG000|Overall Study|Protocol Violation|1|||
106116639|NCT01975220|366084284|FG000|Test Period 1|Not treated|0|||
106116640|NCT01975220|366084285|FG001|Test Period 1|Not treated|1|||
106116641|NCT01975220|366084286|FG002|Test Period 1|Not treated|0|||
106116642|NCT01975220|366084287|FG003|Test Period 1|Not treated|0|||
106116643|NCT01975220|366084288|FG004|Test Period 1|Not treated|0|||
106116644|NCT01975220|366084289|FG005|Test Period 1|Not treated|0|||
106116645|NCT03403426|366084290|FG000|Overall Study|Death|1|||
106116646|NCT03403426|366084290|FG000|Overall Study|Lost to Follow-up|2|||
106116647|NCT01806584|366084291|FG000|Overall Study|Adverse Event|2|||
106116648|NCT01806584|366084292|FG001|Overall Study|Adverse Event|1|||
106116649|NCT01806584|366084291|FG000|Overall Study|Death|1|||
106116650|NCT01806584|366084292|FG001|Overall Study|Death|0|||
106116651|NCT01806584|366084291|FG000|Overall Study|Lost to Follow-up|0|||
106116652|NCT01806584|366084292|FG001|Overall Study|Lost to Follow-up|2|||
106116653|NCT01806584|366084291|FG000|Overall Study|Study terminated by sponsor|9|||
106116654|NCT01806584|366084292|FG001|Overall Study|Study terminated by sponsor|14|||
106116655|NCT01806584|366084291|FG000|Overall Study|Withdrawal by Subject|1|||
106116656|NCT01806584|366084292|FG001|Overall Study|Withdrawal by Subject|1|||
106116657|NCT01806584|366084291|FG000|Overall Study|Other unspecified|1|||
106116658|NCT01806584|366084292|FG001|Overall Study|Other unspecified|0|||
106116659|NCT03021668|366084293|FG000|Overall Study|Physician Decision|0|||
106116660|NCT03021668|366084294|FG001|Overall Study|Physician Decision|1|||
106116661|NCT02669095|366084308|FG000|Overall Study|Adverse Event|1|||
106116662|NCT02669095|366084309|FG001|Overall Study|Adverse Event|0|||
106116663|NCT02669095|366084308|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
106116664|NCT02669095|366084309|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
106116665|NCT02669095|366084308|FG000|Overall Study|Torn Lens|0|||
106116666|NCT02669095|366084309|FG001|Overall Study|Torn Lens|1|||
106116667|NCT02669095|366084308|FG000|Overall Study|Visit 5 assessments not completed|0|||
106116668|NCT02669095|366084309|FG001|Overall Study|Visit 5 assessments not completed|1|||
106116669|NCT03757234|366084310|FG000|Overall Study|Adverse Event|0|||
106116670|NCT03757234|366084311|FG001|Overall Study|Adverse Event|0|||
106116671|NCT03757234|366084312|FG002|Overall Study|Adverse Event|0|||
106116672|NCT03757234|366084313|FG003|Overall Study|Adverse Event|0|||
106116673|NCT03757234|366084314|FG004|Overall Study|Adverse Event|1|||
106116674|NCT03757234|366084310|FG000|Overall Study|Lost to Follow-up|1|||
106116675|NCT03757234|366084311|FG001|Overall Study|Lost to Follow-up|0|||
106116676|NCT03757234|366084312|FG002|Overall Study|Lost to Follow-up|0|||
106116677|NCT03757234|366084313|FG003|Overall Study|Lost to Follow-up|0|||
106116678|NCT03757234|366084314|FG004|Overall Study|Lost to Follow-up|1|||
106116679|NCT03757234|366084310|FG000|Overall Study|Withdrawal by Subject|1|||
106116680|NCT03757234|366084311|FG001|Overall Study|Withdrawal by Subject|1|||
106116681|NCT03757234|366084312|FG002|Overall Study|Withdrawal by Subject|0|||
106116682|NCT03757234|366084313|FG003|Overall Study|Withdrawal by Subject|1|||
106116683|NCT03757234|366084314|FG004|Overall Study|Withdrawal by Subject|2|||
106116684|NCT03757234|366084310|FG000|Overall Study|Other|1|||
106116685|NCT03757234|366084311|FG001|Overall Study|Other|1|||
106116686|NCT03757234|366084312|FG002|Overall Study|Other|0|||
106116687|NCT03757234|366084313|FG003|Overall Study|Other|0|||
106116688|NCT03757234|366084314|FG004|Overall Study|Other|0|||
106116689|NCT00539279|366084316|FG000|Treatment|Withdrawal by Subject|10|||
106116690|NCT00539279|366084317|FG001|Treatment|Withdrawal by Subject|8|||
106116691|NCT00539279|366084316|FG000|Treatment|Death|1|||
106116692|NCT00539279|366084317|FG001|Treatment|Death|0|||
106116693|NCT00539279|366084316|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
106116694|NCT00539279|366084317|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
106116695|NCT00539279|366084316|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
106116696|NCT00539279|366084317|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
106116697|NCT04287868|366084321|FG000|Overall Study|Screening fail|1|||
106116698|NCT04287868|366084322|FG001|Overall Study|Screening fail|0|||
106116699|NCT03935217|366085608|FG000|Overall Study|Adverse Event|1|||
106116700|NCT03935217|366085609|FG001|Overall Study|Adverse Event|0|||
106116701|NCT03935217|366085608|FG000|Overall Study|Lost to Follow-up|0|||
106116702|NCT03935217|366085609|FG001|Overall Study|Lost to Follow-up|1|||
106116703|NCT03935217|366085608|FG000|Overall Study|Withdrawal by Subject|0|||
106116704|NCT03935217|366085609|FG001|Overall Study|Withdrawal by Subject|2|||
106116705|NCT03285295|366085610|FG000|Alinity s HBsAg|Protocol Violation|11|||
106116706|NCT03285295|366085611|FG001|Alinity s HBsAg|Protocol Violation|0|||
106116707|NCT03285295|366085612|FG002|Alinity s HBsAg|Protocol Violation|0|||
106116708|NCT03285295|366085613|FG003|Alinity s HBsAg|Protocol Violation|0|||
106116709|NCT03285295|366085614|FG004|Alinity s HBsAg|Protocol Violation|0|||
106116710|NCT03285295|366085610|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
106116711|NCT03285295|366085611|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
106116712|NCT03285295|366085612|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
106116713|NCT03285295|366085613|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
106116714|NCT03285295|366085614|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
106116715|NCT03285295|366085610|FG000|Alinity s HBsAg|No Results Generated|74|||
106116716|NCT03285295|366085611|FG001|Alinity s HBsAg|No Results Generated|6|||
106116717|NCT03285295|366085612|FG002|Alinity s HBsAg|No Results Generated|0|||
106116718|NCT03285295|366085613|FG003|Alinity s HBsAg|No Results Generated|0|||
106116719|NCT03285295|366085614|FG004|Alinity s HBsAg|No Results Generated|0|||
106116720|NCT03285295|366085610|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
106116721|NCT03285295|366085611|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
106116722|NCT03285295|366085612|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
106116723|NCT03285295|366085613|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
106116724|NCT03285295|366085614|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
106116725|NCT03285295|366085610|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
106116726|NCT03285295|366085611|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
106116727|NCT03285295|366085612|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
106116728|NCT03285295|366085613|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
106116729|NCT03285295|366085614|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
106116730|NCT03285295|366085610|FG000|Alinity s HTLV I/II|No Results Generated|70|||
106116731|NCT03285295|366085611|FG001|Alinity s HTLV I/II|No Results Generated|0|||
106116732|NCT03285295|366085612|FG002|Alinity s HTLV I/II|No Results Generated|0|||
106116733|NCT03285295|366085613|FG003|Alinity s HTLV I/II|No Results Generated|0|||
106116734|NCT03285295|366085614|FG004|Alinity s HTLV I/II|No Results Generated|0|||
106116735|NCT03285295|366085610|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
106116736|NCT03285295|366085611|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
106116737|NCT03285295|366085612|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
106116738|NCT03285295|366085613|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
106116739|NCT03285295|366085614|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
106116740|NCT03285295|366085610|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
106116741|NCT03285295|366085611|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
106116742|NCT03285295|366085612|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
106116743|NCT03285295|366085613|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
106116744|NCT03285295|366085614|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
106116745|NCT03285295|366085610|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
106116746|NCT03285295|366085611|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
106116747|NCT03285295|366085612|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
106116748|NCT03285295|366085613|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
106116749|NCT03285295|366085614|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
106116750|NCT03285295|366085610|FG000|Alinity s Anti-HCV|No Results Generated|71|||
106116751|NCT03285295|366085611|FG001|Alinity s Anti-HCV|No Results Generated|0|||
106116752|NCT03285295|366085612|FG002|Alinity s Anti-HCV|No Results Generated|0|||
106116753|NCT03285295|366085613|FG003|Alinity s Anti-HCV|No Results Generated|0|||
106116754|NCT03285295|366085614|FG004|Alinity s Anti-HCV|No Results Generated|0|||
106116755|NCT03285295|366085610|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
106116756|NCT03285295|366085611|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
106116757|NCT03285295|366085612|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
106116758|NCT03285295|366085613|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
106116759|NCT03285295|366085614|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
106116760|NCT03285295|366085610|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
106116761|NCT03285295|366085611|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
106116762|NCT03285295|366085612|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
106116763|NCT03285295|366085613|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
106116764|NCT03285295|366085614|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
106116765|NCT03285295|366085610|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
106116766|NCT03285295|366085611|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
105994953|NCT04186871|365640377|FG004|Overall Study|Study terminated by sponsor|0|||
105994954|NCT04186871|365640378|FG005|Overall Study|Study terminated by sponsor|0|||
105994955|NCT04186871|365640373|FG000|Overall Study|Other reasons|0|||
105994956|NCT04186871|365640374|FG001|Overall Study|Other reasons|0|||
105994957|NCT04186871|365640375|FG002|Overall Study|Other reasons|0|||
105994958|NCT04186871|365640376|FG003|Overall Study|Other reasons|0|||
105994959|NCT04186871|365640377|FG004|Overall Study|Other reasons|0|||
105994960|NCT04186871|365640378|FG005|Overall Study|Other reasons|1|||
105994961|NCT04186871|365640373|FG000|Overall Study|Withdrawal by Subject|0|||
105994962|NCT04186871|365640374|FG001|Overall Study|Withdrawal by Subject|0|||
105994963|NCT04186871|365640375|FG002|Overall Study|Withdrawal by Subject|0|||
105994964|NCT04186871|365640376|FG003|Overall Study|Withdrawal by Subject|0|||
105994965|NCT04186871|365640377|FG004|Overall Study|Withdrawal by Subject|0|||
105994966|NCT04186871|365640378|FG005|Overall Study|Withdrawal by Subject|1|||
105994967|NCT04186871|365640373|FG000|Overall Study|Lost to Follow-up|0|||
105994968|NCT04186871|365640374|FG001|Overall Study|Lost to Follow-up|0|||
105994969|NCT04186871|365640375|FG002|Overall Study|Lost to Follow-up|0|||
105994970|NCT04186871|365640376|FG003|Overall Study|Lost to Follow-up|0|||
105994971|NCT04186871|365640377|FG004|Overall Study|Lost to Follow-up|0|||
105994972|NCT04186871|365640378|FG005|Overall Study|Lost to Follow-up|1|||
105994973|NCT04178720|365640384|FG000|Overall Study|Withdrawal by Subject|2|||
105994974|NCT04178720|365640385|FG001|Overall Study|Withdrawal by Subject|0|||
105994975|NCT04178720|365640384|FG000|Overall Study|Relocation|0|||
105994976|NCT04178720|365640385|FG001|Overall Study|Relocation|1|||
105994977|NCT04618744|365640386|FG000|Overall Study|Adverse Event|0|||
105994978|NCT04618744|365640387|FG001|Overall Study|Adverse Event|1|||
105994979|NCT04618744|365640386|FG000|Overall Study|Withdrawal by Subject|0|||
105994980|NCT04618744|365640387|FG001|Overall Study|Withdrawal by Subject|1|||
105994981|NCT00930930|365640388|FG000|Overall Study|Death|1|||
105994982|NCT00930930|365640389|FG001|Overall Study|Death|0|||
105994983|NCT00930930|365640388|FG000|Overall Study|Physician Decision|1|||
105994984|NCT00930930|365640389|FG001|Overall Study|Physician Decision|0|||
105994985|NCT00930930|365640388|FG000|Overall Study|Adverse Event|13|||
105994986|NCT00930930|365640389|FG001|Overall Study|Adverse Event|3|||
105994987|NCT00930930|365640388|FG000|Overall Study|Withdrawal by Subject|3|||
105994988|NCT00930930|365640389|FG001|Overall Study|Withdrawal by Subject|1|||
105994989|NCT00930930|365640388|FG000|Overall Study|Disease progression|2|||
105994990|NCT00930930|365640389|FG001|Overall Study|Disease progression|3|||
105994991|NCT00930930|365640388|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
105994992|NCT00930930|365640389|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
105994993|NCT00930930|365640388|FG000|Overall Study|patients not compliant|1|||
105994994|NCT00930930|365640389|FG001|Overall Study|patients not compliant|1|||
105994995|NCT02587819|365640390|FG000|Overall Study|Adverse Event|1|||
105994996|NCT02587819|365640390|FG000|Overall Study|Lost to Follow-up|1|||
105994997|NCT00269919|365641773|FG000|Overall Study|Other|26|||
105994998|NCT00269919|365641773|FG000|Overall Study|Started but not treated|1|||
105994999|NCT05636852|365641774|FG000|Overall Study|Withdrawal by Subject|1|||
105995000|NCT05636852|365641774|FG000|Overall Study|Other than specified|1|||
105995001|NCT01784068|365641780|FG000|NTCS Phase|Adverse Event|5|||
105995002|NCT01784068|365641781|FG001|NTCS Phase|Adverse Event|0|||
105995003|NCT01784068|365641780|FG000|NTCS Phase|Physician Decision|2|||
106116767|NCT03285295|366085612|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
106116768|NCT03285295|366085613|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
106116769|NCT03285295|366085614|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
106116770|NCT03285295|366085610|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
106116771|NCT03285295|366085611|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
106116772|NCT03285295|366085612|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
106116773|NCT03285295|366085613|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
106116774|NCT03285295|366085614|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
106116775|NCT03285295|366085610|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
106116776|NCT03285295|366085611|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
106116777|NCT03285295|366085612|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
106116778|NCT03285295|366085613|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
106116779|NCT03285295|366085614|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
106116780|NCT03285295|366085610|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
105995004|NCT01784068|365641781|FG001|NTCS Phase|Physician Decision|0|||
105995005|NCT01784068|365641780|FG000|NTCS Phase|Patient/guardian decision|3|||
105995006|NCT01784068|365641781|FG001|NTCS Phase|Patient/guardian decision|0|||
105995007|NCT01784068|365641780|FG000|NTCS Phase|Death|2|||
105995008|NCT01784068|365641781|FG001|NTCS Phase|Death|0|||
105995009|NCT01784068|365641780|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
105995010|NCT01784068|365641781|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
105995011|NCT01784068|365641780|FG000|TFR Phase|Physician Decision|0|||
105995012|NCT01784068|365641781|FG001|TFR Phase|Physician Decision|1|||
105995013|NCT01784068|365641780|FG000|TFR Phase|Patient/guardian decision|0|||
105995014|NCT01784068|365641781|FG001|TFR Phase|Patient/guardian decision|3|||
106116781|NCT03285295|366085611|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
106116782|NCT03285295|366085612|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
106116783|NCT03285295|366085613|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
106116784|NCT03285295|366085614|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
106116785|NCT03285295|366085610|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
106116786|NCT03285295|366085611|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
106116787|NCT03285295|366085612|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
106116788|NCT03285295|366085613|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
106116789|NCT03285295|366085614|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
106116790|NCT03285295|366085610|FG000|Alinity s Anti-HBc|No Results Generated|70|||
106116791|NCT03285295|366085611|FG001|Alinity s Anti-HBc|No Results Generated|0|||
106116792|NCT03285295|366085612|FG002|Alinity s Anti-HBc|No Results Generated|0|||
106116793|NCT03285295|366085613|FG003|Alinity s Anti-HBc|No Results Generated|0|||
106116794|NCT03285295|366085614|FG004|Alinity s Anti-HBc|No Results Generated|0|||
106116795|NCT03285295|366085610|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
106116796|NCT03285295|366085611|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
106116797|NCT03285295|366085612|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
106116798|NCT03285295|366085613|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
106116799|NCT03285295|366085614|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
106116800|NCT03285295|366085610|FG000|Alinity s Chagas|Protocol Violation|76|||
106116801|NCT03285295|366085611|FG001|Alinity s Chagas|Protocol Violation|0|||
106116802|NCT03285295|366085612|FG002|Alinity s Chagas|Protocol Violation|0|||
106116803|NCT03285295|366085613|FG003|Alinity s Chagas|Protocol Violation|0|||
106116804|NCT03285295|366085614|FG004|Alinity s Chagas|Protocol Violation|0|||
106116805|NCT03285295|366085610|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
106116806|NCT03285295|366085611|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
106116807|NCT03285295|366085612|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
106116808|NCT03285295|366085613|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
106116809|NCT03285295|366085614|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
106116810|NCT03285295|366085610|FG000|Alinity s Chagas|No Results Generated|105|||
106116811|NCT03285295|366085611|FG001|Alinity s Chagas|No Results Generated|0|||
106116812|NCT03285295|366085612|FG002|Alinity s Chagas|No Results Generated|0|||
106116813|NCT03285295|366085613|FG003|Alinity s Chagas|No Results Generated|0|||
106116814|NCT03285295|366085614|FG004|Alinity s Chagas|No Results Generated|0|||
106116815|NCT03285295|366085610|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
106116816|NCT03285295|366085611|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
106116817|NCT03285295|366085612|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
106116818|NCT03285295|366085613|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
106116819|NCT03285295|366085614|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
106116820|NCT03075501|366085615|FG000|Overall Study|Scheduling difficulties|15|||
106116821|NCT03075501|366085616|FG001|Overall Study|Scheduling difficulties|9|||
106116822|NCT00255346|366085620|FG000|Overall Study|Adverse Event|1|||
106116823|NCT00255346|366085621|FG001|Overall Study|Adverse Event|0|||
106116824|NCT00255346|366085622|FG002|Overall Study|Adverse Event|0|||
106116825|NCT00255346|366085623|FG003|Overall Study|Adverse Event|0|||
106116826|NCT00255346|366085624|FG004|Overall Study|Adverse Event|0|||
106116827|NCT00954733|366085627|FG000|Overall Study|blood gas machine did not work|1|||
106116828|NCT01834222|366085632|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
106116829|NCT05266963|366085633|FG000|Drug Period A|Withdrawal by Subject|0|||
106116830|NCT05266963|366085634|FG001|Drug Period A|Withdrawal by Subject|1|||
106116831|NCT02712398|366085635|FG000|Overall Study|Withdrawal by Subject|6|||
106116832|NCT02712398|366085635|FG000|Overall Study|Lost to Follow-up|6|||
106116833|NCT02712398|366085635|FG000|Overall Study|Sponsor Decision|1|||
106116834|NCT02712398|366085635|FG000|Overall Study|Physician Decision|1|||
106116835|NCT02712398|366085635|FG000|Overall Study|Death|2|||
106116836|NCT02712398|366085635|FG000|Overall Study|Re-operation|21|||
106116837|NCT00393523|366085636|FG000|Overall Study|Lost to Follow-up|0|||
106116838|NCT00393523|366085637|FG001|Overall Study|Lost to Follow-up|0|||
106116839|NCT00393523|366085638|FG002|Overall Study|Lost to Follow-up|0|||
106116840|NCT00393523|366085639|FG003|Overall Study|Lost to Follow-up|2|||
106116841|NCT00393523|366085640|FG004|Overall Study|Lost to Follow-up|1|||
106116842|NCT00393523|366085636|FG000|Overall Study|Protocol Violation|6|||
106116843|NCT00393523|366085637|FG001|Overall Study|Protocol Violation|2|||
106116844|NCT00393523|366085638|FG002|Overall Study|Protocol Violation|0|||
106116845|NCT00393523|366085639|FG003|Overall Study|Protocol Violation|1|||
106116846|NCT00393523|366085640|FG004|Overall Study|Protocol Violation|0|||
106116847|NCT00393523|366085636|FG000|Overall Study|Withdrawal by Subject|6|||
106116848|NCT00393523|366085637|FG001|Overall Study|Withdrawal by Subject|7|||
106116849|NCT00393523|366085638|FG002|Overall Study|Withdrawal by Subject|2|||
106116850|NCT00393523|366085639|FG003|Overall Study|Withdrawal by Subject|3|||
106116851|NCT00393523|366085640|FG004|Overall Study|Withdrawal by Subject|0|||
106116852|NCT00393523|366085636|FG000|Overall Study|Difficulties in specimen collection|0|||
106116853|NCT00393523|366085637|FG001|Overall Study|Difficulties in specimen collection|0|||
106116854|NCT00393523|366085638|FG002|Overall Study|Difficulties in specimen collection|1|||
106116855|NCT00393523|366085639|FG003|Overall Study|Difficulties in specimen collection|0|||
106116856|NCT00393523|366085640|FG004|Overall Study|Difficulties in specimen collection|0|||
106116857|NCT00393523|366085636|FG000|Overall Study|Vaccine supply issue|0|||
106116858|NCT00393523|366085637|FG001|Overall Study|Vaccine supply issue|0|||
106116859|NCT00393523|366085638|FG002|Overall Study|Vaccine supply issue|1|||
106116860|NCT00393523|366085639|FG003|Overall Study|Vaccine supply issue|0|||
106116861|NCT00393523|366085640|FG004|Overall Study|Vaccine supply issue|0|||
106116862|NCT00980005|366085643|FG000|Overall Study|Withdrawal by Subject|6|||
106116863|NCT00980005|366085644|FG001|Overall Study|Withdrawal by Subject|17|||
106116864|NCT00980005|366085643|FG000|Overall Study|Lost to Follow-up|37|||
106116865|NCT00980005|366085644|FG001|Overall Study|Lost to Follow-up|43|||
106116866|NCT00980005|366085643|FG000|Overall Study|Other|4|||
106116867|NCT00980005|366085644|FG001|Overall Study|Other|3|||
106116868|NCT01617005|366085645|FG000|Overall Study|Pregnancy|1|||
106116869|NCT01617005|366085645|FG000|Overall Study|Lack of motivation for treatment|1|||
106116870|NCT05952297|366085649|FG000|Overall Study|Withdrawal by Subject|1|||
106116871|NCT05952297|366085650|FG001|Overall Study|Withdrawal by Subject|0|||
106116872|NCT00098254|366085651|FG000|Overall Study|Adverse Event|2|||
106116873|NCT00098254|366085651|FG000|Overall Study|Death|1|||
106116874|NCT03107377|366085652|FG000|Overall Study|Adverse Event|3|||
106116875|NCT03107377|366085653|FG001|Overall Study|Adverse Event|3|||
106116876|NCT03107377|366085652|FG000|Overall Study|Protocol Violation|9|||
106116877|NCT03107377|366085653|FG001|Overall Study|Protocol Violation|12|||
106116878|NCT03107377|366085652|FG000|Overall Study|Physician Decision|3|||
106116879|NCT03107377|366085653|FG001|Overall Study|Physician Decision|6|||
106116880|NCT03107377|366085652|FG000|Overall Study|Pregnancy|7|||
106116881|NCT03107377|366085653|FG001|Overall Study|Pregnancy|7|||
106116882|NCT03107377|366085652|FG000|Overall Study|Withdrawal by Subject|16|||
106116883|NCT03107377|366085653|FG001|Overall Study|Withdrawal by Subject|22|||
106116884|NCT03107377|366085652|FG000|Overall Study|Lost to Follow-up|37|||
106116885|NCT03107377|366085653|FG001|Overall Study|Lost to Follow-up|34|||
106116886|NCT03107377|366085652|FG000|Overall Study|Other reason not specified|16|||
106116887|NCT03107377|366085653|FG001|Overall Study|Other reason not specified|15|||
106116888|NCT02118337|366085654|FG000|Overall Study|Other|1|||
106116889|NCT02118337|366085655|FG001|Overall Study|Other|0|||
106116890|NCT02118337|366085656|FG002|Overall Study|Other|0|||
106116891|NCT02118337|366085657|FG003|Overall Study|Other|0|||
106116892|NCT02118337|366085658|FG004|Overall Study|Other|2|||
106116893|NCT02118337|366085659|FG005|Overall Study|Other|3|||
106116894|NCT02118337|366085660|FG006|Overall Study|Other|1|||
106116895|NCT02118337|366085661|FG007|Overall Study|Other|28|||
106116896|NCT02118337|366085662|FG008|Overall Study|Other|15|||
106116897|NCT02118337|366085654|FG000|Overall Study|Lost to Follow-up|0|||
106116898|NCT02118337|366085655|FG001|Overall Study|Lost to Follow-up|0|||
106116899|NCT02118337|366085656|FG002|Overall Study|Lost to Follow-up|0|||
106116900|NCT02118337|366085657|FG003|Overall Study|Lost to Follow-up|0|||
106116901|NCT02118337|366085658|FG004|Overall Study|Lost to Follow-up|0|||
106116902|NCT02118337|366085659|FG005|Overall Study|Lost to Follow-up|0|||
106116903|NCT02118337|366085660|FG006|Overall Study|Lost to Follow-up|0|||
106116904|NCT02118337|366085661|FG007|Overall Study|Lost to Follow-up|1|||
106116905|NCT02118337|366085662|FG008|Overall Study|Lost to Follow-up|0|||
106116906|NCT02118337|366085654|FG000|Overall Study|Withdrawal by Subject|1|||
106116907|NCT02118337|366085655|FG001|Overall Study|Withdrawal by Subject|3|||
106116908|NCT02118337|366085656|FG002|Overall Study|Withdrawal by Subject|2|||
106116909|NCT02118337|366085657|FG003|Overall Study|Withdrawal by Subject|1|||
106116910|NCT02118337|366085658|FG004|Overall Study|Withdrawal by Subject|2|||
106116911|NCT02118337|366085659|FG005|Overall Study|Withdrawal by Subject|2|||
106116912|NCT02118337|366085660|FG006|Overall Study|Withdrawal by Subject|1|||
106116913|NCT02118337|366085661|FG007|Overall Study|Withdrawal by Subject|4|||
106116914|NCT02118337|366085662|FG008|Overall Study|Withdrawal by Subject|2|||
106116915|NCT02118337|366085654|FG000|Overall Study|Death|2|||
106116916|NCT02118337|366085655|FG001|Overall Study|Death|2|||
106116917|NCT02118337|366085656|FG002|Overall Study|Death|1|||
106116918|NCT02118337|366085657|FG003|Overall Study|Death|2|||
106116919|NCT02118337|366085658|FG004|Overall Study|Death|5|||
106116920|NCT02118337|366085659|FG005|Overall Study|Death|1|||
105661761|NCT03569891|364425134|FG000|Lead-in|Ineligible during lead-in|8|||
106116921|NCT02118337|366085660|FG006|Overall Study|Death|2|||
106116922|NCT02118337|366085661|FG007|Overall Study|Death|9|||
106116923|NCT02118337|366085662|FG008|Overall Study|Death|4|||
106116924|NCT02100722|366085666|FG000|Overall Study|Withdrawal pre-procedure|4|||
106116925|NCT02100722|366085667|FG001|Overall Study|Withdrawal pre-procedure|9|||
106116926|NCT02100722|366085666|FG000|Overall Study|Withdrawal post-procedure|0|||
106116927|NCT02100722|366085667|FG001|Overall Study|Withdrawal post-procedure|3|||
106116928|NCT02100722|366085666|FG000|Overall Study|Lost to Follow-up|2|||
106116929|NCT02100722|366085667|FG001|Overall Study|Lost to Follow-up|2|||
106116930|NCT02100722|366085666|FG000|Overall Study|Continuing on study|751|||
106116931|NCT02100722|366085667|FG001|Overall Study|Continuing on study|729|||
106116932|NCT03787680|366085669|FG000|Overall Study|Physician Decision|2|||
106116933|NCT03787680|366085670|FG001|Overall Study|Physician Decision|3|||
106116934|NCT03787680|366085669|FG000|Overall Study|Adverse Event|7|||
106116935|NCT03787680|366085670|FG001|Overall Study|Adverse Event|3|||
106116936|NCT03787680|366085669|FG000|Overall Study|Withdrawal by Subject|2|||
106116937|NCT03787680|366085670|FG001|Overall Study|Withdrawal by Subject|1|||
106116938|NCT05229653|366085675|FG000|Overall Study|Lost to Follow-up|1|||
106116939|NCT05229653|366085676|FG001|Overall Study|Lost to Follow-up|0|||
106116940|NCT00265330|366085678|FG000|Overall Study|Adverse Event|41|||
106116941|NCT00265330|366085678|FG000|Overall Study|Lost to Follow-up|8|||
106116942|NCT00265330|366085678|FG000|Overall Study|Withdrawal by Subject|34|||
106116943|NCT00265330|366085678|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
106116944|NCT00265330|366085678|FG000|Overall Study|Lack of Efficacy|4|||
106116945|NCT00265330|366085678|FG000|Overall Study|Family Scheduling Conflicts|1|||
106116946|NCT00265330|366085678|FG000|Overall Study|Began Taking Formulary Geodon|1|||
106116947|NCT00265330|366085678|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
106116948|NCT00265330|366085678|FG000|Overall Study|Site Closed by Sponsor|1|||
106116949|NCT00265330|366085678|FG000|Overall Study|Principal Investigators Request|1|||
106116950|NCT00265330|366085678|FG000|Overall Study|Withdrew Consent|1|||
106116951|NCT00265330|366085678|FG000|Overall Study|Protocol Violation|1|||
106116952|NCT01126060|366085679|FG000|Overall Study|Protocol Violation|0|||
106116953|NCT01126060|366085680|FG001|Overall Study|Protocol Violation|2|||
106116954|NCT04534114|366085681|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
106116955|NCT04534114|366085682|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
106116956|NCT04534114|366085683|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
106116957|NCT04534114|366085684|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
106116958|NCT04534114|366085681|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
106116959|NCT04534114|366085682|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
106116960|NCT04534114|366085683|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
106116961|NCT04534114|366085684|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
106116962|NCT04534114|366085681|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
106116963|NCT04534114|366085682|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
106116964|NCT04534114|366085683|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
106116965|NCT04534114|366085684|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
106116966|NCT04534114|366085681|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
106116967|NCT04534114|366085682|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
106116968|NCT04534114|366085683|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
106116969|NCT04534114|366085684|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
106116970|NCT04534114|366085681|FG000|Main Treatment Period|Physician Decision|0|||
106116971|NCT04534114|366085682|FG001|Main Treatment Period|Physician Decision|0|||
106116972|NCT04534114|366085683|FG002|Main Treatment Period|Physician Decision|0|||
106116973|NCT04534114|366085684|FG003|Main Treatment Period|Physician Decision|1|||
106116974|NCT04534114|366085681|FG000|Main Treatment Period|Death|1|||
106116975|NCT04534114|366085682|FG001|Main Treatment Period|Death|0|||
106116976|NCT04534114|366085683|FG002|Main Treatment Period|Death|0|||
106116977|NCT04534114|366085684|FG003|Main Treatment Period|Death|1|||
106116978|NCT04534114|366085681|FG000|Main Treatment Period|Other reason|1|||
106116979|NCT04534114|366085682|FG001|Main Treatment Period|Other reason|1|||
106116980|NCT04534114|366085683|FG002|Main Treatment Period|Other reason|0|||
106116981|NCT04534114|366085684|FG003|Main Treatment Period|Other reason|0|||
106116982|NCT04534114|366085681|FG000|Main Treatment Period|Participant decision|1|||
106116983|NCT04534114|366085682|FG001|Main Treatment Period|Participant decision|3|||
106116984|NCT04534114|366085683|FG002|Main Treatment Period|Participant decision|3|||
106116985|NCT04534114|366085684|FG003|Main Treatment Period|Participant decision|1|||
106116986|NCT04534114|366085681|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
106116987|NCT04534114|366085682|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
106116988|NCT04534114|366085683|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
106116989|NCT04534114|366085684|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
106116990|NCT04534114|366085681|FG000|Main Treatment Period|Adverse Event|4|||
106116991|NCT04534114|366085682|FG001|Main Treatment Period|Adverse Event|2|||
106116992|NCT04534114|366085683|FG002|Main Treatment Period|Adverse Event|1|||
106116993|NCT04534114|366085684|FG003|Main Treatment Period|Adverse Event|2|||
106116994|NCT04534114|366085681|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
106116995|NCT04534114|366085682|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
106116996|NCT04534114|366085683|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
106116997|NCT04534114|366085684|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
106116998|NCT04534114|366085681|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
106116999|NCT04534114|366085682|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
106117000|NCT04534114|366085683|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
106117001|NCT04534114|366085684|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
106117002|NCT04534114|366085681|FG000|Extension Treatment Period|Other reason|0|||
106117003|NCT04534114|366085682|FG001|Extension Treatment Period|Other reason|1|||
106117004|NCT04534114|366085683|FG002|Extension Treatment Period|Other reason|0|||
106117005|NCT04534114|366085684|FG003|Extension Treatment Period|Other reason|0|||
106117006|NCT04534114|366085681|FG000|Extension Treatment Period|Death|0|||
106117007|NCT04534114|366085682|FG001|Extension Treatment Period|Death|0|||
106117008|NCT04534114|366085683|FG002|Extension Treatment Period|Death|1|||
106117009|NCT04534114|366085684|FG003|Extension Treatment Period|Death|2|||
106117010|NCT04534114|366085681|FG000|Extension Treatment Period|Adverse Event|0|||
106117011|NCT04534114|366085682|FG001|Extension Treatment Period|Adverse Event|1|||
106117012|NCT04534114|366085683|FG002|Extension Treatment Period|Adverse Event|0|||
106117013|NCT04534114|366085684|FG003|Extension Treatment Period|Adverse Event|1|||
106117014|NCT04534114|366085681|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
106117015|NCT04534114|366085682|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
106117016|NCT04534114|366085683|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
106117017|NCT04534114|366085684|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
106117018|NCT02668016|366085685|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
106117019|NCT02668016|366085685|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
106117020|NCT02668016|366085685|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
106117021|NCT02668016|366085685|FG000|Month 4|Withdrawal due to severe symptoms|1|||
106117022|NCT02668016|366085685|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
106117023|NCT02668016|366085685|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
106117024|NCT02668016|366085685|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
106117025|NCT02668016|366085685|FG000|Month 6|Withdrawal due to severe symptoms|2|||
106117026|NCT02668016|366085685|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
106117027|NCT02668016|366085685|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
106117028|NCT02668016|366085685|FG000|Month 8|Withdrawal due to severe symptoms|1|||
106117029|NCT02668016|366085685|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
106117030|NCT02668016|366085685|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
106117031|NCT02668016|366085685|FG000|Month 10|Withdrawal due to severe symptoms|1|||
106117032|NCT02668016|366085685|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
106117033|NCT03556358|366085686|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
106117034|NCT03556358|366085687|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
106117035|NCT03556358|366085686|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
106117036|NCT03556358|366085687|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
106117037|NCT03556358|366085686|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
106117038|NCT03556358|366085687|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
106117039|NCT03556358|366085686|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
106117040|NCT03556358|366085687|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
106117041|NCT03556358|366085686|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
106117042|NCT03556358|366085687|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
106117043|NCT03556358|366085686|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
106117044|NCT03556358|366085687|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
106117045|NCT03556358|366085686|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
106117046|NCT03556358|366085687|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
106117047|NCT00399763|366085695|FG000|Overall Study|Lost to Follow-up|2|||
106117048|NCT00399763|366085696|FG001|Overall Study|Lost to Follow-up|3|||
106117049|NCT05067933|366085703|FG000|Overall Study|Withdrawal by Subject|2|||
106117050|NCT05067933|366085704|FG001|Overall Study|Withdrawal by Subject|0|||
106117051|NCT05067933|366085705|FG002|Overall Study|Withdrawal by Subject|0|||
106117052|NCT05067933|366085706|FG003|Overall Study|Withdrawal by Subject|0|||
106117053|NCT05067933|366085707|FG004|Overall Study|Withdrawal by Subject|0|||
106117054|NCT05067933|366085708|FG005|Overall Study|Withdrawal by Subject|0|||
106117055|NCT05067933|366085703|FG000|Overall Study|Lost to Follow-up|1|||
106117056|NCT05067933|366085704|FG001|Overall Study|Lost to Follow-up|1|||
106117057|NCT05067933|366085705|FG002|Overall Study|Lost to Follow-up|1|||
106117058|NCT05067933|366085706|FG003|Overall Study|Lost to Follow-up|2|||
106117059|NCT05067933|366085707|FG004|Overall Study|Lost to Follow-up|1|||
106117060|NCT05067933|366085708|FG005|Overall Study|Lost to Follow-up|0|||
106117061|NCT05067933|366085703|FG000|Overall Study|Miscellaneous|1|||
106117062|NCT05067933|366085704|FG001|Overall Study|Miscellaneous|0|||
106117063|NCT05067933|366085705|FG002|Overall Study|Miscellaneous|0|||
106117064|NCT05067933|366085706|FG003|Overall Study|Miscellaneous|0|||
106117065|NCT05067933|366085707|FG004|Overall Study|Miscellaneous|0|||
106117066|NCT05067933|366085708|FG005|Overall Study|Miscellaneous|0|||
106117067|NCT05067933|366085703|FG000|Overall Study|Death|0|||
106117068|NCT05067933|366085704|FG001|Overall Study|Death|0|||
106117069|NCT05067933|366085705|FG002|Overall Study|Death|0|||
106117070|NCT05067933|366085706|FG003|Overall Study|Death|1|||
106117071|NCT05067933|366085707|FG004|Overall Study|Death|0|||
105995015|NCT01784068|365641780|FG000|TFR Phase|Death|0|||
105995016|NCT01784068|365641781|FG001|TFR Phase|Death|1|||
105995017|NCT01784068|365641780|FG000|TFR Phase|Lack of Efficacy|0|||
105995018|NCT01784068|365641781|FG001|TFR Phase|Lack of Efficacy|88|||
105995019|NCT03672292|365641789|FG000|Overall Study|Adverse Event|3|||
105995020|NCT03672292|365641790|FG001|Overall Study|Adverse Event|1|||
105995021|NCT03672292|365641789|FG000|Overall Study|Physician Decision|0|||
105995022|NCT03672292|365641790|FG001|Overall Study|Physician Decision|1|||
105995023|NCT03672292|365641789|FG000|Overall Study|Withdrawal by Subject|1|||
105995024|NCT03672292|365641790|FG001|Overall Study|Withdrawal by Subject|2|||
105995025|NCT02518971|365641791|FG000|Overall Study|Lost to Follow-up|0|||
105995026|NCT02518971|365641792|FG001|Overall Study|Lost to Follow-up|1|||
105995027|NCT02518971|365641791|FG000|Overall Study|Physician Decision|6|||
105995028|NCT02518971|365641792|FG001|Overall Study|Physician Decision|6|||
105995029|NCT02518971|365641791|FG000|Overall Study|Protocol Violation|6|||
105995030|NCT02518971|365641792|FG001|Overall Study|Protocol Violation|4|||
105995031|NCT02518971|365641791|FG000|Overall Study|Withdrawal by Subject|4|||
105995032|NCT02518971|365641792|FG001|Overall Study|Withdrawal by Subject|5|||
105995033|NCT02518971|365641791|FG000|Overall Study|Side effects|1|||
105995034|NCT02518971|365641792|FG001|Overall Study|Side effects|0|||
105995035|NCT02518971|365641791|FG000|Overall Study|medication lost in mail|0|||
105995036|NCT02518971|365641792|FG001|Overall Study|medication lost in mail|1|||
105995037|NCT02518971|365641791|FG000|Overall Study|eligibility criteria no longer met|6|||
106117072|NCT05067933|366085708|FG005|Overall Study|Death|0|||
106117073|NCT01657266|366085714|FG000|Overall Study|Lost to Follow-up|2|||
106117074|NCT01657266|366085715|FG001|Overall Study|Lost to Follow-up|2|||
106117075|NCT01657266|366085714|FG000|Overall Study|Adverse Event|2|||
106117076|NCT01657266|366085715|FG001|Overall Study|Adverse Event|3|||
106117077|NCT00457639|366085721|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
106117078|NCT00457639|366085722|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
106117079|NCT00457639|366085721|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
106117080|NCT00457639|366085722|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
106117081|NCT00457639|366085721|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
106117082|NCT00457639|366085722|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
106117083|NCT02395133|366085723|FG000|Overall Study|Adverse Event|4|||
106117084|NCT02395133|366085724|FG001|Overall Study|Adverse Event|1|||
106117085|NCT02395133|366085725|FG002|Overall Study|Adverse Event|3|||
106117086|NCT02395133|366085726|FG003|Overall Study|Adverse Event|0|||
106117087|NCT02395133|366085723|FG000|Overall Study|Lack of Efficacy|1|||
106117088|NCT02395133|366085724|FG001|Overall Study|Lack of Efficacy|0|||
106117089|NCT02395133|366085725|FG002|Overall Study|Lack of Efficacy|1|||
106117090|NCT02395133|366085726|FG003|Overall Study|Lack of Efficacy|1|||
106117091|NCT02395133|366085723|FG000|Overall Study|Protocol Violation|1|||
106117092|NCT02395133|366085724|FG001|Overall Study|Protocol Violation|1|||
106117093|NCT02395133|366085725|FG002|Overall Study|Protocol Violation|0|||
106117094|NCT02395133|366085726|FG003|Overall Study|Protocol Violation|3|||
106117095|NCT02395133|366085723|FG000|Overall Study|Lost to Follow-up|0|||
106117096|NCT02395133|366085724|FG001|Overall Study|Lost to Follow-up|1|||
106117097|NCT02395133|366085725|FG002|Overall Study|Lost to Follow-up|1|||
106117098|NCT02395133|366085726|FG003|Overall Study|Lost to Follow-up|0|||
106117099|NCT02395133|366085723|FG000|Overall Study|Pregnancy|0|||
106117100|NCT02395133|366085724|FG001|Overall Study|Pregnancy|0|||
106117101|NCT02395133|366085725|FG002|Overall Study|Pregnancy|3|||
106117102|NCT02395133|366085726|FG003|Overall Study|Pregnancy|0|||
106117103|NCT02395133|366085723|FG000|Overall Study|Consent withdrawn with no reason given|1|||
106117104|NCT02395133|366085724|FG001|Overall Study|Consent withdrawn with no reason given|3|||
106117105|NCT02395133|366085725|FG002|Overall Study|Consent withdrawn with no reason given|0|||
106117106|NCT02395133|366085726|FG003|Overall Study|Consent withdrawn with no reason given|2|||
106117107|NCT02395133|366085723|FG000|Overall Study|Consent withdrawn with personal reason|0|||
106117108|NCT02395133|366085724|FG001|Overall Study|Consent withdrawn with personal reason|1|||
106117109|NCT02395133|366085725|FG002|Overall Study|Consent withdrawn with personal reason|0|||
106117110|NCT02395133|366085726|FG003|Overall Study|Consent withdrawn with personal reason|3|||
106117111|NCT02395133|366085723|FG000|Overall Study|Sponsor decision|2|||
106117112|NCT02395133|366085724|FG001|Overall Study|Sponsor decision|0|||
106117113|NCT02395133|366085725|FG002|Overall Study|Sponsor decision|0|||
105995038|NCT02518971|365641792|FG001|Overall Study|eligibility criteria no longer met|3|||
105995039|NCT04451161|365641793|FG000|Overall Study|Lost to Follow-up|28|||
105995040|NCT04451161|365641794|FG001|Overall Study|Lost to Follow-up|37|||
105995041|NCT04451161|365641795|FG002|Overall Study|Lost to Follow-up|22|||
105995042|NCT04451161|365641796|FG003|Overall Study|Lost to Follow-up|13|||
105995043|NCT04451161|365641797|FG004|Overall Study|Lost to Follow-up|11|||
106117114|NCT02395133|366085726|FG003|Overall Study|Sponsor decision|1|||
106117115|NCT02395133|366085723|FG000|Overall Study|Other than specified above|5|||
106117116|NCT02395133|366085724|FG001|Overall Study|Other than specified above|2|||
106117117|NCT02395133|366085725|FG002|Overall Study|Other than specified above|2|||
106117118|NCT02395133|366085726|FG003|Overall Study|Other than specified above|4|||
106117119|NCT00962247|366085729|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
105995044|NCT04451161|365641798|FG005|Overall Study|Lost to Follow-up|14|||
105995045|NCT04451161|365641793|FG000|Overall Study|Withdrawal by Subject|3|||
105995046|NCT04451161|365641794|FG001|Overall Study|Withdrawal by Subject|0|||
105995047|NCT04451161|365641795|FG002|Overall Study|Withdrawal by Subject|0|||
105995048|NCT04451161|365641796|FG003|Overall Study|Withdrawal by Subject|0|||
105995049|NCT04451161|365641797|FG004|Overall Study|Withdrawal by Subject|2|||
105995050|NCT04451161|365641798|FG005|Overall Study|Withdrawal by Subject|4|||
105995051|NCT03088917|365641799|FG000|Overall Study|In care/cured elsewhere|15|||
105995052|NCT03088917|365641799|FG000|Overall Study|Refuse re-evaluation|13|||
105995053|NCT03088917|365641799|FG000|Overall Study|Contact not established|13|||
105995054|NCT03088917|365641799|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
105995055|NCT03088917|365641799|FG000|Overall Study|Moved outside study region|50|||
105995056|NCT02336230|365641800|FG000|Overall Study|Adverse Event|1|||
105995057|NCT02336230|365641800|FG000|Overall Study|Withdrawal of consent|1|||
105995058|NCT02336230|365641800|FG000|Overall Study|Death|9|||
105995059|NCT02336230|365641800|FG000|Overall Study|Dose not received due to shipping delay|1|||
105995060|NCT02336230|365641800|FG000|Overall Study|Discontinuation of MSC infusion|1|||
105995061|NCT05150990|365641801|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
106117120|NCT00962247|366085729|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
106117121|NCT00510458|366085730|FG000|Overall Study|5 year not evaluable/missed|21|||
106117122|NCT00510458|366085730|FG000|Overall Study|Death|1|||
106117123|NCT00510458|366085730|FG000|Overall Study|Terminated|14|||
106117124|NCT00510458|366085730|FG000|Overall Study|Lost to Follow-up|6|||
106117125|NCT00510458|366085730|FG000|Overall Study|Withdrawal by Subject|3|||
106117126|NCT00510458|366085730|FG000|Overall Study|Revision|2|||
106117127|NCT03573908|366085731|FG000|Treatment Period|Adverse Event|4|||
106117128|NCT03573908|366085732|FG001|Treatment Period|Adverse Event|9|||
106117129|NCT03573908|366085733|FG002|Treatment Period|Adverse Event|0|||
106117130|NCT03573908|366085734|FG003|Treatment Period|Adverse Event|0|||
106117131|NCT03573908|366085735|FG004|Treatment Period|Adverse Event|0|||
106117132|NCT03573908|366085731|FG000|Treatment Period|Protocol Violation|1|||
106117133|NCT03573908|366085732|FG001|Treatment Period|Protocol Violation|0|||
106117134|NCT03573908|366085733|FG002|Treatment Period|Protocol Violation|0|||
106117135|NCT03573908|366085734|FG003|Treatment Period|Protocol Violation|0|||
106117136|NCT03573908|366085735|FG004|Treatment Period|Protocol Violation|0|||
106117137|NCT03573908|366085731|FG000|Treatment Period|Withdrawal by Subject|7|||
106117138|NCT03573908|366085732|FG001|Treatment Period|Withdrawal by Subject|5|||
106117139|NCT03573908|366085733|FG002|Treatment Period|Withdrawal by Subject|0|||
106117140|NCT03573908|366085734|FG003|Treatment Period|Withdrawal by Subject|0|||
106117141|NCT03573908|366085735|FG004|Treatment Period|Withdrawal by Subject|0|||
106117142|NCT03573908|366085731|FG000|Treatment Period|Lost to Follow-up|7|||
106117143|NCT03573908|366085732|FG001|Treatment Period|Lost to Follow-up|6|||
106117144|NCT03573908|366085733|FG002|Treatment Period|Lost to Follow-up|0|||
106117145|NCT03573908|366085734|FG003|Treatment Period|Lost to Follow-up|0|||
106117146|NCT03573908|366085735|FG004|Treatment Period|Lost to Follow-up|0|||
106117147|NCT03573908|366085731|FG000|Treatment Period|Pregnancy|1|||
106117148|NCT03573908|366085732|FG001|Treatment Period|Pregnancy|0|||
106117149|NCT03573908|366085733|FG002|Treatment Period|Pregnancy|0|||
106117150|NCT03573908|366085734|FG003|Treatment Period|Pregnancy|0|||
106117151|NCT03573908|366085735|FG004|Treatment Period|Pregnancy|0|||
106117152|NCT03573908|366085731|FG000|Treatment Period|Other, Not Specified|4|||
106117153|NCT03573908|366085732|FG001|Treatment Period|Other, Not Specified|6|||
106117154|NCT03573908|366085733|FG002|Treatment Period|Other, Not Specified|0|||
106117155|NCT03573908|366085734|FG003|Treatment Period|Other, Not Specified|0|||
106117156|NCT03573908|366085735|FG004|Treatment Period|Other, Not Specified|0|||
106117157|NCT03573908|366085731|FG000|Randomized Withdrawal Period|Adverse Event|0|||
106117158|NCT03573908|366085732|FG001|Randomized Withdrawal Period|Adverse Event|0|||
106117159|NCT03573908|366085733|FG002|Randomized Withdrawal Period|Adverse Event|3|||
106117160|NCT03573908|366085734|FG003|Randomized Withdrawal Period|Adverse Event|0|||
106117161|NCT03573908|366085735|FG004|Randomized Withdrawal Period|Adverse Event|0|||
106117162|NCT03573908|366085731|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
106117163|NCT03573908|366085732|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
106117164|NCT03573908|366085733|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
106117165|NCT03573908|366085734|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
106117166|NCT03573908|366085735|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
106117167|NCT03573908|366085731|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
106117168|NCT03573908|366085732|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
106117169|NCT03573908|366085733|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
106117170|NCT03573908|366085734|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
106117171|NCT03573908|366085735|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
106117172|NCT03573908|366085731|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
106117173|NCT03573908|366085732|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
106117174|NCT03573908|366085733|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
106117175|NCT03573908|366085734|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
105995062|NCT05150990|365641802|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
105995063|NCT05150990|365641801|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
105995064|NCT05150990|365641802|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
105995065|NCT05150990|365641801|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
105995066|NCT05150990|365641802|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
105995067|NCT05150990|365641801|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
105995068|NCT05150990|365641802|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
105995069|NCT05150990|365641801|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
105995070|NCT05150990|365641802|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
105995071|NCT05150990|365641801|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
105995072|NCT05150990|365641802|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
105995073|NCT05150990|365641801|FG000|Overall Study|Death (unrelated to the intervention)|1|||
105995074|NCT05150990|365641802|FG001|Overall Study|Death (unrelated to the intervention)|2|||
105995075|NCT05729568|365641804|FG000|Overall Study|Still on Study|52|||
105995076|NCT05729568|365641805|FG001|Overall Study|Still on Study|26|||
105995077|NCT05729568|365641804|FG000|Overall Study|Randomized but Never Treated|3|||
105995078|NCT05729568|365641805|FG001|Overall Study|Randomized but Never Treated|0|||
105995079|NCT05729568|365641804|FG000|Overall Study|Adverse Event|0|||
105995080|NCT05729568|365641805|FG001|Overall Study|Adverse Event|1|||
105995081|NCT05729568|365641804|FG000|Overall Study|Investigator's Discretion|1|||
105995082|NCT05729568|365641805|FG001|Overall Study|Investigator's Discretion|0|||
105995083|NCT02864901|365641806|FG000|Overall Study|Withdrawal by Subject|1|||
105995084|NCT02864901|365641807|FG001|Overall Study|Withdrawal by Subject|0|||
105995085|NCT02940496|365641814|FG000|Overall Study|Adverse Event|1|||
105995086|NCT02940496|365641815|FG001|Overall Study|Adverse Event|0|||
105995087|NCT02940496|365641814|FG000|Overall Study|Death|2|||
105995088|NCT02940496|365641815|FG001|Overall Study|Death|0|||
105995089|NCT02940496|365641814|FG000|Overall Study|Hospice Care|1|||
105995090|NCT02940496|365641815|FG001|Overall Study|Hospice Care|0|||
105995091|NCT02940496|365641814|FG000|Overall Study|No MRE Done|1|||
105995092|NCT02940496|365641815|FG001|Overall Study|No MRE Done|0|||
105995093|NCT02940496|365641814|FG000|Overall Study|MRE Failure|1|||
105995094|NCT02940496|365641815|FG001|Overall Study|MRE Failure|0|||
105995095|NCT06964165|365641816|FG000|Overall Study|Withdrawal by Subject|0|||
105995096|NCT06964165|365641817|FG001|Overall Study|Withdrawal by Subject|1|||
105995097|NCT06964165|365641816|FG000|Overall Study|Ongoing at the time of analysis|15|||
105995098|NCT06964165|365641817|FG001|Overall Study|Ongoing at the time of analysis|14|||
105995099|NCT06964165|365641816|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
105995100|NCT06964165|365641817|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
105995101|NCT06964165|365641816|FG000|Overall Study|Participant removed due to non-compliance|0|||
105995102|NCT06964165|365641817|FG001|Overall Study|Participant removed due to non-compliance|1|||
105995103|NCT02657551|365641827|FG000|Overall Study|Adverse Event|2|||
106117176|NCT03573908|366085735|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
106117177|NCT00524030|366085743|FG000|Overall Study|Lack of Efficacy|10|||
106117178|NCT00524030|366085744|FG001|Overall Study|Lack of Efficacy|24|||
106117179|NCT00524030|366085743|FG000|Overall Study|Lost to Follow-up|0|||
106117180|NCT00524030|366085744|FG001|Overall Study|Lost to Follow-up|2|||
106117181|NCT00524030|366085743|FG000|Overall Study|Withdrawal by Subject|3|||
106117182|NCT00524030|366085744|FG001|Overall Study|Withdrawal by Subject|8|||
106117183|NCT00524030|366085743|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
106117184|NCT00524030|366085744|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
106117185|NCT00524030|366085743|FG000|Overall Study|Protocol Violation|0|||
106117186|NCT00524030|366085744|FG001|Overall Study|Protocol Violation|1|||
106117187|NCT00524030|366085743|FG000|Overall Study|Pregnancy|1|||
106117188|NCT00524030|366085744|FG001|Overall Study|Pregnancy|0|||
106117189|NCT00524030|366085743|FG000|Overall Study|Adverse Event|3|||
106117190|NCT00524030|366085744|FG001|Overall Study|Adverse Event|21|||
106117191|NCT00524030|366085743|FG000|Overall Study|Death|0|||
106117192|NCT00524030|366085744|FG001|Overall Study|Death|1|||
106117193|NCT03610737|366087198|FG000|Overall Study|Withdrawal by Subject|1|||
106117194|NCT03610737|366087199|FG001|Overall Study|Withdrawal by Subject|5|||
106117195|NCT03610737|366087198|FG000|Overall Study|Death|1|||
106117196|NCT03610737|366087199|FG001|Overall Study|Death|0|||
106117197|NCT03610737|366087198|FG000|Overall Study|Not treated|5|||
106117198|NCT03610737|366087199|FG001|Overall Study|Not treated|2|||
106117199|NCT03610737|366087198|FG000|Overall Study|Missed Visit|1|||
106117200|NCT03610737|366087199|FG001|Overall Study|Missed Visit|2|||
106117201|NCT02392611|366087201|FG000|Overall Study|Adverse Event|0|||
106117202|NCT02392611|366087202|FG001|Overall Study|Adverse Event|0|||
106117203|NCT02392611|366087203|FG002|Overall Study|Adverse Event|0|||
106117204|NCT02392611|366087204|FG003|Overall Study|Adverse Event|1|||
106117205|NCT02392611|366087205|FG004|Overall Study|Adverse Event|0|||
105995104|NCT02657551|365641827|FG000|Overall Study|Withdrawal by Subject|1|||
105995105|NCT02657551|365641827|FG000|Overall Study|Non-Compliance|1|||
105995106|NCT02657551|365641827|FG000|Overall Study|Progression / Relapse|4|||
105995107|NCT00362648|365641828|FG000|Overall Study|Adverse Event|12|||
105995108|NCT00362648|365641829|FG001|Overall Study|Adverse Event|21|||
105995109|NCT00362648|365641830|FG002|Overall Study|Adverse Event|1|||
105995110|NCT00362648|365641831|FG003|Overall Study|Adverse Event|0|||
105995111|NCT00362648|365641828|FG000|Overall Study|Lost to Follow-up|62|||
106117206|NCT02392611|366087206|FG005|Overall Study|Adverse Event|0|||
106117207|NCT02392611|366087207|FG006|Overall Study|Adverse Event|0|||
106117208|NCT02392611|366087208|FG007|Overall Study|Adverse Event|0|||
106117209|NCT02392611|366087209|FG008|Overall Study|Adverse Event|0|||
106117210|NCT02392611|366087201|FG000|Overall Study|Progressive disease|0|||
106117211|NCT02392611|366087202|FG001|Overall Study|Progressive disease|0|||
106117212|NCT02392611|366087203|FG002|Overall Study|Progressive disease|0|||
106117213|NCT02392611|366087204|FG003|Overall Study|Progressive disease|2|||
106117214|NCT02392611|366087205|FG004|Overall Study|Progressive disease|1|||
106117215|NCT02392611|366087206|FG005|Overall Study|Progressive disease|0|||
106117216|NCT02392611|366087207|FG006|Overall Study|Progressive disease|0|||
106117217|NCT02392611|366087208|FG007|Overall Study|Progressive disease|0|||
106117218|NCT02392611|366087209|FG008|Overall Study|Progressive disease|0|||
106117219|NCT02392611|366087201|FG000|Overall Study|Death|1|||
106117220|NCT02392611|366087202|FG001|Overall Study|Death|0|||
106117221|NCT02392611|366087203|FG002|Overall Study|Death|0|||
106117222|NCT02392611|366087204|FG003|Overall Study|Death|0|||
106117223|NCT02392611|366087205|FG004|Overall Study|Death|0|||
106117224|NCT02392611|366087206|FG005|Overall Study|Death|1|||
106117225|NCT02392611|366087207|FG006|Overall Study|Death|0|||
106117226|NCT02392611|366087208|FG007|Overall Study|Death|0|||
106117227|NCT02392611|366087209|FG008|Overall Study|Death|0|||
106117228|NCT02392611|366087201|FG000|Overall Study|Withdrawal by Subject|0|||
106117229|NCT02392611|366087202|FG001|Overall Study|Withdrawal by Subject|0|||
106117230|NCT02392611|366087203|FG002|Overall Study|Withdrawal by Subject|0|||
106117231|NCT02392611|366087204|FG003|Overall Study|Withdrawal by Subject|1|||
106117232|NCT02392611|366087205|FG004|Overall Study|Withdrawal by Subject|0|||
106117233|NCT02392611|366087206|FG005|Overall Study|Withdrawal by Subject|0|||
106117234|NCT02392611|366087207|FG006|Overall Study|Withdrawal by Subject|0|||
106117235|NCT02392611|366087208|FG007|Overall Study|Withdrawal by Subject|0|||
106117236|NCT02392611|366087209|FG008|Overall Study|Withdrawal by Subject|0|||
106117237|NCT02392611|366087201|FG000|Overall Study|Lost to Follow-up|0|||
106117238|NCT02392611|366087202|FG001|Overall Study|Lost to Follow-up|0|||
106117239|NCT02392611|366087203|FG002|Overall Study|Lost to Follow-up|0|||
106117240|NCT02392611|366087204|FG003|Overall Study|Lost to Follow-up|0|||
106117241|NCT02392611|366087205|FG004|Overall Study|Lost to Follow-up|0|||
106117242|NCT02392611|366087206|FG005|Overall Study|Lost to Follow-up|0|||
106117243|NCT02392611|366087207|FG006|Overall Study|Lost to Follow-up|1|||
106117244|NCT02392611|366087208|FG007|Overall Study|Lost to Follow-up|0|||
106117245|NCT02392611|366087209|FG008|Overall Study|Lost to Follow-up|0|||
106117246|NCT02392611|366087201|FG000|Overall Study|Enrolled, not treated|0|||
106117247|NCT02392611|366087202|FG001|Overall Study|Enrolled, not treated|0|||
106117248|NCT02392611|366087203|FG002|Overall Study|Enrolled, not treated|0|||
106117249|NCT02392611|366087204|FG003|Overall Study|Enrolled, not treated|2|||
106117250|NCT02392611|366087205|FG004|Overall Study|Enrolled, not treated|0|||
106117251|NCT02392611|366087206|FG005|Overall Study|Enrolled, not treated|0|||
106117252|NCT02392611|366087207|FG006|Overall Study|Enrolled, not treated|0|||
106117253|NCT02392611|366087208|FG007|Overall Study|Enrolled, not treated|0|||
106117254|NCT02392611|366087209|FG008|Overall Study|Enrolled, not treated|0|||
106117255|NCT01642602|366087215|FG000|Overall Study|Adverse Event|2|||
106117256|NCT00927355|366087216|FG000|Overall Study|Adverse Event|1|||
106117257|NCT00927355|366087217|FG001|Overall Study|Adverse Event|1|||
106117258|NCT03066622|366087218|FG000|Overall Study|Lost to Follow-up|24|||
106117259|NCT03066622|366087219|FG001|Overall Study|Lost to Follow-up|25|||
106117260|NCT03066622|366087218|FG000|Overall Study|Withdrawal by Subject|2|||
106117261|NCT03066622|366087219|FG001|Overall Study|Withdrawal by Subject|1|||
106117262|NCT02567825|366087220|FG000|Overall Study|No follow-up post-randomization|5|||
106117263|NCT02567825|366087221|FG001|Overall Study|No follow-up post-randomization|1|||
106117264|NCT02567825|366087220|FG000|Overall Study|Follow-up less than 23 months|16|||
106117265|NCT02567825|366087221|FG001|Overall Study|Follow-up less than 23 months|20|||
106117266|NCT02281760|366087223|FG000|Overall Study|Withdrawal by Subject|1|||
106117267|NCT00154310|366087224|FG000|Overall Study|Adverse Event|19|||
106117268|NCT00154310|366087225|FG001|Overall Study|Adverse Event|9|||
106117269|NCT00154310|366087224|FG000|Overall Study|Lack of Efficacy|5|||
106117270|NCT00154310|366087225|FG001|Overall Study|Lack of Efficacy|4|||
106117271|NCT00154310|366087224|FG000|Overall Study|Protocol Violation|4|||
106117272|NCT00154310|366087225|FG001|Overall Study|Protocol Violation|2|||
106117273|NCT00154310|366087224|FG000|Overall Study|Withdrawal by Subject|9|||
106117274|NCT00154310|366087225|FG001|Overall Study|Withdrawal by Subject|3|||
106117275|NCT00154310|366087224|FG000|Overall Study|Lost to Follow-up|0|||
106117276|NCT00154310|366087225|FG001|Overall Study|Lost to Follow-up|8|||
105995112|NCT00362648|365641829|FG001|Overall Study|Lost to Follow-up|69|||
105995113|NCT00362648|365641830|FG002|Overall Study|Lost to Follow-up|4|||
105995114|NCT00362648|365641831|FG003|Overall Study|Lost to Follow-up|3|||
105995115|NCT00362648|365641828|FG000|Overall Study|Protocol Violation|4|||
105995116|NCT00362648|365641829|FG001|Overall Study|Protocol Violation|2|||
105995117|NCT00362648|365641830|FG002|Overall Study|Protocol Violation|2|||
105995118|NCT00362648|365641831|FG003|Overall Study|Protocol Violation|2|||
105995119|NCT00362648|365641828|FG000|Overall Study|Withdrawal by Subject|48|||
105995120|NCT00362648|365641829|FG001|Overall Study|Withdrawal by Subject|42|||
105995121|NCT00362648|365641830|FG002|Overall Study|Withdrawal by Subject|2|||
105995122|NCT00362648|365641831|FG003|Overall Study|Withdrawal by Subject|6|||
105995123|NCT02576795|365641832|FG000|Overall Study|Lost to Follow-up|0|||
105995124|NCT02576795|365641833|FG001|Overall Study|Lost to Follow-up|0|||
105995125|NCT02576795|365641834|FG002|Overall Study|Lost to Follow-up|1|||
105995126|NCT02576795|365641835|FG003|Overall Study|Lost to Follow-up|0|||
105995127|NCT03983304|365641836|FG000|Overall Study|Withdrawal by Subject|5|||
105995128|NCT03983304|365641836|FG000|Overall Study|Lost to Follow-up|2|||
105995129|NCT04752332|365641839|FG000|Overall Study|Adverse Event|3|||
105995130|NCT04752332|365641840|FG001|Overall Study|Adverse Event|1|||
105995131|NCT04752332|365641839|FG000|Overall Study|Disease Relapse|1|||
106117277|NCT00154310|366087224|FG000|Overall Study|Administrative problems|0|||
106117278|NCT00154310|366087225|FG001|Overall Study|Administrative problems|1|||
106117279|NCT00154310|366087224|FG000|Overall Study|Death|0|||
106117280|NCT00154310|366087225|FG001|Overall Study|Death|1|||
106117281|NCT03101241|366087226|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
106117282|NCT03101241|366087227|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
106117283|NCT03101241|366087226|FG000|Overall Study|Participant withdrew consent|3|||
106117284|NCT03101241|366087227|FG001|Overall Study|Participant withdrew consent|1|||
106117285|NCT03101241|366087226|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
106117286|NCT03101241|366087227|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
106117287|NCT03101241|366087226|FG000|Overall Study|Lost to Follow-up|2|||
106117288|NCT03101241|366087227|FG001|Overall Study|Lost to Follow-up|0|||
106117289|NCT03101241|366087226|FG000|Overall Study|Lack of Efficacy|0|||
106117290|NCT03101241|366087227|FG001|Overall Study|Lack of Efficacy|1|||
106117291|NCT03101241|366087226|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
106117292|NCT03101241|366087227|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
106117293|NCT03592277|366087228|FG000|Overall Study|Withdrawal by Subject|6|||
106117294|NCT03592277|366087229|FG001|Overall Study|Withdrawal by Subject|8|||
106117295|NCT04581200|366087230|FG000|Overall Study|Lost to Follow-up|6|||
106117296|NCT04581200|366087231|FG001|Overall Study|Lost to Follow-up|5|||
106117297|NCT01781390|366087232|FG000|Overall Study|Withdrawal of Consent|0|||
106117298|NCT01781390|366087233|FG001|Overall Study|Withdrawal of Consent|3|||
106117299|NCT01781390|366087234|FG002|Overall Study|Withdrawal of Consent|1|||
106117300|NCT01781390|366087232|FG000|Overall Study|Lost to Follow-up|1|||
106117301|NCT01781390|366087233|FG001|Overall Study|Lost to Follow-up|1|||
106117302|NCT01781390|366087234|FG002|Overall Study|Lost to Follow-up|1|||
106117303|NCT01781390|366087232|FG000|Overall Study|Adverse Event|1|||
106117304|NCT01781390|366087233|FG001|Overall Study|Adverse Event|2|||
106117305|NCT01781390|366087234|FG002|Overall Study|Adverse Event|1|||
106117306|NCT01781390|366087232|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
106117307|NCT01781390|366087233|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
106117308|NCT01781390|366087234|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
106117309|NCT04488003|366087235|FG000|Assessed for Eligibility|Screen Failure|24|||
106117310|NCT04488003|366087236|FG001|Assessed for Eligibility|Screen Failure|0|||
106117311|NCT04488003|366087237|FG002|Assessed for Eligibility|Screen Failure|0|||
106117312|NCT04488003|366087235|FG000|Assessed for Eligibility|Adverse Event|1|||
106117313|NCT04488003|366087236|FG001|Assessed for Eligibility|Adverse Event|0|||
106117314|NCT04488003|366087237|FG002|Assessed for Eligibility|Adverse Event|0|||
106117315|NCT04488003|366087235|FG000|Assessed for Eligibility|Death|1|||
106117316|NCT04488003|366087236|FG001|Assessed for Eligibility|Death|0|||
106117317|NCT04488003|366087237|FG002|Assessed for Eligibility|Death|0|||
106117318|NCT04488003|366087235|FG000|Assessed for Eligibility|Physician Decision|1|||
106117319|NCT04488003|366087236|FG001|Assessed for Eligibility|Physician Decision|0|||
106117320|NCT04488003|366087237|FG002|Assessed for Eligibility|Physician Decision|0|||
106117321|NCT04488003|366087235|FG000|Allocated to Treatment|Progressive Disease|51|||
106117322|NCT04488003|366087236|FG001|Allocated to Treatment|Progressive Disease|0|||
106117323|NCT04488003|366087237|FG002|Allocated to Treatment|Progressive Disease|0|||
106117324|NCT04488003|366087235|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
105995132|NCT04752332|365641840|FG001|Overall Study|Disease Relapse|0|||
105995133|NCT04752332|365641839|FG000|Overall Study|Non-compliance With Study Drug|2|||
105995134|NCT04752332|365641840|FG001|Overall Study|Non-compliance With Study Drug|0|||
106117325|NCT04488003|366087236|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
106117326|NCT04488003|366087237|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
106117327|NCT04488003|366087235|FG000|Allocated to Treatment|Adverse Event|6|||
106117328|NCT04488003|366087236|FG001|Allocated to Treatment|Adverse Event|0|||
106117329|NCT04488003|366087237|FG002|Allocated to Treatment|Adverse Event|0|||
106117330|NCT04488003|366087235|FG000|Allocated to Treatment|Other|5|||
106117331|NCT04488003|366087236|FG001|Allocated to Treatment|Other|0|||
106117332|NCT04488003|366087237|FG002|Allocated to Treatment|Other|0|||
106117333|NCT04488003|366087235|FG000|Allocated to Treatment|Physician Decision|4|||
106117334|NCT04488003|366087236|FG001|Allocated to Treatment|Physician Decision|0|||
106117335|NCT04488003|366087237|FG002|Allocated to Treatment|Physician Decision|0|||
106117336|NCT04488003|366087235|FG000|Allocated to Treatment|Death|4|||
106117337|NCT04488003|366087236|FG001|Allocated to Treatment|Death|0|||
106117338|NCT04488003|366087237|FG002|Allocated to Treatment|Death|0|||
106117339|NCT01346514|366087238|FG000|Overall Study|Lost to Follow-up|19|||
106117340|NCT01346514|366087239|FG001|Overall Study|Lost to Follow-up|30|||
106117341|NCT01346514|366087238|FG000|Overall Study|Withdrawal by Subject|7|||
106117342|NCT01346514|366087239|FG001|Overall Study|Withdrawal by Subject|3|||
106117343|NCT01346514|366087238|FG000|Overall Study|Death|3|||
106117344|NCT01346514|366087239|FG001|Overall Study|Death|4|||
106117345|NCT00979602|366087240|FG000|Overall Study|Serious Adverse Event|5|||
106117346|NCT00979602|366087241|FG001|Overall Study|Serious Adverse Event|3|||
106117347|NCT00979602|366087240|FG000|Overall Study|Protocol Violation|3|||
106117348|NCT00979602|366087241|FG001|Overall Study|Protocol Violation|0|||
106117349|NCT00979602|366087240|FG000|Overall Study|Withdrawal by Subject|31|||
106117350|NCT00979602|366087241|FG001|Overall Study|Withdrawal by Subject|25|||
106117351|NCT00979602|366087240|FG000|Overall Study|Lost to Follow-up|100|||
106117352|NCT00979602|366087241|FG001|Overall Study|Lost to Follow-up|96|||
106117353|NCT00979602|366087240|FG000|Overall Study|Migrated/moved from study area|3|||
106117354|NCT00979602|366087241|FG001|Overall Study|Migrated/moved from study area|6|||
106117355|NCT00979602|366087240|FG000|Overall Study|Others|3|||
106117356|NCT00979602|366087241|FG001|Overall Study|Others|3|||
106117357|NCT03500640|366087245|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
106117358|NCT03500640|366087246|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
106117359|NCT03500640|366087247|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
106117360|NCT03500640|366087245|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
106117361|NCT03500640|366087246|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
106117362|NCT03500640|366087247|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
106117363|NCT03500640|366087245|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
106117364|NCT03500640|366087246|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
106117365|NCT03500640|366087247|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
106117366|NCT03500640|366087245|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
106117367|NCT03500640|366087246|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
106117368|NCT03500640|366087247|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
106117369|NCT03500640|366087245|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
106117370|NCT03500640|366087246|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
106117371|NCT03500640|366087247|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
106117372|NCT03500640|366087245|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
106117373|NCT03500640|366087246|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
106117374|NCT03500640|366087247|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
106117375|NCT03500640|366087245|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
106117376|NCT03500640|366087246|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
106117377|NCT03500640|366087247|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
106117378|NCT03500640|366087245|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
106117379|NCT03500640|366087246|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
106117380|NCT03500640|366087247|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
106117381|NCT03500640|366087245|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
106117382|NCT03500640|366087246|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
106117383|NCT03500640|366087247|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
106117384|NCT03500640|366087245|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
106117385|NCT03500640|366087246|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
106117386|NCT03500640|366087247|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
106117387|NCT02513563|366087248|FG000|Overall Study|Death|4|||
106117388|NCT02513563|366087248|FG000|Overall Study|Withdrawal by Subject|4|||
106117389|NCT02513563|366087248|FG000|Overall Study|Physician Decision|1|||
106117390|NCT02521285|366087249|FG000|Overall Study|Lost to Follow-up|1|||
106117391|NCT02521285|366087250|FG001|Overall Study|Lost to Follow-up|1|||
106117392|NCT02521285|366087249|FG000|Overall Study|Withdrawal by Subject|1|||
106117393|NCT02521285|366087250|FG001|Overall Study|Withdrawal by Subject|1|||
106117394|NCT02521285|366087249|FG000|Overall Study|Adverse Event|0|||
106117395|NCT02521285|366087250|FG001|Overall Study|Adverse Event|1|||
106117396|NCT02954458|366087251|FG000|Overall Study|Adverse Event|0|||
106117397|NCT02954458|366087252|FG001|Overall Study|Adverse Event|0|||
106117398|NCT02954458|366087253|FG002|Overall Study|Adverse Event|0|||
106117399|NCT02954458|366087254|FG003|Overall Study|Adverse Event|1|||
106117400|NCT02954458|366087251|FG000|Overall Study|Withdrawal by Subject|0|||
106117401|NCT02954458|366087252|FG001|Overall Study|Withdrawal by Subject|0|||
106117402|NCT02954458|366087253|FG002|Overall Study|Withdrawal by Subject|0|||
106117403|NCT02954458|366087254|FG003|Overall Study|Withdrawal by Subject|1|||
106117404|NCT02954458|366087251|FG000|Overall Study|Physician Decision|0|||
106117405|NCT02954458|366087252|FG001|Overall Study|Physician Decision|0|||
106117406|NCT02954458|366087253|FG002|Overall Study|Physician Decision|1|||
106117407|NCT02954458|366087254|FG003|Overall Study|Physician Decision|1|||
106117408|NCT02954458|366087251|FG000|Overall Study|Lost to Follow-up|1|||
106117409|NCT02954458|366087252|FG001|Overall Study|Lost to Follow-up|0|||
106117410|NCT02954458|366087253|FG002|Overall Study|Lost to Follow-up|0|||
106117411|NCT02954458|366087254|FG003|Overall Study|Lost to Follow-up|1|||
106117412|NCT02954458|366087251|FG000|Overall Study|Death|0|||
106117413|NCT02954458|366087252|FG001|Overall Study|Death|0|||
106117414|NCT02954458|366087253|FG002|Overall Study|Death|0|||
106117415|NCT02954458|366087254|FG003|Overall Study|Death|1|||
106117416|NCT02954458|366087251|FG000|Overall Study|Other|0|||
106117417|NCT02954458|366087252|FG001|Overall Study|Other|0|||
106117418|NCT02954458|366087253|FG002|Overall Study|Other|0|||
106117419|NCT02954458|366087254|FG003|Overall Study|Other|7|||
106117420|NCT02204579|366087256|FG000|Overall Study|Screen failures|2|||
106117421|NCT02213328|366087259|FG000|Overall Study|Withdrawal by Subject|10|||
106117422|NCT02213328|366087259|FG000|Overall Study|Physician Decision|2|||
106117423|NCT02213328|366087259|FG000|Overall Study|Lost to Follow-up|16|||
106117424|NCT01686581|366087264|FG000|Overall Study|Side-effects or Health Problems|15|||
106117425|NCT01686581|366087264|FG000|Overall Study|Lack of Efficacy|90|||
106117426|NCT01686581|366087264|FG000|Overall Study|Participant Concerned about Risks|6|||
106117427|NCT01686581|366087264|FG000|Overall Study|Thinks Injections Too Painful|8|||
106117428|NCT01686581|366087264|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
106117429|NCT01686581|366087264|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
106117430|NCT01686581|366087264|FG000|Overall Study|Thinks it is Inconvenient|17|||
106117431|NCT01686581|366087264|FG000|Overall Study|Other Miscellaneous Reasons|36|||
106117432|NCT01686581|366087264|FG000|Overall Study|Reason Missing|1|||
106117433|NCT02965703|366087265|FG000|Overall Study|Withdrawal by Subject|6|||
106117434|NCT02965703|366087266|FG001|Overall Study|Withdrawal by Subject|3|||
106117435|NCT02965703|366087267|FG002|Overall Study|Withdrawal by Subject|1|||
106117436|NCT02965703|366087265|FG000|Overall Study|Protocol Violation|1|||
106117437|NCT02965703|366087266|FG001|Overall Study|Protocol Violation|0|||
106117438|NCT02965703|366087267|FG002|Overall Study|Protocol Violation|0|||
106117439|NCT02965703|366087265|FG000|Overall Study|Adverse Event|1|||
106117440|NCT02965703|366087266|FG001|Overall Study|Adverse Event|1|||
106117441|NCT02965703|366087267|FG002|Overall Study|Adverse Event|0|||
106117442|NCT02965703|366087265|FG000|Overall Study|Lost to Follow-up|2|||
106117443|NCT02965703|366087266|FG001|Overall Study|Lost to Follow-up|1|||
106117444|NCT02965703|366087267|FG002|Overall Study|Lost to Follow-up|1|||
106117445|NCT00856661|366087268|FG000|Overall Study|Death|15|||
106117446|NCT00856661|366087269|FG001|Overall Study|Death|18|||
106117447|NCT00856661|366087268|FG000|Overall Study|Protocol Violation|2|||
106117448|NCT00856661|366087269|FG001|Overall Study|Protocol Violation|1|||
106117449|NCT00856661|366087268|FG000|Overall Study|Withdrawal by Subject|1|||
106117450|NCT00856661|366087269|FG001|Overall Study|Withdrawal by Subject|2|||
106117451|NCT00856661|366087268|FG000|Overall Study|Lost to Follow-up|1|||
106117452|NCT00856661|366087269|FG001|Overall Study|Lost to Follow-up|3|||
106117453|NCT00856661|366087268|FG000|Overall Study|Physician Judgement|8|||
106117454|NCT00856661|366087269|FG001|Overall Study|Physician Judgement|5|||
106117455|NCT01279343|366087270|FG000|Overall Study|Did not receive treatment|2|||
106117456|NCT01279343|366087271|FG001|Overall Study|Did not receive treatment|6|||
106117457|NCT02759185|366087272|FG000|Stage 1|Adverse Event|0|||
106117458|NCT02759185|366087273|FG001|Stage 1|Adverse Event|1|||
106117459|NCT02759185|366087274|FG002|Stage 1|Adverse Event|3|||
106117460|NCT02759185|366087275|FG003|Stage 1|Adverse Event|0|||
106117461|NCT02759185|366087276|FG004|Stage 1|Adverse Event|0|||
106117462|NCT02759185|366087277|FG005|Stage 1|Adverse Event|0|||
106117463|NCT02759185|366087278|FG006|Stage 1|Adverse Event|0|||
106117464|NCT02759185|366087272|FG000|Stage 1|Withdrawal by Subject|1|||
106117465|NCT02759185|366087273|FG001|Stage 1|Withdrawal by Subject|0|||
106117466|NCT02759185|366087274|FG002|Stage 1|Withdrawal by Subject|0|||
106117467|NCT02759185|366087275|FG003|Stage 1|Withdrawal by Subject|0|||
106117468|NCT02759185|366087276|FG004|Stage 1|Withdrawal by Subject|0|||
106117469|NCT02759185|366087277|FG005|Stage 1|Withdrawal by Subject|0|||
106117470|NCT02759185|366087278|FG006|Stage 1|Withdrawal by Subject|0|||
106117471|NCT02759185|366087272|FG000|Stage 2|Adverse Event|0|||
106117472|NCT02759185|366087273|FG001|Stage 2|Adverse Event|0|||
106117473|NCT02759185|366087274|FG002|Stage 2|Adverse Event|0|||
106117474|NCT02759185|366087275|FG003|Stage 2|Adverse Event|0|||
106117475|NCT02759185|366087276|FG004|Stage 2|Adverse Event|1|||
106117476|NCT02759185|366087277|FG005|Stage 2|Adverse Event|2|||
106117477|NCT02759185|366087278|FG006|Stage 2|Adverse Event|0|||
106117478|NCT02759185|366087272|FG000|Stage 2|Withdrawal by Subject|0|||
106117479|NCT02759185|366087273|FG001|Stage 2|Withdrawal by Subject|0|||
106117480|NCT02759185|366087274|FG002|Stage 2|Withdrawal by Subject|0|||
106117481|NCT02759185|366087275|FG003|Stage 2|Withdrawal by Subject|0|||
105661762|NCT03569891|364425134|FG000|Lead-in|Withdrawal by Subject|3|||
105661763|NCT03569891|364425134|FG000|Lead-in|Risks related to COVID-19|2|||
105661764|NCT03569891|364425134|FG000|AMT-061|Adverse Event|1|||
105661765|NCT03023423|364425138|FG000|Overall Study|Death|5|||
105661766|NCT03023423|364425139|FG001|Overall Study|Death|12|||
105661767|NCT03023423|364425140|FG002|Overall Study|Death|20|||
105661768|NCT03023423|364425138|FG000|Overall Study|Other|0|||
105661769|NCT03023423|364425139|FG001|Overall Study|Other|2|||
105661770|NCT03023423|364425140|FG002|Overall Study|Other|2|||
105661771|NCT03023423|364425138|FG000|Overall Study|Ongoing|2|||
105661772|NCT03023423|364425139|FG001|Overall Study|Ongoing|32|||
105661773|NCT03023423|364425140|FG002|Overall Study|Ongoing|24|||
105661774|NCT03371823|364425141|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
105661775|NCT03371823|364425142|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
106117482|NCT02759185|366087276|FG004|Stage 2|Withdrawal by Subject|1|||
106117483|NCT02759185|366087277|FG005|Stage 2|Withdrawal by Subject|1|||
106117484|NCT02759185|366087278|FG006|Stage 2|Withdrawal by Subject|1|||
106117485|NCT03916744|366087279|FG000|Overall Study|Withdrawal by Subject|0|||
106117486|NCT03916744|366087280|FG001|Overall Study|Withdrawal by Subject|1|||
106117487|NCT03916744|366087281|FG002|Overall Study|Withdrawal by Subject|2|||
106117488|NCT02223754|366087284|FG000|Period 1|Adverse Event|1|||
106117489|NCT02223754|366087285|FG001|Period 1|Adverse Event|0|||
106117490|NCT02223754|366087284|FG000|Period 1|Lost to Follow-up|0|||
106117491|NCT02223754|366087285|FG001|Period 1|Lost to Follow-up|1|||
106117492|NCT02223754|366087284|FG000|Period 1|Protocol Violation|2|||
106117493|NCT02223754|366087285|FG001|Period 1|Protocol Violation|4|||
106117494|NCT02223754|366087284|FG000|Period 1|Withdrawal by Subject|0|||
106117495|NCT02223754|366087285|FG001|Period 1|Withdrawal by Subject|4|||
106117496|NCT02223754|366087284|FG000|Period 1|Test Article No Longer Available|1|||
106117497|NCT02223754|366087285|FG001|Period 1|Test Article No Longer Available|5|||
106117498|NCT02223754|366087284|FG000|Period 1|Unsatisfactory Visual Response|0|||
106117499|NCT02223754|366087285|FG001|Period 1|Unsatisfactory Visual Response|1|||
106117500|NCT02223754|366087284|FG000|Period 2|Adverse Event|0|||
106117501|NCT02223754|366087285|FG001|Period 2|Adverse Event|1|||
106117502|NCT02223754|366087284|FG000|Period 2|Protocol Violation|1|||
106117503|NCT02223754|366087285|FG001|Period 2|Protocol Violation|0|||
106117504|NCT02223754|366087284|FG000|Period 2|Lens Discomfort|1|||
106117505|NCT02223754|366087285|FG001|Period 2|Lens Discomfort|1|||
106117506|NCT02223754|366087284|FG000|Period 2|Lost to Follow-up|1|||
106117507|NCT02223754|366087285|FG001|Period 2|Lost to Follow-up|0|||
105887049|NCT02244463|365241782|FG003|Period 5: Phase II|Intercurrent Illness|0|||
106117508|NCT02223754|366087284|FG000|Period 2|Test Article No Longer Available|0|||
106117509|NCT02223754|366087285|FG001|Period 2|Test Article No Longer Available|1|||
106117510|NCT03176238|366087289|FG000|Overall Study|Unacceptable AEs|15|||
106117511|NCT03176238|366087290|FG001|Overall Study|Unacceptable AEs|8|||
106117512|NCT03176238|366087289|FG000|Overall Study|Abnormal lab value(s)|2|||
106117513|NCT03176238|366087290|FG001|Overall Study|Abnormal lab value(s)|0|||
106117514|NCT03176238|366087289|FG000|Overall Study|Inter-current illness|0|||
106117515|NCT03176238|366087290|FG001|Overall Study|Inter-current illness|1|||
106117516|NCT03176238|366087289|FG000|Overall Study|Consent withdrawal|14|||
106117517|NCT03176238|366087290|FG001|Overall Study|Consent withdrawal|2|||
106117518|NCT03176238|366087289|FG000|Overall Study|Lost to Follow-up|3|||
106117519|NCT03176238|366087290|FG001|Overall Study|Lost to Follow-up|0|||
106117520|NCT03176238|366087289|FG000|Overall Study|Administrative problems|1|||
106117521|NCT03176238|366087290|FG001|Overall Study|Administrative problems|0|||
106117522|NCT03176238|366087289|FG000|Overall Study|Death|3|||
106117523|NCT03176238|366087290|FG001|Overall Study|Death|0|||
106117524|NCT03176238|366087289|FG000|Overall Study|Disease Progression|133|||
106117525|NCT03176238|366087290|FG001|Overall Study|Disease Progression|22|||
106117526|NCT03176238|366087289|FG000|Overall Study|Tx duration completed per EAP|0|||
106117527|NCT03176238|366087290|FG001|Overall Study|Tx duration completed per EAP|1|||
106117528|NCT03176238|366087289|FG000|Overall Study|Patient is switched to commercial drug|16|||
106117529|NCT03176238|366087290|FG001|Overall Study|Patient is switched to commercial drug|1|||
106117530|NCT03176238|366087289|FG000|Overall Study|Protocol Violation|1|||
106117531|NCT03176238|366087290|FG001|Overall Study|Protocol Violation|0|||
106117532|NCT03176238|366087289|FG000|Overall Study|Changes in the patient's condition|2|||
106117533|NCT03176238|366087290|FG001|Overall Study|Changes in the patient's condition|1|||
106117534|NCT03176238|366087289|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
106117535|NCT03176238|366087290|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
106117536|NCT04524598|366087293|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
106117537|NCT04524598|366087294|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
106117538|NCT04524598|366087295|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
105661776|NCT01466790|364425145|FG000|Overall Study|Adverse Event|1|||
105661777|NCT01466790|364425146|FG001|Overall Study|Adverse Event|0|||
105661778|NCT01466790|364425147|FG002|Overall Study|Adverse Event|0|||
105661779|NCT01466790|364425148|FG003|Overall Study|Adverse Event|0|||
106117539|NCT04524598|366087296|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
106117540|NCT04524598|366087297|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
106144091|NCT01317420|366186949|FG000|Overall Study|Non-compliant with protocol|0|||
105661780|NCT01466790|364425149|FG004|Overall Study|Adverse Event|2|||
105661781|NCT01466790|364425150|FG005|Overall Study|Adverse Event|0|||
105661782|NCT01466790|364425151|FG006|Overall Study|Adverse Event|0|||
106117541|NCT04524598|366087293|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
106117542|NCT04524598|366087294|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
106117543|NCT04524598|366087295|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117544|NCT04524598|366087296|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117545|NCT04524598|366087297|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117546|NCT04524598|366087293|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
106117547|NCT04524598|366087294|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
106117548|NCT04524598|366087295|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
106117549|NCT04524598|366087296|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
106117550|NCT04524598|366087297|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
106117551|NCT04524598|366087293|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
106117552|NCT04524598|366087294|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
106117553|NCT04524598|366087295|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
106117554|NCT04524598|366087296|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
106117555|NCT04524598|366087297|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
106117556|NCT04524598|366087293|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117557|NCT04524598|366087294|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117558|NCT04524598|366087295|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
106117559|NCT04524598|366087296|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
106117560|NCT04524598|366087297|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117561|NCT04524598|366087293|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
106117562|NCT04524598|366087294|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
106117563|NCT04524598|366087295|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
106117564|NCT04524598|366087296|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
106117565|NCT04524598|366087297|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
106117566|NCT04524598|366087293|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117567|NCT04524598|366087294|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117568|NCT04524598|366087295|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117569|NCT04524598|366087296|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
106117570|NCT04524598|366087297|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
106117571|NCT04395183|366087298|FG000|Overall Study|Withdrawal by Subject|1|||
106117572|NCT04395183|366087299|FG001|Overall Study|Withdrawal by Subject|0|||
106117573|NCT04395183|366087300|FG002|Overall Study|Withdrawal by Subject|2|||
106117574|NCT04395183|366087301|FG003|Overall Study|Withdrawal by Subject|2|||
106117575|NCT01008475|366087302|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
106117576|NCT01008475|366087303|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
106117577|NCT01008475|366087304|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
106117578|NCT01008475|366087305|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
106117579|NCT01008475|366087306|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
106117580|NCT01008475|366087307|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
106117581|NCT01008475|366087308|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
106117582|NCT04182880|366087309|FG000|Overall Study|Pregnancy|1|||
106117583|NCT04182880|366087310|FG001|Overall Study|Pregnancy|0|||
106117584|NCT02716038|366087311|FG000|Overall Study|Not evaluable|1|||
106117585|NCT02716038|366087311|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
106117586|NCT02716038|366087311|FG000|Overall Study|Unresectable|3|||
106117587|NCT04152343|366087312|FG000|Overall Study|Transplanted|5|||
106117588|NCT04152343|366087312|FG000|Overall Study|Death|20|||
106117589|NCT04152343|366087312|FG000|Overall Study|Lost to Follow-up|3|||
106117590|NCT00550550|366087313|FG000|Overall Study|Adverse Event|13|||
106117591|NCT00550550|366087314|FG001|Overall Study|Adverse Event|5|||
106117592|NCT00550550|366087313|FG000|Overall Study|Treatment Failure|0|||
106117593|NCT00550550|366087314|FG001|Overall Study|Treatment Failure|1|||
106117594|NCT00550550|366087313|FG000|Overall Study|Lost to Follow-up|4|||
106117595|NCT00550550|366087314|FG001|Overall Study|Lost to Follow-up|0|||
106117596|NCT00550550|366087313|FG000|Overall Study|Withdrawal by Subject|10|||
106117597|NCT00550550|366087314|FG001|Overall Study|Withdrawal by Subject|8|||
106117598|NCT00550550|366087313|FG000|Overall Study|Protocol Violation|5|||
106117599|NCT00550550|366087314|FG001|Overall Study|Protocol Violation|14|||
106117600|NCT00550550|366087313|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
106117601|NCT00550550|366087314|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
106117602|NCT00550550|366087313|FG000|Overall Study|Randomized But Not Treated|1|||
106117603|NCT00550550|366087314|FG001|Overall Study|Randomized But Not Treated|0|||
106117604|NCT01965938|366087319|FG000|Overall Study|Withdrawal by Subject|1|||
105661783|NCT01466790|364425152|FG007|Overall Study|Adverse Event|0|||
106117605|NCT01965938|366087320|FG001|Overall Study|Withdrawal by Subject|0|||
106117606|NCT01164228|366087321|FG000|Overall Study|Progression|24|||
106117607|NCT01164228|366087322|FG001|Overall Study|Progression|25|||
106117608|NCT01164228|366087321|FG000|Overall Study|Adverse Event|13|||
106117609|NCT01164228|366087322|FG001|Overall Study|Adverse Event|7|||
106117610|NCT01164228|366087321|FG000|Overall Study|Death|1|||
106117611|NCT01164228|366087322|FG001|Overall Study|Death|1|||
106117612|NCT01164228|366087321|FG000|Overall Study|Withdrawal by Subject|2|||
106117613|NCT01164228|366087322|FG001|Overall Study|Withdrawal by Subject|0|||
106117614|NCT01164228|366087321|FG000|Overall Study|Physician Decision|1|||
106117615|NCT01164228|366087322|FG001|Overall Study|Physician Decision|2|||
106117616|NCT01164228|366087321|FG000|Overall Study|Symptomatic deterioration|1|||
106117617|NCT01164228|366087322|FG001|Overall Study|Symptomatic deterioration|0|||
106117618|NCT01164228|366087321|FG000|Overall Study|Never started treatment|1|||
106117619|NCT01164228|366087322|FG001|Overall Study|Never started treatment|3|||
106117620|NCT01164228|366087321|FG000|Overall Study|Ineligible|1|||
106117621|NCT01164228|366087322|FG001|Overall Study|Ineligible|0|||
106117622|NCT01709305|366087327|FG000|Phase 1|Clinical Adverse Event|80|||
106117623|NCT01709305|366087328|FG001|Phase 1|Clinical Adverse Event|0|||
106117624|NCT01709305|366087329|FG002|Phase 1|Clinical Adverse Event|0|||
106117625|NCT01709305|366087330|FG003|Phase 1|Clinical Adverse Event|0|||
106117626|NCT01709305|366087331|FG004|Phase 1|Clinical Adverse Event|0|||
106117627|NCT01709305|366087327|FG000|Phase 1|Death|2|||
106117628|NCT01709305|366087328|FG001|Phase 1|Death|0|||
106117629|NCT01709305|366087329|FG002|Phase 1|Death|0|||
106117630|NCT01709305|366087330|FG003|Phase 1|Death|0|||
106117631|NCT01709305|366087331|FG004|Phase 1|Death|0|||
106117632|NCT01709305|366087327|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
106117633|NCT01709305|366087328|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
106117634|NCT01709305|366087329|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
106117635|NCT01709305|366087330|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
106117636|NCT01709305|366087331|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
106117637|NCT01709305|366087327|FG000|Phase 1|Laboratory Adverse Event|16|||
106117638|NCT01709305|366087328|FG001|Phase 1|Laboratory Adverse Event|0|||
106117639|NCT01709305|366087329|FG002|Phase 1|Laboratory Adverse Event|0|||
106117640|NCT01709305|366087330|FG003|Phase 1|Laboratory Adverse Event|0|||
106117641|NCT01709305|366087331|FG004|Phase 1|Laboratory Adverse Event|0|||
106117642|NCT01709305|366087327|FG000|Phase 1|Lost to Follow-up|147|||
106117643|NCT01709305|366087328|FG001|Phase 1|Lost to Follow-up|0|||
106117644|NCT01709305|366087329|FG002|Phase 1|Lost to Follow-up|0|||
106117645|NCT01709305|366087330|FG003|Phase 1|Lost to Follow-up|0|||
106117646|NCT01709305|366087331|FG004|Phase 1|Lost to Follow-up|0|||
106117647|NCT01709305|366087327|FG000|Phase 1|Travel, moving, etc.|30|||
106117648|NCT01709305|366087328|FG001|Phase 1|Travel, moving, etc.|0|||
106117649|NCT01709305|366087329|FG002|Phase 1|Travel, moving, etc.|0|||
106117650|NCT01709305|366087330|FG003|Phase 1|Travel, moving, etc.|0|||
106117651|NCT01709305|366087331|FG004|Phase 1|Travel, moving, etc.|0|||
106117652|NCT01709305|366087327|FG000|Phase 1|Physician Decision|13|||
106117653|NCT01709305|366087328|FG001|Phase 1|Physician Decision|0|||
106117654|NCT01709305|366087329|FG002|Phase 1|Physician Decision|0|||
106117655|NCT01709305|366087330|FG003|Phase 1|Physician Decision|0|||
106117656|NCT01709305|366087331|FG004|Phase 1|Physician Decision|0|||
106117657|NCT01709305|366087327|FG000|Phase 1|Protocol Violation|118|||
106117658|NCT01709305|366087328|FG001|Phase 1|Protocol Violation|0|||
106117659|NCT01709305|366087329|FG002|Phase 1|Protocol Violation|0|||
106117660|NCT01709305|366087330|FG003|Phase 1|Protocol Violation|0|||
106117661|NCT01709305|366087331|FG004|Phase 1|Protocol Violation|0|||
106117662|NCT01709305|366087327|FG000|Phase 1|Withdrawal by Subject|218|||
106117663|NCT01709305|366087328|FG001|Phase 1|Withdrawal by Subject|0|||
106117664|NCT01709305|366087329|FG002|Phase 1|Withdrawal by Subject|0|||
106117665|NCT01709305|366087330|FG003|Phase 1|Withdrawal by Subject|0|||
106117666|NCT01709305|366087331|FG004|Phase 1|Withdrawal by Subject|0|||
106117667|NCT01709305|366087327|FG000|Phase 2|Clinical Adverse Event|0|||
106117668|NCT01709305|366087328|FG001|Phase 2|Clinical Adverse Event|10|||
106117669|NCT01709305|366087329|FG002|Phase 2|Clinical Adverse Event|10|||
106117670|NCT01709305|366087330|FG003|Phase 2|Clinical Adverse Event|6|||
106117671|NCT01709305|366087331|FG004|Phase 2|Clinical Adverse Event|11|||
106117672|NCT01709305|366087327|FG000|Phase 2|Death|0|||
106117673|NCT01709305|366087328|FG001|Phase 2|Death|0|||
106117674|NCT01709305|366087329|FG002|Phase 2|Death|1|||
106117675|NCT01709305|366087330|FG003|Phase 2|Death|0|||
106117676|NCT01709305|366087331|FG004|Phase 2|Death|0|||
106117677|NCT01709305|366087327|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
106117678|NCT01709305|366087328|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
106117679|NCT01709305|366087329|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
106117680|NCT01709305|366087330|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
106117681|NCT01709305|366087331|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
106117682|NCT01709305|366087327|FG000|Phase 2|Laboratory Adverse Event|0|||
106117683|NCT01709305|366087328|FG001|Phase 2|Laboratory Adverse Event|1|||
106117684|NCT01709305|366087329|FG002|Phase 2|Laboratory Adverse Event|0|||
106117685|NCT01709305|366087330|FG003|Phase 2|Laboratory Adverse Event|1|||
106117686|NCT01709305|366087331|FG004|Phase 2|Laboratory Adverse Event|1|||
105661784|NCT01466790|364425145|FG000|Overall Study|Lost to Follow-up|2|||
105661785|NCT01466790|364425146|FG001|Overall Study|Lost to Follow-up|0|||
105661786|NCT01466790|364425147|FG002|Overall Study|Lost to Follow-up|0|||
105661787|NCT01466790|364425148|FG003|Overall Study|Lost to Follow-up|0|||
105661788|NCT01466790|364425149|FG004|Overall Study|Lost to Follow-up|0|||
105661789|NCT01466790|364425150|FG005|Overall Study|Lost to Follow-up|0|||
105661790|NCT01466790|364425151|FG006|Overall Study|Lost to Follow-up|0|||
105661791|NCT01466790|364425152|FG007|Overall Study|Lost to Follow-up|0|||
105661792|NCT01466790|364425145|FG000|Overall Study|Withdrawal by Subject|1|||
105661793|NCT01466790|364425146|FG001|Overall Study|Withdrawal by Subject|1|||
105661794|NCT01466790|364425147|FG002|Overall Study|Withdrawal by Subject|0|||
105661795|NCT01466790|364425148|FG003|Overall Study|Withdrawal by Subject|0|||
105661796|NCT01466790|364425149|FG004|Overall Study|Withdrawal by Subject|1|||
105661797|NCT01466790|364425150|FG005|Overall Study|Withdrawal by Subject|0|||
105661798|NCT01466790|364425151|FG006|Overall Study|Withdrawal by Subject|1|||
105661799|NCT01466790|364425152|FG007|Overall Study|Withdrawal by Subject|1|||
105661800|NCT01263054|364425156|FG000|Overall Study|Death|1|||
105661801|NCT01263054|364425157|FG001|Overall Study|Death|0|||
105661802|NCT01263054|364425156|FG000|Overall Study|Lost to Follow-up|2|||
105661803|NCT01263054|364425157|FG001|Overall Study|Lost to Follow-up|2|||
105661804|NCT01263054|364425156|FG000|Overall Study|Withdrawal by Subject|1|||
105661805|NCT01263054|364425157|FG001|Overall Study|Withdrawal by Subject|3|||
105661806|NCT01263054|364425156|FG000|Overall Study|Qualification Violation|1|||
105661807|NCT01263054|364425157|FG001|Overall Study|Qualification Violation|0|||
105661808|NCT01263054|364425156|FG000|Overall Study|Other|0|||
105661809|NCT01263054|364425157|FG001|Overall Study|Other|1|||
105661810|NCT02242643|364425158|FG000|Overall Study|Protocol Violation|1|||
105661811|NCT02242643|364425159|FG001|Overall Study|Protocol Violation|2|||
105661812|NCT02242643|364425158|FG000|Overall Study|Withdrawal by Subject|15|||
105661813|NCT02242643|364425159|FG001|Overall Study|Withdrawal by Subject|10|||
105661814|NCT02242643|364425158|FG000|Overall Study|Migrated/moved from study area|1|||
105661815|NCT02242643|364425159|FG001|Overall Study|Migrated/moved from study area|3|||
105661816|NCT02242643|364425158|FG000|Overall Study|Lost to Follow-up|54|||
105661817|NCT02242643|364425159|FG001|Overall Study|Lost to Follow-up|61|||
105661818|NCT02242643|364425158|FG000|Overall Study|Child placed in foster care by family|0|||
105661819|NCT02242643|364425159|FG001|Overall Study|Child placed in foster care by family|1|||
105661820|NCT02242643|364425158|FG000|Overall Study|Non-compliance|1|||
105661821|NCT02242643|364425159|FG001|Overall Study|Non-compliance|0|||
105661822|NCT02242643|364425158|FG000|Overall Study|Consent withdrawal by parent|1|||
105661823|NCT02242643|364425159|FG001|Overall Study|Consent withdrawal by parent|0|||
105661824|NCT02242643|364425158|FG000|Overall Study|Protocol requirements not followed|1|||
105661825|NCT02242643|364425159|FG001|Overall Study|Protocol requirements not followed|0|||
105661826|NCT02242643|364425158|FG000|Overall Study|Language barrier|1|||
105661827|NCT02242643|364425159|FG001|Overall Study|Language barrier|0|||
105661828|NCT02242643|364425158|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
105661829|NCT02242643|364425159|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
105661830|NCT05093504|364425162|FG000|Overall Study|Death|0|||
105661831|NCT05093504|364425163|FG001|Overall Study|Death|1|||
105661832|NCT06385483|364425164|FG000|Overall Study|Withdrawal by Subject|2|||
105661833|NCT06385483|364425164|FG000|Overall Study|Never start protocol therapy|2|||
105661834|NCT06385483|364425164|FG000|Overall Study|Disease progression|15|||
105661835|NCT04535544|364425166|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
105661836|NCT04535544|364425167|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
105661837|NCT04535544|364425168|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
105661838|NCT04535544|364425169|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
105661839|NCT04535544|364425166|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
105661840|NCT04535544|364425167|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
105661841|NCT04535544|364425168|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
105661842|NCT04535544|364425169|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
105661843|NCT04535544|364425166|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
105661844|NCT04535544|364425167|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
105661845|NCT04535544|364425168|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
105661846|NCT04535544|364425169|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
105661847|NCT04535544|364425166|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
105661848|NCT04535544|364425167|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
106117687|NCT01709305|366087327|FG000|Phase 2|Lost to Follow-up|0|||
105661849|NCT04535544|364425168|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
105661850|NCT04535544|364425169|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
105661851|NCT04535544|364425166|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
105661852|NCT04535544|364425167|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
105661853|NCT04535544|364425168|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
105661854|NCT04535544|364425169|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
105661855|NCT04535544|364425166|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
105661856|NCT04535544|364425167|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
105661857|NCT04535544|364425168|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
105661858|NCT04535544|364425169|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
105661859|NCT04535544|364425166|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
105661860|NCT04535544|364425167|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
105661861|NCT04535544|364425168|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
105661862|NCT04535544|364425169|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
105661863|NCT04535544|364425166|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
105661864|NCT04535544|364425167|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
105661865|NCT04535544|364425168|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
105661866|NCT04535544|364425169|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
105661867|NCT00344032|364425170|FG000|Overall Study|Adverse Event|0|||
105661868|NCT00344032|364425171|FG001|Overall Study|Adverse Event|1|||
105661869|NCT00344032|364425170|FG000|Overall Study|Withdrawal by Subject|6|||
105661870|NCT00344032|364425171|FG001|Overall Study|Withdrawal by Subject|2|||
105661871|NCT00344032|364425170|FG000|Overall Study|Lost to Follow-up|4|||
105661872|NCT00344032|364425171|FG001|Overall Study|Lost to Follow-up|6|||
105661873|NCT00344032|364425170|FG000|Overall Study|Physician Decision|4|||
105661874|NCT00344032|364425171|FG001|Overall Study|Physician Decision|1|||
105661875|NCT01124838|364425176|FG000|Overall Study|Miscellaneous|4|||
105661876|NCT01124838|364425177|FG001|Overall Study|Miscellaneous|2|||
105661877|NCT01124838|364425176|FG000|Overall Study|Adverse Event|7|||
105661878|NCT01124838|364425177|FG001|Overall Study|Adverse Event|11|||
105661879|NCT01124838|364425176|FG000|Overall Study|Lack of Efficacy|2|||
105661880|NCT01124838|364425177|FG001|Overall Study|Lack of Efficacy|0|||
105661881|NCT01124838|364425176|FG000|Overall Study|Withdrawal by Subject|3|||
105661882|NCT01124838|364425177|FG001|Overall Study|Withdrawal by Subject|2|||
105661883|NCT01124838|364425176|FG000|Overall Study|Lost to Follow-up|2|||
105661884|NCT01124838|364425177|FG001|Overall Study|Lost to Follow-up|0|||
105661885|NCT04297618|364425180|FG000|Overall Study|Adverse Event|1|||
105661886|NCT04297618|364425180|FG000|Overall Study|Withdrawal by Subject|1|||
105661887|NCT02104505|364426787|FG000|First Intervention (14 Days)|Adverse Event|2|||
105661888|NCT02104505|364426788|FG001|First Intervention (14 Days)|Adverse Event|0|||
105661889|NCT02104505|364426787|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
105661890|NCT02104505|364426788|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
105661891|NCT02104505|364426787|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
105661892|NCT02104505|364426788|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
105661893|NCT02104505|364426787|FG000|First Intervention (14 Days)|exclusionary condition|0|||
105661894|NCT02104505|364426788|FG001|First Intervention (14 Days)|exclusionary condition|1|||
105661895|NCT02104505|364426787|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
105661896|NCT02104505|364426788|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
105661897|NCT02104505|364426787|FG000|Second Intervention (14 Days)|Adverse Event|2|||
105661898|NCT02104505|364426788|FG001|Second Intervention (14 Days)|Adverse Event|0|||
105661899|NCT01845805|364426789|FG000|Overall Study|Withdrawal by Subject|1|||
105661900|NCT01845805|364426790|FG001|Overall Study|Withdrawal by Subject|2|||
105661901|NCT01845805|364426789|FG000|Overall Study|Disease Progression|13|||
105661902|NCT01845805|364426790|FG001|Overall Study|Disease Progression|14|||
105661903|NCT01845805|364426789|FG000|Overall Study|Drug-related Toxicity|4|||
105661904|NCT01845805|364426790|FG001|Overall Study|Drug-related Toxicity|0|||
105661905|NCT02366143|364426793|FG000|Overall Study|Death|307|||
105661906|NCT02366143|364426794|FG001|Overall Study|Death|278|||
105661907|NCT02366143|364426795|FG002|Overall Study|Death|280|||
105661908|NCT02366143|364426793|FG000|Overall Study|Lost to Follow-up|2|||
105661909|NCT02366143|364426794|FG001|Overall Study|Lost to Follow-up|4|||
105661910|NCT02366143|364426795|FG002|Overall Study|Lost to Follow-up|2|||
105661911|NCT02366143|364426793|FG000|Overall Study|Physician Decision|1|||
105661912|NCT02366143|364426794|FG001|Overall Study|Physician Decision|2|||
105661913|NCT02366143|364426795|FG002|Overall Study|Physician Decision|1|||
105661914|NCT02366143|364426793|FG000|Overall Study|Protocol Violation|0|||
105661915|NCT02366143|364426794|FG001|Overall Study|Protocol Violation|0|||
105661916|NCT02366143|364426795|FG002|Overall Study|Protocol Violation|2|||
105661917|NCT02366143|364426793|FG000|Overall Study|Withdrawal by Subject|16|||
105661918|NCT02366143|364426794|FG001|Overall Study|Withdrawal by Subject|17|||
105661919|NCT02366143|364426795|FG002|Overall Study|Withdrawal by Subject|22|||
105661920|NCT02366143|364426793|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
105661921|NCT02366143|364426794|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
105661922|NCT02366143|364426795|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
105661923|NCT02366143|364426793|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
105661924|NCT02366143|364426794|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
105661925|NCT02366143|364426795|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
106117688|NCT01709305|366087328|FG001|Phase 2|Lost to Follow-up|10|||
105661926|NCT02366143|364426793|FG000|Overall Study|Randomization Error|1|||
105661927|NCT02366143|364426794|FG001|Overall Study|Randomization Error|0|||
105661928|NCT02366143|364426795|FG002|Overall Study|Randomization Error|0|||
105661929|NCT02366143|364426793|FG000|Overall Study|PI Move and Site Closure|1|||
105661930|NCT02366143|364426794|FG001|Overall Study|PI Move and Site Closure|0|||
105995135|NCT04752332|365641839|FG000|Overall Study|Physician Decision|2|||
105995136|NCT04752332|365641840|FG001|Overall Study|Physician Decision|1|||
105995137|NCT04752332|365641839|FG000|Overall Study|Protocol Violation|1|||
105995138|NCT04752332|365641840|FG001|Overall Study|Protocol Violation|1|||
105995139|NCT04752332|365641839|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
106117689|NCT01709305|366087329|FG002|Phase 2|Lost to Follow-up|6|||
106117690|NCT01709305|366087330|FG003|Phase 2|Lost to Follow-up|9|||
106117691|NCT01709305|366087331|FG004|Phase 2|Lost to Follow-up|5|||
106117692|NCT01709305|366087327|FG000|Phase 2|Travel, moving, etc.|0|||
105661931|NCT02366143|364426795|FG002|Overall Study|PI Move and Site Closure|1|||
105661932|NCT02366143|364426793|FG000|Overall Study|Study Terminated By Sponsor|0|||
105661933|NCT02366143|364426794|FG001|Overall Study|Study Terminated By Sponsor|0|||
105661934|NCT02366143|364426795|FG002|Overall Study|Study Terminated By Sponsor|2|||
105661935|NCT02366143|364426793|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
105661936|NCT02366143|364426794|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
105661937|NCT02366143|364426795|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
105661938|NCT02366143|364426793|FG000|Overall Study|Patient moved to roll-over study|1|||
105661939|NCT02366143|364426794|FG001|Overall Study|Patient moved to roll-over study|19|||
105661940|NCT02366143|364426795|FG002|Overall Study|Patient moved to roll-over study|28|||
105661941|NCT02366143|364426793|FG000|Overall Study|Patient moved to commercial stock|0|||
105661942|NCT02366143|364426794|FG001|Overall Study|Patient moved to commercial stock|0|||
105661943|NCT02366143|364426795|FG002|Overall Study|Patient moved to commercial stock|1|||
105661944|NCT02366143|364426793|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
105661945|NCT02366143|364426794|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
105661946|NCT02366143|364426795|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
105661947|NCT02366143|364426793|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
105661948|NCT02366143|364426794|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
105661949|NCT02366143|364426795|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
105661950|NCT02366143|364426793|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
105661951|NCT02366143|364426794|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
105661952|NCT02366143|364426795|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
105661953|NCT02366143|364426793|FG000|Overall Study|Requester's instructions|1|||
105661954|NCT02366143|364426794|FG001|Overall Study|Requester's instructions|1|||
105661955|NCT02366143|364426795|FG002|Overall Study|Requester's instructions|1|||
105661956|NCT02366143|364426793|FG000|Overall Study|Uneligible|0|||
105661957|NCT02366143|364426794|FG001|Overall Study|Uneligible|1|||
105661958|NCT02366143|364426795|FG002|Overall Study|Uneligible|0|||
105661959|NCT02366143|364426793|FG000|Overall Study|Post Trial Migration|0|||
105661960|NCT02366143|364426794|FG001|Overall Study|Post Trial Migration|1|||
105661961|NCT02366143|364426795|FG002|Overall Study|Post Trial Migration|0|||
105661962|NCT02366143|364426793|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
105995140|NCT04752332|365641840|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
105995141|NCT04752332|365641839|FG000|Overall Study|Study Terminated by Sponsor|10|||
106117693|NCT01709305|366087328|FG001|Phase 2|Travel, moving, etc.|2|||
106117694|NCT01709305|366087329|FG002|Phase 2|Travel, moving, etc.|3|||
106117695|NCT01709305|366087330|FG003|Phase 2|Travel, moving, etc.|3|||
106117696|NCT01709305|366087331|FG004|Phase 2|Travel, moving, etc.|5|||
106117697|NCT01709305|366087327|FG000|Phase 2|Physician Decision|0|||
106117698|NCT01709305|366087328|FG001|Phase 2|Physician Decision|2|||
106117699|NCT01709305|366087329|FG002|Phase 2|Physician Decision|0|||
106117700|NCT01709305|366087330|FG003|Phase 2|Physician Decision|1|||
106117701|NCT01709305|366087331|FG004|Phase 2|Physician Decision|2|||
106117702|NCT01709305|366087327|FG000|Phase 2|Protocol Violation|0|||
106117703|NCT01709305|366087328|FG001|Phase 2|Protocol Violation|19|||
106117704|NCT01709305|366087329|FG002|Phase 2|Protocol Violation|19|||
106117705|NCT01709305|366087330|FG003|Phase 2|Protocol Violation|13|||
106117706|NCT01709305|366087331|FG004|Phase 2|Protocol Violation|9|||
106117707|NCT01709305|366087327|FG000|Phase 2|Withdrawal by Subject|0|||
106117708|NCT01709305|366087328|FG001|Phase 2|Withdrawal by Subject|8|||
106117709|NCT01709305|366087329|FG002|Phase 2|Withdrawal by Subject|6|||
106117710|NCT01709305|366087330|FG003|Phase 2|Withdrawal by Subject|15|||
106117711|NCT01709305|366087331|FG004|Phase 2|Withdrawal by Subject|12|||
106117712|NCT02041923|366087332|FG000|Overall Study|Lost to Follow-up|26|||
106117713|NCT02041923|366087333|FG001|Overall Study|Lost to Follow-up|30|||
106117714|NCT00621296|366087334|FG000|Overall Study|Adverse Event|2|||
105661963|NCT02366143|364426794|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
105995142|NCT04752332|365641840|FG001|Overall Study|Study Terminated by Sponsor|48|||
105995143|NCT04752332|365641839|FG000|Overall Study|Withdrawal by Subject|11|||
106117715|NCT00621296|366087334|FG000|Overall Study|Lack of Efficacy|1|||
106117716|NCT00621296|366087334|FG000|Overall Study|Physician Decision|7|||
106117717|NCT00621296|366087334|FG000|Overall Study|Unmatch Criteria|1|||
106117718|NCT00621296|366087334|FG000|Overall Study|Stopping Criteria|3|||
105661964|NCT02366143|364426795|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
105661965|NCT02366143|364426793|FG000|Overall Study|Patient switched to PTAP|0|||
105661966|NCT02366143|364426794|FG001|Overall Study|Patient switched to PTAP|1|||
105661967|NCT02366143|364426795|FG002|Overall Study|Patient switched to PTAP|0|||
105661968|NCT02366143|364426793|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
105661969|NCT02366143|364426794|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
105661970|NCT02366143|364426795|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
105661971|NCT04411186|364426796|FG000|Overall Study|Withdrawn due to protocol violation|0|||
105661972|NCT04411186|364426797|FG001|Overall Study|Withdrawn due to protocol violation|1|||
105661973|NCT00575042|364426798|FG000|Overall Study|Adverse Event|2|||
105661974|NCT00575042|364426798|FG000|Overall Study|Lost to Follow-up|1|||
105661975|NCT04795336|364426799|FG000|Overall Study|Withdrawal by Subject|3|||
105661976|NCT04795336|364426800|FG001|Overall Study|Withdrawal by Subject|4|||
105784921|NCT01484691|364864429|FG001|Overall Study|Physician Decision|2|||
105995144|NCT04752332|365641840|FG001|Overall Study|Withdrawal by Subject|3|||
105995145|NCT02777827|365641843|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
105995146|NCT02777827|365641844|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
105995147|NCT02777827|365641845|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
105995148|NCT02777827|365641846|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
105995149|NCT02777827|365641847|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
106117719|NCT00381641|366087337|FG000|Overall Study|Withdrawal by Subject|0|||
106117720|NCT00381641|366087338|FG001|Overall Study|Withdrawal by Subject|2|||
106117721|NCT00462670|366088614|FG000|Overall Study|Adverse Event|3|||
106117722|NCT00462670|366088615|FG001|Overall Study|Adverse Event|5|||
106117723|NCT00462670|366088614|FG000|Overall Study|Lack of Efficacy|1|||
106117724|NCT00462670|366088615|FG001|Overall Study|Lack of Efficacy|0|||
106117725|NCT00462670|366088614|FG000|Overall Study|Protocol Violation|1|||
106117726|NCT00462670|366088615|FG001|Overall Study|Protocol Violation|0|||
106117727|NCT00462670|366088614|FG000|Overall Study|Resolution of signs and symptoms|0|||
106117728|NCT00462670|366088615|FG001|Overall Study|Resolution of signs and symptoms|2|||
106117729|NCT02110732|366088616|FG000|Overall Study|Physician Decision|5|||
106117730|NCT02110732|366088617|FG001|Overall Study|Physician Decision|2|||
106117731|NCT02110732|366088616|FG000|Overall Study|Lost to Follow-up|1|||
106117732|NCT02110732|366088617|FG001|Overall Study|Lost to Follow-up|1|||
106117733|NCT00871403|366088618|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
106117734|NCT00871403|366088619|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
106117735|NCT00871403|366088620|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
106117736|NCT00871403|366088618|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
106117737|NCT00871403|366088619|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
106117738|NCT00871403|366088620|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
106117739|NCT00871403|366088618|FG000|Combination Treatment Phase|Adverse Event|0|||
106117740|NCT00871403|366088619|FG001|Combination Treatment Phase|Adverse Event|17|||
106117741|NCT00871403|366088620|FG002|Combination Treatment Phase|Adverse Event|2|||
106117742|NCT00871403|366088618|FG000|Combination Treatment Phase|Disease Progression|0|||
106117743|NCT00871403|366088619|FG001|Combination Treatment Phase|Disease Progression|8|||
106117744|NCT00871403|366088620|FG002|Combination Treatment Phase|Disease Progression|5|||
106117745|NCT00871403|366088618|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
106117746|NCT00871403|366088619|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
106117747|NCT00871403|366088620|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
106117748|NCT00871403|366088618|FG000|Combination Treatment Phase|Physician Decision|0|||
106117749|NCT00871403|366088619|FG001|Combination Treatment Phase|Physician Decision|1|||
106117750|NCT00871403|366088620|FG002|Combination Treatment Phase|Physician Decision|3|||
106117751|NCT00871403|366088618|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
106117752|NCT00871403|366088619|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
106117753|NCT00871403|366088620|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
106117754|NCT00871403|366088618|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
106117755|NCT00871403|366088619|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
106117756|NCT00871403|366088620|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
106117757|NCT03075904|366088621|FG000|Overall Study|Physician Decision|3|||
106117758|NCT03075904|366088621|FG000|Overall Study|Need for Medication not Permitted|1|||
106117759|NCT00519896|366088622|FG000|Overall Study|Protocol Violation|1|||
106117760|NCT00519896|366088622|FG000|Overall Study|Adverse Event|1|||
106117761|NCT00810082|366088623|FG000|Overall Study|Lost to Follow-up|0|||
106117762|NCT00810082|366088624|FG001|Overall Study|Lost to Follow-up|4|||
106117763|NCT02367716|366088630|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
106117764|NCT01993823|366088634|FG000|Overall Study|Requested by the patient|6|||
106117765|NCT01993823|366088635|FG001|Overall Study|Requested by the patient|11|||
106117766|NCT01993823|366088634|FG000|Overall Study|Protocol Violation|0|||
106117767|NCT01993823|366088635|FG001|Overall Study|Protocol Violation|1|||
106117768|NCT01993823|366088634|FG000|Overall Study|Lost to Follow-up|1|||
106117769|NCT01993823|366088635|FG001|Overall Study|Lost to Follow-up|4|||
106117770|NCT04741802|366088636|FG000|Overall Study|Death|1|||
106117771|NCT04741802|366088636|FG000|Overall Study|Lost to Follow-up|11|||
105661977|NCT04795336|364426801|FG002|Overall Study|Withdrawal by Subject|3|||
105661978|NCT04795336|364426802|FG003|Overall Study|Withdrawal by Subject|12|||
105661979|NCT04795336|364426799|FG000|Overall Study|Lost study logs|0|||
105661980|NCT04795336|364426800|FG001|Overall Study|Lost study logs|1|||
105661981|NCT04795336|364426801|FG002|Overall Study|Lost study logs|0|||
105661982|NCT04795336|364426802|FG003|Overall Study|Lost study logs|2|||
105661983|NCT04795336|364426799|FG000|Overall Study|Did not take study medication|2|||
105661984|NCT04795336|364426800|FG001|Overall Study|Did not take study medication|0|||
105661985|NCT04795336|364426801|FG002|Overall Study|Did not take study medication|0|||
105661986|NCT04795336|364426802|FG003|Overall Study|Did not take study medication|0|||
105661987|NCT03898700|364426803|FG000|Overall Study|Withdrawal by Subject|2|||
105661988|NCT00701909|364426807|FG000|Overall Study|Withdrawal by Subject|0|||
105661989|NCT00701909|364426808|FG001|Overall Study|Withdrawal by Subject|1|||
105661990|NCT03616964|364426814|FG000|Overall Study|Adverse Event|15|||
105661991|NCT03616964|364426815|FG001|Overall Study|Adverse Event|10|||
105661992|NCT03616964|364426816|FG002|Overall Study|Adverse Event|16|||
105661993|NCT03616964|364426814|FG000|Overall Study|Death|3|||
105661994|NCT03616964|364426815|FG001|Overall Study|Death|0|||
105661995|NCT03616964|364426816|FG002|Overall Study|Death|4|||
105661996|NCT03616964|364426814|FG000|Overall Study|Lack of Efficacy|4|||
105661997|NCT03616964|364426815|FG001|Overall Study|Lack of Efficacy|8|||
105661998|NCT03616964|364426816|FG002|Overall Study|Lack of Efficacy|8|||
105661999|NCT03616964|364426814|FG000|Overall Study|Lost to Follow-up|2|||
105662000|NCT03616964|364426815|FG001|Overall Study|Lost to Follow-up|1|||
105662001|NCT03616964|364426816|FG002|Overall Study|Lost to Follow-up|3|||
105662002|NCT03616964|364426814|FG000|Overall Study|Withdrawal by Subject|18|||
105662003|NCT03616964|364426815|FG001|Overall Study|Withdrawal by Subject|14|||
105662004|NCT03616964|364426816|FG002|Overall Study|Withdrawal by Subject|21|||
105662005|NCT03616964|364426814|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
105887050|NCT02244463|365241783|FG004|Period 5: Phase II|Intercurrent Illness|2|||
105887051|NCT02244463|365241784|FG005|Period 5: Phase II|Intercurrent Illness|0|||
105887052|NCT02244463|365241779|FG000|Period 5: Phase II|Adverse Event|0|||
105887053|NCT02244463|365241780|FG001|Period 5: Phase II|Adverse Event|0|||
105887054|NCT02244463|365241781|FG002|Period 5: Phase II|Adverse Event|0|||
105887055|NCT02244463|365241782|FG003|Period 5: Phase II|Adverse Event|0|||
105887056|NCT02244463|365241783|FG004|Period 5: Phase II|Adverse Event|0|||
105887057|NCT02244463|365241784|FG005|Period 5: Phase II|Adverse Event|2|||
105887058|NCT02244463|365241779|FG000|Period 5: Phase II|Still On treatment|0|||
105887059|NCT02244463|365241780|FG001|Period 5: Phase II|Still On treatment|0|||
105887060|NCT02244463|365241781|FG002|Period 5: Phase II|Still On treatment|0|||
105887061|NCT02244463|365241782|FG003|Period 5: Phase II|Still On treatment|0|||
105887062|NCT02244463|365241783|FG004|Period 5: Phase II|Still On treatment|0|||
105887063|NCT02244463|365241784|FG005|Period 5: Phase II|Still On treatment|3|||
105887064|NCT01769508|365241787|FG000|Overall Study|Death|3|||
105887065|NCT01769508|365241787|FG000|Overall Study|Withdrawal by Subject|1|||
105887066|NCT01769508|365241787|FG000|Overall Study|Adverse Event|1|||
105887067|NCT01769508|365241787|FG000|Overall Study|Lost to Follow-up|1|||
105887068|NCT02829723|365241788|FG000|Overall Study|Adverse Event|0|||
105887069|NCT02829723|365241789|FG001|Overall Study|Adverse Event|0|||
105887070|NCT02829723|365241790|FG002|Overall Study|Adverse Event|1|||
105887071|NCT02829723|365241791|FG003|Overall Study|Adverse Event|1|||
105887072|NCT02829723|365241792|FG004|Overall Study|Adverse Event|0|||
105887073|NCT02829723|365241793|FG005|Overall Study|Adverse Event|0|||
105887074|NCT02829723|365241794|FG006|Overall Study|Adverse Event|0|||
105887075|NCT02829723|365241795|FG007|Overall Study|Adverse Event|1|||
105887076|NCT02829723|365241796|FG008|Overall Study|Adverse Event|0|||
105887077|NCT02829723|365241797|FG009|Overall Study|Adverse Event|0|||
105887078|NCT02829723|365241798|FG010|Overall Study|Adverse Event|0|||
105887079|NCT02829723|365241799|FG011|Overall Study|Adverse Event|0|||
105887080|NCT02829723|365241800|FG012|Overall Study|Adverse Event|0|||
105887081|NCT02829723|365241801|FG013|Overall Study|Adverse Event|0|||
105887082|NCT02829723|365241802|FG014|Overall Study|Adverse Event|1|||
105887083|NCT02829723|365241803|FG015|Overall Study|Adverse Event|1|||
105662006|NCT03616964|364426815|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
105887084|NCT02829723|365241804|FG016|Overall Study|Adverse Event|1|||
105887085|NCT02829723|365241805|FG017|Overall Study|Adverse Event|2|||
105887086|NCT02829723|365241806|FG018|Overall Study|Adverse Event|1|||
105995150|NCT02777827|365641848|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
105995151|NCT00548145|365641849|FG000|Overall Study|Death|0|||
105662007|NCT03616964|364426816|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
105662008|NCT03616964|364426814|FG000|Overall Study|Sponsor's Decision|1|||
105662009|NCT03616964|364426815|FG001|Overall Study|Sponsor's Decision|0|||
105887087|NCT02829723|365241807|FG019|Overall Study|Adverse Event|1|||
105887088|NCT02829723|365241808|FG020|Overall Study|Adverse Event|3|||
105887089|NCT02829723|365241809|FG021|Overall Study|Adverse Event|0|||
105887090|NCT02829723|365241810|FG022|Overall Study|Adverse Event|0|||
105995152|NCT00548145|365641850|FG001|Overall Study|Death|1|||
105887091|NCT02829723|365241811|FG023|Overall Study|Adverse Event|1|||
105887092|NCT02829723|365241812|FG024|Overall Study|Adverse Event|1|||
105887093|NCT02829723|365241813|FG025|Overall Study|Adverse Event|3|||
105887094|NCT02829723|365241814|FG026|Overall Study|Adverse Event|5|||
105887095|NCT02829723|365241788|FG000|Overall Study|Death|1|||
105887096|NCT02829723|365241789|FG001|Overall Study|Death|0|||
105887097|NCT02829723|365241790|FG002|Overall Study|Death|1|||
105887098|NCT02829723|365241791|FG003|Overall Study|Death|1|||
105887099|NCT02829723|365241792|FG004|Overall Study|Death|0|||
105887100|NCT02829723|365241793|FG005|Overall Study|Death|0|||
105887101|NCT02829723|365241794|FG006|Overall Study|Death|2|||
105887102|NCT02829723|365241795|FG007|Overall Study|Death|0|||
105887103|NCT02829723|365241796|FG008|Overall Study|Death|1|||
105887104|NCT02829723|365241797|FG009|Overall Study|Death|0|||
105887105|NCT02829723|365241798|FG010|Overall Study|Death|0|||
105887106|NCT02829723|365241799|FG011|Overall Study|Death|0|||
105887107|NCT02829723|365241800|FG012|Overall Study|Death|2|||
105887108|NCT02829723|365241801|FG013|Overall Study|Death|1|||
105887109|NCT02829723|365241802|FG014|Overall Study|Death|0|||
105887110|NCT02829723|365241803|FG015|Overall Study|Death|0|||
105887111|NCT02829723|365241804|FG016|Overall Study|Death|0|||
105887112|NCT02829723|365241805|FG017|Overall Study|Death|0|||
105887113|NCT02829723|365241806|FG018|Overall Study|Death|0|||
105887114|NCT02829723|365241807|FG019|Overall Study|Death|0|||
105887115|NCT02829723|365241808|FG020|Overall Study|Death|0|||
105887116|NCT02829723|365241809|FG021|Overall Study|Death|2|||
105887117|NCT02829723|365241810|FG022|Overall Study|Death|0|||
105887118|NCT02829723|365241811|FG023|Overall Study|Death|0|||
105887119|NCT02829723|365241812|FG024|Overall Study|Death|0|||
105887120|NCT02829723|365241813|FG025|Overall Study|Death|1|||
105887121|NCT02829723|365241814|FG026|Overall Study|Death|2|||
105887122|NCT02829723|365241788|FG000|Overall Study|Physician Decision|0|||
105887123|NCT02829723|365241789|FG001|Overall Study|Physician Decision|0|||
105887124|NCT02829723|365241790|FG002|Overall Study|Physician Decision|0|||
105887125|NCT02829723|365241791|FG003|Overall Study|Physician Decision|0|||
105887126|NCT02829723|365241792|FG004|Overall Study|Physician Decision|0|||
105887127|NCT02829723|365241793|FG005|Overall Study|Physician Decision|0|||
105887128|NCT02829723|365241794|FG006|Overall Study|Physician Decision|0|||
105887129|NCT02829723|365241795|FG007|Overall Study|Physician Decision|0|||
105887130|NCT02829723|365241796|FG008|Overall Study|Physician Decision|0|||
105887131|NCT02829723|365241797|FG009|Overall Study|Physician Decision|1|||
105887132|NCT02829723|365241798|FG010|Overall Study|Physician Decision|1|||
105887133|NCT02829723|365241799|FG011|Overall Study|Physician Decision|0|||
105887134|NCT02829723|365241800|FG012|Overall Study|Physician Decision|0|||
105887135|NCT02829723|365241801|FG013|Overall Study|Physician Decision|1|||
105887136|NCT02829723|365241802|FG014|Overall Study|Physician Decision|0|||
105887137|NCT02829723|365241803|FG015|Overall Study|Physician Decision|0|||
105887138|NCT02829723|365241804|FG016|Overall Study|Physician Decision|2|||
105887139|NCT02829723|365241805|FG017|Overall Study|Physician Decision|0|||
105887140|NCT02829723|365241806|FG018|Overall Study|Physician Decision|0|||
105887141|NCT02829723|365241807|FG019|Overall Study|Physician Decision|0|||
105887142|NCT02829723|365241808|FG020|Overall Study|Physician Decision|0|||
105887143|NCT02829723|365241809|FG021|Overall Study|Physician Decision|0|||
105887144|NCT02829723|365241810|FG022|Overall Study|Physician Decision|1|||
105887145|NCT02829723|365241811|FG023|Overall Study|Physician Decision|1|||
105887146|NCT02829723|365241812|FG024|Overall Study|Physician Decision|1|||
105887147|NCT02829723|365241813|FG025|Overall Study|Physician Decision|1|||
105887148|NCT02829723|365241814|FG026|Overall Study|Physician Decision|3|||
105887149|NCT02829723|365241788|FG000|Overall Study|Progressive disease|4|||
105887150|NCT02829723|365241789|FG001|Overall Study|Progressive disease|6|||
105887151|NCT02829723|365241790|FG002|Overall Study|Progressive disease|3|||
105887152|NCT02829723|365241791|FG003|Overall Study|Progressive disease|3|||
105887153|NCT02829723|365241792|FG004|Overall Study|Progressive disease|3|||
105887154|NCT02829723|365241793|FG005|Overall Study|Progressive disease|5|||
105887155|NCT02829723|365241794|FG006|Overall Study|Progressive disease|4|||
105887156|NCT02829723|365241795|FG007|Overall Study|Progressive disease|6|||
105887157|NCT02829723|365241796|FG008|Overall Study|Progressive disease|8|||
105887158|NCT02829723|365241797|FG009|Overall Study|Progressive disease|4|||
105887159|NCT02829723|365241798|FG010|Overall Study|Progressive disease|9|||
105887160|NCT02829723|365241799|FG011|Overall Study|Progressive disease|0|||
105887161|NCT02829723|365241800|FG012|Overall Study|Progressive disease|3|||
105887162|NCT02829723|365241801|FG013|Overall Study|Progressive disease|4|||
105887163|NCT02829723|365241802|FG014|Overall Study|Progressive disease|2|||
105887164|NCT02829723|365241803|FG015|Overall Study|Progressive disease|4|||
105887165|NCT02829723|365241804|FG016|Overall Study|Progressive disease|5|||
105662010|NCT03616964|364426816|FG002|Overall Study|Sponsor's Decision|0|||
105887166|NCT02829723|365241805|FG017|Overall Study|Progressive disease|3|||
105887167|NCT02829723|365241806|FG018|Overall Study|Progressive disease|4|||
105887168|NCT02829723|365241807|FG019|Overall Study|Progressive disease|4|||
105887169|NCT02829723|365241808|FG020|Overall Study|Progressive disease|7|||
105887170|NCT02829723|365241809|FG021|Overall Study|Progressive disease|6|||
105887171|NCT02829723|365241810|FG022|Overall Study|Progressive disease|3|||
105887172|NCT02829723|365241811|FG023|Overall Study|Progressive disease|3|||
105887173|NCT02829723|365241812|FG024|Overall Study|Progressive disease|3|||
105887174|NCT02829723|365241813|FG025|Overall Study|Progressive disease|16|||
105887175|NCT02829723|365241814|FG026|Overall Study|Progressive disease|10|||
105887176|NCT02829723|365241788|FG000|Overall Study|Subject/guardian decision|0|||
105887177|NCT02829723|365241789|FG001|Overall Study|Subject/guardian decision|1|||
105887178|NCT02829723|365241790|FG002|Overall Study|Subject/guardian decision|0|||
105887179|NCT02829723|365241791|FG003|Overall Study|Subject/guardian decision|1|||
105887180|NCT02829723|365241792|FG004|Overall Study|Subject/guardian decision|0|||
105887181|NCT02829723|365241793|FG005|Overall Study|Subject/guardian decision|0|||
105887182|NCT02829723|365241794|FG006|Overall Study|Subject/guardian decision|0|||
105887183|NCT02829723|365241795|FG007|Overall Study|Subject/guardian decision|1|||
105887184|NCT02829723|365241796|FG008|Overall Study|Subject/guardian decision|0|||
105887185|NCT02829723|365241797|FG009|Overall Study|Subject/guardian decision|0|||
105887186|NCT02829723|365241798|FG010|Overall Study|Subject/guardian decision|0|||
105887187|NCT02829723|365241799|FG011|Overall Study|Subject/guardian decision|0|||
105887188|NCT02829723|365241800|FG012|Overall Study|Subject/guardian decision|0|||
105887189|NCT02829723|365241801|FG013|Overall Study|Subject/guardian decision|0|||
105887190|NCT02829723|365241802|FG014|Overall Study|Subject/guardian decision|1|||
105887191|NCT02829723|365241803|FG015|Overall Study|Subject/guardian decision|0|||
105887192|NCT02829723|365241804|FG016|Overall Study|Subject/guardian decision|1|||
105887193|NCT02829723|365241805|FG017|Overall Study|Subject/guardian decision|0|||
105887194|NCT02829723|365241806|FG018|Overall Study|Subject/guardian decision|1|||
105887195|NCT02829723|365241807|FG019|Overall Study|Subject/guardian decision|0|||
105887196|NCT02829723|365241808|FG020|Overall Study|Subject/guardian decision|1|||
105887197|NCT02829723|365241809|FG021|Overall Study|Subject/guardian decision|0|||
105887198|NCT02829723|365241810|FG022|Overall Study|Subject/guardian decision|0|||
105887199|NCT02829723|365241811|FG023|Overall Study|Subject/guardian decision|1|||
105887200|NCT02829723|365241812|FG024|Overall Study|Subject/guardian decision|0|||
105887201|NCT02829723|365241813|FG025|Overall Study|Subject/guardian decision|1|||
105887202|NCT02829723|365241814|FG026|Overall Study|Subject/guardian decision|1|||
105887203|NCT02829723|365241788|FG000|Overall Study|Study terminated by sponsor|0|||
105887204|NCT02829723|365241789|FG001|Overall Study|Study terminated by sponsor|0|||
105887205|NCT02829723|365241790|FG002|Overall Study|Study terminated by sponsor|0|||
105887206|NCT02829723|365241791|FG003|Overall Study|Study terminated by sponsor|0|||
105887207|NCT02829723|365241792|FG004|Overall Study|Study terminated by sponsor|0|||
105887208|NCT02829723|365241793|FG005|Overall Study|Study terminated by sponsor|0|||
105887209|NCT02829723|365241794|FG006|Overall Study|Study terminated by sponsor|0|||
105887210|NCT02829723|365241795|FG007|Overall Study|Study terminated by sponsor|0|||
105887211|NCT02829723|365241796|FG008|Overall Study|Study terminated by sponsor|0|||
105887212|NCT02829723|365241797|FG009|Overall Study|Study terminated by sponsor|0|||
105887213|NCT02829723|365241798|FG010|Overall Study|Study terminated by sponsor|0|||
105887214|NCT02829723|365241799|FG011|Overall Study|Study terminated by sponsor|0|||
105887215|NCT02829723|365241800|FG012|Overall Study|Study terminated by sponsor|0|||
105887216|NCT02829723|365241801|FG013|Overall Study|Study terminated by sponsor|0|||
105887217|NCT02829723|365241802|FG014|Overall Study|Study terminated by sponsor|0|||
105887218|NCT02829723|365241803|FG015|Overall Study|Study terminated by sponsor|0|||
105887219|NCT02829723|365241804|FG016|Overall Study|Study terminated by sponsor|0|||
105887220|NCT02829723|365241805|FG017|Overall Study|Study terminated by sponsor|0|||
105887221|NCT02829723|365241806|FG018|Overall Study|Study terminated by sponsor|0|||
105887222|NCT02829723|365241807|FG019|Overall Study|Study terminated by sponsor|0|||
105887223|NCT02829723|365241808|FG020|Overall Study|Study terminated by sponsor|0|||
105887224|NCT02829723|365241809|FG021|Overall Study|Study terminated by sponsor|1|||
105887225|NCT02829723|365241810|FG022|Overall Study|Study terminated by sponsor|0|||
105887226|NCT02829723|365241811|FG023|Overall Study|Study terminated by sponsor|0|||
105887227|NCT02829723|365241812|FG024|Overall Study|Study terminated by sponsor|0|||
105887228|NCT02829723|365241813|FG025|Overall Study|Study terminated by sponsor|0|||
105887229|NCT02829723|365241814|FG026|Overall Study|Study terminated by sponsor|0|||
105887230|NCT00281632|365241815|FG000|Overall Study|Adverse Event|7|||
105887231|NCT00281632|365241815|FG000|Overall Study|Withdrawal by Subject|2|||
105887232|NCT00281632|365241815|FG000|Overall Study|Disease Progression|22|||
105887233|NCT00281632|365241815|FG000|Overall Study|Death|1|||
105887234|NCT00281632|365241815|FG000|Overall Study|Physician Decision|1|||
105887235|NCT00281632|365241815|FG000|Overall Study|Ongoing|3|||
105887236|NCT01475851|365241816|FG000|Overall Study|Protocol defined stopping criteria|1|||
105887237|NCT01475851|365241817|FG001|Overall Study|Protocol defined stopping criteria|0|||
105887238|NCT01508130|365241818|FG000|Overall Study|Adverse Event|81|||
105887239|NCT01508130|365241819|FG001|Overall Study|Adverse Event|28|||
105887240|NCT01508130|365241818|FG000|Overall Study|Death|3|||
105887241|NCT01508130|365241819|FG001|Overall Study|Death|1|||
105662011|NCT03616964|364426814|FG000|Overall Study|Physician Decision|0|||
105887242|NCT01508130|365241818|FG000|Overall Study|Protocol Violation|2|||
105887243|NCT01508130|365241819|FG001|Overall Study|Protocol Violation|0|||
105887244|NCT01508130|365241818|FG000|Overall Study|Lost to Follow-up|25|||
105662012|NCT03616964|364426815|FG001|Overall Study|Physician Decision|2|||
105887245|NCT01508130|365241819|FG001|Overall Study|Lost to Follow-up|2|||
105887246|NCT01508130|365241818|FG000|Overall Study|Withdrawal by Subject|3|||
105887247|NCT01508130|365241819|FG001|Overall Study|Withdrawal by Subject|3|||
105887248|NCT01508130|365241818|FG000|Overall Study|Subject's substantial non-compliance|25|||
105887249|NCT01508130|365241819|FG001|Overall Study|Subject's substantial non-compliance|9|||
105887250|NCT01508130|365241818|FG000|Overall Study|Insufficient therapeutic response|74|||
105887251|NCT01508130|365241819|FG001|Overall Study|Insufficient therapeutic response|23|||
105887252|NCT01508130|365241818|FG000|Overall Study|Administrative|14|||
105887253|NCT01508130|365241819|FG001|Overall Study|Administrative|3|||
105887254|NCT03613649|365241823|FG000|Second Treatment|Lost to Follow-up|0|||
105887255|NCT03613649|365241824|FG001|Second Treatment|Lost to Follow-up|0|||
105887256|NCT03613649|365241825|FG002|Second Treatment|Lost to Follow-up|1|||
105887257|NCT03613649|365241826|FG003|Second Treatment|Lost to Follow-up|0|||
105887258|NCT03613649|365241827|FG004|Second Treatment|Lost to Follow-up|0|||
105887259|NCT03613649|365241828|FG005|Second Treatment|Lost to Follow-up|0|||
105887260|NCT03613649|365241829|FG006|Second Treatment|Lost to Follow-up|0|||
105887261|NCT03613649|365241830|FG007|Second Treatment|Lost to Follow-up|0|||
105887262|NCT03613649|365241831|FG008|Second Treatment|Lost to Follow-up|0|||
105887263|NCT03613649|365241832|FG009|Second Treatment|Lost to Follow-up|0|||
105887264|NCT03613649|365241833|FG010|Second Treatment|Lost to Follow-up|0|||
105887265|NCT03613649|365241834|FG011|Second Treatment|Lost to Follow-up|0|||
105887266|NCT03613649|365241823|FG000|Second Treatment|Withdrawal by Subject|0|||
105887267|NCT03613649|365241824|FG001|Second Treatment|Withdrawal by Subject|0|||
105887268|NCT03613649|365241825|FG002|Second Treatment|Withdrawal by Subject|0|||
105887269|NCT03613649|365241826|FG003|Second Treatment|Withdrawal by Subject|0|||
105887270|NCT03613649|365241827|FG004|Second Treatment|Withdrawal by Subject|1|||
105887271|NCT03613649|365241828|FG005|Second Treatment|Withdrawal by Subject|0|||
105887272|NCT03613649|365241829|FG006|Second Treatment|Withdrawal by Subject|0|||
105887273|NCT03613649|365241830|FG007|Second Treatment|Withdrawal by Subject|0|||
105887274|NCT03613649|365241831|FG008|Second Treatment|Withdrawal by Subject|0|||
105887275|NCT03613649|365241832|FG009|Second Treatment|Withdrawal by Subject|0|||
105887276|NCT03613649|365241833|FG010|Second Treatment|Withdrawal by Subject|0|||
105887277|NCT03613649|365241834|FG011|Second Treatment|Withdrawal by Subject|0|||
105887278|NCT03613649|365241823|FG000|Third Treatment|Lost to Follow-up|0|||
105887279|NCT03613649|365241824|FG001|Third Treatment|Lost to Follow-up|0|||
105887280|NCT03613649|365241825|FG002|Third Treatment|Lost to Follow-up|0|||
105887281|NCT03613649|365241826|FG003|Third Treatment|Lost to Follow-up|0|||
105887282|NCT03613649|365241827|FG004|Third Treatment|Lost to Follow-up|1|||
105887283|NCT03613649|365241828|FG005|Third Treatment|Lost to Follow-up|0|||
105887284|NCT03613649|365241829|FG006|Third Treatment|Lost to Follow-up|0|||
105887285|NCT03613649|365241830|FG007|Third Treatment|Lost to Follow-up|0|||
105887286|NCT03613649|365241831|FG008|Third Treatment|Lost to Follow-up|0|||
105887287|NCT03613649|365241832|FG009|Third Treatment|Lost to Follow-up|0|||
105887288|NCT03613649|365241833|FG010|Third Treatment|Lost to Follow-up|0|||
105887289|NCT03613649|365241834|FG011|Third Treatment|Lost to Follow-up|1|||
105887290|NCT03613649|365241823|FG000|Third Treatment|Protocol Violation|0|||
105887291|NCT03613649|365241824|FG001|Third Treatment|Protocol Violation|0|||
105887292|NCT03613649|365241825|FG002|Third Treatment|Protocol Violation|0|||
105887293|NCT03613649|365241826|FG003|Third Treatment|Protocol Violation|0|||
105887294|NCT03613649|365241827|FG004|Third Treatment|Protocol Violation|0|||
105887295|NCT03613649|365241828|FG005|Third Treatment|Protocol Violation|0|||
105887296|NCT03613649|365241829|FG006|Third Treatment|Protocol Violation|1|||
105887297|NCT03613649|365241830|FG007|Third Treatment|Protocol Violation|0|||
105887298|NCT03613649|365241831|FG008|Third Treatment|Protocol Violation|0|||
105887299|NCT03613649|365241832|FG009|Third Treatment|Protocol Violation|0|||
105887300|NCT03613649|365241833|FG010|Third Treatment|Protocol Violation|0|||
105887301|NCT03613649|365241834|FG011|Third Treatment|Protocol Violation|1|||
105887302|NCT03613649|365241823|FG000|Fourth Treatment|Protocol Violation|1|||
105887303|NCT03613649|365241824|FG001|Fourth Treatment|Protocol Violation|0|||
105887304|NCT03613649|365241825|FG002|Fourth Treatment|Protocol Violation|0|||
105887305|NCT03613649|365241826|FG003|Fourth Treatment|Protocol Violation|0|||
105887306|NCT03613649|365241827|FG004|Fourth Treatment|Protocol Violation|1|||
105887307|NCT03613649|365241828|FG005|Fourth Treatment|Protocol Violation|0|||
105887308|NCT03613649|365241829|FG006|Fourth Treatment|Protocol Violation|0|||
105887309|NCT03613649|365241830|FG007|Fourth Treatment|Protocol Violation|0|||
105887310|NCT03613649|365241831|FG008|Fourth Treatment|Protocol Violation|0|||
105887311|NCT03613649|365241832|FG009|Fourth Treatment|Protocol Violation|0|||
105887312|NCT03613649|365241833|FG010|Fourth Treatment|Protocol Violation|0|||
105887313|NCT03613649|365241834|FG011|Fourth Treatment|Protocol Violation|0|||
105887314|NCT03613649|365241823|FG000|Fourth Treatment|Physician Decision|0|||
105887315|NCT03613649|365241824|FG001|Fourth Treatment|Physician Decision|0|||
105887316|NCT03613649|365241825|FG002|Fourth Treatment|Physician Decision|0|||
105887317|NCT03613649|365241826|FG003|Fourth Treatment|Physician Decision|0|||
105887318|NCT03613649|365241827|FG004|Fourth Treatment|Physician Decision|0|||
105887319|NCT03613649|365241828|FG005|Fourth Treatment|Physician Decision|0|||
105887320|NCT03613649|365241829|FG006|Fourth Treatment|Physician Decision|1|||
105887321|NCT03613649|365241830|FG007|Fourth Treatment|Physician Decision|0|||
106117772|NCT01460160|366088637|FG000|Treatment Phase|Lack of Efficacy|3|||
105887322|NCT03613649|365241831|FG008|Fourth Treatment|Physician Decision|0|||
105887323|NCT03613649|365241832|FG009|Fourth Treatment|Physician Decision|0|||
105887324|NCT03613649|365241833|FG010|Fourth Treatment|Physician Decision|0|||
105887325|NCT03613649|365241834|FG011|Fourth Treatment|Physician Decision|0|||
105887326|NCT00319592|365241836|FG000|Overall Study|Protocol Violation|1|||
105887327|NCT00319592|365241837|FG001|Overall Study|Protocol Violation|0|||
105887328|NCT00319592|365241836|FG000|Overall Study|Physician Decision|0|||
105887329|NCT00319592|365241837|FG001|Overall Study|Physician Decision|1|||
105887330|NCT01880086|365241838|FG000|Overall Study|Lost to Follow-up|1|||
105887331|NCT01880086|365241839|FG001|Overall Study|Lost to Follow-up|1|||
105887332|NCT03429244|365241842|FG000|Overall Study|Withdrawal by Subject|2|||
105887333|NCT03429244|365241843|FG001|Overall Study|Withdrawal by Subject|1|||
105887334|NCT03429244|365241844|FG002|Overall Study|Withdrawal by Subject|1|||
105887335|NCT01500187|365241846|FG000|Overall Study|Lost to Follow-up|6|||
105887336|NCT01500187|365241847|FG001|Overall Study|Lost to Follow-up|0|||
105887337|NCT03843632|365241848|FG000|Overall Study|Withdrawal by Subject|1|||
105887338|NCT03843632|365241849|FG001|Overall Study|Withdrawal by Subject|0|||
105887339|NCT03843632|365241850|FG002|Overall Study|Withdrawal by Subject|0|||
105887340|NCT03843632|365241851|FG003|Overall Study|Withdrawal by Subject|0|||
105887341|NCT00595517|365241852|FG000|Overall Study|Adverse Event|6|||
105662013|NCT03616964|364426816|FG002|Overall Study|Physician Decision|0|||
105887342|NCT00595517|365241852|FG000|Overall Study|Withdrawal by Subject|4|||
105887343|NCT00595517|365241852|FG000|Overall Study|Protocol Violation|2|||
105887344|NCT00595517|365241852|FG000|Overall Study|Recurrence of ulcer|5|||
105887345|NCT00595517|365241852|FG000|Overall Study|usage of prohibited treatment|1|||
105887346|NCT00595517|365241852|FG000|Overall Study|No intention to attend regularly|1|||
105887347|NCT01992653|365241861|FG000|Overall Study|Death|0|||
105887348|NCT01992653|365241862|FG001|Overall Study|Death|0|||
105887349|NCT01992653|365241863|FG002|Overall Study|Death|1|||
105887350|NCT01992653|365241864|FG003|Overall Study|Death|0|||
105887351|NCT01992653|365241865|FG004|Overall Study|Death|1|||
105887352|NCT01992653|365241866|FG005|Overall Study|Death|0|||
105887353|NCT01992653|365241867|FG006|Overall Study|Death|4|||
105887354|NCT01992653|365241868|FG007|Overall Study|Death|2|||
105887355|NCT01992653|365241861|FG000|Overall Study|Lost to Follow-up|0|||
105887356|NCT01992653|365241862|FG001|Overall Study|Lost to Follow-up|0|||
105887357|NCT01992653|365241863|FG002|Overall Study|Lost to Follow-up|0|||
105887358|NCT01992653|365241864|FG003|Overall Study|Lost to Follow-up|0|||
106117773|NCT01460160|366088637|FG000|Treatment Phase|Study Drug Toxicity|2|||
106117774|NCT01460160|366088637|FG000|Treatment Phase|Adverse Event|8|||
106117775|NCT01460160|366088637|FG000|Treatment Phase|Withdrawal by Subject|4|||
106117776|NCT01460160|366088637|FG000|Treatment Phase|Death|2|||
106117777|NCT01460160|366088637|FG000|Treatment Phase|Other reasons|9|||
105784922|NCT01484691|364864430|FG002|Overall Study|Physician Decision|1|||
106117778|NCT01460160|366088637|FG000|Follow-up Phase|Withdrawal by Subject|4|||
106117779|NCT01460160|366088637|FG000|Follow-up Phase|Death|14|||
106117780|NCT01460160|366088637|FG000|Follow-up Phase|Lost to Follow-up|7|||
106117781|NCT01460160|366088637|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
106117782|NCT01460160|366088637|FG000|Follow-up Phase|Other and not reported reasons|5|||
106117783|NCT04041440|366088641|FG000|Overall Study|Withdrawal by Subject|0|||
106117784|NCT04041440|366088642|FG001|Overall Study|Withdrawal by Subject|1|||
106117785|NCT04041440|366088641|FG000|Overall Study|Lost to Follow-up|0|||
106117786|NCT04041440|366088642|FG001|Overall Study|Lost to Follow-up|1|||
106117787|NCT01381874|366088643|FG000|Overall Study|Lost to Follow-up|1|||
106117788|NCT01381874|366088644|FG001|Overall Study|Lost to Follow-up|1|||
106117789|NCT01381874|366088645|FG002|Overall Study|Lost to Follow-up|0|||
106117790|NCT01381874|366088643|FG000|Overall Study|Withdrawal by Subject|9|||
106117791|NCT01381874|366088644|FG001|Overall Study|Withdrawal by Subject|10|||
106117792|NCT01381874|366088645|FG002|Overall Study|Withdrawal by Subject|9|||
106117793|NCT01381874|366088643|FG000|Overall Study|Other|67|||
106117794|NCT01381874|366088644|FG001|Overall Study|Other|52|||
106117795|NCT01381874|366088645|FG002|Overall Study|Other|67|||
106117796|NCT03447730|366088649|FG000|Overall Study|Adverse Event|0|||
106117797|NCT03447730|366088650|FG001|Overall Study|Adverse Event|2|||
106117798|NCT03447730|366088651|FG002|Overall Study|Adverse Event|0|||
106117799|NCT02086162|366088652|FG000|Overall Study|Withdrawal by Subject|4|||
106117800|NCT02086162|366088653|FG001|Overall Study|Withdrawal by Subject|4|||
106117801|NCT02086162|366088652|FG000|Overall Study|moved|1|||
106117802|NCT02086162|366088653|FG001|Overall Study|moved|1|||
106117803|NCT02086162|366088652|FG000|Overall Study|Lost to Follow-up|4|||
106117804|NCT02086162|366088653|FG001|Overall Study|Lost to Follow-up|2|||
106117805|NCT02086162|366088652|FG000|Overall Study|Death|1|||
106117806|NCT02086162|366088653|FG001|Overall Study|Death|0|||
106117807|NCT03119610|366088657|FG000|Overall Study|Adverse Event|1|||
106117808|NCT03119610|366088658|FG001|Overall Study|Adverse Event|0|||
105784923|NCT05807464|364864432|FG000|Overall Study|Adverse Event|1|||
105784924|NCT04298229|364864437|FG000|Overall Study|Physician Decision|1|||
105784925|NCT04298229|364864438|FG001|Overall Study|Physician Decision|1|||
105784926|NCT04298229|364864437|FG000|Overall Study|Withdrawal by Subject|1|||
105784927|NCT04298229|364864438|FG001|Overall Study|Withdrawal by Subject|1|||
105784928|NCT04298229|364864437|FG000|Overall Study|Did not receive IV loop diuretics|2|||
105784929|NCT04298229|364864438|FG001|Overall Study|Did not receive IV loop diuretics|0|||
105887359|NCT01992653|365241865|FG004|Overall Study|Lost to Follow-up|0|||
105887360|NCT01992653|365241866|FG005|Overall Study|Lost to Follow-up|0|||
105887361|NCT01992653|365241867|FG006|Overall Study|Lost to Follow-up|0|||
105887362|NCT01992653|365241868|FG007|Overall Study|Lost to Follow-up|1|||
105887363|NCT01992653|365241861|FG000|Overall Study|Study Completed|0|||
105887364|NCT01992653|365241862|FG001|Overall Study|Study Completed|0|||
105887365|NCT01992653|365241863|FG002|Overall Study|Study Completed|0|||
105887366|NCT01992653|365241864|FG003|Overall Study|Study Completed|0|||
105887367|NCT01992653|365241865|FG004|Overall Study|Study Completed|0|||
105887368|NCT01992653|365241866|FG005|Overall Study|Study Completed|0|||
105887369|NCT01992653|365241867|FG006|Overall Study|Study Completed|0|||
105887370|NCT01992653|365241868|FG007|Overall Study|Study Completed|1|||
105887371|NCT01992653|365241861|FG000|Overall Study|Disease Progression|0|||
105887372|NCT01992653|365241862|FG001|Overall Study|Disease Progression|0|||
105887373|NCT01992653|365241863|FG002|Overall Study|Disease Progression|0|||
105887374|NCT01992653|365241864|FG003|Overall Study|Disease Progression|0|||
105887375|NCT01992653|365241865|FG004|Overall Study|Disease Progression|0|||
105887376|NCT01992653|365241866|FG005|Overall Study|Disease Progression|0|||
105887377|NCT01992653|365241867|FG006|Overall Study|Disease Progression|4|||
105887378|NCT01992653|365241868|FG007|Overall Study|Disease Progression|0|||
105887379|NCT00977314|365241869|FG000|Overall Study|Withdrawal by Subject|1|||
105887380|NCT00977314|365241870|FG001|Overall Study|Withdrawal by Subject|0|||
105887381|NCT00977314|365241869|FG000|Overall Study|Physician Decision|1|||
105887382|NCT00977314|365241870|FG001|Overall Study|Physician Decision|0|||
105887383|NCT01190267|365241874|FG000|Overall Study|Adverse Event|10|||
105887384|NCT01190267|365241875|FG001|Overall Study|Adverse Event|0|||
105887385|NCT01190267|365241874|FG000|Overall Study|Treatment Failure|8|||
105887386|NCT01190267|365241875|FG001|Overall Study|Treatment Failure|2|||
105887387|NCT01190267|365241874|FG000|Overall Study|Lost to Follow-up|2|||
105887388|NCT01190267|365241875|FG001|Overall Study|Lost to Follow-up|0|||
105887389|NCT01190267|365241874|FG000|Overall Study|Withdrawal by Subject|13|||
105887390|NCT01190267|365241875|FG001|Overall Study|Withdrawal by Subject|1|||
105887391|NCT01190267|365241874|FG000|Overall Study|Protocol Violation|8|||
105887392|NCT01190267|365241875|FG001|Overall Study|Protocol Violation|1|||
105887393|NCT02537431|365241877|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
105887394|NCT04687072|365241878|FG000|Overall Study|Adverse Event|2|||
105887395|NCT04687072|365241879|FG001|Overall Study|Adverse Event|0|||
105887396|NCT04687072|365241878|FG000|Overall Study|Death|1|||
105887397|NCT04687072|365241879|FG001|Overall Study|Death|0|||
105887398|NCT04687072|365241878|FG000|Overall Study|Lack of Efficacy|2|||
105887399|NCT04687072|365241879|FG001|Overall Study|Lack of Efficacy|1|||
105887400|NCT04687072|365241878|FG000|Overall Study|Physician Decision|1|||
105887401|NCT04687072|365241879|FG001|Overall Study|Physician Decision|0|||
105887402|NCT04687072|365241878|FG000|Overall Study|Pregnancy|1|||
105887403|NCT04687072|365241879|FG001|Overall Study|Pregnancy|0|||
105887404|NCT04687072|365241878|FG000|Overall Study|Requires Prohibited Medication|2|||
105887405|NCT04687072|365241879|FG001|Overall Study|Requires Prohibited Medication|0|||
105887406|NCT04687072|365241878|FG000|Overall Study|Withdrawal of Consent|11|||
105887407|NCT04687072|365241879|FG001|Overall Study|Withdrawal of Consent|6|||
105887408|NCT04687072|365241878|FG000|Overall Study|Miscellaneous|4|||
105887409|NCT04687072|365241879|FG001|Overall Study|Miscellaneous|1|||
105887410|NCT02572076|365241880|FG000|Overall Study|Protocol Violation|1|||
105887411|NCT01397786|365243135|FG000|Phase A|Lost to Follow-up|0|||
105887412|NCT01397786|365243136|FG001|Phase A|Lost to Follow-up|0|||
105887413|NCT01397786|365243137|FG002|Phase A|Lost to Follow-up|6|||
105887414|NCT01397786|365243135|FG000|Phase A|Adverse Event|0|||
105887415|NCT01397786|365243136|FG001|Phase A|Adverse Event|0|||
105887416|NCT01397786|365243137|FG002|Phase A|Adverse Event|8|||
105887417|NCT01397786|365243135|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
105887418|NCT01397786|365243136|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
105887419|NCT01397786|365243137|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
105887420|NCT01397786|365243135|FG000|Phase A|Physician Decision|0|||
105887421|NCT01397786|365243136|FG001|Phase A|Physician Decision|0|||
105887422|NCT01397786|365243137|FG002|Phase A|Physician Decision|1|||
105887423|NCT01397786|365243135|FG000|Phase A|Withdrawal by Subject|0|||
105887424|NCT01397786|365243136|FG001|Phase A|Withdrawal by Subject|0|||
105887425|NCT01397786|365243137|FG002|Phase A|Withdrawal by Subject|5|||
105887426|NCT01397786|365243135|FG000|Phase A|Lack of Efficacy|0|||
105887427|NCT01397786|365243136|FG001|Phase A|Lack of Efficacy|0|||
105887428|NCT01397786|365243137|FG002|Phase A|Lack of Efficacy|1|||
105887429|NCT01397786|365243135|FG000|Phase B|Lost to Follow-up|22|||
105887430|NCT01397786|365243136|FG001|Phase B|Lost to Follow-up|12|||
106117809|NCT03119610|366088657|FG000|Overall Study|Lost to Follow-up|0|||
105887431|NCT01397786|365243137|FG002|Phase B|Lost to Follow-up|22|||
105887432|NCT01397786|365243135|FG000|Phase B|Adverse Event|109|||
105887433|NCT01397786|365243136|FG001|Phase B|Adverse Event|23|||
105887434|NCT01397786|365243137|FG002|Phase B|Adverse Event|27|||
105887435|NCT01397786|365243135|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
105887436|NCT01397786|365243136|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
105887437|NCT01397786|365243137|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
105887438|NCT01397786|365243135|FG000|Phase B|Physician Decision|9|||
105887439|NCT01397786|365243136|FG001|Phase B|Physician Decision|1|||
105887440|NCT01397786|365243137|FG002|Phase B|Physician Decision|3|||
105887441|NCT01397786|365243135|FG000|Phase B|Withdrawal by Subject|102|||
105887442|NCT01397786|365243136|FG001|Phase B|Withdrawal by Subject|45|||
105887443|NCT01397786|365243137|FG002|Phase B|Withdrawal by Subject|30|||
105887444|NCT01397786|365243135|FG000|Phase B|Protocol Deviation|1|||
105887445|NCT01397786|365243136|FG001|Phase B|Protocol Deviation|2|||
105887446|NCT01397786|365243137|FG002|Phase B|Protocol Deviation|4|||
105887447|NCT01397786|365243135|FG000|Phase B|Lack of Efficacy|22|||
105887448|NCT01397786|365243136|FG001|Phase B|Lack of Efficacy|7|||
105887449|NCT01397786|365243137|FG002|Phase B|Lack of Efficacy|14|||
105887450|NCT02836236|365243144|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
105887451|NCT02836236|365243145|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
105887452|NCT02836236|365243146|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
105887453|NCT02836236|365243147|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
105887454|NCT02836236|365243144|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
105887455|NCT02836236|365243145|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
105887456|NCT02836236|365243146|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
105887457|NCT02836236|365243147|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
105887458|NCT02836236|365243144|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105887459|NCT02836236|365243145|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
105887460|NCT02836236|365243146|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
105887461|NCT02836236|365243147|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105887462|NCT02836236|365243144|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
105887463|NCT02836236|365243145|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105887464|NCT02836236|365243146|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105887465|NCT02836236|365243147|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105887466|NCT02836236|365243144|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
105887467|NCT02836236|365243145|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
105887468|NCT02836236|365243146|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
105887469|NCT02836236|365243147|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
105887470|NCT02836236|365243144|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
105887471|NCT02836236|365243145|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
105887472|NCT02836236|365243146|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
105887473|NCT02836236|365243147|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
105887474|NCT02836236|365243144|FG000|Open-Label TAF Treatment Phase|Death|0|||
105887475|NCT02836236|365243145|FG001|Open-Label TAF Treatment Phase|Death|0|||
105887476|NCT02836236|365243146|FG002|Open-Label TAF Treatment Phase|Death|1|||
105887477|NCT02836236|365243147|FG003|Open-Label TAF Treatment Phase|Death|1|||
105887478|NCT02836236|365243144|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
105887479|NCT02836236|365243145|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
105887480|NCT02836236|365243146|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
105887481|NCT02836236|365243147|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
105887482|NCT02282631|365243150|FG000|Overall Study|Lost to Follow-up|2|||
105887483|NCT02282631|365243151|FG001|Overall Study|Lost to Follow-up|0|||
105887484|NCT03233529|365243153|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
105887485|NCT03233529|365243153|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
105887486|NCT00601172|365243154|FG000|Overall Study|Adverse Event|43|||
105887487|NCT00601172|365243155|FG001|Overall Study|Adverse Event|32|||
105887488|NCT00601172|365243154|FG000|Overall Study|Lack of Efficacy|11|||
105887489|NCT00601172|365243155|FG001|Overall Study|Lack of Efficacy|12|||
105887490|NCT00601172|365243154|FG000|Overall Study|Protocol Violation|2|||
105887491|NCT00601172|365243155|FG001|Overall Study|Protocol Violation|5|||
105887492|NCT00601172|365243154|FG000|Overall Study|Lost to Follow-up|4|||
105887493|NCT00601172|365243155|FG001|Overall Study|Lost to Follow-up|3|||
105887494|NCT00601172|365243154|FG000|Overall Study|Physician Decision|27|||
105887495|NCT00601172|365243155|FG001|Overall Study|Physician Decision|28|||
105887496|NCT00601172|365243154|FG000|Overall Study|Withdrawal by Subject|35|||
105887497|NCT00601172|365243155|FG001|Overall Study|Withdrawal by Subject|27|||
105887498|NCT00601172|365243154|FG000|Overall Study|Did not meet continuation criteria|19|||
106117810|NCT03119610|366088658|FG001|Overall Study|Lost to Follow-up|1|||
106117811|NCT01215357|366088659|FG000|Overall Study|Withdrawal by Subject|3|||
106117812|NCT01215357|366088659|FG000|Overall Study|Protocol Violation|9|||
106117813|NCT01350505|366088669|FG000|Overall Study|Lost to Follow-up|4|||
106117814|NCT00007475|366088670|FG000|Overall Study|Withdrawal by Subject|1|||
106117815|NCT00007475|366088671|FG001|Overall Study|Withdrawal by Subject|0|||
106117816|NCT00007475|366088672|FG002|Overall Study|Withdrawal by Subject|0|||
106117817|NCT00007475|366088673|FG003|Overall Study|Withdrawal by Subject|0|||
105887499|NCT00601172|365243155|FG001|Overall Study|Did not meet continuation criteria|20|||
105887500|NCT01905553|365243158|FG000|Period 2|Adverse Event|1|||
105887501|NCT01905553|365243159|FG001|Period 2|Adverse Event|0|||
105887502|NCT00723255|365243160|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
105887503|NCT00723255|365243160|FG000|Overall Study|Ineligible: Second primary|1|||
106117818|NCT00007475|366088670|FG000|Overall Study|Adverse Event|3|||
105784930|NCT02283411|364864439|FG000|Overall Study|Withdrawal by Subject|3|||
105784931|NCT02283411|364864439|FG000|Overall Study|Screen Failed|28|||
105784932|NCT00383292|364864440|FG000|Overall Study|Adverse Event|4|||
105784933|NCT00383292|364864441|FG001|Overall Study|Adverse Event|1|||
105784934|NCT00383292|364864442|FG002|Overall Study|Adverse Event|2|||
105784935|NCT00383292|364864440|FG000|Overall Study|Death|3|||
105784936|NCT00383292|364864441|FG001|Overall Study|Death|3|||
105784937|NCT00383292|364864442|FG002|Overall Study|Death|3|||
105784938|NCT00383292|364864440|FG000|Overall Study|Physician Decision|4|||
105784939|NCT00383292|364864441|FG001|Overall Study|Physician Decision|0|||
105784940|NCT00383292|364864442|FG002|Overall Study|Physician Decision|1|||
105784941|NCT00383292|364864440|FG000|Overall Study|Withdrawal by Subject|3|||
105887504|NCT00723255|365243160|FG000|Overall Study|Ineligible: Wrong Primary|2|||
105887505|NCT02759055|365243161|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
105887506|NCT02759055|365243162|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
105887507|NCT01424514|365243165|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
105887508|NCT01424514|365243166|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
105887509|NCT01424514|365243165|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
105887510|NCT01424514|365243166|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
105887511|NCT02002533|365243169|FG000|Overall Study|Withdrawal by Subject|6|||
105887512|NCT02002533|365243170|FG001|Overall Study|Withdrawal by Subject|13|||
105887513|NCT02002533|365243169|FG000|Overall Study|Protocol Violation|0|||
105887514|NCT02002533|365243170|FG001|Overall Study|Protocol Violation|1|||
105887515|NCT02002533|365243169|FG000|Overall Study|Adverse Event|0|||
105887516|NCT02002533|365243170|FG001|Overall Study|Adverse Event|3|||
105887517|NCT02002533|365243169|FG000|Overall Study|Lost to Follow-up|0|||
105887518|NCT02002533|365243170|FG001|Overall Study|Lost to Follow-up|1|||
105887519|NCT03991299|365243181|FG000|Overall Study|Study closed, sponsor decision|3|||
105887520|NCT03991299|365243181|FG000|Overall Study|Withdrawal by Subject|1|||
105887521|NCT04304235|365243182|FG000|Overall Study|incomplete triage data|0|||
105887522|NCT04304235|365243183|FG001|Overall Study|incomplete triage data|69|||
105887523|NCT04304235|365243184|FG002|Overall Study|incomplete triage data|0|||
105887524|NCT04304235|365243185|FG003|Overall Study|incomplete triage data|0|||
105887525|NCT04304235|365243186|FG004|Overall Study|incomplete triage data|289|||
105887526|NCT04304235|365243187|FG005|Overall Study|incomplete triage data|123|||
105887527|NCT04304235|365243188|FG006|Overall Study|incomplete triage data|65|||
105887528|NCT04429555|365243194|FG000|Overall Study|Death|0|||
105887529|NCT04429555|365243195|FG001|Overall Study|Death|2|||
105887530|NCT04429555|365243194|FG000|Overall Study|Other|2|||
105887531|NCT04429555|365243195|FG001|Overall Study|Other|0|||
105887532|NCT02703272|365243196|FG000|Overall Study|Death|4|||
105887533|NCT02703272|365243197|FG001|Overall Study|Death|9|||
105887534|NCT02703272|365243198|FG002|Overall Study|Death|19|||
105887535|NCT02703272|365243199|FG003|Overall Study|Death|10|||
105887536|NCT02703272|365243196|FG000|Overall Study|Withdrawal by Subject|0|||
105887537|NCT02703272|365243197|FG001|Overall Study|Withdrawal by Subject|0|||
105887538|NCT02703272|365243198|FG002|Overall Study|Withdrawal by Subject|4|||
105887539|NCT02703272|365243199|FG003|Overall Study|Withdrawal by Subject|2|||
105887540|NCT02703272|365243196|FG000|Overall Study|Study Terminated by Sponsor|6|||
105887541|NCT02703272|365243197|FG001|Overall Study|Study Terminated by Sponsor|1|||
105887542|NCT02703272|365243198|FG002|Overall Study|Study Terminated by Sponsor|12|||
105887543|NCT02703272|365243199|FG003|Overall Study|Study Terminated by Sponsor|4|||
105887544|NCT02703272|365243196|FG000|Overall Study|Other|1|||
105887545|NCT02703272|365243197|FG001|Overall Study|Other|0|||
105887546|NCT02703272|365243198|FG002|Overall Study|Other|0|||
105887547|NCT02703272|365243199|FG003|Overall Study|Other|0|||
105887548|NCT02989649|365243200|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
105887549|NCT02989649|365243200|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
105887550|NCT02989649|365243200|FG000|Overall Study|Lost For Observation During Study|3|||
105887551|NCT02989649|365243200|FG000|Overall Study|Reason Not Specified|13|||
105887552|NCT00330343|365243201|FG000|Overall Study|Lost to Follow-up|5|||
105887553|NCT03990571|365243202|FG000|Overall Study|Withdrawal by Subject|1|||
105887554|NCT03990571|365243202|FG000|Overall Study|Insurance Issues|3|||
105887555|NCT03990571|365243202|FG000|Overall Study|Covid Restrictions|2|||
105887556|NCT00782184|365243203|FG000|Overall Study|Adverse Event|1|||
105887557|NCT00782184|365243204|FG001|Overall Study|Adverse Event|2|||
105887558|NCT00782184|365243203|FG000|Overall Study|Protocol Violation|0|||
105887559|NCT00782184|365243204|FG001|Overall Study|Protocol Violation|1|||
105887560|NCT00782184|365243203|FG000|Overall Study|Withdrawal by Subject|3|||
105887561|NCT00782184|365243204|FG001|Overall Study|Withdrawal by Subject|2|||
105784942|NCT00383292|364864441|FG001|Overall Study|Withdrawal by Subject|2|||
105784943|NCT00383292|364864442|FG002|Overall Study|Withdrawal by Subject|2|||
105784944|NCT00383292|364864440|FG000|Overall Study|Other|1|||
105784945|NCT00383292|364864441|FG001|Overall Study|Other|0|||
105784946|NCT00383292|364864442|FG002|Overall Study|Other|0|||
105784947|NCT05261126|364864443|FG000|Overall Study|Death|0|||
105784948|NCT05261126|364864444|FG001|Overall Study|Death|0|||
105887562|NCT03696108|365243207|FG000|Overall Study|Physician Decision|1|||
105887563|NCT03696108|365243208|FG001|Overall Study|Physician Decision|0|||
105887564|NCT03696108|365243207|FG000|Overall Study|Withdrawal by Subject|3|||
105887565|NCT03696108|365243208|FG001|Overall Study|Withdrawal by Subject|6|||
105887566|NCT02892422|365243210|FG000|Overall Study|Enrolled not treated|4|||
105887567|NCT02892422|365243210|FG000|Overall Study|Adverse Event|38|||
105887568|NCT02892422|365243210|FG000|Overall Study|Lack of Efficacy|32|||
105887569|NCT02892422|365243210|FG000|Overall Study|Non-compliance with study drug|11|||
105887570|NCT02892422|365243210|FG000|Overall Study|Protocol Violation|4|||
105887571|NCT02892422|365243210|FG000|Overall Study|Withdrawal by Subject|56|||
105887572|NCT02892422|365243210|FG000|Overall Study|Lost to Follow-up|5|||
105887573|NCT02892422|365243210|FG000|Overall Study|sponsor information 16159A results|21|||
105887574|NCT02892422|365243210|FG000|Overall Study|withdrawal of consent|13|||
105887575|NCT02892422|365243210|FG000|Overall Study|exclusion criteria met|3|||
105887576|NCT02892422|365243210|FG000|Overall Study|moving elsewhere|4|||
105887577|NCT02892422|365243210|FG000|Overall Study|non-compliance|10|||
105887578|NCT02892422|365243210|FG000|Overall Study|patient legally incapable|1|||
105887579|NCT02892422|365243210|FG000|Overall Study|patient decision|7|||
105887580|NCT02892422|365243210|FG000|Overall Study|Investigator decision|1|||
105887581|NCT03155178|365243211|FG000|Overall Study|Did not meet treatment day baseline|7|||
105887582|NCT03155178|365243212|FG001|Overall Study|Did not meet treatment day baseline|7|||
105887583|NCT03155178|365243213|FG002|Overall Study|Did not meet treatment day baseline|7|||
105887584|NCT03155178|365243214|FG003|Overall Study|Did not meet treatment day baseline|7|||
105887585|NCT00638443|365243215|FG000|First Intervention|Adverse Event|2|||
105887586|NCT00638443|365243216|FG001|First Intervention|Adverse Event|1|||
105887587|NCT01343277|365243220|FG000|Overall Study|Other|3|||
105887588|NCT01343277|365243221|FG001|Overall Study|Other|3|||
105784949|NCT05261126|364864445|FG002|Overall Study|Death|1|||
105784950|NCT05261126|364864446|FG003|Overall Study|Death|0|||
105784951|NCT05261126|364864447|FG004|Overall Study|Death|0|||
105784952|NCT05261126|364864443|FG000|Overall Study|Lost to Follow-up|0|||
105784953|NCT05261126|364864444|FG001|Overall Study|Lost to Follow-up|0|||
105784954|NCT05261126|364864445|FG002|Overall Study|Lost to Follow-up|0|||
105784955|NCT05261126|364864446|FG003|Overall Study|Lost to Follow-up|0|||
105784956|NCT05261126|364864447|FG004|Overall Study|Lost to Follow-up|1|||
105784957|NCT05261126|364864443|FG000|Overall Study|Physician Decision|1|||
105784958|NCT05261126|364864444|FG001|Overall Study|Physician Decision|0|||
105784959|NCT05261126|364864445|FG002|Overall Study|Physician Decision|0|||
105784960|NCT05261126|364864446|FG003|Overall Study|Physician Decision|0|||
105784961|NCT05261126|364864447|FG004|Overall Study|Physician Decision|0|||
105887589|NCT01343277|365243220|FG000|Overall Study|Withdrawal by Subject|18|||
105887590|NCT01343277|365243221|FG001|Overall Study|Withdrawal by Subject|13|||
105887591|NCT01343277|365243220|FG000|Overall Study|Physician Decision|1|||
105887592|NCT01343277|365243221|FG001|Overall Study|Physician Decision|2|||
105887593|NCT01343277|365243220|FG000|Overall Study|Death|10|||
105887594|NCT01343277|365243221|FG001|Overall Study|Death|1|||
105887595|NCT01343277|365243220|FG000|Overall Study|Adverse Event|67|||
105887596|NCT01343277|365243221|FG001|Overall Study|Adverse Event|13|||
105887597|NCT01343277|365243220|FG000|Overall Study|Disease progression|270|||
105887598|NCT01343277|365243221|FG001|Overall Study|Disease progression|138|||
105887599|NCT01343277|365243220|FG000|Overall Study|Randomized not treated|6|||
105887600|NCT01343277|365243221|FG001|Overall Study|Randomized not treated|21|||
105887601|NCT01343277|365243220|FG000|Overall Study|Treatment ongoing|8|||
105887602|NCT01343277|365243221|FG001|Overall Study|Treatment ongoing|2|||
105784962|NCT05261126|364864443|FG000|Overall Study|Screen Failure|0|||
105887603|NCT01343277|365243220|FG000|Overall Study|Subsequent anticancer therapy|1|||
105887604|NCT01343277|365243221|FG001|Overall Study|Subsequent anticancer therapy|0|||
105887605|NCT01582178|365243224|FG000|Overall Study|Physician Decision|6|||
106117819|NCT00007475|366088671|FG001|Overall Study|Adverse Event|0|||
106117820|NCT00007475|366088672|FG002|Overall Study|Adverse Event|0|||
105887606|NCT01582178|365243225|FG001|Overall Study|Physician Decision|5|||
105887607|NCT02847494|365243226|FG000|Overall Study|Lost to Follow-up|8|||
105887608|NCT02847494|365243227|FG001|Overall Study|Lost to Follow-up|5|||
106117821|NCT00007475|366088673|FG003|Overall Study|Adverse Event|0|||
106117822|NCT02357810|366088675|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
105784963|NCT05261126|364864444|FG001|Overall Study|Screen Failure|0|||
105887609|NCT02841280|365243228|FG000|Overall Study|Adverse Event|2|||
105887610|NCT02841280|365243229|FG001|Overall Study|Adverse Event|1|||
105887611|NCT02841280|365243228|FG000|Overall Study|Death|1|||
105887612|NCT02841280|365243229|FG001|Overall Study|Death|0|||
105887613|NCT02841280|365243228|FG000|Overall Study|Lost to Follow-up|2|||
105887614|NCT02841280|365243229|FG001|Overall Study|Lost to Follow-up|2|||
105887615|NCT02841280|365243228|FG000|Overall Study|Withdrawal by Subject|7|||
105784964|NCT05261126|364864445|FG002|Overall Study|Screen Failure|0|||
105784965|NCT05261126|364864446|FG003|Overall Study|Screen Failure|0|||
105784966|NCT05261126|364864447|FG004|Overall Study|Screen Failure|1|||
105784967|NCT05261126|364864443|FG000|Overall Study|Withdrawal by Subject|1|||
105784968|NCT05261126|364864444|FG001|Overall Study|Withdrawal by Subject|0|||
105887616|NCT02841280|365243229|FG001|Overall Study|Withdrawal by Subject|3|||
105887617|NCT02841280|365243228|FG000|Overall Study|Stop Point: BP above threshold|2|||
105887618|NCT02841280|365243229|FG001|Overall Study|Stop Point: BP above threshold|0|||
105887619|NCT02496091|365243230|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105887620|NCT05033262|365243233|FG000|Overall Study|Lost to Follow-up|1|||
105887621|NCT05033262|365243234|FG001|Overall Study|Lost to Follow-up|0|||
105887622|NCT05033262|365243235|FG002|Overall Study|Lost to Follow-up|0|||
105887623|NCT05033262|365243236|FG003|Overall Study|Lost to Follow-up|1|||
105887624|NCT03489707|365243239|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
105887625|NCT03489707|365243240|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
105887626|NCT03489707|365243239|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
105887627|NCT03489707|365243240|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
105887628|NCT03395184|365243243|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
105887629|NCT03395184|365243244|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
105887630|NCT03395184|365243245|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
105887631|NCT03395184|365243246|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
105887632|NCT03395184|365243247|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
105887633|NCT03395184|365243248|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
105887634|NCT03395184|365243249|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
105887635|NCT03395184|365243243|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105887636|NCT03395184|365243244|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
105887637|NCT03395184|365243245|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
105887638|NCT03395184|365243246|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105887639|NCT03395184|365243247|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105887640|NCT03395184|365243248|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105887641|NCT03395184|365243249|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
105887642|NCT03395184|365243243|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
105887643|NCT03395184|365243244|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
105887644|NCT03395184|365243245|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105887645|NCT03395184|365243246|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105887646|NCT03395184|365243247|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105887647|NCT03395184|365243248|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105887648|NCT03395184|365243249|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105887649|NCT03395184|365243243|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105887650|NCT03395184|365243244|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
105887651|NCT03395184|365243245|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105887652|NCT03395184|365243246|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105887653|NCT03395184|365243247|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105887654|NCT03395184|365243248|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105887655|NCT03395184|365243249|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
105887656|NCT03395184|365243243|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
105887657|NCT03395184|365243244|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105887658|NCT03395184|365243245|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
105887659|NCT03395184|365243246|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105887660|NCT03395184|365243247|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105887661|NCT03395184|365243248|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105887662|NCT03395184|365243249|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105887663|NCT03395184|365243243|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
105887664|NCT03395184|365243244|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
105887665|NCT03395184|365243245|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
105887666|NCT03395184|365243246|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
105887667|NCT03395184|365243247|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
105887668|NCT03395184|365243248|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
105887669|NCT03395184|365243249|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
105887670|NCT03395184|365243243|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
105887671|NCT03395184|365243244|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
105887672|NCT03395184|365243245|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
105887673|NCT03395184|365243246|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
105887674|NCT03395184|365243247|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
105887675|NCT03395184|365243248|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
105662014|NCT03616964|364426814|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
105662015|NCT03616964|364426815|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
105662016|NCT03616964|364426816|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
105662017|NCT03616964|364426814|FG000|Overall Study|Protocol Violation|0|||
105662018|NCT03616964|364426815|FG001|Overall Study|Protocol Violation|1|||
105662019|NCT03616964|364426816|FG002|Overall Study|Protocol Violation|0|||
105662020|NCT03616964|364426814|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
105887676|NCT03395184|365243249|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
105887677|NCT03395184|365243243|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
105887678|NCT03395184|365243244|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
105887679|NCT03395184|365243245|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
105887680|NCT03395184|365243246|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
105887681|NCT03395184|365243247|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
105887682|NCT03395184|365243248|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
105887683|NCT03395184|365243249|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
105887684|NCT03395184|365243243|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105887685|NCT03395184|365243244|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105887686|NCT03395184|365243245|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105887687|NCT03395184|365243246|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105887688|NCT03395184|365243247|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
105887689|NCT03395184|365243248|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
105887690|NCT03395184|365243249|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
106117823|NCT02357810|366088675|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
106117824|NCT02357810|366088675|FG000|Reached 12 Weeks Response|Adverse Event|5|||
106117825|NCT02357810|366088675|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
106117826|NCT02357810|366088675|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
105887691|NCT03395184|365243243|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
105887692|NCT03395184|365243244|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
105887693|NCT03395184|365243245|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
105887694|NCT03395184|365243246|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
105887695|NCT03395184|365243247|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
105887696|NCT03395184|365243248|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
105887697|NCT03395184|365243249|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
105887698|NCT03395184|365243243|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105887699|NCT03395184|365243244|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105887700|NCT03395184|365243245|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105887701|NCT03395184|365243246|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
105887702|NCT03395184|365243247|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105887703|NCT03395184|365243248|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
105887704|NCT03395184|365243249|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
105887705|NCT03395184|365243243|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
105887706|NCT03395184|365243244|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
105887707|NCT03395184|365243245|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
105887708|NCT03395184|365243246|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
105887709|NCT03395184|365243247|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
105887710|NCT03395184|365243248|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
105887711|NCT03395184|365243249|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
105887712|NCT05723328|365243251|FG000|Overall Study|Investigator's Decision|5|||
105887713|NCT05723328|365243252|FG001|Overall Study|Investigator's Decision|2|||
105887714|NCT00199797|365245845|FG000|Overall Study|Progressive Disease|1|||
105887715|NCT00199797|365245845|FG000|Overall Study|Adverse Event|1|||
105887716|NCT00199797|365245845|FG000|Overall Study|Physician Decision|1|||
105887717|NCT01806961|365245846|FG000|Overall Study|sponsor decision|16|||
105887718|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
105887719|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
105887720|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
105887721|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
106117827|NCT02357810|366088675|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
106117828|NCT02357810|366088675|FG000|Reached 12 Weeks Response|Death|1|||
106117829|NCT02357810|366088675|FG000|Reached 12 Weeks Response|Physician Decision|1|||
106117830|NCT02357810|366088675|FG000|Reached 12 Weeks Response|Other|1|||
106117831|NCT02357810|366088675|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
106117832|NCT02357810|366088675|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
106117833|NCT02357810|366088675|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
106117834|NCT02357810|366088675|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
106117835|NCT02357810|366088675|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
106117836|NCT02357810|366088675|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
105887722|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Death|0|||
105887723|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Death|0|||
106117837|NCT04091360|366088676|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105887724|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Death|1|||
105887725|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Death|0|||
105887726|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
105887727|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
105887728|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
105887729|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
106117838|NCT04091360|366088677|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
105784969|NCT05261126|364864445|FG002|Overall Study|Withdrawal by Subject|1|||
105784970|NCT05261126|364864446|FG003|Overall Study|Withdrawal by Subject|1|||
106117839|NCT04091360|366088678|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
106117840|NCT04091360|366088679|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
106117841|NCT04091360|366088680|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
106117842|NCT04091360|366088681|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
106117843|NCT04091360|366088682|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
106117844|NCT04091360|366088683|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
106117845|NCT04091360|366088684|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
106117846|NCT04091360|366088685|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
105662021|NCT03616964|364426815|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
105662022|NCT03616964|364426816|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
105662023|NCT03616964|364426814|FG000|Overall Study|Randomized but Never Treated|1|||
105662024|NCT03616964|364426815|FG001|Overall Study|Randomized but Never Treated|1|||
105662025|NCT03616964|364426816|FG002|Overall Study|Randomized but Never Treated|1|||
105662026|NCT04843579|364426822|FG000|Overall Study|Adverse Event|1|||
105662027|NCT04843579|364426822|FG000|Overall Study|Disease Progression|1|||
105662028|NCT04009629|364426823|FG000|Overall Study|Withdrawal by Subject|2|||
105662029|NCT04009629|364426824|FG001|Overall Study|Withdrawal by Subject|0|||
105662030|NCT04398368|364426828|FG000|Overall Study|Withdrawal by Subject|2|||
105662031|NCT00416598|364426829|FG000|Induction & Intensification|Adverse Event|38|||
105662032|NCT00416598|364426829|FG000|Induction & Intensification|Death|32|||
105662033|NCT00416598|364426829|FG000|Induction & Intensification|Withdrawal by Subject|46|||
105662034|NCT00416598|364426829|FG000|Induction & Intensification|Alternative Treatment|135|||
105662035|NCT00416598|364426829|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
105662036|NCT00416598|364426829|FG000|Induction & Intensification|Relapse/progression|29|||
105662037|NCT00416598|364426829|FG000|Induction & Intensification|Failed induction|87|||
105662038|NCT00416598|364426829|FG000|Decitabine Maintenance|Adverse Event|5|||
105662039|NCT00416598|364426829|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
105662040|NCT00416598|364426829|FG000|Decitabine Maintenance|Progression/relapse|38|||
105662041|NCT00416598|364426829|FG000|Decitabine Maintenance|Alternative treatment|2|||
105662042|NCT00416598|364426829|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
105662043|NCT02641587|364426846|FG000|Confinement Period|Adverse Event|1|||
105662044|NCT02641587|364426847|FG001|Confinement Period|Adverse Event|0|||
105662045|NCT02641587|364426846|FG000|Confinement Period|Withdrawal by Subject|2|||
105662046|NCT02641587|364426847|FG001|Confinement Period|Withdrawal by Subject|1|||
105662047|NCT02641587|364426846|FG000|Ambulatory Period|Withdrawal by Subject|1|||
105662048|NCT02641587|364426847|FG001|Ambulatory Period|Withdrawal by Subject|0|||
105662049|NCT01165177|364426848|FG000|Overall Study|Serious Adverse Event|227|||
105662050|NCT01165177|364426849|FG001|Overall Study|Serious Adverse Event|235|||
105662051|NCT01165177|364426848|FG000|Overall Study|Withdrawal by Subject|368|||
105784971|NCT05261126|364864447|FG004|Overall Study|Withdrawal by Subject|0|||
105662052|NCT01165177|364426849|FG001|Overall Study|Withdrawal by Subject|354|||
105662053|NCT01165177|364426848|FG000|Overall Study|Protocol Violation|19|||
105784972|NCT05261126|364864443|FG000|Overall Study|Not Recorded|0|||
105784973|NCT05261126|364864444|FG001|Overall Study|Not Recorded|0|||
105784974|NCT05261126|364864445|FG002|Overall Study|Not Recorded|0|||
105784975|NCT05261126|364864446|FG003|Overall Study|Not Recorded|1|||
105784976|NCT05261126|364864447|FG004|Overall Study|Not Recorded|0|||
105784977|NCT01333501|364864453|FG000|Overall Study|Adverse Event|3|||
105784978|NCT01333501|364864454|FG001|Overall Study|Adverse Event|1|||
105784979|NCT01333501|364864453|FG000|Overall Study|Abnormal laboratory value|2|||
105784980|NCT01333501|364864454|FG001|Overall Study|Abnormal laboratory value|1|||
105784981|NCT01333501|364864453|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105784982|NCT01333501|364864454|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
105784983|NCT01333501|364864453|FG000|Overall Study|Withdrawn consent|3|||
105784984|NCT01333501|364864454|FG001|Overall Study|Withdrawn consent|12|||
105784985|NCT00938366|364864455|FG000|Overall Study|Withdrawal by Subject|1|||
105784986|NCT00938366|364864456|FG001|Overall Study|Withdrawal by Subject|0|||
105784987|NCT00674440|364864457|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
105784988|NCT00674440|364864457|FG000|Overall Study|did not have surgery, so unevaluable|7|||
105784989|NCT00674440|364864457|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
105784990|NCT03329404|364864458|FG000|Overall Study|The study was suspended.|1|||
105784991|NCT03329404|364864459|FG001|Overall Study|The study was suspended.|4|||
105784992|NCT00796367|364864460|FG000|Overall Study|Adverse Event|6|||
105784993|NCT00796367|364864461|FG001|Overall Study|Adverse Event|4|||
105784994|NCT00796367|364864462|FG002|Overall Study|Adverse Event|7|||
105784995|NCT00796367|364864460|FG000|Overall Study|Lost to Follow-up|5|||
105784996|NCT00796367|364864461|FG001|Overall Study|Lost to Follow-up|4|||
105784997|NCT00796367|364864462|FG002|Overall Study|Lost to Follow-up|21|||
105784998|NCT00796367|364864460|FG000|Overall Study|Withdrawal by Subject|9|||
105784999|NCT00796367|364864461|FG001|Overall Study|Withdrawal by Subject|11|||
105887730|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
105887731|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
105887732|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
105887733|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
105887734|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
105887735|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
105887736|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
105887737|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
105887738|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
105887739|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
105887740|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
105887741|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
105887742|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
105887743|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
105887744|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
105887745|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
105887746|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
105887747|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
105887748|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
105887749|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
105887750|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105887751|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
105887752|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105887753|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105887754|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
105887755|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
106117847|NCT04091360|366088676|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
106117848|NCT04091360|366088677|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
106117849|NCT04091360|366088678|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
105887756|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
105887757|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
105887758|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
105887759|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
105887760|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
105887761|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
105887762|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Other|8|||
105887763|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Other|14|||
105887764|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Other|8|||
105887765|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Other|23|||
105887766|NCT01106677|365245850|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
105887767|NCT01106677|365245851|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
105887768|NCT01106677|365245852|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
105887769|NCT01106677|365245853|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
105887770|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105887771|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105887772|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
105887773|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
105887774|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Death|0|||
105887775|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Death|0|||
105887776|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Death|0|||
105887777|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Death|1|||
105887778|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
105887779|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
105887780|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
105887781|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
105887782|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105887783|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
105887784|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
106117850|NCT04091360|366088679|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
106117851|NCT04091360|366088680|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
106117852|NCT04091360|366088681|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
106117853|NCT04091360|366088682|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
106117854|NCT04091360|366088683|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
105662054|NCT01165177|364426849|FG001|Overall Study|Protocol Violation|21|||
105785000|NCT00796367|364864462|FG002|Overall Study|Withdrawal by Subject|12|||
105785001|NCT00796367|364864460|FG000|Overall Study|Lack of Efficacy|2|||
105785002|NCT00796367|364864461|FG001|Overall Study|Lack of Efficacy|1|||
105785003|NCT00796367|364864462|FG002|Overall Study|Lack of Efficacy|0|||
105785004|NCT00796367|364864460|FG000|Overall Study|non compliance|3|||
105785005|NCT00796367|364864461|FG001|Overall Study|non compliance|1|||
105785006|NCT00796367|364864462|FG002|Overall Study|non compliance|1|||
105785007|NCT00796367|364864460|FG000|Overall Study|Pregnancy|1|||
106117855|NCT04091360|366088684|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
106117856|NCT04091360|366088685|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
106117857|NCT04091360|366088676|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
106117858|NCT04091360|366088677|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
106117859|NCT04091360|366088678|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105785008|NCT00796367|364864461|FG001|Overall Study|Pregnancy|0|||
105785009|NCT00796367|364864462|FG002|Overall Study|Pregnancy|1|||
105785010|NCT00796367|364864460|FG000|Overall Study|Requirement for restricted medication|2|||
105785011|NCT00796367|364864461|FG001|Overall Study|Requirement for restricted medication|0|||
105785012|NCT00796367|364864462|FG002|Overall Study|Requirement for restricted medication|2|||
105785013|NCT00796367|364864460|FG000|Overall Study|other|2|||
105785014|NCT00796367|364864461|FG001|Overall Study|other|4|||
105785015|NCT00796367|364864462|FG002|Overall Study|other|3|||
105785016|NCT01288911|364864463|FG000|Double-blind Period|Death|11|||
105785017|NCT01288911|364864464|FG001|Double-blind Period|Death|7|||
105995153|NCT00548145|365641849|FG000|Overall Study|Withdrawal by Subject|0|||
105995154|NCT00548145|365641850|FG001|Overall Study|Withdrawal by Subject|2|||
105995155|NCT00548145|365641849|FG000|Overall Study|Physician Decision|1|||
105785018|NCT01288911|364864463|FG000|Double-blind Period|Lost to Follow-up|0|||
105785019|NCT01288911|364864464|FG001|Double-blind Period|Lost to Follow-up|2|||
105785020|NCT01288911|364864463|FG000|Double-blind Period|Progressive Disease|75|||
105785021|NCT01288911|364864464|FG001|Double-blind Period|Progressive Disease|103|||
105995156|NCT00548145|365641850|FG001|Overall Study|Physician Decision|1|||
105995157|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
105995158|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
105995159|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
105995160|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Death|0|||
105995161|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Death|2|||
105995162|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Death|0|||
105995163|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
105995164|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
105995165|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
105995166|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
105995167|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
105995168|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
105995169|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
105995170|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
105995171|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
105995172|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
105995173|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
105785022|NCT01288911|364864463|FG000|Double-blind Period|Protocol Violation|1|||
105785023|NCT01288911|364864464|FG001|Double-blind Period|Protocol Violation|0|||
105785024|NCT01288911|364864463|FG000|Double-blind Period|Withdrawal by Subject|25|||
105995174|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
105995175|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
105995176|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
105995177|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
105995178|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Recovery|1|||
105995179|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Recovery|0|||
105995180|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Recovery|1|||
105995181|NCT00195663|365641854|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
105995182|NCT00195663|365641855|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
105995183|NCT00195663|365641856|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
106117860|NCT04091360|366088679|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
106117861|NCT04091360|366088680|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
105785025|NCT01288911|364864464|FG001|Double-blind Period|Withdrawal by Subject|26|||
105785026|NCT01288911|364864463|FG000|Double-blind Period|Miscellaneous Reason|29|||
105785027|NCT01288911|364864464|FG001|Double-blind Period|Miscellaneous Reason|42|||
105785028|NCT01288911|364864463|FG000|Double-blind Period|Randomized but never received study drug|1|||
105785029|NCT01288911|364864464|FG001|Double-blind Period|Randomized but never received study drug|2|||
105785030|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Death|0|||
105785031|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Death|1|||
105887785|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
106117862|NCT04091360|366088681|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
106117863|NCT04091360|366088682|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
106117864|NCT04091360|366088683|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
106117865|NCT04091360|366088684|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
106117866|NCT04091360|366088685|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
106117867|NCT00692406|366088686|FG000|Overall Study|PI dropped, bad data|57|||
106117868|NCT02307513|366088687|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
106117869|NCT02307513|366088688|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
106117870|NCT02307513|366088687|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
106117871|NCT02307513|366088688|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
106117872|NCT02307513|366088687|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
106117873|NCT02307513|366088688|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
106117874|NCT02307513|366088687|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
106117875|NCT02307513|366088688|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
106117876|NCT02307513|366088687|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
106117877|NCT02307513|366088688|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
106117878|NCT02307513|366088687|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
106117879|NCT02307513|366088688|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
106117880|NCT02307513|366088687|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
106117881|NCT02307513|366088688|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
106117882|NCT02307513|366088687|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
106117883|NCT02307513|366088688|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
106117884|NCT02307513|366088687|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
106117885|NCT02307513|366088688|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
106117886|NCT02307513|366088687|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
106117887|NCT02307513|366088688|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
106117888|NCT02307513|366088687|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
106117889|NCT02307513|366088688|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
106117890|NCT02307513|366088687|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
106117891|NCT02307513|366088688|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
106117892|NCT02307513|366088687|FG000|Long-term Extension|Physician Decision|1|||
106117893|NCT02307513|366088688|FG001|Long-term Extension|Physician Decision|0|||
106117894|NCT01225822|366088689|FG000|Overall Study|Adverse Event|13|||
106117895|NCT01225822|366088690|FG001|Overall Study|Adverse Event|31|||
106117896|NCT01225822|366088691|FG002|Overall Study|Adverse Event|18|||
106117897|NCT01225822|366088692|FG003|Overall Study|Adverse Event|23|||
106117898|NCT01225822|366088693|FG004|Overall Study|Adverse Event|14|||
106117899|NCT01225822|366088689|FG000|Overall Study|Protocol Violation|6|||
106117900|NCT01225822|366088690|FG001|Overall Study|Protocol Violation|8|||
106117901|NCT01225822|366088691|FG002|Overall Study|Protocol Violation|6|||
106117902|NCT01225822|366088692|FG003|Overall Study|Protocol Violation|7|||
106117903|NCT01225822|366088693|FG004|Overall Study|Protocol Violation|4|||
106117904|NCT01225822|366088689|FG000|Overall Study|Lost to Follow-up|0|||
106117905|NCT01225822|366088690|FG001|Overall Study|Lost to Follow-up|0|||
106117906|NCT01225822|366088691|FG002|Overall Study|Lost to Follow-up|0|||
106117907|NCT01225822|366088692|FG003|Overall Study|Lost to Follow-up|1|||
106117908|NCT01225822|366088693|FG004|Overall Study|Lost to Follow-up|0|||
106117909|NCT01225822|366088689|FG000|Overall Study|Withdrawal by Subject|6|||
106117910|NCT01225822|366088690|FG001|Overall Study|Withdrawal by Subject|7|||
106117911|NCT01225822|366088691|FG002|Overall Study|Withdrawal by Subject|7|||
106117912|NCT01225822|366088692|FG003|Overall Study|Withdrawal by Subject|11|||
106117913|NCT01225822|366088693|FG004|Overall Study|Withdrawal by Subject|6|||
106117914|NCT01225822|366088689|FG000|Overall Study|Other|13|||
106117915|NCT01225822|366088690|FG001|Overall Study|Other|10|||
106117916|NCT01225822|366088691|FG002|Overall Study|Other|7|||
106117917|NCT01225822|366088692|FG003|Overall Study|Other|10|||
106117918|NCT01225822|366088693|FG004|Overall Study|Other|7|||
106117919|NCT00130793|366088694|FG000|Overall Study|Lost to Follow-up|1|||
106117920|NCT00130793|366088695|FG001|Overall Study|Lost to Follow-up|4|||
106117921|NCT00130793|366088694|FG000|Overall Study|Withdrew consent|2|||
106117922|NCT00130793|366088695|FG001|Overall Study|Withdrew consent|0|||
106117923|NCT05796518|366088700|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
106117924|NCT05458024|366088703|FG000|Overall Study|Withdrawal by Subject|1|||
106117925|NCT05458024|366088704|FG001|Overall Study|Withdrawal by Subject|1|||
106117926|NCT01845974|366088705|FG000|Overall Study|screen failure|1|||
106117927|NCT01845974|366088706|FG001|Overall Study|screen failure|0|||
106117928|NCT00594217|366088707|FG000|Overall Study|Withdrawal by Subject|1|||
106117929|NCT00594217|366088708|FG001|Overall Study|Withdrawal by Subject|3|||
106117930|NCT03006848|366088709|FG000|Overall Study|Adverse Event|1|||
106117931|NCT03006848|366088709|FG000|Overall Study|Physician Decision|1|||
106117932|NCT03006848|366088709|FG000|Overall Study|Lack of Efficacy|16|||
105662055|NCT01165177|364426848|FG000|Overall Study|Non-serious adverse event|30|||
105662056|NCT01165177|364426849|FG001|Overall Study|Non-serious adverse event|18|||
105662057|NCT01165177|364426848|FG000|Overall Study|Other unspecified reasons|47|||
105662058|NCT01165177|364426849|FG001|Overall Study|Other unspecified reasons|35|||
105662059|NCT01165177|364426848|FG000|Overall Study|Suspected HZ episode|0|||
105662060|NCT01165177|364426849|FG001|Overall Study|Suspected HZ episode|2|||
105662061|NCT01165177|364426848|FG000|Overall Study|Lost to Follow-up|183|||
105662062|NCT01165177|364426849|FG001|Overall Study|Lost to Follow-up|194|||
105662063|NCT01165177|364426848|FG000|Overall Study|Migrated/ moved from study area|48|||
105662064|NCT01165177|364426849|FG001|Overall Study|Migrated/ moved from study area|43|||
105662065|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
105662066|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
105662067|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
105662068|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
105662069|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
105662070|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
105662071|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
105662072|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
105662073|NCT00781937|364426851|FG000|Main Trial Period Through Week 56|Unclassified|10|||
105662074|NCT00781937|364426852|FG001|Main Trial Period Through Week 56|Unclassified|15|||
105662075|NCT00781937|364426851|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
105662076|NCT00781937|364426852|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
105662077|NCT00781937|364426851|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
105662078|NCT00781937|364426852|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
105662079|NCT03194867|364426856|FG000|Overall Study|Incorrect completion of end of study form|0|||
105662080|NCT03194867|364426857|FG001|Overall Study|Incorrect completion of end of study form|0|||
105662081|NCT03194867|364426858|FG002|Overall Study|Incorrect completion of end of study form|1|||
105662082|NCT03194867|364426859|FG003|Overall Study|Incorrect completion of end of study form|0|||
105662083|NCT00543062|364426860|FG000|Overall Study|Withdrawal by Subject|1|||
105662084|NCT00543062|364426861|FG001|Overall Study|Withdrawal by Subject|0|||
105662085|NCT00543062|364426862|FG002|Overall Study|Withdrawal by Subject|2|||
105662086|NCT00543062|364426863|FG003|Overall Study|Withdrawal by Subject|0|||
105662087|NCT00543062|364426860|FG000|Overall Study|Adverse Event|0|||
105662088|NCT00543062|364426861|FG001|Overall Study|Adverse Event|1|||
105662089|NCT00543062|364426862|FG002|Overall Study|Adverse Event|1|||
105662090|NCT00543062|364426863|FG003|Overall Study|Adverse Event|1|||
105662091|NCT00543062|364426860|FG000|Overall Study|Protocol Violation|1|||
105662092|NCT00543062|364426861|FG001|Overall Study|Protocol Violation|0|||
105662093|NCT00543062|364426862|FG002|Overall Study|Protocol Violation|0|||
105662094|NCT00543062|364426863|FG003|Overall Study|Protocol Violation|0|||
105662095|NCT01663506|364426864|FG000|Overall Study|Lack of Efficacy|3|||
105662096|NCT01663506|364426864|FG000|Overall Study|Consent Withdrawal by Subject|1|||
105662097|NCT01663506|364426864|FG000|Overall Study|Lost to Follow-up|1|||
105662098|NCT01663506|364426864|FG000|Overall Study|Adverse Event|1|||
105662099|NCT01663506|364426864|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
105662100|NCT05382039|364426865|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
105662101|NCT05382039|364426866|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
105662102|NCT05382039|364426867|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
105662103|NCT05382039|364426865|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
105662104|NCT05382039|364426866|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
105662105|NCT05382039|364426867|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
105662106|NCT05382039|364426865|FG000|Overall Study|waiting for confirmation|0|||
105662107|NCT05382039|364426866|FG001|Overall Study|waiting for confirmation|0|||
105662108|NCT05382039|364426867|FG002|Overall Study|waiting for confirmation|1|||
105662109|NCT00328562|364426868|FG000|Overall Study|Disease progression|1|||
105662110|NCT04504630|364426871|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
105662111|NCT04504630|364426872|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
105662112|NCT04504630|364426871|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
105662113|NCT04504630|364426872|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
105887786|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
105887787|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
105887788|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
105887789|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
105887790|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105887791|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105662114|NCT01519778|364426873|FG000|Overall Study|Withdrawal by Subject|3|||
105662115|NCT01519778|364426873|FG000|Overall Study|Lost to Follow-up|10|||
105995184|NCT00195663|365641854|FG000|Open-Label Extension Period|Adverse Event|21|||
105662116|NCT01519778|364426873|FG000|Overall Study|Physician Decision|1|||
105887792|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105887793|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105887794|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105887795|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
105887796|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
105887797|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105887798|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
105887799|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
105887800|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
105887801|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
105887802|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105887803|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105887804|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105887805|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
105887806|NCT01106677|365245850|FG000|Extension Period: Week 26 to Week 52|Other|6|||
105887807|NCT01106677|365245851|FG001|Extension Period: Week 26 to Week 52|Other|5|||
105887808|NCT01106677|365245852|FG002|Extension Period: Week 26 to Week 52|Other|8|||
105887809|NCT01106677|365245853|FG003|Extension Period: Week 26 to Week 52|Other|5|||
105887810|NCT01283334|365245854|FG000|Overall Study|Withdrawal by Subject|1|||
105887811|NCT01283334|365245854|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
105887812|NCT01283334|365245854|FG000|Overall Study|Adverse Event|4|||
105887813|NCT01283334|365245854|FG000|Overall Study|Physician Decision|1|||
105887814|NCT03937908|365245855|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
105887815|NCT03937908|365245856|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
105887816|NCT05413369|365245857|FG000|Overall Study|Adverse Event|1|||
105887817|NCT05413369|365245858|FG001|Overall Study|Adverse Event|1|||
105887818|NCT05413369|365245857|FG000|Overall Study|Withdrawal by Subject|13|||
105887819|NCT05413369|365245858|FG001|Overall Study|Withdrawal by Subject|4|||
105887820|NCT05413369|365245857|FG000|Overall Study|Non-compliance with study schedule|2|||
105887821|NCT05413369|365245858|FG001|Overall Study|Non-compliance with study schedule|1|||
105887822|NCT05413369|365245857|FG000|Overall Study|Other|1|||
105887823|NCT05413369|365245858|FG001|Overall Study|Other|1|||
105887824|NCT00769067|365245859|FG000|Overall Study|Death|89|||
105887825|NCT00769067|365245860|FG001|Overall Study|Death|86|||
105887826|NCT00769067|365245859|FG000|Overall Study|Lost to Follow-up|3|||
105887827|NCT00769067|365245860|FG001|Overall Study|Lost to Follow-up|1|||
105887828|NCT00769067|365245859|FG000|Overall Study|Study terminated by sponsor|1|||
105887829|NCT00769067|365245860|FG001|Overall Study|Study terminated by sponsor|3|||
105887830|NCT00769067|365245859|FG000|Overall Study|Other|1|||
105887831|NCT00769067|365245860|FG001|Overall Study|Other|3|||
105887832|NCT00769067|365245859|FG000|Overall Study|Withdrawal by Subject|0|||
105887833|NCT00769067|365245860|FG001|Overall Study|Withdrawal by Subject|1|||
105887834|NCT04420585|365245861|FG000|Overall Study|Adverse Event|1|||
105887835|NCT04420585|365245861|FG000|Overall Study|Never initiated medication|2|||
105887836|NCT04114357|365245862|FG000|Baseline-Randomization|Adverse Event|2|||
105887837|NCT04114357|365245863|FG001|Baseline-Randomization|Adverse Event|1|||
105887838|NCT04114357|365245862|FG000|Baseline-Randomization|Lost to Follow-up|1|||
105887839|NCT04114357|365245863|FG001|Baseline-Randomization|Lost to Follow-up|1|||
105887840|NCT04114357|365245862|FG000|Cross-over|Adverse Event|0|||
105887841|NCT04114357|365245863|FG001|Cross-over|Adverse Event|1|||
106117933|NCT01483937|366088710|FG000|Overall Study|Withdrawal by Subject|4|||
106117934|NCT01483937|366088711|FG001|Overall Study|Withdrawal by Subject|3|||
106117935|NCT01351025|366088712|FG000|Week 0 - 20|Lost to Follow-up|2|||
106117936|NCT01351025|366088713|FG001|Week 0 - 20|Lost to Follow-up|1|||
106117937|NCT01351025|366088712|FG000|Week 0 - 20|Withdrawal by Subject|1|||
106117938|NCT01351025|366088713|FG001|Week 0 - 20|Withdrawal by Subject|0|||
106117939|NCT01351025|366088712|FG000|Week 24 - 44|Lost to Follow-up|0|||
106117940|NCT01351025|366088713|FG001|Week 24 - 44|Lost to Follow-up|2|||
106117941|NCT01351025|366088712|FG000|Week 24 - 44|Site closed|0|||
106117942|NCT01351025|366088713|FG001|Week 24 - 44|Site closed|1|||
106117943|NCT01351025|366088712|FG000|Week 24 - 44|unable to get to clinic|1|||
106117944|NCT01351025|366088713|FG001|Week 24 - 44|unable to get to clinic|1|||
106117945|NCT03734991|366088714|FG000|Overall Study|Adverse Event|4|||
106117946|NCT03734991|366088715|FG001|Overall Study|Adverse Event|0|||
106117947|NCT03734991|366088714|FG000|Overall Study|Lost to Follow-up|4|||
106117948|NCT03734991|366088715|FG001|Overall Study|Lost to Follow-up|0|||
106117949|NCT03734991|366088714|FG000|Overall Study|Physician Decision|0|||
105887842|NCT03558152|365245866|FG000|Overall Study|Adverse Event|0|||
106117950|NCT03734991|366088715|FG001|Overall Study|Physician Decision|1|||
106117951|NCT03734991|366088714|FG000|Overall Study|Pregnancy|1|||
106117952|NCT03734991|366088715|FG001|Overall Study|Pregnancy|0|||
106117953|NCT03734991|366088714|FG000|Overall Study|Withdrawal by Subject|6|||
106117954|NCT03734991|366088715|FG001|Overall Study|Withdrawal by Subject|3|||
105662117|NCT01375751|364426881|FG000|Overall Study|Other|0|||
105662118|NCT01375751|364426882|FG001|Overall Study|Other|1|||
105662119|NCT01375751|364426883|FG002|Overall Study|Other|0|||
105662120|NCT03865953|364426884|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
105662121|NCT03865953|364426885|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
105662122|NCT03865953|364426884|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
105662123|NCT03865953|364426885|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
105662124|NCT03865953|364426884|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
105662125|NCT03865953|364426885|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
105662126|NCT00882115|364426886|FG000|Overall Study|Withdrawal by Subject|3|||
105662127|NCT00882115|364426886|FG000|Overall Study|did not respond to DEP challe|6|||
105662128|NCT01271504|364426887|FG000|Overall Study|Death|7|||
105662129|NCT01271504|364426888|FG001|Overall Study|Death|6|||
105662130|NCT01271504|364426889|FG002|Overall Study|Death|32|||
105662131|NCT01271504|364426890|FG003|Overall Study|Death|32|||
105662132|NCT01271504|364426887|FG000|Overall Study|Lost to Follow-up|0|||
105662133|NCT01271504|364426888|FG001|Overall Study|Lost to Follow-up|1|||
105662134|NCT01271504|364426889|FG002|Overall Study|Lost to Follow-up|3|||
105662135|NCT01271504|364426890|FG003|Overall Study|Lost to Follow-up|1|||
105662136|NCT01271504|364426887|FG000|Overall Study|Protocol Violation|0|||
105662137|NCT01271504|364426888|FG001|Overall Study|Protocol Violation|0|||
105662138|NCT01271504|364426889|FG002|Overall Study|Protocol Violation|0|||
105662139|NCT01271504|364426890|FG003|Overall Study|Protocol Violation|2|||
105662140|NCT01271504|364426887|FG000|Overall Study|Administrative Reasons|0|||
105662141|NCT01271504|364426888|FG001|Overall Study|Administrative Reasons|0|||
105662142|NCT01271504|364426889|FG002|Overall Study|Administrative Reasons|6|||
105662143|NCT01271504|364426890|FG003|Overall Study|Administrative Reasons|5|||
105662144|NCT01271504|364426887|FG000|Overall Study|Withdrawal by Subject|0|||
105662145|NCT01271504|364426888|FG001|Overall Study|Withdrawal by Subject|0|||
105662146|NCT01271504|364426889|FG002|Overall Study|Withdrawal by Subject|1|||
105662147|NCT01271504|364426890|FG003|Overall Study|Withdrawal by Subject|3|||
105662148|NCT01271504|364426887|FG000|Overall Study|Other|0|||
105662149|NCT01271504|364426888|FG001|Overall Study|Other|1|||
106117955|NCT03734991|366088714|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
106117956|NCT03734991|366088715|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
106117957|NCT03734991|366088714|FG000|Overall Study|Other|2|||
106117958|NCT03734991|366088715|FG001|Overall Study|Other|2|||
106117959|NCT02569710|366088726|FG000|Overall Study|Adverse Event|1|||
106117960|NCT02569710|366088727|FG001|Overall Study|Adverse Event|0|||
106117961|NCT02569710|366088728|FG002|Overall Study|Adverse Event|0|||
106117962|NCT02569710|366088729|FG003|Overall Study|Adverse Event|0|||
106117963|NCT02569710|366088730|FG004|Overall Study|Adverse Event|0|||
106117964|NCT02569710|366088731|FG005|Overall Study|Adverse Event|0|||
106117965|NCT02569710|366088732|FG006|Overall Study|Adverse Event|0|||
106117966|NCT02569710|366088733|FG007|Overall Study|Adverse Event|0|||
106117967|NCT02569710|366088734|FG008|Overall Study|Adverse Event|0|||
106117968|NCT02569710|366088735|FG009|Overall Study|Adverse Event|0|||
106117969|NCT02569710|366088726|FG000|Overall Study|Lost to Follow-up|0|||
106117970|NCT02569710|366088727|FG001|Overall Study|Lost to Follow-up|0|||
106117971|NCT02569710|366088728|FG002|Overall Study|Lost to Follow-up|0|||
106117972|NCT02569710|366088729|FG003|Overall Study|Lost to Follow-up|0|||
106117973|NCT02569710|366088730|FG004|Overall Study|Lost to Follow-up|0|||
106117974|NCT02569710|366088731|FG005|Overall Study|Lost to Follow-up|0|||
106117975|NCT02569710|366088732|FG006|Overall Study|Lost to Follow-up|1|||
106117976|NCT02569710|366088733|FG007|Overall Study|Lost to Follow-up|0|||
106117977|NCT02569710|366088734|FG008|Overall Study|Lost to Follow-up|1|||
106117978|NCT02569710|366088735|FG009|Overall Study|Lost to Follow-up|0|||
106117979|NCT02569710|366088726|FG000|Overall Study|Virologic failure|0|||
106117980|NCT02569710|366088727|FG001|Overall Study|Virologic failure|0|||
106117981|NCT02569710|366088728|FG002|Overall Study|Virologic failure|0|||
106117982|NCT02569710|366088729|FG003|Overall Study|Virologic failure|0|||
106117983|NCT02569710|366088730|FG004|Overall Study|Virologic failure|1|||
106117984|NCT02569710|366088731|FG005|Overall Study|Virologic failure|0|||
106117985|NCT02569710|366088732|FG006|Overall Study|Virologic failure|1|||
106117986|NCT02569710|366088733|FG007|Overall Study|Virologic failure|0|||
106117987|NCT02569710|366088734|FG008|Overall Study|Virologic failure|0|||
106117988|NCT02569710|366088735|FG009|Overall Study|Virologic failure|0|||
106117989|NCT02569710|366088726|FG000|Overall Study|Withdrawal by Subject|0|||
106117990|NCT02569710|366088727|FG001|Overall Study|Withdrawal by Subject|0|||
106117991|NCT02569710|366088728|FG002|Overall Study|Withdrawal by Subject|0|||
106117992|NCT02569710|366088729|FG003|Overall Study|Withdrawal by Subject|0|||
106117993|NCT02569710|366088730|FG004|Overall Study|Withdrawal by Subject|0|||
105662150|NCT01271504|364426889|FG002|Overall Study|Other|2|||
105662151|NCT01271504|364426890|FG003|Overall Study|Other|0|||
105662152|NCT01790295|364426891|FG000|Overall Study|Adverse Event|1|||
105662153|NCT01790295|364426891|FG000|Overall Study|Death|4|||
105662154|NCT01790295|364426891|FG000|Overall Study|Lack of Efficacy|2|||
105662155|NCT01790295|364426891|FG000|Overall Study|Study closure|4|||
106117994|NCT02569710|366088731|FG005|Overall Study|Withdrawal by Subject|1|||
106117995|NCT02569710|366088732|FG006|Overall Study|Withdrawal by Subject|0|||
106117996|NCT02569710|366088733|FG007|Overall Study|Withdrawal by Subject|0|||
106117997|NCT02569710|366088734|FG008|Overall Study|Withdrawal by Subject|0|||
106117998|NCT02569710|366088735|FG009|Overall Study|Withdrawal by Subject|0|||
106117999|NCT03203694|366088740|FG000|Overall Study|Withdrawal by Subject|2|||
106118000|NCT03203694|366088741|FG001|Overall Study|Withdrawal by Subject|0|||
106118001|NCT03203694|366088742|FG002|Overall Study|Withdrawal by Subject|0|||
106118002|NCT03203694|366088743|FG003|Overall Study|Withdrawal by Subject|0|||
106118003|NCT03203694|366088744|FG004|Overall Study|Withdrawal by Subject|0|||
106118004|NCT03203694|366088745|FG005|Overall Study|Withdrawal by Subject|0|||
106118005|NCT02049710|366088746|FG000|Overall Study|Lost to Follow-up|319|||
106118006|NCT02049710|366088747|FG001|Overall Study|Lost to Follow-up|324|||
106118007|NCT05200936|366088748|FG000|Overall Study|Withdrawal by Subject|2|||
106118008|NCT05200936|366088749|FG001|Overall Study|Withdrawal by Subject|2|||
106118009|NCT05200936|366088748|FG000|Overall Study|Lost to Follow-up|2|||
106118010|NCT05200936|366088749|FG001|Overall Study|Lost to Follow-up|0|||
106118011|NCT05200936|366088748|FG000|Overall Study|Pregnancy|0|||
106118012|NCT05200936|366088749|FG001|Overall Study|Pregnancy|1|||
106118013|NCT03713021|366088751|FG000|Overall Study|Did not have CT sim scan available|6|||
106118014|NCT03713021|366088751|FG000|Overall Study|Not eligible|4|||
106118015|NCT03713021|366088751|FG000|Overall Study|Issues with TraceIT markers|5|||
106118016|NCT00976703|366090160|FG000|Overall Study|Physician Decision|1|||
106118017|NCT00976703|366090161|FG001|Overall Study|Physician Decision|1|||
106118018|NCT00976703|366090160|FG000|Overall Study|ineligible for study|2|||
106118019|NCT00976703|366090161|FG001|Overall Study|ineligible for study|2|||
106118020|NCT00975221|366090162|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
106118021|NCT00975221|366090163|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
106118022|NCT00975221|366090162|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
106118023|NCT00975221|366090163|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
106118024|NCT00975221|366090162|FG000|Titration Phase (Weeks 1-12)|Other|0|||
106118025|NCT00975221|366090163|FG001|Titration Phase (Weeks 1-12)|Other|1|||
106118026|NCT00975221|366090162|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
106118027|NCT00975221|366090163|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
106118028|NCT00975221|366090162|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
106118029|NCT00975221|366090163|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
106118030|NCT00975221|366090162|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
106118031|NCT00975221|366090163|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
106118032|NCT00840996|366090170|FG000|Overall Study|Withdrawal by Subject|1|||
106118033|NCT00840996|366090171|FG001|Overall Study|Withdrawal by Subject|0|||
106118034|NCT00332332|366090176|FG000|Overall Study|Adverse Event|13|||
106118035|NCT00332332|366090176|FG000|Overall Study|Death|1|||
106118036|NCT00332332|366090176|FG000|Overall Study|Withdrawal by Subject|8|||
106118037|NCT00332332|366090176|FG000|Overall Study|Physician Decision|1|||
106118038|NCT00332332|366090176|FG000|Overall Study|Lost to Follow-up|3|||
106118039|NCT00332332|366090176|FG000|Overall Study|Protocol deviation|4|||
106118040|NCT00332332|366090176|FG000|Overall Study|Noncompliance|2|||
106118041|NCT00332332|366090176|FG000|Overall Study|Disease progression|2|||
106118042|NCT00332332|366090176|FG000|Overall Study|Other|18|||
106118043|NCT00332332|366090176|FG000|Overall Study|Did not receive study treatment|16|||
106118044|NCT02746575|366090177|FG000|Overall Study|Surgery cancelled or time chaned|13|||
106118045|NCT02746575|366090177|FG000|Overall Study|Received epidural|10|||
106118046|NCT02746575|366090177|FG000|Overall Study|Withdrawal by Subject|3|||
106118047|NCT02746575|366090177|FG000|Overall Study|Bradycardia/hypotension|9|||
106118048|NCT02746575|366090177|FG000|Overall Study|Study paused|8|||
106118049|NCT02746575|366090177|FG000|Overall Study|put on beta-blocker|3|||
106118050|NCT02746575|366090177|FG000|Overall Study|type of surgery|1|||
106118051|NCT02746575|366090177|FG000|Overall Study|typ of surgery|1|||
106118052|NCT02746575|366090177|FG000|Overall Study|PI unavailable|1|||
106118053|NCT02746575|366090177|FG000|Overall Study|Unknown history of CVA|1|||
105887843|NCT03558152|365245867|FG001|Overall Study|Adverse Event|0|||
105887844|NCT03558152|365245868|FG002|Overall Study|Adverse Event|1|||
105887845|NCT03558152|365245869|FG003|Overall Study|Adverse Event|1|||
105887846|NCT03558152|365245870|FG004|Overall Study|Adverse Event|2|||
105887847|NCT03558152|365245871|FG005|Overall Study|Adverse Event|1|||
105887848|NCT03558152|365245872|FG006|Overall Study|Adverse Event|1|||
105887849|NCT03558152|365245873|FG007|Overall Study|Adverse Event|0|||
105887850|NCT03558152|365245866|FG000|Overall Study|Death|0|||
105662156|NCT01646385|364426892|FG000|Overall Study|Death|202|||
105887851|NCT03558152|365245867|FG001|Overall Study|Death|0|||
105887852|NCT03558152|365245868|FG002|Overall Study|Death|0|||
105887853|NCT03558152|365245869|FG003|Overall Study|Death|0|||
106118054|NCT01161472|366090180|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
106118055|NCT01161472|366090181|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
106118056|NCT01161472|366090182|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
106118057|NCT01161472|366090183|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
105662157|NCT01646385|364426893|FG001|Overall Study|Death|222|||
105662158|NCT01646385|364426892|FG000|Overall Study|Switched to alternate biologic|636|||
105662159|NCT01646385|364426893|FG001|Overall Study|Switched to alternate biologic|649|||
105662160|NCT02706951|364426894|FG000|Period 1|Adverse Event|1|||
105662161|NCT02706951|364426895|FG001|Period 1|Adverse Event|5|||
105662162|NCT02706951|364426896|FG002|Period 1|Adverse Event|3|||
105995185|NCT00195663|365641855|FG001|Open-Label Extension Period|Adverse Event|32|||
105995186|NCT00195663|365641856|FG002|Open-Label Extension Period|Adverse Event|36|||
105662163|NCT02706951|364426897|FG003|Period 1|Adverse Event|0|||
105662164|NCT02706951|364426898|FG004|Period 1|Adverse Event|0|||
105662165|NCT02706951|364426894|FG000|Period 1|Withdrawal by Subject|10|||
105662166|NCT02706951|364426895|FG001|Period 1|Withdrawal by Subject|6|||
105662167|NCT02706951|364426896|FG002|Period 1|Withdrawal by Subject|6|||
105662168|NCT02706951|364426897|FG003|Period 1|Withdrawal by Subject|0|||
105662169|NCT02706951|364426898|FG004|Period 1|Withdrawal by Subject|0|||
105662170|NCT02706951|364426894|FG000|Period 1|Lost to Follow-up|0|||
105995187|NCT00195663|365641854|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
105995188|NCT00195663|365641855|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
105995189|NCT00195663|365641856|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
105995190|NCT00195663|365641854|FG000|Open-Label Extension Period|Recovery|0|||
105995191|NCT00195663|365641855|FG001|Open-Label Extension Period|Recovery|2|||
105995192|NCT00195663|365641856|FG002|Open-Label Extension Period|Recovery|2|||
105995193|NCT00195663|365641854|FG000|Open-Label Extension Period|Protocol Violation|3|||
105662171|NCT02706951|364426895|FG001|Period 1|Lost to Follow-up|4|||
105662172|NCT02706951|364426896|FG002|Period 1|Lost to Follow-up|1|||
105662173|NCT02706951|364426897|FG003|Period 1|Lost to Follow-up|0|||
105662174|NCT02706951|364426898|FG004|Period 1|Lost to Follow-up|0|||
105995194|NCT00195663|365641855|FG001|Open-Label Extension Period|Protocol Violation|4|||
105995195|NCT00195663|365641856|FG002|Open-Label Extension Period|Protocol Violation|4|||
105995196|NCT00195663|365641854|FG000|Open-Label Extension Period|Death|2|||
105995197|NCT00195663|365641855|FG001|Open-Label Extension Period|Death|2|||
105662175|NCT02706951|364426894|FG000|Period 1|Other|2|||
105662176|NCT02706951|364426895|FG001|Period 1|Other|1|||
105662177|NCT02706951|364426896|FG002|Period 1|Other|0|||
105887854|NCT03558152|365245870|FG004|Overall Study|Death|1|||
105887855|NCT03558152|365245871|FG005|Overall Study|Death|0|||
105887856|NCT03558152|365245872|FG006|Overall Study|Death|0|||
105887857|NCT03558152|365245873|FG007|Overall Study|Death|0|||
105887858|NCT03558152|365245866|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
105887859|NCT03558152|365245867|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105887860|NCT03558152|365245868|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105887861|NCT03558152|365245869|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105887862|NCT03558152|365245870|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105887863|NCT03558152|365245871|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105887864|NCT03558152|365245872|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105887865|NCT03558152|365245873|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
105887866|NCT03558152|365245866|FG000|Overall Study|Miscalculation in mmcs|0|||
105887867|NCT03558152|365245867|FG001|Overall Study|Miscalculation in mmcs|0|||
105887868|NCT03558152|365245868|FG002|Overall Study|Miscalculation in mmcs|0|||
105887869|NCT03558152|365245869|FG003|Overall Study|Miscalculation in mmcs|0|||
105887870|NCT03558152|365245870|FG004|Overall Study|Miscalculation in mmcs|0|||
105887871|NCT03558152|365245871|FG005|Overall Study|Miscalculation in mmcs|0|||
105887872|NCT03558152|365245872|FG006|Overall Study|Miscalculation in mmcs|1|||
105887873|NCT03558152|365245873|FG007|Overall Study|Miscalculation in mmcs|0|||
105887874|NCT03558152|365245866|FG000|Overall Study|Mistake in calculation|0|||
105887875|NCT03558152|365245867|FG001|Overall Study|Mistake in calculation|0|||
105887876|NCT03558152|365245868|FG002|Overall Study|Mistake in calculation|0|||
105887877|NCT03558152|365245869|FG003|Overall Study|Mistake in calculation|1|||
105887878|NCT03558152|365245870|FG004|Overall Study|Mistake in calculation|0|||
105887879|NCT03558152|365245871|FG005|Overall Study|Mistake in calculation|0|||
105887880|NCT03558152|365245872|FG006|Overall Study|Mistake in calculation|0|||
105887881|NCT03558152|365245873|FG007|Overall Study|Mistake in calculation|0|||
105887882|NCT03558152|365245866|FG000|Overall Study|Mistake in evaluation of disease status|0|||
105887883|NCT03558152|365245867|FG001|Overall Study|Mistake in evaluation of disease status|0|||
105995198|NCT00195663|365641856|FG002|Open-Label Extension Period|Death|2|||
105995199|NCT00195663|365641854|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
105995200|NCT00195663|365641855|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
105662178|NCT02706951|364426897|FG003|Period 1|Other|0|||
105887884|NCT03558152|365245868|FG002|Overall Study|Mistake in evaluation of disease status|0|||
105887885|NCT03558152|365245869|FG003|Overall Study|Mistake in evaluation of disease status|0|||
105887886|NCT03558152|365245870|FG004|Overall Study|Mistake in evaluation of disease status|0|||
105887887|NCT03558152|365245871|FG005|Overall Study|Mistake in evaluation of disease status|0|||
105662179|NCT02706951|364426898|FG004|Period 1|Other|0|||
105662180|NCT02706951|364426894|FG000|Period 2|Adverse Event|0|||
105662181|NCT02706951|364426895|FG001|Period 2|Adverse Event|0|||
105662182|NCT02706951|364426896|FG002|Period 2|Adverse Event|0|||
105887888|NCT03558152|365245872|FG006|Overall Study|Mistake in evaluation of disease status|0|||
105887889|NCT03558152|365245873|FG007|Overall Study|Mistake in evaluation of disease status|1|||
105887890|NCT03558152|365245866|FG000|Overall Study|Physician Decision|0|||
105887891|NCT03558152|365245867|FG001|Overall Study|Physician Decision|0|||
105887892|NCT03558152|365245868|FG002|Overall Study|Physician Decision|0|||
105887893|NCT03558152|365245869|FG003|Overall Study|Physician Decision|0|||
105887894|NCT03558152|365245870|FG004|Overall Study|Physician Decision|0|||
105887895|NCT03558152|365245871|FG005|Overall Study|Physician Decision|0|||
105887896|NCT03558152|365245872|FG006|Overall Study|Physician Decision|1|||
105887897|NCT03558152|365245873|FG007|Overall Study|Physician Decision|0|||
105887898|NCT03558152|365245866|FG000|Overall Study|Withdrawal by Subject|2|||
105887899|NCT03558152|365245867|FG001|Overall Study|Withdrawal by Subject|3|||
105887900|NCT03558152|365245868|FG002|Overall Study|Withdrawal by Subject|2|||
105887901|NCT03558152|365245869|FG003|Overall Study|Withdrawal by Subject|1|||
105887902|NCT03558152|365245870|FG004|Overall Study|Withdrawal by Subject|1|||
105887903|NCT03558152|365245871|FG005|Overall Study|Withdrawal by Subject|1|||
105887904|NCT03558152|365245872|FG006|Overall Study|Withdrawal by Subject|3|||
105887905|NCT03558152|365245873|FG007|Overall Study|Withdrawal by Subject|2|||
105887906|NCT03558152|365245866|FG000|Overall Study|Lack of Efficacy|11|||
105887907|NCT03558152|365245867|FG001|Overall Study|Lack of Efficacy|11|||
105887908|NCT03558152|365245868|FG002|Overall Study|Lack of Efficacy|10|||
105887909|NCT03558152|365245869|FG003|Overall Study|Lack of Efficacy|11|||
105887910|NCT03558152|365245870|FG004|Overall Study|Lack of Efficacy|14|||
105887911|NCT03558152|365245871|FG005|Overall Study|Lack of Efficacy|12|||
105887912|NCT03558152|365245872|FG006|Overall Study|Lack of Efficacy|14|||
105887913|NCT03558152|365245873|FG007|Overall Study|Lack of Efficacy|13|||
105887914|NCT03558152|365245866|FG000|Overall Study|Protocol Violation|1|||
105887915|NCT03558152|365245867|FG001|Overall Study|Protocol Violation|1|||
105887916|NCT03558152|365245868|FG002|Overall Study|Protocol Violation|0|||
105887917|NCT03558152|365245869|FG003|Overall Study|Protocol Violation|1|||
105995201|NCT00195663|365641856|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
106118058|NCT00798174|366090184|FG000|Overall Study|inability to implant azygos coil|3|||
106118059|NCT00798174|366090185|FG001|Overall Study|inability to implant azygos coil|3|||
106118060|NCT00798174|366090184|FG000|Overall Study|Inability to sedate for DFT testing|1|||
106118061|NCT00798174|366090185|FG001|Overall Study|Inability to sedate for DFT testing|0|||
106118062|NCT02887989|366090189|FG000|Overall Study|Withdrawal by Subject|8|||
106118063|NCT02887989|366090190|FG001|Overall Study|Withdrawal by Subject|11|||
106118064|NCT02887989|366090189|FG000|Overall Study|Death|1|||
106118065|NCT02887989|366090190|FG001|Overall Study|Death|0|||
106118066|NCT00674323|366090191|FG000|Overall Study|Adverse Event|0|||
106118067|NCT00674323|366090192|FG001|Overall Study|Adverse Event|1|||
106118068|NCT00674323|366090193|FG002|Overall Study|Adverse Event|0|||
106118069|NCT00674323|366090191|FG000|Overall Study|Protocol Violation|1|||
106118070|NCT00674323|366090192|FG001|Overall Study|Protocol Violation|0|||
106118071|NCT00674323|366090193|FG002|Overall Study|Protocol Violation|0|||
106118072|NCT03093428|366090197|FG000|Overall Study|Not eligible for treatment|2|||
106118073|NCT03093428|366090198|FG001|Overall Study|Not eligible for treatment|1|||
106118074|NCT03093428|366090197|FG000|Overall Study|Progression|14|||
106118075|NCT03093428|366090198|FG001|Overall Study|Progression|4|||
106118076|NCT03093428|366090197|FG000|Overall Study|Death|1|||
106118077|NCT03093428|366090198|FG001|Overall Study|Death|0|||
106118078|NCT03093428|366090197|FG000|Overall Study|Adverse Event|1|||
106118079|NCT03093428|366090198|FG001|Overall Study|Adverse Event|0|||
106118080|NCT03093428|366090197|FG000|Overall Study|Withdrawal by Subject|1|||
106118081|NCT03093428|366090198|FG001|Overall Study|Withdrawal by Subject|1|||
106118082|NCT00041756|366090199|FG000|Overall Study|Adverse Event|4|||
106118083|NCT00041756|366090200|FG001|Overall Study|Adverse Event|10|||
106118084|NCT00041756|366090201|FG002|Overall Study|Adverse Event|6|||
105662183|NCT02706951|364426897|FG003|Period 2|Adverse Event|25|||
105662184|NCT02706951|364426898|FG004|Period 2|Adverse Event|34|||
105662185|NCT02706951|364426894|FG000|Period 2|Withdrawal by Subject|0|||
106118085|NCT00041756|366090202|FG003|Overall Study|Adverse Event|11|||
105662186|NCT02706951|364426895|FG001|Period 2|Withdrawal by Subject|0|||
105662187|NCT02706951|364426896|FG002|Period 2|Withdrawal by Subject|0|||
105887918|NCT03558152|365245870|FG004|Overall Study|Protocol Violation|1|||
105887919|NCT03558152|365245871|FG005|Overall Study|Protocol Violation|0|||
105887920|NCT03558152|365245872|FG006|Overall Study|Protocol Violation|2|||
105887921|NCT03558152|365245873|FG007|Overall Study|Protocol Violation|0|||
105887922|NCT03693612|365245874|FG000|Overall Study|Lost to Follow-up|0|||
105887923|NCT03693612|365245875|FG001|Overall Study|Lost to Follow-up|0|||
105887924|NCT03693612|365245876|FG002|Overall Study|Lost to Follow-up|0|||
105887925|NCT03693612|365245877|FG003|Overall Study|Lost to Follow-up|0|||
105887926|NCT03693612|365245878|FG004|Overall Study|Lost to Follow-up|1|||
106118086|NCT00041756|366090203|FG004|Overall Study|Adverse Event|34|||
106118087|NCT00041756|366090199|FG000|Overall Study|Protocol Violation|1|||
106118088|NCT00041756|366090200|FG001|Overall Study|Protocol Violation|1|||
106118089|NCT00041756|366090201|FG002|Overall Study|Protocol Violation|2|||
106118090|NCT00041756|366090202|FG003|Overall Study|Protocol Violation|2|||
106118091|NCT00041756|366090203|FG004|Overall Study|Protocol Violation|1|||
105662188|NCT02706951|364426897|FG003|Period 2|Withdrawal by Subject|38|||
105662189|NCT02706951|364426898|FG004|Period 2|Withdrawal by Subject|44|||
105662190|NCT02706951|364426894|FG000|Period 2|Lost to Follow-up|0|||
105662191|NCT02706951|364426895|FG001|Period 2|Lost to Follow-up|0|||
105662192|NCT02706951|364426896|FG002|Period 2|Lost to Follow-up|0|||
105662193|NCT02706951|364426897|FG003|Period 2|Lost to Follow-up|17|||
105662194|NCT02706951|364426898|FG004|Period 2|Lost to Follow-up|9|||
105662195|NCT02706951|364426894|FG000|Period 2|COVID-19 Related|0|||
105662196|NCT02706951|364426895|FG001|Period 2|COVID-19 Related|0|||
105662197|NCT02706951|364426896|FG002|Period 2|COVID-19 Related|0|||
105662198|NCT02706951|364426897|FG003|Period 2|COVID-19 Related|1|||
105662199|NCT02706951|364426898|FG004|Period 2|COVID-19 Related|2|||
105662200|NCT02706951|364426894|FG000|Period 2|Other|0|||
105662201|NCT02706951|364426895|FG001|Period 2|Other|0|||
105662202|NCT02706951|364426896|FG002|Period 2|Other|0|||
105662203|NCT02706951|364426897|FG003|Period 2|Other|37|||
105662204|NCT02706951|364426898|FG004|Period 2|Other|31|||
105662205|NCT03721172|364426900|FG000|Placebo-controlled Phase|Adverse Event|7|||
105662206|NCT03721172|364426901|FG001|Placebo-controlled Phase|Adverse Event|7|||
105662207|NCT03721172|364426902|FG002|Placebo-controlled Phase|Adverse Event|0|||
105662208|NCT03721172|364426900|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
105662209|NCT03721172|364426901|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
105662210|NCT03721172|364426902|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
105662211|NCT03721172|364426900|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
105662212|NCT03721172|364426901|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
105662213|NCT03721172|364426902|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
105662214|NCT03721172|364426900|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
105662215|NCT03721172|364426901|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
105662216|NCT03721172|364426902|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
105662217|NCT03721172|364426900|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
105662218|NCT03721172|364426901|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
105662219|NCT03721172|364426902|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
105662220|NCT03721172|364426900|FG000|Placebo-controlled Phase|Other|3|||
105662221|NCT03721172|364426901|FG001|Placebo-controlled Phase|Other|0|||
105662222|NCT03721172|364426902|FG002|Placebo-controlled Phase|Other|0|||
105662223|NCT03721172|364426900|FG000|Apremilast Extension Phase|Adverse Event|0|||
105662224|NCT03721172|364426901|FG001|Apremilast Extension Phase|Adverse Event|0|||
105662225|NCT03721172|364426902|FG002|Apremilast Extension Phase|Adverse Event|10|||
105662226|NCT03721172|364426900|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
105662227|NCT03721172|364426901|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
105662228|NCT03721172|364426902|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
105662229|NCT03721172|364426900|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
105662230|NCT03721172|364426901|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
105662231|NCT03721172|364426902|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
105662232|NCT03721172|364426900|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
105662233|NCT03721172|364426901|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
105662234|NCT03721172|364426902|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
105662235|NCT03721172|364426900|FG000|Apremilast Extension Phase|Protocol Violation|0|||
105662236|NCT03721172|364426901|FG001|Apremilast Extension Phase|Protocol Violation|0|||
105662237|NCT03721172|364426902|FG002|Apremilast Extension Phase|Protocol Violation|1|||
105662238|NCT03721172|364426900|FG000|Apremilast Extension Phase|Physician Decision|0|||
105662239|NCT03721172|364426901|FG001|Apremilast Extension Phase|Physician Decision|0|||
105662240|NCT03721172|364426902|FG002|Apremilast Extension Phase|Physician Decision|1|||
105662241|NCT03721172|364426900|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
105662242|NCT03721172|364426901|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
105662243|NCT03721172|364426902|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
105662244|NCT03721172|364426900|FG000|Apremilast Extension Phase|Other|0|||
105662245|NCT03721172|364426901|FG001|Apremilast Extension Phase|Other|0|||
105662246|NCT03721172|364426902|FG002|Apremilast Extension Phase|Other|3|||
105662247|NCT03721172|364426900|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
105662248|NCT03721172|364426901|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
106118092|NCT00041756|366090199|FG000|Overall Study|Withdrawal by Subject|3|||
105662249|NCT03721172|364426902|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
105662250|NCT01777334|364426906|FG000|Overall Study|Adverse Event|18|||
105662251|NCT01777334|364426907|FG001|Overall Study|Adverse Event|14|||
105662252|NCT01777334|364426906|FG000|Overall Study|Lack of Efficacy|15|||
105662253|NCT01777334|364426907|FG001|Overall Study|Lack of Efficacy|29|||
105662254|NCT01777334|364426906|FG000|Overall Study|Protocol Violation|3|||
105662255|NCT01777334|364426907|FG001|Overall Study|Protocol Violation|7|||
105662256|NCT01777334|364426906|FG000|Overall Study|Lost to Follow-up|3|||
105662257|NCT01777334|364426907|FG001|Overall Study|Lost to Follow-up|2|||
105662258|NCT01777334|364426906|FG000|Overall Study|Withdrawal by Subject|14|||
105662259|NCT01777334|364426907|FG001|Overall Study|Withdrawal by Subject|11|||
105995202|NCT00195663|365641854|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
105662260|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
106118093|NCT00041756|366090200|FG001|Overall Study|Withdrawal by Subject|3|||
106118094|NCT00041756|366090201|FG002|Overall Study|Withdrawal by Subject|4|||
106118095|NCT00041756|366090202|FG003|Overall Study|Withdrawal by Subject|2|||
106118096|NCT00041756|366090203|FG004|Overall Study|Withdrawal by Subject|3|||
106118097|NCT00041756|366090199|FG000|Overall Study|Lost to Follow-up|0|||
106118098|NCT00041756|366090200|FG001|Overall Study|Lost to Follow-up|1|||
106118099|NCT00041756|366090201|FG002|Overall Study|Lost to Follow-up|0|||
106118100|NCT00041756|366090202|FG003|Overall Study|Lost to Follow-up|1|||
106118101|NCT00041756|366090203|FG004|Overall Study|Lost to Follow-up|0|||
106118102|NCT00041756|366090199|FG000|Overall Study|Unable to meet protocol criteria|0|||
106118103|NCT00041756|366090200|FG001|Overall Study|Unable to meet protocol criteria|0|||
106118104|NCT00041756|366090201|FG002|Overall Study|Unable to meet protocol criteria|1|||
106118105|NCT00041756|366090202|FG003|Overall Study|Unable to meet protocol criteria|0|||
106118106|NCT00041756|366090203|FG004|Overall Study|Unable to meet protocol criteria|1|||
106118107|NCT00041756|366090199|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
106118108|NCT00041756|366090200|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
106118109|NCT00041756|366090201|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
106118110|NCT00041756|366090202|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
106118111|NCT00041756|366090203|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
106118112|NCT03980184|366090204|FG000|Overall Study|Dropped out before treatment|2|||
105887927|NCT03693612|365245879|FG005|Overall Study|Lost to Follow-up|0|||
105887928|NCT03693612|365245880|FG006|Overall Study|Lost to Follow-up|0|||
106118113|NCT03980184|366090205|FG001|Overall Study|Dropped out before treatment|2|||
106118114|NCT03980184|366090204|FG000|Overall Study|Lost to Follow-up|11|||
105887929|NCT03693612|365245874|FG000|Overall Study|Withdrawal by Subject|0|||
105887930|NCT03693612|365245875|FG001|Overall Study|Withdrawal by Subject|0|||
105887931|NCT03693612|365245876|FG002|Overall Study|Withdrawal by Subject|1|||
105887932|NCT03693612|365245877|FG003|Overall Study|Withdrawal by Subject|0|||
105887933|NCT03693612|365245878|FG004|Overall Study|Withdrawal by Subject|2|||
105887934|NCT03693612|365245879|FG005|Overall Study|Withdrawal by Subject|0|||
105887935|NCT03693612|365245880|FG006|Overall Study|Withdrawal by Subject|0|||
105887936|NCT03693612|365245874|FG000|Overall Study|Study Terminated by Sponsor|0|||
105887937|NCT03693612|365245875|FG001|Overall Study|Study Terminated by Sponsor|1|||
105887938|NCT03693612|365245876|FG002|Overall Study|Study Terminated by Sponsor|0|||
105887939|NCT03693612|365245877|FG003|Overall Study|Study Terminated by Sponsor|0|||
105887940|NCT03693612|365245878|FG004|Overall Study|Study Terminated by Sponsor|3|||
105887941|NCT03693612|365245879|FG005|Overall Study|Study Terminated by Sponsor|0|||
106118115|NCT03980184|366090205|FG001|Overall Study|Lost to Follow-up|13|||
105887942|NCT03693612|365245880|FG006|Overall Study|Study Terminated by Sponsor|0|||
105887943|NCT05318092|365245881|FG000|Overall Study|Lost to Follow-up|3|||
105887944|NCT05318092|365245881|FG000|Overall Study|Withdrawal by Subject|1|||
105887945|NCT03917472|365245885|FG000|Overall Study|Physician Decision|4|||
105887946|NCT03917472|365245886|FG001|Overall Study|Physician Decision|0|||
105887947|NCT03917472|365245885|FG000|Overall Study|Adverse Event|3|||
105887948|NCT03917472|365245886|FG001|Overall Study|Adverse Event|1|||
105887949|NCT03917472|365245885|FG000|Overall Study|Death|7|||
105887950|NCT03917472|365245886|FG001|Overall Study|Death|5|||
106118116|NCT01112514|366090209|FG000|Overall Study|Lost to Follow-up|1|||
106118117|NCT02948959|366090216|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
106118118|NCT02948959|366090217|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
106118119|NCT02948959|366090216|FG000|52 Weeks Treatment Period|Adverse Event|2|||
106118120|NCT02948959|366090217|FG001|52 Weeks Treatment Period|Adverse Event|5|||
106118121|NCT02948959|366090216|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
106118122|NCT02948959|366090217|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
106118123|NCT02948959|366090216|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
106118124|NCT02948959|366090217|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
106118125|NCT02948959|366090216|FG000|52 Weeks Treatment Period|Randomized by error|0|||
106118126|NCT02948959|366090217|FG001|52 Weeks Treatment Period|Randomized by error|5|||
106118127|NCT02948959|366090216|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
106118128|NCT02948959|366090217|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
106118129|NCT02948959|366090216|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
106118130|NCT02948959|366090217|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
106118131|NCT02948959|366090216|FG000|52 Weeks Treatment Period|Change of residence location|0|||
106118132|NCT02948959|366090217|FG001|52 Weeks Treatment Period|Change of residence location|1|||
106118133|NCT02948959|366090216|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
106118134|NCT02948959|366090217|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
105887951|NCT03917472|365245885|FG000|Overall Study|Withdrawal by Subject|11|||
105887952|NCT03917472|365245886|FG001|Overall Study|Withdrawal by Subject|4|||
105887953|NCT03917472|365245885|FG000|Overall Study|Lost to Follow-up|10|||
105887954|NCT03917472|365245886|FG001|Overall Study|Lost to Follow-up|5|||
105887955|NCT01669174|365245887|FG000|Overall Study|Subject withdrew consent|2|||
105887956|NCT01669174|365245888|FG001|Overall Study|Subject withdrew consent|2|||
105887957|NCT01669174|365245887|FG000|Overall Study|Lost to Follow-up|1|||
105662261|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
105662262|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
105662263|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
105662264|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
105662265|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
105662266|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
105662267|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
105662268|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
105662269|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
105662270|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
105662271|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
105662272|NCT01216072|364426913|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
105662273|NCT01216072|364426914|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
105662274|NCT01216072|364426913|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
105662275|NCT01216072|364426914|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
105662276|NCT01216072|364426913|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
105662277|NCT01216072|364426914|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
105662278|NCT01216072|364426913|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
105662279|NCT01216072|364426914|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
105662280|NCT04294667|364426919|FG000|Overall Study|Lack of Efficacy|4|||
105662281|NCT04294667|364426920|FG001|Overall Study|Lack of Efficacy|4|||
105662282|NCT04294667|364426919|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
105662283|NCT04294667|364426920|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
105662284|NCT04294667|364426919|FG000|Overall Study|Patient has a Renal Flare|1|||
105662285|NCT04294667|364426920|FG001|Overall Study|Patient has a Renal Flare|0|||
105662286|NCT04294667|364426919|FG000|Overall Study|SLE Worsening|0|||
105662287|NCT04294667|364426920|FG001|Overall Study|SLE Worsening|1|||
105662288|NCT04294667|364426919|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
105662289|NCT04294667|364426920|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
105662290|NCT04294667|364426919|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
105662291|NCT04294667|364426920|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
105662292|NCT04294667|364426919|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
105662293|NCT04294667|364426920|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
105662294|NCT04294667|364426919|FG000|Overall Study|Subject Moved to Another State|0|||
105662295|NCT04294667|364426920|FG001|Overall Study|Subject Moved to Another State|1|||
105662296|NCT04294667|364426919|FG000|Overall Study|Adverse event, serious fatal|0|||
105662297|NCT04294667|364426920|FG001|Overall Study|Adverse event, serious fatal|1|||
105662298|NCT04294667|364426919|FG000|Overall Study|Adverse event, non-fatal|3|||
105662299|NCT04294667|364426920|FG001|Overall Study|Adverse event, non-fatal|4|||
105662300|NCT03016598|364426921|FG000|Overall Study|Lost to Follow-up|0|||
105662301|NCT03016598|364426922|FG001|Overall Study|Lost to Follow-up|2|||
105662302|NCT00756457|364426923|FG000|Overall Study|Lost to Follow-up|1|||
105662303|NCT00756457|364426924|FG001|Overall Study|Lost to Follow-up|2|||
105662304|NCT00822770|364426927|FG000|Overall Study|Not treated|1|||
105662305|NCT00822770|364426928|FG001|Overall Study|Not treated|0|||
105662306|NCT00822770|364426927|FG000|Overall Study|Complication/Incomplete treatment|1|||
105662307|NCT00822770|364426928|FG001|Overall Study|Complication/Incomplete treatment|0|||
105662308|NCT00822770|364426927|FG000|Overall Study|Death|1|||
105662309|NCT00822770|364426928|FG001|Overall Study|Death|1|||
105662310|NCT02402322|364426929|FG000|Pretreatment|Withdrawal by Subject|3|||
105662311|NCT02402322|364426930|FG001|Pretreatment|Withdrawal by Subject|1|||
105662312|NCT02402322|364426931|FG002|Pretreatment|Withdrawal by Subject|1|||
105662313|NCT02402322|364426929|FG000|Follow-up|Withdrawal by Subject|6|||
105662314|NCT02402322|364426930|FG001|Follow-up|Withdrawal by Subject|3|||
105662315|NCT02402322|364426931|FG002|Follow-up|Withdrawal by Subject|24|||
105662316|NCT01772563|364426932|FG000|Cycle 1|Dose limiting toxicity|2|||
105662317|NCT01772563|364426932|FG000|Cycle 1|Progressive disease|2|||
105662318|NCT01772563|364426932|FG000|Cycle 2 and Beyond|Progressive disease|17|||
105662319|NCT01772563|364426932|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
105662320|NCT01772563|364426932|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
105662321|NCT01192776|364426933|FG000|Overall Study|Death|8|||
105887958|NCT01669174|365245888|FG001|Overall Study|Lost to Follow-up|0|||
105887959|NCT01669174|365245887|FG000|Overall Study|Adverse Event|2|||
105662322|NCT01192776|364426934|FG001|Overall Study|Death|15|||
105662323|NCT01192776|364426935|FG002|Overall Study|Death|18|||
105662324|NCT01192776|364426936|FG003|Overall Study|Death|15|||
105662325|NCT01192776|364426933|FG000|Overall Study|Lost to Follow-up|3|||
105662326|NCT01192776|364426934|FG001|Overall Study|Lost to Follow-up|6|||
105662327|NCT01192776|364426935|FG002|Overall Study|Lost to Follow-up|3|||
105662328|NCT01192776|364426936|FG003|Overall Study|Lost to Follow-up|5|||
105887960|NCT01669174|365245888|FG001|Overall Study|Adverse Event|2|||
105662329|NCT02993523|364426941|FG000|Overall Study|Withdrew Consent|0|||
105887961|NCT01669174|365245887|FG000|Overall Study|Administrative problems|1|||
105662330|NCT02993523|364426942|FG001|Overall Study|Withdrew Consent|0|||
105662331|NCT02993523|364426943|FG002|Overall Study|Withdrew Consent|2|||
105662332|NCT02993523|364426944|FG003|Overall Study|Withdrew Consent|9|||
105662333|NCT02993523|364426945|FG004|Overall Study|Withdrew Consent|0|||
105662334|NCT02993523|364426941|FG000|Overall Study|Lost to Follow-up|0|||
105662335|NCT02993523|364426942|FG001|Overall Study|Lost to Follow-up|0|||
105662336|NCT02993523|364426943|FG002|Overall Study|Lost to Follow-up|3|||
105662337|NCT02993523|364426944|FG003|Overall Study|Lost to Follow-up|6|||
105662338|NCT02993523|364426945|FG004|Overall Study|Lost to Follow-up|0|||
105662339|NCT02993523|364426941|FG000|Overall Study|Death|1|||
105662340|NCT02993523|364426942|FG001|Overall Study|Death|1|||
105662341|NCT02993523|364426943|FG002|Overall Study|Death|138|||
105662342|NCT02993523|364426944|FG003|Overall Study|Death|222|||
105662343|NCT02993523|364426945|FG004|Overall Study|Death|6|||
105662344|NCT02993523|364426941|FG000|Overall Study|Reason not Specified|0|||
105662345|NCT02993523|364426942|FG001|Overall Study|Reason not Specified|0|||
105662346|NCT02993523|364426943|FG002|Overall Study|Reason not Specified|1|||
105662347|NCT02993523|364426944|FG003|Overall Study|Reason not Specified|1|||
105662348|NCT02993523|364426945|FG004|Overall Study|Reason not Specified|0|||
105662349|NCT04978350|364428081|FG000|Overall Study|Lost to Follow-up|6|||
105662350|NCT05765435|364428083|FG000|Overall Study|Lost to Follow-up|0|||
105662351|NCT05765435|364428084|FG001|Overall Study|Lost to Follow-up|1|||
105662352|NCT05765435|364428085|FG002|Overall Study|Lost to Follow-up|0|||
105662353|NCT05765435|364428083|FG000|Overall Study|Withdrawal by Subject|0|||
105662354|NCT05765435|364428084|FG001|Overall Study|Withdrawal by Subject|0|||
105662355|NCT05765435|364428085|FG002|Overall Study|Withdrawal by Subject|1|||
105662356|NCT03065933|364428087|FG000|Overall Study|study terminated|5|||
105662357|NCT02375347|364428092|FG000|Overall Study|Protocol Violation|1|||
105662358|NCT01547598|364428097|FG000|Overall Study|Withdrew consent|1|||
105662359|NCT01547598|364428098|FG001|Overall Study|Withdrew consent|1|||
105662360|NCT01547598|364428097|FG000|Overall Study|Lost to Follow-up|1|||
105662361|NCT01547598|364428098|FG001|Overall Study|Lost to Follow-up|1|||
105662362|NCT01547598|364428097|FG000|Overall Study|Adverse Event|1|||
105662363|NCT01547598|364428098|FG001|Overall Study|Adverse Event|1|||
105662364|NCT01547598|364428097|FG000|Overall Study|Protocol Violation|1|||
105662365|NCT01547598|364428098|FG001|Overall Study|Protocol Violation|1|||
105662366|NCT01547598|364428097|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105662367|NCT01547598|364428098|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105662368|NCT01288209|364428099|FG000|Overall Study|Withdrawal by Subject|1|||
105662369|NCT01288209|364428100|FG001|Overall Study|Withdrawal by Subject|3|||
105662370|NCT01288209|364428099|FG000|Overall Study|Other|1|||
105662371|NCT01288209|364428100|FG001|Overall Study|Other|0|||
105662372|NCT01841697|364428110|FG000|Overall Study|Death|0|||
105662373|NCT01841697|364428111|FG001|Overall Study|Death|1|||
105662374|NCT01841697|364428110|FG000|Overall Study|Lost to Follow-up|4|||
105662375|NCT01841697|364428111|FG001|Overall Study|Lost to Follow-up|1|||
105662376|NCT01841697|364428110|FG000|Overall Study|Withdrawal by Subject|16|||
105662377|NCT01841697|364428111|FG001|Overall Study|Withdrawal by Subject|16|||
105662378|NCT01777490|364428112|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
105662379|NCT01777490|364428113|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
105662380|NCT01777490|364428114|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
105662381|NCT01777490|364428115|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
105662382|NCT02947100|364428116|FG000|Overall Study|study terminated early|3|||
105662383|NCT02947100|364428116|FG000|Overall Study|did not meet inclusion criteria|1|||
105662384|NCT00992992|364428119|FG000|Overall Study|Lost to Follow-up|3|||
105662385|NCT00992992|364428119|FG000|Overall Study|Death|16|||
105662386|NCT00992992|364428119|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
105662387|NCT00992992|364428119|FG000|Overall Study|Sponsor Closed the Study|4|||
105662388|NCT01776008|364428120|FG000|Overall Study|ineligible|2|||
105662389|NCT02287233|364428124|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
105662390|NCT02287233|364428125|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
105662391|NCT02287233|364428126|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
105662392|NCT02287233|364428124|FG000|Overall Study|Adverse Event Related to Progression|0|||
105662393|NCT02287233|364428125|FG001|Overall Study|Adverse Event Related to Progression|2|||
105662394|NCT02287233|364428126|FG002|Overall Study|Adverse Event Related to Progression|8|||
105662395|NCT02287233|364428124|FG000|Overall Study|Physician Decision|1|||
105662396|NCT02287233|364428125|FG001|Overall Study|Physician Decision|2|||
105662397|NCT02287233|364428126|FG002|Overall Study|Physician Decision|4|||
105662398|NCT02287233|364428124|FG000|Overall Study|Progressive Disease with Death|0|||
105662399|NCT02287233|364428125|FG001|Overall Study|Progressive Disease with Death|0|||
105662400|NCT02287233|364428126|FG002|Overall Study|Progressive Disease with Death|10|||
105662401|NCT02287233|364428124|FG000|Overall Study|Progressive Disease Without Death|2|||
105662402|NCT02287233|364428125|FG001|Overall Study|Progressive Disease Without Death|3|||
105887962|NCT01669174|365245888|FG001|Overall Study|Administrative problems|2|||
105662403|NCT02287233|364428126|FG002|Overall Study|Progressive Disease Without Death|20|||
105662404|NCT02287233|364428124|FG000|Overall Study|Withdrawal by Subject|1|||
105887963|NCT01154296|365245889|FG000|Randomization and Intervention|Decided to decline|1|||
105662405|NCT02287233|364428125|FG001|Overall Study|Withdrawal by Subject|1|||
105662406|NCT02287233|364428126|FG002|Overall Study|Withdrawal by Subject|7|||
105662407|NCT02287233|364428124|FG000|Overall Study|Other|3|||
105662408|NCT02287233|364428125|FG001|Overall Study|Other|0|||
105662409|NCT02287233|364428126|FG002|Overall Study|Other|15|||
105662410|NCT02287233|364428124|FG000|Overall Study|Did Not Receive Treatment|0|||
105662411|NCT02287233|364428125|FG001|Overall Study|Did Not Receive Treatment|0|||
105662412|NCT02287233|364428126|FG002|Overall Study|Did Not Receive Treatment|2|||
105662413|NCT02031536|364428129|FG000|Overall Study|ineligible|1|||
105662414|NCT02031536|364428130|FG001|Overall Study|ineligible|0|||
105662415|NCT01850030|364428131|FG000|Overall Study|Adverse Event|64|||
105662416|NCT01850030|364428132|FG001|Overall Study|Adverse Event|82|||
105662417|NCT01850030|364428131|FG000|Overall Study|Lack of Efficacy|3|||
105662418|NCT01850030|364428132|FG001|Overall Study|Lack of Efficacy|1|||
105662419|NCT01850030|364428131|FG000|Overall Study|Lost to Follow-up|5|||
105662420|NCT01850030|364428132|FG001|Overall Study|Lost to Follow-up|5|||
105662421|NCT01850030|364428131|FG000|Overall Study|Withdrawal by Subject|3|||
105662422|NCT01850030|364428132|FG001|Overall Study|Withdrawal by Subject|4|||
105662423|NCT01850030|364428131|FG000|Overall Study|Protocol Violation|24|||
105662424|NCT01850030|364428132|FG001|Overall Study|Protocol Violation|28|||
105662425|NCT01850030|364428131|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
105662426|NCT01850030|364428132|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
105662427|NCT05594589|364428134|FG000|Overall Study|Other|0|||
105662428|NCT05594589|364428135|FG001|Overall Study|Other|1|||
105662429|NCT05594589|364428136|FG002|Overall Study|Other|0|||
105662430|NCT04462289|364428137|FG000|Overall Study|Lost to Follow-up|4|||
105662431|NCT04462289|364428138|FG001|Overall Study|Lost to Follow-up|5|||
105662432|NCT04462289|364428137|FG000|Overall Study|Death|0|||
105662433|NCT04462289|364428138|FG001|Overall Study|Death|3|||
105662434|NCT04462289|364428137|FG000|Overall Study|Withdrawal by Subject|1|||
105662435|NCT04462289|364428138|FG001|Overall Study|Withdrawal by Subject|3|||
105662436|NCT01056263|364428145|FG000|Overall Study|Adverse Event|12|||
105662437|NCT01056263|364428145|FG000|Overall Study|Death|1|||
105662438|NCT01056263|364428145|FG000|Overall Study|Withdrawal by Subject|1|||
105662439|NCT01056263|364428145|FG000|Overall Study|Lack of Efficacy|29|||
105662440|NCT01056263|364428145|FG000|Overall Study|Progressive disease|2|||
105662441|NCT01056263|364428145|FG000|Overall Study|Neoplasm progression|1|||
105662442|NCT01056263|364428145|FG000|Overall Study|Objective progression or relapse|1|||
105662443|NCT01056263|364428145|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
105662444|NCT04905849|364428149|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
105662445|NCT04905849|364428150|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
105662446|NCT03912532|364428151|FG000|Overall Study|Adverse Event|3|||
105662447|NCT03912532|364428152|FG001|Overall Study|Adverse Event|3|||
105662448|NCT03912532|364428153|FG002|Overall Study|Adverse Event|2|||
105662449|NCT03912532|364428154|FG003|Overall Study|Adverse Event|2|||
105662450|NCT03912532|364428151|FG000|Overall Study|Lost to Follow-up|3|||
105662451|NCT03912532|364428152|FG001|Overall Study|Lost to Follow-up|2|||
105662452|NCT03912532|364428153|FG002|Overall Study|Lost to Follow-up|1|||
105662453|NCT03912532|364428154|FG003|Overall Study|Lost to Follow-up|2|||
105662454|NCT03912532|364428151|FG000|Overall Study|Withdrawal by Subject|1|||
105662455|NCT03912532|364428152|FG001|Overall Study|Withdrawal by Subject|1|||
105662456|NCT03912532|364428153|FG002|Overall Study|Withdrawal by Subject|2|||
105662457|NCT03912532|364428154|FG003|Overall Study|Withdrawal by Subject|0|||
105662458|NCT03912532|364428151|FG000|Overall Study|Physician Decision|1|||
105662459|NCT03912532|364428152|FG001|Overall Study|Physician Decision|0|||
105662460|NCT03912532|364428153|FG002|Overall Study|Physician Decision|0|||
105662461|NCT03912532|364428154|FG003|Overall Study|Physician Decision|3|||
105662462|NCT03912532|364428151|FG000|Overall Study|Other|0|||
105662463|NCT03912532|364428152|FG001|Overall Study|Other|1|||
105662464|NCT03912532|364428153|FG002|Overall Study|Other|1|||
105662465|NCT03912532|364428154|FG003|Overall Study|Other|0|||
105662466|NCT04199052|364428159|FG000|Overall Study|Lost to Follow-up|11|||
105662467|NCT04199052|364428160|FG001|Overall Study|Lost to Follow-up|18|||
105662468|NCT05990387|364428161|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
105662469|NCT05990387|364428162|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
105662470|NCT04907357|364428163|FG000|Overall Study|Death|0|||
105662471|NCT04907357|364428164|FG001|Overall Study|Death|1|||
105662472|NCT04907357|364428163|FG000|Overall Study|Lost to Follow-up|9|||
105662473|NCT04907357|364428164|FG001|Overall Study|Lost to Follow-up|18|||
105662474|NCT04907357|364428163|FG000|Overall Study|Physician Decision|1|||
105662475|NCT04907357|364428164|FG001|Overall Study|Physician Decision|0|||
105662476|NCT04907357|364428163|FG000|Overall Study|Withdrawal by Subject|0|||
105662477|NCT04907357|364428164|FG001|Overall Study|Withdrawal by Subject|1|||
105662478|NCT04907357|364428163|FG000|Overall Study|Unable to attend visits|1|||
105662479|NCT04907357|364428164|FG001|Overall Study|Unable to attend visits|0|||
105662480|NCT04907357|364428163|FG000|Overall Study|Incarcerated|1|||
105662481|NCT04907357|364428164|FG001|Overall Study|Incarcerated|1|||
105662482|NCT03522389|364428165|FG000|Overall Study|Lost to Follow-up|1|||
105995203|NCT00195663|365641855|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
105995204|NCT00195663|365641856|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
105995205|NCT00195663|365641854|FG000|Open-Label Extension Period|Administrative reasons|11|||
105995206|NCT00195663|365641855|FG001|Open-Label Extension Period|Administrative reasons|11|||
105995207|NCT00195663|365641856|FG002|Open-Label Extension Period|Administrative reasons|13|||
105995208|NCT02978833|365641857|FG000|Overall Study|Study terminated|1|||
105995209|NCT02978833|365641858|FG001|Overall Study|Study terminated|1|||
105995210|NCT00103740|365641859|FG000|Period 1 - Core|Adverse Event|1|||
105995211|NCT00103740|365641860|FG001|Period 1 - Core|Adverse Event|0|||
105995212|NCT00103740|365641859|FG000|Period 1 - Core|Protocol Violation|3|||
105995213|NCT00103740|365641860|FG001|Period 1 - Core|Protocol Violation|2|||
105995214|NCT00103740|365641859|FG000|Period 1 - Core|Patient withdrew consent|3|||
105995215|NCT00103740|365641860|FG001|Period 1 - Core|Patient withdrew consent|2|||
105995216|NCT00103740|365641859|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
105995217|NCT00103740|365641860|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
105995218|NCT00103740|365641859|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
105995219|NCT00103740|365641860|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
105995220|NCT00103740|365641859|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
105995221|NCT00103740|365641860|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
105995222|NCT00103740|365641859|FG000|Period 2 - Extended Observation Period|Death|6|||
105995223|NCT00103740|365641860|FG001|Period 2 - Extended Observation Period|Death|2|||
105995224|NCT00103740|365641859|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
105995225|NCT00103740|365641860|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
105995226|NCT00555217|365641861|FG000|Overall Study|Withdrawal by Subject|35|||
105995227|NCT00555217|365641862|FG001|Overall Study|Withdrawal by Subject|31|||
105995228|NCT00555217|365641861|FG000|Overall Study|Lost to Follow-up|19|||
105995229|NCT00555217|365641862|FG001|Overall Study|Lost to Follow-up|20|||
105995230|NCT00555217|365641861|FG000|Overall Study|close out sites|21|||
105995231|NCT00555217|365641862|FG001|Overall Study|close out sites|17|||
105995232|NCT00291486|365641869|FG000|Overall Study|Adverse Event|0|||
105995233|NCT00291486|365641870|FG001|Overall Study|Adverse Event|3|||
105995234|NCT00291486|365641871|FG002|Overall Study|Adverse Event|0|||
105995235|NCT00291486|365641872|FG003|Overall Study|Adverse Event|1|||
105995236|NCT00291486|365641873|FG004|Overall Study|Adverse Event|0|||
106118135|NCT02948959|366090216|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
106118136|NCT02948959|366090217|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
106118137|NCT02948959|366090216|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
105887964|NCT01154296|365245890|FG001|Randomization and Intervention|Decided to decline|1|||
105887965|NCT01154296|365245889|FG000|Randomization and Intervention|Declined by staff|1|||
105887966|NCT01154296|365245890|FG001|Randomization and Intervention|Declined by staff|0|||
105887967|NCT01154296|365245889|FG000|Randomization and Intervention|Did not return|1|||
105887968|NCT01154296|365245890|FG001|Randomization and Intervention|Did not return|0|||
105887969|NCT01154296|365245889|FG000|Randomization and Intervention|Left before test|0|||
105887970|NCT01154296|365245890|FG001|Randomization and Intervention|Left before test|1|||
105887971|NCT01154296|365245889|FG000|Randomization and Intervention|Left clinic early|2|||
105887972|NCT01154296|365245890|FG001|Randomization and Intervention|Left clinic early|0|||
105887973|NCT01154296|365245889|FG000|6-month Follow-up|Lost contact|269|||
105887974|NCT01154296|365245890|FG001|6-month Follow-up|Lost contact|275|||
105887975|NCT01154296|365245889|FG000|6-month Follow-up|Incarcerated|37|||
105887976|NCT01154296|365245890|FG001|6-month Follow-up|Incarcerated|32|||
106118138|NCT02948959|366090217|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
106118139|NCT02948959|366090216|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
106118140|NCT02948959|366090217|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
106118141|NCT02948959|366090216|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
106118142|NCT02948959|366090217|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
106118143|NCT02948959|366090216|FG000|12 Weeks Follow-up Period|Study site closure|1|||
106118144|NCT02948959|366090217|FG001|12 Weeks Follow-up Period|Study site closure|0|||
106118145|NCT00409786|366090218|FG000|Overall Study|Withdrawal by Subject|3|||
106118146|NCT00301080|366090226|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
106118147|NCT00301080|366090227|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
106118148|NCT00301080|366090228|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
106118149|NCT00301080|366090229|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
106118150|NCT00301080|366090230|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
106118151|NCT03560258|366090233|FG000|Overall Study|Lost to Follow-up|3|||
106118152|NCT03560258|366090234|FG001|Overall Study|Lost to Follow-up|0|||
106118153|NCT03560258|366090235|FG002|Overall Study|Lost to Follow-up|0|||
106118154|NCT03560258|366090233|FG000|Overall Study|Protocol Violation|0|||
106118155|NCT03560258|366090234|FG001|Overall Study|Protocol Violation|1|||
105662483|NCT03522389|364428166|FG001|Overall Study|Lost to Follow-up|1|||
105887977|NCT01154296|365245889|FG000|6-month Follow-up|Withdrew consent|14|||
105887978|NCT01154296|365245890|FG001|6-month Follow-up|Withdrew consent|15|||
106118156|NCT03560258|366090235|FG002|Overall Study|Protocol Violation|0|||
106118157|NCT03560258|366090233|FG000|Overall Study|Withdrawal by Subject|0|||
106118158|NCT03560258|366090234|FG001|Overall Study|Withdrawal by Subject|0|||
106118159|NCT03560258|366090235|FG002|Overall Study|Withdrawal by Subject|1|||
106118160|NCT01872910|366090236|FG000|Overall Study|Lost to Follow-up|2|||
106118161|NCT01872910|366090237|FG001|Overall Study|Lost to Follow-up|0|||
106118162|NCT01872910|366090238|FG002|Overall Study|Lost to Follow-up|2|||
106118163|NCT01872910|366090239|FG003|Overall Study|Lost to Follow-up|0|||
106118164|NCT01872910|366090240|FG004|Overall Study|Lost to Follow-up|0|||
106118165|NCT01872910|366090241|FG005|Overall Study|Lost to Follow-up|0|||
106118166|NCT02247804|366090246|FG000|Treatment Period 1|Adverse Event|9|||
106118167|NCT02247804|366090247|FG001|Treatment Period 1|Adverse Event|2|||
106118168|NCT02247804|366090248|FG002|Treatment Period 1|Adverse Event|0|||
106118169|NCT02247804|366090246|FG000|Treatment Period 1|Lack of Efficacy|0|||
106118170|NCT02247804|366090247|FG001|Treatment Period 1|Lack of Efficacy|0|||
106118171|NCT02247804|366090248|FG002|Treatment Period 1|Lack of Efficacy|2|||
106118172|NCT02247804|366090246|FG000|Treatment Period 1|Lost to Follow-up|1|||
106118173|NCT02247804|366090247|FG001|Treatment Period 1|Lost to Follow-up|0|||
106118174|NCT02247804|366090248|FG002|Treatment Period 1|Lost to Follow-up|2|||
106118175|NCT02247804|366090246|FG000|Treatment Period 1|Personal Reasons|7|||
106118176|NCT02247804|366090247|FG001|Treatment Period 1|Personal Reasons|1|||
106118177|NCT02247804|366090248|FG002|Treatment Period 1|Personal Reasons|2|||
106118178|NCT02247804|366090246|FG000|Treatment Period 1|Protocol Deviation|0|||
106118179|NCT02247804|366090247|FG001|Treatment Period 1|Protocol Deviation|0|||
106118180|NCT02247804|366090248|FG002|Treatment Period 1|Protocol Deviation|1|||
106118181|NCT02247804|366090246|FG000|Treatment Period 1|Randomized but not Treated|5|||
106118182|NCT02247804|366090247|FG001|Treatment Period 1|Randomized but not Treated|1|||
106118183|NCT02247804|366090248|FG002|Treatment Period 1|Randomized but not Treated|1|||
106118184|NCT02247804|366090246|FG000|Treatment Period 2|Adverse Event|6|||
106118185|NCT02247804|366090247|FG001|Treatment Period 2|Adverse Event|3|||
106118186|NCT02247804|366090248|FG002|Treatment Period 2|Adverse Event|3|||
106118187|NCT02247804|366090246|FG000|Treatment Period 2|Lack of Efficacy|0|||
106118188|NCT02247804|366090247|FG001|Treatment Period 2|Lack of Efficacy|0|||
106118189|NCT02247804|366090248|FG002|Treatment Period 2|Lack of Efficacy|1|||
106118190|NCT02247804|366090246|FG000|Treatment Period 2|Lost to Follow-up|0|||
106118191|NCT02247804|366090247|FG001|Treatment Period 2|Lost to Follow-up|1|||
106118192|NCT02247804|366090248|FG002|Treatment Period 2|Lost to Follow-up|1|||
106118193|NCT02247804|366090246|FG000|Treatment Period 2|Personal Reasons|2|||
106118194|NCT02247804|366090247|FG001|Treatment Period 2|Personal Reasons|1|||
106118195|NCT02247804|366090248|FG002|Treatment Period 2|Personal Reasons|1|||
106118196|NCT02247804|366090246|FG000|Treatment Period 2|Reason not Specified|0|||
106118197|NCT02247804|366090247|FG001|Treatment Period 2|Reason not Specified|0|||
106118198|NCT02247804|366090248|FG002|Treatment Period 2|Reason not Specified|2|||
106118199|NCT02247804|366090246|FG000|Treatment Period 3|Adverse Event|4|||
106118200|NCT02247804|366090247|FG001|Treatment Period 3|Adverse Event|3|||
106118201|NCT02247804|366090248|FG002|Treatment Period 3|Adverse Event|3|||
106118202|NCT02247804|366090246|FG000|Treatment Period 3|Lack of Efficacy|0|||
106118203|NCT02247804|366090247|FG001|Treatment Period 3|Lack of Efficacy|1|||
106118204|NCT02247804|366090248|FG002|Treatment Period 3|Lack of Efficacy|0|||
106118205|NCT02247804|366090246|FG000|Treatment Period 3|Lost to Follow-up|1|||
106118206|NCT02247804|366090247|FG001|Treatment Period 3|Lost to Follow-up|2|||
106118207|NCT02247804|366090248|FG002|Treatment Period 3|Lost to Follow-up|2|||
106118208|NCT02247804|366090246|FG000|Treatment Period 3|Personal Reasons|4|||
106118209|NCT02247804|366090247|FG001|Treatment Period 3|Personal Reasons|3|||
106118210|NCT02247804|366090248|FG002|Treatment Period 3|Personal Reasons|2|||
106118211|NCT02247804|366090246|FG000|Treatment Period 3|Reason not Specified|2|||
106118212|NCT02247804|366090247|FG001|Treatment Period 3|Reason not Specified|1|||
106118213|NCT02247804|366090248|FG002|Treatment Period 3|Reason not Specified|3|||
106118214|NCT00211237|366090253|FG000|Baseline|Withdrew|1|||
106118215|NCT00211237|366090254|FG001|Baseline|Withdrew|3|||
106118216|NCT00211237|366090255|FG002|Baseline|Withdrew|0|||
106118217|NCT00211237|366090253|FG000|Baseline|Refused random assignment|1|||
106118218|NCT00211237|366090254|FG001|Baseline|Refused random assignment|0|||
106118219|NCT00211237|366090255|FG002|Baseline|Refused random assignment|0|||
105662484|NCT03522389|364428167|FG002|Overall Study|Lost to Follow-up|2|||
106118220|NCT00211237|366090253|FG000|1 Month|Death|2|||
106118221|NCT00211237|366090254|FG001|1 Month|Death|1|||
106118222|NCT00211237|366090255|FG002|1 Month|Death|0|||
106118223|NCT00211237|366090253|FG000|1 Month|Lost to Follow-up|0|||
106118224|NCT00211237|366090254|FG001|1 Month|Lost to Follow-up|2|||
106118225|NCT00211237|366090255|FG002|1 Month|Lost to Follow-up|0|||
106118226|NCT00211237|366090253|FG000|1 Month|Withdrew|0|||
106118227|NCT00211237|366090254|FG001|1 Month|Withdrew|4|||
106118228|NCT00211237|366090255|FG002|1 Month|Withdrew|0|||
106118229|NCT00211237|366090253|FG000|1 Month|Additional surgery needed|1|||
106118230|NCT00211237|366090254|FG001|1 Month|Additional surgery needed|0|||
106118231|NCT00211237|366090255|FG002|1 Month|Additional surgery needed|0|||
106118232|NCT00211237|366090253|FG000|1 Month|Non-medical problem|0|||
106118233|NCT00211237|366090254|FG001|1 Month|Non-medical problem|2|||
106118234|NCT00211237|366090255|FG002|1 Month|Non-medical problem|0|||
106118235|NCT00211237|366090253|FG000|3 Months|Death|7|||
106118236|NCT00211237|366090254|FG001|3 Months|Death|3|||
106118237|NCT00211237|366090255|FG002|3 Months|Death|0|||
106118238|NCT00211237|366090253|FG000|3 Months|Could not comply with protocol|1|||
106118239|NCT00211237|366090254|FG001|3 Months|Could not comply with protocol|0|||
106118240|NCT00211237|366090255|FG002|3 Months|Could not comply with protocol|0|||
106118241|NCT00211237|366090253|FG000|3 Months|Withdrew|0|||
106118242|NCT00211237|366090254|FG001|3 Months|Withdrew|1|||
106118243|NCT00211237|366090255|FG002|3 Months|Withdrew|0|||
106118244|NCT00211237|366090253|FG000|3 Months|Non-medical problem|0|||
106118245|NCT00211237|366090254|FG001|3 Months|Non-medical problem|0|||
106118246|NCT00211237|366090255|FG002|3 Months|Non-medical problem|1|||
106118247|NCT00211237|366090253|FG000|6 Months|Death|6|||
106118248|NCT00211237|366090254|FG001|6 Months|Death|0|||
106118249|NCT00211237|366090255|FG002|6 Months|Death|3|||
106118250|NCT00211237|366090253|FG000|6 Months|Lost to Follow-up|2|||
106118251|NCT00211237|366090254|FG001|6 Months|Lost to Follow-up|0|||
106118252|NCT00211237|366090255|FG002|6 Months|Lost to Follow-up|0|||
106118253|NCT00211237|366090253|FG000|6 Months|Could not comply with protocol|0|||
106118254|NCT00211237|366090254|FG001|6 Months|Could not comply with protocol|2|||
106118255|NCT00211237|366090255|FG002|6 Months|Could not comply with protocol|0|||
106118256|NCT00211237|366090253|FG000|12 Months|Death|8|||
106118257|NCT00211237|366090254|FG001|12 Months|Death|2|||
105887979|NCT01154296|365245889|FG000|6-month Follow-up|Death|3|||
105887980|NCT01154296|365245890|FG001|6-month Follow-up|Death|2|||
105887981|NCT01154296|365245889|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
105887982|NCT01154296|365245890|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
105887983|NCT00614523|365245891|FG000|Overall Study|Adverse Event|4|||
105887984|NCT00614523|365245892|FG001|Overall Study|Adverse Event|20|||
105887985|NCT00614523|365245891|FG000|Overall Study|Death|5|||
105887986|NCT00614523|365245892|FG001|Overall Study|Death|8|||
105887987|NCT00614523|365245891|FG000|Overall Study|Lack of Efficacy|9|||
105887988|NCT00614523|365245892|FG001|Overall Study|Lack of Efficacy|11|||
105887989|NCT00614523|365245891|FG000|Overall Study|Lost to Follow-up|0|||
105887990|NCT00614523|365245892|FG001|Overall Study|Lost to Follow-up|1|||
105887991|NCT00614523|365245891|FG000|Overall Study|Protocol Violation|3|||
105887992|NCT00614523|365245892|FG001|Overall Study|Protocol Violation|2|||
105887993|NCT00614523|365245891|FG000|Overall Study|Withdrawal by Subject|12|||
105887994|NCT00614523|365245892|FG001|Overall Study|Withdrawal by Subject|22|||
105887995|NCT00614523|365245891|FG000|Overall Study|Other|6|||
105887996|NCT00614523|365245892|FG001|Overall Study|Other|11|||
105887997|NCT00614523|365245891|FG000|Overall Study|Ineligibility Determined|1|||
105887998|NCT00614523|365245892|FG001|Overall Study|Ineligibility Determined|2|||
105887999|NCT00614523|365245891|FG000|Overall Study|Disease Progression|0|||
105888000|NCT00614523|365245892|FG001|Overall Study|Disease Progression|8|||
105888001|NCT00614523|365245891|FG000|Overall Study|Administrative Decision|23|||
105888002|NCT00614523|365245892|FG001|Overall Study|Administrative Decision|46|||
105888003|NCT03854370|365245894|FG000|Overall Study|samples not collected|1|||
105888004|NCT03854370|365245895|FG001|Overall Study|samples not collected|1|||
105888005|NCT03854370|365245896|FG002|Overall Study|samples not collected|1|||
105888006|NCT03854370|365245897|FG003|Overall Study|samples not collected|1|||
105888007|NCT01936181|365245899|FG000|Randomised, Double-blind|Adverse Event|27|||
105888008|NCT01936181|365245900|FG001|Randomised, Double-blind|Adverse Event|21|||
105888009|NCT01936181|365245901|FG002|Randomised, Double-blind|Adverse Event|0|||
105888010|NCT01936181|365245902|FG003|Randomised, Double-blind|Adverse Event|0|||
105888011|NCT01936181|365245899|FG000|Randomised, Double-blind|Protocol Violation|1|||
105888012|NCT01936181|365245900|FG001|Randomised, Double-blind|Protocol Violation|5|||
105888013|NCT01936181|365245901|FG002|Randomised, Double-blind|Protocol Violation|0|||
105888014|NCT01936181|365245902|FG003|Randomised, Double-blind|Protocol Violation|0|||
105888015|NCT01936181|365245899|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
105888016|NCT01936181|365245900|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
105888017|NCT01936181|365245901|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
105888018|NCT01936181|365245902|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
105888019|NCT01936181|365245899|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
105888020|NCT01936181|365245900|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
105888021|NCT01936181|365245901|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
105888022|NCT01936181|365245902|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
105888023|NCT01936181|365245899|FG000|Randomised, Double-blind|Pregnancy|0|||
105888024|NCT01936181|365245900|FG001|Randomised, Double-blind|Pregnancy|1|||
105888025|NCT01936181|365245901|FG002|Randomised, Double-blind|Pregnancy|0|||
105888026|NCT01936181|365245902|FG003|Randomised, Double-blind|Pregnancy|0|||
106118258|NCT00211237|366090255|FG002|12 Months|Death|3|||
106118259|NCT00211237|366090253|FG000|12 Months|Lost to Follow-up|1|||
106118260|NCT00211237|366090254|FG001|12 Months|Lost to Follow-up|0|||
106118261|NCT00211237|366090255|FG002|12 Months|Lost to Follow-up|1|||
106118262|NCT00211237|366090253|FG000|12 Months|Withdrew|0|||
106118263|NCT00211237|366090254|FG001|12 Months|Withdrew|0|||
106118264|NCT00211237|366090255|FG002|12 Months|Withdrew|1|||
106118265|NCT00211237|366090253|FG000|12 Months|unrelated medical problem|0|||
105995237|NCT00291486|365641869|FG000|Overall Study|Withdrawal by Subject|0|||
105995238|NCT00291486|365641870|FG001|Overall Study|Withdrawal by Subject|0|||
105995239|NCT00291486|365641871|FG002|Overall Study|Withdrawal by Subject|0|||
105995240|NCT00291486|365641872|FG003|Overall Study|Withdrawal by Subject|0|||
105995241|NCT00291486|365641873|FG004|Overall Study|Withdrawal by Subject|1|||
105995242|NCT00291486|365641869|FG000|Overall Study|Disease progression|1|||
105995243|NCT00291486|365641870|FG001|Overall Study|Disease progression|0|||
105995244|NCT00291486|365641871|FG002|Overall Study|Disease progression|1|||
105995245|NCT00291486|365641872|FG003|Overall Study|Disease progression|0|||
105995246|NCT00291486|365641873|FG004|Overall Study|Disease progression|0|||
105785032|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
105785033|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
105785034|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
105785035|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
105785036|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
105785037|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
105785038|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
105785039|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
105785040|NCT01288911|364864463|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
105785041|NCT01288911|364864464|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
105785042|NCT02950831|364864473|FG000|Overall Study|Lost to Follow-up|1|||
105785043|NCT02950831|364864473|FG000|Overall Study|Withdrawal by Subject|3|||
105785044|NCT02950831|364864473|FG000|Overall Study|stimulation trail failure|5|||
105785045|NCT02576951|364864478|FG000|Overall Study|Lost to Follow-up|0|||
105785046|NCT02576951|364864479|FG001|Overall Study|Lost to Follow-up|0|||
105785047|NCT02576951|364864480|FG002|Overall Study|Lost to Follow-up|2|||
105785048|NCT02576951|364864481|FG003|Overall Study|Lost to Follow-up|2|||
105785049|NCT02576951|364864478|FG000|Overall Study|Withdrawal by Subject|1|||
105785050|NCT02576951|364864479|FG001|Overall Study|Withdrawal by Subject|0|||
105785051|NCT02576951|364864480|FG002|Overall Study|Withdrawal by Subject|0|||
105785052|NCT02576951|364864481|FG003|Overall Study|Withdrawal by Subject|2|||
105785053|NCT02576951|364864478|FG000|Overall Study|Protocol Violation|0|||
105785054|NCT02576951|364864479|FG001|Overall Study|Protocol Violation|0|||
105785055|NCT02576951|364864480|FG002|Overall Study|Protocol Violation|0|||
105785056|NCT02576951|364864481|FG003|Overall Study|Protocol Violation|1|||
105785057|NCT01786707|364866356|FG000|Overall Study|Lost to Follow-up|1|||
105785058|NCT01786707|364866357|FG001|Overall Study|Lost to Follow-up|1|||
105785059|NCT00869362|364866370|FG000|Overall Study|Death|0|||
105785060|NCT00869362|364866371|FG001|Overall Study|Death|2|||
105995247|NCT01099397|365641874|FG000|Overall Study|Lost to Follow-up|4|||
105995248|NCT01099397|365641874|FG000|Overall Study|Protocol Violation|4|||
105995249|NCT01099397|365641874|FG000|Overall Study|Withdrawal by Subject|5|||
105995250|NCT02363959|365641875|FG000|Overall Study|Medical instability|1|||
105995251|NCT02363959|365641876|FG001|Overall Study|Medical instability|0|||
105995252|NCT01408459|365641879|FG000|Overall Study|Withdrawal by Subject|1|||
105995253|NCT01408459|365641880|FG001|Overall Study|Withdrawal by Subject|1|||
105995254|NCT00950248|365641886|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
105995255|NCT00950248|365641887|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
105995256|NCT00950248|365641888|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
105995257|NCT00950248|365641886|FG000|Year 1: Baseline|worsening of symptoms|2|||
105995258|NCT00950248|365641887|FG001|Year 1: Baseline|worsening of symptoms|0|||
105995259|NCT00950248|365641888|FG002|Year 1: Baseline|worsening of symptoms|0|||
105995260|NCT00950248|365641886|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
105995261|NCT00950248|365641887|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
105995262|NCT00950248|365641888|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
105995263|NCT00950248|365641886|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
105995264|NCT00950248|365641887|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
105995265|NCT00950248|365641888|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
105995266|NCT00950248|365641886|FG000|Year 2&3 Treatment Randomization|Death|0|||
105995267|NCT00950248|365641887|FG001|Year 2&3 Treatment Randomization|Death|0|||
105995268|NCT00950248|365641888|FG002|Year 2&3 Treatment Randomization|Death|1|||
105995269|NCT00950248|365641886|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
105785061|NCT00869362|364866370|FG000|Overall Study|Lost to Follow-up|1|||
105995270|NCT00950248|365641887|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
105995271|NCT00950248|365641888|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
105995272|NCT04725500|365641893|FG000|Screening|Screen Failure|26|||
105995273|NCT04725500|365641893|FG000|Screening|Withdrawal by Subject|1|||
105995274|NCT04725500|365641893|FG000|2 Week Take Home|Screen Fail|5|||
105995275|NCT01792115|365641894|FG000|Overall Study|Lost to Follow-up|0|||
105785062|NCT00869362|364866371|FG001|Overall Study|Lost to Follow-up|3|||
105785063|NCT01241591|364866372|FG000|Overall Study|Lack of Efficacy|5|||
105995276|NCT01792115|365641895|FG001|Overall Study|Lost to Follow-up|1|||
105785064|NCT01241591|364866373|FG001|Overall Study|Lack of Efficacy|2|||
105785065|NCT01241591|364866374|FG002|Overall Study|Lack of Efficacy|2|||
105995277|NCT01792115|365641896|FG002|Overall Study|Lost to Follow-up|0|||
105995278|NCT00900029|365641898|FG000|Overall Study|Lost to Follow-up|0|||
105995279|NCT00900029|365641899|FG001|Overall Study|Lost to Follow-up|2|||
105995280|NCT00900029|365641900|FG002|Overall Study|Lost to Follow-up|1|||
105995281|NCT00900029|365641901|FG003|Overall Study|Lost to Follow-up|4|||
105995282|NCT00900029|365641902|FG004|Overall Study|Lost to Follow-up|4|||
105995283|NCT00900029|365641898|FG000|Overall Study|Withdrawal by Subject|2|||
105995284|NCT00900029|365641899|FG001|Overall Study|Withdrawal by Subject|2|||
105995285|NCT00900029|365641900|FG002|Overall Study|Withdrawal by Subject|1|||
105995286|NCT00900029|365641901|FG003|Overall Study|Withdrawal by Subject|1|||
105995287|NCT00900029|365641902|FG004|Overall Study|Withdrawal by Subject|1|||
105995288|NCT00900029|365641898|FG000|Overall Study|Adverse Event|0|||
105995289|NCT00900029|365641899|FG001|Overall Study|Adverse Event|0|||
105995290|NCT00900029|365641900|FG002|Overall Study|Adverse Event|1|||
105995291|NCT00900029|365641901|FG003|Overall Study|Adverse Event|1|||
105995292|NCT00900029|365641902|FG004|Overall Study|Adverse Event|1|||
105995293|NCT00900029|365641898|FG000|Overall Study|Death|1|||
105995294|NCT00900029|365641899|FG001|Overall Study|Death|0|||
105995295|NCT00900029|365641900|FG002|Overall Study|Death|0|||
105995296|NCT00900029|365641901|FG003|Overall Study|Death|1|||
105995297|NCT00900029|365641902|FG004|Overall Study|Death|0|||
105995298|NCT00163020|365641905|FG000|Overall Study|Lost to Follow-up|0|||
105995299|NCT00163020|365641906|FG001|Overall Study|Lost to Follow-up|2|||
105995300|NCT01101035|365642680|FG000|Overall Study|Adverse Event|191|||
105995301|NCT01101035|365642681|FG001|Overall Study|Adverse Event|172|||
105995302|NCT01101035|365642680|FG000|Overall Study|Major Protocol Deviation|52|||
106118266|NCT00211237|366090254|FG001|12 Months|unrelated medical problem|0|||
106118267|NCT00211237|366090255|FG002|12 Months|unrelated medical problem|1|||
106118268|NCT00453102|366090258|FG000|Overall Study|Withdrawal by Subject|2|||
106118269|NCT01650519|366090260|FG000|Overall Study|Withdrawal by Subject|1|||
106118270|NCT01650519|366090261|FG001|Overall Study|Withdrawal by Subject|0|||
106118271|NCT02667886|366090263|FG000|Dose Escalation (Part A)|Adverse Event|1|||
106118272|NCT02667886|366090264|FG001|Dose Escalation (Part A)|Adverse Event|3|||
106118273|NCT02667886|366090265|FG002|Dose Escalation (Part A)|Adverse Event|1|||
106118274|NCT02667886|366090266|FG003|Dose Escalation (Part A)|Adverse Event|0|||
106118275|NCT02667886|366090267|FG004|Dose Escalation (Part A)|Adverse Event|0|||
106118276|NCT02667886|366090263|FG000|Dose Escalation (Part A)|Disease Progression|1|||
106118277|NCT02667886|366090264|FG001|Dose Escalation (Part A)|Disease Progression|4|||
106118278|NCT02667886|366090265|FG002|Dose Escalation (Part A)|Disease Progression|3|||
106118279|NCT02667886|366090266|FG003|Dose Escalation (Part A)|Disease Progression|0|||
106118280|NCT02667886|366090267|FG004|Dose Escalation (Part A)|Disease Progression|0|||
106118281|NCT02667886|366090263|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
106118282|NCT02667886|366090264|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
106118283|NCT02667886|366090265|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
106118284|NCT02667886|366090266|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
106118285|NCT02667886|366090267|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
106118286|NCT02667886|366090263|FG000|Dose Expansion (Part B)|Adverse Event|0|||
106118287|NCT02667886|366090264|FG001|Dose Expansion (Part B)|Adverse Event|0|||
106118288|NCT02667886|366090265|FG002|Dose Expansion (Part B)|Adverse Event|0|||
106118289|NCT02667886|366090266|FG003|Dose Expansion (Part B)|Adverse Event|9|||
106118290|NCT02667886|366090267|FG004|Dose Expansion (Part B)|Adverse Event|0|||
106118291|NCT02667886|366090263|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
106118292|NCT02667886|366090264|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
106118293|NCT02667886|366090265|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
106118294|NCT02667886|366090266|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
106118295|NCT02667886|366090267|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
106118296|NCT02667886|366090263|FG000|Dose Expansion (Part B)|Disease Progression|0|||
106118297|NCT02667886|366090264|FG001|Dose Expansion (Part B)|Disease Progression|0|||
106118298|NCT02667886|366090265|FG002|Dose Expansion (Part B)|Disease Progression|0|||
106118299|NCT02667886|366090266|FG003|Dose Expansion (Part B)|Disease Progression|38|||
106118300|NCT02667886|366090267|FG004|Dose Expansion (Part B)|Disease Progression|0|||
106118301|NCT02667886|366090263|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
106118302|NCT02667886|366090264|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
105995303|NCT01101035|365642681|FG001|Overall Study|Major Protocol Deviation|46|||
105995304|NCT01101035|365642680|FG000|Overall Study|Lost to Follow-up|226|||
106118303|NCT02667886|366090265|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
106118304|NCT02667886|366090266|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
106118305|NCT02667886|366090267|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
106118306|NCT02667886|366090263|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
106118307|NCT02667886|366090264|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
105995305|NCT01101035|365642681|FG001|Overall Study|Lost to Follow-up|223|||
105995306|NCT01101035|365642680|FG000|Overall Study|Voluntary Withdrawal|595|||
105995307|NCT01101035|365642681|FG001|Overall Study|Voluntary Withdrawal|587|||
105995308|NCT01101035|365642680|FG000|Overall Study|Reason not Specified|333|||
105995309|NCT01101035|365642681|FG001|Overall Study|Reason not Specified|363|||
105995310|NCT02871635|365642682|FG000|Overall Study|Primary lack of efficacy|4|||
105995311|NCT02871635|365642683|FG001|Overall Study|Primary lack of efficacy|4|||
105995312|NCT02871635|365642682|FG000|Overall Study|Protocol Violation|3|||
105995313|NCT02871635|365642683|FG001|Overall Study|Protocol Violation|1|||
105995314|NCT02871635|365642682|FG000|Overall Study|Lost to Follow-up|1|||
105995315|NCT02871635|365642683|FG001|Overall Study|Lost to Follow-up|2|||
105995316|NCT02871635|365642682|FG000|Overall Study|Pregnancy|0|||
105995317|NCT02871635|365642683|FG001|Overall Study|Pregnancy|2|||
105995318|NCT02871635|365642682|FG000|Overall Study|Physician Decision|1|||
105995319|NCT02871635|365642683|FG001|Overall Study|Physician Decision|1|||
105995320|NCT02871635|365642682|FG000|Overall Study|Withdrawal by Subject|3|||
105995321|NCT02871635|365642683|FG001|Overall Study|Withdrawal by Subject|4|||
105995322|NCT02871635|365642682|FG000|Overall Study|Adverse Event|4|||
105995323|NCT02871635|365642683|FG001|Overall Study|Adverse Event|4|||
105995324|NCT02871635|365642682|FG000|Overall Study|Secondary lack of efficacy|2|||
105995325|NCT02871635|365642683|FG001|Overall Study|Secondary lack of efficacy|1|||
105995326|NCT02420379|365642684|FG000|Overall Study|Withdrawal by Subject|0|||
105995327|NCT02420379|365642685|FG001|Overall Study|Withdrawal by Subject|3|||
105995328|NCT02420379|365642684|FG000|Overall Study|Unable to complete due to schooling|0|||
105995329|NCT02420379|365642685|FG001|Overall Study|Unable to complete due to schooling|1|||
106118308|NCT02667886|366090265|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
106118309|NCT02667886|366090266|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
106118310|NCT02667886|366090267|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
106118311|NCT02667886|366090263|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
106118312|NCT02667886|366090264|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
106118313|NCT02667886|366090265|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
106118314|NCT02667886|366090266|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
106118315|NCT02667886|366090267|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
106118316|NCT05672680|366090268|FG000|Overall Study|Patient Did Not Complete the Form|5|||
106118317|NCT05672680|366090269|FG001|Overall Study|Patient Did Not Complete the Form|4|||
106118318|NCT05672680|366090268|FG000|Overall Study|Procedure Aborted|1|||
106118319|NCT05672680|366090269|FG001|Overall Study|Procedure Aborted|0|||
106118320|NCT05408468|366090270|FG000|Overall Study|Lost to Follow-up|3|||
106118321|NCT05408468|366090271|FG001|Overall Study|Lost to Follow-up|1|||
106118322|NCT05408468|366090270|FG000|Overall Study|Physician Decision|1|||
106118323|NCT05408468|366090271|FG001|Overall Study|Physician Decision|0|||
106118324|NCT05408468|366090270|FG000|Overall Study|Overwhelmed by clinical situation|3|||
106118325|NCT05408468|366090271|FG001|Overall Study|Overwhelmed by clinical situation|0|||
106118326|NCT05408468|366090270|FG000|Overall Study|Personal illness precluding participation|1|||
106118327|NCT05408468|366090271|FG001|Overall Study|Personal illness precluding participation|0|||
106118328|NCT05408468|366090270|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
106118329|NCT05408468|366090271|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
106118330|NCT00747123|366090272|FG000|Overall Study|Investigator's request|0|||
106118331|NCT00747123|366090273|FG001|Overall Study|Investigator's request|0|||
106118332|NCT00747123|366090274|FG002|Overall Study|Investigator's request|1|||
106118333|NCT00747123|366090275|FG003|Overall Study|Investigator's request|0|||
106118334|NCT00747123|366090272|FG000|Overall Study|Withdrew consent|0|||
106118335|NCT00747123|366090273|FG001|Overall Study|Withdrew consent|1|||
106118336|NCT00747123|366090274|FG002|Overall Study|Withdrew consent|0|||
106118337|NCT00747123|366090275|FG003|Overall Study|Withdrew consent|0|||
106118338|NCT00747123|366090272|FG000|Overall Study|Adverse Event|0|||
106118339|NCT00747123|366090273|FG001|Overall Study|Adverse Event|1|||
106118340|NCT00747123|366090274|FG002|Overall Study|Adverse Event|0|||
106118341|NCT00747123|366090275|FG003|Overall Study|Adverse Event|1|||
106118342|NCT05778526|366090277|FG000|Overall Study|Lost to Follow-up|0|||
106118343|NCT05778526|366090278|FG001|Overall Study|Lost to Follow-up|1|||
106118344|NCT05778526|366090279|FG002|Overall Study|Lost to Follow-up|3|||
106118345|NCT05778526|366090277|FG000|Overall Study|Protocol Violation|0|||
106118346|NCT05778526|366090278|FG001|Overall Study|Protocol Violation|0|||
106118347|NCT05778526|366090279|FG002|Overall Study|Protocol Violation|8|||
106118348|NCT01861522|366090283|FG000|Overall Study|Adverse Event|1|||
106118349|NCT01861522|366090284|FG001|Overall Study|Adverse Event|0|||
106118350|NCT01861522|366090283|FG000|Overall Study|Withdrawal by Subject|2|||
106118351|NCT01861522|366090284|FG001|Overall Study|Withdrawal by Subject|0|||
106118352|NCT01555164|366090285|FG000|Overall Study|Adverse Event|5|||
106118353|NCT01555164|366090286|FG001|Overall Study|Adverse Event|7|||
106118354|NCT01555164|366090285|FG000|Overall Study|Hyperglycemia|0|||
106118355|NCT01555164|366090286|FG001|Overall Study|Hyperglycemia|1|||
106118356|NCT01555164|366090285|FG000|Overall Study|Investigator's Discretion|2|||
106118357|NCT01555164|366090286|FG001|Overall Study|Investigator's Discretion|2|||
106118358|NCT01555164|366090285|FG000|Overall Study|Lost to Follow-up|4|||
106118359|NCT01555164|366090286|FG001|Overall Study|Lost to Follow-up|3|||
106118360|NCT01555164|366090285|FG000|Overall Study|Protocol Violation|9|||
105995330|NCT02420379|365642684|FG000|Overall Study|Transitioned to commercial drug|1|||
106118361|NCT01555164|366090286|FG001|Overall Study|Protocol Violation|5|||
106118362|NCT01555164|366090285|FG000|Overall Study|Subject Non-compliance|14|||
106118363|NCT01555164|366090286|FG001|Overall Study|Subject Non-compliance|6|||
106118364|NCT01555164|366090285|FG000|Overall Study|Subject Withdrew Consent|6|||
106118365|NCT01555164|366090286|FG001|Overall Study|Subject Withdrew Consent|11|||
106118366|NCT00886639|366090287|FG000|Overall Study|acute exacerbation|14|||
106118367|NCT00886639|366090287|FG000|Overall Study|non-compliance|2|||
106118368|NCT01103960|366090288|FG000|Overall Study|Adverse Event|2|||
106118369|NCT01103960|366090289|FG001|Overall Study|Adverse Event|1|||
106118370|NCT01103960|366090288|FG000|Overall Study|Withdrawal by Subject|2|||
106118371|NCT01103960|366090289|FG001|Overall Study|Withdrawal by Subject|1|||
106118372|NCT01103960|366090288|FG000|Overall Study|Other|1|||
106118373|NCT01103960|366090289|FG001|Overall Study|Other|0|||
106118374|NCT03443713|366090292|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
106118375|NCT03443713|366090293|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
106118376|NCT03443713|366090294|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
106118377|NCT01672853|366090296|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
106118378|NCT01672853|366090297|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
106118379|NCT01672853|366090298|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
106118380|NCT01672853|366090296|FG000|Overall Study|Pregnancy|0|||
106118381|NCT01672853|366090297|FG001|Overall Study|Pregnancy|1|||
106118382|NCT01672853|366090298|FG002|Overall Study|Pregnancy|0|||
106118383|NCT01672853|366090296|FG000|Overall Study|Investigator's Discretion|1|||
106118384|NCT01672853|366090297|FG001|Overall Study|Investigator's Discretion|0|||
106118385|NCT01672853|366090298|FG002|Overall Study|Investigator's Discretion|0|||
106118386|NCT01672853|366090296|FG000|Overall Study|Withdrew Consent|5|||
106118387|NCT01672853|366090297|FG001|Overall Study|Withdrew Consent|5|||
106118388|NCT01672853|366090298|FG002|Overall Study|Withdrew Consent|5|||
106118389|NCT01672853|366090296|FG000|Overall Study|Adverse Event|4|||
106118390|NCT01672853|366090297|FG001|Overall Study|Adverse Event|6|||
106118391|NCT01672853|366090298|FG002|Overall Study|Adverse Event|8|||
106118392|NCT01672853|366090296|FG000|Overall Study|Lost to Follow-up|0|||
106118393|NCT01672853|366090297|FG001|Overall Study|Lost to Follow-up|1|||
106118394|NCT01672853|366090298|FG002|Overall Study|Lost to Follow-up|0|||
106118395|NCT01672853|366090296|FG000|Overall Study|Randomized but Never Treated|0|||
106118396|NCT01672853|366090297|FG001|Overall Study|Randomized but Never Treated|0|||
106118397|NCT01672853|366090298|FG002|Overall Study|Randomized but Never Treated|1|||
106118398|NCT02944656|366090299|FG000|Overall Study|No longer eligible|3|||
106118399|NCT02944656|366090300|FG001|Overall Study|No longer eligible|0|||
106118400|NCT02944656|366090299|FG000|Overall Study|Lost to Follow-up|7|||
106118401|NCT02944656|366090300|FG001|Overall Study|Lost to Follow-up|10|||
106118402|NCT02714205|366090301|FG000|Overall Study|Cannot tolerate medication|1|||
106118403|NCT02714205|366090302|FG001|Overall Study|Cannot tolerate medication|0|||
106118404|NCT02714205|366090301|FG000|Overall Study|Adverse Event|2|||
106118405|NCT02714205|366090302|FG001|Overall Study|Adverse Event|0|||
106118406|NCT02714205|366090301|FG000|Overall Study|Too busy|1|||
106118407|NCT02714205|366090302|FG001|Overall Study|Too busy|0|||
106118408|NCT02714205|366090301|FG000|Overall Study|Incomplete outcome data|0|||
106118409|NCT02714205|366090302|FG001|Overall Study|Incomplete outcome data|1|||
106118410|NCT05879198|366090305|FG000|Overall Study|Lost to Follow-up|1|||
106118411|NCT01598298|366090306|FG000|Overall Study|Not eligible|5|||
106118412|NCT01598298|366090307|FG001|Overall Study|Not eligible|5|||
106118413|NCT01598298|366090306|FG000|Overall Study|Adverse Event|21|||
106118414|NCT01598298|366090307|FG001|Overall Study|Adverse Event|19|||
106118415|NCT01598298|366090306|FG000|Overall Study|Progression/relapse|0|||
106118416|NCT01598298|366090307|FG001|Overall Study|Progression/relapse|2|||
106118417|NCT01598298|366090306|FG000|Overall Study|Withdrawal by Subject|10|||
106118418|NCT01598298|366090307|FG001|Overall Study|Withdrawal by Subject|15|||
106118419|NCT01598298|366090306|FG000|Overall Study|Other reason (not protocol specified)|4|||
106118420|NCT01598298|366090307|FG001|Overall Study|Other reason (not protocol specified)|0|||
106118421|NCT03813147|366090308|FG000|Overall Study|Lack of Efficacy|4|||
106118422|NCT03813147|366090309|FG001|Overall Study|Lack of Efficacy|4|||
106118423|NCT03813147|366090308|FG000|Overall Study|Physician Decision|2|||
106118424|NCT03813147|366090309|FG001|Overall Study|Physician Decision|1|||
106118425|NCT02581930|366090310|FG000|Overall Study|Withdrawal by Subject|1|||
106118426|NCT02581930|366090310|FG000|Overall Study|patient declined further treatment|1|||
106118427|NCT01816763|366091750|FG000|Overall Study|The main reason for an incomplete survey|4|||
106118428|NCT01816763|366091751|FG001|Overall Study|The main reason for an incomplete survey|15|||
106118429|NCT01816763|366091752|FG002|Overall Study|The main reason for an incomplete survey|11|||
106118430|NCT01590771|366091753|FG000|Overall Study|Other Protocol Specified Criteria|5|||
106118431|NCT01590771|366091754|FG001|Overall Study|Other Protocol Specified Criteria|14|||
106118432|NCT01590771|366091753|FG000|Overall Study|Withdrawal by Subject|8|||
106118433|NCT01590771|366091754|FG001|Overall Study|Withdrawal by Subject|15|||
106118434|NCT01590771|366091753|FG000|Overall Study|Protocol Violation|1|||
106118435|NCT01590771|366091754|FG001|Overall Study|Protocol Violation|2|||
106118436|NCT01590771|366091753|FG000|Overall Study|Lost to Follow-up|1|||
106118437|NCT01590771|366091754|FG001|Overall Study|Lost to Follow-up|1|||
106118438|NCT01590771|366091753|FG000|Overall Study|Lack of Efficacy|1|||
106118439|NCT01590771|366091754|FG001|Overall Study|Lack of Efficacy|0|||
106118440|NCT01590771|366091753|FG000|Overall Study|Adverse Event|3|||
106118441|NCT01590771|366091754|FG001|Overall Study|Adverse Event|7|||
106118442|NCT05340751|366091763|FG000|Overall Study|Physician Decision|3|||
106118443|NCT01014975|366091765|FG000|Overall Study|Withdrawal by Subject|1|||
106118444|NCT01014975|366091766|FG001|Overall Study|Withdrawal by Subject|0|||
105888027|NCT01936181|365245899|FG000|Randomised, Double-blind|Physician Decision|4|||
106118445|NCT01014975|366091767|FG002|Overall Study|Withdrawal by Subject|1|||
106118446|NCT01014975|366091765|FG000|Overall Study|Death|3|||
106118447|NCT01014975|366091766|FG001|Overall Study|Death|3|||
106118448|NCT01014975|366091767|FG002|Overall Study|Death|4|||
106118449|NCT01014975|366091765|FG000|Overall Study|Lost to Follow-up|0|||
106118450|NCT01014975|366091766|FG001|Overall Study|Lost to Follow-up|0|||
106118451|NCT01014975|366091767|FG002|Overall Study|Lost to Follow-up|1|||
106118452|NCT00633932|366091768|FG000|Overall Study|Adverse Event|1|||
106118453|NCT00633932|366091769|FG001|Overall Study|Adverse Event|3|||
106118454|NCT00633932|366091770|FG002|Overall Study|Adverse Event|4|||
106118455|NCT00633932|366091768|FG000|Overall Study|Withdrawal by Subject|3|||
106118456|NCT00633932|366091769|FG001|Overall Study|Withdrawal by Subject|9|||
106118457|NCT00633932|366091770|FG002|Overall Study|Withdrawal by Subject|1|||
106118458|NCT00633932|366091768|FG000|Overall Study|Lost to Follow-up|1|||
106118459|NCT00633932|366091769|FG001|Overall Study|Lost to Follow-up|0|||
106118460|NCT00633932|366091770|FG002|Overall Study|Lost to Follow-up|2|||
106118461|NCT00633932|366091768|FG000|Overall Study|Protocol Violation|5|||
106118462|NCT00633932|366091769|FG001|Overall Study|Protocol Violation|2|||
106118463|NCT00633932|366091770|FG002|Overall Study|Protocol Violation|3|||
106118464|NCT00633932|366091768|FG000|Overall Study|Physician Decision|0|||
106118465|NCT00633932|366091769|FG001|Overall Study|Physician Decision|0|||
106118466|NCT00633932|366091770|FG002|Overall Study|Physician Decision|1|||
106118467|NCT00633932|366091768|FG000|Overall Study|Doctor's judgement|1|||
106118468|NCT00633932|366091769|FG001|Overall Study|Doctor's judgement|0|||
106118469|NCT00633932|366091770|FG002|Overall Study|Doctor's judgement|0|||
106118470|NCT00633932|366091768|FG000|Overall Study|Moved Away|1|||
106118471|NCT00633932|366091769|FG001|Overall Study|Moved Away|0|||
106118472|NCT00633932|366091770|FG002|Overall Study|Moved Away|0|||
106118473|NCT00482274|366091771|FG000|Overall Study|Adverse Event|1|||
106118474|NCT02176421|366091772|FG000|Overall Study|Lost to Follow-up|4|||
106118475|NCT02176421|366091772|FG000|Overall Study|Adverse Event|1|||
106118476|NCT01932294|366091773|FG000|Overall Study|Death|43|||
106118477|NCT01932294|366091773|FG000|Overall Study|Lost to Follow-up|8|||
106118478|NCT01932294|366091773|FG000|Overall Study|VAD Implantation|20|||
106118479|NCT01932294|366091773|FG000|Overall Study|Heart Transplantation|16|||
106118480|NCT01932294|366091773|FG000|Overall Study|Transferred to other hospitals|12|||
106118481|NCT02145078|366091775|FG000|Overall Study|Death|1|||
106118482|NCT02145078|366091775|FG000|Overall Study|Reason not given|3|||
106118483|NCT00597714|366091778|FG000|Overall Study|Death|56|||
106118484|NCT00597714|366091779|FG001|Overall Study|Death|46|||
106118485|NCT00597714|366091780|FG002|Overall Study|Death|0|||
106118486|NCT00597714|366091778|FG000|Overall Study|Recipient death|0|||
106118487|NCT00597714|366091779|FG001|Overall Study|Recipient death|0|||
106118488|NCT00597714|366091780|FG002|Overall Study|Recipient death|10|||
106118489|NCT01588990|366091781|FG000|Phase A|Withdrawal by Subject|5|||
106118490|NCT01588990|366091781|FG000|Phase A|Physician Decision|11|||
106118491|NCT01588990|366091781|FG000|Phase A|Other|14|||
106118492|NCT01588990|366091781|FG000|Phase A|Lost to Follow-up|1|||
106118493|NCT01588990|366091781|FG000|Phase A|Death|5|||
106118494|NCT01588990|366091781|FG000|Phase A|Adverse Event|28|||
106118495|NCT01588990|366091781|FG000|Phase A|Still on therapy at end of study|6|||
105888028|NCT01936181|365245900|FG001|Randomised, Double-blind|Physician Decision|4|||
105888029|NCT01936181|365245901|FG002|Randomised, Double-blind|Physician Decision|0|||
105888030|NCT01936181|365245902|FG003|Randomised, Double-blind|Physician Decision|0|||
105888031|NCT01936181|365245899|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
106118496|NCT01588990|366091781|FG000|Phase B|Adverse Event|2|||
106118497|NCT01588990|366091781|FG000|Phase B|Still on therapy at end of study|5|||
106118498|NCT01588990|366091781|FG000|Phase B|Withdrawal by Subject|3|||
106118499|NCT01588990|366091781|FG000|Phase B|Physician Decision|4|||
105888032|NCT01936181|365245900|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
106118500|NCT01588990|366091781|FG000|Phase B|Other|2|||
106118501|NCT03327402|366091782|FG000|Overall Study|Withdrawal by Subject|1|||
106118502|NCT03327402|366091782|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
106118503|NCT02440594|366091788|FG000|Overall Study|Lost to Follow-up|34|||
105888033|NCT01936181|365245901|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
105888034|NCT01936181|365245902|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
106118504|NCT02440594|366091789|FG001|Overall Study|Lost to Follow-up|33|||
106118505|NCT02440594|366091790|FG002|Overall Study|Lost to Follow-up|54|||
106118506|NCT02440594|366091791|FG003|Overall Study|Lost to Follow-up|47|||
106118507|NCT02440594|366091792|FG004|Overall Study|Lost to Follow-up|5|||
106118508|NCT02440594|366091793|FG005|Overall Study|Lost to Follow-up|4|||
106118509|NCT02440594|366091794|FG006|Overall Study|Lost to Follow-up|28|||
105662485|NCT03522389|364428165|FG000|Overall Study|had herniated nucleus pulposus|0|||
105662486|NCT03522389|364428166|FG001|Overall Study|had herniated nucleus pulposus|1|||
105662487|NCT03522389|364428167|FG002|Overall Study|had herniated nucleus pulposus|0|||
105662488|NCT03522389|364428165|FG000|Overall Study|go to work in other province|1|||
105662489|NCT03522389|364428166|FG001|Overall Study|go to work in other province|0|||
105662490|NCT03522389|364428167|FG002|Overall Study|go to work in other province|0|||
105662491|NCT04428476|364428168|FG000|Overall Study|Withdrawal by Subject|1|||
105995331|NCT02420379|365642685|FG001|Overall Study|Transitioned to commercial drug|0|||
105995332|NCT04737278|365642686|FG000|Overall Study|Lost to Follow-up|1|||
105995333|NCT04737278|365642687|FG001|Overall Study|Lost to Follow-up|1|||
105995334|NCT04737278|365642686|FG000|Overall Study|Withdrawal by Subject|1|||
105995335|NCT04737278|365642687|FG001|Overall Study|Withdrawal by Subject|0|||
105995336|NCT04737278|365642686|FG000|Overall Study|Protocol Violation|1|||
105995337|NCT04737278|365642687|FG001|Overall Study|Protocol Violation|1|||
105995338|NCT04737278|365642686|FG000|Overall Study|failure to complete questionnaire|1|||
105995339|NCT04737278|365642687|FG001|Overall Study|failure to complete questionnaire|1|||
105995340|NCT02751580|365642690|FG000|Overall Study|Lost to Follow-up|4|||
105995341|NCT02751580|365642690|FG000|Overall Study|Death|2|||
105995342|NCT04829916|365642691|FG000|Overall Study|Withdrawal by Subject|1|||
105995343|NCT04829916|365642692|FG001|Overall Study|Withdrawal by Subject|0|||
105995344|NCT00394706|365642693|FG000|Overall Study|Withdrawal by Subject|2|||
105995345|NCT00394706|365642694|FG001|Overall Study|Withdrawal by Subject|0|||
105995346|NCT00394706|365642695|FG002|Overall Study|Withdrawal by Subject|1|||
105995347|NCT00394706|365642696|FG003|Overall Study|Withdrawal by Subject|0|||
105995348|NCT00394706|365642697|FG004|Overall Study|Withdrawal by Subject|0|||
105995349|NCT00394706|365642698|FG005|Overall Study|Withdrawal by Subject|2|||
105995350|NCT00394706|365642699|FG006|Overall Study|Withdrawal by Subject|1|||
105995351|NCT00394706|365642700|FG007|Overall Study|Withdrawal by Subject|0|||
105995352|NCT00394706|365642693|FG000|Overall Study|Lost to Follow-up|2|||
106118510|NCT02440594|366091795|FG007|Overall Study|Lost to Follow-up|48|||
106118511|NCT02440594|366091788|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
106118512|NCT02440594|366091789|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
106118513|NCT02440594|366091790|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
106118514|NCT02440594|366091791|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
106118515|NCT02440594|366091792|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
106118516|NCT02440594|366091793|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
106118517|NCT02440594|366091794|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
106118518|NCT02440594|366091795|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
106118519|NCT02440594|366091788|FG000|Overall Study|Withdrawal by Subject|81|||
106118520|NCT02440594|366091789|FG001|Overall Study|Withdrawal by Subject|67|||
105662492|NCT04428476|364428168|FG000|Overall Study|Still on treatment|12|||
105662493|NCT01151423|364428169|FG000|Overall Study|Study terminated by Sponsor|9|||
105888035|NCT01936181|365245899|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
105888036|NCT01936181|365245900|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
105888037|NCT01936181|365245901|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
105888038|NCT01936181|365245902|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
105888039|NCT01936181|365245899|FG000|Transition-extension|Adverse Event|3|||
105888040|NCT01936181|365245900|FG001|Transition-extension|Adverse Event|0|||
105888041|NCT01936181|365245901|FG002|Transition-extension|Adverse Event|3|||
105888042|NCT01936181|365245902|FG003|Transition-extension|Adverse Event|1|||
105888043|NCT01936181|365245899|FG000|Transition-extension|Lost to Follow-up|3|||
105888044|NCT01936181|365245900|FG001|Transition-extension|Lost to Follow-up|0|||
105888045|NCT01936181|365245901|FG002|Transition-extension|Lost to Follow-up|1|||
105888046|NCT01936181|365245902|FG003|Transition-extension|Lost to Follow-up|2|||
105888047|NCT01936181|365245899|FG000|Transition-extension|Physician Decision|2|||
105888048|NCT01936181|365245900|FG001|Transition-extension|Physician Decision|0|||
105888049|NCT01936181|365245901|FG002|Transition-extension|Physician Decision|0|||
105888050|NCT01936181|365245902|FG003|Transition-extension|Physician Decision|1|||
105888051|NCT01936181|365245899|FG000|Transition-extension|Withdrawal by Subject|7|||
105888052|NCT01936181|365245900|FG001|Transition-extension|Withdrawal by Subject|0|||
105888053|NCT01936181|365245901|FG002|Transition-extension|Withdrawal by Subject|2|||
105888054|NCT01936181|365245902|FG003|Transition-extension|Withdrawal by Subject|1|||
105888055|NCT02817516|365245905|FG000|Overall Study|Other|0|||
105888056|NCT02817516|365245906|FG001|Overall Study|Other|0|||
105995353|NCT00394706|365642694|FG001|Overall Study|Lost to Follow-up|2|||
105995354|NCT00394706|365642695|FG002|Overall Study|Lost to Follow-up|8|||
105995355|NCT00394706|365642696|FG003|Overall Study|Lost to Follow-up|1|||
106118521|NCT02440594|366091790|FG002|Overall Study|Withdrawal by Subject|59|||
105888057|NCT02817516|365245907|FG002|Overall Study|Other|1|||
105888058|NCT02817516|365245908|FG003|Overall Study|Other|0|||
105662494|NCT01151423|364428170|FG001|Overall Study|Study terminated by Sponsor|10|||
105888059|NCT00348595|365245909|FG000|Overall Study|Adverse Event|5|||
105888060|NCT00348595|365245910|FG001|Overall Study|Adverse Event|8|||
105995356|NCT00394706|365642697|FG004|Overall Study|Lost to Follow-up|2|||
105995357|NCT00394706|365642698|FG005|Overall Study|Lost to Follow-up|5|||
105995358|NCT00394706|365642699|FG006|Overall Study|Lost to Follow-up|2|||
105995359|NCT00394706|365642700|FG007|Overall Study|Lost to Follow-up|0|||
105995360|NCT04098809|365642702|FG000|Overall Study|Withdrawal by Subject|1|||
105995361|NCT04098809|365642703|FG001|Overall Study|Withdrawal by Subject|3|||
105995362|NCT04098809|365642702|FG000|Overall Study|Physician Decision|2|||
105995363|NCT04098809|365642703|FG001|Overall Study|Physician Decision|1|||
105995364|NCT00479336|365642709|FG000|Overall Study|Adverse Event|1|||
105995365|NCT00479336|365642710|FG001|Overall Study|Adverse Event|1|||
105995366|NCT00479336|365642711|FG002|Overall Study|Adverse Event|1|||
105995367|NCT00479336|365642712|FG003|Overall Study|Adverse Event|3|||
105995368|NCT00479336|365642709|FG000|Overall Study|Lack of Efficacy|1|||
105995369|NCT00479336|365642710|FG001|Overall Study|Lack of Efficacy|0|||
105995370|NCT00479336|365642711|FG002|Overall Study|Lack of Efficacy|0|||
105995371|NCT00479336|365642712|FG003|Overall Study|Lack of Efficacy|0|||
105995372|NCT00479336|365642709|FG000|Overall Study|Protocol Violation|0|||
105995373|NCT00479336|365642710|FG001|Overall Study|Protocol Violation|1|||
105995374|NCT00479336|365642711|FG002|Overall Study|Protocol Violation|0|||
105995375|NCT00479336|365642712|FG003|Overall Study|Protocol Violation|0|||
105995376|NCT00479336|365642709|FG000|Overall Study|Withdrawal by Subject|1|||
105995377|NCT00479336|365642710|FG001|Overall Study|Withdrawal by Subject|2|||
105995378|NCT00479336|365642711|FG002|Overall Study|Withdrawal by Subject|0|||
105995379|NCT00479336|365642712|FG003|Overall Study|Withdrawal by Subject|0|||
105995380|NCT00479336|365642709|FG000|Overall Study|Physician Decision|0|||
105995381|NCT00479336|365642710|FG001|Overall Study|Physician Decision|1|||
105995382|NCT00479336|365642711|FG002|Overall Study|Physician Decision|0|||
105995383|NCT00479336|365642712|FG003|Overall Study|Physician Decision|2|||
105995384|NCT00479336|365642709|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
105995385|NCT00479336|365642710|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
105995386|NCT00479336|365642711|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
105995387|NCT00479336|365642712|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
105995388|NCT02741596|365642713|FG000|Overall Study|Adverse Event|1|||
105995389|NCT02741596|365642714|FG001|Overall Study|Adverse Event|5|||
105995390|NCT02741596|365642713|FG000|Overall Study|Lost to Follow-up|1|||
105995391|NCT02741596|365642714|FG001|Overall Study|Lost to Follow-up|1|||
105995392|NCT02741596|365642713|FG000|Overall Study|Physician Decision|2|||
105995393|NCT02741596|365642714|FG001|Overall Study|Physician Decision|1|||
105995394|NCT02741596|365642713|FG000|Overall Study|Pregnancy|3|||
105995395|NCT02741596|365642714|FG001|Overall Study|Pregnancy|1|||
105995396|NCT02741596|365642713|FG000|Overall Study|Other (Unspecified)|0|||
105995397|NCT02741596|365642714|FG001|Overall Study|Other (Unspecified)|3|||
105995398|NCT02741596|365642713|FG000|Overall Study|Subject withdrawn-Other|17|||
105995399|NCT02741596|365642714|FG001|Overall Study|Subject withdrawn-Other|4|||
105995400|NCT02741596|365642713|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
105995401|NCT02741596|365642714|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
105995402|NCT02021643|365642715|FG000|Overall Study|Enrolled but Never Treated|1|||
105995403|NCT02021643|365642716|FG001|Overall Study|Enrolled but Never Treated|0|||
105995404|NCT02021643|365642717|FG002|Overall Study|Enrolled but Never Treated|0|||
105995405|NCT02021643|365642718|FG003|Overall Study|Enrolled but Never Treated|0|||
105995406|NCT02021643|365642715|FG000|Overall Study|Adverse Event|0|||
105995407|NCT02021643|365642716|FG001|Overall Study|Adverse Event|1|||
105995408|NCT02021643|365642717|FG002|Overall Study|Adverse Event|0|||
105995409|NCT02021643|365642718|FG003|Overall Study|Adverse Event|0|||
105995410|NCT02021643|365642715|FG000|Overall Study|Death|0|||
105995411|NCT02021643|365642716|FG001|Overall Study|Death|1|||
105995412|NCT02021643|365642717|FG002|Overall Study|Death|0|||
105995413|NCT02021643|365642718|FG003|Overall Study|Death|0|||
105995414|NCT02021643|365642715|FG000|Overall Study|Investigator's Discretion|1|||
105995415|NCT02021643|365642716|FG001|Overall Study|Investigator's Discretion|0|||
105995416|NCT02021643|365642717|FG002|Overall Study|Investigator's Discretion|0|||
105995417|NCT02021643|365642718|FG003|Overall Study|Investigator's Discretion|0|||
105995418|NCT02021643|365642715|FG000|Overall Study|Lack of Efficacy|7|||
105995419|NCT02021643|365642716|FG001|Overall Study|Lack of Efficacy|6|||
105995420|NCT02021643|365642717|FG002|Overall Study|Lack of Efficacy|0|||
105995421|NCT02021643|365642718|FG003|Overall Study|Lack of Efficacy|12|||
105995422|NCT02021643|365642715|FG000|Overall Study|Lost to Follow-up|0|||
105995423|NCT02021643|365642716|FG001|Overall Study|Lost to Follow-up|1|||
105995424|NCT02021643|365642717|FG002|Overall Study|Lost to Follow-up|0|||
105995425|NCT02021643|365642718|FG003|Overall Study|Lost to Follow-up|0|||
105995426|NCT02021643|365642715|FG000|Overall Study|Withdrew Consent|0|||
105995427|NCT02021643|365642716|FG001|Overall Study|Withdrew Consent|1|||
105995428|NCT02021643|365642717|FG002|Overall Study|Withdrew Consent|0|||
105995429|NCT02021643|365642718|FG003|Overall Study|Withdrew Consent|0|||
105995430|NCT04112303|365642721|FG000|Overall Study|Death|1|||
105995431|NCT01818596|365642724|FG000|Overall Study|Enrolled but Not Treated|4|||
105995432|NCT01818596|365642725|FG001|Overall Study|Enrolled but Not Treated|0|||
105995433|NCT01818596|365642724|FG000|Overall Study|Adverse Event|7|||
105995434|NCT01818596|365642725|FG001|Overall Study|Adverse Event|0|||
105995435|NCT01818596|365642724|FG000|Overall Study|Death|3|||
105662495|NCT01151423|364428169|FG000|Overall Study|Protocol Violation|0|||
105662496|NCT01151423|364428170|FG001|Overall Study|Protocol Violation|1|||
105662497|NCT01151423|364428169|FG000|Overall Study|Physician Decision|1|||
105662498|NCT01151423|364428170|FG001|Overall Study|Physician Decision|1|||
105995436|NCT01818596|365642725|FG001|Overall Study|Death|0|||
105662499|NCT01151423|364428169|FG000|Overall Study|Pregnancy|0|||
105662500|NCT01151423|364428170|FG001|Overall Study|Pregnancy|1|||
105662501|NCT01151423|364428169|FG000|Overall Study|Death|0|||
105662502|NCT01151423|364428170|FG001|Overall Study|Death|1|||
105662503|NCT01151423|364428169|FG000|Overall Study|Adverse Event|3|||
105662504|NCT01151423|364428170|FG001|Overall Study|Adverse Event|0|||
105662505|NCT01151423|364428169|FG000|Overall Study|Withdrawal by Subject|1|||
105662506|NCT01151423|364428170|FG001|Overall Study|Withdrawal by Subject|3|||
105662507|NCT01151423|364428169|FG000|Overall Study|Lost to Follow-up|1|||
105662508|NCT01151423|364428170|FG001|Overall Study|Lost to Follow-up|0|||
105662509|NCT01151423|364428169|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
105662510|NCT01151423|364428170|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
105662511|NCT01151423|364428169|FG000|Overall Study|Participated in other clinical trial|1|||
105662512|NCT01151423|364428170|FG001|Overall Study|Participated in other clinical trial|0|||
105662513|NCT01310699|364428172|FG000|Overall Study|Patients did not complete tandem.|4|||
105662514|NCT01310699|364428173|FG001|Overall Study|Patients did not complete tandem.|6|||
105662515|NCT00936598|364428174|FG000|Overall Study|Withdrawal by Subject|1|||
105662516|NCT00936598|364428175|FG001|Overall Study|Withdrawal by Subject|0|||
105662517|NCT00936598|364428174|FG000|Overall Study|Ineligible after consent|1|||
105662518|NCT00936598|364428175|FG001|Overall Study|Ineligible after consent|0|||
105662519|NCT02201901|364428179|FG000|Overall Study|Randomized but never treated|0|||
105662520|NCT02201901|364428180|FG001|Overall Study|Randomized but never treated|1|||
105662521|NCT02201901|364428181|FG002|Overall Study|Randomized but never treated|0|||
105662522|NCT02201901|364428179|FG000|Overall Study|Lack of Efficacy|7|||
105662523|NCT02201901|364428180|FG001|Overall Study|Lack of Efficacy|1|||
105662524|NCT02201901|364428181|FG002|Overall Study|Lack of Efficacy|6|||
105662525|NCT02201901|364428179|FG000|Overall Study|Death|3|||
105995437|NCT01818596|365642724|FG000|Overall Study|Investigator's Discretion|4|||
105995438|NCT01818596|365642725|FG001|Overall Study|Investigator's Discretion|0|||
105995439|NCT01818596|365642724|FG000|Overall Study|Protocol Violation|1|||
105995440|NCT01818596|365642725|FG001|Overall Study|Protocol Violation|0|||
105995441|NCT01818596|365642724|FG000|Overall Study|Withdrew Consent|5|||
105995442|NCT01818596|365642725|FG001|Overall Study|Withdrew Consent|0|||
105995443|NCT01818596|365642724|FG000|Overall Study|Lost to Follow-up|7|||
105995444|NCT01818596|365642725|FG001|Overall Study|Lost to Follow-up|0|||
105995445|NCT00799903|365642732|FG000|Overall Study|Investigator Site Closed|25|||
105995446|NCT00799903|365642733|FG001|Overall Study|Investigator Site Closed|23|||
105995447|NCT00799903|365642732|FG000|Overall Study|Withdrawal by Subject|179|||
105995448|NCT00799903|365642733|FG001|Overall Study|Withdrawal by Subject|175|||
105995449|NCT00799903|365642732|FG000|Overall Study|Lost to Follow-up|69|||
105995450|NCT00799903|365642733|FG001|Overall Study|Lost to Follow-up|80|||
105995451|NCT02524171|365642734|FG000|6-month Follow-up|Lost to Follow-up|53|||
105995452|NCT02524171|365642735|FG001|6-month Follow-up|Lost to Follow-up|45|||
105995453|NCT02524171|365642734|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
105995454|NCT02524171|365642735|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
105995455|NCT00757237|365642738|FG000|Overall Study|Lost to Follow-up|0|||
105995456|NCT00757237|365642739|FG001|Overall Study|Lost to Follow-up|1|||
105995457|NCT00757237|365642738|FG000|Overall Study|Protocol Violation|0|||
105995458|NCT00757237|365642739|FG001|Overall Study|Protocol Violation|2|||
105995459|NCT00757237|365642738|FG000|Overall Study|Physician Decision|2|||
105995460|NCT00757237|365642739|FG001|Overall Study|Physician Decision|3|||
105995461|NCT00757237|365642738|FG000|Overall Study|Withdrawal by Subject|8|||
105995462|NCT00757237|365642739|FG001|Overall Study|Withdrawal by Subject|12|||
105995463|NCT00757237|365642738|FG000|Overall Study|Safety or Tolerability|3|||
105995464|NCT00757237|365642739|FG001|Overall Study|Safety or Tolerability|5|||
105995465|NCT00757237|365642738|FG000|Overall Study|Other|0|||
105995466|NCT00757237|365642739|FG001|Overall Study|Other|2|||
105995467|NCT00779025|365642740|FG000|Overall Study|Withdrawal by Subject|1|||
105995468|NCT06041919|365642741|FG000|Overall Study|Lost to Follow-up|1|||
105995469|NCT06041919|365642742|FG001|Overall Study|Lost to Follow-up|0|||
105995470|NCT06041919|365642743|FG002|Overall Study|Lost to Follow-up|0|||
105995471|NCT06041919|365642744|FG003|Overall Study|Lost to Follow-up|0|||
105995472|NCT06041919|365642745|FG004|Overall Study|Lost to Follow-up|0|||
105995473|NCT06041919|365642741|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
105995474|NCT06041919|365642742|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
105995475|NCT06041919|365642743|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
105662526|NCT02201901|364428180|FG001|Overall Study|Death|3|||
105662527|NCT02201901|364428181|FG002|Overall Study|Death|3|||
105995476|NCT06041919|365642744|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
105995477|NCT06041919|365642745|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
105995478|NCT05973006|365642746|FG000|Overall Study|Early termination|3|||
105662528|NCT02201901|364428179|FG000|Overall Study|Lost to Follow-up|2|||
105888061|NCT01943851|365245911|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888062|NCT01943851|365245912|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888063|NCT01943851|365245913|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888064|NCT01943851|365245914|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
105888065|NCT01943851|365245915|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888066|NCT01943851|365245916|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888067|NCT01943851|365245917|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
105888068|NCT01943851|365245918|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
105888069|NCT01943851|365245919|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
105888070|NCT01943851|365245920|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888071|NCT01943851|365245921|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888072|NCT01943851|365245922|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
106118522|NCT02440594|366091791|FG003|Overall Study|Withdrawal by Subject|38|||
106118523|NCT02440594|366091792|FG004|Overall Study|Withdrawal by Subject|2|||
106118524|NCT02440594|366091793|FG005|Overall Study|Withdrawal by Subject|2|||
106118525|NCT02440594|366091794|FG006|Overall Study|Withdrawal by Subject|7|||
106118526|NCT02440594|366091795|FG007|Overall Study|Withdrawal by Subject|7|||
106118527|NCT02440594|366091788|FG000|Overall Study|Administratively w/drawn|3|||
106118528|NCT02440594|366091789|FG001|Overall Study|Administratively w/drawn|2|||
106118529|NCT02440594|366091790|FG002|Overall Study|Administratively w/drawn|0|||
106118530|NCT02440594|366091791|FG003|Overall Study|Administratively w/drawn|0|||
106118531|NCT02440594|366091792|FG004|Overall Study|Administratively w/drawn|0|||
106118532|NCT02440594|366091793|FG005|Overall Study|Administratively w/drawn|0|||
106118533|NCT02440594|366091794|FG006|Overall Study|Administratively w/drawn|2|||
106118534|NCT02440594|366091795|FG007|Overall Study|Administratively w/drawn|1|||
106118535|NCT00569803|366091796|FG000|Overall Study|Lost to Follow-up|1|||
106118536|NCT00569803|366091797|FG001|Overall Study|Lost to Follow-up|0|||
106118537|NCT00569803|366091798|FG002|Overall Study|Lost to Follow-up|0|||
106118538|NCT00569803|366091799|FG003|Overall Study|Lost to Follow-up|0|||
106118539|NCT00569803|366091800|FG004|Overall Study|Lost to Follow-up|0|||
106118540|NCT00569803|366091801|FG005|Overall Study|Lost to Follow-up|0|||
106118541|NCT00569803|366091802|FG006|Overall Study|Lost to Follow-up|0|||
106118542|NCT00569803|366091803|FG007|Overall Study|Lost to Follow-up|0|||
106118543|NCT00569803|366091796|FG000|Overall Study|injection syringe leaked during dosing|0|||
106118544|NCT00569803|366091797|FG001|Overall Study|injection syringe leaked during dosing|0|||
106118545|NCT00569803|366091798|FG002|Overall Study|injection syringe leaked during dosing|0|||
106118546|NCT00569803|366091799|FG003|Overall Study|injection syringe leaked during dosing|1|||
106118547|NCT00569803|366091800|FG004|Overall Study|injection syringe leaked during dosing|0|||
106118548|NCT00569803|366091801|FG005|Overall Study|injection syringe leaked during dosing|0|||
106118549|NCT00569803|366091802|FG006|Overall Study|injection syringe leaked during dosing|0|||
106118550|NCT00569803|366091803|FG007|Overall Study|injection syringe leaked during dosing|0|||
106118551|NCT00569803|366091796|FG000|Overall Study|Withdrawal by Subject|0|||
106118552|NCT00569803|366091797|FG001|Overall Study|Withdrawal by Subject|0|||
106118553|NCT00569803|366091798|FG002|Overall Study|Withdrawal by Subject|0|||
106118554|NCT00569803|366091799|FG003|Overall Study|Withdrawal by Subject|0|||
106118555|NCT00569803|366091800|FG004|Overall Study|Withdrawal by Subject|0|||
106118556|NCT00569803|366091801|FG005|Overall Study|Withdrawal by Subject|0|||
106118557|NCT00569803|366091802|FG006|Overall Study|Withdrawal by Subject|0|||
106118558|NCT00569803|366091803|FG007|Overall Study|Withdrawal by Subject|1|||
106118559|NCT01077362|366091804|FG000|Overall Study|Lack of Efficacy|13|||
106118560|NCT01077362|366091805|FG001|Overall Study|Lack of Efficacy|8|||
106118561|NCT01077362|366091806|FG002|Overall Study|Lack of Efficacy|10|||
106118562|NCT01077362|366091804|FG000|Overall Study|Lost to Follow-up|1|||
106118563|NCT01077362|366091805|FG001|Overall Study|Lost to Follow-up|0|||
106118564|NCT01077362|366091806|FG002|Overall Study|Lost to Follow-up|3|||
106118565|NCT01077362|366091804|FG000|Overall Study|Adverse Event|12|||
106118566|NCT01077362|366091805|FG001|Overall Study|Adverse Event|7|||
106118567|NCT01077362|366091806|FG002|Overall Study|Adverse Event|4|||
106118568|NCT01077362|366091804|FG000|Overall Study|Withdrawal by Subject|5|||
106118569|NCT01077362|366091805|FG001|Overall Study|Withdrawal by Subject|3|||
106118570|NCT01077362|366091806|FG002|Overall Study|Withdrawal by Subject|5|||
106118571|NCT01077362|366091804|FG000|Overall Study|Other|0|||
106118572|NCT01077362|366091805|FG001|Overall Study|Other|1|||
106118573|NCT01077362|366091806|FG002|Overall Study|Other|2|||
106118574|NCT00641719|366091807|FG000|Overall Study|Lack of Efficacy|1|||
106118575|NCT00641719|366091808|FG001|Overall Study|Lack of Efficacy|2|||
106118576|NCT00641719|366091807|FG000|Overall Study|Adverse Event|24|||
106118577|NCT00641719|366091808|FG001|Overall Study|Adverse Event|29|||
106118578|NCT00641719|366091807|FG000|Overall Study|Withdrawal by Subject|4|||
106118579|NCT00641719|366091808|FG001|Overall Study|Withdrawal by Subject|4|||
106118580|NCT00641719|366091807|FG000|Overall Study|Reason Not Specified|1|||
105888073|NCT01943851|365245923|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
106118581|NCT00641719|366091808|FG001|Overall Study|Reason Not Specified|2|||
106118582|NCT00100932|366091809|FG000|Overall Study|Adverse Event|11|||
106118583|NCT00100932|366091810|FG001|Overall Study|Adverse Event|2|||
106118584|NCT00100932|366091809|FG000|Overall Study|Withdrawal by Subject|6|||
106118585|NCT00100932|366091810|FG001|Overall Study|Withdrawal by Subject|0|||
106118586|NCT00100932|366091809|FG000|Overall Study|Progressive Disease|44|||
106118587|NCT00100932|366091810|FG001|Overall Study|Progressive Disease|18|||
106118588|NCT00100932|366091809|FG000|Overall Study|Physician Decision|7|||
106118589|NCT00100932|366091810|FG001|Overall Study|Physician Decision|5|||
106118590|NCT00100932|366091809|FG000|Overall Study|Other|5|||
106118591|NCT00100932|366091810|FG001|Overall Study|Other|2|||
106118592|NCT01616771|366091811|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
106118593|NCT00744328|366091812|FG000|Overall Study|Lost to Follow-up|2|||
106118594|NCT00744328|366091813|FG001|Overall Study|Lost to Follow-up|5|||
106118595|NCT00744328|366091814|FG002|Overall Study|Lost to Follow-up|3|||
106118596|NCT00744328|366091812|FG000|Overall Study|Withdrawal by Subject|5|||
106118597|NCT00744328|366091813|FG001|Overall Study|Withdrawal by Subject|3|||
106118598|NCT00744328|366091814|FG002|Overall Study|Withdrawal by Subject|4|||
106118599|NCT00744328|366091812|FG000|Overall Study|Found ineligible after randomization|0|||
106118600|NCT00744328|366091813|FG001|Overall Study|Found ineligible after randomization|0|||
106118601|NCT00744328|366091814|FG002|Overall Study|Found ineligible after randomization|1|||
106118602|NCT01678820|366091820|FG000|Overall Study|Study Terminated by Sponsor|45|||
106118603|NCT01678820|366091821|FG001|Overall Study|Study Terminated by Sponsor|43|||
106118604|NCT01678820|366091822|FG002|Overall Study|Study Terminated by Sponsor|43|||
106118605|NCT01678820|366091820|FG000|Overall Study|Withdrawal by Subject|2|||
106118606|NCT01678820|366091821|FG001|Overall Study|Withdrawal by Subject|5|||
106118607|NCT01678820|366091822|FG002|Overall Study|Withdrawal by Subject|2|||
106118608|NCT01678820|366091820|FG000|Overall Study|Protocol Specified Criteria|2|||
106118609|NCT01678820|366091821|FG001|Overall Study|Protocol Specified Criteria|3|||
106118610|NCT01678820|366091822|FG002|Overall Study|Protocol Specified Criteria|1|||
106118611|NCT01678820|366091820|FG000|Overall Study|Adverse Event|2|||
106118612|NCT01678820|366091821|FG001|Overall Study|Adverse Event|2|||
106118613|NCT01678820|366091822|FG002|Overall Study|Adverse Event|2|||
106118614|NCT01678820|366091820|FG000|Overall Study|Lost to Follow-up|7|||
106118615|NCT01678820|366091821|FG001|Overall Study|Lost to Follow-up|2|||
106118616|NCT01678820|366091822|FG002|Overall Study|Lost to Follow-up|2|||
106118617|NCT01678820|366091820|FG000|Overall Study|Non-compliance with study drug|0|||
106118618|NCT01678820|366091821|FG001|Overall Study|Non-compliance with study drug|1|||
106118619|NCT01678820|366091822|FG002|Overall Study|Non-compliance with study drug|0|||
106118620|NCT01678820|366091820|FG000|Overall Study|Physician Decision|0|||
106118621|NCT01678820|366091821|FG001|Overall Study|Physician Decision|0|||
106118622|NCT01678820|366091822|FG002|Overall Study|Physician Decision|1|||
106118623|NCT01678820|366091820|FG000|Overall Study|Protocol Violation|4|||
106118624|NCT01678820|366091821|FG001|Overall Study|Protocol Violation|5|||
106118625|NCT01678820|366091822|FG002|Overall Study|Protocol Violation|4|||
106118626|NCT01678820|366091820|FG000|Overall Study|Not treated with double-blind study drug|0|||
106118627|NCT01678820|366091821|FG001|Overall Study|Not treated with double-blind study drug|2|||
106118628|NCT01678820|366091822|FG002|Overall Study|Not treated with double-blind study drug|2|||
106118629|NCT02306265|366091823|FG000|Overall Study|Withdrawal by Subject|1|||
106118630|NCT00452413|366091827|FG000|Overall Study|Progressive Disease|4|||
106118631|NCT00452413|366091828|FG001|Overall Study|Progressive Disease|11|||
106118632|NCT00452413|366091829|FG002|Overall Study|Progressive Disease|30|||
106118633|NCT00452413|366091827|FG000|Overall Study|Withdrawal by Subject|0|||
106118634|NCT00452413|366091828|FG001|Overall Study|Withdrawal by Subject|1|||
106118635|NCT00452413|366091829|FG002|Overall Study|Withdrawal by Subject|4|||
106118636|NCT00452413|366091827|FG000|Overall Study|Adverse Event|0|||
106118637|NCT00452413|366091828|FG001|Overall Study|Adverse Event|0|||
106118638|NCT00452413|366091829|FG002|Overall Study|Adverse Event|5|||
106118639|NCT00452413|366091827|FG000|Overall Study|Physician Decision|0|||
106118640|NCT00452413|366091828|FG001|Overall Study|Physician Decision|0|||
106118641|NCT00452413|366091829|FG002|Overall Study|Physician Decision|4|||
106118642|NCT00452413|366091827|FG000|Overall Study|Death due to study disease|0|||
106118643|NCT00452413|366091828|FG001|Overall Study|Death due to study disease|0|||
106118644|NCT00452413|366091829|FG002|Overall Study|Death due to study disease|2|||
106118645|NCT00452413|366091827|FG000|Overall Study|Death due to adverse event (AE)|0|||
106118646|NCT00452413|366091828|FG001|Overall Study|Death due to adverse event (AE)|0|||
106118647|NCT00452413|366091829|FG002|Overall Study|Death due to adverse event (AE)|1|||
106118648|NCT00452413|366091827|FG000|Overall Study|On treatment|0|||
106118649|NCT00452413|366091828|FG001|Overall Study|On treatment|0|||
106118650|NCT00452413|366091829|FG002|Overall Study|On treatment|3|||
106118651|NCT01248962|366091832|FG000|Overall Study|Withdrawal by Subject|1|||
106118652|NCT01248962|366091833|FG001|Overall Study|Withdrawal by Subject|1|||
106118653|NCT01248962|366091832|FG000|Overall Study|Adverse Event|2|||
106118654|NCT01248962|366091833|FG001|Overall Study|Adverse Event|1|||
105785066|NCT01241591|364866375|FG003|Overall Study|Lack of Efficacy|3|||
106118655|NCT01248962|366091832|FG000|Overall Study|Complete Response after 4 Cycles|1|||
106118656|NCT01248962|366091833|FG001|Overall Study|Complete Response after 4 Cycles|0|||
106118657|NCT01248962|366091832|FG000|Overall Study|Complete Response after 3 Cycles|0|||
105785067|NCT01241591|364866372|FG000|Overall Study|Protocol Violation|5|||
105662529|NCT02201901|364428180|FG001|Overall Study|Lost to Follow-up|3|||
105662530|NCT02201901|364428181|FG002|Overall Study|Lost to Follow-up|2|||
105662531|NCT02201901|364428179|FG000|Overall Study|Withdrew Consent|2|||
105662532|NCT02201901|364428180|FG001|Overall Study|Withdrew Consent|0|||
105662533|NCT02201901|364428181|FG002|Overall Study|Withdrew Consent|2|||
105662534|NCT02201901|364428179|FG000|Overall Study|Adverse Event|1|||
105662535|NCT02201901|364428180|FG001|Overall Study|Adverse Event|1|||
105662536|NCT02201901|364428181|FG002|Overall Study|Adverse Event|0|||
105662537|NCT03358238|364428184|FG000|Overall Study|Withdrawal by Subject|0|||
105662538|NCT03358238|364428185|FG001|Overall Study|Withdrawal by Subject|1|||
105662539|NCT02559310|364428188|FG000|Overall Study|Death|4|||
105662540|NCT02559310|364428189|FG001|Overall Study|Death|3|||
105662541|NCT02559310|364428188|FG000|Overall Study|Lost to Follow-up|5|||
105662542|NCT02559310|364428189|FG001|Overall Study|Lost to Follow-up|3|||
105662543|NCT02559310|364428188|FG000|Overall Study|Physician Decision|2|||
105662544|NCT02559310|364428189|FG001|Overall Study|Physician Decision|1|||
105662545|NCT02559310|364428188|FG000|Overall Study|Withdrawal by Subject|13|||
105662546|NCT02559310|364428189|FG001|Overall Study|Withdrawal by Subject|9|||
105662547|NCT02559310|364428188|FG000|Overall Study|Sponsor Decision|0|||
105662548|NCT02559310|364428189|FG001|Overall Study|Sponsor Decision|1|||
105662549|NCT02559310|364428188|FG000|Overall Study|Randomized but not treated|3|||
105662550|NCT02559310|364428189|FG001|Overall Study|Randomized but not treated|2|||
105662551|NCT01740154|364428190|FG000|Overall Study|Adverse Event|1|||
105662552|NCT00469859|364428191|FG000|Overall Study|Inevaluable|0|||
105785068|NCT01241591|364866373|FG001|Overall Study|Protocol Violation|2|||
105785069|NCT01241591|364866374|FG002|Overall Study|Protocol Violation|3|||
105785070|NCT01241591|364866375|FG003|Overall Study|Protocol Violation|0|||
105785071|NCT01241591|364866372|FG000|Overall Study|Lost to Follow-up|1|||
105785072|NCT01241591|364866373|FG001|Overall Study|Lost to Follow-up|2|||
105785073|NCT01241591|364866374|FG002|Overall Study|Lost to Follow-up|2|||
105785074|NCT01241591|364866375|FG003|Overall Study|Lost to Follow-up|2|||
105785075|NCT01241591|364866372|FG000|Overall Study|Screen Failure|3|||
105785076|NCT01241591|364866373|FG001|Overall Study|Screen Failure|2|||
105785077|NCT01241591|364866374|FG002|Overall Study|Screen Failure|1|||
105785078|NCT01241591|364866375|FG003|Overall Study|Screen Failure|0|||
105785079|NCT01241591|364866372|FG000|Overall Study|Withdrawal by Subject|6|||
106118658|NCT01248962|366091833|FG001|Overall Study|Complete Response after 3 Cycles|1|||
106118659|NCT01248962|366091832|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
106118660|NCT01248962|366091833|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
105662553|NCT00469859|364428192|FG001|Overall Study|Inevaluable|2|||
105662554|NCT04855734|364428193|FG000|Overall Study|Lost to Follow-up|2|||
105662555|NCT04855734|364428194|FG001|Overall Study|Lost to Follow-up|2|||
105785080|NCT01241591|364866373|FG001|Overall Study|Withdrawal by Subject|4|||
106118661|NCT00114634|366091835|FG000|Overall Study|failure to return forms|3|||
106118662|NCT00684762|366091836|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
106118663|NCT00684762|366091837|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
106118664|NCT00245856|366091846|FG000|Period Two|Withdrawal by Subject|0|||
106118665|NCT00245856|366091847|FG001|Period Two|Withdrawal by Subject|1|||
106118666|NCT01003184|366091848|FG000|Overall Study|Adverse Event|12|||
106118667|NCT01003184|366091849|FG001|Overall Study|Adverse Event|5|||
106118668|NCT01003184|366091848|FG000|Overall Study|Lost to Follow-up|1|||
106118669|NCT01003184|366091849|FG001|Overall Study|Lost to Follow-up|0|||
106118670|NCT01003184|366091848|FG000|Overall Study|Loss of glucose control|1|||
106118671|NCT01003184|366091849|FG001|Overall Study|Loss of glucose control|1|||
106118672|NCT01003184|366091848|FG000|Overall Study|Protocol Violation|3|||
106118673|NCT01003184|366091849|FG001|Overall Study|Protocol Violation|0|||
106118674|NCT01003184|366091848|FG000|Overall Study|Withdrawal by Subject|1|||
106118675|NCT01003184|366091849|FG001|Overall Study|Withdrawal by Subject|6|||
106118676|NCT01003184|366091848|FG000|Overall Study|Physician Decision|1|||
106118677|NCT01003184|366091849|FG001|Overall Study|Physician Decision|0|||
106118678|NCT01539863|366091850|FG000|Overall Study|Lost to Follow-up|5|||
106118679|NCT01539863|366091851|FG001|Overall Study|Lost to Follow-up|4|||
106118680|NCT00557622|366091852|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
106118681|NCT00557622|366091853|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
106118682|NCT00557622|366091852|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
106118683|NCT00557622|366091853|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
105662556|NCT02520310|364428195|FG000|At 6 Months Clinical Follow-up|Death|1|||
105662557|NCT02520310|364428195|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
105662558|NCT02520310|364428195|FG000|AT 3 Year Clinical Follow-up|Death|2|||
105662559|NCT02520310|364428195|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
105662560|NCT02520310|364428195|FG000|AT 4 Year Clinical Follow-up|Death|1|||
105785081|NCT01241591|364866374|FG002|Overall Study|Withdrawal by Subject|2|||
105785082|NCT01241591|364866375|FG003|Overall Study|Withdrawal by Subject|2|||
105785083|NCT01241591|364866372|FG000|Overall Study|Other|0|||
106118684|NCT00557622|366091852|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
106118685|NCT00557622|366091853|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
105662561|NCT02520310|364428195|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
105785084|NCT01241591|364866373|FG001|Overall Study|Other|1|||
106118686|NCT02693834|366091854|FG000|Baseline Measurement|Withdrawal by Subject|1|||
106118687|NCT02693834|366091855|FG001|Baseline Measurement|Withdrawal by Subject|0|||
106118688|NCT02693834|366091854|FG000|Baseline Measurement|Adverse Event|1|||
106118689|NCT02693834|366091855|FG001|Baseline Measurement|Adverse Event|0|||
106118690|NCT02693834|366091854|FG000|Week 2 Practice|Adverse Event|0|||
106118691|NCT02693834|366091855|FG001|Week 2 Practice|Adverse Event|1|||
106118692|NCT01468922|366091858|FG000|Overall Study|Screening failure|0|||
105785085|NCT01241591|364866374|FG002|Overall Study|Other|0|||
106118693|NCT01468922|366091859|FG001|Overall Study|Screening failure|0|||
106118694|NCT01468922|366091860|FG002|Overall Study|Screening failure|0|||
106118695|NCT01468922|366091861|FG003|Overall Study|Screening failure|0|||
106118696|NCT01468922|366091862|FG004|Overall Study|Screening failure|0|||
106118697|NCT01468922|366091863|FG005|Overall Study|Screening failure|0|||
106118698|NCT01468922|366091864|FG006|Overall Study|Screening failure|0|||
106118699|NCT01468922|366091865|FG007|Overall Study|Screening failure|0|||
106118700|NCT01468922|366091866|FG008|Overall Study|Screening failure|1|||
106118701|NCT01468922|366091858|FG000|Overall Study|Per patient choice|1|||
106118702|NCT01468922|366091859|FG001|Overall Study|Per patient choice|0|||
106118703|NCT01468922|366091860|FG002|Overall Study|Per patient choice|0|||
106118704|NCT01468922|366091861|FG003|Overall Study|Per patient choice|0|||
106118705|NCT01468922|366091862|FG004|Overall Study|Per patient choice|0|||
106118706|NCT01468922|366091863|FG005|Overall Study|Per patient choice|0|||
106118707|NCT01468922|366091864|FG006|Overall Study|Per patient choice|0|||
106118708|NCT01468922|366091865|FG007|Overall Study|Per patient choice|0|||
106118709|NCT01468922|366091866|FG008|Overall Study|Per patient choice|0|||
106118710|NCT01468922|366091858|FG000|Overall Study|Switched to alternative treatment|1|||
106118711|NCT01468922|366091859|FG001|Overall Study|Switched to alternative treatment|0|||
106118712|NCT01468922|366091860|FG002|Overall Study|Switched to alternative treatment|0|||
106118713|NCT01468922|366091861|FG003|Overall Study|Switched to alternative treatment|0|||
106118714|NCT01468922|366091862|FG004|Overall Study|Switched to alternative treatment|1|||
106118715|NCT01468922|366091863|FG005|Overall Study|Switched to alternative treatment|0|||
106118716|NCT01468922|366091864|FG006|Overall Study|Switched to alternative treatment|0|||
106118717|NCT01468922|366091865|FG007|Overall Study|Switched to alternative treatment|0|||
106118718|NCT01468922|366091866|FG008|Overall Study|Switched to alternative treatment|0|||
106118719|NCT01468922|366091858|FG000|Overall Study|Enrolled on new protocol|0|||
106118720|NCT01468922|366091859|FG001|Overall Study|Enrolled on new protocol|0|||
106118721|NCT01468922|366091860|FG002|Overall Study|Enrolled on new protocol|0|||
106118722|NCT01468922|366091861|FG003|Overall Study|Enrolled on new protocol|0|||
106118723|NCT01468922|366091862|FG004|Overall Study|Enrolled on new protocol|1|||
106118724|NCT01468922|366091863|FG005|Overall Study|Enrolled on new protocol|0|||
106118725|NCT01468922|366091864|FG006|Overall Study|Enrolled on new protocol|0|||
106118726|NCT01468922|366091865|FG007|Overall Study|Enrolled on new protocol|0|||
106118727|NCT01468922|366091866|FG008|Overall Study|Enrolled on new protocol|0|||
106118728|NCT01468922|366091858|FG000|Overall Study|Adverse Event|0|||
106118729|NCT01468922|366091859|FG001|Overall Study|Adverse Event|0|||
106118730|NCT01468922|366091860|FG002|Overall Study|Adverse Event|0|||
106118731|NCT01468922|366091861|FG003|Overall Study|Adverse Event|0|||
106118732|NCT01468922|366091862|FG004|Overall Study|Adverse Event|0|||
106118733|NCT01468922|366091863|FG005|Overall Study|Adverse Event|0|||
106118734|NCT01468922|366091864|FG006|Overall Study|Adverse Event|0|||
106118735|NCT01468922|366091865|FG007|Overall Study|Adverse Event|1|||
106118736|NCT01468922|366091866|FG008|Overall Study|Adverse Event|0|||
106118737|NCT01468922|366091858|FG000|Overall Study|Infection of blood|0|||
106118738|NCT01468922|366091859|FG001|Overall Study|Infection of blood|0|||
106118739|NCT01468922|366091860|FG002|Overall Study|Infection of blood|0|||
106118740|NCT01468922|366091861|FG003|Overall Study|Infection of blood|0|||
106118741|NCT01468922|366091862|FG004|Overall Study|Infection of blood|0|||
106118742|NCT01468922|366091863|FG005|Overall Study|Infection of blood|0|||
106118743|NCT01468922|366091864|FG006|Overall Study|Infection of blood|0|||
106118744|NCT01468922|366091865|FG007|Overall Study|Infection of blood|1|||
106118745|NCT01468922|366091866|FG008|Overall Study|Infection of blood|0|||
105785086|NCT01241591|364866375|FG003|Overall Study|Other|1|||
105785087|NCT01241591|364866372|FG000|Overall Study|Adverse Event|3|||
105785088|NCT01241591|364866373|FG001|Overall Study|Adverse Event|11|||
105785089|NCT01241591|364866374|FG002|Overall Study|Adverse Event|12|||
105785090|NCT01241591|364866375|FG003|Overall Study|Adverse Event|4|||
105785091|NCT01798056|364866376|FG000|Overall Study|Serious Adverse Event|13|||
105785092|NCT01798056|364866377|FG001|Overall Study|Serious Adverse Event|12|||
105785093|NCT01798056|364866376|FG000|Overall Study|Withdrawal by Subject|12|||
105785094|NCT01798056|364866377|FG001|Overall Study|Withdrawal by Subject|9|||
105785095|NCT01798056|364866376|FG000|Overall Study|Migrated/moved from study area|1|||
105785096|NCT01798056|364866377|FG001|Overall Study|Migrated/moved from study area|1|||
105785097|NCT01798056|364866376|FG000|Overall Study|Lost to Follow-up|1|||
105785098|NCT01798056|364866377|FG001|Overall Study|Lost to Follow-up|1|||
105785099|NCT01798056|364866376|FG000|Overall Study|Other|0|||
105785100|NCT01798056|364866377|FG001|Overall Study|Other|2|||
106118746|NCT01468922|366091858|FG000|Overall Study|Patient choice - surgery|0|||
106118747|NCT01468922|366091859|FG001|Overall Study|Patient choice - surgery|0|||
105662562|NCT01340014|364428196|FG000|Period 1, First 7 Days|Adverse Event|1|||
105662563|NCT01340014|364428197|FG001|Period 1, First 7 Days|Adverse Event|0|||
105662564|NCT01340014|364428196|FG000|Period 1, First 7 Days|Personal Reasons|1|||
105662565|NCT01340014|364428197|FG001|Period 1, First 7 Days|Personal Reasons|0|||
105662566|NCT01340014|364428196|FG000|Period 2, Second 7 Days|Adverse Event|0|||
105662567|NCT01340014|364428197|FG001|Period 2, Second 7 Days|Adverse Event|1|||
105662568|NCT01053247|364429951|FG000|Overall Study|Withdrawal by Subject|9|||
105662569|NCT01053247|364429952|FG001|Overall Study|Withdrawal by Subject|4|||
105662570|NCT01053247|364429953|FG002|Overall Study|Withdrawal by Subject|15|||
105662571|NCT01053247|364429951|FG000|Overall Study|Lack of Efficacy|1|||
105662572|NCT01053247|364429952|FG001|Overall Study|Lack of Efficacy|0|||
105662573|NCT01053247|364429953|FG002|Overall Study|Lack of Efficacy|1|||
105662574|NCT01053247|364429951|FG000|Overall Study|Protocol Violation|2|||
105662575|NCT01053247|364429952|FG001|Overall Study|Protocol Violation|1|||
105662576|NCT01053247|364429953|FG002|Overall Study|Protocol Violation|2|||
105662577|NCT01053247|364429951|FG000|Overall Study|Lost to Follow-up|8|||
105662578|NCT01053247|364429952|FG001|Overall Study|Lost to Follow-up|5|||
105662579|NCT01053247|364429953|FG002|Overall Study|Lost to Follow-up|7|||
105662580|NCT01053247|364429951|FG000|Overall Study|Adverse Event|0|||
105662581|NCT01053247|364429952|FG001|Overall Study|Adverse Event|9|||
105662582|NCT01053247|364429953|FG002|Overall Study|Adverse Event|3|||
105662583|NCT02354651|364429954|FG000|Overall Study|Withdrawal by Subject|2|||
105662584|NCT02354651|364429954|FG000|Overall Study|Physician Decision|1|||
105662585|NCT01266018|364429958|FG000|Overall Study|Physician Decision|1|||
105662586|NCT01266018|364429959|FG001|Overall Study|Physician Decision|0|||
105662587|NCT01266018|364429958|FG000|Overall Study|Progressive disease|0|||
105662588|NCT01266018|364429959|FG001|Overall Study|Progressive disease|1|||
105662589|NCT01458522|364429960|FG000|Overall Study|Withdrawal by Subject|2|||
105662590|NCT01458522|364429961|FG001|Overall Study|Withdrawal by Subject|2|||
105662591|NCT01458522|364429960|FG000|Overall Study|Physician Decision|1|||
105662592|NCT01458522|364429961|FG001|Overall Study|Physician Decision|9|||
105662593|NCT02684123|364429962|FG000|Phase 1|Lack of Efficacy|5|||
105662594|NCT02684123|364429963|FG001|Phase 1|Lack of Efficacy|0|||
105662595|NCT02684123|364429962|FG000|Phase 1|Adverse Event|3|||
105662596|NCT02684123|364429963|FG001|Phase 1|Adverse Event|0|||
105662597|NCT02684123|364429962|FG000|Phase 1|Lost to Follow-up|0|||
105662598|NCT02684123|364429963|FG001|Phase 1|Lost to Follow-up|1|||
105662599|NCT02684123|364429962|FG000|Phase 2|Lack of Efficacy|1|||
105662600|NCT02684123|364429963|FG001|Phase 2|Lack of Efficacy|8|||
105662601|NCT00589303|364429970|FG000|Overall Study|Withdrawal by Subject|2|||
105662602|NCT00589303|364429971|FG001|Overall Study|Withdrawal by Subject|1|||
105662603|NCT03382561|364429972|FG000|Overall Study|Disease progression|47|||
105662604|NCT03382561|364429973|FG001|Overall Study|Disease progression|6|||
105662605|NCT03382561|364429972|FG000|Overall Study|Adverse Event|10|||
105662606|NCT03382561|364429973|FG001|Overall Study|Adverse Event|2|||
105662607|NCT03382561|364429972|FG000|Overall Study|Death|8|||
105662608|NCT03382561|364429973|FG001|Overall Study|Death|3|||
105662609|NCT03382561|364429972|FG000|Overall Study|Withdrawal by Subject|6|||
105662610|NCT03382561|364429973|FG001|Overall Study|Withdrawal by Subject|5|||
105662611|NCT03382561|364429972|FG000|Overall Study|Alternative therapy|2|||
105662612|NCT03382561|364429973|FG001|Overall Study|Alternative therapy|8|||
105662613|NCT03382561|364429972|FG000|Overall Study|Never started treatment|3|||
105662614|NCT03382561|364429973|FG001|Overall Study|Never started treatment|6|||
105662615|NCT03382561|364429972|FG000|Overall Study|Lack of Efficacy|0|||
105662616|NCT03382561|364429973|FG001|Overall Study|Lack of Efficacy|1|||
105662617|NCT03382561|364429972|FG000|Overall Study|Physician Decision|0|||
105662618|NCT03382561|364429973|FG001|Overall Study|Physician Decision|1|||
105662619|NCT03382561|364429972|FG000|Overall Study|Other complicating disease|0|||
105662620|NCT03382561|364429973|FG001|Overall Study|Other complicating disease|1|||
105662621|NCT02635360|364429974|FG000|Overall Study|Adverse Event|0|||
105662622|NCT02635360|364429975|FG001|Overall Study|Adverse Event|3|||
105662623|NCT02635360|364429974|FG000|Overall Study|Withdrawal by Subject|2|||
105662624|NCT02635360|364429975|FG001|Overall Study|Withdrawal by Subject|0|||
105662625|NCT02635360|364429974|FG000|Overall Study|Non-Compliance|3|||
105662626|NCT02635360|364429975|FG001|Overall Study|Non-Compliance|1|||
105662627|NCT02635360|364429974|FG000|Overall Study|Disease Progression|0|||
105662628|NCT02635360|364429975|FG001|Overall Study|Disease Progression|2|||
105662629|NCT02635360|364429974|FG000|Overall Study|Lost to Follow-up|1|||
105662630|NCT02635360|364429975|FG001|Overall Study|Lost to Follow-up|1|||
105662631|NCT00334542|364429976|FG000|Overall Study|Adverse Event|3|||
105662632|NCT00334542|364429976|FG000|Overall Study|Withdrawal by Subject|1|||
105662633|NCT00334542|364429976|FG000|Overall Study|New cancer diagnosis|1|||
105662634|NCT02370251|364429977|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
105662635|NCT02370251|364429977|FG000|Overall Study|Death|4|||
105662636|NCT00592293|364429979|FG000|Overall Study|Withdrawal by Subject|1|||
105662637|NCT02094898|364429983|FG000|Overall Study|Clinical Worsening|2|||
105662638|NCT02094898|364429983|FG000|Overall Study|Adverse Event|2|||
105662639|NCT02094898|364429983|FG000|Overall Study|Lack of Efficacy|1|||
105662640|NCT03520075|364429984|FG000|Phase 1 (Dose Escalation)|Death|2|||
105662641|NCT03520075|364429985|FG001|Phase 1 (Dose Escalation)|Death|2|||
106118748|NCT01468922|366091860|FG002|Overall Study|Patient choice - surgery|0|||
106118749|NCT01468922|366091861|FG003|Overall Study|Patient choice - surgery|0|||
106118750|NCT01468922|366091862|FG004|Overall Study|Patient choice - surgery|0|||
106118751|NCT01468922|366091863|FG005|Overall Study|Patient choice - surgery|0|||
106118752|NCT01468922|366091864|FG006|Overall Study|Patient choice - surgery|0|||
106118753|NCT01468922|366091865|FG007|Overall Study|Patient choice - surgery|1|||
106118754|NCT01468922|366091866|FG008|Overall Study|Patient choice - surgery|0|||
106118755|NCT01468922|366091858|FG000|Overall Study|Refused further treatment|0|||
106118756|NCT01468922|366091859|FG001|Overall Study|Refused further treatment|0|||
105888074|NCT01943851|365245924|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888075|NCT01943851|365245925|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888076|NCT01943851|365245926|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888077|NCT01943851|365245927|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888078|NCT01943851|365245928|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
105888079|NCT01943851|365245911|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888080|NCT01943851|365245912|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888081|NCT01943851|365245913|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888082|NCT01943851|365245914|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888083|NCT01943851|365245915|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
106118757|NCT01468922|366091860|FG002|Overall Study|Refused further treatment|0|||
106118758|NCT01468922|366091861|FG003|Overall Study|Refused further treatment|0|||
106118759|NCT01468922|366091862|FG004|Overall Study|Refused further treatment|0|||
106118760|NCT01468922|366091863|FG005|Overall Study|Refused further treatment|0|||
106118761|NCT01468922|366091864|FG006|Overall Study|Refused further treatment|0|||
106118762|NCT01468922|366091865|FG007|Overall Study|Refused further treatment|1|||
106118763|NCT01468922|366091866|FG008|Overall Study|Refused further treatment|0|||
106118764|NCT03662997|366091875|FG000|Overall Study|Adverse Event|0|||
106118765|NCT03662997|366091876|FG001|Overall Study|Adverse Event|2|||
106118766|NCT03662997|366091877|FG002|Overall Study|Adverse Event|0|||
106118767|NCT03662997|366091878|FG003|Overall Study|Adverse Event|0|||
106118768|NCT01719224|366091879|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
106118769|NCT01719224|366091880|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
106118770|NCT02563522|366091881|FG000|Overall Study|Adverse Event|2|||
105995479|NCT05973006|365642747|FG001|Overall Study|Early termination|9|||
106118771|NCT02563522|366091882|FG001|Overall Study|Adverse Event|3|||
106118772|NCT02563522|366091881|FG000|Overall Study|Lost to Follow-up|1|||
106118773|NCT02563522|366091882|FG001|Overall Study|Lost to Follow-up|0|||
106118774|NCT02563522|366091881|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
106118775|NCT02563522|366091882|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
106118776|NCT00936221|366091883|FG000|Overall Study|Withdrawal by Subject|1|||
106118777|NCT00936221|366091884|FG001|Overall Study|Withdrawal by Subject|1|||
106118778|NCT03820323|366091885|FG000|Overall Study|Lost to Follow-up|2|||
106118779|NCT03820323|366091886|FG001|Overall Study|Lost to Follow-up|1|||
106118780|NCT03820323|366091885|FG000|Overall Study|Missed 12-month visit|22|||
106118781|NCT03820323|366091886|FG001|Overall Study|Missed 12-month visit|14|||
106118782|NCT03820323|366091885|FG000|Overall Study|Death|2|||
106118783|NCT03820323|366091886|FG001|Overall Study|Death|1|||
106118784|NCT03820323|366091885|FG000|Overall Study|Transferred out|13|||
106118785|NCT03820323|366091886|FG001|Overall Study|Transferred out|11|||
106118786|NCT03820323|366091885|FG000|Overall Study|Terminated|0|||
106118787|NCT03820323|366091886|FG001|Overall Study|Terminated|3|||
106118788|NCT03820323|366091885|FG000|Overall Study|Withdrawal by Subject|1|||
106118789|NCT03820323|366091886|FG001|Overall Study|Withdrawal by Subject|6|||
106118790|NCT00879996|366091887|FG000|Overall Study|Lost to Follow-up|7|||
106118791|NCT00879996|366091888|FG001|Overall Study|Lost to Follow-up|6|||
106118792|NCT00879996|366091887|FG000|Overall Study|non-compliance|6|||
106118793|NCT00879996|366091888|FG001|Overall Study|non-compliance|4|||
106118794|NCT00879996|366091887|FG000|Overall Study|Physician Decision|1|||
106118795|NCT00879996|366091888|FG001|Overall Study|Physician Decision|2|||
106118796|NCT00879996|366091887|FG000|Overall Study|psychiatric problem|0|||
106118797|NCT00879996|366091888|FG001|Overall Study|psychiatric problem|1|||
106118798|NCT00879996|366091887|FG000|Overall Study|put on parole|1|||
106118799|NCT00879996|366091888|FG001|Overall Study|put on parole|0|||
106118800|NCT02912468|366091889|FG000|Overall Study|Adverse Event|3|||
106118801|NCT02912468|366091890|FG001|Overall Study|Adverse Event|2|||
106118802|NCT02912468|366091889|FG000|Overall Study|Withdrawal by Subject|6|||
106118803|NCT02912468|366091890|FG001|Overall Study|Withdrawal by Subject|2|||
106118804|NCT02912468|366091889|FG000|Overall Study|Randomized and not treated|0|||
106118805|NCT02912468|366091890|FG001|Overall Study|Randomized and not treated|1|||
105888084|NCT01943851|365245916|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
106118806|NCT00572624|366091892|FG000|Overall Study|Lost to Follow-up|10|||
106118807|NCT00572624|366091893|FG001|Overall Study|Lost to Follow-up|4|||
106118808|NCT00572624|366091892|FG000|Overall Study|Wanted to do a different diet program|1|||
106118809|NCT00572624|366091893|FG001|Overall Study|Wanted to do a different diet program|0|||
106118810|NCT00572624|366091892|FG000|Overall Study|Medication change|1|||
106118811|NCT00572624|366091893|FG001|Overall Study|Medication change|0|||
105995480|NCT02204072|365642751|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
105995481|NCT02204072|365642752|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
106118812|NCT00572624|366091892|FG000|Overall Study|Started a new job-- no time for study|1|||
106118813|NCT00572624|366091893|FG001|Overall Study|Started a new job-- no time for study|0|||
106118814|NCT00572624|366091892|FG000|Overall Study|Admitted to being a smoker|1|||
106118815|NCT00572624|366091893|FG001|Overall Study|Admitted to being a smoker|0|||
106118816|NCT00572624|366091892|FG000|Overall Study|Refused to do the stress test|1|||
106118817|NCT00572624|366091893|FG001|Overall Study|Refused to do the stress test|0|||
106118818|NCT00572624|366091892|FG000|Overall Study|Problem with vascular access|1|||
106118819|NCT00572624|366091893|FG001|Overall Study|Problem with vascular access|0|||
106118820|NCT00572624|366091892|FG000|Overall Study|Health issues unrelated to the study|1|||
106118821|NCT00572624|366091893|FG001|Overall Study|Health issues unrelated to the study|0|||
106118822|NCT02597933|366091894|FG000|Overall Study|Withdrawal by Subject|7|||
106118823|NCT02597933|366091895|FG001|Overall Study|Withdrawal by Subject|5|||
106118824|NCT02597933|366091894|FG000|Overall Study|Protocol Violation|2|||
106118825|NCT02597933|366091895|FG001|Overall Study|Protocol Violation|2|||
106118826|NCT02597933|366091894|FG000|Overall Study|Adverse Event|20|||
106118827|NCT02597933|366091895|FG001|Overall Study|Adverse Event|28|||
106118828|NCT02597933|366091894|FG000|Overall Study|Not treated|2|||
106118829|NCT02597933|366091895|FG001|Overall Study|Not treated|2|||
106118830|NCT02597933|366091894|FG000|Overall Study|Other than stated above|7|||
106118831|NCT02597933|366091895|FG001|Overall Study|Other than stated above|14|||
106118832|NCT03311230|366091905|FG000|Overall Study|Withdrawal by Subject|1|||
106118833|NCT03311230|366091906|FG001|Overall Study|Withdrawal by Subject|4|||
106118834|NCT03311230|366091907|FG002|Overall Study|Withdrawal by Subject|2|||
106118835|NCT03311230|366091908|FG003|Overall Study|Withdrawal by Subject|7|||
106118836|NCT03311230|366091905|FG000|Overall Study|Unrelated injury|0|||
106118837|NCT03311230|366091906|FG001|Overall Study|Unrelated injury|1|||
106118838|NCT03311230|366091907|FG002|Overall Study|Unrelated injury|0|||
106118839|NCT03311230|366091908|FG003|Overall Study|Unrelated injury|0|||
106118840|NCT00171873|366091909|FG000|Overall Study|Withdrawal by Subject|4|||
106118841|NCT00171873|366091910|FG001|Overall Study|Withdrawal by Subject|2|||
106118842|NCT00171873|366091909|FG000|Overall Study|Adverse Event|5|||
106118843|NCT00171873|366091910|FG001|Overall Study|Adverse Event|0|||
106118844|NCT00171873|366091909|FG000|Overall Study|Switched to Octreotide|0|||
106118845|NCT00171873|366091910|FG001|Overall Study|Switched to Octreotide|1|||
106118846|NCT00876460|366091913|FG000|Combination Therapy Phase|Progressive disease|2|||
106118847|NCT00876460|366091914|FG001|Combination Therapy Phase|Progressive disease|3|||
106118848|NCT00876460|366091915|FG002|Combination Therapy Phase|Progressive disease|3|||
106118849|NCT00876460|366091916|FG003|Combination Therapy Phase|Progressive disease|3|||
106118850|NCT00876460|366091917|FG004|Combination Therapy Phase|Progressive disease|3|||
106118851|NCT00876460|366091918|FG005|Combination Therapy Phase|Progressive disease|1|||
106118852|NCT00876460|366091919|FG006|Combination Therapy Phase|Progressive disease|1|||
106118853|NCT00876460|366091920|FG007|Combination Therapy Phase|Progressive disease|1|||
106118854|NCT00876460|366091913|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
106118855|NCT00876460|366091914|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
106118856|NCT00876460|366091915|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
106118857|NCT00876460|366091916|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
106118858|NCT00876460|366091917|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
106118859|NCT00876460|366091918|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
106118860|NCT00876460|366091919|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
106118861|NCT00876460|366091920|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
106118862|NCT00876460|366091913|FG000|Combination Therapy Phase|Adverse Event|0|||
106118863|NCT00876460|366091914|FG001|Combination Therapy Phase|Adverse Event|2|||
106118864|NCT00876460|366091915|FG002|Combination Therapy Phase|Adverse Event|0|||
106118865|NCT00876460|366091916|FG003|Combination Therapy Phase|Adverse Event|2|||
106118866|NCT00876460|366091917|FG004|Combination Therapy Phase|Adverse Event|2|||
106118867|NCT00876460|366091918|FG005|Combination Therapy Phase|Adverse Event|0|||
106118868|NCT00876460|366091919|FG006|Combination Therapy Phase|Adverse Event|3|||
106118869|NCT00876460|366091920|FG007|Combination Therapy Phase|Adverse Event|2|||
106118870|NCT00876460|366091913|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
106118871|NCT00876460|366091914|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
106118872|NCT00876460|366091915|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
106118873|NCT00876460|366091916|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
106118874|NCT00876460|366091917|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
106118875|NCT00876460|366091918|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
106118876|NCT00876460|366091919|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
106118877|NCT00876460|366091920|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
106118878|NCT00876460|366091913|FG000|Combination Therapy Phase|Other reason not defined above|0|||
106118879|NCT00876460|366091914|FG001|Combination Therapy Phase|Other reason not defined above|0|||
106118880|NCT00876460|366091915|FG002|Combination Therapy Phase|Other reason not defined above|0|||
106118881|NCT00876460|366091916|FG003|Combination Therapy Phase|Other reason not defined above|0|||
105888085|NCT01943851|365245917|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888086|NCT01943851|365245918|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
106118882|NCT00876460|366091917|FG004|Combination Therapy Phase|Other reason not defined above|0|||
106118883|NCT00876460|366091918|FG005|Combination Therapy Phase|Other reason not defined above|0|||
106118884|NCT00876460|366091919|FG006|Combination Therapy Phase|Other reason not defined above|1|||
106118885|NCT00876460|366091920|FG007|Combination Therapy Phase|Other reason not defined above|2|||
106118886|NCT00876460|366091913|FG000|Combination Therapy Phase|Not treated|0|||
106118887|NCT00876460|366091914|FG001|Combination Therapy Phase|Not treated|0|||
106118888|NCT00876460|366091915|FG002|Combination Therapy Phase|Not treated|0|||
106118889|NCT00876460|366091916|FG003|Combination Therapy Phase|Not treated|0|||
106118890|NCT00876460|366091917|FG004|Combination Therapy Phase|Not treated|0|||
106118891|NCT00876460|366091918|FG005|Combination Therapy Phase|Not treated|0|||
106118892|NCT00876460|366091919|FG006|Combination Therapy Phase|Not treated|1|||
106118893|NCT00876460|366091920|FG007|Combination Therapy Phase|Not treated|0|||
106118894|NCT00876460|366091913|FG000|Mono Therapy Phase|Progressive disease|0|||
106118895|NCT00876460|366091914|FG001|Mono Therapy Phase|Progressive disease|0|||
106118896|NCT00876460|366091915|FG002|Mono Therapy Phase|Progressive disease|0|||
106118897|NCT00876460|366091916|FG003|Mono Therapy Phase|Progressive disease|0|||
106118898|NCT00876460|366091917|FG004|Mono Therapy Phase|Progressive disease|2|||
106118899|NCT00876460|366091918|FG005|Mono Therapy Phase|Progressive disease|0|||
106118900|NCT00876460|366091919|FG006|Mono Therapy Phase|Progressive disease|1|||
106118901|NCT00876460|366091920|FG007|Mono Therapy Phase|Progressive disease|3|||
106118902|NCT00876460|366091913|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
106118903|NCT00876460|366091914|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
106118904|NCT00876460|366091915|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
106118905|NCT00876460|366091916|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
106118906|NCT00876460|366091917|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
106118907|NCT00876460|366091918|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
106118908|NCT00876460|366091919|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
106118909|NCT00876460|366091920|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
106118910|NCT00876460|366091913|FG000|Mono Therapy Phase|Adverse Event|0|||
106118911|NCT00876460|366091914|FG001|Mono Therapy Phase|Adverse Event|0|||
106118912|NCT00876460|366091915|FG002|Mono Therapy Phase|Adverse Event|0|||
106118913|NCT00876460|366091916|FG003|Mono Therapy Phase|Adverse Event|1|||
106118914|NCT00876460|366091917|FG004|Mono Therapy Phase|Adverse Event|0|||
106118915|NCT00876460|366091918|FG005|Mono Therapy Phase|Adverse Event|0|||
106118916|NCT00876460|366091919|FG006|Mono Therapy Phase|Adverse Event|0|||
106118917|NCT00876460|366091920|FG007|Mono Therapy Phase|Adverse Event|0|||
106118918|NCT00874432|366091927|FG000|Overall Study|Withdrawal by Subject|1|||
106118919|NCT00874432|366091928|FG001|Overall Study|Withdrawal by Subject|0|||
106118920|NCT00874432|366091929|FG002|Overall Study|Withdrawal by Subject|0|||
106118921|NCT00874432|366091930|FG003|Overall Study|Withdrawal by Subject|0|||
106118922|NCT00874432|366091927|FG000|Overall Study|Physician Decision|1|||
106118923|NCT00874432|366091928|FG001|Overall Study|Physician Decision|0|||
106118924|NCT00874432|366091929|FG002|Overall Study|Physician Decision|0|||
106118925|NCT00874432|366091930|FG003|Overall Study|Physician Decision|0|||
106118926|NCT00874432|366091927|FG000|Overall Study|Other|1|||
106118927|NCT00874432|366091928|FG001|Overall Study|Other|2|||
106118928|NCT00874432|366091929|FG002|Overall Study|Other|8|||
106118929|NCT00874432|366091930|FG003|Overall Study|Other|3|||
106118930|NCT00429494|366093741|FG000|Overall Study|Withdrawal by Subject|9|||
106118931|NCT00429494|366093741|FG000|Overall Study|Death|6|||
106118932|NCT02243631|366093744|FG000|Overall Study|no synovial fluid on second aspirate|0|||
106118933|NCT02243631|366093745|FG001|Overall Study|no synovial fluid on second aspirate|1|||
106118934|NCT01992549|366093746|FG000|Overall Study|Lost to Follow-up|2|||
106118935|NCT01992549|366093746|FG000|Overall Study|Serious Adverse Event|1|||
106118936|NCT01992549|366093746|FG000|Overall Study|Product Switch to Extend Half Life|1|||
106118937|NCT01785628|366093747|FG000|Overall Study|Lost to Follow-up|2|||
106118938|NCT01785628|366093748|FG001|Overall Study|Lost to Follow-up|3|||
106118939|NCT01900054|366093756|FG000|Overall Study|Physician Decision|1|||
106118940|NCT01900054|366093756|FG000|Overall Study|Withdrawal by Subject|1|||
106118941|NCT01186328|366093757|FG000|Overall Study|Death|1|||
106118942|NCT01186328|366093758|FG001|Overall Study|Death|0|||
106118943|NCT01186328|366093759|FG002|Overall Study|Death|0|||
106118944|NCT02936037|366093760|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
106118945|NCT02936037|366093761|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
106118946|NCT02936037|366093760|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
106118947|NCT02936037|366093761|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
106118948|NCT02936037|366093760|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
106118949|NCT02936037|366093761|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
106118950|NCT02936037|366093760|FG000|Double-Blind Treatment Period|Death|0|||
106118951|NCT02936037|366093761|FG001|Double-Blind Treatment Period|Death|1|||
106118952|NCT02936037|366093760|FG000|Double-Blind Treatment Period|Adverse Event|11|||
106118953|NCT02936037|366093761|FG001|Double-Blind Treatment Period|Adverse Event|11|||
106118954|NCT02936037|366093760|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
105662642|NCT03520075|364429986|FG002|Phase 1 (Dose Escalation)|Death|3|||
105995482|NCT02204072|365642753|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
105995483|NCT02204072|365642754|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
105995484|NCT02204072|365642755|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
105995485|NCT02204072|365642751|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
105995486|NCT02204072|365642752|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
105995487|NCT02204072|365642753|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
105995488|NCT02204072|365642754|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
105995489|NCT02204072|365642755|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
105995490|NCT02204072|365642751|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
105995491|NCT02204072|365642752|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
105995492|NCT02204072|365642753|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
105995493|NCT02204072|365642754|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
105995494|NCT02204072|365642755|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
105995495|NCT02204072|365642751|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
105995496|NCT02204072|365642752|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
105995497|NCT02204072|365642753|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
105995498|NCT02204072|365642754|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
105995499|NCT02204072|365642755|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
106118955|NCT02936037|366093761|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
106118956|NCT02936037|366093760|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105888087|NCT01943851|365245919|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888088|NCT01943851|365245920|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888089|NCT01943851|365245921|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888090|NCT01943851|365245922|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888091|NCT01943851|365245923|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888092|NCT01943851|365245924|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888093|NCT01943851|365245925|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888094|NCT01943851|365245926|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888095|NCT01943851|365245927|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888096|NCT01943851|365245928|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
105888097|NCT01943851|365245911|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888098|NCT01943851|365245912|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888099|NCT01943851|365245913|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888100|NCT01943851|365245914|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888101|NCT01943851|365245915|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888102|NCT01943851|365245916|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888103|NCT01943851|365245917|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888104|NCT01943851|365245918|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888105|NCT01943851|365245919|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888106|NCT01943851|365245920|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888107|NCT01943851|365245921|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888108|NCT01943851|365245922|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888109|NCT01943851|365245923|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888110|NCT01943851|365245924|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
105888111|NCT01943851|365245925|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888112|NCT01943851|365245926|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888113|NCT01943851|365245927|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888114|NCT01943851|365245928|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
105888115|NCT01943851|365245911|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888116|NCT01943851|365245912|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888117|NCT01943851|365245913|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888118|NCT01943851|365245914|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888119|NCT01943851|365245915|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888120|NCT01943851|365245916|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888121|NCT01943851|365245917|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888122|NCT01943851|365245918|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888123|NCT01943851|365245919|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888124|NCT01943851|365245920|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888125|NCT01943851|365245921|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888126|NCT01943851|365245922|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888127|NCT01943851|365245923|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888128|NCT01943851|365245924|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888129|NCT01943851|365245925|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888130|NCT01943851|365245926|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
105888131|NCT01943851|365245927|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888132|NCT01943851|365245928|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
105888133|NCT01943851|365245911|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105995500|NCT02451124|365642759|FG000|Overall Study|Withdrawal by Subject|1|||
105662643|NCT03520075|364429987|FG003|Phase 1 (Dose Escalation)|Death|2|||
105662644|NCT03520075|364429988|FG004|Phase 1 (Dose Escalation)|Death|6|||
105662645|NCT03520075|364429989|FG005|Phase 1 (Dose Escalation)|Death|5|||
105662646|NCT03520075|364429990|FG006|Phase 1 (Dose Escalation)|Death|3|||
105662647|NCT03520075|364429991|FG007|Phase 1 (Dose Escalation)|Death|2|||
105662648|NCT03520075|364429992|FG008|Phase 1 (Dose Escalation)|Death|3|||
105662649|NCT03520075|364429993|FG009|Phase 1 (Dose Escalation)|Death|1|||
105662650|NCT03520075|364429994|FG010|Phase 1 (Dose Escalation)|Death|5|||
105662651|NCT03520075|364429995|FG011|Phase 1 (Dose Escalation)|Death|7|||
105662652|NCT03520075|364429996|FG012|Phase 1 (Dose Escalation)|Death|11|||
105662653|NCT03520075|364429997|FG013|Phase 1 (Dose Escalation)|Death|0|||
105662654|NCT03520075|364429998|FG014|Phase 1 (Dose Escalation)|Death|0|||
105662655|NCT03520075|364429999|FG015|Phase 1 (Dose Escalation)|Death|0|||
105662656|NCT03520075|364430000|FG016|Phase 1 (Dose Escalation)|Death|0|||
105662657|NCT03520075|364430001|FG017|Phase 1 (Dose Escalation)|Death|0|||
105662658|NCT03520075|364430002|FG018|Phase 1 (Dose Escalation)|Death|0|||
105662659|NCT03520075|364429984|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
105662660|NCT03520075|364429985|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662661|NCT03520075|364429986|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662662|NCT03520075|364429987|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
105662663|NCT03520075|364429988|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
105662664|NCT03520075|364429989|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
105662665|NCT03520075|364429990|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662666|NCT03520075|364429991|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
105662667|NCT03520075|364429992|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662668|NCT03520075|364429993|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
105662669|NCT03520075|364429994|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662670|NCT03520075|364429995|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662671|NCT03520075|364429996|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
105662672|NCT03520075|364429997|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662673|NCT03520075|364429998|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662674|NCT03520075|364429999|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662675|NCT03520075|364430000|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662676|NCT03520075|364430001|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662677|NCT03520075|364430002|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
105662678|NCT03520075|364429984|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662679|NCT03520075|364429985|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662680|NCT03520075|364429986|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662681|NCT03520075|364429987|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662682|NCT03520075|364429988|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662683|NCT03520075|364429989|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662684|NCT03520075|364429990|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662685|NCT03520075|364429991|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662686|NCT03520075|364429992|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662687|NCT03520075|364429993|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662688|NCT03520075|364429994|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662689|NCT03520075|364429995|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662690|NCT03520075|364429996|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
105662691|NCT03520075|364429997|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662692|NCT03520075|364429998|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662693|NCT03520075|364429999|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662694|NCT03520075|364430000|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662695|NCT03520075|364430001|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662696|NCT03520075|364430002|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
105662697|NCT03520075|364429984|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662698|NCT03520075|364429985|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662699|NCT03520075|364429986|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662700|NCT03520075|364429987|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105995501|NCT01900652|365642760|FG000|Overall Study|Progressive Disease|1|||
105662701|NCT03520075|364429988|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662702|NCT03520075|364429989|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105785101|NCT05637515|364866378|FG000|Overall Study|Withdrawal by Subject|17|||
105785102|NCT05637515|364866379|FG001|Overall Study|Withdrawal by Subject|17|||
105785103|NCT01269346|364866380|FG000|Treatment Phase|Disease progression|3|||
105785104|NCT01269346|364866380|FG000|Treatment Phase|Adverse Event|3|||
105785105|NCT01269346|364866380|FG000|Treatment Phase|Withdrawal by Subject|1|||
105785106|NCT01269346|364866380|FG000|Treatment Phase|Other|2|||
105785107|NCT01269346|364866380|FG000|Extension Phase|Adverse Event|6|||
105785108|NCT01269346|364866380|FG000|Extension Phase|Withdrawal by Subject|4|||
105785109|NCT01269346|364866380|FG000|Extension Phase|Disease progression|22|||
105995502|NCT01900652|365642761|FG001|Overall Study|Progressive Disease|0|||
105995503|NCT01900652|365642760|FG000|Overall Study|Consent withdrawn by subject|1|||
105995504|NCT01900652|365642761|FG001|Overall Study|Consent withdrawn by subject|1|||
105995505|NCT01900652|365642760|FG000|Overall Study|Death|3|||
105995506|NCT01900652|365642761|FG001|Overall Study|Death|0|||
105995507|NCT01900652|365642760|FG000|Overall Study|Adverse Event|2|||
105995508|NCT01900652|365642761|FG001|Overall Study|Adverse Event|1|||
105995509|NCT01900652|365642760|FG000|Overall Study|Physician Decision|1|||
105995510|NCT01900652|365642761|FG001|Overall Study|Physician Decision|1|||
105995511|NCT04775953|365644124|FG000|Overall Study|Lost to Follow-up|6|||
105995512|NCT04775953|365644125|FG001|Overall Study|Lost to Follow-up|11|||
105995513|NCT04775953|365644124|FG000|Overall Study|Death|5|||
106118957|NCT02936037|366093761|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
106118958|NCT02936037|366093760|FG000|Open Label Extension|Adverse Event|0|||
106118959|NCT02936037|366093761|FG001|Open Label Extension|Adverse Event|3|||
106118960|NCT02936037|366093760|FG000|Open Label Extension|Other|0|||
106118961|NCT02936037|366093761|FG001|Open Label Extension|Other|3|||
106118962|NCT02936037|366093760|FG000|Open Label Extension|Withdrawal by Subject|0|||
106118963|NCT02936037|366093761|FG001|Open Label Extension|Withdrawal by Subject|4|||
106118964|NCT03015116|366093762|FG000|Overall Study|Lost to Follow-up|3|||
106118965|NCT03015116|366093763|FG001|Overall Study|Lost to Follow-up|0|||
106118966|NCT03015116|366093764|FG002|Overall Study|Lost to Follow-up|2|||
106118967|NCT03015116|366093762|FG000|Overall Study|Withdrawal by Subject|3|||
106118968|NCT03015116|366093763|FG001|Overall Study|Withdrawal by Subject|1|||
106118969|NCT03015116|366093764|FG002|Overall Study|Withdrawal by Subject|0|||
106118970|NCT03015116|366093762|FG000|Overall Study|Subject has New Medical Status|1|||
106118971|NCT03015116|366093763|FG001|Overall Study|Subject has New Medical Status|0|||
106118972|NCT03015116|366093764|FG002|Overall Study|Subject has New Medical Status|0|||
106118973|NCT03015116|366093762|FG000|Overall Study|Physician Decision|0|||
106118974|NCT03015116|366093763|FG001|Overall Study|Physician Decision|1|||
106118975|NCT03015116|366093764|FG002|Overall Study|Physician Decision|0|||
106118976|NCT02200939|366093769|FG000|Overall Study|Participant withdrew consent|0|||
106118977|NCT02200939|366093770|FG001|Overall Study|Participant withdrew consent|1|||
106118978|NCT02200939|366093769|FG000|Overall Study|Lost to Follow-up|2|||
106118979|NCT02200939|366093770|FG001|Overall Study|Lost to Follow-up|9|||
106118980|NCT02200939|366093769|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
106118981|NCT02200939|366093770|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
106118982|NCT00453310|366093771|FG000|Overall Study|Progression of Disease|10|||
106118983|NCT01806740|366093772|FG000|Overall Study|Withdrawal by Subject|4|||
106118984|NCT01806740|366093772|FG000|Overall Study|Physician Decision|1|||
106118985|NCT01806740|366093772|FG000|Overall Study|Patient's refusal of treatment|1|||
106118986|NCT04567693|366093773|FG000|Overall Study|Death|0|||
106118987|NCT04567693|366093774|FG001|Overall Study|Death|0|||
106118988|NCT04567693|366093775|FG002|Overall Study|Death|2|||
106118989|NCT04567693|366093773|FG000|Overall Study|Lost to Follow-up|1|||
106118990|NCT04567693|366093774|FG001|Overall Study|Lost to Follow-up|0|||
106118991|NCT04567693|366093775|FG002|Overall Study|Lost to Follow-up|2|||
106118992|NCT04567693|366093773|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
106118993|NCT04567693|366093774|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
106118994|NCT04567693|366093775|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
106118995|NCT00244374|366093780|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
106118996|NCT00244374|366093781|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
106118997|NCT00244374|366093782|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
106118998|NCT00244374|366093783|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
106118999|NCT00244374|366093784|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
106119000|NCT00244374|366093780|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
106119001|NCT00244374|366093781|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
105662703|NCT03520075|364429990|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662704|NCT03520075|364429991|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662705|NCT03520075|364429992|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662706|NCT03520075|364429993|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
105662707|NCT03520075|364429994|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662708|NCT03520075|364429995|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662709|NCT03520075|364429996|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
106119002|NCT00244374|366093782|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
106119003|NCT00244374|366093783|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
106119004|NCT00244374|366093784|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
105995514|NCT04775953|365644125|FG001|Overall Study|Death|4|||
105995515|NCT04775953|365644124|FG000|Overall Study|Withdrawal by Subject|3|||
105995516|NCT04775953|365644125|FG001|Overall Study|Withdrawal by Subject|3|||
105662710|NCT03520075|364429997|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662711|NCT03520075|364429998|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662712|NCT03520075|364429999|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662713|NCT03520075|364430000|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662714|NCT03520075|364430001|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662715|NCT03520075|364430002|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
105662716|NCT03520075|364429984|FG000|Phase 2 (Dose Expansion)|Death|0|||
105662717|NCT03520075|364429985|FG001|Phase 2 (Dose Expansion)|Death|0|||
105662718|NCT03520075|364429986|FG002|Phase 2 (Dose Expansion)|Death|0|||
105662719|NCT03520075|364429987|FG003|Phase 2 (Dose Expansion)|Death|0|||
105662720|NCT03520075|364429988|FG004|Phase 2 (Dose Expansion)|Death|0|||
105662721|NCT03520075|364429989|FG005|Phase 2 (Dose Expansion)|Death|0|||
105662722|NCT03520075|364429990|FG006|Phase 2 (Dose Expansion)|Death|0|||
105662723|NCT03520075|364429991|FG007|Phase 2 (Dose Expansion)|Death|0|||
105662724|NCT03520075|364429992|FG008|Phase 2 (Dose Expansion)|Death|0|||
105662725|NCT03520075|364429993|FG009|Phase 2 (Dose Expansion)|Death|0|||
105662726|NCT03520075|364429994|FG010|Phase 2 (Dose Expansion)|Death|0|||
105662727|NCT03520075|364429995|FG011|Phase 2 (Dose Expansion)|Death|0|||
105662728|NCT03520075|364429996|FG012|Phase 2 (Dose Expansion)|Death|0|||
105662729|NCT03520075|364429997|FG013|Phase 2 (Dose Expansion)|Death|20|||
105662730|NCT03520075|364429998|FG014|Phase 2 (Dose Expansion)|Death|13|||
105662731|NCT03520075|364429999|FG015|Phase 2 (Dose Expansion)|Death|9|||
105662732|NCT03520075|364430000|FG016|Phase 2 (Dose Expansion)|Death|5|||
105662733|NCT03520075|364430001|FG017|Phase 2 (Dose Expansion)|Death|14|||
105662734|NCT03520075|364430002|FG018|Phase 2 (Dose Expansion)|Death|12|||
105662735|NCT03520075|364429984|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662736|NCT03520075|364429985|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662737|NCT03520075|364429986|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662738|NCT03520075|364429987|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662739|NCT03520075|364429988|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662740|NCT03520075|364429989|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662741|NCT03520075|364429990|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662742|NCT03520075|364429991|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662743|NCT03520075|364429992|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662744|NCT03520075|364429993|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662745|NCT03520075|364429994|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662746|NCT03520075|364429995|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662747|NCT03520075|364429996|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662748|NCT03520075|364429997|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
105662749|NCT03520075|364429998|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
105662750|NCT03520075|364429999|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
105662751|NCT03520075|364430000|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
105662752|NCT03520075|364430001|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
105662753|NCT03520075|364430002|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
105662754|NCT03520075|364429984|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662755|NCT03520075|364429985|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662756|NCT03520075|364429986|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662757|NCT03520075|364429987|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662758|NCT03520075|364429988|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662759|NCT03520075|364429989|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662760|NCT03520075|364429990|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662761|NCT03520075|364429991|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662762|NCT03520075|364429992|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662763|NCT03520075|364429993|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662764|NCT03520075|364429994|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662765|NCT03520075|364429995|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662766|NCT03520075|364429996|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
106119005|NCT00244374|366093780|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
106119006|NCT00244374|366093781|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
106119007|NCT00244374|366093782|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
106119008|NCT00244374|366093783|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
106119009|NCT00244374|366093784|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
106119010|NCT00244374|366093780|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
106119011|NCT00244374|366093781|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
106119012|NCT00244374|366093782|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
106119013|NCT00244374|366093783|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
106119014|NCT00244374|366093784|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
106119015|NCT00244374|366093780|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
105785110|NCT01269346|364866380|FG000|Extension Phase|Physician decision or participant choice|9|||
105995517|NCT04775953|365644124|FG000|Overall Study|Protocol Violation|2|||
105995518|NCT04775953|365644125|FG001|Overall Study|Protocol Violation|0|||
105995519|NCT04775953|365644124|FG000|Overall Study|Participant non-compliance|0|||
105995520|NCT04775953|365644125|FG001|Overall Study|Participant non-compliance|1|||
105995521|NCT00411671|365644132|FG000|Overall Study|Adverse Event|15|||
105995522|NCT00411671|365644132|FG000|Overall Study|Death|2|||
105995523|NCT00411671|365644132|FG000|Overall Study|Lost to Follow-up|3|||
105995524|NCT00853151|365644138|FG000|Overall Study|Adverse Event|1|||
105995525|NCT00853151|365644139|FG001|Overall Study|Adverse Event|4|||
105995526|NCT00853151|365644140|FG002|Overall Study|Adverse Event|2|||
105995527|NCT00853151|365644141|FG003|Overall Study|Adverse Event|0|||
105995528|NCT00853151|365644138|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105995529|NCT00853151|365644139|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105995530|NCT00853151|365644140|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105785111|NCT01269346|364866380|FG000|Extension Phase|Clinical progression|1|||
105995531|NCT00853151|365644141|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105995532|NCT00853151|365644138|FG000|Overall Study|Lost to Follow-up|2|||
105995533|NCT00853151|365644139|FG001|Overall Study|Lost to Follow-up|0|||
105995534|NCT00853151|365644140|FG002|Overall Study|Lost to Follow-up|3|||
105995535|NCT00853151|365644141|FG003|Overall Study|Lost to Follow-up|0|||
105995536|NCT00853151|365644138|FG000|Overall Study|Death|1|||
105995537|NCT00853151|365644139|FG001|Overall Study|Death|0|||
105995538|NCT00853151|365644140|FG002|Overall Study|Death|0|||
105995539|NCT00853151|365644141|FG003|Overall Study|Death|1|||
105995540|NCT00853151|365644138|FG000|Overall Study|Protocol Violation|0|||
105995541|NCT00853151|365644139|FG001|Overall Study|Protocol Violation|0|||
105995542|NCT00853151|365644140|FG002|Overall Study|Protocol Violation|0|||
105995543|NCT00853151|365644141|FG003|Overall Study|Protocol Violation|1|||
105995544|NCT00853151|365644138|FG000|Overall Study|Withdrawal by Subject|5|||
105995545|NCT00853151|365644139|FG001|Overall Study|Withdrawal by Subject|4|||
105995546|NCT00853151|365644140|FG002|Overall Study|Withdrawal by Subject|2|||
105995547|NCT00853151|365644141|FG003|Overall Study|Withdrawal by Subject|1|||
105995548|NCT00853151|365644138|FG000|Overall Study|Physician Decision|0|||
105995549|NCT00853151|365644139|FG001|Overall Study|Physician Decision|2|||
105995550|NCT00853151|365644140|FG002|Overall Study|Physician Decision|1|||
105995551|NCT00853151|365644141|FG003|Overall Study|Physician Decision|0|||
105995552|NCT00853151|365644138|FG000|Overall Study|Sponsor Decision|0|||
105995553|NCT00853151|365644139|FG001|Overall Study|Sponsor Decision|3|||
105995554|NCT00853151|365644140|FG002|Overall Study|Sponsor Decision|0|||
105995555|NCT00853151|365644141|FG003|Overall Study|Sponsor Decision|0|||
105995556|NCT00713544|365644142|FG000|Overall Study|Adverse Event|5|||
105995557|NCT00713544|365644143|FG001|Overall Study|Adverse Event|3|||
105995558|NCT00713544|365644144|FG002|Overall Study|Adverse Event|7|||
105995559|NCT00713544|365644145|FG003|Overall Study|Adverse Event|7|||
105995560|NCT00713544|365644146|FG004|Overall Study|Adverse Event|3|||
105995561|NCT00713544|365644147|FG005|Overall Study|Adverse Event|5|||
105995562|NCT00713544|365644142|FG000|Overall Study|Withdrawal by Subject|2|||
105995563|NCT00713544|365644143|FG001|Overall Study|Withdrawal by Subject|0|||
105995564|NCT00713544|365644144|FG002|Overall Study|Withdrawal by Subject|3|||
105995565|NCT00713544|365644145|FG003|Overall Study|Withdrawal by Subject|2|||
105995566|NCT00713544|365644146|FG004|Overall Study|Withdrawal by Subject|3|||
105995567|NCT00713544|365644147|FG005|Overall Study|Withdrawal by Subject|1|||
105995568|NCT00713544|365644142|FG000|Overall Study|Protocol Violation|0|||
105995569|NCT00713544|365644143|FG001|Overall Study|Protocol Violation|0|||
105995570|NCT00713544|365644144|FG002|Overall Study|Protocol Violation|0|||
105995571|NCT00713544|365644145|FG003|Overall Study|Protocol Violation|0|||
105995572|NCT00713544|365644146|FG004|Overall Study|Protocol Violation|0|||
106119016|NCT00244374|366093781|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
105995573|NCT00713544|365644147|FG005|Overall Study|Protocol Violation|1|||
105995574|NCT00713544|365644142|FG000|Overall Study|Physician Decision|0|||
106119017|NCT00244374|366093782|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
106119018|NCT00244374|366093783|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
106119019|NCT00244374|366093784|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
106119020|NCT00244374|366093780|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
106119021|NCT00244374|366093781|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
105785112|NCT01269346|364866380|FG000|Extension Phase|Started a prohibited con med|1|||
105995575|NCT00713544|365644143|FG001|Overall Study|Physician Decision|0|||
105995576|NCT00713544|365644144|FG002|Overall Study|Physician Decision|0|||
105995577|NCT00713544|365644145|FG003|Overall Study|Physician Decision|0|||
105995578|NCT00713544|365644146|FG004|Overall Study|Physician Decision|0|||
105995579|NCT00713544|365644147|FG005|Overall Study|Physician Decision|2|||
105995580|NCT00713544|365644142|FG000|Overall Study|Lack of Efficacy|0|||
105995581|NCT00713544|365644143|FG001|Overall Study|Lack of Efficacy|1|||
105995582|NCT00713544|365644144|FG002|Overall Study|Lack of Efficacy|0|||
105995583|NCT00713544|365644145|FG003|Overall Study|Lack of Efficacy|1|||
105785113|NCT00278473|364866381|FG000|Overall Study|drop out|4|||
105785114|NCT00278473|364866382|FG001|Overall Study|drop out|3|||
105785115|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Other|1|||
105785116|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Other|0|||
105785117|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Other|0|||
105785118|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Other|2|||
105785119|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Other|2|||
105785120|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Other|4|||
105785121|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Other|2|||
105785122|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Other|0|||
105785123|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105785124|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
105785125|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105888134|NCT01943851|365245912|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888135|NCT01943851|365245913|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888136|NCT01943851|365245914|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888137|NCT01943851|365245915|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888138|NCT01943851|365245916|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888139|NCT01943851|365245917|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888140|NCT01943851|365245918|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888141|NCT01943851|365245919|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888142|NCT01943851|365245920|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888143|NCT01943851|365245921|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888144|NCT01943851|365245922|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888145|NCT01943851|365245923|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888146|NCT01943851|365245924|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888147|NCT01943851|365245925|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
105888148|NCT01943851|365245926|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
105888149|NCT01943851|365245927|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
105888150|NCT01943851|365245928|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
105888151|NCT00900757|365245929|FG000|Overall Study|screen failure|19|||
105888152|NCT00941863|365245932|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
105888153|NCT00941863|365245933|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
105888154|NCT00941863|365245934|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
105888155|NCT00941863|365245935|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
105888156|NCT00941863|365245936|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
105888157|NCT00941863|365245932|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
105888158|NCT00941863|365245933|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
105888159|NCT00941863|365245934|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
105888160|NCT00941863|365245935|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
105888161|NCT00941863|365245936|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
105888162|NCT00941863|365245932|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
105888163|NCT00941863|365245933|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
105888164|NCT00941863|365245934|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
105888165|NCT00941863|365245935|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
105888166|NCT00941863|365245936|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
105888167|NCT00941863|365245932|FG000|Until Primary Completion Date (PCD)|Death|0|||
105888168|NCT00941863|365245933|FG001|Until Primary Completion Date (PCD)|Death|0|||
105888169|NCT00941863|365245934|FG002|Until Primary Completion Date (PCD)|Death|1|||
105888170|NCT00941863|365245935|FG003|Until Primary Completion Date (PCD)|Death|2|||
105888171|NCT00941863|365245936|FG004|Until Primary Completion Date (PCD)|Death|7|||
105888172|NCT00941863|365245932|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
105888173|NCT00941863|365245933|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
105888174|NCT00941863|365245934|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
105888175|NCT00941863|365245935|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
105888176|NCT00941863|365245936|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
105888177|NCT00941863|365245932|FG000|Continued After PCD|Withdrawal by Subject|0|||
105888178|NCT00941863|365245933|FG001|Continued After PCD|Withdrawal by Subject|0|||
105888179|NCT00941863|365245934|FG002|Continued After PCD|Withdrawal by Subject|0|||
105888180|NCT00941863|365245935|FG003|Continued After PCD|Withdrawal by Subject|0|||
105888181|NCT00941863|365245936|FG004|Continued After PCD|Withdrawal by Subject|1|||
105662767|NCT03520075|364429997|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105785126|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105785127|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105888182|NCT00941863|365245932|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
105888183|NCT00941863|365245933|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
105888184|NCT00941863|365245934|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
105888185|NCT00941863|365245935|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
106119022|NCT00244374|366093782|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
105785128|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105662768|NCT03520075|364429998|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
105662769|NCT03520075|364429999|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
105662770|NCT03520075|364430000|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662771|NCT03520075|364430001|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
105662772|NCT03520075|364430002|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
105662773|NCT03520075|364429984|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662774|NCT03520075|364429985|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662775|NCT03520075|364429986|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662776|NCT03520075|364429987|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662777|NCT03520075|364429988|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662778|NCT03520075|364429989|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662779|NCT03520075|364429990|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662780|NCT03520075|364429991|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662781|NCT03520075|364429992|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662782|NCT03520075|364429993|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662783|NCT03520075|364429994|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662784|NCT03520075|364429995|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662785|NCT03520075|364429996|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662786|NCT03520075|364429997|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
105662787|NCT03520075|364429998|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662788|NCT03520075|364429999|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662789|NCT03520075|364430000|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
105662790|NCT03520075|364430001|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
105662791|NCT03520075|364430002|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
105662792|NCT05144945|364430003|FG000|Overall Study|Withdrawal by Subject|1|||
105662793|NCT05144945|364430004|FG001|Overall Study|Withdrawal by Subject|0|||
105662794|NCT01432626|364430007|FG000|Overall Study|LV function recovered|2|||
105662795|NCT01432626|364430007|FG000|Overall Study|Withdrawal by Subject|2|||
105662796|NCT01432626|364430007|FG000|Overall Study|Only 1 image competed|2|||
105662797|NCT01432626|364430007|FG000|Overall Study|Imaging agent not available|1|||
105662798|NCT02536742|364430011|FG000|Overall Study|Did not start protocol therapy|1|||
105888186|NCT00941863|365245936|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
105888187|NCT00537316|365245937|FG000|Part 1|Adverse Event|7|||
105888188|NCT00537316|365245938|FG001|Part 1|Adverse Event|11|||
105888189|NCT00537316|365245939|FG002|Part 1|Adverse Event|8|||
105888190|NCT00537316|365245940|FG003|Part 1|Adverse Event|0|||
105888191|NCT00537316|365245941|FG004|Part 1|Adverse Event|0|||
105888192|NCT00537316|365245942|FG005|Part 1|Adverse Event|0|||
105888193|NCT00537316|365245943|FG006|Part 1|Adverse Event|0|||
105888194|NCT00537316|365245937|FG000|Part 1|Protocol defined clinical event|1|||
105888195|NCT00537316|365245938|FG001|Part 1|Protocol defined clinical event|0|||
105888196|NCT00537316|365245939|FG002|Part 1|Protocol defined clinical event|0|||
105888197|NCT00537316|365245940|FG003|Part 1|Protocol defined clinical event|0|||
105888198|NCT00537316|365245941|FG004|Part 1|Protocol defined clinical event|0|||
105888199|NCT00537316|365245942|FG005|Part 1|Protocol defined clinical event|0|||
105888200|NCT00537316|365245943|FG006|Part 1|Protocol defined clinical event|0|||
105888201|NCT00537316|365245937|FG000|Part 1|Lost to Follow-up|1|||
105888202|NCT00537316|365245938|FG001|Part 1|Lost to Follow-up|0|||
105888203|NCT00537316|365245939|FG002|Part 1|Lost to Follow-up|0|||
105888204|NCT00537316|365245940|FG003|Part 1|Lost to Follow-up|0|||
105888205|NCT00537316|365245941|FG004|Part 1|Lost to Follow-up|0|||
105888206|NCT00537316|365245942|FG005|Part 1|Lost to Follow-up|0|||
105888207|NCT00537316|365245943|FG006|Part 1|Lost to Follow-up|0|||
105888208|NCT00537316|365245937|FG000|Part 1|Withdrawal by Subject|3|||
105888209|NCT00537316|365245938|FG001|Part 1|Withdrawal by Subject|8|||
105888210|NCT00537316|365245939|FG002|Part 1|Withdrawal by Subject|4|||
105888211|NCT00537316|365245940|FG003|Part 1|Withdrawal by Subject|0|||
105888212|NCT00537316|365245941|FG004|Part 1|Withdrawal by Subject|0|||
105888213|NCT00537316|365245942|FG005|Part 1|Withdrawal by Subject|0|||
105888214|NCT00537316|365245943|FG006|Part 1|Withdrawal by Subject|0|||
105662799|NCT02536742|364430011|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
105662800|NCT01513330|364430012|FG000|SenSura Mio First,|Adverse Event|2|||
105888215|NCT00537316|365245937|FG000|Part 1|Protocol Violation|1|||
105888216|NCT00537316|365245938|FG001|Part 1|Protocol Violation|5|||
105888217|NCT00537316|365245939|FG002|Part 1|Protocol Violation|1|||
105888218|NCT00537316|365245940|FG003|Part 1|Protocol Violation|0|||
105888219|NCT00537316|365245941|FG004|Part 1|Protocol Violation|0|||
105888220|NCT00537316|365245942|FG005|Part 1|Protocol Violation|0|||
105888221|NCT00537316|365245943|FG006|Part 1|Protocol Violation|0|||
105888222|NCT00537316|365245937|FG000|Part 1|Did not meet protocol eligibility|1|||
105888223|NCT00537316|365245938|FG001|Part 1|Did not meet protocol eligibility|3|||
105888224|NCT00537316|365245939|FG002|Part 1|Did not meet protocol eligibility|2|||
105888225|NCT00537316|365245940|FG003|Part 1|Did not meet protocol eligibility|0|||
105888226|NCT00537316|365245941|FG004|Part 1|Did not meet protocol eligibility|0|||
105888227|NCT00537316|365245942|FG005|Part 1|Did not meet protocol eligibility|0|||
105785129|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105785130|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105785131|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785132|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785133|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785134|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
105662801|NCT01513330|364430013|FG001|SenSura Mio First,|Adverse Event|0|||
105662802|NCT01513330|364430012|FG000|SenSura Mio First,|Lack of Efficacy|0|||
105662803|NCT01513330|364430013|FG001|SenSura Mio First,|Lack of Efficacy|1|||
105662804|NCT01513330|364430012|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
105662805|NCT01513330|364430013|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
105662806|NCT01513330|364430012|FG000|SenSura Mio First,|Other|1|||
105662807|NCT01513330|364430013|FG001|SenSura Mio First,|Other|0|||
105662808|NCT01513330|364430012|FG000|Standard Care First,|Lack of Efficacy|2|||
105662809|NCT01513330|364430013|FG001|Standard Care First,|Lack of Efficacy|2|||
105662810|NCT01513330|364430012|FG000|Standard Care First,|Withdrawal by Subject|1|||
105662811|NCT01513330|364430013|FG001|Standard Care First,|Withdrawal by Subject|2|||
105662812|NCT01513330|364430012|FG000|Standard Care First,|Other|1|||
105662813|NCT01513330|364430013|FG001|Standard Care First,|Other|0|||
105662814|NCT05878873|364430014|FG000|Overall Study|Lost to Follow-up|2|||
105785135|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785136|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785137|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785138|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
105785139|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105888228|NCT00537316|365245943|FG006|Part 1|Did not meet protocol eligibility|0|||
105888229|NCT00537316|365245937|FG000|Part 1|Administrative|0|||
105888230|NCT00537316|365245938|FG001|Part 1|Administrative|0|||
105888231|NCT00537316|365245939|FG002|Part 1|Administrative|2|||
105888232|NCT00537316|365245940|FG003|Part 1|Administrative|0|||
105888233|NCT00537316|365245941|FG004|Part 1|Administrative|0|||
105888234|NCT00537316|365245942|FG005|Part 1|Administrative|0|||
105888235|NCT00537316|365245943|FG006|Part 1|Administrative|0|||
105888236|NCT00537316|365245937|FG000|Part 2|Never entered follow-up|0|||
105888237|NCT00537316|365245938|FG001|Part 2|Never entered follow-up|0|||
105888238|NCT00537316|365245939|FG002|Part 2|Never entered follow-up|0|||
105888239|NCT00537316|365245940|FG003|Part 2|Never entered follow-up|0|||
105888240|NCT00537316|365245941|FG004|Part 2|Never entered follow-up|0|||
105888241|NCT00537316|365245942|FG005|Part 2|Never entered follow-up|0|||
105888242|NCT00537316|365245943|FG006|Part 2|Never entered follow-up|1|||
105888243|NCT00537316|365245937|FG000|Part 2|Adverse Event|4|||
105888244|NCT00537316|365245938|FG001|Part 2|Adverse Event|0|||
105888245|NCT00537316|365245939|FG002|Part 2|Adverse Event|2|||
105888246|NCT00537316|365245940|FG003|Part 2|Adverse Event|0|||
105888247|NCT00537316|365245941|FG004|Part 2|Adverse Event|0|||
105888248|NCT00537316|365245942|FG005|Part 2|Adverse Event|0|||
105888249|NCT00537316|365245943|FG006|Part 2|Adverse Event|0|||
105888250|NCT00537316|365245937|FG000|Part 2|Lost to Follow-up|1|||
105888251|NCT00537316|365245938|FG001|Part 2|Lost to Follow-up|0|||
105888252|NCT00537316|365245939|FG002|Part 2|Lost to Follow-up|2|||
105888253|NCT00537316|365245940|FG003|Part 2|Lost to Follow-up|0|||
105888254|NCT00537316|365245941|FG004|Part 2|Lost to Follow-up|0|||
105888255|NCT00537316|365245942|FG005|Part 2|Lost to Follow-up|0|||
105888256|NCT00537316|365245943|FG006|Part 2|Lost to Follow-up|0|||
105888257|NCT00537316|365245937|FG000|Part 2|Withdrawal by Subject|5|||
105888258|NCT00537316|365245938|FG001|Part 2|Withdrawal by Subject|1|||
105888259|NCT00537316|365245939|FG002|Part 2|Withdrawal by Subject|4|||
105888260|NCT00537316|365245940|FG003|Part 2|Withdrawal by Subject|0|||
105888261|NCT00537316|365245941|FG004|Part 2|Withdrawal by Subject|0|||
105888262|NCT00537316|365245942|FG005|Part 2|Withdrawal by Subject|0|||
105888263|NCT00537316|365245943|FG006|Part 2|Withdrawal by Subject|0|||
105888264|NCT00537316|365245937|FG000|Part 2|Administrative|16|||
105888265|NCT00537316|365245938|FG001|Part 2|Administrative|8|||
105888266|NCT00537316|365245939|FG002|Part 2|Administrative|24|||
105888267|NCT00537316|365245940|FG003|Part 2|Administrative|3|||
105888268|NCT00537316|365245941|FG004|Part 2|Administrative|1|||
105888269|NCT00537316|365245942|FG005|Part 2|Administrative|4|||
105888270|NCT00537316|365245943|FG006|Part 2|Administrative|1|||
105888271|NCT01867710|365245946|FG000|Overall Study|Death|25|||
105888272|NCT01867710|365245947|FG001|Overall Study|Death|15|||
105888273|NCT01867710|365245948|FG002|Overall Study|Death|27|||
105888274|NCT01867710|365245949|FG003|Overall Study|Death|20|||
105888275|NCT01867710|365245946|FG000|Overall Study|Lost to Follow-up|3|||
105888276|NCT01867710|365245947|FG001|Overall Study|Lost to Follow-up|4|||
105888277|NCT01867710|365245948|FG002|Overall Study|Lost to Follow-up|3|||
105888278|NCT01867710|365245949|FG003|Overall Study|Lost to Follow-up|2|||
105888279|NCT01867710|365245946|FG000|Overall Study|Withdrawal of consent|2|||
105888280|NCT01867710|365245947|FG001|Overall Study|Withdrawal of consent|5|||
105888281|NCT01867710|365245948|FG002|Overall Study|Withdrawal of consent|1|||
105888282|NCT01867710|365245949|FG003|Overall Study|Withdrawal of consent|2|||
105888283|NCT01867710|365245946|FG000|Overall Study|Study Terminated by Sponsor|9|||
105995584|NCT00713544|365644146|FG004|Overall Study|Lack of Efficacy|1|||
105995585|NCT00713544|365644147|FG005|Overall Study|Lack of Efficacy|0|||
105995586|NCT00713544|365644142|FG000|Overall Study|Lost to Follow-up|0|||
105995587|NCT00713544|365644143|FG001|Overall Study|Lost to Follow-up|0|||
105995588|NCT00713544|365644144|FG002|Overall Study|Lost to Follow-up|1|||
105995589|NCT00713544|365644145|FG003|Overall Study|Lost to Follow-up|0|||
105995590|NCT00713544|365644146|FG004|Overall Study|Lost to Follow-up|0|||
105995591|NCT00713544|365644147|FG005|Overall Study|Lost to Follow-up|0|||
105995592|NCT00713544|365644142|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105995593|NCT00713544|365644143|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
105995594|NCT00713544|365644144|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105995595|NCT00713544|365644145|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105995596|NCT00713544|365644146|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105995597|NCT00713544|365644147|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
105995598|NCT00713544|365644142|FG000|Overall Study|Incorrect enrollment|0|||
105995599|NCT00713544|365644143|FG001|Overall Study|Incorrect enrollment|1|||
105995600|NCT00713544|365644144|FG002|Overall Study|Incorrect enrollment|0|||
105995601|NCT00713544|365644145|FG003|Overall Study|Incorrect enrollment|0|||
105995602|NCT00713544|365644146|FG004|Overall Study|Incorrect enrollment|0|||
105995603|NCT00713544|365644147|FG005|Overall Study|Incorrect enrollment|0|||
105995604|NCT00713544|365644142|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
105995605|NCT00713544|365644143|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
106119023|NCT00244374|366093783|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
106119024|NCT00244374|366093784|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
106119025|NCT00244374|366093780|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
105785140|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105785141|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105785142|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
106119026|NCT00244374|366093781|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
106119027|NCT00244374|366093782|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
106119028|NCT00244374|366093783|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
106119029|NCT00244374|366093784|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
106119030|NCT00244374|366093780|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
106119031|NCT00244374|366093781|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
106119032|NCT00244374|366093782|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
106119033|NCT00244374|366093783|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
106119034|NCT00244374|366093784|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
106119035|NCT00244374|366093780|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
106119036|NCT00244374|366093781|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
106119037|NCT00244374|366093782|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
106119038|NCT00244374|366093783|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
106119039|NCT00244374|366093784|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
106119040|NCT00976482|366093785|FG000|Overall Study|Death|208|||
106119041|NCT00976482|366093785|FG000|Overall Study|Withdrawal by Subject|45|||
106119042|NCT00976482|366093785|FG000|Overall Study|Center terminated|1|||
106119043|NCT00976482|366093785|FG000|Overall Study|Protocol Violation|5|||
106119044|NCT00957931|366093786|FG000|Overall Study|Death|4|||
106119045|NCT04105972|366093793|FG000|Overall Study|Adverse Event|2|||
106119046|NCT04105972|366093794|FG001|Overall Study|Adverse Event|1|||
106119047|NCT00003511|366093799|FG000|Overall Study|Not evaluable|4|||
106119048|NCT02914184|366093800|FG000|Overall Study|Lost to Follow-up|7|||
106119049|NCT02914184|366093801|FG001|Overall Study|Lost to Follow-up|10|||
106119050|NCT02914184|366093802|FG002|Overall Study|Lost to Follow-up|8|||
106119051|NCT02914184|366093803|FG003|Overall Study|Lost to Follow-up|7|||
106119052|NCT02914184|366093800|FG000|Overall Study|Withdrawal by Subject|4|||
106119053|NCT02914184|366093801|FG001|Overall Study|Withdrawal by Subject|2|||
106119054|NCT02914184|366093802|FG002|Overall Study|Withdrawal by Subject|7|||
106119055|NCT02914184|366093803|FG003|Overall Study|Withdrawal by Subject|3|||
106119056|NCT02914184|366093800|FG000|Overall Study|Other|1|||
106119057|NCT02914184|366093801|FG001|Overall Study|Other|0|||
106119058|NCT02914184|366093802|FG002|Overall Study|Other|0|||
106119059|NCT02914184|366093803|FG003|Overall Study|Other|0|||
106119060|NCT02914184|366093800|FG000|Overall Study|Migrated/moved from the study area|2|||
106119061|NCT02914184|366093801|FG001|Overall Study|Migrated/moved from the study area|1|||
106119062|NCT02914184|366093802|FG002|Overall Study|Migrated/moved from the study area|2|||
106119063|NCT02914184|366093803|FG003|Overall Study|Migrated/moved from the study area|1|||
106119064|NCT01478113|366093806|FG000|Overall Study|Withdrawal by Subject|0|||
105785143|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105785144|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105995606|NCT00713544|365644144|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
106119065|NCT01478113|366093807|FG001|Overall Study|Withdrawal by Subject|1|||
106119066|NCT01478113|366093806|FG000|Overall Study|Physician Decision|1|||
106119067|NCT01478113|366093807|FG001|Overall Study|Physician Decision|0|||
106119068|NCT00603265|366093813|FG000|Overall Study|Adverse Event|2|||
106119069|NCT00603265|366093814|FG001|Overall Study|Adverse Event|11|||
106119070|NCT00603265|366093815|FG002|Overall Study|Adverse Event|1|||
106119071|NCT00603265|366093813|FG000|Overall Study|Withdrawal by Subject|1|||
106119072|NCT00603265|366093814|FG001|Overall Study|Withdrawal by Subject|2|||
106119073|NCT00603265|366093815|FG002|Overall Study|Withdrawal by Subject|1|||
106119074|NCT00603265|366093813|FG000|Overall Study|Lack of Efficacy|3|||
106119075|NCT00603265|366093814|FG001|Overall Study|Lack of Efficacy|0|||
106119076|NCT00603265|366093815|FG002|Overall Study|Lack of Efficacy|3|||
106119077|NCT00603265|366093813|FG000|Overall Study|Lost to Follow-up|0|||
106119078|NCT00603265|366093814|FG001|Overall Study|Lost to Follow-up|1|||
106119079|NCT00603265|366093815|FG002|Overall Study|Lost to Follow-up|0|||
106119080|NCT00603265|366093813|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
106119081|NCT00603265|366093814|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
106119082|NCT00603265|366093815|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
106119083|NCT00603265|366093813|FG000|Overall Study|Participant Left Country, No Responses|0|||
106119084|NCT00603265|366093814|FG001|Overall Study|Participant Left Country, No Responses|1|||
106119085|NCT00603265|366093815|FG002|Overall Study|Participant Left Country, No Responses|0|||
106119086|NCT00603265|366093813|FG000|Overall Study|Protocol Violation|1|||
106119087|NCT00603265|366093814|FG001|Overall Study|Protocol Violation|0|||
106119088|NCT00603265|366093815|FG002|Overall Study|Protocol Violation|0|||
106119089|NCT02002884|366093816|FG000|Main Period (MP)|Other|0|||
106119090|NCT02002884|366093817|FG001|Main Period (MP)|Other|3|||
106119091|NCT02002884|366093818|FG002|Main Period (MP)|Other|3|||
106119092|NCT02002884|366093819|FG003|Main Period (MP)|Other|0|||
106119093|NCT02002884|366093816|FG000|Main Period (MP)|Adverse Event|0|||
106119094|NCT02002884|366093817|FG001|Main Period (MP)|Adverse Event|1|||
106119095|NCT02002884|366093818|FG002|Main Period (MP)|Adverse Event|1|||
106119096|NCT02002884|366093819|FG003|Main Period (MP)|Adverse Event|0|||
106119097|NCT02002884|366093816|FG000|Main Period (MP)|Withdrawal by Subject|6|||
106119098|NCT02002884|366093817|FG001|Main Period (MP)|Withdrawal by Subject|2|||
106119099|NCT02002884|366093818|FG002|Main Period (MP)|Withdrawal by Subject|2|||
106119100|NCT02002884|366093819|FG003|Main Period (MP)|Withdrawal by Subject|0|||
106119101|NCT02002884|366093816|FG000|Main Period (MP)|Lost to Follow-up|0|||
106119102|NCT02002884|366093817|FG001|Main Period (MP)|Lost to Follow-up|0|||
106119103|NCT02002884|366093818|FG002|Main Period (MP)|Lost to Follow-up|2|||
106119104|NCT02002884|366093819|FG003|Main Period (MP)|Lost to Follow-up|0|||
105662815|NCT05878873|364430015|FG001|Overall Study|Lost to Follow-up|0|||
105662816|NCT00943787|364430016|FG000|Overall Study|Physician Decision|4|||
105662817|NCT00943787|364430016|FG000|Overall Study|Withdrawal by Subject|3|||
105662818|NCT02229227|364430021|FG000|Overall Study|Adverse Event|14|||
105662819|NCT02229227|364430022|FG001|Overall Study|Adverse Event|9|||
105662820|NCT02229227|364430021|FG000|Overall Study|Lack of Efficacy|3|||
105662821|NCT02229227|364430022|FG001|Overall Study|Lack of Efficacy|3|||
105662822|NCT02229227|364430021|FG000|Overall Study|Protocol Violation|6|||
105662823|NCT02229227|364430022|FG001|Overall Study|Protocol Violation|8|||
105662824|NCT02229227|364430021|FG000|Overall Study|Protocol defined stopping criteria|1|||
105662825|NCT02229227|364430022|FG001|Overall Study|Protocol defined stopping criteria|3|||
105662826|NCT02229227|364430021|FG000|Overall Study|Lost to Follow-up|3|||
105662827|NCT02229227|364430022|FG001|Overall Study|Lost to Follow-up|3|||
105662828|NCT02229227|364430021|FG000|Overall Study|Study terminated by sponsor|11|||
105662829|NCT02229227|364430022|FG001|Overall Study|Study terminated by sponsor|11|||
105662830|NCT02229227|364430021|FG000|Overall Study|Withdrawal by Subject|8|||
105662831|NCT02229227|364430022|FG001|Overall Study|Withdrawal by Subject|12|||
105662832|NCT02229227|364430021|FG000|Overall Study|Other|0|||
105662833|NCT02229227|364430022|FG001|Overall Study|Other|1|||
105662834|NCT02229227|364430021|FG000|Overall Study|Physician Decision|5|||
105662835|NCT02229227|364430022|FG001|Overall Study|Physician Decision|12|||
105662836|NCT00121667|364430023|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
105662837|NCT00121667|364430024|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
105662838|NCT00121667|364430025|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
105662839|NCT00121667|364430026|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
105662840|NCT00121667|364430023|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
105662841|NCT00121667|364430024|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
105662842|NCT00121667|364430025|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
105662843|NCT00121667|364430026|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
106119105|NCT02002884|366093816|FG000|Open-Label Extension Period (OLEX)|Other|0|||
106119106|NCT02002884|366093817|FG001|Open-Label Extension Period (OLEX)|Other|0|||
106119107|NCT02002884|366093818|FG002|Open-Label Extension Period (OLEX)|Other|0|||
106119108|NCT02002884|366093819|FG003|Open-Label Extension Period (OLEX)|Other|24|||
106119109|NCT02002884|366093816|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
106119110|NCT02002884|366093817|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
106119111|NCT02002884|366093818|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
106119112|NCT02002884|366093819|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
105785145|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105785146|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105785147|NCT04516291|364866383|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
105785148|NCT04516291|364866384|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
105785149|NCT04516291|364866385|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
105785150|NCT04516291|364866386|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
105785151|NCT04516291|364866387|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
105785152|NCT04516291|364866388|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
105785153|NCT04516291|364866389|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
105785154|NCT04516291|364866390|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
105785155|NCT04516291|364866383|FG000|Follow-up Period (12 Weeks)|Other|0|||
105662844|NCT00121667|364430023|FG000|Short Term (ST) Period|Adverse Event|5|||
105662845|NCT00121667|364430024|FG001|Short Term (ST) Period|Adverse Event|6|||
105662846|NCT00121667|364430025|FG002|Short Term (ST) Period|Adverse Event|5|||
105662847|NCT00121667|364430026|FG003|Short Term (ST) Period|Adverse Event|3|||
105662848|NCT00121667|364430023|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
105662849|NCT00121667|364430024|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
105662850|NCT00121667|364430025|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
105662851|NCT00121667|364430026|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
105662852|NCT00121667|364430023|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
105662853|NCT00121667|364430024|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
105662854|NCT00121667|364430025|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
105662855|NCT00121667|364430026|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
105662856|NCT00121667|364430023|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
105662857|NCT00121667|364430024|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
105662858|NCT00121667|364430025|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
105662859|NCT00121667|364430026|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
105662860|NCT00121667|364430023|FG000|Short Term (ST) Period|Other Reason|3|||
105662861|NCT00121667|364430024|FG001|Short Term (ST) Period|Other Reason|0|||
105662862|NCT00121667|364430025|FG002|Short Term (ST) Period|Other Reason|0|||
105662863|NCT00121667|364430026|FG003|Short Term (ST) Period|Other Reason|0|||
105662864|NCT00121667|364430023|FG000|Short Term (ST) Period|Death|0|||
105662865|NCT00121667|364430024|FG001|Short Term (ST) Period|Death|0|||
105662866|NCT00121667|364430025|FG002|Short Term (ST) Period|Death|0|||
105662867|NCT00121667|364430026|FG003|Short Term (ST) Period|Death|1|||
105662868|NCT00121667|364430023|FG000|Short Term (ST) Period|Pregnancy|0|||
105888284|NCT01867710|365245947|FG001|Overall Study|Study Terminated by Sponsor|13|||
105888285|NCT01867710|365245948|FG002|Overall Study|Study Terminated by Sponsor|8|||
105888286|NCT01867710|365245949|FG003|Overall Study|Study Terminated by Sponsor|16|||
105888287|NCT01867710|365245946|FG000|Overall Study|Biochemical progression|0|||
105888288|NCT01867710|365245947|FG001|Overall Study|Biochemical progression|1|||
105888289|NCT01867710|365245948|FG002|Overall Study|Biochemical progression|0|||
105888290|NCT01867710|365245949|FG003|Overall Study|Biochemical progression|0|||
105888291|NCT01867710|365245946|FG000|Overall Study|Clinical progression|0|||
105888292|NCT01867710|365245947|FG001|Overall Study|Clinical progression|0|||
105888293|NCT01867710|365245948|FG002|Overall Study|Clinical progression|1|||
105888294|NCT01867710|365245949|FG003|Overall Study|Clinical progression|0|||
105888295|NCT01867710|365245946|FG000|Overall Study|Disease progression|1|||
105888296|NCT01867710|365245947|FG001|Overall Study|Disease progression|0|||
105888297|NCT01867710|365245948|FG002|Overall Study|Disease progression|0|||
105888298|NCT01867710|365245949|FG003|Overall Study|Disease progression|0|||
105888299|NCT01867710|365245946|FG000|Overall Study|Patient decision|0|||
105888300|NCT01867710|365245947|FG001|Overall Study|Patient decision|0|||
105888301|NCT01867710|365245948|FG002|Overall Study|Patient decision|0|||
105888302|NCT01867710|365245949|FG003|Overall Study|Patient decision|1|||
105888303|NCT01867710|365245946|FG000|Overall Study|Patient to follow subsequent treatment|0|||
105888304|NCT01867710|365245947|FG001|Overall Study|Patient to follow subsequent treatment|1|||
105662869|NCT00121667|364430024|FG001|Short Term (ST) Period|Pregnancy|0|||
105785156|NCT04516291|364866384|FG001|Follow-up Period (12 Weeks)|Other|1|||
105785157|NCT04516291|364866385|FG002|Follow-up Period (12 Weeks)|Other|0|||
105785158|NCT04516291|364866386|FG003|Follow-up Period (12 Weeks)|Other|2|||
105785159|NCT04516291|364866387|FG004|Follow-up Period (12 Weeks)|Other|0|||
105785160|NCT04516291|364866388|FG005|Follow-up Period (12 Weeks)|Other|0|||
105785161|NCT04516291|364866389|FG006|Follow-up Period (12 Weeks)|Other|0|||
105785162|NCT04516291|364866390|FG007|Follow-up Period (12 Weeks)|Other|0|||
105888305|NCT01867710|365245948|FG002|Overall Study|Patient to follow subsequent treatment|0|||
105662870|NCT00121667|364430025|FG002|Short Term (ST) Period|Pregnancy|0|||
105662871|NCT00121667|364430026|FG003|Short Term (ST) Period|Pregnancy|1|||
105662872|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
105785163|NCT04516291|364866383|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785164|NCT04516291|364866384|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105888306|NCT01867710|365245949|FG003|Overall Study|Patient to follow subsequent treatment|0|||
105888307|NCT01867710|365245946|FG000|Overall Study|Progressive disease|1|||
105785165|NCT04516291|364866385|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105888308|NCT01867710|365245947|FG001|Overall Study|Progressive disease|0|||
106119113|NCT02002884|366093816|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
106119114|NCT02002884|366093817|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
106119115|NCT02002884|366093818|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
106119116|NCT02002884|366093819|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
106119117|NCT02002884|366093816|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
106119118|NCT02002884|366093817|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
106119119|NCT02002884|366093818|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
106119120|NCT02002884|366093819|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
106119121|NCT02002884|366093816|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
106119122|NCT02002884|366093817|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
106119123|NCT02002884|366093818|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
106119124|NCT02002884|366093819|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
106119125|NCT02966002|366093820|FG000|Overall Study|Withdrawal by Subject|2|||
106119126|NCT02966002|366093820|FG000|Overall Study|Adverse Event|1|||
106119127|NCT02966002|366093820|FG000|Overall Study|Lost to Follow-up|1|||
106119128|NCT00067990|366093821|FG000|Overall Study|Death|5|||
106119129|NCT00067990|366093822|FG001|Overall Study|Death|7|||
106119130|NCT00067990|366093821|FG000|Overall Study|ESRD, Non IF/TA|1|||
106119131|NCT00067990|366093822|FG001|Overall Study|ESRD, Non IF/TA|3|||
106119132|NCT00067990|366093821|FG000|Overall Study|Withdrawal by Subject|4|||
106119133|NCT00067990|366093822|FG001|Overall Study|Withdrawal by Subject|12|||
106119134|NCT01118455|366093823|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
106119135|NCT01118455|366093824|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
106119136|NCT02396537|366093825|FG000|Overall Study|Protocol Violation|0|||
106119137|NCT02396537|366093826|FG001|Overall Study|Protocol Violation|1|||
106119138|NCT02341456|366093827|FG000|Overall Study|Disease progression|2|||
106119139|NCT02341456|366093828|FG001|Overall Study|Disease progression|3|||
106119140|NCT02341456|366093829|FG002|Overall Study|Disease progression|1|||
106119141|NCT02341456|366093827|FG000|Overall Study|Death|1|||
106119142|NCT02341456|366093828|FG001|Overall Study|Death|1|||
106119143|NCT02341456|366093829|FG002|Overall Study|Death|1|||
106119144|NCT02341456|366093827|FG000|Overall Study|Withdrawal by Subject|0|||
106119145|NCT02341456|366093828|FG001|Overall Study|Withdrawal by Subject|1|||
106119146|NCT02341456|366093829|FG002|Overall Study|Withdrawal by Subject|1|||
106119147|NCT02341456|366093827|FG000|Overall Study|Moved to local access programme.|0|||
106119148|NCT02341456|366093828|FG001|Overall Study|Moved to local access programme.|1|||
106119149|NCT02341456|366093829|FG002|Overall Study|Moved to local access programme.|1|||
106119150|NCT02341456|366093827|FG000|Overall Study|Physician Decision|1|||
106119151|NCT02341456|366093828|FG001|Overall Study|Physician Decision|0|||
106119152|NCT02341456|366093829|FG002|Overall Study|Physician Decision|0|||
106119153|NCT00422799|366093830|FG000|Overall Study|Withdrawal by Subject|6|||
106119154|NCT00422799|366093830|FG000|Overall Study|Adverse Event|7|||
106119155|NCT03469349|366093832|FG000|Overall Study|Withdrawal by Subject|1|||
106119156|NCT03469349|366093833|FG001|Overall Study|Withdrawal by Subject|3|||
106119157|NCT03469349|366093832|FG000|Overall Study|Progressive Disease|0|||
106119158|NCT03469349|366093833|FG001|Overall Study|Progressive Disease|1|||
106119159|NCT03469349|366093832|FG000|Overall Study|Lost to Follow-up|2|||
106119160|NCT03469349|366093833|FG001|Overall Study|Lost to Follow-up|2|||
106119161|NCT03469349|366093832|FG000|Overall Study|Adverse Event|2|||
106119162|NCT03469349|366093833|FG001|Overall Study|Adverse Event|4|||
106119163|NCT02917265|366093834|FG000|Overall Study|Physician Decision|1|||
106119164|NCT02917265|366093835|FG001|Overall Study|Physician Decision|0|||
106119165|NCT02917265|366093834|FG000|Overall Study|Withdrawal by Subject|1|||
106119166|NCT02917265|366093835|FG001|Overall Study|Withdrawal by Subject|0|||
106119167|NCT01737996|366093836|FG000|Overall Study|Adverse Event|0|||
106119168|NCT01737996|366093837|FG001|Overall Study|Adverse Event|1|||
106119169|NCT01737996|366093838|FG002|Overall Study|Adverse Event|1|||
106119170|NCT01737996|366093836|FG000|Overall Study|Withdrawal by Subject|0|||
106119171|NCT01737996|366093837|FG001|Overall Study|Withdrawal by Subject|0|||
106119172|NCT01737996|366093838|FG002|Overall Study|Withdrawal by Subject|1|||
106119173|NCT01027364|366093839|FG000|Overall Study|Adverse Event|1|||
106119174|NCT01027364|366093840|FG001|Overall Study|Adverse Event|0|||
106119175|NCT01027364|366093841|FG002|Overall Study|Adverse Event|1|||
106119176|NCT01027364|366093842|FG003|Overall Study|Adverse Event|0|||
106119177|NCT01027364|366093839|FG000|Overall Study|Lost to Follow-up|1|||
105785166|NCT04516291|364866386|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785167|NCT04516291|364866387|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
106119178|NCT01027364|366093840|FG001|Overall Study|Lost to Follow-up|0|||
106119179|NCT01027364|366093841|FG002|Overall Study|Lost to Follow-up|0|||
106119180|NCT01027364|366093842|FG003|Overall Study|Lost to Follow-up|0|||
106119181|NCT01027364|366093839|FG000|Overall Study|Protocol Violation|1|||
106119182|NCT01027364|366093840|FG001|Overall Study|Protocol Violation|0|||
106119183|NCT01027364|366093841|FG002|Overall Study|Protocol Violation|0|||
106119184|NCT01027364|366093842|FG003|Overall Study|Protocol Violation|1|||
106119185|NCT01027364|366093839|FG000|Overall Study|Withdrawal by Subject|1|||
106119186|NCT01027364|366093840|FG001|Overall Study|Withdrawal by Subject|2|||
106119187|NCT01027364|366093841|FG002|Overall Study|Withdrawal by Subject|0|||
105888309|NCT01867710|365245948|FG002|Overall Study|Progressive disease|0|||
106119188|NCT01027364|366093842|FG003|Overall Study|Withdrawal by Subject|0|||
106119189|NCT03283696|366093843|FG000|Overall Study|Physician Decision|5|||
106119190|NCT03283696|366093844|FG001|Overall Study|Physician Decision|6|||
106119191|NCT03283696|366093843|FG000|Overall Study|Withdrawal by Subject|2|||
106119192|NCT03283696|366093844|FG001|Overall Study|Withdrawal by Subject|0|||
106119193|NCT02765490|366093845|FG000|Overall Study|Lost to Follow-up|1|||
106119194|NCT02765490|366093846|FG001|Overall Study|Lost to Follow-up|1|||
106119195|NCT02765490|366093845|FG000|Overall Study|Other|0|||
106119196|NCT02765490|366093846|FG001|Overall Study|Other|1|||
106119197|NCT02765490|366093845|FG000|Overall Study|Death|0|||
106119198|NCT02765490|366093846|FG001|Overall Study|Death|1|||
106119199|NCT00439179|366093847|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
106119200|NCT00439179|366093848|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
106119201|NCT00439179|366093849|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
106119202|NCT00439179|366093850|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
106119203|NCT00675506|366093852|FG000|Overall Study|Lost to Follow-up|1|||
106119204|NCT00675506|366093853|FG001|Overall Study|Lost to Follow-up|5|||
106119205|NCT00675506|366093852|FG000|Overall Study|Lost interest|3|||
106119206|NCT00675506|366093853|FG001|Overall Study|Lost interest|5|||
106119207|NCT00675506|366093852|FG000|Overall Study|Elevated fasting glucose|2|||
106119208|NCT00675506|366093853|FG001|Overall Study|Elevated fasting glucose|1|||
106119209|NCT00675506|366093852|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
106119210|NCT00675506|366093853|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
106119211|NCT00675506|366093852|FG000|Overall Study|Elevated IGF-1|2|||
106119212|NCT00675506|366093853|FG001|Overall Study|Elevated IGF-1|0|||
106119213|NCT00675506|366093852|FG000|Overall Study|Hypersensitivity Reaction|1|||
106119214|NCT00675506|366093853|FG001|Overall Study|Hypersensitivity Reaction|0|||
106119215|NCT00675506|366093852|FG000|Overall Study|Disclosed history of cancer|1|||
106119216|NCT00675506|366093853|FG001|Overall Study|Disclosed history of cancer|0|||
106119217|NCT00675506|366093852|FG000|Overall Study|Declined participation|1|||
106119218|NCT00675506|366093853|FG001|Overall Study|Declined participation|0|||
106119219|NCT00675506|366093852|FG000|Overall Study|Schedule conflict|0|||
106119220|NCT00675506|366093853|FG001|Overall Study|Schedule conflict|1|||
106119221|NCT03151395|366093854|FG000|Overall Study|Adverse Event|2|||
106119222|NCT03151395|366093854|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
106119223|NCT03151395|366093854|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
106119224|NCT03151395|366093854|FG000|Overall Study|Unspecified reason|4|||
106119225|NCT01320735|366093859|FG000|Overall Study|Adverse Event|3|||
106119226|NCT01320735|366093859|FG000|Overall Study|Withdrawal by Subject|3|||
106119227|NCT01320735|366093859|FG000|Overall Study|Lost to Follow-up|13|||
106119228|NCT01320735|366093859|FG000|Overall Study|Administrative Reason|6|||
106119229|NCT01320735|366093859|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
106119230|NCT01320735|366093859|FG000|Overall Study|Protocol Violation|1|||
106119231|NCT01320735|366093859|FG000|Overall Study|Other|1|||
106119232|NCT01320735|366093859|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
106119233|NCT01320735|366093859|FG000|Overall Study|Investigator Unable to be Contacted|17|||
106119234|NCT00406419|366093864|FG000|Overall Study|Death|3|||
106119235|NCT00406419|366093865|FG001|Overall Study|Death|1|||
106119236|NCT00406419|366093866|FG002|Overall Study|Death|4|||
106119237|NCT00406419|366093864|FG000|Overall Study|Protocol Violation|6|||
106119238|NCT00406419|366093865|FG001|Overall Study|Protocol Violation|2|||
106119239|NCT00406419|366093866|FG002|Overall Study|Protocol Violation|5|||
106119240|NCT00406419|366093864|FG000|Overall Study|Study Terminated by Sponsor|260|||
106119241|NCT00406419|366093865|FG001|Overall Study|Study Terminated by Sponsor|288|||
106119242|NCT00406419|366093866|FG002|Overall Study|Study Terminated by Sponsor|282|||
106119243|NCT00406419|366093864|FG000|Overall Study|Withdrawal by Subject|17|||
106119244|NCT00406419|366093865|FG001|Overall Study|Withdrawal by Subject|24|||
106119245|NCT00406419|366093866|FG002|Overall Study|Withdrawal by Subject|26|||
106119246|NCT00406419|366093864|FG000|Overall Study|Lack of Efficacy|12|||
106119247|NCT00406419|366093865|FG001|Overall Study|Lack of Efficacy|1|||
105888310|NCT01867710|365245949|FG003|Overall Study|Progressive disease|0|||
105888311|NCT01867710|365245946|FG000|Overall Study|Protocol Violation|0|||
106119248|NCT00406419|366093866|FG002|Overall Study|Lack of Efficacy|6|||
106119249|NCT00406419|366093864|FG000|Overall Study|Non-Compliance with Study Drug|5|||
106119250|NCT00406419|366093865|FG001|Overall Study|Non-Compliance with Study Drug|6|||
106119251|NCT00406419|366093866|FG002|Overall Study|Non-Compliance with Study Drug|3|||
106119252|NCT00406419|366093864|FG000|Overall Study|Adverse Event|10|||
106119253|NCT00406419|366093865|FG001|Overall Study|Adverse Event|12|||
105888312|NCT01867710|365245947|FG001|Overall Study|Protocol Violation|0|||
106119254|NCT00406419|366093866|FG002|Overall Study|Adverse Event|16|||
106119255|NCT00406419|366093864|FG000|Overall Study|Lost to Follow-up|11|||
106119256|NCT00406419|366093865|FG001|Overall Study|Lost to Follow-up|10|||
106119257|NCT00406419|366093866|FG002|Overall Study|Lost to Follow-up|5|||
106119258|NCT01107743|366093867|FG000|Overall Study|Protocol Violation|46|||
106119259|NCT00308737|366093868|FG000|Overall Study|Adverse Event|104|||
106119260|NCT00308737|366093869|FG001|Overall Study|Adverse Event|9|||
105662873|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
105662874|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
105662875|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
105662876|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
105662877|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
105662878|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
105662879|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
105662880|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
105888313|NCT01867710|365245948|FG002|Overall Study|Protocol Violation|0|||
105888314|NCT01867710|365245949|FG003|Overall Study|Protocol Violation|1|||
105888315|NCT01867710|365245946|FG000|Overall Study|PSA-progression|0|||
105888316|NCT01867710|365245947|FG001|Overall Study|PSA-progression|1|||
105888317|NCT01867710|365245948|FG002|Overall Study|PSA-progression|0|||
106119261|NCT00308737|366093870|FG002|Overall Study|Adverse Event|0|||
106119262|NCT00308737|366093868|FG000|Overall Study|Death|4|||
106119263|NCT00308737|366093869|FG001|Overall Study|Death|3|||
106119264|NCT00308737|366093870|FG002|Overall Study|Death|0|||
106119265|NCT00308737|366093868|FG000|Overall Study|Lost to Follow-up|56|||
106119266|NCT00308737|366093869|FG001|Overall Study|Lost to Follow-up|80|||
106119267|NCT00308737|366093870|FG002|Overall Study|Lost to Follow-up|5|||
106119268|NCT00308737|366093868|FG000|Overall Study|Physician Decision|15|||
106119269|NCT00308737|366093869|FG001|Overall Study|Physician Decision|2|||
106119270|NCT00308737|366093870|FG002|Overall Study|Physician Decision|1|||
106119271|NCT00308737|366093868|FG000|Overall Study|Protocol Violation|34|||
106119272|NCT00308737|366093869|FG001|Overall Study|Protocol Violation|9|||
106119273|NCT00308737|366093870|FG002|Overall Study|Protocol Violation|5|||
106119274|NCT00308737|366093868|FG000|Overall Study|Withdrawal by Subject|218|||
106119275|NCT00308737|366093869|FG001|Overall Study|Withdrawal by Subject|166|||
106119276|NCT00308737|366093870|FG002|Overall Study|Withdrawal by Subject|18|||
106119277|NCT00308737|366093868|FG000|Overall Study|Various|32|||
106119278|NCT00308737|366093869|FG001|Overall Study|Various|20|||
106119279|NCT00308737|366093870|FG002|Overall Study|Various|8|||
106119280|NCT01290822|366093877|FG000|Overall Study|Withdrawal by Subject|1|||
106119281|NCT01290822|366093877|FG000|Overall Study|Physician Decision|10|||
106119282|NCT05644353|366093878|FG000|Overall Study|Physician Decision|1|||
106119283|NCT05644353|366093879|FG001|Overall Study|Physician Decision|0|||
106119284|NCT05644353|366093880|FG002|Overall Study|Physician Decision|0|||
106119285|NCT05644353|366093881|FG003|Overall Study|Physician Decision|0|||
106119286|NCT05644353|366093882|FG004|Overall Study|Physician Decision|0|||
106119287|NCT05644353|366093883|FG005|Overall Study|Physician Decision|0|||
106119288|NCT05644353|366093878|FG000|Overall Study|Protocol Violation|1|||
106119289|NCT05644353|366093879|FG001|Overall Study|Protocol Violation|0|||
106119290|NCT05644353|366093880|FG002|Overall Study|Protocol Violation|0|||
106119291|NCT05644353|366093881|FG003|Overall Study|Protocol Violation|0|||
106119292|NCT05644353|366093882|FG004|Overall Study|Protocol Violation|0|||
106119293|NCT05644353|366093883|FG005|Overall Study|Protocol Violation|0|||
106119294|NCT05644353|366093878|FG000|Overall Study|Withdrawal by Subject|0|||
106119295|NCT05644353|366093879|FG001|Overall Study|Withdrawal by Subject|2|||
106119296|NCT05644353|366093880|FG002|Overall Study|Withdrawal by Subject|0|||
106119297|NCT05644353|366093881|FG003|Overall Study|Withdrawal by Subject|0|||
106119298|NCT05644353|366093882|FG004|Overall Study|Withdrawal by Subject|1|||
106119299|NCT05644353|366093883|FG005|Overall Study|Withdrawal by Subject|0|||
106119300|NCT05644353|366093878|FG000|Overall Study|Lost to Follow-up|0|||
106119301|NCT05644353|366093879|FG001|Overall Study|Lost to Follow-up|0|||
106119302|NCT05644353|366093880|FG002|Overall Study|Lost to Follow-up|1|||
106119303|NCT05644353|366093881|FG003|Overall Study|Lost to Follow-up|0|||
106119304|NCT05644353|366093882|FG004|Overall Study|Lost to Follow-up|0|||
106119305|NCT05644353|366093883|FG005|Overall Study|Lost to Follow-up|0|||
106119306|NCT01155661|366093884|FG000|Overall Study|Adverse Event|101|||
106119307|NCT01155661|366093884|FG000|Overall Study|Death|1|||
106119308|NCT01155661|366093884|FG000|Overall Study|Lack of Efficacy|32|||
106119309|NCT01155661|366093884|FG000|Overall Study|Lost to Follow-up|22|||
106119310|NCT01155661|366093884|FG000|Overall Study|Physician Decision|3|||
106119311|NCT01155661|366093884|FG000|Overall Study|Protocol Violation|35|||
106119312|NCT01155661|366093884|FG000|Overall Study|Withdrawal by Subject|73|||
106119313|NCT01155661|366093884|FG000|Overall Study|Sponsor Decision|13|||
106119314|NCT03679767|366093885|FG000|Overall Study|Death|16|||
106119315|NCT03679767|366093886|FG001|Overall Study|Death|11|||
106119316|NCT03679767|366093887|FG002|Overall Study|Death|17|||
106119317|NCT03679767|366093888|FG003|Overall Study|Death|10|||
106119318|NCT03679767|366093885|FG000|Overall Study|Lost to Follow-up|1|||
106119319|NCT03679767|366093886|FG001|Overall Study|Lost to Follow-up|1|||
106119320|NCT03679767|366093887|FG002|Overall Study|Lost to Follow-up|1|||
106119321|NCT03679767|366093888|FG003|Overall Study|Lost to Follow-up|1|||
106119322|NCT03679767|366093885|FG000|Overall Study|Withdrawal by Subject|0|||
106119323|NCT03679767|366093886|FG001|Overall Study|Withdrawal by Subject|0|||
106119324|NCT03679767|366093887|FG002|Overall Study|Withdrawal by Subject|0|||
106119325|NCT03679767|366093888|FG003|Overall Study|Withdrawal by Subject|1|||
106119326|NCT03679767|366093885|FG000|Overall Study|Follow-up Completed|18|||
106119327|NCT03679767|366093886|FG001|Overall Study|Follow-up Completed|11|||
106119328|NCT03679767|366093887|FG002|Overall Study|Follow-up Completed|11|||
106119329|NCT03679767|366093888|FG003|Overall Study|Follow-up Completed|20|||
106119330|NCT03679767|366093885|FG000|Overall Study|Entered Hospice Care|0|||
106119331|NCT03679767|366093886|FG001|Overall Study|Entered Hospice Care|0|||
106119332|NCT03679767|366093887|FG002|Overall Study|Entered Hospice Care|0|||
106119333|NCT03679767|366093888|FG003|Overall Study|Entered Hospice Care|1|||
106119334|NCT03679767|366093885|FG000|Overall Study|Progressive Disease|0|||
106119335|NCT03679767|366093886|FG001|Overall Study|Progressive Disease|0|||
106119336|NCT03679767|366093887|FG002|Overall Study|Progressive Disease|0|||
106119337|NCT03679767|366093888|FG003|Overall Study|Progressive Disease|1|||
106119338|NCT02120664|366093889|FG000|Overall Study|Withdrawal by Subject|0|||
106119339|NCT02120664|366093890|FG001|Overall Study|Withdrawal by Subject|0|||
106119340|NCT02120664|366093891|FG002|Overall Study|Withdrawal by Subject|0|||
106119341|NCT02120664|366093892|FG003|Overall Study|Withdrawal by Subject|1|||
106119342|NCT02120664|366093893|FG004|Overall Study|Withdrawal by Subject|0|||
105662881|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
106119343|NCT02460263|366093894|FG000|Transition Period|Withdrawal by Subject|1|||
106119344|NCT02460263|366093894|FG000|Transition Period|Death|1|||
106119345|NCT04006925|366093896|FG000|Overall Study|Side effects|2|||
106119346|NCT04006925|366093897|FG001|Overall Study|Side effects|0|||
105785168|NCT04516291|364866388|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785169|NCT04516291|364866389|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785170|NCT04516291|364866390|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105785171|NCT04516291|364866383|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785172|NCT04516291|364866384|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785173|NCT04516291|364866385|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
105785174|NCT04516291|364866386|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785175|NCT04516291|364866387|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
105785176|NCT04516291|364866388|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785177|NCT04516291|364866389|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785178|NCT04516291|364866390|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
105785179|NCT00798161|364866391|FG000|Overall Study|Adverse Event|3|||
105785180|NCT00798161|364866392|FG001|Overall Study|Adverse Event|4|||
105785181|NCT00798161|364866393|FG002|Overall Study|Adverse Event|6|||
105785182|NCT00798161|364866394|FG003|Overall Study|Adverse Event|6|||
105785183|NCT00798161|364866395|FG004|Overall Study|Adverse Event|5|||
105785184|NCT00798161|364866396|FG005|Overall Study|Adverse Event|2|||
105785185|NCT00798161|364866397|FG006|Overall Study|Adverse Event|4|||
105785186|NCT00798161|364866391|FG000|Overall Study|Protocol Violation|2|||
105785187|NCT00798161|364866392|FG001|Overall Study|Protocol Violation|1|||
105785188|NCT00798161|364866393|FG002|Overall Study|Protocol Violation|3|||
105785189|NCT00798161|364866394|FG003|Overall Study|Protocol Violation|3|||
105785190|NCT00798161|364866395|FG004|Overall Study|Protocol Violation|3|||
105785191|NCT00798161|364866396|FG005|Overall Study|Protocol Violation|2|||
105785192|NCT00798161|364866397|FG006|Overall Study|Protocol Violation|0|||
105785193|NCT00798161|364866391|FG000|Overall Study|Lost to Follow-up|1|||
105785194|NCT00798161|364866392|FG001|Overall Study|Lost to Follow-up|3|||
105785195|NCT00798161|364866393|FG002|Overall Study|Lost to Follow-up|4|||
105785196|NCT00798161|364866394|FG003|Overall Study|Lost to Follow-up|3|||
105785197|NCT00798161|364866395|FG004|Overall Study|Lost to Follow-up|4|||
105785198|NCT00798161|364866396|FG005|Overall Study|Lost to Follow-up|0|||
105785199|NCT00798161|364866397|FG006|Overall Study|Lost to Follow-up|0|||
105785200|NCT00798161|364866391|FG000|Overall Study|Withdrawal by Subject|5|||
105785201|NCT00798161|364866392|FG001|Overall Study|Withdrawal by Subject|4|||
105785202|NCT00798161|364866393|FG002|Overall Study|Withdrawal by Subject|5|||
105785203|NCT00798161|364866394|FG003|Overall Study|Withdrawal by Subject|4|||
105785204|NCT00798161|364866395|FG004|Overall Study|Withdrawal by Subject|2|||
105785205|NCT00798161|364866396|FG005|Overall Study|Withdrawal by Subject|3|||
105785206|NCT00798161|364866397|FG006|Overall Study|Withdrawal by Subject|1|||
105785207|NCT00798161|364866391|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
105785208|NCT00798161|364866392|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
105785209|NCT00798161|364866393|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
105785210|NCT00798161|364866394|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
105785211|NCT00798161|364866395|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
105785212|NCT00798161|364866396|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
105785213|NCT00798161|364866397|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
105785214|NCT03472586|364866402|FG000|Overall Study|Physician Decision|6|||
105785215|NCT03472586|364866402|FG000|Overall Study|Death|6|||
105785216|NCT03472586|364866402|FG000|Overall Study|Adverse Event|1|||
105785217|NCT02528331|364866404|FG000|Overall Study|Withdrawal by Subject|2|||
105785218|NCT02392078|364866405|FG000|Overall Study|Did not have procedure|32|||
105785219|NCT02392078|364866406|FG001|Overall Study|Did not have procedure|43|||
105785220|NCT02392078|364866407|FG002|Overall Study|Did not have procedure|20|||
105785221|NCT02392078|364866408|FG003|Overall Study|Did not have procedure|1|||
105662882|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
105662883|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
105662884|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
105662885|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
105662886|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
105662887|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
105662888|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
105662889|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
105662890|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
105662891|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
106119347|NCT00118092|366093898|FG000|Overall Study|Withdrawal by Subject|1|||
105662892|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
105662893|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
105662894|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
105662895|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
105662896|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
105662897|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
105662898|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
105662899|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
105662900|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
105662901|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
105662902|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
105662903|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
105662904|NCT00121667|364430023|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
105662905|NCT00121667|364430024|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
105662906|NCT00121667|364430025|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
105662907|NCT00121667|364430026|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
105662908|NCT02125279|364430027|FG000|Overall Study|Lack of Efficacy|2|||
105662909|NCT02125279|364430027|FG000|Overall Study|Withdrawal by Subject|6|||
105662910|NCT02125279|364430027|FG000|Overall Study|Protocol Violation|1|||
105662911|NCT02125279|364430027|FG000|Overall Study|Lost to Follow-up|4|||
105662912|NCT03721705|364430040|FG000|Overall Study|Adverse Event|2|||
105662913|NCT03721705|364430041|FG001|Overall Study|Adverse Event|0|||
105662914|NCT03721705|364430040|FG000|Overall Study|Withdrawal by Subject|4|||
105662915|NCT03721705|364430041|FG001|Overall Study|Withdrawal by Subject|10|||
105662916|NCT03721705|364430040|FG000|Overall Study|No Suitable Study Partner|1|||
105662917|NCT03721705|364430041|FG001|Overall Study|No Suitable Study Partner|0|||
105662918|NCT03721705|364430040|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
105662919|NCT03721705|364430041|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
105888318|NCT01867710|365245949|FG003|Overall Study|PSA-progression|0|||
105888319|NCT01867710|365245946|FG000|Overall Study|Study medication no longer effective|0|||
105888320|NCT01867710|365245947|FG001|Overall Study|Study medication no longer effective|1|||
105888321|NCT01867710|365245948|FG002|Overall Study|Study medication no longer effective|0|||
105888322|NCT01867710|365245949|FG003|Overall Study|Study medication no longer effective|0|||
105888323|NCT05113979|365245950|FG000|Overall Study|Death|2|||
105888324|NCT05113979|365245950|FG000|Overall Study|Lost to Follow-up|1|||
105888325|NCT01489254|365245955|FG000|Double-blind Part|Adverse Event|7|||
105888326|NCT01489254|365245956|FG001|Double-blind Part|Adverse Event|2|||
105888327|NCT01489254|365245957|FG002|Double-blind Part|Adverse Event|2|||
105888328|NCT01489254|365245958|FG003|Double-blind Part|Adverse Event|0|||
105888329|NCT01489254|365245955|FG000|Double-blind Part|Pregnancy|1|||
105888330|NCT01489254|365245956|FG001|Double-blind Part|Pregnancy|3|||
105888331|NCT01489254|365245957|FG002|Double-blind Part|Pregnancy|0|||
105888332|NCT01489254|365245958|FG003|Double-blind Part|Pregnancy|0|||
105888333|NCT01489254|365245955|FG000|Double-blind Part|Withdrawal by Subject|12|||
105888334|NCT01489254|365245956|FG001|Double-blind Part|Withdrawal by Subject|20|||
105888335|NCT01489254|365245957|FG002|Double-blind Part|Withdrawal by Subject|1|||
105888336|NCT01489254|365245958|FG003|Double-blind Part|Withdrawal by Subject|0|||
105888337|NCT01489254|365245955|FG000|Double-blind Part|Lost to Follow-up|1|||
105888338|NCT01489254|365245956|FG001|Double-blind Part|Lost to Follow-up|2|||
105888339|NCT01489254|365245957|FG002|Double-blind Part|Lost to Follow-up|0|||
105888340|NCT01489254|365245958|FG003|Double-blind Part|Lost to Follow-up|0|||
105888341|NCT01489254|365245955|FG000|Double-blind Part|Other reasons for not completing study|4|||
105888342|NCT01489254|365245956|FG001|Double-blind Part|Other reasons for not completing study|6|||
105888343|NCT01489254|365245957|FG002|Double-blind Part|Other reasons for not completing study|0|||
106119348|NCT00118092|366093898|FG000|Overall Study|Protocol Violation|1|||
105662920|NCT03721705|364430040|FG000|Overall Study|Death|0|||
105662921|NCT03721705|364430041|FG001|Overall Study|Death|1|||
105888344|NCT01489254|365245958|FG003|Double-blind Part|Other reasons for not completing study|0|||
105888345|NCT01489254|365245955|FG000|Open-label Extension Part|Adverse Event|0|||
105995607|NCT00713544|365644145|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
105995608|NCT00713544|365644146|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
105995609|NCT00713544|365644147|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
105995610|NCT00592904|365644148|FG000|Overall Study|Adverse Event|15|||
105995611|NCT00592904|365644149|FG001|Overall Study|Adverse Event|25|||
105995612|NCT00592904|365644150|FG002|Overall Study|Adverse Event|13|||
105995613|NCT00592904|365644151|FG003|Overall Study|Adverse Event|5|||
105995614|NCT00592904|365644148|FG000|Overall Study|Protocol Violation|1|||
105785222|NCT03868410|364866411|FG000|Overall Study|Physician Decision|0|||
105785223|NCT03868410|364866412|FG001|Overall Study|Physician Decision|1|||
105995615|NCT00592904|365644149|FG001|Overall Study|Protocol Violation|1|||
106119349|NCT00591864|366093899|FG000|Overall Study|Incomplete Imaging|5|||
106119350|NCT02459093|366093900|FG000|Overall Study|Protocol Violation|6|||
106119351|NCT02459093|366093901|FG001|Overall Study|Protocol Violation|11|||
106119352|NCT02459093|366093900|FG000|Overall Study|Lost to Follow-up|6|||
106119353|NCT02459093|366093901|FG001|Overall Study|Lost to Follow-up|7|||
106119354|NCT02736968|366093908|FG000|Overall Study|Lost to Follow-up|0|||
106119355|NCT02736968|366093909|FG001|Overall Study|Lost to Follow-up|0|||
106119356|NCT02736968|366093910|FG002|Overall Study|Lost to Follow-up|0|||
106119357|NCT02736968|366093911|FG003|Overall Study|Lost to Follow-up|0|||
106119358|NCT02736968|366093912|FG004|Overall Study|Lost to Follow-up|0|||
106119359|NCT02736968|366093913|FG005|Overall Study|Lost to Follow-up|0|||
106119360|NCT02736968|366093914|FG006|Overall Study|Lost to Follow-up|5|||
106119361|NCT02736968|366093915|FG007|Overall Study|Lost to Follow-up|2|||
106119362|NCT02736968|366093908|FG000|Overall Study|COVID-19 Pandemic|0|||
106119363|NCT02736968|366093909|FG001|Overall Study|COVID-19 Pandemic|0|||
106119364|NCT02736968|366093910|FG002|Overall Study|COVID-19 Pandemic|0|||
106119365|NCT02736968|366093911|FG003|Overall Study|COVID-19 Pandemic|0|||
106119366|NCT02736968|366093912|FG004|Overall Study|COVID-19 Pandemic|0|||
106119367|NCT02736968|366093913|FG005|Overall Study|COVID-19 Pandemic|0|||
106119368|NCT02736968|366093914|FG006|Overall Study|COVID-19 Pandemic|2|||
106119369|NCT02736968|366093915|FG007|Overall Study|COVID-19 Pandemic|0|||
106119370|NCT02736968|366093908|FG000|Overall Study|Withdrawal by Subject|0|||
106119371|NCT02736968|366093909|FG001|Overall Study|Withdrawal by Subject|0|||
106119372|NCT02736968|366093910|FG002|Overall Study|Withdrawal by Subject|0|||
106119373|NCT02736968|366093911|FG003|Overall Study|Withdrawal by Subject|0|||
106119374|NCT02736968|366093912|FG004|Overall Study|Withdrawal by Subject|0|||
106119375|NCT02736968|366093913|FG005|Overall Study|Withdrawal by Subject|0|||
106119376|NCT02736968|366093914|FG006|Overall Study|Withdrawal by Subject|1|||
106119377|NCT02736968|366093915|FG007|Overall Study|Withdrawal by Subject|0|||
106119378|NCT01302938|366093916|FG000|Overall Study|Withdrawal by Subject|1|||
106119379|NCT01302938|366093917|FG001|Overall Study|Withdrawal by Subject|0|||
106119380|NCT01302938|366093916|FG000|Overall Study|Adverse Event|1|||
106119381|NCT01302938|366093917|FG001|Overall Study|Adverse Event|0|||
106119382|NCT03342053|366093918|FG000|Overall Study|Adverse Event|2|||
106119383|NCT03342053|366093919|FG001|Overall Study|Adverse Event|0|||
106119384|NCT03342053|366093918|FG000|Overall Study|Withdrawal by Subject|0|||
106119385|NCT03342053|366093919|FG001|Overall Study|Withdrawal by Subject|1|||
106119386|NCT02294474|366093920|FG000|Overall Study|Adverse Event|7|||
106119387|NCT02294474|366093921|FG001|Overall Study|Adverse Event|7|||
106119388|NCT02294474|366093920|FG000|Overall Study|Lack of Efficacy|2|||
106119389|NCT02294474|366093921|FG001|Overall Study|Lack of Efficacy|1|||
106119390|NCT02294474|366093920|FG000|Overall Study|Protocol Violation|4|||
106119391|NCT02294474|366093921|FG001|Overall Study|Protocol Violation|2|||
106119392|NCT02294474|366093920|FG000|Overall Study|Other than specified above|12|||
106119393|NCT02294474|366093921|FG001|Overall Study|Other than specified above|12|||
106119394|NCT00649389|366095792|FG000|Overall Study|Adverse Event|22|||
106119395|NCT00649389|366095793|FG001|Overall Study|Adverse Event|46|||
106119396|NCT00649389|366095794|FG002|Overall Study|Adverse Event|38|||
106119397|NCT00649389|366095795|FG003|Overall Study|Adverse Event|48|||
106119398|NCT00649389|366095792|FG000|Overall Study|Lost to Follow-up|15|||
105785224|NCT02213666|364866415|FG000|Overall Study|Withdrawal by Subject|1|||
105995616|NCT00592904|365644150|FG002|Overall Study|Protocol Violation|0|||
105995617|NCT00592904|365644151|FG003|Overall Study|Protocol Violation|1|||
105995618|NCT00592904|365644148|FG000|Overall Study|Withdrawal by Subject|4|||
106119399|NCT00649389|366095793|FG001|Overall Study|Lost to Follow-up|17|||
106119400|NCT00649389|366095794|FG002|Overall Study|Lost to Follow-up|21|||
106119401|NCT00649389|366095795|FG003|Overall Study|Lost to Follow-up|26|||
106119402|NCT00649389|366095792|FG000|Overall Study|Protocol Violation|11|||
106119403|NCT00649389|366095793|FG001|Overall Study|Protocol Violation|13|||
106119404|NCT00649389|366095794|FG002|Overall Study|Protocol Violation|9|||
106119405|NCT00649389|366095795|FG003|Overall Study|Protocol Violation|8|||
106119406|NCT00649389|366095792|FG000|Overall Study|Withdrawal by Subject|20|||
106119407|NCT00649389|366095793|FG001|Overall Study|Withdrawal by Subject|21|||
106119408|NCT00649389|366095794|FG002|Overall Study|Withdrawal by Subject|19|||
106119409|NCT00649389|366095795|FG003|Overall Study|Withdrawal by Subject|23|||
106119410|NCT00649389|366095792|FG000|Overall Study|Other|3|||
106119411|NCT00649389|366095793|FG001|Overall Study|Other|9|||
106119412|NCT00649389|366095794|FG002|Overall Study|Other|1|||
106119413|NCT00649389|366095795|FG003|Overall Study|Other|6|||
105662922|NCT03657576|364430050|FG000|Overall Study|Death|0|||
105662923|NCT03657576|364430051|FG001|Overall Study|Death|1|||
105662924|NCT03657576|364430052|FG002|Overall Study|Death|1|||
105662925|NCT03657576|364430053|FG003|Overall Study|Death|0|||
105662926|NCT03657576|364430054|FG004|Overall Study|Death|0|||
105888346|NCT01489254|365245956|FG001|Open-label Extension Part|Adverse Event|0|||
105888347|NCT01489254|365245957|FG002|Open-label Extension Part|Adverse Event|0|||
105888348|NCT01489254|365245958|FG003|Open-label Extension Part|Adverse Event|10|||
105888349|NCT01489254|365245955|FG000|Open-label Extension Part|Pregnancy|0|||
105888350|NCT01489254|365245956|FG001|Open-label Extension Part|Pregnancy|0|||
105888351|NCT01489254|365245957|FG002|Open-label Extension Part|Pregnancy|0|||
105888352|NCT01489254|365245958|FG003|Open-label Extension Part|Pregnancy|3|||
105888353|NCT01489254|365245955|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
105888354|NCT01489254|365245956|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
105888355|NCT01489254|365245957|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
105888356|NCT01489254|365245958|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
105888357|NCT01489254|365245955|FG000|Open-label Extension Part|Protocol Violation|0|||
105888358|NCT01489254|365245956|FG001|Open-label Extension Part|Protocol Violation|0|||
105888359|NCT01489254|365245957|FG002|Open-label Extension Part|Protocol Violation|0|||
105888360|NCT01489254|365245958|FG003|Open-label Extension Part|Protocol Violation|1|||
105888361|NCT01489254|365245955|FG000|Open-label Extension Part|Lost to Follow-up|0|||
105888362|NCT01489254|365245956|FG001|Open-label Extension Part|Lost to Follow-up|0|||
105888363|NCT01489254|365245957|FG002|Open-label Extension Part|Lost to Follow-up|0|||
105888364|NCT01489254|365245958|FG003|Open-label Extension Part|Lost to Follow-up|9|||
105888365|NCT01489254|365245955|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
105888366|NCT01489254|365245956|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
105888367|NCT01489254|365245957|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
105888368|NCT01489254|365245958|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
105888369|NCT01609543|365245959|FG000|Overall Study|Disease Progression|28|||
105888370|NCT01609543|365245959|FG000|Overall Study|Adverse Event|5|||
106119414|NCT04666922|366095796|FG000|Overall Study|Withdrawal by Subject|1|||
106119415|NCT04666922|366095797|FG001|Overall Study|Withdrawal by Subject|0|||
106119416|NCT04666922|366095798|FG002|Overall Study|Withdrawal by Subject|0|||
106119417|NCT04666922|366095799|FG003|Overall Study|Withdrawal by Subject|0|||
106119418|NCT04666922|366095800|FG004|Overall Study|Withdrawal by Subject|0|||
106119419|NCT04666922|366095801|FG005|Overall Study|Withdrawal by Subject|0|||
106119420|NCT04666922|366095802|FG006|Overall Study|Withdrawal by Subject|0|||
106119421|NCT02762981|366095803|FG000|Overall Study|Adverse Event|2|||
106119422|NCT02762981|366095804|FG001|Overall Study|Adverse Event|3|||
105888371|NCT01609543|365245959|FG000|Overall Study|Withdrawal by Subject|1|||
105888372|NCT01609543|365245959|FG000|Overall Study|Protocol Violation|1|||
105888373|NCT01609543|365245959|FG000|Overall Study|Death|7|||
106119423|NCT02762981|366095805|FG002|Overall Study|Adverse Event|1|||
106119424|NCT02762981|366095806|FG003|Overall Study|Adverse Event|1|||
106119425|NCT02762981|366095807|FG004|Overall Study|Adverse Event|3|||
106119426|NCT02762981|366095803|FG000|Overall Study|Physician Decision|0|||
106119427|NCT02762981|366095804|FG001|Overall Study|Physician Decision|1|||
106119428|NCT02762981|366095805|FG002|Overall Study|Physician Decision|0|||
106119429|NCT02762981|366095806|FG003|Overall Study|Physician Decision|0|||
106119430|NCT02762981|366095807|FG004|Overall Study|Physician Decision|1|||
106119431|NCT02762981|366095803|FG000|Overall Study|Disease progression|11|||
106119432|NCT02762981|366095804|FG001|Overall Study|Disease progression|23|||
106119433|NCT02762981|366095805|FG002|Overall Study|Disease progression|4|||
106119434|NCT02762981|366095806|FG003|Overall Study|Disease progression|10|||
106119435|NCT02762981|366095807|FG004|Overall Study|Disease progression|1|||
106119436|NCT02762981|366095803|FG000|Overall Study|Enrolled not treated|1|||
106119437|NCT02762981|366095804|FG001|Overall Study|Enrolled not treated|5|||
106119438|NCT02762981|366095805|FG002|Overall Study|Enrolled not treated|0|||
106119439|NCT02762981|366095806|FG003|Overall Study|Enrolled not treated|2|||
106119440|NCT02762981|366095807|FG004|Overall Study|Enrolled not treated|0|||
106119441|NCT02762981|366095803|FG000|Overall Study|Other|2|||
106119442|NCT02762981|366095804|FG001|Overall Study|Other|3|||
106119443|NCT02762981|366095805|FG002|Overall Study|Other|1|||
106119444|NCT02762981|366095806|FG003|Overall Study|Other|0|||
106119445|NCT02762981|366095807|FG004|Overall Study|Other|0|||
106119446|NCT02762981|366095803|FG000|Overall Study|Missing|1|||
105662927|NCT03657576|364430055|FG005|Overall Study|Death|0|||
106119447|NCT02762981|366095804|FG001|Overall Study|Missing|0|||
106119448|NCT02762981|366095805|FG002|Overall Study|Missing|0|||
106119449|NCT02762981|366095806|FG003|Overall Study|Missing|0|||
106119450|NCT02762981|366095807|FG004|Overall Study|Missing|0|||
105888374|NCT03452488|365245960|FG000|Overall Study|Adverse Event|4|||
105888375|NCT03452488|365245961|FG001|Overall Study|Adverse Event|6|||
105888376|NCT03452488|365245962|FG002|Overall Study|Adverse Event|1|||
106119451|NCT02762981|366095803|FG000|Overall Study|Withdrawal by Subject|0|||
106119452|NCT02762981|366095804|FG001|Overall Study|Withdrawal by Subject|5|||
106119453|NCT02762981|366095805|FG002|Overall Study|Withdrawal by Subject|1|||
105785225|NCT00727246|364866416|FG000|Overall Study|could not complete MRI|0|||
105785226|NCT00727246|364866417|FG001|Overall Study|could not complete MRI|1|||
105785227|NCT00727246|364866418|FG002|Overall Study|could not complete MRI|0|||
105785228|NCT00727246|364866419|FG003|Overall Study|could not complete MRI|1|||
106119454|NCT02762981|366095806|FG003|Overall Study|Withdrawal by Subject|3|||
106119455|NCT02762981|366095807|FG004|Overall Study|Withdrawal by Subject|0|||
106119456|NCT01382940|366095808|FG000|Overall Study|Adverse Event|19|||
106119457|NCT01382940|366095808|FG000|Overall Study|Lost to Follow-up|4|||
106119458|NCT01382940|366095808|FG000|Overall Study|Physician Decision|7|||
106119459|NCT01382940|366095808|FG000|Overall Study|Withdrawal by Subject|23|||
106119460|NCT01382940|366095808|FG000|Overall Study|Protocol Violation|20|||
106119461|NCT00857805|366095813|FG000|Overall Study|Withdrawal by Subject|1|||
106119462|NCT00857805|366095814|FG001|Overall Study|Withdrawal by Subject|1|||
106119463|NCT04867785|366095815|FG000|Overall Study|Adverse Event|1|||
106119464|NCT04867785|366095816|FG001|Overall Study|Adverse Event|0|||
106119465|NCT04867785|366095817|FG002|Overall Study|Adverse Event|1|||
106119466|NCT04867785|366095818|FG003|Overall Study|Adverse Event|0|||
106119467|NCT04867785|366095819|FG004|Overall Study|Adverse Event|0|||
106119468|NCT04867785|366095820|FG005|Overall Study|Adverse Event|0|||
106119469|NCT04867785|366095821|FG006|Overall Study|Adverse Event|0|||
106119470|NCT04867785|366095822|FG007|Overall Study|Adverse Event|2|||
106119471|NCT04867785|366095815|FG000|Overall Study|Lost to Follow-up|4|||
106119472|NCT04867785|366095816|FG001|Overall Study|Lost to Follow-up|4|||
106119473|NCT04867785|366095817|FG002|Overall Study|Lost to Follow-up|3|||
106119474|NCT04867785|366095818|FG003|Overall Study|Lost to Follow-up|2|||
106119475|NCT04867785|366095819|FG004|Overall Study|Lost to Follow-up|0|||
106119476|NCT04867785|366095820|FG005|Overall Study|Lost to Follow-up|1|||
106119477|NCT04867785|366095821|FG006|Overall Study|Lost to Follow-up|0|||
106119478|NCT04867785|366095822|FG007|Overall Study|Lost to Follow-up|1|||
106119479|NCT04867785|366095815|FG000|Overall Study|Withdrawal by Subject|6|||
106119480|NCT04867785|366095816|FG001|Overall Study|Withdrawal by Subject|2|||
106119481|NCT04867785|366095817|FG002|Overall Study|Withdrawal by Subject|2|||
106119482|NCT04867785|366095818|FG003|Overall Study|Withdrawal by Subject|1|||
106119483|NCT04867785|366095819|FG004|Overall Study|Withdrawal by Subject|2|||
106119484|NCT04867785|366095820|FG005|Overall Study|Withdrawal by Subject|0|||
106119485|NCT04867785|366095821|FG006|Overall Study|Withdrawal by Subject|2|||
106119486|NCT04867785|366095822|FG007|Overall Study|Withdrawal by Subject|5|||
106119487|NCT04867785|366095815|FG000|Overall Study|Physician Decision|0|||
106119488|NCT04867785|366095816|FG001|Overall Study|Physician Decision|0|||
106119489|NCT04867785|366095817|FG002|Overall Study|Physician Decision|0|||
106119490|NCT04867785|366095818|FG003|Overall Study|Physician Decision|0|||
106119491|NCT04867785|366095819|FG004|Overall Study|Physician Decision|0|||
106119492|NCT04867785|366095820|FG005|Overall Study|Physician Decision|0|||
106119493|NCT04867785|366095821|FG006|Overall Study|Physician Decision|0|||
106119494|NCT04867785|366095822|FG007|Overall Study|Physician Decision|1|||
106119495|NCT04867785|366095815|FG000|Overall Study|Inadvertent Enrollment|0|||
106119496|NCT04867785|366095816|FG001|Overall Study|Inadvertent Enrollment|0|||
106119497|NCT04867785|366095817|FG002|Overall Study|Inadvertent Enrollment|0|||
106119498|NCT04867785|366095818|FG003|Overall Study|Inadvertent Enrollment|1|||
106119499|NCT04867785|366095819|FG004|Overall Study|Inadvertent Enrollment|1|||
106119500|NCT04867785|366095820|FG005|Overall Study|Inadvertent Enrollment|0|||
106119501|NCT04867785|366095821|FG006|Overall Study|Inadvertent Enrollment|0|||
106119502|NCT04867785|366095822|FG007|Overall Study|Inadvertent Enrollment|1|||
106119503|NCT04867785|366095815|FG000|Overall Study|Eligibility Criteria Not Met|0|||
106119504|NCT04867785|366095816|FG001|Overall Study|Eligibility Criteria Not Met|0|||
106119505|NCT04867785|366095817|FG002|Overall Study|Eligibility Criteria Not Met|0|||
106119506|NCT04867785|366095818|FG003|Overall Study|Eligibility Criteria Not Met|0|||
106119507|NCT04867785|366095819|FG004|Overall Study|Eligibility Criteria Not Met|0|||
106119508|NCT04867785|366095820|FG005|Overall Study|Eligibility Criteria Not Met|0|||
106119509|NCT04867785|366095821|FG006|Overall Study|Eligibility Criteria Not Met|0|||
106119510|NCT04867785|366095822|FG007|Overall Study|Eligibility Criteria Not Met|1|||
106119511|NCT01289041|366095823|FG000|Overall Study|Adverse Event|24|||
105785229|NCT00727246|364866416|FG000|Overall Study|incidental finding|0|||
105785230|NCT00727246|364866417|FG001|Overall Study|incidental finding|0|||
105785231|NCT00727246|364866418|FG002|Overall Study|incidental finding|0|||
105785232|NCT00727246|364866419|FG003|Overall Study|incidental finding|1|||
105785233|NCT00727246|364866416|FG000|Overall Study|withdrawn|0|||
105785234|NCT00727246|364866417|FG001|Overall Study|withdrawn|0|||
105785235|NCT00727246|364866418|FG002|Overall Study|withdrawn|1|||
105785236|NCT00727246|364866419|FG003|Overall Study|withdrawn|0|||
105785237|NCT00812968|364866422|FG000|Overall Study|Relapse after erythroid response|6|||
105785238|NCT00812968|364866422|FG000|Overall Study|Disease progression|1|||
105785239|NCT00812968|364866422|FG000|Overall Study|No further treatment required|1|||
105785240|NCT00812968|364866422|FG000|Overall Study|Study closed due to marketing approval|3|||
105785241|NCT02696382|364866424|FG000|Overall Study|Death|7|||
105785242|NCT02696382|364866425|FG001|Overall Study|Death|2|||
105785243|NCT02696382|364866424|FG000|Overall Study|Withdrawal by Subject|5|||
105995619|NCT00592904|365644149|FG001|Overall Study|Withdrawal by Subject|16|||
105995620|NCT00592904|365644150|FG002|Overall Study|Withdrawal by Subject|1|||
105995621|NCT00592904|365644151|FG003|Overall Study|Withdrawal by Subject|2|||
105995622|NCT00592904|365644148|FG000|Overall Study|Lack of Efficacy|2|||
105995623|NCT00592904|365644149|FG001|Overall Study|Lack of Efficacy|7|||
105995624|NCT00592904|365644150|FG002|Overall Study|Lack of Efficacy|2|||
105995625|NCT00592904|365644151|FG003|Overall Study|Lack of Efficacy|3|||
105995626|NCT00592904|365644148|FG000|Overall Study|Physician Decision|0|||
105995627|NCT00592904|365644149|FG001|Overall Study|Physician Decision|3|||
105995628|NCT00592904|365644150|FG002|Overall Study|Physician Decision|1|||
105995629|NCT00592904|365644151|FG003|Overall Study|Physician Decision|0|||
105995630|NCT00592904|365644148|FG000|Overall Study|Other|3|||
105995631|NCT00592904|365644149|FG001|Overall Study|Other|3|||
105995632|NCT00592904|365644150|FG002|Overall Study|Other|0|||
105995633|NCT00592904|365644151|FG003|Overall Study|Other|0|||
105995634|NCT03078556|365644152|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
105995635|NCT03078556|365644153|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
105995636|NCT03078556|365644154|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
105995637|NCT03078556|365644155|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
105995638|NCT03078556|365644152|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
105995639|NCT03078556|365644153|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
105995640|NCT03078556|365644154|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
105995641|NCT03078556|365644155|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
105995642|NCT03078556|365644152|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
106119512|NCT01289041|366095823|FG000|Overall Study|Physician Decision|1|||
106119513|NCT01289041|366095823|FG000|Overall Study|Progressive Disease|41|||
106119514|NCT01289041|366095823|FG000|Overall Study|Withdrawal by Subject|3|||
106119515|NCT01289041|366095823|FG000|Overall Study|Death|1|||
106119516|NCT02254408|366095829|FG000|Overall Study|Randomized But Not Treated|1|||
106119517|NCT02254408|366095830|FG001|Overall Study|Randomized But Not Treated|3|||
106119518|NCT02254408|366095829|FG000|Overall Study|Adverse Event|1|||
106119519|NCT02254408|366095830|FG001|Overall Study|Adverse Event|0|||
106119520|NCT02254408|366095829|FG000|Overall Study|Death|2|||
106119521|NCT02254408|366095830|FG001|Overall Study|Death|3|||
106119522|NCT02254408|366095829|FG000|Overall Study|Investigator's Discretion|0|||
106119523|NCT02254408|366095830|FG001|Overall Study|Investigator's Discretion|1|||
106119524|NCT02254408|366095829|FG000|Overall Study|Withdrawal by Subject|3|||
106119525|NCT02254408|366095830|FG001|Overall Study|Withdrawal by Subject|3|||
106119526|NCT02254408|366095829|FG000|Overall Study|Lost to Follow-up|1|||
106119527|NCT02254408|366095830|FG001|Overall Study|Lost to Follow-up|0|||
106119528|NCT00553202|366095831|FG000|Overall Study|Death|16|||
106119529|NCT00553202|366095831|FG000|Overall Study|Lost to Follow-up|1|||
106119530|NCT00553202|366095831|FG000|Overall Study|Physician Decision|28|||
106119531|NCT00553202|366095831|FG000|Overall Study|Withdrawal by Subject|1|||
106119532|NCT00553202|366095831|FG000|Overall Study|No donor identified|16|||
106119533|NCT00553202|366095831|FG000|Overall Study|Fails to meet organ function|6|||
106119534|NCT04651114|366095832|FG000|Overall Study|Withdrawal by Subject|8|||
106119535|NCT01923896|366095833|FG000|Overall Study|Adverse Event|1|||
106119536|NCT01923896|366095834|FG001|Overall Study|Adverse Event|0|||
106119537|NCT00592319|366095835|FG000|Overall Study|Lost to Follow-up|0|||
106119538|NCT00592319|366095836|FG001|Overall Study|Lost to Follow-up|3|||
106119539|NCT00235443|366095839|FG000|Overall Study|Adverse Event|4|||
106119540|NCT00235443|366095840|FG001|Overall Study|Adverse Event|12|||
106119541|NCT00235443|366095841|FG002|Overall Study|Adverse Event|17|||
106119542|NCT00235443|366095842|FG003|Overall Study|Adverse Event|44|||
106119543|NCT00235443|366095843|FG004|Overall Study|Adverse Event|10|||
106119544|NCT00235443|366095844|FG005|Overall Study|Adverse Event|15|||
106119545|NCT00235443|366095839|FG000|Overall Study|Lack of Efficacy|0|||
106119546|NCT00235443|366095840|FG001|Overall Study|Lack of Efficacy|1|||
105662928|NCT03657576|364430050|FG000|Overall Study|Withdrawal by Subject|0|||
105662929|NCT03657576|364430051|FG001|Overall Study|Withdrawal by Subject|0|||
105662930|NCT03657576|364430052|FG002|Overall Study|Withdrawal by Subject|0|||
105662931|NCT03657576|364430053|FG003|Overall Study|Withdrawal by Subject|1|||
105785244|NCT02696382|364866425|FG001|Overall Study|Withdrawal by Subject|12|||
105995643|NCT03078556|365644153|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
106119547|NCT00235443|366095841|FG002|Overall Study|Lack of Efficacy|5|||
106119548|NCT00235443|366095842|FG003|Overall Study|Lack of Efficacy|12|||
106119549|NCT00235443|366095843|FG004|Overall Study|Lack of Efficacy|2|||
106119550|NCT00235443|366095844|FG005|Overall Study|Lack of Efficacy|9|||
106119551|NCT00235443|366095839|FG000|Overall Study|Withdrawal by Subject|3|||
106119552|NCT00235443|366095840|FG001|Overall Study|Withdrawal by Subject|9|||
106119553|NCT00235443|366095841|FG002|Overall Study|Withdrawal by Subject|25|||
106119554|NCT00235443|366095842|FG003|Overall Study|Withdrawal by Subject|24|||
106119555|NCT00235443|366095843|FG004|Overall Study|Withdrawal by Subject|10|||
106119556|NCT00235443|366095844|FG005|Overall Study|Withdrawal by Subject|12|||
106119557|NCT00235443|366095839|FG000|Overall Study|Lost to Follow-up|0|||
106119558|NCT00235443|366095840|FG001|Overall Study|Lost to Follow-up|8|||
106119559|NCT00235443|366095841|FG002|Overall Study|Lost to Follow-up|6|||
106119560|NCT00235443|366095842|FG003|Overall Study|Lost to Follow-up|6|||
105995644|NCT03078556|365644154|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
105995645|NCT03078556|365644155|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
105995646|NCT03078556|365644152|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
105995647|NCT03078556|365644153|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
105995648|NCT03078556|365644154|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
105995649|NCT03078556|365644155|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
105995650|NCT00832416|365644156|FG000|Overall Study|Lack of Efficacy|17|||
105995651|NCT00832416|365644157|FG001|Overall Study|Lack of Efficacy|15|||
105995652|NCT00832416|365644158|FG002|Overall Study|Lack of Efficacy|13|||
105995653|NCT00832416|365644159|FG003|Overall Study|Lack of Efficacy|52|||
105995654|NCT00832416|365644156|FG000|Overall Study|Withdrawal by Subject|5|||
105995655|NCT00832416|365644157|FG001|Overall Study|Withdrawal by Subject|7|||
105995656|NCT00832416|365644158|FG002|Overall Study|Withdrawal by Subject|2|||
105995657|NCT00832416|365644159|FG003|Overall Study|Withdrawal by Subject|10|||
105995658|NCT00832416|365644156|FG000|Overall Study|Physician Decision|2|||
106119561|NCT00235443|366095843|FG004|Overall Study|Lost to Follow-up|4|||
106119562|NCT00235443|366095844|FG005|Overall Study|Lost to Follow-up|3|||
105785245|NCT02696382|364866424|FG000|Overall Study|Lost to Follow-up|4|||
105785246|NCT02696382|364866425|FG001|Overall Study|Lost to Follow-up|7|||
105785247|NCT03417245|364866426|FG000|Overall Study|Adverse Event|1|||
105785248|NCT03417245|364866427|FG001|Overall Study|Adverse Event|0|||
105785249|NCT03417245|364866426|FG000|Overall Study|Protocol Violation|1|||
105785250|NCT03417245|364866427|FG001|Overall Study|Protocol Violation|0|||
105785251|NCT03417245|364866426|FG000|Overall Study|Withdrawal by Subject|1|||
105785252|NCT03417245|364866427|FG001|Overall Study|Withdrawal by Subject|1|||
105785253|NCT00229931|364866432|FG000|Overall Study|Death|1|||
105785254|NCT00229931|364866433|FG001|Overall Study|Death|0|||
105785255|NCT00229931|364866432|FG000|Overall Study|Lost to Follow-up|3|||
106119563|NCT00235443|366095839|FG000|Overall Study|Unsatisfactory compliance|0|||
106119564|NCT00235443|366095840|FG001|Overall Study|Unsatisfactory compliance|2|||
106119565|NCT00235443|366095841|FG002|Overall Study|Unsatisfactory compliance|3|||
106119566|NCT00235443|366095842|FG003|Overall Study|Unsatisfactory compliance|4|||
106119567|NCT00235443|366095843|FG004|Overall Study|Unsatisfactory compliance|1|||
106119568|NCT00235443|366095844|FG005|Overall Study|Unsatisfactory compliance|0|||
106119569|NCT00235443|366095839|FG000|Overall Study|Other reasons for premature termination|1|||
106119570|NCT00235443|366095840|FG001|Overall Study|Other reasons for premature termination|6|||
106119571|NCT00235443|366095841|FG002|Overall Study|Other reasons for premature termination|6|||
106119572|NCT00235443|366095842|FG003|Overall Study|Other reasons for premature termination|7|||
106119573|NCT00235443|366095843|FG004|Overall Study|Other reasons for premature termination|3|||
106119574|NCT00235443|366095844|FG005|Overall Study|Other reasons for premature termination|6|||
106119575|NCT03029247|366095845|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
106119576|NCT03029247|366095846|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
106119577|NCT03029247|366095845|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
106119578|NCT03029247|366095846|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
106119579|NCT03029247|366095845|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
106119580|NCT03029247|366095846|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
106119581|NCT03029247|366095845|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
106119582|NCT03029247|366095846|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
106119583|NCT01993017|366095849|FG000|Overall Study|Death|23|||
106119584|NCT01993017|366095850|FG001|Overall Study|Death|26|||
106119585|NCT01993017|366095851|FG002|Overall Study|Death|18|||
106119586|NCT01993017|366095849|FG000|Overall Study|Could not be contacted|43|||
106119587|NCT01993017|366095850|FG001|Overall Study|Could not be contacted|42|||
106119588|NCT01993017|366095851|FG002|Overall Study|Could not be contacted|38|||
106119589|NCT01993017|366095849|FG000|Overall Study|Dropped out|19|||
106119590|NCT01993017|366095850|FG001|Overall Study|Dropped out|6|||
106119591|NCT01993017|366095851|FG002|Overall Study|Dropped out|11|||
106119592|NCT01993017|366095849|FG000|Overall Study|Other reasons|17|||
106119593|NCT01993017|366095850|FG001|Overall Study|Other reasons|11|||
106119594|NCT01993017|366095851|FG002|Overall Study|Other reasons|7|||
106119595|NCT01993017|366095849|FG000|Overall Study|Ineligible after randomization|4|||
105785256|NCT00229931|364866433|FG001|Overall Study|Lost to Follow-up|2|||
105785257|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
105785258|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
106119596|NCT01993017|366095850|FG001|Overall Study|Ineligible after randomization|5|||
106119597|NCT01993017|366095851|FG002|Overall Study|Ineligible after randomization|5|||
106119598|NCT01976364|366095852|FG000|Main Study (36 Months)|Adverse Event|63|||
106119599|NCT01976364|366095853|FG001|Main Study (36 Months)|Adverse Event|0|||
106119600|NCT01976364|366095854|FG002|Main Study (36 Months)|Adverse Event|0|||
106119601|NCT01976364|366095852|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
105785259|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
105785260|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
105785261|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
105785262|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
106119602|NCT01976364|366095853|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
106119603|NCT01976364|366095854|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
106119604|NCT01976364|366095852|FG000|Main Study (36 Months)|Other|13|||
106119605|NCT01976364|366095853|FG001|Main Study (36 Months)|Other|0|||
106119606|NCT01976364|366095854|FG002|Main Study (36 Months)|Other|0|||
106119607|NCT01976364|366095852|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
106119608|NCT01976364|366095853|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
106119609|NCT01976364|366095854|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
106119610|NCT01976364|366095852|FG000|Main Study (36 Months)|Medication error|1|||
106119611|NCT01976364|366095853|FG001|Main Study (36 Months)|Medication error|0|||
106119612|NCT01976364|366095854|FG002|Main Study (36 Months)|Medication error|0|||
106119613|NCT01976364|366095852|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
106119614|NCT01976364|366095853|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
106119615|NCT01976364|366095854|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
106119616|NCT01976364|366095852|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
106119617|NCT01976364|366095853|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
106119618|NCT01976364|366095854|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
106119619|NCT01976364|366095852|FG000|Main Study (36 Months)|Protocol Violation|13|||
106119620|NCT01976364|366095853|FG001|Main Study (36 Months)|Protocol Violation|0|||
106119621|NCT01976364|366095854|FG002|Main Study (36 Months)|Protocol Violation|0|||
106119622|NCT01976364|366095852|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
106119623|NCT01976364|366095853|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
106119624|NCT01976364|366095854|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
106119625|NCT01976364|366095852|FG000|Main Study (36 Months)|Death|5|||
106119626|NCT01976364|366095853|FG001|Main Study (36 Months)|Death|0|||
106119627|NCT01976364|366095854|FG002|Main Study (36 Months)|Death|0|||
106119628|NCT01976364|366095852|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
106119629|NCT01976364|366095853|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
106119630|NCT01976364|366095854|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
106119631|NCT01976364|366095852|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
106119632|NCT01976364|366095853|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
106119633|NCT01976364|366095854|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
106119634|NCT01976364|366095852|FG000|Sub-study (12 Months)|Protocol Violation|0|||
106119635|NCT01976364|366095853|FG001|Sub-study (12 Months)|Protocol Violation|1|||
106119636|NCT01976364|366095854|FG002|Sub-study (12 Months)|Protocol Violation|1|||
106119637|NCT01976364|366095852|FG000|Sub-study (12 Months)|Adverse Event|0|||
106119638|NCT01976364|366095853|FG001|Sub-study (12 Months)|Adverse Event|4|||
106119639|NCT01976364|366095854|FG002|Sub-study (12 Months)|Adverse Event|3|||
106119640|NCT01190215|366095855|FG000|Up to Month 6|Lost to Follow-up|2|||
106119641|NCT01190215|366095856|FG001|Up to Month 6|Lost to Follow-up|0|||
106119642|NCT02670538|366095857|FG000|Overall Study|Withdrawal of Consent|8|||
106119643|NCT02670538|366095858|FG001|Overall Study|Withdrawal of Consent|6|||
106119644|NCT02670538|366095859|FG002|Overall Study|Withdrawal of Consent|5|||
106119645|NCT02670538|366095857|FG000|Overall Study|Lost to Follow-up|8|||
106119646|NCT02670538|366095858|FG001|Overall Study|Lost to Follow-up|12|||
106119647|NCT02670538|366095859|FG002|Overall Study|Lost to Follow-up|7|||
106119648|NCT02670538|366095857|FG000|Overall Study|Adverse Event|5|||
106119649|NCT02670538|366095858|FG001|Overall Study|Adverse Event|5|||
106119650|NCT02670538|366095859|FG002|Overall Study|Adverse Event|11|||
106119651|NCT02670538|366095857|FG000|Overall Study|Lack of Efficacy|7|||
106119652|NCT02670538|366095858|FG001|Overall Study|Lack of Efficacy|1|||
106119653|NCT02670538|366095859|FG002|Overall Study|Lack of Efficacy|2|||
106119654|NCT02670538|366095857|FG000|Overall Study|Protocol Violation|3|||
106119655|NCT02670538|366095858|FG001|Overall Study|Protocol Violation|4|||
106119656|NCT02670538|366095859|FG002|Overall Study|Protocol Violation|1|||
106119657|NCT02670538|366095857|FG000|Overall Study|Noncompliance with Study Drug|1|||
106119658|NCT02670538|366095858|FG001|Overall Study|Noncompliance with Study Drug|3|||
106119659|NCT02670538|366095859|FG002|Overall Study|Noncompliance with Study Drug|2|||
106119660|NCT02670538|366095857|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105662932|NCT03657576|364430054|FG004|Overall Study|Withdrawal by Subject|0|||
105662933|NCT03657576|364430055|FG005|Overall Study|Withdrawal by Subject|0|||
105662934|NCT03657576|364430050|FG000|Overall Study|Screen Fail|0|||
105662935|NCT03657576|364430051|FG001|Overall Study|Screen Fail|0|||
105662936|NCT03657576|364430052|FG002|Overall Study|Screen Fail|0|||
105662937|NCT03657576|364430053|FG003|Overall Study|Screen Fail|0|||
105662938|NCT03657576|364430054|FG004|Overall Study|Screen Fail|0|||
105662939|NCT03657576|364430055|FG005|Overall Study|Screen Fail|5|||
105662940|NCT03657576|364430050|FG000|Overall Study|Disease Progression|1|||
106119661|NCT02670538|366095858|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105662941|NCT03657576|364430051|FG001|Overall Study|Disease Progression|1|||
105662942|NCT03657576|364430052|FG002|Overall Study|Disease Progression|0|||
105662943|NCT03657576|364430053|FG003|Overall Study|Disease Progression|5|||
105662944|NCT03657576|364430054|FG004|Overall Study|Disease Progression|0|||
105662945|NCT03657576|364430055|FG005|Overall Study|Disease Progression|0|||
106119662|NCT02670538|366095859|FG002|Overall Study|Other Miscellaneous Reasons|2|||
105662946|NCT03657576|364430050|FG000|Overall Study|Insurance Coverage|0|||
105662947|NCT03657576|364430051|FG001|Overall Study|Insurance Coverage|0|||
105888377|NCT03452488|365245960|FG000|Overall Study|Death|0|||
105888378|NCT03452488|365245961|FG001|Overall Study|Death|0|||
105888379|NCT03452488|365245962|FG002|Overall Study|Death|1|||
105888380|NCT03452488|365245960|FG000|Overall Study|Lost to Follow-up|1|||
105888381|NCT03452488|365245961|FG001|Overall Study|Lost to Follow-up|2|||
105888382|NCT03452488|365245962|FG002|Overall Study|Lost to Follow-up|0|||
105888383|NCT03452488|365245960|FG000|Overall Study|PI Decision|1|||
105888384|NCT03452488|365245961|FG001|Overall Study|PI Decision|0|||
105888385|NCT03452488|365245962|FG002|Overall Study|PI Decision|0|||
105888386|NCT03452488|365245960|FG000|Overall Study|Withdrew consent|4|||
105888387|NCT03452488|365245961|FG001|Overall Study|Withdrew consent|2|||
105888388|NCT03452488|365245962|FG002|Overall Study|Withdrew consent|2|||
105888389|NCT03452488|365245960|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
105888390|NCT03452488|365245961|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
105888391|NCT03452488|365245962|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
105888392|NCT03452488|365245960|FG000|Overall Study|Other|0|||
105888393|NCT03452488|365245961|FG001|Overall Study|Other|2|||
105888394|NCT03452488|365245962|FG002|Overall Study|Other|2|||
105888395|NCT00623935|365245963|FG000|Overall Study|Death|1|||
105888396|NCT00623935|365245963|FG000|Overall Study|Patient Declined Transplant|1|||
105888397|NCT00355147|365245964|FG000|Overall Study|Lost to Follow-up|10|||
105888398|NCT00355147|365245965|FG001|Overall Study|Lost to Follow-up|8|||
105888399|NCT00355147|365245964|FG000|Overall Study|Withdrawal by Subject|8|||
105888400|NCT00355147|365245965|FG001|Overall Study|Withdrawal by Subject|12|||
105888401|NCT00747474|365245972|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888402|NCT00747474|365245973|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888403|NCT00747474|365245974|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888404|NCT00747474|365245975|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888405|NCT00747474|365245976|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888406|NCT00747474|365245977|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888407|NCT00747474|365245978|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888408|NCT00747474|365245979|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
106119663|NCT02291432|366095860|FG000|Overall Study|Withdrawal by Subject|2|||
106119664|NCT01928225|366095864|FG000|Overall Study|Pregnancy|1|||
106119665|NCT01928225|366095865|FG001|Overall Study|Pregnancy|0|||
106119666|NCT01928225|366095864|FG000|Overall Study|basaloid cervical cancer|1|||
106119667|NCT01928225|366095865|FG001|Overall Study|basaloid cervical cancer|0|||
106119668|NCT01928225|366095864|FG000|Overall Study|Lost to Follow-up|1|||
106119669|NCT01928225|366095865|FG001|Overall Study|Lost to Follow-up|3|||
106119670|NCT00152763|366095866|FG000|Overall Study|Death|4|||
106119671|NCT00152763|366095867|FG001|Overall Study|Death|1|||
106119672|NCT00152763|366095868|FG002|Overall Study|Death|2|||
106119673|NCT00152763|366095869|FG003|Overall Study|Death|1|||
106119674|NCT00152763|366095866|FG000|Overall Study|Lost to Follow-up|6|||
106119675|NCT00152763|366095867|FG001|Overall Study|Lost to Follow-up|4|||
106119676|NCT00152763|366095868|FG002|Overall Study|Lost to Follow-up|2|||
106119677|NCT00152763|366095869|FG003|Overall Study|Lost to Follow-up|13|||
106119678|NCT00584805|366095870|FG000|Overall Study|No longer at risk of exposure|39|||
106119679|NCT00584805|366095870|FG000|Overall Study|Relocation|36|||
106119680|NCT00584805|366095870|FG000|Overall Study|Withdrawal by Subject|18|||
106119681|NCT00584805|366095870|FG000|Overall Study|Non-compliance|1|||
106119682|NCT00584805|366095870|FG000|Overall Study|Lost to follow up|3|||
106119683|NCT00584805|366095870|FG000|Overall Study|Screen failures|2|||
106119684|NCT01235975|366095873|FG000|Overall Study|Serious Adverse Event|0|||
106119685|NCT01235975|366095874|FG001|Overall Study|Serious Adverse Event|1|||
106119686|NCT01235975|366095873|FG000|Overall Study|Withdrawal by Subject|8|||
106119687|NCT01235975|366095874|FG001|Overall Study|Withdrawal by Subject|2|||
106119688|NCT01235975|366095873|FG000|Overall Study|Migrated/moved from study area|2|||
106119689|NCT01235975|366095874|FG001|Overall Study|Migrated/moved from study area|1|||
106119690|NCT01235975|366095873|FG000|Overall Study|Lost to Follow-up|7|||
106119691|NCT01235975|366095874|FG001|Overall Study|Lost to Follow-up|3|||
106119692|NCT00365378|366095875|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
106119693|NCT00365378|366095876|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
106119694|NCT00365378|366095877|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
106119695|NCT00365378|366095875|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
106119696|NCT00365378|366095876|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
106119697|NCT00365378|366095877|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
106119698|NCT00365378|366095875|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
106119699|NCT00365378|366095876|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
106119700|NCT00365378|366095877|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
106119701|NCT00365378|366095875|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
106119702|NCT00365378|366095876|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
106119703|NCT00365378|366095877|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
106119704|NCT00365378|366095875|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
106119705|NCT00365378|366095876|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
106119706|NCT00365378|366095877|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
105785263|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
105785264|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
105785265|NCT01374516|364866448|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
105785266|NCT01374516|364866449|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
105785267|NCT01374516|364866448|FG000|Surveillance Expansion Period|Protocol Violation|386|||
105785268|NCT01374516|364866449|FG001|Surveillance Expansion Period|Protocol Violation|217|||
105785269|NCT01374516|364866448|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
105995659|NCT00832416|365644157|FG001|Overall Study|Physician Decision|12|||
105995660|NCT00832416|365644158|FG002|Overall Study|Physician Decision|5|||
105995661|NCT00832416|365644159|FG003|Overall Study|Physician Decision|10|||
105995662|NCT00832416|365644156|FG000|Overall Study|Administrative|0|||
105785270|NCT01374516|364866449|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
105785271|NCT01374516|364866448|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
105785272|NCT01374516|364866449|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
105785273|NCT01374516|364866448|FG000|Surveillance Expansion Period|Serious adverse event|20|||
105785274|NCT01374516|364866449|FG001|Surveillance Expansion Period|Serious adverse event|5|||
105785275|NCT00505765|364866453|FG000|Overall Study|Withdrawal by Subject|1|||
105785276|NCT00505765|364866454|FG001|Overall Study|Withdrawal by Subject|0|||
105785277|NCT00505765|364866455|FG002|Overall Study|Withdrawal by Subject|0|||
105785278|NCT00505765|364866453|FG000|Overall Study|Adverse Event|1|||
105785279|NCT00505765|364866454|FG001|Overall Study|Adverse Event|2|||
105785280|NCT00505765|364866455|FG002|Overall Study|Adverse Event|0|||
105785281|NCT00505765|364866453|FG000|Overall Study|Noncompliance|0|||
105785282|NCT00505765|364866454|FG001|Overall Study|Noncompliance|1|||
105785283|NCT00505765|364866455|FG002|Overall Study|Noncompliance|3|||
105785284|NCT03219372|364866456|FG000|Overall Study|Withdrawal by Subject|1|||
105785285|NCT03219372|364866457|FG001|Overall Study|Withdrawal by Subject|0|||
105785286|NCT04145531|364866461|FG000|Part A|Adverse Event|2|||
105785287|NCT04145531|364866462|FG001|Part A|Adverse Event|12|||
105785288|NCT04145531|364866463|FG002|Part A|Adverse Event|6|||
105785289|NCT04145531|364866464|FG003|Part A|Adverse Event|0|||
105785290|NCT04145531|364866461|FG000|Part A|Death|1|||
105785291|NCT04145531|364866462|FG001|Part A|Death|2|||
105785292|NCT04145531|364866463|FG002|Part A|Death|0|||
105785293|NCT04145531|364866464|FG003|Part A|Death|0|||
105785294|NCT04145531|364866461|FG000|Part A|Physician Decision|2|||
105785295|NCT04145531|364866462|FG001|Part A|Physician Decision|5|||
105785296|NCT04145531|364866463|FG002|Part A|Physician Decision|2|||
105785297|NCT04145531|364866464|FG003|Part A|Physician Decision|0|||
105785298|NCT04145531|364866461|FG000|Part A|Progressive disease|0|||
105785299|NCT04145531|364866462|FG001|Part A|Progressive disease|2|||
105785300|NCT04145531|364866463|FG002|Part A|Progressive disease|1|||
105785301|NCT04145531|364866464|FG003|Part A|Progressive disease|0|||
105995663|NCT00832416|365644157|FG001|Overall Study|Administrative|0|||
106119707|NCT00365378|366095875|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
106119708|NCT00365378|366095876|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
106119709|NCT00365378|366095877|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
106119710|NCT00365378|366095875|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
106119711|NCT00365378|366095876|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
106119712|NCT00365378|366095877|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
106119713|NCT00365378|366095875|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
106119714|NCT00365378|366095876|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
106119715|NCT00365378|366095877|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
106119716|NCT00365378|366095875|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
106119717|NCT00365378|366095876|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
106119718|NCT00365378|366095877|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
106119719|NCT00365378|366095875|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
106119720|NCT00365378|366095876|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
106119721|NCT00365378|366095877|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
106119722|NCT00365378|366095875|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
106119723|NCT00365378|366095876|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
106119724|NCT00365378|366095877|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
106119725|NCT00365378|366095875|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
106119726|NCT00365378|366095876|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
106119727|NCT00365378|366095877|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
106119728|NCT00365378|366095875|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
105785302|NCT04145531|364866461|FG000|Part A|Protocol deviation|0|||
105785303|NCT04145531|364866462|FG001|Part A|Protocol deviation|0|||
105785304|NCT04145531|364866463|FG002|Part A|Protocol deviation|1|||
105785305|NCT04145531|364866464|FG003|Part A|Protocol deviation|0|||
105785306|NCT04145531|364866461|FG000|Part A|Withdrawal by parent or guardian|1|||
105785307|NCT04145531|364866462|FG001|Part A|Withdrawal by parent or guardian|0|||
105785308|NCT04145531|364866463|FG002|Part A|Withdrawal by parent or guardian|0|||
105785309|NCT04145531|364866464|FG003|Part A|Withdrawal by parent or guardian|0|||
105785310|NCT04145531|364866461|FG000|Part A|Withdrawal by participant|0|||
106119729|NCT00365378|366095876|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
106119730|NCT00365378|366095877|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
106119731|NCT00365378|366095875|FG000|Extension|Adverse Event|0|||
106119732|NCT00365378|366095876|FG001|Extension|Adverse Event|0|||
106119733|NCT00365378|366095877|FG002|Extension|Adverse Event|1|||
106119734|NCT00365378|366095875|FG000|Extension|Moved|0|||
106119735|NCT00365378|366095876|FG001|Extension|Moved|0|||
106119736|NCT00365378|366095877|FG002|Extension|Moved|8|||
106119737|NCT00365378|366095875|FG000|Extension|Lost to Follow-up|0|||
106119738|NCT00365378|366095876|FG001|Extension|Lost to Follow-up|0|||
106119739|NCT00365378|366095877|FG002|Extension|Lost to Follow-up|57|||
106119740|NCT00365378|366095875|FG000|Extension|Protocol Violation|0|||
106119741|NCT00365378|366095876|FG001|Extension|Protocol Violation|0|||
106119742|NCT00365378|366095877|FG002|Extension|Protocol Violation|2|||
106119743|NCT00365378|366095875|FG000|Extension|Withdrawal by Subject|0|||
106119744|NCT00365378|366095876|FG001|Extension|Withdrawal by Subject|0|||
106119745|NCT00365378|366095877|FG002|Extension|Withdrawal by Subject|98|||
106119746|NCT00365378|366095875|FG000|Extension|Other|0|||
106119747|NCT00365378|366095876|FG001|Extension|Other|0|||
106119748|NCT00365378|366095877|FG002|Extension|Other|31|||
106119749|NCT02006121|366095881|FG000|Double Blind Phase|Adverse Event|6|||
106119750|NCT02006121|366095882|FG001|Double Blind Phase|Adverse Event|0|||
106119751|NCT02006121|366095881|FG000|Double Blind Phase|Lack of Efficacy|1|||
106119752|NCT02006121|366095882|FG001|Double Blind Phase|Lack of Efficacy|16|||
106119753|NCT02006121|366095881|FG000|Double Blind Phase|Withdrawal by Subject|3|||
106119754|NCT02006121|366095882|FG001|Double Blind Phase|Withdrawal by Subject|4|||
106119755|NCT02006121|366095881|FG000|Double Blind Phase|Non-compliance with study drug|1|||
106119756|NCT02006121|366095882|FG001|Double Blind Phase|Non-compliance with study drug|3|||
106119757|NCT02006121|366095881|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
106119758|NCT02006121|366095882|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
106119759|NCT02006121|366095881|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
106119760|NCT02006121|366095882|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
106119761|NCT02006121|366095881|FG000|Open Label Phase|Adverse Event|15|||
106119762|NCT02006121|366095882|FG001|Open Label Phase|Adverse Event|0|||
106119763|NCT02006121|366095881|FG000|Open Label Phase|Lack of Efficacy|2|||
106119764|NCT02006121|366095882|FG001|Open Label Phase|Lack of Efficacy|0|||
106119765|NCT02006121|366095881|FG000|Open Label Phase|Protocol Violation|2|||
106119766|NCT02006121|366095882|FG001|Open Label Phase|Protocol Violation|0|||
106119767|NCT02006121|366095881|FG000|Open Label Phase|Withdrawal by Subject|3|||
106119768|NCT02006121|366095882|FG001|Open Label Phase|Withdrawal by Subject|0|||
106119769|NCT02006121|366095881|FG000|Open Label Phase|Non-compliance with study drug|3|||
106119770|NCT02006121|366095882|FG001|Open Label Phase|Non-compliance with study drug|0|||
106119771|NCT02387216|366095886|FG000|Overall Study|Progressive disease|2|||
106119772|NCT02387216|366095887|FG001|Overall Study|Progressive disease|0|||
106119773|NCT02387216|366095886|FG000|Overall Study|Withdrawal by Subject|3|||
106119774|NCT02387216|366095887|FG001|Overall Study|Withdrawal by Subject|5|||
106119775|NCT02387216|366095886|FG000|Overall Study|Physician Decision|2|||
106119776|NCT02387216|366095887|FG001|Overall Study|Physician Decision|0|||
106119777|NCT02387216|366095886|FG000|Overall Study|Sponsor Decision|28|||
106119778|NCT02387216|366095887|FG001|Overall Study|Sponsor Decision|12|||
106119779|NCT02387216|366095886|FG000|Overall Study|Death|60|||
106119780|NCT02387216|366095887|FG001|Overall Study|Death|23|||
106119781|NCT02387216|366095886|FG000|Overall Study|Other|5|||
106119782|NCT02387216|366095887|FG001|Overall Study|Other|4|||
106119783|NCT02387216|366095886|FG000|Overall Study|Lost to Follow-up|0|||
106119784|NCT02387216|366095887|FG001|Overall Study|Lost to Follow-up|3|||
106119785|NCT04498247|366095888|FG000|Overall Study|Lost to Follow-up|0|||
106119786|NCT04498247|366095889|FG001|Overall Study|Lost to Follow-up|0|||
106119787|NCT04498247|366095890|FG002|Overall Study|Lost to Follow-up|0|||
106119788|NCT04498247|366095891|FG003|Overall Study|Lost to Follow-up|1|||
106119789|NCT04498247|366095892|FG004|Overall Study|Lost to Follow-up|0|||
106119790|NCT04498247|366095893|FG005|Overall Study|Lost to Follow-up|0|||
106119791|NCT04498247|366095894|FG006|Overall Study|Lost to Follow-up|0|||
106119792|NCT04498247|366095895|FG007|Overall Study|Lost to Follow-up|0|||
105662948|NCT03657576|364430052|FG002|Overall Study|Insurance Coverage|0|||
105785311|NCT04145531|364866462|FG001|Part A|Withdrawal by participant|0|||
105785312|NCT04145531|364866463|FG002|Part A|Withdrawal by participant|1|||
106119793|NCT04498247|366095888|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
106119794|NCT04498247|366095889|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
106119795|NCT04498247|366095890|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
106119796|NCT04498247|366095891|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
106119797|NCT04498247|366095892|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
106119798|NCT04498247|366095893|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
106119799|NCT04498247|366095894|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
106119800|NCT04498247|366095895|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
106119801|NCT04498247|366095888|FG000|Overall Study|Withdrawal by Subject|0|||
106119802|NCT04498247|366095889|FG001|Overall Study|Withdrawal by Subject|8|||
106119803|NCT04498247|366095890|FG002|Overall Study|Withdrawal by Subject|0|||
106119804|NCT04498247|366095891|FG003|Overall Study|Withdrawal by Subject|7|||
105888409|NCT00747474|365245980|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888410|NCT00747474|365245981|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888411|NCT00747474|365245982|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888412|NCT00747474|365245983|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
105888413|NCT01075646|365245984|FG000|Overall Study|Lost to Follow-up|4|||
105888414|NCT01075646|365245985|FG001|Overall Study|Lost to Follow-up|3|||
105888415|NCT01075646|365245986|FG002|Overall Study|Lost to Follow-up|1|||
106119805|NCT04498247|366095892|FG004|Overall Study|Withdrawal by Subject|0|||
106119806|NCT04498247|366095893|FG005|Overall Study|Withdrawal by Subject|0|||
106119807|NCT04498247|366095894|FG006|Overall Study|Withdrawal by Subject|1|||
106119808|NCT04498247|366095895|FG007|Overall Study|Withdrawal by Subject|0|||
106119809|NCT04498247|366095888|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
106119810|NCT04498247|366095889|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
106119811|NCT04498247|366095890|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
106119812|NCT04498247|366095891|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
106119813|NCT04498247|366095892|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
106119814|NCT04498247|366095893|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
106119815|NCT04498247|366095894|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
106119816|NCT04498247|366095895|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
106119817|NCT00192023|366095896|FG000|Period III - Double-Blind|Adverse Event|3|||
106119818|NCT00192023|366095897|FG001|Period III - Double-Blind|Adverse Event|0|||
106119819|NCT00192023|366095896|FG000|Period III - Double-Blind|Physician Decision|2|||
106119820|NCT00192023|366095897|FG001|Period III - Double-Blind|Physician Decision|0|||
106119821|NCT00192023|366095896|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
106119822|NCT00192023|366095897|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
106119823|NCT00192023|366095896|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
106119824|NCT00192023|366095897|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
106119825|NCT00192023|366095896|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
106119826|NCT00192023|366095897|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
106119827|NCT00192023|366095896|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
106119828|NCT00192023|366095897|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
106119829|NCT00192023|366095896|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
106119830|NCT00192023|366095897|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
106119831|NCT00192023|366095896|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
106119832|NCT00192023|366095897|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
106119833|NCT00192023|366095896|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
106119834|NCT00192023|366095897|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
106119835|NCT00192023|366095896|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
106119836|NCT00192023|366095897|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
106119837|NCT00669903|366095898|FG000|Overall Study|Adverse Event|0|||
106119838|NCT00669903|366095899|FG001|Overall Study|Adverse Event|1|||
106119839|NCT00669903|366095900|FG002|Overall Study|Adverse Event|3|||
106119840|NCT00669903|366095901|FG003|Overall Study|Adverse Event|1|||
106119841|NCT00669903|366095898|FG000|Overall Study|Withdrawal by Subject|0|||
106119842|NCT00669903|366095899|FG001|Overall Study|Withdrawal by Subject|2|||
106119843|NCT00669903|366095900|FG002|Overall Study|Withdrawal by Subject|2|||
106119844|NCT00669903|366095901|FG003|Overall Study|Withdrawal by Subject|2|||
106119845|NCT00669903|366095898|FG000|Overall Study|Lost to Follow-up|1|||
106119846|NCT00669903|366095899|FG001|Overall Study|Lost to Follow-up|1|||
106119847|NCT00669903|366095900|FG002|Overall Study|Lost to Follow-up|0|||
106119848|NCT00669903|366095901|FG003|Overall Study|Lost to Follow-up|1|||
106119849|NCT00669903|366095898|FG000|Overall Study|Protocol Violation|0|||
106119850|NCT00669903|366095899|FG001|Overall Study|Protocol Violation|1|||
106119851|NCT00669903|366095900|FG002|Overall Study|Protocol Violation|0|||
106119852|NCT00669903|366095901|FG003|Overall Study|Protocol Violation|0|||
106119853|NCT00779584|366095902|FG000|Overall Study|Protocol Violation|0|||
106119854|NCT00779584|366095903|FG001|Overall Study|Protocol Violation|0|||
106119855|NCT00779584|366095904|FG002|Overall Study|Protocol Violation|0|||
106119856|NCT00779584|366095905|FG003|Overall Study|Protocol Violation|0|||
106119857|NCT00779584|366095906|FG004|Overall Study|Protocol Violation|0|||
106119858|NCT00779584|366095907|FG005|Overall Study|Protocol Violation|1|||
106119859|NCT00779584|366095908|FG006|Overall Study|Protocol Violation|0|||
106119860|NCT00779584|366095909|FG007|Overall Study|Protocol Violation|0|||
106119861|NCT00779584|366095910|FG008|Overall Study|Protocol Violation|0|||
106119862|NCT00779584|366095902|FG000|Overall Study|Withdrawal by Subject|1|||
106119863|NCT00779584|366095903|FG001|Overall Study|Withdrawal by Subject|1|||
105995664|NCT00832416|365644158|FG002|Overall Study|Administrative|0|||
106119864|NCT00779584|366095904|FG002|Overall Study|Withdrawal by Subject|2|||
106119865|NCT00779584|366095905|FG003|Overall Study|Withdrawal by Subject|0|||
106119866|NCT00779584|366095906|FG004|Overall Study|Withdrawal by Subject|0|||
106119867|NCT00779584|366095907|FG005|Overall Study|Withdrawal by Subject|2|||
106119868|NCT00779584|366095908|FG006|Overall Study|Withdrawal by Subject|1|||
106119869|NCT00779584|366095909|FG007|Overall Study|Withdrawal by Subject|0|||
105995665|NCT00832416|365644159|FG003|Overall Study|Administrative|1|||
105995666|NCT00832416|365644156|FG000|Overall Study|Adverse Event|21|||
105995667|NCT00832416|365644157|FG001|Overall Study|Adverse Event|19|||
105995668|NCT00832416|365644158|FG002|Overall Study|Adverse Event|41|||
105995669|NCT00832416|365644159|FG003|Overall Study|Adverse Event|10|||
105995670|NCT00832416|365644156|FG000|Overall Study|Death|1|||
105995671|NCT00832416|365644157|FG001|Overall Study|Death|0|||
105995672|NCT00832416|365644158|FG002|Overall Study|Death|0|||
105995673|NCT00832416|365644159|FG003|Overall Study|Death|0|||
105995674|NCT00483405|365644160|FG000|Overall Study|Adverse Event|8|||
105995675|NCT00483405|365644160|FG000|Overall Study|Lack of Efficacy|14|||
105995676|NCT00483405|365644160|FG000|Overall Study|Death|3|||
105995677|NCT00483405|365644160|FG000|Overall Study|Withdrawal by Subject|2|||
105995678|NCT00483405|365644160|FG000|Overall Study|Other complicating disease|1|||
105995679|NCT03010319|365644161|FG000|Overall Study|Adverse Event|15|||
105995680|NCT03010319|365644162|FG001|Overall Study|Adverse Event|9|||
105995681|NCT03010319|365644161|FG000|Overall Study|Withdrawal by Subject|1|||
105995682|NCT03010319|365644162|FG001|Overall Study|Withdrawal by Subject|6|||
105995683|NCT03010319|365644161|FG000|Overall Study|Physician Decision|2|||
105995684|NCT03010319|365644162|FG001|Overall Study|Physician Decision|4|||
105995685|NCT03010319|365644161|FG000|Overall Study|Sponsor requested withdrawal|2|||
105995686|NCT03010319|365644162|FG001|Overall Study|Sponsor requested withdrawal|2|||
105995687|NCT03010319|365644161|FG000|Overall Study|Death|1|||
105995688|NCT03010319|365644162|FG001|Overall Study|Death|0|||
105995689|NCT03010319|365644161|FG000|Overall Study|Lost to Follow-up|0|||
105995690|NCT03010319|365644162|FG001|Overall Study|Lost to Follow-up|1|||
105995691|NCT03010319|365644161|FG000|Overall Study|Other Reason|5|||
105995692|NCT03010319|365644162|FG001|Overall Study|Other Reason|7|||
105995693|NCT05786508|365644163|FG000|Overall Study|Withdrawal by Subject|2|||
105995694|NCT05786508|365644164|FG001|Overall Study|Withdrawal by Subject|0|||
105995695|NCT03314987|365644165|FG000|Overall Study|Lost to Follow-up|13|||
105995696|NCT03314987|365644166|FG001|Overall Study|Lost to Follow-up|13|||
105995697|NCT04343755|365644169|FG000|Overall Study|Death|11|||
105995698|NCT04343755|365644169|FG000|Overall Study|Screen Failure|1|||
105995699|NCT01456169|365644170|FG000|Overall Study|Adverse Event|1|||
105995700|NCT01456169|365644171|FG001|Overall Study|Adverse Event|2|||
105995701|NCT01456169|365644172|FG002|Overall Study|Adverse Event|7|||
105995702|NCT01456169|365644170|FG000|Overall Study|Major Protocol Deviation|3|||
105995703|NCT01456169|365644171|FG001|Overall Study|Major Protocol Deviation|2|||
105995704|NCT01456169|365644172|FG002|Overall Study|Major Protocol Deviation|3|||
105995705|NCT01456169|365644170|FG000|Overall Study|Voluntary Withdrawal|3|||
105995706|NCT01456169|365644171|FG001|Overall Study|Voluntary Withdrawal|0|||
105995707|NCT01456169|365644172|FG002|Overall Study|Voluntary Withdrawal|2|||
105995708|NCT01456169|365644170|FG000|Overall Study|Lack of Efficacy|2|||
105995709|NCT01456169|365644171|FG001|Overall Study|Lack of Efficacy|0|||
105995710|NCT01456169|365644172|FG002|Overall Study|Lack of Efficacy|0|||
105995711|NCT01456169|365644170|FG000|Overall Study|Other|1|||
105995712|NCT01456169|365644171|FG001|Overall Study|Other|1|||
105995713|NCT01456169|365644172|FG002|Overall Study|Other|0|||
105995714|NCT02598297|365644173|FG000|Overall Study|Study terminated by Sponsor|21|||
105995715|NCT02598297|365644174|FG001|Overall Study|Study terminated by Sponsor|23|||
105995716|NCT02598297|365644173|FG000|Overall Study|Adverse Event|1|||
105995717|NCT02598297|365644174|FG001|Overall Study|Adverse Event|1|||
105995718|NCT02598297|365644173|FG000|Overall Study|Physician Decision|1|||
105995719|NCT02598297|365644174|FG001|Overall Study|Physician Decision|0|||
105995720|NCT02598297|365644173|FG000|Overall Study|Subject/guardian decision|1|||
105995721|NCT02598297|365644174|FG001|Overall Study|Subject/guardian decision|0|||
106119870|NCT00779584|366095910|FG008|Overall Study|Withdrawal by Subject|0|||
106119871|NCT00779584|366095902|FG000|Overall Study|Lost to Follow-up|0|||
106119872|NCT00779584|366095903|FG001|Overall Study|Lost to Follow-up|0|||
106119873|NCT00779584|366095904|FG002|Overall Study|Lost to Follow-up|0|||
106119874|NCT00779584|366095905|FG003|Overall Study|Lost to Follow-up|0|||
106119875|NCT00779584|366095906|FG004|Overall Study|Lost to Follow-up|1|||
106119876|NCT00779584|366095907|FG005|Overall Study|Lost to Follow-up|0|||
106119877|NCT00779584|366095908|FG006|Overall Study|Lost to Follow-up|0|||
106119878|NCT00779584|366095909|FG007|Overall Study|Lost to Follow-up|0|||
106119879|NCT00779584|366095910|FG008|Overall Study|Lost to Follow-up|0|||
106119880|NCT00779584|366095902|FG000|Overall Study|Progression of Disease|0|||
106119881|NCT00779584|366095903|FG001|Overall Study|Progression of Disease|1|||
106119882|NCT00779584|366095904|FG002|Overall Study|Progression of Disease|2|||
106119883|NCT00779584|366095905|FG003|Overall Study|Progression of Disease|6|||
106119884|NCT00779584|366095906|FG004|Overall Study|Progression of Disease|5|||
106119885|NCT00779584|366095907|FG005|Overall Study|Progression of Disease|1|||
106119886|NCT00779584|366095908|FG006|Overall Study|Progression of Disease|4|||
105995722|NCT02598297|365644173|FG000|Overall Study|Followed for survival|1|||
105995723|NCT02598297|365644174|FG001|Overall Study|Followed for survival|0|||
105995724|NCT00193206|365644175|FG000|Preoperative Therapy|Lack of Efficacy|2|||
105995725|NCT00193206|365644175|FG000|Preoperative Therapy|Adverse Event|2|||
106119887|NCT00779584|366095909|FG007|Overall Study|Progression of Disease|2|||
105995726|NCT00193206|365644175|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
105995727|NCT00193206|365644175|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
105995728|NCT00193206|365644175|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
105995729|NCT00193206|365644175|FG000|Postoperative Therapy|Physician Decision|3|||
105995730|NCT00193206|365644175|FG000|Postoperative Therapy|Intercurrent Illness|2|||
105995731|NCT00193206|365644175|FG000|Postoperative Therapy|Lack of Efficacy|1|||
105995732|NCT00193206|365644175|FG000|Postoperative Therapy|Protocol Violation|1|||
105995733|NCT02631551|365644177|FG000|Overall Study|Adverse Event|1|||
105995734|NCT02631551|365644178|FG001|Overall Study|Adverse Event|2|||
105995735|NCT02631551|365644179|FG002|Overall Study|Adverse Event|4|||
105995736|NCT02631551|365644180|FG003|Overall Study|Adverse Event|0|||
105995737|NCT02631551|365644177|FG000|Overall Study|Lack of Efficacy|0|||
105995738|NCT02631551|365644178|FG001|Overall Study|Lack of Efficacy|0|||
105995739|NCT02631551|365644179|FG002|Overall Study|Lack of Efficacy|1|||
105995740|NCT02631551|365644180|FG003|Overall Study|Lack of Efficacy|0|||
105995741|NCT02631551|365644177|FG000|Overall Study|Lost to Follow-up|1|||
105995742|NCT02631551|365644178|FG001|Overall Study|Lost to Follow-up|2|||
105995743|NCT02631551|365644179|FG002|Overall Study|Lost to Follow-up|0|||
105995744|NCT02631551|365644180|FG003|Overall Study|Lost to Follow-up|3|||
105995745|NCT02631551|365644177|FG000|Overall Study|Withdrawal by Subject|2|||
105995746|NCT02631551|365644178|FG001|Overall Study|Withdrawal by Subject|2|||
105995747|NCT02631551|365644179|FG002|Overall Study|Withdrawal by Subject|0|||
105995748|NCT02631551|365644180|FG003|Overall Study|Withdrawal by Subject|5|||
105995749|NCT02631551|365644177|FG000|Overall Study|Protocol deviation|3|||
105995750|NCT02631551|365644178|FG001|Overall Study|Protocol deviation|6|||
105995751|NCT02631551|365644179|FG002|Overall Study|Protocol deviation|3|||
105995752|NCT02631551|365644180|FG003|Overall Study|Protocol deviation|0|||
105995753|NCT02631551|365644177|FG000|Overall Study|Non-compliance with study procedures|0|||
105995754|NCT02631551|365644178|FG001|Overall Study|Non-compliance with study procedures|0|||
105995755|NCT02631551|365644179|FG002|Overall Study|Non-compliance with study procedures|1|||
105995756|NCT02631551|365644180|FG003|Overall Study|Non-compliance with study procedures|1|||
105995757|NCT02631551|365644177|FG000|Overall Study|Non-compliance with study drug|1|||
105995758|NCT02631551|365644178|FG001|Overall Study|Non-compliance with study drug|0|||
105995759|NCT02631551|365644179|FG002|Overall Study|Non-compliance with study drug|0|||
105995760|NCT02631551|365644180|FG003|Overall Study|Non-compliance with study drug|0|||
105995761|NCT02631551|365644177|FG000|Overall Study|Other, specific reasons not collected|5|||
105995762|NCT02631551|365644178|FG001|Overall Study|Other, specific reasons not collected|7|||
105995763|NCT02631551|365644179|FG002|Overall Study|Other, specific reasons not collected|2|||
105995764|NCT02631551|365644180|FG003|Overall Study|Other, specific reasons not collected|2|||
105995765|NCT01461707|365644181|FG000|Overall Study|Withdrawal by Subject|1|||
106119888|NCT00779584|366095910|FG008|Overall Study|Progression of Disease|1|||
106119889|NCT00779584|366095902|FG000|Overall Study|Adverse Event|1|||
106119890|NCT00779584|366095903|FG001|Overall Study|Adverse Event|0|||
106119891|NCT00779584|366095904|FG002|Overall Study|Adverse Event|2|||
106119892|NCT00779584|366095905|FG003|Overall Study|Adverse Event|0|||
106119893|NCT00779584|366095906|FG004|Overall Study|Adverse Event|0|||
106119894|NCT00779584|366095907|FG005|Overall Study|Adverse Event|0|||
106119895|NCT00779584|366095908|FG006|Overall Study|Adverse Event|2|||
106119896|NCT00779584|366095909|FG007|Overall Study|Adverse Event|1|||
106119897|NCT00779584|366095910|FG008|Overall Study|Adverse Event|1|||
106119898|NCT00779584|366095902|FG000|Overall Study|Symptomatic Deterioration|1|||
106119899|NCT00779584|366095903|FG001|Overall Study|Symptomatic Deterioration|1|||
106119900|NCT00779584|366095904|FG002|Overall Study|Symptomatic Deterioration|1|||
106119901|NCT00779584|366095905|FG003|Overall Study|Symptomatic Deterioration|0|||
106119902|NCT00779584|366095906|FG004|Overall Study|Symptomatic Deterioration|0|||
106119903|NCT00779584|366095907|FG005|Overall Study|Symptomatic Deterioration|1|||
106119904|NCT00779584|366095908|FG006|Overall Study|Symptomatic Deterioration|1|||
106119905|NCT00779584|366095909|FG007|Overall Study|Symptomatic Deterioration|0|||
106119906|NCT00779584|366095910|FG008|Overall Study|Symptomatic Deterioration|0|||
106119907|NCT00779584|366095902|FG000|Overall Study|Ongoing in Study|0|||
106119908|NCT00779584|366095903|FG001|Overall Study|Ongoing in Study|0|||
106119909|NCT00779584|366095904|FG002|Overall Study|Ongoing in Study|0|||
105995766|NCT01461707|365644182|FG001|Overall Study|Withdrawal by Subject|0|||
105995767|NCT01450761|365644183|FG000|Randomization|Subject no longer meets study criteria|1|||
105995768|NCT01450761|365644184|FG001|Randomization|Subject no longer meets study criteria|2|||
106119910|NCT00779584|366095905|FG003|Overall Study|Ongoing in Study|0|||
105662949|NCT03657576|364430053|FG003|Overall Study|Insurance Coverage|1|||
105995769|NCT01450761|365644183|FG000|Randomization|Withdrawal by Subject|2|||
105995770|NCT01450761|365644184|FG001|Randomization|Withdrawal by Subject|0|||
105995771|NCT01450761|365644183|FG000|Randomization|Disease progression|0|||
105995772|NCT01450761|365644184|FG001|Randomization|Disease progression|2|||
106119911|NCT00779584|366095906|FG004|Overall Study|Ongoing in Study|1|||
106119912|NCT00779584|366095907|FG005|Overall Study|Ongoing in Study|1|||
106119913|NCT00779584|366095908|FG006|Overall Study|Ongoing in Study|0|||
106119914|NCT00779584|366095909|FG007|Overall Study|Ongoing in Study|0|||
106119915|NCT00779584|366095910|FG008|Overall Study|Ongoing in Study|0|||
105662950|NCT03657576|364430054|FG004|Overall Study|Insurance Coverage|0|||
105662951|NCT03657576|364430055|FG005|Overall Study|Insurance Coverage|0|||
105662952|NCT00409409|364430058|FG000|Overall Study|Adverse Event|7|||
105662953|NCT00409409|364430059|FG001|Overall Study|Adverse Event|2|||
105662954|NCT00409409|364430058|FG000|Overall Study|Withdrawal by Subject|1|||
105662955|NCT00409409|364430059|FG001|Overall Study|Withdrawal by Subject|1|||
105662956|NCT00409409|364430058|FG000|Overall Study|Any other reason not above-mentioned|0|||
105662957|NCT00409409|364430059|FG001|Overall Study|Any other reason not above-mentioned|1|||
105662958|NCT02196077|364430060|FG000|Overall Study|Adverse Event|4|||
105662959|NCT02196077|364430060|FG000|Overall Study|Lack of Efficacy|1|||
105662960|NCT02196077|364430060|FG000|Overall Study|Withdrawal by Subject|14|||
105662961|NCT02196077|364430060|FG000|Overall Study|Physician Decision|1|||
105662962|NCT02196077|364430060|FG000|Overall Study|Lost to Follow-up|3|||
105662963|NCT02196077|364430060|FG000|Overall Study|Protocol Violation|24|||
105662964|NCT01407276|364430063|FG000|Overall Study|Withdrawal by Subject|0|||
105662965|NCT01407276|364430064|FG001|Overall Study|Withdrawal by Subject|0|||
105662966|NCT01407276|364430065|FG002|Overall Study|Withdrawal by Subject|0|||
105662967|NCT01407276|364430066|FG003|Overall Study|Withdrawal by Subject|0|||
105662968|NCT01407276|364430067|FG004|Overall Study|Withdrawal by Subject|0|||
105662969|NCT01407276|364430068|FG005|Overall Study|Withdrawal by Subject|0|||
105662970|NCT01407276|364430069|FG006|Overall Study|Withdrawal by Subject|0|||
105662971|NCT01407276|364430070|FG007|Overall Study|Withdrawal by Subject|1|||
105995773|NCT01450761|365644183|FG000|Randomization|Adverse Event unrelated to study drug|1|||
105995774|NCT01450761|365644184|FG001|Randomization|Adverse Event unrelated to study drug|0|||
105995775|NCT01450761|365644183|FG000|Randomization|Other|0|||
105995776|NCT01450761|365644184|FG001|Randomization|Other|1|||
105995777|NCT01450761|365644183|FG000|Lead-in Chemotherapy|Disease progression|33|||
105995778|NCT01450761|365644184|FG001|Lead-in Chemotherapy|Disease progression|32|||
105662972|NCT03513068|364430071|FG000|Overall Study|Death|1|||
105662973|NCT03513068|364430072|FG001|Overall Study|Death|0|||
105662974|NCT03513068|364430071|FG000|Overall Study|Withdrawal by Subject|4|||
105662975|NCT03513068|364430072|FG001|Overall Study|Withdrawal by Subject|6|||
105662976|NCT04887506|364430086|FG000|Overall Study|Death|1|||
105662977|NCT04887506|364430087|FG001|Overall Study|Death|1|||
105995779|NCT01450761|365644183|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
105995780|NCT01450761|365644184|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
105995781|NCT01450761|365644183|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
105995782|NCT01450761|365644184|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
105995783|NCT01450761|365644183|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
105995784|NCT01450761|365644184|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
105995785|NCT01450761|365644183|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
105662978|NCT04887506|364430086|FG000|Overall Study|Withdrawal by Subject|0|||
105995786|NCT01450761|365644184|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
105995787|NCT01450761|365644183|FG000|Lead-in Chemotherapy|Death|3|||
105995788|NCT01450761|365644184|FG001|Lead-in Chemotherapy|Death|3|||
105995789|NCT01450761|365644183|FG000|Lead-in Chemotherapy|Other|2|||
105995790|NCT01450761|365644184|FG001|Lead-in Chemotherapy|Other|2|||
105995791|NCT01450761|365644183|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
105995792|NCT01450761|365644184|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
105995793|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
105995794|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
105995795|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
105995796|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
105995797|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
105995798|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
105995799|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
105995800|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
105995801|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
105995802|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
105995803|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Death|5|||
105995804|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Death|6|||
105995805|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
105995806|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
105662979|NCT04887506|364430087|FG001|Overall Study|Withdrawal by Subject|3|||
105662980|NCT04887506|364430086|FG000|Overall Study|Adverse Event|4|||
105662981|NCT04887506|364430087|FG001|Overall Study|Adverse Event|3|||
105662982|NCT04887506|364430086|FG000|Overall Study|Other - Not Reported|1|||
105662983|NCT04887506|364430087|FG001|Overall Study|Other - Not Reported|1|||
106119916|NCT01003639|366095913|FG000|Overall Study|Lost to Follow-up|6|||
105662984|NCT01262092|364430088|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
105662985|NCT01262092|364430089|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
105662986|NCT01262092|364430088|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
105888416|NCT01075646|365245987|FG003|Overall Study|Lost to Follow-up|2|||
105888417|NCT01053962|365245989|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
105888418|NCT01053962|365245990|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
105888419|NCT01053962|365245991|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
105888420|NCT01053962|365245992|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
105888421|NCT01053962|365245993|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
105888422|NCT01053962|365245989|FG000|Pretreatment Period|Venipuncture Failure|0|||
105888423|NCT01053962|365245990|FG001|Pretreatment Period|Venipuncture Failure|0|||
105888424|NCT01053962|365245991|FG002|Pretreatment Period|Venipuncture Failure|1|||
105888425|NCT01053962|365245992|FG003|Pretreatment Period|Venipuncture Failure|0|||
105888426|NCT01053962|365245993|FG004|Pretreatment Period|Venipuncture Failure|0|||
105888427|NCT01053962|365245989|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
105888428|NCT01053962|365245990|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
105888429|NCT01053962|365245991|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
105888430|NCT01053962|365245992|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
105888431|NCT01053962|365245993|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
105888432|NCT01053962|365245989|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
105888433|NCT01053962|365245990|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
105888434|NCT01053962|365245991|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
105888435|NCT01053962|365245992|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
105888436|NCT01053962|365245993|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
105888437|NCT01053962|365245989|FG000|Treatment Period|Lack of Efficacy|0|||
105888438|NCT01053962|365245990|FG001|Treatment Period|Lack of Efficacy|0|||
105888439|NCT01053962|365245991|FG002|Treatment Period|Lack of Efficacy|0|||
105888440|NCT01053962|365245992|FG003|Treatment Period|Lack of Efficacy|0|||
105888441|NCT01053962|365245993|FG004|Treatment Period|Lack of Efficacy|1|||
105888442|NCT01053962|365245989|FG000|Treatment Period|Adverse Event|0|||
105888443|NCT01053962|365245990|FG001|Treatment Period|Adverse Event|0|||
105888444|NCT01053962|365245991|FG002|Treatment Period|Adverse Event|0|||
105888445|NCT01053962|365245992|FG003|Treatment Period|Adverse Event|0|||
105888446|NCT01053962|365245993|FG004|Treatment Period|Adverse Event|1|||
105888447|NCT01053962|365245989|FG000|Treatment Period|Withdrawal by Subject|0|||
105888448|NCT01053962|365245990|FG001|Treatment Period|Withdrawal by Subject|0|||
105888449|NCT01053962|365245991|FG002|Treatment Period|Withdrawal by Subject|0|||
105888450|NCT01053962|365245992|FG003|Treatment Period|Withdrawal by Subject|0|||
105888451|NCT01053962|365245993|FG004|Treatment Period|Withdrawal by Subject|1|||
105888452|NCT01053962|365245989|FG000|Treatment Period|Noncompliance with protocol|1|||
105888453|NCT01053962|365245990|FG001|Treatment Period|Noncompliance with protocol|0|||
105888454|NCT01053962|365245991|FG002|Treatment Period|Noncompliance with protocol|0|||
105888455|NCT01053962|365245992|FG003|Treatment Period|Noncompliance with protocol|0|||
105888456|NCT01053962|365245993|FG004|Treatment Period|Noncompliance with protocol|0|||
105888457|NCT01023256|365245994|FG000|Overall Study|Protocol Violation|2|||
105888458|NCT01023256|365245995|FG001|Overall Study|Protocol Violation|3|||
105888459|NCT01023256|365245996|FG002|Overall Study|Protocol Violation|0|||
105888460|NCT01023256|365245997|FG003|Overall Study|Protocol Violation|0|||
105888461|NCT01023256|365245994|FG000|Overall Study|Randomized but not treated|1|||
105888462|NCT01023256|365245995|FG001|Overall Study|Randomized but not treated|0|||
105888463|NCT01023256|365245996|FG002|Overall Study|Randomized but not treated|1|||
105888464|NCT01023256|365245997|FG003|Overall Study|Randomized but not treated|0|||
105888465|NCT01023256|365245994|FG000|Overall Study|Other|1|||
105888466|NCT01023256|365245995|FG001|Overall Study|Other|0|||
105888467|NCT01023256|365245996|FG002|Overall Study|Other|0|||
105888468|NCT01023256|365245997|FG003|Overall Study|Other|2|||
105888469|NCT01023256|365245994|FG000|Overall Study|Adverse Event|0|||
106119917|NCT01003639|366095914|FG001|Overall Study|Lost to Follow-up|9|||
106119918|NCT01003639|366095913|FG000|Overall Study|Withdrawal by Subject|9|||
106119919|NCT01003639|366095914|FG001|Overall Study|Withdrawal by Subject|5|||
106119920|NCT01003639|366095913|FG000|Overall Study|Lack of Efficacy|1|||
106119921|NCT01003639|366095914|FG001|Overall Study|Lack of Efficacy|6|||
106119922|NCT01003639|366095913|FG000|Overall Study|Adverse Event|0|||
106119923|NCT01003639|366095914|FG001|Overall Study|Adverse Event|1|||
106119924|NCT01003639|366095913|FG000|Overall Study|Protocol Violation|0|||
106119925|NCT01003639|366095914|FG001|Overall Study|Protocol Violation|1|||
106119926|NCT01003639|366095913|FG000|Overall Study|Physician Decision|1|||
106119927|NCT01003639|366095914|FG001|Overall Study|Physician Decision|0|||
106119928|NCT02690077|366095918|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
106119929|NCT02690077|366095919|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
106119930|NCT02690077|366095918|FG000|Overall Study|Withdrawal by Subject|0|||
106119931|NCT02690077|366095919|FG001|Overall Study|Withdrawal by Subject|5|||
106119932|NCT02690077|366095918|FG000|Overall Study|Excluded by IRB|0|||
105888470|NCT01023256|365245995|FG001|Overall Study|Adverse Event|0|||
105888471|NCT01023256|365245996|FG002|Overall Study|Adverse Event|0|||
105888472|NCT01023256|365245997|FG003|Overall Study|Adverse Event|1|||
106119933|NCT02690077|366095919|FG001|Overall Study|Excluded by IRB|2|||
106119934|NCT04186403|366095920|FG000|Overall Study|Adverse Event|1|||
105662987|NCT01262092|364430089|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
105662988|NCT01262092|364430088|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
105662989|NCT01262092|364430089|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
105662990|NCT01262092|364430088|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
105662991|NCT01262092|364430089|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
105662992|NCT03784820|364430090|FG000|Overall Study|Lost to Follow-up|5|||
105662993|NCT03784820|364430091|FG001|Overall Study|Lost to Follow-up|5|||
105662994|NCT03784820|364430092|FG002|Overall Study|Lost to Follow-up|3|||
105662995|NCT03784820|364430093|FG003|Overall Study|Lost to Follow-up|3|||
105662996|NCT05613088|364430096|FG000|Treatment|Ongoing Study Treatment|9|||
105662997|NCT05613088|364430097|FG001|Treatment|Ongoing Study Treatment|2|||
105662998|NCT05613088|364430096|FG000|Treatment|Adverse Event|3|||
105662999|NCT05613088|364430097|FG001|Treatment|Adverse Event|1|||
105663000|NCT05613088|364430096|FG000|Treatment|Other Reasons|0|||
105663001|NCT05613088|364430097|FG001|Treatment|Other Reasons|1|||
105663002|NCT05613088|364430096|FG000|Treatment|Progressive Disease|58|||
105663003|NCT05613088|364430097|FG001|Treatment|Progressive Disease|26|||
105663004|NCT05613088|364430096|FG000|Treatment|Withdrawal by Subject|0|||
105663005|NCT05613088|364430097|FG001|Treatment|Withdrawal by Subject|4|||
105663006|NCT03842436|364430098|FG000|Overall Study|Lost to Follow-up|1|||
105663007|NCT04277507|364430099|FG000|Overall Study|Lost to Follow-up|17|||
105663008|NCT04277507|364430099|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
105663009|NCT04277507|364430099|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
105663010|NCT04277507|364430099|FG000|Overall Study|Withdrawal by Subject|3|||
105663011|NCT04277507|364430099|FG000|Overall Study|Death due to COVID-19|1|||
105663012|NCT04277507|364430099|FG000|Overall Study|Data missing for full evaluation|5|||
105663013|NCT03732677|364430103|FG000|Overall Study|Terminated the study|154|||
105663014|NCT03732677|364430104|FG001|Overall Study|Terminated the study|197|||
105663015|NCT03732677|364430103|FG000|Overall Study|Continuing study off treatment|379|||
105663016|NCT03732677|364430104|FG001|Overall Study|Continuing study off treatment|333|||
105663017|NCT04013971|364430105|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
105663018|NCT04013971|364430106|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
105663019|NCT04013971|364430105|FG000|Overall Study|Missing biomechanical data|0|||
105663020|NCT04013971|364430106|FG001|Overall Study|Missing biomechanical data|1|||
105663021|NCT02194829|364430115|FG000|Overall Study|Adverse Event|2|||
105663022|NCT02194829|364430116|FG001|Overall Study|Adverse Event|2|||
105663023|NCT02194829|364430115|FG000|Overall Study|Death|0|||
105663024|NCT02194829|364430116|FG001|Overall Study|Death|1|||
105663025|NCT02194829|364430115|FG000|Overall Study|Disease progression|0|||
105663026|NCT02194829|364430116|FG001|Overall Study|Disease progression|1|||
105663027|NCT02194829|364430115|FG000|Overall Study|Withdrawal by Subject|0|||
105663028|NCT02194829|364430116|FG001|Overall Study|Withdrawal by Subject|1|||
105663029|NCT02194829|364430115|FG000|Overall Study|Never started protocol therapy|0|||
105663030|NCT02194829|364430116|FG001|Overall Study|Never started protocol therapy|1|||
105663031|NCT02065882|364430119|FG000|Part I: PK/PD|Screening failure|5|||
105663032|NCT02065882|364430119|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
105785313|NCT04145531|364866464|FG003|Part A|Withdrawal by participant|0|||
105663033|NCT02065882|364430119|FG000|Part I: PK/PD|Adverse Event|1|||
105663034|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Screening failure|7|||
105663035|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
105663036|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
105663037|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
105663038|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
105663039|NCT02065882|364430119|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
105663040|NCT06719986|364430120|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
105785314|NCT04145531|364866461|FG000|Part A|Other|0|||
105785315|NCT04145531|364866462|FG001|Part A|Other|0|||
105785316|NCT04145531|364866463|FG002|Part A|Other|1|||
105785317|NCT04145531|364866464|FG003|Part A|Other|0|||
105785318|NCT04145531|364866461|FG000|Part B|Adverse Event|0|||
105785319|NCT04145531|364866462|FG001|Part B|Adverse Event|0|||
105785320|NCT04145531|364866463|FG002|Part B|Adverse Event|0|||
105785321|NCT04145531|364866464|FG003|Part B|Adverse Event|21|||
105785322|NCT04145531|364866461|FG000|Part B|Physician Decision|0|||
105785323|NCT04145531|364866462|FG001|Part B|Physician Decision|0|||
105785324|NCT04145531|364866463|FG002|Part B|Physician Decision|0|||
105785325|NCT04145531|364866464|FG003|Part B|Physician Decision|7|||
105785326|NCT04145531|364866461|FG000|Part B|Progressive disease|0|||
105785327|NCT04145531|364866462|FG001|Part B|Progressive disease|0|||
105785328|NCT04145531|364866463|FG002|Part B|Progressive disease|0|||
105785329|NCT04145531|364866464|FG003|Part B|Progressive disease|1|||
105785330|NCT04145531|364866461|FG000|Part B|Recurrent disease|0|||
105785331|NCT04145531|364866462|FG001|Part B|Recurrent disease|0|||
105785332|NCT04145531|364866463|FG002|Part B|Recurrent disease|0|||
105785333|NCT04145531|364866464|FG003|Part B|Recurrent disease|1|||
105785334|NCT04145531|364866461|FG000|Part B|Withdrawal by parent or guardian|0|||
105785335|NCT04145531|364866462|FG001|Part B|Withdrawal by parent or guardian|0|||
106119935|NCT04186403|366095921|FG001|Overall Study|Adverse Event|8|||
106119936|NCT04186403|366095920|FG000|Overall Study|Lost to Follow-up|7|||
106119937|NCT04186403|366095921|FG001|Overall Study|Lost to Follow-up|3|||
106119938|NCT04186403|366095920|FG000|Overall Study|Physician Decision|1|||
106119939|NCT04186403|366095921|FG001|Overall Study|Physician Decision|0|||
106119940|NCT04186403|366095920|FG000|Overall Study|Withdrawal by Subject|7|||
106119941|NCT04186403|366095921|FG001|Overall Study|Withdrawal by Subject|8|||
106119942|NCT04186403|366095920|FG000|Overall Study|Other: Not Related to Covid-19|3|||
106119943|NCT04186403|366095921|FG001|Overall Study|Other: Not Related to Covid-19|0|||
106119944|NCT01407354|366095925|FG000|First Intervention|Withdrawal by Subject|0|||
106119945|NCT01407354|366095926|FG001|First Intervention|Withdrawal by Subject|2|||
106119946|NCT01407354|366095925|FG000|First Intervention|Adverse Event|1|||
106119947|NCT01407354|366095926|FG001|First Intervention|Adverse Event|0|||
106119948|NCT01407354|366095925|FG000|First Intervention|Physician Decision|1|||
106119949|NCT01407354|366095926|FG001|First Intervention|Physician Decision|0|||
106119950|NCT02778399|366095927|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
106119951|NCT02778399|366095928|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
106119952|NCT02778399|366095929|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
106119953|NCT02778399|366095930|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
106119954|NCT02778399|366095931|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
106119955|NCT02778399|366095932|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
106119956|NCT02778399|366095927|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
106119957|NCT02778399|366095928|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
106119958|NCT02778399|366095929|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
106119959|NCT02778399|366095930|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
106119960|NCT02778399|366095931|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
106119961|NCT02778399|366095932|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
106119962|NCT02778399|366095927|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
106119963|NCT02778399|366095928|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
106119964|NCT02778399|366095929|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
106119965|NCT02778399|366095930|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
106119966|NCT02778399|366095931|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
106119967|NCT02778399|366095932|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
106119968|NCT02778399|366095927|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
106119969|NCT02778399|366095928|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
106119970|NCT02778399|366095929|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
106119971|NCT02778399|366095930|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
106119972|NCT02778399|366095931|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
106119973|NCT02778399|366095932|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
105785336|NCT04145531|364866463|FG002|Part B|Withdrawal by parent or guardian|0|||
105785337|NCT04145531|364866464|FG003|Part B|Withdrawal by parent or guardian|3|||
105785338|NCT04145531|364866461|FG000|Part B|Withdrawal by participant|0|||
105785339|NCT04145531|364866462|FG001|Part B|Withdrawal by participant|0|||
105785340|NCT04145531|364866463|FG002|Part B|Withdrawal by participant|0|||
105785341|NCT04145531|364866464|FG003|Part B|Withdrawal by participant|1|||
105785342|NCT04145531|364866461|FG000|Part B|Other|0|||
105785343|NCT04145531|364866462|FG001|Part B|Other|0|||
105785344|NCT04145531|364866463|FG002|Part B|Other|0|||
105785345|NCT04145531|364866464|FG003|Part B|Other|1|||
105785346|NCT02985996|364866465|FG000|Overall Study|Withdrawal by Subject|0|||
105785347|NCT02985996|364866466|FG001|Overall Study|Withdrawal by Subject|0|||
105785348|NCT02985996|364866467|FG002|Overall Study|Withdrawal by Subject|1|||
105785349|NCT02985996|364866468|FG003|Overall Study|Withdrawal by Subject|0|||
105785350|NCT02985996|364866469|FG004|Overall Study|Withdrawal by Subject|0|||
105785351|NCT02985996|364866465|FG000|Overall Study|Protocol Violation|0|||
105785352|NCT02985996|364866466|FG001|Overall Study|Protocol Violation|1|||
105785353|NCT02985996|364866467|FG002|Overall Study|Protocol Violation|0|||
105785354|NCT02985996|364866468|FG003|Overall Study|Protocol Violation|0|||
105785355|NCT02985996|364866469|FG004|Overall Study|Protocol Violation|0|||
105785356|NCT04837807|364866471|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
105785357|NCT04837807|364866472|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
105785358|NCT03732534|364866473|FG000|Overall Study|Study terminated by Sponsor|6|||
105785359|NCT02058849|364866476|FG000|Overall Study|Hospitalization|1|||
105785360|NCT02058849|364866477|FG001|Overall Study|Hospitalization|1|||
105785361|NCT02058849|364866476|FG000|Overall Study|Death|1|||
105785362|NCT02058849|364866477|FG001|Overall Study|Death|0|||
105785363|NCT02058849|364866476|FG000|Overall Study|Lost to Follow-up|1|||
105785364|NCT02058849|364866477|FG001|Overall Study|Lost to Follow-up|0|||
105785365|NCT02058849|364866476|FG000|Overall Study|Withdrawal by Subject|4|||
105785366|NCT02058849|364866477|FG001|Overall Study|Withdrawal by Subject|0|||
105785367|NCT00976989|364866484|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
105785368|NCT00976989|364866485|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
105785369|NCT00976989|364866486|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
105888473|NCT01023256|365245994|FG000|Overall Study|Withdrawal by Subject|0|||
105888474|NCT01023256|365245995|FG001|Overall Study|Withdrawal by Subject|0|||
105888475|NCT01023256|365245996|FG002|Overall Study|Withdrawal by Subject|0|||
105888476|NCT01023256|365245997|FG003|Overall Study|Withdrawal by Subject|2|||
105888477|NCT03089697|365245998|FG000|Overall Study|Adverse Event|1|||
105888478|NCT03089697|365245999|FG001|Overall Study|Adverse Event|2|||
105888479|NCT03089697|365245998|FG000|Overall Study|Withdrawal by Subject|1|||
105888480|NCT03089697|365245999|FG001|Overall Study|Withdrawal by Subject|0|||
105888481|NCT00937040|365246000|FG000|Overall Study|Adverse Event|5|||
106119974|NCT02778399|366095927|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
106119975|NCT02778399|366095928|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
106119976|NCT02778399|366095929|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
106119977|NCT02778399|366095930|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
106119978|NCT02778399|366095931|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
106119979|NCT02778399|366095932|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
106119980|NCT02778399|366095927|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
106119981|NCT02778399|366095928|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
106119982|NCT02778399|366095929|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
106119983|NCT02778399|366095930|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
106119984|NCT02778399|366095931|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
105888482|NCT00937040|365246001|FG001|Overall Study|Adverse Event|8|||
105888483|NCT00937040|365246000|FG000|Overall Study|Lost to Follow-up|12|||
105888484|NCT00937040|365246001|FG001|Overall Study|Lost to Follow-up|12|||
105888485|NCT00937040|365246000|FG000|Overall Study|Protocol Violation|3|||
105888486|NCT00937040|365246001|FG001|Overall Study|Protocol Violation|0|||
105888487|NCT00937040|365246000|FG000|Overall Study|Withdrawal by Subject|13|||
105888488|NCT00937040|365246001|FG001|Overall Study|Withdrawal by Subject|7|||
105888489|NCT00937040|365246000|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
105888490|NCT00937040|365246001|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
105888491|NCT00937040|365246000|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
105888492|NCT00937040|365246001|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
105888493|NCT03852628|365246007|FG000|Overall Study|Lost to Follow-up|7|||
105888494|NCT03852628|365246008|FG001|Overall Study|Lost to Follow-up|6|||
105888495|NCT03852628|365246007|FG000|Overall Study|Lack of Efficacy|6|||
105888496|NCT03852628|365246008|FG001|Overall Study|Lack of Efficacy|6|||
105888497|NCT03003494|365246009|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
105888498|NCT01758731|365246010|FG000|Overall Study|Physician Decision|1|||
105888499|NCT01340027|365246011|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
105888500|NCT01340027|365246012|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
105888501|NCT01340027|365246013|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
105888502|NCT01340027|365246014|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
105888503|NCT01340027|365246015|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
105888504|NCT01340027|365246016|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
105888505|NCT01340027|365246017|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
105888506|NCT01340027|365246018|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
105888507|NCT01340027|365246019|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
105888508|NCT01340027|365246020|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
105888509|NCT01340027|365246021|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
105888510|NCT01340027|365246022|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
105888511|NCT01340027|365246011|FG000|Overall Study|Adverse Event|0|||
105888512|NCT01340027|365246012|FG001|Overall Study|Adverse Event|1|||
105888513|NCT01340027|365246013|FG002|Overall Study|Adverse Event|2|||
105888514|NCT01340027|365246014|FG003|Overall Study|Adverse Event|0|||
105888515|NCT01340027|365246015|FG004|Overall Study|Adverse Event|1|||
105888516|NCT01340027|365246016|FG005|Overall Study|Adverse Event|2|||
105888517|NCT01340027|365246017|FG006|Overall Study|Adverse Event|2|||
106119985|NCT02778399|366095932|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
106119986|NCT02778399|366095927|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
106119987|NCT02778399|366095928|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
106119988|NCT02778399|366095929|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
106119989|NCT02778399|366095930|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
106119990|NCT02778399|366095931|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
106119991|NCT02778399|366095932|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
106119992|NCT02778399|366095927|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
106119993|NCT02778399|366095928|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
106119994|NCT02778399|366095929|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
105888518|NCT01340027|365246018|FG007|Overall Study|Adverse Event|1|||
105888519|NCT01340027|365246019|FG008|Overall Study|Adverse Event|4|||
105888520|NCT01340027|365246020|FG009|Overall Study|Adverse Event|1|||
105888521|NCT01340027|365246021|FG010|Overall Study|Adverse Event|1|||
105888522|NCT01340027|365246022|FG011|Overall Study|Adverse Event|3|||
105888523|NCT01340027|365246011|FG000|Overall Study|Lack of Efficacy|0|||
105785370|NCT00976989|364866484|FG000|Overall Study|Death|5|||
105785371|NCT00976989|364866485|FG001|Overall Study|Death|7|||
105785372|NCT00976989|364866486|FG002|Overall Study|Death|10|||
105995807|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
105995808|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
105995809|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
105995810|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
105995811|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
105995812|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
105995813|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
105995814|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
105995815|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
105995816|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
105995817|NCT01450761|365644183|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
105995818|NCT01450761|365644184|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
105995819|NCT02754726|365644195|FG000|Overall Study|Progressive Disease by RECIST|13|||
105995820|NCT02754726|365644195|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
105995821|NCT02754726|365644195|FG000|Overall Study|Clinical Disease Progression|5|||
105995822|NCT02754726|365644195|FG000|Overall Study|Adverse Event|3|||
105995823|NCT02754726|365644195|FG000|Overall Study|Withdrawal by Subject|1|||
105995824|NCT02754726|365644195|FG000|Overall Study|Tolerability|1|||
105995825|NCT00216671|365644201|FG000|Overall Study|Adverse Event|4|||
105995826|NCT00216671|365644202|FG001|Overall Study|Adverse Event|9|||
105995827|NCT00216671|365644201|FG000|Overall Study|Pregnancy|0|||
105995828|NCT00216671|365644202|FG001|Overall Study|Pregnancy|1|||
105995829|NCT00216671|365644201|FG000|Overall Study|Withdrawal by Subject|4|||
105995830|NCT00216671|365644202|FG001|Overall Study|Withdrawal by Subject|2|||
105995831|NCT00216671|365644201|FG000|Overall Study|Refused Injections|3|||
105995832|NCT00216671|365644202|FG001|Overall Study|Refused Injections|13|||
105995833|NCT00216671|365644201|FG000|Overall Study|No Need to Continue Medication|1|||
105995834|NCT00216671|365644202|FG001|Overall Study|No Need to Continue Medication|1|||
105995835|NCT00216671|365644201|FG000|Overall Study|Insufficient Response|9|||
105995836|NCT00216671|365644202|FG001|Overall Study|Insufficient Response|4|||
105995837|NCT00216671|365644201|FG000|Overall Study|Lost to Follow-up|3|||
105995838|NCT00216671|365644202|FG001|Overall Study|Lost to Follow-up|5|||
106119995|NCT02778399|366095930|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
106119996|NCT02778399|366095931|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
106119997|NCT02778399|366095932|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
106119998|NCT02778399|366095927|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
106119999|NCT02778399|366095928|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
106120000|NCT02778399|366095929|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
106120001|NCT02778399|366095930|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
106120002|NCT02778399|366095931|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
106120003|NCT02778399|366095932|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
106120004|NCT02778399|366095927|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
106120005|NCT02778399|366095928|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
106120006|NCT02778399|366095929|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
106120007|NCT02778399|366095930|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
106120008|NCT02778399|366095931|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
106120009|NCT02778399|366095932|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
106120010|NCT02778399|366095927|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
106120011|NCT02778399|366095928|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
106120012|NCT02778399|366095929|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
106120013|NCT02778399|366095930|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
106120014|NCT02778399|366095931|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
106120015|NCT02778399|366095932|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
106120016|NCT02009696|366095933|FG000|Overall Study|Withdrawal by Subject|2|||
106120017|NCT02301156|366095934|FG000|Overall Study|Adverse Event|13|||
106120018|NCT02301156|366095935|FG001|Overall Study|Adverse Event|14|||
106120019|NCT02301156|366095934|FG000|Overall Study|Death|1|||
106120020|NCT02301156|366095935|FG001|Overall Study|Death|5|||
106120021|NCT02301156|366095934|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
105785373|NCT00976989|364866484|FG000|Overall Study|Refused Treatment|4|||
105785374|NCT00976989|364866485|FG001|Overall Study|Refused Treatment|3|||
105785375|NCT00976989|364866486|FG002|Overall Study|Refused Treatment|5|||
105995839|NCT00216671|365644201|FG000|Overall Study|Non compliant|2|||
105995840|NCT00216671|365644202|FG001|Overall Study|Non compliant|2|||
105995841|NCT00216671|365644201|FG000|Overall Study|Ineligible|0|||
105995842|NCT00216671|365644202|FG001|Overall Study|Ineligible|2|||
105995843|NCT00216671|365644201|FG000|Overall Study|Physician Decision|1|||
106120022|NCT02301156|366095935|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
106120023|NCT02301156|366095934|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
106120024|NCT02301156|366095935|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
105888524|NCT01340027|365246012|FG001|Overall Study|Lack of Efficacy|0|||
105888525|NCT01340027|365246013|FG002|Overall Study|Lack of Efficacy|0|||
106120025|NCT02301156|366095934|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
106120026|NCT02301156|366095935|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
106120027|NCT02301156|366095934|FG000|Overall Study|Reason not Specified|6|||
106120028|NCT02301156|366095935|FG001|Overall Study|Reason not Specified|3|||
106120029|NCT00785707|366095936|FG000|Overall Study|Lost to Follow-up|7|||
106120030|NCT00105586|366095937|FG000|Overall Study|Adverse Event|4|||
106120031|NCT00105586|366095938|FG001|Overall Study|Adverse Event|3|||
105888526|NCT01340027|365246014|FG003|Overall Study|Lack of Efficacy|0|||
105888527|NCT01340027|365246015|FG004|Overall Study|Lack of Efficacy|0|||
105888528|NCT01340027|365246016|FG005|Overall Study|Lack of Efficacy|0|||
105888529|NCT01340027|365246017|FG006|Overall Study|Lack of Efficacy|1|||
105888530|NCT01340027|365246018|FG007|Overall Study|Lack of Efficacy|1|||
105888531|NCT01340027|365246019|FG008|Overall Study|Lack of Efficacy|1|||
105888532|NCT01340027|365246020|FG009|Overall Study|Lack of Efficacy|0|||
105888533|NCT01340027|365246021|FG010|Overall Study|Lack of Efficacy|0|||
105888534|NCT01340027|365246022|FG011|Overall Study|Lack of Efficacy|0|||
105888535|NCT01340027|365246011|FG000|Overall Study|Lost to Follow-up|0|||
105888536|NCT01340027|365246012|FG001|Overall Study|Lost to Follow-up|1|||
105888537|NCT01340027|365246013|FG002|Overall Study|Lost to Follow-up|0|||
105888538|NCT01340027|365246014|FG003|Overall Study|Lost to Follow-up|0|||
105888539|NCT01340027|365246015|FG004|Overall Study|Lost to Follow-up|0|||
105888540|NCT01340027|365246016|FG005|Overall Study|Lost to Follow-up|0|||
105888541|NCT01340027|365246017|FG006|Overall Study|Lost to Follow-up|1|||
105888542|NCT01340027|365246018|FG007|Overall Study|Lost to Follow-up|0|||
105888543|NCT01340027|365246019|FG008|Overall Study|Lost to Follow-up|0|||
105888544|NCT01340027|365246020|FG009|Overall Study|Lost to Follow-up|1|||
105888545|NCT01340027|365246021|FG010|Overall Study|Lost to Follow-up|0|||
105888546|NCT01340027|365246022|FG011|Overall Study|Lost to Follow-up|0|||
105888547|NCT01340027|365246011|FG000|Overall Study|Protocol Violation|1|||
105888548|NCT01340027|365246012|FG001|Overall Study|Protocol Violation|2|||
105888549|NCT01340027|365246013|FG002|Overall Study|Protocol Violation|0|||
105888550|NCT01340027|365246014|FG003|Overall Study|Protocol Violation|0|||
105888551|NCT01340027|365246015|FG004|Overall Study|Protocol Violation|6|||
105888552|NCT01340027|365246016|FG005|Overall Study|Protocol Violation|0|||
105888553|NCT01340027|365246017|FG006|Overall Study|Protocol Violation|0|||
105888554|NCT01340027|365246018|FG007|Overall Study|Protocol Violation|1|||
105888555|NCT01340027|365246019|FG008|Overall Study|Protocol Violation|2|||
105888556|NCT01340027|365246020|FG009|Overall Study|Protocol Violation|2|||
105888557|NCT01340027|365246021|FG010|Overall Study|Protocol Violation|0|||
105888558|NCT01340027|365246022|FG011|Overall Study|Protocol Violation|0|||
105888559|NCT01340027|365246011|FG000|Overall Study|Withdrawal by Subject|4|||
105888560|NCT01340027|365246012|FG001|Overall Study|Withdrawal by Subject|3|||
105888561|NCT01340027|365246013|FG002|Overall Study|Withdrawal by Subject|1|||
105888562|NCT01340027|365246014|FG003|Overall Study|Withdrawal by Subject|3|||
105888563|NCT01340027|365246015|FG004|Overall Study|Withdrawal by Subject|3|||
105888564|NCT01340027|365246016|FG005|Overall Study|Withdrawal by Subject|2|||
105888565|NCT01340027|365246017|FG006|Overall Study|Withdrawal by Subject|3|||
105888566|NCT01340027|365246018|FG007|Overall Study|Withdrawal by Subject|4|||
105888567|NCT01340027|365246019|FG008|Overall Study|Withdrawal by Subject|1|||
105888568|NCT01340027|365246020|FG009|Overall Study|Withdrawal by Subject|2|||
106120032|NCT00105586|366095937|FG000|Overall Study|Physician Decision|13|||
106120033|NCT00105586|366095938|FG001|Overall Study|Physician Decision|13|||
106120034|NCT02917941|366095939|FG000|Treatment Period|Adverse Event|11|||
106120035|NCT02917941|366095939|FG000|Treatment Period|Progressive Disease|11|||
106120036|NCT02917941|366095939|FG000|Treatment Period|Reason not Specified|2|||
106120037|NCT02917941|366095939|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
106120038|NCT02917941|366095939|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
106120039|NCT02306122|366095940|FG000|Initial Physician Randomization|Physician Decision|0|||
106120040|NCT02306122|366095941|FG001|Initial Physician Randomization|Physician Decision|0|||
106120041|NCT02306122|366095942|FG002|Initial Physician Randomization|Physician Decision|0|||
106120042|NCT02306122|366095943|FG003|Initial Physician Randomization|Physician Decision|0|||
106120043|NCT02306122|366095944|FG004|Initial Physician Randomization|Physician Decision|0|||
106120044|NCT02306122|366095945|FG005|Initial Physician Randomization|Physician Decision|0|||
106120045|NCT02306122|366095946|FG006|Initial Physician Randomization|Physician Decision|0|||
105888569|NCT01340027|365246021|FG010|Overall Study|Withdrawal by Subject|0|||
105888570|NCT01340027|365246022|FG011|Overall Study|Withdrawal by Subject|1|||
105888571|NCT01340027|365246011|FG000|Overall Study|Miscellaneous|0|||
105888572|NCT01340027|365246012|FG001|Overall Study|Miscellaneous|0|||
105888573|NCT01340027|365246013|FG002|Overall Study|Miscellaneous|0|||
105888574|NCT01340027|365246014|FG003|Overall Study|Miscellaneous|1|||
105888575|NCT01340027|365246015|FG004|Overall Study|Miscellaneous|0|||
106120046|NCT02306122|366095947|FG007|Initial Physician Randomization|Physician Decision|0|||
106120047|NCT02306122|366095948|FG008|Initial Physician Randomization|Physician Decision|1|||
106120048|NCT02306122|366095949|FG009|Initial Physician Randomization|Physician Decision|0|||
106120049|NCT02306122|366095950|FG010|Initial Physician Randomization|Physician Decision|0|||
106120050|NCT02638623|366095956|FG000|Overall Study|Surgery timing|5|||
106120051|NCT02638623|366095957|FG001|Overall Study|Surgery timing|6|||
106120052|NCT02638623|366095956|FG000|Overall Study|Not given intervention|2|||
106120053|NCT02638623|366095957|FG001|Overall Study|Not given intervention|0|||
106120054|NCT02322814|366095958|FG000|Overall Study|Death|7|||
106120055|NCT02322814|366095959|FG001|Overall Study|Death|29|||
106120056|NCT02322814|366095960|FG002|Overall Study|Death|32|||
106120057|NCT02322814|366095961|FG003|Overall Study|Death|23|||
106120058|NCT02322814|366095962|FG004|Overall Study|Death|14|||
106120059|NCT02322814|366095958|FG000|Overall Study|Lost to Follow-up|1|||
106120060|NCT02322814|366095959|FG001|Overall Study|Lost to Follow-up|3|||
106120061|NCT02322814|366095960|FG002|Overall Study|Lost to Follow-up|3|||
106120062|NCT02322814|366095961|FG003|Overall Study|Lost to Follow-up|1|||
106120063|NCT02322814|366095962|FG004|Overall Study|Lost to Follow-up|0|||
106120064|NCT02322814|366095958|FG000|Overall Study|Various Reasons|2|||
106120065|NCT02322814|366095959|FG001|Overall Study|Various Reasons|0|||
106120066|NCT02322814|366095960|FG002|Overall Study|Various Reasons|1|||
106120067|NCT02322814|366095961|FG003|Overall Study|Various Reasons|1|||
106120068|NCT02322814|366095962|FG004|Overall Study|Various Reasons|0|||
106120069|NCT02322814|366095958|FG000|Overall Study|Progressive Disease|0|||
106120070|NCT02322814|366095959|FG001|Overall Study|Progressive Disease|0|||
106120071|NCT02322814|366095960|FG002|Overall Study|Progressive Disease|0|||
106120072|NCT02322814|366095961|FG003|Overall Study|Progressive Disease|1|||
106120073|NCT02322814|366095962|FG004|Overall Study|Progressive Disease|1|||
106120074|NCT02322814|366095958|FG000|Overall Study|Protocol Violation|1|||
106120075|NCT02322814|366095959|FG001|Overall Study|Protocol Violation|0|||
106120076|NCT02322814|366095960|FG002|Overall Study|Protocol Violation|0|||
106120077|NCT02322814|366095961|FG003|Overall Study|Protocol Violation|0|||
106120078|NCT02322814|366095962|FG004|Overall Study|Protocol Violation|0|||
106120079|NCT02322814|366095958|FG000|Overall Study|Study Terminated by Sponsor|0|||
106120080|NCT02322814|366095959|FG001|Overall Study|Study Terminated by Sponsor|7|||
106120081|NCT02322814|366095960|FG002|Overall Study|Study Terminated by Sponsor|9|||
106120082|NCT02322814|366095961|FG003|Overall Study|Study Terminated by Sponsor|5|||
106120083|NCT02322814|366095962|FG004|Overall Study|Study Terminated by Sponsor|13|||
106120084|NCT02322814|366095958|FG000|Overall Study|Withdrawal by Subject|5|||
106120085|NCT02322814|366095959|FG001|Overall Study|Withdrawal by Subject|4|||
106120086|NCT02322814|366095960|FG002|Overall Study|Withdrawal by Subject|2|||
106120087|NCT02322814|366095961|FG003|Overall Study|Withdrawal by Subject|1|||
106120088|NCT02322814|366095962|FG004|Overall Study|Withdrawal by Subject|3|||
106120089|NCT01486758|366097420|FG000|Overall Study|Lost to Follow-up|0|||
106120090|NCT01486758|366097421|FG001|Overall Study|Lost to Follow-up|1|||
106120091|NCT00917267|366097428|FG000|Overall Study|Adverse Event|15|||
106120092|NCT00917267|366097429|FG001|Overall Study|Adverse Event|36|||
106120093|NCT00917267|366097428|FG000|Overall Study|Physician Decision|2|||
106120094|NCT00917267|366097429|FG001|Overall Study|Physician Decision|4|||
106120095|NCT00917267|366097428|FG000|Overall Study|Protocol Violation|9|||
106120096|NCT00917267|366097429|FG001|Overall Study|Protocol Violation|18|||
106120097|NCT00917267|366097428|FG000|Overall Study|Withdrawal by Subject|5|||
106120098|NCT00917267|366097429|FG001|Overall Study|Withdrawal by Subject|12|||
106120099|NCT00917267|366097428|FG000|Overall Study|Lost to follow up|0|||
106120100|NCT00917267|366097429|FG001|Overall Study|Lost to follow up|2|||
106120101|NCT00917267|366097428|FG000|Overall Study|Entry Criteria Not Met|1|||
106120102|NCT00917267|366097429|FG001|Overall Study|Entry Criteria Not Met|0|||
106120103|NCT00917267|366097428|FG000|Overall Study|Sponsor Decision|5|||
106120104|NCT00917267|366097429|FG001|Overall Study|Sponsor Decision|5|||
106120105|NCT00917267|366097428|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
106120106|NCT00917267|366097429|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
106120107|NCT00768430|366097430|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
106120108|NCT00768430|366097431|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
106120109|NCT01336634|366097445|FG000|Overall Study|Study closed/terminated|5|||
106120110|NCT01336634|366097446|FG001|Overall Study|Study closed/terminated|6|||
105785376|NCT00976989|364866484|FG000|Overall Study|Failure to Return|2|||
105785377|NCT00976989|364866485|FG001|Overall Study|Failure to Return|1|||
106120111|NCT01336634|366097447|FG002|Overall Study|Study closed/terminated|6|||
106120112|NCT01336634|366097445|FG000|Overall Study|Lost to Follow-up|2|||
106120113|NCT01336634|366097446|FG001|Overall Study|Lost to Follow-up|1|||
106120114|NCT01336634|366097447|FG002|Overall Study|Lost to Follow-up|1|||
106120115|NCT01336634|366097445|FG000|Overall Study|Physician Decision|1|||
106120116|NCT01336634|366097446|FG001|Overall Study|Physician Decision|1|||
106120117|NCT01336634|366097447|FG002|Overall Study|Physician Decision|0|||
106120118|NCT01336634|366097445|FG000|Overall Study|Withdrawal by Subject|6|||
106120119|NCT01336634|366097446|FG001|Overall Study|Withdrawal by Subject|0|||
106120120|NCT01336634|366097447|FG002|Overall Study|Withdrawal by Subject|2|||
106120121|NCT02961881|366097448|FG000|Overall Study|Adverse Event|1|||
106120122|NCT02961881|366097449|FG001|Overall Study|Adverse Event|2|||
106120123|NCT02961881|366097450|FG002|Overall Study|Adverse Event|2|||
106120124|NCT02961881|366097451|FG003|Overall Study|Adverse Event|0|||
106120125|NCT02961881|366097452|FG004|Overall Study|Adverse Event|1|||
106120126|NCT02961881|366097448|FG000|Overall Study|Participant request|0|||
106120127|NCT02961881|366097449|FG001|Overall Study|Participant request|2|||
106120128|NCT02961881|366097450|FG002|Overall Study|Participant request|0|||
106120129|NCT02961881|366097451|FG003|Overall Study|Participant request|0|||
105888576|NCT01340027|365246016|FG005|Overall Study|Miscellaneous|0|||
105888577|NCT01340027|365246017|FG006|Overall Study|Miscellaneous|0|||
105888578|NCT01340027|365246018|FG007|Overall Study|Miscellaneous|0|||
105888579|NCT01340027|365246019|FG008|Overall Study|Miscellaneous|0|||
106120130|NCT02961881|366097452|FG004|Overall Study|Participant request|0|||
106120131|NCT02961881|366097448|FG000|Overall Study|Disease progression|1|||
106120132|NCT02961881|366097449|FG001|Overall Study|Disease progression|0|||
106120133|NCT02961881|366097450|FG002|Overall Study|Disease progression|1|||
106120134|NCT02961881|366097451|FG003|Overall Study|Disease progression|0|||
106120135|NCT02961881|366097452|FG004|Overall Study|Disease progression|0|||
106120136|NCT02632786|366097456|FG000|Overall Study|Adverse Event|2|||
106120137|NCT02632786|366097457|FG001|Overall Study|Adverse Event|1|||
106120138|NCT02632786|366097456|FG000|Overall Study|Death|3|||
106120139|NCT02632786|366097457|FG001|Overall Study|Death|2|||
106120140|NCT02632786|366097456|FG000|Overall Study|Physician Decision|5|||
106120141|NCT02632786|366097457|FG001|Overall Study|Physician Decision|4|||
106120142|NCT02632786|366097456|FG000|Overall Study|Withdrawal by Subject|1|||
106120143|NCT02632786|366097457|FG001|Overall Study|Withdrawal by Subject|0|||
106120144|NCT01454830|366097458|FG000|Overall Study|Withdrawal by Subject|4|||
106120145|NCT01454830|366097459|FG001|Overall Study|Withdrawal by Subject|4|||
106120146|NCT01454830|366097458|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
106120147|NCT01454830|366097459|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
106120148|NCT01454830|366097458|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
106120149|NCT01454830|366097459|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
106120150|NCT01454830|366097458|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
106120151|NCT01454830|366097459|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
106120152|NCT01454830|366097458|FG000|Overall Study|Withdrawal - no polysomnography|3|||
106120153|NCT01454830|366097459|FG001|Overall Study|Withdrawal - no polysomnography|2|||
106120154|NCT03810313|366097460|FG000|Overall Study|Study terminated by sponsor|164|||
106120155|NCT03810313|366097461|FG001|Overall Study|Study terminated by sponsor|159|||
106120156|NCT03810313|366097460|FG000|Overall Study|Subject decision|10|||
106120157|NCT03810313|366097461|FG001|Overall Study|Subject decision|11|||
106120158|NCT03810313|366097460|FG000|Overall Study|Lost to Follow-up|3|||
106120159|NCT03810313|366097461|FG001|Overall Study|Lost to Follow-up|3|||
106120160|NCT03810313|366097460|FG000|Overall Study|Adverse Event|2|||
106120161|NCT03810313|366097461|FG001|Overall Study|Adverse Event|1|||
106120162|NCT03810313|366097460|FG000|Overall Study|Death|2|||
106120163|NCT03810313|366097461|FG001|Overall Study|Death|1|||
106120164|NCT03810313|366097460|FG000|Overall Study|Physician Decision|0|||
106120165|NCT03810313|366097461|FG001|Overall Study|Physician Decision|1|||
106120166|NCT04422639|366097489|FG000|Overall Study|Death|1|||
106120167|NCT04422639|366097490|FG001|Overall Study|Death|0|||
106120168|NCT04422639|366097489|FG000|Overall Study|study closed prior to completion of FU visits|0|||
106120169|NCT04422639|366097490|FG001|Overall Study|study closed prior to completion of FU visits|2|||
106120170|NCT01964521|366097491|FG000|Overall Study|Lost to Follow-up|4|||
106120171|NCT01108510|366097492|FG000|Overall Study|Randomized but Not Treated|5|||
106120172|NCT01108510|366097493|FG001|Overall Study|Randomized but Not Treated|1|||
106120173|NCT01108510|366097492|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
106120174|NCT01108510|366097493|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
106120175|NCT01108510|366097492|FG000|Overall Study|Adverse Event|26|||
106120176|NCT01108510|366097493|FG001|Overall Study|Adverse Event|19|||
105888580|NCT01340027|365246020|FG009|Overall Study|Miscellaneous|0|||
105888581|NCT01340027|365246021|FG010|Overall Study|Miscellaneous|1|||
105888582|NCT01340027|365246022|FG011|Overall Study|Miscellaneous|0|||
106120177|NCT01108510|366097492|FG000|Overall Study|Lost to Follow-up|20|||
106120178|NCT01108510|366097493|FG001|Overall Study|Lost to Follow-up|17|||
106120179|NCT01108510|366097492|FG000|Overall Study|Withdrew Consent|21|||
106120180|NCT01108510|366097493|FG001|Overall Study|Withdrew Consent|15|||
106120181|NCT01108510|366097492|FG000|Overall Study|Investigator's Discretion|12|||
106120182|NCT01108510|366097493|FG001|Overall Study|Investigator's Discretion|10|||
106120183|NCT01108510|366097492|FG000|Overall Study|Participant Noncompliance|5|||
106120184|NCT01108510|366097493|FG001|Overall Study|Participant Noncompliance|7|||
106120185|NCT01108510|366097492|FG000|Overall Study|Lack of Efficacy|3|||
106120186|NCT01108510|366097493|FG001|Overall Study|Lack of Efficacy|0|||
105888583|NCT05238025|365246023|FG000|Overall Study|Adverse Event|2|||
106120187|NCT01108510|366097492|FG000|Overall Study|Pregnancy|0|||
106120188|NCT01108510|366097493|FG001|Overall Study|Pregnancy|3|||
106120189|NCT01108510|366097492|FG000|Overall Study|Death|1|||
106120190|NCT01108510|366097493|FG001|Overall Study|Death|1|||
106120191|NCT03853317|366097494|FG000|Overall Study|Progressive Disease|5|||
105663041|NCT06719986|364430121|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
105663042|NCT06719986|364430122|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
105663043|NCT06719986|364430120|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
106120192|NCT03853317|366097494|FG000|Overall Study|Adverse Event|1|||
105785378|NCT00976989|364866486|FG002|Overall Study|Failure to Return|0|||
105785379|NCT00976989|364866484|FG000|Overall Study|Recurrence of Disease|0|||
105785380|NCT00976989|364866485|FG001|Overall Study|Recurrence of Disease|1|||
105785381|NCT00976989|364866486|FG002|Overall Study|Recurrence of Disease|0|||
105785382|NCT00976989|364866484|FG000|Overall Study|Other|1|||
105663044|NCT06719986|364430121|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
105663045|NCT06719986|364430122|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
105663046|NCT00966264|364432352|FG000|Overall Study|Lost to Follow-up|4|||
105663047|NCT00966264|364432353|FG001|Overall Study|Lost to Follow-up|3|||
105663048|NCT01867047|364432354|FG000|Overall Study|Lost to Follow-up|3|||
105785383|NCT00976989|364866485|FG001|Overall Study|Other|0|||
105785384|NCT00976989|364866486|FG002|Overall Study|Other|1|||
106120193|NCT03853317|366097494|FG000|Overall Study|Death|1|||
106120194|NCT03853317|366097494|FG000|Overall Study|other event|2|||
106120195|NCT03856996|366097498|FG000|Overall Study|Withdrawal by Subject|1|||
106120196|NCT03856996|366097499|FG001|Overall Study|Withdrawal by Subject|0|||
106120197|NCT03856996|366097498|FG000|Overall Study|Lost to Follow-up|0|||
106120198|NCT03856996|366097499|FG001|Overall Study|Lost to Follow-up|1|||
106120199|NCT03856996|366097498|FG000|Overall Study|Adverse Event|1|||
106120200|NCT03856996|366097499|FG001|Overall Study|Adverse Event|1|||
106120201|NCT03856996|366097498|FG000|Overall Study|Other|1|||
106120202|NCT03856996|366097499|FG001|Overall Study|Other|0|||
106120203|NCT00089895|366097500|FG000|Overall Study|Consent Withdrawn|11|||
106120204|NCT00089895|366097501|FG001|Overall Study|Consent Withdrawn|14|||
106120205|NCT00089895|366097500|FG000|Overall Study|Technical reason|7|||
106120206|NCT00089895|366097501|FG001|Overall Study|Technical reason|2|||
106120207|NCT00089895|366097500|FG000|Overall Study|Surgery|0|||
106120208|NCT00089895|366097501|FG001|Overall Study|Surgery|1|||
106120209|NCT00089895|366097500|FG000|Overall Study|Bleeding|0|||
106120210|NCT00089895|366097501|FG001|Overall Study|Bleeding|2|||
106120211|NCT00089895|366097500|FG000|Overall Study|Physician Decision|3|||
106120212|NCT00089895|366097501|FG001|Overall Study|Physician Decision|7|||
106120213|NCT00089895|366097500|FG000|Overall Study|Exclusion criteria met|6|||
106120214|NCT00089895|366097501|FG001|Overall Study|Exclusion criteria met|6|||
106120215|NCT00089895|366097500|FG000|Overall Study|Not otherwise specified|4|||
106120216|NCT00089895|366097501|FG001|Overall Study|Not otherwise specified|8|||
106120217|NCT00089895|366097500|FG000|Overall Study|Missing|4|||
106120218|NCT00089895|366097501|FG001|Overall Study|Missing|2|||
106120219|NCT00785538|366097502|FG000|Treatment Period|Adverse Event|1|||
106120220|NCT00785538|366097503|FG001|Treatment Period|Adverse Event|2|||
106120221|NCT00785538|366097504|FG002|Treatment Period|Adverse Event|2|||
106120222|NCT00785538|366097505|FG003|Treatment Period|Adverse Event|0|||
106120223|NCT00785538|366097502|FG000|Treatment Period|Withdrawal by Subject|0|||
106120224|NCT00785538|366097503|FG001|Treatment Period|Withdrawal by Subject|0|||
106120225|NCT00785538|366097504|FG002|Treatment Period|Withdrawal by Subject|0|||
106120226|NCT00785538|366097505|FG003|Treatment Period|Withdrawal by Subject|1|||
106120227|NCT01234649|366097506|FG000|Overall Study|Withdrawal by Subject|32|||
106120228|NCT01234649|366097507|FG001|Overall Study|Withdrawal by Subject|26|||
106120229|NCT01234649|366097506|FG000|Overall Study|Pregnancy|6|||
106120230|NCT01234649|366097507|FG001|Overall Study|Pregnancy|6|||
106120231|NCT01234649|366097506|FG000|Overall Study|intolerant to side effects|4|||
106120232|NCT01234649|366097507|FG001|Overall Study|intolerant to side effects|3|||
106120233|NCT01234649|366097506|FG000|Overall Study|Allergic reaction|1|||
106120234|NCT01234649|366097507|FG001|Overall Study|Allergic reaction|0|||
106120235|NCT01234649|366097506|FG000|Overall Study|Lack of Efficacy|0|||
106120236|NCT01234649|366097507|FG001|Overall Study|Lack of Efficacy|3|||
106120237|NCT04986982|366097511|FG000|Overall Study|Withdrawal by Subject|3|||
106120238|NCT04986982|366097512|FG001|Overall Study|Withdrawal by Subject|1|||
106120239|NCT04986982|366097511|FG000|Overall Study|Lack of Efficacy|0|||
106120240|NCT04986982|366097512|FG001|Overall Study|Lack of Efficacy|2|||
106120241|NCT04986982|366097511|FG000|Overall Study|Ineligibility|3|||
106120242|NCT04986982|366097512|FG001|Overall Study|Ineligibility|0|||
106120243|NCT04986982|366097511|FG000|Overall Study|Adverse Event|4|||
105663049|NCT01867047|364432355|FG001|Overall Study|Lost to Follow-up|3|||
105785385|NCT01016912|364866487|FG000|End of Treatment Period|Lack of Efficacy|0|||
105785386|NCT01016912|364866488|FG001|End of Treatment Period|Lack of Efficacy|1|||
106120244|NCT04986982|366097512|FG001|Overall Study|Adverse Event|4|||
106120245|NCT04986982|366097511|FG000|Overall Study|Lost to Follow-up|0|||
106120246|NCT04986982|366097512|FG001|Overall Study|Lost to Follow-up|1|||
106120247|NCT04986982|366097511|FG000|Overall Study|Sponsor's discretion|1|||
106120248|NCT04986982|366097512|FG001|Overall Study|Sponsor's discretion|0|||
106120249|NCT01535274|366097515|FG000|Overall Study|Determined to be ineligible|0|||
106120250|NCT01535274|366097516|FG001|Overall Study|Determined to be ineligible|1|||
105663050|NCT01867047|364432354|FG000|Overall Study|Withdrawal by Subject|2|||
105785387|NCT01016912|364866489|FG002|End of Treatment Period|Lack of Efficacy|0|||
106120251|NCT01535274|366097515|FG000|Overall Study|Misallocated to propofol intervention|0|||
106120252|NCT01535274|366097516|FG001|Overall Study|Misallocated to propofol intervention|1|||
106120253|NCT01396395|366097523|FG000|Overall Study|Withdrawal by Subject|10|||
106120254|NCT01396395|366097524|FG001|Overall Study|Withdrawal by Subject|12|||
106120255|NCT01396395|366097523|FG000|Overall Study|Protocol Violation|3|||
106120256|NCT01396395|366097524|FG001|Overall Study|Protocol Violation|1|||
106120257|NCT01396395|366097523|FG000|Overall Study|Adverse Event|10|||
106120258|NCT01396395|366097524|FG001|Overall Study|Adverse Event|2|||
106120259|NCT01396395|366097523|FG000|Overall Study|Lost to Follow-up|17|||
106120260|NCT01396395|366097524|FG001|Overall Study|Lost to Follow-up|11|||
106120261|NCT01396395|366097523|FG000|Overall Study|Other|0|||
106120262|NCT01396395|366097524|FG001|Overall Study|Other|1|||
106120263|NCT00882921|366097535|FG000|Overall Study|Death|2|||
106120264|NCT00882921|366097535|FG000|Overall Study|Other|3|||
106120265|NCT00882921|366097535|FG000|Overall Study|Lost to Follow-up|2|||
106120266|NCT00882921|366097535|FG000|Overall Study|Termination By Investigator|3|||
106120267|NCT00882921|366097535|FG000|Overall Study|Withdrawal Of Consent|1|||
106120268|NCT01370005|366097536|FG000|Overall Study|Not treated|1|||
106120269|NCT01370005|366097537|FG001|Overall Study|Not treated|0|||
106120270|NCT01370005|366097538|FG002|Overall Study|Not treated|0|||
106120271|NCT01370005|366097536|FG000|Overall Study|Adverse Event|5|||
106120272|NCT01370005|366097537|FG001|Overall Study|Adverse Event|5|||
106120273|NCT01370005|366097538|FG002|Overall Study|Adverse Event|6|||
106120274|NCT01370005|366097536|FG000|Overall Study|Lack of Efficacy|1|||
106120275|NCT01370005|366097537|FG001|Overall Study|Lack of Efficacy|0|||
106120276|NCT01370005|366097538|FG002|Overall Study|Lack of Efficacy|0|||
106120277|NCT01370005|366097536|FG000|Overall Study|Non compliant with protocol|0|||
106120278|NCT01370005|366097537|FG001|Overall Study|Non compliant with protocol|1|||
106120279|NCT01370005|366097538|FG002|Overall Study|Non compliant with protocol|2|||
106120280|NCT01370005|366097536|FG000|Overall Study|Lost to Follow-up|1|||
106120281|NCT01370005|366097537|FG001|Overall Study|Lost to Follow-up|1|||
106120282|NCT01370005|366097538|FG002|Overall Study|Lost to Follow-up|1|||
106120283|NCT01370005|366097536|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
106120284|NCT01370005|366097537|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
106120285|NCT01370005|366097538|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
106120286|NCT01370005|366097536|FG000|Overall Study|Other reason not defined above|3|||
106120287|NCT01370005|366097537|FG001|Overall Study|Other reason not defined above|0|||
106120288|NCT01370005|366097538|FG002|Overall Study|Other reason not defined above|2|||
106120289|NCT02302066|366097542|FG000|Overall Study|Adverse Event|1|||
106120290|NCT02302066|366097543|FG001|Overall Study|Adverse Event|1|||
106120291|NCT02302066|366097544|FG002|Overall Study|Adverse Event|3|||
106120292|NCT02302066|366097545|FG003|Overall Study|Adverse Event|0|||
106120293|NCT02302066|366097542|FG000|Overall Study|Lost to Follow-up|4|||
106120294|NCT02302066|366097543|FG001|Overall Study|Lost to Follow-up|5|||
106120295|NCT02302066|366097544|FG002|Overall Study|Lost to Follow-up|24|||
106120296|NCT02302066|366097545|FG003|Overall Study|Lost to Follow-up|7|||
106120297|NCT02302066|366097542|FG000|Overall Study|Withdrawal by Subject|25|||
106120298|NCT02302066|366097543|FG001|Overall Study|Withdrawal by Subject|58|||
106120299|NCT02302066|366097544|FG002|Overall Study|Withdrawal by Subject|124|||
106120300|NCT02302066|366097545|FG003|Overall Study|Withdrawal by Subject|33|||
106120301|NCT02302066|366097542|FG000|Overall Study|Pregnancy|2|||
106120302|NCT02302066|366097543|FG001|Overall Study|Pregnancy|10|||
106120303|NCT02302066|366097544|FG002|Overall Study|Pregnancy|12|||
106120304|NCT02302066|366097545|FG003|Overall Study|Pregnancy|0|||
106120305|NCT02302066|366097542|FG000|Overall Study|Reason Not Specified|1|||
106120306|NCT02302066|366097543|FG001|Overall Study|Reason Not Specified|1|||
105663051|NCT01867047|364432355|FG001|Overall Study|Withdrawal by Subject|0|||
105663052|NCT01867047|364432354|FG000|Overall Study|Physician Decision|2|||
105663053|NCT01867047|364432355|FG001|Overall Study|Physician Decision|0|||
105663054|NCT01867047|364432354|FG000|Overall Study|surgery not indicated in protocol|1|||
105663055|NCT01867047|364432355|FG001|Overall Study|surgery not indicated in protocol|2|||
105663056|NCT04650698|364432356|FG000|Overall Study|Protocol Violation|2|||
105663057|NCT04650698|364432357|FG001|Overall Study|Protocol Violation|1|||
106120307|NCT02302066|366097544|FG002|Overall Study|Reason Not Specified|9|||
105663058|NCT04650698|364432356|FG000|Overall Study|Withdrawal by Subject|0|||
105663059|NCT04650698|364432357|FG001|Overall Study|Withdrawal by Subject|1|||
105663060|NCT01090011|364432358|FG000|Overall Study|Progressive disease|128|||
105663061|NCT01090011|364432358|FG000|Overall Study|Adverse Event|32|||
106120308|NCT02302066|366097545|FG003|Overall Study|Reason Not Specified|1|||
106120309|NCT00960752|366097546|FG000|Overall Study|Adverse Event|0|||
106120310|NCT00960752|366097547|FG001|Overall Study|Adverse Event|0|||
106120311|NCT00960752|366097548|FG002|Overall Study|Adverse Event|1|||
106120312|NCT00960752|366097546|FG000|Overall Study|Progression|0|||
106120313|NCT00960752|366097547|FG001|Overall Study|Progression|0|||
106120314|NCT00960752|366097548|FG002|Overall Study|Progression|1|||
106120315|NCT05490329|366097549|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
106120316|NCT05490329|366097550|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
106120317|NCT05490329|366097549|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
105663062|NCT01090011|364432358|FG000|Overall Study|Protocol Violation|1|||
105663063|NCT01090011|364432358|FG000|Overall Study|Refusal to start/continue medication|5|||
105663064|NCT01090011|364432358|FG000|Overall Study|Other reason not defined above|5|||
105663065|NCT02820597|364432359|FG000|Overall Study|Lost to Follow-up|12|||
105663066|NCT01638390|364432360|FG000|Overall Study|screening failures|21|||
105663067|NCT02666664|364432361|FG000|Overall Study|Physician Decision|0|||
105663068|NCT02666664|364432362|FG001|Overall Study|Physician Decision|1|||
105663069|NCT02666664|364432361|FG000|Overall Study|Protocol Violation|0|||
105663070|NCT02666664|364432362|FG001|Overall Study|Protocol Violation|2|||
105663071|NCT02666664|364432361|FG000|Overall Study|Other|0|||
105663072|NCT02666664|364432362|FG001|Overall Study|Other|1|||
105663073|NCT02666664|364432361|FG000|Overall Study|Adverse Event|12|||
105663074|NCT02666664|364432362|FG001|Overall Study|Adverse Event|37|||
105663075|NCT02666664|364432361|FG000|Overall Study|Withdrawal by participant|23|||
105663076|NCT02666664|364432362|FG001|Overall Study|Withdrawal by participant|40|||
105663077|NCT02666664|364432361|FG000|Overall Study|Sponsor decision|0|||
105663078|NCT02666664|364432362|FG001|Overall Study|Sponsor decision|1|||
105663079|NCT02666664|364432361|FG000|Overall Study|Lost to Follow-up|1|||
105663080|NCT02666664|364432362|FG001|Overall Study|Lost to Follow-up|2|||
105663081|NCT01385748|364432363|FG000|Overall Study|Withdrawal by Subject|7|||
105663082|NCT01385748|364432364|FG001|Overall Study|Withdrawal by Subject|4|||
105663083|NCT01385748|364432365|FG002|Overall Study|Withdrawal by Subject|5|||
105663084|NCT01385748|364432363|FG000|Overall Study|Noncompliance|3|||
105663085|NCT01385748|364432364|FG001|Overall Study|Noncompliance|1|||
105663086|NCT01385748|364432365|FG002|Overall Study|Noncompliance|6|||
105663087|NCT01385748|364432363|FG000|Overall Study|Other|1|||
105663088|NCT01385748|364432364|FG001|Overall Study|Other|7|||
105663089|NCT01385748|364432365|FG002|Overall Study|Other|1|||
105663090|NCT01385748|364432363|FG000|Overall Study|Adverse Event|4|||
105663091|NCT01385748|364432364|FG001|Overall Study|Adverse Event|2|||
105663092|NCT01385748|364432365|FG002|Overall Study|Adverse Event|1|||
105663093|NCT01377389|364432366|FG000|Overall Study|Withdrawal by Subject|1|||
105663094|NCT01377389|364432366|FG000|Overall Study|Screen failure|2|||
105663095|NCT03167151|364432368|FG000|Overall Study|Withdrawal by Subject|1|||
105663096|NCT03167151|364432369|FG001|Overall Study|Withdrawal by Subject|0|||
105663097|NCT03167151|364432370|FG002|Overall Study|Withdrawal by Subject|0|||
105663098|NCT03167151|364432368|FG000|Overall Study|No evidence of tumour at surgery|0|||
105663099|NCT03167151|364432369|FG001|Overall Study|No evidence of tumour at surgery|1|||
105663100|NCT03167151|364432370|FG002|Overall Study|No evidence of tumour at surgery|1|||
105663101|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663102|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
105663103|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
105663104|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
105663105|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663106|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663107|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663108|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
105663109|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663110|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
105663111|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
105663112|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
105663113|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663114|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663115|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663116|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
105663117|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
105663118|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663119|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663120|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663121|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663122|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663123|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663124|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
105663125|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
105663126|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663127|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663128|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663129|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663130|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663131|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
105663132|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
105888584|NCT05238025|365246024|FG001|Overall Study|Adverse Event|2|||
105785388|NCT01016912|364866490|FG003|End of Treatment Period|Lack of Efficacy|4|||
105785389|NCT01016912|364866491|FG004|End of Treatment Period|Lack of Efficacy|4|||
105785390|NCT01016912|364866487|FG000|End of Treatment Period|Adverse Event|0|||
105785391|NCT01016912|364866488|FG001|End of Treatment Period|Adverse Event|1|||
106120318|NCT05490329|366097550|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
106120319|NCT05490329|366097549|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
106120320|NCT05490329|366097550|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
106120321|NCT00447954|366097551|FG000|Overall Study|Adverse Event|0|||
106120322|NCT00447954|366097552|FG001|Overall Study|Adverse Event|2|||
106120323|NCT00447954|366097553|FG002|Overall Study|Adverse Event|0|||
106120324|NCT00447954|366097551|FG000|Overall Study|Withdrawal by Subject|0|||
106120325|NCT00447954|366097552|FG001|Overall Study|Withdrawal by Subject|1|||
106120326|NCT00447954|366097553|FG002|Overall Study|Withdrawal by Subject|1|||
106120327|NCT00447954|366097551|FG000|Overall Study|Lost to Follow-up|0|||
106120328|NCT00447954|366097552|FG001|Overall Study|Lost to Follow-up|1|||
106120329|NCT00447954|366097553|FG002|Overall Study|Lost to Follow-up|0|||
106120330|NCT00447954|366097551|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
106120331|NCT00447954|366097552|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
106120332|NCT00447954|366097553|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
106120333|NCT00926003|366097557|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
106120334|NCT00926003|366097558|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
106120335|NCT00926003|366097559|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
106120336|NCT00926003|366097557|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
106120337|NCT00926003|366097558|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
106120338|NCT00926003|366097559|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
106120339|NCT01032044|366097560|FG000|Overall Study|Protocol Violation|14|||
106120340|NCT01032044|366097561|FG001|Overall Study|Protocol Violation|8|||
106120341|NCT01032044|366097560|FG000|Overall Study|Adverse Event|0|||
106120342|NCT01032044|366097561|FG001|Overall Study|Adverse Event|1|||
106120343|NCT01032044|366097560|FG000|Overall Study|Lost to Follow-up|11|||
105663133|NCT04836559|364432371|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663134|NCT04836559|364432372|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663135|NCT04836559|364432373|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663136|NCT04836559|364432374|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
105663137|NCT04836559|364432375|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663138|NCT04836559|364432376|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663139|NCT04836559|364432377|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663140|NCT04836559|364432378|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
105663141|NCT04836559|364432371|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
105663142|NCT04836559|364432372|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
105663143|NCT04836559|364432373|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
105663144|NCT04836559|364432374|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
105663145|NCT04836559|364432375|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
105663146|NCT04836559|364432376|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
105663147|NCT04836559|364432377|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
105663148|NCT04836559|364432378|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
105663149|NCT04836559|364432371|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
105663150|NCT04836559|364432372|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
105663151|NCT04836559|364432373|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
105663152|NCT04836559|364432374|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
105663153|NCT04836559|364432375|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
105663154|NCT04836559|364432376|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
105663155|NCT04836559|364432377|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
105663156|NCT04836559|364432378|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
105663157|NCT04836559|364432371|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105663158|NCT04836559|364432372|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105663159|NCT04836559|364432373|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105663160|NCT04836559|364432374|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
105663161|NCT04836559|364432375|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
105785392|NCT01016912|364866489|FG002|End of Treatment Period|Adverse Event|1|||
105785393|NCT01016912|364866490|FG003|End of Treatment Period|Adverse Event|0|||
105785394|NCT01016912|364866491|FG004|End of Treatment Period|Adverse Event|0|||
106120344|NCT01032044|366097561|FG001|Overall Study|Lost to Follow-up|11|||
106120345|NCT00735644|366097562|FG000|Overall Study|Did not receive study vaccine|0|||
106120346|NCT00735644|366097563|FG001|Overall Study|Did not receive study vaccine|1|||
106120347|NCT00735644|366097564|FG002|Overall Study|Did not receive study vaccine|0|||
106120348|NCT00735644|366097565|FG003|Overall Study|Did not receive study vaccine|0|||
105663162|NCT04836559|364432376|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
105663163|NCT04836559|364432377|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
106120349|NCT00735644|366097566|FG004|Overall Study|Did not receive study vaccine|0|||
106120350|NCT00735644|366097562|FG000|Overall Study|Withdrawal by Subject|0|||
105663164|NCT04836559|364432378|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
105663165|NCT04836559|364432371|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663166|NCT04836559|364432372|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663167|NCT04836559|364432373|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663168|NCT04836559|364432374|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663169|NCT04836559|364432375|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663170|NCT04836559|364432376|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663171|NCT04836559|364432377|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
105663172|NCT04836559|364432378|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
105663173|NCT04698915|364432382|FG000|Overall Study|Adverse Event|2|||
105663174|NCT04698915|364432383|FG001|Overall Study|Adverse Event|0|||
105663175|NCT04698915|364432382|FG000|Overall Study|Death|23|||
105663176|NCT04698915|364432383|FG001|Overall Study|Death|20|||
105663177|NCT04698915|364432382|FG000|Overall Study|Physician Decision|1|||
105663178|NCT04698915|364432383|FG001|Overall Study|Physician Decision|1|||
105663179|NCT04698915|364432382|FG000|Overall Study|Lost to Follow-up|1|||
105663180|NCT04698915|364432383|FG001|Overall Study|Lost to Follow-up|0|||
105663181|NCT04698915|364432382|FG000|Overall Study|Study Terminated by Sponsor|55|||
105663182|NCT04698915|364432383|FG001|Overall Study|Study Terminated by Sponsor|60|||
105663183|NCT04698915|364432382|FG000|Overall Study|Withdrawal by Subject|2|||
105663184|NCT04698915|364432383|FG001|Overall Study|Withdrawal by Subject|3|||
105663185|NCT00013611|364432384|FG000|Overall Study|Lost to Follow-up|91|||
105663186|NCT00013611|364432385|FG001|Overall Study|Lost to Follow-up|100|||
105663187|NCT01437423|364432391|FG000|Overall Study|Lost to Follow-up|12|||
105663188|NCT01437423|364432391|FG000|Overall Study|Off label usage|3|||
105663189|NCT00633945|364432392|FG000|Overall Study|Physician Decision|2|||
105663190|NCT02552147|364432403|FG000|First Intervention (7 Days)|Protocol Violation|1|||
105663191|NCT02552147|364432404|FG001|First Intervention (7 Days)|Protocol Violation|0|||
105663192|NCT02552147|364432403|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
105663193|NCT02552147|364432404|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
105663194|NCT00940875|364432405|FG000|Treatment Phase|Adverse Event|9|||
106120351|NCT00735644|366097563|FG001|Overall Study|Withdrawal by Subject|1|||
106120352|NCT00735644|366097564|FG002|Overall Study|Withdrawal by Subject|1|||
106120353|NCT00735644|366097565|FG003|Overall Study|Withdrawal by Subject|1|||
106120354|NCT00735644|366097566|FG004|Overall Study|Withdrawal by Subject|0|||
106120355|NCT02961374|366097567|FG000|Overall Study|Adverse Event|4|||
106120356|NCT01734434|366097568|FG000|Overall Study|Death Infant|3|||
106120357|NCT01734434|366097569|FG001|Overall Study|Death Infant|1|||
106120358|NCT01734434|366097570|FG002|Overall Study|Death Infant|17|||
106120359|NCT01734434|366097571|FG003|Overall Study|Death Infant|5|||
106120360|NCT01734434|366097568|FG000|Overall Study|Lost to Follow-up|2|||
106120361|NCT01734434|366097569|FG001|Overall Study|Lost to Follow-up|9|||
106120362|NCT01734434|366097570|FG002|Overall Study|Lost to Follow-up|67|||
106120363|NCT01734434|366097571|FG003|Overall Study|Lost to Follow-up|11|||
106120364|NCT01734434|366097568|FG000|Overall Study|No Live Birth|1|||
106120365|NCT01734434|366097569|FG001|Overall Study|No Live Birth|2|||
106120366|NCT01734434|366097570|FG002|Overall Study|No Live Birth|32|||
106120367|NCT01734434|366097571|FG003|Overall Study|No Live Birth|6|||
106120368|NCT01734434|366097568|FG000|Overall Study|Withdrawal by Subject|4|||
106120369|NCT01734434|366097569|FG001|Overall Study|Withdrawal by Subject|0|||
106120370|NCT01734434|366097570|FG002|Overall Study|Withdrawal by Subject|8|||
106120371|NCT01734434|366097571|FG003|Overall Study|Withdrawal by Subject|1|||
106120372|NCT01734434|366097568|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
106120373|NCT01734434|366097569|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
106120374|NCT01734434|366097570|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
106120375|NCT01734434|366097571|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
105888585|NCT05238025|365246023|FG000|Overall Study|Lost to Follow-up|334|||
105888586|NCT05238025|365246024|FG001|Overall Study|Lost to Follow-up|339|||
105888587|NCT05238025|365246023|FG000|Overall Study|Withdrawal by Subject|203|||
105888588|NCT05238025|365246024|FG001|Overall Study|Withdrawal by Subject|222|||
106120376|NCT01734434|366097568|FG000|Overall Study|Subject Not Reachable|0|||
106120377|NCT01734434|366097569|FG001|Overall Study|Subject Not Reachable|0|||
106120378|NCT01734434|366097570|FG002|Overall Study|Subject Not Reachable|1|||
106120379|NCT01734434|366097571|FG003|Overall Study|Subject Not Reachable|0|||
106120380|NCT01734434|366097568|FG000|Overall Study|Treatment Defaulter|0|||
105663195|NCT00940875|364432406|FG001|Treatment Phase|Adverse Event|3|||
105663196|NCT00940875|364432405|FG000|Treatment Phase|Death|3|||
105663197|NCT00940875|364432406|FG001|Treatment Phase|Death|5|||
105888589|NCT05238025|365246023|FG000|Overall Study|Physician Decision|20|||
106120381|NCT01734434|366097569|FG001|Overall Study|Treatment Defaulter|0|||
105888590|NCT05238025|365246024|FG001|Overall Study|Physician Decision|8|||
105888591|NCT05238025|365246023|FG000|Overall Study|Protocol Violation|6|||
105888592|NCT05238025|365246024|FG001|Overall Study|Protocol Violation|2|||
106120382|NCT01734434|366097570|FG002|Overall Study|Treatment Defaulter|1|||
106120383|NCT01734434|366097571|FG003|Overall Study|Treatment Defaulter|0|||
106120384|NCT01734434|366097568|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
106120385|NCT01734434|366097569|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
106120386|NCT01734434|366097570|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
106120387|NCT01734434|366097571|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
106120388|NCT01734434|366097568|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
106120389|NCT01734434|366097569|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
106120390|NCT01734434|366097570|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
106120391|NCT01734434|366097571|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
106120392|NCT01567865|366097574|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
106120393|NCT01567865|366097575|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
106120394|NCT01567865|366097576|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
106120395|NCT01567865|366097577|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
106120396|NCT01567865|366097574|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
106120397|NCT01567865|366097575|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
106120398|NCT01567865|366097576|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
106120399|NCT01567865|366097577|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
106120400|NCT04921969|366097583|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
106120401|NCT04921969|366097584|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
106120402|NCT04921969|366097585|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
106120403|NCT04921969|366097586|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
106120404|NCT04921969|366097587|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
106120405|NCT04921969|366097588|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
106120406|NCT04921969|366097589|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
106120407|NCT04921969|366097583|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
106120408|NCT04921969|366097584|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
106120409|NCT04921969|366097585|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
106120410|NCT04921969|366097586|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
106120411|NCT04921969|366097587|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
106120412|NCT04921969|366097588|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
106120413|NCT04921969|366097589|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
106120414|NCT04921969|366097583|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
106120415|NCT04921969|366097584|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
106120416|NCT04921969|366097585|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
106120417|NCT04921969|366097586|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
106120418|NCT04921969|366097587|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
106120419|NCT04921969|366097588|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
106120420|NCT04921969|366097589|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
106120421|NCT04921969|366097583|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
106120422|NCT04921969|366097584|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
106120423|NCT04921969|366097585|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
106120424|NCT04921969|366097586|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
106120425|NCT04921969|366097587|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
106120426|NCT04921969|366097588|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
106120427|NCT04921969|366097589|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
106120428|NCT04921969|366097583|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
106120429|NCT04921969|366097584|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
106120430|NCT04921969|366097585|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
106120431|NCT04921969|366097586|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
106120432|NCT04921969|366097587|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
106120433|NCT04921969|366097588|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
106120434|NCT04921969|366097589|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
106120435|NCT04921969|366097583|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
106120436|NCT04921969|366097584|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
106120437|NCT04921969|366097585|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
106120438|NCT04921969|366097586|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
106120439|NCT04921969|366097587|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
106120440|NCT04921969|366097588|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
106120441|NCT04921969|366097589|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
106120442|NCT04921969|366097583|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
106120443|NCT04921969|366097584|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
106120444|NCT04921969|366097585|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
106120445|NCT04921969|366097586|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
105663198|NCT00940875|364432405|FG000|Treatment Phase|Lack of Efficacy|1|||
105888593|NCT05238025|365246023|FG000|Overall Study|Death|38|||
106120446|NCT04921969|366097587|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
106120447|NCT04921969|366097588|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
106120448|NCT04921969|366097589|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
106120449|NCT04921969|366097583|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
106120450|NCT04921969|366097584|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
106120451|NCT04921969|366097585|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
106120452|NCT04921969|366097586|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
106120453|NCT04921969|366097587|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
106120454|NCT04921969|366097588|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
106120455|NCT04921969|366097589|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
106120456|NCT04921969|366097583|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
106120457|NCT04921969|366097584|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
106120458|NCT04921969|366097585|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
106120459|NCT04921969|366097586|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
106120460|NCT04921969|366097587|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
106120461|NCT04921969|366097588|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
106120462|NCT04921969|366097589|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
106120463|NCT04921969|366097583|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
106120464|NCT04921969|366097584|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
106120465|NCT04921969|366097585|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
106120466|NCT04921969|366097586|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
106120467|NCT04921969|366097587|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
106120468|NCT04921969|366097588|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
106120469|NCT04921969|366097589|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
106120470|NCT04921969|366097583|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
106120471|NCT04921969|366097584|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
106120472|NCT04921969|366097585|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
106120473|NCT04921969|366097586|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
106120474|NCT04921969|366097587|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
106120475|NCT04921969|366097588|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
106120476|NCT04921969|366097589|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
106120477|NCT04921969|366097583|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
106120478|NCT04921969|366097584|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
106120479|NCT04921969|366097585|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
106120480|NCT04921969|366097586|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
106120481|NCT04921969|366097587|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
106120482|NCT04921969|366097588|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
106120483|NCT04921969|366097589|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
106120484|NCT04921969|366097583|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
106120485|NCT04921969|366097584|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
106120486|NCT04921969|366097585|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
106120487|NCT04921969|366097586|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
106120488|NCT04921969|366097587|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
106120489|NCT04921969|366097588|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
106120490|NCT04921969|366097589|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
106120491|NCT04921969|366097583|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
106120492|NCT04921969|366097584|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
106120493|NCT04921969|366097585|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
106120494|NCT04921969|366097586|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
106120495|NCT04921969|366097587|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
106120496|NCT04921969|366097588|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
106120497|NCT04921969|366097589|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
106120498|NCT04921969|366097583|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
106120499|NCT04921969|366097584|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
106120500|NCT04921969|366097585|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
106120501|NCT04921969|366097586|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
106120502|NCT04921969|366097587|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
106120503|NCT04921969|366097588|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
106120504|NCT04921969|366097589|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
106120505|NCT03391960|366097590|FG000|Overall Study|Protocol Violation|0|||
106120506|NCT03391960|366097591|FG001|Overall Study|Protocol Violation|0|||
106120507|NCT02924389|366097592|FG000|Overall Study|Lost to Follow-up|1|||
106120508|NCT02924389|366097593|FG001|Overall Study|Lost to Follow-up|0|||
106120509|NCT02924389|366097592|FG000|Overall Study|Physician Decision|2|||
106120510|NCT02924389|366097593|FG001|Overall Study|Physician Decision|0|||
106120511|NCT02924389|366097592|FG000|Overall Study|Withdrawal by Subject|3|||
106120512|NCT02924389|366097593|FG001|Overall Study|Withdrawal by Subject|0|||
106120513|NCT02924389|366097592|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
105995844|NCT00216671|365644202|FG001|Overall Study|Physician Decision|1|||
105995845|NCT00216671|365644201|FG000|Overall Study|Protocol Violation|3|||
105995846|NCT00216671|365644202|FG001|Overall Study|Protocol Violation|5|||
105995847|NCT00216671|365644201|FG000|Overall Study|Relapse|1|||
105995848|NCT00216671|365644202|FG001|Overall Study|Relapse|0|||
105995849|NCT00216671|365644201|FG000|Overall Study|Investigator Illness|0|||
105995850|NCT00216671|365644202|FG001|Overall Study|Investigator Illness|1|||
105995851|NCT00216671|365644201|FG000|Overall Study|Patient Moved|0|||
105995852|NCT00216671|365644202|FG001|Overall Study|Patient Moved|1|||
105995853|NCT00216671|365644201|FG000|Overall Study|Ineligible, no efficacy data|2|||
105995854|NCT00216671|365644202|FG001|Overall Study|Ineligible, no efficacy data|2|||
105995855|NCT00216671|365644201|FG000|Overall Study|Insufficient Response Adverse Event|2|||
105995856|NCT00216671|365644202|FG001|Overall Study|Insufficient Response Adverse Event|1|||
105995857|NCT03710642|365644203|FG000|Overall Study|Adverse Event|5|||
105995858|NCT03710642|365644204|FG001|Overall Study|Adverse Event|1|||
105995859|NCT03710642|365644203|FG000|Overall Study|non-site physician recommendation|1|||
105995860|NCT03710642|365644204|FG001|Overall Study|non-site physician recommendation|0|||
105995861|NCT03710642|365644203|FG000|Overall Study|Participant unwilling or unable to participate|1|||
105995862|NCT03710642|365644204|FG001|Overall Study|Participant unwilling or unable to participate|1|||
105995863|NCT03710642|365644203|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
105995864|NCT03710642|365644204|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
105995865|NCT03710642|365644203|FG000|Overall Study|NA-no code provided|1|||
105995866|NCT03710642|365644204|FG001|Overall Study|NA-no code provided|0|||
105995867|NCT03710642|365644203|FG000|Overall Study|Withdrawal by Subject|1|||
105995868|NCT03710642|365644204|FG001|Overall Study|Withdrawal by Subject|0|||
105995869|NCT01427933|365644205|FG000|Overall Study|Withdrawal by Subject|5|||
105995870|NCT01427933|365644206|FG001|Overall Study|Withdrawal by Subject|8|||
105995871|NCT01427933|365644205|FG000|Overall Study|Lost to Follow-up|1|||
105995872|NCT01427933|365644206|FG001|Overall Study|Lost to Follow-up|5|||
105995873|NCT01427933|365644205|FG000|Overall Study|Other|1|||
105995874|NCT01427933|365644206|FG001|Overall Study|Other|0|||
105995875|NCT01427933|365644205|FG000|Overall Study|Investigator's Decision|1|||
105995876|NCT01427933|365644206|FG001|Overall Study|Investigator's Decision|0|||
105995877|NCT03472326|365644207|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
105995878|NCT03472326|365644208|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
105995879|NCT03472326|365644209|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
105995880|NCT03472326|365644210|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
105995881|NCT03472326|365644207|FG000|Part 2: Combination Therapy|Pregnancy|0|||
105995882|NCT03472326|365644208|FG001|Part 2: Combination Therapy|Pregnancy|0|||
105995883|NCT03472326|365644209|FG002|Part 2: Combination Therapy|Pregnancy|0|||
105995884|NCT03472326|365644210|FG003|Part 2: Combination Therapy|Pregnancy|1|||
105995885|NCT05447663|365644211|FG000|Overall Study|Study terminated by Sponsor|5|||
105995886|NCT05447663|365644211|FG000|Overall Study|Death|2|||
105995887|NCT05447663|365644211|FG000|Overall Study|Withdrawal by Subject|1|||
105995888|NCT03797586|365644212|FG000|Overall Study|Lost to Follow-up|3|||
105995889|NCT03797586|365644213|FG001|Overall Study|Lost to Follow-up|6|||
105995890|NCT03797586|365644212|FG000|Overall Study|Death|1|||
105995891|NCT03797586|365644213|FG001|Overall Study|Death|1|||
105995892|NCT03797586|365644212|FG000|Overall Study|Adverse Event|0|||
105995893|NCT03797586|365644213|FG001|Overall Study|Adverse Event|2|||
105995894|NCT01369784|365644214|FG000|Overall Study|Protocol Violation|12|||
105995895|NCT04797780|365644215|FG000|Overall Study|Lost to Follow-up|1|||
105995896|NCT04797780|365644216|FG001|Overall Study|Lost to Follow-up|1|||
105995897|NCT04797780|365644215|FG000|Overall Study|Withdrawal by Subject|14|||
105888594|NCT05238025|365246024|FG001|Overall Study|Death|32|||
105888595|NCT05238025|365246023|FG000|Overall Study|Study terminated by Sponsor|6358|||
105888596|NCT05238025|365246024|FG001|Overall Study|Study terminated by Sponsor|6358|||
105888597|NCT05238025|365246023|FG000|Overall Study|Other Reason|669|||
105888598|NCT05238025|365246024|FG001|Overall Study|Other Reason|690|||
105888599|NCT03626363|365246028|FG000|Overall Study|Protocol Violation|4|||
105888600|NCT03626363|365246029|FG001|Overall Study|Protocol Violation|0|||
105888601|NCT03626363|365246028|FG000|Overall Study|Lost to Follow-up|5|||
105888602|NCT03626363|365246029|FG001|Overall Study|Lost to Follow-up|7|||
105888603|NCT00533702|365246030|FG000|Overall Study|Withdrawal by Subject|3|||
105995898|NCT04797780|365644216|FG001|Overall Study|Withdrawal by Subject|9|||
105995899|NCT04797780|365644215|FG000|Overall Study|Death|49|||
105995900|NCT04797780|365644216|FG001|Overall Study|Death|20|||
105995901|NCT02586727|365644217|FG000|Overall Study|Lost to Follow-up|1|||
105995902|NCT02586727|365644218|FG001|Overall Study|Lost to Follow-up|0|||
105888604|NCT00533702|365246031|FG001|Overall Study|Withdrawal by Subject|1|||
105888605|NCT00533702|365246030|FG000|Overall Study|Found ineligible after randomization|2|||
105995903|NCT00566852|365644221|FG000|Overall Study|Protocol Violation|22|||
105995904|NCT00566852|365644222|FG001|Overall Study|Protocol Violation|24|||
105995905|NCT00566852|365644221|FG000|Overall Study|Death|95|||
105995906|NCT00566852|365644222|FG001|Overall Study|Death|78|||
105995907|NCT00566852|365644221|FG000|Overall Study|Withdrawal by Subject|30|||
105995908|NCT00566852|365644222|FG001|Overall Study|Withdrawal by Subject|25|||
105663199|NCT00940875|364432406|FG001|Treatment Phase|Lack of Efficacy|0|||
105663200|NCT00940875|364432405|FG000|Treatment Phase|Withdrawal by Subject|3|||
105663201|NCT00940875|364432406|FG001|Treatment Phase|Withdrawal by Subject|0|||
105663202|NCT00940875|364432405|FG000|Treatment Phase|Disease progression|9|||
105663203|NCT00940875|364432406|FG001|Treatment Phase|Disease progression|11|||
105663204|NCT00940875|364432405|FG000|Treatment Phase|Physician Decision|1|||
105663205|NCT00940875|364432406|FG001|Treatment Phase|Physician Decision|0|||
105663206|NCT00940875|364432405|FG000|Post-Study Treatment|Death|0|||
105663207|NCT00940875|364432406|FG001|Post-Study Treatment|Death|1|||
105663208|NCT00940875|364432405|FG000|Post-Study Treatment|Disease Progression|0|||
105663209|NCT00940875|364432406|FG001|Post-Study Treatment|Disease Progression|2|||
105663210|NCT04071301|364432412|FG000|Overall Study|Withdrawal by Subject|6|||
105663211|NCT04071301|364432412|FG000|Overall Study|Death|1|||
105663212|NCT01453023|364432413|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
105663213|NCT01453023|364432414|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
105663214|NCT01453023|364432413|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
106120514|NCT02924389|366097593|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
106120515|NCT00663117|366100127|FG000|Overall Study|Lack of Efficacy|1|||
106120516|NCT00663117|366100128|FG001|Overall Study|Lack of Efficacy|0|||
106120517|NCT00311155|366100129|FG000|Overall Study|Adverse Event|21|||
106120518|NCT00311155|366100129|FG000|Overall Study|Withdrawal by Subject|17|||
106120519|NCT00311155|366100129|FG000|Overall Study|Did not meet entry criteria|55|||
106120520|NCT02769065|366100130|FG000|Overall Study|Voluntary Withdrawal|1|||
105663215|NCT01453023|364432414|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
105785395|NCT01016912|364866487|FG000|End of Treatment Period|Completed double-blind period only|0|||
106120521|NCT02769065|366100131|FG001|Overall Study|Voluntary Withdrawal|0|||
106120522|NCT02769065|366100132|FG002|Overall Study|Voluntary Withdrawal|0|||
106120523|NCT02769065|366100133|FG003|Overall Study|Voluntary Withdrawal|0|||
105785396|NCT01016912|364866488|FG001|End of Treatment Period|Completed double-blind period only|1|||
105785397|NCT01016912|364866489|FG002|End of Treatment Period|Completed double-blind period only|0|||
105785398|NCT01016912|364866490|FG003|End of Treatment Period|Completed double-blind period only|0|||
105785399|NCT01016912|364866491|FG004|End of Treatment Period|Completed double-blind period only|0|||
105785400|NCT01016912|364866487|FG000|Follow-up Period|Other reason|0|||
105785401|NCT01016912|364866488|FG001|Follow-up Period|Other reason|0|||
105785402|NCT01016912|364866489|FG002|Follow-up Period|Other reason|1|||
105785403|NCT01016912|364866490|FG003|Follow-up Period|Other reason|1|||
105785404|NCT01016912|364866491|FG004|Follow-up Period|Other reason|0|||
105785405|NCT01119118|364866492|FG000|Overall Study|Adverse Event|1|||
105785406|NCT01003691|364866494|FG000|Overall Study|Adverse Event|0|||
105785407|NCT01003691|364866495|FG001|Overall Study|Adverse Event|0|||
105785408|NCT01003691|364866496|FG002|Overall Study|Adverse Event|0|||
105785409|NCT01003691|364866497|FG003|Overall Study|Adverse Event|1|||
105785410|NCT01875731|364866498|FG000|Overall Study|Fail to obtain lab sample|1|||
105785411|NCT01875731|364866499|FG001|Overall Study|Fail to obtain lab sample|0|||
105785412|NCT03417102|364866500|FG000|Overall Study|Adverse Event|0|||
105785413|NCT03417102|364866501|FG001|Overall Study|Adverse Event|1|||
105785414|NCT03417102|364866500|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
105785415|NCT03417102|364866501|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
105785416|NCT03417102|364866500|FG000|Overall Study|Other|0|||
105785417|NCT03417102|364866501|FG001|Overall Study|Other|1|||
105785418|NCT03418727|364866502|FG000|Overall Study|Adverse Event|1|||
105785419|NCT03418727|364866503|FG001|Overall Study|Adverse Event|2|||
105785420|NCT03418727|364866504|FG002|Overall Study|Adverse Event|0|||
105785421|NCT03418727|364866502|FG000|Overall Study|Withdrawal by Subject|0|||
105785422|NCT03418727|364866503|FG001|Overall Study|Withdrawal by Subject|0|||
105785423|NCT03418727|364866504|FG002|Overall Study|Withdrawal by Subject|2|||
105785424|NCT01018680|364868458|FG000|Overall Study|Adverse Event|23|||
105785425|NCT01018680|364868459|FG001|Overall Study|Adverse Event|40|||
105785426|NCT01018680|364868458|FG000|Overall Study|Withdrawal by Subject|10|||
105785427|NCT01018680|364868459|FG001|Overall Study|Withdrawal by Subject|10|||
105785428|NCT01018680|364868458|FG000|Overall Study|Protocol Violation|5|||
105785429|NCT01018680|364868459|FG001|Overall Study|Protocol Violation|8|||
105785430|NCT01018680|364868458|FG000|Overall Study|Sponsor Decision|6|||
105785431|NCT01018680|364868459|FG001|Overall Study|Sponsor Decision|7|||
105785432|NCT01018680|364868458|FG000|Overall Study|Lack of Efficacy|8|||
105785433|NCT01018680|364868459|FG001|Overall Study|Lack of Efficacy|2|||
105785434|NCT01018680|364868458|FG000|Overall Study|Lost to Follow-up|5|||
105785435|NCT01018680|364868459|FG001|Overall Study|Lost to Follow-up|3|||
105785436|NCT01018680|364868458|FG000|Overall Study|Entry Criteria Not Met|1|||
105785437|NCT01018680|364868459|FG001|Overall Study|Entry Criteria Not Met|4|||
105785438|NCT01018680|364868458|FG000|Overall Study|Physician Decision|3|||
105785439|NCT01018680|364868459|FG001|Overall Study|Physician Decision|1|||
105785440|NCT02930889|364868460|FG000|Overall Study|Lost to Follow-up|2|||
105785441|NCT02930889|364868460|FG000|Overall Study|Withdrawal by Subject|6|||
105663216|NCT01453023|364432413|FG000|Treatment Period 2|Protocol Violation|0|||
105663217|NCT01453023|364432414|FG001|Treatment Period 2|Protocol Violation|1|||
105663218|NCT04468230|364432420|FG000|Overall Study|Adverse Event|2|||
105663219|NCT00420784|364432421|FG000|Overall Study|Adverse Event|11|||
105663220|NCT00420784|364432422|FG001|Overall Study|Adverse Event|29|||
105663221|NCT00420784|364432423|FG002|Overall Study|Adverse Event|10|||
105663222|NCT00420784|364432424|FG003|Overall Study|Adverse Event|5|||
105663223|NCT00420784|364432421|FG000|Overall Study|Withdrawal by Subject|0|||
105663224|NCT00420784|364432422|FG001|Overall Study|Withdrawal by Subject|1|||
105663225|NCT00420784|364432423|FG002|Overall Study|Withdrawal by Subject|0|||
105663226|NCT00420784|364432424|FG003|Overall Study|Withdrawal by Subject|0|||
105663227|NCT00420784|364432421|FG000|Overall Study|Lost to Follow-up|0|||
105663228|NCT00420784|364432422|FG001|Overall Study|Lost to Follow-up|0|||
105663229|NCT00420784|364432423|FG002|Overall Study|Lost to Follow-up|2|||
105663230|NCT00420784|364432424|FG003|Overall Study|Lost to Follow-up|1|||
105663231|NCT00420784|364432421|FG000|Overall Study|Virologic Stopping Rule|17|||
105663232|NCT00420784|364432422|FG001|Overall Study|Virologic Stopping Rule|26|||
105663233|NCT00420784|364432423|FG002|Overall Study|Virologic Stopping Rule|41|||
105663234|NCT00420784|364432424|FG003|Overall Study|Virologic Stopping Rule|67|||
105663235|NCT00420784|364432421|FG000|Overall Study|Other|1|||
105663236|NCT00420784|364432422|FG001|Overall Study|Other|2|||
105663237|NCT00420784|364432423|FG002|Overall Study|Other|0|||
105663238|NCT00420784|364432424|FG003|Overall Study|Other|5|||
105663239|NCT04799418|364432425|FG000|Overall Study|Death|1|||
105663240|NCT04799418|364432426|FG001|Overall Study|Death|1|||
105663241|NCT04799418|364432425|FG000|Overall Study|Lack of Efficacy|14|||
105663242|NCT04799418|364432426|FG001|Overall Study|Lack of Efficacy|14|||
105663243|NCT04799418|364432425|FG000|Overall Study|Withdrawal by Subject|10|||
105663244|NCT04799418|364432426|FG001|Overall Study|Withdrawal by Subject|7|||
105663245|NCT04799418|364432425|FG000|Overall Study|Adverse Event|3|||
105663246|NCT04799418|364432426|FG001|Overall Study|Adverse Event|2|||
105663247|NCT02844777|364432438|FG000|Overall Study|Withdrawal by Subject|2|||
105663248|NCT02844777|364432439|FG001|Overall Study|Withdrawal by Subject|0|||
105663249|NCT02844777|364432440|FG002|Overall Study|Withdrawal by Subject|0|||
105663250|NCT04092452|364432442|FG000|Overall Study|Adverse Event|1|||
105663251|NCT04092452|364432443|FG001|Overall Study|Adverse Event|3|||
105663252|NCT04092452|364432444|FG002|Overall Study|Adverse Event|3|||
105663253|NCT04092452|364432445|FG003|Overall Study|Adverse Event|7|||
105663254|NCT04092452|364432442|FG000|Overall Study|Lack of Efficacy|1|||
105888606|NCT00533702|365246031|FG001|Overall Study|Found ineligible after randomization|1|||
105888607|NCT03467217|365247673|FG000|Overall Study|Trial stopped early|5|||
105663255|NCT04092452|364432443|FG001|Overall Study|Lack of Efficacy|1|||
105663256|NCT04092452|364432444|FG002|Overall Study|Lack of Efficacy|1|||
105663257|NCT04092452|364432445|FG003|Overall Study|Lack of Efficacy|0|||
105663258|NCT04092452|364432442|FG000|Overall Study|Lost to Follow-up|4|||
105663259|NCT04092452|364432443|FG001|Overall Study|Lost to Follow-up|3|||
105663260|NCT04092452|364432444|FG002|Overall Study|Lost to Follow-up|5|||
105663261|NCT04092452|364432445|FG003|Overall Study|Lost to Follow-up|1|||
105663262|NCT04092452|364432442|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105663263|NCT04092452|364432443|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105663264|NCT04092452|364432444|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105663265|NCT04092452|364432445|FG003|Overall Study|Non-Compliance With Study Drug|1|||
105663266|NCT04092452|364432442|FG000|Overall Study|Physician Decision|1|||
105663267|NCT04092452|364432443|FG001|Overall Study|Physician Decision|0|||
105663268|NCT04092452|364432444|FG002|Overall Study|Physician Decision|1|||
105663269|NCT04092452|364432445|FG003|Overall Study|Physician Decision|0|||
105663270|NCT04092452|364432442|FG000|Overall Study|Pregnancy|2|||
105663271|NCT04092452|364432443|FG001|Overall Study|Pregnancy|0|||
105888608|NCT03467217|365247674|FG001|Overall Study|Trial stopped early|2|||
105888609|NCT03467217|365247673|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
105888610|NCT03467217|365247674|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
105663272|NCT04092452|364432444|FG002|Overall Study|Pregnancy|0|||
105663273|NCT04092452|364432445|FG003|Overall Study|Pregnancy|0|||
105663274|NCT04092452|364432442|FG000|Overall Study|Protocol Deviation|1|||
105888611|NCT03467217|365247673|FG000|Overall Study|Lost to Follow-up|0|||
105888612|NCT03467217|365247674|FG001|Overall Study|Lost to Follow-up|2|||
105888613|NCT00972816|365247676|FG000|Overall Study|Adverse Event|0|||
105888614|NCT00972816|365247677|FG001|Overall Study|Adverse Event|0|||
105663275|NCT04092452|364432443|FG001|Overall Study|Protocol Deviation|0|||
105663276|NCT04092452|364432444|FG002|Overall Study|Protocol Deviation|0|||
105663277|NCT04092452|364432445|FG003|Overall Study|Protocol Deviation|0|||
105663278|NCT04092452|364432442|FG000|Overall Study|Withdrawal by Subject|3|||
105663279|NCT04092452|364432443|FG001|Overall Study|Withdrawal by Subject|10|||
105663280|NCT04092452|364432444|FG002|Overall Study|Withdrawal by Subject|3|||
105663281|NCT04092452|364432445|FG003|Overall Study|Withdrawal by Subject|5|||
105888615|NCT00972816|365247678|FG002|Overall Study|Adverse Event|1|||
105663282|NCT04092452|364432442|FG000|Overall Study|Other|0|||
105663283|NCT04092452|364432443|FG001|Overall Study|Other|0|||
105663284|NCT04092452|364432444|FG002|Overall Study|Other|1|||
105888616|NCT00972816|365247679|FG003|Overall Study|Adverse Event|0|||
105888617|NCT00972816|365247680|FG004|Overall Study|Adverse Event|0|||
105888618|NCT00972816|365247681|FG005|Overall Study|Adverse Event|0|||
105888619|NCT00972816|365247682|FG006|Overall Study|Adverse Event|0|||
105888620|NCT00972816|365247683|FG007|Overall Study|Adverse Event|0|||
105888621|NCT00972816|365247676|FG000|Overall Study|Withdrawal by Subject|4|||
105888622|NCT00972816|365247677|FG001|Overall Study|Withdrawal by Subject|2|||
105888623|NCT00972816|365247678|FG002|Overall Study|Withdrawal by Subject|1|||
105888624|NCT00972816|365247679|FG003|Overall Study|Withdrawal by Subject|3|||
105888625|NCT00972816|365247680|FG004|Overall Study|Withdrawal by Subject|0|||
105888626|NCT00972816|365247681|FG005|Overall Study|Withdrawal by Subject|1|||
105888627|NCT00972816|365247682|FG006|Overall Study|Withdrawal by Subject|1|||
105888628|NCT00972816|365247683|FG007|Overall Study|Withdrawal by Subject|2|||
105888629|NCT00972816|365247676|FG000|Overall Study|Lost to Follow-up|11|||
105888630|NCT00972816|365247677|FG001|Overall Study|Lost to Follow-up|9|||
105888631|NCT00972816|365247678|FG002|Overall Study|Lost to Follow-up|7|||
105888632|NCT00972816|365247679|FG003|Overall Study|Lost to Follow-up|5|||
105888633|NCT00972816|365247680|FG004|Overall Study|Lost to Follow-up|11|||
105888634|NCT00972816|365247681|FG005|Overall Study|Lost to Follow-up|10|||
105888635|NCT00972816|365247682|FG006|Overall Study|Lost to Follow-up|7|||
105888636|NCT00972816|365247683|FG007|Overall Study|Lost to Follow-up|7|||
105888637|NCT00972816|365247676|FG000|Overall Study|Inappropriate enrolment|0|||
105888638|NCT00972816|365247677|FG001|Overall Study|Inappropriate enrolment|0|||
105888639|NCT00972816|365247678|FG002|Overall Study|Inappropriate enrolment|0|||
105888640|NCT00972816|365247679|FG003|Overall Study|Inappropriate enrolment|0|||
105888641|NCT00972816|365247680|FG004|Overall Study|Inappropriate enrolment|0|||
105888642|NCT00972816|365247681|FG005|Overall Study|Inappropriate enrolment|0|||
105888643|NCT00972816|365247682|FG006|Overall Study|Inappropriate enrolment|2|||
105888644|NCT00972816|365247683|FG007|Overall Study|Inappropriate enrolment|0|||
105888645|NCT00972816|365247676|FG000|Overall Study|Unable to classify|2|||
105888646|NCT00972816|365247677|FG001|Overall Study|Unable to classify|0|||
105888647|NCT00972816|365247678|FG002|Overall Study|Unable to classify|0|||
105888648|NCT00972816|365247679|FG003|Overall Study|Unable to classify|0|||
106120524|NCT02769065|366100134|FG004|Overall Study|Voluntary Withdrawal|0|||
106120525|NCT02769065|366100135|FG005|Overall Study|Voluntary Withdrawal|0|||
106120526|NCT02769065|366100136|FG006|Overall Study|Voluntary Withdrawal|0|||
106120527|NCT02769065|366100137|FG007|Overall Study|Voluntary Withdrawal|0|||
106120528|NCT02769065|366100138|FG008|Overall Study|Voluntary Withdrawal|0|||
106120529|NCT02769065|366100139|FG009|Overall Study|Voluntary Withdrawal|0|||
106120530|NCT02769065|366100140|FG010|Overall Study|Voluntary Withdrawal|0|||
106120531|NCT02769065|366100141|FG011|Overall Study|Voluntary Withdrawal|0|||
106120532|NCT02769065|366100142|FG012|Overall Study|Voluntary Withdrawal|0|||
106120533|NCT02769065|366100143|FG013|Overall Study|Voluntary Withdrawal|0|||
106120534|NCT02769065|366100144|FG014|Overall Study|Voluntary Withdrawal|0|||
106120535|NCT02769065|366100145|FG015|Overall Study|Voluntary Withdrawal|0|||
106120536|NCT02769065|366100146|FG016|Overall Study|Voluntary Withdrawal|0|||
106120537|NCT02769065|366100147|FG017|Overall Study|Voluntary Withdrawal|0|||
106120538|NCT02769065|366100148|FG018|Overall Study|Voluntary Withdrawal|0|||
106120539|NCT02769065|366100149|FG019|Overall Study|Voluntary Withdrawal|0|||
106120540|NCT02769065|366100150|FG020|Overall Study|Voluntary Withdrawal|0|||
106120541|NCT02769065|366100151|FG021|Overall Study|Voluntary Withdrawal|0|||
106120542|NCT02769065|366100152|FG022|Overall Study|Voluntary Withdrawal|0|||
106120543|NCT02769065|366100153|FG023|Overall Study|Voluntary Withdrawal|0|||
106120544|NCT02769065|366100154|FG024|Overall Study|Voluntary Withdrawal|0|||
106120545|NCT02769065|366100155|FG025|Overall Study|Voluntary Withdrawal|0|||
106120546|NCT02769065|366100156|FG026|Overall Study|Voluntary Withdrawal|0|||
106120547|NCT02769065|366100157|FG027|Overall Study|Voluntary Withdrawal|0|||
106120548|NCT02769065|366100158|FG028|Overall Study|Voluntary Withdrawal|0|||
106120549|NCT02769065|366100159|FG029|Overall Study|Voluntary Withdrawal|0|||
106120550|NCT02769065|366100130|FG000|Overall Study|Reason Not Specified|0|||
106120551|NCT02769065|366100131|FG001|Overall Study|Reason Not Specified|0|||
106120552|NCT02769065|366100132|FG002|Overall Study|Reason Not Specified|0|||
106120553|NCT02769065|366100133|FG003|Overall Study|Reason Not Specified|0|||
106120554|NCT02769065|366100134|FG004|Overall Study|Reason Not Specified|0|||
106120555|NCT02769065|366100135|FG005|Overall Study|Reason Not Specified|0|||
106120556|NCT02769065|366100136|FG006|Overall Study|Reason Not Specified|1|||
106120557|NCT02769065|366100137|FG007|Overall Study|Reason Not Specified|0|||
106120558|NCT02769065|366100138|FG008|Overall Study|Reason Not Specified|0|||
106120559|NCT02769065|366100139|FG009|Overall Study|Reason Not Specified|0|||
106120560|NCT02769065|366100140|FG010|Overall Study|Reason Not Specified|0|||
106120561|NCT02769065|366100141|FG011|Overall Study|Reason Not Specified|0|||
106120562|NCT02769065|366100142|FG012|Overall Study|Reason Not Specified|0|||
106120563|NCT02769065|366100143|FG013|Overall Study|Reason Not Specified|0|||
106120564|NCT02769065|366100144|FG014|Overall Study|Reason Not Specified|0|||
105888649|NCT00972816|365247680|FG004|Overall Study|Unable to classify|1|||
105888650|NCT00972816|365247681|FG005|Overall Study|Unable to classify|0|||
105663285|NCT04092452|364432445|FG003|Overall Study|Other|2|||
105663286|NCT04016272|364432446|FG000|Overall Study|Withdrawal by Subject|1|||
105663287|NCT04016272|364432447|FG001|Overall Study|Withdrawal by Subject|2|||
105663288|NCT03355209|364432448|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
105663289|NCT03355209|364432449|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
105663290|NCT03355209|364432450|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
105663291|NCT03355209|364432451|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
105663292|NCT03355209|364432452|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
105663293|NCT03355209|364432453|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
105663294|NCT03355209|364432448|FG000|Part 1: Double-Blind Period|Death|0|||
105663295|NCT03355209|364432449|FG001|Part 1: Double-Blind Period|Death|0|||
105663296|NCT03355209|364432450|FG002|Part 1: Double-Blind Period|Death|1|||
105888651|NCT00972816|365247682|FG006|Overall Study|Unable to classify|0|||
105888652|NCT00972816|365247683|FG007|Overall Study|Unable to classify|0|||
105888653|NCT00784238|365247685|FG000|Overall Study|Adverse Event|14|||
105888654|NCT00784238|365247685|FG000|Overall Study|Death|2|||
105888655|NCT00784238|365247685|FG000|Overall Study|Lack of Efficacy|33|||
105888656|NCT00784238|365247685|FG000|Overall Study|Lost to Follow-up|29|||
105888657|NCT00784238|365247685|FG000|Overall Study|Pregnancy|1|||
105888658|NCT00784238|365247685|FG000|Overall Study|Withdrawal by Subject|26|||
105888659|NCT00784238|365247685|FG000|Overall Study|Other|14|||
105888660|NCT03030989|365247687|FG000|Overall Study|Fever|2|||
105888661|NCT03030989|365247688|FG001|Overall Study|Fever|2|||
105663297|NCT03355209|364432451|FG003|Part 1: Double-Blind Period|Death|0|||
105663298|NCT03355209|364432452|FG004|Part 1: Double-Blind Period|Death|0|||
105663299|NCT03355209|364432453|FG005|Part 1: Double-Blind Period|Death|0|||
105663300|NCT03355209|364432448|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
105663301|NCT03355209|364432449|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
105663302|NCT03355209|364432450|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
105663303|NCT03355209|364432451|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
105663304|NCT03355209|364432452|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
105663305|NCT03355209|364432453|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
105663306|NCT03355209|364432448|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
105663307|NCT03355209|364432449|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
105663308|NCT03355209|364432450|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
105663309|NCT03355209|364432451|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105663310|NCT03355209|364432452|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105663311|NCT03355209|364432453|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
105663312|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
105663313|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
105663314|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
105663315|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
105663316|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
105663317|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
105663318|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663319|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
105663320|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663321|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663322|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663323|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
105663324|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
106120565|NCT02769065|366100145|FG015|Overall Study|Reason Not Specified|0|||
106120566|NCT02769065|366100146|FG016|Overall Study|Reason Not Specified|0|||
106120567|NCT02769065|366100147|FG017|Overall Study|Reason Not Specified|0|||
106120568|NCT02769065|366100148|FG018|Overall Study|Reason Not Specified|0|||
106120569|NCT02769065|366100149|FG019|Overall Study|Reason Not Specified|0|||
106120570|NCT02769065|366100150|FG020|Overall Study|Reason Not Specified|0|||
106120571|NCT02769065|366100151|FG021|Overall Study|Reason Not Specified|0|||
106120572|NCT02769065|366100152|FG022|Overall Study|Reason Not Specified|0|||
106120573|NCT02769065|366100153|FG023|Overall Study|Reason Not Specified|0|||
106120574|NCT02769065|366100154|FG024|Overall Study|Reason Not Specified|0|||
106120575|NCT02769065|366100155|FG025|Overall Study|Reason Not Specified|0|||
106120576|NCT02769065|366100156|FG026|Overall Study|Reason Not Specified|0|||
106120577|NCT02769065|366100157|FG027|Overall Study|Reason Not Specified|0|||
105663325|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
105663326|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
105663327|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
105663328|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
105888662|NCT03030989|365247687|FG000|Overall Study|Rash|2|||
105888663|NCT03030989|365247688|FG001|Overall Study|Rash|1|||
105888664|NCT03030989|365247687|FG000|Overall Study|Fatigue/Overwhelmed|1|||
106120578|NCT02769065|366100158|FG028|Overall Study|Reason Not Specified|0|||
105888665|NCT03030989|365247688|FG001|Overall Study|Fatigue/Overwhelmed|5|||
105888666|NCT03030989|365247687|FG000|Overall Study|Positive Blood Cultures|2|||
105995909|NCT00566852|365644221|FG000|Overall Study|Patient refusal|37|||
105995910|NCT00566852|365644222|FG001|Overall Study|Patient refusal|37|||
105995911|NCT00566852|365644221|FG000|Overall Study|Not tested due to disability|6|||
105995912|NCT00566852|365644222|FG001|Overall Study|Not tested due to disability|12|||
105995913|NCT00566852|365644221|FG000|Overall Study|Missing reason not specified|1|||
105995914|NCT00566852|365644222|FG001|Overall Study|Missing reason not specified|2|||
105995915|NCT00566852|365644221|FG000|Overall Study|Missing reason not reported|16|||
105995916|NCT00566852|365644222|FG001|Overall Study|Missing reason not reported|20|||
105995917|NCT01147055|365644223|FG000|First Intervention Period|Lost to Follow-up|1|||
105995918|NCT01147055|365644224|FG001|First Intervention Period|Lost to Follow-up|0|||
105995919|NCT01327599|365644225|FG000|Overall Study|Adverse Event|1|||
105995920|NCT01327599|365644225|FG000|Overall Study|Could Not Attend Visit|1|||
105995921|NCT01327599|365644225|FG000|Overall Study|Withdrawal of Consent|1|||
105995922|NCT03952039|365644226|FG000|Overall Study|Adverse Event|22|||
105995923|NCT03952039|365644227|FG001|Overall Study|Adverse Event|8|||
105995924|NCT03952039|365644226|FG000|Overall Study|Withdrawal by Participant|17|||
105995925|NCT03952039|365644227|FG001|Overall Study|Withdrawal by Participant|12|||
105995926|NCT03952039|365644226|FG000|Overall Study|Death|13|||
105995927|NCT03952039|365644227|FG001|Overall Study|Death|6|||
105995928|NCT03952039|365644226|FG000|Overall Study|Lack of Efficacy|12|||
105995929|NCT03952039|365644227|FG001|Overall Study|Lack of Efficacy|2|||
105995930|NCT03952039|365644226|FG000|Overall Study|Physician Decision|9|||
105995931|NCT03952039|365644227|FG001|Overall Study|Physician Decision|3|||
105995932|NCT03952039|365644226|FG000|Overall Study|Progressive Disease|6|||
105995933|NCT03952039|365644227|FG001|Overall Study|Progressive Disease|4|||
105995934|NCT03952039|365644226|FG000|Overall Study|Other Reasons|12|||
105995935|NCT03952039|365644227|FG001|Overall Study|Other Reasons|4|||
105995936|NCT00874848|365644230|FG000|Overall Study|Adverse Event|13|||
105995937|NCT00874848|365644231|FG001|Overall Study|Adverse Event|2|||
105995938|NCT00874848|365644230|FG000|Overall Study|Progressive neoplastic disease|38|||
105995939|NCT00874848|365644231|FG001|Overall Study|Progressive neoplastic disease|18|||
105995940|NCT00874848|365644230|FG000|Overall Study|Withdrawal by Subject|7|||
105995941|NCT00874848|365644231|FG001|Overall Study|Withdrawal by Subject|4|||
105663329|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
105663330|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
105663331|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
105663332|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
105663333|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
105663334|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
105663335|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
105995942|NCT00874848|365644230|FG000|Overall Study|Noncompliance|1|||
105995943|NCT00874848|365644231|FG001|Overall Study|Noncompliance|1|||
105995944|NCT00874848|365644230|FG000|Overall Study|Failure to comply with protocol|0|||
105995945|NCT00874848|365644231|FG001|Overall Study|Failure to comply with protocol|1|||
105995946|NCT00874848|365644230|FG000|Overall Study|Physician Decision|0|||
105995947|NCT00874848|365644231|FG001|Overall Study|Physician Decision|2|||
105995948|NCT00892775|365644235|FG000|Overall Study|Protocol Violation|1|||
105995949|NCT00892775|365644236|FG001|Overall Study|Protocol Violation|0|||
106120579|NCT02769065|366100159|FG029|Overall Study|Reason Not Specified|0|||
106120580|NCT02769065|366100130|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120581|NCT02769065|366100131|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120582|NCT02769065|366100132|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120583|NCT02769065|366100133|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120584|NCT02769065|366100134|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120585|NCT02769065|366100135|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120586|NCT02769065|366100136|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120587|NCT02769065|366100137|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120588|NCT02769065|366100138|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120589|NCT02769065|366100139|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120590|NCT02769065|366100140|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
106120591|NCT02769065|366100141|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120592|NCT02769065|366100142|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120593|NCT02769065|366100143|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120594|NCT02769065|366100144|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120595|NCT02769065|366100145|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120596|NCT02769065|366100146|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120597|NCT02769065|366100147|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120598|NCT02769065|366100148|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120599|NCT02769065|366100149|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120600|NCT02769065|366100150|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120601|NCT02769065|366100151|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120602|NCT02769065|366100152|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120603|NCT02769065|366100153|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
105995950|NCT00892775|365644235|FG000|Overall Study|Subject difficulties with blood drawing|1|||
105995951|NCT00892775|365644236|FG001|Overall Study|Subject difficulties with blood drawing|0|||
105995952|NCT00892775|365644235|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
105995953|NCT00892775|365644236|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
105995954|NCT00892775|365644235|FG000|Overall Study|Migrated/ moved from study area|1|||
105995955|NCT00892775|365644236|FG001|Overall Study|Migrated/ moved from study area|0|||
105995956|NCT00892775|365644235|FG000|Overall Study|Withdrawal by Subject|0|||
105995957|NCT00892775|365644236|FG001|Overall Study|Withdrawal by Subject|1|||
105995958|NCT00892775|365644235|FG000|Overall Study|Lost to Follow-up|1|||
105995959|NCT00892775|365644236|FG001|Overall Study|Lost to Follow-up|0|||
105995960|NCT00064792|365644237|FG000|Overall Study|Withdrawal by Subject|2|||
105995961|NCT00064792|365644238|FG001|Overall Study|Withdrawal by Subject|0|||
105995962|NCT00064792|365644237|FG000|Overall Study|Adverse Event|3|||
105995963|NCT00064792|365644238|FG001|Overall Study|Adverse Event|0|||
105995964|NCT03301350|365644239|FG000|Overall Study|Withdrawal by Subject|4|||
105995965|NCT03301350|365644239|FG000|Overall Study|Adverse Event|1|||
105995966|NCT03301350|365644239|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
105995967|NCT03301350|365644239|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
105995968|NCT03301350|365644239|FG000|Overall Study|no detail provided|1|||
105995969|NCT03405818|365644242|FG000|Overall Study|Withdrawal by Subject|4|||
105995970|NCT03405818|365644242|FG000|Overall Study|Lost to Follow-up|4|||
105995971|NCT02464410|365644245|FG000|Overall Study|Death|3|||
105995972|NCT02464410|365644246|FG001|Overall Study|Death|4|||
105995973|NCT02464410|365644245|FG000|Overall Study|Lost to Follow-up|7|||
105995974|NCT02464410|365644246|FG001|Overall Study|Lost to Follow-up|9|||
105995975|NCT02464410|365644245|FG000|Overall Study|Withdrawal by Subject|12|||
105995976|NCT02464410|365644246|FG001|Overall Study|Withdrawal by Subject|3|||
105995977|NCT00176462|365644247|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
105995978|NCT00176462|365644248|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
105995979|NCT00176462|365644247|FG000|Induction (4 Weeks)|Death|1|||
105995980|NCT00176462|365644248|FG001|Induction (4 Weeks)|Death|2|||
105995981|NCT00176462|365644247|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
105995982|NCT00176462|365644248|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
105995983|NCT00176462|365644247|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
106120604|NCT02769065|366100154|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120605|NCT02769065|366100155|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
105888667|NCT03030989|365247688|FG001|Overall Study|Positive Blood Cultures|1|||
105888668|NCT03030989|365247687|FG000|Overall Study|Line Removed|0|||
105888669|NCT03030989|365247688|FG001|Overall Study|Line Removed|2|||
105888670|NCT03030989|365247687|FG000|Overall Study|No longer interested|5|||
105888671|NCT03030989|365247688|FG001|Overall Study|No longer interested|3|||
105888672|NCT02706886|365247689|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
105888673|NCT02706886|365247690|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
105888674|NCT02706886|365247691|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
105888675|NCT02706886|365247692|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
106120606|NCT02769065|366100156|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120607|NCT02769065|366100157|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120608|NCT02769065|366100158|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120609|NCT02769065|366100159|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
106120610|NCT03017235|366100160|FG000|Overall Study|Withdrawal by Subject|4|||
106120611|NCT03017235|366100161|FG001|Overall Study|Withdrawal by Subject|3|||
106120612|NCT03017235|366100160|FG000|Overall Study|Lost to Follow-up|2|||
106120613|NCT03017235|366100161|FG001|Overall Study|Lost to Follow-up|7|||
106120614|NCT03017235|366100160|FG000|Overall Study|Adverse Event|0|||
106120615|NCT03017235|366100161|FG001|Overall Study|Adverse Event|1|||
106120616|NCT03017235|366100160|FG000|Overall Study|Protocol Violation|2|||
106120617|NCT03017235|366100161|FG001|Overall Study|Protocol Violation|1|||
106120618|NCT03017235|366100160|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
106120619|NCT03017235|366100161|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
106120620|NCT02764775|366100162|FG000|Overall Study|Death|1|||
106120621|NCT02764775|366100162|FG000|Overall Study|Lost to Follow-up|2|||
106120622|NCT02764775|366100162|FG000|Overall Study|Withdrawal by Subject|3|||
106120623|NCT00767104|366100171|FG000|Overall Study|Lost to Follow-up|1|||
106120624|NCT00767104|366100172|FG001|Overall Study|Lost to Follow-up|2|||
105663336|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
105888676|NCT02706886|365247693|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
105888677|NCT02706886|365247694|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
105995984|NCT00176462|365644248|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
105995985|NCT00176462|365644247|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
105995986|NCT00176462|365644248|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
105995987|NCT00176462|365644247|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
106120625|NCT02791490|366100173|FG000|Overall Study|Lost to Follow-up|1|||
106120626|NCT02791490|366100174|FG001|Overall Study|Lost to Follow-up|2|||
105888678|NCT02706886|365247695|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
105995988|NCT00176462|365644248|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
105995989|NCT00176462|365644247|FG000|Consolidation (12 Weeks)|Not documented|0|||
105995990|NCT00176462|365644248|FG001|Consolidation (12 Weeks)|Not documented|1|||
105995991|NCT00176462|365644247|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
105995992|NCT00176462|365644248|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
105995993|NCT00176462|365644247|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
105995994|NCT00176462|365644248|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
105995995|NCT00543387|365644249|FG000|Panel 1 + Panel 2|Adverse Event|0|||
105995996|NCT00543387|365644250|FG001|Panel 1 + Panel 2|Adverse Event|1|||
105995997|NCT00543387|365644251|FG002|Panel 1 + Panel 2|Adverse Event|0|||
105995998|NCT00543387|365644252|FG003|Panel 1 + Panel 2|Adverse Event|0|||
105995999|NCT00543387|365644253|FG004|Panel 1 + Panel 2|Adverse Event|0|||
105996000|NCT00543387|365644254|FG005|Panel 1 + Panel 2|Adverse Event|0|||
105996001|NCT00543387|365644255|FG006|Panel 1 + Panel 2|Adverse Event|0|||
105996002|NCT00543387|365644256|FG007|Panel 1 + Panel 2|Adverse Event|1|||
105996003|NCT00543387|365644257|FG008|Panel 1 + Panel 2|Adverse Event|1|||
105996004|NCT00543387|365644258|FG009|Panel 1 + Panel 2|Adverse Event|0|||
105996005|NCT00543387|365644259|FG010|Panel 1 + Panel 2|Adverse Event|0|||
105996006|NCT00543387|365644249|FG000|Panel 1 + Panel 2|Physician Decision|0|||
105996007|NCT00543387|365644250|FG001|Panel 1 + Panel 2|Physician Decision|0|||
105996008|NCT00543387|365644251|FG002|Panel 1 + Panel 2|Physician Decision|1|||
105996009|NCT00543387|365644252|FG003|Panel 1 + Panel 2|Physician Decision|0|||
105996010|NCT00543387|365644253|FG004|Panel 1 + Panel 2|Physician Decision|0|||
105996011|NCT00543387|365644254|FG005|Panel 1 + Panel 2|Physician Decision|0|||
105996012|NCT00543387|365644255|FG006|Panel 1 + Panel 2|Physician Decision|0|||
105996013|NCT00543387|365644256|FG007|Panel 1 + Panel 2|Physician Decision|1|||
105996014|NCT00543387|365644257|FG008|Panel 1 + Panel 2|Physician Decision|0|||
105996015|NCT00543387|365644258|FG009|Panel 1 + Panel 2|Physician Decision|0|||
105996016|NCT00543387|365644259|FG010|Panel 1 + Panel 2|Physician Decision|0|||
105996017|NCT00543387|365644249|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
105996018|NCT00543387|365644250|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
105996019|NCT00543387|365644251|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
105996020|NCT00543387|365644252|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
105996021|NCT00543387|365644253|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
105996022|NCT00543387|365644254|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
105996023|NCT00543387|365644255|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
105996024|NCT00543387|365644256|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
105996025|NCT00543387|365644257|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
105996026|NCT00543387|365644258|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
105996027|NCT00543387|365644259|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
105996028|NCT00543387|365644249|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996029|NCT00543387|365644250|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996030|NCT00543387|365644251|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996031|NCT00543387|365644252|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996032|NCT00543387|365644253|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996033|NCT00543387|365644254|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996034|NCT00543387|365644255|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
105996035|NCT00543387|365644256|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996036|NCT00543387|365644257|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996037|NCT00543387|365644258|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996038|NCT00543387|365644259|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
105996039|NCT00543387|365644249|FG000|Crossover Participants|Progressive Disease|0|||
105996040|NCT00543387|365644250|FG001|Crossover Participants|Progressive Disease|0|||
105996041|NCT00543387|365644251|FG002|Crossover Participants|Progressive Disease|0|||
105996042|NCT00543387|365644252|FG003|Crossover Participants|Progressive Disease|0|||
105996043|NCT00543387|365644253|FG004|Crossover Participants|Progressive Disease|0|||
105996044|NCT00543387|365644254|FG005|Crossover Participants|Progressive Disease|0|||
105996045|NCT00543387|365644255|FG006|Crossover Participants|Progressive Disease|0|||
105996046|NCT00543387|365644256|FG007|Crossover Participants|Progressive Disease|0|||
105996047|NCT00543387|365644257|FG008|Crossover Participants|Progressive Disease|0|||
105996048|NCT00543387|365644258|FG009|Crossover Participants|Progressive Disease|1|||
105996049|NCT00543387|365644259|FG010|Crossover Participants|Progressive Disease|2|||
105996050|NCT00543387|365644249|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
105996051|NCT00543387|365644250|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
105996052|NCT00543387|365644251|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
105996053|NCT00543387|365644252|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
105996054|NCT00543387|365644253|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
105996055|NCT00543387|365644254|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
105996056|NCT00543387|365644255|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
105996057|NCT00543387|365644256|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
105996058|NCT00543387|365644257|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
105996059|NCT00543387|365644258|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
105996060|NCT00543387|365644259|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
105663337|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
105663338|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
105663339|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105663340|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
105663341|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105663342|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
105663343|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
105663344|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
105663345|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
105663346|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
105663347|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
105663348|NCT03355209|364432448|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
105663349|NCT03355209|364432449|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
105663350|NCT03355209|364432450|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
105663351|NCT03355209|364432451|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
105663352|NCT03355209|364432452|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
105663353|NCT03355209|364432453|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
105663354|NCT01825577|364432454|FG000|Overall Study|Physician Decision|2|||
105663355|NCT01825577|364432454|FG000|Overall Study|Withdrawal by Subject|1|||
105663356|NCT01825577|364432454|FG000|Overall Study|Withdrawn by family members|2|||
105663357|NCT01825577|364432454|FG000|Overall Study|Lack of Efficacy|3|||
105663358|NCT02734004|364432455|FG000|Overall Study|Death|36|||
105663359|NCT02734004|364432456|FG001|Overall Study|Death|24|||
105663360|NCT02734004|364432457|FG002|Overall Study|Death|26|||
105663361|NCT02734004|364432458|FG003|Overall Study|Death|35|||
105663362|NCT02734004|364432459|FG004|Overall Study|Death|13|||
105663363|NCT02734004|364432460|FG005|Overall Study|Death|17|||
105663364|NCT02734004|364432461|FG006|Overall Study|Death|20|||
105663365|NCT02734004|364432455|FG000|Overall Study|Lost to Follow-up|1|||
105663366|NCT02734004|364432456|FG001|Overall Study|Lost to Follow-up|1|||
105663367|NCT02734004|364432457|FG002|Overall Study|Lost to Follow-up|0|||
105663368|NCT02734004|364432458|FG003|Overall Study|Lost to Follow-up|0|||
105663369|NCT02734004|364432459|FG004|Overall Study|Lost to Follow-up|1|||
105663370|NCT02734004|364432460|FG005|Overall Study|Lost to Follow-up|0|||
105888679|NCT02706886|365247696|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
105888680|NCT02706886|365247697|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
105888681|NCT04310397|365247708|FG000|Overall Study|Lack of Efficacy|3|||
105888682|NCT04310397|365247708|FG000|Overall Study|Withdrawal by Subject|1|||
105888683|NCT00970632|365247716|FG000|Overall Study|Adverse Event|2|||
105888684|NCT00970632|365247717|FG001|Overall Study|Adverse Event|2|||
105888685|NCT00970632|365247718|FG002|Overall Study|Adverse Event|1|||
106120627|NCT02791490|366100173|FG000|Overall Study|Withdrawal by Subject|2|||
105663371|NCT02734004|364432461|FG006|Overall Study|Lost to Follow-up|0|||
105663372|NCT02734004|364432455|FG000|Overall Study|Withdrawal by Subject|3|||
105663373|NCT02734004|364432456|FG001|Overall Study|Withdrawal by Subject|1|||
105663374|NCT02734004|364432457|FG002|Overall Study|Withdrawal by Subject|1|||
105663375|NCT02734004|364432458|FG003|Overall Study|Withdrawal by Subject|1|||
105663376|NCT02734004|364432459|FG004|Overall Study|Withdrawal by Subject|3|||
105663377|NCT02734004|364432460|FG005|Overall Study|Withdrawal by Subject|0|||
105663378|NCT02734004|364432461|FG006|Overall Study|Withdrawal by Subject|2|||
105663379|NCT02734004|364432455|FG000|Overall Study|Other|0|||
105663380|NCT02734004|364432456|FG001|Overall Study|Other|8|||
105663381|NCT02734004|364432457|FG002|Overall Study|Other|7|||
105663382|NCT02734004|364432458|FG003|Overall Study|Other|4|||
105663383|NCT02734004|364432459|FG004|Overall Study|Other|34|||
105663384|NCT02734004|364432460|FG005|Overall Study|Other|14|||
105663385|NCT02734004|364432461|FG006|Overall Study|Other|10|||
105888686|NCT00970632|365247716|FG000|Overall Study|Lack of Efficacy|3|||
105888687|NCT00970632|365247717|FG001|Overall Study|Lack of Efficacy|0|||
105888688|NCT00970632|365247718|FG002|Overall Study|Lack of Efficacy|0|||
105663389|NCT00926575|364432468|FG000|Overall Study|Adverse Event|1|||
105663390|NCT00926575|364432469|FG001|Overall Study|Adverse Event|1|||
105663391|NCT00926575|364432468|FG000|Overall Study|Death|4|||
105663392|NCT00926575|364432469|FG001|Overall Study|Death|4|||
105663393|NCT00926575|364432468|FG000|Overall Study|Lost to Follow-up|1|||
105663394|NCT00926575|364432469|FG001|Overall Study|Lost to Follow-up|1|||
105663395|NCT00926575|364432468|FG000|Overall Study|Physician Decision|1|||
105663396|NCT00926575|364432469|FG001|Overall Study|Physician Decision|2|||
105663397|NCT00926575|364432468|FG000|Overall Study|Protocol Violation|1|||
105663398|NCT00926575|364432469|FG001|Overall Study|Protocol Violation|0|||
105663399|NCT00926575|364432468|FG000|Overall Study|Withdrawal by Subject|8|||
105663400|NCT00926575|364432469|FG001|Overall Study|Withdrawal by Subject|9|||
105663401|NCT01431950|364432470|FG000|Overall Study|Study Site Closed/Terminated|7|||
105663402|NCT01431950|364432471|FG001|Overall Study|Study Site Closed/Terminated|3|||
105888689|NCT00970632|365247716|FG000|Overall Study|Lost to Follow-up|3|||
106120628|NCT02791490|366100174|FG001|Overall Study|Withdrawal by Subject|6|||
106120629|NCT03462706|366100175|FG000|Overall Study|Polyp was pedunculated|1|||
106120630|NCT03462706|366100176|FG001|Overall Study|Polyp was pedunculated|0|||
106120631|NCT03462706|366100177|FG002|Overall Study|Polyp was pedunculated|1|||
106120632|NCT03462706|366100178|FG003|Overall Study|Polyp was pedunculated|0|||
106120633|NCT03462706|366100175|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
106120634|NCT03462706|366100176|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
106120635|NCT03462706|366100177|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
106120636|NCT03462706|366100178|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
106120637|NCT01984424|366100184|FG000|Overall Study|Withdrawal by Subject|3|||
106120638|NCT01984424|366100185|FG001|Overall Study|Withdrawal by Subject|5|||
106120639|NCT01984424|366100184|FG000|Overall Study|Sponsor Decision|0|||
106120640|NCT01984424|366100185|FG001|Overall Study|Sponsor Decision|1|||
106120641|NCT01984424|366100184|FG000|Overall Study|Lost to Follow-up|0|||
106120642|NCT01984424|366100185|FG001|Overall Study|Lost to Follow-up|1|||
106120643|NCT03661996|366100190|FG000|Overall Study|Adverse Event|0|||
106120644|NCT03661996|366100191|FG001|Overall Study|Adverse Event|0|||
106120645|NCT03661996|366100192|FG002|Overall Study|Adverse Event|1|||
106120646|NCT03661996|366100193|FG003|Overall Study|Adverse Event|1|||
106120647|NCT03661996|366100194|FG004|Overall Study|Adverse Event|0|||
105663403|NCT01431950|364432470|FG000|Overall Study|Withdrawal by Subject|4|||
105663404|NCT01431950|364432471|FG001|Overall Study|Withdrawal by Subject|3|||
105663405|NCT01431950|364432470|FG000|Overall Study|Protocol Violation|2|||
105663406|NCT01431950|364432471|FG001|Overall Study|Protocol Violation|3|||
105663407|NCT01431950|364432470|FG000|Overall Study|Adverse Event|2|||
105663408|NCT01431950|364432471|FG001|Overall Study|Adverse Event|2|||
105663409|NCT01431950|364432470|FG000|Overall Study|Physician Decision|2|||
105663410|NCT01431950|364432471|FG001|Overall Study|Physician Decision|1|||
105663411|NCT01431950|364432470|FG000|Overall Study|Lack of Efficacy|2|||
105663412|NCT01431950|364432471|FG001|Overall Study|Lack of Efficacy|1|||
105663413|NCT01431950|364432470|FG000|Overall Study|Lost to Follow-up|0|||
105663414|NCT01431950|364432471|FG001|Overall Study|Lost to Follow-up|1|||
105663415|NCT01431950|364432470|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105663416|NCT01431950|364432471|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105663417|NCT01210651|364432472|FG000|Overall Study|Lost to Follow-up|1|||
105663418|NCT01210651|364432473|FG001|Overall Study|Lost to Follow-up|1|||
105663419|NCT01210651|364432472|FG000|Overall Study|schedule conflicts|1|||
105663420|NCT01210651|364432473|FG001|Overall Study|schedule conflicts|5|||
105996061|NCT03922620|365644260|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
105996062|NCT03922620|365644261|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
106120648|NCT03661996|366100190|FG000|Overall Study|Lost to Follow-up|5|||
106120649|NCT03661996|366100191|FG001|Overall Study|Lost to Follow-up|1|||
106120650|NCT03661996|366100192|FG002|Overall Study|Lost to Follow-up|2|||
106120651|NCT03661996|366100193|FG003|Overall Study|Lost to Follow-up|2|||
106120652|NCT03661996|366100194|FG004|Overall Study|Lost to Follow-up|6|||
106120653|NCT03661996|366100190|FG000|Overall Study|Physician Decision|1|||
105996063|NCT03566082|365644262|FG000|Overall Study|Death|7|||
105996064|NCT03566082|365644262|FG000|Overall Study|Failures (revision required)|2|||
105996065|NCT03566082|365644262|FG000|Overall Study|Lost to Follow-up|8|||
105996066|NCT02663622|365644263|FG000|Overall Study|Death|3|||
105996067|NCT02663622|365644264|FG001|Overall Study|Death|1|||
105996068|NCT02663622|365644265|FG002|Overall Study|Death|1|||
105996069|NCT02663622|365644266|FG003|Overall Study|Death|8|||
105996070|NCT02663622|365644263|FG000|Overall Study|Protocol Violation|0|||
105996071|NCT02663622|365644264|FG001|Overall Study|Protocol Violation|0|||
105996072|NCT02663622|365644265|FG002|Overall Study|Protocol Violation|0|||
105996073|NCT02663622|365644266|FG003|Overall Study|Protocol Violation|1|||
105996074|NCT01173601|365646944|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
105996075|NCT01173601|365646945|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105996076|NCT01173601|365646946|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105996077|NCT01173601|365646947|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105996078|NCT01173601|365646948|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105996079|NCT01173601|365646944|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
105996080|NCT01173601|365646945|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105996081|NCT01173601|365646946|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105996082|NCT01173601|365646947|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105996083|NCT01173601|365646948|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
106120654|NCT03661996|366100191|FG001|Overall Study|Physician Decision|1|||
106120655|NCT03661996|366100192|FG002|Overall Study|Physician Decision|1|||
106120656|NCT03661996|366100193|FG003|Overall Study|Physician Decision|2|||
106120657|NCT03661996|366100194|FG004|Overall Study|Physician Decision|0|||
106120658|NCT03661996|366100190|FG000|Overall Study|Protocol Violation|0|||
106120659|NCT03661996|366100191|FG001|Overall Study|Protocol Violation|0|||
106120660|NCT03661996|366100192|FG002|Overall Study|Protocol Violation|0|||
105663421|NCT01210651|364432472|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
105663422|NCT01210651|364432473|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
105996084|NCT01173601|365646944|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
105996085|NCT01173601|365646945|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105996086|NCT01173601|365646946|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105996087|NCT01173601|365646947|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105996088|NCT01173601|365646948|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105996089|NCT01173601|365646944|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
105996090|NCT01173601|365646945|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105996091|NCT01173601|365646946|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105996092|NCT01173601|365646947|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105996093|NCT01173601|365646948|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105996094|NCT01173601|365646944|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
105996095|NCT01173601|365646945|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105996096|NCT01173601|365646946|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105996097|NCT01173601|365646947|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105996098|NCT01173601|365646948|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105996099|NCT01173601|365646944|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
105996100|NCT01173601|365646945|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105996101|NCT01173601|365646946|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105996102|NCT01173601|365646947|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105996103|NCT01173601|365646948|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105996104|NCT01173601|365646944|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
105996105|NCT01173601|365646945|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105996106|NCT01173601|365646946|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105996107|NCT01173601|365646947|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105996108|NCT01173601|365646948|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105996109|NCT01173601|365646944|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
105996110|NCT01173601|365646945|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
105996111|NCT01173601|365646946|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
105996112|NCT01173601|365646947|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
105996113|NCT01173601|365646948|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
105996114|NCT01173601|365646944|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
105996115|NCT01173601|365646945|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
106120661|NCT03661996|366100193|FG003|Overall Study|Protocol Violation|0|||
106120662|NCT03661996|366100194|FG004|Overall Study|Protocol Violation|1|||
106120663|NCT03661996|366100190|FG000|Overall Study|Withdrawal by Subject|3|||
106120664|NCT03661996|366100191|FG001|Overall Study|Withdrawal by Subject|5|||
106120665|NCT03661996|366100192|FG002|Overall Study|Withdrawal by Subject|1|||
106120666|NCT03661996|366100193|FG003|Overall Study|Withdrawal by Subject|7|||
106120667|NCT03661996|366100194|FG004|Overall Study|Withdrawal by Subject|7|||
106120668|NCT03661996|366100190|FG000|Overall Study|Sponsors Decision|2|||
106120669|NCT03661996|366100191|FG001|Overall Study|Sponsors Decision|0|||
106120670|NCT03661996|366100192|FG002|Overall Study|Sponsors Decision|0|||
106120671|NCT03661996|366100193|FG003|Overall Study|Sponsors Decision|0|||
106120672|NCT03661996|366100194|FG004|Overall Study|Sponsors Decision|0|||
106120673|NCT03661996|366100190|FG000|Overall Study|Other|1|||
106120674|NCT03661996|366100191|FG001|Overall Study|Other|1|||
106120675|NCT03661996|366100192|FG002|Overall Study|Other|1|||
106120676|NCT03661996|366100193|FG003|Overall Study|Other|1|||
106120677|NCT03661996|366100194|FG004|Overall Study|Other|0|||
106120678|NCT03321513|366100195|FG000|Overall Study|Death|11|||
106120679|NCT03321513|366100196|FG001|Overall Study|Death|5|||
106120680|NCT03321513|366100195|FG000|Overall Study|Withdrawal by Subject|5|||
106120681|NCT03321513|366100196|FG001|Overall Study|Withdrawal by Subject|10|||
106120682|NCT03321513|366100195|FG000|Overall Study|Lost to Follow-up|10|||
106120683|NCT03321513|366100196|FG001|Overall Study|Lost to Follow-up|11|||
106120684|NCT02593305|366100197|FG000|Post 1|Comparison only group. No intervention.|0|||
106120685|NCT02593305|366100198|FG001|Post 1|Comparison only group. No intervention.|0|||
106120686|NCT02593305|366100199|FG002|Post 1|Comparison only group. No intervention.|10|||
106120687|NCT01317875|366100200|FG000|Overall Study|Other|0|||
106120688|NCT01317875|366100201|FG001|Overall Study|Other|0|||
106120689|NCT01317875|366100202|FG002|Overall Study|Other|1|||
106120690|NCT01317875|366100203|FG003|Overall Study|Other|0|||
106120691|NCT01317875|366100204|FG004|Overall Study|Other|0|||
106120692|NCT01317875|366100205|FG005|Overall Study|Other|0|||
106120693|NCT01317875|366100206|FG006|Overall Study|Other|0|||
106120694|NCT01317875|366100207|FG007|Overall Study|Other|0|||
106120695|NCT01317875|366100208|FG008|Overall Study|Other|0|||
106120696|NCT01317875|366100209|FG009|Overall Study|Other|0|||
106120697|NCT01317875|366100200|FG000|Overall Study|Noncompliance with study drug|0|||
106120698|NCT01317875|366100201|FG001|Overall Study|Noncompliance with study drug|0|||
106120699|NCT01317875|366100202|FG002|Overall Study|Noncompliance with study drug|1|||
106120700|NCT01317875|366100203|FG003|Overall Study|Noncompliance with study drug|0|||
106120701|NCT01317875|366100204|FG004|Overall Study|Noncompliance with study drug|0|||
106120702|NCT01317875|366100205|FG005|Overall Study|Noncompliance with study drug|0|||
106120703|NCT01317875|366100206|FG006|Overall Study|Noncompliance with study drug|0|||
106120704|NCT01317875|366100207|FG007|Overall Study|Noncompliance with study drug|0|||
106120705|NCT01317875|366100208|FG008|Overall Study|Noncompliance with study drug|0|||
106120706|NCT01317875|366100209|FG009|Overall Study|Noncompliance with study drug|0|||
106120707|NCT01317875|366100200|FG000|Overall Study|Progressive Disease|1|||
106120708|NCT01317875|366100201|FG001|Overall Study|Progressive Disease|0|||
106120709|NCT01317875|366100202|FG002|Overall Study|Progressive Disease|2|||
106120710|NCT01317875|366100203|FG003|Overall Study|Progressive Disease|0|||
106120711|NCT01317875|366100204|FG004|Overall Study|Progressive Disease|1|||
106120712|NCT01317875|366100205|FG005|Overall Study|Progressive Disease|0|||
106120713|NCT01317875|366100206|FG006|Overall Study|Progressive Disease|0|||
106120714|NCT01317875|366100207|FG007|Overall Study|Progressive Disease|1|||
106120715|NCT01317875|366100208|FG008|Overall Study|Progressive Disease|0|||
106120716|NCT01317875|366100209|FG009|Overall Study|Progressive Disease|0|||
106120717|NCT01317875|366100200|FG000|Overall Study|Withdrawal by Subject|0|||
106120718|NCT01317875|366100201|FG001|Overall Study|Withdrawal by Subject|0|||
106120719|NCT01317875|366100202|FG002|Overall Study|Withdrawal by Subject|0|||
106120720|NCT01317875|366100203|FG003|Overall Study|Withdrawal by Subject|0|||
106120721|NCT01317875|366100204|FG004|Overall Study|Withdrawal by Subject|1|||
106120722|NCT01317875|366100205|FG005|Overall Study|Withdrawal by Subject|0|||
106120723|NCT01317875|366100206|FG006|Overall Study|Withdrawal by Subject|0|||
106120724|NCT01317875|366100207|FG007|Overall Study|Withdrawal by Subject|3|||
106120725|NCT01317875|366100208|FG008|Overall Study|Withdrawal by Subject|0|||
106120726|NCT01317875|366100209|FG009|Overall Study|Withdrawal by Subject|0|||
106120727|NCT01317875|366100200|FG000|Overall Study|Physician Decision|0|||
106120728|NCT01317875|366100201|FG001|Overall Study|Physician Decision|1|||
106120729|NCT01317875|366100202|FG002|Overall Study|Physician Decision|1|||
106120730|NCT01317875|366100203|FG003|Overall Study|Physician Decision|0|||
106120731|NCT01317875|366100204|FG004|Overall Study|Physician Decision|2|||
106120732|NCT01317875|366100205|FG005|Overall Study|Physician Decision|0|||
106120733|NCT01317875|366100206|FG006|Overall Study|Physician Decision|0|||
106120734|NCT01317875|366100207|FG007|Overall Study|Physician Decision|2|||
106120735|NCT01317875|366100208|FG008|Overall Study|Physician Decision|0|||
106120736|NCT01317875|366100209|FG009|Overall Study|Physician Decision|0|||
106120737|NCT01317875|366100200|FG000|Overall Study|Death|0|||
106120738|NCT01317875|366100201|FG001|Overall Study|Death|0|||
106120739|NCT01317875|366100202|FG002|Overall Study|Death|2|||
106120740|NCT01317875|366100203|FG003|Overall Study|Death|1|||
106120741|NCT01317875|366100204|FG004|Overall Study|Death|0|||
106120742|NCT01317875|366100205|FG005|Overall Study|Death|1|||
106120743|NCT01317875|366100206|FG006|Overall Study|Death|0|||
106120744|NCT01317875|366100207|FG007|Overall Study|Death|4|||
106120745|NCT01317875|366100208|FG008|Overall Study|Death|0|||
106120746|NCT01317875|366100209|FG009|Overall Study|Death|0|||
105888690|NCT00970632|365247717|FG001|Overall Study|Lost to Follow-up|0|||
105888691|NCT00970632|365247718|FG002|Overall Study|Lost to Follow-up|2|||
105888692|NCT00970632|365247716|FG000|Overall Study|Protocol Violation|8|||
105888693|NCT00970632|365247717|FG001|Overall Study|Protocol Violation|5|||
105888694|NCT00970632|365247718|FG002|Overall Study|Protocol Violation|8|||
105888695|NCT00970632|365247716|FG000|Overall Study|Withdrawal by Subject|7|||
105888696|NCT00970632|365247717|FG001|Overall Study|Withdrawal by Subject|6|||
105888697|NCT00970632|365247718|FG002|Overall Study|Withdrawal by Subject|4|||
105888698|NCT00970632|365247716|FG000|Overall Study|Entry criteria not met|0|||
105888699|NCT00970632|365247717|FG001|Overall Study|Entry criteria not met|2|||
105888700|NCT00970632|365247718|FG002|Overall Study|Entry criteria not met|2|||
105888701|NCT00970632|365247716|FG000|Overall Study|Sponsor decision|1|||
105888702|NCT00970632|365247717|FG001|Overall Study|Sponsor decision|0|||
105888703|NCT00970632|365247718|FG002|Overall Study|Sponsor decision|1|||
105888704|NCT01942486|365247719|FG000|Overall Study|Lost to Follow-up|27|||
105888705|NCT02005692|365247722|FG000|Overall Study|Protocol Violation|1|||
105888706|NCT02005692|365247722|FG000|Overall Study|Withdrawal by Subject|1|||
105996116|NCT01173601|365646946|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
105996117|NCT01173601|365646947|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
105996118|NCT01173601|365646948|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
106120747|NCT01317875|366100200|FG000|Overall Study|Adverse Event|2|||
105888707|NCT02005692|365247722|FG000|Overall Study|Discharged earlier than anticipated|5|||
105888708|NCT02651155|365247723|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105888709|NCT02651155|365247724|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
105888710|NCT02651155|365247723|FG000|Overall Study|Voluntary Withdrawal|5|||
106120748|NCT01317875|366100201|FG001|Overall Study|Adverse Event|1|||
106120749|NCT01317875|366100202|FG002|Overall Study|Adverse Event|2|||
106120750|NCT01317875|366100203|FG003|Overall Study|Adverse Event|1|||
106120751|NCT01317875|366100204|FG004|Overall Study|Adverse Event|5|||
106120752|NCT01317875|366100205|FG005|Overall Study|Adverse Event|1|||
106120753|NCT01317875|366100206|FG006|Overall Study|Adverse Event|2|||
106120754|NCT01317875|366100207|FG007|Overall Study|Adverse Event|5|||
106120755|NCT01317875|366100208|FG008|Overall Study|Adverse Event|0|||
106120756|NCT01317875|366100209|FG009|Overall Study|Adverse Event|0|||
106120757|NCT02045433|366100210|FG000|Overall Study|Withdrawal by Subject|1|||
106120758|NCT01973491|366100211|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
106120759|NCT01973491|366100211|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
106120760|NCT01973491|366100211|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
106120761|NCT01863043|366100212|FG000|Overall Study|Death|6|||
106120762|NCT01863043|366100213|FG001|Overall Study|Death|1|||
106120763|NCT01863043|366100212|FG000|Overall Study|Withdrawal by Subject|0|||
106120764|NCT01863043|366100213|FG001|Overall Study|Withdrawal by Subject|2|||
106120765|NCT01863043|366100212|FG000|Overall Study|Adverse Event|7|||
106120766|NCT01863043|366100213|FG001|Overall Study|Adverse Event|8|||
106120767|NCT01863043|366100212|FG000|Overall Study|exclusion criteria found after enrollment|0|||
106120768|NCT01863043|366100213|FG001|Overall Study|exclusion criteria found after enrollment|1|||
106120769|NCT01533714|366100214|FG000|Overall Study|Adverse Event|0|||
106120770|NCT01533714|366100215|FG001|Overall Study|Adverse Event|1|||
106120771|NCT01533714|366100216|FG002|Overall Study|Adverse Event|2|||
106120772|NCT01533714|366100217|FG003|Overall Study|Adverse Event|2|||
106120773|NCT01533714|366100218|FG004|Overall Study|Adverse Event|2|||
106120774|NCT01533714|366100219|FG005|Overall Study|Adverse Event|1|||
106120775|NCT01533714|366100214|FG000|Overall Study|Lack of Efficacy|0|||
106120776|NCT01533714|366100215|FG001|Overall Study|Lack of Efficacy|0|||
106120777|NCT01533714|366100216|FG002|Overall Study|Lack of Efficacy|0|||
106120778|NCT01533714|366100217|FG003|Overall Study|Lack of Efficacy|0|||
106120779|NCT01533714|366100218|FG004|Overall Study|Lack of Efficacy|0|||
106120780|NCT01533714|366100219|FG005|Overall Study|Lack of Efficacy|1|||
106120781|NCT01533714|366100214|FG000|Overall Study|Withdrawal by Subject|0|||
106120782|NCT01533714|366100215|FG001|Overall Study|Withdrawal by Subject|1|||
106120783|NCT01533714|366100216|FG002|Overall Study|Withdrawal by Subject|0|||
106120784|NCT01533714|366100217|FG003|Overall Study|Withdrawal by Subject|1|||
106120785|NCT01533714|366100218|FG004|Overall Study|Withdrawal by Subject|1|||
106120786|NCT01533714|366100219|FG005|Overall Study|Withdrawal by Subject|0|||
106120787|NCT01533714|366100214|FG000|Overall Study|Exclusion criteria|0|||
106120788|NCT01533714|366100215|FG001|Overall Study|Exclusion criteria|1|||
106120789|NCT01533714|366100216|FG002|Overall Study|Exclusion criteria|0|||
106120790|NCT01533714|366100217|FG003|Overall Study|Exclusion criteria|0|||
106120791|NCT01533714|366100218|FG004|Overall Study|Exclusion criteria|0|||
106120792|NCT01533714|366100219|FG005|Overall Study|Exclusion criteria|0|||
106120793|NCT01533714|366100214|FG000|Overall Study|Positive for purified protein derivative|0|||
106120794|NCT01533714|366100215|FG001|Overall Study|Positive for purified protein derivative|0|||
106120795|NCT01533714|366100216|FG002|Overall Study|Positive for purified protein derivative|1|||
106120796|NCT01533714|366100217|FG003|Overall Study|Positive for purified protein derivative|0|||
106120797|NCT01533714|366100218|FG004|Overall Study|Positive for purified protein derivative|1|||
106120798|NCT01533714|366100219|FG005|Overall Study|Positive for purified protein derivative|0|||
106120799|NCT01533714|366100214|FG000|Overall Study|Withdrawal criteria|0|||
106120800|NCT01533714|366100215|FG001|Overall Study|Withdrawal criteria|0|||
106120801|NCT01533714|366100216|FG002|Overall Study|Withdrawal criteria|1|||
106120802|NCT01533714|366100217|FG003|Overall Study|Withdrawal criteria|0|||
106120803|NCT01533714|366100218|FG004|Overall Study|Withdrawal criteria|3|||
106120804|NCT01533714|366100219|FG005|Overall Study|Withdrawal criteria|1|||
106120805|NCT01533714|366100214|FG000|Overall Study|Ineligibility reason|0|||
106120806|NCT01533714|366100215|FG001|Overall Study|Ineligibility reason|0|||
106120807|NCT01533714|366100216|FG002|Overall Study|Ineligibility reason|0|||
106120808|NCT01533714|366100217|FG003|Overall Study|Ineligibility reason|1|||
106120809|NCT01533714|366100218|FG004|Overall Study|Ineligibility reason|0|||
106120810|NCT01533714|366100219|FG005|Overall Study|Ineligibility reason|0|||
106120811|NCT04250337|366100220|FG000|Overall Study|Adverse Event|0|||
106120812|NCT04250337|366100221|FG001|Overall Study|Adverse Event|3|||
105888711|NCT02651155|365247724|FG001|Overall Study|Voluntary Withdrawal|0|||
106120813|NCT04250337|366100220|FG000|Overall Study|Lack of Efficacy|1|||
106120814|NCT04250337|366100221|FG001|Overall Study|Lack of Efficacy|3|||
106120815|NCT04250337|366100220|FG000|Overall Study|Physician Decision|1|||
106120816|NCT04250337|366100221|FG001|Overall Study|Physician Decision|0|||
105888712|NCT03843541|365247733|FG000|Overall Study|Adverse Event|4|||
105888713|NCT03843541|365247734|FG001|Overall Study|Adverse Event|2|||
106120817|NCT04250337|366100220|FG000|Overall Study|Protocol Deviation|2|||
106120818|NCT04250337|366100221|FG001|Overall Study|Protocol Deviation|2|||
106120819|NCT04250337|366100220|FG000|Overall Study|Withdrawal by Subject|4|||
106120820|NCT04250337|366100221|FG001|Overall Study|Withdrawal by Subject|3|||
106120821|NCT00791921|366100224|FG000|Overall Study|Protocol planed|24|||
106120822|NCT00791921|366100225|FG001|Overall Study|Protocol planed|88|||
106120823|NCT00791921|366100224|FG000|Overall Study|Withdrawal by Subject|1|||
106120824|NCT00791921|366100225|FG001|Overall Study|Withdrawal by Subject|2|||
106120825|NCT00791921|366100224|FG000|Overall Study|Adverse Event|8|||
106120826|NCT00791921|366100225|FG001|Overall Study|Adverse Event|2|||
106120827|NCT00791921|366100224|FG000|Overall Study|Lack of Efficacy|0|||
106120828|NCT00791921|366100225|FG001|Overall Study|Lack of Efficacy|2|||
106120829|NCT00791921|366100224|FG000|Overall Study|Lack of study drug administration|1|||
106120830|NCT00791921|366100225|FG001|Overall Study|Lack of study drug administration|1|||
106120831|NCT00791921|366100224|FG000|Overall Study|Reason other than those above|0|||
106120832|NCT00791921|366100225|FG001|Overall Study|Reason other than those above|1|||
106120833|NCT04537897|366100228|FG000|Overall Study|Other than listed|0|||
106120834|NCT04537897|366100229|FG001|Overall Study|Other than listed|0|||
106120835|NCT04537897|366100230|FG002|Overall Study|Other than listed|0|||
106120836|NCT04537897|366100231|FG003|Overall Study|Other than listed|0|||
106120837|NCT04537897|366100232|FG004|Overall Study|Other than listed|0|||
106120838|NCT04537897|366100233|FG005|Overall Study|Other than listed|0|||
106120839|NCT04537897|366100234|FG006|Overall Study|Other than listed|1|||
106120840|NCT04537897|366100235|FG007|Overall Study|Other than listed|0|||
106120841|NCT04537897|366100236|FG008|Overall Study|Other than listed|0|||
106120842|NCT04537897|366100228|FG000|Overall Study|Adverse Event|0|||
106120843|NCT04537897|366100229|FG001|Overall Study|Adverse Event|0|||
106120844|NCT04537897|366100230|FG002|Overall Study|Adverse Event|0|||
106120845|NCT04537897|366100231|FG003|Overall Study|Adverse Event|1|||
106120846|NCT04537897|366100232|FG004|Overall Study|Adverse Event|0|||
106120847|NCT04537897|366100233|FG005|Overall Study|Adverse Event|0|||
106120848|NCT04537897|366100234|FG006|Overall Study|Adverse Event|0|||
106120849|NCT04537897|366100235|FG007|Overall Study|Adverse Event|0|||
106120850|NCT04537897|366100236|FG008|Overall Study|Adverse Event|0|||
105663423|NCT01210651|364432472|FG000|Overall Study|Withdrawal by Subject|1|||
105663424|NCT01210651|364432473|FG001|Overall Study|Withdrawal by Subject|1|||
105663425|NCT01210651|364432472|FG000|Overall Study|Injury outside study|2|||
105663426|NCT01210651|364432473|FG001|Overall Study|Injury outside study|0|||
105663427|NCT02592707|364432477|FG000|Overall Study|Consent Withdrawn|0|||
105663428|NCT02592707|364432478|FG001|Overall Study|Consent Withdrawn|1|||
105663429|NCT02592707|364432479|FG002|Overall Study|Consent Withdrawn|2|||
105663430|NCT02592707|364432480|FG003|Overall Study|Consent Withdrawn|0|||
105663431|NCT02592707|364432477|FG000|Overall Study|Death|1|||
105663432|NCT02592707|364432478|FG001|Overall Study|Death|0|||
105663433|NCT02592707|364432479|FG002|Overall Study|Death|0|||
105663434|NCT02592707|364432480|FG003|Overall Study|Death|0|||
105663435|NCT02592707|364432477|FG000|Overall Study|Progressive Disease|4|||
105663436|NCT02592707|364432478|FG001|Overall Study|Progressive Disease|4|||
105663437|NCT02592707|364432479|FG002|Overall Study|Progressive Disease|3|||
105663438|NCT02592707|364432480|FG003|Overall Study|Progressive Disease|3|||
105663439|NCT02592707|364432477|FG000|Overall Study|Other|0|||
105663440|NCT02592707|364432478|FG001|Overall Study|Other|0|||
105663441|NCT02592707|364432479|FG002|Overall Study|Other|1|||
105663442|NCT02592707|364432480|FG003|Overall Study|Other|2|||
105663443|NCT02592707|364432477|FG000|Overall Study|Never entered LTFU period|1|||
105663444|NCT02592707|364432478|FG001|Overall Study|Never entered LTFU period|0|||
105663445|NCT02592707|364432479|FG002|Overall Study|Never entered LTFU period|0|||
105663446|NCT02592707|364432480|FG003|Overall Study|Never entered LTFU period|2|||
105663447|NCT02282059|364432482|FG000|Overall Study|Other|15|||
105663448|NCT02282059|364432483|FG001|Overall Study|Other|3|||
105663449|NCT02282059|364432482|FG000|Overall Study|Participant refused further follow-up|8|||
105663450|NCT02282059|364432483|FG001|Overall Study|Participant refused further follow-up|4|||
105663451|NCT02282059|364432482|FG000|Overall Study|Lost to Follow-up|19|||
105663452|NCT02282059|364432483|FG001|Overall Study|Lost to Follow-up|3|||
105663453|NCT02282059|364432482|FG000|Overall Study|Death|40|||
105663454|NCT02282059|364432483|FG001|Overall Study|Death|8|||
105663455|NCT05131477|364432484|FG000|PART 1|Withdrawal by Subject|2|||
105663456|NCT05131477|364432485|FG001|PART 1|Withdrawal by Subject|9|||
105663457|NCT05131477|364432486|FG002|PART 1|Withdrawal by Subject|6|||
105663458|NCT05131477|364432487|FG003|PART 1|Withdrawal by Subject|2|||
105663459|NCT05131477|364432488|FG004|PART 1|Withdrawal by Subject|8|||
105663460|NCT05131477|364432489|FG005|PART 1|Withdrawal by Subject|0|||
105663461|NCT05131477|364432490|FG006|PART 1|Withdrawal by Subject|0|||
105663462|NCT05131477|364432491|FG007|PART 1|Withdrawal by Subject|0|||
106120851|NCT04537897|366100228|FG000|Overall Study|Withdrawal by Subject|0|||
105663463|NCT05131477|364432492|FG008|PART 1|Withdrawal by Subject|0|||
105663464|NCT05131477|364432493|FG009|PART 1|Withdrawal by Subject|0|||
105663465|NCT05131477|364432494|FG010|PART 1|Withdrawal by Subject|0|||
105663466|NCT05131477|364432495|FG011|PART 1|Withdrawal by Subject|0|||
105663467|NCT05131477|364432496|FG012|PART 1|Withdrawal by Subject|0|||
105663468|NCT05131477|364432497|FG013|PART 1|Withdrawal by Subject|0|||
105663469|NCT05131477|364432484|FG000|PART 1|Physician Decision|1|||
105663470|NCT05131477|364432485|FG001|PART 1|Physician Decision|0|||
105663471|NCT05131477|364432486|FG002|PART 1|Physician Decision|0|||
105663472|NCT05131477|364432487|FG003|PART 1|Physician Decision|0|||
105663473|NCT05131477|364432488|FG004|PART 1|Physician Decision|0|||
106120852|NCT04537897|366100229|FG001|Overall Study|Withdrawal by Subject|1|||
105663474|NCT05131477|364432489|FG005|PART 1|Physician Decision|0|||
105663475|NCT05131477|364432490|FG006|PART 1|Physician Decision|0|||
105663476|NCT05131477|364432491|FG007|PART 1|Physician Decision|0|||
105663477|NCT05131477|364432492|FG008|PART 1|Physician Decision|0|||
106120853|NCT04537897|366100230|FG002|Overall Study|Withdrawal by Subject|0|||
106120854|NCT04537897|366100231|FG003|Overall Study|Withdrawal by Subject|0|||
106120855|NCT04537897|366100232|FG004|Overall Study|Withdrawal by Subject|0|||
106120856|NCT04537897|366100233|FG005|Overall Study|Withdrawal by Subject|0|||
105663478|NCT05131477|364432493|FG009|PART 1|Physician Decision|0|||
105663479|NCT05131477|364432494|FG010|PART 1|Physician Decision|0|||
105663480|NCT05131477|364432495|FG011|PART 1|Physician Decision|0|||
105663481|NCT05131477|364432496|FG012|PART 1|Physician Decision|0|||
105663482|NCT05131477|364432497|FG013|PART 1|Physician Decision|0|||
105663483|NCT05131477|364432484|FG000|PART 1|Adverse Event|3|||
105663484|NCT05131477|364432485|FG001|PART 1|Adverse Event|5|||
105663485|NCT05131477|364432486|FG002|PART 1|Adverse Event|1|||
105663486|NCT05131477|364432487|FG003|PART 1|Adverse Event|6|||
105663487|NCT05131477|364432488|FG004|PART 1|Adverse Event|4|||
105663488|NCT05131477|364432489|FG005|PART 1|Adverse Event|0|||
105663489|NCT05131477|364432490|FG006|PART 1|Adverse Event|0|||
105663490|NCT05131477|364432491|FG007|PART 1|Adverse Event|0|||
105663491|NCT05131477|364432492|FG008|PART 1|Adverse Event|0|||
105663492|NCT05131477|364432493|FG009|PART 1|Adverse Event|0|||
105663493|NCT05131477|364432494|FG010|PART 1|Adverse Event|0|||
105663494|NCT05131477|364432495|FG011|PART 1|Adverse Event|0|||
105663495|NCT05131477|364432496|FG012|PART 1|Adverse Event|0|||
105663496|NCT05131477|364432497|FG013|PART 1|Adverse Event|0|||
105663497|NCT05131477|364432484|FG000|PART 1|unclassified|1|||
105663498|NCT05131477|364432485|FG001|PART 1|unclassified|1|||
105663499|NCT05131477|364432486|FG002|PART 1|unclassified|0|||
105663500|NCT05131477|364432487|FG003|PART 1|unclassified|0|||
105663501|NCT05131477|364432488|FG004|PART 1|unclassified|4|||
105663502|NCT05131477|364432489|FG005|PART 1|unclassified|0|||
105663503|NCT05131477|364432490|FG006|PART 1|unclassified|0|||
105663504|NCT05131477|364432491|FG007|PART 1|unclassified|0|||
105663505|NCT05131477|364432492|FG008|PART 1|unclassified|0|||
105663506|NCT05131477|364432493|FG009|PART 1|unclassified|0|||
105663507|NCT05131477|364432494|FG010|PART 1|unclassified|0|||
105663508|NCT05131477|364432495|FG011|PART 1|unclassified|0|||
105663509|NCT05131477|364432496|FG012|PART 1|unclassified|0|||
105663510|NCT05131477|364432497|FG013|PART 1|unclassified|0|||
105663511|NCT05131477|364432484|FG000|PART 1|Randomized and not treated|0|||
105663512|NCT05131477|364432485|FG001|PART 1|Randomized and not treated|0|||
105663513|NCT05131477|364432486|FG002|PART 1|Randomized and not treated|0|||
105663514|NCT05131477|364432487|FG003|PART 1|Randomized and not treated|1|||
105663515|NCT05131477|364432488|FG004|PART 1|Randomized and not treated|1|||
105663516|NCT05131477|364432489|FG005|PART 1|Randomized and not treated|0|||
105663517|NCT05131477|364432490|FG006|PART 1|Randomized and not treated|0|||
105663518|NCT05131477|364432491|FG007|PART 1|Randomized and not treated|0|||
105663519|NCT05131477|364432492|FG008|PART 1|Randomized and not treated|0|||
105663520|NCT05131477|364432493|FG009|PART 1|Randomized and not treated|0|||
105663521|NCT05131477|364432494|FG010|PART 1|Randomized and not treated|0|||
105663522|NCT05131477|364432495|FG011|PART 1|Randomized and not treated|0|||
105663523|NCT05131477|364432496|FG012|PART 1|Randomized and not treated|0|||
105663524|NCT05131477|364432497|FG013|PART 1|Randomized and not treated|0|||
105663525|NCT05131477|364432484|FG000|PART 1|Protocol Violation|2|||
105663526|NCT05131477|364432485|FG001|PART 1|Protocol Violation|0|||
105663527|NCT05131477|364432486|FG002|PART 1|Protocol Violation|0|||
105663528|NCT05131477|364432487|FG003|PART 1|Protocol Violation|1|||
105663529|NCT05131477|364432488|FG004|PART 1|Protocol Violation|0|||
105663530|NCT05131477|364432489|FG005|PART 1|Protocol Violation|0|||
105663531|NCT05131477|364432490|FG006|PART 1|Protocol Violation|0|||
105663532|NCT05131477|364432491|FG007|PART 1|Protocol Violation|0|||
105663533|NCT05131477|364432492|FG008|PART 1|Protocol Violation|0|||
105663534|NCT05131477|364432493|FG009|PART 1|Protocol Violation|0|||
105663535|NCT05131477|364432494|FG010|PART 1|Protocol Violation|0|||
105663536|NCT05131477|364432495|FG011|PART 1|Protocol Violation|0|||
105663537|NCT05131477|364432496|FG012|PART 1|Protocol Violation|0|||
105663538|NCT05131477|364432497|FG013|PART 1|Protocol Violation|0|||
105663539|NCT05131477|364432484|FG000|PART 1|Lack of Efficacy|0|||
105888714|NCT03843541|365247735|FG002|Overall Study|Adverse Event|3|||
105888715|NCT03843541|365247733|FG000|Overall Study|Death|1|||
105888716|NCT03843541|365247734|FG001|Overall Study|Death|0|||
105888717|NCT03843541|365247735|FG002|Overall Study|Death|0|||
105888718|NCT03843541|365247733|FG000|Overall Study|Lack of adherence to study medication|0|||
105888719|NCT03843541|365247734|FG001|Overall Study|Lack of adherence to study medication|0|||
105663540|NCT05131477|364432485|FG001|PART 1|Lack of Efficacy|1|||
105663541|NCT05131477|364432486|FG002|PART 1|Lack of Efficacy|1|||
105663542|NCT05131477|364432487|FG003|PART 1|Lack of Efficacy|2|||
105663543|NCT05131477|364432488|FG004|PART 1|Lack of Efficacy|5|||
105663544|NCT05131477|364432489|FG005|PART 1|Lack of Efficacy|0|||
105663545|NCT05131477|364432490|FG006|PART 1|Lack of Efficacy|0|||
105663546|NCT05131477|364432491|FG007|PART 1|Lack of Efficacy|0|||
105663547|NCT05131477|364432492|FG008|PART 1|Lack of Efficacy|0|||
105888720|NCT03843541|365247735|FG002|Overall Study|Lack of adherence to study medication|1|||
105663548|NCT05131477|364432493|FG009|PART 1|Lack of Efficacy|0|||
105663549|NCT05131477|364432494|FG010|PART 1|Lack of Efficacy|0|||
105663550|NCT05131477|364432495|FG011|PART 1|Lack of Efficacy|0|||
105663551|NCT05131477|364432496|FG012|PART 1|Lack of Efficacy|0|||
105663552|NCT05131477|364432497|FG013|PART 1|Lack of Efficacy|0|||
105663553|NCT05131477|364432484|FG000|PART 2|Withdrawal by Subject|0|||
105663554|NCT05131477|364432485|FG001|PART 2|Withdrawal by Subject|0|||
105663555|NCT05131477|364432486|FG002|PART 2|Withdrawal by Subject|0|||
105888721|NCT03843541|365247733|FG000|Overall Study|Physician Decision|1|||
105663556|NCT05131477|364432487|FG003|PART 2|Withdrawal by Subject|0|||
105663557|NCT05131477|364432488|FG004|PART 2|Withdrawal by Subject|0|||
105663558|NCT05131477|364432489|FG005|PART 2|Withdrawal by Subject|0|||
105663559|NCT05131477|364432490|FG006|PART 2|Withdrawal by Subject|2|||
105663560|NCT05131477|364432491|FG007|PART 2|Withdrawal by Subject|0|||
105663561|NCT05131477|364432492|FG008|PART 2|Withdrawal by Subject|0|||
105663562|NCT05131477|364432493|FG009|PART 2|Withdrawal by Subject|0|||
105663563|NCT05131477|364432494|FG010|PART 2|Withdrawal by Subject|2|||
105663564|NCT05131477|364432495|FG011|PART 2|Withdrawal by Subject|0|||
105663565|NCT05131477|364432496|FG012|PART 2|Withdrawal by Subject|2|||
105663566|NCT05131477|364432497|FG013|PART 2|Withdrawal by Subject|2|||
105663567|NCT05131477|364432484|FG000|PART 2|Other|0|||
105663568|NCT05131477|364432485|FG001|PART 2|Other|0|||
105663569|NCT05131477|364432486|FG002|PART 2|Other|0|||
105663570|NCT05131477|364432487|FG003|PART 2|Other|0|||
105663571|NCT05131477|364432488|FG004|PART 2|Other|0|||
105663572|NCT05131477|364432489|FG005|PART 2|Other|0|||
105663573|NCT05131477|364432490|FG006|PART 2|Other|0|||
105663574|NCT05131477|364432491|FG007|PART 2|Other|0|||
106120857|NCT04537897|366100234|FG006|Overall Study|Withdrawal by Subject|0|||
106120858|NCT04537897|366100235|FG007|Overall Study|Withdrawal by Subject|0|||
106120859|NCT04537897|366100236|FG008|Overall Study|Withdrawal by Subject|0|||
106120860|NCT01130883|366100239|FG000|Overall Study|Patient Noncompliance|6|||
106120861|NCT01130883|366100239|FG000|Overall Study|Reason Unknown|1|||
106120862|NCT01130883|366100239|FG000|Overall Study|Adverse Event|3|||
106120863|NCT03029780|366100243|FG000|Overall Study|Disease Progression|20|||
106120864|NCT03029780|366100244|FG001|Overall Study|Disease Progression|22|||
105663575|NCT05131477|364432492|FG008|PART 2|Other|1|||
106120865|NCT03029780|366100243|FG000|Overall Study|Study Drug Toxicity|15|||
106120866|NCT03029780|366100244|FG001|Overall Study|Study Drug Toxicity|11|||
106120867|NCT03029780|366100243|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
106120868|NCT03029780|366100244|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
106120869|NCT03029780|366100243|FG000|Overall Study|Participant request to discontinue study treatment|4|||
106120870|NCT03029780|366100244|FG001|Overall Study|Participant request to discontinue study treatment|1|||
106120871|NCT03029780|366100243|FG000|Overall Study|Maximum clinical benefit|1|||
106120872|NCT03029780|366100244|FG001|Overall Study|Maximum clinical benefit|0|||
106120873|NCT03029780|366100243|FG000|Overall Study|Participant no longer meets study criteria|0|||
106120874|NCT03029780|366100244|FG001|Overall Study|Participant no longer meets study criteria|1|||
106120875|NCT03029780|366100243|FG000|Overall Study|Other reasons|6|||
106120876|NCT03029780|366100244|FG001|Overall Study|Other reasons|6|||
106120877|NCT03029780|366100243|FG000|Overall Study|Not reported|1|||
106120878|NCT03029780|366100244|FG001|Overall Study|Not reported|1|||
106120879|NCT03029780|366100243|FG000|Overall Study|Death|2|||
106120880|NCT03029780|366100244|FG001|Overall Study|Death|6|||
106120881|NCT03321006|366100247|FG000|Overall Study|Death|1|||
106120882|NCT03321006|366100248|FG001|Overall Study|Death|0|||
106120883|NCT03321006|366100247|FG000|Overall Study|Lack of Efficacy|1|||
106120884|NCT03321006|366100248|FG001|Overall Study|Lack of Efficacy|0|||
106120885|NCT00885352|366100251|FG000|Overall Study|Adverse Event|2|||
106120886|NCT00885352|366100252|FG001|Overall Study|Adverse Event|3|||
106120887|NCT00885352|366100251|FG000|Overall Study|Lost to Follow-up|2|||
106120888|NCT00885352|366100252|FG001|Overall Study|Lost to Follow-up|2|||
106120889|NCT00885352|366100251|FG000|Overall Study|Physician Decision|0|||
106120890|NCT00885352|366100252|FG001|Overall Study|Physician Decision|3|||
106120891|NCT00885352|366100251|FG000|Overall Study|Protocol Violation|0|||
106120892|NCT00885352|366100252|FG001|Overall Study|Protocol Violation|2|||
106120893|NCT00885352|366100251|FG000|Overall Study|Withdrawal by Subject|1|||
105663576|NCT05131477|364432493|FG009|PART 2|Other|1|||
105663577|NCT05131477|364432494|FG010|PART 2|Other|0|||
105663578|NCT05131477|364432495|FG011|PART 2|Other|0|||
106120894|NCT00885352|366100252|FG001|Overall Study|Withdrawal by Subject|5|||
106120895|NCT00885352|366100251|FG000|Overall Study|Contradiction to study medication|0|||
105785442|NCT02930889|364868460|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
105785443|NCT00509223|364868463|FG000|Overall Study|Lost to Follow-up|1|||
106120896|NCT00885352|366100252|FG001|Overall Study|Contradiction to study medication|2|||
106120897|NCT00885352|366100251|FG000|Overall Study|Excluded medication|2|||
106120898|NCT00885352|366100252|FG001|Overall Study|Excluded medication|2|||
106120899|NCT00885352|366100251|FG000|Overall Study|Lab abnormalities|1|||
106120900|NCT00885352|366100252|FG001|Overall Study|Lab abnormalities|1|||
106120901|NCT04161807|366100253|FG000|Overall Study|Withdrawal by Subject|2|||
106120902|NCT04161807|366100253|FG000|Overall Study|Performed only 1 treatment|2|||
106120903|NCT04789577|366100264|FG000|Overall Study|Withdrawal by Subject|1|||
105663579|NCT05131477|364432496|FG012|PART 2|Other|1|||
105663580|NCT05131477|364432497|FG013|PART 2|Other|0|||
105663581|NCT05131477|364432484|FG000|PART 2|Lack of Efficacy|0|||
105663582|NCT05131477|364432485|FG001|PART 2|Lack of Efficacy|0|||
105663583|NCT05131477|364432486|FG002|PART 2|Lack of Efficacy|0|||
105663584|NCT05131477|364432487|FG003|PART 2|Lack of Efficacy|0|||
105663585|NCT05131477|364432488|FG004|PART 2|Lack of Efficacy|0|||
105663586|NCT05131477|364432489|FG005|PART 2|Lack of Efficacy|1|||
105663587|NCT05131477|364432490|FG006|PART 2|Lack of Efficacy|1|||
105663588|NCT05131477|364432491|FG007|PART 2|Lack of Efficacy|0|||
105663589|NCT05131477|364432492|FG008|PART 2|Lack of Efficacy|3|||
105663590|NCT05131477|364432493|FG009|PART 2|Lack of Efficacy|0|||
105663591|NCT05131477|364432494|FG010|PART 2|Lack of Efficacy|1|||
105663592|NCT05131477|364432495|FG011|PART 2|Lack of Efficacy|0|||
105663593|NCT05131477|364432496|FG012|PART 2|Lack of Efficacy|2|||
105663594|NCT05131477|364432497|FG013|PART 2|Lack of Efficacy|0|||
105663595|NCT05131477|364432484|FG000|PART 2|Unclassified|0|||
105663596|NCT05131477|364432485|FG001|PART 2|Unclassified|0|||
105663597|NCT05131477|364432486|FG002|PART 2|Unclassified|0|||
105663598|NCT05131477|364432487|FG003|PART 2|Unclassified|0|||
105663599|NCT05131477|364432488|FG004|PART 2|Unclassified|0|||
105663600|NCT05131477|364432489|FG005|PART 2|Unclassified|0|||
105663601|NCT05131477|364432490|FG006|PART 2|Unclassified|0|||
105663602|NCT05131477|364432491|FG007|PART 2|Unclassified|0|||
105663603|NCT05131477|364432492|FG008|PART 2|Unclassified|0|||
105663604|NCT05131477|364432493|FG009|PART 2|Unclassified|0|||
105663605|NCT05131477|364432494|FG010|PART 2|Unclassified|1|||
105663606|NCT05131477|364432495|FG011|PART 2|Unclassified|0|||
105663607|NCT05131477|364432496|FG012|PART 2|Unclassified|0|||
105663608|NCT05131477|364432497|FG013|PART 2|Unclassified|0|||
105663609|NCT05131477|364432484|FG000|PART 2|Re-randomized and not treated|0|||
105663610|NCT05131477|364432485|FG001|PART 2|Re-randomized and not treated|0|||
105663611|NCT05131477|364432486|FG002|PART 2|Re-randomized and not treated|0|||
105663612|NCT05131477|364432487|FG003|PART 2|Re-randomized and not treated|0|||
105663613|NCT05131477|364432488|FG004|PART 2|Re-randomized and not treated|0|||
105663614|NCT05131477|364432489|FG005|PART 2|Re-randomized and not treated|0|||
105663615|NCT05131477|364432490|FG006|PART 2|Re-randomized and not treated|0|||
105663616|NCT05131477|364432491|FG007|PART 2|Re-randomized and not treated|1|||
105663617|NCT05131477|364432492|FG008|PART 2|Re-randomized and not treated|0|||
105663618|NCT05131477|364432493|FG009|PART 2|Re-randomized and not treated|0|||
105663619|NCT05131477|364432494|FG010|PART 2|Re-randomized and not treated|1|||
105663620|NCT05131477|364432495|FG011|PART 2|Re-randomized and not treated|0|||
105663621|NCT05131477|364432496|FG012|PART 2|Re-randomized and not treated|1|||
105663622|NCT05131477|364432497|FG013|PART 2|Re-randomized and not treated|1|||
105663623|NCT01246999|364434712|FG000|Overall Study|Lost to Follow-up|0|||
105663624|NCT01246999|364434713|FG001|Overall Study|Lost to Follow-up|1|||
105663625|NCT01246999|364434714|FG002|Overall Study|Lost to Follow-up|0|||
105663626|NCT01246999|364434715|FG003|Overall Study|Lost to Follow-up|0|||
105663627|NCT01246999|364434712|FG000|Overall Study|Withdrawal by Subject|0|||
105663628|NCT01246999|364434713|FG001|Overall Study|Withdrawal by Subject|0|||
105663629|NCT01246999|364434714|FG002|Overall Study|Withdrawal by Subject|0|||
105663630|NCT01246999|364434715|FG003|Overall Study|Withdrawal by Subject|2|||
105663631|NCT00307047|364434716|FG000|Overall Study|Lost to Follow-up|35|||
105663632|NCT00307047|364434717|FG001|Overall Study|Lost to Follow-up|24|||
105663633|NCT00307047|364434716|FG000|Overall Study|Withdrawal by Subject|6|||
105888722|NCT03843541|365247734|FG001|Overall Study|Physician Decision|2|||
105888723|NCT03843541|365247735|FG002|Overall Study|Physician Decision|2|||
105888724|NCT03843541|365247733|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
105888725|NCT03843541|365247734|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
105888726|NCT03843541|365247735|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
105888727|NCT03843541|365247733|FG000|Overall Study|Withdrawal by Subject|6|||
105888728|NCT03843541|365247734|FG001|Overall Study|Withdrawal by Subject|9|||
105888729|NCT03843541|365247735|FG002|Overall Study|Withdrawal by Subject|7|||
105888730|NCT03843541|365247733|FG000|Overall Study|Administration of rescue mucolytic|0|||
105888731|NCT03843541|365247734|FG001|Overall Study|Administration of rescue mucolytic|0|||
105888732|NCT03843541|365247735|FG002|Overall Study|Administration of rescue mucolytic|1|||
105888733|NCT03843541|365247733|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
105888734|NCT03843541|365247734|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
105888735|NCT03843541|365247735|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
105888736|NCT02691013|365247738|FG000|Overall Study|Withdrawal by Subject|3|||
105888737|NCT02691013|365247739|FG001|Overall Study|Withdrawal by Subject|0|||
105888738|NCT01895608|365247744|FG000|Overall Study|change in health status|0|||
105663634|NCT00307047|364434717|FG001|Overall Study|Withdrawal by Subject|6|||
105663635|NCT00307047|364434716|FG000|Overall Study|Physician Decision|1|||
105663636|NCT00307047|364434717|FG001|Overall Study|Physician Decision|2|||
105663637|NCT00307047|364434716|FG000|Overall Study|Lost to follow-up for other reasons|0|||
105663638|NCT00307047|364434717|FG001|Overall Study|Lost to follow-up for other reasons|1|||
105663639|NCT00307047|364434716|FG000|Overall Study|All death, all MI, all Revascularization|27|||
105663640|NCT00307047|364434717|FG001|Overall Study|All death, all MI, all Revascularization|16|||
105663641|NCT00903760|364434718|FG000|Overall Study|Disease Progression/Death|8|||
105663642|NCT00903760|364434719|FG001|Overall Study|Disease Progression/Death|6|||
105663643|NCT00903760|364434718|FG000|Overall Study|Stem Cell Transplant|8|||
105663644|NCT00903760|364434719|FG001|Overall Study|Stem Cell Transplant|4|||
105663645|NCT00903760|364434718|FG000|Overall Study|Physician Decision|1|||
105663646|NCT00903760|364434719|FG001|Overall Study|Physician Decision|2|||
105663647|NCT00903760|364434718|FG000|Overall Study|Death|0|||
105663648|NCT00903760|364434719|FG001|Overall Study|Death|1|||
105663649|NCT00903760|364434718|FG000|Overall Study|Lost to Follow-up|1|||
105663650|NCT00903760|364434719|FG001|Overall Study|Lost to Follow-up|0|||
105663651|NCT00903760|364434718|FG000|Overall Study|Withdrawal by Subject|1|||
105663652|NCT00903760|364434719|FG001|Overall Study|Withdrawal by Subject|2|||
105663653|NCT00903760|364434718|FG000|Overall Study|Off treatment for long period|0|||
105663654|NCT00903760|364434719|FG001|Overall Study|Off treatment for long period|1|||
105663655|NCT00379769|364434720|FG000|Main Study|Death|57|||
105663656|NCT00379769|364434721|FG001|Main Study|Death|67|||
105663657|NCT00379769|364434722|FG002|Main Study|Death|54|||
105663658|NCT00379769|364434723|FG003|Main Study|Death|72|||
105663659|NCT00379769|364434724|FG004|Main Study|Death|0|||
105663660|NCT00379769|364434725|FG005|Main Study|Death|0|||
105663661|NCT00379769|364434720|FG000|Main Study|Adverse Event|5|||
105663662|NCT00379769|364434721|FG001|Main Study|Adverse Event|8|||
105663663|NCT00379769|364434722|FG002|Main Study|Adverse Event|10|||
105663664|NCT00379769|364434723|FG003|Main Study|Adverse Event|11|||
105663665|NCT00379769|364434724|FG004|Main Study|Adverse Event|0|||
105663666|NCT00379769|364434725|FG005|Main Study|Adverse Event|0|||
105663667|NCT00379769|364434720|FG000|Main Study|Lost to Follow-up|29|||
105663668|NCT00379769|364434721|FG001|Main Study|Lost to Follow-up|29|||
105663669|NCT00379769|364434722|FG002|Main Study|Lost to Follow-up|25|||
105663670|NCT00379769|364434723|FG003|Main Study|Lost to Follow-up|26|||
105663671|NCT00379769|364434724|FG004|Main Study|Lost to Follow-up|0|||
105888739|NCT01895608|365247745|FG001|Overall Study|change in health status|1|||
105888740|NCT01895608|365247746|FG002|Overall Study|change in health status|1|||
105888741|NCT01895608|365247747|FG003|Overall Study|change in health status|0|||
105888742|NCT01895608|365247744|FG000|Overall Study|Withdrawal by Subject|0|||
105888743|NCT01895608|365247745|FG001|Overall Study|Withdrawal by Subject|0|||
105888744|NCT01895608|365247746|FG002|Overall Study|Withdrawal by Subject|2|||
105888745|NCT01895608|365247747|FG003|Overall Study|Withdrawal by Subject|0|||
105888746|NCT02833844|365247748|FG000|Double-Blind Period|Withdrawal by Subject|2|||
105888747|NCT02833844|365247749|FG001|Double-Blind Period|Withdrawal by Subject|3|||
105888748|NCT02833844|365247748|FG000|Double-Blind Period|Protocol Violation|0|||
105888749|NCT02833844|365247749|FG001|Double-Blind Period|Protocol Violation|4|||
105888750|NCT02833844|365247748|FG000|Open-Label Period|Death|0|||
105888751|NCT02833844|365247749|FG001|Open-Label Period|Death|2|||
105888752|NCT02833844|365247748|FG000|Open-Label Period|Lost to Follow-up|1|||
105888753|NCT02833844|365247749|FG001|Open-Label Period|Lost to Follow-up|0|||
105888754|NCT02833844|365247748|FG000|Open-Label Period|Withdrawal by Subject|1|||
105888755|NCT02833844|365247749|FG001|Open-Label Period|Withdrawal by Subject|0|||
105888756|NCT02662764|365247750|FG000|Overall Study|Adverse Event|6|||
106120904|NCT04789577|366100265|FG001|Overall Study|Withdrawal by Subject|1|||
106120905|NCT04789577|366100266|FG002|Overall Study|Withdrawal by Subject|1|||
106120906|NCT04789577|366100267|FG003|Overall Study|Withdrawal by Subject|3|||
106120907|NCT04789577|366100268|FG004|Overall Study|Withdrawal by Subject|1|||
106120908|NCT04789577|366100269|FG005|Overall Study|Withdrawal by Subject|7|||
106120909|NCT04789577|366100270|FG006|Overall Study|Withdrawal by Subject|1|||
106120910|NCT04789577|366100264|FG000|Overall Study|Lost to Follow-up|7|||
106120911|NCT04789577|366100265|FG001|Overall Study|Lost to Follow-up|12|||
106120912|NCT04789577|366100266|FG002|Overall Study|Lost to Follow-up|7|||
106120913|NCT04789577|366100267|FG003|Overall Study|Lost to Follow-up|10|||
106120914|NCT04789577|366100268|FG004|Overall Study|Lost to Follow-up|8|||
106120915|NCT04789577|366100269|FG005|Overall Study|Lost to Follow-up|6|||
106120916|NCT04789577|366100270|FG006|Overall Study|Lost to Follow-up|10|||
106120917|NCT04789577|366100264|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
106120918|NCT04789577|366100265|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
106120919|NCT04789577|366100266|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
106120920|NCT04789577|366100267|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
106120921|NCT04789577|366100268|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
106120922|NCT04789577|366100269|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
106120923|NCT04789577|366100270|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
106120924|NCT04789577|366100264|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
106120925|NCT04789577|366100265|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
106120926|NCT04789577|366100266|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
106120927|NCT04789577|366100267|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
106120928|NCT04789577|366100268|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
106120929|NCT04789577|366100269|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
106120930|NCT04789577|366100270|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
105663672|NCT00379769|364434725|FG005|Main Study|Lost to Follow-up|0|||
105663673|NCT00379769|364434720|FG000|Main Study|Withdrawal by Subject|46|||
105663674|NCT00379769|364434721|FG001|Main Study|Withdrawal by Subject|56|||
105663675|NCT00379769|364434722|FG002|Main Study|Withdrawal by Subject|72|||
105663676|NCT00379769|364434723|FG003|Main Study|Withdrawal by Subject|70|||
105663677|NCT00379769|364434724|FG004|Main Study|Withdrawal by Subject|0|||
105888757|NCT02662764|365247750|FG000|Overall Study|Lack of Efficacy|8|||
106120931|NCT02441946|366100273|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
106120932|NCT02441946|366100274|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
106120933|NCT02441946|366100275|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
106120934|NCT02441946|366100273|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
106120935|NCT02441946|366100274|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
106120936|NCT02441946|366100275|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
106120937|NCT02441946|366100273|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
106120938|NCT02441946|366100274|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
106120939|NCT02441946|366100275|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
106120940|NCT02441946|366100273|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
106120941|NCT02441946|366100274|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
106120942|NCT02441946|366100275|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
106120943|NCT02441946|366100273|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
106120944|NCT02441946|366100274|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
105996119|NCT01173601|365646944|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
105996120|NCT01173601|365646945|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
105996121|NCT01173601|365646946|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
105996122|NCT01173601|365646947|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
105996123|NCT01173601|365646948|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
105996124|NCT01173601|365646944|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105996125|NCT01173601|365646945|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
105996126|NCT01173601|365646946|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105996127|NCT01173601|365646947|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
105996128|NCT01173601|365646948|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
105996129|NCT01173601|365646944|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
105996130|NCT01173601|365646945|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
105996131|NCT01173601|365646946|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105996132|NCT01173601|365646947|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
105996133|NCT01173601|365646948|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105996134|NCT01173601|365646944|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
105996135|NCT01173601|365646945|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
105996136|NCT01173601|365646946|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
105996137|NCT01173601|365646947|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
105996138|NCT01173601|365646948|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
105996139|NCT01173601|365646944|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105996140|NCT01173601|365646945|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105996141|NCT01173601|365646946|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105996142|NCT01173601|365646947|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
105996143|NCT01173601|365646948|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
105996144|NCT03951077|365646949|FG000|Overall Study|Adverse Event|1|||
105996145|NCT03951077|365646950|FG001|Overall Study|Adverse Event|0|||
105996146|NCT03951077|365646951|FG002|Overall Study|Adverse Event|0|||
105996147|NCT03951077|365646952|FG003|Overall Study|Adverse Event|0|||
105996148|NCT03951077|365646953|FG004|Overall Study|Adverse Event|0|||
105996149|NCT03951077|365646954|FG005|Overall Study|Adverse Event|0|||
105996150|NCT03951077|365646949|FG000|Overall Study|Withdrawal by Subject|3|||
105996151|NCT03951077|365646950|FG001|Overall Study|Withdrawal by Subject|3|||
105996152|NCT03951077|365646951|FG002|Overall Study|Withdrawal by Subject|0|||
106120945|NCT02441946|366100275|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
106120946|NCT02441946|366100273|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
106120947|NCT02441946|366100274|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
106120948|NCT02441946|366100275|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
106120949|NCT02441946|366100273|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
106120950|NCT02441946|366100274|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
105996153|NCT03951077|365646952|FG003|Overall Study|Withdrawal by Subject|3|||
106120951|NCT02441946|366100275|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
106120952|NCT02441946|366100273|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
106120953|NCT02441946|366100274|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
105996154|NCT03951077|365646953|FG004|Overall Study|Withdrawal by Subject|3|||
105996155|NCT03951077|365646954|FG005|Overall Study|Withdrawal by Subject|2|||
105996156|NCT03951077|365646949|FG000|Overall Study|Lost to Follow-up|1|||
105996157|NCT03951077|365646950|FG001|Overall Study|Lost to Follow-up|1|||
105996158|NCT03951077|365646951|FG002|Overall Study|Lost to Follow-up|2|||
105996159|NCT03951077|365646952|FG003|Overall Study|Lost to Follow-up|3|||
105996160|NCT03951077|365646953|FG004|Overall Study|Lost to Follow-up|2|||
105996161|NCT03951077|365646954|FG005|Overall Study|Lost to Follow-up|3|||
106120954|NCT02441946|366100275|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
106120955|NCT02441946|366100273|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
106120956|NCT02441946|366100274|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
105663678|NCT00379769|364434725|FG005|Main Study|Withdrawal by Subject|0|||
105663679|NCT00379769|364434720|FG000|Main Study|Moved to survival status follow-up only|27|||
105663680|NCT00379769|364434721|FG001|Main Study|Moved to survival status follow-up only|25|||
105663681|NCT00379769|364434722|FG002|Main Study|Moved to survival status follow-up only|32|||
105663682|NCT00379769|364434723|FG003|Main Study|Moved to survival status follow-up only|36|||
105663683|NCT00379769|364434724|FG004|Main Study|Moved to survival status follow-up only|0|||
105663684|NCT00379769|364434725|FG005|Main Study|Moved to survival status follow-up only|0|||
105663685|NCT00379769|364434720|FG000|Main Study|Participant moved|3|||
105663686|NCT00379769|364434721|FG001|Main Study|Participant moved|2|||
105663687|NCT00379769|364434722|FG002|Main Study|Participant moved|3|||
105663688|NCT00379769|364434723|FG003|Main Study|Participant moved|3|||
105663689|NCT00379769|364434724|FG004|Main Study|Participant moved|0|||
105663690|NCT00379769|364434725|FG005|Main Study|Participant moved|0|||
105663691|NCT00379769|364434720|FG000|Main Study|Poor compliance|3|||
105663692|NCT00379769|364434721|FG001|Main Study|Poor compliance|2|||
105663693|NCT00379769|364434722|FG002|Main Study|Poor compliance|2|||
105663694|NCT00379769|364434723|FG003|Main Study|Poor compliance|1|||
105663695|NCT00379769|364434724|FG004|Main Study|Poor compliance|0|||
105663696|NCT00379769|364434725|FG005|Main Study|Poor compliance|0|||
105663697|NCT00379769|364434720|FG000|Main Study|Prohibited glucose lowering medication|0|||
105663698|NCT00379769|364434721|FG001|Main Study|Prohibited glucose lowering medication|3|||
105663699|NCT00379769|364434722|FG002|Main Study|Prohibited glucose lowering medication|0|||
105663700|NCT00379769|364434723|FG003|Main Study|Prohibited glucose lowering medication|1|||
105663701|NCT00379769|364434724|FG004|Main Study|Prohibited glucose lowering medication|0|||
105663702|NCT00379769|364434725|FG005|Main Study|Prohibited glucose lowering medication|0|||
105663703|NCT00379769|364434720|FG000|Main Study|Site closed|4|||
105663704|NCT00379769|364434721|FG001|Main Study|Site closed|4|||
105663705|NCT00379769|364434722|FG002|Main Study|Site closed|4|||
105663706|NCT00379769|364434723|FG003|Main Study|Site closed|8|||
105663707|NCT00379769|364434724|FG004|Main Study|Site closed|0|||
105663708|NCT00379769|364434725|FG005|Main Study|Site closed|0|||
105663709|NCT00379769|364434720|FG000|Main Study|Entry criteria violation|0|||
105663710|NCT00379769|364434721|FG001|Main Study|Entry criteria violation|0|||
105663711|NCT00379769|364434722|FG002|Main Study|Entry criteria violation|1|||
105663712|NCT00379769|364434723|FG003|Main Study|Entry criteria violation|1|||
105663713|NCT00379769|364434724|FG004|Main Study|Entry criteria violation|0|||
105663714|NCT00379769|364434725|FG005|Main Study|Entry criteria violation|0|||
105663715|NCT00379769|364434720|FG000|Main Study|Participant did not take study drug|0|||
105663716|NCT00379769|364434721|FG001|Main Study|Participant did not take study drug|0|||
105663717|NCT00379769|364434722|FG002|Main Study|Participant did not take study drug|1|||
105663718|NCT00379769|364434723|FG003|Main Study|Participant did not take study drug|0|||
105663719|NCT00379769|364434724|FG004|Main Study|Participant did not take study drug|0|||
105663720|NCT00379769|364434725|FG005|Main Study|Participant did not take study drug|0|||
105663721|NCT00379769|364434720|FG000|Main Study|Physician Decision|2|||
105663722|NCT00379769|364434721|FG001|Main Study|Physician Decision|2|||
105888758|NCT02662764|365247750|FG000|Overall Study|Protocol Violation|1|||
105888759|NCT02662764|365247750|FG000|Overall Study|Withdrawal by Subject|5|||
105888760|NCT02662764|365247750|FG000|Overall Study|Device failure|4|||
105888761|NCT02662764|365247750|FG000|Overall Study|Patient changed treatment|1|||
105888762|NCT02662764|365247750|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
105888763|NCT03973918|365247751|FG000|Overall Study|Adverse Event|0|||
105888764|NCT03973918|365247752|FG001|Overall Study|Adverse Event|0|||
105888765|NCT03973918|365247753|FG002|Overall Study|Adverse Event|0|||
105888766|NCT03973918|365247754|FG003|Overall Study|Adverse Event|1|||
105888767|NCT03973918|365247751|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
105888768|NCT03973918|365247752|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
105888769|NCT03973918|365247753|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
105888770|NCT03973918|365247754|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
105888771|NCT03403751|365247756|FG000|Overall Study|Death|5|||
105888772|NCT03403751|365247757|FG001|Overall Study|Death|6|||
105888773|NCT03403751|365247756|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
105663723|NCT00379769|364434722|FG002|Main Study|Physician Decision|1|||
105663724|NCT00379769|364434723|FG003|Main Study|Physician Decision|1|||
105663725|NCT00379769|364434724|FG004|Main Study|Physician Decision|0|||
105663726|NCT00379769|364434725|FG005|Main Study|Physician Decision|0|||
105663727|NCT00379769|364434720|FG000|Main Study|Participant completed study at visit 27|1|||
105663728|NCT00379769|364434721|FG001|Main Study|Participant completed study at visit 27|0|||
105663729|NCT00379769|364434722|FG002|Main Study|Participant completed study at visit 27|0|||
105888774|NCT03403751|365247757|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
105663730|NCT00379769|364434723|FG003|Main Study|Participant completed study at visit 27|0|||
105663731|NCT00379769|364434724|FG004|Main Study|Participant completed study at visit 27|0|||
105663732|NCT00379769|364434725|FG005|Main Study|Participant completed study at visit 27|0|||
105888775|NCT01820572|365247758|FG000|Randomization|Not Treated|2|||
105663733|NCT00379769|364434720|FG000|Main Study|Personal reasons|1|||
105663734|NCT00379769|364434721|FG001|Main Study|Personal reasons|0|||
105663735|NCT00379769|364434722|FG002|Main Study|Personal reasons|0|||
105663736|NCT00379769|364434723|FG003|Main Study|Personal reasons|0|||
105663737|NCT00379769|364434724|FG004|Main Study|Personal reasons|0|||
105663738|NCT00379769|364434725|FG005|Main Study|Personal reasons|0|||
105663739|NCT00379769|364434720|FG000|Main Study|Risk of heart failure|0|||
105663740|NCT00379769|364434721|FG001|Main Study|Risk of heart failure|1|||
105663741|NCT00379769|364434722|FG002|Main Study|Risk of heart failure|0|||
105663742|NCT00379769|364434723|FG003|Main Study|Risk of heart failure|0|||
105663743|NCT00379769|364434724|FG004|Main Study|Risk of heart failure|0|||
105663744|NCT00379769|364434725|FG005|Main Study|Risk of heart failure|0|||
105663745|NCT00379769|364434720|FG000|Main Study|Investigator refused to log temperature|0|||
105663746|NCT00379769|364434721|FG001|Main Study|Investigator refused to log temperature|0|||
105663747|NCT00379769|364434722|FG002|Main Study|Investigator refused to log temperature|1|||
105663748|NCT00379769|364434723|FG003|Main Study|Investigator refused to log temperature|0|||
105663749|NCT00379769|364434724|FG004|Main Study|Investigator refused to log temperature|0|||
105663750|NCT00379769|364434725|FG005|Main Study|Investigator refused to log temperature|0|||
105663751|NCT00379769|364434720|FG000|Main Study|Reason unspecified|0|||
105663752|NCT00379769|364434721|FG001|Main Study|Reason unspecified|0|||
105663753|NCT00379769|364434722|FG002|Main Study|Reason unspecified|1|||
105663754|NCT00379769|364434723|FG003|Main Study|Reason unspecified|0|||
105663755|NCT00379769|364434724|FG004|Main Study|Reason unspecified|0|||
105663756|NCT00379769|364434725|FG005|Main Study|Reason unspecified|0|||
105663757|NCT00379769|364434720|FG000|Observational Follow-up|Death|0|||
105663758|NCT00379769|364434721|FG001|Observational Follow-up|Death|0|||
105663759|NCT00379769|364434722|FG002|Observational Follow-up|Death|0|||
105663760|NCT00379769|364434723|FG003|Observational Follow-up|Death|0|||
105663761|NCT00379769|364434724|FG004|Observational Follow-up|Death|78|||
105663762|NCT00379769|364434725|FG005|Observational Follow-up|Death|70|||
105663763|NCT00379769|364434720|FG000|Observational Follow-up|Adverse Event|0|||
105663764|NCT00379769|364434721|FG001|Observational Follow-up|Adverse Event|0|||
105663765|NCT00379769|364434722|FG002|Observational Follow-up|Adverse Event|0|||
105663766|NCT00379769|364434723|FG003|Observational Follow-up|Adverse Event|0|||
106120957|NCT02441946|366100275|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
106120958|NCT02441946|366100273|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
105663767|NCT00379769|364434724|FG004|Observational Follow-up|Adverse Event|1|||
105663768|NCT00379769|364434725|FG005|Observational Follow-up|Adverse Event|0|||
105663769|NCT00379769|364434720|FG000|Observational Follow-up|Lost to Follow-up|0|||
105663770|NCT00379769|364434721|FG001|Observational Follow-up|Lost to Follow-up|0|||
105663771|NCT00379769|364434722|FG002|Observational Follow-up|Lost to Follow-up|0|||
105663772|NCT00379769|364434723|FG003|Observational Follow-up|Lost to Follow-up|0|||
105663773|NCT00379769|364434724|FG004|Observational Follow-up|Lost to Follow-up|25|||
105663774|NCT00379769|364434725|FG005|Observational Follow-up|Lost to Follow-up|27|||
105663775|NCT00379769|364434720|FG000|Observational Follow-up|Withdrawal by Subject|0|||
105663776|NCT00379769|364434721|FG001|Observational Follow-up|Withdrawal by Subject|0|||
105663777|NCT00379769|364434722|FG002|Observational Follow-up|Withdrawal by Subject|0|||
105663778|NCT00379769|364434723|FG003|Observational Follow-up|Withdrawal by Subject|0|||
105663779|NCT00379769|364434724|FG004|Observational Follow-up|Withdrawal by Subject|12|||
105663780|NCT00379769|364434725|FG005|Observational Follow-up|Withdrawal by Subject|12|||
105663781|NCT00379769|364434720|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
105663782|NCT00379769|364434721|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
105663783|NCT00379769|364434722|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
105663784|NCT00379769|364434723|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
105663785|NCT00379769|364434724|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
105663786|NCT00379769|364434725|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
105663787|NCT00379769|364434720|FG000|Observational Follow-up|Physician Decision|0|||
106120959|NCT02441946|366100274|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
105663788|NCT00379769|364434721|FG001|Observational Follow-up|Physician Decision|0|||
106120960|NCT02441946|366100275|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
106120961|NCT02441946|366100273|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
106120962|NCT02441946|366100274|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105663789|NCT00379769|364434722|FG002|Observational Follow-up|Physician Decision|0|||
105663790|NCT00379769|364434723|FG003|Observational Follow-up|Physician Decision|0|||
105663791|NCT00379769|364434724|FG004|Observational Follow-up|Physician Decision|8|||
105663792|NCT00379769|364434725|FG005|Observational Follow-up|Physician Decision|8|||
105663793|NCT00379769|364434720|FG000|Observational Follow-up|Site Closed Early|0|||
105663794|NCT00379769|364434721|FG001|Observational Follow-up|Site Closed Early|0|||
105663795|NCT00379769|364434722|FG002|Observational Follow-up|Site Closed Early|0|||
105663796|NCT00379769|364434723|FG003|Observational Follow-up|Site Closed Early|0|||
105663797|NCT00379769|364434724|FG004|Observational Follow-up|Site Closed Early|6|||
106120963|NCT02441946|366100275|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
106120964|NCT04848662|366100276|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
106120965|NCT04848662|366100277|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
106120966|NCT03000673|366100278|FG000|Overall Study|Withdrawal by Subject|1|||
106120967|NCT03000673|366100279|FG001|Overall Study|Withdrawal by Subject|0|||
106120968|NCT03000673|366100280|FG002|Overall Study|Withdrawal by Subject|0|||
106120969|NCT03000673|366100281|FG003|Overall Study|Withdrawal by Subject|0|||
106120970|NCT01121484|366100283|FG000|Overall Study|Adverse Event|12|||
106120971|NCT01121484|366100284|FG001|Overall Study|Adverse Event|5|||
106120972|NCT01121484|366100283|FG000|Overall Study|Lack of Efficacy|3|||
106120973|NCT01121484|366100284|FG001|Overall Study|Lack of Efficacy|11|||
106120974|NCT01121484|366100283|FG000|Overall Study|Lost to Follow-up|5|||
106120975|NCT01121484|366100284|FG001|Overall Study|Lost to Follow-up|9|||
106120976|NCT01121484|366100283|FG000|Overall Study|Physician Decision|0|||
106120977|NCT01121484|366100284|FG001|Overall Study|Physician Decision|3|||
106120978|NCT01121484|366100283|FG000|Overall Study|Protocol Violation|1|||
106120979|NCT01121484|366100284|FG001|Overall Study|Protocol Violation|0|||
106120980|NCT01121484|366100283|FG000|Overall Study|Withdrawal by Subject|8|||
106120981|NCT01121484|366100284|FG001|Overall Study|Withdrawal by Subject|7|||
106120982|NCT01121484|366100283|FG000|Overall Study|Discontinuation of study by sponsor|0|||
106120983|NCT01121484|366100284|FG001|Overall Study|Discontinuation of study by sponsor|1|||
106120984|NCT01121484|366100283|FG000|Overall Study|Other|3|||
106120985|NCT01121484|366100284|FG001|Overall Study|Other|3|||
106120986|NCT01121484|366100283|FG000|Overall Study|Randomized, not treated|1|||
106120987|NCT01121484|366100284|FG001|Overall Study|Randomized, not treated|4|||
106120988|NCT01512745|366100285|FG000|Overall Study|Adverse Event|22|||
105663798|NCT00379769|364434725|FG005|Observational Follow-up|Site Closed Early|7|||
105996162|NCT03951077|365646949|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
105996163|NCT03951077|365646950|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
105996164|NCT03951077|365646951|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
105996165|NCT03951077|365646952|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
105996166|NCT03951077|365646953|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
105663799|NCT00379769|364434720|FG000|Observational Follow-up|Participant Moved|0|||
105663800|NCT00379769|364434721|FG001|Observational Follow-up|Participant Moved|0|||
105663801|NCT00379769|364434722|FG002|Observational Follow-up|Participant Moved|0|||
105663802|NCT00379769|364434723|FG003|Observational Follow-up|Participant Moved|0|||
105663803|NCT00379769|364434724|FG004|Observational Follow-up|Participant Moved|0|||
105996167|NCT03951077|365646954|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
105996168|NCT03951077|365646949|FG000|Overall Study|Other, Not Specified|12|||
105996169|NCT03951077|365646950|FG001|Overall Study|Other, Not Specified|10|||
105996170|NCT03951077|365646951|FG002|Overall Study|Other, Not Specified|10|||
105996171|NCT03951077|365646952|FG003|Overall Study|Other, Not Specified|5|||
105996172|NCT03951077|365646953|FG004|Overall Study|Other, Not Specified|9|||
105996173|NCT03951077|365646954|FG005|Overall Study|Other, Not Specified|6|||
105996174|NCT03951077|365646949|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
105996175|NCT03951077|365646950|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
105996176|NCT03951077|365646951|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
105996177|NCT03951077|365646952|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
105996178|NCT03951077|365646953|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
105996179|NCT03951077|365646954|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
105996180|NCT01799226|365646957|FG000|Overall Study|Withdrawal by Subject|1|||
105996181|NCT01799226|365646958|FG001|Overall Study|Withdrawal by Subject|0|||
105996182|NCT01799226|365646957|FG000|Overall Study|Disqualified at Day 14|1|||
105996183|NCT01799226|365646958|FG001|Overall Study|Disqualified at Day 14|0|||
105996184|NCT02178995|365646959|FG000|Double Blind|Adverse Event|0|||
105996185|NCT02178995|365646960|FG001|Double Blind|Adverse Event|0|||
105996186|NCT02178995|365646961|FG002|Double Blind|Adverse Event|0|||
105996187|NCT02178995|365646962|FG003|Double Blind|Adverse Event|0|||
105996188|NCT02178995|365646963|FG004|Double Blind|Adverse Event|0|||
105996189|NCT02178995|365646964|FG005|Double Blind|Adverse Event|1|||
105996190|NCT02178995|365646965|FG006|Double Blind|Adverse Event|0|||
105996191|NCT02178995|365646966|FG007|Double Blind|Adverse Event|1|||
105996192|NCT02178995|365646967|FG008|Double Blind|Adverse Event|1|||
105996193|NCT02178995|365646959|FG000|Double Blind|Lost to Follow-up|0|||
105996194|NCT02178995|365646960|FG001|Double Blind|Lost to Follow-up|1|||
105996195|NCT02178995|365646961|FG002|Double Blind|Lost to Follow-up|0|||
105996196|NCT02178995|365646962|FG003|Double Blind|Lost to Follow-up|0|||
105996197|NCT02178995|365646963|FG004|Double Blind|Lost to Follow-up|0|||
105996198|NCT02178995|365646964|FG005|Double Blind|Lost to Follow-up|0|||
105996199|NCT02178995|365646965|FG006|Double Blind|Lost to Follow-up|0|||
105996200|NCT02178995|365646966|FG007|Double Blind|Lost to Follow-up|1|||
105996201|NCT02178995|365646967|FG008|Double Blind|Lost to Follow-up|0|||
105996202|NCT02178995|365646959|FG000|Open Label|Adverse Event|2|||
105996203|NCT02178995|365646960|FG001|Open Label|Adverse Event|0|||
105996204|NCT02178995|365646961|FG002|Open Label|Adverse Event|0|||
106120989|NCT01512745|366100286|FG001|Overall Study|Adverse Event|3|||
106120990|NCT01512745|366100285|FG000|Overall Study|Death|9|||
105996205|NCT02178995|365646962|FG003|Open Label|Adverse Event|0|||
105996206|NCT02178995|365646963|FG004|Open Label|Adverse Event|0|||
105663804|NCT00379769|364434725|FG005|Observational Follow-up|Participant Moved|1|||
105996207|NCT02178995|365646964|FG005|Open Label|Adverse Event|0|||
105996208|NCT02178995|365646965|FG006|Open Label|Adverse Event|0|||
105996209|NCT02178995|365646966|FG007|Open Label|Adverse Event|0|||
105996210|NCT02178995|365646967|FG008|Open Label|Adverse Event|0|||
105996211|NCT00699608|365646968|FG000|First Intervention|Withdrawal by Subject|0|||
106120991|NCT01512745|366100286|FG001|Overall Study|Death|13|||
105663805|NCT00379769|364434720|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
105663806|NCT00379769|364434721|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
105663807|NCT00379769|364434722|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
105663808|NCT00379769|364434723|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
105663809|NCT00379769|364434724|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
105663810|NCT00379769|364434725|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
105663811|NCT03778294|364434726|FG000|Overall Study|Death|1|||
105663812|NCT03778294|364434726|FG000|Overall Study|Issues with insurance|1|||
105663813|NCT03778294|364434726|FG000|Overall Study|disease progression before treatment|2|||
105663814|NCT02388347|364434727|FG000|Overall Study|Withdrawal by Subject|0|||
105663815|NCT02388347|364434728|FG001|Overall Study|Withdrawal by Subject|0|||
105663816|NCT02388347|364434729|FG002|Overall Study|Withdrawal by Subject|1|||
105663817|NCT02388347|364434730|FG003|Overall Study|Withdrawal by Subject|0|||
105663818|NCT02388347|364434731|FG004|Overall Study|Withdrawal by Subject|0|||
105663819|NCT02825251|364434734|FG000|Overall Study|Adverse Event|0|||
105663820|NCT02825251|364434735|FG001|Overall Study|Adverse Event|1|||
105663821|NCT02825251|364434734|FG000|Overall Study|Lost to Follow-up|0|||
105663822|NCT02825251|364434735|FG001|Overall Study|Lost to Follow-up|1|||
105663823|NCT02825251|364434734|FG000|Overall Study|Withdrawal by Subject|1|||
105663824|NCT02825251|364434735|FG001|Overall Study|Withdrawal by Subject|4|||
105663825|NCT02825251|364434734|FG000|Overall Study|Unclassified|2|||
105663826|NCT02825251|364434735|FG001|Overall Study|Unclassified|0|||
105663827|NCT01689363|364434742|FG000|Overall Study|Protocol Violation|0|||
105663828|NCT01689363|364434743|FG001|Overall Study|Protocol Violation|1|||
105663829|NCT01689363|364434744|FG002|Overall Study|Protocol Violation|0|||
105663830|NCT01689363|364434745|FG003|Overall Study|Protocol Violation|0|||
105663831|NCT01689363|364434746|FG004|Overall Study|Protocol Violation|0|||
105663832|NCT01689363|364434747|FG005|Overall Study|Protocol Violation|0|||
105663833|NCT01689363|364434748|FG006|Overall Study|Protocol Violation|0|||
105663834|NCT01689363|364434749|FG007|Overall Study|Protocol Violation|0|||
105663835|NCT02859064|364434750|FG000|Overall Study|Progressive Disease|3|||
105663836|NCT02859064|364434750|FG000|Overall Study|Physician Decision|1|||
105663837|NCT02859064|364434750|FG000|Overall Study|Withdrawal by Subject|1|||
105663838|NCT02859064|364434750|FG000|Overall Study|Death|1|||
105663839|NCT00321685|364434751|FG000|Overall Study|Adverse Event|18|||
105663840|NCT00321685|364434751|FG000|Overall Study|Death|2|||
105663841|NCT00321685|364434751|FG000|Overall Study|Withdrawal by Subject|8|||
105663842|NCT00321685|364434751|FG000|Overall Study|Alternative therapy|1|||
105663843|NCT00321685|364434751|FG000|Overall Study|Complicating disese|1|||
105663844|NCT00321685|364434751|FG000|Overall Study|Other|5|||
105663845|NCT00321685|364434751|FG000|Overall Study|Not start protocol therapy|2|||
105663846|NCT00321685|364434751|FG000|Overall Study|Ineligible|2|||
105663847|NCT02172911|364434756|FG000|Overall Study|Serious Adverse Event|0|||
105888776|NCT01820572|365247759|FG001|Randomization|Not Treated|1|||
105888777|NCT01820572|365247758|FG000|Treatment Period|Adverse Event|12|||
105888778|NCT01820572|365247759|FG001|Treatment Period|Adverse Event|7|||
105888779|NCT01820572|365247758|FG000|Treatment Period|Death|3|||
105888780|NCT01820572|365247759|FG001|Treatment Period|Death|3|||
105888781|NCT01820572|365247758|FG000|Treatment Period|Lack of Efficacy|1|||
105888782|NCT01820572|365247759|FG001|Treatment Period|Lack of Efficacy|0|||
105888783|NCT01820572|365247758|FG000|Treatment Period|poor/non compliance|0|||
105888784|NCT01820572|365247759|FG001|Treatment Period|poor/non compliance|3|||
105888785|NCT01820572|365247758|FG000|Treatment Period|request to discontinue|6|||
105888786|NCT01820572|365247759|FG001|Treatment Period|request to discontinue|11|||
105888787|NCT01820572|365247758|FG000|Treatment Period|No longer meets study criteria|3|||
105888788|NCT01820572|365247759|FG001|Treatment Period|No longer meets study criteria|10|||
105888789|NCT01820572|365247758|FG000|Treatment Period|withdrew consent|1|||
105888790|NCT01820572|365247759|FG001|Treatment Period|withdrew consent|2|||
105888791|NCT00125242|365247762|FG000|Overall Study|did not qualify|7|||
105888792|NCT00125242|365247763|FG001|Overall Study|did not qualify|2|||
105888793|NCT01738503|365247764|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
105888794|NCT01738503|365247765|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
105888795|NCT01738503|365247766|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
105888796|NCT01738503|365247767|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
105888797|NCT01738503|365247768|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
105888798|NCT01738503|365247769|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
105996212|NCT00699608|365646969|FG001|First Intervention|Withdrawal by Subject|0|||
105996213|NCT00699608|365646970|FG002|First Intervention|Withdrawal by Subject|1|||
105888799|NCT01738503|365247770|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
105996214|NCT00699608|365646971|FG003|First Intervention|Withdrawal by Subject|0|||
105663848|NCT02172911|364434757|FG001|Overall Study|Serious Adverse Event|1|||
105663849|NCT02172911|364434756|FG000|Overall Study|Progression of Disease|0|||
105663850|NCT02172911|364434757|FG001|Overall Study|Progression of Disease|1|||
105663851|NCT02172911|364434756|FG000|Overall Study|Loss of insurance coverage|1|||
105663852|NCT02172911|364434757|FG001|Overall Study|Loss of insurance coverage|0|||
105663853|NCT00127842|364434758|FG000|Overall Study|Adverse Event|15|||
105663854|NCT00127842|364434758|FG000|Overall Study|Withdrawal by Subject|3|||
105663855|NCT00127842|364434758|FG000|Overall Study|Lost to Follow-up|1|||
105663856|NCT00127842|364434758|FG000|Overall Study|Lack of Efficacy|12|||
105663857|NCT00127842|364434758|FG000|Overall Study|Noncompliance|2|||
105663858|NCT00127842|364434758|FG000|Overall Study|Protocol Violation|1|||
105663859|NCT00127842|364434758|FG000|Overall Study|Other|5|||
105663860|NCT01536587|364434761|FG000|Overall Study|Adverse Event|2|||
105663861|NCT03023722|364434762|FG000|Overall Study|No follow-up assessment|4|||
105663862|NCT00129935|364434763|FG000|Overall Study|Adverse Event|18|||
105888800|NCT01738503|365247764|FG000|Treatment Period|Adverse Event|0|||
105888801|NCT01738503|365247765|FG001|Treatment Period|Adverse Event|1|||
105888802|NCT01738503|365247766|FG002|Treatment Period|Adverse Event|0|||
105888803|NCT01738503|365247767|FG003|Treatment Period|Adverse Event|1|||
105888804|NCT01738503|365247768|FG004|Treatment Period|Adverse Event|2|||
105888805|NCT01738503|365247769|FG005|Treatment Period|Adverse Event|2|||
105888806|NCT01738503|365247770|FG006|Treatment Period|Adverse Event|2|||
105888807|NCT01738503|365247764|FG000|Treatment Period|Lost to Follow-up|0|||
105888808|NCT01738503|365247765|FG001|Treatment Period|Lost to Follow-up|0|||
105888809|NCT01738503|365247766|FG002|Treatment Period|Lost to Follow-up|3|||
105888810|NCT01738503|365247767|FG003|Treatment Period|Lost to Follow-up|4|||
105888811|NCT01738503|365247768|FG004|Treatment Period|Lost to Follow-up|1|||
105888812|NCT01738503|365247769|FG005|Treatment Period|Lost to Follow-up|1|||
105888813|NCT01738503|365247770|FG006|Treatment Period|Lost to Follow-up|5|||
105888814|NCT01738503|365247764|FG000|Treatment Period|Withdrawal by Subject|0|||
105888815|NCT01738503|365247765|FG001|Treatment Period|Withdrawal by Subject|1|||
105888816|NCT01738503|365247766|FG002|Treatment Period|Withdrawal by Subject|0|||
105888817|NCT01738503|365247767|FG003|Treatment Period|Withdrawal by Subject|1|||
105888818|NCT01738503|365247768|FG004|Treatment Period|Withdrawal by Subject|1|||
105888819|NCT01738503|365247769|FG005|Treatment Period|Withdrawal by Subject|1|||
105888820|NCT01738503|365247770|FG006|Treatment Period|Withdrawal by Subject|1|||
105888821|NCT01738503|365247764|FG000|Treatment Period|Protocol Violation|0|||
105888822|NCT01738503|365247765|FG001|Treatment Period|Protocol Violation|3|||
105888823|NCT01738503|365247766|FG002|Treatment Period|Protocol Violation|1|||
105888824|NCT01738503|365247767|FG003|Treatment Period|Protocol Violation|0|||
105888825|NCT01738503|365247768|FG004|Treatment Period|Protocol Violation|4|||
105888826|NCT01738503|365247769|FG005|Treatment Period|Protocol Violation|2|||
105888827|NCT01738503|365247770|FG006|Treatment Period|Protocol Violation|0|||
105888828|NCT01738503|365247764|FG000|Treatment Period|Other|0|||
105888829|NCT01738503|365247765|FG001|Treatment Period|Other|0|||
105888830|NCT01738503|365247766|FG002|Treatment Period|Other|1|||
105888831|NCT01738503|365247767|FG003|Treatment Period|Other|0|||
105888832|NCT01738503|365247768|FG004|Treatment Period|Other|0|||
105888833|NCT01738503|365247769|FG005|Treatment Period|Other|0|||
105888834|NCT01738503|365247770|FG006|Treatment Period|Other|0|||
105888835|NCT01738503|365247764|FG000|PET Imaging Sub-study|Adverse Event|0|||
105888836|NCT01738503|365247765|FG001|PET Imaging Sub-study|Adverse Event|0|||
105888837|NCT01738503|365247766|FG002|PET Imaging Sub-study|Adverse Event|0|||
105888838|NCT01738503|365247767|FG003|PET Imaging Sub-study|Adverse Event|0|||
105888839|NCT01738503|365247768|FG004|PET Imaging Sub-study|Adverse Event|0|||
105888840|NCT01738503|365247769|FG005|PET Imaging Sub-study|Adverse Event|1|||
105888841|NCT01738503|365247770|FG006|PET Imaging Sub-study|Adverse Event|0|||
105888842|NCT01738503|365247764|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105888843|NCT01738503|365247765|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
106120992|NCT01512745|366100285|FG000|Overall Study|Withdrawal by Subject|2|||
106120993|NCT01512745|366100286|FG001|Overall Study|Withdrawal by Subject|2|||
106120994|NCT01512745|366100285|FG000|Overall Study|Lost to Follow-up|4|||
106120995|NCT01512745|366100286|FG001|Overall Study|Lost to Follow-up|0|||
105663863|NCT00129935|364434764|FG001|Overall Study|Adverse Event|56|||
105663864|NCT00129935|364434763|FG000|Overall Study|Death|1|||
105663865|NCT00129935|364434764|FG001|Overall Study|Death|1|||
105888844|NCT01738503|365247766|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105888845|NCT01738503|365247767|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105888846|NCT01738503|365247768|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
105888847|NCT01738503|365247769|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
105888848|NCT01738503|365247770|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
105996215|NCT00699608|365646972|FG004|First Intervention|Withdrawal by Subject|0|||
105996216|NCT00699608|365646973|FG005|First Intervention|Withdrawal by Subject|0|||
105663866|NCT00129935|364434763|FG000|Overall Study|Withdrawal by Subject|7|||
105663867|NCT00129935|364434764|FG001|Overall Study|Withdrawal by Subject|20|||
105663868|NCT00129935|364434763|FG000|Overall Study|Protocol Violation|0|||
106120996|NCT01512745|366100285|FG000|Overall Study|Lack of Efficacy|2|||
106120997|NCT01512745|366100286|FG001|Overall Study|Lack of Efficacy|2|||
106120998|NCT01512745|366100285|FG000|Overall Study|Protocol Violation|1|||
106120999|NCT01512745|366100286|FG001|Overall Study|Protocol Violation|0|||
106121000|NCT00562978|366100287|FG000|Overall Study|Patient had imaging dose only|1|||
106121001|NCT00562978|366100288|FG001|Overall Study|Patient had imaging dose only|11|||
106121002|NCT00152971|366100297|FG000|Overall Study|Adverse Event|12|||
106121003|NCT00152971|366100298|FG001|Overall Study|Adverse Event|10|||
106121004|NCT00152971|366100299|FG002|Overall Study|Adverse Event|9|||
106121005|NCT00152971|366100297|FG000|Overall Study|Protocol Violation|10|||
106121006|NCT00152971|366100298|FG001|Overall Study|Protocol Violation|11|||
106121007|NCT00152971|366100299|FG002|Overall Study|Protocol Violation|8|||
106121008|NCT00152971|366100297|FG000|Overall Study|Lost to Follow-up|17|||
106121009|NCT00152971|366100298|FG001|Overall Study|Lost to Follow-up|14|||
106121010|NCT00152971|366100299|FG002|Overall Study|Lost to Follow-up|13|||
106121011|NCT00152971|366100297|FG000|Overall Study|Withdrawal by Subject|9|||
106121012|NCT00152971|366100298|FG001|Overall Study|Withdrawal by Subject|8|||
106121013|NCT00152971|366100299|FG002|Overall Study|Withdrawal by Subject|14|||
106121014|NCT00152971|366100297|FG000|Overall Study|Other|3|||
106121015|NCT00152971|366100298|FG001|Overall Study|Other|5|||
106121016|NCT00152971|366100299|FG002|Overall Study|Other|5|||
106121017|NCT00152971|366100297|FG000|Treatment|Adverse Event|49|||
106121018|NCT00152971|366100298|FG001|Treatment|Adverse Event|40|||
106121019|NCT00152971|366100299|FG002|Treatment|Adverse Event|54|||
106121020|NCT00152971|366100297|FG000|Treatment|Protocol Violation|8|||
106121021|NCT00152971|366100298|FG001|Treatment|Protocol Violation|6|||
106121022|NCT00152971|366100299|FG002|Treatment|Protocol Violation|10|||
106121023|NCT00152971|366100297|FG000|Treatment|Lost to Follow-up|1|||
106121024|NCT00152971|366100298|FG001|Treatment|Lost to Follow-up|2|||
106121025|NCT00152971|366100299|FG002|Treatment|Lost to Follow-up|1|||
106121026|NCT00152971|366100297|FG000|Treatment|Withdrawal by Subject|4|||
106121027|NCT00152971|366100298|FG001|Treatment|Withdrawal by Subject|4|||
106121028|NCT00152971|366100299|FG002|Treatment|Withdrawal by Subject|5|||
106121029|NCT00152971|366100297|FG000|Treatment|Other|9|||
106121030|NCT00152971|366100298|FG001|Treatment|Other|11|||
106121031|NCT00152971|366100299|FG002|Treatment|Other|10|||
105996217|NCT00699608|365646968|FG000|First Intervention|Protocol Violation|0|||
105996218|NCT00699608|365646969|FG001|First Intervention|Protocol Violation|0|||
106121032|NCT03292146|366100301|FG000|Baseline to 12 Months|Relocation|1|||
106121033|NCT03292146|366100302|FG001|Baseline to 12 Months|Relocation|0|||
106121034|NCT03292146|366100301|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
106121035|NCT03292146|366100302|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
106121036|NCT03292146|366100301|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
105663869|NCT00129935|364434764|FG001|Overall Study|Protocol Violation|4|||
105663870|NCT00129935|364434763|FG000|Overall Study|Physician Decision|3|||
105996219|NCT00699608|365646970|FG002|First Intervention|Protocol Violation|0|||
105996220|NCT00699608|365646971|FG003|First Intervention|Protocol Violation|0|||
105996221|NCT00699608|365646972|FG004|First Intervention|Protocol Violation|1|||
105996222|NCT00699608|365646973|FG005|First Intervention|Protocol Violation|0|||
105996223|NCT00699608|365646968|FG000|Second Intervention|Adverse Event|0|||
105996224|NCT00699608|365646969|FG001|Second Intervention|Adverse Event|0|||
105996225|NCT00699608|365646970|FG002|Second Intervention|Adverse Event|1|||
105996226|NCT00699608|365646971|FG003|Second Intervention|Adverse Event|0|||
105996227|NCT00699608|365646972|FG004|Second Intervention|Adverse Event|0|||
105996228|NCT00699608|365646973|FG005|Second Intervention|Adverse Event|0|||
106121037|NCT03292146|366100302|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
106121038|NCT03292146|366100301|FG000|12 Months to 24 Months|Planning pregnancy|2|||
105996229|NCT00699608|365646968|FG000|Second Intervention|Withdrawal by Subject|0|||
105996230|NCT00699608|365646969|FG001|Second Intervention|Withdrawal by Subject|0|||
105996231|NCT00699608|365646970|FG002|Second Intervention|Withdrawal by Subject|0|||
106121039|NCT03292146|366100302|FG001|12 Months to 24 Months|Planning pregnancy|2|||
106121040|NCT03292146|366100301|FG000|12 Months to 24 Months|Personal reasons|1|||
106121041|NCT03292146|366100302|FG001|12 Months to 24 Months|Personal reasons|0|||
106121042|NCT03292146|366100301|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
106121043|NCT03292146|366100302|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
106121044|NCT00758160|366100303|FG000|Overall Study|No Longer Requires Study Medication|4|||
106121045|NCT00758160|366100303|FG000|Overall Study|Administration Problems|3|||
106121046|NCT00758160|366100303|FG000|Overall Study|Adverse Event|15|||
106121047|NCT00758160|366100303|FG000|Overall Study|Lack of Efficacy|10|||
106121048|NCT00758160|366100303|FG000|Overall Study|Lost to Follow-up|14|||
106121049|NCT00758160|366100303|FG000|Overall Study|Protocol Violation|12|||
106121050|NCT00758160|366100303|FG000|Overall Study|Withdrawal by Subject|8|||
106121051|NCT01613027|366100304|FG000|Overall Study|Lost to Follow-up|5|||
106121052|NCT01613027|366100304|FG000|Overall Study|Switched Physician|1|||
106121053|NCT01613027|366100304|FG000|Overall Study|Lack of Efficacy|1|||
106121054|NCT01613027|366100304|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
106121055|NCT02153359|366100305|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
106121056|NCT02153359|366100306|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
105663871|NCT00129935|364434764|FG001|Overall Study|Physician Decision|4|||
105663872|NCT00129935|364434763|FG000|Overall Study|Recurrence|1|||
105663873|NCT00129935|364434764|FG001|Overall Study|Recurrence|3|||
105663874|NCT00129935|364434763|FG000|Overall Study|Second primary|0|||
105663875|NCT00129935|364434764|FG001|Overall Study|Second primary|1|||
105663876|NCT00129935|364434763|FG000|Overall Study|Other|3|||
105663877|NCT00129935|364434764|FG001|Overall Study|Other|2|||
105663878|NCT00129935|364434763|FG000|Overall Study|Crossed to the other arm|2|||
105663879|NCT00129935|364434764|FG001|Overall Study|Crossed to the other arm|1|||
105663880|NCT00129935|364434763|FG000|Overall Study|Incorrect study treatment|1|||
105663881|NCT00129935|364434764|FG001|Overall Study|Incorrect study treatment|0|||
105663882|NCT00590564|364434766|FG000|Overall Study|Withdrawal by Subject|4|||
105663883|NCT00590564|364434766|FG000|Overall Study|Lost to Follow-up|6|||
105663884|NCT00590564|364434766|FG000|Overall Study|Protocol Violation|1|||
105663885|NCT00590564|364434766|FG000|Overall Study|Patient Found to be Ineligible|1|||
105663886|NCT00590564|364434766|FG000|Overall Study|Patient Non-compliance|6|||
105663887|NCT01434680|364434769|FG000|Overall Study|Withdrawal by Subject|1|||
105663888|NCT01434680|364434770|FG001|Overall Study|Withdrawal by Subject|0|||
105888849|NCT02272842|365247773|FG000|Overall Study|Lost to Follow-up|8|||
105888850|NCT02272842|365247774|FG001|Overall Study|Lost to Follow-up|8|||
105888851|NCT02272842|365247773|FG000|Overall Study|Withdrawal by Subject|8|||
105888852|NCT02272842|365247774|FG001|Overall Study|Withdrawal by Subject|2|||
105888853|NCT01493284|365247777|FG000|Overall Study|Death|29|||
105888854|NCT01493284|365247777|FG000|Overall Study|Withdrawal by Subject|32|||
105888855|NCT03814720|365247778|FG000|Overall Study|Lost to Follow-up|0|||
105888856|NCT03814720|365247779|FG001|Overall Study|Lost to Follow-up|1|||
105888857|NCT03814720|365247780|FG002|Overall Study|Lost to Follow-up|0|||
105888858|NCT03814720|365247781|FG003|Overall Study|Lost to Follow-up|0|||
105888859|NCT03814720|365247782|FG004|Overall Study|Lost to Follow-up|0|||
105888860|NCT03053063|365247791|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
105888861|NCT03053063|365247792|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
105888862|NCT03053063|365247793|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
105888863|NCT03053063|365247794|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
105888864|NCT03053063|365247791|FG000|Randomized Phase|Withdrew consent|8|||
105888865|NCT03053063|365247792|FG001|Randomized Phase|Withdrew consent|11|||
105888866|NCT03053063|365247793|FG002|Randomized Phase|Withdrew consent|5|||
105888867|NCT03053063|365247794|FG003|Randomized Phase|Withdrew consent|0|||
105888868|NCT03053063|365247791|FG000|Randomized Phase|Investigator's Discretion|8|||
105888869|NCT03053063|365247792|FG001|Randomized Phase|Investigator's Discretion|6|||
105888870|NCT03053063|365247793|FG002|Randomized Phase|Investigator's Discretion|2|||
105888871|NCT03053063|365247794|FG003|Randomized Phase|Investigator's Discretion|0|||
105888872|NCT03053063|365247791|FG000|Randomized Phase|Lost to Follow-up|3|||
105888873|NCT03053063|365247792|FG001|Randomized Phase|Lost to Follow-up|5|||
105888874|NCT03053063|365247793|FG002|Randomized Phase|Lost to Follow-up|1|||
105888875|NCT03053063|365247794|FG003|Randomized Phase|Lost to Follow-up|0|||
105888876|NCT03053063|365247791|FG000|Randomized Phase|Adverse Event|0|||
105888877|NCT03053063|365247792|FG001|Randomized Phase|Adverse Event|1|||
105888878|NCT03053063|365247793|FG002|Randomized Phase|Adverse Event|0|||
105888879|NCT03053063|365247794|FG003|Randomized Phase|Adverse Event|0|||
105888880|NCT03053063|365247791|FG000|Randomized Phase|Randomized but Never Treated|1|||
105888881|NCT03053063|365247792|FG001|Randomized Phase|Randomized but Never Treated|3|||
105888882|NCT03053063|365247793|FG002|Randomized Phase|Randomized but Never Treated|2|||
105888883|NCT03053063|365247794|FG003|Randomized Phase|Randomized but Never Treated|0|||
105888884|NCT03053063|365247791|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
105888885|NCT03053063|365247792|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
105888886|NCT03053063|365247793|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
105888887|NCT03053063|365247794|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
105888888|NCT03053063|365247791|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
105888889|NCT03053063|365247792|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
105888890|NCT03053063|365247793|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
105996232|NCT00699608|365646971|FG003|Second Intervention|Withdrawal by Subject|1|||
105663889|NCT01434680|364434771|FG002|Overall Study|Withdrawal by Subject|2|||
105663890|NCT01434680|364434772|FG003|Overall Study|Withdrawal by Subject|0|||
105663891|NCT01434680|364434769|FG000|Overall Study|Lost to Follow-up|1|||
105663892|NCT01434680|364434770|FG001|Overall Study|Lost to Follow-up|1|||
105663893|NCT01434680|364434771|FG002|Overall Study|Lost to Follow-up|0|||
105888891|NCT03053063|365247794|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
105888892|NCT03053063|365247791|FG000|Open-Label Phase|Death|0|||
105888893|NCT03053063|365247792|FG001|Open-Label Phase|Death|0|||
105888894|NCT03053063|365247793|FG002|Open-Label Phase|Death|0|||
105888895|NCT03053063|365247794|FG003|Open-Label Phase|Death|2|||
105888896|NCT03053063|365247791|FG000|Open-Label Phase|Investigator's discretion|0|||
105888897|NCT03053063|365247792|FG001|Open-Label Phase|Investigator's discretion|0|||
105888898|NCT03053063|365247793|FG002|Open-Label Phase|Investigator's discretion|0|||
105888899|NCT03053063|365247794|FG003|Open-Label Phase|Investigator's discretion|2|||
105663894|NCT01434680|364434772|FG003|Overall Study|Lost to Follow-up|0|||
105663895|NCT01434680|364434769|FG000|Overall Study|Protocol Violation|1|||
106121057|NCT01586338|366100314|FG000|Overall Study|Adverse Event|3|||
105663896|NCT01434680|364434770|FG001|Overall Study|Protocol Violation|1|||
105663897|NCT01434680|364434771|FG002|Overall Study|Protocol Violation|0|||
105663898|NCT01434680|364434772|FG003|Overall Study|Protocol Violation|0|||
105663899|NCT03020069|364434776|FG000|Overall Study|Lost to Follow-up|0|||
105663900|NCT03020069|364434777|FG001|Overall Study|Lost to Follow-up|1|||
105663901|NCT01367847|364434778|FG000|Overall Study|Withdrawal by Subject|2|||
106121058|NCT01586338|366100314|FG000|Overall Study|Lost to Follow-up|1|||
106121059|NCT01586338|366100314|FG000|Overall Study|Withdrawal by participant|3|||
106121060|NCT01586338|366100314|FG000|Overall Study|Other|1|||
106121061|NCT04078035|366100315|FG000|Session 2|Lost to Follow-up|3|||
106121062|NCT04078035|366100316|FG001|Session 2|Lost to Follow-up|1|||
106121063|NCT04078035|366100315|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
106121064|NCT04078035|366100316|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
106121065|NCT03560245|366100330|FG000|Overall Study|Withdrawal by Subject|3|||
106121066|NCT03560245|366100331|FG001|Overall Study|Withdrawal by Subject|2|||
106121067|NCT03560245|366100330|FG000|Overall Study|Adverse Event|1|||
106121068|NCT03560245|366100331|FG001|Overall Study|Adverse Event|1|||
106121069|NCT03560245|366100330|FG000|Overall Study|Protocol Violation|1|||
106121070|NCT03560245|366100331|FG001|Overall Study|Protocol Violation|0|||
106121071|NCT03560245|366100330|FG000|Overall Study|Death|0|||
106121072|NCT03560245|366100331|FG001|Overall Study|Death|1|||
106121073|NCT03560245|366100330|FG000|Overall Study|Lost to Follow-up|0|||
106121074|NCT03560245|366100331|FG001|Overall Study|Lost to Follow-up|1|||
106121075|NCT03560245|366100330|FG000|Overall Study|Physician Decision|0|||
106121076|NCT03560245|366100331|FG001|Overall Study|Physician Decision|1|||
106121077|NCT03560245|366100330|FG000|Overall Study|Other|0|||
106121078|NCT03560245|366100331|FG001|Overall Study|Other|1|||
106121079|NCT00337662|366100332|FG000|Study Period II|Lost to Follow-up|0|||
106121080|NCT00337662|366100333|FG001|Study Period II|Lost to Follow-up|0|||
106121081|NCT00337662|366100334|FG002|Study Period II|Lost to Follow-up|0|||
106121082|NCT00337662|366100335|FG003|Study Period II|Lost to Follow-up|35|||
106121083|NCT00337662|366100332|FG000|Study Period II|Withdrawal by Subject|0|||
106121084|NCT00337662|366100333|FG001|Study Period II|Withdrawal by Subject|0|||
106121085|NCT00337662|366100334|FG002|Study Period II|Withdrawal by Subject|0|||
106121086|NCT00337662|366100335|FG003|Study Period II|Withdrawal by Subject|20|||
106121087|NCT00337662|366100332|FG000|Study Period II|Adverse Event|0|||
106121088|NCT00337662|366100333|FG001|Study Period II|Adverse Event|0|||
106121089|NCT00337662|366100334|FG002|Study Period II|Adverse Event|0|||
106121090|NCT00337662|366100335|FG003|Study Period II|Adverse Event|16|||
106121091|NCT00337662|366100332|FG000|Study Period II|Physician Decision|0|||
106121092|NCT00337662|366100333|FG001|Study Period II|Physician Decision|0|||
106121093|NCT00337662|366100334|FG002|Study Period II|Physician Decision|0|||
105663902|NCT01367847|364434779|FG001|Overall Study|Withdrawal by Subject|2|||
105663903|NCT00953147|364434780|FG000|Overall Study|Adverse Event|8|||
105785444|NCT00509223|364868464|FG001|Overall Study|Lost to Follow-up|1|||
105663904|NCT00953147|364434781|FG001|Overall Study|Adverse Event|16|||
105785445|NCT00509223|364868463|FG000|Overall Study|Adverse Event|1|||
105785446|NCT00509223|364868464|FG001|Overall Study|Adverse Event|1|||
105785447|NCT00509223|364868463|FG000|Overall Study|Withdrawal by Subject|25|||
105785448|NCT00509223|364868464|FG001|Overall Study|Withdrawal by Subject|6|||
105785449|NCT00509223|364868463|FG000|Overall Study|Including: subject change of address|5|||
105785450|NCT00509223|364868464|FG001|Overall Study|Including: subject change of address|2|||
105785451|NCT00509223|364868463|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
105785452|NCT00509223|364868464|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
105785453|NCT00198107|364868465|FG000|Double-Blind Period|Adverse Event|1|||
105785454|NCT00198107|364868466|FG001|Double-Blind Period|Adverse Event|1|||
105785455|NCT00198107|364868467|FG002|Double-Blind Period|Adverse Event|0|||
105785456|NCT00198107|364868465|FG000|Double-Blind Period|Lack of Efficacy|2|||
105785457|NCT00198107|364868466|FG001|Double-Blind Period|Lack of Efficacy|0|||
105785458|NCT00198107|364868467|FG002|Double-Blind Period|Lack of Efficacy|0|||
105785459|NCT00198107|364868465|FG000|Double-Blind Period|Lost to Follow-up|2|||
105785460|NCT00198107|364868466|FG001|Double-Blind Period|Lost to Follow-up|1|||
105785461|NCT00198107|364868467|FG002|Double-Blind Period|Lost to Follow-up|0|||
105785462|NCT00198107|364868465|FG000|Double-Blind Period|Physician Decision|1|||
105785463|NCT00198107|364868466|FG001|Double-Blind Period|Physician Decision|0|||
105785464|NCT00198107|364868467|FG002|Double-Blind Period|Physician Decision|0|||
105785465|NCT00198107|364868465|FG000|Double-Blind Period|Withdrawal by Subject|0|||
105785466|NCT00198107|364868466|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105785467|NCT00198107|364868467|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105785468|NCT00198107|364868465|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
105785469|NCT00198107|364868466|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
105785470|NCT00198107|364868467|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
105785471|NCT02513732|364868468|FG000|Overall Study|Lost to Follow-up|11|||
105785472|NCT02513732|364868468|FG000|Overall Study|Death|9|||
105888900|NCT02600845|365247795|FG000|Overall Study|Reason Not Specified|3|||
105888901|NCT02600845|365247795|FG000|Overall Study|Non-compliance with Study Procedures|10|||
105888902|NCT02600845|365247795|FG000|Overall Study|Consent Withdrawal|5|||
105888903|NCT04413552|365247796|FG000|Overall Study|Adverse Event|0|||
105888904|NCT04413552|365247797|FG001|Overall Study|Adverse Event|0|||
105888905|NCT04413552|365247798|FG002|Overall Study|Adverse Event|0|||
105888906|NCT04413552|365247799|FG003|Overall Study|Adverse Event|0|||
105888907|NCT04413552|365247800|FG004|Overall Study|Adverse Event|0|||
105888908|NCT04413552|365247801|FG005|Overall Study|Adverse Event|0|||
105888909|NCT04413552|365247802|FG006|Overall Study|Adverse Event|1|||
105888910|NCT04413552|365247803|FG007|Overall Study|Adverse Event|0|||
105888911|NCT04413552|365247804|FG008|Overall Study|Adverse Event|0|||
105888912|NCT04413552|365247805|FG009|Overall Study|Adverse Event|0|||
105888913|NCT05685732|365247806|FG000|Overall Study|Withdrawal by Subject|2|||
105888914|NCT05685732|365247807|FG001|Overall Study|Withdrawal by Subject|0|||
105888915|NCT05685732|365247808|FG002|Overall Study|Withdrawal by Subject|2|||
105888916|NCT05685732|365247809|FG003|Overall Study|Withdrawal by Subject|3|||
105888917|NCT05685732|365247806|FG000|Overall Study|Protocol Violation|1|||
105888918|NCT05685732|365247807|FG001|Overall Study|Protocol Violation|2|||
105888919|NCT05685732|365247808|FG002|Overall Study|Protocol Violation|4|||
105888920|NCT05685732|365247809|FG003|Overall Study|Protocol Violation|1|||
105888921|NCT05685732|365247806|FG000|Overall Study|Lost to Follow-up|5|||
105888922|NCT05685732|365247807|FG001|Overall Study|Lost to Follow-up|1|||
105888923|NCT05685732|365247808|FG002|Overall Study|Lost to Follow-up|3|||
105888924|NCT05685732|365247809|FG003|Overall Study|Lost to Follow-up|1|||
105888925|NCT05685732|365247806|FG000|Overall Study|Adverse Event|2|||
105888926|NCT05685732|365247807|FG001|Overall Study|Adverse Event|1|||
105888927|NCT05685732|365247808|FG002|Overall Study|Adverse Event|0|||
105888928|NCT05685732|365247809|FG003|Overall Study|Adverse Event|0|||
105888929|NCT05685732|365247806|FG000|Overall Study|Physician Decision|1|||
105888930|NCT05685732|365247807|FG001|Overall Study|Physician Decision|0|||
105888931|NCT05685732|365247808|FG002|Overall Study|Physician Decision|0|||
105888932|NCT05685732|365247809|FG003|Overall Study|Physician Decision|0|||
105888933|NCT02100670|365247810|FG000|Overall Study|Adverse Event|10|||
105888934|NCT02100670|365247811|FG001|Overall Study|Adverse Event|3|||
105888935|NCT02100670|365247812|FG002|Overall Study|Adverse Event|3|||
105888936|NCT02100670|365247813|FG003|Overall Study|Adverse Event|0|||
105888937|NCT02100670|365247810|FG000|Overall Study|Lost to Follow-up|1|||
105888938|NCT02100670|365247811|FG001|Overall Study|Lost to Follow-up|0|||
105888939|NCT02100670|365247812|FG002|Overall Study|Lost to Follow-up|0|||
105888940|NCT02100670|365247813|FG003|Overall Study|Lost to Follow-up|0|||
105888941|NCT02100670|365247810|FG000|Overall Study|Protocol Violation|0|||
105888942|NCT02100670|365247811|FG001|Overall Study|Protocol Violation|1|||
105888943|NCT02100670|365247812|FG002|Overall Study|Protocol Violation|0|||
106121094|NCT00337662|366100335|FG003|Study Period II|Physician Decision|13|||
106121095|NCT00337662|366100332|FG000|Study Period II|Entry Criteria Not Met|0|||
106121096|NCT00337662|366100333|FG001|Study Period II|Entry Criteria Not Met|0|||
106121097|NCT00337662|366100334|FG002|Study Period II|Entry Criteria Not Met|0|||
106121098|NCT00337662|366100335|FG003|Study Period II|Entry Criteria Not Met|6|||
106121099|NCT00337662|366100332|FG000|Study Period II|Protocol Violation|0|||
106121100|NCT00337662|366100333|FG001|Study Period II|Protocol Violation|0|||
106121101|NCT00337662|366100334|FG002|Study Period II|Protocol Violation|0|||
106121102|NCT00337662|366100335|FG003|Study Period II|Protocol Violation|6|||
106121103|NCT00337662|366100332|FG000|Study Period II|Lack of Efficacy|0|||
106121104|NCT00337662|366100333|FG001|Study Period II|Lack of Efficacy|0|||
106121105|NCT00337662|366100334|FG002|Study Period II|Lack of Efficacy|0|||
106121106|NCT00337662|366100335|FG003|Study Period II|Lack of Efficacy|7|||
106121107|NCT00337662|366100332|FG000|Study Period II|Sponsor Decision|0|||
106121108|NCT00337662|366100333|FG001|Study Period II|Sponsor Decision|0|||
106121109|NCT00337662|366100334|FG002|Study Period II|Sponsor Decision|0|||
106121110|NCT00337662|366100335|FG003|Study Period II|Sponsor Decision|2|||
106121111|NCT00337662|366100332|FG000|Study Period II|Parent/Caregiver Decision|0|||
106121112|NCT00337662|366100333|FG001|Study Period II|Parent/Caregiver Decision|0|||
106121113|NCT00337662|366100334|FG002|Study Period II|Parent/Caregiver Decision|0|||
106121114|NCT00337662|366100335|FG003|Study Period II|Parent/Caregiver Decision|1|||
106121115|NCT00337662|366100332|FG000|Study Period III|Lost to Follow-up|14|||
106121116|NCT00337662|366100333|FG001|Study Period III|Lost to Follow-up|16|||
106121117|NCT00337662|366100334|FG002|Study Period III|Lost to Follow-up|14|||
105888944|NCT02100670|365247813|FG003|Overall Study|Protocol Violation|1|||
105888945|NCT02100670|365247810|FG000|Overall Study|Withdrawal of Consent|0|||
106121118|NCT00337662|366100335|FG003|Study Period III|Lost to Follow-up|0|||
106121119|NCT00337662|366100332|FG000|Study Period III|Withdrawal by Subject|18|||
105888946|NCT02100670|365247811|FG001|Overall Study|Withdrawal of Consent|1|||
105888947|NCT02100670|365247812|FG002|Overall Study|Withdrawal of Consent|1|||
105888948|NCT02100670|365247813|FG003|Overall Study|Withdrawal of Consent|0|||
105888949|NCT02100670|365247810|FG000|Overall Study|No swelling no pain|1|||
106121120|NCT00337662|366100333|FG001|Study Period III|Withdrawal by Subject|14|||
105888950|NCT02100670|365247811|FG001|Overall Study|No swelling no pain|0|||
105888951|NCT02100670|365247812|FG002|Overall Study|No swelling no pain|0|||
105663905|NCT00953147|364434782|FG002|Overall Study|Adverse Event|6|||
105663906|NCT00953147|364434780|FG000|Overall Study|Protocol Violation|2|||
105663907|NCT00953147|364434781|FG001|Overall Study|Protocol Violation|8|||
105663908|NCT00953147|364434782|FG002|Overall Study|Protocol Violation|4|||
105663909|NCT00953147|364434780|FG000|Overall Study|Withdrawal by Subject|13|||
105663910|NCT00953147|364434781|FG001|Overall Study|Withdrawal by Subject|15|||
105663911|NCT00953147|364434782|FG002|Overall Study|Withdrawal by Subject|12|||
105663912|NCT00953147|364434780|FG000|Overall Study|Lost to Follow-up|8|||
105663913|NCT00953147|364434781|FG001|Overall Study|Lost to Follow-up|9|||
105663914|NCT00953147|364434782|FG002|Overall Study|Lost to Follow-up|4|||
105663915|NCT00953147|364434780|FG000|Overall Study|Physician Decision|2|||
105663916|NCT00953147|364434781|FG001|Overall Study|Physician Decision|7|||
105663917|NCT00953147|364434782|FG002|Overall Study|Physician Decision|3|||
105663918|NCT00953147|364434780|FG000|Overall Study|Other|4|||
105663919|NCT00953147|364434781|FG001|Overall Study|Other|11|||
105663920|NCT00953147|364434782|FG002|Overall Study|Other|13|||
105663921|NCT04367480|364434783|FG000|Overall Study|Adverse Event|1|||
105663922|NCT04367480|364434784|FG001|Overall Study|Adverse Event|1|||
105663923|NCT04367480|364434783|FG000|Overall Study|Death|1|||
105663924|NCT04367480|364434784|FG001|Overall Study|Death|0|||
105663925|NCT04367480|364434783|FG000|Overall Study|Lost to Follow-up|1|||
105663926|NCT04367480|364434784|FG001|Overall Study|Lost to Follow-up|1|||
105663927|NCT04367480|364434783|FG000|Overall Study|Withdrawal by Subject|0|||
105663928|NCT04367480|364434784|FG001|Overall Study|Withdrawal by Subject|3|||
105663929|NCT04367480|364434783|FG000|Overall Study|App glitch during the study|1|||
105663930|NCT04367480|364434784|FG001|Overall Study|App glitch during the study|0|||
105663931|NCT04367480|364434783|FG000|Overall Study|Device Distribution Error|0|||
105663932|NCT04367480|364434784|FG001|Overall Study|Device Distribution Error|2|||
105663933|NCT04367480|364434783|FG000|Overall Study|Ineligible after Randomization|0|||
105663934|NCT04367480|364434784|FG001|Overall Study|Ineligible after Randomization|1|||
105663935|NCT04367480|364434783|FG000|Overall Study|Other Medical Reasons|0|||
105663936|NCT04367480|364434784|FG001|Overall Study|Other Medical Reasons|2|||
105663937|NCT01245140|364434789|FG000|Overall Study|Adverse Event|1|||
105663938|NCT01245140|364434790|FG001|Overall Study|Adverse Event|3|||
105663939|NCT01245140|364434789|FG000|Overall Study|Lack of Efficacy|2|||
105663940|NCT01245140|364434790|FG001|Overall Study|Lack of Efficacy|4|||
105663941|NCT01245140|364434789|FG000|Overall Study|Protocol Violation|0|||
105663942|NCT01245140|364434790|FG001|Overall Study|Protocol Violation|1|||
105663943|NCT01245140|364434789|FG000|Overall Study|Withdrawal by Subject|0|||
105663944|NCT01245140|364434790|FG001|Overall Study|Withdrawal by Subject|1|||
105663945|NCT01245140|364434789|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
105663946|NCT01245140|364434790|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
105663947|NCT01150045|364434793|FG000|Overall Study|Protocol Violation|0|||
105663948|NCT01150045|364434794|FG001|Overall Study|Protocol Violation|1|||
105663949|NCT01150045|364434795|FG002|Overall Study|Protocol Violation|0|||
105663950|NCT01150045|364434796|FG003|Overall Study|Protocol Violation|1|||
105663951|NCT00634842|364434797|FG000|Overall Study|Adverse Event|2|||
105663952|NCT00634842|364434798|FG001|Overall Study|Adverse Event|3|||
105663953|NCT00634842|364434797|FG000|Overall Study|Protocol Violation|8|||
105663954|NCT00634842|364434798|FG001|Overall Study|Protocol Violation|4|||
105663955|NCT00634842|364434797|FG000|Overall Study|Move to another state|1|||
105663956|NCT00634842|364434798|FG001|Overall Study|Move to another state|0|||
105888952|NCT02100670|365247813|FG003|Overall Study|No swelling no pain|0|||
105888953|NCT02100670|365247810|FG000|Overall Study|Poor Efficacy|0|||
105888954|NCT02100670|365247811|FG001|Overall Study|Poor Efficacy|1|||
105888955|NCT02100670|365247812|FG002|Overall Study|Poor Efficacy|0|||
105888956|NCT02100670|365247813|FG003|Overall Study|Poor Efficacy|0|||
105888957|NCT02100670|365247810|FG000|Overall Study|Physician Decision|0|||
105888958|NCT02100670|365247811|FG001|Overall Study|Physician Decision|1|||
105888959|NCT02100670|365247812|FG002|Overall Study|Physician Decision|0|||
105888960|NCT02100670|365247813|FG003|Overall Study|Physician Decision|0|||
105888961|NCT02100670|365247810|FG000|Overall Study|Withdrawal by Subject|1|||
105888962|NCT02100670|365247811|FG001|Overall Study|Withdrawal by Subject|0|||
105888963|NCT02100670|365247812|FG002|Overall Study|Withdrawal by Subject|0|||
105888964|NCT02100670|365247813|FG003|Overall Study|Withdrawal by Subject|0|||
105888965|NCT04250350|365249729|FG000|Overall Study|Withdrawal by Subject|13|||
105888966|NCT04250350|365249729|FG000|Overall Study|Lost to Follow-up|8|||
105663957|NCT00634842|364434797|FG000|Overall Study|Inclusion criteria were not met|1|||
105663958|NCT00634842|364434798|FG001|Overall Study|Inclusion criteria were not met|0|||
105663959|NCT00634842|364434797|FG000|Overall Study|Lost to Follow-up|1|||
105663960|NCT00634842|364434798|FG001|Overall Study|Lost to Follow-up|2|||
105663961|NCT00634842|364434797|FG000|Overall Study|Physician Decision|1|||
105663962|NCT00634842|364434798|FG001|Overall Study|Physician Decision|0|||
105663963|NCT00634842|364434797|FG000|Overall Study|Withdrawal by Subject|1|||
105663964|NCT00634842|364434798|FG001|Overall Study|Withdrawal by Subject|3|||
105663965|NCT00634842|364434797|FG000|Overall Study|Lack of time and intolerance to drug|0|||
105663966|NCT00634842|364434798|FG001|Overall Study|Lack of time and intolerance to drug|1|||
105663967|NCT00634842|364434797|FG000|Overall Study|Discontinued due to injection|0|||
105996233|NCT00699608|365646972|FG004|Second Intervention|Withdrawal by Subject|0|||
105996234|NCT00699608|365646973|FG005|Second Intervention|Withdrawal by Subject|0|||
105996235|NCT02003534|365646974|FG000|Overall Study|Lost to Follow-up|47|||
106121121|NCT00337662|366100334|FG002|Study Period III|Withdrawal by Subject|12|||
106121122|NCT00337662|366100335|FG003|Study Period III|Withdrawal by Subject|0|||
106121123|NCT00337662|366100332|FG000|Study Period III|Adverse Event|9|||
106121124|NCT00337662|366100333|FG001|Study Period III|Adverse Event|10|||
106121125|NCT00337662|366100334|FG002|Study Period III|Adverse Event|8|||
106121126|NCT00337662|366100335|FG003|Study Period III|Adverse Event|0|||
106121127|NCT00337662|366100332|FG000|Study Period III|Protocol Violation|3|||
106121128|NCT00337662|366100333|FG001|Study Period III|Protocol Violation|8|||
106121129|NCT00337662|366100334|FG002|Study Period III|Protocol Violation|2|||
106121130|NCT00337662|366100335|FG003|Study Period III|Protocol Violation|0|||
106121131|NCT00337662|366100332|FG000|Study Period III|Physician Decision|6|||
106121132|NCT00337662|366100333|FG001|Study Period III|Physician Decision|5|||
106121133|NCT00337662|366100334|FG002|Study Period III|Physician Decision|0|||
106121134|NCT00337662|366100335|FG003|Study Period III|Physician Decision|0|||
106121135|NCT00337662|366100332|FG000|Study Period III|Entry Criteria Not Met|4|||
106121136|NCT00337662|366100333|FG001|Study Period III|Entry Criteria Not Met|1|||
106121137|NCT00337662|366100334|FG002|Study Period III|Entry Criteria Not Met|3|||
106121138|NCT00337662|366100335|FG003|Study Period III|Entry Criteria Not Met|0|||
106121139|NCT00337662|366100332|FG000|Study Period III|Lack of Efficacy|4|||
106121140|NCT00337662|366100333|FG001|Study Period III|Lack of Efficacy|4|||
106121141|NCT00337662|366100334|FG002|Study Period III|Lack of Efficacy|2|||
106121142|NCT00337662|366100335|FG003|Study Period III|Lack of Efficacy|0|||
106121143|NCT00337662|366100332|FG000|Study Period III|Parent/Caregiver Decision|0|||
106121144|NCT00337662|366100333|FG001|Study Period III|Parent/Caregiver Decision|0|||
106121145|NCT00337662|366100334|FG002|Study Period III|Parent/Caregiver Decision|2|||
106121146|NCT00337662|366100335|FG003|Study Period III|Parent/Caregiver Decision|0|||
106121147|NCT00337662|366100332|FG000|Study Period III|Sponsor Decision|1|||
106121148|NCT00337662|366100333|FG001|Study Period III|Sponsor Decision|0|||
106121149|NCT00337662|366100334|FG002|Study Period III|Sponsor Decision|1|||
105785473|NCT02513732|364868468|FG000|Overall Study|Changing hospital|2|||
105785474|NCT00934661|364868469|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
105785475|NCT00934661|364868470|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
105785476|NCT00467051|364868471|FG000|Overall Study|Adverse Event|2|||
105785477|NCT01740297|364868472|FG000|Overall Study|Withdrawal by Subject|4|||
105785478|NCT01740297|364868473|FG001|Overall Study|Withdrawal by Subject|16|||
105785479|NCT01740297|364868474|FG002|Overall Study|Withdrawal by Subject|17|||
105785480|NCT01740297|364868472|FG000|Overall Study|Death|8|||
105785481|NCT01740297|364868473|FG001|Overall Study|Death|46|||
105785482|NCT01740297|364868474|FG002|Overall Study|Death|40|||
105785483|NCT01740297|364868472|FG000|Overall Study|Lost to Follow-up|1|||
105785484|NCT01740297|364868473|FG001|Overall Study|Lost to Follow-up|2|||
105785485|NCT01740297|364868474|FG002|Overall Study|Lost to Follow-up|4|||
105785486|NCT00761462|364868478|FG000|Treatment|Subjects never received study medication|23|||
105785487|NCT00761462|364868479|FG001|Treatment|Subjects never received study medication|12|||
105785488|NCT00761462|364868478|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
105785489|NCT00761462|364868479|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
105785490|NCT00761462|364868478|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
105785491|NCT00761462|364868479|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
105785492|NCT00761462|364868478|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
105785493|NCT00761462|364868479|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
105785494|NCT02383966|364868486|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
105785495|NCT02383966|364868487|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
105785496|NCT02383966|364868486|FG000|Overall Study|Randomized, but not treated|1|||
105785497|NCT02383966|364868487|FG001|Overall Study|Randomized, but not treated|3|||
105785498|NCT02163759|364868488|FG000|Overall Study|Withdrawal by Subject|1|||
105785499|NCT02163759|364868489|FG001|Overall Study|Withdrawal by Subject|5|||
105785500|NCT02163759|364868490|FG002|Overall Study|Withdrawal by Subject|1|||
105785501|NCT02163759|364868488|FG000|Overall Study|Adverse Event|0|||
105785502|NCT02163759|364868489|FG001|Overall Study|Adverse Event|0|||
105785503|NCT02163759|364868490|FG002|Overall Study|Adverse Event|1|||
105785504|NCT02163759|364868488|FG000|Overall Study|Death|0|||
105785505|NCT02163759|364868489|FG001|Overall Study|Death|0|||
105785506|NCT02163759|364868490|FG002|Overall Study|Death|1|||
105785507|NCT03996694|364868492|FG000|First Washout (7 Days)|positive urine drug screen|0|||
105785508|NCT03996694|364868493|FG001|First Washout (7 Days)|positive urine drug screen|0|||
105785509|NCT03996694|364868494|FG002|First Washout (7 Days)|positive urine drug screen|1|||
105785510|NCT03996694|364868495|FG003|First Washout (7 Days)|positive urine drug screen|0|||
105785511|NCT03996694|364868496|FG004|First Washout (7 Days)|positive urine drug screen|0|||
105785512|NCT03996694|364868497|FG005|First Washout (7 Days)|positive urine drug screen|0|||
105785513|NCT03996694|364868492|FG000|First Washout (7 Days)|Adverse Event|0|||
105785514|NCT03996694|364868493|FG001|First Washout (7 Days)|Adverse Event|1|||
105888967|NCT04250350|365249729|FG000|Overall Study|Adverse Event|5|||
105888968|NCT04250350|365249729|FG000|Overall Study|Lack of Efficacy|4|||
105888969|NCT04250350|365249729|FG000|Overall Study|Physician Decision|1|||
105888970|NCT04250350|365249729|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
105888971|NCT01608087|365249734|FG000|Overall Study|Lost to Follow-up|0|||
105888972|NCT01608087|365249735|FG001|Overall Study|Lost to Follow-up|1|||
106121150|NCT00337662|366100335|FG003|Study Period III|Sponsor Decision|0|||
106121151|NCT00337662|366100332|FG000|Study Period III|Clinical Relapse|1|||
106121152|NCT00337662|366100333|FG001|Study Period III|Clinical Relapse|0|||
106121153|NCT00337662|366100334|FG002|Study Period III|Clinical Relapse|0|||
106121154|NCT00337662|366100335|FG003|Study Period III|Clinical Relapse|0|||
106121155|NCT01263106|366100336|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
106121156|NCT01263106|366100337|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
106121157|NCT02344537|366100341|FG000|Overall Study|Protocol Violation|1|||
106121158|NCT02344537|366100342|FG001|Overall Study|Protocol Violation|1|||
106121159|NCT02344537|366100341|FG000|Overall Study|Subject started another treatment after wk 6|1|||
106121160|NCT02344537|366100342|FG001|Overall Study|Subject started another treatment after wk 6|0|||
106121161|NCT02344537|366100341|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
106121162|NCT02344537|366100342|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
106121163|NCT01871558|366100348|FG000|Overall Study|Other reason|0|||
106121164|NCT01871558|366100349|FG001|Overall Study|Other reason|1|||
106121165|NCT01871558|366100348|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
106121166|NCT01871558|366100349|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
106121167|NCT01871558|366100348|FG000|Overall Study|Withdrawal by Subject|2|||
106121168|NCT01871558|366100349|FG001|Overall Study|Withdrawal by Subject|0|||
106121169|NCT00147225|366100350|FG000|Overall Study|Withdrawal by Subject|1|||
106121170|NCT00147225|366100351|FG001|Overall Study|Withdrawal by Subject|0|||
106121171|NCT00147225|366100352|FG002|Overall Study|Withdrawal by Subject|1|||
106121172|NCT00147225|366100353|FG003|Overall Study|Withdrawal by Subject|0|||
106121173|NCT00147225|366100354|FG004|Overall Study|Withdrawal by Subject|0|||
106121174|NCT00147225|366100355|FG005|Overall Study|Withdrawal by Subject|1|||
106121175|NCT00147225|366100350|FG000|Overall Study|Adverse Event|0|||
106121176|NCT00147225|366100351|FG001|Overall Study|Adverse Event|0|||
106121177|NCT00147225|366100352|FG002|Overall Study|Adverse Event|1|||
106121178|NCT00147225|366100353|FG003|Overall Study|Adverse Event|1|||
106121179|NCT00147225|366100354|FG004|Overall Study|Adverse Event|0|||
106121180|NCT00147225|366100355|FG005|Overall Study|Adverse Event|0|||
106121181|NCT00147225|366100350|FG000|Overall Study|Screen Failure|0|||
106121182|NCT00147225|366100351|FG001|Overall Study|Screen Failure|0|||
106121183|NCT00147225|366100352|FG002|Overall Study|Screen Failure|0|||
106121184|NCT00147225|366100353|FG003|Overall Study|Screen Failure|0|||
106121185|NCT00147225|366100354|FG004|Overall Study|Screen Failure|1|||
106121186|NCT00147225|366100355|FG005|Overall Study|Screen Failure|0|||
106121187|NCT00147225|366100350|FG000|Overall Study|Chemotherapy Changed|0|||
106121188|NCT00147225|366100351|FG001|Overall Study|Chemotherapy Changed|0|||
106121189|NCT00147225|366100352|FG002|Overall Study|Chemotherapy Changed|0|||
106121190|NCT00147225|366100353|FG003|Overall Study|Chemotherapy Changed|0|||
106121191|NCT00147225|366100354|FG004|Overall Study|Chemotherapy Changed|0|||
106121192|NCT00147225|366100355|FG005|Overall Study|Chemotherapy Changed|1|||
106121193|NCT02875834|366100356|FG000|Open-label Phase|Withdrawal by Subject|3|||
106121194|NCT02875834|366100357|FG001|Open-label Phase|Withdrawal by Subject|0|||
106121195|NCT02875834|366100358|FG002|Open-label Phase|Withdrawal by Subject|0|||
106121196|NCT02875834|366100359|FG003|Open-label Phase|Withdrawal by Subject|0|||
106121197|NCT02875834|366100356|FG000|Open-label Phase|(Not collected)|4|||
106121198|NCT02875834|366100357|FG001|Open-label Phase|(Not collected)|0|||
106121199|NCT02875834|366100358|FG002|Open-label Phase|(Not collected)|0|||
106121200|NCT02875834|366100359|FG003|Open-label Phase|(Not collected)|0|||
106121201|NCT02875834|366100356|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
106121202|NCT02875834|366100357|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
106121203|NCT02875834|366100358|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
106121204|NCT02875834|366100359|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
106121205|NCT02875834|366100356|FG000|Randomized Treatment Phase|Protocol Violation|0|||
106121206|NCT02875834|366100357|FG001|Randomized Treatment Phase|Protocol Violation|2|||
106121207|NCT02875834|366100358|FG002|Randomized Treatment Phase|Protocol Violation|0|||
106121208|NCT02875834|366100359|FG003|Randomized Treatment Phase|Protocol Violation|0|||
106121209|NCT02875834|366100356|FG000|Randomized Treatment Phase|(Not collected)|0|||
106121210|NCT02875834|366100357|FG001|Randomized Treatment Phase|(Not collected)|9|||
105888973|NCT01608087|365249736|FG002|Overall Study|Lost to Follow-up|0|||
105888974|NCT01608087|365249734|FG000|Overall Study|Other Reason|0|||
105888975|NCT01608087|365249735|FG001|Overall Study|Other Reason|1|||
105888976|NCT01608087|365249736|FG002|Overall Study|Other Reason|0|||
106121211|NCT02875834|366100358|FG002|Randomized Treatment Phase|(Not collected)|10|||
106121212|NCT02875834|366100359|FG003|Randomized Treatment Phase|(Not collected)|9|||
106121213|NCT01233609|366100360|FG000|Overall Study|Death|1|||
106121214|NCT01233609|366100361|FG001|Overall Study|Death|0|||
105888977|NCT02222545|365249749|FG000|Overall Study|Adverse Event|1|||
105888978|NCT02222545|365249750|FG001|Overall Study|Adverse Event|0|||
105888979|NCT02222545|365249751|FG002|Overall Study|Adverse Event|2|||
105888980|NCT02222545|365249749|FG000|Overall Study|Death|0|||
105888981|NCT02222545|365249750|FG001|Overall Study|Death|0|||
105888982|NCT02222545|365249751|FG002|Overall Study|Death|9|||
105888983|NCT02222545|365249749|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
105888984|NCT02222545|365249750|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
105888985|NCT02222545|365249751|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
105888986|NCT02222545|365249749|FG000|Overall Study|Withdrawal by Subject|0|||
105888987|NCT02222545|365249750|FG001|Overall Study|Withdrawal by Subject|0|||
105888988|NCT02222545|365249751|FG002|Overall Study|Withdrawal by Subject|3|||
105888989|NCT02222545|365249749|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
105888990|NCT02222545|365249750|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
105888991|NCT02222545|365249751|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
105888992|NCT03875482|365249752|FG000|Overall Study|Adverse Event|0|||
105888993|NCT03875482|365249753|FG001|Overall Study|Adverse Event|1|||
105888994|NCT03875482|365249752|FG000|Overall Study|Withdrew consent|5|||
105888995|NCT03875482|365249753|FG001|Overall Study|Withdrew consent|6|||
105888996|NCT03875482|365249752|FG000|Overall Study|Lost to Follow-up|8|||
105888997|NCT03875482|365249753|FG001|Overall Study|Lost to Follow-up|2|||
105888998|NCT03875482|365249752|FG000|Overall Study|Lack of Efficacy|0|||
105996236|NCT03187132|365646975|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
105996237|NCT03187132|365646976|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
105996238|NCT03187132|365646975|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
105996239|NCT03187132|365646976|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
105996240|NCT03187132|365646975|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
105996241|NCT03187132|365646976|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
105996242|NCT03187132|365646975|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
105996243|NCT03187132|365646976|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
105996244|NCT03187132|365646975|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
105996245|NCT03187132|365646976|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
105996246|NCT03187132|365646975|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
105996247|NCT03187132|365646976|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
105996248|NCT03187132|365646975|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
105996249|NCT03187132|365646976|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
105996250|NCT03187132|365646975|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
105996251|NCT03187132|365646976|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
105996252|NCT03187132|365646975|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
105996253|NCT03187132|365646976|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
105996254|NCT03187132|365646975|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
105996255|NCT03187132|365646976|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
105996256|NCT03187132|365646975|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
105996257|NCT03187132|365646976|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
105996258|NCT03594773|365646977|FG000|Overall Study|Withdrawal by Subject|3|||
105996259|NCT03594773|365646978|FG001|Overall Study|Withdrawal by Subject|2|||
105996260|NCT03594773|365646977|FG000|Overall Study|Lost to Follow-up|3|||
105996261|NCT03594773|365646978|FG001|Overall Study|Lost to Follow-up|4|||
105996262|NCT02342223|365646982|FG000|Overall Study|Lost to Follow-up|1|||
105996263|NCT00496080|365646985|FG000|Overall Study|Lost to Follow-up|9|||
105996264|NCT00496080|365646985|FG000|Overall Study|Surgical re-intervention|7|||
105996265|NCT00496080|365646985|FG000|Overall Study|Withdrawal by Subject|5|||
105996266|NCT00496080|365646985|FG000|Overall Study|Physician Decision|6|||
105996267|NCT01290757|365646986|FG000|Overall Study|Adverse Event|1|||
106121215|NCT01233609|366100360|FG000|Overall Study|Lost to Follow-up|3|||
106121216|NCT01233609|366100361|FG001|Overall Study|Lost to Follow-up|1|||
106121217|NCT01233609|366100360|FG000|Overall Study|Adverse Event|2|||
106121218|NCT01233609|366100361|FG001|Overall Study|Adverse Event|1|||
105663968|NCT00634842|364434798|FG001|Overall Study|Discontinued due to injection|2|||
105663969|NCT00634842|364434797|FG000|Overall Study|No need of study drug to treat diabetes|0|||
105663970|NCT00634842|364434798|FG001|Overall Study|No need of study drug to treat diabetes|1|||
105888999|NCT03875482|365249753|FG001|Overall Study|Lack of Efficacy|11|||
105889000|NCT02137850|365249754|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
105889001|NCT02137850|365249755|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
105889002|NCT02137850|365249756|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
105889003|NCT02137850|365249754|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
105889004|NCT02137850|365249755|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
105996268|NCT01290757|365646987|FG001|Overall Study|Adverse Event|0|||
105996269|NCT01290757|365646986|FG000|Overall Study|Protocol Violation|1|||
105996270|NCT01290757|365646987|FG001|Overall Study|Protocol Violation|1|||
105996271|NCT01290757|365646986|FG000|Overall Study|Other|0|||
106121219|NCT01233609|366100360|FG000|Overall Study|Withdrawal by Subject|3|||
105996272|NCT01290757|365646987|FG001|Overall Study|Other|1|||
106121220|NCT01233609|366100361|FG001|Overall Study|Withdrawal by Subject|0|||
106121221|NCT04022889|366101808|FG000|Stage 1: Period 1|Adverse Event|1|||
106121222|NCT04022889|366101809|FG001|Stage 1: Period 1|Adverse Event|0|||
106121223|NCT04022889|366101810|FG002|Stage 1: Period 1|Adverse Event|0|||
106121224|NCT04022889|366101808|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
106121225|NCT04022889|366101809|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
106121226|NCT04022889|366101810|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
106121227|NCT04022889|366101808|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
106121228|NCT04022889|366101809|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
105889005|NCT02137850|365249756|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
105889006|NCT02137850|365249754|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
105889007|NCT02137850|365249755|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
105889008|NCT02137850|365249756|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
106121229|NCT04022889|366101810|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
106121230|NCT04022889|366101808|FG000|Stage 2|Screen Failure|0|||
106121231|NCT04022889|366101809|FG001|Stage 2|Screen Failure|0|||
106121232|NCT04022889|366101810|FG002|Stage 2|Screen Failure|3|||
106121233|NCT04022889|366101808|FG000|Stage 2|Ineligible for apheresis donation|0|||
106121234|NCT04022889|366101809|FG001|Stage 2|Ineligible for apheresis donation|0|||
106121235|NCT04022889|366101810|FG002|Stage 2|Ineligible for apheresis donation|2|||
106121236|NCT04022889|366101808|FG000|Stage 2|Adverse Event|0|||
106121237|NCT04022889|366101809|FG001|Stage 2|Adverse Event|0|||
106121238|NCT04022889|366101810|FG002|Stage 2|Adverse Event|2|||
106121239|NCT04022889|366101808|FG000|Stage 2|Protocol Violation|0|||
106121240|NCT04022889|366101809|FG001|Stage 2|Protocol Violation|0|||
106121241|NCT04022889|366101810|FG002|Stage 2|Protocol Violation|1|||
106121242|NCT04022889|366101808|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
106121243|NCT04022889|366101809|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
106121244|NCT04022889|366101810|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
106121245|NCT02248961|366101811|FG000|Overall Study|Adverse Event|1|||
106121246|NCT02248961|366101812|FG001|Overall Study|Adverse Event|0|||
106121247|NCT02248961|366101811|FG000|Overall Study|Withdrawal by Subject|1|||
106121248|NCT02248961|366101812|FG001|Overall Study|Withdrawal by Subject|2|||
106121249|NCT02248961|366101811|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
106121250|NCT02248961|366101812|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
106121251|NCT00720902|366101816|FG000|Overall Study|Withdrawal by Subject|1|||
105663971|NCT00634842|364434797|FG000|Overall Study|No wish to keep taking Avandia|0|||
105785515|NCT03996694|364868494|FG002|First Washout (7 Days)|Adverse Event|0|||
105785516|NCT03996694|364868495|FG003|First Washout (7 Days)|Adverse Event|0|||
105785517|NCT03996694|364868496|FG004|First Washout (7 Days)|Adverse Event|0|||
105785518|NCT03996694|364868497|FG005|First Washout (7 Days)|Adverse Event|0|||
105785519|NCT03996694|364868492|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
105785520|NCT03996694|364868493|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
105785521|NCT03996694|364868494|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
105785522|NCT03996694|364868495|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
105785523|NCT03996694|364868496|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
105785524|NCT03996694|364868497|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
105785525|NCT03996694|364868492|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785526|NCT03996694|364868493|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785527|NCT03996694|364868494|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785528|NCT03996694|364868495|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785529|NCT03996694|364868496|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
105785530|NCT03996694|364868497|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
105785531|NCT00665366|364868506|FG000|Overall Study|Lack of Efficacy|11|||
105785532|NCT00665366|364868507|FG001|Overall Study|Lack of Efficacy|10|||
105785533|NCT00665366|364868506|FG000|Overall Study|Adverse Event|25|||
105785534|NCT00665366|364868507|FG001|Overall Study|Adverse Event|23|||
105785535|NCT00665366|364868506|FG000|Overall Study|Withdrawal by Subject|11|||
105785536|NCT00665366|364868507|FG001|Overall Study|Withdrawal by Subject|14|||
105785537|NCT00665366|364868506|FG000|Overall Study|Lost to Follow-up|3|||
105785538|NCT00665366|364868507|FG001|Overall Study|Lost to Follow-up|5|||
105785539|NCT00665366|364868506|FG000|Overall Study|Poor compliance/noncompliance|3|||
105785540|NCT00665366|364868507|FG001|Overall Study|Poor compliance/noncompliance|5|||
105785541|NCT00665366|364868506|FG000|Overall Study|Pregnancy|1|||
105785542|NCT00665366|364868507|FG001|Overall Study|Pregnancy|0|||
105785543|NCT00665366|364868506|FG000|Overall Study|No longer meets study criteria|0|||
105785544|NCT00665366|364868507|FG001|Overall Study|No longer meets study criteria|1|||
105785545|NCT00665366|364868506|FG000|Overall Study|Other reasons|4|||
105785546|NCT00665366|364868507|FG001|Overall Study|Other reasons|1|||
105785547|NCT03628781|364868511|FG000|Overall Study|Lost to Follow-up|16|||
105785548|NCT03628781|364868512|FG001|Overall Study|Lost to Follow-up|8|||
105785549|NCT03628781|364868511|FG000|Overall Study|Withdrawal by Subject|16|||
105785550|NCT03628781|364868512|FG001|Overall Study|Withdrawal by Subject|1|||
105785551|NCT03575806|364868517|FG000|Overall Study|Withdrawal by Subject|0|||
105785552|NCT03575806|364868518|FG001|Overall Study|Withdrawal by Subject|2|||
105996273|NCT00887549|365646988|FG000|Induction Therapy|Adverse Event|8|||
105996274|NCT00887549|365646988|FG000|Induction Therapy|Physician Decision|1|||
105996275|NCT00887549|365646988|FG000|Induction Therapy|Progressive Disease|13|||
105996276|NCT00887549|365646988|FG000|Induction Therapy|Death due to Study Disease|4|||
105663972|NCT00634842|364434798|FG001|Overall Study|No wish to keep taking Avandia|1|||
105996277|NCT00887549|365646988|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
105996278|NCT00887549|365646988|FG000|Maintenance Therapy|Adverse Event|16|||
105996279|NCT00887549|365646988|FG000|Maintenance Therapy|Physician Decision|1|||
105996280|NCT00887549|365646988|FG000|Maintenance Therapy|Progressive Disease|25|||
105889009|NCT02137850|365249754|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
105889010|NCT02137850|365249755|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
105889011|NCT02137850|365249756|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
105889012|NCT02137850|365249754|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
105889013|NCT02137850|365249755|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
105889014|NCT02137850|365249756|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
105889015|NCT02137850|365249754|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
105996281|NCT00887549|365646988|FG000|Maintenance Therapy|Death due to adverse event|1|||
105996282|NCT00100789|365646989|FG000|Overall Study|Adverse Event|10|||
105889016|NCT02137850|365249755|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
105889017|NCT02137850|365249756|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
105889018|NCT02137850|365249754|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
105889019|NCT02137850|365249755|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
105889020|NCT02137850|365249756|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
105889021|NCT02137850|365249754|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
105996283|NCT00100789|365646989|FG000|Overall Study|Withdrawal by Subject|1|||
105889022|NCT02137850|365249755|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
105889023|NCT02137850|365249756|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
105996284|NCT00100789|365646989|FG000|Overall Study|Progression/relapse|42|||
105996285|NCT00100789|365646989|FG000|Overall Study|Death|2|||
105996286|NCT00100789|365646989|FG000|Overall Study|Not protocol specified|5|||
105996287|NCT00100789|365646989|FG000|Overall Study|Ineligible|3|||
105996288|NCT00100789|365646989|FG000|Overall Study|Never received treatment|1|||
105996289|NCT00991939|365646993|FG000|Overall Study|Lost to Follow-up|0|||
105996290|NCT00991939|365646994|FG001|Overall Study|Lost to Follow-up|1|||
105996291|NCT00991939|365646993|FG000|Overall Study|Withdrawal by Subject|1|||
105996292|NCT00991939|365646994|FG001|Overall Study|Withdrawal by Subject|0|||
105996293|NCT00991939|365646993|FG000|Overall Study|Entire study terminated|4|||
105996294|NCT00991939|365646994|FG001|Overall Study|Entire study terminated|1|||
105996295|NCT00714415|365646997|FG000|Overall Study|Lack of Efficacy|1|||
105996296|NCT00714415|365646998|FG001|Overall Study|Lack of Efficacy|0|||
105996297|NCT00714415|365646997|FG000|Overall Study|Death|1|||
105996298|NCT00714415|365646998|FG001|Overall Study|Death|0|||
105996299|NCT00740584|365646999|FG000|Overall Study|Withdrawal by Subject|1|||
105996300|NCT00687804|365647011|FG000|Core Study|Adverse Event|5|||
105996301|NCT00687804|365647012|FG001|Core Study|Adverse Event|3|||
105996302|NCT00687804|365647013|FG002|Core Study|Adverse Event|3|||
105996303|NCT00687804|365647011|FG000|Core Study|Abnormal laboratory value(s)|1|||
105663973|NCT00634842|364434797|FG000|Overall Study|Subject off study drug for too long|0|||
105889024|NCT02137850|365249754|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
105996304|NCT00687804|365647012|FG001|Core Study|Abnormal laboratory value(s)|0|||
105996305|NCT00687804|365647013|FG002|Core Study|Abnormal laboratory value(s)|0|||
105996306|NCT00687804|365647011|FG000|Core Study|Lack of Efficacy|1|||
105996307|NCT00687804|365647012|FG001|Core Study|Lack of Efficacy|1|||
105996308|NCT00687804|365647013|FG002|Core Study|Lack of Efficacy|1|||
105996309|NCT00687804|365647011|FG000|Core Study|Withdrawal by Subject|4|||
105996310|NCT00687804|365647012|FG001|Core Study|Withdrawal by Subject|7|||
105996311|NCT00687804|365647013|FG002|Core Study|Withdrawal by Subject|7|||
105996312|NCT00687804|365647011|FG000|Core Study|Lost to Follow-up|0|||
105996313|NCT00687804|365647012|FG001|Core Study|Lost to Follow-up|1|||
105996314|NCT00687804|365647013|FG002|Core Study|Lost to Follow-up|0|||
105996315|NCT00687804|365647011|FG000|Core Study|Death|2|||
105996316|NCT00687804|365647012|FG001|Core Study|Death|2|||
105996317|NCT00687804|365647013|FG002|Core Study|Death|2|||
105996318|NCT00687804|365647011|FG000|Core Study|Protocol Violation|1|||
105996319|NCT00687804|365647012|FG001|Core Study|Protocol Violation|1|||
105996320|NCT00687804|365647013|FG002|Core Study|Protocol Violation|0|||
105996321|NCT00687804|365647011|FG000|Open-Label Extension Study|Adverse Event|2|||
105996322|NCT00687804|365647012|FG001|Open-Label Extension Study|Adverse Event|2|||
105996323|NCT00687804|365647013|FG002|Open-Label Extension Study|Adverse Event|2|||
105996324|NCT00687804|365647011|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
105996325|NCT00687804|365647012|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
105889025|NCT02137850|365249755|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
105889026|NCT02137850|365249756|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
105996326|NCT00687804|365647013|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
105996327|NCT00687804|365647011|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
105996328|NCT00687804|365647012|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
105663974|NCT00634842|364434798|FG001|Overall Study|Subject off study drug for too long|1|||
105663975|NCT01594827|364434800|FG000|Overall Study|Adverse Event|1|||
105663976|NCT01594827|364434801|FG001|Overall Study|Adverse Event|0|||
105663977|NCT01594827|364434800|FG000|Overall Study|Physician Decision|3|||
105663978|NCT01594827|364434801|FG001|Overall Study|Physician Decision|0|||
105663979|NCT03210519|364434802|FG000|Overall Study|Adverse Event|2|||
105663980|NCT03210519|364434803|FG001|Overall Study|Adverse Event|0|||
105663981|NCT04351269|364434804|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
105663982|NCT04351269|364434805|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
105663983|NCT04351269|364434806|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
105663984|NCT04351269|364434804|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
105663985|NCT04351269|364434805|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
105663986|NCT04351269|364434806|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
105663987|NCT04351269|364434804|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
105663988|NCT04351269|364434805|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
105663989|NCT04351269|364434806|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
105663990|NCT04351269|364434804|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
105663991|NCT04351269|364434805|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
105663992|NCT04351269|364434806|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
105663993|NCT04351269|364434804|FG000|Overall Study|Lost to Follow-up|1|||
105663994|NCT04351269|364434805|FG001|Overall Study|Lost to Follow-up|3|||
105663995|NCT04351269|364434806|FG002|Overall Study|Lost to Follow-up|0|||
105663996|NCT01677299|364434807|FG000|Overall Study|Adverse Event|0|||
105663997|NCT01677299|364434808|FG001|Overall Study|Adverse Event|2|||
105663998|NCT01677299|364434809|FG002|Overall Study|Adverse Event|1|||
105663999|NCT01677299|364434810|FG003|Overall Study|Adverse Event|0|||
105664000|NCT01677299|364434807|FG000|Overall Study|Withdrawal by Subject|0|||
105664001|NCT01677299|364434808|FG001|Overall Study|Withdrawal by Subject|1|||
105664002|NCT01677299|364434809|FG002|Overall Study|Withdrawal by Subject|0|||
105664003|NCT01677299|364434810|FG003|Overall Study|Withdrawal by Subject|1|||
105664004|NCT00174447|364434816|FG000|Overall Study|Adverse Event|19|||
105664005|NCT00174447|364434816|FG000|Overall Study|Withdrawal by Subject|15|||
105664006|NCT00174447|364434816|FG000|Overall Study|Protocol Violation|1|||
105664007|NCT00174447|364434816|FG000|Overall Study|Lack of Efficacy|1|||
105664008|NCT00174447|364434816|FG000|Overall Study|Administrative reason/Other|2|||
105664009|NCT01013961|364434817|FG000|Overall Study|Adverse Event|2|||
105664010|NCT01013961|364434818|FG001|Overall Study|Adverse Event|2|||
105664011|NCT01013961|364434817|FG000|Overall Study|Withdrawal by Subject|1|||
105664012|NCT01013961|364434818|FG001|Overall Study|Withdrawal by Subject|0|||
105664013|NCT01013961|364434817|FG000|Overall Study|Physician Decision|0|||
105664014|NCT01013961|364434818|FG001|Overall Study|Physician Decision|1|||
105664015|NCT02879383|364434819|FG000|First 24 Weeks|Physician Decision|0|||
105664016|NCT02879383|364434820|FG001|First 24 Weeks|Physician Decision|1|||
105664017|NCT02879383|364434821|FG002|First 24 Weeks|Physician Decision|0|||
105664018|NCT02879383|364434822|FG003|First 24 Weeks|Physician Decision|0|||
105664019|NCT00609947|364434825|FG000|Overall Study|Death|1|||
105664020|NCT03603639|364434826|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664021|NCT03603639|364434827|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664022|NCT03603639|364434828|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664023|NCT03603639|364434829|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
105664024|NCT03603639|364434830|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664025|NCT03603639|364434831|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
105664026|NCT03603639|364434826|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
105664027|NCT03603639|364434827|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
105664028|NCT03603639|364434828|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
105664029|NCT03603639|364434829|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
105664030|NCT03603639|364434830|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
105664031|NCT03603639|364434831|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
105664032|NCT02643628|364434835|FG000|Overall Study|Lost to Follow-up|1|||
105664033|NCT02643628|364434836|FG001|Overall Study|Lost to Follow-up|4|||
105664034|NCT02643628|364434835|FG000|Overall Study|Withdrawal by Subject|0|||
105664035|NCT02643628|364434836|FG001|Overall Study|Withdrawal by Subject|1|||
105664036|NCT02643628|364434835|FG000|Overall Study|Relocated out of state|0|||
105664037|NCT02643628|364434836|FG001|Overall Study|Relocated out of state|1|||
105664038|NCT04042077|364434838|FG000|Overall Study|Adverse Event|0|||
105664039|NCT04042077|364434839|FG001|Overall Study|Adverse Event|1|||
105664040|NCT04042077|364434838|FG000|Overall Study|Death|2|||
105664041|NCT04042077|364434839|FG001|Overall Study|Death|1|||
105664042|NCT04042077|364434838|FG000|Overall Study|Physician Decision|2|||
105664043|NCT04042077|364434839|FG001|Overall Study|Physician Decision|0|||
105664044|NCT04042077|364434838|FG000|Overall Study|Withdrawal by Subject|3|||
105664045|NCT04042077|364434839|FG001|Overall Study|Withdrawal by Subject|2|||
105664046|NCT04042077|364434838|FG000|Overall Study|Lack of Efficacy|0|||
105664047|NCT04042077|364434839|FG001|Overall Study|Lack of Efficacy|1|||
105664048|NCT03482752|364434840|FG000|Overall Study|Withdrawal by Subject|2|||
105664049|NCT03482752|364434840|FG000|Overall Study|Lost to Follow-up|1|||
105664050|NCT03482752|364434840|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
105664051|NCT01807182|364434841|FG000|Overall Study|Death|1|||
105664052|NCT01807182|364434841|FG000|Overall Study|New therapy|1|||
105664053|NCT01807182|364434841|FG000|Overall Study|Moved to hospice care|1|||
105664054|NCT00478205|364434843|FG000|Overall Study|Adverse Event|182|||
105664055|NCT00478205|364434844|FG001|Overall Study|Adverse Event|39|||
105664056|NCT00478205|364434843|FG000|Overall Study|Medication Non-compliance|9|||
105664057|NCT00478205|364434844|FG001|Overall Study|Medication Non-compliance|4|||
105664058|NCT00478205|364434843|FG000|Overall Study|Protocol Violation|15|||
105664059|NCT00478205|364434844|FG001|Overall Study|Protocol Violation|5|||
105664060|NCT00478205|364434843|FG000|Overall Study|Request of Investigator or Sponsor|4|||
105664061|NCT00478205|364434844|FG001|Overall Study|Request of Investigator or Sponsor|5|||
105664062|NCT00478205|364434843|FG000|Overall Study|Withdrawal by Subject|61|||
105664063|NCT00478205|364434844|FG001|Overall Study|Withdrawal by Subject|22|||
105664064|NCT00478205|364434843|FG000|Overall Study|Lack of Efficacy|1|||
105664065|NCT00478205|364434844|FG001|Overall Study|Lack of Efficacy|0|||
105664066|NCT00478205|364434843|FG000|Overall Study|Other|24|||
105664067|NCT00478205|364434844|FG001|Overall Study|Other|12|||
105664068|NCT02344342|364434847|FG000|Overall Study|Industry partner dropped out|11|||
105664069|NCT02344342|364434848|FG001|Overall Study|Industry partner dropped out|9|||
105664070|NCT02344342|364434849|FG002|Overall Study|Industry partner dropped out|14|||
105889027|NCT02137850|365249754|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
105889028|NCT02137850|365249755|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
105889029|NCT02137850|365249756|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
105889030|NCT02137850|365249754|FG000|Main Phase: Prophylaxis|Other|0|||
105889031|NCT02137850|365249755|FG001|Main Phase: Prophylaxis|Other|1|||
106121252|NCT00720902|366101817|FG001|Overall Study|Withdrawal by Subject|0|||
106121253|NCT00720902|366101816|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
106121254|NCT00720902|366101817|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
106121255|NCT02959671|366101818|FG000|Overall Study|Adverse Event|2|||
106121256|NCT02959671|366101818|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
106121257|NCT00077636|366101819|FG000|Overall Study|Refused Treatment|9|||
106121258|NCT00077636|366101820|FG001|Overall Study|Refused Treatment|31|||
106121259|NCT00077636|366101819|FG000|Overall Study|Admin|3|||
106121260|NCT00077636|366101820|FG001|Overall Study|Admin|3|||
106121261|NCT00077636|366101819|FG000|Overall Study|Withdrawal by Subject|2|||
106121262|NCT00077636|366101820|FG001|Overall Study|Withdrawal by Subject|2|||
106121263|NCT00077636|366101819|FG000|Overall Study|Adverse Event|17|||
106121264|NCT00077636|366101820|FG001|Overall Study|Adverse Event|34|||
106121265|NCT00077636|366101819|FG000|Overall Study|Protocol Violation|0|||
106121266|NCT00077636|366101820|FG001|Overall Study|Protocol Violation|2|||
106121267|NCT00077636|366101819|FG000|Overall Study|Lost to Follow-up|10|||
106121268|NCT00077636|366101820|FG001|Overall Study|Lost to Follow-up|18|||
106121269|NCT00077636|366101819|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
106121270|NCT00077636|366101820|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
106121271|NCT00474929|366101828|FG000|Overall Study|Withdrawal by Subject|0|||
106121272|NCT00474929|366101829|FG001|Overall Study|Withdrawal by Subject|1|||
106121273|NCT00474929|366101830|FG002|Overall Study|Withdrawal by Subject|0|||
106121274|NCT00474929|366101831|FG003|Overall Study|Withdrawal by Subject|0|||
106121275|NCT00474929|366101832|FG004|Overall Study|Withdrawal by Subject|0|||
106121276|NCT00474929|366101828|FG000|Overall Study|Unrelated medical condition|0|||
106121277|NCT00474929|366101829|FG001|Overall Study|Unrelated medical condition|0|||
106121278|NCT00474929|366101830|FG002|Overall Study|Unrelated medical condition|1|||
106121279|NCT00474929|366101831|FG003|Overall Study|Unrelated medical condition|0|||
106121280|NCT00474929|366101832|FG004|Overall Study|Unrelated medical condition|0|||
106121281|NCT00474929|366101828|FG000|Overall Study|Physician Decision|0|||
106121282|NCT00474929|366101829|FG001|Overall Study|Physician Decision|0|||
106121283|NCT00474929|366101830|FG002|Overall Study|Physician Decision|1|||
106121284|NCT00474929|366101831|FG003|Overall Study|Physician Decision|2|||
106121285|NCT00474929|366101832|FG004|Overall Study|Physician Decision|0|||
106121286|NCT00068380|366101836|FG000|Overall Study|Withdrawal by Subject|3|||
106121287|NCT00068380|366101836|FG000|Overall Study|Adverse Event|2|||
106121288|NCT02757521|366101837|FG000|Overall Study|Adverse Event|1|||
105664071|NCT02344342|364434850|FG003|Overall Study|Industry partner dropped out|10|||
105664072|NCT00762476|364434851|FG000|Overall Study|Adverse Event|7|||
105664073|NCT00762476|364434852|FG001|Overall Study|Adverse Event|1|||
105664074|NCT00762476|364434851|FG000|Overall Study|Lost to Follow-up|2|||
105664075|NCT00762476|364434852|FG001|Overall Study|Lost to Follow-up|0|||
105664076|NCT00762476|364434851|FG000|Overall Study|Protocol Violation|5|||
105889032|NCT02137850|365249756|FG002|Main Phase: Prophylaxis|Other|0|||
106121289|NCT02757521|366101838|FG001|Overall Study|Adverse Event|0|||
106121290|NCT03239873|366101839|FG000|Overall Study|Lost to Follow-up|15|||
105664077|NCT00762476|364434852|FG001|Overall Study|Protocol Violation|6|||
105664078|NCT00762476|364434851|FG000|Overall Study|Physician Decision|2|||
105664079|NCT00762476|364434852|FG001|Overall Study|Physician Decision|14|||
105664080|NCT00762476|364434851|FG000|Overall Study|Withdrawal by Subject|6|||
105664081|NCT00762476|364434852|FG001|Overall Study|Withdrawal by Subject|12|||
105664082|NCT00762476|364434851|FG000|Overall Study|antibiotic use|0|||
105664083|NCT00762476|364434852|FG001|Overall Study|antibiotic use|1|||
105664084|NCT00762476|364434851|FG000|Overall Study|non-compliance with study visits|0|||
105664085|NCT00762476|364434852|FG001|Overall Study|non-compliance with study visits|2|||
105664086|NCT00762476|364434851|FG000|Overall Study|Seasonal allergies|1|||
105664087|NCT00762476|364434852|FG001|Overall Study|Seasonal allergies|0|||
105664088|NCT02838134|364434854|FG000|Overall Study|Lost to Follow-up|1|||
105664089|NCT02838134|364434855|FG001|Overall Study|Lost to Follow-up|2|||
105664090|NCT02838134|364434854|FG000|Overall Study|logistic problems|1|||
105664091|NCT02838134|364434855|FG001|Overall Study|logistic problems|1|||
105664092|NCT00794924|364434856|FG000|Overall Study|Lost to Follow-up|6|||
105664093|NCT00794924|364434857|FG001|Overall Study|Lost to Follow-up|8|||
105664094|NCT00794924|364434856|FG000|Overall Study|Withdrawal by Subject|48|||
105664095|NCT00794924|364434857|FG001|Overall Study|Withdrawal by Subject|60|||
105664096|NCT00794924|364434856|FG000|Overall Study|Adverse Event|6|||
105664097|NCT00794924|364434857|FG001|Overall Study|Adverse Event|2|||
105664098|NCT01594970|364434858|FG000|Overall Study|Non-Adverse Event Related|4|||
105664099|NCT01594970|364434859|FG001|Overall Study|Non-Adverse Event Related|5|||
105664100|NCT01594970|364434860|FG002|Overall Study|Non-Adverse Event Related|6|||
105664101|NCT01594970|364434858|FG000|Overall Study|Adverse Event|17|||
105664102|NCT01594970|364434859|FG001|Overall Study|Adverse Event|23|||
105664103|NCT01594970|364434860|FG002|Overall Study|Adverse Event|23|||
105664104|NCT01594970|364434858|FG000|Overall Study|Lost to Follow-up|54|||
105664105|NCT01594970|364434859|FG001|Overall Study|Lost to Follow-up|54|||
105664106|NCT01594970|364434860|FG002|Overall Study|Lost to Follow-up|37|||
105664107|NCT00617929|364434861|FG000|Overall Study|Physician Decision|1|||
105664108|NCT03229486|364434862|FG000|Overall Study|Protocol Violation|0|||
105664109|NCT03229486|364434863|FG001|Overall Study|Protocol Violation|1|||
105664110|NCT02296892|364434864|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
105664111|NCT02296892|364434865|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
105664112|NCT02296892|364434866|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
105664113|NCT02296892|364434864|FG000|Overall Study|Lost to Follow-up|5|||
105664114|NCT02296892|364434865|FG001|Overall Study|Lost to Follow-up|0|||
105664115|NCT02296892|364434866|FG002|Overall Study|Lost to Follow-up|1|||
105664116|NCT00585078|364434867|FG000|Overall Study|Withdrawal by Subject|4|||
105664117|NCT00585078|364434867|FG000|Overall Study|Poor performance status|1|||
105664118|NCT00585078|364434867|FG000|Overall Study|Disease Progression|24|||
105664119|NCT00585078|364434867|FG000|Overall Study|Adverse Event|10|||
105664120|NCT00585078|364434867|FG000|Overall Study|Death|1|||
105664121|NCT00455741|364434868|FG000|Overall Study|Physician Decision|0|||
105664122|NCT00455741|364434869|FG001|Overall Study|Physician Decision|1|||
105664123|NCT00243074|364434870|FG000|Overall Study|Ineligible|6|||
105664124|NCT00243074|364434870|FG000|Overall Study|Adverse Event|6|||
105664125|NCT00243074|364434870|FG000|Overall Study|Withdrawal by Subject|2|||
105664126|NCT00243074|364434870|FG000|Overall Study|Lack of Efficacy|36|||
105664127|NCT00243074|364434870|FG000|Overall Study|Death|2|||
105664128|NCT00243074|364434870|FG000|Overall Study|not protocol specified|1|||
105664129|NCT00243074|364434870|FG000|Overall Study|Did not receive any treatment|1|||
105664130|NCT02336425|364434871|FG000|Overall Study|Study terminated.|2|||
105664131|NCT02336425|364434872|FG001|Overall Study|Study terminated.|2|||
105664132|NCT02336425|364434873|FG002|Overall Study|Study terminated.|3|||
105664133|NCT02336425|364434874|FG003|Overall Study|Study terminated.|3|||
105664134|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
105664135|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
105664136|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
105664137|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
105664138|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
105664139|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
105664140|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
105664141|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
105664142|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
105664143|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
105889033|NCT02137850|365249754|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
105889034|NCT02137850|365249755|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
105664144|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
105664145|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
105664146|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
105664147|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
105664148|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
105664149|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Death|1|||
105664150|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Death|0|||
105664151|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Death|0|||
105996329|NCT00687804|365647013|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
105996330|NCT00687804|365647011|FG000|Open-Label Extension Study|Administrative problems|1|||
105996331|NCT00687804|365647012|FG001|Open-Label Extension Study|Administrative problems|1|||
105996332|NCT00687804|365647013|FG002|Open-Label Extension Study|Administrative problems|0|||
105996333|NCT00687804|365647011|FG000|Open-Label Extension Study|Death|2|||
105996334|NCT00687804|365647012|FG001|Open-Label Extension Study|Death|3|||
105996335|NCT00687804|365647013|FG002|Open-Label Extension Study|Death|3|||
105664152|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Death|0|||
105664153|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Death|0|||
105664154|NCT04641962|364434875|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
105996336|NCT04390243|365647014|FG000|Overall Study|Death|1|||
105996337|NCT04390243|365647014|FG000|Overall Study|Disease Progression|4|||
105996338|NCT04390243|365647014|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
105664155|NCT04641962|364434876|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
105664156|NCT04641962|364434877|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
105664157|NCT04641962|364434878|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
105664158|NCT04641962|364434879|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
105664159|NCT04641962|364434875|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
105664160|NCT04641962|364434876|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
105664161|NCT04641962|364434877|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
105664162|NCT04641962|364434878|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
105664163|NCT04641962|364434879|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
105889035|NCT02137850|365249756|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
105889036|NCT02137850|365249754|FG000|Main Phase: Prophylaxis|Early site closure|0|||
105889037|NCT02137850|365249755|FG001|Main Phase: Prophylaxis|Early site closure|2|||
105889038|NCT02137850|365249756|FG002|Main Phase: Prophylaxis|Early site closure|0|||
105889039|NCT02137850|365249754|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
105889040|NCT02137850|365249755|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
105889041|NCT02137850|365249756|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
105889042|NCT02137850|365249754|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
105889043|NCT02137850|365249755|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
105889044|NCT02137850|365249756|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
105889045|NCT02137850|365249754|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
105889046|NCT02137850|365249755|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
105889047|NCT02137850|365249756|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
105889048|NCT02137850|365249754|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
105889049|NCT02137850|365249755|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
105889050|NCT02137850|365249756|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
105889051|NCT02137850|365249754|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
105889052|NCT02137850|365249755|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
105889053|NCT02137850|365249756|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
105889054|NCT02137850|365249754|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
105889055|NCT02137850|365249755|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
105889056|NCT02137850|365249756|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
105889057|NCT02137850|365249754|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
105889058|NCT02137850|365249755|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
105889059|NCT02137850|365249756|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
105889060|NCT02137850|365249754|FG000|Extension Phase: Prophylaxis|Other|0|||
105889061|NCT02137850|365249755|FG001|Extension Phase: Prophylaxis|Other|1|||
105889062|NCT02137850|365249756|FG002|Extension Phase: Prophylaxis|Other|0|||
105889063|NCT02137850|365249754|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
105889064|NCT02137850|365249755|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
105889065|NCT02137850|365249756|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
105889066|NCT01730534|365249758|FG000|Overall Study|Withdrawal by Subject|97|||
105889067|NCT01730534|365249759|FG001|Overall Study|Withdrawal by Subject|127|||
105889068|NCT01730534|365249758|FG000|Overall Study|Lost to Follow-up|12|||
105889069|NCT01730534|365249759|FG001|Overall Study|Lost to Follow-up|18|||
105889070|NCT01647516|365249760|FG000|Induction Period (IP)|Physician Decision|2|||
105889071|NCT01647516|365249761|FG001|Induction Period (IP)|Physician Decision|0|||
105889072|NCT01647516|365249762|FG002|Induction Period (IP)|Physician Decision|0|||
105889073|NCT01647516|365249763|FG003|Induction Period (IP)|Physician Decision|0|||
105996339|NCT00337207|365647015|FG000|Overall Study|Withdrawal by Subject|3|||
105996340|NCT01196026|365647017|FG000|Overall Study|Withdrawal by Subject|1|||
105664164|NCT04641962|364434875|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
105664165|NCT04641962|364434876|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
105664166|NCT04641962|364434877|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
105664167|NCT04641962|364434878|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
105996341|NCT01196026|365647018|FG001|Overall Study|Withdrawal by Subject|4|||
105996342|NCT01196026|365647019|FG002|Overall Study|Withdrawal by Subject|0|||
106121291|NCT03239873|366101840|FG001|Overall Study|Lost to Follow-up|16|||
106121292|NCT03239873|366101839|FG000|Overall Study|Physician Decision|1|||
105889074|NCT01647516|365249764|FG004|Induction Period (IP)|Physician Decision|0|||
105889075|NCT01647516|365249765|FG005|Induction Period (IP)|Physician Decision|0|||
105889076|NCT01647516|365249760|FG000|Induction Period (IP)|Adverse Event|1|||
105889077|NCT01647516|365249761|FG001|Induction Period (IP)|Adverse Event|2|||
105889078|NCT01647516|365249762|FG002|Induction Period (IP)|Adverse Event|0|||
105889079|NCT01647516|365249763|FG003|Induction Period (IP)|Adverse Event|0|||
105889080|NCT01647516|365249764|FG004|Induction Period (IP)|Adverse Event|0|||
105889081|NCT01647516|365249765|FG005|Induction Period (IP)|Adverse Event|0|||
105889082|NCT01647516|365249760|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
105664168|NCT04641962|364434879|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
105664169|NCT00583947|364434882|FG000|Cross-over Period|Adverse Event|2|||
105664170|NCT00583947|364434883|FG001|Cross-over Period|Adverse Event|0|||
105664171|NCT00583947|364434882|FG000|Cross-over Period|Withdrawal by Subject|2|||
105664172|NCT00583947|364434883|FG001|Cross-over Period|Withdrawal by Subject|0|||
105664173|NCT00583947|364434882|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
105664174|NCT00583947|364434883|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
105664175|NCT00583947|364434882|FG000|Cross-over Period|Other|1|||
105664176|NCT00583947|364434883|FG001|Cross-over Period|Other|1|||
105664177|NCT05101993|364434884|FG000|Overall Study|Withdrawal by Subject|1|||
105664178|NCT06926673|364434886|FG000|Overall Study|Lost to Follow-up|0|||
105664179|NCT06926673|364434887|FG001|Overall Study|Lost to Follow-up|0|||
105664180|NCT06926673|364434888|FG002|Overall Study|Lost to Follow-up|0|||
105664181|NCT06926673|364434889|FG003|Overall Study|Lost to Follow-up|1|||
105664182|NCT06926673|364434890|FG004|Overall Study|Lost to Follow-up|0|||
105664183|NCT06926673|364434891|FG005|Overall Study|Lost to Follow-up|0|||
105664184|NCT06926673|364434892|FG006|Overall Study|Lost to Follow-up|0|||
105664185|NCT06926673|364434886|FG000|Overall Study|Physician Decision|0|||
105664186|NCT06926673|364434887|FG001|Overall Study|Physician Decision|0|||
105664187|NCT06926673|364434888|FG002|Overall Study|Physician Decision|0|||
105664188|NCT06926673|364434889|FG003|Overall Study|Physician Decision|0|||
105664189|NCT06926673|364434890|FG004|Overall Study|Physician Decision|0|||
105664190|NCT06926673|364434891|FG005|Overall Study|Physician Decision|0|||
105664191|NCT06926673|364434892|FG006|Overall Study|Physician Decision|1|||
105664192|NCT06926673|364434886|FG000|Overall Study|Withdrawal by Subject|0|||
105664193|NCT06926673|364434887|FG001|Overall Study|Withdrawal by Subject|3|||
105664194|NCT06926673|364434888|FG002|Overall Study|Withdrawal by Subject|2|||
105664195|NCT06926673|364434889|FG003|Overall Study|Withdrawal by Subject|1|||
105664196|NCT06926673|364434890|FG004|Overall Study|Withdrawal by Subject|0|||
105664197|NCT06926673|364434891|FG005|Overall Study|Withdrawal by Subject|2|||
105664198|NCT06926673|364434892|FG006|Overall Study|Withdrawal by Subject|0|||
105664199|NCT02797522|364436565|FG000|Overall Study|Study Terminated by Sponsor|0|||
105664200|NCT02797522|364436566|FG001|Overall Study|Study Terminated by Sponsor|0|||
105664201|NCT02797522|364436567|FG002|Overall Study|Study Terminated by Sponsor|0|||
105664202|NCT02797522|364436568|FG003|Overall Study|Study Terminated by Sponsor|0|||
105889083|NCT01647516|365249761|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
105889084|NCT01647516|365249762|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
105889085|NCT01647516|365249763|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
105889086|NCT01647516|365249764|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
105889087|NCT01647516|365249765|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
105889088|NCT01647516|365249760|FG000|Induction Period (IP)|Participant Choice|0|||
105889089|NCT01647516|365249761|FG001|Induction Period (IP)|Participant Choice|0|||
105889090|NCT01647516|365249762|FG002|Induction Period (IP)|Participant Choice|1|||
105889091|NCT01647516|365249763|FG003|Induction Period (IP)|Participant Choice|0|||
105889092|NCT01647516|365249764|FG004|Induction Period (IP)|Participant Choice|0|||
105889093|NCT01647516|365249765|FG005|Induction Period (IP)|Participant Choice|0|||
105889094|NCT01647516|365249760|FG000|Induction Period (IP)|Lack of Efficacy|1|||
105889095|NCT01647516|365249761|FG001|Induction Period (IP)|Lack of Efficacy|0|||
105889096|NCT01647516|365249762|FG002|Induction Period (IP)|Lack of Efficacy|0|||
105889097|NCT01647516|365249763|FG003|Induction Period (IP)|Lack of Efficacy|0|||
105889098|NCT01647516|365249764|FG004|Induction Period (IP)|Lack of Efficacy|0|||
105889099|NCT01647516|365249765|FG005|Induction Period (IP)|Lack of Efficacy|0|||
105664203|NCT02797522|364436569|FG004|Overall Study|Study Terminated by Sponsor|0|||
105664204|NCT02797522|364436570|FG005|Overall Study|Study Terminated by Sponsor|0|||
105664205|NCT02797522|364436571|FG006|Overall Study|Study Terminated by Sponsor|0|||
105664206|NCT02797522|364436572|FG007|Overall Study|Study Terminated by Sponsor|4|||
105664207|NCT02797522|364436573|FG008|Overall Study|Study Terminated by Sponsor|2|||
105889100|NCT01647516|365249760|FG000|Induction Period (IP)|No study drug received|1|||
105889101|NCT01647516|365249761|FG001|Induction Period (IP)|No study drug received|1|||
105889102|NCT01647516|365249762|FG002|Induction Period (IP)|No study drug received|0|||
105664208|NCT02797522|364436574|FG009|Overall Study|Study Terminated by Sponsor|4|||
105664209|NCT02797522|364436575|FG010|Overall Study|Study Terminated by Sponsor|1|||
105664210|NCT00516139|364436577|FG000|Overall Study|Adverse Event|27|||
105664211|NCT00516139|364436577|FG000|Overall Study|Lost to Follow-up|1|||
105889103|NCT01647516|365249763|FG003|Induction Period (IP)|No study drug received|0|||
106121293|NCT03239873|366101840|FG001|Overall Study|Physician Decision|0|||
105664212|NCT00516139|364436577|FG000|Overall Study|Protocol Violation|1|||
105889104|NCT01647516|365249764|FG004|Induction Period (IP)|No study drug received|0|||
106121294|NCT03239873|366101839|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
105664213|NCT00516139|364436577|FG000|Overall Study|Withdrawal by Subject|8|||
105664214|NCT00516139|364436577|FG000|Overall Study|Lack of Efficacy|1|||
105664215|NCT01439867|364436578|FG000|Overall Study|Non-compliance|0|||
105664216|NCT01439867|364436579|FG001|Overall Study|Non-compliance|1|||
105664217|NCT01439867|364436578|FG000|Overall Study|Withdrawal by Subject|1|||
105664218|NCT01439867|364436579|FG001|Overall Study|Withdrawal by Subject|2|||
105664219|NCT01439867|364436578|FG000|Overall Study|Administrative Decision|4|||
105664220|NCT01439867|364436579|FG001|Overall Study|Administrative Decision|5|||
105664221|NCT01439867|364436578|FG000|Overall Study|Protocol-specified Criteria|1|||
105664222|NCT01439867|364436579|FG001|Overall Study|Protocol-specified Criteria|0|||
105664223|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
105664224|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
105664225|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
105664226|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
105664227|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
105664228|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
105664229|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
105664230|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
105664231|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
105664232|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
105664233|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
105664234|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
105664235|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
105664236|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
105664237|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664238|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664239|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664240|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664241|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664242|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
105664243|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
105664244|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
105664245|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
105664246|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
105664247|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
105664248|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
105664249|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
105785553|NCT03575806|364868517|FG000|Overall Study|Protocol Violation|0|||
105785554|NCT03575806|364868518|FG001|Overall Study|Protocol Violation|2|||
105785555|NCT00219349|364868519|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
105785556|NCT00219349|364868519|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
105785557|NCT00219349|364868519|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
105785558|NCT00219349|364868519|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
105785559|NCT02079740|364868520|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
105785560|NCT02079740|364868521|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
105785561|NCT02079740|364868522|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
105785562|NCT02079740|364868523|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
105785563|NCT02079740|364868524|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
105785564|NCT02079740|364868525|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
105785565|NCT02079740|364868526|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
105785566|NCT02079740|364868527|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
105785567|NCT02079740|364868528|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
105785568|NCT02079740|364868529|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
105785569|NCT02079740|364868530|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
105785570|NCT02079740|364868531|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
105785571|NCT02079740|364868532|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
105785572|NCT02079740|364868520|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
105785573|NCT02079740|364868521|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
105785574|NCT02079740|364868522|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
105785575|NCT02079740|364868523|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
105785576|NCT02079740|364868524|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
105785577|NCT02079740|364868525|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
105785578|NCT02079740|364868526|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
105785579|NCT02079740|364868527|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
105785580|NCT02079740|364868528|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
105785581|NCT02079740|364868529|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
105785582|NCT02079740|364868530|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
105785583|NCT02079740|364868531|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
105785584|NCT02079740|364868532|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
105889105|NCT01647516|365249765|FG005|Induction Period (IP)|No study drug received|0|||
105889106|NCT01647516|365249760|FG000|Maintenance Period (MP)|Adverse Event|2|||
105889107|NCT01647516|365249761|FG001|Maintenance Period (MP)|Adverse Event|1|||
105889108|NCT01647516|365249762|FG002|Maintenance Period (MP)|Adverse Event|0|||
105889109|NCT01647516|365249763|FG003|Maintenance Period (MP)|Adverse Event|0|||
105889110|NCT01647516|365249764|FG004|Maintenance Period (MP)|Adverse Event|0|||
105889111|NCT01647516|365249765|FG005|Maintenance Period (MP)|Adverse Event|0|||
105889112|NCT01647516|365249760|FG000|Maintenance Period (MP)|Non-compliance|1|||
105889113|NCT01647516|365249761|FG001|Maintenance Period (MP)|Non-compliance|0|||
105889114|NCT01647516|365249762|FG002|Maintenance Period (MP)|Non-compliance|0|||
105889115|NCT01647516|365249763|FG003|Maintenance Period (MP)|Non-compliance|0|||
105889116|NCT01647516|365249764|FG004|Maintenance Period (MP)|Non-compliance|0|||
105664250|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
105664251|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664252|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664253|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664254|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664255|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
105664256|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664257|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105664258|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664259|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
105664260|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664261|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664262|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664263|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664264|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
105664265|NCT01888874|364436580|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664266|NCT01888874|364436581|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
105664267|NCT01888874|364436582|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664268|NCT01888874|364436583|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664269|NCT01888874|364436584|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664270|NCT01888874|364436585|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
105664271|NCT01888874|364436586|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
105664272|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
105664273|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
105664274|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
105664275|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105664276|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
105664277|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105664278|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105664279|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664280|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664281|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664282|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664283|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
105664284|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105664285|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
105889117|NCT01647516|365249765|FG005|Maintenance Period (MP)|Non-compliance|0|||
105889118|NCT01647516|365249760|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
105889119|NCT01647516|365249761|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
105889120|NCT01647516|365249762|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
105889121|NCT01647516|365249763|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
105889122|NCT01647516|365249764|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
105889123|NCT01647516|365249765|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
105889124|NCT01647516|365249760|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
105889125|NCT01647516|365249761|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
105889126|NCT01647516|365249762|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
105889127|NCT01647516|365249763|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
105889128|NCT01647516|365249764|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
105889129|NCT01647516|365249765|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
105889130|NCT01647516|365249760|FG000|Open-Label Period|Adverse Event|0|||
105889131|NCT01647516|365249761|FG001|Open-Label Period|Adverse Event|0|||
105889132|NCT01647516|365249762|FG002|Open-Label Period|Adverse Event|0|||
105889133|NCT01647516|365249763|FG003|Open-Label Period|Adverse Event|5|||
105889134|NCT01647516|365249764|FG004|Open-Label Period|Adverse Event|6|||
105889135|NCT01647516|365249765|FG005|Open-Label Period|Adverse Event|3|||
105889136|NCT01647516|365249760|FG000|Open-Label Period|Pregnancy|0|||
105889137|NCT01647516|365249761|FG001|Open-Label Period|Pregnancy|0|||
105889138|NCT01647516|365249762|FG002|Open-Label Period|Pregnancy|0|||
105889139|NCT01647516|365249763|FG003|Open-Label Period|Pregnancy|0|||
105889140|NCT01647516|365249764|FG004|Open-Label Period|Pregnancy|0|||
105889141|NCT01647516|365249765|FG005|Open-Label Period|Pregnancy|1|||
105664286|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664287|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105889142|NCT01647516|365249760|FG000|Open-Label Period|Non-compliance|0|||
105889143|NCT01647516|365249761|FG001|Open-Label Period|Non-compliance|0|||
105889144|NCT01647516|365249762|FG002|Open-Label Period|Non-compliance|0|||
105889145|NCT01647516|365249763|FG003|Open-Label Period|Non-compliance|1|||
105889146|NCT01647516|365249764|FG004|Open-Label Period|Non-compliance|0|||
105664288|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
105664289|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664290|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664291|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
105664292|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
105664293|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664294|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664295|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
105664296|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664297|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664298|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664299|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
105664300|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
105664301|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
105664302|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
105664303|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
105664304|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
105664305|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
105664306|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
105664307|NCT01888874|364436580|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664308|NCT01888874|364436581|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
105664309|NCT01888874|364436582|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664310|NCT01888874|364436583|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664311|NCT01888874|364436584|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664312|NCT01888874|364436585|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
105664313|NCT01888874|364436586|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
105664314|NCT02980042|364436587|FG000|Overall Study|Lost to Follow-up|5|||
105664315|NCT02980042|364436588|FG001|Overall Study|Lost to Follow-up|0|||
105664316|NCT02980042|364436587|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
105664317|NCT02980042|364436588|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
105664318|NCT01131104|364436589|FG000|Overall Study|Withdrawal by Subject|3|||
105664319|NCT01131104|364436589|FG000|Overall Study|Physician Decision|4|||
105664320|NCT01131104|364436589|FG000|Overall Study|Information Not Available|5|||
105664321|NCT01131104|364436589|FG000|Overall Study|No Information on Index Date of Onset|1|||
105664322|NCT00863512|364436590|FG000|Overall Study|Adverse Event|2|||
105664323|NCT00863512|364436591|FG001|Overall Study|Adverse Event|0|||
105664324|NCT00863512|364436590|FG000|Overall Study|Withdrawal by Subject|11|||
105664325|NCT00863512|364436591|FG001|Overall Study|Withdrawal by Subject|0|||
105664326|NCT00863512|364436590|FG000|Overall Study|Physician Decision|1|||
105664327|NCT00863512|364436591|FG001|Overall Study|Physician Decision|0|||
105664328|NCT02037477|364436592|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
105664329|NCT02037477|364436593|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
105664330|NCT02037477|364436594|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
105889147|NCT01647516|365249765|FG005|Open-Label Period|Non-compliance|1|||
105889148|NCT01647516|365249760|FG000|Open-Label Period|Physician Decision|0|||
105889149|NCT01647516|365249761|FG001|Open-Label Period|Physician Decision|0|||
105889150|NCT01647516|365249762|FG002|Open-Label Period|Physician Decision|0|||
105996343|NCT01196026|365647020|FG003|Overall Study|Withdrawal by Subject|0|||
105996344|NCT01196026|365647021|FG004|Overall Study|Withdrawal by Subject|0|||
105889151|NCT01647516|365249763|FG003|Open-Label Period|Physician Decision|1|||
105889152|NCT01647516|365249764|FG004|Open-Label Period|Physician Decision|1|||
105889153|NCT01647516|365249765|FG005|Open-Label Period|Physician Decision|0|||
105889154|NCT01647516|365249760|FG000|Open-Label Period|Withdrawal by Subject|0|||
105889155|NCT01647516|365249761|FG001|Open-Label Period|Withdrawal by Subject|0|||
105889156|NCT01647516|365249762|FG002|Open-Label Period|Withdrawal by Subject|0|||
105889157|NCT01647516|365249763|FG003|Open-Label Period|Withdrawal by Subject|9|||
105889158|NCT01647516|365249764|FG004|Open-Label Period|Withdrawal by Subject|11|||
105889159|NCT01647516|365249765|FG005|Open-Label Period|Withdrawal by Subject|6|||
105996345|NCT01196026|365647022|FG005|Overall Study|Withdrawal by Subject|0|||
105664331|NCT02037477|364436595|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
105664332|NCT00983749|364436597|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
105664333|NCT00983749|364436598|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
105664334|NCT01270828|364436599|FG000|Pregabalin CR SB|Reason Unspecified|0|||
105664335|NCT01270828|364436600|FG001|Pregabalin CR SB|Reason Unspecified|0|||
105664336|NCT01270828|364436601|FG002|Pregabalin CR SB|Reason Unspecified|8|||
105664337|NCT01270828|364436599|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
105664338|NCT01270828|364436600|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
105664339|NCT01270828|364436601|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
105664340|NCT01270828|364436599|FG000|Pregabalin CR SB|Related adverse event|0|||
105664341|NCT01270828|364436600|FG001|Pregabalin CR SB|Related adverse event|0|||
105664342|NCT01270828|364436601|FG002|Pregabalin CR SB|Related adverse event|46|||
105664343|NCT01270828|364436599|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
105664344|NCT01270828|364436600|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
105664345|NCT01270828|364436601|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
105664346|NCT01270828|364436599|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
105664347|NCT01270828|364436600|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
105664348|NCT01270828|364436601|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
105664349|NCT01270828|364436599|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
105664350|NCT01270828|364436600|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
105664351|NCT01270828|364436601|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
105664352|NCT01270828|364436599|FG000|Pregabalin CR SB|Unrelated AE|0|||
105664353|NCT01270828|364436600|FG001|Pregabalin CR SB|Unrelated AE|0|||
105664354|NCT01270828|364436601|FG002|Pregabalin CR SB|Unrelated AE|8|||
105664355|NCT01270828|364436599|FG000|Pregabalin CR SB|Protocol Violation|0|||
105664356|NCT01270828|364436600|FG001|Pregabalin CR SB|Protocol Violation|0|||
105664357|NCT01270828|364436601|FG002|Pregabalin CR SB|Protocol Violation|8|||
105664358|NCT01270828|364436599|FG000|Double Blind Phase|Death|0|||
105664359|NCT01270828|364436600|FG001|Double Blind Phase|Death|1|||
105664360|NCT01270828|364436601|FG002|Double Blind Phase|Death|0|||
105664361|NCT01270828|364436599|FG000|Double Blind Phase|Protocol Violation|0|||
105664362|NCT01270828|364436600|FG001|Double Blind Phase|Protocol Violation|1|||
105664363|NCT01270828|364436601|FG002|Double Blind Phase|Protocol Violation|0|||
105664364|NCT01270828|364436599|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
105664365|NCT01270828|364436600|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
105664366|NCT01270828|364436601|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
105664367|NCT01270828|364436599|FG000|Double Blind Phase|Reason Unspecified|7|||
105664368|NCT01270828|364436600|FG001|Double Blind Phase|Reason Unspecified|4|||
105664369|NCT01270828|364436601|FG002|Double Blind Phase|Reason Unspecified|0|||
105664370|NCT01270828|364436599|FG000|Double Blind Phase|Withdrawal by Subject|6|||
105664371|NCT01270828|364436600|FG001|Double Blind Phase|Withdrawal by Subject|15|||
105664372|NCT01270828|364436601|FG002|Double Blind Phase|Withdrawal by Subject|0|||
105664373|NCT01270828|364436599|FG000|Double Blind Phase|Lost to Follow-up|1|||
105664374|NCT01270828|364436600|FG001|Double Blind Phase|Lost to Follow-up|2|||
105664375|NCT01270828|364436601|FG002|Double Blind Phase|Lost to Follow-up|0|||
105664376|NCT01270828|364436599|FG000|Double Blind Phase|Lack of Efficacy|2|||
105664377|NCT01270828|364436600|FG001|Double Blind Phase|Lack of Efficacy|11|||
105664378|NCT01270828|364436601|FG002|Double Blind Phase|Lack of Efficacy|0|||
105664379|NCT01270828|364436599|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
105664380|NCT01270828|364436600|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
105664381|NCT01270828|364436601|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
105664382|NCT01270828|364436599|FG000|Double Blind Phase|Adverse event related to study drug|5|||
105664383|NCT01270828|364436600|FG001|Double Blind Phase|Adverse event related to study drug|7|||
105664384|NCT01270828|364436601|FG002|Double Blind Phase|Adverse event related to study drug|0|||
105664385|NCT04292470|364436602|FG000|Overall Study|Withdrawal by Subject|0|||
105664386|NCT04292470|364436603|FG001|Overall Study|Withdrawal by Subject|1|||
105664387|NCT01454739|364436604|FG000|Overall Study|Protocol Violation|2|||
105664388|NCT01454739|364436605|FG001|Overall Study|Protocol Violation|3|||
105664389|NCT01454739|364436604|FG000|Overall Study|Withdrawal by Subject|2|||
105664390|NCT01454739|364436605|FG001|Overall Study|Withdrawal by Subject|6|||
105664391|NCT01454739|364436604|FG000|Overall Study|Other|3|||
105664392|NCT01454739|364436605|FG001|Overall Study|Other|5|||
105664393|NCT01454739|364436604|FG000|Overall Study|Physician Decision|0|||
105664394|NCT01454739|364436605|FG001|Overall Study|Physician Decision|5|||
105664395|NCT01454739|364436604|FG000|Overall Study|Lost to Follow-up|0|||
105664396|NCT01454739|364436605|FG001|Overall Study|Lost to Follow-up|1|||
105664397|NCT01454739|364436604|FG000|Overall Study|Adverse Event|0|||
105664398|NCT01454739|364436605|FG001|Overall Study|Adverse Event|1|||
105664399|NCT00884650|364436619|FG000|Overall Study|Did not return complete pain diaries|7|||
105664400|NCT00884650|364436620|FG001|Overall Study|Did not return complete pain diaries|7|||
105664401|NCT00884650|364436619|FG000|Overall Study|Admitted Post-Op|1|||
105664402|NCT00884650|364436620|FG001|Overall Study|Admitted Post-Op|0|||
105664403|NCT00884650|364436619|FG000|Overall Study|Femoral Stress Fracture|1|||
105664404|NCT00884650|364436620|FG001|Overall Study|Femoral Stress Fracture|0|||
105664405|NCT00884650|364436619|FG000|Overall Study|Pain Pump Complication|0|||
105664406|NCT00884650|364436620|FG001|Overall Study|Pain Pump Complication|1|||
105664407|NCT01124097|364436622|FG000|Overall Study|Withdrawal by Subject|4|||
105664408|NCT01124097|364436623|FG001|Overall Study|Withdrawal by Subject|3|||
105664409|NCT01124097|364436624|FG002|Overall Study|Withdrawal by Subject|2|||
105664410|NCT01124097|364436625|FG003|Overall Study|Withdrawal by Subject|3|||
105664411|NCT01124097|364436622|FG000|Overall Study|Lack of Efficacy|2|||
105889160|NCT01647516|365249760|FG000|Open-Label Period|Lost to Follow-up|0|||
105889161|NCT01647516|365249761|FG001|Open-Label Period|Lost to Follow-up|0|||
105889162|NCT01647516|365249762|FG002|Open-Label Period|Lost to Follow-up|0|||
105889163|NCT01647516|365249763|FG003|Open-Label Period|Lost to Follow-up|1|||
105889164|NCT01647516|365249764|FG004|Open-Label Period|Lost to Follow-up|0|||
105889165|NCT01647516|365249765|FG005|Open-Label Period|Lost to Follow-up|1|||
105889166|NCT01647516|365249760|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
105889167|NCT01647516|365249761|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
105889168|NCT01647516|365249762|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
106121295|NCT03239873|366101840|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
105664412|NCT01124097|364436623|FG001|Overall Study|Lack of Efficacy|3|||
105664413|NCT01124097|364436624|FG002|Overall Study|Lack of Efficacy|1|||
105664414|NCT01124097|364436625|FG003|Overall Study|Lack of Efficacy|3|||
105664415|NCT01124097|364436622|FG000|Overall Study|Adverse Event|24|||
105664416|NCT01124097|364436623|FG001|Overall Study|Adverse Event|15|||
105664417|NCT01124097|364436624|FG002|Overall Study|Adverse Event|15|||
105664418|NCT01124097|364436625|FG003|Overall Study|Adverse Event|7|||
105664419|NCT01124097|364436622|FG000|Overall Study|Protocol Violation|2|||
105664420|NCT01124097|364436623|FG001|Overall Study|Protocol Violation|0|||
105664421|NCT01124097|364436624|FG002|Overall Study|Protocol Violation|2|||
105664422|NCT01124097|364436625|FG003|Overall Study|Protocol Violation|1|||
105664423|NCT01124097|364436622|FG000|Overall Study|Physician Decision|2|||
105664424|NCT01124097|364436623|FG001|Overall Study|Physician Decision|1|||
105664425|NCT01124097|364436624|FG002|Overall Study|Physician Decision|0|||
105664426|NCT01124097|364436625|FG003|Overall Study|Physician Decision|0|||
105664427|NCT01821937|364436626|FG000|Overall Study|Adverse Event|0|||
105664428|NCT01821937|364436627|FG001|Overall Study|Adverse Event|3|||
105664429|NCT02270671|364436628|FG000|Overall Study|Withdrawal by Subject|1|||
105664430|NCT02270671|364436629|FG001|Overall Study|Withdrawal by Subject|1|||
105664431|NCT02270671|364436628|FG000|Overall Study|Protocol Violation|0|||
105664432|NCT02270671|364436629|FG001|Overall Study|Protocol Violation|1|||
105664433|NCT02270671|364436628|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
105664434|NCT02270671|364436629|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
105664435|NCT02270671|364436628|FG000|Overall Study|Lost to Follow-up|2|||
105664436|NCT02270671|364436629|FG001|Overall Study|Lost to Follow-up|1|||
105664437|NCT02980523|364436634|FG000|Overall Study|Lost to Follow-up|1|||
105664438|NCT02980523|364436635|FG001|Overall Study|Lost to Follow-up|4|||
105664439|NCT02980523|364436636|FG002|Overall Study|Lost to Follow-up|1|||
105664440|NCT02980523|364436637|FG003|Overall Study|Lost to Follow-up|2|||
105664441|NCT02980523|364436638|FG004|Overall Study|Lost to Follow-up|1|||
105664442|NCT02980523|364436634|FG000|Overall Study|Excluded from analysis|1|||
105664443|NCT02980523|364436635|FG001|Overall Study|Excluded from analysis|3|||
105664444|NCT02980523|364436636|FG002|Overall Study|Excluded from analysis|1|||
105664445|NCT02980523|364436637|FG003|Overall Study|Excluded from analysis|1|||
105664446|NCT02980523|364436638|FG004|Overall Study|Excluded from analysis|1|||
105664447|NCT02980523|364436634|FG000|Overall Study|Lack of Efficacy|1|||
105664448|NCT02980523|364436635|FG001|Overall Study|Lack of Efficacy|4|||
105664449|NCT02980523|364436636|FG002|Overall Study|Lack of Efficacy|4|||
105664450|NCT02980523|364436637|FG003|Overall Study|Lack of Efficacy|5|||
105664451|NCT02980523|364436638|FG004|Overall Study|Lack of Efficacy|8|||
105664452|NCT02980523|364436634|FG000|Overall Study|Did not receive intervention|0|||
105664453|NCT02980523|364436635|FG001|Overall Study|Did not receive intervention|0|||
105664454|NCT02980523|364436636|FG002|Overall Study|Did not receive intervention|0|||
105664455|NCT02980523|364436637|FG003|Overall Study|Did not receive intervention|1|||
106121296|NCT03239873|366101839|FG000|Overall Study|Withdrawal by Subject|2|||
106121297|NCT03239873|366101840|FG001|Overall Study|Withdrawal by Subject|0|||
105664456|NCT02980523|364436638|FG004|Overall Study|Did not receive intervention|0|||
105664457|NCT02153905|364436639|FG000|Overall Study|Death|1|||
105889169|NCT01647516|365249763|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
105889170|NCT01647516|365249764|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
105664458|NCT02153905|364436640|FG001|Overall Study|Death|0|||
105664459|NCT00193479|364436645|FG000|Induction Chemotherapy|Adverse Event|2|||
105664460|NCT00193479|364436645|FG000|Induction Chemotherapy|Disease Progression|1|||
105664461|NCT00193479|364436645|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
105664462|NCT00193479|364436645|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
105664463|NCT02229578|364436646|FG000|Overall Study|Withdrawal by Subject|1|||
105664464|NCT02229578|364436647|FG001|Overall Study|Withdrawal by Subject|3|||
105664465|NCT02229578|364436646|FG000|Overall Study|Protocol Violation|2|||
106121298|NCT03239873|366101839|FG000|Overall Study|Contraindication to study medication|1|||
106121299|NCT03239873|366101840|FG001|Overall Study|Contraindication to study medication|0|||
106121300|NCT03239873|366101839|FG000|Overall Study|Protocol Violation|1|||
106121301|NCT03239873|366101840|FG001|Overall Study|Protocol Violation|0|||
106121302|NCT00605319|366101845|FG000|Overall Study|Adverse Event|6|||
106121303|NCT02960763|366101846|FG000|Step 1|Withdrawal by Subject|10|||
106121304|NCT02960763|366101847|FG001|Step 1|Withdrawal by Subject|8|||
106121305|NCT02960763|366101848|FG002|Step 1|Withdrawal by Subject|13|||
106121306|NCT02960763|366101849|FG003|Step 1|Withdrawal by Subject|0|||
106121307|NCT02960763|366101850|FG004|Step 1|Withdrawal by Subject|0|||
106121308|NCT02960763|366101846|FG000|Step 1|Lost to Follow-up|7|||
106121309|NCT02960763|366101847|FG001|Step 1|Lost to Follow-up|9|||
106121310|NCT02960763|366101848|FG002|Step 1|Lost to Follow-up|12|||
106121311|NCT02960763|366101849|FG003|Step 1|Lost to Follow-up|0|||
106121312|NCT02960763|366101850|FG004|Step 1|Lost to Follow-up|0|||
106121313|NCT02960763|366101846|FG000|Step 1|Death|1|||
106121314|NCT02960763|366101847|FG001|Step 1|Death|1|||
106121315|NCT02960763|366101848|FG002|Step 1|Death|1|||
106121316|NCT02960763|366101849|FG003|Step 1|Death|0|||
106121317|NCT02960763|366101850|FG004|Step 1|Death|0|||
106121318|NCT02960763|366101846|FG000|Step 1|Investigator discretion|1|||
106121319|NCT02960763|366101847|FG001|Step 1|Investigator discretion|0|||
106121320|NCT02960763|366101848|FG002|Step 1|Investigator discretion|1|||
106121321|NCT02960763|366101849|FG003|Step 1|Investigator discretion|0|||
106121322|NCT02960763|366101850|FG004|Step 1|Investigator discretion|0|||
106121323|NCT02960763|366101846|FG000|Step 1|Other|0|||
106121324|NCT02960763|366101847|FG001|Step 1|Other|0|||
106121325|NCT02960763|366101848|FG002|Step 1|Other|1|||
106121326|NCT02960763|366101849|FG003|Step 1|Other|0|||
106121327|NCT02960763|366101850|FG004|Step 1|Other|0|||
106121328|NCT02960763|366101846|FG000|Step 2|Withdrawal by Subject|0|||
106121329|NCT02960763|366101847|FG001|Step 2|Withdrawal by Subject|0|||
106121330|NCT02960763|366101848|FG002|Step 2|Withdrawal by Subject|0|||
106121331|NCT02960763|366101849|FG003|Step 2|Withdrawal by Subject|7|||
106121332|NCT02960763|366101850|FG004|Step 2|Withdrawal by Subject|3|||
106121333|NCT02960763|366101846|FG000|Step 2|Lost to Follow-up|0|||
106121334|NCT02960763|366101847|FG001|Step 2|Lost to Follow-up|0|||
106121335|NCT02960763|366101848|FG002|Step 2|Lost to Follow-up|0|||
106121336|NCT02960763|366101849|FG003|Step 2|Lost to Follow-up|4|||
106121337|NCT02960763|366101850|FG004|Step 2|Lost to Follow-up|1|||
106121338|NCT02960763|366101846|FG000|Step 2|Investigator discretion|0|||
106121339|NCT02960763|366101847|FG001|Step 2|Investigator discretion|0|||
106121340|NCT02960763|366101848|FG002|Step 2|Investigator discretion|0|||
106121341|NCT02960763|366101849|FG003|Step 2|Investigator discretion|0|||
106121342|NCT02960763|366101850|FG004|Step 2|Investigator discretion|1|||
106121343|NCT01868035|366101853|FG000|Overall Study|Lost to Follow-up|3|||
106121344|NCT01868035|366101853|FG000|Overall Study|Withdrawal by Subject|1|||
106121345|NCT01868035|366101853|FG000|Overall Study|Progressive Disease|2|||
106121346|NCT01868035|366101853|FG000|Overall Study|Non-compliance|1|||
106121347|NCT02318719|366101854|FG000|Double-blind Phase|Adverse Event|7|||
106121348|NCT02318719|366101855|FG001|Double-blind Phase|Adverse Event|6|||
106121349|NCT02318719|366101856|FG002|Double-blind Phase|Adverse Event|12|||
106121350|NCT02318719|366101857|FG003|Double-blind Phase|Adverse Event|4|||
106121351|NCT02318719|366101858|FG004|Double-blind Phase|Adverse Event|0|||
106121352|NCT02318719|366101854|FG000|Double-blind Phase|Lack of Efficacy|5|||
106121353|NCT02318719|366101855|FG001|Double-blind Phase|Lack of Efficacy|0|||
106121354|NCT02318719|366101856|FG002|Double-blind Phase|Lack of Efficacy|1|||
106121355|NCT02318719|366101857|FG003|Double-blind Phase|Lack of Efficacy|1|||
106121356|NCT02318719|366101858|FG004|Double-blind Phase|Lack of Efficacy|0|||
106121357|NCT02318719|366101854|FG000|Double-blind Phase|Protocol Violation|0|||
106121358|NCT02318719|366101855|FG001|Double-blind Phase|Protocol Violation|1|||
106121359|NCT02318719|366101856|FG002|Double-blind Phase|Protocol Violation|3|||
106121360|NCT02318719|366101857|FG003|Double-blind Phase|Protocol Violation|0|||
106121361|NCT02318719|366101858|FG004|Double-blind Phase|Protocol Violation|0|||
106121362|NCT02318719|366101854|FG000|Double-blind Phase|Withdrawal by Subject|25|||
106121363|NCT02318719|366101855|FG001|Double-blind Phase|Withdrawal by Subject|7|||
106121364|NCT02318719|366101856|FG002|Double-blind Phase|Withdrawal by Subject|9|||
106121365|NCT02318719|366101857|FG003|Double-blind Phase|Withdrawal by Subject|10|||
106121366|NCT02318719|366101858|FG004|Double-blind Phase|Withdrawal by Subject|0|||
106121367|NCT02318719|366101854|FG000|Double-blind Phase|Other|1|||
106121368|NCT02318719|366101855|FG001|Double-blind Phase|Other|2|||
106121369|NCT02318719|366101856|FG002|Double-blind Phase|Other|0|||
106121370|NCT02318719|366101857|FG003|Double-blind Phase|Other|0|||
106121371|NCT02318719|366101858|FG004|Double-blind Phase|Other|0|||
106121372|NCT02318719|366101854|FG000|Open-label Extension Phase|Adverse Event|0|||
106121373|NCT02318719|366101855|FG001|Open-label Extension Phase|Adverse Event|0|||
106121374|NCT02318719|366101856|FG002|Open-label Extension Phase|Adverse Event|0|||
106121375|NCT02318719|366101857|FG003|Open-label Extension Phase|Adverse Event|0|||
106121376|NCT02318719|366101858|FG004|Open-label Extension Phase|Adverse Event|15|||
106121377|NCT02318719|366101854|FG000|Open-label Extension Phase|Death|0|||
106121378|NCT02318719|366101855|FG001|Open-label Extension Phase|Death|0|||
106121379|NCT02318719|366101856|FG002|Open-label Extension Phase|Death|0|||
105889171|NCT01647516|365249765|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
105889172|NCT01647516|365249760|FG000|Open-Label Period|Lack of Efficacy|0|||
105889173|NCT01647516|365249761|FG001|Open-Label Period|Lack of Efficacy|0|||
105889174|NCT01647516|365249762|FG002|Open-Label Period|Lack of Efficacy|0|||
105889175|NCT01647516|365249763|FG003|Open-Label Period|Lack of Efficacy|7|||
105889176|NCT01647516|365249764|FG004|Open-Label Period|Lack of Efficacy|9|||
105889177|NCT01647516|365249765|FG005|Open-Label Period|Lack of Efficacy|10|||
105889178|NCT01647516|365249760|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
105889179|NCT01647516|365249761|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
105889180|NCT01647516|365249762|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
105996346|NCT01196026|365647017|FG000|Overall Study|Lost to Follow-up|0|||
105664466|NCT02229578|364436647|FG001|Overall Study|Protocol Violation|0|||
105664467|NCT00559377|364436649|FG000|Overall Study|Withdrawal by Subject|9|||
105664468|NCT00872001|364436650|FG000|Overall Study|Adverse Event|34|||
105664469|NCT00872001|364436651|FG001|Overall Study|Adverse Event|23|||
105664470|NCT00872001|364436650|FG000|Overall Study|Protocol Defined Clinical Event|5|||
105664471|NCT00872001|364436651|FG001|Overall Study|Protocol Defined Clinical Event|7|||
105664472|NCT00872001|364436650|FG000|Overall Study|Lost to Follow-up|13|||
105664473|NCT00872001|364436651|FG001|Overall Study|Lost to Follow-up|12|||
105664474|NCT00872001|364436650|FG000|Overall Study|Withdrawal by Subject|18|||
105664475|NCT00872001|364436651|FG001|Overall Study|Withdrawal by Subject|30|||
105664476|NCT00872001|364436650|FG000|Overall Study|Protocol Violation|5|||
105664477|NCT00872001|364436651|FG001|Overall Study|Protocol Violation|8|||
105664478|NCT00872001|364436650|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
105664479|NCT00872001|364436651|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
105664480|NCT00872001|364436650|FG000|Overall Study|Administrative|23|||
105664481|NCT00872001|364436651|FG001|Overall Study|Administrative|15|||
105664482|NCT00340704|364436652|FG000|PK Study|Adverse Event|0|||
105664483|NCT00340704|364436653|FG001|PK Study|Adverse Event|1|||
105664484|NCT00340704|364436654|FG002|PK Study|Adverse Event|0|||
105664485|NCT00340704|364436655|FG003|PK Study|Adverse Event|0|||
105664486|NCT00340704|364436656|FG004|PK Study|Adverse Event|0|||
105664487|NCT00340704|364436657|FG005|PK Study|Adverse Event|0|||
105664488|NCT00340704|364436658|FG006|PK Study|Adverse Event|0|||
105664489|NCT00340704|364436659|FG007|PK Study|Adverse Event|0|||
105664490|NCT00340704|364436660|FG008|PK Study|Adverse Event|0|||
105664491|NCT00340704|364436652|FG000|PK Study|Not treated|0|||
105664492|NCT00340704|364436653|FG001|PK Study|Not treated|0|||
105664493|NCT00340704|364436654|FG002|PK Study|Not treated|1|||
105664494|NCT00340704|364436655|FG003|PK Study|Not treated|0|||
105664495|NCT00340704|364436656|FG004|PK Study|Not treated|0|||
105664496|NCT00340704|364436657|FG005|PK Study|Not treated|0|||
105664497|NCT00340704|364436658|FG006|PK Study|Not treated|0|||
105664498|NCT00340704|364436659|FG007|PK Study|Not treated|0|||
105664499|NCT00340704|364436660|FG008|PK Study|Not treated|0|||
105664500|NCT00340704|364436652|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664501|NCT00340704|364436653|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664502|NCT00340704|364436654|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664503|NCT00340704|364436655|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
105664504|NCT00340704|364436656|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
105664505|NCT00340704|364436657|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664506|NCT00340704|364436658|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
105664507|NCT00340704|364436659|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
105664508|NCT00340704|364436660|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
105664509|NCT00340704|364436652|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664510|NCT00340704|364436653|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664511|NCT00340704|364436654|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664512|NCT00340704|364436655|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664513|NCT00340704|364436656|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664514|NCT00340704|364436657|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
105996347|NCT01196026|365647018|FG001|Overall Study|Lost to Follow-up|3|||
105664515|NCT00340704|364436658|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664516|NCT00340704|364436659|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105664517|NCT00340704|364436660|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
105889181|NCT01647516|365249763|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
105996348|NCT01196026|365647019|FG002|Overall Study|Lost to Follow-up|0|||
105996349|NCT01196026|365647020|FG003|Overall Study|Lost to Follow-up|0|||
105664518|NCT00340704|364436652|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664519|NCT00340704|364436653|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664520|NCT00340704|364436654|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105996350|NCT01196026|365647021|FG004|Overall Study|Lost to Follow-up|1|||
105664521|NCT00340704|364436655|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664522|NCT00340704|364436656|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
105889182|NCT01647516|365249764|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
105889183|NCT01647516|365249765|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
105889184|NCT01647516|365249760|FG000|Open-Label Period|No completion / discontinuation visit|0|||
105889185|NCT01647516|365249761|FG001|Open-Label Period|No completion / discontinuation visit|0|||
105889186|NCT01647516|365249762|FG002|Open-Label Period|No completion / discontinuation visit|0|||
105889187|NCT01647516|365249763|FG003|Open-Label Period|No completion / discontinuation visit|0|||
105889188|NCT01647516|365249764|FG004|Open-Label Period|No completion / discontinuation visit|2|||
105889189|NCT01647516|365249765|FG005|Open-Label Period|No completion / discontinuation visit|1|||
105889190|NCT01676896|365249766|FG000|Overall Study|Withdrawal by Subject|12|||
105889191|NCT01676896|365249767|FG001|Overall Study|Withdrawal by Subject|7|||
105889192|NCT01676896|365249768|FG002|Overall Study|Withdrawal by Subject|19|||
105889193|NCT02980341|365249769|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
105889194|NCT02980341|365249770|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
105889195|NCT02980341|365249771|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
105889196|NCT02980341|365249772|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
105664523|NCT00340704|364436657|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
105664524|NCT00340704|364436658|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105889197|NCT02980341|365249773|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
105889198|NCT02980341|365249774|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105889199|NCT02980341|365249775|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105889200|NCT02980341|365249776|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105889201|NCT02980341|365249777|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105889202|NCT02980341|365249778|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105889203|NCT02980341|365249779|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
105889204|NCT02980341|365249769|FG000|Dose Escalation|Clinical progression|0|||
105889205|NCT02980341|365249770|FG001|Dose Escalation|Clinical progression|0|||
105889206|NCT02980341|365249771|FG002|Dose Escalation|Clinical progression|2|||
105889207|NCT02980341|365249772|FG003|Dose Escalation|Clinical progression|1|||
105889208|NCT02980341|365249773|FG004|Dose Escalation|Clinical progression|0|||
105889209|NCT02980341|365249774|FG005|Dose Escalation|Clinical progression|0|||
105889210|NCT02980341|365249775|FG006|Dose Escalation|Clinical progression|0|||
105889211|NCT02980341|365249776|FG007|Dose Escalation|Clinical progression|0|||
105889212|NCT02980341|365249777|FG008|Dose Escalation|Clinical progression|0|||
105889213|NCT02980341|365249778|FG009|Dose Escalation|Clinical progression|0|||
105889214|NCT02980341|365249779|FG010|Dose Escalation|Clinical progression|0|||
105889215|NCT02980341|365249769|FG000|Dose Escalation|Adverse Event|0|||
105889216|NCT02980341|365249770|FG001|Dose Escalation|Adverse Event|0|||
105889217|NCT02980341|365249771|FG002|Dose Escalation|Adverse Event|1|||
105889218|NCT02980341|365249772|FG003|Dose Escalation|Adverse Event|2|||
105889219|NCT02980341|365249773|FG004|Dose Escalation|Adverse Event|2|||
105889220|NCT02980341|365249774|FG005|Dose Escalation|Adverse Event|0|||
105889221|NCT02980341|365249775|FG006|Dose Escalation|Adverse Event|0|||
105889222|NCT02980341|365249776|FG007|Dose Escalation|Adverse Event|0|||
105889223|NCT02980341|365249777|FG008|Dose Escalation|Adverse Event|0|||
105889224|NCT02980341|365249778|FG009|Dose Escalation|Adverse Event|0|||
105889225|NCT02980341|365249779|FG010|Dose Escalation|Adverse Event|0|||
106121380|NCT02318719|366101857|FG003|Open-label Extension Phase|Death|0|||
106121381|NCT02318719|366101858|FG004|Open-label Extension Phase|Death|1|||
106121382|NCT02318719|366101854|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
105664525|NCT00340704|364436659|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664526|NCT00340704|364436660|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
105664527|NCT00340704|364436652|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664528|NCT00340704|364436653|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664529|NCT00340704|364436654|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664530|NCT00340704|364436655|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664531|NCT00340704|364436656|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
105664532|NCT00340704|364436657|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
105664533|NCT00340704|364436658|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
105664534|NCT00340704|364436659|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
105664535|NCT00340704|364436660|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
105889226|NCT02980341|365249769|FG000|Dose Escalation|Withdrawal by Subject|0|||
105889227|NCT02980341|365249770|FG001|Dose Escalation|Withdrawal by Subject|0|||
105889228|NCT02980341|365249771|FG002|Dose Escalation|Withdrawal by Subject|1|||
105889229|NCT02980341|365249772|FG003|Dose Escalation|Withdrawal by Subject|0|||
105889230|NCT02980341|365249773|FG004|Dose Escalation|Withdrawal by Subject|0|||
105889231|NCT02980341|365249774|FG005|Dose Escalation|Withdrawal by Subject|0|||
105889232|NCT02980341|365249775|FG006|Dose Escalation|Withdrawal by Subject|0|||
105889233|NCT02980341|365249776|FG007|Dose Escalation|Withdrawal by Subject|0|||
105889234|NCT02980341|365249777|FG008|Dose Escalation|Withdrawal by Subject|0|||
105889235|NCT02980341|365249778|FG009|Dose Escalation|Withdrawal by Subject|0|||
106121383|NCT02318719|366101855|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
106121384|NCT02318719|366101856|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
106121385|NCT02318719|366101857|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
106121386|NCT02318719|366101858|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
106121387|NCT02318719|366101854|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
106121388|NCT02318719|366101855|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
106121389|NCT02318719|366101856|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
106121390|NCT02318719|366101857|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
106121391|NCT02318719|366101858|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
106121392|NCT02318719|366101854|FG000|Open-label Extension Phase|Other|0|||
106121393|NCT02318719|366101855|FG001|Open-label Extension Phase|Other|0|||
106121394|NCT02318719|366101856|FG002|Open-label Extension Phase|Other|0|||
106121395|NCT02318719|366101857|FG003|Open-label Extension Phase|Other|0|||
106121396|NCT02318719|366101858|FG004|Open-label Extension Phase|Other|7|||
106121397|NCT00423293|366101859|FG000|Overall Study|Ineligible / No protocol treatment|11|||
106121398|NCT05033743|366101864|FG000|Overall Study|Lost to Follow-up|1|||
106121399|NCT05033743|366101864|FG000|Overall Study|Protocol Violation|2|||
106121400|NCT05033743|366101864|FG000|Overall Study|Withdrawal by Subject|1|||
106121401|NCT01965158|366101866|FG000|Overall Study|Adverse Event|14|||
106121402|NCT01965158|366101867|FG001|Overall Study|Adverse Event|5|||
106121403|NCT01965158|366101866|FG000|Overall Study|Withdrawal by Subject|16|||
106121404|NCT01965158|366101867|FG001|Overall Study|Withdrawal by Subject|24|||
106121405|NCT01965158|366101866|FG000|Overall Study|Lost to Follow-up|7|||
106121406|NCT01965158|366101867|FG001|Overall Study|Lost to Follow-up|5|||
106121407|NCT01965158|366101866|FG000|Overall Study|Protocol Violation|1|||
106121408|NCT01965158|366101867|FG001|Overall Study|Protocol Violation|1|||
106121409|NCT01965158|366101866|FG000|Overall Study|Other - Miscellaneous|3|||
106121410|NCT01965158|366101867|FG001|Overall Study|Other - Miscellaneous|0|||
106121411|NCT00474175|366101868|FG000|Overall Study|Lack of Efficacy|0|||
106121412|NCT00474175|366101869|FG001|Overall Study|Lack of Efficacy|0|||
106121413|NCT00474175|366101870|FG002|Overall Study|Lack of Efficacy|1|||
106121414|NCT00474175|366101868|FG000|Overall Study|Withdrawal by Subject|0|||
106121415|NCT00474175|366101869|FG001|Overall Study|Withdrawal by Subject|1|||
106121416|NCT00474175|366101870|FG002|Overall Study|Withdrawal by Subject|1|||
106121417|NCT00474175|366101868|FG000|Overall Study|Ineligible|1|||
106121418|NCT00474175|366101869|FG001|Overall Study|Ineligible|3|||
106121419|NCT00474175|366101870|FG002|Overall Study|Ineligible|1|||
106121420|NCT00474175|366101868|FG000|Overall Study|Protocol Violation|0|||
106121421|NCT00474175|366101869|FG001|Overall Study|Protocol Violation|2|||
106121422|NCT00474175|366101870|FG002|Overall Study|Protocol Violation|1|||
106121423|NCT00474175|366101868|FG000|Overall Study|Administrative|0|||
106121424|NCT00474175|366101869|FG001|Overall Study|Administrative|1|||
106121425|NCT00474175|366101870|FG002|Overall Study|Administrative|0|||
106121426|NCT01619787|366101871|FG000|Overall Study|Lost to Follow-up|5|||
106121427|NCT02111213|366101872|FG000|Overall Study|Withdrawal by Subject|3|||
106121428|NCT02111213|366101873|FG001|Overall Study|Withdrawal by Subject|2|||
106121429|NCT02111213|366101872|FG000|Overall Study|Lost to Follow-up|3|||
106121430|NCT02111213|366101873|FG001|Overall Study|Lost to Follow-up|4|||
106121431|NCT01463293|366101876|FG000|Overall Study|Lost to Follow-up|1|||
106121432|NCT01463293|366101877|FG001|Overall Study|Lost to Follow-up|4|||
106121433|NCT01463293|366101878|FG002|Overall Study|Lost to Follow-up|5|||
106121434|NCT01463293|366101876|FG000|Overall Study|Adverse Event|1|||
106121435|NCT01463293|366101877|FG001|Overall Study|Adverse Event|2|||
106121436|NCT01463293|366101878|FG002|Overall Study|Adverse Event|0|||
106121437|NCT01463293|366101876|FG000|Overall Study|Withdrawal by Subject|4|||
106121438|NCT01463293|366101877|FG001|Overall Study|Withdrawal by Subject|10|||
106121439|NCT01463293|366101878|FG002|Overall Study|Withdrawal by Subject|5|||
106121440|NCT01463293|366101876|FG000|Overall Study|Other|0|||
106121441|NCT01463293|366101877|FG001|Overall Study|Other|0|||
106121442|NCT01463293|366101878|FG002|Overall Study|Other|2|||
106121443|NCT01821898|366101884|FG000|Overall Study|Withdrawal by Subject|2|||
106121444|NCT01821898|366101885|FG001|Overall Study|Withdrawal by Subject|1|||
106121445|NCT02611830|366101886|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
106121446|NCT02611830|366101887|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
106121447|NCT02611830|366101888|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
106121448|NCT02611830|366101889|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
106121449|NCT02611830|366101886|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
106121450|NCT02611830|366101887|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
106121451|NCT02611830|366101888|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
106121452|NCT02611830|366101889|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
106121453|NCT02611830|366101886|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
106121454|NCT02611830|366101887|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
106121455|NCT02611830|366101888|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
106121456|NCT02611830|366101889|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
106121457|NCT02611830|366101886|FG000|OL Induction Phase|Lack of Efficacy|9|||
106121458|NCT02611830|366101887|FG001|OL Induction Phase|Lack of Efficacy|0|||
106121459|NCT02611830|366101888|FG002|OL Induction Phase|Lack of Efficacy|0|||
105785585|NCT02079740|364868520|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785586|NCT02079740|364868521|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785587|NCT02079740|364868522|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785588|NCT02079740|364868523|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785589|NCT02079740|364868524|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785590|NCT02079740|364868525|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785591|NCT02079740|364868526|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785592|NCT02079740|364868527|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
105785593|NCT02079740|364868528|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785594|NCT02079740|364868529|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785595|NCT02079740|364868530|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785596|NCT02079740|364868531|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785597|NCT02079740|364868532|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
105785598|NCT02079740|364868520|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785599|NCT02079740|364868521|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785600|NCT02079740|364868522|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785601|NCT02079740|364868523|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785602|NCT02079740|364868524|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785603|NCT02079740|364868525|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785604|NCT02079740|364868526|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785605|NCT02079740|364868527|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
105785606|NCT02079740|364868528|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785607|NCT02079740|364868529|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785608|NCT02079740|364868530|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785609|NCT02079740|364868531|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785610|NCT02079740|364868532|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
105785611|NCT02079740|364868520|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785612|NCT02079740|364868521|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785613|NCT02079740|364868522|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785614|NCT02079740|364868523|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785615|NCT02079740|364868524|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785616|NCT02079740|364868525|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785617|NCT02079740|364868526|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785618|NCT02079740|364868527|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785619|NCT02079740|364868528|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785620|NCT02079740|364868529|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
105785621|NCT02079740|364868530|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
105785622|NCT02079740|364868531|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
105785623|NCT02079740|364868532|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
105785624|NCT02842736|364868535|FG000|Overall Study|Lost to Follow-up|13|||
105785625|NCT02842736|364868535|FG000|Overall Study|Intervention for menstrual bleeding|17|||
105785626|NCT02842736|364868535|FG000|Overall Study|Withdrawal by Subject|4|||
105785627|NCT02842736|364868535|FG000|Overall Study|Pregnancy|3|||
105785628|NCT02842736|364868535|FG000|Overall Study|Hysterectomy for fibroids|2|||
105785629|NCT02842736|364868535|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
105785630|NCT02842736|364868535|FG000|Overall Study|IUD: Mirena|1|||
105785631|NCT01238861|364868537|FG000|Overall Study|Lost to Follow-up|4|||
105785632|NCT01238861|364868538|FG001|Overall Study|Lost to Follow-up|2|||
105785633|NCT01238861|364868539|FG002|Overall Study|Lost to Follow-up|3|||
105785634|NCT01238861|364868540|FG003|Overall Study|Lost to Follow-up|1|||
105785635|NCT01238861|364868541|FG004|Overall Study|Lost to Follow-up|1|||
105785636|NCT01238861|364868542|FG005|Overall Study|Lost to Follow-up|2|||
105785637|NCT01238861|364868537|FG000|Overall Study|Unplanned surgery|1|||
105785638|NCT01238861|364868538|FG001|Overall Study|Unplanned surgery|0|||
105785639|NCT01238861|364868539|FG002|Overall Study|Unplanned surgery|0|||
105785640|NCT01238861|364868540|FG003|Overall Study|Unplanned surgery|0|||
105785641|NCT01238861|364868541|FG004|Overall Study|Unplanned surgery|0|||
105785642|NCT01238861|364868542|FG005|Overall Study|Unplanned surgery|0|||
105785643|NCT01238861|364868537|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
105785644|NCT01238861|364868538|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
105785645|NCT01238861|364868539|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
105785646|NCT01238861|364868540|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
105785647|NCT01238861|364868541|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
105785648|NCT01238861|364868542|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
105785649|NCT01238861|364868537|FG000|Overall Study|Incorrect enrollment/randomization|0|||
105785650|NCT01238861|364868538|FG001|Overall Study|Incorrect enrollment/randomization|0|||
105785651|NCT01238861|364868539|FG002|Overall Study|Incorrect enrollment/randomization|1|||
105889236|NCT02980341|365249779|FG010|Dose Escalation|Withdrawal by Subject|0|||
105889237|NCT02980341|365249769|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889238|NCT02980341|365249770|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889239|NCT02980341|365249771|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889240|NCT02980341|365249772|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
105889241|NCT02980341|365249773|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889242|NCT02980341|365249774|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889243|NCT02980341|365249775|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889244|NCT02980341|365249776|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889245|NCT02980341|365249777|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889246|NCT02980341|365249778|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889247|NCT02980341|365249779|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
105889248|NCT02980341|365249769|FG000|Dose Escalation|Due to investigator's decision|0|||
105889249|NCT02980341|365249770|FG001|Dose Escalation|Due to investigator's decision|0|||
105889250|NCT02980341|365249771|FG002|Dose Escalation|Due to investigator's decision|0|||
105889251|NCT02980341|365249772|FG003|Dose Escalation|Due to investigator's decision|0|||
105889252|NCT02980341|365249773|FG004|Dose Escalation|Due to investigator's decision|1|||
105889253|NCT02980341|365249774|FG005|Dose Escalation|Due to investigator's decision|0|||
105889254|NCT02980341|365249775|FG006|Dose Escalation|Due to investigator's decision|0|||
105889255|NCT02980341|365249776|FG007|Dose Escalation|Due to investigator's decision|0|||
105889256|NCT02980341|365249777|FG008|Dose Escalation|Due to investigator's decision|0|||
105889257|NCT02980341|365249778|FG009|Dose Escalation|Due to investigator's decision|0|||
105889258|NCT02980341|365249779|FG010|Dose Escalation|Due to investigator's decision|0|||
105889259|NCT02980341|365249769|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
105889260|NCT02980341|365249770|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
105889261|NCT02980341|365249771|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
105889262|NCT02980341|365249772|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
105996351|NCT01196026|365647022|FG005|Overall Study|Lost to Follow-up|0|||
105996352|NCT01196026|365647017|FG000|Overall Study|Other|0|||
105996353|NCT01196026|365647018|FG001|Overall Study|Other|1|||
105996354|NCT01196026|365647019|FG002|Overall Study|Other|0|||
105996355|NCT01196026|365647020|FG003|Overall Study|Other|0|||
105996356|NCT01196026|365647021|FG004|Overall Study|Other|0|||
105996357|NCT01196026|365647022|FG005|Overall Study|Other|0|||
105996358|NCT02915263|365647025|FG000|Overall Study|Covid|3|||
105996359|NCT02915263|365647026|FG001|Overall Study|Covid|2|||
105996360|NCT04950465|365647029|FG000|Overall Study|Lost to Follow-up|1|||
105996361|NCT04950465|365647030|FG001|Overall Study|Lost to Follow-up|0|||
105996362|NCT04950465|365647031|FG002|Overall Study|Lost to Follow-up|0|||
105996363|NCT00684996|365647032|FG000|Overall Study|Adverse Event|1|||
105996364|NCT00684996|365647032|FG000|Overall Study|Refusal unrelated to adverse event|1|||
105996365|NCT00684996|365647032|FG000|Overall Study|Progression/relapse|2|||
105996366|NCT00684996|365647032|FG000|Overall Study|Other reasons not protocol specified|1|||
105996367|NCT03030417|365647033|FG000|Dose Expansion|Disease progression before treatment|0|||
105996368|NCT03030417|365647034|FG001|Dose Expansion|Disease progression before treatment|0|||
106121460|NCT02611830|366101889|FG003|OL Induction Phase|Lack of Efficacy|0|||
106121461|NCT02611830|366101886|FG000|OL Induction Phase|Reason not specified|3|||
106121462|NCT02611830|366101887|FG001|OL Induction Phase|Reason not specified|0|||
106121463|NCT02611830|366101888|FG002|OL Induction Phase|Reason not specified|0|||
106121464|NCT02611830|366101889|FG003|OL Induction Phase|Reason not specified|0|||
106121465|NCT02611830|366101886|FG000|Maintenance Phase|Lack of Efficacy|0|||
106121466|NCT02611830|366101887|FG001|Maintenance Phase|Lack of Efficacy|29|||
106121467|NCT02611830|366101888|FG002|Maintenance Phase|Lack of Efficacy|18|||
106121468|NCT02611830|366101889|FG003|Maintenance Phase|Lack of Efficacy|6|||
106121469|NCT02611830|366101886|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
106121470|NCT02611830|366101887|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
106121471|NCT02611830|366101888|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
105889263|NCT02980341|365249773|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
105889264|NCT02980341|365249774|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
105889265|NCT02980341|365249775|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
105889266|NCT02980341|365249776|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
105889267|NCT02980341|365249777|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
105889268|NCT02980341|365249778|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
106121472|NCT02611830|366101889|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
105889269|NCT02980341|365249779|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
105889270|NCT02980341|365249769|FG000|Dose Finding|Adverse Event|0|||
105996369|NCT03030417|365647035|FG002|Dose Expansion|Disease progression before treatment|0|||
105664536|NCT01732549|364436661|FG000|Overall Study|Adverse Event|13|||
105996370|NCT03030417|365647036|FG003|Dose Expansion|Disease progression before treatment|0|||
105996371|NCT03030417|365647037|FG004|Dose Expansion|Disease progression before treatment|0|||
106121473|NCT02611830|366101886|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
105889271|NCT02980341|365249770|FG001|Dose Finding|Adverse Event|0|||
105889272|NCT02980341|365249771|FG002|Dose Finding|Adverse Event|0|||
105889273|NCT02980341|365249772|FG003|Dose Finding|Adverse Event|0|||
105889274|NCT02980341|365249773|FG004|Dose Finding|Adverse Event|0|||
105889275|NCT02980341|365249774|FG005|Dose Finding|Adverse Event|3|||
105889276|NCT02980341|365249775|FG006|Dose Finding|Adverse Event|0|||
105889277|NCT02980341|365249776|FG007|Dose Finding|Adverse Event|0|||
105889278|NCT02980341|365249777|FG008|Dose Finding|Adverse Event|0|||
105889279|NCT02980341|365249778|FG009|Dose Finding|Adverse Event|0|||
105889280|NCT02980341|365249779|FG010|Dose Finding|Adverse Event|0|||
105889281|NCT02980341|365249769|FG000|Dose Finding|Withdrawal by Subject|0|||
105889282|NCT02980341|365249770|FG001|Dose Finding|Withdrawal by Subject|0|||
105889283|NCT02980341|365249771|FG002|Dose Finding|Withdrawal by Subject|0|||
105889284|NCT02980341|365249772|FG003|Dose Finding|Withdrawal by Subject|0|||
105889285|NCT02980341|365249773|FG004|Dose Finding|Withdrawal by Subject|0|||
105889286|NCT02980341|365249774|FG005|Dose Finding|Withdrawal by Subject|1|||
105889287|NCT02980341|365249775|FG006|Dose Finding|Withdrawal by Subject|1|||
105889288|NCT02980341|365249776|FG007|Dose Finding|Withdrawal by Subject|0|||
105889289|NCT02980341|365249777|FG008|Dose Finding|Withdrawal by Subject|0|||
105889290|NCT02980341|365249778|FG009|Dose Finding|Withdrawal by Subject|0|||
105889291|NCT02980341|365249779|FG010|Dose Finding|Withdrawal by Subject|0|||
105889292|NCT02980341|365249769|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105889293|NCT02980341|365249770|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105889294|NCT02980341|365249771|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105889295|NCT02980341|365249772|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105889296|NCT02980341|365249773|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105889297|NCT02980341|365249774|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105889298|NCT02980341|365249775|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
105889299|NCT02980341|365249776|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
105889300|NCT02980341|365249777|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
105889301|NCT02980341|365249778|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
105889302|NCT02980341|365249779|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
105889303|NCT02980341|365249769|FG000|Dose Expansion|Clinical progression|0|||
105889304|NCT02980341|365249770|FG001|Dose Expansion|Clinical progression|0|||
105889305|NCT02980341|365249771|FG002|Dose Expansion|Clinical progression|0|||
105889306|NCT02980341|365249772|FG003|Dose Expansion|Clinical progression|0|||
105889307|NCT02980341|365249773|FG004|Dose Expansion|Clinical progression|0|||
105889308|NCT02980341|365249774|FG005|Dose Expansion|Clinical progression|0|||
105889309|NCT02980341|365249775|FG006|Dose Expansion|Clinical progression|0|||
105889310|NCT02980341|365249776|FG007|Dose Expansion|Clinical progression|4|||
105889311|NCT02980341|365249777|FG008|Dose Expansion|Clinical progression|3|||
105889312|NCT02980341|365249778|FG009|Dose Expansion|Clinical progression|1|||
105889313|NCT02980341|365249779|FG010|Dose Expansion|Clinical progression|4|||
105889314|NCT02980341|365249769|FG000|Dose Expansion|Adverse Event|0|||
105889315|NCT02980341|365249770|FG001|Dose Expansion|Adverse Event|0|||
105889316|NCT02980341|365249771|FG002|Dose Expansion|Adverse Event|0|||
105889317|NCT02980341|365249772|FG003|Dose Expansion|Adverse Event|0|||
105889318|NCT02980341|365249773|FG004|Dose Expansion|Adverse Event|0|||
105889319|NCT02980341|365249774|FG005|Dose Expansion|Adverse Event|0|||
105889320|NCT02980341|365249775|FG006|Dose Expansion|Adverse Event|0|||
105889321|NCT02980341|365249776|FG007|Dose Expansion|Adverse Event|3|||
105889322|NCT02980341|365249777|FG008|Dose Expansion|Adverse Event|0|||
105889323|NCT02980341|365249778|FG009|Dose Expansion|Adverse Event|1|||
105889324|NCT02980341|365249779|FG010|Dose Expansion|Adverse Event|3|||
105889325|NCT02980341|365249769|FG000|Dose Expansion|Death|0|||
105889326|NCT02980341|365249770|FG001|Dose Expansion|Death|0|||
105889327|NCT02980341|365249771|FG002|Dose Expansion|Death|0|||
105889328|NCT02980341|365249772|FG003|Dose Expansion|Death|0|||
105889329|NCT02980341|365249773|FG004|Dose Expansion|Death|0|||
105889330|NCT02980341|365249774|FG005|Dose Expansion|Death|0|||
105889331|NCT02980341|365249775|FG006|Dose Expansion|Death|0|||
105889332|NCT02980341|365249776|FG007|Dose Expansion|Death|0|||
105889333|NCT02980341|365249777|FG008|Dose Expansion|Death|2|||
105889334|NCT02980341|365249778|FG009|Dose Expansion|Death|1|||
105889335|NCT02980341|365249779|FG010|Dose Expansion|Death|0|||
105889336|NCT02980341|365249769|FG000|Dose Expansion|Withdrawal by Subject|0|||
105889337|NCT02980341|365249770|FG001|Dose Expansion|Withdrawal by Subject|0|||
105889338|NCT02980341|365249771|FG002|Dose Expansion|Withdrawal by Subject|0|||
105889339|NCT02980341|365249772|FG003|Dose Expansion|Withdrawal by Subject|0|||
105664537|NCT01732549|364436662|FG001|Overall Study|Adverse Event|3|||
105889340|NCT02980341|365249773|FG004|Dose Expansion|Withdrawal by Subject|0|||
105664538|NCT01732549|364436661|FG000|Overall Study|Consent withdrawn|13|||
105889341|NCT02980341|365249774|FG005|Dose Expansion|Withdrawal by Subject|0|||
105889342|NCT02980341|365249775|FG006|Dose Expansion|Withdrawal by Subject|0|||
105889343|NCT02980341|365249776|FG007|Dose Expansion|Withdrawal by Subject|2|||
105889344|NCT02980341|365249777|FG008|Dose Expansion|Withdrawal by Subject|0|||
105889345|NCT02980341|365249778|FG009|Dose Expansion|Withdrawal by Subject|1|||
105889346|NCT02980341|365249779|FG010|Dose Expansion|Withdrawal by Subject|0|||
105889347|NCT02980341|365249769|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889348|NCT02980341|365249770|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889349|NCT02980341|365249771|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889350|NCT02980341|365249772|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889351|NCT02980341|365249773|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889352|NCT02980341|365249774|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889353|NCT02980341|365249775|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889354|NCT02980341|365249776|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
105889355|NCT02980341|365249777|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889356|NCT02980341|365249778|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889357|NCT02980341|365249779|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
105889358|NCT02980341|365249769|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889359|NCT02980341|365249770|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889360|NCT02980341|365249771|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889361|NCT02980341|365249772|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889362|NCT02980341|365249773|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889363|NCT02980341|365249774|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889364|NCT02980341|365249775|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889365|NCT02980341|365249776|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889366|NCT02980341|365249777|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
105889367|NCT02980341|365249778|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889368|NCT02980341|365249779|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
105889369|NCT02980341|365249769|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889370|NCT02980341|365249770|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889371|NCT02980341|365249771|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889372|NCT02980341|365249772|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889373|NCT02980341|365249773|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889374|NCT02980341|365249774|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889375|NCT02980341|365249775|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889376|NCT02980341|365249776|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889377|NCT02980341|365249777|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
105889378|NCT02980341|365249778|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889379|NCT02980341|365249779|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
105889380|NCT02980341|365249769|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889381|NCT02980341|365249770|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889382|NCT02980341|365249771|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889383|NCT02980341|365249772|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889384|NCT02980341|365249773|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889385|NCT02980341|365249774|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889386|NCT02980341|365249775|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889387|NCT02980341|365249776|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889388|NCT02980341|365249777|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889389|NCT02980341|365249778|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
105889390|NCT02980341|365249779|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
105889391|NCT03505593|365249780|FG000|Overall Study|Withdrawal by Subject|1|||
105889392|NCT03505593|365249780|FG000|Overall Study|Died before procedure|1|||
105889393|NCT03505593|365249780|FG000|Overall Study|Anatomical abnormality|1|||
105889394|NCT03505593|365249780|FG000|Overall Study|Unable to pass through esophagus|1|||
105889395|NCT03505593|365249780|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
105889396|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Adverse Event|6|||
105889397|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Adverse Event|14|||
105889398|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Death|3|||
105889399|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Death|1|||
105889400|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
105889401|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
105664539|NCT01732549|364436662|FG001|Overall Study|Consent withdrawn|6|||
105664540|NCT01732549|364436661|FG000|Overall Study|Disease progression|37|||
105889402|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
105889403|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
105889404|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
105889405|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
105889406|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
105889407|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
105889408|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
105889409|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
105889410|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Physician Decision|2|||
105889411|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Physician Decision|4|||
105889412|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Pregnancy|2|||
105889413|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Pregnancy|1|||
105889414|NCT02275780|365249781|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
105889415|NCT02275780|365249782|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
105889416|NCT02275780|365249781|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
105889417|NCT02275780|365249782|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
105889418|NCT02275780|365249781|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
105889419|NCT02275780|365249782|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
105889420|NCT02275780|365249781|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
105889421|NCT02275780|365249782|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
105889422|NCT02275780|365249781|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
105889423|NCT02275780|365249782|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
105889424|NCT02275780|365249781|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
105889425|NCT02275780|365249782|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
105889426|NCT02275780|365249781|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
105889427|NCT02275780|365249782|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
105889428|NCT02275780|365249781|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
105889429|NCT02275780|365249782|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
105889430|NCT02275780|365249781|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
105889431|NCT02275780|365249782|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
105889432|NCT02275780|365249781|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
105889433|NCT02275780|365249782|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
105889434|NCT02275780|365249781|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
105889435|NCT02275780|365249782|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
105889436|NCT02275780|365249781|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
105889437|NCT02275780|365249782|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
105889438|NCT02275780|365249781|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
105889439|NCT02275780|365249782|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
105889440|NCT02275780|365249781|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
105889441|NCT02275780|365249782|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
105889442|NCT02275780|365249781|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
105889443|NCT02275780|365249782|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
105889444|NCT02275780|365249781|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
105889445|NCT02275780|365249782|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
105889446|NCT02275780|365249781|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
105889447|NCT02275780|365249782|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
105889448|NCT02275780|365249781|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
105889449|NCT02275780|365249782|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
105889450|NCT02275780|365249781|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
105889451|NCT02275780|365249782|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
105889452|NCT02275780|365249781|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
105889453|NCT02275780|365249782|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
105889454|NCT02275780|365249781|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
105889455|NCT02275780|365249782|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
105996372|NCT03030417|365647038|FG005|Dose Expansion|Disease progression before treatment|0|||
105996373|NCT03030417|365647039|FG006|Dose Expansion|Disease progression before treatment|0|||
105996374|NCT03030417|365647040|FG007|Dose Expansion|Disease progression before treatment|0|||
105996375|NCT03030417|365647041|FG008|Dose Expansion|Disease progression before treatment|0|||
105996376|NCT03030417|365647042|FG009|Dose Expansion|Disease progression before treatment|0|||
105996377|NCT03030417|365647043|FG010|Dose Expansion|Disease progression before treatment|0|||
105996378|NCT03030417|365647044|FG011|Dose Expansion|Disease progression before treatment|0|||
105996379|NCT03030417|365647045|FG012|Dose Expansion|Disease progression before treatment|1|||
105996380|NCT02491983|365647046|FG000|Overall Study|Physician Decision|1|||
105996381|NCT02491983|365647047|FG001|Overall Study|Physician Decision|0|||
106121474|NCT02611830|366101887|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
105889456|NCT02275780|365249781|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
105889457|NCT02275780|365249782|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
105889458|NCT01899742|365249789|FG000|Overall Study|Adverse Event|5|||
105889459|NCT01899742|365249790|FG001|Overall Study|Adverse Event|4|||
105889460|NCT01899742|365249789|FG000|Overall Study|Lack of Efficacy|1|||
105889461|NCT01899742|365249790|FG001|Overall Study|Lack of Efficacy|5|||
105889462|NCT01899742|365249789|FG000|Overall Study|Protocol Violation|2|||
105889463|NCT01899742|365249790|FG001|Overall Study|Protocol Violation|2|||
105889464|NCT01899742|365249789|FG000|Overall Study|Withdrawal by Subject|9|||
105889465|NCT01899742|365249790|FG001|Overall Study|Withdrawal by Subject|5|||
105889466|NCT01044290|365249791|FG000|Follow-up 1|Death|3|||
106121475|NCT02611830|366101888|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
106121476|NCT02611830|366101889|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
106121477|NCT02611830|366101886|FG000|Maintenance Phase|Lost to Follow-up|0|||
106121478|NCT02611830|366101887|FG001|Maintenance Phase|Lost to Follow-up|0|||
105889467|NCT01044290|365249792|FG001|Follow-up 1|Death|3|||
105889468|NCT01044290|365249793|FG002|Follow-up 1|Death|1|||
105889469|NCT01044290|365249791|FG000|Follow-up 1|Withdrawal by Subject|2|||
105889470|NCT01044290|365249792|FG001|Follow-up 1|Withdrawal by Subject|2|||
105889471|NCT01044290|365249793|FG002|Follow-up 1|Withdrawal by Subject|0|||
105889472|NCT01044290|365249791|FG000|Follow-Up 2|Death|0|||
105889473|NCT01044290|365249792|FG001|Follow-Up 2|Death|1|||
105889474|NCT01044290|365249793|FG002|Follow-Up 2|Death|1|||
105889475|NCT01044290|365249791|FG000|Follow-Up 2|Withdrawal by Subject|0|||
105889476|NCT01044290|365249792|FG001|Follow-Up 2|Withdrawal by Subject|1|||
105889477|NCT01044290|365249793|FG002|Follow-Up 2|Withdrawal by Subject|1|||
105889478|NCT00348790|365249794|FG000|Completed Treatment|Withdrawal by Subject|4|||
105889479|NCT00348790|365249794|FG000|Completed Treatment|Disease progression|14|||
105889480|NCT00348790|365249794|FG000|Completed Treatment|Adverse Event|4|||
105889481|NCT00348790|365249794|FG000|Completed Treatment|Required surgery|2|||
105889482|NCT00348790|365249794|FG000|Completed Treatment|Unable to travel to study site|1|||
105889483|NCT04323306|365249795|FG000|Overall Study|Physician Decision|1|||
105889484|NCT04323306|365249796|FG001|Overall Study|Physician Decision|0|||
105889485|NCT04323306|365249797|FG002|Overall Study|Physician Decision|0|||
105889486|NCT04323306|365249798|FG003|Overall Study|Physician Decision|0|||
105889487|NCT04323306|365249799|FG004|Overall Study|Physician Decision|0|||
105889488|NCT04323306|365249800|FG005|Overall Study|Physician Decision|0|||
105889489|NCT04323306|365249801|FG006|Overall Study|Physician Decision|0|||
105889490|NCT04323306|365249802|FG007|Overall Study|Physician Decision|0|||
105889491|NCT04323306|365249803|FG008|Overall Study|Physician Decision|0|||
105889492|NCT04323306|365249795|FG000|Overall Study|Withdrawal by Subject|0|||
105889493|NCT04323306|365249796|FG001|Overall Study|Withdrawal by Subject|0|||
105889494|NCT04323306|365249797|FG002|Overall Study|Withdrawal by Subject|0|||
105889495|NCT04323306|365249798|FG003|Overall Study|Withdrawal by Subject|0|||
105889496|NCT04323306|365249799|FG004|Overall Study|Withdrawal by Subject|0|||
105889497|NCT04323306|365249800|FG005|Overall Study|Withdrawal by Subject|1|||
105889498|NCT04323306|365249801|FG006|Overall Study|Withdrawal by Subject|3|||
105889499|NCT04323306|365249802|FG007|Overall Study|Withdrawal by Subject|0|||
105889500|NCT04323306|365249803|FG008|Overall Study|Withdrawal by Subject|1|||
105889501|NCT01282164|365249804|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
105889502|NCT01282164|365249805|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
105889503|NCT00834639|365249806|FG000|Second Intervention|Physician Decision|0|||
105889504|NCT00834639|365249807|FG001|Second Intervention|Physician Decision|2|||
105889505|NCT01867294|365249808|FG000|Overall Study|Withdrawal by Subject|1|||
105889506|NCT01867294|365249809|FG001|Overall Study|Withdrawal by Subject|1|||
105889507|NCT01867294|365249810|FG002|Overall Study|Withdrawal by Subject|0|||
105889508|NCT01867294|365249811|FG003|Overall Study|Withdrawal by Subject|0|||
105889509|NCT02658734|365249812|FG000|Overall Study|Adverse Event|2|||
105889510|NCT02658734|365249812|FG000|Overall Study|Death|4|||
105889511|NCT02658734|365249812|FG000|Overall Study|Lost to Follow-up|7|||
105889512|NCT02658734|365249812|FG000|Overall Study|Withdrawal of Consent|16|||
105889513|NCT02658734|365249812|FG000|Overall Study|Disease Progression|28|||
105889514|NCT01322035|365249813|FG000|Overall Study|Lost to Follow-up|8|||
106121479|NCT02611830|366101888|FG002|Maintenance Phase|Lost to Follow-up|0|||
106121480|NCT02611830|366101889|FG003|Maintenance Phase|Lost to Follow-up|1|||
106121481|NCT02611830|366101886|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
106121482|NCT02611830|366101887|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
105889515|NCT01322035|365249814|FG001|Overall Study|Lost to Follow-up|3|||
105889516|NCT00535847|365249815|FG000|Overall Study|Adverse Event|5|||
105889517|NCT00535847|365249816|FG001|Overall Study|Adverse Event|3|||
105889518|NCT00535847|365249817|FG002|Overall Study|Adverse Event|2|||
105889519|NCT00535847|365249815|FG000|Overall Study|Non compliance|1|||
106121483|NCT02611830|366101888|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
105889520|NCT00535847|365249816|FG001|Overall Study|Non compliance|1|||
105889521|NCT00535847|365249817|FG002|Overall Study|Non compliance|0|||
105889522|NCT00535847|365249815|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
105889523|NCT00535847|365249816|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
105889524|NCT00535847|365249817|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
105889525|NCT04569968|365249818|FG000|Overall Study|Lost to Follow-up|2|||
105889526|NCT04569968|365249819|FG001|Overall Study|Lost to Follow-up|5|||
105889527|NCT04569968|365249818|FG000|Overall Study|Story of head and/or neck surgery|2|||
105889528|NCT04569968|365249819|FG001|Overall Study|Story of head and/or neck surgery|2|||
105889529|NCT04569968|365249818|FG000|Overall Study|Time of stroke onset|8|||
105889530|NCT04569968|365249819|FG001|Overall Study|Time of stroke onset|7|||
105996382|NCT02491983|365647046|FG000|Overall Study|Not meet selection criteria|1|||
105996383|NCT02491983|365647047|FG001|Overall Study|Not meet selection criteria|0|||
105996384|NCT02491983|365647046|FG000|Overall Study|Withdrawal by Subject|0|||
105996385|NCT02491983|365647047|FG001|Overall Study|Withdrawal by Subject|1|||
105996386|NCT04961541|365647048|FG000|Overall Study|Adverse Event|0|||
105996387|NCT04961541|365647049|FG001|Overall Study|Adverse Event|0|||
105996388|NCT04961541|365647050|FG002|Overall Study|Adverse Event|0|||
105996389|NCT04961541|365647051|FG003|Overall Study|Adverse Event|0|||
105996390|NCT04961541|365647052|FG004|Overall Study|Adverse Event|0|||
105996391|NCT04961541|365647053|FG005|Overall Study|Adverse Event|1|||
105996392|NCT04961541|365647054|FG006|Overall Study|Adverse Event|0|||
105996393|NCT04961541|365647055|FG007|Overall Study|Adverse Event|0|||
105996394|NCT04961541|365647056|FG008|Overall Study|Adverse Event|0|||
105996395|NCT04961541|365647057|FG009|Overall Study|Adverse Event|0|||
105996396|NCT04961541|365647058|FG010|Overall Study|Adverse Event|0|||
105996397|NCT04961541|365647059|FG011|Overall Study|Adverse Event|0|||
105996398|NCT04961541|365647060|FG012|Overall Study|Adverse Event|0|||
105996399|NCT04961541|365647061|FG013|Overall Study|Adverse Event|0|||
105996400|NCT04961541|365647048|FG000|Overall Study|Lost to Follow-up|0|||
105996401|NCT04961541|365647049|FG001|Overall Study|Lost to Follow-up|0|||
105996402|NCT04961541|365647050|FG002|Overall Study|Lost to Follow-up|3|||
105996403|NCT04961541|365647051|FG003|Overall Study|Lost to Follow-up|0|||
105996404|NCT04961541|365647052|FG004|Overall Study|Lost to Follow-up|0|||
106121484|NCT02611830|366101889|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
105889531|NCT04569968|365249818|FG000|Overall Study|Type of strokr|12|||
105889532|NCT04569968|365249819|FG001|Overall Study|Type of strokr|8|||
105889533|NCT04569968|365249818|FG000|Overall Study|Cooperation|8|||
105889534|NCT04569968|365249819|FG001|Overall Study|Cooperation|8|||
105996405|NCT04961541|365647053|FG005|Overall Study|Lost to Follow-up|0|||
105996406|NCT04961541|365647054|FG006|Overall Study|Lost to Follow-up|1|||
105996407|NCT04961541|365647055|FG007|Overall Study|Lost to Follow-up|1|||
105996408|NCT04961541|365647056|FG008|Overall Study|Lost to Follow-up|0|||
106121485|NCT02611830|366101886|FG000|Maintenance Phase|Pregnancy|0|||
106121486|NCT02611830|366101887|FG001|Maintenance Phase|Pregnancy|0|||
106121487|NCT02611830|366101888|FG002|Maintenance Phase|Pregnancy|1|||
106121488|NCT02611830|366101889|FG003|Maintenance Phase|Pregnancy|0|||
106121489|NCT02611830|366101886|FG000|Maintenance Phase|Reason not specified|0|||
106121490|NCT02611830|366101887|FG001|Maintenance Phase|Reason not specified|1|||
106121491|NCT02611830|366101888|FG002|Maintenance Phase|Reason not specified|4|||
106121492|NCT02611830|366101889|FG003|Maintenance Phase|Reason not specified|0|||
106121493|NCT00903786|366101894|FG000|Overall Study|Physician Decision|6|||
106121494|NCT00903786|366101894|FG000|Overall Study|Lack of Efficacy|5|||
106121495|NCT00903786|366101894|FG000|Overall Study|Reason other than lack of efficacy|4|||
106121496|NCT02180438|366101895|FG000|Overall Study|Lost to Follow-up|1|||
105785652|NCT01238861|364868540|FG003|Overall Study|Incorrect enrollment/randomization|0|||
105785653|NCT01238861|364868541|FG004|Overall Study|Incorrect enrollment/randomization|1|||
105785654|NCT01238861|364868542|FG005|Overall Study|Incorrect enrollment/randomization|0|||
105785655|NCT01238861|364868537|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785656|NCT01238861|364868538|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785657|NCT01238861|364868539|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
105785658|NCT01238861|364868540|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785659|NCT01238861|364868541|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785660|NCT01238861|364868542|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
105785661|NCT01238861|364868537|FG000|Overall Study|Subject moved out of state/area|0|||
105785662|NCT01238861|364868538|FG001|Overall Study|Subject moved out of state/area|0|||
105785663|NCT01238861|364868539|FG002|Overall Study|Subject moved out of state/area|1|||
105785664|NCT01238861|364868540|FG003|Overall Study|Subject moved out of state/area|1|||
105785665|NCT01238861|364868541|FG004|Overall Study|Subject moved out of state/area|0|||
105785666|NCT01238861|364868542|FG005|Overall Study|Subject moved out of state/area|0|||
105785667|NCT01238861|364868537|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785668|NCT01238861|364868538|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785669|NCT01238861|364868539|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785670|NCT01238861|364868540|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
105785671|NCT01238861|364868541|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785672|NCT01238861|364868542|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
105785673|NCT01238861|364868537|FG000|Overall Study|Personal problems|0|||
105785674|NCT01238861|364868538|FG001|Overall Study|Personal problems|0|||
105785675|NCT01238861|364868539|FG002|Overall Study|Personal problems|0|||
105785676|NCT01238861|364868540|FG003|Overall Study|Personal problems|1|||
105664541|NCT01732549|364436662|FG001|Overall Study|Disease progression|50|||
105664542|NCT01732549|364436661|FG000|Overall Study|Other|8|||
105664543|NCT01732549|364436662|FG001|Overall Study|Other|14|||
105664544|NCT05186311|364436663|FG000|Part A: Serum|Withdrawal by Subject|1|||
105664545|NCT01850589|364436664|FG000|Overall Study|Withdrawal by Subject|8|||
105664546|NCT01850589|364436665|FG001|Overall Study|Withdrawal by Subject|0|||
105664547|NCT01592045|364436666|FG000|Overall Study|Disease Progression|1|||
105664548|NCT01592045|364436667|FG001|Overall Study|Disease Progression|1|||
105664549|NCT01592045|364436666|FG000|Overall Study|Adverse Event|1|||
105664550|NCT01592045|364436667|FG001|Overall Study|Adverse Event|1|||
105664551|NCT01592045|364436666|FG000|Overall Study|Withdrawal by Subject|1|||
105664552|NCT01592045|364436667|FG001|Overall Study|Withdrawal by Subject|0|||
105664553|NCT01592045|364436666|FG000|Overall Study|Moved out of country|2|||
105664554|NCT01592045|364436667|FG001|Overall Study|Moved out of country|0|||
105889535|NCT04569968|365249818|FG000|Overall Study|Age interval|17|||
105889536|NCT04569968|365249819|FG001|Overall Study|Age interval|6|||
105889537|NCT04569968|365249818|FG000|Overall Study|Denial of participation to the study|0|||
105889538|NCT04569968|365249819|FG001|Overall Study|Denial of participation to the study|3|||
105889539|NCT04569968|365249818|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
105889540|NCT04569968|365249819|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
105889541|NCT04569968|365249818|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
105889542|NCT04569968|365249819|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
105889543|NCT04569968|365249818|FG000|Overall Study|Quarantine|1|||
105889544|NCT04569968|365249819|FG001|Overall Study|Quarantine|0|||
105889545|NCT04569968|365249818|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
105889546|NCT04569968|365249819|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
105889547|NCT04569968|365249818|FG000|Overall Study|Repetitive stroke|8|||
105889548|NCT04569968|365249819|FG001|Overall Study|Repetitive stroke|0|||
105889549|NCT04569968|365249818|FG000|Overall Study|Insufficient mastication|1|||
105889550|NCT04569968|365249819|FG001|Overall Study|Insufficient mastication|0|||
105889551|NCT04569968|365249818|FG000|Overall Study|Infection|1|||
105889552|NCT04569968|365249819|FG001|Overall Study|Infection|0|||
105889553|NCT00732758|365249820|FG000|Overall Study|Lost to Follow-up|8|||
105889554|NCT00732758|365249821|FG001|Overall Study|Lost to Follow-up|16|||
105889555|NCT05007041|365249822|FG000|Overall Study|Missing Diary Entries|0|||
105889556|NCT05007041|365249823|FG001|Overall Study|Missing Diary Entries|1|||
105889557|NCT01552915|365249824|FG000|Overall Study|Adverse Event|3|||
105889558|NCT01552915|365249825|FG001|Overall Study|Adverse Event|14|||
105889559|NCT01552915|365249826|FG002|Overall Study|Adverse Event|3|||
105889560|NCT01552915|365249824|FG000|Overall Study|Lost to Follow-up|4|||
105889561|NCT01552915|365249825|FG001|Overall Study|Lost to Follow-up|6|||
105889562|NCT01552915|365249826|FG002|Overall Study|Lost to Follow-up|5|||
105889563|NCT01552915|365249824|FG000|Overall Study|Withdrawal by Subject|6|||
105889564|NCT01552915|365249825|FG001|Overall Study|Withdrawal by Subject|4|||
105889565|NCT01552915|365249826|FG002|Overall Study|Withdrawal by Subject|5|||
105889566|NCT01552915|365249824|FG000|Overall Study|Protocol Violation|0|||
105889567|NCT01552915|365249825|FG001|Overall Study|Protocol Violation|4|||
105889568|NCT01552915|365249826|FG002|Overall Study|Protocol Violation|4|||
105889569|NCT01552915|365249824|FG000|Overall Study|Lack of Efficacy|8|||
105889570|NCT01552915|365249825|FG001|Overall Study|Lack of Efficacy|1|||
105889571|NCT01552915|365249826|FG002|Overall Study|Lack of Efficacy|4|||
105889572|NCT01552915|365249824|FG000|Overall Study|Other|2|||
105889573|NCT01552915|365249825|FG001|Overall Study|Other|0|||
105889574|NCT01552915|365249826|FG002|Overall Study|Other|6|||
105889575|NCT01252563|365249828|FG000|Overall Study|Contract Deviation|41|||
105889576|NCT01252563|365249828|FG000|Overall Study|Centralized Registration Deviation|30|||
105889577|NCT01252563|365249828|FG000|Overall Study|Lost to Follow-up|161|||
105889578|NCT01252563|365249828|FG000|Overall Study|No visit after first day of treatment|194|||
105889579|NCT01252563|365249828|FG000|Overall Study|No drug administration|6|||
105889580|NCT00750139|365249840|FG000|Overall Study|Adverse Event|1|||
105889581|NCT00750139|365249841|FG001|Overall Study|Adverse Event|2|||
105889582|NCT00750139|365249842|FG002|Overall Study|Adverse Event|0|||
105889583|NCT00750139|365249843|FG003|Overall Study|Adverse Event|1|||
105889584|NCT00750139|365249840|FG000|Overall Study|Lost to Follow-up|17|||
105889585|NCT00750139|365249841|FG001|Overall Study|Lost to Follow-up|12|||
105889586|NCT00750139|365249842|FG002|Overall Study|Lost to Follow-up|15|||
105889587|NCT00750139|365249843|FG003|Overall Study|Lost to Follow-up|6|||
106121497|NCT02058290|366101896|FG000|Overall Study|Protocol Violation|2|||
105664555|NCT02417441|364436668|FG000|Overall Study|Inconclusive due to missing data|52|||
105889588|NCT00750139|365249840|FG000|Overall Study|Withdrawal by Subject|3|||
105889589|NCT00750139|365249841|FG001|Overall Study|Withdrawal by Subject|2|||
105889590|NCT00750139|365249842|FG002|Overall Study|Withdrawal by Subject|6|||
105889591|NCT00750139|365249843|FG003|Overall Study|Withdrawal by Subject|2|||
105889592|NCT00750139|365249840|FG000|Overall Study|Physician Decision|1|||
105889593|NCT00750139|365249841|FG001|Overall Study|Physician Decision|1|||
105889594|NCT00750139|365249842|FG002|Overall Study|Physician Decision|0|||
105664556|NCT02417441|364436669|FG001|Overall Study|Inconclusive due to missing data|19|||
105889595|NCT00750139|365249843|FG003|Overall Study|Physician Decision|0|||
105664557|NCT00983853|364436672|FG000|Overall Study|Lost to Follow-up|1|||
105664558|NCT00983853|364436673|FG001|Overall Study|Lost to Follow-up|1|||
105664559|NCT00983853|364436674|FG002|Overall Study|Lost to Follow-up|2|||
105664560|NCT00983853|364436675|FG003|Overall Study|Lost to Follow-up|2|||
105664561|NCT00983853|364436676|FG004|Overall Study|Lost to Follow-up|2|||
105664562|NCT00983853|364436677|FG005|Overall Study|Lost to Follow-up|1|||
105664563|NCT00983853|364436672|FG000|Overall Study|Withdrawal by Subject|0|||
105664564|NCT00983853|364436673|FG001|Overall Study|Withdrawal by Subject|0|||
105664565|NCT00983853|364436674|FG002|Overall Study|Withdrawal by Subject|1|||
105664566|NCT00983853|364436675|FG003|Overall Study|Withdrawal by Subject|0|||
105664567|NCT00983853|364436676|FG004|Overall Study|Withdrawal by Subject|1|||
105664568|NCT00983853|364436677|FG005|Overall Study|Withdrawal by Subject|0|||
105664569|NCT00983853|364436672|FG000|Overall Study|Unable to come to study follow-up visits|0|||
105664570|NCT00983853|364436673|FG001|Overall Study|Unable to come to study follow-up visits|1|||
105664571|NCT00983853|364436674|FG002|Overall Study|Unable to come to study follow-up visits|0|||
105889596|NCT00750139|365249840|FG000|Overall Study|Non-compliance|1|||
105889597|NCT00750139|365249841|FG001|Overall Study|Non-compliance|0|||
105889598|NCT00750139|365249842|FG002|Overall Study|Non-compliance|1|||
105889599|NCT00750139|365249843|FG003|Overall Study|Non-compliance|3|||
105889600|NCT00750139|365249840|FG000|Overall Study|Termination by sponsor|4|||
105889601|NCT00750139|365249841|FG001|Overall Study|Termination by sponsor|0|||
105889602|NCT00750139|365249842|FG002|Overall Study|Termination by sponsor|0|||
105889603|NCT00750139|365249843|FG003|Overall Study|Termination by sponsor|1|||
105889604|NCT00750139|365249840|FG000|Overall Study|Non-specific|62|||
105889605|NCT00750139|365249841|FG001|Overall Study|Non-specific|42|||
105889606|NCT00750139|365249842|FG002|Overall Study|Non-specific|79|||
105889607|NCT00750139|365249843|FG003|Overall Study|Non-specific|33|||
105889608|NCT02253316|365249844|FG000|Consolidation|Progression|4|||
105889609|NCT02253316|365249845|FG001|Consolidation|Progression|0|||
105889610|NCT02253316|365249846|FG002|Consolidation|Progression|0|||
105889611|NCT02253316|365249844|FG000|Consolidation|Non-Compliance|1|||
105889612|NCT02253316|365249845|FG001|Consolidation|Non-Compliance|0|||
105889613|NCT02253316|365249846|FG002|Consolidation|Non-Compliance|0|||
105889614|NCT02253316|365249844|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
105889615|NCT02253316|365249845|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
105889616|NCT02253316|365249846|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
105889617|NCT02253316|365249844|FG000|Consolidation|Secondary Malignancy|2|||
105889618|NCT02253316|365249845|FG001|Consolidation|Secondary Malignancy|0|||
105889619|NCT02253316|365249846|FG002|Consolidation|Secondary Malignancy|0|||
105889620|NCT02253316|365249844|FG000|Consolidation|Adverse Event|7|||
105889621|NCT02253316|365249845|FG001|Consolidation|Adverse Event|0|||
105889622|NCT02253316|365249846|FG002|Consolidation|Adverse Event|0|||
105889623|NCT02253316|365249844|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
105889624|NCT02253316|365249845|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
105889625|NCT02253316|365249846|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
105889626|NCT02253316|365249844|FG000|Maintenance|Physician Decision|0|||
105889627|NCT02253316|365249845|FG001|Maintenance|Physician Decision|7|||
105889628|NCT02253316|365249846|FG002|Maintenance|Physician Decision|16|||
105889629|NCT02253316|365249844|FG000|Maintenance|Non-Compliance|0|||
105889630|NCT02253316|365249845|FG001|Maintenance|Non-Compliance|1|||
105889631|NCT02253316|365249846|FG002|Maintenance|Non-Compliance|1|||
105889632|NCT02253316|365249844|FG000|Maintenance|Secondary Malignancy|0|||
105889633|NCT02253316|365249845|FG001|Maintenance|Secondary Malignancy|2|||
105889634|NCT02253316|365249846|FG002|Maintenance|Secondary Malignancy|6|||
105889635|NCT02253316|365249844|FG000|Maintenance|Adverse Event|0|||
105664572|NCT00983853|364436675|FG003|Overall Study|Unable to come to study follow-up visits|0|||
105664573|NCT00983853|364436676|FG004|Overall Study|Unable to come to study follow-up visits|0|||
105889636|NCT02253316|365249845|FG001|Maintenance|Adverse Event|8|||
105889637|NCT02253316|365249846|FG002|Maintenance|Adverse Event|12|||
105889638|NCT02253316|365249844|FG000|Maintenance|Still receiving active treatment|0|||
105889639|NCT02253316|365249845|FG001|Maintenance|Still receiving active treatment|5|||
105889640|NCT02253316|365249846|FG002|Maintenance|Still receiving active treatment|0|||
105889641|NCT05036668|365249849|FG000|Overall Study|lost to follow Up|0|||
105889642|NCT05036668|365249850|FG001|Overall Study|lost to follow Up|0|||
105889643|NCT05036668|365249851|FG002|Overall Study|lost to follow Up|1|||
105889644|NCT00387010|365249852|FG000|Dose Titration Period|Adverse Event|12|||
105664574|NCT00983853|364436677|FG005|Overall Study|Unable to come to study follow-up visits|0|||
105664575|NCT02159040|364436685|FG000|Overall Study|Death|1|||
105664576|NCT02472145|364436686|FG000|Overall Study|Death|10|||
105664577|NCT02472145|364436687|FG001|Overall Study|Death|101|||
105664578|NCT02472145|364436688|FG002|Overall Study|Death|99|||
105664579|NCT02472145|364436686|FG000|Overall Study|Lost to Follow-up|0|||
105664580|NCT02472145|364436687|FG001|Overall Study|Lost to Follow-up|1|||
105889645|NCT00387010|365249852|FG000|Dose Titration Period|Lack of Efficacy|5|||
105889646|NCT00387010|365249852|FG000|Dose Titration Period|Withdrawal by Subject|3|||
105889647|NCT00387010|365249852|FG000|Dose Titration Period|Protocol Violation|1|||
105889648|NCT00387010|365249852|FG000|Dose Titration Period|Lost to Follow-up|2|||
105889649|NCT00387010|365249852|FG000|Dose Titration Period|Noncompliance with study medication|8|||
105889650|NCT00387010|365249852|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
105889651|NCT00387010|365249852|FG000|Treatment Period|Adverse Event|4|||
105889652|NCT00387010|365249852|FG000|Treatment Period|Withdrawal by Subject|1|||
105889653|NCT00387010|365249852|FG000|Treatment Period|Noncompliance with study medication|2|||
105889654|NCT00387010|365249852|FG000|Treatment Period|Noncompliance with study procedures|3|||
105889655|NCT00387010|365249852|FG000|Treatment Period|Participant reported study drug stolen|1|||
105889656|NCT00520481|365249853|FG000|Overall Study|Adverse Event|4|||
105889657|NCT00520481|365249854|FG001|Overall Study|Adverse Event|1|||
105889658|NCT00520481|365249853|FG000|Overall Study|Withdrawal by Subject|3|||
105889659|NCT00520481|365249854|FG001|Overall Study|Withdrawal by Subject|0|||
105889660|NCT01597375|365249859|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
105889661|NCT01597375|365249860|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
105889662|NCT01597375|365249859|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
105889663|NCT01597375|365249860|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
105889664|NCT01597375|365249859|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
105889665|NCT01597375|365249860|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
105889666|NCT01597375|365249859|FG000|Washout (2 Weeks)|Adverse Event|1|||
105889667|NCT01597375|365249860|FG001|Washout (2 Weeks)|Adverse Event|0|||
105889668|NCT01597375|365249859|FG000|Second Intervention|Failed to react at both Aspirin|1|||
105889669|NCT01597375|365249860|FG001|Second Intervention|Failed to react at both Aspirin|1|||
105889670|NCT01931956|365249866|FG000|Overall Study|Death|42|||
105889671|NCT01931956|365249867|FG001|Overall Study|Death|7|||
105889672|NCT01931956|365249868|FG002|Overall Study|Death|379|||
105889673|NCT01931956|365249869|FG003|Overall Study|Death|96|||
105889674|NCT01931956|365249866|FG000|Overall Study|Withdrawal by Subject|5|||
105889675|NCT01931956|365249867|FG001|Overall Study|Withdrawal by Subject|0|||
105889676|NCT01931956|365249868|FG002|Overall Study|Withdrawal by Subject|70|||
105889677|NCT01931956|365249869|FG003|Overall Study|Withdrawal by Subject|30|||
105889678|NCT01931956|365249866|FG000|Overall Study|Lost to Follow-up|2|||
105889679|NCT01931956|365249867|FG001|Overall Study|Lost to Follow-up|0|||
105889680|NCT01931956|365249868|FG002|Overall Study|Lost to Follow-up|11|||
105889681|NCT01931956|365249869|FG003|Overall Study|Lost to Follow-up|7|||
105889682|NCT01931956|365249866|FG000|Overall Study|Expected|2|||
105889683|NCT01931956|365249867|FG001|Overall Study|Expected|0|||
105889684|NCT01931956|365249868|FG002|Overall Study|Expected|6|||
105889685|NCT01931956|365249869|FG003|Overall Study|Expected|0|||
105889686|NCT01931956|365249866|FG000|Overall Study|Not due|0|||
105889687|NCT01931956|365249867|FG001|Overall Study|Not due|0|||
105889688|NCT01931956|365249868|FG002|Overall Study|Not due|21|||
105889689|NCT01931956|365249869|FG003|Overall Study|Not due|0|||
105889690|NCT01901653|365249874|FG000|Overall Study|Death|2|||
105889691|NCT01901653|365249875|FG001|Overall Study|Death|1|||
105889692|NCT01901653|365249876|FG002|Overall Study|Death|8|||
105889693|NCT01901653|365249877|FG003|Overall Study|Death|3|||
105889694|NCT01901653|365249878|FG004|Overall Study|Death|2|||
105889695|NCT01901653|365249879|FG005|Overall Study|Death|2|||
105889696|NCT01901653|365249880|FG006|Overall Study|Death|6|||
105889697|NCT01901653|365249881|FG007|Overall Study|Death|9|||
105889698|NCT01901653|365249882|FG008|Overall Study|Death|1|||
105889699|NCT01901653|365249883|FG009|Overall Study|Death|16|||
105889700|NCT01901653|365249884|FG010|Overall Study|Death|2|||
105889701|NCT01901653|365249885|FG011|Overall Study|Death|15|||
105889702|NCT01901653|365249886|FG012|Overall Study|Death|4|||
105889703|NCT01901653|365249874|FG000|Overall Study|Lost to Follow-up|1|||
105889704|NCT01901653|365249875|FG001|Overall Study|Lost to Follow-up|0|||
105996409|NCT04961541|365647057|FG009|Overall Study|Lost to Follow-up|1|||
105996410|NCT04961541|365647058|FG010|Overall Study|Lost to Follow-up|0|||
105996411|NCT04961541|365647059|FG011|Overall Study|Lost to Follow-up|0|||
105996412|NCT04961541|365647060|FG012|Overall Study|Lost to Follow-up|1|||
105889705|NCT01901653|365249876|FG002|Overall Study|Lost to Follow-up|2|||
105889706|NCT01901653|365249877|FG003|Overall Study|Lost to Follow-up|0|||
105889707|NCT01901653|365249878|FG004|Overall Study|Lost to Follow-up|0|||
105889708|NCT01901653|365249879|FG005|Overall Study|Lost to Follow-up|1|||
105889709|NCT01901653|365249880|FG006|Overall Study|Lost to Follow-up|0|||
105996413|NCT04961541|365647061|FG013|Overall Study|Lost to Follow-up|0|||
106121498|NCT02058290|366101897|FG001|Overall Study|Protocol Violation|1|||
106121499|NCT02058290|366101896|FG000|Overall Study|Physician Decision|1|||
106121500|NCT02058290|366101897|FG001|Overall Study|Physician Decision|0|||
105889710|NCT01901653|365249881|FG007|Overall Study|Lost to Follow-up|1|||
105889711|NCT01901653|365249882|FG008|Overall Study|Lost to Follow-up|0|||
105889712|NCT01901653|365249883|FG009|Overall Study|Lost to Follow-up|0|||
105889713|NCT01901653|365249884|FG010|Overall Study|Lost to Follow-up|0|||
105889714|NCT01901653|365249885|FG011|Overall Study|Lost to Follow-up|0|||
105889715|NCT01901653|365249886|FG012|Overall Study|Lost to Follow-up|0|||
105889716|NCT01901653|365249874|FG000|Overall Study|Withdrawal by Subject|0|||
105889717|NCT01901653|365249875|FG001|Overall Study|Withdrawal by Subject|0|||
105889718|NCT01901653|365249876|FG002|Overall Study|Withdrawal by Subject|0|||
105996414|NCT04961541|365647048|FG000|Overall Study|Withdrawal by Subject|0|||
106121501|NCT02058290|366101896|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
106121502|NCT02058290|366101897|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
106121503|NCT02058290|366101896|FG000|Overall Study|Withdrawal by Subject|0|||
106121504|NCT02058290|366101897|FG001|Overall Study|Withdrawal by Subject|1|||
106121505|NCT00195715|366101899|FG000|Overall Study|Adverse Event|122|||
106121506|NCT00195715|366101899|FG000|Overall Study|Withdrawal by Subject|58|||
106121507|NCT00195715|366101899|FG000|Overall Study|Lost to Follow-up|27|||
106121508|NCT00195715|366101899|FG000|Overall Study|Protocol Violation|13|||
106121509|NCT00195715|366101899|FG000|Overall Study|Lack of Efficacy|93|||
106121510|NCT00195715|366101899|FG000|Overall Study|Pregnancy|14|||
106121511|NCT00195715|366101899|FG000|Overall Study|Investigative site closure|8|||
106121512|NCT00195715|366101899|FG000|Overall Study|Subject moved/relocated|7|||
106121513|NCT00195715|366101899|FG000|Overall Study|Subject non-compliance|6|||
106121514|NCT00195715|366101899|FG000|Overall Study|Subject started commercial Humira|5|||
106121515|NCT00195715|366101899|FG000|Overall Study|Subject choice|3|||
106121516|NCT00195715|366101899|FG000|Overall Study|Loss of response/no improvement|3|||
106121517|NCT00195715|366101899|FG000|Overall Study|Sponsor stopped study|1|||
106121518|NCT00195715|366101899|FG000|Overall Study|Administrative reasons|2|||
106121519|NCT00195715|366101899|FG000|Overall Study|Investigator's decision|2|||
106121520|NCT00195715|366101899|FG000|Overall Study|Subject wants to get pregnant|4|||
106121521|NCT00195715|366101899|FG000|Overall Study|Use of prohibited medication|2|||
106121522|NCT00195715|366101899|FG000|Overall Study|Planned surgery|2|||
106121523|NCT00195715|366101899|FG000|Overall Study|Increased infection rate|1|||
106121524|NCT00195715|366101899|FG000|Overall Study|Ineligible|1|||
106121525|NCT00195715|366101899|FG000|Overall Study|Colonic stricture|1|||
106121526|NCT00195715|366101899|FG000|Overall Study|Sponsor discontinued trial|1|||
106121527|NCT00195715|366101899|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
106121528|NCT03012061|366101904|FG000|Overall Study|Withdrawal by Subject|1|||
106121529|NCT03012061|366101905|FG001|Overall Study|Withdrawal by Subject|5|||
106121530|NCT03012061|366101906|FG002|Overall Study|Withdrawal by Subject|4|||
106121531|NCT03012061|366101904|FG000|Overall Study|Investigator Site Closed|1|||
106121532|NCT03012061|366101905|FG001|Overall Study|Investigator Site Closed|2|||
106121533|NCT03012061|366101906|FG002|Overall Study|Investigator Site Closed|0|||
106121534|NCT03012061|366101904|FG000|Overall Study|Lost to Follow-up|2|||
106121535|NCT03012061|366101905|FG001|Overall Study|Lost to Follow-up|1|||
106121536|NCT03012061|366101906|FG002|Overall Study|Lost to Follow-up|0|||
106121537|NCT03012061|366101904|FG000|Overall Study|Study closed/ Terminated|0|||
106121538|NCT03012061|366101905|FG001|Overall Study|Study closed/ Terminated|0|||
106121539|NCT03012061|366101906|FG002|Overall Study|Study closed/ Terminated|1|||
106121540|NCT03012061|366101904|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
106121541|NCT03012061|366101905|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
106121542|NCT03012061|366101906|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
106121543|NCT03012061|366101904|FG000|Overall Study|Protocol Violation|0|||
106121544|NCT03012061|366101905|FG001|Overall Study|Protocol Violation|0|||
106121545|NCT03012061|366101906|FG002|Overall Study|Protocol Violation|2|||
106121546|NCT03012061|366101904|FG000|Overall Study|Lack of Efficacy|0|||
106121547|NCT03012061|366101905|FG001|Overall Study|Lack of Efficacy|1|||
106121548|NCT03012061|366101906|FG002|Overall Study|Lack of Efficacy|0|||
106121549|NCT03012061|366101904|FG000|Overall Study|Adverse Event|2|||
106121550|NCT03012061|366101905|FG001|Overall Study|Adverse Event|0|||
106121551|NCT03012061|366101906|FG002|Overall Study|Adverse Event|0|||
106121552|NCT02696902|366101907|FG000|Overall Study|Lost to Follow-up|0|||
106121553|NCT02696902|366101908|FG001|Overall Study|Lost to Follow-up|1|||
106121554|NCT02696902|366101909|FG002|Overall Study|Lost to Follow-up|1|||
106121555|NCT02696902|366101907|FG000|Overall Study|Withdrawal by Subject|0|||
106121556|NCT02696902|366101908|FG001|Overall Study|Withdrawal by Subject|0|||
106121557|NCT02696902|366101909|FG002|Overall Study|Withdrawal by Subject|1|||
106121558|NCT02696902|366101907|FG000|Overall Study|Death|19|||
106121559|NCT02696902|366101908|FG001|Overall Study|Death|3|||
105889719|NCT01901653|365249877|FG003|Overall Study|Withdrawal by Subject|0|||
105889720|NCT01901653|365249878|FG004|Overall Study|Withdrawal by Subject|0|||
105889721|NCT01901653|365249879|FG005|Overall Study|Withdrawal by Subject|0|||
105889722|NCT01901653|365249880|FG006|Overall Study|Withdrawal by Subject|1|||
105889723|NCT01901653|365249881|FG007|Overall Study|Withdrawal by Subject|0|||
105889724|NCT01901653|365249882|FG008|Overall Study|Withdrawal by Subject|0|||
105889725|NCT01901653|365249883|FG009|Overall Study|Withdrawal by Subject|0|||
105889726|NCT01901653|365249884|FG010|Overall Study|Withdrawal by Subject|0|||
105889727|NCT01901653|365249885|FG011|Overall Study|Withdrawal by Subject|0|||
105889728|NCT01901653|365249886|FG012|Overall Study|Withdrawal by Subject|0|||
105889729|NCT01901653|365249874|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
105889730|NCT01901653|365249875|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
105889731|NCT01901653|365249876|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
106121560|NCT02696902|366101909|FG002|Overall Study|Death|24|||
106121561|NCT02696902|366101907|FG000|Overall Study|Participant not fit post-randomization|0|||
106121562|NCT02696902|366101908|FG001|Overall Study|Participant not fit post-randomization|0|||
106121563|NCT02696902|366101909|FG002|Overall Study|Participant not fit post-randomization|1|||
105889732|NCT01901653|365249877|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
105889733|NCT01901653|365249878|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
105889734|NCT01901653|365249879|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
105889735|NCT01901653|365249880|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
105889736|NCT01901653|365249881|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
105889737|NCT01901653|365249882|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
105889738|NCT01901653|365249883|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
105889739|NCT01901653|365249884|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
105889740|NCT01901653|365249885|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
105889741|NCT01901653|365249886|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
105889742|NCT02548351|365249889|FG000|Overall Study|Withdrawal by Subject|149|||
105889743|NCT02548351|365249890|FG001|Overall Study|Withdrawal by Subject|154|||
105889744|NCT02548351|365249891|FG002|Overall Study|Withdrawal by Subject|152|||
105889745|NCT02548351|365249889|FG000|Overall Study|Death|11|||
105889746|NCT02548351|365249890|FG001|Overall Study|Death|15|||
105889747|NCT02548351|365249891|FG002|Overall Study|Death|12|||
105889748|NCT02548351|365249889|FG000|Overall Study|Adverse Event|22|||
105889749|NCT02548351|365249890|FG001|Overall Study|Adverse Event|56|||
105889750|NCT02548351|365249891|FG002|Overall Study|Adverse Event|36|||
105889751|NCT02548351|365249889|FG000|Overall Study|Study Terminated by Sponsor|549|||
105889752|NCT02548351|365249890|FG001|Overall Study|Study Terminated by Sponsor|509|||
105889753|NCT02548351|365249891|FG002|Overall Study|Study Terminated by Sponsor|528|||
105889754|NCT02548351|365249889|FG000|Overall Study|Site Closure|14|||
105889755|NCT02548351|365249890|FG001|Overall Study|Site Closure|5|||
105889756|NCT02548351|365249891|FG002|Overall Study|Site Closure|7|||
105889757|NCT02548351|365249889|FG000|Overall Study|Non-compliance with Study Drug|4|||
105889758|NCT02548351|365249890|FG001|Overall Study|Non-compliance with Study Drug|2|||
105889759|NCT02548351|365249891|FG002|Overall Study|Non-compliance with Study Drug|0|||
105889760|NCT02548351|365249889|FG000|Overall Study|Protocol Violation|2|||
105889761|NCT02548351|365249890|FG001|Overall Study|Protocol Violation|1|||
105889762|NCT02548351|365249891|FG002|Overall Study|Protocol Violation|2|||
105889763|NCT02548351|365249889|FG000|Overall Study|Physician Decision|11|||
105889764|NCT02548351|365249890|FG001|Overall Study|Physician Decision|18|||
105889765|NCT02548351|365249891|FG002|Overall Study|Physician Decision|11|||
105889766|NCT02548351|365249889|FG000|Overall Study|Lost to Follow-up|43|||
105889767|NCT02548351|365249890|FG001|Overall Study|Lost to Follow-up|50|||
105889768|NCT02548351|365249891|FG002|Overall Study|Lost to Follow-up|57|||
105889769|NCT02548351|365249889|FG000|Overall Study|Other|19|||
105889770|NCT02548351|365249890|FG001|Overall Study|Other|16|||
105889771|NCT02548351|365249891|FG002|Overall Study|Other|20|||
105889772|NCT02548351|365249889|FG000|Overall Study|Missing|1|||
105889773|NCT02548351|365249890|FG001|Overall Study|Missing|1|||
105889774|NCT02548351|365249891|FG002|Overall Study|Missing|0|||
105889775|NCT00325156|365249892|FG000|Overall Study|Protocol Violation|8|||
105889776|NCT00325156|365249892|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
105889777|NCT00325156|365249892|FG000|Overall Study|Migrated/moved from study area|12|||
105889778|NCT00325156|365249892|FG000|Overall Study|Adverse event, non-fatal|3|||
105889779|NCT00325156|365249892|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
105889780|NCT00325156|365249892|FG000|Overall Study|Other|1|||
105889781|NCT00325156|365249892|FG000|Overall Study|Withdrawal by Subject|31|||
105889782|NCT00519428|365249893|FG000|Overall Study|Adverse Event|5|||
105889783|NCT00519428|365249894|FG001|Overall Study|Adverse Event|2|||
105889784|NCT00519428|365249895|FG002|Overall Study|Adverse Event|10|||
105889785|NCT00519428|365249893|FG000|Overall Study|Lost to Follow-up|7|||
105889786|NCT00519428|365249894|FG001|Overall Study|Lost to Follow-up|7|||
105889787|NCT00519428|365249895|FG002|Overall Study|Lost to Follow-up|6|||
105889788|NCT00519428|365249893|FG000|Overall Study|Withdrawal by Subject|8|||
105889789|NCT00519428|365249894|FG001|Overall Study|Withdrawal by Subject|3|||
105889790|NCT00519428|365249895|FG002|Overall Study|Withdrawal by Subject|7|||
105889791|NCT00519428|365249893|FG000|Overall Study|unstated|1|||
105889792|NCT00519428|365249894|FG001|Overall Study|unstated|3|||
105889793|NCT00519428|365249895|FG002|Overall Study|unstated|2|||
105889794|NCT04064411|365249896|FG000|Overall Study|Adverse Event|29|||
105889795|NCT04064411|365249897|FG001|Overall Study|Adverse Event|19|||
105889796|NCT04064411|365249896|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
105889797|NCT04064411|365249897|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
105889798|NCT04064411|365249896|FG000|Overall Study|Protocol Deviation|0|||
105889799|NCT04064411|365249897|FG001|Overall Study|Protocol Deviation|2|||
105889800|NCT04064411|365249896|FG000|Overall Study|Withdrawal by Subject|25|||
105889801|NCT04064411|365249897|FG001|Overall Study|Withdrawal by Subject|29|||
105889802|NCT04064411|365249896|FG000|Overall Study|Lost to Follow-up|5|||
105889803|NCT04064411|365249897|FG001|Overall Study|Lost to Follow-up|2|||
105664581|NCT02472145|364436688|FG002|Overall Study|Lost to Follow-up|0|||
105889804|NCT04064411|365249896|FG000|Overall Study|Other than Specified|4|||
105889805|NCT04064411|365249897|FG001|Overall Study|Other than Specified|1|||
105889806|NCT04064411|365249896|FG000|Overall Study|Death|1|||
105889807|NCT04064411|365249897|FG001|Overall Study|Death|0|||
105889808|NCT04464720|365249901|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
105889809|NCT00954512|365249907|FG000|Overall Study|Withdrawal by Subject|0|||
105889810|NCT00954512|365249908|FG001|Overall Study|Withdrawal by Subject|0|||
105889811|NCT00954512|365249909|FG002|Overall Study|Withdrawal by Subject|0|||
105889812|NCT00954512|365249910|FG003|Overall Study|Withdrawal by Subject|0|||
105889813|NCT00954512|365249911|FG004|Overall Study|Withdrawal by Subject|0|||
105889814|NCT00954512|365249912|FG005|Overall Study|Withdrawal by Subject|1|||
105889815|NCT00954512|365249907|FG000|Overall Study|Adverse Event|0|||
105889816|NCT00954512|365249908|FG001|Overall Study|Adverse Event|0|||
105889817|NCT00954512|365249909|FG002|Overall Study|Adverse Event|0|||
105889818|NCT00954512|365249910|FG003|Overall Study|Adverse Event|0|||
105889819|NCT00954512|365249911|FG004|Overall Study|Adverse Event|1|||
105889820|NCT00954512|365249912|FG005|Overall Study|Adverse Event|2|||
105889821|NCT00954512|365249907|FG000|Overall Study|Physician Decision|0|||
105889822|NCT00954512|365249908|FG001|Overall Study|Physician Decision|1|||
105889823|NCT00954512|365249909|FG002|Overall Study|Physician Decision|0|||
105889824|NCT00954512|365249910|FG003|Overall Study|Physician Decision|1|||
105889825|NCT00954512|365249911|FG004|Overall Study|Physician Decision|0|||
105889826|NCT00954512|365249912|FG005|Overall Study|Physician Decision|0|||
105889827|NCT00954512|365249907|FG000|Overall Study|Symptomatic Deterioration|0|||
105889828|NCT00954512|365249908|FG001|Overall Study|Symptomatic Deterioration|1|||
105889829|NCT00954512|365249909|FG002|Overall Study|Symptomatic Deterioration|0|||
105889830|NCT00954512|365249910|FG003|Overall Study|Symptomatic Deterioration|0|||
105889831|NCT00954512|365249911|FG004|Overall Study|Symptomatic Deterioration|2|||
105664582|NCT02472145|364436686|FG000|Overall Study|Withdrawal by Subject|0|||
105664583|NCT02472145|364436687|FG001|Overall Study|Withdrawal by Subject|9|||
105664584|NCT02472145|364436688|FG002|Overall Study|Withdrawal by Subject|13|||
105664585|NCT02472145|364436686|FG000|Overall Study|Sponsor decision|0|||
105664586|NCT02472145|364436687|FG001|Overall Study|Sponsor decision|3|||
105664587|NCT02472145|364436688|FG002|Overall Study|Sponsor decision|2|||
105664588|NCT02472145|364436686|FG000|Overall Study|Other|0|||
105889832|NCT00954512|365249912|FG005|Overall Study|Symptomatic Deterioration|0|||
105889833|NCT00954512|365249907|FG000|Overall Study|Progression of Disease|2|||
105889834|NCT00954512|365249908|FG001|Overall Study|Progression of Disease|1|||
105889835|NCT00954512|365249909|FG002|Overall Study|Progression of Disease|0|||
105889836|NCT00954512|365249910|FG003|Overall Study|Progression of Disease|1|||
105889837|NCT00954512|365249911|FG004|Overall Study|Progression of Disease|1|||
105889838|NCT00954512|365249912|FG005|Overall Study|Progression of Disease|1|||
105889839|NCT01794793|365249914|FG000|Treatment Period|Withdrawal by Subject|24|||
105889840|NCT01794793|365249914|FG000|Treatment Period|Lack of Efficacy|22|||
105889841|NCT01794793|365249914|FG000|Treatment Period|Adverse Event|17|||
105889842|NCT01794793|365249914|FG000|Treatment Period|Physician Decision|14|||
105889843|NCT01794793|365249914|FG000|Treatment Period|Lost to Follow-up|7|||
105889844|NCT01794793|365249914|FG000|Treatment Period|Death|6|||
105889845|NCT01794793|365249914|FG000|Treatment Period|Protocol Violation|5|||
105889846|NCT01794793|365249914|FG000|Treatment Period|administrative problem|3|||
105889847|NCT01794793|365249914|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
105889848|NCT01794793|365249914|FG000|Post-treatment Follow-up|Adverse Event|8|||
105889849|NCT01794793|365249914|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
105889850|NCT01794793|365249914|FG000|Post-treatment Follow-up|administrative problem|5|||
105889851|NCT01794793|365249914|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
105664589|NCT02472145|364436687|FG001|Overall Study|Other|45|||
105664590|NCT02472145|364436688|FG002|Overall Study|Other|43|||
105664591|NCT01318876|364436689|FG000|Day 8 Survey|email address invalid|96|||
105664592|NCT01318876|364436689|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
105664593|NCT01318876|364436689|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
105664594|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
105664595|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
105664596|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
105889852|NCT01794793|365249914|FG000|Post-treatment Follow-up|Protocol Violation|3|||
105889853|NCT02640404|365249915|FG000|Overall Study|Protocol Violation|1|||
105889854|NCT02640404|365249916|FG001|Overall Study|Protocol Violation|0|||
105889855|NCT02640404|365249915|FG000|Overall Study|Withdrawal by Subject|1|||
105889856|NCT02640404|365249916|FG001|Overall Study|Withdrawal by Subject|0|||
105889857|NCT05397171|365249917|FG000|Overall Study|Death|2|||
105889858|NCT05397171|365249918|FG001|Overall Study|Death|3|||
105889859|NCT05397171|365249919|FG002|Overall Study|Death|3|||
105889860|NCT05397171|365249917|FG000|Overall Study|Study Terminated By Sponsor|1|||
105664597|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
105664598|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
105889861|NCT05397171|365249918|FG001|Overall Study|Study Terminated By Sponsor|2|||
105889862|NCT05397171|365249919|FG002|Overall Study|Study Terminated By Sponsor|3|||
105889863|NCT05397171|365249917|FG000|Overall Study|Withdrawal by Subject|0|||
105889864|NCT05397171|365249918|FG001|Overall Study|Withdrawal by Subject|1|||
105889865|NCT05397171|365249919|FG002|Overall Study|Withdrawal by Subject|1|||
105996415|NCT04961541|365647049|FG001|Overall Study|Withdrawal by Subject|0|||
105996416|NCT04961541|365647050|FG002|Overall Study|Withdrawal by Subject|1|||
105996417|NCT04961541|365647051|FG003|Overall Study|Withdrawal by Subject|1|||
105996418|NCT04961541|365647052|FG004|Overall Study|Withdrawal by Subject|0|||
105996419|NCT04961541|365647053|FG005|Overall Study|Withdrawal by Subject|0|||
105996420|NCT04961541|365647054|FG006|Overall Study|Withdrawal by Subject|0|||
105889866|NCT01275755|365252605|FG000|Double-blind Treatment Period|Adverse Event|0|||
105889867|NCT01275755|365252606|FG001|Double-blind Treatment Period|Adverse Event|2|||
105889868|NCT01275755|365252605|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
105889869|NCT01275755|365252606|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
105889870|NCT01275755|365252605|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105889871|NCT01275755|365252606|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105889872|NCT01275755|365252605|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
105889873|NCT01275755|365252606|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
105889874|NCT00174967|365252607|FG000|Overall Study|Adverse Event|1|||
105889875|NCT00174967|365252608|FG001|Overall Study|Adverse Event|2|||
105996421|NCT04961541|365647055|FG007|Overall Study|Withdrawal by Subject|0|||
105996422|NCT04961541|365647056|FG008|Overall Study|Withdrawal by Subject|0|||
105996423|NCT04961541|365647057|FG009|Overall Study|Withdrawal by Subject|1|||
105996424|NCT04961541|365647058|FG010|Overall Study|Withdrawal by Subject|0|||
105996425|NCT04961541|365647059|FG011|Overall Study|Withdrawal by Subject|0|||
105889876|NCT00174967|365252609|FG002|Overall Study|Adverse Event|2|||
105889877|NCT00174967|365252610|FG003|Overall Study|Adverse Event|1|||
105889878|NCT00174967|365252607|FG000|Overall Study|Gout Flare|0|||
105889879|NCT00174967|365252608|FG001|Overall Study|Gout Flare|0|||
105889880|NCT00174967|365252609|FG002|Overall Study|Gout Flare|0|||
105889881|NCT00174967|365252610|FG003|Overall Study|Gout Flare|1|||
105889882|NCT00174967|365252607|FG000|Overall Study|Other|0|||
105889883|NCT00174967|365252608|FG001|Overall Study|Other|1|||
105889884|NCT00174967|365252609|FG002|Overall Study|Other|0|||
105889885|NCT00174967|365252610|FG003|Overall Study|Other|0|||
105889886|NCT00636194|365252611|FG000|Overall Study|Study related symptoms and complaints|1|||
105889887|NCT00636194|365252612|FG001|Overall Study|Study related symptoms and complaints|0|||
105996426|NCT04961541|365647060|FG012|Overall Study|Withdrawal by Subject|0|||
105996427|NCT04961541|365647061|FG013|Overall Study|Withdrawal by Subject|0|||
105996428|NCT01684202|365647062|FG000|Dose-escalation Period|Adverse Event|0|||
105889888|NCT00636194|365252611|FG000|Overall Study|Protocol Violation|2|||
105889889|NCT00636194|365252612|FG001|Overall Study|Protocol Violation|0|||
105889890|NCT03104400|365252614|FG000|Overall Study|Adverse Event|5|||
105889891|NCT03104400|365252615|FG001|Overall Study|Adverse Event|7|||
105889892|NCT03104400|365252616|FG002|Overall Study|Adverse Event|11|||
105889893|NCT03104400|365252617|FG003|Overall Study|Adverse Event|9|||
105996429|NCT01684202|365647063|FG001|Dose-escalation Period|Adverse Event|1|||
105996430|NCT01684202|365647064|FG002|Dose-escalation Period|Adverse Event|0|||
105996431|NCT01684202|365647065|FG003|Dose-escalation Period|Adverse Event|0|||
106121564|NCT02696902|366101907|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
106121565|NCT02696902|366101908|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
106121566|NCT02696902|366101909|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
106121567|NCT02696902|366101907|FG000|Overall Study|Principal investigator's decision|1|||
106121568|NCT02696902|366101908|FG001|Overall Study|Principal investigator's decision|0|||
106121569|NCT02696902|366101909|FG002|Overall Study|Principal investigator's decision|0|||
106121570|NCT02696902|366101907|FG000|Overall Study|Sponsor's decision|1|||
106121571|NCT02696902|366101908|FG001|Overall Study|Sponsor's decision|0|||
106121572|NCT02696902|366101909|FG002|Overall Study|Sponsor's decision|0|||
106121573|NCT02696902|366101907|FG000|Overall Study|Transferred to other hospital|1|||
106121574|NCT02696902|366101908|FG001|Overall Study|Transferred to other hospital|0|||
106121575|NCT02696902|366101909|FG002|Overall Study|Transferred to other hospital|0|||
106121576|NCT05822921|366101912|FG000|Overall Study|Lost to Follow-up|1|||
106121577|NCT05822921|366101913|FG001|Overall Study|Lost to Follow-up|1|||
106121578|NCT03406702|366101914|FG000|Overall Study|Missed Day 27 Dosing|1|||
106121579|NCT00845871|366101919|FG000|Assessment Period|Adverse Event|2|||
106121580|NCT00845871|366101919|FG000|Assessment Period|Abnormal laboratory values|1|||
106121581|NCT00845871|366101919|FG000|Assessment Period|Abnormal test procedure results|1|||
106121582|NCT00845871|366101919|FG000|Assessment Period|Patient withdrew consent|3|||
106121583|NCT01857622|366101921|FG000|Overall Study|Adverse Event|5|||
106121584|NCT01857622|366101922|FG001|Overall Study|Adverse Event|0|||
106121585|NCT01857622|366101923|FG002|Overall Study|Adverse Event|2|||
106121586|NCT01857622|366101921|FG000|Overall Study|Physician Decision|1|||
106121587|NCT01857622|366101922|FG001|Overall Study|Physician Decision|0|||
106121588|NCT01857622|366101923|FG002|Overall Study|Physician Decision|0|||
106121589|NCT01857622|366101921|FG000|Overall Study|Protocol Violation|4|||
106121590|NCT01857622|366101922|FG001|Overall Study|Protocol Violation|1|||
106121591|NCT01857622|366101923|FG002|Overall Study|Protocol Violation|0|||
106121592|NCT01857622|366101921|FG000|Overall Study|Withdrawal by Subject|1|||
106121593|NCT01857622|366101922|FG001|Overall Study|Withdrawal by Subject|0|||
106121594|NCT01857622|366101923|FG002|Overall Study|Withdrawal by Subject|0|||
105889894|NCT03104400|365252618|FG004|Overall Study|Adverse Event|21|||
105889895|NCT03104400|365252614|FG000|Overall Study|Withdrawal by Subject|17|||
105889896|NCT03104400|365252615|FG001|Overall Study|Withdrawal by Subject|19|||
105889897|NCT03104400|365252616|FG002|Overall Study|Withdrawal by Subject|29|||
105889898|NCT03104400|365252617|FG003|Overall Study|Withdrawal by Subject|25|||
105889899|NCT03104400|365252618|FG004|Overall Study|Withdrawal by Subject|24|||
105889900|NCT03104400|365252614|FG000|Overall Study|Lost to Follow-up|4|||
105889901|NCT03104400|365252615|FG001|Overall Study|Lost to Follow-up|1|||
105889902|NCT03104400|365252616|FG002|Overall Study|Lost to Follow-up|4|||
105889903|NCT03104400|365252617|FG003|Overall Study|Lost to Follow-up|8|||
105889904|NCT03104400|365252618|FG004|Overall Study|Lost to Follow-up|7|||
105889905|NCT03104400|365252614|FG000|Overall Study|Lack of Efficacy|6|||
105889906|NCT03104400|365252615|FG001|Overall Study|Lack of Efficacy|3|||
105889907|NCT03104400|365252616|FG002|Overall Study|Lack of Efficacy|8|||
105889908|NCT03104400|365252617|FG003|Overall Study|Lack of Efficacy|2|||
105889909|NCT03104400|365252618|FG004|Overall Study|Lack of Efficacy|1|||
105889910|NCT03104400|365252614|FG000|Overall Study|COVID Logistical Restrictions|0|||
105889911|NCT03104400|365252615|FG001|Overall Study|COVID Logistical Restrictions|0|||
105889912|NCT03104400|365252616|FG002|Overall Study|COVID Logistical Restrictions|0|||
105889913|NCT03104400|365252617|FG003|Overall Study|COVID Logistical Restrictions|1|||
105889914|NCT03104400|365252618|FG004|Overall Study|COVID Logistical Restrictions|0|||
105889915|NCT03104400|365252614|FG000|Overall Study|Other|2|||
105996432|NCT01684202|365647062|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
105996433|NCT01684202|365647063|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
105996434|NCT01684202|365647064|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
105996435|NCT01684202|365647065|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
106121595|NCT02401308|366101928|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
106121596|NCT02401308|366101929|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
106121597|NCT01267253|366101930|FG000|Overall Study|Ineligible - required test not done|1|||
106121598|NCT01267253|366101930|FG000|Overall Study|Inevaluable-never received study treatme|2|||
106121599|NCT04318093|366101933|FG000|Overall Study|Adverse Event|2|||
106121600|NCT04318093|366101934|FG001|Overall Study|Adverse Event|2|||
106121601|NCT04318093|366101933|FG000|Overall Study|Participant withdrew consent|1|||
106121602|NCT04318093|366101934|FG001|Overall Study|Participant withdrew consent|0|||
106121603|NCT04318093|366101933|FG000|Overall Study|Other reasons|0|||
106121604|NCT04318093|366101934|FG001|Overall Study|Other reasons|1|||
106121605|NCT02998021|366101935|FG000|Overall Study|Withdrawal by Subject|3|||
105996436|NCT01684202|365647062|FG000|Maintenance Period|Adverse Event|1|||
105996437|NCT01684202|365647063|FG001|Maintenance Period|Adverse Event|1|||
105996438|NCT01684202|365647064|FG002|Maintenance Period|Adverse Event|1|||
106121606|NCT02998021|366101936|FG001|Overall Study|Withdrawal by Subject|1|||
105889916|NCT03104400|365252615|FG001|Overall Study|Other|3|||
105889917|NCT03104400|365252616|FG002|Overall Study|Other|7|||
105889918|NCT03104400|365252617|FG003|Overall Study|Other|6|||
106121607|NCT02998021|366101935|FG000|Overall Study|unsafe home|0|||
106121608|NCT02998021|366101936|FG001|Overall Study|unsafe home|1|||
106121609|NCT00514046|366101937|FG000|Overall Study|transferred to another protocol|2|||
106121610|NCT00514046|366101938|FG001|Overall Study|transferred to another protocol|1|||
106121611|NCT00514046|366101939|FG002|Overall Study|transferred to another protocol|3|||
106121612|NCT00514046|366101940|FG003|Overall Study|transferred to another protocol|0|||
106121613|NCT00514046|366101941|FG004|Overall Study|transferred to another protocol|1|||
106121614|NCT00514046|366101942|FG005|Overall Study|transferred to another protocol|0|||
106121615|NCT00514046|366101943|FG006|Overall Study|transferred to another protocol|0|||
106121616|NCT00514046|366101944|FG007|Overall Study|transferred to another protocol|0|||
106121617|NCT00514046|366101945|FG008|Overall Study|transferred to another protocol|0|||
106121618|NCT00514046|366101937|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
106121619|NCT00514046|366101938|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
106121620|NCT00514046|366101939|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
106121621|NCT00514046|366101940|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
106121622|NCT00514046|366101941|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
106121623|NCT00514046|366101942|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
106121624|NCT00514046|366101943|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
106121625|NCT00514046|366101944|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
106121626|NCT00514046|366101945|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
105889919|NCT03104400|365252618|FG004|Overall Study|Other|4|||
105889920|NCT03104400|365252614|FG000|Overall Study|Other|0|||
105889921|NCT03104400|365252615|FG001|Overall Study|Other|1|||
105889922|NCT03104400|365252616|FG002|Overall Study|Other|0|||
105889923|NCT03104400|365252617|FG003|Overall Study|Other|0|||
106121627|NCT00514046|366101937|FG000|Overall Study|Disease progression on study|0|||
105889924|NCT03104400|365252618|FG004|Overall Study|Other|0|||
105889925|NCT02752165|365252624|FG000|Overall Study|Withdrawal by Subject|6|||
105889926|NCT02752165|365252625|FG001|Overall Study|Withdrawal by Subject|6|||
105889927|NCT02752165|365252624|FG000|Overall Study|Protocol Violation|6|||
105996439|NCT01684202|365647065|FG003|Maintenance Period|Adverse Event|1|||
105996440|NCT01684202|365647062|FG000|Maintenance Period|Physician Decision|0|||
105889928|NCT02752165|365252625|FG001|Overall Study|Protocol Violation|5|||
105664599|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
105889929|NCT02752165|365252624|FG000|Overall Study|Lost to Follow-up|33|||
105889930|NCT02752165|365252625|FG001|Overall Study|Lost to Follow-up|38|||
105889931|NCT01953601|365252626|FG000|Part 1 (Base Study)|Adverse Event|24|||
105889932|NCT01953601|365252627|FG001|Part 1 (Base Study)|Adverse Event|37|||
105889933|NCT01953601|365252628|FG002|Part 1 (Base Study)|Adverse Event|15|||
105889934|NCT01953601|365252626|FG000|Part 1 (Base Study)|Death|2|||
105889935|NCT01953601|365252627|FG001|Part 1 (Base Study)|Death|0|||
105889936|NCT01953601|365252628|FG002|Part 1 (Base Study)|Death|3|||
105889937|NCT01953601|365252626|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
105889938|NCT01953601|365252627|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
105889939|NCT01953601|365252628|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
105889940|NCT01953601|365252626|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
105889941|NCT01953601|365252627|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
105889942|NCT01953601|365252628|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
105889943|NCT01953601|365252626|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
105889944|NCT01953601|365252627|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
105889945|NCT01953601|365252628|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
105889946|NCT01953601|365252626|FG000|Part 1 (Base Study)|Physician Decision|3|||
105889947|NCT01953601|365252627|FG001|Part 1 (Base Study)|Physician Decision|7|||
105889948|NCT01953601|365252628|FG002|Part 1 (Base Study)|Physician Decision|4|||
105889949|NCT01953601|365252626|FG000|Part 1 (Base Study)|Screen failure|1|||
105889950|NCT01953601|365252627|FG001|Part 1 (Base Study)|Screen failure|0|||
105889951|NCT01953601|365252628|FG002|Part 1 (Base Study)|Screen failure|1|||
105889952|NCT01953601|365252626|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
105889953|NCT01953601|365252627|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
105889954|NCT01953601|365252628|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
105889955|NCT01953601|365252626|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
105889956|NCT01953601|365252627|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
105889957|NCT01953601|365252628|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
105889958|NCT01953601|365252626|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
105889959|NCT01953601|365252627|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
105889960|NCT01953601|365252628|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
105889961|NCT01953601|365252626|FG000|Part 1 (Base Study)|Subject moved|2|||
105889962|NCT01953601|365252627|FG001|Part 1 (Base Study)|Subject moved|2|||
105889963|NCT01953601|365252628|FG002|Part 1 (Base Study)|Subject moved|1|||
105889964|NCT01953601|365252626|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
105889965|NCT01953601|365252627|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
105889966|NCT01953601|365252628|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
105889967|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Adverse Event|1|||
105889968|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Adverse Event|1|||
105889969|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Adverse Event|10|||
105889970|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Death|0|||
105889971|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Death|3|||
105889972|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Death|0|||
105664600|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
105664601|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
105664602|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
105664603|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
105664604|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
105664605|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
105664606|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
105664607|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
105664608|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
105664609|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
105889973|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
105889974|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
105889975|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
105996441|NCT01684202|365647063|FG001|Maintenance Period|Physician Decision|1|||
106121628|NCT00514046|366101938|FG001|Overall Study|Disease progression on study|0|||
105664610|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
105889976|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
105889977|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
105889978|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
105889979|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Physician Decision|2|||
105889980|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Physician Decision|0|||
105889981|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Physician Decision|2|||
105889982|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
105889983|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
105996442|NCT01684202|365647064|FG002|Maintenance Period|Physician Decision|0|||
105889984|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
105889985|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
105889986|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
105889987|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
105889988|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
105889989|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
105889990|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
105889991|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Subject moved|0|||
105889992|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Subject moved|0|||
105889993|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Subject moved|1|||
105889994|NCT01953601|365252626|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
105889995|NCT01953601|365252627|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
105889996|NCT01953601|365252628|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
105889997|NCT04934189|365252631|FG000|Overall Study|Lost to Follow-up|4|||
105889998|NCT04934189|365252631|FG000|Overall Study|Withdrawal by Subject|17|||
105889999|NCT03692325|365252642|FG000|Overall Study|Adverse Event|2|||
105890000|NCT03692325|365252642|FG000|Overall Study|Progression/Recurrence|2|||
105890001|NCT01300338|365252643|FG000|Overall Study|Lost to Follow-up|5|||
105890002|NCT01300338|365252644|FG001|Overall Study|Lost to Follow-up|0|||
105890003|NCT00664859|365252646|FG000|Overall Study|Adverse Event|2|||
105890004|NCT00664859|365252647|FG001|Overall Study|Adverse Event|1|||
105890005|NCT00664859|365252648|FG002|Overall Study|Adverse Event|3|||
105890006|NCT00664859|365252646|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
105890007|NCT00664859|365252647|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
105890008|NCT00664859|365252648|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
105890009|NCT00664859|365252646|FG000|Overall Study|Noncompliance with protocol|1|||
105890010|NCT00664859|365252647|FG001|Overall Study|Noncompliance with protocol|0|||
105890011|NCT00664859|365252648|FG002|Overall Study|Noncompliance with protocol|4|||
105890012|NCT00664859|365252646|FG000|Overall Study|Laboratory abnormality|2|||
105890013|NCT00664859|365252647|FG001|Overall Study|Laboratory abnormality|1|||
105890014|NCT00664859|365252648|FG002|Overall Study|Laboratory abnormality|4|||
105890015|NCT00664859|365252646|FG000|Overall Study|Withdrawal by Subject|4|||
105890016|NCT00664859|365252647|FG001|Overall Study|Withdrawal by Subject|1|||
105890017|NCT00664859|365252648|FG002|Overall Study|Withdrawal by Subject|3|||
105890018|NCT00664859|365252646|FG000|Overall Study|Lost to Follow-up|2|||
105890019|NCT00664859|365252647|FG001|Overall Study|Lost to Follow-up|2|||
105890020|NCT00664859|365252648|FG002|Overall Study|Lost to Follow-up|1|||
105890021|NCT00664859|365252646|FG000|Overall Study|Other|0|||
105890022|NCT00664859|365252647|FG001|Overall Study|Other|1|||
105890023|NCT00664859|365252648|FG002|Overall Study|Other|2|||
105890024|NCT00748189|365252649|FG000|Overall Study|Death|99|||
105890025|NCT00748189|365252650|FG001|Overall Study|Death|84|||
105890026|NCT00748189|365252649|FG000|Overall Study|Withdrawal by Subject|23|||
105890027|NCT00748189|365252650|FG001|Overall Study|Withdrawal by Subject|29|||
105890028|NCT00748189|365252649|FG000|Overall Study|Physician Decision|16|||
105890029|NCT00748189|365252650|FG001|Overall Study|Physician Decision|5|||
105890030|NCT00748189|365252649|FG000|Overall Study|Lost to Follow-up|8|||
105890031|NCT00748189|365252650|FG001|Overall Study|Lost to Follow-up|15|||
105890032|NCT00748189|365252649|FG000|Overall Study|Study terminated by Sponsor|70|||
105890033|NCT00748189|365252650|FG001|Overall Study|Study terminated by Sponsor|79|||
105890034|NCT04481191|365252651|FG000|Overall Study|Withdrawn by parent/guardian|15|||
105890035|NCT04481191|365252652|FG001|Overall Study|Withdrawn by parent/guardian|10|||
105890036|NCT02487771|365252653|FG000|Overall Study|Lost to Follow-up|2|||
105890037|NCT02487771|365252654|FG001|Overall Study|Lost to Follow-up|3|||
105890038|NCT02487771|365252653|FG000|Overall Study|Moved out of area|5|||
105890039|NCT02487771|365252654|FG001|Overall Study|Moved out of area|6|||
105890040|NCT02487771|365252653|FG000|Overall Study|Withdrawal by Subject|3|||
105890041|NCT02487771|365252654|FG001|Overall Study|Withdrawal by Subject|5|||
105890042|NCT04598451|365252655|FG000|Overall Study|Adverse Event|3|||
105890043|NCT04598451|365252656|FG001|Overall Study|Adverse Event|2|||
105890044|NCT04598451|365252655|FG000|Overall Study|Withdrawal by Subject|3|||
105890045|NCT04598451|365252656|FG001|Overall Study|Withdrawal by Subject|7|||
105890046|NCT04598451|365252655|FG000|Overall Study|Lost to Follow-up|2|||
105890047|NCT04598451|365252656|FG001|Overall Study|Lost to Follow-up|0|||
105890048|NCT04598451|365252655|FG000|Overall Study|Physician Decision|4|||
105890049|NCT04598451|365252656|FG001|Overall Study|Physician Decision|1|||
105890050|NCT04598451|365252655|FG000|Overall Study|Requires Prohibited Medication|1|||
105890051|NCT04598451|365252656|FG001|Overall Study|Requires Prohibited Medication|0|||
105890052|NCT04598451|365252655|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
105890053|NCT04598451|365252656|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
105890054|NCT00843037|365252659|FG000|Overall Study|Lost to Follow-up|1|||
105890055|NCT04594941|365252660|FG000|Overall Study|Other|0|||
105890056|NCT04594941|365252661|FG001|Overall Study|Other|3|||
105890057|NCT04594941|365252662|FG002|Overall Study|Other|1|||
105890058|NCT04594941|365252663|FG003|Overall Study|Other|0|||
105890059|NCT01482065|365252664|FG000|Overall Study|Withdrawal by Subject|0|||
105890060|NCT01482065|365252665|FG001|Overall Study|Withdrawal by Subject|1|||
105890061|NCT02424630|365252666|FG000|Overall Study|No rotator cuff tear|1|||
105890062|NCT02424630|365252667|FG001|Overall Study|No rotator cuff tear|2|||
105890063|NCT02424630|365252666|FG000|Overall Study|Open procedure|0|||
105890064|NCT02424630|365252667|FG001|Overall Study|Open procedure|1|||
105890065|NCT00425061|365252668|FG000|Overall Study|Adverse Event|1|||
105890066|NCT00425061|365252669|FG001|Overall Study|Adverse Event|0|||
105890067|NCT00425061|365252670|FG002|Overall Study|Adverse Event|0|||
105890068|NCT00425061|365252671|FG003|Overall Study|Adverse Event|2|||
105890069|NCT00425061|365252672|FG004|Overall Study|Adverse Event|2|||
105890070|NCT00425061|365252673|FG005|Overall Study|Adverse Event|0|||
105890071|NCT00425061|365252674|FG006|Overall Study|Adverse Event|0|||
105890072|NCT00425061|365252668|FG000|Overall Study|Lost to Follow-up|0|||
105890073|NCT00425061|365252669|FG001|Overall Study|Lost to Follow-up|1|||
105890074|NCT00425061|365252670|FG002|Overall Study|Lost to Follow-up|0|||
105890075|NCT00425061|365252671|FG003|Overall Study|Lost to Follow-up|0|||
105890076|NCT00425061|365252672|FG004|Overall Study|Lost to Follow-up|0|||
105890077|NCT00425061|365252673|FG005|Overall Study|Lost to Follow-up|0|||
105890078|NCT00425061|365252674|FG006|Overall Study|Lost to Follow-up|0|||
105890079|NCT00425061|365252668|FG000|Overall Study|Protocol Violation|1|||
105890080|NCT00425061|365252669|FG001|Overall Study|Protocol Violation|0|||
105890081|NCT00425061|365252670|FG002|Overall Study|Protocol Violation|0|||
105890082|NCT00425061|365252671|FG003|Overall Study|Protocol Violation|0|||
105890083|NCT00425061|365252672|FG004|Overall Study|Protocol Violation|0|||
105890084|NCT00425061|365252673|FG005|Overall Study|Protocol Violation|0|||
105890085|NCT00425061|365252674|FG006|Overall Study|Protocol Violation|0|||
105890086|NCT00425061|365252668|FG000|Overall Study|Withdrawal by Subject|0|||
105890087|NCT00425061|365252669|FG001|Overall Study|Withdrawal by Subject|1|||
105890088|NCT00425061|365252670|FG002|Overall Study|Withdrawal by Subject|0|||
105890089|NCT00425061|365252671|FG003|Overall Study|Withdrawal by Subject|0|||
105890090|NCT00425061|365252672|FG004|Overall Study|Withdrawal by Subject|1|||
105890091|NCT00425061|365252673|FG005|Overall Study|Withdrawal by Subject|0|||
105890092|NCT00425061|365252674|FG006|Overall Study|Withdrawal by Subject|3|||
105890093|NCT00425061|365252668|FG000|Overall Study|Sponsor's request|0|||
105890094|NCT00425061|365252669|FG001|Overall Study|Sponsor's request|0|||
105890095|NCT00425061|365252670|FG002|Overall Study|Sponsor's request|0|||
105890096|NCT00425061|365252671|FG003|Overall Study|Sponsor's request|0|||
105890097|NCT00425061|365252672|FG004|Overall Study|Sponsor's request|19|||
105890098|NCT00425061|365252673|FG005|Overall Study|Sponsor's request|4|||
105890099|NCT00425061|365252674|FG006|Overall Study|Sponsor's request|15|||
105890100|NCT00425061|365252668|FG000|Overall Study|Physician Decision|0|||
105890101|NCT00425061|365252669|FG001|Overall Study|Physician Decision|0|||
105890102|NCT00425061|365252670|FG002|Overall Study|Physician Decision|0|||
105890103|NCT00425061|365252671|FG003|Overall Study|Physician Decision|0|||
105890104|NCT00425061|365252672|FG004|Overall Study|Physician Decision|1|||
105890105|NCT00425061|365252673|FG005|Overall Study|Physician Decision|0|||
105890106|NCT00425061|365252674|FG006|Overall Study|Physician Decision|0|||
105890107|NCT00425061|365252668|FG000|Overall Study|Other|0|||
105890108|NCT00425061|365252669|FG001|Overall Study|Other|0|||
105890109|NCT00425061|365252670|FG002|Overall Study|Other|0|||
105890110|NCT00425061|365252671|FG003|Overall Study|Other|0|||
105890111|NCT00425061|365252672|FG004|Overall Study|Other|3|||
105890112|NCT00425061|365252673|FG005|Overall Study|Other|0|||
105890113|NCT00425061|365252674|FG006|Overall Study|Other|1|||
105890114|NCT02031640|365252675|FG000|Screening Period|Adverse Event|1|||
105890115|NCT02031640|365252676|FG001|Screening Period|Adverse Event|0|||
105890116|NCT02031640|365252677|FG002|Screening Period|Adverse Event|0|||
105890117|NCT02031640|365252678|FG003|Screening Period|Adverse Event|0|||
105890118|NCT02031640|365252679|FG004|Screening Period|Adverse Event|0|||
105890119|NCT02031640|365252680|FG005|Screening Period|Adverse Event|0|||
105890120|NCT02031640|365252675|FG000|Screening Period|Withdrawal by Subject|29|||
105890121|NCT02031640|365252676|FG001|Screening Period|Withdrawal by Subject|0|||
105890122|NCT02031640|365252677|FG002|Screening Period|Withdrawal by Subject|0|||
105890123|NCT02031640|365252678|FG003|Screening Period|Withdrawal by Subject|0|||
105890124|NCT02031640|365252679|FG004|Screening Period|Withdrawal by Subject|0|||
105996443|NCT01684202|365647065|FG003|Maintenance Period|Physician Decision|0|||
105996444|NCT01684202|365647062|FG000|Maintenance Period|Withdrawal by Subject|0|||
105890125|NCT02031640|365252680|FG005|Screening Period|Withdrawal by Subject|0|||
105890126|NCT02031640|365252675|FG000|Screening Period|Inclusion criteria not met|312|||
105996445|NCT01684202|365647063|FG001|Maintenance Period|Withdrawal by Subject|1|||
105890127|NCT02031640|365252676|FG001|Screening Period|Inclusion criteria not met|0|||
105890128|NCT02031640|365252677|FG002|Screening Period|Inclusion criteria not met|0|||
105890129|NCT02031640|365252678|FG003|Screening Period|Inclusion criteria not met|0|||
105890130|NCT02031640|365252679|FG004|Screening Period|Inclusion criteria not met|0|||
105890131|NCT02031640|365252680|FG005|Screening Period|Inclusion criteria not met|0|||
105890132|NCT02031640|365252675|FG000|Screening Period|Exclusion criteria met|30|||
105890133|NCT02031640|365252676|FG001|Screening Period|Exclusion criteria met|0|||
105890134|NCT02031640|365252677|FG002|Screening Period|Exclusion criteria met|0|||
106121629|NCT00514046|366101939|FG002|Overall Study|Disease progression on study|2|||
106121630|NCT00514046|366101940|FG003|Overall Study|Disease progression on study|0|||
106121631|NCT00514046|366101941|FG004|Overall Study|Disease progression on study|0|||
106121632|NCT00514046|366101942|FG005|Overall Study|Disease progression on study|1|||
106121633|NCT00514046|366101943|FG006|Overall Study|Disease progression on study|0|||
106121634|NCT00514046|366101944|FG007|Overall Study|Disease progression on study|0|||
106121635|NCT00514046|366101945|FG008|Overall Study|Disease progression on study|0|||
106121636|NCT00655551|366101946|FG000|All Periods Combined|Adverse Event|0|||
106121637|NCT00655551|366101947|FG001|All Periods Combined|Adverse Event|3|||
106121638|NCT00655551|366101948|FG002|All Periods Combined|Adverse Event|4|||
106121639|NCT00655551|366101946|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
106121640|NCT00655551|366101947|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
106121641|NCT00655551|366101948|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
106121642|NCT00655551|366101946|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
106121643|NCT00655551|366101947|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
106121644|NCT00655551|366101948|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
106121645|NCT00655551|366101946|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
106121646|NCT00655551|366101947|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
106121647|NCT00655551|366101948|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
106121648|NCT00309608|366101958|FG000|Overall Study|Adverse Event|1|||
106121649|NCT00309608|366101959|FG001|Overall Study|Adverse Event|5|||
106121650|NCT00309608|366101960|FG002|Overall Study|Adverse Event|3|||
106121651|NCT00309608|366101961|FG003|Overall Study|Adverse Event|2|||
106121652|NCT00309608|366101962|FG004|Overall Study|Adverse Event|3|||
106121653|NCT00309608|366101958|FG000|Overall Study|Protocol Violation|2|||
106121654|NCT00309608|366101959|FG001|Overall Study|Protocol Violation|0|||
106121655|NCT00309608|366101960|FG002|Overall Study|Protocol Violation|0|||
106121656|NCT00309608|366101961|FG003|Overall Study|Protocol Violation|0|||
106121657|NCT00309608|366101962|FG004|Overall Study|Protocol Violation|0|||
106121658|NCT00309608|366101958|FG000|Overall Study|Lost to Follow-up|0|||
106121659|NCT00309608|366101959|FG001|Overall Study|Lost to Follow-up|0|||
106121660|NCT00309608|366101960|FG002|Overall Study|Lost to Follow-up|2|||
106121661|NCT00309608|366101961|FG003|Overall Study|Lost to Follow-up|0|||
106121662|NCT00309608|366101962|FG004|Overall Study|Lost to Follow-up|1|||
106121663|NCT00309608|366101958|FG000|Overall Study|Withdrawal by Subject|1|||
106121664|NCT00309608|366101959|FG001|Overall Study|Withdrawal by Subject|4|||
106121665|NCT00309608|366101960|FG002|Overall Study|Withdrawal by Subject|2|||
105785677|NCT01238861|364868541|FG004|Overall Study|Personal problems|0|||
105785678|NCT01238861|364868542|FG005|Overall Study|Personal problems|0|||
105785679|NCT01238861|364868537|FG000|Overall Study|Unable to continue visits|0|||
105785680|NCT01238861|364868538|FG001|Overall Study|Unable to continue visits|0|||
105785681|NCT01238861|364868539|FG002|Overall Study|Unable to continue visits|0|||
105785682|NCT01238861|364868540|FG003|Overall Study|Unable to continue visits|1|||
105785683|NCT01238861|364868541|FG004|Overall Study|Unable to continue visits|0|||
105785684|NCT01238861|364868542|FG005|Overall Study|Unable to continue visits|1|||
105785685|NCT01238861|364868537|FG000|Overall Study|Serious adverse event|0|||
105785686|NCT01238861|364868538|FG001|Overall Study|Serious adverse event|0|||
105785687|NCT01238861|364868539|FG002|Overall Study|Serious adverse event|0|||
105785688|NCT01238861|364868540|FG003|Overall Study|Serious adverse event|0|||
105785689|NCT01238861|364868541|FG004|Overall Study|Serious adverse event|0|||
105785690|NCT01238861|364868542|FG005|Overall Study|Serious adverse event|1|||
105785691|NCT01238861|364868537|FG000|Overall Study|Lack of compliance|0|||
105785692|NCT01238861|364868538|FG001|Overall Study|Lack of compliance|0|||
105785693|NCT01238861|364868539|FG002|Overall Study|Lack of compliance|0|||
105785694|NCT01238861|364868540|FG003|Overall Study|Lack of compliance|0|||
105785695|NCT01238861|364868541|FG004|Overall Study|Lack of compliance|0|||
105785696|NCT01238861|364868542|FG005|Overall Study|Lack of compliance|1|||
105785697|NCT01238861|364868537|FG000|Overall Study|Adverse Event|0|||
105785698|NCT01238861|364868538|FG001|Overall Study|Adverse Event|1|||
105785699|NCT01238861|364868539|FG002|Overall Study|Adverse Event|0|||
105785700|NCT01238861|364868540|FG003|Overall Study|Adverse Event|0|||
105785701|NCT01238861|364868541|FG004|Overall Study|Adverse Event|0|||
105785702|NCT01238861|364868542|FG005|Overall Study|Adverse Event|0|||
105785703|NCT01238861|364868537|FG000|Overall Study|Withdrawal by Subject|6|||
105785704|NCT01238861|364868538|FG001|Overall Study|Withdrawal by Subject|5|||
105785705|NCT01238861|364868539|FG002|Overall Study|Withdrawal by Subject|4|||
105785706|NCT01238861|364868540|FG003|Overall Study|Withdrawal by Subject|8|||
105785707|NCT01238861|364868541|FG004|Overall Study|Withdrawal by Subject|10|||
105785708|NCT01238861|364868542|FG005|Overall Study|Withdrawal by Subject|9|||
105785709|NCT00247416|364868543|FG000|Overall Study|3 patients were found to be ineligible|1|||
105785710|NCT00247416|364868544|FG001|Overall Study|3 patients were found to be ineligible|2|||
105785711|NCT06104423|364868545|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
105785712|NCT06104423|364868546|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
105785713|NCT06104423|364868547|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
105664611|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
105664612|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Missing|2|||
105664613|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Missing|1|||
105664614|NCT00443209|364436690|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
105664615|NCT00443209|364436691|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
105664616|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
105664617|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
105664618|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
105664619|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
105664620|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
105664621|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
105664622|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
105664623|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
105664624|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
105664625|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
105664626|NCT00443209|364436690|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
105664627|NCT00443209|364436691|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
105664628|NCT01296555|364436692|FG000|Overall Study|Adverse Event|0|||
105664629|NCT01296555|364436693|FG001|Overall Study|Adverse Event|0|||
105664630|NCT01296555|364436694|FG002|Overall Study|Adverse Event|1|||
105664631|NCT01296555|364436695|FG003|Overall Study|Adverse Event|1|||
105664632|NCT01296555|364436696|FG004|Overall Study|Adverse Event|2|||
105664633|NCT01296555|364436697|FG005|Overall Study|Adverse Event|4|||
105664634|NCT01296555|364436698|FG006|Overall Study|Adverse Event|1|||
105664635|NCT01296555|364436699|FG007|Overall Study|Adverse Event|4|||
105664636|NCT01296555|364436700|FG008|Overall Study|Adverse Event|3|||
105664637|NCT01296555|364436701|FG009|Overall Study|Adverse Event|1|||
105664638|NCT01296555|364436702|FG010|Overall Study|Adverse Event|0|||
105664639|NCT01296555|364436703|FG011|Overall Study|Adverse Event|4|||
105664640|NCT01296555|364436704|FG012|Overall Study|Adverse Event|1|||
105664641|NCT01296555|364436705|FG013|Overall Study|Adverse Event|4|||
105664642|NCT01296555|364436706|FG014|Overall Study|Adverse Event|0|||
105664643|NCT01296555|364436707|FG015|Overall Study|Adverse Event|0|||
105664644|NCT01296555|364436708|FG016|Overall Study|Adverse Event|0|||
105664645|NCT01296555|364436709|FG017|Overall Study|Adverse Event|0|||
105664646|NCT01296555|364436710|FG018|Overall Study|Adverse Event|0|||
105664647|NCT01296555|364436711|FG019|Overall Study|Adverse Event|1|||
105664648|NCT01296555|364436712|FG020|Overall Study|Adverse Event|0|||
105664649|NCT01296555|364436713|FG021|Overall Study|Adverse Event|0|||
105664650|NCT01296555|364436714|FG022|Overall Study|Adverse Event|0|||
105664651|NCT01296555|364436715|FG023|Overall Study|Adverse Event|0|||
105664652|NCT01296555|364436716|FG024|Overall Study|Adverse Event|0|||
105664653|NCT01296555|364436717|FG025|Overall Study|Adverse Event|0|||
105664654|NCT01296555|364436718|FG026|Overall Study|Adverse Event|0|||
105664655|NCT01296555|364436719|FG027|Overall Study|Adverse Event|0|||
105664656|NCT01296555|364436720|FG028|Overall Study|Adverse Event|0|||
105664657|NCT01296555|364436692|FG000|Overall Study|Reason Not Specified|0|||
105664658|NCT01296555|364436693|FG001|Overall Study|Reason Not Specified|0|||
105664659|NCT01296555|364436694|FG002|Overall Study|Reason Not Specified|0|||
105664660|NCT01296555|364436695|FG003|Overall Study|Reason Not Specified|0|||
105664661|NCT01296555|364436696|FG004|Overall Study|Reason Not Specified|0|||
105664662|NCT01296555|364436697|FG005|Overall Study|Reason Not Specified|0|||
105664663|NCT01296555|364436698|FG006|Overall Study|Reason Not Specified|0|||
105664664|NCT01296555|364436699|FG007|Overall Study|Reason Not Specified|0|||
105664665|NCT01296555|364436700|FG008|Overall Study|Reason Not Specified|0|||
105664666|NCT01296555|364436701|FG009|Overall Study|Reason Not Specified|0|||
105664667|NCT01296555|364436702|FG010|Overall Study|Reason Not Specified|0|||
105664668|NCT01296555|364436703|FG011|Overall Study|Reason Not Specified|0|||
105890135|NCT02031640|365252678|FG003|Screening Period|Exclusion criteria met|0|||
105890136|NCT02031640|365252679|FG004|Screening Period|Exclusion criteria met|0|||
105890137|NCT02031640|365252680|FG005|Screening Period|Exclusion criteria met|0|||
105890138|NCT02031640|365252675|FG000|Screening Period|Lost to Follow-up|14|||
105890139|NCT02031640|365252676|FG001|Screening Period|Lost to Follow-up|0|||
105664669|NCT01296555|364436704|FG012|Overall Study|Reason Not Specified|0|||
105664670|NCT01296555|364436705|FG013|Overall Study|Reason Not Specified|1|||
105664671|NCT01296555|364436706|FG014|Overall Study|Reason Not Specified|2|||
105890140|NCT02031640|365252677|FG002|Screening Period|Lost to Follow-up|0|||
105890141|NCT02031640|365252678|FG003|Screening Period|Lost to Follow-up|0|||
105664672|NCT01296555|364436707|FG015|Overall Study|Reason Not Specified|3|||
105664673|NCT01296555|364436708|FG016|Overall Study|Reason Not Specified|7|||
105664674|NCT01296555|364436709|FG017|Overall Study|Reason Not Specified|4|||
105664675|NCT01296555|364436710|FG018|Overall Study|Reason Not Specified|3|||
105664676|NCT01296555|364436711|FG019|Overall Study|Reason Not Specified|7|||
105664677|NCT01296555|364436712|FG020|Overall Study|Reason Not Specified|11|||
105664678|NCT01296555|364436713|FG021|Overall Study|Reason Not Specified|5|||
105890142|NCT02031640|365252679|FG004|Screening Period|Lost to Follow-up|0|||
105890143|NCT02031640|365252680|FG005|Screening Period|Lost to Follow-up|0|||
105890144|NCT02031640|365252675|FG000|Screening Period|Enrollment closed|26|||
105890145|NCT02031640|365252676|FG001|Screening Period|Enrollment closed|0|||
105890146|NCT02031640|365252677|FG002|Screening Period|Enrollment closed|0|||
105890147|NCT02031640|365252678|FG003|Screening Period|Enrollment closed|0|||
105890148|NCT02031640|365252679|FG004|Screening Period|Enrollment closed|0|||
105890149|NCT02031640|365252680|FG005|Screening Period|Enrollment closed|0|||
105890150|NCT02031640|365252675|FG000|Run-In Period|Adverse Event|4|||
105890151|NCT02031640|365252676|FG001|Run-In Period|Adverse Event|0|||
105890152|NCT02031640|365252677|FG002|Run-In Period|Adverse Event|0|||
105890153|NCT02031640|365252678|FG003|Run-In Period|Adverse Event|0|||
105890154|NCT02031640|365252679|FG004|Run-In Period|Adverse Event|0|||
105890155|NCT02031640|365252680|FG005|Run-In Period|Adverse Event|0|||
105890156|NCT02031640|365252675|FG000|Run-In Period|Withdrawal by Subject|17|||
105890157|NCT02031640|365252676|FG001|Run-In Period|Withdrawal by Subject|0|||
105890158|NCT02031640|365252677|FG002|Run-In Period|Withdrawal by Subject|0|||
105890159|NCT02031640|365252678|FG003|Run-In Period|Withdrawal by Subject|0|||
105890160|NCT02031640|365252679|FG004|Run-In Period|Withdrawal by Subject|0|||
106121666|NCT00309608|366101961|FG003|Overall Study|Withdrawal by Subject|0|||
106121667|NCT00309608|366101962|FG004|Overall Study|Withdrawal by Subject|0|||
106121668|NCT00309608|366101958|FG000|Overall Study|Other incl. Lack of efficacy|10|||
105890161|NCT02031640|365252680|FG005|Run-In Period|Withdrawal by Subject|0|||
105890162|NCT02031640|365252675|FG000|Run-In Period|Inclusion criteria not met|38|||
105890163|NCT02031640|365252676|FG001|Run-In Period|Inclusion criteria not met|0|||
105890164|NCT02031640|365252677|FG002|Run-In Period|Inclusion criteria not met|0|||
105890165|NCT02031640|365252678|FG003|Run-In Period|Inclusion criteria not met|0|||
105890166|NCT02031640|365252679|FG004|Run-In Period|Inclusion criteria not met|0|||
105890167|NCT02031640|365252680|FG005|Run-In Period|Inclusion criteria not met|0|||
105890168|NCT02031640|365252675|FG000|Run-In Period|Exclusion criteria met|8|||
105890169|NCT02031640|365252676|FG001|Run-In Period|Exclusion criteria met|0|||
105890170|NCT02031640|365252677|FG002|Run-In Period|Exclusion criteria met|0|||
105890171|NCT02031640|365252678|FG003|Run-In Period|Exclusion criteria met|0|||
105890172|NCT02031640|365252679|FG004|Run-In Period|Exclusion criteria met|0|||
105890173|NCT02031640|365252680|FG005|Run-In Period|Exclusion criteria met|0|||
105890174|NCT02031640|365252675|FG000|Run-In Period|Randomization criteria not met|85|||
105890175|NCT02031640|365252676|FG001|Run-In Period|Randomization criteria not met|0|||
105890176|NCT02031640|365252677|FG002|Run-In Period|Randomization criteria not met|0|||
105890177|NCT02031640|365252678|FG003|Run-In Period|Randomization criteria not met|0|||
105890178|NCT02031640|365252679|FG004|Run-In Period|Randomization criteria not met|0|||
105890179|NCT02031640|365252680|FG005|Run-In Period|Randomization criteria not met|0|||
105890180|NCT02031640|365252675|FG000|Run-In Period|Various administrative reasons|17|||
105890181|NCT02031640|365252676|FG001|Run-In Period|Various administrative reasons|0|||
105890182|NCT02031640|365252677|FG002|Run-In Period|Various administrative reasons|0|||
105890183|NCT02031640|365252678|FG003|Run-In Period|Various administrative reasons|0|||
105890184|NCT02031640|365252679|FG004|Run-In Period|Various administrative reasons|0|||
105890185|NCT02031640|365252680|FG005|Run-In Period|Various administrative reasons|0|||
105890186|NCT02031640|365252675|FG000|Double-blind Treatment Period|Protocol deviation|0|||
105890187|NCT02031640|365252676|FG001|Double-blind Treatment Period|Protocol deviation|2|||
105890188|NCT02031640|365252677|FG002|Double-blind Treatment Period|Protocol deviation|0|||
105890189|NCT02031640|365252678|FG003|Double-blind Treatment Period|Protocol deviation|1|||
105890190|NCT02031640|365252679|FG004|Double-blind Treatment Period|Protocol deviation|3|||
105890191|NCT02031640|365252680|FG005|Double-blind Treatment Period|Protocol deviation|1|||
105890192|NCT02031640|365252675|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105890193|NCT02031640|365252676|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
105890194|NCT02031640|365252677|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
105890195|NCT02031640|365252678|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
105890196|NCT02031640|365252679|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
105890197|NCT02031640|365252680|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
105890198|NCT02031640|365252675|FG000|Double-blind Treatment Period|Non-compliance|0|||
105890199|NCT02031640|365252676|FG001|Double-blind Treatment Period|Non-compliance|1|||
105890200|NCT02031640|365252677|FG002|Double-blind Treatment Period|Non-compliance|0|||
105890201|NCT02031640|365252678|FG003|Double-blind Treatment Period|Non-compliance|1|||
105890202|NCT02031640|365252679|FG004|Double-blind Treatment Period|Non-compliance|1|||
105890203|NCT02031640|365252680|FG005|Double-blind Treatment Period|Non-compliance|0|||
105890204|NCT02031640|365252675|FG000|Double-blind Treatment Period|Adverse Event|0|||
105890205|NCT02031640|365252676|FG001|Double-blind Treatment Period|Adverse Event|0|||
105890206|NCT02031640|365252677|FG002|Double-blind Treatment Period|Adverse Event|0|||
105890207|NCT02031640|365252678|FG003|Double-blind Treatment Period|Adverse Event|2|||
105890208|NCT02031640|365252679|FG004|Double-blind Treatment Period|Adverse Event|0|||
105890209|NCT02031640|365252680|FG005|Double-blind Treatment Period|Adverse Event|0|||
106121669|NCT00309608|366101959|FG001|Overall Study|Other incl. Lack of efficacy|4|||
106121670|NCT00309608|366101960|FG002|Overall Study|Other incl. Lack of efficacy|3|||
106121671|NCT00309608|366101961|FG003|Overall Study|Other incl. Lack of efficacy|4|||
105664679|NCT01296555|364436714|FG022|Overall Study|Reason Not Specified|5|||
105664680|NCT01296555|364436715|FG023|Overall Study|Reason Not Specified|7|||
105664681|NCT01296555|364436716|FG024|Overall Study|Reason Not Specified|2|||
105664682|NCT01296555|364436717|FG025|Overall Study|Reason Not Specified|2|||
105664683|NCT01296555|364436718|FG026|Overall Study|Reason Not Specified|19|||
105664684|NCT01296555|364436719|FG027|Overall Study|Reason Not Specified|11|||
105664685|NCT01296555|364436720|FG028|Overall Study|Reason Not Specified|9|||
105890210|NCT02031640|365252675|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
105890211|NCT02031640|365252676|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105890212|NCT02031640|365252677|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
105664686|NCT01296555|364436692|FG000|Overall Study|Physician Decision|0|||
105664687|NCT01296555|364436693|FG001|Overall Study|Physician Decision|0|||
105664688|NCT01296555|364436694|FG002|Overall Study|Physician Decision|0|||
105890213|NCT02031640|365252678|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
105890214|NCT02031640|365252679|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
105890215|NCT02031640|365252680|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
105890216|NCT02031640|365252675|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105890217|NCT02031640|365252676|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
105890218|NCT02031640|365252677|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105890219|NCT02031640|365252678|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
105890220|NCT02031640|365252679|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
105890221|NCT02031640|365252680|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
105890222|NCT02091375|365252683|FG000|Overall Study|Adverse Event|8|||
105890223|NCT02091375|365252684|FG001|Overall Study|Adverse Event|1|||
105890224|NCT02091375|365252683|FG000|Overall Study|Lost to Follow-up|0|||
105890225|NCT02091375|365252684|FG001|Overall Study|Lost to Follow-up|1|||
105890226|NCT02091375|365252683|FG000|Overall Study|Withdrawal by Subject|0|||
105890227|NCT02091375|365252684|FG001|Overall Study|Withdrawal by Subject|1|||
105890228|NCT02091375|365252683|FG000|Overall Study|Withdrawn by the investigator|1|||
105890229|NCT02091375|365252684|FG001|Overall Study|Withdrawn by the investigator|0|||
105890230|NCT03085238|365252685|FG000|Overall Study|Adverse Event|2|||
105890231|NCT03085238|365252685|FG000|Overall Study|Death|2|||
105890232|NCT01741792|365252686|FG000|Overall Study|Death|6|||
105890233|NCT01741792|365252687|FG001|Overall Study|Death|1|||
105890234|NCT01741792|365252688|FG002|Overall Study|Death|12|||
105890235|NCT00761280|365252689|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
105890236|NCT00761280|365252690|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
105890237|NCT00761280|365252689|FG000|Randomization to First Dose|Sponsor decision|1|||
105890238|NCT00761280|365252690|FG001|Randomization to First Dose|Sponsor decision|0|||
105890239|NCT00761280|365252689|FG000|Randomization to First Dose|Other|1|||
105890240|NCT00761280|365252690|FG001|Randomization to First Dose|Other|0|||
105890241|NCT00761280|365252689|FG000|First Dose to End of Study|End of trial|5|||
105890242|NCT00761280|365252690|FG001|First Dose to End of Study|End of trial|5|||
105890243|NCT00761280|365252689|FG000|First Dose to End of Study|Progressive disease|5|||
105890244|NCT00761280|365252690|FG001|First Dose to End of Study|Progressive disease|3|||
105890245|NCT00761280|365252689|FG000|First Dose to End of Study|Sponsor decision|1|||
105890246|NCT00761280|365252690|FG001|First Dose to End of Study|Sponsor decision|2|||
105890247|NCT00761280|365252689|FG000|First Dose to End of Study|Death|1|||
105890248|NCT00761280|365252690|FG001|First Dose to End of Study|Death|0|||
105890249|NCT00761280|365252689|FG000|First Dose to End of Study|Lost to Follow-up|0|||
105890250|NCT00761280|365252690|FG001|First Dose to End of Study|Lost to Follow-up|1|||
105890251|NCT01938430|365252694|FG000|Overall Study|Randomized but Not Treated|0|||
105890252|NCT01938430|365252695|FG001|Overall Study|Randomized but Not Treated|0|||
105890253|NCT01938430|365252696|FG002|Overall Study|Randomized but Not Treated|0|||
105890254|NCT01938430|365252697|FG003|Overall Study|Randomized but Not Treated|0|||
105890255|NCT01938430|365252698|FG004|Overall Study|Randomized but Not Treated|0|||
105890256|NCT01938430|365252699|FG005|Overall Study|Randomized but Not Treated|0|||
105890257|NCT01938430|365252700|FG006|Overall Study|Randomized but Not Treated|0|||
105890258|NCT01938430|365252701|FG007|Overall Study|Randomized but Not Treated|0|||
105890259|NCT01938430|365252702|FG008|Overall Study|Randomized but Not Treated|0|||
105890260|NCT01938430|365252703|FG009|Overall Study|Randomized but Not Treated|0|||
105890261|NCT01938430|365252704|FG010|Overall Study|Randomized but Not Treated|1|||
105890262|NCT01938430|365252705|FG011|Overall Study|Randomized but Not Treated|0|||
105890263|NCT01938430|365252706|FG012|Overall Study|Randomized but Not Treated|0|||
105890264|NCT01938430|365252707|FG013|Overall Study|Randomized but Not Treated|1|||
105890265|NCT01938430|365252694|FG000|Overall Study|Adverse Event|0|||
105890266|NCT01938430|365252695|FG001|Overall Study|Adverse Event|0|||
105890267|NCT01938430|365252696|FG002|Overall Study|Adverse Event|0|||
105890268|NCT01938430|365252697|FG003|Overall Study|Adverse Event|0|||
105890269|NCT01938430|365252698|FG004|Overall Study|Adverse Event|0|||
105890270|NCT01938430|365252699|FG005|Overall Study|Adverse Event|0|||
105664689|NCT01296555|364436695|FG003|Overall Study|Physician Decision|0|||
105664690|NCT01296555|364436696|FG004|Overall Study|Physician Decision|1|||
105890271|NCT01938430|365252700|FG006|Overall Study|Adverse Event|1|||
105890272|NCT01938430|365252701|FG007|Overall Study|Adverse Event|0|||
105664691|NCT01296555|364436697|FG005|Overall Study|Physician Decision|0|||
105664692|NCT01296555|364436698|FG006|Overall Study|Physician Decision|0|||
105664693|NCT01296555|364436699|FG007|Overall Study|Physician Decision|0|||
105664694|NCT01296555|364436700|FG008|Overall Study|Physician Decision|0|||
105996446|NCT01684202|365647064|FG002|Maintenance Period|Withdrawal by Subject|0|||
105996447|NCT01684202|365647065|FG003|Maintenance Period|Withdrawal by Subject|0|||
105996448|NCT03539601|365647067|FG000|Overall Study|Withdraw by parent/guardian|1|||
105996449|NCT03539601|365647068|FG001|Overall Study|Withdraw by parent/guardian|0|||
105996450|NCT03539601|365647069|FG002|Overall Study|Withdraw by parent/guardian|1|||
105996451|NCT03539601|365647070|FG003|Overall Study|Withdraw by parent/guardian|0|||
105996452|NCT03539601|365647067|FG000|Overall Study|Adverse Event|0|||
105996453|NCT03539601|365647068|FG001|Overall Study|Adverse Event|2|||
105996454|NCT03539601|365647069|FG002|Overall Study|Adverse Event|0|||
105996455|NCT03539601|365647070|FG003|Overall Study|Adverse Event|0|||
105996456|NCT03539601|365647067|FG000|Overall Study|Lost to Follow-up|2|||
105996457|NCT03539601|365647068|FG001|Overall Study|Lost to Follow-up|4|||
105996458|NCT03539601|365647069|FG002|Overall Study|Lost to Follow-up|5|||
105996459|NCT03539601|365647070|FG003|Overall Study|Lost to Follow-up|0|||
105996460|NCT03539601|365647067|FG000|Overall Study|Withdrawal by Subject|2|||
105996461|NCT03539601|365647068|FG001|Overall Study|Withdrawal by Subject|0|||
105996462|NCT03539601|365647069|FG002|Overall Study|Withdrawal by Subject|0|||
105996463|NCT03539601|365647070|FG003|Overall Study|Withdrawal by Subject|1|||
105996464|NCT03539601|365647067|FG000|Overall Study|Randomized but not treated|1|||
105996465|NCT03539601|365647068|FG001|Overall Study|Randomized but not treated|1|||
105996466|NCT03539601|365647069|FG002|Overall Study|Randomized but not treated|0|||
105996467|NCT03539601|365647070|FG003|Overall Study|Randomized but not treated|0|||
105996468|NCT01633541|365647071|FG000|Overall Study|Death|1|||
105996469|NCT01633541|365647072|FG001|Overall Study|Death|0|||
105996470|NCT00700713|365647075|FG000|Overall Study|Protocol Violation|1|||
105996471|NCT00700713|365647076|FG001|Overall Study|Protocol Violation|0|||
105996472|NCT00700713|365647077|FG002|Overall Study|Protocol Violation|1|||
105996473|NCT00700713|365647075|FG000|Overall Study|Withdrawal by Subject|0|||
105996474|NCT00700713|365647076|FG001|Overall Study|Withdrawal by Subject|0|||
105996475|NCT00700713|365647077|FG002|Overall Study|Withdrawal by Subject|1|||
105996476|NCT00770601|365647078|FG000|Overall Study|Withdrawal by Subject|1|||
105996477|NCT00132808|365647079|FG000|Stratum I|Adverse Event|2|||
105996478|NCT00132808|365647080|FG001|Stratum I|Adverse Event|1|||
105996479|NCT00132808|365647081|FG002|Stratum I|Adverse Event|0|||
105664695|NCT01296555|364436701|FG009|Overall Study|Physician Decision|0|||
105664696|NCT01296555|364436702|FG010|Overall Study|Physician Decision|0|||
105664697|NCT01296555|364436703|FG011|Overall Study|Physician Decision|0|||
105664698|NCT01296555|364436704|FG012|Overall Study|Physician Decision|0|||
105664699|NCT01296555|364436705|FG013|Overall Study|Physician Decision|1|||
105664700|NCT01296555|364436706|FG014|Overall Study|Physician Decision|0|||
105664701|NCT01296555|364436707|FG015|Overall Study|Physician Decision|0|||
105664702|NCT01296555|364436708|FG016|Overall Study|Physician Decision|0|||
105664703|NCT01296555|364436709|FG017|Overall Study|Physician Decision|0|||
105664704|NCT01296555|364436710|FG018|Overall Study|Physician Decision|0|||
105664705|NCT01296555|364436711|FG019|Overall Study|Physician Decision|1|||
105664706|NCT01296555|364436712|FG020|Overall Study|Physician Decision|0|||
105664707|NCT01296555|364436713|FG021|Overall Study|Physician Decision|0|||
105664708|NCT01296555|364436714|FG022|Overall Study|Physician Decision|0|||
105664709|NCT01296555|364436715|FG023|Overall Study|Physician Decision|0|||
105664710|NCT01296555|364436716|FG024|Overall Study|Physician Decision|0|||
105664711|NCT01296555|364436717|FG025|Overall Study|Physician Decision|0|||
105664712|NCT01296555|364436718|FG026|Overall Study|Physician Decision|0|||
105664713|NCT01296555|364436719|FG027|Overall Study|Physician Decision|0|||
105664714|NCT01296555|364436720|FG028|Overall Study|Physician Decision|0|||
105664715|NCT01296555|364436692|FG000|Overall Study|Progressive Disease|6|||
105664716|NCT01296555|364436693|FG001|Overall Study|Progressive Disease|3|||
105664717|NCT01296555|364436694|FG002|Overall Study|Progressive Disease|3|||
105996480|NCT00132808|365647079|FG000|Stratum I|Lost to Follow-up|3|||
105996481|NCT00132808|365647080|FG001|Stratum I|Lost to Follow-up|4|||
105996482|NCT00132808|365647081|FG002|Stratum I|Lost to Follow-up|1|||
105996483|NCT00132808|365647079|FG000|Stratum I|Withdrawal by Subject|4|||
105996484|NCT00132808|365647080|FG001|Stratum I|Withdrawal by Subject|7|||
105664718|NCT01296555|364436695|FG003|Overall Study|Progressive Disease|7|||
105664719|NCT01296555|364436696|FG004|Overall Study|Progressive Disease|6|||
105664720|NCT01296555|364436697|FG005|Overall Study|Progressive Disease|16|||
105664721|NCT01296555|364436698|FG006|Overall Study|Progressive Disease|16|||
105996485|NCT00132808|365647081|FG002|Stratum I|Withdrawal by Subject|3|||
105996486|NCT00132808|365647079|FG000|Stratum I|Abnormal test procedure result (s)|0|||
105996487|NCT00132808|365647080|FG001|Stratum I|Abnormal test procedure result (s)|0|||
105664722|NCT01296555|364436699|FG007|Overall Study|Progressive Disease|8|||
105664723|NCT01296555|364436700|FG008|Overall Study|Progressive Disease|7|||
105664724|NCT01296555|364436701|FG009|Overall Study|Progressive Disease|18|||
105664725|NCT01296555|364436702|FG010|Overall Study|Progressive Disease|7|||
105664726|NCT01296555|364436703|FG011|Overall Study|Progressive Disease|14|||
105996488|NCT00132808|365647081|FG002|Stratum I|Abnormal test procedure result (s)|1|||
105996489|NCT00132808|365647079|FG000|Stratum II|Adverse Event|1|||
105890273|NCT01938430|365252702|FG008|Overall Study|Adverse Event|0|||
105890274|NCT01938430|365252703|FG009|Overall Study|Adverse Event|0|||
105890275|NCT01938430|365252704|FG010|Overall Study|Adverse Event|0|||
105890276|NCT01938430|365252705|FG011|Overall Study|Adverse Event|0|||
105890277|NCT01938430|365252706|FG012|Overall Study|Adverse Event|0|||
105890278|NCT01938430|365252707|FG013|Overall Study|Adverse Event|0|||
105890279|NCT01938430|365252694|FG000|Overall Study|Death|1|||
105890280|NCT01938430|365252695|FG001|Overall Study|Death|2|||
105890281|NCT01938430|365252696|FG002|Overall Study|Death|2|||
105890282|NCT01938430|365252697|FG003|Overall Study|Death|1|||
105890283|NCT01938430|365252698|FG004|Overall Study|Death|0|||
105890284|NCT01938430|365252699|FG005|Overall Study|Death|0|||
105890285|NCT01938430|365252700|FG006|Overall Study|Death|1|||
105890286|NCT01938430|365252701|FG007|Overall Study|Death|1|||
105890287|NCT01938430|365252702|FG008|Overall Study|Death|2|||
105890288|NCT01938430|365252703|FG009|Overall Study|Death|3|||
105890289|NCT01938430|365252704|FG010|Overall Study|Death|0|||
105890290|NCT01938430|365252705|FG011|Overall Study|Death|0|||
105890291|NCT01938430|365252706|FG012|Overall Study|Death|0|||
105890292|NCT01938430|365252707|FG013|Overall Study|Death|0|||
105890293|NCT01938430|365252694|FG000|Overall Study|Investigator's Discretion|0|||
105890294|NCT01938430|365252695|FG001|Overall Study|Investigator's Discretion|0|||
105890295|NCT01938430|365252696|FG002|Overall Study|Investigator's Discretion|1|||
105890296|NCT01938430|365252697|FG003|Overall Study|Investigator's Discretion|0|||
105890297|NCT01938430|365252698|FG004|Overall Study|Investigator's Discretion|0|||
105890298|NCT01938430|365252699|FG005|Overall Study|Investigator's Discretion|0|||
105890299|NCT01938430|365252700|FG006|Overall Study|Investigator's Discretion|0|||
105890300|NCT01938430|365252701|FG007|Overall Study|Investigator's Discretion|0|||
105890301|NCT01938430|365252702|FG008|Overall Study|Investigator's Discretion|0|||
105890302|NCT01938430|365252703|FG009|Overall Study|Investigator's Discretion|0|||
105890303|NCT01938430|365252704|FG010|Overall Study|Investigator's Discretion|0|||
105890304|NCT01938430|365252705|FG011|Overall Study|Investigator's Discretion|0|||
105890305|NCT01938430|365252706|FG012|Overall Study|Investigator's Discretion|0|||
105890306|NCT01938430|365252707|FG013|Overall Study|Investigator's Discretion|0|||
105890307|NCT01938430|365252694|FG000|Overall Study|Lack of Efficacy|3|||
105890308|NCT01938430|365252695|FG001|Overall Study|Lack of Efficacy|1|||
105890309|NCT01938430|365252696|FG002|Overall Study|Lack of Efficacy|1|||
105890310|NCT01938430|365252697|FG003|Overall Study|Lack of Efficacy|1|||
105890311|NCT01938430|365252698|FG004|Overall Study|Lack of Efficacy|0|||
105890312|NCT01938430|365252699|FG005|Overall Study|Lack of Efficacy|0|||
105890313|NCT01938430|365252700|FG006|Overall Study|Lack of Efficacy|0|||
105890314|NCT01938430|365252701|FG007|Overall Study|Lack of Efficacy|0|||
105890315|NCT01938430|365252702|FG008|Overall Study|Lack of Efficacy|1|||
105890316|NCT01938430|365252703|FG009|Overall Study|Lack of Efficacy|0|||
105890317|NCT01938430|365252704|FG010|Overall Study|Lack of Efficacy|2|||
105890318|NCT01938430|365252705|FG011|Overall Study|Lack of Efficacy|1|||
105890319|NCT01938430|365252706|FG012|Overall Study|Lack of Efficacy|0|||
105890320|NCT01938430|365252707|FG013|Overall Study|Lack of Efficacy|0|||
105890321|NCT01938430|365252694|FG000|Overall Study|Lost to Follow-up|0|||
105890322|NCT01938430|365252695|FG001|Overall Study|Lost to Follow-up|0|||
105890323|NCT01938430|365252696|FG002|Overall Study|Lost to Follow-up|1|||
105890324|NCT01938430|365252697|FG003|Overall Study|Lost to Follow-up|0|||
105890325|NCT01938430|365252698|FG004|Overall Study|Lost to Follow-up|0|||
105890326|NCT01938430|365252699|FG005|Overall Study|Lost to Follow-up|1|||
105890327|NCT01938430|365252700|FG006|Overall Study|Lost to Follow-up|0|||
105890328|NCT01938430|365252701|FG007|Overall Study|Lost to Follow-up|0|||
105890329|NCT01938430|365252702|FG008|Overall Study|Lost to Follow-up|0|||
105890330|NCT01938430|365252703|FG009|Overall Study|Lost to Follow-up|0|||
106121672|NCT00309608|366101962|FG004|Overall Study|Other incl. Lack of efficacy|0|||
106121673|NCT01051063|366101963|FG000|Overall Study|Death|2|||
106121674|NCT01051063|366101964|FG001|Overall Study|Death|2|||
106121675|NCT01051063|366101963|FG000|Overall Study|Withdrawal by Subject|1|||
106121676|NCT01051063|366101964|FG001|Overall Study|Withdrawal by Subject|1|||
105890331|NCT01938430|365252704|FG010|Overall Study|Lost to Follow-up|0|||
105890332|NCT01938430|365252705|FG011|Overall Study|Lost to Follow-up|0|||
105890333|NCT01938430|365252706|FG012|Overall Study|Lost to Follow-up|0|||
105890334|NCT01938430|365252707|FG013|Overall Study|Lost to Follow-up|0|||
105890335|NCT01938430|365252694|FG000|Overall Study|Withdrew Consent|0|||
105890336|NCT01938430|365252695|FG001|Overall Study|Withdrew Consent|0|||
106121677|NCT01051063|366101963|FG000|Overall Study|Termination of the study|5|||
105664727|NCT01296555|364436704|FG012|Overall Study|Progressive Disease|5|||
105890337|NCT01938430|365252696|FG002|Overall Study|Withdrew Consent|0|||
105890338|NCT01938430|365252697|FG003|Overall Study|Withdrew Consent|0|||
105890339|NCT01938430|365252698|FG004|Overall Study|Withdrew Consent|0|||
105890340|NCT01938430|365252699|FG005|Overall Study|Withdrew Consent|0|||
105890341|NCT01938430|365252700|FG006|Overall Study|Withdrew Consent|0|||
105890342|NCT01938430|365252701|FG007|Overall Study|Withdrew Consent|0|||
105890343|NCT01938430|365252702|FG008|Overall Study|Withdrew Consent|1|||
105890344|NCT01938430|365252703|FG009|Overall Study|Withdrew Consent|0|||
105890345|NCT01938430|365252704|FG010|Overall Study|Withdrew Consent|0|||
105890346|NCT01938430|365252705|FG011|Overall Study|Withdrew Consent|0|||
105890347|NCT01938430|365252706|FG012|Overall Study|Withdrew Consent|0|||
105890348|NCT01938430|365252707|FG013|Overall Study|Withdrew Consent|0|||
105890349|NCT04533412|365252708|FG000|Overall Study|Withdrawal by Subject|1|||
105890350|NCT04533412|365252709|FG001|Overall Study|Withdrawal by Subject|1|||
105890351|NCT04533412|365252708|FG000|Overall Study|Lost to Follow-up|1|||
105890352|NCT04533412|365252709|FG001|Overall Study|Lost to Follow-up|4|||
105890353|NCT00976820|365252710|FG000|Overall Study|Lost to Follow-up|5|||
105890354|NCT00976820|365252711|FG001|Overall Study|Lost to Follow-up|16|||
105890355|NCT00976820|365252712|FG002|Overall Study|Lost to Follow-up|2|||
105890356|NCT00976820|365252713|FG003|Overall Study|Lost to Follow-up|3|||
105890357|NCT00976820|365252710|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
105890358|NCT00976820|365252711|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
105890359|NCT00976820|365252712|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
105890360|NCT00976820|365252713|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
105890361|NCT00976820|365252710|FG000|Overall Study|Withdrawal by Subject|2|||
105890362|NCT00976820|365252711|FG001|Overall Study|Withdrawal by Subject|4|||
105890363|NCT00976820|365252712|FG002|Overall Study|Withdrawal by Subject|1|||
105890364|NCT00976820|365252713|FG003|Overall Study|Withdrawal by Subject|4|||
105890365|NCT00680901|365252714|FG000|Overall Study|Lost to Follow-up|8|||
105890366|NCT00680901|365252715|FG001|Overall Study|Lost to Follow-up|8|||
105890367|NCT00680901|365252714|FG000|Overall Study|Withdrawal by Subject|4|||
105890368|NCT00680901|365252715|FG001|Overall Study|Withdrawal by Subject|13|||
105890369|NCT00680901|365252714|FG000|Overall Study|Physician Decision|0|||
105890370|NCT00680901|365252715|FG001|Overall Study|Physician Decision|1|||
105890371|NCT00680901|365252714|FG000|Overall Study|Ongoing: On Study Treatment|16|||
105890372|NCT00680901|365252715|FG001|Overall Study|Ongoing: On Study Treatment|13|||
105890373|NCT00680901|365252714|FG000|Overall Study|Ongoing: In Follow Up|45|||
105890374|NCT00680901|365252715|FG001|Overall Study|Ongoing: In Follow Up|41|||
105890375|NCT00968981|365252716|FG000|Overall Study|Adverse Event|2|||
105890376|NCT00968981|365252717|FG001|Overall Study|Adverse Event|0|||
105890377|NCT00968981|365252718|FG002|Overall Study|Adverse Event|0|||
105890378|NCT00968981|365252716|FG000|Overall Study|Disease Progression|14|||
105890379|NCT00968981|365252717|FG001|Overall Study|Disease Progression|16|||
105890380|NCT00968981|365252718|FG002|Overall Study|Disease Progression|13|||
105890381|NCT00968981|365252716|FG000|Overall Study|Lost to Follow-up|0|||
105890382|NCT00968981|365252717|FG001|Overall Study|Lost to Follow-up|0|||
105890383|NCT00968981|365252718|FG002|Overall Study|Lost to Follow-up|1|||
105890384|NCT00968981|365252716|FG000|Overall Study|Physician Decision|5|||
105890385|NCT00968981|365252717|FG001|Overall Study|Physician Decision|3|||
105890386|NCT00968981|365252718|FG002|Overall Study|Physician Decision|5|||
105890387|NCT00968981|365252716|FG000|Overall Study|Withdrawal by Subject|1|||
105890388|NCT00968981|365252717|FG001|Overall Study|Withdrawal by Subject|3|||
105890389|NCT00968981|365252718|FG002|Overall Study|Withdrawal by Subject|3|||
105890390|NCT03261674|365252721|FG000|Overall Study|Lost to Follow-up|6|||
105890391|NCT03261674|365252722|FG001|Overall Study|Lost to Follow-up|7|||
105890392|NCT03261674|365252721|FG000|Overall Study|Protocol Violation|1|||
105890393|NCT03261674|365252722|FG001|Overall Study|Protocol Violation|4|||
105890394|NCT03261674|365252721|FG000|Overall Study|Withdrawal by Subject|1|||
105890395|NCT03261674|365252722|FG001|Overall Study|Withdrawal by Subject|4|||
105890396|NCT03261674|365252721|FG000|Overall Study|Physician Decision|1|||
105890397|NCT03261674|365252722|FG001|Overall Study|Physician Decision|0|||
105890398|NCT02045862|365252723|FG000|Overall Study|Death|0|||
105890399|NCT02045862|365252724|FG001|Overall Study|Death|0|||
105890400|NCT02045862|365252725|FG002|Overall Study|Death|1|||
105890401|NCT02045862|365252723|FG000|Overall Study|Miscellaneous|5|||
105890402|NCT02045862|365252724|FG001|Overall Study|Miscellaneous|0|||
106121678|NCT01051063|366101964|FG001|Overall Study|Termination of the study|0|||
106121679|NCT01051063|366101963|FG000|Overall Study|Moved from the study site area|1|||
106121680|NCT01051063|366101964|FG001|Overall Study|Moved from the study site area|0|||
106121681|NCT01051063|366101963|FG000|Overall Study|Other|1|||
106121682|NCT01051063|366101964|FG001|Overall Study|Other|0|||
106121683|NCT01051063|366101963|FG000|Overall Study|Lost to Follow-up|0|||
106121684|NCT01051063|366101964|FG001|Overall Study|Lost to Follow-up|1|||
106121685|NCT01282476|366103609|FG000|Overall Study|Death|11|||
105890403|NCT02045862|365252725|FG002|Overall Study|Miscellaneous|8|||
105890404|NCT02045862|365252723|FG000|Overall Study|Withdrawal by Patient|18|||
105890405|NCT02045862|365252724|FG001|Overall Study|Withdrawal by Patient|27|||
105890406|NCT02045862|365252725|FG002|Overall Study|Withdrawal by Patient|57|||
105890407|NCT02045862|365252723|FG000|Overall Study|Protocol Violation|0|||
105890408|NCT02045862|365252724|FG001|Overall Study|Protocol Violation|0|||
105890409|NCT02045862|365252725|FG002|Overall Study|Protocol Violation|6|||
105890410|NCT02045862|365252723|FG000|Overall Study|Lack of Efficacy|8|||
105890411|NCT02045862|365252724|FG001|Overall Study|Lack of Efficacy|4|||
105890412|NCT02045862|365252725|FG002|Overall Study|Lack of Efficacy|13|||
105890413|NCT02045862|365252723|FG000|Overall Study|Randomized but not Received Study Drug|0|||
105890414|NCT02045862|365252724|FG001|Overall Study|Randomized but not Received Study Drug|2|||
106121686|NCT00437125|366103612|FG000|Overall Study|Adverse Event|12|||
106121687|NCT00437125|366103612|FG000|Overall Study|Death|1|||
105664728|NCT01296555|364436705|FG013|Overall Study|Progressive Disease|12|||
105664729|NCT01296555|364436706|FG014|Overall Study|Progressive Disease|1|||
105664730|NCT01296555|364436707|FG015|Overall Study|Progressive Disease|1|||
105664731|NCT01296555|364436708|FG016|Overall Study|Progressive Disease|0|||
105664732|NCT01296555|364436709|FG017|Overall Study|Progressive Disease|0|||
105664733|NCT01296555|364436710|FG018|Overall Study|Progressive Disease|0|||
105664734|NCT01296555|364436711|FG019|Overall Study|Progressive Disease|1|||
105664735|NCT01296555|364436712|FG020|Overall Study|Progressive Disease|0|||
105664736|NCT01296555|364436713|FG021|Overall Study|Progressive Disease|0|||
105664737|NCT01296555|364436714|FG022|Overall Study|Progressive Disease|0|||
105664738|NCT01296555|364436715|FG023|Overall Study|Progressive Disease|0|||
105664739|NCT01296555|364436716|FG024|Overall Study|Progressive Disease|1|||
105664740|NCT01296555|364436717|FG025|Overall Study|Progressive Disease|0|||
105664741|NCT01296555|364436718|FG026|Overall Study|Progressive Disease|5|||
105890415|NCT02045862|365252725|FG002|Overall Study|Randomized but not Received Study Drug|8|||
105890416|NCT02045862|365252723|FG000|Overall Study|Adverse Event|7|||
105890417|NCT02045862|365252724|FG001|Overall Study|Adverse Event|5|||
105664742|NCT01296555|364436719|FG027|Overall Study|Progressive Disease|1|||
105664743|NCT01296555|364436720|FG028|Overall Study|Progressive Disease|0|||
105664744|NCT01296555|364436692|FG000|Overall Study|Protocol Violation|0|||
105664745|NCT01296555|364436693|FG001|Overall Study|Protocol Violation|0|||
105664746|NCT01296555|364436694|FG002|Overall Study|Protocol Violation|0|||
105664747|NCT01296555|364436695|FG003|Overall Study|Protocol Violation|0|||
105664748|NCT01296555|364436696|FG004|Overall Study|Protocol Violation|0|||
105664749|NCT01296555|364436697|FG005|Overall Study|Protocol Violation|0|||
105664750|NCT01296555|364436698|FG006|Overall Study|Protocol Violation|0|||
105664751|NCT01296555|364436699|FG007|Overall Study|Protocol Violation|0|||
105664752|NCT01296555|364436700|FG008|Overall Study|Protocol Violation|0|||
105664753|NCT01296555|364436701|FG009|Overall Study|Protocol Violation|0|||
105890418|NCT02045862|365252725|FG002|Overall Study|Adverse Event|27|||
105890419|NCT02045862|365252723|FG000|Overall Study|Lost to Follow-up|1|||
105890420|NCT02045862|365252724|FG001|Overall Study|Lost to Follow-up|2|||
105890421|NCT02045862|365252725|FG002|Overall Study|Lost to Follow-up|6|||
105890422|NCT00631410|365252726|FG000|Overall Study|Adverse Event|1|||
105890423|NCT00631410|365252727|FG001|Overall Study|Adverse Event|3|||
105890424|NCT00631410|365252726|FG000|Overall Study|Objective Progression or Relapse|4|||
105890425|NCT00631410|365252727|FG001|Overall Study|Objective Progression or Relapse|3|||
105890426|NCT00631410|365252726|FG000|Overall Study|Surgery|1|||
105890427|NCT00631410|365252727|FG001|Overall Study|Surgery|0|||
105890428|NCT00890084|365252728|FG000|Overall Study|Adverse Event|16|||
105890429|NCT00890084|365252728|FG000|Overall Study|Lost to Follow-up|126|||
105890430|NCT01438294|365252730|FG000|Overall Study|Lost to Follow-up|3|||
105890431|NCT01438294|365252731|FG001|Overall Study|Lost to Follow-up|7|||
105890432|NCT01346189|365252736|FG000|Overall Study|Withdrawal by Subject|7|||
105890433|NCT01346189|365252737|FG001|Overall Study|Withdrawal by Subject|5|||
105890434|NCT01346189|365252738|FG002|Overall Study|Withdrawal by Subject|3|||
105890435|NCT01346189|365252739|FG003|Overall Study|Withdrawal by Subject|5|||
105890436|NCT01346189|365252736|FG000|Overall Study|Physician Decision|4|||
105890437|NCT01346189|365252737|FG001|Overall Study|Physician Decision|0|||
105890438|NCT01346189|365252738|FG002|Overall Study|Physician Decision|0|||
105890439|NCT01346189|365252739|FG003|Overall Study|Physician Decision|0|||
105890440|NCT01346189|365252736|FG000|Overall Study|Moved|3|||
105890441|NCT01346189|365252737|FG001|Overall Study|Moved|0|||
105890442|NCT01346189|365252738|FG002|Overall Study|Moved|4|||
105890443|NCT01346189|365252739|FG003|Overall Study|Moved|0|||
105890444|NCT01346189|365252736|FG000|Overall Study|Other|2|||
105890445|NCT01346189|365252737|FG001|Overall Study|Other|4|||
105890446|NCT01346189|365252738|FG002|Overall Study|Other|7|||
105664754|NCT01296555|364436702|FG010|Overall Study|Protocol Violation|0|||
105664755|NCT01296555|364436703|FG011|Overall Study|Protocol Violation|0|||
105664756|NCT01296555|364436704|FG012|Overall Study|Protocol Violation|0|||
105664757|NCT01296555|364436705|FG013|Overall Study|Protocol Violation|1|||
105664758|NCT01296555|364436706|FG014|Overall Study|Protocol Violation|0|||
105664759|NCT01296555|364436707|FG015|Overall Study|Protocol Violation|0|||
105664760|NCT01296555|364436708|FG016|Overall Study|Protocol Violation|0|||
105664761|NCT01296555|364436709|FG017|Overall Study|Protocol Violation|0|||
105664762|NCT01296555|364436710|FG018|Overall Study|Protocol Violation|0|||
105664763|NCT01296555|364436711|FG019|Overall Study|Protocol Violation|0|||
105664764|NCT01296555|364436712|FG020|Overall Study|Protocol Violation|0|||
105664765|NCT01296555|364436713|FG021|Overall Study|Protocol Violation|0|||
105664766|NCT01296555|364436714|FG022|Overall Study|Protocol Violation|0|||
105890447|NCT01346189|365252739|FG003|Overall Study|Other|3|||
105890448|NCT01346189|365252736|FG000|Overall Study|Death|0|||
105664767|NCT01296555|364436715|FG023|Overall Study|Protocol Violation|0|||
105664768|NCT01296555|364436716|FG024|Overall Study|Protocol Violation|0|||
105890449|NCT01346189|365252737|FG001|Overall Study|Death|3|||
105890450|NCT01346189|365252738|FG002|Overall Study|Death|0|||
105890451|NCT01346189|365252739|FG003|Overall Study|Death|0|||
105890452|NCT01346189|365252736|FG000|Overall Study|Non-health system primary care physician|0|||
105890453|NCT01346189|365252737|FG001|Overall Study|Non-health system primary care physician|5|||
105890454|NCT01346189|365252738|FG002|Overall Study|Non-health system primary care physician|0|||
106121688|NCT00437125|366103612|FG000|Overall Study|Clinical Relapse|1|||
106121689|NCT00437125|366103612|FG000|Overall Study|Lack of Efficacy|1|||
106121690|NCT00437125|366103612|FG000|Overall Study|Lost to Follow-up|1|||
106121691|NCT00437125|366103612|FG000|Overall Study|Withdrawal by Subject|13|||
106121692|NCT00437125|366103612|FG000|Overall Study|Withdrawal by Caregiver|2|||
106121693|NCT00437125|366103612|FG000|Overall Study|Physician Decision|1|||
106121694|NCT00871351|366103619|FG000|Overall Study|Withdrawal by Subject|1|||
106121695|NCT00871351|366103620|FG001|Overall Study|Withdrawal by Subject|0|||
106121696|NCT00871351|366103621|FG002|Overall Study|Withdrawal by Subject|0|||
106121697|NCT00871351|366103619|FG000|Overall Study|Adverse Event|3|||
106121698|NCT00871351|366103620|FG001|Overall Study|Adverse Event|1|||
106121699|NCT00871351|366103621|FG002|Overall Study|Adverse Event|0|||
106121700|NCT02032173|366103622|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
106121701|NCT01912222|366103628|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
106121702|NCT01912222|366103629|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
106121703|NCT01912222|366103630|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
106121704|NCT01912222|366103628|FG000|Part B: Treatment Period|Progressive disease|10|||
106121705|NCT01912222|366103629|FG001|Part B: Treatment Period|Progressive disease|12|||
106121706|NCT01912222|366103630|FG002|Part B: Treatment Period|Progressive disease|15|||
106121707|NCT01912222|366103628|FG000|Part B: Treatment Period|Adverse Event|1|||
106121708|NCT01912222|366103629|FG001|Part B: Treatment Period|Adverse Event|2|||
106121709|NCT01912222|366103630|FG002|Part B: Treatment Period|Adverse Event|3|||
106121710|NCT01912222|366103628|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
106121711|NCT01912222|366103629|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
106121712|NCT01912222|366103630|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
105785714|NCT06104423|364868545|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
105785715|NCT06104423|364868546|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
105785716|NCT06104423|364868547|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
105785717|NCT00145795|364868550|FG000|Overall Study|Adverse Event|1|||
105785718|NCT00145795|364868551|FG001|Overall Study|Adverse Event|0|||
105785719|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
105785720|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
105785721|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
105785722|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
105785723|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
105785724|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
105785725|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
105785726|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
105785727|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
105785728|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
105785729|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
105785730|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
105785731|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
105785732|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
105785733|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
105785734|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
105785735|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
105785736|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
105785737|NCT00570492|364868552|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
105785738|NCT00570492|364868553|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
105785739|NCT00570492|364868554|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
105785740|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105785741|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
105785742|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
105785743|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
105785744|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
105785745|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
105785746|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
105785747|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
105785748|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
105785749|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
105785750|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
105785751|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
105785752|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
105785753|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
105890455|NCT01346189|365252739|FG003|Overall Study|Non-health system primary care physician|0|||
105890456|NCT01346189|365252736|FG000|Overall Study|Travel|0|||
105890457|NCT01346189|365252737|FG001|Overall Study|Travel|0|||
105890458|NCT01346189|365252738|FG002|Overall Study|Travel|0|||
105890459|NCT01346189|365252739|FG003|Overall Study|Travel|3|||
105890460|NCT03193801|365252743|FG000|Overall Study|Physician Decision|2|||
105890461|NCT03193801|365252743|FG000|Overall Study|Withdrawal by Subject|1|||
105890462|NCT04964544|365252744|FG000|Overall Study|Screen failure or other uncategorised|10|||
105890463|NCT04964544|365252744|FG000|Overall Study|Physician Decision|4|||
105890464|NCT04964544|365252744|FG000|Overall Study|Lost to Follow-up|9|||
105890465|NCT04964544|365252744|FG000|Overall Study|Withdrawal by Subject|18|||
105890466|NCT04964544|365252744|FG000|Overall Study|Death|1|||
105890467|NCT02855359|365252748|FG000|Overall Study|Death|2|||
105890468|NCT02855359|365252749|FG001|Overall Study|Death|2|||
105890469|NCT02855359|365252750|FG002|Overall Study|Death|0|||
105890470|NCT02855359|365252751|FG003|Overall Study|Death|0|||
105890471|NCT02855359|365252748|FG000|Overall Study|Study Termination by Sponsor|9|||
105890472|NCT02855359|365252749|FG001|Overall Study|Study Termination by Sponsor|11|||
105890473|NCT02855359|365252750|FG002|Overall Study|Study Termination by Sponsor|0|||
105890474|NCT02855359|365252751|FG003|Overall Study|Study Termination by Sponsor|0|||
105890475|NCT04712019|365252752|FG000|Overall Study|Withdrawal by Subject|2|||
105890476|NCT04712019|365252753|FG001|Overall Study|Withdrawal by Subject|2|||
105890477|NCT04712019|365252752|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
105890478|NCT04712019|365252753|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
105890479|NCT05845567|365252754|FG000|Overall Study|Withdrawal by Subject|1|||
105890480|NCT02541669|365252760|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
105890481|NCT02541669|365252761|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
105890482|NCT02541669|365252762|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
105890483|NCT02541669|365252763|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
105890484|NCT02541669|365252764|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
105890485|NCT01154088|365252765|FG000|Overall Study|Lost to Follow-up|4|||
105890486|NCT01154088|365252766|FG001|Overall Study|Lost to Follow-up|6|||
105890487|NCT01154088|365252767|FG002|Overall Study|Lost to Follow-up|7|||
105890488|NCT02122770|365252770|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
105890489|NCT02122770|365252771|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
105890490|NCT02122770|365252772|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
105890491|NCT02122770|365252773|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
105890492|NCT02122770|365252774|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
105890493|NCT02122770|365252775|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
105890494|NCT02122770|365252770|FG000|Part A: Drug-drug Interaction 2|Other|0|||
105890495|NCT02122770|365252771|FG001|Part A: Drug-drug Interaction 2|Other|0|||
105890496|NCT02122770|365252772|FG002|Part A: Drug-drug Interaction 2|Other|1|||
105890497|NCT02122770|365252773|FG003|Part A: Drug-drug Interaction 2|Other|0|||
105890498|NCT02122770|365252774|FG004|Part A: Drug-drug Interaction 2|Other|0|||
105890499|NCT02122770|365252775|FG005|Part A: Drug-drug Interaction 2|Other|0|||
105890500|NCT02122770|365252770|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105890501|NCT02122770|365252771|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
105890502|NCT02122770|365252772|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105890503|NCT02122770|365252773|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105890504|NCT02122770|365252774|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105890505|NCT02122770|365252775|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
105890506|NCT02122770|365252770|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
105890507|NCT02122770|365252771|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
105890508|NCT02122770|365252772|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
105890509|NCT02122770|365252773|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
105890510|NCT02122770|365252774|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
105890511|NCT02122770|365252775|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
105890512|NCT02122770|365252770|FG000|Part B: Standard of Care|Adverse Event|0|||
105890513|NCT02122770|365252771|FG001|Part B: Standard of Care|Adverse Event|0|||
105890514|NCT02122770|365252772|FG002|Part B: Standard of Care|Adverse Event|0|||
105890515|NCT02122770|365252773|FG003|Part B: Standard of Care|Adverse Event|0|||
105890516|NCT02122770|365252774|FG004|Part B: Standard of Care|Adverse Event|4|||
105890517|NCT02122770|365252775|FG005|Part B: Standard of Care|Adverse Event|1|||
105890518|NCT02122770|365252770|FG000|Part B: Standard of Care|Other|0|||
105890519|NCT02122770|365252771|FG001|Part B: Standard of Care|Other|0|||
105890520|NCT02122770|365252772|FG002|Part B: Standard of Care|Other|0|||
105890521|NCT02122770|365252773|FG003|Part B: Standard of Care|Other|0|||
105890522|NCT02122770|365252774|FG004|Part B: Standard of Care|Other|0|||
105890523|NCT02122770|365252775|FG005|Part B: Standard of Care|Other|2|||
105890524|NCT02122770|365252770|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
105890525|NCT02122770|365252771|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
105890526|NCT02122770|365252772|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
105890527|NCT02122770|365252773|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
105664769|NCT01296555|364436717|FG025|Overall Study|Protocol Violation|0|||
105664770|NCT01296555|364436718|FG026|Overall Study|Protocol Violation|0|||
105890528|NCT02122770|365252774|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
105890529|NCT02122770|365252775|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
105890530|NCT02122770|365252770|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
105890531|NCT02122770|365252771|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
105890532|NCT02122770|365252772|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
105890533|NCT02122770|365252773|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
105890534|NCT02122770|365252774|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
105890535|NCT02122770|365252775|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
105890536|NCT02122770|365252770|FG000|Part B: Standard of Care|Progressive Disease|0|||
105890537|NCT02122770|365252771|FG001|Part B: Standard of Care|Progressive Disease|0|||
105890538|NCT02122770|365252772|FG002|Part B: Standard of Care|Progressive Disease|0|||
105890539|NCT02122770|365252773|FG003|Part B: Standard of Care|Progressive Disease|0|||
105890540|NCT02122770|365252774|FG004|Part B: Standard of Care|Progressive Disease|10|||
105890541|NCT02122770|365252775|FG005|Part B: Standard of Care|Progressive Disease|8|||
105890542|NCT02017912|365252776|FG000|Overall Study|Withdrawal by Subject|2|||
105890543|NCT02017912|365252777|FG001|Overall Study|Withdrawal by Subject|1|||
105890544|NCT02017912|365252776|FG000|Overall Study|miscellaneous|1|||
105890545|NCT02017912|365252777|FG001|Overall Study|miscellaneous|1|||
105890546|NCT00658775|365252778|FG000|Overall Study|Adverse Event|4|||
105890547|NCT00658775|365252779|FG001|Overall Study|Adverse Event|6|||
105890548|NCT00658775|365252778|FG000|Overall Study|Lost to Follow-up|17|||
105890549|NCT00658775|365252779|FG001|Overall Study|Lost to Follow-up|18|||
105890550|NCT00658775|365252778|FG000|Overall Study|Withdrawal by Subject|6|||
105890551|NCT00658775|365252779|FG001|Overall Study|Withdrawal by Subject|4|||
105890552|NCT00658775|365252778|FG000|Overall Study|Withdrawal of consent|8|||
105890553|NCT00658775|365252779|FG001|Overall Study|Withdrawal of consent|7|||
105890554|NCT00658775|365252778|FG000|Overall Study|Other|7|||
105890555|NCT00658775|365252779|FG001|Overall Study|Other|8|||
105890556|NCT00688701|365254452|FG000|Overall Study|Adverse Event|1|||
105890557|NCT00688701|365254453|FG001|Overall Study|Adverse Event|0|||
105890558|NCT00688701|365254454|FG002|Overall Study|Adverse Event|5|||
105890559|NCT00688701|365254455|FG003|Overall Study|Adverse Event|3|||
105890560|NCT00688701|365254452|FG000|Overall Study|Lack of Efficacy|0|||
105890561|NCT00688701|365254453|FG001|Overall Study|Lack of Efficacy|1|||
105890562|NCT00688701|365254454|FG002|Overall Study|Lack of Efficacy|0|||
105890563|NCT00688701|365254455|FG003|Overall Study|Lack of Efficacy|0|||
105890564|NCT00688701|365254452|FG000|Overall Study|Withdrawal by Subject|3|||
105890565|NCT00688701|365254453|FG001|Overall Study|Withdrawal by Subject|3|||
105890566|NCT00688701|365254454|FG002|Overall Study|Withdrawal by Subject|4|||
105890567|NCT00688701|365254455|FG003|Overall Study|Withdrawal by Subject|8|||
105890568|NCT00688701|365254452|FG000|Overall Study|Poor compliance to protocol|0|||
105890569|NCT00688701|365254453|FG001|Overall Study|Poor compliance to protocol|1|||
105890570|NCT00688701|365254454|FG002|Overall Study|Poor compliance to protocol|1|||
105890571|NCT00688701|365254455|FG003|Overall Study|Poor compliance to protocol|0|||
105890572|NCT03339726|365254462|FG000|Overall Study|Withdrawal by Subject|1|||
105890573|NCT03339726|365254463|FG001|Overall Study|Withdrawal by Subject|0|||
105890574|NCT03339726|365254464|FG002|Overall Study|Withdrawal by Subject|0|||
105890575|NCT03339726|365254462|FG000|Overall Study|Lost to Follow-up|0|||
105890576|NCT03339726|365254463|FG001|Overall Study|Lost to Follow-up|1|||
105890577|NCT03339726|365254464|FG002|Overall Study|Lost to Follow-up|0|||
105890578|NCT03875092|365254472|FG000|Overall Study|Adverse Event|2|||
105890579|NCT03875092|365254473|FG001|Overall Study|Adverse Event|5|||
105890580|NCT03875092|365254472|FG000|Overall Study|Death|44|||
105890581|NCT03875092|365254473|FG001|Overall Study|Death|51|||
105890582|NCT03875092|365254472|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
105890583|NCT03875092|365254473|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
105890584|NCT03205761|365254474|FG000|Overall Study|Withdrawal by Subject|1|||
105890585|NCT03205761|365254474|FG000|Overall Study|Progressive Disease|10|||
105664771|NCT01296555|364436719|FG027|Overall Study|Protocol Violation|0|||
105890586|NCT00546117|365254481|FG000|Overall Study|Withdrawal by Subject|3|||
105890587|NCT00546117|365254482|FG001|Overall Study|Withdrawal by Subject|0|||
105890588|NCT00546117|365254481|FG000|Overall Study|Inability to schedule follow-up visit|1|||
105890589|NCT00546117|365254482|FG001|Overall Study|Inability to schedule follow-up visit|0|||
105890590|NCT00381238|365254483|FG000|Overall Study|Adverse Event|3|||
105890591|NCT00381238|365254483|FG000|Overall Study|Protocol Violation|1|||
105890592|NCT00381238|365254483|FG000|Overall Study|Withdrawal by Subject|4|||
105890593|NCT00381238|365254483|FG000|Overall Study|Lack of Efficacy|2|||
105890594|NCT00381238|365254483|FG000|Overall Study|Withdrew by physician|1|||
105890595|NCT00381238|365254483|FG000|Overall Study|Disease progression|1|||
105890596|NCT04984278|365254486|FG000|Period 1|Withdrawal by Subject|1|||
105890597|NCT04984278|365254487|FG001|Period 1|Withdrawal by Subject|0|||
106121713|NCT03377790|366103631|FG000|Overall Study|Withdrawal by Subject|1|||
106121714|NCT03377790|366103632|FG001|Overall Study|Withdrawal by Subject|0|||
105890598|NCT04984278|365254486|FG000|Period 1|Other|0|||
105996490|NCT00132808|365647080|FG001|Stratum II|Adverse Event|2|||
105996491|NCT00132808|365647081|FG002|Stratum II|Adverse Event|1|||
105996492|NCT00132808|365647079|FG000|Stratum II|Death|1|||
105996493|NCT00132808|365647080|FG001|Stratum II|Death|0|||
105996494|NCT00132808|365647081|FG002|Stratum II|Death|0|||
105996495|NCT00132808|365647079|FG000|Stratum II|Lost to Follow-up|2|||
105996496|NCT00132808|365647080|FG001|Stratum II|Lost to Follow-up|2|||
105996497|NCT00132808|365647081|FG002|Stratum II|Lost to Follow-up|1|||
105996498|NCT00132808|365647079|FG000|Stratum II|Protocol Violation|0|||
105890599|NCT04984278|365254487|FG001|Period 1|Other|1|||
105664772|NCT01296555|364436720|FG028|Overall Study|Protocol Violation|0|||
105996499|NCT00132808|365647080|FG001|Stratum II|Protocol Violation|2|||
105996500|NCT00132808|365647081|FG002|Stratum II|Protocol Violation|1|||
105996501|NCT00132808|365647079|FG000|Stratum II|Withdrawal by Subject|4|||
105996502|NCT00132808|365647080|FG001|Stratum II|Withdrawal by Subject|9|||
105996503|NCT00132808|365647081|FG002|Stratum II|Withdrawal by Subject|6|||
105996504|NCT04739436|365647082|FG000|Overall Study|Lost to Follow-up|21|||
105996505|NCT04739436|365647083|FG001|Overall Study|Lost to Follow-up|23|||
105996506|NCT04739436|365647082|FG000|Overall Study|Withdrawal by Subject|4|||
105996507|NCT04739436|365647083|FG001|Overall Study|Withdrawal by Subject|6|||
105996508|NCT04739436|365647082|FG000|Overall Study|not randomized properly|1|||
105996509|NCT04739436|365647083|FG001|Overall Study|not randomized properly|0|||
105996510|NCT04544956|365647084|FG000|Overall Study|Withdrawal by Subject|1|||
105996511|NCT04491136|365647085|FG000|Overall Study|Patient withdraw informed consent|9|||
105996512|NCT04491136|365647085|FG000|Overall Study|Adverse Event|2|||
105996513|NCT04491136|365647085|FG000|Overall Study|Death|3|||
105996514|NCT04491136|365647085|FG000|Overall Study|Lost to Follow-up|3|||
105996515|NCT04491136|365647085|FG000|Overall Study|Physician Decision|45|||
105996516|NCT04491136|365647085|FG000|Overall Study|sponsor terminated the study early|16|||
105996517|NCT04491136|365647085|FG000|Overall Study|Patient/guardian's decision|1|||
105996518|NCT02452424|365647089|FG000|Overall Study|Death|2|||
105996519|NCT02452424|365647090|FG001|Overall Study|Death|2|||
105996520|NCT02452424|365647091|FG002|Overall Study|Death|2|||
105996521|NCT02452424|365647092|FG003|Overall Study|Death|6|||
105996522|NCT02452424|365647093|FG004|Overall Study|Death|2|||
105996523|NCT02452424|365647094|FG005|Overall Study|Death|0|||
105996524|NCT02452424|365647095|FG006|Overall Study|Death|5|||
105996525|NCT02452424|365647096|FG007|Overall Study|Death|1|||
105996526|NCT02452424|365647097|FG008|Overall Study|Death|3|||
105996527|NCT02452424|365647098|FG009|Overall Study|Death|1|||
105996528|NCT02452424|365647099|FG010|Overall Study|Death|0|||
105996529|NCT02452424|365647089|FG000|Overall Study|Lost to Follow-up|0|||
105890600|NCT04984278|365254486|FG000|Period 2|Adverse Event|1|||
105890601|NCT04984278|365254487|FG001|Period 2|Adverse Event|0|||
105890602|NCT04984278|365254486|FG000|Period 2|Other|0|||
105890603|NCT04984278|365254487|FG001|Period 2|Other|1|||
105890604|NCT02637895|365254490|FG000|Overall Study|Lost to Follow-up|4|||
105890605|NCT02637895|365254491|FG001|Overall Study|Lost to Follow-up|0|||
105890606|NCT02637895|365254490|FG000|Overall Study|Protocol Violation|0|||
105890607|NCT02637895|365254491|FG001|Overall Study|Protocol Violation|1|||
105890608|NCT02637895|365254490|FG000|Overall Study|Lack of Efficacy|1|||
105890609|NCT02637895|365254491|FG001|Overall Study|Lack of Efficacy|0|||
105890610|NCT02637895|365254490|FG000|Overall Study|Withdrawal by Subject|1|||
105890611|NCT02637895|365254491|FG001|Overall Study|Withdrawal by Subject|1|||
105890612|NCT02637895|365254490|FG000|Overall Study|Abnormal baseline lab|0|||
105996530|NCT02452424|365647090|FG001|Overall Study|Lost to Follow-up|1|||
105996531|NCT02452424|365647091|FG002|Overall Study|Lost to Follow-up|1|||
105996532|NCT02452424|365647092|FG003|Overall Study|Lost to Follow-up|0|||
105996533|NCT02452424|365647093|FG004|Overall Study|Lost to Follow-up|0|||
105996534|NCT02452424|365647094|FG005|Overall Study|Lost to Follow-up|0|||
105664773|NCT01296555|364436692|FG000|Overall Study|Study Terminated By Sponsor|0|||
105890613|NCT02637895|365254491|FG001|Overall Study|Abnormal baseline lab|1|||
105996535|NCT02452424|365647095|FG006|Overall Study|Lost to Follow-up|0|||
105996536|NCT02452424|365647096|FG007|Overall Study|Lost to Follow-up|0|||
105996537|NCT02452424|365647097|FG008|Overall Study|Lost to Follow-up|0|||
105996538|NCT02452424|365647098|FG009|Overall Study|Lost to Follow-up|0|||
105996539|NCT02452424|365647099|FG010|Overall Study|Lost to Follow-up|0|||
105664774|NCT01296555|364436693|FG001|Overall Study|Study Terminated By Sponsor|0|||
105890614|NCT03164564|365254494|FG000|Overall Study|Death|3|||
105890615|NCT03164564|365254495|FG001|Overall Study|Death|0|||
105890616|NCT03164564|365254494|FG000|Overall Study|Withdrawal by Subject|20|||
105890617|NCT03164564|365254495|FG001|Overall Study|Withdrawal by Subject|15|||
105890618|NCT03164564|365254494|FG000|Overall Study|Lost to Follow-up|2|||
105890619|NCT03164564|365254495|FG001|Overall Study|Lost to Follow-up|0|||
105890620|NCT03164564|365254494|FG000|Overall Study|Physician Decision|0|||
105996540|NCT02452424|365647089|FG000|Overall Study|Withdrawal by Subject|0|||
105996541|NCT02452424|365647090|FG001|Overall Study|Withdrawal by Subject|0|||
105996542|NCT02452424|365647091|FG002|Overall Study|Withdrawal by Subject|3|||
105996543|NCT02452424|365647092|FG003|Overall Study|Withdrawal by Subject|2|||
105996544|NCT02452424|365647093|FG004|Overall Study|Withdrawal by Subject|0|||
105996545|NCT02452424|365647094|FG005|Overall Study|Withdrawal by Subject|0|||
105996546|NCT02452424|365647095|FG006|Overall Study|Withdrawal by Subject|1|||
105890621|NCT03164564|365254495|FG001|Overall Study|Physician Decision|1|||
105890622|NCT03164564|365254494|FG000|Overall Study|Adverse Event|0|||
105890623|NCT03164564|365254495|FG001|Overall Study|Adverse Event|1|||
105890624|NCT03164564|365254494|FG000|Overall Study|Ongoing|1586|||
105890625|NCT03164564|365254495|FG001|Overall Study|Ongoing|1586|||
105890626|NCT04507256|365254499|FG000|Overall Study|Withdrawal by Subject|1|||
105890627|NCT04507256|365254500|FG001|Overall Study|Withdrawal by Subject|0|||
105890628|NCT04507256|365254501|FG002|Overall Study|Withdrawal by Subject|0|||
105890629|NCT04507256|365254502|FG003|Overall Study|Withdrawal by Subject|1|||
105890630|NCT04507256|365254503|FG004|Overall Study|Withdrawal by Subject|0|||
105890631|NCT04507256|365254504|FG005|Overall Study|Withdrawal by Subject|0|||
105890632|NCT02111785|365254505|FG000|Overall Study|Death|0|||
105890633|NCT02111785|365254506|FG001|Overall Study|Death|1|||
105890634|NCT02111785|365254507|FG002|Overall Study|Death|0|||
105890635|NCT02111785|365254508|FG003|Overall Study|Death|0|||
105890636|NCT02738879|365254515|FG000|Overall Study|Adverse Event|1|||
105890637|NCT02738879|365254516|FG001|Overall Study|Adverse Event|1|||
105890638|NCT02738879|365254515|FG000|Overall Study|Death|0|||
105890639|NCT02738879|365254516|FG001|Overall Study|Death|2|||
105890640|NCT02738879|365254515|FG000|Overall Study|Lost to Follow-up|1|||
105890641|NCT02738879|365254516|FG001|Overall Study|Lost to Follow-up|5|||
105890642|NCT02738879|365254515|FG000|Overall Study|Protocol Violation|1|||
105890643|NCT02738879|365254516|FG001|Overall Study|Protocol Violation|3|||
105890644|NCT02738879|365254515|FG000|Overall Study|Physician Decision|3|||
105890645|NCT02738879|365254516|FG001|Overall Study|Physician Decision|4|||
105890646|NCT02738879|365254515|FG000|Overall Study|Pregnancy|0|||
105890647|NCT02738879|365254516|FG001|Overall Study|Pregnancy|1|||
105890648|NCT02738879|365254515|FG000|Overall Study|Screen Failure|1|||
105890649|NCT02738879|365254516|FG001|Overall Study|Screen Failure|2|||
105890650|NCT02738879|365254515|FG000|Overall Study|Site Discontinued Study Participation|1|||
105890651|NCT02738879|365254516|FG001|Overall Study|Site Discontinued Study Participation|0|||
105890652|NCT02738879|365254515|FG000|Overall Study|Withdrawal by Subject|5|||
105890653|NCT02738879|365254516|FG001|Overall Study|Withdrawal by Subject|7|||
105890654|NCT02822573|365254521|FG000|Overall Study|Lost to Follow-up|5|||
105890655|NCT02822573|365254522|FG001|Overall Study|Lost to Follow-up|3|||
105890656|NCT02822573|365254521|FG000|Overall Study|Physician Decision|1|||
105890657|NCT02822573|365254522|FG001|Overall Study|Physician Decision|1|||
105890658|NCT02822573|365254521|FG000|Overall Study|Withdrawal by Subject|9|||
105890659|NCT02822573|365254522|FG001|Overall Study|Withdrawal by Subject|5|||
105890660|NCT02822573|365254521|FG000|Overall Study|Protocol Violation|6|||
105890661|NCT02822573|365254522|FG001|Overall Study|Protocol Violation|4|||
105890662|NCT02822573|365254521|FG000|Overall Study|Too sick or ill|2|||
105890663|NCT02822573|365254522|FG001|Overall Study|Too sick or ill|1|||
105890664|NCT02822573|365254521|FG000|Overall Study|Disease Progression|1|||
105890665|NCT02822573|365254522|FG001|Overall Study|Disease Progression|1|||
105890666|NCT02822573|365254521|FG000|Overall Study|No reason given|6|||
106121715|NCT03377790|366103631|FG000|Overall Study|Adverse Event|1|||
106121716|NCT03377790|366103632|FG001|Overall Study|Adverse Event|0|||
106121717|NCT03377790|366103631|FG000|Overall Study|Lost to Follow-up|0|||
106121718|NCT03377790|366103632|FG001|Overall Study|Lost to Follow-up|2|||
106121719|NCT03377790|366103631|FG000|Overall Study|Randomized but not treated|1|||
105890667|NCT02822573|365254522|FG001|Overall Study|No reason given|4|||
105890668|NCT00738881|365254523|FG000|Overall Study|Withdrawal by Subject|0|||
105890669|NCT00738881|365254524|FG001|Overall Study|Withdrawal by Subject|2|||
105890670|NCT00759785|365254525|FG000|Overall Study|Participant sample not evaluable|11|||
105890671|NCT00759785|365254526|FG001|Overall Study|Participant sample not evaluable|2|||
105890672|NCT00759785|365254525|FG000|Overall Study|Participant sample lost|0|||
105890673|NCT00759785|365254526|FG001|Overall Study|Participant sample lost|1|||
105890674|NCT00759785|365254525|FG000|Overall Study|Protocol Violation|1|||
105890675|NCT00759785|365254526|FG001|Overall Study|Protocol Violation|0|||
105890676|NCT00759785|365254525|FG000|Overall Study|Physician Decision|0|||
105890677|NCT00759785|365254526|FG001|Overall Study|Physician Decision|1|||
105890678|NCT00759785|365254525|FG000|Overall Study|Withdrawal by Subject|0|||
105890679|NCT00759785|365254526|FG001|Overall Study|Withdrawal by Subject|1|||
105890680|NCT00089778|365254527|FG000|Overall Study|Protocol Violation|0|||
105890681|NCT00089778|365254528|FG001|Overall Study|Protocol Violation|0|||
105890682|NCT00089778|365254529|FG002|Overall Study|Protocol Violation|1|||
105890683|NCT04521621|365254530|FG000|Overall Study|Death|17|||
105890684|NCT04521621|365254531|FG001|Overall Study|Death|8|||
105890685|NCT04521621|365254532|FG002|Overall Study|Death|8|||
105890686|NCT04521621|365254533|FG003|Overall Study|Death|5|||
105890687|NCT04521621|365254534|FG004|Overall Study|Death|2|||
105890688|NCT04521621|365254535|FG005|Overall Study|Death|7|||
106121720|NCT03377790|366103632|FG001|Overall Study|Randomized but not treated|0|||
106121721|NCT03377790|366103631|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
106121722|NCT03377790|366103632|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
106121723|NCT00467142|366103633|FG000|Overall Study|Withdrawal by Subject|1|||
106121724|NCT00467142|366103633|FG000|Overall Study|Adverse Event|1|||
106121725|NCT00467142|366103633|FG000|Overall Study|Protocol Violation|1|||
106121726|NCT02091739|366103635|FG000|MP: 16 Weeks|Adverse Event|1|||
105664775|NCT01296555|364436694|FG002|Overall Study|Study Terminated By Sponsor|0|||
105664776|NCT01296555|364436695|FG003|Overall Study|Study Terminated By Sponsor|0|||
105664777|NCT01296555|364436696|FG004|Overall Study|Study Terminated By Sponsor|0|||
105664778|NCT01296555|364436697|FG005|Overall Study|Study Terminated By Sponsor|0|||
105664779|NCT01296555|364436698|FG006|Overall Study|Study Terminated By Sponsor|0|||
105664780|NCT01296555|364436699|FG007|Overall Study|Study Terminated By Sponsor|0|||
105664781|NCT01296555|364436700|FG008|Overall Study|Study Terminated By Sponsor|0|||
105664782|NCT01296555|364436701|FG009|Overall Study|Study Terminated By Sponsor|0|||
105664783|NCT01296555|364436702|FG010|Overall Study|Study Terminated By Sponsor|0|||
105664784|NCT01296555|364436703|FG011|Overall Study|Study Terminated By Sponsor|0|||
105664785|NCT01296555|364436704|FG012|Overall Study|Study Terminated By Sponsor|0|||
105664786|NCT01296555|364436705|FG013|Overall Study|Study Terminated By Sponsor|0|||
105664787|NCT01296555|364436706|FG014|Overall Study|Study Terminated By Sponsor|0|||
105664788|NCT01296555|364436707|FG015|Overall Study|Study Terminated By Sponsor|0|||
106121727|NCT02091739|366103636|FG001|MP: 16 Weeks|Adverse Event|1|||
106121728|NCT02091739|366103637|FG002|MP: 16 Weeks|Adverse Event|1|||
106121729|NCT02091739|366103638|FG003|MP: 16 Weeks|Adverse Event|0|||
106121730|NCT02091739|366103639|FG004|MP: 16 Weeks|Adverse Event|0|||
106121731|NCT02091739|366103635|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
106121732|NCT02091739|366103636|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
106121733|NCT02091739|366103637|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
106121734|NCT02091739|366103638|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
106121735|NCT02091739|366103639|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
106121736|NCT02091739|366103635|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
106121737|NCT02091739|366103636|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
106121738|NCT02091739|366103637|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
106121739|NCT02091739|366103638|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
106121740|NCT02091739|366103639|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
106121741|NCT02091739|366103635|FG000|EP: 48 Weeks|Other|0|||
106121742|NCT02091739|366103636|FG001|EP: 48 Weeks|Other|0|||
106121743|NCT02091739|366103637|FG002|EP: 48 Weeks|Other|0|||
106121744|NCT02091739|366103638|FG003|EP: 48 Weeks|Other|1|||
105664789|NCT01296555|364436708|FG016|Overall Study|Study Terminated By Sponsor|0|||
105664790|NCT01296555|364436709|FG017|Overall Study|Study Terminated By Sponsor|0|||
105664791|NCT01296555|364436710|FG018|Overall Study|Study Terminated By Sponsor|0|||
105664792|NCT01296555|364436711|FG019|Overall Study|Study Terminated By Sponsor|0|||
105664793|NCT01296555|364436712|FG020|Overall Study|Study Terminated By Sponsor|0|||
105664794|NCT01296555|364436713|FG021|Overall Study|Study Terminated By Sponsor|0|||
105664795|NCT01296555|364436714|FG022|Overall Study|Study Terminated By Sponsor|0|||
105664796|NCT01296555|364436715|FG023|Overall Study|Study Terminated By Sponsor|0|||
105664797|NCT01296555|364436716|FG024|Overall Study|Study Terminated By Sponsor|0|||
105664798|NCT01296555|364436717|FG025|Overall Study|Study Terminated By Sponsor|1|||
105664799|NCT01296555|364436718|FG026|Overall Study|Study Terminated By Sponsor|0|||
105664800|NCT01296555|364436719|FG027|Overall Study|Study Terminated By Sponsor|0|||
105664801|NCT01296555|364436720|FG028|Overall Study|Study Terminated By Sponsor|0|||
105664802|NCT01296555|364436692|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664803|NCT01296555|364436693|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664804|NCT01296555|364436694|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664805|NCT01296555|364436695|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664806|NCT01296555|364436696|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664807|NCT01296555|364436697|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664808|NCT01296555|364436698|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664809|NCT01296555|364436699|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664810|NCT01296555|364436700|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664811|NCT01296555|364436701|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664812|NCT01296555|364436702|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664813|NCT01296555|364436703|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105890689|NCT04521621|365254536|FG006|Overall Study|Death|0|||
105890690|NCT04521621|365254537|FG007|Overall Study|Death|0|||
105890691|NCT04521621|365254530|FG000|Overall Study|Study Terminated by Sponsor|4|||
105890692|NCT04521621|365254531|FG001|Overall Study|Study Terminated by Sponsor|6|||
105890693|NCT04521621|365254532|FG002|Overall Study|Study Terminated by Sponsor|8|||
105890694|NCT04521621|365254533|FG003|Overall Study|Study Terminated by Sponsor|0|||
105890695|NCT04521621|365254534|FG004|Overall Study|Study Terminated by Sponsor|1|||
105890696|NCT04521621|365254535|FG005|Overall Study|Study Terminated by Sponsor|7|||
105664814|NCT01296555|364436704|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664815|NCT01296555|364436705|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664816|NCT01296555|364436706|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664817|NCT01296555|364436707|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664818|NCT01296555|364436708|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105890697|NCT04521621|365254536|FG006|Overall Study|Study Terminated by Sponsor|0|||
106121745|NCT02091739|366103639|FG004|EP: 48 Weeks|Other|0|||
106121746|NCT02091739|366103635|FG000|EP: 48 Weeks|Death|0|||
106121747|NCT02091739|366103636|FG001|EP: 48 Weeks|Death|0|||
106121748|NCT02091739|366103637|FG002|EP: 48 Weeks|Death|0|||
106121749|NCT02091739|366103638|FG003|EP: 48 Weeks|Death|3|||
105664819|NCT01296555|364436709|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664820|NCT01296555|364436710|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664821|NCT01296555|364436711|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
105664822|NCT01296555|364436712|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664823|NCT01296555|364436713|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664824|NCT01296555|364436714|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664825|NCT01296555|364436715|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664826|NCT01296555|364436716|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664827|NCT01296555|364436717|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664828|NCT01296555|364436718|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664829|NCT01296555|364436719|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664830|NCT01296555|364436720|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
105664831|NCT01296555|364436692|FG000|Overall Study|Death|0|||
105664832|NCT01296555|364436693|FG001|Overall Study|Death|0|||
105890698|NCT04521621|365254537|FG007|Overall Study|Study Terminated by Sponsor|0|||
105890699|NCT04521621|365254530|FG000|Overall Study|Withdrawal by Subject|0|||
105890700|NCT04521621|365254531|FG001|Overall Study|Withdrawal by Subject|0|||
105890701|NCT04521621|365254532|FG002|Overall Study|Withdrawal by Subject|1|||
105890702|NCT04521621|365254533|FG003|Overall Study|Withdrawal by Subject|1|||
105890703|NCT04521621|365254534|FG004|Overall Study|Withdrawal by Subject|0|||
105890704|NCT04521621|365254535|FG005|Overall Study|Withdrawal by Subject|0|||
105890705|NCT04521621|365254536|FG006|Overall Study|Withdrawal by Subject|0|||
105890706|NCT04521621|365254537|FG007|Overall Study|Withdrawal by Subject|0|||
105890707|NCT04521621|365254530|FG000|Overall Study|Allocated in error without study intervention|1|||
105890708|NCT04521621|365254531|FG001|Overall Study|Allocated in error without study intervention|0|||
105890709|NCT04521621|365254532|FG002|Overall Study|Allocated in error without study intervention|0|||
105890710|NCT04521621|365254533|FG003|Overall Study|Allocated in error without study intervention|0|||
105890711|NCT04521621|365254534|FG004|Overall Study|Allocated in error without study intervention|0|||
105890712|NCT04521621|365254535|FG005|Overall Study|Allocated in error without study intervention|0|||
105890713|NCT04521621|365254536|FG006|Overall Study|Allocated in error without study intervention|0|||
105890714|NCT04521621|365254537|FG007|Overall Study|Allocated in error without study intervention|0|||
105890715|NCT02777970|365254541|FG000|Overall Study|Lost to Follow-up|0|||
105890716|NCT02777970|365254542|FG001|Overall Study|Lost to Follow-up|1|||
106121750|NCT02091739|366103639|FG004|EP: 48 Weeks|Death|2|||
106121751|NCT02091739|366103635|FG000|EP: 48 Weeks|Adverse Event|0|||
105664833|NCT01296555|364436694|FG002|Overall Study|Death|0|||
105664834|NCT01296555|364436695|FG003|Overall Study|Death|2|||
105664835|NCT01296555|364436696|FG004|Overall Study|Death|1|||
105664836|NCT01296555|364436697|FG005|Overall Study|Death|0|||
105664837|NCT01296555|364436698|FG006|Overall Study|Death|2|||
105664838|NCT01296555|364436699|FG007|Overall Study|Death|0|||
105664839|NCT01296555|364436700|FG008|Overall Study|Death|0|||
105664840|NCT01296555|364436701|FG009|Overall Study|Death|1|||
105664841|NCT01296555|364436702|FG010|Overall Study|Death|0|||
105664842|NCT01296555|364436703|FG011|Overall Study|Death|1|||
105664843|NCT01296555|364436704|FG012|Overall Study|Death|0|||
105664844|NCT01296555|364436705|FG013|Overall Study|Death|2|||
105664845|NCT01296555|364436706|FG014|Overall Study|Death|27|||
105664846|NCT01296555|364436707|FG015|Overall Study|Death|15|||
105664847|NCT01296555|364436708|FG016|Overall Study|Death|11|||
105664848|NCT01296555|364436709|FG017|Overall Study|Death|11|||
105664849|NCT01296555|364436710|FG018|Overall Study|Death|17|||
105664850|NCT01296555|364436711|FG019|Overall Study|Death|12|||
105664851|NCT01296555|364436712|FG020|Overall Study|Death|13|||
105664852|NCT01296555|364436713|FG021|Overall Study|Death|12|||
105664853|NCT01296555|364436714|FG022|Overall Study|Death|12|||
105664854|NCT01296555|364436715|FG023|Overall Study|Death|13|||
105664855|NCT01296555|364436716|FG024|Overall Study|Death|7|||
105664856|NCT01296555|364436717|FG025|Overall Study|Death|7|||
105664857|NCT01296555|364436718|FG026|Overall Study|Death|35|||
105664858|NCT01296555|364436719|FG027|Overall Study|Death|92|||
105664859|NCT01296555|364436720|FG028|Overall Study|Death|44|||
105664860|NCT01296555|364436692|FG000|Overall Study|Lost to Follow-up|0|||
105664861|NCT01296555|364436693|FG001|Overall Study|Lost to Follow-up|0|||
105890717|NCT02777970|365254543|FG002|Overall Study|Lost to Follow-up|0|||
105664862|NCT01296555|364436694|FG002|Overall Study|Lost to Follow-up|0|||
105664863|NCT01296555|364436695|FG003|Overall Study|Lost to Follow-up|0|||
105664864|NCT01296555|364436696|FG004|Overall Study|Lost to Follow-up|0|||
105664865|NCT01296555|364436697|FG005|Overall Study|Lost to Follow-up|0|||
105664866|NCT01296555|364436698|FG006|Overall Study|Lost to Follow-up|0|||
105664867|NCT01296555|364436699|FG007|Overall Study|Lost to Follow-up|0|||
105890718|NCT02777970|365254541|FG000|Overall Study|Protocol Violation|1|||
105890719|NCT02777970|365254542|FG001|Overall Study|Protocol Violation|0|||
105664868|NCT01296555|364436700|FG008|Overall Study|Lost to Follow-up|0|||
105664869|NCT01296555|364436701|FG009|Overall Study|Lost to Follow-up|0|||
105664870|NCT01296555|364436702|FG010|Overall Study|Lost to Follow-up|0|||
105664871|NCT01296555|364436703|FG011|Overall Study|Lost to Follow-up|0|||
105664872|NCT01296555|364436704|FG012|Overall Study|Lost to Follow-up|0|||
105890720|NCT02777970|365254543|FG002|Overall Study|Protocol Violation|0|||
105890721|NCT01967706|365254544|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
105890722|NCT01967706|365254545|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
105890723|NCT01967706|365254546|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
105890724|NCT01967706|365254547|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
105890725|NCT02347891|365254550|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
105890726|NCT02347891|365254551|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
105890727|NCT02347891|365254550|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
105890728|NCT02347891|365254551|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
105890729|NCT00725608|365254552|FG000|Overall Study|Lost to Follow-up|60|||
105890730|NCT00725608|365254552|FG000|Overall Study|Adverse Event|14|||
105890731|NCT00725608|365254552|FG000|Overall Study|Individual reasons|86|||
105890732|NCT00725608|365254552|FG000|Overall Study|Other|7|||
105890733|NCT05129137|365254553|FG000|Second Period|Adverse Event|1|||
105890734|NCT05129137|365254554|FG001|Second Period|Adverse Event|0|||
105890735|NCT05129137|365254555|FG002|Second Period|Adverse Event|0|||
105890736|NCT05129137|365254556|FG003|Second Period|Adverse Event|0|||
105890737|NCT05129137|365254553|FG000|Second Period|Protocol Violation|0|||
105890738|NCT05129137|365254554|FG001|Second Period|Protocol Violation|0|||
105890739|NCT05129137|365254555|FG002|Second Period|Protocol Violation|0|||
105890740|NCT05129137|365254556|FG003|Second Period|Protocol Violation|1|||
105890741|NCT05129137|365254553|FG000|Third Period|Protocol Violation|0|||
105890742|NCT05129137|365254554|FG001|Third Period|Protocol Violation|0|||
105890743|NCT05129137|365254555|FG002|Third Period|Protocol Violation|0|||
105890744|NCT05129137|365254556|FG003|Third Period|Protocol Violation|1|||
105890745|NCT05129137|365254553|FG000|Forth Period|Protocol Violation|0|||
105890746|NCT05129137|365254554|FG001|Forth Period|Protocol Violation|1|||
105890747|NCT05129137|365254555|FG002|Forth Period|Protocol Violation|0|||
105890748|NCT05129137|365254556|FG003|Forth Period|Protocol Violation|0|||
105890749|NCT05129137|365254553|FG000|Forth Period|Withdrawal by Subject|0|||
105890750|NCT05129137|365254554|FG001|Forth Period|Withdrawal by Subject|0|||
105890751|NCT05129137|365254555|FG002|Forth Period|Withdrawal by Subject|1|||
105890752|NCT05129137|365254556|FG003|Forth Period|Withdrawal by Subject|0|||
105890753|NCT01084668|365254557|FG000|Overall Study|Lack of Efficacy|5|||
105890754|NCT01084668|365254557|FG000|Overall Study|Withdrawal by Subject|2|||
105890755|NCT01084668|365254557|FG000|Overall Study|Pregnancy|1|||
105890756|NCT01084668|365254557|FG000|Overall Study|Non-compliance|1|||
105890757|NCT02447497|365254559|FG000|Overall Study|Did not meet treatment day baseline.|6|||
105890758|NCT02447497|365254560|FG001|Overall Study|Did not meet treatment day baseline.|5|||
105890759|NCT02447497|365254561|FG002|Overall Study|Did not meet treatment day baseline.|2|||
105890760|NCT02447497|365254562|FG003|Overall Study|Did not meet treatment day baseline.|2|||
105890761|NCT02447497|365254559|FG000|Overall Study|Dressing was compromised|0|||
105890762|NCT02447497|365254560|FG001|Overall Study|Dressing was compromised|1|||
105890763|NCT02447497|365254561|FG002|Overall Study|Dressing was compromised|0|||
105890764|NCT02447497|365254562|FG003|Overall Study|Dressing was compromised|0|||
105890765|NCT03640481|365254563|FG000|Overall Study|Death|14|||
105890766|NCT03640481|365254564|FG001|Overall Study|Death|14|||
105890767|NCT03640481|365254565|FG002|Overall Study|Death|0|||
105890768|NCT03640481|365254566|FG003|Overall Study|Death|0|||
105890769|NCT03640481|365254563|FG000|Overall Study|Lost to Follow-up|2|||
105890770|NCT03640481|365254564|FG001|Overall Study|Lost to Follow-up|0|||
105890771|NCT03640481|365254565|FG002|Overall Study|Lost to Follow-up|0|||
105890772|NCT03640481|365254566|FG003|Overall Study|Lost to Follow-up|0|||
105890773|NCT03640481|365254563|FG000|Overall Study|Site terminated by sponsor|1|||
105890774|NCT03640481|365254564|FG001|Overall Study|Site terminated by sponsor|3|||
105890775|NCT03640481|365254565|FG002|Overall Study|Site terminated by sponsor|0|||
105890776|NCT03640481|365254566|FG003|Overall Study|Site terminated by sponsor|0|||
105890777|NCT03640481|365254563|FG000|Overall Study|Study terminated by sponsor|29|||
105890778|NCT03640481|365254564|FG001|Overall Study|Study terminated by sponsor|42|||
106121752|NCT02091739|366103636|FG001|EP: 48 Weeks|Adverse Event|0|||
106121753|NCT02091739|366103637|FG002|EP: 48 Weeks|Adverse Event|0|||
106121754|NCT02091739|366103638|FG003|EP: 48 Weeks|Adverse Event|2|||
106121755|NCT02091739|366103639|FG004|EP: 48 Weeks|Adverse Event|6|||
106121756|NCT02091739|366103635|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
105890779|NCT03640481|365254565|FG002|Overall Study|Study terminated by sponsor|1|||
105890780|NCT03640481|365254566|FG003|Overall Study|Study terminated by sponsor|0|||
105890781|NCT03640481|365254563|FG000|Overall Study|Withdrawal by Subject|5|||
105890782|NCT03640481|365254564|FG001|Overall Study|Withdrawal by Subject|4|||
105890783|NCT03640481|365254565|FG002|Overall Study|Withdrawal by Subject|0|||
105890784|NCT03640481|365254566|FG003|Overall Study|Withdrawal by Subject|1|||
105890785|NCT03640481|365254563|FG000|Overall Study|Other|26|||
105890786|NCT03640481|365254564|FG001|Overall Study|Other|12|||
105890787|NCT03640481|365254565|FG002|Overall Study|Other|1|||
105890788|NCT03640481|365254566|FG003|Overall Study|Other|0|||
105890789|NCT03640481|365254563|FG000|Overall Study|Randomized, but not treated|1|||
105890790|NCT03640481|365254564|FG001|Overall Study|Randomized, but not treated|3|||
105890791|NCT03640481|365254565|FG002|Overall Study|Randomized, but not treated|0|||
105890792|NCT03640481|365254566|FG003|Overall Study|Randomized, but not treated|0|||
105890793|NCT00727844|365254567|FG000|Initial Randomization|Physician Decision|2|||
105890794|NCT00727844|365254568|FG001|Initial Randomization|Physician Decision|0|||
105890795|NCT00727844|365254569|FG002|Initial Randomization|Physician Decision|0|||
105890796|NCT00727844|365254570|FG003|Initial Randomization|Physician Decision|0|||
105890797|NCT05174949|365254580|FG000|Overall Study|Physician Decision|1|||
105890798|NCT05174949|365254581|FG001|Overall Study|Physician Decision|2|||
105890799|NCT05174949|365254582|FG002|Overall Study|Physician Decision|0|||
105890800|NCT05174949|365254583|FG003|Overall Study|Physician Decision|1|||
105890801|NCT05174949|365254584|FG004|Overall Study|Physician Decision|0|||
105890802|NCT05174949|365254585|FG005|Overall Study|Physician Decision|0|||
105890803|NCT05174949|365254580|FG000|Overall Study|Withdrawal by Subject|0|||
105890804|NCT05174949|365254581|FG001|Overall Study|Withdrawal by Subject|1|||
105890805|NCT05174949|365254582|FG002|Overall Study|Withdrawal by Subject|0|||
105890806|NCT05174949|365254583|FG003|Overall Study|Withdrawal by Subject|0|||
105890807|NCT05174949|365254584|FG004|Overall Study|Withdrawal by Subject|0|||
105890808|NCT05174949|365254585|FG005|Overall Study|Withdrawal by Subject|0|||
105890809|NCT05174949|365254580|FG000|Overall Study|Lost to Follow-up|0|||
105890810|NCT05174949|365254581|FG001|Overall Study|Lost to Follow-up|0|||
105890811|NCT05174949|365254582|FG002|Overall Study|Lost to Follow-up|0|||
105890812|NCT05174949|365254583|FG003|Overall Study|Lost to Follow-up|1|||
105890813|NCT05174949|365254584|FG004|Overall Study|Lost to Follow-up|0|||
105890814|NCT05174949|365254585|FG005|Overall Study|Lost to Follow-up|0|||
105890815|NCT02951533|365254586|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
105890816|NCT02951533|365254587|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
105890817|NCT02951533|365254588|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
105890818|NCT02951533|365254586|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
105890819|NCT02951533|365254587|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
105890820|NCT02951533|365254588|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
105890821|NCT02951533|365254586|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
105890822|NCT02951533|365254587|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
105890823|NCT02951533|365254588|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
105890824|NCT02951533|365254586|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
105890825|NCT02951533|365254587|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
105890826|NCT02951533|365254588|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
105890827|NCT02951533|365254586|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
105890828|NCT02951533|365254587|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
105890829|NCT02951533|365254588|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
105890830|NCT02951533|365254586|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
105890831|NCT02951533|365254587|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
105890832|NCT02951533|365254588|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
105890833|NCT02951533|365254586|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
105890834|NCT02951533|365254587|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
105890835|NCT02951533|365254588|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
105890836|NCT02951533|365254586|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
105890837|NCT02951533|365254587|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
105890838|NCT02951533|365254588|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
105890839|NCT02951533|365254586|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
105890840|NCT02951533|365254587|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
105890841|NCT02951533|365254588|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
105890842|NCT02951533|365254586|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
105890843|NCT02951533|365254587|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
105890844|NCT02951533|365254588|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
105890845|NCT02951533|365254586|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
105890846|NCT02951533|365254587|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
105890847|NCT02951533|365254588|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
105890848|NCT02029989|365254589|FG000|Overall Study|Withdrawal by Subject|1|||
105890849|NCT02029989|365254590|FG001|Overall Study|Withdrawal by Subject|0|||
105890850|NCT02029989|365254589|FG000|Overall Study|Withdrawal: Fear of needles|1|||
105890851|NCT02029989|365254590|FG001|Overall Study|Withdrawal: Fear of needles|0|||
105890852|NCT02029989|365254589|FG000|Overall Study|Change of location|2|||
105890853|NCT02029989|365254590|FG001|Overall Study|Change of location|3|||
105890854|NCT02029989|365254589|FG000|Overall Study|Physician Decision|2|||
105890855|NCT02029989|365254590|FG001|Overall Study|Physician Decision|0|||
105890856|NCT02029989|365254589|FG000|Overall Study|Lost to Follow-up|9|||
105664873|NCT01296555|364436705|FG013|Overall Study|Lost to Follow-up|0|||
105890857|NCT02029989|365254590|FG001|Overall Study|Lost to Follow-up|7|||
105890858|NCT02029989|365254589|FG000|Overall Study|Death|0|||
105890859|NCT02029989|365254590|FG001|Overall Study|Death|1|||
105890860|NCT02029989|365254589|FG000|Overall Study|Protocol Violation|1|||
106121757|NCT02091739|366103636|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
105890861|NCT02029989|365254590|FG001|Overall Study|Protocol Violation|0|||
106121758|NCT02091739|366103637|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
105890862|NCT04351373|365254591|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
105890863|NCT04601103|365254594|FG000|Overall Study|Needed crown & cleaning|0|||
105890864|NCT04601103|365254595|FG001|Overall Study|Needed crown & cleaning|0|||
105890865|NCT04601103|365254596|FG002|Overall Study|Needed crown & cleaning|1|||
105890866|NCT04601103|365254594|FG000|Overall Study|study was terminated|18|||
105890867|NCT04601103|365254595|FG001|Overall Study|study was terminated|18|||
105890868|NCT04601103|365254596|FG002|Overall Study|study was terminated|16|||
105890869|NCT03782298|365254611|FG000|Overall Study|Protocol Deviation|4|||
105890870|NCT00742508|365254612|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
105890871|NCT00742508|365254613|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
105890872|NCT00742508|365254612|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
105890873|NCT00742508|365254613|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
105890874|NCT00742508|365254612|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
105890875|NCT00742508|365254613|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
105890876|NCT00742508|365254612|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
105890877|NCT00742508|365254613|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
105890878|NCT00742508|365254612|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
105890879|NCT00742508|365254613|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
105890880|NCT01698879|365254616|FG000|Overall Study|Withdrawal by Subject|1|||
105890881|NCT01698879|365254617|FG001|Overall Study|Withdrawal by Subject|0|||
105890882|NCT01698879|365254618|FG002|Overall Study|Withdrawal by Subject|0|||
105890883|NCT03005327|365254624|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
105890884|NCT03005327|365254625|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
105890885|NCT03005327|365254626|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
105890886|NCT03005327|365254627|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
105890887|NCT03005327|365254624|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105890888|NCT03005327|365254625|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105890889|NCT03005327|365254626|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105890890|NCT03005327|365254627|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105890891|NCT00960986|365254628|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
105890892|NCT00960986|365254629|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
105890893|NCT00960986|365254630|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
105890894|NCT00960986|365254631|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
105890895|NCT00960986|365254628|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
105890896|NCT00960986|365254629|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
105890897|NCT00960986|365254630|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
105890898|NCT00960986|365254631|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
105890899|NCT00960986|365254628|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
105890900|NCT00960986|365254629|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
105890901|NCT00960986|365254630|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
105890902|NCT00960986|365254631|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
105890903|NCT00960986|365254628|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
105890904|NCT00960986|365254629|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
105890905|NCT00960986|365254630|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
105890906|NCT00960986|365254631|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
105890907|NCT00960986|365254628|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
105890908|NCT00960986|365254629|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
105890909|NCT00960986|365254630|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
105890910|NCT00960986|365254631|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
105890911|NCT00960986|365254628|FG000|Period 3 (7-week Therapy Period)|Death|0|||
105890912|NCT00960986|365254629|FG001|Period 3 (7-week Therapy Period)|Death|0|||
105890913|NCT00960986|365254630|FG002|Period 3 (7-week Therapy Period)|Death|1|||
105890914|NCT00960986|365254631|FG003|Period 3 (7-week Therapy Period)|Death|0|||
105890915|NCT00960986|365254628|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
106121759|NCT02091739|366103638|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
106121760|NCT02091739|366103639|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
106121761|NCT02823964|366103644|FG000|Overall Study|Adverse Event|2|||
106121762|NCT02823964|366103644|FG000|Overall Study|Physician Decision|1|||
106121763|NCT02823964|366103644|FG000|Overall Study|Lack of Efficacy|1|||
106121764|NCT02823964|366103644|FG000|Overall Study|Withdrawal by Subject|1|||
106121765|NCT00251927|366103648|FG000|Overall Study|Adverse Event|3|||
105890916|NCT00960986|365254629|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
105890917|NCT00960986|365254630|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
105890918|NCT00960986|365254631|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
105890919|NCT00960986|365254628|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
105890920|NCT00960986|365254629|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
105890921|NCT00960986|365254630|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
105890922|NCT00960986|365254631|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
106121766|NCT00251927|366103649|FG001|Overall Study|Adverse Event|15|||
105664874|NCT01296555|364436706|FG014|Overall Study|Lost to Follow-up|2|||
105664875|NCT01296555|364436707|FG015|Overall Study|Lost to Follow-up|1|||
105664876|NCT01296555|364436708|FG016|Overall Study|Lost to Follow-up|0|||
105664877|NCT01296555|364436709|FG017|Overall Study|Lost to Follow-up|2|||
105664878|NCT01296555|364436710|FG018|Overall Study|Lost to Follow-up|0|||
105664879|NCT01296555|364436711|FG019|Overall Study|Lost to Follow-up|2|||
105664880|NCT01296555|364436712|FG020|Overall Study|Lost to Follow-up|3|||
105664881|NCT01296555|364436713|FG021|Overall Study|Lost to Follow-up|2|||
105664882|NCT01296555|364436714|FG022|Overall Study|Lost to Follow-up|0|||
105664883|NCT01296555|364436715|FG023|Overall Study|Lost to Follow-up|0|||
105664884|NCT01296555|364436716|FG024|Overall Study|Lost to Follow-up|0|||
105664885|NCT01296555|364436717|FG025|Overall Study|Lost to Follow-up|0|||
105664886|NCT01296555|364436718|FG026|Overall Study|Lost to Follow-up|3|||
105664887|NCT01296555|364436719|FG027|Overall Study|Lost to Follow-up|13|||
105664888|NCT01296555|364436720|FG028|Overall Study|Lost to Follow-up|5|||
105664889|NCT01296555|364436692|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105664890|NCT01296555|364436693|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105664891|NCT01296555|364436694|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105664892|NCT01296555|364436695|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105664893|NCT01296555|364436696|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105664894|NCT01296555|364436697|FG005|Overall Study|Non-Compliance With Study Drug|0|||
105664895|NCT01296555|364436698|FG006|Overall Study|Non-Compliance With Study Drug|0|||
105664896|NCT01296555|364436699|FG007|Overall Study|Non-Compliance With Study Drug|1|||
105664897|NCT01296555|364436700|FG008|Overall Study|Non-Compliance With Study Drug|0|||
105664898|NCT01296555|364436701|FG009|Overall Study|Non-Compliance With Study Drug|0|||
105664899|NCT01296555|364436702|FG010|Overall Study|Non-Compliance With Study Drug|0|||
105664900|NCT01296555|364436703|FG011|Overall Study|Non-Compliance With Study Drug|0|||
105664901|NCT01296555|364436704|FG012|Overall Study|Non-Compliance With Study Drug|0|||
105664902|NCT01296555|364436705|FG013|Overall Study|Non-Compliance With Study Drug|0|||
105664903|NCT01296555|364436706|FG014|Overall Study|Non-Compliance With Study Drug|0|||
105664904|NCT01296555|364436707|FG015|Overall Study|Non-Compliance With Study Drug|0|||
105664905|NCT01296555|364436708|FG016|Overall Study|Non-Compliance With Study Drug|0|||
105664906|NCT01296555|364436709|FG017|Overall Study|Non-Compliance With Study Drug|0|||
105664907|NCT01296555|364436710|FG018|Overall Study|Non-Compliance With Study Drug|0|||
105664908|NCT01296555|364436711|FG019|Overall Study|Non-Compliance With Study Drug|0|||
105664909|NCT01296555|364436712|FG020|Overall Study|Non-Compliance With Study Drug|0|||
105664910|NCT01296555|364436713|FG021|Overall Study|Non-Compliance With Study Drug|0|||
105664911|NCT01296555|364436714|FG022|Overall Study|Non-Compliance With Study Drug|0|||
105664912|NCT01296555|364436715|FG023|Overall Study|Non-Compliance With Study Drug|0|||
105664913|NCT01296555|364436716|FG024|Overall Study|Non-Compliance With Study Drug|0|||
105664914|NCT01296555|364436717|FG025|Overall Study|Non-Compliance With Study Drug|0|||
105664915|NCT01296555|364436718|FG026|Overall Study|Non-Compliance With Study Drug|0|||
105664916|NCT01296555|364436719|FG027|Overall Study|Non-Compliance With Study Drug|0|||
105664917|NCT01296555|364436720|FG028|Overall Study|Non-Compliance With Study Drug|0|||
105664918|NCT01296555|364436692|FG000|Overall Study|Withdrawal by Subject|0|||
105664919|NCT01296555|364436693|FG001|Overall Study|Withdrawal by Subject|0|||
105664920|NCT01296555|364436694|FG002|Overall Study|Withdrawal by Subject|0|||
105664921|NCT01296555|364436695|FG003|Overall Study|Withdrawal by Subject|0|||
105664922|NCT01296555|364436696|FG004|Overall Study|Withdrawal by Subject|1|||
105664923|NCT01296555|364436697|FG005|Overall Study|Withdrawal by Subject|0|||
105664924|NCT01296555|364436698|FG006|Overall Study|Withdrawal by Subject|1|||
105890923|NCT00960986|365254628|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
105890924|NCT00960986|365254629|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
105890925|NCT00960986|365254630|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
105890926|NCT00960986|365254631|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
105890927|NCT00960986|365254628|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
105890928|NCT00960986|365254629|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
105890929|NCT00960986|365254630|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
105890930|NCT00960986|365254631|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
105664925|NCT01296555|364436699|FG007|Overall Study|Withdrawal by Subject|0|||
105664926|NCT01296555|364436700|FG008|Overall Study|Withdrawal by Subject|0|||
105664927|NCT01296555|364436701|FG009|Overall Study|Withdrawal by Subject|0|||
105664928|NCT01296555|364436702|FG010|Overall Study|Withdrawal by Subject|1|||
105664929|NCT01296555|364436703|FG011|Overall Study|Withdrawal by Subject|1|||
105664930|NCT01296555|364436704|FG012|Overall Study|Withdrawal by Subject|0|||
105664931|NCT01296555|364436705|FG013|Overall Study|Withdrawal by Subject|0|||
105664932|NCT01296555|364436706|FG014|Overall Study|Withdrawal by Subject|3|||
105890931|NCT01077739|365254632|FG000|Overall Study|Premature withdrawal|1|||
105996547|NCT02452424|365647096|FG007|Overall Study|Withdrawal by Subject|0|||
105664933|NCT01296555|364436707|FG015|Overall Study|Withdrawal by Subject|0|||
105664934|NCT01296555|364436708|FG016|Overall Study|Withdrawal by Subject|2|||
105664935|NCT01296555|364436709|FG017|Overall Study|Withdrawal by Subject|1|||
105664936|NCT01296555|364436710|FG018|Overall Study|Withdrawal by Subject|0|||
105890932|NCT01077739|365254633|FG001|Overall Study|Premature withdrawal|3|||
105890933|NCT01077739|365254632|FG000|Overall Study|Withdrawal by Subject|1|||
105890934|NCT01077739|365254633|FG001|Overall Study|Withdrawal by Subject|0|||
105890935|NCT01077739|365254632|FG000|Overall Study|Death|0|||
105890936|NCT01077739|365254633|FG001|Overall Study|Death|3|||
105890937|NCT01077739|365254632|FG000|Overall Study|Unacceptable toxicity|1|||
105890938|NCT01077739|365254633|FG001|Overall Study|Unacceptable toxicity|2|||
105890939|NCT01077739|365254632|FG000|Overall Study|Other|2|||
105890940|NCT01077739|365254633|FG001|Overall Study|Other|2|||
105890941|NCT00877071|365254634|FG000|Overall Study|disease progression|2|||
105890942|NCT02163226|365256285|FG000|Overall Study|Death|2|||
105890943|NCT02163226|365256286|FG001|Overall Study|Death|1|||
105890944|NCT02163226|365256285|FG000|Overall Study|Withdrawal by Subject|5|||
105890945|NCT02163226|365256286|FG001|Overall Study|Withdrawal by Subject|2|||
105890946|NCT02163226|365256285|FG000|Overall Study|Returned home, local radiotherapy|3|||
105890947|NCT02163226|365256286|FG001|Overall Study|Returned home, local radiotherapy|0|||
105890948|NCT02163226|365256285|FG000|Overall Study|Repeat imaging showed no disease|2|||
105890949|NCT02163226|365256286|FG001|Overall Study|Repeat imaging showed no disease|0|||
105890950|NCT02163226|365256285|FG000|Overall Study|Incomplete radiotherapy|3|||
105890951|NCT02163226|365256286|FG001|Overall Study|Incomplete radiotherapy|0|||
105890952|NCT02163226|365256285|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
105890953|NCT02163226|365256286|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
105890954|NCT02163226|365256285|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
105890955|NCT02163226|365256286|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
105890956|NCT02163226|365256285|FG000|Overall Study|ineligible|0|||
105890957|NCT02163226|365256286|FG001|Overall Study|ineligible|3|||
105890958|NCT00477750|365256287|FG000|Overall Study|Currently Receiving Treatment|11|||
105890959|NCT04166591|365256288|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
105890960|NCT04166591|365256289|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
105890961|NCT04166591|365256290|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105890962|NCT04166591|365256291|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105890963|NCT04166591|365256288|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
105890964|NCT04166591|365256289|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
105890965|NCT04166591|365256290|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105890966|NCT04166591|365256291|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
105890967|NCT04434469|365256292|FG000|Overall Study|Death|2|||
105890968|NCT04434469|365256293|FG001|Overall Study|Death|3|||
105890969|NCT04434469|365256294|FG002|Overall Study|Death|2|||
105785754|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
105785755|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
105785756|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
105785757|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
105785758|NCT00570492|364868552|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
105785759|NCT00570492|364868553|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
105785760|NCT00570492|364868554|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
105785761|NCT01539512|364868556|FG000|Overall Study|Adverse Event|9|||
105785762|NCT01539512|364868557|FG001|Overall Study|Adverse Event|7|||
105785763|NCT01539512|364868556|FG000|Overall Study|Physician Decision|1|||
105785764|NCT01539512|364868557|FG001|Overall Study|Physician Decision|1|||
105785765|NCT01539512|364868556|FG000|Overall Study|Withdrawal by Subject|12|||
105785766|NCT01539512|364868557|FG001|Overall Study|Withdrawal by Subject|5|||
105785767|NCT01539512|364868556|FG000|Overall Study|Richter's Transformation|1|||
105785768|NCT01539512|364868557|FG001|Overall Study|Richter's Transformation|0|||
105785769|NCT05146999|364868560|FG000|Overall Study|Withdrew consent|6|||
105785770|NCT05146999|364868561|FG001|Overall Study|Withdrew consent|1|||
105785771|NCT05146999|364868560|FG000|Overall Study|Lost to Follow-up|3|||
105785772|NCT05146999|364868561|FG001|Overall Study|Lost to Follow-up|2|||
105785773|NCT05146999|364868560|FG000|Overall Study|Other|1|||
105785774|NCT05146999|364868561|FG001|Overall Study|Other|3|||
105785775|NCT04668157|364868562|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
105785776|NCT04668157|364868563|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
105785777|NCT04668157|364868562|FG000|Treatment Period (52 Weeks)|Other|0|||
105785778|NCT04668157|364868563|FG001|Treatment Period (52 Weeks)|Other|2|||
105785779|NCT03958045|364868564|FG000|Overall Study|Withdrawal by Subject|1|||
105785780|NCT04479358|364868567|FG000|Overall Study|Withdrawal by Subject|0|||
105785781|NCT04479358|364868568|FG001|Overall Study|Withdrawal by Subject|0|||
105785782|NCT04479358|364868569|FG002|Overall Study|Withdrawal by Subject|1|||
105785783|NCT04479358|364868570|FG003|Overall Study|Withdrawal by Subject|0|||
105785784|NCT04479358|364868571|FG004|Overall Study|Withdrawal by Subject|0|||
105785785|NCT04479358|364868572|FG005|Overall Study|Withdrawal by Subject|1|||
105785786|NCT05437211|364868574|FG000|Overall Study|Patient's decision|1|||
105785787|NCT05437211|364868575|FG001|Overall Study|Patient's decision|1|||
105785788|NCT01463631|364868585|FG000|Overall Study|Withdrawal by Subject|0|||
105890970|NCT04434469|365256295|FG003|Overall Study|Death|2|||
105890971|NCT04434469|365256296|FG004|Overall Study|Death|2|||
105890972|NCT04434469|365256297|FG005|Overall Study|Death|0|||
105890973|NCT04434469|365256292|FG000|Overall Study|Lost to Follow-up|0|||
105890974|NCT04434469|365256293|FG001|Overall Study|Lost to Follow-up|0|||
105890975|NCT04434469|365256294|FG002|Overall Study|Lost to Follow-up|0|||
106121767|NCT00251927|366103648|FG000|Overall Study|Lack of Efficacy|22|||
106121768|NCT00251927|366103649|FG001|Overall Study|Lack of Efficacy|16|||
106121769|NCT00251927|366103648|FG000|Overall Study|Lost to Follow-up|22|||
106121770|NCT00251927|366103649|FG001|Overall Study|Lost to Follow-up|8|||
106121771|NCT00251927|366103648|FG000|Overall Study|Protocol Violation|1|||
106121772|NCT00251927|366103649|FG001|Overall Study|Protocol Violation|2|||
106121773|NCT00251927|366103648|FG000|Overall Study|Pregnancy|2|||
106121774|NCT00251927|366103649|FG001|Overall Study|Pregnancy|0|||
106121775|NCT00251927|366103648|FG000|Overall Study|Withdrawal by Subject|40|||
106121776|NCT00251927|366103649|FG001|Overall Study|Withdrawal by Subject|25|||
106121777|NCT00251927|366103648|FG000|Overall Study|Study-specific discont. achieved|13|||
106121778|NCT00251927|366103649|FG001|Overall Study|Study-specific discont. achieved|2|||
106121779|NCT00251927|366103648|FG000|Overall Study|Study procedure non-compliance|5|||
106121780|NCT00251927|366103649|FG001|Overall Study|Study procedure non-compliance|6|||
106121781|NCT01275196|366103657|FG000|Overall Study|Adverse Event|3|||
106121782|NCT01275196|366103658|FG001|Overall Study|Adverse Event|5|||
106121783|NCT01275196|366103657|FG000|Overall Study|Withdrawal by Subject|4|||
106121784|NCT01275196|366103658|FG001|Overall Study|Withdrawal by Subject|5|||
106121785|NCT01275196|366103657|FG000|Overall Study|Lost to Follow-up|1|||
106121786|NCT01275196|366103658|FG001|Overall Study|Lost to Follow-up|0|||
106121787|NCT01275196|366103657|FG000|Overall Study|Disease Progression|6|||
106121788|NCT01275196|366103658|FG001|Overall Study|Disease Progression|5|||
106121789|NCT01275196|366103657|FG000|Overall Study|Protocol Violation|1|||
106121790|NCT01275196|366103658|FG001|Overall Study|Protocol Violation|0|||
106121791|NCT01275196|366103657|FG000|Overall Study|Suboptimal response/treatment failure|5|||
106121792|NCT01275196|366103658|FG001|Overall Study|Suboptimal response/treatment failure|6|||
106121793|NCT01827254|366103659|FG000|Overall Study|Death|10|||
106121794|NCT01827254|366103659|FG000|Overall Study|Case report form not completed|4|||
106121795|NCT01827254|366103659|FG000|Overall Study|Invalidated centre|3|||
106121796|NCT01827254|366103659|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
106121797|NCT01827254|366103659|FG000|Overall Study|Did not complete re-challenge|1|||
106121798|NCT01827254|366103659|FG000|Overall Study|Disease progression|36|||
106121799|NCT01827254|366103659|FG000|Overall Study|Intolerance to treatment|4|||
105890976|NCT04434469|365256295|FG003|Overall Study|Lost to Follow-up|1|||
105890977|NCT04434469|365256296|FG004|Overall Study|Lost to Follow-up|1|||
105890978|NCT04434469|365256297|FG005|Overall Study|Lost to Follow-up|0|||
105890979|NCT04434469|365256292|FG000|Overall Study|Study terminated by sponsor|1|||
105785789|NCT01463631|364868586|FG001|Overall Study|Withdrawal by Subject|0|||
105785790|NCT01463631|364868587|FG002|Overall Study|Withdrawal by Subject|0|||
105785791|NCT01463631|364868588|FG003|Overall Study|Withdrawal by Subject|1|||
105785792|NCT01463631|364868585|FG000|Overall Study|Death|0|||
105785793|NCT01463631|364868586|FG001|Overall Study|Death|0|||
105785794|NCT01463631|364868587|FG002|Overall Study|Death|1|||
105785795|NCT01463631|364868588|FG003|Overall Study|Death|0|||
105785796|NCT01463631|364868585|FG000|Overall Study|Progressive Disease|0|||
105785797|NCT01463631|364868586|FG001|Overall Study|Progressive Disease|0|||
105785798|NCT01463631|364868587|FG002|Overall Study|Progressive Disease|0|||
105785799|NCT01463631|364868588|FG003|Overall Study|Progressive Disease|5|||
105785800|NCT05966129|364868591|FG000|Overall Study|Death|1|||
105785801|NCT05966129|364868592|FG001|Overall Study|Death|2|||
105785802|NCT05966129|364868591|FG000|Overall Study|Lost to Follow-up|63|||
105785803|NCT05966129|364868592|FG001|Overall Study|Lost to Follow-up|66|||
105785804|NCT05966129|364868591|FG000|Overall Study|Protocol Violation|1|||
105785805|NCT05966129|364868592|FG001|Overall Study|Protocol Violation|0|||
105785806|NCT05966129|364868591|FG000|Overall Study|Withdrawal by Subject|26|||
105785807|NCT05966129|364868592|FG001|Overall Study|Withdrawal by Subject|25|||
105785808|NCT05966129|364868591|FG000|Overall Study|Surgery not completed|63|||
105785809|NCT05966129|364868592|FG001|Overall Study|Surgery not completed|69|||
105785810|NCT05966129|364868591|FG000|Overall Study|Surgery logistics issue|2|||
105785811|NCT05966129|364868592|FG001|Overall Study|Surgery logistics issue|1|||
105785812|NCT01298323|364868593|FG000|Overall Study|Adverse Event|2|||
105785813|NCT01298323|364868594|FG001|Overall Study|Adverse Event|4|||
105785814|NCT01298323|364868593|FG000|Overall Study|Death|11|||
105785815|NCT01298323|364868594|FG001|Overall Study|Death|16|||
105785816|NCT01298323|364868593|FG000|Overall Study|Lost to Follow-up|1|||
105785817|NCT01298323|364868594|FG001|Overall Study|Lost to Follow-up|0|||
105785818|NCT01298323|364868593|FG000|Overall Study|Withdrawal by Subject|6|||
105785819|NCT01298323|364868594|FG001|Overall Study|Withdrawal by Subject|3|||
105785820|NCT01298323|364868593|FG000|Overall Study|Protocol Violation|1|||
105785821|NCT01298323|364868594|FG001|Overall Study|Protocol Violation|0|||
105785822|NCT01298323|364868593|FG000|Overall Study|Other|10|||
105785823|NCT01298323|364868594|FG001|Overall Study|Other|9|||
105785824|NCT01298323|364868593|FG000|Overall Study|Ongoing|55|||
105785825|NCT01298323|364868594|FG001|Overall Study|Ongoing|55|||
105785826|NCT01298323|364868593|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105785827|NCT01298323|364868594|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105785828|NCT04502862|364868598|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
105785829|NCT04502862|364868599|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
105785830|NCT04502862|364868598|FG000|Overall Study|Withdrawal by Subject|1|||
105785831|NCT04502862|364868599|FG001|Overall Study|Withdrawal by Subject|0|||
105785832|NCT04502862|364868598|FG000|Overall Study|Adverse Event|1|||
105785833|NCT04502862|364868599|FG001|Overall Study|Adverse Event|1|||
105785834|NCT02646566|364870354|FG000|Overall Study|Lost to Follow-up|5|||
105785835|NCT02646566|364870355|FG001|Overall Study|Lost to Follow-up|4|||
105785836|NCT02646566|364870356|FG002|Overall Study|Lost to Follow-up|5|||
105785837|NCT02646566|364870354|FG000|Overall Study|Treatment failure|1|||
105785838|NCT02646566|364870355|FG001|Overall Study|Treatment failure|0|||
105785839|NCT02646566|364870356|FG002|Overall Study|Treatment failure|0|||
105785840|NCT02222246|364870357|FG000|Overall Study|No Emergency Department Visits|27|||
105785841|NCT02222246|364870358|FG001|Overall Study|No Emergency Department Visits|26|||
105785842|NCT02222246|364870357|FG000|Overall Study|Physician Decision|0|||
105785843|NCT02222246|364870358|FG001|Overall Study|Physician Decision|1|||
105785844|NCT00474994|364870359|FG000|Overall Study|Patient Not treated|1|||
105785845|NCT00474994|364870359|FG000|Overall Study|Patient evaluable for toxicity only|3|||
105785846|NCT00474994|364870359|FG000|Overall Study|Patient found to be ineligible|1|||
105785847|NCT02064231|364870360|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
105785848|NCT02064231|364870361|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
105785849|NCT02064231|364870362|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
105785850|NCT02064231|364870363|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
105785851|NCT02064231|364870360|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
105785852|NCT02064231|364870361|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
105785853|NCT02064231|364870362|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
105785854|NCT02064231|364870363|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
105890980|NCT04434469|365256293|FG001|Overall Study|Study terminated by sponsor|1|||
105890981|NCT04434469|365256294|FG002|Overall Study|Study terminated by sponsor|1|||
105890982|NCT04434469|365256295|FG003|Overall Study|Study terminated by sponsor|2|||
105890983|NCT04434469|365256296|FG004|Overall Study|Study terminated by sponsor|3|||
105890984|NCT04434469|365256297|FG005|Overall Study|Study terminated by sponsor|3|||
105890985|NCT04434469|365256292|FG000|Overall Study|Withdrawal by Subject|0|||
105890986|NCT04434469|365256293|FG001|Overall Study|Withdrawal by Subject|0|||
105890987|NCT04434469|365256294|FG002|Overall Study|Withdrawal by Subject|1|||
105890988|NCT04434469|365256295|FG003|Overall Study|Withdrawal by Subject|0|||
105890989|NCT04434469|365256296|FG004|Overall Study|Withdrawal by Subject|0|||
105890990|NCT04434469|365256297|FG005|Overall Study|Withdrawal by Subject|0|||
105890991|NCT02086448|365256299|FG000|Overall Study|Withdrawal by Subject|1|||
105890992|NCT02086448|365256300|FG001|Overall Study|Withdrawal by Subject|0|||
105890993|NCT02086448|365256301|FG002|Overall Study|Withdrawal by Subject|0|||
105890994|NCT02086448|365256302|FG003|Overall Study|Withdrawal by Subject|2|||
105890995|NCT00401544|365256309|FG000|Overall Study|Adverse Event|5|||
105890996|NCT00401544|365256310|FG001|Overall Study|Adverse Event|1|||
105890997|NCT00401544|365256311|FG002|Overall Study|Adverse Event|1|||
105890998|NCT00401544|365256312|FG003|Overall Study|Adverse Event|1|||
105890999|NCT00401544|365256309|FG000|Overall Study|Death|3|||
105891000|NCT00401544|365256310|FG001|Overall Study|Death|6|||
105891001|NCT00401544|365256311|FG002|Overall Study|Death|2|||
105891002|NCT00401544|365256312|FG003|Overall Study|Death|5|||
105891003|NCT00401544|365256309|FG000|Overall Study|Lost to Follow-up|2|||
105891004|NCT00401544|365256310|FG001|Overall Study|Lost to Follow-up|0|||
105891005|NCT00401544|365256311|FG002|Overall Study|Lost to Follow-up|1|||
105891006|NCT00401544|365256312|FG003|Overall Study|Lost to Follow-up|1|||
105891007|NCT00401544|365256309|FG000|Overall Study|Withdrawal by Subject|7|||
105891008|NCT00401544|365256310|FG001|Overall Study|Withdrawal by Subject|6|||
105891009|NCT00401544|365256311|FG002|Overall Study|Withdrawal by Subject|6|||
105891010|NCT00401544|365256312|FG003|Overall Study|Withdrawal by Subject|5|||
105891011|NCT00401544|365256309|FG000|Overall Study|Physician Decision|1|||
105891012|NCT00401544|365256310|FG001|Overall Study|Physician Decision|3|||
105891013|NCT00401544|365256311|FG002|Overall Study|Physician Decision|0|||
105891014|NCT00401544|365256312|FG003|Overall Study|Physician Decision|0|||
105891015|NCT00401544|365256309|FG000|Overall Study|Ineligibility determined|0|||
105891016|NCT00401544|365256310|FG001|Overall Study|Ineligibility determined|1|||
105891017|NCT00401544|365256311|FG002|Overall Study|Ineligibility determined|0|||
105891018|NCT00401544|365256312|FG003|Overall Study|Ineligibility determined|2|||
105891019|NCT00401544|365256309|FG000|Overall Study|Disease progression|0|||
105891020|NCT00401544|365256310|FG001|Overall Study|Disease progression|1|||
105891021|NCT00401544|365256311|FG002|Overall Study|Disease progression|0|||
105891022|NCT00401544|365256312|FG003|Overall Study|Disease progression|0|||
105891023|NCT00401544|365256309|FG000|Overall Study|Other|0|||
105891024|NCT00401544|365256310|FG001|Overall Study|Other|0|||
105891025|NCT00401544|365256311|FG002|Overall Study|Other|2|||
105891026|NCT00401544|365256312|FG003|Overall Study|Other|2|||
105891027|NCT01871402|365256313|FG000|Overall Study|Lost to Follow-up|1|||
105891028|NCT01871402|365256314|FG001|Overall Study|Lost to Follow-up|0|||
105891029|NCT01871402|365256313|FG000|Overall Study|Withdrawal by Subject|0|||
105891030|NCT01871402|365256314|FG001|Overall Study|Withdrawal by Subject|2|||
105891031|NCT01871402|365256313|FG000|Overall Study|Non-compliance|0|||
105891032|NCT01871402|365256314|FG001|Overall Study|Non-compliance|1|||
105891033|NCT01877551|365256319|FG000|Overall Study|Physician Decision|0|||
105891034|NCT01877551|365256320|FG001|Overall Study|Physician Decision|1|||
105891035|NCT05139303|365256321|FG000|Overall Study|Lost to Follow-up|3|||
105891036|NCT05139303|365256322|FG001|Overall Study|Lost to Follow-up|0|||
105891037|NCT05139303|365256321|FG000|Overall Study|Adverse Event|1|||
105891038|NCT05139303|365256322|FG001|Overall Study|Adverse Event|0|||
105891039|NCT02256982|365256327|FG000|Overall Study|Disease Progression|0|||
105891040|NCT02256982|365256328|FG001|Overall Study|Disease Progression|1|||
105891041|NCT01613222|365256333|FG000|Overall Study|Physician Decision|1|||
105891042|NCT01613222|365256333|FG000|Overall Study|Unable to place arterial line|1|||
105891043|NCT01613222|365256333|FG000|Overall Study|Reused disposable sensors|10|||
105891044|NCT01054300|365256334|FG000|Period 1|Adverse Event|1|||
105891045|NCT01054300|365256335|FG001|Period 1|Adverse Event|0|||
105891046|NCT01054300|365256336|FG002|Period 1|Adverse Event|0|||
105891047|NCT01054300|365256337|FG003|Period 1|Adverse Event|0|||
105891048|NCT01054300|365256334|FG000|Period 2|Withdrawal by Subject|0|||
105891049|NCT01054300|365256335|FG001|Period 2|Withdrawal by Subject|0|||
105891050|NCT01054300|365256336|FG002|Period 2|Withdrawal by Subject|1|||
105891051|NCT01054300|365256337|FG003|Period 2|Withdrawal by Subject|0|||
105891052|NCT00308087|365256340|FG000|Overall Study|Progressive Disease|19|||
105891053|NCT00308087|365256341|FG001|Overall Study|Progressive Disease|21|||
105891054|NCT00308087|365256340|FG000|Overall Study|Study Closure|11|||
105891055|NCT00308087|365256341|FG001|Overall Study|Study Closure|12|||
105891056|NCT00308087|365256340|FG000|Overall Study|Withdrawal by Subject|2|||
105891057|NCT00308087|365256341|FG001|Overall Study|Withdrawal by Subject|1|||
105891058|NCT00308087|365256340|FG000|Overall Study|Other|4|||
106121850|NCT02222896|366103677|FG000|Abdomen|Did not qualify|34|||
106121851|NCT02222896|366103678|FG001|Abdomen|Did not qualify|10|||
106121852|NCT02222896|366103679|FG002|Abdomen|Did not qualify|32|||
106121853|NCT02222896|366103677|FG000|Groin|Did not qualify|43|||
106121854|NCT02222896|366103678|FG001|Groin|Did not qualify|9|||
106121855|NCT02222896|366103679|FG002|Groin|Did not qualify|40|||
106121856|NCT00545363|366103681|FG000|Overall Study|Adverse Event|6|||
106121857|NCT00545363|366103682|FG001|Overall Study|Adverse Event|7|||
105664937|NCT01296555|364436711|FG019|Overall Study|Withdrawal by Subject|1|||
105664938|NCT01296555|364436712|FG020|Overall Study|Withdrawal by Subject|1|||
105785855|NCT02064231|364870360|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
105785856|NCT02064231|364870361|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
105785857|NCT02064231|364870362|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
105785858|NCT02064231|364870363|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
105785859|NCT02064231|364870360|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
105785860|NCT02064231|364870361|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
105785861|NCT02064231|364870362|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
105785862|NCT02064231|364870363|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
105785863|NCT04887922|364870364|FG000|1st Randomization|Decided not to have surgery|0|||
105785864|NCT04887922|364870365|FG001|1st Randomization|Decided not to have surgery|1|||
105785865|NCT04887922|364870366|FG002|1st Randomization|Decided not to have surgery|0|||
105785866|NCT04887922|364870367|FG003|1st Randomization|Decided not to have surgery|0|||
105785867|NCT04887922|364870368|FG004|1st Randomization|Decided not to have surgery|0|||
105785868|NCT00536991|364870369|FG000|Overall Study|Withdrawal by Subject|10|||
105785869|NCT00536991|364870369|FG000|Overall Study|Physician Decision|1|||
105785870|NCT00536991|364870369|FG000|Overall Study|patient ineligible|2|||
105785871|NCT04576702|364870370|FG000|Overall Study|Death|1|||
105785872|NCT04576702|364870371|FG001|Overall Study|Death|0|||
105785873|NCT04576702|364870372|FG002|Overall Study|Death|0|||
105785874|NCT04576702|364870373|FG003|Overall Study|Death|0|||
105785875|NCT04576702|364870370|FG000|Overall Study|Withdrawal by Subject|0|||
105785876|NCT04576702|364870371|FG001|Overall Study|Withdrawal by Subject|2|||
105785877|NCT04576702|364870372|FG002|Overall Study|Withdrawal by Subject|1|||
105785878|NCT04576702|364870373|FG003|Overall Study|Withdrawal by Subject|0|||
105785879|NCT04576702|364870370|FG000|Overall Study|Lost to Follow-up|3|||
105785880|NCT04576702|364870371|FG001|Overall Study|Lost to Follow-up|3|||
105785881|NCT04576702|364870372|FG002|Overall Study|Lost to Follow-up|3|||
105785882|NCT04576702|364870373|FG003|Overall Study|Lost to Follow-up|4|||
105785883|NCT03471507|364870377|FG000|Overall Study|Lost to Follow-up|1|||
105785884|NCT03471507|364870378|FG001|Overall Study|Lost to Follow-up|3|||
105785885|NCT03471507|364870377|FG000|Overall Study|Physician Decision|0|||
105785886|NCT03471507|364870378|FG001|Overall Study|Physician Decision|1|||
105785887|NCT03471507|364870377|FG000|Overall Study|Withdrawal by Subject|2|||
105785888|NCT03471507|364870378|FG001|Overall Study|Withdrawal by Subject|1|||
105785889|NCT00998166|364870379|FG000|Overall Study|Early Study Termination|8|||
105785890|NCT03841331|364870380|FG000|Overall Study|Withdrawal by Subject|4|||
105785891|NCT03841331|364870381|FG001|Overall Study|Withdrawal by Subject|9|||
105785892|NCT03841331|364870380|FG000|Overall Study|Lost to Follow-up|5|||
105785893|NCT03841331|364870381|FG001|Overall Study|Lost to Follow-up|1|||
105785894|NCT04988035|364870382|FG000|Overall Study|Death|19|||
105785895|NCT04988035|364870383|FG001|Overall Study|Death|13|||
105785896|NCT04988035|364870382|FG000|Overall Study|Lost to Follow-up|12|||
105785897|NCT04988035|364870383|FG001|Overall Study|Lost to Follow-up|6|||
105785898|NCT04988035|364870382|FG000|Overall Study|Protocol Violation|0|||
105785899|NCT04988035|364870383|FG001|Overall Study|Protocol Violation|1|||
105785900|NCT04988035|364870382|FG000|Overall Study|Withdrawal by Subject|2|||
105785901|NCT04988035|364870383|FG001|Overall Study|Withdrawal by Subject|4|||
105785902|NCT04988035|364870382|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
105785903|NCT04988035|364870383|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
105785904|NCT03602976|364870384|FG000|Overall Study|Withdrawal by Subject|1|||
105785905|NCT00442572|364870386|FG000|Overall Study|Relapse|8|||
105785906|NCT00442572|364870387|FG001|Overall Study|Relapse|1|||
105891059|NCT00308087|365256341|FG001|Overall Study|Other|3|||
105891060|NCT04186806|365256350|FG000|Period 1: 7 Days|Adverse Event|1|||
105891061|NCT04186806|365256351|FG001|Period 1: 7 Days|Adverse Event|0|||
105891062|NCT00878969|365256364|FG000|Overall Study|Physician Decision|5|||
105891063|NCT00878969|365256365|FG001|Overall Study|Physician Decision|3|||
105891064|NCT00878969|365256366|FG002|Overall Study|Physician Decision|2|||
105891065|NCT00878969|365256364|FG000|Overall Study|Withdrawal by Subject|1|||
105891066|NCT00878969|365256365|FG001|Overall Study|Withdrawal by Subject|6|||
105891067|NCT00878969|365256366|FG002|Overall Study|Withdrawal by Subject|3|||
105891068|NCT00878969|365256364|FG000|Overall Study|kidney transplant|2|||
105891069|NCT00878969|365256365|FG001|Overall Study|kidney transplant|3|||
105891070|NCT00878969|365256366|FG002|Overall Study|kidney transplant|2|||
105891071|NCT00878969|365256364|FG000|Overall Study|Adverse Event|3|||
105891072|NCT00878969|365256365|FG001|Overall Study|Adverse Event|1|||
105891073|NCT00878969|365256366|FG002|Overall Study|Adverse Event|2|||
105891074|NCT00878969|365256364|FG000|Overall Study|Lost to Follow-up|2|||
105891075|NCT00878969|365256365|FG001|Overall Study|Lost to Follow-up|1|||
105891076|NCT00878969|365256366|FG002|Overall Study|Lost to Follow-up|0|||
105891077|NCT00878969|365256364|FG000|Overall Study|Protocol Violation|2|||
105891078|NCT00878969|365256365|FG001|Overall Study|Protocol Violation|0|||
105891079|NCT00878969|365256366|FG002|Overall Study|Protocol Violation|0|||
105891080|NCT00878969|365256364|FG000|Overall Study|Death|0|||
105891081|NCT00878969|365256365|FG001|Overall Study|Death|0|||
105891082|NCT00878969|365256366|FG002|Overall Study|Death|2|||
105891083|NCT00878969|365256364|FG000|Overall Study|Pregnancy|0|||
105891084|NCT00878969|365256365|FG001|Overall Study|Pregnancy|1|||
105891085|NCT00878969|365256366|FG002|Overall Study|Pregnancy|0|||
105891086|NCT00655733|365256371|FG000|Overall Study|Lost to Follow-up|2|||
105891087|NCT00655733|365256372|FG001|Overall Study|Lost to Follow-up|2|||
105891088|NCT00655733|365256371|FG000|Overall Study|Adverse Event|2|||
105891089|NCT00655733|365256372|FG001|Overall Study|Adverse Event|2|||
105891090|NCT00655733|365256371|FG000|Overall Study|Withdrawal by Subject|3|||
105891091|NCT00655733|365256372|FG001|Overall Study|Withdrawal by Subject|3|||
105891092|NCT00655733|365256371|FG000|Overall Study|Physician Decision|0|||
105891093|NCT00655733|365256372|FG001|Overall Study|Physician Decision|1|||
105891094|NCT01740128|365256375|FG000|Overall Study|Pregnancy|0|||
105891095|NCT01740128|365256376|FG001|Overall Study|Pregnancy|1|||
105891096|NCT01740128|365256375|FG000|Overall Study|Protocol Violation|1|||
105891097|NCT01740128|365256376|FG001|Overall Study|Protocol Violation|2|||
105891098|NCT01740128|365256375|FG000|Overall Study|Lost to Follow-up|2|||
105891099|NCT01740128|365256376|FG001|Overall Study|Lost to Follow-up|2|||
105891100|NCT01740128|365256375|FG000|Overall Study|Withdrawal by Subject|1|||
105891101|NCT01740128|365256376|FG001|Overall Study|Withdrawal by Subject|0|||
105891102|NCT01740128|365256375|FG000|Overall Study|Insufficient protocol compliance|2|||
105891103|NCT01740128|365256376|FG001|Overall Study|Insufficient protocol compliance|2|||
105891104|NCT01041976|365256377|FG000|Overall Study|Withdrawal by Subject|3|||
105891105|NCT01041976|365256378|FG001|Overall Study|Withdrawal by Subject|0|||
105891106|NCT01041976|365256377|FG000|Overall Study|Incarceration|2|||
105891107|NCT01041976|365256378|FG001|Overall Study|Incarceration|0|||
105891108|NCT01041976|365256377|FG000|Overall Study|Death|0|||
105891109|NCT01041976|365256378|FG001|Overall Study|Death|4|||
105891110|NCT00380081|365256379|FG000|Overall Study|Withdrawal by Subject|0|||
105891111|NCT00380081|365256380|FG001|Overall Study|Withdrawal by Subject|0|||
105891112|NCT00380081|365256381|FG002|Overall Study|Withdrawal by Subject|0|||
105891113|NCT00380081|365256382|FG003|Overall Study|Withdrawal by Subject|0|||
105891114|NCT00380081|365256383|FG004|Overall Study|Withdrawal by Subject|1|||
105891115|NCT00380081|365256384|FG005|Overall Study|Withdrawal by Subject|0|||
105891116|NCT00380081|365256379|FG000|Overall Study|Family Emergency|0|||
105891117|NCT00380081|365256380|FG001|Overall Study|Family Emergency|0|||
105891118|NCT00380081|365256381|FG002|Overall Study|Family Emergency|0|||
105891119|NCT00380081|365256382|FG003|Overall Study|Family Emergency|0|||
106121858|NCT00545363|366103681|FG000|Overall Study|Withdrawal by Subject|6|||
105891120|NCT00380081|365256383|FG004|Overall Study|Family Emergency|0|||
105891121|NCT00380081|365256384|FG005|Overall Study|Family Emergency|1|||
105891122|NCT00189306|365256386|FG000|Treatment Period|Withdrawal by Subject|2|||
105891123|NCT00189306|365256386|FG000|Treatment Period|Adverse Event|2|||
105891124|NCT00189306|365256386|FG000|Treatment Period|Protocol Violation|1|||
105891125|NCT00189306|365256386|FG000|Posttreatment Period|Death|1|||
105891126|NCT00189306|365256386|FG000|Posttreatment Period|Withdrawal by Subject|2|||
105891127|NCT00189306|365256386|FG000|Posttreatment Period|Noncompliance|1|||
105891128|NCT00189306|365256386|FG000|Posttreatment Period|Target lesion excised|1|||
105891129|NCT00189306|365256386|FG000|Posttreatment Period|Protocol Violation|1|||
105891130|NCT00189306|365256386|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
105891131|NCT00189306|365256386|FG000|Posttreatment Period|Local skin reaction/sign|1|||
105891132|NCT00189306|365256386|FG000|Long-Term Follow-up|Adverse Event|2|||
105891133|NCT00189306|365256386|FG000|Long-Term Follow-up|Death|4|||
105891134|NCT00189306|365256386|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
105891135|NCT00189306|365256386|FG000|Long-Term Follow-up|Intercurrent disease|2|||
105891136|NCT00189306|365256386|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
105664939|NCT01296555|364436713|FG021|Overall Study|Withdrawal by Subject|1|||
105664940|NCT01296555|364436714|FG022|Overall Study|Withdrawal by Subject|3|||
105664941|NCT01296555|364436715|FG023|Overall Study|Withdrawal by Subject|0|||
105664942|NCT01296555|364436716|FG024|Overall Study|Withdrawal by Subject|0|||
105664943|NCT01296555|364436717|FG025|Overall Study|Withdrawal by Subject|0|||
105664944|NCT01296555|364436718|FG026|Overall Study|Withdrawal by Subject|8|||
105664945|NCT01296555|364436719|FG027|Overall Study|Withdrawal by Subject|4|||
105891137|NCT00189306|365256386|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
105891138|NCT00373958|365256387|FG000|Infant Series|Withdrawal by Subject|13|||
105891139|NCT00373958|365256388|FG001|Infant Series|Withdrawal by Subject|15|||
105891140|NCT00373958|365256387|FG000|Infant Series|Failed to return|8|||
105891141|NCT00373958|365256388|FG001|Infant Series|Failed to return|13|||
105891142|NCT00373958|365256387|FG000|Infant Series|Lost to Follow-up|6|||
105996548|NCT02452424|365647097|FG008|Overall Study|Withdrawal by Subject|1|||
105996549|NCT02452424|365647098|FG009|Overall Study|Withdrawal by Subject|1|||
105996550|NCT02452424|365647099|FG010|Overall Study|Withdrawal by Subject|0|||
105996551|NCT02452424|365647089|FG000|Overall Study|Other|0|||
105996552|NCT02452424|365647090|FG001|Overall Study|Other|0|||
105996553|NCT02452424|365647091|FG002|Overall Study|Other|1|||
105996554|NCT02452424|365647092|FG003|Overall Study|Other|0|||
105996555|NCT02452424|365647093|FG004|Overall Study|Other|0|||
105996556|NCT02452424|365647094|FG005|Overall Study|Other|1|||
105996557|NCT02452424|365647095|FG006|Overall Study|Other|4|||
105996558|NCT02452424|365647096|FG007|Overall Study|Other|3|||
105996559|NCT02452424|365647097|FG008|Overall Study|Other|0|||
105996560|NCT02452424|365647098|FG009|Overall Study|Other|0|||
105996561|NCT02452424|365647099|FG010|Overall Study|Other|1|||
105996562|NCT02452424|365647089|FG000|Overall Study|Progressive disease (per RECIST)|0|||
105996563|NCT02452424|365647090|FG001|Overall Study|Progressive disease (per RECIST)|0|||
105996564|NCT02452424|365647091|FG002|Overall Study|Progressive disease (per RECIST)|0|||
105996565|NCT02452424|365647092|FG003|Overall Study|Progressive disease (per RECIST)|0|||
105996566|NCT02452424|365647093|FG004|Overall Study|Progressive disease (per RECIST)|0|||
105996567|NCT02452424|365647094|FG005|Overall Study|Progressive disease (per RECIST)|0|||
105996568|NCT02452424|365647095|FG006|Overall Study|Progressive disease (per RECIST)|0|||
105996569|NCT02452424|365647096|FG007|Overall Study|Progressive disease (per RECIST)|0|||
105996570|NCT02452424|365647097|FG008|Overall Study|Progressive disease (per RECIST)|2|||
105996571|NCT02452424|365647098|FG009|Overall Study|Progressive disease (per RECIST)|0|||
105996572|NCT02452424|365647099|FG010|Overall Study|Progressive disease (per RECIST)|0|||
105996573|NCT02452424|365647089|FG000|Overall Study|Adverse Event|0|||
105996574|NCT02452424|365647090|FG001|Overall Study|Adverse Event|0|||
105996575|NCT02452424|365647091|FG002|Overall Study|Adverse Event|0|||
105996576|NCT02452424|365647092|FG003|Overall Study|Adverse Event|0|||
105891143|NCT00373958|365256388|FG001|Infant Series|Lost to Follow-up|5|||
105891144|NCT00373958|365256387|FG000|Infant Series|Protocol Violation|3|||
105891145|NCT00373958|365256388|FG001|Infant Series|Protocol Violation|7|||
105891146|NCT00373958|365256387|FG000|Infant Series|Lost Kaiser coverage|4|||
105891147|NCT00373958|365256388|FG001|Infant Series|Lost Kaiser coverage|0|||
105891148|NCT00373958|365256387|FG000|Infant Series|Child relocated|1|||
105891149|NCT00373958|365256388|FG001|Infant Series|Child relocated|0|||
105891150|NCT00373958|365256387|FG000|Infant Series|Consent was not received|1|||
105891151|NCT00373958|365256388|FG001|Infant Series|Consent was not received|0|||
105891152|NCT00373958|365256387|FG000|Infant Series|Adverse Event|3|||
105891153|NCT00373958|365256388|FG001|Infant Series|Adverse Event|1|||
105891154|NCT00373958|365256387|FG000|Infant Series|Physician Decision|1|||
105891155|NCT00373958|365256388|FG001|Infant Series|Physician Decision|1|||
105891156|NCT00373958|365256387|FG000|Toddler Dose|Lost to Follow-up|5|||
105891157|NCT00373958|365256388|FG001|Toddler Dose|Lost to Follow-up|8|||
105891158|NCT00373958|365256387|FG000|Toddler Dose|Withdrawal by Subject|2|||
105891159|NCT00373958|365256388|FG001|Toddler Dose|Withdrawal by Subject|2|||
105996577|NCT02452424|365647093|FG004|Overall Study|Adverse Event|0|||
105996578|NCT02452424|365647094|FG005|Overall Study|Adverse Event|0|||
105996579|NCT02452424|365647095|FG006|Overall Study|Adverse Event|0|||
105996580|NCT02452424|365647096|FG007|Overall Study|Adverse Event|0|||
105996581|NCT02452424|365647097|FG008|Overall Study|Adverse Event|0|||
105996582|NCT02452424|365647098|FG009|Overall Study|Adverse Event|0|||
105664946|NCT01296555|364436720|FG028|Overall Study|Withdrawal by Subject|2|||
105664947|NCT01358331|364436721|FG000|Overall Study|Lost to Follow-up|0|||
105664948|NCT01358331|364436722|FG001|Overall Study|Lost to Follow-up|0|||
105891160|NCT00373958|365256387|FG000|Toddler Dose|Failed to return|1|||
105891161|NCT00373958|365256388|FG001|Toddler Dose|Failed to return|2|||
105891162|NCT00373958|365256387|FG000|Toddler Dose|Protocol Violation|0|||
105891163|NCT00373958|365256388|FG001|Toddler Dose|Protocol Violation|1|||
105891164|NCT00373958|365256387|FG000|Toddler Dose|Withdrawn after infant series|22|||
105996583|NCT02452424|365647099|FG010|Overall Study|Adverse Event|1|||
105996584|NCT00983385|365647105|FG000|Observation Period|Not eligible to be dosed|20|||
105996585|NCT00983385|365647105|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
105996586|NCT04177212|365647107|FG000|Overall Study|Withdrawal by Subject|9|||
105996587|NCT04177212|365647108|FG001|Overall Study|Withdrawal by Subject|7|||
105996588|NCT04177212|365647107|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
105996589|NCT04177212|365647108|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
105996590|NCT04177212|365647107|FG000|Overall Study|Physician Decision|1|||
105996591|NCT04177212|365647108|FG001|Overall Study|Physician Decision|0|||
105996592|NCT04177212|365647107|FG000|Overall Study|Lost to Follow-up|0|||
105996593|NCT04177212|365647108|FG001|Overall Study|Lost to Follow-up|3|||
105996594|NCT04177212|365647107|FG000|Overall Study|Adverse Event|0|||
105996595|NCT04177212|365647108|FG001|Overall Study|Adverse Event|1|||
105996596|NCT04177212|365647107|FG000|Overall Study|Other|1|||
105996597|NCT04177212|365647108|FG001|Overall Study|Other|2|||
105996598|NCT01392547|365649451|FG000|Overall Study|Adverse Event|2|||
105996599|NCT01392547|365649451|FG000|Overall Study|Non-compliance|2|||
105996600|NCT01392547|365649451|FG000|Overall Study|Withdrawal criteria|3|||
105996601|NCT01392547|365649451|FG000|Overall Study|Unclassified|1|||
105996602|NCT02936635|365649452|FG000|Overall Study|Adverse Event|43|||
105996603|NCT02936635|365649453|FG001|Overall Study|Adverse Event|25|||
105996604|NCT02936635|365649452|FG000|Overall Study|Progressive Disease|10|||
105996605|NCT02936635|365649453|FG001|Overall Study|Progressive Disease|18|||
105996606|NCT02936635|365649452|FG000|Overall Study|Sponsor Discretion|10|||
105996607|NCT02936635|365649453|FG001|Overall Study|Sponsor Discretion|16|||
105996608|NCT02936635|365649452|FG000|Overall Study|Death|9|||
105996609|NCT02936635|365649453|FG001|Overall Study|Death|15|||
105996610|NCT02936635|365649452|FG000|Overall Study|Withdrawal by Subject|8|||
105996611|NCT02936635|365649453|FG001|Overall Study|Withdrawal by Subject|15|||
105996612|NCT02936635|365649452|FG000|Overall Study|Physician Decision|2|||
105996613|NCT02936635|365649453|FG001|Overall Study|Physician Decision|9|||
105996614|NCT02936635|365649452|FG000|Overall Study|Lost to Follow-up|1|||
105996615|NCT02936635|365649453|FG001|Overall Study|Lost to Follow-up|2|||
105996616|NCT02936635|365649452|FG000|Overall Study|Protocol Violation|1|||
105996617|NCT02936635|365649453|FG001|Overall Study|Protocol Violation|0|||
105996618|NCT02936635|365649452|FG000|Overall Study|Lack of effect/Entry into other study|31|||
105996619|NCT02936635|365649453|FG001|Overall Study|Lack of effect/Entry into other study|65|||
105996620|NCT04050618|365649459|FG000|First Intervention|Withdrawal by Subject|2|||
105996621|NCT04050618|365649460|FG001|First Intervention|Withdrawal by Subject|0|||
105996622|NCT04050618|365649459|FG000|Second Intervention|Withdrawal by Subject|1|||
105996623|NCT04050618|365649460|FG001|Second Intervention|Withdrawal by Subject|0|||
105996624|NCT03777059|365649461|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
105996625|NCT03777059|365649462|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
105996626|NCT03777059|365649463|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
105996627|NCT03777059|365649464|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
105996628|NCT03777059|365649461|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
105996629|NCT03777059|365649462|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
105996630|NCT03777059|365649463|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
105996631|NCT03777059|365649464|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
105996632|NCT03777059|365649461|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
105996633|NCT03777059|365649462|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
105996634|NCT03777059|365649463|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
105996635|NCT03777059|365649464|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
105996636|NCT03777059|365649461|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
105996637|NCT03777059|365649462|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
106121859|NCT00545363|366103682|FG001|Overall Study|Withdrawal by Subject|5|||
106121860|NCT00545363|366103681|FG000|Overall Study|Non-compliance|3|||
105996638|NCT03777059|365649463|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
105996639|NCT03777059|365649464|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
105996640|NCT03777059|365649461|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
105996641|NCT03777059|365649462|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
105996642|NCT03777059|365649463|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
105996643|NCT03777059|365649464|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
105996644|NCT03777059|365649461|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
105996645|NCT03777059|365649462|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
105996646|NCT03777059|365649463|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
105996647|NCT03777059|365649464|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
106121861|NCT00545363|366103682|FG001|Overall Study|Non-compliance|1|||
106121862|NCT00545363|366103681|FG000|Overall Study|Did not meet entry criteria|1|||
106121863|NCT00545363|366103682|FG001|Overall Study|Did not meet entry criteria|1|||
106121864|NCT00545363|366103681|FG000|Overall Study|Lost to Follow-up|2|||
106121865|NCT00545363|366103682|FG001|Overall Study|Lost to Follow-up|0|||
106121866|NCT00545363|366103681|FG000|Overall Study|Other|1|||
106121867|NCT00545363|366103682|FG001|Overall Study|Other|1|||
106121868|NCT00993317|366103683|FG000|Overall Study|Adverse Event|2|||
106121869|NCT00993317|366103684|FG001|Overall Study|Adverse Event|4|||
106121870|NCT00993317|366103683|FG000|Overall Study|Lack of Efficacy|18|||
106121871|NCT00993317|366103684|FG001|Overall Study|Lack of Efficacy|18|||
106121872|NCT00993317|366103683|FG000|Overall Study|Withdrawal by Subject|0|||
106121873|NCT00993317|366103684|FG001|Overall Study|Withdrawal by Subject|2|||
105664949|NCT01358331|364436723|FG002|Overall Study|Lost to Follow-up|0|||
105664950|NCT01358331|364436724|FG003|Overall Study|Lost to Follow-up|1|||
105664951|NCT01358331|364436725|FG004|Overall Study|Lost to Follow-up|0|||
105664952|NCT01358331|364436726|FG005|Overall Study|Lost to Follow-up|0|||
105664953|NCT01358331|364436721|FG000|Overall Study|Withdrawal by Subject|0|||
105664954|NCT01358331|364436722|FG001|Overall Study|Withdrawal by Subject|0|||
105664955|NCT01358331|364436723|FG002|Overall Study|Withdrawal by Subject|0|||
105664956|NCT01358331|364436724|FG003|Overall Study|Withdrawal by Subject|1|||
105664957|NCT01358331|364436725|FG004|Overall Study|Withdrawal by Subject|1|||
105664958|NCT01358331|364436726|FG005|Overall Study|Withdrawal by Subject|1|||
105664959|NCT01358331|364436721|FG000|Overall Study|Adverse Events|1|||
105664960|NCT01358331|364436722|FG001|Overall Study|Adverse Events|1|||
105664961|NCT01358331|364436723|FG002|Overall Study|Adverse Events|1|||
105664962|NCT01358331|364436724|FG003|Overall Study|Adverse Events|0|||
105664963|NCT01358331|364436725|FG004|Overall Study|Adverse Events|1|||
105891165|NCT00373958|365256388|FG001|Toddler Dose|Withdrawn after infant series|25|||
105891166|NCT02288091|365256399|FG000|Overall Study|Lost to Follow-up|1|||
105891167|NCT02288091|365256399|FG000|Overall Study|Screen fail|7|||
105891168|NCT00656851|365256402|FG000|Overall Study|Withdrawal by Subject|0|||
105891169|NCT00656851|365256403|FG001|Overall Study|Withdrawal by Subject|4|||
105891170|NCT00978250|365256404|FG000|Overall Study|Late determination of ineligibility|0|||
105891171|NCT00978250|365256405|FG001|Overall Study|Late determination of ineligibility|1|||
105891172|NCT00978250|365256406|FG002|Overall Study|Late determination of ineligibility|0|||
105891173|NCT00978250|365256407|FG003|Overall Study|Late determination of ineligibility|1|||
105891174|NCT02291601|365256412|FG000|Abdomen|Did not qualify|333|||
105891175|NCT02291601|365256413|FG001|Abdomen|Did not qualify|54|||
105891176|NCT02291601|365256414|FG002|Abdomen|Did not qualify|339|||
106121874|NCT00993317|366103683|FG000|Overall Study|Investigator's opinion|0|||
106121875|NCT00993317|366103684|FG001|Overall Study|Investigator's opinion|1|||
106121876|NCT00993317|366103683|FG000|Overall Study|Early study termination at the site|1|||
106121877|NCT00993317|366103684|FG001|Overall Study|Early study termination at the site|0|||
106121878|NCT00366301|366103685|FG000|Overall Study|Lost to Follow-up|4|||
106121879|NCT00366301|366103686|FG001|Overall Study|Lost to Follow-up|4|||
106121880|NCT00366301|366103687|FG002|Overall Study|Lost to Follow-up|3|||
106121881|NCT00366301|366103688|FG003|Overall Study|Lost to Follow-up|7|||
106121882|NCT00366301|366103685|FG000|Overall Study|Withdrawal by Subject|4|||
106121883|NCT00366301|366103686|FG001|Overall Study|Withdrawal by Subject|2|||
106121884|NCT00366301|366103687|FG002|Overall Study|Withdrawal by Subject|1|||
106121885|NCT00366301|366103688|FG003|Overall Study|Withdrawal by Subject|1|||
106121886|NCT01348776|366103694|FG000|Overall Study|Lost to Follow-up|3|||
106121887|NCT02796963|366103695|FG000|Overall Study|Lost to Follow-up|89|||
106121888|NCT02796963|366103696|FG001|Overall Study|Lost to Follow-up|76|||
106121889|NCT02796963|366103697|FG002|Overall Study|Lost to Follow-up|69|||
106121890|NCT02796963|366103698|FG003|Overall Study|Lost to Follow-up|72|||
106121891|NCT00951509|366103702|FG000|Overall Study|Withdrawal by Subject|2|||
106121892|NCT02878213|366103708|FG000|Overall Study|Withdrawal by Subject|2|||
106121893|NCT02878213|366103708|FG000|Overall Study|Adverse Event|1|||
106121894|NCT00924469|366103709|FG000|Overall Study|Adverse Event|2|||
106121895|NCT00924469|366103710|FG001|Overall Study|Adverse Event|0|||
106121896|NCT00924469|366103709|FG000|Overall Study|Withdrawal by Subject|0|||
106121897|NCT00924469|366103710|FG001|Overall Study|Withdrawal by Subject|1|||
106121898|NCT00924469|366103709|FG000|Overall Study|Lost to Follow-up|0|||
106121899|NCT00924469|366103710|FG001|Overall Study|Lost to Follow-up|1|||
106121900|NCT01231503|366103715|FG000|Overall Study|Adverse Event|0|||
105664964|NCT01358331|364436726|FG005|Overall Study|Adverse Events|5|||
105664965|NCT01358331|364436721|FG000|Overall Study|Symptomatic Deterioration|0|||
105664966|NCT01358331|364436722|FG001|Overall Study|Symptomatic Deterioration|0|||
105664967|NCT01358331|364436723|FG002|Overall Study|Symptomatic Deterioration|0|||
105891177|NCT02291601|365256412|FG000|Groin|Did not qualify|183|||
106121901|NCT01231503|366103716|FG001|Overall Study|Adverse Event|0|||
105891178|NCT02291601|365256413|FG001|Groin|Did not qualify|30|||
105664968|NCT01358331|364436724|FG003|Overall Study|Symptomatic Deterioration|0|||
105891179|NCT02291601|365256414|FG002|Groin|Did not qualify|177|||
105891180|NCT02880865|365256417|FG000|Overall Study|Adverse Event|1|||
106121902|NCT01231503|366103717|FG002|Overall Study|Adverse Event|0|||
105891181|NCT02880865|365256418|FG001|Overall Study|Adverse Event|0|||
105891182|NCT02880865|365256417|FG000|Overall Study|Withdrawal by Subject|0|||
105891183|NCT02880865|365256418|FG001|Overall Study|Withdrawal by Subject|2|||
105891184|NCT02880865|365256417|FG000|Overall Study|Physician Decision|0|||
105891185|NCT02880865|365256418|FG001|Overall Study|Physician Decision|1|||
105891186|NCT01032239|365256419|FG000|Overall Study|Lost to Follow-up|3|||
105891187|NCT01032239|365256420|FG001|Overall Study|Lost to Follow-up|2|||
105891188|NCT01032239|365256419|FG000|Overall Study|Withdrawal by Subject|2|||
105891189|NCT01032239|365256420|FG001|Overall Study|Withdrawal by Subject|3|||
105891190|NCT01032239|365256419|FG000|Overall Study|Death|1|||
105891191|NCT01032239|365256420|FG001|Overall Study|Death|0|||
105891192|NCT01032239|365256419|FG000|Overall Study|Protocol Violation|1|||
105891193|NCT01032239|365256420|FG001|Overall Study|Protocol Violation|0|||
105891194|NCT02091986|365256434|FG000|Overall Study|7 rand in error 1 patient decision|2|||
105891195|NCT02091986|365256435|FG001|Overall Study|7 rand in error 1 patient decision|3|||
105891196|NCT02091986|365256436|FG002|Overall Study|7 rand in error 1 patient decision|3|||
105891197|NCT02091986|365256434|FG000|Overall Study|Lost to Follow-up|1|||
105891198|NCT02091986|365256435|FG001|Overall Study|Lost to Follow-up|0|||
105891199|NCT02091986|365256436|FG002|Overall Study|Lost to Follow-up|0|||
105891200|NCT02091986|365256434|FG000|Overall Study|Withdrawal by Subject|4|||
105891201|NCT02091986|365256435|FG001|Overall Study|Withdrawal by Subject|8|||
105891202|NCT02091986|365256436|FG002|Overall Study|Withdrawal by Subject|3|||
105891203|NCT02091986|365256434|FG000|Overall Study|Adverse Event|0|||
105891204|NCT02091986|365256435|FG001|Overall Study|Adverse Event|0|||
105891205|NCT02091986|365256436|FG002|Overall Study|Adverse Event|2|||
105891206|NCT01664949|365256437|FG000|Overall Study|Adverse Event|11|||
105891207|NCT01664949|365256438|FG001|Overall Study|Adverse Event|12|||
105891208|NCT01664949|365256437|FG000|Overall Study|Lack of Efficacy|1|||
105891209|NCT01664949|365256438|FG001|Overall Study|Lack of Efficacy|1|||
105891210|NCT01664949|365256437|FG000|Overall Study|Lost to Follow-up|1|||
105891211|NCT01664949|365256438|FG001|Overall Study|Lost to Follow-up|2|||
105891212|NCT01664949|365256437|FG000|Overall Study|Personal Reasons|3|||
105891213|NCT01664949|365256438|FG001|Overall Study|Personal Reasons|4|||
105891214|NCT01664949|365256437|FG000|Overall Study|Protocol Violation|5|||
105891215|NCT01664949|365256438|FG001|Overall Study|Protocol Violation|5|||
105891216|NCT01664949|365256437|FG000|Overall Study|Other Miscellaneous Reasons|3|||
105891217|NCT01664949|365256438|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105891218|NCT00957268|365256439|FG000|Overall Study|Voluntary Withdrawal|0|||
105891219|NCT00957268|365256440|FG001|Overall Study|Voluntary Withdrawal|0|||
105891220|NCT00957268|365256441|FG002|Overall Study|Voluntary Withdrawal|1|||
105891221|NCT00957268|365256442|FG003|Overall Study|Voluntary Withdrawal|0|||
105891222|NCT00957268|365256443|FG004|Overall Study|Voluntary Withdrawal|0|||
105891223|NCT00794040|365256444|FG000|Overall Study|Withdrawal by Subject|3|||
105891224|NCT00794040|365256445|FG001|Overall Study|Withdrawal by Subject|4|||
105891225|NCT00794040|365256444|FG000|Overall Study|Physician Decision|0|||
105891226|NCT00794040|365256445|FG001|Overall Study|Physician Decision|1|||
105891227|NCT02396420|365256446|FG000|Overall Study|Death|1|||
105891228|NCT01273623|365256449|FG000|Overall Study|did not meet IVUS criteria|29|||
105891229|NCT02135107|365256450|FG000|Treatment Period|Withdrawal by Subject|11|||
105891230|NCT02135107|365256451|FG001|Treatment Period|Withdrawal by Subject|0|||
105891231|NCT02135107|365256452|FG002|Treatment Period|Withdrawal by Subject|0|||
105996648|NCT03777059|365649461|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
105996649|NCT03777059|365649462|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
105996650|NCT03777059|365649463|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
105996651|NCT03777059|365649464|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
105996652|NCT03777059|365649461|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
105996653|NCT03777059|365649462|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
105996654|NCT03777059|365649463|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
105996655|NCT03777059|365649464|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
105996656|NCT03777059|365649461|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
105996657|NCT03777059|365649462|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
105891232|NCT02135107|365256453|FG003|Treatment Period|Withdrawal by Subject|0|||
105996658|NCT03777059|365649463|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
105891233|NCT02135107|365256450|FG000|Treatment Period|Adverse Event|5|||
105891234|NCT02135107|365256451|FG001|Treatment Period|Adverse Event|2|||
105891235|NCT02135107|365256452|FG002|Treatment Period|Adverse Event|0|||
105891236|NCT02135107|365256453|FG003|Treatment Period|Adverse Event|0|||
105891237|NCT02135107|365256450|FG000|Treatment Period|Pregnancy|1|||
105891238|NCT02135107|365256451|FG001|Treatment Period|Pregnancy|0|||
105891239|NCT02135107|365256452|FG002|Treatment Period|Pregnancy|0|||
105891240|NCT02135107|365256453|FG003|Treatment Period|Pregnancy|0|||
105891241|NCT02135107|365256450|FG000|Treatment Period|Other|115|||
105891242|NCT02135107|365256451|FG001|Treatment Period|Other|24|||
105891243|NCT02135107|365256452|FG002|Treatment Period|Other|0|||
105996659|NCT03777059|365649464|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
105996660|NCT03777059|365649461|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
105664969|NCT01358331|364436725|FG004|Overall Study|Symptomatic Deterioration|1|||
105664970|NCT01358331|364436726|FG005|Overall Study|Symptomatic Deterioration|0|||
105664971|NCT01358331|364436721|FG000|Overall Study|Participants did not wish to continue|0|||
105664972|NCT01358331|364436722|FG001|Overall Study|Participants did not wish to continue|0|||
105664973|NCT01358331|364436723|FG002|Overall Study|Participants did not wish to continue|0|||
105664974|NCT01358331|364436724|FG003|Overall Study|Participants did not wish to continue|0|||
105664975|NCT01358331|364436725|FG004|Overall Study|Participants did not wish to continue|1|||
105664976|NCT01358331|364436726|FG005|Overall Study|Participants did not wish to continue|0|||
105664977|NCT01358331|364436721|FG000|Overall Study|Progress of disease under investigation|1|||
105664978|NCT01358331|364436722|FG001|Overall Study|Progress of disease under investigation|2|||
105664979|NCT01358331|364436723|FG002|Overall Study|Progress of disease under investigation|3|||
105664980|NCT01358331|364436724|FG003|Overall Study|Progress of disease under investigation|1|||
105664981|NCT01358331|364436725|FG004|Overall Study|Progress of disease under investigation|3|||
105664982|NCT01358331|364436726|FG005|Overall Study|Progress of disease under investigation|0|||
105664983|NCT01637077|364436727|FG000|Overall Study|Cancel|1|||
105664984|NCT01637077|364436728|FG001|Overall Study|Cancel|1|||
105664985|NCT01637077|364436727|FG000|Overall Study|Withdrawal by Subject|1|||
105664986|NCT01637077|364436728|FG001|Overall Study|Withdrawal by Subject|0|||
105891244|NCT02135107|365256453|FG003|Treatment Period|Other|0|||
105664987|NCT01637077|364436727|FG000|Overall Study|No cycle 1 questionnaire data|2|||
105664988|NCT01637077|364436728|FG001|Overall Study|No cycle 1 questionnaire data|0|||
105664989|NCT02595372|364436729|FG000|Overall Study|Adverse Event|6|||
105664990|NCT02595372|364436729|FG000|Overall Study|Physician Decision|2|||
105664991|NCT02595372|364436729|FG000|Overall Study|Disease Progression|1|||
105664992|NCT01889069|364436732|FG000|Overall Study|Death|18|||
105664993|NCT01889069|364436732|FG000|Overall Study|Progression of Disease|14|||
105664994|NCT01889069|364436732|FG000|Overall Study|Lost to Follow-up|6|||
105664995|NCT01889069|364436732|FG000|Overall Study|Other|4|||
105664996|NCT01889069|364436732|FG000|Overall Study|Consent Withdrawal|3|||
105664997|NCT00658606|364436734|FG000|Overall Study|Adverse Event|2|||
105664998|NCT00658606|364436735|FG001|Overall Study|Adverse Event|1|||
105664999|NCT00658606|364436734|FG000|Overall Study|Lack of Efficacy|6|||
105891245|NCT02135107|365256450|FG000|Maintenance Therapy Period|Adverse Event|0|||
105891246|NCT02135107|365256451|FG001|Maintenance Therapy Period|Adverse Event|0|||
105891247|NCT02135107|365256452|FG002|Maintenance Therapy Period|Adverse Event|3|||
105665000|NCT00658606|364436735|FG001|Overall Study|Lack of Efficacy|3|||
105665001|NCT00658606|364436734|FG000|Overall Study|Lost to Follow-up|1|||
105665002|NCT00658606|364436735|FG001|Overall Study|Lost to Follow-up|0|||
105665003|NCT00658606|364436734|FG000|Overall Study|Withdrawal by Subject|7|||
105665004|NCT00658606|364436735|FG001|Overall Study|Withdrawal by Subject|16|||
105665005|NCT00658606|364436734|FG000|Overall Study|Lack of Compliance|0|||
105891248|NCT02135107|365256453|FG003|Maintenance Therapy Period|Adverse Event|7|||
105891249|NCT02135107|365256450|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
105891250|NCT02135107|365256451|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
105891251|NCT02135107|365256452|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
105891252|NCT02135107|365256453|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
105891253|NCT02135107|365256450|FG000|Maintenance Therapy Period|Pregnancy|0|||
105891254|NCT02135107|365256451|FG001|Maintenance Therapy Period|Pregnancy|0|||
105891255|NCT02135107|365256452|FG002|Maintenance Therapy Period|Pregnancy|0|||
105891256|NCT02135107|365256453|FG003|Maintenance Therapy Period|Pregnancy|1|||
105891257|NCT02135107|365256450|FG000|Maintenance Therapy Period|Other|0|||
105891258|NCT02135107|365256451|FG001|Maintenance Therapy Period|Other|0|||
105891259|NCT02135107|365256452|FG002|Maintenance Therapy Period|Other|7|||
105891260|NCT02135107|365256453|FG003|Maintenance Therapy Period|Other|8|||
105891261|NCT01095978|365256454|FG000|Overall Study|Did not take Klacid SR|2|||
105891262|NCT01095978|365256454|FG000|Overall Study|Adverse Event|1|||
105891263|NCT02009397|365256461|FG000|Overall Study|Protocol Violation|6|||
105891264|NCT02009397|365256461|FG000|Overall Study|Death|8|||
105891265|NCT02009397|365256461|FG000|Overall Study|Lost to Follow-up|6|||
105891266|NCT02278120|365256462|FG000|Treatment Period|Progressive disease|234|||
105891267|NCT02278120|365256463|FG001|Treatment Period|Progressive disease|260|||
105665006|NCT00658606|364436735|FG001|Overall Study|Lack of Compliance|3|||
105665007|NCT04982575|364436736|FG000|Overall Study|Withdrawal by Subject|2|||
105665008|NCT04982575|364436737|FG001|Overall Study|Withdrawal by Subject|0|||
105665009|NCT04982575|364436738|FG002|Overall Study|Withdrawal by Subject|2|||
105665010|NCT03075527|364436739|FG000|Overall Study|Death|1|||
105665011|NCT03075527|364436739|FG000|Overall Study|Withdrawal by Subject|1|||
105665012|NCT03075527|364436739|FG000|Overall Study|Physician Decision|3|||
105665013|NCT03075527|364436739|FG000|Overall Study|Progression/Relapse|14|||
105665014|NCT04946942|364436740|FG000|Overall Study|Lost to Follow-up|6|||
105891268|NCT02278120|365256462|FG000|Treatment Period|Subject/guardian decision|23|||
105891269|NCT02278120|365256463|FG001|Treatment Period|Subject/guardian decision|20|||
105891270|NCT02278120|365256462|FG000|Treatment Period|Adverse Event|16|||
105891271|NCT02278120|365256463|FG001|Treatment Period|Adverse Event|14|||
105891272|NCT02278120|365256462|FG000|Treatment Period|Physician Decision|14|||
105891273|NCT02278120|365256463|FG001|Treatment Period|Physician Decision|27|||
105891274|NCT02278120|365256462|FG000|Treatment Period|Death|3|||
105891275|NCT02278120|365256463|FG001|Treatment Period|Death|3|||
105891276|NCT02278120|365256462|FG000|Treatment Period|Lost to Follow-up|2|||
105891277|NCT02278120|365256463|FG001|Treatment Period|Lost to Follow-up|0|||
105891278|NCT02278120|365256462|FG000|Treatment Period|Protocol deviation|0|||
105891279|NCT02278120|365256463|FG001|Treatment Period|Protocol deviation|2|||
105891280|NCT02278120|365256462|FG000|Treatment Period|Study terminated as per protocol|43|||
105891281|NCT02278120|365256463|FG001|Treatment Period|Study terminated as per protocol|11|||
105891282|NCT02278120|365256462|FG000|Post-treatment Efficacy Follow-up|Death|0|||
105891283|NCT02278120|365256463|FG001|Post-treatment Efficacy Follow-up|Death|1|||
105785907|NCT00442572|364870386|FG000|Overall Study|Lost to Follow-up|0|||
105785908|NCT00442572|364870387|FG001|Overall Study|Lost to Follow-up|1|||
105785909|NCT00442572|364870386|FG000|Overall Study|Withdrawal by Subject|0|||
105785910|NCT00442572|364870387|FG001|Overall Study|Withdrawal by Subject|1|||
105785911|NCT03532048|364870388|FG000|Overall Study|Lost to Follow-up|12|||
105785912|NCT03532048|364870389|FG001|Overall Study|Lost to Follow-up|17|||
105785913|NCT03532048|364870388|FG000|Overall Study|Withdrawal by Subject|7|||
105785914|NCT03532048|364870389|FG001|Overall Study|Withdrawal by Subject|0|||
105785915|NCT02190604|364870392|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785916|NCT02190604|364870393|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785917|NCT02190604|364870394|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785918|NCT02190604|364870395|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785919|NCT02190604|364870396|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785920|NCT02190604|364870397|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785921|NCT02190604|364870398|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785922|NCT02190604|364870399|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785923|NCT02190604|364870400|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785924|NCT02190604|364870401|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785925|NCT02190604|364870402|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785926|NCT02190604|364870403|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785927|NCT02190604|364870404|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785928|NCT02190604|364870405|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785929|NCT02190604|364870406|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
105785930|NCT02190604|364870407|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785931|NCT02190604|364870408|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785932|NCT02190604|364870409|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785933|NCT02190604|364870410|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
105785934|NCT02190604|364870392|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785935|NCT02190604|364870393|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785936|NCT02190604|364870394|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785937|NCT02190604|364870395|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785938|NCT02190604|364870396|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785939|NCT02190604|364870397|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785940|NCT02190604|364870398|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785941|NCT02190604|364870399|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785942|NCT02190604|364870400|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785943|NCT02190604|364870401|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785944|NCT02190604|364870402|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785945|NCT02190604|364870403|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785946|NCT02190604|364870404|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785947|NCT02190604|364870405|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
105785948|NCT02190604|364870406|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785949|NCT02190604|364870407|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785950|NCT02190604|364870408|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785951|NCT02190604|364870409|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785952|NCT02190604|364870410|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
105785953|NCT02797951|364870413|FG000|Overall Study|Adverse Event|4|||
105785954|NCT02797951|364870413|FG000|Overall Study|Death|1|||
105785955|NCT02797951|364870413|FG000|Overall Study|Lack of Efficacy|19|||
105785956|NCT02797951|364870413|FG000|Overall Study|Lost to Follow-up|4|||
105785957|NCT02797951|364870413|FG000|Overall Study|Physician Decision|6|||
105785958|NCT02797951|364870413|FG000|Overall Study|Withdrawal by Subject|15|||
105785959|NCT00814502|364870414|FG000|Overall Study|Adverse Event|1|||
105785960|NCT00814502|364870415|FG001|Overall Study|Adverse Event|0|||
105785961|NCT00814502|364870414|FG000|Overall Study|Withdrawal by Subject|0|||
105785962|NCT00814502|364870415|FG001|Overall Study|Withdrawal by Subject|2|||
105785963|NCT03735849|364870419|FG000|Overall Study|Lost to Follow-up|1|||
105785964|NCT03735849|364870420|FG001|Overall Study|Lost to Follow-up|0|||
105785965|NCT03735849|364870421|FG002|Overall Study|Lost to Follow-up|0|||
105785966|NCT03735849|364870419|FG000|Overall Study|Participant unable to adhere to visit|1|||
105891284|NCT02278120|365256462|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
106121903|NCT01231503|366103718|FG003|Overall Study|Adverse Event|0|||
105891285|NCT02278120|365256463|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
106121904|NCT01231503|366103719|FG004|Overall Study|Adverse Event|0|||
106121905|NCT01231503|366103720|FG005|Overall Study|Adverse Event|1|||
106121906|NCT01231503|366103721|FG006|Overall Study|Adverse Event|0|||
106121907|NCT01231503|366103722|FG007|Overall Study|Adverse Event|0|||
105665015|NCT04946942|364436741|FG001|Overall Study|Lost to Follow-up|2|||
105891286|NCT02278120|365256462|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
105891287|NCT02278120|365256463|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
105891288|NCT02278120|365256462|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
105891289|NCT02278120|365256463|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
105891290|NCT02278120|365256462|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105891291|NCT02278120|365256463|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105891292|NCT00965341|365256465|FG000|Overall Study|Withdrew consent|1|||
105891293|NCT00965341|365256466|FG001|Overall Study|Withdrew consent|5|||
105891294|NCT00965341|365256465|FG000|Overall Study|Lost to Follow-up|1|||
105891295|NCT00965341|365256466|FG001|Overall Study|Lost to Follow-up|0|||
105891296|NCT00965341|365256465|FG000|Overall Study|Transportation issues|4|||
105891297|NCT00965341|365256466|FG001|Overall Study|Transportation issues|3|||
105891298|NCT01970475|365256472|FG000|Overall Study|Withdrawal by Subject|11|||
105891299|NCT01970475|365256473|FG001|Overall Study|Withdrawal by Subject|6|||
105891300|NCT01970475|365256472|FG000|Overall Study|Adverse Event|7|||
105891301|NCT01970475|365256473|FG001|Overall Study|Adverse Event|3|||
105891302|NCT01970475|365256472|FG000|Overall Study|Lost to Follow-up|2|||
105891303|NCT01970475|365256473|FG001|Overall Study|Lost to Follow-up|2|||
105891304|NCT01970475|365256472|FG000|Overall Study|Protocol Violation|1|||
105891305|NCT01970475|365256473|FG001|Overall Study|Protocol Violation|0|||
105891306|NCT02234596|365256474|FG000|Overall Study|Participant not treated|2|||
105891307|NCT04852679|365256477|FG000|Main Intervention Period|Withdrawal by Subject|3|||
105891308|NCT04852679|365256477|FG000|Main Intervention Period|Adverse Event|1|||
105891309|NCT04852679|365256477|FG000|Main Intervention Period|Progressive Disease|16|||
105891310|NCT04852679|365256477|FG000|Main Intervention Period|Refused study visit|1|||
105891311|NCT04852679|365256477|FG000|Independent Injection Period|Missed study visit|1|||
105891312|NCT04542499|365257570|FG000|Overall Study|Adverse Event|23|||
105891313|NCT04542499|365257571|FG001|Overall Study|Adverse Event|43|||
105891314|NCT04542499|365257570|FG000|Overall Study|Lack of Efficacy|5|||
105891315|NCT04542499|365257571|FG001|Overall Study|Lack of Efficacy|2|||
105891316|NCT04542499|365257570|FG000|Overall Study|Lost to Follow-up|3|||
105891317|NCT04542499|365257571|FG001|Overall Study|Lost to Follow-up|4|||
105891318|NCT04542499|365257570|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
105891319|NCT04542499|365257571|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
105891320|NCT04542499|365257570|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
105891321|NCT04542499|365257571|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
105891322|NCT04542499|365257570|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105891323|NCT04542499|365257571|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105891324|NCT04542499|365257570|FG000|Overall Study|Physician Decision|0|||
105891325|NCT04542499|365257571|FG001|Overall Study|Physician Decision|1|||
105891326|NCT04542499|365257570|FG000|Overall Study|Site Terminated by Sponsor|3|||
105891327|NCT04542499|365257571|FG001|Overall Study|Site Terminated by Sponsor|5|||
105891328|NCT04542499|365257570|FG000|Overall Study|Withdrawal by Subject|12|||
105891329|NCT04542499|365257571|FG001|Overall Study|Withdrawal by Subject|33|||
105891330|NCT04542499|365257570|FG000|Overall Study|Other|2|||
105891331|NCT04542499|365257571|FG001|Overall Study|Other|2|||
105891332|NCT03320850|365257577|FG000|Overall Study|Lost to Follow-up|0|||
105891333|NCT03320850|365257578|FG001|Overall Study|Lost to Follow-up|0|||
105891334|NCT03320850|365257579|FG002|Overall Study|Lost to Follow-up|0|||
105891335|NCT03320850|365257580|FG003|Overall Study|Lost to Follow-up|0|||
105891336|NCT03320850|365257581|FG004|Overall Study|Lost to Follow-up|1|||
105891337|NCT03320850|365257582|FG005|Overall Study|Lost to Follow-up|2|||
105891338|NCT03320850|365257583|FG006|Overall Study|Lost to Follow-up|2|||
106121908|NCT01231503|366103715|FG000|Overall Study|Adverse event, serious fatal|0|||
106121909|NCT01231503|366103716|FG001|Overall Study|Adverse event, serious fatal|0|||
105665016|NCT04946942|364436742|FG002|Overall Study|Lost to Follow-up|0|||
105760663|NCT02999100|364776121|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105891339|NCT03320850|365257584|FG007|Overall Study|Lost to Follow-up|0|||
105891340|NCT03320850|365257585|FG008|Overall Study|Lost to Follow-up|6|||
105891341|NCT03320850|365257586|FG009|Overall Study|Lost to Follow-up|4|||
106121910|NCT01231503|366103717|FG002|Overall Study|Adverse event, serious fatal|1|||
106121911|NCT01231503|366103718|FG003|Overall Study|Adverse event, serious fatal|1|||
105760664|NCT00293241|364776123|FG000|Overall Study|Lost to Follow-up|9|||
105891342|NCT03320850|365257577|FG000|Overall Study|Withdrawal by Subject|0|||
105891343|NCT03320850|365257578|FG001|Overall Study|Withdrawal by Subject|0|||
105891344|NCT03320850|365257579|FG002|Overall Study|Withdrawal by Subject|0|||
105891345|NCT03320850|365257580|FG003|Overall Study|Withdrawal by Subject|0|||
105996661|NCT03777059|365649462|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
105996662|NCT03777059|365649463|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
105996663|NCT03777059|365649464|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
105996664|NCT03777059|365649461|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
105996665|NCT03777059|365649462|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
105996666|NCT03777059|365649463|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
105996667|NCT03777059|365649464|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
105996668|NCT00763386|365649472|FG000|Overall Study|Adverse Event|43|||
105996669|NCT00763386|365649473|FG001|Overall Study|Adverse Event|33|||
105996670|NCT00763386|365649472|FG000|Overall Study|Death|1|||
105996671|NCT00763386|365649473|FG001|Overall Study|Death|2|||
105996672|NCT00763386|365649472|FG000|Overall Study|Lost to Follow-up|3|||
105996673|NCT00763386|365649473|FG001|Overall Study|Lost to Follow-up|3|||
105996674|NCT00763386|365649472|FG000|Overall Study|Withdrawal by Subject|0|||
105996675|NCT00763386|365649473|FG001|Overall Study|Withdrawal by Subject|1|||
105996676|NCT00763386|365649472|FG000|Overall Study|CRF missing|0|||
105996677|NCT00763386|365649473|FG001|Overall Study|CRF missing|1|||
105996678|NCT00763386|365649472|FG000|Overall Study|Study Prosthesis Removed|1|||
105996679|NCT00763386|365649473|FG001|Overall Study|Study Prosthesis Removed|0|||
105996680|NCT01395901|365649476|FG000|Overall Study|Lost to Follow-up|4|||
105996681|NCT01395901|365649477|FG001|Overall Study|Lost to Follow-up|0|||
105996682|NCT01395901|365649476|FG000|Overall Study|Randomized but not received study drug|5|||
105996683|NCT01395901|365649477|FG001|Overall Study|Randomized but not received study drug|4|||
105996684|NCT01395901|365649476|FG000|Overall Study|Adverse Event|0|||
105996685|NCT01395901|365649477|FG001|Overall Study|Adverse Event|1|||
105996686|NCT01395901|365649476|FG000|Overall Study|Withdrawal of consent|1|||
105996687|NCT01395901|365649477|FG001|Overall Study|Withdrawal of consent|0|||
105996688|NCT02471014|365649478|FG000|Overall Study|Lost to Follow-up|2|||
105996689|NCT02471014|365649479|FG001|Overall Study|Lost to Follow-up|2|||
105996690|NCT02380287|365649480|FG000|Overall Study|Adverse Event|0|||
105996691|NCT02380287|365649481|FG001|Overall Study|Adverse Event|0|||
105996692|NCT02380287|365649482|FG002|Overall Study|Adverse Event|1|||
105996693|NCT02380287|365649483|FG003|Overall Study|Adverse Event|0|||
105996694|NCT02380287|365649484|FG004|Overall Study|Adverse Event|0|||
105996695|NCT02380287|365649485|FG005|Overall Study|Adverse Event|0|||
105996696|NCT02380287|365649486|FG006|Overall Study|Adverse Event|0|||
105996697|NCT02380287|365649487|FG007|Overall Study|Adverse Event|0|||
105996698|NCT01751984|365649488|FG000|Overall Study|Adverse Event|5|||
105996699|NCT01751984|365649489|FG001|Overall Study|Adverse Event|3|||
105996700|NCT01751984|365649488|FG000|Overall Study|Withdrawal by Subject|0|||
105996701|NCT01751984|365649489|FG001|Overall Study|Withdrawal by Subject|1|||
105996702|NCT01751984|365649488|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
105996703|NCT01751984|365649489|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
105996704|NCT04473963|365649490|FG000|Overall Study|Withdrawal by Subject|1|||
105996705|NCT04473963|365649491|FG001|Overall Study|Withdrawal by Subject|1|||
105996706|NCT04473963|365649492|FG002|Overall Study|Withdrawal by Subject|0|||
105996707|NCT04473963|365649490|FG000|Overall Study|Not inducible in AF|0|||
105996708|NCT04473963|365649491|FG001|Overall Study|Not inducible in AF|0|||
105996709|NCT04473963|365649492|FG002|Overall Study|Not inducible in AF|2|||
105996710|NCT04640311|365649493|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
105996711|NCT04640311|365649494|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996712|NCT04640311|365649495|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996713|NCT04640311|365649496|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996714|NCT04640311|365649497|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996715|NCT04640311|365649498|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105665017|NCT00487825|364438532|FG000|Overall Study|Adverse Event|2|||
105665018|NCT00487825|364438533|FG001|Overall Study|Adverse Event|2|||
105665019|NCT00487825|364438532|FG000|Overall Study|Lack of Efficacy|1|||
105996716|NCT04640311|365649499|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996717|NCT04640311|365649500|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996718|NCT04640311|365649501|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996719|NCT04640311|365649502|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996720|NCT04640311|365649503|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996721|NCT04640311|365649504|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996722|NCT04640311|365649505|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996723|NCT04640311|365649493|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996724|NCT04640311|365649494|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
105996725|NCT04640311|365649495|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996726|NCT04640311|365649496|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996727|NCT04640311|365649497|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996728|NCT04640311|365649498|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996729|NCT04640311|365649499|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105891346|NCT03320850|365257581|FG004|Overall Study|Withdrawal by Subject|1|||
105891347|NCT03320850|365257582|FG005|Overall Study|Withdrawal by Subject|2|||
105891348|NCT03320850|365257583|FG006|Overall Study|Withdrawal by Subject|4|||
105891349|NCT03320850|365257584|FG007|Overall Study|Withdrawal by Subject|5|||
105891350|NCT03320850|365257585|FG008|Overall Study|Withdrawal by Subject|2|||
105891351|NCT03320850|365257586|FG009|Overall Study|Withdrawal by Subject|1|||
105891352|NCT03320850|365257577|FG000|Overall Study|Lack of Efficacy|0|||
106121912|NCT01231503|366103719|FG004|Overall Study|Adverse event, serious fatal|0|||
106121913|NCT01231503|366103720|FG005|Overall Study|Adverse event, serious fatal|1|||
106121914|NCT01231503|366103721|FG006|Overall Study|Adverse event, serious fatal|0|||
106121915|NCT01231503|366103722|FG007|Overall Study|Adverse event, serious fatal|0|||
106121916|NCT01231503|366103715|FG000|Overall Study|Withdrawal by Subject|6|||
106121917|NCT01231503|366103716|FG001|Overall Study|Withdrawal by Subject|3|||
106121918|NCT01231503|366103717|FG002|Overall Study|Withdrawal by Subject|3|||
106121919|NCT01231503|366103718|FG003|Overall Study|Withdrawal by Subject|1|||
106121920|NCT01231503|366103719|FG004|Overall Study|Withdrawal by Subject|3|||
106121921|NCT01231503|366103720|FG005|Overall Study|Withdrawal by Subject|5|||
106121922|NCT01231503|366103721|FG006|Overall Study|Withdrawal by Subject|1|||
106121923|NCT01231503|366103722|FG007|Overall Study|Withdrawal by Subject|2|||
106121924|NCT01231503|366103715|FG000|Overall Study|Lost to Follow-up|8|||
106121925|NCT01231503|366103716|FG001|Overall Study|Lost to Follow-up|10|||
106121926|NCT01231503|366103717|FG002|Overall Study|Lost to Follow-up|8|||
106121927|NCT01231503|366103718|FG003|Overall Study|Lost to Follow-up|5|||
106121928|NCT01231503|366103719|FG004|Overall Study|Lost to Follow-up|7|||
106121929|NCT01231503|366103720|FG005|Overall Study|Lost to Follow-up|9|||
106121930|NCT01231503|366103721|FG006|Overall Study|Lost to Follow-up|6|||
106121931|NCT01231503|366103722|FG007|Overall Study|Lost to Follow-up|6|||
106121932|NCT01231503|366103715|FG000|Overall Study|Protocol Violation|0|||
106121933|NCT01231503|366103716|FG001|Overall Study|Protocol Violation|0|||
106121934|NCT01231503|366103717|FG002|Overall Study|Protocol Violation|0|||
106121935|NCT01231503|366103718|FG003|Overall Study|Protocol Violation|1|||
106121936|NCT01231503|366103719|FG004|Overall Study|Protocol Violation|0|||
106121937|NCT01231503|366103720|FG005|Overall Study|Protocol Violation|0|||
106121938|NCT01231503|366103721|FG006|Overall Study|Protocol Violation|0|||
106121939|NCT01231503|366103722|FG007|Overall Study|Protocol Violation|0|||
106121940|NCT00284089|366103724|FG000|Multiple Dose Phase|Adverse Event|1|||
106121941|NCT00284089|366103725|FG001|Multiple Dose Phase|Adverse Event|0|||
106121942|NCT00284089|366103726|FG002|Multiple Dose Phase|Adverse Event|1|||
106121943|NCT00284089|366103727|FG003|Multiple Dose Phase|Adverse Event|1|||
106121944|NCT00284089|366103724|FG000|Multiple Dose Phase|Protocol Violation|0|||
106121945|NCT00284089|366103725|FG001|Multiple Dose Phase|Protocol Violation|0|||
106121946|NCT00284089|366103726|FG002|Multiple Dose Phase|Protocol Violation|1|||
106121947|NCT00284089|366103727|FG003|Multiple Dose Phase|Protocol Violation|0|||
106121948|NCT00284089|366103724|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
106121949|NCT00284089|366103725|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
106121950|NCT00284089|366103726|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
106121951|NCT00284089|366103727|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
106121952|NCT00284089|366103724|FG000|Multiple Dose Phase|Death|0|||
106121953|NCT00284089|366103725|FG001|Multiple Dose Phase|Death|0|||
106121954|NCT00284089|366103726|FG002|Multiple Dose Phase|Death|1|||
106121955|NCT00284089|366103727|FG003|Multiple Dose Phase|Death|1|||
106121956|NCT00284089|366103724|FG000|Extension Phase|Adverse Event|0|||
106121957|NCT00284089|366103725|FG001|Extension Phase|Adverse Event|0|||
106121958|NCT00284089|366103726|FG002|Extension Phase|Adverse Event|2|||
106121959|NCT00284089|366103727|FG003|Extension Phase|Adverse Event|2|||
106121960|NCT00284089|366103724|FG000|Extension Phase|condition no longer requires study drug|2|||
106121961|NCT00284089|366103725|FG001|Extension Phase|condition no longer requires study drug|0|||
106121962|NCT00284089|366103726|FG002|Extension Phase|condition no longer requires study drug|2|||
105891353|NCT03320850|365257578|FG001|Overall Study|Lack of Efficacy|0|||
106121963|NCT00284089|366103727|FG003|Extension Phase|condition no longer requires study drug|7|||
106121964|NCT00284089|366103724|FG000|Extension Phase|Protocol Violation|0|||
106121965|NCT00284089|366103725|FG001|Extension Phase|Protocol Violation|0|||
106121966|NCT00284089|366103726|FG002|Extension Phase|Protocol Violation|1|||
106121967|NCT00284089|366103727|FG003|Extension Phase|Protocol Violation|0|||
106121968|NCT00284089|366103724|FG000|Extension Phase|Withdrawal by Subject|0|||
106121969|NCT00284089|366103725|FG001|Extension Phase|Withdrawal by Subject|0|||
106121970|NCT00284089|366103726|FG002|Extension Phase|Withdrawal by Subject|1|||
106121971|NCT00284089|366103727|FG003|Extension Phase|Withdrawal by Subject|3|||
106121972|NCT03051659|366103728|FG000|Treatment Period|Withdrawal by Subject|0|||
106121973|NCT03051659|366103729|FG001|Treatment Period|Withdrawal by Subject|2|||
106121974|NCT03051659|366103728|FG000|Survival Follow-up|Lost to Follow-up|23|||
106121975|NCT03051659|366103729|FG001|Survival Follow-up|Lost to Follow-up|22|||
106121976|NCT04362137|366103730|FG000|Overall Study|Death|9|||
106121977|NCT04362137|366103731|FG001|Overall Study|Death|3|||
105996730|NCT04640311|365649500|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
106121978|NCT04362137|366103730|FG000|Overall Study|Patient decision|6|||
105891354|NCT03320850|365257579|FG002|Overall Study|Lack of Efficacy|0|||
105891355|NCT03320850|365257580|FG003|Overall Study|Lack of Efficacy|1|||
105891356|NCT03320850|365257581|FG004|Overall Study|Lack of Efficacy|0|||
105891357|NCT03320850|365257582|FG005|Overall Study|Lack of Efficacy|1|||
105891358|NCT03320850|365257583|FG006|Overall Study|Lack of Efficacy|0|||
105891359|NCT03320850|365257584|FG007|Overall Study|Lack of Efficacy|2|||
105891360|NCT03320850|365257585|FG008|Overall Study|Lack of Efficacy|0|||
105891361|NCT03320850|365257586|FG009|Overall Study|Lack of Efficacy|3|||
105891362|NCT03320850|365257577|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
105891363|NCT03320850|365257578|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
105891364|NCT03320850|365257579|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
105891365|NCT03320850|365257580|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
105891366|NCT03320850|365257581|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
105891367|NCT03320850|365257582|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
105891368|NCT03320850|365257583|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
105891369|NCT03320850|365257584|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
105891370|NCT03320850|365257585|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
105891371|NCT03320850|365257586|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
105891372|NCT03320850|365257577|FG000|Overall Study|Adverse Event|0|||
105891373|NCT03320850|365257578|FG001|Overall Study|Adverse Event|0|||
105891374|NCT03320850|365257579|FG002|Overall Study|Adverse Event|0|||
105891375|NCT03320850|365257580|FG003|Overall Study|Adverse Event|0|||
105891376|NCT03320850|365257581|FG004|Overall Study|Adverse Event|0|||
105891377|NCT03320850|365257582|FG005|Overall Study|Adverse Event|2|||
105891378|NCT03320850|365257583|FG006|Overall Study|Adverse Event|1|||
105891379|NCT03320850|365257584|FG007|Overall Study|Adverse Event|0|||
105891380|NCT03320850|365257585|FG008|Overall Study|Adverse Event|2|||
105891381|NCT03320850|365257586|FG009|Overall Study|Adverse Event|0|||
105891382|NCT03320850|365257577|FG000|Overall Study|Reason Not Specified|0|||
105891383|NCT03320850|365257578|FG001|Overall Study|Reason Not Specified|0|||
105891384|NCT03320850|365257579|FG002|Overall Study|Reason Not Specified|0|||
105891385|NCT03320850|365257580|FG003|Overall Study|Reason Not Specified|0|||
105891386|NCT03320850|365257581|FG004|Overall Study|Reason Not Specified|0|||
105891387|NCT03320850|365257582|FG005|Overall Study|Reason Not Specified|1|||
105891388|NCT03320850|365257583|FG006|Overall Study|Reason Not Specified|0|||
105891389|NCT03320850|365257584|FG007|Overall Study|Reason Not Specified|0|||
105891390|NCT03320850|365257585|FG008|Overall Study|Reason Not Specified|0|||
105891391|NCT03320850|365257586|FG009|Overall Study|Reason Not Specified|1|||
105891392|NCT03361865|365257589|FG000|Overall Study|Death|17|||
105891393|NCT03361865|365257590|FG001|Overall Study|Death|18|||
105891394|NCT03361865|365257589|FG000|Overall Study|Physician Decision|1|||
105891395|NCT03361865|365257590|FG001|Overall Study|Physician Decision|9|||
105891396|NCT03361865|365257589|FG000|Overall Study|Withdrawal by Subject|1|||
105891397|NCT03361865|365257590|FG001|Overall Study|Withdrawal by Subject|0|||
105891398|NCT01632150|365257599|FG000|Overall Study|Disease progression|27|||
105891399|NCT01632150|365257599|FG000|Overall Study|Study drug toxicity|1|||
105891400|NCT01632150|365257599|FG000|Overall Study|Unrelated adverse event|7|||
105891401|NCT01632150|365257599|FG000|Overall Study|Withdrawal by Subject|2|||
105891402|NCT01632150|365257599|FG000|Overall Study|Patient underwent autologous transplant|1|||
105891403|NCT01632150|365257599|FG000|Overall Study|Moved to compassionate program|2|||
105891404|NCT00177307|365257603|FG000|Overall Study|Withdrawal by Subject|1|||
105891405|NCT01646021|365257604|FG000|Overall Study|Death|77|||
105891406|NCT01646021|365257605|FG001|Overall Study|Death|83|||
105891407|NCT01646021|365257604|FG000|Overall Study|Study Terminated by Sponsor|50|||
105891408|NCT01646021|365257605|FG001|Overall Study|Study Terminated by Sponsor|41|||
105891409|NCT01646021|365257604|FG000|Overall Study|Lost to Follow-up|2|||
105891410|NCT01646021|365257605|FG001|Overall Study|Lost to Follow-up|2|||
105891411|NCT01646021|365257604|FG000|Overall Study|Withdrawal by Subject|10|||
105891412|NCT01646021|365257605|FG001|Overall Study|Withdrawal by Subject|15|||
105891413|NCT01104246|365257607|FG000|Overall Study|Withdrawal by Subject|1|||
105891414|NCT01104246|365257607|FG000|Overall Study|did not meet inclusion criteria|4|||
105891415|NCT05178641|365257608|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
105891416|NCT05178641|365257609|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
106121979|NCT04362137|366103731|FG001|Overall Study|Patient decision|3|||
106121980|NCT04362137|366103730|FG000|Overall Study|Adverse Event|1|||
105891417|NCT05178641|365257608|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
105891418|NCT05178641|365257609|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
105891419|NCT01869699|365257611|FG000|Overall Study|Withdrawal by Subject|1|||
105891420|NCT01869699|365257612|FG001|Overall Study|Withdrawal by Subject|0|||
105891421|NCT01083186|365257613|FG000|Overall Study|Lost to Follow-up|48|||
105891422|NCT01083186|365257613|FG000|Overall Study|Consent Withdrawal|7|||
105891423|NCT01083186|365257613|FG000|Overall Study|Death|3|||
105891424|NCT01083186|365257613|FG000|Overall Study|Adverse Event|3|||
105891425|NCT01083186|365257613|FG000|Overall Study|Lack of Efficacy|2|||
105665020|NCT00487825|364438533|FG001|Overall Study|Lack of Efficacy|1|||
105665021|NCT00487825|364438532|FG000|Overall Study|Other|3|||
105665022|NCT00487825|364438533|FG001|Overall Study|Other|2|||
105665023|NCT04596995|364438538|FG000|Overall Study|Lack of Efficacy|8|||
105891426|NCT01083186|365257613|FG000|Overall Study|Hemodialysis Initiation|28|||
105891427|NCT01083186|365257613|FG000|Overall Study|Administrative Reasons|2|||
105891428|NCT01083186|365257613|FG000|Overall Study|Non-compliance to Study Treatment|1|||
105891429|NCT00108485|365257616|FG000|Overall Study|Withdrawal by Subject|3|||
105891430|NCT00108485|365257617|FG001|Overall Study|Withdrawal by Subject|0|||
105891431|NCT00108485|365257616|FG000|Overall Study|Lost to Follow-up|0|||
105891432|NCT00108485|365257617|FG001|Overall Study|Lost to Follow-up|2|||
105891433|NCT01097421|365257618|FG000|Overall Study|Adverse Event|8|||
105891434|NCT01097421|365257618|FG000|Overall Study|Protocol Violation|2|||
105891435|NCT01097421|365257618|FG000|Overall Study|Lost to Follow-up|1|||
105891436|NCT01097421|365257618|FG000|Overall Study|Withdrawal by Subject|3|||
105891437|NCT01701193|365257622|FG000|Overall Study|Withdrawal by Subject|2|||
105891438|NCT01701193|365257623|FG001|Overall Study|Withdrawal by Subject|2|||
105891439|NCT01701193|365257624|FG002|Overall Study|Withdrawal by Subject|1|||
105891440|NCT01701193|365257625|FG003|Overall Study|Withdrawal by Subject|2|||
105891441|NCT01701193|365257622|FG000|Overall Study|Adverse Event|1|||
105891442|NCT01701193|365257623|FG001|Overall Study|Adverse Event|0|||
105891443|NCT01701193|365257624|FG002|Overall Study|Adverse Event|0|||
105891444|NCT01701193|365257625|FG003|Overall Study|Adverse Event|0|||
105891445|NCT02062944|365257626|FG000|Overall Study|Lost to Follow-up|1|||
105891446|NCT02062944|365257626|FG000|Overall Study|New hemotological disorder identified|1|||
105891447|NCT02062944|365257626|FG000|Overall Study|Uncontrolled Hypertension|1|||
105891448|NCT02062944|365257626|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
105891449|NCT00278148|365257627|FG000|Phase II - Expansion Phase|Disease progression|0|||
105891450|NCT00278148|365257628|FG001|Phase II - Expansion Phase|Disease progression|0|||
105891451|NCT00278148|365257629|FG002|Phase II - Expansion Phase|Disease progression|4|||
105891452|NCT00278148|365257627|FG000|Phase II - Expansion Phase|Adverse Event|0|||
105891453|NCT00278148|365257628|FG001|Phase II - Expansion Phase|Adverse Event|0|||
105891454|NCT00278148|365257629|FG002|Phase II - Expansion Phase|Adverse Event|2|||
105891455|NCT02407457|365257630|FG000|1 Month|Death|3|||
105891456|NCT02407457|365257631|FG001|1 Month|Death|0|||
105891457|NCT02407457|365257630|FG000|1 Month|Lost to Follow-up|1|||
105891458|NCT02407457|365257631|FG001|1 Month|Lost to Follow-up|1|||
105891459|NCT02407457|365257630|FG000|1 Month|missed visit|2|||
105891460|NCT02407457|365257631|FG001|1 Month|missed visit|5|||
105891461|NCT02407457|365257630|FG000|6-Month|Death|2|||
105891462|NCT02407457|365257631|FG001|6-Month|Death|8|||
105891463|NCT02407457|365257630|FG000|6-Month|Lost to Follow-up|2|||
105891464|NCT02407457|365257631|FG001|6-Month|Lost to Follow-up|2|||
105891465|NCT02407457|365257630|FG000|6-Month|missed visit|16|||
105891466|NCT02407457|365257631|FG001|6-Month|missed visit|14|||
105891467|NCT02407457|365257630|FG000|6-Month|Open Repair|0|||
105891468|NCT02407457|365257631|FG001|6-Month|Open Repair|1|||
105891469|NCT02407457|365257630|FG000|1 Year|Death|6|||
105891470|NCT02407457|365257631|FG001|1 Year|Death|11|||
105891471|NCT02407457|365257630|FG000|1 Year|Lost to Follow-up|3|||
105891472|NCT02407457|365257631|FG001|1 Year|Lost to Follow-up|2|||
105891473|NCT02407457|365257630|FG000|1 Year|Missed Visit|24|||
105891474|NCT02407457|365257631|FG001|1 Year|Missed Visit|14|||
105891475|NCT02407457|365257630|FG000|1 Year|Open Repair|0|||
105891476|NCT02407457|365257631|FG001|1 Year|Open Repair|1|||
105891477|NCT02407457|365257630|FG000|2-year|Death|14|||
105891478|NCT02407457|365257631|FG001|2-year|Death|8|||
105891479|NCT02407457|365257630|FG000|2-year|Lost to Follow-up|7|||
105891480|NCT02407457|365257631|FG001|2-year|Lost to Follow-up|10|||
105665024|NCT04596995|364438538|FG000|Overall Study|Lost to Follow-up|3|||
105665025|NCT04596995|364438538|FG000|Overall Study|Withdrawal by Subject|12|||
105665026|NCT04596995|364438538|FG000|Overall Study|Sponsor decision|3|||
105665027|NCT04596995|364438538|FG000|Overall Study|Enrolled in managed access program|3|||
105891481|NCT02407457|365257630|FG000|2-year|Missed Visit|13|||
105665028|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
105891482|NCT02407457|365257631|FG001|2-year|Missed Visit|15|||
105891483|NCT02407457|365257630|FG000|2-year|Open Repair|0|||
105665029|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
105891484|NCT02407457|365257631|FG001|2-year|Open Repair|2|||
105891485|NCT02407457|365257630|FG000|3-year|Death|11|||
105891486|NCT02407457|365257631|FG001|3-year|Death|10|||
105891487|NCT02407457|365257630|FG000|3-year|Lost to Follow-up|9|||
105665030|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
105891488|NCT02407457|365257631|FG001|3-year|Lost to Follow-up|10|||
105891489|NCT02407457|365257630|FG000|3-year|Missed Visit|19|||
105891490|NCT02407457|365257631|FG001|3-year|Missed Visit|16|||
105891491|NCT02407457|365257630|FG000|4-year|Death|18|||
105891492|NCT02407457|365257631|FG001|4-year|Death|10|||
105891493|NCT02407457|365257630|FG000|4-year|Lost to Follow-up|10|||
105891494|NCT02407457|365257631|FG001|4-year|Lost to Follow-up|12|||
105891495|NCT02407457|365257630|FG000|4-year|Missed Visit|18|||
105891496|NCT02407457|365257631|FG001|4-year|Missed Visit|16|||
105891497|NCT02407457|365257630|FG000|5-year|Death|10|||
105665031|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Death|4|||
105891498|NCT02407457|365257631|FG001|5-year|Death|3|||
105996731|NCT04640311|365649501|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996732|NCT04640311|365649502|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996733|NCT04640311|365649503|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996734|NCT04640311|365649504|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996735|NCT04640311|365649505|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
105996736|NCT04640311|365649493|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996737|NCT04640311|365649494|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
105996738|NCT04640311|365649495|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105891499|NCT02407457|365257630|FG000|5-year|Lost to Follow-up|22|||
105891500|NCT02407457|365257631|FG001|5-year|Lost to Follow-up|13|||
105891501|NCT02407457|365257630|FG000|5-year|Missed Visit|9|||
105891502|NCT02407457|365257631|FG001|5-year|Missed Visit|1|||
105891503|NCT03419598|365257632|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
105891504|NCT01546168|365257633|FG000|Overall Study|Lost to Follow-up|1|||
105891505|NCT01546168|365257634|FG001|Overall Study|Lost to Follow-up|0|||
105891506|NCT01546168|365257633|FG000|Overall Study|Withdrawal by Subject|1|||
105891507|NCT01546168|365257634|FG001|Overall Study|Withdrawal by Subject|0|||
105891508|NCT01546168|365257633|FG000|Overall Study|ineligible after signing consent|2|||
105891509|NCT01546168|365257634|FG001|Overall Study|ineligible after signing consent|0|||
105891510|NCT06137703|365257635|FG000|Overall Study|Other|0|||
105891511|NCT06137703|365257636|FG001|Overall Study|Other|1|||
105891512|NCT06137703|365257637|FG002|Overall Study|Other|0|||
105891513|NCT06137703|365257638|FG003|Overall Study|Other|0|||
105891514|NCT06137703|365257635|FG000|Overall Study|Adverse Event|0|||
105891515|NCT06137703|365257636|FG001|Overall Study|Adverse Event|0|||
105891516|NCT06137703|365257637|FG002|Overall Study|Adverse Event|1|||
105891517|NCT06137703|365257638|FG003|Overall Study|Adverse Event|0|||
105891518|NCT01258075|365257643|FG000|Overall Study|Adverse Event|8|||
105891519|NCT01258075|365257644|FG001|Overall Study|Adverse Event|3|||
105891520|NCT01258075|365257643|FG000|Overall Study|Lost to Follow-up|11|||
105891521|NCT01258075|365257644|FG001|Overall Study|Lost to Follow-up|6|||
105891522|NCT01258075|365257643|FG000|Overall Study|Withdrawal by Subject|10|||
105891523|NCT01258075|365257644|FG001|Overall Study|Withdrawal by Subject|7|||
105891524|NCT01258075|365257643|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
105891525|NCT01258075|365257644|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
105891526|NCT01258075|365257643|FG000|Overall Study|Other|12|||
105891527|NCT01258075|365257644|FG001|Overall Study|Other|5|||
105891528|NCT01618019|365257645|FG000|Overall Study|Withdrawal by Subject|14|||
105891529|NCT01618019|365257646|FG001|Overall Study|Withdrawal by Subject|14|||
105891530|NCT00471718|365257647|FG000|Overall Study|Adverse Event|3|||
105891531|NCT00471718|365257647|FG000|Overall Study|other complicating disease|1|||
105891532|NCT00471718|365257647|FG000|Overall Study|disease progression|22|||
105891533|NCT00471718|365257647|FG000|Overall Study|Withdrawal by Subject|1|||
105891534|NCT01446237|365257648|FG000|Overall Study|Adverse Event|1|||
105891535|NCT01446237|365257648|FG000|Overall Study|Lost to Follow-up|2|||
105891536|NCT01446237|365257648|FG000|Overall Study|Withdrawal by Subject|7|||
105891537|NCT01940900|365257649|FG000|Overall Study|Physician Decision|4|||
105891538|NCT01940900|365257650|FG001|Overall Study|Physician Decision|0|||
105891539|NCT01940900|365257649|FG000|Overall Study|Adverse Event|10|||
105891540|NCT01940900|365257650|FG001|Overall Study|Adverse Event|15|||
105891541|NCT01940900|365257649|FG000|Overall Study|Withdrawal by Subject|11|||
105891542|NCT01940900|365257650|FG001|Overall Study|Withdrawal by Subject|15|||
105891543|NCT01940900|365257649|FG000|Overall Study|Lost to Follow-up|1|||
105891544|NCT01940900|365257650|FG001|Overall Study|Lost to Follow-up|0|||
105891545|NCT01940900|365257649|FG000|Overall Study|Sponsor Decision|1|||
105665032|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Death|2|||
105665033|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Death|3|||
105665034|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
105665035|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
105665036|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
105760665|NCT00293241|364776124|FG001|Overall Study|Lost to Follow-up|16|||
105891546|NCT01940900|365257650|FG001|Overall Study|Sponsor Decision|0|||
105891547|NCT01940900|365257649|FG000|Overall Study|subject non-compliance|1|||
105891548|NCT01940900|365257650|FG001|Overall Study|subject non-compliance|1|||
105891549|NCT01940900|365257649|FG000|Overall Study|other|1|||
105891550|NCT01940900|365257650|FG001|Overall Study|other|0|||
105891551|NCT04713592|365257655|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
105891552|NCT04713592|365257656|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
105891553|NCT04713592|365257657|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
105891554|NCT04713592|365257658|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
105891555|NCT04713592|365257655|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
106121981|NCT04362137|366103731|FG001|Overall Study|Adverse Event|0|||
105891556|NCT04713592|365257656|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
105891557|NCT04713592|365257657|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
105891558|NCT04713592|365257658|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
105891559|NCT04713592|365257655|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
105891560|NCT04713592|365257656|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
105891561|NCT04713592|365257657|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
105891562|NCT04713592|365257658|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
105891563|NCT04713592|365257655|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105891564|NCT04713592|365257656|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105891565|NCT04713592|365257657|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
105891566|NCT04713592|365257658|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
105891567|NCT04713592|365257655|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
105891568|NCT04713592|365257656|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
105891569|NCT04713592|365257657|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
105891570|NCT04713592|365257658|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
105891571|NCT04713592|365257655|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105891572|NCT04713592|365257656|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105891573|NCT04713592|365257657|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
105891574|NCT04713592|365257658|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
105891575|NCT04713592|365257655|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
105891576|NCT04713592|365257656|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
105891577|NCT04713592|365257657|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
105891578|NCT04713592|365257658|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
105891579|NCT01263782|365257659|FG000|Overall Study|Death|0|||
105891580|NCT01263782|365257660|FG001|Overall Study|Death|0|||
105891581|NCT01263782|365257661|FG002|Overall Study|Death|1|||
105891582|NCT01263782|365257662|FG003|Overall Study|Death|0|||
105891583|NCT01263782|365257659|FG000|Overall Study|Progressive disease|0|||
105891584|NCT01263782|365257660|FG001|Overall Study|Progressive disease|0|||
105891585|NCT01263782|365257661|FG002|Overall Study|Progressive disease|0|||
105891586|NCT01263782|365257662|FG003|Overall Study|Progressive disease|1|||
105891587|NCT01263782|365257659|FG000|Overall Study|Too early|0|||
105891588|NCT01263782|365257660|FG001|Overall Study|Too early|0|||
105891589|NCT01263782|365257661|FG002|Overall Study|Too early|1|||
105891590|NCT01263782|365257662|FG003|Overall Study|Too early|0|||
105891591|NCT01263782|365257659|FG000|Overall Study|Inevaluable|0|||
105891592|NCT01263782|365257660|FG001|Overall Study|Inevaluable|0|||
105891593|NCT01263782|365257661|FG002|Overall Study|Inevaluable|1|||
105891594|NCT01263782|365257662|FG003|Overall Study|Inevaluable|0|||
105891595|NCT00191282|365257667|FG000|Overall Study|Adverse Event|5|||
105891596|NCT00191282|365257668|FG001|Overall Study|Adverse Event|6|||
105891597|NCT00191282|365257667|FG000|Overall Study|Death|51|||
105891598|NCT00191282|365257668|FG001|Overall Study|Death|51|||
105891599|NCT00191282|365257667|FG000|Overall Study|Lack of Efficacy|11|||
105891600|NCT00191282|365257668|FG001|Overall Study|Lack of Efficacy|6|||
105891601|NCT00191282|365257667|FG000|Overall Study|Noncompliance|14|||
105891602|NCT00191282|365257668|FG001|Overall Study|Noncompliance|17|||
105891603|NCT00191282|365257667|FG000|Overall Study|Patient moved|11|||
105891604|NCT00191282|365257668|FG001|Overall Study|Patient moved|14|||
105891605|NCT00191282|365257667|FG000|Overall Study|Withdrawal by Subject|59|||
105891606|NCT00191282|365257668|FG001|Overall Study|Withdrawal by Subject|44|||
105891607|NCT00191282|365257667|FG000|Overall Study|Physician Decision|18|||
105891608|NCT00191282|365257668|FG001|Overall Study|Physician Decision|15|||
105891609|NCT00191282|365257667|FG000|Overall Study|Protocol entry criteria not met|14|||
105891610|NCT00191282|365257668|FG001|Overall Study|Protocol entry criteria not met|9|||
106121982|NCT04362137|366103730|FG000|Overall Study|Lost to Follow-up|1|||
106121983|NCT04362137|366103731|FG001|Overall Study|Lost to Follow-up|0|||
106121984|NCT04362137|366103730|FG000|Overall Study|Protocol deviation|1|||
106121985|NCT04362137|366103731|FG001|Overall Study|Protocol deviation|0|||
106121986|NCT00967018|366103735|FG000|Overall Study|Adverse Event|2|||
106121987|NCT00967018|366103735|FG000|Overall Study|Physician Decision|7|||
106121988|NCT00967018|366103735|FG000|Overall Study|Lost to Follow-up|2|||
106121989|NCT00967018|366103735|FG000|Overall Study|Withdrawal by Subject|1|||
106121990|NCT00967018|366103735|FG000|Overall Study|Miscellaneous Reasons|9|||
105891611|NCT00191282|365257667|FG000|Overall Study|Protocol Violation|9|||
105891612|NCT00191282|365257668|FG001|Overall Study|Protocol Violation|12|||
105891613|NCT00191282|365257667|FG000|Overall Study|Severity of outcome|2|||
105891614|NCT00191282|365257668|FG001|Overall Study|Severity of outcome|5|||
105891615|NCT00191282|365257667|FG000|Overall Study|Sponsor's decision|2|||
105891616|NCT00191282|365257668|FG001|Overall Study|Sponsor's decision|2|||
105891617|NCT00191282|365257667|FG000|Overall Study|Lost to Follow-up|24|||
105891618|NCT00191282|365257668|FG001|Overall Study|Lost to Follow-up|31|||
105891619|NCT03057054|365257669|FG000|Overall Study|Death|4|||
106121991|NCT02494206|366103736|FG000|Overall Study|Adverse Event|1|||
105996739|NCT04640311|365649496|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996740|NCT04640311|365649497|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996741|NCT04640311|365649498|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996742|NCT04640311|365649499|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105665037|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
105665038|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
105665039|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
105665040|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
105665041|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
105665042|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
105665043|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
105665044|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
105665045|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
105665046|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
105665047|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
105665048|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
105665049|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
105665050|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
105665051|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
105665052|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
105665053|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
105665054|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
105665055|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
105665056|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
105665057|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
105665058|NCT02783573|364438539|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
105665059|NCT02783573|364438540|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
105665060|NCT02783573|364438541|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
105665061|NCT02783573|364438539|FG000|Delayed-Start Period|Sponsor Decision|0|||
105665062|NCT02783573|364438540|FG001|Delayed-Start Period|Sponsor Decision|17|||
105665063|NCT02783573|364438541|FG002|Delayed-Start Period|Sponsor Decision|12|||
105665064|NCT01375673|364438542|FG000|Overall Study|Withdrawal by Subject|0|||
105665065|NCT01375673|364438543|FG001|Overall Study|Withdrawal by Subject|1|||
105665066|NCT01784523|364438544|FG000|Overall Study|Study closed early|7|||
105665067|NCT01784523|364438545|FG001|Overall Study|Study closed early|4|||
105665068|NCT01907906|364438548|FG000|Overall Study|Withdrawal by Subject|1|||
105665069|NCT01907906|364438549|FG001|Overall Study|Withdrawal by Subject|0|||
105665070|NCT01907906|364438548|FG000|Overall Study|Physician Decision|3|||
105665071|NCT01907906|364438549|FG001|Overall Study|Physician Decision|1|||
105665072|NCT04334278|364438555|FG000|Overall Study|Lost to Follow-up|0|||
105891620|NCT03057054|365257670|FG001|Overall Study|Death|4|||
105891621|NCT03057054|365257669|FG000|Overall Study|Withdrawal by Subject|6|||
105891622|NCT03057054|365257670|FG001|Overall Study|Withdrawal by Subject|3|||
105891623|NCT03057054|365257669|FG000|Overall Study|Ineligible|1|||
105891624|NCT03057054|365257670|FG001|Overall Study|Ineligible|1|||
105891625|NCT01790828|365257672|FG000|Overall Study|Other|34|||
105891626|NCT01984892|365257673|FG000|Overall Study|Progressive disease|7|||
105891627|NCT03495154|365257679|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
105891628|NCT03495154|365257679|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
105891629|NCT03495154|365257679|FG000|Overall Study|Screen Failures During Surgery|6|||
105891630|NCT03495154|365257679|FG000|Overall Study|Death|2|||
105891631|NCT03495154|365257679|FG000|Overall Study|Lost to Follow-up|16|||
105891632|NCT03495154|365257679|FG000|Overall Study|Withdrawal by Subject|2|||
105891633|NCT03495154|365257679|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
105891634|NCT00784550|365259619|FG000|Overall Study|Adverse Event|12|||
105891635|NCT00784550|365259620|FG001|Overall Study|Adverse Event|10|||
105996743|NCT04640311|365649500|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996744|NCT04640311|365649501|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996745|NCT04640311|365649502|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996746|NCT04640311|365649503|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105891636|NCT00784550|365259619|FG000|Overall Study|Lack of Efficacy|0|||
105891637|NCT00784550|365259620|FG001|Overall Study|Lack of Efficacy|1|||
105891638|NCT00784550|365259619|FG000|Overall Study|Protocol Violation|10|||
105891639|NCT00784550|365259620|FG001|Overall Study|Protocol Violation|10|||
105891640|NCT00784550|365259619|FG000|Overall Study|Lost to Follow-up|8|||
105891641|NCT00784550|365259620|FG001|Overall Study|Lost to Follow-up|5|||
105891642|NCT00784550|365259619|FG000|Overall Study|Physician Decision|2|||
105891643|NCT00784550|365259620|FG001|Overall Study|Physician Decision|3|||
105891644|NCT00784550|365259619|FG000|Overall Study|Withdrawal by Subject|4|||
105891645|NCT00784550|365259620|FG001|Overall Study|Withdrawal by Subject|13|||
105891646|NCT00860249|365259621|FG000|Overall Study|trial was terminated prior to completion|21|||
105891647|NCT00860249|365259622|FG001|Overall Study|trial was terminated prior to completion|18|||
105891648|NCT00860249|365259623|FG002|Overall Study|trial was terminated prior to completion|21|||
105891649|NCT01944670|365259624|FG000|Overall Study|Lost to Follow-up|2|||
105891650|NCT02730377|365259625|FG000|Overall Study|Other|5|||
105891651|NCT02730377|365259626|FG001|Overall Study|Other|4|||
105891652|NCT02730377|365259625|FG000|Overall Study|Death|1|||
105891653|NCT02730377|365259626|FG001|Overall Study|Death|8|||
105891654|NCT02730377|365259625|FG000|Overall Study|Inadequate glycaemic control|368|||
105891655|NCT02730377|365259626|FG001|Overall Study|Inadequate glycaemic control|473|||
105891656|NCT02730377|365259625|FG000|Overall Study|Adverse Event|79|||
105891657|NCT02730377|365259626|FG001|Overall Study|Adverse Event|41|||
105891658|NCT02730377|365259625|FG000|Overall Study|Protocol Violation|23|||
105891659|NCT02730377|365259626|FG001|Overall Study|Protocol Violation|30|||
105891660|NCT02730377|365259625|FG000|Overall Study|Lack of Efficacy|4|||
105891661|NCT02730377|365259626|FG001|Overall Study|Lack of Efficacy|13|||
105891662|NCT02730377|365259625|FG000|Overall Study|Pregnancy|0|||
105891663|NCT02730377|365259626|FG001|Overall Study|Pregnancy|1|||
105891664|NCT02730377|365259625|FG000|Overall Study|Withdrawal by Subject|45|||
105891665|NCT02730377|365259626|FG001|Overall Study|Withdrawal by Subject|42|||
105891666|NCT02730377|365259625|FG000|Overall Study|Lost to Follow-up|25|||
105891667|NCT02730377|365259626|FG001|Overall Study|Lost to Follow-up|21|||
105891668|NCT01286168|365259631|FG000|Overall Study|Withdrawal by Subject|1|||
105891669|NCT01286168|365259631|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
105891670|NCT02143791|365259632|FG000|Enrolled|Withdrawal by Subject|4|||
105891671|NCT02143791|365259632|FG000|Trial Stimulation|Lack of Efficacy|21|||
105891672|NCT02143791|365259632|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
105891673|NCT02143791|365259632|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
105891674|NCT02143791|365259632|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
105891675|NCT02143791|365259632|FG000|Any Programming (3-6 Months)|Missing Data|1|||
105891676|NCT02143791|365259632|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
105891677|NCT02091960|365259635|FG000|Overall Study|Death|7|||
105891678|NCT02091960|365259635|FG000|Overall Study|Withdrawal by Subject|1|||
105891679|NCT02091960|365259635|FG000|Overall Study|Miscellaneous Reasons|37|||
105891680|NCT02677038|365259639|FG000|Overall Study|Physician Decision|1|||
105891681|NCT02677038|365259639|FG000|Overall Study|Withdrawal by Subject|1|||
105891682|NCT03671564|365259640|FG000|Overall Study|Progressive Disease|3|||
105891683|NCT03671564|365259641|FG001|Overall Study|Progressive Disease|5|||
105891684|NCT03671564|365259642|FG002|Overall Study|Progressive Disease|3|||
105891685|NCT03671564|365259640|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
105891686|NCT03671564|365259641|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
105891687|NCT03671564|365259642|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
105891688|NCT03671564|365259640|FG000|Overall Study|Withdrawal by Subject|1|||
105891689|NCT03671564|365259641|FG001|Overall Study|Withdrawal by Subject|1|||
105891690|NCT03671564|365259642|FG002|Overall Study|Withdrawal by Subject|0|||
105891695|NCT04739722|365259651|FG000|Overall Study|Lost to Follow-up|5301|||
105891696|NCT04739722|365259651|FG000|Overall Study|Withdrawal by Subject|42|||
106121992|NCT02494206|366103736|FG000|Overall Study|Disease Progression|1|||
106121993|NCT04276090|366103738|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
106121994|NCT04276090|366103739|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
106121995|NCT00318149|366103740|FG000|Overall Study|Adverse Event|0|||
106121996|NCT00318149|366103741|FG001|Overall Study|Adverse Event|0|||
106121997|NCT00318149|366103742|FG002|Overall Study|Adverse Event|0|||
106121998|NCT00318149|366103743|FG003|Overall Study|Adverse Event|0|||
106121999|NCT00318149|366103744|FG004|Overall Study|Adverse Event|0|||
106122000|NCT00318149|366103745|FG005|Overall Study|Adverse Event|2|||
106122001|NCT01088529|366103746|FG000|Overall Study|Did not receive study treatment|0|||
105891697|NCT04739722|365259651|FG000|Overall Study|Non Average-risk|1157|||
105891698|NCT03047720|365259655|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
105891699|NCT03047720|365259656|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
105891700|NCT00614120|365259657|FG000|Overall Study|Adverse Event|9|||
105891701|NCT00614120|365259658|FG001|Overall Study|Adverse Event|22|||
105891702|NCT00614120|365259659|FG002|Overall Study|Adverse Event|30|||
105891703|NCT00614120|365259660|FG003|Overall Study|Adverse Event|3|||
105891704|NCT00614120|365259657|FG000|Overall Study|Lack of Efficacy|3|||
105891705|NCT00614120|365259658|FG001|Overall Study|Lack of Efficacy|3|||
105891706|NCT00614120|365259659|FG002|Overall Study|Lack of Efficacy|2|||
105891707|NCT00614120|365259660|FG003|Overall Study|Lack of Efficacy|2|||
105891708|NCT00614120|365259657|FG000|Overall Study|Protocol Violation|2|||
105891709|NCT00614120|365259658|FG001|Overall Study|Protocol Violation|5|||
105891710|NCT00614120|365259659|FG002|Overall Study|Protocol Violation|3|||
105891711|NCT00614120|365259660|FG003|Overall Study|Protocol Violation|1|||
105891712|NCT00614120|365259657|FG000|Overall Study|Withdrawal criteria|1|||
105891713|NCT00614120|365259658|FG001|Overall Study|Withdrawal criteria|0|||
105891714|NCT00614120|365259659|FG002|Overall Study|Withdrawal criteria|0|||
105891715|NCT00614120|365259660|FG003|Overall Study|Withdrawal criteria|0|||
105891716|NCT00614120|365259657|FG000|Overall Study|Withdrawal by Subject|9|||
105891717|NCT00614120|365259658|FG001|Overall Study|Withdrawal by Subject|10|||
105891718|NCT00614120|365259659|FG002|Overall Study|Withdrawal by Subject|16|||
105891719|NCT00614120|365259660|FG003|Overall Study|Withdrawal by Subject|3|||
105891720|NCT00614120|365259657|FG000|Overall Study|Did not meet trial criteria|0|||
105891721|NCT00614120|365259658|FG001|Overall Study|Did not meet trial criteria|1|||
105891722|NCT00614120|365259659|FG002|Overall Study|Did not meet trial criteria|1|||
105891723|NCT00614120|365259660|FG003|Overall Study|Did not meet trial criteria|1|||
105891724|NCT00614120|365259657|FG000|Overall Study|hCG positive (not pregnant)|0|||
105891725|NCT00614120|365259658|FG001|Overall Study|hCG positive (not pregnant)|0|||
105891726|NCT00614120|365259659|FG002|Overall Study|hCG positive (not pregnant)|1|||
105891727|NCT00614120|365259660|FG003|Overall Study|hCG positive (not pregnant)|0|||
105891728|NCT00614120|365259657|FG000|Overall Study|Hypoglycaemia|0|||
105891729|NCT00614120|365259658|FG001|Overall Study|Hypoglycaemia|0|||
105891730|NCT00614120|365259659|FG002|Overall Study|Hypoglycaemia|0|||
105891731|NCT00614120|365259660|FG003|Overall Study|Hypoglycaemia|1|||
105891732|NCT00614120|365259657|FG000|Overall Study|Lack of trial product|3|||
105891733|NCT00614120|365259658|FG001|Overall Study|Lack of trial product|3|||
105891734|NCT00614120|365259659|FG002|Overall Study|Lack of trial product|2|||
105891735|NCT00614120|365259660|FG003|Overall Study|Lack of trial product|0|||
105891736|NCT00614120|365259657|FG000|Overall Study|Late syphilis, latent|1|||
105891737|NCT00614120|365259658|FG001|Overall Study|Late syphilis, latent|0|||
105891738|NCT00614120|365259659|FG002|Overall Study|Late syphilis, latent|0|||
105891739|NCT00614120|365259660|FG003|Overall Study|Late syphilis, latent|0|||
105891740|NCT00614120|365259657|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
105891741|NCT00614120|365259658|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
105891742|NCT00614120|365259659|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
105891743|NCT00614120|365259660|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
105891744|NCT00614120|365259657|FG000|Overall Study|Lost to Follow-up|1|||
105891745|NCT00614120|365259658|FG001|Overall Study|Lost to Follow-up|2|||
105891746|NCT00614120|365259659|FG002|Overall Study|Lost to Follow-up|3|||
105891747|NCT00614120|365259660|FG003|Overall Study|Lost to Follow-up|4|||
105891748|NCT03409107|365259664|FG000|Overall Study|Withdrawal by Subject|4|||
105891749|NCT03409107|365259665|FG001|Overall Study|Withdrawal by Subject|2|||
105891750|NCT03409107|365259664|FG000|Overall Study|Physician Decision|1|||
105891751|NCT03409107|365259665|FG001|Overall Study|Physician Decision|0|||
105891752|NCT03409107|365259664|FG000|Overall Study|Lost to Follow-up|7|||
105891753|NCT03409107|365259665|FG001|Overall Study|Lost to Follow-up|2|||
105891754|NCT03409107|365259664|FG000|Overall Study|Adverse Event|5|||
105891755|NCT03409107|365259665|FG001|Overall Study|Adverse Event|3|||
105891756|NCT01185509|365259666|FG000|Overall Study|Progression/Relapse|9|||
105891757|NCT01185509|365259667|FG001|Overall Study|Progression/Relapse|15|||
105891758|NCT01185509|365259666|FG000|Overall Study|Physician Decision|2|||
105891759|NCT01185509|365259667|FG001|Overall Study|Physician Decision|2|||
105891760|NCT01185509|365259666|FG000|Overall Study|Withdrawal by Subject|0|||
105891761|NCT01185509|365259667|FG001|Overall Study|Withdrawal by Subject|1|||
105891762|NCT01185509|365259666|FG000|Overall Study|Death|0|||
105891763|NCT01185509|365259667|FG001|Overall Study|Death|1|||
105891764|NCT01185509|365259666|FG000|Overall Study|Intercurrent Illness|0|||
105891765|NCT01185509|365259667|FG001|Overall Study|Intercurrent Illness|1|||
105891766|NCT00423189|365259679|FG000|Overall Study|Death|0|||
105891767|NCT00423189|365259680|FG001|Overall Study|Death|1|||
105891768|NCT00423189|365259681|FG002|Overall Study|Death|0|||
105891769|NCT04240457|365259684|FG000|Overall Study|Lost to Follow-up|5|||
105891770|NCT04240457|365259685|FG001|Overall Study|Lost to Follow-up|1|||
106122002|NCT01088529|366103747|FG001|Overall Study|Did not receive study treatment|1|||
106122003|NCT03691948|366103750|FG000|Overall Study|Lost to Follow-up|1|||
106122004|NCT03691948|366103751|FG001|Overall Study|Lost to Follow-up|3|||
105891771|NCT01500213|365259686|FG000|Overall Study|Adverse Event|35|||
105891772|NCT01500213|365259687|FG001|Overall Study|Adverse Event|35|||
105891773|NCT01500213|365259686|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
105891774|NCT01500213|365259687|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
105891775|NCT01500213|365259686|FG000|Overall Study|Withdrawal by Subject|28|||
105891776|NCT01500213|365259687|FG001|Overall Study|Withdrawal by Subject|37|||
106122005|NCT00383240|366103757|FG000|Overall Study|Adverse Event|4|||
105891777|NCT01500213|365259686|FG000|Overall Study|Death|7|||
105891778|NCT01500213|365259687|FG001|Overall Study|Death|3|||
105891779|NCT01500213|365259686|FG000|Overall Study|Disease Progression|13|||
105891780|NCT01500213|365259687|FG001|Overall Study|Disease Progression|21|||
105891781|NCT01500213|365259686|FG000|Overall Study|Protocol Violation|19|||
105891782|NCT01500213|365259687|FG001|Overall Study|Protocol Violation|19|||
105891783|NCT01500213|365259686|FG000|Overall Study|Physician Decision|12|||
105891784|NCT01500213|365259687|FG001|Overall Study|Physician Decision|10|||
105891785|NCT01500213|365259686|FG000|Overall Study|Lack of Efficacy|9|||
105891786|NCT01500213|365259687|FG001|Overall Study|Lack of Efficacy|7|||
105891787|NCT01500213|365259686|FG000|Overall Study|Lost to Follow-up|3|||
105891788|NCT01500213|365259687|FG001|Overall Study|Lost to Follow-up|6|||
105891789|NCT01500213|365259686|FG000|Overall Study|Other Reasons|7|||
105891790|NCT01500213|365259687|FG001|Overall Study|Other Reasons|5|||
105891791|NCT00985959|365259688|FG000|Overall Study|Adverse Event|0|||
105891792|NCT00985959|365259689|FG001|Overall Study|Adverse Event|0|||
105891793|NCT00985959|365259690|FG002|Overall Study|Adverse Event|19|||
105891794|NCT00985959|365259688|FG000|Overall Study|Withdrawal by Subject|0|||
105891795|NCT00985959|365259689|FG001|Overall Study|Withdrawal by Subject|0|||
105891796|NCT00985959|365259690|FG002|Overall Study|Withdrawal by Subject|8|||
105891797|NCT00985959|365259688|FG000|Overall Study|Progressive disease|1|||
105891798|NCT00985959|365259689|FG001|Overall Study|Progressive disease|2|||
105891799|NCT00985959|365259690|FG002|Overall Study|Progressive disease|8|||
105891800|NCT00985959|365259688|FG000|Overall Study|Unrecovered toxicity|0|||
105891801|NCT00985959|365259689|FG001|Overall Study|Unrecovered toxicity|0|||
105891802|NCT00985959|365259690|FG002|Overall Study|Unrecovered toxicity|7|||
105891803|NCT00985959|365259688|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
105891804|NCT00985959|365259689|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
105891805|NCT00985959|365259690|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
105891806|NCT00985959|365259688|FG000|Overall Study|Complete response observed over 2 cycles|0|||
105891807|NCT00985959|365259689|FG001|Overall Study|Complete response observed over 2 cycles|1|||
105891808|NCT00985959|365259690|FG002|Overall Study|Complete response observed over 2 cycles|4|||
105891809|NCT00985959|365259688|FG000|Overall Study|Other|0|||
105891810|NCT00985959|365259689|FG001|Overall Study|Other|0|||
105891811|NCT00985959|365259690|FG002|Overall Study|Other|11|||
105891812|NCT03197870|365259695|FG000|Overall Study|Adverse Event|9|||
105891813|NCT03197870|365259696|FG001|Overall Study|Adverse Event|4|||
105891814|NCT03197870|365259697|FG002|Overall Study|Adverse Event|6|||
105891815|NCT03197870|365259695|FG000|Overall Study|Withdrawal by Subject|2|||
105891816|NCT03197870|365259696|FG001|Overall Study|Withdrawal by Subject|3|||
105891817|NCT03197870|365259697|FG002|Overall Study|Withdrawal by Subject|0|||
105891818|NCT03197870|365259695|FG000|Overall Study|Lost to Follow-up|2|||
105891819|NCT03197870|365259696|FG001|Overall Study|Lost to Follow-up|2|||
105891820|NCT03197870|365259697|FG002|Overall Study|Lost to Follow-up|0|||
105891821|NCT03197870|365259695|FG000|Overall Study|data not available|1|||
105891822|NCT03197870|365259696|FG001|Overall Study|data not available|1|||
105891823|NCT03197870|365259697|FG002|Overall Study|data not available|0|||
105891824|NCT02998476|365259698|FG000|Overall Study|Lost to Follow-up|1|||
105891825|NCT02998476|365259699|FG001|Overall Study|Lost to Follow-up|0|||
105891826|NCT02998476|365259698|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
105891827|NCT02998476|365259699|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
105891828|NCT02998476|365259698|FG000|Overall Study|Withdrawal by Subject|1|||
105891829|NCT02998476|365259699|FG001|Overall Study|Withdrawal by Subject|2|||
105891830|NCT02998476|365259698|FG000|Overall Study|Death|45|||
105891831|NCT02998476|365259699|FG001|Overall Study|Death|2|||
105891832|NCT02998476|365259698|FG000|Overall Study|Other|6|||
105891833|NCT02998476|365259699|FG001|Overall Study|Other|1|||
105891834|NCT00986986|365259700|FG000|Overall Study|Lost to Follow-up|0|||
105891835|NCT00986986|365259701|FG001|Overall Study|Lost to Follow-up|1|||
105891836|NCT01542034|365259705|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
105891837|NCT01542034|365259706|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
105891838|NCT01542034|365259705|FG000|Overall Study|Administrative decision|0|||
105891839|NCT01542034|365259706|FG001|Overall Study|Administrative decision|3|||
106122006|NCT00383240|366103758|FG001|Overall Study|Adverse Event|6|||
106122007|NCT00383240|366103759|FG002|Overall Study|Adverse Event|9|||
106122008|NCT00383240|366103760|FG003|Overall Study|Adverse Event|7|||
106122009|NCT00383240|366103757|FG000|Overall Study|Treatment Failure|8|||
106122010|NCT00383240|366103758|FG001|Overall Study|Treatment Failure|13|||
105891840|NCT01542034|365259705|FG000|Overall Study|Subject Noncompliance|1|||
105891841|NCT01542034|365259706|FG001|Overall Study|Subject Noncompliance|0|||
105891842|NCT01542034|365259705|FG000|Overall Study|Adverse Event|2|||
105891843|NCT01542034|365259706|FG001|Overall Study|Adverse Event|2|||
105891844|NCT01542034|365259705|FG000|Overall Study|Lost to Follow-up|7|||
105891845|NCT01542034|365259706|FG001|Overall Study|Lost to Follow-up|6|||
105891846|NCT00478699|365259707|FG000|Overall Study|Inclusion Error|1|||
105891847|NCT00478699|365259708|FG001|Overall Study|Inclusion Error|7|||
105891848|NCT00478699|365259707|FG000|Overall Study|Not receive study treatment|6|||
105891849|NCT00478699|365259708|FG001|Overall Study|Not receive study treatment|30|||
105891850|NCT02612610|365259709|FG000|Overall Study|Withdrawal by Subject|1|||
105891851|NCT02612610|365259710|FG001|Overall Study|Withdrawal by Subject|1|||
105891852|NCT02612610|365259711|FG002|Overall Study|Withdrawal by Subject|0|||
105891853|NCT02612610|365259712|FG003|Overall Study|Withdrawal by Subject|2|||
106122011|NCT00383240|366103759|FG002|Overall Study|Treatment Failure|47|||
105891854|NCT02612610|365259709|FG000|Overall Study|Adverse Event|2|||
105891855|NCT02612610|365259710|FG001|Overall Study|Adverse Event|2|||
105891856|NCT02612610|365259711|FG002|Overall Study|Adverse Event|3|||
105891857|NCT02612610|365259712|FG003|Overall Study|Adverse Event|10|||
105891858|NCT02612610|365259709|FG000|Overall Study|Lost to Follow-up|0|||
105891859|NCT02612610|365259710|FG001|Overall Study|Lost to Follow-up|1|||
105891860|NCT02612610|365259711|FG002|Overall Study|Lost to Follow-up|0|||
105891861|NCT02612610|365259712|FG003|Overall Study|Lost to Follow-up|0|||
105891862|NCT02612610|365259709|FG000|Overall Study|Protocol Violation|0|||
105891863|NCT02612610|365259710|FG001|Overall Study|Protocol Violation|1|||
105891864|NCT02612610|365259711|FG002|Overall Study|Protocol Violation|1|||
105891865|NCT02612610|365259712|FG003|Overall Study|Protocol Violation|0|||
105891866|NCT02612610|365259709|FG000|Overall Study|Lack of Efficacy|1|||
105891867|NCT02612610|365259710|FG001|Overall Study|Lack of Efficacy|2|||
105891868|NCT02612610|365259711|FG002|Overall Study|Lack of Efficacy|0|||
106122012|NCT00383240|366103760|FG003|Overall Study|Treatment Failure|46|||
106122013|NCT00383240|366103757|FG000|Overall Study|Lost to Follow-up|3|||
106122014|NCT00383240|366103758|FG001|Overall Study|Lost to Follow-up|0|||
106122015|NCT00383240|366103759|FG002|Overall Study|Lost to Follow-up|0|||
106122016|NCT00383240|366103760|FG003|Overall Study|Lost to Follow-up|2|||
106122017|NCT00383240|366103757|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
106122018|NCT00383240|366103758|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
106122019|NCT00383240|366103759|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
106122020|NCT00383240|366103760|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
106122021|NCT00383240|366103757|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
106122022|NCT00383240|366103758|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
106122023|NCT00383240|366103759|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
106122024|NCT00383240|366103760|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
106122025|NCT00383240|366103757|FG000|Overall Study|Protocol Violation|4|||
106122026|NCT00383240|366103758|FG001|Overall Study|Protocol Violation|5|||
106122027|NCT00383240|366103759|FG002|Overall Study|Protocol Violation|9|||
106122028|NCT00383240|366103760|FG003|Overall Study|Protocol Violation|6|||
105891869|NCT02612610|365259712|FG003|Overall Study|Lack of Efficacy|1|||
106122029|NCT00383240|366103757|FG000|Overall Study|Did not meet protocol eligibility|9|||
106122030|NCT00383240|366103758|FG001|Overall Study|Did not meet protocol eligibility|4|||
106122031|NCT00383240|366103759|FG002|Overall Study|Did not meet protocol eligibility|9|||
106122032|NCT00383240|366103760|FG003|Overall Study|Did not meet protocol eligibility|3|||
106122033|NCT00383240|366103757|FG000|Overall Study|Administrative|1|||
106122034|NCT00383240|366103758|FG001|Overall Study|Administrative|1|||
106122035|NCT00383240|366103759|FG002|Overall Study|Administrative|0|||
106122036|NCT00383240|366103760|FG003|Overall Study|Administrative|0|||
106122037|NCT00641186|366103761|FG000|Overall Study|Adverse Event|3|||
106122038|NCT00547911|366103762|FG000|Overall Study|Adverse Event|0|||
106122039|NCT00547911|366103763|FG001|Overall Study|Adverse Event|0|||
106122040|NCT00547911|366103764|FG002|Overall Study|Adverse Event|0|||
106122041|NCT00547911|366103765|FG003|Overall Study|Adverse Event|1|||
105891870|NCT02612610|365259709|FG000|Overall Study|Physician Decision|0|||
105891871|NCT02612610|365259710|FG001|Overall Study|Physician Decision|1|||
105891872|NCT02612610|365259711|FG002|Overall Study|Physician Decision|0|||
105891873|NCT02612610|365259712|FG003|Overall Study|Physician Decision|0|||
105891874|NCT02612610|365259709|FG000|Overall Study|Noncompliance|1|||
105891875|NCT02612610|365259710|FG001|Overall Study|Noncompliance|0|||
105891876|NCT02612610|365259711|FG002|Overall Study|Noncompliance|0|||
105891877|NCT02612610|365259712|FG003|Overall Study|Noncompliance|0|||
105891878|NCT02612610|365259709|FG000|Overall Study|Cough Improvement|0|||
105891879|NCT02612610|365259710|FG001|Overall Study|Cough Improvement|0|||
105891880|NCT02612610|365259711|FG002|Overall Study|Cough Improvement|1|||
105891881|NCT02612610|365259712|FG003|Overall Study|Cough Improvement|0|||
105891882|NCT01801280|365259714|FG000|Period 1|Withdrawal by Subject|0|||
106122042|NCT00547911|366103766|FG004|Overall Study|Adverse Event|0|||
106122043|NCT00547911|366103767|FG005|Overall Study|Adverse Event|0|||
106122044|NCT03872388|366103769|FG000|Overall Study|Disease Progression|0|||
105891883|NCT01801280|365259715|FG001|Period 1|Withdrawal by Subject|1|||
105891884|NCT01801280|365259716|FG002|Period 1|Withdrawal by Subject|0|||
105891885|NCT01801280|365259717|FG003|Period 1|Withdrawal by Subject|0|||
105891886|NCT01801280|365259714|FG000|Period 2|Withdrawal by Subject|1|||
105891887|NCT01801280|365259715|FG001|Period 2|Withdrawal by Subject|0|||
105891888|NCT01801280|365259716|FG002|Period 2|Withdrawal by Subject|0|||
105891889|NCT01801280|365259717|FG003|Period 2|Withdrawal by Subject|0|||
105891890|NCT01801280|365259714|FG000|Period 4|Protocol Violation|0|||
106122045|NCT03872388|366103770|FG001|Overall Study|Disease Progression|0|||
106122046|NCT03872388|366103771|FG002|Overall Study|Disease Progression|0|||
106122047|NCT03872388|366103772|FG003|Overall Study|Disease Progression|0|||
106122048|NCT03872388|366103773|FG004|Overall Study|Disease Progression|0|||
105891891|NCT01801280|365259715|FG001|Period 4|Protocol Violation|0|||
105891892|NCT01801280|365259716|FG002|Period 4|Protocol Violation|1|||
105891893|NCT01801280|365259717|FG003|Period 4|Protocol Violation|0|||
105891894|NCT00176644|365259718|FG000|Overall Study|Withdrawal by Subject|1|||
105665073|NCT04334278|364438556|FG001|Overall Study|Lost to Follow-up|3|||
105665074|NCT04334278|364438555|FG000|Overall Study|Withdrawal by Subject|4|||
105665075|NCT04334278|364438556|FG001|Overall Study|Withdrawal by Subject|2|||
105665076|NCT02577003|364438557|FG000|Overall Study|Adverse Event|2|||
105665077|NCT02577003|364438558|FG001|Overall Study|Adverse Event|4|||
105665078|NCT02577003|364438557|FG000|Overall Study|Withdrawal by Subject|0|||
105665079|NCT02577003|364438558|FG001|Overall Study|Withdrawal by Subject|1|||
105665080|NCT02786004|364438559|FG000|Overall Study|Withdrawal by Subject|0|||
105665081|NCT02786004|364438560|FG001|Overall Study|Withdrawal by Subject|1|||
105891895|NCT02783729|365259719|FG000|Overall Study|Lack of Efficacy|1|||
105665082|NCT01234883|364438561|FG000|Overall Study|Early treatment release|8|||
105665083|NCT01234883|364438562|FG001|Overall Study|Early treatment release|10|||
105665084|NCT01234883|364438561|FG000|Overall Study|Parent/guardian withdrew consent|1|||
105665085|NCT01234883|364438562|FG001|Overall Study|Parent/guardian withdrew consent|2|||
105665086|NCT01234883|364438561|FG000|Overall Study|Technical difficulties with IV infusion|0|||
105665087|NCT01234883|364438562|FG001|Overall Study|Technical difficulties with IV infusion|1|||
105665088|NCT01234883|364438561|FG000|Overall Study|Inclusion/exclusion failure|1|||
105665089|NCT01234883|364438562|FG001|Overall Study|Inclusion/exclusion failure|0|||
105665090|NCT00126659|364438566|FG000|Overall Study|Adverse Event|0|||
105665091|NCT00126659|364438567|FG001|Overall Study|Adverse Event|0|||
105665092|NCT00126659|364438568|FG002|Overall Study|Adverse Event|2|||
105665093|NCT02367352|364438569|FG000|Overall Study|Progressive disease|7|||
105665094|NCT02367352|364438570|FG001|Overall Study|Progressive disease|0|||
105665095|NCT02367352|364438571|FG002|Overall Study|Progressive disease|0|||
105665096|NCT02367352|364438569|FG000|Overall Study|Participant Received Alternative Therapy|1|||
105665097|NCT02367352|364438570|FG001|Overall Study|Participant Received Alternative Therapy|0|||
105665098|NCT02367352|364438571|FG002|Overall Study|Participant Received Alternative Therapy|0|||
105665099|NCT02367352|364438569|FG000|Overall Study|Adverse Event|1|||
105665100|NCT02367352|364438570|FG001|Overall Study|Adverse Event|0|||
105665101|NCT02367352|364438571|FG002|Overall Study|Adverse Event|0|||
105665102|NCT00490945|364438576|FG000|Overall Study|Adverse Event|0|||
105665103|NCT00490945|364438577|FG001|Overall Study|Adverse Event|1|||
105665104|NCT00490945|364438578|FG002|Overall Study|Adverse Event|0|||
105665105|NCT00490945|364438579|FG003|Overall Study|Adverse Event|0|||
105665106|NCT00490945|364438580|FG004|Overall Study|Adverse Event|0|||
105665107|NCT00520845|364438581|FG000|Overall Study|Death|3|||
105665108|NCT00520845|364438581|FG000|Overall Study|Adverse Event|4|||
105665109|NCT00520845|364438581|FG000|Overall Study|Disease Progression, relapse|13|||
105665110|NCT00520845|364438581|FG000|Overall Study|Withdrawal by Subject|1|||
105665111|NCT00520845|364438581|FG000|Overall Study|Alternative Therapy|1|||
105665112|NCT03334253|364438582|FG000|Overall Study|Withdrawal by Subject|1|||
105665113|NCT03334253|364438583|FG001|Overall Study|Withdrawal by Subject|0|||
105665114|NCT03334253|364438582|FG000|Overall Study|Lost to Follow-up|4|||
105665115|NCT03334253|364438583|FG001|Overall Study|Lost to Follow-up|3|||
105665116|NCT03334253|364438582|FG000|Overall Study|Moved residence|2|||
105665117|NCT03334253|364438583|FG001|Overall Study|Moved residence|2|||
105665118|NCT00203047|364438584|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
105665119|NCT00203047|364438585|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
105665120|NCT00203047|364438584|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
105665121|NCT00203047|364438585|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
105665122|NCT00203047|364438584|FG000|Overall Study|Withdrawal by Subject|13|||
105665123|NCT00203047|364438585|FG001|Overall Study|Withdrawal by Subject|47|||
105665124|NCT00203047|364438584|FG000|Overall Study|Teva requested participant withdrawal|1|||
105665125|NCT00203047|364438585|FG001|Overall Study|Teva requested participant withdrawal|1|||
105665126|NCT00203047|364438584|FG000|Overall Study|Physician Decision|8|||
105891896|NCT02783729|365259720|FG001|Overall Study|Lack of Efficacy|0|||
105891897|NCT02783729|365259721|FG002|Overall Study|Lack of Efficacy|0|||
105891898|NCT02783729|365259722|FG003|Overall Study|Lack of Efficacy|0|||
105891899|NCT02783729|365259719|FG000|Overall Study|Adverse Event|2|||
105891900|NCT02783729|365259720|FG001|Overall Study|Adverse Event|6|||
105891901|NCT02783729|365259721|FG002|Overall Study|Adverse Event|2|||
105665127|NCT00203047|364438585|FG001|Overall Study|Physician Decision|7|||
105665128|NCT00203047|364438584|FG000|Overall Study|Non-compliance|4|||
105665129|NCT00203047|364438585|FG001|Overall Study|Non-compliance|8|||
105665130|NCT00203047|364438584|FG000|Overall Study|Protocol Violation|1|||
105665131|NCT00203047|364438585|FG001|Overall Study|Protocol Violation|0|||
106122049|NCT03872388|366103774|FG005|Overall Study|Disease Progression|0|||
105665132|NCT00203047|364438584|FG000|Overall Study|Lost to Follow-up|11|||
105665133|NCT00203047|364438585|FG001|Overall Study|Lost to Follow-up|5|||
105665134|NCT00203047|364438584|FG000|Overall Study|Adverse Event|8|||
105665135|NCT00203047|364438585|FG001|Overall Study|Adverse Event|18|||
105891902|NCT02783729|365259722|FG003|Overall Study|Adverse Event|3|||
105665136|NCT00203047|364438584|FG000|Overall Study|Death|1|||
105665137|NCT00203047|364438585|FG001|Overall Study|Death|2|||
105891903|NCT02783729|365259719|FG000|Overall Study|Other|1|||
105891904|NCT02783729|365259720|FG001|Overall Study|Other|6|||
105891905|NCT02783729|365259721|FG002|Overall Study|Other|2|||
105665138|NCT00203047|364438584|FG000|Overall Study|Pregnancy|3|||
105665139|NCT00203047|364438585|FG001|Overall Study|Pregnancy|0|||
105665140|NCT00203047|364438584|FG000|Overall Study|Other|5|||
105665141|NCT00203047|364438585|FG001|Overall Study|Other|5|||
105665142|NCT03994731|364438594|FG000|Pegloticase + IMM Period|Death|2|||
105665143|NCT03994731|364438595|FG001|Pegloticase + IMM Period|Death|0|||
105665144|NCT03994731|364438594|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
105665145|NCT03994731|364438595|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
105665146|NCT03994731|364438594|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
105665147|NCT03994731|364438595|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
105665148|NCT00742326|364438600|FG000|Overall Study|Physician Decision|0|||
105665149|NCT00742326|364438601|FG001|Overall Study|Physician Decision|1|||
105665150|NCT00790205|364438602|FG000|Overall Study|Lost to Follow-up|61|||
105665151|NCT00790205|364438603|FG001|Overall Study|Lost to Follow-up|71|||
105665152|NCT00790205|364438602|FG000|Overall Study|Withdrawal by Subject|299|||
105665153|NCT00790205|364438603|FG001|Overall Study|Withdrawal by Subject|363|||
105665154|NCT01080326|364438604|FG000|Overall Study|Patient deterioration prior to procedure|3|||
105665155|NCT01080326|364438604|FG000|Overall Study|Surgeon decision|1|||
105665156|NCT03080493|364438605|FG000|Overall Study|Did not provide NRS pain results|1|||
105891906|NCT02783729|365259722|FG003|Overall Study|Other|3|||
105891907|NCT02783729|365259719|FG000|Overall Study|Withdrawal by Subject|2|||
105891908|NCT02783729|365259720|FG001|Overall Study|Withdrawal by Subject|3|||
105891909|NCT02783729|365259721|FG002|Overall Study|Withdrawal by Subject|1|||
105891910|NCT02783729|365259722|FG003|Overall Study|Withdrawal by Subject|2|||
105891911|NCT02783729|365259719|FG000|Overall Study|Participant's choice|2|||
105891912|NCT02783729|365259720|FG001|Overall Study|Participant's choice|1|||
105891913|NCT02783729|365259721|FG002|Overall Study|Participant's choice|2|||
105891914|NCT02783729|365259722|FG003|Overall Study|Participant's choice|1|||
105891915|NCT02783729|365259719|FG000|Overall Study|Lost to Follow-up|2|||
105891916|NCT02783729|365259720|FG001|Overall Study|Lost to Follow-up|1|||
105891917|NCT02783729|365259721|FG002|Overall Study|Lost to Follow-up|1|||
105891918|NCT02783729|365259722|FG003|Overall Study|Lost to Follow-up|0|||
105891919|NCT03589326|365259723|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
105891920|NCT03589326|365259724|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
105665157|NCT03080493|364438606|FG001|Overall Study|Did not provide NRS pain results|0|||
105665158|NCT03080493|364438605|FG000|Overall Study|Adverse Event|0|||
105891921|NCT03589326|365259723|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
105891922|NCT03589326|365259724|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
105891923|NCT03589326|365259723|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
105891924|NCT03589326|365259724|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
105891925|NCT03589326|365259723|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
105891926|NCT03589326|365259724|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
105891927|NCT03589326|365259723|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
105891928|NCT03589326|365259724|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
105891929|NCT02693171|365259726|FG000|Overall Study|Adverse Event|1|||
105891930|NCT02693171|365259726|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
105891931|NCT00435487|365259727|FG000|Overall Study|Death|3|||
105891932|NCT00435487|365259728|FG001|Overall Study|Death|4|||
105891933|NCT00435487|365259727|FG000|Overall Study|Adverse Event|0|||
105891934|NCT00435487|365259728|FG001|Overall Study|Adverse Event|3|||
105891935|NCT00435487|365259727|FG000|Overall Study|Lost to Follow-up|2|||
105891936|NCT00435487|365259728|FG001|Overall Study|Lost to Follow-up|2|||
105891937|NCT00435487|365259727|FG000|Overall Study|Other|5|||
105891938|NCT00435487|365259728|FG001|Overall Study|Other|2|||
105891939|NCT00435487|365259727|FG000|Overall Study|Withdrawal by Subject|2|||
105891940|NCT00435487|365259728|FG001|Overall Study|Withdrawal by Subject|1|||
105891941|NCT00435487|365259727|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
105891942|NCT00435487|365259728|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
105891943|NCT00435487|365259727|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
105891944|NCT00435487|365259728|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
105891945|NCT04021121|365259731|FG000|Overall Study|Death|3|||
105891946|NCT04021121|365259732|FG001|Overall Study|Death|3|||
105891947|NCT04021121|365259733|FG002|Overall Study|Death|5|||
105891948|NCT04021121|365259734|FG003|Overall Study|Death|4|||
105891949|NCT00347919|365259735|FG000|Overall Study|Lost to Follow-up|11|||
105891950|NCT00347919|365259736|FG001|Overall Study|Lost to Follow-up|13|||
105891951|NCT00347919|365259737|FG002|Overall Study|Lost to Follow-up|0|||
105665159|NCT03080493|364438606|FG001|Overall Study|Adverse Event|1|||
105665160|NCT03080493|364438605|FG000|Overall Study|Randomization error (parity group)|0|||
105665161|NCT03080493|364438606|FG001|Overall Study|Randomization error (parity group)|1|||
105665162|NCT00755417|364438607|FG000|Overall Study|Adverse Event|28|||
105891952|NCT00347919|365259735|FG000|Overall Study|Withdrawal by Subject|6|||
105891953|NCT00347919|365259736|FG001|Overall Study|Withdrawal by Subject|8|||
105891954|NCT00347919|365259737|FG002|Overall Study|Withdrawal by Subject|0|||
105891955|NCT00347919|365259735|FG000|Overall Study|Physician Decision|1|||
105891956|NCT00347919|365259736|FG001|Overall Study|Physician Decision|1|||
105891957|NCT00347919|365259737|FG002|Overall Study|Physician Decision|0|||
105665163|NCT00755417|364438608|FG001|Overall Study|Adverse Event|20|||
105665164|NCT00755417|364438609|FG002|Overall Study|Adverse Event|7|||
105665165|NCT00755417|364438607|FG000|Overall Study|Lack of Efficacy|8|||
105665166|NCT00755417|364438608|FG001|Overall Study|Lack of Efficacy|4|||
105665167|NCT00755417|364438609|FG002|Overall Study|Lack of Efficacy|9|||
105665168|NCT00755417|364438607|FG000|Overall Study|Protocol Violation|2|||
105665169|NCT00755417|364438608|FG001|Overall Study|Protocol Violation|1|||
105665170|NCT00755417|364438609|FG002|Overall Study|Protocol Violation|1|||
105891958|NCT00347919|365259735|FG000|Overall Study|Sponsor terminated study|15|||
105891959|NCT00347919|365259736|FG001|Overall Study|Sponsor terminated study|10|||
105891960|NCT00347919|365259737|FG002|Overall Study|Sponsor terminated study|16|||
105891961|NCT00347919|365259735|FG000|Overall Study|Death|35|||
105891962|NCT00347919|365259736|FG001|Overall Study|Death|42|||
105891963|NCT00347919|365259737|FG002|Overall Study|Death|19|||
105891964|NCT00347919|365259735|FG000|Overall Study|Par. Started Other Treatment|1|||
105891965|NCT00347919|365259736|FG001|Overall Study|Par. Started Other Treatment|1|||
105891966|NCT00347919|365259737|FG002|Overall Study|Par. Started Other Treatment|1|||
105891967|NCT00347919|365259735|FG000|Overall Study|Missing|2|||
105891968|NCT00347919|365259736|FG001|Overall Study|Missing|1|||
105891969|NCT00347919|365259737|FG002|Overall Study|Missing|2|||
105891970|NCT04017832|365259742|FG000|Overall Study|Withdrawal by Subject|13|||
105891971|NCT04017832|365259743|FG001|Overall Study|Withdrawal by Subject|12|||
105891972|NCT04017832|365259744|FG002|Overall Study|Withdrawal by Subject|21|||
105891973|NCT04017832|365259745|FG003|Overall Study|Withdrawal by Subject|7|||
105891974|NCT04017832|365259742|FG000|Overall Study|Lost to Follow-up|0|||
105891975|NCT04017832|365259743|FG001|Overall Study|Lost to Follow-up|3|||
105891976|NCT04017832|365259744|FG002|Overall Study|Lost to Follow-up|3|||
105891977|NCT04017832|365259745|FG003|Overall Study|Lost to Follow-up|1|||
105891978|NCT04017832|365259742|FG000|Overall Study|Physician Decision|1|||
105891979|NCT04017832|365259743|FG001|Overall Study|Physician Decision|1|||
105891980|NCT04017832|365259744|FG002|Overall Study|Physician Decision|1|||
105891981|NCT04017832|365259745|FG003|Overall Study|Physician Decision|1|||
105891982|NCT04017832|365259742|FG000|Overall Study|Death|2|||
105891983|NCT04017832|365259743|FG001|Overall Study|Death|2|||
105891984|NCT04017832|365259744|FG002|Overall Study|Death|1|||
105891985|NCT04017832|365259745|FG003|Overall Study|Death|0|||
105891986|NCT00819780|365259750|FG000|Overall Study|Did not receive study drug|3|||
105891987|NCT00819780|365259751|FG001|Overall Study|Did not receive study drug|4|||
105891988|NCT00819780|365259750|FG000|Overall Study|Still in treatment|25|||
105891989|NCT00819780|365259751|FG001|Overall Study|Still in treatment|17|||
105891990|NCT02344290|365259752|FG000|Overall Study|Withdrawal by Subject|315|||
105891991|NCT02344290|365259753|FG001|Overall Study|Withdrawal by Subject|324|||
105891992|NCT02344290|365259752|FG000|Overall Study|Lost to Follow-up|258|||
105891993|NCT02344290|365259753|FG001|Overall Study|Lost to Follow-up|249|||
105891994|NCT02344290|365259752|FG000|Overall Study|Unable to get to clinic|69|||
105891995|NCT02344290|365259753|FG001|Overall Study|Unable to get to clinic|60|||
105891996|NCT02344290|365259752|FG000|Overall Study|Physician Decision|25|||
105891997|NCT02344290|365259753|FG001|Overall Study|Physician Decision|25|||
105891998|NCT02344290|365259752|FG000|Overall Study|Site Closure|15|||
105891999|NCT02344290|365259753|FG001|Overall Study|Site Closure|19|||
105892000|NCT02344290|365259752|FG000|Overall Study|Other|5|||
105892001|NCT02344290|365259753|FG001|Overall Study|Other|3|||
105892002|NCT02484651|365259754|FG000|Overall Study|Patients' data files were corrupted.|1|||
105892003|NCT02484651|365259755|FG001|Overall Study|Patients' data files were corrupted.|1|||
105892004|NCT02484651|365259754|FG000|Overall Study|BIS monitoring failed.|1|||
105892005|NCT02484651|365259755|FG001|Overall Study|BIS monitoring failed.|1|||
105892006|NCT02484651|365259754|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
105892007|NCT02484651|365259755|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
105892008|NCT04972968|365259756|FG000|Overall Study|Adverse Event|3|||
105892009|NCT04972968|365259757|FG001|Overall Study|Adverse Event|1|||
105892010|NCT04972968|365259758|FG002|Overall Study|Adverse Event|1|||
105892011|NCT04972968|365259759|FG003|Overall Study|Adverse Event|7|||
105665171|NCT00755417|364438607|FG000|Overall Study|Lost to Follow-up|3|||
105665172|NCT00755417|364438608|FG001|Overall Study|Lost to Follow-up|0|||
105665173|NCT00755417|364438609|FG002|Overall Study|Lost to Follow-up|1|||
105665174|NCT00755417|364438607|FG000|Overall Study|Withdrawal by Subject|12|||
105665175|NCT00755417|364438608|FG001|Overall Study|Withdrawal by Subject|12|||
105665176|NCT00755417|364438609|FG002|Overall Study|Withdrawal by Subject|12|||
105665177|NCT00755417|364438607|FG000|Overall Study|Not specified or missing data|9|||
105760666|NCT00293241|364776123|FG000|Overall Study|Physician Decision|23|||
105892012|NCT04972968|365259756|FG000|Overall Study|Lack of Efficacy|2|||
105892013|NCT04972968|365259757|FG001|Overall Study|Lack of Efficacy|1|||
105892014|NCT04972968|365259758|FG002|Overall Study|Lack of Efficacy|0|||
105892015|NCT04972968|365259759|FG003|Overall Study|Lack of Efficacy|0|||
105892016|NCT04972968|365259756|FG000|Overall Study|Withdrawal by Subject|7|||
105892017|NCT04972968|365259757|FG001|Overall Study|Withdrawal by Subject|4|||
105892018|NCT04972968|365259758|FG002|Overall Study|Withdrawal by Subject|3|||
105892019|NCT04972968|365259759|FG003|Overall Study|Withdrawal by Subject|2|||
105892020|NCT04972968|365259756|FG000|Overall Study|Study Terminated by Sponsor|25|||
105892021|NCT04972968|365259757|FG001|Overall Study|Study Terminated by Sponsor|28|||
105892022|NCT04972968|365259758|FG002|Overall Study|Study Terminated by Sponsor|32|||
105892023|NCT04972968|365259759|FG003|Overall Study|Study Terminated by Sponsor|27|||
105892024|NCT04972968|365259756|FG000|Overall Study|Other|1|||
105892025|NCT04972968|365259757|FG001|Overall Study|Other|0|||
105892026|NCT04972968|365259758|FG002|Overall Study|Other|1|||
105892027|NCT04972968|365259759|FG003|Overall Study|Other|1|||
106122050|NCT03872388|366103775|FG006|Overall Study|Disease Progression|1|||
106122051|NCT03872388|366103776|FG007|Overall Study|Disease Progression|1|||
106122052|NCT04399551|366105944|FG000|Overall Study|Adverse Event|15|||
106122053|NCT04399551|366105944|FG000|Overall Study|Withdrawal by Subject|6|||
106122054|NCT04399551|366105944|FG000|Overall Study|Physician Decision|3|||
106122055|NCT04399551|366105944|FG000|Overall Study|Lost to Follow-up|2|||
106122056|NCT04399551|366105944|FG000|Overall Study|Protocol Deviation|2|||
106122057|NCT02254421|366105947|FG000|Overall Study|Randomized but Not Treated|1|||
106122058|NCT02254421|366105948|FG001|Overall Study|Randomized but Not Treated|0|||
106122059|NCT02254421|366105947|FG000|Overall Study|Death|0|||
106122060|NCT02254421|366105948|FG001|Overall Study|Death|2|||
106122061|NCT02254421|366105947|FG000|Overall Study|Withdrew Consent|1|||
106122062|NCT02254421|366105948|FG001|Overall Study|Withdrew Consent|1|||
106122063|NCT00313911|366105950|FG000|Overall Study|Serious adverse event|6|||
106122064|NCT00313911|366105951|FG001|Overall Study|Serious adverse event|1|||
106122065|NCT00313911|366105950|FG000|Overall Study|Adverse Event|2|||
106122066|NCT00313911|366105951|FG001|Overall Study|Adverse Event|3|||
106122067|NCT00313911|366105950|FG000|Overall Study|Protocol Violation|19|||
106122068|NCT00313911|366105951|FG001|Overall Study|Protocol Violation|10|||
106122069|NCT00313911|366105950|FG000|Overall Study|Lost to Follow-up|27|||
106122070|NCT00313911|366105951|FG001|Overall Study|Lost to Follow-up|14|||
106122071|NCT00313911|366105950|FG000|Overall Study|Withdrawal by Subject|39|||
106122072|NCT00313911|366105951|FG001|Overall Study|Withdrawal by Subject|12|||
106122073|NCT00313911|366105950|FG000|Overall Study|Did not meet age criteria|1|||
106122074|NCT00313911|366105951|FG001|Overall Study|Did not meet age criteria|1|||
106122075|NCT01912781|366105952|FG000|Overall Study|Withdrawal by Subject|2|||
106122076|NCT01912781|366105953|FG001|Overall Study|Withdrawal by Subject|0|||
106122077|NCT00854295|366105954|FG000|Overall Study|Death|7|||
106122078|NCT00854295|366105955|FG001|Overall Study|Death|0|||
106122079|NCT00854295|366105956|FG002|Overall Study|Death|1|||
106122080|NCT00854295|366105957|FG003|Overall Study|Death|1|||
106122081|NCT00854295|366105954|FG000|Overall Study|Adverse Event|6|||
106122082|NCT00854295|366105955|FG001|Overall Study|Adverse Event|1|||
106122083|NCT00854295|366105956|FG002|Overall Study|Adverse Event|1|||
106122084|NCT00854295|366105957|FG003|Overall Study|Adverse Event|3|||
106122085|NCT00854295|366105954|FG000|Overall Study|Lost to Follow-up|18|||
106122086|NCT00854295|366105955|FG001|Overall Study|Lost to Follow-up|5|||
106122087|NCT00854295|366105956|FG002|Overall Study|Lost to Follow-up|21|||
106122088|NCT00854295|366105957|FG003|Overall Study|Lost to Follow-up|21|||
106122089|NCT00854295|366105954|FG000|Overall Study|Physician Decision|10|||
106122090|NCT00854295|366105955|FG001|Overall Study|Physician Decision|0|||
106122091|NCT00854295|366105956|FG002|Overall Study|Physician Decision|0|||
106122092|NCT00854295|366105957|FG003|Overall Study|Physician Decision|0|||
106122093|NCT03154359|366105959|FG000|Overall Study|Adverse Event|1|||
106122094|NCT03154359|366105959|FG000|Overall Study|Lack of Efficacy|2|||
106122095|NCT03154359|366105959|FG000|Overall Study|Lost to Follow-up|3|||
106122096|NCT03154359|366105959|FG000|Overall Study|Physician Decision|3|||
106122097|NCT03154359|366105959|FG000|Overall Study|Protocol Violation|4|||
106122098|NCT03154359|366105959|FG000|Overall Study|Withdrawal by Subject|5|||
106122099|NCT03154359|366105959|FG000|Overall Study|Disruption of study due to COVID-19|4|||
105760667|NCT00293241|364776124|FG001|Overall Study|Physician Decision|17|||
105892028|NCT00150800|365259760|FG000|Overall Study|Adverse Event|89|||
105892029|NCT00150800|365259760|FG000|Overall Study|Death|18|||
105892030|NCT00150800|365259760|FG000|Overall Study|Lack of Efficacy|166|||
105892031|NCT00150800|365259760|FG000|Overall Study|Lost to Follow-up|58|||
105892032|NCT00150800|365259760|FG000|Overall Study|Subject's choice|90|||
105892033|NCT00150800|365259760|FG000|Overall Study|No compliance|18|||
105892034|NCT00150800|365259760|FG000|Overall Study|IP misshandling|1|||
105892035|NCT00150800|365259760|FG000|Overall Study|Site closure|24|||
105892036|NCT00150800|365259760|FG000|Overall Study|Protocol non-adherence|2|||
105892037|NCT00150800|365259760|FG000|Overall Study|Nobody to accompany patient|1|||
105892038|NCT00150800|365259760|FG000|Overall Study|Distance too long for patient|1|||
105892039|NCT00150800|365259760|FG000|Overall Study|Neurosurgery|2|||
105892040|NCT00150800|365259760|FG000|Overall Study|BRV monotherapy|1|||
106122100|NCT02086552|366105963|FG000|Overall Study|Withdrawal by Subject|1|||
106122101|NCT00708305|366105964|FG000|Period 1|Protocol Violation|1|||
106122102|NCT00708305|366105965|FG001|Period 1|Protocol Violation|0|||
106122103|NCT00708305|366105966|FG002|Period 1|Protocol Violation|1|||
106122104|NCT00708305|366105967|FG003|Period 1|Protocol Violation|0|||
106122105|NCT00708305|366105964|FG000|Period 1|Other Reason|0|||
106122106|NCT00708305|366105965|FG001|Period 1|Other Reason|0|||
106122107|NCT00708305|366105966|FG002|Period 1|Other Reason|0|||
106122108|NCT00708305|366105967|FG003|Period 1|Other Reason|2|||
105665178|NCT00755417|364438608|FG001|Overall Study|Not specified or missing data|18|||
105665179|NCT00755417|364438609|FG002|Overall Study|Not specified or missing data|12|||
105665180|NCT01834586|364438612|FG000|Overall Study|Adverse Event|1|||
105665181|NCT00825305|364438614|FG000|Overall Study|Adverse Event|1|||
105665182|NCT00825305|364438615|FG001|Overall Study|Adverse Event|1|||
105665183|NCT00825305|364438614|FG000|Overall Study|Withdrawal by Subject|6|||
105665184|NCT00825305|364438615|FG001|Overall Study|Withdrawal by Subject|12|||
105665185|NCT00825305|364438614|FG000|Overall Study|Inappropriate inclusion|1|||
105665186|NCT00825305|364438615|FG001|Overall Study|Inappropriate inclusion|0|||
105665187|NCT00825305|364438614|FG000|Overall Study|Protocol Violation|9|||
105665188|NCT00825305|364438615|FG001|Overall Study|Protocol Violation|9|||
105665189|NCT00825305|364438614|FG000|Overall Study|Can not be classified|0|||
105665190|NCT00825305|364438615|FG001|Overall Study|Can not be classified|1|||
106016832|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
106016833|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
106016834|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
106016835|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
106016836|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
106016837|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
106016838|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
106016839|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
106016840|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
106016841|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
106016842|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
106016843|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
106016844|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
106016845|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
106016846|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
106016847|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
106016848|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Other|1|||
106016849|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Other|2|||
106016850|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Other|0|||
106016851|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Other|0|||
106016852|NCT00554216|365725902|FG000|Overall Study|Lost to Follow-up|92|||
106016853|NCT00554216|365725903|FG001|Overall Study|Lost to Follow-up|31|||
106016854|NCT00554216|365725904|FG002|Overall Study|Lost to Follow-up|63|||
106016855|NCT00554216|365725902|FG000|Overall Study|Adverse Event|16|||
106016856|NCT00554216|365725903|FG001|Overall Study|Adverse Event|16|||
106016857|NCT00554216|365725904|FG002|Overall Study|Adverse Event|36|||
106016858|NCT00554216|365725902|FG000|Overall Study|Withdrawal by Subject|92|||
106016859|NCT00554216|365725903|FG001|Overall Study|Withdrawal by Subject|31|||
106016860|NCT00554216|365725904|FG002|Overall Study|Withdrawal by Subject|43|||
106016861|NCT00554216|365725902|FG000|Overall Study|Non compliance|10|||
106016862|NCT00554216|365725903|FG001|Overall Study|Non compliance|4|||
106016863|NCT00554216|365725904|FG002|Overall Study|Non compliance|5|||
106016864|NCT00554216|365725902|FG000|Overall Study|Pregnancy|2|||
106016865|NCT00554216|365725903|FG001|Overall Study|Pregnancy|1|||
106016866|NCT00554216|365725904|FG002|Overall Study|Pregnancy|14|||
106016867|NCT00554216|365725902|FG000|Overall Study|Restricted med|3|||
106016868|NCT00554216|365725903|FG001|Overall Study|Restricted med|1|||
106016869|NCT00554216|365725904|FG002|Overall Study|Restricted med|1|||
106016870|NCT00554216|365725902|FG000|Overall Study|Other|12|||
106016871|NCT00554216|365725903|FG001|Overall Study|Other|7|||
106016872|NCT00554216|365725904|FG002|Overall Study|Other|10|||
106016873|NCT00554216|365725902|FG000|Overall Study|Lack of Efficacy|15|||
106016874|NCT00554216|365725903|FG001|Overall Study|Lack of Efficacy|3|||
106016875|NCT00554216|365725904|FG002|Overall Study|Lack of Efficacy|0|||
106016876|NCT03847896|365725905|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
106016877|NCT03847896|365725906|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
106016878|NCT03847896|365725907|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
106016879|NCT03847896|365725908|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
106016880|NCT03847896|365725909|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
106016881|NCT03847896|365725905|FG000|Overall Study|Withdrawal by Subject|2|||
106016882|NCT03847896|365725906|FG001|Overall Study|Withdrawal by Subject|10|||
106016883|NCT03847896|365725907|FG002|Overall Study|Withdrawal by Subject|5|||
106016884|NCT03847896|365725908|FG003|Overall Study|Withdrawal by Subject|9|||
106016885|NCT03847896|365725909|FG004|Overall Study|Withdrawal by Subject|8|||
106016886|NCT03847896|365725905|FG000|Overall Study|Withdrawal by parent/guardian|0|||
106016887|NCT03847896|365725906|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105892041|NCT00150800|365259760|FG000|Overall Study|Visit refusal|3|||
105892042|NCT00150800|365259760|FG000|Overall Study|Sponsor's request|2|||
105892043|NCT00150800|365259760|FG000|Overall Study|Generalized Epilepsy|1|||
105892044|NCT00150800|365259760|FG000|Overall Study|Moved from area/country|8|||
105892045|NCT00150800|365259760|FG000|Overall Study|PI retiring|2|||
105892046|NCT00150800|365259760|FG000|Overall Study|PI leaving site|2|||
105892047|NCT00150800|365259760|FG000|Overall Study|Patient insurance|1|||
105892048|NCT00150800|365259760|FG000|Overall Study|Surgical intervention|4|||
105892049|NCT00150800|365259760|FG000|Overall Study|Pregnancy planned|1|||
105892050|NCT00150800|365259760|FG000|Overall Study|PI discontinuation request|1|||
105892051|NCT04696354|365259769|FG000|Overall Study|Study termination|6|||
105892052|NCT04696354|365259770|FG001|Overall Study|Study termination|6|||
105892053|NCT04545567|365259774|FG000|Overall Study|tested positive for SARS-co-V2|1|||
105892054|NCT04545567|365259775|FG001|Overall Study|tested positive for SARS-co-V2|1|||
105892055|NCT04545567|365259774|FG000|Overall Study|Withdrawal by Subject|0|||
105892056|NCT04545567|365259775|FG001|Overall Study|Withdrawal by Subject|1|||
105892057|NCT02419612|365259781|FG000|Short-term Treatment Period|Adverse Event|1|||
105892058|NCT02419612|365259782|FG001|Short-term Treatment Period|Adverse Event|1|||
105892059|NCT02419612|365259781|FG000|Short-term Treatment Period|Death|0|||
105892060|NCT02419612|365259782|FG001|Short-term Treatment Period|Death|2|||
105892061|NCT02419612|365259781|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
105892062|NCT02419612|365259782|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
105892063|NCT02419612|365259781|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
105892064|NCT02419612|365259782|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
105892065|NCT02419612|365259781|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
105892066|NCT02419612|365259782|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
105892067|NCT02419612|365259781|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
105892068|NCT02419612|365259782|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
105892069|NCT02419612|365259781|FG000|Short-term Treatment Period|Worsening of liver function|0|||
105892070|NCT02419612|365259782|FG001|Short-term Treatment Period|Worsening of liver function|1|||
105892071|NCT02419612|365259781|FG000|Short-term Treatment Period|Subject moved out of state|0|||
105892072|NCT02419612|365259782|FG001|Short-term Treatment Period|Subject moved out of state|1|||
105892073|NCT02419612|365259781|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
105892074|NCT02419612|365259782|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
105892075|NCT02419612|365259781|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
105892076|NCT02419612|365259782|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
105892077|NCT02419612|365259781|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
105892078|NCT02419612|365259782|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
105892079|NCT02419612|365259781|FG000|Long-term Treatment Period|Death|0|||
105892080|NCT02419612|365259782|FG001|Long-term Treatment Period|Death|1|||
105892081|NCT02419612|365259781|FG000|Long-term Treatment Period|Adverse Event|0|||
105996747|NCT04640311|365649504|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996748|NCT04640311|365649505|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996749|NCT04640311|365649493|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
105996750|NCT04640311|365649494|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
105996751|NCT04640311|365649495|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
105996752|NCT04640311|365649496|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996753|NCT04640311|365649497|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996754|NCT04640311|365649498|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996755|NCT04640311|365649499|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996756|NCT04640311|365649500|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996757|NCT04640311|365649501|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996758|NCT04640311|365649502|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996759|NCT04640311|365649503|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996760|NCT04640311|365649504|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105665191|NCT01721954|364438618|FG000|Overall Study|Death|58|||
105892082|NCT02419612|365259782|FG001|Long-term Treatment Period|Adverse Event|5|||
105892083|NCT02419612|365259781|FG000|Long-term Treatment Period|Other|4|||
105892084|NCT02419612|365259782|FG001|Long-term Treatment Period|Other|4|||
105892085|NCT02419612|365259781|FG000|Long-term Treatment Period|Subject Decision|2|||
105892086|NCT02419612|365259782|FG001|Long-term Treatment Period|Subject Decision|4|||
105892087|NCT02419612|365259781|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
105892088|NCT02419612|365259782|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
105892089|NCT00474045|365259783|FG000|Overall Study|Adverse Event|18|||
105892090|NCT00474045|365259784|FG001|Overall Study|Adverse Event|8|||
105892091|NCT00474045|365259783|FG000|Overall Study|Unclassified|1|||
105892092|NCT00474045|365259784|FG001|Overall Study|Unclassified|3|||
105892093|NCT00474045|365259783|FG000|Overall Study|Lack of Efficacy|0|||
105892094|NCT00474045|365259784|FG001|Overall Study|Lack of Efficacy|9|||
105892095|NCT00474045|365259783|FG000|Overall Study|Lost to Follow-up|1|||
105892096|NCT00474045|365259784|FG001|Overall Study|Lost to Follow-up|1|||
105892097|NCT00474045|365259783|FG000|Overall Study|Protocol Violation|10|||
105892098|NCT00474045|365259784|FG001|Overall Study|Protocol Violation|12|||
105892099|NCT00474045|365259783|FG000|Overall Study|Withdrawal by Subject|16|||
105892100|NCT00474045|365259784|FG001|Overall Study|Withdrawal by Subject|18|||
105892101|NCT00474045|365259783|FG000|Overall Study|Withdrawal criteria|60|||
105892102|NCT00474045|365259784|FG001|Overall Study|Withdrawal criteria|50|||
105892103|NCT00808639|365259793|FG000|Overall Study|Disease progression before surgery.|1|||
105892104|NCT03197324|365259794|FG000|Overall Study|Adverse Event|0|||
105892105|NCT03197324|365259795|FG001|Overall Study|Adverse Event|1|||
105892106|NCT04253782|365259796|FG000|Overall Study|Death|2|||
105892107|NCT04253782|365259797|FG001|Overall Study|Death|0|||
105892108|NCT03721835|365259798|FG000|Overall Study|Participant not able to return|1|||
105892109|NCT03721835|365259798|FG000|Overall Study|Lost to Follow-up|1|||
105892110|NCT03721835|365259798|FG000|Overall Study|Revision of the components of the study device|2|||
105892111|NCT03721835|365259798|FG000|Overall Study|Sponsor terminated study|6|||
105892112|NCT03721835|365259798|FG000|Overall Study|Death|1|||
105892113|NCT03721835|365259798|FG000|Overall Study|Sponsor decision|1|||
105892114|NCT05072964|365259799|FG000|Overall Study|Withdrawal by Subject|4|||
105892115|NCT05072964|365259799|FG000|Overall Study|Death|1|||
105892116|NCT01328548|365259805|FG000|Overall Study|Death|3|||
105892117|NCT01328548|365259806|FG001|Overall Study|Death|0|||
105892118|NCT01328548|365259805|FG000|Overall Study|Protocol Violation|1|||
105892119|NCT01328548|365259806|FG001|Overall Study|Protocol Violation|0|||
105892120|NCT00073983|365259807|FG000|Overall Study|not evaluable|1|||
105892121|NCT00743288|365261082|FG000|Overall Study|Adverse Event|1|||
105892122|NCT00743288|365261083|FG001|Overall Study|Adverse Event|1|||
105892123|NCT00743288|365261084|FG002|Overall Study|Adverse Event|2|||
105892124|NCT00743288|365261085|FG003|Overall Study|Adverse Event|2|||
105892125|NCT00743288|365261086|FG004|Overall Study|Adverse Event|1|||
105892126|NCT00743288|365261087|FG005|Overall Study|Adverse Event|1|||
105892127|NCT00743288|365261088|FG006|Overall Study|Adverse Event|2|||
105892128|NCT00743288|365261082|FG000|Overall Study|Withdrawal by Subject|0|||
105892129|NCT00743288|365261083|FG001|Overall Study|Withdrawal by Subject|0|||
105892130|NCT00743288|365261084|FG002|Overall Study|Withdrawal by Subject|1|||
105892131|NCT00743288|365261085|FG003|Overall Study|Withdrawal by Subject|0|||
105892132|NCT00743288|365261086|FG004|Overall Study|Withdrawal by Subject|0|||
105892133|NCT00743288|365261087|FG005|Overall Study|Withdrawal by Subject|1|||
105892134|NCT00743288|365261088|FG006|Overall Study|Withdrawal by Subject|1|||
105892135|NCT00743288|365261082|FG000|Overall Study|Progressive disease (PD)|2|||
105892136|NCT00743288|365261083|FG001|Overall Study|Progressive disease (PD)|0|||
105892137|NCT00743288|365261084|FG002|Overall Study|Progressive disease (PD)|1|||
105892138|NCT00743288|365261085|FG003|Overall Study|Progressive disease (PD)|4|||
105892139|NCT00743288|365261086|FG004|Overall Study|Progressive disease (PD)|5|||
105892140|NCT00743288|365261087|FG005|Overall Study|Progressive disease (PD)|3|||
105892141|NCT00743288|365261088|FG006|Overall Study|Progressive disease (PD)|6|||
105892142|NCT00743288|365261082|FG000|Overall Study|Worsening of condition (Not PD)|0|||
105892143|NCT00743288|365261083|FG001|Overall Study|Worsening of condition (Not PD)|2|||
105892144|NCT00743288|365261084|FG002|Overall Study|Worsening of condition (Not PD)|1|||
105892145|NCT00743288|365261085|FG003|Overall Study|Worsening of condition (Not PD)|1|||
105892146|NCT00743288|365261086|FG004|Overall Study|Worsening of condition (Not PD)|0|||
105892147|NCT00743288|365261087|FG005|Overall Study|Worsening of condition (Not PD)|0|||
105892148|NCT00743288|365261088|FG006|Overall Study|Worsening of condition (Not PD)|0|||
105892149|NCT04338269|365261089|FG000|Overall Study|Death|86|||
105892150|NCT04338269|365261090|FG001|Overall Study|Death|89|||
105892151|NCT04338269|365261089|FG000|Overall Study|Lost to Follow-up|1|||
105892152|NCT04338269|365261090|FG001|Overall Study|Lost to Follow-up|2|||
105892153|NCT04338269|365261089|FG000|Overall Study|Physician Decision|1|||
105892154|NCT04338269|365261090|FG001|Overall Study|Physician Decision|0|||
105892155|NCT04338269|365261089|FG000|Overall Study|Withdrawal by Subject|14|||
105892156|NCT04338269|365261090|FG001|Overall Study|Withdrawal by Subject|11|||
105996761|NCT04640311|365649505|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
105996762|NCT04640311|365649493|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105892157|NCT01214252|365261096|FG000|Overall Study|Not eligible per protocol|82|||
105892158|NCT01279070|365261099|FG000|Overall Study|Withdrawal by Subject|2|||
105892159|NCT01279070|365261100|FG001|Overall Study|Withdrawal by Subject|3|||
105892160|NCT01279070|365261099|FG000|Overall Study|Acute exacerbation|3|||
105892161|NCT01279070|365261100|FG001|Overall Study|Acute exacerbation|1|||
105892162|NCT03687372|365261101|FG000|Overall Study|Lost to Follow-up|12|||
105892163|NCT03687372|365261102|FG001|Overall Study|Lost to Follow-up|21|||
105892164|NCT03687372|365261101|FG000|Overall Study|Withdrawal by Subject|4|||
105892165|NCT03687372|365261102|FG001|Overall Study|Withdrawal by Subject|17|||
105665192|NCT01721954|364438619|FG001|Overall Study|Death|64|||
105665193|NCT01721954|364438618|FG000|Overall Study|Withdrawal by Subject|8|||
105665194|NCT01721954|364438619|FG001|Overall Study|Withdrawal by Subject|4|||
105665195|NCT01721954|364438618|FG000|Overall Study|Adverse Event|2|||
105665196|NCT01721954|364438619|FG001|Overall Study|Adverse Event|0|||
105665197|NCT01721954|364438618|FG000|Overall Study|Lost to Follow-up|2|||
105665198|NCT01721954|364438619|FG001|Overall Study|Lost to Follow-up|1|||
105665199|NCT00965497|364438625|FG000|Overall Study|Physician Decision|1|||
105665200|NCT02638103|364438627|FG000|Overall Study|Adverse Event|13|||
105665201|NCT02638103|364438628|FG001|Overall Study|Adverse Event|12|||
105665202|NCT02638103|364438629|FG002|Overall Study|Adverse Event|19|||
105665203|NCT02638103|364438630|FG003|Overall Study|Adverse Event|12|||
105665204|NCT02638103|364438627|FG000|Overall Study|Withdrawal by Subject|43|||
105665205|NCT02638103|364438628|FG001|Overall Study|Withdrawal by Subject|53|||
105665206|NCT02638103|364438629|FG002|Overall Study|Withdrawal by Subject|30|||
105665207|NCT02638103|364438630|FG003|Overall Study|Withdrawal by Subject|61|||
105892166|NCT03687372|365261101|FG000|Overall Study|Investigator Decision|1|||
105892167|NCT03687372|365261102|FG001|Overall Study|Investigator Decision|1|||
105892168|NCT01482962|365261107|FG000|Overall Study|Progressive Disease|65|||
105892169|NCT01482962|365261108|FG001|Overall Study|Progressive Disease|53|||
105892170|NCT01482962|365261107|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
105892171|NCT01482962|365261108|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
105892172|NCT01482962|365261107|FG000|Overall Study|Adverse Event|18|||
105892173|NCT01482962|365261108|FG001|Overall Study|Adverse Event|22|||
105892174|NCT01482962|365261107|FG000|Overall Study|Withdrawal by Participant|8|||
105892175|NCT01482962|365261108|FG001|Overall Study|Withdrawal by Participant|13|||
105892176|NCT01482962|365261107|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
105892177|NCT01482962|365261108|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
105892178|NCT01482962|365261107|FG000|Overall Study|Other Reason|1|||
105892179|NCT01482962|365261108|FG001|Overall Study|Other Reason|5|||
105892180|NCT01482962|365261107|FG000|Overall Study|Study Terminated by Sponsor|5|||
105892181|NCT01482962|365261108|FG001|Overall Study|Study Terminated by Sponsor|2|||
105892182|NCT01482962|365261107|FG000|Overall Study|Did not Receive Study Drug|1|||
105892183|NCT01482962|365261108|FG001|Overall Study|Did not Receive Study Drug|6|||
105892184|NCT02035748|365261109|FG000|Overall Study|Adverse Event|5|||
105892185|NCT02035748|365261109|FG000|Overall Study|Death|3|||
105665208|NCT02638103|364438627|FG000|Overall Study|Protocol Violation|1|||
105665209|NCT02638103|364438628|FG001|Overall Study|Protocol Violation|2|||
105892186|NCT02035748|365261109|FG000|Overall Study|Lost to Follow-up|2|||
105892187|NCT02035748|365261109|FG000|Overall Study|Physician Decision|3|||
105892188|NCT02035748|365261109|FG000|Overall Study|Withdrawal by Subject|6|||
105892189|NCT02035748|365261109|FG000|Overall Study|Progressive Disease|1|||
105892190|NCT01088243|365261111|FG000|Overall Study|Adverse Event|1|||
105892191|NCT01088243|365261112|FG001|Overall Study|Adverse Event|0|||
105892192|NCT02231879|365261113|FG000|Overall Study|Adverse Event|2|||
105892193|NCT02231879|365261114|FG001|Overall Study|Adverse Event|1|||
105892194|NCT02231879|365261113|FG000|Overall Study|Lack of Efficacy|0|||
105892195|NCT02231879|365261114|FG001|Overall Study|Lack of Efficacy|1|||
105892196|NCT02850016|365261117|FG000|Overall Study|Withdrawal by Subject|1|||
105892197|NCT02850016|365261118|FG001|Overall Study|Withdrawal by Subject|2|||
105892198|NCT00705718|365261119|FG000|Overall Study|Death|6|||
105892199|NCT00705718|365261120|FG001|Overall Study|Death|6|||
105892200|NCT00705718|365261119|FG000|Overall Study|Not due for Visit|0|||
105892201|NCT00705718|365261120|FG001|Overall Study|Not due for Visit|12|||
105892202|NCT00705718|365261119|FG000|Overall Study|Follow up not done|1|||
105892203|NCT00705718|365261120|FG001|Overall Study|Follow up not done|4|||
105892204|NCT02954653|365261125|FG000|Overall Study|Death|3|||
105892205|NCT02954653|365261126|FG001|Overall Study|Death|1|||
105892206|NCT02954653|365261127|FG002|Overall Study|Death|0|||
105892207|NCT02954653|365261128|FG003|Overall Study|Death|0|||
105892208|NCT02954653|365261129|FG004|Overall Study|Death|0|||
105892209|NCT02954653|365261130|FG005|Overall Study|Death|0|||
105892210|NCT02954653|365261131|FG006|Overall Study|Death|0|||
105892211|NCT02954653|365261132|FG007|Overall Study|Death|0|||
105892212|NCT02954653|365261133|FG008|Overall Study|Death|0|||
105892213|NCT02954653|365261125|FG000|Overall Study|Randomized but did not receive treatment|1|||
105892214|NCT02954653|365261126|FG001|Overall Study|Randomized but did not receive treatment|0|||
105892215|NCT02954653|365261127|FG002|Overall Study|Randomized but did not receive treatment|0|||
105892216|NCT02954653|365261128|FG003|Overall Study|Randomized but did not receive treatment|0|||
105892217|NCT02954653|365261129|FG004|Overall Study|Randomized but did not receive treatment|0|||
105665210|NCT02638103|364438629|FG002|Overall Study|Protocol Violation|1|||
105665211|NCT02638103|364438630|FG003|Overall Study|Protocol Violation|4|||
105892218|NCT02954653|365261130|FG005|Overall Study|Randomized but did not receive treatment|0|||
105892219|NCT02954653|365261131|FG006|Overall Study|Randomized but did not receive treatment|0|||
105892220|NCT02954653|365261132|FG007|Overall Study|Randomized but did not receive treatment|0|||
105892221|NCT02954653|365261133|FG008|Overall Study|Randomized but did not receive treatment|0|||
105665212|NCT02638103|364438627|FG000|Overall Study|Pregnancy|2|||
105665213|NCT02638103|364438628|FG001|Overall Study|Pregnancy|3|||
105892222|NCT02954653|365261125|FG000|Overall Study|Started another anti-cancer therapy|0|||
105892223|NCT02954653|365261126|FG001|Overall Study|Started another anti-cancer therapy|1|||
105892224|NCT02954653|365261127|FG002|Overall Study|Started another anti-cancer therapy|0|||
105892225|NCT02954653|365261128|FG003|Overall Study|Started another anti-cancer therapy|0|||
105892226|NCT02954653|365261129|FG004|Overall Study|Started another anti-cancer therapy|0|||
105892227|NCT02954653|365261130|FG005|Overall Study|Started another anti-cancer therapy|0|||
105892228|NCT02954653|365261131|FG006|Overall Study|Started another anti-cancer therapy|0|||
105892229|NCT02954653|365261132|FG007|Overall Study|Started another anti-cancer therapy|0|||
105892230|NCT02954653|365261133|FG008|Overall Study|Started another anti-cancer therapy|0|||
105892231|NCT02954653|365261125|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
105892232|NCT02954653|365261126|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
105892233|NCT02954653|365261127|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
105892234|NCT02954653|365261128|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
105892235|NCT02954653|365261129|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
105892236|NCT02954653|365261130|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
105892237|NCT02954653|365261131|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
105892238|NCT02954653|365261132|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
105892239|NCT02954653|365261133|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
105892240|NCT03054064|365261134|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
105892241|NCT03054064|365261134|FG000|Overall Study|Investigator Decision|2|||
105892242|NCT03054064|365261134|FG000|Overall Study|Bladder Issue|1|||
105892243|NCT03054064|365261134|FG000|Overall Study|High Blood Pressure|1|||
105892244|NCT03054064|365261134|FG000|Overall Study|Change in Status|1|||
106122109|NCT00708305|366105964|FG000|Period 2|Lost to Follow-up|0|||
106122110|NCT00708305|366105965|FG001|Period 2|Lost to Follow-up|1|||
106122111|NCT00708305|366105966|FG002|Period 2|Lost to Follow-up|0|||
106122112|NCT00708305|366105967|FG003|Period 2|Lost to Follow-up|0|||
106122113|NCT00708305|366105964|FG000|Period 2|Protocol Violation|0|||
106122114|NCT00708305|366105965|FG001|Period 2|Protocol Violation|1|||
106122115|NCT00708305|366105966|FG002|Period 2|Protocol Violation|0|||
106122116|NCT00708305|366105967|FG003|Period 2|Protocol Violation|0|||
106122117|NCT00708305|366105964|FG000|Period 2|Other Reason|1|||
106122118|NCT00708305|366105965|FG001|Period 2|Other Reason|0|||
106122119|NCT00708305|366105966|FG002|Period 2|Other Reason|0|||
106122120|NCT00708305|366105967|FG003|Period 2|Other Reason|1|||
106122121|NCT00708305|366105964|FG000|Period 3|Protocol Violation|0|||
106122122|NCT00708305|366105965|FG001|Period 3|Protocol Violation|2|||
106122123|NCT00708305|366105966|FG002|Period 3|Protocol Violation|0|||
106122124|NCT00708305|366105967|FG003|Period 3|Protocol Violation|0|||
106122125|NCT00708305|366105964|FG000|Period 3|Other Reason|1|||
106122126|NCT00708305|366105965|FG001|Period 3|Other Reason|0|||
106122127|NCT00708305|366105966|FG002|Period 3|Other Reason|0|||
106122128|NCT00708305|366105967|FG003|Period 3|Other Reason|0|||
106122129|NCT02771210|366105968|FG000|Period 1|Adverse Event|5|||
106122130|NCT02771210|366105969|FG001|Period 1|Adverse Event|3|||
106122131|NCT02771210|366105968|FG000|Period 1|Lack of Efficacy|3|||
106122132|NCT02771210|366105969|FG001|Period 1|Lack of Efficacy|6|||
106122133|NCT02771210|366105968|FG000|Period 1|Lost to Follow-up|2|||
106122134|NCT02771210|366105969|FG001|Period 1|Lost to Follow-up|0|||
106122135|NCT02771210|366105968|FG000|Period 1|Physician Decision|0|||
106122136|NCT02771210|366105969|FG001|Period 1|Physician Decision|1|||
106122137|NCT02771210|366105968|FG000|Period 1|Withdrawal by Subject|0|||
106122138|NCT02771210|366105969|FG001|Period 1|Withdrawal by Subject|3|||
106122139|NCT02771210|366105968|FG000|Period 1|Withdrawal of informed consent|1|||
106122140|NCT02771210|366105969|FG001|Period 1|Withdrawal of informed consent|5|||
106122141|NCT02771210|366105968|FG000|Period 2|Adverse Event|1|||
106122142|NCT02771210|366105969|FG001|Period 2|Adverse Event|0|||
106122143|NCT02771210|366105968|FG000|Period 2|Lack of Efficacy|0|||
106122144|NCT02771210|366105969|FG001|Period 2|Lack of Efficacy|1|||
106122145|NCT02771210|366105968|FG000|Period 2|Withdrawal by Subject|1|||
106122146|NCT02771210|366105969|FG001|Period 2|Withdrawal by Subject|0|||
106122147|NCT02771210|366105968|FG000|Period 2|Withdrawal of informed consent|0|||
106122148|NCT02771210|366105969|FG001|Period 2|Withdrawal of informed consent|2|||
106122149|NCT01923389|366105971|FG000|Overall Study|Protocol Violation|1|||
106122150|NCT01923389|366105972|FG001|Overall Study|Protocol Violation|0|||
105892245|NCT03787303|365261138|FG000|Overall Study|Death|1|||
105892246|NCT03787303|365261138|FG000|Overall Study|Premature Termination of Study|1|||
105892247|NCT01472757|365261141|FG000|Overall Study|Withdrawal by Subject|1|||
105892248|NCT01472757|365261142|FG001|Overall Study|Withdrawal by Subject|2|||
105892249|NCT01472757|365261143|FG002|Overall Study|Withdrawal by Subject|2|||
105892250|NCT01472757|365261144|FG003|Overall Study|Withdrawal by Subject|0|||
105892251|NCT01472757|365261141|FG000|Overall Study|Asthma exacerbation|4|||
105892252|NCT01472757|365261142|FG001|Overall Study|Asthma exacerbation|1|||
105892253|NCT01472757|365261143|FG002|Overall Study|Asthma exacerbation|2|||
105892254|NCT01472757|365261144|FG003|Overall Study|Asthma exacerbation|1|||
105892255|NCT01472757|365261141|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
105892256|NCT01472757|365261142|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
105892257|NCT01472757|365261143|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
105892258|NCT01472757|365261144|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
105892259|NCT01472757|365261141|FG000|Overall Study|Protocol Violation|3|||
105892260|NCT01472757|365261142|FG001|Overall Study|Protocol Violation|2|||
105892261|NCT01472757|365261143|FG002|Overall Study|Protocol Violation|4|||
105892262|NCT01472757|365261144|FG003|Overall Study|Protocol Violation|4|||
105892263|NCT01472757|365261141|FG000|Overall Study|Other reasons|1|||
105892264|NCT01472757|365261142|FG001|Overall Study|Other reasons|0|||
105892265|NCT01472757|365261143|FG002|Overall Study|Other reasons|2|||
105892266|NCT01472757|365261144|FG003|Overall Study|Other reasons|2|||
105892267|NCT00976209|365261148|FG000|Treatment Period 1|Protocol Violation|1|||
105892268|NCT00976209|365261149|FG001|Treatment Period 1|Protocol Violation|0|||
105892269|NCT00976209|365261148|FG000|Treatment Period 1|Lost to Follow-up|2|||
105892270|NCT00976209|365261149|FG001|Treatment Period 1|Lost to Follow-up|0|||
105892271|NCT00976209|365261148|FG000|Treatment Period 1|Other|0|||
105892272|NCT00976209|365261149|FG001|Treatment Period 1|Other|1|||
105892273|NCT00976209|365261148|FG000|Wash-out Period|Adverse Event|1|||
105892274|NCT00976209|365261149|FG001|Wash-out Period|Adverse Event|2|||
105892275|NCT00976209|365261148|FG000|Wash-out Period|Lost to Follow-up|1|||
105892276|NCT00976209|365261149|FG001|Wash-out Period|Lost to Follow-up|0|||
105892277|NCT00976209|365261148|FG000|Wash-out Period|Protocol Violation|1|||
105892278|NCT00976209|365261149|FG001|Wash-out Period|Protocol Violation|0|||
105892279|NCT00976209|365261148|FG000|Wash-out Period|Other|1|||
105892280|NCT00976209|365261149|FG001|Wash-out Period|Other|0|||
105892281|NCT00976209|365261148|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105892282|NCT00976209|365261149|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105892283|NCT00976209|365261148|FG000|Treatment Period 2|Lost to Follow-up|0|||
105892284|NCT00976209|365261149|FG001|Treatment Period 2|Lost to Follow-up|1|||
105892285|NCT00574249|365261150|FG000|Overall Study|Adverse Event|6|||
105892286|NCT00574249|365261151|FG001|Overall Study|Adverse Event|18|||
105892287|NCT00574249|365261150|FG000|Overall Study|Lack of Efficacy|5|||
105892288|NCT00574249|365261151|FG001|Overall Study|Lack of Efficacy|3|||
105892289|NCT00574249|365261150|FG000|Overall Study|Lost to Follow-up|4|||
105892290|NCT00574249|365261151|FG001|Overall Study|Lost to Follow-up|3|||
105892291|NCT00574249|365261150|FG000|Overall Study|Protocol Violation|5|||
105892292|NCT00574249|365261151|FG001|Overall Study|Protocol Violation|2|||
105892293|NCT00574249|365261150|FG000|Overall Study|History of carcinoma|1|||
105892294|NCT00574249|365261151|FG001|Overall Study|History of carcinoma|0|||
105892295|NCT00574249|365261150|FG000|Overall Study|Withdrawal by Subject|3|||
105892296|NCT00574249|365261151|FG001|Overall Study|Withdrawal by Subject|0|||
105892297|NCT00574249|365261150|FG000|Overall Study|Physician Decision|1|||
105892298|NCT00574249|365261151|FG001|Overall Study|Physician Decision|0|||
105892299|NCT00574249|365261150|FG000|Overall Study|Pregnancy|1|||
105892300|NCT00574249|365261151|FG001|Overall Study|Pregnancy|0|||
105892301|NCT00574249|365261150|FG000|Overall Study|Excluded by company|0|||
105892302|NCT00574249|365261151|FG001|Overall Study|Excluded by company|1|||
105892303|NCT00574249|365261150|FG000|Overall Study|PPD test taken twice|0|||
106122165|NCT02226172|366105977|FG000|Overall Study|Participant refused further follow-up|4|||
106122166|NCT02226172|366105977|FG000|Overall Study|Other|5|||
106122167|NCT02226172|366105977|FG000|Overall Study|Death|1|||
106122168|NCT02226172|366105977|FG000|Overall Study|Study terminated by sponsor|1|||
106122169|NCT02226172|366105977|FG000|Overall Study|Adverse Event|6|||
106122170|NCT01865617|366105978|FG000|Overall Study|Death|27|||
106122171|NCT01865617|366105979|FG001|Overall Study|Death|3|||
106122172|NCT01865617|366105980|FG002|Overall Study|Death|1|||
106122173|NCT01865617|366105981|FG003|Overall Study|Death|1|||
106122174|NCT01865617|366105982|FG004|Overall Study|Death|5|||
106122175|NCT01865617|366105983|FG005|Overall Study|Death|1|||
106122176|NCT01865617|366105984|FG006|Overall Study|Death|11|||
106122177|NCT01865617|366105985|FG007|Overall Study|Death|1|||
106122178|NCT01865617|366105986|FG008|Overall Study|Death|11|||
105892304|NCT00574249|365261151|FG001|Overall Study|PPD test taken twice|1|||
105892305|NCT01866657|365261152|FG000|Overall Study|Surgery canceled|2|||
105892306|NCT01866657|365261153|FG001|Overall Study|Surgery canceled|0|||
106122179|NCT01865617|366105987|FG009|Overall Study|Death|3|||
106122180|NCT01865617|366105988|FG010|Overall Study|Death|32|||
106122181|NCT01865617|366105989|FG011|Overall Study|Death|6|||
105892307|NCT01123941|365261160|FG000|Overall Study|Lost to Follow-up|2|||
105892308|NCT01123941|365261161|FG001|Overall Study|Lost to Follow-up|1|||
105892309|NCT02375555|365261166|FG000|Induction Period|Adverse Event|7|||
105892310|NCT02375555|365261166|FG000|Induction Period|Withdrawal by Subject|2|||
105892311|NCT02375555|365261166|FG000|Induction Period|Other|1|||
105892312|NCT02375555|365261166|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
105892313|NCT02375555|365261166|FG000|Maintenance Period|Adverse Event|2|||
105892314|NCT02375555|365261166|FG000|Maintenance Period|Withdrawal by Subject|4|||
105892315|NCT02375555|365261166|FG000|Maintenance Period|Death|1|||
105892316|NCT02375555|365261166|FG000|Maintenance Period|Disease Progression|5|||
105892317|NCT02375555|365261166|FG000|Maintenance Period|Patient Non-compliance|1|||
105892318|NCT02375555|365261166|FG000|Maintenance Period|Still on maintenance|16|||
105892319|NCT02294175|365261168|FG000|Overall Study|Withdrawal by Subject|1|||
105892320|NCT02294175|365261169|FG001|Overall Study|Withdrawal by Subject|2|||
105892321|NCT02294175|365261168|FG000|Overall Study|pt taking excluded medication|3|||
105892322|NCT02294175|365261169|FG001|Overall Study|pt taking excluded medication|1|||
105892323|NCT02294175|365261168|FG000|Overall Study|Protocol Violation|1|||
105892324|NCT02294175|365261169|FG001|Overall Study|Protocol Violation|0|||
105892325|NCT02294175|365261168|FG000|Overall Study|Lost to Follow-up|0|||
105892326|NCT02294175|365261169|FG001|Overall Study|Lost to Follow-up|1|||
105892327|NCT02294175|365261168|FG000|Overall Study|wound healed|0|||
105892328|NCT02294175|365261169|FG001|Overall Study|wound healed|2|||
105892329|NCT00948506|365261170|FG000|Overall Study|Withdrawal by Subject|3|||
105892330|NCT00948506|365261171|FG001|Overall Study|Withdrawal by Subject|1|||
105892331|NCT01744184|365261172|FG000|Overall Study|Adverse Event|1|||
105892332|NCT01744184|365261173|FG001|Overall Study|Adverse Event|0|||
105892333|NCT01744184|365261172|FG000|Overall Study|Withdrawal by Subject|0|||
106122182|NCT01865617|366105990|FG012|Overall Study|Death|13|||
106122183|NCT01865617|366105978|FG000|Overall Study|Lost to Follow-up|2|||
106122184|NCT01865617|366105979|FG001|Overall Study|Lost to Follow-up|0|||
106122185|NCT01865617|366105980|FG002|Overall Study|Lost to Follow-up|0|||
106122186|NCT01865617|366105981|FG003|Overall Study|Lost to Follow-up|0|||
106122187|NCT01865617|366105982|FG004|Overall Study|Lost to Follow-up|0|||
106122188|NCT01865617|366105983|FG005|Overall Study|Lost to Follow-up|0|||
105892334|NCT01744184|365261173|FG001|Overall Study|Withdrawal by Subject|1|||
105892335|NCT04756154|365261178|FG000|Overall Study|Did not meet treatment day baseline|30|||
105892336|NCT04756154|365261179|FG001|Overall Study|Did not meet treatment day baseline|28|||
105892337|NCT04756154|365261180|FG002|Overall Study|Did not meet treatment day baseline|7|||
105892338|NCT04756154|365261178|FG000|Overall Study|Did not return for final sample collection|1|||
105892339|NCT04756154|365261179|FG001|Overall Study|Did not return for final sample collection|1|||
106122189|NCT01865617|366105984|FG006|Overall Study|Lost to Follow-up|0|||
106122190|NCT01865617|366105985|FG007|Overall Study|Lost to Follow-up|0|||
106122191|NCT01865617|366105986|FG008|Overall Study|Lost to Follow-up|0|||
106122192|NCT01865617|366105987|FG009|Overall Study|Lost to Follow-up|0|||
106122193|NCT01865617|366105988|FG010|Overall Study|Lost to Follow-up|0|||
106122194|NCT01865617|366105989|FG011|Overall Study|Lost to Follow-up|0|||
106122195|NCT01865617|366105990|FG012|Overall Study|Lost to Follow-up|0|||
105892340|NCT04756154|365261180|FG002|Overall Study|Did not return for final sample collection|0|||
105892341|NCT03589976|365261182|FG000|Overall Study|Death|5|||
105892342|NCT03589976|365261183|FG001|Overall Study|Death|1|||
105892343|NCT03589976|365261182|FG000|Overall Study|Adverse Event|5|||
105892344|NCT03589976|365261183|FG001|Overall Study|Adverse Event|1|||
105892345|NCT03589976|365261182|FG000|Overall Study|Withdrawal by Subject|4|||
105892346|NCT03589976|365261183|FG001|Overall Study|Withdrawal by Subject|1|||
105892347|NCT03589976|365261182|FG000|Overall Study|Lost to Follow-up|1|||
105892348|NCT03589976|365261183|FG001|Overall Study|Lost to Follow-up|0|||
105892349|NCT03589976|365261182|FG000|Overall Study|Other|4|||
105892350|NCT03589976|365261183|FG001|Overall Study|Other|3|||
105892351|NCT00514904|365261189|FG000|Overall Study|Withdrawal by Subject|3|||
105892352|NCT00514904|365261190|FG001|Overall Study|Withdrawal by Subject|2|||
105892353|NCT00514904|365261189|FG000|Overall Study|Lost to Follow-up|21|||
105892354|NCT00514904|365261190|FG001|Overall Study|Lost to Follow-up|3|||
105892355|NCT03430895|365261192|FG000|Overall Study|Not Treated|2|||
105892356|NCT00138073|365261193|FG000|Overall Study|lack of resources|55|||
105892357|NCT01173055|365261194|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
105892358|NCT01173055|365261195|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
105892359|NCT01173055|365261194|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
105892360|NCT01173055|365261195|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
105892361|NCT04325698|365261196|FG000|Overall Study|Study Terminated By Sponsor|1|||
105892362|NCT04325698|365261197|FG001|Overall Study|Study Terminated By Sponsor|1|||
105892363|NCT04325698|365261196|FG000|Overall Study|Withdrawal by Subject|0|||
105892364|NCT04325698|365261197|FG001|Overall Study|Withdrawal by Subject|2|||
105892365|NCT00962091|365261198|FG000|Overall Study|Withdrawal by Subject|1|||
106122196|NCT01865617|366105978|FG000|Overall Study|Withdrawal by Subject|1|||
106122197|NCT01865617|366105979|FG001|Overall Study|Withdrawal by Subject|0|||
106122198|NCT01865617|366105980|FG002|Overall Study|Withdrawal by Subject|0|||
106122199|NCT01865617|366105981|FG003|Overall Study|Withdrawal by Subject|0|||
106122200|NCT01865617|366105982|FG004|Overall Study|Withdrawal by Subject|0|||
105892366|NCT00962091|365261199|FG001|Overall Study|Withdrawal by Subject|2|||
105892367|NCT00962091|365261200|FG002|Overall Study|Withdrawal by Subject|1|||
105892368|NCT00962091|365261201|FG003|Overall Study|Withdrawal by Subject|1|||
105892369|NCT00962091|365261202|FG004|Overall Study|Withdrawal by Subject|0|||
105892370|NCT00962091|365261203|FG005|Overall Study|Withdrawal by Subject|1|||
105892371|NCT00962091|365261204|FG006|Overall Study|Withdrawal by Subject|0|||
105892372|NCT00962091|365261198|FG000|Overall Study|Adverse Event|0|||
105892373|NCT00962091|365261199|FG001|Overall Study|Adverse Event|0|||
105892374|NCT00962091|365261200|FG002|Overall Study|Adverse Event|0|||
105892375|NCT00962091|365261201|FG003|Overall Study|Adverse Event|0|||
105892376|NCT00962091|365261202|FG004|Overall Study|Adverse Event|0|||
105892377|NCT00962091|365261203|FG005|Overall Study|Adverse Event|0|||
105892378|NCT00962091|365261204|FG006|Overall Study|Adverse Event|1|||
105892379|NCT02044874|365261205|FG000|Overall Study|Adverse Event|5|||
105892380|NCT02044874|365261206|FG001|Overall Study|Adverse Event|6|||
105892381|NCT02044874|365261207|FG002|Overall Study|Adverse Event|6|||
105892382|NCT02044874|365261205|FG000|Overall Study|Withdrawal by Subject|8|||
105892383|NCT02044874|365261206|FG001|Overall Study|Withdrawal by Subject|16|||
105892384|NCT02044874|365261207|FG002|Overall Study|Withdrawal by Subject|23|||
105892385|NCT02044874|365261205|FG000|Overall Study|Physician Decision|0|||
105892386|NCT02044874|365261206|FG001|Overall Study|Physician Decision|2|||
105892387|NCT02044874|365261207|FG002|Overall Study|Physician Decision|1|||
105892388|NCT02044874|365261205|FG000|Overall Study|Lost to Follow-up|10|||
105892389|NCT02044874|365261206|FG001|Overall Study|Lost to Follow-up|27|||
105892390|NCT02044874|365261207|FG002|Overall Study|Lost to Follow-up|21|||
105892391|NCT02044874|365261205|FG000|Overall Study|Sponsor Decision|0|||
105892392|NCT02044874|365261206|FG001|Overall Study|Sponsor Decision|1|||
105892393|NCT02044874|365261207|FG002|Overall Study|Sponsor Decision|1|||
105892394|NCT02044874|365261205|FG000|Overall Study|Other|7|||
105892395|NCT02044874|365261206|FG001|Overall Study|Other|3|||
105892396|NCT02044874|365261207|FG002|Overall Study|Other|8|||
105892397|NCT03800836|365261210|FG000|Overall Study|Other|2|||
105892398|NCT03800836|365261211|FG001|Overall Study|Other|1|||
105892399|NCT03800836|365261212|FG002|Overall Study|Other|0|||
105892400|NCT03800836|365261213|FG003|Overall Study|Other|2|||
105892401|NCT03800836|365261214|FG004|Overall Study|Other|0|||
105892402|NCT03800836|365261215|FG005|Overall Study|Other|1|||
105892403|NCT03800836|365261210|FG000|Overall Study|Lost to Follow-up|2|||
105892404|NCT03800836|365261211|FG001|Overall Study|Lost to Follow-up|0|||
105892405|NCT03800836|365261212|FG002|Overall Study|Lost to Follow-up|1|||
105892406|NCT03800836|365261213|FG003|Overall Study|Lost to Follow-up|1|||
105892407|NCT03800836|365261214|FG004|Overall Study|Lost to Follow-up|3|||
105892408|NCT03800836|365261215|FG005|Overall Study|Lost to Follow-up|0|||
105892409|NCT03800836|365261210|FG000|Overall Study|Withdrawal by Subject|1|||
105892410|NCT03800836|365261211|FG001|Overall Study|Withdrawal by Subject|0|||
105996763|NCT04640311|365649494|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
106122201|NCT01865617|366105983|FG005|Overall Study|Withdrawal by Subject|0|||
106122202|NCT01865617|366105984|FG006|Overall Study|Withdrawal by Subject|0|||
106122203|NCT01865617|366105985|FG007|Overall Study|Withdrawal by Subject|0|||
106122204|NCT01865617|366105986|FG008|Overall Study|Withdrawal by Subject|0|||
106122205|NCT01865617|366105987|FG009|Overall Study|Withdrawal by Subject|0|||
106122206|NCT01865617|366105988|FG010|Overall Study|Withdrawal by Subject|0|||
106122207|NCT01865617|366105989|FG011|Overall Study|Withdrawal by Subject|0|||
106122208|NCT01865617|366105990|FG012|Overall Study|Withdrawal by Subject|0|||
106122209|NCT01865617|366105978|FG000|Overall Study|Patient proceeded to new therapy|0|||
106122210|NCT01865617|366105979|FG001|Overall Study|Patient proceeded to new therapy|0|||
106122211|NCT01865617|366105980|FG002|Overall Study|Patient proceeded to new therapy|0|||
106122212|NCT01865617|366105981|FG003|Overall Study|Patient proceeded to new therapy|0|||
106122213|NCT01865617|366105982|FG004|Overall Study|Patient proceeded to new therapy|2|||
106122214|NCT01865617|366105983|FG005|Overall Study|Patient proceeded to new therapy|0|||
106122215|NCT01865617|366105984|FG006|Overall Study|Patient proceeded to new therapy|0|||
106122216|NCT01865617|366105985|FG007|Overall Study|Patient proceeded to new therapy|0|||
106122217|NCT01865617|366105986|FG008|Overall Study|Patient proceeded to new therapy|0|||
105665214|NCT02638103|364438629|FG002|Overall Study|Pregnancy|0|||
105665215|NCT02638103|364438630|FG003|Overall Study|Pregnancy|1|||
105892411|NCT03800836|365261212|FG002|Overall Study|Withdrawal by Subject|0|||
105892412|NCT03800836|365261213|FG003|Overall Study|Withdrawal by Subject|0|||
105892413|NCT03800836|365261214|FG004|Overall Study|Withdrawal by Subject|0|||
105892414|NCT03800836|365261215|FG005|Overall Study|Withdrawal by Subject|0|||
105892415|NCT03800836|365261210|FG000|Overall Study|Physician Decision|31|||
105892416|NCT03800836|365261211|FG001|Overall Study|Physician Decision|3|||
105892417|NCT03800836|365261212|FG002|Overall Study|Physician Decision|6|||
105665216|NCT02638103|364438627|FG000|Overall Study|Non-compliance to Study Procedures|2|||
105892418|NCT03800836|365261213|FG003|Overall Study|Physician Decision|4|||
105892419|NCT03800836|365261214|FG004|Overall Study|Physician Decision|4|||
105892420|NCT03800836|365261215|FG005|Overall Study|Physician Decision|5|||
105892421|NCT03800836|365261210|FG000|Overall Study|Death|34|||
105892422|NCT03800836|365261211|FG001|Overall Study|Death|16|||
105665217|NCT02638103|364438628|FG001|Overall Study|Non-compliance to Study Procedures|1|||
105665218|NCT02638103|364438629|FG002|Overall Study|Non-compliance to Study Procedures|1|||
105665219|NCT02638103|364438630|FG003|Overall Study|Non-compliance to Study Procedures|1|||
105892423|NCT03800836|365261212|FG002|Overall Study|Death|5|||
105892424|NCT03800836|365261213|FG003|Overall Study|Death|5|||
105892425|NCT03800836|365261214|FG004|Overall Study|Death|10|||
105892426|NCT03800836|365261215|FG005|Overall Study|Death|0|||
105892427|NCT03800836|365261210|FG000|Overall Study|Symptomatic Deterioration|1|||
105892428|NCT03800836|365261211|FG001|Overall Study|Symptomatic Deterioration|0|||
105892429|NCT03800836|365261212|FG002|Overall Study|Symptomatic Deterioration|1|||
105892430|NCT03800836|365261213|FG003|Overall Study|Symptomatic Deterioration|0|||
105892431|NCT03800836|365261214|FG004|Overall Study|Symptomatic Deterioration|0|||
105892432|NCT03800836|365261215|FG005|Overall Study|Symptomatic Deterioration|0|||
105892433|NCT03634033|365262287|FG000|Overall Study|Did not have a post-assessment|384|||
105892434|NCT03634033|365262288|FG001|Overall Study|Did not have a post-assessment|291|||
105892435|NCT03634033|365262289|FG002|Overall Study|Did not have a post-assessment|114|||
105892436|NCT03634033|365262290|FG003|Overall Study|Did not have a post-assessment|161|||
105892437|NCT03634033|365262291|FG004|Overall Study|Did not have a post-assessment|5|||
105892438|NCT03634033|365262292|FG005|Overall Study|Did not have a post-assessment|0|||
105892439|NCT03634033|365262293|FG006|Overall Study|Did not have a post-assessment|0|||
105892440|NCT03634033|365262287|FG000|Overall Study|Death|0|||
105892441|NCT03634033|365262288|FG001|Overall Study|Death|0|||
105892442|NCT03634033|365262289|FG002|Overall Study|Death|0|||
105892443|NCT03634033|365262290|FG003|Overall Study|Death|0|||
105892444|NCT03634033|365262291|FG004|Overall Study|Death|0|||
105892445|NCT03634033|365262292|FG005|Overall Study|Death|7|||
105892446|NCT03634033|365262293|FG006|Overall Study|Death|7|||
105892447|NCT03634033|365262287|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
106122218|NCT01865617|366105987|FG009|Overall Study|Patient proceeded to new therapy|0|||
106122219|NCT01865617|366105988|FG010|Overall Study|Patient proceeded to new therapy|0|||
106122220|NCT01865617|366105989|FG011|Overall Study|Patient proceeded to new therapy|0|||
106122221|NCT01865617|366105990|FG012|Overall Study|Patient proceeded to new therapy|0|||
106122222|NCT01865617|366105978|FG000|Overall Study|Other|0|||
106122223|NCT01865617|366105979|FG001|Overall Study|Other|0|||
106122224|NCT01865617|366105980|FG002|Overall Study|Other|0|||
106122225|NCT01865617|366105981|FG003|Overall Study|Other|0|||
106122226|NCT01865617|366105982|FG004|Overall Study|Other|0|||
106122227|NCT01865617|366105983|FG005|Overall Study|Other|0|||
106122228|NCT01865617|366105984|FG006|Overall Study|Other|1|||
106122229|NCT01865617|366105985|FG007|Overall Study|Other|0|||
106122230|NCT01865617|366105986|FG008|Overall Study|Other|0|||
106122231|NCT01865617|366105987|FG009|Overall Study|Other|0|||
106122232|NCT01865617|366105988|FG010|Overall Study|Other|0|||
106122233|NCT01865617|366105989|FG011|Overall Study|Other|0|||
106122234|NCT01865617|366105990|FG012|Overall Study|Other|0|||
106122235|NCT00258440|366105995|FG000|Overall Study|Withdrawal by Subject|0|||
106122236|NCT00258440|366105996|FG001|Overall Study|Withdrawal by Subject|0|||
106122237|NCT00258440|366105997|FG002|Overall Study|Withdrawal by Subject|1|||
106122238|NCT00737061|366105998|FG000|Waiting Period|Lost to Follow-up|6|||
106122239|NCT00737061|366105998|FG000|Waiting Period|Withdrawal by Subject|1|||
106122240|NCT00737061|366105998|FG000|Waiting Period|Bilateral placement failure|34|||
106122241|NCT00737061|366105998|FG000|Waiting Period|Deemed patent following HSG|26|||
106122242|NCT00737061|366105998|FG000|Waiting Period|Alternative contraception failure|3|||
106122243|NCT00737061|366105998|FG000|Waiting Period|Elected surgical tubal ligation|5|||
106122244|NCT00737061|366105998|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
106122245|NCT00737061|366105998|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
106122246|NCT00737061|366105998|FG000|1 Year Wearing Period|Discontinued reilance|3|||
106122247|NCT00737061|366105998|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
106122248|NCT01844115|366105999|FG000|Overall Study|Adverse Event|4|||
106122249|NCT01844115|366106000|FG001|Overall Study|Adverse Event|22|||
106122250|NCT01844115|366105999|FG000|Overall Study|Lack of Efficacy|1|||
106122251|NCT01844115|366106000|FG001|Overall Study|Lack of Efficacy|4|||
106122252|NCT01844115|366105999|FG000|Overall Study|Protocol Violation|12|||
106122253|NCT01844115|366106000|FG001|Overall Study|Protocol Violation|10|||
106122254|NCT01844115|366105999|FG000|Overall Study|Withdrawal by Subject|11|||
106122255|NCT01844115|366106000|FG001|Overall Study|Withdrawal by Subject|11|||
106122256|NCT01844115|366105999|FG000|Overall Study|Lost to Follow-up|11|||
106122257|NCT01844115|366106000|FG001|Overall Study|Lost to Follow-up|10|||
105665220|NCT02638103|364438627|FG000|Overall Study|Lost to Follow-up|26|||
105892448|NCT03634033|365262288|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
105892449|NCT03634033|365262289|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
105892450|NCT03634033|365262290|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
106122258|NCT01844115|366105999|FG000|Overall Study|Pregnancy|0|||
106122259|NCT01844115|366106000|FG001|Overall Study|Pregnancy|1|||
106122260|NCT01372605|366106001|FG000|Overall Study|Death|1|||
106122261|NCT01372605|366106002|FG001|Overall Study|Death|2|||
106122262|NCT01372605|366106001|FG000|Overall Study|Lost to Follow-up|2|||
106122263|NCT01372605|366106002|FG001|Overall Study|Lost to Follow-up|1|||
105665221|NCT02638103|364438628|FG001|Overall Study|Lost to Follow-up|33|||
105665222|NCT02638103|364438629|FG002|Overall Study|Lost to Follow-up|20|||
105665223|NCT02638103|364438630|FG003|Overall Study|Lost to Follow-up|37|||
105665224|NCT02638103|364438627|FG000|Overall Study|Lack of Efficacy|14|||
105665225|NCT02638103|364438628|FG001|Overall Study|Lack of Efficacy|10|||
105665226|NCT02638103|364438629|FG002|Overall Study|Lack of Efficacy|12|||
105665227|NCT02638103|364438630|FG003|Overall Study|Lack of Efficacy|22|||
105892451|NCT03634033|365262291|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
105892452|NCT03634033|365262292|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
105665228|NCT02638103|364438627|FG000|Overall Study|Other than specified|5|||
105665229|NCT02638103|364438628|FG001|Overall Study|Other than specified|4|||
105892453|NCT03634033|365262293|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
105665230|NCT02638103|364438629|FG002|Overall Study|Other than specified|2|||
105892454|NCT03634033|365262287|FG000|Overall Study|Lost to Follow-up|0|||
105892455|NCT03634033|365262288|FG001|Overall Study|Lost to Follow-up|0|||
105892456|NCT03634033|365262289|FG002|Overall Study|Lost to Follow-up|0|||
105892457|NCT03634033|365262290|FG003|Overall Study|Lost to Follow-up|0|||
105892458|NCT03634033|365262291|FG004|Overall Study|Lost to Follow-up|0|||
105892459|NCT03634033|365262292|FG005|Overall Study|Lost to Follow-up|1|||
105892460|NCT03634033|365262293|FG006|Overall Study|Lost to Follow-up|2|||
105892461|NCT03634033|365262287|FG000|Overall Study|Withdrawal by Subject|0|||
105892462|NCT03634033|365262288|FG001|Overall Study|Withdrawal by Subject|0|||
105892463|NCT03634033|365262289|FG002|Overall Study|Withdrawal by Subject|0|||
105892464|NCT03634033|365262290|FG003|Overall Study|Withdrawal by Subject|0|||
105892465|NCT03634033|365262291|FG004|Overall Study|Withdrawal by Subject|0|||
105892466|NCT03634033|365262292|FG005|Overall Study|Withdrawal by Subject|0|||
105892467|NCT03634033|365262293|FG006|Overall Study|Withdrawal by Subject|1|||
105892468|NCT05897827|365262294|FG000|Overall Study|Lost to Follow-up|33|||
105892469|NCT05897827|365262295|FG001|Overall Study|Lost to Follow-up|14|||
105892470|NCT05897827|365262294|FG000|Overall Study|Withdrawal by Subject|1|||
105892471|NCT05897827|365262295|FG001|Overall Study|Withdrawal by Subject|1|||
105892472|NCT00197002|365262296|FG000|Overall Study|Adverse Event|0|||
105892473|NCT00197002|365262297|FG001|Overall Study|Adverse Event|1|||
105892474|NCT00197002|365262298|FG002|Overall Study|Adverse Event|0|||
105892475|NCT00197002|365262296|FG000|Overall Study|Protocol Violation|1|||
105892476|NCT00197002|365262297|FG001|Overall Study|Protocol Violation|0|||
105665231|NCT02638103|364438630|FG003|Overall Study|Other than specified|4|||
105665232|NCT00358644|364438631|FG000|Overall Study|Progressive Disease|21|||
105665233|NCT00358644|364438631|FG000|Overall Study|Adverse Event|7|||
105892477|NCT00197002|365262298|FG002|Overall Study|Protocol Violation|2|||
105892478|NCT00197002|365262296|FG000|Overall Study|Withdrawal by Subject|9|||
105892479|NCT00197002|365262297|FG001|Overall Study|Withdrawal by Subject|5|||
105892480|NCT00197002|365262298|FG002|Overall Study|Withdrawal by Subject|7|||
105892481|NCT00197002|365262296|FG000|Overall Study|Migrated/moved from study area|3|||
105892482|NCT00197002|365262297|FG001|Overall Study|Migrated/moved from study area|5|||
105892483|NCT00197002|365262298|FG002|Overall Study|Migrated/moved from study area|1|||
105892484|NCT00197002|365262296|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
105892485|NCT00197002|365262297|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
105892486|NCT00197002|365262298|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
105892487|NCT00197002|365262296|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
105892488|NCT00197002|365262297|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
105892489|NCT00197002|365262298|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
105892490|NCT00197002|365262296|FG000|Overall Study|Others|3|||
105892491|NCT00197002|365262297|FG001|Overall Study|Others|1|||
105892492|NCT00197002|365262298|FG002|Overall Study|Others|1|||
105892493|NCT02017717|365262299|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105892494|NCT02017717|365262300|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105892495|NCT02017717|365262301|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105665234|NCT00358644|364438631|FG000|Overall Study|Death|11|||
105665235|NCT00358644|364438631|FG000|Overall Study|Withdrawal by Subject|4|||
105892496|NCT02017717|365262302|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105892497|NCT02017717|365262303|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105892498|NCT02017717|365262304|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105892499|NCT02017717|365262305|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105892500|NCT02017717|365262306|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
105892501|NCT02017717|365262307|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
105892502|NCT02017717|365262299|FG000|Before Treatment Period|Participant request to stop therapy|0|||
105665236|NCT00358644|364438631|FG000|Overall Study|Physician Decision|6|||
105665237|NCT00358644|364438631|FG000|Overall Study|Patient not eligible for study|1|||
105665238|NCT00513708|364438632|FG000|Overall Study|Lost to Follow-up|4|||
105665239|NCT00513708|364438633|FG001|Overall Study|Lost to Follow-up|4|||
105665240|NCT00513708|364438634|FG002|Overall Study|Lost to Follow-up|4|||
105892503|NCT02017717|365262300|FG001|Before Treatment Period|Participant request to stop therapy|0|||
105665241|NCT03327831|364438635|FG000|Overall Study|Lost to Follow-up|2|||
105665242|NCT04674189|364438636|FG000|Overall Study|Adverse Event|0|||
105665243|NCT04674189|364438637|FG001|Overall Study|Adverse Event|0|||
105665244|NCT04674189|364438638|FG002|Overall Study|Adverse Event|1|||
105892504|NCT02017717|365262301|FG002|Before Treatment Period|Participant request to stop therapy|0|||
105892505|NCT02017717|365262302|FG003|Before Treatment Period|Participant request to stop therapy|0|||
105892506|NCT02017717|365262303|FG004|Before Treatment Period|Participant request to stop therapy|0|||
105892507|NCT02017717|365262304|FG005|Before Treatment Period|Participant request to stop therapy|0|||
105892508|NCT02017717|365262305|FG006|Before Treatment Period|Participant request to stop therapy|0|||
105892509|NCT02017717|365262306|FG007|Before Treatment Period|Participant request to stop therapy|0|||
105892510|NCT02017717|365262307|FG008|Before Treatment Period|Participant request to stop therapy|5|||
105892511|NCT02017717|365262299|FG000|Before Treatment Period|Participant withdrew consent|0|||
105892512|NCT02017717|365262300|FG001|Before Treatment Period|Participant withdrew consent|0|||
105892513|NCT02017717|365262301|FG002|Before Treatment Period|Participant withdrew consent|0|||
105892514|NCT02017717|365262302|FG003|Before Treatment Period|Participant withdrew consent|0|||
105892515|NCT02017717|365262303|FG004|Before Treatment Period|Participant withdrew consent|0|||
105892516|NCT02017717|365262304|FG005|Before Treatment Period|Participant withdrew consent|0|||
105892517|NCT02017717|365262305|FG006|Before Treatment Period|Participant withdrew consent|2|||
105892518|NCT02017717|365262306|FG007|Before Treatment Period|Participant withdrew consent|0|||
105892519|NCT02017717|365262307|FG008|Before Treatment Period|Participant withdrew consent|11|||
105892520|NCT02017717|365262299|FG000|Before Treatment Period|Lost to Follow-up|0|||
105892521|NCT02017717|365262300|FG001|Before Treatment Period|Lost to Follow-up|0|||
105892522|NCT02017717|365262301|FG002|Before Treatment Period|Lost to Follow-up|0|||
105892523|NCT02017717|365262302|FG003|Before Treatment Period|Lost to Follow-up|0|||
105892524|NCT02017717|365262303|FG004|Before Treatment Period|Lost to Follow-up|0|||
105892525|NCT02017717|365262304|FG005|Before Treatment Period|Lost to Follow-up|0|||
105892526|NCT02017717|365262305|FG006|Before Treatment Period|Lost to Follow-up|0|||
105892527|NCT02017717|365262306|FG007|Before Treatment Period|Lost to Follow-up|0|||
105892528|NCT02017717|365262307|FG008|Before Treatment Period|Lost to Follow-up|1|||
105892529|NCT02017717|365262299|FG000|Before Treatment Period|Participant no longer met criteria|0|||
105892530|NCT02017717|365262300|FG001|Before Treatment Period|Participant no longer met criteria|0|||
106122264|NCT01372605|366106001|FG000|Overall Study|Withdrawal by Subject|4|||
106122265|NCT01372605|366106002|FG001|Overall Study|Withdrawal by Subject|7|||
106122266|NCT01372605|366106001|FG000|Overall Study|Moved|3|||
106122267|NCT01372605|366106002|FG001|Overall Study|Moved|0|||
106122268|NCT01372605|366106001|FG000|Overall Study|Changed medical home|2|||
106122269|NCT01372605|366106002|FG001|Overall Study|Changed medical home|0|||
106122270|NCT01830881|366106009|FG000|Overall Study|Changed decision to have an abortion|0|||
106122271|NCT01830881|366106010|FG001|Overall Study|Changed decision to have an abortion|1|||
106122272|NCT00119262|366106011|FG000|Overall Study|Lack of Efficacy|0|||
106122273|NCT00119262|366106012|FG001|Overall Study|Lack of Efficacy|3|||
106122274|NCT00119262|366106011|FG000|Overall Study|Withdrawal by Subject|12|||
106122275|NCT00119262|366106012|FG001|Overall Study|Withdrawal by Subject|11|||
106122276|NCT00119262|366106011|FG000|Overall Study|Adverse Event|33|||
106122277|NCT00119262|366106012|FG001|Overall Study|Adverse Event|35|||
106122278|NCT00119262|366106011|FG000|Overall Study|other disease|0|||
106122279|NCT00119262|366106012|FG001|Overall Study|other disease|2|||
106122280|NCT00119262|366106011|FG000|Overall Study|ineligble|1|||
106122281|NCT00119262|366106012|FG001|Overall Study|ineligble|2|||
106122282|NCT00119262|366106011|FG000|Overall Study|others|0|||
106122283|NCT00119262|366106012|FG001|Overall Study|others|5|||
106122284|NCT03125941|366106013|FG000|Overall Study|did not receive intervention|1|||
106122285|NCT03125941|366106014|FG001|Overall Study|did not receive intervention|2|||
105665245|NCT04674189|364438636|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
105665246|NCT04674189|364438637|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
105665247|NCT04674189|364438638|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
105665248|NCT04674189|364438636|FG000|Overall Study|Physician Decision|1|||
106122286|NCT01258660|366106015|FG000|Overall Study|Adverse Event|2|||
106122287|NCT01258660|366106016|FG001|Overall Study|Adverse Event|4|||
105892531|NCT02017717|365262301|FG002|Before Treatment Period|Participant no longer met criteria|0|||
106122288|NCT01258660|366106015|FG000|Overall Study|Withdrawal by Subject|3|||
106122289|NCT01258660|366106016|FG001|Overall Study|Withdrawal by Subject|0|||
106122290|NCT01258660|366106015|FG000|Overall Study|due to relocation|2|||
105665249|NCT04674189|364438637|FG001|Overall Study|Physician Decision|0|||
106122291|NCT01258660|366106016|FG001|Overall Study|due to relocation|0|||
106122292|NCT01258660|366106015|FG000|Overall Study|Protocol Violation|0|||
106122293|NCT01258660|366106016|FG001|Overall Study|Protocol Violation|1|||
105665250|NCT04674189|364438638|FG002|Overall Study|Physician Decision|0|||
106122294|NCT01258660|366106015|FG000|Overall Study|Invalid for primary analysis data set|4|||
106122295|NCT01258660|366106016|FG001|Overall Study|Invalid for primary analysis data set|6|||
105665251|NCT04674189|364438636|FG000|Overall Study|Withdrawal by Participant|83|||
105665252|NCT04674189|364438637|FG001|Overall Study|Withdrawal by Participant|71|||
105665253|NCT04674189|364438638|FG002|Overall Study|Withdrawal by Participant|142|||
105892532|NCT02017717|365262302|FG003|Before Treatment Period|Participant no longer met criteria|0|||
105892533|NCT02017717|365262303|FG004|Before Treatment Period|Participant no longer met criteria|0|||
105892534|NCT02017717|365262304|FG005|Before Treatment Period|Participant no longer met criteria|1|||
105892535|NCT02017717|365262305|FG006|Before Treatment Period|Participant no longer met criteria|0|||
105892536|NCT02017717|365262306|FG007|Before Treatment Period|Participant no longer met criteria|1|||
105892537|NCT02017717|365262307|FG008|Before Treatment Period|Participant no longer met criteria|2|||
105892538|NCT02017717|365262299|FG000|Before Treatment Period|other reason|0|||
105892539|NCT02017717|365262300|FG001|Before Treatment Period|other reason|0|||
105892540|NCT02017717|365262301|FG002|Before Treatment Period|other reason|0|||
105892541|NCT02017717|365262302|FG003|Before Treatment Period|other reason|0|||
105892542|NCT02017717|365262303|FG004|Before Treatment Period|other reason|0|||
105892543|NCT02017717|365262304|FG005|Before Treatment Period|other reason|0|||
105892544|NCT02017717|365262305|FG006|Before Treatment Period|other reason|0|||
105892545|NCT02017717|365262306|FG007|Before Treatment Period|other reason|0|||
105892546|NCT02017717|365262307|FG008|Before Treatment Period|other reason|1|||
105892547|NCT02017717|365262299|FG000|Treatment Period|Disease progression|7|||
105892548|NCT02017717|365262300|FG001|Treatment Period|Disease progression|9|||
105892549|NCT02017717|365262301|FG002|Treatment Period|Disease progression|12|||
105892550|NCT02017717|365262302|FG003|Treatment Period|Disease progression|20|||
105892551|NCT02017717|365262303|FG004|Treatment Period|Disease progression|26|||
105892552|NCT02017717|365262304|FG005|Treatment Period|Disease progression|16|||
105892553|NCT02017717|365262305|FG006|Treatment Period|Disease progression|22|||
105892554|NCT02017717|365262306|FG007|Treatment Period|Disease progression|165|||
105892555|NCT02017717|365262307|FG008|Treatment Period|Disease progression|135|||
105892556|NCT02017717|365262299|FG000|Treatment Period|Study drug toxicity|3|||
105892557|NCT02017717|365262300|FG001|Treatment Period|Study drug toxicity|0|||
105892558|NCT02017717|365262301|FG002|Treatment Period|Study drug toxicity|1|||
105892559|NCT02017717|365262302|FG003|Treatment Period|Study drug toxicity|4|||
105892560|NCT02017717|365262303|FG004|Treatment Period|Study drug toxicity|4|||
105892561|NCT02017717|365262304|FG005|Treatment Period|Study drug toxicity|5|||
105892562|NCT02017717|365262305|FG006|Treatment Period|Study drug toxicity|3|||
105892563|NCT02017717|365262306|FG007|Treatment Period|Study drug toxicity|7|||
105892564|NCT02017717|365262307|FG008|Treatment Period|Study drug toxicity|11|||
105892565|NCT02017717|365262299|FG000|Treatment Period|Death|0|||
105892566|NCT02017717|365262300|FG001|Treatment Period|Death|0|||
105892567|NCT02017717|365262301|FG002|Treatment Period|Death|1|||
105892568|NCT02017717|365262302|FG003|Treatment Period|Death|0|||
105892569|NCT02017717|365262303|FG004|Treatment Period|Death|0|||
105892570|NCT02017717|365262304|FG005|Treatment Period|Death|2|||
105892571|NCT02017717|365262305|FG006|Treatment Period|Death|0|||
105892572|NCT02017717|365262306|FG007|Treatment Period|Death|0|||
105892573|NCT02017717|365262307|FG008|Treatment Period|Death|0|||
105892574|NCT02017717|365262299|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
105892575|NCT02017717|365262300|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
105892576|NCT02017717|365262301|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
105892577|NCT02017717|365262302|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
105892578|NCT02017717|365262303|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
105892579|NCT02017717|365262304|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
105892580|NCT02017717|365262305|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
105892581|NCT02017717|365262306|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
105892582|NCT02017717|365262307|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
105892583|NCT02017717|365262299|FG000|Treatment Period|Participant request to stop therapy|0|||
105892584|NCT02017717|365262300|FG001|Treatment Period|Participant request to stop therapy|0|||
105892585|NCT02017717|365262301|FG002|Treatment Period|Participant request to stop therapy|3|||
105892586|NCT02017717|365262302|FG003|Treatment Period|Participant request to stop therapy|6|||
105892587|NCT02017717|365262303|FG004|Treatment Period|Participant request to stop therapy|0|||
105892588|NCT02017717|365262304|FG005|Treatment Period|Participant request to stop therapy|2|||
105892589|NCT02017717|365262305|FG006|Treatment Period|Participant request to stop therapy|1|||
105892590|NCT02017717|365262306|FG007|Treatment Period|Participant request to stop therapy|4|||
105892591|NCT02017717|365262307|FG008|Treatment Period|Participant request to stop therapy|7|||
105892592|NCT02017717|365262299|FG000|Treatment Period|Participant withdrew consent|0|||
105892593|NCT02017717|365262300|FG001|Treatment Period|Participant withdrew consent|0|||
105892594|NCT02017717|365262301|FG002|Treatment Period|Participant withdrew consent|1|||
105892595|NCT02017717|365262302|FG003|Treatment Period|Participant withdrew consent|0|||
105892596|NCT02017717|365262303|FG004|Treatment Period|Participant withdrew consent|0|||
105892597|NCT02017717|365262304|FG005|Treatment Period|Participant withdrew consent|2|||
105892598|NCT02017717|365262305|FG006|Treatment Period|Participant withdrew consent|0|||
105892599|NCT02017717|365262306|FG007|Treatment Period|Participant withdrew consent|1|||
105996764|NCT04640311|365649495|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
105892600|NCT02017717|365262307|FG008|Treatment Period|Participant withdrew consent|4|||
106122296|NCT00582491|366106017|FG000|Overall Study|Withdrawal by Subject|1|||
106122297|NCT00582491|366106018|FG001|Overall Study|Withdrawal by Subject|0|||
105892601|NCT02017717|365262299|FG000|Treatment Period|Participant no longer met criteria|0|||
105892602|NCT02017717|365262300|FG001|Treatment Period|Participant no longer met criteria|0|||
105892603|NCT02017717|365262301|FG002|Treatment Period|Participant no longer met criteria|0|||
105892604|NCT02017717|365262302|FG003|Treatment Period|Participant no longer met criteria|0|||
105892605|NCT02017717|365262303|FG004|Treatment Period|Participant no longer met criteria|0|||
105892606|NCT02017717|365262304|FG005|Treatment Period|Participant no longer met criteria|0|||
105892607|NCT02017717|365262305|FG006|Treatment Period|Participant no longer met criteria|0|||
105892608|NCT02017717|365262306|FG007|Treatment Period|Participant no longer met criteria|0|||
105892609|NCT02017717|365262307|FG008|Treatment Period|Participant no longer met criteria|1|||
105892610|NCT02017717|365262299|FG000|Treatment Period|Other reasons|0|||
105892611|NCT02017717|365262300|FG001|Treatment Period|Other reasons|0|||
105892612|NCT02017717|365262301|FG002|Treatment Period|Other reasons|0|||
105892613|NCT02017717|365262302|FG003|Treatment Period|Other reasons|1|||
105892614|NCT02017717|365262303|FG004|Treatment Period|Other reasons|0|||
105665254|NCT04674189|364438636|FG000|Overall Study|Lost to Follow-up|55|||
105665255|NCT04674189|364438637|FG001|Overall Study|Lost to Follow-up|53|||
105665256|NCT04674189|364438638|FG002|Overall Study|Lost to Follow-up|44|||
105892615|NCT02017717|365262304|FG005|Treatment Period|Other reasons|1|||
105892616|NCT02017717|365262305|FG006|Treatment Period|Other reasons|1|||
105892617|NCT02017717|365262306|FG007|Treatment Period|Other reasons|1|||
105892618|NCT02017717|365262307|FG008|Treatment Period|Other reasons|1|||
105892619|NCT02017717|365262299|FG000|Treatment Period|Maximum clinical benefit|0|||
105892620|NCT02017717|365262300|FG001|Treatment Period|Maximum clinical benefit|0|||
105892621|NCT02017717|365262301|FG002|Treatment Period|Maximum clinical benefit|0|||
105892622|NCT02017717|365262302|FG003|Treatment Period|Maximum clinical benefit|0|||
105892623|NCT02017717|365262303|FG004|Treatment Period|Maximum clinical benefit|0|||
105892624|NCT02017717|365262304|FG005|Treatment Period|Maximum clinical benefit|0|||
105892625|NCT02017717|365262305|FG006|Treatment Period|Maximum clinical benefit|0|||
105892626|NCT02017717|365262306|FG007|Treatment Period|Maximum clinical benefit|0|||
105892627|NCT02017717|365262307|FG008|Treatment Period|Maximum clinical benefit|1|||
105892628|NCT02017717|365262299|FG000|Treatment Period|Not reported|0|||
105892629|NCT02017717|365262300|FG001|Treatment Period|Not reported|1|||
105892630|NCT02017717|365262301|FG002|Treatment Period|Not reported|0|||
105892631|NCT02017717|365262302|FG003|Treatment Period|Not reported|0|||
105892632|NCT02017717|365262303|FG004|Treatment Period|Not reported|0|||
105892633|NCT02017717|365262304|FG005|Treatment Period|Not reported|0|||
105892634|NCT02017717|365262305|FG006|Treatment Period|Not reported|0|||
105892635|NCT02017717|365262306|FG007|Treatment Period|Not reported|0|||
105892636|NCT02017717|365262307|FG008|Treatment Period|Not reported|0|||
105892637|NCT06366087|365262308|FG000|Overall Study|Withdrawal by Subject|0|||
105892638|NCT06366087|365262309|FG001|Overall Study|Withdrawal by Subject|1|||
105892639|NCT03839459|365262314|FG000|Overall Study|Withdrawal by Subject|2|||
106122298|NCT04192630|366106020|FG000|Overall Study|Discontinued before surgery|2|||
106122299|NCT04192630|366106021|FG001|Overall Study|Discontinued before surgery|0|||
106122300|NCT04192630|366106020|FG000|Overall Study|Discontinued after surgery|5|||
106122301|NCT04192630|366106021|FG001|Overall Study|Discontinued after surgery|3|||
106122302|NCT01193582|366106022|FG000|Vaccination Series|Withdrawal by Subject|11|||
106122303|NCT01193582|366106023|FG001|Vaccination Series|Withdrawal by Subject|13|||
106122304|NCT01193582|366106024|FG002|Vaccination Series|Withdrawal by Subject|8|||
106122305|NCT01193582|366106025|FG003|Vaccination Series|Withdrawal by Subject|3|||
106122306|NCT01193582|366106022|FG000|12 Month Follow-up|Death|0|||
106122307|NCT01193582|366106023|FG001|12 Month Follow-up|Death|0|||
106122308|NCT01193582|366106024|FG002|12 Month Follow-up|Death|1|||
106122309|NCT01193582|366106025|FG003|12 Month Follow-up|Death|0|||
106122310|NCT01193582|366106022|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
106122311|NCT01193582|366106023|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
106122312|NCT01193582|366106024|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
106122313|NCT01193582|366106025|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
106122314|NCT01425632|366106030|FG000|Overall Study|Adverse Event|0|||
106122315|NCT01425632|366106031|FG001|Overall Study|Adverse Event|1|||
106122316|NCT01425632|366106032|FG002|Overall Study|Adverse Event|1|||
106122317|NCT01425632|366106030|FG000|Overall Study|Physician Decision|1|||
106122318|NCT01425632|366106031|FG001|Overall Study|Physician Decision|0|||
106122319|NCT01425632|366106032|FG002|Overall Study|Physician Decision|0|||
106122320|NCT01425632|366106030|FG000|Overall Study|Protocol Violation|0|||
106122321|NCT01425632|366106031|FG001|Overall Study|Protocol Violation|0|||
106122322|NCT01425632|366106032|FG002|Overall Study|Protocol Violation|2|||
106122323|NCT01425632|366106030|FG000|Overall Study|Withdrawal by Subject|0|||
105892640|NCT03839459|365262314|FG000|Overall Study|progression of disease|3|||
105892641|NCT02276053|365262316|FG000|Overall Study|Death|2|||
105892642|NCT02276053|365262316|FG000|Overall Study|Adverse Event|5|||
106122324|NCT01425632|366106031|FG001|Overall Study|Withdrawal by Subject|0|||
105892643|NCT02276053|365262316|FG000|Overall Study|Lack of Efficacy|2|||
105892644|NCT02276053|365262316|FG000|Overall Study|Withdrawal by Subject|1|||
105892645|NCT02276053|365262316|FG000|Overall Study|Patient does not meet selection criteria|3|||
105892646|NCT02276053|365262316|FG000|Overall Study|Patient needs to increase baseline AED|1|||
105892647|NCT02203851|365262321|FG000|Overall Study|Lost to Follow-up|4|||
105892648|NCT02203851|365262321|FG000|Overall Study|Withdrawal by Subject|6|||
105892649|NCT02203851|365262321|FG000|Overall Study|Other|1|||
105892650|NCT04161079|365262322|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
105892651|NCT03617861|365262323|FG000|Second Intervention (1 Day)|Adverse Event|0|||
105892652|NCT03617861|365262324|FG001|Second Intervention (1 Day)|Adverse Event|0|||
105892653|NCT03617861|365262325|FG002|Second Intervention (1 Day)|Adverse Event|1|||
105892654|NCT03617861|365262326|FG003|Second Intervention (1 Day)|Adverse Event|0|||
105892655|NCT04045132|365262340|FG000|Overall Study|Lost to Follow-up|3|||
105892656|NCT04045132|365262341|FG001|Overall Study|Lost to Follow-up|6|||
106122325|NCT01425632|366106032|FG002|Overall Study|Withdrawal by Subject|1|||
105892657|NCT03408444|365262348|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
105892658|NCT03408444|365262349|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
105892659|NCT03408444|365262350|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
105892660|NCT03408444|365262351|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
105892661|NCT03408444|365262348|FG000|Overall Study|Lens Discomfort|0|||
105892662|NCT03408444|365262349|FG001|Overall Study|Lens Discomfort|1|||
105892663|NCT03408444|365262350|FG002|Overall Study|Lens Discomfort|0|||
105892664|NCT03408444|365262351|FG003|Overall Study|Lens Discomfort|0|||
105892665|NCT03408444|365262348|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
105892666|NCT03408444|365262349|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
105892667|NCT03408444|365262350|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
105892668|NCT03408444|365262351|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
105892669|NCT03408444|365262348|FG000|Overall Study|Withdrawal by Subject|0|||
105892670|NCT03408444|365262349|FG001|Overall Study|Withdrawal by Subject|2|||
105892671|NCT03408444|365262350|FG002|Overall Study|Withdrawal by Subject|3|||
105892672|NCT03408444|365262351|FG003|Overall Study|Withdrawal by Subject|0|||
105892673|NCT03408444|365262348|FG000|Overall Study|Lost to Follow-up|0|||
105892674|NCT03408444|365262349|FG001|Overall Study|Lost to Follow-up|0|||
105892675|NCT03408444|365262350|FG002|Overall Study|Lost to Follow-up|1|||
105892676|NCT03408444|365262351|FG003|Overall Study|Lost to Follow-up|0|||
105892677|NCT03408444|365262348|FG000|Overall Study|Adverse Event|0|||
105892678|NCT03408444|365262349|FG001|Overall Study|Adverse Event|0|||
105892679|NCT03408444|365262350|FG002|Overall Study|Adverse Event|0|||
105892680|NCT03408444|365262351|FG003|Overall Study|Adverse Event|1|||
105892681|NCT03408444|365262348|FG000|Overall Study|Lens Handling Difficulties|0|||
105892682|NCT03408444|365262349|FG001|Overall Study|Lens Handling Difficulties|0|||
105892683|NCT03408444|365262350|FG002|Overall Study|Lens Handling Difficulties|1|||
105892684|NCT03408444|365262351|FG003|Overall Study|Lens Handling Difficulties|0|||
105892685|NCT03408444|365262348|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
105892686|NCT03408444|365262349|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
105892687|NCT03408444|365262350|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
105892688|NCT03408444|365262351|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
105892689|NCT04327661|365262352|FG000|Overall Study|Withdrawal by Subject|1|||
105892690|NCT04327661|365262353|FG001|Overall Study|Withdrawal by Subject|0|||
105892691|NCT04327661|365262354|FG002|Overall Study|Withdrawal by Subject|0|||
105892692|NCT03535194|365262356|FG000|Induction Period|Adverse Event|2|||
105892693|NCT03535194|365262357|FG001|Induction Period|Adverse Event|2|||
105892694|NCT03535194|365262358|FG002|Induction Period|Adverse Event|1|||
105892695|NCT03535194|365262359|FG003|Induction Period|Adverse Event|3|||
105892696|NCT03535194|365262360|FG004|Induction Period|Adverse Event|0|||
105892697|NCT03535194|365262356|FG000|Induction Period|Death|0|||
105892698|NCT03535194|365262357|FG001|Induction Period|Death|1|||
105892699|NCT03535194|365262358|FG002|Induction Period|Death|0|||
105892700|NCT03535194|365262359|FG003|Induction Period|Death|0|||
105892701|NCT03535194|365262360|FG004|Induction Period|Death|0|||
105892702|NCT03535194|365262356|FG000|Induction Period|Lack of Efficacy|1|||
105892703|NCT03535194|365262357|FG001|Induction Period|Lack of Efficacy|3|||
105892704|NCT03535194|365262358|FG002|Induction Period|Lack of Efficacy|2|||
106122326|NCT03632434|366106034|FG000|Overall Study|Withdrawal by Subject|2|||
106122327|NCT01751113|366106037|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
106122328|NCT01751113|366106038|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
106122329|NCT01751113|366106039|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
106122330|NCT01751113|366106040|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
106122331|NCT01751113|366106041|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
105892705|NCT03535194|365262359|FG003|Induction Period|Lack of Efficacy|2|||
105892706|NCT03535194|365262360|FG004|Induction Period|Lack of Efficacy|0|||
105892707|NCT03535194|365262356|FG000|Induction Period|Lost to Follow-up|3|||
105892708|NCT03535194|365262357|FG001|Induction Period|Lost to Follow-up|5|||
105892709|NCT03535194|365262358|FG002|Induction Period|Lost to Follow-up|2|||
105892710|NCT03535194|365262359|FG003|Induction Period|Lost to Follow-up|3|||
105892711|NCT03535194|365262360|FG004|Induction Period|Lost to Follow-up|0|||
105892712|NCT03535194|365262356|FG000|Induction Period|Physician Decision|1|||
105892713|NCT03535194|365262357|FG001|Induction Period|Physician Decision|1|||
105892714|NCT03535194|365262358|FG002|Induction Period|Physician Decision|0|||
106122332|NCT01751113|366106042|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105665257|NCT04674189|364438636|FG000|Overall Study|Miscellaneous|27|||
105665258|NCT04674189|364438637|FG001|Overall Study|Miscellaneous|23|||
105892715|NCT03535194|365262359|FG003|Induction Period|Physician Decision|0|||
105892716|NCT03535194|365262360|FG004|Induction Period|Physician Decision|0|||
105892717|NCT03535194|365262356|FG000|Induction Period|Protocol Violation|1|||
105892718|NCT03535194|365262357|FG001|Induction Period|Protocol Violation|0|||
105892719|NCT03535194|365262358|FG002|Induction Period|Protocol Violation|0|||
105892720|NCT03535194|365262359|FG003|Induction Period|Protocol Violation|1|||
105892721|NCT03535194|365262360|FG004|Induction Period|Protocol Violation|0|||
105892722|NCT03535194|365262356|FG000|Induction Period|Screen Failure|0|||
105892723|NCT03535194|365262357|FG001|Induction Period|Screen Failure|1|||
105892724|NCT03535194|365262358|FG002|Induction Period|Screen Failure|0|||
105892725|NCT03535194|365262359|FG003|Induction Period|Screen Failure|0|||
105892726|NCT03535194|365262360|FG004|Induction Period|Screen Failure|0|||
105892727|NCT03535194|365262356|FG000|Induction Period|Withdrawal by Subject|3|||
105892728|NCT03535194|365262357|FG001|Induction Period|Withdrawal by Subject|4|||
105892729|NCT03535194|365262358|FG002|Induction Period|Withdrawal by Subject|3|||
105892730|NCT03535194|365262359|FG003|Induction Period|Withdrawal by Subject|2|||
105892731|NCT03535194|365262360|FG004|Induction Period|Withdrawal by Subject|0|||
105892732|NCT03535194|365262356|FG000|Maintenance Period|Adverse Event|6|||
105892733|NCT03535194|365262357|FG001|Maintenance Period|Adverse Event|5|||
105892734|NCT03535194|365262358|FG002|Maintenance Period|Adverse Event|1|||
105665259|NCT04674189|364438638|FG002|Overall Study|Miscellaneous|207|||
105665260|NCT04674189|364438636|FG000|Overall Study|Did Not Receive Treatment|3|||
105665261|NCT04674189|364438637|FG001|Overall Study|Did Not Receive Treatment|1|||
105665262|NCT04674189|364438638|FG002|Overall Study|Did Not Receive Treatment|2|||
105665263|NCT01564277|364438639|FG000|Overall Study|Protocol Violation|0|||
105665264|NCT01564277|364438640|FG001|Overall Study|Protocol Violation|1|||
105665265|NCT01564277|364438639|FG000|Overall Study|Physician Decision|1|||
105665266|NCT01564277|364438640|FG001|Overall Study|Physician Decision|0|||
105665267|NCT03332784|364438647|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665268|NCT03332784|364438648|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
105665269|NCT03332784|364438649|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665270|NCT03332784|364438650|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665271|NCT03332784|364438651|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665272|NCT03332784|364438652|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665273|NCT03332784|364438653|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665274|NCT03332784|364438654|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665275|NCT03332784|364438655|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665276|NCT03332784|364438656|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665277|NCT03332784|364438657|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665278|NCT03332784|364438658|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105892735|NCT03535194|365262359|FG003|Maintenance Period|Adverse Event|11|||
105892736|NCT03535194|365262360|FG004|Maintenance Period|Adverse Event|4|||
106122333|NCT01751113|366106037|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
106122334|NCT01751113|366106038|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
106122335|NCT01751113|366106039|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
106122336|NCT01751113|366106040|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
106122337|NCT01751113|366106041|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
106122338|NCT01751113|366106042|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
106122339|NCT01775930|366106043|FG000|Overall Study|Futility stopping boundary met|1|||
106122340|NCT01551303|366106044|FG000|Overall Study|failed awareness check on vision test|4|||
106122341|NCT01551303|366106045|FG001|Overall Study|failed awareness check on vision test|7|||
106122342|NCT01208415|366106046|FG000|Overall Study|Death|1|||
106122343|NCT01208415|366106046|FG000|Overall Study|Lost to Follow-up|2|||
106122344|NCT01208415|366106046|FG000|Overall Study|Withdrawal by Subject|3|||
106122345|NCT01208415|366106046|FG000|Overall Study|Device not placed|1|||
106122346|NCT01208415|366106046|FG000|Overall Study|Still be eligible for follow-up|33|||
106122347|NCT00363896|366106047|FG000|Overall Study|Withdrawal by Subject|29|||
106122348|NCT00363896|366106048|FG001|Overall Study|Withdrawal by Subject|16|||
105892737|NCT03535194|365262356|FG000|Maintenance Period|Lack of Efficacy|3|||
105892738|NCT03535194|365262357|FG001|Maintenance Period|Lack of Efficacy|2|||
105892739|NCT03535194|365262358|FG002|Maintenance Period|Lack of Efficacy|5|||
105892740|NCT03535194|365262359|FG003|Maintenance Period|Lack of Efficacy|9|||
105892741|NCT03535194|365262360|FG004|Maintenance Period|Lack of Efficacy|0|||
105892742|NCT03535194|365262356|FG000|Maintenance Period|Lost to Follow-up|4|||
105996765|NCT04640311|365649496|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105665279|NCT03332784|364438659|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665280|NCT03332784|364438660|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665281|NCT03332784|364438661|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
105665282|NCT03332784|364438662|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665283|NCT03332784|364438663|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665284|NCT03332784|364438664|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665285|NCT03332784|364438665|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665286|NCT03332784|364438666|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
105665287|NCT01969851|364438676|FG000|Overall Study|Adverse Event|0|||
105665288|NCT01969851|364438677|FG001|Overall Study|Adverse Event|0|||
105665289|NCT01969851|364438678|FG002|Overall Study|Adverse Event|3|||
105665290|NCT01969851|364438676|FG000|Overall Study|Lack of Efficacy|0|||
105665291|NCT01969851|364438677|FG001|Overall Study|Lack of Efficacy|3|||
105665292|NCT01969851|364438678|FG002|Overall Study|Lack of Efficacy|1|||
105665293|NCT01969851|364438676|FG000|Overall Study|Withdrawal by Subject|1|||
105665294|NCT01969851|364438677|FG001|Overall Study|Withdrawal by Subject|0|||
105665295|NCT01969851|364438678|FG002|Overall Study|Withdrawal by Subject|1|||
105665296|NCT01969851|364438676|FG000|Overall Study|No effective dose in Titration period|0|||
105665297|NCT01969851|364438677|FG001|Overall Study|No effective dose in Titration period|0|||
105665298|NCT01969851|364438678|FG002|Overall Study|No effective dose in Titration period|1|||
105665299|NCT01969851|364438676|FG000|Overall Study|Sponsor decision|0|||
105665300|NCT01969851|364438677|FG001|Overall Study|Sponsor decision|0|||
105665301|NCT01969851|364438678|FG002|Overall Study|Sponsor decision|1|||
105665302|NCT01299480|364438679|FG000|Overall Study|No longer willing to participate|19|||
105665303|NCT01299480|364438680|FG001|Overall Study|No longer willing to participate|17|||
105665304|NCT01299480|364438681|FG002|Overall Study|No longer willing to participate|14|||
105665305|NCT01299480|364438682|FG003|Overall Study|No longer willing to participate|13|||
105665306|NCT01299480|364438683|FG004|Overall Study|No longer willing to participate|10|||
105665307|NCT01299480|364438679|FG000|Overall Study|Protocol Violation|7|||
105665308|NCT01299480|364438680|FG001|Overall Study|Protocol Violation|5|||
105665309|NCT01299480|364438681|FG002|Overall Study|Protocol Violation|8|||
105665310|NCT01299480|364438682|FG003|Overall Study|Protocol Violation|1|||
105665311|NCT01299480|364438683|FG004|Overall Study|Protocol Violation|1|||
105665312|NCT01299480|364438679|FG000|Overall Study|Withdrawal by Subject|3|||
105665313|NCT01299480|364438680|FG001|Overall Study|Withdrawal by Subject|4|||
105665314|NCT01299480|364438681|FG002|Overall Study|Withdrawal by Subject|7|||
105665315|NCT01299480|364438682|FG003|Overall Study|Withdrawal by Subject|3|||
105665316|NCT01299480|364438683|FG004|Overall Study|Withdrawal by Subject|4|||
105665317|NCT01299480|364438679|FG000|Overall Study|Adverse Event|6|||
105665318|NCT01299480|364438680|FG001|Overall Study|Adverse Event|4|||
105665319|NCT01299480|364438681|FG002|Overall Study|Adverse Event|5|||
105665320|NCT01299480|364438682|FG003|Overall Study|Adverse Event|4|||
105665321|NCT01299480|364438683|FG004|Overall Study|Adverse Event|0|||
105665322|NCT01299480|364438679|FG000|Overall Study|Withdrawal due to pregnancy|0|||
105665323|NCT01299480|364438680|FG001|Overall Study|Withdrawal due to pregnancy|1|||
105665324|NCT01299480|364438681|FG002|Overall Study|Withdrawal due to pregnancy|1|||
105665325|NCT01299480|364438682|FG003|Overall Study|Withdrawal due to pregnancy|0|||
105665326|NCT01299480|364438683|FG004|Overall Study|Withdrawal due to pregnancy|0|||
105665327|NCT01299480|364438679|FG000|Overall Study|Physician Decision|1|||
105665328|NCT01299480|364438680|FG001|Overall Study|Physician Decision|1|||
105892743|NCT03535194|365262357|FG001|Maintenance Period|Lost to Follow-up|2|||
105892744|NCT03535194|365262358|FG002|Maintenance Period|Lost to Follow-up|1|||
105892745|NCT03535194|365262359|FG003|Maintenance Period|Lost to Follow-up|5|||
105892746|NCT03535194|365262360|FG004|Maintenance Period|Lost to Follow-up|2|||
105892747|NCT03535194|365262356|FG000|Maintenance Period|Other|1|||
105892748|NCT03535194|365262357|FG001|Maintenance Period|Other|2|||
105892749|NCT03535194|365262358|FG002|Maintenance Period|Other|0|||
105892750|NCT03535194|365262359|FG003|Maintenance Period|Other|0|||
105892751|NCT03535194|365262360|FG004|Maintenance Period|Other|0|||
105892752|NCT03535194|365262356|FG000|Maintenance Period|Physician Decision|1|||
105892753|NCT03535194|365262357|FG001|Maintenance Period|Physician Decision|2|||
105892754|NCT03535194|365262358|FG002|Maintenance Period|Physician Decision|0|||
105892755|NCT03535194|365262359|FG003|Maintenance Period|Physician Decision|2|||
105892756|NCT03535194|365262360|FG004|Maintenance Period|Physician Decision|0|||
105892757|NCT03535194|365262356|FG000|Maintenance Period|Pregnancy|0|||
105892758|NCT03535194|365262357|FG001|Maintenance Period|Pregnancy|0|||
105892759|NCT03535194|365262358|FG002|Maintenance Period|Pregnancy|0|||
105892760|NCT03535194|365262359|FG003|Maintenance Period|Pregnancy|2|||
105892761|NCT03535194|365262360|FG004|Maintenance Period|Pregnancy|0|||
105996766|NCT04640311|365649497|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105996767|NCT04640311|365649498|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105996768|NCT04640311|365649499|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105996769|NCT04640311|365649500|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105996770|NCT04640311|365649501|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105996771|NCT04640311|365649502|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105996772|NCT04640311|365649503|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105996773|NCT04640311|365649504|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105996774|NCT04640311|365649505|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
105892762|NCT03535194|365262356|FG000|Maintenance Period|Protocol Violation|0|||
105892763|NCT03535194|365262357|FG001|Maintenance Period|Protocol Violation|1|||
105892764|NCT03535194|365262358|FG002|Maintenance Period|Protocol Violation|0|||
105892765|NCT03535194|365262359|FG003|Maintenance Period|Protocol Violation|0|||
105892766|NCT03535194|365262360|FG004|Maintenance Period|Protocol Violation|0|||
105892767|NCT03535194|365262356|FG000|Maintenance Period|Withdrawal by Subject|7|||
105892768|NCT03535194|365262357|FG001|Maintenance Period|Withdrawal by Subject|2|||
105892769|NCT03535194|365262358|FG002|Maintenance Period|Withdrawal by Subject|1|||
105892770|NCT03535194|365262359|FG003|Maintenance Period|Withdrawal by Subject|8|||
105892771|NCT03535194|365262360|FG004|Maintenance Period|Withdrawal by Subject|0|||
105892772|NCT03535194|365262356|FG000|Post-Treatment Followup Period|Adverse Event|4|||
105665329|NCT01299480|364438681|FG002|Overall Study|Physician Decision|0|||
105665330|NCT01299480|364438682|FG003|Overall Study|Physician Decision|2|||
105665331|NCT01299480|364438683|FG004|Overall Study|Physician Decision|0|||
105665332|NCT01299480|364438679|FG000|Overall Study|Lost to Follow-up|3|||
105665333|NCT01299480|364438680|FG001|Overall Study|Lost to Follow-up|1|||
105892773|NCT03535194|365262357|FG001|Post-Treatment Followup Period|Adverse Event|5|||
105892774|NCT03535194|365262358|FG002|Post-Treatment Followup Period|Adverse Event|1|||
105892775|NCT03535194|365262359|FG003|Post-Treatment Followup Period|Adverse Event|8|||
105892776|NCT03535194|365262360|FG004|Post-Treatment Followup Period|Adverse Event|0|||
105892777|NCT03535194|365262356|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
105892778|NCT03535194|365262357|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
105892779|NCT03535194|365262358|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
105892780|NCT03535194|365262359|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
105892781|NCT03535194|365262360|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
105892782|NCT03535194|365262356|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
105892783|NCT03535194|365262357|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
105892784|NCT03535194|365262358|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
105892785|NCT03535194|365262359|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
105892786|NCT03535194|365262360|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
105892787|NCT03535194|365262356|FG000|Post-Treatment Followup Period|Other|1|||
105892788|NCT03535194|365262357|FG001|Post-Treatment Followup Period|Other|0|||
105892789|NCT03535194|365262358|FG002|Post-Treatment Followup Period|Other|0|||
105892790|NCT03535194|365262359|FG003|Post-Treatment Followup Period|Other|5|||
105665334|NCT01299480|364438681|FG002|Overall Study|Lost to Follow-up|2|||
105665335|NCT01299480|364438682|FG003|Overall Study|Lost to Follow-up|1|||
105665336|NCT01299480|364438683|FG004|Overall Study|Lost to Follow-up|2|||
105665337|NCT01299480|364438679|FG000|Overall Study|Other|3|||
105665338|NCT01299480|364438680|FG001|Overall Study|Other|2|||
105665339|NCT01299480|364438681|FG002|Overall Study|Other|3|||
105665340|NCT01299480|364438682|FG003|Overall Study|Other|0|||
105665341|NCT01299480|364438683|FG004|Overall Study|Other|3|||
105665342|NCT01299480|364438679|FG000|Overall Study|Started, but not vaccinated|0|||
105665343|NCT01299480|364438680|FG001|Overall Study|Started, but not vaccinated|0|||
105665344|NCT01299480|364438681|FG002|Overall Study|Started, but not vaccinated|1|||
105665345|NCT01299480|364438682|FG003|Overall Study|Started, but not vaccinated|1|||
105665346|NCT01299480|364438683|FG004|Overall Study|Started, but not vaccinated|0|||
105665347|NCT01827046|364438684|FG000|Overall Study|Lost to Follow-up|1|||
105665348|NCT01827046|364438685|FG001|Overall Study|Lost to Follow-up|5|||
105665349|NCT01827046|364438684|FG000|Overall Study|Withdrawal by Subject|0|||
105665350|NCT01827046|364438685|FG001|Overall Study|Withdrawal by Subject|4|||
105665351|NCT02498236|364438692|FG000|Overall Study|Did not show for testing|1|||
105665352|NCT02498236|364438693|FG001|Overall Study|Did not show for testing|0|||
105665353|NCT02498236|364438694|FG002|Overall Study|Did not show for testing|0|||
105665354|NCT02498236|364438695|FG003|Overall Study|Did not show for testing|0|||
105665355|NCT02498236|364438696|FG004|Overall Study|Did not show for testing|0|||
105665356|NCT02498236|364438697|FG005|Overall Study|Did not show for testing|0|||
105892791|NCT03535194|365262360|FG004|Post-Treatment Followup Period|Other|0|||
105892792|NCT03535194|365262356|FG000|Post-Treatment Followup Period|Physician Decision|0|||
105892793|NCT03535194|365262357|FG001|Post-Treatment Followup Period|Physician Decision|2|||
105892794|NCT03535194|365262358|FG002|Post-Treatment Followup Period|Physician Decision|1|||
105892795|NCT03535194|365262359|FG003|Post-Treatment Followup Period|Physician Decision|1|||
105892796|NCT03535194|365262360|FG004|Post-Treatment Followup Period|Physician Decision|0|||
105665357|NCT02498236|364438698|FG006|Overall Study|Did not show for testing|0|||
105665358|NCT02498236|364438699|FG007|Overall Study|Did not show for testing|1|||
105665359|NCT02498236|364438692|FG000|Overall Study|Equipment failure|0|||
105665360|NCT02498236|364438693|FG001|Overall Study|Equipment failure|0|||
105665361|NCT02498236|364438694|FG002|Overall Study|Equipment failure|0|||
105665362|NCT02498236|364438695|FG003|Overall Study|Equipment failure|0|||
105665363|NCT02498236|364438696|FG004|Overall Study|Equipment failure|0|||
105892797|NCT03535194|365262356|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
105892798|NCT03535194|365262357|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
105892799|NCT03535194|365262358|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
105892800|NCT03535194|365262359|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
105665364|NCT02498236|364438697|FG005|Overall Study|Equipment failure|0|||
105892801|NCT03535194|365262360|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
105892802|NCT05896527|365262361|FG000|Overall Study|Withdrawal by Subject|11|||
105892803|NCT05896527|365262362|FG001|Overall Study|Withdrawal by Subject|10|||
105892804|NCT05896527|365262363|FG002|Overall Study|Withdrawal by Subject|4|||
105892805|NCT05896527|365262364|FG003|Overall Study|Withdrawal by Subject|3|||
105892806|NCT05896527|365262365|FG004|Overall Study|Withdrawal by Subject|2|||
105892807|NCT05896527|365262361|FG000|Overall Study|Lost to Follow-up|0|||
105892808|NCT05896527|365262362|FG001|Overall Study|Lost to Follow-up|2|||
105892809|NCT05896527|365262363|FG002|Overall Study|Lost to Follow-up|2|||
105892810|NCT05896527|365262364|FG003|Overall Study|Lost to Follow-up|2|||
105892811|NCT05896527|365262365|FG004|Overall Study|Lost to Follow-up|1|||
105892812|NCT05896527|365262361|FG000|Overall Study|Significant protocol noncompliance|0|||
105892813|NCT05896527|365262362|FG001|Overall Study|Significant protocol noncompliance|1|||
105892814|NCT05896527|365262363|FG002|Overall Study|Significant protocol noncompliance|0|||
105892815|NCT05896527|365262364|FG003|Overall Study|Significant protocol noncompliance|0|||
105892816|NCT05896527|365262365|FG004|Overall Study|Significant protocol noncompliance|0|||
105892817|NCT05896527|365262361|FG000|Overall Study|Eligibility criteria not met|1|||
105892818|NCT05896527|365262362|FG001|Overall Study|Eligibility criteria not met|0|||
105892819|NCT05896527|365262363|FG002|Overall Study|Eligibility criteria not met|0|||
105892820|NCT05896527|365262364|FG003|Overall Study|Eligibility criteria not met|0|||
105892821|NCT05896527|365262365|FG004|Overall Study|Eligibility criteria not met|0|||
105892822|NCT05896527|365262361|FG000|Overall Study|Sponsor's decision|0|||
105892823|NCT05896527|365262362|FG001|Overall Study|Sponsor's decision|0|||
105892824|NCT05896527|365262363|FG002|Overall Study|Sponsor's decision|0|||
105892825|NCT05896527|365262364|FG003|Overall Study|Sponsor's decision|1|||
105892826|NCT05896527|365262365|FG004|Overall Study|Sponsor's decision|0|||
105892827|NCT05896527|365262361|FG000|Overall Study|Investigator's decision|0|||
105892828|NCT05896527|365262362|FG001|Overall Study|Investigator's decision|1|||
105892829|NCT05896527|365262363|FG002|Overall Study|Investigator's decision|0|||
105892830|NCT05896527|365262364|FG003|Overall Study|Investigator's decision|0|||
105892831|NCT05896527|365262365|FG004|Overall Study|Investigator's decision|0|||
105892832|NCT05896527|365262361|FG000|Overall Study|Pregnancy of his partner|0|||
105892833|NCT05896527|365262362|FG001|Overall Study|Pregnancy of his partner|0|||
105892834|NCT05896527|365262363|FG002|Overall Study|Pregnancy of his partner|0|||
105892835|NCT05896527|365262364|FG003|Overall Study|Pregnancy of his partner|1|||
105892836|NCT05896527|365262365|FG004|Overall Study|Pregnancy of his partner|0|||
105892837|NCT02370667|365262374|FG000|Overall Study|Lost to Follow-up|0|||
105892838|NCT02370667|365262375|FG001|Overall Study|Lost to Follow-up|1|||
105892839|NCT02370667|365262376|FG002|Overall Study|Lost to Follow-up|0|||
105892840|NCT02052596|365262377|FG000|Active Phase|Adverse Event|3|||
105892841|NCT02052596|365262378|FG001|Active Phase|Adverse Event|2|||
105892842|NCT02052596|365262377|FG000|Active Phase|Lost to Follow-up|8|||
105892843|NCT02052596|365262378|FG001|Active Phase|Lost to Follow-up|11|||
105892844|NCT02052596|365262377|FG000|Active Phase|Protocol Violation|1|||
105892845|NCT02052596|365262378|FG001|Active Phase|Protocol Violation|2|||
105665365|NCT02498236|364438698|FG006|Overall Study|Equipment failure|1|||
105665366|NCT02498236|364438699|FG007|Overall Study|Equipment failure|0|||
105665367|NCT02498236|364438692|FG000|Overall Study|Withdrawal by Subject|0|||
105665368|NCT02498236|364438693|FG001|Overall Study|Withdrawal by Subject|0|||
105665369|NCT02498236|364438694|FG002|Overall Study|Withdrawal by Subject|0|||
105665370|NCT02498236|364438695|FG003|Overall Study|Withdrawal by Subject|0|||
105665371|NCT02498236|364438696|FG004|Overall Study|Withdrawal by Subject|1|||
105665372|NCT02498236|364438697|FG005|Overall Study|Withdrawal by Subject|0|||
105665373|NCT02498236|364438698|FG006|Overall Study|Withdrawal by Subject|0|||
105665374|NCT02498236|364438699|FG007|Overall Study|Withdrawal by Subject|0|||
105665375|NCT01426347|364438700|FG000|Overall Study|Lost to Follow-up|0|||
105665376|NCT01426347|364438701|FG001|Overall Study|Lost to Follow-up|3|||
105665377|NCT01426347|364438700|FG000|Overall Study|Protocol Violation|2|||
105665378|NCT01426347|364438701|FG001|Overall Study|Protocol Violation|0|||
105665379|NCT01426347|364438700|FG000|Overall Study|Withdrawal by Subject|5|||
105892846|NCT02052596|365262377|FG000|Active Phase|Withdrawal by Subject|3|||
105892847|NCT02052596|365262378|FG001|Active Phase|Withdrawal by Subject|4|||
106122349|NCT00363896|366106047|FG000|Overall Study|Adverse Event|24|||
105665380|NCT01426347|364438701|FG001|Overall Study|Withdrawal by Subject|0|||
105892848|NCT02052596|365262377|FG000|Active Phase|Enrolled in error|1|||
105892849|NCT02052596|365262378|FG001|Active Phase|Enrolled in error|0|||
105892850|NCT02052596|365262377|FG000|Active Phase|Lost due to Crohn's disease|0|||
105892851|NCT02052596|365262378|FG001|Active Phase|Lost due to Crohn's disease|1|||
105892852|NCT02052596|365262377|FG000|Safety Phase|Adverse Event|6|||
105892853|NCT02052596|365262378|FG001|Safety Phase|Adverse Event|3|||
105892854|NCT02052596|365262377|FG000|Safety Phase|Lost to Follow-up|11|||
105892855|NCT02052596|365262378|FG001|Safety Phase|Lost to Follow-up|18|||
105892856|NCT02052596|365262377|FG000|Safety Phase|Protocol Violation|1|||
105665381|NCT01948076|364438704|FG000|Overall Study|Withdrawal by Subject|0|||
105892857|NCT02052596|365262378|FG001|Safety Phase|Protocol Violation|2|||
105892858|NCT02052596|365262377|FG000|Safety Phase|Withdrawal by Subject|8|||
105892859|NCT02052596|365262378|FG001|Safety Phase|Withdrawal by Subject|11|||
105892860|NCT02052596|365262377|FG000|Safety Phase|Enrolled in error|1|||
105892861|NCT02052596|365262378|FG001|Safety Phase|Enrolled in error|0|||
105892862|NCT02052596|365262377|FG000|Safety Phase|Lost due to Crohn's disease|0|||
105892863|NCT02052596|365262378|FG001|Safety Phase|Lost due to Crohn's disease|1|||
105892864|NCT00558896|365262379|FG000|Overall Study|Adverse Event|1|||
105892865|NCT00558896|365262380|FG001|Overall Study|Adverse Event|1|||
105892866|NCT00558896|365262381|FG002|Overall Study|Adverse Event|1|||
105892867|NCT00558896|365262382|FG003|Overall Study|Adverse Event|3|||
105892868|NCT00558896|365262383|FG004|Overall Study|Adverse Event|4|||
105892869|NCT00558896|365262384|FG005|Overall Study|Adverse Event|10|||
105892870|NCT00558896|365262385|FG006|Overall Study|Adverse Event|3|||
105892871|NCT00558896|365262379|FG000|Overall Study|Death|3|||
105892872|NCT00558896|365262380|FG001|Overall Study|Death|0|||
105892873|NCT00558896|365262381|FG002|Overall Study|Death|2|||
105892874|NCT00558896|365262382|FG003|Overall Study|Death|3|||
105892875|NCT00558896|365262383|FG004|Overall Study|Death|2|||
105892876|NCT00558896|365262384|FG005|Overall Study|Death|2|||
105892877|NCT00558896|365262385|FG006|Overall Study|Death|6|||
105892878|NCT00558896|365262379|FG000|Overall Study|Withdrawal by Subject|2|||
105892879|NCT00558896|365262380|FG001|Overall Study|Withdrawal by Subject|1|||
106122350|NCT00363896|366106048|FG001|Overall Study|Adverse Event|13|||
105892880|NCT00558896|365262381|FG002|Overall Study|Withdrawal by Subject|1|||
105892881|NCT00558896|365262382|FG003|Overall Study|Withdrawal by Subject|1|||
105892882|NCT00558896|365262383|FG004|Overall Study|Withdrawal by Subject|1|||
105892883|NCT00558896|365262384|FG005|Overall Study|Withdrawal by Subject|5|||
105892884|NCT00558896|365262385|FG006|Overall Study|Withdrawal by Subject|5|||
105892885|NCT00558896|365262379|FG000|Overall Study|Alternative Treatment|2|||
105892886|NCT00558896|365262380|FG001|Overall Study|Alternative Treatment|2|||
105892887|NCT00558896|365262381|FG002|Overall Study|Alternative Treatment|0|||
105892888|NCT00558896|365262382|FG003|Overall Study|Alternative Treatment|2|||
105892889|NCT00558896|365262383|FG004|Overall Study|Alternative Treatment|6|||
105892890|NCT00558896|365262384|FG005|Overall Study|Alternative Treatment|7|||
105892891|NCT00558896|365262385|FG006|Overall Study|Alternative Treatment|1|||
105892892|NCT00558896|365262379|FG000|Overall Study|Physician discretion|3|||
105892893|NCT00558896|365262380|FG001|Overall Study|Physician discretion|2|||
105892894|NCT00558896|365262381|FG002|Overall Study|Physician discretion|1|||
105892895|NCT00558896|365262382|FG003|Overall Study|Physician discretion|2|||
105892896|NCT00558896|365262383|FG004|Overall Study|Physician discretion|1|||
105996775|NCT04640311|365649493|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105996776|NCT04640311|365649494|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
106122351|NCT00363896|366106047|FG000|Overall Study|COPD exacerbation|13|||
106122352|NCT00363896|366106048|FG001|Overall Study|COPD exacerbation|7|||
106122353|NCT00363896|366106047|FG000|Overall Study|Lack of Efficacy|12|||
106122354|NCT00363896|366106048|FG001|Overall Study|Lack of Efficacy|8|||
105996777|NCT04640311|365649495|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
106122355|NCT00363896|366106047|FG000|Overall Study|Protocol Violation|6|||
106122356|NCT00363896|366106048|FG001|Overall Study|Protocol Violation|1|||
106122357|NCT00363896|366106047|FG000|Overall Study|Lost to Follow-up|3|||
106122358|NCT00363896|366106048|FG001|Overall Study|Lost to Follow-up|0|||
106122359|NCT00363896|366106047|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
106122360|NCT00363896|366106048|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
106122361|NCT00363896|366106047|FG000|Overall Study|Other|1|||
106122362|NCT00363896|366106048|FG001|Overall Study|Other|2|||
106122363|NCT01651936|366106051|FG000|Base Study|Adverse Event|3|||
106122364|NCT01651936|366106052|FG001|Base Study|Adverse Event|0|||
106122365|NCT01651936|366106053|FG002|Base Study|Adverse Event|0|||
106122366|NCT01651936|366106051|FG000|Base Study|Withdrawal by Subject|1|||
106122367|NCT01651936|366106052|FG001|Base Study|Withdrawal by Subject|1|||
106122368|NCT01651936|366106053|FG002|Base Study|Withdrawal by Subject|0|||
106122369|NCT01651936|366106051|FG000|Base Study|Early Escape|2|||
106122370|NCT01651936|366106052|FG001|Base Study|Early Escape|8|||
106122371|NCT01651936|366106053|FG002|Base Study|Early Escape|0|||
106122372|NCT01651936|366106051|FG000|Base Study|Study terminated by sponsor|21|||
106122373|NCT01651936|366106052|FG001|Base Study|Study terminated by sponsor|16|||
105892897|NCT00558896|365262384|FG005|Overall Study|Physician discretion|3|||
105996778|NCT04640311|365649496|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
105996779|NCT04640311|365649497|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
106122374|NCT01651936|366106053|FG002|Base Study|Study terminated by sponsor|0|||
106122375|NCT01651936|366106051|FG000|Extension Study|Lack of Efficacy|0|||
105892898|NCT00558896|365262385|FG006|Overall Study|Physician discretion|3|||
105892899|NCT00558896|365262379|FG000|Overall Study|Continues on treatment|10|||
105892900|NCT00558896|365262380|FG001|Overall Study|Continues on treatment|1|||
105892901|NCT00558896|365262381|FG002|Overall Study|Continues on treatment|0|||
105892902|NCT00558896|365262382|FG003|Overall Study|Continues on treatment|1|||
106122376|NCT01651936|366106052|FG001|Extension Study|Lack of Efficacy|0|||
106122377|NCT01651936|366106053|FG002|Extension Study|Lack of Efficacy|1|||
106122378|NCT01651936|366106051|FG000|Extension Study|Study terminated by sponsor|0|||
105892903|NCT00558896|365262383|FG004|Overall Study|Continues on treatment|9|||
105892904|NCT00558896|365262384|FG005|Overall Study|Continues on treatment|25|||
105892905|NCT00558896|365262385|FG006|Overall Study|Continues on treatment|6|||
105892906|NCT03536949|365262386|FG000|Overall Study|Adverse Event|4|||
105892907|NCT03536949|365262387|FG001|Overall Study|Adverse Event|0|||
105892908|NCT03536949|365262386|FG000|Overall Study|Lost to Follow-up|2|||
105892909|NCT03536949|365262387|FG001|Overall Study|Lost to Follow-up|1|||
105892910|NCT03536949|365262386|FG000|Overall Study|Withdrawal by Subject|6|||
105892911|NCT03536949|365262387|FG001|Overall Study|Withdrawal by Subject|0|||
105892912|NCT03536949|365262386|FG000|Overall Study|Non-compliance|2|||
105892913|NCT03536949|365262387|FG001|Overall Study|Non-compliance|1|||
105892914|NCT02457832|365262388|FG000|Training|Lost to Follow-up|10|||
105892915|NCT02457832|365262389|FG001|Training|Lost to Follow-up|6|||
105892916|NCT02457832|365262390|FG002|Training|Lost to Follow-up|3|||
105892917|NCT02457832|365262388|FG000|One Month Washout|Lost to Follow-up|0|||
105892918|NCT02457832|365262389|FG001|One Month Washout|Lost to Follow-up|1|||
105892919|NCT02457832|365262390|FG002|One Month Washout|Lost to Follow-up|1|||
105892920|NCT00250458|365262391|FG000|Overall Study|Lost to Follow-up|4|||
105892921|NCT00250458|365262392|FG001|Overall Study|Lost to Follow-up|2|||
105892922|NCT00250458|365262391|FG000|Overall Study|Protocol Violation|0|||
105892923|NCT00250458|365262392|FG001|Overall Study|Protocol Violation|1|||
105892924|NCT00250458|365262391|FG000|Overall Study|Withdrawal by Subject|4|||
105892925|NCT00250458|365262392|FG001|Overall Study|Withdrawal by Subject|2|||
105892926|NCT00250458|365262391|FG000|Overall Study|Lack of Migraine Attack|20|||
105892927|NCT00250458|365262392|FG001|Overall Study|Lack of Migraine Attack|9|||
105892928|NCT00250458|365262391|FG000|Overall Study|Qualifying migraine but did not treat|3|||
105892929|NCT00250458|365262392|FG001|Overall Study|Qualifying migraine but did not treat|3|||
105892930|NCT00250458|365262391|FG000|Overall Study|Other|1|||
105892931|NCT00250458|365262392|FG001|Overall Study|Other|0|||
105892932|NCT01459718|365262393|FG000|Overall Study|Physician Decision|1|||
105892933|NCT01459718|365262393|FG000|Overall Study|Lost to Follow-up|1|||
105892934|NCT01459718|365262393|FG000|Overall Study|Adverse Event|1|||
105892935|NCT01537068|365262399|FG000|Overall Study|Lost to Follow-up|2|||
105892936|NCT01537068|365262400|FG001|Overall Study|Lost to Follow-up|1|||
105892937|NCT01537068|365262399|FG000|Overall Study|Adverse Event|0|||
105892938|NCT01537068|365262400|FG001|Overall Study|Adverse Event|1|||
105892939|NCT01537068|365262399|FG000|Overall Study|Withdrawal by Subject|1|||
105892940|NCT01537068|365262400|FG001|Overall Study|Withdrawal by Subject|1|||
105892941|NCT01537068|365262399|FG000|Overall Study|Lack of Efficacy|1|||
105892942|NCT01537068|365262400|FG001|Overall Study|Lack of Efficacy|0|||
105892943|NCT00430352|365262401|FG000|Overall Study|Disease progression|58|||
105892944|NCT00430352|365262401|FG000|Overall Study|Withdrawal by Subject|11|||
105892945|NCT00430352|365262401|FG000|Overall Study|Adverse Event|16|||
105892946|NCT00430352|365262401|FG000|Overall Study|Death|5|||
105892947|NCT00430352|365262401|FG000|Overall Study|Other|48|||
105892948|NCT04326439|365262402|FG000|Overall Study|Withdrawal by Subject|1|||
105892949|NCT04326439|365262403|FG001|Overall Study|Withdrawal by Subject|0|||
105892950|NCT04326439|365262402|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
105892951|NCT04326439|365262403|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
105892952|NCT04326439|365262402|FG000|Overall Study|Relapse after Induction 2|0|||
105892953|NCT04326439|365262403|FG001|Overall Study|Relapse after Induction 2|1|||
105892954|NCT04326439|365262402|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
105892955|NCT04326439|365262403|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
105892956|NCT01793688|365262415|FG000|Overall Study|Protocol Violation|2|||
105892957|NCT01966068|365262416|FG000|Overall Study|Withdrawal by Subject|57|||
105892958|NCT01966068|365262416|FG000|Overall Study|Lost to Follow-up|81|||
105892959|NCT00102531|365262417|FG000|Overall Study|Adverse Event|0|||
105892960|NCT00102531|365262418|FG001|Overall Study|Adverse Event|1|||
105892961|NCT00102531|365262417|FG000|Overall Study|Disease Progression|5|||
105892962|NCT00102531|365262418|FG001|Overall Study|Disease Progression|9|||
105892963|NCT00102531|365262417|FG000|Overall Study|Physician Decision|0|||
105892964|NCT00102531|365262418|FG001|Overall Study|Physician Decision|1|||
105892965|NCT04216589|365262428|FG000|Overall Study|Withdrawal by Subject|2|||
105892966|NCT04216589|365262428|FG000|Overall Study|Protocol Violation|1|||
105892967|NCT04216589|365262428|FG000|Overall Study|Incarceration|1|||
105892968|NCT02326298|365262432|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892969|NCT02326298|365262433|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892970|NCT02326298|365262434|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
105892971|NCT02326298|365262435|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892972|NCT02326298|365262436|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892973|NCT02326298|365262437|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892974|NCT02326298|365262438|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892975|NCT02326298|365262439|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892976|NCT02326298|365262440|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892977|NCT02326298|365262441|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892978|NCT02326298|365262442|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892979|NCT02326298|365262443|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892980|NCT02326298|365262444|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892981|NCT02326298|365262445|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105892982|NCT02326298|365262432|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
105892983|NCT02326298|365262433|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892984|NCT02326298|365262434|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892985|NCT02326298|365262435|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892986|NCT02326298|365262436|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892987|NCT02326298|365262437|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892988|NCT02326298|365262438|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892989|NCT02326298|365262439|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892990|NCT02326298|365262440|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892991|NCT02326298|365262441|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892992|NCT02326298|365262442|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892993|NCT02326298|365262443|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892994|NCT02326298|365262444|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892995|NCT02326298|365262445|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
105892996|NCT02326298|365262432|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
105665382|NCT01948076|364438705|FG001|Overall Study|Withdrawal by Subject|1|||
105665383|NCT00475228|364438708|FG000|Overall Study|Lost to Follow-up|17|||
105665384|NCT00475228|364438709|FG001|Overall Study|Lost to Follow-up|17|||
105665385|NCT00738283|364438713|FG000|Overall Study|Death|1|||
105892997|NCT02326298|365262433|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
105892998|NCT02326298|365262434|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105892999|NCT02326298|365262435|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893000|NCT02326298|365262436|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893001|NCT02326298|365262437|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893002|NCT02326298|365262438|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893003|NCT02326298|365262439|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893004|NCT02326298|365262440|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893005|NCT02326298|365262441|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893006|NCT02326298|365262442|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893007|NCT02326298|365262443|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893008|NCT02326298|365262444|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893009|NCT02326298|365262445|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105893010|NCT02326298|365262432|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
105893011|NCT02326298|365262433|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
105893012|NCT02326298|365262434|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893013|NCT02326298|365262435|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893014|NCT02326298|365262436|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893015|NCT02326298|365262437|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893016|NCT02326298|365262438|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893017|NCT02326298|365262439|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893018|NCT02326298|365262440|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893019|NCT02326298|365262441|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893020|NCT02326298|365262442|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893021|NCT02326298|365262443|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893022|NCT02326298|365262444|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893023|NCT02326298|365262445|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105893024|NCT02326298|365262432|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893025|NCT02326298|365262433|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893026|NCT02326298|365262434|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
105893027|NCT02326298|365262435|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893028|NCT02326298|365262436|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893029|NCT02326298|365262437|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893030|NCT02326298|365262438|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893031|NCT02326298|365262439|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893032|NCT02326298|365262440|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893033|NCT02326298|365262441|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893034|NCT02326298|365262442|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105952039|NCT00527618|365488180|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
105952040|NCT00527618|365488181|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
105952041|NCT00527618|365488180|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
105665386|NCT00738283|364438713|FG000|Overall Study|Transfer to another facility|2|||
105893035|NCT02326298|365262443|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893036|NCT02326298|365262444|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893037|NCT02326298|365262445|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
105893038|NCT02326298|365262432|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893039|NCT02326298|365262433|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893040|NCT02326298|365262434|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893041|NCT02326298|365262435|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893042|NCT02326298|365262436|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893043|NCT02326298|365262437|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105893044|NCT02326298|365262438|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
105893045|NCT02326298|365262439|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105893046|NCT02326298|365262440|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105893047|NCT02326298|365262441|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105893048|NCT02326298|365262442|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893049|NCT02326298|365262443|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893050|NCT02326298|365262444|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893051|NCT02326298|365262445|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105893052|NCT02326298|365262432|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893053|NCT02326298|365262433|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893054|NCT02326298|365262434|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893055|NCT02326298|365262435|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893056|NCT02326298|365262436|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893057|NCT02326298|365262437|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
105893058|NCT02326298|365262438|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
105893059|NCT02326298|365262439|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893060|NCT02326298|365262440|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
105893061|NCT02326298|365262441|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893062|NCT02326298|365262442|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893063|NCT02326298|365262443|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893064|NCT02326298|365262444|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893065|NCT02326298|365262445|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
105893066|NCT02326298|365262432|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893067|NCT02326298|365262433|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893068|NCT02326298|365262434|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893069|NCT02326298|365262435|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893070|NCT02326298|365262436|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893071|NCT02326298|365262437|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
105893072|NCT02326298|365262438|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893073|NCT02326298|365262439|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893074|NCT02326298|365262440|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893075|NCT02326298|365262441|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893076|NCT02326298|365262442|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893077|NCT02326298|365262443|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893078|NCT02326298|365262444|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893079|NCT02326298|365262445|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
105893080|NCT02326298|365262432|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893081|NCT02326298|365262433|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893082|NCT02326298|365262434|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893083|NCT02326298|365262435|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893084|NCT02326298|365262436|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893085|NCT02326298|365262437|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893086|NCT02326298|365262438|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
105893087|NCT02326298|365262439|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893088|NCT02326298|365262440|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893089|NCT02326298|365262441|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893090|NCT02326298|365262442|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893091|NCT02326298|365262443|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893092|NCT02326298|365262444|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893093|NCT02326298|365262445|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105893094|NCT02326298|365262432|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893095|NCT02326298|365262433|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893096|NCT02326298|365262434|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893097|NCT02326298|365262435|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893098|NCT02326298|365262436|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893099|NCT02326298|365262437|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893100|NCT02326298|365262438|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893101|NCT02326298|365262439|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
105893102|NCT02326298|365262440|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893103|NCT02326298|365262441|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893104|NCT02326298|365262442|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893105|NCT02326298|365262443|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893106|NCT02326298|365262444|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893107|NCT02326298|365262445|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
105893108|NCT02326298|365262432|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893109|NCT02326298|365262433|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893110|NCT02326298|365262434|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893111|NCT02326298|365262435|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893112|NCT02326298|365262436|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893113|NCT02326298|365262437|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893114|NCT02326298|365262438|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
105893115|NCT02326298|365262439|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
105893116|NCT02326298|365262440|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893117|NCT02326298|365262441|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893118|NCT02326298|365262442|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893119|NCT02326298|365262443|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893120|NCT02326298|365262444|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893121|NCT02326298|365262445|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105893122|NCT02326298|365262432|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893123|NCT02326298|365262433|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893124|NCT02326298|365262434|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893125|NCT02326298|365262435|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893126|NCT02326298|365262436|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893127|NCT02326298|365262437|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893128|NCT02326298|365262438|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893129|NCT02326298|365262439|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
105893130|NCT02326298|365262440|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893131|NCT02326298|365262441|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893132|NCT02326298|365262442|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893133|NCT02326298|365262443|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893134|NCT02326298|365262444|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893135|NCT02326298|365262445|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105893136|NCT02326298|365262432|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893137|NCT02326298|365262433|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893138|NCT02326298|365262434|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893139|NCT02326298|365262435|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893140|NCT02326298|365262436|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893141|NCT02326298|365262437|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
105893142|NCT02326298|365262438|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893143|NCT02326298|365262439|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893144|NCT02326298|365262440|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893145|NCT02326298|365262441|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893146|NCT02326298|365262442|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893147|NCT02326298|365262443|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893148|NCT02326298|365262444|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893149|NCT02326298|365262445|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
105893150|NCT02326298|365262432|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
106122379|NCT01651936|366106052|FG001|Extension Study|Study terminated by sponsor|0|||
106122380|NCT01651936|366106053|FG002|Extension Study|Study terminated by sponsor|13|||
106122381|NCT03044353|366106057|FG000|Overall Study|Adverse Event|0|||
106122382|NCT03044353|366106058|FG001|Overall Study|Adverse Event|1|||
106122383|NCT03044353|366106059|FG002|Overall Study|Adverse Event|0|||
106122384|NCT02340520|366106070|FG000|Overall Study|Lost to Follow-up|1|||
106122385|NCT02340520|366106070|FG000|Overall Study|Patient did not take drug as specified|1|||
106122386|NCT02340520|366106070|FG000|Overall Study|Withdrawal by Subject|1|||
106122387|NCT05284019|366106071|FG000|Overall Study|Study terminated|2|||
106122388|NCT05284019|366106072|FG001|Overall Study|Study terminated|2|||
106122389|NCT05284019|366106073|FG002|Overall Study|Study terminated|2|||
106122390|NCT05284019|366106074|FG003|Overall Study|Study terminated|5|||
106122391|NCT05284019|366106075|FG004|Overall Study|Study terminated|15|||
106122392|NCT05284019|366106071|FG000|Overall Study|Withdrawal by Subject|0|||
105893151|NCT02326298|365262433|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
105893152|NCT02326298|365262434|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
106122393|NCT05284019|366106072|FG001|Overall Study|Withdrawal by Subject|0|||
105893153|NCT02326298|365262435|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
105893154|NCT02326298|365262436|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
105893155|NCT02326298|365262437|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
105893156|NCT02326298|365262438|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
105893157|NCT02326298|365262439|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
105893158|NCT02326298|365262440|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
105893159|NCT02326298|365262441|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
105893160|NCT02326298|365262442|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
105893161|NCT02326298|365262443|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
105893162|NCT02326298|365262444|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
105893163|NCT02326298|365262445|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
105893164|NCT02326298|365262432|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893165|NCT02326298|365262433|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893166|NCT02326298|365262434|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893167|NCT02326298|365262435|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893168|NCT02326298|365262436|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893169|NCT02326298|365262437|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893170|NCT02326298|365262438|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893171|NCT02326298|365262439|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893172|NCT02326298|365262440|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893173|NCT02326298|365262441|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893174|NCT02326298|365262442|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893175|NCT02326298|365262443|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
105893176|NCT02326298|365262444|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
105893177|NCT02326298|365262445|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105893178|NCT02326298|365262432|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893179|NCT02326298|365262433|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893180|NCT02326298|365262434|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893181|NCT02326298|365262435|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893182|NCT02326298|365262436|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893183|NCT02326298|365262437|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893184|NCT02326298|365262438|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893185|NCT02326298|365262439|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893186|NCT02326298|365262440|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893187|NCT02326298|365262441|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893188|NCT02326298|365262442|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893189|NCT02326298|365262443|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105893190|NCT02326298|365262444|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105893191|NCT02326298|365262445|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105893192|NCT02326298|365262432|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893193|NCT02326298|365262433|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893194|NCT02326298|365262434|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893195|NCT02326298|365262435|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893196|NCT02326298|365262436|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893197|NCT02326298|365262437|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893198|NCT02326298|365262438|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893199|NCT02326298|365262439|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893200|NCT02326298|365262440|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893201|NCT02326298|365262441|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893202|NCT02326298|365262442|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893203|NCT02326298|365262443|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893204|NCT02326298|365262444|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105893205|NCT02326298|365262445|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
105893206|NCT02326298|365262432|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893207|NCT02326298|365262433|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893208|NCT02326298|365262434|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893209|NCT02326298|365262435|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893210|NCT02326298|365262436|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893211|NCT02326298|365262437|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893212|NCT02326298|365262438|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893213|NCT02326298|365262439|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893214|NCT02326298|365262440|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893215|NCT02326298|365262441|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893216|NCT02326298|365262442|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105893217|NCT02326298|365262443|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
105893218|NCT02326298|365262444|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
105893219|NCT02326298|365262445|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
105893220|NCT02326298|365262432|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893221|NCT02326298|365262433|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893222|NCT02326298|365262434|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893223|NCT02326298|365262435|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893224|NCT02326298|365262436|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893225|NCT02326298|365262437|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893226|NCT02326298|365262438|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893227|NCT02326298|365262439|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893228|NCT02326298|365262440|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893229|NCT02326298|365262441|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893230|NCT02326298|365262442|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105893231|NCT02326298|365262443|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
105893232|NCT02326298|365262444|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
105893233|NCT02326298|365262445|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
105893234|NCT02326298|365262432|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893235|NCT02326298|365262433|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893236|NCT02326298|365262434|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893237|NCT02326298|365262435|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893238|NCT02326298|365262436|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893239|NCT02326298|365262437|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893240|NCT02326298|365262438|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893241|NCT02326298|365262439|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893242|NCT02326298|365262440|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893243|NCT02326298|365262441|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893244|NCT02326298|365262442|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105893245|NCT02326298|365262443|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
105893246|NCT02326298|365262444|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
105893247|NCT02326298|365262445|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
105893248|NCT01668966|365263940|FG000|Overall Study|Withdrawal by Subject|1|||
105893249|NCT01668966|365263940|FG000|Overall Study|Death|1|||
105893250|NCT01668966|365263940|FG000|Overall Study|Not treated|2|||
105893251|NCT04599933|365263942|FG000|Overall Study|Adverse Event|4|||
105893252|NCT04599933|365263943|FG001|Overall Study|Adverse Event|1|||
105893253|NCT04599933|365263942|FG000|Overall Study|Withdrawal by Subject|4|||
105893254|NCT04599933|365263943|FG001|Overall Study|Withdrawal by Subject|2|||
105893255|NCT04599933|365263942|FG000|Overall Study|Lost to Follow-up|0|||
105893256|NCT04599933|365263943|FG001|Overall Study|Lost to Follow-up|1|||
105893257|NCT04599933|365263942|FG000|Overall Study|Physician Decision|0|||
105893258|NCT04599933|365263943|FG001|Overall Study|Physician Decision|1|||
105893259|NCT04599933|365263942|FG000|Overall Study|Screen Failure|1|||
105893260|NCT04599933|365263943|FG001|Overall Study|Screen Failure|2|||
105893261|NCT04063657|365263944|FG000|Overall Study|Lost to Follow-up|1|||
105893262|NCT04063657|365263945|FG001|Overall Study|Lost to Follow-up|0|||
105893263|NCT03781583|365263947|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
105893264|NCT03781583|365263948|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
105893265|NCT03781583|365263949|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
105893266|NCT03781583|365263950|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
105893267|NCT03781583|365263947|FG000|Overall Study|Technology did not work for that person in that environment|1|||
105893268|NCT03781583|365263948|FG001|Overall Study|Technology did not work for that person in that environment|0|||
105893269|NCT03781583|365263949|FG002|Overall Study|Technology did not work for that person in that environment|0|||
105893270|NCT03781583|365263950|FG003|Overall Study|Technology did not work for that person in that environment|0|||
105893271|NCT03781583|365263947|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
105893272|NCT03781583|365263948|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
105893273|NCT03781583|365263949|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
105893274|NCT03781583|365263950|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
105893275|NCT03781583|365263947|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
105893276|NCT03781583|365263948|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
105893277|NCT03781583|365263949|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
105893278|NCT03781583|365263950|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
105893279|NCT01968707|365263951|FG000|Overall Study|Did not meet treatment day baseline|49|||
105893280|NCT01968707|365263952|FG001|Overall Study|Did not meet treatment day baseline|12|||
105893281|NCT01968707|365263953|FG002|Overall Study|Did not meet treatment day baseline|41|||
105893282|NCT01968707|365263954|FG003|Overall Study|Did not meet treatment day baseline|44|||
105893283|NCT01968707|365263955|FG004|Overall Study|Did not meet treatment day baseline|36|||
105893284|NCT01968707|365263956|FG005|Overall Study|Did not meet treatment day baseline|11|||
105893285|NCT01968707|365263957|FG006|Overall Study|Did not meet treatment day baseline|34|||
105893286|NCT01968707|365263958|FG007|Overall Study|Did not meet treatment day baseline|35|||
105893287|NCT00916344|365263959|FG000|Overall Study|Death|2|||
105893288|NCT00916344|365263959|FG000|Overall Study|ICD upgrade|1|||
105893289|NCT00916344|365263959|FG000|Overall Study|Drop-out|5|||
105893290|NCT02474589|365263960|FG000|Overall Study|Adverse Event|6|||
105893291|NCT02474589|365263961|FG001|Overall Study|Adverse Event|2|||
105893292|NCT02474589|365263960|FG000|Overall Study|Lost to Follow-up|6|||
105893293|NCT02474589|365263961|FG001|Overall Study|Lost to Follow-up|1|||
105893294|NCT02474589|365263960|FG000|Overall Study|Protocol Violation|4|||
105893295|NCT02474589|365263961|FG001|Overall Study|Protocol Violation|1|||
105893296|NCT02474589|365263960|FG000|Overall Study|Withdrawal by Subject|4|||
105893297|NCT02474589|365263961|FG001|Overall Study|Withdrawal by Subject|0|||
105893298|NCT02474589|365263960|FG000|Overall Study|Inability to complete study procedures|5|||
105893299|NCT02474589|365263961|FG001|Overall Study|Inability to complete study procedures|1|||
105893300|NCT00459706|365263962|FG000|Overall Study|Adverse Event|19|||
105893301|NCT00459706|365263963|FG001|Overall Study|Adverse Event|13|||
105893302|NCT00459706|365263962|FG000|Overall Study|Withdrawal by Subject|1|||
105893303|NCT00459706|365263963|FG001|Overall Study|Withdrawal by Subject|6|||
105893304|NCT00459706|365263962|FG000|Overall Study|Physician Decision|2|||
105893305|NCT00459706|365263963|FG001|Overall Study|Physician Decision|0|||
105893306|NCT00459706|365263962|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
105893307|NCT00459706|365263963|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105893308|NCT00459706|365263962|FG000|Overall Study|Protocol Violation|2|||
105893309|NCT00459706|365263963|FG001|Overall Study|Protocol Violation|1|||
105893310|NCT00459706|365263962|FG000|Overall Study|Failed to Return|1|||
105893311|NCT00459706|365263963|FG001|Overall Study|Failed to Return|0|||
105893312|NCT00459706|365263962|FG000|Overall Study|Other|0|||
105893313|NCT00459706|365263963|FG001|Overall Study|Other|1|||
105893314|NCT04329091|365263966|FG000|Overall Study|Physician Decision|5|||
105893315|NCT01801358|365263967|FG000|Overall Study|Adverse Event|0|||
105893316|NCT01801358|365263968|FG001|Overall Study|Adverse Event|2|||
105996780|NCT04640311|365649498|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105996781|NCT04640311|365649499|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
105996782|NCT04640311|365649500|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105996783|NCT04640311|365649501|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105996784|NCT04640311|365649502|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105996785|NCT04640311|365649503|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105996786|NCT04640311|365649504|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105996787|NCT04640311|365649505|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
105996788|NCT04640311|365649493|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996789|NCT04640311|365649494|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996790|NCT04640311|365649495|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996791|NCT04640311|365649496|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996792|NCT04640311|365649497|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996793|NCT04640311|365649498|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
105996794|NCT04640311|365649499|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996795|NCT04640311|365649500|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996796|NCT04640311|365649501|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
105996797|NCT04640311|365649502|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105665387|NCT00738283|364438713|FG000|Overall Study|Discharge home prior to end of study|1|||
105665388|NCT04463680|364438714|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
105665389|NCT04463680|364438714|FG000|Overall Study|Not eligible due to implant duration of use|1|||
105665390|NCT04463680|364438714|FG000|Overall Study|Withdrawal by Subject|3|||
105665391|NCT05239598|364438715|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
105665392|NCT05239598|364438716|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
105665393|NCT05239598|364438715|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
105665394|NCT05239598|364438716|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
105665395|NCT04124471|364438717|FG000|Overall Study|screen failure|1|||
105665396|NCT05226130|364438718|FG000|Overall Study|Lost to Follow-up|0|||
105665397|NCT05226130|364438719|FG001|Overall Study|Lost to Follow-up|1|||
105665398|NCT05226130|364438718|FG000|Overall Study|Not treatment adherent|0|||
105665399|NCT05226130|364438719|FG001|Overall Study|Not treatment adherent|2|||
105665400|NCT03358472|364438720|FG000|Overall Study|Death|6|||
105665401|NCT03358472|364438721|FG001|Overall Study|Death|3|||
105665402|NCT03358472|364438722|FG002|Overall Study|Death|10|||
105665403|NCT03358472|364438720|FG000|Overall Study|Physician Decision|0|||
105665404|NCT03358472|364438721|FG001|Overall Study|Physician Decision|1|||
105665405|NCT03358472|364438722|FG002|Overall Study|Physician Decision|0|||
105665406|NCT03358472|364438720|FG000|Overall Study|Withdrawal by Subject|0|||
105665407|NCT03358472|364438721|FG001|Overall Study|Withdrawal by Subject|0|||
105665408|NCT03358472|364438722|FG002|Overall Study|Withdrawal by Subject|1|||
105665409|NCT03358472|364438720|FG000|Overall Study|On-going at clinical cut off date|9|||
105665410|NCT03358472|364438721|FG001|Overall Study|On-going at clinical cut off date|6|||
105665411|NCT03358472|364438722|FG002|Overall Study|On-going at clinical cut off date|5|||
105665412|NCT00078377|364440732|FG000|Overall Study|Adverse Event|2|||
105665413|NCT00078377|364440733|FG001|Overall Study|Adverse Event|5|||
105665414|NCT00078377|364440734|FG002|Overall Study|Adverse Event|1|||
105665415|NCT00078377|364440732|FG000|Overall Study|Lack of Efficacy|2|||
105893317|NCT01801358|365263969|FG002|Overall Study|Adverse Event|1|||
105893318|NCT01801358|365263970|FG003|Overall Study|Adverse Event|0|||
105893319|NCT01801358|365263971|FG004|Overall Study|Adverse Event|0|||
105893320|NCT01801358|365263972|FG005|Overall Study|Adverse Event|1|||
105893321|NCT01801358|365263967|FG000|Overall Study|Physician Decision|0|||
105893322|NCT01801358|365263968|FG001|Overall Study|Physician Decision|0|||
105893323|NCT01801358|365263969|FG002|Overall Study|Physician Decision|1|||
105893324|NCT01801358|365263970|FG003|Overall Study|Physician Decision|0|||
105893325|NCT01801358|365263971|FG004|Overall Study|Physician Decision|0|||
105893326|NCT01801358|365263972|FG005|Overall Study|Physician Decision|0|||
105893327|NCT01801358|365263967|FG000|Overall Study|Progressive Disease|6|||
105893328|NCT01801358|365263968|FG001|Overall Study|Progressive Disease|4|||
105893329|NCT01801358|365263969|FG002|Overall Study|Progressive Disease|4|||
105893330|NCT01801358|365263970|FG003|Overall Study|Progressive Disease|5|||
105893331|NCT01801358|365263971|FG004|Overall Study|Progressive Disease|6|||
105893332|NCT01801358|365263972|FG005|Overall Study|Progressive Disease|5|||
105893333|NCT01801358|365263967|FG000|Overall Study|Withdrawal by Subject|0|||
105893334|NCT01801358|365263968|FG001|Overall Study|Withdrawal by Subject|0|||
105893335|NCT01801358|365263969|FG002|Overall Study|Withdrawal by Subject|0|||
105893336|NCT01801358|365263970|FG003|Overall Study|Withdrawal by Subject|1|||
105893337|NCT01801358|365263971|FG004|Overall Study|Withdrawal by Subject|0|||
105893338|NCT01801358|365263972|FG005|Overall Study|Withdrawal by Subject|2|||
105893339|NCT01527487|365263975|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
106122394|NCT05284019|366106073|FG002|Overall Study|Withdrawal by Subject|0|||
106122395|NCT05284019|366106074|FG003|Overall Study|Withdrawal by Subject|1|||
105893340|NCT01527487|365263976|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
106122396|NCT05284019|366106075|FG004|Overall Study|Withdrawal by Subject|1|||
106122397|NCT05284019|366106071|FG000|Overall Study|Lost to Follow-up|1|||
106122398|NCT05284019|366106072|FG001|Overall Study|Lost to Follow-up|0|||
106122399|NCT05284019|366106073|FG002|Overall Study|Lost to Follow-up|0|||
106122400|NCT05284019|366106074|FG003|Overall Study|Lost to Follow-up|2|||
106122401|NCT05284019|366106075|FG004|Overall Study|Lost to Follow-up|1|||
106122402|NCT02743793|366106076|FG000|Overall Study|Death|1|||
106122403|NCT02743793|366106077|FG001|Overall Study|Death|1|||
106122404|NCT02743793|366106076|FG000|Overall Study|Withdrawal by Subject|0|||
106122405|NCT02743793|366106077|FG001|Overall Study|Withdrawal by Subject|1|||
106122406|NCT02743793|366106076|FG000|Overall Study|Screen Failure|4|||
106122407|NCT02743793|366106077|FG001|Overall Study|Screen Failure|0|||
106122408|NCT02743793|366106076|FG000|Overall Study|No Primary Care Physician|0|||
106122409|NCT02743793|366106077|FG001|Overall Study|No Primary Care Physician|1|||
106122410|NCT02743793|366106076|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
105665416|NCT00078377|364440733|FG001|Overall Study|Lack of Efficacy|0|||
105893341|NCT01527487|365263975|FG000|Overall Study|Disease Progression|4|||
105893342|NCT01527487|365263976|FG001|Overall Study|Disease Progression|1|||
106122411|NCT02743793|366106077|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
106122412|NCT02743793|366106076|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
105665417|NCT00078377|364440734|FG002|Overall Study|Lack of Efficacy|2|||
105893343|NCT01527487|365263975|FG000|Overall Study|Adverse Event|1|||
105893344|NCT01527487|365263976|FG001|Overall Study|Adverse Event|1|||
105893345|NCT01527487|365263975|FG000|Overall Study|Death|0|||
105893346|NCT01527487|365263976|FG001|Overall Study|Death|1|||
105893347|NCT01210495|365263977|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
105893348|NCT01210495|365263978|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
105893349|NCT01210495|365263979|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
105893350|NCT01210495|365263980|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
105893351|NCT01210495|365263977|FG000|Overall Study|Death|14|||
105893352|NCT01210495|365263978|FG001|Overall Study|Death|7|||
105893353|NCT01210495|365263979|FG002|Overall Study|Death|112|||
105893354|NCT01210495|365263980|FG003|Overall Study|Death|54|||
105893355|NCT01210495|365263977|FG000|Overall Study|Study Terminated by Sponsor|0|||
105893356|NCT01210495|365263978|FG001|Overall Study|Study Terminated by Sponsor|0|||
105893357|NCT01210495|365263979|FG002|Overall Study|Study Terminated by Sponsor|4|||
105893358|NCT01210495|365263980|FG003|Overall Study|Study Terminated by Sponsor|11|||
105893359|NCT01210495|365263977|FG000|Overall Study|Lost to Follow-up|0|||
105893360|NCT01210495|365263978|FG001|Overall Study|Lost to Follow-up|0|||
105893361|NCT01210495|365263979|FG002|Overall Study|Lost to Follow-up|1|||
105893362|NCT01210495|365263980|FG003|Overall Study|Lost to Follow-up|1|||
105893363|NCT01210495|365263977|FG000|Overall Study|Other unspecified|0|||
105893364|NCT01210495|365263978|FG001|Overall Study|Other unspecified|0|||
105893365|NCT01210495|365263979|FG002|Overall Study|Other unspecified|6|||
105893366|NCT01210495|365263980|FG003|Overall Study|Other unspecified|0|||
105893367|NCT00723190|365263982|FG000|Overall Study|Withdrawal by Subject|45|||
105893368|NCT00723190|365263982|FG000|Overall Study|Lost to Follow-up|37|||
105893369|NCT00723190|365263982|FG000|Overall Study|Adverse Event|18|||
105893370|NCT00723190|365263982|FG000|Overall Study|Lack of Efficacy|16|||
105996798|NCT04640311|365649503|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996799|NCT04640311|365649504|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996800|NCT04640311|365649505|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
105996801|NCT04640311|365649493|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996802|NCT04640311|365649494|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996803|NCT04640311|365649495|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996804|NCT04640311|365649496|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996805|NCT04640311|365649497|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996806|NCT04640311|365649498|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996807|NCT04640311|365649499|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
105996808|NCT04640311|365649500|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996809|NCT04640311|365649501|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996810|NCT04640311|365649502|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996811|NCT04640311|365649503|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
105996812|NCT04640311|365649504|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996813|NCT04640311|365649505|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
105996814|NCT04640311|365649493|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996815|NCT04640311|365649494|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996816|NCT04640311|365649495|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996817|NCT04640311|365649496|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996818|NCT04640311|365649497|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996819|NCT04640311|365649498|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996820|NCT04640311|365649499|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996821|NCT04640311|365649500|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996822|NCT04640311|365649501|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996823|NCT04640311|365649502|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996824|NCT04640311|365649503|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996825|NCT04640311|365649504|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
105996826|NCT04640311|365649505|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
105996827|NCT00950846|365649506|FG000|Overall Study|Death|6|||
105996828|NCT00950846|365649506|FG000|Overall Study|Lost to Follow-up|3|||
105996829|NCT00950846|365649506|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
105996830|NCT00587158|365649507|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
105996831|NCT00587158|365649508|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
105996832|NCT00587158|365649507|FG000|Overall Study|Physician Decision|0|||
105996833|NCT00587158|365649508|FG001|Overall Study|Physician Decision|1|||
105996834|NCT00587158|365649507|FG000|Overall Study|Lost to Follow-up|1|||
105996835|NCT00587158|365649508|FG001|Overall Study|Lost to Follow-up|2|||
105996836|NCT00587158|365649507|FG000|Overall Study|Death|0|||
105996837|NCT00587158|365649508|FG001|Overall Study|Death|1|||
105893371|NCT00723190|365263982|FG000|Overall Study|Protocol Violation|15|||
105893372|NCT00723190|365263982|FG000|Overall Study|Other-Premature Discontinuation|9|||
105996838|NCT00587158|365649507|FG000|Overall Study|Subject did not want to take study med|0|||
105893373|NCT00723190|365263982|FG000|Overall Study|Other-Not included in safety population|2|||
105893374|NCT00454818|365263983|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
105893375|NCT00454818|365263984|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
105893376|NCT00454818|365263985|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
105893377|NCT00454818|365263986|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
105893378|NCT00454818|365263987|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
105893379|NCT00454818|365263983|FG000|Phase I: Open-label Dose-escalation|Death|0|||
105893380|NCT00454818|365263984|FG001|Phase I: Open-label Dose-escalation|Death|1|||
105893381|NCT00454818|365263985|FG002|Phase I: Open-label Dose-escalation|Death|0|||
105893382|NCT00454818|365263986|FG003|Phase I: Open-label Dose-escalation|Death|0|||
105893383|NCT00454818|365263987|FG004|Phase I: Open-label Dose-escalation|Death|0|||
105893384|NCT00454818|365263983|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
105893385|NCT00454818|365263984|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
105893386|NCT00454818|365263985|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
105893387|NCT00454818|365263986|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
105893388|NCT00454818|365263987|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
105893389|NCT00454818|365263983|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
105893390|NCT00454818|365263984|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
105893391|NCT00454818|365263985|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
105893392|NCT00454818|365263986|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
105893393|NCT00454818|365263987|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
105893394|NCT00454818|365263983|FG000|Phase 2: Randomized Double-blind|Death|0|||
105893395|NCT00454818|365263984|FG001|Phase 2: Randomized Double-blind|Death|1|||
105893396|NCT00454818|365263985|FG002|Phase 2: Randomized Double-blind|Death|0|||
105893397|NCT00454818|365263986|FG003|Phase 2: Randomized Double-blind|Death|0|||
105893398|NCT00454818|365263987|FG004|Phase 2: Randomized Double-blind|Death|1|||
105893399|NCT00454818|365263983|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
105893400|NCT00454818|365263984|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
105893401|NCT00454818|365263985|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
105893402|NCT00454818|365263986|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
105893403|NCT00454818|365263987|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
105893404|NCT00454818|365263983|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
105893405|NCT00454818|365263984|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
105893406|NCT00454818|365263985|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
105893407|NCT00454818|365263986|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
105893408|NCT00454818|365263987|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
105893409|NCT04416737|365263988|FG000|Week 1 (First Injection)|Physician Decision|0|||
105893410|NCT04416737|365263989|FG001|Week 1 (First Injection)|Physician Decision|1|||
105893411|NCT03332628|365263990|FG000|Overall Study|Physician Decision|2|||
105893412|NCT04489381|365263991|FG000|Overall Study|Lost to Follow-up|2|||
105893413|NCT04489381|365263992|FG001|Overall Study|Lost to Follow-up|3|||
105893414|NCT04489381|365263991|FG000|Overall Study|Withdrawal by Subject|1|||
105893415|NCT04489381|365263992|FG001|Overall Study|Withdrawal by Subject|0|||
105893416|NCT02505334|365263993|FG000|Main Treatment Period|Adverse Event|3|||
105893417|NCT02505334|365263994|FG001|Main Treatment Period|Adverse Event|3|||
105893418|NCT02505334|365263993|FG000|Main Treatment Period|Lack of Efficacy|7|||
105893419|NCT02505334|365263994|FG001|Main Treatment Period|Lack of Efficacy|17|||
105893420|NCT02505334|365263993|FG000|Main Treatment Period|Protocol Violation|0|||
105893421|NCT02505334|365263994|FG001|Main Treatment Period|Protocol Violation|1|||
105893422|NCT02505334|365263993|FG000|Main Treatment Period|Withdrawal by Subject|1|||
105893423|NCT02505334|365263994|FG001|Main Treatment Period|Withdrawal by Subject|8|||
105893424|NCT02505334|365263993|FG000|Main Treatment Period|Unclassified|4|||
105893425|NCT02505334|365263994|FG001|Main Treatment Period|Unclassified|10|||
105893426|NCT02505334|365263993|FG000|Extension Treatment Period|Adverse Event|5|||
105893427|NCT02505334|365263994|FG001|Extension Treatment Period|Adverse Event|0|||
105893428|NCT02505334|365263993|FG000|Extension Treatment Period|Lack of Efficacy|4|||
105893429|NCT02505334|365263994|FG001|Extension Treatment Period|Lack of Efficacy|0|||
105893430|NCT02505334|365263993|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
105893431|NCT02505334|365263994|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105893432|NCT02505334|365263993|FG000|Extension Treatment Period|Unclassified|3|||
105893433|NCT02505334|365263994|FG001|Extension Treatment Period|Unclassified|0|||
105996839|NCT00587158|365649508|FG001|Overall Study|Subject did not want to take study med|1|||
105996840|NCT02517541|365649509|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
105996841|NCT02517541|365649509|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
105996842|NCT02517541|365649509|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
106122413|NCT02743793|366106077|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
105665418|NCT00078377|364440732|FG000|Overall Study|Lost to Follow-up|0|||
106122414|NCT01146574|366106080|FG000|Overall Study|Death|0|||
106122415|NCT01146574|366106081|FG001|Overall Study|Death|1|||
106122416|NCT01146574|366106082|FG002|Overall Study|Death|1|||
106122417|NCT01146574|366106083|FG003|Overall Study|Death|0|||
106122418|NCT01146574|366106084|FG004|Overall Study|Death|0|||
106122419|NCT01146574|366106085|FG005|Overall Study|Death|0|||
106122420|NCT01146574|366106086|FG006|Overall Study|Death|0|||
105665419|NCT00078377|364440733|FG001|Overall Study|Lost to Follow-up|1|||
105665420|NCT00078377|364440734|FG002|Overall Study|Lost to Follow-up|1|||
105665421|NCT00078377|364440732|FG000|Overall Study|Physician Decision|2|||
105665422|NCT00078377|364440733|FG001|Overall Study|Physician Decision|0|||
105665423|NCT00078377|364440734|FG002|Overall Study|Physician Decision|0|||
105665424|NCT00078377|364440732|FG000|Overall Study|Withdrawal by Subject|3|||
105665425|NCT00078377|364440733|FG001|Overall Study|Withdrawal by Subject|4|||
105893434|NCT01549041|365263997|FG000|Overall Study|Lack of Efficacy|2|||
105893435|NCT01549041|365263998|FG001|Overall Study|Lack of Efficacy|4|||
105893436|NCT01549041|365263997|FG000|Overall Study|Adverse Event|0|||
105893437|NCT01549041|365263998|FG001|Overall Study|Adverse Event|4|||
105893438|NCT02939716|365264001|FG000|Overall Study|scanner failure|0|||
105893439|NCT02939716|365264002|FG001|Overall Study|scanner failure|0|||
105893440|NCT02939716|365264003|FG002|Overall Study|scanner failure|0|||
105893441|NCT02939716|365264004|FG003|Overall Study|scanner failure|1|||
105893442|NCT02939716|365264005|FG004|Overall Study|scanner failure|1|||
105893443|NCT02939716|365264006|FG005|Overall Study|scanner failure|1|||
105893444|NCT02543892|365264012|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
105893445|NCT02543892|365264013|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
105893446|NCT02543892|365264014|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
105893447|NCT02543892|365264015|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
105893448|NCT02543892|365264016|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
105893449|NCT02543892|365264017|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
105893450|NCT02543892|365264018|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
105893451|NCT02543892|365264019|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
105893452|NCT02543892|365264012|FG000|Received Vaccination 2|Physician Decision|0|||
105893453|NCT02543892|365264013|FG001|Received Vaccination 2|Physician Decision|0|||
105893454|NCT02543892|365264014|FG002|Received Vaccination 2|Physician Decision|0|||
105893455|NCT02543892|365264015|FG003|Received Vaccination 2|Physician Decision|0|||
105893456|NCT02543892|365264016|FG004|Received Vaccination 2|Physician Decision|0|||
105893457|NCT02543892|365264017|FG005|Received Vaccination 2|Physician Decision|1|||
105893458|NCT02543892|365264018|FG006|Received Vaccination 2|Physician Decision|0|||
105893459|NCT02543892|365264019|FG007|Received Vaccination 2|Physician Decision|0|||
105893460|NCT02543892|365264012|FG000|Received Vaccination 2|Adverse Event|0|||
105893461|NCT02543892|365264013|FG001|Received Vaccination 2|Adverse Event|1|||
105893462|NCT02543892|365264014|FG002|Received Vaccination 2|Adverse Event|0|||
105893463|NCT02543892|365264015|FG003|Received Vaccination 2|Adverse Event|0|||
105893464|NCT02543892|365264016|FG004|Received Vaccination 2|Adverse Event|0|||
105893465|NCT02543892|365264017|FG005|Received Vaccination 2|Adverse Event|0|||
105893466|NCT02543892|365264018|FG006|Received Vaccination 2|Adverse Event|0|||
105893467|NCT02543892|365264019|FG007|Received Vaccination 2|Adverse Event|0|||
105893468|NCT02543892|365264012|FG000|Had Immunology Data|Withdrawal by Subject|0|||
105893469|NCT02543892|365264013|FG001|Had Immunology Data|Withdrawal by Subject|0|||
105893470|NCT02543892|365264014|FG002|Had Immunology Data|Withdrawal by Subject|0|||
105893471|NCT02543892|365264015|FG003|Had Immunology Data|Withdrawal by Subject|0|||
105893472|NCT02543892|365264016|FG004|Had Immunology Data|Withdrawal by Subject|0|||
105893473|NCT02543892|365264017|FG005|Had Immunology Data|Withdrawal by Subject|0|||
105893474|NCT02543892|365264018|FG006|Had Immunology Data|Withdrawal by Subject|1|||
105893475|NCT02543892|365264019|FG007|Had Immunology Data|Withdrawal by Subject|0|||
105893476|NCT00785213|365264020|FG000|Quinine Sulfate Alone|Adverse Event|4|||
105893477|NCT00785213|365264020|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
105893478|NCT01259375|365264021|FG000|Overall Study|Adverse Event|1|||
105893479|NCT01043705|365264024|FG000|Overall Study|Death|28|||
105893480|NCT01043705|365264025|FG001|Overall Study|Death|60|||
105893481|NCT01043705|365264026|FG002|Overall Study|Death|26|||
105893482|NCT01043705|365264024|FG000|Overall Study|Lost to Follow-up|27|||
105893483|NCT01043705|365264025|FG001|Overall Study|Lost to Follow-up|12|||
105893484|NCT01043705|365264026|FG002|Overall Study|Lost to Follow-up|0|||
105893485|NCT01043705|365264024|FG000|Overall Study|Multiple Reasons|4|||
105893486|NCT01043705|365264025|FG001|Overall Study|Multiple Reasons|7|||
105893487|NCT01043705|365264026|FG002|Overall Study|Multiple Reasons|0|||
105893488|NCT01043705|365264024|FG000|Overall Study|Protocol Violation|2|||
105893489|NCT01043705|365264025|FG001|Overall Study|Protocol Violation|1|||
105893490|NCT01043705|365264026|FG002|Overall Study|Protocol Violation|0|||
105893491|NCT01043705|365264024|FG000|Overall Study|Withdrawal by Subject|8|||
105893492|NCT01043705|365264025|FG001|Overall Study|Withdrawal by Subject|6|||
105893493|NCT01043705|365264026|FG002|Overall Study|Withdrawal by Subject|0|||
105893494|NCT01043705|365264024|FG000|Overall Study|Site Closure|8|||
105893495|NCT01043705|365264025|FG001|Overall Study|Site Closure|0|||
105893496|NCT01043705|365264026|FG002|Overall Study|Site Closure|0|||
106122421|NCT01146574|366106080|FG000|Overall Study|Other reasons|0|||
105665426|NCT00078377|364440734|FG002|Overall Study|Withdrawal by Subject|4|||
105665427|NCT00078377|364440732|FG000|Overall Study|Miscellaneous|2|||
105665428|NCT00078377|364440733|FG001|Overall Study|Miscellaneous|6|||
105665429|NCT00078377|364440734|FG002|Overall Study|Miscellaneous|1|||
105665430|NCT02568397|364440735|FG000|Period 2|Withdrawal by Subject|0|||
105665431|NCT02568397|364440736|FG001|Period 2|Withdrawal by Subject|1|||
106122422|NCT01146574|366106081|FG001|Overall Study|Other reasons|0|||
106122423|NCT01146574|366106082|FG002|Overall Study|Other reasons|3|||
106122424|NCT01146574|366106083|FG003|Overall Study|Other reasons|0|||
106122425|NCT01146574|366106084|FG004|Overall Study|Other reasons|0|||
105665432|NCT02568397|364440735|FG000|Period 2|Physician Decision|0|||
105785967|NCT03735849|364870420|FG001|Overall Study|Participant unable to adhere to visit|0|||
106122426|NCT01146574|366106085|FG005|Overall Study|Other reasons|0|||
105785968|NCT03735849|364870421|FG002|Overall Study|Participant unable to adhere to visit|0|||
105785969|NCT03735849|364870419|FG000|Overall Study|Not Randomized|0|||
105785970|NCT03735849|364870420|FG001|Overall Study|Not Randomized|0|||
105785971|NCT03735849|364870421|FG002|Overall Study|Not Randomized|4|||
106122427|NCT01146574|366106086|FG006|Overall Study|Other reasons|0|||
106122428|NCT01146574|366106080|FG000|Overall Study|Kidney transplant|0|||
106122429|NCT01146574|366106081|FG001|Overall Study|Kidney transplant|0|||
106122430|NCT01146574|366106082|FG002|Overall Study|Kidney transplant|1|||
106122431|NCT01146574|366106083|FG003|Overall Study|Kidney transplant|1|||
106122432|NCT01146574|366106084|FG004|Overall Study|Kidney transplant|0|||
106122433|NCT01146574|366106085|FG005|Overall Study|Kidney transplant|0|||
106122434|NCT01146574|366106086|FG006|Overall Study|Kidney transplant|0|||
106122435|NCT01146574|366106080|FG000|Overall Study|Withdrew consent|0|||
106122436|NCT01146574|366106081|FG001|Overall Study|Withdrew consent|0|||
106122437|NCT01146574|366106082|FG002|Overall Study|Withdrew consent|1|||
106122438|NCT01146574|366106083|FG003|Overall Study|Withdrew consent|1|||
106122439|NCT01146574|366106084|FG004|Overall Study|Withdrew consent|2|||
106122440|NCT01146574|366106085|FG005|Overall Study|Withdrew consent|1|||
106122441|NCT01146574|366106086|FG006|Overall Study|Withdrew consent|1|||
106122442|NCT01076088|366106089|FG000|Overall Study|Adverse Event|1|||
106122443|NCT01076088|366106090|FG001|Overall Study|Adverse Event|6|||
106122444|NCT01076088|366106091|FG002|Overall Study|Adverse Event|3|||
106122445|NCT01076088|366106092|FG003|Overall Study|Adverse Event|2|||
106122446|NCT01076088|366106093|FG004|Overall Study|Adverse Event|3|||
106122447|NCT01076088|366106094|FG005|Overall Study|Adverse Event|3|||
106122448|NCT01076088|366106089|FG000|Overall Study|Lost to Follow-up|1|||
106122449|NCT01076088|366106090|FG001|Overall Study|Lost to Follow-up|1|||
106122450|NCT01076088|366106091|FG002|Overall Study|Lost to Follow-up|0|||
106122451|NCT01076088|366106092|FG003|Overall Study|Lost to Follow-up|1|||
106122452|NCT01076088|366106093|FG004|Overall Study|Lost to Follow-up|1|||
106122453|NCT01076088|366106094|FG005|Overall Study|Lost to Follow-up|2|||
106122454|NCT01076088|366106089|FG000|Overall Study|Non-compliance with study drug|0|||
106122455|NCT01076088|366106090|FG001|Overall Study|Non-compliance with study drug|0|||
106122456|NCT01076088|366106091|FG002|Overall Study|Non-compliance with study drug|0|||
106122457|NCT01076088|366106092|FG003|Overall Study|Non-compliance with study drug|1|||
106122458|NCT01076088|366106093|FG004|Overall Study|Non-compliance with study drug|0|||
106122459|NCT01076088|366106094|FG005|Overall Study|Non-compliance with study drug|0|||
106122460|NCT01076088|366106089|FG000|Overall Study|Physician Decision|1|||
106122461|NCT01076088|366106090|FG001|Overall Study|Physician Decision|3|||
106122462|NCT01076088|366106091|FG002|Overall Study|Physician Decision|0|||
106122463|NCT01076088|366106092|FG003|Overall Study|Physician Decision|1|||
106122464|NCT01076088|366106093|FG004|Overall Study|Physician Decision|1|||
106122465|NCT01076088|366106094|FG005|Overall Study|Physician Decision|0|||
106122466|NCT01076088|366106089|FG000|Overall Study|Withdrawal by Subject|8|||
106122467|NCT01076088|366106090|FG001|Overall Study|Withdrawal by Subject|8|||
106122468|NCT01076088|366106091|FG002|Overall Study|Withdrawal by Subject|14|||
106122469|NCT01076088|366106092|FG003|Overall Study|Withdrawal by Subject|10|||
106122470|NCT01076088|366106093|FG004|Overall Study|Withdrawal by Subject|11|||
106122471|NCT01076088|366106094|FG005|Overall Study|Withdrawal by Subject|17|||
106122472|NCT01076088|366106089|FG000|Overall Study|Other protocol specified criteria|0|||
106122473|NCT01076088|366106090|FG001|Overall Study|Other protocol specified criteria|0|||
106122474|NCT01076088|366106091|FG002|Overall Study|Other protocol specified criteria|0|||
106122475|NCT01076088|366106092|FG003|Overall Study|Other protocol specified criteria|0|||
106122476|NCT01076088|366106093|FG004|Overall Study|Other protocol specified criteria|0|||
106122477|NCT01076088|366106094|FG005|Overall Study|Other protocol specified criteria|1|||
106122478|NCT03053492|366106095|FG000|Overall Study|Adverse Event|1|||
106122479|NCT03053492|366106096|FG001|Overall Study|Adverse Event|1|||
106122480|NCT03053492|366106095|FG000|Overall Study|Withdrawal by Subject|7|||
106122481|NCT03053492|366106096|FG001|Overall Study|Withdrawal by Subject|5|||
106122482|NCT00786474|366106097|FG000|Overall Study|Death|5|||
106122483|NCT00786474|366106098|FG001|Overall Study|Death|4|||
106122484|NCT00786474|366106097|FG000|Overall Study|Withdrawal by Subject|23|||
106122485|NCT00786474|366106098|FG001|Overall Study|Withdrawal by Subject|31|||
105893497|NCT01043705|365264024|FG000|Overall Study|Subsequent Procedure|9|||
105893498|NCT01043705|365264025|FG001|Overall Study|Subsequent Procedure|24|||
105893499|NCT01043705|365264026|FG002|Overall Study|Subsequent Procedure|29|||
105893500|NCT01043705|365264024|FG000|Overall Study|Adverse Event|0|||
105893501|NCT01043705|365264025|FG001|Overall Study|Adverse Event|2|||
105893502|NCT01043705|365264026|FG002|Overall Study|Adverse Event|0|||
105893503|NCT01043705|365264024|FG000|Overall Study|Screen Fail|21|||
105893504|NCT01043705|365264025|FG001|Overall Study|Screen Fail|0|||
105893505|NCT01043705|365264026|FG002|Overall Study|Screen Fail|0|||
105893506|NCT01043705|365264024|FG000|Overall Study|Other|0|||
105893507|NCT01043705|365264025|FG001|Overall Study|Other|19|||
105893508|NCT01043705|365264026|FG002|Overall Study|Other|25|||
105893509|NCT01195844|365264031|FG000|Overall Study|Fecal sample not collected|40|||
105893510|NCT00581542|365264032|FG000|Overall Study|they met an exclusion criteria|2|||
105893511|NCT00581542|365264033|FG001|Overall Study|they met an exclusion criteria|2|||
105893512|NCT00581542|365264032|FG000|Overall Study|Lost to Follow-up|9|||
105893513|NCT00581542|365264033|FG001|Overall Study|Lost to Follow-up|21|||
105893514|NCT00551161|365264034|FG000|Overall Study|Withdrawal by Subject|1|||
105893515|NCT03301844|365264035|FG000|Overall Study|suspected colon cancer|1|||
105893516|NCT03301844|365264036|FG001|Overall Study|suspected colon cancer|1|||
105893517|NCT06011161|365264040|FG000|Overall Study|Withdrawal by Subject|2|||
105893518|NCT06011161|365264040|FG000|Overall Study|Lost to Follow-up|5|||
105893519|NCT00381043|365264044|FG000|Overall Study|Lost to Follow-up|8|||
105893520|NCT00381043|365264045|FG001|Overall Study|Lost to Follow-up|6|||
105893521|NCT00381043|365264044|FG000|Overall Study|Withdrawal by Subject|3|||
105893522|NCT00381043|365264045|FG001|Overall Study|Withdrawal by Subject|1|||
105893523|NCT00381043|365264044|FG000|Overall Study|wanted more care|0|||
105893524|NCT00381043|365264045|FG001|Overall Study|wanted more care|1|||
105893525|NCT00381043|365264044|FG000|Overall Study|incarcerated|1|||
105893526|NCT00381043|365264045|FG001|Overall Study|incarcerated|0|||
105893527|NCT03379753|365264046|FG000|Overall Study|Withdrawal by Subject|2|||
105893528|NCT03379753|365264047|FG001|Overall Study|Withdrawal by Subject|1|||
105893529|NCT03379753|365264046|FG000|Overall Study|not having correct procedure|1|||
105893530|NCT03379753|365264047|FG001|Overall Study|not having correct procedure|2|||
105893531|NCT03379753|365264046|FG000|Overall Study|No primary outcome|12|||
105893532|NCT03379753|365264047|FG001|Overall Study|No primary outcome|22|||
105893533|NCT02225366|365264048|FG000|Overall Study|Lack of Efficacy|1|||
105893534|NCT02225366|365264049|FG001|Overall Study|Lack of Efficacy|0|||
105893535|NCT01382225|365264050|FG000|Overall Study|Adverse Event|3|||
105893536|NCT01382225|365264051|FG001|Overall Study|Adverse Event|2|||
105893537|NCT01382225|365264050|FG000|Overall Study|Protocol Violation|2|||
105893538|NCT01382225|365264051|FG001|Overall Study|Protocol Violation|1|||
105893539|NCT01382225|365264050|FG000|Overall Study|Subject Withdrew Consent|5|||
105893540|NCT01382225|365264051|FG001|Overall Study|Subject Withdrew Consent|2|||
105893541|NCT01382225|365264050|FG000|Overall Study|Other|4|||
105893542|NCT01382225|365264051|FG001|Overall Study|Other|2|||
105893543|NCT00622336|365264052|FG000|Treatment Phase|Progression of Disease|181|||
105893544|NCT00622336|365264052|FG000|Treatment Phase|Adverse Event|46|||
105893545|NCT00622336|365264052|FG000|Treatment Phase|Other|40|||
105893546|NCT00622336|365264052|FG000|Treatment Phase|Death|14|||
105893547|NCT00622336|365264052|FG000|Treatment Phase|Lack of therapeutic effect|13|||
105996843|NCT02517541|365649509|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
105996844|NCT02517541|365649509|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
105996845|NCT02517541|365649509|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
106122486|NCT00786474|366106097|FG000|Overall Study|Lost to Follow-up|3|||
105893548|NCT00622336|365264052|FG000|Treatment Phase|Withdrawal by Subject|13|||
105893549|NCT00622336|365264052|FG000|Treatment Phase|Lost to Follow-up|2|||
105893550|NCT00622336|365264052|FG000|Extension Phase|Adverse Event|2|||
105893551|NCT00622336|365264052|FG000|Extension Phase|Progressive Disease|6|||
105893552|NCT00622336|365264052|FG000|Extension Phase|Lack of therapeutic effect|2|||
105893553|NCT00622336|365264052|FG000|Extension Phase|Withdrawal by Subject|1|||
105893554|NCT00622336|365264052|FG000|Extension Phase|Lost to Follow-up|1|||
105893555|NCT00622336|365264052|FG000|Extension Phase|Other|9|||
105893556|NCT04450407|365264053|FG000|Overall Study|Withdrawal by Subject|10|||
105893557|NCT04450407|365264054|FG001|Overall Study|Withdrawal by Subject|1|||
105893558|NCT04450407|365264055|FG002|Overall Study|Withdrawal by Subject|4|||
105893559|NCT04450407|365264053|FG000|Overall Study|Adverse Event|0|||
105893560|NCT04450407|365264054|FG001|Overall Study|Adverse Event|0|||
106122487|NCT00786474|366106098|FG001|Overall Study|Lost to Follow-up|3|||
106122488|NCT00786474|366106097|FG000|Overall Study|Physician Decision|2|||
106122489|NCT00786474|366106098|FG001|Overall Study|Physician Decision|1|||
106122490|NCT00786474|366106097|FG000|Overall Study|Other|4|||
106122491|NCT00786474|366106098|FG001|Overall Study|Other|4|||
106122492|NCT01868074|366106099|FG000|Overall Study|Lost to Follow-up|3|||
106122493|NCT01868074|366106100|FG001|Overall Study|Lost to Follow-up|2|||
105893561|NCT04450407|365264055|FG002|Overall Study|Adverse Event|1|||
105893562|NCT04450407|365264053|FG000|Overall Study|Lost to Follow-up|1|||
106122494|NCT01868074|366106099|FG000|Overall Study|Withdrawal by Subject|4|||
105893563|NCT04450407|365264054|FG001|Overall Study|Lost to Follow-up|0|||
105893564|NCT04450407|365264055|FG002|Overall Study|Lost to Follow-up|0|||
105893565|NCT04450407|365264053|FG000|Overall Study|Physician Decision|0|||
105893566|NCT04450407|365264054|FG001|Overall Study|Physician Decision|0|||
105893567|NCT04450407|365264055|FG002|Overall Study|Physician Decision|1|||
105893568|NCT04450407|365264053|FG000|Overall Study|Pregnancy|1|||
105893569|NCT04450407|365264054|FG001|Overall Study|Pregnancy|0|||
105893570|NCT04450407|365264055|FG002|Overall Study|Pregnancy|0|||
105893571|NCT04450407|365264053|FG000|Overall Study|Protocol Violation|2|||
105893572|NCT04450407|365264054|FG001|Overall Study|Protocol Violation|0|||
105893573|NCT04450407|365264055|FG002|Overall Study|Protocol Violation|0|||
105893574|NCT04450407|365264053|FG000|Overall Study|Investigational site terminated by sponsor|3|||
105893575|NCT04450407|365264054|FG001|Overall Study|Investigational site terminated by sponsor|0|||
105893576|NCT04450407|365264055|FG002|Overall Study|Investigational site terminated by sponsor|2|||
105893577|NCT00721279|365264057|FG000|Overall Study|Lack of Efficacy|6|||
105893578|NCT00721279|365264058|FG001|Overall Study|Lack of Efficacy|3|||
105893579|NCT00721279|365264057|FG000|Overall Study|Tolerability insufficient|5|||
105893580|NCT00721279|365264058|FG001|Overall Study|Tolerability insufficient|2|||
105893581|NCT00721279|365264057|FG000|Overall Study|Withdrawal by Subject|13|||
105893582|NCT00721279|365264058|FG001|Overall Study|Withdrawal by Subject|3|||
105893583|NCT00721279|365264057|FG000|Overall Study|Other|12|||
105893584|NCT00721279|365264058|FG001|Overall Study|Other|16|||
105893585|NCT02089334|365264059|FG000|Overall Study|Withdrawal by Subject|0|||
105893586|NCT02089334|365264060|FG001|Overall Study|Withdrawal by Subject|0|||
105893587|NCT02089334|365264061|FG002|Overall Study|Withdrawal by Subject|0|||
105893588|NCT02089334|365264062|FG003|Overall Study|Withdrawal by Subject|2|||
105893589|NCT02089334|365264059|FG000|Overall Study|Adverse Event|0|||
105893590|NCT02089334|365264060|FG001|Overall Study|Adverse Event|0|||
105893591|NCT02089334|365264061|FG002|Overall Study|Adverse Event|0|||
105893592|NCT02089334|365264062|FG003|Overall Study|Adverse Event|2|||
105893593|NCT02089334|365264059|FG000|Overall Study|Progressive disease|0|||
105893594|NCT02089334|365264060|FG001|Overall Study|Progressive disease|0|||
105893595|NCT02089334|365264061|FG002|Overall Study|Progressive disease|0|||
105893596|NCT02089334|365264062|FG003|Overall Study|Progressive disease|2|||
105893597|NCT02089334|365264059|FG000|Overall Study|Physician Decision|0|||
105893598|NCT02089334|365264060|FG001|Overall Study|Physician Decision|0|||
105893599|NCT02089334|365264061|FG002|Overall Study|Physician Decision|1|||
105893600|NCT02089334|365264062|FG003|Overall Study|Physician Decision|1|||
105893601|NCT01317797|365264065|FG000|Overall Study|Other|0|||
105893602|NCT01317797|365264066|FG001|Overall Study|Other|1|||
105893603|NCT01317797|365264067|FG002|Overall Study|Other|0|||
105893604|NCT01317797|365264065|FG000|Overall Study|Withdrawal of Patient|0|||
105893605|NCT01317797|365264066|FG001|Overall Study|Withdrawal of Patient|0|||
105893606|NCT01317797|365264067|FG002|Overall Study|Withdrawal of Patient|1|||
105893607|NCT02637713|365264074|FG000|Overall Study|Screen Failure|2|||
105893608|NCT01047332|365264075|FG000|Overall Study|SEMS Obstruction|11|||
105893609|NCT01047332|365264076|FG001|Overall Study|SEMS Obstruction|20|||
105893610|NCT01047332|365264075|FG000|Overall Study|Died Unobstructed|38|||
105893611|NCT01047332|365264076|FG001|Overall Study|Died Unobstructed|41|||
105996846|NCT05258149|365649512|FG000|Period 1|Protocol Deviation|1|||
105996847|NCT05258149|365649513|FG001|Period 1|Protocol Deviation|0|||
105996848|NCT05258149|365649512|FG000|Period 1|Adverse Event|0|||
105996849|NCT05258149|365649513|FG001|Period 1|Adverse Event|1|||
105996850|NCT05258149|365649512|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
105996851|NCT05258149|365649513|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105996852|NCT05258149|365649512|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
105996853|NCT05258149|365649513|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
105893612|NCT01047332|365264075|FG000|Overall Study|Lost to Follow-up|8|||
105996854|NCT05258149|365649512|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
105996855|NCT05258149|365649513|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
105996856|NCT01388907|365649522|FG000|Overall Study|Adverse Event|2|||
105893613|NCT01047332|365264076|FG001|Overall Study|Lost to Follow-up|3|||
105996857|NCT01388907|365649523|FG001|Overall Study|Adverse Event|0|||
105996858|NCT00981461|365649524|FG000|Overall Study|Lost to Follow-up|5|||
105996859|NCT00981461|365649525|FG001|Overall Study|Lost to Follow-up|2|||
105893614|NCT03521817|365264077|FG000|Overall Study|Protocol Violation|0|||
105893615|NCT03521817|365264078|FG001|Overall Study|Protocol Violation|1|||
105893616|NCT00778102|365264079|FG000|Overall Study|Adverse Event|8|||
105665433|NCT02568397|364440736|FG001|Period 2|Physician Decision|1|||
105665434|NCT00971997|364440737|FG000|Overall Study|Adverse Event|2|||
105665435|NCT00971997|364440737|FG000|Overall Study|Death|1|||
105665436|NCT00971997|364440737|FG000|Overall Study|Protocol Violation|4|||
105665437|NCT00971997|364440737|FG000|Overall Study|Withdrawal by Subject|5|||
105665438|NCT00971997|364440737|FG000|Overall Study|Physician Decision|7|||
105665439|NCT00725712|364440738|FG000|Overall Study|Withdrawal by Subject|2|||
105665440|NCT00725712|364440739|FG001|Overall Study|Withdrawal by Subject|1|||
105665441|NCT00725712|364440738|FG000|Overall Study|Protocol Violation|1|||
105665442|NCT00725712|364440739|FG001|Overall Study|Protocol Violation|0|||
105665443|NCT00725712|364440738|FG000|Overall Study|Progressive disease|37|||
105893617|NCT00778102|365264080|FG001|Overall Study|Adverse Event|5|||
105893618|NCT00778102|365264079|FG000|Overall Study|Death|1|||
105893619|NCT00778102|365264080|FG001|Overall Study|Death|1|||
105893620|NCT00778102|365264079|FG000|Overall Study|Lost to Follow-up|1|||
105893621|NCT00778102|365264080|FG001|Overall Study|Lost to Follow-up|0|||
105893622|NCT00778102|365264079|FG000|Overall Study|Violation of Selection Criteria|1|||
105893623|NCT00778102|365264080|FG001|Overall Study|Violation of Selection Criteria|1|||
105893624|NCT00778102|365264079|FG000|Overall Study|Protocol Violation|0|||
105893625|NCT00778102|365264080|FG001|Overall Study|Protocol Violation|1|||
105893626|NCT00778102|365264079|FG000|Overall Study|Refused Treatment|2|||
105893627|NCT00778102|365264080|FG001|Overall Study|Refused Treatment|3|||
105893628|NCT00778102|365264079|FG000|Overall Study|Withdrawal by Subject|1|||
105893629|NCT00778102|365264080|FG001|Overall Study|Withdrawal by Subject|1|||
105893630|NCT00778102|365264079|FG000|Overall Study|Administrative Reason|7|||
105893631|NCT00778102|365264080|FG001|Overall Study|Administrative Reason|10|||
105893632|NCT03055494|365265877|FG000|Overall Study|Lost to Follow-up|6|||
105893633|NCT03055494|365265878|FG001|Overall Study|Lost to Follow-up|0|||
105893634|NCT03055494|365265877|FG000|Overall Study|Physician Decision|2|||
105893635|NCT03055494|365265878|FG001|Overall Study|Physician Decision|0|||
105893636|NCT03055494|365265877|FG000|Overall Study|Withdrawal by Subject|1|||
105893637|NCT03055494|365265878|FG001|Overall Study|Withdrawal by Subject|0|||
105893638|NCT03055494|365265877|FG000|Overall Study|Adverse Event|0|||
105893639|NCT03055494|365265878|FG001|Overall Study|Adverse Event|1|||
105893640|NCT03055494|365265877|FG000|Overall Study|Non-compliance with study treatment|1|||
105893641|NCT03055494|365265878|FG001|Overall Study|Non-compliance with study treatment|0|||
105893642|NCT02417961|365265879|FG000|Overall Study|Adverse Event|1|||
105893643|NCT02417961|365265879|FG000|Overall Study|Lost to Follow-up|1|||
105893644|NCT02417961|365265879|FG000|Overall Study|Withdrawal by Subject|2|||
105893645|NCT05079750|365265880|FG000|Overall Study|Lost to Follow-up|0|||
105893646|NCT05079750|365265881|FG001|Overall Study|Lost to Follow-up|0|||
105893647|NCT05079750|365265882|FG002|Overall Study|Lost to Follow-up|1|||
105893648|NCT03197467|365265883|FG000|Overall Study|Withdrawal by Subject|1|||
105893649|NCT04488419|365265884|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
105893650|NCT04488419|365265885|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
105893651|NCT04488419|365265886|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
105893652|NCT04488419|365265884|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
105893653|NCT04488419|365265885|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
105893654|NCT04488419|365265886|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
105893655|NCT04488419|365265884|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
106122495|NCT01868074|366106100|FG001|Overall Study|Withdrawal by Subject|2|||
105893656|NCT04488419|365265885|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
105893657|NCT04488419|365265886|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
105996860|NCT03361293|365649534|FG000|Overall Study|Lost to Follow-up|0|||
106122496|NCT03306043|366106102|FG000|Overall Study|Adverse Event|1|||
106122497|NCT03306043|366106102|FG000|Overall Study|Lost to Follow-up|1|||
106122498|NCT03306043|366106102|FG000|Overall Study|Withdrawal by Subject|2|||
106122499|NCT01799720|366106103|FG000|Overall Study|Withdrawal by Subject|3|||
106122500|NCT01799720|366106104|FG001|Overall Study|Withdrawal by Subject|0|||
106122501|NCT01799720|366106105|FG002|Overall Study|Withdrawal by Subject|0|||
106122502|NCT01799720|366106103|FG000|Overall Study|Protocol Violation|0|||
106122503|NCT01799720|366106104|FG001|Overall Study|Protocol Violation|1|||
106122504|NCT01799720|366106105|FG002|Overall Study|Protocol Violation|0|||
106122505|NCT01799720|366106103|FG000|Overall Study|Pregnancy|0|||
106122506|NCT01799720|366106104|FG001|Overall Study|Pregnancy|0|||
106122507|NCT01799720|366106105|FG002|Overall Study|Pregnancy|1|||
106122508|NCT04642469|366106109|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
106122509|NCT04642469|366106110|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
106122510|NCT04642469|366106109|FG000|Overall Study|Death|1|||
106122511|NCT04642469|366106110|FG001|Overall Study|Death|2|||
106122512|NCT04642469|366106109|FG000|Overall Study|Study/site closed following amendment 1|11|||
106122513|NCT04642469|366106110|FG001|Overall Study|Study/site closed following amendment 1|11|||
106122514|NCT04642469|366106109|FG000|Overall Study|Other|1|||
106122515|NCT04642469|366106110|FG001|Overall Study|Other|1|||
106122516|NCT04642469|366106109|FG000|Overall Study|Withdrawal by Subject|1|||
105893658|NCT04488419|365265884|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
105893659|NCT04488419|365265885|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
105893660|NCT04488419|365265886|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
105893661|NCT04488419|365265884|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
105893662|NCT04488419|365265885|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
105893663|NCT04488419|365265886|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
105893664|NCT04488419|365265884|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
105893665|NCT04488419|365265885|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
105893666|NCT04488419|365265886|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
105893667|NCT04488419|365265884|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
105893668|NCT04488419|365265885|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
105893669|NCT04488419|365265886|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
105893670|NCT04488419|365265884|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
105893671|NCT04488419|365265885|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
105893672|NCT04488419|365265886|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
105893673|NCT04488419|365265884|FG000|Primary Analysis Population|Adverse Event|6|||
105893674|NCT04488419|365265885|FG001|Primary Analysis Population|Adverse Event|9|||
105893675|NCT04488419|365265886|FG002|Primary Analysis Population|Adverse Event|0|||
105893676|NCT04488419|365265884|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
105893677|NCT04488419|365265885|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
105893678|NCT04488419|365265886|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
105893679|NCT04488419|365265884|FG000|Primary Analysis Population|Protocol Violation|1|||
105893680|NCT04488419|365265885|FG001|Primary Analysis Population|Protocol Violation|1|||
105893681|NCT04488419|365265886|FG002|Primary Analysis Population|Protocol Violation|0|||
105893682|NCT04488419|365265884|FG000|Primary Analysis Population|Undetermined|7|||
105893683|NCT04488419|365265885|FG001|Primary Analysis Population|Undetermined|3|||
105893684|NCT04488419|365265886|FG002|Primary Analysis Population|Undetermined|0|||
105893685|NCT04488419|365265884|FG000|Primary Analysis Population|>1 Reason|2|||
105893686|NCT04488419|365265885|FG001|Primary Analysis Population|>1 Reason|4|||
105893687|NCT04488419|365265886|FG002|Primary Analysis Population|>1 Reason|0|||
105893688|NCT04743804|365265889|FG000|Overall Study|Other|1|||
105893689|NCT04743804|365265890|FG001|Overall Study|Other|0|||
105893690|NCT04743804|365265889|FG000|Overall Study|Withdrawal by Subject|0|||
105893691|NCT04743804|365265890|FG001|Overall Study|Withdrawal by Subject|1|||
105893692|NCT04743804|365265889|FG000|Overall Study|Study Terminated by Sponsor|1|||
105893693|NCT04743804|365265890|FG001|Overall Study|Study Terminated by Sponsor|4|||
105893694|NCT04743804|365265889|FG000|Overall Study|Physician Decision|0|||
105893695|NCT04743804|365265890|FG001|Overall Study|Physician Decision|1|||
105893696|NCT04743804|365265889|FG000|Overall Study|Death|3|||
105893697|NCT04743804|365265890|FG001|Overall Study|Death|0|||
105893698|NCT01632904|365265891|FG000|Overall Study|Adverse Event|4|||
105893699|NCT01632904|365265892|FG001|Overall Study|Adverse Event|1|||
105893700|NCT01632904|365265891|FG000|Overall Study|Physician Decision|0|||
105893701|NCT01632904|365265892|FG001|Overall Study|Physician Decision|1|||
105893702|NCT01632904|365265891|FG000|Overall Study|Subject decision|3|||
105893703|NCT01632904|365265892|FG001|Overall Study|Subject decision|2|||
105893704|NCT01632904|365265891|FG000|Overall Study|Disease Progression|0|||
105893705|NCT01632904|365265892|FG001|Overall Study|Disease Progression|1|||
105893706|NCT01632904|365265891|FG000|Overall Study|Reason for discontinuation not available|0|||
105893707|NCT01632904|365265892|FG001|Overall Study|Reason for discontinuation not available|1|||
105893708|NCT03201874|365265895|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
105893709|NCT03201874|365265896|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
105893710|NCT03201874|365265895|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
105893711|NCT03201874|365265896|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
105893712|NCT04676412|365265897|FG000|Overall Study|Death|28|||
105996861|NCT03361293|365649535|FG001|Overall Study|Lost to Follow-up|2|||
105996862|NCT03361293|365649534|FG000|Overall Study|Withdrawal by Subject|1|||
105996863|NCT03361293|365649535|FG001|Overall Study|Withdrawal by Subject|3|||
105996864|NCT01910402|365649538|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
105996865|NCT01910402|365649539|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
105996866|NCT01910402|365649540|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
106122517|NCT04642469|366106110|FG001|Overall Study|Withdrawal by Subject|0|||
106122518|NCT00680056|366106113|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
106122519|NCT00680056|366106114|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
106122520|NCT00680056|366106113|FG000|Second Intervention|Protocol Violation|3|||
106122521|NCT00680056|366106114|FG001|Second Intervention|Protocol Violation|1|||
106122522|NCT02733042|366106120|FG000|Overall Study|Adverse Event|1|||
106122523|NCT02733042|366106121|FG001|Overall Study|Adverse Event|0|||
106122524|NCT02733042|366106122|FG002|Overall Study|Adverse Event|1|||
106122525|NCT02733042|366106123|FG003|Overall Study|Adverse Event|1|||
106122526|NCT02733042|366106124|FG004|Overall Study|Adverse Event|0|||
106122527|NCT02733042|366106125|FG005|Overall Study|Adverse Event|0|||
106122528|NCT02733042|366106126|FG006|Overall Study|Adverse Event|0|||
106122529|NCT02733042|366106127|FG007|Overall Study|Adverse Event|0|||
106122530|NCT02733042|366106128|FG008|Overall Study|Adverse Event|0|||
106122531|NCT02733042|366106129|FG009|Overall Study|Adverse Event|0|||
106122532|NCT02733042|366106130|FG010|Overall Study|Adverse Event|2|||
106122533|NCT02733042|366106131|FG011|Overall Study|Adverse Event|2|||
106122534|NCT02733042|366106132|FG012|Overall Study|Adverse Event|0|||
105893713|NCT04676412|365265898|FG001|Overall Study|Death|31|||
105893714|NCT04676412|365265897|FG000|Overall Study|Lost to Follow-up|1|||
105893715|NCT04676412|365265898|FG001|Overall Study|Lost to Follow-up|2|||
105893716|NCT04676412|365265897|FG000|Overall Study|Sponsor Decision|20|||
105893717|NCT04676412|365265898|FG001|Overall Study|Sponsor Decision|23|||
105893718|NCT04676412|365265897|FG000|Overall Study|Withdrawal by Subject|0|||
105893719|NCT04676412|365265898|FG001|Overall Study|Withdrawal by Subject|2|||
105893720|NCT04322539|365265903|FG000|Overall Study|Adverse Event|2|||
105893721|NCT04322539|365265904|FG001|Overall Study|Adverse Event|0|||
105893722|NCT04322539|365265903|FG000|Overall Study|Death|411|||
105893723|NCT04322539|365265904|FG001|Overall Study|Death|203|||
105893724|NCT04322539|365265903|FG000|Overall Study|Lost to Follow-up|3|||
105893725|NCT04322539|365265904|FG001|Overall Study|Lost to Follow-up|1|||
105893726|NCT04322539|365265903|FG000|Overall Study|Withdrawal of consent|14|||
105893727|NCT04322539|365265904|FG001|Overall Study|Withdrawal of consent|8|||
105893728|NCT04322539|365265903|FG000|Overall Study|Radiological Disease Progression|6|||
105893729|NCT04322539|365265904|FG001|Overall Study|Radiological Disease Progression|0|||
105893730|NCT04322539|365265903|FG000|Overall Study|Sponsor Decision|19|||
105893731|NCT04322539|365265904|FG001|Overall Study|Sponsor Decision|14|||
105893732|NCT04322539|365265903|FG000|Overall Study|Other|6|||
105893733|NCT04322539|365265904|FG001|Overall Study|Other|4|||
105893734|NCT01846221|365265907|FG000|Overall Study|Catheter Failure|2|||
105893735|NCT01846221|365265908|FG001|Overall Study|Catheter Failure|0|||
105893736|NCT01846221|365265907|FG000|Overall Study|Age Exclusion|1|||
105893737|NCT01846221|365265908|FG001|Overall Study|Age Exclusion|0|||
105893738|NCT04984681|365265909|FG000|Overall Study|Lost to Follow-up|3|||
105893739|NCT04984681|365265910|FG001|Overall Study|Lost to Follow-up|1|||
105893740|NCT02339155|365265911|FG000|Overall Study|Adverse Event|0|||
105893741|NCT02339155|365265912|FG001|Overall Study|Adverse Event|6|||
105893742|NCT02339155|365265911|FG000|Overall Study|Death|1|||
105893743|NCT02339155|365265912|FG001|Overall Study|Death|1|||
105893744|NCT02339155|365265911|FG000|Overall Study|Lost to Follow-up|8|||
105893745|NCT02339155|365265912|FG001|Overall Study|Lost to Follow-up|9|||
105893746|NCT02339155|365265911|FG000|Overall Study|Physician Decision|2|||
105893747|NCT02339155|365265912|FG001|Overall Study|Physician Decision|1|||
105893748|NCT02339155|365265911|FG000|Overall Study|Withdrawal by Subject|4|||
105893749|NCT02339155|365265912|FG001|Overall Study|Withdrawal by Subject|4|||
105893750|NCT03226678|365265917|FG000|Part A (Core Study Phase)|Adverse Event|0|||
105893751|NCT03226678|365265918|FG001|Part A (Core Study Phase)|Adverse Event|1|||
105893752|NCT03226678|365265919|FG002|Part A (Core Study Phase)|Adverse Event|0|||
105893753|NCT03226678|365265920|FG003|Part A (Core Study Phase)|Adverse Event|0|||
105893754|NCT03226678|365265921|FG004|Part A (Core Study Phase)|Adverse Event|0|||
105893755|NCT03226678|365265922|FG005|Part A (Core Study Phase)|Adverse Event|0|||
105996867|NCT01910402|365649538|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
105996868|NCT01910402|365649539|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
105996869|NCT01910402|365649540|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
105996870|NCT01910402|365649538|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
105996871|NCT01910402|365649539|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
105996872|NCT01910402|365649540|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
105996873|NCT01910402|365649538|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
105996874|NCT01910402|365649539|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
105996875|NCT01910402|365649540|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
105996876|NCT01910402|365649538|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
105996877|NCT01910402|365649539|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
105996878|NCT01910402|365649540|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
105996879|NCT01910402|365649538|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
105996880|NCT01910402|365649539|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
105996881|NCT01910402|365649540|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
105996882|NCT01910402|365649538|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
105996883|NCT01910402|365649539|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
105996884|NCT01910402|365649540|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
105996885|NCT01910402|365649538|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
106122535|NCT02733042|366106133|FG013|Overall Study|Adverse Event|2|||
105893756|NCT03226678|365265917|FG000|Part A (Core Study Phase)|Death|0|||
105893757|NCT03226678|365265918|FG001|Part A (Core Study Phase)|Death|0|||
105893758|NCT03226678|365265919|FG002|Part A (Core Study Phase)|Death|1|||
105893759|NCT03226678|365265920|FG003|Part A (Core Study Phase)|Death|0|||
105893760|NCT03226678|365265921|FG004|Part A (Core Study Phase)|Death|0|||
105893761|NCT03226678|365265922|FG005|Part A (Core Study Phase)|Death|0|||
105893762|NCT03226678|365265917|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
105893763|NCT03226678|365265918|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
105893764|NCT03226678|365265919|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
105893765|NCT03226678|365265920|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
105893766|NCT03226678|365265921|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
105893767|NCT03226678|365265922|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
105893768|NCT03226678|365265917|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105893769|NCT03226678|365265918|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105893770|NCT03226678|365265919|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
105893771|NCT03226678|365265920|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105893772|NCT03226678|365265921|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105893773|NCT03226678|365265922|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
105893774|NCT03226678|365265917|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105893775|NCT03226678|365265918|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105893776|NCT03226678|365265919|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105893777|NCT03226678|365265920|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
105893778|NCT03226678|365265921|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105893779|NCT03226678|365265922|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
105893780|NCT03226678|365265917|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
105893781|NCT03226678|365265918|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
105893782|NCT03226678|365265919|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
105893783|NCT03226678|365265920|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
105893784|NCT03226678|365265921|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
105893785|NCT03226678|365265922|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
105893786|NCT03226678|365265917|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
105893787|NCT03226678|365265918|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
105893788|NCT03226678|365265919|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
105893789|NCT03226678|365265920|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
105893790|NCT03226678|365265921|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
105893791|NCT03226678|365265922|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
105893792|NCT03226678|365265917|FG000|Part B (Long-Term Extension Phase)|Death|0|||
105893793|NCT03226678|365265918|FG001|Part B (Long-Term Extension Phase)|Death|0|||
105893794|NCT03226678|365265919|FG002|Part B (Long-Term Extension Phase)|Death|0|||
105893795|NCT03226678|365265920|FG003|Part B (Long-Term Extension Phase)|Death|0|||
105893796|NCT03226678|365265921|FG004|Part B (Long-Term Extension Phase)|Death|0|||
105893797|NCT03226678|365265922|FG005|Part B (Long-Term Extension Phase)|Death|1|||
105893798|NCT03226678|365265917|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
106122536|NCT02733042|366106134|FG014|Overall Study|Adverse Event|0|||
106122537|NCT02733042|366106135|FG015|Overall Study|Adverse Event|0|||
106122538|NCT02733042|366106136|FG016|Overall Study|Adverse Event|0|||
106122539|NCT02733042|366106137|FG017|Overall Study|Adverse Event|1|||
106122540|NCT02733042|366106138|FG018|Overall Study|Adverse Event|0|||
106122541|NCT02733042|366106120|FG000|Overall Study|Progressive Disease|2|||
106122542|NCT02733042|366106121|FG001|Overall Study|Progressive Disease|1|||
106122543|NCT02733042|366106122|FG002|Overall Study|Progressive Disease|3|||
106122544|NCT02733042|366106123|FG003|Overall Study|Progressive Disease|1|||
106122545|NCT02733042|366106124|FG004|Overall Study|Progressive Disease|2|||
106122546|NCT02733042|366106125|FG005|Overall Study|Progressive Disease|3|||
106122547|NCT02733042|366106126|FG006|Overall Study|Progressive Disease|0|||
106122548|NCT02733042|366106127|FG007|Overall Study|Progressive Disease|3|||
106122549|NCT02733042|366106128|FG008|Overall Study|Progressive Disease|3|||
106122550|NCT02733042|366106129|FG009|Overall Study|Progressive Disease|2|||
106122551|NCT02733042|366106130|FG010|Overall Study|Progressive Disease|2|||
106122552|NCT02733042|366106131|FG011|Overall Study|Progressive Disease|2|||
106122553|NCT02733042|366106132|FG012|Overall Study|Progressive Disease|8|||
105665444|NCT00725712|364440739|FG001|Overall Study|Progressive disease|16|||
105665445|NCT00725712|364440738|FG000|Overall Study|Clinical progression not based on RECIST|0|||
105665446|NCT00725712|364440739|FG001|Overall Study|Clinical progression not based on RECIST|3|||
105893799|NCT03226678|365265918|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105893800|NCT03226678|365265919|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105893801|NCT03226678|365265920|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105893802|NCT03226678|365265921|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
105893803|NCT03226678|365265922|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
105893804|NCT03226678|365265917|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
105893805|NCT03226678|365265918|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
105893806|NCT03226678|365265919|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
105893807|NCT03226678|365265920|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
106122554|NCT02733042|366106133|FG013|Overall Study|Progressive Disease|1|||
106122555|NCT02733042|366106134|FG014|Overall Study|Progressive Disease|4|||
106122556|NCT02733042|366106135|FG015|Overall Study|Progressive Disease|7|||
106122557|NCT02733042|366106136|FG016|Overall Study|Progressive Disease|2|||
106122558|NCT02733042|366106137|FG017|Overall Study|Progressive Disease|3|||
106122559|NCT02733042|366106138|FG018|Overall Study|Progressive Disease|4|||
106122560|NCT02733042|366106120|FG000|Overall Study|Withdrawal by Subject|0|||
106122561|NCT02733042|366106121|FG001|Overall Study|Withdrawal by Subject|1|||
106122562|NCT02733042|366106122|FG002|Overall Study|Withdrawal by Subject|2|||
106122563|NCT02733042|366106123|FG003|Overall Study|Withdrawal by Subject|1|||
106122564|NCT02733042|366106124|FG004|Overall Study|Withdrawal by Subject|1|||
106122565|NCT02733042|366106125|FG005|Overall Study|Withdrawal by Subject|0|||
106122566|NCT02733042|366106126|FG006|Overall Study|Withdrawal by Subject|0|||
106122567|NCT02733042|366106127|FG007|Overall Study|Withdrawal by Subject|0|||
106122568|NCT02733042|366106128|FG008|Overall Study|Withdrawal by Subject|1|||
106122569|NCT02733042|366106129|FG009|Overall Study|Withdrawal by Subject|1|||
106122570|NCT02733042|366106130|FG010|Overall Study|Withdrawal by Subject|0|||
106122571|NCT02733042|366106131|FG011|Overall Study|Withdrawal by Subject|2|||
106122572|NCT02733042|366106132|FG012|Overall Study|Withdrawal by Subject|1|||
106122573|NCT02733042|366106133|FG013|Overall Study|Withdrawal by Subject|1|||
106122574|NCT02733042|366106134|FG014|Overall Study|Withdrawal by Subject|0|||
106122575|NCT02733042|366106135|FG015|Overall Study|Withdrawal by Subject|0|||
106122576|NCT02733042|366106136|FG016|Overall Study|Withdrawal by Subject|0|||
106122577|NCT02733042|366106137|FG017|Overall Study|Withdrawal by Subject|0|||
106122578|NCT02733042|366106138|FG018|Overall Study|Withdrawal by Subject|0|||
106122579|NCT02733042|366106120|FG000|Overall Study|Other Reasons|0|||
106122580|NCT02733042|366106121|FG001|Overall Study|Other Reasons|0|||
106122581|NCT02733042|366106122|FG002|Overall Study|Other Reasons|1|||
106122582|NCT02733042|366106123|FG003|Overall Study|Other Reasons|0|||
106122583|NCT02733042|366106124|FG004|Overall Study|Other Reasons|0|||
106122584|NCT02733042|366106125|FG005|Overall Study|Other Reasons|0|||
106122585|NCT02733042|366106126|FG006|Overall Study|Other Reasons|0|||
106122586|NCT02733042|366106127|FG007|Overall Study|Other Reasons|0|||
106122587|NCT02733042|366106128|FG008|Overall Study|Other Reasons|0|||
106122588|NCT02733042|366106129|FG009|Overall Study|Other Reasons|1|||
106122589|NCT02733042|366106130|FG010|Overall Study|Other Reasons|1|||
106122590|NCT02733042|366106131|FG011|Overall Study|Other Reasons|0|||
106122591|NCT02733042|366106132|FG012|Overall Study|Other Reasons|0|||
106122592|NCT02733042|366106133|FG013|Overall Study|Other Reasons|0|||
106122593|NCT02733042|366106134|FG014|Overall Study|Other Reasons|0|||
106122594|NCT02733042|366106135|FG015|Overall Study|Other Reasons|1|||
106122595|NCT02733042|366106136|FG016|Overall Study|Other Reasons|0|||
106122596|NCT02733042|366106137|FG017|Overall Study|Other Reasons|1|||
106122597|NCT02733042|366106138|FG018|Overall Study|Other Reasons|0|||
106122598|NCT02733042|366106120|FG000|Overall Study|Death|0|||
106122599|NCT02733042|366106121|FG001|Overall Study|Death|0|||
106122600|NCT02733042|366106122|FG002|Overall Study|Death|0|||
106122601|NCT02733042|366106123|FG003|Overall Study|Death|0|||
106122602|NCT02733042|366106124|FG004|Overall Study|Death|0|||
106122603|NCT02733042|366106125|FG005|Overall Study|Death|0|||
106122604|NCT02733042|366106126|FG006|Overall Study|Death|1|||
106122605|NCT02733042|366106127|FG007|Overall Study|Death|0|||
106122606|NCT02733042|366106128|FG008|Overall Study|Death|1|||
106122607|NCT02733042|366106129|FG009|Overall Study|Death|0|||
106122608|NCT02733042|366106130|FG010|Overall Study|Death|1|||
105665447|NCT00725712|364440738|FG000|Overall Study|Adverse Event|5|||
106122609|NCT02733042|366106131|FG011|Overall Study|Death|0|||
106122610|NCT02733042|366106132|FG012|Overall Study|Death|0|||
106122611|NCT02733042|366106133|FG013|Overall Study|Death|0|||
106122612|NCT02733042|366106134|FG014|Overall Study|Death|1|||
106122613|NCT02733042|366106135|FG015|Overall Study|Death|2|||
106122614|NCT02733042|366106136|FG016|Overall Study|Death|0|||
106122615|NCT02733042|366106137|FG017|Overall Study|Death|0|||
105665448|NCT00725712|364440739|FG001|Overall Study|Adverse Event|5|||
105665449|NCT00725712|364440738|FG000|Overall Study|Death|2|||
106122616|NCT02733042|366106138|FG018|Overall Study|Death|0|||
106122617|NCT02838628|366106140|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
106122618|NCT02838628|366106141|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
106122619|NCT02838628|366106140|FG000|Recurrence Follow-up Period|Adverse Event|1|||
105893808|NCT03226678|365265921|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
105893809|NCT03226678|365265922|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
105893810|NCT03226678|365265917|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105893811|NCT03226678|365265918|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105996886|NCT01910402|365649539|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
105996887|NCT01910402|365649540|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
105996888|NCT01910402|365649538|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
105996889|NCT01910402|365649539|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
105996890|NCT01910402|365649540|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
105996891|NCT01910402|365649538|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
105996892|NCT01910402|365649539|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
105996893|NCT01910402|365649540|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
105996894|NCT01910402|365649538|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
105996895|NCT01910402|365649539|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
105996896|NCT01910402|365649540|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
105996897|NCT01910402|365649538|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
105996898|NCT01910402|365649539|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
105996899|NCT01910402|365649540|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
105996900|NCT01910402|365649538|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
105996901|NCT01910402|365649539|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
105996902|NCT01910402|365649540|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
105996903|NCT00571038|365649541|FG000|Overall Study|Lost to Follow-up|1|||
105996904|NCT00571038|365649542|FG001|Overall Study|Lost to Follow-up|4|||
105996905|NCT00571038|365649541|FG000|Overall Study|Death|7|||
105996906|NCT00571038|365649542|FG001|Overall Study|Death|5|||
105996907|NCT00571038|365649541|FG000|Overall Study|Withdrawal by Subject|1|||
105996908|NCT00571038|365649542|FG001|Overall Study|Withdrawal by Subject|3|||
105996909|NCT00571038|365649541|FG000|Overall Study|Moved out of state|2|||
105996910|NCT00571038|365649542|FG001|Overall Study|Moved out of state|2|||
105996911|NCT01442714|365649543|FG000|Overall Study|Death|11|||
105996912|NCT01442714|365649543|FG000|Overall Study|Withdrawal by Subject|1|||
105996913|NCT04306510|365649544|FG000|Overall Study|Voluntarily withdrawal|1|||
106122620|NCT02838628|366106141|FG001|Recurrence Follow-up Period|Adverse Event|0|||
106122621|NCT02838628|366106140|FG000|Recurrence Follow-up Period|Non-compliance|0|||
106122622|NCT02838628|366106141|FG001|Recurrence Follow-up Period|Non-compliance|1|||
105893812|NCT03226678|365265919|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105893813|NCT03226678|365265920|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105893814|NCT03226678|365265921|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
105893815|NCT03226678|365265922|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
105893816|NCT03427268|365265923|FG000|Overall Study|Progressive disease|25|||
105893817|NCT03427268|365265923|FG000|Overall Study|Never treated|2|||
105893818|NCT03427268|365265923|FG000|Overall Study|Compassionate use|1|||
105893819|NCT03427268|365265923|FG000|Overall Study|Withdrawal by Subject|1|||
105893820|NCT03427268|365265923|FG000|Overall Study|Adverse Event|3|||
105893821|NCT00345878|365265924|FG000|Overall Study|Adverse Event|1|||
105893822|NCT00345878|365265925|FG001|Overall Study|Adverse Event|0|||
105893823|NCT00345878|365265924|FG000|Overall Study|Lost to Follow-up|2|||
105893824|NCT00345878|365265925|FG001|Overall Study|Lost to Follow-up|1|||
105893825|NCT00345878|365265924|FG000|Overall Study|Other|1|||
105893826|NCT00345878|365265925|FG001|Overall Study|Other|0|||
105893827|NCT01995175|365265930|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
105996914|NCT04306510|365649544|FG000|Overall Study|Enrolled but Not Treated|1|||
105996915|NCT00622505|365649549|FG000|Overall Study|Adverse Event|9|||
105996916|NCT00622505|365649550|FG001|Overall Study|Adverse Event|7|||
106122623|NCT02838628|366106140|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
106122624|NCT02838628|366106141|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
106122625|NCT02838628|366106140|FG000|Recurrence Follow-up Period|Other un-specified|1|||
106122626|NCT02838628|366106141|FG001|Recurrence Follow-up Period|Other un-specified|1|||
106122627|NCT02397460|366106142|FG000|Treatment Period 2|Adverse Event|0|||
106122628|NCT02397460|366106143|FG001|Treatment Period 2|Adverse Event|0|||
106122629|NCT02397460|366106144|FG002|Treatment Period 2|Adverse Event|0|||
106122630|NCT02397460|366106145|FG003|Treatment Period 2|Adverse Event|0|||
106122631|NCT02397460|366106146|FG004|Treatment Period 2|Adverse Event|0|||
106122632|NCT02397460|366106147|FG005|Treatment Period 2|Adverse Event|0|||
106122633|NCT02397460|366106148|FG006|Treatment Period 2|Adverse Event|0|||
106122634|NCT02397460|366106149|FG007|Treatment Period 2|Adverse Event|1|||
106122635|NCT02397460|366106142|FG000|Treatment Period 4|Adverse Event|0|||
106122636|NCT02397460|366106143|FG001|Treatment Period 4|Adverse Event|1|||
106122637|NCT02397460|366106144|FG002|Treatment Period 4|Adverse Event|0|||
105893828|NCT01995175|365265930|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
105893829|NCT01995175|365265930|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
105996917|NCT00622505|365649549|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
105996918|NCT00622505|365649550|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
105996919|NCT00622505|365649549|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
105996920|NCT00622505|365649550|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105996921|NCT00622505|365649549|FG000|Overall Study|Withdrawal by Subject|12|||
105996922|NCT00622505|365649550|FG001|Overall Study|Withdrawal by Subject|5|||
105996923|NCT00622505|365649549|FG000|Overall Study|Administrative Problems|2|||
105996924|NCT00622505|365649550|FG001|Overall Study|Administrative Problems|4|||
105996925|NCT00622505|365649549|FG000|Overall Study|Death|2|||
105996926|NCT00622505|365649550|FG001|Overall Study|Death|2|||
105996927|NCT01359904|365649551|FG000|Overall Study|Withdrawal by Subject|1|||
105996928|NCT01359904|365649552|FG001|Overall Study|Withdrawal by Subject|0|||
105996929|NCT01797263|365649554|FG000|Overall Study|Withdrawal by Subject|21|||
105996930|NCT01797263|365649555|FG001|Overall Study|Withdrawal by Subject|25|||
105996931|NCT01797263|365649554|FG000|Overall Study|Death|1|||
105996932|NCT01797263|365649555|FG001|Overall Study|Death|0|||
105996933|NCT01797263|365649554|FG000|Overall Study|Lost to Follow-up|15|||
105996934|NCT01797263|365649555|FG001|Overall Study|Lost to Follow-up|15|||
105996935|NCT02045095|365649556|FG000|Overall Study|Other|0|||
105996936|NCT02045095|365649557|FG001|Overall Study|Other|0|||
105996937|NCT02045095|365649558|FG002|Overall Study|Other|1|||
105996938|NCT02045095|365649559|FG003|Overall Study|Other|0|||
105996939|NCT02045095|365649560|FG004|Overall Study|Other|0|||
105996940|NCT02045095|365649561|FG005|Overall Study|Other|2|||
105996941|NCT02045095|365649562|FG006|Overall Study|Other|0|||
105996942|NCT02045095|365649556|FG000|Overall Study|Progressive Disease|3|||
105996943|NCT02045095|365649557|FG001|Overall Study|Progressive Disease|3|||
105996944|NCT02045095|365649558|FG002|Overall Study|Progressive Disease|2|||
105996945|NCT02045095|365649559|FG003|Overall Study|Progressive Disease|4|||
105996946|NCT02045095|365649560|FG004|Overall Study|Progressive Disease|2|||
105996947|NCT02045095|365649561|FG005|Overall Study|Progressive Disease|4|||
105996948|NCT02045095|365649562|FG006|Overall Study|Progressive Disease|1|||
105996949|NCT02045095|365649556|FG000|Overall Study|Withdrawal by Subject|0|||
105996950|NCT02045095|365649557|FG001|Overall Study|Withdrawal by Subject|0|||
105996951|NCT02045095|365649558|FG002|Overall Study|Withdrawal by Subject|0|||
105996952|NCT02045095|365649559|FG003|Overall Study|Withdrawal by Subject|0|||
105996953|NCT02045095|365649560|FG004|Overall Study|Withdrawal by Subject|3|||
105996954|NCT02045095|365649561|FG005|Overall Study|Withdrawal by Subject|0|||
105996955|NCT02045095|365649562|FG006|Overall Study|Withdrawal by Subject|0|||
105996956|NCT02045095|365649556|FG000|Overall Study|Adverse Event|0|||
105996957|NCT02045095|365649557|FG001|Overall Study|Adverse Event|1|||
105996958|NCT02045095|365649558|FG002|Overall Study|Adverse Event|1|||
105996959|NCT02045095|365649559|FG003|Overall Study|Adverse Event|0|||
105996960|NCT02045095|365649560|FG004|Overall Study|Adverse Event|0|||
105996961|NCT02045095|365649561|FG005|Overall Study|Adverse Event|2|||
105996962|NCT02045095|365649562|FG006|Overall Study|Adverse Event|0|||
105996963|NCT01550757|365649565|FG000|Overall Study|Lost to Follow-up|21|||
105996964|NCT01550757|365649566|FG001|Overall Study|Lost to Follow-up|14|||
106122638|NCT02397460|366106145|FG003|Treatment Period 4|Adverse Event|0|||
106122639|NCT02397460|366106146|FG004|Treatment Period 4|Adverse Event|0|||
105996965|NCT01550757|365649567|FG002|Overall Study|Lost to Follow-up|42|||
105996966|NCT01550757|365649568|FG003|Overall Study|Lost to Follow-up|53|||
105996967|NCT01550757|365649565|FG000|Overall Study|Withdrawal by Subject|2|||
105996968|NCT01550757|365649566|FG001|Overall Study|Withdrawal by Subject|0|||
105996969|NCT01550757|365649567|FG002|Overall Study|Withdrawal by Subject|3|||
105996970|NCT01550757|365649568|FG003|Overall Study|Withdrawal by Subject|1|||
105996971|NCT01879683|365649570|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
105996972|NCT01970306|365649571|FG000|Overall Study|Not eligible|3|||
105996973|NCT01970306|365649571|FG000|Overall Study|Not able to be treated|9|||
105996974|NCT04980612|365649573|FG000|Overall Study|Withdrawal by Subject|7|||
106122640|NCT02397460|366106147|FG005|Treatment Period 4|Adverse Event|0|||
106122641|NCT02397460|366106148|FG006|Treatment Period 4|Adverse Event|0|||
106122642|NCT02397460|366106149|FG007|Treatment Period 4|Adverse Event|0|||
106122643|NCT02397460|366106142|FG000|Treatment Period 4|Physician Decision|0|||
106122644|NCT02397460|366106143|FG001|Treatment Period 4|Physician Decision|0|||
106122645|NCT02397460|366106144|FG002|Treatment Period 4|Physician Decision|0|||
106122646|NCT02397460|366106145|FG003|Treatment Period 4|Physician Decision|0|||
105996975|NCT04980612|365649574|FG001|Overall Study|Withdrawal by Subject|5|||
105996976|NCT03384940|365649575|FG000|Overall Study|Progressive disease|36|||
105996977|NCT03384940|365649576|FG001|Overall Study|Progressive disease|11|||
105996978|NCT03384940|365649577|FG002|Overall Study|Progressive disease|13|||
105996979|NCT03384940|365649575|FG000|Overall Study|Clinical progression|4|||
105996980|NCT03384940|365649576|FG001|Overall Study|Clinical progression|0|||
105996981|NCT03384940|365649577|FG002|Overall Study|Clinical progression|3|||
105996982|NCT03384940|365649575|FG000|Overall Study|Adverse Event|7|||
105996983|NCT03384940|365649576|FG001|Overall Study|Adverse Event|1|||
105996984|NCT03384940|365649577|FG002|Overall Study|Adverse Event|1|||
105996985|NCT03384940|365649575|FG000|Overall Study|Withdrawal by Subject|3|||
105996986|NCT03384940|365649576|FG001|Overall Study|Withdrawal by Subject|1|||
105665450|NCT00725712|364440739|FG001|Overall Study|Death|0|||
105665451|NCT00725712|364440738|FG000|Overall Study|Other: Death|1|||
105665452|NCT00725712|364440739|FG001|Overall Study|Other: Death|0|||
105893830|NCT01995175|365265930|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
105893831|NCT01995175|365265930|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
105893832|NCT01995175|365265930|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
105893833|NCT01995175|365265930|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
105893834|NCT01995175|365265930|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
105893835|NCT01995175|365265930|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
105893836|NCT03602391|365265933|FG000|Overall Study|COVID-19|7|||
105893837|NCT03602391|365265934|FG001|Overall Study|COVID-19|6|||
105893838|NCT04258254|365265943|FG000|Overall Study|Withdrawal by Subject|0|||
105893839|NCT04258254|365265944|FG001|Overall Study|Withdrawal by Subject|1|||
105893840|NCT04258254|365265945|FG002|Overall Study|Withdrawal by Subject|0|||
105893841|NCT03729570|365265946|FG000|Overall Study|Lost to Follow-up|16|||
105893842|NCT03729570|365265947|FG001|Overall Study|Lost to Follow-up|20|||
105893843|NCT03729570|365265946|FG000|Overall Study|Seroconversion|5|||
105893844|NCT03729570|365265947|FG001|Overall Study|Seroconversion|0|||
105893845|NCT03729570|365265946|FG000|Overall Study|Moved out of the city|1|||
105893846|NCT03729570|365265947|FG001|Overall Study|Moved out of the city|0|||
105893847|NCT03729570|365265946|FG000|Overall Study|Time Conflict|1|||
105893848|NCT03729570|365265947|FG001|Overall Study|Time Conflict|0|||
105893849|NCT03729570|365265946|FG000|Overall Study|Time Commitment|2|||
105893850|NCT03729570|365265947|FG001|Overall Study|Time Commitment|0|||
105893851|NCT03729570|365265946|FG000|Overall Study|Bad Experience|0|||
105893852|NCT03729570|365265947|FG001|Overall Study|Bad Experience|1|||
105893853|NCT03729570|365265946|FG000|Overall Study|No reason provided|2|||
105893854|NCT03729570|365265947|FG001|Overall Study|No reason provided|1|||
105893855|NCT03729570|365265946|FG000|Overall Study|Family Conflict|0|||
105893856|NCT03729570|365265947|FG001|Overall Study|Family Conflict|1|||
105893857|NCT03729570|365265946|FG000|Overall Study|Did not want to continue taking medications|0|||
105893858|NCT03729570|365265947|FG001|Overall Study|Did not want to continue taking medications|1|||
105893859|NCT03729570|365265946|FG000|Overall Study|Found another PrEP provider|1|||
105893860|NCT03729570|365265947|FG001|Overall Study|Found another PrEP provider|0|||
105893861|NCT03729570|365265946|FG000|Overall Study|Did not enjoy being in the control group|0|||
105893862|NCT03729570|365265947|FG001|Overall Study|Did not enjoy being in the control group|1|||
105893863|NCT02083185|365265948|FG000|Overall Study|Lost to Follow-up|0|||
105893864|NCT02083185|365265949|FG001|Overall Study|Lost to Follow-up|3|||
105893865|NCT02083185|365265950|FG002|Overall Study|Lost to Follow-up|0|||
105893866|NCT02083185|365265948|FG000|Overall Study|Withdrawal by Subject|9|||
105893867|NCT02083185|365265949|FG001|Overall Study|Withdrawal by Subject|15|||
105893868|NCT02083185|365265950|FG002|Overall Study|Withdrawal by Subject|1|||
105893869|NCT02083185|365265948|FG000|Overall Study|Death|2|||
105893870|NCT02083185|365265949|FG001|Overall Study|Death|2|||
105893871|NCT02083185|365265950|FG002|Overall Study|Death|1|||
105893872|NCT02083185|365265948|FG000|Overall Study|Reason not Specified|9|||
105893873|NCT02083185|365265949|FG001|Overall Study|Reason not Specified|6|||
105893874|NCT02083185|365265950|FG002|Overall Study|Reason not Specified|5|||
105893875|NCT02083185|365265948|FG000|Overall Study|Study Terminated by Sponsor|0|||
105893876|NCT02083185|365265949|FG001|Overall Study|Study Terminated by Sponsor|1|||
105893877|NCT02083185|365265950|FG002|Overall Study|Study Terminated by Sponsor|0|||
105893878|NCT02083185|365265948|FG000|Overall Study|Did not Receive Study Drug|0|||
105893879|NCT02083185|365265949|FG001|Overall Study|Did not Receive Study Drug|2|||
105893880|NCT02083185|365265950|FG002|Overall Study|Did not Receive Study Drug|0|||
105893881|NCT01384019|365265955|FG000|Overall Study|Withdrawal by Subject|3|||
105893882|NCT01384019|365265956|FG001|Overall Study|Withdrawal by Subject|0|||
105893883|NCT01384019|365265955|FG000|Overall Study|Death|1|||
105893884|NCT01384019|365265956|FG001|Overall Study|Death|0|||
105996987|NCT03384940|365649577|FG002|Overall Study|Withdrawal by Subject|0|||
105893885|NCT01384019|365265955|FG000|Overall Study|MRI refusal|6|||
105893886|NCT01384019|365265956|FG001|Overall Study|MRI refusal|6|||
105893887|NCT02258542|365265958|FG000|Overall Study|eg. not made to the visit|7|||
105893888|NCT02258542|365265959|FG001|Overall Study|eg. not made to the visit|4|||
105893889|NCT02258542|365265960|FG002|Overall Study|eg. not made to the visit|0|||
105893890|NCT02258542|365265961|FG003|Overall Study|eg. not made to the visit|1|||
105893891|NCT02258542|365265958|FG000|Overall Study|study specific discount. criteria|1|||
105893892|NCT02258542|365265959|FG001|Overall Study|study specific discount. criteria|1|||
105893893|NCT02258542|365265960|FG002|Overall Study|study specific discount. criteria|0|||
105893894|NCT02258542|365265961|FG003|Overall Study|study specific discount. criteria|0|||
105893895|NCT02258542|365265958|FG000|Overall Study|Withdrawal by Subject|20|||
105996988|NCT03384940|365649575|FG000|Overall Study|Physician Decision|1|||
105996989|NCT03384940|365649576|FG001|Overall Study|Physician Decision|1|||
105996990|NCT03384940|365649577|FG002|Overall Study|Physician Decision|0|||
105665453|NCT00725712|364440738|FG000|Overall Study|Hospitalized, unable to continue|0|||
105893896|NCT02258542|365265959|FG001|Overall Study|Withdrawal by Subject|20|||
105996991|NCT03384940|365649575|FG000|Overall Study|Death|2|||
106122647|NCT02397460|366106146|FG004|Treatment Period 4|Physician Decision|1|||
106122648|NCT02397460|366106147|FG005|Treatment Period 4|Physician Decision|0|||
106122649|NCT02397460|366106148|FG006|Treatment Period 4|Physician Decision|0|||
105893897|NCT02258542|365265960|FG002|Overall Study|Withdrawal by Subject|7|||
105893898|NCT02258542|365265961|FG003|Overall Study|Withdrawal by Subject|1|||
105893899|NCT02258542|365265958|FG000|Overall Study|Lost to Follow-up|5|||
105893900|NCT02258542|365265959|FG001|Overall Study|Lost to Follow-up|12|||
105893901|NCT02258542|365265960|FG002|Overall Study|Lost to Follow-up|1|||
105893902|NCT02258542|365265961|FG003|Overall Study|Lost to Follow-up|2|||
105893903|NCT02258542|365265958|FG000|Overall Study|Death|5|||
105893904|NCT02258542|365265959|FG001|Overall Study|Death|4|||
105893905|NCT02258542|365265960|FG002|Overall Study|Death|0|||
105893906|NCT02258542|365265961|FG003|Overall Study|Death|1|||
105893907|NCT02258542|365265958|FG000|Overall Study|Adverse Event|3|||
105893908|NCT02258542|365265959|FG001|Overall Study|Adverse Event|4|||
105893909|NCT02258542|365265960|FG002|Overall Study|Adverse Event|0|||
105893910|NCT02258542|365265961|FG003|Overall Study|Adverse Event|0|||
105893911|NCT02258542|365265958|FG000|Overall Study|Protocol Violation|1|||
105893912|NCT02258542|365265959|FG001|Overall Study|Protocol Violation|2|||
105893913|NCT02258542|365265960|FG002|Overall Study|Protocol Violation|0|||
105893914|NCT02258542|365265961|FG003|Overall Study|Protocol Violation|0|||
105893915|NCT02258542|365265958|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105893916|NCT02258542|365265959|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
105893917|NCT02258542|365265960|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105893918|NCT02258542|365265961|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
105893919|NCT00844480|365265968|FG000|Overall Study|Withdrawal by Subject|2|||
105893920|NCT00844480|365265969|FG001|Overall Study|Withdrawal by Subject|3|||
105893921|NCT02858180|365265970|FG000|Overall Study|Lost to Follow-up|0|||
105893922|NCT02858180|365265971|FG001|Overall Study|Lost to Follow-up|2|||
105893923|NCT00526331|365265972|FG000|Overall Study|Sponsor Termination|55|||
105893924|NCT00979420|365265973|FG000|Overall Study|Adverse Event|1|||
105893925|NCT00979420|365265974|FG001|Overall Study|Adverse Event|0|||
105893926|NCT00979420|365265975|FG002|Overall Study|Adverse Event|0|||
105893927|NCT00979420|365265976|FG003|Overall Study|Adverse Event|0|||
105893928|NCT00979420|365265973|FG000|Overall Study|Lack of Efficacy|3|||
105893929|NCT00979420|365265974|FG001|Overall Study|Lack of Efficacy|0|||
105893930|NCT00979420|365265975|FG002|Overall Study|Lack of Efficacy|1|||
105893931|NCT00979420|365265976|FG003|Overall Study|Lack of Efficacy|1|||
105893932|NCT00979420|365265973|FG000|Overall Study|Other reasons not related to Viramune|3|||
105893933|NCT00979420|365265974|FG001|Overall Study|Other reasons not related to Viramune|0|||
105893934|NCT00979420|365265975|FG002|Overall Study|Other reasons not related to Viramune|0|||
105893935|NCT00979420|365265976|FG003|Overall Study|Other reasons not related to Viramune|1|||
105893936|NCT05087966|365265979|FG000|Overall Study|Lost to Follow-up|1|||
105893937|NCT05087966|365265979|FG000|Overall Study|Withdrawal by Subject|5|||
105893938|NCT04050124|365265980|FG000|Overall Study|Death|1|||
105893939|NCT04050124|365265981|FG001|Overall Study|Death|0|||
105893940|NCT03099694|365265983|FG000|Overall Study|Withdrawal by Subject|11|||
105893941|NCT03099694|365265984|FG001|Overall Study|Withdrawal by Subject|13|||
105893942|NCT03099694|365265983|FG000|Overall Study|Lost to Follow-up|9|||
105893943|NCT03099694|365265984|FG001|Overall Study|Lost to Follow-up|5|||
105893944|NCT03045276|365265985|FG000|Intervention Phase|Withdrawal by Subject|7|||
105893945|NCT03045276|365265986|FG001|Intervention Phase|Withdrawal by Subject|2|||
105893946|NCT03045276|365265987|FG002|Intervention Phase|Withdrawal by Subject|3|||
105893947|NCT03045276|365265988|FG003|Intervention Phase|Withdrawal by Subject|7|||
105893948|NCT03045276|365265985|FG000|Intervention Phase|Developed exclusionary criteria|3|||
105893949|NCT03045276|365265986|FG001|Intervention Phase|Developed exclusionary criteria|3|||
105893950|NCT03045276|365265987|FG002|Intervention Phase|Developed exclusionary criteria|0|||
105893951|NCT03045276|365265988|FG003|Intervention Phase|Developed exclusionary criteria|0|||
105893952|NCT03045276|365265985|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
105893953|NCT03045276|365265986|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
105893954|NCT03045276|365265987|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
105893955|NCT03045276|365265988|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
105893956|NCT03045276|365265985|FG000|Follow-Up Phase|Lost to Follow-up|0|||
105893957|NCT03045276|365265986|FG001|Follow-Up Phase|Lost to Follow-up|1|||
105893958|NCT03045276|365265987|FG002|Follow-Up Phase|Lost to Follow-up|0|||
105893959|NCT03045276|365265988|FG003|Follow-Up Phase|Lost to Follow-up|1|||
105893960|NCT03045276|365265985|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
105893961|NCT03045276|365265986|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
105893962|NCT03045276|365265987|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
105893963|NCT03045276|365265988|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
105893964|NCT01797081|365265989|FG000|Overall Study|Adverse Event|1|||
106122650|NCT02397460|366106149|FG007|Treatment Period 4|Physician Decision|0|||
106122651|NCT02388074|366106152|FG000|Overall Study|Lost in Transit|2|||
105893965|NCT01797081|365265990|FG001|Overall Study|Adverse Event|0|||
105893966|NCT01797081|365265991|FG002|Overall Study|Adverse Event|1|||
106122652|NCT02388074|366106152|FG000|Overall Study|Sample Not Returned|1|||
105893967|NCT01797081|365265992|FG003|Overall Study|Adverse Event|0|||
105665454|NCT00725712|364440739|FG001|Overall Study|Hospitalized, unable to continue|1|||
105665455|NCT02763215|364440740|FG000|Overall Study|Participants withdrew from study|3|||
105665456|NCT02763215|364440740|FG000|Overall Study|Missed visit|1|||
105665457|NCT02763215|364440740|FG000|Overall Study|Visit outside visit-window|1|||
105665458|NCT02763215|364440740|FG000|Overall Study|Death|1|||
105665459|NCT02763215|364440740|FG000|Overall Study|Lost to Follow-up|1|||
105665460|NCT01667926|364440741|FG000|Overall Study|Withdrawal by Subject|1|||
105665461|NCT01667926|364440742|FG001|Overall Study|Withdrawal by Subject|2|||
105665462|NCT01667926|364440743|FG002|Overall Study|Withdrawal by Subject|2|||
105665463|NCT01667926|364440741|FG000|Overall Study|Physician Decision|0|||
105665464|NCT01667926|364440742|FG001|Overall Study|Physician Decision|0|||
105665465|NCT01667926|364440743|FG002|Overall Study|Physician Decision|1|||
105665466|NCT01667926|364440741|FG000|Overall Study|Time committment|0|||
105665467|NCT01667926|364440742|FG001|Overall Study|Time committment|0|||
105665468|NCT01667926|364440743|FG002|Overall Study|Time committment|2|||
105665469|NCT01667926|364440741|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
105665470|NCT01667926|364440742|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
105893968|NCT01797081|365265989|FG000|Overall Study|Pregnancy|1|||
105893969|NCT01797081|365265990|FG001|Overall Study|Pregnancy|0|||
105893970|NCT01797081|365265991|FG002|Overall Study|Pregnancy|0|||
105893971|NCT01797081|365265992|FG003|Overall Study|Pregnancy|0|||
105893972|NCT01797081|365265989|FG000|Overall Study|Personal Reasons|12|||
105893973|NCT01797081|365265990|FG001|Overall Study|Personal Reasons|4|||
105893974|NCT01797081|365265991|FG002|Overall Study|Personal Reasons|4|||
105893975|NCT01797081|365265992|FG003|Overall Study|Personal Reasons|8|||
105893976|NCT01797081|365265989|FG000|Overall Study|Protocol Violation|0|||
105893977|NCT01797081|365265990|FG001|Overall Study|Protocol Violation|0|||
105893978|NCT01797081|365265991|FG002|Overall Study|Protocol Violation|0|||
105893979|NCT01797081|365265992|FG003|Overall Study|Protocol Violation|1|||
105893980|NCT00824382|365265993|FG000|Overall Study|Adverse Event|4|||
105893981|NCT00824382|365265994|FG001|Overall Study|Adverse Event|1|||
105893982|NCT00824382|365265995|FG002|Overall Study|Adverse Event|1|||
105893983|NCT00824382|365265996|FG003|Overall Study|Adverse Event|4|||
105893984|NCT00824382|365265993|FG000|Overall Study|Protocol Violation|1|||
105893985|NCT00824382|365265994|FG001|Overall Study|Protocol Violation|0|||
105893986|NCT00824382|365265995|FG002|Overall Study|Protocol Violation|0|||
105893987|NCT00824382|365265996|FG003|Overall Study|Protocol Violation|1|||
105893988|NCT00824382|365265993|FG000|Overall Study|Investigator's decision|0|||
105893989|NCT00824382|365265994|FG001|Overall Study|Investigator's decision|1|||
105893990|NCT00824382|365265995|FG002|Overall Study|Investigator's decision|2|||
105893991|NCT00824382|365265996|FG003|Overall Study|Investigator's decision|0|||
105893992|NCT02832375|365265999|FG000|Overall Study|Lost to Follow-up|1|||
105893993|NCT02832375|365266000|FG001|Overall Study|Lost to Follow-up|0|||
105893994|NCT02832375|365265999|FG000|Overall Study|Withdrawal of Consent|1|||
105893995|NCT02832375|365266000|FG001|Overall Study|Withdrawal of Consent|0|||
105893996|NCT00336024|365266001|FG000|Overall Study|Death|2|||
105893997|NCT00336024|365266002|FG001|Overall Study|Death|1|||
105893998|NCT00336024|365266001|FG000|Overall Study|Physician Decision|4|||
105893999|NCT00336024|365266002|FG001|Overall Study|Physician Decision|1|||
105894000|NCT00336024|365266001|FG000|Overall Study|Protocol Violation|1|||
105894001|NCT00336024|365266002|FG001|Overall Study|Protocol Violation|0|||
105894002|NCT00336024|365266001|FG000|Overall Study|Withdrawal by Subject|1|||
105894003|NCT00336024|365266002|FG001|Overall Study|Withdrawal by Subject|2|||
105894004|NCT00336024|365266001|FG000|Overall Study|Failure to fulfill consolidation|1|||
105894005|NCT00336024|365266002|FG001|Overall Study|Failure to fulfill consolidation|1|||
105894006|NCT00336024|365266001|FG000|Overall Study|Progressive Disease|4|||
105894007|NCT00336024|365266002|FG001|Overall Study|Progressive Disease|7|||
105894008|NCT00336024|365266001|FG000|Overall Study|Ineligible|7|||
105894009|NCT00336024|365266002|FG001|Overall Study|Ineligible|7|||
105894010|NCT00084318|365266003|FG000|Overall Study|Withdrawal by Subject|5|||
105894011|NCT00084318|365266004|FG001|Overall Study|Withdrawal by Subject|2|||
105894012|NCT00084318|365266003|FG000|Overall Study|Protocol Violation|15|||
105894013|NCT00084318|365266004|FG001|Overall Study|Protocol Violation|11|||
105894014|NCT00084318|365266003|FG000|Overall Study|No protocol treatment|2|||
105665471|NCT01667926|364440743|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
105665472|NCT01667926|364440741|FG000|Overall Study|Lost to Follow-up|1|||
105665473|NCT01667926|364440742|FG001|Overall Study|Lost to Follow-up|2|||
105894015|NCT00084318|365266004|FG001|Overall Study|No protocol treatment|0|||
105894016|NCT01645891|365266005|FG000|Overall Study|Adverse Event|6|||
105894017|NCT01645891|365266006|FG001|Overall Study|Adverse Event|10|||
105665474|NCT01667926|364440743|FG002|Overall Study|Lost to Follow-up|1|||
105894018|NCT01645891|365266005|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
105894019|NCT01645891|365266006|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
105894020|NCT01645891|365266005|FG000|Overall Study|Withdrawal by Subject|3|||
105894021|NCT01645891|365266006|FG001|Overall Study|Withdrawal by Subject|3|||
105894022|NCT01645891|365266005|FG000|Overall Study|Protocol Violation|4|||
105894023|NCT01645891|365266006|FG001|Overall Study|Protocol Violation|0|||
105894024|NCT01645891|365266005|FG000|Overall Study|Lost to Follow-up|4|||
105894025|NCT01645891|365266006|FG001|Overall Study|Lost to Follow-up|1|||
105996992|NCT03384940|365649576|FG001|Overall Study|Death|1|||
105996993|NCT03384940|365649577|FG002|Overall Study|Death|0|||
105996994|NCT03384940|365649575|FG000|Overall Study|Other|0|||
105996995|NCT03384940|365649576|FG001|Overall Study|Other|0|||
105996996|NCT03384940|365649577|FG002|Overall Study|Other|1|||
105996997|NCT01288989|365649581|FG000|Overall Study|Death|0|||
105996998|NCT01288989|365649582|FG001|Overall Study|Death|0|||
105996999|NCT01288989|365649583|FG002|Overall Study|Death|0|||
105997000|NCT01288989|365649584|FG003|Overall Study|Death|1|||
105997001|NCT01288989|365649585|FG004|Overall Study|Death|0|||
105997002|NCT01288989|365649581|FG000|Overall Study|Dose limiting toxicity|1|||
105997003|NCT01288989|365649582|FG001|Overall Study|Dose limiting toxicity|0|||
105997004|NCT01288989|365649583|FG002|Overall Study|Dose limiting toxicity|0|||
105997005|NCT01288989|365649584|FG003|Overall Study|Dose limiting toxicity|0|||
105997006|NCT01288989|365649585|FG004|Overall Study|Dose limiting toxicity|0|||
105997007|NCT01288989|365649581|FG000|Overall Study|Adverse Event|0|||
105997008|NCT01288989|365649582|FG001|Overall Study|Adverse Event|0|||
105997009|NCT01288989|365649583|FG002|Overall Study|Adverse Event|0|||
105997010|NCT01288989|365649584|FG003|Overall Study|Adverse Event|0|||
105997011|NCT01288989|365649585|FG004|Overall Study|Adverse Event|2|||
105997012|NCT01288989|365649581|FG000|Overall Study|Physician Decision|0|||
105997013|NCT01288989|365649582|FG001|Overall Study|Physician Decision|0|||
105997014|NCT01288989|365649583|FG002|Overall Study|Physician Decision|0|||
105997015|NCT01288989|365649584|FG003|Overall Study|Physician Decision|0|||
105997016|NCT01288989|365649585|FG004|Overall Study|Physician Decision|1|||
105997017|NCT01288989|365649581|FG000|Overall Study|Withdrawal by Subject|0|||
105997018|NCT01288989|365649582|FG001|Overall Study|Withdrawal by Subject|0|||
105997019|NCT01288989|365649583|FG002|Overall Study|Withdrawal by Subject|0|||
105997020|NCT01288989|365649584|FG003|Overall Study|Withdrawal by Subject|0|||
105997021|NCT01288989|365649585|FG004|Overall Study|Withdrawal by Subject|3|||
105997022|NCT04378270|365649586|FG000|Overall Study|Lack of Efficacy|1|||
105997023|NCT04378270|365649586|FG000|Overall Study|Withdrawal by Subject|1|||
105997024|NCT04378270|365649586|FG000|Overall Study|Screen Failure|1|||
105997025|NCT04378270|365649586|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
105997026|NCT01156714|365649587|FG000|Overall Study|Withdrawal by Subject|9|||
105997027|NCT01156714|365649588|FG001|Overall Study|Withdrawal by Subject|4|||
105997028|NCT01156714|365649589|FG002|Overall Study|Withdrawal by Subject|3|||
105997029|NCT03201419|365649602|FG000|Overall Study|Adverse Event|3|||
106122653|NCT00003458|366106153|FG000|Overall Study|Not evaluable|4|||
106122654|NCT02601937|366106154|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122655|NCT02601937|366106155|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122656|NCT02601937|366106156|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122657|NCT02601937|366106157|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122658|NCT02601937|366106158|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122659|NCT02601937|366106159|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
106122660|NCT02601937|366106160|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122661|NCT02601937|366106161|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122662|NCT02601937|366106162|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122663|NCT02601937|366106163|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122664|NCT02601937|366106164|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
106122665|NCT02601937|366106154|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
106122666|NCT02601937|366106155|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122667|NCT02601937|366106156|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122668|NCT02601937|366106157|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122669|NCT02601937|366106158|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122670|NCT02601937|366106159|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122671|NCT02601937|366106160|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
106122672|NCT02601937|366106161|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122673|NCT02601937|366106162|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122674|NCT02601937|366106163|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122675|NCT02601937|366106164|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
106122676|NCT02601937|366106154|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
106122677|NCT02601937|366106155|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105997030|NCT03201419|365649603|FG001|Overall Study|Adverse Event|1|||
105997031|NCT03201419|365649604|FG002|Overall Study|Adverse Event|0|||
105997032|NCT03201419|365649605|FG003|Overall Study|Adverse Event|0|||
105997033|NCT03201419|365649606|FG004|Overall Study|Adverse Event|1|||
105997034|NCT03201419|365649607|FG005|Overall Study|Adverse Event|1|||
105997035|NCT03201419|365649608|FG006|Overall Study|Adverse Event|5|||
105997036|NCT03201419|365649609|FG007|Overall Study|Adverse Event|0|||
105997037|NCT03201419|365649610|FG008|Overall Study|Adverse Event|0|||
105997038|NCT03201419|365649602|FG000|Overall Study|Lost to Follow-up|1|||
105997039|NCT03201419|365649603|FG001|Overall Study|Lost to Follow-up|0|||
106122678|NCT02601937|366106156|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
106122679|NCT02601937|366106157|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
106122680|NCT02601937|366106158|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
106122681|NCT02601937|366106159|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
106122682|NCT02601937|366106160|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
106122683|NCT02601937|366106161|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
105894026|NCT01645891|365266005|FG000|Overall Study|Death|0|||
105894027|NCT01645891|365266006|FG001|Overall Study|Death|2|||
105894028|NCT03026530|365266007|FG000|Overall Study|Lost to Follow-up|19|||
105894029|NCT03026530|365266008|FG001|Overall Study|Lost to Follow-up|24|||
105894030|NCT03026530|365266007|FG000|Overall Study|Protocol Violation|2|||
105894031|NCT03026530|365266008|FG001|Overall Study|Protocol Violation|5|||
105894032|NCT03301740|365266009|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
106122684|NCT02601937|366106162|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
106122685|NCT02601937|366106163|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
106122686|NCT02601937|366106164|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
106122687|NCT02601937|366106154|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
106122688|NCT02601937|366106155|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
106122689|NCT02601937|366106156|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
106122690|NCT02601937|366106157|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
106122691|NCT02601937|366106158|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
106122692|NCT02601937|366106159|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
106122693|NCT02601937|366106160|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
106122694|NCT02601937|366106161|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
106122695|NCT02601937|366106162|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
106122696|NCT02601937|366106163|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
106122697|NCT02601937|366106164|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
106122698|NCT02601937|366106154|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122699|NCT02601937|366106155|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122700|NCT02601937|366106156|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122701|NCT02601937|366106157|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122702|NCT02601937|366106158|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122703|NCT02601937|366106159|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122704|NCT02601937|366106160|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122705|NCT02601937|366106161|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122706|NCT02601937|366106162|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122707|NCT02601937|366106163|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
106122708|NCT02601937|366106164|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
106122709|NCT02601937|366106154|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
105894033|NCT03301740|365266010|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
105894034|NCT03301740|365266009|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
105894035|NCT03301740|365266010|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
105894036|NCT02847182|365266012|FG000|Overall Study|Withdrawal by Subject|0|||
105665475|NCT01667926|364440741|FG000|Overall Study|Side effects|3|||
105665476|NCT01667926|364440742|FG001|Overall Study|Side effects|0|||
105665477|NCT01667926|364440743|FG002|Overall Study|Side effects|0|||
105665478|NCT00475644|364440745|FG000|Overall Study|Protocol Violation|13|||
105665479|NCT01411241|364440746|FG000|Overall Study|Protocol Violation|0|||
105665480|NCT01411241|364440747|FG001|Overall Study|Protocol Violation|5|||
105665481|NCT01411241|364440746|FG000|Overall Study|Withdrawal by Subject|9|||
105665482|NCT01411241|364440747|FG001|Overall Study|Withdrawal by Subject|10|||
105665483|NCT01411241|364440746|FG000|Overall Study|Serious Adverse Event|0|||
105665484|NCT01411241|364440747|FG001|Overall Study|Serious Adverse Event|3|||
105665485|NCT01411241|364440746|FG000|Overall Study|Lost to Follow-up|2|||
105665486|NCT01411241|364440747|FG001|Overall Study|Lost to Follow-up|4|||
105665487|NCT00078338|364440748|FG000|Overall Study|Adverse Event|31|||
105894037|NCT02847182|365266013|FG001|Overall Study|Withdrawal by Subject|1|||
105894038|NCT03191864|365266014|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
105894039|NCT03191864|365266015|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
105894040|NCT03191864|365266016|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
105894041|NCT03191864|365266017|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
105894042|NCT03191864|365266018|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
105894043|NCT03191864|365266019|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
105894044|NCT03191864|365266014|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105894045|NCT03191864|365266015|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105894046|NCT03191864|365266016|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105894047|NCT03191864|365266017|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105894048|NCT03191864|365266018|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
105894049|NCT03191864|365266019|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
105894050|NCT03191864|365266014|FG000|Baseline Symptom Assessment|Adverse Event|0|||
105894051|NCT03191864|365266015|FG001|Baseline Symptom Assessment|Adverse Event|0|||
105894052|NCT03191864|365266016|FG002|Baseline Symptom Assessment|Adverse Event|0|||
105894053|NCT03191864|365266017|FG003|Baseline Symptom Assessment|Adverse Event|0|||
105894054|NCT03191864|365266018|FG004|Baseline Symptom Assessment|Adverse Event|0|||
105894055|NCT03191864|365266019|FG005|Baseline Symptom Assessment|Adverse Event|2|||
105894056|NCT03191864|365266014|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105894057|NCT03191864|365266015|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105894058|NCT03191864|365266016|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105894059|NCT03191864|365266017|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105894060|NCT03191864|365266018|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
105894061|NCT03191864|365266019|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
105894062|NCT03191864|365266014|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105894063|NCT03191864|365266015|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105894064|NCT03191864|365266016|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105894065|NCT03191864|365266017|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105894066|NCT03191864|365266018|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
105894067|NCT03191864|365266019|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
105894068|NCT03191864|365266014|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
105894069|NCT03191864|365266015|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
105894070|NCT03191864|365266016|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
105894071|NCT03191864|365266017|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
105894072|NCT03191864|365266018|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
105894073|NCT03191864|365266019|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
105894074|NCT03191864|365266014|FG000|Part 1 - Induction|Adverse Event|0|||
105894075|NCT03191864|365266015|FG001|Part 1 - Induction|Adverse Event|2|||
105894076|NCT03191864|365266016|FG002|Part 1 - Induction|Adverse Event|0|||
105894077|NCT03191864|365266017|FG003|Part 1 - Induction|Adverse Event|1|||
105894078|NCT03191864|365266018|FG004|Part 1 - Induction|Adverse Event|0|||
105894079|NCT03191864|365266019|FG005|Part 1 - Induction|Adverse Event|2|||
105894080|NCT03191864|365266014|FG000|Part 1 - Induction|Randomized but never dosed|0|||
105894081|NCT03191864|365266015|FG001|Part 1 - Induction|Randomized but never dosed|0|||
105894082|NCT03191864|365266016|FG002|Part 1 - Induction|Randomized but never dosed|1|||
105894083|NCT03191864|365266017|FG003|Part 1 - Induction|Randomized but never dosed|0|||
105894084|NCT03191864|365266018|FG004|Part 1 - Induction|Randomized but never dosed|0|||
105894085|NCT03191864|365266019|FG005|Part 1 - Induction|Randomized but never dosed|0|||
105894086|NCT03191864|365266014|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
105894087|NCT03191864|365266015|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
105894088|NCT03191864|365266016|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
105894089|NCT03191864|365266017|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
105665488|NCT00078338|364440749|FG001|Overall Study|Adverse Event|24|||
105665489|NCT00078338|364440748|FG000|Overall Study|Lost to Follow-up|17|||
105665490|NCT00078338|364440749|FG001|Overall Study|Lost to Follow-up|2|||
105665491|NCT00078338|364440748|FG000|Overall Study|Protocol Violation|2|||
105665492|NCT00078338|364440749|FG001|Overall Study|Protocol Violation|2|||
105894090|NCT03191864|365266018|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
105894091|NCT03191864|365266019|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
105894092|NCT03191864|365266014|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105894093|NCT03191864|365266015|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105894094|NCT03191864|365266016|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
105894095|NCT03191864|365266017|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105894096|NCT03191864|365266018|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105894097|NCT03191864|365266019|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
105894098|NCT03191864|365266014|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
105894099|NCT03191864|365266015|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105894100|NCT03191864|365266016|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105894101|NCT03191864|365266017|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105894102|NCT03191864|365266018|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105894103|NCT03191864|365266019|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
105894104|NCT03191864|365266014|FG000|Part 2 - Maintenance|Physician Decision|1|||
105894105|NCT03191864|365266015|FG001|Part 2 - Maintenance|Physician Decision|0|||
105894106|NCT03191864|365266016|FG002|Part 2 - Maintenance|Physician Decision|0|||
105894107|NCT03191864|365266017|FG003|Part 2 - Maintenance|Physician Decision|0|||
105894108|NCT03191864|365266018|FG004|Part 2 - Maintenance|Physician Decision|0|||
105894109|NCT03191864|365266019|FG005|Part 2 - Maintenance|Physician Decision|0|||
105894110|NCT03191864|365266014|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
105894111|NCT03191864|365266015|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
105894112|NCT03191864|365266016|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
105894113|NCT03191864|365266017|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
105894114|NCT03191864|365266018|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
105894115|NCT03191864|365266019|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
105894116|NCT03191864|365266014|FG000|Part 2 - Maintenance|Adverse Event|0|||
105894117|NCT03191864|365266015|FG001|Part 2 - Maintenance|Adverse Event|0|||
105894118|NCT03191864|365266016|FG002|Part 2 - Maintenance|Adverse Event|0|||
105894119|NCT03191864|365266017|FG003|Part 2 - Maintenance|Adverse Event|0|||
105894120|NCT03191864|365266018|FG004|Part 2 - Maintenance|Adverse Event|1|||
105894121|NCT03191864|365266019|FG005|Part 2 - Maintenance|Adverse Event|0|||
105894122|NCT03191864|365266014|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
105894123|NCT03191864|365266015|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
105894124|NCT03191864|365266016|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
105894125|NCT03191864|365266017|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
105894126|NCT03191864|365266018|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
105894127|NCT03191864|365266019|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
105894128|NCT03191864|365266014|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105894129|NCT03191864|365266015|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105894130|NCT03191864|365266016|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105894131|NCT03191864|365266017|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105894132|NCT03191864|365266018|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
105894133|NCT03191864|365266019|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
105894134|NCT01702532|365267586|FG000|Overall Study|Adverse Event|0|||
105894135|NCT01702532|365267587|FG001|Overall Study|Adverse Event|1|||
105894136|NCT00623597|365267588|FG000|Overall Study|Failed to return|1|||
105894137|NCT00623597|365267589|FG001|Overall Study|Failed to return|0|||
105894138|NCT02515994|365267590|FG000|Overall Study|Protocol Violation|3|||
105894139|NCT02515994|365267591|FG001|Overall Study|Protocol Violation|5|||
105894140|NCT02515994|365267590|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
105894141|NCT02515994|365267591|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
105894142|NCT02515994|365267590|FG000|Overall Study|Adverse Event|3|||
105894143|NCT02515994|365267591|FG001|Overall Study|Adverse Event|1|||
105894144|NCT02515994|365267590|FG000|Overall Study|Withdrawal by Subject|2|||
105894145|NCT02515994|365267591|FG001|Overall Study|Withdrawal by Subject|0|||
105894146|NCT02659514|365267594|FG000|Overall Study|Adverse Event|3|||
105894147|NCT02659514|365267595|FG001|Overall Study|Adverse Event|12|||
105894148|NCT02659514|365267594|FG000|Overall Study|Disease Progression|23|||
105894149|NCT02659514|365267595|FG001|Overall Study|Disease Progression|13|||
105997040|NCT03201419|365649604|FG002|Overall Study|Lost to Follow-up|0|||
105997041|NCT03201419|365649605|FG003|Overall Study|Lost to Follow-up|0|||
105997042|NCT03201419|365649606|FG004|Overall Study|Lost to Follow-up|0|||
105894150|NCT02659514|365267594|FG000|Overall Study|Withdrawal by Subject|0|||
105894151|NCT02659514|365267595|FG001|Overall Study|Withdrawal by Subject|4|||
105894152|NCT02659514|365267594|FG000|Overall Study|Lost to Follow-up|0|||
105894153|NCT02659514|365267595|FG001|Overall Study|Lost to Follow-up|1|||
105894154|NCT02659514|365267594|FG000|Overall Study|Death|6|||
105997043|NCT03201419|365649607|FG005|Overall Study|Lost to Follow-up|0|||
105894155|NCT02659514|365267595|FG001|Overall Study|Death|1|||
105894156|NCT02659514|365267594|FG000|Overall Study|Reason Unspecified|0|||
105894157|NCT02659514|365267595|FG001|Overall Study|Reason Unspecified|3|||
105894158|NCT01661933|365267596|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
105894159|NCT01661933|365267596|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
105894160|NCT03385304|365267601|FG000|Overall Study|Death|19|||
105894161|NCT03385304|365267602|FG001|Overall Study|Death|7|||
105894162|NCT03385304|365267601|FG000|Overall Study|Lost to Follow-up|17|||
105894163|NCT03385304|365267602|FG001|Overall Study|Lost to Follow-up|14|||
105894164|NCT03385304|365267601|FG000|Overall Study|Withdrawal by Subject|3|||
105894165|NCT03385304|365267602|FG001|Overall Study|Withdrawal by Subject|2|||
105894166|NCT03385304|365267601|FG000|Overall Study|Incarceration|2|||
105894167|NCT03385304|365267602|FG001|Overall Study|Incarceration|3|||
105894168|NCT01565668|365267603|FG000|Overall Study|Death|2|||
105894169|NCT01565668|365267604|FG001|Overall Study|Death|1|||
105894170|NCT01565668|365267603|FG000|Overall Study|Lack of Efficacy|4|||
105894171|NCT01565668|365267604|FG001|Overall Study|Lack of Efficacy|2|||
105894172|NCT01565668|365267603|FG000|Overall Study|Participant went on Hospice Care|1|||
105894173|NCT01565668|365267604|FG001|Overall Study|Participant went on Hospice Care|0|||
105894174|NCT01565668|365267603|FG000|Overall Study|Adverse Event|6|||
105894175|NCT01565668|365267604|FG001|Overall Study|Adverse Event|1|||
105894176|NCT01565668|365267603|FG000|Overall Study|Randomized, but never received drug|0|||
105894177|NCT01565668|365267604|FG001|Overall Study|Randomized, but never received drug|2|||
105894178|NCT01565668|365267603|FG000|Overall Study|Progressive disease|13|||
105894179|NCT01565668|365267604|FG001|Overall Study|Progressive disease|14|||
105894180|NCT01565668|365267603|FG000|Overall Study|Withdrawal by Subject|1|||
105894181|NCT01565668|365267604|FG001|Overall Study|Withdrawal by Subject|3|||
105894182|NCT01565668|365267603|FG000|Overall Study|HSCT Transplant|11|||
105894183|NCT01565668|365267604|FG001|Overall Study|HSCT Transplant|15|||
105894184|NCT02499146|365267607|FG000|Overall Study|Lost to Follow-up|1|||
105894185|NCT02499146|365267607|FG000|Overall Study|Withdrawal by Subject|1|||
105894186|NCT02499146|365267607|FG000|Overall Study|Other|2|||
105894187|NCT02499146|365267607|FG000|Overall Study|Ongoing at date of cut-off|9|||
105894188|NCT02499146|365267607|FG000|Overall Study|Began other treatment/therapy|13|||
105894189|NCT04495816|365267625|FG000|Overall Study|Lost to Follow-up|10|||
105894190|NCT04495816|365267626|FG001|Overall Study|Lost to Follow-up|4|||
105894191|NCT04495816|365267625|FG000|Overall Study|Withdrawal by Subject|3|||
105894192|NCT04495816|365267626|FG001|Overall Study|Withdrawal by Subject|5|||
105894193|NCT01149421|365267627|FG000|Overall Study|Adverse Event|22|||
105894194|NCT01149421|365267628|FG001|Overall Study|Adverse Event|6|||
105894195|NCT01149421|365267629|FG002|Overall Study|Adverse Event|11|||
105894196|NCT01149421|365267627|FG000|Overall Study|Withdrawal by Subject|20|||
105894197|NCT01149421|365267628|FG001|Overall Study|Withdrawal by Subject|12|||
105894198|NCT01149421|365267629|FG002|Overall Study|Withdrawal by Subject|13|||
105894199|NCT01149421|365267627|FG000|Overall Study|Sponsor Decision|0|||
105894200|NCT01149421|365267628|FG001|Overall Study|Sponsor Decision|1|||
105894201|NCT01149421|365267629|FG002|Overall Study|Sponsor Decision|1|||
105894202|NCT01149421|365267627|FG000|Overall Study|Lost to Follow-up|2|||
105894203|NCT01149421|365267628|FG001|Overall Study|Lost to Follow-up|4|||
105894204|NCT01149421|365267629|FG002|Overall Study|Lost to Follow-up|5|||
105894205|NCT01149421|365267627|FG000|Overall Study|Physician Decision|5|||
105894206|NCT01149421|365267628|FG001|Overall Study|Physician Decision|3|||
105894207|NCT01149421|365267629|FG002|Overall Study|Physician Decision|6|||
105894208|NCT01149421|365267627|FG000|Overall Study|Entry Criteria Not Met|1|||
105894209|NCT01149421|365267628|FG001|Overall Study|Entry Criteria Not Met|1|||
105894210|NCT01149421|365267629|FG002|Overall Study|Entry Criteria Not Met|2|||
105894211|NCT01149421|365267627|FG000|Overall Study|Protocol Violation|2|||
105894212|NCT01149421|365267628|FG001|Overall Study|Protocol Violation|2|||
105894213|NCT01149421|365267629|FG002|Overall Study|Protocol Violation|6|||
105894214|NCT03181503|365267630|FG000|Overall Study|Adverse Event|2|||
105894215|NCT03181503|365267631|FG001|Overall Study|Adverse Event|2|||
105894216|NCT03181503|365267630|FG000|Overall Study|Protocol Violation|1|||
105894217|NCT03181503|365267631|FG001|Overall Study|Protocol Violation|0|||
105894218|NCT03181503|365267630|FG000|Overall Study|Withdrawal by Subject|3|||
105894219|NCT03181503|365267631|FG001|Overall Study|Withdrawal by Subject|0|||
105894220|NCT03181503|365267630|FG000|Overall Study|Lost to Follow-up|1|||
105894221|NCT03181503|365267631|FG001|Overall Study|Lost to Follow-up|1|||
105894222|NCT01892085|365267632|FG000|Overall Study|Death|4|||
105894223|NCT01892085|365267633|FG001|Overall Study|Death|1|||
105894224|NCT01892085|365267634|FG002|Overall Study|Death|3|||
105894225|NCT01892085|365267632|FG000|Overall Study|Withdrawal by Subject|2|||
105894226|NCT01892085|365267633|FG001|Overall Study|Withdrawal by Subject|0|||
105894227|NCT01892085|365267634|FG002|Overall Study|Withdrawal by Subject|2|||
105894228|NCT00767039|365267637|FG000|Overall Study|Death|5|||
105894229|NCT00767039|365267638|FG001|Overall Study|Death|2|||
105894230|NCT01826370|365267639|FG000|Overall Study|Protocol Violation|6|||
105894231|NCT01826370|365267639|FG000|Overall Study|Lost to Follow-up|12|||
105894232|NCT01826370|365267639|FG000|Overall Study|Other reason not defined above|2|||
105997044|NCT03201419|365649608|FG006|Overall Study|Lost to Follow-up|0|||
105997045|NCT03201419|365649609|FG007|Overall Study|Lost to Follow-up|0|||
105997046|NCT03201419|365649610|FG008|Overall Study|Lost to Follow-up|0|||
105997047|NCT03201419|365649602|FG000|Overall Study|Protocol Deviation|0|||
105997048|NCT03201419|365649603|FG001|Overall Study|Protocol Deviation|0|||
105997049|NCT03201419|365649604|FG002|Overall Study|Protocol Deviation|0|||
105997050|NCT03201419|365649605|FG003|Overall Study|Protocol Deviation|0|||
105997051|NCT03201419|365649606|FG004|Overall Study|Protocol Deviation|0|||
105997052|NCT03201419|365649607|FG005|Overall Study|Protocol Deviation|0|||
105997053|NCT03201419|365649608|FG006|Overall Study|Protocol Deviation|1|||
105997054|NCT03201419|365649609|FG007|Overall Study|Protocol Deviation|0|||
105997055|NCT03201419|365649610|FG008|Overall Study|Protocol Deviation|0|||
105997056|NCT03201419|365649602|FG000|Overall Study|Withdrawal by Subject|4|||
105997057|NCT03201419|365649603|FG001|Overall Study|Withdrawal by Subject|2|||
105997058|NCT03201419|365649604|FG002|Overall Study|Withdrawal by Subject|1|||
105997059|NCT03201419|365649605|FG003|Overall Study|Withdrawal by Subject|0|||
105997060|NCT03201419|365649606|FG004|Overall Study|Withdrawal by Subject|0|||
105997061|NCT03201419|365649607|FG005|Overall Study|Withdrawal by Subject|0|||
105894233|NCT00070018|365267640|FG000|Overall Study|Adverse Event|2|||
105997062|NCT03201419|365649608|FG006|Overall Study|Withdrawal by Subject|0|||
105997063|NCT03201419|365649609|FG007|Overall Study|Withdrawal by Subject|1|||
105997064|NCT03201419|365649610|FG008|Overall Study|Withdrawal by Subject|2|||
105894234|NCT00070018|365267640|FG000|Overall Study|Lack of Efficacy|1|||
105894235|NCT00070018|365267640|FG000|Overall Study|Withdrawal by Subject|1|||
105894236|NCT03199612|365267643|FG000|Overall Study|Adverse Event|1|||
105894237|NCT03199612|365267644|FG001|Overall Study|Adverse Event|0|||
105894238|NCT01629823|365267651|FG000|Trial Period|Missed visit|11|||
105894239|NCT01629823|365267652|FG001|Trial Period|Missed visit|9|||
105894240|NCT01629823|365267653|FG002|Trial Period|Missed visit|8|||
105997065|NCT03201419|365649602|FG000|Overall Study|Other|0|||
105997066|NCT03201419|365649603|FG001|Overall Study|Other|0|||
105997067|NCT03201419|365649604|FG002|Overall Study|Other|1|||
105997068|NCT03201419|365649605|FG003|Overall Study|Other|0|||
105997069|NCT03201419|365649606|FG004|Overall Study|Other|0|||
105997070|NCT03201419|365649607|FG005|Overall Study|Other|0|||
105997071|NCT03201419|365649608|FG006|Overall Study|Other|0|||
105997072|NCT03201419|365649609|FG007|Overall Study|Other|0|||
105997073|NCT03201419|365649610|FG008|Overall Study|Other|0|||
105997074|NCT05864586|365649613|FG000|Overall Study|Ineligible|4|||
105997075|NCT05864586|365649614|FG001|Overall Study|Ineligible|12|||
105997076|NCT05864586|365649613|FG000|Overall Study|Pregnancy|0|||
105997077|NCT05864586|365649614|FG001|Overall Study|Pregnancy|1|||
105997078|NCT05864586|365649613|FG000|Overall Study|Withdrawal by Subject|0|||
105997079|NCT05864586|365649614|FG001|Overall Study|Withdrawal by Subject|1|||
105997080|NCT00801216|365649647|FG000|Overall Study|Screening Failure|2|||
105997081|NCT05907395|365649648|FG000|Period 1|No longer met eligibility criteria|0|||
105997082|NCT05907395|365649649|FG001|Period 1|No longer met eligibility criteria|1|||
105997083|NCT05907395|365649650|FG002|Period 1|No longer met eligibility criteria|0|||
105997084|NCT05907395|365649651|FG003|Period 1|No longer met eligibility criteria|0|||
105997085|NCT05907395|365649652|FG004|Period 1|No longer met eligibility criteria|0|||
105997086|NCT05907395|365649653|FG005|Period 1|No longer met eligibility criteria|1|||
105997087|NCT05907395|365649654|FG006|Period 1|No longer met eligibility criteria|1|||
105997088|NCT05907395|365649655|FG007|Period 1|No longer met eligibility criteria|0|||
105997089|NCT05907395|365649656|FG008|Period 1|No longer met eligibility criteria|0|||
105997090|NCT05907395|365649657|FG009|Period 1|No longer met eligibility criteria|0|||
105997091|NCT05907395|365649658|FG010|Period 1|No longer met eligibility criteria|0|||
105997092|NCT05907395|365649659|FG011|Period 1|No longer met eligibility criteria|0|||
105997093|NCT05907395|365649648|FG000|Period 2|Adverse Event|0|||
105997094|NCT05907395|365649649|FG001|Period 2|Adverse Event|0|||
105997095|NCT05907395|365649650|FG002|Period 2|Adverse Event|0|||
105997096|NCT05907395|365649651|FG003|Period 2|Adverse Event|1|||
105997097|NCT05907395|365649652|FG004|Period 2|Adverse Event|0|||
105997098|NCT05907395|365649653|FG005|Period 2|Adverse Event|0|||
105997099|NCT05907395|365649654|FG006|Period 2|Adverse Event|0|||
105997100|NCT05907395|365649655|FG007|Period 2|Adverse Event|1|||
105997101|NCT05907395|365649656|FG008|Period 2|Adverse Event|0|||
105997102|NCT05907395|365649657|FG009|Period 2|Adverse Event|0|||
105997103|NCT05907395|365649658|FG010|Period 2|Adverse Event|0|||
105997104|NCT05907395|365649659|FG011|Period 2|Adverse Event|0|||
105997105|NCT05907395|365649648|FG000|Period 2|Personal reason|0|||
105997106|NCT05907395|365649649|FG001|Period 2|Personal reason|0|||
105997107|NCT05907395|365649650|FG002|Period 2|Personal reason|0|||
105997108|NCT05907395|365649651|FG003|Period 2|Personal reason|0|||
105997109|NCT05907395|365649652|FG004|Period 2|Personal reason|0|||
105997110|NCT05907395|365649653|FG005|Period 2|Personal reason|0|||
105997111|NCT05907395|365649654|FG006|Period 2|Personal reason|0|||
105997112|NCT05907395|365649655|FG007|Period 2|Personal reason|0|||
105997113|NCT05907395|365649656|FG008|Period 2|Personal reason|0|||
105997114|NCT05907395|365649657|FG009|Period 2|Personal reason|1|||
105997115|NCT05907395|365649658|FG010|Period 2|Personal reason|0|||
105665493|NCT00078338|364440748|FG000|Overall Study|Disease Progression|4|||
105997116|NCT05907395|365649659|FG011|Period 2|Personal reason|0|||
105997117|NCT05907395|365649648|FG000|Period 3|Adverse Event|0|||
105997118|NCT05907395|365649649|FG001|Period 3|Adverse Event|0|||
105997119|NCT05907395|365649650|FG002|Period 3|Adverse Event|0|||
105997120|NCT05907395|365649651|FG003|Period 3|Adverse Event|0|||
105997121|NCT05907395|365649652|FG004|Period 3|Adverse Event|1|||
105997122|NCT05907395|365649653|FG005|Period 3|Adverse Event|0|||
105997123|NCT05907395|365649654|FG006|Period 3|Adverse Event|0|||
105997124|NCT05907395|365649655|FG007|Period 3|Adverse Event|0|||
105997125|NCT05907395|365649656|FG008|Period 3|Adverse Event|0|||
105997126|NCT05907395|365649657|FG009|Period 3|Adverse Event|0|||
105997127|NCT05907395|365649658|FG010|Period 3|Adverse Event|0|||
105894241|NCT01629823|365267651|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
105894242|NCT01629823|365267652|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
105894243|NCT01629823|365267653|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
105894244|NCT01629823|365267651|FG000|Trial Period|Pregnancy|1|||
105894245|NCT01629823|365267652|FG001|Trial Period|Pregnancy|0|||
105894246|NCT01629823|365267653|FG002|Trial Period|Pregnancy|0|||
105894247|NCT01629823|365267651|FG000|Trial Period|Adverse Event|0|||
105894248|NCT01629823|365267652|FG001|Trial Period|Adverse Event|1|||
105894249|NCT01629823|365267653|FG002|Trial Period|Adverse Event|0|||
105894250|NCT01629823|365267651|FG000|Trial Period|Out-of-window visit|0|||
105894251|NCT01629823|365267652|FG001|Trial Period|Out-of-window visit|2|||
105894252|NCT01629823|365267653|FG002|Trial Period|Out-of-window visit|0|||
105894253|NCT01629823|365267651|FG000|Trial Period|Failed to hold medication|0|||
105894254|NCT01629823|365267652|FG001|Trial Period|Failed to hold medication|0|||
105894255|NCT01629823|365267653|FG002|Trial Period|Failed to hold medication|1|||
105894256|NCT01629823|365267651|FG000|Washout Period|Safety|2|||
105894257|NCT01629823|365267652|FG001|Washout Period|Safety|5|||
105894258|NCT01629823|365267653|FG002|Washout Period|Safety|0|||
105894259|NCT01629823|365267651|FG000|Washout Period|Pregnancy|1|||
105894260|NCT01629823|365267652|FG001|Washout Period|Pregnancy|0|||
105894261|NCT01629823|365267653|FG002|Washout Period|Pregnancy|0|||
105894262|NCT01629823|365267651|FG000|Washout Period|Protocol Violation|0|||
105894263|NCT01629823|365267652|FG001|Washout Period|Protocol Violation|1|||
105894264|NCT01629823|365267653|FG002|Washout Period|Protocol Violation|0|||
105894265|NCT00525902|365267654|FG000|Overall Study|Lack of Efficacy|1|||
105894266|NCT02386345|365267655|FG000|Overall Study|Not treated|14|||
105894267|NCT02386345|365267655|FG000|Overall Study|Lost to Follow-up|1|||
105894268|NCT02386345|365267655|FG000|Overall Study|Adverse Event|5|||
105894269|NCT02386345|365267655|FG000|Overall Study|Repeat Procedure|10|||
105894270|NCT02386345|365267655|FG000|Overall Study|Did not complete 12-month follow-up|72|||
105894271|NCT02609724|365267656|FG000|Overall Study|Death|2|||
105894272|NCT02609724|365267657|FG001|Overall Study|Death|0|||
105894273|NCT02609724|365267658|FG002|Overall Study|Death|1|||
105894274|NCT02609724|365267656|FG000|Overall Study|Withdrawal by Subject|1|||
105894275|NCT02609724|365267657|FG001|Overall Study|Withdrawal by Subject|2|||
106122710|NCT02601937|366106155|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122711|NCT02601937|366106156|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122712|NCT02601937|366106157|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122713|NCT02601937|366106158|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122714|NCT02601937|366106159|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122715|NCT02601937|366106160|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122716|NCT02601937|366106161|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
106122717|NCT02601937|366106162|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122718|NCT02601937|366106163|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122719|NCT02601937|366106164|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
106122720|NCT02601937|366106154|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
106122721|NCT02601937|366106155|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
105894276|NCT02609724|365267658|FG002|Overall Study|Withdrawal by Subject|3|||
105894277|NCT02609724|365267656|FG000|Overall Study|Illness|2|||
105894278|NCT02609724|365267657|FG001|Overall Study|Illness|1|||
105894279|NCT02609724|365267658|FG002|Overall Study|Illness|0|||
105894280|NCT02844907|365267659|FG000|With Dexamethasone|No IV access|1|||
105894281|NCT00738062|365267660|FG000|Open Label Treatment|Lack of Efficacy|5|||
105894282|NCT00738062|365267661|FG001|Open Label Treatment|Lack of Efficacy|0|||
105894283|NCT00738062|365267662|FG002|Open Label Treatment|Lack of Efficacy|0|||
105894284|NCT00738062|365267660|FG000|Open Label Treatment|Adverse Event|11|||
105894285|NCT00738062|365267661|FG001|Open Label Treatment|Adverse Event|0|||
105894286|NCT00738062|365267662|FG002|Open Label Treatment|Adverse Event|0|||
105894287|NCT00738062|365267660|FG000|Open Label Treatment|Protocol Violation|2|||
105894288|NCT00738062|365267661|FG001|Open Label Treatment|Protocol Violation|0|||
105894289|NCT00738062|365267662|FG002|Open Label Treatment|Protocol Violation|0|||
105894290|NCT00738062|365267660|FG000|Open Label Treatment|Withdrawal by Subject|9|||
105894291|NCT00738062|365267661|FG001|Open Label Treatment|Withdrawal by Subject|0|||
105894292|NCT00738062|365267662|FG002|Open Label Treatment|Withdrawal by Subject|0|||
105894293|NCT00738062|365267660|FG000|Open Label Treatment|Investigator Decision|1|||
105894294|NCT00738062|365267661|FG001|Open Label Treatment|Investigator Decision|0|||
105894295|NCT00738062|365267662|FG002|Open Label Treatment|Investigator Decision|0|||
105894296|NCT00738062|365267660|FG000|Open-Label Extension|Adverse Event|5|||
105894297|NCT00738062|365267661|FG001|Open-Label Extension|Adverse Event|0|||
105894298|NCT00738062|365267662|FG002|Open-Label Extension|Adverse Event|0|||
105894299|NCT00738062|365267660|FG000|Open-Label Extension|Physician Decision|1|||
105894300|NCT00738062|365267661|FG001|Open-Label Extension|Physician Decision|0|||
105894301|NCT00738062|365267662|FG002|Open-Label Extension|Physician Decision|0|||
105894302|NCT00738062|365267660|FG000|Open-Label Extension|Lack of Efficacy|2|||
105894303|NCT00738062|365267661|FG001|Open-Label Extension|Lack of Efficacy|0|||
105894304|NCT00738062|365267662|FG002|Open-Label Extension|Lack of Efficacy|0|||
105665494|NCT00078338|364440749|FG001|Overall Study|Disease Progression|7|||
105894305|NCT00738062|365267660|FG000|Open-Label Extension|Withdrawal by Subject|6|||
105894306|NCT00738062|365267661|FG001|Open-Label Extension|Withdrawal by Subject|0|||
105997128|NCT05907395|365649659|FG011|Period 3|Adverse Event|0|||
105997129|NCT01712204|365649663|FG000|Overall Study|Adverse Event|3|||
105894307|NCT00738062|365267662|FG002|Open-Label Extension|Withdrawal by Subject|0|||
105894308|NCT00738062|365267660|FG000|Open-Label Extension|Protocol Violation|1|||
105894309|NCT00738062|365267661|FG001|Open-Label Extension|Protocol Violation|0|||
105894310|NCT00738062|365267662|FG002|Open-Label Extension|Protocol Violation|0|||
105894311|NCT00738062|365267660|FG000|Open-Label Extension|Study Terminated|2|||
105894312|NCT00738062|365267661|FG001|Open-Label Extension|Study Terminated|0|||
105894313|NCT00738062|365267662|FG002|Open-Label Extension|Study Terminated|0|||
105894314|NCT00550862|365267663|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
105894315|NCT00550862|365267664|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
105894316|NCT00550862|365267665|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
105894317|NCT00550862|365267666|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
105894318|NCT00550862|365267667|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
105894319|NCT00550862|365267663|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
105894320|NCT00550862|365267664|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
105894321|NCT00550862|365267665|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
105894322|NCT00550862|365267666|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
105997130|NCT01712204|365649664|FG001|Overall Study|Adverse Event|1|||
105997131|NCT01712204|365649663|FG000|Overall Study|Withdrawal by Subject|3|||
106122722|NCT02601937|366106156|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
106122723|NCT02601937|366106157|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
106122724|NCT02601937|366106158|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
106122725|NCT02601937|366106159|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
106122726|NCT02601937|366106160|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
106122727|NCT02601937|366106161|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
106122728|NCT02601937|366106162|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
106122729|NCT02601937|366106163|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
106122730|NCT02601937|366106164|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
106122731|NCT02601937|366106154|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
106122732|NCT02601937|366106155|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
106122733|NCT02601937|366106156|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
106122734|NCT02601937|366106157|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
106122735|NCT02601937|366106158|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
106122736|NCT02601937|366106159|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
106122737|NCT02601937|366106160|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
106122738|NCT02601937|366106161|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
106122739|NCT02601937|366106162|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
106122740|NCT02601937|366106163|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
106122741|NCT02601937|366106164|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
106122742|NCT02601937|366106154|FG000|Period 2: Dose Expansion Cohort|Other|0|||
106122743|NCT02601937|366106155|FG001|Period 2: Dose Expansion Cohort|Other|0|||
106122744|NCT02601937|366106156|FG002|Period 2: Dose Expansion Cohort|Other|0|||
106122745|NCT02601937|366106157|FG003|Period 2: Dose Expansion Cohort|Other|0|||
106122746|NCT02601937|366106158|FG004|Period 2: Dose Expansion Cohort|Other|0|||
106122747|NCT02601937|366106159|FG005|Period 2: Dose Expansion Cohort|Other|0|||
106122748|NCT02601937|366106160|FG006|Period 2: Dose Expansion Cohort|Other|0|||
106122749|NCT02601937|366106161|FG007|Period 2: Dose Expansion Cohort|Other|0|||
106122750|NCT02601937|366106162|FG008|Period 2: Dose Expansion Cohort|Other|2|||
106122751|NCT02601937|366106163|FG009|Period 2: Dose Expansion Cohort|Other|2|||
106122752|NCT02601937|366106164|FG010|Period 2: Dose Expansion Cohort|Other|0|||
106122753|NCT02601937|366106154|FG000|Period 2: Dose Expansion Cohort|Death|0|||
106122754|NCT02601937|366106155|FG001|Period 2: Dose Expansion Cohort|Death|0|||
106122755|NCT02601937|366106156|FG002|Period 2: Dose Expansion Cohort|Death|0|||
106122756|NCT02601937|366106157|FG003|Period 2: Dose Expansion Cohort|Death|0|||
106122757|NCT02601937|366106158|FG004|Period 2: Dose Expansion Cohort|Death|0|||
106122758|NCT02601937|366106159|FG005|Period 2: Dose Expansion Cohort|Death|0|||
106122759|NCT02601937|366106160|FG006|Period 2: Dose Expansion Cohort|Death|0|||
106122760|NCT02601937|366106161|FG007|Period 2: Dose Expansion Cohort|Death|0|||
106122761|NCT02601937|366106162|FG008|Period 2: Dose Expansion Cohort|Death|1|||
106122762|NCT02601937|366106163|FG009|Period 2: Dose Expansion Cohort|Death|0|||
106122763|NCT02601937|366106164|FG010|Period 2: Dose Expansion Cohort|Death|0|||
106122764|NCT01167179|366107678|FG000|Overall Study|disease recurrence|4|||
106122765|NCT01167179|366107679|FG001|Overall Study|disease recurrence|4|||
106122766|NCT01167179|366107678|FG000|Overall Study|Death|4|||
106122767|NCT01167179|366107679|FG001|Overall Study|Death|10|||
106122768|NCT01167179|366107678|FG000|Overall Study|Withdrawal by Subject|1|||
106122769|NCT01167179|366107679|FG001|Overall Study|Withdrawal by Subject|2|||
106122770|NCT01167179|366107678|FG000|Overall Study|diverse|6|||
106122771|NCT01167179|366107679|FG001|Overall Study|diverse|5|||
106122772|NCT01158378|366107680|FG000|Overall Study|Death|4|||
106122773|NCT01158378|366107681|FG001|Overall Study|Death|5|||
105665495|NCT00078338|364440748|FG000|Overall Study|Other|28|||
105665496|NCT00078338|364440749|FG001|Overall Study|Other|16|||
105665497|NCT00078338|364440748|FG000|Overall Study|Subjects randomized, but not treated|3|||
105665498|NCT00078338|364440749|FG001|Overall Study|Subjects randomized, but not treated|3|||
105665499|NCT03258723|364440750|FG000|Overall Study|COVID Interruption of study|54|||
105665500|NCT03258723|364440750|FG000|Overall Study|Lost to Follow-up|8|||
105665501|NCT00944229|364440751|FG000|Overall Study|Withdrawal by Subject|11|||
105665502|NCT00944229|364440751|FG000|Overall Study|Physician Decision|14|||
105665503|NCT01606319|364440752|FG000|Overall Study|Lost to Follow-up|17|||
105665504|NCT01606319|364440753|FG001|Overall Study|Lost to Follow-up|14|||
105665505|NCT01606319|364440752|FG000|Overall Study|Withdrawal by Subject|9|||
105665506|NCT01606319|364440753|FG001|Overall Study|Withdrawal by Subject|12|||
105665507|NCT01606319|364440752|FG000|Overall Study|Physician Decision|1|||
105665508|NCT01606319|364440753|FG001|Overall Study|Physician Decision|2|||
105665509|NCT01606319|364440752|FG000|Overall Study|Lack of Efficacy|6|||
105665510|NCT01606319|364440753|FG001|Overall Study|Lack of Efficacy|8|||
105665511|NCT01606319|364440752|FG000|Overall Study|Adverse Event|1|||
105665512|NCT01606319|364440753|FG001|Overall Study|Adverse Event|4|||
105665513|NCT02906020|364440758|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
105665514|NCT02906020|364440759|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
105665515|NCT02906020|364440760|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
105665516|NCT02906020|364440761|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
105665517|NCT02906020|364440762|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
105665518|NCT02906020|364440763|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
105665519|NCT02906020|364440764|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
105665520|NCT02906020|364440765|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
105665521|NCT02906020|364440766|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
105665522|NCT02906020|364440767|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
105665523|NCT02906020|364440768|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
105665524|NCT02906020|364440769|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
105665525|NCT02906020|364440770|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
105665526|NCT02906020|364440771|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
105665527|NCT02906020|364440772|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
105665528|NCT02906020|364440773|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
105665529|NCT02906020|364440758|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665530|NCT02906020|364440759|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665531|NCT02906020|364440760|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665532|NCT02906020|364440761|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665533|NCT02906020|364440762|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665534|NCT02906020|364440763|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665535|NCT02906020|364440764|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665536|NCT02906020|364440765|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665537|NCT02906020|364440766|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
105665538|NCT02906020|364440767|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
105665539|NCT02906020|364440768|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665540|NCT02906020|364440769|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665541|NCT02906020|364440770|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665542|NCT02906020|364440771|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665543|NCT02906020|364440772|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105665544|NCT02906020|364440773|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
105894323|NCT00550862|365267667|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
105894324|NCT00550862|365267663|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
105894325|NCT00550862|365267664|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
105894326|NCT00550862|365267665|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
105894327|NCT00550862|365267666|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
105894328|NCT00550862|365267667|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
105894329|NCT00550862|365267663|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
105894330|NCT00550862|365267664|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
105894331|NCT00550862|365267665|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
105894332|NCT00550862|365267666|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
105894333|NCT00550862|365267667|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
105894334|NCT00550862|365267663|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
105665545|NCT02906020|364440758|FG000|Part 2: Double-blind Treatment Period|Other|0|||
105665546|NCT02906020|364440759|FG001|Part 2: Double-blind Treatment Period|Other|0|||
105665547|NCT02906020|364440760|FG002|Part 2: Double-blind Treatment Period|Other|0|||
105665548|NCT02906020|364440761|FG003|Part 2: Double-blind Treatment Period|Other|0|||
105665549|NCT02906020|364440762|FG004|Part 2: Double-blind Treatment Period|Other|0|||
105894335|NCT00550862|365267664|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
105894336|NCT00550862|365267665|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
105894337|NCT00550862|365267666|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
105894338|NCT00550862|365267667|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
105894339|NCT00550862|365267663|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
105894340|NCT00550862|365267664|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
105894341|NCT00550862|365267665|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
105894342|NCT00550862|365267666|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
105894343|NCT00550862|365267667|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
105894344|NCT00550862|365267663|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
105894345|NCT00550862|365267664|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
105894346|NCT00550862|365267665|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
105894347|NCT00550862|365267666|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
105894348|NCT00550862|365267667|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
105894349|NCT00550862|365267663|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
105894350|NCT00550862|365267664|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
105894351|NCT00550862|365267665|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
105894352|NCT00550862|365267666|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
105894353|NCT00550862|365267667|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
105894354|NCT00550862|365267663|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
105894355|NCT00550862|365267664|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
105894356|NCT00550862|365267665|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
105894357|NCT00550862|365267666|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
105894358|NCT00550862|365267667|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
105894359|NCT00550862|365267663|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
105894360|NCT00550862|365267664|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
105894361|NCT00550862|365267665|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
105894362|NCT00550862|365267666|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
105894363|NCT00550862|365267667|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
105894364|NCT00980174|365267668|FG000|Overall Study|Withdrawal by Subject|1|||
105894365|NCT00980174|365267669|FG001|Overall Study|Withdrawal by Subject|4|||
105894366|NCT00980174|365267668|FG000|Overall Study|Adverse Event|0|||
105894367|NCT00980174|365267669|FG001|Overall Study|Adverse Event|3|||
105894368|NCT00980174|365267668|FG000|Overall Study|Ineligibility determined|2|||
105894369|NCT00980174|365267669|FG001|Overall Study|Ineligibility determined|1|||
105894370|NCT00980174|365267668|FG000|Overall Study|Death|1|||
105894371|NCT00980174|365267669|FG001|Overall Study|Death|1|||
105894372|NCT00980174|365267668|FG000|Overall Study|Other|0|||
105894373|NCT00980174|365267669|FG001|Overall Study|Other|1|||
105894374|NCT02248974|365267672|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
105894375|NCT02248974|365267673|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
105894376|NCT02248974|365267672|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
105894377|NCT02248974|365267673|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
105894378|NCT02248974|365267672|FG000|1-Day Follow-Up|Enrolled in another study|1|||
105894379|NCT02248974|365267673|FG001|1-Day Follow-Up|Enrolled in another study|0|||
105894380|NCT02248974|365267672|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
105894381|NCT02248974|365267673|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
105894382|NCT02248974|365267672|FG000|1-Week Follow-Up|Enrolled in another study|1|||
105894383|NCT02248974|365267673|FG001|1-Week Follow-Up|Enrolled in another study|1|||
105894384|NCT02248974|365267672|FG000|1-Week Follow-Up|Transferred to another facility|1|||
105894385|NCT02248974|365267673|FG001|1-Week Follow-Up|Transferred to another facility|0|||
105894386|NCT02248974|365267672|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
105894387|NCT02248974|365267673|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
105894388|NCT02248974|365267672|FG000|1-Week Follow-Up|Death|1|||
105894389|NCT02248974|365267673|FG001|1-Week Follow-Up|Death|1|||
105997132|NCT01712204|365649664|FG001|Overall Study|Withdrawal by Subject|3|||
105997133|NCT01712204|365649663|FG000|Overall Study|Lost to Follow-up|1|||
105997134|NCT01712204|365649664|FG001|Overall Study|Lost to Follow-up|0|||
105997135|NCT01712204|365649663|FG000|Overall Study|Protocol Violation|1|||
105997136|NCT01712204|365649664|FG001|Overall Study|Protocol Violation|1|||
105894390|NCT02248974|365267672|FG000|1-Week Follow-Up|Excluded because of age|0|||
105894391|NCT02248974|365267673|FG001|1-Week Follow-Up|Excluded because of age|1|||
105894392|NCT02248974|365267672|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
105894393|NCT02248974|365267673|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
105894394|NCT02248974|365267672|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
105894395|NCT02248974|365267673|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
105894396|NCT02248974|365267672|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
105894397|NCT02248974|365267673|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
105894398|NCT02248974|365267672|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
105894399|NCT02248974|365267673|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
105894400|NCT02248974|365267672|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
105894401|NCT02248974|365267673|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
105894402|NCT03488225|365267677|FG000|Overall Study|Off Protocol Therapy|2|||
105894403|NCT03488225|365267677|FG000|Overall Study|Stem Cell Transplant|2|||
105894404|NCT00894790|365267678|FG000|Overall Study|Protocol Violation|0|||
105894405|NCT00894790|365267679|FG001|Overall Study|Protocol Violation|1|||
105894406|NCT00894790|365267678|FG000|Overall Study|Lost to Follow-up|0|||
105894407|NCT00894790|365267679|FG001|Overall Study|Lost to Follow-up|1|||
105894408|NCT00894790|365267678|FG000|Overall Study|Did not meet entrance criteria|1|||
105894409|NCT00894790|365267679|FG001|Overall Study|Did not meet entrance criteria|0|||
105894410|NCT04093492|365267680|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
105894411|NCT04093492|365267681|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
105894412|NCT04093492|365267682|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
105894413|NCT04093492|365267683|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
105894414|NCT04093492|365267680|FG000|25 Weeks Gestational Age (GA)|No response|5|||
105894415|NCT04093492|365267681|FG001|25 Weeks Gestational Age (GA)|No response|5|||
105894416|NCT04093492|365267682|FG002|25 Weeks Gestational Age (GA)|No response|5|||
105894417|NCT04093492|365267683|FG003|25 Weeks Gestational Age (GA)|No response|2|||
105894418|NCT04093492|365267680|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
105894419|NCT04093492|365267681|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
105894420|NCT04093492|365267682|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
105894421|NCT04093492|365267683|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
105894422|NCT04093492|365267680|FG000|30 Weeks GA|Delivered before assessment|1|||
105894423|NCT04093492|365267681|FG001|30 Weeks GA|Delivered before assessment|2|||
105894424|NCT04093492|365267682|FG002|30 Weeks GA|Delivered before assessment|0|||
105894425|NCT04093492|365267683|FG003|30 Weeks GA|Delivered before assessment|0|||
105894426|NCT04093492|365267680|FG000|30 Weeks GA|No response|7|||
105894427|NCT04093492|365267681|FG001|30 Weeks GA|No response|5|||
105894428|NCT04093492|365267682|FG002|30 Weeks GA|No response|5|||
105894429|NCT04093492|365267683|FG003|30 Weeks GA|No response|2|||
105894430|NCT04093492|365267680|FG000|30 Weeks GA|Lost to Follow-up|0|||
105894431|NCT04093492|365267681|FG001|30 Weeks GA|Lost to Follow-up|1|||
105894432|NCT04093492|365267682|FG002|30 Weeks GA|Lost to Follow-up|0|||
105997137|NCT02360228|365649665|FG000|Overall Study|Withdrawal by Subject|1|||
105997138|NCT02360228|365649666|FG001|Overall Study|Withdrawal by Subject|0|||
105997139|NCT02360228|365649667|FG002|Overall Study|Withdrawal by Subject|0|||
106122774|NCT01158378|366107680|FG000|Overall Study|Lost to Follow-up|2|||
106122775|NCT01158378|366107681|FG001|Overall Study|Lost to Follow-up|4|||
106122776|NCT01158378|366107680|FG000|Overall Study|Withdrawal by Subject|4|||
106122777|NCT01158378|366107681|FG001|Overall Study|Withdrawal by Subject|0|||
106122778|NCT01340482|366107683|FG000|Overall Study|Adverse Event|2|||
106122779|NCT01340482|366107684|FG001|Overall Study|Adverse Event|0|||
106122780|NCT01340482|366107685|FG002|Overall Study|Adverse Event|0|||
106122781|NCT02593539|366107686|FG000|Overall Study|Adverse Event|1|||
106122782|NCT04424290|366107689|FG000|Overall Study|Not treated|0|||
106122783|NCT04424290|366107690|FG001|Overall Study|Not treated|0|||
106122784|NCT04424290|366107691|FG002|Overall Study|Not treated|1|||
106122785|NCT04424290|366107692|FG003|Overall Study|Not treated|0|||
106122786|NCT04424290|366107693|FG004|Overall Study|Not treated|1|||
106122787|NCT04424290|366107689|FG000|Overall Study|Adverse Event|0|||
106122788|NCT04424290|366107690|FG001|Overall Study|Adverse Event|0|||
106122789|NCT04424290|366107691|FG002|Overall Study|Adverse Event|0|||
106122790|NCT04424290|366107692|FG003|Overall Study|Adverse Event|2|||
106122791|NCT04424290|366107693|FG004|Overall Study|Adverse Event|0|||
106122792|NCT04424290|366107689|FG000|Overall Study|Withdrawal by Subject|0|||
106122793|NCT04424290|366107690|FG001|Overall Study|Withdrawal by Subject|0|||
106122794|NCT04424290|366107691|FG002|Overall Study|Withdrawal by Subject|0|||
106122795|NCT04424290|366107692|FG003|Overall Study|Withdrawal by Subject|0|||
106122796|NCT04424290|366107693|FG004|Overall Study|Withdrawal by Subject|1|||
106122797|NCT04424290|366107689|FG000|Overall Study|Other than listed|0|||
106122798|NCT04424290|366107690|FG001|Overall Study|Other than listed|0|||
106122799|NCT04424290|366107691|FG002|Overall Study|Other than listed|0|||
106122800|NCT04424290|366107692|FG003|Overall Study|Other than listed|1|||
106122801|NCT04424290|366107693|FG004|Overall Study|Other than listed|0|||
106122802|NCT01267825|366107694|FG000|Overall Study|study terminated. no data collected.|1|||
106122803|NCT01267825|366107695|FG001|Overall Study|study terminated. no data collected.|0|||
106122804|NCT03722264|366107696|FG000|Overall Study|Physician Decision|3|||
106122805|NCT01683994|366107702|FG000|Overall Study|Withdrawal by Subject|1|||
105894433|NCT04093492|365267683|FG003|30 Weeks GA|Lost to Follow-up|0|||
105894434|NCT04093492|365267680|FG000|34 Weeks GA|Delivered before assessment|6|||
105894435|NCT04093492|365267681|FG001|34 Weeks GA|Delivered before assessment|3|||
105894436|NCT04093492|365267682|FG002|34 Weeks GA|Delivered before assessment|0|||
105894437|NCT04093492|365267683|FG003|34 Weeks GA|Delivered before assessment|0|||
105894438|NCT04093492|365267680|FG000|34 Weeks GA|No response|0|||
105894439|NCT04093492|365267681|FG001|34 Weeks GA|No response|7|||
105894440|NCT04093492|365267682|FG002|34 Weeks GA|No response|5|||
105894441|NCT04093492|365267683|FG003|34 Weeks GA|No response|3|||
105894442|NCT04093492|365267680|FG000|34 Weeks GA|Lost to Follow-up|0|||
105894443|NCT04093492|365267681|FG001|34 Weeks GA|Lost to Follow-up|1|||
105894444|NCT04093492|365267682|FG002|34 Weeks GA|Lost to Follow-up|0|||
105894445|NCT04093492|365267683|FG003|34 Weeks GA|Lost to Follow-up|0|||
105894446|NCT04631107|365267689|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
105894447|NCT04631107|365267689|FG000|Second Intervention (1 Night)|Adverse Event|1|||
105894448|NCT04631107|365267689|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
105894449|NCT04631107|365267689|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
105894450|NCT05619536|365267692|FG000|Overall Study|Withdrawal by Subject|0|||
105894451|NCT05619536|365267693|FG001|Overall Study|Withdrawal by Subject|1|||
105894452|NCT05619536|365267694|FG002|Overall Study|Withdrawal by Subject|0|||
105894453|NCT05619536|365267695|FG003|Overall Study|Withdrawal by Subject|1|||
105894454|NCT05619536|365267692|FG000|Overall Study|Lost to Follow-up|0|||
105894455|NCT05619536|365267693|FG001|Overall Study|Lost to Follow-up|1|||
105894456|NCT05619536|365267694|FG002|Overall Study|Lost to Follow-up|1|||
105894457|NCT05619536|365267695|FG003|Overall Study|Lost to Follow-up|0|||
105894458|NCT04272606|365267696|FG000|Overall Study|Protocol Violation|1|||
105894459|NCT04272606|365267697|FG001|Overall Study|Protocol Violation|1|||
105894460|NCT04272606|365267696|FG000|Overall Study|Physician Decision|0|||
105894461|NCT04272606|365267697|FG001|Overall Study|Physician Decision|1|||
105894462|NCT03467763|365267698|FG000|Overall Study|Lost to Follow-up|1|||
105894463|NCT03467763|365267698|FG000|Overall Study|Protocol Violation|2|||
105894464|NCT01306045|365267703|FG000|Met General Eligibility Criteria|Screen failures|193|||
105894465|NCT01306045|365267704|FG001|Met General Eligibility Criteria|Screen failures|11|||
105894466|NCT01306045|365267705|FG002|Met General Eligibility Criteria|Screen failures|8|||
105894467|NCT00432276|365267707|FG000|Overall Study|Hyperglycemic Rescue|44|||
105894468|NCT00432276|365267708|FG001|Overall Study|Hyperglycemic Rescue|87|||
105894469|NCT00432276|365267707|FG000|Overall Study|Adverse Event|13|||
105894470|NCT00432276|365267708|FG001|Overall Study|Adverse Event|16|||
105894471|NCT00432276|365267707|FG000|Overall Study|Protocol Violation|25|||
105894472|NCT00432276|365267708|FG001|Overall Study|Protocol Violation|20|||
105894473|NCT00432276|365267707|FG000|Overall Study|Lost to Follow-up|6|||
105894474|NCT00432276|365267708|FG001|Overall Study|Lost to Follow-up|2|||
105894475|NCT00432276|365267707|FG000|Overall Study|Withdrawal by Subject|25|||
105894476|NCT00432276|365267708|FG001|Overall Study|Withdrawal by Subject|20|||
105894477|NCT00432276|365267707|FG000|Overall Study|Physician Decision|6|||
105894478|NCT00432276|365267708|FG001|Overall Study|Physician Decision|8|||
105894479|NCT00432276|365267707|FG000|Overall Study|Other|2|||
105894480|NCT00432276|365267708|FG001|Overall Study|Other|3|||
105894481|NCT02889835|365267713|FG000|Overall Study|Lost to Follow-up|13|||
105894482|NCT02889835|365267714|FG001|Overall Study|Lost to Follow-up|13|||
105894483|NCT02889835|365267715|FG002|Overall Study|Lost to Follow-up|13|||
105894484|NCT02889835|365267713|FG000|Overall Study|Withdrawal by Subject|2|||
105894485|NCT02889835|365267714|FG001|Overall Study|Withdrawal by Subject|2|||
105894486|NCT02889835|365267715|FG002|Overall Study|Withdrawal by Subject|2|||
105894487|NCT02889835|365267713|FG000|Overall Study|Protocol Violation|1|||
105894488|NCT02889835|365267714|FG001|Overall Study|Protocol Violation|1|||
105894489|NCT02889835|365267715|FG002|Overall Study|Protocol Violation|1|||
105894490|NCT02889835|365267713|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
105894491|NCT02889835|365267714|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
105894492|NCT02889835|365267715|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
105894493|NCT02889835|365267713|FG000|Overall Study|Death|1|||
105894494|NCT02889835|365267714|FG001|Overall Study|Death|1|||
105894495|NCT02889835|365267715|FG002|Overall Study|Death|1|||
105894496|NCT05903924|365269705|FG000|Overall Study|Lost to Follow-up|1|||
105894497|NCT05903924|365269706|FG001|Overall Study|Lost to Follow-up|0|||
105894498|NCT05903924|365269707|FG002|Overall Study|Lost to Follow-up|0|||
105894499|NCT04250714|365269708|FG000|Overall Study|Treatment - withdrawal by subject|14|||
105894500|NCT04250714|365269708|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
105894501|NCT04250714|365269708|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
105894502|NCT04250714|365269708|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
105894503|NCT04250714|365269708|FG000|Overall Study|Treatment - Death|1|||
105894504|NCT04250714|365269708|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
105894505|NCT04250714|365269708|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
105894506|NCT04250714|365269708|FG000|Overall Study|Attempt|2|||
105894507|NCT04250714|365269708|FG000|Overall Study|Intent|7|||
105894508|NCT02304380|365269715|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105665550|NCT02906020|364440763|FG005|Part 2: Double-blind Treatment Period|Other|0|||
105665551|NCT02906020|364440764|FG006|Part 2: Double-blind Treatment Period|Other|0|||
105665552|NCT02906020|364440765|FG007|Part 2: Double-blind Treatment Period|Other|0|||
105665553|NCT02906020|364440766|FG008|Part 2: Double-blind Treatment Period|Other|6|||
105665554|NCT02906020|364440767|FG009|Part 2: Double-blind Treatment Period|Other|10|||
105665555|NCT02906020|364440768|FG010|Part 2: Double-blind Treatment Period|Other|0|||
105665556|NCT02906020|364440769|FG011|Part 2: Double-blind Treatment Period|Other|0|||
105665557|NCT02906020|364440770|FG012|Part 2: Double-blind Treatment Period|Other|0|||
105665558|NCT02906020|364440771|FG013|Part 2: Double-blind Treatment Period|Other|0|||
105665559|NCT02906020|364440772|FG014|Part 2: Double-blind Treatment Period|Other|0|||
105665560|NCT02906020|364440773|FG015|Part 2: Double-blind Treatment Period|Other|0|||
105665561|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665562|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665563|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665564|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665565|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665566|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665567|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665568|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665569|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665570|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665571|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665572|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665573|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
105665574|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
105665575|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665576|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
105665577|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665578|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665579|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665580|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665581|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665582|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105894509|NCT02304380|365269716|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105894510|NCT02304380|365269717|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105894511|NCT02304380|365269718|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
105894512|NCT02304380|365269719|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105894513|NCT02304380|365269720|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
105894514|NCT02368210|365269721|FG000|Overall Study|Withdrawal by Subject|1|||
105894515|NCT02368210|365269722|FG001|Overall Study|Withdrawal by Subject|0|||
105894516|NCT02368210|365269721|FG000|Overall Study|Adverse Event|0|||
105894517|NCT02368210|365269722|FG001|Overall Study|Adverse Event|1|||
105894518|NCT04068688|365269723|FG000|Overall Study|Lost to Follow-up|1|||
105894519|NCT04068688|365269724|FG001|Overall Study|Lost to Follow-up|1|||
105894520|NCT04068688|365269725|FG002|Overall Study|Lost to Follow-up|0|||
105894521|NCT04068688|365269726|FG003|Overall Study|Lost to Follow-up|0|||
105894522|NCT04068688|365269727|FG004|Overall Study|Lost to Follow-up|5|||
105894523|NCT04068688|365269728|FG005|Overall Study|Lost to Follow-up|5|||
105894524|NCT04068688|365269729|FG006|Overall Study|Lost to Follow-up|0|||
105894525|NCT04068688|365269730|FG007|Overall Study|Lost to Follow-up|0|||
105894526|NCT04068688|365269731|FG008|Overall Study|Lost to Follow-up|1|||
105894527|NCT04068688|365269732|FG009|Overall Study|Lost to Follow-up|0|||
105894528|NCT04068688|365269723|FG000|Overall Study|Withdrawal by Subject|1|||
105894529|NCT04068688|365269724|FG001|Overall Study|Withdrawal by Subject|1|||
105894530|NCT04068688|365269725|FG002|Overall Study|Withdrawal by Subject|0|||
105894531|NCT04068688|365269726|FG003|Overall Study|Withdrawal by Subject|0|||
105894532|NCT04068688|365269727|FG004|Overall Study|Withdrawal by Subject|0|||
105894533|NCT04068688|365269728|FG005|Overall Study|Withdrawal by Subject|0|||
105665583|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665584|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105894534|NCT04068688|365269729|FG006|Overall Study|Withdrawal by Subject|0|||
105894535|NCT04068688|365269730|FG007|Overall Study|Withdrawal by Subject|0|||
105894536|NCT04068688|365269731|FG008|Overall Study|Withdrawal by Subject|0|||
105894537|NCT04068688|365269732|FG009|Overall Study|Withdrawal by Subject|0|||
105894538|NCT04068688|365269723|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
105894539|NCT04068688|365269724|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
105894540|NCT04068688|365269725|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105665585|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665586|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665587|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105894541|NCT04068688|365269726|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105894542|NCT04068688|365269727|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105894543|NCT04068688|365269728|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105894544|NCT04068688|365269729|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105894545|NCT04068688|365269730|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105894546|NCT04068688|365269731|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105894547|NCT04068688|365269732|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
105894548|NCT01432275|365269733|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
105894549|NCT01432275|365269734|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
105894550|NCT01432275|365269733|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
105894551|NCT01432275|365269734|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
105894552|NCT01432275|365269733|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
105894553|NCT01432275|365269734|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
105894554|NCT01432275|365269733|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
105894555|NCT01432275|365269734|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
105894556|NCT01432275|365269733|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
105894557|NCT01432275|365269734|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
105894558|NCT01432275|365269733|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
105894559|NCT01432275|365269734|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
105894560|NCT01432275|365269733|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
105894561|NCT01432275|365269734|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
105894562|NCT01432275|365269733|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
105894563|NCT01432275|365269734|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
105894564|NCT01432275|365269733|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
105894565|NCT01432275|365269734|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
105894566|NCT02649426|365269735|FG000|Overall Study|Follow-up on going|1|||
105894567|NCT02649426|365269736|FG001|Overall Study|Follow-up on going|26|||
105894568|NCT02649426|365269737|FG002|Overall Study|Follow-up on going|28|||
105894569|NCT02649426|365269738|FG003|Overall Study|Follow-up on going|31|||
105894570|NCT01440569|365269739|FG000|Main Study|Enrolled but not treated|1|||
105894571|NCT01440569|365269740|FG001|Main Study|Enrolled but not treated|0|||
105894572|NCT01440569|365269739|FG000|Main Study|Adverse Event|9|||
105894573|NCT01440569|365269740|FG001|Main Study|Adverse Event|0|||
105894574|NCT01440569|365269739|FG000|Main Study|Pregnancy|1|||
105894575|NCT01440569|365269740|FG001|Main Study|Pregnancy|0|||
105894576|NCT01440569|365269739|FG000|Main Study|Investigator's Discretion|1|||
105894577|NCT01440569|365269740|FG001|Main Study|Investigator's Discretion|1|||
105894578|NCT01440569|365269739|FG000|Main Study|Withdrew Consent|7|||
105894579|NCT01440569|365269740|FG001|Main Study|Withdrew Consent|1|||
105894580|NCT01440569|365269739|FG000|Main Study|Lost to Follow-up|13|||
105894581|NCT01440569|365269740|FG001|Main Study|Lost to Follow-up|2|||
105894582|NCT01440569|365269739|FG000|Main Study|Subject Non-Compliance|3|||
105894583|NCT01440569|365269740|FG001|Main Study|Subject Non-Compliance|0|||
105894584|NCT01440569|365269739|FG000|Main Study|Protocol Violation|1|||
105894585|NCT01440569|365269740|FG001|Main Study|Protocol Violation|0|||
105894586|NCT01440569|365269739|FG000|Open-Label Rollover Phase|Adverse Event|3|||
105894587|NCT01440569|365269740|FG001|Open-Label Rollover Phase|Adverse Event|0|||
105894588|NCT01440569|365269739|FG000|Open-Label Rollover Phase|Pregnancy|1|||
105894589|NCT01440569|365269740|FG001|Open-Label Rollover Phase|Pregnancy|0|||
105894590|NCT01440569|365269739|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
105894591|NCT01440569|365269740|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
105894592|NCT01440569|365269739|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
105997140|NCT02360228|365649665|FG000|Overall Study|Self-discontinued medication|0|||
105997141|NCT02360228|365649666|FG001|Overall Study|Self-discontinued medication|1|||
105997142|NCT02360228|365649667|FG002|Overall Study|Self-discontinued medication|0|||
105785972|NCT04626947|364870422|FG000|Overall Study|Study terminated|14|||
105894593|NCT01440569|365269740|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
105894594|NCT01440569|365269739|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
105894595|NCT01440569|365269740|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
105665588|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665589|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
105665590|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
105665591|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
105665592|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
105665593|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665594|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665595|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665596|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665597|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665598|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665599|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665600|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665601|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665602|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665603|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665604|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665605|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
105665606|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
105665607|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665608|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
105665609|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665610|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665611|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665612|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665613|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665614|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105894596|NCT01440569|365269739|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
105894597|NCT01440569|365269740|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
105894598|NCT01440569|365269739|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
105894599|NCT01440569|365269740|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
105894600|NCT00195494|365269751|FG000|Year 1|Adverse Event|0|||
105894601|NCT00195494|365269752|FG001|Year 1|Adverse Event|0|||
105894602|NCT00195494|365269753|FG002|Year 1|Adverse Event|0|||
105894603|NCT00195494|365269754|FG003|Year 1|Adverse Event|0|||
105894604|NCT00195494|365269755|FG004|Year 1|Adverse Event|34|||
105894605|NCT00195494|365269756|FG005|Year 1|Adverse Event|27|||
105894606|NCT00195494|365269751|FG000|Year 1|System Toxicity|0|||
105894607|NCT00195494|365269752|FG001|Year 1|System Toxicity|0|||
105894608|NCT00195494|365269753|FG002|Year 1|System Toxicity|0|||
105894609|NCT00195494|365269754|FG003|Year 1|System Toxicity|0|||
105894610|NCT00195494|365269755|FG004|Year 1|System Toxicity|0|||
105894611|NCT00195494|365269756|FG005|Year 1|System Toxicity|1|||
105894612|NCT00195494|365269751|FG000|Year 1|Lack of Efficacy|0|||
105894613|NCT00195494|365269752|FG001|Year 1|Lack of Efficacy|0|||
105894614|NCT00195494|365269753|FG002|Year 1|Lack of Efficacy|0|||
105894615|NCT00195494|365269754|FG003|Year 1|Lack of Efficacy|0|||
105894616|NCT00195494|365269755|FG004|Year 1|Lack of Efficacy|24|||
105894617|NCT00195494|365269756|FG005|Year 1|Lack of Efficacy|9|||
105894618|NCT00195494|365269751|FG000|Year 1|Compliance|0|||
105894619|NCT00195494|365269752|FG001|Year 1|Compliance|0|||
105894620|NCT00195494|365269753|FG002|Year 1|Compliance|0|||
105894621|NCT00195494|365269754|FG003|Year 1|Compliance|0|||
105894622|NCT00195494|365269755|FG004|Year 1|Compliance|5|||
105894623|NCT00195494|365269756|FG005|Year 1|Compliance|1|||
105894624|NCT00195494|365269751|FG000|Year 1|Lost to Follow-up|0|||
105894625|NCT00195494|365269752|FG001|Year 1|Lost to Follow-up|0|||
105894626|NCT00195494|365269753|FG002|Year 1|Lost to Follow-up|0|||
105894627|NCT00195494|365269754|FG003|Year 1|Lost to Follow-up|0|||
105894628|NCT00195494|365269755|FG004|Year 1|Lost to Follow-up|1|||
105894629|NCT00195494|365269756|FG005|Year 1|Lost to Follow-up|0|||
105894630|NCT00195494|365269751|FG000|Year 1|Missed >4 consecutive doses|0|||
105894631|NCT00195494|365269752|FG001|Year 1|Missed >4 consecutive doses|0|||
105894632|NCT00195494|365269753|FG002|Year 1|Missed >4 consecutive doses|0|||
105894633|NCT00195494|365269754|FG003|Year 1|Missed >4 consecutive doses|0|||
105894634|NCT00195494|365269755|FG004|Year 1|Missed >4 consecutive doses|3|||
105894635|NCT00195494|365269756|FG005|Year 1|Missed >4 consecutive doses|2|||
105894636|NCT00195494|365269751|FG000|Year 1|Protocol deviation|0|||
105894637|NCT00195494|365269752|FG001|Year 1|Protocol deviation|0|||
105894638|NCT00195494|365269753|FG002|Year 1|Protocol deviation|0|||
105894639|NCT00195494|365269754|FG003|Year 1|Protocol deviation|0|||
105894640|NCT00195494|365269755|FG004|Year 1|Protocol deviation|2|||
105894641|NCT00195494|365269756|FG005|Year 1|Protocol deviation|3|||
105894642|NCT00195494|365269751|FG000|Year 1|Physician Decision|0|||
105894643|NCT00195494|365269752|FG001|Year 1|Physician Decision|0|||
105894644|NCT00195494|365269753|FG002|Year 1|Physician Decision|0|||
105894645|NCT00195494|365269754|FG003|Year 1|Physician Decision|0|||
105894646|NCT00195494|365269755|FG004|Year 1|Physician Decision|1|||
105894647|NCT00195494|365269756|FG005|Year 1|Physician Decision|0|||
105894648|NCT00195494|365269751|FG000|Year 1|Withdrawal by Subject|0|||
105894649|NCT00195494|365269752|FG001|Year 1|Withdrawal by Subject|0|||
105894650|NCT00195494|365269753|FG002|Year 1|Withdrawal by Subject|0|||
105894651|NCT00195494|365269754|FG003|Year 1|Withdrawal by Subject|0|||
105894652|NCT00195494|365269755|FG004|Year 1|Withdrawal by Subject|8|||
105894653|NCT00195494|365269756|FG005|Year 1|Withdrawal by Subject|9|||
105894654|NCT00195494|365269751|FG000|Year 1|Protocol Violation|0|||
105894655|NCT00195494|365269752|FG001|Year 1|Protocol Violation|0|||
105894656|NCT00195494|365269753|FG002|Year 1|Protocol Violation|0|||
105894657|NCT00195494|365269754|FG003|Year 1|Protocol Violation|0|||
105894658|NCT00195494|365269755|FG004|Year 1|Protocol Violation|1|||
105894659|NCT00195494|365269756|FG005|Year 1|Protocol Violation|1|||
105894660|NCT00195494|365269751|FG000|Year 2|Adverse Event|3|||
105894661|NCT00195494|365269752|FG001|Year 2|Adverse Event|7|||
105894662|NCT00195494|365269753|FG002|Year 2|Adverse Event|5|||
105894663|NCT00195494|365269754|FG003|Year 2|Adverse Event|9|||
105894664|NCT00195494|365269755|FG004|Year 2|Adverse Event|0|||
105894665|NCT00195494|365269756|FG005|Year 2|Adverse Event|0|||
105894666|NCT00195494|365269751|FG000|Year 2|Lack of Efficacy|0|||
105894667|NCT00195494|365269752|FG001|Year 2|Lack of Efficacy|1|||
105894668|NCT00195494|365269753|FG002|Year 2|Lack of Efficacy|7|||
105894669|NCT00195494|365269754|FG003|Year 2|Lack of Efficacy|7|||
105894670|NCT00195494|365269755|FG004|Year 2|Lack of Efficacy|0|||
105894671|NCT00195494|365269756|FG005|Year 2|Lack of Efficacy|0|||
105894672|NCT00195494|365269751|FG000|Year 2|Compliance|1|||
105894673|NCT00195494|365269752|FG001|Year 2|Compliance|0|||
105894674|NCT00195494|365269753|FG002|Year 2|Compliance|0|||
105894675|NCT00195494|365269754|FG003|Year 2|Compliance|2|||
105894676|NCT00195494|365269755|FG004|Year 2|Compliance|0|||
105894677|NCT00195494|365269756|FG005|Year 2|Compliance|0|||
105894678|NCT00195494|365269751|FG000|Year 2|Lost to Follow-up|0|||
105894679|NCT00195494|365269752|FG001|Year 2|Lost to Follow-up|0|||
105894680|NCT00195494|365269753|FG002|Year 2|Lost to Follow-up|1|||
105997143|NCT02360228|365649665|FG000|Overall Study|Unstable symptoms during screening|0|||
106122806|NCT01683994|366107703|FG001|Overall Study|Withdrawal by Subject|0|||
106122807|NCT01683994|366107704|FG002|Overall Study|Withdrawal by Subject|0|||
106122808|NCT01683994|366107705|FG003|Overall Study|Withdrawal by Subject|1|||
106122809|NCT01683994|366107706|FG004|Overall Study|Withdrawal by Subject|0|||
106122810|NCT01683994|366107702|FG000|Overall Study|Intercurrent illness|0|||
106122811|NCT01683994|366107703|FG001|Overall Study|Intercurrent illness|0|||
106122812|NCT01683994|366107704|FG002|Overall Study|Intercurrent illness|0|||
106122813|NCT01683994|366107705|FG003|Overall Study|Intercurrent illness|2|||
106122814|NCT01683994|366107706|FG004|Overall Study|Intercurrent illness|1|||
106122815|NCT00636792|366107707|FG000|Overall Study|Adverse Event|16|||
106122816|NCT00636792|366107707|FG000|Overall Study|Physician Decision|7|||
106122817|NCT00636792|366107707|FG000|Overall Study|Progressive Disease|4|||
106122818|NCT00636792|366107707|FG000|Overall Study|Withdrawal by Subject|3|||
106122819|NCT00636792|366107707|FG000|Overall Study|Other|3|||
106122820|NCT01987596|366107708|FG000|Overall Study|Physician Decision|1|||
106122821|NCT01987596|366107709|FG001|Overall Study|Physician Decision|0|||
106122822|NCT01987596|366107708|FG000|Overall Study|Progressive Disease; missing all period|0|||
106122823|NCT01987596|366107709|FG001|Overall Study|Progressive Disease; missing all period|1|||
106122824|NCT00451217|366107712|FG000|Overall Study|Lost to Follow-up|0|||
106122825|NCT00451217|366107713|FG001|Overall Study|Lost to Follow-up|1|||
106122826|NCT00451217|366107714|FG002|Overall Study|Lost to Follow-up|1|||
106122827|NCT00451217|366107715|FG003|Overall Study|Lost to Follow-up|1|||
106122828|NCT00451217|366107712|FG000|Overall Study|Withdrawal by Subject|1|||
106122829|NCT00451217|366107713|FG001|Overall Study|Withdrawal by Subject|0|||
106122830|NCT00451217|366107714|FG002|Overall Study|Withdrawal by Subject|0|||
105894681|NCT00195494|365269754|FG003|Year 2|Lost to Follow-up|1|||
105894682|NCT00195494|365269755|FG004|Year 2|Lost to Follow-up|0|||
105894683|NCT00195494|365269756|FG005|Year 2|Lost to Follow-up|0|||
105997144|NCT02360228|365649666|FG001|Overall Study|Unstable symptoms during screening|0|||
105997145|NCT02360228|365649667|FG002|Overall Study|Unstable symptoms during screening|1|||
105894684|NCT00195494|365269751|FG000|Year 2|Missed >4 consecutive doses|1|||
106122831|NCT00451217|366107715|FG003|Overall Study|Withdrawal by Subject|0|||
106122832|NCT00451217|366107712|FG000|Overall Study|Not Treated|1|||
105894685|NCT00195494|365269752|FG001|Year 2|Missed >4 consecutive doses|1|||
105894686|NCT00195494|365269753|FG002|Year 2|Missed >4 consecutive doses|1|||
106122833|NCT00451217|366107713|FG001|Overall Study|Not Treated|1|||
105894687|NCT00195494|365269754|FG003|Year 2|Missed >4 consecutive doses|0|||
105894688|NCT00195494|365269755|FG004|Year 2|Missed >4 consecutive doses|0|||
105894689|NCT00195494|365269756|FG005|Year 2|Missed >4 consecutive doses|0|||
106122834|NCT00451217|366107714|FG002|Overall Study|Not Treated|3|||
106122835|NCT00451217|366107715|FG003|Overall Study|Not Treated|4|||
105894690|NCT00195494|365269751|FG000|Year 2|Protocol deviation|0|||
106122836|NCT00358150|366107718|FG000|Overall Study|Adverse Event|3|||
106122837|NCT00358150|366107718|FG000|Overall Study|Withdrawal by Subject|1|||
105894691|NCT00195494|365269752|FG001|Year 2|Protocol deviation|1|||
105894692|NCT00195494|365269753|FG002|Year 2|Protocol deviation|0|||
105894693|NCT00195494|365269754|FG003|Year 2|Protocol deviation|0|||
105894694|NCT00195494|365269755|FG004|Year 2|Protocol deviation|0|||
105894695|NCT00195494|365269756|FG005|Year 2|Protocol deviation|0|||
105894696|NCT00195494|365269751|FG000|Year 2|Physician Decision|1|||
105894697|NCT00195494|365269752|FG001|Year 2|Physician Decision|1|||
105894698|NCT00195494|365269753|FG002|Year 2|Physician Decision|0|||
105894699|NCT00195494|365269754|FG003|Year 2|Physician Decision|0|||
105894700|NCT00195494|365269755|FG004|Year 2|Physician Decision|0|||
105894701|NCT00195494|365269756|FG005|Year 2|Physician Decision|0|||
105894702|NCT00195494|365269751|FG000|Year 2|Withdrawal by Subject|1|||
105894703|NCT00195494|365269752|FG001|Year 2|Withdrawal by Subject|5|||
105894704|NCT00195494|365269753|FG002|Year 2|Withdrawal by Subject|4|||
105894705|NCT00195494|365269754|FG003|Year 2|Withdrawal by Subject|3|||
105894706|NCT00195494|365269755|FG004|Year 2|Withdrawal by Subject|0|||
105894707|NCT00195494|365269756|FG005|Year 2|Withdrawal by Subject|0|||
105894708|NCT00195494|365269751|FG000|Year 2|System toxicity|0|||
105894709|NCT00195494|365269752|FG001|Year 2|System toxicity|0|||
105894710|NCT00195494|365269753|FG002|Year 2|System toxicity|0|||
105894711|NCT00195494|365269754|FG003|Year 2|System toxicity|1|||
105894712|NCT00195494|365269755|FG004|Year 2|System toxicity|0|||
105894713|NCT00195494|365269756|FG005|Year 2|System toxicity|0|||
105894714|NCT00835679|365269767|FG000|Overall Study|Withdrawal by Subject|1|||
105894715|NCT00835679|365269768|FG001|Overall Study|Withdrawal by Subject|0|||
105894716|NCT00835679|365269769|FG002|Overall Study|Withdrawal by Subject|0|||
105894717|NCT00835679|365269770|FG003|Overall Study|Withdrawal by Subject|0|||
105894718|NCT00501059|365269771|FG000|Overall Study|Protocol Violation|80|||
105894719|NCT00501059|365269772|FG001|Overall Study|Protocol Violation|69|||
105894720|NCT00501059|365269771|FG000|Overall Study|Death|140|||
105894721|NCT00501059|365269772|FG001|Overall Study|Death|137|||
105894722|NCT00501059|365269771|FG000|Overall Study|Other|236|||
105894723|NCT00501059|365269772|FG001|Overall Study|Other|239|||
105894724|NCT00501059|365269771|FG000|Overall Study|Missing end-of-study page|91|||
105894725|NCT00501059|365269772|FG001|Overall Study|Missing end-of-study page|92|||
105894726|NCT00501059|365269771|FG000|Overall Study|Clinical endpoint reached|110|||
105894727|NCT00501059|365269772|FG001|Overall Study|Clinical endpoint reached|123|||
105894728|NCT00501059|365269771|FG000|Overall Study|Insufficient therapeutic effect|4|||
105894729|NCT00501059|365269772|FG001|Overall Study|Insufficient therapeutic effect|5|||
105894730|NCT00501059|365269771|FG000|Overall Study|Consent withdrawn by subject|817|||
105894731|NCT00501059|365269772|FG001|Overall Study|Consent withdrawn by subject|873|||
105894732|NCT00501059|365269771|FG000|Overall Study|Non-compliant with study treatment|23|||
105894733|NCT00501059|365269772|FG001|Overall Study|Non-compliant with study treatment|16|||
105894734|NCT00501059|365269771|FG000|Overall Study|Reason not given|3|||
105894735|NCT00501059|365269772|FG001|Overall Study|Reason not given|1|||
105894736|NCT00501059|365269771|FG000|Overall Study|Adverse Event|129|||
105894737|NCT00501059|365269772|FG001|Overall Study|Adverse Event|122|||
105894738|NCT00501059|365269771|FG000|Overall Study|Lost to Follow-up|210|||
105894739|NCT00501059|365269772|FG001|Overall Study|Lost to Follow-up|198|||
105894740|NCT00501059|365269771|FG000|Overall Study|Not treated|25|||
105894741|NCT00501059|365269772|FG001|Overall Study|Not treated|17|||
105894742|NCT00955968|365269777|FG000|Overall Study|Death|2|||
105894743|NCT00955968|365269778|FG001|Overall Study|Death|4|||
105894744|NCT00955968|365269777|FG000|Overall Study|Withdrawal by Subject|35|||
106122838|NCT00358150|366107718|FG000|Overall Study|Undefined|3|||
106122839|NCT00197028|366107728|FG000|Overall Study|Adverse Event|2|||
106122840|NCT00197028|366107729|FG001|Overall Study|Adverse Event|2|||
106122841|NCT00197028|366107728|FG000|Overall Study|Protocol Violation|2|||
105665615|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105894745|NCT00955968|365269778|FG001|Overall Study|Withdrawal by Subject|31|||
105894746|NCT00955968|365269777|FG000|Overall Study|Lost to Follow-up|45|||
105894747|NCT00955968|365269778|FG001|Overall Study|Lost to Follow-up|39|||
105894748|NCT00955968|365269777|FG000|Overall Study|Site closed|55|||
105894749|NCT00955968|365269778|FG001|Overall Study|Site closed|52|||
105894750|NCT03802565|365269779|FG000|Overall Study|Adverse Event|0|||
105894751|NCT03802565|365269780|FG001|Overall Study|Adverse Event|1|||
106122842|NCT00197028|366107729|FG001|Overall Study|Protocol Violation|1|||
105894752|NCT03802565|365269781|FG002|Overall Study|Adverse Event|2|||
106122843|NCT00197028|366107728|FG000|Overall Study|Withdrawal by Subject|8|||
106122844|NCT00197028|366107729|FG001|Overall Study|Withdrawal by Subject|12|||
105894753|NCT03802565|365269782|FG003|Overall Study|Adverse Event|1|||
105894754|NCT03802565|365269783|FG004|Overall Study|Adverse Event|1|||
105894755|NCT03802565|365269779|FG000|Overall Study|Withdrawal by Subject|2|||
105894756|NCT03802565|365269780|FG001|Overall Study|Withdrawal by Subject|2|||
105894757|NCT03802565|365269781|FG002|Overall Study|Withdrawal by Subject|2|||
105894758|NCT03802565|365269782|FG003|Overall Study|Withdrawal by Subject|0|||
105894759|NCT03802565|365269783|FG004|Overall Study|Withdrawal by Subject|1|||
106122845|NCT00197028|366107728|FG000|Overall Study|Lost to Follow-up|1|||
105894760|NCT03802565|365269779|FG000|Overall Study|Protocol Violation|2|||
105894761|NCT03802565|365269780|FG001|Overall Study|Protocol Violation|1|||
105894762|NCT03802565|365269781|FG002|Overall Study|Protocol Violation|4|||
105894763|NCT03802565|365269782|FG003|Overall Study|Protocol Violation|5|||
105894764|NCT03802565|365269783|FG004|Overall Study|Protocol Violation|1|||
105894765|NCT03802565|365269779|FG000|Overall Study|Lost to Follow-up|0|||
105894766|NCT03802565|365269780|FG001|Overall Study|Lost to Follow-up|0|||
105894767|NCT03802565|365269781|FG002|Overall Study|Lost to Follow-up|1|||
105894768|NCT03802565|365269782|FG003|Overall Study|Lost to Follow-up|0|||
105894769|NCT03802565|365269783|FG004|Overall Study|Lost to Follow-up|0|||
105894770|NCT03802565|365269779|FG000|Overall Study|Subjects Related to Each Other|1|||
105894771|NCT03802565|365269780|FG001|Overall Study|Subjects Related to Each Other|0|||
105997146|NCT02679287|365649672|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
105997147|NCT02679287|365649673|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
105997148|NCT02679287|365649672|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
105997149|NCT02679287|365649673|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
105997150|NCT02679287|365649672|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
105997151|NCT02679287|365649673|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
105997152|NCT02679287|365649672|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
105997153|NCT02679287|365649673|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
105997154|NCT02679287|365649672|FG000|Period 2|Work/Scheduling Conflict|1|||
105997155|NCT02679287|365649673|FG001|Period 2|Work/Scheduling Conflict|0|||
105997156|NCT02679287|365649672|FG000|Period 2|Disliked Mobile System|2|||
105997157|NCT02679287|365649673|FG001|Period 2|Disliked Mobile System|0|||
105997158|NCT02679287|365649672|FG000|Period 3|Work/Scheduling Conflict|0|||
105894772|NCT03802565|365269781|FG002|Overall Study|Subjects Related to Each Other|0|||
105894773|NCT03802565|365269782|FG003|Overall Study|Subjects Related to Each Other|2|||
105997159|NCT02679287|365649673|FG001|Period 3|Work/Scheduling Conflict|1|||
105997160|NCT01045694|365649675|FG000|Overall Study|Withdrawal by Subject|2|||
105665616|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665617|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665618|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665619|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665620|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665621|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
105665622|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
105665623|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665624|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
105665625|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665626|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105894774|NCT03802565|365269783|FG004|Overall Study|Subjects Related to Each Other|1|||
105894775|NCT03802565|365269779|FG000|Overall Study|Elevated Enzymes|0|||
105894776|NCT03802565|365269780|FG001|Overall Study|Elevated Enzymes|0|||
105894777|NCT03802565|365269781|FG002|Overall Study|Elevated Enzymes|0|||
105894778|NCT03802565|365269782|FG003|Overall Study|Elevated Enzymes|0|||
105894779|NCT03802565|365269783|FG004|Overall Study|Elevated Enzymes|2|||
105894780|NCT05020899|365269784|FG000|8 Week Follow-up|Lost to Follow-up|3|||
105894781|NCT05020899|365269785|FG001|8 Week Follow-up|Lost to Follow-up|6|||
105894782|NCT05020899|365269784|FG000|12 Week Follow-up|Lost to Follow-up|1|||
105894783|NCT05020899|365269785|FG001|12 Week Follow-up|Lost to Follow-up|0|||
105894784|NCT05020899|365269784|FG000|12 Week Follow-up|Death|0|||
105894785|NCT05020899|365269785|FG001|12 Week Follow-up|Death|1|||
105894786|NCT01717391|365269790|FG000|Overall Study|Withdrawal by Subject|5|||
105894787|NCT01717391|365269790|FG000|Overall Study|Physician Decision|1|||
105894788|NCT01717391|365269790|FG000|Overall Study|FLT technical failure|3|||
105894789|NCT01068626|365269791|FG000|Overall Study|Adverse Event|3|||
105894790|NCT01068626|365269792|FG001|Overall Study|Adverse Event|0|||
105894791|NCT01068626|365269791|FG000|Overall Study|Withdrawal by Subject|0|||
105997161|NCT00999544|365651355|FG000|Overall Study|Withdrawal by Subject|1|||
105665627|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665628|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665629|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665630|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665631|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665632|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665633|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665634|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665635|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665636|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
105665637|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
105665638|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
105665639|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
105665640|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
105665641|NCT02906020|364440758|FG000|Part 2: Long-term Follow-up Period|Other|0|||
105665642|NCT02906020|364440759|FG001|Part 2: Long-term Follow-up Period|Other|0|||
105665643|NCT02906020|364440760|FG002|Part 2: Long-term Follow-up Period|Other|0|||
105665644|NCT02906020|364440761|FG003|Part 2: Long-term Follow-up Period|Other|0|||
105665645|NCT02906020|364440762|FG004|Part 2: Long-term Follow-up Period|Other|0|||
105665646|NCT02906020|364440763|FG005|Part 2: Long-term Follow-up Period|Other|0|||
105665647|NCT02906020|364440764|FG006|Part 2: Long-term Follow-up Period|Other|0|||
105665648|NCT02906020|364440765|FG007|Part 2: Long-term Follow-up Period|Other|0|||
105665649|NCT02906020|364440766|FG008|Part 2: Long-term Follow-up Period|Other|0|||
105665650|NCT02906020|364440767|FG009|Part 2: Long-term Follow-up Period|Other|0|||
105665651|NCT02906020|364440768|FG010|Part 2: Long-term Follow-up Period|Other|0|||
105665652|NCT02906020|364440769|FG011|Part 2: Long-term Follow-up Period|Other|0|||
105665653|NCT02906020|364440770|FG012|Part 2: Long-term Follow-up Period|Other|13|||
105665654|NCT02906020|364440771|FG013|Part 2: Long-term Follow-up Period|Other|8|||
105665655|NCT02906020|364440772|FG014|Part 2: Long-term Follow-up Period|Other|3|||
105665656|NCT02906020|364440773|FG015|Part 2: Long-term Follow-up Period|Other|2|||
105665657|NCT01810939|364440774|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
105665658|NCT01810939|364440775|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
105665659|NCT01810939|364440776|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
105665660|NCT01810939|364440774|FG000|Part A Treatment Period|Protocol Violation|2|||
105665661|NCT01810939|364440775|FG001|Part A Treatment Period|Protocol Violation|0|||
105665662|NCT01810939|364440776|FG002|Part A Treatment Period|Protocol Violation|0|||
105665663|NCT01810939|364440774|FG000|Part A Treatment Period|Adverse Event|10|||
105665664|NCT01810939|364440775|FG001|Part A Treatment Period|Adverse Event|0|||
105665665|NCT01810939|364440776|FG002|Part A Treatment Period|Adverse Event|0|||
105665666|NCT01810939|364440774|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
105665667|NCT01810939|364440775|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
105665668|NCT01810939|364440776|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
105665669|NCT01810939|364440774|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
105665670|NCT01810939|364440775|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
105665671|NCT01810939|364440776|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
105665672|NCT01810939|364440774|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
105665673|NCT01810939|364440775|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
105665674|NCT01810939|364440776|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
105665675|NCT01810939|364440774|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
105665676|NCT01810939|364440775|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
105665677|NCT01810939|364440776|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
105665678|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
105665679|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
105665680|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
105665681|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
105665682|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
105665683|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
105997162|NCT01594931|365651356|FG000|Overall Study|Adverse Event|3|||
105665684|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
105665685|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
105665686|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
105665687|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
105665688|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
105665689|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
105665690|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
105665691|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
105997163|NCT01594931|365651357|FG001|Overall Study|Adverse Event|1|||
105997164|NCT01594931|365651358|FG002|Overall Study|Adverse Event|1|||
105665692|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
105665693|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
105665694|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
105665695|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
105665696|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
105665697|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
105665698|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
105665699|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
105665700|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
105665701|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
105665702|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
105665703|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
105665704|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
105665705|NCT01810939|364440774|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
105665706|NCT01810939|364440775|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
105894792|NCT01068626|365269792|FG001|Overall Study|Withdrawal by Subject|2|||
105894793|NCT01785849|365269795|FG000|Overall Study|Death|7|||
105894794|NCT01785849|365269796|FG001|Overall Study|Death|9|||
105894795|NCT01785849|365269795|FG000|Overall Study|Protocol Specified Criteria|29|||
105894796|NCT01785849|365269796|FG001|Overall Study|Protocol Specified Criteria|1|||
105894797|NCT01785849|365269795|FG000|Overall Study|Withdrawal by Subject|15|||
105894798|NCT01785849|365269796|FG001|Overall Study|Withdrawal by Subject|12|||
105894799|NCT01785849|365269795|FG000|Overall Study|Sponsor Decision|0|||
105894800|NCT01785849|365269796|FG001|Overall Study|Sponsor Decision|1|||
105894801|NCT01785849|365269795|FG000|Overall Study|Lost to Follow-up|10|||
105894802|NCT01785849|365269796|FG001|Overall Study|Lost to Follow-up|11|||
105894803|NCT00204477|365269797|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
105894804|NCT00204477|365269798|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
105894805|NCT00204477|365269797|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
105894806|NCT00204477|365269798|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
105894807|NCT03627416|365269800|FG000|Overall Study|Adverse Event|0|||
105894808|NCT03627416|365269801|FG001|Overall Study|Adverse Event|1|||
106122846|NCT00197028|366107729|FG001|Overall Study|Lost to Follow-up|0|||
106122847|NCT00197028|366107728|FG000|Overall Study|Other|3|||
106122848|NCT00197028|366107729|FG001|Overall Study|Other|6|||
106122849|NCT01763788|366107730|FG000|Overall Study|Lost to Follow-up|0|||
106122850|NCT01763788|366107731|FG001|Overall Study|Lost to Follow-up|0|||
106122851|NCT01763788|366107732|FG002|Overall Study|Lost to Follow-up|1|||
106122852|NCT01763788|366107733|FG003|Overall Study|Lost to Follow-up|0|||
106122853|NCT03893825|366107734|FG000|Overall Study|Death|2|||
106122854|NCT03893825|366107735|FG001|Overall Study|Death|1|||
106122855|NCT03893825|366107734|FG000|Overall Study|Adverse Event|0|||
106122856|NCT03893825|366107735|FG001|Overall Study|Adverse Event|2|||
106122857|NCT03893825|366107734|FG000|Overall Study|Withdrawal by Subject|19|||
106122858|NCT03893825|366107735|FG001|Overall Study|Withdrawal by Subject|21|||
106122859|NCT03893825|366107734|FG000|Overall Study|Protocol deviation|1|||
106122860|NCT03893825|366107735|FG001|Overall Study|Protocol deviation|0|||
106122861|NCT03893825|366107734|FG000|Overall Study|Lost to Follow-up|10|||
106122862|NCT03893825|366107735|FG001|Overall Study|Lost to Follow-up|10|||
106122863|NCT03893825|366107734|FG000|Overall Study|Other than specified|7|||
106122864|NCT03893825|366107735|FG001|Overall Study|Other than specified|6|||
106122865|NCT00988351|366107742|FG000|Overall Study|Withdrawal by Subject|8|||
106122866|NCT00988351|366107743|FG001|Overall Study|Withdrawal by Subject|0|||
106122867|NCT00988351|366107742|FG000|Overall Study|Lost to Follow-up|6|||
106122868|NCT00988351|366107743|FG001|Overall Study|Lost to Follow-up|9|||
106122869|NCT00988351|366107742|FG000|Overall Study|not using CPAP|5|||
106122870|NCT00988351|366107743|FG001|Overall Study|not using CPAP|3|||
106122871|NCT00734214|366107744|FG000|Overall Study|Withdrawal by Subject|3|||
106122872|NCT00734214|366107745|FG001|Overall Study|Withdrawal by Subject|4|||
106122873|NCT00734214|366107744|FG000|Overall Study|MD withdrawal|1|||
106122874|NCT00734214|366107745|FG001|Overall Study|MD withdrawal|0|||
106122875|NCT02038764|366107748|FG000|Overall Study|Adverse Event|0|||
106122876|NCT02038764|366107749|FG001|Overall Study|Adverse Event|0|||
106122877|NCT02038764|366107750|FG002|Overall Study|Adverse Event|1|||
106122878|NCT02038764|366107751|FG003|Overall Study|Adverse Event|0|||
106122879|NCT02038764|366107752|FG004|Overall Study|Adverse Event|0|||
106122880|NCT02038764|366107748|FG000|Overall Study|Lost to Follow-up|0|||
106122881|NCT02038764|366107749|FG001|Overall Study|Lost to Follow-up|1|||
106122882|NCT02038764|366107750|FG002|Overall Study|Lost to Follow-up|0|||
106122883|NCT02038764|366107751|FG003|Overall Study|Lost to Follow-up|0|||
106122884|NCT02038764|366107752|FG004|Overall Study|Lost to Follow-up|0|||
106122885|NCT02038764|366107748|FG000|Overall Study|Withdrawal by Subject|0|||
106122886|NCT02038764|366107749|FG001|Overall Study|Withdrawal by Subject|0|||
106122887|NCT02038764|366107750|FG002|Overall Study|Withdrawal by Subject|0|||
106122888|NCT02038764|366107751|FG003|Overall Study|Withdrawal by Subject|0|||
106122889|NCT02038764|366107752|FG004|Overall Study|Withdrawal by Subject|1|||
106122890|NCT02038764|366107748|FG000|Overall Study|Other|1|||
106122891|NCT02038764|366107749|FG001|Overall Study|Other|0|||
106122892|NCT02038764|366107750|FG002|Overall Study|Other|1|||
106122893|NCT02038764|366107751|FG003|Overall Study|Other|0|||
106122894|NCT02038764|366107752|FG004|Overall Study|Other|0|||
106122895|NCT02443103|366107755|FG000|Overall Study|Adverse Event|2|||
106122896|NCT02443103|366107755|FG000|Overall Study|Noncompliance|1|||
106122897|NCT01115491|366107756|FG000|Overall Study|Death|22|||
106122898|NCT01115491|366107756|FG000|Overall Study|Adverse Event|3|||
106122899|NCT01115491|366107756|FG000|Overall Study|Lost to Follow-up|3|||
106122900|NCT01115491|366107756|FG000|Overall Study|Withdrawal by Subject|1|||
105894809|NCT01294371|365269802|FG000|Overall Study|Adverse Event|1|||
106122901|NCT01115491|366107756|FG000|Overall Study|Physician Decision|1|||
106122902|NCT01913639|366107761|FG000|Overall Study|Not Eligible|3|||
106122903|NCT04297241|366107762|FG000|Overall Study|Withdrawal by Subject|1|||
106122904|NCT04297241|366107762|FG000|Overall Study|Adverse Event|1|||
106122905|NCT04297241|366107762|FG000|Overall Study|Physician Decision|3|||
106122906|NCT00630058|366107763|FG000|Overall Study|Adverse Event|1|||
106122907|NCT00630058|366107764|FG001|Overall Study|Adverse Event|1|||
106122908|NCT00630058|366107763|FG000|Overall Study|Withdrawal by Subject|0|||
106122909|NCT00630058|366107764|FG001|Overall Study|Withdrawal by Subject|1|||
106122910|NCT00630058|366107763|FG000|Overall Study|stopping criteria|3|||
106122911|NCT00630058|366107764|FG001|Overall Study|stopping criteria|2|||
105894810|NCT01294371|365269802|FG000|Overall Study|Withdrawal by Subject|12|||
105894811|NCT01294371|365269802|FG000|Overall Study|Lost to Follow-up|6|||
105894812|NCT01294371|365269802|FG000|Overall Study|Administrative Reason|1|||
105894813|NCT01294371|365269802|FG000|Overall Study|Other|14|||
105894814|NCT02079636|365269803|FG000|Overall Study|Death|2|||
105894815|NCT02079636|365269804|FG001|Overall Study|Death|1|||
105894816|NCT02079636|365269805|FG002|Overall Study|Death|0|||
105894817|NCT02079636|365269806|FG003|Overall Study|Death|5|||
105894818|NCT02079636|365269807|FG004|Overall Study|Death|1|||
105894819|NCT02079636|365269808|FG005|Overall Study|Death|2|||
105894820|NCT02079636|365269809|FG006|Overall Study|Death|1|||
105894821|NCT02079636|365269810|FG007|Overall Study|Death|0|||
105894822|NCT02079636|365269811|FG008|Overall Study|Death|0|||
105894823|NCT02079636|365269812|FG009|Overall Study|Death|0|||
105894824|NCT02079636|365269813|FG010|Overall Study|Death|0|||
105894825|NCT02079636|365269814|FG011|Overall Study|Death|1|||
105894826|NCT02079636|365269815|FG012|Overall Study|Death|1|||
105894827|NCT02079636|365269816|FG013|Overall Study|Death|0|||
105894828|NCT02079636|365269817|FG014|Overall Study|Death|2|||
105894829|NCT02079636|365269803|FG000|Overall Study|Adverse Event|1|||
105894830|NCT02079636|365269804|FG001|Overall Study|Adverse Event|1|||
105894831|NCT02079636|365269805|FG002|Overall Study|Adverse Event|0|||
105894832|NCT02079636|365269806|FG003|Overall Study|Adverse Event|1|||
105997165|NCT01594931|365651356|FG000|Overall Study|Withdrawal by Subject|2|||
105997166|NCT01594931|365651357|FG001|Overall Study|Withdrawal by Subject|1|||
105997167|NCT01594931|365651358|FG002|Overall Study|Withdrawal by Subject|1|||
105997168|NCT01594931|365651356|FG000|Overall Study|Lack of Efficacy|7|||
105997169|NCT01594931|365651357|FG001|Overall Study|Lack of Efficacy|2|||
105894833|NCT02079636|365269807|FG004|Overall Study|Adverse Event|1|||
105894834|NCT02079636|365269808|FG005|Overall Study|Adverse Event|2|||
105894835|NCT02079636|365269809|FG006|Overall Study|Adverse Event|0|||
105894836|NCT02079636|365269810|FG007|Overall Study|Adverse Event|0|||
105997170|NCT01594931|365651358|FG002|Overall Study|Lack of Efficacy|2|||
105997171|NCT01594931|365651356|FG000|Overall Study|Lost to Follow-up|4|||
105894837|NCT02079636|365269811|FG008|Overall Study|Adverse Event|0|||
105894838|NCT02079636|365269812|FG009|Overall Study|Adverse Event|0|||
106122912|NCT02141659|366107765|FG000|Overall Study|Major Protocol Deviation|0|||
106122913|NCT02141659|366107766|FG001|Overall Study|Major Protocol Deviation|1|||
106122914|NCT02141659|366107767|FG002|Overall Study|Major Protocol Deviation|0|||
106122915|NCT02141659|366107768|FG003|Overall Study|Major Protocol Deviation|0|||
106122916|NCT02141659|366107769|FG004|Overall Study|Major Protocol Deviation|0|||
106122917|NCT02141659|366107770|FG005|Overall Study|Major Protocol Deviation|0|||
106122918|NCT02141659|366107765|FG000|Overall Study|Lack of Efficacy|0|||
106122919|NCT02141659|366107766|FG001|Overall Study|Lack of Efficacy|0|||
106122920|NCT02141659|366107767|FG002|Overall Study|Lack of Efficacy|0|||
106122921|NCT02141659|366107768|FG003|Overall Study|Lack of Efficacy|0|||
106122922|NCT02141659|366107769|FG004|Overall Study|Lack of Efficacy|0|||
106122923|NCT02141659|366107770|FG005|Overall Study|Lack of Efficacy|1|||
105785973|NCT04246593|364870423|FG000|Overall Study|Withdrawal by Subject|14|||
105894839|NCT02079636|365269813|FG010|Overall Study|Adverse Event|0|||
106122924|NCT02141659|366107765|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
105665707|NCT01810939|364440776|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
105665708|NCT01952847|364440777|FG000|Overall Study|Ineligible|1|||
105665709|NCT01952847|364440778|FG001|Overall Study|Ineligible|0|||
105665710|NCT01952847|364440779|FG002|Overall Study|Ineligible|0|||
105665711|NCT01952847|364440780|FG003|Overall Study|Ineligible|0|||
105665712|NCT01952847|364440777|FG000|Overall Study|Lack of Insurance Coverage|0|||
105665713|NCT01952847|364440778|FG001|Overall Study|Lack of Insurance Coverage|1|||
105665714|NCT01952847|364440779|FG002|Overall Study|Lack of Insurance Coverage|0|||
105665715|NCT01952847|364440780|FG003|Overall Study|Lack of Insurance Coverage|0|||
105665716|NCT01952847|364440777|FG000|Overall Study|Withdrawal by Subject|1|||
105665717|NCT01952847|364440778|FG001|Overall Study|Withdrawal by Subject|1|||
105665718|NCT01952847|364440779|FG002|Overall Study|Withdrawal by Subject|0|||
105665719|NCT01952847|364440780|FG003|Overall Study|Withdrawal by Subject|1|||
105665720|NCT01661205|364440785|FG000|Overall Study|Physician Decision|2|||
105665721|NCT02803593|364440786|FG000|Overall Study|Lost to Follow-up|17|||
105665722|NCT02803593|364440787|FG001|Overall Study|Lost to Follow-up|35|||
105665723|NCT04245345|364440798|FG000|Overall Study|Death|1|||
105665724|NCT04245345|364440798|FG000|Overall Study|Exited prior to implant|5|||
105665725|NCT04245345|364440798|FG000|Overall Study|Exited prior to 1-month|9|||
105665726|NCT04245345|364440798|FG000|Overall Study|Missed 1-month visit|3|||
105665727|NCT04245345|364440798|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
105665728|NCT04245345|364440798|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
105665729|NCT01667549|364440800|FG000|Overall Study|Withdrawal by Subject|3|||
105665730|NCT01667549|364440801|FG001|Overall Study|Withdrawal by Subject|5|||
105665731|NCT01667549|364440802|FG002|Overall Study|Withdrawal by Subject|7|||
105665732|NCT01667549|364440803|FG003|Overall Study|Withdrawal by Subject|6|||
105665733|NCT01667549|364440804|FG004|Overall Study|Withdrawal by Subject|1|||
105665734|NCT01080300|364440807|FG000|Overall Study|Adverse Event|49|||
105665735|NCT01080300|364440808|FG001|Overall Study|Adverse Event|35|||
105665736|NCT01080300|364440807|FG000|Overall Study|Lack of Efficacy|12|||
105665737|NCT01080300|364440808|FG001|Overall Study|Lack of Efficacy|15|||
105665738|NCT01080300|364440807|FG000|Overall Study|Protocol Violation|7|||
105665739|NCT01080300|364440808|FG001|Overall Study|Protocol Violation|13|||
105665740|NCT01080300|364440807|FG000|Overall Study|Lost to Follow-up|10|||
105665741|NCT01080300|364440808|FG001|Overall Study|Lost to Follow-up|6|||
105665742|NCT01080300|364440807|FG000|Overall Study|Death|0|||
105665743|NCT01080300|364440808|FG001|Overall Study|Death|1|||
105665744|NCT01080300|364440807|FG000|Overall Study|Withdrawal by Subject|12|||
105665745|NCT01080300|364440808|FG001|Overall Study|Withdrawal by Subject|28|||
105665746|NCT01080300|364440807|FG000|Overall Study|Reasons not specified|4|||
105665747|NCT01080300|364440808|FG001|Overall Study|Reasons not specified|6|||
105665748|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
105665749|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
105665750|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
105665751|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
105665752|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
105665753|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
105665754|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
105665755|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
105665756|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
105665757|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
105665758|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
105665759|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
105665760|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
105665761|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
105665762|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
105665763|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
105665764|NCT04210843|364440809|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
105665765|NCT04210843|364440810|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
105665766|NCT04210843|364440809|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
105665767|NCT04210843|364440810|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
105665768|NCT04210843|364440809|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
105665769|NCT04210843|364440810|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
105665770|NCT04210843|364440809|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
105665771|NCT04210843|364440810|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
105665772|NCT04210843|364440809|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
105665773|NCT04210843|364440810|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
105894840|NCT02079636|365269814|FG011|Overall Study|Adverse Event|0|||
105894841|NCT02079636|365269815|FG012|Overall Study|Adverse Event|0|||
106122925|NCT02141659|366107766|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
105665774|NCT04210843|364440809|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
105665775|NCT04210843|364440810|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
105894842|NCT02079636|365269816|FG013|Overall Study|Adverse Event|0|||
105894843|NCT02079636|365269817|FG014|Overall Study|Adverse Event|0|||
105894844|NCT02079636|365269803|FG000|Overall Study|Progressive disease|0|||
105894845|NCT02079636|365269804|FG001|Overall Study|Progressive disease|0|||
105894846|NCT02079636|365269805|FG002|Overall Study|Progressive disease|0|||
105894847|NCT02079636|365269806|FG003|Overall Study|Progressive disease|2|||
105894848|NCT02079636|365269807|FG004|Overall Study|Progressive disease|0|||
105894849|NCT02079636|365269808|FG005|Overall Study|Progressive disease|0|||
105894850|NCT02079636|365269809|FG006|Overall Study|Progressive disease|0|||
105894851|NCT02079636|365269810|FG007|Overall Study|Progressive disease|0|||
105894852|NCT02079636|365269811|FG008|Overall Study|Progressive disease|0|||
105894853|NCT02079636|365269812|FG009|Overall Study|Progressive disease|0|||
105894854|NCT02079636|365269813|FG010|Overall Study|Progressive disease|0|||
105894855|NCT02079636|365269814|FG011|Overall Study|Progressive disease|0|||
105894856|NCT02079636|365269815|FG012|Overall Study|Progressive disease|1|||
105894857|NCT02079636|365269816|FG013|Overall Study|Progressive disease|0|||
105894858|NCT02079636|365269817|FG014|Overall Study|Progressive disease|0|||
105894859|NCT02079636|365269803|FG000|Overall Study|Withdrawal by Subject|0|||
105894860|NCT02079636|365269804|FG001|Overall Study|Withdrawal by Subject|0|||
105894861|NCT02079636|365269805|FG002|Overall Study|Withdrawal by Subject|0|||
105894862|NCT02079636|365269806|FG003|Overall Study|Withdrawal by Subject|4|||
105894863|NCT02079636|365269807|FG004|Overall Study|Withdrawal by Subject|0|||
105894864|NCT02079636|365269808|FG005|Overall Study|Withdrawal by Subject|1|||
105894865|NCT02079636|365269809|FG006|Overall Study|Withdrawal by Subject|0|||
105894866|NCT02079636|365269810|FG007|Overall Study|Withdrawal by Subject|0|||
105894867|NCT02079636|365269811|FG008|Overall Study|Withdrawal by Subject|0|||
105894868|NCT02079636|365269812|FG009|Overall Study|Withdrawal by Subject|2|||
105894869|NCT02079636|365269813|FG010|Overall Study|Withdrawal by Subject|1|||
105894870|NCT02079636|365269814|FG011|Overall Study|Withdrawal by Subject|1|||
105894871|NCT02079636|365269815|FG012|Overall Study|Withdrawal by Subject|1|||
105894872|NCT02079636|365269816|FG013|Overall Study|Withdrawal by Subject|0|||
105894873|NCT02079636|365269817|FG014|Overall Study|Withdrawal by Subject|2|||
105894874|NCT02079636|365269803|FG000|Overall Study|Physician Decision|0|||
105894875|NCT02079636|365269804|FG001|Overall Study|Physician Decision|0|||
105894876|NCT02079636|365269805|FG002|Overall Study|Physician Decision|0|||
105894877|NCT02079636|365269806|FG003|Overall Study|Physician Decision|0|||
105894878|NCT02079636|365269807|FG004|Overall Study|Physician Decision|0|||
105894879|NCT02079636|365269808|FG005|Overall Study|Physician Decision|1|||
105894880|NCT02079636|365269809|FG006|Overall Study|Physician Decision|0|||
105894881|NCT02079636|365269810|FG007|Overall Study|Physician Decision|0|||
105894882|NCT02079636|365269811|FG008|Overall Study|Physician Decision|0|||
105894883|NCT02079636|365269812|FG009|Overall Study|Physician Decision|1|||
105894884|NCT02079636|365269813|FG010|Overall Study|Physician Decision|1|||
105894885|NCT02079636|365269814|FG011|Overall Study|Physician Decision|0|||
105894886|NCT02079636|365269815|FG012|Overall Study|Physician Decision|0|||
105894887|NCT02079636|365269816|FG013|Overall Study|Physician Decision|0|||
105665776|NCT04210843|364440809|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
105894888|NCT02079636|365269817|FG014|Overall Study|Physician Decision|1|||
105894889|NCT02079636|365269803|FG000|Overall Study|Lost to Follow-up|0|||
105894890|NCT02079636|365269804|FG001|Overall Study|Lost to Follow-up|0|||
105894891|NCT02079636|365269805|FG002|Overall Study|Lost to Follow-up|0|||
105894892|NCT02079636|365269806|FG003|Overall Study|Lost to Follow-up|0|||
105894893|NCT02079636|365269807|FG004|Overall Study|Lost to Follow-up|0|||
105894894|NCT02079636|365269808|FG005|Overall Study|Lost to Follow-up|0|||
105894895|NCT02079636|365269809|FG006|Overall Study|Lost to Follow-up|0|||
105894896|NCT02079636|365269810|FG007|Overall Study|Lost to Follow-up|1|||
105894897|NCT02079636|365269811|FG008|Overall Study|Lost to Follow-up|0|||
105894898|NCT02079636|365269812|FG009|Overall Study|Lost to Follow-up|0|||
105894899|NCT02079636|365269813|FG010|Overall Study|Lost to Follow-up|0|||
105894900|NCT02079636|365269814|FG011|Overall Study|Lost to Follow-up|0|||
105894901|NCT02079636|365269815|FG012|Overall Study|Lost to Follow-up|0|||
105894902|NCT02079636|365269816|FG013|Overall Study|Lost to Follow-up|0|||
105894903|NCT02079636|365269817|FG014|Overall Study|Lost to Follow-up|0|||
105894904|NCT00875433|365269820|FG000|Overall Study|Progressive disease|41|||
105894905|NCT00875433|365269820|FG000|Overall Study|Other Adverse Event|14|||
105894906|NCT00875433|365269820|FG000|Overall Study|Withdrawal by Subject|2|||
105894907|NCT00875433|365269820|FG000|Overall Study|Other|3|||
105894908|NCT00637806|365269821|FG000|Double-blind Phase|Study Discontinued|2|||
105894909|NCT00637806|365269822|FG001|Double-blind Phase|Study Discontinued|0|||
105894910|NCT00637806|365269823|FG002|Double-blind Phase|Study Discontinued|1|||
105894911|NCT00637806|365269824|FG003|Double-blind Phase|Study Discontinued|0|||
105894912|NCT00637806|365269821|FG000|Extension Phase|Study Discontinued|0|||
105894913|NCT00637806|365269822|FG001|Extension Phase|Study Discontinued|0|||
105894914|NCT00637806|365269823|FG002|Extension Phase|Study Discontinued|0|||
105894915|NCT00637806|365269824|FG003|Extension Phase|Study Discontinued|1|||
105894916|NCT03434249|365269825|FG000|Overall Study|Adverse Event|1|||
105894917|NCT03434249|365269826|FG001|Overall Study|Adverse Event|0|||
105894918|NCT03434249|365269825|FG000|Overall Study|Lost to Follow-up|0|||
105894919|NCT03434249|365269826|FG001|Overall Study|Lost to Follow-up|1|||
105894920|NCT03434249|365269825|FG000|Overall Study|Non-compliance of family|2|||
105894921|NCT03434249|365269826|FG001|Overall Study|Non-compliance of family|1|||
105894922|NCT03434249|365269825|FG000|Overall Study|Difficulties in completing daily diary|2|||
105894923|NCT03434249|365269826|FG001|Overall Study|Difficulties in completing daily diary|1|||
105894924|NCT02450552|365269827|FG000|Overall Study|Withdrawal by Subject|4|||
105894925|NCT02450552|365269828|FG001|Overall Study|Withdrawal by Subject|0|||
105894926|NCT02450552|365269829|FG002|Overall Study|Withdrawal by Subject|4|||
105894927|NCT02450552|365269827|FG000|Overall Study|Physician Decision|1|||
105894928|NCT02450552|365269828|FG001|Overall Study|Physician Decision|0|||
105894929|NCT02450552|365269829|FG002|Overall Study|Physician Decision|1|||
105894930|NCT03233204|365269837|FG000|Overall Study|Adverse Event|1|||
105894931|NCT03233204|365269837|FG000|Overall Study|Death|1|||
105894932|NCT03233204|365269837|FG000|Overall Study|Withdrawal by Subject|1|||
105894933|NCT03233204|365269837|FG000|Overall Study|Progressive Disease|3|||
105894934|NCT02680834|365269838|FG000|Overall Study|Physician Decision|5|||
105894935|NCT02680834|365269839|FG001|Overall Study|Physician Decision|2|||
105894936|NCT02680834|365269838|FG000|Overall Study|Withdrawal by Subject|6|||
105894937|NCT02680834|365269839|FG001|Overall Study|Withdrawal by Subject|0|||
105894938|NCT02680834|365269838|FG000|Overall Study|Lost to Follow-up|0|||
105894939|NCT02680834|365269839|FG001|Overall Study|Lost to Follow-up|1|||
105894940|NCT02520427|365269840|FG000|Overall Study|Decision by sponsor|0|||
105894941|NCT02520427|365269841|FG001|Overall Study|Decision by sponsor|0|||
105894942|NCT02520427|365269842|FG002|Overall Study|Decision by sponsor|0|||
105894943|NCT02520427|365269843|FG003|Overall Study|Decision by sponsor|0|||
105894944|NCT02520427|365269844|FG004|Overall Study|Decision by sponsor|0|||
105894945|NCT02520427|365269845|FG005|Overall Study|Decision by sponsor|0|||
105894946|NCT02520427|365269846|FG006|Overall Study|Decision by sponsor|0|||
105785974|NCT04246593|364870424|FG001|Overall Study|Withdrawal by Subject|13|||
105894947|NCT02520427|365269847|FG007|Overall Study|Decision by sponsor|0|||
105894948|NCT02520427|365269848|FG008|Overall Study|Decision by sponsor|1|||
105894949|NCT02520427|365269849|FG009|Overall Study|Decision by sponsor|1|||
105894950|NCT02520427|365269850|FG010|Overall Study|Decision by sponsor|0|||
105894951|NCT02520427|365269851|FG011|Overall Study|Decision by sponsor|0|||
105894952|NCT02520427|365269852|FG012|Overall Study|Decision by sponsor|0|||
105894953|NCT02520427|365269853|FG013|Overall Study|Decision by sponsor|0|||
105894954|NCT02520427|365269854|FG014|Overall Study|Decision by sponsor|0|||
105894955|NCT02520427|365269855|FG015|Overall Study|Decision by sponsor|0|||
105894956|NCT02520427|365269856|FG016|Overall Study|Decision by sponsor|0|||
105894957|NCT02520427|365269857|FG017|Overall Study|Decision by sponsor|0|||
105894958|NCT02520427|365269858|FG018|Overall Study|Decision by sponsor|0|||
105997172|NCT01594931|365651357|FG001|Overall Study|Lost to Follow-up|3|||
105997173|NCT01594931|365651358|FG002|Overall Study|Lost to Follow-up|3|||
105997174|NCT01594931|365651356|FG000|Overall Study|Protocol Violation|2|||
105997175|NCT01594931|365651357|FG001|Overall Study|Protocol Violation|1|||
105997176|NCT01594931|365651358|FG002|Overall Study|Protocol Violation|0|||
105997177|NCT01594931|365651356|FG000|Overall Study|No defiined|11|||
105997178|NCT01594931|365651357|FG001|Overall Study|No defiined|4|||
105997179|NCT01594931|365651358|FG002|Overall Study|No defiined|7|||
105665777|NCT04210843|364440810|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
105665778|NCT04210843|364440809|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
105665779|NCT04210843|364440810|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
105665780|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
105665781|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
105665782|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
105665783|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
105665784|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
105665785|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
105665786|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
105665787|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
105665788|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
105894959|NCT02520427|365269859|FG019|Overall Study|Decision by sponsor|0|||
105894960|NCT02520427|365269860|FG020|Overall Study|Decision by sponsor|0|||
105894961|NCT02520427|365269861|FG021|Overall Study|Decision by sponsor|0|||
105894962|NCT02520427|365269862|FG022|Overall Study|Decision by sponsor|0|||
105894963|NCT02520427|365269863|FG023|Overall Study|Decision by sponsor|0|||
105894964|NCT02520427|365269864|FG024|Overall Study|Decision by sponsor|0|||
105894965|NCT02520427|365269865|FG025|Overall Study|Decision by sponsor|0|||
105894966|NCT02520427|365269840|FG000|Overall Study|Withdrawal by Subject|0|||
105997180|NCT01633788|365651366|FG000|Overall Study|Adverse Event|1|||
105665789|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
105665790|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
105665791|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
105665792|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
105665793|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
105665794|NCT04210843|364440809|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
105665795|NCT04210843|364440810|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
105665796|NCT00150618|364440811|FG000|Overall Study|Adverse Event|2|||
105665797|NCT00150618|364440812|FG001|Overall Study|Adverse Event|2|||
105665798|NCT00150618|364440813|FG002|Overall Study|Adverse Event|6|||
105665799|NCT00150618|364440814|FG003|Overall Study|Adverse Event|9|||
105665800|NCT00150618|364440815|FG004|Overall Study|Adverse Event|5|||
105665801|NCT00150618|364440811|FG000|Overall Study|Withdrawal by Subject|6|||
105665802|NCT00150618|364440812|FG001|Overall Study|Withdrawal by Subject|8|||
105665803|NCT00150618|364440813|FG002|Overall Study|Withdrawal by Subject|8|||
105665804|NCT00150618|364440814|FG003|Overall Study|Withdrawal by Subject|4|||
105894967|NCT02520427|365269841|FG001|Overall Study|Withdrawal by Subject|0|||
105894968|NCT02520427|365269842|FG002|Overall Study|Withdrawal by Subject|1|||
105894969|NCT02520427|365269843|FG003|Overall Study|Withdrawal by Subject|0|||
105997181|NCT01633788|365651367|FG001|Overall Study|Adverse Event|3|||
105997182|NCT01633788|365651368|FG002|Overall Study|Adverse Event|3|||
105997183|NCT01633788|365651369|FG003|Overall Study|Adverse Event|3|||
105997184|NCT01633788|365651366|FG000|Overall Study|Lost to Follow-up|2|||
105997185|NCT01633788|365651367|FG001|Overall Study|Lost to Follow-up|2|||
105997186|NCT01633788|365651368|FG002|Overall Study|Lost to Follow-up|2|||
106122926|NCT02141659|366107767|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
106122927|NCT02141659|366107768|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
106122928|NCT02141659|366107769|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
106122929|NCT02141659|366107770|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
106122930|NCT02471404|366107771|FG000|Overall Study|Adverse Event|7|||
105665805|NCT00150618|364440815|FG004|Overall Study|Withdrawal by Subject|5|||
105665806|NCT00150618|364440811|FG000|Overall Study|Lost to Follow-up|4|||
105665807|NCT00150618|364440812|FG001|Overall Study|Lost to Follow-up|1|||
105665808|NCT00150618|364440813|FG002|Overall Study|Lost to Follow-up|5|||
105665809|NCT00150618|364440814|FG003|Overall Study|Lost to Follow-up|8|||
105665810|NCT00150618|364440815|FG004|Overall Study|Lost to Follow-up|4|||
105894970|NCT02520427|365269844|FG004|Overall Study|Withdrawal by Subject|0|||
105894971|NCT02520427|365269845|FG005|Overall Study|Withdrawal by Subject|0|||
105894972|NCT02520427|365269846|FG006|Overall Study|Withdrawal by Subject|0|||
105997187|NCT01633788|365651369|FG003|Overall Study|Lost to Follow-up|0|||
105894973|NCT02520427|365269847|FG007|Overall Study|Withdrawal by Subject|0|||
105894974|NCT02520427|365269848|FG008|Overall Study|Withdrawal by Subject|0|||
105997188|NCT01633788|365651366|FG000|Overall Study|Personal Reasons|3|||
105997189|NCT01633788|365651367|FG001|Overall Study|Personal Reasons|1|||
106122931|NCT02471404|366107772|FG001|Overall Study|Adverse Event|1|||
106122932|NCT02471404|366107773|FG002|Overall Study|Adverse Event|2|||
105894975|NCT02520427|365269849|FG009|Overall Study|Withdrawal by Subject|0|||
105894976|NCT02520427|365269850|FG010|Overall Study|Withdrawal by Subject|0|||
105894977|NCT02520427|365269851|FG011|Overall Study|Withdrawal by Subject|0|||
105894978|NCT02520427|365269852|FG012|Overall Study|Withdrawal by Subject|1|||
105894979|NCT02520427|365269853|FG013|Overall Study|Withdrawal by Subject|1|||
105894980|NCT02520427|365269854|FG014|Overall Study|Withdrawal by Subject|1|||
105894981|NCT02520427|365269855|FG015|Overall Study|Withdrawal by Subject|0|||
105894982|NCT02520427|365269856|FG016|Overall Study|Withdrawal by Subject|1|||
105894983|NCT02520427|365269857|FG017|Overall Study|Withdrawal by Subject|0|||
105894984|NCT02520427|365269858|FG018|Overall Study|Withdrawal by Subject|0|||
105894985|NCT02520427|365269859|FG019|Overall Study|Withdrawal by Subject|3|||
105894986|NCT02520427|365269860|FG020|Overall Study|Withdrawal by Subject|2|||
105894987|NCT02520427|365269861|FG021|Overall Study|Withdrawal by Subject|0|||
105894988|NCT02520427|365269862|FG022|Overall Study|Withdrawal by Subject|0|||
105894989|NCT02520427|365269863|FG023|Overall Study|Withdrawal by Subject|0|||
105894990|NCT02520427|365269864|FG024|Overall Study|Withdrawal by Subject|0|||
105894991|NCT02520427|365269865|FG025|Overall Study|Withdrawal by Subject|0|||
105894992|NCT02520427|365269840|FG000|Overall Study|Death|1|||
105894993|NCT02520427|365269841|FG001|Overall Study|Death|0|||
105894994|NCT02520427|365269842|FG002|Overall Study|Death|0|||
105894995|NCT02520427|365269843|FG003|Overall Study|Death|0|||
105894996|NCT02520427|365269844|FG004|Overall Study|Death|0|||
105894997|NCT02520427|365269845|FG005|Overall Study|Death|0|||
105894998|NCT02520427|365269846|FG006|Overall Study|Death|0|||
105894999|NCT02520427|365269847|FG007|Overall Study|Death|0|||
105895000|NCT02520427|365269848|FG008|Overall Study|Death|0|||
105895001|NCT02520427|365269849|FG009|Overall Study|Death|0|||
105665811|NCT00150618|364440811|FG000|Overall Study|Protocol Violation|1|||
105665812|NCT00150618|364440812|FG001|Overall Study|Protocol Violation|0|||
105665813|NCT00150618|364440813|FG002|Overall Study|Protocol Violation|0|||
105665814|NCT00150618|364440814|FG003|Overall Study|Protocol Violation|0|||
105665815|NCT00150618|364440815|FG004|Overall Study|Protocol Violation|1|||
105665816|NCT00150618|364440811|FG000|Overall Study|Lack of Efficacy|1|||
105665817|NCT00150618|364440812|FG001|Overall Study|Lack of Efficacy|4|||
105665818|NCT00150618|364440813|FG002|Overall Study|Lack of Efficacy|7|||
105665819|NCT00150618|364440814|FG003|Overall Study|Lack of Efficacy|4|||
105665820|NCT00150618|364440815|FG004|Overall Study|Lack of Efficacy|6|||
105665821|NCT00150618|364440811|FG000|Overall Study|No study meds|0|||
105665822|NCT00150618|364440812|FG001|Overall Study|No study meds|0|||
105665823|NCT00150618|364440813|FG002|Overall Study|No study meds|0|||
105665824|NCT00150618|364440814|FG003|Overall Study|No study meds|0|||
105665825|NCT00150618|364440815|FG004|Overall Study|No study meds|2|||
105665826|NCT00150618|364440811|FG000|Overall Study|Physician Decision|0|||
105665827|NCT00150618|364440812|FG001|Overall Study|Physician Decision|2|||
105665828|NCT00150618|364440813|FG002|Overall Study|Physician Decision|0|||
105665829|NCT00150618|364440814|FG003|Overall Study|Physician Decision|0|||
105665830|NCT00150618|364440815|FG004|Overall Study|Physician Decision|1|||
105665831|NCT00150618|364440811|FG000|Overall Study|Lack of compliance|2|||
105665832|NCT00150618|364440812|FG001|Overall Study|Lack of compliance|1|||
105665833|NCT00150618|364440813|FG002|Overall Study|Lack of compliance|1|||
105665834|NCT00150618|364440814|FG003|Overall Study|Lack of compliance|0|||
105665835|NCT00150618|364440815|FG004|Overall Study|Lack of compliance|1|||
105665836|NCT00150618|364440811|FG000|Overall Study|Abnormal ECG|1|||
105665837|NCT00150618|364440812|FG001|Overall Study|Abnormal ECG|0|||
105665838|NCT00150618|364440813|FG002|Overall Study|Abnormal ECG|0|||
105665839|NCT00150618|364440814|FG003|Overall Study|Abnormal ECG|0|||
105665840|NCT00150618|364440815|FG004|Overall Study|Abnormal ECG|0|||
105665841|NCT00150618|364440811|FG000|Overall Study|Sponsor's decision|0|||
105665842|NCT00150618|364440812|FG001|Overall Study|Sponsor's decision|0|||
105665843|NCT00150618|364440813|FG002|Overall Study|Sponsor's decision|0|||
105665844|NCT00150618|364440814|FG003|Overall Study|Sponsor's decision|1|||
105665845|NCT00150618|364440815|FG004|Overall Study|Sponsor's decision|0|||
105665846|NCT01012947|364440816|FG000|Overall Study|Lost to Follow-up|131|||
105665847|NCT01012947|364440817|FG001|Overall Study|Lost to Follow-up|135|||
105665848|NCT01012947|364440818|FG002|Overall Study|Lost to Follow-up|130|||
105665849|NCT01012947|364440819|FG003|Overall Study|Lost to Follow-up|118|||
105665850|NCT01012947|364440820|FG004|Overall Study|Lost to Follow-up|142|||
105665851|NCT01791413|364440821|FG000|Overall Study|Lost to Follow-up|5|||
105665852|NCT01791413|364440822|FG001|Overall Study|Lost to Follow-up|1|||
105665853|NCT02493946|364440823|FG000|DB Period|Withdrawal by Subject|8|||
105665854|NCT02493946|364440824|FG001|DB Period|Withdrawal by Subject|5|||
105665855|NCT02493946|364440825|FG002|DB Period|Withdrawal by Subject|0|||
105665856|NCT02493946|364440823|FG000|Open Label Period|Withdrawal by Subject|0|||
105665857|NCT02493946|364440824|FG001|Open Label Period|Withdrawal by Subject|0|||
105665858|NCT02493946|364440825|FG002|Open Label Period|Withdrawal by Subject|74|||
105665859|NCT02493946|364440823|FG000|Open Label Period|Adverse Event|0|||
105665860|NCT02493946|364440824|FG001|Open Label Period|Adverse Event|0|||
105665861|NCT02493946|364440825|FG002|Open Label Period|Adverse Event|4|||
105665862|NCT02493946|364440823|FG000|Open Label Period|Lost to Follow-up|0|||
105665863|NCT02493946|364440824|FG001|Open Label Period|Lost to Follow-up|0|||
105665864|NCT02493946|364440825|FG002|Open Label Period|Lost to Follow-up|1|||
105895002|NCT02520427|365269850|FG010|Overall Study|Death|0|||
105895003|NCT02520427|365269851|FG011|Overall Study|Death|0|||
105895004|NCT02520427|365269852|FG012|Overall Study|Death|0|||
105895005|NCT02520427|365269853|FG013|Overall Study|Death|0|||
105895006|NCT02520427|365269854|FG014|Overall Study|Death|0|||
105895007|NCT02520427|365269855|FG015|Overall Study|Death|0|||
105665865|NCT02493946|364440823|FG000|Open Label Period|Investigator decision, non-compliance|0|||
105665866|NCT02493946|364440824|FG001|Open Label Period|Investigator decision, non-compliance|0|||
105665867|NCT02493946|364440825|FG002|Open Label Period|Investigator decision, non-compliance|2|||
105665868|NCT02493946|364440823|FG000|Open Label Period|Investigator decision, non-availability|0|||
105665869|NCT02493946|364440824|FG001|Open Label Period|Investigator decision, non-availability|0|||
105665870|NCT02493946|364440825|FG002|Open Label Period|Investigator decision, non-availability|1|||
105665871|NCT02493946|364440823|FG000|Open Label Period|Pregnancy|0|||
105665872|NCT02493946|364440824|FG001|Open Label Period|Pregnancy|0|||
105665873|NCT02493946|364440825|FG002|Open Label Period|Pregnancy|3|||
105665874|NCT02493946|364440823|FG000|Open Label Period|Site error|0|||
105665875|NCT02493946|364440824|FG001|Open Label Period|Site error|0|||
105665876|NCT02493946|364440825|FG002|Open Label Period|Site error|1|||
105665877|NCT01575873|364440826|FG000|Overall Study|Withdrawal by Subject|15|||
105665878|NCT01575873|364440827|FG001|Overall Study|Withdrawal by Subject|20|||
105665879|NCT01575873|364440828|FG002|Overall Study|Withdrawal by Subject|34|||
105665880|NCT01575873|364440829|FG003|Overall Study|Withdrawal by Subject|34|||
105895008|NCT02520427|365269856|FG016|Overall Study|Death|2|||
105895009|NCT02520427|365269857|FG017|Overall Study|Death|1|||
105895010|NCT02520427|365269858|FG018|Overall Study|Death|3|||
105895011|NCT02520427|365269859|FG019|Overall Study|Death|2|||
105895012|NCT02520427|365269860|FG020|Overall Study|Death|0|||
105665881|NCT01575873|364440826|FG000|Overall Study|Adverse Event|7|||
105665882|NCT01575873|364440827|FG001|Overall Study|Adverse Event|7|||
105665883|NCT01575873|364440828|FG002|Overall Study|Adverse Event|9|||
105665884|NCT01575873|364440829|FG003|Overall Study|Adverse Event|12|||
105665885|NCT01575873|364440826|FG000|Overall Study|Lost to Follow-up|1|||
105665886|NCT01575873|364440827|FG001|Overall Study|Lost to Follow-up|3|||
105665887|NCT01575873|364440828|FG002|Overall Study|Lost to Follow-up|13|||
105665888|NCT01575873|364440829|FG003|Overall Study|Lost to Follow-up|5|||
105665889|NCT01575873|364440826|FG000|Overall Study|Death|3|||
105665890|NCT01575873|364440827|FG001|Overall Study|Death|2|||
105665891|NCT01575873|364440828|FG002|Overall Study|Death|8|||
105665892|NCT01575873|364440829|FG003|Overall Study|Death|9|||
105665893|NCT01575873|364440826|FG000|Overall Study|Noncompliance|1|||
105665894|NCT01575873|364440827|FG001|Overall Study|Noncompliance|2|||
105665895|NCT01575873|364440828|FG002|Overall Study|Noncompliance|4|||
105665896|NCT01575873|364440829|FG003|Overall Study|Noncompliance|3|||
105665897|NCT01575873|364440826|FG000|Overall Study|Administrative decision|1|||
105665898|NCT01575873|364440827|FG001|Overall Study|Administrative decision|1|||
105665899|NCT01575873|364440828|FG002|Overall Study|Administrative decision|1|||
105665900|NCT01575873|364440829|FG003|Overall Study|Administrative decision|0|||
105665901|NCT01575873|364440826|FG000|Overall Study|Protocol deviation|0|||
105665902|NCT01575873|364440827|FG001|Overall Study|Protocol deviation|1|||
105665903|NCT01575873|364440828|FG002|Overall Study|Protocol deviation|0|||
105665904|NCT01575873|364440829|FG003|Overall Study|Protocol deviation|1|||
105665905|NCT01575873|364440826|FG000|Overall Study|Requirement for Alternative Therapy|0|||
105665906|NCT01575873|364440827|FG001|Overall Study|Requirement for Alternative Therapy|0|||
105665907|NCT01575873|364440828|FG002|Overall Study|Requirement for Alternative Therapy|1|||
105665908|NCT01575873|364440829|FG003|Overall Study|Requirement for Alternative Therapy|1|||
105665909|NCT01575873|364440826|FG000|Overall Study|Other|0|||
105665910|NCT01575873|364440827|FG001|Overall Study|Other|0|||
105665911|NCT01575873|364440828|FG002|Overall Study|Other|4|||
105665912|NCT01575873|364440829|FG003|Overall Study|Other|2|||
105665913|NCT03017742|364440831|FG000|Overall Study|Protocol Violation|36|||
105665914|NCT03017742|364440831|FG000|Overall Study|Withdrawal by Subject|37|||
105665915|NCT01151215|364440832|FG000|Overall Study|Worsening of condition under study|1|||
105665916|NCT01151215|364440833|FG001|Overall Study|Worsening of condition under study|1|||
105665917|NCT01151215|364440834|FG002|Overall Study|Worsening of condition under study|1|||
105665918|NCT01151215|364440832|FG000|Overall Study|Death|16|||
105665919|NCT01151215|364440833|FG001|Overall Study|Death|20|||
105665920|NCT01151215|364440834|FG002|Overall Study|Death|11|||
105665921|NCT01151215|364440832|FG000|Overall Study|Lost to Follow-up|0|||
105665922|NCT01151215|364440833|FG001|Overall Study|Lost to Follow-up|0|||
105665923|NCT01151215|364440834|FG002|Overall Study|Lost to Follow-up|3|||
105665924|NCT01151215|364440832|FG000|Overall Study|Withdrawal by Subject|3|||
105665925|NCT01151215|364440833|FG001|Overall Study|Withdrawal by Subject|1|||
105665926|NCT01151215|364440834|FG002|Overall Study|Withdrawal by Subject|2|||
105665927|NCT01151215|364440832|FG000|Overall Study|Disease progression|0|||
105665928|NCT01151215|364440833|FG001|Overall Study|Disease progression|1|||
105665929|NCT01151215|364440834|FG002|Overall Study|Disease progression|1|||
105665930|NCT01151215|364440832|FG000|Overall Study|Safety as judged by the investigator|0|||
105665931|NCT01151215|364440833|FG001|Overall Study|Safety as judged by the investigator|0|||
105665932|NCT01151215|364440834|FG002|Overall Study|Safety as judged by the investigator|1|||
105665933|NCT02956837|364440838|FG000|Overall Study|Serious Adverse Events|0|||
105665934|NCT02956837|364440839|FG001|Overall Study|Serious Adverse Events|1|||
105665935|NCT02956837|364440840|FG002|Overall Study|Serious Adverse Events|0|||
105665936|NCT02956837|364440841|FG003|Overall Study|Serious Adverse Events|0|||
105665937|NCT02956837|364440838|FG000|Overall Study|Withdrawal by Subject|0|||
105665938|NCT02956837|364440839|FG001|Overall Study|Withdrawal by Subject|1|||
105665939|NCT02956837|364440840|FG002|Overall Study|Withdrawal by Subject|0|||
105895013|NCT02520427|365269861|FG021|Overall Study|Death|0|||
105895014|NCT02520427|365269862|FG022|Overall Study|Death|1|||
105665940|NCT02956837|364440841|FG003|Overall Study|Withdrawal by Subject|3|||
105665941|NCT02956837|364440838|FG000|Overall Study|Lost to Follow-up|0|||
105665942|NCT02956837|364440839|FG001|Overall Study|Lost to Follow-up|1|||
105665943|NCT02956837|364440840|FG002|Overall Study|Lost to Follow-up|2|||
105665944|NCT02956837|364440841|FG003|Overall Study|Lost to Follow-up|0|||
105665945|NCT01727505|364440842|FG000|First 24 Hours|Adverse Event|0|||
105665946|NCT01727505|364440843|FG001|First 24 Hours|Adverse Event|1|||
105895015|NCT02520427|365269863|FG023|Overall Study|Death|0|||
105895016|NCT02520427|365269864|FG024|Overall Study|Death|1|||
105665947|NCT01727505|364440842|FG000|Second 24 Hours|Missing data|0|||
105665948|NCT01727505|364440843|FG001|Second 24 Hours|Missing data|1|||
105665949|NCT01441635|364440844|FG000|Overall Study|Adverse Event|4|||
105665950|NCT01441635|364440845|FG001|Overall Study|Adverse Event|3|||
105665951|NCT01441635|364440846|FG002|Overall Study|Adverse Event|1|||
105665952|NCT01441635|364440847|FG003|Overall Study|Adverse Event|5|||
105895017|NCT02520427|365269865|FG025|Overall Study|Death|0|||
105665953|NCT01441635|364440848|FG004|Overall Study|Adverse Event|1|||
105895018|NCT00793624|365269868|FG000|Overall Study|Adverse Event|18|||
105895019|NCT00793624|365269869|FG001|Overall Study|Adverse Event|16|||
105895020|NCT00793624|365269870|FG002|Overall Study|Adverse Event|15|||
105895021|NCT00793624|365269871|FG003|Overall Study|Adverse Event|20|||
105895022|NCT00793624|365269868|FG000|Overall Study|Lost to Follow-up|2|||
105895023|NCT00793624|365269869|FG001|Overall Study|Lost to Follow-up|2|||
105895024|NCT00793624|365269870|FG002|Overall Study|Lost to Follow-up|4|||
105895025|NCT00793624|365269871|FG003|Overall Study|Lost to Follow-up|0|||
105895026|NCT00793624|365269868|FG000|Overall Study|Withdrawal by Subject|20|||
105895027|NCT00793624|365269869|FG001|Overall Study|Withdrawal by Subject|9|||
105665954|NCT01441635|364440849|FG005|Overall Study|Adverse Event|2|||
105665955|NCT01441635|364440850|FG006|Overall Study|Adverse Event|2|||
105665956|NCT01441635|364440851|FG007|Overall Study|Adverse Event|2|||
105665957|NCT01441635|364440852|FG008|Overall Study|Adverse Event|1|||
105665958|NCT01441635|364440853|FG009|Overall Study|Adverse Event|0|||
105665959|NCT01441635|364440844|FG000|Overall Study|Withdrawal by Subject|1|||
105665960|NCT01441635|364440845|FG001|Overall Study|Withdrawal by Subject|1|||
105665961|NCT01441635|364440846|FG002|Overall Study|Withdrawal by Subject|0|||
105665962|NCT01441635|364440847|FG003|Overall Study|Withdrawal by Subject|1|||
105665963|NCT01441635|364440848|FG004|Overall Study|Withdrawal by Subject|0|||
105665964|NCT01441635|364440849|FG005|Overall Study|Withdrawal by Subject|0|||
105665965|NCT01441635|364440850|FG006|Overall Study|Withdrawal by Subject|2|||
105665966|NCT01441635|364440851|FG007|Overall Study|Withdrawal by Subject|0|||
105665967|NCT01441635|364440852|FG008|Overall Study|Withdrawal by Subject|1|||
105665968|NCT01441635|364440853|FG009|Overall Study|Withdrawal by Subject|1|||
105665969|NCT01441635|364440844|FG000|Overall Study|Lost to Follow-up|0|||
105665970|NCT01441635|364440845|FG001|Overall Study|Lost to Follow-up|1|||
105665971|NCT01441635|364440846|FG002|Overall Study|Lost to Follow-up|1|||
105665972|NCT01441635|364440847|FG003|Overall Study|Lost to Follow-up|1|||
105665973|NCT01441635|364440848|FG004|Overall Study|Lost to Follow-up|1|||
105665974|NCT01441635|364440849|FG005|Overall Study|Lost to Follow-up|3|||
105665975|NCT01441635|364440850|FG006|Overall Study|Lost to Follow-up|1|||
105665976|NCT01441635|364440851|FG007|Overall Study|Lost to Follow-up|1|||
105665977|NCT01441635|364440852|FG008|Overall Study|Lost to Follow-up|0|||
105665978|NCT01441635|364440853|FG009|Overall Study|Lost to Follow-up|1|||
105665979|NCT01441635|364440844|FG000|Overall Study|Noncompliance|0|||
105665980|NCT01441635|364440845|FG001|Overall Study|Noncompliance|1|||
105665981|NCT01441635|364440846|FG002|Overall Study|Noncompliance|0|||
105665982|NCT01441635|364440847|FG003|Overall Study|Noncompliance|0|||
105665983|NCT01441635|364440848|FG004|Overall Study|Noncompliance|0|||
105665984|NCT01441635|364440849|FG005|Overall Study|Noncompliance|0|||
105665985|NCT01441635|364440850|FG006|Overall Study|Noncompliance|1|||
105665986|NCT01441635|364440851|FG007|Overall Study|Noncompliance|0|||
105665987|NCT01441635|364440852|FG008|Overall Study|Noncompliance|0|||
105665988|NCT01441635|364440853|FG009|Overall Study|Noncompliance|0|||
105665989|NCT01441635|364440844|FG000|Overall Study|Surgery or Invasive Intervention|0|||
105665990|NCT01441635|364440845|FG001|Overall Study|Surgery or Invasive Intervention|0|||
105665991|NCT01441635|364440846|FG002|Overall Study|Surgery or Invasive Intervention|1|||
105665992|NCT01441635|364440847|FG003|Overall Study|Surgery or Invasive Intervention|0|||
105665993|NCT01441635|364440848|FG004|Overall Study|Surgery or Invasive Intervention|0|||
105665994|NCT01441635|364440849|FG005|Overall Study|Surgery or Invasive Intervention|0|||
105665995|NCT01441635|364440850|FG006|Overall Study|Surgery or Invasive Intervention|0|||
105665996|NCT01441635|364440851|FG007|Overall Study|Surgery or Invasive Intervention|0|||
105665997|NCT01441635|364440852|FG008|Overall Study|Surgery or Invasive Intervention|0|||
105665998|NCT01441635|364440853|FG009|Overall Study|Surgery or Invasive Intervention|0|||
105665999|NCT01441635|364440844|FG000|Overall Study|Received Exclusionary Medication|1|||
105666000|NCT01441635|364440845|FG001|Overall Study|Received Exclusionary Medication|0|||
105666001|NCT01441635|364440846|FG002|Overall Study|Received Exclusionary Medication|0|||
105666002|NCT01441635|364440847|FG003|Overall Study|Received Exclusionary Medication|0|||
105666003|NCT01441635|364440848|FG004|Overall Study|Received Exclusionary Medication|0|||
105666004|NCT01441635|364440849|FG005|Overall Study|Received Exclusionary Medication|0|||
105666005|NCT01441635|364440850|FG006|Overall Study|Received Exclusionary Medication|0|||
105666006|NCT01441635|364440851|FG007|Overall Study|Received Exclusionary Medication|0|||
105666007|NCT01441635|364440852|FG008|Overall Study|Received Exclusionary Medication|0|||
105666008|NCT01441635|364440853|FG009|Overall Study|Received Exclusionary Medication|0|||
105666009|NCT01441635|364440844|FG000|Overall Study|Other|0|||
105666010|NCT01441635|364440845|FG001|Overall Study|Other|0|||
105666011|NCT01441635|364440846|FG002|Overall Study|Other|0|||
105666012|NCT01441635|364440847|FG003|Overall Study|Other|0|||
105666013|NCT01441635|364440848|FG004|Overall Study|Other|0|||
105666014|NCT01441635|364440849|FG005|Overall Study|Other|0|||
105666015|NCT01441635|364440850|FG006|Overall Study|Other|0|||
105895028|NCT00793624|365269870|FG002|Overall Study|Withdrawal by Subject|11|||
105895029|NCT00793624|365269871|FG003|Overall Study|Withdrawal by Subject|14|||
105666016|NCT01441635|364440851|FG007|Overall Study|Other|1|||
105666017|NCT01441635|364440852|FG008|Overall Study|Other|0|||
105666018|NCT01441635|364440853|FG009|Overall Study|Other|0|||
105666019|NCT02878603|364440854|FG000|Overall Study|Lost to Follow-up|4|||
105666020|NCT02878603|364440855|FG001|Overall Study|Lost to Follow-up|1|||
105666021|NCT02878603|364440854|FG000|Overall Study|Withdrawal by Subject|1|||
105666022|NCT02878603|364440855|FG001|Overall Study|Withdrawal by Subject|1|||
105666023|NCT02878603|364440854|FG000|Overall Study|Death|1|||
105666024|NCT02878603|364440855|FG001|Overall Study|Death|0|||
105666025|NCT02878603|364440854|FG000|Overall Study|Physician Decision|0|||
105666026|NCT02878603|364440855|FG001|Overall Study|Physician Decision|3|||
105666027|NCT02637323|364440856|FG000|Overall Study|Lost to Follow-up|2|||
105666028|NCT02637323|364440857|FG001|Overall Study|Lost to Follow-up|0|||
105666029|NCT02637323|364440856|FG000|Overall Study|Protocol Violation|0|||
105895030|NCT00793624|365269868|FG000|Overall Study|Lack of Efficacy|9|||
105895031|NCT00793624|365269869|FG001|Overall Study|Lack of Efficacy|2|||
105895032|NCT00793624|365269870|FG002|Overall Study|Lack of Efficacy|1|||
105895033|NCT00793624|365269871|FG003|Overall Study|Lack of Efficacy|3|||
105895034|NCT00793624|365269868|FG000|Overall Study|Non compliance with protocol|2|||
105895035|NCT00793624|365269869|FG001|Overall Study|Non compliance with protocol|3|||
105895036|NCT00793624|365269870|FG002|Overall Study|Non compliance with protocol|2|||
105895037|NCT00793624|365269871|FG003|Overall Study|Non compliance with protocol|3|||
105895038|NCT00793624|365269868|FG000|Overall Study|Other reason not described above|6|||
105895039|NCT00793624|365269869|FG001|Overall Study|Other reason not described above|4|||
105895040|NCT00793624|365269870|FG002|Overall Study|Other reason not described above|6|||
105895041|NCT00793624|365269871|FG003|Overall Study|Other reason not described above|3|||
105895042|NCT00710684|365269872|FG000|Overall Study|Adverse Event|11|||
105895043|NCT00710684|365269873|FG001|Overall Study|Adverse Event|19|||
105895044|NCT00710684|365269874|FG002|Overall Study|Adverse Event|16|||
105895045|NCT00710684|365269872|FG000|Overall Study|Lack of Efficacy|4|||
105895046|NCT00710684|365269873|FG001|Overall Study|Lack of Efficacy|3|||
105895047|NCT00710684|365269874|FG002|Overall Study|Lack of Efficacy|5|||
105895048|NCT00710684|365269872|FG000|Overall Study|Protocol Violation|5|||
105895049|NCT00710684|365269873|FG001|Overall Study|Protocol Violation|5|||
105895050|NCT00710684|365269874|FG002|Overall Study|Protocol Violation|5|||
105895051|NCT00710684|365269872|FG000|Overall Study|Lost to Follow-up|4|||
105895052|NCT00710684|365269873|FG001|Overall Study|Lost to Follow-up|6|||
105895053|NCT00710684|365269874|FG002|Overall Study|Lost to Follow-up|7|||
105895054|NCT00710684|365269872|FG000|Overall Study|Physician Decision|0|||
105895055|NCT00710684|365269873|FG001|Overall Study|Physician Decision|2|||
105895056|NCT00710684|365269874|FG002|Overall Study|Physician Decision|4|||
105895057|NCT00710684|365269872|FG000|Overall Study|Withdrawal by Subject|24|||
105895058|NCT00710684|365269873|FG001|Overall Study|Withdrawal by Subject|18|||
105895059|NCT00710684|365269874|FG002|Overall Study|Withdrawal by Subject|11|||
105895060|NCT00710684|365269872|FG000|Overall Study|Missing|1|||
105895061|NCT00710684|365269873|FG001|Overall Study|Missing|0|||
105895062|NCT00710684|365269874|FG002|Overall Study|Missing|0|||
105895063|NCT00710684|365269872|FG000|Overall Study|Did not continue after week 24|25|||
105895064|NCT00710684|365269873|FG001|Overall Study|Did not continue after week 24|21|||
105895065|NCT00710684|365269874|FG002|Overall Study|Did not continue after week 24|16|||
105895066|NCT04778059|365269875|FG000|Overall Study|Death|2|||
105895067|NCT04778059|365269876|FG001|Overall Study|Death|2|||
105895068|NCT04778059|365269877|FG002|Overall Study|Death|1|||
105895069|NCT04778059|365269878|FG003|Overall Study|Death|1|||
105895070|NCT04778059|365269879|FG004|Overall Study|Death|1|||
105895071|NCT04778059|365269875|FG000|Overall Study|Lost to Follow-up|0|||
105895072|NCT04778059|365269876|FG001|Overall Study|Lost to Follow-up|0|||
105895073|NCT04778059|365269877|FG002|Overall Study|Lost to Follow-up|0|||
105895074|NCT04778059|365269878|FG003|Overall Study|Lost to Follow-up|0|||
105895075|NCT04778059|365269879|FG004|Overall Study|Lost to Follow-up|1|||
105895076|NCT04778059|365269875|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
105895077|NCT04778059|365269876|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
105895078|NCT04778059|365269877|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
105895079|NCT04778059|365269878|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
105895080|NCT04778059|365269879|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
105895081|NCT05153148|365269880|FG000|Overall Study|Adverse Event|1|||
105895082|NCT05153148|365269881|FG001|Overall Study|Adverse Event|0|||
105895083|NCT05153148|365269882|FG002|Overall Study|Adverse Event|3|||
106122933|NCT02471404|366107771|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
106122934|NCT02471404|366107772|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
106122935|NCT02471404|366107773|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
106122936|NCT02471404|366107771|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
106122937|NCT02471404|366107772|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
106122938|NCT02471404|366107773|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
106122939|NCT02471404|366107771|FG000|Overall Study|Lost to Follow-up|1|||
106122940|NCT02471404|366107772|FG001|Overall Study|Lost to Follow-up|1|||
106122941|NCT02471404|366107773|FG002|Overall Study|Lost to Follow-up|3|||
106122942|NCT02471404|366107771|FG000|Overall Study|Protocol Violation|1|||
106122943|NCT02471404|366107772|FG001|Overall Study|Protocol Violation|0|||
106122944|NCT02471404|366107773|FG002|Overall Study|Protocol Violation|0|||
106122945|NCT02471404|366107771|FG000|Overall Study|Withdrawal by Subject|8|||
106122946|NCT02471404|366107772|FG001|Overall Study|Withdrawal by Subject|4|||
106122947|NCT02471404|366107773|FG002|Overall Study|Withdrawal by Subject|5|||
106122948|NCT02471404|366107771|FG000|Overall Study|Other reasons not specified|10|||
106122949|NCT02471404|366107772|FG001|Overall Study|Other reasons not specified|7|||
106122950|NCT02471404|366107773|FG002|Overall Study|Other reasons not specified|12|||
106122951|NCT01927731|366107774|FG000|Overall Study|Graft Failure|1|||
106122952|NCT01927731|366107775|FG001|Overall Study|Graft Failure|2|||
106122953|NCT01927731|366107774|FG000|Overall Study|Physician Decision|2|||
106122954|NCT01927731|366107775|FG001|Overall Study|Physician Decision|3|||
106122955|NCT01927731|366107774|FG000|Overall Study|Withdrawal by Subject|0|||
106122956|NCT01927731|366107775|FG001|Overall Study|Withdrawal by Subject|2|||
106122957|NCT01927731|366107774|FG000|Overall Study|Death|0|||
106122958|NCT01927731|366107775|FG001|Overall Study|Death|3|||
106122959|NCT02982720|366107776|FG000|Overall Study|Adverse Event|3|||
106122960|NCT02982720|366107776|FG000|Overall Study|Death|1|||
106122961|NCT01388530|366107777|FG000|Overall Study|Lost to Follow-up|5|||
106122962|NCT01464255|366107780|FG000|Overall Study|unresolve corneal staining|0|||
106122963|NCT01464255|366107781|FG001|Overall Study|unresolve corneal staining|1|||
106122964|NCT02836613|366107782|FG000|Overall Study|Accidental drowning|1|||
106122965|NCT02836613|366107783|FG001|Overall Study|Accidental drowning|0|||
106122966|NCT02836613|366107782|FG000|Overall Study|Lost to Follow-up|0|||
106122967|NCT02836613|366107783|FG001|Overall Study|Lost to Follow-up|1|||
106122968|NCT02836613|366107782|FG000|Overall Study|Withdrawal by Subject|0|||
106122969|NCT02836613|366107783|FG001|Overall Study|Withdrawal by Subject|2|||
106122970|NCT02066532|366107790|FG000|Phase II|Withdrawal by Subject|1|||
106122971|NCT02066532|366107791|FG001|Phase II|Withdrawal by Subject|0|||
106122972|NCT02066532|366107792|FG002|Phase II|Withdrawal by Subject|0|||
106122973|NCT02066532|366107793|FG003|Phase II|Withdrawal by Subject|0|||
106122974|NCT05033080|366107794|FG000|Overall Study|Adverse Event|4|||
106122975|NCT05033080|366107795|FG001|Overall Study|Adverse Event|4|||
106122976|NCT05033080|366107794|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
106122977|NCT05033080|366107795|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
106122978|NCT05033080|366107794|FG000|Overall Study|Lost to Follow-up|1|||
106122979|NCT05033080|366107795|FG001|Overall Study|Lost to Follow-up|0|||
106122980|NCT05033080|366107794|FG000|Overall Study|Other non-compliance|0|||
106122981|NCT05033080|366107795|FG001|Overall Study|Other non-compliance|1|||
106122982|NCT05033080|366107794|FG000|Overall Study|Physician Decision|0|||
106122983|NCT05033080|366107795|FG001|Overall Study|Physician Decision|1|||
106122984|NCT05033080|366107794|FG000|Overall Study|Other|1|||
106122985|NCT05033080|366107795|FG001|Overall Study|Other|1|||
106122986|NCT02584855|366107804|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
106122987|NCT02584855|366107805|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
106122988|NCT02584855|366107806|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
105895084|NCT05153148|365269883|FG003|Overall Study|Adverse Event|5|||
105895085|NCT05153148|365269880|FG000|Overall Study|Lost to Follow-up|1|||
105895086|NCT05153148|365269881|FG001|Overall Study|Lost to Follow-up|1|||
105895087|NCT05153148|365269882|FG002|Overall Study|Lost to Follow-up|2|||
106122989|NCT02584855|366107807|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
106122990|NCT02584855|366107808|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
106122991|NCT02584855|366107809|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
106122992|NCT02584855|366107804|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
106122993|NCT02584855|366107805|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
106122994|NCT02584855|366107806|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
106122995|NCT02584855|366107807|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
106122996|NCT02584855|366107808|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
106122997|NCT02584855|366107809|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
106122998|NCT02584855|366107804|FG000|Open-Label Treatment Period|Adverse Event|14|||
106122999|NCT02584855|366107805|FG001|Open-Label Treatment Period|Adverse Event|0|||
106123000|NCT02584855|366107806|FG002|Open-Label Treatment Period|Adverse Event|0|||
106123001|NCT02584855|366107807|FG003|Open-Label Treatment Period|Adverse Event|0|||
106123002|NCT02584855|366107808|FG004|Open-Label Treatment Period|Adverse Event|0|||
106123003|NCT02584855|366107809|FG005|Open-Label Treatment Period|Adverse Event|0|||
106123004|NCT02584855|366107804|FG000|Open-Label Treatment Period|Death|2|||
106123005|NCT02584855|366107805|FG001|Open-Label Treatment Period|Death|0|||
106123006|NCT02584855|366107806|FG002|Open-Label Treatment Period|Death|0|||
106123007|NCT02584855|366107807|FG003|Open-Label Treatment Period|Death|0|||
106123008|NCT02584855|366107808|FG004|Open-Label Treatment Period|Death|0|||
106123009|NCT02584855|366107809|FG005|Open-Label Treatment Period|Death|0|||
106123010|NCT02584855|366107804|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
106123011|NCT02584855|366107805|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
106123012|NCT02584855|366107806|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
106123013|NCT02584855|366107807|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
106123014|NCT02584855|366107808|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
106123015|NCT02584855|366107809|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
106123016|NCT02584855|366107804|FG000|Open-Label Treatment Period|Protocol Violation|1|||
106123017|NCT02584855|366107805|FG001|Open-Label Treatment Period|Protocol Violation|0|||
106123018|NCT02584855|366107806|FG002|Open-Label Treatment Period|Protocol Violation|0|||
106123019|NCT02584855|366107807|FG003|Open-Label Treatment Period|Protocol Violation|0|||
106123020|NCT02584855|366107808|FG004|Open-Label Treatment Period|Protocol Violation|0|||
106123021|NCT02584855|366107809|FG005|Open-Label Treatment Period|Protocol Violation|0|||
106123022|NCT02584855|366107804|FG000|Open-Label Treatment Period|No PI Available|2|||
106123023|NCT02584855|366107805|FG001|Open-Label Treatment Period|No PI Available|0|||
106123024|NCT02584855|366107806|FG002|Open-Label Treatment Period|No PI Available|0|||
106123025|NCT02584855|366107807|FG003|Open-Label Treatment Period|No PI Available|0|||
106123026|NCT02584855|366107808|FG004|Open-Label Treatment Period|No PI Available|0|||
106123027|NCT02584855|366107809|FG005|Open-Label Treatment Period|No PI Available|0|||
106123028|NCT02584855|366107804|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
106123029|NCT02584855|366107805|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
106123030|NCT02584855|366107806|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
106123031|NCT02584855|366107807|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
106123032|NCT02584855|366107808|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
106123033|NCT02584855|366107809|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
106123034|NCT02584855|366107804|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
106123035|NCT02584855|366107805|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
106123036|NCT02584855|366107806|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
106123037|NCT02584855|366107807|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
106123038|NCT02584855|366107808|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
106123039|NCT02584855|366107809|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
106123040|NCT02584855|366107804|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
106123041|NCT02584855|366107805|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
106123042|NCT02584855|366107806|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
106123043|NCT02584855|366107807|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
106123044|NCT02584855|366107808|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
106123045|NCT02584855|366107809|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
106123046|NCT02584855|366107804|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
106123047|NCT02584855|366107805|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
106123048|NCT02584855|366107806|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
106123049|NCT02584855|366107807|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
106123050|NCT02584855|366107808|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
105895088|NCT05153148|365269883|FG003|Overall Study|Lost to Follow-up|0|||
106123051|NCT02584855|366107809|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
106123052|NCT02584855|366107804|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
106123053|NCT02584855|366107805|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
106123054|NCT02584855|366107806|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
105895089|NCT05153148|365269880|FG000|Overall Study|Withdrawal by Subject|6|||
105895090|NCT05153148|365269881|FG001|Overall Study|Withdrawal by Subject|8|||
105895091|NCT05153148|365269882|FG002|Overall Study|Withdrawal by Subject|6|||
105895092|NCT05153148|365269883|FG003|Overall Study|Withdrawal by Subject|8|||
105895093|NCT05153148|365269880|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
105895094|NCT05153148|365269881|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
105895095|NCT05153148|365269882|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
105895096|NCT05153148|365269883|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
105895097|NCT05153148|365269880|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
105895098|NCT05153148|365269881|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
105895099|NCT05153148|365269882|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
105895100|NCT05153148|365269883|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
105895101|NCT05153148|365269880|FG000|Overall Study|Reason not Specified|1|||
105895102|NCT05153148|365269881|FG001|Overall Study|Reason not Specified|1|||
105895103|NCT05153148|365269882|FG002|Overall Study|Reason not Specified|1|||
105895104|NCT05153148|365269883|FG003|Overall Study|Reason not Specified|1|||
105895105|NCT00232596|365269884|FG000|6-Week Titration Phase|Adverse Event|6|||
105895106|NCT00232596|365269885|FG001|6-Week Titration Phase|Adverse Event|19|||
105895107|NCT00232596|365269884|FG000|6-Week Titration Phase|Failed to Return|2|||
106123055|NCT02584855|366107807|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
106123056|NCT02584855|366107808|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
106123057|NCT02584855|366107809|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
106123058|NCT02584855|366107804|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106123059|NCT02584855|366107805|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106123060|NCT02584855|366107806|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106123061|NCT02584855|366107807|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106123062|NCT02584855|366107808|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
106123063|NCT02584855|366107809|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106123064|NCT02584855|366107804|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
106123065|NCT02584855|366107805|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
106123066|NCT02584855|366107806|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
106123067|NCT02584855|366107807|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
106123068|NCT02584855|366107808|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
106123069|NCT02584855|366107809|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
106123070|NCT02262260|366107814|FG000|Overall Study|Adverse Event|4|||
106123071|NCT02262260|366107815|FG001|Overall Study|Adverse Event|1|||
106123072|NCT02262260|366107814|FG000|Overall Study|Withdrawal of consent|4|||
106123073|NCT02262260|366107815|FG001|Overall Study|Withdrawal of consent|2|||
106123074|NCT02262260|366107814|FG000|Overall Study|Lost to Follow-up|1|||
106123075|NCT02262260|366107815|FG001|Overall Study|Lost to Follow-up|2|||
106123076|NCT02262260|366107814|FG000|Overall Study|Protocol deviation|2|||
106123077|NCT02262260|366107815|FG001|Overall Study|Protocol deviation|5|||
106123078|NCT01794117|366107816|FG000|Overall Study|Adverse Event|1|||
106123079|NCT01794117|366107817|FG001|Overall Study|Adverse Event|0|||
106123080|NCT01794117|366107818|FG002|Overall Study|Adverse Event|0|||
106123081|NCT01794117|366107819|FG003|Overall Study|Adverse Event|0|||
106123082|NCT01794117|366107816|FG000|Overall Study|Participant noncompliance|0|||
106123083|NCT01794117|366107817|FG001|Overall Study|Participant noncompliance|1|||
106123084|NCT01794117|366107818|FG002|Overall Study|Participant noncompliance|0|||
106123085|NCT01794117|366107819|FG003|Overall Study|Participant noncompliance|0|||
106123086|NCT01794117|366107816|FG000|Overall Study|Refused further treatment|0|||
106123087|NCT01794117|366107817|FG001|Overall Study|Refused further treatment|2|||
106123088|NCT01794117|366107818|FG002|Overall Study|Refused further treatment|0|||
106123089|NCT01794117|366107819|FG003|Overall Study|Refused further treatment|0|||
106123090|NCT00180713|366107822|FG000|Overall Study|Withdrawal by Subject|2|||
106123091|NCT00180713|366107823|FG001|Overall Study|Withdrawal by Subject|0|||
106123092|NCT00180713|366107822|FG000|Overall Study|Adverse Event|3|||
106123093|NCT00180713|366107823|FG001|Overall Study|Adverse Event|3|||
106123094|NCT01078662|366107828|FG000|Overall Study|Death|41|||
106123095|NCT01078662|366107829|FG001|Overall Study|Death|103|||
106123096|NCT01078662|366107830|FG002|Overall Study|Death|18|||
106123097|NCT01078662|366107831|FG003|Overall Study|Death|5|||
106123098|NCT01078662|366107832|FG004|Overall Study|Death|8|||
106123099|NCT01078662|366107828|FG000|Overall Study|Patients reached data cut-off|12|||
106123100|NCT01078662|366107829|FG001|Overall Study|Patients reached data cut-off|53|||
106123101|NCT01078662|366107830|FG002|Overall Study|Patients reached data cut-off|2|||
106123102|NCT01078662|366107831|FG003|Overall Study|Patients reached data cut-off|2|||
106123103|NCT01078662|366107832|FG004|Overall Study|Patients reached data cut-off|3|||
106123104|NCT01078662|366107828|FG000|Overall Study|Withdrawal by Subject|4|||
106123105|NCT01078662|366107829|FG001|Overall Study|Withdrawal by Subject|11|||
106123106|NCT01078662|366107830|FG002|Overall Study|Withdrawal by Subject|1|||
105895108|NCT00232596|365269885|FG001|6-Week Titration Phase|Failed to Return|1|||
105997190|NCT01633788|365651368|FG002|Overall Study|Personal Reasons|1|||
106123107|NCT01078662|366107831|FG003|Overall Study|Withdrawal by Subject|0|||
105666030|NCT02637323|364440857|FG001|Overall Study|Protocol Violation|1|||
105666031|NCT00246090|364440858|FG000|Overall Study|Adverse Event|25|||
105666032|NCT00246090|364440858|FG000|Overall Study|Withdrawal by Subject|7|||
105666033|NCT00246090|364440858|FG000|Overall Study|Progressive Disease|212|||
105666034|NCT00246090|364440858|FG000|Overall Study|Clinical Progression|30|||
105666035|NCT00246090|364440858|FG000|Overall Study|Physician Decision|11|||
105666036|NCT00246090|364440858|FG000|Overall Study|Not Otherwise Specified|10|||
105666037|NCT01162486|364440860|FG000|Overall Study|low ANC|1|||
105666038|NCT01162486|364440861|FG001|Overall Study|low ANC|0|||
105666039|NCT01162486|364440862|FG002|Overall Study|low ANC|0|||
105666040|NCT01162486|364440863|FG003|Overall Study|low ANC|0|||
105666041|NCT01162486|364440864|FG004|Overall Study|low ANC|0|||
105666042|NCT01162486|364440860|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
105666043|NCT01162486|364440861|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
105666044|NCT01162486|364440862|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
105666045|NCT01162486|364440863|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
105666046|NCT01162486|364440864|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
105666047|NCT01162486|364440860|FG000|Overall Study|elevated LFTs|0|||
105666048|NCT01162486|364440861|FG001|Overall Study|elevated LFTs|0|||
105666049|NCT01162486|364440862|FG002|Overall Study|elevated LFTs|1|||
105666050|NCT01162486|364440863|FG003|Overall Study|elevated LFTs|0|||
105666051|NCT01162486|364440864|FG004|Overall Study|elevated LFTs|0|||
105666052|NCT01162486|364440860|FG000|Overall Study|Pregnancy|0|||
105666053|NCT01162486|364440861|FG001|Overall Study|Pregnancy|0|||
105666054|NCT01162486|364440862|FG002|Overall Study|Pregnancy|0|||
105666055|NCT01162486|364440863|FG003|Overall Study|Pregnancy|1|||
105666056|NCT01162486|364440864|FG004|Overall Study|Pregnancy|0|||
105666057|NCT00953615|364440870|FG000|Overall Study|Adverse Event|1|||
105666058|NCT01461005|364440874|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
105666059|NCT01814072|364440879|FG000|Overall Study|Lost to Follow-up|2|||
105666060|NCT01814072|364440880|FG001|Overall Study|Lost to Follow-up|2|||
105666061|NCT01814072|364440881|FG002|Overall Study|Lost to Follow-up|2|||
105666062|NCT01814072|364440882|FG003|Overall Study|Lost to Follow-up|0|||
105666063|NCT01814072|364440883|FG004|Overall Study|Lost to Follow-up|2|||
105895109|NCT00232596|365269884|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
106123108|NCT01078662|366107832|FG004|Overall Study|Withdrawal by Subject|0|||
105785975|NCT04246593|364870423|FG000|Overall Study|Lost to Follow-up|124|||
105895110|NCT00232596|365269885|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
105895111|NCT00232596|365269884|FG000|6-Week Titration Phase|Protocol Violation|1|||
105895112|NCT00232596|365269885|FG001|6-Week Titration Phase|Protocol Violation|3|||
105895113|NCT00232596|365269884|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
105895114|NCT00232596|365269885|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
105895115|NCT00232596|365269884|FG000|6-Week Titration Phase|Other|3|||
105895116|NCT00232596|365269885|FG001|6-Week Titration Phase|Other|3|||
105895117|NCT00232596|365269884|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
105895118|NCT00232596|365269885|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
105895119|NCT00232596|365269884|FG000|12-Week Maintenance Phase|Adverse Event|7|||
105895120|NCT00232596|365269885|FG001|12-Week Maintenance Phase|Adverse Event|22|||
105895121|NCT00232596|365269884|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
105895122|NCT00232596|365269885|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
105895123|NCT00232596|365269884|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
105895124|NCT00232596|365269885|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
105895125|NCT00232596|365269884|FG000|12-Week Maintenance Phase|Other|1|||
105895126|NCT00232596|365269885|FG001|12-Week Maintenance Phase|Other|3|||
105895127|NCT01732471|365269886|FG000|Overall Study|Withdrawal by Subject|1|||
105895128|NCT01253174|365269887|FG000|Period 1|Randomized but not treated|0|||
105895129|NCT01253174|365269888|FG001|Period 1|Randomized but not treated|1|||
105895130|NCT01253174|365269889|FG002|Period 1|Randomized but not treated|1|||
105895131|NCT01253174|365269890|FG003|Period 1|Randomized but not treated|0|||
105895132|NCT01253174|365269891|FG004|Period 1|Randomized but not treated|1|||
105895133|NCT01253174|365269892|FG005|Period 1|Randomized but not treated|0|||
105895134|NCT01253174|365269887|FG000|Period 2|Adverse Event|0|||
105895135|NCT01253174|365269888|FG001|Period 2|Adverse Event|0|||
106123109|NCT01078662|366107828|FG000|Overall Study|Protocol Violation|0|||
105666064|NCT01814072|364440884|FG005|Overall Study|Lost to Follow-up|3|||
105895136|NCT01253174|365269889|FG002|Period 2|Adverse Event|1|||
105895137|NCT01253174|365269890|FG003|Period 2|Adverse Event|0|||
105895138|NCT01253174|365269891|FG004|Period 2|Adverse Event|0|||
105895139|NCT01253174|365269892|FG005|Period 2|Adverse Event|0|||
106123110|NCT01078662|366107829|FG001|Overall Study|Protocol Violation|1|||
105666065|NCT01814072|364440885|FG006|Overall Study|Lost to Follow-up|3|||
105666066|NCT01814072|364440886|FG007|Overall Study|Lost to Follow-up|1|||
105666067|NCT01814072|364440887|FG008|Overall Study|Lost to Follow-up|2|||
105666068|NCT01814072|364440888|FG009|Overall Study|Lost to Follow-up|3|||
105666069|NCT01814072|364440889|FG010|Overall Study|Lost to Follow-up|1|||
105666070|NCT01814072|364440890|FG011|Overall Study|Lost to Follow-up|2|||
105666071|NCT01814072|364440891|FG012|Overall Study|Lost to Follow-up|2|||
105666072|NCT01814072|364440892|FG013|Overall Study|Lost to Follow-up|1|||
105997191|NCT01633788|365651369|FG003|Overall Study|Personal Reasons|3|||
105997192|NCT01633788|365651366|FG000|Overall Study|Protocol Violation|1|||
105997193|NCT01633788|365651367|FG001|Overall Study|Protocol Violation|0|||
105997194|NCT01633788|365651368|FG002|Overall Study|Protocol Violation|1|||
105666073|NCT01814072|364440893|FG014|Overall Study|Lost to Follow-up|2|||
106123111|NCT01078662|366107830|FG002|Overall Study|Protocol Violation|0|||
106123112|NCT01078662|366107831|FG003|Overall Study|Protocol Violation|0|||
106123113|NCT01078662|366107832|FG004|Overall Study|Protocol Violation|0|||
106123114|NCT01078662|366107828|FG000|Overall Study|Lost to Follow-up|1|||
106123115|NCT01078662|366107829|FG001|Overall Study|Lost to Follow-up|0|||
106123116|NCT01078662|366107830|FG002|Overall Study|Lost to Follow-up|0|||
106123117|NCT01078662|366107831|FG003|Overall Study|Lost to Follow-up|0|||
106123118|NCT01078662|366107832|FG004|Overall Study|Lost to Follow-up|0|||
106123119|NCT04157686|366107833|FG000|Overall Study|Adverse Event|1|||
106123120|NCT04157686|366107834|FG001|Overall Study|Adverse Event|0|||
106123121|NCT04157686|366107835|FG002|Overall Study|Adverse Event|1|||
106123122|NCT04157686|366107836|FG003|Overall Study|Adverse Event|0|||
106123123|NCT04157686|366107837|FG004|Overall Study|Adverse Event|1|||
106123124|NCT04157686|366107838|FG005|Overall Study|Adverse Event|0|||
106123125|NCT04157686|366107839|FG006|Overall Study|Adverse Event|0|||
106123126|NCT04157686|366107840|FG007|Overall Study|Adverse Event|0|||
106123127|NCT04157686|366107833|FG000|Overall Study|Pregnancy|0|||
106123128|NCT04157686|366107834|FG001|Overall Study|Pregnancy|1|||
106123129|NCT04157686|366107835|FG002|Overall Study|Pregnancy|3|||
106123130|NCT04157686|366107836|FG003|Overall Study|Pregnancy|0|||
106123131|NCT04157686|366107837|FG004|Overall Study|Pregnancy|0|||
106123132|NCT04157686|366107838|FG005|Overall Study|Pregnancy|0|||
106123133|NCT04157686|366107839|FG006|Overall Study|Pregnancy|3|||
106123134|NCT04157686|366107840|FG007|Overall Study|Pregnancy|0|||
106123135|NCT04157686|366107833|FG000|Overall Study|Lost to Follow-up|1|||
105666074|NCT01814072|364440894|FG015|Overall Study|Lost to Follow-up|1|||
105666075|NCT01814072|364440895|FG016|Overall Study|Lost to Follow-up|3|||
105666076|NCT01814072|364440896|FG017|Overall Study|Lost to Follow-up|1|||
105666077|NCT01814072|364440897|FG018|Overall Study|Lost to Follow-up|3|||
105666078|NCT01814072|364440898|FG019|Overall Study|Lost to Follow-up|3|||
106123136|NCT04157686|366107834|FG001|Overall Study|Lost to Follow-up|2|||
106123137|NCT04157686|366107835|FG002|Overall Study|Lost to Follow-up|8|||
106123138|NCT04157686|366107836|FG003|Overall Study|Lost to Follow-up|6|||
106123139|NCT04157686|366107837|FG004|Overall Study|Lost to Follow-up|6|||
106123140|NCT04157686|366107838|FG005|Overall Study|Lost to Follow-up|3|||
106123141|NCT04157686|366107839|FG006|Overall Study|Lost to Follow-up|7|||
106123142|NCT04157686|366107840|FG007|Overall Study|Lost to Follow-up|9|||
106123143|NCT04157686|366107833|FG000|Overall Study|Lack of Efficacy|0|||
106123144|NCT04157686|366107834|FG001|Overall Study|Lack of Efficacy|0|||
106123145|NCT04157686|366107835|FG002|Overall Study|Lack of Efficacy|0|||
106123146|NCT04157686|366107836|FG003|Overall Study|Lack of Efficacy|0|||
106123147|NCT04157686|366107837|FG004|Overall Study|Lack of Efficacy|0|||
106123148|NCT04157686|366107838|FG005|Overall Study|Lack of Efficacy|2|||
106123149|NCT04157686|366107839|FG006|Overall Study|Lack of Efficacy|0|||
106123150|NCT04157686|366107840|FG007|Overall Study|Lack of Efficacy|1|||
106123151|NCT04157686|366107833|FG000|Overall Study|Withdrawal by Subject|10|||
106123152|NCT04157686|366107834|FG001|Overall Study|Withdrawal by Subject|10|||
106123153|NCT04157686|366107835|FG002|Overall Study|Withdrawal by Subject|12|||
106123154|NCT04157686|366107836|FG003|Overall Study|Withdrawal by Subject|20|||
106123155|NCT04157686|366107837|FG004|Overall Study|Withdrawal by Subject|12|||
106123156|NCT04157686|366107838|FG005|Overall Study|Withdrawal by Subject|11|||
106123157|NCT04157686|366107839|FG006|Overall Study|Withdrawal by Subject|18|||
106123158|NCT04157686|366107840|FG007|Overall Study|Withdrawal by Subject|24|||
106123159|NCT04157686|366107833|FG000|Overall Study|Physician Decision|0|||
106123160|NCT04157686|366107834|FG001|Overall Study|Physician Decision|0|||
106123161|NCT04157686|366107835|FG002|Overall Study|Physician Decision|1|||
106123162|NCT04157686|366107836|FG003|Overall Study|Physician Decision|0|||
106123163|NCT04157686|366107837|FG004|Overall Study|Physician Decision|1|||
106123164|NCT04157686|366107838|FG005|Overall Study|Physician Decision|0|||
106123165|NCT04157686|366107839|FG006|Overall Study|Physician Decision|3|||
106123166|NCT04157686|366107840|FG007|Overall Study|Physician Decision|0|||
106123167|NCT04157686|366107833|FG000|Overall Study|Death|0|||
106123168|NCT04157686|366107834|FG001|Overall Study|Death|0|||
106123169|NCT04157686|366107835|FG002|Overall Study|Death|0|||
106123170|NCT04157686|366107836|FG003|Overall Study|Death|2|||
106123171|NCT04157686|366107837|FG004|Overall Study|Death|0|||
106123172|NCT04157686|366107838|FG005|Overall Study|Death|0|||
106123173|NCT04157686|366107839|FG006|Overall Study|Death|0|||
106123174|NCT04157686|366107840|FG007|Overall Study|Death|0|||
106123175|NCT04157686|366107833|FG000|Overall Study|Protocol Violation|0|||
106123176|NCT04157686|366107834|FG001|Overall Study|Protocol Violation|0|||
106123177|NCT04157686|366107835|FG002|Overall Study|Protocol Violation|0|||
106123178|NCT04157686|366107836|FG003|Overall Study|Protocol Violation|0|||
106123179|NCT04157686|366107837|FG004|Overall Study|Protocol Violation|1|||
106123180|NCT04157686|366107838|FG005|Overall Study|Protocol Violation|0|||
106123181|NCT04157686|366107839|FG006|Overall Study|Protocol Violation|0|||
106123182|NCT04157686|366107840|FG007|Overall Study|Protocol Violation|0|||
106123183|NCT04157686|366107833|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
106123184|NCT04157686|366107834|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
106123185|NCT04157686|366107835|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
106123186|NCT04157686|366107836|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
106123187|NCT04157686|366107837|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
106123188|NCT04157686|366107838|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
106123189|NCT04157686|366107839|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
106123190|NCT04157686|366107840|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
106123191|NCT01216293|366107841|FG000|Main Study|Adverse Event|1|||
106123192|NCT01216293|366107842|FG001|Main Study|Adverse Event|4|||
106123193|NCT01216293|366107843|FG002|Main Study|Adverse Event|2|||
106123194|NCT01216293|366107841|FG000|Main Study|Major Protocol Deviation|1|||
106123195|NCT01216293|366107842|FG001|Main Study|Major Protocol Deviation|0|||
106123196|NCT01216293|366107843|FG002|Main Study|Major Protocol Deviation|1|||
106123197|NCT01216293|366107841|FG000|Main Study|Lost to Follow-up|3|||
106123198|NCT01216293|366107842|FG001|Main Study|Lost to Follow-up|1|||
105666079|NCT01814072|364440899|FG020|Overall Study|Lost to Follow-up|2|||
106123199|NCT01216293|366107843|FG002|Main Study|Lost to Follow-up|0|||
106123200|NCT01216293|366107841|FG000|Main Study|Voluntary Withdrawal|2|||
106123201|NCT01216293|366107842|FG001|Main Study|Voluntary Withdrawal|2|||
106123202|NCT01216293|366107843|FG002|Main Study|Voluntary Withdrawal|2|||
106123203|NCT01216293|366107841|FG000|Main Study|Other Reason Not Specified|0|||
106123204|NCT01216293|366107842|FG001|Main Study|Other Reason Not Specified|1|||
106123205|NCT01216293|366107843|FG002|Main Study|Other Reason Not Specified|1|||
106123206|NCT01216293|366107841|FG000|Main Study|Randomized, Not Treated|1|||
106123207|NCT01216293|366107842|FG001|Main Study|Randomized, Not Treated|0|||
106123208|NCT01216293|366107843|FG002|Main Study|Randomized, Not Treated|0|||
105666080|NCT01814072|364440900|FG021|Overall Study|Lost to Follow-up|1|||
105666081|NCT01814072|364440901|FG022|Overall Study|Lost to Follow-up|3|||
105666082|NCT01814072|364440902|FG023|Overall Study|Lost to Follow-up|1|||
105666083|NCT01814072|364440903|FG024|Overall Study|Lost to Follow-up|4|||
105666084|NCT01814072|364440904|FG025|Overall Study|Lost to Follow-up|1|||
105666085|NCT01814072|364440905|FG026|Overall Study|Lost to Follow-up|1|||
105666086|NCT01814072|364440906|FG027|Overall Study|Lost to Follow-up|2|||
105666087|NCT01814072|364440907|FG028|Overall Study|Lost to Follow-up|3|||
105666088|NCT01814072|364440908|FG029|Overall Study|Lost to Follow-up|3|||
105666089|NCT01814072|364440909|FG030|Overall Study|Lost to Follow-up|2|||
105666090|NCT01814072|364440910|FG031|Overall Study|Lost to Follow-up|0|||
105666091|NCT01814072|364440879|FG000|Overall Study|Withdrawal by Subject|2|||
105666092|NCT01814072|364440880|FG001|Overall Study|Withdrawal by Subject|0|||
105666093|NCT01814072|364440881|FG002|Overall Study|Withdrawal by Subject|1|||
105666094|NCT01814072|364440882|FG003|Overall Study|Withdrawal by Subject|0|||
105666095|NCT01814072|364440883|FG004|Overall Study|Withdrawal by Subject|2|||
105666096|NCT01814072|364440884|FG005|Overall Study|Withdrawal by Subject|3|||
105666097|NCT01814072|364440885|FG006|Overall Study|Withdrawal by Subject|1|||
105666098|NCT01814072|364440886|FG007|Overall Study|Withdrawal by Subject|0|||
105666099|NCT01814072|364440887|FG008|Overall Study|Withdrawal by Subject|1|||
105666100|NCT01814072|364440888|FG009|Overall Study|Withdrawal by Subject|2|||
105666101|NCT01814072|364440889|FG010|Overall Study|Withdrawal by Subject|0|||
105666102|NCT01814072|364440890|FG011|Overall Study|Withdrawal by Subject|0|||
105666103|NCT01814072|364440891|FG012|Overall Study|Withdrawal by Subject|1|||
105666104|NCT01814072|364440892|FG013|Overall Study|Withdrawal by Subject|1|||
105666105|NCT01814072|364440893|FG014|Overall Study|Withdrawal by Subject|1|||
105666106|NCT01814072|364440894|FG015|Overall Study|Withdrawal by Subject|1|||
105666107|NCT01814072|364440895|FG016|Overall Study|Withdrawal by Subject|0|||
105666108|NCT01814072|364440896|FG017|Overall Study|Withdrawal by Subject|0|||
105666109|NCT01814072|364440897|FG018|Overall Study|Withdrawal by Subject|0|||
105666110|NCT01814072|364440898|FG019|Overall Study|Withdrawal by Subject|2|||
105666111|NCT01814072|364440899|FG020|Overall Study|Withdrawal by Subject|0|||
105666112|NCT01814072|364440900|FG021|Overall Study|Withdrawal by Subject|0|||
105666113|NCT01814072|364440901|FG022|Overall Study|Withdrawal by Subject|1|||
105666114|NCT01814072|364440902|FG023|Overall Study|Withdrawal by Subject|0|||
105666115|NCT01814072|364440903|FG024|Overall Study|Withdrawal by Subject|2|||
105666116|NCT01814072|364440904|FG025|Overall Study|Withdrawal by Subject|1|||
105666117|NCT01814072|364440905|FG026|Overall Study|Withdrawal by Subject|1|||
105666118|NCT01814072|364440906|FG027|Overall Study|Withdrawal by Subject|2|||
105666119|NCT01814072|364440907|FG028|Overall Study|Withdrawal by Subject|1|||
105666120|NCT01814072|364440908|FG029|Overall Study|Withdrawal by Subject|0|||
105666121|NCT01814072|364440909|FG030|Overall Study|Withdrawal by Subject|0|||
105666122|NCT01814072|364440910|FG031|Overall Study|Withdrawal by Subject|0|||
105666123|NCT00760747|364440913|FG000|Study Period II|Adverse Event|3|||
105666124|NCT00760747|364440914|FG001|Study Period II|Adverse Event|4|||
105666125|NCT00760747|364440913|FG000|Study Period II|Lack of Efficacy|0|||
105666126|NCT00760747|364440914|FG001|Study Period II|Lack of Efficacy|6|||
105666127|NCT00760747|364440913|FG000|Study Period II|Parent/Caregiver Decision|3|||
105666128|NCT00760747|364440914|FG001|Study Period II|Parent/Caregiver Decision|0|||
105666129|NCT00760747|364440913|FG000|Study Period II|Protocol Violation|6|||
105666130|NCT00760747|364440914|FG001|Study Period II|Protocol Violation|3|||
105666131|NCT00760747|364440913|FG000|Study Period II|Withdrawal by Subject|1|||
105666132|NCT00760747|364440914|FG001|Study Period II|Withdrawal by Subject|0|||
105666133|NCT00760747|364440913|FG000|Study Period II|No drug administered|0|||
105666134|NCT00760747|364440914|FG001|Study Period II|No drug administered|1|||
105666135|NCT00760747|364440913|FG000|Study Period III|Adverse Event|1|||
105666136|NCT00760747|364440914|FG001|Study Period III|Adverse Event|0|||
105666137|NCT00760747|364440913|FG000|Study Period III|Lack of Efficacy|1|||
105666138|NCT00760747|364440914|FG001|Study Period III|Lack of Efficacy|0|||
105895140|NCT01253174|365269887|FG000|Period 3|Withdrawal by Subject|0|||
105895141|NCT01253174|365269888|FG001|Period 3|Withdrawal by Subject|1|||
105895142|NCT01253174|365269889|FG002|Period 3|Withdrawal by Subject|0|||
105895143|NCT01253174|365269890|FG003|Period 3|Withdrawal by Subject|0|||
105895144|NCT01253174|365269891|FG004|Period 3|Withdrawal by Subject|1|||
106123209|NCT01216293|366107841|FG000|Calcium Absorption Substudy|Adverse Event|0|||
105666139|NCT00760747|364440913|FG000|Study Period III|Parent/Caregiver Decision|0|||
105666140|NCT00760747|364440914|FG001|Study Period III|Parent/Caregiver Decision|1|||
105666141|NCT00760747|364440913|FG000|Study Period III|Protocol Violation|1|||
105666142|NCT00760747|364440914|FG001|Study Period III|Protocol Violation|1|||
105666143|NCT00760747|364440913|FG000|Study Period III|Physician Decision|0|||
105666144|NCT00760747|364440914|FG001|Study Period III|Physician Decision|1|||
105666145|NCT01443923|364440915|FG000|Overall Study|Adverse Event|1|||
105895145|NCT01253174|365269892|FG005|Period 3|Withdrawal by Subject|0|||
105666146|NCT01443923|364440916|FG001|Overall Study|Adverse Event|0|||
105666147|NCT00250432|364440917|FG000|Overall Study|Adverse Event|25|||
105666148|NCT00250432|364440918|FG001|Overall Study|Adverse Event|29|||
105666149|NCT00250432|364440917|FG000|Overall Study|Lack of Efficacy|2|||
106123210|NCT01216293|366107842|FG001|Calcium Absorption Substudy|Adverse Event|2|||
105666150|NCT00250432|364440918|FG001|Overall Study|Lack of Efficacy|1|||
105666151|NCT00250432|364440917|FG000|Overall Study|Lost to Follow-up|6|||
106123211|NCT01216293|366107843|FG002|Calcium Absorption Substudy|Adverse Event|0|||
106123212|NCT01216293|366107841|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
105666152|NCT00250432|364440918|FG001|Overall Study|Lost to Follow-up|5|||
105666153|NCT00250432|364440917|FG000|Overall Study|Patient Moved|0|||
105666154|NCT00250432|364440918|FG001|Overall Study|Patient Moved|1|||
105666155|NCT00250432|364440917|FG000|Overall Study|Protocol Violation|0|||
105666156|NCT00250432|364440918|FG001|Overall Study|Protocol Violation|3|||
105666157|NCT00250432|364440917|FG000|Overall Study|Withdrawal by Subject|6|||
105666158|NCT00250432|364440918|FG001|Overall Study|Withdrawal by Subject|2|||
105666159|NCT00250432|364440917|FG000|Overall Study|Pt died out of posttherapy report period|6|||
105666160|NCT00250432|364440918|FG001|Overall Study|Pt died out of posttherapy report period|5|||
105666161|NCT00250432|364440917|FG000|Overall Study|Pt was considered untreatable|0|||
105666162|NCT00250432|364440918|FG001|Overall Study|Pt was considered untreatable|1|||
105666163|NCT00935532|364440922|FG000|Overall Study|Adverse Event|11|||
105666164|NCT00935532|364440923|FG001|Overall Study|Adverse Event|6|||
105666165|NCT00935532|364440922|FG000|Overall Study|Death|1|||
105666166|NCT00935532|364440923|FG001|Overall Study|Death|0|||
105666167|NCT00935532|364440922|FG000|Overall Study|Lost to Follow-up|1|||
105666168|NCT00935532|364440923|FG001|Overall Study|Lost to Follow-up|0|||
105666169|NCT00935532|364440922|FG000|Overall Study|Physician Decision|1|||
105666170|NCT00935532|364440923|FG001|Overall Study|Physician Decision|2|||
105666171|NCT00935532|364440922|FG000|Overall Study|Protocol Violation|2|||
105666172|NCT00935532|364440923|FG001|Overall Study|Protocol Violation|1|||
105666173|NCT00935532|364440922|FG000|Overall Study|Subject Decision|2|||
105666174|NCT00935532|364440923|FG001|Overall Study|Subject Decision|1|||
105666175|NCT00935532|364440922|FG000|Overall Study|Sponsor Decision|0|||
105666176|NCT00935532|364440923|FG001|Overall Study|Sponsor Decision|1|||
105666177|NCT00935532|364440922|FG000|Overall Study|Loss Glucose Control|4|||
105666178|NCT00935532|364440923|FG001|Overall Study|Loss Glucose Control|0|||
105666179|NCT04954326|364440924|FG000|Overall Study|Protocol Violation|0|||
105666180|NCT04954326|364440925|FG001|Overall Study|Protocol Violation|1|||
105666181|NCT04954326|364440924|FG000|Overall Study|Death|0|||
105666182|NCT04954326|364440925|FG001|Overall Study|Death|2|||
105895146|NCT01253174|365269887|FG000|Period 3|Pregnancy|0|||
105895147|NCT01253174|365269888|FG001|Period 3|Pregnancy|0|||
105895148|NCT01253174|365269889|FG002|Period 3|Pregnancy|1|||
105895149|NCT01253174|365269890|FG003|Period 3|Pregnancy|0|||
105895150|NCT01253174|365269891|FG004|Period 3|Pregnancy|0|||
105895151|NCT01253174|365269892|FG005|Period 3|Pregnancy|0|||
105895152|NCT02345889|365269893|FG000|Overall Study|Inadequate Bowel Prep|17|||
105895153|NCT02345889|365269894|FG001|Overall Study|Inadequate Bowel Prep|16|||
105895154|NCT02345889|365269895|FG002|Overall Study|Inadequate Bowel Prep|18|||
105895155|NCT02345889|365269896|FG003|Overall Study|Inadequate Bowel Prep|14|||
105895156|NCT02345889|365269893|FG000|Overall Study|Polyposis identified during procedure|1|||
105895157|NCT02345889|365269894|FG001|Overall Study|Polyposis identified during procedure|1|||
105895158|NCT02345889|365269895|FG002|Overall Study|Polyposis identified during procedure|0|||
105895159|NCT02345889|365269896|FG003|Overall Study|Polyposis identified during procedure|1|||
105895160|NCT02345889|365269893|FG000|Overall Study|Recognized ineligible post-randomization|1|||
105895161|NCT02345889|365269894|FG001|Overall Study|Recognized ineligible post-randomization|0|||
105895162|NCT02345889|365269895|FG002|Overall Study|Recognized ineligible post-randomization|2|||
106123213|NCT01216293|366107842|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
106123214|NCT01216293|366107843|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
106123215|NCT01216293|366107841|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
106123216|NCT01216293|366107842|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
105666183|NCT04954326|364440924|FG000|Overall Study|Physician Decision|0|||
105666184|NCT04954326|364440925|FG001|Overall Study|Physician Decision|1|||
105666185|NCT01782690|364440926|FG000|Overall Study|Not reported|7|||
105666186|NCT01782690|364440926|FG000|Overall Study|Toxicity of gemcitabine|1|||
105666187|NCT01782690|364440926|FG000|Overall Study|Toxicity of erlotinib|1|||
105666188|NCT01782690|364440926|FG000|Overall Study|Lost to Follow-up|31|||
105895163|NCT02345889|365269896|FG003|Overall Study|Recognized ineligible post-randomization|1|||
105895164|NCT02345889|365269893|FG000|Overall Study|Ulcerative Colitis identified|1|||
105666189|NCT01782690|364440926|FG000|Overall Study|Withdrawal of informed consent|2|||
105666190|NCT01782690|364440926|FG000|Overall Study|Absent rash|9|||
105666191|NCT01782690|364440926|FG000|Overall Study|Physician Decision|13|||
105666192|NCT01782690|364440926|FG000|Overall Study|Patient's wish|21|||
105666193|NCT01782690|364440926|FG000|Overall Study|Tumor progression|74|||
105666194|NCT01782690|364440926|FG000|Overall Study|Death|133|||
105895165|NCT02345889|365269894|FG001|Overall Study|Ulcerative Colitis identified|0|||
105895166|NCT02345889|365269895|FG002|Overall Study|Ulcerative Colitis identified|0|||
105666195|NCT01782690|364440926|FG000|Overall Study|Study completion unknown|7|||
105666196|NCT00277095|364440927|FG000|Overall Study|Death|2|||
105666197|NCT00277095|364440927|FG000|Overall Study|Explanted|7|||
105666198|NCT00277095|364440927|FG000|Overall Study|Lost to Follow-up|2|||
105666199|NCT00277095|364440927|FG000|Overall Study|Missed Follow-up|9|||
105666200|NCT00277095|364440927|FG000|Overall Study|Physician Decision|1|||
105666201|NCT01806389|364440929|FG000|Overall Study|Withdrawal by Subject|4|||
105666202|NCT00681668|364440930|FG000|Overall Study|Protocol Violation|1|||
105666203|NCT00681668|364440930|FG000|Overall Study|Withdrawal by Subject|1|||
105666204|NCT02209181|364440931|FG000|Overall Study|Adverse Event|1|||
105666205|NCT02209181|364440932|FG001|Overall Study|Adverse Event|0|||
105666206|NCT02209181|364440933|FG002|Overall Study|Adverse Event|1|||
105666207|NCT02209181|364440934|FG003|Overall Study|Adverse Event|0|||
105666208|NCT02209181|364440931|FG000|Overall Study|Withdrawal by Subject|0|||
105666209|NCT02209181|364440932|FG001|Overall Study|Withdrawal by Subject|1|||
105666210|NCT02209181|364440933|FG002|Overall Study|Withdrawal by Subject|0|||
105666211|NCT02209181|364440934|FG003|Overall Study|Withdrawal by Subject|0|||
105666212|NCT02548078|364440935|FG000|Overall Study|Serious adverse event/Adverse event|1|||
105666213|NCT02548078|364440936|FG001|Overall Study|Serious adverse event/Adverse event|0|||
105666214|NCT02548078|364440935|FG000|Overall Study|Moved from study area|3|||
105666215|NCT02548078|364440936|FG001|Overall Study|Moved from study area|3|||
105666216|NCT02548078|364440935|FG000|Overall Study|Lost to Follow-up|1|||
105666217|NCT02548078|364440936|FG001|Overall Study|Lost to Follow-up|3|||
105666218|NCT00490698|364440937|FG000|Overall Study|Withdrawal by Subject|1|||
105666219|NCT00490698|364440937|FG000|Overall Study|Disease Progression|7|||
105666220|NCT00490698|364440937|FG000|Overall Study|Physician Decision|2|||
105666221|NCT02963090|364442136|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
105666222|NCT02963090|364442137|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
105666223|NCT03445533|364442138|FG000|Overall Study|Progressive Disease|48|||
105666224|NCT03445533|364442139|FG001|Overall Study|Progressive Disease|81|||
105666225|NCT03445533|364442138|FG000|Overall Study|Adverse Event|60|||
105666226|NCT03445533|364442139|FG001|Overall Study|Adverse Event|64|||
105666227|NCT03445533|364442138|FG000|Overall Study|Death|9|||
105666228|NCT03445533|364442139|FG001|Overall Study|Death|19|||
105666229|NCT03445533|364442138|FG000|Overall Study|Miscellaneous|0|||
105666230|NCT03445533|364442139|FG001|Overall Study|Miscellaneous|16|||
105666231|NCT03445533|364442138|FG000|Overall Study|Withdrawal by Subject|3|||
105666232|NCT03445533|364442139|FG001|Overall Study|Withdrawal by Subject|4|||
105666233|NCT03445533|364442138|FG000|Overall Study|Physician Decision|1|||
105895167|NCT02345889|365269896|FG003|Overall Study|Ulcerative Colitis identified|0|||
105895168|NCT02345889|365269893|FG000|Overall Study|Cecum not intubated|1|||
105895169|NCT02345889|365269894|FG001|Overall Study|Cecum not intubated|0|||
105895170|NCT02345889|365269895|FG002|Overall Study|Cecum not intubated|0|||
105895171|NCT02345889|365269896|FG003|Overall Study|Cecum not intubated|0|||
105895172|NCT02892513|365269897|FG000|Overall Study|Withdrawal by Subject|0|||
105895173|NCT02892513|365269898|FG001|Overall Study|Withdrawal by Subject|1|||
105895174|NCT03426436|365269899|FG000|Overall Study|Incorrect lead placement|12|||
105895175|NCT03426436|365269899|FG000|Overall Study|Withdrawal by Subject|2|||
105895176|NCT03426436|365269899|FG000|Overall Study|Consent issue|1|||
105895177|NCT03426436|365269899|FG000|Overall Study|ECGs not saved|4|||
105895178|NCT04506905|365269900|FG000|Overall Study|Lost to Follow-up|1|||
105895179|NCT04506905|365269901|FG001|Overall Study|Lost to Follow-up|0|||
105895180|NCT04506905|365269902|FG002|Overall Study|Lost to Follow-up|0|||
105895181|NCT04506905|365269903|FG003|Overall Study|Lost to Follow-up|1|||
105895182|NCT04506905|365269904|FG004|Overall Study|Lost to Follow-up|0|||
105895183|NCT04506905|365269905|FG005|Overall Study|Lost to Follow-up|0|||
105895184|NCT04506905|365269906|FG006|Overall Study|Lost to Follow-up|0|||
105895185|NCT04506905|365269907|FG007|Overall Study|Lost to Follow-up|0|||
105895186|NCT04506905|365269908|FG008|Overall Study|Lost to Follow-up|0|||
105895187|NCT04506905|365269900|FG000|Overall Study|Withdrawal by Subject|0|||
105895188|NCT04506905|365269901|FG001|Overall Study|Withdrawal by Subject|0|||
105895189|NCT04506905|365269902|FG002|Overall Study|Withdrawal by Subject|0|||
105895190|NCT04506905|365269903|FG003|Overall Study|Withdrawal by Subject|2|||
105895191|NCT04506905|365269904|FG004|Overall Study|Withdrawal by Subject|0|||
105895192|NCT04506905|365269905|FG005|Overall Study|Withdrawal by Subject|0|||
105895193|NCT04506905|365269906|FG006|Overall Study|Withdrawal by Subject|0|||
105895194|NCT04506905|365269907|FG007|Overall Study|Withdrawal by Subject|0|||
105666234|NCT03445533|364442139|FG001|Overall Study|Physician Decision|3|||
105666235|NCT03445533|364442138|FG000|Overall Study|Sponsor Decision|0|||
105666236|NCT03445533|364442139|FG001|Overall Study|Sponsor Decision|1|||
105666237|NCT03445533|364442138|FG000|Overall Study|Lost to Follow-up|0|||
105666238|NCT03445533|364442139|FG001|Overall Study|Lost to Follow-up|1|||
105666239|NCT03445533|364442138|FG000|Overall Study|Never Received any Study Treatment|7|||
105666240|NCT03445533|364442139|FG001|Overall Study|Never Received any Study Treatment|4|||
105895195|NCT04506905|365269908|FG008|Overall Study|Withdrawal by Subject|0|||
105895196|NCT04683939|365269909|FG000|Overall Study|Study termination by the sponsor|0|||
105895197|NCT04683939|365269910|FG001|Overall Study|Study termination by the sponsor|1|||
105895198|NCT04683939|365269911|FG002|Overall Study|Study termination by the sponsor|2|||
105895199|NCT04683939|365269912|FG003|Overall Study|Study termination by the sponsor|2|||
105895200|NCT04683939|365269909|FG000|Overall Study|Death|1|||
105895201|NCT04683939|365269910|FG001|Overall Study|Death|1|||
105666241|NCT00079339|364442140|FG000|Overall Study|Adverse Event|1|||
105666242|NCT00079339|364442141|FG001|Overall Study|Adverse Event|7|||
105666243|NCT00079339|364442142|FG002|Overall Study|Adverse Event|2|||
105666244|NCT00079339|364442140|FG000|Overall Study|Death|1|||
105666245|NCT00079339|364442141|FG001|Overall Study|Death|0|||
105666246|NCT00079339|364442142|FG002|Overall Study|Death|0|||
105666247|NCT00079339|364442140|FG000|Overall Study|Non-compliance|0|||
105666248|NCT00079339|364442141|FG001|Overall Study|Non-compliance|0|||
105666249|NCT00079339|364442142|FG002|Overall Study|Non-compliance|1|||
105666250|NCT00079339|364442140|FG000|Overall Study|Withdrawal by Subject|0|||
105666251|NCT00079339|364442141|FG001|Overall Study|Withdrawal by Subject|4|||
105666252|NCT00079339|364442142|FG002|Overall Study|Withdrawal by Subject|1|||
105666253|NCT00079339|364442140|FG000|Overall Study|Disease progression|3|||
105666254|NCT00079339|364442141|FG001|Overall Study|Disease progression|28|||
105895202|NCT04683939|365269911|FG002|Overall Study|Death|2|||
105895203|NCT04683939|365269912|FG003|Overall Study|Death|1|||
105895204|NCT04683939|365269909|FG000|Overall Study|Withdrawal by Subject|1|||
105895205|NCT04683939|365269910|FG001|Overall Study|Withdrawal by Subject|0|||
105895206|NCT04683939|365269911|FG002|Overall Study|Withdrawal by Subject|0|||
105895207|NCT04683939|365269912|FG003|Overall Study|Withdrawal by Subject|0|||
105895208|NCT04683939|365269909|FG000|Overall Study|Physician Decision|1|||
105895209|NCT04683939|365269910|FG001|Overall Study|Physician Decision|0|||
105895210|NCT04683939|365269911|FG002|Overall Study|Physician Decision|0|||
105895211|NCT04683939|365269912|FG003|Overall Study|Physician Decision|0|||
105895212|NCT04683939|365269909|FG000|Overall Study|Lost to Follow-up|0|||
105895213|NCT04683939|365269910|FG001|Overall Study|Lost to Follow-up|1|||
105895214|NCT04683939|365269911|FG002|Overall Study|Lost to Follow-up|0|||
105895215|NCT04683939|365269912|FG003|Overall Study|Lost to Follow-up|0|||
105895216|NCT02059434|365271672|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
105895217|NCT02059434|365271673|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
105895218|NCT02059434|365271674|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
105895219|NCT02059434|365271675|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
105895220|NCT02059434|365271676|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
105895221|NCT02059434|365271677|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
105895222|NCT02059434|365271678|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
105895223|NCT02059434|365271679|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
105895224|NCT02059434|365271680|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
105895225|NCT02059434|365271672|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
105895226|NCT02059434|365271673|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
105895227|NCT02059434|365271674|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
105895228|NCT02059434|365271675|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
105895229|NCT02059434|365271676|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
105895230|NCT02059434|365271677|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
105895231|NCT02059434|365271678|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
105895232|NCT02059434|365271679|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
105895233|NCT02059434|365271680|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
105895234|NCT02059434|365271672|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
105895235|NCT02059434|365271673|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
105895236|NCT02059434|365271674|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
105895237|NCT02059434|365271675|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
105895238|NCT02059434|365271676|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
105895239|NCT02059434|365271677|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
105997195|NCT01633788|365651369|FG003|Overall Study|Protocol Violation|0|||
105997196|NCT01633788|365651366|FG000|Overall Study|Other Reasons|0|||
105997197|NCT01633788|365651367|FG001|Overall Study|Other Reasons|2|||
105997198|NCT01633788|365651368|FG002|Overall Study|Other Reasons|3|||
105997199|NCT01633788|365651369|FG003|Overall Study|Other Reasons|7|||
105997200|NCT02407223|365651370|FG000|Overall Study|Adverse Event|1|||
105997201|NCT02407223|365651371|FG001|Overall Study|Adverse Event|0|||
105997202|NCT02407223|365651372|FG002|Overall Study|Adverse Event|1|||
105997203|NCT02407223|365651370|FG000|Overall Study|Lack of Efficacy|6|||
105666255|NCT00079339|364442142|FG002|Overall Study|Disease progression|2|||
105895240|NCT02059434|365271678|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
105895241|NCT02059434|365271679|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
105895242|NCT02059434|365271680|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
105895243|NCT02059434|365271672|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
105895244|NCT02059434|365271673|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
105997204|NCT02407223|365651371|FG001|Overall Study|Lack of Efficacy|6|||
105895245|NCT02059434|365271674|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
105895246|NCT02059434|365271675|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
105997205|NCT02407223|365651372|FG002|Overall Study|Lack of Efficacy|4|||
105666256|NCT02563548|364442143|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
105666257|NCT02563548|364442144|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
105666258|NCT02563548|364442145|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
105666259|NCT02563548|364442146|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
105666260|NCT02563548|364442147|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
105666261|NCT02563548|364442148|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
105895247|NCT02059434|365271676|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
105895248|NCT02059434|365271677|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
105997206|NCT02407223|365651370|FG000|Overall Study|Lost to Follow-up|1|||
105997207|NCT02407223|365651371|FG001|Overall Study|Lost to Follow-up|0|||
105997208|NCT02407223|365651372|FG002|Overall Study|Lost to Follow-up|2|||
105997209|NCT02407223|365651370|FG000|Overall Study|Withdrawal by Subject|2|||
105997210|NCT02407223|365651371|FG001|Overall Study|Withdrawal by Subject|4|||
105997211|NCT02407223|365651372|FG002|Overall Study|Withdrawal by Subject|4|||
105997212|NCT02407223|365651370|FG000|Overall Study|Study Terminated by Sponsor|77|||
105997213|NCT02407223|365651371|FG001|Overall Study|Study Terminated by Sponsor|80|||
105997214|NCT02407223|365651372|FG002|Overall Study|Study Terminated by Sponsor|86|||
105997215|NCT02407223|365651370|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
105997216|NCT02407223|365651371|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
105997217|NCT02407223|365651372|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
105997218|NCT02407223|365651370|FG000|Overall Study|Other|29|||
105997219|NCT02407223|365651371|FG001|Overall Study|Other|27|||
105997220|NCT02407223|365651372|FG002|Overall Study|Other|25|||
106123217|NCT01216293|366107843|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
106123218|NCT01671748|366107844|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
106123219|NCT01671748|366107845|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
106123220|NCT01671748|366107844|FG000|4 Week run-in Phase|Adverse Event|1|||
106123221|NCT01671748|366107845|FG001|4 Week run-in Phase|Adverse Event|0|||
106123222|NCT01671748|366107844|FG000|4 Week run-in Phase|Not eligible|9|||
106123223|NCT01671748|366107845|FG001|4 Week run-in Phase|Not eligible|0|||
106123224|NCT01091428|366109671|FG000|Phase 1|Progressive Disease|24|||
106123225|NCT01091428|366109672|FG001|Phase 1|Progressive Disease|8|||
106123226|NCT01091428|366109673|FG002|Phase 1|Progressive Disease|0|||
106123227|NCT01091428|366109674|FG003|Phase 1|Progressive Disease|0|||
105895249|NCT02059434|365271678|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
105895250|NCT02059434|365271679|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
105895251|NCT02059434|365271680|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
105895252|NCT02059434|365271672|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105895253|NCT02059434|365271673|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105895254|NCT02059434|365271674|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105895255|NCT02059434|365271675|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105895256|NCT02059434|365271676|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105895257|NCT02059434|365271677|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105895258|NCT02059434|365271678|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105895259|NCT02059434|365271679|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
105895260|NCT02059434|365271680|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
105895261|NCT01004406|365271683|FG000|Overall Study|Withdrawal by Subject|2|||
105895262|NCT01004406|365271684|FG001|Overall Study|Withdrawal by Subject|0|||
105895263|NCT01004406|365271683|FG000|Overall Study|Lost to Follow-up|1|||
105895264|NCT01004406|365271684|FG001|Overall Study|Lost to Follow-up|0|||
105895265|NCT02928770|365271685|FG000|Overall Study|Withdrawal by Subject|2|||
105895266|NCT02907593|365271688|FG000|Overall Study|Withdrawal by Subject|0|||
105895267|NCT02907593|365271689|FG001|Overall Study|Withdrawal by Subject|0|||
105895268|NCT02907593|365271690|FG002|Overall Study|Withdrawal by Subject|1|||
105895269|NCT02907593|365271691|FG003|Overall Study|Withdrawal by Subject|0|||
105895270|NCT01092637|365271692|FG000|Overall Study|Death|47|||
105895271|NCT01092637|365271693|FG001|Overall Study|Death|49|||
105895272|NCT01752634|365271697|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
105895273|NCT01752634|365271698|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
105895274|NCT01752634|365271699|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
105895275|NCT01752634|365271700|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
105997221|NCT00855959|365651379|FG000|Overall Study|Adverse Event|2|||
105997222|NCT00855959|365651379|FG000|Overall Study|Lost to Follow-up|2|||
105997223|NCT00855959|365651379|FG000|Overall Study|Withdrawal by Subject|3|||
105997224|NCT00855959|365651379|FG000|Overall Study|Pregnancy|1|||
105997225|NCT00855959|365651379|FG000|Overall Study|Incorrect enrolment|1|||
105997226|NCT02813889|365651380|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
105997227|NCT02813889|365651381|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
106123228|NCT01091428|366109671|FG000|Phase 1|Symptomatic Deterioration|3|||
106123229|NCT01091428|366109672|FG001|Phase 1|Symptomatic Deterioration|2|||
105895276|NCT01752634|365271701|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
105895277|NCT01752634|365271702|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
105895278|NCT01752634|365271697|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
106123230|NCT01091428|366109673|FG002|Phase 1|Symptomatic Deterioration|0|||
106123231|NCT01091428|366109674|FG003|Phase 1|Symptomatic Deterioration|0|||
105666262|NCT02563548|364442143|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
105666263|NCT02563548|364442144|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
105666264|NCT02563548|364442145|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
105666265|NCT02563548|364442146|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
105666266|NCT02563548|364442147|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
105666267|NCT02563548|364442148|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
105666268|NCT02563548|364442143|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666269|NCT02563548|364442144|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666270|NCT02563548|364442145|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
105666271|NCT02563548|364442146|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666272|NCT02563548|364442147|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666273|NCT02563548|364442148|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
105666274|NCT02563548|364442143|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
105666275|NCT02563548|364442144|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
105666276|NCT02563548|364442145|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
105666277|NCT02563548|364442146|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
105666278|NCT02563548|364442147|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
105666279|NCT02563548|364442148|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
105666280|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
105666281|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
105666282|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
105666283|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
105666284|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
105666285|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
105666286|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
105666287|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
105666288|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
105666289|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
105666290|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
105666291|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
105666292|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666293|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666294|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666295|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666296|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
105666297|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
105666298|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
105666299|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
105666300|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
105666301|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
105666302|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
105666303|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
105666304|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666305|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666306|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666307|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666308|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
105666309|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
105666310|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666311|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666312|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666313|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666314|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
105666315|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
105666316|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105666317|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105895279|NCT01752634|365271698|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
105895280|NCT01752634|365271699|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105895281|NCT01752634|365271700|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105895282|NCT01752634|365271701|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105895283|NCT01752634|365271702|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
105895284|NCT01752634|365271697|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
105666318|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105895285|NCT01752634|365271698|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
105895286|NCT01752634|365271699|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
105895287|NCT01752634|365271700|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
105666319|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105666320|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
105666321|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
105666322|NCT02563548|364442143|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666323|NCT02563548|364442144|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666324|NCT02563548|364442145|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666325|NCT02563548|364442146|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666326|NCT02563548|364442147|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
105666327|NCT02563548|364442148|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
105666328|NCT01023958|364442151|FG000|Overall Study|Progressive disease|48|||
105666329|NCT01023958|364442151|FG000|Overall Study|Other adverse event|1|||
105666330|NCT01023958|364442151|FG000|Overall Study|Refused to continue medication|1|||
105666331|NCT01099917|364442158|FG000|Overall Study|Adverse Event|3|||
105666332|NCT01099917|364442158|FG000|Overall Study|Not Treated|24|||
105666333|NCT01266161|364442159|FG000|Overall Study|Ineligible|1|||
105666334|NCT01266161|364442160|FG001|Overall Study|Ineligible|0|||
105666335|NCT01266161|364442159|FG000|Overall Study|Lack of Efficacy|0|||
105666336|NCT01266161|364442160|FG001|Overall Study|Lack of Efficacy|1|||
105666337|NCT01266161|364442159|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
105666338|NCT01266161|364442160|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
105666339|NCT01485120|364442161|FG000|Overall Study|Withdrawal by Subject|2|||
105666340|NCT00422734|364442162|FG000|Overall Study|Physician Decision|1|||
105666341|NCT00422734|364442163|FG001|Overall Study|Physician Decision|1|||
105666342|NCT00422734|364442162|FG000|Overall Study|Protocol Violation|1|||
105666343|NCT00422734|364442163|FG001|Overall Study|Protocol Violation|6|||
105666344|NCT00422734|364442162|FG000|Overall Study|Withdrawal by Subject|12|||
105666345|NCT00422734|364442163|FG001|Overall Study|Withdrawal by Subject|8|||
105666346|NCT00422734|364442162|FG000|Overall Study|Adverse Event|0|||
105666347|NCT00422734|364442163|FG001|Overall Study|Adverse Event|3|||
105666348|NCT00422734|364442162|FG000|Overall Study|Partner Decision|0|||
105666349|NCT00422734|364442163|FG001|Overall Study|Partner Decision|3|||
105666350|NCT02353468|364442164|FG000|Overall Study|Study terminated|3|||
105666351|NCT00848484|364442165|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
105666352|NCT00848484|364442166|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
105666353|NCT00848484|364442165|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
105666354|NCT00848484|364442166|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
105666355|NCT00848484|364442165|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
105666356|NCT00848484|364442166|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
105666357|NCT00848484|364442165|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
105666358|NCT00848484|364442166|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
105666359|NCT00848484|364442165|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
105666360|NCT00848484|364442166|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
105666361|NCT00706654|364442174|FG000|Conversion Phase|Lost to Follow-up|4|||
105666362|NCT00706654|364442175|FG001|Conversion Phase|Lost to Follow-up|0|||
105666363|NCT00706654|364442176|FG002|Conversion Phase|Lost to Follow-up|0|||
105666364|NCT00706654|364442177|FG003|Conversion Phase|Lost to Follow-up|0|||
105666365|NCT00706654|364442174|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
105666366|NCT00706654|364442175|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
105666367|NCT00706654|364442176|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
105666368|NCT00706654|364442177|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
105666369|NCT00706654|364442174|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
105666370|NCT00706654|364442175|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
105666371|NCT00706654|364442176|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
105666372|NCT00706654|364442177|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
105997228|NCT00502671|365651385|FG000|Overall Study|Disease Progression|13|||
105666373|NCT00706654|364442174|FG000|Conversion Phase|Withdrawn by Investigator|14|||
105666374|NCT00706654|364442175|FG001|Conversion Phase|Withdrawn by Investigator|0|||
105666375|NCT00706654|364442176|FG002|Conversion Phase|Withdrawn by Investigator|0|||
105666376|NCT00706654|364442177|FG003|Conversion Phase|Withdrawn by Investigator|0|||
105666377|NCT00706654|364442174|FG000|Conversion Phase|Withdrew Consent|38|||
105666378|NCT00706654|364442175|FG001|Conversion Phase|Withdrew Consent|0|||
105666379|NCT00706654|364442176|FG002|Conversion Phase|Withdrew Consent|0|||
105666380|NCT00706654|364442177|FG003|Conversion Phase|Withdrew Consent|0|||
105666381|NCT00706654|364442174|FG000|Conversion Phase|Adverse Event|18|||
105666382|NCT00706654|364442175|FG001|Conversion Phase|Adverse Event|0|||
105666383|NCT00706654|364442176|FG002|Conversion Phase|Adverse Event|0|||
105666384|NCT00706654|364442177|FG003|Conversion Phase|Adverse Event|0|||
105666385|NCT00706654|364442174|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
105666386|NCT00706654|364442175|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105666387|NCT00706654|364442176|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105666388|NCT00706654|364442177|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105666389|NCT00706654|364442174|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
105785976|NCT04246593|364870424|FG001|Overall Study|Lost to Follow-up|71|||
105997229|NCT00502671|365651385|FG000|Overall Study|Personal Reasons|22|||
105997230|NCT00502671|365651385|FG000|Overall Study|Lost to Follow-up|7|||
105997231|NCT00502671|365651385|FG000|Overall Study|Protocol Violation|16|||
105997232|NCT00502671|365651385|FG000|Overall Study|Adverse Event|19|||
105997233|NCT00681629|365651392|FG000|Overall Study|Study termination|4|||
105997234|NCT00681629|365651393|FG001|Overall Study|Study termination|2|||
105997235|NCT00681629|365651392|FG000|Overall Study|Adverse Event|1|||
105997236|NCT00681629|365651393|FG001|Overall Study|Adverse Event|0|||
105997237|NCT02859246|365651403|FG000|Overall Study|Screen fails|3|||
105997238|NCT02859246|365651403|FG000|Overall Study|Adverse Event|1|||
105997239|NCT02859246|365651403|FG000|Overall Study|Withdrawal by Subject|1|||
105997240|NCT01746368|365651404|FG000|Overall Study|Lost to Follow-up|2|||
105666390|NCT00706654|364442175|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105997241|NCT01746368|365651405|FG001|Overall Study|Lost to Follow-up|0|||
105997242|NCT01746368|365651404|FG000|Overall Study|Withdrawal by Subject|0|||
105997243|NCT01746368|365651405|FG001|Overall Study|Withdrawal by Subject|1|||
105997244|NCT02562716|365651406|FG000|Overall Study|Adverse Event|7|||
105997245|NCT02562716|365651407|FG001|Overall Study|Adverse Event|14|||
105997246|NCT02562716|365651406|FG000|Overall Study|Withdrawal unrelated to AE|7|||
106123232|NCT01091428|366109671|FG000|Phase 1|Adverse Event|2|||
106123233|NCT01091428|366109672|FG001|Phase 1|Adverse Event|0|||
106123234|NCT01091428|366109673|FG002|Phase 1|Adverse Event|0|||
106123235|NCT01091428|366109674|FG003|Phase 1|Adverse Event|0|||
106123236|NCT01091428|366109671|FG000|Phase 1|Withdrawal by Subject|7|||
106123237|NCT01091428|366109672|FG001|Phase 1|Withdrawal by Subject|0|||
106123238|NCT01091428|366109673|FG002|Phase 1|Withdrawal by Subject|0|||
106123239|NCT01091428|366109674|FG003|Phase 1|Withdrawal by Subject|0|||
106123240|NCT01091428|366109671|FG000|Phase 1|Reason not specified|0|||
106123241|NCT01091428|366109672|FG001|Phase 1|Reason not specified|1|||
106123242|NCT01091428|366109673|FG002|Phase 1|Reason not specified|0|||
106123243|NCT01091428|366109674|FG003|Phase 1|Reason not specified|0|||
106123244|NCT01091428|366109671|FG000|Phase 1|Single-Patient IND|2|||
106123245|NCT01091428|366109672|FG001|Phase 1|Single-Patient IND|0|||
106123246|NCT01091428|366109673|FG002|Phase 1|Single-Patient IND|0|||
106123247|NCT01091428|366109674|FG003|Phase 1|Single-Patient IND|0|||
106123248|NCT01091428|366109671|FG000|Phase 2|Progressive Disease|0|||
106123249|NCT01091428|366109672|FG001|Phase 2|Progressive Disease|0|||
106123250|NCT01091428|366109673|FG002|Phase 2|Progressive Disease|44|||
106123251|NCT01091428|366109674|FG003|Phase 2|Progressive Disease|46|||
106123252|NCT01091428|366109671|FG000|Phase 2|Symptomatic Deterioration|0|||
106123253|NCT01091428|366109672|FG001|Phase 2|Symptomatic Deterioration|0|||
106123254|NCT01091428|366109673|FG002|Phase 2|Symptomatic Deterioration|1|||
106123255|NCT01091428|366109674|FG003|Phase 2|Symptomatic Deterioration|6|||
106123256|NCT01091428|366109671|FG000|Phase 2|Adverse Event|0|||
105895288|NCT01752634|365271701|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
105895289|NCT01752634|365271702|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
105895290|NCT01752634|365271697|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
105895291|NCT01752634|365271698|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
105895292|NCT01752634|365271699|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
105895293|NCT01752634|365271700|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
105895294|NCT01752634|365271701|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
105895295|NCT01752634|365271702|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
105895296|NCT01752634|365271697|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
105895297|NCT01752634|365271698|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
105895298|NCT01752634|365271699|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
105895299|NCT01752634|365271700|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
105895300|NCT01752634|365271701|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
105895301|NCT01752634|365271702|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
105895302|NCT01752634|365271697|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
105895303|NCT01752634|365271698|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
105895304|NCT01752634|365271699|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
105895305|NCT01752634|365271700|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
105895306|NCT01752634|365271701|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
105895307|NCT01752634|365271702|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
105895308|NCT01752634|365271697|FG000|Week 24 to Week 260|Physician Decision|1|||
105895309|NCT01752634|365271698|FG001|Week 24 to Week 260|Physician Decision|2|||
105895310|NCT01752634|365271699|FG002|Week 24 to Week 260|Physician Decision|4|||
105895311|NCT01752634|365271700|FG003|Week 24 to Week 260|Physician Decision|2|||
105895312|NCT01752634|365271701|FG004|Week 24 to Week 260|Physician Decision|1|||
105895313|NCT01752634|365271702|FG005|Week 24 to Week 260|Physician Decision|0|||
105895314|NCT01752634|365271697|FG000|Week 24 to Week 260|Death|0|||
105895315|NCT01752634|365271698|FG001|Week 24 to Week 260|Death|1|||
105895316|NCT01752634|365271699|FG002|Week 24 to Week 260|Death|0|||
105895317|NCT01752634|365271700|FG003|Week 24 to Week 260|Death|0|||
105895318|NCT01752634|365271701|FG004|Week 24 to Week 260|Death|0|||
105895319|NCT01752634|365271702|FG005|Week 24 to Week 260|Death|0|||
105895320|NCT01752634|365271697|FG000|Week 24 to Week 260|Pregnancy|0|||
105895321|NCT01752634|365271698|FG001|Week 24 to Week 260|Pregnancy|0|||
105895322|NCT01752634|365271699|FG002|Week 24 to Week 260|Pregnancy|1|||
105895323|NCT01752634|365271700|FG003|Week 24 to Week 260|Pregnancy|0|||
105895324|NCT01752634|365271701|FG004|Week 24 to Week 260|Pregnancy|0|||
105895325|NCT01752634|365271702|FG005|Week 24 to Week 260|Pregnancy|0|||
105895326|NCT01752634|365271697|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
105895327|NCT01752634|365271698|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
106123257|NCT01091428|366109672|FG001|Phase 2|Adverse Event|0|||
106123258|NCT01091428|366109673|FG002|Phase 2|Adverse Event|12|||
105895328|NCT01752634|365271699|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
105895329|NCT01752634|365271700|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
105895330|NCT01752634|365271701|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
105895331|NCT01752634|365271702|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
105895332|NCT01752634|365271697|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
106123259|NCT01091428|366109674|FG003|Phase 2|Adverse Event|5|||
106123260|NCT01091428|366109671|FG000|Phase 2|Withdrawal by Subject|0|||
106123261|NCT01091428|366109672|FG001|Phase 2|Withdrawal by Subject|0|||
106123262|NCT01091428|366109673|FG002|Phase 2|Withdrawal by Subject|9|||
106123263|NCT01091428|366109674|FG003|Phase 2|Withdrawal by Subject|8|||
105666391|NCT00706654|364442176|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105666392|NCT00706654|364442177|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105666393|NCT00706654|364442174|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
105666394|NCT00706654|364442175|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
105666395|NCT00706654|364442176|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
105666396|NCT00706654|364442177|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
105666397|NCT00706654|364442174|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
105666398|NCT00706654|364442175|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
105666399|NCT00706654|364442176|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
105666400|NCT00706654|364442177|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
105666401|NCT00706654|364442174|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
105666402|NCT00706654|364442175|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105666403|NCT00706654|364442176|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105666404|NCT00706654|364442177|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105666405|NCT00706654|364442174|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
105666406|NCT00706654|364442175|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105666407|NCT00706654|364442176|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105666408|NCT00706654|364442177|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105666409|NCT00706654|364442174|FG000|Oral Stabilization Phase|Withdrew consent|55|||
105666410|NCT00706654|364442175|FG001|Oral Stabilization Phase|Withdrew consent|0|||
105666411|NCT00706654|364442176|FG002|Oral Stabilization Phase|Withdrew consent|0|||
105666412|NCT00706654|364442177|FG003|Oral Stabilization Phase|Withdrew consent|0|||
105666413|NCT00706654|364442174|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
105666414|NCT00706654|364442175|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
105666415|NCT00706654|364442176|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
105666416|NCT00706654|364442177|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
105666417|NCT00706654|364442174|FG000|Oral Stabilization Phase|Adverse Event|21|||
105666418|NCT00706654|364442175|FG001|Oral Stabilization Phase|Adverse Event|0|||
105666419|NCT00706654|364442176|FG002|Oral Stabilization Phase|Adverse Event|0|||
105666420|NCT00706654|364442177|FG003|Oral Stabilization Phase|Adverse Event|0|||
105666421|NCT00706654|364442174|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
105666422|NCT00706654|364442175|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105666423|NCT00706654|364442176|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105666424|NCT00706654|364442177|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105666425|NCT00706654|364442174|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
105666426|NCT00706654|364442175|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105666427|NCT00706654|364442176|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105666428|NCT00706654|364442177|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105895333|NCT01752634|365271698|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
105895334|NCT01752634|365271699|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
105895335|NCT01752634|365271700|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
105895336|NCT01752634|365271701|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
105895337|NCT01752634|365271702|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
105895338|NCT01752634|365271697|FG000|Week 24 to Week 260|Adverse Event|4|||
105895339|NCT01752634|365271698|FG001|Week 24 to Week 260|Adverse Event|8|||
105895340|NCT01752634|365271699|FG002|Week 24 to Week 260|Adverse Event|8|||
105666429|NCT00706654|364442174|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
105666430|NCT00706654|364442175|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
105895341|NCT01752634|365271700|FG003|Week 24 to Week 260|Adverse Event|4|||
105895342|NCT01752634|365271701|FG004|Week 24 to Week 260|Adverse Event|2|||
105666431|NCT00706654|364442176|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
105666432|NCT00706654|364442177|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
105666433|NCT00706654|364442174|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
105666434|NCT00706654|364442175|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
105666435|NCT00706654|364442176|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
105666436|NCT00706654|364442177|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
105666437|NCT00706654|364442174|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
105666438|NCT00706654|364442175|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
105666439|NCT00706654|364442176|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
105666440|NCT00706654|364442177|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
105666441|NCT00706654|364442174|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
105666442|NCT00706654|364442175|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
105666443|NCT00706654|364442176|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
105666444|NCT00706654|364442177|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
105666445|NCT00706654|364442174|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
105666446|NCT00706654|364442175|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
105666447|NCT00706654|364442176|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
105666448|NCT00706654|364442177|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
105666449|NCT00706654|364442174|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
105666450|NCT00706654|364442175|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
105666451|NCT00706654|364442176|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
105666452|NCT00706654|364442177|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
105666453|NCT00706654|364442174|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
105666454|NCT00706654|364442175|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
105666455|NCT00706654|364442176|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
105666456|NCT00706654|364442177|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
105666457|NCT00706654|364442174|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
105666458|NCT00706654|364442175|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
105666459|NCT00706654|364442176|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
105666460|NCT00706654|364442177|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
105666461|NCT02975102|364442183|FG000|Overall Study|Adverse Event|2|||
105666462|NCT02975102|364442184|FG001|Overall Study|Adverse Event|1|||
105666463|NCT01001390|364442190|FG000|Overall Study|Failure to wear AFO device|2|||
105666464|NCT01001390|364442191|FG001|Overall Study|Failure to wear AFO device|0|||
105666465|NCT01430468|364442199|FG000|Overall Study|Physician Decision|2|||
105666466|NCT01430468|364442200|FG001|Overall Study|Physician Decision|1|||
105666467|NCT01430468|364442199|FG000|Overall Study|Withdrawal by Subject|5|||
105666468|NCT01430468|364442200|FG001|Overall Study|Withdrawal by Subject|5|||
105666469|NCT01294436|364442201|FG000|Overall Study|Adverse Event|10|||
105666470|NCT01294436|364442202|FG001|Overall Study|Adverse Event|17|||
105666471|NCT01294436|364442201|FG000|Overall Study|Withdrawal by Subject|11|||
105666472|NCT01294436|364442202|FG001|Overall Study|Withdrawal by Subject|28|||
105666473|NCT01294436|364442201|FG000|Overall Study|subject no longer meets study criteria|5|||
105666474|NCT01294436|364442202|FG001|Overall Study|subject no longer meets study criteria|20|||
105666475|NCT01294436|364442201|FG000|Overall Study|poor/non-compliance|2|||
105666476|NCT01294436|364442202|FG001|Overall Study|poor/non-compliance|5|||
105666477|NCT02389764|364442203|FG000|Overall Study|Lack of Efficacy|9|||
105666478|NCT04978090|364442204|FG000|Overall Study|unable to adequately fit device|2|||
105666479|NCT00996606|364442206|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
105666480|NCT00996606|364442206|FG000|Overall Study|Insufficient Therapeutic Response|2|||
105666481|NCT00996606|364442206|FG000|Overall Study|Protocol Violation|1|||
105666482|NCT00996606|364442206|FG000|Overall Study|Withdrawal by Subject|3|||
105666483|NCT00978562|364442211|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
105666484|NCT00632502|364442212|FG000|Overall Study|Adverse Event|0|||
105666485|NCT00632502|364442213|FG001|Overall Study|Adverse Event|1|||
105666486|NCT00632502|364442212|FG000|Overall Study|Randomized not treated|3|||
105666487|NCT00632502|364442213|FG001|Overall Study|Randomized not treated|0|||
105666488|NCT01213524|364442214|FG000|Baseline|Withdrawal by Subject|5|||
106123264|NCT01091428|366109671|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
106123265|NCT01091428|366109672|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
106123266|NCT01091428|366109673|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
106123267|NCT01091428|366109674|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
106123268|NCT01091428|366109671|FG000|Phase 2|Reason not specified|0|||
105666489|NCT01213524|364442214|FG000|Baseline|high breath alcohol levels|1|||
105666490|NCT01213524|364442214|FG000|Baseline|Physician Decision|1|||
105666491|NCT01213524|364442214|FG000|Session 2|Withdrawal by Subject|5|||
105666492|NCT01213524|364442214|FG000|Session 3|Withdrawal by Subject|4|||
105895343|NCT01752634|365271702|FG005|Week 24 to Week 260|Adverse Event|0|||
105895344|NCT02879994|365271707|FG000|Overall Study|off treatment early|7|||
105895345|NCT02879994|365271707|FG000|Overall Study|Adverse Event|2|||
106123269|NCT01091428|366109672|FG001|Phase 2|Reason not specified|0|||
105895346|NCT02879994|365271707|FG000|Overall Study|Death|2|||
105666493|NCT01213524|364442214|FG000|Session 4|Physician Decision|1|||
105666494|NCT01213524|364442214|FG000|Session 4|Withdrawal by Subject|2|||
105666495|NCT00281320|364442215|FG000|Overall Study|Adverse Event|12|||
105666496|NCT00281320|364442216|FG001|Overall Study|Adverse Event|9|||
105666497|NCT00281320|364442215|FG000|Overall Study|Lack of Efficacy|4|||
105666498|NCT00281320|364442216|FG001|Overall Study|Lack of Efficacy|3|||
105666499|NCT00281320|364442215|FG000|Overall Study|Withdrawal by Subject|5|||
105666500|NCT00281320|364442216|FG001|Overall Study|Withdrawal by Subject|6|||
105666501|NCT00281320|364442215|FG000|Overall Study|Lost to Follow-up|1|||
105666502|NCT00281320|364442216|FG001|Overall Study|Lost to Follow-up|2|||
105666503|NCT00281320|364442215|FG000|Overall Study|Other|3|||
105666504|NCT00281320|364442216|FG001|Overall Study|Other|1|||
105666505|NCT03128671|364442221|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
105666506|NCT03128671|364442222|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
105666507|NCT03128671|364442221|FG000|Allocation|Death|1|||
105666508|NCT03128671|364442222|FG001|Allocation|Death|0|||
105666509|NCT03128671|364442221|FG000|Allocation|Withdrawal by Subject|4|||
105666510|NCT03128671|364442222|FG001|Allocation|Withdrawal by Subject|0|||
105666511|NCT03128671|364442221|FG000|Intervention|Withdrawal by Subject|11|||
105666512|NCT03128671|364442222|FG001|Intervention|Withdrawal by Subject|10|||
105666513|NCT03128671|364442221|FG000|Intervention|Palliative/hospice care initiated|9|||
105666514|NCT03128671|364442222|FG001|Intervention|Palliative/hospice care initiated|10|||
105666515|NCT03128671|364442221|FG000|Intervention|Death|13|||
105666516|NCT03128671|364442222|FG001|Intervention|Death|11|||
105666517|NCT03128671|364442221|FG000|Intervention|Interrupted by hurricane|1|||
105666518|NCT03128671|364442222|FG001|Intervention|Interrupted by hurricane|0|||
105666519|NCT03128671|364442221|FG000|Intervention|Physician Decision|2|||
105666520|NCT03128671|364442222|FG001|Intervention|Physician Decision|3|||
105666521|NCT00862836|364442224|FG000|Overall Study|Withdrawal by Subject|1|||
105666522|NCT00486252|364442226|FG000|Overall Study|Adverse Event|7|||
105666523|NCT00486252|364442226|FG000|Overall Study|Lack of Efficacy|9|||
105666524|NCT00486252|364442226|FG000|Overall Study|Lost to Follow-up|24|||
105666525|NCT00486252|364442226|FG000|Overall Study|Other|18|||
105666526|NCT01261247|364442227|FG000|Overall Study|Ineligible|2|||
105666527|NCT03277352|364442234|FG000|Overall Study|Study Terminated By Sponsor|2|||
105666528|NCT03277352|364442234|FG000|Overall Study|Withdrawal by Subject|4|||
105666529|NCT03277352|364442234|FG000|Overall Study|Death|4|||
105666530|NCT02397447|364442236|FG000|Overall Study|Lost to Follow-up|2|||
105666531|NCT02397447|364442237|FG001|Overall Study|Lost to Follow-up|2|||
105666532|NCT01435772|364442238|FG000|Overall Study|Adverse Event|1|||
105666533|NCT01435772|364442239|FG001|Overall Study|Adverse Event|0|||
105666534|NCT01435772|364442240|FG002|Overall Study|Adverse Event|2|||
105666535|NCT01435772|364442238|FG000|Overall Study|Withdrawal by Subject|0|||
105666536|NCT01435772|364442239|FG001|Overall Study|Withdrawal by Subject|1|||
105666537|NCT01435772|364442240|FG002|Overall Study|Withdrawal by Subject|3|||
105666538|NCT01435772|364442238|FG000|Overall Study|Other - study termination|2|||
105666539|NCT01435772|364442239|FG001|Overall Study|Other - study termination|2|||
105666540|NCT01435772|364442240|FG002|Overall Study|Other - study termination|10|||
105666541|NCT05823012|364442241|FG000|Titration Period|Adverse Event|1|||
105666542|NCT05823012|364442241|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
105666543|NCT05823012|364442241|FG000|Maintenance Period|Adverse Event|1|||
105666544|NCT05823012|364442241|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
105666545|NCT05823012|364442241|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
105666546|NCT02419417|364443974|FG000|Overall Study|Disease progression|5|||
105666547|NCT02419417|364443975|FG001|Overall Study|Disease progression|4|||
106123270|NCT01091428|366109673|FG002|Phase 2|Reason not specified|4|||
106123271|NCT01091428|366109674|FG003|Phase 2|Reason not specified|3|||
105666548|NCT02419417|364443976|FG002|Overall Study|Disease progression|13|||
105666549|NCT02419417|364443977|FG003|Overall Study|Disease progression|10|||
105666550|NCT02419417|364443978|FG004|Overall Study|Disease progression|10|||
106123272|NCT01091428|366109671|FG000|Phase 2|Physician Decision|0|||
106123273|NCT01091428|366109672|FG001|Phase 2|Physician Decision|0|||
105666551|NCT02419417|364443979|FG005|Overall Study|Disease progression|3|||
105666552|NCT02419417|364443980|FG006|Overall Study|Disease progression|4|||
105666553|NCT02419417|364443981|FG007|Overall Study|Disease progression|5|||
105666554|NCT02419417|364443982|FG008|Overall Study|Disease progression|13|||
105666555|NCT02419417|364443983|FG009|Overall Study|Disease progression|9|||
105666556|NCT02419417|364443984|FG010|Overall Study|Disease progression|0|||
105666557|NCT02419417|364443974|FG000|Overall Study|Study drug toxicity|0|||
105666558|NCT02419417|364443975|FG001|Overall Study|Study drug toxicity|0|||
106123274|NCT01091428|366109673|FG002|Phase 2|Physician Decision|2|||
106123275|NCT01091428|366109674|FG003|Phase 2|Physician Decision|0|||
105666559|NCT02419417|364443976|FG002|Overall Study|Study drug toxicity|0|||
105666560|NCT02419417|364443977|FG003|Overall Study|Study drug toxicity|0|||
105666561|NCT02419417|364443978|FG004|Overall Study|Study drug toxicity|1|||
105666562|NCT02419417|364443979|FG005|Overall Study|Study drug toxicity|0|||
105666563|NCT02419417|364443980|FG006|Overall Study|Study drug toxicity|0|||
105666564|NCT02419417|364443981|FG007|Overall Study|Study drug toxicity|0|||
106123276|NCT03518658|366109675|FG000|Overall Study|Other|51|||
105895347|NCT04392167|365271708|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
105895348|NCT02963558|365271710|FG000|Overall Study|Withdrawn by investigator|1|||
105666565|NCT02419417|364443982|FG008|Overall Study|Study drug toxicity|0|||
105666566|NCT02419417|364443983|FG009|Overall Study|Study drug toxicity|0|||
105666567|NCT02419417|364443984|FG010|Overall Study|Study drug toxicity|0|||
105666568|NCT02419417|364443974|FG000|Overall Study|Adverse event unrelated to study drug|0|||
105666569|NCT02419417|364443975|FG001|Overall Study|Adverse event unrelated to study drug|0|||
105666570|NCT02419417|364443976|FG002|Overall Study|Adverse event unrelated to study drug|0|||
105666571|NCT02419417|364443977|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105666572|NCT02419417|364443978|FG004|Overall Study|Adverse event unrelated to study drug|2|||
105666573|NCT02419417|364443979|FG005|Overall Study|Adverse event unrelated to study drug|1|||
105666574|NCT02419417|364443980|FG006|Overall Study|Adverse event unrelated to study drug|0|||
105666575|NCT02419417|364443981|FG007|Overall Study|Adverse event unrelated to study drug|1|||
105666576|NCT02419417|364443982|FG008|Overall Study|Adverse event unrelated to study drug|0|||
105666577|NCT02419417|364443983|FG009|Overall Study|Adverse event unrelated to study drug|0|||
105666578|NCT02419417|364443984|FG010|Overall Study|Adverse event unrelated to study drug|0|||
105666579|NCT02419417|364443974|FG000|Overall Study|Participant request to discontinue|0|||
105666580|NCT02419417|364443975|FG001|Overall Study|Participant request to discontinue|0|||
105666581|NCT02419417|364443976|FG002|Overall Study|Participant request to discontinue|0|||
105666582|NCT02419417|364443977|FG003|Overall Study|Participant request to discontinue|0|||
105666583|NCT02419417|364443978|FG004|Overall Study|Participant request to discontinue|0|||
105666584|NCT02419417|364443979|FG005|Overall Study|Participant request to discontinue|0|||
105666585|NCT02419417|364443980|FG006|Overall Study|Participant request to discontinue|0|||
105666586|NCT02419417|364443981|FG007|Overall Study|Participant request to discontinue|0|||
105666587|NCT02419417|364443982|FG008|Overall Study|Participant request to discontinue|0|||
105666588|NCT02419417|364443983|FG009|Overall Study|Participant request to discontinue|1|||
105666589|NCT02419417|364443984|FG010|Overall Study|Participant request to discontinue|0|||
105666590|NCT02419417|364443974|FG000|Overall Study|Withdrawal by Subject|0|||
105666591|NCT02419417|364443975|FG001|Overall Study|Withdrawal by Subject|0|||
105666592|NCT02419417|364443976|FG002|Overall Study|Withdrawal by Subject|0|||
105666593|NCT02419417|364443977|FG003|Overall Study|Withdrawal by Subject|0|||
105666594|NCT02419417|364443978|FG004|Overall Study|Withdrawal by Subject|0|||
105666595|NCT02419417|364443979|FG005|Overall Study|Withdrawal by Subject|0|||
105666596|NCT02419417|364443980|FG006|Overall Study|Withdrawal by Subject|0|||
105666597|NCT02419417|364443981|FG007|Overall Study|Withdrawal by Subject|0|||
105666598|NCT02419417|364443982|FG008|Overall Study|Withdrawal by Subject|0|||
105666599|NCT02419417|364443983|FG009|Overall Study|Withdrawal by Subject|0|||
105666600|NCT02419417|364443984|FG010|Overall Study|Withdrawal by Subject|1|||
105666601|NCT01730950|364443992|FG000|Overall Study|Protocol Violation|6|||
105666602|NCT01730950|364443993|FG001|Overall Study|Protocol Violation|6|||
105666603|NCT00667459|364443994|FG000|Overall Study|Death|0|||
105666604|NCT00667459|364443995|FG001|Overall Study|Death|2|||
105666605|NCT00667459|364443994|FG000|Overall Study|Lost to Follow-up|8|||
105666606|NCT00667459|364443995|FG001|Overall Study|Lost to Follow-up|43|||
105666607|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
105666608|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
105666609|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
105666610|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
105666611|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
105666612|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
105666613|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
105666614|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
105666615|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
105666616|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
105666617|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
105666618|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
105895349|NCT02963558|365271711|FG001|Overall Study|Withdrawn by investigator|0|||
105895350|NCT02963558|365271710|FG000|Overall Study|Withdrawal by Subject|0|||
105895351|NCT02963558|365271711|FG001|Overall Study|Withdrawal by Subject|1|||
105666619|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
105666620|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
105666621|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
105666622|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
105666623|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
105666624|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
105895352|NCT03117881|365271716|FG000|Baseline|Withdrawal by Subject|21|||
105895353|NCT03117881|365271717|FG001|Baseline|Withdrawal by Subject|10|||
105895354|NCT03117881|365271718|FG002|Baseline|Withdrawal by Subject|0|||
105895355|NCT03117881|365271716|FG000|Baseline|Lost to Follow-up|22|||
105666625|NCT00132678|364444004|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
105666626|NCT00132678|364444005|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
105666627|NCT00132678|364444006|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
105666628|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Death|2|||
105895356|NCT03117881|365271717|FG001|Baseline|Lost to Follow-up|25|||
105895357|NCT03117881|365271718|FG002|Baseline|Lost to Follow-up|0|||
105895358|NCT03117881|365271716|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
106123277|NCT03518658|366109676|FG001|Overall Study|Other|0|||
106123278|NCT00312858|366109684|FG000|Overall Study|Adverse Event|0|||
106123279|NCT00312858|366109685|FG001|Overall Study|Adverse Event|1|||
106123280|NCT00312858|366109684|FG000|Overall Study|Lost to Follow-up|25|||
106123281|NCT00312858|366109685|FG001|Overall Study|Lost to Follow-up|42|||
106123282|NCT00312858|366109684|FG000|Overall Study|Protocol Violation|3|||
106123283|NCT00312858|366109685|FG001|Overall Study|Protocol Violation|8|||
106123284|NCT00312858|366109684|FG000|Overall Study|Withdraw by Participant|20|||
106123285|NCT00312858|366109685|FG001|Overall Study|Withdraw by Participant|20|||
106123286|NCT00312858|366109684|FG000|Overall Study|Participant Moved|11|||
106123287|NCT00312858|366109685|FG001|Overall Study|Participant Moved|10|||
106123288|NCT00312858|366109684|FG000|Overall Study|Other|9|||
106123289|NCT00312858|366109685|FG001|Overall Study|Other|12|||
106123290|NCT00802659|366109687|FG000|Overall Study|Physician Decision|0|||
106123291|NCT00802659|366109688|FG001|Overall Study|Physician Decision|1|||
106123292|NCT00802659|366109689|FG002|Overall Study|Physician Decision|0|||
106123293|NCT00802659|366109690|FG003|Overall Study|Physician Decision|0|||
106123294|NCT00289770|366109691|FG000|Year 15|Withdrawal by Subject|1|||
106123295|NCT00154063|366109692|FG000|Overall Study|Adverse Event|4|||
106123296|NCT00154063|366109693|FG001|Overall Study|Adverse Event|8|||
106123297|NCT00154063|366109692|FG000|Overall Study|Protocol Violation|1|||
106123298|NCT00154063|366109693|FG001|Overall Study|Protocol Violation|1|||
106123299|NCT00154063|366109692|FG000|Overall Study|Investigator or Sponsor Request|0|||
106123300|NCT00154063|366109693|FG001|Overall Study|Investigator or Sponsor Request|1|||
106123301|NCT00154063|366109692|FG000|Overall Study|Withdrawal by Subject|4|||
106123302|NCT00154063|366109693|FG001|Overall Study|Withdrawal by Subject|9|||
106123303|NCT00154063|366109692|FG000|Overall Study|Other|3|||
106123304|NCT00154063|366109693|FG001|Overall Study|Other|3|||
106123305|NCT01804673|366109694|FG000|Overall Study|Adverse Event|4|||
106123306|NCT01804673|366109694|FG000|Overall Study|Withdrawal by Subject|1|||
106123307|NCT01804673|366109694|FG000|Overall Study|Lack of Efficacy|9|||
106123308|NCT01804673|366109694|FG000|Overall Study|Change to Oral Therapy|37|||
106123309|NCT01804673|366109694|FG000|Overall Study|No Further Therapy Required|84|||
106123310|NCT01804673|366109694|FG000|Overall Study|Use of Prohibited Medication|1|||
106123311|NCT01804673|366109694|FG000|Overall Study|Other|4|||
106123312|NCT01622348|366109697|FG000|Overall Study|Withdrawal by Subject|1|||
106123313|NCT01622348|366109698|FG001|Overall Study|Withdrawal by Subject|0|||
106123314|NCT01622348|366109699|FG002|Overall Study|Withdrawal by Subject|1|||
106123315|NCT04747275|366109700|FG000|Overall Study|Study terminated|0|||
106123316|NCT04747275|366109701|FG001|Overall Study|Study terminated|1|||
106123317|NCT00531011|366109702|FG000|Overall Study|Withdrawal by Subject|2|||
106123318|NCT00531011|366109703|FG001|Overall Study|Withdrawal by Subject|4|||
106123319|NCT00531011|366109702|FG000|Overall Study|Death|1|||
106123320|NCT00531011|366109703|FG001|Overall Study|Death|0|||
106123321|NCT00531011|366109702|FG000|Overall Study|Lost to Follow-up|1|||
106123322|NCT00531011|366109703|FG001|Overall Study|Lost to Follow-up|0|||
106123323|NCT00531011|366109702|FG000|Overall Study|Physician Decision|0|||
106123324|NCT00531011|366109703|FG001|Overall Study|Physician Decision|3|||
106123325|NCT00919893|366109708|FG000|Overall Study|Protocol Violation|19|||
106123326|NCT00919893|366109709|FG001|Overall Study|Protocol Violation|9|||
106123327|NCT00390455|366109714|FG000|Overall Study|Adverse Event|17|||
106123328|NCT00390455|366109715|FG001|Overall Study|Adverse Event|3|||
106123329|NCT00390455|366109714|FG000|Overall Study|Withdrawal by Subject|8|||
106123330|NCT00390455|366109715|FG001|Overall Study|Withdrawal by Subject|8|||
106123331|NCT00390455|366109714|FG000|Overall Study|Alternate Treatment|0|||
106123332|NCT00390455|366109715|FG001|Overall Study|Alternate Treatment|1|||
106123333|NCT00390455|366109714|FG000|Overall Study|Other Medical Reasons|7|||
106123334|NCT00390455|366109715|FG001|Overall Study|Other Medical Reasons|11|||
106123335|NCT04012814|366109716|FG000|Overall Study|Lost to Follow-up|4|||
106123336|NCT04012814|366109716|FG000|Overall Study|Withdrawal by Subject|2|||
106123337|NCT04012814|366109716|FG000|Overall Study|Protocol Violation|1|||
106123338|NCT04012814|366109716|FG000|Overall Study|Adverse Event|1|||
106123339|NCT04397523|366109717|FG000|Overall Study|Lost to Follow-up|3|||
106123340|NCT04397523|366109717|FG000|Overall Study|Transfer from/to other hospital|8|||
106123341|NCT04076020|366109724|FG000|Overall Study|Death|4|||
106123342|NCT04076020|366109725|FG001|Overall Study|Death|6|||
106123343|NCT04076020|366109724|FG000|Overall Study|Withdrawal by Subject|12|||
106123344|NCT04076020|366109725|FG001|Overall Study|Withdrawal by Subject|8|||
106123345|NCT02406261|366109726|FG000|Period 1|Lost to Follow-up|2|||
106123346|NCT02406261|366109727|FG001|Period 1|Lost to Follow-up|0|||
106123347|NCT02406261|366109726|FG000|Period 1|Adverse Event|1|||
106123348|NCT02406261|366109727|FG001|Period 1|Adverse Event|0|||
106123349|NCT02406261|366109726|FG000|Period 2|Physician Decision|0|||
105895359|NCT03117881|365271717|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
106123350|NCT02406261|366109727|FG001|Period 2|Physician Decision|1|||
106123351|NCT02406261|366109726|FG000|Period 2|Protocol Violation|0|||
106123352|NCT02406261|366109727|FG001|Period 2|Protocol Violation|1|||
106123353|NCT02406261|366109726|FG000|Period 2|Withdrawal by Subject|0|||
106123354|NCT02406261|366109727|FG001|Period 2|Withdrawal by Subject|1|||
106123355|NCT02572817|366109728|FG000|Overall Study|Death|6|||
106123356|NCT02572817|366109729|FG001|Overall Study|Death|3|||
106123357|NCT02572817|366109728|FG000|Overall Study|Lost to Follow-up|3|||
106123358|NCT02572817|366109729|FG001|Overall Study|Lost to Follow-up|3|||
106123359|NCT02310126|366109730|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
106123360|NCT02310126|366109731|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
106123361|NCT02310126|366109730|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
106123362|NCT02310126|366109731|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
106123363|NCT00672958|366109742|FG000|Overall Study|Adverse Event|11|||
106123364|NCT00672958|366109743|FG001|Overall Study|Adverse Event|9|||
106123365|NCT00672958|366109742|FG000|Overall Study|Lack of Efficacy|6|||
106123366|NCT00672958|366109743|FG001|Overall Study|Lack of Efficacy|11|||
106123367|NCT00672958|366109742|FG000|Overall Study|Non-compliance with study drug|2|||
106123368|NCT00672958|366109743|FG001|Overall Study|Non-compliance with study drug|3|||
106123369|NCT00672958|366109742|FG000|Overall Study|Protocol deviations|11|||
106123370|NCT00672958|366109743|FG001|Overall Study|Protocol deviations|5|||
106123371|NCT00672958|366109742|FG000|Overall Study|Voluntary withdrawal|12|||
106123372|NCT00672958|366109743|FG001|Overall Study|Voluntary withdrawal|8|||
106123373|NCT00672958|366109742|FG000|Overall Study|Lost to Follow-up|22|||
106123374|NCT00672958|366109743|FG001|Overall Study|Lost to Follow-up|17|||
106123375|NCT00672958|366109742|FG000|Overall Study|Reason not specified|0|||
106123376|NCT00672958|366109743|FG001|Overall Study|Reason not specified|3|||
106123377|NCT01630590|366109747|FG000|Overall Study|Adverse Event|9|||
106123378|NCT01630590|366109747|FG000|Overall Study|Lack of Efficacy|37|||
106123379|NCT01630590|366109747|FG000|Overall Study|Withdrawal by Subject|4|||
106123380|NCT01630590|366109747|FG000|Overall Study|2nd primary tumor|2|||
106123381|NCT01630590|366109747|FG000|Overall Study|Automobile accident|1|||
106123382|NCT01630590|366109747|FG000|Overall Study|Maximum benefit|4|||
106123383|NCT02293837|366109750|FG000|Overall Study|Lost to Follow-up|0|||
106123384|NCT02293837|366109751|FG001|Overall Study|Lost to Follow-up|2|||
106123385|NCT02293837|366109752|FG002|Overall Study|Lost to Follow-up|1|||
106123386|NCT02293837|366109753|FG003|Overall Study|Lost to Follow-up|0|||
106123387|NCT02293837|366109750|FG000|Overall Study|Withdrawal by Subject|2|||
106123388|NCT02293837|366109751|FG001|Overall Study|Withdrawal by Subject|1|||
106123389|NCT02293837|366109752|FG002|Overall Study|Withdrawal by Subject|2|||
106123390|NCT02293837|366109753|FG003|Overall Study|Withdrawal by Subject|1|||
106123391|NCT02293837|366109750|FG000|Overall Study|COVID-19 Related|1|||
106123392|NCT02293837|366109751|FG001|Overall Study|COVID-19 Related|1|||
106123393|NCT02293837|366109752|FG002|Overall Study|COVID-19 Related|0|||
106123394|NCT02293837|366109753|FG003|Overall Study|COVID-19 Related|0|||
106123395|NCT02293837|366109750|FG000|Overall Study|Participant ill and could not be infused|0|||
106123396|NCT02293837|366109751|FG001|Overall Study|Participant ill and could not be infused|0|||
106123397|NCT02293837|366109752|FG002|Overall Study|Participant ill and could not be infused|1|||
106123398|NCT02293837|366109753|FG003|Overall Study|Participant ill and could not be infused|0|||
106123399|NCT04779242|366109754|FG000|Overall Study|Adverse Event|1|||
106123400|NCT04779242|366109755|FG001|Overall Study|Adverse Event|1|||
106123401|NCT04779242|366109754|FG000|Overall Study|Lost to Follow-up|2|||
106123402|NCT04779242|366109755|FG001|Overall Study|Lost to Follow-up|4|||
106123403|NCT04779242|366109754|FG000|Overall Study|Withdrawal by Subject|7|||
106123404|NCT04779242|366109755|FG001|Overall Study|Withdrawal by Subject|9|||
106123405|NCT04779242|366109754|FG000|Overall Study|Death|6|||
106123406|NCT04779242|366109755|FG001|Overall Study|Death|6|||
106123407|NCT04779242|366109754|FG000|Overall Study|COVID-19 related reasons|2|||
106123408|NCT04779242|366109755|FG001|Overall Study|COVID-19 related reasons|1|||
106123409|NCT04779242|366109754|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
106123410|NCT04779242|366109755|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
106123411|NCT04779242|366109754|FG000|Overall Study|Martial Law in Ukraine|2|||
106123412|NCT04779242|366109755|FG001|Overall Study|Martial Law in Ukraine|3|||
106123413|NCT00849680|366109756|FG000|Overall Study|Adverse Event|0|||
106123414|NCT00849680|366109757|FG001|Overall Study|Adverse Event|0|||
106123415|NCT00849680|366109758|FG002|Overall Study|Adverse Event|0|||
106123416|NCT00849680|366109759|FG003|Overall Study|Adverse Event|0|||
106123417|NCT00849680|366109760|FG004|Overall Study|Adverse Event|0|||
106123418|NCT00849680|366109761|FG005|Overall Study|Adverse Event|0|||
106123419|NCT00849680|366109762|FG006|Overall Study|Adverse Event|2|||
106123420|NCT00849680|366109763|FG007|Overall Study|Adverse Event|0|||
106123421|NCT00849680|366109756|FG000|Overall Study|Lost to Follow-up|7|||
106123422|NCT00849680|366109757|FG001|Overall Study|Lost to Follow-up|3|||
106123423|NCT00849680|366109758|FG002|Overall Study|Lost to Follow-up|12|||
105666629|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Death|0|||
105666630|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Death|0|||
105666631|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
105666632|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
105666633|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
105895360|NCT03117881|365271718|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
105895361|NCT03117881|365271716|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
105895362|NCT03117881|365271717|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
105895363|NCT03117881|365271718|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
105895364|NCT03117881|365271716|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
105895365|NCT03117881|365271717|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
105895366|NCT03117881|365271718|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
105895367|NCT03117881|365271716|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
105895368|NCT03117881|365271717|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
105666634|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
105895369|NCT03117881|365271718|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
105895370|NCT03117881|365271716|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
105895371|NCT03117881|365271717|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
105895372|NCT03117881|365271718|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
105895373|NCT03117881|365271716|FG000|6-Month Follow-Up|Did not complete test|53|||
105895374|NCT03117881|365271717|FG001|6-Month Follow-Up|Did not complete test|25|||
105895375|NCT03117881|365271718|FG002|6-Month Follow-Up|Did not complete test|7|||
105895376|NCT03117881|365271716|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
105895377|NCT03117881|365271717|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
105895378|NCT03117881|365271718|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
105895379|NCT03117881|365271716|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
105895380|NCT03117881|365271717|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
105895381|NCT03117881|365271718|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
105895382|NCT03117881|365271716|FG000|12-Month Follow-Up|Did not complete test|40|||
105895383|NCT03117881|365271717|FG001|12-Month Follow-Up|Did not complete test|0|||
105895384|NCT03117881|365271718|FG002|12-Month Follow-Up|Did not complete test|0|||
105895385|NCT00552032|365271720|FG000|Overall Study|Withdrawal by Subject|2|||
105895386|NCT00552032|365271721|FG001|Overall Study|Withdrawal by Subject|2|||
105895387|NCT00552032|365271720|FG000|Overall Study|Protocol Violation|7|||
105895388|NCT00552032|365271721|FG001|Overall Study|Protocol Violation|12|||
105895389|NCT00552032|365271720|FG000|Overall Study|Lost to Follow-up|8|||
105895390|NCT00552032|365271721|FG001|Overall Study|Lost to Follow-up|5|||
105895391|NCT01643798|365271724|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
105895392|NCT01643798|365271725|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
105895393|NCT01027897|365271726|FG000|Overall Study|Protocol Violation|1|||
105895394|NCT01027897|365271726|FG000|Overall Study|Withdrawal by Subject|1|||
105895395|NCT01911780|365271729|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
106123424|NCT00849680|366109759|FG003|Overall Study|Lost to Follow-up|11|||
106123425|NCT00849680|366109760|FG004|Overall Study|Lost to Follow-up|8|||
106123426|NCT00849680|366109761|FG005|Overall Study|Lost to Follow-up|11|||
106123427|NCT00849680|366109762|FG006|Overall Study|Lost to Follow-up|12|||
106123428|NCT00849680|366109763|FG007|Overall Study|Lost to Follow-up|5|||
106123429|NCT00849680|366109756|FG000|Overall Study|Subject moved|1|||
106123430|NCT00849680|366109757|FG001|Overall Study|Subject moved|0|||
106123431|NCT00849680|366109758|FG002|Overall Study|Subject moved|3|||
106123432|NCT00849680|366109759|FG003|Overall Study|Subject moved|1|||
106123433|NCT00849680|366109760|FG004|Overall Study|Subject moved|0|||
106123434|NCT00849680|366109761|FG005|Overall Study|Subject moved|2|||
106123435|NCT00849680|366109762|FG006|Overall Study|Subject moved|2|||
106123436|NCT00849680|366109763|FG007|Overall Study|Subject moved|2|||
106123437|NCT00849680|366109756|FG000|Overall Study|Withdrawal by Subject|2|||
106123438|NCT00849680|366109757|FG001|Overall Study|Withdrawal by Subject|0|||
106123439|NCT00849680|366109758|FG002|Overall Study|Withdrawal by Subject|0|||
106123440|NCT00849680|366109759|FG003|Overall Study|Withdrawal by Subject|2|||
106123441|NCT00849680|366109760|FG004|Overall Study|Withdrawal by Subject|2|||
106123442|NCT00849680|366109761|FG005|Overall Study|Withdrawal by Subject|2|||
106123443|NCT00849680|366109762|FG006|Overall Study|Withdrawal by Subject|1|||
106123444|NCT00849680|366109763|FG007|Overall Study|Withdrawal by Subject|1|||
106123445|NCT00849680|366109756|FG000|Overall Study|Subject unable to comply with protocol|1|||
106123446|NCT00849680|366109757|FG001|Overall Study|Subject unable to comply with protocol|0|||
105895396|NCT01911780|365271730|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
105895397|NCT01911780|365271729|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
106123447|NCT00849680|366109758|FG002|Overall Study|Subject unable to comply with protocol|0|||
106123448|NCT00849680|366109759|FG003|Overall Study|Subject unable to comply with protocol|0|||
106123449|NCT00849680|366109760|FG004|Overall Study|Subject unable to comply with protocol|0|||
105666635|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
105666636|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
105895398|NCT01911780|365271730|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
105895399|NCT01911780|365271729|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
105895400|NCT01911780|365271730|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
105895401|NCT01911780|365271729|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
105895402|NCT01911780|365271730|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
105895403|NCT01911780|365271729|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
105895404|NCT01911780|365271730|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
105895405|NCT01911780|365271729|FG000|Extension Period (52 Weeks)|Personal reason|1|||
105895406|NCT01911780|365271730|FG001|Extension Period (52 Weeks)|Personal reason|1|||
105895407|NCT00078949|365271731|FG000|Overall Study|No treated|4|||
105895408|NCT00078949|365271732|FG001|Overall Study|No treated|5|||
105895409|NCT00078949|365271733|FG002|Overall Study|No treated|3|||
105895410|NCT00078949|365271734|FG003|Overall Study|No treated|3|||
105895411|NCT02045732|365271735|FG000|Overall Study|At the discretion of the investigator|1|||
105895412|NCT02045732|365271736|FG001|Overall Study|At the discretion of the investigator|1|||
105895413|NCT00473824|365271737|FG000|Overall Study|Virologic Breakthrough|1|||
105895414|NCT00473824|365271738|FG001|Overall Study|Virologic Breakthrough|0|||
105895415|NCT00473824|365271737|FG000|Overall Study|Adverse Event|1|||
105895416|NCT00473824|365271738|FG001|Overall Study|Adverse Event|0|||
105895417|NCT00473824|365271737|FG000|Overall Study|Death|1|||
105895418|NCT00473824|365271738|FG001|Overall Study|Death|0|||
105895419|NCT00473824|365271737|FG000|Overall Study|Lost to Follow-up|1|||
105895420|NCT00473824|365271738|FG001|Overall Study|Lost to Follow-up|0|||
105895421|NCT00473824|365271737|FG000|Overall Study|Withdrawal by physician|1|||
105895422|NCT00473824|365271738|FG001|Overall Study|Withdrawal by physician|0|||
105895423|NCT04105010|365271739|FG000|Overall Study|Death|3|||
105895424|NCT04105010|365271740|FG001|Overall Study|Death|1|||
105895425|NCT04105010|365271741|FG002|Overall Study|Death|1|||
105895426|NCT04105010|365271742|FG003|Overall Study|Death|54|||
105895427|NCT04105010|365271739|FG000|Overall Study|Lost to Follow-up|0|||
105895428|NCT04105010|365271740|FG001|Overall Study|Lost to Follow-up|0|||
105895429|NCT04105010|365271741|FG002|Overall Study|Lost to Follow-up|0|||
105895430|NCT04105010|365271742|FG003|Overall Study|Lost to Follow-up|4|||
105895431|NCT04105010|365271739|FG000|Overall Study|Withdrawal by Subject|8|||
105895432|NCT04105010|365271740|FG001|Overall Study|Withdrawal by Subject|1|||
105895433|NCT04105010|365271741|FG002|Overall Study|Withdrawal by Subject|1|||
105895434|NCT04105010|365271742|FG003|Overall Study|Withdrawal by Subject|4|||
105895435|NCT04105010|365271739|FG000|Overall Study|Other reason|4|||
105895436|NCT04105010|365271740|FG001|Overall Study|Other reason|7|||
105895437|NCT04105010|365271741|FG002|Overall Study|Other reason|0|||
105895438|NCT04105010|365271742|FG003|Overall Study|Other reason|19|||
105895439|NCT02539134|365271746|FG000|Overall Study|Lost to Follow-up|1|||
105895440|NCT02539134|365271747|FG001|Overall Study|Lost to Follow-up|0|||
105895441|NCT02539134|365271748|FG002|Overall Study|Lost to Follow-up|0|||
105895442|NCT02539134|365271749|FG003|Overall Study|Lost to Follow-up|0|||
105895443|NCT02539134|365271750|FG004|Overall Study|Lost to Follow-up|0|||
105895444|NCT02539134|365271751|FG005|Overall Study|Lost to Follow-up|0|||
105895445|NCT00984061|365271752|FG000|Clarithromycin Alone|Protocol Violation|1|||
105895446|NCT02327013|365271753|FG000|Overall Study|Adverse Event|4|||
105895447|NCT02327013|365271754|FG001|Overall Study|Adverse Event|4|||
105895448|NCT02327013|365271755|FG002|Overall Study|Adverse Event|3|||
105895449|NCT02327013|365271756|FG003|Overall Study|Adverse Event|0|||
105895450|NCT02327013|365271757|FG004|Overall Study|Adverse Event|1|||
105895451|NCT02327013|365271753|FG000|Overall Study|Lack of Efficacy|2|||
105895452|NCT02327013|365271754|FG001|Overall Study|Lack of Efficacy|0|||
105895453|NCT02327013|365271755|FG002|Overall Study|Lack of Efficacy|5|||
105895454|NCT02327013|365271756|FG003|Overall Study|Lack of Efficacy|0|||
105895455|NCT02327013|365271757|FG004|Overall Study|Lack of Efficacy|1|||
105895456|NCT02327013|365271753|FG000|Overall Study|Non-compliance with IMP|1|||
105895457|NCT02327013|365271754|FG001|Overall Study|Non-compliance with IMP|2|||
105895458|NCT02327013|365271755|FG002|Overall Study|Non-compliance with IMP|7|||
105895459|NCT02327013|365271756|FG003|Overall Study|Non-compliance with IMP|0|||
105895460|NCT02327013|365271757|FG004|Overall Study|Non-compliance with IMP|0|||
105895461|NCT02327013|365271753|FG000|Overall Study|Withdrawal of Consent|1|||
105895462|NCT02327013|365271754|FG001|Overall Study|Withdrawal of Consent|0|||
105895463|NCT02327013|365271755|FG002|Overall Study|Withdrawal of Consent|3|||
105895464|NCT02327013|365271756|FG003|Overall Study|Withdrawal of Consent|0|||
105895465|NCT02327013|365271757|FG004|Overall Study|Withdrawal of Consent|0|||
105895466|NCT02327013|365271753|FG000|Overall Study|Lost to Follow-up|2|||
105895467|NCT02327013|365271754|FG001|Overall Study|Lost to Follow-up|4|||
105895468|NCT02327013|365271755|FG002|Overall Study|Lost to Follow-up|5|||
105895469|NCT02327013|365271756|FG003|Overall Study|Lost to Follow-up|0|||
105895470|NCT02327013|365271757|FG004|Overall Study|Lost to Follow-up|0|||
105895471|NCT02327013|365271753|FG000|Overall Study|Administrative or other reason(s)|1|||
105895472|NCT02327013|365271754|FG001|Overall Study|Administrative or other reason(s)|5|||
106123450|NCT00849680|366109761|FG005|Overall Study|Subject unable to comply with protocol|0|||
106123451|NCT00849680|366109762|FG006|Overall Study|Subject unable to comply with protocol|0|||
106123452|NCT00849680|366109763|FG007|Overall Study|Subject unable to comply with protocol|0|||
106123453|NCT01556763|366109769|FG000|Overall Study|Withdrawal by Subject|0|||
106123454|NCT01556763|366109770|FG001|Overall Study|Withdrawal by Subject|1|||
106123455|NCT01556763|366109771|FG002|Overall Study|Withdrawal by Subject|0|||
105666637|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
105666638|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
105666639|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
105666640|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
105666641|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
105666642|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
105666643|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
105666644|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
105666645|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
105666646|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
105666647|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
105666648|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
105666649|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
105666650|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
105666651|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
105666652|NCT00132678|364444004|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
105666653|NCT00132678|364444005|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
105666654|NCT00132678|364444006|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
105666655|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
105666656|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
105666657|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
105666658|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
105666659|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
105666660|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
105666661|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
105666662|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
105666663|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
105666664|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
105666665|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
105666666|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
105666667|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
105666668|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
105666669|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
105666670|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
105666671|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
105666672|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
105666673|NCT00132678|364444004|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
105666674|NCT00132678|364444005|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
105666675|NCT00132678|364444006|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
105666676|NCT02056626|364444011|FG000|Overall Study|patient did not follow directions|3|||
105666677|NCT02056626|364444012|FG001|Overall Study|patient did not follow directions|1|||
105666678|NCT02056626|364444013|FG002|Overall Study|patient did not follow directions|0|||
105666679|NCT02056626|364444014|FG003|Overall Study|patient did not follow directions|0|||
105666680|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
105666681|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
105666682|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
105666683|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
105666684|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
105666685|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
105666686|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
105666687|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
105666688|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
105666689|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
105666690|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
105666691|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
105666692|NCT00790400|364444015|FG000|Double-blind Period (Core Phase)|Death|1|||
105666693|NCT00790400|364444016|FG001|Double-blind Period (Core Phase)|Death|0|||
106123456|NCT02258464|366109772|FG000|Overall Study|Progressive disease (PD)|9|||
106123457|NCT02258464|366109773|FG001|Overall Study|Progressive disease (PD)|17|||
106123458|NCT02258464|366109772|FG000|Overall Study|Study drug never administered|1|||
106123459|NCT02258464|366109773|FG001|Overall Study|Study drug never administered|1|||
105666694|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
105666695|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
105666696|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
105666697|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
105666698|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
105666699|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
105666700|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
105666701|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
105666702|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
105666703|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
105666704|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Death|1|||
105666705|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Death|0|||
105666706|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
105666707|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
105666708|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
105666709|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
105666710|NCT00790400|364444015|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
105666711|NCT00790400|364444016|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
105666712|NCT01483144|364444017|FG000|Overall Study|Adverse Event|9|||
105666713|NCT01483144|364444018|FG001|Overall Study|Adverse Event|4|||
105666714|NCT01483144|364444019|FG002|Overall Study|Adverse Event|6|||
105666715|NCT01483144|364444017|FG000|Overall Study|Withdrawal by Subject|0|||
105666716|NCT01483144|364444018|FG001|Overall Study|Withdrawal by Subject|2|||
105666717|NCT01483144|364444019|FG002|Overall Study|Withdrawal by Subject|5|||
105666718|NCT01483144|364444017|FG000|Overall Study|Physician Decision|1|||
105666719|NCT01483144|364444018|FG001|Overall Study|Physician Decision|0|||
105666720|NCT01483144|364444019|FG002|Overall Study|Physician Decision|0|||
105666721|NCT01483144|364444017|FG000|Overall Study|Lost to Follow-up|2|||
105666722|NCT01483144|364444018|FG001|Overall Study|Lost to Follow-up|4|||
105666723|NCT01483144|364444019|FG002|Overall Study|Lost to Follow-up|1|||
105666724|NCT01483144|364444017|FG000|Overall Study|Protocol Violation|3|||
105666725|NCT01483144|364444018|FG001|Overall Study|Protocol Violation|3|||
105666726|NCT01483144|364444019|FG002|Overall Study|Protocol Violation|3|||
105666727|NCT01107899|364444020|FG000|Overall Study|Physician Decision|5|||
105666728|NCT01107899|364444021|FG001|Overall Study|Physician Decision|0|||
105666729|NCT01107899|364444022|FG002|Overall Study|Physician Decision|3|||
105666730|NCT01107899|364444020|FG000|Overall Study|Withdrawal by Subject|0|||
105666731|NCT01107899|364444021|FG001|Overall Study|Withdrawal by Subject|0|||
105666732|NCT01107899|364444022|FG002|Overall Study|Withdrawal by Subject|1|||
105666733|NCT02179177|364444023|FG000|Overall Study|Lost to Follow-up|1|||
105666734|NCT02179177|364444024|FG001|Overall Study|Lost to Follow-up|1|||
105666735|NCT02179177|364444023|FG000|Overall Study|Withdrawal by Subject|1|||
105666736|NCT02179177|364444024|FG001|Overall Study|Withdrawal by Subject|1|||
105666737|NCT03274453|364444027|FG000|Overall Study|Lost to Follow-up|2|||
105666738|NCT03274453|364444028|FG001|Overall Study|Lost to Follow-up|5|||
105666739|NCT03274453|364444029|FG002|Overall Study|Lost to Follow-up|4|||
105666740|NCT03274453|364444030|FG003|Overall Study|Lost to Follow-up|1|||
105997247|NCT02562716|365651407|FG001|Overall Study|Withdrawal unrelated to AE|1|||
105997248|NCT02562716|365651406|FG000|Overall Study|Progression|8|||
105997249|NCT02562716|365651407|FG001|Overall Study|Progression|10|||
105997250|NCT02562716|365651406|FG000|Overall Study|Death|2|||
106123460|NCT02258464|366109772|FG000|Overall Study|AE not related to clinical PD|1|||
106123461|NCT02258464|366109773|FG001|Overall Study|AE not related to clinical PD|3|||
105666741|NCT03274453|364444027|FG000|Overall Study|Physician Decision|2|||
105666742|NCT03274453|364444028|FG001|Overall Study|Physician Decision|0|||
105666743|NCT03274453|364444029|FG002|Overall Study|Physician Decision|0|||
105666744|NCT03274453|364444030|FG003|Overall Study|Physician Decision|3|||
105666745|NCT03274453|364444027|FG000|Overall Study|Surgery Cancelled|0|||
105666746|NCT03274453|364444028|FG001|Overall Study|Surgery Cancelled|1|||
105666747|NCT03274453|364444029|FG002|Overall Study|Surgery Cancelled|0|||
105666748|NCT03274453|364444030|FG003|Overall Study|Surgery Cancelled|0|||
105666749|NCT01516749|364444031|FG000|Active Therapy|Lost to Follow-up|1|||
105666750|NCT01516749|364444031|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
105666751|NCT00351377|364444032|FG000|Overall Study|Adverse Event|5|||
105666752|NCT00351377|364444032|FG000|Overall Study|Death|1|||
105666753|NCT00351377|364444032|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105666754|NCT03845140|364444034|FG000|Overall Study|Participant travelled outside study area|0|||
105666755|NCT03845140|364444035|FG001|Overall Study|Participant travelled outside study area|1|||
105666756|NCT03845140|364444036|FG002|Overall Study|Participant travelled outside study area|0|||
105666757|NCT03845140|364444037|FG003|Overall Study|Participant travelled outside study area|0|||
105666758|NCT03845140|364444038|FG004|Overall Study|Participant travelled outside study area|0|||
105997251|NCT02562716|365651407|FG001|Overall Study|Death|1|||
105666759|NCT03845140|364444039|FG005|Overall Study|Participant travelled outside study area|0|||
105666760|NCT02030002|364444040|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
105666761|NCT02030002|364444040|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
105666762|NCT02030002|364444040|FG000|Follow-up|Lost to Follow-up|2|||
105666763|NCT00447590|364444041|FG000|Overall Study|Withdrawal by Subject|26|||
106123462|NCT02258464|366109772|FG000|Overall Study|Withdrawal by Subject|5|||
106123463|NCT02258464|366109773|FG001|Overall Study|Withdrawal by Subject|4|||
106123464|NCT02258464|366109772|FG000|Overall Study|AE related to clinical PD|1|||
106123465|NCT02258464|366109773|FG001|Overall Study|AE related to clinical PD|0|||
106123466|NCT02337478|366109774|FG000|Overall Study|Lack of Efficacy|5|||
106123467|NCT04170296|366109775|FG000|Overall Study|Adverse Event|1|||
106123468|NCT04170296|366109776|FG001|Overall Study|Adverse Event|0|||
105666764|NCT00447590|364444041|FG000|Overall Study|Lost to Follow-up|24|||
105666765|NCT00447590|364444041|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
105666766|NCT01967069|364444042|FG000|Overall Study|Adverse Event|2|||
105666767|NCT01967069|364444043|FG001|Overall Study|Adverse Event|2|||
105666768|NCT01967069|364444042|FG000|Overall Study|Lost to Follow-up|5|||
105666769|NCT01967069|364444043|FG001|Overall Study|Lost to Follow-up|2|||
105666770|NCT01967069|364444042|FG000|Overall Study|Withdrawal by Subject|1|||
105666771|NCT01967069|364444043|FG001|Overall Study|Withdrawal by Subject|3|||
105666772|NCT01967069|364444042|FG000|Overall Study|Lack of Efficacy|0|||
105666773|NCT01967069|364444043|FG001|Overall Study|Lack of Efficacy|1|||
105666774|NCT00504075|364444046|FG000|Overall Study|Adverse Event|1|||
105666775|NCT00504075|364444046|FG000|Overall Study|Lost to Follow-up|5|||
105666776|NCT00504075|364444046|FG000|Overall Study|Withdrawal by Subject|1|||
105666777|NCT00504075|364444046|FG000|Overall Study|Required other therapeutic intervention|1|||
105666778|NCT02406248|364444047|FG000|Overall Study|Death|7|||
105666779|NCT02406248|364444047|FG000|Overall Study|Withdrawal by Subject|2|||
105666780|NCT01689857|364444049|FG000|Overall Study|Lost to Follow-up|5|||
105666781|NCT01689857|364444050|FG001|Overall Study|Lost to Follow-up|2|||
105666782|NCT01730378|364444051|FG000|Overall Study|Lost to Follow-up|1|||
105666783|NCT01730378|364444052|FG001|Overall Study|Lost to Follow-up|0|||
105666784|NCT01736540|364444056|FG000|Overall Study|Did not complete scan within 45 days|2|||
105666785|NCT01736540|364444056|FG000|Overall Study|Death|1|||
105666786|NCT01736540|364444056|FG000|Overall Study|Abnormal test procedure|1|||
105666787|NCT01736540|364444056|FG000|Overall Study|Withdrawal by Subject|5|||
105666788|NCT01736540|364444056|FG000|Overall Study|Protocol Violation|1|||
105666789|NCT01736540|364444056|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
105666790|NCT01736540|364444056|FG000|Overall Study|No show for MRI appointment|1|||
105666791|NCT01736540|364444056|FG000|Overall Study|Unable to make MRI appointment|3|||
106123469|NCT04170296|366109775|FG000|Overall Study|Withdrawal by Subject|3|||
106123470|NCT04170296|366109776|FG001|Overall Study|Withdrawal by Subject|2|||
106123471|NCT04170296|366109775|FG000|Overall Study|Lost to Follow-up|4|||
106123472|NCT04170296|366109776|FG001|Overall Study|Lost to Follow-up|2|||
105666792|NCT03812029|364444061|FG000|Overall Study|Protocol Violation|1|||
105666793|NCT03812029|364444062|FG001|Overall Study|Protocol Violation|0|||
105666794|NCT03812029|364444063|FG002|Overall Study|Protocol Violation|0|||
105666795|NCT03812029|364444064|FG003|Overall Study|Protocol Violation|1|||
105666796|NCT03812029|364444065|FG004|Overall Study|Protocol Violation|0|||
105666797|NCT03812029|364444061|FG000|Overall Study|Withdrawal by Subject|1|||
105895473|NCT02327013|365271755|FG002|Overall Study|Administrative or other reason(s)|11|||
105895474|NCT02327013|365271756|FG003|Overall Study|Administrative or other reason(s)|1|||
105895475|NCT02327013|365271757|FG004|Overall Study|Administrative or other reason(s)|1|||
105895476|NCT02327013|365271753|FG000|Overall Study|Protocol Violation|0|||
105895477|NCT02327013|365271754|FG001|Overall Study|Protocol Violation|0|||
105895478|NCT02327013|365271755|FG002|Overall Study|Protocol Violation|3|||
105895479|NCT02327013|365271756|FG003|Overall Study|Protocol Violation|0|||
105895480|NCT02327013|365271757|FG004|Overall Study|Protocol Violation|1|||
105895481|NCT02327013|365271753|FG000|Overall Study|Withdrawal before treatment|2|||
105895482|NCT02327013|365271754|FG001|Overall Study|Withdrawal before treatment|1|||
105895483|NCT02327013|365271755|FG002|Overall Study|Withdrawal before treatment|5|||
105895484|NCT02327013|365271756|FG003|Overall Study|Withdrawal before treatment|0|||
105895485|NCT02327013|365271757|FG004|Overall Study|Withdrawal before treatment|0|||
105895486|NCT02720744|365271758|FG000|Overall Study|Protocol Violation|0|||
105895487|NCT02720744|365271759|FG001|Overall Study|Protocol Violation|2|||
105666798|NCT03812029|364444062|FG001|Overall Study|Withdrawal by Subject|0|||
105666799|NCT03812029|364444063|FG002|Overall Study|Withdrawal by Subject|0|||
105666800|NCT03812029|364444064|FG003|Overall Study|Withdrawal by Subject|2|||
105666801|NCT03812029|364444065|FG004|Overall Study|Withdrawal by Subject|2|||
105666802|NCT03812029|364444061|FG000|Overall Study|Stopping rules|0|||
105895488|NCT02720744|365271758|FG000|Overall Study|Pregnancy|2|||
105895489|NCT02720744|365271759|FG001|Overall Study|Pregnancy|0|||
105895490|NCT02720744|365271758|FG000|Overall Study|Lack of Efficacy|2|||
105895491|NCT02720744|365271759|FG001|Overall Study|Lack of Efficacy|8|||
106123473|NCT00932646|366109777|FG000|Overall Study|Adverse Event|2|||
106123474|NCT00932646|366109778|FG001|Overall Study|Adverse Event|1|||
105895492|NCT02720744|365271758|FG000|Overall Study|Adverse Event|21|||
105895493|NCT02720744|365271759|FG001|Overall Study|Adverse Event|3|||
105895494|NCT02720744|365271758|FG000|Overall Study|Withdrawal by Subject|11|||
105895495|NCT02720744|365271759|FG001|Overall Study|Withdrawal by Subject|11|||
105895496|NCT02720744|365271758|FG000|Overall Study|Lost to follow up|2|||
105895497|NCT02720744|365271759|FG001|Overall Study|Lost to follow up|0|||
105895498|NCT02720744|365271758|FG000|Overall Study|Non Compliance with Investigational Product|0|||
105895499|NCT02720744|365271759|FG001|Overall Study|Non Compliance with Investigational Product|1|||
105895500|NCT02720744|365271758|FG000|Overall Study|Excluded Concomitant Medication|0|||
105895501|NCT02720744|365271759|FG001|Overall Study|Excluded Concomitant Medication|1|||
105895502|NCT01447446|365271760|FG000|Overall Study|Death|6|||
105895503|NCT01447446|365271761|FG001|Overall Study|Death|3|||
105895504|NCT01447446|365271762|FG002|Overall Study|Death|2|||
105895505|NCT01447446|365271763|FG003|Overall Study|Death|1|||
105895506|NCT01447446|365271764|FG004|Overall Study|Death|7|||
105895507|NCT01447446|365271765|FG005|Overall Study|Death|0|||
105895508|NCT01447446|365271760|FG000|Overall Study|Adverse Event|3|||
105895509|NCT01447446|365271761|FG001|Overall Study|Adverse Event|0|||
105895510|NCT01447446|365271762|FG002|Overall Study|Adverse Event|1|||
105895511|NCT01447446|365271763|FG003|Overall Study|Adverse Event|0|||
105895512|NCT01447446|365271764|FG004|Overall Study|Adverse Event|2|||
105895513|NCT01447446|365271765|FG005|Overall Study|Adverse Event|0|||
105895514|NCT01447446|365271760|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
105666803|NCT03812029|364444062|FG001|Overall Study|Stopping rules|1|||
105666804|NCT03812029|364444063|FG002|Overall Study|Stopping rules|0|||
105666805|NCT03812029|364444064|FG003|Overall Study|Stopping rules|0|||
105666806|NCT03812029|364444065|FG004|Overall Study|Stopping rules|0|||
105666807|NCT03812029|364444061|FG000|Overall Study|Adverse Event|0|||
105666808|NCT03812029|364444062|FG001|Overall Study|Adverse Event|9|||
105666809|NCT03812029|364444063|FG002|Overall Study|Adverse Event|0|||
105666810|NCT03812029|364444064|FG003|Overall Study|Adverse Event|3|||
105895515|NCT01447446|365271761|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
105895516|NCT01447446|365271762|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
105666811|NCT03812029|364444065|FG004|Overall Study|Adverse Event|5|||
105666812|NCT03812029|364444061|FG000|Overall Study|Lost to Follow-up|0|||
105666813|NCT03812029|364444062|FG001|Overall Study|Lost to Follow-up|0|||
105666814|NCT03812029|364444063|FG002|Overall Study|Lost to Follow-up|0|||
105895517|NCT01447446|365271763|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
105895518|NCT01447446|365271764|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
105895519|NCT01447446|365271765|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
105666815|NCT03812029|364444064|FG003|Overall Study|Lost to Follow-up|0|||
105666816|NCT03812029|364444065|FG004|Overall Study|Lost to Follow-up|3|||
105666817|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
105666818|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
105666819|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
105666820|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
105666821|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
105666822|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
105666823|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
105666824|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
105666825|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
105666826|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
105666827|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
105666828|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
105666829|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
105666830|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
105666831|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
105666832|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
105666833|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
105666834|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
105666835|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
105666836|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
105666837|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
105666838|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
105666839|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
105666840|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
105666841|NCT00479882|364444066|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
105666842|NCT00479882|364444067|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
105666843|NCT00479882|364444068|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
105666844|NCT00479882|364444069|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
105666845|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
105666846|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
105666847|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
105666848|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
105666849|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
105666850|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
105666851|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
105666852|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
105666853|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
105666854|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
105666855|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
105666856|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
105666857|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
105666858|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
105666859|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
105666860|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
105666861|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
105666862|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
105666863|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
105666864|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
105666865|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
105666866|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
105666867|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
105666868|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
105666869|NCT00479882|364444066|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
105666870|NCT00479882|364444067|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
105666871|NCT00479882|364444068|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
105666872|NCT00479882|364444069|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
105666873|NCT03738475|364444070|FG000|Overall Study|Participant Non-Compliance|1|||
105666874|NCT03738475|364444071|FG001|Overall Study|Participant Non-Compliance|0|||
105666875|NCT03106753|364444072|FG000|Overall Study|Withdrawal by Subject|0|||
105666876|NCT03106753|364444073|FG001|Overall Study|Withdrawal by Subject|1|||
105666877|NCT03149042|364444074|FG000|Overall Study|Invasive FFR not performed|21|||
105666878|NCT03149042|364444074|FG000|Overall Study|Poor CT Image Quality|1|||
105666879|NCT03149042|364444074|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
105666880|NCT01735175|364444075|FG000|Overall Study|Withdrawal by Subject|9|||
106123475|NCT00932646|366109779|FG002|Overall Study|Adverse Event|1|||
106123476|NCT00932646|366109780|FG003|Overall Study|Adverse Event|1|||
106123477|NCT00932646|366109777|FG000|Overall Study|Lost to Follow-up|2|||
106123478|NCT00932646|366109778|FG001|Overall Study|Lost to Follow-up|1|||
106123479|NCT00932646|366109779|FG002|Overall Study|Lost to Follow-up|0|||
106123480|NCT00932646|366109780|FG003|Overall Study|Lost to Follow-up|0|||
106123481|NCT00932646|366109777|FG000|Overall Study|Withdrawal by Subject|1|||
106123482|NCT00932646|366109778|FG001|Overall Study|Withdrawal by Subject|1|||
106123483|NCT00932646|366109779|FG002|Overall Study|Withdrawal by Subject|3|||
106123484|NCT00932646|366109780|FG003|Overall Study|Withdrawal by Subject|0|||
105666881|NCT01735175|364444076|FG001|Overall Study|Withdrawal by Subject|2|||
105666882|NCT01735175|364444075|FG000|Overall Study|Lost to Follow-up|4|||
105666883|NCT01735175|364444076|FG001|Overall Study|Lost to Follow-up|2|||
105666884|NCT01735175|364444075|FG000|Overall Study|Death|3|||
105666885|NCT01735175|364444076|FG001|Overall Study|Death|2|||
105666886|NCT01735175|364444075|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
105666887|NCT01735175|364444076|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
105666888|NCT04593823|364444079|FG000|Overall Study|Withdrawal by Subject|1|||
105666889|NCT04593823|364444080|FG001|Overall Study|Withdrawal by Subject|1|||
105666890|NCT04593823|364444079|FG000|Overall Study|Lost to Follow-up|0|||
105666891|NCT04593823|364444080|FG001|Overall Study|Lost to Follow-up|1|||
105666892|NCT01304498|364444081|FG000|Overall Study|Adverse Event|1|||
105666893|NCT01304498|364444082|FG001|Overall Study|Adverse Event|1|||
105666894|NCT01304498|364444081|FG000|Overall Study|Withdrawal by Subject|2|||
105666895|NCT01304498|364444082|FG001|Overall Study|Withdrawal by Subject|3|||
105666896|NCT01304498|364444081|FG000|Overall Study|Protocol Violation|1|||
105666897|NCT01304498|364444082|FG001|Overall Study|Protocol Violation|0|||
105666898|NCT01304498|364444081|FG000|Overall Study|Lost to Follow-up|2|||
105666899|NCT01304498|364444082|FG001|Overall Study|Lost to Follow-up|1|||
105666900|NCT03443414|364444083|FG000|Overall Study|Adverse Event|6|||
105666901|NCT03443414|364444084|FG001|Overall Study|Adverse Event|0|||
105666902|NCT03443414|364444085|FG002|Overall Study|Adverse Event|4|||
105666903|NCT03443414|364444086|FG003|Overall Study|Adverse Event|2|||
105666904|NCT03443414|364444087|FG004|Overall Study|Adverse Event|3|||
105666905|NCT03443414|364444083|FG000|Overall Study|Withdrawal by Subject|3|||
105666906|NCT03443414|364444084|FG001|Overall Study|Withdrawal by Subject|2|||
105666907|NCT03443414|364444085|FG002|Overall Study|Withdrawal by Subject|2|||
105666908|NCT03443414|364444086|FG003|Overall Study|Withdrawal by Subject|2|||
105666909|NCT03443414|364444087|FG004|Overall Study|Withdrawal by Subject|1|||
105666910|NCT03443414|364444083|FG000|Overall Study|Death|0|||
106123485|NCT02138747|366109782|FG000|Treatment Period 1|Adverse Event|10|||
106123486|NCT02138747|366109783|FG001|Treatment Period 1|Adverse Event|14|||
106123487|NCT02138747|366109784|FG002|Treatment Period 1|Adverse Event|2|||
106123488|NCT02138747|366109785|FG003|Treatment Period 1|Adverse Event|1|||
106123489|NCT02138747|366109782|FG000|Treatment Period 1|Lost to Follow-up|0|||
106123490|NCT02138747|366109783|FG001|Treatment Period 1|Lost to Follow-up|1|||
106123491|NCT02138747|366109784|FG002|Treatment Period 1|Lost to Follow-up|1|||
106123492|NCT02138747|366109785|FG003|Treatment Period 1|Lost to Follow-up|0|||
106123493|NCT02138747|366109782|FG000|Treatment Period 1|Protocol Violation|0|||
105666911|NCT03443414|364444084|FG001|Overall Study|Death|1|||
105666912|NCT03443414|364444085|FG002|Overall Study|Death|0|||
105666913|NCT03443414|364444086|FG003|Overall Study|Death|1|||
105666914|NCT03443414|364444087|FG004|Overall Study|Death|0|||
105666915|NCT03443414|364444083|FG000|Overall Study|Reason not specified|2|||
105666916|NCT03443414|364444084|FG001|Overall Study|Reason not specified|0|||
105666917|NCT03443414|364444085|FG002|Overall Study|Reason not specified|0|||
105666918|NCT03443414|364444086|FG003|Overall Study|Reason not specified|0|||
105666919|NCT03443414|364444087|FG004|Overall Study|Reason not specified|1|||
105666920|NCT00732992|364444088|FG000|Overall Study|Adverse Event|1|||
105666921|NCT00732992|364444089|FG001|Overall Study|Adverse Event|1|||
105666922|NCT00732992|364444088|FG000|Overall Study|Objective Progression or Relapse|3|||
105666923|NCT00732992|364444089|FG001|Overall Study|Objective Progression or Relapse|5|||
106123494|NCT02138747|366109783|FG001|Treatment Period 1|Protocol Violation|2|||
105666924|NCT00732992|364444088|FG000|Overall Study|Global Deterioration of Health Status|1|||
105785977|NCT04246593|364870423|FG000|Overall Study|Moved out of area/became ineligible|3|||
105895520|NCT01447446|365271760|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
105895521|NCT01447446|365271761|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
105666925|NCT00732992|364444089|FG001|Overall Study|Global Deterioration of Health Status|0|||
105666926|NCT00732992|364444088|FG000|Overall Study|Withdrawal by Subject|1|||
105666927|NCT00732992|364444089|FG001|Overall Study|Withdrawal by Subject|0|||
105666928|NCT03933462|364444090|FG000|Overall Study|Adverse Event|2|||
105666929|NCT03933462|364444091|FG001|Overall Study|Adverse Event|0|||
106123495|NCT02138747|366109784|FG002|Treatment Period 1|Protocol Violation|0|||
106123496|NCT02138747|366109785|FG003|Treatment Period 1|Protocol Violation|0|||
106123497|NCT02138747|366109782|FG000|Treatment Period 1|Withdrawal by Subject|8|||
106123498|NCT02138747|366109783|FG001|Treatment Period 1|Withdrawal by Subject|4|||
106123499|NCT02138747|366109784|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105666930|NCT02522728|364444092|FG000|Overall Study|Withdrawal by Subject|6|||
105666931|NCT02522728|364444093|FG001|Overall Study|Withdrawal by Subject|6|||
105666932|NCT02522728|364444092|FG000|Overall Study|Death|4|||
105666933|NCT02522728|364444093|FG001|Overall Study|Death|3|||
105666934|NCT02522728|364444092|FG000|Overall Study|Adverse Event|2|||
105666935|NCT02522728|364444093|FG001|Overall Study|Adverse Event|1|||
105666936|NCT02522728|364444092|FG000|Overall Study|Did not receive randomized study device|0|||
105666937|NCT02522728|364444093|FG001|Overall Study|Did not receive randomized study device|1|||
105666938|NCT00967005|364444094|FG000|Overall Study|Lost to Follow-up|7|||
105666939|NCT00967005|364444095|FG001|Overall Study|Lost to Follow-up|10|||
105666940|NCT02127125|364444096|FG000|Overall Study|Lost to Follow-up|0|||
105666941|NCT02127125|364444097|FG001|Overall Study|Lost to Follow-up|0|||
105666942|NCT02127125|364444098|FG002|Overall Study|Lost to Follow-up|0|||
105666943|NCT02127125|364444099|FG003|Overall Study|Lost to Follow-up|0|||
105666944|NCT02127125|364444100|FG004|Overall Study|Lost to Follow-up|2|||
105666945|NCT02127125|364444101|FG005|Overall Study|Lost to Follow-up|1|||
105666946|NCT02127125|364444102|FG006|Overall Study|Lost to Follow-up|0|||
105666947|NCT02127125|364444103|FG007|Overall Study|Lost to Follow-up|0|||
105666948|NCT02127125|364444104|FG008|Overall Study|Lost to Follow-up|0|||
105666949|NCT02127125|364444096|FG000|Overall Study|Withdrawal by Subject|0|||
105666950|NCT02127125|364444097|FG001|Overall Study|Withdrawal by Subject|0|||
105666951|NCT02127125|364444098|FG002|Overall Study|Withdrawal by Subject|0|||
105666952|NCT02127125|364444099|FG003|Overall Study|Withdrawal by Subject|1|||
105666953|NCT02127125|364444100|FG004|Overall Study|Withdrawal by Subject|0|||
105666954|NCT02127125|364444101|FG005|Overall Study|Withdrawal by Subject|0|||
105666955|NCT02127125|364444102|FG006|Overall Study|Withdrawal by Subject|0|||
105895522|NCT01447446|365271762|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
105895523|NCT01447446|365271763|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
105666956|NCT02127125|364444103|FG007|Overall Study|Withdrawal by Subject|0|||
105666957|NCT02127125|364444104|FG008|Overall Study|Withdrawal by Subject|0|||
105666958|NCT02127125|364444096|FG000|Overall Study|Physician Decision|0|||
105666959|NCT02127125|364444097|FG001|Overall Study|Physician Decision|0|||
105666960|NCT02127125|364444098|FG002|Overall Study|Physician Decision|1|||
105895524|NCT01447446|365271764|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
105895525|NCT01447446|365271765|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
105895526|NCT01447446|365271760|FG000|Overall Study|Administrative/Other|34|||
105895527|NCT01447446|365271761|FG001|Overall Study|Administrative/Other|9|||
105895528|NCT01447446|365271762|FG002|Overall Study|Administrative/Other|10|||
105895529|NCT01447446|365271763|FG003|Overall Study|Administrative/Other|2|||
105895530|NCT01447446|365271764|FG004|Overall Study|Administrative/Other|33|||
105895531|NCT01447446|365271765|FG005|Overall Study|Administrative/Other|4|||
105895532|NCT01447446|365271760|FG000|Overall Study|SVR12 Assessment|13|||
105895533|NCT01447446|365271761|FG001|Overall Study|SVR12 Assessment|1|||
105895534|NCT01447446|365271762|FG002|Overall Study|SVR12 Assessment|2|||
105895535|NCT01447446|365271763|FG003|Overall Study|SVR12 Assessment|1|||
105895536|NCT01447446|365271764|FG004|Overall Study|SVR12 Assessment|5|||
105895537|NCT01447446|365271765|FG005|Overall Study|SVR12 Assessment|5|||
105895538|NCT01447446|365271760|FG000|Overall Study|New Treatment Started|8|||
105895539|NCT01447446|365271761|FG001|Overall Study|New Treatment Started|2|||
105895540|NCT01447446|365271762|FG002|Overall Study|New Treatment Started|1|||
105997252|NCT02562716|365651406|FG000|Overall Study|Not protocol specified|4|||
105997253|NCT02562716|365651407|FG001|Overall Study|Not protocol specified|2|||
105997254|NCT00556998|365651408|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
105997255|NCT00556998|365651408|FG000|Voriconazole Intravenous (IV)|Other|4|||
105997256|NCT00556998|365651408|FG000|Voriconazole Oral|Adverse Event|1|||
105997257|NCT00556998|365651408|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
105997258|NCT01843023|365651409|FG000|Overall Study|Death|1|||
105997259|NCT01843023|365651410|FG001|Overall Study|Death|0|||
105997260|NCT01843023|365651409|FG000|Overall Study|Lost to Follow-up|24|||
105997261|NCT01843023|365651410|FG001|Overall Study|Lost to Follow-up|29|||
105666961|NCT02127125|364444099|FG003|Overall Study|Physician Decision|0|||
105666962|NCT02127125|364444100|FG004|Overall Study|Physician Decision|1|||
105666963|NCT02127125|364444101|FG005|Overall Study|Physician Decision|2|||
105666964|NCT02127125|364444102|FG006|Overall Study|Physician Decision|0|||
105666965|NCT02127125|364444103|FG007|Overall Study|Physician Decision|0|||
105997262|NCT01843023|365651409|FG000|Overall Study|Withdrawal by Subject|8|||
105997263|NCT01843023|365651410|FG001|Overall Study|Withdrawal by Subject|6|||
105666966|NCT02127125|364444104|FG008|Overall Study|Physician Decision|0|||
105666967|NCT00856245|364444110|FG000|Overall Study|Was not transplanted|5|||
105666968|NCT00844597|364444111|FG000|Overall Study|Adverse Event|0|||
105666969|NCT00844597|364444112|FG001|Overall Study|Adverse Event|0|||
105666970|NCT00844597|364444113|FG002|Overall Study|Adverse Event|0|||
105895541|NCT01447446|365271763|FG003|Overall Study|New Treatment Started|0|||
105895542|NCT01447446|365271764|FG004|Overall Study|New Treatment Started|2|||
105895543|NCT01447446|365271765|FG005|Overall Study|New Treatment Started|0|||
105895544|NCT01447446|365271760|FG000|Overall Study|Reason not Specified|1|||
105997264|NCT00226811|365651413|FG000|Overall Study|Death|8|||
105666971|NCT00844597|364444114|FG003|Overall Study|Adverse Event|1|||
105666972|NCT00844597|364444115|FG004|Overall Study|Adverse Event|0|||
105666973|NCT00844597|364444116|FG005|Overall Study|Adverse Event|0|||
105666974|NCT03566979|364444117|FG000|Overall Study|Withdrawal by Subject|2|||
105666975|NCT03566979|364444118|FG001|Overall Study|Withdrawal by Subject|0|||
105666976|NCT03566979|364444119|FG002|Overall Study|Withdrawal by Subject|1|||
105666977|NCT03566979|364444120|FG003|Overall Study|Withdrawal by Subject|1|||
105666978|NCT03566979|364444117|FG000|Overall Study|Lost to Follow-up|2|||
105666979|NCT03566979|364444118|FG001|Overall Study|Lost to Follow-up|7|||
105666980|NCT03566979|364444119|FG002|Overall Study|Lost to Follow-up|9|||
105666981|NCT03566979|364444120|FG003|Overall Study|Lost to Follow-up|5|||
105666982|NCT03566979|364444117|FG000|Overall Study|Adverse Event|1|||
105666983|NCT03566979|364444118|FG001|Overall Study|Adverse Event|0|||
105666984|NCT03566979|364444119|FG002|Overall Study|Adverse Event|0|||
105666985|NCT03566979|364444120|FG003|Overall Study|Adverse Event|0|||
105666986|NCT02762903|364444121|FG000|Overall Study|Lost to Follow-up|0|||
105666987|NCT02762903|364444122|FG001|Overall Study|Lost to Follow-up|1|||
105666988|NCT00108745|364444123|FG000|Overall Study|Withdrawal by Subject|19|||
105666989|NCT00108745|364444124|FG001|Overall Study|Withdrawal by Subject|12|||
105666990|NCT00108745|364444125|FG002|Overall Study|Withdrawal by Subject|12|||
105666991|NCT00108745|364444123|FG000|Overall Study|Never Treated|8|||
105666992|NCT00108745|364444124|FG001|Overall Study|Never Treated|10|||
105666993|NCT00108745|364444125|FG002|Overall Study|Never Treated|12|||
105666994|NCT00108745|364444123|FG000|Overall Study|Ineligible|7|||
105666995|NCT00108745|364444124|FG001|Overall Study|Ineligible|13|||
105666996|NCT00108745|364444125|FG002|Overall Study|Ineligible|13|||
105666997|NCT02473965|364445950|FG000|Overall Study|Adverse Event|6|||
105666998|NCT02473965|364445951|FG001|Overall Study|Adverse Event|4|||
105666999|NCT02473965|364445950|FG000|Overall Study|MG worsening|4|||
105667000|NCT02473965|364445951|FG001|Overall Study|MG worsening|1|||
105667001|NCT02473965|364445950|FG000|Overall Study|Withdrawal by Subject|2|||
105667002|NCT02473965|364445951|FG001|Overall Study|Withdrawal by Subject|3|||
105667003|NCT02473965|364445950|FG000|Overall Study|Physician Decision|0|||
105895545|NCT01447446|365271761|FG001|Overall Study|Reason not Specified|1|||
105895546|NCT01447446|365271762|FG002|Overall Study|Reason not Specified|1|||
105895547|NCT01447446|365271763|FG003|Overall Study|Reason not Specified|1|||
105895548|NCT01447446|365271764|FG004|Overall Study|Reason not Specified|1|||
105895549|NCT01447446|365271765|FG005|Overall Study|Reason not Specified|0|||
105895550|NCT00741091|365271768|FG000|Overall Study|Death|13|||
105895551|NCT00741091|365271768|FG000|Overall Study|Lost to Follow-up|16|||
105895552|NCT00741091|365271768|FG000|Overall Study|Withdrawal by Subject|6|||
105895553|NCT00741091|365271768|FG000|Overall Study|Missed Visit|22|||
105895554|NCT03570554|365271774|FG000|Overall Study|Non-compliance with study drug|0|||
105895555|NCT03570554|365271775|FG001|Overall Study|Non-compliance with study drug|0|||
105895556|NCT03570554|365271776|FG002|Overall Study|Non-compliance with study drug|1|||
105895557|NCT03570554|365271777|FG003|Overall Study|Non-compliance with study drug|0|||
105895558|NCT03570554|365271774|FG000|Overall Study|Adverse Event|0|||
105895559|NCT03570554|365271775|FG001|Overall Study|Adverse Event|0|||
105895560|NCT03570554|365271776|FG002|Overall Study|Adverse Event|0|||
105895561|NCT03570554|365271777|FG003|Overall Study|Adverse Event|1|||
105895562|NCT02719353|365271779|FG000|First Intervention|Physician Decision|0|||
105895563|NCT02719353|365271780|FG001|First Intervention|Physician Decision|1|||
105895564|NCT02956057|365271789|FG000|Overall Study|Discontinued intervention|14|||
105895565|NCT02956057|365271790|FG001|Overall Study|Discontinued intervention|10|||
105895566|NCT02956057|365271791|FG002|Overall Study|Discontinued intervention|7|||
105895567|NCT02956057|365271792|FG003|Overall Study|Discontinued intervention|14|||
105895568|NCT02956057|365271793|FG004|Overall Study|Discontinued intervention|4|||
105895569|NCT02956057|365271794|FG005|Overall Study|Discontinued intervention|17|||
105895570|NCT02956057|365271789|FG000|Overall Study|Lost to Follow-up|0|||
105895571|NCT02956057|365271790|FG001|Overall Study|Lost to Follow-up|2|||
105895572|NCT02956057|365271791|FG002|Overall Study|Lost to Follow-up|1|||
105895573|NCT02956057|365271792|FG003|Overall Study|Lost to Follow-up|1|||
105667004|NCT02473965|364445951|FG001|Overall Study|Physician Decision|2|||
105667005|NCT03192462|364445952|FG000|Overall Study|Death|13|||
105667006|NCT03192462|364445953|FG001|Overall Study|Death|11|||
105667007|NCT03192462|364445954|FG002|Overall Study|Death|9|||
105667008|NCT03192462|364445952|FG000|Overall Study|Lost to Follow-up|0|||
105895574|NCT02956057|365271793|FG004|Overall Study|Lost to Follow-up|1|||
105895575|NCT02956057|365271794|FG005|Overall Study|Lost to Follow-up|0|||
105895576|NCT03435224|365271803|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
105667009|NCT03192462|364445953|FG001|Overall Study|Lost to Follow-up|1|||
105667010|NCT03192462|364445954|FG002|Overall Study|Lost to Follow-up|0|||
105667011|NCT03192462|364445952|FG000|Overall Study|On follow up|0|||
105895577|NCT00081731|365271808|FG000|Overall Study|scientific integrity issue|8|||
105667012|NCT03192462|364445953|FG001|Overall Study|On follow up|0|||
105667013|NCT03192462|364445954|FG002|Overall Study|On follow up|3|||
105667014|NCT01183390|364445955|FG000|First Intervention|Adverse Event|0|||
105667015|NCT01183390|364445956|FG001|First Intervention|Adverse Event|1|||
105667016|NCT03816761|364445957|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667017|NCT03816761|364445958|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667018|NCT03816761|364445959|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667019|NCT03816761|364445960|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667020|NCT03816761|364445961|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
105667021|NCT03816761|364445962|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
105667022|NCT03816761|364445957|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
105667023|NCT03816761|364445958|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
105667024|NCT03816761|364445959|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
105667025|NCT03816761|364445960|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
105667026|NCT03816761|364445961|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
105667027|NCT03816761|364445962|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
105667028|NCT02358668|364445963|FG000|Overall Study|Adverse Event|2|||
105667029|NCT02358668|364445964|FG001|Overall Study|Adverse Event|0|||
105667030|NCT02358668|364445965|FG002|Overall Study|Adverse Event|0|||
105667031|NCT02358668|364445963|FG000|Overall Study|Withdrawal by Subject|0|||
105667032|NCT02358668|364445964|FG001|Overall Study|Withdrawal by Subject|1|||
105667033|NCT02358668|364445965|FG002|Overall Study|Withdrawal by Subject|0|||
105667034|NCT02737826|364445966|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
105667035|NCT02737826|364445967|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
105667036|NCT02737826|364445968|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
105667037|NCT00581893|364445969|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
105895578|NCT00081731|365271809|FG001|Overall Study|scientific integrity issue|8|||
105895579|NCT01404208|365271811|FG000|Overall Study|Discontinued|3|||
105895580|NCT01404208|365271812|FG001|Overall Study|Discontinued|0|||
105895581|NCT03448939|365271813|FG000|Overall Study|Adverse Event|5|||
105895582|NCT03448939|365271814|FG001|Overall Study|Adverse Event|1|||
105895583|NCT03448939|365271813|FG000|Overall Study|Lost to Follow-up|6|||
105895584|NCT03448939|365271814|FG001|Overall Study|Lost to Follow-up|6|||
105895585|NCT03448939|365271813|FG000|Overall Study|Pregnancy|1|||
105895586|NCT03448939|365271814|FG001|Overall Study|Pregnancy|1|||
105895587|NCT03448939|365271813|FG000|Overall Study|Withdrawal by Subject|9|||
105895588|NCT03448939|365271814|FG001|Overall Study|Withdrawal by Subject|3|||
105895589|NCT01472965|365271815|FG000|Overall Study|Withdrawal by Subject|1|||
105895590|NCT01472965|365271816|FG001|Overall Study|Withdrawal by Subject|0|||
105895591|NCT02945254|365271817|FG000|Overall Study|Lost to Follow-up|1|||
105895592|NCT02945254|365271818|FG001|Overall Study|Lost to Follow-up|0|||
105895593|NCT02945254|365271817|FG000|Overall Study|Withdrawal by Subject|1|||
105895594|NCT02945254|365271818|FG001|Overall Study|Withdrawal by Subject|0|||
105895595|NCT02470403|365271819|FG000|Overall Study|Adverse Event|1|||
105895596|NCT02470403|365271820|FG001|Overall Study|Adverse Event|0|||
105895597|NCT02470403|365271821|FG002|Overall Study|Adverse Event|0|||
105895598|NCT02470403|365271822|FG003|Overall Study|Adverse Event|0|||
105895599|NCT02470403|365271823|FG004|Overall Study|Adverse Event|0|||
105895600|NCT02470403|365271819|FG000|Overall Study|Lost to Follow-up|0|||
105895601|NCT02470403|365271820|FG001|Overall Study|Lost to Follow-up|1|||
105895602|NCT02470403|365271821|FG002|Overall Study|Lost to Follow-up|0|||
105895603|NCT02470403|365271822|FG003|Overall Study|Lost to Follow-up|0|||
105895604|NCT02470403|365271823|FG004|Overall Study|Lost to Follow-up|0|||
105895605|NCT02470403|365271819|FG000|Overall Study|Subject/guardian decision|1|||
105895606|NCT02470403|365271820|FG001|Overall Study|Subject/guardian decision|0|||
105895607|NCT02470403|365271821|FG002|Overall Study|Subject/guardian decision|0|||
105895608|NCT02470403|365271822|FG003|Overall Study|Subject/guardian decision|4|||
105895609|NCT02470403|365271823|FG004|Overall Study|Subject/guardian decision|0|||
105895610|NCT00503997|365271825|FG000|Overall Study|disease progression|1|||
105895611|NCT00503997|365271825|FG000|Overall Study|Adverse Event|5|||
105895612|NCT00503997|365271825|FG000|Overall Study|Death|1|||
105895613|NCT00503997|365271825|FG000|Overall Study|Withdrawal by Subject|1|||
105895614|NCT00725101|365271827|FG000|Overall Study|Death|3|||
105895615|NCT00725101|365271827|FG000|Overall Study|Lost to Follow-up|353|||
105895616|NCT00725101|365271827|FG000|Overall Study|Protocol Violation|1|||
105895617|NCT00725101|365271827|FG000|Overall Study|Withdrawal by Subject|127|||
105895618|NCT00725101|365271827|FG000|Overall Study|not specified/no reason given|11|||
105895619|NCT01592292|365271828|FG000|Overall Study|Follow-up loss|3|||
105895620|NCT01592292|365271829|FG001|Overall Study|Follow-up loss|3|||
105895621|NCT01592292|365271830|FG002|Overall Study|Follow-up loss|1|||
105895622|NCT01592292|365271831|FG003|Overall Study|Follow-up loss|0|||
105895623|NCT01592292|365271828|FG000|Overall Study|Withdrew consent|2|||
105895624|NCT01592292|365271829|FG001|Overall Study|Withdrew consent|1|||
105667038|NCT00581893|364445970|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
105667039|NCT01381575|364445971|FG000|Overall Study|Serious Adverse Event|1|||
105895625|NCT01592292|365271830|FG002|Overall Study|Withdrew consent|0|||
105895626|NCT01592292|365271831|FG003|Overall Study|Withdrew consent|0|||
105895627|NCT01592292|365271828|FG000|Overall Study|Other|1|||
105895628|NCT01592292|365271829|FG001|Overall Study|Other|1|||
105895629|NCT01592292|365271830|FG002|Overall Study|Other|2|||
105895630|NCT01592292|365271831|FG003|Overall Study|Other|1|||
105895631|NCT00157248|365271837|FG000|Overall Study|Adverse Event|36|||
105895632|NCT00157248|365271838|FG001|Overall Study|Adverse Event|25|||
105895633|NCT00157248|365271839|FG002|Overall Study|Adverse Event|13|||
105895634|NCT00157248|365271840|FG003|Overall Study|Adverse Event|33|||
105895635|NCT00157248|365271837|FG000|Overall Study|Protocol Violation|4|||
105895636|NCT00157248|365271838|FG001|Overall Study|Protocol Violation|0|||
105895637|NCT00157248|365271839|FG002|Overall Study|Protocol Violation|2|||
105895638|NCT00157248|365271840|FG003|Overall Study|Protocol Violation|2|||
105895639|NCT00157248|365271837|FG000|Overall Study|Lost to Follow-up|0|||
105895640|NCT00157248|365271838|FG001|Overall Study|Lost to Follow-up|1|||
105895641|NCT00157248|365271839|FG002|Overall Study|Lost to Follow-up|0|||
105895642|NCT00157248|365271840|FG003|Overall Study|Lost to Follow-up|0|||
105895643|NCT00157248|365271837|FG000|Overall Study|Withdrawal by Subject|1|||
105895644|NCT00157248|365271838|FG001|Overall Study|Withdrawal by Subject|4|||
105895645|NCT00157248|365271839|FG002|Overall Study|Withdrawal by Subject|3|||
105895646|NCT00157248|365271840|FG003|Overall Study|Withdrawal by Subject|3|||
105895647|NCT00157248|365271837|FG000|Overall Study|site closures, subject moving|7|||
105895648|NCT00157248|365271838|FG001|Overall Study|site closures, subject moving|7|||
105895649|NCT00157248|365271839|FG002|Overall Study|site closures, subject moving|3|||
105895650|NCT00157248|365271840|FG003|Overall Study|site closures, subject moving|9|||
105895651|NCT02342548|365271841|FG000|Overall Study|Adverse Event|12|||
105895652|NCT02342548|365271842|FG001|Overall Study|Adverse Event|17|||
105895653|NCT02342548|365271843|FG002|Overall Study|Adverse Event|13|||
105997265|NCT00226811|365651413|FG000|Overall Study|Adverse Event|11|||
105997266|NCT00226811|365651413|FG000|Overall Study|Lack of Efficacy|55|||
105997267|NCT00226811|365651413|FG000|Overall Study|Withdrawal by Subject|2|||
105997268|NCT00369577|365651416|FG000|Overall Study|Withdrawal by Subject|0|||
105997269|NCT00369577|365651417|FG001|Overall Study|Withdrawal by Subject|0|||
105997270|NCT00369577|365651418|FG002|Overall Study|Withdrawal by Subject|1|||
105997271|NCT03386721|365651419|FG000|Overall Study|Death|12|||
105997272|NCT03386721|365651420|FG001|Overall Study|Death|21|||
105997273|NCT03386721|365651421|FG002|Overall Study|Death|2|||
106123500|NCT02138747|366109785|FG003|Treatment Period 1|Withdrawal by Subject|3|||
106123501|NCT02138747|366109782|FG000|Treatment Period 1|Other - Miscellaneous|2|||
106123502|NCT02138747|366109783|FG001|Treatment Period 1|Other - Miscellaneous|4|||
105667040|NCT01381575|364445972|FG001|Overall Study|Serious Adverse Event|0|||
106123503|NCT02138747|366109784|FG002|Treatment Period 1|Other - Miscellaneous|0|||
106123504|NCT02138747|366109785|FG003|Treatment Period 1|Other - Miscellaneous|0|||
106123505|NCT02138747|366109782|FG000|Treatment Period 2|Adverse Event|6|||
106123506|NCT02138747|366109783|FG001|Treatment Period 2|Adverse Event|3|||
106123507|NCT02138747|366109784|FG002|Treatment Period 2|Adverse Event|1|||
106123508|NCT02138747|366109785|FG003|Treatment Period 2|Adverse Event|1|||
106123509|NCT02138747|366109782|FG000|Treatment Period 2|Lost to Follow-up|2|||
106123510|NCT02138747|366109783|FG001|Treatment Period 2|Lost to Follow-up|0|||
106123511|NCT02138747|366109784|FG002|Treatment Period 2|Lost to Follow-up|0|||
106123512|NCT02138747|366109785|FG003|Treatment Period 2|Lost to Follow-up|0|||
106123513|NCT02138747|366109782|FG000|Treatment Period 2|Protocol Violation|1|||
106123514|NCT02138747|366109783|FG001|Treatment Period 2|Protocol Violation|0|||
105667041|NCT01381575|364445973|FG002|Overall Study|Serious Adverse Event|0|||
105667042|NCT01381575|364445971|FG000|Overall Study|Non-Serious Adverse Event|0|||
105895654|NCT02342548|365271841|FG000|Overall Study|Lost to Follow-up|0|||
106123515|NCT02138747|366109784|FG002|Treatment Period 2|Protocol Violation|0|||
106123516|NCT02138747|366109785|FG003|Treatment Period 2|Protocol Violation|0|||
106123517|NCT02138747|366109782|FG000|Treatment Period 2|Withdrawal by Subject|5|||
106123518|NCT02138747|366109783|FG001|Treatment Period 2|Withdrawal by Subject|4|||
106123519|NCT02138747|366109784|FG002|Treatment Period 2|Withdrawal by Subject|1|||
106123520|NCT02138747|366109785|FG003|Treatment Period 2|Withdrawal by Subject|2|||
106123521|NCT02138747|366109782|FG000|Treatment Period 2|Other - Miscellaneous|3|||
106123522|NCT02138747|366109783|FG001|Treatment Period 2|Other - Miscellaneous|0|||
106123523|NCT02138747|366109784|FG002|Treatment Period 2|Other - Miscellaneous|0|||
106123524|NCT02138747|366109785|FG003|Treatment Period 2|Other - Miscellaneous|0|||
106123525|NCT00653263|366109786|FG000|Overall Study|Withdrawal by Subject|1|||
106123526|NCT00653263|366109786|FG000|Overall Study|Physician Decision|1|||
106123527|NCT03567993|366109790|FG000|Overall Study|Lost to Follow-up|4|||
106123528|NCT03567993|366109791|FG001|Overall Study|Lost to Follow-up|2|||
106123529|NCT03567993|366109790|FG000|Overall Study|Death|1|||
106123530|NCT03567993|366109791|FG001|Overall Study|Death|1|||
106123531|NCT03567993|366109790|FG000|Overall Study|Withdrawal by Subject|1|||
106123532|NCT03567993|366109791|FG001|Overall Study|Withdrawal by Subject|0|||
105667043|NCT01381575|364445972|FG001|Overall Study|Non-Serious Adverse Event|0|||
106123533|NCT00556374|366109796|FG000|Overall Study|Withdrawal by Subject|235|||
105895655|NCT02342548|365271842|FG001|Overall Study|Lost to Follow-up|1|||
105895656|NCT02342548|365271843|FG002|Overall Study|Lost to Follow-up|0|||
105895657|NCT02342548|365271841|FG000|Overall Study|Study terminated by sponsor|20|||
105895658|NCT02342548|365271842|FG001|Overall Study|Study terminated by sponsor|39|||
105997274|NCT03386721|365651422|FG003|Overall Study|Death|5|||
106123534|NCT00556374|366109797|FG001|Overall Study|Withdrawal by Subject|205|||
106123535|NCT00556374|366109796|FG000|Overall Study|Death|158|||
106123536|NCT00556374|366109797|FG001|Overall Study|Death|127|||
105667044|NCT01381575|364445973|FG002|Overall Study|Non-Serious Adverse Event|1|||
105667045|NCT01381575|364445971|FG000|Overall Study|Protocol Violation|0|||
105667046|NCT01381575|364445972|FG001|Overall Study|Protocol Violation|1|||
105667047|NCT01381575|364445973|FG002|Overall Study|Protocol Violation|1|||
105667048|NCT01381575|364445971|FG000|Overall Study|Withdrawal by Subject|15|||
105667049|NCT01381575|364445972|FG001|Overall Study|Withdrawal by Subject|9|||
105667050|NCT01381575|364445973|FG002|Overall Study|Withdrawal by Subject|7|||
105667051|NCT01381575|364445971|FG000|Overall Study|Migrated/moved from study area|2|||
105667052|NCT01381575|364445972|FG001|Overall Study|Migrated/moved from study area|12|||
105667053|NCT01381575|364445973|FG002|Overall Study|Migrated/moved from study area|2|||
105667054|NCT01381575|364445971|FG000|Overall Study|Lost to Follow-up|8|||
105667055|NCT01381575|364445972|FG001|Overall Study|Lost to Follow-up|17|||
105667056|NCT01381575|364445973|FG002|Overall Study|Lost to Follow-up|9|||
105667057|NCT01200342|364445974|FG000|Overall Study|Disease Progression|1|||
105667058|NCT02271984|364445983|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667059|NCT02271984|364445984|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105895659|NCT02342548|365271843|FG002|Overall Study|Study terminated by sponsor|25|||
105895660|NCT02342548|365271841|FG000|Overall Study|Protocol Violation|0|||
105895661|NCT02342548|365271842|FG001|Overall Study|Protocol Violation|1|||
105895662|NCT02342548|365271843|FG002|Overall Study|Protocol Violation|0|||
105895663|NCT02342548|365271841|FG000|Overall Study|Withdrawal by Subject|1|||
105895664|NCT02342548|365271842|FG001|Overall Study|Withdrawal by Subject|3|||
105895665|NCT02342548|365271843|FG002|Overall Study|Withdrawal by Subject|4|||
105895666|NCT02342548|365271841|FG000|Overall Study|Other|1|||
105895667|NCT02342548|365271842|FG001|Overall Study|Other|1|||
105895668|NCT02342548|365271843|FG002|Overall Study|Other|1|||
105895669|NCT00787917|365271846|FG000|Blinded Treatment|Adverse Event|1|||
105895670|NCT00787917|365271847|FG001|Blinded Treatment|Adverse Event|0|||
105895671|NCT00787917|365271846|FG000|Blinded Treatment|Lack of Efficacy|1|||
105895672|NCT00787917|365271847|FG001|Blinded Treatment|Lack of Efficacy|0|||
105895673|NCT00787917|365271846|FG000|Blinded Treatment|Administrative problems|3|||
105895674|NCT00787917|365271847|FG001|Blinded Treatment|Administrative problems|2|||
105895675|NCT00787917|365271846|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
105667060|NCT02271984|364445985|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667061|NCT02271984|364445986|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667062|NCT02271984|364445987|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667063|NCT02271984|364445988|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
105667064|NCT02271984|364445989|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667065|NCT02271984|364445990|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
105667066|NCT02271984|364445991|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667067|NCT02271984|364445992|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667068|NCT02271984|364445993|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667069|NCT02271984|364445994|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105667070|NCT02460575|364445995|FG000|Overall Study|Lost to Follow-up|1|||
105667071|NCT02460575|364445996|FG001|Overall Study|Lost to Follow-up|0|||
105667072|NCT04307940|364445997|FG000|Overall Study|Adverse Event|1|||
105667073|NCT04307940|364445998|FG001|Overall Study|Adverse Event|0|||
105667074|NCT04307940|364445999|FG002|Overall Study|Adverse Event|0|||
105667075|NCT04307940|364445997|FG000|Overall Study|Withdrawal by Subject|2|||
105667076|NCT04307940|364445998|FG001|Overall Study|Withdrawal by Subject|3|||
105667077|NCT04307940|364445999|FG002|Overall Study|Withdrawal by Subject|1|||
105667078|NCT04307940|364445997|FG000|Overall Study|Lost to Follow-up|2|||
105667079|NCT04307940|364445998|FG001|Overall Study|Lost to Follow-up|0|||
105667080|NCT04307940|364445999|FG002|Overall Study|Lost to Follow-up|1|||
105667081|NCT00974259|364446005|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
105667082|NCT00974259|364446006|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
105667083|NCT02870972|364446013|FG000|Overall Study|Adverse Event|1|||
105667084|NCT02870972|364446014|FG001|Overall Study|Adverse Event|0|||
105667085|NCT02870972|364446015|FG002|Overall Study|Adverse Event|0|||
105667086|NCT02870972|364446016|FG003|Overall Study|Adverse Event|0|||
105667087|NCT02870972|364446017|FG004|Overall Study|Adverse Event|0|||
105667088|NCT04497389|364446018|FG000|Overall Study|Withdrawal by Subject|1|||
105667089|NCT04497389|364446019|FG001|Overall Study|Withdrawal by Subject|0|||
105667090|NCT04400487|364446022|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105667091|NCT04400487|364446022|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
105667092|NCT04400487|364446022|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
105667093|NCT00979953|364446023|FG000|Overall Study|Adverse Event|5|||
105667094|NCT00979953|364446024|FG001|Overall Study|Adverse Event|2|||
105667095|NCT00979953|364446025|FG002|Overall Study|Adverse Event|17|||
105667096|NCT00979953|364446026|FG003|Overall Study|Adverse Event|4|||
105667097|NCT00979953|364446023|FG000|Overall Study|Lack of Efficacy|1|||
105667098|NCT00979953|364446024|FG001|Overall Study|Lack of Efficacy|2|||
105667099|NCT00979953|364446025|FG002|Overall Study|Lack of Efficacy|0|||
105895676|NCT00787917|365271847|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
105895677|NCT00787917|365271846|FG000|Open Label|Administrative problems|3|||
105895678|NCT00787917|365271847|FG001|Open Label|Administrative problems|0|||
105895679|NCT04618471|365274007|FG000|Overall Study|Screen Failure|62|||
105895680|NCT04618471|365274007|FG000|Overall Study|Withdrawal by Subject|6|||
105895681|NCT04618471|365274007|FG000|Overall Study|Physician Decision|2|||
105895682|NCT04618471|365274007|FG000|Overall Study|Lost to Follow-up|1|||
105895683|NCT04618471|365274007|FG000|Overall Study|Various other reasons|2|||
105895684|NCT04618471|365274007|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
105895685|NCT01250171|365274008|FG000|Overall Study|Administrative reasons|1|||
105895686|NCT01250171|365274009|FG001|Overall Study|Administrative reasons|0|||
105895687|NCT01250171|365274010|FG002|Overall Study|Administrative reasons|0|||
105895688|NCT03292458|365274013|FG000|Period 1|Adverse Event|2|||
105895689|NCT03292458|365274014|FG001|Period 1|Adverse Event|0|||
105895690|NCT04529850|365274015|FG000|Overall Study|Death|2|||
105895691|NCT04529850|365274015|FG000|Overall Study|Physician Decision|1|||
105895692|NCT04529850|365274015|FG000|Overall Study|Withdrawal by Subject|2|||
105895693|NCT01143064|365274016|FG000|Overall Study|Death|109|||
105895694|NCT01143064|365274017|FG001|Overall Study|Death|91|||
105895695|NCT01143064|365274016|FG000|Overall Study|Adverse Event|0|||
105895696|NCT01143064|365274017|FG001|Overall Study|Adverse Event|1|||
105895697|NCT01143064|365274016|FG000|Overall Study|Withdrawal by Subject|7|||
105667100|NCT00979953|364446026|FG003|Overall Study|Lack of Efficacy|0|||
105667101|NCT00979953|364446023|FG000|Overall Study|Lost to Follow-up|1|||
105667102|NCT00979953|364446024|FG001|Overall Study|Lost to Follow-up|1|||
105667103|NCT00979953|364446025|FG002|Overall Study|Lost to Follow-up|1|||
105667104|NCT00979953|364446026|FG003|Overall Study|Lost to Follow-up|0|||
105667105|NCT00979953|364446023|FG000|Overall Study|Withdrawal by Subject|0|||
105667106|NCT00979953|364446024|FG001|Overall Study|Withdrawal by Subject|0|||
105667107|NCT00979953|364446025|FG002|Overall Study|Withdrawal by Subject|2|||
105667108|NCT00979953|364446026|FG003|Overall Study|Withdrawal by Subject|1|||
105667109|NCT00979953|364446023|FG000|Overall Study|Protocol Violation|1|||
105667110|NCT00979953|364446024|FG001|Overall Study|Protocol Violation|0|||
105895698|NCT01143064|365274017|FG001|Overall Study|Withdrawal by Subject|5|||
105895699|NCT01143064|365274016|FG000|Overall Study|Lost to Follow-up|17|||
105895700|NCT01143064|365274017|FG001|Overall Study|Lost to Follow-up|14|||
105895701|NCT01143064|365274016|FG000|Overall Study|Physician Decision|0|||
105667111|NCT00979953|364446025|FG002|Overall Study|Protocol Violation|2|||
105667112|NCT00979953|364446026|FG003|Overall Study|Protocol Violation|2|||
105667113|NCT04829747|364446029|FG000|Overall Study|Protocol Violation|1|||
105667114|NCT02615509|364446030|FG000|Overall Study|Lost to Follow-up|134|||
105667115|NCT02615509|364446030|FG000|Overall Study|Death|4|||
105667116|NCT02615509|364446030|FG000|Overall Study|Withdrawal by Subject|8|||
105667117|NCT00425607|364446031|FG000|Overall Study|Death|1|||
105667118|NCT00425607|364446031|FG000|Overall Study|Withdrawal by Subject|1|||
105667119|NCT01706705|364446033|FG000|Overall Study|Death|1|||
105667120|NCT01706705|364446033|FG000|Overall Study|Lack of Efficacy|13|||
105667121|NCT01706705|364446033|FG000|Overall Study|Non-clinical|6|||
105667122|NCT00968526|364446034|FG000|Overall Study|Adverse Event|2|||
105667123|NCT00968526|364446035|FG001|Overall Study|Adverse Event|0|||
105667124|NCT00968526|364446034|FG000|Overall Study|Migrated/moved from study area|1|||
105667125|NCT00968526|364446035|FG001|Overall Study|Migrated/moved from study area|0|||
105667126|NCT01607879|364446036|FG000|Overall Study|Death|1|||
105667127|NCT01607879|364446037|FG001|Overall Study|Death|0|||
105667128|NCT03054337|364446038|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
105667129|NCT03054337|364446039|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
105667130|NCT03054337|364446040|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
105667131|NCT03054337|364446041|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
105667132|NCT03054337|364446042|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
105667133|NCT03054337|364446043|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
105667134|NCT02088957|364446044|FG000|Overall Study|Lack of Efficacy|1|||
105667135|NCT02088957|364446045|FG001|Overall Study|Lack of Efficacy|0|||
105667136|NCT00678301|364446046|FG000|Overall Study|Non-compliance with study procedures|0|||
105667137|NCT00678301|364446047|FG001|Overall Study|Non-compliance with study procedures|1|||
105667138|NCT00678301|364446046|FG000|Overall Study|Adverse Event|1|||
105667139|NCT00678301|364446047|FG001|Overall Study|Adverse Event|0|||
105667140|NCT00678301|364446046|FG000|Overall Study|Withdrawal by Subject|4|||
105667141|NCT00678301|364446047|FG001|Overall Study|Withdrawal by Subject|0|||
105667142|NCT00678301|364446046|FG000|Overall Study|Lost to Follow-up|3|||
105667143|NCT00678301|364446047|FG001|Overall Study|Lost to Follow-up|1|||
105667144|NCT01132820|364446050|FG000|Overall Study|Ineligible: wrong cell type|1|||
105667145|NCT01132820|364446050|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
105667146|NCT01132820|364446050|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
105667147|NCT01132820|364446050|FG000|Overall Study|Never treated|1|||
105667148|NCT01132820|364446050|FG000|Overall Study|Inadequate data|1|||
105667149|NCT02224703|364446055|FG000|Overall Study|Adverse Event|0|||
105667150|NCT02224703|364446056|FG001|Overall Study|Adverse Event|5|||
105667151|NCT02224703|364446057|FG002|Overall Study|Adverse Event|0|||
105667152|NCT02224703|364446055|FG000|Overall Study|Withdrawn by investigator|1|||
105667153|NCT02224703|364446056|FG001|Overall Study|Withdrawn by investigator|0|||
105667154|NCT02224703|364446057|FG002|Overall Study|Withdrawn by investigator|0|||
105667155|NCT02224703|364446055|FG000|Overall Study|Advised by medical monitor|1|||
105667156|NCT02224703|364446056|FG001|Overall Study|Advised by medical monitor|0|||
105667157|NCT02224703|364446057|FG002|Overall Study|Advised by medical monitor|0|||
105667158|NCT02224703|364446055|FG000|Overall Study|Withdrawn by parent/guardian|0|||
105667159|NCT02224703|364446056|FG001|Overall Study|Withdrawn by parent/guardian|1|||
105667160|NCT02224703|364446057|FG002|Overall Study|Withdrawn by parent/guardian|0|||
105667161|NCT02224703|364446055|FG000|Overall Study|Lack of Efficacy|1|||
105667162|NCT02224703|364446056|FG001|Overall Study|Lack of Efficacy|0|||
105667163|NCT02224703|364446057|FG002|Overall Study|Lack of Efficacy|0|||
105667164|NCT02990468|364446062|FG000|Phase 2: MTD|Change in treatment|0|||
105667165|NCT02990468|364446063|FG001|Phase 2: MTD|Change in treatment|0|||
105667166|NCT02990468|364446064|FG002|Phase 2: MTD|Change in treatment|1|||
105667167|NCT01602510|364446067|FG000|Open Label Phase|Adverse Event|46|||
105667168|NCT01602510|364446068|FG001|Open Label Phase|Adverse Event|0|||
105667169|NCT01602510|364446069|FG002|Open Label Phase|Adverse Event|0|||
105667170|NCT01602510|364446067|FG000|Open Label Phase|Lack of Efficacy|22|||
105667171|NCT01602510|364446068|FG001|Open Label Phase|Lack of Efficacy|0|||
105667172|NCT01602510|364446069|FG002|Open Label Phase|Lack of Efficacy|0|||
105667173|NCT01602510|364446067|FG000|Open Label Phase|Protocol Violation|15|||
105667174|NCT01602510|364446068|FG001|Open Label Phase|Protocol Violation|0|||
105667175|NCT01602510|364446069|FG002|Open Label Phase|Protocol Violation|0|||
105667176|NCT01602510|364446067|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
105667177|NCT01602510|364446068|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
105667178|NCT01602510|364446069|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
105667179|NCT01602510|364446067|FG000|Open Label Phase|Lost to Follow-up|22|||
105667180|NCT01602510|364446068|FG001|Open Label Phase|Lost to Follow-up|0|||
105667181|NCT01602510|364446069|FG002|Open Label Phase|Lost to Follow-up|0|||
105667182|NCT01602510|364446067|FG000|Open Label Phase|Physician Decision|19|||
105667183|NCT01602510|364446068|FG001|Open Label Phase|Physician Decision|0|||
105667184|NCT01602510|364446069|FG002|Open Label Phase|Physician Decision|0|||
105667185|NCT01602510|364446067|FG000|Open Label Phase|Withdrawal by Subject|57|||
105667186|NCT01602510|364446068|FG001|Open Label Phase|Withdrawal by Subject|0|||
105895702|NCT01143064|365274017|FG001|Overall Study|Physician Decision|4|||
105895703|NCT00985426|365274018|FG000|Overall Study|Adverse Event|0|||
105895704|NCT00985426|365274019|FG001|Overall Study|Adverse Event|1|||
105895705|NCT00985426|365274018|FG000|Overall Study|Subject Non-Compliance|3|||
105895706|NCT00985426|365274019|FG001|Overall Study|Subject Non-Compliance|3|||
105895707|NCT00985426|365274018|FG000|Overall Study|Withdrawal by Subject|12|||
105895708|NCT00985426|365274019|FG001|Overall Study|Withdrawal by Subject|16|||
105895709|NCT00985426|365274018|FG000|Overall Study|Lost to Follow-up|8|||
105895710|NCT00985426|365274019|FG001|Overall Study|Lost to Follow-up|10|||
105895711|NCT00985426|365274018|FG000|Overall Study|Death|7|||
105895712|NCT00985426|365274019|FG001|Overall Study|Death|3|||
105895713|NCT00985426|365274018|FG000|Overall Study|Protocol Violation|2|||
105895714|NCT00985426|365274019|FG001|Overall Study|Protocol Violation|0|||
105895715|NCT00985426|365274018|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
105895716|NCT00985426|365274019|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
105895717|NCT02284568|365274022|FG000|Overall Study|Adverse Event|2|||
105895718|NCT02284568|365274023|FG001|Overall Study|Adverse Event|9|||
105895719|NCT02284568|365274024|FG002|Overall Study|Adverse Event|4|||
105895720|NCT02284568|365274022|FG000|Overall Study|Withdrawal by Subject|22|||
105895721|NCT02284568|365274023|FG001|Overall Study|Withdrawal by Subject|21|||
105895722|NCT02284568|365274024|FG002|Overall Study|Withdrawal by Subject|1|||
105895723|NCT02284568|365274022|FG000|Overall Study|Noncompliance with study drug admin|1|||
105895724|NCT02284568|365274023|FG001|Overall Study|Noncompliance with study drug admin|2|||
105895725|NCT02284568|365274024|FG002|Overall Study|Noncompliance with study drug admin|0|||
105895726|NCT02284568|365274022|FG000|Overall Study|Noncompliance|1|||
105895727|NCT02284568|365274023|FG001|Overall Study|Noncompliance|0|||
105895728|NCT02284568|365274024|FG002|Overall Study|Noncompliance|0|||
105895729|NCT02284568|365274022|FG000|Overall Study|Protocol Violation|0|||
105895730|NCT02284568|365274023|FG001|Overall Study|Protocol Violation|1|||
105895731|NCT02284568|365274024|FG002|Overall Study|Protocol Violation|0|||
105667187|NCT01602510|364446069|FG002|Open Label Phase|Withdrawal by Subject|0|||
105667188|NCT01602510|364446067|FG000|Randomized Phase|Adverse Event|0|||
105667189|NCT01602510|364446068|FG001|Randomized Phase|Adverse Event|2|||
105667190|NCT01602510|364446069|FG002|Randomized Phase|Adverse Event|6|||
105667191|NCT01602510|364446067|FG000|Randomized Phase|Lack of Efficacy|0|||
105667192|NCT01602510|364446068|FG001|Randomized Phase|Lack of Efficacy|4|||
105667193|NCT01602510|364446069|FG002|Randomized Phase|Lack of Efficacy|4|||
105667194|NCT01602510|364446067|FG000|Randomized Phase|Protocol Violation|0|||
105667195|NCT01602510|364446068|FG001|Randomized Phase|Protocol Violation|3|||
105667196|NCT01602510|364446069|FG002|Randomized Phase|Protocol Violation|3|||
105667197|NCT01602510|364446067|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
105667198|NCT01602510|364446068|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
105895732|NCT02284568|365274022|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
105667199|NCT01602510|364446069|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
105895733|NCT02284568|365274023|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
105667200|NCT01602510|364446067|FG000|Randomized Phase|Lost to Follow-up|0|||
105667201|NCT01602510|364446068|FG001|Randomized Phase|Lost to Follow-up|1|||
105895734|NCT02284568|365274024|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
105895735|NCT02284568|365274022|FG000|Overall Study|Lost to Follow-up|0|||
105895736|NCT02284568|365274023|FG001|Overall Study|Lost to Follow-up|3|||
105667202|NCT01602510|364446069|FG002|Randomized Phase|Lost to Follow-up|3|||
105667203|NCT01602510|364446067|FG000|Randomized Phase|Physician Decision|0|||
105667204|NCT01602510|364446068|FG001|Randomized Phase|Physician Decision|0|||
105667205|NCT01602510|364446069|FG002|Randomized Phase|Physician Decision|2|||
105667206|NCT01602510|364446067|FG000|Randomized Phase|Withdrawal by Subject|0|||
105667207|NCT01602510|364446068|FG001|Randomized Phase|Withdrawal by Subject|6|||
105667208|NCT01602510|364446069|FG002|Randomized Phase|Withdrawal by Subject|7|||
105667209|NCT02992691|364446071|FG000|Overall Study|Adverse Event|2|||
105667210|NCT02992691|364446071|FG000|Overall Study|Withdrawal by Subject|1|||
105667211|NCT04276051|364446073|FG000|Overall Study|Lost to Follow-up|0|||
105667212|NCT04276051|364446074|FG001|Overall Study|Lost to Follow-up|1|||
105667213|NCT04276051|364446073|FG000|Overall Study|Physician Decision|0|||
105667214|NCT04276051|364446074|FG001|Overall Study|Physician Decision|1|||
105667215|NCT04276051|364446073|FG000|Overall Study|Withdrawal by Subject|1|||
105667216|NCT04276051|364446074|FG001|Overall Study|Withdrawal by Subject|1|||
105785978|NCT04246593|364870424|FG001|Overall Study|Moved out of area/became ineligible|1|||
105785979|NCT04246593|364870423|FG000|Overall Study|Reason unknown|4|||
105785980|NCT04246593|364870424|FG001|Overall Study|Reason unknown|2|||
105785981|NCT04338685|364870433|FG000|Overall Study|Death|3|||
105667217|NCT03552523|364446075|FG000|Overall Study|Withdrawal by Subject|1|||
105667218|NCT03552523|364446076|FG001|Overall Study|Withdrawal by Subject|1|||
105667219|NCT03995316|364446078|FG000|Overall Study|Lost to Follow-up|10|||
105667220|NCT03995316|364446079|FG001|Overall Study|Lost to Follow-up|3|||
105667221|NCT01281839|364446080|FG000|Overall Study|Lost to Follow-up|6|||
105667222|NCT01281839|364446081|FG001|Overall Study|Lost to Follow-up|3|||
105667223|NCT01281839|364446080|FG000|Overall Study|Withdrawal by Subject|4|||
105667224|NCT01281839|364446081|FG001|Overall Study|Withdrawal by Subject|10|||
105667225|NCT01281839|364446080|FG000|Overall Study|Reason not specified|0|||
105667226|NCT01281839|364446081|FG001|Overall Study|Reason not specified|1|||
105667227|NCT01305239|364446082|FG000|Overall Study|Adverse Event|22|||
105667228|NCT01305239|364446082|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
105667229|NCT01518153|364446088|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
105667230|NCT01518153|364446089|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
105667231|NCT01518153|364446090|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
105667232|NCT01518153|364446088|FG000|Stem Cell Transplant|Death|2|||
105667233|NCT01518153|364446089|FG001|Stem Cell Transplant|Death|0|||
105667234|NCT01518153|364446090|FG002|Stem Cell Transplant|Death|0|||
105667235|NCT01518153|364446088|FG000|Stem Cell Transplant|Secondary graft failure|1|||
105667236|NCT01518153|364446089|FG001|Stem Cell Transplant|Secondary graft failure|0|||
105785982|NCT04338685|364870434|FG001|Overall Study|Death|4|||
105785983|NCT04338685|364870435|FG002|Overall Study|Death|2|||
105895737|NCT02284568|365274024|FG002|Overall Study|Lost to Follow-up|0|||
105895738|NCT02284568|365274022|FG000|Overall Study|Lack of Efficacy|4|||
105895739|NCT02284568|365274023|FG001|Overall Study|Lack of Efficacy|7|||
105667237|NCT01518153|364446090|FG002|Stem Cell Transplant|Secondary graft failure|0|||
105667238|NCT01518153|364446088|FG000|Stem Cell Transplant|Adverse Event|1|||
105667239|NCT01518153|364446089|FG001|Stem Cell Transplant|Adverse Event|0|||
105667240|NCT01518153|364446090|FG002|Stem Cell Transplant|Adverse Event|0|||
105785984|NCT04338685|364870436|FG003|Overall Study|Death|4|||
105667241|NCT01518153|364446088|FG000|Donor Lymphocyte Infusion|Death|0|||
105667242|NCT01518153|364446089|FG001|Donor Lymphocyte Infusion|Death|2|||
105667243|NCT01518153|364446090|FG002|Donor Lymphocyte Infusion|Death|1|||
105997275|NCT03386721|365651423|FG004|Overall Study|Death|1|||
105997276|NCT03386721|365651424|FG005|Overall Study|Death|12|||
105997277|NCT03386721|365651425|FG006|Overall Study|Death|1|||
105997278|NCT03386721|365651426|FG007|Overall Study|Death|1|||
105997279|NCT03386721|365651427|FG008|Overall Study|Death|12|||
105997280|NCT03386721|365651428|FG009|Overall Study|Death|20|||
105667244|NCT02670122|364446093|FG000|Overall Study|Lost to Follow-up|4|||
105667245|NCT01011868|364446096|FG000|After Week 18 Follow-up|Adverse Event|8|||
105667246|NCT01011868|364446097|FG001|After Week 18 Follow-up|Adverse Event|6|||
105667247|NCT01011868|364446098|FG002|After Week 18 Follow-up|Adverse Event|13|||
105667248|NCT01011868|364446096|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
105667249|NCT01011868|364446097|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
105667250|NCT01011868|364446098|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
105667251|NCT01011868|364446096|FG000|After Week 18 Follow-up|Protocol Violation|1|||
105667252|NCT01011868|364446097|FG001|After Week 18 Follow-up|Protocol Violation|1|||
105667253|NCT01011868|364446098|FG002|After Week 18 Follow-up|Protocol Violation|1|||
105667254|NCT01011868|364446096|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
105667255|NCT01011868|364446097|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
105667256|NCT01011868|364446098|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
105667257|NCT01011868|364446096|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
105667258|NCT01011868|364446097|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
105667259|NCT01011868|364446098|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
105667260|NCT01011868|364446096|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
105667261|NCT01011868|364446097|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
105667262|NCT01011868|364446098|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
105667263|NCT01011868|364446096|FG000|After Week 78 Follow-up|Adverse Event|14|||
105667264|NCT01011868|364446097|FG001|After Week 78 Follow-up|Adverse Event|18|||
105667265|NCT01011868|364446098|FG002|After Week 78 Follow-up|Adverse Event|21|||
105667266|NCT01011868|364446096|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
105667267|NCT01011868|364446097|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
105667268|NCT01011868|364446098|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
105667269|NCT01011868|364446096|FG000|After Week 78 Follow-up|Protocol Violation|9|||
105667270|NCT01011868|364446097|FG001|After Week 78 Follow-up|Protocol Violation|1|||
105667271|NCT01011868|364446098|FG002|After Week 78 Follow-up|Protocol Violation|2|||
105667272|NCT01011868|364446096|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
105667273|NCT01011868|364446097|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
105667274|NCT01011868|364446098|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
105667275|NCT01011868|364446096|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
105667276|NCT01011868|364446097|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
105667277|NCT01011868|364446098|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
105667278|NCT01011868|364446096|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
105667279|NCT01011868|364446097|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
105997281|NCT03386721|365651429|FG010|Overall Study|Death|21|||
105997282|NCT03386721|365651430|FG011|Overall Study|Death|21|||
105997283|NCT03386721|365651431|FG012|Overall Study|Death|14|||
105997284|NCT03386721|365651432|FG013|Overall Study|Death|2|||
105997285|NCT03386721|365651433|FG014|Overall Study|Death|1|||
105997286|NCT03386721|365651419|FG000|Overall Study|Lost to Follow-up|1|||
105997287|NCT03386721|365651420|FG001|Overall Study|Lost to Follow-up|3|||
105997288|NCT03386721|365651421|FG002|Overall Study|Lost to Follow-up|0|||
105997289|NCT03386721|365651422|FG003|Overall Study|Lost to Follow-up|0|||
105997290|NCT03386721|365651423|FG004|Overall Study|Lost to Follow-up|0|||
105997291|NCT03386721|365651424|FG005|Overall Study|Lost to Follow-up|2|||
105997292|NCT03386721|365651425|FG006|Overall Study|Lost to Follow-up|1|||
105997293|NCT03386721|365651426|FG007|Overall Study|Lost to Follow-up|0|||
105997294|NCT03386721|365651427|FG008|Overall Study|Lost to Follow-up|1|||
105997295|NCT03386721|365651428|FG009|Overall Study|Lost to Follow-up|2|||
105997296|NCT03386721|365651429|FG010|Overall Study|Lost to Follow-up|1|||
105997297|NCT03386721|365651430|FG011|Overall Study|Lost to Follow-up|0|||
105997298|NCT03386721|365651431|FG012|Overall Study|Lost to Follow-up|0|||
105997299|NCT03386721|365651432|FG013|Overall Study|Lost to Follow-up|0|||
105997300|NCT03386721|365651433|FG014|Overall Study|Lost to Follow-up|0|||
105997301|NCT03386721|365651419|FG000|Overall Study|Reason not specified|3|||
105997302|NCT03386721|365651420|FG001|Overall Study|Reason not specified|0|||
105997303|NCT03386721|365651421|FG002|Overall Study|Reason not specified|0|||
105997304|NCT03386721|365651422|FG003|Overall Study|Reason not specified|0|||
105997305|NCT03386721|365651423|FG004|Overall Study|Reason not specified|0|||
105997306|NCT03386721|365651424|FG005|Overall Study|Reason not specified|3|||
105997307|NCT03386721|365651425|FG006|Overall Study|Reason not specified|1|||
105667280|NCT01011868|364446098|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
105667281|NCT01228175|364446099|FG000|Overall Study|Lost to Follow-up|64|||
105667282|NCT01228175|364446100|FG001|Overall Study|Lost to Follow-up|50|||
105997308|NCT03386721|365651426|FG007|Overall Study|Reason not specified|0|||
105997309|NCT03386721|365651427|FG008|Overall Study|Reason not specified|0|||
105667283|NCT01228175|364446099|FG000|Overall Study|Withdrawal by Subject|1|||
105667284|NCT01228175|364446100|FG001|Overall Study|Withdrawal by Subject|2|||
105667285|NCT01228175|364446099|FG000|Overall Study|Physician Decision|1|||
105667286|NCT01228175|364446100|FG001|Overall Study|Physician Decision|1|||
105997310|NCT03386721|365651428|FG009|Overall Study|Reason not specified|1|||
105997311|NCT03386721|365651429|FG010|Overall Study|Reason not specified|2|||
105997312|NCT03386721|365651430|FG011|Overall Study|Reason not specified|6|||
105997313|NCT03386721|365651431|FG012|Overall Study|Reason not specified|1|||
105667287|NCT03041792|364446103|FG000|Overall Study|Adverse Event|4|||
105667288|NCT03041792|364446104|FG001|Overall Study|Adverse Event|0|||
105667289|NCT03041792|364446103|FG000|Overall Study|Death in the family|0|||
105667290|NCT03041792|364446104|FG001|Overall Study|Death in the family|2|||
105667291|NCT03041792|364446103|FG000|Overall Study|Randomized but not treated|0|||
105667292|NCT03041792|364446104|FG001|Overall Study|Randomized but not treated|1|||
105667293|NCT01647542|364446105|FG000|Overall Study|Major Protocol Deviation|1|||
105667294|NCT01647542|364446106|FG001|Overall Study|Major Protocol Deviation|0|||
105667295|NCT01647542|364446107|FG002|Overall Study|Major Protocol Deviation|0|||
105667296|NCT01647542|364446105|FG000|Overall Study|Adverse Event|4|||
105667297|NCT01647542|364446106|FG001|Overall Study|Adverse Event|5|||
105667298|NCT01647542|364446107|FG002|Overall Study|Adverse Event|4|||
105667299|NCT01647542|364446105|FG000|Overall Study|Lost to Follow-up|0|||
105667300|NCT01647542|364446106|FG001|Overall Study|Lost to Follow-up|2|||
105667301|NCT01647542|364446107|FG002|Overall Study|Lost to Follow-up|2|||
105667302|NCT01647542|364446105|FG000|Overall Study|Withdrawal by Subject|6|||
105667303|NCT01647542|364446106|FG001|Overall Study|Withdrawal by Subject|4|||
105667304|NCT01647542|364446107|FG002|Overall Study|Withdrawal by Subject|0|||
105667305|NCT01647542|364446105|FG000|Overall Study|Study Termination|64|||
105667306|NCT01647542|364446106|FG001|Overall Study|Study Termination|61|||
105667307|NCT01647542|364446107|FG002|Overall Study|Study Termination|65|||
105667308|NCT01647542|364446105|FG000|Overall Study|Lack of Efficacy|1|||
105667309|NCT01647542|364446106|FG001|Overall Study|Lack of Efficacy|1|||
105667310|NCT01647542|364446107|FG002|Overall Study|Lack of Efficacy|0|||
105667311|NCT01647542|364446105|FG000|Overall Study|Death|0|||
105667312|NCT01647542|364446106|FG001|Overall Study|Death|0|||
105667313|NCT01647542|364446107|FG002|Overall Study|Death|1|||
106123537|NCT00556374|366109796|FG000|Overall Study|Lost to Follow-up|24|||
105667314|NCT00975676|364446112|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
105667315|NCT00975676|364446113|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
105667316|NCT01424813|364446117|FG000|Overall Study|Withdrawal by Subject|3|||
105667317|NCT01424813|364446118|FG001|Overall Study|Withdrawal by Subject|0|||
105667318|NCT01424813|364446117|FG000|Overall Study|Protocol Violation|1|||
105667319|NCT01424813|364446118|FG001|Overall Study|Protocol Violation|0|||
105667320|NCT01424813|364446117|FG000|Overall Study|Other|1|||
105667321|NCT01424813|364446118|FG001|Overall Study|Other|2|||
105667322|NCT01484431|364448086|FG000|Period 1: High Dose|Physician Decision|0|||
105667323|NCT01484431|364448087|FG001|Period 1: High Dose|Physician Decision|1|||
105667324|NCT01484431|364448088|FG002|Period 1: High Dose|Physician Decision|0|||
105667325|NCT01484431|364448086|FG000|Period 2|Death|0|||
105667326|NCT01484431|364448087|FG001|Period 2|Death|1|||
105667327|NCT01484431|364448088|FG002|Period 2|Death|1|||
105667328|NCT01484431|364448086|FG000|Period 2|Physician Decision|0|||
105667329|NCT01484431|364448087|FG001|Period 2|Physician Decision|0|||
105667330|NCT01484431|364448088|FG002|Period 2|Physician Decision|1|||
105667331|NCT01484431|364448086|FG000|Period 2|Non-Compliance with Study Drug|1|||
106123538|NCT00556374|366109797|FG001|Overall Study|Lost to Follow-up|17|||
106123539|NCT00556374|366109796|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
106123540|NCT00556374|366109797|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
106123541|NCT00544544|366109798|FG000|Overall Study|Withdrawal by Subject|1|||
106123542|NCT00544544|366109798|FG000|Overall Study|Adverse Event|1|||
106123543|NCT00544544|366109798|FG000|Overall Study|Lost to Follow-up|1|||
106123544|NCT01291225|366109800|FG000|Overall Study|Lost to Follow-up|85|||
106123545|NCT01291225|366109801|FG001|Overall Study|Lost to Follow-up|39|||
106123546|NCT02855164|366109808|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
106123547|NCT02855164|366109809|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
106123548|NCT02855164|366109810|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
106123549|NCT02855164|366109811|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
105667332|NCT01484431|364448087|FG001|Period 2|Non-Compliance with Study Drug|0|||
105667333|NCT01484431|364448088|FG002|Period 2|Non-Compliance with Study Drug|0|||
105667334|NCT01251770|364448089|FG000|Overall Study|Protocol Violation|13|||
105667335|NCT01251770|364448090|FG001|Overall Study|Protocol Violation|7|||
105667336|NCT00426127|364448093|FG000|Overall Study|Adverse Event|1|||
105667337|NCT00426127|364448093|FG000|Overall Study|Removed due to disease progression|1|||
105667338|NCT01016262|364448095|FG000|Double-blind Phase|Adverse Event|0|||
105667339|NCT01016262|364448096|FG001|Double-blind Phase|Adverse Event|0|||
105667340|NCT01016262|364448097|FG002|Double-blind Phase|Adverse Event|1|||
105785985|NCT04338685|364870437|FG004|Overall Study|Death|4|||
106123550|NCT02855164|366109812|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
105667341|NCT01016262|364448098|FG003|Double-blind Phase|Adverse Event|0|||
105667342|NCT01016262|364448099|FG004|Double-blind Phase|Adverse Event|0|||
105667343|NCT01016262|364448100|FG005|Double-blind Phase|Adverse Event|0|||
105667344|NCT01016262|364448095|FG000|Double-blind Phase|Lack of Efficacy|1|||
105667345|NCT01016262|364448096|FG001|Double-blind Phase|Lack of Efficacy|0|||
105667346|NCT01016262|364448097|FG002|Double-blind Phase|Lack of Efficacy|5|||
106123551|NCT02855164|366109813|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
106123552|NCT02855164|366109814|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
105895740|NCT02284568|365274024|FG002|Overall Study|Lack of Efficacy|0|||
105895741|NCT02284568|365274022|FG000|Overall Study|Other|1|||
105895742|NCT02284568|365274023|FG001|Overall Study|Other|2|||
105895743|NCT02284568|365274024|FG002|Overall Study|Other|0|||
105895744|NCT02284568|365274022|FG000|Overall Study|Withdrew before taking study drug|0|||
105895745|NCT02284568|365274023|FG001|Overall Study|Withdrew before taking study drug|1|||
105895746|NCT02284568|365274024|FG002|Overall Study|Withdrew before taking study drug|0|||
105895747|NCT02255552|365274025|FG000|Overall Study|Participants enrolled into another study|0|||
105895748|NCT02255552|365274026|FG001|Overall Study|Participants enrolled into another study|11|||
105895749|NCT02255552|365274025|FG000|Overall Study|Withdrawal by Subject|1|||
105895750|NCT02255552|365274026|FG001|Overall Study|Withdrawal by Subject|4|||
105895751|NCT04829331|365274027|FG000|Overall Study|Lost to Follow-up|1|||
105895752|NCT04829331|365274028|FG001|Overall Study|Lost to Follow-up|0|||
105895753|NCT05323994|365274029|FG000|Overall Study|Protocol Violation|1|||
105895754|NCT00460265|365274030|FG000|Overall Study|Lost to Follow-up|14|||
105895755|NCT00460265|365274031|FG001|Overall Study|Lost to Follow-up|15|||
106123553|NCT02855164|366109815|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
106123554|NCT02855164|366109808|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
106123555|NCT02855164|366109809|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
106123556|NCT02855164|366109810|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
106123557|NCT02855164|366109811|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
106123558|NCT02855164|366109812|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
106123559|NCT02855164|366109813|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
106123560|NCT02855164|366109814|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
106123561|NCT02855164|366109815|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
106123562|NCT02855164|366109808|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
106123563|NCT02855164|366109809|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
106123564|NCT02855164|366109810|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
106123565|NCT02855164|366109811|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
106123566|NCT02855164|366109812|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
106123567|NCT02855164|366109813|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
106123568|NCT02855164|366109814|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
106123569|NCT02855164|366109815|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
106123570|NCT02855164|366109808|FG000|Part C (Randomized Set)|Adverse Event|0|||
106123571|NCT02855164|366109809|FG001|Part C (Randomized Set)|Adverse Event|0|||
106123572|NCT02855164|366109810|FG002|Part C (Randomized Set)|Adverse Event|0|||
106123573|NCT02855164|366109811|FG003|Part C (Randomized Set)|Adverse Event|0|||
106123574|NCT02855164|366109812|FG004|Part C (Randomized Set)|Adverse Event|0|||
106123575|NCT02855164|366109813|FG005|Part C (Randomized Set)|Adverse Event|5|||
106123576|NCT02855164|366109814|FG006|Part C (Randomized Set)|Adverse Event|9|||
106123577|NCT02855164|366109815|FG007|Part C (Randomized Set)|Adverse Event|2|||
106123578|NCT02855164|366109808|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
106123579|NCT02855164|366109809|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
106123580|NCT02855164|366109810|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
106123581|NCT02855164|366109811|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
106123582|NCT02855164|366109812|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
106123583|NCT02855164|366109813|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
106123584|NCT02855164|366109814|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
106123585|NCT02855164|366109815|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
106123586|NCT02855164|366109808|FG000|Part C (Randomized Set)|Physician Decision|0|||
106123587|NCT02855164|366109809|FG001|Part C (Randomized Set)|Physician Decision|0|||
106123588|NCT02855164|366109810|FG002|Part C (Randomized Set)|Physician Decision|0|||
106123589|NCT02855164|366109811|FG003|Part C (Randomized Set)|Physician Decision|0|||
106123590|NCT02855164|366109812|FG004|Part C (Randomized Set)|Physician Decision|0|||
106123591|NCT02855164|366109813|FG005|Part C (Randomized Set)|Physician Decision|1|||
106123592|NCT02855164|366109814|FG006|Part C (Randomized Set)|Physician Decision|0|||
106123593|NCT02855164|366109815|FG007|Part C (Randomized Set)|Physician Decision|1|||
106123594|NCT02855164|366109808|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
106123595|NCT02855164|366109809|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
106123596|NCT02855164|366109810|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
106123597|NCT02855164|366109811|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
106123598|NCT02855164|366109812|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
106123599|NCT02855164|366109813|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
106123600|NCT02855164|366109814|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
106123601|NCT02855164|366109815|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
106123602|NCT01370603|366109822|FG000|Period 1|Adverse Event|5|||
106123603|NCT01370603|366109823|FG001|Period 1|Adverse Event|3|||
106123604|NCT01370603|366109822|FG000|Period 1|Lost to Follow-up|2|||
106123605|NCT01370603|366109823|FG001|Period 1|Lost to Follow-up|0|||
106123606|NCT01370603|366109822|FG000|Period 1|Protocol Violation|2|||
106123607|NCT01370603|366109823|FG001|Period 1|Protocol Violation|2|||
106123608|NCT01370603|366109822|FG000|Period 1|Withdrawal by Subject|5|||
106123609|NCT01370603|366109823|FG001|Period 1|Withdrawal by Subject|5|||
105895756|NCT00460265|365274030|FG000|Overall Study|Physician Decision|1|||
105667347|NCT01016262|364448098|FG003|Double-blind Phase|Lack of Efficacy|0|||
105667348|NCT01016262|364448099|FG004|Double-blind Phase|Lack of Efficacy|0|||
105667349|NCT01016262|364448100|FG005|Double-blind Phase|Lack of Efficacy|0|||
105667350|NCT01016262|364448095|FG000|Double-blind Phase|Disease Progression|0|||
105667351|NCT01016262|364448096|FG001|Double-blind Phase|Disease Progression|1|||
105667352|NCT01016262|364448097|FG002|Double-blind Phase|Disease Progression|2|||
105895757|NCT00460265|365274031|FG001|Overall Study|Physician Decision|2|||
105895758|NCT00460265|365274030|FG000|Overall Study|Withdrawal by Subject|10|||
105895759|NCT00460265|365274031|FG001|Overall Study|Withdrawal by Subject|25|||
105895760|NCT00460265|365274030|FG000|Overall Study|Ongoing|60|||
105895761|NCT00460265|365274031|FG001|Overall Study|Ongoing|47|||
105895762|NCT00616603|365274034|FG000|Overall Study|Physician Decision|2|||
105895763|NCT00616603|365274035|FG001|Overall Study|Physician Decision|0|||
105895764|NCT00616603|365274036|FG002|Overall Study|Physician Decision|2|||
105895765|NCT00597506|365274042|FG000|Overall Study|Subject is being followed for survival|1|||
105895766|NCT03077659|365274043|FG000|Overall Study|Withdrawal by Subject|0|||
105667353|NCT01016262|364448098|FG003|Double-blind Phase|Disease Progression|0|||
105667354|NCT01016262|364448099|FG004|Double-blind Phase|Disease Progression|0|||
105667355|NCT01016262|364448100|FG005|Double-blind Phase|Disease Progression|0|||
105667356|NCT01016262|364448095|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
105667357|NCT01016262|364448096|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
105895767|NCT03077659|365274044|FG001|Overall Study|Withdrawal by Subject|0|||
105895768|NCT03077659|365274045|FG002|Overall Study|Withdrawal by Subject|1|||
105895769|NCT00480493|365274046|FG000|Overall Study|moved|2|||
106123610|NCT01370603|366109822|FG000|Crossover Washout|Adverse Event|2|||
106123611|NCT01370603|366109823|FG001|Crossover Washout|Adverse Event|1|||
106123612|NCT01370603|366109822|FG000|Crossover Washout|Lost to Follow-up|2|||
106123613|NCT01370603|366109823|FG001|Crossover Washout|Lost to Follow-up|0|||
106123614|NCT01370603|366109822|FG000|Crossover Washout|Protocol Violation|1|||
106123615|NCT01370603|366109823|FG001|Crossover Washout|Protocol Violation|0|||
106123616|NCT01370603|366109822|FG000|Crossover Washout|Withdrawal by Subject|4|||
106123617|NCT01370603|366109823|FG001|Crossover Washout|Withdrawal by Subject|1|||
106123618|NCT01370603|366109822|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
106123619|NCT01370603|366109823|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
106123620|NCT01370603|366109822|FG000|Period 2|Adverse Event|1|||
106123621|NCT01370603|366109823|FG001|Period 2|Adverse Event|4|||
106123622|NCT01370603|366109822|FG000|Period 2|Lost to Follow-up|1|||
106123623|NCT01370603|366109823|FG001|Period 2|Lost to Follow-up|0|||
106123624|NCT01370603|366109822|FG000|Period 2|Withdrawal by Subject|1|||
106123625|NCT01370603|366109823|FG001|Period 2|Withdrawal by Subject|0|||
106123626|NCT00127413|366109824|FG000|Overall Study|Lost to Follow-up|6|||
106123627|NCT00127413|366109825|FG001|Overall Study|Lost to Follow-up|4|||
106123628|NCT00127413|366109826|FG002|Overall Study|Lost to Follow-up|8|||
106123629|NCT00127413|366109827|FG003|Overall Study|Lost to Follow-up|2|||
106123630|NCT05221749|366109828|FG000|Overall Study|Lost to Follow-up|2|||
106123631|NCT05221749|366109829|FG001|Overall Study|Lost to Follow-up|3|||
106123632|NCT01254890|366109830|FG000|Overall Study|Ineligible|0|||
106123633|NCT01254890|366109831|FG001|Overall Study|Ineligible|3|||
106123634|NCT01254890|366109830|FG000|Overall Study|Withdrawal by Subject|1|||
106123635|NCT01254890|366109831|FG001|Overall Study|Withdrawal by Subject|2|||
106123636|NCT01254890|366109830|FG000|Overall Study|Disease Progression|0|||
106123637|NCT01254890|366109831|FG001|Overall Study|Disease Progression|5|||
106123638|NCT04039503|366109833|FG000|Overall Study|Adverse Event|3|||
106123639|NCT04039503|366109834|FG001|Overall Study|Adverse Event|0|||
106123640|NCT04039503|366109835|FG002|Overall Study|Adverse Event|2|||
106123641|NCT04039503|366109836|FG003|Overall Study|Adverse Event|0|||
106123642|NCT04039503|366109833|FG000|Overall Study|Lost to Follow-up|0|||
106123643|NCT04039503|366109834|FG001|Overall Study|Lost to Follow-up|0|||
106123644|NCT04039503|366109835|FG002|Overall Study|Lost to Follow-up|1|||
106123645|NCT04039503|366109836|FG003|Overall Study|Lost to Follow-up|0|||
106123646|NCT04039503|366109833|FG000|Overall Study|Protocol Violation|0|||
106123647|NCT04039503|366109834|FG001|Overall Study|Protocol Violation|1|||
106123648|NCT04039503|366109835|FG002|Overall Study|Protocol Violation|2|||
106123649|NCT04039503|366109836|FG003|Overall Study|Protocol Violation|1|||
106123650|NCT04039503|366109833|FG000|Overall Study|Withdrawal by Subject|4|||
106123651|NCT04039503|366109834|FG001|Overall Study|Withdrawal by Subject|3|||
106123652|NCT04039503|366109835|FG002|Overall Study|Withdrawal by Subject|5|||
106123653|NCT04039503|366109836|FG003|Overall Study|Withdrawal by Subject|2|||
106123654|NCT02023879|366109838|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
106123655|NCT02023879|366109839|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
106123656|NCT02023879|366109840|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
106123657|NCT02023879|366109838|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
106123658|NCT02023879|366109839|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
106123659|NCT02023879|366109840|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
106123660|NCT02023879|366109838|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
105895770|NCT00480493|365274047|FG001|Overall Study|moved|7|||
105895771|NCT01032070|365274048|FG000|Overall Study|Disease progression|13|||
105895772|NCT01032070|365274049|FG001|Overall Study|Disease progression|8|||
105895773|NCT01032070|365274048|FG000|Overall Study|Medical or ethical reasons|0|||
105895774|NCT01032070|365274049|FG001|Overall Study|Medical or ethical reasons|2|||
105895775|NCT01032070|365274048|FG000|Overall Study|Withdrawal by Subject|0|||
105895776|NCT01032070|365274049|FG001|Overall Study|Withdrawal by Subject|2|||
105895777|NCT03769675|365274052|FG000|Overall Study|Lost to Follow-up|1|||
105895778|NCT00426660|365274058|FG000|Overall Study|Death|14|||
105895779|NCT00426660|365274058|FG000|Overall Study|Adverse Event|23|||
105895780|NCT00426660|365274058|FG000|Overall Study|Insufficient Clinical Response|22|||
105895781|NCT00426660|365274058|FG000|Overall Study|Lost to Follow-up|15|||
105895782|NCT00426660|365274058|FG000|Overall Study|Other|23|||
105895783|NCT00426660|365274058|FG000|Overall Study|Withdrawal by Subject|18|||
105895784|NCT00426660|365274058|FG000|Overall Study|Protocol Violation|1|||
105895785|NCT00426660|365274058|FG000|Overall Study|Enrolled Not Treated|15|||
105895786|NCT00455520|365274059|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
105895787|NCT00455520|365274060|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
105895788|NCT00455520|365274059|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
105895789|NCT00455520|365274060|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
105895790|NCT00455520|365274059|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
105895791|NCT00455520|365274060|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
105895792|NCT00455520|365274059|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
106123661|NCT02023879|366109839|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
106123662|NCT02023879|366109840|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
106123663|NCT02023879|366109838|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
106123664|NCT02023879|366109839|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
106123665|NCT02023879|366109840|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
106123666|NCT02023879|366109838|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
106123667|NCT02023879|366109839|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
106123668|NCT02023879|366109840|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
106123669|NCT02023879|366109838|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
106123670|NCT02023879|366109839|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
106123671|NCT02023879|366109840|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
106123672|NCT02023879|366109838|FG000|Extension Open Label Treatment|Adverse Event|1|||
106123673|NCT02023879|366109839|FG001|Extension Open Label Treatment|Adverse Event|7|||
106123674|NCT02023879|366109840|FG002|Extension Open Label Treatment|Adverse Event|3|||
106123675|NCT02023879|366109838|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
106123676|NCT02023879|366109839|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
106123677|NCT02023879|366109840|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
106123678|NCT02023879|366109838|FG000|Extension Open Label Treatment|Participant moved|1|||
106123679|NCT02023879|366109839|FG001|Extension Open Label Treatment|Participant moved|2|||
106123680|NCT02023879|366109840|FG002|Extension Open Label Treatment|Participant moved|0|||
106123681|NCT02023879|366109838|FG000|Extension Open Label Treatment|Other than specified above|2|||
106123682|NCT02023879|366109839|FG001|Extension Open Label Treatment|Other than specified above|7|||
106123683|NCT02023879|366109840|FG002|Extension Open Label Treatment|Other than specified above|2|||
106123684|NCT02044458|366109841|FG000|Overall Study|Protocol Violation|3|||
106123685|NCT02044458|366109842|FG001|Overall Study|Protocol Violation|8|||
106123686|NCT03363659|366109843|FG000|Overall Study|Adverse Event|1|||
106123687|NCT03363659|366109843|FG000|Overall Study|Screen fail|1|||
106123688|NCT03363659|366109843|FG000|Overall Study|Withdrawal by Subject|1|||
106123689|NCT03857841|366109844|FG000|Overall Study|Death|1|||
105667358|NCT01016262|364448097|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
105895793|NCT00455520|365274060|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
106123690|NCT03857841|366109845|FG001|Overall Study|Death|0|||
106123691|NCT03857841|366109846|FG002|Overall Study|Death|0|||
106123692|NCT03857841|366109847|FG003|Overall Study|Death|0|||
105895794|NCT00455520|365274059|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
105895795|NCT00455520|365274060|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
105895796|NCT00455520|365274059|FG000|Open Label Tapentadol Extended Release|All other|33|||
105895797|NCT00455520|365274060|FG001|Open Label Tapentadol Extended Release|All other|0|||
105895798|NCT00455520|365274059|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
105895799|NCT00455520|365274060|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
105895800|NCT00455520|365274059|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
105895801|NCT00455520|365274060|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
105895802|NCT00455520|365274059|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
105895803|NCT00455520|365274060|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
105895804|NCT00455520|365274059|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
105895805|NCT00455520|365274060|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
105895806|NCT00455520|365274059|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
105895807|NCT00455520|365274060|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
105895808|NCT00455520|365274059|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
105895809|NCT00455520|365274060|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
105895810|NCT00628095|365274062|FG000|Overall Study|Adverse Event|5|||
105895811|NCT00628095|365274063|FG001|Overall Study|Adverse Event|3|||
105895812|NCT00628095|365274062|FG000|Overall Study|Lack of Efficacy|0|||
105895813|NCT00628095|365274063|FG001|Overall Study|Lack of Efficacy|3|||
105895814|NCT00628095|365274062|FG000|Overall Study|Withdrawal by Subject|2|||
105895815|NCT00628095|365274063|FG001|Overall Study|Withdrawal by Subject|0|||
105895816|NCT00628095|365274062|FG000|Overall Study|Other|0|||
105895817|NCT00628095|365274063|FG001|Overall Study|Other|1|||
105895818|NCT03235115|365274067|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105895819|NCT03235115|365274068|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105895820|NCT03235115|365274069|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105895821|NCT03235115|365274070|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105895822|NCT03235115|365274071|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
105895823|NCT03235115|365274072|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
105895824|NCT00006305|365274073|FG000|Overall Study|Withdrawal by Subject|17|||
105895825|NCT00006305|365274074|FG001|Overall Study|Withdrawal by Subject|10|||
105895826|NCT00006305|365274075|FG002|Overall Study|Withdrawal by Subject|15|||
105895827|NCT00006305|365274076|FG003|Overall Study|Withdrawal by Subject|14|||
105895828|NCT00662558|365274077|FG000|Overall Study|Adverse Event|21|||
105895829|NCT00662558|365274078|FG001|Overall Study|Adverse Event|59|||
105895830|NCT00662558|365274077|FG000|Overall Study|Lack of Efficacy|4|||
105895831|NCT00662558|365274078|FG001|Overall Study|Lack of Efficacy|7|||
105895832|NCT00662558|365274077|FG000|Overall Study|Lost to Follow-up|13|||
105895833|NCT00662558|365274078|FG001|Overall Study|Lost to Follow-up|10|||
105895834|NCT00662558|365274077|FG000|Overall Study|Other|9|||
105895835|NCT00662558|365274078|FG001|Overall Study|Other|14|||
105895836|NCT00662558|365274077|FG000|Overall Study|Withdrawal by Subject|7|||
105895837|NCT00662558|365274078|FG001|Overall Study|Withdrawal by Subject|12|||
105895838|NCT00662558|365274077|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
105895839|NCT00662558|365274078|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
105895840|NCT00115037|365274079|FG000|Phase1|Lost to Follow-up|16|||
105895841|NCT00115037|365274080|FG001|Phase1|Lost to Follow-up|23|||
105895842|NCT00115037|365274081|FG002|Phase1|Lost to Follow-up|0|||
105895843|NCT00115037|365274082|FG003|Phase1|Lost to Follow-up|0|||
105895844|NCT00115037|365274083|FG004|Phase1|Lost to Follow-up|0|||
105895845|NCT00115037|365274084|FG005|Phase1|Lost to Follow-up|0|||
105997314|NCT03386721|365651432|FG013|Overall Study|Reason not specified|0|||
105997315|NCT03386721|365651433|FG014|Overall Study|Reason not specified|0|||
105997316|NCT03386721|365651419|FG000|Overall Study|Progressive Disease|0|||
105895846|NCT00115037|365274079|FG000|Phase1|Withdrawal by Subject|9|||
105895847|NCT00115037|365274080|FG001|Phase1|Withdrawal by Subject|4|||
105667359|NCT01016262|364448098|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
105895848|NCT00115037|365274081|FG002|Phase1|Withdrawal by Subject|0|||
105895849|NCT00115037|365274082|FG003|Phase1|Withdrawal by Subject|0|||
105895850|NCT00115037|365274083|FG004|Phase1|Withdrawal by Subject|0|||
105895851|NCT00115037|365274084|FG005|Phase1|Withdrawal by Subject|0|||
105895852|NCT00115037|365274079|FG000|Phase2|Death|0|||
105895853|NCT00115037|365274080|FG001|Phase2|Death|0|||
105895854|NCT00115037|365274081|FG002|Phase2|Death|1|||
105895855|NCT00115037|365274082|FG003|Phase2|Death|0|||
105895856|NCT00115037|365274083|FG004|Phase2|Death|0|||
105667360|NCT01016262|364448099|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
105667361|NCT01016262|364448100|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
105667362|NCT01016262|364448095|FG000|Open-Label Phase|Adverse Event|0|||
105667363|NCT01016262|364448096|FG001|Open-Label Phase|Adverse Event|0|||
105667364|NCT01016262|364448097|FG002|Open-Label Phase|Adverse Event|0|||
105667365|NCT01016262|364448098|FG003|Open-Label Phase|Adverse Event|1|||
105667366|NCT01016262|364448099|FG004|Open-Label Phase|Adverse Event|0|||
105667367|NCT01016262|364448100|FG005|Open-Label Phase|Adverse Event|0|||
105667368|NCT01016262|364448095|FG000|Open-Label Phase|Lost to Follow-up|0|||
105667369|NCT01016262|364448096|FG001|Open-Label Phase|Lost to Follow-up|0|||
105667370|NCT01016262|364448097|FG002|Open-Label Phase|Lost to Follow-up|0|||
105667371|NCT01016262|364448098|FG003|Open-Label Phase|Lost to Follow-up|0|||
105667372|NCT01016262|364448099|FG004|Open-Label Phase|Lost to Follow-up|1|||
105667373|NCT01016262|364448100|FG005|Open-Label Phase|Lost to Follow-up|0|||
105667374|NCT01016262|364448095|FG000|Open-Label Phase|Lack of Efficacy|0|||
105667375|NCT01016262|364448096|FG001|Open-Label Phase|Lack of Efficacy|0|||
105667376|NCT01016262|364448097|FG002|Open-Label Phase|Lack of Efficacy|0|||
105667377|NCT01016262|364448098|FG003|Open-Label Phase|Lack of Efficacy|1|||
105667378|NCT01016262|364448099|FG004|Open-Label Phase|Lack of Efficacy|0|||
105667379|NCT01016262|364448100|FG005|Open-Label Phase|Lack of Efficacy|0|||
105667380|NCT01016262|364448095|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667381|NCT01016262|364448096|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667382|NCT01016262|364448097|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667383|NCT01016262|364448098|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667384|NCT01016262|364448099|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
105667385|NCT01016262|364448100|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
105667386|NCT01725126|364448101|FG000|Overall Study|Protocol Violation|0|||
105667387|NCT01725126|364448102|FG001|Overall Study|Protocol Violation|1|||
105667388|NCT01725126|364448103|FG002|Overall Study|Protocol Violation|0|||
105667389|NCT01725126|364448104|FG003|Overall Study|Protocol Violation|0|||
105667390|NCT01725126|364448105|FG004|Overall Study|Protocol Violation|0|||
105667391|NCT01725126|364448106|FG005|Overall Study|Protocol Violation|0|||
105667392|NCT01725126|364448101|FG000|Overall Study|Withdrawal by Subject|0|||
105667393|NCT01725126|364448102|FG001|Overall Study|Withdrawal by Subject|0|||
105667394|NCT01725126|364448103|FG002|Overall Study|Withdrawal by Subject|0|||
105667395|NCT01725126|364448104|FG003|Overall Study|Withdrawal by Subject|1|||
105667396|NCT01725126|364448105|FG004|Overall Study|Withdrawal by Subject|0|||
105667397|NCT01725126|364448106|FG005|Overall Study|Withdrawal by Subject|0|||
105667398|NCT00581477|364448110|FG000|Overall Study|Physician Decision|2|||
105667399|NCT00667394|364448112|FG000|Overall Study|Adverse Event|3|||
105667400|NCT00667394|364448113|FG001|Overall Study|Adverse Event|0|||
105667401|NCT00667394|364448112|FG000|Overall Study|Progressive disease|1|||
105667402|NCT00667394|364448113|FG001|Overall Study|Progressive disease|0|||
105997317|NCT03386721|365651420|FG001|Overall Study|Progressive Disease|0|||
105997318|NCT03386721|365651421|FG002|Overall Study|Progressive Disease|1|||
105997319|NCT03386721|365651422|FG003|Overall Study|Progressive Disease|0|||
105997320|NCT03386721|365651423|FG004|Overall Study|Progressive Disease|0|||
105997321|NCT03386721|365651424|FG005|Overall Study|Progressive Disease|1|||
105997322|NCT03386721|365651425|FG006|Overall Study|Progressive Disease|0|||
105997323|NCT03386721|365651426|FG007|Overall Study|Progressive Disease|0|||
105997324|NCT03386721|365651427|FG008|Overall Study|Progressive Disease|2|||
105997325|NCT03386721|365651428|FG009|Overall Study|Progressive Disease|1|||
105997326|NCT03386721|365651429|FG010|Overall Study|Progressive Disease|1|||
105997327|NCT03386721|365651430|FG011|Overall Study|Progressive Disease|0|||
105997328|NCT03386721|365651431|FG012|Overall Study|Progressive Disease|1|||
105997329|NCT03386721|365651432|FG013|Overall Study|Progressive Disease|0|||
105997330|NCT03386721|365651433|FG014|Overall Study|Progressive Disease|0|||
105667403|NCT02057575|364448115|FG000|Overall Study|Adverse Event|0|||
105667404|NCT02057575|364448116|FG001|Overall Study|Adverse Event|2|||
105667405|NCT02057575|364448117|FG002|Overall Study|Adverse Event|0|||
105667406|NCT02057575|364448118|FG003|Overall Study|Adverse Event|1|||
105667407|NCT02057575|364448115|FG000|Overall Study|Withdrawal by Subject|1|||
105997331|NCT03386721|365651419|FG000|Overall Study|Site Terminated by Sponsor|5|||
105997332|NCT03386721|365651420|FG001|Overall Study|Site Terminated by Sponsor|5|||
105667408|NCT02057575|364448116|FG001|Overall Study|Withdrawal by Subject|0|||
105667409|NCT02057575|364448117|FG002|Overall Study|Withdrawal by Subject|0|||
105997333|NCT03386721|365651421|FG002|Overall Study|Site Terminated by Sponsor|0|||
105667410|NCT02057575|364448118|FG003|Overall Study|Withdrawal by Subject|0|||
105667411|NCT02057575|364448115|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
105667412|NCT02057575|364448116|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
105667413|NCT02057575|364448117|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
105667414|NCT02057575|364448118|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
105667415|NCT02057575|364448115|FG000|Overall Study|Protocol Violation|0|||
105667416|NCT02057575|364448116|FG001|Overall Study|Protocol Violation|1|||
105667417|NCT02057575|364448117|FG002|Overall Study|Protocol Violation|0|||
105667418|NCT02057575|364448118|FG003|Overall Study|Protocol Violation|0|||
105667419|NCT01643044|364448119|FG000|Overall Study|Lost to Follow-up|1|||
105997334|NCT03386721|365651422|FG003|Overall Study|Site Terminated by Sponsor|0|||
105667420|NCT01643044|364448120|FG001|Overall Study|Lost to Follow-up|1|||
105667421|NCT01643044|364448119|FG000|Overall Study|Miscarried baby|2|||
105667422|NCT01643044|364448120|FG001|Overall Study|Miscarried baby|2|||
105667423|NCT01643044|364448119|FG000|Overall Study|Delivered outside of hospital|1|||
105667424|NCT01643044|364448120|FG001|Overall Study|Delivered outside of hospital|2|||
105667425|NCT00863681|364448121|FG000|Overall Study|Other|2|||
105667426|NCT00863681|364448122|FG001|Overall Study|Other|0|||
105667427|NCT00863681|364448123|FG002|Overall Study|Other|0|||
105667428|NCT00863681|364448121|FG000|Overall Study|Missing|1|||
105667429|NCT00863681|364448122|FG001|Overall Study|Missing|0|||
105667430|NCT00863681|364448123|FG002|Overall Study|Missing|0|||
105667431|NCT00863681|364448121|FG000|Overall Study|Death|40|||
105667432|NCT00863681|364448122|FG001|Overall Study|Death|23|||
105667433|NCT00863681|364448123|FG002|Overall Study|Death|6|||
105667434|NCT00863681|364448121|FG000|Overall Study|Withdrawal by Subject|12|||
105667435|NCT00863681|364448122|FG001|Overall Study|Withdrawal by Subject|5|||
105667436|NCT00863681|364448123|FG002|Overall Study|Withdrawal by Subject|2|||
105667437|NCT00863681|364448121|FG000|Overall Study|Protocol Violation|2|||
105667438|NCT00863681|364448122|FG001|Overall Study|Protocol Violation|0|||
105667439|NCT00863681|364448123|FG002|Overall Study|Protocol Violation|0|||
105667440|NCT00863681|364448121|FG000|Overall Study|Lost to Follow-up|3|||
105667441|NCT00863681|364448122|FG001|Overall Study|Lost to Follow-up|0|||
105667442|NCT00863681|364448123|FG002|Overall Study|Lost to Follow-up|3|||
105667443|NCT00863681|364448121|FG000|Overall Study|Adverse Event|28|||
105667444|NCT00863681|364448122|FG001|Overall Study|Adverse Event|10|||
105667445|NCT00863681|364448123|FG002|Overall Study|Adverse Event|6|||
105667446|NCT00863681|364448121|FG000|Overall Study|Lack of Efficacy|2|||
105667447|NCT00863681|364448122|FG001|Overall Study|Lack of Efficacy|2|||
105667448|NCT00863681|364448123|FG002|Overall Study|Lack of Efficacy|1|||
105667449|NCT00863681|364448121|FG000|Overall Study|Non-compliance with study drug|1|||
105667450|NCT00863681|364448122|FG001|Overall Study|Non-compliance with study drug|3|||
105667451|NCT00863681|364448123|FG002|Overall Study|Non-compliance with study drug|0|||
105667452|NCT03325777|364448129|FG000|Overall Study|Lost to Follow-up|9|||
105667453|NCT03325777|364448130|FG001|Overall Study|Lost to Follow-up|12|||
105667454|NCT03004404|364448131|FG000|Period 2|Adverse Event|0|||
105667455|NCT03004404|364448132|FG001|Period 2|Adverse Event|0|||
105667456|NCT03004404|364448133|FG002|Period 2|Adverse Event|0|||
105667457|NCT03004404|364448134|FG003|Period 2|Adverse Event|0|||
105667458|NCT03004404|364448135|FG004|Period 2|Adverse Event|0|||
105667459|NCT03004404|364448136|FG005|Period 2|Adverse Event|0|||
105667460|NCT03004404|364448137|FG006|Period 2|Adverse Event|0|||
105667461|NCT03004404|364448138|FG007|Period 2|Adverse Event|0|||
105667462|NCT03004404|364448139|FG008|Period 2|Adverse Event|1|||
105667463|NCT03004404|364448140|FG009|Period 2|Adverse Event|0|||
105667464|NCT03004404|364448141|FG010|Period 2|Adverse Event|0|||
105667465|NCT03004404|364448142|FG011|Period 2|Adverse Event|0|||
105667466|NCT03004404|364448143|FG012|Period 2|Adverse Event|0|||
105667467|NCT03004404|364448144|FG013|Period 2|Adverse Event|0|||
105667468|NCT03004404|364448145|FG014|Period 2|Adverse Event|0|||
105667469|NCT03004404|364448146|FG015|Period 2|Adverse Event|1|||
105667470|NCT03126110|364448151|FG000|Phase 1|Death|2|||
105667471|NCT03126110|364448152|FG001|Phase 1|Death|2|||
105667472|NCT03126110|364448153|FG002|Phase 1|Death|4|||
105667473|NCT03126110|364448154|FG003|Phase 1|Death|3|||
105667474|NCT03126110|364448155|FG004|Phase 1|Death|4|||
105667475|NCT03126110|364448156|FG005|Phase 1|Death|4|||
105667476|NCT03126110|364448157|FG006|Phase 1|Death|3|||
105667477|NCT03126110|364448158|FG007|Phase 1|Death|4|||
105667478|NCT03126110|364448159|FG008|Phase 1|Death|5|||
105667479|NCT03126110|364448160|FG009|Phase 1|Death|2|||
105667480|NCT03126110|364448161|FG010|Phase 1|Death|6|||
105667481|NCT03126110|364448162|FG011|Phase 1|Death|0|||
105667482|NCT03126110|364448163|FG012|Phase 1|Death|0|||
105667483|NCT03126110|364448164|FG013|Phase 1|Death|0|||
105667484|NCT03126110|364448165|FG014|Phase 1|Death|0|||
105667485|NCT03126110|364448166|FG015|Phase 1|Death|0|||
105667486|NCT03126110|364448167|FG016|Phase 1|Death|0|||
105667487|NCT03126110|364448151|FG000|Phase 1|Lost to Follow-up|0|||
105667488|NCT03126110|364448152|FG001|Phase 1|Lost to Follow-up|1|||
105667489|NCT03126110|364448153|FG002|Phase 1|Lost to Follow-up|0|||
105667490|NCT03126110|364448154|FG003|Phase 1|Lost to Follow-up|0|||
105667491|NCT03126110|364448155|FG004|Phase 1|Lost to Follow-up|0|||
105667492|NCT03126110|364448156|FG005|Phase 1|Lost to Follow-up|0|||
105667493|NCT03126110|364448157|FG006|Phase 1|Lost to Follow-up|0|||
105667494|NCT03126110|364448158|FG007|Phase 1|Lost to Follow-up|0|||
105667495|NCT03126110|364448159|FG008|Phase 1|Lost to Follow-up|1|||
105667496|NCT03126110|364448160|FG009|Phase 1|Lost to Follow-up|0|||
105667497|NCT03126110|364448161|FG010|Phase 1|Lost to Follow-up|0|||
105667498|NCT03126110|364448162|FG011|Phase 1|Lost to Follow-up|0|||
105667499|NCT03126110|364448163|FG012|Phase 1|Lost to Follow-up|0|||
105667500|NCT03126110|364448164|FG013|Phase 1|Lost to Follow-up|0|||
105667501|NCT03126110|364448165|FG014|Phase 1|Lost to Follow-up|0|||
105667502|NCT03126110|364448166|FG015|Phase 1|Lost to Follow-up|0|||
105667503|NCT03126110|364448167|FG016|Phase 1|Lost to Follow-up|0|||
105667504|NCT03126110|364448151|FG000|Phase 1|Withdrawal by Subject|1|||
105667505|NCT03126110|364448152|FG001|Phase 1|Withdrawal by Subject|0|||
105667506|NCT03126110|364448153|FG002|Phase 1|Withdrawal by Subject|0|||
105667507|NCT03126110|364448154|FG003|Phase 1|Withdrawal by Subject|1|||
105667508|NCT03126110|364448155|FG004|Phase 1|Withdrawal by Subject|1|||
105667509|NCT03126110|364448156|FG005|Phase 1|Withdrawal by Subject|0|||
105667510|NCT03126110|364448157|FG006|Phase 1|Withdrawal by Subject|0|||
105667511|NCT03126110|364448158|FG007|Phase 1|Withdrawal by Subject|0|||
105667512|NCT03126110|364448159|FG008|Phase 1|Withdrawal by Subject|2|||
105667513|NCT03126110|364448160|FG009|Phase 1|Withdrawal by Subject|1|||
105667514|NCT03126110|364448161|FG010|Phase 1|Withdrawal by Subject|0|||
105667515|NCT03126110|364448162|FG011|Phase 1|Withdrawal by Subject|0|||
105667516|NCT03126110|364448163|FG012|Phase 1|Withdrawal by Subject|0|||
105667517|NCT03126110|364448164|FG013|Phase 1|Withdrawal by Subject|0|||
105895857|NCT00115037|365274084|FG005|Phase2|Death|1|||
105895858|NCT00115037|365274079|FG000|Phase2|Withdrawal by Subject|0|||
105895859|NCT00115037|365274080|FG001|Phase2|Withdrawal by Subject|0|||
105895860|NCT00115037|365274081|FG002|Phase2|Withdrawal by Subject|2|||
105895861|NCT00115037|365274082|FG003|Phase2|Withdrawal by Subject|1|||
105895862|NCT00115037|365274083|FG004|Phase2|Withdrawal by Subject|2|||
105895863|NCT00115037|365274084|FG005|Phase2|Withdrawal by Subject|1|||
105895864|NCT00115037|365274079|FG000|Phase2|Lost to Follow-up|0|||
105895865|NCT00115037|365274080|FG001|Phase2|Lost to Follow-up|0|||
105895866|NCT00115037|365274081|FG002|Phase2|Lost to Follow-up|12|||
105895867|NCT00115037|365274082|FG003|Phase2|Lost to Follow-up|14|||
105895868|NCT00115037|365274083|FG004|Phase2|Lost to Follow-up|4|||
105895869|NCT00115037|365274084|FG005|Phase2|Lost to Follow-up|10|||
105895870|NCT00396877|365274085|FG000|Overall Study|Lost to Follow-up|2|||
105895871|NCT00396877|365274086|FG001|Overall Study|Lost to Follow-up|1|||
105895872|NCT00396877|365274085|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
105895873|NCT00396877|365274086|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
105895874|NCT00783224|365274087|FG000|Overall Study|Adverse Event|0|||
105895875|NCT00783224|365274088|FG001|Overall Study|Adverse Event|0|||
105895876|NCT00783224|365274089|FG002|Overall Study|Adverse Event|1|||
105895877|NCT00783224|365274090|FG003|Overall Study|Adverse Event|0|||
105895878|NCT00783224|365274087|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
105895879|NCT00783224|365274088|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
105895880|NCT00783224|365274089|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
105895881|NCT00783224|365274090|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
105895882|NCT00783224|365274087|FG000|Overall Study|Inappropriate as a study subject|0|||
105895883|NCT00783224|365274088|FG001|Overall Study|Inappropriate as a study subject|0|||
105895884|NCT00783224|365274089|FG002|Overall Study|Inappropriate as a study subject|0|||
105895885|NCT00783224|365274090|FG003|Overall Study|Inappropriate as a study subject|1|||
105895886|NCT01711619|365274091|FG000|Overall Study|Early study termination|10|||
105895887|NCT01711619|365274092|FG001|Overall Study|Early study termination|14|||
105895888|NCT01711619|365274091|FG000|Overall Study|Withdrawal by Subject|3|||
105667518|NCT03126110|364448165|FG014|Phase 1|Withdrawal by Subject|0|||
105667519|NCT03126110|364448166|FG015|Phase 1|Withdrawal by Subject|0|||
105667520|NCT03126110|364448167|FG016|Phase 1|Withdrawal by Subject|0|||
105667521|NCT03126110|364448151|FG000|Phase 1|Safety follow-up no longer necessary|1|||
105667522|NCT03126110|364448152|FG001|Phase 1|Safety follow-up no longer necessary|0|||
105667523|NCT03126110|364448153|FG002|Phase 1|Safety follow-up no longer necessary|0|||
105667524|NCT03126110|364448154|FG003|Phase 1|Safety follow-up no longer necessary|0|||
105667525|NCT03126110|364448155|FG004|Phase 1|Safety follow-up no longer necessary|0|||
105667526|NCT03126110|364448156|FG005|Phase 1|Safety follow-up no longer necessary|0|||
105667527|NCT03126110|364448157|FG006|Phase 1|Safety follow-up no longer necessary|0|||
105895889|NCT01711619|365274092|FG001|Overall Study|Withdrawal by Subject|7|||
105895890|NCT01711619|365274091|FG000|Overall Study|Protocol Violation|2|||
105895891|NCT01711619|365274092|FG001|Overall Study|Protocol Violation|3|||
105895892|NCT01711619|365274091|FG000|Overall Study|Adverse Event|2|||
105895893|NCT01711619|365274092|FG001|Overall Study|Adverse Event|0|||
105895894|NCT01711619|365274091|FG000|Overall Study|Lost to Follow-up|1|||
105895895|NCT01711619|365274092|FG001|Overall Study|Lost to Follow-up|0|||
105895896|NCT02003963|365274093|FG000|Overall Study|Lost to Follow-up|2|||
105667528|NCT03126110|364448158|FG007|Phase 1|Safety follow-up no longer necessary|0|||
105667529|NCT03126110|364448159|FG008|Phase 1|Safety follow-up no longer necessary|0|||
105667530|NCT03126110|364448160|FG009|Phase 1|Safety follow-up no longer necessary|0|||
105667531|NCT03126110|364448161|FG010|Phase 1|Safety follow-up no longer necessary|0|||
105667532|NCT03126110|364448162|FG011|Phase 1|Safety follow-up no longer necessary|0|||
105895897|NCT02003963|365274094|FG001|Overall Study|Lost to Follow-up|1|||
105895898|NCT03515629|365274098|FG000|Overall Study|Death|0|||
105895899|NCT03515629|365274099|FG001|Overall Study|Death|1|||
105895900|NCT03515629|365274100|FG002|Overall Study|Death|1|||
105895901|NCT03515629|365274098|FG000|Overall Study|Progressive disease|0|||
105895902|NCT03515629|365274099|FG001|Overall Study|Progressive disease|1|||
105895903|NCT03515629|365274100|FG002|Overall Study|Progressive disease|0|||
105895904|NCT03769194|365274101|FG000|Overall Study|Withdrawal by Subject|0|||
105895905|NCT03769194|365274102|FG001|Overall Study|Withdrawal by Subject|7|||
105667533|NCT03126110|364448163|FG012|Phase 1|Safety follow-up no longer necessary|0|||
105895906|NCT03769194|365274103|FG002|Overall Study|Withdrawal by Subject|4|||
105667534|NCT03126110|364448164|FG013|Phase 1|Safety follow-up no longer necessary|0|||
105667535|NCT03126110|364448165|FG014|Phase 1|Safety follow-up no longer necessary|0|||
105667536|NCT03126110|364448166|FG015|Phase 1|Safety follow-up no longer necessary|0|||
105667537|NCT03126110|364448167|FG016|Phase 1|Safety follow-up no longer necessary|0|||
105667538|NCT03126110|364448151|FG000|Phase 1|Survival follow-up no longer necessary|0|||
105667539|NCT03126110|364448152|FG001|Phase 1|Survival follow-up no longer necessary|0|||
105667540|NCT03126110|364448153|FG002|Phase 1|Survival follow-up no longer necessary|1|||
105667541|NCT03126110|364448154|FG003|Phase 1|Survival follow-up no longer necessary|0|||
105667542|NCT03126110|364448155|FG004|Phase 1|Survival follow-up no longer necessary|0|||
105667543|NCT03126110|364448156|FG005|Phase 1|Survival follow-up no longer necessary|0|||
105667544|NCT03126110|364448157|FG006|Phase 1|Survival follow-up no longer necessary|0|||
105667545|NCT03126110|364448158|FG007|Phase 1|Survival follow-up no longer necessary|0|||
105667546|NCT03126110|364448159|FG008|Phase 1|Survival follow-up no longer necessary|0|||
105667547|NCT03126110|364448160|FG009|Phase 1|Survival follow-up no longer necessary|0|||
105667548|NCT03126110|364448161|FG010|Phase 1|Survival follow-up no longer necessary|0|||
105667549|NCT03126110|364448162|FG011|Phase 1|Survival follow-up no longer necessary|0|||
105667550|NCT03126110|364448163|FG012|Phase 1|Survival follow-up no longer necessary|0|||
105667551|NCT03126110|364448164|FG013|Phase 1|Survival follow-up no longer necessary|0|||
105667552|NCT03126110|364448165|FG014|Phase 1|Survival follow-up no longer necessary|0|||
105667553|NCT03126110|364448166|FG015|Phase 1|Survival follow-up no longer necessary|0|||
105667554|NCT03126110|364448167|FG016|Phase 1|Survival follow-up no longer necessary|0|||
105667555|NCT03126110|364448151|FG000|Phase 2|Study terminated by the sponsor|0|||
105667556|NCT03126110|364448152|FG001|Phase 2|Study terminated by the sponsor|0|||
105667557|NCT03126110|364448153|FG002|Phase 2|Study terminated by the sponsor|0|||
105667558|NCT03126110|364448154|FG003|Phase 2|Study terminated by the sponsor|0|||
105667559|NCT03126110|364448155|FG004|Phase 2|Study terminated by the sponsor|0|||
105667560|NCT03126110|364448156|FG005|Phase 2|Study terminated by the sponsor|0|||
105667561|NCT03126110|364448157|FG006|Phase 2|Study terminated by the sponsor|0|||
105667562|NCT03126110|364448158|FG007|Phase 2|Study terminated by the sponsor|0|||
105667563|NCT03126110|364448159|FG008|Phase 2|Study terminated by the sponsor|0|||
105667564|NCT03126110|364448160|FG009|Phase 2|Study terminated by the sponsor|0|||
105667565|NCT03126110|364448161|FG010|Phase 2|Study terminated by the sponsor|0|||
105667566|NCT03126110|364448162|FG011|Phase 2|Study terminated by the sponsor|0|||
105667567|NCT03126110|364448163|FG012|Phase 2|Study terminated by the sponsor|0|||
105667568|NCT03126110|364448164|FG013|Phase 2|Study terminated by the sponsor|4|||
105667569|NCT03126110|364448165|FG014|Phase 2|Study terminated by the sponsor|0|||
105667570|NCT03126110|364448166|FG015|Phase 2|Study terminated by the sponsor|0|||
105667571|NCT03126110|364448167|FG016|Phase 2|Study terminated by the sponsor|0|||
105667572|NCT03126110|364448151|FG000|Phase 2|Withdrawal by Subject|0|||
105667573|NCT03126110|364448152|FG001|Phase 2|Withdrawal by Subject|0|||
105667574|NCT03126110|364448153|FG002|Phase 2|Withdrawal by Subject|0|||
105667575|NCT03126110|364448154|FG003|Phase 2|Withdrawal by Subject|0|||
105667576|NCT03126110|364448155|FG004|Phase 2|Withdrawal by Subject|0|||
105667577|NCT03126110|364448156|FG005|Phase 2|Withdrawal by Subject|0|||
105667578|NCT03126110|364448157|FG006|Phase 2|Withdrawal by Subject|0|||
105667579|NCT03126110|364448158|FG007|Phase 2|Withdrawal by Subject|0|||
105667580|NCT03126110|364448159|FG008|Phase 2|Withdrawal by Subject|0|||
105667581|NCT03126110|364448160|FG009|Phase 2|Withdrawal by Subject|0|||
105667582|NCT03126110|364448161|FG010|Phase 2|Withdrawal by Subject|0|||
105667583|NCT03126110|364448162|FG011|Phase 2|Withdrawal by Subject|1|||
105667584|NCT03126110|364448163|FG012|Phase 2|Withdrawal by Subject|3|||
105667585|NCT03126110|364448164|FG013|Phase 2|Withdrawal by Subject|3|||
105667586|NCT03126110|364448165|FG014|Phase 2|Withdrawal by Subject|2|||
105667587|NCT03126110|364448166|FG015|Phase 2|Withdrawal by Subject|1|||
105667588|NCT03126110|364448167|FG016|Phase 2|Withdrawal by Subject|0|||
105667589|NCT03126110|364448151|FG000|Phase 2|Lost to Follow-up|0|||
105785986|NCT04338685|364870438|FG005|Overall Study|Death|8|||
105667590|NCT03126110|364448152|FG001|Phase 2|Lost to Follow-up|0|||
105667591|NCT03126110|364448153|FG002|Phase 2|Lost to Follow-up|0|||
105667592|NCT03126110|364448154|FG003|Phase 2|Lost to Follow-up|0|||
105785987|NCT04338685|364870439|FG006|Overall Study|Death|1|||
105785988|NCT04338685|364870440|FG007|Overall Study|Death|0|||
105785989|NCT04338685|364870441|FG008|Overall Study|Death|0|||
105785990|NCT04338685|364870433|FG000|Overall Study|Study terminated by Sponsor|0|||
105785991|NCT04338685|364870434|FG001|Overall Study|Study terminated by Sponsor|0|||
105785992|NCT04338685|364870435|FG002|Overall Study|Study terminated by Sponsor|1|||
105785993|NCT04338685|364870436|FG003|Overall Study|Study terminated by Sponsor|4|||
105667593|NCT03126110|364448155|FG004|Phase 2|Lost to Follow-up|0|||
105667594|NCT03126110|364448156|FG005|Phase 2|Lost to Follow-up|0|||
105667595|NCT03126110|364448157|FG006|Phase 2|Lost to Follow-up|0|||
105667596|NCT03126110|364448158|FG007|Phase 2|Lost to Follow-up|0|||
105785994|NCT04338685|364870437|FG004|Overall Study|Study terminated by Sponsor|0|||
105667597|NCT03126110|364448159|FG008|Phase 2|Lost to Follow-up|0|||
105667598|NCT03126110|364448160|FG009|Phase 2|Lost to Follow-up|0|||
105667599|NCT03126110|364448161|FG010|Phase 2|Lost to Follow-up|0|||
105667600|NCT03126110|364448162|FG011|Phase 2|Lost to Follow-up|1|||
105667601|NCT03126110|364448163|FG012|Phase 2|Lost to Follow-up|1|||
105667602|NCT03126110|364448164|FG013|Phase 2|Lost to Follow-up|1|||
105667603|NCT03126110|364448165|FG014|Phase 2|Lost to Follow-up|2|||
105895907|NCT03769194|365274104|FG003|Overall Study|Withdrawal by Subject|1|||
105667604|NCT03126110|364448166|FG015|Phase 2|Lost to Follow-up|0|||
105667605|NCT03126110|364448167|FG016|Phase 2|Lost to Follow-up|0|||
105667606|NCT03126110|364448151|FG000|Phase 2|Death|0|||
105667607|NCT03126110|364448152|FG001|Phase 2|Death|0|||
105667608|NCT03126110|364448153|FG002|Phase 2|Death|0|||
105667609|NCT03126110|364448154|FG003|Phase 2|Death|0|||
105667610|NCT03126110|364448155|FG004|Phase 2|Death|0|||
105667611|NCT03126110|364448156|FG005|Phase 2|Death|0|||
105667612|NCT03126110|364448157|FG006|Phase 2|Death|0|||
105895908|NCT03769194|365274101|FG000|Overall Study|moved from study area|0|||
105895909|NCT03769194|365274102|FG001|Overall Study|moved from study area|2|||
105895910|NCT03769194|365274103|FG002|Overall Study|moved from study area|1|||
105895911|NCT03769194|365274104|FG003|Overall Study|moved from study area|1|||
105895912|NCT03769194|365274101|FG000|Overall Study|Lost to Follow-up|3|||
105895913|NCT03769194|365274102|FG001|Overall Study|Lost to Follow-up|6|||
106123693|NCT03857841|366109844|FG000|Overall Study|Study Terminated by Sponsor|1|||
106123694|NCT03857841|366109845|FG001|Overall Study|Study Terminated by Sponsor|0|||
106123695|NCT03857841|366109846|FG002|Overall Study|Study Terminated by Sponsor|0|||
106123696|NCT03857841|366109847|FG003|Overall Study|Study Terminated by Sponsor|0|||
106123697|NCT02781506|366111587|FG000|Overall Study|Adverse Event|5|||
106123698|NCT00581113|366111588|FG000|Overall Study|Withdrawal by Subject|0|||
106123699|NCT00581113|366111589|FG001|Overall Study|Withdrawal by Subject|1|||
106123700|NCT01818141|366111590|FG000|Overall Study|Withdrawal by Subject|2|||
106123701|NCT01818141|366111591|FG001|Overall Study|Withdrawal by Subject|0|||
106123702|NCT01818141|366111590|FG000|Overall Study|No baseline C.diff colonies|1|||
106123703|NCT01818141|366111591|FG001|Overall Study|No baseline C.diff colonies|1|||
105667613|NCT03126110|364448158|FG007|Phase 2|Death|0|||
105667614|NCT03126110|364448159|FG008|Phase 2|Death|0|||
105667615|NCT03126110|364448160|FG009|Phase 2|Death|0|||
105667616|NCT03126110|364448161|FG010|Phase 2|Death|0|||
105667617|NCT03126110|364448162|FG011|Phase 2|Death|6|||
105667618|NCT03126110|364448163|FG012|Phase 2|Death|12|||
105667619|NCT03126110|364448164|FG013|Phase 2|Death|25|||
105667620|NCT03126110|364448165|FG014|Phase 2|Death|11|||
105667621|NCT03126110|364448166|FG015|Phase 2|Death|3|||
105667622|NCT03126110|364448167|FG016|Phase 2|Death|2|||
105667623|NCT03126110|364448151|FG000|Phase 2|Progressive Disease|0|||
105667624|NCT03126110|364448152|FG001|Phase 2|Progressive Disease|0|||
105667625|NCT03126110|364448153|FG002|Phase 2|Progressive Disease|0|||
105667626|NCT03126110|364448154|FG003|Phase 2|Progressive Disease|0|||
105895914|NCT03769194|365274103|FG002|Overall Study|Lost to Follow-up|3|||
105667627|NCT03126110|364448155|FG004|Phase 2|Progressive Disease|0|||
105667628|NCT03126110|364448156|FG005|Phase 2|Progressive Disease|0|||
105667629|NCT03126110|364448157|FG006|Phase 2|Progressive Disease|0|||
105667630|NCT03126110|364448158|FG007|Phase 2|Progressive Disease|0|||
105667631|NCT03126110|364448159|FG008|Phase 2|Progressive Disease|0|||
105667632|NCT03126110|364448160|FG009|Phase 2|Progressive Disease|0|||
105667633|NCT03126110|364448161|FG010|Phase 2|Progressive Disease|0|||
105667634|NCT03126110|364448162|FG011|Phase 2|Progressive Disease|0|||
105667635|NCT03126110|364448163|FG012|Phase 2|Progressive Disease|0|||
105667636|NCT03126110|364448164|FG013|Phase 2|Progressive Disease|1|||
105667637|NCT03126110|364448165|FG014|Phase 2|Progressive Disease|0|||
105667638|NCT03126110|364448166|FG015|Phase 2|Progressive Disease|0|||
105667639|NCT03126110|364448167|FG016|Phase 2|Progressive Disease|0|||
105667640|NCT03126110|364448151|FG000|Phase 2|Started new treatment|0|||
105667641|NCT03126110|364448152|FG001|Phase 2|Started new treatment|0|||
105667642|NCT03126110|364448153|FG002|Phase 2|Started new treatment|0|||
105895915|NCT03769194|365274104|FG003|Overall Study|Lost to Follow-up|6|||
105895916|NCT03769194|365274101|FG000|Overall Study|other|1|||
105667643|NCT03126110|364448154|FG003|Phase 2|Started new treatment|0|||
105667644|NCT03126110|364448155|FG004|Phase 2|Started new treatment|0|||
105667645|NCT03126110|364448156|FG005|Phase 2|Started new treatment|0|||
105895917|NCT03769194|365274102|FG001|Overall Study|other|3|||
105667646|NCT03126110|364448157|FG006|Phase 2|Started new treatment|0|||
105895918|NCT03769194|365274103|FG002|Overall Study|other|0|||
105895919|NCT03769194|365274104|FG003|Overall Study|other|1|||
105895920|NCT05385224|365274105|FG000|Overall Study|Unable to swallow capsule|2|||
106123704|NCT01818141|366111590|FG000|Overall Study|Lost to Follow-up|0|||
106123705|NCT01818141|366111591|FG001|Overall Study|Lost to Follow-up|2|||
105667647|NCT03126110|364448158|FG007|Phase 2|Started new treatment|0|||
105667648|NCT03126110|364448159|FG008|Phase 2|Started new treatment|0|||
105667649|NCT03126110|364448160|FG009|Phase 2|Started new treatment|0|||
105667650|NCT03126110|364448161|FG010|Phase 2|Started new treatment|0|||
105667651|NCT03126110|364448162|FG011|Phase 2|Started new treatment|0|||
105667652|NCT03126110|364448163|FG012|Phase 2|Started new treatment|0|||
105667653|NCT03126110|364448164|FG013|Phase 2|Started new treatment|0|||
105667654|NCT03126110|364448165|FG014|Phase 2|Started new treatment|1|||
105667655|NCT03126110|364448166|FG015|Phase 2|Started new treatment|0|||
105667656|NCT03126110|364448167|FG016|Phase 2|Started new treatment|0|||
105895921|NCT05385224|365274105|FG000|Overall Study|Withdrawal by Subject|2|||
105895922|NCT05385224|365274105|FG000|Overall Study|Did not meet study criteria|1|||
105895923|NCT00087126|365274110|FG000|Overall Study|Ineligible - second primary|1|||
105895924|NCT00087126|365274110|FG000|Overall Study|Never treated|1|||
106123706|NCT01807221|366111593|FG000|Overall Study|Progressive disease|1|||
105667657|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
105667658|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
105667659|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
105667660|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
105667661|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105667662|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
105667663|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105667664|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105667665|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105667666|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105667667|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105667668|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105667669|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
105667670|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
105667671|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105667672|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105667673|NCT01263509|364448168|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
105667674|NCT01263509|364448169|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
105667675|NCT01263509|364448170|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
105667676|NCT01263509|364448171|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
105667677|NCT01436305|364448179|FG000|Overall Study|Death|1|||
105667678|NCT01436305|364448180|FG001|Overall Study|Death|0|||
105667679|NCT01436305|364448181|FG002|Overall Study|Death|0|||
105667680|NCT01436305|364448179|FG000|Overall Study|Lost to Follow-up|0|||
105667681|NCT01436305|364448180|FG001|Overall Study|Lost to Follow-up|1|||
105667682|NCT01436305|364448181|FG002|Overall Study|Lost to Follow-up|0|||
105667683|NCT01436305|364448179|FG000|Overall Study|Withdrawal by Subject|1|||
105667684|NCT01436305|364448180|FG001|Overall Study|Withdrawal by Subject|3|||
105667685|NCT01436305|364448181|FG002|Overall Study|Withdrawal by Subject|0|||
105667686|NCT01081886|364448182|FG000|Overall Study|Study termination|11|||
105667687|NCT01081886|364448183|FG001|Overall Study|Study termination|13|||
105667688|NCT02567708|364448184|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
105667689|NCT02567708|364448185|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
105667690|NCT02567708|364448184|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
105667691|NCT02567708|364448185|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
105667692|NCT02567708|364448184|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
105667693|NCT02567708|364448185|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
105667694|NCT02567708|364448184|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
105667695|NCT02567708|364448185|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
105667696|NCT04148651|364448186|FG000|Overall Study|Lost to Follow-up|2|||
105667697|NCT01371825|364448187|FG000|Overall Study|Death|4|||
105667698|NCT05262751|364448188|FG000|Washout Period 2|Adverse Event|1|||
105667699|NCT05262751|364448189|FG001|Washout Period 2|Adverse Event|0|||
105667700|NCT05262751|364448190|FG002|Washout Period 2|Adverse Event|0|||
105667701|NCT05262751|364448191|FG003|Washout Period 2|Adverse Event|0|||
105667702|NCT05262751|364448192|FG004|Washout Period 2|Adverse Event|0|||
105667703|NCT05262751|364448193|FG005|Washout Period 2|Adverse Event|0|||
105667704|NCT05262751|364448188|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
105667705|NCT05262751|364448189|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
105667706|NCT05262751|364448190|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
105667707|NCT05262751|364448191|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
105667708|NCT05262751|364448192|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
105667709|NCT05262751|364448193|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
105667710|NCT00895895|364448196|FG000|Period 1|Adverse Event|7|||
105667711|NCT00895895|364448197|FG001|Period 1|Adverse Event|6|||
105667712|NCT00895895|364448198|FG002|Period 1|Adverse Event|4|||
105667713|NCT00895895|364448199|FG003|Period 1|Adverse Event|6|||
105667714|NCT00895895|364448200|FG004|Period 1|Adverse Event|7|||
105667715|NCT00895895|364448196|FG000|Period 1|Death|0|||
105667716|NCT00895895|364448197|FG001|Period 1|Death|0|||
105667717|NCT00895895|364448198|FG002|Period 1|Death|0|||
105667718|NCT00895895|364448199|FG003|Period 1|Death|0|||
105667719|NCT00895895|364448200|FG004|Period 1|Death|1|||
105667720|NCT00895895|364448196|FG000|Period 1|discontinued by sponsor|2|||
105667721|NCT00895895|364448197|FG001|Period 1|discontinued by sponsor|1|||
105667722|NCT00895895|364448198|FG002|Period 1|discontinued by sponsor|2|||
105667723|NCT00895895|364448199|FG003|Period 1|discontinued by sponsor|1|||
105895925|NCT02565706|365274115|FG000|Overall Study|Withdrawal by Subject|5|||
105895926|NCT02565706|365274116|FG001|Overall Study|Withdrawal by Subject|7|||
105667724|NCT00895895|364448200|FG004|Period 1|discontinued by sponsor|1|||
105667725|NCT00895895|364448196|FG000|Period 1|failed to return|0|||
105667726|NCT00895895|364448197|FG001|Period 1|failed to return|0|||
105667727|NCT00895895|364448198|FG002|Period 1|failed to return|1|||
105667728|NCT00895895|364448199|FG003|Period 1|failed to return|0|||
105667729|NCT00895895|364448200|FG004|Period 1|failed to return|1|||
105667730|NCT00895895|364448196|FG000|Period 1|investigator request|0|||
105667731|NCT00895895|364448197|FG001|Period 1|investigator request|1|||
105667732|NCT00895895|364448198|FG002|Period 1|investigator request|0|||
105667733|NCT00895895|364448199|FG003|Period 1|investigator request|0|||
105667734|NCT00895895|364448200|FG004|Period 1|investigator request|0|||
105667735|NCT00895895|364448196|FG000|Period 1|Lost to Follow-up|2|||
105667736|NCT00895895|364448197|FG001|Period 1|Lost to Follow-up|1|||
105667737|NCT00895895|364448198|FG002|Period 1|Lost to Follow-up|3|||
105667738|NCT00895895|364448199|FG003|Period 1|Lost to Follow-up|2|||
105667739|NCT00895895|364448200|FG004|Period 1|Lost to Follow-up|3|||
105667740|NCT00895895|364448196|FG000|Period 1|Other|1|||
105667741|NCT00895895|364448197|FG001|Period 1|Other|2|||
105667742|NCT00895895|364448198|FG002|Period 1|Other|1|||
105667743|NCT00895895|364448199|FG003|Period 1|Other|1|||
105667744|NCT00895895|364448200|FG004|Period 1|Other|1|||
105667745|NCT00895895|364448196|FG000|Period 1|Protocol Violation|0|||
105667746|NCT00895895|364448197|FG001|Period 1|Protocol Violation|1|||
105667747|NCT00895895|364448198|FG002|Period 1|Protocol Violation|0|||
105667748|NCT00895895|364448199|FG003|Period 1|Protocol Violation|0|||
105667749|NCT00895895|364448200|FG004|Period 1|Protocol Violation|0|||
105667750|NCT00895895|364448196|FG000|Period 1|Withdrawal by Subject|6|||
105667751|NCT00895895|364448197|FG001|Period 1|Withdrawal by Subject|6|||
105667752|NCT00895895|364448198|FG002|Period 1|Withdrawal by Subject|8|||
105667753|NCT00895895|364448199|FG003|Period 1|Withdrawal by Subject|2|||
105667754|NCT00895895|364448200|FG004|Period 1|Withdrawal by Subject|4|||
105667755|NCT00895895|364448196|FG000|Period 1|unsatisfactory response-efficacy|2|||
105667756|NCT00895895|364448197|FG001|Period 1|unsatisfactory response-efficacy|0|||
105667757|NCT00895895|364448198|FG002|Period 1|unsatisfactory response-efficacy|0|||
105667758|NCT00895895|364448199|FG003|Period 1|unsatisfactory response-efficacy|0|||
105667759|NCT00895895|364448200|FG004|Period 1|unsatisfactory response-efficacy|0|||
105667760|NCT00895895|364448196|FG000|Period 1|randomized and not treated|1|||
105667761|NCT00895895|364448197|FG001|Period 1|randomized and not treated|3|||
105667762|NCT00895895|364448198|FG002|Period 1|randomized and not treated|1|||
105667763|NCT00895895|364448199|FG003|Period 1|randomized and not treated|1|||
105667764|NCT00895895|364448200|FG004|Period 1|randomized and not treated|2|||
105667765|NCT00895895|364448196|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
105667766|NCT00895895|364448197|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
105667767|NCT00895895|364448198|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
105667768|NCT00895895|364448199|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
105667769|NCT00895895|364448200|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
105667770|NCT00895895|364448196|FG000|After Period 1, Prior to Period 2|Other|0|||
105667771|NCT00895895|364448197|FG001|After Period 1, Prior to Period 2|Other|0|||
105667772|NCT00895895|364448198|FG002|After Period 1, Prior to Period 2|Other|1|||
105667773|NCT00895895|364448199|FG003|After Period 1, Prior to Period 2|Other|0|||
105667774|NCT00895895|364448200|FG004|After Period 1, Prior to Period 2|Other|0|||
105667775|NCT00895895|364448196|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
105667776|NCT00895895|364448197|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
105667777|NCT00895895|364448198|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
105667778|NCT00895895|364448199|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
105895927|NCT02565706|365274117|FG002|Overall Study|Withdrawal by Subject|7|||
105895928|NCT02565706|365274118|FG003|Overall Study|Withdrawal by Subject|11|||
105895929|NCT02565706|365274115|FG000|Overall Study|Lost to Follow-up|72|||
105895930|NCT02565706|365274116|FG001|Overall Study|Lost to Follow-up|75|||
105895931|NCT02565706|365274117|FG002|Overall Study|Lost to Follow-up|82|||
106123707|NCT01807221|366111594|FG001|Overall Study|Progressive disease|0|||
105667779|NCT00895895|364448200|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
105667780|NCT00895895|364448196|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
105667781|NCT00895895|364448197|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
105667782|NCT00895895|364448198|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
105667783|NCT00895895|364448199|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
105667784|NCT00895895|364448200|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
105895932|NCT02565706|365274118|FG003|Overall Study|Lost to Follow-up|74|||
105667785|NCT00895895|364448196|FG000|Period 2|Adverse Event|3|||
105667786|NCT00895895|364448197|FG001|Period 2|Adverse Event|3|||
105667787|NCT00895895|364448198|FG002|Period 2|Adverse Event|5|||
105667788|NCT00895895|364448199|FG003|Period 2|Adverse Event|2|||
105667789|NCT00895895|364448200|FG004|Period 2|Adverse Event|5|||
105667790|NCT00895895|364448196|FG000|Period 2|Death|0|||
105667791|NCT00895895|364448197|FG001|Period 2|Death|0|||
105667792|NCT00895895|364448198|FG002|Period 2|Death|1|||
105667793|NCT00895895|364448199|FG003|Period 2|Death|0|||
105895933|NCT01935700|365274121|FG000|Overall Study|Withdrawal by Subject|1|||
105667794|NCT00895895|364448200|FG004|Period 2|Death|0|||
105667795|NCT00895895|364448196|FG000|Period 2|discontinued by sponsor|44|||
105667796|NCT00895895|364448197|FG001|Period 2|discontinued by sponsor|44|||
105667797|NCT00895895|364448198|FG002|Period 2|discontinued by sponsor|38|||
105667798|NCT00895895|364448199|FG003|Period 2|discontinued by sponsor|46|||
105667799|NCT00895895|364448200|FG004|Period 2|discontinued by sponsor|37|||
105667800|NCT00895895|364448196|FG000|Period 2|failed to return|2|||
105667801|NCT00895895|364448197|FG001|Period 2|failed to return|0|||
105667802|NCT00895895|364448198|FG002|Period 2|failed to return|0|||
105667803|NCT00895895|364448199|FG003|Period 2|failed to return|0|||
105667804|NCT00895895|364448200|FG004|Period 2|failed to return|0|||
105667805|NCT00895895|364448196|FG000|Period 2|investigator request|2|||
105667806|NCT00895895|364448197|FG001|Period 2|investigator request|0|||
105667807|NCT00895895|364448198|FG002|Period 2|investigator request|0|||
105667808|NCT00895895|364448199|FG003|Period 2|investigator request|0|||
105667809|NCT00895895|364448200|FG004|Period 2|investigator request|0|||
105667810|NCT00895895|364448196|FG000|Period 2|Lost to Follow-up|1|||
105667811|NCT00895895|364448197|FG001|Period 2|Lost to Follow-up|2|||
105667812|NCT00895895|364448198|FG002|Period 2|Lost to Follow-up|1|||
105667813|NCT00895895|364448199|FG003|Period 2|Lost to Follow-up|1|||
105667814|NCT00895895|364448200|FG004|Period 2|Lost to Follow-up|0|||
105667815|NCT00895895|364448196|FG000|Period 2|Other|1|||
105895934|NCT01935700|365274122|FG001|Overall Study|Withdrawal by Subject|0|||
105667816|NCT00895895|364448197|FG001|Period 2|Other|1|||
105667817|NCT00895895|364448198|FG002|Period 2|Other|3|||
105667818|NCT00895895|364448199|FG003|Period 2|Other|1|||
105667819|NCT00895895|364448200|FG004|Period 2|Other|1|||
105667820|NCT00895895|364448196|FG000|Period 2|Protocol Violation|1|||
105667821|NCT00895895|364448197|FG001|Period 2|Protocol Violation|0|||
105667822|NCT00895895|364448198|FG002|Period 2|Protocol Violation|1|||
105667823|NCT00895895|364448199|FG003|Period 2|Protocol Violation|1|||
105667824|NCT00895895|364448200|FG004|Period 2|Protocol Violation|1|||
105895935|NCT01935700|365274121|FG000|Overall Study|Physician Decision|4|||
105895936|NCT01935700|365274122|FG001|Overall Study|Physician Decision|0|||
105895937|NCT00772005|365274124|FG000|Overall Study|Adverse Event|9|||
105895938|NCT00772005|365274125|FG001|Overall Study|Adverse Event|14|||
105895939|NCT00772005|365274126|FG002|Overall Study|Adverse Event|10|||
105895940|NCT00772005|365274127|FG003|Overall Study|Adverse Event|13|||
105895941|NCT00772005|365274124|FG000|Overall Study|Lack of Efficacy|0|||
105895942|NCT00772005|365274125|FG001|Overall Study|Lack of Efficacy|1|||
105895943|NCT00772005|365274126|FG002|Overall Study|Lack of Efficacy|0|||
105895944|NCT00772005|365274127|FG003|Overall Study|Lack of Efficacy|0|||
105895945|NCT00772005|365274124|FG000|Overall Study|Withdrawal by Subject|3|||
105895946|NCT00772005|365274125|FG001|Overall Study|Withdrawal by Subject|7|||
105895947|NCT00772005|365274126|FG002|Overall Study|Withdrawal by Subject|10|||
106123708|NCT01807221|366111595|FG002|Overall Study|Progressive disease|1|||
106123709|NCT01807221|366111596|FG003|Overall Study|Progressive disease|0|||
106123710|NCT01807221|366111597|FG004|Overall Study|Progressive disease|0|||
106123711|NCT01807221|366111598|FG005|Overall Study|Progressive disease|0|||
106123712|NCT01807221|366111593|FG000|Overall Study|Death|7|||
106123713|NCT01807221|366111594|FG001|Overall Study|Death|9|||
106123714|NCT01807221|366111595|FG002|Overall Study|Death|4|||
106123715|NCT01807221|366111596|FG003|Overall Study|Death|2|||
106123716|NCT01807221|366111597|FG004|Overall Study|Death|1|||
106123717|NCT01807221|366111598|FG005|Overall Study|Death|6|||
106123718|NCT01807221|366111593|FG000|Overall Study|Physician Decision|2|||
106123719|NCT01807221|366111594|FG001|Overall Study|Physician Decision|1|||
106123720|NCT01807221|366111595|FG002|Overall Study|Physician Decision|0|||
106123721|NCT01807221|366111596|FG003|Overall Study|Physician Decision|0|||
106123722|NCT01807221|366111597|FG004|Overall Study|Physician Decision|0|||
106123723|NCT01807221|366111598|FG005|Overall Study|Physician Decision|0|||
106123724|NCT01807221|366111593|FG000|Overall Study|Adverse Event|33|||
106123725|NCT01807221|366111594|FG001|Overall Study|Adverse Event|22|||
106123726|NCT01807221|366111595|FG002|Overall Study|Adverse Event|26|||
106123727|NCT01807221|366111596|FG003|Overall Study|Adverse Event|25|||
106123728|NCT01807221|366111597|FG004|Overall Study|Adverse Event|18|||
106123729|NCT01807221|366111598|FG005|Overall Study|Adverse Event|21|||
106123730|NCT01807221|366111593|FG000|Overall Study|Protocol Violation|0|||
106123731|NCT01807221|366111594|FG001|Overall Study|Protocol Violation|2|||
106123732|NCT01807221|366111595|FG002|Overall Study|Protocol Violation|1|||
106123733|NCT01807221|366111596|FG003|Overall Study|Protocol Violation|2|||
106123734|NCT01807221|366111597|FG004|Overall Study|Protocol Violation|0|||
106123735|NCT01807221|366111598|FG005|Overall Study|Protocol Violation|1|||
106123736|NCT01807221|366111593|FG000|Overall Study|Non-compliance|1|||
106123737|NCT01807221|366111594|FG001|Overall Study|Non-compliance|2|||
106123738|NCT01807221|366111595|FG002|Overall Study|Non-compliance|0|||
106123739|NCT01807221|366111596|FG003|Overall Study|Non-compliance|1|||
106123740|NCT01807221|366111597|FG004|Overall Study|Non-compliance|0|||
106123741|NCT01807221|366111598|FG005|Overall Study|Non-compliance|0|||
106123742|NCT01807221|366111593|FG000|Overall Study|Logistical difficulties|0|||
106123743|NCT01807221|366111594|FG001|Overall Study|Logistical difficulties|1|||
106123744|NCT01807221|366111595|FG002|Overall Study|Logistical difficulties|0|||
106123745|NCT01807221|366111596|FG003|Overall Study|Logistical difficulties|0|||
106123746|NCT01807221|366111597|FG004|Overall Study|Logistical difficulties|1|||
106123747|NCT01807221|366111598|FG005|Overall Study|Logistical difficulties|0|||
106123748|NCT01807221|366111593|FG000|Overall Study|Withdrawal by Subject|33|||
106123749|NCT01807221|366111594|FG001|Overall Study|Withdrawal by Subject|15|||
106123750|NCT01807221|366111595|FG002|Overall Study|Withdrawal by Subject|8|||
106123751|NCT01807221|366111596|FG003|Overall Study|Withdrawal by Subject|14|||
106123752|NCT01807221|366111597|FG004|Overall Study|Withdrawal by Subject|16|||
106123753|NCT01807221|366111598|FG005|Overall Study|Withdrawal by Subject|13|||
106123754|NCT01807221|366111593|FG000|Overall Study|Sponsor decision|2|||
106123755|NCT01807221|366111594|FG001|Overall Study|Sponsor decision|0|||
106123756|NCT01807221|366111595|FG002|Overall Study|Sponsor decision|1|||
106123757|NCT01807221|366111596|FG003|Overall Study|Sponsor decision|1|||
106123758|NCT01807221|366111597|FG004|Overall Study|Sponsor decision|0|||
106123759|NCT01807221|366111598|FG005|Overall Study|Sponsor decision|0|||
106123760|NCT01807221|366111593|FG000|Overall Study|Lost to Follow-up|1|||
106123761|NCT01807221|366111594|FG001|Overall Study|Lost to Follow-up|0|||
106123762|NCT01807221|366111595|FG002|Overall Study|Lost to Follow-up|2|||
106123763|NCT01807221|366111596|FG003|Overall Study|Lost to Follow-up|1|||
105895948|NCT00772005|365274127|FG003|Overall Study|Withdrawal by Subject|2|||
106123764|NCT01807221|366111597|FG004|Overall Study|Lost to Follow-up|0|||
105895949|NCT00772005|365274124|FG000|Overall Study|Protocol Violation|2|||
105895950|NCT00772005|365274125|FG001|Overall Study|Protocol Violation|4|||
106123765|NCT01807221|366111598|FG005|Overall Study|Lost to Follow-up|0|||
106123766|NCT02609659|366111599|FG000|Overall Study|Adverse Event|1|||
106123767|NCT02609659|366111599|FG000|Overall Study|Lost to Follow-up|6|||
106123768|NCT02609659|366111599|FG000|Overall Study|Other|1|||
106123769|NCT03545113|366111600|FG000|Overall Study|Surgery Cancelled|1|||
106123770|NCT03545113|366111601|FG001|Overall Study|Surgery Cancelled|0|||
106123771|NCT03545113|366111600|FG000|Overall Study|Death|1|||
106123772|NCT03545113|366111601|FG001|Overall Study|Death|0|||
105895951|NCT00772005|365274126|FG002|Overall Study|Protocol Violation|1|||
105895952|NCT00772005|365274127|FG003|Overall Study|Protocol Violation|6|||
105895953|NCT00772005|365274124|FG000|Overall Study|Lost to Follow-up|7|||
105895954|NCT00772005|365274125|FG001|Overall Study|Lost to Follow-up|3|||
105895955|NCT00772005|365274126|FG002|Overall Study|Lost to Follow-up|6|||
105895956|NCT00772005|365274127|FG003|Overall Study|Lost to Follow-up|3|||
105895957|NCT00772005|365274124|FG000|Overall Study|Non-compliance with study procedures|1|||
105895958|NCT00772005|365274125|FG001|Overall Study|Non-compliance with study procedures|1|||
105895959|NCT00772005|365274126|FG002|Overall Study|Non-compliance with study procedures|0|||
105895960|NCT00772005|365274127|FG003|Overall Study|Non-compliance with study procedures|1|||
105895961|NCT00772005|365274124|FG000|Overall Study|Non-compliance with drug administration|3|||
105895962|NCT00772005|365274125|FG001|Overall Study|Non-compliance with drug administration|0|||
105895963|NCT00772005|365274126|FG002|Overall Study|Non-compliance with drug administration|1|||
105895964|NCT00772005|365274127|FG003|Overall Study|Non-compliance with drug administration|1|||
105895965|NCT01273155|365274129|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
105895966|NCT01273155|365274130|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
105895967|NCT01273155|365274131|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
105895968|NCT01273155|365274132|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
105895969|NCT01273155|365274133|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
105895970|NCT01273155|365274134|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
105895971|NCT01273155|365274135|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
105895972|NCT01273155|365274129|FG000|Overall Study|Change in liver function/no longer eval.|0|||
105895973|NCT01273155|365274130|FG001|Overall Study|Change in liver function/no longer eval.|1|||
105895974|NCT01273155|365274131|FG002|Overall Study|Change in liver function/no longer eval.|0|||
105895975|NCT01273155|365274132|FG003|Overall Study|Change in liver function/no longer eval.|0|||
105895976|NCT01273155|365274133|FG004|Overall Study|Change in liver function/no longer eval.|1|||
105895977|NCT01273155|365274134|FG005|Overall Study|Change in liver function/no longer eval.|0|||
105895978|NCT01273155|365274135|FG006|Overall Study|Change in liver function/no longer eval.|0|||
105895979|NCT01273155|365274129|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
105895980|NCT01273155|365274130|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
105895981|NCT01273155|365274131|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
105895982|NCT01273155|365274132|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
105895983|NCT01273155|365274133|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
105895984|NCT01273155|365274134|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
105895985|NCT01273155|365274135|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
105895986|NCT01273155|365274129|FG000|Overall Study|Died during Cycle 1|0|||
105895987|NCT01273155|365274130|FG001|Overall Study|Died during Cycle 1|0|||
105895988|NCT01273155|365274131|FG002|Overall Study|Died during Cycle 1|1|||
105895989|NCT01273155|365274132|FG003|Overall Study|Died during Cycle 1|1|||
105895990|NCT01273155|365274133|FG004|Overall Study|Died during Cycle 1|0|||
105895991|NCT01273155|365274134|FG005|Overall Study|Died during Cycle 1|2|||
105895992|NCT01273155|365274135|FG006|Overall Study|Died during Cycle 1|2|||
105895993|NCT01273155|365274129|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
105895994|NCT01273155|365274130|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
105895995|NCT01273155|365274131|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
105895996|NCT01273155|365274132|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
105895997|NCT01273155|365274133|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
105895998|NCT01273155|365274134|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
105895999|NCT01273155|365274135|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
105896000|NCT00090987|365274138|FG000|Overall Study|Adverse Event|5|||
105896001|NCT00090987|365274138|FG000|Overall Study|Lack of Efficacy|7|||
105896002|NCT00090987|365274138|FG000|Overall Study|Withdrawal by Subject|3|||
105896003|NCT00090987|365274138|FG000|Overall Study|alternative therapy|1|||
105896004|NCT00090987|365274138|FG000|Overall Study|Non-compliance|4|||
106123773|NCT03545113|366111600|FG000|Overall Study|Adverse Event|2|||
106123774|NCT03545113|366111601|FG001|Overall Study|Adverse Event|0|||
106123775|NCT03545113|366111600|FG000|Overall Study|Received different surgery|1|||
106123776|NCT03545113|366111601|FG001|Overall Study|Received different surgery|0|||
106123777|NCT01017120|366111606|FG000|Overall Study|Adverse Event|9|||
106123778|NCT01017120|366111607|FG001|Overall Study|Adverse Event|0|||
106123779|NCT01017120|366111606|FG000|Overall Study|Lost to Follow-up|13|||
106123780|NCT01017120|366111607|FG001|Overall Study|Lost to Follow-up|11|||
106123781|NCT01017120|366111606|FG000|Overall Study|Lack of Efficacy|1|||
106123782|NCT01017120|366111607|FG001|Overall Study|Lack of Efficacy|0|||
106123783|NCT01017120|366111606|FG000|Overall Study|Withdrawal by Subject|39|||
106123784|NCT01017120|366111607|FG001|Overall Study|Withdrawal by Subject|21|||
105896005|NCT00090987|365274138|FG000|Overall Study|Incarcerated|1|||
105896006|NCT02124759|365274142|FG000|Overall Study|Withdrawal by Subject|3|||
105896007|NCT02124759|365274143|FG001|Overall Study|Withdrawal by Subject|1|||
106123785|NCT01017120|366111606|FG000|Overall Study|Pregnancy|1|||
106123786|NCT01017120|366111607|FG001|Overall Study|Pregnancy|1|||
106123787|NCT01017120|366111606|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
105896008|NCT02124759|365274144|FG002|Overall Study|Withdrawal by Subject|1|||
105896009|NCT02124759|365274142|FG000|Overall Study|Screen Fail|2|||
105896010|NCT02124759|365274143|FG001|Overall Study|Screen Fail|2|||
105896011|NCT02124759|365274144|FG002|Overall Study|Screen Fail|3|||
105896012|NCT04769739|365274145|FG000|Overall Study|Colorectal cancer obstruction|2|||
105896013|NCT04769739|365274146|FG001|Overall Study|Colorectal cancer obstruction|0|||
105896014|NCT04769739|365274147|FG002|Overall Study|Colorectal cancer obstruction|0|||
105896015|NCT04769739|365274148|FG003|Overall Study|Colorectal cancer obstruction|0|||
105896016|NCT04769739|365274145|FG000|Overall Study|Failed cecal intubation|1|||
105896017|NCT04769739|365274146|FG001|Overall Study|Failed cecal intubation|0|||
105896018|NCT04769739|365274147|FG002|Overall Study|Failed cecal intubation|0|||
105896019|NCT04769739|365274148|FG003|Overall Study|Failed cecal intubation|1|||
105896020|NCT04769739|365274145|FG000|Overall Study|Poor bowel preparation|0|||
105896021|NCT04769739|365274146|FG001|Overall Study|Poor bowel preparation|0|||
105896022|NCT04769739|365274147|FG002|Overall Study|Poor bowel preparation|0|||
105896023|NCT04769739|365274148|FG003|Overall Study|Poor bowel preparation|1|||
105896024|NCT01731470|365274149|FG000|Overall Study|Withdrawal by Subject|1|||
105896025|NCT01731470|365274149|FG000|Overall Study|Did not meet study criteria|1|||
105896026|NCT03325894|365274150|FG000|Overall Study|Adverse Event|2|||
105896027|NCT03325894|365274151|FG001|Overall Study|Adverse Event|3|||
105896028|NCT03325894|365274150|FG000|Overall Study|Protocol Violation|1|||
105896029|NCT03325894|365274151|FG001|Overall Study|Protocol Violation|2|||
105896030|NCT03325894|365274150|FG000|Overall Study|Withdrawal by Subject|10|||
105896031|NCT03325894|365274151|FG001|Overall Study|Withdrawal by Subject|6|||
105896032|NCT03325894|365274150|FG000|Overall Study|Lost to Follow-up|4|||
105896033|NCT03325894|365274151|FG001|Overall Study|Lost to Follow-up|9|||
105896034|NCT03325894|365274150|FG000|Overall Study|Lack of Efficacy|8|||
105896035|NCT03325894|365274151|FG001|Overall Study|Lack of Efficacy|14|||
105896036|NCT03325894|365274150|FG000|Overall Study|Study Terminated by Sponsor|38|||
105896037|NCT03325894|365274151|FG001|Overall Study|Study Terminated by Sponsor|43|||
105896038|NCT03325894|365274150|FG000|Overall Study|Other (Not received Treatment)|1|||
105896039|NCT03325894|365274151|FG001|Overall Study|Other (Not received Treatment)|0|||
105896040|NCT01001598|365274154|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
105896041|NCT01001598|365274154|FG000|Overall Study|Adverse Event|1|||
105896042|NCT02923245|365274162|FG000|Overall Study|ultrasound order was cancelled|2|||
105896043|NCT02923245|365274163|FG001|Overall Study|ultrasound order was cancelled|1|||
105896044|NCT01037127|365274165|FG000|Overall Study|Lost to Follow-up|2|||
105896045|NCT01037127|365274166|FG001|Overall Study|Lost to Follow-up|4|||
105896046|NCT01037127|365274165|FG000|Overall Study|Physician Decision|1|||
105896047|NCT01037127|365274166|FG001|Overall Study|Physician Decision|0|||
105896048|NCT01037127|365274165|FG000|Overall Study|Study Closed Terminated|2|||
105896049|NCT01037127|365274166|FG001|Overall Study|Study Closed Terminated|17|||
105896050|NCT02987972|365274167|FG000|Overall Study|Adverse Event|1|||
105896051|NCT02987972|365274168|FG001|Overall Study|Adverse Event|1|||
105896052|NCT02987972|365274169|FG002|Overall Study|Adverse Event|0|||
105896053|NCT02987972|365274167|FG000|Overall Study|Death|1|||
105896054|NCT02987972|365274168|FG001|Overall Study|Death|0|||
105896055|NCT02987972|365274169|FG002|Overall Study|Death|0|||
105896056|NCT02987972|365274167|FG000|Overall Study|Lack of Efficacy|9|||
105896057|NCT02987972|365274168|FG001|Overall Study|Lack of Efficacy|12|||
105896058|NCT02987972|365274169|FG002|Overall Study|Lack of Efficacy|12|||
105896059|NCT02987972|365274167|FG000|Overall Study|Lost to Follow-up|7|||
105896060|NCT02987972|365274168|FG001|Overall Study|Lost to Follow-up|8|||
105896061|NCT02987972|365274169|FG002|Overall Study|Lost to Follow-up|4|||
105896062|NCT02987972|365274167|FG000|Overall Study|Physician Decision|1|||
105896063|NCT02987972|365274168|FG001|Overall Study|Physician Decision|6|||
106123788|NCT01017120|366111607|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
106123789|NCT01017120|366111606|FG000|Overall Study|Relocated Out of Town|0|||
106123790|NCT01017120|366111607|FG001|Overall Study|Relocated Out of Town|2|||
106123791|NCT01017120|366111606|FG000|Overall Study|Protocol Violation|1|||
106123792|NCT01017120|366111607|FG001|Overall Study|Protocol Violation|0|||
105896064|NCT02987972|365274169|FG002|Overall Study|Physician Decision|0|||
105896065|NCT02987972|365274167|FG000|Overall Study|Protocol Violation|2|||
105896066|NCT02987972|365274168|FG001|Overall Study|Protocol Violation|1|||
105896067|NCT02987972|365274169|FG002|Overall Study|Protocol Violation|5|||
105896068|NCT02987972|365274167|FG000|Overall Study|Withdrawal by Subject|22|||
105896069|NCT02987972|365274168|FG001|Overall Study|Withdrawal by Subject|17|||
105896070|NCT02987972|365274169|FG002|Overall Study|Withdrawal by Subject|21|||
105896071|NCT04438499|365274170|FG000|Overall Study|Lack of Efficacy|3|||
105896072|NCT01390428|365275914|FG000|Overall Study|Elective Surgery|0|||
105896073|NCT01390428|365275915|FG001|Overall Study|Elective Surgery|0|||
105896074|NCT01390428|365275916|FG002|Overall Study|Elective Surgery|0|||
105896075|NCT01390428|365275917|FG003|Overall Study|Elective Surgery|0|||
105896076|NCT01390428|365275918|FG004|Overall Study|Elective Surgery|1|||
105896077|NCT01390428|365275919|FG005|Overall Study|Elective Surgery|0|||
105896078|NCT01390428|365275914|FG000|Overall Study|Withdrawal by Subject|0|||
105896079|NCT01390428|365275915|FG001|Overall Study|Withdrawal by Subject|0|||
105896080|NCT01390428|365275916|FG002|Overall Study|Withdrawal by Subject|1|||
105667825|NCT00895895|364448196|FG000|Period 2|Withdrawal by Subject|0|||
105667826|NCT00895895|364448197|FG001|Period 2|Withdrawal by Subject|2|||
105896081|NCT01390428|365275917|FG003|Overall Study|Withdrawal by Subject|0|||
105896082|NCT01390428|365275918|FG004|Overall Study|Withdrawal by Subject|0|||
105896083|NCT01390428|365275919|FG005|Overall Study|Withdrawal by Subject|0|||
105896084|NCT01556997|365275920|FG000|Overall Study|Adverse Event|10|||
105896085|NCT01556997|365275921|FG001|Overall Study|Adverse Event|12|||
105896086|NCT01556997|365275922|FG002|Overall Study|Adverse Event|12|||
105896087|NCT01556997|365275920|FG000|Overall Study|Lost to Follow-up|6|||
105896088|NCT01556997|365275921|FG001|Overall Study|Lost to Follow-up|6|||
105896089|NCT01556997|365275922|FG002|Overall Study|Lost to Follow-up|4|||
105896090|NCT01556997|365275920|FG000|Overall Study|Physician Decision|1|||
105896091|NCT01556997|365275921|FG001|Overall Study|Physician Decision|1|||
105896092|NCT01556997|365275922|FG002|Overall Study|Physician Decision|1|||
105896093|NCT01556997|365275920|FG000|Overall Study|Withdrawal by Subject|7|||
105896094|NCT01556997|365275921|FG001|Overall Study|Withdrawal by Subject|6|||
105896095|NCT01556997|365275922|FG002|Overall Study|Withdrawal by Subject|8|||
105896096|NCT01556997|365275920|FG000|Overall Study|Other|2|||
105896097|NCT01556997|365275921|FG001|Overall Study|Other|3|||
105896098|NCT01556997|365275922|FG002|Overall Study|Other|7|||
105896099|NCT01937715|365275928|FG000|Overall Study|Death|0|||
105896100|NCT01937715|365275929|FG001|Overall Study|Death|0|||
105896101|NCT01937715|365275930|FG002|Overall Study|Death|0|||
105896102|NCT01937715|365275931|FG003|Overall Study|Death|1|||
105896103|NCT01937715|365275932|FG004|Overall Study|Death|0|||
105896104|NCT01937715|365275928|FG000|Overall Study|Withdrawal by Subject|0|||
105896105|NCT01937715|365275929|FG001|Overall Study|Withdrawal by Subject|1|||
105896106|NCT01937715|365275930|FG002|Overall Study|Withdrawal by Subject|0|||
105896107|NCT01937715|365275931|FG003|Overall Study|Withdrawal by Subject|0|||
105896108|NCT01937715|365275932|FG004|Overall Study|Withdrawal by Subject|2|||
105896109|NCT01937715|365275928|FG000|Overall Study|Other|0|||
105896110|NCT01937715|365275929|FG001|Overall Study|Other|0|||
105896111|NCT01937715|365275930|FG002|Overall Study|Other|0|||
105896112|NCT01937715|365275931|FG003|Overall Study|Other|3|||
105896113|NCT01937715|365275932|FG004|Overall Study|Other|0|||
105896114|NCT01777139|365275933|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
105896115|NCT01777139|365275934|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
105896116|NCT01777139|365275933|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
105896117|NCT01777139|365275934|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
105896118|NCT01777139|365275933|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
105896119|NCT01777139|365275934|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
105896120|NCT01777139|365275933|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
105896121|NCT01777139|365275934|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
105896122|NCT01777139|365275933|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
105896123|NCT01777139|365275934|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
105896124|NCT01777139|365275933|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
105896125|NCT01777139|365275934|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
105896126|NCT01777139|365275933|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
105896127|NCT01777139|365275934|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
105896128|NCT01777139|365275933|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
105896129|NCT01777139|365275934|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
105896130|NCT02921750|365275935|FG000|Overall Study|Adverse Event|1|||
105896131|NCT02921750|365275936|FG001|Overall Study|Adverse Event|2|||
105896132|NCT02921750|365275935|FG000|Overall Study|Withdrawal by Subject|1|||
105896133|NCT02921750|365275936|FG001|Overall Study|Withdrawal by Subject|1|||
105896134|NCT02921750|365275935|FG000|Overall Study|Lost to Follow-up|3|||
105896135|NCT02921750|365275936|FG001|Overall Study|Lost to Follow-up|3|||
105896136|NCT02921750|365275935|FG000|Overall Study|Wound healed|3|||
105896137|NCT02921750|365275936|FG001|Overall Study|Wound healed|3|||
105667827|NCT00895895|364448198|FG002|Period 2|Withdrawal by Subject|0|||
105896138|NCT02921750|365275935|FG000|Overall Study|Serious Adverse Event|1|||
105896139|NCT02921750|365275936|FG001|Overall Study|Serious Adverse Event|2|||
105896140|NCT01451164|365275941|FG000|Overall Study|Adverse Event|19|||
105896141|NCT01451164|365275942|FG001|Overall Study|Adverse Event|12|||
105896142|NCT01451164|365275943|FG002|Overall Study|Adverse Event|18|||
105896143|NCT01451164|365275944|FG003|Overall Study|Adverse Event|21|||
105896144|NCT01451164|365275941|FG000|Overall Study|Withdrawal Criteria|1|||
105896145|NCT01451164|365275942|FG001|Overall Study|Withdrawal Criteria|1|||
105896146|NCT01451164|365275943|FG002|Overall Study|Withdrawal Criteria|1|||
105896147|NCT01451164|365275944|FG003|Overall Study|Withdrawal Criteria|1|||
105896148|NCT01451164|365275941|FG000|Overall Study|Physician Decision|2|||
105896149|NCT01451164|365275942|FG001|Overall Study|Physician Decision|0|||
105896150|NCT01451164|365275943|FG002|Overall Study|Physician Decision|1|||
105896151|NCT01451164|365275944|FG003|Overall Study|Physician Decision|0|||
105896152|NCT01451164|365275941|FG000|Overall Study|Withdrawal by Subject|14|||
105896153|NCT01451164|365275942|FG001|Overall Study|Withdrawal by Subject|11|||
105896154|NCT01451164|365275943|FG002|Overall Study|Withdrawal by Subject|16|||
105896155|NCT01451164|365275944|FG003|Overall Study|Withdrawal by Subject|17|||
105896156|NCT01451164|365275941|FG000|Overall Study|Protocol Violation|0|||
105896157|NCT01451164|365275942|FG001|Overall Study|Protocol Violation|1|||
105896158|NCT01451164|365275943|FG002|Overall Study|Protocol Violation|0|||
105896159|NCT01451164|365275944|FG003|Overall Study|Protocol Violation|0|||
105896160|NCT01451164|365275941|FG000|Overall Study|Lack of Efficacy|7|||
105896161|NCT01451164|365275942|FG001|Overall Study|Lack of Efficacy|9|||
105896162|NCT01451164|365275943|FG002|Overall Study|Lack of Efficacy|9|||
105896163|NCT01451164|365275944|FG003|Overall Study|Lack of Efficacy|7|||
105896164|NCT01458951|365275945|FG000|Overall Study|Other|1|||
105896165|NCT01458951|365275946|FG001|Overall Study|Other|0|||
105896166|NCT01458951|365275947|FG002|Overall Study|Other|0|||
105896167|NCT01458951|365275945|FG000|Overall Study|Protocol Violation|5|||
105896168|NCT01458951|365275946|FG001|Overall Study|Protocol Violation|1|||
105896169|NCT01458951|365275947|FG002|Overall Study|Protocol Violation|0|||
105896170|NCT01458951|365275945|FG000|Overall Study|Withdrawal by Subject|2|||
105896171|NCT01458951|365275946|FG001|Overall Study|Withdrawal by Subject|0|||
105896172|NCT01458951|365275947|FG002|Overall Study|Withdrawal by Subject|2|||
105896173|NCT01458951|365275945|FG000|Overall Study|Adverse Event|7|||
105896174|NCT01458951|365275946|FG001|Overall Study|Adverse Event|0|||
105896175|NCT01458951|365275947|FG002|Overall Study|Adverse Event|2|||
105896176|NCT01458951|365275945|FG000|Overall Study|Insufficient Clinical Response|17|||
105896177|NCT01458951|365275946|FG001|Overall Study|Insufficient Clinical Response|0|||
105896178|NCT01458951|365275947|FG002|Overall Study|Insufficient Clinical Response|11|||
105896179|NCT03309696|365275948|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
105896180|NCT03309696|365275949|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
105896181|NCT03309696|365275950|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
105896182|NCT03309696|365275951|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
105896183|NCT01573767|365275952|FG000|Overall Study|Adverse Event|0|||
105896184|NCT01573767|365275953|FG001|Overall Study|Adverse Event|1|||
105896185|NCT01573767|365275954|FG002|Overall Study|Adverse Event|0|||
105896186|NCT01573767|365275955|FG003|Overall Study|Adverse Event|1|||
105896187|NCT01573767|365275952|FG000|Overall Study|Lack of Efficacy|18|||
105896188|NCT01573767|365275953|FG001|Overall Study|Lack of Efficacy|15|||
105896189|NCT01573767|365275954|FG002|Overall Study|Lack of Efficacy|12|||
105896190|NCT01573767|365275955|FG003|Overall Study|Lack of Efficacy|17|||
105896191|NCT01573767|365275952|FG000|Overall Study|Protocol Violation|3|||
105896192|NCT01573767|365275953|FG001|Overall Study|Protocol Violation|1|||
105896193|NCT01573767|365275954|FG002|Overall Study|Protocol Violation|1|||
105896194|NCT01573767|365275955|FG003|Overall Study|Protocol Violation|3|||
105896195|NCT01573767|365275952|FG000|Overall Study|Lost to Follow-up|0|||
105896196|NCT01573767|365275953|FG001|Overall Study|Lost to Follow-up|1|||
105896197|NCT01573767|365275954|FG002|Overall Study|Lost to Follow-up|1|||
105896198|NCT01573767|365275955|FG003|Overall Study|Lost to Follow-up|1|||
105896199|NCT01573767|365275952|FG000|Overall Study|Physician Decision|1|||
105896200|NCT01573767|365275953|FG001|Overall Study|Physician Decision|2|||
105896201|NCT01573767|365275954|FG002|Overall Study|Physician Decision|0|||
105896202|NCT01573767|365275955|FG003|Overall Study|Physician Decision|2|||
105896203|NCT01573767|365275952|FG000|Overall Study|Withdrawal by Subject|0|||
105896204|NCT01573767|365275953|FG001|Overall Study|Withdrawal by Subject|1|||
105896205|NCT01573767|365275954|FG002|Overall Study|Withdrawal by Subject|0|||
105896206|NCT01573767|365275955|FG003|Overall Study|Withdrawal by Subject|0|||
105896207|NCT01371877|365275956|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
105896208|NCT01371877|365275957|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
105896209|NCT05932225|365275958|FG000|Overall Study|Lost to Follow-up|0|||
105896210|NCT05932225|365275959|FG001|Overall Study|Lost to Follow-up|1|||
105896211|NCT05932225|365275960|FG002|Overall Study|Lost to Follow-up|0|||
105896212|NCT05932225|365275958|FG000|Overall Study|Withdrawal by Subject|1|||
105896213|NCT05932225|365275959|FG001|Overall Study|Withdrawal by Subject|0|||
105896214|NCT05932225|365275960|FG002|Overall Study|Withdrawal by Subject|0|||
106123793|NCT01017120|366111606|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
105896215|NCT05932225|365275958|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
105896216|NCT05932225|365275959|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
105896217|NCT05932225|365275960|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
105997335|NCT03386721|365651423|FG004|Overall Study|Site Terminated by Sponsor|1|||
105997336|NCT03386721|365651424|FG005|Overall Study|Site Terminated by Sponsor|3|||
105997337|NCT03386721|365651425|FG006|Overall Study|Site Terminated by Sponsor|0|||
105997338|NCT03386721|365651426|FG007|Overall Study|Site Terminated by Sponsor|1|||
105997339|NCT03386721|365651427|FG008|Overall Study|Site Terminated by Sponsor|4|||
105997340|NCT03386721|365651428|FG009|Overall Study|Site Terminated by Sponsor|5|||
105997341|NCT03386721|365651429|FG010|Overall Study|Site Terminated by Sponsor|3|||
105997342|NCT03386721|365651430|FG011|Overall Study|Site Terminated by Sponsor|11|||
105997343|NCT03386721|365651431|FG012|Overall Study|Site Terminated by Sponsor|6|||
105997344|NCT03386721|365651432|FG013|Overall Study|Site Terminated by Sponsor|0|||
105997345|NCT03386721|365651433|FG014|Overall Study|Site Terminated by Sponsor|0|||
105997346|NCT03386721|365651419|FG000|Overall Study|Symptomatic Deterioration|0|||
105997347|NCT03386721|365651420|FG001|Overall Study|Symptomatic Deterioration|0|||
105997348|NCT03386721|365651421|FG002|Overall Study|Symptomatic Deterioration|0|||
105997349|NCT03386721|365651422|FG003|Overall Study|Symptomatic Deterioration|0|||
105997350|NCT03386721|365651423|FG004|Overall Study|Symptomatic Deterioration|0|||
105997351|NCT03386721|365651424|FG005|Overall Study|Symptomatic Deterioration|0|||
105997352|NCT03386721|365651425|FG006|Overall Study|Symptomatic Deterioration|0|||
105997353|NCT03386721|365651426|FG007|Overall Study|Symptomatic Deterioration|0|||
105997354|NCT03386721|365651427|FG008|Overall Study|Symptomatic Deterioration|1|||
105997355|NCT03386721|365651428|FG009|Overall Study|Symptomatic Deterioration|0|||
105997356|NCT03386721|365651429|FG010|Overall Study|Symptomatic Deterioration|0|||
105997357|NCT03386721|365651430|FG011|Overall Study|Symptomatic Deterioration|1|||
105997358|NCT03386721|365651431|FG012|Overall Study|Symptomatic Deterioration|0|||
105997359|NCT03386721|365651432|FG013|Overall Study|Symptomatic Deterioration|0|||
105997360|NCT03386721|365651433|FG014|Overall Study|Symptomatic Deterioration|0|||
105997361|NCT03386721|365651419|FG000|Overall Study|Withdrawal by Subject|1|||
105997362|NCT03386721|365651420|FG001|Overall Study|Withdrawal by Subject|2|||
105997363|NCT03386721|365651421|FG002|Overall Study|Withdrawal by Subject|0|||
105997364|NCT03386721|365651422|FG003|Overall Study|Withdrawal by Subject|0|||
106123794|NCT01017120|366111607|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
106123795|NCT00432835|366111610|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
105997365|NCT03386721|365651423|FG004|Overall Study|Withdrawal by Subject|0|||
105997366|NCT03386721|365651424|FG005|Overall Study|Withdrawal by Subject|0|||
106123796|NCT00432835|366111611|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
106123797|NCT02091869|366111619|FG000|Overall Study|Withdrawal by Subject|0|||
106123798|NCT02091869|366111620|FG001|Overall Study|Withdrawal by Subject|3|||
106123799|NCT01024959|366111628|FG000|Overall Study|ineligible|12|||
106123800|NCT01024959|366111628|FG000|Overall Study|results not evaluable|12|||
106123801|NCT01024959|366111628|FG000|Overall Study|missing results required for analysis|17|||
106123802|NCT00594906|366111635|FG000|Overall Study|Physician Decision|1|||
106123803|NCT00594906|366111636|FG001|Overall Study|Physician Decision|0|||
106123804|NCT00594906|366111635|FG000|Overall Study|Physician Decision|0|||
106123805|NCT00594906|366111636|FG001|Overall Study|Physician Decision|1|||
106123806|NCT00594906|366111635|FG000|Overall Study|Death|0|||
106123807|NCT00594906|366111636|FG001|Overall Study|Death|1|||
106123808|NCT00839917|366111637|FG000|Overall Study|Lost to Follow-up|1|||
106123809|NCT00839917|366111638|FG001|Overall Study|Lost to Follow-up|0|||
106123810|NCT00839917|366111637|FG000|Overall Study|Did not receive vaccine|0|||
106123811|NCT00839917|366111638|FG001|Overall Study|Did not receive vaccine|1|||
106123812|NCT01129336|366111639|FG000|Overall Study|Protocol Violation|1|||
106123813|NCT01129336|366111640|FG001|Overall Study|Protocol Violation|0|||
106123814|NCT01129336|366111639|FG000|Overall Study|Disease Progression|1|||
106123815|NCT01129336|366111640|FG001|Overall Study|Disease Progression|4|||
105785995|NCT04338685|364870438|FG005|Overall Study|Study terminated by Sponsor|5|||
105785996|NCT04338685|364870439|FG006|Overall Study|Study terminated by Sponsor|2|||
105785997|NCT04338685|364870440|FG007|Overall Study|Study terminated by Sponsor|4|||
105785998|NCT04338685|364870441|FG008|Overall Study|Study terminated by Sponsor|1|||
105785999|NCT04338685|364870433|FG000|Overall Study|Withdrawal by Subject|1|||
105786000|NCT04338685|364870434|FG001|Overall Study|Withdrawal by Subject|2|||
105786001|NCT04338685|364870435|FG002|Overall Study|Withdrawal by Subject|0|||
105786002|NCT04338685|364870436|FG003|Overall Study|Withdrawal by Subject|2|||
105786003|NCT04338685|364870437|FG004|Overall Study|Withdrawal by Subject|0|||
105786004|NCT04338685|364870438|FG005|Overall Study|Withdrawal by Subject|5|||
105786005|NCT04338685|364870439|FG006|Overall Study|Withdrawal by Subject|1|||
105786006|NCT04338685|364870440|FG007|Overall Study|Withdrawal by Subject|1|||
105786007|NCT04338685|364870441|FG008|Overall Study|Withdrawal by Subject|0|||
105786008|NCT00234533|364870442|FG000|Overall Study|Withdrawal by Subject|6|||
105997367|NCT03386721|365651425|FG006|Overall Study|Withdrawal by Subject|0|||
105997368|NCT03386721|365651426|FG007|Overall Study|Withdrawal by Subject|0|||
105997369|NCT03386721|365651427|FG008|Overall Study|Withdrawal by Subject|2|||
105997370|NCT03386721|365651428|FG009|Overall Study|Withdrawal by Subject|1|||
105997371|NCT03386721|365651429|FG010|Overall Study|Withdrawal by Subject|3|||
105997372|NCT03386721|365651430|FG011|Overall Study|Withdrawal by Subject|2|||
105786009|NCT00234533|364870442|FG000|Overall Study|Adverse Event|2|||
106123816|NCT01129336|366111639|FG000|Overall Study|Lost to Follow-up|1|||
105896218|NCT02638129|365275961|FG000|Overall Study|Study terminated|28|||
105896219|NCT02638129|365275962|FG001|Overall Study|Study terminated|30|||
105896220|NCT00869557|365275963|FG000|Randomized Phase|Lost to Follow-up|2|||
105896221|NCT00869557|365275964|FG001|Randomized Phase|Lost to Follow-up|1|||
105896222|NCT00869557|365275963|FG000|Randomized Phase|Investigator's Discretion|1|||
105896223|NCT00869557|365275964|FG001|Randomized Phase|Investigator's Discretion|0|||
105896224|NCT00869557|365275963|FG000|Randomized Phase|Withdrew Consent|0|||
105896225|NCT00869557|365275964|FG001|Randomized Phase|Withdrew Consent|1|||
105896226|NCT00869557|365275963|FG000|Extension Phase|Adverse Event|2|||
105896227|NCT00869557|365275964|FG001|Extension Phase|Adverse Event|2|||
105896228|NCT00869557|365275963|FG000|Extension Phase|Lack of Efficacy|1|||
105896229|NCT00869557|365275964|FG001|Extension Phase|Lack of Efficacy|0|||
105997373|NCT03386721|365651431|FG012|Overall Study|Withdrawal by Subject|3|||
105997374|NCT03386721|365651432|FG013|Overall Study|Withdrawal by Subject|0|||
105997375|NCT03386721|365651433|FG014|Overall Study|Withdrawal by Subject|0|||
106123817|NCT01129336|366111640|FG001|Overall Study|Lost to Follow-up|0|||
106123818|NCT01129336|366111639|FG000|Overall Study|Withdrawal by Subject|7|||
106123819|NCT01129336|366111640|FG001|Overall Study|Withdrawal by Subject|4|||
106123820|NCT01129336|366111639|FG000|Overall Study|Adverse Event|0|||
106123821|NCT01129336|366111640|FG001|Overall Study|Adverse Event|1|||
106123822|NCT01129336|366111639|FG000|Overall Study|Missing Study Completion Status|2|||
106123823|NCT01129336|366111640|FG001|Overall Study|Missing Study Completion Status|3|||
106123824|NCT01129336|366111639|FG000|Overall Study|Death|0|||
106123825|NCT01129336|366111640|FG001|Overall Study|Death|4|||
106123826|NCT01950273|366111641|FG000|Overall Study|Protocol Violation|1|||
106123827|NCT01950273|366111642|FG001|Overall Study|Protocol Violation|0|||
106123828|NCT01950273|366111641|FG000|Overall Study|Withdrawal by Subject|2|||
106123829|NCT01950273|366111642|FG001|Overall Study|Withdrawal by Subject|0|||
106123830|NCT01950273|366111641|FG000|Overall Study|Other not defined above|1|||
106123831|NCT01950273|366111642|FG001|Overall Study|Other not defined above|0|||
106123832|NCT00472186|366111643|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
106123833|NCT00472186|366111644|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
106123834|NCT01254565|366111645|FG000|Overall Study|Non-compliance to Study Procedures|0|||
106123835|NCT01254565|366111646|FG001|Overall Study|Non-compliance to Study Procedures|0|||
106123836|NCT01254565|366111647|FG002|Overall Study|Non-compliance to Study Procedures|0|||
106123837|NCT01254565|366111648|FG003|Overall Study|Non-compliance to Study Procedures|0|||
106123838|NCT01254565|366111649|FG004|Overall Study|Non-compliance to Study Procedures|1|||
106123839|NCT01254565|366111650|FG005|Overall Study|Non-compliance to Study Procedures|0|||
106123840|NCT01254565|366111645|FG000|Overall Study|Did not Receive Treatment|1|||
106123841|NCT01254565|366111646|FG001|Overall Study|Did not Receive Treatment|1|||
106123842|NCT01254565|366111647|FG002|Overall Study|Did not Receive Treatment|0|||
106123843|NCT01254565|366111648|FG003|Overall Study|Did not Receive Treatment|0|||
106123844|NCT01254565|366111649|FG004|Overall Study|Did not Receive Treatment|3|||
106123845|NCT01254565|366111650|FG005|Overall Study|Did not Receive Treatment|4|||
106123846|NCT01254565|366111645|FG000|Overall Study|Other|0|||
106123847|NCT01254565|366111646|FG001|Overall Study|Other|0|||
106123848|NCT01254565|366111647|FG002|Overall Study|Other|0|||
106123849|NCT01254565|366111648|FG003|Overall Study|Other|1|||
106123850|NCT01254565|366111649|FG004|Overall Study|Other|0|||
106123851|NCT01254565|366111650|FG005|Overall Study|Other|0|||
106123852|NCT00179010|366111651|FG000|Overall Study|Muscle probe defective|1|||
106123853|NCT00179010|366111652|FG001|Overall Study|Muscle probe defective|1|||
106123854|NCT00179010|366111651|FG000|Overall Study|Failure to place arterial line|0|||
106123855|NCT00179010|366111652|FG001|Overall Study|Failure to place arterial line|1|||
106123856|NCT00794820|366111656|FG000|Overall Study|Adverse Event|11|||
106123857|NCT00794820|366111656|FG000|Overall Study|Secondary Malignancies|2|||
106123858|NCT00794820|366111656|FG000|Overall Study|Resistant Disease|2|||
106123859|NCT00794820|366111656|FG000|Overall Study|Ineligible/Screen Failure|1|||
106123860|NCT01394250|366111659|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
106123861|NCT01394250|366111660|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
106123862|NCT01394250|366111659|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
106123863|NCT01394250|366111660|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
106123864|NCT03230864|366111661|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
106123865|NCT03230864|366111662|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
106123866|NCT03230864|366111663|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
105786010|NCT00234533|364870442|FG000|Overall Study|Enrolled but not treated|3|||
106123867|NCT03230864|366111664|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
106123868|NCT03230864|366111661|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
106123869|NCT03230864|366111662|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
105896230|NCT00869557|365275963|FG000|Extension Phase|Lost to Follow-up|3|||
105896231|NCT00869557|365275964|FG001|Extension Phase|Lost to Follow-up|1|||
105896232|NCT00869557|365275963|FG000|Extension Phase|Investigator's Discretion|2|||
105896233|NCT00869557|365275964|FG001|Extension Phase|Investigator's Discretion|0|||
105896234|NCT00869557|365275963|FG000|Extension Phase|Withdrew Consent|2|||
105896235|NCT00869557|365275964|FG001|Extension Phase|Withdrew Consent|0|||
105896236|NCT01473394|365275965|FG000|Overall Study|Adverse Event|13|||
105896237|NCT01473394|365275966|FG001|Overall Study|Adverse Event|16|||
105896238|NCT01473394|365275965|FG000|Overall Study|Insufficient Therapeutic Response|4|||
105896239|NCT01473394|365275966|FG001|Overall Study|Insufficient Therapeutic Response|1|||
105896240|NCT01473394|365275965|FG000|Overall Study|Protocol Violation|7|||
105896241|NCT01473394|365275966|FG001|Overall Study|Protocol Violation|5|||
105896242|NCT01473394|365275965|FG000|Overall Study|Withdrew Consent|12|||
105896243|NCT01473394|365275966|FG001|Overall Study|Withdrew Consent|10|||
105896244|NCT01473394|365275965|FG000|Overall Study|Lost to Follow-up|9|||
105896245|NCT01473394|365275966|FG001|Overall Study|Lost to Follow-up|11|||
105896246|NCT03391232|365275967|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
105896247|NCT03391232|365275968|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
105896248|NCT03391232|365275967|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
105896249|NCT03391232|365275968|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
105896250|NCT01358578|365275971|FG000|Induction Period|Adverse Event|2|||
105997376|NCT03081884|365651434|FG000|Overall Study|deferred prostate cancer treatment|1|||
105667828|NCT00895895|364448199|FG003|Period 2|Withdrawal by Subject|3|||
105667829|NCT00895895|364448200|FG004|Period 2|Withdrawal by Subject|5|||
105667830|NCT00895895|364448196|FG000|Period 2|unsatisfactory response-efficacy|2|||
105667831|NCT00895895|364448197|FG001|Period 2|unsatisfactory response-efficacy|1|||
105667832|NCT00895895|364448198|FG002|Period 2|unsatisfactory response-efficacy|0|||
105667833|NCT00895895|364448199|FG003|Period 2|unsatisfactory response-efficacy|0|||
105667834|NCT00895895|364448200|FG004|Period 2|unsatisfactory response-efficacy|0|||
105896251|NCT01358578|365275972|FG001|Induction Period|Adverse Event|4|||
105896252|NCT01358578|365275973|FG002|Induction Period|Adverse Event|2|||
105896253|NCT01358578|365275974|FG003|Induction Period|Adverse Event|6|||
105896254|NCT01358578|365275975|FG004|Induction Period|Adverse Event|0|||
105896255|NCT01358578|365275976|FG005|Induction Period|Adverse Event|0|||
105896256|NCT01358578|365275971|FG000|Induction Period|Lack of Efficacy|0|||
105896257|NCT01358578|365275972|FG001|Induction Period|Lack of Efficacy|0|||
105896258|NCT01358578|365275973|FG002|Induction Period|Lack of Efficacy|9|||
105896259|NCT01358578|365275974|FG003|Induction Period|Lack of Efficacy|1|||
105896260|NCT01358578|365275975|FG004|Induction Period|Lack of Efficacy|0|||
105896261|NCT01358578|365275976|FG005|Induction Period|Lack of Efficacy|0|||
105896262|NCT01358578|365275971|FG000|Induction Period|Lost to Follow-up|0|||
105896263|NCT01358578|365275972|FG001|Induction Period|Lost to Follow-up|0|||
105896264|NCT01358578|365275973|FG002|Induction Period|Lost to Follow-up|1|||
105896265|NCT01358578|365275974|FG003|Induction Period|Lost to Follow-up|4|||
105896266|NCT01358578|365275975|FG004|Induction Period|Lost to Follow-up|0|||
105896267|NCT01358578|365275976|FG005|Induction Period|Lost to Follow-up|0|||
105896268|NCT01358578|365275971|FG000|Induction Period|Physician Decision|2|||
105896269|NCT01358578|365275972|FG001|Induction Period|Physician Decision|1|||
105896270|NCT01358578|365275973|FG002|Induction Period|Physician Decision|2|||
105896271|NCT01358578|365275974|FG003|Induction Period|Physician Decision|0|||
105896272|NCT01358578|365275975|FG004|Induction Period|Physician Decision|0|||
105896273|NCT01358578|365275976|FG005|Induction Period|Physician Decision|0|||
105896274|NCT01358578|365275971|FG000|Induction Period|Protocol Deviation|3|||
105896275|NCT01358578|365275972|FG001|Induction Period|Protocol Deviation|5|||
105896276|NCT01358578|365275973|FG002|Induction Period|Protocol Deviation|0|||
105896277|NCT01358578|365275974|FG003|Induction Period|Protocol Deviation|3|||
105896278|NCT01358578|365275975|FG004|Induction Period|Protocol Deviation|0|||
105896279|NCT01358578|365275976|FG005|Induction Period|Protocol Deviation|0|||
105896280|NCT01358578|365275971|FG000|Induction Period|technical problems|0|||
105667835|NCT01261000|364448201|FG000|Overall Study|Screen failure|1|||
105667836|NCT03690427|364448202|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
105667837|NCT03690427|364448203|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
105667838|NCT03519204|364448204|FG000|Overall Study|Lost to Follow-up|3|||
105667839|NCT03519204|364448205|FG001|Overall Study|Lost to Follow-up|8|||
105667840|NCT03519204|364448204|FG000|Overall Study|Withdrawal by Subject|9|||
105667841|NCT03519204|364448205|FG001|Overall Study|Withdrawal by Subject|7|||
105667842|NCT03519204|364448204|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105667843|NCT03519204|364448205|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105667844|NCT03392168|364448206|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
105667845|NCT03392168|364448207|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
105667846|NCT03392168|364448208|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
105667847|NCT03392168|364448209|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
105896281|NCT01358578|365275972|FG001|Induction Period|technical problems|0|||
105896282|NCT01358578|365275973|FG002|Induction Period|technical problems|1|||
105896283|NCT01358578|365275974|FG003|Induction Period|technical problems|1|||
105896284|NCT01358578|365275975|FG004|Induction Period|technical problems|0|||
105896285|NCT01358578|365275976|FG005|Induction Period|technical problems|0|||
105896286|NCT01358578|365275971|FG000|Induction Period|Withdrawal by Subject|5|||
105896287|NCT01358578|365275972|FG001|Induction Period|Withdrawal by Subject|5|||
105896288|NCT01358578|365275973|FG002|Induction Period|Withdrawal by Subject|10|||
105896289|NCT01358578|365275974|FG003|Induction Period|Withdrawal by Subject|6|||
105896290|NCT01358578|365275975|FG004|Induction Period|Withdrawal by Subject|0|||
105896291|NCT01358578|365275976|FG005|Induction Period|Withdrawal by Subject|0|||
105896292|NCT01358578|365275971|FG000|Maintenance Period|Adverse Event|2|||
105896293|NCT01358578|365275972|FG001|Maintenance Period|Adverse Event|7|||
105896294|NCT01358578|365275973|FG002|Maintenance Period|Adverse Event|0|||
105896295|NCT01358578|365275974|FG003|Maintenance Period|Adverse Event|6|||
105997377|NCT03081884|365651434|FG000|Overall Study|metastasis managed with systemic therapy|3|||
105997378|NCT03948334|365651435|FG000|Overall Study|Adverse Event|1|||
105997379|NCT03948334|365651436|FG001|Overall Study|Adverse Event|4|||
105997380|NCT03948334|365651435|FG000|Overall Study|Lack of Efficacy|2|||
105997381|NCT03948334|365651436|FG001|Overall Study|Lack of Efficacy|0|||
105997382|NCT03948334|365651435|FG000|Overall Study|Lost to Follow-up|1|||
105997383|NCT03948334|365651436|FG001|Overall Study|Lost to Follow-up|0|||
105997384|NCT03948334|365651435|FG000|Overall Study|Physician Decision|1|||
105997385|NCT03948334|365651436|FG001|Overall Study|Physician Decision|0|||
105997386|NCT03948334|365651435|FG000|Overall Study|Pregnancy|0|||
105997387|NCT03948334|365651436|FG001|Overall Study|Pregnancy|1|||
105997388|NCT03948334|365651435|FG000|Overall Study|Protocol Deviation|1|||
105997389|NCT03948334|365651436|FG001|Overall Study|Protocol Deviation|0|||
105997390|NCT03948334|365651435|FG000|Overall Study|Study terminated by Sponsor|50|||
105997391|NCT03948334|365651436|FG001|Overall Study|Study terminated by Sponsor|51|||
105997392|NCT03948334|365651435|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
105997393|NCT03948334|365651436|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
105997394|NCT02294058|365651437|FG000|Overall Study|Adverse Event|16|||
105997395|NCT02294058|365651438|FG001|Overall Study|Adverse Event|7|||
105997396|NCT02294058|365651439|FG002|Overall Study|Adverse Event|13|||
105997397|NCT02294058|365651437|FG000|Overall Study|Lack of Efficacy|3|||
105997398|NCT02294058|365651438|FG001|Overall Study|Lack of Efficacy|3|||
105997399|NCT02294058|365651439|FG002|Overall Study|Lack of Efficacy|0|||
105997400|NCT02294058|365651437|FG000|Overall Study|Lost to Follow-up|1|||
105997401|NCT02294058|365651438|FG001|Overall Study|Lost to Follow-up|0|||
105997402|NCT02294058|365651439|FG002|Overall Study|Lost to Follow-up|2|||
105997403|NCT02294058|365651437|FG000|Overall Study|Withdrawal by Subject|10|||
105997404|NCT02294058|365651438|FG001|Overall Study|Withdrawal by Subject|14|||
105997405|NCT02294058|365651439|FG002|Overall Study|Withdrawal by Subject|13|||
105667848|NCT03392168|364448206|FG000|Period 2: Cohort 2|Other|0|||
105667849|NCT03392168|364448207|FG001|Period 2: Cohort 2|Other|1|||
105667850|NCT03392168|364448208|FG002|Period 2: Cohort 2|Other|0|||
105667851|NCT03392168|364448209|FG003|Period 2: Cohort 2|Other|0|||
105997406|NCT02294058|365651437|FG000|Overall Study|Physician Decision|2|||
105997407|NCT02294058|365651438|FG001|Overall Study|Physician Decision|1|||
105997408|NCT02294058|365651439|FG002|Overall Study|Physician Decision|0|||
105896296|NCT01358578|365275975|FG004|Maintenance Period|Adverse Event|4|||
105997409|NCT02294058|365651437|FG000|Overall Study|Miscellaneous|4|||
105997410|NCT02294058|365651438|FG001|Overall Study|Miscellaneous|1|||
105896297|NCT01358578|365275976|FG005|Maintenance Period|Adverse Event|3|||
105896298|NCT01358578|365275971|FG000|Maintenance Period|Lack of Efficacy|10|||
105997411|NCT02294058|365651439|FG002|Overall Study|Miscellaneous|1|||
105997412|NCT03575403|365651441|FG000|Overall Study|Adverse Event|1|||
105997413|NCT03575403|365651442|FG001|Overall Study|Adverse Event|0|||
105997414|NCT03575403|365651443|FG002|Overall Study|Adverse Event|0|||
105997415|NCT03575403|365651441|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
105667852|NCT02609672|364448210|FG000|Overall Study|Lost to Follow-up|3|||
105667853|NCT02609672|364448211|FG001|Overall Study|Lost to Follow-up|1|||
105667854|NCT02597712|364448212|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
105896299|NCT01358578|365275972|FG001|Maintenance Period|Lack of Efficacy|2|||
105896300|NCT01358578|365275973|FG002|Maintenance Period|Lack of Efficacy|0|||
105896301|NCT01358578|365275974|FG003|Maintenance Period|Lack of Efficacy|11|||
105896302|NCT01358578|365275975|FG004|Maintenance Period|Lack of Efficacy|3|||
105896303|NCT01358578|365275976|FG005|Maintenance Period|Lack of Efficacy|0|||
105896304|NCT01358578|365275971|FG000|Maintenance Period|Lost to Follow-up|4|||
105896305|NCT01358578|365275972|FG001|Maintenance Period|Lost to Follow-up|0|||
105896306|NCT01358578|365275973|FG002|Maintenance Period|Lost to Follow-up|0|||
105896307|NCT01358578|365275974|FG003|Maintenance Period|Lost to Follow-up|5|||
105896308|NCT01358578|365275975|FG004|Maintenance Period|Lost to Follow-up|1|||
105896309|NCT01358578|365275976|FG005|Maintenance Period|Lost to Follow-up|1|||
105896310|NCT01358578|365275971|FG000|Maintenance Period|Non-compliance with study treatment|3|||
105896311|NCT01358578|365275972|FG001|Maintenance Period|Non-compliance with study treatment|1|||
105896312|NCT01358578|365275973|FG002|Maintenance Period|Non-compliance with study treatment|0|||
105896313|NCT01358578|365275974|FG003|Maintenance Period|Non-compliance with study treatment|2|||
105896314|NCT01358578|365275975|FG004|Maintenance Period|Non-compliance with study treatment|1|||
105896315|NCT01358578|365275976|FG005|Maintenance Period|Non-compliance with study treatment|2|||
105896316|NCT01358578|365275971|FG000|Maintenance Period|Physician Decision|0|||
105896317|NCT01358578|365275972|FG001|Maintenance Period|Physician Decision|1|||
105896318|NCT01358578|365275973|FG002|Maintenance Period|Physician Decision|0|||
105896319|NCT01358578|365275974|FG003|Maintenance Period|Physician Decision|1|||
105896320|NCT01358578|365275975|FG004|Maintenance Period|Physician Decision|0|||
105896321|NCT01358578|365275976|FG005|Maintenance Period|Physician Decision|0|||
105896322|NCT01358578|365275971|FG000|Maintenance Period|Pregnancy|1|||
105896323|NCT01358578|365275972|FG001|Maintenance Period|Pregnancy|0|||
105896324|NCT01358578|365275973|FG002|Maintenance Period|Pregnancy|0|||
105896325|NCT01358578|365275974|FG003|Maintenance Period|Pregnancy|0|||
105896326|NCT01358578|365275975|FG004|Maintenance Period|Pregnancy|0|||
105896327|NCT01358578|365275976|FG005|Maintenance Period|Pregnancy|0|||
105896328|NCT01358578|365275971|FG000|Maintenance Period|Protocol deviation|7|||
105896329|NCT01358578|365275972|FG001|Maintenance Period|Protocol deviation|4|||
105896330|NCT01358578|365275973|FG002|Maintenance Period|Protocol deviation|0|||
105896331|NCT01358578|365275974|FG003|Maintenance Period|Protocol deviation|2|||
105896332|NCT01358578|365275975|FG004|Maintenance Period|Protocol deviation|2|||
105896333|NCT01358578|365275976|FG005|Maintenance Period|Protocol deviation|2|||
105896334|NCT01358578|365275971|FG000|Maintenance Period|Withdrawal by Subject|12|||
105896335|NCT01358578|365275972|FG001|Maintenance Period|Withdrawal by Subject|7|||
105896336|NCT01358578|365275973|FG002|Maintenance Period|Withdrawal by Subject|2|||
105896337|NCT01358578|365275974|FG003|Maintenance Period|Withdrawal by Subject|15|||
105896338|NCT01358578|365275975|FG004|Maintenance Period|Withdrawal by Subject|6|||
105896339|NCT01358578|365275976|FG005|Maintenance Period|Withdrawal by Subject|3|||
105896340|NCT01358578|365275971|FG000|Follow-up Period|Adverse Event|1|||
105896341|NCT01358578|365275972|FG001|Follow-up Period|Adverse Event|1|||
105667855|NCT02597712|364448213|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
105896342|NCT01358578|365275973|FG002|Follow-up Period|Adverse Event|0|||
105997416|NCT03575403|365651442|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
105997417|NCT03575403|365651443|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
105997418|NCT05114473|365651444|FG000|Overall Study|Lost to Follow-up|2|||
105997419|NCT05114473|365651445|FG001|Overall Study|Lost to Follow-up|2|||
105997420|NCT05114473|365651446|FG002|Overall Study|Lost to Follow-up|0|||
105997421|NCT05730387|365651448|FG000|Overall Study|Stillbirth|0|||
105997422|NCT05730387|365651449|FG001|Overall Study|Stillbirth|262|||
105997423|NCT05730387|365651448|FG000|Overall Study|Died during or after delivery|2|||
105997424|NCT05730387|365651449|FG001|Overall Study|Died during or after delivery|85|||
105997425|NCT05730387|365651448|FG000|Overall Study|Died after being admitted|0|||
105997426|NCT05730387|365651449|FG001|Overall Study|Died after being admitted|44|||
105997427|NCT05730387|365651448|FG000|Overall Study|Lost to Follow-up|69|||
105997428|NCT05730387|365651449|FG001|Overall Study|Lost to Follow-up|77|||
105997429|NCT00782717|365651452|FG000|Overall Study|Adverse Event|2|||
105997430|NCT00782717|365651453|FG001|Overall Study|Adverse Event|5|||
105997431|NCT00782717|365651452|FG000|Overall Study|Patient decision unrelated to AE|6|||
105997432|NCT00782717|365651453|FG001|Overall Study|Patient decision unrelated to AE|3|||
105997433|NCT00782717|365651452|FG000|Overall Study|Noncompliance|2|||
105786011|NCT00596466|364870443|FG000|Overall Study|Lack of Efficacy|5|||
105786012|NCT00596466|364870443|FG000|Overall Study|Adverse Event|4|||
105997434|NCT00782717|365651453|FG001|Overall Study|Noncompliance|1|||
105997435|NCT00782717|365651452|FG000|Overall Study|Treatment failure|3|||
105997436|NCT00782717|365651453|FG001|Overall Study|Treatment failure|14|||
105896343|NCT01358578|365275974|FG003|Follow-up Period|Adverse Event|0|||
105896344|NCT01358578|365275975|FG004|Follow-up Period|Adverse Event|0|||
105896345|NCT01358578|365275976|FG005|Follow-up Period|Adverse Event|0|||
105896346|NCT01358578|365275971|FG000|Follow-up Period|Lack of Efficacy|3|||
105896347|NCT01358578|365275972|FG001|Follow-up Period|Lack of Efficacy|0|||
105896348|NCT01358578|365275973|FG002|Follow-up Period|Lack of Efficacy|4|||
105896349|NCT01358578|365275974|FG003|Follow-up Period|Lack of Efficacy|1|||
105896350|NCT01358578|365275975|FG004|Follow-up Period|Lack of Efficacy|0|||
105896351|NCT01358578|365275976|FG005|Follow-up Period|Lack of Efficacy|0|||
105896352|NCT01358578|365275971|FG000|Follow-up Period|Lost to Follow-up|0|||
105896353|NCT01358578|365275972|FG001|Follow-up Period|Lost to Follow-up|1|||
105896354|NCT01358578|365275973|FG002|Follow-up Period|Lost to Follow-up|0|||
105896355|NCT01358578|365275974|FG003|Follow-up Period|Lost to Follow-up|4|||
105896356|NCT01358578|365275975|FG004|Follow-up Period|Lost to Follow-up|0|||
105896357|NCT01358578|365275976|FG005|Follow-up Period|Lost to Follow-up|0|||
105896358|NCT01358578|365275971|FG000|Follow-up Period|non- compliance with study treatment|1|||
105896359|NCT01358578|365275972|FG001|Follow-up Period|non- compliance with study treatment|0|||
105896360|NCT01358578|365275973|FG002|Follow-up Period|non- compliance with study treatment|0|||
105896361|NCT01358578|365275974|FG003|Follow-up Period|non- compliance with study treatment|0|||
105896362|NCT01358578|365275975|FG004|Follow-up Period|non- compliance with study treatment|0|||
105896363|NCT01358578|365275976|FG005|Follow-up Period|non- compliance with study treatment|0|||
105896364|NCT01358578|365275971|FG000|Follow-up Period|Pregnancy|1|||
105896365|NCT01358578|365275972|FG001|Follow-up Period|Pregnancy|0|||
105896366|NCT01358578|365275973|FG002|Follow-up Period|Pregnancy|0|||
105896367|NCT01358578|365275974|FG003|Follow-up Period|Pregnancy|0|||
105896368|NCT01358578|365275975|FG004|Follow-up Period|Pregnancy|0|||
105896369|NCT01358578|365275976|FG005|Follow-up Period|Pregnancy|0|||
105896370|NCT01358578|365275971|FG000|Follow-up Period|Withdrawal by Subject|3|||
105896371|NCT01358578|365275972|FG001|Follow-up Period|Withdrawal by Subject|3|||
105896372|NCT01358578|365275973|FG002|Follow-up Period|Withdrawal by Subject|1|||
105896373|NCT01358578|365275974|FG003|Follow-up Period|Withdrawal by Subject|12|||
105896374|NCT01358578|365275975|FG004|Follow-up Period|Withdrawal by Subject|0|||
105896375|NCT01358578|365275976|FG005|Follow-up Period|Withdrawal by Subject|0|||
105896376|NCT01358578|365275971|FG000|Follow-up Period|Physician Decision|1|||
105896377|NCT01358578|365275972|FG001|Follow-up Period|Physician Decision|1|||
105896378|NCT01358578|365275973|FG002|Follow-up Period|Physician Decision|0|||
105896379|NCT01358578|365275974|FG003|Follow-up Period|Physician Decision|2|||
105896380|NCT01358578|365275975|FG004|Follow-up Period|Physician Decision|0|||
105896381|NCT01358578|365275976|FG005|Follow-up Period|Physician Decision|0|||
105896382|NCT05940077|365275977|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
105896383|NCT02696434|365275980|FG000|Overall Study|Adverse Event|3|||
105896384|NCT02696434|365275981|FG001|Overall Study|Adverse Event|1|||
105896385|NCT02696434|365275980|FG000|Overall Study|Lost to Follow-up|5|||
105896386|NCT02696434|365275981|FG001|Overall Study|Lost to Follow-up|4|||
105896387|NCT02696434|365275980|FG000|Overall Study|Withdrawal by Subject|14|||
105896388|NCT02696434|365275981|FG001|Overall Study|Withdrawal by Subject|12|||
105896389|NCT02696434|365275980|FG000|Overall Study|Physician Decision|0|||
105896390|NCT02696434|365275981|FG001|Overall Study|Physician Decision|1|||
105896391|NCT00590538|365275982|FG000|Overall Study|Study terminated before completed|2|||
105896392|NCT02560623|365275983|FG000|Overall Study|Unable to swallow sponge|0|||
105896393|NCT02560623|365275984|FG001|Overall Study|Unable to swallow sponge|1|||
105896394|NCT02560623|365275985|FG002|Overall Study|Unable to swallow sponge|0|||
105896395|NCT02560623|365275986|FG003|Overall Study|Unable to swallow sponge|0|||
105896396|NCT02560623|365275983|FG000|Overall Study|Intervention prior to sponge administration|0|||
105896397|NCT02560623|365275984|FG001|Overall Study|Intervention prior to sponge administration|1|||
105896398|NCT02560623|365275985|FG002|Overall Study|Intervention prior to sponge administration|0|||
105896399|NCT02560623|365275986|FG003|Overall Study|Intervention prior to sponge administration|0|||
105896400|NCT01125813|365275987|FG000|Overall Study|Death|1|||
105896401|NCT01125813|365275987|FG000|Overall Study|Withdrawal by Subject|1|||
105896402|NCT01125813|365275987|FG000|Overall Study|Screen Failures|4|||
105896403|NCT01211483|365275988|FG000|Phase 1b|Death|6|||
105896404|NCT01211483|365275989|FG001|Phase 1b|Death|0|||
105896405|NCT01211483|365275990|FG002|Phase 1b|Death|0|||
105896406|NCT01211483|365275991|FG003|Phase 1b|Death|0|||
105896407|NCT01211483|365275988|FG000|Phase 1b|Withdrawal by Subject|1|||
105896408|NCT01211483|365275989|FG001|Phase 1b|Withdrawal by Subject|0|||
105896409|NCT01211483|365275990|FG002|Phase 1b|Withdrawal by Subject|0|||
105896410|NCT01211483|365275991|FG003|Phase 1b|Withdrawal by Subject|0|||
105896411|NCT01211483|365275988|FG000|Phase 2|Lost to Follow-up|0|||
105896412|NCT01211483|365275989|FG001|Phase 2|Lost to Follow-up|1|||
105896413|NCT01211483|365275990|FG002|Phase 2|Lost to Follow-up|1|||
105896414|NCT01211483|365275991|FG003|Phase 2|Lost to Follow-up|2|||
105896415|NCT01211483|365275988|FG000|Phase 2|Death|0|||
105896416|NCT01211483|365275989|FG001|Phase 2|Death|64|||
105896417|NCT01211483|365275990|FG002|Phase 2|Death|53|||
105667856|NCT02597712|364448212|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
105896418|NCT01211483|365275991|FG003|Phase 2|Death|53|||
105896419|NCT01211483|365275988|FG000|Phase 2|Withdrawal by Subject|0|||
105896420|NCT01211483|365275989|FG001|Phase 2|Withdrawal by Subject|1|||
105896421|NCT01211483|365275990|FG002|Phase 2|Withdrawal by Subject|10|||
105896422|NCT01211483|365275991|FG003|Phase 2|Withdrawal by Subject|5|||
105896423|NCT01211483|365275988|FG000|Phase 2|Study terminated by Sponsor|0|||
105896424|NCT01211483|365275989|FG001|Phase 2|Study terminated by Sponsor|6|||
105896425|NCT01211483|365275990|FG002|Phase 2|Study terminated by Sponsor|8|||
105896426|NCT01211483|365275991|FG003|Phase 2|Study terminated by Sponsor|11|||
105896427|NCT01675154|365275992|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
105896428|NCT01675154|365275993|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
105896429|NCT01675154|365275994|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
105896430|NCT01675154|365275995|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
105896431|NCT03738800|365275998|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
105896432|NCT03738800|365275999|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105896433|NCT03738800|365276000|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105896434|NCT03738800|365275998|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
105896435|NCT03738800|365275999|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
105896436|NCT03738800|365276000|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
105896437|NCT03738800|365275998|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
105896438|NCT03738800|365275999|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
105896439|NCT03738800|365276000|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
105896440|NCT01917344|365276010|FG000|Overall Study|Withdrawal by Subject|1|||
105896441|NCT00367484|365276013|FG000|Overall Study|Adverse Event|7|||
105896442|NCT00367484|365276013|FG000|Overall Study|Withdrew informed consent|5|||
105896443|NCT00367484|365276013|FG000|Overall Study|Travel to USA|1|||
105896444|NCT00367484|365276013|FG000|Overall Study|Lost to Follow-up|1|||
105896445|NCT00367484|365276013|FG000|Overall Study|Protocol Violation|1|||
105896446|NCT00367484|365276013|FG000|Overall Study|The choice of the patient|1|||
105896447|NCT00367484|365276013|FG000|Overall Study|Lack of Efficacy|1|||
105896448|NCT00943670|365276014|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
105896449|NCT00943670|365276014|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
105896450|NCT00943670|365276014|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
105896451|NCT00943670|365276014|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
105896452|NCT00943670|365276014|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
105896453|NCT00943670|365276014|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
105896454|NCT00943670|365276014|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
105896455|NCT00943670|365276014|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
105896456|NCT00943670|365276014|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
105896457|NCT00943670|365276014|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
105896458|NCT04472026|365276015|FG000|Overall Study|Lost to Follow-up|5|||
105896459|NCT01777295|365276016|FG000|Overall Study|Withdrawal by Subject|2|||
105896460|NCT01777295|365276017|FG001|Overall Study|Withdrawal by Subject|2|||
105896461|NCT01777295|365276016|FG000|Overall Study|Pregnancy|0|||
105896462|NCT01777295|365276017|FG001|Overall Study|Pregnancy|1|||
105896463|NCT01777295|365276016|FG000|Overall Study|Personal problem|1|||
105896464|NCT01777295|365276017|FG001|Overall Study|Personal problem|0|||
105896465|NCT01777295|365276016|FG000|Overall Study|Investigator call for AEs check|1|||
105896466|NCT01777295|365276017|FG001|Overall Study|Investigator call for AEs check|0|||
105896467|NCT00908076|365276020|FG000|Overall Study|Lack of Efficacy|1|||
105896468|NCT00908076|365276021|FG001|Overall Study|Lack of Efficacy|1|||
105896469|NCT03747302|365276022|FG000|Overall Study|Withdrawal by Subject|1|||
105896470|NCT03747302|365276023|FG001|Overall Study|Withdrawal by Subject|2|||
106123870|NCT03230864|366111663|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
106123871|NCT03230864|366111664|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
106123872|NCT03230864|366111661|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
106123873|NCT03230864|366111662|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
105896471|NCT04679051|365276024|FG000|Overall Study|felt tired after restricted time in bed|3|||
105896472|NCT04679051|365276025|FG001|Overall Study|felt tired after restricted time in bed|0|||
105896473|NCT04679051|365276024|FG000|Overall Study|discomfort with blood pressure cuff|2|||
106123874|NCT03230864|366111663|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
106123875|NCT03230864|366111664|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
106123876|NCT03230864|366111661|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
106123877|NCT03230864|366111662|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
106123878|NCT03230864|366111663|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
106123879|NCT03230864|366111664|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
106123880|NCT03230864|366111661|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
105896474|NCT04679051|365276025|FG001|Overall Study|discomfort with blood pressure cuff|0|||
105896475|NCT04679051|365276024|FG000|Overall Study|scheduling conflict|1|||
106123881|NCT03230864|366111662|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
106123882|NCT03230864|366111663|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
106123883|NCT03230864|366111664|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
106123884|NCT03230864|366111661|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
106123885|NCT03230864|366111662|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
105896476|NCT04679051|365276025|FG001|Overall Study|scheduling conflict|1|||
105896477|NCT04679051|365276024|FG000|Overall Study|Protocol Violation|0|||
105896478|NCT04679051|365276025|FG001|Overall Study|Protocol Violation|4|||
105997437|NCT00782717|365651452|FG000|Overall Study|Enrollment close prior to surgery|1|||
105997438|NCT00782717|365651453|FG001|Overall Study|Enrollment close prior to surgery|0|||
105997439|NCT00782717|365651452|FG000|Overall Study|Did not meet entrance criteria|1|||
105997440|NCT00782717|365651453|FG001|Overall Study|Did not meet entrance criteria|3|||
105997441|NCT00782717|365651452|FG000|Overall Study|Exited in error|0|||
105997442|NCT00782717|365651453|FG001|Overall Study|Exited in error|2|||
105997443|NCT02446717|365651454|FG000|Overall Study|Adverse Event|0|||
105997444|NCT02446717|365651455|FG001|Overall Study|Adverse Event|0|||
105997445|NCT02446717|365651456|FG002|Overall Study|Adverse Event|1|||
105997446|NCT02446717|365651457|FG003|Overall Study|Adverse Event|0|||
105997447|NCT02446717|365651458|FG004|Overall Study|Adverse Event|0|||
105997448|NCT02446717|365651454|FG000|Overall Study|Lost to Follow-up|0|||
105896479|NCT02772276|365276027|FG000|Overall Study|Lost to Follow-up|0|||
105997449|NCT02446717|365651455|FG001|Overall Study|Lost to Follow-up|1|||
105997450|NCT02446717|365651456|FG002|Overall Study|Lost to Follow-up|1|||
105997451|NCT02446717|365651457|FG003|Overall Study|Lost to Follow-up|0|||
105997452|NCT02446717|365651458|FG004|Overall Study|Lost to Follow-up|1|||
105997453|NCT02446717|365651454|FG000|Overall Study|Withdrew consent|0|||
105997454|NCT02446717|365651455|FG001|Overall Study|Withdrew consent|0|||
105997455|NCT02446717|365651456|FG002|Overall Study|Withdrew consent|0|||
105997456|NCT02446717|365651457|FG003|Overall Study|Withdrew consent|1|||
105997457|NCT02446717|365651458|FG004|Overall Study|Withdrew consent|0|||
105997458|NCT02680665|365651459|FG000|Overall Study|No visit after the first prescription|5|||
105997459|NCT02292719|365651463|FG000|Overall Study|Withdrawal by Subject|0|||
105997460|NCT02292719|365651464|FG001|Overall Study|Withdrawal by Subject|0|||
105997461|NCT02292719|365651465|FG002|Overall Study|Withdrawal by Subject|0|||
105997462|NCT02292719|365651466|FG003|Overall Study|Withdrawal by Subject|1|||
105997463|NCT02292719|365651467|FG004|Overall Study|Withdrawal by Subject|1|||
105997464|NCT02292719|365651468|FG005|Overall Study|Withdrawal by Subject|0|||
105997465|NCT02292719|365651463|FG000|Overall Study|Subject enrolled in new study.|0|||
105997466|NCT02292719|365651464|FG001|Overall Study|Subject enrolled in new study.|0|||
105997467|NCT02292719|365651465|FG002|Overall Study|Subject enrolled in new study.|1|||
105997468|NCT02292719|365651466|FG003|Overall Study|Subject enrolled in new study.|0|||
105997469|NCT02292719|365651467|FG004|Overall Study|Subject enrolled in new study.|0|||
105997470|NCT02292719|365651468|FG005|Overall Study|Subject enrolled in new study.|0|||
106123886|NCT03230864|366111663|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
106123887|NCT03230864|366111664|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
106123888|NCT03230864|366111661|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
106123889|NCT03230864|366111662|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
106123890|NCT03230864|366111663|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
106123891|NCT03230864|366111664|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
106123892|NCT03230864|366111661|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
106123893|NCT03230864|366111662|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
105896480|NCT02772276|365276028|FG001|Overall Study|Lost to Follow-up|0|||
105896481|NCT02772276|365276029|FG002|Overall Study|Lost to Follow-up|0|||
105896482|NCT02772276|365276030|FG003|Overall Study|Lost to Follow-up|0|||
105896483|NCT02772276|365276031|FG004|Overall Study|Lost to Follow-up|0|||
105896484|NCT02772276|365276032|FG005|Overall Study|Lost to Follow-up|0|||
105896485|NCT02772276|365276033|FG006|Overall Study|Lost to Follow-up|1|||
105896486|NCT02772276|365276034|FG007|Overall Study|Lost to Follow-up|0|||
105997471|NCT00596752|365651469|FG000|Overall Study|Other Reason|44|||
105997472|NCT00596752|365651470|FG001|Overall Study|Other Reason|49|||
105997473|NCT00596752|365651469|FG000|Overall Study|Adverse Event|34|||
105997474|NCT00596752|365651470|FG001|Overall Study|Adverse Event|34|||
105997475|NCT00596752|365651469|FG000|Overall Study|Lost to Follow-up|22|||
105997476|NCT00596752|365651470|FG001|Overall Study|Lost to Follow-up|38|||
106123894|NCT03230864|366111663|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
105997477|NCT00596752|365651469|FG000|Overall Study|Withdrawal by Subject|12|||
106123895|NCT03230864|366111664|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
106123896|NCT03230864|366111661|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105667857|NCT02597712|364448213|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
105896487|NCT02772276|365276035|FG008|Overall Study|Lost to Follow-up|0|||
105896488|NCT02772276|365276036|FG009|Overall Study|Lost to Follow-up|0|||
105997478|NCT00596752|365651470|FG001|Overall Study|Withdrawal by Subject|9|||
106123897|NCT03230864|366111662|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105896489|NCT02772276|365276037|FG010|Overall Study|Lost to Follow-up|0|||
105896490|NCT02772276|365276038|FG011|Overall Study|Lost to Follow-up|0|||
105896491|NCT02772276|365276039|FG012|Overall Study|Lost to Follow-up|0|||
105896492|NCT02772276|365276027|FG000|Overall Study|Withdrew consent|0|||
105896493|NCT02772276|365276028|FG001|Overall Study|Withdrew consent|0|||
105896494|NCT02772276|365276029|FG002|Overall Study|Withdrew consent|0|||
105896495|NCT02772276|365276030|FG003|Overall Study|Withdrew consent|0|||
105896496|NCT02772276|365276031|FG004|Overall Study|Withdrew consent|0|||
105896497|NCT02772276|365276032|FG005|Overall Study|Withdrew consent|0|||
105667858|NCT02597712|364448212|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
105667859|NCT02597712|364448213|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
105667860|NCT00504777|364448218|FG000|Overall Study|Adverse Event|1|||
105667861|NCT01154140|364448223|FG000|Overall Study|Death|71|||
105896498|NCT02772276|365276033|FG006|Overall Study|Withdrew consent|0|||
105896499|NCT02772276|365276034|FG007|Overall Study|Withdrew consent|1|||
105896500|NCT02772276|365276035|FG008|Overall Study|Withdrew consent|0|||
105896501|NCT02772276|365276036|FG009|Overall Study|Withdrew consent|0|||
105896502|NCT02772276|365276037|FG010|Overall Study|Withdrew consent|0|||
105896503|NCT02772276|365276038|FG011|Overall Study|Withdrew consent|0|||
105896504|NCT02772276|365276039|FG012|Overall Study|Withdrew consent|0|||
105896505|NCT02554318|365276042|FG000|Overall Study|Withdrawal by Subject|10|||
105896506|NCT02554318|365276043|FG001|Overall Study|Withdrawal by Subject|8|||
105896507|NCT00033657|365276044|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
105896508|NCT00033657|365276045|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
105896509|NCT00033657|365276044|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
105896510|NCT00033657|365276045|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
105896511|NCT00033657|365276044|FG000|Neoadjuvant Chemotherapy|Death|1|||
105896512|NCT00033657|365276045|FG001|Neoadjuvant Chemotherapy|Death|1|||
105896513|NCT00033657|365276044|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
105896514|NCT00033657|365276045|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
105896515|NCT00033657|365276044|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
105896516|NCT00033657|365276045|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
105896517|NCT00033657|365276044|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
105896518|NCT00033657|365276045|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
105896519|NCT00033657|365276044|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
105896520|NCT00033657|365276045|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
105896521|NCT00033657|365276044|FG000|Surgical Resection|not complete resection|0|||
105896522|NCT00033657|365276045|FG001|Surgical Resection|not complete resection|3|||
105896523|NCT00033657|365276044|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
105896524|NCT00033657|365276045|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
105896525|NCT00033657|365276044|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
105896526|NCT00033657|365276045|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
105896527|NCT00033657|365276044|FG000|Adjuvant Chemotherapy|Death|2|||
105896528|NCT00033657|365276045|FG001|Adjuvant Chemotherapy|Death|1|||
105896529|NCT00033657|365276044|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
105896530|NCT00033657|365276045|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
105896531|NCT00033657|365276044|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
105896532|NCT00033657|365276045|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
105896533|NCT00033657|365276044|FG000|Adjuvant Chemotherapy|Other|0|||
105896534|NCT00033657|365276045|FG001|Adjuvant Chemotherapy|Other|2|||
105896535|NCT02332239|365276046|FG000|Overall Study|Lost to Follow-up|4|||
105896536|NCT02332239|365276047|FG001|Overall Study|Lost to Follow-up|6|||
105896537|NCT03114657|365276050|FG000|Overall Study|Adverse Event|9|||
105896538|NCT03114657|365276051|FG001|Overall Study|Adverse Event|6|||
105896539|NCT03114657|365276050|FG000|Overall Study|Death|4|||
105896540|NCT03114657|365276051|FG001|Overall Study|Death|0|||
105896541|NCT03114657|365276050|FG000|Overall Study|Multiple Reasons|1|||
105896542|NCT03114657|365276051|FG001|Overall Study|Multiple Reasons|2|||
105896543|NCT03114657|365276050|FG000|Overall Study|Physician Decision|2|||
105896544|NCT03114657|365276051|FG001|Overall Study|Physician Decision|2|||
105896545|NCT03114657|365276050|FG000|Overall Study|Study Terminated By Sponsor|355|||
105896546|NCT03114657|365276051|FG001|Overall Study|Study Terminated By Sponsor|374|||
105896547|NCT03114657|365276050|FG000|Overall Study|Symptomatic Deterioration|0|||
105896548|NCT03114657|365276051|FG001|Overall Study|Symptomatic Deterioration|1|||
105896549|NCT03114657|365276050|FG000|Overall Study|Withdrawal by Subject|28|||
105896550|NCT03114657|365276051|FG001|Overall Study|Withdrawal by Subject|22|||
105896551|NCT00329641|365276052|FG000|Overall Study|Did not start treatment|1|||
105667862|NCT01154140|364448224|FG001|Overall Study|Death|81|||
105667863|NCT01154140|364448223|FG000|Overall Study|Lost to Follow-up|4|||
105896552|NCT00329641|365276052|FG000|Overall Study|Not eligible|1|||
105896553|NCT00329641|365276052|FG000|Overall Study|Adverse Event|3|||
105896554|NCT00329641|365276052|FG000|Overall Study|Other reason, not protocol specified|1|||
105896555|NCT01256385|365276053|FG000|Overall Study|Physician Decision|1|||
105896556|NCT01256385|365276054|FG001|Overall Study|Physician Decision|1|||
105896557|NCT01256385|365276053|FG000|Overall Study|Withdrawal by Subject|2|||
105896558|NCT01256385|365276054|FG001|Overall Study|Withdrawal by Subject|2|||
105896559|NCT01606202|365276055|FG000|Overall Study|Adverse Event|5|||
105896560|NCT01606202|365276056|FG001|Overall Study|Adverse Event|0|||
105896561|NCT01606202|365276055|FG000|Overall Study|Withdrawal by Subject|2|||
105896562|NCT01606202|365276056|FG001|Overall Study|Withdrawal by Subject|1|||
105896563|NCT01606202|365276055|FG000|Overall Study|Personal problems|0|||
105896564|NCT01606202|365276056|FG001|Overall Study|Personal problems|1|||
105896565|NCT01606202|365276055|FG000|Overall Study|Problems with administration|0|||
105896566|NCT01606202|365276056|FG001|Overall Study|Problems with administration|1|||
105896567|NCT05020366|365276057|FG000|Overall Study|Lost to Follow-up|2|||
105896568|NCT05020366|365276058|FG001|Overall Study|Lost to Follow-up|0|||
105896569|NCT05020366|365276057|FG000|Overall Study|Withdrawal by Subject|2|||
105896570|NCT05020366|365276058|FG001|Overall Study|Withdrawal by Subject|0|||
105896571|NCT02584959|365276059|FG000|Period 1|Withdrawn from study|3|||
105896572|NCT02584959|365276060|FG001|Period 1|Withdrawn from study|4|||
105896573|NCT02584959|365276061|FG002|Period 1|Withdrawn from study|0|||
105896574|NCT02584959|365276059|FG000|Period 2|Withdrawn from study|6|||
105896575|NCT02584959|365276060|FG001|Period 2|Withdrawn from study|1|||
105896576|NCT02584959|365276061|FG002|Period 2|Withdrawn from study|2|||
105896577|NCT01267201|365276065|FG000|First Intervention Period|Withdrawal by Subject|1|||
105896578|NCT01267201|365276066|FG001|First Intervention Period|Withdrawal by Subject|0|||
105896579|NCT01267201|365276067|FG002|First Intervention Period|Withdrawal by Subject|0|||
105896580|NCT01267201|365276068|FG003|First Intervention Period|Withdrawal by Subject|0|||
105896581|NCT01267201|365276069|FG004|First Intervention Period|Withdrawal by Subject|0|||
105896582|NCT01267201|365276070|FG005|First Intervention Period|Withdrawal by Subject|0|||
105896583|NCT01267201|365276065|FG000|Second Intervention Period|Withdrawal by Subject|0|||
105896584|NCT01267201|365276066|FG001|Second Intervention Period|Withdrawal by Subject|1|||
105896585|NCT01267201|365276067|FG002|Second Intervention Period|Withdrawal by Subject|0|||
105896586|NCT01267201|365276068|FG003|Second Intervention Period|Withdrawal by Subject|0|||
105896587|NCT01267201|365276069|FG004|Second Intervention Period|Withdrawal by Subject|0|||
105896588|NCT01267201|365276070|FG005|Second Intervention Period|Withdrawal by Subject|0|||
105896589|NCT00483704|365276071|FG000|Randomization|Withdrawal by Subject|19|||
105896590|NCT00483704|365276072|FG001|Randomization|Withdrawal by Subject|28|||
105896591|NCT00483704|365276073|FG002|Randomization|Withdrawal by Subject|18|||
105896592|NCT00483704|365276071|FG000|Randomization|Protocol Violation|14|||
105896593|NCT00483704|365276072|FG001|Randomization|Protocol Violation|25|||
105896594|NCT00483704|365276073|FG002|Randomization|Protocol Violation|22|||
105896595|NCT00483704|365276071|FG000|Randomization|Lost to Follow-up|14|||
105896596|NCT00483704|365276072|FG001|Randomization|Lost to Follow-up|14|||
105896597|NCT00483704|365276073|FG002|Randomization|Lost to Follow-up|19|||
105896598|NCT00483704|365276071|FG000|Randomization|Pregnancy|1|||
105896599|NCT00483704|365276072|FG001|Randomization|Pregnancy|0|||
105896600|NCT00483704|365276073|FG002|Randomization|Pregnancy|0|||
105896601|NCT00483704|365276071|FG000|Randomization|Physician Decision|2|||
105896602|NCT00483704|365276072|FG001|Randomization|Physician Decision|4|||
105997479|NCT00596752|365651469|FG000|Overall Study|Unsatisfactory Compliance|9|||
105997480|NCT00596752|365651470|FG001|Overall Study|Unsatisfactory Compliance|6|||
105997481|NCT00596752|365651469|FG000|Overall Study|Lack of Efficacy|4|||
105997482|NCT00596752|365651470|FG001|Overall Study|Lack of Efficacy|7|||
105997483|NCT00596752|365651469|FG000|Overall Study|Protocol Violation|1|||
105997484|NCT00596752|365651470|FG001|Overall Study|Protocol Violation|0|||
105997485|NCT01807598|365651474|FG000|Overall Study|Withdrawal by Subject|4|||
105997486|NCT01807598|365651474|FG000|Overall Study|Adverse Event|1|||
105997487|NCT01807598|365651474|FG000|Overall Study|Other Physician Decision|1|||
105997488|NCT03622814|365651475|FG000|Overall Study|Lost to Follow-up|8|||
105997489|NCT03622814|365651476|FG001|Overall Study|Lost to Follow-up|14|||
105997490|NCT04037891|365651479|FG000|Open-label Period|Withdrawal by Subject|1|||
105997491|NCT04037891|365651480|FG001|Open-label Period|Withdrawal by Subject|0|||
105997492|NCT04037891|365651481|FG002|Open-label Period|Withdrawal by Subject|0|||
105997493|NCT04037891|365651479|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
105997494|NCT04037891|365651480|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
105997495|NCT04037891|365651481|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
105997496|NCT03828292|365651484|FG000|Part 1 (Up to 141 Weeks)|Death|0|||
106123898|NCT03230864|366111663|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
106123899|NCT03230864|366111664|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
106123900|NCT03230864|366111661|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
106123901|NCT03230864|366111662|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
105896603|NCT00483704|365276073|FG002|Randomization|Physician Decision|0|||
105896604|NCT00483704|365276071|FG000|Randomization|Progressive disease|0|||
105896605|NCT00483704|365276072|FG001|Randomization|Progressive disease|0|||
105997497|NCT03828292|365651485|FG001|Part 1 (Up to 141 Weeks)|Death|1|||
105896606|NCT00483704|365276073|FG002|Randomization|Progressive disease|1|||
105896607|NCT00483704|365276071|FG000|Randomization|Lack of qualifying migraines|21|||
105896608|NCT00483704|365276072|FG001|Randomization|Lack of qualifying migraines|25|||
105896609|NCT00483704|365276073|FG002|Randomization|Lack of qualifying migraines|31|||
105997498|NCT03828292|365651486|FG002|Part 1 (Up to 141 Weeks)|Death|0|||
105997499|NCT03828292|365651487|FG003|Part 1 (Up to 141 Weeks)|Death|0|||
105997500|NCT03828292|365651484|FG000|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
105997501|NCT03828292|365651485|FG001|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
105896610|NCT00483704|365276071|FG000|Treatment|Lack of qualifying migraines|101|||
105896611|NCT00483704|365276072|FG001|Treatment|Lack of qualifying migraines|99|||
105896612|NCT00483704|365276073|FG002|Treatment|Lack of qualifying migraines|116|||
105896613|NCT00483704|365276071|FG000|Treatment|Adverse Event|3|||
105896614|NCT00483704|365276072|FG001|Treatment|Adverse Event|5|||
105896615|NCT00483704|365276073|FG002|Treatment|Adverse Event|4|||
105896616|NCT00483704|365276071|FG000|Treatment|Withdrawal by Subject|16|||
105896617|NCT00483704|365276072|FG001|Treatment|Withdrawal by Subject|12|||
105896618|NCT00483704|365276073|FG002|Treatment|Withdrawal by Subject|21|||
105896619|NCT00483704|365276071|FG000|Treatment|Protocol Violation|6|||
105896620|NCT00483704|365276072|FG001|Treatment|Protocol Violation|3|||
105896621|NCT00483704|365276073|FG002|Treatment|Protocol Violation|5|||
105896622|NCT00483704|365276071|FG000|Treatment|Lost to Follow-up|2|||
105896623|NCT00483704|365276072|FG001|Treatment|Lost to Follow-up|7|||
105896624|NCT00483704|365276073|FG002|Treatment|Lost to Follow-up|5|||
105896625|NCT00483704|365276071|FG000|Treatment|Lack of Efficacy|1|||
105896626|NCT00483704|365276072|FG001|Treatment|Lack of Efficacy|1|||
105896627|NCT00483704|365276073|FG002|Treatment|Lack of Efficacy|1|||
105896628|NCT00483704|365276071|FG000|Treatment|Pregnancy|0|||
105896629|NCT00483704|365276072|FG001|Treatment|Pregnancy|1|||
105896630|NCT00483704|365276073|FG002|Treatment|Pregnancy|0|||
105896631|NCT00483704|365276071|FG000|Treatment|Physician Decision|0|||
105896632|NCT00483704|365276072|FG001|Treatment|Physician Decision|1|||
105896633|NCT00483704|365276073|FG002|Treatment|Physician Decision|4|||
105896634|NCT00672841|365276074|FG000|Overall Study|Comfort care|1|||
105896635|NCT00672841|365276075|FG001|Overall Study|Comfort care|4|||
105896636|NCT00672841|365276074|FG000|Overall Study|icteric specimens|0|||
105896637|NCT00672841|365276075|FG001|Overall Study|icteric specimens|3|||
105896638|NCT00672841|365276074|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
105896639|NCT00672841|365276075|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
105896640|NCT00672841|365276074|FG000|Overall Study|Adverse Event|0|||
105896641|NCT00672841|365276075|FG001|Overall Study|Adverse Event|3|||
105896642|NCT00672841|365276074|FG000|Overall Study|Pregnancy|0|||
105896643|NCT00672841|365276075|FG001|Overall Study|Pregnancy|1|||
105896644|NCT01298141|365276078|FG000|Overall Study|Adverse Event|3|||
105896645|NCT01298141|365276078|FG000|Overall Study|Refusal of Required Study Procedures|1|||
105896646|NCT01298141|365276078|FG000|Overall Study|Withdrawal by Subject|6|||
105896647|NCT01298141|365276078|FG000|Overall Study|Termination of Study by the Investigator|5|||
105896648|NCT01298141|365276078|FG000|Overall Study|Other|5|||
105896649|NCT01298141|365276078|FG000|Overall Study|Lost to Follow-up|1|||
105896650|NCT01298141|365276078|FG000|Overall Study|Death|6|||
105896651|NCT01298141|365276078|FG000|Overall Study|Not treated|4|||
105896652|NCT00593606|365277898|FG000|Overall Study|Adverse Event|13|||
105896653|NCT00593606|365277898|FG000|Overall Study|Withdrawal by Subject|1|||
105896654|NCT00593606|365277898|FG000|Overall Study|Protocol Violation|3|||
105896655|NCT00593606|365277898|FG000|Overall Study|Lost to Follow-up|2|||
105896656|NCT00593606|365277898|FG000|Overall Study|Run-In Failure|5|||
105896657|NCT00593606|365277898|FG000|Overall Study|Screen Failure|3|||
105896658|NCT02278367|365277899|FG000|Overall Study|Physician Decision|5|||
105896659|NCT02278367|365277900|FG001|Overall Study|Physician Decision|0|||
105896660|NCT02278367|365277899|FG000|Overall Study|Withdrawal by Subject|5|||
105896661|NCT02278367|365277900|FG001|Overall Study|Withdrawal by Subject|0|||
105896662|NCT04643964|365277902|FG000|Overall Study|Lost to Follow-up|55|||
105896663|NCT04643964|365277903|FG001|Overall Study|Lost to Follow-up|59|||
105896664|NCT04643964|365277904|FG002|Overall Study|Lost to Follow-up|54|||
105896665|NCT04643964|365277905|FG003|Overall Study|Lost to Follow-up|129|||
105896666|NCT04643964|365277906|FG004|Overall Study|Lost to Follow-up|48|||
105896667|NCT04643964|365277902|FG000|Overall Study|Failed attention check|1|||
105896668|NCT04643964|365277903|FG001|Overall Study|Failed attention check|8|||
105896669|NCT04643964|365277904|FG002|Overall Study|Failed attention check|2|||
105896670|NCT04643964|365277905|FG003|Overall Study|Failed attention check|14|||
105896671|NCT04643964|365277906|FG004|Overall Study|Failed attention check|11|||
105896672|NCT02949908|365277907|FG000|Overall Study|Study termination|2|||
105896673|NCT01472939|365277908|FG000|Overall Study|Adverse Event|3|||
105896674|NCT01472939|365277909|FG001|Overall Study|Adverse Event|7|||
105896675|NCT01472939|365277910|FG002|Overall Study|Adverse Event|7|||
105896676|NCT01472939|365277911|FG003|Overall Study|Adverse Event|14|||
105896677|NCT01472939|365277908|FG000|Overall Study|Lack of Efficacy|1|||
105786013|NCT00596466|364870443|FG000|Overall Study|Withdrawal by Subject|2|||
105896678|NCT01472939|365277909|FG001|Overall Study|Lack of Efficacy|0|||
105896679|NCT01472939|365277910|FG002|Overall Study|Lack of Efficacy|0|||
105896680|NCT01472939|365277911|FG003|Overall Study|Lack of Efficacy|1|||
105896681|NCT01472939|365277908|FG000|Overall Study|Lost to Follow-up|3|||
105896682|NCT01472939|365277909|FG001|Overall Study|Lost to Follow-up|0|||
105896683|NCT01472939|365277910|FG002|Overall Study|Lost to Follow-up|2|||
105896684|NCT01472939|365277911|FG003|Overall Study|Lost to Follow-up|0|||
105896685|NCT01472939|365277908|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
105896686|NCT01472939|365277909|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
105896687|NCT01472939|365277910|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
105896688|NCT01472939|365277911|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
105896689|NCT01472939|365277908|FG000|Overall Study|Prohibited Medication|0|||
105896690|NCT01472939|365277909|FG001|Overall Study|Prohibited Medication|1|||
105896691|NCT01472939|365277910|FG002|Overall Study|Prohibited Medication|0|||
105896692|NCT01472939|365277911|FG003|Overall Study|Prohibited Medication|0|||
105896693|NCT01472939|365277908|FG000|Overall Study|Withdrawal By PI|1|||
105896694|NCT01472939|365277909|FG001|Overall Study|Withdrawal By PI|0|||
105896695|NCT01472939|365277910|FG002|Overall Study|Withdrawal By PI|0|||
105896696|NCT01472939|365277911|FG003|Overall Study|Withdrawal By PI|0|||
105896697|NCT01472939|365277908|FG000|Overall Study|Protocol Violation|3|||
105896698|NCT01472939|365277909|FG001|Overall Study|Protocol Violation|3|||
105896699|NCT01472939|365277910|FG002|Overall Study|Protocol Violation|0|||
105896700|NCT01472939|365277911|FG003|Overall Study|Protocol Violation|1|||
105896701|NCT01472939|365277908|FG000|Overall Study|Withdrawal by Subject|9|||
105896702|NCT01472939|365277909|FG001|Overall Study|Withdrawal by Subject|3|||
105896703|NCT01472939|365277910|FG002|Overall Study|Withdrawal by Subject|1|||
105896704|NCT01472939|365277911|FG003|Overall Study|Withdrawal by Subject|4|||
105896705|NCT00114738|365277912|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
105896706|NCT00114738|365277913|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
105896707|NCT00114738|365277914|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
105896708|NCT00114738|365277912|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
105896709|NCT00114738|365277913|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
105896710|NCT00114738|365277914|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
105896711|NCT00114738|365277912|FG000|Screening for Randomization|Neuropathy|17|||
105896712|NCT00114738|365277913|FG001|Screening for Randomization|Neuropathy|0|||
105896713|NCT00114738|365277914|FG002|Screening for Randomization|Neuropathy|0|||
105896714|NCT00114738|365277912|FG000|Screening for Randomization|Progressive disease|2|||
105896715|NCT00114738|365277913|FG001|Screening for Randomization|Progressive disease|0|||
105896716|NCT00114738|365277914|FG002|Screening for Randomization|Progressive disease|0|||
105896717|NCT00114738|365277912|FG000|Screening for Randomization|CNS Hemorrhage|1|||
105896718|NCT00114738|365277913|FG001|Screening for Randomization|CNS Hemorrhage|0|||
105896719|NCT00114738|365277914|FG002|Screening for Randomization|CNS Hemorrhage|0|||
105896720|NCT00114738|365277912|FG000|Screening for Randomization|Other|1|||
105896721|NCT00114738|365277913|FG001|Screening for Randomization|Other|0|||
105896722|NCT00114738|365277914|FG002|Screening for Randomization|Other|0|||
105896723|NCT00308750|365277915|FG000|Overall Study|Adverse Event|9|||
105896724|NCT00308750|365277916|FG001|Overall Study|Adverse Event|9|||
105896725|NCT00308750|365277917|FG002|Overall Study|Adverse Event|13|||
105896726|NCT00308750|365277915|FG000|Overall Study|Withdrawal by Subject|6|||
105896727|NCT00308750|365277916|FG001|Overall Study|Withdrawal by Subject|2|||
105896728|NCT00308750|365277917|FG002|Overall Study|Withdrawal by Subject|3|||
105896729|NCT00308750|365277915|FG000|Overall Study|Physician Decision|3|||
105896730|NCT00308750|365277916|FG001|Overall Study|Physician Decision|4|||
105896731|NCT00308750|365277917|FG002|Overall Study|Physician Decision|3|||
105896732|NCT00308750|365277915|FG000|Overall Study|Sponsor Decision|1|||
105896733|NCT00308750|365277916|FG001|Overall Study|Sponsor Decision|0|||
105896734|NCT00308750|365277917|FG002|Overall Study|Sponsor Decision|0|||
105896735|NCT00308750|365277915|FG000|Overall Study|Disease Progression|47|||
105896736|NCT00308750|365277916|FG001|Overall Study|Disease Progression|24|||
105896737|NCT00308750|365277917|FG002|Overall Study|Disease Progression|28|||
105896738|NCT00308750|365277915|FG000|Overall Study|Unrelated Complication|3|||
105896739|NCT00308750|365277916|FG001|Overall Study|Unrelated Complication|0|||
105896740|NCT00308750|365277917|FG002|Overall Study|Unrelated Complication|1|||
105896741|NCT00308750|365277915|FG000|Overall Study|Death|1|||
105896742|NCT00308750|365277916|FG001|Overall Study|Death|0|||
105896743|NCT00308750|365277917|FG002|Overall Study|Death|1|||
105896744|NCT00308750|365277915|FG000|Overall Study|Protocol Violation|1|||
105896745|NCT00308750|365277916|FG001|Overall Study|Protocol Violation|0|||
105896746|NCT00308750|365277917|FG002|Overall Study|Protocol Violation|0|||
105896747|NCT00308750|365277915|FG000|Overall Study|New Primary Disease Identified|1|||
105896748|NCT00308750|365277916|FG001|Overall Study|New Primary Disease Identified|1|||
105896749|NCT00308750|365277917|FG002|Overall Study|New Primary Disease Identified|0|||
105896750|NCT00388297|365277918|FG000|Overall Study|Lost to Follow-up|16|||
105896751|NCT00388297|365277919|FG001|Overall Study|Lost to Follow-up|12|||
105896752|NCT00388297|365277920|FG002|Overall Study|Lost to Follow-up|11|||
105896753|NCT00388297|365277921|FG003|Overall Study|Lost to Follow-up|8|||
105896754|NCT01546038|365277922|FG000|Overall Study|Death|15|||
105896755|NCT01546038|365277923|FG001|Overall Study|Death|6|||
105896756|NCT01546038|365277924|FG002|Overall Study|Death|4|||
105896757|NCT01546038|365277925|FG003|Overall Study|Death|2|||
105896758|NCT01546038|365277926|FG004|Overall Study|Death|9|||
105896759|NCT01546038|365277927|FG005|Overall Study|Death|3|||
105896760|NCT01546038|365277928|FG006|Overall Study|Death|46|||
105896761|NCT01546038|365277929|FG007|Overall Study|Death|76|||
105896762|NCT01546038|365277930|FG008|Overall Study|Death|39|||
105896763|NCT01546038|365277922|FG000|Overall Study|Lost to Follow-up|0|||
105896764|NCT01546038|365277923|FG001|Overall Study|Lost to Follow-up|0|||
105896765|NCT01546038|365277924|FG002|Overall Study|Lost to Follow-up|0|||
105896766|NCT01546038|365277925|FG003|Overall Study|Lost to Follow-up|0|||
105896767|NCT01546038|365277926|FG004|Overall Study|Lost to Follow-up|1|||
105896768|NCT01546038|365277927|FG005|Overall Study|Lost to Follow-up|0|||
105896769|NCT01546038|365277928|FG006|Overall Study|Lost to Follow-up|2|||
105896770|NCT01546038|365277929|FG007|Overall Study|Lost to Follow-up|1|||
105896771|NCT01546038|365277930|FG008|Overall Study|Lost to Follow-up|0|||
105896772|NCT01546038|365277922|FG000|Overall Study|Withdrawal by Subject|1|||
105896773|NCT01546038|365277923|FG001|Overall Study|Withdrawal by Subject|0|||
105896774|NCT01546038|365277924|FG002|Overall Study|Withdrawal by Subject|0|||
105896775|NCT01546038|365277925|FG003|Overall Study|Withdrawal by Subject|1|||
105896776|NCT01546038|365277926|FG004|Overall Study|Withdrawal by Subject|0|||
105896777|NCT01546038|365277927|FG005|Overall Study|Withdrawal by Subject|1|||
105997502|NCT03828292|365651486|FG002|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
105997503|NCT03828292|365651487|FG003|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
105997504|NCT03828292|365651484|FG000|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
105896778|NCT01546038|365277928|FG006|Overall Study|Withdrawal by Subject|3|||
105896779|NCT01546038|365277929|FG007|Overall Study|Withdrawal by Subject|3|||
105896780|NCT01546038|365277930|FG008|Overall Study|Withdrawal by Subject|1|||
105896781|NCT01546038|365277922|FG000|Overall Study|: Randomized, not treated|0|||
105896782|NCT01546038|365277923|FG001|Overall Study|: Randomized, not treated|0|||
105896783|NCT01546038|365277924|FG002|Overall Study|: Randomized, not treated|0|||
105896784|NCT01546038|365277925|FG003|Overall Study|: Randomized, not treated|0|||
105896785|NCT01546038|365277926|FG004|Overall Study|: Randomized, not treated|0|||
105896786|NCT01546038|365277927|FG005|Overall Study|: Randomized, not treated|0|||
105896787|NCT01546038|365277928|FG006|Overall Study|: Randomized, not treated|2|||
105896788|NCT01546038|365277929|FG007|Overall Study|: Randomized, not treated|4|||
105896789|NCT01546038|365277930|FG008|Overall Study|: Randomized, not treated|3|||
105896790|NCT04245202|365277931|FG000|Overall Study|Lack of Efficacy|10|||
105896791|NCT04245202|365277932|FG001|Overall Study|Lack of Efficacy|1|||
105896792|NCT00334802|365277933|FG000|Overall Study|Progressive Disease|2|||
105896793|NCT00334802|365277934|FG001|Overall Study|Progressive Disease|24|||
105896794|NCT00334802|365277933|FG000|Overall Study|Toxicity|1|||
105896795|NCT00334802|365277934|FG001|Overall Study|Toxicity|5|||
105896796|NCT00334802|365277933|FG000|Overall Study|Lack of Efficacy|1|||
105896797|NCT00334802|365277934|FG001|Overall Study|Lack of Efficacy|3|||
105896798|NCT00334802|365277933|FG000|Overall Study|Patient Condition Aggrevated|1|||
105896799|NCT00334802|365277934|FG001|Overall Study|Patient Condition Aggrevated|0|||
105896800|NCT00334802|365277933|FG000|Overall Study|Physician Decision|1|||
105896801|NCT00334802|365277934|FG001|Overall Study|Physician Decision|0|||
105896802|NCT00334802|365277933|FG000|Overall Study|Withdrawal by Subject|0|||
105896803|NCT00334802|365277934|FG001|Overall Study|Withdrawal by Subject|4|||
105896804|NCT00334802|365277933|FG000|Overall Study|Adverse Event|0|||
105896805|NCT00334802|365277934|FG001|Overall Study|Adverse Event|3|||
105896806|NCT00334802|365277933|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
105896807|NCT00334802|365277934|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
105896808|NCT03422159|365277935|FG000|Overall Study|Exclusion due to terminal disease|2|||
105896809|NCT03422159|365277936|FG001|Overall Study|Exclusion due to terminal disease|1|||
105896810|NCT00717275|365277941|FG000|Overall Study|Premature study termination.|3|||
105896811|NCT01285492|365277946|FG000|Overall Study|Adverse Event|11|||
105896812|NCT01285492|365277947|FG001|Overall Study|Adverse Event|0|||
105896813|NCT01285492|365277946|FG000|Overall Study|Protocol Violation|3|||
105896814|NCT01285492|365277947|FG001|Overall Study|Protocol Violation|0|||
105896815|NCT01285492|365277946|FG000|Overall Study|Withdrawal by Subject|2|||
105896816|NCT01285492|365277947|FG001|Overall Study|Withdrawal by Subject|1|||
105896817|NCT01285492|365277946|FG000|Overall Study|Death|1|||
105896818|NCT01285492|365277947|FG001|Overall Study|Death|0|||
105896819|NCT01935128|365277948|FG000|Overall Study|Death|1|||
105896820|NCT01935128|365277948|FG000|Overall Study|Adverse Event|6|||
105896821|NCT00096993|365277949|FG000|Overall Study|Death|1|||
105896822|NCT00096993|365277950|FG001|Overall Study|Death|0|||
105896823|NCT00096993|365277949|FG000|Overall Study|Disease progression|56|||
105896824|NCT00096993|365277950|FG001|Overall Study|Disease progression|53|||
105896825|NCT00096993|365277949|FG000|Overall Study|Adverse Event|2|||
105896826|NCT00096993|365277950|FG001|Overall Study|Adverse Event|8|||
105896827|NCT00096993|365277949|FG000|Overall Study|Subject's decision|3|||
105896828|NCT00096993|365277950|FG001|Overall Study|Subject's decision|1|||
105896829|NCT00096993|365277949|FG000|Overall Study|Physician Decision|2|||
105896830|NCT00096993|365277950|FG001|Overall Study|Physician Decision|1|||
105896831|NCT00096993|365277949|FG000|Overall Study|Non-compliance|0|||
105896832|NCT00096993|365277950|FG001|Overall Study|Non-compliance|1|||
105896833|NCT00096993|365277949|FG000|Overall Study|Other unspecified|1|||
105896834|NCT00096993|365277950|FG001|Overall Study|Other unspecified|1|||
105896835|NCT01162122|365277953|FG000|Overall Study|Withdrawal by Subject|52|||
105896836|NCT01162122|365277954|FG001|Overall Study|Withdrawal by Subject|43|||
105896837|NCT01162122|365277953|FG000|Overall Study|Lost to Follow-up|73|||
105896838|NCT01162122|365277954|FG001|Overall Study|Lost to Follow-up|91|||
105896839|NCT01162122|365277953|FG000|Overall Study|Adverse Event|3|||
105896840|NCT01162122|365277954|FG001|Overall Study|Adverse Event|2|||
105896841|NCT01162122|365277953|FG000|Overall Study|Death|51|||
105896842|NCT01162122|365277954|FG001|Overall Study|Death|46|||
105896843|NCT01162122|365277953|FG000|Overall Study|Protocol Violation|2|||
105896844|NCT01162122|365277954|FG001|Overall Study|Protocol Violation|2|||
105896845|NCT01162122|365277953|FG000|Overall Study|Inappropriate enrollment|5|||
105896846|NCT01162122|365277954|FG001|Overall Study|Inappropriate enrollment|4|||
105896847|NCT01162122|365277953|FG000|Overall Study|Administrative reason|1|||
105896848|NCT01162122|365277954|FG001|Overall Study|Administrative reason|1|||
105896849|NCT01162122|365277953|FG000|Overall Study|Unable to classify|3|||
105896850|NCT01162122|365277954|FG001|Overall Study|Unable to classify|7|||
105896851|NCT01162122|365277953|FG000|Overall Study|Missing primary reason|1|||
105896852|NCT01162122|365277954|FG001|Overall Study|Missing primary reason|0|||
105896853|NCT01074255|365277955|FG000|Overall Study|Did not receive EMEND|2|||
105896854|NCT00926536|365277961|FG000|Overall Study|Physician Decision|1|||
105896855|NCT00926536|365277962|FG001|Overall Study|Physician Decision|2|||
105896856|NCT01217385|365277963|FG000|Overall Study|Withdrawal by Subject|3|||
105896857|NCT01217385|365277963|FG000|Overall Study|DOSI not performed/not eval|12|||
105896858|NCT01217385|365277963|FG000|Overall Study|Central Path not Available|1|||
105896859|NCT01217385|365277963|FG000|Overall Study|Normal Breast TOI not available|10|||
105896860|NCT00990665|365277964|FG000|Overall Study|Unsuccessful Implant|8|||
105896861|NCT00990665|365277964|FG000|Overall Study|Death|29|||
105896862|NCT00990665|365277964|FG000|Overall Study|Heart Transplant|1|||
105896863|NCT00990665|365277964|FG000|Overall Study|Withdrawal by Subject|6|||
105896864|NCT00990665|365277964|FG000|Overall Study|Lost to Follow-up|1|||
105896865|NCT00990665|365277964|FG000|Overall Study|System Explant|3|||
105896866|NCT00090584|365277968|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
105896867|NCT00090584|365277969|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
105896868|NCT00090584|365277968|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
105896869|NCT00090584|365277969|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
105896870|NCT04442269|365277970|FG000|Overall Study|Adverse Event|1|||
105896871|NCT04442269|365277971|FG001|Overall Study|Adverse Event|0|||
105896872|NCT04442269|365277970|FG000|Overall Study|Death|0|||
105896873|NCT04442269|365277971|FG001|Overall Study|Death|1|||
105896874|NCT04442269|365277970|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
105896875|NCT04442269|365277971|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
105896876|NCT04442269|365277970|FG000|Overall Study|Lost to Follow-up|1|||
105896877|NCT04442269|365277971|FG001|Overall Study|Lost to Follow-up|0|||
105896878|NCT04442269|365277970|FG000|Overall Study|Withdrawal by Subject|3|||
105896879|NCT04442269|365277971|FG001|Overall Study|Withdrawal by Subject|2|||
105896880|NCT04442269|365277970|FG000|Overall Study|Protocol Deviation|0|||
105896881|NCT04442269|365277971|FG001|Overall Study|Protocol Deviation|1|||
105896882|NCT04442269|365277970|FG000|Overall Study|Travel Limitations|1|||
105896883|NCT04442269|365277971|FG001|Overall Study|Travel Limitations|1|||
105896884|NCT02117713|365277985|FG000|Week 48|Adverse Event|4|||
105896885|NCT02117713|365277985|FG000|Week 48|Withdrawal by caregiver|2|||
105896886|NCT02117713|365277985|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
105896887|NCT02117713|365277985|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
105896888|NCT02117713|365277985|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
105896889|NCT02117713|365277985|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
105896890|NCT01706575|365277988|FG000|Overall Study|Participant Withdrew Consent|4|||
105896891|NCT01706575|365277988|FG000|Overall Study|Lost to Follow-up|2|||
105896892|NCT01706575|365277988|FG000|Overall Study|Started but not Treated|6|||
105896893|NCT01987232|365277989|FG000|Overall Study|Ongoing in Study|0|||
105896894|NCT01987232|365277990|FG001|Overall Study|Ongoing in Study|0|||
105896895|NCT01987232|365277991|FG002|Overall Study|Ongoing in Study|0|||
105896896|NCT01987232|365277992|FG003|Overall Study|Ongoing in Study|1|||
105896897|NCT01987232|365277993|FG004|Overall Study|Ongoing in Study|0|||
105896898|NCT01634659|365278011|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
105896899|NCT01634659|365278012|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
105896900|NCT01634659|365278011|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
105896901|NCT01634659|365278012|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
105896902|NCT02431806|365278013|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
105896903|NCT02431806|365278014|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
105896904|NCT02431806|365278015|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
105896905|NCT02431806|365278016|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
105896906|NCT02431806|365278013|FG000|Double-blind Treatment Period|Adverse Event|4|||
105896907|NCT02431806|365278014|FG001|Double-blind Treatment Period|Adverse Event|7|||
105896908|NCT02431806|365278015|FG002|Double-blind Treatment Period|Adverse Event|11|||
105896909|NCT02431806|365278016|FG003|Double-blind Treatment Period|Adverse Event|7|||
105896910|NCT02431806|365278013|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
105896911|NCT02431806|365278014|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
105896912|NCT02431806|365278015|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
105896913|NCT02431806|365278016|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
105896914|NCT02431806|365278013|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
105896915|NCT02431806|365278014|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
105896916|NCT02431806|365278015|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
105896917|NCT02431806|365278016|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
105896918|NCT02431806|365278013|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
105896919|NCT02431806|365278014|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
105896920|NCT02431806|365278015|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
105896921|NCT02431806|365278016|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
105896922|NCT02431806|365278013|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
105896923|NCT02431806|365278014|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
105896924|NCT02431806|365278015|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
105896925|NCT02431806|365278016|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
105896926|NCT02431806|365278013|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
105896927|NCT02431806|365278014|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
105896928|NCT02431806|365278015|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
105896929|NCT02431806|365278016|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
105896930|NCT02968433|365278017|FG000|Overall Study|Withdrawal by Subject|1|||
105896931|NCT02918552|365278018|FG000|Overall Study|Failed Pharmacokinetics|1|||
105896932|NCT02918552|365278019|FG001|Overall Study|Failed Pharmacokinetics|0|||
105896933|NCT02918552|365278018|FG000|Overall Study|Withdrawal by Subject|0|||
105896934|NCT02918552|365278019|FG001|Overall Study|Withdrawal by Subject|1|||
105896935|NCT02918552|365278018|FG000|Overall Study|Lost to Follow-up|0|||
105896936|NCT02918552|365278019|FG001|Overall Study|Lost to Follow-up|1|||
105896937|NCT04395274|365278020|FG000|Overall Study|Lost to Follow-up|20|||
105896938|NCT04395274|365278021|FG001|Overall Study|Lost to Follow-up|11|||
105896939|NCT04395274|365278020|FG000|Overall Study|Withdrawal by Subject|13|||
105896940|NCT04395274|365278021|FG001|Overall Study|Withdrawal by Subject|10|||
105896941|NCT04395274|365278020|FG000|Overall Study|Moved Abroad|0|||
105896942|NCT04395274|365278021|FG001|Overall Study|Moved Abroad|1|||
105896943|NCT03482167|365278022|FG000|Allocated to Intervention|Physician Decision|1|||
105896944|NCT03482167|365278023|FG001|Allocated to Intervention|Physician Decision|2|||
105896945|NCT03482167|365278022|FG000|Received Intervention|Adverse Event|3|||
105896946|NCT03482167|365278023|FG001|Received Intervention|Adverse Event|1|||
105896947|NCT03482167|365278022|FG000|Received Intervention|Physician Decision|1|||
105896948|NCT03482167|365278023|FG001|Received Intervention|Physician Decision|1|||
105896949|NCT03482167|365278022|FG000|Received Intervention|Withdrawal by Subject|1|||
105896950|NCT03482167|365278023|FG001|Received Intervention|Withdrawal by Subject|0|||
105896951|NCT01524783|365278027|FG000|Blinded Period|Adverse Event|64|||
105896952|NCT01524783|365278028|FG001|Blinded Period|Adverse Event|7|||
105896953|NCT01524783|365278029|FG002|Blinded Period|Adverse Event|0|||
105896954|NCT01524783|365278027|FG000|Blinded Period|Disease Progression|89|||
105896955|NCT01524783|365278028|FG001|Blinded Period|Disease Progression|75|||
105896956|NCT01524783|365278029|FG002|Blinded Period|Disease Progression|0|||
105896957|NCT01524783|365278027|FG000|Blinded Period|Withdrawal by Subject|19|||
105896958|NCT01524783|365278028|FG001|Blinded Period|Withdrawal by Subject|6|||
105896959|NCT01524783|365278029|FG002|Blinded Period|Withdrawal by Subject|0|||
105896960|NCT01524783|365278027|FG000|Blinded Period|Protocol deviation|2|||
105896961|NCT01524783|365278028|FG001|Blinded Period|Protocol deviation|1|||
105896962|NCT01524783|365278029|FG002|Blinded Period|Protocol deviation|0|||
105896963|NCT01524783|365278027|FG000|Blinded Period|Death|5|||
105896964|NCT01524783|365278028|FG001|Blinded Period|Death|2|||
105896965|NCT01524783|365278029|FG002|Blinded Period|Death|0|||
105896966|NCT01524783|365278027|FG000|Open-label Period|Disease progression|13|||
105896967|NCT01524783|365278028|FG001|Open-label Period|Disease progression|0|||
105896968|NCT01524783|365278029|FG002|Open-label Period|Disease progression|2|||
105896969|NCT01524783|365278027|FG000|Open-label Period|Administrative problems|5|||
105896970|NCT01524783|365278028|FG001|Open-label Period|Administrative problems|0|||
105896971|NCT01524783|365278029|FG002|Open-label Period|Administrative problems|2|||
105896972|NCT01524783|365278027|FG000|Open-label Period|Adverse Event|5|||
105896973|NCT01524783|365278028|FG001|Open-label Period|Adverse Event|0|||
105896974|NCT01524783|365278029|FG002|Open-label Period|Adverse Event|1|||
105896975|NCT01524783|365278027|FG000|Open-label Period|Withdrawal by Subject|2|||
105896976|NCT01524783|365278028|FG001|Open-label Period|Withdrawal by Subject|0|||
105896977|NCT01524783|365278029|FG002|Open-label Period|Withdrawal by Subject|1|||
105896978|NCT01524783|365278027|FG000|Open-label Period|Protocol deviation|1|||
105896979|NCT01524783|365278028|FG001|Open-label Period|Protocol deviation|0|||
105896980|NCT01524783|365278029|FG002|Open-label Period|Protocol deviation|0|||
105896981|NCT02920177|365278030|FG000|Overall Study|Withdrawal by Subject|1|||
105896982|NCT02920177|365278031|FG001|Overall Study|Withdrawal by Subject|1|||
105896983|NCT02920177|365278030|FG000|Overall Study|Physician Decision|1|||
105896984|NCT02920177|365278031|FG001|Overall Study|Physician Decision|0|||
105896985|NCT02920177|365278030|FG000|Overall Study|Lost to Follow-up|0|||
105896986|NCT02920177|365278031|FG001|Overall Study|Lost to Follow-up|1|||
105896987|NCT01876979|365278032|FG000|Overall Study|Physician Decision|2|||
105896988|NCT01876979|365278033|FG001|Overall Study|Physician Decision|3|||
105896989|NCT01096589|365278034|FG000|Overall Study|Adverse Event|2|||
105896990|NCT01096589|365278035|FG001|Overall Study|Adverse Event|1|||
105896991|NCT01096589|365278036|FG002|Overall Study|Adverse Event|2|||
105896992|NCT01096589|365278037|FG003|Overall Study|Adverse Event|1|||
105896993|NCT01096589|365278034|FG000|Overall Study|Withdrawal by Subject|2|||
105896994|NCT01096589|365278035|FG001|Overall Study|Withdrawal by Subject|1|||
105896995|NCT01096589|365278036|FG002|Overall Study|Withdrawal by Subject|1|||
105896996|NCT01096589|365278037|FG003|Overall Study|Withdrawal by Subject|1|||
105896997|NCT01096589|365278034|FG000|Overall Study|Compliance with protocol|0|||
105896998|NCT01096589|365278035|FG001|Overall Study|Compliance with protocol|0|||
105896999|NCT01096589|365278036|FG002|Overall Study|Compliance with protocol|1|||
105897000|NCT01096589|365278037|FG003|Overall Study|Compliance with protocol|0|||
105897001|NCT01096589|365278034|FG000|Overall Study|found treatment exhausting|0|||
105897002|NCT01096589|365278035|FG001|Overall Study|found treatment exhausting|0|||
105897003|NCT01096589|365278036|FG002|Overall Study|found treatment exhausting|0|||
105897004|NCT01096589|365278037|FG003|Overall Study|found treatment exhausting|1|||
105897005|NCT00900731|365278038|FG000|Overall Study|Adverse Event|31|||
105897006|NCT00900731|365278039|FG001|Overall Study|Adverse Event|27|||
105897007|NCT00900731|365278038|FG000|Overall Study|Withdrawal by Subject|8|||
105897008|NCT00900731|365278039|FG001|Overall Study|Withdrawal by Subject|7|||
105897009|NCT00900731|365278038|FG000|Overall Study|Protocol Deviation|8|||
105897010|NCT00900731|365278039|FG001|Overall Study|Protocol Deviation|11|||
105897011|NCT00900731|365278038|FG000|Overall Study|Administrative Problems|5|||
105897012|NCT00900731|365278039|FG001|Overall Study|Administrative Problems|4|||
105897013|NCT00900731|365278038|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
105897014|NCT00900731|365278039|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105897015|NCT00900731|365278038|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
105897016|NCT00900731|365278039|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
105897017|NCT00900731|365278038|FG000|Overall Study|Lost to Follow-up|2|||
105897018|NCT00900731|365278039|FG001|Overall Study|Lost to Follow-up|3|||
105897019|NCT00900731|365278038|FG000|Overall Study|Lack of Efficacy|1|||
105897020|NCT00900731|365278039|FG001|Overall Study|Lack of Efficacy|3|||
105897021|NCT00900731|365278038|FG000|Overall Study|Death|0|||
105897022|NCT00900731|365278039|FG001|Overall Study|Death|2|||
105897023|NCT03806231|365278040|FG000|Overall Study|Physician Decision|1|||
105897024|NCT03806231|365278041|FG001|Overall Study|Physician Decision|0|||
105897025|NCT03806231|365278040|FG000|Overall Study|Withdrawal by Subject|1|||
105897026|NCT03806231|365278041|FG001|Overall Study|Withdrawal by Subject|0|||
105897027|NCT02919267|365278042|FG000|Overall Study|Protocol Violation|0|||
105897028|NCT02919267|365278043|FG001|Overall Study|Protocol Violation|3|||
105897029|NCT02919267|365278044|FG002|Overall Study|Protocol Violation|3|||
105897030|NCT02919267|365278045|FG003|Overall Study|Protocol Violation|4|||
105897031|NCT02407054|365278046|FG000|Overall Study|Adverse Event|1|||
105897032|NCT02407054|365278047|FG001|Overall Study|Adverse Event|4|||
105897033|NCT02407054|365278048|FG002|Overall Study|Adverse Event|1|||
105897034|NCT02407054|365278046|FG000|Overall Study|Non-compliance with Study|0|||
105897035|NCT02407054|365278047|FG001|Overall Study|Non-compliance with Study|2|||
105897036|NCT02407054|365278048|FG002|Overall Study|Non-compliance with Study|1|||
105897037|NCT02407054|365278046|FG000|Overall Study|Physician Decision|1|||
105897038|NCT02407054|365278047|FG001|Overall Study|Physician Decision|3|||
105897039|NCT02407054|365278048|FG002|Overall Study|Physician Decision|3|||
105897040|NCT02407054|365278046|FG000|Overall Study|Withdrawal by Subject|5|||
105897041|NCT02407054|365278047|FG001|Overall Study|Withdrawal by Subject|9|||
105897042|NCT02407054|365278048|FG002|Overall Study|Withdrawal by Subject|2|||
105897043|NCT00932698|365278049|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
105897044|NCT00932698|365278050|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
105897045|NCT00932698|365278051|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
105897046|NCT00932698|365278052|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
105897047|NCT00932698|365278053|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
105897048|NCT00932698|365278054|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
105897049|NCT00932698|365278055|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
105667864|NCT01154140|364448224|FG001|Overall Study|Lost to Follow-up|5|||
105897050|NCT00932698|365278056|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
105897051|NCT00932698|365278057|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
105897052|NCT00932698|365278058|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
105897053|NCT00932698|365278059|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
105897054|NCT00932698|365278049|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105897055|NCT00932698|365278050|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
105897056|NCT00932698|365278051|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105897057|NCT00932698|365278052|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
105897058|NCT00932698|365278053|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105897059|NCT00932698|365278054|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
105897060|NCT00932698|365278055|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
105897061|NCT00932698|365278056|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105897062|NCT00932698|365278057|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105897063|NCT00932698|365278058|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105897064|NCT00932698|365278059|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
105897065|NCT00932698|365278049|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
105897066|NCT00932698|365278050|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
105897067|NCT00932698|365278051|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
105897068|NCT00932698|365278052|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
105897069|NCT00932698|365278053|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
105897070|NCT00932698|365278054|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
105897071|NCT00932698|365278055|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
105897072|NCT00932698|365278056|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
105897073|NCT00932698|365278057|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
105897074|NCT00932698|365278058|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
105897075|NCT00932698|365278059|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
105897076|NCT00932698|365278049|FG000|Part 1 (Dose Escalation)|Other|0|||
105897077|NCT00932698|365278050|FG001|Part 1 (Dose Escalation)|Other|0|||
105897078|NCT00932698|365278051|FG002|Part 1 (Dose Escalation)|Other|1|||
105897079|NCT00932698|365278052|FG003|Part 1 (Dose Escalation)|Other|0|||
105897080|NCT00932698|365278053|FG004|Part 1 (Dose Escalation)|Other|0|||
105897081|NCT00932698|365278054|FG005|Part 1 (Dose Escalation)|Other|0|||
105897082|NCT00932698|365278055|FG006|Part 1 (Dose Escalation)|Other|1|||
105897083|NCT00932698|365278056|FG007|Part 1 (Dose Escalation)|Other|0|||
105897084|NCT00932698|365278057|FG008|Part 1 (Dose Escalation)|Other|0|||
105897085|NCT00932698|365278058|FG009|Part 1 (Dose Escalation)|Other|0|||
105897086|NCT00932698|365278059|FG010|Part 1 (Dose Escalation)|Other|0|||
105897087|NCT00932698|365278049|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
105897088|NCT00932698|365278050|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
105897089|NCT00932698|365278051|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
105897090|NCT00932698|365278052|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
105897091|NCT00932698|365278053|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
105897092|NCT00932698|365278054|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
105897093|NCT00932698|365278055|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
105897094|NCT00932698|365278056|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
105897095|NCT00932698|365278057|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
105897096|NCT00932698|365278058|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
105897097|NCT00932698|365278059|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
105897098|NCT00932698|365278049|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105897099|NCT00932698|365278050|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105897100|NCT00932698|365278051|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105897101|NCT00932698|365278052|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105897102|NCT00932698|365278053|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105897103|NCT00932698|365278054|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105897104|NCT00932698|365278055|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105897105|NCT00932698|365278056|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
105897106|NCT00932698|365278057|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
105897107|NCT00932698|365278058|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
105897108|NCT00932698|365278059|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
105897109|NCT00932698|365278049|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
105897110|NCT00932698|365278050|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
105897111|NCT00932698|365278051|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
105897112|NCT00932698|365278052|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
105897113|NCT00932698|365278053|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
105897114|NCT00932698|365278054|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
105897115|NCT00932698|365278055|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
105897116|NCT00932698|365278056|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
105897117|NCT00932698|365278057|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
105897118|NCT00932698|365278058|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
105897119|NCT00932698|365278059|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
105897120|NCT00131365|365278060|FG000|Overall Study|Withdrawal by Subject|1|||
105897121|NCT00131365|365278060|FG000|Overall Study|Alternative treatment|3|||
105897122|NCT00655681|365278061|FG000|Overall Study|Lost to Follow-up|1|||
105897123|NCT00655681|365278062|FG001|Overall Study|Lost to Follow-up|1|||
105897124|NCT01085136|365278063|FG000|Part A|Other Adverse event|223|||
105897125|NCT01085136|365278064|FG001|Part A|Other Adverse event|0|||
105897126|NCT01085136|365278065|FG002|Part A|Other Adverse event|0|||
105897127|NCT01085136|365278063|FG000|Part A|Protocol Violation|3|||
105897128|NCT01085136|365278064|FG001|Part A|Protocol Violation|0|||
105897129|NCT01085136|365278065|FG002|Part A|Protocol Violation|0|||
105897130|NCT01085136|365278063|FG000|Part A|Lost to Follow-up|3|||
105897131|NCT01085136|365278064|FG001|Part A|Lost to Follow-up|0|||
105897132|NCT01085136|365278065|FG002|Part A|Lost to Follow-up|0|||
105897133|NCT01085136|365278063|FG000|Part A|Refusal to continue trial medication|64|||
105897134|NCT01085136|365278064|FG001|Part A|Refusal to continue trial medication|0|||
105897135|NCT01085136|365278065|FG002|Part A|Refusal to continue trial medication|0|||
105897136|NCT01085136|365278063|FG000|Part A|Other reason not defined above|30|||
105897137|NCT01085136|365278064|FG001|Part A|Other reason not defined above|0|||
105897138|NCT01085136|365278065|FG002|Part A|Other reason not defined above|0|||
105897139|NCT01085136|365278063|FG000|Part B|Other AE|0|||
105897140|NCT01085136|365278064|FG001|Part B|Other AE|29|||
105897141|NCT01085136|365278065|FG002|Part B|Other AE|8|||
105897142|NCT01085136|365278063|FG000|Part B|Refusal to continue trial medication|0|||
105897143|NCT01085136|365278064|FG001|Part B|Refusal to continue trial medication|12|||
105897144|NCT01085136|365278065|FG002|Part B|Refusal to continue trial medication|7|||
105897145|NCT01085136|365278063|FG000|Part B|Not treated|0|||
105897146|NCT01085136|365278064|FG001|Part B|Not treated|4|||
105897147|NCT01085136|365278065|FG002|Part B|Not treated|8|||
105897148|NCT01085136|365278063|FG000|Part B|Other reason not defined above|0|||
105897149|NCT01085136|365278064|FG001|Part B|Other reason not defined above|6|||
105897150|NCT01085136|365278065|FG002|Part B|Other reason not defined above|3|||
105897151|NCT03605849|365279400|FG000|Overall Study|Adverse Event|20|||
105897152|NCT03605849|365279401|FG001|Overall Study|Adverse Event|21|||
105897153|NCT03605849|365279402|FG002|Overall Study|Adverse Event|29|||
105897154|NCT03605849|365279403|FG003|Overall Study|Adverse Event|11|||
105897155|NCT03605849|365279400|FG000|Overall Study|Lack of Efficacy|4|||
105897156|NCT03605849|365279401|FG001|Overall Study|Lack of Efficacy|7|||
105897157|NCT03605849|365279402|FG002|Overall Study|Lack of Efficacy|9|||
105897158|NCT03605849|365279403|FG003|Overall Study|Lack of Efficacy|2|||
105897159|NCT03605849|365279400|FG000|Overall Study|Lost to Follow-up|8|||
105897160|NCT03605849|365279401|FG001|Overall Study|Lost to Follow-up|8|||
105897161|NCT03605849|365279402|FG002|Overall Study|Lost to Follow-up|14|||
105897162|NCT03605849|365279403|FG003|Overall Study|Lost to Follow-up|11|||
105997505|NCT03828292|365651485|FG001|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
105997506|NCT03828292|365651486|FG002|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
105997507|NCT03828292|365651487|FG003|Part 2 (Up to 212 Weeks)|Progressive disease|1|||
105997508|NCT03828292|365651484|FG000|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
105997509|NCT03828292|365651485|FG001|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
105997510|NCT03828292|365651486|FG002|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
105997511|NCT03828292|365651487|FG003|Part 2 (Up to 212 Weeks)|Adverse Event|1|||
105997512|NCT03828292|365651484|FG000|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|0|||
105997513|NCT03828292|365651485|FG001|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|0|||
105997514|NCT03828292|365651486|FG002|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|2|||
105997515|NCT03828292|365651487|FG003|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|2|||
105997516|NCT04896593|365651488|FG000|Overall Study|Withdrawal by Subject|2|||
105997517|NCT04896593|365651488|FG000|Overall Study|Lost to Follow-up|1|||
105997518|NCT04896593|365651488|FG000|Overall Study|Did not complete onboarding|2|||
105997519|NCT00319254|365651493|FG000|Overall Study|Withdrawal by Subject|4|||
105997520|NCT00319254|365651493|FG000|Overall Study|Death|46|||
105997521|NCT00319254|365651493|FG000|Overall Study|Lost to Follow-up|2|||
105997522|NCT00319254|365651493|FG000|Overall Study|Enrolled, Not Treated|2|||
105997523|NCT01657292|365651498|FG000|Overall Study|Adverse Event|6|||
105997524|NCT01657292|365651498|FG000|Overall Study|Withdrawal by Subject|2|||
105997525|NCT01657292|365651498|FG000|Overall Study|Violation of eligibility criteria|1|||
105897163|NCT03605849|365279400|FG000|Overall Study|Non-compliance With IMP|6|||
105897164|NCT03605849|365279401|FG001|Overall Study|Non-compliance With IMP|5|||
106123902|NCT03230864|366111663|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
105897165|NCT03605849|365279402|FG002|Overall Study|Non-compliance With IMP|2|||
105897166|NCT03605849|365279403|FG003|Overall Study|Non-compliance With IMP|1|||
105897167|NCT03605849|365279400|FG000|Overall Study|Protocol Deviation|1|||
105997526|NCT01657292|365651498|FG000|Overall Study|Change of therapy|1|||
105997527|NCT01279681|365651500|FG000|Overall Study|Disease Progression|9|||
106123903|NCT03230864|366111664|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
105897168|NCT03605849|365279401|FG001|Overall Study|Protocol Deviation|2|||
105897169|NCT03605849|365279402|FG002|Overall Study|Protocol Deviation|1|||
105897170|NCT03605849|365279403|FG003|Overall Study|Protocol Deviation|3|||
106123904|NCT00432679|366111671|FG000|Overall Study|Adverse Event|2|||
105897171|NCT03605849|365279400|FG000|Overall Study|Withdrawal by Subject|33|||
105897172|NCT03605849|365279401|FG001|Overall Study|Withdrawal by Subject|28|||
105897173|NCT03605849|365279402|FG002|Overall Study|Withdrawal by Subject|30|||
105897174|NCT03605849|365279403|FG003|Overall Study|Withdrawal by Subject|28|||
105897175|NCT03605849|365279400|FG000|Overall Study|Site Terminated by Sponsor|0|||
105897176|NCT03605849|365279401|FG001|Overall Study|Site Terminated by Sponsor|0|||
105897177|NCT03605849|365279402|FG002|Overall Study|Site Terminated by Sponsor|0|||
105897178|NCT03605849|365279403|FG003|Overall Study|Site Terminated by Sponsor|1|||
105897179|NCT03605849|365279400|FG000|Overall Study|Physician Decision|2|||
105897180|NCT03605849|365279401|FG001|Overall Study|Physician Decision|1|||
105897181|NCT03605849|365279402|FG002|Overall Study|Physician Decision|2|||
105897182|NCT03605849|365279403|FG003|Overall Study|Physician Decision|1|||
105897183|NCT03605849|365279400|FG000|Overall Study|Enrolled, but not Treated|2|||
105897184|NCT03605849|365279401|FG001|Overall Study|Enrolled, but not Treated|2|||
105897185|NCT03605849|365279402|FG002|Overall Study|Enrolled, but not Treated|3|||
105897186|NCT03605849|365279403|FG003|Overall Study|Enrolled, but not Treated|2|||
105897187|NCT03605849|365279400|FG000|Overall Study|Other (COVID-19 Related)|0|||
105897188|NCT03605849|365279401|FG001|Overall Study|Other (COVID-19 Related)|1|||
105897189|NCT03605849|365279402|FG002|Overall Study|Other (COVID-19 Related)|1|||
105897190|NCT03605849|365279403|FG003|Overall Study|Other (COVID-19 Related)|0|||
105897191|NCT03605849|365279400|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
105897192|NCT03605849|365279401|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
105897193|NCT03605849|365279402|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
105897194|NCT03605849|365279403|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
105897195|NCT02607280|365279404|FG000|Overall Study|Adverse Event|4|||
105897196|NCT02607280|365279405|FG001|Overall Study|Adverse Event|0|||
105897197|NCT02607280|365279404|FG000|Overall Study|Decrease in CrCl <15|0|||
105897198|NCT02607280|365279405|FG001|Overall Study|Decrease in CrCl <15|1|||
105897199|NCT00328094|365279406|FG000|Overall Study|Physician Decision|3|||
105897200|NCT00328094|365279407|FG001|Overall Study|Physician Decision|3|||
105897201|NCT02667626|365279408|FG000|Overall Study|Withdrawal by Subject|0|||
105897202|NCT02667626|365279409|FG001|Overall Study|Withdrawal by Subject|1|||
105897203|NCT00766467|365279416|FG000|Overall Study|Withdrawal by Subject|7|||
105897204|NCT00766467|365279417|FG001|Overall Study|Withdrawal by Subject|2|||
105897205|NCT00766467|365279416|FG000|Overall Study|Adverse Event|1|||
105897206|NCT00766467|365279417|FG001|Overall Study|Adverse Event|1|||
105897207|NCT00766467|365279416|FG000|Overall Study|Protocol Violation|2|||
105897208|NCT00766467|365279417|FG001|Overall Study|Protocol Violation|4|||
105897209|NCT00766467|365279416|FG000|Overall Study|Tumor Progression on Study|0|||
105897210|NCT00766467|365279417|FG001|Overall Study|Tumor Progression on Study|1|||
105897211|NCT00766467|365279416|FG000|Overall Study|Physician Decision|1|||
105897212|NCT00766467|365279417|FG001|Overall Study|Physician Decision|0|||
105897213|NCT02223819|365279419|FG000|Overall Study|Lost to Follow-up|2|||
105897214|NCT01420679|365279422|FG000|Overall Study|Disease Progression|3|||
105897215|NCT01420679|365279423|FG001|Overall Study|Disease Progression|2|||
105897216|NCT01420679|365279422|FG000|Overall Study|Adverse Event|4|||
105897217|NCT01420679|365279423|FG001|Overall Study|Adverse Event|0|||
105897218|NCT01420679|365279422|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
105897219|NCT01420679|365279423|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
105897220|NCT01420679|365279422|FG000|Overall Study|Patient Decision|1|||
105897221|NCT01420679|365279423|FG001|Overall Study|Patient Decision|0|||
105897222|NCT01420679|365279422|FG000|Overall Study|Investigator Decision|1|||
105897223|NCT01420679|365279423|FG001|Overall Study|Investigator Decision|2|||
105897224|NCT01420679|365279422|FG000|Overall Study|Sponsor Decision|3|||
105897225|NCT01420679|365279423|FG001|Overall Study|Sponsor Decision|3|||
105897226|NCT01420679|365279422|FG000|Overall Study|Other|1|||
105897227|NCT01420679|365279423|FG001|Overall Study|Other|0|||
105897228|NCT03956615|365279426|FG000|Overall Study|No multiple myeloma confirmed|2|||
105897229|NCT03956615|365279426|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
105897230|NCT03956615|365279426|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
105897231|NCT03956615|365279426|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
105897232|NCT02604550|365279427|FG000|Overall Study|Lost to Follow-up|7|||
105897233|NCT02604550|365279428|FG001|Overall Study|Lost to Follow-up|6|||
105897234|NCT02604550|365279427|FG000|Overall Study|Withdrawal by Subject|0|||
105897235|NCT02604550|365279428|FG001|Overall Study|Withdrawal by Subject|1|||
105897236|NCT02604550|365279427|FG000|Overall Study|Incomplete data using paper journal|18|||
105897237|NCT02604550|365279428|FG001|Overall Study|Incomplete data using paper journal|19|||
105897238|NCT01199822|365279429|FG000|Overall Study|Investigator discontinued therapy|0|||
105897239|NCT01199822|365279430|FG001|Overall Study|Investigator discontinued therapy|1|||
105897240|NCT01199822|365279431|FG002|Overall Study|Investigator discontinued therapy|0|||
105897241|NCT01069419|365279432|FG000|Overall Study|Adverse Event|233|||
105897242|NCT01069419|365279432|FG000|Overall Study|Lack of Efficacy|332|||
105897243|NCT01069419|365279432|FG000|Overall Study|Lost to Follow-up|49|||
105897244|NCT01069419|365279432|FG000|Overall Study|Remission of disease|11|||
105897245|NCT01069419|365279432|FG000|Overall Study|Withdrawal by Subject|34|||
105897246|NCT01069419|365279432|FG000|Overall Study|Other Reason|43|||
105897247|NCT01069419|365279432|FG000|Overall Study|Missing termination information|13|||
105897248|NCT02382796|365279433|FG000|Overall Study|Global deterioration of health status|1|||
106123905|NCT00432679|366111672|FG001|Overall Study|Adverse Event|1|||
106123906|NCT00432679|366111671|FG000|Overall Study|Withdrawal by Subject|3|||
106123907|NCT00432679|366111672|FG001|Overall Study|Withdrawal by Subject|2|||
106123908|NCT01744496|366111673|FG000|Titration Period|Adverse Event|2|||
106123909|NCT01744496|366111674|FG001|Titration Period|Adverse Event|1|||
106123910|NCT01744496|366111673|FG000|Titration Period|Personal reasons|0|||
106123911|NCT01744496|366111674|FG001|Titration Period|Personal reasons|1|||
106123912|NCT01744496|366111673|FG000|Maintenance Period|Adverse Event|1|||
106123913|NCT01744496|366111674|FG001|Maintenance Period|Adverse Event|3|||
106123914|NCT01744496|366111673|FG000|Maintenance Period|Protocol Violation|1|||
106123915|NCT01744496|366111674|FG001|Maintenance Period|Protocol Violation|0|||
106123916|NCT01744496|366111673|FG000|Maintenance Period|Withdrawal by Subject|1|||
106123917|NCT01744496|366111674|FG001|Maintenance Period|Withdrawal by Subject|1|||
105897249|NCT02382796|365279433|FG000|Overall Study|Objective progression or relapse|3|||
105897250|NCT02382796|365279433|FG000|Overall Study|Commercial dacomitinib became available|3|||
105897251|NCT04007107|365279438|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
105897252|NCT04007107|365279439|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
105897253|NCT04007107|365279440|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
105897254|NCT04007107|365279441|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
105897255|NCT04027075|365279442|FG000|Overall Study|Lost to Follow-up|41|||
105897256|NCT04027075|365279443|FG001|Overall Study|Lost to Follow-up|22|||
105897257|NCT01179737|365279445|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
105897258|NCT01179737|365279446|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
105897259|NCT01179737|365279447|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
105897260|NCT01179737|365279448|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
105897261|NCT01179737|365279445|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
105897262|NCT01179737|365279446|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
105897263|NCT01179737|365279447|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
105897264|NCT01179737|365279448|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
105897265|NCT01179737|365279445|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
105897266|NCT01179737|365279446|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
105897267|NCT01179737|365279447|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
105897268|NCT01179737|365279448|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
105897269|NCT01179737|365279445|FG000|Cohort 1 & Cohort 2|Death|0|||
105897270|NCT01179737|365279446|FG001|Cohort 1 & Cohort 2|Death|0|||
105897271|NCT01179737|365279447|FG002|Cohort 1 & Cohort 2|Death|1|||
105897272|NCT01179737|365279448|FG003|Cohort 1 & Cohort 2|Death|0|||
105897273|NCT01179737|365279445|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
105897274|NCT01179737|365279446|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
105897275|NCT01179737|365279447|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
105897276|NCT01179737|365279448|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
105897277|NCT01179737|365279445|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
105897278|NCT01179737|365279446|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
105897279|NCT01179737|365279447|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
105897280|NCT01179737|365279448|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
105897281|NCT01179737|365279445|FG000|Extension|The study was terminated|3|||
105897282|NCT01179737|365279446|FG001|Extension|The study was terminated|0|||
105897283|NCT01179737|365279447|FG002|Extension|The study was terminated|0|||
105897284|NCT01179737|365279448|FG003|Extension|The study was terminated|0|||
105897285|NCT00401960|365279451|FG000|Overall Study|Lost to Follow-up|3|||
105897286|NCT00401960|365279452|FG001|Overall Study|Lost to Follow-up|0|||
105897287|NCT00401960|365279451|FG000|Overall Study|Death|2|||
105897288|NCT00401960|365279452|FG001|Overall Study|Death|0|||
105897289|NCT01870297|365279453|FG000|Overall Study|Adverse Event|0|||
105897290|NCT01870297|365279454|FG001|Overall Study|Adverse Event|0|||
105897291|NCT01870297|365279455|FG002|Overall Study|Adverse Event|0|||
105897292|NCT01870297|365279456|FG003|Overall Study|Adverse Event|0|||
105897293|NCT01870297|365279457|FG004|Overall Study|Adverse Event|2|||
106123918|NCT01744496|366111673|FG000|Maintenance Period|Subject left town|1|||
106123919|NCT01744496|366111674|FG001|Maintenance Period|Subject left town|0|||
106123920|NCT03537261|366111675|FG000|Overall Study|Lost to Follow-up|4|||
105897294|NCT01870297|365279458|FG005|Overall Study|Adverse Event|0|||
105897295|NCT01870297|365279459|FG006|Overall Study|Adverse Event|0|||
105897296|NCT01870297|365279453|FG000|Overall Study|Lost to Follow-up|0|||
105897297|NCT01870297|365279454|FG001|Overall Study|Lost to Follow-up|1|||
105897298|NCT01870297|365279455|FG002|Overall Study|Lost to Follow-up|1|||
105897299|NCT01870297|365279456|FG003|Overall Study|Lost to Follow-up|0|||
105897300|NCT01870297|365279457|FG004|Overall Study|Lost to Follow-up|0|||
105897301|NCT01870297|365279458|FG005|Overall Study|Lost to Follow-up|0|||
105897302|NCT01870297|365279459|FG006|Overall Study|Lost to Follow-up|0|||
105897303|NCT01870297|365279453|FG000|Overall Study|Withdrawal by Subject|0|||
105897304|NCT01870297|365279454|FG001|Overall Study|Withdrawal by Subject|0|||
106123921|NCT03537261|366111676|FG001|Overall Study|Lost to Follow-up|5|||
105897305|NCT01870297|365279455|FG002|Overall Study|Withdrawal by Subject|0|||
105897306|NCT01870297|365279456|FG003|Overall Study|Withdrawal by Subject|0|||
105897307|NCT01870297|365279457|FG004|Overall Study|Withdrawal by Subject|1|||
105897308|NCT01870297|365279458|FG005|Overall Study|Withdrawal by Subject|1|||
105897309|NCT01870297|365279459|FG006|Overall Study|Withdrawal by Subject|1|||
105897310|NCT01870297|365279453|FG000|Overall Study|Sponsor Decision|0|||
105897311|NCT01870297|365279454|FG001|Overall Study|Sponsor Decision|6|||
105897312|NCT01870297|365279455|FG002|Overall Study|Sponsor Decision|0|||
105897313|NCT01870297|365279456|FG003|Overall Study|Sponsor Decision|0|||
105897314|NCT01870297|365279457|FG004|Overall Study|Sponsor Decision|0|||
105897315|NCT01870297|365279458|FG005|Overall Study|Sponsor Decision|0|||
105897316|NCT01870297|365279459|FG006|Overall Study|Sponsor Decision|1|||
105897317|NCT00513357|365279460|FG000|Overall Study|did not receive allocated placebo|2|||
105897318|NCT00513357|365279461|FG001|Overall Study|did not receive allocated placebo|3|||
105897319|NCT00513357|365279460|FG000|Overall Study|Adverse Event|4|||
105897320|NCT00513357|365279461|FG001|Overall Study|Adverse Event|2|||
105897321|NCT00513357|365279460|FG000|Overall Study|Death|2|||
105897322|NCT00513357|365279461|FG001|Overall Study|Death|0|||
105897323|NCT00513357|365279460|FG000|Overall Study|Withdrawal by Subject|5|||
105897324|NCT00513357|365279461|FG001|Overall Study|Withdrawal by Subject|4|||
105897325|NCT00513357|365279460|FG000|Overall Study|Disease Progression|2|||
105897326|NCT00513357|365279461|FG001|Overall Study|Disease Progression|1|||
105897327|NCT02020512|365279462|FG000|Overall Study|Adverse Event|1|||
105897328|NCT02020512|365279462|FG000|Overall Study|Lost to Follow-up|3|||
105897329|NCT02020512|365279462|FG000|Overall Study|Protocol Violation|4|||
105897330|NCT00422422|365279463|FG000|Overall Study|Lack of Efficacy|1|||
105897331|NCT00422422|365279463|FG000|Overall Study|Protocol Violation|1|||
105897332|NCT00422422|365279463|FG000|Overall Study|Withdrawal by Subject|2|||
105897333|NCT00422422|365279463|FG000|Overall Study|SAE, non-fatal|1|||
105897334|NCT00422422|365279463|FG000|Overall Study|AE, non-serious non-fatal|5|||
105897335|NCT01534208|365279468|FG000|Overall Study|Lost to Follow-up|19|||
105897336|NCT01534208|365279469|FG001|Overall Study|Lost to Follow-up|14|||
105897337|NCT01534208|365279468|FG000|Overall Study|Withdrawal by Subject|6|||
105897338|NCT01534208|365279469|FG001|Overall Study|Withdrawal by Subject|20|||
105897339|NCT01534208|365279468|FG000|Overall Study|Adverse Event|15|||
105897340|NCT01534208|365279469|FG001|Overall Study|Adverse Event|8|||
105897341|NCT01534208|365279468|FG000|Overall Study|Physician Decision|2|||
105897342|NCT01534208|365279469|FG001|Overall Study|Physician Decision|0|||
105897343|NCT01534208|365279468|FG000|Overall Study|Lack of Efficacy|0|||
105897344|NCT01534208|365279469|FG001|Overall Study|Lack of Efficacy|3|||
105897345|NCT01534208|365279468|FG000|Overall Study|Protocol Violation|2|||
105897346|NCT01534208|365279469|FG001|Overall Study|Protocol Violation|2|||
105897347|NCT01534208|365279468|FG000|Overall Study|Sponsor decision|4|||
105897348|NCT01534208|365279469|FG001|Overall Study|Sponsor decision|1|||
105897349|NCT01534208|365279468|FG000|Overall Study|Subject relocation|2|||
105897350|NCT01534208|365279469|FG001|Overall Study|Subject relocation|0|||
105897351|NCT01534208|365279468|FG000|Overall Study|Lab assessment|2|||
105897352|NCT01534208|365279469|FG001|Overall Study|Lab assessment|1|||
105897353|NCT01534208|365279468|FG000|Overall Study|Eligibility error|3|||
105897354|NCT01534208|365279469|FG001|Overall Study|Eligibility error|0|||
105897355|NCT01534208|365279468|FG000|Overall Study|PCP decision|1|||
105897356|NCT01534208|365279469|FG001|Overall Study|PCP decision|0|||
105897357|NCT01534208|365279468|FG000|Overall Study|Needed prohibited meds|1|||
105897358|NCT01534208|365279469|FG001|Overall Study|Needed prohibited meds|0|||
105897359|NCT01904903|365279470|FG000|Overall Study|Withdrawal by Subject|1|||
105897360|NCT00574795|365279471|FG000|Infant Series|Withdrawal by Subject|2|||
105897361|NCT00574795|365279471|FG000|Infant Series|Protocol Violation|2|||
105897362|NCT00574795|365279471|FG000|Infant Series|Adverse Event|1|||
105897363|NCT00574795|365279471|FG000|After Infant Series|Withdrawal by Subject|1|||
105897364|NCT00574795|365279471|FG000|After Infant Series|Adverse Event|2|||
105897365|NCT00574795|365279471|FG000|Toddler Dose|Withdrawal by Subject|1|||
105897366|NCT03578146|365279472|FG000|Overall Study|Did Not Receive Treatment|1|||
105897367|NCT03578146|365279473|FG001|Overall Study|Did Not Receive Treatment|0|||
105897368|NCT03578146|365279474|FG002|Overall Study|Did Not Receive Treatment|0|||
105897369|NCT03578146|365279475|FG003|Overall Study|Did Not Receive Treatment|0|||
106123922|NCT03537261|366111675|FG000|Overall Study|Withdrawal by Subject|4|||
105897370|NCT03578146|365279476|FG004|Overall Study|Did Not Receive Treatment|0|||
105897371|NCT03578146|365279477|FG005|Overall Study|Did Not Receive Treatment|2|||
105897372|NCT03578146|365279472|FG000|Overall Study|Lost to Follow-up|0|||
105897373|NCT03578146|365279473|FG001|Overall Study|Lost to Follow-up|1|||
105897374|NCT03578146|365279474|FG002|Overall Study|Lost to Follow-up|1|||
105897375|NCT03578146|365279475|FG003|Overall Study|Lost to Follow-up|0|||
105897376|NCT03578146|365279476|FG004|Overall Study|Lost to Follow-up|0|||
105897377|NCT03578146|365279477|FG005|Overall Study|Lost to Follow-up|1|||
105897378|NCT04299048|365279479|FG000|Overall Study|Death|1|||
105897379|NCT04299048|365279479|FG000|Overall Study|Global deterioration of health status|2|||
105897380|NCT04299048|365279479|FG000|Overall Study|Enrolled and not treated|1|||
105897381|NCT00634049|365279482|FG000|Overall Study|Never received study drug|1|||
105997528|NCT01279681|365651501|FG001|Overall Study|Disease Progression|6|||
105897382|NCT00634049|365279482|FG000|Overall Study|Died prior to receiving study drug|1|||
105897383|NCT00634049|365279482|FG000|Overall Study|Screening failure|1|||
105897384|NCT00314132|365279483|FG000|Overall Study|Lost to Follow-up|3|||
105897385|NCT00314132|365279484|FG001|Overall Study|Lost to Follow-up|13|||
105897386|NCT00314132|365279483|FG000|Overall Study|Withdrawal by Subject|3|||
105897387|NCT00314132|365279484|FG001|Overall Study|Withdrawal by Subject|5|||
105897388|NCT00314132|365279483|FG000|Overall Study|Adverse Event|1|||
105897389|NCT00314132|365279484|FG001|Overall Study|Adverse Event|0|||
105897390|NCT00314132|365279483|FG000|Overall Study|Physician Decision|1|||
105897391|NCT00314132|365279484|FG001|Overall Study|Physician Decision|0|||
105897392|NCT03677934|365279486|FG000|Overall Study|Adverse Event|1|||
105897393|NCT03677934|365279487|FG001|Overall Study|Adverse Event|1|||
105897394|NCT03677934|365279486|FG000|Overall Study|Death|8|||
105897395|NCT03677934|365279487|FG001|Overall Study|Death|4|||
105897396|NCT03677934|365279486|FG000|Overall Study|Lost to Follow-up|3|||
105897397|NCT03677934|365279487|FG001|Overall Study|Lost to Follow-up|0|||
105897398|NCT03677934|365279486|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105897399|NCT03677934|365279487|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105897400|NCT03677934|365279486|FG000|Overall Study|Physician Decision|0|||
105897401|NCT03677934|365279487|FG001|Overall Study|Physician Decision|1|||
105897402|NCT03677934|365279486|FG000|Overall Study|Withdrawal by Subject|1|||
105897403|NCT03677934|365279487|FG001|Overall Study|Withdrawal by Subject|7|||
105897404|NCT00932451|365279491|FG000|Overall Study|Withdrawal by Subject|69|||
105897405|NCT00932451|365279491|FG000|Overall Study|Lost to Follow-up|22|||
105897406|NCT00932451|365279491|FG000|Overall Study|Death|726|||
105897407|NCT00932451|365279491|FG000|Overall Study|Other reasons|5|||
105897408|NCT00335959|365279492|FG000|Overall Study|Adverse Event|2|||
105897409|NCT00335959|365279492|FG000|Overall Study|Ineligible|1|||
105897410|NCT03564795|365279495|FG000|Overall Study|Withdrawal by Subject|3|||
105897411|NCT03564795|365279495|FG000|Overall Study|Lost to Follow-up|6|||
105897412|NCT03564795|365279495|FG000|Overall Study|Physician Decision|2|||
105897413|NCT05079230|365279496|FG000|Overall Study|Study Terminated by Sponsor|101|||
105897414|NCT05079230|365279497|FG001|Overall Study|Study Terminated by Sponsor|102|||
105897415|NCT05079230|365279496|FG000|Overall Study|Death|72|||
105897416|NCT05079230|365279497|FG001|Overall Study|Death|66|||
105897417|NCT05079230|365279496|FG000|Overall Study|Withdrew Consent|16|||
105897418|NCT05079230|365279497|FG001|Overall Study|Withdrew Consent|18|||
105897419|NCT05079230|365279496|FG000|Overall Study|Lost to Follow-up|0|||
105897420|NCT05079230|365279497|FG001|Overall Study|Lost to Follow-up|3|||
105897421|NCT01333956|365279498|FG000|Overall Study|Lost to Follow-up|1|||
105897422|NCT01333956|365279499|FG001|Overall Study|Lost to Follow-up|2|||
105897423|NCT01333956|365279500|FG002|Overall Study|Lost to Follow-up|0|||
105897424|NCT01333956|365279501|FG003|Overall Study|Lost to Follow-up|1|||
105897425|NCT01333956|365279498|FG000|Overall Study|Unable to complete study procedure|1|||
105897426|NCT01333956|365279499|FG001|Overall Study|Unable to complete study procedure|0|||
105897427|NCT01333956|365279500|FG002|Overall Study|Unable to complete study procedure|0|||
105897428|NCT01333956|365279501|FG003|Overall Study|Unable to complete study procedure|1|||
105897429|NCT01333956|365279498|FG000|Overall Study|Withdrawal by Subject|0|||
105897430|NCT01333956|365279499|FG001|Overall Study|Withdrawal by Subject|2|||
105897431|NCT01333956|365279500|FG002|Overall Study|Withdrawal by Subject|1|||
105897432|NCT01333956|365279501|FG003|Overall Study|Withdrawal by Subject|0|||
105897433|NCT03673345|365279502|FG000|Overall Study|Lost to Follow-up|1|||
106123923|NCT03537261|366111676|FG001|Overall Study|Withdrawal by Subject|6|||
106123924|NCT03537261|366111675|FG000|Overall Study|Did not return study questionnaires|0|||
106123925|NCT03537261|366111676|FG001|Overall Study|Did not return study questionnaires|1|||
106123926|NCT02500979|366111679|FG000|Period 1|Hyperglycemia|1|||
106123927|NCT02500979|366111680|FG001|Period 1|Hyperglycemia|0|||
106123928|NCT02500979|366111679|FG000|Period 1|Severe non-compliance to protocol|0|||
106123929|NCT02500979|366111680|FG001|Period 1|Severe non-compliance to protocol|1|||
106123930|NCT02500979|366111679|FG000|Period 1|Adverse Event|1|||
106123931|NCT02500979|366111680|FG001|Period 1|Adverse Event|0|||
106123932|NCT02500979|366111679|FG000|Period 1|Subject decision|2|||
106123933|NCT02500979|366111680|FG001|Period 1|Subject decision|0|||
105786014|NCT00596466|364870443|FG000|Overall Study|Protocol Violation|2|||
105897434|NCT03673345|365279503|FG001|Overall Study|Lost to Follow-up|0|||
105897435|NCT03673345|365279504|FG002|Overall Study|Lost to Follow-up|3|||
105897436|NCT03673345|365279505|FG003|Overall Study|Lost to Follow-up|3|||
105897437|NCT03673345|365279506|FG004|Overall Study|Lost to Follow-up|2|||
105897438|NCT03673345|365279507|FG005|Overall Study|Lost to Follow-up|1|||
105897439|NCT03673345|365279508|FG006|Overall Study|Lost to Follow-up|0|||
105897440|NCT03673345|365279509|FG007|Overall Study|Lost to Follow-up|0|||
105897441|NCT03673345|365279502|FG000|Overall Study|Withdrawal by Subject|1|||
105897442|NCT03673345|365279503|FG001|Overall Study|Withdrawal by Subject|0|||
106123934|NCT02500979|366111679|FG000|Period 2|Change in risk|1|||
106123935|NCT02500979|366111680|FG001|Period 2|Change in risk|0|||
105667865|NCT01154140|364448223|FG000|Overall Study|Withdrawal by Subject|12|||
105667866|NCT01154140|364448224|FG001|Overall Study|Withdrawal by Subject|13|||
105667867|NCT01154140|364448223|FG000|Overall Study|Other|3|||
105667868|NCT01154140|364448224|FG001|Overall Study|Other|1|||
105667869|NCT01154140|364448223|FG000|Overall Study|Randomized but not treated|1|||
105667870|NCT01154140|364448224|FG001|Overall Study|Randomized but not treated|2|||
105667871|NCT00368875|364448225|FG000|Overall Study|Adverse Event|0|||
106123936|NCT01380990|366111685|FG000|Overall Study|Treatment Failure|1|||
106123937|NCT01380990|366111686|FG001|Overall Study|Treatment Failure|0|||
106123938|NCT01380990|366111685|FG000|Overall Study|Death|0|||
106123939|NCT01380990|366111686|FG001|Overall Study|Death|1|||
106123940|NCT04844918|366111688|FG000|Overall Study|Adverse Event|7|||
106123941|NCT04844918|366111689|FG001|Overall Study|Adverse Event|8|||
106123942|NCT04844918|366111690|FG002|Overall Study|Adverse Event|5|||
105667872|NCT00368875|364448226|FG001|Overall Study|Adverse Event|12|||
105667873|NCT00368875|364448225|FG000|Overall Study|Progressive disease|3|||
105667874|NCT00368875|364448226|FG001|Overall Study|Progressive disease|27|||
105667875|NCT00368875|364448225|FG000|Overall Study|Withdrawal by Subject|2|||
105667876|NCT00368875|364448226|FG001|Overall Study|Withdrawal by Subject|6|||
105667877|NCT00368875|364448225|FG000|Overall Study|Other Reason|0|||
105667878|NCT00368875|364448226|FG001|Overall Study|Other Reason|2|||
105897443|NCT03673345|365279504|FG002|Overall Study|Withdrawal by Subject|4|||
105897444|NCT03673345|365279505|FG003|Overall Study|Withdrawal by Subject|2|||
105897445|NCT03673345|365279506|FG004|Overall Study|Withdrawal by Subject|0|||
105897446|NCT03673345|365279507|FG005|Overall Study|Withdrawal by Subject|0|||
105897447|NCT03673345|365279508|FG006|Overall Study|Withdrawal by Subject|0|||
105897448|NCT03673345|365279509|FG007|Overall Study|Withdrawal by Subject|0|||
105897449|NCT03673345|365279502|FG000|Overall Study|Physician Decision|0|||
105897450|NCT03673345|365279503|FG001|Overall Study|Physician Decision|0|||
105897451|NCT03673345|365279504|FG002|Overall Study|Physician Decision|2|||
105667879|NCT00368875|364448225|FG000|Overall Study|Alternative Therapy|1|||
105667880|NCT00368875|364448226|FG001|Overall Study|Alternative Therapy|1|||
105667881|NCT01572740|364448227|FG000|Overall Study|Adverse Event|1|||
105667882|NCT01572740|364448228|FG001|Overall Study|Adverse Event|1|||
105667883|NCT01572740|364448227|FG000|Overall Study|Withdrawal by Subject|1|||
105667884|NCT01572740|364448228|FG001|Overall Study|Withdrawal by Subject|1|||
105897452|NCT03673345|365279505|FG003|Overall Study|Physician Decision|0|||
105897453|NCT03673345|365279506|FG004|Overall Study|Physician Decision|0|||
105897454|NCT03673345|365279507|FG005|Overall Study|Physician Decision|0|||
105897455|NCT03673345|365279508|FG006|Overall Study|Physician Decision|0|||
105897456|NCT03673345|365279509|FG007|Overall Study|Physician Decision|0|||
105897457|NCT01712334|365279510|FG000|Treatment Period 1|Randomized in Error|0|||
105897458|NCT01712334|365279511|FG001|Treatment Period 1|Randomized in Error|2|||
105897459|NCT00474786|365279512|FG000|Overall Study|Not Meeting Study Criteria|0|||
105897460|NCT00474786|365279513|FG001|Overall Study|Not Meeting Study Criteria|1|||
105897461|NCT00474786|365279512|FG000|Overall Study|Investigator Request|2|||
105897462|NCT00474786|365279513|FG001|Overall Study|Investigator Request|1|||
105897463|NCT00474786|365279512|FG000|Overall Study|Death|189|||
105897464|NCT00474786|365279513|FG001|Overall Study|Death|170|||
105897465|NCT00474786|365279512|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
105897466|NCT00474786|365279513|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
105897467|NCT00474786|365279512|FG000|Overall Study|Lost to Follow-up|4|||
105897468|NCT00474786|365279513|FG001|Overall Study|Lost to Follow-up|7|||
105897469|NCT00474786|365279512|FG000|Overall Study|Protocol Violation|2|||
105897470|NCT00474786|365279513|FG001|Overall Study|Protocol Violation|0|||
105897471|NCT00474786|365279512|FG000|Overall Study|Withdrawal by Subject|15|||
105897472|NCT00474786|365279513|FG001|Overall Study|Withdrawal by Subject|15|||
105897473|NCT00474786|365279512|FG000|Overall Study|Other|5|||
105897474|NCT00474786|365279513|FG001|Overall Study|Other|0|||
105897475|NCT04608344|365279514|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
105897476|NCT04608344|365279515|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
105897477|NCT04608344|365279514|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
105897478|NCT04608344|365279515|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
105897479|NCT05249127|365279516|FG000|Overall Study|Protocol Violation|13|||
106123943|NCT04844918|366111688|FG000|Overall Study|Physician Decision|0|||
105667885|NCT01572740|364448227|FG000|Overall Study|unclassified|4|||
105667886|NCT01572740|364448228|FG001|Overall Study|unclassified|3|||
105897480|NCT05249127|365279516|FG000|Overall Study|Physician Decision|4|||
105897481|NCT05249127|365279516|FG000|Overall Study|Withdrawal by Subject|2|||
105897482|NCT05249127|365279516|FG000|Overall Study|Participant Non-compliance|1|||
105897483|NCT00415597|365279518|FG000|Enrollment|Withdrawal by Subject|1|||
105897484|NCT00415597|365279518|FG000|Enrollment|Protocol Violation|1|||
105897485|NCT00415597|365279518|FG000|Treatment|Adverse Event|110|||
106123944|NCT04844918|366111689|FG001|Overall Study|Physician Decision|1|||
106123945|NCT04844918|366111690|FG002|Overall Study|Physician Decision|0|||
105667887|NCT01289210|364448229|FG000|Overall Study|Adverse Event|1|||
106123946|NCT04844918|366111688|FG000|Overall Study|Withdrawal by Subject|6|||
105897486|NCT00415597|365279518|FG000|Treatment|Lack of Efficacy|39|||
105897487|NCT00415597|365279518|FG000|Treatment|Protocol Violation|67|||
105897488|NCT00415597|365279518|FG000|Treatment|Physician Decision|3|||
105897489|NCT00415597|365279518|FG000|Treatment|Withdrawal by Subject|51|||
105897490|NCT00415597|365279518|FG000|Treatment|Lost to Follow-up|28|||
105897491|NCT00415597|365279518|FG000|Treatment|Drug Screen|2|||
105897492|NCT00415597|365279518|FG000|Treatment|Administrative|3|||
105897493|NCT00415597|365279518|FG000|Treatment|Sponsor Decision|1|||
105897494|NCT00415597|365279518|FG000|Treatment|Multiple Reasons|1|||
105897495|NCT02172040|365279525|FG000|Overall Study|Adverse Event|0|||
105897496|NCT02172040|365279526|FG001|Overall Study|Adverse Event|2|||
105897497|NCT02172040|365279527|FG002|Overall Study|Adverse Event|0|||
105897498|NCT02172040|365279528|FG003|Overall Study|Adverse Event|0|||
105897499|NCT02172040|365279525|FG000|Overall Study|Protocol Violation|0|||
105897500|NCT02172040|365279526|FG001|Overall Study|Protocol Violation|1|||
105897501|NCT02172040|365279527|FG002|Overall Study|Protocol Violation|0|||
105897502|NCT02172040|365279528|FG003|Overall Study|Protocol Violation|0|||
105897503|NCT02172040|365279525|FG000|Overall Study|Withdrawal by Subject|0|||
105897504|NCT02172040|365279526|FG001|Overall Study|Withdrawal by Subject|0|||
105897505|NCT02172040|365279527|FG002|Overall Study|Withdrawal by Subject|1|||
105897506|NCT02172040|365279528|FG003|Overall Study|Withdrawal by Subject|0|||
105897507|NCT02172040|365279525|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
105897508|NCT02172040|365279526|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
105897509|NCT02172040|365279527|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
105897510|NCT02172040|365279528|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
105897511|NCT02172040|365279525|FG000|Overall Study|Family emergency abroad|0|||
105897512|NCT02172040|365279526|FG001|Overall Study|Family emergency abroad|0|||
105897513|NCT02172040|365279527|FG002|Overall Study|Family emergency abroad|0|||
105897514|NCT02172040|365279528|FG003|Overall Study|Family emergency abroad|1|||
105897515|NCT01900431|365279529|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
105897516|NCT01900431|365279530|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
105897517|NCT01900431|365279531|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
105897518|NCT01900431|365279529|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
105897519|NCT01900431|365279530|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
105897520|NCT01900431|365279531|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
105897521|NCT01900431|365279529|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
105897522|NCT01900431|365279530|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
105897523|NCT01900431|365279531|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
105897524|NCT01900431|365279529|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
105997529|NCT01279681|365651500|FG000|Overall Study|Withdrawal by Subject|3|||
105997530|NCT01279681|365651501|FG001|Overall Study|Withdrawal by Subject|4|||
105997531|NCT01279681|365651500|FG000|Overall Study|Adverse Event|2|||
105997532|NCT01279681|365651501|FG001|Overall Study|Adverse Event|3|||
105997533|NCT01279681|365651500|FG000|Overall Study|Death|0|||
105997534|NCT01279681|365651501|FG001|Overall Study|Death|1|||
105997535|NCT01279681|365651500|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
105997536|NCT01279681|365651501|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
105997537|NCT01279681|365651500|FG000|Overall Study|Physician Decision|1|||
105997538|NCT01279681|365651501|FG001|Overall Study|Physician Decision|0|||
105997539|NCT01279681|365651500|FG000|Overall Study|Other Reason|0|||
105997540|NCT01279681|365651501|FG001|Overall Study|Other Reason|2|||
105897525|NCT01900431|365279530|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
105897526|NCT01900431|365279531|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
105897527|NCT01900431|365279529|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
105897528|NCT01900431|365279530|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
105897529|NCT01900431|365279531|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
105897530|NCT01900431|365279529|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
105997541|NCT01943591|365651502|FG000|Overall Study|Lost to Follow-up|3|||
106123947|NCT04844918|366111689|FG001|Overall Study|Withdrawal by Subject|3|||
106123948|NCT04844918|366111690|FG002|Overall Study|Withdrawal by Subject|3|||
106123949|NCT04844918|366111688|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
106123950|NCT04844918|366111689|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
106123951|NCT04844918|366111690|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
106123952|NCT01009047|366111692|FG000|Overall Study|Adverse Event|5|||
106123953|NCT01009047|366111693|FG001|Overall Study|Adverse Event|0|||
106123954|NCT01009047|366111692|FG000|Overall Study|Lost to Follow-up|0|||
106123955|NCT01009047|366111693|FG001|Overall Study|Lost to Follow-up|2|||
106123956|NCT01009047|366111692|FG000|Overall Study|Lack of Efficacy|4|||
106123957|NCT01009047|366111693|FG001|Overall Study|Lack of Efficacy|11|||
106123958|NCT01009047|366111692|FG000|Overall Study|Withdrawal by consent|16|||
106123959|NCT01009047|366111693|FG001|Overall Study|Withdrawal by consent|11|||
106123960|NCT01009047|366111692|FG000|Overall Study|Other|3|||
106123961|NCT01009047|366111693|FG001|Overall Study|Other|2|||
106123962|NCT02366936|366111698|FG000|Overall Study|Withdrawal by Subject|2|||
106123963|NCT02366936|366111698|FG000|Overall Study|Lost to Follow-up|4|||
106123964|NCT02366936|366111698|FG000|Overall Study|Physician Decision|2|||
106123965|NCT03881059|366111701|FG000|Treatment Period - Part A|Adverse Event|1|||
106123966|NCT03881059|366111702|FG001|Treatment Period - Part A|Adverse Event|3|||
106123967|NCT03881059|366111703|FG002|Treatment Period - Part A|Adverse Event|4|||
106123968|NCT03881059|366111701|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
106123969|NCT03881059|366111702|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
106123970|NCT03881059|366111703|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
106123971|NCT03881059|366111701|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
106123972|NCT03881059|366111702|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
106123973|NCT03881059|366111703|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
106123974|NCT03881059|366111701|FG000|Treatment Period - Part A|Other reasons|2|||
106123975|NCT03881059|366111702|FG001|Treatment Period - Part A|Other reasons|1|||
106123976|NCT03881059|366111703|FG002|Treatment Period - Part A|Other reasons|0|||
106123977|NCT03881059|366111701|FG000|Treatment Period - Part B|Adverse Event|0|||
106123978|NCT03881059|366111702|FG001|Treatment Period - Part B|Adverse Event|0|||
106123979|NCT03881059|366111703|FG002|Treatment Period - Part B|Adverse Event|3|||
106123980|NCT03881059|366111701|FG000|Treatment Period - Part B|Death|0|||
106123981|NCT03881059|366111702|FG001|Treatment Period - Part B|Death|1|||
106123982|NCT03881059|366111703|FG002|Treatment Period - Part B|Death|1|||
106123983|NCT03881059|366111701|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
105897531|NCT01900431|365279530|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
105897532|NCT01900431|365279531|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
105897533|NCT01900431|365279529|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
105897534|NCT01900431|365279530|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
105897535|NCT01900431|365279531|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
105897536|NCT01900431|365279529|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
105897537|NCT01900431|365279530|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
105897538|NCT01900431|365279531|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
105897539|NCT01900431|365279529|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
105897540|NCT01900431|365279530|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
105897541|NCT01900431|365279531|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
105897542|NCT04226495|365279532|FG000|Overall Study|Withdrawal by Subject|3|||
105897543|NCT04226495|365279533|FG001|Overall Study|Withdrawal by Subject|3|||
105897544|NCT04226495|365279532|FG000|Overall Study|PI discretion|3|||
105897545|NCT04226495|365279533|FG001|Overall Study|PI discretion|4|||
105897546|NCT02093390|365279537|FG000|Overall Study|Withdrawal by Subject|0|||
105897547|NCT02093390|365279538|FG001|Overall Study|Withdrawal by Subject|1|||
105897548|NCT01854879|365279539|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
105897549|NCT01854879|365279539|FG000|Overall Study|screen fail|3|||
105897550|NCT01854879|365279539|FG000|Overall Study|incomplete data set|1|||
105897551|NCT00908596|365281398|FG000|Overall Study|Other reasons|46|||
105897552|NCT00908596|365281399|FG001|Overall Study|Other reasons|6|||
105897553|NCT00908596|365281400|FG002|Overall Study|Other reasons|2|||
105897554|NCT00908596|365281401|FG003|Overall Study|Other reasons|0|||
105897555|NCT00908596|365281398|FG000|Overall Study|Lost to Follow-up|0|||
105897556|NCT00908596|365281399|FG001|Overall Study|Lost to Follow-up|1|||
105897557|NCT00908596|365281400|FG002|Overall Study|Lost to Follow-up|12|||
105897558|NCT00908596|365281401|FG003|Overall Study|Lost to Follow-up|4|||
105897559|NCT00908596|365281398|FG000|Overall Study|Death|0|||
105897560|NCT00908596|365281399|FG001|Overall Study|Death|5|||
105897561|NCT00908596|365281400|FG002|Overall Study|Death|57|||
105897562|NCT00908596|365281401|FG003|Overall Study|Death|32|||
105897563|NCT00908596|365281398|FG000|Overall Study|Protocol Violation|1|||
105997542|NCT01943591|365651503|FG001|Overall Study|Lost to Follow-up|4|||
105997543|NCT01943591|365651502|FG000|Overall Study|Death|2|||
106123984|NCT03881059|366111702|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
106123985|NCT03881059|366111703|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
106123986|NCT03881059|366111701|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
105897564|NCT00908596|365281399|FG001|Overall Study|Protocol Violation|0|||
105897565|NCT00908596|365281400|FG002|Overall Study|Protocol Violation|0|||
105897566|NCT00908596|365281401|FG003|Overall Study|Protocol Violation|0|||
106123987|NCT03881059|366111702|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
106123988|NCT03881059|366111703|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
106123989|NCT03881059|366111701|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
105667888|NCT01818531|364448230|FG000|Overall Study|Withdrawn for case delay after block|1|||
105897567|NCT00908596|365281398|FG000|Overall Study|Withdrawal by Subject|0|||
105897568|NCT00908596|365281399|FG001|Overall Study|Withdrawal by Subject|1|||
105897569|NCT00908596|365281400|FG002|Overall Study|Withdrawal by Subject|3|||
105897570|NCT00908596|365281401|FG003|Overall Study|Withdrawal by Subject|1|||
105897571|NCT01937884|365281406|FG000|Overall Study|Withdrawal by Subject|1|||
105897572|NCT01937884|365281407|FG001|Overall Study|Withdrawal by Subject|0|||
105897573|NCT02305446|365281408|FG000|Overall Study|Adverse Event|1|||
105897574|NCT00577005|365281412|FG000|Overall Study|Lost to Follow-up|3|||
105897575|NCT00577005|365281413|FG001|Overall Study|Lost to Follow-up|2|||
105897576|NCT00577005|365281412|FG000|Overall Study|Withdrawal by Subject|2|||
105897577|NCT00577005|365281413|FG001|Overall Study|Withdrawal by Subject|1|||
105897578|NCT01004432|365281414|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
105897579|NCT01004432|365281415|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
105897580|NCT01004432|365281416|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
105897581|NCT01004432|365281417|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
105897582|NCT01004432|365281418|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
105897583|NCT01004432|365281414|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
105897584|NCT01004432|365281415|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
105897585|NCT01004432|365281416|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
105897586|NCT01004432|365281417|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
105897587|NCT01004432|365281418|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
105897588|NCT01004432|365281414|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
105897589|NCT01004432|365281415|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
105897590|NCT01004432|365281416|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
105897591|NCT01004432|365281417|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
105897592|NCT01004432|365281418|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
105897593|NCT01004432|365281414|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
105897594|NCT01004432|365281415|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
105897595|NCT01004432|365281416|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
105897596|NCT01004432|365281417|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
105897597|NCT01004432|365281418|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
105897598|NCT01004432|365281414|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
105897599|NCT01004432|365281415|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
105897600|NCT01004432|365281416|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
105897601|NCT01004432|365281417|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
105897602|NCT01004432|365281418|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
105897603|NCT01004432|365281414|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
105897604|NCT01004432|365281415|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
105897605|NCT01004432|365281416|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
105897606|NCT01004432|365281417|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
105897607|NCT01004432|365281418|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
105897608|NCT01004432|365281414|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
105897609|NCT01004432|365281415|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
105897610|NCT01004432|365281416|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
105897611|NCT01004432|365281417|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
105897612|NCT01004432|365281418|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
105897613|NCT01004432|365281414|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
105897614|NCT01004432|365281415|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
105897615|NCT01004432|365281416|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
105897616|NCT01004432|365281417|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
105897617|NCT01004432|365281418|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
105897618|NCT01004432|365281414|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
105897619|NCT01004432|365281415|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
105897620|NCT01004432|365281416|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
105897621|NCT01004432|365281417|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
105897622|NCT01004432|365281418|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
105897623|NCT01004432|365281414|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
105897624|NCT01004432|365281415|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
105667889|NCT01818531|364448231|FG001|Overall Study|Withdrawn for case delay after block|0|||
105667890|NCT01818531|364448230|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
105667891|NCT01818531|364448231|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
105667892|NCT01818531|364448230|FG000|Overall Study|Withdrawn for failure to place block|0|||
105667893|NCT01818531|364448231|FG001|Overall Study|Withdrawn for failure to place block|1|||
105997544|NCT01943591|365651503|FG001|Overall Study|Death|7|||
105997545|NCT01929226|365653164|FG000|Overall Study|Lost to Follow-up|4|||
105667894|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
106123990|NCT03881059|366111702|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
106123991|NCT03881059|366111703|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
106123992|NCT03881059|366111701|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
106123993|NCT03881059|366111702|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
106123994|NCT03881059|366111703|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
106123995|NCT03881059|366111701|FG000|Treatment Period - Part B|Other reasons|4|||
106123996|NCT03881059|366111702|FG001|Treatment Period - Part B|Other reasons|3|||
106123997|NCT03881059|366111703|FG002|Treatment Period - Part B|Other reasons|3|||
106123998|NCT02065570|366111704|FG000|Induction Study|Adverse Event|5|||
106123999|NCT02065570|366111705|FG001|Induction Study|Adverse Event|12|||
106124000|NCT02065570|366111706|FG002|Induction Study|Adverse Event|0|||
106124001|NCT02065570|366111707|FG003|Induction Study|Adverse Event|0|||
106124002|NCT02065570|366111704|FG000|Induction Study|Withdrawal by Subject|2|||
106124003|NCT02065570|366111705|FG001|Induction Study|Withdrawal by Subject|3|||
106124004|NCT02065570|366111706|FG002|Induction Study|Withdrawal by Subject|0|||
106124005|NCT02065570|366111707|FG003|Induction Study|Withdrawal by Subject|0|||
105897625|NCT01004432|365281416|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
105897626|NCT01004432|365281417|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
105897627|NCT01004432|365281418|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
105897628|NCT01004432|365281414|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
105897629|NCT01004432|365281415|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
105897630|NCT01004432|365281416|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
105897631|NCT01004432|365281417|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
105897632|NCT01004432|365281418|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
105897633|NCT01004432|365281414|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
105897634|NCT01004432|365281415|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
105897635|NCT01004432|365281416|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
105897636|NCT01004432|365281417|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
105897637|NCT01004432|365281418|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
105897638|NCT01004432|365281414|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
105897639|NCT01004432|365281415|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
105897640|NCT01004432|365281416|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
105897641|NCT01004432|365281417|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
105897642|NCT01004432|365281418|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
105897643|NCT01004432|365281414|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
105897644|NCT01004432|365281415|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
105897645|NCT01004432|365281416|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
105997546|NCT01929226|365653165|FG001|Overall Study|Lost to Follow-up|0|||
105997547|NCT01929226|365653164|FG000|Overall Study|Withdrawal by Subject|1|||
105997548|NCT01929226|365653165|FG001|Overall Study|Withdrawal by Subject|1|||
105997549|NCT03553758|365653166|FG000|Overall Study|Lost to Follow-up|1|||
105997550|NCT00412893|365653171|FG000|Overall Study|Adverse Event|31|||
105997551|NCT00412893|365653172|FG001|Overall Study|Adverse Event|53|||
105997552|NCT00412893|365653171|FG000|Overall Study|Death|17|||
105997553|NCT00412893|365653172|FG001|Overall Study|Death|21|||
105997554|NCT00412893|365653171|FG000|Overall Study|Insufficient Therapeutic Response|39|||
105997555|NCT00412893|365653172|FG001|Overall Study|Insufficient Therapeutic Response|23|||
105997556|NCT00412893|365653171|FG000|Overall Study|Lost to Follow-up|2|||
105997557|NCT00412893|365653172|FG001|Overall Study|Lost to Follow-up|1|||
105997558|NCT00412893|365653171|FG000|Overall Study|Violation of Selection at Entry|17|||
105997559|NCT00412893|365653172|FG001|Overall Study|Violation of Selection at Entry|10|||
105997560|NCT00412893|365653171|FG000|Overall Study|Other Protocol Violation|10|||
105997561|NCT00412893|365653172|FG001|Overall Study|Other Protocol Violation|6|||
105997562|NCT00412893|365653171|FG000|Overall Study|Did Not Cooperate|12|||
105997563|NCT00412893|365653172|FG001|Overall Study|Did Not Cooperate|9|||
105997564|NCT00412893|365653171|FG000|Overall Study|Administrative Reason|12|||
105997565|NCT00412893|365653172|FG001|Overall Study|Administrative Reason|15|||
105997566|NCT00412893|365653171|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
105997567|NCT00412893|365653172|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
105997568|NCT01217944|365653178|FG000|Overall Study|Protocol Violation|1|||
105997569|NCT01217944|365653179|FG001|Overall Study|Protocol Violation|1|||
105997570|NCT01217944|365653180|FG002|Overall Study|Protocol Violation|0|||
105997571|NCT01217944|365653178|FG000|Overall Study|Lost to Follow-up|3|||
105997572|NCT01217944|365653179|FG001|Overall Study|Lost to Follow-up|1|||
105897646|NCT01004432|365281417|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
105997573|NCT01217944|365653180|FG002|Overall Study|Lost to Follow-up|0|||
105997574|NCT01217944|365653178|FG000|Overall Study|Withdrawal by Subject|1|||
105997575|NCT01217944|365653179|FG001|Overall Study|Withdrawal by Subject|2|||
106124006|NCT02065570|366111704|FG000|Induction Study|Lost to Follow-up|1|||
105897647|NCT01004432|365281418|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
105997576|NCT01217944|365653180|FG002|Overall Study|Withdrawal by Subject|0|||
106124007|NCT02065570|366111705|FG001|Induction Study|Lost to Follow-up|1|||
106124008|NCT02065570|366111706|FG002|Induction Study|Lost to Follow-up|0|||
106124009|NCT02065570|366111707|FG003|Induction Study|Lost to Follow-up|0|||
106124010|NCT02065570|366111704|FG000|Induction Study|Other, Not Specified|6|||
106124011|NCT02065570|366111705|FG001|Induction Study|Other, Not Specified|5|||
106124012|NCT02065570|366111706|FG002|Induction Study|Other, Not Specified|0|||
106124013|NCT02065570|366111707|FG003|Induction Study|Other, Not Specified|0|||
106124014|NCT02065570|366111704|FG000|Maintenance Study|Adverse Event|0|||
106124015|NCT02065570|366111705|FG001|Maintenance Study|Adverse Event|0|||
106124016|NCT02065570|366111706|FG002|Maintenance Study|Adverse Event|8|||
106124017|NCT02065570|366111707|FG003|Maintenance Study|Adverse Event|8|||
106124018|NCT02065570|366111704|FG000|Maintenance Study|Withdrawal by Subject|0|||
106124019|NCT02065570|366111705|FG001|Maintenance Study|Withdrawal by Subject|0|||
106124020|NCT02065570|366111706|FG002|Maintenance Study|Withdrawal by Subject|1|||
106124021|NCT02065570|366111707|FG003|Maintenance Study|Withdrawal by Subject|4|||
106124022|NCT02065570|366111704|FG000|Maintenance Study|Lost to Follow-up|0|||
106124023|NCT02065570|366111705|FG001|Maintenance Study|Lost to Follow-up|0|||
106124024|NCT02065570|366111706|FG002|Maintenance Study|Lost to Follow-up|2|||
106124025|NCT02065570|366111707|FG003|Maintenance Study|Lost to Follow-up|2|||
106124026|NCT02065570|366111704|FG000|Maintenance Study|Other, Not Specified|0|||
105897648|NCT01004432|365281414|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
105897649|NCT01004432|365281415|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
105897650|NCT01004432|365281416|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
105897651|NCT01004432|365281417|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
105897652|NCT01004432|365281418|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
105897653|NCT00427999|365281419|FG000|Overall Study|Adverse Event|6|||
105897654|NCT00427999|365281419|FG000|Overall Study|Abnormal laboratory values|1|||
105897655|NCT00427999|365281419|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
105897656|NCT00427999|365281419|FG000|Overall Study|Protocol Violation|2|||
105897657|NCT00427999|365281419|FG000|Overall Study|Withdrawal by Subject|9|||
105897658|NCT00427999|365281419|FG000|Overall Study|Death|1|||
105897659|NCT02380859|365281420|FG000|Overall Study|Withdrawal by Subject|2|||
105897660|NCT02380859|365281421|FG001|Overall Study|Withdrawal by Subject|0|||
105897661|NCT02971800|365281422|FG000|Overall Study|Protocol Violation|1|||
105897662|NCT02971800|365281422|FG000|Overall Study|Withdrawal by Subject|1|||
105897663|NCT02971800|365281422|FG000|Overall Study|Exclusion criteria prior intervention|1|||
105897664|NCT02971800|365281422|FG000|Overall Study|Number evaluable participant already reached|4|||
105897665|NCT02631070|365281423|FG000|Overall Study|Withdrawal by Subject|35|||
105897666|NCT02631070|365281424|FG001|Overall Study|Withdrawal by Subject|13|||
105897667|NCT02631070|365281423|FG000|Overall Study|Death|45|||
105897668|NCT02631070|365281424|FG001|Overall Study|Death|24|||
105897669|NCT02631070|365281423|FG000|Overall Study|Lost to Follow-up|5|||
105897670|NCT02631070|365281424|FG001|Overall Study|Lost to Follow-up|1|||
105897671|NCT02631070|365281423|FG000|Overall Study|Transition to rollover protocol|52|||
105897672|NCT02631070|365281424|FG001|Overall Study|Transition to rollover protocol|21|||
105897673|NCT02631070|365281423|FG000|Overall Study|Other reasons|12|||
105897674|NCT02631070|365281424|FG001|Overall Study|Other reasons|5|||
105897675|NCT01886781|365281435|FG000|Overall Study|Protocol Violation|5|||
105897676|NCT01886781|365281436|FG001|Overall Study|Protocol Violation|0|||
105897677|NCT01886781|365281435|FG000|Overall Study|Adverse Event|1|||
105897678|NCT01886781|365281436|FG001|Overall Study|Adverse Event|0|||
105897679|NCT01886781|365281435|FG000|Overall Study|Lost to Follow-up|5|||
105897680|NCT01886781|365281436|FG001|Overall Study|Lost to Follow-up|0|||
105897681|NCT01886781|365281435|FG000|Overall Study|Withdrawal by Subject|2|||
105897682|NCT01886781|365281436|FG001|Overall Study|Withdrawal by Subject|1|||
105897683|NCT01886781|365281435|FG000|Overall Study|Worsening of symptoms|1|||
105897684|NCT01886781|365281436|FG001|Overall Study|Worsening of symptoms|1|||
105897685|NCT00980018|365281437|FG000|Overall Study|Adverse Event|8|||
106124027|NCT02065570|366111705|FG001|Maintenance Study|Other, Not Specified|0|||
106124028|NCT02065570|366111706|FG002|Maintenance Study|Other, Not Specified|11|||
106124029|NCT02065570|366111707|FG003|Maintenance Study|Other, Not Specified|5|||
106124030|NCT02207374|366111710|FG000|Overall Study|Withdrawal by Subject|5|||
106124031|NCT02207374|366111711|FG001|Overall Study|Withdrawal by Subject|9|||
106124032|NCT02207374|366111712|FG002|Overall Study|Withdrawal by Subject|4|||
106124033|NCT02207374|366111710|FG000|Overall Study|Death|1|||
106124034|NCT02207374|366111711|FG001|Overall Study|Death|0|||
106124035|NCT02207374|366111712|FG002|Overall Study|Death|1|||
106124036|NCT02207374|366111710|FG000|Overall Study|Missing follow-up information|0|||
106124037|NCT02207374|366111711|FG001|Overall Study|Missing follow-up information|1|||
106124038|NCT02207374|366111712|FG002|Overall Study|Missing follow-up information|1|||
106124039|NCT02087150|366111713|FG000|Overall Study|Death|0|||
106124040|NCT02087150|366111714|FG001|Overall Study|Death|1|||
106124041|NCT02087150|366111715|FG002|Overall Study|Death|0|||
106124042|NCT02087150|366111713|FG000|Overall Study|Lost to Follow-up|6|||
106124043|NCT02087150|366111714|FG001|Overall Study|Lost to Follow-up|13|||
106124044|NCT02087150|366111715|FG002|Overall Study|Lost to Follow-up|7|||
106124045|NCT02087150|366111713|FG000|Overall Study|Withdrawal by Subject|2|||
106124046|NCT02087150|366111714|FG001|Overall Study|Withdrawal by Subject|5|||
106124047|NCT02087150|366111715|FG002|Overall Study|Withdrawal by Subject|3|||
106124048|NCT02087150|366111713|FG000|Overall Study|Physician Decision|0|||
106124049|NCT02087150|366111714|FG001|Overall Study|Physician Decision|1|||
106124050|NCT02087150|366111715|FG002|Overall Study|Physician Decision|0|||
106124051|NCT02087150|366111713|FG000|Overall Study|Procedure not done|1|||
106124052|NCT02087150|366111714|FG001|Overall Study|Procedure not done|13|||
106124053|NCT02087150|366111715|FG002|Overall Study|Procedure not done|0|||
106124054|NCT02087150|366111713|FG000|Overall Study|F/U not completed w/in study window|0|||
106124055|NCT02087150|366111714|FG001|Overall Study|F/U not completed w/in study window|0|||
106124056|NCT02087150|366111715|FG002|Overall Study|F/U not completed w/in study window|1|||
106124057|NCT02087150|366111713|FG000|Overall Study|Other|1|||
106124058|NCT02087150|366111714|FG001|Overall Study|Other|0|||
106124059|NCT02087150|366111715|FG002|Overall Study|Other|0|||
106124060|NCT02087150|366111713|FG000|Overall Study|Pt moved out of town|0|||
106124061|NCT02087150|366111714|FG001|Overall Study|Pt moved out of town|1|||
106124062|NCT02087150|366111715|FG002|Overall Study|Pt moved out of town|0|||
106124063|NCT03382600|366111718|FG000|Overall Study|Adverse Event|3|||
106124064|NCT03382600|366111719|FG001|Overall Study|Adverse Event|3|||
106124065|NCT03382600|366111718|FG000|Overall Study|Clinical Disease Progression|2|||
106124066|NCT03382600|366111719|FG001|Overall Study|Clinical Disease Progression|4|||
106124067|NCT03382600|366111718|FG000|Overall Study|Radiological Progression|40|||
106124068|NCT03382600|366111719|FG001|Overall Study|Radiological Progression|31|||
106124069|NCT03382600|366111718|FG000|Overall Study|Withdrawal by Subject|0|||
106124070|NCT03382600|366111719|FG001|Overall Study|Withdrawal by Subject|1|||
106124071|NCT03382600|366111718|FG000|Overall Study|Other|9|||
106124072|NCT03382600|366111719|FG001|Overall Study|Other|7|||
106124073|NCT01265823|366111722|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
106124074|NCT01265823|366111722|FG000|Overall Study|Failure to Return|4|||
106124075|NCT01265823|366111722|FG000|Overall Study|Protocol Violation|1|||
106124076|NCT01265823|366111722|FG000|Overall Study|Participant Request|1|||
106124077|NCT00064025|366111723|FG000|Overall Study|Ineligible|4|||
106124078|NCT00064025|366111723|FG000|Overall Study|Inevaluable|3|||
106124079|NCT02468934|366111724|FG000|Overall Study|Withdrawal by Subject|4|||
106124080|NCT02468934|366111724|FG000|Overall Study|Screen Failure|3|||
106124081|NCT00519636|366111729|FG000|Treatment Period 1|Adverse Event|1|||
106124082|NCT00519636|366111730|FG001|Treatment Period 1|Adverse Event|0|||
106124083|NCT00519636|366111731|FG002|Treatment Period 1|Adverse Event|1|||
106124084|NCT00519636|366111732|FG003|Treatment Period 1|Adverse Event|0|||
106124085|NCT00519636|366111729|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
106124086|NCT00519636|366111730|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
106124087|NCT00519636|366111731|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
106124088|NCT00519636|366111732|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
106124089|NCT00519636|366111729|FG000|Washout Period|Adverse Event|2|||
106124090|NCT00519636|366111730|FG001|Washout Period|Adverse Event|1|||
106124091|NCT00519636|366111731|FG002|Washout Period|Adverse Event|1|||
105667895|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
105667896|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
105667897|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
105667898|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
105667899|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
105667900|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
105667901|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
105667902|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
105667903|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
106124092|NCT00519636|366111732|FG003|Washout Period|Adverse Event|0|||
105667904|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
106124093|NCT00519636|366111729|FG000|Washout Period|Lost to Follow-up|1|||
106124094|NCT00519636|366111730|FG001|Washout Period|Lost to Follow-up|0|||
106124095|NCT00519636|366111731|FG002|Washout Period|Lost to Follow-up|0|||
106124096|NCT00519636|366111732|FG003|Washout Period|Lost to Follow-up|0|||
106124097|NCT00519636|366111729|FG000|Washout Period|Protocol Violation|0|||
106124098|NCT00519636|366111730|FG001|Washout Period|Protocol Violation|0|||
106124099|NCT00519636|366111731|FG002|Washout Period|Protocol Violation|1|||
106124100|NCT00519636|366111732|FG003|Washout Period|Protocol Violation|2|||
106124101|NCT00519636|366111729|FG000|Washout Period|Withdrawal by Subject|1|||
106124102|NCT00519636|366111730|FG001|Washout Period|Withdrawal by Subject|0|||
105667905|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667906|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
106124103|NCT00519636|366111731|FG002|Washout Period|Withdrawal by Subject|1|||
106124104|NCT00519636|366111732|FG003|Washout Period|Withdrawal by Subject|0|||
106124105|NCT00519636|366111729|FG000|Washout Period|Failed to meet continuation criteria|14|||
106124106|NCT00519636|366111730|FG001|Washout Period|Failed to meet continuation criteria|11|||
106124107|NCT00519636|366111731|FG002|Washout Period|Failed to meet continuation criteria|9|||
106124108|NCT00519636|366111732|FG003|Washout Period|Failed to meet continuation criteria|3|||
106124109|NCT00519636|366111729|FG000|Washout Period|Out of pollen area > 48 hours|1|||
105667907|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
105897686|NCT00980018|365281437|FG000|Overall Study|Patient withdrew consent|3|||
105897687|NCT00980018|365281437|FG000|Overall Study|Lost to Follow-up|1|||
105897688|NCT01522235|365281438|FG000|Overall Study|Physician Decision|1|||
105897689|NCT01522235|365281439|FG001|Overall Study|Physician Decision|1|||
105897690|NCT00987402|365281440|FG000|Overall Study|Insufficient data entry|86|||
105897691|NCT00987402|365281441|FG001|Overall Study|Insufficient data entry|98|||
105897692|NCT00424021|365281442|FG000|NCT00046319 Study Period|Adverse Event|1|||
105897693|NCT00424021|365281443|FG001|NCT00046319 Study Period|Adverse Event|0|||
105897694|NCT00424021|365281444|FG002|NCT00046319 Study Period|Adverse Event|1|||
105897695|NCT00424021|365281445|FG003|NCT00046319 Study Period|Adverse Event|1|||
105897696|NCT00424021|365281442|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
105897697|NCT00424021|365281443|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
105897698|NCT00424021|365281444|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
105897699|NCT00424021|365281445|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
105897700|NCT00424021|365281442|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
105897701|NCT00424021|365281443|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
105897702|NCT00424021|365281444|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
105897703|NCT00424021|365281445|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
105897704|NCT00424021|365281442|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
105897705|NCT00424021|365281443|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
105897706|NCT00424021|365281444|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
105897707|NCT00424021|365281445|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
105897708|NCT00424021|365281442|FG000|AMB-220-E Study Period|Adverse Event|1|||
105897709|NCT00424021|365281443|FG001|AMB-220-E Study Period|Adverse Event|1|||
105897710|NCT00424021|365281444|FG002|AMB-220-E Study Period|Adverse Event|3|||
105897711|NCT00424021|365281445|FG003|AMB-220-E Study Period|Adverse Event|7|||
105897712|NCT00424021|365281442|FG000|AMB-220-E Study Period|Death|0|||
105897713|NCT00424021|365281443|FG001|AMB-220-E Study Period|Death|0|||
105897714|NCT00424021|365281444|FG002|AMB-220-E Study Period|Death|1|||
105897715|NCT00424021|365281445|FG003|AMB-220-E Study Period|Death|1|||
105897716|NCT00424021|365281442|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
105897717|NCT00424021|365281443|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
105897718|NCT00424021|365281444|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
105897719|NCT00424021|365281445|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
105897720|NCT00424021|365281442|FG000|AMB-220-E Study Period|Physician Decision|0|||
105897721|NCT00424021|365281443|FG001|AMB-220-E Study Period|Physician Decision|0|||
105897722|NCT00424021|365281444|FG002|AMB-220-E Study Period|Physician Decision|0|||
105897723|NCT00424021|365281445|FG003|AMB-220-E Study Period|Physician Decision|1|||
105897724|NCT01955109|365281446|FG000|Overall Study|Adverse Event|2|||
105897725|NCT01955109|365281447|FG001|Overall Study|Adverse Event|0|||
105897726|NCT01955109|365281446|FG000|Overall Study|Participant unwilling to continue|35|||
105897727|NCT01955109|365281447|FG001|Overall Study|Participant unwilling to continue|7|||
105897728|NCT01955109|365281446|FG000|Overall Study|Physician Decision|2|||
105897729|NCT01955109|365281447|FG001|Overall Study|Physician Decision|0|||
105897730|NCT01955109|365281446|FG000|Overall Study|Lost to Follow-up|3|||
105897731|NCT01955109|365281447|FG001|Overall Study|Lost to Follow-up|1|||
105897732|NCT01955109|365281446|FG000|Overall Study|Non-compliance|3|||
105897733|NCT01955109|365281447|FG001|Overall Study|Non-compliance|1|||
105897734|NCT03597022|365281449|FG000|Overall Study|Premature termination of the study|7|||
105897735|NCT03597022|365281450|FG001|Overall Study|Premature termination of the study|7|||
105897736|NCT03597022|365281451|FG002|Overall Study|Premature termination of the study|8|||
105897737|NCT03597022|365281449|FG000|Overall Study|Serious adverse event|1|||
105897738|NCT03597022|365281450|FG001|Overall Study|Serious adverse event|1|||
105897739|NCT03597022|365281451|FG002|Overall Study|Serious adverse event|0|||
105897740|NCT00904839|365281452|FG000|Overall Study|Adverse Event|0|||
105897741|NCT00904839|365281453|FG001|Overall Study|Adverse Event|5|||
105897742|NCT00904839|365281454|FG002|Overall Study|Adverse Event|4|||
105897743|NCT00904839|365281452|FG000|Overall Study|Protocol Violation|0|||
105897744|NCT00904839|365281453|FG001|Overall Study|Protocol Violation|1|||
105897745|NCT00904839|365281454|FG002|Overall Study|Protocol Violation|1|||
105897746|NCT00904839|365281452|FG000|Overall Study|Lost to Follow-up|0|||
105897747|NCT00904839|365281453|FG001|Overall Study|Lost to Follow-up|1|||
105897748|NCT00904839|365281454|FG002|Overall Study|Lost to Follow-up|2|||
105897749|NCT00904839|365281452|FG000|Overall Study|Withdrawal by Subject|0|||
105897750|NCT00904839|365281453|FG001|Overall Study|Withdrawal by Subject|2|||
105897751|NCT00904839|365281454|FG002|Overall Study|Withdrawal by Subject|0|||
105897752|NCT00904839|365281452|FG000|Overall Study|Not treated|1|||
105897753|NCT00904839|365281453|FG001|Overall Study|Not treated|0|||
105897754|NCT00904839|365281454|FG002|Overall Study|Not treated|1|||
105897755|NCT00904839|365281452|FG000|Overall Study|Other than above|0|||
105897756|NCT00904839|365281453|FG001|Overall Study|Other than above|9|||
105897757|NCT00904839|365281454|FG002|Overall Study|Other than above|7|||
105897758|NCT01167634|365281457|FG000|Overall Study|Lost to Follow-up|1|||
105897759|NCT01167634|365281458|FG001|Overall Study|Lost to Follow-up|3|||
105897760|NCT01167634|365281459|FG002|Overall Study|Lost to Follow-up|3|||
105897761|NCT01167634|365281460|FG003|Overall Study|Lost to Follow-up|4|||
105897762|NCT01167634|365281457|FG000|Overall Study|Withdrawal by Subject|1|||
105897763|NCT01167634|365281458|FG001|Overall Study|Withdrawal by Subject|1|||
105897764|NCT01167634|365281459|FG002|Overall Study|Withdrawal by Subject|0|||
105897765|NCT01167634|365281460|FG003|Overall Study|Withdrawal by Subject|0|||
105897766|NCT01832818|365281463|FG000|Overall Study|Lost to Follow-up|6|||
105897767|NCT00236899|365281464|FG000|Overall Study|Adverse Event (Study Related)|1|||
105897768|NCT00236899|365281465|FG001|Overall Study|Adverse Event (Study Related)|1|||
105897769|NCT00236899|365281466|FG002|Overall Study|Adverse Event (Study Related)|2|||
105897770|NCT00236899|365281467|FG003|Overall Study|Adverse Event (Study Related)|1|||
105897771|NCT00236899|365281464|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
105897772|NCT00236899|365281465|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
105897773|NCT00236899|365281466|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
105897774|NCT00236899|365281467|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
105897775|NCT00236899|365281464|FG000|Overall Study|Death (Study Disease)|1|||
105897776|NCT00236899|365281465|FG001|Overall Study|Death (Study Disease)|4|||
105897777|NCT00236899|365281466|FG002|Overall Study|Death (Study Disease)|0|||
105897778|NCT00236899|365281467|FG003|Overall Study|Death (Study Disease)|0|||
105897779|NCT00236899|365281464|FG000|Overall Study|Death (Not Study Related)|2|||
105897780|NCT00236899|365281465|FG001|Overall Study|Death (Not Study Related)|0|||
105897781|NCT00236899|365281466|FG002|Overall Study|Death (Not Study Related)|0|||
105897782|NCT00236899|365281467|FG003|Overall Study|Death (Not Study Related)|0|||
105897783|NCT00236899|365281464|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
105897784|NCT00236899|365281465|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
105897785|NCT00236899|365281466|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
105897786|NCT00236899|365281467|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
105897787|NCT00236899|365281464|FG000|Overall Study|Lost to Follow-up|0|||
105667908|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667909|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105897788|NCT00236899|365281465|FG001|Overall Study|Lost to Follow-up|1|||
105897789|NCT00236899|365281466|FG002|Overall Study|Lost to Follow-up|0|||
105897790|NCT00236899|365281467|FG003|Overall Study|Lost to Follow-up|0|||
105897791|NCT00236899|365281464|FG000|Overall Study|Entry Criteria Exclusion|0|||
105897792|NCT00236899|365281465|FG001|Overall Study|Entry Criteria Exclusion|1|||
105897793|NCT00236899|365281466|FG002|Overall Study|Entry Criteria Exclusion|1|||
105897794|NCT00236899|365281467|FG003|Overall Study|Entry Criteria Exclusion|0|||
105897795|NCT00236899|365281464|FG000|Overall Study|Protocol Violation|1|||
105897796|NCT00236899|365281465|FG001|Overall Study|Protocol Violation|0|||
105897797|NCT00236899|365281466|FG002|Overall Study|Protocol Violation|0|||
105897798|NCT00236899|365281467|FG003|Overall Study|Protocol Violation|0|||
105897799|NCT00236899|365281464|FG000|Overall Study|Withdrawal by Subject|6|||
105897800|NCT00236899|365281465|FG001|Overall Study|Withdrawal by Subject|4|||
105897801|NCT00236899|365281466|FG002|Overall Study|Withdrawal by Subject|5|||
105897802|NCT00236899|365281467|FG003|Overall Study|Withdrawal by Subject|2|||
105897803|NCT00236899|365281464|FG000|Overall Study|Physician Decision|7|||
105897804|NCT00236899|365281465|FG001|Overall Study|Physician Decision|8|||
105897805|NCT00236899|365281466|FG002|Overall Study|Physician Decision|7|||
105897806|NCT00236899|365281467|FG003|Overall Study|Physician Decision|6|||
105897807|NCT00236899|365281464|FG000|Overall Study|Satisfactory Response|2|||
105897808|NCT00236899|365281465|FG001|Overall Study|Satisfactory Response|0|||
105897809|NCT00236899|365281466|FG002|Overall Study|Satisfactory Response|0|||
105897810|NCT00236899|365281467|FG003|Overall Study|Satisfactory Response|1|||
105667910|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667911|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
105667912|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
105667913|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667914|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667915|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667916|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
105667917|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667918|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
105897811|NCT00236899|365281464|FG000|Overall Study|Lack of Efficacy|18|||
105897812|NCT00236899|365281465|FG001|Overall Study|Lack of Efficacy|18|||
105897813|NCT00236899|365281466|FG002|Overall Study|Lack of Efficacy|25|||
105897814|NCT00236899|365281467|FG003|Overall Study|Lack of Efficacy|23|||
105897815|NCT00934856|365281468|FG000|Feasibility Part|Progressive disease|4|||
105897816|NCT00934856|365281469|FG001|Feasibility Part|Progressive disease|4|||
105897817|NCT00934856|365281470|FG002|Feasibility Part|Progressive disease|2|||
105897818|NCT00934856|365281471|FG003|Feasibility Part|Progressive disease|3|||
105897819|NCT00934856|365281472|FG004|Feasibility Part|Progressive disease|0|||
105897820|NCT00934856|365281473|FG005|Feasibility Part|Progressive disease|0|||
105897821|NCT00934856|365281468|FG000|Feasibility Part|Physician Decision|0|||
105897822|NCT00934856|365281469|FG001|Feasibility Part|Physician Decision|0|||
105897823|NCT00934856|365281470|FG002|Feasibility Part|Physician Decision|1|||
105897824|NCT00934856|365281471|FG003|Feasibility Part|Physician Decision|0|||
105897825|NCT00934856|365281472|FG004|Feasibility Part|Physician Decision|0|||
105897826|NCT00934856|365281473|FG005|Feasibility Part|Physician Decision|0|||
105897827|NCT00934856|365281468|FG000|Feasibility Part|Adverse Event|1|||
105897828|NCT00934856|365281469|FG001|Feasibility Part|Adverse Event|1|||
105897829|NCT00934856|365281470|FG002|Feasibility Part|Adverse Event|0|||
105897830|NCT00934856|365281471|FG003|Feasibility Part|Adverse Event|1|||
105897831|NCT00934856|365281472|FG004|Feasibility Part|Adverse Event|0|||
105897832|NCT00934856|365281473|FG005|Feasibility Part|Adverse Event|2|||
105897833|NCT00934856|365281468|FG000|Feasibility Part|Withdrawal by Subject|0|||
105897834|NCT00934856|365281469|FG001|Feasibility Part|Withdrawal by Subject|0|||
105897835|NCT00934856|365281470|FG002|Feasibility Part|Withdrawal by Subject|0|||
105897836|NCT00934856|365281471|FG003|Feasibility Part|Withdrawal by Subject|1|||
105897837|NCT00934856|365281472|FG004|Feasibility Part|Withdrawal by Subject|0|||
105897838|NCT00934856|365281473|FG005|Feasibility Part|Withdrawal by Subject|1|||
105897839|NCT00934856|365281468|FG000|Extension Part|Adverse Event|0|||
106124110|NCT00519636|366111730|FG001|Washout Period|Out of pollen area > 48 hours|0|||
106124111|NCT00519636|366111731|FG002|Washout Period|Out of pollen area > 48 hours|0|||
106124112|NCT00519636|366111732|FG003|Washout Period|Out of pollen area > 48 hours|0|||
105897840|NCT00934856|365281469|FG001|Extension Part|Adverse Event|0|||
105897841|NCT00934856|365281470|FG002|Extension Part|Adverse Event|0|||
105897842|NCT00934856|365281471|FG003|Extension Part|Adverse Event|1|||
105897843|NCT00934856|365281472|FG004|Extension Part|Adverse Event|4|||
105897844|NCT00934856|365281473|FG005|Extension Part|Adverse Event|4|||
105897845|NCT00934856|365281468|FG000|Extension Part|Progressive disease|0|||
105897846|NCT00934856|365281469|FG001|Extension Part|Progressive disease|0|||
105897847|NCT00934856|365281470|FG002|Extension Part|Progressive disease|0|||
105897848|NCT00934856|365281471|FG003|Extension Part|Progressive disease|1|||
105897849|NCT00934856|365281472|FG004|Extension Part|Progressive disease|0|||
105897850|NCT00934856|365281473|FG005|Extension Part|Progressive disease|0|||
105897851|NCT00934856|365281468|FG000|Extension Part|Non-compliance with drug|0|||
105897852|NCT00934856|365281469|FG001|Extension Part|Non-compliance with drug|0|||
105897853|NCT00934856|365281470|FG002|Extension Part|Non-compliance with drug|0|||
105897854|NCT00934856|365281471|FG003|Extension Part|Non-compliance with drug|0|||
105897855|NCT00934856|365281472|FG004|Extension Part|Non-compliance with drug|0|||
105897856|NCT00934856|365281473|FG005|Extension Part|Non-compliance with drug|1|||
105897857|NCT01672294|365281479|FG000|Overall Study|Withdrawal by Subject|4|||
105897858|NCT01672294|365281480|FG001|Overall Study|Withdrawal by Subject|4|||
105897859|NCT01672294|365281481|FG002|Overall Study|Withdrawal by Subject|4|||
105897860|NCT01672294|365281482|FG003|Overall Study|Withdrawal by Subject|4|||
105897861|NCT01672294|365281479|FG000|Overall Study|Excluded by study|1|||
105897862|NCT01672294|365281480|FG001|Overall Study|Excluded by study|1|||
105897863|NCT01672294|365281481|FG002|Overall Study|Excluded by study|0|||
105897864|NCT01672294|365281482|FG003|Overall Study|Excluded by study|0|||
105897865|NCT01672294|365281479|FG000|Overall Study|Lost to Follow-up|1|||
105897866|NCT01672294|365281480|FG001|Overall Study|Lost to Follow-up|16|||
105897867|NCT01672294|365281481|FG002|Overall Study|Lost to Follow-up|7|||
105897868|NCT01672294|365281482|FG003|Overall Study|Lost to Follow-up|9|||
105897869|NCT02854605|365281491|FG000|Overall Study|Adverse Event|1|||
105897870|NCT02854605|365281492|FG001|Overall Study|Adverse Event|5|||
105897871|NCT02854605|365281493|FG002|Overall Study|Adverse Event|2|||
105897872|NCT02854605|365281491|FG000|Overall Study|Lost to Follow-up|0|||
105897873|NCT02854605|365281492|FG001|Overall Study|Lost to Follow-up|2|||
105897874|NCT02854605|365281493|FG002|Overall Study|Lost to Follow-up|0|||
105897875|NCT02854605|365281491|FG000|Overall Study|Withdrew Consent|1|||
105897876|NCT02854605|365281492|FG001|Overall Study|Withdrew Consent|0|||
105897877|NCT02854605|365281493|FG002|Overall Study|Withdrew Consent|1|||
105897878|NCT02854605|365281491|FG000|Overall Study|Investigator's Discretion|1|||
105897879|NCT02854605|365281492|FG001|Overall Study|Investigator's Discretion|0|||
105897880|NCT02854605|365281493|FG002|Overall Study|Investigator's Discretion|0|||
105897881|NCT02854605|365281491|FG000|Overall Study|Protocol Violation|0|||
105897882|NCT02854605|365281492|FG001|Overall Study|Protocol Violation|0|||
105897883|NCT02854605|365281493|FG002|Overall Study|Protocol Violation|1|||
105897884|NCT00568334|365281498|FG000|Overall Study|Withdrawal by Subject|0|||
106124113|NCT00519636|366111729|FG000|Washout Period|Participating in study at another site|1|||
105667919|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
105667920|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
105897885|NCT00568334|365281499|FG001|Overall Study|Withdrawal by Subject|1|||
105897886|NCT00568334|365281498|FG000|Overall Study|Lost to Follow-up|1|||
105897887|NCT00568334|365281499|FG001|Overall Study|Lost to Follow-up|0|||
105897888|NCT01897571|365281500|FG000|Overall Study|Lost to Follow-up|3|||
105897889|NCT01897571|365281501|FG001|Overall Study|Lost to Follow-up|0|||
105897890|NCT01897571|365281502|FG002|Overall Study|Lost to Follow-up|0|||
105897891|NCT01897571|365281503|FG003|Overall Study|Lost to Follow-up|0|||
105897892|NCT01897571|365281504|FG004|Overall Study|Lost to Follow-up|2|||
105897893|NCT01897571|365281505|FG005|Overall Study|Lost to Follow-up|0|||
105897894|NCT01897571|365281506|FG006|Overall Study|Lost to Follow-up|0|||
105897895|NCT01897571|365281507|FG007|Overall Study|Lost to Follow-up|0|||
105786015|NCT00596466|364870443|FG000|Overall Study|Unpecified|2|||
105897896|NCT01897571|365281508|FG008|Overall Study|Lost to Follow-up|1|||
105897897|NCT01897571|365281509|FG009|Overall Study|Lost to Follow-up|2|||
105897898|NCT01897571|365281510|FG010|Overall Study|Lost to Follow-up|4|||
105897899|NCT01897571|365281500|FG000|Overall Study|Withdrawal by Subject|0|||
105897900|NCT01897571|365281501|FG001|Overall Study|Withdrawal by Subject|0|||
105897901|NCT01897571|365281502|FG002|Overall Study|Withdrawal by Subject|0|||
105897902|NCT01897571|365281503|FG003|Overall Study|Withdrawal by Subject|0|||
105897903|NCT01897571|365281504|FG004|Overall Study|Withdrawal by Subject|0|||
105897904|NCT01897571|365281505|FG005|Overall Study|Withdrawal by Subject|0|||
105897905|NCT01897571|365281506|FG006|Overall Study|Withdrawal by Subject|0|||
105897906|NCT01897571|365281507|FG007|Overall Study|Withdrawal by Subject|1|||
105897907|NCT01897571|365281508|FG008|Overall Study|Withdrawal by Subject|4|||
105897908|NCT01897571|365281509|FG009|Overall Study|Withdrawal by Subject|3|||
105897909|NCT01897571|365281510|FG010|Overall Study|Withdrawal by Subject|1|||
105897910|NCT01897571|365281500|FG000|Overall Study|Other|1|||
105897911|NCT01897571|365281501|FG001|Overall Study|Other|0|||
105897912|NCT01897571|365281502|FG002|Overall Study|Other|0|||
105897913|NCT01897571|365281503|FG003|Overall Study|Other|3|||
105897914|NCT01897571|365281504|FG004|Overall Study|Other|3|||
105897915|NCT01897571|365281505|FG005|Overall Study|Other|4|||
105897916|NCT01897571|365281506|FG006|Overall Study|Other|7|||
105897917|NCT01897571|365281507|FG007|Overall Study|Other|0|||
105897918|NCT01897571|365281508|FG008|Overall Study|Other|0|||
105897919|NCT01897571|365281509|FG009|Overall Study|Other|0|||
105897920|NCT01897571|365281510|FG010|Overall Study|Other|0|||
105897921|NCT01897571|365281500|FG000|Overall Study|Enrolled in rollover study|0|||
105897922|NCT01897571|365281501|FG001|Overall Study|Enrolled in rollover study|0|||
105897923|NCT01897571|365281502|FG002|Overall Study|Enrolled in rollover study|0|||
105897924|NCT01897571|365281503|FG003|Overall Study|Enrolled in rollover study|0|||
105897925|NCT01897571|365281504|FG004|Overall Study|Enrolled in rollover study|0|||
105897926|NCT01897571|365281505|FG005|Overall Study|Enrolled in rollover study|0|||
105897927|NCT01897571|365281506|FG006|Overall Study|Enrolled in rollover study|0|||
105897928|NCT01897571|365281507|FG007|Overall Study|Enrolled in rollover study|9|||
105897929|NCT01897571|365281508|FG008|Overall Study|Enrolled in rollover study|7|||
105897930|NCT01897571|365281509|FG009|Overall Study|Enrolled in rollover study|9|||
105897931|NCT01897571|365281510|FG010|Overall Study|Enrolled in rollover study|1|||
105897932|NCT01897571|365281500|FG000|Overall Study|Death|2|||
105897933|NCT01897571|365281501|FG001|Overall Study|Death|2|||
105897934|NCT01897571|365281502|FG002|Overall Study|Death|3|||
105897935|NCT01897571|365281503|FG003|Overall Study|Death|6|||
105897936|NCT01897571|365281504|FG004|Overall Study|Death|7|||
105897937|NCT01897571|365281505|FG005|Overall Study|Death|9|||
105897938|NCT01897571|365281506|FG006|Overall Study|Death|5|||
105897939|NCT01897571|365281507|FG007|Overall Study|Death|22|||
105897940|NCT01897571|365281508|FG008|Overall Study|Death|23|||
105897941|NCT01897571|365281509|FG009|Overall Study|Death|129|||
105897942|NCT01897571|365281510|FG010|Overall Study|Death|59|||
105897943|NCT01797094|365281512|FG000|Overall Study|Adverse Event|1|||
105897944|NCT01797094|365281513|FG001|Overall Study|Adverse Event|1|||
105897945|NCT01797094|365281512|FG000|Overall Study|Personal Reasons|4|||
105897946|NCT01797094|365281513|FG001|Overall Study|Personal Reasons|0|||
105897947|NCT01797094|365281512|FG000|Overall Study|Protocol Violation|0|||
105897948|NCT01797094|365281513|FG001|Overall Study|Protocol Violation|1|||
105897949|NCT01797094|365281512|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105897950|NCT01797094|365281513|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105897951|NCT03217968|365281514|FG000|Overall Study|Withdrawal by Subject|4|||
105897952|NCT03217968|365281514|FG000|Overall Study|Lost to Follow-up|1|||
105897953|NCT03217968|365281514|FG000|Overall Study|Protocol Violation|6|||
105897954|NCT04490018|365281517|FG000|Overall Study|Protocol Violation|0|||
105897955|NCT04490018|365281518|FG001|Overall Study|Protocol Violation|2|||
105897956|NCT04490018|365281519|FG002|Overall Study|Protocol Violation|1|||
105897957|NCT04490018|365281517|FG000|Overall Study|Lost to Follow-up|2|||
105897958|NCT04490018|365281518|FG001|Overall Study|Lost to Follow-up|2|||
105897959|NCT04490018|365281519|FG002|Overall Study|Lost to Follow-up|0|||
105897960|NCT04490018|365281517|FG000|Overall Study|Withdrawal by Subject|2|||
105897961|NCT04490018|365281518|FG001|Overall Study|Withdrawal by Subject|1|||
105897962|NCT04490018|365281519|FG002|Overall Study|Withdrawal by Subject|0|||
105897963|NCT04490018|365281517|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105897964|NCT04490018|365281518|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105897965|NCT04490018|365281519|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105897966|NCT01389258|365281520|FG000|Overall Study|Lost to Follow-up|5|||
105897967|NCT00089635|365281521|FG000|Overall Study|Adverse Event|2|||
105897968|NCT00089635|365281521|FG000|Overall Study|Death|17|||
105897969|NCT00089635|365281521|FG000|Overall Study|Disease Progression|12|||
105897970|NCT00089635|365281521|FG000|Overall Study|Lost to Follow-up|3|||
105897971|NCT00089635|365281521|FG000|Overall Study|Withdrawal by Subject|6|||
105897972|NCT00089635|365281521|FG000|Overall Study|Ineligibility determined|1|||
105897973|NCT00089635|365281521|FG000|Overall Study|Other|2|||
105897974|NCT03313310|365281523|FG000|Phase 2|Lost to Follow-up|4|||
105897975|NCT03313310|365281524|FG001|Phase 2|Lost to Follow-up|0|||
105897976|NCT03313310|365281523|FG000|Phase 3|Lost to Follow-up|0|||
105897977|NCT03313310|365281524|FG001|Phase 3|Lost to Follow-up|1|||
105997577|NCT01217944|365653178|FG000|Overall Study|Lack of Efficacy|1|||
105997578|NCT01217944|365653179|FG001|Overall Study|Lack of Efficacy|0|||
105897978|NCT01593254|365281527|FG000|Overall Study|Disease progression|2|||
105897979|NCT01593254|365281528|FG001|Overall Study|Disease progression|7|||
105897980|NCT01593254|365281527|FG000|Overall Study|Study drug toxicity|6|||
105897981|NCT01593254|365281528|FG001|Overall Study|Study drug toxicity|20|||
105897982|NCT01593254|365281527|FG000|Overall Study|Death|3|||
105897983|NCT01593254|365281528|FG001|Overall Study|Death|3|||
105897984|NCT01593254|365281527|FG000|Overall Study|AE unrelated to study drug|0|||
105897985|NCT01593254|365281528|FG001|Overall Study|AE unrelated to study drug|1|||
105897986|NCT01593254|365281527|FG000|Overall Study|participant request to discontinue study treatment|1|||
105897987|NCT01593254|365281528|FG001|Overall Study|participant request to discontinue study treatment|3|||
105897988|NCT01593254|365281527|FG000|Overall Study|participant withdrew consent|0|||
105897989|NCT01593254|365281528|FG001|Overall Study|participant withdrew consent|9|||
105897990|NCT01593254|365281527|FG000|Overall Study|lost to follow up|1|||
105897991|NCT01593254|365281528|FG001|Overall Study|lost to follow up|6|||
105897992|NCT01593254|365281527|FG000|Overall Study|maximum clinical benefit|1|||
105897993|NCT01593254|365281528|FG001|Overall Study|maximum clinical benefit|2|||
105997579|NCT01217944|365653180|FG002|Overall Study|Lack of Efficacy|0|||
105997580|NCT01380769|365653181|FG000|Overall Study|Withdrawal by Subject|7|||
105897994|NCT01593254|365281527|FG000|Overall Study|Poor/non compliance|1|||
105897995|NCT01593254|365281528|FG001|Overall Study|Poor/non compliance|1|||
105897996|NCT01593254|365281527|FG000|Overall Study|Pregnancy|0|||
105897997|NCT01593254|365281528|FG001|Overall Study|Pregnancy|3|||
105897998|NCT01593254|365281527|FG000|Overall Study|participant no longer meets study criteria|1|||
105897999|NCT01593254|365281528|FG001|Overall Study|participant no longer meets study criteria|1|||
105898000|NCT01593254|365281527|FG000|Overall Study|Admin reason by sponsor|7|||
105997581|NCT01380769|365653182|FG001|Overall Study|Withdrawal by Subject|11|||
105997582|NCT01380769|365653181|FG000|Overall Study|Physician Decision|1|||
105997583|NCT01380769|365653182|FG001|Overall Study|Physician Decision|1|||
105997584|NCT01380769|365653181|FG000|Overall Study|Adverse Event|1|||
105997585|NCT01380769|365653182|FG001|Overall Study|Adverse Event|1|||
105997586|NCT01380769|365653181|FG000|Overall Study|Protocol Violation|0|||
105997587|NCT01380769|365653182|FG001|Overall Study|Protocol Violation|1|||
105997588|NCT01080807|365653191|FG000|Overall Study|Adverse Event|9|||
105997589|NCT01080807|365653192|FG001|Overall Study|Adverse Event|1|||
105997590|NCT01080807|365653191|FG000|Overall Study|Lack of Efficacy|0|||
105997591|NCT01080807|365653192|FG001|Overall Study|Lack of Efficacy|1|||
105997592|NCT01080807|365653191|FG000|Overall Study|Withdrawal by Subject|7|||
105997593|NCT01080807|365653192|FG001|Overall Study|Withdrawal by Subject|2|||
105997594|NCT01080807|365653191|FG000|Overall Study|Protocol Violation|7|||
105997595|NCT01080807|365653192|FG001|Overall Study|Protocol Violation|6|||
105997596|NCT01080807|365653191|FG000|Overall Study|Lost to Follow-up|6|||
105997597|NCT01080807|365653192|FG001|Overall Study|Lost to Follow-up|4|||
105997598|NCT01080807|365653191|FG000|Overall Study|Noncompliance with drug administration|1|||
105997599|NCT01080807|365653192|FG001|Overall Study|Noncompliance with drug administration|1|||
105997600|NCT01080807|365653191|FG000|Overall Study|Noncompliance to study procedures|1|||
105997601|NCT01080807|365653192|FG001|Overall Study|Noncompliance to study procedures|1|||
105997602|NCT01080807|365653191|FG000|Overall Study|Began working day shift|0|||
105997603|NCT01080807|365653192|FG001|Overall Study|Began working day shift|2|||
105997604|NCT01080807|365653191|FG000|Overall Study|Laid off or terminated from job|1|||
105997605|NCT01080807|365653192|FG001|Overall Study|Laid off or terminated from job|2|||
105997606|NCT01080807|365653191|FG000|Overall Study|Stopped working consistent night shifts|0|||
105997607|NCT01080807|365653192|FG001|Overall Study|Stopped working consistent night shifts|1|||
105997608|NCT01080807|365653191|FG000|Overall Study|Work schedule changing|1|||
105997609|NCT01080807|365653192|FG001|Overall Study|Work schedule changing|1|||
105997610|NCT01080807|365653191|FG000|Overall Study|Work schedule and travel|0|||
105997611|NCT01080807|365653192|FG001|Overall Study|Work schedule and travel|1|||
105997612|NCT01080807|365653191|FG000|Overall Study|Switched to first shift|1|||
105997613|NCT01080807|365653192|FG001|Overall Study|Switched to first shift|0|||
105997614|NCT01080807|365653191|FG000|Overall Study|Moved away without notifying center|1|||
105997615|NCT01080807|365653192|FG001|Overall Study|Moved away without notifying center|0|||
105997616|NCT01641601|365653193|FG000|Overall Study|Study discontinued.|3|||
105997617|NCT01641601|365653194|FG001|Overall Study|Study discontinued.|5|||
105997618|NCT03400852|365653202|FG000|Blinded Treatment Period|Physician Decision|0|||
105898001|NCT01593254|365281528|FG001|Overall Study|Admin reason by sponsor|3|||
105898002|NCT01593254|365281527|FG000|Overall Study|Imatinib treatment failure|2|||
105898003|NCT01593254|365281528|FG001|Overall Study|Imatinib treatment failure|0|||
105898004|NCT01593254|365281527|FG000|Overall Study|Other Reasons|61|||
105898005|NCT01593254|365281528|FG001|Overall Study|Other Reasons|115|||
105898006|NCT02912455|365281529|FG000|Overall Study|Withdrawal by Subject|0|||
105898007|NCT02912455|365281530|FG001|Overall Study|Withdrawal by Subject|1|||
105898008|NCT02912455|365281529|FG000|Overall Study|Lack of Efficacy|0|||
105898009|NCT02912455|365281530|FG001|Overall Study|Lack of Efficacy|1|||
105898010|NCT02912455|365281529|FG000|Overall Study|Lost to Follow-up|2|||
105898011|NCT02912455|365281530|FG001|Overall Study|Lost to Follow-up|1|||
105898012|NCT01380691|365281531|FG000|Washout (7 Days)|Protocol Violation|0|||
105898013|NCT01380691|365281532|FG001|Washout (7 Days)|Protocol Violation|0|||
105898014|NCT01380691|365281533|FG002|Washout (7 Days)|Protocol Violation|0|||
105898015|NCT01380691|365281534|FG003|Washout (7 Days)|Protocol Violation|1|||
105898016|NCT01380691|365281531|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
105898017|NCT01380691|365281532|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
105898018|NCT01380691|365281533|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
105898019|NCT01380691|365281534|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
105898020|NCT02536781|365281535|FG000|Overall Study|Lost to Follow-up|2|||
105898021|NCT02536781|365281536|FG001|Overall Study|Lost to Follow-up|0|||
105898022|NCT01260584|365281537|FG000|Period 1|Protocol Violation|0|||
105898023|NCT01260584|365281538|FG001|Period 1|Protocol Violation|0|||
105898024|NCT01260584|365281539|FG002|Period 1|Protocol Violation|1|||
105898025|NCT01260584|365281540|FG003|Period 1|Protocol Violation|1|||
105898026|NCT01260584|365281537|FG000|Period 1|Adverse Event|0|||
105898027|NCT01260584|365281538|FG001|Period 1|Adverse Event|0|||
105898028|NCT01260584|365281539|FG002|Period 1|Adverse Event|1|||
105898029|NCT01260584|365281540|FG003|Period 1|Adverse Event|0|||
105898030|NCT01260584|365281537|FG000|Period 2|Protocol Violation|0|||
105898031|NCT01260584|365281538|FG001|Period 2|Protocol Violation|2|||
105898032|NCT01260584|365281539|FG002|Period 2|Protocol Violation|3|||
105898033|NCT01260584|365281540|FG003|Period 2|Protocol Violation|1|||
105898034|NCT01260584|365281537|FG000|Period 2|Adverse Event|1|||
105898035|NCT01260584|365281538|FG001|Period 2|Adverse Event|0|||
105898036|NCT01260584|365281539|FG002|Period 2|Adverse Event|2|||
105898037|NCT01260584|365281540|FG003|Period 2|Adverse Event|0|||
105898038|NCT01260584|365281537|FG000|Period 2|Withdrawal by Subject|0|||
105898039|NCT01260584|365281538|FG001|Period 2|Withdrawal by Subject|1|||
105898040|NCT01260584|365281539|FG002|Period 2|Withdrawal by Subject|0|||
105898041|NCT01260584|365281540|FG003|Period 2|Withdrawal by Subject|0|||
105898042|NCT00045734|365281541|FG000|Overall Study|Protocol Violation|1|||
105898043|NCT00561470|365281542|FG000|Overall Study|Adverse Event|74|||
105898044|NCT00561470|365281543|FG001|Overall Study|Adverse Event|163|||
105898045|NCT00561470|365281542|FG000|Overall Study|Disease progression|437|||
105898046|NCT00561470|365281543|FG001|Overall Study|Disease progression|305|||
105898047|NCT00561470|365281542|FG000|Overall Study|poor compliance to protocol|4|||
105898048|NCT00561470|365281543|FG001|Overall Study|poor compliance to protocol|4|||
105898049|NCT00561470|365281542|FG000|Overall Study|Lost to Follow-up|2|||
105898050|NCT00561470|365281543|FG001|Overall Study|Lost to Follow-up|0|||
105898051|NCT00561470|365281542|FG000|Overall Study|Physician Decision|21|||
105898052|NCT00561470|365281543|FG001|Overall Study|Physician Decision|20|||
105898053|NCT00561470|365281542|FG000|Overall Study|Consent Withdrawn|2|||
105898054|NCT00561470|365281543|FG001|Overall Study|Consent Withdrawn|6|||
105898055|NCT00561470|365281542|FG000|Overall Study|Subject request|43|||
105898056|NCT00561470|365281543|FG001|Overall Study|Subject request|77|||
105898057|NCT00561470|365281542|FG000|Overall Study|Metastatic surgery|10|||
105898058|NCT00561470|365281543|FG001|Overall Study|Metastatic surgery|12|||
105898059|NCT00561470|365281542|FG000|Overall Study|Unauthorized procedure|3|||
105898060|NCT00561470|365281543|FG001|Overall Study|Unauthorized procedure|1|||
105898061|NCT00561470|365281542|FG000|Overall Study|Randomized but not treated|5|||
105898062|NCT00561470|365281543|FG001|Overall Study|Randomized but not treated|5|||
105898063|NCT00561470|365281542|FG000|Overall Study|Missed visit window|1|||
105898064|NCT00561470|365281543|FG001|Overall Study|Missed visit window|4|||
105898065|NCT00561470|365281542|FG000|Overall Study|Planning surgery|1|||
105898066|NCT00561470|365281543|FG001|Overall Study|Planning surgery|1|||
105898067|NCT00561470|365281542|FG000|Overall Study|Ongoing Treatment|11|||
105898068|NCT00561470|365281543|FG001|Overall Study|Ongoing Treatment|14|||
105898069|NCT02258334|365281548|FG000|Overall Study|Adverse Event|1|||
105898070|NCT02258334|365281549|FG001|Overall Study|Adverse Event|0|||
105898071|NCT02258334|365281550|FG002|Overall Study|Adverse Event|0|||
105898072|NCT02258334|365281551|FG003|Overall Study|Adverse Event|0|||
105898073|NCT02054910|365281556|FG000|Overall Study|Lost to Follow-up|4|||
105898074|NCT02054910|365281557|FG001|Overall Study|Lost to Follow-up|1|||
105898075|NCT01625689|365281558|FG000|Overall Study|Migration|2|||
105898076|NCT01625689|365281559|FG001|Overall Study|Migration|1|||
105898077|NCT02267135|365281567|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
105898078|NCT02267135|365281568|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
105898079|NCT02267135|365281567|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
105898080|NCT02267135|365281568|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
105898081|NCT02267135|365281567|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
105898082|NCT02267135|365281568|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
105898083|NCT02267135|365281567|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
105898084|NCT02267135|365281568|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
105898085|NCT02267135|365281567|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
105898086|NCT02267135|365281568|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
105898087|NCT04776018|365281569|FG000|Overall Study|Death|0|||
105898088|NCT04776018|365281570|FG001|Overall Study|Death|1|||
105898089|NCT04776018|365281571|FG002|Overall Study|Death|4|||
105898090|NCT04776018|365281572|FG003|Overall Study|Death|1|||
105898091|NCT04776018|365281573|FG004|Overall Study|Death|4|||
105898092|NCT04776018|365281574|FG005|Overall Study|Death|0|||
105898093|NCT04776018|365281575|FG006|Overall Study|Death|0|||
105898094|NCT04776018|365281569|FG000|Overall Study|Study terminated by sponsor|2|||
105898095|NCT04776018|365281570|FG001|Overall Study|Study terminated by sponsor|1|||
105898096|NCT04776018|365281571|FG002|Overall Study|Study terminated by sponsor|4|||
105898097|NCT04776018|365281572|FG003|Overall Study|Study terminated by sponsor|0|||
105898098|NCT04776018|365281573|FG004|Overall Study|Study terminated by sponsor|3|||
105898099|NCT04776018|365281574|FG005|Overall Study|Study terminated by sponsor|0|||
105898100|NCT04776018|365281575|FG006|Overall Study|Study terminated by sponsor|0|||
105898101|NCT04776018|365281569|FG000|Overall Study|Withdrawal by Subject|1|||
105898102|NCT04776018|365281570|FG001|Overall Study|Withdrawal by Subject|0|||
105898103|NCT04776018|365281571|FG002|Overall Study|Withdrawal by Subject|0|||
105898104|NCT04776018|365281572|FG003|Overall Study|Withdrawal by Subject|2|||
105898105|NCT04776018|365281573|FG004|Overall Study|Withdrawal by Subject|1|||
105898106|NCT04776018|365281574|FG005|Overall Study|Withdrawal by Subject|0|||
105898107|NCT04776018|365281575|FG006|Overall Study|Withdrawal by Subject|0|||
105898108|NCT04776018|365281569|FG000|Overall Study|Other|0|||
105898109|NCT04776018|365281570|FG001|Overall Study|Other|1|||
105898110|NCT04776018|365281571|FG002|Overall Study|Other|1|||
105898111|NCT04776018|365281572|FG003|Overall Study|Other|0|||
105898112|NCT04776018|365281573|FG004|Overall Study|Other|0|||
105898113|NCT04776018|365281574|FG005|Overall Study|Other|0|||
105898114|NCT04776018|365281575|FG006|Overall Study|Other|0|||
105898115|NCT04776018|365281569|FG000|Overall Study|Lost to Follow-up|0|||
105898116|NCT04776018|365281570|FG001|Overall Study|Lost to Follow-up|0|||
105898117|NCT04776018|365281571|FG002|Overall Study|Lost to Follow-up|1|||
105898118|NCT04776018|365281572|FG003|Overall Study|Lost to Follow-up|0|||
105898119|NCT04776018|365281573|FG004|Overall Study|Lost to Follow-up|0|||
105898120|NCT04776018|365281574|FG005|Overall Study|Lost to Follow-up|0|||
105898121|NCT04776018|365281575|FG006|Overall Study|Lost to Follow-up|0|||
105898122|NCT00435019|365281576|FG000|Overall Study|Adverse Event|1|||
105898123|NCT00435019|365281577|FG001|Overall Study|Adverse Event|0|||
105898124|NCT00435019|365281576|FG000|Overall Study|Lack of Efficacy|1|||
105898125|NCT00435019|365281577|FG001|Overall Study|Lack of Efficacy|2|||
105898126|NCT00435019|365281576|FG000|Overall Study|Protocol Violation|3|||
105898127|NCT00435019|365281577|FG001|Overall Study|Protocol Violation|1|||
105898128|NCT00435019|365281576|FG000|Overall Study|Personal reasons for withdrawal|8|||
105997619|NCT03400852|365653203|FG001|Blinded Treatment Period|Physician Decision|1|||
105997620|NCT03400852|365653204|FG002|Blinded Treatment Period|Physician Decision|0|||
105997621|NCT03400852|365653202|FG000|Blinded Treatment Period|Adverse Event|1|||
105997622|NCT03400852|365653203|FG001|Blinded Treatment Period|Adverse Event|1|||
105997623|NCT03400852|365653204|FG002|Blinded Treatment Period|Adverse Event|0|||
105997624|NCT03400852|365653202|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
105997625|NCT03400852|365653203|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
105997626|NCT03400852|365653204|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
105997627|NCT03400852|365653202|FG000|Open Label Period|Physician Decision|0|||
105997628|NCT03400852|365653203|FG001|Open Label Period|Physician Decision|0|||
105997629|NCT03400852|365653204|FG002|Open Label Period|Physician Decision|1|||
105997630|NCT03400852|365653202|FG000|Open Label Period|Study terminated by sponsor|0|||
105997631|NCT03400852|365653203|FG001|Open Label Period|Study terminated by sponsor|0|||
105997632|NCT03400852|365653204|FG002|Open Label Period|Study terminated by sponsor|21|||
105997633|NCT02274792|365653205|FG000|Overall Study|Withdrawal by Subject|13|||
106124114|NCT00519636|366111730|FG001|Washout Period|Participating in study at another site|0|||
106124115|NCT00519636|366111731|FG002|Washout Period|Participating in study at another site|0|||
106124116|NCT00519636|366111732|FG003|Washout Period|Participating in study at another site|0|||
105667921|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
105667922|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
105667923|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
105898129|NCT00435019|365281577|FG001|Overall Study|Personal reasons for withdrawal|7|||
105898130|NCT02678000|365281580|FG000|PART 2|Adverse Event|0|||
105898131|NCT02678000|365281581|FG001|PART 2|Adverse Event|0|||
105898132|NCT02678000|365281582|FG002|PART 2|Adverse Event|2|||
105898133|NCT02678000|365281583|FG003|PART 2|Adverse Event|1|||
105898134|NCT02678000|365281584|FG004|PART 2|Adverse Event|0|||
105898135|NCT02678000|365281580|FG000|PART 2|Withdrawal by Subject|0|||
105898136|NCT02678000|365281581|FG001|PART 2|Withdrawal by Subject|0|||
105898137|NCT02678000|365281582|FG002|PART 2|Withdrawal by Subject|1|||
105898138|NCT02678000|365281583|FG003|PART 2|Withdrawal by Subject|0|||
105898139|NCT02678000|365281584|FG004|PART 2|Withdrawal by Subject|0|||
105898140|NCT01324570|365281595|FG000|Overall Study|Adverse Event|4|||
105898141|NCT01324570|365281596|FG001|Overall Study|Adverse Event|7|||
105667924|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
105898142|NCT01324570|365281595|FG000|Overall Study|Withdrawal by Subject|0|||
105898143|NCT01324570|365281596|FG001|Overall Study|Withdrawal by Subject|3|||
105898144|NCT01324570|365281595|FG000|Overall Study|Lack of Efficacy|0|||
105898145|NCT01324570|365281596|FG001|Overall Study|Lack of Efficacy|1|||
105898146|NCT01324570|365281595|FG000|Overall Study|Confirmed or suspected diversion|0|||
105898147|NCT01324570|365281596|FG001|Overall Study|Confirmed or suspected diversion|1|||
105898148|NCT01324570|365281595|FG000|Overall Study|Administrative|0|||
105898149|NCT01324570|365281596|FG001|Overall Study|Administrative|2|||
105898150|NCT02360475|365281597|FG000|Overall Study|Lost to Follow-up|4|||
105898151|NCT02360475|365281598|FG001|Overall Study|Lost to Follow-up|12|||
105898152|NCT02360475|365281599|FG002|Overall Study|Lost to Follow-up|6|||
105898153|NCT02360475|365281600|FG003|Overall Study|Lost to Follow-up|4|||
105898154|NCT02360475|365281597|FG000|Overall Study|Withdrawal by Subject|0|||
105898155|NCT02360475|365281598|FG001|Overall Study|Withdrawal by Subject|1|||
105898156|NCT02360475|365281599|FG002|Overall Study|Withdrawal by Subject|2|||
105898157|NCT02360475|365281600|FG003|Overall Study|Withdrawal by Subject|0|||
105898158|NCT02360475|365281597|FG000|Overall Study|Migrated/moved from study area|0|||
105898159|NCT02360475|365281598|FG001|Overall Study|Migrated/moved from study area|0|||
105898160|NCT02360475|365281599|FG002|Overall Study|Migrated/moved from study area|0|||
105667925|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
105667926|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
105667927|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
105667928|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
105667929|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
105667930|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
105667931|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
105667932|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
105667933|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
105667934|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
105667935|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
105667936|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
105667937|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
105667938|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
105667939|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
105667940|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
105667941|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
105667942|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
105667943|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
105667944|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
105667945|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
105667946|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
105667947|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
105667948|NCT00477490|364448234|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
105667949|NCT00477490|364448235|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
105667950|NCT00477490|364448236|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
105667951|NCT00477490|364448237|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
105667952|NCT00477490|364448238|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
105667953|NCT00477490|364448239|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
105667954|NCT00477490|364448240|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
105667955|NCT00477490|364448241|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
105667956|NCT00477490|364448242|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
105667957|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
105667958|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
105667959|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
105667960|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
105667961|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
105667962|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
105667963|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
105667964|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
105667965|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
105667966|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
105898161|NCT02360475|365281600|FG003|Overall Study|Migrated/moved from study area|1|||
105898162|NCT00207727|365281601|FG000|Overall Study|Withdrawal by Subject|0|||
105667967|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
105898163|NCT00207727|365281602|FG001|Overall Study|Withdrawal by Subject|0|||
105898164|NCT00207727|365281603|FG002|Overall Study|Withdrawal by Subject|0|||
105667968|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
105667969|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105667970|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105898165|NCT00207727|365281604|FG003|Overall Study|Withdrawal by Subject|0|||
105898166|NCT00207727|365281605|FG004|Overall Study|Withdrawal by Subject|1|||
105898167|NCT00207727|365281601|FG000|Overall Study|Lost to Follow-up|0|||
105898168|NCT00207727|365281602|FG001|Overall Study|Lost to Follow-up|1|||
105898169|NCT00207727|365281603|FG002|Overall Study|Lost to Follow-up|0|||
106124117|NCT00519636|366111729|FG000|Washout Period|Non-compliant|0|||
106124118|NCT00519636|366111730|FG001|Washout Period|Non-compliant|1|||
106124119|NCT00519636|366111731|FG002|Washout Period|Non-compliant|0|||
106124120|NCT00519636|366111732|FG003|Washout Period|Non-compliant|0|||
106124121|NCT00519636|366111729|FG000|Washout Period|Per doctors request|0|||
106124122|NCT00519636|366111730|FG001|Washout Period|Per doctors request|1|||
106124123|NCT00519636|366111731|FG002|Washout Period|Per doctors request|0|||
106124124|NCT00519636|366111732|FG003|Washout Period|Per doctors request|0|||
106124125|NCT00519636|366111729|FG000|Washout Period|Subject randomized in error|0|||
106124126|NCT00519636|366111730|FG001|Washout Period|Subject randomized in error|0|||
106124127|NCT00519636|366111731|FG002|Washout Period|Subject randomized in error|1|||
106124128|NCT00519636|366111732|FG003|Washout Period|Subject randomized in error|0|||
106124129|NCT00519636|366111729|FG000|Washout Period|Prohibited medications|0|||
106124130|NCT00519636|366111730|FG001|Washout Period|Prohibited medications|0|||
106124131|NCT00519636|366111731|FG002|Washout Period|Prohibited medications|1|||
106124132|NCT00519636|366111732|FG003|Washout Period|Prohibited medications|0|||
106124133|NCT00519636|366111729|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
106124134|NCT00519636|366111730|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
106124135|NCT00519636|366111731|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
106124136|NCT00519636|366111732|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
105898170|NCT00207727|365281604|FG003|Overall Study|Lost to Follow-up|0|||
105898171|NCT00207727|365281605|FG004|Overall Study|Lost to Follow-up|0|||
105898172|NCT00207727|365281601|FG000|Overall Study|Other|38|||
105898173|NCT00207727|365281602|FG001|Overall Study|Other|41|||
105898174|NCT00207727|365281603|FG002|Overall Study|Other|41|||
105898175|NCT00207727|365281604|FG003|Overall Study|Other|37|||
105898176|NCT00207727|365281605|FG004|Overall Study|Other|33|||
105898177|NCT00306787|365283402|FG000|Overall Study|Discontinued without taking study drug|208|||
105898178|NCT00306787|365283403|FG001|Overall Study|Discontinued without taking study drug|215|||
105898179|NCT00306787|365283402|FG000|Overall Study|Adverse Event|1|||
105898180|NCT00306787|365283403|FG001|Overall Study|Adverse Event|1|||
105898181|NCT00306787|365283402|FG000|Overall Study|Lack of Efficacy|1|||
105898182|NCT00306787|365283403|FG001|Overall Study|Lack of Efficacy|0|||
105898183|NCT00306787|365283402|FG000|Overall Study|Protocol Violation|8|||
105898184|NCT00306787|365283403|FG001|Overall Study|Protocol Violation|10|||
105898185|NCT00306787|365283402|FG000|Overall Study|Withdrawal by Subject|2|||
105898186|NCT00306787|365283403|FG001|Overall Study|Withdrawal by Subject|9|||
105898187|NCT00306787|365283402|FG000|Overall Study|Lost to Follow-up|9|||
105898188|NCT00306787|365283403|FG001|Overall Study|Lost to Follow-up|6|||
105898189|NCT00306787|365283402|FG000|Overall Study|Administrative problems|4|||
105898190|NCT00306787|365283403|FG001|Overall Study|Administrative problems|0|||
105898191|NCT00306787|365283402|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105898192|NCT00306787|365283403|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105898193|NCT01438814|365283410|FG000|Overall Study|Adverse Event|3|||
105898194|NCT01438814|365283411|FG001|Overall Study|Adverse Event|3|||
105898195|NCT01438814|365283410|FG000|Overall Study|Protocol Violation|1|||
105898196|NCT01438814|365283411|FG001|Overall Study|Protocol Violation|2|||
105898197|NCT01438814|365283410|FG000|Overall Study|Lost to Follow-up|4|||
105898198|NCT01438814|365283411|FG001|Overall Study|Lost to Follow-up|3|||
105898199|NCT01438814|365283410|FG000|Overall Study|Withdrawal by Subject|4|||
105898200|NCT01438814|365283411|FG001|Overall Study|Withdrawal by Subject|2|||
105898201|NCT01438814|365283410|FG000|Overall Study|Other|2|||
105898202|NCT01438814|365283411|FG001|Overall Study|Other|4|||
105898203|NCT03887117|365283414|FG000|Overall Study|Discontinued prematurely|0|||
105898204|NCT03887117|365283415|FG001|Overall Study|Discontinued prematurely|1|||
105898205|NCT03887117|365283416|FG002|Overall Study|Discontinued prematurely|1|||
105898206|NCT03887117|365283417|FG003|Overall Study|Discontinued prematurely|2|||
105898207|NCT04908475|365283418|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
105898208|NCT04908475|365283419|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105898209|NCT04908475|365283420|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
106124137|NCT00519636|366111729|FG000|Treatment Period 2|Subject randomized in error|0|||
106124138|NCT00519636|366111730|FG001|Treatment Period 2|Subject randomized in error|1|||
105898210|NCT04908475|365283421|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
106124139|NCT00519636|366111731|FG002|Treatment Period 2|Subject randomized in error|0|||
106124140|NCT00519636|366111732|FG003|Treatment Period 2|Subject randomized in error|0|||
105898211|NCT04908475|365283422|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105898212|NCT04908475|365283423|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105898213|NCT04908475|365283418|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
105898214|NCT04908475|365283419|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105898215|NCT04908475|365283420|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105997634|NCT02274792|365653205|FG000|Overall Study|Lost to Follow-up|8|||
105997635|NCT02274792|365653205|FG000|Overall Study|Protocol Specified Criteria|2|||
105997636|NCT02274792|365653205|FG000|Overall Study|Sponsor Decision|2|||
105997637|NCT00965081|365653207|FG000|Overall Study|Adverse Event|14|||
105997638|NCT00965081|365653208|FG001|Overall Study|Adverse Event|9|||
105997639|NCT00965081|365653207|FG000|Overall Study|Lack of Efficacy|2|||
105997640|NCT00965081|365653208|FG001|Overall Study|Lack of Efficacy|5|||
105997641|NCT00965081|365653207|FG000|Overall Study|Lost to Follow-up|4|||
105997642|NCT00965081|365653208|FG001|Overall Study|Lost to Follow-up|5|||
105997643|NCT00965081|365653207|FG000|Overall Study|Physician Decision|2|||
105997644|NCT00965081|365653208|FG001|Overall Study|Physician Decision|0|||
105997645|NCT00965081|365653207|FG000|Overall Study|Protocol Violation|2|||
105997646|NCT00965081|365653208|FG001|Overall Study|Protocol Violation|5|||
105997647|NCT00965081|365653207|FG000|Overall Study|Sponsor Decision|1|||
105997648|NCT00965081|365653208|FG001|Overall Study|Sponsor Decision|0|||
105997649|NCT00965081|365653207|FG000|Overall Study|Withdrawal by Subject|4|||
105997650|NCT00965081|365653208|FG001|Overall Study|Withdrawal by Subject|7|||
105997651|NCT00965081|365653207|FG000|Overall Study|Switched to Rescue Arm|5|||
105997652|NCT00965081|365653208|FG001|Overall Study|Switched to Rescue Arm|12|||
105997653|NCT00796666|365653209|FG000|Overall Study|Death|2|||
105997654|NCT00796666|365653210|FG001|Overall Study|Death|4|||
105997655|NCT00796666|365653209|FG000|Overall Study|Withdrawal by Subject|2|||
105997656|NCT00796666|365653210|FG001|Overall Study|Withdrawal by Subject|0|||
105997657|NCT00796666|365653209|FG000|Overall Study|Adverse Event|7|||
105997658|NCT00796666|365653210|FG001|Overall Study|Adverse Event|5|||
105997659|NCT00796666|365653209|FG000|Overall Study|Protocol Violation|1|||
105997660|NCT00796666|365653210|FG001|Overall Study|Protocol Violation|0|||
105997661|NCT00796666|365653209|FG000|Overall Study|Other|1|||
105997662|NCT00796666|365653210|FG001|Overall Study|Other|0|||
105997663|NCT00796666|365653209|FG000|Overall Study|Terminated by sponsor|53|||
105997664|NCT00796666|365653210|FG001|Overall Study|Terminated by sponsor|55|||
105997665|NCT00796666|365653209|FG000|Overall Study|Randomized and not treated|1|||
105997666|NCT00796666|365653210|FG001|Overall Study|Randomized and not treated|0|||
105997667|NCT05280717|365653211|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
105997668|NCT05280717|365653212|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
105997669|NCT05280717|365653213|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
105997670|NCT05280717|365653214|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
105997671|NCT05280717|365653215|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
105997672|NCT05280717|365653216|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
105997673|NCT05280717|365653217|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
105997674|NCT05280717|365653211|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
105997675|NCT05280717|365653212|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105997676|NCT05280717|365653213|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105997677|NCT05280717|365653214|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105997678|NCT05280717|365653215|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105997679|NCT05280717|365653216|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105997680|NCT05280717|365653217|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
105997681|NCT05280717|365653211|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105997682|NCT05280717|365653212|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
105997683|NCT05280717|365653213|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
106124141|NCT00519636|366111729|FG000|Treatment Period 2|Per doctors request|0|||
106124142|NCT00519636|366111730|FG001|Treatment Period 2|Per doctors request|0|||
106124143|NCT00519636|366111731|FG002|Treatment Period 2|Per doctors request|1|||
106124144|NCT00519636|366111732|FG003|Treatment Period 2|Per doctors request|0|||
106124145|NCT00519636|366111729|FG000|Treatment Period 2|Subject misrandomized|0|||
106124146|NCT00519636|366111730|FG001|Treatment Period 2|Subject misrandomized|0|||
106124147|NCT00519636|366111731|FG002|Treatment Period 2|Subject misrandomized|0|||
106124148|NCT00519636|366111732|FG003|Treatment Period 2|Subject misrandomized|1|||
106124149|NCT00519636|366111729|FG000|Post Study Period|Subject randomized in error|0|||
105898216|NCT04908475|365283421|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105898217|NCT04908475|365283422|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105898218|NCT04908475|365283423|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
105898219|NCT04908475|365283418|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
105898220|NCT04908475|365283419|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105898221|NCT04908475|365283420|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105898222|NCT04908475|365283421|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105898223|NCT04908475|365283422|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105898224|NCT04908475|365283423|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
105898225|NCT04908475|365283418|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105898226|NCT04908475|365283419|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
105898227|NCT04908475|365283420|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
105898228|NCT04908475|365283421|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
105898229|NCT04908475|365283422|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105898230|NCT04908475|365283423|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105898231|NCT04908475|365283418|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
105898232|NCT04908475|365283419|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
105898233|NCT04908475|365283420|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
105898234|NCT04908475|365283421|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
105898235|NCT04908475|365283422|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
105898236|NCT04908475|365283423|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
105898237|NCT04908475|365283418|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
105898238|NCT04908475|365283419|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
105898239|NCT04908475|365283420|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
105898240|NCT04908475|365283421|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
105898241|NCT04908475|365283422|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
105898242|NCT04908475|365283423|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
105898243|NCT01739764|365283424|FG000|Overall Study|Adverse Event|0|||
105898244|NCT01739764|365283425|FG001|Overall Study|Adverse Event|3|||
105898245|NCT01739764|365283426|FG002|Overall Study|Adverse Event|4|||
105898246|NCT01739764|365283424|FG000|Overall Study|Death|4|||
105898247|NCT01739764|365283425|FG001|Overall Study|Death|6|||
105898248|NCT01739764|365283426|FG002|Overall Study|Death|38|||
105898249|NCT01739764|365283424|FG000|Overall Study|Lost to Follow-up|0|||
105898250|NCT01739764|365283425|FG001|Overall Study|Lost to Follow-up|0|||
105898251|NCT01739764|365283426|FG002|Overall Study|Lost to Follow-up|5|||
105898252|NCT01739764|365283424|FG000|Overall Study|Non-Compliance|0|||
105898253|NCT01739764|365283425|FG001|Overall Study|Non-Compliance|0|||
105898254|NCT01739764|365283426|FG002|Overall Study|Non-Compliance|1|||
105898255|NCT01739764|365283424|FG000|Overall Study|Multiple Reasons|3|||
105898256|NCT01739764|365283425|FG001|Overall Study|Multiple Reasons|2|||
105898257|NCT01739764|365283426|FG002|Overall Study|Multiple Reasons|3|||
105898258|NCT01739764|365283424|FG000|Overall Study|Physician Decision|2|||
105898259|NCT01739764|365283425|FG001|Overall Study|Physician Decision|2|||
105898260|NCT01739764|365283426|FG002|Overall Study|Physician Decision|4|||
105898261|NCT01739764|365283424|FG000|Overall Study|Progressive Disease|3|||
105898262|NCT01739764|365283425|FG001|Overall Study|Progressive Disease|5|||
105898263|NCT01739764|365283426|FG002|Overall Study|Progressive Disease|16|||
105898264|NCT01739764|365283424|FG000|Overall Study|Protocol Violation|0|||
105898265|NCT01739764|365283425|FG001|Overall Study|Protocol Violation|0|||
105898266|NCT01739764|365283426|FG002|Overall Study|Protocol Violation|2|||
105898267|NCT01739764|365283424|FG000|Overall Study|Study Terminated by Sponsor|8|||
105898268|NCT01739764|365283425|FG001|Overall Study|Study Terminated by Sponsor|13|||
105898269|NCT01739764|365283426|FG002|Overall Study|Study Terminated by Sponsor|26|||
105898270|NCT01739764|365283424|FG000|Overall Study|Withdrawal by Subject|6|||
105898271|NCT01739764|365283425|FG001|Overall Study|Withdrawal by Subject|5|||
105898272|NCT01739764|365283426|FG002|Overall Study|Withdrawal by Subject|27|||
105898273|NCT00337779|365283427|FG000|Overall Study|Withdrawal by Subject|10|||
105898274|NCT00337779|365283428|FG001|Overall Study|Withdrawal by Subject|12|||
105898275|NCT00337779|365283427|FG000|Overall Study|Sponsor decision|1|||
105898276|NCT00337779|365283428|FG001|Overall Study|Sponsor decision|1|||
105898277|NCT00337779|365283427|FG000|Overall Study|Physician Decision|3|||
105898278|NCT00337779|365283428|FG001|Overall Study|Physician Decision|6|||
105898279|NCT00337779|365283427|FG000|Overall Study|Protocol Violation|1|||
106124150|NCT00519636|366111730|FG001|Post Study Period|Subject randomized in error|0|||
106124151|NCT00519636|366111731|FG002|Post Study Period|Subject randomized in error|0|||
106124152|NCT00519636|366111732|FG003|Post Study Period|Subject randomized in error|1|||
106124153|NCT02404493|366111733|FG000|Overall Study|Adverse Event|1|||
106124154|NCT02404493|366111734|FG001|Overall Study|Adverse Event|1|||
105667971|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
106124155|NCT02133924|366111739|FG000|Overall Study|Death|38|||
106124156|NCT02133924|366111739|FG000|Overall Study|Physician Decision|1|||
106124157|NCT02133924|366111739|FG000|Overall Study|Withdrawal by Subject|3|||
106124158|NCT00386308|366113988|FG000|Overall Study|Adverse Event|3|||
105898280|NCT00337779|365283428|FG001|Overall Study|Protocol Violation|1|||
105898281|NCT00337779|365283427|FG000|Overall Study|Lost to Follow-up|6|||
105898282|NCT00337779|365283428|FG001|Overall Study|Lost to Follow-up|5|||
105898283|NCT00337779|365283427|FG000|Overall Study|Adverse Event|28|||
105898284|NCT00337779|365283428|FG001|Overall Study|Adverse Event|51|||
105898285|NCT00337779|365283427|FG000|Overall Study|Pregnancy|3|||
105898286|NCT00337779|365283428|FG001|Overall Study|Pregnancy|2|||
106124159|NCT00386308|366113989|FG001|Overall Study|Adverse Event|3|||
106124160|NCT00386308|366113988|FG000|Overall Study|Protocol Violation|2|||
105898287|NCT00337779|365283427|FG000|Overall Study|Death|0|||
105898288|NCT00337779|365283428|FG001|Overall Study|Death|1|||
105898289|NCT00404924|365283431|FG000|Overall Study|Adverse Event|75|||
105898290|NCT00404924|365283432|FG001|Overall Study|Adverse Event|16|||
105898291|NCT00404924|365283431|FG000|Overall Study|Condition under investigation worsened|475|||
105898292|NCT00404924|365283432|FG001|Overall Study|Condition under investigation worsened|264|||
105898293|NCT00404924|365283431|FG000|Overall Study|Lost to Follow-up|1|||
105898294|NCT00404924|365283432|FG001|Overall Study|Lost to Follow-up|1|||
105997684|NCT05280717|365653214|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105997685|NCT05280717|365653215|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105997686|NCT05280717|365653216|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105997687|NCT05280717|365653217|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
105997688|NCT05280717|365653211|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105997689|NCT05280717|365653212|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105997690|NCT05280717|365653213|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
105997691|NCT05280717|365653214|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105997692|NCT05280717|365653215|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105997693|NCT05280717|365653216|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105997694|NCT05280717|365653217|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
105997695|NCT05280717|365653211|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105997696|NCT05280717|365653212|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105997697|NCT05280717|365653213|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105997698|NCT05280717|365653214|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105997699|NCT05280717|365653215|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105997700|NCT05280717|365653216|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
105997701|NCT05280717|365653217|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
105997702|NCT05280717|365653211|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105997703|NCT05280717|365653212|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105997704|NCT05280717|365653213|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105997705|NCT05280717|365653214|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105997706|NCT05280717|365653215|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105997707|NCT05280717|365653216|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
105997708|NCT05280717|365653217|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
105997709|NCT03801174|365653221|FG000|Overall Study|Withdrawal by Subject|14|||
105997710|NCT03801174|365653222|FG001|Overall Study|Withdrawal by Subject|15|||
105997711|NCT03801174|365653221|FG000|Overall Study|Death|1|||
105997712|NCT03801174|365653222|FG001|Overall Study|Death|0|||
105997713|NCT03801174|365653221|FG000|Overall Study|Pregnancy|2|||
105898295|NCT00404924|365283431|FG000|Overall Study|Withdrawal by Subject|26|||
105898296|NCT00404924|365283432|FG001|Overall Study|Withdrawal by Subject|13|||
105898297|NCT00404924|365283431|FG000|Overall Study|Other|25|||
105898298|NCT00404924|365283432|FG001|Overall Study|Other|11|||
105898299|NCT00404924|365283431|FG000|Overall Study|Randomised but not received treatment|1|||
105898300|NCT00404924|365283432|FG001|Overall Study|Randomised but not received treatment|1|||
105898301|NCT03913104|365283439|FG000|Overall Study|Lost to Follow-up|20|||
105898302|NCT03913104|365283439|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
105898303|NCT03913104|365283439|FG000|Overall Study|Withdrawal by Subject|2|||
105898304|NCT02603107|365283440|FG000|Randomized Phase|Withdrew consent|8|||
105997714|NCT03801174|365653222|FG001|Overall Study|Pregnancy|2|||
105997715|NCT03801174|365653221|FG000|Overall Study|Lost to Follow-up|19|||
105997716|NCT03801174|365653222|FG001|Overall Study|Lost to Follow-up|10|||
105997717|NCT03801174|365653221|FG000|Overall Study|Other|4|||
105997718|NCT03801174|365653222|FG001|Overall Study|Other|3|||
106124161|NCT00386308|366113989|FG001|Overall Study|Protocol Violation|5|||
106124162|NCT00386308|366113988|FG000|Overall Study|Lack of Efficacy|0|||
106124163|NCT00386308|366113989|FG001|Overall Study|Lack of Efficacy|2|||
106124164|NCT00386308|366113988|FG000|Overall Study|Lost to Follow-up|10|||
106124165|NCT00386308|366113989|FG001|Overall Study|Lost to Follow-up|6|||
106124166|NCT00386308|366113988|FG000|Overall Study|Withdrawal by Subject|6|||
106124167|NCT00386308|366113989|FG001|Overall Study|Withdrawal by Subject|2|||
106124168|NCT00386308|366113988|FG000|Overall Study|Other Event|8|||
106124169|NCT00386308|366113989|FG001|Overall Study|Other Event|1|||
106124170|NCT00445601|366113990|FG000|Overall Study|Withdrawal by Subject|11|||
106124171|NCT00445601|366113991|FG001|Overall Study|Withdrawal by Subject|11|||
105898305|NCT02603107|365283441|FG001|Randomized Phase|Withdrew consent|15|||
105898306|NCT02603107|365283440|FG000|Randomized Phase|Lost to Follow-up|1|||
105898307|NCT02603107|365283441|FG001|Randomized Phase|Lost to Follow-up|3|||
105898308|NCT02603107|365283440|FG000|Randomized Phase|Adverse Event|2|||
106124172|NCT00445601|366113990|FG000|Overall Study|TURBT Complication|12|||
105997719|NCT03801174|365653221|FG000|Overall Study|Lack of Efficacy|4|||
105997720|NCT03801174|365653222|FG001|Overall Study|Lack of Efficacy|0|||
105997721|NCT03801174|365653221|FG000|Overall Study|Unwilling to complete activities|5|||
105997722|NCT03801174|365653222|FG001|Overall Study|Unwilling to complete activities|6|||
105997723|NCT03801174|365653221|FG000|Overall Study|Moved out of area|3|||
105997724|NCT03801174|365653222|FG001|Overall Study|Moved out of area|0|||
105997725|NCT00181766|365653223|FG000|Overall Study|Lost to Follow-up|6|||
105997726|NCT00181766|365653223|FG000|Overall Study|Adverse Event|4|||
105997727|NCT00181766|365653223|FG000|Overall Study|non-compliance|2|||
105997728|NCT00413218|365653228|FG000|Overall Study|Randomized but didn't receive study drug|2|||
105997729|NCT00413218|365653229|FG001|Overall Study|Randomized but didn't receive study drug|8|||
105997730|NCT00413218|365653228|FG000|Overall Study|Death|57|||
105997731|NCT00413218|365653229|FG001|Overall Study|Death|56|||
105997732|NCT00413218|365653228|FG000|Overall Study|Lost to Follow-up|14|||
105997733|NCT00413218|365653229|FG001|Overall Study|Lost to Follow-up|17|||
105997734|NCT00413218|365653228|FG000|Overall Study|Admin|20|||
105997735|NCT00413218|365653229|FG001|Overall Study|Admin|14|||
105997736|NCT00413218|365653228|FG000|Overall Study|Missing|1|||
105997737|NCT00413218|365653229|FG001|Overall Study|Missing|0|||
105997738|NCT00413218|365653228|FG000|Overall Study|Withdrawal by Subject|9|||
105997739|NCT00413218|365653229|FG001|Overall Study|Withdrawal by Subject|1|||
105997740|NCT01687296|365653230|FG000|Overall Study|Lack of Efficacy|1|||
105997741|NCT01687296|365653231|FG001|Overall Study|Lack of Efficacy|1|||
105997742|NCT01687296|365653230|FG000|Overall Study|Protocol Violation|0|||
105997743|NCT01687296|365653231|FG001|Overall Study|Protocol Violation|1|||
105997744|NCT01687296|365653230|FG000|Overall Study|Withdrawal by Subject|6|||
105997745|NCT01687296|365653231|FG001|Overall Study|Withdrawal by Subject|3|||
105997746|NCT02698826|365653233|FG000|Overall Study|Death|13|||
105997747|NCT02698826|365653233|FG000|Overall Study|Adverse Event|1|||
105997748|NCT02478463|365653234|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
105997749|NCT02478463|365653234|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
105997750|NCT02478463|365653234|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
105997751|NCT01618669|365653239|FG000|Overall Study|Lost to Follow-up|1|||
105997752|NCT01618669|365653240|FG001|Overall Study|Lost to Follow-up|1|||
105997753|NCT01618669|365653239|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
105997754|NCT01618669|365653240|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
105997755|NCT01618669|365653239|FG000|Overall Study|Adverse Event|16|||
105997756|NCT01618669|365653240|FG001|Overall Study|Adverse Event|7|||
105997757|NCT01618669|365653239|FG000|Overall Study|Protocol Violation|5|||
105997758|NCT01618669|365653240|FG001|Overall Study|Protocol Violation|3|||
105997759|NCT01618669|365653239|FG000|Overall Study|Withdrawal by Subject|9|||
105997760|NCT01618669|365653240|FG001|Overall Study|Withdrawal by Subject|9|||
105997761|NCT01618669|365653239|FG000|Overall Study|Miscellaneous Reason|0|||
105997762|NCT01618669|365653240|FG001|Overall Study|Miscellaneous Reason|1|||
105997763|NCT04317040|365653241|FG000|Overall Study|Lost to Follow-up|2|||
105997764|NCT04317040|365653242|FG001|Overall Study|Lost to Follow-up|0|||
105997765|NCT04317040|365653241|FG000|Overall Study|Death|16|||
105997766|NCT04317040|365653242|FG001|Overall Study|Death|18|||
106124173|NCT00445601|366113991|FG001|Overall Study|TURBT Complication|8|||
106124174|NCT00445601|366113990|FG000|Overall Study|Incorrect Disease Status|6|||
106124175|NCT00445601|366113991|FG001|Overall Study|Incorrect Disease Status|6|||
106124176|NCT00445601|366113990|FG000|Overall Study|Drug Delivery Issue|2|||
106124177|NCT00445601|366113991|FG001|Overall Study|Drug Delivery Issue|2|||
106124178|NCT00445601|366113990|FG000|Overall Study|Adverse Event|2|||
106124179|NCT00445601|366113991|FG001|Overall Study|Adverse Event|0|||
106124180|NCT00445601|366113990|FG000|Overall Study|Death prior to TURBT|0|||
105997767|NCT04317040|365653241|FG000|Overall Study|Withdrawal by Subject|0|||
106124181|NCT00445601|366113991|FG001|Overall Study|Death prior to TURBT|1|||
106124182|NCT04781647|366113996|FG000|Overall Study|Study terminated by Sponsor|11|||
106124183|NCT04781647|366113997|FG001|Overall Study|Study terminated by Sponsor|9|||
106124184|NCT04781647|366113998|FG002|Overall Study|Study terminated by Sponsor|9|||
105997768|NCT04317040|365653242|FG001|Overall Study|Withdrawal by Subject|1|||
105997769|NCT04317040|365653241|FG000|Overall Study|Incomplete assessments|0|||
106124185|NCT04781647|366113996|FG000|Overall Study|Withdrawal by Subject|1|||
105997770|NCT04317040|365653242|FG001|Overall Study|Incomplete assessments|1|||
105997771|NCT01177007|365653243|FG000|Overall Study|Lost to Follow-up|2|||
105997772|NCT01177007|365653243|FG000|Overall Study|Death|4|||
105997773|NCT01177007|365653243|FG000|Overall Study|Entered hospice care|5|||
105997774|NCT01177007|365653243|FG000|Overall Study|Required additional Y90 treatment|6|||
106124186|NCT04781647|366113997|FG001|Overall Study|Withdrawal by Subject|2|||
106124187|NCT04781647|366113998|FG002|Overall Study|Withdrawal by Subject|0|||
106124188|NCT04781647|366113996|FG000|Overall Study|Adverse Event|0|||
106124189|NCT04781647|366113997|FG001|Overall Study|Adverse Event|1|||
106124190|NCT04781647|366113998|FG002|Overall Study|Adverse Event|1|||
105997775|NCT01177007|365653243|FG000|Overall Study|Change in treatment modality|21|||
105997776|NCT01012258|365653244|FG000|Overall Study|Death|14|||
105997777|NCT01012258|365653244|FG000|Overall Study|Lost to Follow-up|1|||
105997778|NCT01012258|365653244|FG000|Overall Study|Adverse Event|1|||
105898309|NCT02603107|365283441|FG001|Randomized Phase|Adverse Event|0|||
105898310|NCT02603107|365283440|FG000|Randomized Phase|Death|1|||
105898311|NCT02603107|365283441|FG001|Randomized Phase|Death|1|||
105898312|NCT02603107|365283440|FG000|Randomized Phase|Non-compliance with study drug|1|||
105898313|NCT02603107|365283441|FG001|Randomized Phase|Non-compliance with study drug|1|||
105898314|NCT02603107|365283440|FG000|Randomized Phase|Investigator's discretion|0|||
105898315|NCT02603107|365283441|FG001|Randomized Phase|Investigator's discretion|1|||
105898316|NCT02603107|365283440|FG000|Randomized Phase|Lack of Efficacy|1|||
105898317|NCT02603107|365283441|FG001|Randomized Phase|Lack of Efficacy|0|||
105898318|NCT02603107|365283440|FG000|Randomized Phase|Protocol Violation|1|||
105898319|NCT02603107|365283441|FG001|Randomized Phase|Protocol Violation|0|||
105898320|NCT02603107|365283440|FG000|Optional Extension Phase|Lost to Follow-up|3|||
105898321|NCT02603107|365283441|FG001|Optional Extension Phase|Lost to Follow-up|3|||
105898322|NCT02603107|365283440|FG000|Optional Extension Phase|Withdrew consent|3|||
105898323|NCT02603107|365283441|FG001|Optional Extension Phase|Withdrew consent|2|||
105898324|NCT02603107|365283440|FG000|Optional Extension Phase|Investigator's discretion|2|||
105898325|NCT02603107|365283441|FG001|Optional Extension Phase|Investigator's discretion|2|||
105898326|NCT02603107|365283440|FG000|Optional Extension Phase|Pregnancy|0|||
105898327|NCT02603107|365283441|FG001|Optional Extension Phase|Pregnancy|3|||
105898328|NCT02603107|365283440|FG000|Optional Extension Phase|Adverse Event|0|||
105898329|NCT02603107|365283441|FG001|Optional Extension Phase|Adverse Event|2|||
105898330|NCT02603107|365283440|FG000|Optional Extension Phase|Not treated in extension phase|0|||
105898331|NCT02603107|365283441|FG001|Optional Extension Phase|Not treated in extension phase|1|||
105898332|NCT02603107|365283440|FG000|Optional Extension Phase|Protocol Violation|1|||
105898333|NCT02603107|365283441|FG001|Optional Extension Phase|Protocol Violation|0|||
105898334|NCT03013985|365283442|FG000|Overall Study|Protocol Violation|2|||
105898335|NCT03013985|365283443|FG001|Overall Study|Protocol Violation|2|||
105898336|NCT03013985|365283442|FG000|Overall Study|Withdrawal by Subject|14|||
105898337|NCT03013985|365283443|FG001|Overall Study|Withdrawal by Subject|17|||
105898338|NCT01887678|365283444|FG000|Overall Study|Adverse Event|4|||
105898339|NCT01887678|365283445|FG001|Overall Study|Adverse Event|6|||
105898340|NCT01887678|365283444|FG000|Overall Study|Exceeded rescue medication dosage|4|||
105898341|NCT01887678|365283445|FG001|Overall Study|Exceeded rescue medication dosage|5|||
105898342|NCT01887678|365283444|FG000|Overall Study|Withdrawal of consent|3|||
105898343|NCT01887678|365283445|FG001|Overall Study|Withdrawal of consent|4|||
105898344|NCT01887678|365283444|FG000|Overall Study|Lost to Follow-up|4|||
105898345|NCT01887678|365283445|FG001|Overall Study|Lost to Follow-up|2|||
105898346|NCT01887678|365283444|FG000|Overall Study|Deterioration of clinical condition|0|||
105898347|NCT01887678|365283445|FG001|Overall Study|Deterioration of clinical condition|4|||
105898348|NCT01887678|365283444|FG000|Overall Study|Lack of Efficacy|1|||
105898349|NCT01887678|365283445|FG001|Overall Study|Lack of Efficacy|2|||
105898350|NCT01887678|365283444|FG000|Overall Study|Non-compliance|0|||
105898351|NCT01887678|365283445|FG001|Overall Study|Non-compliance|3|||
105898352|NCT01887678|365283444|FG000|Overall Study|Specified|1|||
105898353|NCT01887678|365283445|FG001|Overall Study|Specified|2|||
105898354|NCT01080391|365283453|FG000|Overall Study|Randomized but not treated|7|||
105898355|NCT01080391|365283454|FG001|Overall Study|Randomized but not treated|4|||
105898356|NCT04907227|365283455|FG000|Overall Study|Death|12|||
105898357|NCT04907227|365283456|FG001|Overall Study|Death|8|||
105898358|NCT04907227|365283455|FG000|Overall Study|Withdrawal by Subject|2|||
105898359|NCT04907227|365283456|FG001|Overall Study|Withdrawal by Subject|2|||
105898360|NCT04907227|365283455|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
105898361|NCT04907227|365283456|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
105898362|NCT04907227|365283455|FG000|Overall Study|Sponsor Decision|25|||
105898363|NCT04907227|365283456|FG001|Overall Study|Sponsor Decision|30|||
105898364|NCT04907227|365283455|FG000|Overall Study|Physician Decision|1|||
105898365|NCT04907227|365283456|FG001|Overall Study|Physician Decision|0|||
105898366|NCT00106639|365283457|FG000|Overall Study|Adverse Event|3|||
105898367|NCT00106639|365283458|FG001|Overall Study|Adverse Event|4|||
106124191|NCT04781647|366113996|FG000|Overall Study|Protocol Violation|1|||
106124192|NCT04781647|366113997|FG001|Overall Study|Protocol Violation|0|||
106124193|NCT04781647|366113998|FG002|Overall Study|Protocol Violation|0|||
106124194|NCT04781647|366113996|FG000|Overall Study|Pregnancy|0|||
105898368|NCT00106639|365283459|FG002|Overall Study|Adverse Event|1|||
105898369|NCT00106639|365283457|FG000|Overall Study|Protocol Violation|0|||
105898370|NCT00106639|365283458|FG001|Overall Study|Protocol Violation|1|||
105898371|NCT00106639|365283459|FG002|Overall Study|Protocol Violation|0|||
105898372|NCT00106639|365283457|FG000|Overall Study|Withdrawal by Subject|0|||
105898373|NCT00106639|365283458|FG001|Overall Study|Withdrawal by Subject|1|||
105898374|NCT00106639|365283459|FG002|Overall Study|Withdrawal by Subject|0|||
105898375|NCT00106639|365283457|FG000|Overall Study|Participant defaulted|0|||
105898376|NCT00106639|365283458|FG001|Overall Study|Participant defaulted|1|||
105898377|NCT00106639|365283459|FG002|Overall Study|Participant defaulted|1|||
105898378|NCT03723070|365283460|FG000|Overall Study|Lost to Follow-up|2|||
106124195|NCT04781647|366113997|FG001|Overall Study|Pregnancy|0|||
105898379|NCT03723070|365283460|FG000|Overall Study|Physician Decision|1|||
106124196|NCT04781647|366113998|FG002|Overall Study|Pregnancy|1|||
105898380|NCT03723070|365283460|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
105898381|NCT02134353|365283464|FG000|Overall Study|Adverse Event|10|||
105898382|NCT02134353|365283465|FG001|Overall Study|Adverse Event|6|||
105898383|NCT02134353|365283464|FG000|Overall Study|Lost to Follow-up|1|||
105898384|NCT02134353|365283465|FG001|Overall Study|Lost to Follow-up|1|||
105898385|NCT02134353|365283464|FG000|Overall Study|Lack of Efficacy|2|||
105898386|NCT02134353|365283465|FG001|Overall Study|Lack of Efficacy|1|||
105898387|NCT02134353|365283464|FG000|Overall Study|Withdrawal by Subject|12|||
105898388|NCT02134353|365283465|FG001|Overall Study|Withdrawal by Subject|13|||
105898389|NCT02134353|365283464|FG000|Overall Study|Death|0|||
105898390|NCT02134353|365283465|FG001|Overall Study|Death|1|||
105898391|NCT02134353|365283464|FG000|Overall Study|Pregnancy|0|||
105898392|NCT02134353|365283465|FG001|Overall Study|Pregnancy|1|||
105898393|NCT02134353|365283464|FG000|Overall Study|Relocation|1|||
105898394|NCT02134353|365283465|FG001|Overall Study|Relocation|0|||
105898395|NCT02134353|365283464|FG000|Overall Study|Other - Patient's Choice|0|||
105898396|NCT02134353|365283465|FG001|Overall Study|Other - Patient's Choice|1|||
105898397|NCT00477607|365283466|FG000|Overall Study|Lost to Follow-up|7|||
105898398|NCT00477607|365283467|FG001|Overall Study|Lost to Follow-up|7|||
105898399|NCT01362244|365283468|FG000|Overall Study|Adverse Event|3|||
105898400|NCT01362244|365283469|FG001|Overall Study|Adverse Event|5|||
105898401|NCT01362244|365283468|FG000|Overall Study|Lack of Efficacy|5|||
105898402|NCT01362244|365283469|FG001|Overall Study|Lack of Efficacy|11|||
105898403|NCT01362244|365283468|FG000|Overall Study|Lost to Follow-up|0|||
105898404|NCT01362244|365283469|FG001|Overall Study|Lost to Follow-up|2|||
105898405|NCT01362244|365283468|FG000|Overall Study|Protocol Violation|5|||
105898406|NCT01362244|365283469|FG001|Overall Study|Protocol Violation|1|||
105898407|NCT01362244|365283468|FG000|Overall Study|Withdrawal by Subject|2|||
105898408|NCT01362244|365283469|FG001|Overall Study|Withdrawal by Subject|1|||
105898409|NCT01362244|365283468|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
105898410|NCT01362244|365283469|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
105898411|NCT01362244|365283468|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
105898412|NCT01362244|365283469|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
105898413|NCT00467961|365283475|FG000|Overall Study|Technical Failures|5|||
105898414|NCT00467961|365283475|FG000|Overall Study|Disease Progression|2|||
105898415|NCT01447927|365283476|FG000|Overall Study|Adverse Event|4|||
105898416|NCT01447927|365283477|FG001|Overall Study|Adverse Event|3|||
105898417|NCT01447927|365283476|FG000|Overall Study|Withdrawal by Subject|1|||
105898418|NCT01447927|365283477|FG001|Overall Study|Withdrawal by Subject|0|||
105898419|NCT02908074|365283478|FG000|Overall Study|sponsor/ICON decision|0|||
105898420|NCT02908074|365283479|FG001|Overall Study|sponsor/ICON decision|0|||
105898421|NCT02908074|365283480|FG002|Overall Study|sponsor/ICON decision|1|||
105898422|NCT02908074|365283481|FG003|Overall Study|sponsor/ICON decision|0|||
105898423|NCT02908074|365283482|FG004|Overall Study|sponsor/ICON decision|0|||
105898424|NCT02908074|365283483|FG005|Overall Study|sponsor/ICON decision|0|||
105898425|NCT02908074|365283478|FG000|Overall Study|Protocol Violation|0|||
105898426|NCT02908074|365283479|FG001|Overall Study|Protocol Violation|1|||
105898427|NCT02908074|365283480|FG002|Overall Study|Protocol Violation|0|||
105898428|NCT02908074|365283481|FG003|Overall Study|Protocol Violation|0|||
105898429|NCT02908074|365283482|FG004|Overall Study|Protocol Violation|0|||
105898430|NCT02908074|365283483|FG005|Overall Study|Protocol Violation|0|||
105898431|NCT02908074|365283478|FG000|Overall Study|Adverse Event|5|||
105898432|NCT02908074|365283479|FG001|Overall Study|Adverse Event|2|||
105898433|NCT02908074|365283480|FG002|Overall Study|Adverse Event|0|||
105898434|NCT02908074|365283481|FG003|Overall Study|Adverse Event|0|||
105898435|NCT02908074|365283482|FG004|Overall Study|Adverse Event|1|||
105898436|NCT02908074|365283483|FG005|Overall Study|Adverse Event|0|||
105898437|NCT02908074|365283478|FG000|Overall Study|AESI|1|||
105898438|NCT02908074|365283479|FG001|Overall Study|AESI|0|||
105898439|NCT02908074|365283480|FG002|Overall Study|AESI|1|||
105898440|NCT02908074|365283481|FG003|Overall Study|AESI|0|||
105898441|NCT02908074|365283482|FG004|Overall Study|AESI|1|||
105898442|NCT02908074|365283483|FG005|Overall Study|AESI|0|||
105898443|NCT02908074|365283478|FG000|Overall Study|Discontinuation criteria per protocol|0|||
105898444|NCT02908074|365283479|FG001|Overall Study|Discontinuation criteria per protocol|0|||
105898445|NCT02908074|365283480|FG002|Overall Study|Discontinuation criteria per protocol|1|||
105898446|NCT02908074|365283481|FG003|Overall Study|Discontinuation criteria per protocol|0|||
105898447|NCT02908074|365283482|FG004|Overall Study|Discontinuation criteria per protocol|0|||
105898448|NCT02908074|365283483|FG005|Overall Study|Discontinuation criteria per protocol|1|||
105898449|NCT02908074|365283478|FG000|Overall Study|Withdrawal by Subject|3|||
105898450|NCT02908074|365283479|FG001|Overall Study|Withdrawal by Subject|2|||
105898451|NCT02908074|365283480|FG002|Overall Study|Withdrawal by Subject|2|||
105898452|NCT02908074|365283481|FG003|Overall Study|Withdrawal by Subject|2|||
105898453|NCT02908074|365283482|FG004|Overall Study|Withdrawal by Subject|2|||
105898454|NCT02908074|365283483|FG005|Overall Study|Withdrawal by Subject|2|||
105898455|NCT02908074|365283478|FG000|Overall Study|Lost to Follow-up|0|||
105667972|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105667973|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
105667974|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
105667975|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667976|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
105667977|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
105667978|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667979|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
105667980|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667981|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
105667982|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667983|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
105667984|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105898456|NCT02908074|365283479|FG001|Overall Study|Lost to Follow-up|1|||
105898457|NCT02908074|365283480|FG002|Overall Study|Lost to Follow-up|1|||
105898458|NCT02908074|365283481|FG003|Overall Study|Lost to Follow-up|1|||
105898459|NCT02908074|365283482|FG004|Overall Study|Lost to Follow-up|0|||
105898460|NCT02908074|365283483|FG005|Overall Study|Lost to Follow-up|1|||
105898461|NCT04102865|365283484|FG000|Overall Study|Adverse Event|4|||
105898462|NCT04102865|365283485|FG001|Overall Study|Adverse Event|0|||
105898463|NCT04102865|365283484|FG000|Overall Study|Lost to Follow-up|1|||
105898464|NCT04102865|365283485|FG001|Overall Study|Lost to Follow-up|0|||
105898465|NCT04102865|365283484|FG000|Overall Study|Withdrawal by Subject|2|||
105898466|NCT04102865|365283485|FG001|Overall Study|Withdrawal by Subject|0|||
105898467|NCT02073565|365283486|FG000|Cohort A|Withdrawal by Subject|1|||
105898468|NCT02073565|365283487|FG001|Cohort A|Withdrawal by Subject|0|||
105898469|NCT02073565|365283486|FG000|Cohort B|Withdrawal by Subject|1|||
105898470|NCT02073565|365283487|FG001|Cohort B|Withdrawal by Subject|2|||
105898471|NCT02073565|365283486|FG000|Cohort C|Withdrawal by Subject|0|||
105898472|NCT02073565|365283487|FG001|Cohort C|Withdrawal by Subject|2|||
105898473|NCT02073565|365283486|FG000|Cohort C|Lost to Follow-up|0|||
105898474|NCT02073565|365283487|FG001|Cohort C|Lost to Follow-up|2|||
105898475|NCT00394433|365283488|FG000|Overall Study|Adverse Event|2|||
105898476|NCT00394433|365283488|FG000|Overall Study|Alternative Therapy|1|||
105898477|NCT01764997|365283489|FG000|Run-in Period|Adverse Event|15|||
105898478|NCT01764997|365283490|FG001|Run-in Period|Adverse Event|0|||
105898479|NCT01764997|365283491|FG002|Run-in Period|Adverse Event|0|||
105898480|NCT01764997|365283492|FG003|Run-in Period|Adverse Event|0|||
105898481|NCT01764997|365283493|FG004|Run-in Period|Adverse Event|0|||
105898482|NCT01764997|365283489|FG000|Run-in Period|Lack of Efficacy|5|||
105898483|NCT01764997|365283490|FG001|Run-in Period|Lack of Efficacy|0|||
105898484|NCT01764997|365283491|FG002|Run-in Period|Lack of Efficacy|0|||
105898485|NCT01764997|365283492|FG003|Run-in Period|Lack of Efficacy|0|||
105898486|NCT01764997|365283493|FG004|Run-in Period|Lack of Efficacy|0|||
105898487|NCT01764997|365283489|FG000|Run-in Period|Poor compliance to protocol|1|||
105898488|NCT01764997|365283490|FG001|Run-in Period|Poor compliance to protocol|0|||
105898489|NCT01764997|365283491|FG002|Run-in Period|Poor compliance to protocol|0|||
105898490|NCT01764997|365283492|FG003|Run-in Period|Poor compliance to protocol|0|||
105898491|NCT01764997|365283493|FG004|Run-in Period|Poor compliance to protocol|0|||
105898492|NCT01764997|365283489|FG000|Run-in Period|Other than specified above|17|||
105898493|NCT01764997|365283490|FG001|Run-in Period|Other than specified above|0|||
105898494|NCT01764997|365283491|FG002|Run-in Period|Other than specified above|0|||
105898495|NCT01764997|365283492|FG003|Run-in Period|Other than specified above|0|||
105898496|NCT01764997|365283493|FG004|Run-in Period|Other than specified above|0|||
105898497|NCT01764997|365283489|FG000|Study Drug Treatment Period|Adverse Event|0|||
105898498|NCT01764997|365283490|FG001|Study Drug Treatment Period|Adverse Event|1|||
105898499|NCT01764997|365283491|FG002|Study Drug Treatment Period|Adverse Event|0|||
105898500|NCT01764997|365283492|FG003|Study Drug Treatment Period|Adverse Event|0|||
105898501|NCT01764997|365283493|FG004|Study Drug Treatment Period|Adverse Event|24|||
105898502|NCT01764997|365283489|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
105898503|NCT01764997|365283490|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
105898504|NCT01764997|365283491|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
105898505|NCT01764997|365283492|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
105898506|NCT01764997|365283493|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
105898507|NCT01764997|365283489|FG000|Study Drug Treatment Period|Other than specified above|0|||
105898508|NCT01764997|365283490|FG001|Study Drug Treatment Period|Other than specified above|0|||
105898509|NCT01764997|365283491|FG002|Study Drug Treatment Period|Other than specified above|0|||
105898510|NCT01764997|365283492|FG003|Study Drug Treatment Period|Other than specified above|0|||
105898511|NCT01764997|365283493|FG004|Study Drug Treatment Period|Other than specified above|10|||
105898512|NCT01554176|365283494|FG000|Treatment Phase|Protocol Violation|1|||
105898513|NCT01554176|365283495|FG001|Treatment Phase|Protocol Violation|2|||
105898514|NCT01554176|365283496|FG002|Treatment Phase|Protocol Violation|0|||
105898515|NCT01554176|365283497|FG003|Treatment Phase|Protocol Violation|0|||
105898516|NCT01554176|365283498|FG004|Treatment Phase|Protocol Violation|0|||
105898517|NCT01554176|365283494|FG000|Treatment Phase|Physician Decision|1|||
105898518|NCT01554176|365283495|FG001|Treatment Phase|Physician Decision|1|||
106124197|NCT04781647|366113996|FG000|Overall Study|Virology rebounded|1|||
106124198|NCT04781647|366113997|FG001|Overall Study|Virology rebounded|0|||
105898519|NCT01554176|365283496|FG002|Treatment Phase|Physician Decision|0|||
105898520|NCT01554176|365283497|FG003|Treatment Phase|Physician Decision|0|||
105898521|NCT01554176|365283498|FG004|Treatment Phase|Physician Decision|0|||
105898522|NCT01554176|365283494|FG000|Treatment Phase|Lack of Efficacy|0|||
105898523|NCT01554176|365283495|FG001|Treatment Phase|Lack of Efficacy|1|||
105898524|NCT01554176|365283496|FG002|Treatment Phase|Lack of Efficacy|0|||
105898525|NCT01554176|365283497|FG003|Treatment Phase|Lack of Efficacy|0|||
105898526|NCT01554176|365283498|FG004|Treatment Phase|Lack of Efficacy|0|||
105898527|NCT01554176|365283494|FG000|Treatment Phase|Adverse event, non-fatal|1|||
105898528|NCT01554176|365283495|FG001|Treatment Phase|Adverse event, non-fatal|1|||
105898529|NCT01554176|365283496|FG002|Treatment Phase|Adverse event, non-fatal|0|||
105898530|NCT01554176|365283497|FG003|Treatment Phase|Adverse event, non-fatal|0|||
105898531|NCT01554176|365283498|FG004|Treatment Phase|Adverse event, non-fatal|0|||
105898532|NCT01554176|365283494|FG000|Treatment Phase|Non-compliance with study drug|1|||
105898533|NCT01554176|365283495|FG001|Treatment Phase|Non-compliance with study drug|0|||
105898534|NCT01554176|365283496|FG002|Treatment Phase|Non-compliance with study drug|0|||
105898535|NCT01554176|365283497|FG003|Treatment Phase|Non-compliance with study drug|0|||
105898536|NCT01554176|365283498|FG004|Treatment Phase|Non-compliance with study drug|0|||
105898537|NCT01554176|365283494|FG000|Treatment Phase|Withdrawal by Subject|1|||
105898538|NCT01554176|365283495|FG001|Treatment Phase|Withdrawal by Subject|0|||
105898539|NCT01554176|365283496|FG002|Treatment Phase|Withdrawal by Subject|0|||
105898540|NCT01554176|365283497|FG003|Treatment Phase|Withdrawal by Subject|0|||
105898541|NCT01554176|365283498|FG004|Treatment Phase|Withdrawal by Subject|0|||
105898542|NCT01554176|365283494|FG000|Treatment Phase|Lost to Follow-up|3|||
105898543|NCT01554176|365283495|FG001|Treatment Phase|Lost to Follow-up|0|||
105898544|NCT01554176|365283496|FG002|Treatment Phase|Lost to Follow-up|0|||
105898545|NCT01554176|365283497|FG003|Treatment Phase|Lost to Follow-up|0|||
105898546|NCT01554176|365283498|FG004|Treatment Phase|Lost to Follow-up|0|||
105898547|NCT01554176|365283494|FG000|Run-out Phase|Protocol Violation|0|||
105898548|NCT01554176|365283495|FG001|Run-out Phase|Protocol Violation|0|||
105898549|NCT01554176|365283496|FG002|Run-out Phase|Protocol Violation|0|||
105898550|NCT01554176|365283497|FG003|Run-out Phase|Protocol Violation|1|||
105898551|NCT01554176|365283498|FG004|Run-out Phase|Protocol Violation|0|||
105898552|NCT03168919|365283499|FG000|Overall Study|Withdrawal by Subject|2|||
105898553|NCT04015518|365283500|FG000|Overall Study|Adverse Event|6|||
105898554|NCT04015518|365283501|FG001|Overall Study|Adverse Event|1|||
105898555|NCT04015518|365283502|FG002|Overall Study|Adverse Event|1|||
105898556|NCT04015518|365283503|FG003|Overall Study|Adverse Event|3|||
105898557|NCT04015518|365283504|FG004|Overall Study|Adverse Event|3|||
105898558|NCT04015518|365283500|FG000|Overall Study|Lack of Efficacy|1|||
105898559|NCT04015518|365283501|FG001|Overall Study|Lack of Efficacy|0|||
105898560|NCT04015518|365283502|FG002|Overall Study|Lack of Efficacy|1|||
105898561|NCT04015518|365283503|FG003|Overall Study|Lack of Efficacy|0|||
105898562|NCT04015518|365283504|FG004|Overall Study|Lack of Efficacy|4|||
105898563|NCT04015518|365283500|FG000|Overall Study|Lost to Follow-up|0|||
105898564|NCT04015518|365283501|FG001|Overall Study|Lost to Follow-up|0|||
105898565|NCT04015518|365283502|FG002|Overall Study|Lost to Follow-up|0|||
105898566|NCT04015518|365283503|FG003|Overall Study|Lost to Follow-up|0|||
105898567|NCT04015518|365283504|FG004|Overall Study|Lost to Follow-up|1|||
105898568|NCT04015518|365283500|FG000|Overall Study|Withdrawal by Subject|0|||
105898569|NCT04015518|365283501|FG001|Overall Study|Withdrawal by Subject|1|||
105898570|NCT04015518|365283502|FG002|Overall Study|Withdrawal by Subject|0|||
105898571|NCT04015518|365283503|FG003|Overall Study|Withdrawal by Subject|1|||
105898572|NCT04015518|365283504|FG004|Overall Study|Withdrawal by Subject|1|||
105898573|NCT04015518|365283500|FG000|Overall Study|Patient did not come for consecutive visits|0|||
106124199|NCT04781647|366113998|FG002|Overall Study|Virology rebounded|0|||
106124200|NCT02531295|366113999|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
106124201|NCT02531295|366114000|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
106124202|NCT02531295|366114001|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
106124203|NCT02531295|366114002|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
105898574|NCT04015518|365283501|FG001|Overall Study|Patient did not come for consecutive visits|1|||
105898575|NCT04015518|365283502|FG002|Overall Study|Patient did not come for consecutive visits|0|||
105898576|NCT04015518|365283503|FG003|Overall Study|Patient did not come for consecutive visits|0|||
105898577|NCT04015518|365283504|FG004|Overall Study|Patient did not come for consecutive visits|0|||
105898578|NCT04015518|365283500|FG000|Overall Study|not willing to travel due to Covid-19|0|||
105898579|NCT04015518|365283501|FG001|Overall Study|not willing to travel due to Covid-19|0|||
105898580|NCT04015518|365283502|FG002|Overall Study|not willing to travel due to Covid-19|1|||
105898581|NCT04015518|365283503|FG003|Overall Study|not willing to travel due to Covid-19|0|||
105898582|NCT04015518|365283504|FG004|Overall Study|not willing to travel due to Covid-19|0|||
105898583|NCT04015518|365283500|FG000|Overall Study|Patient wants to discontinue treatment|0|||
105898584|NCT04015518|365283501|FG001|Overall Study|Patient wants to discontinue treatment|0|||
105898585|NCT04015518|365283502|FG002|Overall Study|Patient wants to discontinue treatment|0|||
105898586|NCT04015518|365283503|FG003|Overall Study|Patient wants to discontinue treatment|1|||
105898587|NCT04015518|365283504|FG004|Overall Study|Patient wants to discontinue treatment|0|||
105898588|NCT04015518|365283500|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
105898589|NCT04015518|365283501|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
105898590|NCT04015518|365283502|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
105898591|NCT04015518|365283503|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
105898592|NCT04015518|365283504|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
105898593|NCT04015518|365283500|FG000|Overall Study|Pregnancy|0|||
105898594|NCT04015518|365283501|FG001|Overall Study|Pregnancy|0|||
105898595|NCT04015518|365283502|FG002|Overall Study|Pregnancy|0|||
105898596|NCT04015518|365283503|FG003|Overall Study|Pregnancy|0|||
105898597|NCT04015518|365283504|FG004|Overall Study|Pregnancy|1|||
105898598|NCT04015518|365283500|FG000|Overall Study|Personal reasons|1|||
105898599|NCT04015518|365283501|FG001|Overall Study|Personal reasons|0|||
105898600|NCT04015518|365283502|FG002|Overall Study|Personal reasons|0|||
105898601|NCT04015518|365283503|FG003|Overall Study|Personal reasons|0|||
106124204|NCT02531295|366114003|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
106124205|NCT02531295|366114004|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
106124206|NCT04213989|366114005|FG000|Overall Study|Withdrawal by Subject|3|||
106124207|NCT04213989|366114006|FG001|Overall Study|Withdrawal by Subject|2|||
106124208|NCT04213989|366114005|FG000|Overall Study|Physician Decision|1|||
106124209|NCT04213989|366114006|FG001|Overall Study|Physician Decision|0|||
106124210|NCT04213989|366114005|FG000|Overall Study|Lost to Follow-up|0|||
106124211|NCT04213989|366114006|FG001|Overall Study|Lost to Follow-up|4|||
106124212|NCT04249336|366114009|FG000|Overall Study|Lost to Follow-up|3|||
106124213|NCT04249336|366114010|FG001|Overall Study|Lost to Follow-up|3|||
106124214|NCT04249336|366114011|FG002|Overall Study|Lost to Follow-up|3|||
106124215|NCT04249336|366114012|FG003|Overall Study|Lost to Follow-up|3|||
106124216|NCT01242176|366114013|FG000|Washout Period of 7 Days|Adverse Event|0|||
106124217|NCT01242176|366114014|FG001|Washout Period of 7 Days|Adverse Event|2|||
106124218|NCT01242176|366114013|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
105898602|NCT04015518|365283504|FG004|Overall Study|Personal reasons|1|||
105898603|NCT04015518|365283500|FG000|Overall Study|Withdrew consent|1|||
105898604|NCT04015518|365283501|FG001|Overall Study|Withdrew consent|0|||
105898605|NCT04015518|365283502|FG002|Overall Study|Withdrew consent|0|||
105898606|NCT04015518|365283503|FG003|Overall Study|Withdrew consent|0|||
105898607|NCT04015518|365283504|FG004|Overall Study|Withdrew consent|0|||
105898608|NCT04015518|365283500|FG000|Overall Study|Prostate carcinoma|1|||
105898609|NCT04015518|365283501|FG001|Overall Study|Prostate carcinoma|0|||
105898610|NCT04015518|365283502|FG002|Overall Study|Prostate carcinoma|0|||
105898611|NCT04015518|365283503|FG003|Overall Study|Prostate carcinoma|0|||
105898612|NCT04015518|365283504|FG004|Overall Study|Prostate carcinoma|0|||
105898613|NCT04015518|365283500|FG000|Overall Study|Could not keep appointments due to work|1|||
105898614|NCT04015518|365283501|FG001|Overall Study|Could not keep appointments due to work|0|||
105898615|NCT04015518|365283502|FG002|Overall Study|Could not keep appointments due to work|0|||
105898616|NCT04015518|365283503|FG003|Overall Study|Could not keep appointments due to work|0|||
105898617|NCT04015518|365283504|FG004|Overall Study|Could not keep appointments due to work|0|||
106124219|NCT01242176|366114014|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
106124220|NCT02105636|366114016|FG000|Pre-Treatment|Disease Progression|1|||
106124221|NCT02105636|366114017|FG001|Pre-Treatment|Disease Progression|0|||
106124222|NCT02105636|366114016|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
106124223|NCT02105636|366114017|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
106124224|NCT02105636|366114016|FG000|Pre-Treatment|Participant withdrew consent|0|||
106124225|NCT02105636|366114017|FG001|Pre-Treatment|Participant withdrew consent|6|||
106124226|NCT02105636|366114016|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
105898618|NCT02195427|365283505|FG000|Overall Study|Did not consent to study extension|13|||
105898619|NCT02195427|365283506|FG001|Overall Study|Did not consent to study extension|9|||
105898620|NCT02195427|365283505|FG000|Overall Study|Withdrawal by Subject|4|||
105898621|NCT02195427|365283506|FG001|Overall Study|Withdrawal by Subject|2|||
105898622|NCT02195427|365283505|FG000|Overall Study|Lost to Follow-up|0|||
105898623|NCT02195427|365283506|FG001|Overall Study|Lost to Follow-up|1|||
105898624|NCT02195427|365283505|FG000|Overall Study|Protocol Violation|7|||
105898625|NCT02195427|365283506|FG001|Overall Study|Protocol Violation|14|||
105898626|NCT02195427|365283505|FG000|Overall Study|Conditional re-treatment at W52|2|||
106124227|NCT02105636|366114017|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
106124228|NCT02105636|366114016|FG000|Treatment|Study Drug Toxicity|14|||
106124229|NCT02105636|366114017|FG001|Treatment|Study Drug Toxicity|10|||
106124230|NCT02105636|366114016|FG000|Treatment|Adverse event unrelated to study drug|19|||
106124231|NCT02105636|366114017|FG001|Treatment|Adverse event unrelated to study drug|3|||
106124232|NCT02105636|366114016|FG000|Treatment|Participant request to discontinue study treatment|8|||
106124233|NCT02105636|366114017|FG001|Treatment|Participant request to discontinue study treatment|6|||
106124234|NCT02105636|366114016|FG000|Treatment|Participant withdrew consent|5|||
106124235|NCT02105636|366114017|FG001|Treatment|Participant withdrew consent|1|||
106124236|NCT02105636|366114016|FG000|Treatment|Lost to Follow-up|1|||
106124237|NCT02105636|366114017|FG001|Treatment|Lost to Follow-up|0|||
106124238|NCT02105636|366114016|FG000|Treatment|Maximum Clinical Benefit|1|||
106124239|NCT02105636|366114017|FG001|Treatment|Maximum Clinical Benefit|3|||
106124240|NCT02105636|366114016|FG000|Treatment|Poor/Non-compliance|0|||
106124241|NCT02105636|366114017|FG001|Treatment|Poor/Non-compliance|1|||
106124242|NCT02105636|366114016|FG000|Treatment|Participant no longer meets study criteria|1|||
106124243|NCT02105636|366114017|FG001|Treatment|Participant no longer meets study criteria|0|||
106124244|NCT02105636|366114016|FG000|Treatment|Other reasons|1|||
106124245|NCT02105636|366114017|FG001|Treatment|Other reasons|0|||
106124246|NCT02105636|366114016|FG000|Treatment|Disease Progression|185|||
106124247|NCT02105636|366114017|FG001|Treatment|Disease Progression|87|||
106124248|NCT03390036|366114018|FG000|Overall Study|Lost to Follow-up|1|||
106124249|NCT03390036|366114019|FG001|Overall Study|Lost to Follow-up|0|||
106124250|NCT03390036|366114020|FG002|Overall Study|Lost to Follow-up|0|||
106124251|NCT03390036|366114018|FG000|Overall Study|Lack of Efficacy|1|||
106124252|NCT03390036|366114019|FG001|Overall Study|Lack of Efficacy|0|||
106124253|NCT03390036|366114020|FG002|Overall Study|Lack of Efficacy|0|||
106124254|NCT00358215|366114023|FG000|Overall Study|Ineligibility determined|4|||
106124255|NCT00358215|366114024|FG001|Overall Study|Ineligibility determined|3|||
106124256|NCT00358215|366114023|FG000|Overall Study|Adverse Event|83|||
105898627|NCT02195427|365283506|FG001|Overall Study|Conditional re-treatment at W52|1|||
105898628|NCT03759366|365283507|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
105898629|NCT03759366|365283507|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
105898630|NCT03759366|365283507|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
105898631|NCT03759366|365283507|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
106124257|NCT00358215|366114024|FG001|Overall Study|Adverse Event|65|||
106124258|NCT00358215|366114023|FG000|Overall Study|Withdrawal by Subject|111|||
106124259|NCT00358215|366114024|FG001|Overall Study|Withdrawal by Subject|102|||
105898632|NCT03759366|365283507|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
105898633|NCT03759366|365283507|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
105898634|NCT03759366|365283507|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
105898635|NCT00597012|365283508|FG000|Overall Study|Death|1|||
105898636|NCT00597012|365283509|FG001|Overall Study|Death|1|||
105898637|NCT00597012|365283508|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
105898638|NCT00597012|365283509|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
105898639|NCT00597012|365283508|FG000|Overall Study|Withdrawal by Subject|7|||
105898640|NCT00597012|365283509|FG001|Overall Study|Withdrawal by Subject|4|||
105898641|NCT00597012|365283508|FG000|Overall Study|Ineligible|2|||
105898642|NCT00597012|365283509|FG001|Overall Study|Ineligible|0|||
105898643|NCT00597012|365283508|FG000|Overall Study|Lost to Follow-up|0|||
105898644|NCT00597012|365283509|FG001|Overall Study|Lost to Follow-up|2|||
105898645|NCT03755518|365283510|FG000|Overall Study|Lack of Efficacy|10|||
105898646|NCT03755518|365283510|FG000|Overall Study|Adverse Event|7|||
105898647|NCT03755518|365283510|FG000|Overall Study|Study Terminated by Sponsor|5|||
105898648|NCT03755518|365283510|FG000|Overall Study|Death|1|||
105898649|NCT03755518|365283510|FG000|Overall Study|Withdrawal by Subject|3|||
105898650|NCT03755518|365283510|FG000|Overall Study|Progressive Disease|4|||
105898651|NCT03755518|365283510|FG000|Overall Study|Bone Marrow Transplant|4|||
105898652|NCT03755518|365283510|FG000|Overall Study|Physicians Decision|1|||
105898653|NCT03755518|365283510|FG000|Overall Study|Relapse|1|||
105898654|NCT03755518|365283510|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
105898655|NCT03755518|365283510|FG000|Overall Study|Withdrawal by PI|1|||
105898656|NCT04459598|365283511|FG000|Overall Study|Adverse Event|1|||
105898657|NCT04459598|365283512|FG001|Overall Study|Adverse Event|1|||
105898658|NCT01078298|365283514|FG000|Overall Study|Lost to Follow-up|12|||
105898659|NCT01078298|365283515|FG001|Overall Study|Lost to Follow-up|13|||
105898660|NCT01078298|365283514|FG000|Overall Study|Withdrawal by Subject|31|||
105898661|NCT01078298|365283515|FG001|Overall Study|Withdrawal by Subject|33|||
105898662|NCT01078298|365283514|FG000|Overall Study|Protocol Violation|6|||
105898663|NCT01078298|365283515|FG001|Overall Study|Protocol Violation|6|||
106124260|NCT00358215|366114023|FG000|Overall Study|Participant request|65|||
106124261|NCT00358215|366114024|FG001|Overall Study|Participant request|64|||
106124262|NCT00358215|366114023|FG000|Overall Study|Physician Decision|47|||
106124263|NCT00358215|366114024|FG001|Overall Study|Physician Decision|39|||
106124264|NCT00358215|366114023|FG000|Overall Study|Lost to Follow-up|16|||
106124265|NCT00358215|366114024|FG001|Overall Study|Lost to Follow-up|22|||
106124266|NCT00358215|366114023|FG000|Overall Study|Death|265|||
105898664|NCT01078298|365283514|FG000|Overall Study|Adverse Event|6|||
105898665|NCT01078298|365283515|FG001|Overall Study|Adverse Event|5|||
105898666|NCT01078298|365283514|FG000|Overall Study|Death|2|||
105898667|NCT01078298|365283515|FG001|Overall Study|Death|0|||
105898668|NCT01078298|365283514|FG000|Overall Study|Did not meet entrance criteria|0|||
106124267|NCT00358215|366114024|FG001|Overall Study|Death|281|||
106124268|NCT00358215|366114023|FG000|Overall Study|Protocol Violation|64|||
106124269|NCT00358215|366114024|FG001|Overall Study|Protocol Violation|59|||
106124270|NCT00358215|366114023|FG000|Overall Study|Pregnancy|1|||
106124271|NCT00358215|366114024|FG001|Overall Study|Pregnancy|0|||
106124272|NCT00358215|366114023|FG000|Overall Study|Other|21|||
106124273|NCT00358215|366114024|FG001|Overall Study|Other|14|||
106124274|NCT00358215|366114023|FG000|Overall Study|Did not receive investigational product|2|||
106124275|NCT00358215|366114024|FG001|Overall Study|Did not receive investigational product|3|||
106124276|NCT00744237|366114025|FG000|Overall Study|Lack of Efficacy|1|||
105898669|NCT01078298|365283515|FG001|Overall Study|Did not meet entrance criteria|1|||
105898670|NCT01078298|365283514|FG000|Overall Study|Other|24|||
105898671|NCT01078298|365283515|FG001|Overall Study|Other|32|||
105898672|NCT01653327|365283521|FG000|Overall Study|Withdrawal by Subject|1|||
105898673|NCT01764659|365283522|FG000|Overall Study|Death|1|||
105898674|NCT01764659|365283522|FG000|Overall Study|Physician Decision|1|||
105898675|NCT01210352|365283523|FG000|Overall Study|Adverse Event|0|||
105898676|NCT01210352|365283524|FG001|Overall Study|Adverse Event|0|||
105898677|NCT01210352|365283525|FG002|Overall Study|Adverse Event|0|||
105898678|NCT01210352|365283526|FG003|Overall Study|Adverse Event|0|||
105898679|NCT01210352|365283527|FG004|Overall Study|Adverse Event|0|||
105898680|NCT01210352|365283528|FG005|Overall Study|Adverse Event|0|||
105898681|NCT01210352|365283529|FG006|Overall Study|Adverse Event|0|||
105898682|NCT01210352|365283530|FG007|Overall Study|Adverse Event|2|||
105898683|NCT01210352|365283531|FG008|Overall Study|Adverse Event|1|||
105898684|NCT01210352|365283523|FG000|Overall Study|Lack of Efficacy|0|||
105898685|NCT01210352|365283524|FG001|Overall Study|Lack of Efficacy|0|||
105898686|NCT01210352|365283525|FG002|Overall Study|Lack of Efficacy|0|||
105898687|NCT01210352|365283526|FG003|Overall Study|Lack of Efficacy|0|||
105898688|NCT01210352|365283527|FG004|Overall Study|Lack of Efficacy|0|||
105898689|NCT01210352|365283528|FG005|Overall Study|Lack of Efficacy|0|||
105898690|NCT01210352|365283529|FG006|Overall Study|Lack of Efficacy|1|||
105898691|NCT01210352|365283530|FG007|Overall Study|Lack of Efficacy|0|||
105898692|NCT01210352|365283531|FG008|Overall Study|Lack of Efficacy|0|||
105997779|NCT01012258|365653244|FG000|Overall Study|Progressive Disease (PD)|18|||
105997780|NCT01012258|365653244|FG000|Overall Study|Symptomatic Deterioration|1|||
105997781|NCT01012258|365653244|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
105997782|NCT01012258|365653244|FG000|Overall Study|Another Tumor Discovered|1|||
105997783|NCT01012258|365653244|FG000|Overall Study|Ongoing|29|||
105997784|NCT01292187|365653245|FG000|Overall Study|Adverse Event|10|||
105997785|NCT01292187|365653246|FG001|Overall Study|Adverse Event|5|||
105997786|NCT01292187|365653245|FG000|Overall Study|Withdrawal by Subject|6|||
105997787|NCT01292187|365653246|FG001|Overall Study|Withdrawal by Subject|5|||
105997788|NCT01292187|365653245|FG000|Overall Study|All other reasons|1|||
105997789|NCT01292187|365653246|FG001|Overall Study|All other reasons|3|||
105997790|NCT01702558|365653247|FG000|Overall Study|Withdrawal by Subject|0|||
105997791|NCT01702558|365653248|FG001|Overall Study|Withdrawal by Subject|0|||
105997792|NCT01702558|365653249|FG002|Overall Study|Withdrawal by Subject|0|||
105997793|NCT01702558|365653250|FG003|Overall Study|Withdrawal by Subject|12|||
105997794|NCT01702558|365653251|FG004|Overall Study|Withdrawal by Subject|4|||
105997795|NCT01702558|365653247|FG000|Overall Study|Lost to Follow-up|0|||
105997796|NCT01702558|365653248|FG001|Overall Study|Lost to Follow-up|0|||
105997797|NCT01702558|365653249|FG002|Overall Study|Lost to Follow-up|0|||
105997798|NCT01702558|365653250|FG003|Overall Study|Lost to Follow-up|3|||
105997799|NCT01702558|365653251|FG004|Overall Study|Lost to Follow-up|0|||
105997800|NCT01702558|365653247|FG000|Overall Study|Death|4|||
105997801|NCT01702558|365653248|FG001|Overall Study|Death|3|||
105997802|NCT01702558|365653249|FG002|Overall Study|Death|3|||
105997803|NCT01702558|365653250|FG003|Overall Study|Death|16|||
105997804|NCT01702558|365653251|FG004|Overall Study|Death|20|||
105997805|NCT01702558|365653247|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
105997806|NCT01702558|365653248|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
105997807|NCT01702558|365653249|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
105997808|NCT01702558|365653250|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
105997809|NCT01702558|365653251|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
105997810|NCT01702558|365653247|FG000|Overall Study|Study Terminated by Sponsor|0|||
105997811|NCT01702558|365653248|FG001|Overall Study|Study Terminated by Sponsor|1|||
105997812|NCT01702558|365653249|FG002|Overall Study|Study Terminated by Sponsor|0|||
105997813|NCT01702558|365653250|FG003|Overall Study|Study Terminated by Sponsor|0|||
105997814|NCT01702558|365653251|FG004|Overall Study|Study Terminated by Sponsor|1|||
106124277|NCT00744237|366114026|FG001|Overall Study|Lack of Efficacy|1|||
105898693|NCT01210352|365283523|FG000|Overall Study|Physician Decision|0|||
105997815|NCT01702558|365653247|FG000|Overall Study|Other|0|||
105997816|NCT01702558|365653248|FG001|Overall Study|Other|0|||
105997817|NCT01702558|365653249|FG002|Overall Study|Other|0|||
105898694|NCT01210352|365283524|FG001|Overall Study|Physician Decision|0|||
105898695|NCT01210352|365283525|FG002|Overall Study|Physician Decision|0|||
105898696|NCT01210352|365283526|FG003|Overall Study|Physician Decision|0|||
105898697|NCT01210352|365283527|FG004|Overall Study|Physician Decision|0|||
105898698|NCT01210352|365283528|FG005|Overall Study|Physician Decision|0|||
106124278|NCT00744237|366114027|FG002|Overall Study|Lack of Efficacy|0|||
105898699|NCT01210352|365283529|FG006|Overall Study|Physician Decision|0|||
105898700|NCT01210352|365283530|FG007|Overall Study|Physician Decision|1|||
106124279|NCT00744237|366114025|FG000|Overall Study|Withdrawal by Subject|9|||
106124280|NCT00744237|366114026|FG001|Overall Study|Withdrawal by Subject|5|||
106124281|NCT00744237|366114027|FG002|Overall Study|Withdrawal by Subject|3|||
106124282|NCT00744237|366114025|FG000|Overall Study|Lost to Follow-up|1|||
105898701|NCT01210352|365283531|FG008|Overall Study|Physician Decision|2|||
105898702|NCT01210352|365283523|FG000|Overall Study|Withdrawal by Subject|0|||
105898703|NCT01210352|365283524|FG001|Overall Study|Withdrawal by Subject|0|||
106124283|NCT00744237|366114026|FG001|Overall Study|Lost to Follow-up|1|||
106124284|NCT00744237|366114027|FG002|Overall Study|Lost to Follow-up|1|||
106124285|NCT00744237|366114025|FG000|Overall Study|Protocol Violation|3|||
106124286|NCT00744237|366114026|FG001|Overall Study|Protocol Violation|4|||
106124287|NCT00744237|366114027|FG002|Overall Study|Protocol Violation|3|||
106124288|NCT00744237|366114025|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
106124289|NCT00744237|366114026|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
106124290|NCT00744237|366114027|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
105667985|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105667986|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105667987|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105667988|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
105667989|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105898704|NCT01210352|365283525|FG002|Overall Study|Withdrawal by Subject|1|||
105898705|NCT01210352|365283526|FG003|Overall Study|Withdrawal by Subject|0|||
105898706|NCT01210352|365283527|FG004|Overall Study|Withdrawal by Subject|0|||
105898707|NCT01210352|365283528|FG005|Overall Study|Withdrawal by Subject|0|||
105898708|NCT01210352|365283529|FG006|Overall Study|Withdrawal by Subject|1|||
105898709|NCT01210352|365283530|FG007|Overall Study|Withdrawal by Subject|0|||
105898710|NCT01210352|365283531|FG008|Overall Study|Withdrawal by Subject|1|||
105898711|NCT01210352|365283523|FG000|Overall Study|Patient Discharged Early|0|||
105898712|NCT01210352|365283524|FG001|Overall Study|Patient Discharged Early|0|||
105898713|NCT01210352|365283525|FG002|Overall Study|Patient Discharged Early|1|||
105898714|NCT01210352|365283526|FG003|Overall Study|Patient Discharged Early|0|||
105898715|NCT01210352|365283527|FG004|Overall Study|Patient Discharged Early|0|||
105898716|NCT01210352|365283528|FG005|Overall Study|Patient Discharged Early|0|||
105898717|NCT01210352|365283529|FG006|Overall Study|Patient Discharged Early|0|||
105898718|NCT01210352|365283530|FG007|Overall Study|Patient Discharged Early|0|||
105898719|NCT01210352|365283531|FG008|Overall Study|Patient Discharged Early|0|||
105898720|NCT01738191|365283532|FG000|Overall Study|Withdrawal by Subject|4|||
105898721|NCT01738191|365283533|FG001|Overall Study|Withdrawal by Subject|1|||
105898722|NCT00422292|365283534|FG000|Overall Study|Serious adverse events|1|||
105898723|NCT00422292|365283535|FG001|Overall Study|Serious adverse events|4|||
105898724|NCT00422292|365283536|FG002|Overall Study|Serious adverse events|0|||
105898725|NCT00422292|365283537|FG003|Overall Study|Serious adverse events|0|||
105898726|NCT00422292|365283534|FG000|Overall Study|Adverse Event|1|||
105898727|NCT00422292|365283535|FG001|Overall Study|Adverse Event|0|||
105898728|NCT00422292|365283536|FG002|Overall Study|Adverse Event|1|||
105898729|NCT00422292|365283537|FG003|Overall Study|Adverse Event|0|||
105898730|NCT00422292|365283534|FG000|Overall Study|Protocol Violation|4|||
105898731|NCT00422292|365283535|FG001|Overall Study|Protocol Violation|25|||
105898732|NCT00422292|365283536|FG002|Overall Study|Protocol Violation|8|||
105898733|NCT00422292|365283537|FG003|Overall Study|Protocol Violation|5|||
105898734|NCT00422292|365283534|FG000|Overall Study|Lost to Follow-up|6|||
105898735|NCT00422292|365283535|FG001|Overall Study|Lost to Follow-up|12|||
105898736|NCT00422292|365283536|FG002|Overall Study|Lost to Follow-up|6|||
105898737|NCT00422292|365283537|FG003|Overall Study|Lost to Follow-up|6|||
105898738|NCT00422292|365283534|FG000|Overall Study|Withdrawal by Subject|6|||
105898739|NCT00422292|365283535|FG001|Overall Study|Withdrawal by Subject|25|||
105898740|NCT00422292|365283536|FG002|Overall Study|Withdrawal by Subject|7|||
105898741|NCT00422292|365283537|FG003|Overall Study|Withdrawal by Subject|13|||
105898742|NCT04852276|365283538|FG000|Overall Study|Death|2|||
105898743|NCT04852276|365283539|FG001|Overall Study|Death|0|||
105898744|NCT04852276|365283538|FG000|Overall Study|Lost to Follow-up|15|||
105898745|NCT04852276|365283539|FG001|Overall Study|Lost to Follow-up|9|||
105898746|NCT04852276|365283538|FG000|Overall Study|Withdrawal by Subject|26|||
105898747|NCT04852276|365283539|FG001|Overall Study|Withdrawal by Subject|6|||
105898748|NCT00224406|365285721|FG000|Overall Study|Re-transplant|0|||
105898749|NCT00224406|365285722|FG001|Overall Study|Re-transplant|2|||
105898750|NCT00224406|365285721|FG000|Overall Study|Death|0|||
105898751|NCT00224406|365285722|FG001|Overall Study|Death|1|||
105898752|NCT00224406|365285721|FG000|Overall Study|Transplant cancelled|0|||
105898753|NCT00224406|365285722|FG001|Overall Study|Transplant cancelled|4|||
105898754|NCT00224406|365285721|FG000|Overall Study|Drug not delivered|2|||
105898755|NCT00224406|365285722|FG001|Overall Study|Drug not delivered|0|||
106124291|NCT00744237|366114025|FG000|Overall Study|Dosing Error|1|||
106124292|NCT00744237|366114026|FG001|Overall Study|Dosing Error|0|||
105667990|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
105667991|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
105667992|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
105667993|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667994|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
105667995|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667996|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667997|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667998|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105667999|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105668000|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105668001|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
105668002|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
105668003|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
105668004|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
105668005|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
105668006|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
105668007|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
105668008|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
105668009|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
105668010|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
105668011|NCT00477490|364448234|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668012|NCT00477490|364448235|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
105668013|NCT00477490|364448236|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
105668014|NCT00477490|364448237|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668015|NCT00477490|364448238|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
105668016|NCT00477490|364448239|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668017|NCT00477490|364448240|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668018|NCT00477490|364448241|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668019|NCT00477490|364448242|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
105668020|NCT03274895|364448243|FG000|Overall Study|Lack of Efficacy|1|||
105668021|NCT03274895|364448244|FG001|Overall Study|Lack of Efficacy|0|||
105668022|NCT03274895|364448243|FG000|Overall Study|Adverse Event|8|||
105668023|NCT03274895|364448244|FG001|Overall Study|Adverse Event|7|||
105668024|NCT03274895|364448243|FG000|Overall Study|Lost to Follow-up|1|||
105668025|NCT03274895|364448244|FG001|Overall Study|Lost to Follow-up|0|||
105668026|NCT03274895|364448243|FG000|Overall Study|Diagnosis not confirmed|3|||
105668027|NCT03274895|364448244|FG001|Overall Study|Diagnosis not confirmed|4|||
105668028|NCT00401258|364448248|FG000|Overall Study|Adverse Event|7|||
105668029|NCT01110408|364448249|FG000|Overall Study|Protocol Violation|1|||
105668030|NCT01110408|364448250|FG001|Overall Study|Protocol Violation|0|||
105668031|NCT02269423|364448254|FG000|Overall Study|Discontinued due to change in residence|0|||
105668032|NCT02269423|364448255|FG001|Overall Study|Discontinued due to change in residence|1|||
105668033|NCT02269423|364448256|FG002|Overall Study|Discontinued due to change in residence|0|||
105668034|NCT02269423|364448257|FG003|Overall Study|Discontinued due to change in residence|1|||
105668035|NCT00604708|364448258|FG000|Overall Study|Withdrawal by Subject|9|||
105668036|NCT00604708|364448259|FG001|Overall Study|Withdrawal by Subject|10|||
105668037|NCT00604708|364448258|FG000|Overall Study|Protocol Violation|2|||
105668038|NCT00604708|364448259|FG001|Overall Study|Protocol Violation|8|||
105668039|NCT00604708|364448258|FG000|Overall Study|Lost to Follow-up|5|||
105668040|NCT00604708|364448259|FG001|Overall Study|Lost to Follow-up|5|||
105668041|NCT00604708|364448258|FG000|Overall Study|administrative reasons|9|||
105668042|NCT00604708|364448259|FG001|Overall Study|administrative reasons|11|||
105668043|NCT00604708|364448258|FG000|Overall Study|Adverse Event|6|||
105668044|NCT00604708|364448259|FG001|Overall Study|Adverse Event|6|||
105668045|NCT02284009|364448262|FG000|Overall Study|Adverse Event|3|||
105668046|NCT02284009|364448263|FG001|Overall Study|Adverse Event|0|||
105668047|NCT02284009|364448262|FG000|Overall Study|Lost to Follow-up|1|||
105668048|NCT02284009|364448263|FG001|Overall Study|Lost to Follow-up|3|||
105668049|NCT02284009|364448262|FG000|Overall Study|Physician Decision|0|||
105668050|NCT02284009|364448263|FG001|Overall Study|Physician Decision|2|||
105668051|NCT02284009|364448262|FG000|Overall Study|Withdrawal by Subject|2|||
105668052|NCT02284009|364448263|FG001|Overall Study|Withdrawal by Subject|5|||
105668053|NCT04147195|364448264|FG000|Overall Study|Adverse Event|0|||
105668054|NCT04147195|364448265|FG001|Overall Study|Adverse Event|3|||
105668055|NCT04147195|364448264|FG000|Overall Study|Study Terminated by Sponsor|4|||
105668056|NCT04147195|364448265|FG001|Overall Study|Study Terminated by Sponsor|2|||
105668057|NCT04147195|364448264|FG000|Overall Study|Withdrawal by Subject|0|||
105668058|NCT04147195|364448265|FG001|Overall Study|Withdrawal by Subject|1|||
105898756|NCT00224406|365285721|FG000|Overall Study|Other|4|||
105898757|NCT00224406|365285722|FG001|Overall Study|Other|0|||
105898758|NCT00224406|365285721|FG000|Overall Study|Transplant cancelled|3|||
105898759|NCT00224406|365285722|FG001|Overall Study|Transplant cancelled|0|||
105898760|NCT02437188|365285725|FG000|Overall Study|Randomized but did not receive surgery|4|||
105898761|NCT02437188|365285726|FG001|Overall Study|Randomized but did not receive surgery|8|||
105898762|NCT02437188|365285725|FG000|Overall Study|Adverse Event|0|||
105898763|NCT02437188|365285726|FG001|Overall Study|Adverse Event|1|||
105898764|NCT01172808|365285727|FG000|Overall Study|Adverse Event|8|||
105898765|NCT01172808|365285728|FG001|Overall Study|Adverse Event|4|||
105898766|NCT01172808|365285729|FG002|Overall Study|Adverse Event|8|||
105898767|NCT01172808|365285730|FG003|Overall Study|Adverse Event|3|||
105898768|NCT01172808|365285727|FG000|Overall Study|Lack of Efficacy|1|||
105898769|NCT01172808|365285728|FG001|Overall Study|Lack of Efficacy|0|||
105898770|NCT01172808|365285729|FG002|Overall Study|Lack of Efficacy|0|||
105898771|NCT01172808|365285730|FG003|Overall Study|Lack of Efficacy|0|||
105898772|NCT01172808|365285727|FG000|Overall Study|Protocol Violation|2|||
105898773|NCT01172808|365285728|FG001|Overall Study|Protocol Violation|2|||
105898774|NCT01172808|365285729|FG002|Overall Study|Protocol Violation|2|||
105898775|NCT01172808|365285730|FG003|Overall Study|Protocol Violation|0|||
105898776|NCT01172808|365285727|FG000|Overall Study|Lost to Follow-up|0|||
105898777|NCT01172808|365285728|FG001|Overall Study|Lost to Follow-up|1|||
105898778|NCT01172808|365285729|FG002|Overall Study|Lost to Follow-up|1|||
105898779|NCT01172808|365285730|FG003|Overall Study|Lost to Follow-up|3|||
105898780|NCT01172808|365285727|FG000|Overall Study|Withdrawal by Subject|4|||
105898781|NCT01172808|365285728|FG001|Overall Study|Withdrawal by Subject|1|||
105898782|NCT01172808|365285729|FG002|Overall Study|Withdrawal by Subject|3|||
105898783|NCT01172808|365285730|FG003|Overall Study|Withdrawal by Subject|2|||
105898784|NCT01172808|365285727|FG000|Overall Study|Other|6|||
105898785|NCT01172808|365285728|FG001|Overall Study|Other|5|||
105898786|NCT01172808|365285729|FG002|Overall Study|Other|9|||
105898787|NCT01172808|365285730|FG003|Overall Study|Other|7|||
105898788|NCT03774394|365285733|FG000|Overall Study|Withdrawal by Subject|2|||
105898789|NCT03774394|365285734|FG001|Overall Study|Withdrawal by Subject|0|||
105898790|NCT00153816|365285735|FG000|Overall Study|Death|6|||
105898791|NCT00153816|365285736|FG001|Overall Study|Death|5|||
105898792|NCT00153816|365285737|FG002|Overall Study|Death|4|||
105898793|NCT00153816|365285738|FG003|Overall Study|Death|6|||
105898794|NCT00153816|365285739|FG004|Overall Study|Death|0|||
105898795|NCT00153816|365285740|FG005|Overall Study|Death|2|||
105898796|NCT00153816|365285735|FG000|Overall Study|Lost to Follow-up|7|||
105898797|NCT00153816|365285736|FG001|Overall Study|Lost to Follow-up|8|||
105898798|NCT00153816|365285737|FG002|Overall Study|Lost to Follow-up|5|||
105898799|NCT00153816|365285738|FG003|Overall Study|Lost to Follow-up|8|||
105898800|NCT00153816|365285739|FG004|Overall Study|Lost to Follow-up|7|||
105898801|NCT00153816|365285740|FG005|Overall Study|Lost to Follow-up|9|||
105898802|NCT00153816|365285735|FG000|Overall Study|Withdrawal by Subject|9|||
105898803|NCT00153816|365285736|FG001|Overall Study|Withdrawal by Subject|9|||
105898804|NCT00153816|365285737|FG002|Overall Study|Withdrawal by Subject|9|||
105898805|NCT00153816|365285738|FG003|Overall Study|Withdrawal by Subject|4|||
105898806|NCT00153816|365285739|FG004|Overall Study|Withdrawal by Subject|1|||
105898807|NCT00153816|365285740|FG005|Overall Study|Withdrawal by Subject|5|||
105898808|NCT00153816|365285735|FG000|Overall Study|Follow-up exam not done|8|||
105898809|NCT00153816|365285736|FG001|Overall Study|Follow-up exam not done|7|||
105898810|NCT00153816|365285737|FG002|Overall Study|Follow-up exam not done|11|||
105898811|NCT00153816|365285738|FG003|Overall Study|Follow-up exam not done|10|||
105898812|NCT00153816|365285739|FG004|Overall Study|Follow-up exam not done|8|||
105898813|NCT00153816|365285740|FG005|Overall Study|Follow-up exam not done|9|||
105898814|NCT00153816|365285735|FG000|Overall Study|Follow-up exam done, histology missing|2|||
105898815|NCT00153816|365285736|FG001|Overall Study|Follow-up exam done, histology missing|3|||
105898816|NCT00153816|365285737|FG002|Overall Study|Follow-up exam done, histology missing|3|||
105898817|NCT00153816|365285738|FG003|Overall Study|Follow-up exam done, histology missing|3|||
105898818|NCT00153816|365285739|FG004|Overall Study|Follow-up exam done, histology missing|1|||
105898819|NCT00153816|365285740|FG005|Overall Study|Follow-up exam done, histology missing|2|||
105898820|NCT02907619|365285741|FG000|Overall Study|Study terminated by sponsor|18|||
105898821|NCT02907619|365285742|FG001|Overall Study|Study terminated by sponsor|18|||
105898822|NCT02907619|365285743|FG002|Overall Study|Study terminated by sponsor|19|||
105898823|NCT02907619|365285741|FG000|Overall Study|Death|0|||
105898824|NCT02907619|365285742|FG001|Overall Study|Death|0|||
105898825|NCT02907619|365285743|FG002|Overall Study|Death|1|||
105898826|NCT02907619|365285741|FG000|Overall Study|Withdrawal by Subject|1|||
105898827|NCT02907619|365285742|FG001|Overall Study|Withdrawal by Subject|1|||
105898828|NCT02907619|365285743|FG002|Overall Study|Withdrawal by Subject|0|||
105898829|NCT02907619|365285741|FG000|Overall Study|Other|0|||
105898830|NCT02907619|365285742|FG001|Overall Study|Other|1|||
105898831|NCT02907619|365285743|FG002|Overall Study|Other|0|||
105898832|NCT04942210|365285749|FG000|Overall Study|Adverse Event|0|||
105898833|NCT04942210|365285750|FG001|Overall Study|Adverse Event|1|||
105898834|NCT04942210|365285749|FG000|Overall Study|Protocol Deviation|4|||
105898835|NCT04942210|365285750|FG001|Overall Study|Protocol Deviation|1|||
105898836|NCT04942210|365285749|FG000|Overall Study|Withdrawal by Subject|5|||
105898837|NCT04942210|365285750|FG001|Overall Study|Withdrawal by Subject|2|||
105898838|NCT04942210|365285749|FG000|Overall Study|Lost to Follow-up|16|||
105898839|NCT04942210|365285750|FG001|Overall Study|Lost to Follow-up|7|||
105898840|NCT04942210|365285749|FG000|Overall Study|Ongoing at the time of DBL date|60|||
105898841|NCT04942210|365285750|FG001|Overall Study|Ongoing at the time of DBL date|25|||
105898842|NCT04942210|365285749|FG000|Overall Study|Randomized but did not receive vaccination|3|||
105898843|NCT04942210|365285750|FG001|Overall Study|Randomized but did not receive vaccination|0|||
105898844|NCT05697627|365285753|FG000|Overall Study|Adverse Event|1|||
105898845|NCT02570750|365285754|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
105898846|NCT02570750|365285755|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
105898847|NCT02570750|365285754|FG000|Overall Study|Protocol deviation|4|||
105898848|NCT02570750|365285755|FG001|Overall Study|Protocol deviation|2|||
105898849|NCT02570750|365285754|FG000|Overall Study|Withdrawal by Subject|5|||
105898850|NCT02570750|365285755|FG001|Overall Study|Withdrawal by Subject|0|||
105898851|NCT02570750|365285754|FG000|Overall Study|Lost to Follow-up|2|||
105898852|NCT02570750|365285755|FG001|Overall Study|Lost to Follow-up|2|||
105898853|NCT02570750|365285754|FG000|Overall Study|Adverse Event|2|||
105898854|NCT02570750|365285755|FG001|Overall Study|Adverse Event|1|||
105898855|NCT04122625|365285756|FG000|Part A (up to 2.92 Years)|Death|2|||
105898856|NCT04122625|365285757|FG001|Part A (up to 2.92 Years)|Death|4|||
105898857|NCT04122625|365285758|FG002|Part A (up to 2.92 Years)|Death|0|||
105898858|NCT04122625|365285759|FG003|Part A (up to 2.92 Years)|Death|0|||
105898859|NCT04122625|365285760|FG004|Part A (up to 2.92 Years)|Death|0|||
105898860|NCT04122625|365285761|FG005|Part A (up to 2.92 Years)|Death|0|||
105898861|NCT04122625|365285756|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
105898862|NCT04122625|365285757|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
105898863|NCT04122625|365285758|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
105898864|NCT04122625|365285759|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
105898865|NCT04122625|365285760|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
105898866|NCT04122625|365285761|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
105898867|NCT04122625|365285756|FG000|Part B (up to 2.33 Years)|Death|0|||
105898868|NCT04122625|365285757|FG001|Part B (up to 2.33 Years)|Death|0|||
105898869|NCT04122625|365285758|FG002|Part B (up to 2.33 Years)|Death|5|||
105898870|NCT04122625|365285759|FG003|Part B (up to 2.33 Years)|Death|7|||
105898871|NCT04122625|365285760|FG004|Part B (up to 2.33 Years)|Death|6|||
105898872|NCT04122625|365285761|FG005|Part B (up to 2.33 Years)|Death|7|||
105898873|NCT02636699|365285762|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
105898874|NCT02636699|365285763|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
105898875|NCT02636699|365285764|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
105898876|NCT02636699|365285762|FG000|Screening Period|Withdrawal by Subject|0|||
105898877|NCT02636699|365285763|FG001|Screening Period|Withdrawal by Subject|0|||
105898878|NCT02636699|365285764|FG002|Screening Period|Withdrawal by Subject|23|||
105898879|NCT02636699|365285762|FG000|Screening Period|Adverse Event|0|||
105898880|NCT02636699|365285763|FG001|Screening Period|Adverse Event|0|||
105898881|NCT02636699|365285764|FG002|Screening Period|Adverse Event|1|||
105898882|NCT02636699|365285762|FG000|Screening Period|Other not specified|0|||
105898883|NCT02636699|365285763|FG001|Screening Period|Other not specified|0|||
105898884|NCT02636699|365285764|FG002|Screening Period|Other not specified|3|||
105898885|NCT02636699|365285762|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
105898886|NCT02636699|365285763|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
105898887|NCT02636699|365285764|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
105898888|NCT02636699|365285762|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
105898889|NCT02636699|365285763|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
105898890|NCT02636699|365285764|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
105898891|NCT02636699|365285762|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
105898892|NCT02636699|365285763|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
105898893|NCT02636699|365285764|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
105898894|NCT02636699|365285762|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
105898895|NCT02636699|365285763|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
105898896|NCT02636699|365285764|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
105898897|NCT02636699|365285762|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
105898898|NCT02636699|365285763|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
105898899|NCT02636699|365285764|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
105898900|NCT02636699|365285762|FG000|Treatment and Follow-up Periods|Other|3|||
105898901|NCT02636699|365285763|FG001|Treatment and Follow-up Periods|Other|1|||
105898902|NCT02636699|365285764|FG002|Treatment and Follow-up Periods|Other|0|||
105898903|NCT04379700|365285765|FG000|Overall Study|Withdrawal by Subject|10|||
105898904|NCT04379700|365285765|FG000|Overall Study|Screen Fail|4|||
105898905|NCT04379700|365285765|FG000|Overall Study|Lost to Follow-up|3|||
105898906|NCT05916131|365285768|FG000|Overall Study|Lost to Follow-up|0|||
105898907|NCT05916131|365285769|FG001|Overall Study|Lost to Follow-up|0|||
105898908|NCT05916131|365285770|FG002|Overall Study|Lost to Follow-up|1|||
105898909|NCT05916131|365285771|FG003|Overall Study|Lost to Follow-up|0|||
105898910|NCT05619692|365285772|FG000|Overall Study|Adverse Event|2|||
105898911|NCT05619692|365285773|FG001|Overall Study|Adverse Event|2|||
105898912|NCT05619692|365285772|FG000|Overall Study|Withdrawal by Participant|3|||
105898913|NCT05619692|365285773|FG001|Overall Study|Withdrawal by Participant|4|||
105898914|NCT05619692|365285772|FG000|Overall Study|Lost to Follow-up|2|||
105898915|NCT05619692|365285773|FG001|Overall Study|Lost to Follow-up|1|||
105898916|NCT05619692|365285772|FG000|Overall Study|Randomized but not treated|1|||
105898917|NCT05619692|365285773|FG001|Overall Study|Randomized but not treated|3|||
105898918|NCT01492101|365285774|FG000|Overall Study|Death|323|||
105898919|NCT01492101|365285775|FG001|Overall Study|Death|322|||
105898920|NCT01492101|365285774|FG000|Overall Study|Withdrawal by Subject|14|||
105898921|NCT01492101|365285775|FG001|Overall Study|Withdrawal by Subject|18|||
105898922|NCT01492101|365285774|FG000|Overall Study|Lost to Follow-up|0|||
105898923|NCT01492101|365285775|FG001|Overall Study|Lost to Follow-up|2|||
105898924|NCT01038752|365285776|FG000|Overall Study|Tumor Progression|2|||
105898925|NCT01038752|365285777|FG001|Overall Study|Tumor Progression|2|||
105898926|NCT01038752|365285776|FG000|Overall Study|Lost to Follow-up|3|||
105898927|NCT01038752|365285777|FG001|Overall Study|Lost to Follow-up|3|||
105898928|NCT02309723|365285802|FG000|Overall Study|Withdrawal by Subject|24|||
105898929|NCT02309723|365285803|FG001|Overall Study|Withdrawal by Subject|23|||
105898930|NCT02309723|365285804|FG002|Overall Study|Withdrawal by Subject|24|||
105898931|NCT00316914|365285805|FG000|Overall Study|Withdrawal by Subject|5|||
105898932|NCT00316914|365285806|FG001|Overall Study|Withdrawal by Subject|3|||
105898933|NCT00316914|365285805|FG000|Overall Study|Adverse Event|8|||
105898934|NCT00316914|365285806|FG001|Overall Study|Adverse Event|7|||
105898935|NCT00316914|365285805|FG000|Overall Study|Other Problems|6|||
105898936|NCT00316914|365285806|FG001|Overall Study|Other Problems|11|||
105898937|NCT00316914|365285805|FG000|Overall Study|Missing end of treatment documentation|14|||
105898938|NCT00316914|365285806|FG001|Overall Study|Missing end of treatment documentation|15|||
105898939|NCT03810235|365285807|FG000|Overall Study|Withdrawal by Subject|2|||
105898940|NCT03810235|365285808|FG001|Overall Study|Withdrawal by Subject|0|||
105898941|NCT00412217|365285814|FG000|Overall Study|Insufficient Data Available|8|||
105898942|NCT00412217|365285815|FG001|Overall Study|Insufficient Data Available|3|||
105898943|NCT00412217|365285814|FG000|Overall Study|Death|5|||
105898944|NCT00412217|365285815|FG001|Overall Study|Death|4|||
105898945|NCT00412217|365285814|FG000|Overall Study|Disease Progression|2|||
105898946|NCT00412217|365285815|FG001|Overall Study|Disease Progression|3|||
105898947|NCT00412217|365285814|FG000|Overall Study|Investigator Decision|1|||
105898948|NCT00412217|365285815|FG001|Overall Study|Investigator Decision|0|||
105898949|NCT00412217|365285814|FG000|Overall Study|Withdrawal by Subject|2|||
105898950|NCT00412217|365285815|FG001|Overall Study|Withdrawal by Subject|0|||
105898951|NCT00412217|365285814|FG000|Overall Study|Lost to Follow-up|1|||
105898952|NCT00412217|365285815|FG001|Overall Study|Lost to Follow-up|4|||
105898953|NCT00412217|365285814|FG000|Overall Study|Study Terminated by Sponsor|26|||
105898954|NCT00412217|365285815|FG001|Overall Study|Study Terminated by Sponsor|33|||
105898955|NCT00412217|365285814|FG000|Overall Study|Other|1|||
105898956|NCT00412217|365285815|FG001|Overall Study|Other|1|||
105898957|NCT04526574|365285822|FG000|Overall Study|Protocol Violation|3|||
105898958|NCT04526574|365285823|FG001|Overall Study|Protocol Violation|1|||
105898959|NCT04526574|365285822|FG000|Overall Study|Withdrawal by Subject|12|||
105898960|NCT04526574|365285823|FG001|Overall Study|Withdrawal by Subject|9|||
105898961|NCT04526574|365285822|FG000|Overall Study|Other|1|||
105898962|NCT04526574|365285823|FG001|Overall Study|Other|2|||
105898963|NCT04526574|365285822|FG000|Overall Study|Adverse Event|1|||
105898964|NCT04526574|365285823|FG001|Overall Study|Adverse Event|1|||
105898965|NCT04526574|365285822|FG000|Overall Study|Death|2|||
105898966|NCT04526574|365285823|FG001|Overall Study|Death|3|||
105898967|NCT04526574|365285822|FG000|Overall Study|Lost to Follow-up|9|||
105898968|NCT04526574|365285823|FG001|Overall Study|Lost to Follow-up|9|||
105898969|NCT04526574|365285822|FG000|Overall Study|No longer meets eligibility criteria|8|||
105898970|NCT04526574|365285823|FG001|Overall Study|No longer meets eligibility criteria|8|||
105898971|NCT01398410|365285824|FG000|Overall Study|Adverse Event|12|||
105898972|NCT01398410|365285825|FG001|Overall Study|Adverse Event|16|||
105898973|NCT01398410|365285824|FG000|Overall Study|Participants Choice|8|||
105898974|NCT01398410|365285825|FG001|Overall Study|Participants Choice|11|||
105898975|NCT01398410|365285824|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
105898976|NCT01398410|365285825|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
105898977|NCT01398410|365285824|FG000|Overall Study|Other|36|||
105898978|NCT01398410|365285825|FG001|Overall Study|Other|29|||
105898979|NCT03436199|365285829|FG000|Overall Study|Adverse Event|15|||
105898980|NCT03436199|365285830|FG001|Overall Study|Adverse Event|40|||
105898981|NCT03436199|365285831|FG002|Overall Study|Adverse Event|7|||
105898982|NCT03436199|365285829|FG000|Overall Study|Withdrawal by Subject|4|||
105898983|NCT03436199|365285830|FG001|Overall Study|Withdrawal by Subject|10|||
105898984|NCT03436199|365285831|FG002|Overall Study|Withdrawal by Subject|3|||
105898985|NCT03436199|365285829|FG000|Overall Study|Lost to Follow-up|1|||
105898986|NCT03436199|365285830|FG001|Overall Study|Lost to Follow-up|0|||
105898987|NCT03436199|365285831|FG002|Overall Study|Lost to Follow-up|2|||
105898988|NCT03436199|365285829|FG000|Overall Study|Protocol Violation|1|||
105898989|NCT03436199|365285830|FG001|Overall Study|Protocol Violation|1|||
105898990|NCT03436199|365285831|FG002|Overall Study|Protocol Violation|0|||
105898991|NCT03436199|365285829|FG000|Overall Study|Physician Decision|0|||
105898992|NCT03436199|365285830|FG001|Overall Study|Physician Decision|1|||
105898993|NCT03436199|365285831|FG002|Overall Study|Physician Decision|0|||
105898994|NCT03436199|365285829|FG000|Overall Study|Could not return to clinic|1|||
105898995|NCT03436199|365285830|FG001|Overall Study|Could not return to clinic|0|||
105898996|NCT03436199|365285831|FG002|Overall Study|Could not return to clinic|0|||
105898997|NCT03436199|365285829|FG000|Overall Study|Withdrawn per physician|0|||
105898998|NCT03436199|365285830|FG001|Overall Study|Withdrawn per physician|1|||
105898999|NCT03436199|365285831|FG002|Overall Study|Withdrawn per physician|0|||
105899000|NCT00085098|365285832|FG000|Overall Study|Withdrawal by Subject|0|||
105899001|NCT00085098|365285833|FG001|Overall Study|Withdrawal by Subject|1|||
105899002|NCT00085098|365285832|FG000|Overall Study|Ineligible|1|||
105899003|NCT00085098|365285833|FG001|Overall Study|Ineligible|1|||
105899004|NCT03329248|365285834|FG000|Overall Study|Progressive Disease|6|||
105899005|NCT01254721|365285835|FG000|Overall Study|Lost to Follow-up|0|||
105899006|NCT01254721|365285836|FG001|Overall Study|Lost to Follow-up|4|||
105899007|NCT01254721|365285835|FG000|Overall Study|Lack of Efficacy|4|||
105899008|NCT01254721|365285836|FG001|Overall Study|Lack of Efficacy|2|||
105899009|NCT01254721|365285835|FG000|Overall Study|Death|0|||
105899010|NCT01254721|365285836|FG001|Overall Study|Death|1|||
105899011|NCT01254721|365285835|FG000|Overall Study|technical problum|1|||
105899012|NCT01254721|365285836|FG001|Overall Study|technical problum|0|||
105899013|NCT01254721|365285835|FG000|Overall Study|Adverse Event|2|||
105899014|NCT01254721|365285836|FG001|Overall Study|Adverse Event|3|||
105899015|NCT01254721|365285835|FG000|Overall Study|Withdrawal by Subject|8|||
105899016|NCT01254721|365285836|FG001|Overall Study|Withdrawal by Subject|11|||
105899017|NCT01254721|365285835|FG000|Overall Study|Wrongly randomization|0|||
105899018|NCT01254721|365285836|FG001|Overall Study|Wrongly randomization|1|||
105899019|NCT03000530|365285837|FG000|Overall Study|Adverse Event|0|||
105899020|NCT03000530|365285838|FG001|Overall Study|Adverse Event|0|||
105899021|NCT03000530|365285839|FG002|Overall Study|Adverse Event|2|||
105899022|NCT03000530|365285837|FG000|Overall Study|Lost to Follow-up|0|||
105899023|NCT03000530|365285838|FG001|Overall Study|Lost to Follow-up|3|||
105899024|NCT03000530|365285839|FG002|Overall Study|Lost to Follow-up|1|||
105899025|NCT03000530|365285837|FG000|Overall Study|Withdrawal by Subject|0|||
105899026|NCT03000530|365285838|FG001|Overall Study|Withdrawal by Subject|2|||
105899027|NCT03000530|365285839|FG002|Overall Study|Withdrawal by Subject|1|||
105899028|NCT01430624|365285843|FG000|Overall Study|Lost to Follow-up|23|||
105899029|NCT01430624|365285844|FG001|Overall Study|Lost to Follow-up|29|||
105899030|NCT01430624|365285845|FG002|Overall Study|Lost to Follow-up|27|||
105899031|NCT01430624|365285843|FG000|Overall Study|technical or eligibility|5|||
105899032|NCT01430624|365285844|FG001|Overall Study|technical or eligibility|5|||
105899033|NCT01430624|365285845|FG002|Overall Study|technical or eligibility|2|||
105899034|NCT01362517|365285848|FG000|Overall Study|Protocol Violation|1|||
105899035|NCT01362517|365285848|FG000|Overall Study|Lost to Follow-up|1|||
105899036|NCT02614131|365285849|FG000|Overall Study|Withdrawal by Subject|1|||
105899037|NCT02614131|365285850|FG001|Overall Study|Withdrawal by Subject|0|||
105899038|NCT02614131|365285851|FG002|Overall Study|Withdrawal by Subject|0|||
105899039|NCT02614131|365285852|FG003|Overall Study|Withdrawal by Subject|0|||
105899040|NCT02614131|365285853|FG004|Overall Study|Withdrawal by Subject|0|||
105899041|NCT02614131|365285854|FG005|Overall Study|Withdrawal by Subject|0|||
105899042|NCT02614131|365285855|FG006|Overall Study|Withdrawal by Subject|0|||
105899043|NCT02614131|365285849|FG000|Overall Study|Adverse Event|0|||
105899044|NCT02614131|365285850|FG001|Overall Study|Adverse Event|0|||
105899045|NCT02614131|365285851|FG002|Overall Study|Adverse Event|0|||
105899046|NCT02614131|365285852|FG003|Overall Study|Adverse Event|0|||
105899047|NCT02614131|365285853|FG004|Overall Study|Adverse Event|0|||
105899048|NCT02614131|365285854|FG005|Overall Study|Adverse Event|0|||
105997818|NCT01702558|365653250|FG003|Overall Study|Other|16|||
105997819|NCT01702558|365653251|FG004|Overall Study|Other|17|||
105899049|NCT02614131|365285855|FG006|Overall Study|Adverse Event|1|||
105899050|NCT03209518|365285856|FG000|Overall Study|Case Report Forms Uncollected|1|||
105899051|NCT03209518|365285856|FG000|Overall Study|Protocol Deviation|1|||
105899052|NCT03379792|365285857|FG000|Overall Study|Physician Decision|0|||
105899053|NCT03379792|365285858|FG001|Overall Study|Physician Decision|0|||
105899054|NCT03379792|365285859|FG002|Overall Study|Physician Decision|0|||
105899055|NCT03379792|365285860|FG003|Overall Study|Physician Decision|1|||
105899056|NCT03379792|365285861|FG004|Overall Study|Physician Decision|0|||
105899057|NCT03379792|365285862|FG005|Overall Study|Physician Decision|0|||
105899058|NCT03379792|365285857|FG000|Overall Study|Withdrawal by Subject|0|||
105899059|NCT03379792|365285858|FG001|Overall Study|Withdrawal by Subject|0|||
105899060|NCT03379792|365285859|FG002|Overall Study|Withdrawal by Subject|0|||
105899061|NCT03379792|365285860|FG003|Overall Study|Withdrawal by Subject|0|||
105899062|NCT03379792|365285861|FG004|Overall Study|Withdrawal by Subject|1|||
105899063|NCT03379792|365285862|FG005|Overall Study|Withdrawal by Subject|1|||
105899064|NCT01121536|365285863|FG000|Overall Study|Adverse Event|63|||
105899065|NCT01121536|365285863|FG000|Overall Study|Lack of Efficacy|35|||
105899066|NCT01121536|365285863|FG000|Overall Study|Withdrawal by Subject|65|||
105899067|NCT01121536|365285863|FG000|Overall Study|Protocol Violation|20|||
105899068|NCT01121536|365285863|FG000|Overall Study|Noncompliance with study medication|12|||
105899069|NCT01121536|365285863|FG000|Overall Study|Noncompliance with study procedures|9|||
105899070|NCT01121536|365285863|FG000|Overall Study|Lost to Follow-up|39|||
105899071|NCT01121536|365285863|FG000|Overall Study|Other|118|||
105899072|NCT02273908|365285866|FG000|Overall Study|Adverse Event|16|||
105899073|NCT02273908|365285867|FG001|Overall Study|Adverse Event|0|||
105899074|NCT02273908|365285866|FG000|Overall Study|Lost to Follow-up|10|||
105899075|NCT02273908|365285867|FG001|Overall Study|Lost to Follow-up|1|||
105899076|NCT02273908|365285866|FG000|Overall Study|Did not meet entrance criteria|3|||
105899077|NCT02273908|365285867|FG001|Overall Study|Did not meet entrance criteria|2|||
105899078|NCT02273908|365285866|FG000|Overall Study|Withdrawal by Subject|4|||
105899079|NCT02273908|365285867|FG001|Overall Study|Withdrawal by Subject|2|||
105899080|NCT00821015|365285868|FG000|Overall Study|Lost to Follow-up|12|||
105899081|NCT01281956|365285869|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
105899082|NCT01281956|365285870|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
105899083|NCT01490697|365285875|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
105899084|NCT01490697|365285876|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
105899085|NCT00270231|365285879|FG000|First Intervention|Lost to Follow-up|1|||
105899086|NCT00270231|365285880|FG001|First Intervention|Lost to Follow-up|1|||
105899087|NCT00270231|365285879|FG000|Washout Period|Lost to Follow-up|1|||
105899088|NCT00270231|365285880|FG001|Washout Period|Lost to Follow-up|0|||
105899089|NCT00270231|365285879|FG000|Second Intervention|Lost to Follow-up|0|||
105899090|NCT00270231|365285880|FG001|Second Intervention|Lost to Follow-up|1|||
105899091|NCT02638259|365285888|FG000|Treatment Period 1|Adverse Event|1|||
105899092|NCT02638259|365285889|FG001|Treatment Period 1|Adverse Event|5|||
105899093|NCT02638259|365285888|FG000|Treatment Period 1|Death|0|||
105899094|NCT02638259|365285889|FG001|Treatment Period 1|Death|1|||
105899095|NCT02638259|365285888|FG000|Treatment Period 1|Lack of Efficacy|0|||
105899096|NCT02638259|365285889|FG001|Treatment Period 1|Lack of Efficacy|1|||
105899097|NCT02638259|365285888|FG000|Treatment Period 1|Protocol Violation|0|||
105899098|NCT02638259|365285889|FG001|Treatment Period 1|Protocol Violation|3|||
105899099|NCT02638259|365285888|FG000|Treatment Period 1|Withdrawal by Subject|4|||
105899100|NCT02638259|365285889|FG001|Treatment Period 1|Withdrawal by Subject|6|||
105899101|NCT02638259|365285888|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
105899102|NCT02638259|365285889|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
105899103|NCT02638259|365285888|FG000|Treatment Period 2|Adverse Event|5|||
105899104|NCT02638259|365285889|FG001|Treatment Period 2|Adverse Event|4|||
105899105|NCT02638259|365285888|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105899106|NCT02638259|365285889|FG001|Treatment Period 2|Withdrawal by Subject|7|||
105899107|NCT02069093|365285894|FG000|Overall Study|Disease progression|14|||
105899108|NCT02069093|365285894|FG000|Overall Study|New cancer therapy|1|||
105899109|NCT02069093|365285894|FG000|Overall Study|Death|1|||
105899110|NCT02069093|365285894|FG000|Overall Study|Administrative problems|1|||
105899111|NCT02069093|365285894|FG000|Overall Study|Withdrawal by Subject|2|||
105899112|NCT02069093|365285894|FG000|Overall Study|Abnormal laboratory values|1|||
105899113|NCT02069093|365285894|FG000|Overall Study|Adverse Event|10|||
105899114|NCT00862459|365285895|FG000|Overall Study|Lost to Follow-up|1|||
105899115|NCT00862459|365285896|FG001|Overall Study|Lost to Follow-up|2|||
105899116|NCT00862459|365285897|FG002|Overall Study|Lost to Follow-up|2|||
105899117|NCT00862459|365285895|FG000|Overall Study|Protocol Violation|1|||
105899118|NCT00862459|365285896|FG001|Overall Study|Protocol Violation|0|||
105899119|NCT00862459|365285897|FG002|Overall Study|Protocol Violation|0|||
105899120|NCT00862459|365285895|FG000|Overall Study|Withdrawal by Subject|1|||
105899121|NCT00862459|365285896|FG001|Overall Study|Withdrawal by Subject|1|||
105899122|NCT00862459|365285897|FG002|Overall Study|Withdrawal by Subject|3|||
105899123|NCT00862459|365285895|FG000|Overall Study|Adverse Event|0|||
105899124|NCT00862459|365285896|FG001|Overall Study|Adverse Event|1|||
105899125|NCT00862459|365285897|FG002|Overall Study|Adverse Event|0|||
105899126|NCT00862459|365285895|FG000|Overall Study|Personal reasons|1|||
105899127|NCT00862459|365285896|FG001|Overall Study|Personal reasons|0|||
105899128|NCT00862459|365285897|FG002|Overall Study|Personal reasons|0|||
105899129|NCT00862459|365285895|FG000|Overall Study|Operation|1|||
105899130|NCT00862459|365285896|FG001|Overall Study|Operation|1|||
105668059|NCT03238963|364448266|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
105899131|NCT00862459|365285897|FG002|Overall Study|Operation|0|||
105899132|NCT00862459|365285895|FG000|Overall Study|Intravenous (IV) site problems|1|||
105899133|NCT00862459|365285896|FG001|Overall Study|Intravenous (IV) site problems|0|||
105899134|NCT00862459|365285897|FG002|Overall Study|Intravenous (IV) site problems|1|||
105899135|NCT00862459|365285895|FG000|Overall Study|Unable to hold still for imaging|0|||
105899136|NCT00862459|365285896|FG001|Overall Study|Unable to hold still for imaging|1|||
105899137|NCT00862459|365285897|FG002|Overall Study|Unable to hold still for imaging|0|||
105899138|NCT00862459|365285895|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
105899139|NCT00862459|365285896|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
105899140|NCT00862459|365285897|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
105899141|NCT00862459|365285895|FG000|Overall Study|Administrative problems|0|||
105899142|NCT00862459|365285896|FG001|Overall Study|Administrative problems|1|||
105899143|NCT00862459|365285897|FG002|Overall Study|Administrative problems|0|||
105899144|NCT02906033|365285898|FG000|Baseline|Protocol Violation|37|||
105899145|NCT02906033|365285899|FG001|Baseline|Protocol Violation|33|||
105899146|NCT02906033|365285898|FG000|Follow-up|Lost to Follow-up|46|||
105899147|NCT02906033|365285899|FG001|Follow-up|Lost to Follow-up|62|||
105899148|NCT02240069|365285908|FG000|Overall Study|Withdrawal by Subject|5|||
105899149|NCT02240069|365285909|FG001|Overall Study|Withdrawal by Subject|5|||
105899150|NCT02240069|365285910|FG002|Overall Study|Withdrawal by Subject|2|||
105899151|NCT02429310|365285911|FG000|Overall Study|Lost to Follow-up|1|||
105899152|NCT02429310|365285912|FG001|Overall Study|Lost to Follow-up|2|||
105899153|NCT02429310|365285911|FG000|Overall Study|Protocol Violation|1|||
105899154|NCT02429310|365285912|FG001|Overall Study|Protocol Violation|1|||
105899155|NCT00628927|365285913|FG000|Overall Study|Problems performing blood draw|6|||
105899156|NCT00628927|365285914|FG001|Overall Study|Problems performing blood draw|0|||
105899157|NCT00628927|365285913|FG000|Overall Study|Lost to Follow-up|1|||
105899158|NCT00628927|365285914|FG001|Overall Study|Lost to Follow-up|0|||
105899159|NCT00628927|365285913|FG000|Overall Study|Equipment failure|1|||
105899160|NCT00628927|365285914|FG001|Overall Study|Equipment failure|0|||
105899161|NCT02440854|365285915|FG000|Overall Study|Relocation of patient|1|||
105899162|NCT02440854|365285915|FG000|Overall Study|Death|6|||
105899163|NCT02440854|365285915|FG000|Overall Study|Lost to Follow-up|10|||
105899164|NCT02440854|365285915|FG000|Overall Study|Afatinib discontinuation|46|||
105899165|NCT02440854|365285915|FG000|Overall Study|stopped study at earlier timepoint|14|||
105899166|NCT02440854|365285915|FG000|Overall Study|Study medication not received|1|||
105899167|NCT02440854|365285915|FG000|Overall Study|Violation of inclusion criteria|2|||
105899168|NCT04607980|365285916|FG000|Overall Study|Adverse Event|3|||
105899169|NCT04607980|365285917|FG001|Overall Study|Adverse Event|4|||
105899170|NCT04607980|365285916|FG000|Overall Study|Death|0|||
105899171|NCT04607980|365285917|FG001|Overall Study|Death|1|||
105899172|NCT04607980|365285916|FG000|Overall Study|Withdrawal by Subject|2|||
105899173|NCT04607980|365285917|FG001|Overall Study|Withdrawal by Subject|5|||
105899174|NCT04607980|365285916|FG000|Overall Study|Lost to Follow-up|4|||
105899175|NCT04607980|365285917|FG001|Overall Study|Lost to Follow-up|8|||
105899176|NCT04607980|365285916|FG000|Overall Study|Protocol Violation|0|||
105899177|NCT04607980|365285917|FG001|Overall Study|Protocol Violation|3|||
105899178|NCT04607980|365285916|FG000|Overall Study|Other|3|||
105899179|NCT04607980|365285917|FG001|Overall Study|Other|0|||
105899180|NCT02669082|365285918|FG000|Overall Study|Adverse Event|1|||
105899181|NCT02661061|365287468|FG000|Overall Study|Lack of Efficacy|1|||
105899182|NCT02661061|365287469|FG001|Overall Study|Lack of Efficacy|1|||
105899183|NCT02661061|365287468|FG000|Overall Study|Withdrawal by Subject|1|||
105899184|NCT02661061|365287469|FG001|Overall Study|Withdrawal by Subject|1|||
105899185|NCT00312572|365287472|FG000|Overall Study|Adverse Event|10|||
105899186|NCT00312572|365287473|FG001|Overall Study|Adverse Event|16|||
105899187|NCT00312572|365287472|FG000|Overall Study|Lost to Follow-up|1|||
105899188|NCT00312572|365287473|FG001|Overall Study|Lost to Follow-up|1|||
105899189|NCT00312572|365287472|FG000|Overall Study|Administrative|4|||
105899190|NCT00312572|365287473|FG001|Overall Study|Administrative|2|||
105899191|NCT00312572|365287472|FG000|Overall Study|Lack of Efficacy|1|||
105899192|NCT00312572|365287473|FG001|Overall Study|Lack of Efficacy|2|||
105899193|NCT04150068|365287478|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
105899194|NCT04150068|365287479|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
105899195|NCT04150068|365287480|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
105899196|NCT04150068|365287478|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
105899197|NCT04150068|365287479|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
105899198|NCT04150068|365287480|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
105899199|NCT05268016|365287488|FG000|Overall Study|Unacceptable toxicity or AE|2|||
105899200|NCT05268016|365287489|FG001|Overall Study|Unacceptable toxicity or AE|2|||
105899201|NCT05268016|365287490|FG002|Overall Study|Unacceptable toxicity or AE|4|||
105899202|NCT05268016|365287491|FG003|Overall Study|Unacceptable toxicity or AE|3|||
105899203|NCT05268016|365287492|FG004|Overall Study|Unacceptable toxicity or AE|1|||
105899204|NCT05268016|365287488|FG000|Overall Study|Withdrawal by Subject|1|||
105899205|NCT05268016|365287489|FG001|Overall Study|Withdrawal by Subject|3|||
105899206|NCT05268016|365287490|FG002|Overall Study|Withdrawal by Subject|2|||
105899207|NCT05268016|365287491|FG003|Overall Study|Withdrawal by Subject|2|||
105899208|NCT05268016|365287492|FG004|Overall Study|Withdrawal by Subject|1|||
105899209|NCT05268016|365287488|FG000|Overall Study|Lost to Follow-up|4|||
105899210|NCT05268016|365287489|FG001|Overall Study|Lost to Follow-up|7|||
105899211|NCT05268016|365287490|FG002|Overall Study|Lost to Follow-up|1|||
105899212|NCT05268016|365287491|FG003|Overall Study|Lost to Follow-up|3|||
105899213|NCT05268016|365287492|FG004|Overall Study|Lost to Follow-up|5|||
105899214|NCT05268016|365287488|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
105899215|NCT05268016|365287489|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
105899216|NCT05268016|365287490|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
105899217|NCT05268016|365287491|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
105899218|NCT05268016|365287492|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
105899219|NCT05268016|365287488|FG000|Overall Study|Lack of Efficacy|0|||
105899220|NCT05268016|365287489|FG001|Overall Study|Lack of Efficacy|0|||
105899221|NCT05268016|365287490|FG002|Overall Study|Lack of Efficacy|0|||
105899222|NCT05268016|365287491|FG003|Overall Study|Lack of Efficacy|0|||
105899223|NCT05268016|365287492|FG004|Overall Study|Lack of Efficacy|4|||
105899224|NCT05268016|365287488|FG000|Overall Study|Physician Decision|0|||
105899225|NCT05268016|365287489|FG001|Overall Study|Physician Decision|0|||
105899226|NCT05268016|365287490|FG002|Overall Study|Physician Decision|0|||
105899227|NCT05268016|365287491|FG003|Overall Study|Physician Decision|1|||
105899228|NCT05268016|365287492|FG004|Overall Study|Physician Decision|0|||
105899229|NCT05268016|365287488|FG000|Overall Study|Other|1|||
105899230|NCT05268016|365287489|FG001|Overall Study|Other|0|||
105899231|NCT05268016|365287490|FG002|Overall Study|Other|1|||
105899232|NCT05268016|365287491|FG003|Overall Study|Other|2|||
105899233|NCT05268016|365287492|FG004|Overall Study|Other|0|||
105899234|NCT02147067|365287493|FG000|Overall Study|Withdrawal by Subject|2|||
105899235|NCT02147067|365287494|FG001|Overall Study|Withdrawal by Subject|2|||
105899236|NCT00791492|365287506|FG000|Overall Study|Withdrawal by Subject|1|||
105899237|NCT00791492|365287507|FG001|Overall Study|Withdrawal by Subject|2|||
105899238|NCT00791492|365287506|FG000|Overall Study|Liver transplantation|5|||
105899239|NCT00791492|365287507|FG001|Overall Study|Liver transplantation|1|||
105899240|NCT00803205|365287513|FG000|Overall Study|Adverse Event|7|||
105899241|NCT00803205|365287514|FG001|Overall Study|Adverse Event|2|||
105899242|NCT00803205|365287513|FG000|Overall Study|Lost to Follow-up|1|||
105899243|NCT00803205|365287514|FG001|Overall Study|Lost to Follow-up|0|||
105899244|NCT00803205|365287513|FG000|Overall Study|Withdrawal by Subject|9|||
105899245|NCT00803205|365287514|FG001|Overall Study|Withdrawal by Subject|9|||
105899246|NCT00803205|365287513|FG000|Overall Study|Physician Decision|1|||
105899247|NCT00803205|365287514|FG001|Overall Study|Physician Decision|0|||
105899248|NCT00803205|365287513|FG000|Overall Study|Protocol Violation|1|||
105899249|NCT00803205|365287514|FG001|Overall Study|Protocol Violation|1|||
105899250|NCT00803205|365287513|FG000|Overall Study|Medical Monitor Decision|1|||
105899251|NCT00803205|365287514|FG001|Overall Study|Medical Monitor Decision|0|||
105899252|NCT00803205|365287513|FG000|Overall Study|Acquired a Lung Infection|0|||
105899253|NCT00803205|365287514|FG001|Overall Study|Acquired a Lung Infection|1|||
105899254|NCT00803205|365287513|FG000|Overall Study|Sponsor Decision|0|||
105899255|NCT00803205|365287514|FG001|Overall Study|Sponsor Decision|1|||
105899256|NCT01857102|365287515|FG000|Period 1|No longer meets Eligibility Criteria|0|||
105899257|NCT01857102|365287516|FG001|Period 1|No longer meets Eligibility Criteria|2|||
105899258|NCT01857102|365287515|FG000|Period 1|Lost to Follow-up|0|||
105899259|NCT01857102|365287516|FG001|Period 1|Lost to Follow-up|3|||
105899260|NCT01857102|365287515|FG000|Period 1|Unsatisfactory Lens Fit|1|||
105899261|NCT01857102|365287516|FG001|Period 1|Unsatisfactory Lens Fit|0|||
105899262|NCT01857102|365287515|FG000|Period 1|Unsatisfactory Visual Response|1|||
105899263|NCT01857102|365287516|FG001|Period 1|Unsatisfactory Visual Response|0|||
105899264|NCT01857102|365287515|FG000|Period 1|Physician Decision|1|||
105899265|NCT01857102|365287516|FG001|Period 1|Physician Decision|0|||
105899266|NCT01857102|365287515|FG000|Period 2|Lens Discomfort|1|||
105899267|NCT01857102|365287516|FG001|Period 2|Lens Discomfort|0|||
105899268|NCT01857102|365287515|FG000|Period 2|Unsatisfactory Lens Fit|1|||
105899269|NCT01857102|365287516|FG001|Period 2|Unsatisfactory Lens Fit|0|||
105899270|NCT02603562|365287517|FG000|Overall Study|Lost to Follow-up|1|||
105899271|NCT00379808|365287518|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
105899272|NCT00379808|365287519|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
105899273|NCT01606748|365287521|FG000|Overall Study|Adverse Event|1|||
105899274|NCT01606748|365287522|FG001|Overall Study|Adverse Event|0|||
105899275|NCT01606748|365287521|FG000|Overall Study|Progressive Disease|1|||
105899276|NCT01606748|365287522|FG001|Overall Study|Progressive Disease|0|||
105899277|NCT01606748|365287521|FG000|Overall Study|Withdrawal by Subject|1|||
105899278|NCT01606748|365287522|FG001|Overall Study|Withdrawal by Subject|0|||
105899279|NCT03742258|365287523|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
105899280|NCT03742258|365287524|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
105899281|NCT03742258|365287525|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
105899282|NCT03742258|365287523|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
105997820|NCT03259087|365653254|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
105997821|NCT03259087|365653255|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
105997822|NCT03259087|365653256|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
105997823|NCT03259087|365653257|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
105997824|NCT03259087|365653258|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
105997825|NCT03259087|365653254|FG000|Period 2 of Part 2|Adverse Event|0|||
105997826|NCT03259087|365653255|FG001|Period 2 of Part 2|Adverse Event|0|||
105997827|NCT03259087|365653256|FG002|Period 2 of Part 2|Adverse Event|0|||
105997828|NCT03259087|365653257|FG003|Period 2 of Part 2|Adverse Event|0|||
105997829|NCT03259087|365653258|FG004|Period 2 of Part 2|Adverse Event|1|||
105997830|NCT03571204|365653259|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
105997831|NCT03571204|365653260|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
105997832|NCT03571204|365653261|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
105997833|NCT03571204|365653259|FG000|Overall Study|Physician Decision|0|||
105997834|NCT03571204|365653260|FG001|Overall Study|Physician Decision|1|||
105997835|NCT03571204|365653261|FG002|Overall Study|Physician Decision|0|||
105997836|NCT02396212|365653262|FG000|Overall Study|Adverse Event|1|||
105997837|NCT02396212|365653262|FG000|Overall Study|Lack of Efficacy|2|||
105997838|NCT02366195|365653269|FG000|Overall Study|Protocol-specified criteria|3|||
105997839|NCT02366195|365653269|FG000|Overall Study|Withdrawal by Subject|9|||
105997840|NCT02366195|365653269|FG000|Overall Study|Lost to Follow-up|1|||
105997841|NCT02366195|365653269|FG000|Overall Study|Death|41|||
105997842|NCT01338818|365653270|FG000|Overall Study|Adverse Event|8|||
105997843|NCT01338818|365653270|FG000|Overall Study|Lack of Efficacy|5|||
105997844|NCT01338818|365653270|FG000|Overall Study|no longer require study drug|1|||
105997845|NCT01338818|365653270|FG000|Overall Study|Withdrawal by Subject|11|||
105997846|NCT01338818|365653270|FG000|Overall Study|Lost to Follow-up|4|||
105997847|NCT01338818|365653270|FG000|Overall Study|Administrative problems|3|||
105997848|NCT01338818|365653270|FG000|Overall Study|Protocol Deviation|4|||
105997849|NCT01620086|365653271|FG000|Overall Study|Withdrawal by Subject|3|||
105997850|NCT01620086|365653272|FG001|Overall Study|Withdrawal by Subject|3|||
105997851|NCT01620086|365653273|FG002|Overall Study|Withdrawal by Subject|0|||
105997852|NCT01620086|365653271|FG000|Overall Study|failed study criteria|1|||
105997853|NCT01620086|365653272|FG001|Overall Study|failed study criteria|4|||
105997854|NCT01620086|365653273|FG002|Overall Study|failed study criteria|0|||
105997855|NCT01620086|365653271|FG000|Overall Study|Physician Decision|1|||
105997856|NCT01620086|365653272|FG001|Overall Study|Physician Decision|0|||
105997857|NCT01620086|365653273|FG002|Overall Study|Physician Decision|0|||
105997858|NCT02714569|365653281|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
105997859|NCT02714569|365653282|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
105997860|NCT02714569|365653283|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
105997861|NCT02714569|365653284|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
105997862|NCT02714569|365653285|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
105997863|NCT02714569|365653286|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
105997864|NCT02714569|365653287|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
105997865|NCT02714569|365653288|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
105997866|NCT02714569|365653289|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
105997867|NCT02714569|365653290|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
105997868|NCT02714569|365653291|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
105997869|NCT02714569|365653281|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997870|NCT02714569|365653282|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997871|NCT02714569|365653283|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997872|NCT02714569|365653284|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
105997873|NCT02714569|365653285|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997874|NCT02714569|365653286|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997875|NCT02714569|365653287|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997876|NCT02714569|365653288|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105899283|NCT03742258|365287524|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
105997877|NCT02714569|365653289|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997878|NCT02714569|365653290|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997879|NCT02714569|365653291|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
105997880|NCT02714569|365653281|FG000|Part A Third Intervention|Adverse Event|0|||
105997881|NCT02714569|365653282|FG001|Part A Third Intervention|Adverse Event|0|||
105899284|NCT03742258|365287525|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
105899285|NCT03742258|365287523|FG000|Survival Follow-Up|Still in Follow-up|0|||
105899286|NCT03742258|365287524|FG001|Survival Follow-Up|Still in Follow-up|0|||
105899287|NCT03742258|365287525|FG002|Survival Follow-Up|Still in Follow-up|2|||
105899288|NCT00957905|365287526|FG000|Part B|Not Treated|0|||
105899289|NCT00957905|365287527|FG001|Part B|Not Treated|1|||
105899290|NCT00957905|365287526|FG000|Part B|Physician Decision|0|||
105899291|NCT00957905|365287527|FG001|Part B|Physician Decision|1|||
105899292|NCT00957905|365287526|FG000|Part B|Death|0|||
105899293|NCT00957905|365287527|FG001|Part B|Death|1|||
105899294|NCT00957905|365287526|FG000|Part B|Protocol Violation|0|||
105899295|NCT00957905|365287527|FG001|Part B|Protocol Violation|1|||
105899296|NCT02073656|365287544|FG000|Primary Study|Lost to Follow-up|6|||
105899297|NCT02073656|365287544|FG000|Primary Study|Death|1|||
105899298|NCT02073656|365287544|FG000|Primary Study|Withdrew Consent|1|||
105899299|NCT03423147|365287545|FG000|Overall Study|Lost to Follow-up|5|||
105899300|NCT03423147|365287546|FG001|Overall Study|Lost to Follow-up|8|||
105899301|NCT03423147|365287545|FG000|Overall Study|Withdrawal by Subject|1|||
105899302|NCT03423147|365287546|FG001|Overall Study|Withdrawal by Subject|0|||
105899303|NCT03423147|365287545|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
105899304|NCT03423147|365287546|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
105899305|NCT03423147|365287545|FG000|Overall Study|Age < 18|1|||
105899306|NCT03423147|365287546|FG001|Overall Study|Age < 18|0|||
105899307|NCT03423147|365287545|FG000|Overall Study|No Trial of Labor|0|||
105899308|NCT03423147|365287546|FG001|Overall Study|No Trial of Labor|1|||
105899309|NCT01969084|365287550|FG000|Overall Study|Adverse Event|0|||
105899310|NCT01969084|365287551|FG001|Overall Study|Adverse Event|1|||
105899311|NCT01926197|365287552|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
105899312|NCT01926197|365287553|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
105899313|NCT01926197|365287552|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
105899314|NCT01926197|365287553|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
105899315|NCT01810783|365287554|FG000|Overall Study|Adverse Event|32|||
105899316|NCT01810783|365287554|FG000|Overall Study|Withdrawal by Subject|22|||
105899317|NCT01810783|365287554|FG000|Overall Study|Lack of Efficacy|12|||
105899318|NCT01810783|365287554|FG000|Overall Study|Lost to Follow-up|10|||
105899319|NCT01810783|365287554|FG000|Overall Study|Protocol Violation|5|||
105899320|NCT01810783|365287554|FG000|Overall Study|Non-compliance with IMP|4|||
105899321|NCT01810783|365287554|FG000|Overall Study|Adminstrative or other reason(s)|23|||
105899322|NCT01810783|365287554|FG000|Overall Study|Enrolled, not treated|1|||
105899323|NCT00358956|365287555|FG000|Overall Study|Adverse Event|3|||
105899324|NCT00358956|365287555|FG000|Overall Study|condition under investigation worsened|4|||
105899325|NCT00358956|365287555|FG000|Overall Study|Withdrawal by Subject|1|||
105899326|NCT03646305|365287558|FG000|Overall Study|Lost to Follow-up|4|||
105899327|NCT03646305|365287559|FG001|Overall Study|Lost to Follow-up|2|||
105899328|NCT03646305|365287560|FG002|Overall Study|Lost to Follow-up|2|||
105899329|NCT03646305|365287561|FG003|Overall Study|Lost to Follow-up|1|||
105899330|NCT03646305|365287558|FG000|Overall Study|Withdrawal by Subject|1|||
105899331|NCT03646305|365287559|FG001|Overall Study|Withdrawal by Subject|0|||
105899332|NCT03646305|365287560|FG002|Overall Study|Withdrawal by Subject|0|||
105899333|NCT03646305|365287561|FG003|Overall Study|Withdrawal by Subject|1|||
105899334|NCT03417024|365287564|FG000|Overall Study|Study Termination prior to follow-up|11|||
105899335|NCT03417024|365287564|FG000|Overall Study|Physician Decision|2|||
105899336|NCT00386425|365287565|FG000|Overall Study|Physician Decision|3|||
105899337|NCT00386425|365287566|FG001|Overall Study|Physician Decision|0|||
105899338|NCT00386425|365287567|FG002|Overall Study|Physician Decision|0|||
105899339|NCT00386425|365287565|FG000|Overall Study|Withdrawal by Subject|0|||
105899340|NCT00386425|365287566|FG001|Overall Study|Withdrawal by Subject|1|||
105899341|NCT00386425|365287567|FG002|Overall Study|Withdrawal by Subject|0|||
105899342|NCT02655419|365287568|FG000|Overall Study|Enrolled but not treated|1|||
105899343|NCT02655419|365287569|FG001|Overall Study|Enrolled but not treated|5|||
105899344|NCT02655419|365287568|FG000|Overall Study|Withdrawal by Subject|4|||
105899345|NCT02655419|365287569|FG001|Overall Study|Withdrawal by Subject|1|||
105899346|NCT02655419|365287568|FG000|Overall Study|Other|0|||
105899347|NCT02655419|365287569|FG001|Overall Study|Other|1|||
105899348|NCT02607306|365287572|FG000|Overall Study|Adverse Event|8|||
105899349|NCT02607306|365287573|FG001|Overall Study|Adverse Event|6|||
105899350|NCT02607306|365287574|FG002|Overall Study|Adverse Event|6|||
105899351|NCT02607306|365287572|FG000|Overall Study|Unclassified|1|||
105899352|NCT02607306|365287573|FG001|Overall Study|Unclassified|4|||
105899353|NCT02607306|365287574|FG002|Overall Study|Unclassified|0|||
105899354|NCT02607306|365287572|FG000|Overall Study|Withdrawal by Subject|8|||
105899355|NCT02607306|365287573|FG001|Overall Study|Withdrawal by Subject|10|||
105899356|NCT02607306|365287574|FG002|Overall Study|Withdrawal by Subject|2|||
105899357|NCT02607306|365287572|FG000|Overall Study|Lack of Efficacy|0|||
105899358|NCT02607306|365287573|FG001|Overall Study|Lack of Efficacy|1|||
105899359|NCT02607306|365287574|FG002|Overall Study|Lack of Efficacy|1|||
105899360|NCT02607306|365287572|FG000|Overall Study|Protocol Violation|4|||
105899361|NCT02607306|365287573|FG001|Overall Study|Protocol Violation|2|||
106124293|NCT00744237|366114027|FG002|Overall Study|Dosing Error|1|||
105899362|NCT02607306|365287574|FG002|Overall Study|Protocol Violation|1|||
105997882|NCT02714569|365653283|FG002|Part A Third Intervention|Adverse Event|1|||
105997883|NCT02714569|365653284|FG003|Part A Third Intervention|Adverse Event|0|||
105899363|NCT00539032|365287578|FG000|Overall Study|Withdrawal by Subject|2|||
105899364|NCT00539032|365287579|FG001|Overall Study|Withdrawal by Subject|1|||
105899365|NCT02306694|365287580|FG000|Overall Study|Withdrawal by Subject|3|||
105899366|NCT02306694|365287580|FG000|Overall Study|Lost to Follow-up|1|||
105899367|NCT03403621|365287581|FG000|Overall Study|Withdrawal by Subject|2|||
105899368|NCT03403621|365287582|FG001|Overall Study|Withdrawal by Subject|2|||
105899369|NCT00583102|365287583|FG000|Overall Study|Adverse Event|3|||
105899370|NCT00395642|365287588|FG000|Overall Study|Death|4|||
105899371|NCT00395642|365287588|FG000|Overall Study|Lost to Follow-up|1|||
105899372|NCT00395642|365287588|FG000|Overall Study|Physician Decision|7|||
105899373|NCT00395642|365287588|FG000|Overall Study|Withdrawal by Subject|1|||
105899374|NCT00505661|365287591|FG000|Overall Study|Not Eligible|4|||
105899375|NCT03611582|365287592|FG000|Overall Study|Adverse Event|26|||
105899376|NCT03611582|365287593|FG001|Overall Study|Adverse Event|6|||
105899377|NCT03611582|365287592|FG000|Overall Study|Protocol Violation|0|||
105899378|NCT03611582|365287593|FG001|Overall Study|Protocol Violation|1|||
105899379|NCT03611582|365287592|FG000|Overall Study|Pregnancy|1|||
105899380|NCT03611582|365287593|FG001|Overall Study|Pregnancy|2|||
105899381|NCT03611582|365287592|FG000|Overall Study|Lack of Efficacy|0|||
105899382|NCT03611582|365287593|FG001|Overall Study|Lack of Efficacy|1|||
105899383|NCT03611582|365287592|FG000|Overall Study|At the discretion of the investigator|1|||
105899384|NCT03611582|365287593|FG001|Overall Study|At the discretion of the investigator|0|||
105899385|NCT03611582|365287592|FG000|Overall Study|Safety concern as judged by the investigator|1|||
105899386|NCT03611582|365287593|FG001|Overall Study|Safety concern as judged by the investigator|2|||
105899387|NCT03611582|365287592|FG000|Overall Study|Withdrawal by Subject|4|||
105899388|NCT03611582|365287593|FG001|Overall Study|Withdrawal by Subject|3|||
105899389|NCT03611582|365287592|FG000|Overall Study|Lost to Follow-up|18|||
105997884|NCT02714569|365653285|FG004|Part A Third Intervention|Adverse Event|0|||
105997885|NCT02714569|365653286|FG005|Part A Third Intervention|Adverse Event|0|||
105997886|NCT02714569|365653287|FG006|Part A Third Intervention|Adverse Event|0|||
105997887|NCT02714569|365653288|FG007|Part A Third Intervention|Adverse Event|0|||
105997888|NCT02714569|365653289|FG008|Part A Third Intervention|Adverse Event|0|||
105997889|NCT02714569|365653290|FG009|Part A Third Intervention|Adverse Event|0|||
105997890|NCT02714569|365653291|FG010|Part A Third Intervention|Adverse Event|0|||
105997891|NCT02714569|365653281|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
105997892|NCT02714569|365653282|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997893|NCT02714569|365653283|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997894|NCT02714569|365653284|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997895|NCT02714569|365653285|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997896|NCT02714569|365653286|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
105997897|NCT02714569|365653287|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997898|NCT02714569|365653288|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997899|NCT02714569|365653289|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997900|NCT02714569|365653290|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997901|NCT02714569|365653291|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
105997902|NCT02714569|365653281|FG000|Part B (Overall)|Lost to Follow-up|0|||
105997903|NCT02714569|365653282|FG001|Part B (Overall)|Lost to Follow-up|0|||
105997904|NCT02714569|365653283|FG002|Part B (Overall)|Lost to Follow-up|0|||
105997905|NCT02714569|365653284|FG003|Part B (Overall)|Lost to Follow-up|0|||
105997906|NCT02714569|365653285|FG004|Part B (Overall)|Lost to Follow-up|0|||
105997907|NCT02714569|365653286|FG005|Part B (Overall)|Lost to Follow-up|0|||
105997908|NCT02714569|365653287|FG006|Part B (Overall)|Lost to Follow-up|1|||
105997909|NCT02714569|365653288|FG007|Part B (Overall)|Lost to Follow-up|0|||
105997910|NCT02714569|365653289|FG008|Part B (Overall)|Lost to Follow-up|0|||
105997911|NCT02714569|365653290|FG009|Part B (Overall)|Lost to Follow-up|0|||
105997912|NCT02714569|365653291|FG010|Part B (Overall)|Lost to Follow-up|0|||
105997913|NCT02714569|365653281|FG000|Part B (Overall)|Withdrawal by Subject|0|||
105997914|NCT02714569|365653282|FG001|Part B (Overall)|Withdrawal by Subject|0|||
105668060|NCT03238963|364448267|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
105668061|NCT03238963|364448266|FG000|Overall Study|Withdrawal by Subject|1|||
105668062|NCT03238963|364448267|FG001|Overall Study|Withdrawal by Subject|1|||
105668063|NCT03238963|364448266|FG000|Overall Study|Lost to Follow-up|1|||
105997915|NCT02714569|365653283|FG002|Part B (Overall)|Withdrawal by Subject|0|||
105668064|NCT03238963|364448267|FG001|Overall Study|Lost to Follow-up|0|||
105668065|NCT03238963|364448266|FG000|Overall Study|Protocol Violation|1|||
105899390|NCT03611582|365287593|FG001|Overall Study|Lost to Follow-up|7|||
105899391|NCT03611582|365287592|FG000|Overall Study|other|17|||
105899392|NCT03611582|365287593|FG001|Overall Study|other|16|||
105899393|NCT00463840|365287595|FG000|Overall Study|Disease progression|7|||
105899394|NCT00463840|365287595|FG000|Overall Study|Withdrawal by Subject|2|||
105899395|NCT00463840|365287595|FG000|Overall Study|Adverse Event|3|||
105899396|NCT00866333|365287596|FG000|Overall Study|Withdrawal of consent|0|||
105899397|NCT00866333|365287597|FG001|Overall Study|Withdrawal of consent|1|||
105899398|NCT00866333|365287598|FG002|Overall Study|Withdrawal of consent|2|||
105899399|NCT00866333|365287596|FG000|Overall Study|Reason not Specified|3|||
105899400|NCT00866333|365287597|FG001|Overall Study|Reason not Specified|1|||
105899401|NCT00866333|365287598|FG002|Overall Study|Reason not Specified|1|||
105899402|NCT00866333|365287596|FG000|Overall Study|Study Terminated by Sponsor|2|||
105899403|NCT00866333|365287597|FG001|Overall Study|Study Terminated by Sponsor|5|||
105899404|NCT00866333|365287598|FG002|Overall Study|Study Terminated by Sponsor|9|||
105899405|NCT01180049|365287599|FG000|Overall Study|Other|9|||
105899406|NCT01180049|365287600|FG001|Overall Study|Other|7|||
105899407|NCT01180049|365287599|FG000|Overall Study|Lost to Follow-up|8|||
105899408|NCT01180049|365287600|FG001|Overall Study|Lost to Follow-up|6|||
105899409|NCT01180049|365287599|FG000|Overall Study|Death|36|||
106124294|NCT00744237|366114025|FG000|Overall Study|Study Drug Error|1|||
106124295|NCT00744237|366114026|FG001|Overall Study|Study Drug Error|0|||
106124296|NCT00744237|366114027|FG002|Overall Study|Study Drug Error|0|||
106124297|NCT00744237|366114025|FG000|Overall Study|Prohibited Concomitant Medication|0|||
106124298|NCT00744237|366114026|FG001|Overall Study|Prohibited Concomitant Medication|0|||
106124299|NCT00744237|366114027|FG002|Overall Study|Prohibited Concomitant Medication|1|||
106124300|NCT00744237|366114025|FG000|Overall Study|Poor Compliance|0|||
106124301|NCT00744237|366114026|FG001|Overall Study|Poor Compliance|2|||
106124302|NCT00744237|366114027|FG002|Overall Study|Poor Compliance|0|||
106124303|NCT00744237|366114025|FG000|Overall Study|Administrative. Site Closed|1|||
106124304|NCT00744237|366114026|FG001|Overall Study|Administrative. Site Closed|1|||
106124305|NCT00744237|366114027|FG002|Overall Study|Administrative. Site Closed|1|||
106124306|NCT00744237|366114025|FG000|Overall Study|Adverse Event|9|||
106124307|NCT00744237|366114026|FG001|Overall Study|Adverse Event|13|||
106124308|NCT00744237|366114027|FG002|Overall Study|Adverse Event|5|||
106124309|NCT01995357|366114028|FG000|Period 5|Lack of Efficacy|1|||
106124310|NCT01995357|366114029|FG001|Period 5|Lack of Efficacy|0|||
106124311|NCT01995357|366114030|FG002|Period 5|Lack of Efficacy|0|||
106124312|NCT01995357|366114031|FG003|Period 5|Lack of Efficacy|0|||
106124313|NCT01995357|366114032|FG004|Period 5|Lack of Efficacy|0|||
106124314|NCT01995357|366114033|FG005|Period 5|Lack of Efficacy|0|||
106124315|NCT01995357|366114028|FG000|Period 5|Adverse Event|1|||
106124316|NCT01995357|366114029|FG001|Period 5|Adverse Event|0|||
106124317|NCT01995357|366114030|FG002|Period 5|Adverse Event|1|||
106124318|NCT01995357|366114031|FG003|Period 5|Adverse Event|0|||
106124319|NCT01995357|366114032|FG004|Period 5|Adverse Event|0|||
106124320|NCT01995357|366114033|FG005|Period 5|Adverse Event|0|||
106124321|NCT01702428|366114034|FG000|Overall Study|Adverse Event|2|||
106124322|NCT01702428|366114035|FG001|Overall Study|Adverse Event|0|||
106124323|NCT01702428|366114036|FG002|Overall Study|Adverse Event|0|||
105899410|NCT01180049|365287600|FG001|Overall Study|Death|35|||
105899411|NCT03338569|365287601|FG000|Overall Study|Physician Decision|8|||
105899412|NCT03338569|365287602|FG001|Overall Study|Physician Decision|3|||
105899413|NCT03338569|365287601|FG000|Overall Study|Withdrawal by Subject|0|||
105899414|NCT03338569|365287602|FG001|Overall Study|Withdrawal by Subject|1|||
105899415|NCT03338569|365287601|FG000|Overall Study|Lost to Follow-up|0|||
105899416|NCT03338569|365287602|FG001|Overall Study|Lost to Follow-up|1|||
105899417|NCT00958412|365287605|FG000|Overall Study|Study prematurely terminated|18|||
105899418|NCT01533688|365288964|FG000|Overall Study|Withdrawal by Subject|5|||
105899419|NCT01533688|365288965|FG001|Overall Study|Withdrawal by Subject|4|||
105899420|NCT01533688|365288966|FG002|Overall Study|Withdrawal by Subject|3|||
105899421|NCT01533688|365288964|FG000|Overall Study|Medically unstable|1|||
105899422|NCT01533688|365288965|FG001|Overall Study|Medically unstable|3|||
105899423|NCT01533688|365288966|FG002|Overall Study|Medically unstable|3|||
105899424|NCT01533688|365288964|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
106124324|NCT01702428|366114037|FG003|Overall Study|Adverse Event|0|||
106124325|NCT01702428|366114034|FG000|Overall Study|Lost to Follow-up|33|||
106124326|NCT01702428|366114035|FG001|Overall Study|Lost to Follow-up|41|||
106124327|NCT01702428|366114036|FG002|Overall Study|Lost to Follow-up|37|||
106124328|NCT01702428|366114037|FG003|Overall Study|Lost to Follow-up|44|||
106124329|NCT01702428|366114034|FG000|Overall Study|Parents cannot assist to site|1|||
105899425|NCT01533688|365288965|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
105899426|NCT01533688|365288966|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
105899427|NCT06439095|365288971|FG000|Overall Study|Lost to Follow-up|2|||
105899428|NCT01410240|365288979|FG000|Overall Study|Physician Decision|0|||
105899429|NCT01410240|365288980|FG001|Overall Study|Physician Decision|0|||
106124330|NCT01702428|366114035|FG001|Overall Study|Parents cannot assist to site|0|||
105899430|NCT01410240|365288981|FG002|Overall Study|Physician Decision|1|||
105899431|NCT01410240|365288979|FG000|Overall Study|Missed week 6 assessments|1|||
106124331|NCT01702428|366114036|FG002|Overall Study|Parents cannot assist to site|1|||
106124332|NCT01702428|366114037|FG003|Overall Study|Parents cannot assist to site|0|||
106124333|NCT01702428|366114034|FG000|Overall Study|Lost Coverage|0|||
106124334|NCT01702428|366114035|FG001|Overall Study|Lost Coverage|0|||
106124335|NCT01702428|366114036|FG002|Overall Study|Lost Coverage|0|||
106124336|NCT01702428|366114037|FG003|Overall Study|Lost Coverage|1|||
106124337|NCT01702428|366114034|FG000|Overall Study|Lost Health Plan|3|||
106124338|NCT01702428|366114035|FG001|Overall Study|Lost Health Plan|5|||
106124339|NCT01702428|366114036|FG002|Overall Study|Lost Health Plan|0|||
105899432|NCT01410240|365288980|FG001|Overall Study|Missed week 6 assessments|1|||
106124340|NCT01702428|366114037|FG003|Overall Study|Lost Health Plan|2|||
106124341|NCT01702428|366114034|FG000|Overall Study|Mother transferred care|0|||
106124342|NCT01702428|366114035|FG001|Overall Study|Mother transferred care|1|||
106124343|NCT01702428|366114036|FG002|Overall Study|Mother transferred care|0|||
106124344|NCT01702428|366114037|FG003|Overall Study|Mother transferred care|0|||
106124345|NCT01702428|366114034|FG000|Overall Study|Parents too busy|1|||
106124346|NCT01702428|366114035|FG001|Overall Study|Parents too busy|0|||
106124347|NCT01702428|366114036|FG002|Overall Study|Parents too busy|0|||
106124348|NCT01702428|366114037|FG003|Overall Study|Parents too busy|0|||
106124349|NCT01702428|366114034|FG000|Overall Study|Protocol Violation|3|||
106124350|NCT01702428|366114035|FG001|Overall Study|Protocol Violation|0|||
106124351|NCT01702428|366114036|FG002|Overall Study|Protocol Violation|1|||
106124352|NCT01702428|366114037|FG003|Overall Study|Protocol Violation|0|||
106124353|NCT01702428|366114034|FG000|Overall Study|Withdrawal by Subject|21|||
106124354|NCT01702428|366114035|FG001|Overall Study|Withdrawal by Subject|23|||
106124355|NCT01702428|366114036|FG002|Overall Study|Withdrawal by Subject|14|||
106124356|NCT01702428|366114037|FG003|Overall Study|Withdrawal by Subject|10|||
106124357|NCT03249376|366114038|FG000|Overall Study|Adverse Event|11|||
106124358|NCT03249376|366114039|FG001|Overall Study|Adverse Event|5|||
106124359|NCT03249376|366114038|FG000|Overall Study|Lack of Efficacy|2|||
106124360|NCT03249376|366114039|FG001|Overall Study|Lack of Efficacy|4|||
106124361|NCT03249376|366114038|FG000|Overall Study|Protocol Violation|3|||
106124362|NCT03249376|366114039|FG001|Overall Study|Protocol Violation|2|||
106124363|NCT03249376|366114038|FG000|Overall Study|Physician Decision|0|||
106124364|NCT03249376|366114039|FG001|Overall Study|Physician Decision|2|||
106124365|NCT03249376|366114038|FG000|Overall Study|Withdrawal by Subject|3|||
106124366|NCT03249376|366114039|FG001|Overall Study|Withdrawal by Subject|9|||
106124367|NCT03249376|366114038|FG000|Overall Study|LTFU|2|||
106124368|NCT03249376|366114039|FG001|Overall Study|LTFU|1|||
106124369|NCT02139982|366114046|FG000|Overall Study|Lack of Efficacy|0|||
106124370|NCT02139982|366114047|FG001|Overall Study|Lack of Efficacy|1|||
106124371|NCT02139982|366114048|FG002|Overall Study|Lack of Efficacy|0|||
105899433|NCT01410240|365288981|FG002|Overall Study|Missed week 6 assessments|1|||
105899434|NCT04348500|365288982|FG000|Overall Study|Death|2|||
105899435|NCT04348500|365288983|FG001|Overall Study|Death|2|||
105899436|NCT04348500|365288982|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
106124372|NCT02139982|366114049|FG003|Overall Study|Lack of Efficacy|1|||
105668066|NCT03238963|364448267|FG001|Overall Study|Protocol Violation|1|||
105899437|NCT04348500|365288983|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
105899438|NCT02722746|365288985|FG000|Overall Study|Withdrawal by Subject|0|||
105899439|NCT02722746|365288986|FG001|Overall Study|Withdrawal by Subject|1|||
105899440|NCT02722746|365288987|FG002|Overall Study|Withdrawal by Subject|0|||
105899441|NCT02722746|365288985|FG000|Overall Study|Protocol Violation|8|||
105899442|NCT02722746|365288986|FG001|Overall Study|Protocol Violation|4|||
105899443|NCT02722746|365288987|FG002|Overall Study|Protocol Violation|6|||
105899444|NCT01636947|365288998|FG000|Overall Study|Not Treated|2|||
105899445|NCT01636947|365288999|FG001|Overall Study|Not Treated|2|||
105899446|NCT01636947|365288998|FG000|Overall Study|Lost to Follow-up|4|||
105899447|NCT01636947|365288999|FG001|Overall Study|Lost to Follow-up|0|||
105899448|NCT01636947|365288998|FG000|Overall Study|Protocol Violation|1|||
105899449|NCT01636947|365288999|FG001|Overall Study|Protocol Violation|1|||
105899450|NCT01636947|365288998|FG000|Overall Study|Withdrawal by Subject|3|||
105899451|NCT01636947|365288999|FG001|Overall Study|Withdrawal by Subject|3|||
105899452|NCT01636947|365288998|FG000|Overall Study|Adverse Event|1|||
105899453|NCT01636947|365288999|FG001|Overall Study|Adverse Event|1|||
105899454|NCT01636947|365288998|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
105899455|NCT01636947|365288999|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
105668067|NCT03238963|364448266|FG000|Overall Study|Adverse Event|1|||
105668068|NCT03238963|364448267|FG001|Overall Study|Adverse Event|0|||
105899456|NCT00957424|365289000|FG000|Overall Study|Lost to Follow-up|19|||
105899457|NCT00957424|365289000|FG000|Overall Study|Protocol Violation|3|||
105899458|NCT00957424|365289000|FG000|Overall Study|Withdrawal by Subject|1|||
105997916|NCT02714569|365653284|FG003|Part B (Overall)|Withdrawal by Subject|0|||
106124373|NCT02139982|366114050|FG004|Overall Study|Lack of Efficacy|0|||
106124374|NCT02139982|366114051|FG005|Overall Study|Lack of Efficacy|0|||
106124375|NCT02139982|366114052|FG006|Overall Study|Lack of Efficacy|0|||
106124376|NCT02139982|366114053|FG007|Overall Study|Lack of Efficacy|0|||
106124377|NCT02139982|366114054|FG008|Overall Study|Lack of Efficacy|0|||
106124378|NCT02139982|366114055|FG009|Overall Study|Lack of Efficacy|0|||
105899459|NCT02700698|365289004|FG000|Overall Study|Withdrawal by Subject|1|||
105899460|NCT02700698|365289005|FG001|Overall Study|Withdrawal by Subject|0|||
105899461|NCT00530790|365289008|FG000|Overall Study|Adverse Event|2|||
105899462|NCT00530790|365289008|FG000|Overall Study|Withdrawal by Subject|2|||
106124379|NCT04254679|366114078|FG000|Overall Study|Protocol Violation|1|||
106124380|NCT04254679|366114079|FG001|Overall Study|Protocol Violation|1|||
106124381|NCT04254679|366114078|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
106124382|NCT04254679|366114079|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
106124383|NCT01591460|366114093|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
106124384|NCT01591460|366114093|FG000|Overall Study|Futility Rule (Week 12)|7|||
106124385|NCT01591460|366114093|FG000|Overall Study|Futility Rule (Week 24)|3|||
106124386|NCT01591460|366114093|FG000|Overall Study|Rebound or Breakthrough|3|||
106124387|NCT01591460|366114093|FG000|Overall Study|Treatment Discontinued by Error|1|||
106124388|NCT01591460|366114093|FG000|Overall Study|Lost to Follow-up|1|||
106124389|NCT01591460|366114093|FG000|Overall Study|Noncompliance|1|||
106124390|NCT01591460|366114093|FG000|Overall Study|Participant Refusal|3|||
106124391|NCT01591460|366114093|FG000|Overall Study|Withdrawal by Subject|1|||
106124392|NCT01591460|366114093|FG000|Overall Study|Protocol Violation|1|||
106124393|NCT00502996|366114096|FG000|Overall Study|Lost to Follow-up|9|||
106124394|NCT00502996|366114096|FG000|Overall Study|Protocol Violation|2|||
106124395|NCT00502996|366114096|FG000|Overall Study|Treatment failure|25|||
106124396|NCT00502996|366114096|FG000|Overall Study|Withdrawal Informed Consent|6|||
106124397|NCT00502996|366114096|FG000|Overall Study|Adverse Event|2|||
106124398|NCT01729728|366114097|FG000|Overall Study|Adverse Event|0|||
106124399|NCT01729728|366114098|FG001|Overall Study|Adverse Event|6|||
106124400|NCT01729728|366114099|FG002|Overall Study|Adverse Event|0|||
106124401|NCT01729728|366114097|FG000|Overall Study|Protocol Violation|1|||
106124402|NCT01729728|366114098|FG001|Overall Study|Protocol Violation|0|||
106124403|NCT01729728|366114099|FG002|Overall Study|Protocol Violation|1|||
106124404|NCT01536145|366114100|FG000|Overall Study|Progressive disease|3|||
106124405|NCT01536145|366114101|FG001|Overall Study|Progressive disease|4|||
106124406|NCT01536145|366114102|FG002|Overall Study|Progressive disease|1|||
106124407|NCT01536145|366114103|FG003|Overall Study|Progressive disease|2|||
106124408|NCT01536145|366114104|FG004|Overall Study|Progressive disease|1|||
106124409|NCT01536145|366114105|FG005|Overall Study|Progressive disease|2|||
106124410|NCT01536145|366114106|FG006|Overall Study|Progressive disease|1|||
106124411|NCT01536145|366114107|FG007|Overall Study|Progressive disease|2|||
106124412|NCT01536145|366114108|FG008|Overall Study|Progressive disease|1|||
106124413|NCT01536145|366114109|FG009|Overall Study|Progressive disease|3|||
106124414|NCT01536145|366114110|FG010|Overall Study|Progressive disease|3|||
106124415|NCT01536145|366114100|FG000|Overall Study|Withdrawal by Subject|0|||
106124416|NCT01536145|366114101|FG001|Overall Study|Withdrawal by Subject|0|||
106124417|NCT01536145|366114102|FG002|Overall Study|Withdrawal by Subject|1|||
106124418|NCT01536145|366114103|FG003|Overall Study|Withdrawal by Subject|0|||
106124419|NCT01536145|366114104|FG004|Overall Study|Withdrawal by Subject|0|||
106124420|NCT01536145|366114105|FG005|Overall Study|Withdrawal by Subject|1|||
106124421|NCT01536145|366114106|FG006|Overall Study|Withdrawal by Subject|0|||
106124422|NCT01536145|366114107|FG007|Overall Study|Withdrawal by Subject|0|||
106124423|NCT01536145|366114108|FG008|Overall Study|Withdrawal by Subject|2|||
106124424|NCT01536145|366114109|FG009|Overall Study|Withdrawal by Subject|0|||
106124425|NCT01536145|366114110|FG010|Overall Study|Withdrawal by Subject|2|||
106124426|NCT01536145|366114100|FG000|Overall Study|Other|0|||
106124427|NCT01536145|366114101|FG001|Overall Study|Other|0|||
106124428|NCT01536145|366114102|FG002|Overall Study|Other|0|||
106124429|NCT01536145|366114103|FG003|Overall Study|Other|0|||
106124430|NCT01536145|366114104|FG004|Overall Study|Other|1|||
106124431|NCT01536145|366114105|FG005|Overall Study|Other|0|||
106124432|NCT01536145|366114106|FG006|Overall Study|Other|0|||
105899463|NCT00530790|365289008|FG000|Overall Study|Physician Decision|1|||
105899464|NCT00553358|365289009|FG000|Overall Study|Randomized but did not receive treatment|3|||
105899465|NCT00553358|365289010|FG001|Overall Study|Randomized but did not receive treatment|3|||
105899466|NCT00553358|365289011|FG002|Overall Study|Randomized but did not receive treatment|1|||
105899467|NCT00553358|365289009|FG000|Overall Study|Lost to Follow-up|22|||
105899468|NCT00553358|365289010|FG001|Overall Study|Lost to Follow-up|26|||
105899469|NCT00553358|365289011|FG002|Overall Study|Lost to Follow-up|18|||
105899470|NCT00553358|365289009|FG000|Overall Study|Withdrew completely|23|||
105899471|NCT00553358|365289010|FG001|Overall Study|Withdrew completely|33|||
106124433|NCT01536145|366114107|FG007|Overall Study|Other|0|||
106124434|NCT01536145|366114108|FG008|Overall Study|Other|0|||
106124435|NCT01536145|366114109|FG009|Overall Study|Other|3|||
106124436|NCT01536145|366114110|FG010|Overall Study|Other|2|||
105668069|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Adverse Event|10|||
106124437|NCT01536145|366114100|FG000|Overall Study|Death|0|||
106124438|NCT01536145|366114101|FG001|Overall Study|Death|0|||
106124439|NCT01536145|366114102|FG002|Overall Study|Death|0|||
106124440|NCT01536145|366114103|FG003|Overall Study|Death|0|||
106124441|NCT01536145|366114104|FG004|Overall Study|Death|0|||
106124442|NCT01536145|366114105|FG005|Overall Study|Death|0|||
106124443|NCT01536145|366114106|FG006|Overall Study|Death|1|||
106124444|NCT01536145|366114107|FG007|Overall Study|Death|0|||
105668070|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Adverse Event|9|||
106124445|NCT01536145|366114108|FG008|Overall Study|Death|0|||
106124446|NCT01536145|366114109|FG009|Overall Study|Death|0|||
106124447|NCT01536145|366114110|FG010|Overall Study|Death|0|||
106124448|NCT01536145|366114100|FG000|Overall Study|Adverse Event|0|||
106124449|NCT01536145|366114101|FG001|Overall Study|Adverse Event|0|||
106124450|NCT01536145|366114102|FG002|Overall Study|Adverse Event|0|||
105899472|NCT00553358|365289011|FG002|Overall Study|Withdrew completely|34|||
105899473|NCT00553358|365289009|FG000|Overall Study|Died during clinical follow-up|25|||
105899474|NCT00553358|365289010|FG001|Overall Study|Died during clinical follow-up|29|||
105899475|NCT00553358|365289011|FG002|Overall Study|Died during clinical follow-up|32|||
105899476|NCT00553358|365289009|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
105899477|NCT00553358|365289010|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
105899478|NCT00553358|365289011|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
105899479|NCT00553358|365289009|FG000|Overall Study|Died after clinical follow-up ended|1|||
105899480|NCT00553358|365289010|FG001|Overall Study|Died after clinical follow-up ended|2|||
105899481|NCT00553358|365289011|FG002|Overall Study|Died after clinical follow-up ended|0|||
105899482|NCT00553358|365289009|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
105899483|NCT00553358|365289010|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
105899484|NCT00553358|365289011|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
105899485|NCT01133288|365289012|FG000|Eligibility Assessment|met exclusion criteria|5|||
105899486|NCT01133288|365289012|FG000|Intervention Allocation|study terminated|2|||
105899487|NCT04933617|365289015|FG000|Dose Escalation|Early closure of study|0|||
105899488|NCT04933617|365289016|FG001|Dose Escalation|Early closure of study|3|||
105899489|NCT04933617|365289017|FG002|Dose Escalation|Early closure of study|0|||
105899490|NCT04933617|365289018|FG003|Dose Escalation|Early closure of study|0|||
105899491|NCT04933617|365289019|FG004|Dose Escalation|Early closure of study|0|||
105899492|NCT00369161|365289020|FG000|Overall Study|Adverse Event|15|||
105899493|NCT00369161|365289021|FG001|Overall Study|Adverse Event|13|||
105899494|NCT00369161|365289020|FG000|Overall Study|Abnormal laboratory value|0|||
105899495|NCT00369161|365289021|FG001|Overall Study|Abnormal laboratory value|1|||
105899496|NCT00369161|365289020|FG000|Overall Study|Lack of Efficacy|3|||
105668071|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Adverse Event|7|||
105668072|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
105668073|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
105668074|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
105899497|NCT00369161|365289021|FG001|Overall Study|Lack of Efficacy|1|||
105899498|NCT00369161|365289020|FG000|Overall Study|Protocol Violation|0|||
105899499|NCT00369161|365289021|FG001|Overall Study|Protocol Violation|2|||
105899500|NCT00369161|365289020|FG000|Overall Study|Withdrawal by Subject|2|||
105899501|NCT00369161|365289021|FG001|Overall Study|Withdrawal by Subject|3|||
105899502|NCT00369161|365289020|FG000|Overall Study|Death|1|||
105899503|NCT00369161|365289021|FG001|Overall Study|Death|2|||
105899504|NCT00369161|365289020|FG000|Overall Study|Graft loss|4|||
105899505|NCT00369161|365289021|FG001|Overall Study|Graft loss|0|||
105899506|NCT00369161|365289020|FG000|Overall Study|Administrative Problem|2|||
105899507|NCT00369161|365289021|FG001|Overall Study|Administrative Problem|2|||
105899508|NCT03760458|365289022|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
105899509|NCT03760458|365289023|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
105899510|NCT03760458|365289024|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
105899511|NCT03760458|365289025|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
105899512|NCT03760458|365289026|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
105899513|NCT00750919|365289027|FG000|Overall Study|Adverse Event|9|||
105899514|NCT00750919|365289027|FG000|Overall Study|Withdrawal by Subject|1|||
105899515|NCT00750919|365289027|FG000|Overall Study|Lack of Efficacy|8|||
105899516|NCT00750919|365289027|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
105899517|NCT00750919|365289027|FG000|Overall Study|Other|36|||
105899518|NCT02943785|365289028|FG000|Overall Study|Adverse Event|112|||
105899519|NCT02943785|365289029|FG001|Overall Study|Adverse Event|97|||
105899520|NCT02943785|365289028|FG000|Overall Study|Withdrawal by Subject|63|||
105899521|NCT02943785|365289029|FG001|Overall Study|Withdrawal by Subject|126|||
105899522|NCT02943785|365289028|FG000|Overall Study|Physician Decision|23|||
105899523|NCT02943785|365289029|FG001|Overall Study|Physician Decision|47|||
105899524|NCT02943785|365289028|FG000|Overall Study|Death|46|||
105899525|NCT02943785|365289029|FG001|Overall Study|Death|46|||
105899526|NCT02943785|365289028|FG000|Overall Study|Lost to Follow-up|1|||
105899527|NCT02943785|365289029|FG001|Overall Study|Lost to Follow-up|0|||
105899528|NCT02943785|365289028|FG000|Overall Study|Other|16|||
105899529|NCT02943785|365289029|FG001|Overall Study|Other|19|||
105899530|NCT02943785|365289028|FG000|Overall Study|Did not receive any study medication|21|||
105899531|NCT02943785|365289029|FG001|Overall Study|Did not receive any study medication|28|||
105899532|NCT03170609|365289032|FG000|Overall Study|Death|0|||
105899533|NCT03170609|365289033|FG001|Overall Study|Death|0|||
105899534|NCT03170609|365289034|FG002|Overall Study|Death|1|||
105899535|NCT03170609|365289035|FG003|Overall Study|Death|0|||
105899536|NCT03170609|365289036|FG004|Overall Study|Death|0|||
105668075|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
105899537|NCT03170609|365289037|FG005|Overall Study|Death|0|||
105899538|NCT03170609|365289038|FG006|Overall Study|Death|0|||
105899539|NCT03170609|365289032|FG000|Overall Study|Withdrawal by Subject|1|||
105899540|NCT03170609|365289033|FG001|Overall Study|Withdrawal by Subject|2|||
105899541|NCT03170609|365289034|FG002|Overall Study|Withdrawal by Subject|0|||
105899542|NCT03170609|365289035|FG003|Overall Study|Withdrawal by Subject|0|||
105899543|NCT03170609|365289036|FG004|Overall Study|Withdrawal by Subject|0|||
105899544|NCT03170609|365289037|FG005|Overall Study|Withdrawal by Subject|0|||
105899545|NCT03170609|365289038|FG006|Overall Study|Withdrawal by Subject|1|||
105899546|NCT03170609|365289032|FG000|Overall Study|Lost to Follow-up|1|||
105899547|NCT03170609|365289033|FG001|Overall Study|Lost to Follow-up|0|||
105899548|NCT03170609|365289034|FG002|Overall Study|Lost to Follow-up|5|||
105899549|NCT03170609|365289035|FG003|Overall Study|Lost to Follow-up|2|||
105899550|NCT03170609|365289036|FG004|Overall Study|Lost to Follow-up|1|||
105899551|NCT03170609|365289037|FG005|Overall Study|Lost to Follow-up|1|||
105899552|NCT03170609|365289038|FG006|Overall Study|Lost to Follow-up|0|||
105899553|NCT03170609|365289032|FG000|Overall Study|Other|1|||
105899554|NCT03170609|365289033|FG001|Overall Study|Other|0|||
105899555|NCT03170609|365289034|FG002|Overall Study|Other|0|||
105899556|NCT03170609|365289035|FG003|Overall Study|Other|0|||
105899557|NCT03170609|365289036|FG004|Overall Study|Other|0|||
105899558|NCT03170609|365289037|FG005|Overall Study|Other|1|||
105899559|NCT03170609|365289038|FG006|Overall Study|Other|0|||
105899560|NCT00575510|365289041|FG000|Overall Study|Lost to Follow-up|4|||
105899561|NCT00575510|365289042|FG001|Overall Study|Lost to Follow-up|6|||
105899562|NCT00575510|365289043|FG002|Overall Study|Lost to Follow-up|9|||
105899563|NCT00575510|365289041|FG000|Overall Study|Withdrawal by Subject|1|||
105899564|NCT00575510|365289042|FG001|Overall Study|Withdrawal by Subject|0|||
105899565|NCT00575510|365289043|FG002|Overall Study|Withdrawal by Subject|0|||
105899566|NCT00575510|365289041|FG000|Overall Study|Clinic Called Patient|7|||
105899567|NCT00575510|365289042|FG001|Overall Study|Clinic Called Patient|7|||
105899568|NCT00575510|365289043|FG002|Overall Study|Clinic Called Patient|7|||
105899569|NCT00575510|365289041|FG000|Overall Study|Pregnancy|0|||
105899570|NCT00575510|365289042|FG001|Overall Study|Pregnancy|0|||
105899571|NCT00575510|365289043|FG002|Overall Study|Pregnancy|1|||
105899572|NCT00419159|365289044|FG000|Overall Study|Adverse Event|7|||
105899573|NCT00419159|365289045|FG001|Overall Study|Adverse Event|15|||
105899574|NCT00419159|365289044|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105899575|NCT00419159|365289045|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105899576|NCT00419159|365289044|FG000|Overall Study|Subject's no longer requires study drug|0|||
105899577|NCT00419159|365289045|FG001|Overall Study|Subject's no longer requires study drug|1|||
105899578|NCT00419159|365289044|FG000|Overall Study|Protocol Violation|1|||
105899579|NCT00419159|365289045|FG001|Overall Study|Protocol Violation|0|||
105899580|NCT00419159|365289044|FG000|Overall Study|Withdrawal by Subject|10|||
105899581|NCT00419159|365289045|FG001|Overall Study|Withdrawal by Subject|3|||
105899582|NCT00419159|365289044|FG000|Overall Study|Lost to Follow-up|0|||
105899583|NCT00419159|365289045|FG001|Overall Study|Lost to Follow-up|1|||
105899584|NCT00419159|365289044|FG000|Overall Study|Death|2|||
105899585|NCT00419159|365289045|FG001|Overall Study|Death|2|||
105899586|NCT00419159|365289044|FG000|Overall Study|Disease progression|79|||
105899587|NCT00419159|365289045|FG001|Overall Study|Disease progression|76|||
105899588|NCT01017601|365289046|FG000|Overall Study|Disease Progression|12|||
105899589|NCT01017601|365289047|FG001|Overall Study|Disease Progression|12|||
105899590|NCT01017601|365289046|FG000|Overall Study|Withdrawal by Subject|0|||
105899591|NCT01017601|365289047|FG001|Overall Study|Withdrawal by Subject|1|||
105899592|NCT02839876|365289056|FG000|Overall Study|Protocol Violation|10|||
105899593|NCT02839876|365289057|FG001|Overall Study|Protocol Violation|11|||
105899594|NCT00586898|365289058|FG000|Overall Study|Adverse Event|1|||
105899595|NCT00586898|365289058|FG000|Overall Study|Patiemt Non-compliance|1|||
106124451|NCT01536145|366114103|FG003|Overall Study|Adverse Event|0|||
105899596|NCT00586898|365289058|FG000|Overall Study|Evaluable for Toxicity Only|5|||
105899597|NCT02208050|365289064|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
105899598|NCT02208050|365289065|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
105899599|NCT01210144|365289066|FG000|Overall Study|Lack of ovarian response|1|||
105899600|NCT01210144|365289067|FG001|Overall Study|Lack of ovarian response|0|||
105899601|NCT01210144|365289066|FG000|Overall Study|No fertilization|1|||
105899602|NCT01210144|365289067|FG001|Overall Study|No fertilization|0|||
105899603|NCT01210144|365289066|FG000|Overall Study|No transfer|1|||
105899604|NCT01210144|365289067|FG001|Overall Study|No transfer|0|||
105899605|NCT00094536|365289070|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
105899606|NCT00094536|365289070|FG000|Treatment and Follow-up|Adverse Event|4|||
105899607|NCT00094536|365289070|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
105899608|NCT00094536|365289070|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
105899609|NCT00094536|365289070|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
106124452|NCT01536145|366114104|FG004|Overall Study|Adverse Event|0|||
105899610|NCT00094536|365289070|FG000|Treatment and Follow-up|Subject non-compliance|9|||
105899611|NCT00094536|365289070|FG000|Treatment and Follow-up|Unable to attend visits|1|||
105899612|NCT02620384|365289071|FG000|Overall Study|Adverse Event|2|||
106124453|NCT01536145|366114105|FG005|Overall Study|Adverse Event|0|||
105899613|NCT02620384|365289072|FG001|Overall Study|Adverse Event|1|||
105899614|NCT02620384|365289071|FG000|Overall Study|Discharged prior to 2nd dose|2|||
106124454|NCT01536145|366114106|FG006|Overall Study|Adverse Event|0|||
105899615|NCT02620384|365289072|FG001|Overall Study|Discharged prior to 2nd dose|5|||
106124455|NCT01536145|366114107|FG007|Overall Study|Adverse Event|2|||
105899616|NCT02620384|365289071|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
105899617|NCT02620384|365289072|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
105899618|NCT03053427|365289073|FG000|Overall Study|Adverse Event|4|||
105899619|NCT03053427|365289074|FG001|Overall Study|Adverse Event|4|||
105899620|NCT03053427|365289073|FG000|Overall Study|Lack of Efficacy|1|||
105899621|NCT03053427|365289074|FG001|Overall Study|Lack of Efficacy|3|||
105899622|NCT03053427|365289073|FG000|Overall Study|Lost to Follow-up|2|||
105899623|NCT03053427|365289074|FG001|Overall Study|Lost to Follow-up|2|||
105899624|NCT03053427|365289073|FG000|Overall Study|Worsening of the target disease|0|||
105899625|NCT03053427|365289074|FG001|Overall Study|Worsening of the target disease|1|||
105899626|NCT03053427|365289073|FG000|Overall Study|Protocol Deviation|3|||
105899627|NCT03053427|365289074|FG001|Overall Study|Protocol Deviation|3|||
105899628|NCT03053427|365289073|FG000|Overall Study|Withdrawal by Subject|3|||
105899629|NCT03053427|365289074|FG001|Overall Study|Withdrawal by Subject|2|||
105899630|NCT03053427|365289073|FG000|Overall Study|Miscellaneous|0|||
105899631|NCT03053427|365289074|FG001|Overall Study|Miscellaneous|1|||
105899632|NCT01416155|365289075|FG000|Overall Study|Adverse Event|8|||
105899633|NCT01416155|365289075|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
105899634|NCT01416155|365289075|FG000|Overall Study|Withdrawal by Subject|33|||
105899635|NCT01416155|365289075|FG000|Overall Study|Investigator decision|8|||
105899636|NCT01416155|365289075|FG000|Overall Study|Other|7|||
105899637|NCT01714609|365289076|FG000|Overall Study|Protocol Violation|1|||
105899638|NCT01714609|365289077|FG001|Overall Study|Protocol Violation|0|||
105899639|NCT00549601|365290652|FG000|Randomized|Protocol Violation|0|||
105899640|NCT00549601|365290653|FG001|Randomized|Protocol Violation|0|||
105899641|NCT00549601|365290654|FG002|Randomized|Protocol Violation|1|||
105899642|NCT00549601|365290652|FG000|Randomized|Withdrawal by Subject|0|||
105899643|NCT00549601|365290653|FG001|Randomized|Withdrawal by Subject|1|||
105899644|NCT00549601|365290654|FG002|Randomized|Withdrawal by Subject|1|||
105899645|NCT00549601|365290652|FG000|Received Study Drug|Adverse Event|2|||
105899646|NCT00549601|365290653|FG001|Received Study Drug|Adverse Event|5|||
105899647|NCT00549601|365290654|FG002|Received Study Drug|Adverse Event|1|||
105899648|NCT00549601|365290652|FG000|Received Study Drug|Death|0|||
105899649|NCT00549601|365290653|FG001|Received Study Drug|Death|1|||
105899650|NCT00549601|365290654|FG002|Received Study Drug|Death|0|||
105899651|NCT00549601|365290652|FG000|Received Study Drug|Lost to Follow-up|0|||
105899652|NCT00549601|365290653|FG001|Received Study Drug|Lost to Follow-up|1|||
105899653|NCT00549601|365290654|FG002|Received Study Drug|Lost to Follow-up|1|||
105899654|NCT00549601|365290652|FG000|Received Study Drug|Protocol Violation|3|||
105899655|NCT00549601|365290653|FG001|Received Study Drug|Protocol Violation|4|||
105899656|NCT00549601|365290654|FG002|Received Study Drug|Protocol Violation|1|||
105899657|NCT00549601|365290652|FG000|Received Study Drug|Withdrawal by Subject|2|||
105899658|NCT00549601|365290653|FG001|Received Study Drug|Withdrawal by Subject|0|||
105899659|NCT00549601|365290654|FG002|Received Study Drug|Withdrawal by Subject|1|||
105899660|NCT04114656|365290655|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
105899661|NCT04114656|365290656|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
105899662|NCT04114656|365290655|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
105899663|NCT04114656|365290656|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
105899664|NCT04114656|365290655|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
105899665|NCT04114656|365290656|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
105899666|NCT04114656|365290655|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
105899667|NCT04114656|365290656|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
105899668|NCT04114656|365290655|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
105899669|NCT04114656|365290656|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
105899670|NCT02732015|365290657|FG000|Overall Study|Lost to Follow-up|0|||
105899671|NCT02732015|365290658|FG001|Overall Study|Lost to Follow-up|1|||
105899672|NCT03052920|365290659|FG000|Overall Study|Withdrawal by Subject|1|||
105899673|NCT01313221|365290662|FG000|Overall Study|Protocol Violation|0|||
105899674|NCT01313221|365290663|FG001|Overall Study|Protocol Violation|1|||
105899675|NCT01313221|365290664|FG002|Overall Study|Protocol Violation|1|||
105899676|NCT01313221|365290662|FG000|Overall Study|Non-compliance|3|||
105899677|NCT01313221|365290663|FG001|Overall Study|Non-compliance|0|||
105899678|NCT01313221|365290664|FG002|Overall Study|Non-compliance|2|||
105899679|NCT01313221|365290662|FG000|Overall Study|Withdrawal by Subject|2|||
105899680|NCT01313221|365290663|FG001|Overall Study|Withdrawal by Subject|3|||
105899681|NCT01313221|365290664|FG002|Overall Study|Withdrawal by Subject|5|||
105899682|NCT01313221|365290662|FG000|Overall Study|Requirement for alternative therapy|0|||
105899683|NCT01313221|365290663|FG001|Overall Study|Requirement for alternative therapy|1|||
105899684|NCT01313221|365290664|FG002|Overall Study|Requirement for alternative therapy|1|||
105899685|NCT01313221|365290662|FG000|Overall Study|Lost to Follow-up|6|||
105899686|NCT01313221|365290663|FG001|Overall Study|Lost to Follow-up|3|||
106124456|NCT01536145|366114108|FG008|Overall Study|Adverse Event|0|||
105899687|NCT01313221|365290664|FG002|Overall Study|Lost to Follow-up|1|||
105899688|NCT01313221|365290662|FG000|Overall Study|Other|1|||
105899689|NCT01313221|365290663|FG001|Overall Study|Other|0|||
105899690|NCT01313221|365290664|FG002|Overall Study|Other|0|||
105899691|NCT01313221|365290662|FG000|Overall Study|Adverse Event|0|||
105899692|NCT01313221|365290663|FG001|Overall Study|Adverse Event|0|||
105899693|NCT01313221|365290664|FG002|Overall Study|Adverse Event|7|||
105899694|NCT01313221|365290662|FG000|Overall Study|Disease progression|0|||
105899695|NCT01313221|365290663|FG001|Overall Study|Disease progression|0|||
105899696|NCT01313221|365290664|FG002|Overall Study|Disease progression|2|||
105899697|NCT01313221|365290662|FG000|Overall Study|Physician Decision|0|||
105899698|NCT01313221|365290663|FG001|Overall Study|Physician Decision|0|||
105899699|NCT01313221|365290664|FG002|Overall Study|Physician Decision|2|||
105899700|NCT01313221|365290662|FG000|Overall Study|Pregnancy|0|||
105899701|NCT01313221|365290663|FG001|Overall Study|Pregnancy|0|||
105899702|NCT01313221|365290664|FG002|Overall Study|Pregnancy|2|||
105899703|NCT00994214|365290665|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
105899704|NCT00994214|365290666|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
105899705|NCT00994214|365290667|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
105899706|NCT00994214|365290668|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
105899707|NCT00994214|365290665|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
105899708|NCT00994214|365290666|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
105899709|NCT00994214|365290667|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
105899710|NCT00994214|365290668|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
105899711|NCT00994214|365290665|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
105899712|NCT00994214|365290666|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
105899713|NCT00994214|365290667|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
105899714|NCT00994214|365290668|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
105899715|NCT00994214|365290665|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
105899716|NCT00994214|365290666|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
105899717|NCT00994214|365290667|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
105899718|NCT00994214|365290668|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
105899719|NCT00994214|365290665|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
105899720|NCT00994214|365290666|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
105899721|NCT00994214|365290667|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
105899722|NCT00994214|365290668|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
105899723|NCT00994214|365290665|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
105899724|NCT00994214|365290666|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
105899725|NCT00994214|365290667|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
105899726|NCT00994214|365290668|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
105899727|NCT02864316|365290671|FG000|Overall Study|Progressive Disease|2|||
105899728|NCT02864316|365290672|FG001|Overall Study|Progressive Disease|1|||
105899729|NCT02864316|365290671|FG000|Overall Study|Adverse Event|0|||
105899730|NCT02864316|365290672|FG001|Overall Study|Adverse Event|1|||
105899731|NCT00298363|365290674|FG000|Overall Study|Lost to Follow-up|0|||
105899732|NCT00298363|365290675|FG001|Overall Study|Lost to Follow-up|0|||
105899733|NCT00298363|365290676|FG002|Overall Study|Lost to Follow-up|1|||
105899734|NCT00298363|365290674|FG000|Overall Study|Physician Decision|4|||
105899735|NCT00298363|365290675|FG001|Overall Study|Physician Decision|1|||
105899736|NCT00298363|365290676|FG002|Overall Study|Physician Decision|0|||
105899737|NCT00298363|365290674|FG000|Overall Study|Protocol Violation|1|||
105899738|NCT00298363|365290675|FG001|Overall Study|Protocol Violation|1|||
105899739|NCT00298363|365290676|FG002|Overall Study|Protocol Violation|0|||
105899740|NCT00298363|365290674|FG000|Overall Study|Withdrawal by Subject|5|||
105899741|NCT00298363|365290675|FG001|Overall Study|Withdrawal by Subject|1|||
105899742|NCT00298363|365290676|FG002|Overall Study|Withdrawal by Subject|3|||
105899743|NCT00298363|365290674|FG000|Overall Study|Adverse Event|5|||
105899744|NCT00298363|365290675|FG001|Overall Study|Adverse Event|2|||
105899745|NCT00298363|365290676|FG002|Overall Study|Adverse Event|2|||
105899746|NCT00298363|365290674|FG000|Overall Study|Lack of Efficacy|2|||
105899747|NCT00298363|365290675|FG001|Overall Study|Lack of Efficacy|3|||
105899748|NCT00298363|365290676|FG002|Overall Study|Lack of Efficacy|0|||
105899749|NCT00433017|365290677|FG000|Overall Study|Adverse Event|5|||
105899750|NCT00433017|365290678|FG001|Overall Study|Adverse Event|3|||
105899751|NCT00433017|365290677|FG000|Overall Study|Withdrawal by Subject|4|||
105899752|NCT00433017|365290678|FG001|Overall Study|Withdrawal by Subject|5|||
105899753|NCT00433017|365290677|FG000|Overall Study|Lost to Follow-up|3|||
105899754|NCT00433017|365290678|FG001|Overall Study|Lost to Follow-up|4|||
105899755|NCT00433017|365290677|FG000|Overall Study|Administrative problems|80|||
105997917|NCT02714569|365653285|FG004|Part B (Overall)|Withdrawal by Subject|0|||
105997918|NCT02714569|365653286|FG005|Part B (Overall)|Withdrawal by Subject|0|||
105899756|NCT00433017|365290678|FG001|Overall Study|Administrative problems|86|||
105997919|NCT02714569|365653287|FG006|Part B (Overall)|Withdrawal by Subject|0|||
105899757|NCT00433017|365290677|FG000|Overall Study|Protocol Violation|1|||
105899758|NCT00433017|365290678|FG001|Overall Study|Protocol Violation|0|||
105899759|NCT00433017|365290677|FG000|Overall Study|Death|2|||
105899760|NCT00433017|365290678|FG001|Overall Study|Death|2|||
105899761|NCT00433017|365290677|FG000|Overall Study|Subject no longer requires study drug|1|||
105899762|NCT00433017|365290678|FG001|Overall Study|Subject no longer requires study drug|1|||
105899763|NCT04710368|365290679|FG000|Overall Study|Withdrawal by Subject|9|||
105899764|NCT04710368|365290679|FG000|Overall Study|Lost to Follow-up|4|||
105899765|NCT04710368|365290679|FG000|Overall Study|Death|2|||
105899766|NCT04710368|365290679|FG000|Overall Study|Patient preference|11|||
105899767|NCT04710368|365290679|FG000|Overall Study|Treatment discontinuation|1|||
105899768|NCT00135356|365290680|FG000|Overall Study|Adverse Event|6|||
105899769|NCT00135356|365290681|FG001|Overall Study|Adverse Event|2|||
105899770|NCT00135356|365290680|FG000|Overall Study|Lack of Efficacy|2|||
105899771|NCT00135356|365290681|FG001|Overall Study|Lack of Efficacy|0|||
105899772|NCT00135356|365290680|FG000|Overall Study|Lost to Follow-up|3|||
105899773|NCT00135356|365290681|FG001|Overall Study|Lost to Follow-up|1|||
105899774|NCT00135356|365290680|FG000|Overall Study|Surgery for abdominal fat|1|||
105899775|NCT00135356|365290681|FG001|Overall Study|Surgery for abdominal fat|0|||
105899776|NCT00135356|365290680|FG000|Overall Study|Change in antiviral regimen|0|||
105899777|NCT00135356|365290681|FG001|Overall Study|Change in antiviral regimen|1|||
105899778|NCT00135356|365290680|FG000|Overall Study|Poor/noncompliance|1|||
105899779|NCT00135356|365290681|FG001|Overall Study|Poor/noncompliance|1|||
105899780|NCT00135356|365290680|FG000|Overall Study|No longer meets study criteria|2|||
105899781|NCT00135356|365290681|FG001|Overall Study|No longer meets study criteria|0|||
105899782|NCT00135356|365290680|FG000|Overall Study|Withdrawal by Subject|2|||
105899783|NCT00135356|365290681|FG001|Overall Study|Withdrawal by Subject|4|||
105899784|NCT04767529|365290688|FG000|Overall Study|Adverse Event|0|||
105899785|NCT04767529|365290689|FG001|Overall Study|Adverse Event|4|||
105899786|NCT04767529|365290690|FG002|Overall Study|Adverse Event|3|||
105899787|NCT04767529|365290688|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
105899788|NCT04767529|365290689|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
105899789|NCT04767529|365290690|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
105899790|NCT04767529|365290688|FG000|Overall Study|Required use of a prohibited medication|0|||
105899791|NCT04767529|365290689|FG001|Overall Study|Required use of a prohibited medication|1|||
105899792|NCT04767529|365290690|FG002|Overall Study|Required use of a prohibited medication|0|||
105899793|NCT04767529|365290688|FG000|Overall Study|Withdrawal by Subject|7|||
105899794|NCT04767529|365290689|FG001|Overall Study|Withdrawal by Subject|5|||
105899795|NCT04767529|365290690|FG002|Overall Study|Withdrawal by Subject|4|||
105899796|NCT04767529|365290688|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
105899797|NCT04767529|365290689|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
105899798|NCT04767529|365290690|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
105899799|NCT04767529|365290688|FG000|Overall Study|Lost to Follow-up|0|||
105899800|NCT04767529|365290689|FG001|Overall Study|Lost to Follow-up|2|||
105899801|NCT04767529|365290690|FG002|Overall Study|Lost to Follow-up|3|||
105899802|NCT04847232|365290691|FG000|Overall Study|Death|123|||
105899803|NCT04847232|365290692|FG001|Overall Study|Death|115|||
105899804|NCT04847232|365290691|FG000|Overall Study|Lost to Follow-up|3|||
105899805|NCT04847232|365290692|FG001|Overall Study|Lost to Follow-up|10|||
105899806|NCT04847232|365290691|FG000|Overall Study|Withdrawal by Subject|73|||
105899807|NCT04847232|365290692|FG001|Overall Study|Withdrawal by Subject|101|||
105899808|NCT04847232|365290691|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
105899809|NCT04847232|365290692|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
105899810|NCT02697591|365290694|FG000|Overall Study|Lost to Follow-up|0|||
105899811|NCT02697591|365290695|FG001|Overall Study|Lost to Follow-up|0|||
105899812|NCT02697591|365290696|FG002|Overall Study|Lost to Follow-up|0|||
105899813|NCT02697591|365290697|FG003|Overall Study|Lost to Follow-up|0|||
105899814|NCT02697591|365290698|FG004|Overall Study|Lost to Follow-up|0|||
105899815|NCT02697591|365290699|FG005|Overall Study|Lost to Follow-up|1|||
105899816|NCT02697591|365290700|FG006|Overall Study|Lost to Follow-up|1|||
105899817|NCT02697591|365290701|FG007|Overall Study|Lost to Follow-up|0|||
105899818|NCT02697591|365290702|FG008|Overall Study|Lost to Follow-up|0|||
105899819|NCT02697591|365290703|FG009|Overall Study|Lost to Follow-up|1|||
105899820|NCT02697591|365290694|FG000|Overall Study|Withdrawal by Subject|1|||
105899821|NCT02697591|365290695|FG001|Overall Study|Withdrawal by Subject|1|||
105899822|NCT02697591|365290696|FG002|Overall Study|Withdrawal by Subject|2|||
105899823|NCT02697591|365290697|FG003|Overall Study|Withdrawal by Subject|1|||
105899824|NCT02697591|365290698|FG004|Overall Study|Withdrawal by Subject|7|||
105899825|NCT02697591|365290699|FG005|Overall Study|Withdrawal by Subject|6|||
105899826|NCT02697591|365290700|FG006|Overall Study|Withdrawal by Subject|9|||
105899827|NCT02697591|365290701|FG007|Overall Study|Withdrawal by Subject|1|||
105899828|NCT02697591|365290702|FG008|Overall Study|Withdrawal by Subject|6|||
105899829|NCT02697591|365290703|FG009|Overall Study|Withdrawal by Subject|10|||
105899830|NCT02697591|365290694|FG000|Overall Study|Physician Decision|1|||
105899831|NCT02697591|365290695|FG001|Overall Study|Physician Decision|0|||
105899832|NCT02697591|365290696|FG002|Overall Study|Physician Decision|0|||
105899833|NCT02697591|365290697|FG003|Overall Study|Physician Decision|0|||
105899834|NCT02697591|365290698|FG004|Overall Study|Physician Decision|1|||
105899835|NCT02697591|365290699|FG005|Overall Study|Physician Decision|2|||
105899836|NCT02697591|365290700|FG006|Overall Study|Physician Decision|0|||
105899837|NCT02697591|365290701|FG007|Overall Study|Physician Decision|0|||
105899838|NCT02697591|365290702|FG008|Overall Study|Physician Decision|1|||
105899839|NCT02697591|365290703|FG009|Overall Study|Physician Decision|1|||
105899840|NCT02697591|365290694|FG000|Overall Study|Death|2|||
105899841|NCT02697591|365290695|FG001|Overall Study|Death|3|||
105899842|NCT02697591|365290696|FG002|Overall Study|Death|1|||
105899843|NCT02697591|365290697|FG003|Overall Study|Death|1|||
105899844|NCT02697591|365290698|FG004|Overall Study|Death|4|||
105899845|NCT02697591|365290699|FG005|Overall Study|Death|5|||
105899846|NCT02697591|365290700|FG006|Overall Study|Death|3|||
105899847|NCT02697591|365290701|FG007|Overall Study|Death|1|||
105899848|NCT02697591|365290702|FG008|Overall Study|Death|1|||
105899849|NCT02697591|365290703|FG009|Overall Study|Death|5|||
105899850|NCT02697591|365290694|FG000|Overall Study|Reason not Specified|0|||
105899851|NCT02697591|365290695|FG001|Overall Study|Reason not Specified|0|||
105899852|NCT02697591|365290696|FG002|Overall Study|Reason not Specified|0|||
105899853|NCT02697591|365290697|FG003|Overall Study|Reason not Specified|1|||
105899854|NCT02697591|365290698|FG004|Overall Study|Reason not Specified|1|||
105899855|NCT02697591|365290699|FG005|Overall Study|Reason not Specified|2|||
105899856|NCT02697591|365290700|FG006|Overall Study|Reason not Specified|3|||
105899857|NCT02697591|365290701|FG007|Overall Study|Reason not Specified|1|||
105899858|NCT02697591|365290702|FG008|Overall Study|Reason not Specified|1|||
105899859|NCT02697591|365290703|FG009|Overall Study|Reason not Specified|3|||
105899860|NCT00004088|365290705|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
105899861|NCT00004088|365290705|FG000|Overall Study|Withdrawal by Subject|1|||
105899862|NCT00004088|365290705|FG000|Overall Study|Protocol Violation|3|||
105899863|NCT00004088|365290705|FG000|Overall Study|Physician Decision|1|||
105899864|NCT00981058|365290706|FG000|Overall Study|Progressive Disease|38|||
105899865|NCT00981058|365290707|FG001|Overall Study|Progressive Disease|31|||
105899866|NCT00981058|365290706|FG000|Overall Study|Lost to Follow-up|3|||
106124457|NCT01536145|366114109|FG009|Overall Study|Adverse Event|0|||
106124458|NCT01536145|366114110|FG010|Overall Study|Adverse Event|3|||
106124459|NCT04267614|366114111|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
106124460|NCT04267614|366114111|FG000|Overall Study|Lost to Follow-up|115|||
105899867|NCT00981058|365290707|FG001|Overall Study|Lost to Follow-up|2|||
105899868|NCT00981058|365290706|FG000|Overall Study|Physician Decision|4|||
105899869|NCT00981058|365290707|FG001|Overall Study|Physician Decision|5|||
105899870|NCT00981058|365290706|FG000|Overall Study|Randomization Error|0|||
105899871|NCT00981058|365290707|FG001|Overall Study|Randomization Error|1|||
105899872|NCT00981058|365290706|FG000|Overall Study|Withdrawal by Subject|24|||
105899873|NCT00981058|365290707|FG001|Overall Study|Withdrawal by Subject|22|||
105899874|NCT01134263|365290708|FG000|Overall Study|Serious adverse event|2|||
105899875|NCT01134263|365290709|FG001|Overall Study|Serious adverse event|1|||
105899876|NCT01134263|365290710|FG002|Overall Study|Serious adverse event|1|||
105899877|NCT01134263|365290711|FG003|Overall Study|Serious adverse event|1|||
105899878|NCT01134263|365290712|FG004|Overall Study|Serious adverse event|1|||
105899879|NCT01134263|365290708|FG000|Overall Study|Other adverse event|1|||
105899880|NCT01134263|365290709|FG001|Overall Study|Other adverse event|2|||
105899881|NCT01134263|365290710|FG002|Overall Study|Other adverse event|5|||
105899882|NCT01134263|365290711|FG003|Overall Study|Other adverse event|3|||
105899883|NCT01134263|365290712|FG004|Overall Study|Other adverse event|0|||
105899884|NCT01134263|365290708|FG000|Overall Study|Protocol Violation|8|||
105899885|NCT01134263|365290709|FG001|Overall Study|Protocol Violation|7|||
105899886|NCT01134263|365290710|FG002|Overall Study|Protocol Violation|2|||
105899887|NCT01134263|365290711|FG003|Overall Study|Protocol Violation|4|||
105899888|NCT01134263|365290712|FG004|Overall Study|Protocol Violation|2|||
105899889|NCT01134263|365290708|FG000|Overall Study|Lost to Follow-up|4|||
105899890|NCT01134263|365290709|FG001|Overall Study|Lost to Follow-up|3|||
105899891|NCT01134263|365290710|FG002|Overall Study|Lost to Follow-up|5|||
105899892|NCT01134263|365290711|FG003|Overall Study|Lost to Follow-up|3|||
105899893|NCT01134263|365290712|FG004|Overall Study|Lost to Follow-up|1|||
105899894|NCT01134263|365290708|FG000|Overall Study|Withdrawal by Subject|8|||
105899895|NCT01134263|365290709|FG001|Overall Study|Withdrawal by Subject|6|||
105899896|NCT01134263|365290710|FG002|Overall Study|Withdrawal by Subject|16|||
105899897|NCT01134263|365290711|FG003|Overall Study|Withdrawal by Subject|7|||
105899898|NCT01134263|365290712|FG004|Overall Study|Withdrawal by Subject|5|||
105899899|NCT01134263|365290708|FG000|Overall Study|Enrolled, but not treated|1|||
105899900|NCT01134263|365290709|FG001|Overall Study|Enrolled, but not treated|1|||
105899901|NCT01134263|365290710|FG002|Overall Study|Enrolled, but not treated|0|||
106124461|NCT01284140|366114112|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
105899902|NCT01134263|365290711|FG003|Overall Study|Enrolled, but not treated|1|||
105899903|NCT01134263|365290712|FG004|Overall Study|Enrolled, but not treated|0|||
105899904|NCT05053035|365290718|FG000|Overall Study|Withdrawal by Subject|1|||
105899905|NCT05053035|365290719|FG001|Overall Study|Withdrawal by Subject|0|||
105899906|NCT03008278|365290726|FG000|Overall Study|Progressive Disease|0|||
105899907|NCT03008278|365290727|FG001|Overall Study|Progressive Disease|0|||
105899908|NCT03008278|365290728|FG002|Overall Study|Progressive Disease|32|||
105899909|NCT03008278|365290726|FG000|Overall Study|Adverse Event|0|||
105899910|NCT03008278|365290727|FG001|Overall Study|Adverse Event|0|||
105899911|NCT03008278|365290728|FG002|Overall Study|Adverse Event|4|||
105899912|NCT03008278|365290726|FG000|Overall Study|Withdrawal by Subject|0|||
105899913|NCT03008278|365290727|FG001|Overall Study|Withdrawal by Subject|0|||
105899914|NCT03008278|365290728|FG002|Overall Study|Withdrawal by Subject|3|||
105899915|NCT03008278|365290726|FG000|Overall Study|Physician Decision|0|||
105899916|NCT03008278|365290727|FG001|Overall Study|Physician Decision|2|||
105899917|NCT03008278|365290728|FG002|Overall Study|Physician Decision|0|||
105899918|NCT03411902|365290732|FG000|Overall Study|Lost to Follow-up|3|||
105899919|NCT03411902|365290733|FG001|Overall Study|Lost to Follow-up|0|||
105899920|NCT02279745|365290734|FG000|Overall Study|Adverse Event|7|||
105899921|NCT02279745|365290734|FG000|Overall Study|Death|6|||
105899922|NCT02279745|365290734|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
105899923|NCT02279745|365290734|FG000|Overall Study|Withdrawal by Subject|2|||
105899924|NCT02279745|365290734|FG000|Overall Study|Pregnancy|1|||
105899925|NCT02279745|365290734|FG000|Overall Study|Study Non-compliance|1|||
105899926|NCT02279745|365290734|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
105899927|NCT01094782|365290736|FG000|Overall Study|Withdrawal by Subject|5|||
105899928|NCT01094782|365290737|FG001|Overall Study|Withdrawal by Subject|5|||
105899929|NCT01094782|365290738|FG002|Overall Study|Withdrawal by Subject|1|||
105899930|NCT01094782|365290739|FG003|Overall Study|Withdrawal by Subject|5|||
105899931|NCT01094782|365290740|FG004|Overall Study|Withdrawal by Subject|5|||
105899932|NCT01094782|365290741|FG005|Overall Study|Withdrawal by Subject|0|||
105899933|NCT01094782|365290736|FG000|Overall Study|Lost to Follow-up|1|||
105899934|NCT01094782|365290737|FG001|Overall Study|Lost to Follow-up|0|||
105899935|NCT01094782|365290738|FG002|Overall Study|Lost to Follow-up|0|||
105899936|NCT01094782|365290739|FG003|Overall Study|Lost to Follow-up|2|||
105899937|NCT01094782|365290740|FG004|Overall Study|Lost to Follow-up|1|||
105899938|NCT01094782|365290741|FG005|Overall Study|Lost to Follow-up|4|||
105899939|NCT01094782|365290736|FG000|Overall Study|Positive Drug Screen|2|||
105899940|NCT01094782|365290737|FG001|Overall Study|Positive Drug Screen|2|||
105899941|NCT01094782|365290738|FG002|Overall Study|Positive Drug Screen|1|||
105899942|NCT01094782|365290739|FG003|Overall Study|Positive Drug Screen|1|||
105899943|NCT01094782|365290740|FG004|Overall Study|Positive Drug Screen|3|||
105899944|NCT01094782|365290741|FG005|Overall Study|Positive Drug Screen|2|||
105899945|NCT01094782|365290736|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
105899946|NCT01094782|365290737|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
105899947|NCT01094782|365290738|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
105899948|NCT01094782|365290739|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
105899949|NCT01094782|365290740|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
105899950|NCT01094782|365290741|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
105899951|NCT01094782|365290736|FG000|Overall Study|Unable to Complete Questionnaires|0|||
105899952|NCT01094782|365290737|FG001|Overall Study|Unable to Complete Questionnaires|1|||
105899953|NCT01094782|365290738|FG002|Overall Study|Unable to Complete Questionnaires|0|||
105899954|NCT01094782|365290739|FG003|Overall Study|Unable to Complete Questionnaires|0|||
105899955|NCT01094782|365290740|FG004|Overall Study|Unable to Complete Questionnaires|0|||
105899956|NCT01094782|365290741|FG005|Overall Study|Unable to Complete Questionnaires|0|||
105899957|NCT01094782|365290736|FG000|Overall Study|Healthy Subject Had Pain|0|||
105899958|NCT01094782|365290737|FG001|Overall Study|Healthy Subject Had Pain|1|||
105899959|NCT01094782|365290738|FG002|Overall Study|Healthy Subject Had Pain|0|||
105899960|NCT01094782|365290739|FG003|Overall Study|Healthy Subject Had Pain|0|||
105899961|NCT01094782|365290740|FG004|Overall Study|Healthy Subject Had Pain|0|||
105899962|NCT01094782|365290741|FG005|Overall Study|Healthy Subject Had Pain|0|||
105899963|NCT01094782|365290736|FG000|Overall Study|Hypertension|0|||
105899964|NCT01094782|365290737|FG001|Overall Study|Hypertension|0|||
105899965|NCT01094782|365290738|FG002|Overall Study|Hypertension|1|||
105899966|NCT01094782|365290739|FG003|Overall Study|Hypertension|0|||
105899967|NCT01094782|365290740|FG004|Overall Study|Hypertension|0|||
106124462|NCT01284140|366114113|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
106124463|NCT01284140|366114112|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
106124464|NCT01284140|366114113|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
106124465|NCT00210119|366114114|FG000|Overall Study|Protocol Violation|1|||
106124466|NCT00210119|366114114|FG000|Overall Study|Withdrawal by Subject|1|||
105899968|NCT01094782|365290741|FG005|Overall Study|Hypertension|0|||
105899969|NCT01094782|365290736|FG000|Overall Study|Wrong Pain Condition|0|||
105899970|NCT01094782|365290737|FG001|Overall Study|Wrong Pain Condition|0|||
105899971|NCT01094782|365290738|FG002|Overall Study|Wrong Pain Condition|0|||
105899972|NCT01094782|365290739|FG003|Overall Study|Wrong Pain Condition|2|||
105899973|NCT01094782|365290740|FG004|Overall Study|Wrong Pain Condition|1|||
105899974|NCT01094782|365290741|FG005|Overall Study|Wrong Pain Condition|1|||
105899975|NCT01094782|365290736|FG000|Overall Study|Recent Interventional Injection|0|||
105668076|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
105668077|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
105668078|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Physician Decision|7|||
105668079|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Physician Decision|3|||
105668080|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Physician Decision|2|||
105668081|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Pregnancy|2|||
105668082|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Pregnancy|1|||
105668083|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Pregnancy|3|||
105668084|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
105668085|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
105668086|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
105668087|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
105668088|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
105668089|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
105668090|NCT02614183|364448268|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
105668091|NCT02614183|364448269|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
105668092|NCT02614183|364448270|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
105668093|NCT02614183|364448268|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
105668094|NCT02614183|364448269|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
105668095|NCT02614183|364448270|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
105668096|NCT02614183|364448268|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
105668097|NCT02614183|364448269|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
105668098|NCT02614183|364448270|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
105668099|NCT02614183|364448268|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
105668100|NCT02614183|364448269|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
105668101|NCT02614183|364448270|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
105668102|NCT02614183|364448268|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
105668103|NCT02614183|364448269|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
105668104|NCT02614183|364448270|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
105668105|NCT04949802|364450153|FG000|Overall Study|Lost to Follow-up|3|||
105668106|NCT01240551|364450154|FG000|Overall Study|Refused further treatment|3|||
105668107|NCT01240551|364450155|FG001|Overall Study|Refused further treatment|2|||
105668108|NCT01240551|364450154|FG000|Overall Study|Lost to Follow-up|1|||
105668109|NCT01240551|364450155|FG001|Overall Study|Lost to Follow-up|1|||
105668110|NCT00233480|364450156|FG000|Overall Study|Underwent status II heart transplant|0|||
105668111|NCT00233480|364450157|FG001|Overall Study|Underwent status II heart transplant|1|||
105668112|NCT01920477|364450158|FG000|Overall Study|Adverse Event|0|||
105668113|NCT01920477|364450159|FG001|Overall Study|Adverse Event|1|||
105668114|NCT01920477|364450158|FG000|Overall Study|Lack of Efficacy|1|||
105668115|NCT01920477|364450159|FG001|Overall Study|Lack of Efficacy|0|||
105668116|NCT01920477|364450158|FG000|Overall Study|Study closed/terminated|14|||
105668117|NCT01920477|364450159|FG001|Overall Study|Study closed/terminated|15|||
105668118|NCT01920477|364450158|FG000|Overall Study|Withdrawal by Subject|0|||
105668119|NCT01920477|364450159|FG001|Overall Study|Withdrawal by Subject|1|||
105668120|NCT01443403|364450160|FG000|Overall Study|Adverse Event|1|||
105668121|NCT01443403|364450161|FG001|Overall Study|Adverse Event|1|||
105668122|NCT01443403|364450162|FG002|Overall Study|Adverse Event|4|||
105668123|NCT01443403|364450163|FG003|Overall Study|Adverse Event|5|||
105668124|NCT01443403|364450160|FG000|Overall Study|Withdrawal by Subject|0|||
105899976|NCT01094782|365290737|FG001|Overall Study|Recent Interventional Injection|0|||
105899977|NCT01094782|365290738|FG002|Overall Study|Recent Interventional Injection|0|||
105899978|NCT01094782|365290739|FG003|Overall Study|Recent Interventional Injection|0|||
105899979|NCT01094782|365290740|FG004|Overall Study|Recent Interventional Injection|0|||
105899980|NCT01094782|365290741|FG005|Overall Study|Recent Interventional Injection|1|||
105668125|NCT01443403|364450161|FG001|Overall Study|Withdrawal by Subject|1|||
105899981|NCT01094782|365290736|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105899982|NCT01094782|365290737|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105899983|NCT01094782|365290738|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105899984|NCT01094782|365290739|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105668126|NCT01443403|364450162|FG002|Overall Study|Withdrawal by Subject|2|||
105899985|NCT01094782|365290740|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
105899986|NCT01094782|365290741|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
105899987|NCT01094782|365290736|FG000|Overall Study|Noncompliance With Study Schedule|0|||
105668127|NCT01443403|364450163|FG003|Overall Study|Withdrawal by Subject|1|||
105668128|NCT01443403|364450160|FG000|Overall Study|Lost to Follow-up|0|||
105668129|NCT01443403|364450161|FG001|Overall Study|Lost to Follow-up|0|||
105668130|NCT01443403|364450162|FG002|Overall Study|Lost to Follow-up|0|||
105668131|NCT01443403|364450163|FG003|Overall Study|Lost to Follow-up|1|||
105668132|NCT01443403|364450160|FG000|Overall Study|Protocol Violation|2|||
105668133|NCT01443403|364450161|FG001|Overall Study|Protocol Violation|1|||
105668134|NCT01443403|364450162|FG002|Overall Study|Protocol Violation|1|||
105668135|NCT01443403|364450163|FG003|Overall Study|Protocol Violation|1|||
105668136|NCT01443403|364450160|FG000|Overall Study|Use of Prohibited Treatment|2|||
105899988|NCT01094782|365290737|FG001|Overall Study|Noncompliance With Study Schedule|0|||
105899989|NCT01094782|365290738|FG002|Overall Study|Noncompliance With Study Schedule|0|||
105899990|NCT01094782|365290739|FG003|Overall Study|Noncompliance With Study Schedule|1|||
105899991|NCT01094782|365290740|FG004|Overall Study|Noncompliance With Study Schedule|0|||
105899992|NCT01094782|365290741|FG005|Overall Study|Noncompliance With Study Schedule|0|||
105899993|NCT03084315|365290742|FG000|Overall Study|Lost to Follow-up|8|||
105899994|NCT03084315|365290743|FG001|Overall Study|Lost to Follow-up|7|||
105899995|NCT03084315|365290742|FG000|Overall Study|Withdrawal by Subject|2|||
105899996|NCT03084315|365290743|FG001|Overall Study|Withdrawal by Subject|2|||
105899997|NCT00586508|365290744|FG000|Overall Study|Progressive disease|52|||
105899998|NCT00586508|365290745|FG001|Overall Study|Progressive disease|8|||
105899999|NCT00586508|365290744|FG000|Overall Study|Death|0|||
105900000|NCT00586508|365290745|FG001|Overall Study|Death|1|||
105900001|NCT00586508|365290744|FG000|Overall Study|Adverse Event|12|||
105900002|NCT00586508|365290745|FG001|Overall Study|Adverse Event|4|||
105900003|NCT00586508|365290744|FG000|Overall Study|Withdrawal by Subject|4|||
105900004|NCT00586508|365290745|FG001|Overall Study|Withdrawal by Subject|0|||
105900005|NCT02028169|365290747|FG000|Overall Study|Lost to Follow-up|21|||
105900006|NCT02028169|365290747|FG000|Overall Study|Lack of Efficacy|2|||
105900007|NCT02028169|365290747|FG000|Overall Study|Withdrawal by Subject|2|||
105900008|NCT02028169|365290747|FG000|Overall Study|Adverse Event|1|||
105900009|NCT02028169|365290747|FG000|Overall Study|Cessation of Drug|1|||
105900010|NCT02028169|365290747|FG000|Overall Study|Concomitant Medication Usage|1|||
105900011|NCT04266795|365290748|FG000|Overall Study|Adverse Event|10|||
105900012|NCT04266795|365290749|FG001|Overall Study|Adverse Event|19|||
105900013|NCT04266795|365290748|FG000|Overall Study|Death|7|||
105900014|NCT04266795|365290749|FG001|Overall Study|Death|8|||
105900015|NCT04266795|365290748|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
105900016|NCT04266795|365290749|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
105900017|NCT04266795|365290748|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
105900018|NCT04266795|365290749|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105900019|NCT04266795|365290748|FG000|Overall Study|Progressive Disease|12|||
105900020|NCT04266795|365290749|FG001|Overall Study|Progressive Disease|9|||
105900021|NCT04266795|365290748|FG000|Overall Study|Withdrawal by Patient|5|||
105900022|NCT04266795|365290749|FG001|Overall Study|Withdrawal by Patient|6|||
105900023|NCT04266795|365290748|FG000|Overall Study|Disease Relapse|3|||
105900024|NCT04266795|365290749|FG001|Overall Study|Disease Relapse|6|||
105900025|NCT04266795|365290748|FG000|Overall Study|Reason not Specified|12|||
105900026|NCT04266795|365290749|FG001|Overall Study|Reason not Specified|10|||
105900027|NCT04266795|365290748|FG000|Overall Study|Participants Ongoing on Treatment|25|||
105900028|NCT04266795|365290749|FG001|Overall Study|Participants Ongoing on Treatment|23|||
105900029|NCT00793546|365290750|FG000|Overall Study|Death|3|||
105900030|NCT00793546|365290751|FG001|Overall Study|Death|0|||
105900031|NCT00793546|365290750|FG000|Overall Study|Lost to Follow-up|1|||
105900032|NCT00793546|365290751|FG001|Overall Study|Lost to Follow-up|0|||
105900033|NCT00793546|365290750|FG000|Overall Study|Withdrawal by Subject|1|||
105900034|NCT00793546|365290751|FG001|Overall Study|Withdrawal by Subject|1|||
105900035|NCT00793546|365290750|FG000|Overall Study|Study Terminated by Sponsor|8|||
105900036|NCT00793546|365290751|FG001|Overall Study|Study Terminated by Sponsor|27|||
105900037|NCT00793546|365290750|FG000|Overall Study|Other|1|||
105900038|NCT00793546|365290751|FG001|Overall Study|Other|0|||
105900039|NCT02071082|365290756|FG000|Overall Study|Enrolled and Never Treated|1|||
105900040|NCT02071082|365290757|FG001|Overall Study|Enrolled and Never Treated|1|||
105900041|NCT02071082|365290756|FG000|Overall Study|Adverse Event|0|||
105900042|NCT02071082|365290757|FG001|Overall Study|Adverse Event|1|||
105900043|NCT02071082|365290756|FG000|Overall Study|Withdrew Consent|0|||
105900044|NCT02071082|365290757|FG001|Overall Study|Withdrew Consent|4|||
105900045|NCT02071082|365290756|FG000|Overall Study|Lost to Follow-up|1|||
105900046|NCT02071082|365290757|FG001|Overall Study|Lost to Follow-up|1|||
105900047|NCT02101359|365290758|FG000|Overall Study|Not included|23|||
105900048|NCT02101359|365290759|FG001|Overall Study|Not included|13|||
105668137|NCT01443403|364450161|FG001|Overall Study|Use of Prohibited Treatment|3|||
105668138|NCT01443403|364450162|FG002|Overall Study|Use of Prohibited Treatment|0|||
105668139|NCT01443403|364450163|FG003|Overall Study|Use of Prohibited Treatment|0|||
105900049|NCT02101359|365290758|FG000|Overall Study|Withdrawal by Subject|5|||
105668140|NCT01443403|364450160|FG000|Overall Study|Other - Miscellaneous|1|||
105900050|NCT02101359|365290759|FG001|Overall Study|Withdrawal by Subject|4|||
105668141|NCT01443403|364450161|FG001|Overall Study|Other - Miscellaneous|0|||
105668142|NCT01443403|364450162|FG002|Overall Study|Other - Miscellaneous|0|||
105900051|NCT02101359|365290758|FG000|Overall Study|Lost to Follow-up|1|||
105900052|NCT02101359|365290759|FG001|Overall Study|Lost to Follow-up|0|||
105900053|NCT02101359|365290758|FG000|Overall Study|Protocol Violation|0|||
105900054|NCT02101359|365290759|FG001|Overall Study|Protocol Violation|2|||
105900055|NCT02732327|365290762|FG000|Overall Study|Protocol Violation|0|||
105900056|NCT02732327|365290763|FG001|Overall Study|Protocol Violation|1|||
105900057|NCT00603382|365290764|FG000|Overall Study|Adverse Event|0|||
105900058|NCT00603382|365290765|FG001|Overall Study|Adverse Event|1|||
105900059|NCT00603382|365290766|FG002|Overall Study|Adverse Event|1|||
105900060|NCT00603382|365290767|FG003|Overall Study|Adverse Event|2|||
105900061|NCT00603382|365290768|FG004|Overall Study|Adverse Event|1|||
105900062|NCT00603382|365290769|FG005|Overall Study|Adverse Event|2|||
105900063|NCT00603382|365290764|FG000|Overall Study|Lack of Efficacy|14|||
105900064|NCT00603382|365290765|FG001|Overall Study|Lack of Efficacy|9|||
105900065|NCT00603382|365290766|FG002|Overall Study|Lack of Efficacy|3|||
105900066|NCT00603382|365290767|FG003|Overall Study|Lack of Efficacy|6|||
105900067|NCT00603382|365290768|FG004|Overall Study|Lack of Efficacy|6|||
105900068|NCT00603382|365290769|FG005|Overall Study|Lack of Efficacy|11|||
105900069|NCT00603382|365290764|FG000|Overall Study|Protocol Violation|1|||
105900070|NCT00603382|365290765|FG001|Overall Study|Protocol Violation|0|||
105900071|NCT00603382|365290766|FG002|Overall Study|Protocol Violation|1|||
105900072|NCT00603382|365290767|FG003|Overall Study|Protocol Violation|2|||
105900073|NCT00603382|365290768|FG004|Overall Study|Protocol Violation|1|||
105900074|NCT00603382|365290769|FG005|Overall Study|Protocol Violation|0|||
105900075|NCT00603382|365290764|FG000|Overall Study|Lost to Follow-up|0|||
105900076|NCT00603382|365290765|FG001|Overall Study|Lost to Follow-up|1|||
105900077|NCT00603382|365290766|FG002|Overall Study|Lost to Follow-up|1|||
105900078|NCT00603382|365290767|FG003|Overall Study|Lost to Follow-up|1|||
105900079|NCT00603382|365290768|FG004|Overall Study|Lost to Follow-up|0|||
105900080|NCT00603382|365290769|FG005|Overall Study|Lost to Follow-up|1|||
105900081|NCT00603382|365290764|FG000|Overall Study|Physician Decision|0|||
105900082|NCT00603382|365290765|FG001|Overall Study|Physician Decision|0|||
105900083|NCT00603382|365290766|FG002|Overall Study|Physician Decision|2|||
105900084|NCT00603382|365290767|FG003|Overall Study|Physician Decision|0|||
106124467|NCT04827134|366114115|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
106124468|NCT04827134|366114116|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
106124469|NCT04827134|366114117|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
106124470|NCT04827134|366114118|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
106124471|NCT01313923|366114125|FG000|Overall Study|Physician Decision|3|||
106124472|NCT03358329|366114126|FG000|Overall Study|Lost to Follow-up|2|||
106124473|NCT03358329|366114126|FG000|Overall Study|Withdrawal by Subject|2|||
106124474|NCT03875911|366114129|FG000|Overall Study|Lost to Follow-up|3|||
106124475|NCT03875911|366114130|FG001|Overall Study|Lost to Follow-up|6|||
106124476|NCT03875911|366114131|FG002|Overall Study|Lost to Follow-up|2|||
106124477|NCT03875911|366114129|FG000|Overall Study|Surgery cancelled|1|||
106124478|NCT03875911|366114130|FG001|Overall Study|Surgery cancelled|0|||
106124479|NCT03875911|366114131|FG002|Overall Study|Surgery cancelled|1|||
106124480|NCT03875911|366114129|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
105900085|NCT00603382|365290768|FG004|Overall Study|Physician Decision|1|||
105900086|NCT00603382|365290769|FG005|Overall Study|Physician Decision|3|||
105900087|NCT00603382|365290764|FG000|Overall Study|Withdrawal by Subject|3|||
105900088|NCT00603382|365290765|FG001|Overall Study|Withdrawal by Subject|3|||
105900089|NCT00603382|365290766|FG002|Overall Study|Withdrawal by Subject|1|||
105900090|NCT00603382|365290767|FG003|Overall Study|Withdrawal by Subject|1|||
105900091|NCT00603382|365290768|FG004|Overall Study|Withdrawal by Subject|0|||
105900092|NCT00603382|365290769|FG005|Overall Study|Withdrawal by Subject|1|||
105900093|NCT02012959|365290770|FG000|Treatment Phase A|Adverse Event|2|||
105900094|NCT02012959|365290771|FG001|Treatment Phase A|Adverse Event|0|||
105900095|NCT02012959|365290772|FG002|Treatment Phase A|Adverse Event|0|||
105900096|NCT02012959|365290773|FG003|Treatment Phase A|Adverse Event|0|||
105900097|NCT02012959|365290774|FG004|Treatment Phase A|Adverse Event|0|||
105900098|NCT01783821|365290776|FG000|Overall Study|Screen Failure|1|||
105900099|NCT01783821|365290777|FG001|Overall Study|Screen Failure|1|||
105900100|NCT01907217|365290780|FG000|Overall Study|Withdrawal by Subject|0|||
105900101|NCT01907217|365290781|FG001|Overall Study|Withdrawal by Subject|2|||
105900102|NCT00659776|365290782|FG000|Overall Study|Withdrawal by Subject|12|||
105900103|NCT00659776|365290783|FG001|Overall Study|Withdrawal by Subject|2|||
106124481|NCT03875911|366114130|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
105900104|NCT00659776|365290784|FG002|Overall Study|Withdrawal by Subject|0|||
106124482|NCT03875911|366114131|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
105900105|NCT01249833|365290787|FG000|Overall Study|Lost to Follow-up|0|||
105900106|NCT01249833|365290788|FG001|Overall Study|Lost to Follow-up|1|||
105900107|NCT02243046|365290789|FG000|Overall Study|Lost to Follow-up|1|||
105900108|NCT02243046|365290790|FG001|Overall Study|Lost to Follow-up|1|||
105900109|NCT02243046|365290791|FG002|Overall Study|Lost to Follow-up|4|||
105900110|NCT00350779|365290792|FG000|Overall Study|Adverse Event|4|||
105900111|NCT00350779|365290793|FG001|Overall Study|Adverse Event|2|||
105900112|NCT00350779|365290792|FG000|Overall Study|Lack of Efficacy|0|||
105900113|NCT00350779|365290793|FG001|Overall Study|Lack of Efficacy|4|||
105900114|NCT00350779|365290792|FG000|Overall Study|Lost to Follow-up|2|||
105900115|NCT00350779|365290793|FG001|Overall Study|Lost to Follow-up|0|||
105900116|NCT00350779|365290792|FG000|Overall Study|Physician Decision|2|||
105900117|NCT00350779|365290793|FG001|Overall Study|Physician Decision|4|||
105900118|NCT00350779|365290792|FG000|Overall Study|Protocol Violation|3|||
105900119|NCT00350779|365290793|FG001|Overall Study|Protocol Violation|1|||
105900120|NCT00350779|365290792|FG000|Overall Study|Withdrawal by Subject|9|||
105900121|NCT00350779|365290793|FG001|Overall Study|Withdrawal by Subject|8|||
106124483|NCT00305864|366114132|FG000|Overall Study|Ineligible / No protocol treatment|0|||
106124484|NCT00305864|366114133|FG001|Overall Study|Ineligible / No protocol treatment|1|||
106124485|NCT00305864|366114134|FG002|Overall Study|Ineligible / No protocol treatment|1|||
106124486|NCT00305864|366114135|FG003|Overall Study|Ineligible / No protocol treatment|13|||
106124487|NCT01734850|366114138|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
106124488|NCT01734850|366114139|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
106124489|NCT01734850|366114140|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
106124490|NCT01734850|366114138|FG000|Overall Study|Not infused due to manufacturing failure|0|||
106124491|NCT01734850|366114139|FG001|Overall Study|Not infused due to manufacturing failure|0|||
106124492|NCT01734850|366114140|FG002|Overall Study|Not infused due to manufacturing failure|1|||
106124493|NCT00750893|366114141|FG000|Overall Study|Adverse Event|5|||
106124494|NCT00750893|366114141|FG000|Overall Study|Withdrawal by Subject|10|||
106124495|NCT00750893|366114141|FG000|Overall Study|Lost to Follow-up|510|||
105668143|NCT01443403|364450163|FG003|Overall Study|Other - Miscellaneous|1|||
105668144|NCT01681277|364450164|FG000|Overall Study|Adverse Event|1|||
105668145|NCT01681277|364450165|FG001|Overall Study|Adverse Event|0|||
105668146|NCT01681277|364450166|FG002|Overall Study|Adverse Event|0|||
105668147|NCT01681277|364450167|FG003|Overall Study|Adverse Event|0|||
105668148|NCT01681277|364450168|FG004|Overall Study|Adverse Event|0|||
105668149|NCT00474526|364450169|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
105668150|NCT00474526|364450170|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
105668151|NCT00474526|364450171|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
105668152|NCT00474526|364450172|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
105668153|NCT00474526|364450173|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
105668154|NCT00474526|364450174|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
105900122|NCT00350779|365290792|FG000|Overall Study|Patient Moved|2|||
105900123|NCT00350779|365290793|FG001|Overall Study|Patient Moved|1|||
105900124|NCT00350779|365290792|FG000|Overall Study|Non-compliance with study procedures|0|||
105900125|NCT00350779|365290793|FG001|Overall Study|Non-compliance with study procedures|1|||
105900126|NCT03796676|365290794|FG000|Overall Study|Adverse Event|2|||
105900127|NCT03796676|365290795|FG001|Overall Study|Adverse Event|1|||
105900128|NCT03796676|365290796|FG002|Overall Study|Adverse Event|2|||
105900129|NCT03796676|365290794|FG000|Overall Study|Lost to Follow-up|2|||
105900130|NCT03796676|365290795|FG001|Overall Study|Lost to Follow-up|1|||
105900131|NCT03796676|365290796|FG002|Overall Study|Lost to Follow-up|0|||
105900132|NCT03796676|365290794|FG000|Overall Study|Protocol Violation|0|||
105900133|NCT03796676|365290795|FG001|Overall Study|Protocol Violation|0|||
105900134|NCT03796676|365290796|FG002|Overall Study|Protocol Violation|1|||
105900135|NCT03796676|365290794|FG000|Overall Study|Withdrawal by Subject|1|||
105900136|NCT03796676|365290795|FG001|Overall Study|Withdrawal by Subject|1|||
105900137|NCT03796676|365290796|FG002|Overall Study|Withdrawal by Subject|0|||
105900138|NCT03796676|365290794|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
105900139|NCT03796676|365290795|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
105900140|NCT03796676|365290796|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
105900141|NCT01900899|365290797|FG000|Overall Study|Withdrawal by Subject|7|||
105900142|NCT01900899|365290798|FG001|Overall Study|Withdrawal by Subject|1|||
105900143|NCT01900899|365290797|FG000|Overall Study|Migrated from study area|2|||
105900144|NCT01900899|365290798|FG001|Overall Study|Migrated from study area|0|||
105900145|NCT02427802|365290799|FG000|Overall Study|Adverse Event|11|||
105900146|NCT02427802|365290800|FG001|Overall Study|Adverse Event|3|||
105900147|NCT02427802|365290801|FG002|Overall Study|Adverse Event|7|||
105900148|NCT02427802|365290799|FG000|Overall Study|Death|0|||
105900149|NCT02427802|365290800|FG001|Overall Study|Death|4|||
105900150|NCT02427802|365290801|FG002|Overall Study|Death|1|||
105900151|NCT02427802|365290799|FG000|Overall Study|Lost to Follow-up|13|||
105900152|NCT02427802|365290800|FG001|Overall Study|Lost to Follow-up|8|||
105900153|NCT02427802|365290801|FG002|Overall Study|Lost to Follow-up|8|||
105900154|NCT02427802|365290799|FG000|Overall Study|Physician Decision|4|||
105900155|NCT02427802|365290800|FG001|Overall Study|Physician Decision|2|||
105900156|NCT02427802|365290801|FG002|Overall Study|Physician Decision|4|||
105900157|NCT02427802|365290799|FG000|Overall Study|Withdrawal by Subject|10|||
105900158|NCT02427802|365290800|FG001|Overall Study|Withdrawal by Subject|5|||
105900159|NCT02427802|365290801|FG002|Overall Study|Withdrawal by Subject|11|||
106124496|NCT00750893|366114141|FG000|Overall Study|Other|17|||
106124497|NCT03824938|366114142|FG000|Overall Study|Withdrawal by Subject|2|||
106124498|NCT03824938|366114143|FG001|Overall Study|Withdrawal by Subject|1|||
105668155|NCT00474526|364450175|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
105900160|NCT02427802|365290799|FG000|Overall Study|Protocol Violation|3|||
105900161|NCT02427802|365290800|FG001|Overall Study|Protocol Violation|1|||
105900162|NCT02427802|365290801|FG002|Overall Study|Protocol Violation|1|||
105900163|NCT02427802|365290799|FG000|Overall Study|protocol specific treatment unrelated|18|||
105900164|NCT02427802|365290800|FG001|Overall Study|protocol specific treatment unrelated|11|||
105900165|NCT02427802|365290801|FG002|Overall Study|protocol specific treatment unrelated|11|||
105668156|NCT00474526|364450176|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
105668157|NCT00474526|364450177|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
105900166|NCT02109445|365290802|FG000|Overall Study|Symptomatic deterioration|2|||
105900167|NCT02109445|365290802|FG000|Overall Study|Adverse Event|1|||
105900168|NCT02000882|365292659|FG000|Overall Study|Adverse Event|3|||
105900169|NCT02000882|365292659|FG000|Overall Study|Physician Decision|2|||
105900170|NCT02000882|365292659|FG000|Overall Study|Withdrawal by Subject|1|||
105900171|NCT02824562|365292660|FG000|Overall Study|Lost to Follow-up|3|||
105900172|NCT02824562|365292661|FG001|Overall Study|Lost to Follow-up|4|||
105900173|NCT02824562|365292660|FG000|Overall Study|Death|0|||
105900174|NCT02824562|365292661|FG001|Overall Study|Death|1|||
105900175|NCT03089853|365292665|FG000|Overall Study|Lost to Follow-up|2|||
105900176|NCT03089853|365292666|FG001|Overall Study|Lost to Follow-up|1|||
105900177|NCT02168777|365292667|FG000|Overall Study|Withdrawal by Subject|1|||
105900178|NCT02168777|365292668|FG001|Overall Study|Withdrawal by Subject|0|||
105900179|NCT02168777|365292669|FG002|Overall Study|Withdrawal by Subject|2|||
105900180|NCT02168777|365292667|FG000|Overall Study|Adverse Event|1|||
105900181|NCT02168777|365292668|FG001|Overall Study|Adverse Event|0|||
105900182|NCT02168777|365292669|FG002|Overall Study|Adverse Event|1|||
105900183|NCT02168777|365292667|FG000|Overall Study|Disease recurrence|0|||
105900184|NCT02168777|365292668|FG001|Overall Study|Disease recurrence|0|||
105900185|NCT02168777|365292669|FG002|Overall Study|Disease recurrence|1|||
105900186|NCT02168777|365292667|FG000|Overall Study|Radiological disease progression|0|||
105900187|NCT02168777|365292668|FG001|Overall Study|Radiological disease progression|5|||
105900188|NCT02168777|365292669|FG002|Overall Study|Radiological disease progression|5|||
105900189|NCT02168777|365292667|FG000|Overall Study|Clinical disease progression|0|||
105900190|NCT02168777|365292668|FG001|Overall Study|Clinical disease progression|1|||
105900191|NCT02168777|365292669|FG002|Overall Study|Clinical disease progression|2|||
105900192|NCT02168777|365292667|FG000|Overall Study|Other reason|0|||
105900193|NCT02168777|365292668|FG001|Overall Study|Other reason|1|||
105900194|NCT02168777|365292669|FG002|Overall Study|Other reason|0|||
105900195|NCT05243563|365292670|FG000|Overall Study|Withdrawal by Subject|1|||
105900196|NCT05243563|365292671|FG001|Overall Study|Withdrawal by Subject|0|||
105900197|NCT05243563|365292670|FG000|Overall Study|Physician Decision|1|||
105900198|NCT05243563|365292671|FG001|Overall Study|Physician Decision|0|||
105900199|NCT00441363|365292672|FG000|Overall Study|Adverse Event|4|||
105900200|NCT00441363|365292673|FG001|Overall Study|Adverse Event|2|||
105900201|NCT00441363|365292672|FG000|Overall Study|Withdrawal by Subject|3|||
105900202|NCT00441363|365292673|FG001|Overall Study|Withdrawal by Subject|4|||
105900203|NCT00441363|365292672|FG000|Overall Study|Physician Decision|6|||
105900204|NCT00441363|365292673|FG001|Overall Study|Physician Decision|7|||
105900205|NCT00441363|365292672|FG000|Overall Study|Lost to Follow-up|2|||
105900206|NCT00441363|365292673|FG001|Overall Study|Lost to Follow-up|2|||
105900207|NCT00441363|365292672|FG000|Overall Study|Other|2|||
105900208|NCT00441363|365292673|FG001|Overall Study|Other|0|||
105900209|NCT01663857|365292674|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
105900210|NCT01663857|365292675|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
105900211|NCT01663857|365292676|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
105900212|NCT01663857|365292677|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
105900213|NCT01663857|365292674|FG000|Overall Study|Lost to Follow-up|0|||
105900214|NCT01663857|365292675|FG001|Overall Study|Lost to Follow-up|0|||
105900215|NCT01663857|365292676|FG002|Overall Study|Lost to Follow-up|3|||
105900216|NCT01663857|365292677|FG003|Overall Study|Lost to Follow-up|1|||
105900217|NCT04494425|365292678|FG000|Overall Study|Death|160|||
105900218|NCT04494425|365292679|FG001|Overall Study|Death|166|||
105900219|NCT04494425|365292678|FG000|Overall Study|Withdrawal by Subject|10|||
105900220|NCT04494425|365292679|FG001|Overall Study|Withdrawal by Subject|40|||
105900221|NCT04494425|365292678|FG000|Overall Study|Other|1|||
105900222|NCT04494425|365292679|FG001|Overall Study|Other|1|||
105900223|NCT04494425|365292678|FG000|Overall Study|Ongoing at the time of PCD|265|||
105900224|NCT04494425|365292679|FG001|Overall Study|Ongoing at the time of PCD|223|||
105900225|NCT03041467|365292680|FG000|Overall Study|Death|46|||
105900226|NCT03041467|365292681|FG001|Overall Study|Death|39|||
105900227|NCT03041467|365292680|FG000|Overall Study|Withdrawal by Subject|36|||
105900228|NCT03041467|365292681|FG001|Overall Study|Withdrawal by Subject|37|||
105900229|NCT03041467|365292680|FG000|Overall Study|Lost to Follow-up|6|||
105900230|NCT03041467|365292681|FG001|Overall Study|Lost to Follow-up|8|||
105900231|NCT03041467|365292680|FG000|Overall Study|Declined consent for study extension|21|||
105900232|NCT03041467|365292681|FG001|Overall Study|Declined consent for study extension|33|||
105900233|NCT03041467|365292680|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
105900234|NCT03041467|365292681|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
105900235|NCT02474355|365292682|FG000|Overall Study|Other|43|||
105900236|NCT02474355|365292682|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
105900237|NCT02474355|365292682|FG000|Overall Study|Lost to Follow-up|98|||
105900238|NCT02474355|365292682|FG000|Overall Study|Withdrawal by Subject|124|||
105900239|NCT02474355|365292682|FG000|Overall Study|Death|1361|||
105900240|NCT02578940|365292683|FG000|Overall Study|Screening failure|5|||
105900241|NCT02578940|365292683|FG000|Overall Study|Lost to Follow-up|1|||
105900242|NCT01066793|365292684|FG000|Overall Study|Death|4|||
105900243|NCT01066793|365292685|FG001|Overall Study|Death|1|||
105900244|NCT01066793|365292686|FG002|Overall Study|Death|1|||
105900245|NCT01066793|365292687|FG003|Overall Study|Death|0|||
105900246|NCT01066793|365292688|FG004|Overall Study|Death|0|||
105900247|NCT01066793|365292689|FG005|Overall Study|Death|0|||
105900248|NCT01066793|365292684|FG000|Overall Study|Lack of Efficacy|2|||
105900249|NCT01066793|365292685|FG001|Overall Study|Lack of Efficacy|1|||
105997920|NCT02714569|365653288|FG007|Part B (Overall)|Withdrawal by Subject|1|||
105997921|NCT02714569|365653289|FG008|Part B (Overall)|Withdrawal by Subject|0|||
105997922|NCT02714569|365653290|FG009|Part B (Overall)|Withdrawal by Subject|1|||
105997923|NCT02714569|365653291|FG010|Part B (Overall)|Withdrawal by Subject|0|||
105997924|NCT02714569|365653281|FG000|Part B (Overall)|Adverse Event|0|||
105997925|NCT02714569|365653282|FG001|Part B (Overall)|Adverse Event|0|||
105997926|NCT02714569|365653283|FG002|Part B (Overall)|Adverse Event|0|||
105997927|NCT02714569|365653284|FG003|Part B (Overall)|Adverse Event|0|||
105997928|NCT02714569|365653285|FG004|Part B (Overall)|Adverse Event|0|||
105997929|NCT02714569|365653286|FG005|Part B (Overall)|Adverse Event|0|||
105997930|NCT02714569|365653287|FG006|Part B (Overall)|Adverse Event|0|||
105997931|NCT02714569|365653288|FG007|Part B (Overall)|Adverse Event|0|||
105997932|NCT02714569|365653289|FG008|Part B (Overall)|Adverse Event|0|||
105900250|NCT01066793|365292686|FG002|Overall Study|Lack of Efficacy|0|||
105900251|NCT01066793|365292687|FG003|Overall Study|Lack of Efficacy|0|||
105900252|NCT01066793|365292688|FG004|Overall Study|Lack of Efficacy|0|||
105900253|NCT01066793|365292689|FG005|Overall Study|Lack of Efficacy|0|||
105900254|NCT01066793|365292684|FG000|Overall Study|Lost to Follow-up|180|||
105900255|NCT01066793|365292685|FG001|Overall Study|Lost to Follow-up|39|||
105900256|NCT01066793|365292686|FG002|Overall Study|Lost to Follow-up|82|||
105900257|NCT01066793|365292687|FG003|Overall Study|Lost to Follow-up|16|||
105900258|NCT01066793|365292688|FG004|Overall Study|Lost to Follow-up|0|||
105900259|NCT01066793|365292689|FG005|Overall Study|Lost to Follow-up|1|||
105900260|NCT01066793|365292684|FG000|Overall Study|Physician Decision|3|||
105900261|NCT01066793|365292685|FG001|Overall Study|Physician Decision|0|||
105900262|NCT01066793|365292686|FG002|Overall Study|Physician Decision|0|||
105900263|NCT01066793|365292687|FG003|Overall Study|Physician Decision|0|||
105900264|NCT01066793|365292688|FG004|Overall Study|Physician Decision|0|||
105900265|NCT01066793|365292689|FG005|Overall Study|Physician Decision|0|||
105900266|NCT01066793|365292684|FG000|Overall Study|Protocol Violation|3|||
105900267|NCT01066793|365292685|FG001|Overall Study|Protocol Violation|2|||
105900268|NCT01066793|365292686|FG002|Overall Study|Protocol Violation|2|||
105900269|NCT01066793|365292687|FG003|Overall Study|Protocol Violation|0|||
105900270|NCT01066793|365292688|FG004|Overall Study|Protocol Violation|0|||
105900271|NCT01066793|365292689|FG005|Overall Study|Protocol Violation|0|||
105900272|NCT01066793|365292684|FG000|Overall Study|Withdrawal by Subject|7|||
105900273|NCT01066793|365292685|FG001|Overall Study|Withdrawal by Subject|4|||
105900274|NCT01066793|365292686|FG002|Overall Study|Withdrawal by Subject|1|||
105900275|NCT01066793|365292687|FG003|Overall Study|Withdrawal by Subject|0|||
105900276|NCT01066793|365292688|FG004|Overall Study|Withdrawal by Subject|0|||
105900277|NCT01066793|365292689|FG005|Overall Study|Withdrawal by Subject|0|||
105997933|NCT02714569|365653290|FG009|Part B (Overall)|Adverse Event|1|||
105997934|NCT02714569|365653291|FG010|Part B (Overall)|Adverse Event|0|||
105997935|NCT04915729|365653292|FG000|Overall Study|Lost to Follow-up|20|||
105997936|NCT04915729|365653293|FG001|Overall Study|Lost to Follow-up|10|||
105997937|NCT04915729|365653292|FG000|Overall Study|Withdrawal by Subject|12|||
105997938|NCT04915729|365653293|FG001|Overall Study|Withdrawal by Subject|5|||
105997939|NCT04915729|365653292|FG000|Overall Study|Death|34|||
105997940|NCT04915729|365653293|FG001|Overall Study|Death|44|||
105997941|NCT04915729|365653292|FG000|Overall Study|not treated|3|||
105997942|NCT04915729|365653293|FG001|Overall Study|not treated|6|||
105997943|NCT04915729|365653292|FG000|Overall Study|Investigator removed subject|1|||
105997944|NCT04915729|365653293|FG001|Overall Study|Investigator removed subject|2|||
105997945|NCT04915729|365653292|FG000|Overall Study|questionnaire result not evaluated|1|||
105997946|NCT04915729|365653293|FG001|Overall Study|questionnaire result not evaluated|0|||
105997947|NCT04915729|365653292|FG000|Overall Study|refuse of hospital visit|1|||
105900278|NCT01066793|365292684|FG000|Overall Study|Early Termination|3|||
105900279|NCT01066793|365292685|FG001|Overall Study|Early Termination|0|||
105900280|NCT01066793|365292686|FG002|Overall Study|Early Termination|0|||
105900281|NCT01066793|365292687|FG003|Overall Study|Early Termination|0|||
105900282|NCT01066793|365292688|FG004|Overall Study|Early Termination|0|||
105900283|NCT01066793|365292689|FG005|Overall Study|Early Termination|0|||
105900284|NCT01066793|365292684|FG000|Overall Study|Lab test not done|7|||
105900285|NCT01066793|365292685|FG001|Overall Study|Lab test not done|0|||
105900286|NCT01066793|365292686|FG002|Overall Study|Lab test not done|0|||
105900287|NCT01066793|365292687|FG003|Overall Study|Lab test not done|1|||
105900288|NCT01066793|365292688|FG004|Overall Study|Lab test not done|0|||
105900289|NCT01066793|365292689|FG005|Overall Study|Lab test not done|0|||
105900290|NCT01066793|365292684|FG000|Overall Study|Miscellaneous|4|||
105997948|NCT04915729|365653293|FG001|Overall Study|refuse of hospital visit|3|||
105997949|NCT04915729|365653292|FG000|Overall Study|Subject withdrew|1|||
105997950|NCT04915729|365653293|FG001|Overall Study|Subject withdrew|0|||
105997951|NCT00191308|365653294|FG000|Overall Study|Adverse Event|1|||
105997952|NCT01433172|365653295|FG000|Overall Study|Withdrawal by Subject|0|||
105900291|NCT01066793|365292685|FG001|Overall Study|Miscellaneous|5|||
105900292|NCT01066793|365292686|FG002|Overall Study|Miscellaneous|6|||
105900293|NCT01066793|365292687|FG003|Overall Study|Miscellaneous|0|||
105900294|NCT01066793|365292688|FG004|Overall Study|Miscellaneous|0|||
105900295|NCT01066793|365292689|FG005|Overall Study|Miscellaneous|0|||
105900296|NCT01066793|365292684|FG000|Overall Study|Non-responders|104|||
105900297|NCT01066793|365292685|FG001|Overall Study|Non-responders|5|||
105900298|NCT01066793|365292686|FG002|Overall Study|Non-responders|11|||
105900299|NCT01066793|365292687|FG003|Overall Study|Non-responders|25|||
105900300|NCT01066793|365292688|FG004|Overall Study|Non-responders|0|||
105900301|NCT01066793|365292689|FG005|Overall Study|Non-responders|0|||
105900302|NCT01066793|365292684|FG000|Overall Study|Other|15|||
105900303|NCT01066793|365292685|FG001|Overall Study|Other|5|||
105900304|NCT01066793|365292686|FG002|Overall Study|Other|6|||
105900305|NCT01066793|365292687|FG003|Overall Study|Other|2|||
105900306|NCT01066793|365292688|FG004|Overall Study|Other|0|||
105900307|NCT01066793|365292689|FG005|Overall Study|Other|0|||
105900308|NCT01066793|365292684|FG000|Overall Study|Relapse|20|||
105900309|NCT01066793|365292685|FG001|Overall Study|Relapse|8|||
105900310|NCT01066793|365292686|FG002|Overall Study|Relapse|2|||
105900311|NCT01066793|365292687|FG003|Overall Study|Relapse|3|||
105900312|NCT01066793|365292688|FG004|Overall Study|Relapse|0|||
105900313|NCT01066793|365292689|FG005|Overall Study|Relapse|0|||
105900314|NCT01066793|365292684|FG000|Overall Study|Result Not Available|1|||
105900315|NCT01066793|365292685|FG001|Overall Study|Result Not Available|0|||
105900316|NCT01066793|365292686|FG002|Overall Study|Result Not Available|0|||
105900317|NCT01066793|365292687|FG003|Overall Study|Result Not Available|0|||
105900318|NCT01066793|365292688|FG004|Overall Study|Result Not Available|0|||
105900319|NCT01066793|365292689|FG005|Overall Study|Result Not Available|0|||
105900320|NCT01066793|365292684|FG000|Overall Study|Treatment Interrupted|1|||
105900321|NCT01066793|365292685|FG001|Overall Study|Treatment Interrupted|1|||
105900322|NCT01066793|365292686|FG002|Overall Study|Treatment Interrupted|0|||
105900323|NCT01066793|365292687|FG003|Overall Study|Treatment Interrupted|0|||
105900324|NCT01066793|365292688|FG004|Overall Study|Treatment Interrupted|0|||
105900325|NCT01066793|365292689|FG005|Overall Study|Treatment Interrupted|0|||
105900326|NCT01066793|365292684|FG000|Overall Study|Treatment Never Started|18|||
105900327|NCT01066793|365292685|FG001|Overall Study|Treatment Never Started|5|||
105900328|NCT01066793|365292686|FG002|Overall Study|Treatment Never Started|4|||
105900329|NCT01066793|365292687|FG003|Overall Study|Treatment Never Started|1|||
105900330|NCT01066793|365292688|FG004|Overall Study|Treatment Never Started|0|||
105900331|NCT01066793|365292689|FG005|Overall Study|Treatment Never Started|0|||
105900332|NCT01066793|365292684|FG000|Overall Study|Treatment Stopped|2|||
105900333|NCT01066793|365292685|FG001|Overall Study|Treatment Stopped|1|||
105900334|NCT01066793|365292686|FG002|Overall Study|Treatment Stopped|0|||
105900335|NCT01066793|365292687|FG003|Overall Study|Treatment Stopped|1|||
105900336|NCT01066793|365292688|FG004|Overall Study|Treatment Stopped|0|||
105900337|NCT01066793|365292689|FG005|Overall Study|Treatment Stopped|0|||
105900338|NCT02697916|365292691|FG000|Overall Study|Death|357|||
106124499|NCT03824938|366114144|FG002|Overall Study|Withdrawal by Subject|0|||
106124500|NCT03824938|366114145|FG003|Overall Study|Withdrawal by Subject|2|||
106124501|NCT03824938|366114146|FG004|Overall Study|Withdrawal by Subject|0|||
105900339|NCT02697916|365292692|FG001|Overall Study|Death|315|||
105900340|NCT02697916|365292691|FG000|Overall Study|Withdrawal by Subject|221|||
105900341|NCT02697916|365292692|FG001|Overall Study|Withdrawal by Subject|393|||
105900342|NCT03334422|365292693|FG000|Overall Study|Adverse Event|1|||
105900343|NCT03334422|365292694|FG001|Overall Study|Adverse Event|3|||
105900344|NCT03334422|365292695|FG002|Overall Study|Adverse Event|2|||
105900345|NCT03334422|365292696|FG003|Overall Study|Adverse Event|2|||
105900346|NCT03334422|365292693|FG000|Overall Study|Lack of Efficacy|10|||
105900347|NCT03334422|365292694|FG001|Overall Study|Lack of Efficacy|2|||
105900348|NCT03334422|365292695|FG002|Overall Study|Lack of Efficacy|7|||
105900349|NCT03334422|365292696|FG003|Overall Study|Lack of Efficacy|3|||
105900350|NCT03334422|365292693|FG000|Overall Study|Withdrawal by Subject|8|||
105900351|NCT03334422|365292694|FG001|Overall Study|Withdrawal by Subject|3|||
105900352|NCT03334422|365292695|FG002|Overall Study|Withdrawal by Subject|1|||
105900353|NCT03334422|365292696|FG003|Overall Study|Withdrawal by Subject|0|||
105900354|NCT03334422|365292693|FG000|Overall Study|Lost to Follow-up|0|||
106124502|NCT03824938|366114147|FG005|Overall Study|Withdrawal by Subject|1|||
105900355|NCT03334422|365292694|FG001|Overall Study|Lost to Follow-up|0|||
105900356|NCT03334422|365292695|FG002|Overall Study|Lost to Follow-up|0|||
105900357|NCT03334422|365292696|FG003|Overall Study|Lost to Follow-up|1|||
105900358|NCT03334422|365292693|FG000|Overall Study|Inability to obtain laboratory samples|0|||
105900359|NCT03334422|365292694|FG001|Overall Study|Inability to obtain laboratory samples|1|||
105900360|NCT03334422|365292695|FG002|Overall Study|Inability to obtain laboratory samples|0|||
106124503|NCT03824938|366114142|FG000|Overall Study|Lost to Follow-up|0|||
106124504|NCT03824938|366114143|FG001|Overall Study|Lost to Follow-up|1|||
106124505|NCT03824938|366114144|FG002|Overall Study|Lost to Follow-up|0|||
105900361|NCT03334422|365292696|FG003|Overall Study|Inability to obtain laboratory samples|0|||
105900362|NCT03334422|365292693|FG000|Overall Study|Pregnancy|0|||
105900363|NCT03334422|365292694|FG001|Overall Study|Pregnancy|1|||
105900364|NCT03334422|365292695|FG002|Overall Study|Pregnancy|0|||
105900365|NCT03334422|365292696|FG003|Overall Study|Pregnancy|0|||
105900366|NCT05459558|365292697|FG000|Overall Study|Adverse Event|1|||
105900367|NCT05459558|365292698|FG001|Overall Study|Adverse Event|0|||
105900368|NCT05459558|365292699|FG002|Overall Study|Adverse Event|0|||
105900369|NCT05459558|365292697|FG000|Overall Study|Scheduling issue|0|||
105900370|NCT05459558|365292698|FG001|Overall Study|Scheduling issue|1|||
105900371|NCT05459558|365292699|FG002|Overall Study|Scheduling issue|3|||
105900372|NCT05459558|365292697|FG000|Overall Study|Withdrawal by Subject|0|||
105900373|NCT05459558|365292698|FG001|Overall Study|Withdrawal by Subject|0|||
105900374|NCT05459558|365292699|FG002|Overall Study|Withdrawal by Subject|2|||
105900375|NCT04571385|365292700|FG000|Overall Study|Participant non-compliance|1|||
105900376|NCT04571385|365292701|FG001|Overall Study|Participant non-compliance|0|||
105900377|NCT04571385|365292702|FG002|Overall Study|Participant non-compliance|0|||
105900378|NCT04571385|365292700|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
105900379|NCT04571385|365292701|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
105900380|NCT04571385|365292702|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
105900381|NCT04571385|365292700|FG000|Overall Study|Screen failure|0|||
105900382|NCT04571385|365292701|FG001|Overall Study|Screen failure|0|||
105900383|NCT04571385|365292702|FG002|Overall Study|Screen failure|1|||
105900384|NCT05025332|365292704|FG000|Screening|Screen failure|12|||
105900385|NCT05025332|365292704|FG000|Treatment & Follow Up|Protocol Violation|1|||
105900386|NCT05025332|365292704|FG000|Treatment & Follow Up|Adverse Event|4|||
105900387|NCT04591015|365292705|FG000|Overall Study|Death|6|||
105900388|NCT04591015|365292706|FG001|Overall Study|Death|4|||
105900389|NCT04591015|365292705|FG000|Overall Study|Withdrawal by Subject|6|||
105900390|NCT04591015|365292706|FG001|Overall Study|Withdrawal by Subject|3|||
105900391|NCT04591015|365292705|FG000|Overall Study|Lost to Follow-up|16|||
105900392|NCT04591015|365292706|FG001|Overall Study|Lost to Follow-up|11|||
105900393|NCT02509078|365292707|FG000|Overall Study|Protocol Violation|1|||
105900394|NCT02509078|365292708|FG001|Overall Study|Protocol Violation|1|||
105900395|NCT02686814|365292709|FG000|Overall Study|Physician Decision|14|||
105900396|NCT02686814|365292709|FG000|Overall Study|Withdrawal by Subject|4|||
105900397|NCT02686814|365292709|FG000|Overall Study|Death|1|||
105900398|NCT01887288|365292710|FG000|Overall Study|The study was terminated and the PI has|16|||
105900399|NCT01908582|365292711|FG000|Period 2|Physician Decision|1|||
105900400|NCT01908582|365292711|FG000|Period 2|Withdrawal by Subject|1|||
105900401|NCT00564278|365292712|FG000|Overall Study|Lost to Follow-up|35|||
105900402|NCT00564278|365292713|FG001|Overall Study|Lost to Follow-up|33|||
105900403|NCT00564278|365292712|FG000|Overall Study|Physician Decision|1|||
105900404|NCT00564278|365292713|FG001|Overall Study|Physician Decision|2|||
105900405|NCT00564278|365292712|FG000|Overall Study|Withdrawal by Subject|11|||
105900406|NCT00564278|365292713|FG001|Overall Study|Withdrawal by Subject|7|||
105900407|NCT00255840|365292714|FG000|Overall Study|Lost to Follow-up|10|||
105900408|NCT00255840|365292715|FG001|Overall Study|Lost to Follow-up|14|||
105900409|NCT00255840|365292714|FG000|Overall Study|Discontinued intervention|53|||
105900410|NCT00255840|365292715|FG001|Overall Study|Discontinued intervention|56|||
105900411|NCT03341936|365292716|FG000|Overall Study|Ineligible|1|||
105900412|NCT03341936|365292716|FG000|Overall Study|Disease Progression|2|||
105900413|NCT03341936|365292716|FG000|Overall Study|Withdrew Consent|4|||
105900414|NCT03341936|365292716|FG000|Overall Study|Non-Compliance|1|||
105900415|NCT03341936|365292716|FG000|Overall Study|Physician Decision|1|||
105900416|NCT03341936|365292716|FG000|Overall Study|Withdrawal by Subject|1|||
105900417|NCT03341936|365292716|FG000|Overall Study|Other|1|||
105900418|NCT02368886|365292717|FG000|Overall Study|Cancel|1|||
105900419|NCT02368886|365292718|FG001|Overall Study|Cancel|1|||
105900420|NCT02368886|365292719|FG002|Overall Study|Cancel|1|||
105900421|NCT02368886|365292720|FG003|Overall Study|Cancel|3|||
105900422|NCT02368886|365292717|FG000|Overall Study|Ineligible|0|||
105900423|NCT02368886|365292718|FG001|Overall Study|Ineligible|0|||
105900424|NCT02368886|365292719|FG002|Overall Study|Ineligible|0|||
105900425|NCT02368886|365292720|FG003|Overall Study|Ineligible|1|||
105900426|NCT04849416|365292722|FG000|Overall Study|Ongoing Treatment|12|||
105900427|NCT04849416|365292723|FG001|Overall Study|Ongoing Treatment|5|||
105900428|NCT04849416|365292724|FG002|Overall Study|Ongoing Treatment|3|||
105900429|NCT04849416|365292722|FG000|Overall Study|On Post-Treatment Follow-up|8|||
105900430|NCT04849416|365292723|FG001|Overall Study|On Post-Treatment Follow-up|9|||
105900431|NCT04849416|365292724|FG002|Overall Study|On Post-Treatment Follow-up|10|||
105900432|NCT04849416|365292722|FG000|Overall Study|Withdrawal by Subject|0|||
105997953|NCT01433172|365653296|FG001|Overall Study|Withdrawal by Subject|1|||
105900433|NCT04849416|365292723|FG001|Overall Study|Withdrawal by Subject|0|||
105900434|NCT04849416|365292724|FG002|Overall Study|Withdrawal by Subject|1|||
105900435|NCT04849416|365292722|FG000|Overall Study|Lost to Follow-up|1|||
105900436|NCT04849416|365292723|FG001|Overall Study|Lost to Follow-up|0|||
105900437|NCT04849416|365292724|FG002|Overall Study|Lost to Follow-up|0|||
105900438|NCT02173379|365292728|FG000|Overall Study|Lost to Follow-up|89|||
106124506|NCT03824938|366114145|FG003|Overall Study|Lost to Follow-up|0|||
106124507|NCT03824938|366114146|FG004|Overall Study|Lost to Follow-up|1|||
105900439|NCT02173379|365292729|FG001|Overall Study|Lost to Follow-up|81|||
105900440|NCT02173379|365292728|FG000|Overall Study|Withdrawal by Subject|24|||
105900441|NCT02173379|365292729|FG001|Overall Study|Withdrawal by Subject|29|||
105900442|NCT02173379|365292728|FG000|Overall Study|Physician Decision|8|||
105900443|NCT02173379|365292729|FG001|Overall Study|Physician Decision|8|||
105900444|NCT02173379|365292728|FG000|Overall Study|Death|75|||
105900445|NCT02173379|365292729|FG001|Overall Study|Death|72|||
105900446|NCT02173379|365292728|FG000|Overall Study|Other Reason|1|||
105900447|NCT02173379|365292729|FG001|Overall Study|Other Reason|0|||
105900448|NCT00253370|365292738|FG000|Overall Study|Adverse Event|18|||
105900449|NCT00253370|365292738|FG000|Overall Study|Disease progression|13|||
105900450|NCT00253370|365292738|FG000|Overall Study|Death|2|||
105900451|NCT00253370|365292738|FG000|Overall Study|Withdrawal by Subject|6|||
105900452|NCT00253370|365292738|FG000|Overall Study|Non-protocol therapy|1|||
105900453|NCT00253370|365292738|FG000|Overall Study|Physician Decision|1|||
105900454|NCT00253370|365292738|FG000|Overall Study|Protocol Violation|1|||
105900455|NCT00253370|365292738|FG000|Overall Study|Abdominal pain due to disease|1|||
105900456|NCT02667587|365292739|FG000|Pre-Treatment|Not reported|1|||
105900457|NCT02667587|365292740|FG001|Pre-Treatment|Not reported|0|||
105900458|NCT02667587|365292739|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
105900459|NCT02667587|365292740|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
105900460|NCT02667587|365292739|FG000|Pre-Treatment|Participant withdrew consent|0|||
105900461|NCT02667587|365292740|FG001|Pre-Treatment|Participant withdrew consent|1|||
105900462|NCT02667587|365292739|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
105900463|NCT02667587|365292740|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
105900464|NCT02667587|365292739|FG000|End of Treatment|Disease Progression|193|||
105900465|NCT02667587|365292740|FG001|End of Treatment|Disease Progression|226|||
105900466|NCT02667587|365292739|FG000|End of Treatment|Study Drug Toxicity|75|||
106124508|NCT03824938|366114147|FG005|Overall Study|Lost to Follow-up|0|||
105900467|NCT02667587|365292740|FG001|End of Treatment|Study Drug Toxicity|19|||
105900468|NCT02667587|365292739|FG000|End of Treatment|Death|2|||
105900469|NCT02667587|365292740|FG001|End of Treatment|Death|1|||
105900470|NCT02667587|365292739|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
105900471|NCT02667587|365292740|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
105900472|NCT02667587|365292739|FG000|End of Treatment|participant request to discontinue treatment|33|||
105900473|NCT02667587|365292740|FG001|End of Treatment|participant request to discontinue treatment|35|||
105900474|NCT02667587|365292739|FG000|End of Treatment|participant withdrew consent|5|||
105900475|NCT02667587|365292740|FG001|End of Treatment|participant withdrew consent|6|||
105900476|NCT02667587|365292739|FG000|End of Treatment|Lost to Follow-up|1|||
106124509|NCT01990300|366114151|FG000|Overall Study|Case Report Forms Uncollected|89|||
106124510|NCT01990300|366114151|FG000|Overall Study|Protocol Deviation|53|||
106124511|NCT00287469|366114154|FG000|Overall Study|serious adverse event|1|||
106124512|NCT00287469|366114155|FG001|Overall Study|serious adverse event|6|||
106124513|NCT00287469|366114154|FG000|Overall Study|Adverse Event|1|||
106124514|NCT00287469|366114155|FG001|Overall Study|Adverse Event|1|||
106124515|NCT00287469|366114154|FG000|Overall Study|moved from area|144|||
106124516|NCT00287469|366114155|FG001|Overall Study|moved from area|138|||
106124517|NCT00287469|366114154|FG000|Overall Study|Lost to Follow-up|74|||
106124518|NCT00287469|366114155|FG001|Overall Study|Lost to Follow-up|69|||
106124519|NCT01225835|366114156|FG000|Overall Study|Completed protocol|2|||
106124520|NCT01225835|366114157|FG001|Overall Study|Completed protocol|1|||
106124521|NCT01225835|366114156|FG000|Overall Study|Did not meet hCG criterion|2|||
106124522|NCT01225835|366114157|FG001|Overall Study|Did not meet hCG criterion|0|||
105900477|NCT02667587|365292740|FG001|End of Treatment|Lost to Follow-up|2|||
105900478|NCT02667587|365292739|FG000|End of Treatment|maximum clinical benefit|4|||
105900479|NCT02667587|365292740|FG001|End of Treatment|maximum clinical benefit|4|||
105900480|NCT02667587|365292739|FG000|End of Treatment|poor or non compliant|0|||
105900481|NCT02667587|365292740|FG001|End of Treatment|poor or non compliant|1|||
105900482|NCT02667587|365292739|FG000|End of Treatment|participant no longer meets study criteria|1|||
105900483|NCT02667587|365292740|FG001|End of Treatment|participant no longer meets study criteria|1|||
105900484|NCT02667587|365292739|FG000|End of Treatment|administrative reason by sponsor|1|||
105900485|NCT02667587|365292740|FG001|End of Treatment|administrative reason by sponsor|29|||
105900486|NCT02667587|365292739|FG000|End of Treatment|other reasonse|21|||
105900487|NCT02667587|365292740|FG001|End of Treatment|other reasonse|10|||
105900488|NCT05182606|365292741|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
105900489|NCT00048997|365292742|FG000|Overall Study|Protocol Violation|7|||
105900490|NCT00048997|365292743|FG001|Overall Study|Protocol Violation|2|||
106124523|NCT01225835|366114156|FG000|Overall Study|Adverse Event|2|||
106124524|NCT01225835|366114157|FG001|Overall Study|Adverse Event|1|||
105900491|NCT00048997|365292742|FG000|Overall Study|Withdrawal by Subject|6|||
106124525|NCT01225835|366114156|FG000|Overall Study|Other|1|||
106124526|NCT01225835|366114157|FG001|Overall Study|Other|1|||
105900492|NCT00048997|365292743|FG001|Overall Study|Withdrawal by Subject|1|||
105900493|NCT03304184|365292745|FG000|Overall Study|Withdrawal by Subject|1|||
105900494|NCT03304184|365292746|FG001|Overall Study|Withdrawal by Subject|2|||
105900495|NCT00076999|365292753|FG000|Overall Study|Adverse Event|2|||
105900496|NCT00076999|365292754|FG001|Overall Study|Adverse Event|8|||
105900497|NCT00076999|365292755|FG002|Overall Study|Adverse Event|6|||
105900498|NCT00076999|365292756|FG003|Overall Study|Adverse Event|0|||
105900499|NCT00076999|365292757|FG004|Overall Study|Adverse Event|2|||
105900500|NCT00076999|365292753|FG000|Overall Study|Protocol Violation|0|||
105900501|NCT00076999|365292754|FG001|Overall Study|Protocol Violation|3|||
105900502|NCT00076999|365292755|FG002|Overall Study|Protocol Violation|4|||
105900503|NCT00076999|365292756|FG003|Overall Study|Protocol Violation|0|||
105900504|NCT00076999|365292757|FG004|Overall Study|Protocol Violation|9|||
105900505|NCT00076999|365292753|FG000|Overall Study|Lost to Follow-up|2|||
105900506|NCT00076999|365292754|FG001|Overall Study|Lost to Follow-up|1|||
105900507|NCT00076999|365292755|FG002|Overall Study|Lost to Follow-up|0|||
105900508|NCT00076999|365292756|FG003|Overall Study|Lost to Follow-up|0|||
105900509|NCT00076999|365292757|FG004|Overall Study|Lost to Follow-up|0|||
105900510|NCT00076999|365292753|FG000|Overall Study|Withdrawal by Subject|0|||
105900511|NCT00076999|365292754|FG001|Overall Study|Withdrawal by Subject|4|||
105900512|NCT00076999|365292755|FG002|Overall Study|Withdrawal by Subject|3|||
105900513|NCT00076999|365292756|FG003|Overall Study|Withdrawal by Subject|0|||
105900514|NCT00076999|365292757|FG004|Overall Study|Withdrawal by Subject|1|||
105900515|NCT00076999|365292753|FG000|Overall Study|Other reason (not specified)|8|||
105900516|NCT00076999|365292754|FG001|Overall Study|Other reason (not specified)|8|||
105900517|NCT00076999|365292755|FG002|Overall Study|Other reason (not specified)|4|||
105900518|NCT00076999|365292756|FG003|Overall Study|Other reason (not specified)|1|||
105900519|NCT00076999|365292757|FG004|Overall Study|Other reason (not specified)|13|||
105900520|NCT00187278|365292758|FG000|Overall Study|Protocol Violation|10|||
105900521|NCT00187278|365292759|FG001|Overall Study|Protocol Violation|13|||
105900522|NCT02735096|365292760|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
105900523|NCT00380718|365292761|FG000|Overall Study|Adverse Event|1|||
105900524|NCT00380718|365292761|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
105900525|NCT00630747|365292777|FG000|Overall Study|Death|1|||
105900526|NCT00630747|365292777|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
105900527|NCT00630747|365292777|FG000|Overall Study|Returned to country of origin|1|||
105900528|NCT00248833|365292783|FG000|Overall Study|Adverse Event|2|||
105900529|NCT00248833|365292784|FG001|Overall Study|Adverse Event|0|||
105900530|NCT00248833|365292785|FG002|Overall Study|Adverse Event|0|||
105900531|NCT00248833|365292783|FG000|Overall Study|Withdrawal by Subject|0|||
105900532|NCT00248833|365292784|FG001|Overall Study|Withdrawal by Subject|1|||
105900533|NCT00248833|365292785|FG002|Overall Study|Withdrawal by Subject|1|||
105900534|NCT00248833|365292783|FG000|Overall Study|Lost to Follow-up|1|||
105900535|NCT00248833|365292784|FG001|Overall Study|Lost to Follow-up|1|||
105900536|NCT00248833|365292785|FG002|Overall Study|Lost to Follow-up|1|||
105900537|NCT00248833|365292783|FG000|Overall Study|Other|0|||
105900538|NCT00248833|365292784|FG001|Overall Study|Other|1|||
105900539|NCT00248833|365292785|FG002|Overall Study|Other|0|||
105900540|NCT02772809|365292788|FG000|Overall Study|not completed some tasks|6|||
105900541|NCT01905592|365292789|FG000|Overall Study|Disease Progression|51|||
105900542|NCT01905592|365292790|FG001|Overall Study|Disease Progression|110|||
105900543|NCT01905592|365292789|FG000|Overall Study|Toxicity|1|||
105900544|NCT01905592|365292790|FG001|Overall Study|Toxicity|16|||
105900545|NCT01905592|365292789|FG000|Overall Study|Physician Decision|0|||
105900546|NCT01905592|365292790|FG001|Overall Study|Physician Decision|2|||
105900547|NCT01905592|365292789|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
105900548|NCT01905592|365292790|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
105900549|NCT01905592|365292789|FG000|Overall Study|Protocol Violation|0|||
105900550|NCT01905592|365292790|FG001|Overall Study|Protocol Violation|1|||
105900551|NCT01905592|365292789|FG000|Overall Study|Sponsor's decision|1|||
105900552|NCT01905592|365292790|FG001|Overall Study|Sponsor's decision|1|||
105900553|NCT01905592|365292789|FG000|Overall Study|Not treated|7|||
105900554|NCT01905592|365292790|FG001|Overall Study|Not treated|3|||
105900555|NCT01905592|365292789|FG000|Overall Study|Withdrawal by Subject|10|||
105900556|NCT01905592|365292790|FG001|Overall Study|Withdrawal by Subject|2|||
105900557|NCT05188729|365292791|FG000|Overall Study|Withdrawal by Subject|0|||
105900558|NCT05188729|365292792|FG001|Overall Study|Withdrawal by Subject|0|||
105668158|NCT00474526|364450178|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
105668159|NCT00474526|364450179|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
105668160|NCT00474526|364450180|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
105668161|NCT00474526|364450181|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
105900559|NCT05188729|365292793|FG002|Overall Study|Withdrawal by Subject|0|||
105900560|NCT05188729|365292794|FG003|Overall Study|Withdrawal by Subject|0|||
105900561|NCT05188729|365292795|FG004|Overall Study|Withdrawal by Subject|0|||
105900562|NCT05188729|365292796|FG005|Overall Study|Withdrawal by Subject|0|||
105900563|NCT05188729|365292797|FG006|Overall Study|Withdrawal by Subject|0|||
105900564|NCT05188729|365292798|FG007|Overall Study|Withdrawal by Subject|0|||
105900565|NCT05188729|365292799|FG008|Overall Study|Withdrawal by Subject|0|||
105900566|NCT05188729|365292800|FG009|Overall Study|Withdrawal by Subject|1|||
106124527|NCT01266993|366114158|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
106124528|NCT01266993|366114159|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
106124529|NCT01266993|366114158|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
106124530|NCT01266993|366114159|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
106124531|NCT03285113|366114160|FG000|Overall Study|Unable to implant leads|2|||
106124532|NCT02942004|366114163|FG000|Overall Study|Withdrawal by Subject|0|||
106124533|NCT02942004|366114164|FG001|Overall Study|Withdrawal by Subject|2|||
106124534|NCT02942004|366114165|FG002|Overall Study|Withdrawal by Subject|3|||
105668162|NCT00474526|364450182|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
105668163|NCT00474526|364450183|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
105668164|NCT00474526|364450184|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
105668165|NCT00474526|364450185|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
105668166|NCT00474526|364450169|FG000|Overall Study|Adverse Event|2|||
105668167|NCT00474526|364450170|FG001|Overall Study|Adverse Event|0|||
105668168|NCT00474526|364450171|FG002|Overall Study|Adverse Event|2|||
105668169|NCT00474526|364450172|FG003|Overall Study|Adverse Event|4|||
105668170|NCT00474526|364450173|FG004|Overall Study|Adverse Event|2|||
105668171|NCT00474526|364450174|FG005|Overall Study|Adverse Event|1|||
105668172|NCT00474526|364450175|FG006|Overall Study|Adverse Event|1|||
105668173|NCT00474526|364450176|FG007|Overall Study|Adverse Event|0|||
105668174|NCT00474526|364450177|FG008|Overall Study|Adverse Event|0|||
105668175|NCT00474526|364450178|FG009|Overall Study|Adverse Event|0|||
105668176|NCT00474526|364450179|FG010|Overall Study|Adverse Event|0|||
105668177|NCT00474526|364450180|FG011|Overall Study|Adverse Event|0|||
105668178|NCT00474526|364450181|FG012|Overall Study|Adverse Event|0|||
105668179|NCT00474526|364450182|FG013|Overall Study|Adverse Event|0|||
105668180|NCT00474526|364450183|FG014|Overall Study|Adverse Event|1|||
105668181|NCT00474526|364450184|FG015|Overall Study|Adverse Event|1|||
105668182|NCT00474526|364450185|FG016|Overall Study|Adverse Event|0|||
105668183|NCT00474526|364450169|FG000|Overall Study|Death|0|||
105668184|NCT00474526|364450170|FG001|Overall Study|Death|0|||
105668185|NCT00474526|364450171|FG002|Overall Study|Death|0|||
105668186|NCT00474526|364450172|FG003|Overall Study|Death|0|||
105668187|NCT00474526|364450173|FG004|Overall Study|Death|0|||
105668188|NCT00474526|364450174|FG005|Overall Study|Death|0|||
105668189|NCT00474526|364450175|FG006|Overall Study|Death|0|||
105668190|NCT00474526|364450176|FG007|Overall Study|Death|0|||
105668191|NCT00474526|364450177|FG008|Overall Study|Death|0|||
105668192|NCT00474526|364450178|FG009|Overall Study|Death|0|||
105668193|NCT00474526|364450179|FG010|Overall Study|Death|0|||
105668194|NCT00474526|364450180|FG011|Overall Study|Death|0|||
105668195|NCT00474526|364450181|FG012|Overall Study|Death|0|||
105668196|NCT00474526|364450182|FG013|Overall Study|Death|3|||
105668197|NCT00474526|364450183|FG014|Overall Study|Death|0|||
105668198|NCT00474526|364450184|FG015|Overall Study|Death|0|||
105668199|NCT00474526|364450185|FG016|Overall Study|Death|0|||
105668200|NCT00474526|364450169|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668201|NCT00474526|364450170|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
105668202|NCT00474526|364450171|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668203|NCT00474526|364450172|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
105668204|NCT00474526|364450173|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
105668205|NCT00474526|364450174|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668206|NCT00474526|364450175|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105900567|NCT05188729|365292801|FG010|Overall Study|Withdrawal by Subject|0|||
105900568|NCT05188729|365292802|FG011|Overall Study|Withdrawal by Subject|0|||
105900569|NCT05188729|365292803|FG012|Overall Study|Withdrawal by Subject|0|||
105900570|NCT05188729|365292791|FG000|Overall Study|Lost to Follow-up|0|||
106124535|NCT02942004|366114163|FG000|Overall Study|Lost to Follow-up|1|||
105668207|NCT00474526|364450176|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668208|NCT00474526|364450177|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668209|NCT00474526|364450178|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668210|NCT00474526|364450179|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668211|NCT00474526|364450180|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668212|NCT00474526|364450181|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668213|NCT00474526|364450182|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
105668214|NCT00474526|364450183|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
105668215|NCT00474526|364450184|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105900571|NCT05188729|365292792|FG001|Overall Study|Lost to Follow-up|0|||
105900572|NCT05188729|365292793|FG002|Overall Study|Lost to Follow-up|0|||
105668216|NCT00474526|364450185|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
105668217|NCT00474526|364450169|FG000|Overall Study|Lost to Follow-up|8|||
105668218|NCT00474526|364450170|FG001|Overall Study|Lost to Follow-up|6|||
105668219|NCT00474526|364450171|FG002|Overall Study|Lost to Follow-up|13|||
105668220|NCT00474526|364450172|FG003|Overall Study|Lost to Follow-up|29|||
105668221|NCT00474526|364450173|FG004|Overall Study|Lost to Follow-up|11|||
105668222|NCT00474526|364450174|FG005|Overall Study|Lost to Follow-up|5|||
105668223|NCT00474526|364450175|FG006|Overall Study|Lost to Follow-up|8|||
105668224|NCT00474526|364450176|FG007|Overall Study|Lost to Follow-up|1|||
105668225|NCT00474526|364450177|FG008|Overall Study|Lost to Follow-up|0|||
105668226|NCT00474526|364450178|FG009|Overall Study|Lost to Follow-up|6|||
105668227|NCT00474526|364450179|FG010|Overall Study|Lost to Follow-up|2|||
105668228|NCT00474526|364450180|FG011|Overall Study|Lost to Follow-up|4|||
105668229|NCT00474526|364450181|FG012|Overall Study|Lost to Follow-up|6|||
105668230|NCT00474526|364450182|FG013|Overall Study|Lost to Follow-up|74|||
105668231|NCT00474526|364450183|FG014|Overall Study|Lost to Follow-up|29|||
105668232|NCT00474526|364450184|FG015|Overall Study|Lost to Follow-up|4|||
105668233|NCT00474526|364450185|FG016|Overall Study|Lost to Follow-up|5|||
105668234|NCT00474526|364450169|FG000|Overall Study|Protocol Violation|2|||
105668235|NCT00474526|364450170|FG001|Overall Study|Protocol Violation|6|||
105668236|NCT00474526|364450171|FG002|Overall Study|Protocol Violation|4|||
105668237|NCT00474526|364450172|FG003|Overall Study|Protocol Violation|12|||
105668238|NCT00474526|364450173|FG004|Overall Study|Protocol Violation|3|||
105668239|NCT00474526|364450174|FG005|Overall Study|Protocol Violation|1|||
105668240|NCT00474526|364450175|FG006|Overall Study|Protocol Violation|3|||
105668241|NCT00474526|364450176|FG007|Overall Study|Protocol Violation|0|||
105668242|NCT00474526|364450177|FG008|Overall Study|Protocol Violation|0|||
105900573|NCT05188729|365292794|FG003|Overall Study|Lost to Follow-up|0|||
105900574|NCT05188729|365292795|FG004|Overall Study|Lost to Follow-up|0|||
105900575|NCT05188729|365292796|FG005|Overall Study|Lost to Follow-up|0|||
105900576|NCT05188729|365292797|FG006|Overall Study|Lost to Follow-up|0|||
105900577|NCT05188729|365292798|FG007|Overall Study|Lost to Follow-up|0|||
105900578|NCT05188729|365292799|FG008|Overall Study|Lost to Follow-up|0|||
105900579|NCT05188729|365292800|FG009|Overall Study|Lost to Follow-up|0|||
105900580|NCT05188729|365292801|FG010|Overall Study|Lost to Follow-up|1|||
105900581|NCT05188729|365292802|FG011|Overall Study|Lost to Follow-up|1|||
105900582|NCT05188729|365292803|FG012|Overall Study|Lost to Follow-up|0|||
105900583|NCT01980628|365293907|FG000|Overall Study|Adverse Event|12|||
105900584|NCT01980628|365293907|FG000|Overall Study|Physician Decision|5|||
105900585|NCT01980628|365293907|FG000|Overall Study|Withdrawal by Subject|4|||
105900586|NCT01980628|365293907|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
105900587|NCT01911793|365293908|FG000|Overall Study|Physician Decision|1|||
105900588|NCT01911793|365293909|FG001|Overall Study|Physician Decision|5|||
105900589|NCT01375374|365293912|FG000|Overall Study|Adverse Event|1|||
105668243|NCT00474526|364450178|FG009|Overall Study|Protocol Violation|4|||
105668244|NCT00474526|364450179|FG010|Overall Study|Protocol Violation|2|||
105668245|NCT00474526|364450180|FG011|Overall Study|Protocol Violation|2|||
105668246|NCT00474526|364450181|FG012|Overall Study|Protocol Violation|4|||
105668247|NCT00474526|364450182|FG013|Overall Study|Protocol Violation|19|||
105668248|NCT00474526|364450183|FG014|Overall Study|Protocol Violation|9|||
105668249|NCT00474526|364450184|FG015|Overall Study|Protocol Violation|6|||
105668250|NCT00474526|364450185|FG016|Overall Study|Protocol Violation|2|||
105668251|NCT00474526|364450169|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
105668252|NCT00474526|364450170|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
105668253|NCT00474526|364450171|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
105668254|NCT00474526|364450172|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
105668255|NCT00474526|364450173|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
105668256|NCT00474526|364450174|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
105668257|NCT00474526|364450175|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
105668258|NCT00474526|364450176|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
105668259|NCT00474526|364450177|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
105668260|NCT00474526|364450178|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
105668261|NCT00474526|364450179|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
105668262|NCT00474526|364450180|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
105668263|NCT00474526|364450181|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
105668264|NCT00474526|364450182|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
105668265|NCT00474526|364450183|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
105668266|NCT00474526|364450184|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
105668267|NCT00474526|364450185|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
105668268|NCT00474526|364450169|FG000|Overall Study|Withdrawal by Subject|9|||
105668269|NCT00474526|364450170|FG001|Overall Study|Withdrawal by Subject|24|||
105668270|NCT00474526|364450171|FG002|Overall Study|Withdrawal by Subject|21|||
105668271|NCT00474526|364450172|FG003|Overall Study|Withdrawal by Subject|52|||
105668272|NCT00474526|364450173|FG004|Overall Study|Withdrawal by Subject|38|||
105668273|NCT00474526|364450174|FG005|Overall Study|Withdrawal by Subject|6|||
105668274|NCT00474526|364450175|FG006|Overall Study|Withdrawal by Subject|12|||
105668275|NCT00474526|364450176|FG007|Overall Study|Withdrawal by Subject|4|||
105668276|NCT00474526|364450177|FG008|Overall Study|Withdrawal by Subject|4|||
105668277|NCT00474526|364450178|FG009|Overall Study|Withdrawal by Subject|13|||
105668278|NCT00474526|364450179|FG010|Overall Study|Withdrawal by Subject|5|||
105668279|NCT00474526|364450180|FG011|Overall Study|Withdrawal by Subject|4|||
105668280|NCT00474526|364450181|FG012|Overall Study|Withdrawal by Subject|4|||
105668281|NCT00474526|364450182|FG013|Overall Study|Withdrawal by Subject|37|||
105668282|NCT00474526|364450183|FG014|Overall Study|Withdrawal by Subject|22|||
105668283|NCT00474526|364450184|FG015|Overall Study|Withdrawal by Subject|1|||
105668284|NCT00474526|364450185|FG016|Overall Study|Withdrawal by Subject|1|||
105668285|NCT04546217|364450188|FG000|Overall Study|Withdrawal by Subject|2|||
105668286|NCT04546217|364450189|FG001|Overall Study|Withdrawal by Subject|0|||
105668287|NCT04546217|364450188|FG000|Overall Study|Uncontrolled hypertension|1|||
105668288|NCT04546217|364450189|FG001|Overall Study|Uncontrolled hypertension|0|||
105668289|NCT02550938|364450192|FG000|Overall Study|Lost to Follow-up|8|||
105668290|NCT02550938|364450193|FG001|Overall Study|Lost to Follow-up|7|||
105668291|NCT02550938|364450194|FG002|Overall Study|Lost to Follow-up|12|||
105668292|NCT02550938|364450195|FG003|Overall Study|Lost to Follow-up|11|||
105668293|NCT04491877|364450196|FG000|Overall Study|Protocol Deviation|1|||
105668294|NCT04491877|364450197|FG001|Overall Study|Protocol Deviation|0|||
105668295|NCT04491877|364450198|FG002|Overall Study|Protocol Deviation|2|||
105668296|NCT04491877|364450199|FG003|Overall Study|Protocol Deviation|0|||
105668297|NCT04491877|364450200|FG004|Overall Study|Protocol Deviation|0|||
105668298|NCT04491877|364450201|FG005|Overall Study|Protocol Deviation|0|||
105668299|NCT04491877|364450202|FG006|Overall Study|Protocol Deviation|1|||
105668300|NCT04491877|364450203|FG007|Overall Study|Protocol Deviation|1|||
105668301|NCT04491877|364450204|FG008|Overall Study|Protocol Deviation|0|||
105668302|NCT04491877|364450196|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105668303|NCT04491877|364450197|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105668304|NCT04491877|364450198|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105668305|NCT04491877|364450199|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
105668306|NCT04491877|364450200|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105668307|NCT04491877|364450201|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
105668308|NCT04491877|364450202|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
105668309|NCT04491877|364450203|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
105668310|NCT04491877|364450204|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
105668311|NCT04491877|364450196|FG000|Overall Study|Lost to Follow-up|0|||
105668312|NCT04491877|364450197|FG001|Overall Study|Lost to Follow-up|2|||
105668313|NCT04491877|364450198|FG002|Overall Study|Lost to Follow-up|0|||
105668314|NCT04491877|364450199|FG003|Overall Study|Lost to Follow-up|0|||
105668315|NCT04491877|364450200|FG004|Overall Study|Lost to Follow-up|0|||
105668316|NCT04491877|364450201|FG005|Overall Study|Lost to Follow-up|0|||
105668317|NCT04491877|364450202|FG006|Overall Study|Lost to Follow-up|2|||
105668318|NCT04491877|364450203|FG007|Overall Study|Lost to Follow-up|1|||
105668319|NCT04491877|364450204|FG008|Overall Study|Lost to Follow-up|1|||
105668320|NCT01020877|364450209|FG000|Second Intervention|Withdrawal by Subject|1|||
105668321|NCT01020877|364450210|FG001|Second Intervention|Withdrawal by Subject|0|||
105668322|NCT00789360|364450212|FG000|Overall Study|Protocol Violation|3|||
105668323|NCT00789360|364450213|FG001|Overall Study|Protocol Violation|1|||
105668324|NCT01077128|364450215|FG000|Overall Study|Adverse Event|8|||
105668325|NCT01077128|364450215|FG000|Overall Study|Lack of Efficacy|1|||
105668326|NCT01077128|364450215|FG000|Overall Study|Disease exacerbation|1|||
105668327|NCT01077128|364450215|FG000|Overall Study|Adverse event and consent withdrawal|1|||
105668328|NCT01077128|364450215|FG000|Overall Study|Adverse event and disease exacerbation|1|||
105668329|NCT01077128|364450215|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
105668330|NCT01077128|364450215|FG000|Overall Study|Other|54|||
105900632|NCT03077607|365293920|FG000|Period 1 (15 Days)|Adverse Event|1|||
105900633|NCT03077607|365293921|FG001|Period 1 (15 Days)|Adverse Event|0|||
105900634|NCT03077607|365293920|FG000|Period 1 (15 Days)|Death|1|||
105900635|NCT03077607|365293921|FG001|Period 1 (15 Days)|Death|0|||
105900636|NCT03077607|365293920|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
105900637|NCT03077607|365293921|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
105900638|NCT03077607|365293920|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
105900639|NCT03077607|365293921|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
105900640|NCT05600036|365293922|FG000|Overall Study|Adverse Event|0|||
105997954|NCT01433172|365653297|FG002|Overall Study|Withdrawal by Subject|0|||
105997955|NCT01433172|365653295|FG000|Overall Study|Disease Progression|0|||
105997956|NCT01433172|365653296|FG001|Overall Study|Disease Progression|0|||
105997957|NCT01433172|365653297|FG002|Overall Study|Disease Progression|1|||
105997958|NCT01433172|365653295|FG000|Overall Study|Death|0|||
105997959|NCT01433172|365653296|FG001|Overall Study|Death|2|||
105997960|NCT01433172|365653297|FG002|Overall Study|Death|0|||
105997961|NCT01010971|365653298|FG000|Overall Study|Adverse Event|2|||
105997962|NCT01010971|365653299|FG001|Overall Study|Adverse Event|4|||
105997963|NCT01010971|365653300|FG002|Overall Study|Adverse Event|3|||
105997964|NCT01010971|365653298|FG000|Overall Study|Withdrawal by Subject|0|||
105997965|NCT01010971|365653299|FG001|Overall Study|Withdrawal by Subject|2|||
105997966|NCT01010971|365653300|FG002|Overall Study|Withdrawal by Subject|5|||
105997967|NCT01010971|365653298|FG000|Overall Study|Lost to Follow-up|0|||
105997968|NCT01010971|365653299|FG001|Overall Study|Lost to Follow-up|2|||
105997969|NCT01010971|365653300|FG002|Overall Study|Lost to Follow-up|3|||
105997970|NCT01010971|365653298|FG000|Overall Study|Other|1|||
105997971|NCT01010971|365653299|FG001|Overall Study|Other|0|||
105997972|NCT01010971|365653300|FG002|Overall Study|Other|2|||
105997973|NCT02717494|365653302|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
105997974|NCT02717494|365653303|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
105997975|NCT02717494|365653304|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
105997976|NCT02717494|365653302|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
105997977|NCT02717494|365653303|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
105997978|NCT02717494|365653304|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
105997979|NCT02717494|365653302|FG000|First Intervention (Step 1)|Death|0|||
105997980|NCT02717494|365653303|FG001|First Intervention (Step 1)|Death|0|||
105997981|NCT02717494|365653304|FG002|First Intervention (Step 1)|Death|1|||
105997982|NCT02717494|365653302|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
105997983|NCT02717494|365653303|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
105997984|NCT02717494|365653304|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
106124536|NCT02942004|366114164|FG001|Overall Study|Lost to Follow-up|1|||
106124537|NCT02942004|366114165|FG002|Overall Study|Lost to Follow-up|2|||
105900641|NCT05600036|365293923|FG001|Overall Study|Adverse Event|2|||
105900642|NCT05600036|365293924|FG002|Overall Study|Adverse Event|1|||
105900643|NCT05600036|365293925|FG003|Overall Study|Adverse Event|0|||
105997985|NCT00731679|365653307|FG000|Overall Study|Adverse Event|7|||
105997986|NCT00731679|365653308|FG001|Overall Study|Adverse Event|8|||
105997987|NCT00731679|365653307|FG000|Overall Study|Withdrawal by Subject|8|||
105997988|NCT00731679|365653308|FG001|Overall Study|Withdrawal by Subject|8|||
105997989|NCT00731679|365653307|FG000|Overall Study|Lost to Follow-up|7|||
105997990|NCT00731679|365653308|FG001|Overall Study|Lost to Follow-up|8|||
105997991|NCT00731679|365653307|FG000|Overall Study|Noncompliance|0|||
105997992|NCT00731679|365653308|FG001|Overall Study|Noncompliance|1|||
106124538|NCT02942004|366114163|FG000|Overall Study|Randomized but not dosed|3|||
105900644|NCT05600036|365293926|FG004|Overall Study|Adverse Event|1|||
105900645|NCT05600036|365293927|FG005|Overall Study|Adverse Event|0|||
105900646|NCT05600036|365293922|FG000|Overall Study|Lost to Follow-up|0|||
105900647|NCT05600036|365293923|FG001|Overall Study|Lost to Follow-up|2|||
105900648|NCT05600036|365293924|FG002|Overall Study|Lost to Follow-up|1|||
105900649|NCT05600036|365293925|FG003|Overall Study|Lost to Follow-up|1|||
105997993|NCT00731679|365653307|FG000|Overall Study|Pregnancy|0|||
105900650|NCT05600036|365293926|FG004|Overall Study|Lost to Follow-up|0|||
105900651|NCT05600036|365293927|FG005|Overall Study|Lost to Follow-up|0|||
105900652|NCT05600036|365293922|FG000|Overall Study|Protocol Violation|0|||
105900653|NCT05600036|365293923|FG001|Overall Study|Protocol Violation|0|||
105900654|NCT05600036|365293924|FG002|Overall Study|Protocol Violation|2|||
105900655|NCT05600036|365293925|FG003|Overall Study|Protocol Violation|0|||
105900656|NCT05600036|365293926|FG004|Overall Study|Protocol Violation|0|||
105900657|NCT05600036|365293927|FG005|Overall Study|Protocol Violation|0|||
105900658|NCT05600036|365293922|FG000|Overall Study|Withdrawal by Subject|0|||
105900659|NCT05600036|365293923|FG001|Overall Study|Withdrawal by Subject|1|||
105900660|NCT05600036|365293924|FG002|Overall Study|Withdrawal by Subject|2|||
105900661|NCT05600036|365293925|FG003|Overall Study|Withdrawal by Subject|0|||
105900662|NCT05600036|365293926|FG004|Overall Study|Withdrawal by Subject|3|||
105900663|NCT05600036|365293927|FG005|Overall Study|Withdrawal by Subject|5|||
105900664|NCT05600036|365293922|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105900665|NCT05600036|365293923|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105900666|NCT05600036|365293924|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105900667|NCT05600036|365293925|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
105900668|NCT05600036|365293926|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105900669|NCT05600036|365293927|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
105900670|NCT05600036|365293922|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105900671|NCT05600036|365293923|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
105900672|NCT05600036|365293924|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105900673|NCT05600036|365293925|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105900674|NCT05600036|365293926|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105900675|NCT05600036|365293927|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
105900676|NCT05600036|365293922|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105900677|NCT05600036|365293923|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105900678|NCT05600036|365293924|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105900679|NCT05600036|365293925|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
105900680|NCT05600036|365293926|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105900681|NCT05600036|365293927|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
105900682|NCT01006590|365293929|FG000|Overall Study|Adverse Event|2|||
105900683|NCT01006590|365293930|FG001|Overall Study|Adverse Event|3|||
105900684|NCT01006590|365293929|FG000|Overall Study|Death|1|||
105900685|NCT01006590|365293930|FG001|Overall Study|Death|1|||
105900686|NCT01006590|365293929|FG000|Overall Study|Lost to Follow-up|1|||
105900687|NCT01006590|365293930|FG001|Overall Study|Lost to Follow-up|1|||
105900688|NCT01006590|365293929|FG000|Overall Study|Protocol Violation|1|||
105900689|NCT01006590|365293930|FG001|Overall Study|Protocol Violation|0|||
105900690|NCT01006590|365293929|FG000|Overall Study|Withdrawal by Subject|4|||
105900691|NCT01006590|365293930|FG001|Overall Study|Withdrawal by Subject|2|||
105900692|NCT01006590|365293929|FG000|Overall Study|Study specific discontinuation criteria|16|||
105900693|NCT01006590|365293930|FG001|Overall Study|Study specific discontinuation criteria|23|||
105900694|NCT01006590|365293929|FG000|Overall Study|Other|3|||
105900695|NCT01006590|365293930|FG001|Overall Study|Other|2|||
105900696|NCT02776670|365293936|FG000|Overall Study|Adverse Event|0|||
105900697|NCT02776670|365293937|FG001|Overall Study|Adverse Event|2|||
105900698|NCT02776670|365293936|FG000|Overall Study|Protocol Violation|0|||
105900699|NCT02776670|365293937|FG001|Overall Study|Protocol Violation|2|||
105900700|NCT02776670|365293936|FG000|Overall Study|Withdrawal by Subject|0|||
105900701|NCT02776670|365293937|FG001|Overall Study|Withdrawal by Subject|1|||
105900702|NCT02776670|365293936|FG000|Overall Study|Other - Reason not given|0|||
105900703|NCT02776670|365293937|FG001|Overall Study|Other - Reason not given|1|||
105900704|NCT03699540|365293938|FG000|Overall Study|Lost to Follow-up|1|||
105900705|NCT00482170|365293950|FG000|Overall Study|Adverse Event|5|||
105900706|NCT00482170|365293951|FG001|Overall Study|Adverse Event|14|||
105900707|NCT00482170|365293950|FG000|Overall Study|Withdrawal by Subject|6|||
105900708|NCT00482170|365293951|FG001|Overall Study|Withdrawal by Subject|1|||
105900709|NCT00482170|365293950|FG000|Overall Study|Protocol Violation|2|||
105900710|NCT00482170|365293951|FG001|Overall Study|Protocol Violation|3|||
105900711|NCT00482170|365293950|FG000|Overall Study|Lost to Follow-up|2|||
105997994|NCT00731679|365653308|FG001|Overall Study|Pregnancy|1|||
105997995|NCT03089580|365653313|FG000|Overall Study|Lost to Follow-up|2|||
105900712|NCT00482170|365293951|FG001|Overall Study|Lost to Follow-up|0|||
105900713|NCT00482170|365293950|FG000|Overall Study|Unspecified reason|0|||
105997996|NCT04089761|365653314|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
105900714|NCT00482170|365293951|FG001|Overall Study|Unspecified reason|2|||
105900715|NCT00592592|365293952|FG000|Overall Study|Patient found ineligible upon chart review|1|||
105900716|NCT00703118|365293953|FG000|Overall Study|Adverse Event|1|||
105900717|NCT00703118|365293954|FG001|Overall Study|Adverse Event|2|||
105900718|NCT00703118|365293955|FG002|Overall Study|Adverse Event|2|||
105900719|NCT00703118|365293953|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
105900720|NCT00703118|365293954|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
105900721|NCT00703118|365293955|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
105900722|NCT00703118|365293953|FG000|Overall Study|Lost to Follow-up|6|||
105900723|NCT00703118|365293954|FG001|Overall Study|Lost to Follow-up|4|||
105900724|NCT00703118|365293955|FG002|Overall Study|Lost to Follow-up|4|||
105900725|NCT00703118|365293953|FG000|Overall Study|Withdrawal by Subject|8|||
105900726|NCT00703118|365293954|FG001|Overall Study|Withdrawal by Subject|7|||
105900727|NCT00703118|365293955|FG002|Overall Study|Withdrawal by Subject|13|||
105900728|NCT00703118|365293953|FG000|Overall Study|Other|0|||
105900729|NCT00703118|365293954|FG001|Overall Study|Other|0|||
105900730|NCT00703118|365293955|FG002|Overall Study|Other|1|||
105900731|NCT01618916|365293956|FG000|Overall Study|Adverse Event|1|||
105900732|NCT01618916|365293957|FG001|Overall Study|Adverse Event|0|||
105900733|NCT01618916|365293958|FG002|Overall Study|Adverse Event|0|||
105900734|NCT01618916|365293959|FG003|Overall Study|Adverse Event|0|||
106124539|NCT02942004|366114164|FG001|Overall Study|Randomized but not dosed|9|||
106124540|NCT02942004|366114165|FG002|Overall Study|Randomized but not dosed|4|||
106124541|NCT01544491|366114166|FG000|Overall Study|Withdrawal by Subject|3|||
106124542|NCT01544491|366114167|FG001|Overall Study|Withdrawal by Subject|2|||
106124543|NCT01544491|366114166|FG000|Overall Study|Lost to Follow-up|0|||
106124544|NCT01544491|366114167|FG001|Overall Study|Lost to Follow-up|1|||
106124545|NCT01544491|366114166|FG000|Overall Study|administrative problems|2|||
106124546|NCT01544491|366114167|FG001|Overall Study|administrative problems|0|||
106124547|NCT01448044|366114168|FG000|Treatment Period|Adverse Event|4|||
106124548|NCT01448044|366114169|FG001|Treatment Period|Adverse Event|3|||
106124549|NCT01448044|366114168|FG000|Treatment Period|Lack of Efficacy|5|||
106124550|NCT01448044|366114169|FG001|Treatment Period|Lack of Efficacy|12|||
106124551|NCT01448044|366114168|FG000|Treatment Period|Subject requested discontinue study drug|1|||
105900735|NCT01618916|365293960|FG004|Overall Study|Adverse Event|0|||
105900736|NCT01618916|365293961|FG005|Overall Study|Adverse Event|0|||
105900737|NCT01618916|365293956|FG000|Overall Study|Withdrawal by Subject|0|||
105900738|NCT01618916|365293957|FG001|Overall Study|Withdrawal by Subject|1|||
105900739|NCT01618916|365293958|FG002|Overall Study|Withdrawal by Subject|1|||
105900740|NCT01618916|365293959|FG003|Overall Study|Withdrawal by Subject|0|||
105900741|NCT01618916|365293960|FG004|Overall Study|Withdrawal by Subject|1|||
105900742|NCT01618916|365293961|FG005|Overall Study|Withdrawal by Subject|0|||
105900743|NCT01618916|365293956|FG000|Overall Study|Lost to Follow-up|1|||
105900744|NCT01618916|365293957|FG001|Overall Study|Lost to Follow-up|0|||
105900745|NCT01618916|365293958|FG002|Overall Study|Lost to Follow-up|0|||
105900746|NCT01618916|365293959|FG003|Overall Study|Lost to Follow-up|2|||
105900747|NCT01618916|365293960|FG004|Overall Study|Lost to Follow-up|0|||
105900748|NCT01618916|365293961|FG005|Overall Study|Lost to Follow-up|0|||
105900749|NCT02005627|365293962|FG000|Overall Study|Lost to Follow-up|1|||
105900750|NCT02005627|365293963|FG001|Overall Study|Lost to Follow-up|2|||
105900751|NCT02005627|365293962|FG000|Overall Study|Withdrawal by Subject|1|||
105900752|NCT02005627|365293963|FG001|Overall Study|Withdrawal by Subject|2|||
105900753|NCT00269477|365293964|FG000|Overall Study|Protocol Violation|5|||
105900754|NCT00269477|365293965|FG001|Overall Study|Protocol Violation|5|||
105900755|NCT00269477|365293966|FG002|Overall Study|Protocol Violation|1|||
105900756|NCT00269477|365293967|FG003|Overall Study|Protocol Violation|0|||
105900757|NCT00269477|365293964|FG000|Overall Study|Missed post-vaccination blood draw|0|||
105900758|NCT00269477|365293965|FG001|Overall Study|Missed post-vaccination blood draw|1|||
105900759|NCT00269477|365293966|FG002|Overall Study|Missed post-vaccination blood draw|0|||
105900760|NCT00269477|365293967|FG003|Overall Study|Missed post-vaccination blood draw|0|||
105900761|NCT01404949|365293976|FG000|Overall Study|Not Treated|1|||
105900762|NCT02007278|365293977|FG000|Overall Study|Failure to comply with an eligibility|0|||
105900763|NCT02007278|365293978|FG001|Overall Study|Failure to comply with an eligibility|1|||
105900764|NCT02007278|365293977|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
105900765|NCT02007278|365293978|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
105900766|NCT02007278|365293977|FG000|Overall Study|Incorrect medication administration|1|||
105900767|NCT02007278|365293978|FG001|Overall Study|Incorrect medication administration|0|||
106124552|NCT01448044|366114169|FG001|Treatment Period|Subject requested discontinue study drug|0|||
105900768|NCT02007278|365293977|FG000|Overall Study|Mis-randomization|1|||
106124553|NCT01448044|366114168|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
105900769|NCT02007278|365293978|FG001|Overall Study|Mis-randomization|1|||
105900770|NCT02886884|365293980|FG000|Follow-up|Withdrawal by Subject|0|||
105900771|NCT02886884|365293981|FG001|Follow-up|Withdrawal by Subject|0|||
105900772|NCT02886884|365293982|FG002|Follow-up|Withdrawal by Subject|0|||
105900773|NCT02886884|365293983|FG003|Follow-up|Withdrawal by Subject|1|||
105900774|NCT02112877|365293986|FG000|Overall Study|Withdrawal by Subject|1|||
105997997|NCT04089761|365653314|FG000|"Run In Phase"|Lost to Follow-up|1|||
105900775|NCT02112877|365293987|FG001|Overall Study|Withdrawal by Subject|7|||
105900776|NCT02112877|365293986|FG000|Overall Study|Visit Missed|1|||
105900777|NCT02112877|365293987|FG001|Overall Study|Visit Missed|6|||
105900778|NCT01693185|365293988|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
105900779|NCT01693185|365293989|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
105900780|NCT00621517|365293990|FG000|Overall Study|Lost to Follow-up|3|||
105900781|NCT00621517|365293991|FG001|Overall Study|Lost to Follow-up|3|||
106124554|NCT01448044|366114169|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
106124555|NCT01448044|366114168|FG000|Treatment Period|Participant does not meet study criteria|1|||
106124556|NCT01448044|366114169|FG001|Treatment Period|Participant does not meet study criteria|0|||
106124557|NCT01448044|366114168|FG000|Treatment Period|Lost to Follow-up|2|||
106124558|NCT01448044|366114169|FG001|Treatment Period|Lost to Follow-up|1|||
106124559|NCT01448044|366114168|FG000|Treatment Period|Other reason|2|||
106124560|NCT01448044|366114169|FG001|Treatment Period|Other reason|0|||
106124561|NCT01448044|366114168|FG000|Follow Up Period|Withdrawal by Subject|1|||
105668331|NCT00945672|364450216|FG000|Overall Study|Withdrawal by Subject|0|||
105668332|NCT00945672|364450217|FG001|Overall Study|Withdrawal by Subject|0|||
105668333|NCT00945672|364450218|FG002|Overall Study|Withdrawal by Subject|0|||
105668334|NCT00945672|364450219|FG003|Overall Study|Withdrawal by Subject|1|||
105668335|NCT03926195|364450223|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
105668336|NCT03926195|364450224|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
105668337|NCT03926195|364450223|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
105668338|NCT03926195|364450224|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
105668339|NCT03926195|364450223|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
105668340|NCT03926195|364450224|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
105668341|NCT03926195|364450223|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
105668342|NCT03926195|364450224|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
105668343|NCT03926195|364450223|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
105900782|NCT00621517|365293990|FG000|Overall Study|Withdrawal by Subject|3|||
105900783|NCT00621517|365293991|FG001|Overall Study|Withdrawal by Subject|4|||
105900784|NCT00621517|365293990|FG000|Overall Study|Adverse Event|1|||
105900785|NCT00621517|365293991|FG001|Overall Study|Adverse Event|0|||
105900786|NCT01048099|365293992|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
105900787|NCT01048099|365293992|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
105900788|NCT01863732|365293993|FG000|Overall Study|Adverse Event|2|||
105900789|NCT01863732|365293994|FG001|Overall Study|Adverse Event|0|||
105900790|NCT01863732|365293995|FG002|Overall Study|Adverse Event|3|||
105900791|NCT01863732|365293996|FG003|Overall Study|Adverse Event|3|||
105900792|NCT01863732|365293993|FG000|Overall Study|Lack of Efficacy|1|||
105900793|NCT01863732|365293994|FG001|Overall Study|Lack of Efficacy|0|||
105900794|NCT01863732|365293995|FG002|Overall Study|Lack of Efficacy|2|||
105900795|NCT01863732|365293996|FG003|Overall Study|Lack of Efficacy|1|||
105900796|NCT01863732|365293993|FG000|Overall Study|Lost to Follow-up|2|||
105900797|NCT01863732|365293994|FG001|Overall Study|Lost to Follow-up|2|||
105900798|NCT01863732|365293995|FG002|Overall Study|Lost to Follow-up|1|||
105900799|NCT01863732|365293996|FG003|Overall Study|Lost to Follow-up|1|||
105900800|NCT01863732|365293993|FG000|Overall Study|Physician Decision|1|||
105900801|NCT01863732|365293994|FG001|Overall Study|Physician Decision|0|||
105900802|NCT01863732|365293995|FG002|Overall Study|Physician Decision|1|||
105900803|NCT01863732|365293996|FG003|Overall Study|Physician Decision|0|||
105900804|NCT01863732|365293993|FG000|Overall Study|Pregnancy|0|||
105900805|NCT01863732|365293994|FG001|Overall Study|Pregnancy|0|||
105900806|NCT01863732|365293995|FG002|Overall Study|Pregnancy|0|||
105900807|NCT01863732|365293996|FG003|Overall Study|Pregnancy|1|||
105900808|NCT01863732|365293993|FG000|Overall Study|Technical problems|0|||
105900809|NCT01863732|365293994|FG001|Overall Study|Technical problems|1|||
105900810|NCT01863732|365293995|FG002|Overall Study|Technical problems|1|||
105668344|NCT03926195|364450224|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
105668345|NCT03926195|364450223|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
105668346|NCT03926195|364450224|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
105668347|NCT01294397|364450227|FG000|Overall Study|Withdrawal by Subject|1|||
105668348|NCT01294397|364450227|FG000|Overall Study|Administrative Decision|1|||
105668349|NCT01250925|364450228|FG000|Overall Study|Lost to Follow-up|1|||
105668350|NCT01250925|364450229|FG001|Overall Study|Lost to Follow-up|1|||
105668351|NCT01250925|364450230|FG002|Overall Study|Lost to Follow-up|0|||
105668352|NCT01250925|364450228|FG000|Overall Study|Withdrawal by Subject|2|||
105668353|NCT01250925|364450229|FG001|Overall Study|Withdrawal by Subject|0|||
105668354|NCT01250925|364450230|FG002|Overall Study|Withdrawal by Subject|0|||
105668355|NCT01250925|364450228|FG000|Overall Study|Protocol Violation|2|||
105668356|NCT01250925|364450229|FG001|Overall Study|Protocol Violation|0|||
105668357|NCT01250925|364450230|FG002|Overall Study|Protocol Violation|0|||
105668358|NCT01250925|364450228|FG000|Overall Study|Physician Decision|0|||
105668359|NCT01250925|364450229|FG001|Overall Study|Physician Decision|2|||
105668360|NCT01250925|364450230|FG002|Overall Study|Physician Decision|1|||
105668361|NCT01250925|364450228|FG000|Overall Study|Adverse Event|0|||
105668362|NCT01250925|364450229|FG001|Overall Study|Adverse Event|0|||
105668363|NCT01250925|364450230|FG002|Overall Study|Adverse Event|1|||
105668364|NCT01939353|364450231|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
105668365|NCT01939353|364450231|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
105668366|NCT01939353|364450231|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
105668367|NCT01939353|364450231|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
105668368|NCT01939353|364450231|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
105668369|NCT00737477|364450232|FG000|Overall Study|Adverse Event|9|||
105668370|NCT00737477|364450232|FG000|Overall Study|Death|9|||
105668371|NCT00737477|364450232|FG000|Overall Study|Treatment Refusal|1|||
105668372|NCT00737477|364450232|FG000|Overall Study|Withdrawal by Subject|1|||
105668373|NCT00737477|364450232|FG000|Overall Study|Renal Transplantation|10|||
105668374|NCT00737477|364450232|FG000|Overall Study|Other|4|||
105668375|NCT01370655|364450233|FG000|Period 1|Adverse Event|2|||
105668376|NCT01370655|364450234|FG001|Period 1|Adverse Event|0|||
105668377|NCT01370655|364450235|FG002|Period 1|Adverse Event|0|||
105668378|NCT01370655|364450236|FG003|Period 1|Adverse Event|0|||
105668379|NCT01370655|364450237|FG004|Period 1|Adverse Event|0|||
105668380|NCT01370655|364450238|FG005|Period 1|Adverse Event|0|||
105668381|NCT01370655|364450239|FG006|Period 1|Adverse Event|1|||
105900811|NCT01863732|365293996|FG003|Overall Study|Technical problems|0|||
105900812|NCT01863732|365293993|FG000|Overall Study|Subject/guardian decision|6|||
105900813|NCT01863732|365293994|FG001|Overall Study|Subject/guardian decision|9|||
105900814|NCT01863732|365293995|FG002|Overall Study|Subject/guardian decision|3|||
105900815|NCT01863732|365293996|FG003|Overall Study|Subject/guardian decision|1|||
105900816|NCT01863732|365293993|FG000|Overall Study|Death|1|||
105900817|NCT01863732|365293994|FG001|Overall Study|Death|0|||
105668382|NCT01370655|364450240|FG007|Period 1|Adverse Event|0|||
105668383|NCT01370655|364450241|FG008|Period 1|Adverse Event|0|||
105668384|NCT01370655|364450242|FG009|Period 1|Adverse Event|0|||
105668385|NCT01370655|364450243|FG010|Period 1|Adverse Event|0|||
105900818|NCT01863732|365293995|FG002|Overall Study|Death|0|||
105900819|NCT01863732|365293996|FG003|Overall Study|Death|1|||
105900820|NCT00508157|365293997|FG000|Overall Study|Adverse Event|0|||
105900821|NCT00508157|365293998|FG001|Overall Study|Adverse Event|1|||
105900822|NCT00508157|365293997|FG000|Overall Study|Subject Withdrew Consent|1|||
106124562|NCT01448044|366114169|FG001|Follow Up Period|Withdrawal by Subject|1|||
106124563|NCT01448044|366114168|FG000|Follow Up Period|Lost to Follow-up|6|||
106124564|NCT01448044|366114169|FG001|Follow Up Period|Lost to Follow-up|2|||
106124565|NCT01448044|366114168|FG000|Follow Up Period|Other|5|||
105668386|NCT01370655|364450244|FG011|Period 1|Adverse Event|0|||
105668387|NCT01370655|364450233|FG000|Period 2|Adverse Event|0|||
105668388|NCT01370655|364450234|FG001|Period 2|Adverse Event|0|||
105900823|NCT00508157|365293998|FG001|Overall Study|Subject Withdrew Consent|0|||
105900824|NCT00508157|365293997|FG000|Overall Study|Lost to Follow-up|1|||
105900825|NCT00508157|365293998|FG001|Overall Study|Lost to Follow-up|0|||
105900826|NCT00508157|365293997|FG000|Overall Study|Subject no longer met study criteria|0|||
105900827|NCT00508157|365293998|FG001|Overall Study|Subject no longer met study criteria|1|||
105900828|NCT00508157|365293997|FG000|Overall Study|Other known cause|0|||
105900829|NCT00508157|365293998|FG001|Overall Study|Other known cause|1|||
105900830|NCT00073008|365293999|FG000|Overall Study|Missing|6|||
105900831|NCT00073008|365294000|FG001|Overall Study|Missing|6|||
105900832|NCT00073008|365293999|FG000|Overall Study|Withdrawal by Subject|2|||
105900833|NCT00073008|365294000|FG001|Overall Study|Withdrawal by Subject|2|||
105900834|NCT00073008|365293999|FG000|Overall Study|Lost to Follow-up|1|||
105900835|NCT00073008|365294000|FG001|Overall Study|Lost to Follow-up|3|||
105900836|NCT00073008|365293999|FG000|Overall Study|Death|46|||
105900837|NCT00073008|365294000|FG001|Overall Study|Death|47|||
105900838|NCT00073008|365293999|FG000|Overall Study|"Other selected on Case Report Form"|7|||
105900839|NCT00073008|365294000|FG001|Overall Study|"Other selected on Case Report Form"|5|||
105900840|NCT01156051|365294001|FG000|Overall Study|Lost to Follow-up|1|||
105900841|NCT01156051|365294002|FG001|Overall Study|Lost to Follow-up|0|||
105900842|NCT01156051|365294001|FG000|Overall Study|patient not compliant with protocol|0|||
105900843|NCT01156051|365294002|FG001|Overall Study|patient not compliant with protocol|1|||
105900844|NCT01428115|365294004|FG000|Overall Study|Lack of Efficacy|3|||
105900845|NCT01428115|365294004|FG000|Overall Study|Lost to Follow-up|10|||
105900846|NCT01428115|365294004|FG000|Overall Study|Pregnancy|1|||
105900847|NCT01428115|365294004|FG000|Overall Study|Protocol Violation|3|||
105900848|NCT01428115|365294004|FG000|Overall Study|Withdrawal by Subject|4|||
105900849|NCT02179749|365294005|FG000|Overall Study|Adverse Event|0|||
105900850|NCT02179749|365294006|FG001|Overall Study|Adverse Event|0|||
105900851|NCT02179749|365294007|FG002|Overall Study|Adverse Event|1|||
105900852|NCT02179749|365294005|FG000|Overall Study|Withdrawal by Subject|0|||
105900853|NCT02179749|365294006|FG001|Overall Study|Withdrawal by Subject|0|||
105900854|NCT02179749|365294007|FG002|Overall Study|Withdrawal by Subject|1|||
105900855|NCT00494221|365294008|FG000|Overall Study|Death|15|||
106124566|NCT01448044|366114169|FG001|Follow Up Period|Other|11|||
106124567|NCT01000376|366114170|FG000|Cycle 1 Day 1|Adverse Event|1|||
105668389|NCT01370655|364450235|FG002|Period 2|Adverse Event|1|||
105668390|NCT01370655|364450236|FG003|Period 2|Adverse Event|0|||
105668391|NCT01370655|364450237|FG004|Period 2|Adverse Event|1|||
105668392|NCT01370655|364450238|FG005|Period 2|Adverse Event|0|||
105668393|NCT01370655|364450239|FG006|Period 2|Adverse Event|0|||
105668394|NCT01370655|364450240|FG007|Period 2|Adverse Event|1|||
105668395|NCT01370655|364450241|FG008|Period 2|Adverse Event|0|||
105668396|NCT01370655|364450242|FG009|Period 2|Adverse Event|0|||
105900856|NCT00494221|365294009|FG001|Overall Study|Death|9|||
105900857|NCT00494221|365294010|FG002|Overall Study|Death|14|||
105900858|NCT00494221|365294008|FG000|Overall Study|Withdrawal by Subject|1|||
105900859|NCT00494221|365294009|FG001|Overall Study|Withdrawal by Subject|2|||
105900860|NCT00494221|365294010|FG002|Overall Study|Withdrawal by Subject|0|||
105900861|NCT01994902|365294011|FG000|Test Period 1|Withdrawal by Subject|3|||
105900862|NCT01994902|365294012|FG001|Test Period 1|Withdrawal by Subject|0|||
105900863|NCT01994902|365294011|FG000|Test Period 1|device deficiency with adverse event|0|||
105900864|NCT01994902|365294012|FG001|Test Period 1|device deficiency with adverse event|1|||
105900865|NCT01994902|365294011|FG000|Test Period 1|Adverse Event|2|||
105900866|NCT01994902|365294012|FG001|Test Period 1|Adverse Event|1|||
105900867|NCT01994902|365294011|FG000|Test Period 1|Lack of Efficacy|0|||
106124568|NCT01000376|366114171|FG001|Cycle 1 Day 1|Adverse Event|0|||
106124569|NCT01000376|366114170|FG000|Cycle 1 Day 1|Progressive Disease|1|||
105900868|NCT01994902|365294012|FG001|Test Period 1|Lack of Efficacy|1|||
105900869|NCT01994902|365294011|FG000|Test Period 1|bag too small|1|||
105900870|NCT01994902|365294012|FG001|Test Period 1|bag too small|0|||
105900871|NCT01994902|365294011|FG000|Test Period 2|Withdrawal by Subject|0|||
105668397|NCT01370655|364450243|FG010|Period 2|Adverse Event|0|||
105668398|NCT01370655|364450244|FG011|Period 2|Adverse Event|0|||
105900872|NCT01994902|365294012|FG001|Test Period 2|Withdrawal by Subject|2|||
105668399|NCT01370655|364450233|FG000|Period 2|met protocol specified stopping criteria|0|||
105900873|NCT01994902|365294011|FG000|Test Period 2|Lack of Efficacy|0|||
105997998|NCT04089761|365653314|FG000|"Treatment Phase"|No evaluable data|5|||
106124570|NCT01000376|366114171|FG001|Cycle 1 Day 1|Progressive Disease|0|||
105668400|NCT01370655|364450234|FG001|Period 2|met protocol specified stopping criteria|0|||
106124571|NCT00681187|366114172|FG000|Overall Study|Withdrawal by Subject|1|||
105668401|NCT01370655|364450235|FG002|Period 2|met protocol specified stopping criteria|1|||
105900874|NCT01994902|365294012|FG001|Test Period 2|Lack of Efficacy|1|||
105900875|NCT01994902|365294011|FG000|Test Period 2|Other|0|||
105900876|NCT01994902|365294012|FG001|Test Period 2|Other|3|||
105900877|NCT02634983|365294016|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
105900878|NCT02634983|365294017|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
105900879|NCT00467558|365294022|FG000|Overall Study|Lost to Follow-up|2|||
105900880|NCT00467558|365294023|FG001|Overall Study|Lost to Follow-up|0|||
105900881|NCT02636439|365294024|FG000|Overall Study|Adverse Event|2|||
105900882|NCT02636439|365294025|FG001|Overall Study|Adverse Event|2|||
106124572|NCT00681187|366114173|FG001|Overall Study|Withdrawal by Subject|0|||
106124573|NCT00681187|366114172|FG000|Overall Study|Death|0|||
105900883|NCT02636439|365294024|FG000|Overall Study|Lost to Follow-up|1|||
105900884|NCT02636439|365294025|FG001|Overall Study|Lost to Follow-up|0|||
105900885|NCT02636439|365294024|FG000|Overall Study|Non-compliance|1|||
105900886|NCT02636439|365294025|FG001|Overall Study|Non-compliance|1|||
105900887|NCT02636439|365294024|FG000|Overall Study|Personal reasons|2|||
105900888|NCT02636439|365294025|FG001|Overall Study|Personal reasons|0|||
105900889|NCT01709864|365296224|FG000|Overall Study|Physician Decision|0|||
105900890|NCT01709864|365296225|FG001|Overall Study|Physician Decision|1|||
105900891|NCT01709864|365296224|FG000|Overall Study|subject/guardian decision|5|||
105900892|NCT01709864|365296225|FG001|Overall Study|subject/guardian decision|6|||
105900893|NCT01709864|365296224|FG000|Overall Study|Lost to Follow-up|1|||
105900894|NCT01709864|365296225|FG001|Overall Study|Lost to Follow-up|0|||
105900895|NCT01709864|365296224|FG000|Overall Study|non-compliance with study treatment|1|||
105900896|NCT01709864|365296225|FG001|Overall Study|non-compliance with study treatment|1|||
105900897|NCT01709864|365296224|FG000|Overall Study|Adverse Event|0|||
105900898|NCT01709864|365296225|FG001|Overall Study|Adverse Event|2|||
106124574|NCT00681187|366114173|FG001|Overall Study|Death|1|||
106124575|NCT00681187|366114172|FG000|Overall Study|Adverse Event|0|||
106124576|NCT00681187|366114173|FG001|Overall Study|Adverse Event|1|||
106124577|NCT00896454|366114174|FG000|Overall Study|Death|10|||
106124578|NCT00896454|366114174|FG000|Overall Study|Adverse Event|8|||
106124579|NCT00896454|366114174|FG000|Overall Study|Disease Progression|5|||
106124580|NCT00896454|366114174|FG000|Overall Study|Other|4|||
106124581|NCT00896454|366114174|FG000|Overall Study|Requirement for alternative therapy|3|||
106124582|NCT00896454|366114174|FG000|Overall Study|Ongoing in study|2|||
106124583|NCT00896454|366114174|FG000|Overall Study|Withdrawal by Subject|1|||
106124584|NCT03688711|366114177|FG000|Overall Study|Withdrawal by Subject|0|||
106124585|NCT03688711|366114178|FG001|Overall Study|Withdrawal by Subject|1|||
106124586|NCT00219141|366114179|FG000|Overall Study|Adverse Event|4|||
106124587|NCT00219141|366114180|FG001|Overall Study|Adverse Event|10|||
106124588|NCT00219141|366114181|FG002|Overall Study|Adverse Event|5|||
106124589|NCT00219141|366114179|FG000|Overall Study|Lack of Efficacy|3|||
106124590|NCT00219141|366114180|FG001|Overall Study|Lack of Efficacy|2|||
106124591|NCT00219141|366114181|FG002|Overall Study|Lack of Efficacy|0|||
105900899|NCT01709864|365296224|FG000|Overall Study|Death|0|||
105900900|NCT01709864|365296225|FG001|Overall Study|Death|1|||
105997999|NCT04089761|365653314|FG000|"Treatment Phase"|Lost to Follow-up|1|||
105998000|NCT04864639|365654762|FG000|Overall Study|Death|1|||
105998001|NCT04864639|365654762|FG000|Overall Study|Lost to Follow-up|1|||
105998002|NCT00447226|365654763|FG000|12-Week Open-label Phase|Adverse Event|0|||
105998003|NCT00447226|365654764|FG001|12-Week Open-label Phase|Adverse Event|3|||
105998004|NCT00447226|365654763|FG000|12-Week Open-label Phase|Protocol Violation|0|||
105998005|NCT00447226|365654764|FG001|12-Week Open-label Phase|Protocol Violation|1|||
105998006|NCT00447226|365654763|FG000|12-Week Open-label Phase|Disease Progression|0|||
105998007|NCT00447226|365654764|FG001|12-Week Open-label Phase|Disease Progression|20|||
105998008|NCT00447226|365654763|FG000|12-Week Open-label Phase|Physician Decision|0|||
105998009|NCT00447226|365654764|FG001|12-Week Open-label Phase|Physician Decision|1|||
106124592|NCT00219141|366114179|FG000|Overall Study|Administrative problems|0|||
105900901|NCT01709409|365296229|FG000|Overall Study|Protocol Violation|1|||
106124593|NCT00219141|366114180|FG001|Overall Study|Administrative problems|1|||
106124594|NCT00219141|366114181|FG002|Overall Study|Administrative problems|0|||
106124595|NCT00219141|366114179|FG000|Overall Study|Lost to Follow-up|2|||
105900902|NCT01709409|365296230|FG001|Overall Study|Protocol Violation|0|||
105900903|NCT02815267|365296234|FG000|Double-Blind Phase|Adverse Event|0|||
105900904|NCT02815267|365296235|FG001|Double-Blind Phase|Adverse Event|3|||
105900905|NCT02815267|365296234|FG000|Double-Blind Phase|Lost to Follow-up|17|||
105900906|NCT02815267|365296235|FG001|Double-Blind Phase|Lost to Follow-up|9|||
105998010|NCT00447226|365654763|FG000|Double-blind Phase|Disease Progression|4|||
106124596|NCT00219141|366114180|FG001|Overall Study|Lost to Follow-up|4|||
106124597|NCT00219141|366114181|FG002|Overall Study|Lost to Follow-up|1|||
106124598|NCT00219141|366114179|FG000|Overall Study|Protocol Violation|3|||
105900907|NCT02815267|365296234|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
106124599|NCT00219141|366114180|FG001|Overall Study|Protocol Violation|1|||
105900908|NCT02815267|365296235|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
105900909|NCT02815267|365296234|FG000|Double-Blind Phase|Protocol Violation|3|||
105900910|NCT02815267|365296235|FG001|Double-Blind Phase|Protocol Violation|2|||
105998011|NCT00447226|365654764|FG001|Double-blind Phase|Disease Progression|3|||
105998012|NCT01467505|365654768|FG000|Overall Study|Adverse Event|1|||
105668402|NCT01370655|364450236|FG003|Period 2|met protocol specified stopping criteria|0|||
105668403|NCT01370655|364450237|FG004|Period 2|met protocol specified stopping criteria|0|||
105668404|NCT01370655|364450238|FG005|Period 2|met protocol specified stopping criteria|0|||
105668405|NCT01370655|364450239|FG006|Period 2|met protocol specified stopping criteria|1|||
105668406|NCT01370655|364450240|FG007|Period 2|met protocol specified stopping criteria|0|||
105668407|NCT01370655|364450241|FG008|Period 2|met protocol specified stopping criteria|1|||
105668408|NCT01370655|364450242|FG009|Period 2|met protocol specified stopping criteria|0|||
105668409|NCT01370655|364450243|FG010|Period 2|met protocol specified stopping criteria|1|||
105668410|NCT01370655|364450244|FG011|Period 2|met protocol specified stopping criteria|0|||
105668411|NCT01370655|364450233|FG000|Period 2|Withdrawal by Subject|0|||
105668412|NCT01370655|364450234|FG001|Period 2|Withdrawal by Subject|0|||
105668413|NCT01370655|364450235|FG002|Period 2|Withdrawal by Subject|0|||
105668414|NCT01370655|364450236|FG003|Period 2|Withdrawal by Subject|0|||
105668415|NCT01370655|364450237|FG004|Period 2|Withdrawal by Subject|0|||
105668416|NCT01370655|364450238|FG005|Period 2|Withdrawal by Subject|0|||
105668417|NCT01370655|364450239|FG006|Period 2|Withdrawal by Subject|0|||
105668418|NCT01370655|364450240|FG007|Period 2|Withdrawal by Subject|0|||
105668419|NCT01370655|364450241|FG008|Period 2|Withdrawal by Subject|1|||
105668420|NCT01370655|364450242|FG009|Period 2|Withdrawal by Subject|0|||
105668421|NCT01370655|364450243|FG010|Period 2|Withdrawal by Subject|0|||
105668422|NCT01370655|364450244|FG011|Period 2|Withdrawal by Subject|0|||
105668423|NCT01465763|364450246|FG000|Overall Study|Withdrawal by Subject|4|||
105668424|NCT01465763|364450247|FG001|Overall Study|Withdrawal by Subject|0|||
105668425|NCT01465763|364450248|FG002|Overall Study|Withdrawal by Subject|1|||
105668426|NCT01465763|364450246|FG000|Overall Study|Insufficient Clinical Response|11|||
105668427|NCT01465763|364450247|FG001|Overall Study|Insufficient Clinical Response|0|||
105668428|NCT01465763|364450248|FG002|Overall Study|Insufficient Clinical Response|1|||
105668429|NCT01465763|364450246|FG000|Overall Study|Adverse Event|9|||
105668430|NCT01465763|364450247|FG001|Overall Study|Adverse Event|0|||
105668431|NCT01465763|364450248|FG002|Overall Study|Adverse Event|1|||
105668432|NCT01465763|364450246|FG000|Overall Study|Other|2|||
105668433|NCT01465763|364450247|FG001|Overall Study|Other|0|||
105668434|NCT01465763|364450248|FG002|Overall Study|Other|0|||
105668435|NCT01465763|364450246|FG000|Overall Study|Protocol Violation|4|||
105668436|NCT01465763|364450247|FG001|Overall Study|Protocol Violation|1|||
105668437|NCT01465763|364450248|FG002|Overall Study|Protocol Violation|1|||
105668438|NCT01465763|364450246|FG000|Overall Study|Death|1|||
105668439|NCT01465763|364450247|FG001|Overall Study|Death|0|||
105668440|NCT01465763|364450248|FG002|Overall Study|Death|0|||
105668441|NCT01427725|364450254|FG000|Overall Study|Lost to Follow-up|17|||
105668442|NCT01427725|364450254|FG000|Overall Study|Protocol Violation|1|||
105668443|NCT01427725|364450254|FG000|Overall Study|Drug not administered|1|||
105668444|NCT01427725|364450254|FG000|Overall Study|Failure to visit|7|||
105668445|NCT01427725|364450254|FG000|Overall Study|Adverse Event|46|||
105998013|NCT01467505|365654769|FG001|Overall Study|Adverse Event|0|||
105998014|NCT01467505|365654768|FG000|Overall Study|Withdrawal by Subject|4|||
105668446|NCT01427725|364450254|FG000|Overall Study|Failure to visit after administration|40|||
105668447|NCT01427725|364450254|FG000|Overall Study|Patient's rejection|27|||
105668448|NCT01427725|364450254|FG000|Overall Study|Transfer to a different hospital|17|||
105668449|NCT01427725|364450254|FG000|Overall Study|Lack of Efficacy|8|||
105668450|NCT01427725|364450254|FG000|Overall Study|Death|7|||
105668451|NCT01427725|364450254|FG000|Overall Study|Symptom improvement|6|||
105668452|NCT01427725|364450254|FG000|Overall Study|AE and Patient's rejection|5|||
105668453|NCT01427725|364450254|FG000|Overall Study|Physician Decision|5|||
105668454|NCT01427725|364450254|FG000|Overall Study|Exacerbation of underlying disease|5|||
105668455|NCT01427725|364450254|FG000|Overall Study|Oral feeding difficulty|5|||
105668456|NCT01427725|364450254|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
105668457|NCT01427725|364450254|FG000|Overall Study|Forgetting prescription|1|||
105668458|NCT01427725|364450254|FG000|Overall Study|Other|2|||
105668459|NCT00588692|364450255|FG000|Overall Study|Withdrawal by Subject|4|||
105668460|NCT00588692|364450256|FG001|Overall Study|Withdrawal by Subject|2|||
105668461|NCT00588692|364450255|FG000|Overall Study|Hip Surgery|0|||
105668462|NCT00588692|364450256|FG001|Overall Study|Hip Surgery|1|||
105668463|NCT00588692|364450255|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
105668464|NCT00588692|364450256|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
105668465|NCT00588692|364450255|FG000|Overall Study|Cancer|1|||
105668466|NCT00588692|364450256|FG001|Overall Study|Cancer|0|||
105668467|NCT00588692|364450255|FG000|Overall Study|Death|1|||
105668468|NCT00588692|364450256|FG001|Overall Study|Death|0|||
105668469|NCT01374568|364450257|FG000|Overall Study|Lab unable to analyze BTM|0|||
105668470|NCT01374568|364450258|FG001|Overall Study|Lab unable to analyze BTM|2|||
105668471|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
105668472|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
105668473|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
105668474|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
105668475|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
105668476|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
105900911|NCT02815267|365296234|FG000|Double-Blind Phase|Site withdrawal|1|||
105900912|NCT02815267|365296235|FG001|Double-Blind Phase|Site withdrawal|6|||
105900913|NCT02815267|365296234|FG000|Double-Blind Phase|Received a disallowed medication|1|||
105900914|NCT02815267|365296235|FG001|Double-Blind Phase|Received a disallowed medication|1|||
105900915|NCT02815267|365296234|FG000|Open-Label Phase|Adverse Event|1|||
105900916|NCT02815267|365296235|FG001|Open-Label Phase|Adverse Event|1|||
105900917|NCT02815267|365296234|FG000|Open-Label Phase|Lost to Follow-up|23|||
105900918|NCT02815267|365296235|FG001|Open-Label Phase|Lost to Follow-up|9|||
105900919|NCT02815267|365296234|FG000|Open-Label Phase|Withdrawal by Subject|24|||
105900920|NCT02815267|365296235|FG001|Open-Label Phase|Withdrawal by Subject|13|||
105900921|NCT02815267|365296234|FG000|Open-Label Phase|Protocol Violation|0|||
105900922|NCT02815267|365296235|FG001|Open-Label Phase|Protocol Violation|1|||
105900923|NCT02815267|365296234|FG000|Open-Label Phase|Administrative|21|||
105900924|NCT02815267|365296235|FG001|Open-Label Phase|Administrative|12|||
105900925|NCT02815267|365296234|FG000|Open-Label Phase|Other|2|||
105900926|NCT02815267|365296235|FG001|Open-Label Phase|Other|5|||
105900927|NCT01853696|365296236|FG000|Overall Study|Withdrawal by Subject|1|||
105900928|NCT01853696|365296237|FG001|Overall Study|Withdrawal by Subject|1|||
105900929|NCT01853696|365296236|FG000|Overall Study|Lost to Follow-up|5|||
105900930|NCT01853696|365296237|FG001|Overall Study|Lost to Follow-up|4|||
105900931|NCT00431067|365296244|FG000|Overall Study|Other Adverse Event|9|||
105900932|NCT00431067|365296244|FG000|Overall Study|Progressive disease|30|||
105900933|NCT00431067|365296244|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
105900934|NCT03420222|365296253|FG000|Overall Study|Withdrawal by Subject|5|||
105900935|NCT03420222|365296254|FG001|Overall Study|Withdrawal by Subject|0|||
105900936|NCT03420222|365296253|FG000|Overall Study|Physician Decision|0|||
105900937|NCT03420222|365296254|FG001|Overall Study|Physician Decision|1|||
105900938|NCT02697734|365296257|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
105900939|NCT02697734|365296258|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
105900940|NCT02697734|365296257|FG000|Core Phase - up to Week 48|Adverse Event|1|||
105900941|NCT02697734|365296258|FG001|Core Phase - up to Week 48|Adverse Event|2|||
105900942|NCT02697734|365296257|FG000|Core Phase - up to Week 48|Physician Decision|1|||
105900943|NCT02697734|365296258|FG001|Core Phase - up to Week 48|Physician Decision|0|||
105900944|NCT02697734|365296257|FG000|Optional Extension Phase|Adverse Event|5|||
105900945|NCT02697734|365296258|FG001|Optional Extension Phase|Adverse Event|1|||
105900946|NCT02697734|365296257|FG000|Optional Extension Phase|Physician Decision|0|||
105900947|NCT02697734|365296258|FG001|Optional Extension Phase|Physician Decision|1|||
105900948|NCT02334384|365296260|FG000|Overall Study|Lost to Follow-up|1|||
105900949|NCT02334384|365296261|FG001|Overall Study|Lost to Follow-up|1|||
105900950|NCT02651688|365296262|FG000|Overall Study|Non-compliance|0|||
105900951|NCT02651688|365296263|FG001|Overall Study|Non-compliance|0|||
105900952|NCT02651688|365296264|FG002|Overall Study|Non-compliance|1|||
105900953|NCT02651688|365296262|FG000|Overall Study|Principal Investigator (PI) decision|0|||
105900954|NCT02651688|365296263|FG001|Overall Study|Principal Investigator (PI) decision|2|||
105900955|NCT02651688|365296264|FG002|Overall Study|Principal Investigator (PI) decision|0|||
105900956|NCT02651688|365296262|FG000|Overall Study|Lost to Follow-up|1|||
105900957|NCT02651688|365296263|FG001|Overall Study|Lost to Follow-up|3|||
105900958|NCT02651688|365296264|FG002|Overall Study|Lost to Follow-up|0|||
105900959|NCT02651688|365296262|FG000|Overall Study|Withdrawal by Subject|1|||
105900960|NCT02651688|365296263|FG001|Overall Study|Withdrawal by Subject|0|||
105900961|NCT02651688|365296264|FG002|Overall Study|Withdrawal by Subject|2|||
105900962|NCT00055497|365296265|FG000|Overall Study|Adverse Event|1|||
105900963|NCT00055497|365296266|FG001|Overall Study|Adverse Event|1|||
105900964|NCT00055497|365296267|FG002|Overall Study|Adverse Event|1|||
105900965|NCT00055497|365296268|FG003|Overall Study|Adverse Event|28|||
105900966|NCT00055497|365296265|FG000|Overall Study|Withdrawal by Subject|3|||
105900967|NCT00055497|365296266|FG001|Overall Study|Withdrawal by Subject|1|||
105900968|NCT00055497|365296267|FG002|Overall Study|Withdrawal by Subject|1|||
105900969|NCT00055497|365296268|FG003|Overall Study|Withdrawal by Subject|15|||
105900970|NCT00055497|365296265|FG000|Overall Study|Lost to Follow-up|0|||
105900971|NCT00055497|365296266|FG001|Overall Study|Lost to Follow-up|1|||
105900972|NCT00055497|365296267|FG002|Overall Study|Lost to Follow-up|0|||
105900973|NCT00055497|365296268|FG003|Overall Study|Lost to Follow-up|5|||
105998015|NCT01467505|365654769|FG001|Overall Study|Withdrawal by Subject|0|||
105900974|NCT00055497|365296265|FG000|Overall Study|Protocol Violation|0|||
105900975|NCT00055497|365296266|FG001|Overall Study|Protocol Violation|0|||
106124600|NCT00219141|366114181|FG002|Overall Study|Protocol Violation|1|||
106124601|NCT00219141|366114179|FG000|Overall Study|Withdrawal by Subject|1|||
105900976|NCT00055497|365296267|FG002|Overall Study|Protocol Violation|0|||
105900977|NCT00055497|365296268|FG003|Overall Study|Protocol Violation|3|||
105900978|NCT00055497|365296265|FG000|Overall Study|Lack of Efficacy|1|||
105900979|NCT00055497|365296266|FG001|Overall Study|Lack of Efficacy|0|||
105900980|NCT00055497|365296267|FG002|Overall Study|Lack of Efficacy|0|||
105900981|NCT00055497|365296268|FG003|Overall Study|Lack of Efficacy|27|||
105900982|NCT00055497|365296265|FG000|Overall Study|Administrative Reasons|0|||
105900983|NCT00055497|365296266|FG001|Overall Study|Administrative Reasons|0|||
105900984|NCT00055497|365296267|FG002|Overall Study|Administrative Reasons|0|||
106124602|NCT00219141|366114180|FG001|Overall Study|Withdrawal by Subject|3|||
106124603|NCT00219141|366114181|FG002|Overall Study|Withdrawal by Subject|5|||
106124604|NCT00219141|366114179|FG000|Overall Study|Condition no longer requires study drug|1|||
106124605|NCT00219141|366114180|FG001|Overall Study|Condition no longer requires study drug|0|||
106124606|NCT00219141|366114181|FG002|Overall Study|Condition no longer requires study drug|0|||
106124607|NCT00972179|366114182|FG000|Overall Study|Noncompliance|1|||
106124608|NCT00972179|366114183|FG001|Overall Study|Noncompliance|0|||
106124609|NCT00972179|366114184|FG002|Overall Study|Noncompliance|0|||
106124610|NCT00972179|366114185|FG003|Overall Study|Noncompliance|0|||
106124611|NCT00972179|366114186|FG004|Overall Study|Noncompliance|1|||
106124612|NCT00972179|366114187|FG005|Overall Study|Noncompliance|0|||
106124613|NCT00972179|366114188|FG006|Overall Study|Noncompliance|1|||
106124614|NCT00972179|366114182|FG000|Overall Study|Withdrawal by Subject|0|||
106124615|NCT00972179|366114183|FG001|Overall Study|Withdrawal by Subject|3|||
106124616|NCT00972179|366114184|FG002|Overall Study|Withdrawal by Subject|0|||
106124617|NCT00972179|366114185|FG003|Overall Study|Withdrawal by Subject|1|||
106124618|NCT00972179|366114186|FG004|Overall Study|Withdrawal by Subject|0|||
106124619|NCT00972179|366114187|FG005|Overall Study|Withdrawal by Subject|0|||
106124620|NCT00972179|366114188|FG006|Overall Study|Withdrawal by Subject|2|||
106124621|NCT00972179|366114182|FG000|Overall Study|Administrative Decision|0|||
106124622|NCT00972179|366114183|FG001|Overall Study|Administrative Decision|0|||
106124623|NCT00972179|366114184|FG002|Overall Study|Administrative Decision|0|||
106124624|NCT00972179|366114185|FG003|Overall Study|Administrative Decision|0|||
106124625|NCT00972179|366114186|FG004|Overall Study|Administrative Decision|1|||
106124626|NCT00972179|366114187|FG005|Overall Study|Administrative Decision|0|||
106124627|NCT00972179|366114188|FG006|Overall Study|Administrative Decision|0|||
106124628|NCT00972179|366114182|FG000|Overall Study|Lost to Follow-up|0|||
106124629|NCT00972179|366114183|FG001|Overall Study|Lost to Follow-up|0|||
106124630|NCT00972179|366114184|FG002|Overall Study|Lost to Follow-up|1|||
106124631|NCT00972179|366114185|FG003|Overall Study|Lost to Follow-up|0|||
106124632|NCT00972179|366114186|FG004|Overall Study|Lost to Follow-up|0|||
106124633|NCT00972179|366114187|FG005|Overall Study|Lost to Follow-up|3|||
106124634|NCT00972179|366114188|FG006|Overall Study|Lost to Follow-up|1|||
106124635|NCT04285229|366114189|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
106124636|NCT04285229|366114190|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106124637|NCT04285229|366114191|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106124638|NCT04285229|366114192|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106124639|NCT04285229|366114193|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106124640|NCT04285229|366114194|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106124641|NCT04285229|366114189|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
106124642|NCT04285229|366114190|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
106124643|NCT04285229|366114191|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
106124644|NCT04285229|366114192|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
106124645|NCT04285229|366114193|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
106124646|NCT04285229|366114194|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
106124647|NCT04285229|366114189|FG000|Extended Treatment Period|Adverse Event|0|||
106124648|NCT04285229|366114190|FG001|Extended Treatment Period|Adverse Event|0|||
106124649|NCT04285229|366114191|FG002|Extended Treatment Period|Adverse Event|0|||
106124650|NCT04285229|366114192|FG003|Extended Treatment Period|Adverse Event|1|||
106124651|NCT04285229|366114193|FG004|Extended Treatment Period|Adverse Event|0|||
106124652|NCT04285229|366114194|FG005|Extended Treatment Period|Adverse Event|0|||
106124653|NCT04285229|366114189|FG000|Extended Treatment Period|Physician Decision|0|||
106124654|NCT04285229|366114190|FG001|Extended Treatment Period|Physician Decision|0|||
106124655|NCT04285229|366114191|FG002|Extended Treatment Period|Physician Decision|1|||
106124656|NCT04285229|366114192|FG003|Extended Treatment Period|Physician Decision|0|||
106124657|NCT04285229|366114193|FG004|Extended Treatment Period|Physician Decision|0|||
106124658|NCT04285229|366114194|FG005|Extended Treatment Period|Physician Decision|0|||
106124659|NCT04285229|366114189|FG000|Follow-up Period|Adverse Event|0|||
106124660|NCT04285229|366114190|FG001|Follow-up Period|Adverse Event|0|||
106124661|NCT04285229|366114191|FG002|Follow-up Period|Adverse Event|0|||
105668477|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
106124662|NCT04285229|366114192|FG003|Follow-up Period|Adverse Event|0|||
106124663|NCT04285229|366114193|FG004|Follow-up Period|Adverse Event|1|||
106124664|NCT04285229|366114194|FG005|Follow-up Period|Adverse Event|4|||
106124665|NCT04285229|366114189|FG000|Follow-up Period|Withdrawal by Subject|0|||
106124666|NCT04285229|366114190|FG001|Follow-up Period|Withdrawal by Subject|0|||
106124667|NCT04285229|366114191|FG002|Follow-up Period|Withdrawal by Subject|0|||
105668478|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
106124668|NCT04285229|366114192|FG003|Follow-up Period|Withdrawal by Subject|0|||
106124669|NCT04285229|366114193|FG004|Follow-up Period|Withdrawal by Subject|0|||
106124670|NCT04285229|366114194|FG005|Follow-up Period|Withdrawal by Subject|5|||
106124671|NCT04285229|366114189|FG000|Follow-up Period|Covid-19|0|||
106124672|NCT04285229|366114190|FG001|Follow-up Period|Covid-19|0|||
106124673|NCT04285229|366114191|FG002|Follow-up Period|Covid-19|0|||
106124674|NCT04285229|366114192|FG003|Follow-up Period|Covid-19|0|||
106124675|NCT04285229|366114193|FG004|Follow-up Period|Covid-19|0|||
106124676|NCT04285229|366114194|FG005|Follow-up Period|Covid-19|2|||
106124677|NCT04285229|366114189|FG000|Follow-up Period|Physician Decision|0|||
106124678|NCT04285229|366114190|FG001|Follow-up Period|Physician Decision|0|||
106124679|NCT04285229|366114191|FG002|Follow-up Period|Physician Decision|0|||
106124680|NCT04285229|366114192|FG003|Follow-up Period|Physician Decision|0|||
106124681|NCT04285229|366114193|FG004|Follow-up Period|Physician Decision|0|||
106124682|NCT04285229|366114194|FG005|Follow-up Period|Physician Decision|1|||
106124683|NCT02061761|366114195|FG000|Overall Study|Disease progression|2|||
106124684|NCT02061761|366114196|FG001|Overall Study|Disease progression|8|||
106124685|NCT02061761|366114197|FG002|Overall Study|Disease progression|4|||
106124686|NCT02061761|366114198|FG003|Overall Study|Disease progression|5|||
106124687|NCT02061761|366114199|FG004|Overall Study|Disease progression|9|||
106124688|NCT02061761|366114200|FG005|Overall Study|Disease progression|3|||
106124689|NCT02061761|366114201|FG006|Overall Study|Disease progression|1|||
106124690|NCT02061761|366114202|FG007|Overall Study|Disease progression|2|||
106124691|NCT02061761|366114203|FG008|Overall Study|Disease progression|28|||
106124692|NCT02061761|366114195|FG000|Overall Study|Study Drug toxicity|0|||
106124693|NCT02061761|366114196|FG001|Overall Study|Study Drug toxicity|0|||
105668479|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
105668480|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
105900985|NCT00055497|365296268|FG003|Overall Study|Administrative Reasons|1|||
105900986|NCT00055497|365296265|FG000|Overall Study|Other|0|||
105900987|NCT00055497|365296266|FG001|Overall Study|Other|0|||
105900988|NCT00055497|365296267|FG002|Overall Study|Other|0|||
105900989|NCT00055497|365296268|FG003|Overall Study|Other|11|||
106124694|NCT02061761|366114197|FG002|Overall Study|Study Drug toxicity|0|||
105668481|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
105900990|NCT01370616|365296269|FG000|Overall Study|Adverse Event|11|||
105900991|NCT01370616|365296270|FG001|Overall Study|Adverse Event|16|||
105900992|NCT01370616|365296269|FG000|Overall Study|Death|1|||
105900993|NCT01370616|365296270|FG001|Overall Study|Death|0|||
105668482|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
105900994|NCT01370616|365296269|FG000|Overall Study|Lack of Efficacy|6|||
105900995|NCT01370616|365296270|FG001|Overall Study|Lack of Efficacy|2|||
105900996|NCT01370616|365296269|FG000|Overall Study|Lost to Follow-up|0|||
105900997|NCT01370616|365296270|FG001|Overall Study|Lost to Follow-up|3|||
105900998|NCT01370616|365296269|FG000|Overall Study|Physician Decision|6|||
105900999|NCT01370616|365296270|FG001|Overall Study|Physician Decision|6|||
105901000|NCT01370616|365296269|FG000|Overall Study|Progressive Disease|0|||
105901001|NCT01370616|365296270|FG001|Overall Study|Progressive Disease|1|||
105901002|NCT01370616|365296269|FG000|Overall Study|Recovery|1|||
105901003|NCT01370616|365296270|FG001|Overall Study|Recovery|0|||
105901004|NCT01370616|365296269|FG000|Overall Study|Technical Problems|3|||
105901005|NCT01370616|365296270|FG001|Overall Study|Technical Problems|5|||
105901006|NCT01370616|365296269|FG000|Overall Study|Withdrawal by Subject|34|||
106124695|NCT02061761|366114198|FG003|Overall Study|Study Drug toxicity|0|||
106124696|NCT02061761|366114199|FG004|Overall Study|Study Drug toxicity|0|||
105668483|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
105668484|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
105668485|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
105901007|NCT01370616|365296270|FG001|Overall Study|Withdrawal by Subject|34|||
105901008|NCT00731731|365296271|FG000|Overall Study|Protocol Violation|0|||
105901009|NCT00731731|365296272|FG001|Overall Study|Protocol Violation|0|||
105901010|NCT00731731|365296273|FG002|Overall Study|Protocol Violation|1|||
105901011|NCT00731731|365296271|FG000|Overall Study|Cancel prior to treatment|0|||
105901012|NCT00731731|365296272|FG001|Overall Study|Cancel prior to treatment|0|||
105901013|NCT00731731|365296273|FG002|Overall Study|Cancel prior to treatment|2|||
105901014|NCT03970200|365296274|FG000|Overall Study|Death|2|||
105901015|NCT03970200|365296275|FG001|Overall Study|Death|2|||
105901016|NCT03970200|365296276|FG002|Overall Study|Death|1|||
105901017|NCT03970200|365296274|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
106124697|NCT02061761|366114200|FG005|Overall Study|Study Drug toxicity|1|||
105668486|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
105668487|NCT00392925|364450259|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
105901018|NCT03970200|365296275|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
105901019|NCT03970200|365296276|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
106124698|NCT02061761|366114201|FG006|Overall Study|Study Drug toxicity|0|||
106124699|NCT02061761|366114202|FG007|Overall Study|Study Drug toxicity|2|||
105901020|NCT01084538|365296277|FG000|Overall Study|Drug not available|30|||
106124700|NCT02061761|366114203|FG008|Overall Study|Study Drug toxicity|6|||
106124701|NCT02061761|366114195|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
105901021|NCT01084538|365296277|FG000|Overall Study|Adverse Event|9|||
105901022|NCT01084538|365296277|FG000|Overall Study|Kidney transplant|6|||
105901023|NCT01084538|365296277|FG000|Overall Study|Serious Adverse Event|3|||
106124702|NCT02061761|366114196|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
106124703|NCT02061761|366114197|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
106124704|NCT02061761|366114198|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
106124705|NCT02061761|366114199|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
106124706|NCT02061761|366114200|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
106124707|NCT02061761|366114201|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
106124708|NCT02061761|366114202|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
106124709|NCT02061761|366114203|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
106124710|NCT02061761|366114195|FG000|Overall Study|Participant request to discontinue study treatment|0|||
106124711|NCT02061761|366114196|FG001|Overall Study|Participant request to discontinue study treatment|0|||
106124712|NCT02061761|366114197|FG002|Overall Study|Participant request to discontinue study treatment|2|||
106124713|NCT02061761|366114198|FG003|Overall Study|Participant request to discontinue study treatment|2|||
106124714|NCT02061761|366114199|FG004|Overall Study|Participant request to discontinue study treatment|0|||
106124715|NCT02061761|366114200|FG005|Overall Study|Participant request to discontinue study treatment|1|||
106124716|NCT02061761|366114201|FG006|Overall Study|Participant request to discontinue study treatment|0|||
106124717|NCT02061761|366114202|FG007|Overall Study|Participant request to discontinue study treatment|0|||
106124718|NCT02061761|366114203|FG008|Overall Study|Participant request to discontinue study treatment|2|||
106124719|NCT02061761|366114195|FG000|Overall Study|Withdrawal by Subject|0|||
106124720|NCT02061761|366114196|FG001|Overall Study|Withdrawal by Subject|0|||
106124721|NCT02061761|366114197|FG002|Overall Study|Withdrawal by Subject|0|||
106124722|NCT02061761|366114198|FG003|Overall Study|Withdrawal by Subject|0|||
106124723|NCT02061761|366114199|FG004|Overall Study|Withdrawal by Subject|0|||
106124724|NCT02061761|366114200|FG005|Overall Study|Withdrawal by Subject|0|||
106124725|NCT02061761|366114201|FG006|Overall Study|Withdrawal by Subject|0|||
106124726|NCT02061761|366114202|FG007|Overall Study|Withdrawal by Subject|0|||
106124727|NCT02061761|366114203|FG008|Overall Study|Withdrawal by Subject|2|||
106124728|NCT02061761|366114195|FG000|Overall Study|Maximum clinical benefit|0|||
106124729|NCT02061761|366114196|FG001|Overall Study|Maximum clinical benefit|0|||
105901024|NCT01084538|365296277|FG000|Overall Study|Lack of effectiveness|2|||
105901025|NCT01084538|365296277|FG000|Overall Study|Patient noncompliance|2|||
105901026|NCT01084538|365296277|FG000|Overall Study|Hyperphosphatemia|2|||
105901027|NCT01084538|365296277|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
105901028|NCT01084538|365296277|FG000|Overall Study|Change of residence|2|||
105901029|NCT01084538|365296277|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
105901030|NCT01084538|365296277|FG000|Overall Study|Reason unknown|8|||
105901031|NCT01429441|365296278|FG000|Overall Study|Adverse Event|5|||
105901032|NCT01429441|365296279|FG001|Overall Study|Adverse Event|1|||
105901033|NCT01429441|365296278|FG000|Overall Study|Death|0|||
105901034|NCT01429441|365296279|FG001|Overall Study|Death|2|||
105901035|NCT01429441|365296278|FG000|Overall Study|Lost to Follow-up|5|||
105901036|NCT01429441|365296279|FG001|Overall Study|Lost to Follow-up|2|||
105901037|NCT01429441|365296278|FG000|Overall Study|Physician Decision|1|||
105901038|NCT01429441|365296279|FG001|Overall Study|Physician Decision|0|||
105901039|NCT01429441|365296278|FG000|Overall Study|Withdrawal by Subject|27|||
105901040|NCT01429441|365296279|FG001|Overall Study|Withdrawal by Subject|18|||
105901041|NCT03469999|365296283|FG000|Overall Study|Lost to Follow-up|2|||
105901042|NCT03337048|365296289|FG000|Overall Study|Withdrawal by Subject|2|||
105901043|NCT03337048|365296290|FG001|Overall Study|Withdrawal by Subject|0|||
105901044|NCT03337048|365296291|FG002|Overall Study|Withdrawal by Subject|0|||
105901045|NCT02791438|365296293|FG000|Treatment Period|Adverse Event|1|||
105901046|NCT02791438|365296294|FG001|Treatment Period|Adverse Event|0|||
105901047|NCT02791438|365296293|FG000|Treatment Period|Withdrawal by Subject|0|||
105901048|NCT02791438|365296294|FG001|Treatment Period|Withdrawal by Subject|1|||
105901049|NCT02791438|365296293|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
105901050|NCT02791438|365296294|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
105901051|NCT01952080|365296295|FG000|Overall Study|Withdrawal by Subject|0|||
105901052|NCT01952080|365296296|FG001|Overall Study|Withdrawal by Subject|0|||
105901053|NCT01952080|365296297|FG002|Overall Study|Withdrawal by Subject|0|||
105901054|NCT01952080|365296298|FG003|Overall Study|Withdrawal by Subject|1|||
105901055|NCT01952080|365296295|FG000|Overall Study|Protocol Non-compliance|0|||
105901056|NCT01952080|365296296|FG001|Overall Study|Protocol Non-compliance|1|||
105901057|NCT01952080|365296297|FG002|Overall Study|Protocol Non-compliance|0|||
105901058|NCT01952080|365296298|FG003|Overall Study|Protocol Non-compliance|0|||
105901059|NCT03172364|365296301|FG000|Overall Study|Adverse Event|1|||
105901060|NCT03172364|365296302|FG001|Overall Study|Adverse Event|1|||
105901061|NCT03172364|365296301|FG000|Overall Study|Protocol Violation|1|||
105901062|NCT03172364|365296302|FG001|Overall Study|Protocol Violation|0|||
106124730|NCT02061761|366114197|FG002|Overall Study|Maximum clinical benefit|0|||
106124731|NCT02061761|366114198|FG003|Overall Study|Maximum clinical benefit|1|||
106124732|NCT02061761|366114199|FG004|Overall Study|Maximum clinical benefit|0|||
106124733|NCT02061761|366114200|FG005|Overall Study|Maximum clinical benefit|0|||
105901063|NCT04503668|365296303|FG000|Overall Study|Incomplete data|4|||
105901064|NCT04503668|365296304|FG001|Overall Study|Incomplete data|3|||
105901065|NCT04503668|365296303|FG000|Overall Study|Withdrawal by Subject|1|||
105901066|NCT04503668|365296304|FG001|Overall Study|Withdrawal by Subject|1|||
105901067|NCT04503668|365296303|FG000|Overall Study|Adverse Event|2|||
105901068|NCT04503668|365296304|FG001|Overall Study|Adverse Event|0|||
105901069|NCT03782974|365296305|FG000|Overall Study|Withdrawal by Subject|7|||
105901070|NCT03782974|365296306|FG001|Overall Study|Withdrawal by Subject|7|||
105901071|NCT03782974|365296305|FG000|Overall Study|Pregnancy|1|||
105901072|NCT03782974|365296306|FG001|Overall Study|Pregnancy|0|||
105901073|NCT02333383|365296308|FG000|Overall Study|Adalimumab discontinuation|21|||
105901074|NCT02333383|365296308|FG000|Overall Study|Lost to Follow-up|15|||
105901075|NCT02333383|365296308|FG000|Overall Study|Withdrawal by Subject|3|||
105901076|NCT02333383|365296308|FG000|Overall Study|Transfer to another hospital|2|||
105901077|NCT00520767|365296310|FG000|Overall Study|Death|2|||
105901078|NCT03597139|365296311|FG000|Overall Study|Adverse Event|3|||
105901079|NCT03597139|365296312|FG001|Overall Study|Adverse Event|0|||
105668488|NCT00392925|364450260|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
105668489|NCT00392925|364450261|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
105668490|NCT00392925|364450262|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
105668491|NCT00392925|364450259|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
105901080|NCT03597139|365296311|FG000|Overall Study|Protocol Non-compliance|1|||
105668492|NCT00392925|364450260|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
105668493|NCT00392925|364450261|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
105668494|NCT00392925|364450262|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
105668495|NCT00392925|364450259|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
105668496|NCT00392925|364450260|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
105668497|NCT00392925|364450261|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
105668498|NCT00392925|364450262|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
105668499|NCT00392925|364450259|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
105901081|NCT03597139|365296312|FG001|Overall Study|Protocol Non-compliance|0|||
105901082|NCT04811664|365296315|FG000|Overall Study|Lost to Follow-up|78|||
105901083|NCT04811664|365296316|FG001|Overall Study|Lost to Follow-up|125|||
105901084|NCT04811664|365296317|FG002|Overall Study|Lost to Follow-up|46|||
105901085|NCT04811664|365296315|FG000|Overall Study|Withdrawal by Subject|39|||
105901086|NCT04811664|365296316|FG001|Overall Study|Withdrawal by Subject|76|||
105901087|NCT04811664|365296317|FG002|Overall Study|Withdrawal by Subject|12|||
105901088|NCT04811664|365296315|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
105901089|NCT04811664|365296316|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
105901090|NCT04811664|365296317|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
105901091|NCT04811664|365296315|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
105901092|NCT04811664|365296316|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
105901093|NCT04811664|365296317|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
105901094|NCT04811664|365296315|FG000|Overall Study|Protocol Violation|0|||
105901095|NCT04811664|365296316|FG001|Overall Study|Protocol Violation|5|||
105901096|NCT04811664|365296317|FG002|Overall Study|Protocol Violation|11|||
105901097|NCT04811664|365296315|FG000|Overall Study|Study Terminated by Sponsor|4|||
105901098|NCT04811664|365296316|FG001|Overall Study|Study Terminated by Sponsor|3|||
105901099|NCT04811664|365296317|FG002|Overall Study|Study Terminated by Sponsor|34|||
105901100|NCT04811664|365296315|FG000|Overall Study|Early Study Closure|3|||
105901101|NCT04811664|365296316|FG001|Overall Study|Early Study Closure|7|||
105901102|NCT04811664|365296317|FG002|Overall Study|Early Study Closure|79|||
105901103|NCT04811664|365296315|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
105901104|NCT04811664|365296316|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
105901105|NCT04811664|365296317|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
105901106|NCT02717442|365296318|FG000|Overall Study|Study Terminated by Sponsor|31|||
105901107|NCT02717442|365296319|FG001|Overall Study|Study Terminated by Sponsor|29|||
105901108|NCT02717442|365296318|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
105901109|NCT02717442|365296319|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
105901110|NCT02717442|365296318|FG000|Overall Study|Other - Not Specified|2|||
105901111|NCT02717442|365296319|FG001|Overall Study|Other - Not Specified|0|||
105901112|NCT00382109|365296320|FG000|Overall Study|Adverse Event|3|||
105901113|NCT00382109|365296321|FG001|Overall Study|Adverse Event|0|||
105901114|NCT00382109|365296320|FG000|Overall Study|Physician Decision|6|||
105901115|NCT00382109|365296321|FG001|Overall Study|Physician Decision|1|||
105901116|NCT00382109|365296320|FG000|Overall Study|Withdrawal by Subject|1|||
105901117|NCT00382109|365296321|FG001|Overall Study|Withdrawal by Subject|0|||
105901118|NCT00382109|365296320|FG000|Overall Study|ineligible|2|||
105901119|NCT00382109|365296321|FG001|Overall Study|ineligible|0|||
105901120|NCT00382109|365296320|FG000|Overall Study|Other|0|||
105901121|NCT00382109|365296321|FG001|Overall Study|Other|2|||
105901122|NCT00382109|365296320|FG000|Overall Study|consent withdrawal|0|||
105901123|NCT00382109|365296321|FG001|Overall Study|consent withdrawal|1|||
105901124|NCT02756364|365296323|FG000|Overall Study|Site Terminated by Sponsor|24|||
105901125|NCT02756364|365296324|FG001|Overall Study|Site Terminated by Sponsor|30|||
105901126|NCT02756364|365296325|FG002|Overall Study|Site Terminated by Sponsor|21|||
105901127|NCT02756364|365296323|FG000|Overall Study|Death|20|||
105901128|NCT02756364|365296324|FG001|Overall Study|Death|15|||
105901129|NCT02756364|365296325|FG002|Overall Study|Death|18|||
105901130|NCT02756364|365296323|FG000|Overall Study|Withdrawal by Patient|2|||
105901131|NCT02756364|365296324|FG001|Overall Study|Withdrawal by Patient|1|||
105901132|NCT02756364|365296325|FG002|Overall Study|Withdrawal by Patient|8|||
105901133|NCT02756364|365296323|FG000|Overall Study|Lost to Follow-up|0|||
105901134|NCT02756364|365296324|FG001|Overall Study|Lost to Follow-up|1|||
105901135|NCT02756364|365296325|FG002|Overall Study|Lost to Follow-up|1|||
105668500|NCT00392925|364450260|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
105668501|NCT00392925|364450261|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
105668502|NCT00392925|364450262|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
105668503|NCT00392925|364450259|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
105668504|NCT00392925|364450260|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
105668505|NCT00392925|364450261|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
105668506|NCT00392925|364450262|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
105668507|NCT04160988|364450263|FG000|Overall Study|poor image quality|28|||
105668508|NCT00664534|364450264|FG000|Overall Study|Adverse Event|2|||
105668509|NCT00664534|364450265|FG001|Overall Study|Adverse Event|3|||
105668510|NCT00664534|364450264|FG000|Overall Study|Lost to Follow-up|6|||
105668511|NCT00664534|364450265|FG001|Overall Study|Lost to Follow-up|10|||
105668512|NCT00664534|364450264|FG000|Overall Study|Protocol Violation|10|||
105668513|NCT00664534|364450265|FG001|Overall Study|Protocol Violation|8|||
105668514|NCT00664534|364450264|FG000|Overall Study|Withdrawal by Subject|7|||
105668515|NCT00664534|364450265|FG001|Overall Study|Withdrawal by Subject|6|||
105668516|NCT00664534|364450264|FG000|Overall Study|Physician Decision|8|||
105668517|NCT00664534|364450265|FG001|Overall Study|Physician Decision|0|||
105668518|NCT00664534|364450264|FG000|Overall Study|Sponsor decision|8|||
105668519|NCT00664534|364450265|FG001|Overall Study|Sponsor decision|6|||
105668520|NCT00600613|364450266|FG000|Overall Study|Protocol Deviation|1|||
105668521|NCT01245374|364450268|FG000|Overall Study|Protocol Violation|1|||
105668522|NCT01245374|364450268|FG000|Overall Study|Withdrawal by Subject|3|||
105668523|NCT00839956|364450269|FG000|Overall Study|Adverse Event|2|||
105668524|NCT00839956|364450269|FG000|Overall Study|Lack of Efficacy|6|||
105901136|NCT00723697|365296329|FG000|Overall Study|Physician questionnaires not received|2|||
105901137|NCT00723697|365296329|FG000|Overall Study|Missing Informed Consent Form|10|||
105901138|NCT00723697|365296329|FG000|Overall Study|Other exclusion criteria applied|6|||
105901139|NCT00534105|365296330|FG000|Overall Study|Lost to Follow-up|23|||
105901140|NCT00534105|365296331|FG001|Overall Study|Lost to Follow-up|39|||
105901141|NCT02774005|365296332|FG000|Overall Study|Adverse Event|8|||
105901142|NCT02774005|365296332|FG000|Overall Study|Withdrawal by Subject|23|||
105901143|NCT02774005|365296332|FG000|Overall Study|Lost to Follow-up|7|||
105901144|NCT02774005|365296332|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
105901145|NCT02774005|365296332|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
105901146|NCT02774005|365296332|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
105901147|NCT02774005|365296332|FG000|Overall Study|Death|1|||
105901148|NCT02774005|365296332|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
105901149|NCT02774005|365296332|FG000|Overall Study|Lack of compliance with study medication|4|||
105901150|NCT02774005|365296332|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
105901151|NCT02774005|365296332|FG000|Overall Study|another study|1|||
105901152|NCT02774005|365296332|FG000|Overall Study|cardiologist imposed travel restriction|1|||
105901153|NCT03275389|365296333|FG000|Overall Study|Lost to Follow-up|10|||
106124734|NCT02061761|366114201|FG006|Overall Study|Maximum clinical benefit|0|||
106124735|NCT02061761|366114202|FG007|Overall Study|Maximum clinical benefit|0|||
106124736|NCT02061761|366114203|FG008|Overall Study|Maximum clinical benefit|6|||
106124737|NCT02061761|366114195|FG000|Overall Study|Participant no longer meets study criteria|0|||
106124738|NCT02061761|366114196|FG001|Overall Study|Participant no longer meets study criteria|0|||
106124739|NCT02061761|366114197|FG002|Overall Study|Participant no longer meets study criteria|0|||
106124740|NCT02061761|366114198|FG003|Overall Study|Participant no longer meets study criteria|0|||
106124741|NCT02061761|366114199|FG004|Overall Study|Participant no longer meets study criteria|0|||
106124742|NCT02061761|366114200|FG005|Overall Study|Participant no longer meets study criteria|0|||
106124743|NCT02061761|366114201|FG006|Overall Study|Participant no longer meets study criteria|0|||
106124744|NCT02061761|366114202|FG007|Overall Study|Participant no longer meets study criteria|0|||
106124745|NCT02061761|366114203|FG008|Overall Study|Participant no longer meets study criteria|1|||
106124746|NCT02061761|366114195|FG000|Overall Study|Other reasons|0|||
106124747|NCT02061761|366114196|FG001|Overall Study|Other reasons|0|||
106124748|NCT02061761|366114197|FG002|Overall Study|Other reasons|0|||
106124749|NCT02061761|366114198|FG003|Overall Study|Other reasons|0|||
106124750|NCT02061761|366114199|FG004|Overall Study|Other reasons|2|||
106124751|NCT02061761|366114200|FG005|Overall Study|Other reasons|0|||
105668525|NCT00839956|364450269|FG000|Overall Study|Physician Decision|1|||
105668526|NCT00839956|364450269|FG000|Overall Study|Withdrawal by Subject|3|||
105668527|NCT02227992|364450270|FG000|Overall Study|Lost to Follow-up|1|||
105668528|NCT02227992|364450271|FG001|Overall Study|Lost to Follow-up|1|||
105668529|NCT01509547|364450274|FG000|Overall Study|Lost to Follow-up|24|||
105668530|NCT01509547|364450275|FG001|Overall Study|Lost to Follow-up|14|||
105668531|NCT01509547|364450274|FG000|Overall Study|Withdrawal by Subject|11|||
105668532|NCT01509547|364450275|FG001|Overall Study|Withdrawal by Subject|24|||
105668533|NCT01509547|364450274|FG000|Overall Study|Physician Decision|0|||
105668534|NCT01509547|364450275|FG001|Overall Study|Physician Decision|1|||
105668535|NCT00402051|364450278|FG000|Overall Study|Progressive Disease|13|||
105668536|NCT00402051|364450279|FG001|Overall Study|Progressive Disease|20|||
105668537|NCT00402051|364450278|FG000|Overall Study|Adverse Event|11|||
105668538|NCT00402051|364450279|FG001|Overall Study|Adverse Event|4|||
105668539|NCT00402051|364450278|FG000|Overall Study|Physician Decision|7|||
105668540|NCT00402051|364450279|FG001|Overall Study|Physician Decision|3|||
105668541|NCT00402051|364450278|FG000|Overall Study|Withdrawal by Subject|3|||
105668542|NCT00402051|364450279|FG001|Overall Study|Withdrawal by Subject|3|||
105668543|NCT00402051|364450278|FG000|Overall Study|Death - Related to Study Drug|1|||
105668544|NCT00402051|364450279|FG001|Overall Study|Death - Related to Study Drug|2|||
105668545|NCT00402051|364450278|FG000|Overall Study|Death Due to Study Disease|2|||
105668546|NCT00402051|364450279|FG001|Overall Study|Death Due to Study Disease|1|||
105668547|NCT00402051|364450278|FG000|Overall Study|Death Due to Adverse Event|0|||
105668548|NCT00402051|364450279|FG001|Overall Study|Death Due to Adverse Event|2|||
105668549|NCT00402051|364450278|FG000|Overall Study|Lost to Follow-up|1|||
106124752|NCT02061761|366114201|FG006|Overall Study|Other reasons|0|||
106124753|NCT02061761|366114202|FG007|Overall Study|Other reasons|0|||
105668550|NCT00402051|364450279|FG001|Overall Study|Lost to Follow-up|0|||
105668551|NCT01254747|364450292|FG000|Overall Study|Unacceptable subjective vision|0|||
105668552|NCT01254747|364450293|FG001|Overall Study|Unacceptable subjective vision|0|||
106124754|NCT02061761|366114203|FG008|Overall Study|Other reasons|6|||
106124755|NCT01932996|366114209|FG000|Overall Study|Protocol Violation|2|||
106124756|NCT01932996|366114210|FG001|Overall Study|Protocol Violation|0|||
106124757|NCT02500316|366114211|FG000|Overall Study|Adverse Event|3|||
105668553|NCT01254747|364450294|FG002|Overall Study|Unacceptable subjective vision|0|||
105668554|NCT01254747|364450295|FG003|Overall Study|Unacceptable subjective vision|2|||
105668555|NCT01254747|364450292|FG000|Overall Study|Difficult removal handling|0|||
105668556|NCT01254747|364450293|FG001|Overall Study|Difficult removal handling|0|||
105668557|NCT01254747|364450294|FG002|Overall Study|Difficult removal handling|1|||
105668558|NCT01254747|364450295|FG003|Overall Study|Difficult removal handling|0|||
105668559|NCT01254747|364450292|FG000|Overall Study|Symptoms and problems|0|||
105668560|NCT01254747|364450293|FG001|Overall Study|Symptoms and problems|2|||
105901154|NCT03275389|365296334|FG001|Overall Study|Lost to Follow-up|10|||
105901155|NCT03275389|365296335|FG002|Overall Study|Lost to Follow-up|19|||
105901156|NCT03275389|365296336|FG003|Overall Study|Lost to Follow-up|12|||
105901157|NCT03275389|365296337|FG004|Overall Study|Lost to Follow-up|11|||
105901158|NCT03275389|365296338|FG005|Overall Study|Lost to Follow-up|12|||
105901159|NCT03275389|365296339|FG006|Overall Study|Lost to Follow-up|21|||
105901160|NCT03275389|365296340|FG007|Overall Study|Lost to Follow-up|15|||
105901161|NCT03275389|365296341|FG008|Overall Study|Lost to Follow-up|12|||
105901162|NCT03275389|365296342|FG009|Overall Study|Lost to Follow-up|14|||
105901163|NCT03275389|365296333|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105901164|NCT03275389|365296334|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105901165|NCT03275389|365296335|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105901166|NCT03275389|365296336|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
106124758|NCT02500316|366114211|FG000|Overall Study|Lost to Follow-up|2|||
106124759|NCT02500316|366114211|FG000|Overall Study|Protocol Violation|1|||
106124760|NCT02500316|366114211|FG000|Overall Study|Withdrawal by Subject|15|||
106124761|NCT02500316|366114211|FG000|Overall Study|Final height achieved|5|||
106124762|NCT02500316|366114211|FG000|Overall Study|Due to war activity|1|||
106124763|NCT01406717|366114212|FG000|Overall Study|Subject non-compliance|4|||
106124764|NCT01406717|366114213|FG001|Overall Study|Subject non-compliance|3|||
106124765|NCT01406717|366114212|FG000|Overall Study|Protocol Violation|5|||
106124766|NCT01406717|366114213|FG001|Overall Study|Protocol Violation|1|||
106124767|NCT01406717|366114212|FG000|Overall Study|Lost to Follow-up|14|||
106124768|NCT01406717|366114213|FG001|Overall Study|Lost to Follow-up|8|||
106124769|NCT01406717|366114212|FG000|Overall Study|Withdrawal by Subject|19|||
106124770|NCT01406717|366114213|FG001|Overall Study|Withdrawal by Subject|15|||
106124771|NCT01406717|366114212|FG000|Overall Study|Adverse Event|1|||
106124772|NCT01406717|366114213|FG001|Overall Study|Adverse Event|2|||
106124773|NCT01406717|366114212|FG000|Overall Study|Lack of Efficacy|0|||
106124774|NCT01406717|366114213|FG001|Overall Study|Lack of Efficacy|1|||
106124775|NCT01406717|366114212|FG000|Overall Study|Non-completion of visit activity|0|||
106124776|NCT01406717|366114213|FG001|Overall Study|Non-completion of visit activity|1|||
106124777|NCT03257995|366114214|FG000|Overall Study|Adverse Event|0|||
106124778|NCT03257995|366114215|FG001|Overall Study|Adverse Event|1|||
106124779|NCT03257995|366114216|FG002|Overall Study|Adverse Event|0|||
106124780|NCT03257995|366114217|FG003|Overall Study|Adverse Event|0|||
106124781|NCT03257995|366114218|FG004|Overall Study|Adverse Event|0|||
106124782|NCT03257995|366114219|FG005|Overall Study|Adverse Event|0|||
106124783|NCT03257995|366114214|FG000|Overall Study|Protocol deviation|0|||
106124784|NCT03257995|366114215|FG001|Overall Study|Protocol deviation|0|||
106124785|NCT03257995|366114216|FG002|Overall Study|Protocol deviation|0|||
106124786|NCT03257995|366114217|FG003|Overall Study|Protocol deviation|0|||
106124787|NCT03257995|366114218|FG004|Overall Study|Protocol deviation|0|||
106124788|NCT03257995|366114219|FG005|Overall Study|Protocol deviation|2|||
106124789|NCT01680458|366114223|FG000|Overall Study|Protocol Violation|3|||
106124790|NCT01018563|366114224|FG000|Overall Study|Termination of the study by Sponsor|2|||
106124791|NCT01018563|366114225|FG001|Overall Study|Termination of the study by Sponsor|1|||
106124792|NCT01644474|366114231|FG000|Overall Study|Poor compliance to protocol|1|||
106124793|NCT01644474|366114232|FG001|Overall Study|Poor compliance to protocol|0|||
106124794|NCT01644474|366114231|FG000|Overall Study|Consent withdrawn by participant|0|||
106124795|NCT01644474|366114232|FG001|Overall Study|Consent withdrawn by participant|1|||
106124796|NCT01644474|366114231|FG000|Overall Study|Participant moved|0|||
106124797|NCT01644474|366114232|FG001|Overall Study|Participant moved|1|||
106124798|NCT01644474|366114231|FG000|Overall Study|Adverse Event|4|||
106124799|NCT01644474|366114232|FG001|Overall Study|Adverse Event|5|||
106124800|NCT01644474|366114231|FG000|Overall Study|Site scheduling error|1|||
106124801|NCT01644474|366114232|FG001|Overall Study|Site scheduling error|1|||
106124802|NCT01644474|366114231|FG000|Overall Study|Protocol Violation|1|||
106124803|NCT01644474|366114232|FG001|Overall Study|Protocol Violation|0|||
106124804|NCT03864926|366115799|FG000|Overall Study|Death|0|||
106124805|NCT03864926|366115800|FG001|Overall Study|Death|2|||
106124806|NCT03918239|366115804|FG000|Overall Study|Lost to Follow-up|3|||
106124807|NCT03918239|366115805|FG001|Overall Study|Lost to Follow-up|1|||
106124808|NCT03918239|366115804|FG000|Overall Study|Pregnancy|0|||
106124809|NCT03918239|366115805|FG001|Overall Study|Pregnancy|2|||
106124810|NCT03918239|366115804|FG000|Overall Study|Withdrawal by Subject|3|||
105668561|NCT01254747|364450294|FG002|Overall Study|Symptoms and problems|1|||
105901167|NCT03275389|365296337|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105901168|NCT03275389|365296338|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
106124811|NCT03918239|366115805|FG001|Overall Study|Withdrawal by Subject|3|||
105668562|NCT01254747|364450295|FG003|Overall Study|Symptoms and problems|0|||
105668563|NCT01254747|364450292|FG000|Overall Study|Lost to Follow-up|0|||
105668564|NCT01254747|364450293|FG001|Overall Study|Lost to Follow-up|0|||
105668565|NCT01254747|364450294|FG002|Overall Study|Lost to Follow-up|1|||
105668566|NCT01254747|364450295|FG003|Overall Study|Lost to Follow-up|0|||
105901169|NCT03275389|365296339|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105901170|NCT03275389|365296340|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105901171|NCT03275389|365296341|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
105901172|NCT03275389|365296342|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
105901173|NCT03275389|365296333|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
105901174|NCT03275389|365296334|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105901175|NCT03275389|365296335|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105901176|NCT03275389|365296336|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
105901177|NCT03275389|365296337|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
105901178|NCT03275389|365296338|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
105901179|NCT03275389|365296339|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
105901180|NCT03275389|365296340|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
105901181|NCT03275389|365296341|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
105901182|NCT03275389|365296342|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
105901183|NCT03275389|365296333|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105901184|NCT03275389|365296334|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105901185|NCT03275389|365296335|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105901186|NCT03275389|365296336|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
105901187|NCT03275389|365296337|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105901188|NCT03275389|365296338|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105901189|NCT03275389|365296339|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105901190|NCT03275389|365296340|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105901191|NCT03275389|365296341|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105901192|NCT03275389|365296342|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105901193|NCT03275389|365296333|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105901194|NCT03275389|365296334|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105901195|NCT03275389|365296335|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
105901196|NCT03275389|365296336|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105901197|NCT03275389|365296337|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105901198|NCT03275389|365296338|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105901199|NCT03275389|365296339|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105901200|NCT03275389|365296340|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105901201|NCT03275389|365296341|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105901202|NCT03275389|365296342|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
105901203|NCT03275389|365296333|FG000|Overall Study|Other|0|||
105901204|NCT03275389|365296334|FG001|Overall Study|Other|4|||
105901205|NCT03275389|365296335|FG002|Overall Study|Other|3|||
105901206|NCT03275389|365296336|FG003|Overall Study|Other|2|||
105901207|NCT03275389|365296337|FG004|Overall Study|Other|2|||
105901208|NCT03275389|365296338|FG005|Overall Study|Other|2|||
105901209|NCT03275389|365296339|FG006|Overall Study|Other|0|||
105901210|NCT03275389|365296340|FG007|Overall Study|Other|0|||
105901211|NCT03275389|365296341|FG008|Overall Study|Other|1|||
105901212|NCT03275389|365296342|FG009|Overall Study|Other|0|||
105901213|NCT02432144|365296347|FG000|Overall Study|Participant Non-Compliance|1|||
105901214|NCT00978341|365296348|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
105901215|NCT00978341|365296349|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
105901216|NCT03035916|365296350|FG000|Overall Study|Puncture failed|0|||
105901217|NCT03035916|365296351|FG001|Overall Study|Puncture failed|2|||
105901218|NCT03035916|365296352|FG002|Overall Study|Puncture failed|0|||
105901219|NCT00448812|365296353|FG000|Year 2|Missed visit but remained in study|4|||
105901220|NCT00448812|365296354|FG001|Year 2|Missed visit but remained in study|1|||
105901221|NCT00448812|365296353|FG000|Year 3|Withdrawal by Subject|1|||
105901222|NCT00448812|365296354|FG001|Year 3|Withdrawal by Subject|3|||
105901223|NCT00448812|365296353|FG000|Year 3|Lost to Follow-up|1|||
105901224|NCT00448812|365296354|FG001|Year 3|Lost to Follow-up|0|||
105901225|NCT00448812|365296353|FG000|Year 3|Missed visit but remained in study|2|||
105901226|NCT00448812|365296354|FG001|Year 3|Missed visit but remained in study|0|||
105901227|NCT00448812|365296353|FG000|Year 5|Missed visit but remained in study|1|||
105901228|NCT00448812|365296354|FG001|Year 5|Missed visit but remained in study|0|||
105901229|NCT02452554|365296355|FG000|Overall Study|Death|2|||
105901230|NCT02452554|365296356|FG001|Overall Study|Death|1|||
105901231|NCT02452554|365296357|FG002|Overall Study|Death|0|||
105901232|NCT02452554|365296358|FG003|Overall Study|Death|0|||
105901233|NCT02452554|365296359|FG004|Overall Study|Death|0|||
105668567|NCT01254747|364450292|FG000|Overall Study|Biomicroscopy|0|||
105901234|NCT02452554|365296360|FG005|Overall Study|Death|0|||
105901235|NCT02452554|365296355|FG000|Overall Study|Lack of Efficacy|13|||
105901236|NCT02452554|365296356|FG001|Overall Study|Lack of Efficacy|14|||
106124812|NCT03918239|366115804|FG000|Overall Study|positive urine drug screening results|4|||
106124813|NCT03918239|366115805|FG001|Overall Study|positive urine drug screening results|1|||
106124814|NCT02291289|366115806|FG000|Induction Treatment|Withdrawal by Subject|0|||
106124815|NCT02291289|366115807|FG001|Induction Treatment|Withdrawal by Subject|0|||
106124816|NCT02291289|366115808|FG002|Induction Treatment|Withdrawal by Subject|0|||
106124817|NCT02291289|366115809|FG003|Induction Treatment|Withdrawal by Subject|24|||
106124818|NCT02291289|366115810|FG004|Induction Treatment|Withdrawal by Subject|0|||
106124819|NCT02291289|366115811|FG005|Induction Treatment|Withdrawal by Subject|0|||
106124820|NCT02291289|366115812|FG006|Induction Treatment|Withdrawal by Subject|0|||
106124821|NCT02291289|366115813|FG007|Induction Treatment|Withdrawal by Subject|0|||
106124822|NCT02291289|366115814|FG008|Induction Treatment|Withdrawal by Subject|0|||
106124823|NCT02291289|366115815|FG009|Induction Treatment|Withdrawal by Subject|18|||
106124824|NCT02291289|366115816|FG010|Induction Treatment|Withdrawal by Subject|0|||
106124825|NCT02291289|366115817|FG011|Induction Treatment|Withdrawal by Subject|0|||
106124826|NCT02291289|366115818|FG012|Induction Treatment|Withdrawal by Subject|0|||
106124827|NCT02291289|366115806|FG000|Induction Treatment|Adverse Event|0|||
106124828|NCT02291289|366115807|FG001|Induction Treatment|Adverse Event|0|||
105901237|NCT02452554|365296357|FG002|Overall Study|Lack of Efficacy|9|||
105901238|NCT02452554|365296358|FG003|Overall Study|Lack of Efficacy|1|||
105901239|NCT02452554|365296359|FG004|Overall Study|Lack of Efficacy|5|||
105901240|NCT02452554|365296360|FG005|Overall Study|Lack of Efficacy|8|||
106124829|NCT02291289|366115808|FG002|Induction Treatment|Adverse Event|0|||
106124830|NCT02291289|366115809|FG003|Induction Treatment|Adverse Event|3|||
106124831|NCT02291289|366115810|FG004|Induction Treatment|Adverse Event|0|||
106124832|NCT02291289|366115811|FG005|Induction Treatment|Adverse Event|0|||
106124833|NCT02291289|366115812|FG006|Induction Treatment|Adverse Event|0|||
106124834|NCT02291289|366115813|FG007|Induction Treatment|Adverse Event|0|||
106124835|NCT02291289|366115814|FG008|Induction Treatment|Adverse Event|0|||
106124836|NCT02291289|366115815|FG009|Induction Treatment|Adverse Event|1|||
106124837|NCT02291289|366115816|FG010|Induction Treatment|Adverse Event|0|||
106124838|NCT02291289|366115817|FG011|Induction Treatment|Adverse Event|0|||
106124839|NCT02291289|366115818|FG012|Induction Treatment|Adverse Event|0|||
106124840|NCT02291289|366115806|FG000|Induction Treatment|Death|25|||
106124841|NCT02291289|366115807|FG001|Induction Treatment|Death|0|||
106124842|NCT02291289|366115808|FG002|Induction Treatment|Death|0|||
106124843|NCT02291289|366115809|FG003|Induction Treatment|Death|111|||
106124844|NCT02291289|366115810|FG004|Induction Treatment|Death|0|||
106124845|NCT02291289|366115811|FG005|Induction Treatment|Death|0|||
106124846|NCT02291289|366115812|FG006|Induction Treatment|Death|1|||
106124847|NCT02291289|366115813|FG007|Induction Treatment|Death|0|||
106124848|NCT02291289|366115814|FG008|Induction Treatment|Death|0|||
106124849|NCT02291289|366115815|FG009|Induction Treatment|Death|82|||
106124850|NCT02291289|366115816|FG010|Induction Treatment|Death|0|||
106124851|NCT02291289|366115817|FG011|Induction Treatment|Death|0|||
106124852|NCT02291289|366115818|FG012|Induction Treatment|Death|0|||
106124853|NCT02291289|366115806|FG000|Induction Treatment|Lost to Follow-up|1|||
106124854|NCT02291289|366115807|FG001|Induction Treatment|Lost to Follow-up|0|||
106124855|NCT02291289|366115808|FG002|Induction Treatment|Lost to Follow-up|0|||
106124856|NCT02291289|366115809|FG003|Induction Treatment|Lost to Follow-up|12|||
106124857|NCT02291289|366115810|FG004|Induction Treatment|Lost to Follow-up|0|||
106124858|NCT02291289|366115811|FG005|Induction Treatment|Lost to Follow-up|0|||
106124859|NCT02291289|366115812|FG006|Induction Treatment|Lost to Follow-up|0|||
106124860|NCT02291289|366115813|FG007|Induction Treatment|Lost to Follow-up|0|||
106124861|NCT02291289|366115814|FG008|Induction Treatment|Lost to Follow-up|0|||
106124862|NCT02291289|366115815|FG009|Induction Treatment|Lost to Follow-up|9|||
106124863|NCT02291289|366115816|FG010|Induction Treatment|Lost to Follow-up|0|||
106124864|NCT02291289|366115817|FG011|Induction Treatment|Lost to Follow-up|0|||
106124865|NCT02291289|366115818|FG012|Induction Treatment|Lost to Follow-up|0|||
106124866|NCT02291289|366115806|FG000|Induction Treatment|Non-Compliance|0|||
106124867|NCT02291289|366115807|FG001|Induction Treatment|Non-Compliance|0|||
106124868|NCT02291289|366115808|FG002|Induction Treatment|Non-Compliance|0|||
106124869|NCT02291289|366115809|FG003|Induction Treatment|Non-Compliance|1|||
106124870|NCT02291289|366115810|FG004|Induction Treatment|Non-Compliance|0|||
106124871|NCT02291289|366115811|FG005|Induction Treatment|Non-Compliance|0|||
106124872|NCT02291289|366115812|FG006|Induction Treatment|Non-Compliance|0|||
106124873|NCT02291289|366115813|FG007|Induction Treatment|Non-Compliance|0|||
106124874|NCT02291289|366115814|FG008|Induction Treatment|Non-Compliance|0|||
106124875|NCT02291289|366115815|FG009|Induction Treatment|Non-Compliance|1|||
106124876|NCT02291289|366115816|FG010|Induction Treatment|Non-Compliance|0|||
106124877|NCT02291289|366115817|FG011|Induction Treatment|Non-Compliance|0|||
106124878|NCT02291289|366115818|FG012|Induction Treatment|Non-Compliance|0|||
106124879|NCT02291289|366115806|FG000|Induction Treatment|Reason Not Specified|0|||
106124880|NCT02291289|366115807|FG001|Induction Treatment|Reason Not Specified|0|||
106124881|NCT02291289|366115808|FG002|Induction Treatment|Reason Not Specified|0|||
106124882|NCT02291289|366115809|FG003|Induction Treatment|Reason Not Specified|4|||
106124883|NCT02291289|366115810|FG004|Induction Treatment|Reason Not Specified|0|||
106124884|NCT02291289|366115811|FG005|Induction Treatment|Reason Not Specified|0|||
106124885|NCT02291289|366115812|FG006|Induction Treatment|Reason Not Specified|0|||
105901241|NCT02452554|365296355|FG000|Overall Study|Physician Decision|0|||
105901242|NCT02452554|365296356|FG001|Overall Study|Physician Decision|1|||
105901243|NCT02452554|365296357|FG002|Overall Study|Physician Decision|0|||
105901244|NCT02452554|365296358|FG003|Overall Study|Physician Decision|0|||
105901245|NCT02452554|365296359|FG004|Overall Study|Physician Decision|0|||
105901246|NCT02452554|365296360|FG005|Overall Study|Physician Decision|0|||
105901247|NCT02452554|365296355|FG000|Overall Study|Withdrawal by Subject|1|||
105901248|NCT02452554|365296356|FG001|Overall Study|Withdrawal by Subject|0|||
105901249|NCT02452554|365296357|FG002|Overall Study|Withdrawal by Subject|2|||
105901250|NCT02452554|365296358|FG003|Overall Study|Withdrawal by Subject|0|||
105901251|NCT02452554|365296359|FG004|Overall Study|Withdrawal by Subject|0|||
105901252|NCT02452554|365296360|FG005|Overall Study|Withdrawal by Subject|1|||
105668568|NCT01254747|364450293|FG001|Overall Study|Biomicroscopy|0|||
105668569|NCT01254747|364450294|FG002|Overall Study|Biomicroscopy|1|||
105668570|NCT01254747|364450295|FG003|Overall Study|Biomicroscopy|0|||
105668571|NCT01254747|364450292|FG000|Overall Study|Discomfort|0|||
105668572|NCT01254747|364450293|FG001|Overall Study|Discomfort|4|||
105668573|NCT01254747|364450294|FG002|Overall Study|Discomfort|0|||
105668574|NCT01254747|364450295|FG003|Overall Study|Discomfort|0|||
105668575|NCT00570908|364450296|FG000|Overall Study|Adverse Event|5|||
105668576|NCT00570908|364450296|FG000|Overall Study|Withdrawal by Subject|2|||
105668577|NCT01495598|364450300|FG000|Overall Study|Death during follow up period|2|||
105901253|NCT02452554|365296355|FG000|Overall Study|Ineligible|0|||
105901254|NCT02452554|365296356|FG001|Overall Study|Ineligible|1|||
105901255|NCT02452554|365296357|FG002|Overall Study|Ineligible|0|||
105901256|NCT02452554|365296358|FG003|Overall Study|Ineligible|0|||
105901257|NCT02452554|365296359|FG004|Overall Study|Ineligible|0|||
105901258|NCT02452554|365296360|FG005|Overall Study|Ineligible|0|||
105901259|NCT02452554|365296355|FG000|Overall Study|Never Received Treatment|1|||
105901260|NCT02452554|365296356|FG001|Overall Study|Never Received Treatment|0|||
105901261|NCT02452554|365296357|FG002|Overall Study|Never Received Treatment|0|||
105901262|NCT02452554|365296358|FG003|Overall Study|Never Received Treatment|0|||
105901263|NCT02452554|365296359|FG004|Overall Study|Never Received Treatment|0|||
105901264|NCT02452554|365296360|FG005|Overall Study|Never Received Treatment|0|||
105901265|NCT00594386|365296361|FG000|Overall Study|Major protocol violation|2|||
105901266|NCT00594386|365296361|FG000|Overall Study|Lack of Efficacy|12|||
105901267|NCT00594386|365296361|FG000|Overall Study|Adverse Event|68|||
105901268|NCT00594386|365296361|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
105901269|NCT00594386|365296361|FG000|Overall Study|Subject withdrew consent|35|||
105901270|NCT00594386|365296361|FG000|Overall Study|Study ended per sponsor|115|||
105901271|NCT00594386|365296361|FG000|Overall Study|Lost to Follow-up|6|||
105901272|NCT00594386|365296361|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
105901273|NCT00594386|365296361|FG000|Overall Study|Other: Subject moved to Seattle|1|||
105901274|NCT00594386|365296361|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
105901275|NCT00594386|365296361|FG000|Overall Study|Other: Study terminated per investigator|2|||
105901276|NCT00594386|365296361|FG000|Overall Study|Other: Sponsor closure of study|1|||
105901277|NCT00594386|365296361|FG000|Overall Study|Other: Site terminated participation|1|||
105901278|NCT00594386|365296361|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
105901279|NCT00594386|365296361|FG000|Overall Study|Other: Loss of drivers license|1|||
105901280|NCT01402986|365296362|FG000|Overall Study|Withdrawal by Subject|7|||
105901281|NCT01402986|365296363|FG001|Overall Study|Withdrawal by Subject|10|||
105901282|NCT01402986|365296364|FG002|Overall Study|Withdrawal by Subject|7|||
105901283|NCT01402986|365296365|FG003|Overall Study|Withdrawal by Subject|13|||
105901284|NCT01402986|365296362|FG000|Overall Study|Death|0|||
105901285|NCT01402986|365296363|FG001|Overall Study|Death|0|||
105901286|NCT01402986|365296364|FG002|Overall Study|Death|0|||
105901287|NCT01402986|365296365|FG003|Overall Study|Death|2|||
105901288|NCT01402986|365296362|FG000|Overall Study|Lost to Follow-up|0|||
105901289|NCT01402986|365296363|FG001|Overall Study|Lost to Follow-up|0|||
105901290|NCT01402986|365296364|FG002|Overall Study|Lost to Follow-up|0|||
105901291|NCT01402986|365296365|FG003|Overall Study|Lost to Follow-up|1|||
105901292|NCT01402986|365296362|FG000|Overall Study|Other|2|||
105901293|NCT01402986|365296363|FG001|Overall Study|Other|5|||
105901294|NCT01402986|365296364|FG002|Overall Study|Other|1|||
105901295|NCT01402986|365296365|FG003|Overall Study|Other|6|||
105901296|NCT01554163|365296366|FG000|Overall Study|Adverse Event|3|||
105901297|NCT01554163|365296367|FG001|Overall Study|Adverse Event|0|||
105901298|NCT01554163|365296366|FG000|Overall Study|Lack of Efficacy|1|||
105901299|NCT01554163|365296367|FG001|Overall Study|Lack of Efficacy|0|||
105668578|NCT01495598|364450300|FG000|Overall Study|Death on study|1|||
105668579|NCT01495598|364450300|FG000|Overall Study|Lost to Follow-up|3|||
105668580|NCT01495598|364450300|FG000|Overall Study|Physician Decision|8|||
105668581|NCT02671500|364450306|FG000|Overall Study|Lack of Efficacy|12|||
105901300|NCT01554163|365296366|FG000|Overall Study|Lost to Follow-up|1|||
105901301|NCT01554163|365296367|FG001|Overall Study|Lost to Follow-up|0|||
105901302|NCT01554163|365296366|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105901303|NCT01554163|365296367|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105901304|NCT01554163|365296366|FG000|Overall Study|Protocol Violation|0|||
105901305|NCT01554163|365296367|FG001|Overall Study|Protocol Violation|4|||
105668582|NCT02671500|364450306|FG000|Overall Study|Lost to Follow-up|2|||
105668583|NCT00798434|364450307|FG000|Double-Blind|Adverse Event|22|||
105668584|NCT00798434|364450308|FG001|Double-Blind|Adverse Event|46|||
105668585|NCT00798434|364450307|FG000|Double-Blind|Death|0|||
105668586|NCT00798434|364450308|FG001|Double-Blind|Death|1|||
105668587|NCT00798434|364450307|FG000|Double-Blind|Lost to Follow-up|1|||
105668588|NCT00798434|364450308|FG001|Double-Blind|Lost to Follow-up|0|||
105668589|NCT00798434|364450307|FG000|Double-Blind|Lack of Efficacy|8|||
105668590|NCT00798434|364450308|FG001|Double-Blind|Lack of Efficacy|12|||
105668591|NCT00798434|364450307|FG000|Double-Blind|Withdrawal by Subject|17|||
105668592|NCT00798434|364450308|FG001|Double-Blind|Withdrawal by Subject|14|||
105668593|NCT00798434|364450307|FG000|Double-Blind|Protocol Violation|1|||
105668594|NCT00798434|364450308|FG001|Double-Blind|Protocol Violation|4|||
105668595|NCT00798434|364450307|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
105668596|NCT00798434|364450308|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
105668597|NCT00798434|364450307|FG000|Double-Blind|Other|1|||
105668598|NCT00798434|364450308|FG001|Double-Blind|Other|0|||
105668599|NCT00798434|364450307|FG000|Double-Blind|Not Treated|3|||
105668600|NCT00798434|364450308|FG001|Double-Blind|Not Treated|6|||
105668601|NCT00798434|364450307|FG000|Open-Label|Adverse Event|33|||
105668602|NCT00798434|364450308|FG001|Open-Label|Adverse Event|11|||
105668603|NCT00798434|364450307|FG000|Open-Label|Lack of Efficacy|5|||
105668604|NCT00798434|364450308|FG001|Open-Label|Lack of Efficacy|11|||
105668605|NCT00798434|364450307|FG000|Open-Label|Withdrawal by Subject|2|||
105668606|NCT00798434|364450308|FG001|Open-Label|Withdrawal by Subject|7|||
105668607|NCT00798434|364450307|FG000|Open-Label|Protocol Violation|1|||
105668608|NCT00798434|364450308|FG001|Open-Label|Protocol Violation|0|||
105668609|NCT00798434|364450307|FG000|Open-Label|Other|1|||
105668610|NCT00798434|364450308|FG001|Open-Label|Other|2|||
105668611|NCT00798434|364450307|FG000|Open-Label|Not Treated|0|||
105668612|NCT00798434|364450308|FG001|Open-Label|Not Treated|1|||
105668613|NCT01447576|364450313|FG000|Overall Study|Lost to Follow-up|52|||
105668614|NCT01447576|364450313|FG000|Overall Study|Adverse Event|127|||
105668615|NCT01447576|364450313|FG000|Overall Study|Participant met withdrawal criteria|40|||
105668616|NCT01447576|364450313|FG000|Overall Study|Withdrawal by Subject|100|||
105901306|NCT01554163|365296366|FG000|Overall Study|Withdrawal by Subject|1|||
105901307|NCT01554163|365296367|FG001|Overall Study|Withdrawal by Subject|5|||
105901308|NCT01554163|365296366|FG000|Overall Study|Not Treated|1|||
105901309|NCT01554163|365296367|FG001|Overall Study|Not Treated|0|||
105901310|NCT01085084|365296368|FG000|Overall Study|Withdrawal by Subject|1|||
105901311|NCT01085084|365296369|FG001|Overall Study|Withdrawal by Subject|0|||
105901312|NCT01085084|365296370|FG002|Overall Study|Withdrawal by Subject|0|||
105901313|NCT01085084|365296368|FG000|Overall Study|Lost to Follow-up|2|||
105901314|NCT01085084|365296369|FG001|Overall Study|Lost to Follow-up|1|||
105901315|NCT01085084|365296370|FG002|Overall Study|Lost to Follow-up|1|||
105901316|NCT01085084|365296368|FG000|Overall Study|Adverse Event|4|||
105901317|NCT01085084|365296369|FG001|Overall Study|Adverse Event|3|||
105901318|NCT01085084|365296370|FG002|Overall Study|Adverse Event|6|||
105901319|NCT01085084|365296368|FG000|Overall Study|Treatment Failure|0|||
105901320|NCT01085084|365296369|FG001|Overall Study|Treatment Failure|1|||
105901321|NCT01085084|365296370|FG002|Overall Study|Treatment Failure|2|||
105901322|NCT03749109|365296371|FG000|Overall Study|Adverse Event|2|||
105901323|NCT03749109|365296372|FG001|Overall Study|Adverse Event|0|||
105901324|NCT02494401|365296375|FG000|Overall Study|Lost to Follow-up|22|||
105901325|NCT02494401|365296376|FG001|Overall Study|Lost to Follow-up|25|||
105901326|NCT02494401|365296375|FG000|Overall Study|Withdrawal by Subject|3|||
105901327|NCT02494401|365296376|FG001|Overall Study|Withdrawal by Subject|2|||
105901328|NCT00966355|365296377|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
105901329|NCT00966355|365296378|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
105901330|NCT00966355|365296379|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
106124886|NCT02291289|366115813|FG007|Induction Treatment|Reason Not Specified|0|||
105668617|NCT01447576|364450313|FG000|Overall Study|Protocol deviation|83|||
105668618|NCT01447576|364450313|FG000|Overall Study|Lack of Efficacy|68|||
105668619|NCT01447576|364450313|FG000|Overall Study|Physician Decision|6|||
105668620|NCT02579772|364450314|FG000|Overall Study|Withdrawal by Subject|0|||
105668621|NCT02579772|364450315|FG001|Overall Study|Withdrawal by Subject|1|||
105668622|NCT02579772|364450314|FG000|Overall Study|Usage of additional antioxidants|1|||
105668623|NCT02579772|364450315|FG001|Overall Study|Usage of additional antioxidants|0|||
105668624|NCT02579772|364450314|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
105668625|NCT02579772|364450315|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
105668626|NCT04942366|364452175|FG000|Overall Study|Withdrawal by Subject|5|||
105668627|NCT04942366|364452176|FG001|Overall Study|Withdrawal by Subject|5|||
105668628|NCT02113124|364452177|FG000|Overall Study|Unable to retrieve blood sample|1|||
105901331|NCT00966355|365296377|FG000|Overall Study|newly diagnosed advanced HCC|11|||
105668629|NCT02113124|364452178|FG001|Overall Study|Unable to retrieve blood sample|1|||
105901332|NCT00966355|365296378|FG001|Overall Study|newly diagnosed advanced HCC|12|||
105901333|NCT00966355|365296379|FG002|Overall Study|newly diagnosed advanced HCC|10|||
105901334|NCT00966355|365296377|FG000|Overall Study|Lost to Follow-up|5|||
105901335|NCT00966355|365296378|FG001|Overall Study|Lost to Follow-up|4|||
105901336|NCT00966355|365296379|FG002|Overall Study|Lost to Follow-up|3|||
105901337|NCT01393106|365297824|FG000|Overall Study|Adverse Event|3|||
105901338|NCT01393106|365297824|FG000|Overall Study|Withdrawal by Subject|1|||
105901339|NCT01393106|365297824|FG000|Overall Study|Lack of Efficacy|1|||
105901340|NCT03307837|365297825|FG000|Overall Study|Withdrawal by Subject|0|||
105901341|NCT03307837|365297826|FG001|Overall Study|Withdrawal by Subject|0|||
105901342|NCT03307837|365297827|FG002|Overall Study|Withdrawal by Subject|1|||
105901343|NCT03307837|365297828|FG003|Overall Study|Withdrawal by Subject|0|||
105901344|NCT03307837|365297829|FG004|Overall Study|Withdrawal by Subject|0|||
105901345|NCT03307837|365297830|FG005|Overall Study|Withdrawal by Subject|1|||
105901346|NCT03307837|365297825|FG000|Overall Study|Lost to Follow-up|1|||
105901347|NCT03307837|365297826|FG001|Overall Study|Lost to Follow-up|1|||
105901348|NCT03307837|365297827|FG002|Overall Study|Lost to Follow-up|0|||
105901349|NCT03307837|365297828|FG003|Overall Study|Lost to Follow-up|0|||
105901350|NCT03307837|365297829|FG004|Overall Study|Lost to Follow-up|0|||
105901351|NCT03307837|365297830|FG005|Overall Study|Lost to Follow-up|1|||
105901352|NCT01744483|365297831|FG000|Overall Study|Death|9|||
105901353|NCT01744483|365297832|FG001|Overall Study|Death|4|||
105901354|NCT01744483|365297833|FG002|Overall Study|Death|11|||
105901355|NCT01744483|365297831|FG000|Overall Study|Lost to Follow-up|8|||
105901356|NCT01744483|365297832|FG001|Overall Study|Lost to Follow-up|9|||
105901357|NCT01744483|365297833|FG002|Overall Study|Lost to Follow-up|11|||
105901358|NCT01744483|365297831|FG000|Overall Study|Protocol Violation|1|||
105901359|NCT01744483|365297832|FG001|Overall Study|Protocol Violation|2|||
105901360|NCT01744483|365297833|FG002|Overall Study|Protocol Violation|1|||
105901361|NCT01744483|365297831|FG000|Overall Study|Withdrawal by Subject|4|||
105901362|NCT01744483|365297832|FG001|Overall Study|Withdrawal by Subject|6|||
105901363|NCT01744483|365297833|FG002|Overall Study|Withdrawal by Subject|2|||
105901364|NCT01744483|365297831|FG000|Overall Study|No ICU Admit|5|||
105901365|NCT01744483|365297832|FG001|Overall Study|No ICU Admit|1|||
105901366|NCT01744483|365297833|FG002|Overall Study|No ICU Admit|2|||
105901367|NCT01744483|365297831|FG000|Overall Study|Routed to OSH|2|||
105901368|NCT01744483|365297832|FG001|Overall Study|Routed to OSH|0|||
105901369|NCT01744483|365297833|FG002|Overall Study|Routed to OSH|1|||
105901370|NCT03015194|365297835|FG000|Overall Study|Death|10|||
105901371|NCT03015194|365297835|FG000|Overall Study|Withdrawal by Subject|2|||
105901372|NCT03246061|365297839|FG000|Overall Study|Still in follow-up|15|||
105901373|NCT03246061|365297840|FG001|Overall Study|Still in follow-up|21|||
105901374|NCT01698268|365297841|FG000|Overall Study|Physician Decision|2|||
105901375|NCT01698268|365297842|FG001|Overall Study|Physician Decision|1|||
105901376|NCT02469168|365297843|FG000|Overall Study|Trial closed|1|||
105901377|NCT02469168|365297844|FG001|Overall Study|Trial closed|0|||
105901378|NCT02412878|365297849|FG000|Overall Study|Withdrawal by Subject|19|||
105901379|NCT02412878|365297850|FG001|Overall Study|Withdrawal by Subject|10|||
105901380|NCT02412878|365297849|FG000|Overall Study|Lost to Follow-up|2|||
105901381|NCT02412878|365297850|FG001|Overall Study|Lost to Follow-up|3|||
105901382|NCT03488563|365297857|FG000|Overall Study|Lost to Follow-up|7|||
105901383|NCT03488563|365297858|FG001|Overall Study|Lost to Follow-up|6|||
105901384|NCT03488563|365297859|FG002|Overall Study|Lost to Follow-up|7|||
105901385|NCT03488563|365297857|FG000|Overall Study|Withdrawal by Subject|8|||
105901386|NCT03488563|365297858|FG001|Overall Study|Withdrawal by Subject|7|||
105901387|NCT03488563|365297859|FG002|Overall Study|Withdrawal by Subject|7|||
105901388|NCT03488563|365297857|FG000|Overall Study|Physician Decision|0|||
105901389|NCT03488563|365297858|FG001|Overall Study|Physician Decision|0|||
105901390|NCT03488563|365297859|FG002|Overall Study|Physician Decision|1|||
105901391|NCT03488563|365297857|FG000|Overall Study|Protocol Violation|3|||
105901392|NCT03488563|365297858|FG001|Overall Study|Protocol Violation|2|||
105668630|NCT02514239|364452179|FG000|Overall Study|Refused to continue trial medication|0|||
105668631|NCT02514239|364452180|FG001|Overall Study|Refused to continue trial medication|0|||
105668632|NCT02514239|364452181|FG002|Overall Study|Refused to continue trial medication|0|||
105668633|NCT02514239|364452182|FG003|Overall Study|Refused to continue trial medication|0|||
105668634|NCT02514239|364452183|FG004|Overall Study|Refused to continue trial medication|0|||
105668635|NCT02514239|364452184|FG005|Overall Study|Refused to continue trial medication|0|||
105668636|NCT02514239|364452185|FG006|Overall Study|Refused to continue trial medication|0|||
105668637|NCT02514239|364452186|FG007|Overall Study|Refused to continue trial medication|0|||
105668638|NCT02514239|364452187|FG008|Overall Study|Refused to continue trial medication|0|||
105668639|NCT02514239|364452188|FG009|Overall Study|Refused to continue trial medication|1|||
105668640|NCT02514239|364452179|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
105901393|NCT03488563|365297859|FG002|Overall Study|Protocol Violation|6|||
105901394|NCT03488563|365297857|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
105901395|NCT03488563|365297858|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
105901396|NCT03488563|365297859|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
105901397|NCT03488563|365297857|FG000|Overall Study|Use of prohibited medication|2|||
105901398|NCT03488563|365297858|FG001|Overall Study|Use of prohibited medication|0|||
105901399|NCT03488563|365297859|FG002|Overall Study|Use of prohibited medication|0|||
105901400|NCT03488563|365297857|FG000|Overall Study|Adverse Event|1|||
105901401|NCT03488563|365297858|FG001|Overall Study|Adverse Event|0|||
105901402|NCT03488563|365297859|FG002|Overall Study|Adverse Event|1|||
105901403|NCT03488563|365297857|FG000|Overall Study|Subject returned for ET visit|0|||
105901404|NCT03488563|365297858|FG001|Overall Study|Subject returned for ET visit|1|||
105901405|NCT03488563|365297859|FG002|Overall Study|Subject returned for ET visit|0|||
105901406|NCT03488563|365297857|FG000|Overall Study|Sponsor's decision|0|||
105901407|NCT03488563|365297858|FG001|Overall Study|Sponsor's decision|0|||
105901408|NCT03488563|365297859|FG002|Overall Study|Sponsor's decision|1|||
105901409|NCT00290693|365297878|FG000|Overall Study|Withdrawal by Subject|2|||
105901410|NCT03326518|365297879|FG000|Overall Study|Protocol Violation|1|||
105901411|NCT03326518|365297880|FG001|Overall Study|Protocol Violation|0|||
105901412|NCT03326518|365297881|FG002|Overall Study|Protocol Violation|0|||
105901413|NCT03326518|365297879|FG000|Overall Study|Withdrawal by Subject|1|||
105901414|NCT03326518|365297880|FG001|Overall Study|Withdrawal by Subject|0|||
105901415|NCT03326518|365297881|FG002|Overall Study|Withdrawal by Subject|0|||
105901416|NCT03326518|365297879|FG000|Overall Study|Lost to Follow-up|1|||
105901417|NCT03326518|365297880|FG001|Overall Study|Lost to Follow-up|0|||
105901418|NCT03326518|365297881|FG002|Overall Study|Lost to Follow-up|1|||
105901419|NCT03594955|365297882|FG000|Overall Study|Adverse Event|1|||
105901420|NCT03594955|365297882|FG000|Overall Study|Progressive disease|5|||
105901421|NCT03594955|365297882|FG000|Overall Study|Sponsor's decision|1|||
105901422|NCT03042910|365297883|FG000|Overall Study|Adverse Event|1|||
105901423|NCT03042910|365297883|FG000|Overall Study|Disease Progression|2|||
105901424|NCT03042910|365297883|FG000|Overall Study|Withdrawal by Subject|3|||
105901425|NCT03042910|365297883|FG000|Overall Study|Enrolled but not treated|1|||
105901426|NCT02756819|365297884|FG000|Overall Study|Lost for observation|23|||
105901427|NCT02756819|365297884|FG000|Overall Study|Patient's unwillingness|16|||
105901428|NCT02756819|365297884|FG000|Overall Study|Insufficient efficacy|2|||
105901429|NCT02756819|365297884|FG000|Overall Study|Adverse Event|2|||
105901430|NCT02756819|365297884|FG000|Overall Study|Reason not Specified|9|||
105901431|NCT03297021|365297887|FG000|Overall Study|Incomplete/illegible data sheet|4|||
105901432|NCT03297021|365297888|FG001|Overall Study|Incomplete/illegible data sheet|2|||
105901433|NCT03297021|365297889|FG002|Overall Study|Incomplete/illegible data sheet|3|||
105901434|NCT03297021|365297887|FG000|Overall Study|Missing Post-Op Data|1|||
105901435|NCT03297021|365297888|FG001|Overall Study|Missing Post-Op Data|2|||
105901436|NCT03297021|365297889|FG002|Overall Study|Missing Post-Op Data|1|||
105901437|NCT00948922|365297890|FG000|Overall Study|Did not start study treatment|2|||
105901438|NCT00948922|365297891|FG001|Overall Study|Did not start study treatment|5|||
105901439|NCT00948922|365297892|FG002|Overall Study|Did not start study treatment|0|||
105901440|NCT00948922|365297890|FG000|Overall Study|Withdrawal by Subject|0|||
105901441|NCT00948922|365297891|FG001|Overall Study|Withdrawal by Subject|2|||
105998016|NCT01467505|365654768|FG000|Overall Study|Study Terminated by Sponsor|28|||
106124887|NCT02291289|366115814|FG008|Induction Treatment|Reason Not Specified|0|||
106124888|NCT02291289|366115815|FG009|Induction Treatment|Reason Not Specified|7|||
105901442|NCT00948922|365297892|FG002|Overall Study|Withdrawal by Subject|1|||
105901443|NCT00948922|365297890|FG000|Overall Study|Death|3|||
105901444|NCT00948922|365297891|FG001|Overall Study|Death|0|||
105901445|NCT00948922|365297892|FG002|Overall Study|Death|0|||
105998017|NCT01467505|365654769|FG001|Overall Study|Study Terminated by Sponsor|3|||
105901446|NCT00948922|365297890|FG000|Overall Study|Disease progression|0|||
105901447|NCT00948922|365297891|FG001|Overall Study|Disease progression|1|||
105901448|NCT00948922|365297892|FG002|Overall Study|Disease progression|0|||
105901449|NCT00948922|365297890|FG000|Overall Study|Insurance issues|1|||
105901450|NCT00948922|365297891|FG001|Overall Study|Insurance issues|0|||
105901451|NCT00948922|365297892|FG002|Overall Study|Insurance issues|0|||
105901452|NCT00948922|365297890|FG000|Overall Study|Transplant eligibility issues|2|||
105901453|NCT00948922|365297891|FG001|Overall Study|Transplant eligibility issues|3|||
105901454|NCT00948922|365297892|FG002|Overall Study|Transplant eligibility issues|0|||
105901455|NCT00948922|365297890|FG000|Overall Study|Not evaluable at time of analysis|0|||
105901456|NCT00948922|365297891|FG001|Overall Study|Not evaluable at time of analysis|3|||
105901457|NCT00948922|365297892|FG002|Overall Study|Not evaluable at time of analysis|0|||
105901458|NCT06226649|365297896|FG000|Overall Study|Withdrawal by Subject|4|||
105901459|NCT06226649|365297897|FG001|Overall Study|Withdrawal by Subject|1|||
105901460|NCT00329745|365297898|FG000|Overall Study|Protocol Violation|1|||
105901461|NCT00329745|365297899|FG001|Overall Study|Protocol Violation|0|||
105901462|NCT00329745|365297898|FG000|Overall Study|Withdrawal by Subject|0|||
105901463|NCT00329745|365297899|FG001|Overall Study|Withdrawal by Subject|1|||
105901464|NCT00329745|365297898|FG000|Overall Study|Lost to Follow-up|86|||
105901465|NCT00329745|365297899|FG001|Overall Study|Lost to Follow-up|101|||
105901466|NCT04165135|365297900|FG000|Overall Study|Protocol Violation|10|||
105901467|NCT04165135|365297900|FG000|Overall Study|Participants withdrawal of consent|5|||
105901468|NCT03517449|365297907|FG000|Overall Study|Death|184|||
105901469|NCT03517449|365297908|FG001|Overall Study|Death|236|||
105901470|NCT03517449|365297907|FG000|Overall Study|Lost to Follow-up|0|||
105901471|NCT03517449|365297908|FG001|Overall Study|Lost to Follow-up|2|||
105901472|NCT03517449|365297907|FG000|Overall Study|Withdrawal by Subject|7|||
105901473|NCT03517449|365297908|FG001|Overall Study|Withdrawal by Subject|26|||
105901474|NCT03517449|365297907|FG000|Overall Study|Participants Ongoing|220|||
105901475|NCT03517449|365297908|FG001|Overall Study|Participants Ongoing|152|||
105901476|NCT04521114|365297909|FG000|Overall Study|Lost to Follow-up|1|||
105901477|NCT04521114|365297910|FG001|Overall Study|Lost to Follow-up|2|||
105901478|NCT04521114|365297911|FG002|Overall Study|Lost to Follow-up|0|||
105901479|NCT04521114|365297909|FG000|Overall Study|Withdrawal by Subject|1|||
105901480|NCT04521114|365297910|FG001|Overall Study|Withdrawal by Subject|2|||
105901481|NCT04521114|365297911|FG002|Overall Study|Withdrawal by Subject|2|||
105901482|NCT04521114|365297909|FG000|Overall Study|Adverse Event|1|||
105901483|NCT04521114|365297910|FG001|Overall Study|Adverse Event|0|||
105901484|NCT04521114|365297911|FG002|Overall Study|Adverse Event|0|||
105901485|NCT04521114|365297909|FG000|Overall Study|Sponsor Wish|1|||
105901486|NCT04521114|365297910|FG001|Overall Study|Sponsor Wish|0|||
105901487|NCT04521114|365297911|FG002|Overall Study|Sponsor Wish|0|||
105901488|NCT04521114|365297909|FG000|Overall Study|Withdrawal of Consent|2|||
105901489|NCT04521114|365297910|FG001|Overall Study|Withdrawal of Consent|2|||
105901490|NCT04521114|365297911|FG002|Overall Study|Withdrawal of Consent|0|||
105901491|NCT00548249|365297915|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
105901492|NCT00548249|365297916|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
105901493|NCT00548249|365297917|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
105901494|NCT00548249|365297918|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
105901495|NCT00548249|365297919|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
105901496|NCT00548249|365297915|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
105901497|NCT00548249|365297916|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
105901498|NCT00548249|365297917|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
105901499|NCT00548249|365297918|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
105901500|NCT00548249|365297919|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
105901501|NCT00548249|365297915|FG000|Overall Study|Protocol Violation|1|||
105901502|NCT00548249|365297916|FG001|Overall Study|Protocol Violation|1|||
105901503|NCT00548249|365297917|FG002|Overall Study|Protocol Violation|4|||
105901504|NCT00548249|365297918|FG003|Overall Study|Protocol Violation|0|||
105901505|NCT00548249|365297919|FG004|Overall Study|Protocol Violation|3|||
105901506|NCT00548249|365297915|FG000|Overall Study|Miscellaneous|2|||
105901507|NCT00548249|365297916|FG001|Overall Study|Miscellaneous|3|||
105901508|NCT00548249|365297917|FG002|Overall Study|Miscellaneous|2|||
105901509|NCT00548249|365297918|FG003|Overall Study|Miscellaneous|0|||
105901510|NCT00548249|365297919|FG004|Overall Study|Miscellaneous|2|||
105998018|NCT02807623|365654770|FG000|Overall Study|Lost to Follow-up|23|||
105998019|NCT02807623|365654771|FG001|Overall Study|Lost to Follow-up|18|||
105901511|NCT00548249|365297915|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
105901512|NCT00548249|365297916|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
105901513|NCT00548249|365297917|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
105901514|NCT00548249|365297918|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
105901515|NCT00548249|365297919|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
105901516|NCT00548249|365297915|FG000|Overall Study|Adverse Event|2|||
105901517|NCT00548249|365297916|FG001|Overall Study|Adverse Event|2|||
105901518|NCT00548249|365297917|FG002|Overall Study|Adverse Event|0|||
105901519|NCT00548249|365297918|FG003|Overall Study|Adverse Event|1|||
105901520|NCT00548249|365297919|FG004|Overall Study|Adverse Event|1|||
105901521|NCT00548249|365297915|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
105901522|NCT00548249|365297916|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
105901523|NCT00548249|365297917|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
105901524|NCT00548249|365297918|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
105998020|NCT02807623|365654772|FG002|Overall Study|Lost to Follow-up|22|||
105901525|NCT00548249|365297919|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
105901526|NCT00548249|365297915|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
105901527|NCT00548249|365297916|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
105901528|NCT00548249|365297917|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
105901529|NCT00548249|365297918|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
105901530|NCT00548249|365297919|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
105901531|NCT00548249|365297915|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
105901532|NCT00548249|365297916|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
105901533|NCT00548249|365297917|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
105901534|NCT00548249|365297918|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
105901535|NCT00548249|365297919|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
105901536|NCT00548249|365297915|FG000|Overall Study|Prolonged hospitalization|0|||
105901537|NCT00548249|365297916|FG001|Overall Study|Prolonged hospitalization|0|||
105901538|NCT00548249|365297917|FG002|Overall Study|Prolonged hospitalization|2|||
105901539|NCT00548249|365297918|FG003|Overall Study|Prolonged hospitalization|1|||
105901540|NCT00548249|365297919|FG004|Overall Study|Prolonged hospitalization|0|||
105901541|NCT00548249|365297915|FG000|Overall Study|Withdrawal by Subject|2|||
105901542|NCT00548249|365297916|FG001|Overall Study|Withdrawal by Subject|0|||
105901543|NCT00548249|365297917|FG002|Overall Study|Withdrawal by Subject|0|||
105901544|NCT00548249|365297918|FG003|Overall Study|Withdrawal by Subject|0|||
105901545|NCT00548249|365297919|FG004|Overall Study|Withdrawal by Subject|0|||
105901546|NCT00548249|365297915|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
105901547|NCT00548249|365297916|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
105901548|NCT00548249|365297917|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
105901549|NCT00548249|365297918|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
105901550|NCT00548249|365297919|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
105901551|NCT00548249|365297915|FG000|Overall Study|Sponsor's request|0|||
105901552|NCT00548249|365297916|FG001|Overall Study|Sponsor's request|0|||
105901553|NCT00548249|365297917|FG002|Overall Study|Sponsor's request|0|||
105901554|NCT00548249|365297918|FG003|Overall Study|Sponsor's request|1|||
105901555|NCT00548249|365297919|FG004|Overall Study|Sponsor's request|0|||
105901556|NCT03003000|365297920|FG000|Overall Study|Adverse Event|1|||
106124889|NCT02291289|366115816|FG010|Induction Treatment|Reason Not Specified|0|||
106124890|NCT02291289|366115817|FG011|Induction Treatment|Reason Not Specified|0|||
106124891|NCT02291289|366115818|FG012|Induction Treatment|Reason Not Specified|0|||
106124892|NCT02291289|366115806|FG000|Induction Treatment|Physician Decision|0|||
106124893|NCT02291289|366115807|FG001|Induction Treatment|Physician Decision|0|||
106124894|NCT02291289|366115808|FG002|Induction Treatment|Physician Decision|0|||
106124895|NCT02291289|366115809|FG003|Induction Treatment|Physician Decision|3|||
106124896|NCT02291289|366115810|FG004|Induction Treatment|Physician Decision|0|||
105668641|NCT02514239|364452180|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668642|NCT02514239|364452181|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668643|NCT02514239|364452182|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668644|NCT02514239|364452183|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668645|NCT02514239|364452184|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668646|NCT02514239|364452185|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668647|NCT02514239|364452186|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
105668648|NCT02514239|364452187|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
105668649|NCT02514239|364452188|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
105668650|NCT02514239|364452179|FG000|Overall Study|Not treated|0|||
105668651|NCT02514239|364452180|FG001|Overall Study|Not treated|1|||
105668652|NCT02514239|364452181|FG002|Overall Study|Not treated|0|||
105668653|NCT02514239|364452182|FG003|Overall Study|Not treated|0|||
105668654|NCT02514239|364452183|FG004|Overall Study|Not treated|0|||
105668655|NCT02514239|364452184|FG005|Overall Study|Not treated|0|||
105668656|NCT02514239|364452185|FG006|Overall Study|Not treated|0|||
105668657|NCT02514239|364452186|FG007|Overall Study|Not treated|0|||
105668658|NCT02514239|364452187|FG008|Overall Study|Not treated|0|||
105668659|NCT02514239|364452188|FG009|Overall Study|Not treated|0|||
105668660|NCT02514239|364452179|FG000|Overall Study|Other Adverse Events|2|||
105668661|NCT02514239|364452180|FG001|Overall Study|Other Adverse Events|0|||
105668662|NCT02514239|364452181|FG002|Overall Study|Other Adverse Events|0|||
105901557|NCT03003000|365297921|FG001|Overall Study|Adverse Event|2|||
105901558|NCT03003000|365297922|FG002|Overall Study|Adverse Event|3|||
105901559|NCT03003000|365297920|FG000|Overall Study|Lack of Efficacy|1|||
105901560|NCT03003000|365297921|FG001|Overall Study|Lack of Efficacy|0|||
105668663|NCT02514239|364452182|FG003|Overall Study|Other Adverse Events|1|||
105668664|NCT02514239|364452183|FG004|Overall Study|Other Adverse Events|0|||
105901561|NCT03003000|365297922|FG002|Overall Study|Lack of Efficacy|0|||
106124897|NCT02291289|366115811|FG005|Induction Treatment|Physician Decision|0|||
106124898|NCT02291289|366115812|FG006|Induction Treatment|Physician Decision|0|||
105668665|NCT02514239|364452184|FG005|Overall Study|Other Adverse Events|1|||
105668666|NCT02514239|364452185|FG006|Overall Study|Other Adverse Events|0|||
105668667|NCT02514239|364452186|FG007|Overall Study|Other Adverse Events|1|||
105901562|NCT03003000|365297920|FG000|Overall Study|Non-compliant with protocol|0|||
105901563|NCT03003000|365297921|FG001|Overall Study|Non-compliant with protocol|1|||
105901564|NCT03003000|365297922|FG002|Overall Study|Non-compliant with protocol|1|||
105901565|NCT03003000|365297920|FG000|Overall Study|Refused to continue medication|2|||
105901566|NCT03003000|365297921|FG001|Overall Study|Refused to continue medication|0|||
105901567|NCT03003000|365297922|FG002|Overall Study|Refused to continue medication|0|||
105901568|NCT03003000|365297920|FG000|Overall Study|Other than listed|1|||
105901569|NCT03003000|365297921|FG001|Overall Study|Other than listed|1|||
105901570|NCT03003000|365297922|FG002|Overall Study|Other than listed|1|||
105901571|NCT02191046|365297924|FG000|Overall Study|low compliance|5|||
105901572|NCT02191046|365297925|FG001|Overall Study|low compliance|1|||
105901573|NCT03230838|365297927|FG000|Overall Study|Withdrawal by Subject|3|||
105901574|NCT03230838|365297928|FG001|Overall Study|Withdrawal by Subject|0|||
105901575|NCT03230838|365297927|FG000|Overall Study|Temperature excursion|1|||
105901576|NCT03230838|365297928|FG001|Overall Study|Temperature excursion|0|||
105901577|NCT01915771|365297929|FG000|Day 1|Withdrawal by Subject|1|||
105901578|NCT01915771|365297929|FG000|Day 15|Withdrawal by Subject|1|||
105901579|NCT01578499|365297931|FG000|Overall Study|Reason not Specified|0|||
105901580|NCT01578499|365297932|FG001|Overall Study|Reason not Specified|1|||
105901581|NCT01578499|365297931|FG000|Overall Study|Lost to Follow-up|2|||
105901582|NCT01578499|365297932|FG001|Overall Study|Lost to Follow-up|1|||
105901583|NCT01578499|365297931|FG000|Overall Study|Withdrawal by Subject|10|||
105901584|NCT01578499|365297932|FG001|Overall Study|Withdrawal by Subject|16|||
105901585|NCT01578499|365297931|FG000|Overall Study|Death|20|||
105901586|NCT01578499|365297932|FG001|Overall Study|Death|25|||
105901587|NCT01578499|365297931|FG000|Overall Study|Died and End of Study Page not Completed|2|||
105901588|NCT01578499|365297932|FG001|Overall Study|Died and End of Study Page not Completed|0|||
105901589|NCT02670382|365297933|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
105901590|NCT02670382|365297934|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
105901591|NCT00830518|365297935|FG000|Overall Study|Progressive Disease|18|||
105901592|NCT00830518|365297936|FG001|Overall Study|Progressive Disease|8|||
105901593|NCT00830518|365297935|FG000|Overall Study|Symptomatic Deterioration|4|||
105901594|NCT00830518|365297936|FG001|Overall Study|Symptomatic Deterioration|1|||
105901595|NCT00830518|365297935|FG000|Overall Study|Adverse Event|14|||
105901596|NCT00830518|365297936|FG001|Overall Study|Adverse Event|1|||
105901597|NCT00830518|365297935|FG000|Overall Study|Withdrawal by Patient|2|||
105901598|NCT00830518|365297936|FG001|Overall Study|Withdrawal by Patient|0|||
105901599|NCT00830518|365297935|FG000|Overall Study|Reason not Specified|8|||
105901600|NCT00830518|365297936|FG001|Overall Study|Reason not Specified|1|||
105901601|NCT00913770|365297941|FG000|Overall Study|Unable to contact|24|||
105901602|NCT00913770|365297942|FG001|Overall Study|Unable to contact|19|||
105901603|NCT00913770|365297943|FG002|Overall Study|Unable to contact|13|||
105901604|NCT00913770|365297941|FG000|Overall Study|Refused|11|||
105901605|NCT00913770|365297942|FG001|Overall Study|Refused|10|||
105901606|NCT00913770|365297943|FG002|Overall Study|Refused|8|||
105901607|NCT02669667|365297949|FG000|Overall Study|Lost to Follow-up|0|||
105901608|NCT02669667|365297950|FG001|Overall Study|Lost to Follow-up|0|||
105901609|NCT02669667|365297951|FG002|Overall Study|Lost to Follow-up|0|||
105901610|NCT02669667|365297952|FG003|Overall Study|Lost to Follow-up|0|||
106124899|NCT02291289|366115813|FG007|Induction Treatment|Physician Decision|0|||
106124900|NCT02291289|366115814|FG008|Induction Treatment|Physician Decision|0|||
105901611|NCT02669667|365297953|FG004|Overall Study|Lost to Follow-up|0|||
105901612|NCT02669667|365297954|FG005|Overall Study|Lost to Follow-up|1|||
105901613|NCT02669667|365297955|FG006|Overall Study|Lost to Follow-up|0|||
105901614|NCT00840034|365297956|FG000|Acute Treatment Phase|Adverse Event|6|||
105901615|NCT00840034|365297957|FG001|Acute Treatment Phase|Adverse Event|8|||
105901616|NCT00840034|365297956|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
105901617|NCT00840034|365297957|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
105901618|NCT00840034|365297956|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
105901619|NCT00840034|365297957|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
105901620|NCT00840034|365297956|FG000|Acute Treatment Phase|Physician Decision|0|||
105901621|NCT00840034|365297957|FG001|Acute Treatment Phase|Physician Decision|1|||
105901622|NCT00840034|365297956|FG000|Acute Treatment Phase|Protocol Violation|2|||
105901623|NCT00840034|365297957|FG001|Acute Treatment Phase|Protocol Violation|4|||
105901624|NCT00840034|365297956|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
105901625|NCT00840034|365297957|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
105998021|NCT02807623|365654770|FG000|Overall Study|Drug intolerance|0|||
105901626|NCT00840034|365297956|FG000|Taper Phase|Adverse Event|1|||
105901627|NCT00840034|365297957|FG001|Taper Phase|Adverse Event|0|||
105901628|NCT00840034|365297956|FG000|Taper Phase|Lost to Follow-up|1|||
105901629|NCT00840034|365297957|FG001|Taper Phase|Lost to Follow-up|1|||
105901630|NCT00840034|365297956|FG000|Taper Phase|Withdrawal by Subject|1|||
105901631|NCT00840034|365297957|FG001|Taper Phase|Withdrawal by Subject|1|||
105901632|NCT00394771|365297958|FG000|Overall Study|Did not meet protocol requirements|1|||
105901633|NCT00394771|365297959|FG001|Overall Study|Did not meet protocol requirements|0|||
105901634|NCT00394771|365297960|FG002|Overall Study|Did not meet protocol requirements|2|||
105901635|NCT00394771|365297961|FG003|Overall Study|Did not meet protocol requirements|0|||
105901636|NCT00394771|365297958|FG000|Overall Study|Protocol Violation|2|||
105901637|NCT00394771|365297959|FG001|Overall Study|Protocol Violation|4|||
105901638|NCT00394771|365297960|FG002|Overall Study|Protocol Violation|9|||
105668668|NCT02514239|364452187|FG008|Overall Study|Other Adverse Events|2|||
105668669|NCT02514239|364452188|FG009|Overall Study|Other Adverse Events|0|||
105668670|NCT02514239|364452179|FG000|Overall Study|Progressive disease|3|||
105668671|NCT02514239|364452180|FG001|Overall Study|Progressive disease|3|||
105668672|NCT02514239|364452181|FG002|Overall Study|Progressive disease|2|||
105668673|NCT02514239|364452182|FG003|Overall Study|Progressive disease|2|||
105668674|NCT02514239|364452183|FG004|Overall Study|Progressive disease|3|||
105668675|NCT02514239|364452184|FG005|Overall Study|Progressive disease|3|||
105668676|NCT02514239|364452185|FG006|Overall Study|Progressive disease|4|||
105668677|NCT02514239|364452186|FG007|Overall Study|Progressive disease|2|||
105668678|NCT02514239|364452187|FG008|Overall Study|Progressive disease|5|||
105668679|NCT02514239|364452188|FG009|Overall Study|Progressive disease|0|||
105901639|NCT00394771|365297961|FG003|Overall Study|Protocol Violation|7|||
105901640|NCT00394771|365297958|FG000|Overall Study|Withdrawal by Subject|10|||
105901641|NCT00394771|365297959|FG001|Overall Study|Withdrawal by Subject|6|||
105901642|NCT00394771|365297960|FG002|Overall Study|Withdrawal by Subject|8|||
105901643|NCT00394771|365297961|FG003|Overall Study|Withdrawal by Subject|12|||
105901644|NCT00394771|365297958|FG000|Overall Study|Adverse Event|10|||
105901645|NCT00394771|365297959|FG001|Overall Study|Adverse Event|5|||
105901646|NCT00394771|365297960|FG002|Overall Study|Adverse Event|12|||
105901647|NCT00394771|365297961|FG003|Overall Study|Adverse Event|8|||
105901648|NCT00394771|365297958|FG000|Overall Study|Participant pregnant|0|||
105901649|NCT00394771|365297959|FG001|Overall Study|Participant pregnant|1|||
105901650|NCT00394771|365297960|FG002|Overall Study|Participant pregnant|2|||
105901651|NCT00394771|365297961|FG003|Overall Study|Participant pregnant|2|||
105901652|NCT00394771|365297958|FG000|Overall Study|Lost to Follow-up|15|||
105901653|NCT00394771|365297959|FG001|Overall Study|Lost to Follow-up|15|||
105901654|NCT00394771|365297960|FG002|Overall Study|Lost to Follow-up|13|||
105901655|NCT00394771|365297961|FG003|Overall Study|Lost to Follow-up|10|||
105901656|NCT00394771|365297958|FG000|Overall Study|Other|3|||
105901657|NCT00394771|365297959|FG001|Overall Study|Other|3|||
105901658|NCT00394771|365297960|FG002|Overall Study|Other|1|||
105901659|NCT00394771|365297961|FG003|Overall Study|Other|0|||
105901660|NCT00564395|365297969|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
105901661|NCT00564395|365297970|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
105901662|NCT00564395|365297969|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
105901663|NCT00564395|365297970|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
105901664|NCT02984267|365297972|FG000|Overall Study|Protocol Violation|1|||
105901665|NCT02984267|365297973|FG001|Overall Study|Protocol Violation|0|||
105901666|NCT02984267|365297972|FG000|Overall Study|Withdrawal by Subject|0|||
105901667|NCT02984267|365297973|FG001|Overall Study|Withdrawal by Subject|1|||
105901668|NCT00742027|365297974|FG000|Overall Study|Disease Progression|76|||
105901669|NCT00742027|365297974|FG000|Overall Study|New Cancer Therapy|19|||
105901670|NCT00742027|365297974|FG000|Overall Study|Withdrawal by Subject|18|||
105901671|NCT00742027|365297974|FG000|Overall Study|Death|7|||
105901672|NCT00742027|365297974|FG000|Overall Study|Lost to Follow-up|4|||
105901673|NCT00742027|365297974|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
105901674|NCT00742027|365297974|FG000|Overall Study|Missing|2|||
105901675|NCT00742027|365297974|FG000|Overall Study|Administrative Problems|1|||
105901676|NCT02634710|365297975|FG000|Overall Study|Death|4|||
105901677|NCT01289574|365297978|FG000|Overall Study|Lack of Efficacy|4|||
105901678|NCT01289574|365297979|FG001|Overall Study|Lack of Efficacy|0|||
105901679|NCT01289574|365297980|FG002|Overall Study|Lack of Efficacy|1|||
105901680|NCT01289574|365297978|FG000|Overall Study|Lost to Follow-up|2|||
105901681|NCT01289574|365297979|FG001|Overall Study|Lost to Follow-up|0|||
105901682|NCT01289574|365297980|FG002|Overall Study|Lost to Follow-up|1|||
105901683|NCT01289574|365297978|FG000|Overall Study|Withdrawal by Subject|1|||
105901684|NCT01289574|365297979|FG001|Overall Study|Withdrawal by Subject|1|||
105901685|NCT01289574|365297980|FG002|Overall Study|Withdrawal by Subject|1|||
106124901|NCT02291289|366115815|FG009|Induction Treatment|Physician Decision|1|||
106124902|NCT02291289|366115816|FG010|Induction Treatment|Physician Decision|0|||
106124903|NCT02291289|366115817|FG011|Induction Treatment|Physician Decision|0|||
105901686|NCT01289574|365297978|FG000|Overall Study|Adverse Event|0|||
106124904|NCT02291289|366115818|FG012|Induction Treatment|Physician Decision|0|||
105998022|NCT02807623|365654771|FG001|Overall Study|Drug intolerance|1|||
105668680|NCT01901419|364452191|FG000|Overall Study|Protocol Violation|2|||
105901687|NCT01289574|365297979|FG001|Overall Study|Adverse Event|1|||
105901688|NCT01289574|365297980|FG002|Overall Study|Adverse Event|0|||
105901689|NCT01289574|365297978|FG000|Overall Study|Subject wanted alternate treatment|0|||
105901690|NCT01289574|365297979|FG001|Overall Study|Subject wanted alternate treatment|1|||
105668681|NCT01901419|364452192|FG001|Overall Study|Protocol Violation|6|||
105901691|NCT01289574|365297980|FG002|Overall Study|Subject wanted alternate treatment|0|||
105901692|NCT01483599|365297981|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
105668682|NCT01901419|364452191|FG000|Overall Study|unavailable researchers|6|||
105901693|NCT01483599|365297982|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901694|NCT01483599|365297983|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901695|NCT01483599|365297984|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
105901696|NCT01483599|365297985|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
105901697|NCT01483599|365297986|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
105901698|NCT01483599|365297987|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
105901699|NCT01483599|365297988|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901700|NCT01483599|365297989|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901701|NCT01483599|365297990|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901702|NCT01483599|365297991|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901703|NCT01483599|365297992|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901704|NCT01483599|365297993|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901705|NCT01483599|365297994|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
105901706|NCT01483599|365297981|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901707|NCT01483599|365297982|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
105901708|NCT01483599|365297983|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901709|NCT01483599|365297984|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
105901710|NCT01483599|365297985|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901711|NCT01483599|365297986|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901712|NCT01483599|365297987|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
105901713|NCT01483599|365297988|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901714|NCT01483599|365297989|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105998023|NCT02807623|365654772|FG002|Overall Study|Drug intolerance|0|||
106124905|NCT02291289|366115806|FG000|Induction Treatment|Protocol Violation|0|||
106124906|NCT02291289|366115807|FG001|Induction Treatment|Protocol Violation|0|||
106124907|NCT02291289|366115808|FG002|Induction Treatment|Protocol Violation|0|||
106124908|NCT02291289|366115809|FG003|Induction Treatment|Protocol Violation|3|||
106124909|NCT02291289|366115810|FG004|Induction Treatment|Protocol Violation|0|||
106124910|NCT02291289|366115811|FG005|Induction Treatment|Protocol Violation|0|||
106124911|NCT02291289|366115812|FG006|Induction Treatment|Protocol Violation|0|||
105668683|NCT01901419|364452192|FG001|Overall Study|unavailable researchers|3|||
105668684|NCT03838731|364452197|FG000|Overall Study|Pregnancy|0|||
105668685|NCT03838731|364452198|FG001|Overall Study|Pregnancy|1|||
105668686|NCT03838731|364452197|FG000|Overall Study|Withdrawal of consent|1|||
105668687|NCT03838731|364452198|FG001|Overall Study|Withdrawal of consent|0|||
105668688|NCT01088984|364452203|FG000|Phase 1|Death|2|||
106124912|NCT02291289|366115813|FG007|Induction Treatment|Protocol Violation|0|||
106124913|NCT02291289|366115814|FG008|Induction Treatment|Protocol Violation|0|||
106124914|NCT02291289|366115815|FG009|Induction Treatment|Protocol Violation|2|||
106124915|NCT02291289|366115816|FG010|Induction Treatment|Protocol Violation|0|||
106124916|NCT02291289|366115817|FG011|Induction Treatment|Protocol Violation|0|||
106124917|NCT02291289|366115818|FG012|Induction Treatment|Protocol Violation|0|||
106124918|NCT02291289|366115806|FG000|Induction Treatment|Missing|4|||
106124919|NCT02291289|366115807|FG001|Induction Treatment|Missing|0|||
106124920|NCT02291289|366115808|FG002|Induction Treatment|Missing|0|||
106124921|NCT02291289|366115809|FG003|Induction Treatment|Missing|14|||
106124922|NCT02291289|366115810|FG004|Induction Treatment|Missing|0|||
106124923|NCT02291289|366115811|FG005|Induction Treatment|Missing|0|||
106124924|NCT02291289|366115812|FG006|Induction Treatment|Missing|0|||
106124925|NCT02291289|366115813|FG007|Induction Treatment|Missing|0|||
106124926|NCT02291289|366115814|FG008|Induction Treatment|Missing|0|||
106124927|NCT02291289|366115815|FG009|Induction Treatment|Missing|54|||
106124928|NCT02291289|366115816|FG010|Induction Treatment|Missing|0|||
106124929|NCT02291289|366115817|FG011|Induction Treatment|Missing|0|||
105668689|NCT01088984|364452204|FG001|Phase 1|Death|1|||
105668690|NCT01088984|364452203|FG000|Phase 1|Disease Progression|2|||
105668691|NCT01088984|364452204|FG001|Phase 1|Disease Progression|4|||
106124930|NCT02291289|366115818|FG012|Induction Treatment|Missing|0|||
106124931|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124932|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124933|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124934|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124935|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
106124936|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
106124937|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124938|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124939|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124940|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124941|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
105668692|NCT01088984|364452203|FG000|Phase 1|Other|1|||
105668693|NCT01088984|364452204|FG001|Phase 1|Other|1|||
105668694|NCT01088984|364452203|FG000|Phase 2|Death|0|||
105668695|NCT01088984|364452204|FG001|Phase 2|Death|5|||
105668696|NCT01088984|364452203|FG000|Phase 2|Withdrawal by Subject|0|||
105668697|NCT01088984|364452204|FG001|Phase 2|Withdrawal by Subject|1|||
105668698|NCT01088984|364452203|FG000|Phase 2|DIsease Progression|0|||
105668699|NCT01088984|364452204|FG001|Phase 2|DIsease Progression|25|||
105668700|NCT01088984|364452203|FG000|Phase 2|Other|0|||
105668701|NCT01088984|364452204|FG001|Phase 2|Other|1|||
105668702|NCT00699153|364452205|FG000|Overall Study|Lost to Follow-up|1|||
105668703|NCT00699153|364452206|FG001|Overall Study|Lost to Follow-up|0|||
105668704|NCT00699153|364452205|FG000|Overall Study|Adverse Event|0|||
105668705|NCT00699153|364452206|FG001|Overall Study|Adverse Event|2|||
105668706|NCT00699153|364452205|FG000|Overall Study|Protocol Violation|1|||
105668707|NCT00699153|364452206|FG001|Overall Study|Protocol Violation|0|||
105668708|NCT00699153|364452205|FG000|Overall Study|Travel Problem|1|||
105668709|NCT00699153|364452206|FG001|Overall Study|Travel Problem|0|||
105668710|NCT01228318|364452216|FG000|Overall Study|Clinic no show to receive intervention|1|||
105668711|NCT01228318|364452217|FG001|Overall Study|Clinic no show to receive intervention|0|||
105668712|NCT01228318|364452216|FG000|Overall Study|Unable to contact|2|||
105998024|NCT02807623|365654770|FG000|Overall Study|incomplete blood draw|0|||
106124942|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
106124943|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106124944|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Death|0|||
106124945|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Death|29|||
106124946|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Death|16|||
106124947|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Death|0|||
106124948|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Death|188|||
105668713|NCT01228318|364452217|FG001|Overall Study|Unable to contact|5|||
105668714|NCT01228318|364452216|FG000|Overall Study|Moved|0|||
105668715|NCT01228318|364452217|FG001|Overall Study|Moved|2|||
105668716|NCT01228318|364452216|FG000|Overall Study|Incarcerated|1|||
106124949|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Death|107|||
106124950|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Death|0|||
106124951|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Death|1|||
106124952|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Death|1|||
106124953|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Death|0|||
106124954|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Death|46|||
106124955|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Death|19|||
106124956|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Death|0|||
106124957|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Adverse Event|0|||
106124958|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Adverse Event|0|||
106124959|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Adverse Event|0|||
106124960|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Adverse Event|0|||
106124961|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Adverse Event|1|||
106124962|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Adverse Event|1|||
106124963|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Adverse Event|0|||
106124964|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Adverse Event|0|||
106124965|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Adverse Event|0|||
106124966|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Adverse Event|0|||
106124967|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Adverse Event|0|||
106124968|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Adverse Event|0|||
106124969|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Adverse Event|0|||
106124970|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
106124971|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
106124972|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
106124973|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
106124974|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
106124975|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
106124976|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
106124977|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
106124978|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
106124979|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
106124980|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
106124981|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
106124982|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
106124983|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
106124984|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
106124985|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
106124986|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
106124987|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
106124988|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
106124989|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
106124990|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
106124991|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
106124992|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
106124993|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
106124994|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
106124995|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
106124996|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Physician Decision|0|||
106124997|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Physician Decision|2|||
106124998|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Physician Decision|0|||
106124999|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Physician Decision|0|||
106125000|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Physician Decision|3|||
106125001|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Physician Decision|0|||
106125002|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Physician Decision|0|||
106125003|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Physician Decision|0|||
106125004|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Physician Decision|0|||
106125005|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Physician Decision|0|||
106125006|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Physician Decision|1|||
106125007|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Physician Decision|3|||
105998025|NCT02807623|365654771|FG001|Overall Study|incomplete blood draw|2|||
106125008|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Physician Decision|0|||
106125009|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Not Treated|0|||
106125010|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Not Treated|0|||
106125011|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Not Treated|2|||
106125012|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Not Treated|0|||
106125013|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Not Treated|0|||
106125014|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Not Treated|0|||
106125015|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Not Treated|0|||
106125016|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Not Treated|0|||
105998026|NCT02807623|365654772|FG002|Overall Study|incomplete blood draw|1|||
105901715|NCT01483599|365297990|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901716|NCT01483599|365297991|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901717|NCT01483599|365297992|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901718|NCT01483599|365297993|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901719|NCT01483599|365297994|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
105901720|NCT01483599|365297981|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
105901721|NCT01483599|365297982|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901722|NCT01483599|365297983|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901723|NCT01483599|365297984|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901724|NCT01483599|365297985|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901725|NCT01483599|365297986|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901726|NCT01483599|365297987|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901727|NCT01483599|365297988|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901728|NCT01483599|365297989|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901729|NCT01483599|365297990|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901730|NCT01483599|365297991|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901731|NCT01483599|365297992|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901732|NCT01483599|365297993|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901733|NCT01483599|365297994|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
105901734|NCT01483599|365297981|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
106125017|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Not Treated|0|||
106125018|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Not Treated|0|||
106125019|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Not Treated|0|||
106125020|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Not Treated|0|||
106125021|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Not Treated|0|||
105901735|NCT01483599|365297982|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
105901736|NCT01483599|365297983|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
105901737|NCT01483599|365297984|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
105901738|NCT01483599|365297985|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
106125022|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125023|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
106125024|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125025|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125026|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125027|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125028|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125029|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125030|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125031|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125032|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125033|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125034|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
106125035|NCT02291289|366115806|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
106125036|NCT02291289|366115807|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
106125037|NCT02291289|366115808|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
106125038|NCT02291289|366115809|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
106125039|NCT02291289|366115810|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
106125040|NCT02291289|366115811|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
106125041|NCT02291289|366115812|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
106125042|NCT02291289|366115813|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
106125043|NCT02291289|366115814|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
106125044|NCT02291289|366115815|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
106125045|NCT02291289|366115816|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
106125046|NCT02291289|366115817|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
106125047|NCT02291289|366115818|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
106125048|NCT02291289|366115806|FG000|Early Disease Progression|Death|0|||
106125049|NCT02291289|366115807|FG001|Early Disease Progression|Death|0|||
105998027|NCT00227721|365654773|FG000|Overall Study|On study, but never treated.|1|||
106125050|NCT02291289|366115808|FG002|Early Disease Progression|Death|0|||
106125051|NCT02291289|366115809|FG003|Early Disease Progression|Death|0|||
106125052|NCT02291289|366115810|FG004|Early Disease Progression|Death|0|||
106125053|NCT02291289|366115811|FG005|Early Disease Progression|Death|0|||
106125054|NCT02291289|366115812|FG006|Early Disease Progression|Death|0|||
106125055|NCT02291289|366115813|FG007|Early Disease Progression|Death|0|||
106125056|NCT02291289|366115814|FG008|Early Disease Progression|Death|0|||
106125057|NCT02291289|366115815|FG009|Early Disease Progression|Death|0|||
105998028|NCT00806988|365654780|FG000|Overall Study|Death|15|||
105998029|NCT00806988|365654781|FG001|Overall Study|Death|16|||
106125058|NCT02291289|366115816|FG010|Early Disease Progression|Death|0|||
106125059|NCT02291289|366115817|FG011|Early Disease Progression|Death|0|||
105901739|NCT01483599|365297986|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
105901740|NCT01483599|365297987|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
105901741|NCT01483599|365297988|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
105901742|NCT01483599|365297989|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
105901743|NCT01483599|365297990|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
105901744|NCT01483599|365297991|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
105901745|NCT01483599|365297992|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
105901746|NCT01483599|365297993|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
105901747|NCT01483599|365297994|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
105901748|NCT01483599|365297981|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
105901749|NCT01483599|365297982|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
105901750|NCT01483599|365297983|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
105901751|NCT01483599|365297984|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
105901752|NCT01483599|365297985|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
105901753|NCT01483599|365297986|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
105901754|NCT01483599|365297987|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
105901755|NCT01483599|365297988|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
105901756|NCT01483599|365297989|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
105901757|NCT01483599|365297990|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
105901758|NCT01483599|365297991|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
105901759|NCT01483599|365297992|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
105901760|NCT01483599|365297993|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
105901761|NCT01483599|365297994|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
105901762|NCT01483599|365297981|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901763|NCT01483599|365297982|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901764|NCT01483599|365297983|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901765|NCT01483599|365297984|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901766|NCT01483599|365297985|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901767|NCT01483599|365297986|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901768|NCT01483599|365297987|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901769|NCT01483599|365297988|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
105901770|NCT01483599|365297989|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
105901771|NCT01483599|365297990|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901772|NCT01483599|365297991|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901773|NCT01483599|365297992|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
105901774|NCT01483599|365297993|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
105668717|NCT01228318|364452217|FG001|Overall Study|Incarcerated|0|||
105668718|NCT00709228|364452220|FG000|Overall Study|Not treated|14|||
105668719|NCT00709228|364452220|FG000|Overall Study|Eligibility criteria not met|281|||
105668720|NCT00709228|364452220|FG000|Overall Study|Adverse events|2|||
105668721|NCT00709228|364452220|FG000|Overall Study|Discontinued treatment|14|||
105668722|NCT00709228|364452220|FG000|Overall Study|Did not enter follow-up|4|||
105668723|NCT00709228|364452220|FG000|Overall Study|Discontinued follow-up|5|||
105668724|NCT00709228|364452220|FG000|Overall Study|Disease progression|1|||
105901775|NCT01483599|365297994|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
105901776|NCT01483599|365297981|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901777|NCT01483599|365297982|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901778|NCT01483599|365297983|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901779|NCT01483599|365297984|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901780|NCT01483599|365297985|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901781|NCT01483599|365297986|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901782|NCT01483599|365297987|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901783|NCT01483599|365297988|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901784|NCT01483599|365297989|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
105901785|NCT01483599|365297990|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105901786|NCT01483599|365297991|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
106125060|NCT02291289|366115818|FG012|Early Disease Progression|Death|10|||
105668725|NCT00709228|364452220|FG000|Overall Study|Lost to Follow-up|6|||
105668726|NCT00709228|364452220|FG000|Overall Study|Non-compliance|5|||
105668727|NCT01174446|364452221|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
105901787|NCT01483599|365297992|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
105901788|NCT01483599|365297993|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
105668728|NCT01174446|364452222|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
105668729|NCT01174446|364452223|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
105668730|NCT01174446|364452224|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
105668731|NCT01174446|364452221|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
105668732|NCT01174446|364452222|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
105901789|NCT01483599|365297994|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
105901790|NCT01483599|365297981|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901791|NCT01483599|365297982|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901792|NCT01483599|365297983|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901793|NCT01483599|365297984|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901794|NCT01483599|365297985|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901795|NCT01483599|365297986|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901796|NCT01483599|365297987|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901797|NCT01483599|365297988|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901798|NCT01483599|365297989|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
105901799|NCT01483599|365297990|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901800|NCT01483599|365297991|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
105901801|NCT01483599|365297992|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901802|NCT01483599|365297993|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
105901803|NCT01483599|365297994|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
105901804|NCT01483599|365297981|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901805|NCT01483599|365297982|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901806|NCT01483599|365297983|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901807|NCT01483599|365297984|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901808|NCT01483599|365297985|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901809|NCT01483599|365297986|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901810|NCT01483599|365297987|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901811|NCT01483599|365297988|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901812|NCT01483599|365297989|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
105901813|NCT01483599|365297990|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901814|NCT01483599|365297991|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901815|NCT01483599|365297992|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
105901816|NCT01483599|365297993|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
105901817|NCT01483599|365297994|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
105901818|NCT01483599|365297981|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
105901819|NCT01483599|365297982|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
105901820|NCT01483599|365297983|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
105901821|NCT01483599|365297984|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
105901822|NCT01483599|365297985|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
105901823|NCT01483599|365297986|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
105901824|NCT01483599|365297987|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
105901825|NCT01483599|365297988|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
105901826|NCT01483599|365297989|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
105901827|NCT01483599|365297990|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
105901828|NCT01483599|365297991|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
105901829|NCT01483599|365297992|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
105901830|NCT01483599|365297993|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
105901831|NCT01483599|365297994|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
105901832|NCT02552888|365297995|FG000|Overall Study|Lost to Follow-up|1|||
105901833|NCT02552888|365297996|FG001|Overall Study|Lost to Follow-up|1|||
105901834|NCT02227368|365299795|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
105901835|NCT02227368|365299796|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
105901836|NCT02227368|365299795|FG000|Overall Study|Lost to Follow-up|1|||
105901837|NCT02227368|365299796|FG001|Overall Study|Lost to Follow-up|0|||
105901838|NCT02227368|365299795|FG000|Overall Study|Adverse Event|1|||
105901839|NCT02227368|365299796|FG001|Overall Study|Adverse Event|0|||
105901840|NCT01687283|365299800|FG000|Overall Study|Adverse Event|11|||
105901841|NCT01687283|365299801|FG001|Overall Study|Adverse Event|4|||
105901842|NCT01687283|365299800|FG000|Overall Study|Lack of Efficacy|3|||
105901843|NCT01687283|365299801|FG001|Overall Study|Lack of Efficacy|1|||
105901844|NCT01687283|365299800|FG000|Overall Study|Protocol Violation|1|||
105901845|NCT01687283|365299801|FG001|Overall Study|Protocol Violation|3|||
105901846|NCT01687283|365299800|FG000|Overall Study|protocol defined stopping criteria|8|||
105901847|NCT01687283|365299801|FG001|Overall Study|protocol defined stopping criteria|10|||
105901848|NCT01687283|365299800|FG000|Overall Study|Lost to Follow-up|1|||
105901849|NCT01687283|365299801|FG001|Overall Study|Lost to Follow-up|1|||
105901850|NCT01687283|365299800|FG000|Overall Study|Investigator discretion|2|||
105901851|NCT01687283|365299801|FG001|Overall Study|Investigator discretion|0|||
105998030|NCT00806988|365654780|FG000|Overall Study|Withdrawal by Subject|8|||
105998031|NCT00806988|365654781|FG001|Overall Study|Withdrawal by Subject|8|||
105998032|NCT00806988|365654780|FG000|Overall Study|Lost to Follow-up|4|||
105998033|NCT00806988|365654781|FG001|Overall Study|Lost to Follow-up|19|||
105998034|NCT01389882|365654790|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
105998035|NCT01389882|365654791|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
105998036|NCT01389882|365654790|FG000|Overall Study|Withdrawal by Subject|0|||
105998037|NCT01389882|365654791|FG001|Overall Study|Withdrawal by Subject|1|||
105668733|NCT01174446|364452223|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
105668734|NCT01174446|364452224|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
105668735|NCT01174446|364452221|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
105668736|NCT01174446|364452222|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
105668737|NCT01174446|364452223|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
105668738|NCT01174446|364452224|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
105668739|NCT01174446|364452221|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
105668740|NCT01174446|364452222|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
105668741|NCT01174446|364452223|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
105668742|NCT01174446|364452224|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
105668743|NCT00847626|364452227|FG000|Overall Study|Adverse Event|10|||
105668744|NCT00847626|364452228|FG001|Overall Study|Adverse Event|10|||
105668745|NCT00847626|364452229|FG002|Overall Study|Adverse Event|6|||
105668746|NCT00847626|364452230|FG003|Overall Study|Adverse Event|19|||
105668747|NCT00847626|364452231|FG004|Overall Study|Adverse Event|11|||
105668748|NCT00847626|364452232|FG005|Overall Study|Adverse Event|22|||
105668749|NCT00847626|364452233|FG006|Overall Study|Adverse Event|4|||
105668750|NCT00847626|364452234|FG007|Overall Study|Adverse Event|6|||
105668751|NCT00847626|364452235|FG008|Overall Study|Adverse Event|3|||
105668752|NCT00847626|364452236|FG009|Overall Study|Adverse Event|6|||
105668753|NCT00847626|364452237|FG010|Overall Study|Adverse Event|6|||
105668754|NCT00847626|364452227|FG000|Overall Study|Protocol Violation|2|||
105668755|NCT00847626|364452228|FG001|Overall Study|Protocol Violation|1|||
105668756|NCT00847626|364452229|FG002|Overall Study|Protocol Violation|2|||
105668757|NCT00847626|364452230|FG003|Overall Study|Protocol Violation|1|||
105668758|NCT00847626|364452231|FG004|Overall Study|Protocol Violation|1|||
105668759|NCT00847626|364452232|FG005|Overall Study|Protocol Violation|1|||
105668760|NCT00847626|364452233|FG006|Overall Study|Protocol Violation|1|||
105668761|NCT00847626|364452234|FG007|Overall Study|Protocol Violation|1|||
105668762|NCT00847626|364452235|FG008|Overall Study|Protocol Violation|0|||
105668763|NCT00847626|364452236|FG009|Overall Study|Protocol Violation|1|||
105668764|NCT00847626|364452237|FG010|Overall Study|Protocol Violation|1|||
105668765|NCT00847626|364452227|FG000|Overall Study|Lost to Follow-up|0|||
105668766|NCT00847626|364452228|FG001|Overall Study|Lost to Follow-up|1|||
105668767|NCT00847626|364452229|FG002|Overall Study|Lost to Follow-up|1|||
105668768|NCT00847626|364452230|FG003|Overall Study|Lost to Follow-up|1|||
105668769|NCT00847626|364452231|FG004|Overall Study|Lost to Follow-up|0|||
105668770|NCT00847626|364452232|FG005|Overall Study|Lost to Follow-up|3|||
105668771|NCT00847626|364452233|FG006|Overall Study|Lost to Follow-up|1|||
105668772|NCT00847626|364452234|FG007|Overall Study|Lost to Follow-up|3|||
105668773|NCT00847626|364452235|FG008|Overall Study|Lost to Follow-up|1|||
105668774|NCT00847626|364452236|FG009|Overall Study|Lost to Follow-up|0|||
105668775|NCT00847626|364452237|FG010|Overall Study|Lost to Follow-up|1|||
105668776|NCT00847626|364452227|FG000|Overall Study|Withdrawal by Subject|5|||
105668777|NCT00847626|364452228|FG001|Overall Study|Withdrawal by Subject|5|||
105668778|NCT00847626|364452229|FG002|Overall Study|Withdrawal by Subject|3|||
105668779|NCT00847626|364452230|FG003|Overall Study|Withdrawal by Subject|8|||
105668780|NCT00847626|364452231|FG004|Overall Study|Withdrawal by Subject|12|||
105668781|NCT00847626|364452232|FG005|Overall Study|Withdrawal by Subject|9|||
105668782|NCT00847626|364452233|FG006|Overall Study|Withdrawal by Subject|8|||
105668783|NCT00847626|364452234|FG007|Overall Study|Withdrawal by Subject|4|||
105668784|NCT00847626|364452235|FG008|Overall Study|Withdrawal by Subject|4|||
105668785|NCT00847626|364452236|FG009|Overall Study|Withdrawal by Subject|5|||
105668786|NCT00847626|364452237|FG010|Overall Study|Withdrawal by Subject|2|||
105668787|NCT00847626|364452227|FG000|Overall Study|Lack of Efficacy|3|||
105668788|NCT00847626|364452228|FG001|Overall Study|Lack of Efficacy|1|||
105668789|NCT00847626|364452229|FG002|Overall Study|Lack of Efficacy|0|||
105668790|NCT00847626|364452230|FG003|Overall Study|Lack of Efficacy|1|||
105668791|NCT00847626|364452231|FG004|Overall Study|Lack of Efficacy|2|||
105668792|NCT00847626|364452232|FG005|Overall Study|Lack of Efficacy|0|||
105668793|NCT00847626|364452233|FG006|Overall Study|Lack of Efficacy|6|||
105668794|NCT00847626|364452234|FG007|Overall Study|Lack of Efficacy|2|||
105668795|NCT00847626|364452235|FG008|Overall Study|Lack of Efficacy|5|||
105668796|NCT00847626|364452236|FG009|Overall Study|Lack of Efficacy|1|||
105668797|NCT00847626|364452237|FG010|Overall Study|Lack of Efficacy|7|||
105668798|NCT00847626|364452227|FG000|Overall Study|Other|1|||
105668799|NCT00847626|364452228|FG001|Overall Study|Other|5|||
105998038|NCT01402817|365654792|FG000|Overall Study|Withdrawal by Subject|3|||
105998039|NCT01402817|365654792|FG000|Overall Study|Study Suspended by FDA|8|||
105901852|NCT01687283|365299800|FG000|Overall Study|Withdrawal by Subject|9|||
105901853|NCT01687283|365299801|FG001|Overall Study|Withdrawal by Subject|8|||
105901854|NCT02913105|365299802|FG000|Overall Study|Adverse Event|11|||
105901855|NCT02913105|365299803|FG001|Overall Study|Adverse Event|0|||
105901856|NCT02913105|365299804|FG002|Overall Study|Adverse Event|4|||
105901857|NCT02913105|365299802|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105901858|NCT02913105|365299803|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105901859|NCT02913105|365299804|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105901860|NCT02913105|365299802|FG000|Overall Study|Reason Not Specified|3|||
105901861|NCT02913105|365299803|FG001|Overall Study|Reason Not Specified|1|||
105901862|NCT02913105|365299804|FG002|Overall Study|Reason Not Specified|1|||
105901863|NCT02913105|365299802|FG000|Overall Study|Physician Decision|1|||
105901864|NCT02913105|365299803|FG001|Overall Study|Physician Decision|1|||
105901865|NCT02913105|365299804|FG002|Overall Study|Physician Decision|0|||
105901866|NCT02913105|365299802|FG000|Overall Study|Withdrawal by Subject|0|||
105901867|NCT02913105|365299803|FG001|Overall Study|Withdrawal by Subject|3|||
105901868|NCT02913105|365299804|FG002|Overall Study|Withdrawal by Subject|1|||
105901869|NCT01421147|365299806|FG000|Treatment Period|Adverse Event|2|||
105901870|NCT01421147|365299807|FG001|Treatment Period|Adverse Event|3|||
105901871|NCT01421147|365299806|FG000|Treatment Period|Lost to Follow-up|2|||
105901872|NCT01421147|365299807|FG001|Treatment Period|Lost to Follow-up|1|||
105901873|NCT01421147|365299806|FG000|Treatment Period|Physician Decision|2|||
105901874|NCT01421147|365299807|FG001|Treatment Period|Physician Decision|2|||
105901875|NCT01421147|365299806|FG000|Treatment Period|Withdrawal by Subject|10|||
105901876|NCT01421147|365299807|FG001|Treatment Period|Withdrawal by Subject|5|||
105901877|NCT01421147|365299806|FG000|Extension Period|Adverse Event|0|||
105901878|NCT01421147|365299807|FG001|Extension Period|Adverse Event|2|||
105901879|NCT01421147|365299806|FG000|Extension Period|Death|0|||
105901880|NCT01421147|365299807|FG001|Extension Period|Death|1|||
105901881|NCT01421147|365299806|FG000|Extension Period|Lost to Follow-up|2|||
105901882|NCT01421147|365299807|FG001|Extension Period|Lost to Follow-up|5|||
105901883|NCT01421147|365299806|FG000|Extension Period|Physician Decision|1|||
105901884|NCT01421147|365299807|FG001|Extension Period|Physician Decision|0|||
105901885|NCT01421147|365299806|FG000|Extension Period|Withdrawal by Subject|5|||
105901886|NCT01421147|365299807|FG001|Extension Period|Withdrawal by Subject|3|||
105901887|NCT04228965|365299814|FG000|Overall Study|Lost to Follow-up|26|||
105901888|NCT04228965|365299815|FG001|Overall Study|Lost to Follow-up|11|||
105901889|NCT04228965|365299814|FG000|Overall Study|Withdrawal by Subject|18|||
105901890|NCT04228965|365299815|FG001|Overall Study|Withdrawal by Subject|5|||
105901891|NCT02190721|365299816|FG000|Overall Study|Patient was out of the city|0|||
105901892|NCT02190721|365299817|FG001|Overall Study|Patient was out of the city|1|||
105901893|NCT02190721|365299818|FG002|Overall Study|Patient was out of the city|0|||
105901894|NCT02263729|365299820|FG000|Overall Study|Lost to Follow-up|1|||
105901895|NCT02263729|365299821|FG001|Overall Study|Lost to Follow-up|1|||
105901896|NCT01212159|365299822|FG000|Overall Study|Withdrawal by Subject|12|||
105901897|NCT01212159|365299823|FG001|Overall Study|Withdrawal by Subject|12|||
105901898|NCT01306214|365299824|FG000|Overall Study|Death|0|||
105901899|NCT01306214|365299825|FG001|Overall Study|Death|0|||
105901900|NCT01306214|365299826|FG002|Overall Study|Death|1|||
105901901|NCT01306214|365299824|FG000|Overall Study|Lost to Follow-up|3|||
105901902|NCT01306214|365299825|FG001|Overall Study|Lost to Follow-up|5|||
105901903|NCT01306214|365299826|FG002|Overall Study|Lost to Follow-up|4|||
105901904|NCT01306214|365299824|FG000|Overall Study|Withdrawal by Subject|24|||
105901905|NCT01306214|365299825|FG001|Overall Study|Withdrawal by Subject|22|||
105901906|NCT01306214|365299826|FG002|Overall Study|Withdrawal by Subject|16|||
105901907|NCT01306214|365299824|FG000|Overall Study|Not treated|1|||
105901908|NCT01306214|365299825|FG001|Overall Study|Not treated|1|||
105901909|NCT01306214|365299826|FG002|Overall Study|Not treated|1|||
105901910|NCT01928199|365299827|FG000|Overall Study|Lost to Follow-up|2|||
105901911|NCT01928199|365299828|FG001|Overall Study|Lost to Follow-up|1|||
105901912|NCT01928199|365299827|FG000|Overall Study|Withdrawal by Subject|3|||
105901913|NCT01928199|365299828|FG001|Overall Study|Withdrawal by Subject|5|||
106125061|NCT02291289|366115806|FG000|Early Disease Progression|Lost to Follow-up|0|||
105786016|NCT00596466|364870443|FG000|Overall Study|Enrolled, not treated|2|||
105901914|NCT01502956|365299830|FG000|Overall Study|Death|0|||
105901915|NCT01502956|365299831|FG001|Overall Study|Death|2|||
105901916|NCT01502956|365299830|FG000|Overall Study|Lost to Follow-up|14|||
105901917|NCT01502956|365299831|FG001|Overall Study|Lost to Follow-up|11|||
105901918|NCT01502956|365299830|FG000|Overall Study|Physician Decision|2|||
105901919|NCT01502956|365299831|FG001|Overall Study|Physician Decision|3|||
105901920|NCT01502956|365299830|FG000|Overall Study|Withdrawal by Subject|8|||
105901921|NCT01502956|365299831|FG001|Overall Study|Withdrawal by Subject|10|||
105901922|NCT03959488|365299832|FG000|Season 1|Other|6|||
105901923|NCT03959488|365299833|FG001|Season 1|Other|7|||
105901924|NCT03959488|365299834|FG002|Season 1|Other|0|||
105901925|NCT03959488|365299835|FG003|Season 1|Other|0|||
105901926|NCT03959488|365299836|FG004|Season 1|Other|0|||
105901927|NCT03959488|365299832|FG000|Season 1|Withdrawal by parent/guardian|43|||
105901928|NCT03959488|365299833|FG001|Season 1|Withdrawal by parent/guardian|28|||
105901929|NCT03959488|365299834|FG002|Season 1|Withdrawal by parent/guardian|0|||
105901930|NCT03959488|365299835|FG003|Season 1|Withdrawal by parent/guardian|0|||
105901931|NCT03959488|365299836|FG004|Season 1|Withdrawal by parent/guardian|0|||
105901932|NCT03959488|365299832|FG000|Season 1|Due to COVID-19 pandemic|2|||
105901933|NCT03959488|365299833|FG001|Season 1|Due to COVID-19 pandemic|3|||
105901934|NCT03959488|365299834|FG002|Season 1|Due to COVID-19 pandemic|0|||
105901935|NCT03959488|365299835|FG003|Season 1|Due to COVID-19 pandemic|0|||
105901936|NCT03959488|365299836|FG004|Season 1|Due to COVID-19 pandemic|0|||
105901937|NCT03959488|365299832|FG000|Season 1|Lost to Follow-up|17|||
105901938|NCT03959488|365299833|FG001|Season 1|Lost to Follow-up|7|||
105901939|NCT03959488|365299834|FG002|Season 1|Lost to Follow-up|0|||
105901940|NCT03959488|365299835|FG003|Season 1|Lost to Follow-up|0|||
105901941|NCT03959488|365299836|FG004|Season 1|Lost to Follow-up|0|||
105901942|NCT03959488|365299832|FG000|Season 1|Death|5|||
105901943|NCT03959488|365299833|FG001|Season 1|Death|1|||
105901944|NCT03959488|365299834|FG002|Season 1|Death|0|||
105901945|NCT03959488|365299835|FG003|Season 1|Death|0|||
105901946|NCT03959488|365299836|FG004|Season 1|Death|0|||
105901947|NCT03959488|365299832|FG000|Season 2|Other|0|||
105901948|NCT03959488|365299833|FG001|Season 2|Other|0|||
105901949|NCT03959488|365299834|FG002|Season 2|Other|2|||
105901950|NCT03959488|365299835|FG003|Season 2|Other|0|||
105901951|NCT03959488|365299836|FG004|Season 2|Other|0|||
105901952|NCT03959488|365299832|FG000|Season 2|Withdrawal by parent/guardian|0|||
105901953|NCT03959488|365299833|FG001|Season 2|Withdrawal by parent/guardian|0|||
105901954|NCT03959488|365299834|FG002|Season 2|Withdrawal by parent/guardian|3|||
105901955|NCT03959488|365299835|FG003|Season 2|Withdrawal by parent/guardian|1|||
105998040|NCT02223715|365654804|FG000|Overall Study|Death|31|||
105998041|NCT02223715|365654804|FG000|Overall Study|Lost to Follow-up|73|||
105998042|NCT03956550|365654805|FG000|Overall Study|Sponsor decision|65|||
105998043|NCT03956550|365654806|FG001|Overall Study|Sponsor decision|66|||
105998044|NCT03956550|365654807|FG002|Overall Study|Sponsor decision|64|||
105998045|NCT03956550|365654805|FG000|Overall Study|Adverse Event|0|||
105998046|NCT03956550|365654806|FG001|Overall Study|Adverse Event|1|||
105998047|NCT03956550|365654807|FG002|Overall Study|Adverse Event|0|||
105998048|NCT03956550|365654805|FG000|Overall Study|Withdrawal by Subject|5|||
105998049|NCT03956550|365654806|FG001|Overall Study|Withdrawal by Subject|5|||
105998050|NCT03956550|365654807|FG002|Overall Study|Withdrawal by Subject|6|||
105998051|NCT00824473|365654812|FG000|Overall Study|Adverse Event|4|||
105998052|NCT00824473|365654813|FG001|Overall Study|Adverse Event|5|||
105998053|NCT00824473|365654812|FG000|Overall Study|Lack of Efficacy|2|||
105998054|NCT00824473|365654813|FG001|Overall Study|Lack of Efficacy|2|||
105998055|NCT00824473|365654812|FG000|Overall Study|Protocol Violation|2|||
105998056|NCT00824473|365654813|FG001|Overall Study|Protocol Violation|0|||
105998057|NCT00824473|365654812|FG000|Overall Study|Non-Compliance|4|||
105998058|NCT00824473|365654813|FG001|Overall Study|Non-Compliance|2|||
105998059|NCT00824473|365654812|FG000|Overall Study|Withdrawal by Subject|2|||
105998060|NCT00824473|365654813|FG001|Overall Study|Withdrawal by Subject|3|||
105998061|NCT00824473|365654812|FG000|Overall Study|Other|1|||
105998062|NCT00824473|365654813|FG001|Overall Study|Other|1|||
105998063|NCT00466440|365654818|FG000|Overall Study|Adverse Event|0|||
105998064|NCT00466440|365654819|FG001|Overall Study|Adverse Event|3|||
105998065|NCT00466440|365654820|FG002|Overall Study|Adverse Event|1|||
105998066|NCT00466440|365654818|FG000|Overall Study|Death|1|||
105998067|NCT00466440|365654819|FG001|Overall Study|Death|1|||
105998068|NCT00466440|365654820|FG002|Overall Study|Death|0|||
105998069|NCT00466440|365654818|FG000|Overall Study|Progressive disease|13|||
105998070|NCT00466440|365654819|FG001|Overall Study|Progressive disease|5|||
105998071|NCT00466440|365654820|FG002|Overall Study|Progressive disease|4|||
105998072|NCT00466440|365654818|FG000|Overall Study|Lost to Follow-up|0|||
105998073|NCT00466440|365654819|FG001|Overall Study|Lost to Follow-up|1|||
105998074|NCT00466440|365654820|FG002|Overall Study|Lost to Follow-up|0|||
105901956|NCT03959488|365299836|FG004|Season 2|Withdrawal by parent/guardian|1|||
105998075|NCT00466440|365654818|FG000|Overall Study|Physician Decision|0|||
105998076|NCT00466440|365654819|FG001|Overall Study|Physician Decision|1|||
105998077|NCT00466440|365654820|FG002|Overall Study|Physician Decision|2|||
105998078|NCT00466440|365654818|FG000|Overall Study|Protocol entry criteria not met|0|||
105998079|NCT00466440|365654819|FG001|Overall Study|Protocol entry criteria not met|0|||
105998080|NCT00466440|365654820|FG002|Overall Study|Protocol entry criteria not met|4|||
105998081|NCT00466440|365654818|FG000|Overall Study|Withdrawal by Subject|0|||
105901957|NCT03959488|365299832|FG000|Season 2|Lost to Follow-up|0|||
105901958|NCT03959488|365299833|FG001|Season 2|Lost to Follow-up|0|||
105998082|NCT00466440|365654819|FG001|Overall Study|Withdrawal by Subject|1|||
105901959|NCT03959488|365299834|FG002|Season 2|Lost to Follow-up|1|||
105998083|NCT00466440|365654820|FG002|Overall Study|Withdrawal by Subject|0|||
105998084|NCT00466440|365654818|FG000|Overall Study|Sponsor decision|0|||
105998085|NCT00466440|365654819|FG001|Overall Study|Sponsor decision|0|||
105998086|NCT00466440|365654820|FG002|Overall Study|Sponsor decision|1|||
105998087|NCT03191630|365654823|FG000|Overall Study|Lost to Follow-up|7|||
105901960|NCT03959488|365299835|FG003|Season 2|Lost to Follow-up|0|||
105901961|NCT03959488|365299836|FG004|Season 2|Lost to Follow-up|1|||
105998088|NCT03191630|365654824|FG001|Overall Study|Lost to Follow-up|7|||
105901962|NCT01026818|365299837|FG000|Screening Period|Entry Criteria Not Met|105|||
105901963|NCT01026818|365299838|FG001|Screening Period|Entry Criteria Not Met|0|||
105901964|NCT01026818|365299839|FG002|Screening Period|Entry Criteria Not Met|0|||
105901965|NCT01026818|365299840|FG003|Screening Period|Entry Criteria Not Met|0|||
105901966|NCT01026818|365299837|FG000|Screening Period|Withdrawal by Subject|49|||
105901967|NCT01026818|365299838|FG001|Screening Period|Withdrawal by Subject|0|||
105901968|NCT01026818|365299839|FG002|Screening Period|Withdrawal by Subject|0|||
105668800|NCT00847626|364452229|FG002|Overall Study|Other|4|||
105901969|NCT01026818|365299840|FG003|Screening Period|Withdrawal by Subject|0|||
105901970|NCT01026818|365299837|FG000|Screening Period|Protocol Deviation|3|||
105901971|NCT01026818|365299838|FG001|Screening Period|Protocol Deviation|0|||
105901972|NCT01026818|365299839|FG002|Screening Period|Protocol Deviation|0|||
105901973|NCT01026818|365299840|FG003|Screening Period|Protocol Deviation|0|||
105901974|NCT01026818|365299837|FG000|Screening Period|Adverse Event|2|||
105901975|NCT01026818|365299838|FG001|Screening Period|Adverse Event|0|||
105901976|NCT01026818|365299839|FG002|Screening Period|Adverse Event|0|||
105901977|NCT01026818|365299840|FG003|Screening Period|Adverse Event|0|||
105901978|NCT01026818|365299837|FG000|Screening Period|Physician Decision|1|||
105901979|NCT01026818|365299838|FG001|Screening Period|Physician Decision|0|||
105901980|NCT01026818|365299839|FG002|Screening Period|Physician Decision|0|||
105901981|NCT01026818|365299840|FG003|Screening Period|Physician Decision|0|||
105901982|NCT01026818|365299837|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
105901983|NCT01026818|365299838|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
105901984|NCT01026818|365299839|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
105901985|NCT01026818|365299840|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
105901986|NCT01026818|365299837|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
105901987|NCT01026818|365299838|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
105901988|NCT01026818|365299839|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
105901989|NCT01026818|365299840|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
105901990|NCT01026818|365299837|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
105901991|NCT01026818|365299838|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
105901992|NCT01026818|365299839|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
105901993|NCT01026818|365299840|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
105901994|NCT01026818|365299837|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
105901995|NCT01026818|365299838|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
105901996|NCT01026818|365299839|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
105901997|NCT01026818|365299840|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
105901998|NCT01026818|365299837|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
105901999|NCT01026818|365299838|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
105902000|NCT01026818|365299839|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
105902001|NCT01026818|365299840|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
105902002|NCT01026818|365299837|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
105902003|NCT01026818|365299838|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
105668801|NCT00847626|364452230|FG003|Overall Study|Other|1|||
105668802|NCT00847626|364452231|FG004|Overall Study|Other|2|||
105668803|NCT00847626|364452232|FG005|Overall Study|Other|2|||
105668804|NCT00847626|364452233|FG006|Overall Study|Other|2|||
105668805|NCT00847626|364452234|FG007|Overall Study|Other|3|||
105668806|NCT00847626|364452235|FG008|Overall Study|Other|1|||
105668807|NCT00847626|364452236|FG009|Overall Study|Other|1|||
105668808|NCT00847626|364452237|FG010|Overall Study|Other|3|||
105668809|NCT03057847|364452238|FG000|Overall Study|Lost to Follow-up|16|||
105668810|NCT00731133|364452241|FG000|Overall Study|Withdrawal by Subject|10|||
105668811|NCT02493062|364452242|FG000|Overall Study|Physician Decision|12|||
105668812|NCT01681992|364452249|FG000|Overall Study|Adverse Event|3|||
105668813|NCT01681992|364452250|FG001|Overall Study|Adverse Event|2|||
105668814|NCT01681992|364452251|FG002|Overall Study|Adverse Event|3|||
105668815|NCT01681992|364452249|FG000|Overall Study|Lost to Follow-up|36|||
105668816|NCT01681992|364452250|FG001|Overall Study|Lost to Follow-up|38|||
105668817|NCT01681992|364452251|FG002|Overall Study|Lost to Follow-up|53|||
105668818|NCT01681992|364452249|FG000|Overall Study|As Per Sponsor Decision|0|||
105668819|NCT01681992|364452250|FG001|Overall Study|As Per Sponsor Decision|0|||
105668820|NCT01681992|364452251|FG002|Overall Study|As Per Sponsor Decision|1|||
105668821|NCT01681992|364452249|FG000|Overall Study|Protocol Violation|0|||
105668822|NCT01681992|364452250|FG001|Overall Study|Protocol Violation|0|||
105668823|NCT01681992|364452251|FG002|Overall Study|Protocol Violation|1|||
105668824|NCT01681992|364452249|FG000|Overall Study|Withdrawal by Subject|27|||
105668825|NCT01681992|364452250|FG001|Overall Study|Withdrawal by Subject|30|||
105668826|NCT01681992|364452251|FG002|Overall Study|Withdrawal by Subject|25|||
105668827|NCT01327612|364452252|FG000|Overall Study|Withdrawal by Subject|0|||
105668828|NCT01327612|364452253|FG001|Overall Study|Withdrawal by Subject|0|||
105668829|NCT01327612|364452254|FG002|Overall Study|Withdrawal by Subject|0|||
105902004|NCT01026818|365299839|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
105902005|NCT01026818|365299840|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
105902006|NCT01026818|365299837|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
105902007|NCT01026818|365299838|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
105902008|NCT01026818|365299839|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
105902009|NCT01026818|365299840|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
105902010|NCT01026818|365299837|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
105902011|NCT01026818|365299838|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
105902012|NCT01026818|365299839|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
105902013|NCT01026818|365299840|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
105902014|NCT01026818|365299837|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
105902015|NCT01026818|365299838|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
105902016|NCT01026818|365299839|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
105902017|NCT01026818|365299840|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
105902018|NCT01026818|365299837|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
105902019|NCT01026818|365299838|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
105902020|NCT01026818|365299839|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
105902021|NCT01026818|365299840|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
105902022|NCT01026818|365299837|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
105902023|NCT01026818|365299838|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
105902024|NCT01026818|365299839|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
105902025|NCT01026818|365299840|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
105902026|NCT01026818|365299837|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
105902027|NCT01026818|365299838|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
105902028|NCT01026818|365299839|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
105902029|NCT01026818|365299840|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
105902030|NCT01026818|365299837|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
105902031|NCT01026818|365299838|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
105902032|NCT01026818|365299839|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
105902033|NCT01026818|365299840|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
105902034|NCT01026818|365299837|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
105902035|NCT01026818|365299838|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
105668830|NCT01327612|364452255|FG003|Overall Study|Withdrawal by Subject|0|||
105902036|NCT01026818|365299839|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
105902037|NCT01026818|365299840|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
105902038|NCT01026818|365299837|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
105668831|NCT01327612|364452256|FG004|Overall Study|Withdrawal by Subject|0|||
105668832|NCT01327612|364452257|FG005|Overall Study|Withdrawal by Subject|1|||
105668833|NCT01327612|364452258|FG006|Overall Study|Withdrawal by Subject|0|||
105668834|NCT01327612|364452252|FG000|Overall Study|Disease Progression|1|||
105668835|NCT01327612|364452253|FG001|Overall Study|Disease Progression|1|||
105668836|NCT01327612|364452254|FG002|Overall Study|Disease Progression|1|||
105668837|NCT01327612|364452255|FG003|Overall Study|Disease Progression|0|||
105668838|NCT01327612|364452256|FG004|Overall Study|Disease Progression|1|||
105668839|NCT01327612|364452257|FG005|Overall Study|Disease Progression|2|||
105668840|NCT01327612|364452258|FG006|Overall Study|Disease Progression|2|||
105668841|NCT01327612|364452252|FG000|Overall Study|Administrative Decision|0|||
105668842|NCT01327612|364452253|FG001|Overall Study|Administrative Decision|0|||
105668843|NCT01327612|364452254|FG002|Overall Study|Administrative Decision|0|||
105668844|NCT01327612|364452255|FG003|Overall Study|Administrative Decision|1|||
105668845|NCT01327612|364452256|FG004|Overall Study|Administrative Decision|0|||
105668846|NCT01327612|364452257|FG005|Overall Study|Administrative Decision|0|||
105668847|NCT01327612|364452258|FG006|Overall Study|Administrative Decision|0|||
105668848|NCT01327612|364452252|FG000|Overall Study|Death|0|||
105668849|NCT01327612|364452253|FG001|Overall Study|Death|0|||
105668850|NCT01327612|364452254|FG002|Overall Study|Death|0|||
105902039|NCT01026818|365299838|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
105902040|NCT01026818|365299839|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
105902041|NCT01026818|365299840|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
106125062|NCT02291289|366115807|FG001|Early Disease Progression|Lost to Follow-up|0|||
106125063|NCT02291289|366115808|FG002|Early Disease Progression|Lost to Follow-up|0|||
106125064|NCT02291289|366115809|FG003|Early Disease Progression|Lost to Follow-up|0|||
106125065|NCT02291289|366115810|FG004|Early Disease Progression|Lost to Follow-up|0|||
106125066|NCT02291289|366115811|FG005|Early Disease Progression|Lost to Follow-up|0|||
106125067|NCT02291289|366115812|FG006|Early Disease Progression|Lost to Follow-up|0|||
106125068|NCT02291289|366115813|FG007|Early Disease Progression|Lost to Follow-up|0|||
106125069|NCT02291289|366115814|FG008|Early Disease Progression|Lost to Follow-up|0|||
106125070|NCT02291289|366115815|FG009|Early Disease Progression|Lost to Follow-up|0|||
106125071|NCT02291289|366115816|FG010|Early Disease Progression|Lost to Follow-up|0|||
106125072|NCT02291289|366115817|FG011|Early Disease Progression|Lost to Follow-up|0|||
106125073|NCT02291289|366115818|FG012|Early Disease Progression|Lost to Follow-up|1|||
106125074|NCT03699124|366115819|FG000|Overall Study|Adverse Event|6|||
106125075|NCT03699124|366115820|FG001|Overall Study|Adverse Event|5|||
106125076|NCT03699124|366115821|FG002|Overall Study|Adverse Event|2|||
106125077|NCT03699124|366115819|FG000|Overall Study|Death|0|||
106125078|NCT03699124|366115820|FG001|Overall Study|Death|2|||
106125079|NCT03699124|366115821|FG002|Overall Study|Death|0|||
106125080|NCT03699124|366115819|FG000|Overall Study|Lost to Follow-up|20|||
106125081|NCT03699124|366115820|FG001|Overall Study|Lost to Follow-up|16|||
106125082|NCT03699124|366115821|FG002|Overall Study|Lost to Follow-up|15|||
106125083|NCT03699124|366115819|FG000|Overall Study|Protocol Violation|1|||
106125084|NCT03699124|366115820|FG001|Overall Study|Protocol Violation|0|||
106125085|NCT03699124|366115821|FG002|Overall Study|Protocol Violation|0|||
106125086|NCT03699124|366115819|FG000|Overall Study|Withdrawal by Subject|13|||
106125087|NCT03699124|366115820|FG001|Overall Study|Withdrawal by Subject|14|||
106125088|NCT03699124|366115821|FG002|Overall Study|Withdrawal by Subject|13|||
106125089|NCT03699124|366115819|FG000|Overall Study|Other reasons|5|||
106125090|NCT03699124|366115820|FG001|Overall Study|Other reasons|3|||
106125091|NCT03699124|366115821|FG002|Overall Study|Other reasons|10|||
106125092|NCT00999661|366115822|FG000|Overall Study|Lost to Follow-up|59|||
105902042|NCT01026818|365299837|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
105902043|NCT01026818|365299838|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
105902044|NCT01026818|365299839|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
105902045|NCT01026818|365299840|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
105902046|NCT01026818|365299837|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
105902047|NCT01026818|365299838|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
105902048|NCT01026818|365299839|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
105902049|NCT01026818|365299840|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
105902050|NCT01026818|365299837|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
105902051|NCT01026818|365299838|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
106125093|NCT00999661|366115822|FG000|Overall Study|Adverse Event|1|||
106125094|NCT00999661|366115822|FG000|Overall Study|Withdrawal by Subject|1|||
106125095|NCT00999661|366115822|FG000|Overall Study|Not meeting eligibility criteria|9|||
105902052|NCT01026818|365299839|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
106125096|NCT01238575|366115823|FG000|Overall Study|Lack of Efficacy|2|||
106125097|NCT01238575|366115824|FG001|Overall Study|Lack of Efficacy|4|||
106125098|NCT01238575|366115823|FG000|Overall Study|Adverse Event|2|||
106125099|NCT01238575|366115824|FG001|Overall Study|Adverse Event|0|||
106125100|NCT01087723|366115827|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
106125101|NCT01087723|366115828|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
106125102|NCT01087723|366115827|FG000|Overall Study|Withdrawal by Subject|10|||
105668851|NCT01327612|364452255|FG003|Overall Study|Death|0|||
105668852|NCT01327612|364452256|FG004|Overall Study|Death|1|||
105668853|NCT01327612|364452257|FG005|Overall Study|Death|0|||
105668854|NCT01327612|364452258|FG006|Overall Study|Death|0|||
105902053|NCT01026818|365299840|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
106125103|NCT01087723|366115828|FG001|Overall Study|Withdrawal by Subject|13|||
106125104|NCT01087723|366115827|FG000|Overall Study|Physician Decision|2|||
105902054|NCT01026818|365299837|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
105902055|NCT01026818|365299838|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
105902056|NCT01026818|365299839|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
105902057|NCT01026818|365299840|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
105902058|NCT01760447|365299843|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
105902059|NCT01760447|365299844|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
105902060|NCT01760447|365299845|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
105902061|NCT01760447|365299846|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
105902062|NCT01760447|365299843|FG000|Weeks 0-20|Withdrawal by Subject|2|||
105902063|NCT01760447|365299844|FG001|Weeks 0-20|Withdrawal by Subject|0|||
105902064|NCT01760447|365299845|FG002|Weeks 0-20|Withdrawal by Subject|1|||
105902065|NCT01760447|365299846|FG003|Weeks 0-20|Withdrawal by Subject|0|||
105902066|NCT01760447|365299843|FG000|Weeks 0-20|Lost to Follow-up|1|||
105902067|NCT01760447|365299844|FG001|Weeks 0-20|Lost to Follow-up|0|||
105902068|NCT01760447|365299845|FG002|Weeks 0-20|Lost to Follow-up|1|||
105902069|NCT01760447|365299846|FG003|Weeks 0-20|Lost to Follow-up|1|||
105902070|NCT01760447|365299843|FG000|Weeks 0-20|Randomized but not treated|0|||
105902071|NCT01760447|365299844|FG001|Weeks 0-20|Randomized but not treated|0|||
105902072|NCT01760447|365299845|FG002|Weeks 0-20|Randomized but not treated|2|||
105902073|NCT01760447|365299846|FG003|Weeks 0-20|Randomized but not treated|0|||
105902074|NCT01760447|365299843|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
105902075|NCT01760447|365299844|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
105902076|NCT01760447|365299845|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
105902077|NCT01760447|365299846|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
105902078|NCT01760447|365299843|FG000|Weeks 20-54|Withdrawal by Subject|2|||
105902079|NCT01760447|365299844|FG001|Weeks 20-54|Withdrawal by Subject|1|||
105902080|NCT01760447|365299845|FG002|Weeks 20-54|Withdrawal by Subject|1|||
105902081|NCT01760447|365299846|FG003|Weeks 20-54|Withdrawal by Subject|2|||
105902082|NCT01760447|365299843|FG000|Weeks 20-54|Lost to Follow-up|0|||
105902083|NCT01760447|365299844|FG001|Weeks 20-54|Lost to Follow-up|0|||
105902084|NCT01760447|365299845|FG002|Weeks 20-54|Lost to Follow-up|1|||
105902085|NCT01760447|365299846|FG003|Weeks 20-54|Lost to Follow-up|2|||
105902086|NCT01641471|365299847|FG000|Overall Study|Withdrawal by Subject|19|||
105902087|NCT01641471|365299848|FG001|Overall Study|Withdrawal by Subject|19|||
105902088|NCT01641471|365299847|FG000|Overall Study|Lost to Follow-up|2|||
105902089|NCT01641471|365299848|FG001|Overall Study|Lost to Follow-up|4|||
105902090|NCT01641471|365299847|FG000|Overall Study|Protocol Violation|2|||
105902091|NCT01641471|365299848|FG001|Overall Study|Protocol Violation|4|||
105902092|NCT04575584|365299849|FG000|Overall Study|Death|6|||
105902093|NCT04575584|365299850|FG001|Overall Study|Death|4|||
105902094|NCT04575584|365299851|FG002|Overall Study|Death|6|||
105902095|NCT04575584|365299852|FG003|Overall Study|Death|2|||
105902096|NCT04575584|365299853|FG004|Overall Study|Death|0|||
105902097|NCT04575584|365299854|FG005|Overall Study|Death|0|||
105902098|NCT04575584|365299849|FG000|Overall Study|Lost to Follow-up|1|||
105902099|NCT04575584|365299850|FG001|Overall Study|Lost to Follow-up|1|||
105902100|NCT04575584|365299851|FG002|Overall Study|Lost to Follow-up|1|||
105902101|NCT04575584|365299852|FG003|Overall Study|Lost to Follow-up|1|||
105902102|NCT04575584|365299853|FG004|Overall Study|Lost to Follow-up|0|||
105902103|NCT04575584|365299854|FG005|Overall Study|Lost to Follow-up|0|||
105902104|NCT04575584|365299849|FG000|Overall Study|Physician Decision|0|||
105902105|NCT04575584|365299850|FG001|Overall Study|Physician Decision|1|||
105902106|NCT04575584|365299851|FG002|Overall Study|Physician Decision|1|||
105902107|NCT04575584|365299852|FG003|Overall Study|Physician Decision|1|||
105902108|NCT04575584|365299853|FG004|Overall Study|Physician Decision|0|||
105902109|NCT04575584|365299854|FG005|Overall Study|Physician Decision|0|||
105902110|NCT04575584|365299849|FG000|Overall Study|Withdrawal by Subject|7|||
105902111|NCT04575584|365299850|FG001|Overall Study|Withdrawal by Subject|9|||
105902112|NCT04575584|365299851|FG002|Overall Study|Withdrawal by Subject|5|||
105902113|NCT04575584|365299852|FG003|Overall Study|Withdrawal by Subject|3|||
105902114|NCT04575584|365299853|FG004|Overall Study|Withdrawal by Subject|0|||
105902115|NCT04575584|365299854|FG005|Overall Study|Withdrawal by Subject|0|||
105902116|NCT04575584|365299849|FG000|Overall Study|Not recorded|0|||
105902117|NCT04575584|365299850|FG001|Overall Study|Not recorded|0|||
105902118|NCT04575584|365299851|FG002|Overall Study|Not recorded|0|||
105902119|NCT04575584|365299852|FG003|Overall Study|Not recorded|1|||
105902120|NCT04575584|365299853|FG004|Overall Study|Not recorded|0|||
105902121|NCT04575584|365299854|FG005|Overall Study|Not recorded|0|||
105902122|NCT00582426|365299859|FG000|Overall Study|Lost to Follow-up|0|||
105902123|NCT00582426|365299860|FG001|Overall Study|Lost to Follow-up|2|||
105902124|NCT00582426|365299859|FG000|Overall Study|Adverse Event|4|||
105902125|NCT00582426|365299860|FG001|Overall Study|Adverse Event|2|||
105902126|NCT00582426|365299859|FG000|Overall Study|Protocol Violation|6|||
105902127|NCT00582426|365299860|FG001|Overall Study|Protocol Violation|2|||
105902128|NCT00582426|365299859|FG000|Overall Study|Death|4|||
105902129|NCT00582426|365299860|FG001|Overall Study|Death|3|||
105902130|NCT00582426|365299859|FG000|Overall Study|Withdrawal by Subject|3|||
105902131|NCT00582426|365299860|FG001|Overall Study|Withdrawal by Subject|2|||
105902132|NCT00582426|365299859|FG000|Overall Study|Disease Progression|2|||
105902133|NCT00582426|365299860|FG001|Overall Study|Disease Progression|2|||
105902134|NCT00582426|365299859|FG000|Overall Study|Use of illicit drugs|1|||
105902135|NCT00582426|365299860|FG001|Overall Study|Use of illicit drugs|0|||
105902136|NCT02164318|365299865|FG000|Overall Study|Withdrawal by Subject|0|||
105902137|NCT02164318|365299866|FG001|Overall Study|Withdrawal by Subject|1|||
105902138|NCT02164318|365299867|FG002|Overall Study|Withdrawal by Subject|0|||
105902139|NCT02164318|365299868|FG003|Overall Study|Withdrawal by Subject|1|||
105902140|NCT02335346|365299869|FG000|Overall Study|Adverse Event|11|||
105902141|NCT02335346|365299869|FG000|Overall Study|Withdrawal by Subject|1|||
105902142|NCT02065518|365299870|FG000|Overall Study|Lost to Follow-up|3|||
105902143|NCT02065518|365299871|FG001|Overall Study|Lost to Follow-up|4|||
105902144|NCT02065518|365299872|FG002|Overall Study|Lost to Follow-up|0|||
105902145|NCT02065518|365299873|FG003|Overall Study|Lost to Follow-up|3|||
105902146|NCT02065518|365299870|FG000|Overall Study|Withdrawal by Subject|3|||
105902147|NCT02065518|365299871|FG001|Overall Study|Withdrawal by Subject|4|||
105902148|NCT02065518|365299872|FG002|Overall Study|Withdrawal by Subject|9|||
105902149|NCT02065518|365299873|FG003|Overall Study|Withdrawal by Subject|2|||
105902150|NCT00217581|365299874|FG000|Overall Study|Withdrawal by Subject|1|||
105902151|NCT02087943|365299875|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
105902152|NCT02087943|365299876|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
105902153|NCT02087943|365299877|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
105902154|NCT02087943|365299878|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
105902155|NCT02087943|365299879|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
105902156|NCT02087943|365299875|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
105902157|NCT02087943|365299876|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
105902158|NCT02087943|365299877|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
105902159|NCT02087943|365299878|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
105902160|NCT02087943|365299879|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
105902161|NCT02087943|365299875|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
105902162|NCT02087943|365299876|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
105902163|NCT02087943|365299877|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
105902164|NCT02087943|365299878|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
105902165|NCT02087943|365299879|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
105902166|NCT02087943|365299875|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
105902167|NCT02087943|365299876|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
105902168|NCT02087943|365299877|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
105902169|NCT02087943|365299878|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
105902170|NCT02087943|365299879|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
105902171|NCT02087943|365299875|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
105902172|NCT02087943|365299876|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
105902173|NCT02087943|365299877|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
105902174|NCT02087943|365299878|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
105902175|NCT02087943|365299879|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
105902176|NCT02087943|365299875|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
105902177|NCT02087943|365299876|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
105902178|NCT02087943|365299877|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
105902179|NCT02087943|365299878|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
105902180|NCT02087943|365299879|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
105902181|NCT02087943|365299875|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
105902182|NCT02087943|365299876|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
105902183|NCT02087943|365299877|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
105902184|NCT02087943|365299878|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
105902185|NCT02087943|365299879|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
105902186|NCT02087943|365299875|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
105902187|NCT02087943|365299876|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
105902188|NCT02087943|365299877|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
105902189|NCT02087943|365299878|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
105902190|NCT02087943|365299879|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
105902191|NCT02087943|365299875|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
105902192|NCT02087943|365299876|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
105902193|NCT02087943|365299877|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
105902194|NCT02087943|365299878|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
105902195|NCT02087943|365299879|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
105902196|NCT02087943|365299875|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
105902197|NCT02087943|365299876|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
105902198|NCT02087943|365299877|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
105902199|NCT02087943|365299878|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
105902200|NCT02087943|365299879|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
105902201|NCT02131636|365299880|FG000|Overall Study|Personal Reasons|4|||
105902202|NCT02131636|365299881|FG001|Overall Study|Personal Reasons|4|||
105902203|NCT02131636|365299880|FG000|Overall Study|Lost to Follow-up|4|||
105902204|NCT02131636|365299881|FG001|Overall Study|Lost to Follow-up|0|||
105902205|NCT02131636|365299880|FG000|Overall Study|Adverse Event|4|||
105902206|NCT02131636|365299881|FG001|Overall Study|Adverse Event|1|||
105902207|NCT03484403|365299882|FG000|Overall Study|Withdrawal by Subject|6|||
105902208|NCT03484403|365299883|FG001|Overall Study|Withdrawal by Subject|4|||
105902209|NCT03836209|365299884|FG000|Overall Study|Adverse Event|5|||
105902210|NCT03836209|365299885|FG001|Overall Study|Adverse Event|2|||
105902211|NCT03836209|365299884|FG000|Overall Study|Death|4|||
105902212|NCT03836209|365299885|FG001|Overall Study|Death|1|||
105902213|NCT03836209|365299884|FG000|Overall Study|Lack of Efficacy|7|||
105902214|NCT03836209|365299885|FG001|Overall Study|Lack of Efficacy|10|||
105902215|NCT03836209|365299884|FG000|Overall Study|Physician Decision|7|||
105902216|NCT03836209|365299885|FG001|Overall Study|Physician Decision|11|||
105902217|NCT03836209|365299884|FG000|Overall Study|Protocol Violation|0|||
105902218|NCT03836209|365299885|FG001|Overall Study|Protocol Violation|3|||
105902219|NCT03836209|365299884|FG000|Overall Study|Withdrawal by Subject|2|||
105902220|NCT03836209|365299885|FG001|Overall Study|Withdrawal by Subject|10|||
105902221|NCT03836209|365299884|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
105902222|NCT03836209|365299885|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
105902223|NCT03739710|365299886|FG000|Overall Study|Screen Failed|81|||
105902224|NCT01753115|365299887|FG000|Overall Study|Lost to Follow-up|3|||
105902225|NCT01753115|365299888|FG001|Overall Study|Lost to Follow-up|6|||
105902226|NCT01753115|365299889|FG002|Overall Study|Lost to Follow-up|8|||
105902227|NCT01753115|365299887|FG000|Overall Study|Withdrawal by Subject|6|||
105902228|NCT01753115|365299888|FG001|Overall Study|Withdrawal by Subject|5|||
105902229|NCT01753115|365299889|FG002|Overall Study|Withdrawal by Subject|6|||
105902230|NCT01753115|365299887|FG000|Overall Study|Subject non-compliant|3|||
105902231|NCT01753115|365299888|FG001|Overall Study|Subject non-compliant|3|||
105902232|NCT01753115|365299889|FG002|Overall Study|Subject non-compliant|0|||
105902233|NCT01753115|365299887|FG000|Overall Study|Used excluded drug|0|||
105902234|NCT01753115|365299888|FG001|Overall Study|Used excluded drug|1|||
105902235|NCT01753115|365299889|FG002|Overall Study|Used excluded drug|0|||
105902236|NCT00631163|365299893|FG000|Number of Participants in Year 1|Adverse Event|12|||
105902237|NCT00631163|365299893|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
105902238|NCT00631163|365299893|FG000|Number of Participants in Year 1|Death|6|||
105902239|NCT00631163|365299893|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
105902240|NCT00631163|365299893|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
105902241|NCT00631163|365299893|FG000|Number of Participants in Year 1|Administrative problems|6|||
105902242|NCT00631163|365299893|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
105902243|NCT00631163|365299893|FG000|Number of Participants in Year 2|Adverse Event|1|||
105902244|NCT00631163|365299893|FG000|Number of Participants in Year 2|Protocol Violation|1|||
105902245|NCT00631163|365299893|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
105902246|NCT02714036|365299894|FG000|Overall Study|Adverse Event|9|||
105902247|NCT02714036|365299895|FG001|Overall Study|Adverse Event|2|||
105902248|NCT02714036|365299894|FG000|Overall Study|Withdrawal by Subject|3|||
105902249|NCT02714036|365299895|FG001|Overall Study|Withdrawal by Subject|2|||
105902250|NCT00715520|365299897|FG000|Overall Study|Screen failure|8|||
105902251|NCT00715520|365299898|FG001|Overall Study|Screen failure|1|||
105902252|NCT00715520|365299899|FG002|Overall Study|Screen failure|1|||
105902253|NCT00715520|365299897|FG000|Overall Study|Withdrawal by Subject|2|||
105902254|NCT00715520|365299898|FG001|Overall Study|Withdrawal by Subject|0|||
105902255|NCT00715520|365299899|FG002|Overall Study|Withdrawal by Subject|1|||
105902256|NCT03332095|365299900|FG000|Overall Study|Lost to Follow-up|1|||
105902257|NCT03332095|365299901|FG001|Overall Study|Lost to Follow-up|0|||
105902258|NCT03332095|365299900|FG000|Overall Study|Pregnancy|0|||
105902259|NCT03332095|365299901|FG001|Overall Study|Pregnancy|1|||
105902260|NCT02290925|365299902|FG000|First Period of Three Months|Lost to Follow-up|2|||
105902261|NCT02290925|365299903|FG001|First Period of Three Months|Lost to Follow-up|1|||
105902262|NCT02290925|365299902|FG000|First Period of Three Months|Death|1|||
105902263|NCT02290925|365299903|FG001|First Period of Three Months|Death|0|||
105902264|NCT02290925|365299902|FG000|First Period of Three Months|Insulin Started|1|||
105902265|NCT02290925|365299903|FG001|First Period of Three Months|Insulin Started|1|||
105902266|NCT02290925|365299902|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
105902267|NCT02290925|365299903|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
105902268|NCT02290925|365299902|FG000|Second Period of 3 Months|insulin started|0|||
105902269|NCT02290925|365299903|FG001|Second Period of 3 Months|insulin started|1|||
105902270|NCT01597492|365299904|FG000|Overall Study|Withdrawal by Subject|1|||
105902271|NCT01597492|365299905|FG001|Overall Study|Withdrawal by Subject|2|||
105902272|NCT01597492|365299904|FG000|Overall Study|Adverse Event|3|||
105902273|NCT01597492|365299905|FG001|Overall Study|Adverse Event|0|||
105902274|NCT01597492|365299904|FG000|Overall Study|Lost to Follow-up|0|||
105902275|NCT01597492|365299905|FG001|Overall Study|Lost to Follow-up|2|||
105902276|NCT01597492|365299904|FG000|Overall Study|Other Reason|2|||
105902277|NCT01597492|365299905|FG001|Overall Study|Other Reason|0|||
105902278|NCT00496587|365299908|FG000|Overall Study|Adverse Event|2|||
105902279|NCT00496587|365299908|FG000|Overall Study|Progressive Disease|24|||
105902280|NCT00496587|365299908|FG000|Overall Study|Withdrawal by Subject|2|||
105902281|NCT00496587|365299908|FG000|Overall Study|Death|1|||
105902282|NCT00496587|365299908|FG000|Overall Study|Complications unrelated|2|||
105902283|NCT00624832|365299909|FG000|Overall Study|Adverse Event|0|||
105902284|NCT00624832|365299910|FG001|Overall Study|Adverse Event|1|||
105902285|NCT00624832|365299911|FG002|Overall Study|Adverse Event|0|||
105902286|NCT00624832|365299912|FG003|Overall Study|Adverse Event|1|||
105902287|NCT00624832|365299909|FG000|Overall Study|Abnormal Laboratory Value|2|||
105902288|NCT00624832|365299910|FG001|Overall Study|Abnormal Laboratory Value|0|||
105902289|NCT00624832|365299911|FG002|Overall Study|Abnormal Laboratory Value|0|||
105902290|NCT00624832|365299912|FG003|Overall Study|Abnormal Laboratory Value|0|||
105902291|NCT03624569|365299914|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
106125105|NCT01087723|366115828|FG001|Overall Study|Physician Decision|0|||
106125106|NCT01087723|366115827|FG000|Overall Study|Lost to Follow-up|1|||
106125107|NCT01087723|366115828|FG001|Overall Study|Lost to Follow-up|4|||
106125108|NCT01087723|366115827|FG000|Overall Study|Reason Not Specified|1|||
106125109|NCT01087723|366115828|FG001|Overall Study|Reason Not Specified|2|||
106125110|NCT00806624|366115832|FG000|Overall Study|Adverse Event|2|||
105902292|NCT03624569|365299915|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
105902293|NCT03624569|365299914|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
105902294|NCT03624569|365299915|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
105902295|NCT01557517|365299916|FG000|Overall Study|Death|1|||
106125111|NCT00806624|366115833|FG001|Overall Study|Adverse Event|8|||
106125112|NCT00806624|366115834|FG002|Overall Study|Adverse Event|0|||
106125113|NCT00806624|366115832|FG000|Overall Study|Death|0|||
106125114|NCT00806624|366115833|FG001|Overall Study|Death|1|||
106125115|NCT00806624|366115834|FG002|Overall Study|Death|1|||
106125116|NCT00806624|366115832|FG000|Overall Study|Lost to Follow-up|1|||
106125117|NCT00806624|366115833|FG001|Overall Study|Lost to Follow-up|0|||
106125118|NCT00806624|366115834|FG002|Overall Study|Lost to Follow-up|1|||
106125119|NCT00806624|366115832|FG000|Overall Study|Withdrawal by Subject|6|||
106125120|NCT00806624|366115833|FG001|Overall Study|Withdrawal by Subject|3|||
106125121|NCT00806624|366115834|FG002|Overall Study|Withdrawal by Subject|3|||
106125122|NCT00806624|366115832|FG000|Overall Study|discontinued before start of treatment|0|||
106125123|NCT00806624|366115833|FG001|Overall Study|discontinued before start of treatment|0|||
106125124|NCT00806624|366115834|FG002|Overall Study|discontinued before start of treatment|1|||
106125125|NCT00709592|366115836|FG000|Overall Study|Unable to proceed to transplant|0|||
106125126|NCT00709592|366115837|FG001|Overall Study|Unable to proceed to transplant|1|||
106125127|NCT00867490|366115838|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
106125128|NCT00867490|366115838|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
106125129|NCT00867490|366115838|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
106125130|NCT00867490|366115838|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
106125131|NCT00867490|366115838|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
106125132|NCT04668989|366115839|FG000|First Intervention|Covid-19 related self-isolation|0|||
106125133|NCT04668989|366115840|FG001|First Intervention|Covid-19 related self-isolation|1|||
105902296|NCT01557517|365299917|FG001|Overall Study|Death|0|||
105902297|NCT01557517|365299916|FG000|Overall Study|Refused further treatment|0|||
105902298|NCT01557517|365299917|FG001|Overall Study|Refused further treatment|2|||
105902299|NCT01557517|365299916|FG000|Overall Study|Adverse Event|0|||
106125134|NCT04668989|366115839|FG000|Second Intervention|Adverse Event|0|||
106125135|NCT04668989|366115840|FG001|Second Intervention|Adverse Event|1|||
106125136|NCT02564055|366115847|FG000|Overall Study|Adverse Event|1|||
106125137|NCT02564055|366115848|FG001|Overall Study|Adverse Event|0|||
106125138|NCT02564055|366115849|FG002|Overall Study|Adverse Event|4|||
106125139|NCT02564055|366115850|FG003|Overall Study|Adverse Event|1|||
106125140|NCT02564055|366115851|FG004|Overall Study|Adverse Event|4|||
106125141|NCT02564055|366115852|FG005|Overall Study|Adverse Event|1|||
106125142|NCT02564055|366115847|FG000|Overall Study|Protocol Violation|1|||
106125143|NCT02564055|366115848|FG001|Overall Study|Protocol Violation|0|||
106125144|NCT02564055|366115849|FG002|Overall Study|Protocol Violation|0|||
106125145|NCT02564055|366115850|FG003|Overall Study|Protocol Violation|0|||
106125146|NCT02564055|366115851|FG004|Overall Study|Protocol Violation|0|||
106125147|NCT02564055|366115852|FG005|Overall Study|Protocol Violation|0|||
106125148|NCT02564055|366115847|FG000|Overall Study|Reached stopping criteria|0|||
105902300|NCT01557517|365299917|FG001|Overall Study|Adverse Event|2|||
105902301|NCT01557517|365299916|FG000|Overall Study|Pt declined before treatment started|1|||
105902302|NCT01557517|365299917|FG001|Overall Study|Pt declined before treatment started|0|||
105902303|NCT01204918|365299924|FG000|Overall Study|Withdrawal by Subject|4|||
105902304|NCT01204918|365299925|FG001|Overall Study|Withdrawal by Subject|10|||
105902305|NCT01204918|365299926|FG002|Overall Study|Withdrawal by Subject|5|||
105902306|NCT03004924|365299929|FG000|Overall Study|Adverse Event|6|||
105902307|NCT03004924|365299930|FG001|Overall Study|Adverse Event|5|||
105902308|NCT03004924|365299931|FG002|Overall Study|Adverse Event|10|||
105902309|NCT03004924|365299929|FG000|Overall Study|Protocol Violation|4|||
105902310|NCT03004924|365299930|FG001|Overall Study|Protocol Violation|0|||
105902311|NCT03004924|365299931|FG002|Overall Study|Protocol Violation|1|||
105902312|NCT03004924|365299929|FG000|Overall Study|Withdrawal by Subject|5|||
105902313|NCT03004924|365299930|FG001|Overall Study|Withdrawal by Subject|3|||
105902314|NCT03004924|365299931|FG002|Overall Study|Withdrawal by Subject|5|||
105902315|NCT03004924|365299929|FG000|Overall Study|Lost to Follow-up|6|||
105902316|NCT03004924|365299930|FG001|Overall Study|Lost to Follow-up|1|||
105902317|NCT03004924|365299931|FG002|Overall Study|Lost to Follow-up|4|||
105902318|NCT03004924|365299929|FG000|Overall Study|Lack of Efficacy|2|||
105902319|NCT03004924|365299930|FG001|Overall Study|Lack of Efficacy|4|||
105902320|NCT03004924|365299931|FG002|Overall Study|Lack of Efficacy|2|||
105902321|NCT03004924|365299929|FG000|Overall Study|Physician Decision|1|||
105902322|NCT03004924|365299930|FG001|Overall Study|Physician Decision|0|||
105902323|NCT03004924|365299931|FG002|Overall Study|Physician Decision|1|||
105902324|NCT03004924|365299929|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105902325|NCT03004924|365299930|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105902326|NCT03004924|365299931|FG002|Overall Study|Withdrawal by parent/guardian|2|||
105902327|NCT03004924|365299929|FG000|Overall Study|Screen Failure|1|||
105902328|NCT03004924|365299930|FG001|Overall Study|Screen Failure|0|||
105902329|NCT03004924|365299931|FG002|Overall Study|Screen Failure|0|||
105902330|NCT03004924|365299929|FG000|Overall Study|Pregnancy|0|||
105902331|NCT03004924|365299930|FG001|Overall Study|Pregnancy|1|||
105902332|NCT03004924|365299931|FG002|Overall Study|Pregnancy|0|||
105998089|NCT03369418|365654826|FG000|Overall Study|Withdrawal by Subject|3|||
105998090|NCT03369418|365654827|FG001|Overall Study|Withdrawal by Subject|3|||
105902333|NCT03004924|365299929|FG000|Overall Study|Terminated by Sponsor|0|||
105998091|NCT01485094|365654828|FG000|Overall Study|Adverse Event|1|||
105998092|NCT01485094|365654829|FG001|Overall Study|Adverse Event|1|||
105998093|NCT01485094|365654830|FG002|Overall Study|Adverse Event|1|||
105998094|NCT01485094|365654828|FG000|Overall Study|Lost to Follow-up|1|||
105998095|NCT01485094|365654829|FG001|Overall Study|Lost to Follow-up|0|||
105998096|NCT01485094|365654830|FG002|Overall Study|Lost to Follow-up|0|||
105998097|NCT01485094|365654828|FG000|Overall Study|Withdrawal by Subject|1|||
105998098|NCT01485094|365654829|FG001|Overall Study|Withdrawal by Subject|1|||
105998099|NCT01485094|365654830|FG002|Overall Study|Withdrawal by Subject|0|||
105998100|NCT01426958|365654831|FG000|Overall Study|Adverse Event|2|||
105998101|NCT01479868|365654841|FG000|Overall Study|Adverse Event|1|||
105998102|NCT01479868|365654841|FG000|Overall Study|Lost to Follow-up|4|||
105998103|NCT01479868|365654841|FG000|Overall Study|Protocol Violation|1|||
105998104|NCT01479868|365654841|FG000|Overall Study|Withdrawal by Subject|1|||
105998105|NCT01479868|365654841|FG000|Overall Study|Sponsor's Decision|1|||
105998106|NCT01479868|365654841|FG000|Overall Study|Initiation of new HCV Therapy|1|||
105998107|NCT01076959|365654845|FG000|Overall Study|Adverse Event|767|||
105998108|NCT01076959|365654845|FG000|Overall Study|Lack of Efficacy|849|||
105998109|NCT01076959|365654845|FG000|Overall Study|Non-compliance|274|||
105998110|NCT01076959|365654845|FG000|Overall Study|Lost to Follow-up|241|||
105998111|NCT01076959|365654845|FG000|Overall Study|Other|119|||
105998112|NCT01078441|365654846|FG000|Overall Study|Withdrawal by Subject|1|||
105998113|NCT01425801|365654847|FG000|Period 1|Withdrawal by Subject|0|||
105998114|NCT01425801|365654848|FG001|Period 1|Withdrawal by Subject|0|||
105998115|NCT01425801|365654849|FG002|Period 1|Withdrawal by Subject|0|||
105998116|NCT01425801|365654850|FG003|Period 1|Withdrawal by Subject|0|||
105998117|NCT01425801|365654851|FG004|Period 1|Withdrawal by Subject|1|||
106125149|NCT02564055|366115848|FG001|Overall Study|Reached stopping criteria|0|||
105998118|NCT01425801|365654852|FG005|Period 1|Withdrawal by Subject|0|||
105998119|NCT01425801|365654847|FG000|Period 2|Withdrawal by Subject|0|||
105998120|NCT01425801|365654848|FG001|Period 2|Withdrawal by Subject|0|||
105998121|NCT01425801|365654849|FG002|Period 2|Withdrawal by Subject|0|||
106125150|NCT02564055|366115849|FG002|Overall Study|Reached stopping criteria|0|||
106125151|NCT02564055|366115850|FG003|Overall Study|Reached stopping criteria|0|||
106125152|NCT02564055|366115851|FG004|Overall Study|Reached stopping criteria|0|||
106125153|NCT02564055|366115852|FG005|Overall Study|Reached stopping criteria|1|||
106125154|NCT02564055|366115847|FG000|Overall Study|Lost to Follow-up|0|||
106125155|NCT02564055|366115848|FG001|Overall Study|Lost to Follow-up|1|||
106125156|NCT02564055|366115849|FG002|Overall Study|Lost to Follow-up|4|||
105902334|NCT03004924|365299930|FG001|Overall Study|Terminated by Sponsor|0|||
105902335|NCT03004924|365299931|FG002|Overall Study|Terminated by Sponsor|1|||
105902336|NCT03004924|365299929|FG000|Overall Study|Missed Study Visit|0|||
105902337|NCT03004924|365299930|FG001|Overall Study|Missed Study Visit|0|||
105902338|NCT03004924|365299931|FG002|Overall Study|Missed Study Visit|2|||
105902339|NCT03004924|365299929|FG000|Overall Study|HSV1 Positive|1|||
105902340|NCT03004924|365299930|FG001|Overall Study|HSV1 Positive|0|||
105902341|NCT03004924|365299931|FG002|Overall Study|HSV1 Positive|0|||
105998122|NCT01425801|365654850|FG003|Period 2|Withdrawal by Subject|0|||
105902342|NCT00438256|365299932|FG000|Overall Study|Ineligible for Resection|2|||
105902343|NCT00438256|365299933|FG001|Overall Study|Ineligible for Resection|1|||
105902344|NCT00438256|365299934|FG002|Overall Study|Ineligible for Resection|1|||
105902345|NCT00438256|365299935|FG003|Overall Study|Ineligible for Resection|7|||
105902346|NCT00438256|365299932|FG000|Overall Study|Excluded final Diagnosis|0|||
105902347|NCT00438256|365299933|FG001|Overall Study|Excluded final Diagnosis|0|||
105902348|NCT00438256|365299934|FG002|Overall Study|Excluded final Diagnosis|0|||
105902349|NCT00438256|365299935|FG003|Overall Study|Excluded final Diagnosis|2|||
105902350|NCT00938587|365299936|FG000|Overall Study|Adverse Event|2|||
105902351|NCT00938587|365299937|FG001|Overall Study|Adverse Event|0|||
105902352|NCT00938587|365299938|FG002|Overall Study|Adverse Event|0|||
105902353|NCT00938587|365299939|FG003|Overall Study|Adverse Event|2|||
105902354|NCT00938587|365299936|FG000|Overall Study|Did not meet entrance criteria|0|||
105902355|NCT00938587|365299937|FG001|Overall Study|Did not meet entrance criteria|0|||
105902356|NCT00938587|365299938|FG002|Overall Study|Did not meet entrance criteria|1|||
105902357|NCT00938587|365299939|FG003|Overall Study|Did not meet entrance criteria|0|||
105902358|NCT00938587|365299936|FG000|Overall Study|Withdrawal by Subject|1|||
105902359|NCT00938587|365299937|FG001|Overall Study|Withdrawal by Subject|1|||
105902360|NCT00938587|365299938|FG002|Overall Study|Withdrawal by Subject|0|||
105902361|NCT00938587|365299939|FG003|Overall Study|Withdrawal by Subject|0|||
105902362|NCT04527978|365299945|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
105902363|NCT04527978|365299946|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
105902364|NCT01215435|365299953|FG000|Overall Study|Adverse Event|1|||
105902365|NCT01215435|365299954|FG001|Overall Study|Adverse Event|0|||
105902366|NCT01215435|365299953|FG000|Overall Study|Protocol Violation|2|||
105902367|NCT01215435|365299954|FG001|Overall Study|Protocol Violation|0|||
105902368|NCT01215435|365299953|FG000|Overall Study|Withdrawal Criteria|8|||
105902369|NCT01215435|365299954|FG001|Overall Study|Withdrawal Criteria|11|||
105902370|NCT01215435|365299953|FG000|Overall Study|Lost to Follow-up|3|||
105902371|NCT01215435|365299954|FG001|Overall Study|Lost to Follow-up|0|||
105902372|NCT01215435|365299953|FG000|Overall Study|Unclassified|5|||
105902373|NCT01215435|365299954|FG001|Overall Study|Unclassified|5|||
105902374|NCT03046056|365301259|FG000|Overall Study|Non-responder at Week 10|6|||
105902375|NCT03046056|365301260|FG001|Overall Study|Non-responder at Week 10|6|||
105902376|NCT03046056|365301261|FG002|Overall Study|Non-responder at Week 10|4|||
105902377|NCT03046056|365301259|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
105902378|NCT03046056|365301260|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
105902379|NCT03046056|365301261|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
105902380|NCT03046056|365301259|FG000|Overall Study|Adverse Event|1|||
105902381|NCT03046056|365301260|FG001|Overall Study|Adverse Event|5|||
105902382|NCT03046056|365301261|FG002|Overall Study|Adverse Event|0|||
105902383|NCT03046056|365301259|FG000|Overall Study|Non-compliance With Study Drug|0|||
105902384|NCT03046056|365301260|FG001|Overall Study|Non-compliance With Study Drug|0|||
105902385|NCT03046056|365301261|FG002|Overall Study|Non-compliance With Study Drug|2|||
105902386|NCT03046056|365301259|FG000|Overall Study|Protocol Violation|1|||
105902387|NCT03046056|365301260|FG001|Overall Study|Protocol Violation|1|||
105668855|NCT01199068|364452261|FG000|Overall Study|Unacceptable toxicity|0|||
105668856|NCT01199068|364452262|FG001|Overall Study|Unacceptable toxicity|0|||
105668857|NCT01199068|364452263|FG002|Overall Study|Unacceptable toxicity|2|||
105668858|NCT01199068|364452261|FG000|Overall Study|Progressive disease|3|||
105668859|NCT01199068|364452262|FG001|Overall Study|Progressive disease|3|||
105668860|NCT01199068|364452263|FG002|Overall Study|Progressive disease|6|||
105668861|NCT01199068|364452261|FG000|Overall Study|Withdrawal by Subject|0|||
105668862|NCT01199068|364452262|FG001|Overall Study|Withdrawal by Subject|0|||
105668863|NCT01199068|364452263|FG002|Overall Study|Withdrawal by Subject|1|||
105668864|NCT00874731|364452265|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
105668865|NCT00874731|364452266|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
105668866|NCT00874731|364452267|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
105668867|NCT00874731|364452265|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
105668868|NCT00874731|364452266|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
105668869|NCT00874731|364452267|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
105668870|NCT00874731|364452265|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
105668871|NCT00874731|364452266|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
105668872|NCT00874731|364452267|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
105668873|NCT00955708|364452268|FG000|Overall Study|Death|269|||
105668874|NCT00955708|364452268|FG000|Overall Study|Lost to Follow-up|72|||
105668875|NCT00955708|364452268|FG000|Overall Study|Physician Decision|36|||
105668876|NCT00955708|364452268|FG000|Overall Study|Protocol Violation|134|||
105668877|NCT00955708|364452268|FG000|Overall Study|Registry Conclusion|186|||
105668878|NCT00955708|364452268|FG000|Overall Study|Product removed from service|94|||
105668879|NCT00955708|364452268|FG000|Overall Study|Patient Refused to participate further|116|||
105668880|NCT00955708|364452268|FG000|Overall Study|Closure of study location|60|||
105902388|NCT03046056|365301261|FG002|Overall Study|Protocol Violation|0|||
105902389|NCT03046056|365301259|FG000|Overall Study|Investigator's Discretion|0|||
105902390|NCT03046056|365301260|FG001|Overall Study|Investigator's Discretion|1|||
105902391|NCT03046056|365301261|FG002|Overall Study|Investigator's Discretion|0|||
105902392|NCT03046056|365301259|FG000|Overall Study|Withdrew Consent|1|||
105902393|NCT03046056|365301260|FG001|Overall Study|Withdrew Consent|0|||
105902394|NCT03046056|365301261|FG002|Overall Study|Withdrew Consent|0|||
105902395|NCT00642954|365301262|FG000|Overall Study|Progressive Disease|3|||
105902396|NCT00642954|365301263|FG001|Overall Study|Progressive Disease|3|||
105902397|NCT00642954|365301264|FG002|Overall Study|Progressive Disease|3|||
105902398|NCT00642954|365301265|FG003|Overall Study|Progressive Disease|3|||
105902399|NCT00642954|365301266|FG004|Overall Study|Progressive Disease|9|||
105902400|NCT00642954|365301262|FG000|Overall Study|Withdrawal by Subject|0|||
105902401|NCT00642954|365301263|FG001|Overall Study|Withdrawal by Subject|0|||
105902402|NCT00642954|365301264|FG002|Overall Study|Withdrawal by Subject|0|||
105902403|NCT00642954|365301265|FG003|Overall Study|Withdrawal by Subject|0|||
105902404|NCT00642954|365301266|FG004|Overall Study|Withdrawal by Subject|1|||
105902405|NCT00642954|365301262|FG000|Overall Study|Adverse Event|1|||
105902406|NCT00642954|365301263|FG001|Overall Study|Adverse Event|1|||
105902407|NCT00642954|365301264|FG002|Overall Study|Adverse Event|0|||
105902408|NCT00642954|365301265|FG003|Overall Study|Adverse Event|0|||
105902409|NCT00642954|365301266|FG004|Overall Study|Adverse Event|6|||
105902410|NCT01270321|365301267|FG000|Overall Study|Death|3|||
105902411|NCT01270321|365301268|FG001|Overall Study|Death|1|||
105902412|NCT01270321|365301269|FG002|Overall Study|Death|4|||
105902413|NCT01270321|365301267|FG000|Overall Study|Adverse Event|7|||
105902414|NCT01270321|365301268|FG001|Overall Study|Adverse Event|9|||
105902415|NCT01270321|365301269|FG002|Overall Study|Adverse Event|5|||
105902416|NCT04003623|365301270|FG000|Overall Study|Withdrawal by Subject|1|||
105902417|NCT04003623|365301271|FG001|Overall Study|Withdrawal by Subject|0|||
105902418|NCT01548768|365301274|FG000|Overall Study|Withdrawal by Subject|0|||
105902419|NCT01548768|365301275|FG001|Overall Study|Withdrawal by Subject|2|||
105902420|NCT01548768|365301276|FG002|Overall Study|Withdrawal by Subject|1|||
105902421|NCT01548768|365301277|FG003|Overall Study|Withdrawal by Subject|0|||
105902422|NCT01548768|365301274|FG000|Overall Study|Physician Decision|1|||
105902423|NCT01548768|365301275|FG001|Overall Study|Physician Decision|0|||
105902424|NCT01548768|365301276|FG002|Overall Study|Physician Decision|0|||
105902425|NCT01548768|365301277|FG003|Overall Study|Physician Decision|0|||
105902426|NCT01548768|365301274|FG000|Overall Study|Adverse Event|0|||
105902427|NCT01548768|365301275|FG001|Overall Study|Adverse Event|0|||
105902428|NCT01548768|365301276|FG002|Overall Study|Adverse Event|0|||
105902429|NCT01548768|365301277|FG003|Overall Study|Adverse Event|1|||
105902430|NCT01548768|365301274|FG000|Overall Study|Non-Compliance|0|||
105902431|NCT01548768|365301275|FG001|Overall Study|Non-Compliance|0|||
105902432|NCT01548768|365301276|FG002|Overall Study|Non-Compliance|0|||
105902433|NCT01548768|365301277|FG003|Overall Study|Non-Compliance|3|||
105902434|NCT02769312|365301280|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
105902435|NCT02769312|365301281|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
105902436|NCT02769312|365301280|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
105902437|NCT02769312|365301281|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
105902438|NCT02769312|365301280|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
105902439|NCT02769312|365301281|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
105902440|NCT02769312|365301280|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
105902441|NCT02769312|365301281|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
105902442|NCT02769312|365301280|FG000|Follow-up|Lost to Follow-up|1|||
105902443|NCT02769312|365301281|FG001|Follow-up|Lost to Follow-up|1|||
105902444|NCT04126317|365301282|FG000|Overall Study|Adverse Event|0|||
105902445|NCT04126317|365301283|FG001|Overall Study|Adverse Event|1|||
105902446|NCT04126317|365301282|FG000|Overall Study|Withdrawal by Subject|4|||
105902447|NCT04126317|365301283|FG001|Overall Study|Withdrawal by Subject|1|||
105902448|NCT01796301|365301284|FG000|Overall Study|Withdrawal by Subject|15|||
105902449|NCT01796301|365301285|FG001|Overall Study|Withdrawal by Subject|15|||
105902450|NCT01796301|365301284|FG000|Overall Study|Lost to Follow-up|3|||
105902451|NCT01796301|365301285|FG001|Overall Study|Lost to Follow-up|3|||
105902452|NCT01796301|365301284|FG000|Overall Study|Death|0|||
105902453|NCT01796301|365301285|FG001|Overall Study|Death|1|||
105902454|NCT01796301|365301284|FG000|Overall Study|Decision by Sponsor|0|||
105902455|NCT01796301|365301285|FG001|Overall Study|Decision by Sponsor|1|||
105902456|NCT01108237|365301286|FG000|Overall Study|No alignment data|2|||
105902457|NCT01108237|365301287|FG001|Overall Study|No alignment data|15|||
105902458|NCT01108237|365301286|FG000|Overall Study|Did not meet criteria for analysis|7|||
105902459|NCT01108237|365301287|FG001|Overall Study|Did not meet criteria for analysis|0|||
106125157|NCT02564055|366115850|FG003|Overall Study|Lost to Follow-up|2|||
105902460|NCT00694356|365301295|FG000|Overall Study|Adverse Event|1|||
105902461|NCT00694356|365301296|FG001|Overall Study|Adverse Event|0|||
105902462|NCT00694356|365301297|FG002|Overall Study|Adverse Event|0|||
105902463|NCT00694356|365301295|FG000|Overall Study|Progressive Disease|2|||
105902464|NCT00694356|365301296|FG001|Overall Study|Progressive Disease|6|||
105902465|NCT00694356|365301297|FG002|Overall Study|Progressive Disease|6|||
105902466|NCT01090050|365301298|FG000|Overall Study|Lost to Follow-up|0|||
105902467|NCT01090050|365301299|FG001|Overall Study|Lost to Follow-up|1|||
105902468|NCT01090050|365301298|FG000|Overall Study|Lack of Efficacy|1|||
106125158|NCT02564055|366115851|FG004|Overall Study|Lost to Follow-up|1|||
105902469|NCT01090050|365301299|FG001|Overall Study|Lack of Efficacy|5|||
105902470|NCT01090050|365301298|FG000|Overall Study|Physician Decision|0|||
105902471|NCT01090050|365301299|FG001|Overall Study|Physician Decision|1|||
105902472|NCT02232061|365301300|FG000|Overall Study|Administrative problems|1|||
105902473|NCT02232061|365301300|FG000|Overall Study|Withdrawal by Subject|1|||
105902474|NCT00560703|365301301|FG000|Overall Study|Adverse Event|0|||
105902475|NCT00560703|365301302|FG001|Overall Study|Adverse Event|2|||
105902476|NCT00560703|365301301|FG000|Overall Study|Protocol Violation|0|||
105902477|NCT00560703|365301302|FG001|Overall Study|Protocol Violation|2|||
105902478|NCT00560703|365301301|FG000|Overall Study|Withdrawal by Subject|0|||
105902479|NCT00560703|365301302|FG001|Overall Study|Withdrawal by Subject|1|||
105902480|NCT00560703|365301301|FG000|Overall Study|non-compliance|0|||
105902481|NCT00560703|365301302|FG001|Overall Study|non-compliance|1|||
105902482|NCT00339833|365301303|FG000|Overall Study|Withdrawal by Subject|1|||
105902483|NCT00339833|365301304|FG001|Overall Study|Withdrawal by Subject|2|||
105902484|NCT00339833|365301303|FG000|Overall Study|toothache|0|||
105902485|NCT00339833|365301304|FG001|Overall Study|toothache|1|||
105902486|NCT00339833|365301303|FG000|Overall Study|indigestion|0|||
105902487|NCT00339833|365301304|FG001|Overall Study|indigestion|1|||
105902488|NCT00339833|365301303|FG000|Overall Study|Chest pain|0|||
105902489|NCT00339833|365301304|FG001|Overall Study|Chest pain|1|||
105902490|NCT00339833|365301303|FG000|Overall Study|minor infection|0|||
105902491|NCT00339833|365301304|FG001|Overall Study|minor infection|1|||
105902492|NCT00339833|365301303|FG000|Overall Study|Poor venous access|2|||
105902493|NCT00339833|365301304|FG001|Overall Study|Poor venous access|2|||
105902494|NCT00339833|365301303|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
105902495|NCT00339833|365301304|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
105902496|NCT00339833|365301303|FG000|Overall Study|Error in data records|1|||
105902497|NCT00339833|365301304|FG001|Overall Study|Error in data records|0|||
105902498|NCT02819440|365301305|FG000|Overall Study|Adverse Event|3|||
105902499|NCT02819440|365301306|FG001|Overall Study|Adverse Event|1|||
105902500|NCT02819440|365301305|FG000|Overall Study|Lost to Follow-up|1|||
105902501|NCT02819440|365301306|FG001|Overall Study|Lost to Follow-up|3|||
105902502|NCT02819440|365301305|FG000|Overall Study|Withdrawal by Subject|9|||
105902503|NCT02819440|365301306|FG001|Overall Study|Withdrawal by Subject|8|||
105902504|NCT00524680|365301312|FG000|Overall Study|progression|0|||
105902505|NCT00524680|365301313|FG001|Overall Study|progression|0|||
105902506|NCT00524680|365301314|FG002|Overall Study|progression|0|||
105902507|NCT00524680|365301315|FG003|Overall Study|progression|1|||
105902508|NCT00524680|365301312|FG000|Overall Study|Adverse Event|2|||
105902509|NCT00524680|365301313|FG001|Overall Study|Adverse Event|0|||
105902510|NCT00524680|365301314|FG002|Overall Study|Adverse Event|0|||
105902511|NCT00524680|365301315|FG003|Overall Study|Adverse Event|1|||
105902512|NCT00524680|365301312|FG000|Overall Study|Other|0|||
105902513|NCT00524680|365301313|FG001|Overall Study|Other|1|||
105902514|NCT00524680|365301314|FG002|Overall Study|Other|2|||
105902515|NCT00524680|365301315|FG003|Overall Study|Other|3|||
105902516|NCT00524680|365301312|FG000|Overall Study|Withdrawal by Subject|1|||
105902517|NCT00524680|365301313|FG001|Overall Study|Withdrawal by Subject|0|||
105902518|NCT00524680|365301314|FG002|Overall Study|Withdrawal by Subject|1|||
105902519|NCT00524680|365301315|FG003|Overall Study|Withdrawal by Subject|1|||
105902520|NCT00002525|365301316|FG000|Overall Study|Adverse Event|36|||
105902521|NCT00002525|365301317|FG001|Overall Study|Adverse Event|0|||
105902522|NCT00002525|365301316|FG000|Overall Study|Death|5|||
105902523|NCT00002525|365301317|FG001|Overall Study|Death|0|||
105902524|NCT00002525|365301316|FG000|Overall Study|Withdrawal by Subject|11|||
105902525|NCT00002525|365301317|FG001|Overall Study|Withdrawal by Subject|0|||
105902526|NCT00002525|365301316|FG000|Overall Study|Start non-protocol therapy|1|||
105902527|NCT00002525|365301317|FG001|Overall Study|Start non-protocol therapy|0|||
105902528|NCT00002525|365301316|FG000|Overall Study|Other complicating disease|1|||
105902529|NCT00002525|365301317|FG001|Overall Study|Other complicating disease|0|||
105902530|NCT00002525|365301316|FG000|Overall Study|Duke's A, B1, D disease|92|||
105902531|NCT00002525|365301317|FG001|Overall Study|Duke's A, B1, D disease|0|||
105902532|NCT00002525|365301316|FG000|Overall Study|Error|6|||
105902533|NCT00002525|365301317|FG001|Overall Study|Error|0|||
105902534|NCT00002525|365301316|FG000|Overall Study|Other|26|||
105902535|NCT00002525|365301317|FG001|Overall Study|Other|0|||
105902536|NCT00002525|365301316|FG000|Overall Study|Never start protocol therapy|8|||
105902537|NCT00002525|365301317|FG001|Overall Study|Never start protocol therapy|0|||
105902538|NCT00435188|365301320|FG000|Overall Study|Death|1|||
105902539|NCT00435188|365301321|FG001|Overall Study|Death|6|||
105668881|NCT00955708|364452268|FG000|Overall Study|Patient changed care provider/moved|91|||
105668882|NCT00677534|364452273|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
105668883|NCT00677534|364452273|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
105668884|NCT00677534|364452273|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
105668885|NCT02687035|364452274|FG000|Overall Study|Withdrawal by Subject|1|||
105668886|NCT02687035|364452274|FG000|Overall Study|Death|87|||
105668887|NCT02687035|364452274|FG000|Overall Study|Lost to Follow-up|1|||
105668888|NCT02687035|364452274|FG000|Overall Study|Missed Visit|87|||
105668889|NCT02687035|364452274|FG000|Overall Study|Did not receive Study Device|8|||
105668890|NCT00332462|364452275|FG000|Overall Study|Adverse Event|5|||
105668891|NCT00332462|364452275|FG000|Overall Study|Abnormal Lab Value|1|||
105668892|NCT00332462|364452275|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105668893|NCT00332462|364452275|FG000|Overall Study|no longer requires study drug|1|||
105668894|NCT00332462|364452275|FG000|Overall Study|Death|3|||
105668895|NCT00332462|364452275|FG000|Overall Study|Graft Loss|2|||
105668896|NCT01853475|364452276|FG000|Overall Study|Withdrawal by Subject|0|||
105668897|NCT01853475|364452277|FG001|Overall Study|Withdrawal by Subject|1|||
105668898|NCT01853475|364452278|FG002|Overall Study|Withdrawal by Subject|0|||
105668899|NCT00820170|364452279|FG000|Overall Study|Adverse Event|0|||
105668900|NCT00820170|364452280|FG001|Overall Study|Adverse Event|0|||
105668901|NCT00820170|364452281|FG002|Overall Study|Adverse Event|0|||
105668902|NCT00820170|364452282|FG003|Overall Study|Adverse Event|0|||
105668903|NCT00820170|364452283|FG004|Overall Study|Adverse Event|2|||
105668904|NCT00820170|364452279|FG000|Overall Study|Progressive Disease|0|||
105668905|NCT00820170|364452280|FG001|Overall Study|Progressive Disease|0|||
105668906|NCT00820170|364452281|FG002|Overall Study|Progressive Disease|0|||
105668907|NCT00820170|364452282|FG003|Overall Study|Progressive Disease|0|||
105668908|NCT00820170|364452283|FG004|Overall Study|Progressive Disease|2|||
105668909|NCT03192475|364452284|FG000|Overall Study|Death|0|||
105668910|NCT03192475|364452285|FG001|Overall Study|Death|1|||
105668911|NCT03192475|364452284|FG000|Overall Study|Lost to Follow-up|13|||
105668912|NCT03192475|364452285|FG001|Overall Study|Lost to Follow-up|8|||
105668913|NCT00755105|364452288|FG000|Overall Study|Withdrawal by Subject|9|||
105668914|NCT00755105|364452289|FG001|Overall Study|Withdrawal by Subject|11|||
105902540|NCT00435188|365301320|FG000|Overall Study|Withdrawal by Subject|16|||
105902541|NCT00435188|365301321|FG001|Overall Study|Withdrawal by Subject|11|||
105902542|NCT00435188|365301320|FG000|Overall Study|Lost to Follow-up|5|||
105998123|NCT01425801|365654851|FG004|Period 2|Withdrawal by Subject|1|||
105998124|NCT01425801|365654852|FG005|Period 2|Withdrawal by Subject|0|||
105998125|NCT01425801|365654847|FG000|Period 3|Stability criteria not fullfilled|0|||
105998126|NCT01425801|365654848|FG001|Period 3|Stability criteria not fullfilled|0|||
105998127|NCT01425801|365654849|FG002|Period 3|Stability criteria not fullfilled|1|||
105998128|NCT01425801|365654850|FG003|Period 3|Stability criteria not fullfilled|0|||
105998129|NCT01425801|365654851|FG004|Period 3|Stability criteria not fullfilled|0|||
105998130|NCT01425801|365654852|FG005|Period 3|Stability criteria not fullfilled|0|||
105998131|NCT01425801|365654847|FG000|Period 4|Not able to maintain visit schedule|0|||
105998132|NCT01425801|365654848|FG001|Period 4|Not able to maintain visit schedule|0|||
105998133|NCT01425801|365654849|FG002|Period 4|Not able to maintain visit schedule|1|||
105998134|NCT01425801|365654850|FG003|Period 4|Not able to maintain visit schedule|0|||
105902543|NCT00435188|365301321|FG001|Overall Study|Lost to Follow-up|6|||
105902544|NCT02324699|365301324|FG000|Overall Study|study terminated|1|||
105902545|NCT03244618|365301326|FG000|Overall Study|Lost to Follow-up|3|||
105902546|NCT03244618|365301327|FG001|Overall Study|Lost to Follow-up|4|||
105902547|NCT03244618|365301326|FG000|Overall Study|Protocol Violation|4|||
105902548|NCT03244618|365301327|FG001|Overall Study|Protocol Violation|3|||
105902549|NCT03244618|365301326|FG000|Overall Study|Withdrawal by Subject|0|||
105902550|NCT03244618|365301327|FG001|Overall Study|Withdrawal by Subject|2|||
105902551|NCT02083653|365301328|FG000|Overall Study|Randomized but not Treated|0|||
105902552|NCT02083653|365301329|FG001|Overall Study|Randomized but not Treated|2|||
105902553|NCT02083653|365301330|FG002|Overall Study|Randomized but not Treated|7|||
105902554|NCT02083653|365301328|FG000|Overall Study|Adverse Event|12|||
105902555|NCT02083653|365301329|FG001|Overall Study|Adverse Event|5|||
105998135|NCT01425801|365654851|FG004|Period 4|Not able to maintain visit schedule|0|||
105998136|NCT01425801|365654852|FG005|Period 4|Not able to maintain visit schedule|0|||
106125159|NCT02564055|366115852|FG005|Overall Study|Lost to Follow-up|0|||
105902556|NCT02083653|365301330|FG002|Overall Study|Adverse Event|4|||
105902557|NCT02083653|365301328|FG000|Overall Study|Lost to Follow-up|1|||
105998137|NCT02175017|365654853|FG000|Overall Study|Did not receive the investigational product|1|||
105668915|NCT00755105|364452290|FG002|Overall Study|Withdrawal by Subject|4|||
105668916|NCT02180243|364452291|FG000|Overall Study|Withdrawal by Subject|12|||
105668917|NCT02180243|364452292|FG001|Overall Study|Withdrawal by Subject|12|||
105668918|NCT02180243|364452291|FG000|Overall Study|Lost to Follow-up|12|||
105668919|NCT02180243|364452292|FG001|Overall Study|Lost to Follow-up|2|||
105668920|NCT02202785|364452293|FG000|Overall Study|Study Terminated by Sponsor|1|||
105668921|NCT02202785|364452294|FG001|Overall Study|Study Terminated by Sponsor|6|||
105902558|NCT02083653|365301329|FG001|Overall Study|Lost to Follow-up|0|||
105902559|NCT02083653|365301330|FG002|Overall Study|Lost to Follow-up|0|||
105902560|NCT02083653|365301328|FG000|Overall Study|Death|2|||
105902561|NCT02083653|365301329|FG001|Overall Study|Death|2|||
105902562|NCT02083653|365301330|FG002|Overall Study|Death|2|||
105902563|NCT02083653|365301328|FG000|Overall Study|Progressive Disease|65|||
105902564|NCT02083653|365301329|FG001|Overall Study|Progressive Disease|73|||
105902565|NCT02083653|365301330|FG002|Overall Study|Progressive Disease|63|||
105902566|NCT02083653|365301328|FG000|Overall Study|Withdrawal by Subject|2|||
105902567|NCT02083653|365301329|FG001|Overall Study|Withdrawal by Subject|1|||
105902568|NCT02083653|365301330|FG002|Overall Study|Withdrawal by Subject|2|||
105902569|NCT02083653|365301328|FG000|Overall Study|Other Events|0|||
105902570|NCT02083653|365301329|FG001|Overall Study|Other Events|2|||
105902571|NCT02083653|365301330|FG002|Overall Study|Other Events|2|||
105902572|NCT02083653|365301328|FG000|Overall Study|Reason Missing|0|||
105902573|NCT02083653|365301329|FG001|Overall Study|Reason Missing|0|||
105902574|NCT02083653|365301330|FG002|Overall Study|Reason Missing|4|||
105902575|NCT02155322|365301331|FG000|Overall Study|Adverse Event|1|||
105902576|NCT02155322|365301331|FG000|Overall Study|Physician Decision|1|||
105902577|NCT02155322|365301331|FG000|Overall Study|Relapse/Recurrence|8|||
105902578|NCT02155322|365301331|FG000|Overall Study|Withdrawal by Subject|4|||
106125160|NCT02564055|366115847|FG000|Overall Study|Physician Decision|0|||
105902579|NCT00460746|365301332|FG000|Overall Study|Adverse Event|1|||
105902580|NCT00460746|365301332|FG000|Overall Study|Lost to Follow-up|1|||
106125161|NCT02564055|366115848|FG001|Overall Study|Physician Decision|0|||
106125162|NCT02564055|366115849|FG002|Overall Study|Physician Decision|1|||
106125163|NCT02564055|366115850|FG003|Overall Study|Physician Decision|0|||
106125164|NCT02564055|366115851|FG004|Overall Study|Physician Decision|0|||
106125165|NCT02564055|366115852|FG005|Overall Study|Physician Decision|0|||
106125166|NCT02564055|366115847|FG000|Overall Study|Withdrawal by Subject|4|||
106125167|NCT02564055|366115848|FG001|Overall Study|Withdrawal by Subject|4|||
106125168|NCT02564055|366115849|FG002|Overall Study|Withdrawal by Subject|3|||
106125169|NCT02564055|366115850|FG003|Overall Study|Withdrawal by Subject|3|||
106125170|NCT02564055|366115851|FG004|Overall Study|Withdrawal by Subject|10|||
106125171|NCT02564055|366115852|FG005|Overall Study|Withdrawal by Subject|10|||
106125172|NCT03268590|366115853|FG000|Overall Study|Previously unknown exclusion criteria|1|||
106125173|NCT02080520|366115860|FG000|Overall Study|Self-reported symptoms|5|||
106125174|NCT02080520|366115861|FG001|Overall Study|Self-reported symptoms|6|||
106125175|NCT02080520|366115860|FG000|Overall Study|Unable to contact|2|||
106125176|NCT02080520|366115861|FG001|Overall Study|Unable to contact|1|||
106125177|NCT02080520|366115860|FG000|Overall Study|Initiated aspirin|2|||
106125178|NCT02080520|366115861|FG001|Overall Study|Initiated aspirin|0|||
106125179|NCT02080520|366115860|FG000|Overall Study|Atrial fibrillation|1|||
106125180|NCT02080520|366115861|FG001|Overall Study|Atrial fibrillation|1|||
106125181|NCT02080520|366115860|FG000|Overall Study|Cancer|1|||
106125182|NCT02080520|366115861|FG001|Overall Study|Cancer|2|||
106125183|NCT02080520|366115860|FG000|Overall Study|Not interested in study|1|||
106125184|NCT02080520|366115861|FG001|Overall Study|Not interested in study|3|||
106125185|NCT02080520|366115860|FG000|Overall Study|Too busy|1|||
106125186|NCT02080520|366115861|FG001|Overall Study|Too busy|1|||
106125187|NCT02080520|366115860|FG000|Overall Study|Work-related injury|1|||
106125188|NCT02080520|366115861|FG001|Overall Study|Work-related injury|0|||
106125189|NCT02080520|366115860|FG000|Overall Study|Personal reasons|0|||
106125190|NCT02080520|366115861|FG001|Overall Study|Personal reasons|3|||
106125191|NCT01349907|366115862|FG000|Overall Study|Adverse Event|37|||
106125192|NCT01349907|366115863|FG001|Overall Study|Adverse Event|11|||
106125193|NCT01349907|366115862|FG000|Overall Study|Treatment failure|13|||
106125194|NCT01349907|366115863|FG001|Overall Study|Treatment failure|4|||
106125195|NCT01349907|366115862|FG000|Overall Study|Lost to Follow-up|25|||
106125196|NCT01349907|366115863|FG001|Overall Study|Lost to Follow-up|6|||
106125197|NCT01349907|366115862|FG000|Overall Study|Withdrawal by Subject|30|||
106125198|NCT01349907|366115863|FG001|Overall Study|Withdrawal by Subject|8|||
106125199|NCT01349907|366115862|FG000|Overall Study|Protocol Violation|33|||
106125200|NCT01349907|366115863|FG001|Overall Study|Protocol Violation|13|||
106125201|NCT01349907|366115862|FG000|Overall Study|Administrative|1|||
106125202|NCT01349907|366115863|FG001|Overall Study|Administrative|1|||
106125203|NCT00109928|366115871|FG000|Overall Study|Adverse Event|2|||
105902581|NCT01603394|365301333|FG000|Overall Study|Adverse Event|1|||
105902582|NCT04399538|365301335|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
105902583|NCT04399538|365301336|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
105902584|NCT04399538|365301337|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
105902585|NCT04399538|365301338|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
105902586|NCT04399538|365301339|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
106125204|NCT00109928|366115871|FG000|Overall Study|Progression|6|||
106125205|NCT00109928|366115871|FG000|Overall Study|Death|2|||
106125206|NCT00109928|366115871|FG000|Overall Study|not protocol specified|2|||
106125207|NCT00109928|366115871|FG000|Overall Study|not eligible|1|||
106125208|NCT01196104|366115872|FG000|Overall Study|Lost to Follow-up|1|||
106125209|NCT01196104|366115873|FG001|Overall Study|Lost to Follow-up|0|||
106125210|NCT01196104|366115872|FG000|Overall Study|Physician Decision|0|||
106125211|NCT01196104|366115873|FG001|Overall Study|Physician Decision|1|||
105902587|NCT04399538|365301335|FG000|Double-Blind Treatment|Adverse Event|0|||
105902588|NCT04399538|365301336|FG001|Double-Blind Treatment|Adverse Event|0|||
105902589|NCT04399538|365301337|FG002|Double-Blind Treatment|Adverse Event|0|||
105902590|NCT04399538|365301338|FG003|Double-Blind Treatment|Adverse Event|0|||
105902591|NCT04399538|365301339|FG004|Double-Blind Treatment|Adverse Event|1|||
105902592|NCT04399538|365301335|FG000|Follow-Up|Adverse Event|0|||
105902593|NCT04399538|365301336|FG001|Follow-Up|Adverse Event|0|||
105902594|NCT04399538|365301337|FG002|Follow-Up|Adverse Event|0|||
105902595|NCT04399538|365301338|FG003|Follow-Up|Adverse Event|0|||
105902596|NCT04399538|365301339|FG004|Follow-Up|Adverse Event|1|||
105902597|NCT04399538|365301335|FG000|Follow-Up|Withdrawal by Subject|0|||
105668922|NCT02202785|364452295|FG002|Overall Study|Study Terminated by Sponsor|4|||
105668923|NCT02202785|364452293|FG000|Overall Study|Withdrawal by Subject|0|||
105902598|NCT04399538|365301336|FG001|Follow-Up|Withdrawal by Subject|0|||
105902599|NCT04399538|365301337|FG002|Follow-Up|Withdrawal by Subject|0|||
105902600|NCT04399538|365301338|FG003|Follow-Up|Withdrawal by Subject|2|||
105902601|NCT04399538|365301339|FG004|Follow-Up|Withdrawal by Subject|0|||
105902602|NCT00334295|365301340|FG000|Overall Study|Patients received fewer than 3 injection|5|||
105902603|NCT00636961|365301347|FG000|Period 1|Administrative problems|1|||
105902604|NCT00636961|365301348|FG001|Period 1|Administrative problems|1|||
105902605|NCT00636961|365301347|FG000|Period 2|Adverse Event|1|||
105902606|NCT00636961|365301348|FG001|Period 2|Adverse Event|0|||
105902607|NCT00893971|365301349|FG000|Overall Study|Physician Decision|3|||
105902608|NCT03816007|365301350|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
105902609|NCT03816007|365301351|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
105902610|NCT03816007|365301350|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
105902611|NCT03816007|365301351|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
105902612|NCT03816007|365301350|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
105902613|NCT03816007|365301351|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
105902614|NCT00856843|365301352|FG000|Overall Study|Withdrawal by Subject|1|||
105902615|NCT00856843|365301353|FG001|Overall Study|Withdrawal by Subject|5|||
105902616|NCT00856843|365301352|FG000|Overall Study|Lack of Efficacy|1|||
105902617|NCT00856843|365301353|FG001|Overall Study|Lack of Efficacy|0|||
105902618|NCT01573754|365301357|FG000|Overall Study|Noncompliance or remission not achieved|3|||
105902619|NCT01573754|365301358|FG001|Overall Study|Noncompliance or remission not achieved|15|||
105902620|NCT02685072|365301363|FG000|Treatment Period|Lost to Follow-up|12|||
105902621|NCT02685072|365301364|FG001|Treatment Period|Lost to Follow-up|6|||
105902622|NCT02685072|365301363|FG000|Treatment Period|Withdrawal by Subject|1|||
105902623|NCT02685072|365301364|FG001|Treatment Period|Withdrawal by Subject|3|||
105902624|NCT02685072|365301363|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
105902625|NCT02685072|365301364|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
105902626|NCT01237327|365301365|FG000|Overall Study|Protocol Violation: Core Study|1|||
105902627|NCT01237327|365301366|FG001|Overall Study|Protocol Violation: Core Study|0|||
105902628|NCT01237327|365301365|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
105902629|NCT01237327|365301366|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
105902630|NCT01237327|365301365|FG000|Overall Study|Progression of Disease: Core Study|18|||
105902631|NCT01237327|365301366|FG001|Overall Study|Progression of Disease: Core Study|22|||
105902632|NCT01237327|365301365|FG000|Overall Study|Progression of Disease: Extension Study|15|||
105902633|NCT01237327|365301366|FG001|Overall Study|Progression of Disease: Extension Study|13|||
105902634|NCT01237327|365301365|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
105902635|NCT01237327|365301366|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
105668924|NCT02202785|364452294|FG001|Overall Study|Withdrawal by Subject|1|||
105902636|NCT01237327|365301365|FG000|Overall Study|Withdrawal by Subject|1|||
105902637|NCT01237327|365301366|FG001|Overall Study|Withdrawal by Subject|3|||
105902638|NCT01237327|365301365|FG000|Overall Study|Lost to Follow-up|3|||
105902639|NCT01237327|365301366|FG001|Overall Study|Lost to Follow-up|0|||
105902640|NCT00262002|365301367|FG000|Overall Study|Adverse Event|2|||
105902641|NCT00262002|365301368|FG001|Overall Study|Adverse Event|1|||
105902642|NCT00262002|365301369|FG002|Overall Study|Adverse Event|0|||
105902643|NCT00262002|365301370|FG003|Overall Study|Adverse Event|0|||
105902644|NCT00262002|365301371|FG004|Overall Study|Adverse Event|0|||
105902645|NCT00262002|365301372|FG005|Overall Study|Adverse Event|1|||
105902646|NCT00262002|365301373|FG006|Overall Study|Adverse Event|0|||
105902647|NCT00262002|365301367|FG000|Overall Study|Withdrawal by Subject|4|||
105902648|NCT00262002|365301368|FG001|Overall Study|Withdrawal by Subject|2|||
105902649|NCT00262002|365301369|FG002|Overall Study|Withdrawal by Subject|0|||
105902650|NCT00262002|365301370|FG003|Overall Study|Withdrawal by Subject|1|||
105902651|NCT00262002|365301371|FG004|Overall Study|Withdrawal by Subject|2|||
105902652|NCT00262002|365301372|FG005|Overall Study|Withdrawal by Subject|2|||
105902653|NCT00262002|365301373|FG006|Overall Study|Withdrawal by Subject|2|||
105902654|NCT00262002|365301367|FG000|Overall Study|Lost to Follow-up|2|||
105902655|NCT00262002|365301368|FG001|Overall Study|Lost to Follow-up|0|||
105902656|NCT00262002|365301369|FG002|Overall Study|Lost to Follow-up|0|||
105902657|NCT00262002|365301370|FG003|Overall Study|Lost to Follow-up|2|||
105902658|NCT00262002|365301371|FG004|Overall Study|Lost to Follow-up|0|||
105902659|NCT00262002|365301372|FG005|Overall Study|Lost to Follow-up|1|||
105902660|NCT00262002|365301373|FG006|Overall Study|Lost to Follow-up|0|||
105902661|NCT00262002|365301367|FG000|Overall Study|Inapropriate enrollment|0|||
105902662|NCT00262002|365301368|FG001|Overall Study|Inapropriate enrollment|1|||
105902663|NCT00262002|365301369|FG002|Overall Study|Inapropriate enrollment|0|||
105902664|NCT00262002|365301370|FG003|Overall Study|Inapropriate enrollment|0|||
105902665|NCT00262002|365301371|FG004|Overall Study|Inapropriate enrollment|0|||
105902666|NCT00262002|365301372|FG005|Overall Study|Inapropriate enrollment|0|||
105902667|NCT00262002|365301373|FG006|Overall Study|Inapropriate enrollment|0|||
105902668|NCT00262002|365301367|FG000|Overall Study|Protocol Violation|3|||
105902669|NCT00262002|365301368|FG001|Overall Study|Protocol Violation|2|||
105902670|NCT00262002|365301369|FG002|Overall Study|Protocol Violation|0|||
105902671|NCT00262002|365301370|FG003|Overall Study|Protocol Violation|2|||
105902672|NCT00262002|365301371|FG004|Overall Study|Protocol Violation|5|||
105902673|NCT00262002|365301372|FG005|Overall Study|Protocol Violation|3|||
105902674|NCT00262002|365301373|FG006|Overall Study|Protocol Violation|2|||
105902675|NCT00262002|365301367|FG000|Overall Study|Unable to classify|0|||
105902676|NCT00262002|365301368|FG001|Overall Study|Unable to classify|0|||
105902677|NCT00262002|365301369|FG002|Overall Study|Unable to classify|0|||
105902678|NCT00262002|365301370|FG003|Overall Study|Unable to classify|0|||
105902679|NCT00262002|365301371|FG004|Overall Study|Unable to classify|0|||
105902680|NCT00262002|365301372|FG005|Overall Study|Unable to classify|0|||
105902681|NCT00262002|365301373|FG006|Overall Study|Unable to classify|2|||
105902682|NCT03885999|365301374|FG000|Overall Study|Adverse Event|1|||
105902683|NCT01451554|365301375|FG000|Overall Study|Withdrawal by Subject|14|||
105902684|NCT01451554|365301376|FG001|Overall Study|Withdrawal by Subject|9|||
105902685|NCT01790516|365301377|FG000|Overall Study|Physician Decision|1|||
105902686|NCT01790516|365301378|FG001|Overall Study|Physician Decision|0|||
105902687|NCT02749799|365301379|FG000|Overall Study|Adverse Event|2|||
105902688|NCT02749799|365301379|FG000|Overall Study|Lost to Follow-up|4|||
105902689|NCT02749799|365301379|FG000|Overall Study|Protocol Violation|1|||
105998138|NCT02175017|365654854|FG001|Overall Study|Did not receive the investigational product|2|||
105998139|NCT02175017|365654853|FG000|Overall Study|Withdrawal by Subject|6|||
105902690|NCT02749799|365301379|FG000|Overall Study|Withdrawal by Subject|1|||
105902691|NCT03178851|365301380|FG000|Overall Study|Death|48|||
105902692|NCT03178851|365301381|FG001|Overall Study|Death|2|||
105902693|NCT03178851|365301382|FG002|Overall Study|Death|25|||
105902694|NCT03178851|365301380|FG000|Overall Study|Withdrawal by Subject|8|||
105902695|NCT03178851|365301381|FG001|Overall Study|Withdrawal by Subject|0|||
105902696|NCT03178851|365301382|FG002|Overall Study|Withdrawal by Subject|0|||
105902697|NCT03178851|365301380|FG000|Overall Study|Lost to Follow-up|5|||
105902698|NCT03178851|365301381|FG001|Overall Study|Lost to Follow-up|2|||
105902699|NCT03178851|365301382|FG002|Overall Study|Lost to Follow-up|0|||
105902700|NCT03178851|365301380|FG000|Overall Study|Adverse Event|0|||
105902701|NCT03178851|365301381|FG001|Overall Study|Adverse Event|0|||
105902702|NCT03178851|365301382|FG002|Overall Study|Adverse Event|1|||
105902703|NCT03178851|365301380|FG000|Overall Study|Study Termination by Sponsor|31|||
105902704|NCT03178851|365301381|FG001|Overall Study|Study Termination by Sponsor|7|||
105902705|NCT03178851|365301382|FG002|Overall Study|Study Termination by Sponsor|26|||
105902706|NCT02669043|365301383|FG000|Overall Study|Didn't meet I/E criteria|4|||
105902707|NCT02510820|365303370|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105902708|NCT02510820|365303371|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105902709|NCT02510820|365303370|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105902710|NCT02510820|365303371|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
105902711|NCT00703326|365303375|FG000|Overall Study|Lost to Follow-up|47|||
105902712|NCT00703326|365303376|FG001|Overall Study|Lost to Follow-up|18|||
105902713|NCT00703326|365303375|FG000|Overall Study|Withdrawal by Subject|54|||
105902714|NCT00703326|365303376|FG001|Overall Study|Withdrawal by Subject|20|||
105668925|NCT02202785|364452295|FG002|Overall Study|Withdrawal by Subject|0|||
105668926|NCT02202785|364452293|FG000|Overall Study|Lost to Follow-up|0|||
105668927|NCT02202785|364452294|FG001|Overall Study|Lost to Follow-up|1|||
105668928|NCT02202785|364452295|FG002|Overall Study|Lost to Follow-up|0|||
105668929|NCT02202785|364452293|FG000|Overall Study|Reason not Specified|10|||
105668930|NCT02202785|364452294|FG001|Overall Study|Reason not Specified|7|||
105668931|NCT02202785|364452295|FG002|Overall Study|Reason not Specified|13|||
105668932|NCT01361594|364452296|FG000|Overall Study|Withdrawal by Subject|1|||
105668933|NCT01361594|364452297|FG001|Overall Study|Withdrawal by Subject|2|||
105668934|NCT01111240|364452298|FG000|Overall Study|Adverse Event|190|||
105668935|NCT01111240|364452298|FG000|Overall Study|Lack of Efficacy|545|||
105668936|NCT01111240|364452298|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
105668937|NCT01111240|364452298|FG000|Overall Study|Other|312|||
105668938|NCT04343976|364452302|FG000|Overall Study|Withdrawal by Subject|0|||
105902715|NCT00703326|365303375|FG000|Overall Study|Adverse Event|1|||
105902716|NCT00703326|365303376|FG001|Overall Study|Adverse Event|0|||
105902717|NCT01190189|365303377|FG000|Overall Study|Lost to Follow-up|4|||
105902718|NCT01190189|365303377|FG000|Overall Study|Withdrawal by Subject|1|||
105902719|NCT01190189|365303377|FG000|Overall Study|Migrated/moved from study area|1|||
105902720|NCT00171158|365303378|FG000|Core Study|Death|27|||
105902721|NCT00171158|365303378|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
105902722|NCT00171158|365303378|FG000|Core Study|Protocol Violation|4|||
105902723|NCT00171158|365303378|FG000|Core Study|Administrative problems|1|||
105902724|NCT00171158|365303378|FG000|Core Study|Adverse event, non-fatal|21|||
105902725|NCT00171158|365303378|FG000|Core Study|Consent withdrawn by subject|6|||
105902726|NCT00171158|365303378|FG000|Core Study|No longer required drug (BMT)|14|||
105902727|NCT00171158|365303378|FG000|Core Study|Abnormal Laboratory Values|2|||
105902728|NCT00171158|365303378|FG000|Core Study|Lost to Follow-up|1|||
105902729|NCT00171158|365303378|FG000|E2 Extension|Other|7|||
105902730|NCT05437640|365303379|FG000|Washout (1 Week)|Adverse Event|1|||
105902731|NCT05437640|365303380|FG001|Washout (1 Week)|Adverse Event|0|||
105902732|NCT00904917|365303381|FG000|Overall Study|Lost to Follow-up|2|||
105902733|NCT00904917|365303382|FG001|Overall Study|Lost to Follow-up|2|||
105902734|NCT00904917|365303383|FG002|Overall Study|Lost to Follow-up|2|||
105902735|NCT00904917|365303384|FG003|Overall Study|Lost to Follow-up|2|||
105902736|NCT03214679|365303388|FG000|Overall Study|Lost to Follow-up|12|||
105902737|NCT03214679|365303389|FG001|Overall Study|Lost to Follow-up|14|||
105902738|NCT03214679|365303388|FG000|Overall Study|not eligible|2|||
105902739|NCT03214679|365303389|FG001|Overall Study|not eligible|0|||
105902740|NCT01754766|365303392|FG000|Overall Study|Personal reasons|1|||
105902741|NCT01754766|365303393|FG001|Overall Study|Personal reasons|1|||
105902742|NCT01754766|365303394|FG002|Overall Study|Personal reasons|0|||
105902743|NCT04676152|365303395|FG000|Overall Study|screen fail|9|||
105902744|NCT00493311|365303423|FG000|Overall Study|Need for rescue medication|2|||
105902745|NCT00493311|365303424|FG001|Overall Study|Need for rescue medication|2|||
105902746|NCT02779075|365303425|FG000|Overall Study|Withdrawal by Subject|1|||
105902747|NCT02779075|365303426|FG001|Overall Study|Withdrawal by Subject|3|||
105902748|NCT02779075|365303425|FG000|Overall Study|IV lost during 2nd study|1|||
105902749|NCT02779075|365303426|FG001|Overall Study|IV lost during 2nd study|0|||
105902750|NCT04399889|365303433|FG000|Overall Study|Death|5|||
105902751|NCT04399889|365303434|FG001|Overall Study|Death|1|||
105902752|NCT04399889|365303435|FG002|Overall Study|Death|1|||
105902753|NCT00707980|365303436|FG000|Overall Study|Adverse Event|49|||
105902754|NCT00707980|365303436|FG000|Overall Study|Lack of Efficacy|35|||
105902755|NCT00707980|365303436|FG000|Overall Study|Non-Compliance with Study Drug|28|||
105902756|NCT00707980|365303436|FG000|Overall Study|Protocol Deviations|19|||
105902757|NCT00707980|365303436|FG000|Overall Study|Withdrawal of Consent|81|||
105668939|NCT04343976|364452303|FG001|Overall Study|Withdrawal by Subject|1|||
105902758|NCT00707980|365303436|FG000|Overall Study|Lost to Follow-up|59|||
105902759|NCT00707980|365303436|FG000|Overall Study|Other|39|||
105998140|NCT02175017|365654854|FG001|Overall Study|Withdrawal by Subject|3|||
105902760|NCT02829047|365303440|FG000|Overall Study|Withdrawal by Subject|1|||
105902761|NCT01690299|365303443|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
105902762|NCT01690299|365303444|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
105902763|NCT01690299|365303445|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
105998141|NCT02175017|365654853|FG000|Overall Study|Met an exclusion criteria|0|||
105668940|NCT00594880|364452304|FG000|Overall Study|Withdrawal by Subject|1|||
105668941|NCT00594880|364452305|FG001|Overall Study|Withdrawal by Subject|1|||
105902764|NCT01690299|365303446|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
105902765|NCT01690299|365303447|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
105902766|NCT01690299|365303448|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
105902767|NCT01690299|365303443|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
105902768|NCT01690299|365303444|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105902769|NCT01690299|365303445|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105902770|NCT01690299|365303446|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105902771|NCT01690299|365303447|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105902772|NCT01690299|365303448|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105902773|NCT01690299|365303443|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
105902774|NCT01690299|365303444|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
105902775|NCT01690299|365303445|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105902776|NCT01690299|365303446|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105902777|NCT01690299|365303447|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105902778|NCT01690299|365303448|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105902779|NCT01690299|365303443|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
105902780|NCT01690299|365303444|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
105902781|NCT01690299|365303445|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
105902782|NCT01690299|365303446|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
105902783|NCT01690299|365303447|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
105902784|NCT01690299|365303448|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
105902785|NCT01690299|365303443|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
105902786|NCT01690299|365303444|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
105902787|NCT01690299|365303445|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
105902788|NCT01690299|365303446|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
105902789|NCT01690299|365303447|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
105902790|NCT01690299|365303448|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
105902791|NCT01690299|365303443|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
105902792|NCT01690299|365303444|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
105902793|NCT01690299|365303445|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
105902794|NCT01690299|365303446|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
105902795|NCT01690299|365303447|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
105902796|NCT01690299|365303448|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
105902797|NCT01690299|365303443|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
105902798|NCT01690299|365303444|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
105902799|NCT01690299|365303445|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
105902800|NCT01690299|365303446|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
105902801|NCT01690299|365303447|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
105902802|NCT01690299|365303448|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
105902803|NCT01690299|365303443|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
105902804|NCT01690299|365303444|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
105902805|NCT01690299|365303445|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
105902806|NCT01690299|365303446|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
105902807|NCT01690299|365303447|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
105902808|NCT01690299|365303448|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
105902809|NCT01690299|365303443|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
105902810|NCT01690299|365303444|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
105902811|NCT01690299|365303445|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
105902812|NCT01690299|365303446|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
105902813|NCT01690299|365303447|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
105902814|NCT01690299|365303448|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
105902815|NCT01690299|365303443|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105902816|NCT01690299|365303444|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105902817|NCT01690299|365303445|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105902818|NCT01690299|365303446|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105902819|NCT01690299|365303447|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
105902820|NCT01690299|365303448|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
105902821|NCT04278924|365303449|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
105902822|NCT04278924|365303450|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
105902823|NCT04278924|365303451|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
105668942|NCT00594880|364452304|FG000|Overall Study|Lost to Follow-up|1|||
105668943|NCT00594880|364452305|FG001|Overall Study|Lost to Follow-up|0|||
105668944|NCT01371708|364452308|FG000|Overall Study|Insufficient clinical response|3|||
105668945|NCT01371708|364452309|FG001|Overall Study|Insufficient clinical response|2|||
105668946|NCT01371708|364452310|FG002|Overall Study|Insufficient clinical response|0|||
105668947|NCT01371708|364452308|FG000|Overall Study|Lost to Follow-up|5|||
105668948|NCT01371708|364452309|FG001|Overall Study|Lost to Follow-up|9|||
105668949|NCT01371708|364452310|FG002|Overall Study|Lost to Follow-up|7|||
105668950|NCT01371708|364452308|FG000|Overall Study|Protocol Violation|2|||
105668951|NCT01371708|364452309|FG001|Overall Study|Protocol Violation|1|||
105668952|NCT01371708|364452310|FG002|Overall Study|Protocol Violation|2|||
105668953|NCT01371708|364452308|FG000|Overall Study|No longer willing to participate|7|||
105668954|NCT01371708|364452309|FG001|Overall Study|No longer willing to participate|7|||
105668955|NCT01371708|364452310|FG002|Overall Study|No longer willing to participate|13|||
105668956|NCT01371708|364452308|FG000|Overall Study|Medication error/not related to AE|0|||
106125212|NCT01196104|366115872|FG000|Overall Study|Withdrawal by Subject|3|||
105668957|NCT01371708|364452309|FG001|Overall Study|Medication error/not related to AE|1|||
105668958|NCT01371708|364452310|FG002|Overall Study|Medication error/not related to AE|0|||
105668959|NCT01371708|364452308|FG000|Overall Study|Other|3|||
105668960|NCT01371708|364452309|FG001|Overall Study|Other|2|||
105668961|NCT01371708|364452310|FG002|Overall Study|Other|4|||
105668962|NCT01371708|364452308|FG000|Overall Study|Adverse Event|5|||
105668963|NCT01371708|364452309|FG001|Overall Study|Adverse Event|8|||
105668964|NCT01371708|364452310|FG002|Overall Study|Adverse Event|12|||
105668965|NCT01371708|364452308|FG000|Overall Study|Started but did not receive treatment|1|||
105668966|NCT01371708|364452309|FG001|Overall Study|Started but did not receive treatment|0|||
105668967|NCT01371708|364452310|FG002|Overall Study|Started but did not receive treatment|1|||
105668968|NCT00694109|364452311|FG000|Overall Study|Physician Decision|3|||
105668969|NCT00694109|364452311|FG000|Overall Study|Adverse Event|74|||
105668970|NCT00694109|364452311|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
105668971|NCT00694109|364452311|FG000|Overall Study|Lack of Efficacy|2|||
105668972|NCT00694109|364452311|FG000|Overall Study|Withdrawal by Subject|13|||
105668973|NCT00694109|364452311|FG000|Overall Study|Pregnancy|1|||
105668974|NCT00694109|364452311|FG000|Overall Study|Enrolled but not treated|1|||
105668975|NCT00694109|364452311|FG000|Overall Study|Other|2|||
105668976|NCT00694109|364452311|FG000|Overall Study|Consented but no additional treatment|3|||
105668977|NCT02514551|364452312|FG000|Overall Study|Lost to Follow-up|0|||
105668978|NCT02514551|364452313|FG001|Overall Study|Lost to Follow-up|1|||
105668979|NCT02514551|364452312|FG000|Overall Study|Participant Never Treated|0|||
105668980|NCT02514551|364452313|FG001|Overall Study|Participant Never Treated|2|||
105668981|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
105668982|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
105668983|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
105668984|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
105668985|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
105668986|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
105668987|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
105668988|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
105668989|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
105668990|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
105902824|NCT04278924|365303452|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
105902825|NCT04278924|365303453|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
105902826|NCT04278924|365303454|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
105902827|NCT04278924|365303455|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
105902828|NCT04278924|365303449|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
106125213|NCT01196104|366115873|FG001|Overall Study|Withdrawal by Subject|3|||
106125214|NCT01196104|366115872|FG000|Overall Study|Various|0|||
105668991|NCT00245960|364452314|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
105668992|NCT00245960|364452315|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
105668993|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
105668994|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
105668995|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
105668996|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
105668997|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
105668998|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
106125215|NCT01196104|366115873|FG001|Overall Study|Various|1|||
106125216|NCT00610675|366115874|FG000|Overall Study|Untreated|4|||
105668999|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
106125217|NCT00610675|366115874|FG000|Overall Study|Adverse Event|67|||
106125218|NCT00610675|366115874|FG000|Overall Study|Insufficient Effect|31|||
106125219|NCT00610675|366115874|FG000|Overall Study|Withdrawal by Subject|28|||
106125220|NCT00610675|366115874|FG000|Overall Study|Reasons unrelated to trial|27|||
105669000|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
105669001|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
105902829|NCT04278924|365303450|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
105902830|NCT04278924|365303451|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
105902831|NCT04278924|365303452|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
105902832|NCT04278924|365303453|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
105902833|NCT04278924|365303454|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
105902834|NCT04278924|365303455|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
105902835|NCT05161481|365303456|FG000|Overall Study|Withdrawal of consent|0|||
105902836|NCT05161481|365303457|FG001|Overall Study|Withdrawal of consent|1|||
105902837|NCT05161481|365303458|FG002|Overall Study|Withdrawal of consent|1|||
105902838|NCT05161481|365303456|FG000|Overall Study|Study terminated by sponsor|3|||
105902839|NCT05161481|365303457|FG001|Overall Study|Study terminated by sponsor|3|||
105902840|NCT05161481|365303458|FG002|Overall Study|Study terminated by sponsor|2|||
105902841|NCT05161481|365303456|FG000|Overall Study|Adverse Event|3|||
105902842|NCT05161481|365303457|FG001|Overall Study|Adverse Event|0|||
105902843|NCT05161481|365303458|FG002|Overall Study|Adverse Event|6|||
105902844|NCT05161481|365303456|FG000|Overall Study|Randomised in error and was not treated|1|||
105902845|NCT05161481|365303457|FG001|Overall Study|Randomised in error and was not treated|0|||
105902846|NCT05161481|365303458|FG002|Overall Study|Randomised in error and was not treated|0|||
105902847|NCT05161481|365303456|FG000|Overall Study|Subject decision|0|||
105902848|NCT05161481|365303457|FG001|Overall Study|Subject decision|0|||
105902849|NCT05161481|365303458|FG002|Overall Study|Subject decision|1|||
105902850|NCT06010732|365303459|FG000|Crossover Period 1|Protocol Violation|0|||
105902851|NCT06010732|365303460|FG001|Crossover Period 1|Protocol Violation|0|||
105902852|NCT06010732|365303461|FG002|Crossover Period 1|Protocol Violation|1|||
105902853|NCT06010732|365303462|FG003|Crossover Period 1|Protocol Violation|0|||
105902854|NCT06010732|365303463|FG004|Crossover Period 1|Protocol Violation|1|||
105902855|NCT06010732|365303464|FG005|Crossover Period 1|Protocol Violation|0|||
105902856|NCT06010732|365303459|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105902857|NCT06010732|365303460|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
105902858|NCT06010732|365303461|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105902859|NCT06010732|365303462|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105902860|NCT06010732|365303463|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105902861|NCT06010732|365303464|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
105902862|NCT06010732|365303459|FG000|Crossover Period 2|Adverse Event|0|||
105902863|NCT06010732|365303460|FG001|Crossover Period 2|Adverse Event|1|||
105902864|NCT06010732|365303461|FG002|Crossover Period 2|Adverse Event|0|||
105902865|NCT06010732|365303462|FG003|Crossover Period 2|Adverse Event|0|||
105902866|NCT06010732|365303463|FG004|Crossover Period 2|Adverse Event|0|||
105902867|NCT06010732|365303464|FG005|Crossover Period 2|Adverse Event|0|||
105902868|NCT06010732|365303459|FG000|Crossover Period 2|broken denture|0|||
105902869|NCT06010732|365303460|FG001|Crossover Period 2|broken denture|0|||
105902870|NCT06010732|365303461|FG002|Crossover Period 2|broken denture|1|||
105902871|NCT06010732|365303462|FG003|Crossover Period 2|broken denture|0|||
105902872|NCT06010732|365303463|FG004|Crossover Period 2|broken denture|0|||
105902873|NCT06010732|365303464|FG005|Crossover Period 2|broken denture|0|||
105902874|NCT04401202|365303465|FG000|Overall Study|Lost to Follow-up|2|||
105902875|NCT04401202|365303466|FG001|Overall Study|Lost to Follow-up|2|||
105902876|NCT04401202|365303465|FG000|Overall Study|Adverse Event|0|||
105902877|NCT04401202|365303466|FG001|Overall Study|Adverse Event|1|||
105902878|NCT04401202|365303465|FG000|Overall Study|Hospitalized|4|||
105902879|NCT04401202|365303466|FG001|Overall Study|Hospitalized|1|||
105902880|NCT01716520|365303470|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
105902881|NCT01716520|365303471|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
105902882|NCT01716520|365303472|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
105902883|NCT01716520|365303473|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
105902884|NCT01716520|365303474|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
105902885|NCT01716520|365303475|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
105669002|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
105902886|NCT01716520|365303470|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
105902887|NCT01716520|365303471|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
105902888|NCT01716520|365303472|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
105902889|NCT01716520|365303473|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
105902890|NCT01716520|365303474|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
105902891|NCT01716520|365303475|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
105902892|NCT01716520|365303470|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105902893|NCT01716520|365303471|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105902894|NCT01716520|365303472|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105902895|NCT01716520|365303473|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105902896|NCT01716520|365303474|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105902897|NCT01716520|365303475|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105902898|NCT01716520|365303470|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105902899|NCT01716520|365303471|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
105902900|NCT01716520|365303472|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105902901|NCT01716520|365303473|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105902902|NCT01716520|365303474|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105902903|NCT01716520|365303475|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
105902904|NCT01716520|365303470|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105902905|NCT01716520|365303471|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105902906|NCT01716520|365303472|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105902907|NCT01716520|365303473|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105902908|NCT01716520|365303474|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105902909|NCT01716520|365303475|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
105669003|NCT00245960|364452314|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
105669004|NCT00245960|364452315|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
105669005|NCT03197766|364452316|FG000|Overall Study|Withdrawal by Subject|2|||
105669006|NCT03197766|364452317|FG001|Overall Study|Withdrawal by Subject|0|||
105669007|NCT01607476|364452322|FG000|Overall Study|Withdrawal by Subject|1|||
105902910|NCT01716520|365303470|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
105902911|NCT01716520|365303471|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
105902912|NCT01716520|365303472|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
105902913|NCT01716520|365303473|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
105902914|NCT01716520|365303474|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
105902915|NCT01716520|365303475|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
105902916|NCT01716520|365303470|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
105902917|NCT01716520|365303471|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
105902918|NCT01716520|365303472|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
105902919|NCT01716520|365303473|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
105902920|NCT01716520|365303474|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
105902921|NCT01716520|365303475|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
105902922|NCT01716520|365303470|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105902923|NCT01716520|365303471|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105902924|NCT01716520|365303472|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105902925|NCT01716520|365303473|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105902926|NCT01716520|365303474|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105902927|NCT01716520|365303475|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105902928|NCT01716520|365303470|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105902929|NCT01716520|365303471|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105902930|NCT01716520|365303472|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105902931|NCT01716520|365303473|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
105902932|NCT01716520|365303474|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105902933|NCT01716520|365303475|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
105902934|NCT01716520|365303470|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
105902935|NCT01716520|365303471|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
105669008|NCT01607476|364452323|FG001|Overall Study|Withdrawal by Subject|0|||
105902936|NCT01716520|365303472|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
105902937|NCT01716520|365303473|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
105902938|NCT01716520|365303474|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
105902939|NCT01716520|365303475|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
105902940|NCT01716520|365303470|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
105902941|NCT01716520|365303471|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105902942|NCT01716520|365303472|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105902943|NCT01716520|365303473|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105902944|NCT01716520|365303474|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105902945|NCT01716520|365303475|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
105902946|NCT01716520|365303470|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105902947|NCT01716520|365303471|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105902948|NCT01716520|365303472|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105902949|NCT01716520|365303473|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
105902950|NCT01716520|365303474|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
106125221|NCT00610675|366115874|FG000|Overall Study|Lack of Compliance|7|||
105669009|NCT01607476|364452324|FG002|Overall Study|Withdrawal by Subject|1|||
105669010|NCT01607476|364452322|FG000|Overall Study|Lost to Follow-up|0|||
105902951|NCT01716520|365303475|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
105902952|NCT01716520|365303470|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105902953|NCT01716520|365303471|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
105902954|NCT01716520|365303472|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105669011|NCT01607476|364452323|FG001|Overall Study|Lost to Follow-up|0|||
105669012|NCT01607476|364452324|FG002|Overall Study|Lost to Follow-up|2|||
105669013|NCT02833077|364452331|FG000|Overall Study|Adverse Event|1|||
105669014|NCT02833077|364452332|FG001|Overall Study|Adverse Event|2|||
106125222|NCT00610675|366115874|FG000|Overall Study|Lost to Follow-up|31|||
106125223|NCT00610675|366115874|FG000|Overall Study|Other reason (not specified)|25|||
106125224|NCT02761629|366115875|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
106125225|NCT02761629|366115876|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
106125226|NCT02761629|366115875|FG000|Overall Study|Insufficient Therapeutic Response|2|||
106125227|NCT02761629|366115876|FG001|Overall Study|Insufficient Therapeutic Response|7|||
106125228|NCT02761629|366115875|FG000|Overall Study|Failure to Return|2|||
105786017|NCT03556202|364870444|FG000|Extension Treatment Period|Adverse Event|18|||
105786018|NCT03556202|364870445|FG001|Extension Treatment Period|Adverse Event|14|||
105786019|NCT03556202|364870446|FG002|Extension Treatment Period|Adverse Event|9|||
105786020|NCT03556202|364870444|FG000|Extension Treatment Period|Death|2|||
105786021|NCT03556202|364870445|FG001|Extension Treatment Period|Death|6|||
105786022|NCT03556202|364870446|FG002|Extension Treatment Period|Death|0|||
105786023|NCT03556202|364870444|FG000|Extension Treatment Period|Lack of Efficacy|5|||
105786024|NCT03556202|364870445|FG001|Extension Treatment Period|Lack of Efficacy|12|||
105786025|NCT03556202|364870446|FG002|Extension Treatment Period|Lack of Efficacy|18|||
105786026|NCT03556202|364870444|FG000|Extension Treatment Period|Lost to Follow-up|9|||
105786027|NCT03556202|364870445|FG001|Extension Treatment Period|Lost to Follow-up|20|||
105786028|NCT03556202|364870446|FG002|Extension Treatment Period|Lost to Follow-up|2|||
105786029|NCT03556202|364870444|FG000|Extension Treatment Period|Pregnancy|2|||
105786030|NCT03556202|364870445|FG001|Extension Treatment Period|Pregnancy|4|||
105786031|NCT03556202|364870446|FG002|Extension Treatment Period|Pregnancy|3|||
105786032|NCT03556202|364870444|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
105786033|NCT03556202|364870445|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
105786034|NCT03556202|364870446|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
105786035|NCT03556202|364870444|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
105786036|NCT03556202|364870445|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
105786037|NCT03556202|364870446|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
105786038|NCT03556202|364870444|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
105786039|NCT03556202|364870445|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
105786040|NCT03556202|364870446|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
105786041|NCT03556202|364870444|FG000|Extension Treatment Period|Physician Decision|0|||
105786042|NCT03556202|364870445|FG001|Extension Treatment Period|Physician Decision|8|||
105786043|NCT03556202|364870446|FG002|Extension Treatment Period|Physician Decision|2|||
105786044|NCT03556202|364870444|FG000|Extension Treatment Period|Protocol Violation|0|||
105786045|NCT03556202|364870445|FG001|Extension Treatment Period|Protocol Violation|1|||
105786046|NCT03556202|364870446|FG002|Extension Treatment Period|Protocol Violation|1|||
105786047|NCT03556202|364870444|FG000|Extension Treatment Period|Sponsor Decision|0|||
105786048|NCT03556202|364870445|FG001|Extension Treatment Period|Sponsor Decision|1|||
105786049|NCT03556202|364870446|FG002|Extension Treatment Period|Sponsor Decision|0|||
105786050|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
105786051|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
105786052|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
105786053|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Death|1|||
105786054|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Death|0|||
105786055|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Death|0|||
105786056|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
105786057|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
105786058|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
105786059|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
105786060|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
105786061|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
105786062|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
105902955|NCT01716520|365303473|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105902956|NCT01716520|365303474|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105902957|NCT01716520|365303475|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
105902958|NCT01716520|365303470|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105902959|NCT01716520|365303471|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105902960|NCT01716520|365303472|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105902961|NCT01716520|365303473|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105902962|NCT01716520|365303474|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105902963|NCT01716520|365303475|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
105902964|NCT01716520|365303470|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105902965|NCT01716520|365303471|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105902966|NCT01716520|365303472|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
105902967|NCT01716520|365303473|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105902968|NCT01716520|365303474|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105902969|NCT01716520|365303475|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105902970|NCT00162097|365303477|FG000|Overall Study|Participant no longer met study criteria|0|||
106125229|NCT02761629|366115876|FG001|Overall Study|Failure to Return|4|||
105902971|NCT00162097|365303478|FG001|Overall Study|Participant no longer met study criteria|0|||
105902972|NCT00162097|365303479|FG002|Overall Study|Participant no longer met study criteria|0|||
105902973|NCT00162097|365303480|FG003|Overall Study|Participant no longer met study criteria|1|||
105902974|NCT01964716|365303487|FG000|Overall Study|Withdrawal by Subject|2|||
105902975|NCT01964716|365303488|FG001|Overall Study|Withdrawal by Subject|3|||
105902976|NCT01964716|365303487|FG000|Overall Study|Lost to Follow-up|1|||
105902977|NCT01964716|365303488|FG001|Overall Study|Lost to Follow-up|2|||
105902978|NCT01964716|365303487|FG000|Overall Study|No longer met eligibility criteria|1|||
105902979|NCT01964716|365303488|FG001|Overall Study|No longer met eligibility criteria|1|||
105902980|NCT01964716|365303487|FG000|Overall Study|Death|1|||
105902981|NCT01964716|365303488|FG001|Overall Study|Death|0|||
105902982|NCT03148067|365303489|FG000|Overall Study|Lost to Follow-up|3|||
105902983|NCT03148067|365303489|FG000|Overall Study|Death|1|||
105902984|NCT02559570|365303490|FG000|Overall Study|Adverse Event|0|||
105902985|NCT02559570|365303491|FG001|Overall Study|Adverse Event|2|||
105902986|NCT02559570|365303492|FG002|Overall Study|Adverse Event|0|||
105902987|NCT02559570|365303493|FG003|Overall Study|Adverse Event|1|||
105902988|NCT02559570|365303494|FG004|Overall Study|Adverse Event|0|||
105902989|NCT02559570|365303490|FG000|Overall Study|Withdrawal of Consent|0|||
105902990|NCT02559570|365303491|FG001|Overall Study|Withdrawal of Consent|0|||
105902991|NCT02559570|365303492|FG002|Overall Study|Withdrawal of Consent|1|||
105902992|NCT02559570|365303493|FG003|Overall Study|Withdrawal of Consent|2|||
105902993|NCT02559570|365303494|FG004|Overall Study|Withdrawal of Consent|1|||
105902994|NCT02559570|365303490|FG000|Overall Study|Lost to Follow-up|1|||
105902995|NCT02559570|365303491|FG001|Overall Study|Lost to Follow-up|0|||
105902996|NCT02559570|365303492|FG002|Overall Study|Lost to Follow-up|0|||
105902997|NCT02559570|365303493|FG003|Overall Study|Lost to Follow-up|0|||
105902998|NCT02559570|365303494|FG004|Overall Study|Lost to Follow-up|0|||
105902999|NCT02559570|365303490|FG000|Overall Study|Protocol Violation|1|||
105903000|NCT02559570|365303491|FG001|Overall Study|Protocol Violation|0|||
105903001|NCT02559570|365303492|FG002|Overall Study|Protocol Violation|0|||
105903002|NCT02559570|365303493|FG003|Overall Study|Protocol Violation|0|||
105903003|NCT02559570|365303494|FG004|Overall Study|Protocol Violation|1|||
105903004|NCT02559570|365303490|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105903005|NCT02559570|365303491|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105998142|NCT02175017|365654854|FG001|Overall Study|Met an exclusion criteria|1|||
105998143|NCT02175017|365654853|FG000|Overall Study|Adverse Event|3|||
105998144|NCT02175017|365654854|FG001|Overall Study|Adverse Event|10|||
105998145|NCT02175017|365654853|FG000|Overall Study|Disease progression|20|||
105998146|NCT02175017|365654854|FG001|Overall Study|Disease progression|27|||
105998147|NCT02175017|365654853|FG000|Overall Study|Other than above reasons|3|||
105998148|NCT02175017|365654854|FG001|Overall Study|Other than above reasons|0|||
105998149|NCT02741635|365654859|FG000|Overall Study|Withdrawal by Subject|1|||
105998150|NCT00104650|365654863|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
105998151|NCT00104650|365654864|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
105998152|NCT00104650|365654865|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
105998153|NCT00104650|365654863|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
105998154|NCT00104650|365654864|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
105998155|NCT00104650|365654865|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
105998156|NCT00104650|365654863|FG000|Treatment Period (25 Weeks)|Death|7|||
105998157|NCT00104650|365654864|FG001|Treatment Period (25 Weeks)|Death|5|||
105998158|NCT00104650|365654865|FG002|Treatment Period (25 Weeks)|Death|6|||
105998159|NCT00104650|365654863|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
105998160|NCT00104650|365654864|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
105998161|NCT00104650|365654865|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
105998162|NCT00104650|365654863|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
105998163|NCT00104650|365654864|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
105998164|NCT00104650|365654865|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
105998165|NCT00104650|365654863|FG000|Treatment Period (25 Weeks)|Other|1|||
105998166|NCT00104650|365654864|FG001|Treatment Period (25 Weeks)|Other|0|||
105998167|NCT00104650|365654865|FG002|Treatment Period (25 Weeks)|Other|0|||
105998168|NCT00104650|365654863|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
105998169|NCT00104650|365654864|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
105998170|NCT00104650|365654865|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
105998171|NCT00104650|365654863|FG000|Follow-up Period|Physician Decision|1|||
105998172|NCT00104650|365654864|FG001|Follow-up Period|Physician Decision|1|||
105998173|NCT00104650|365654865|FG002|Follow-up Period|Physician Decision|0|||
105998174|NCT00104650|365654863|FG000|Follow-up Period|Adverse Event|1|||
105998175|NCT00104650|365654864|FG001|Follow-up Period|Adverse Event|0|||
105998176|NCT00104650|365654865|FG002|Follow-up Period|Adverse Event|1|||
105669015|NCT02833077|364452331|FG000|Overall Study|Lost to Follow-up|10|||
105786063|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
105998177|NCT00104650|365654863|FG000|Follow-up Period|Withdrawal by Subject|0|||
105669016|NCT02833077|364452332|FG001|Overall Study|Lost to Follow-up|1|||
105903006|NCT02559570|365303492|FG002|Overall Study|Other Miscellaneous Reasons|1|||
105903007|NCT02559570|365303493|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105903008|NCT02559570|365303494|FG004|Overall Study|Other Miscellaneous Reasons|0|||
105903009|NCT01146561|365303497|FG000|Overall Study|Withdrawal by Subject|1|||
105903010|NCT01146561|365303497|FG000|Overall Study|Lost to Follow-up|1|||
105903011|NCT03124537|365303498|FG000|Overall Study|Lost to Follow-up|3|||
105903012|NCT03124537|365303499|FG001|Overall Study|Lost to Follow-up|5|||
105903013|NCT03124537|365303498|FG000|Overall Study|App Crash, Incomplete Data|7|||
105903014|NCT03124537|365303499|FG001|Overall Study|App Crash, Incomplete Data|8|||
105903015|NCT03681184|365303500|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
105903016|NCT03681184|365303501|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
105903017|NCT00396383|365303504|FG000|Overall Study|Death|2|||
105903018|NCT00396383|365303504|FG000|Overall Study|Lost to Follow-up|1|||
105903019|NCT00048165|365303505|FG000|Completed 6 Months Study|Administration/Other|8|||
105903020|NCT00048165|365303506|FG001|Completed 6 Months Study|Administration/Other|8|||
105903021|NCT00048165|365303505|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
105903022|NCT00048165|365303506|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
105903023|NCT00048165|365303505|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
105903024|NCT00048165|365303506|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
105903025|NCT00048165|365303505|FG000|Completed 6 Months Study|Death|12|||
105903026|NCT00048165|365303506|FG001|Completed 6 Months Study|Death|6|||
105903027|NCT00048165|365303505|FG000|Completed 6 Months Study|Insufficient therapy|1|||
105903028|NCT00048165|365303506|FG001|Completed 6 Months Study|Insufficient therapy|4|||
105903029|NCT00048165|365303505|FG000|Completed 6 Months Study|Other violation|4|||
105903030|NCT00048165|365303506|FG001|Completed 6 Months Study|Other violation|6|||
105903031|NCT00048165|365303505|FG000|Completed 6 Months Study|Refused treatment|5|||
105903032|NCT00048165|365303506|FG001|Completed 6 Months Study|Refused treatment|5|||
105903033|NCT00048165|365303505|FG000|Completed 6 Months Study|Violation criteria|0|||
105903034|NCT00048165|365303506|FG001|Completed 6 Months Study|Violation criteria|2|||
105903035|NCT00048165|365303505|FG000|Completed 6 Months Study|Did not receive study drug|6|||
105903036|NCT00048165|365303506|FG001|Completed 6 Months Study|Did not receive study drug|6|||
105903037|NCT00048165|365303505|FG000|Completed 12 Months Study|Administration/Other|0|||
105903038|NCT00048165|365303506|FG001|Completed 12 Months Study|Administration/Other|2|||
105903039|NCT00048165|365303505|FG000|Completed 12 Months Study|Death|2|||
105903040|NCT00048165|365303506|FG001|Completed 12 Months Study|Death|1|||
105903041|NCT00048165|365303505|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
105903042|NCT00048165|365303506|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
105903043|NCT01605825|365303515|FG000|Overall Study|Adverse Event|4|||
105903044|NCT01605825|365303516|FG001|Overall Study|Adverse Event|2|||
105903045|NCT01605825|365303515|FG000|Overall Study|Withdrawal by Subject|0|||
105903046|NCT01605825|365303516|FG001|Overall Study|Withdrawal by Subject|1|||
105903047|NCT01605825|365303515|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
105903048|NCT01605825|365303516|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
105903049|NCT01605825|365303515|FG000|Overall Study|Non-Compliance with Protocol|3|||
105903050|NCT01605825|365303516|FG001|Overall Study|Non-Compliance with Protocol|0|||
105903051|NCT02223364|365303529|FG000|Overall Study|Protocol Violation|3|||
105903052|NCT02223364|365303530|FG001|Overall Study|Protocol Violation|0|||
105903053|NCT02223364|365303531|FG002|Overall Study|Protocol Violation|3|||
105903054|NCT02223364|365303529|FG000|Overall Study|subject expired before surgery|1|||
105903055|NCT02223364|365303530|FG001|Overall Study|subject expired before surgery|0|||
105903056|NCT02223364|365303531|FG002|Overall Study|subject expired before surgery|0|||
105903057|NCT02223364|365303529|FG000|Overall Study|Physician Decision|1|||
105903058|NCT02223364|365303530|FG001|Overall Study|Physician Decision|0|||
105903059|NCT02223364|365303531|FG002|Overall Study|Physician Decision|0|||
105903060|NCT01841567|365303532|FG000|Overall Study|Adverse Event|3|||
105903061|NCT01366638|365303533|FG000|Overall Study|Withdrawal by Subject|0|||
105903062|NCT01366638|365303534|FG001|Overall Study|Withdrawal by Subject|0|||
105903063|NCT01366638|365303535|FG002|Overall Study|Withdrawal by Subject|6|||
105903064|NCT01366638|365303533|FG000|Overall Study|Other|1|||
105903065|NCT01366638|365303534|FG001|Overall Study|Other|0|||
105903066|NCT01366638|365303535|FG002|Overall Study|Other|0|||
105903067|NCT00636636|365303536|FG000|Overall Study|Other reason|4|||
105903068|NCT00636636|365303537|FG001|Overall Study|Other reason|6|||
105903069|NCT00636636|365303536|FG000|Overall Study|Adverse Event|19|||
105903070|NCT00636636|365303537|FG001|Overall Study|Adverse Event|8|||
105903071|NCT00636636|365303536|FG000|Overall Study|Lack of Efficacy|7|||
105903072|NCT00636636|365303537|FG001|Overall Study|Lack of Efficacy|12|||
105903073|NCT00636636|365303536|FG000|Overall Study|Protocol Violation|2|||
105903074|NCT00636636|365303537|FG001|Overall Study|Protocol Violation|2|||
105903075|NCT00636636|365303536|FG000|Overall Study|Lost to Follow-up|0|||
105903076|NCT00636636|365303537|FG001|Overall Study|Lost to Follow-up|1|||
105903077|NCT00636636|365303536|FG000|Overall Study|Death|0|||
105998178|NCT00104650|365654864|FG001|Follow-up Period|Withdrawal by Subject|3|||
105903078|NCT00636636|365303537|FG001|Overall Study|Death|1|||
105903079|NCT00636636|365303536|FG000|Overall Study|Withdrawal by Subject|4|||
106125230|NCT02761629|366115875|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
106125231|NCT02761629|366115876|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
106125232|NCT02761629|366115875|FG000|Overall Study|Protocol Violation|2|||
106125233|NCT02761629|366115876|FG001|Overall Study|Protocol Violation|2|||
106125234|NCT02761629|366115875|FG000|Overall Study|Withdrawal by Subject|0|||
106125235|NCT02761629|366115876|FG001|Overall Study|Withdrawal by Subject|3|||
106125236|NCT02761629|366115875|FG000|Overall Study|Other|0|||
106125237|NCT02761629|366115876|FG001|Overall Study|Other|2|||
106125238|NCT02761629|366115875|FG000|Overall Study|Lost to Follow-up|4|||
106125239|NCT02761629|366115876|FG001|Overall Study|Lost to Follow-up|1|||
106125240|NCT02761629|366115875|FG000|Overall Study|Randomized But Not Treated|8|||
106125241|NCT02761629|366115876|FG001|Overall Study|Randomized But Not Treated|4|||
106125242|NCT01316692|366115877|FG000|Overall Study|Adverse Event|5|||
106125243|NCT01316692|366115877|FG000|Overall Study|Disease Progression|7|||
106125244|NCT02001974|366115886|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
106125245|NCT02001974|366115887|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
106125246|NCT02001974|366115888|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
106125247|NCT02001974|366115886|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
106125248|NCT02001974|366115887|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
106125249|NCT02001974|366115888|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
106125250|NCT02001974|366115886|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
106125251|NCT02001974|366115887|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
106125252|NCT02001974|366115888|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
106125253|NCT02001974|366115886|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
106125254|NCT02001974|366115887|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
106125255|NCT02001974|366115888|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
106125256|NCT02374593|366115889|FG000|Overall Study|non-compliant|2|||
106125257|NCT02374593|366115890|FG001|Overall Study|non-compliant|0|||
106125258|NCT04716881|366115895|FG000|Overall Study|Adverse Event|1|||
105669017|NCT02833077|364452331|FG000|Overall Study|Personal Reasons|6|||
105669018|NCT02833077|364452332|FG001|Overall Study|Personal Reasons|4|||
106125259|NCT04716881|366115895|FG000|Overall Study|Lost to Follow-up|1|||
106125260|NCT00393094|366115896|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
106125261|NCT00393094|366115896|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
106125262|NCT00507026|366115899|FG000|Overall Study|Lack of Efficacy|6|||
106125263|NCT00507026|366115900|FG001|Overall Study|Lack of Efficacy|4|||
106125264|NCT00507026|366115901|FG002|Overall Study|Lack of Efficacy|21|||
106125265|NCT00507026|366115899|FG000|Overall Study|Withdrawal by Subject|2|||
105669019|NCT02833077|364452331|FG000|Overall Study|Protocol Deviation|0|||
105669020|NCT02833077|364452332|FG001|Overall Study|Protocol Deviation|1|||
105669021|NCT01077518|364452333|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
105669022|NCT01077518|364452334|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
105669023|NCT01077518|364452335|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
105669024|NCT01077518|364452333|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
105669025|NCT01077518|364452334|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
105669026|NCT01077518|364452335|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
105669027|NCT01077518|364452333|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
105669028|NCT01077518|364452334|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
105669029|NCT01077518|364452335|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
105669030|NCT01077518|364452333|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
105669031|NCT01077518|364452334|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
105669032|NCT01077518|364452335|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
105669033|NCT01077518|364452333|FG000|Optional Ofa Phase|Physician Decision|0|||
105669034|NCT01077518|364452334|FG001|Optional Ofa Phase|Physician Decision|0|||
105669035|NCT01077518|364452335|FG002|Optional Ofa Phase|Physician Decision|1|||
105669036|NCT01077518|364452333|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
105669037|NCT01077518|364452334|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
106125266|NCT00507026|366115900|FG001|Overall Study|Withdrawal by Subject|0|||
106125267|NCT00507026|366115901|FG002|Overall Study|Withdrawal by Subject|0|||
106125268|NCT00507026|366115899|FG000|Overall Study|Investigator Decision|1|||
105669038|NCT01077518|364452335|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
105669039|NCT01077518|364452333|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
106125269|NCT00507026|366115900|FG001|Overall Study|Investigator Decision|0|||
106125270|NCT00507026|366115901|FG002|Overall Study|Investigator Decision|0|||
106125271|NCT00507026|366115899|FG000|Overall Study|Adverse Event|2|||
106125272|NCT00507026|366115900|FG001|Overall Study|Adverse Event|0|||
106125273|NCT00507026|366115901|FG002|Overall Study|Adverse Event|0|||
106125274|NCT00507026|366115899|FG000|Overall Study|Protocol Violation|1|||
106125275|NCT00507026|366115900|FG001|Overall Study|Protocol Violation|0|||
106125276|NCT00507026|366115901|FG002|Overall Study|Protocol Violation|0|||
105669040|NCT01077518|364452334|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
105903080|NCT00636636|365303537|FG001|Overall Study|Withdrawal by Subject|9|||
105903081|NCT02483572|365303538|FG000|Overall Study|Withdrawal by Subject|1|||
105903082|NCT02483572|365303539|FG001|Overall Study|Withdrawal by Subject|0|||
105903083|NCT02483572|365303538|FG000|Overall Study|Lost to Follow-up|1|||
105903084|NCT02483572|365303539|FG001|Overall Study|Lost to Follow-up|0|||
105903085|NCT02483572|365303538|FG000|Overall Study|Physician Decision|0|||
105903086|NCT02483572|365303539|FG001|Overall Study|Physician Decision|1|||
105903087|NCT05052697|365303543|FG000|Substudy A|Lost to Follow-up|0|||
105903088|NCT05052697|365303544|FG001|Substudy A|Lost to Follow-up|0|||
105903089|NCT05052697|365303545|FG002|Substudy A|Lost to Follow-up|0|||
105903090|NCT05052697|365303546|FG003|Substudy A|Lost to Follow-up|0|||
105903091|NCT05052697|365303547|FG004|Substudy A|Lost to Follow-up|0|||
105903092|NCT05052697|365303548|FG005|Substudy A|Lost to Follow-up|1|||
105903093|NCT05052697|365303549|FG006|Substudy A|Lost to Follow-up|0|||
105903094|NCT05052697|365303550|FG007|Substudy A|Lost to Follow-up|0|||
105903095|NCT05052697|365303551|FG008|Substudy A|Lost to Follow-up|0|||
105903096|NCT05052697|365303552|FG009|Substudy A|Lost to Follow-up|0|||
105903097|NCT05052697|365303553|FG010|Substudy A|Lost to Follow-up|0|||
105903098|NCT05052697|365303554|FG011|Substudy A|Lost to Follow-up|0|||
105903099|NCT05052697|365303555|FG012|Substudy A|Lost to Follow-up|0|||
105903100|NCT05052697|365303556|FG013|Substudy A|Lost to Follow-up|0|||
105903101|NCT05052697|365303557|FG014|Substudy A|Lost to Follow-up|0|||
105903102|NCT05052697|365303558|FG015|Substudy A|Lost to Follow-up|2|||
105903103|NCT05052697|365303559|FG016|Substudy A|Lost to Follow-up|0|||
105903104|NCT05052697|365303560|FG017|Substudy A|Lost to Follow-up|0|||
105998179|NCT00104650|365654865|FG002|Follow-up Period|Withdrawal by Subject|3|||
105998180|NCT00104650|365654863|FG000|Follow-up Period|Death|6|||
105998181|NCT00104650|365654864|FG001|Follow-up Period|Death|6|||
105998182|NCT00104650|365654865|FG002|Follow-up Period|Death|4|||
105903105|NCT05052697|365303561|FG018|Substudy A|Lost to Follow-up|0|||
105903106|NCT05052697|365303562|FG019|Substudy A|Lost to Follow-up|0|||
105903107|NCT05052697|365303563|FG020|Substudy A|Lost to Follow-up|0|||
105998183|NCT00104650|365654863|FG000|Follow-up Period|Disease progression|3|||
105998184|NCT00104650|365654864|FG001|Follow-up Period|Disease progression|1|||
105998185|NCT00104650|365654865|FG002|Follow-up Period|Disease progression|0|||
105998186|NCT00104650|365654863|FG000|Follow-up Period|Lost to Follow-up|0|||
105998187|NCT00104650|365654864|FG001|Follow-up Period|Lost to Follow-up|1|||
105998188|NCT00104650|365654865|FG002|Follow-up Period|Lost to Follow-up|2|||
105998189|NCT00104650|365654863|FG000|Follow-up Period|Other|0|||
105998190|NCT00104650|365654864|FG001|Follow-up Period|Other|1|||
105998191|NCT00104650|365654865|FG002|Follow-up Period|Other|0|||
105998192|NCT02330055|365654871|FG000|Overall Study|technical issues|2|||
105998193|NCT02330055|365654872|FG001|Overall Study|technical issues|0|||
105998194|NCT02330055|365654871|FG000|Overall Study|participant forgot to wear device|5|||
105998195|NCT02330055|365654872|FG001|Overall Study|participant forgot to wear device|5|||
105998196|NCT02330055|365654871|FG000|Overall Study|data for less than 60 minutes|3|||
105998197|NCT02330055|365654872|FG001|Overall Study|data for less than 60 minutes|3|||
105998198|NCT02330055|365654871|FG000|Overall Study|participant did not sleep|0|||
105998199|NCT02330055|365654872|FG001|Overall Study|participant did not sleep|1|||
105998200|NCT01100320|365654873|FG000|Period 1|Withdrawal by Subject|2|||
105903108|NCT05052697|365303564|FG021|Substudy A|Lost to Follow-up|0|||
105903109|NCT05052697|365303565|FG022|Substudy A|Lost to Follow-up|0|||
105903110|NCT05052697|365303566|FG023|Substudy A|Lost to Follow-up|0|||
105903111|NCT05052697|365303567|FG024|Substudy A|Lost to Follow-up|0|||
105903112|NCT05052697|365303568|FG025|Substudy A|Lost to Follow-up|0|||
105903113|NCT05052697|365303569|FG026|Substudy A|Lost to Follow-up|0|||
105903114|NCT05052697|365303570|FG027|Substudy A|Lost to Follow-up|0|||
105903115|NCT05052697|365303571|FG028|Substudy A|Lost to Follow-up|0|||
105903116|NCT05052697|365303572|FG029|Substudy A|Lost to Follow-up|0|||
105903117|NCT05052697|365303573|FG030|Substudy A|Lost to Follow-up|0|||
105903118|NCT05052697|365303574|FG031|Substudy A|Lost to Follow-up|0|||
105903119|NCT05052697|365303575|FG032|Substudy A|Lost to Follow-up|0|||
105903120|NCT05052697|365303576|FG033|Substudy A|Lost to Follow-up|0|||
105903121|NCT05052697|365303543|FG000|Substudy A|No longer met eligibility criteria|0|||
105903122|NCT05052697|365303544|FG001|Substudy A|No longer met eligibility criteria|0|||
105903123|NCT05052697|365303545|FG002|Substudy A|No longer met eligibility criteria|0|||
105786064|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
105786065|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
105786066|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
105903124|NCT05052697|365303546|FG003|Substudy A|No longer met eligibility criteria|0|||
105903125|NCT05052697|365303547|FG004|Substudy A|No longer met eligibility criteria|0|||
105903126|NCT05052697|365303548|FG005|Substudy A|No longer met eligibility criteria|0|||
105903127|NCT05052697|365303549|FG006|Substudy A|No longer met eligibility criteria|0|||
105903128|NCT05052697|365303550|FG007|Substudy A|No longer met eligibility criteria|0|||
105903129|NCT05052697|365303551|FG008|Substudy A|No longer met eligibility criteria|0|||
105903130|NCT05052697|365303552|FG009|Substudy A|No longer met eligibility criteria|0|||
105903131|NCT05052697|365303553|FG010|Substudy A|No longer met eligibility criteria|0|||
105903132|NCT05052697|365303554|FG011|Substudy A|No longer met eligibility criteria|0|||
105903133|NCT05052697|365303555|FG012|Substudy A|No longer met eligibility criteria|0|||
105903134|NCT05052697|365303556|FG013|Substudy A|No longer met eligibility criteria|1|||
105903135|NCT05052697|365303557|FG014|Substudy A|No longer met eligibility criteria|0|||
105903136|NCT05052697|365303558|FG015|Substudy A|No longer met eligibility criteria|0|||
105903137|NCT05052697|365303559|FG016|Substudy A|No longer met eligibility criteria|0|||
105903138|NCT05052697|365303560|FG017|Substudy A|No longer met eligibility criteria|0|||
105903139|NCT05052697|365303561|FG018|Substudy A|No longer met eligibility criteria|0|||
105903140|NCT05052697|365303562|FG019|Substudy A|No longer met eligibility criteria|0|||
105903141|NCT05052697|365303563|FG020|Substudy A|No longer met eligibility criteria|0|||
105903142|NCT05052697|365303564|FG021|Substudy A|No longer met eligibility criteria|0|||
105903143|NCT05052697|365303565|FG022|Substudy A|No longer met eligibility criteria|0|||
105903144|NCT05052697|365303566|FG023|Substudy A|No longer met eligibility criteria|0|||
105903145|NCT05052697|365303567|FG024|Substudy A|No longer met eligibility criteria|0|||
105903146|NCT05052697|365303568|FG025|Substudy A|No longer met eligibility criteria|0|||
105903147|NCT05052697|365303569|FG026|Substudy A|No longer met eligibility criteria|0|||
105903148|NCT05052697|365303570|FG027|Substudy A|No longer met eligibility criteria|0|||
105903149|NCT05052697|365303571|FG028|Substudy A|No longer met eligibility criteria|0|||
105903150|NCT05052697|365303572|FG029|Substudy A|No longer met eligibility criteria|0|||
105903151|NCT05052697|365303573|FG030|Substudy A|No longer met eligibility criteria|0|||
105903152|NCT05052697|365303574|FG031|Substudy A|No longer met eligibility criteria|0|||
105903153|NCT05052697|365303575|FG032|Substudy A|No longer met eligibility criteria|0|||
105998201|NCT01100320|365654874|FG001|Period 1|Withdrawal by Subject|4|||
105998202|NCT01100320|365654873|FG000|Period 1|Positive Drug Screen|1|||
105998203|NCT01100320|365654874|FG001|Period 1|Positive Drug Screen|1|||
105786067|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
105903154|NCT05052697|365303576|FG033|Substudy A|No longer met eligibility criteria|0|||
105903155|NCT05052697|365303543|FG000|Substudy A|Not vaccinated|0|||
105998204|NCT01100320|365654873|FG000|Period 1|Adverse Event|2|||
105903156|NCT05052697|365303544|FG001|Substudy A|Not vaccinated|0|||
105903157|NCT05052697|365303545|FG002|Substudy A|Not vaccinated|0|||
105903158|NCT05052697|365303546|FG003|Substudy A|Not vaccinated|1|||
105903159|NCT05052697|365303547|FG004|Substudy A|Not vaccinated|0|||
105903160|NCT05052697|365303548|FG005|Substudy A|Not vaccinated|0|||
105903161|NCT05052697|365303549|FG006|Substudy A|Not vaccinated|0|||
105903162|NCT05052697|365303550|FG007|Substudy A|Not vaccinated|0|||
105903163|NCT05052697|365303551|FG008|Substudy A|Not vaccinated|1|||
105903164|NCT05052697|365303552|FG009|Substudy A|Not vaccinated|0|||
105903165|NCT05052697|365303553|FG010|Substudy A|Not vaccinated|0|||
105903166|NCT05052697|365303554|FG011|Substudy A|Not vaccinated|0|||
105903167|NCT05052697|365303555|FG012|Substudy A|Not vaccinated|0|||
105903168|NCT05052697|365303556|FG013|Substudy A|Not vaccinated|0|||
105903169|NCT05052697|365303557|FG014|Substudy A|Not vaccinated|0|||
105903170|NCT05052697|365303558|FG015|Substudy A|Not vaccinated|0|||
105903171|NCT05052697|365303559|FG016|Substudy A|Not vaccinated|0|||
105903172|NCT05052697|365303560|FG017|Substudy A|Not vaccinated|0|||
105903173|NCT05052697|365303561|FG018|Substudy A|Not vaccinated|0|||
105903174|NCT05052697|365303562|FG019|Substudy A|Not vaccinated|0|||
105903175|NCT05052697|365303563|FG020|Substudy A|Not vaccinated|0|||
105903176|NCT05052697|365303564|FG021|Substudy A|Not vaccinated|0|||
105903177|NCT05052697|365303565|FG022|Substudy A|Not vaccinated|0|||
105903178|NCT05052697|365303566|FG023|Substudy A|Not vaccinated|0|||
105903179|NCT05052697|365303567|FG024|Substudy A|Not vaccinated|0|||
105903180|NCT05052697|365303568|FG025|Substudy A|Not vaccinated|0|||
105903181|NCT05052697|365303569|FG026|Substudy A|Not vaccinated|0|||
105903182|NCT05052697|365303570|FG027|Substudy A|Not vaccinated|0|||
105903183|NCT05052697|365303571|FG028|Substudy A|Not vaccinated|0|||
105903184|NCT05052697|365303572|FG029|Substudy A|Not vaccinated|0|||
105903185|NCT05052697|365303573|FG030|Substudy A|Not vaccinated|0|||
105903186|NCT05052697|365303574|FG031|Substudy A|Not vaccinated|0|||
105903187|NCT05052697|365303575|FG032|Substudy A|Not vaccinated|0|||
105903188|NCT05052697|365303576|FG033|Substudy A|Not vaccinated|0|||
105903189|NCT05052697|365303543|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903190|NCT05052697|365303544|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903191|NCT05052697|365303545|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903192|NCT05052697|365303546|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903193|NCT05052697|365303547|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903194|NCT05052697|365303548|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903195|NCT05052697|365303549|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903196|NCT05052697|365303550|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903197|NCT05052697|365303551|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903198|NCT05052697|365303552|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903199|NCT05052697|365303553|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903200|NCT05052697|365303554|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105669041|NCT01077518|364452335|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
105669042|NCT00972322|364452336|FG000|Overall Study|Adverse Event|2|||
105669043|NCT00972322|364452337|FG001|Overall Study|Adverse Event|1|||
105669044|NCT00972322|364452336|FG000|Overall Study|Positive drug screen|0|||
105669045|NCT00972322|364452337|FG001|Overall Study|Positive drug screen|1|||
105669046|NCT00972322|364452336|FG000|Overall Study|Lost to Follow-up|0|||
105669047|NCT00972322|364452337|FG001|Overall Study|Lost to Follow-up|1|||
105669048|NCT00972322|364452336|FG000|Overall Study|Consistently high glucose values|1|||
105669049|NCT00972322|364452337|FG001|Overall Study|Consistently high glucose values|0|||
105669050|NCT02138786|364453929|FG000|Overall Study|Adverse Event|0|||
105669051|NCT02138786|364453930|FG001|Overall Study|Adverse Event|2|||
105669052|NCT02138786|364453931|FG002|Overall Study|Adverse Event|1|||
105669053|NCT02138786|364453929|FG000|Overall Study|Death|1|||
105669054|NCT02138786|364453930|FG001|Overall Study|Death|7|||
105669055|NCT02138786|364453931|FG002|Overall Study|Death|2|||
105669056|NCT02138786|364453929|FG000|Overall Study|Disease Progression|1|||
105669057|NCT02138786|364453930|FG001|Overall Study|Disease Progression|1|||
105669058|NCT02138786|364453931|FG002|Overall Study|Disease Progression|3|||
105903201|NCT05052697|365303555|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903202|NCT05052697|365303556|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903203|NCT05052697|365303557|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105669059|NCT02138786|364453929|FG000|Overall Study|Withdrawal by Subject|1|||
105903204|NCT05052697|365303558|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105669060|NCT02138786|364453930|FG001|Overall Study|Withdrawal by Subject|2|||
105669061|NCT02138786|364453931|FG002|Overall Study|Withdrawal by Subject|0|||
105903205|NCT05052697|365303559|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903206|NCT05052697|365303560|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903207|NCT05052697|365303561|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
105903208|NCT05052697|365303562|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
105998205|NCT01100320|365654874|FG001|Period 1|Adverse Event|2|||
105669062|NCT02138786|364453929|FG000|Overall Study|Patient's Wish|0|||
105669063|NCT02138786|364453930|FG001|Overall Study|Patient's Wish|2|||
105903209|NCT05052697|365303563|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105669064|NCT02138786|364453931|FG002|Overall Study|Patient's Wish|0|||
105669065|NCT02138786|364453929|FG000|Overall Study|Sponsor Terminated Study|0|||
105669066|NCT02138786|364453930|FG001|Overall Study|Sponsor Terminated Study|1|||
105669067|NCT02138786|364453931|FG002|Overall Study|Sponsor Terminated Study|1|||
105669068|NCT02138786|364453929|FG000|Overall Study|Non-Compliance|0|||
105669069|NCT02138786|364453930|FG001|Overall Study|Non-Compliance|0|||
105669070|NCT02138786|364453931|FG002|Overall Study|Non-Compliance|1|||
105669071|NCT00608868|364453932|FG000|Overall Study|Withdrawal by Subject|7|||
105669072|NCT00608868|364453932|FG000|Overall Study|Protocol Violation|3|||
105669073|NCT00608868|364453932|FG000|Overall Study|Lost to Follow-up|2|||
105669074|NCT00608868|364453932|FG000|Overall Study|Adverse Event|1|||
105669075|NCT00608868|364453932|FG000|Overall Study|Physician Decision|2|||
105669076|NCT00335140|364453935|FG000|Overall Study|Ineligible|1|||
105669077|NCT02922023|364453940|FG000|Overall Study|Lost to Follow-up|2|||
105669078|NCT02922023|364453941|FG001|Overall Study|Lost to Follow-up|0|||
105669079|NCT01125046|364453943|FG000|First 6 Months of Treatment|Death|1|||
105669080|NCT01125046|364453943|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
105669081|NCT01125046|364453943|FG000|First 6 Months of Treatment|Non-compliance|1|||
105669082|NCT01125046|364453943|FG000|First 6 Months of Treatment|Surgery|1|||
105669083|NCT01125046|364453943|FG000|First 6 Months of Treatment|Progressive Disease|7|||
105669084|NCT01125046|364453943|FG000|First 6 Months of Treatment|Adverse Event|2|||
105669085|NCT01125046|364453943|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
105669086|NCT01125046|364453943|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
105669087|NCT01125046|364453943|FG000|Follow-up/Data Cut Off Point|Death|29|||
105669088|NCT01125046|364453943|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
105669089|NCT01240915|364453944|FG000|Overall Study|Adverse Event|0|||
105669090|NCT01240915|364453945|FG001|Overall Study|Adverse Event|0|||
105669091|NCT01240915|364453946|FG002|Overall Study|Adverse Event|0|||
105669092|NCT01240915|364453947|FG003|Overall Study|Adverse Event|1|||
105669093|NCT01240915|364453948|FG004|Overall Study|Adverse Event|0|||
105669094|NCT01240915|364453949|FG005|Overall Study|Adverse Event|2|||
105669095|NCT01240915|364453950|FG006|Overall Study|Adverse Event|0|||
105669096|NCT01240915|364453951|FG007|Overall Study|Adverse Event|0|||
105669097|NCT01240915|364453952|FG008|Overall Study|Adverse Event|1|||
105669098|NCT01240915|364453944|FG000|Overall Study|Lost to Follow-up|0|||
105669099|NCT01240915|364453945|FG001|Overall Study|Lost to Follow-up|0|||
105669100|NCT01240915|364453946|FG002|Overall Study|Lost to Follow-up|0|||
105669101|NCT01240915|364453947|FG003|Overall Study|Lost to Follow-up|0|||
105669102|NCT01240915|364453948|FG004|Overall Study|Lost to Follow-up|1|||
105669103|NCT01240915|364453949|FG005|Overall Study|Lost to Follow-up|1|||
105669104|NCT01240915|364453950|FG006|Overall Study|Lost to Follow-up|0|||
105669105|NCT01240915|364453951|FG007|Overall Study|Lost to Follow-up|1|||
105669106|NCT01240915|364453952|FG008|Overall Study|Lost to Follow-up|1|||
105669107|NCT01240915|364453944|FG000|Overall Study|Withdrawal by Subject|2|||
105669108|NCT01240915|364453945|FG001|Overall Study|Withdrawal by Subject|1|||
105669109|NCT01240915|364453946|FG002|Overall Study|Withdrawal by Subject|0|||
105669110|NCT01240915|364453947|FG003|Overall Study|Withdrawal by Subject|2|||
105669111|NCT01240915|364453948|FG004|Overall Study|Withdrawal by Subject|0|||
105669112|NCT01240915|364453949|FG005|Overall Study|Withdrawal by Subject|4|||
105669113|NCT01240915|364453950|FG006|Overall Study|Withdrawal by Subject|2|||
105669114|NCT01240915|364453951|FG007|Overall Study|Withdrawal by Subject|3|||
105669115|NCT01240915|364453952|FG008|Overall Study|Withdrawal by Subject|3|||
105669116|NCT01240915|364453944|FG000|Overall Study|Other|0|||
105669117|NCT01240915|364453945|FG001|Overall Study|Other|0|||
105669118|NCT01240915|364453946|FG002|Overall Study|Other|0|||
105669119|NCT01240915|364453947|FG003|Overall Study|Other|0|||
105669120|NCT01240915|364453948|FG004|Overall Study|Other|2|||
105669121|NCT01240915|364453949|FG005|Overall Study|Other|0|||
105669122|NCT01240915|364453950|FG006|Overall Study|Other|0|||
105669123|NCT01240915|364453951|FG007|Overall Study|Other|0|||
105669124|NCT01240915|364453952|FG008|Overall Study|Other|0|||
105669125|NCT01240915|364453944|FG000|Overall Study|Insufficient Clinical Response|0|||
105669126|NCT01240915|364453945|FG001|Overall Study|Insufficient Clinical Response|0|||
105669127|NCT01240915|364453946|FG002|Overall Study|Insufficient Clinical Response|0|||
105669128|NCT01240915|364453947|FG003|Overall Study|Insufficient Clinical Response|0|||
105669129|NCT01240915|364453948|FG004|Overall Study|Insufficient Clinical Response|1|||
105669130|NCT01240915|364453949|FG005|Overall Study|Insufficient Clinical Response|3|||
105669131|NCT01240915|364453950|FG006|Overall Study|Insufficient Clinical Response|6|||
105669132|NCT01240915|364453951|FG007|Overall Study|Insufficient Clinical Response|0|||
105669133|NCT01240915|364453952|FG008|Overall Study|Insufficient Clinical Response|3|||
105669134|NCT01685229|364453954|FG000|Overall Study|Subjects missing Study Exit form|3|||
105998206|NCT01100320|365654873|FG000|Period 2|Withdrawal by Subject|1|||
105669135|NCT01685229|364453955|FG001|Overall Study|Subjects missing Study Exit form|1|||
105669136|NCT01685229|364453954|FG000|Overall Study|Lost to Follow-up|16|||
105669137|NCT01685229|364453955|FG001|Overall Study|Lost to Follow-up|10|||
105998207|NCT01100320|365654874|FG001|Period 2|Withdrawal by Subject|1|||
105669138|NCT01685229|364453954|FG000|Overall Study|Withdrawal by Subject|6|||
105669139|NCT01685229|364453955|FG001|Overall Study|Withdrawal by Subject|5|||
105903210|NCT05052697|365303564|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
105903211|NCT05052697|365303565|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
105903212|NCT05052697|365303566|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903213|NCT05052697|365303567|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903214|NCT05052697|365303568|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903215|NCT05052697|365303569|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903216|NCT05052697|365303570|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903217|NCT05052697|365303571|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903218|NCT05052697|365303572|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903219|NCT05052697|365303573|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903220|NCT05052697|365303574|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903221|NCT05052697|365303575|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903222|NCT05052697|365303576|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
105903223|NCT05052697|365303543|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903224|NCT05052697|365303544|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903225|NCT05052697|365303545|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903226|NCT05052697|365303546|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903227|NCT05052697|365303547|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903228|NCT05052697|365303548|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903229|NCT05052697|365303549|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903230|NCT05052697|365303550|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903231|NCT05052697|365303551|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903232|NCT05052697|365303552|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903233|NCT05052697|365303553|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903234|NCT05052697|365303554|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903235|NCT05052697|365303555|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903236|NCT05052697|365303556|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903237|NCT05052697|365303557|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903238|NCT05052697|365303558|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903239|NCT05052697|365303559|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903240|NCT05052697|365303560|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
105903241|NCT05052697|365303561|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903242|NCT05052697|365303562|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903243|NCT05052697|365303563|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903244|NCT05052697|365303564|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903245|NCT05052697|365303565|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903246|NCT05052697|365303566|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903247|NCT05052697|365303567|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903248|NCT05052697|365303568|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903249|NCT05052697|365303569|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903250|NCT05052697|365303570|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903251|NCT05052697|365303571|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903252|NCT05052697|365303572|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903253|NCT05052697|365303573|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903254|NCT05052697|365303574|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903255|NCT05052697|365303575|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903256|NCT05052697|365303576|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
105903257|NCT05052697|365303543|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903258|NCT05052697|365303544|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903259|NCT05052697|365303545|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903260|NCT05052697|365303546|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903261|NCT05052697|365303547|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903262|NCT05052697|365303548|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903263|NCT05052697|365303549|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903264|NCT05052697|365303550|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903265|NCT05052697|365303551|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903266|NCT05052697|365303552|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903267|NCT05052697|365303553|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105669140|NCT01685229|364453954|FG000|Overall Study|Death|1|||
105903268|NCT05052697|365303554|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903269|NCT05052697|365303555|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903270|NCT05052697|365303556|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903271|NCT05052697|365303557|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903272|NCT05052697|365303558|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903273|NCT05052697|365303559|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903274|NCT05052697|365303560|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903275|NCT05052697|365303561|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903276|NCT05052697|365303562|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
105669141|NCT01685229|364453955|FG001|Overall Study|Death|0|||
105669142|NCT03868787|364453956|FG000|Overall Study|Withdrawal by Subject|2|||
105669143|NCT03868787|364453957|FG001|Overall Study|Withdrawal by Subject|1|||
105669144|NCT01598662|364453958|FG000|Overall Study|Lost to Follow-up|10|||
105669145|NCT01598662|364453959|FG001|Overall Study|Lost to Follow-up|17|||
105669146|NCT01598662|364453958|FG000|Overall Study|Physician Decision|1|||
105669147|NCT01598662|364453959|FG001|Overall Study|Physician Decision|2|||
105669148|NCT01598662|364453958|FG000|Overall Study|IUD expelled before month 6|0|||
105669149|NCT01598662|364453959|FG001|Overall Study|IUD expelled before month 6|2|||
105669150|NCT01399697|364453972|FG000|Overall Study|Adverse Event|13|||
105669151|NCT01399697|364453973|FG001|Overall Study|Adverse Event|3|||
105669152|NCT01399697|364453974|FG002|Overall Study|Adverse Event|1|||
105669153|NCT01399697|364453972|FG000|Overall Study|Lost to Follow-up|2|||
105669154|NCT01399697|364453973|FG001|Overall Study|Lost to Follow-up|0|||
105669155|NCT01399697|364453974|FG002|Overall Study|Lost to Follow-up|0|||
105669156|NCT01399697|364453972|FG000|Overall Study|Withdrawal by Subject|8|||
105669157|NCT01399697|364453973|FG001|Overall Study|Withdrawal by Subject|0|||
105669158|NCT01399697|364453974|FG002|Overall Study|Withdrawal by Subject|0|||
105669159|NCT01399697|364453972|FG000|Overall Study|Investigator Decisión|1|||
105669160|NCT01399697|364453973|FG001|Overall Study|Investigator Decisión|0|||
105669161|NCT01399697|364453974|FG002|Overall Study|Investigator Decisión|2|||
105669162|NCT01399697|364453972|FG000|Overall Study|Lack of Efficacy|9|||
105669163|NCT01399697|364453973|FG001|Overall Study|Lack of Efficacy|0|||
105669164|NCT01399697|364453974|FG002|Overall Study|Lack of Efficacy|1|||
105669165|NCT01399697|364453972|FG000|Overall Study|Protocol Violation|2|||
105669166|NCT01399697|364453973|FG001|Overall Study|Protocol Violation|0|||
105669167|NCT01399697|364453974|FG002|Overall Study|Protocol Violation|0|||
105669168|NCT01399697|364453972|FG000|Overall Study|Non-Compliant|1|||
105669169|NCT01399697|364453973|FG001|Overall Study|Non-Compliant|0|||
105669170|NCT01399697|364453974|FG002|Overall Study|Non-Compliant|0|||
105669171|NCT01399697|364453972|FG000|Overall Study|Inclusion Error|2|||
105669172|NCT01399697|364453973|FG001|Overall Study|Inclusion Error|0|||
105669173|NCT01399697|364453974|FG002|Overall Study|Inclusion Error|0|||
105669174|NCT01399697|364453972|FG000|Overall Study|Positive result for hepatitis B|1|||
105786068|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
105786069|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
105903277|NCT05052697|365303563|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903278|NCT05052697|365303564|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903279|NCT05052697|365303565|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903280|NCT05052697|365303566|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903281|NCT05052697|365303567|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903282|NCT05052697|365303568|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903283|NCT05052697|365303569|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903284|NCT05052697|365303570|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903285|NCT05052697|365303571|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903286|NCT05052697|365303572|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903287|NCT05052697|365303573|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903288|NCT05052697|365303574|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903289|NCT05052697|365303575|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903290|NCT05052697|365303576|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
105903291|NCT05052697|365303543|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903292|NCT05052697|365303544|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903293|NCT05052697|365303545|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903294|NCT05052697|365303546|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903295|NCT05052697|365303547|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903296|NCT05052697|365303548|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903297|NCT05052697|365303549|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903298|NCT05052697|365303550|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903299|NCT05052697|365303551|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903300|NCT05052697|365303552|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903301|NCT05052697|365303553|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903302|NCT05052697|365303554|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903303|NCT05052697|365303555|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105669175|NCT01399697|364453973|FG001|Overall Study|Positive result for hepatitis B|0|||
105669176|NCT01399697|364453974|FG002|Overall Study|Positive result for hepatitis B|0|||
105786070|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
105903304|NCT05052697|365303556|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903305|NCT05052697|365303557|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903306|NCT05052697|365303558|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903307|NCT05052697|365303559|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105998208|NCT00550953|365654875|FG000|Overall Study|Adverse Event|4|||
105669177|NCT01399697|364453972|FG000|Overall Study|Clinical RA remission|1|||
105669178|NCT01399697|364453973|FG001|Overall Study|Clinical RA remission|0|||
105669179|NCT01399697|364453974|FG002|Overall Study|Clinical RA remission|0|||
105669180|NCT01399697|364453972|FG000|Overall Study|Sponsor Decision|1|||
105903308|NCT05052697|365303560|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
105903309|NCT05052697|365303561|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903310|NCT05052697|365303562|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903311|NCT05052697|365303563|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903312|NCT05052697|365303564|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903313|NCT05052697|365303565|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903314|NCT05052697|365303566|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903315|NCT05052697|365303567|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903316|NCT05052697|365303568|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
105903317|NCT05052697|365303569|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903318|NCT05052697|365303570|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
105903319|NCT05052697|365303571|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903320|NCT05052697|365303572|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903321|NCT05052697|365303573|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903322|NCT05052697|365303574|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903323|NCT05052697|365303575|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903324|NCT05052697|365303576|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
105903325|NCT05052697|365303543|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903326|NCT05052697|365303544|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903327|NCT05052697|365303545|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903328|NCT05052697|365303546|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903329|NCT05052697|365303547|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903330|NCT05052697|365303548|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903331|NCT05052697|365303549|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903332|NCT05052697|365303550|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903333|NCT05052697|365303551|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903334|NCT05052697|365303552|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903335|NCT05052697|365303553|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903336|NCT05052697|365303554|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903337|NCT05052697|365303555|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903338|NCT05052697|365303556|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903339|NCT05052697|365303557|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903340|NCT05052697|365303558|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903341|NCT05052697|365303559|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903342|NCT05052697|365303560|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903343|NCT05052697|365303561|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903344|NCT05052697|365303562|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903345|NCT05052697|365303563|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903346|NCT05052697|365303564|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903347|NCT05052697|365303565|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903348|NCT05052697|365303566|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903349|NCT05052697|365303567|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903350|NCT05052697|365303568|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903351|NCT05052697|365303569|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903352|NCT05052697|365303570|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903353|NCT05052697|365303571|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
105903354|NCT05052697|365303572|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903355|NCT05052697|365303573|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
105903356|NCT05052697|365303574|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
105903357|NCT05052697|365303575|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
105903358|NCT05052697|365303576|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
105903359|NCT05052697|365303543|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903360|NCT05052697|365303544|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903361|NCT05052697|365303545|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903362|NCT05052697|365303546|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903363|NCT05052697|365303547|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903364|NCT05052697|365303548|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903365|NCT05052697|365303549|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903366|NCT05052697|365303550|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903367|NCT05052697|365303551|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903368|NCT05052697|365303552|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903369|NCT05052697|365303553|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903370|NCT05052697|365303554|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903371|NCT05052697|365303555|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903372|NCT05052697|365303556|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903373|NCT05052697|365303557|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903374|NCT05052697|365303558|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903375|NCT05052697|365303559|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105669181|NCT01399697|364453973|FG001|Overall Study|Sponsor Decision|0|||
105669182|NCT01399697|364453974|FG002|Overall Study|Sponsor Decision|0|||
105669183|NCT00659880|364453979|FG000|Overall Study|Lost to Follow-up|5|||
105669184|NCT03435692|364453980|FG000|Overall Study|Lack of Efficacy|2|||
105669185|NCT03435692|364453981|FG001|Overall Study|Lack of Efficacy|2|||
105669186|NCT03435692|364453982|FG002|Overall Study|Lack of Efficacy|0|||
105669187|NCT02766777|364453986|FG000|Overall Study|Adverse Event|12|||
105669188|NCT02766777|364453986|FG000|Overall Study|Lost to Follow-up|16|||
105669189|NCT02766777|364453986|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105669190|NCT02766777|364453986|FG000|Overall Study|Protocol Violation|1|||
105669191|NCT02766777|364453986|FG000|Overall Study|Withdrawal by Subject|4|||
105669192|NCT04313608|364453994|FG000|Overall Study|Death|12|||
105669193|NCT04313608|364453995|FG001|Overall Study|Death|3|||
105669194|NCT01886287|364453996|FG000|Overall Study|Radiographic disease progression|1|||
105669195|NCT01886287|364453996|FG000|Overall Study|Clinical progression due to disease|1|||
105669196|NCT02233803|364454010|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
105669197|NCT02233803|364454011|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
105669198|NCT02233803|364454010|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
105669199|NCT02233803|364454011|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
105669200|NCT02233803|364454010|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
105669201|NCT02233803|364454011|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
105669202|NCT02233803|364454010|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
105669203|NCT02233803|364454011|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
105669204|NCT02233803|364454010|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
105669205|NCT02233803|364454011|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
105669206|NCT02233803|364454010|FG000|Washout Period (4-Wks)|Physician Decision|1|||
105903376|NCT05052697|365303560|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903377|NCT05052697|365303561|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903378|NCT05052697|365303562|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903379|NCT05052697|365303563|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903380|NCT05052697|365303564|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903381|NCT05052697|365303565|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903382|NCT05052697|365303566|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903383|NCT05052697|365303567|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903384|NCT05052697|365303568|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903385|NCT05052697|365303569|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903386|NCT05052697|365303570|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903387|NCT05052697|365303571|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
105903388|NCT05052697|365303572|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
105903389|NCT05052697|365303573|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
105903390|NCT05052697|365303574|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
105903391|NCT05052697|365303575|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
105903392|NCT05052697|365303576|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
105903393|NCT05052697|365303543|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903394|NCT05052697|365303544|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903395|NCT05052697|365303545|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903396|NCT05052697|365303546|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903397|NCT05052697|365303547|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903398|NCT05052697|365303548|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903399|NCT05052697|365303549|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105669207|NCT02233803|364454011|FG001|Washout Period (4-Wks)|Physician Decision|0|||
105669208|NCT02233803|364454010|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
105903400|NCT05052697|365303550|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903401|NCT05052697|365303551|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903402|NCT05052697|365303552|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903403|NCT05052697|365303553|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903404|NCT05052697|365303554|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903405|NCT05052697|365303555|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903406|NCT05052697|365303556|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903407|NCT05052697|365303557|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105669209|NCT02233803|364454011|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
105669210|NCT02233803|364454010|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
105669211|NCT02233803|364454011|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
105903408|NCT05052697|365303558|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903409|NCT05052697|365303559|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105669212|NCT02233803|364454010|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
105669213|NCT02233803|364454011|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
105669214|NCT00669877|364454012|FG000|Overall Study|Disease Progression/Death|4|||
105669215|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
105669216|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
105998209|NCT00550953|365654876|FG001|Overall Study|Adverse Event|3|||
105669217|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
105669218|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
105669219|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669220|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669221|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669222|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669223|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105903410|NCT05052697|365303560|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903411|NCT05052697|365303561|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105669224|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105903412|NCT05052697|365303562|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903413|NCT05052697|365303563|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903414|NCT05052697|365303564|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903415|NCT05052697|365303565|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903416|NCT05052697|365303566|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903417|NCT05052697|365303567|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903418|NCT05052697|365303568|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903419|NCT05052697|365303569|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903420|NCT05052697|365303570|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903421|NCT05052697|365303571|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903422|NCT05052697|365303572|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903423|NCT05052697|365303573|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903424|NCT05052697|365303574|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903425|NCT05052697|365303575|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
105903426|NCT05052697|365303576|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
105903427|NCT05052697|365303543|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903428|NCT05052697|365303544|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903429|NCT05052697|365303545|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903430|NCT05052697|365303546|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903431|NCT05052697|365303547|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903432|NCT05052697|365303548|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903433|NCT05052697|365303549|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903434|NCT05052697|365303550|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903435|NCT05052697|365303551|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903436|NCT05052697|365303552|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903437|NCT05052697|365303553|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903438|NCT05052697|365303554|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903439|NCT05052697|365303555|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903440|NCT05052697|365303556|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903441|NCT05052697|365303557|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903442|NCT05052697|365303558|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903443|NCT05052697|365303559|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903444|NCT05052697|365303560|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903445|NCT05052697|365303561|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903446|NCT05052697|365303562|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903447|NCT05052697|365303563|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903448|NCT05052697|365303564|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903449|NCT05052697|365303565|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903450|NCT05052697|365303566|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903451|NCT05052697|365303567|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903452|NCT05052697|365303568|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903453|NCT05052697|365303569|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903454|NCT05052697|365303570|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903455|NCT05052697|365303571|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
105903456|NCT05052697|365303572|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
105903457|NCT05052697|365303573|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
105903458|NCT05052697|365303574|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903459|NCT05052697|365303575|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903460|NCT05052697|365303576|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
105903461|NCT00528372|365303577|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
105903462|NCT00528372|365303578|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105903463|NCT00528372|365303579|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105903464|NCT00528372|365303580|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105669225|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105903465|NCT00528372|365303581|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105903466|NCT00528372|365303582|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105903467|NCT00528372|365303583|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105903468|NCT00528372|365303584|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105669226|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
105669227|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
105669228|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
105669229|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
105669230|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
105669231|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669232|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669233|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669234|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669235|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669236|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669237|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669238|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
105669239|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
105669240|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
105669241|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
105669242|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
105669243|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669244|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669245|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669246|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669247|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669248|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669249|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669250|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
105669251|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
105669252|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
105669253|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
105903469|NCT00528372|365303585|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
105903470|NCT00528372|365303577|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
105903471|NCT00528372|365303578|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
105903472|NCT00528372|365303579|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
105903473|NCT00528372|365303580|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
105903474|NCT00528372|365303581|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
105903475|NCT00528372|365303582|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
105903476|NCT00528372|365303583|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
105903477|NCT00528372|365303584|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
105903478|NCT00528372|365303585|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
105903479|NCT00528372|365303577|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
105903480|NCT00528372|365303578|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
105903481|NCT00528372|365303579|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
105669254|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
105669255|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669256|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105903482|NCT00528372|365303580|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
105903483|NCT00528372|365303581|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
105903484|NCT00528372|365303582|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
105903485|NCT00528372|365303583|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
105903486|NCT00528372|365303584|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
105903487|NCT00528372|365303585|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
105903488|NCT00528372|365303577|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
105903489|NCT00528372|365303578|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
105903490|NCT00528372|365303579|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
105903491|NCT00528372|365303580|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
105903492|NCT00528372|365303581|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
105903493|NCT00528372|365303582|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
105903494|NCT00528372|365303583|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
105903495|NCT00528372|365303584|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
105903496|NCT00528372|365303585|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
105903497|NCT00528372|365303577|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105903498|NCT00528372|365303578|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105669257|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669258|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105903499|NCT00528372|365303579|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105903500|NCT00528372|365303580|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
105903501|NCT00528372|365303581|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105903502|NCT00528372|365303582|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
105903503|NCT00528372|365303583|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105903504|NCT00528372|365303584|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105903505|NCT00528372|365303585|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
105903506|NCT00528372|365303577|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
105903507|NCT00528372|365303578|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105903508|NCT00528372|365303579|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
105903509|NCT00528372|365303580|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105903510|NCT00528372|365303581|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105903511|NCT00528372|365303582|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
105903512|NCT00528372|365303583|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105903513|NCT00528372|365303584|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105903514|NCT00528372|365303585|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
105903515|NCT00528372|365303577|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
105903516|NCT00528372|365303578|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105903517|NCT00528372|365303579|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105903518|NCT00528372|365303580|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
105903519|NCT00528372|365303581|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105903520|NCT00528372|365303582|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105903521|NCT00528372|365303583|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105903522|NCT00528372|365303584|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
105903523|NCT00528372|365303585|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
105903524|NCT00528372|365303577|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
105903525|NCT00528372|365303578|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
105903526|NCT00528372|365303579|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
105903527|NCT00528372|365303580|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
105903528|NCT00528372|365303581|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
105903529|NCT00528372|365303582|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
105903530|NCT00528372|365303583|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
105903531|NCT00528372|365303584|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
105903532|NCT00528372|365303585|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
105903533|NCT00528372|365303577|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
105903534|NCT00528372|365303578|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
105903535|NCT00528372|365303579|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
105903536|NCT00528372|365303580|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
105903537|NCT00528372|365303581|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
105903538|NCT00528372|365303582|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
105903539|NCT00528372|365303583|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
105903540|NCT00528372|365303584|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
105903541|NCT00528372|365303585|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
105903542|NCT00528372|365303577|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
105903543|NCT00528372|365303578|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
105903544|NCT00528372|365303579|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
105903545|NCT00528372|365303580|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
105903546|NCT00528372|365303581|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
105903547|NCT00528372|365303582|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
105903548|NCT00528372|365303583|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
105903549|NCT00528372|365303584|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
105903550|NCT00528372|365303585|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
105903551|NCT00528372|365303577|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
105903552|NCT00528372|365303578|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
105903553|NCT00528372|365303579|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
105903554|NCT00528372|365303580|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
105903555|NCT00528372|365303581|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
105903556|NCT00528372|365303582|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
105903557|NCT00528372|365303583|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
105903558|NCT00528372|365303584|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
105903559|NCT00528372|365303585|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
105903560|NCT00528372|365303577|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105903561|NCT00528372|365303578|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
105998210|NCT00550953|365654875|FG000|Overall Study|Not able to visit the site|2|||
105998211|NCT00550953|365654876|FG001|Overall Study|Not able to visit the site|3|||
105669259|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669260|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669261|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669262|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
105669263|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669264|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669265|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
105669266|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
105669267|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669268|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669269|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669270|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669271|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669272|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669273|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669274|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
105669275|NCT01646177|364454013|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
105669276|NCT01646177|364454014|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
105669277|NCT01646177|364454015|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
105669278|NCT01646177|364454016|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669279|NCT01646177|364454017|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105903562|NCT00528372|365303579|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
105903563|NCT00528372|365303580|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
105903564|NCT00528372|365303581|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105903565|NCT00528372|365303582|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105903566|NCT00528372|365303583|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
105903567|NCT00528372|365303584|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105903568|NCT00528372|365303585|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
105669280|NCT01646177|364454018|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669281|NCT01646177|364454019|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669282|NCT01646177|364454020|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105903569|NCT00528372|365303577|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105903570|NCT00528372|365303578|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105903571|NCT00528372|365303579|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105903572|NCT00528372|365303580|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105903573|NCT00528372|365303581|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
105903574|NCT00528372|365303582|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
105903575|NCT00528372|365303583|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105903576|NCT00528372|365303584|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105903577|NCT00528372|365303585|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
105903578|NCT00528372|365303577|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105903579|NCT00528372|365303578|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
105903580|NCT00528372|365303579|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105903581|NCT00528372|365303580|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105903582|NCT00528372|365303581|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105903583|NCT00528372|365303582|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105903584|NCT00528372|365303583|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
105903585|NCT00528372|365303584|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
105903586|NCT00528372|365303585|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
105903587|NCT00528372|365303577|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
105903588|NCT00528372|365303578|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
105903589|NCT00528372|365303579|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
105903590|NCT00528372|365303580|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
105903591|NCT00528372|365303581|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
105903592|NCT00528372|365303582|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
105903593|NCT00528372|365303583|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
105903594|NCT00528372|365303584|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
105903595|NCT00528372|365303585|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
105903596|NCT02226120|365303588|FG000|Overall Study|Adverse Event|60|||
105903597|NCT02226120|365303588|FG000|Overall Study|Death|172|||
105903598|NCT02226120|365303588|FG000|Overall Study|Study terminated by sponsor|1|||
105903599|NCT02226120|365303588|FG000|Overall Study|Technical problems|4|||
105903600|NCT02226120|365303588|FG000|Overall Study|Lost to Follow-up|13|||
105903601|NCT02226120|365303588|FG000|Overall Study|Physician Decision|21|||
105998212|NCT02488005|365654877|FG000|Overall Study|Lost to Follow-up|2|||
105998213|NCT02326597|365654882|FG000|Overall Study|Lost to Follow-up|42|||
105998214|NCT02326597|365654883|FG001|Overall Study|Lost to Follow-up|32|||
105998215|NCT04970654|365654884|FG000|Overall Study|Withdrawal by parents/guardian|1|||
105998216|NCT04970654|365654885|FG001|Overall Study|Withdrawal by parents/guardian|2|||
105998217|NCT04970654|365654884|FG000|Overall Study|Unclassified|2|||
105998218|NCT04970654|365654885|FG001|Overall Study|Unclassified|1|||
105998219|NCT04970654|365654884|FG000|Overall Study|Lost to Follow-up|1|||
105998220|NCT04970654|365654885|FG001|Overall Study|Lost to Follow-up|0|||
105998221|NCT01463306|365654887|FG000|Overall Study|Adverse Event|6|||
105998222|NCT01463306|365654888|FG001|Overall Study|Adverse Event|9|||
105998223|NCT01463306|365654889|FG002|Overall Study|Adverse Event|3|||
105998224|NCT01463306|365654887|FG000|Overall Study|Death|3|||
105998225|NCT01463306|365654888|FG001|Overall Study|Death|3|||
105998226|NCT01463306|365654889|FG002|Overall Study|Death|0|||
105998227|NCT01463306|365654887|FG000|Overall Study|Lack of Efficacy|22|||
105998228|NCT01463306|365654888|FG001|Overall Study|Lack of Efficacy|16|||
105998229|NCT01463306|365654889|FG002|Overall Study|Lack of Efficacy|1|||
105998230|NCT01463306|365654887|FG000|Overall Study|Lost to Follow-up|5|||
105998231|NCT01463306|365654888|FG001|Overall Study|Lost to Follow-up|2|||
105998232|NCT01463306|365654889|FG002|Overall Study|Lost to Follow-up|0|||
105998233|NCT01463306|365654887|FG000|Overall Study|Protocol Violation|4|||
105998234|NCT01463306|365654888|FG001|Overall Study|Protocol Violation|0|||
105998235|NCT01463306|365654889|FG002|Overall Study|Protocol Violation|0|||
106125277|NCT00507026|366115899|FG000|Overall Study|Other|1|||
106125278|NCT00507026|366115900|FG001|Overall Study|Other|0|||
105903602|NCT02226120|365303588|FG000|Overall Study|Withdrawal by parent/guardian|36|||
105903603|NCT02226120|365303588|FG000|Overall Study|Non-compliance with study drug|10|||
105903604|NCT02226120|365303588|FG000|Overall Study|Protocol deviation|1|||
105903605|NCT02226120|365303588|FG000|Overall Study|missing treatment disposition pages|2|||
105903606|NCT01344759|365305969|FG000|Overall Study|Patients failed to reach sedation level|0|||
105903607|NCT01344759|365305970|FG001|Overall Study|Patients failed to reach sedation level|2|||
105903608|NCT02442206|365305975|FG000|Period 1|Adverse Event|1|||
105903609|NCT02442206|365305976|FG001|Period 1|Adverse Event|1|||
105903610|NCT02442206|365305975|FG000|Period 1|withdrew consent|0|||
105903611|NCT02442206|365305976|FG001|Period 1|withdrew consent|1|||
105903612|NCT02442206|365305975|FG000|Period 1|COPD exacerbation|0|||
105903613|NCT02442206|365305976|FG001|Period 1|COPD exacerbation|1|||
105903614|NCT02442206|365305975|FG000|Period 2|Adverse Event|1|||
105903615|NCT02442206|365305976|FG001|Period 2|Adverse Event|0|||
105903616|NCT00734656|365305977|FG000|Lab Session 1|Withdrawal by Subject|2|||
105903617|NCT00734656|365305978|FG001|Lab Session 1|Withdrawal by Subject|0|||
105903618|NCT00734656|365305979|FG002|Lab Session 1|Withdrawal by Subject|0|||
105903619|NCT00734656|365305980|FG003|Lab Session 1|Withdrawal by Subject|0|||
105903620|NCT00734656|365305977|FG000|Washout 1|Withdrawal by Subject|1|||
105903621|NCT00734656|365305978|FG001|Washout 1|Withdrawal by Subject|5|||
105903622|NCT00734656|365305979|FG002|Washout 1|Withdrawal by Subject|2|||
105903623|NCT00734656|365305980|FG003|Washout 1|Withdrawal by Subject|3|||
105903624|NCT00734656|365305977|FG000|Lab Session 2|Withdrawal by Subject|1|||
105903625|NCT00734656|365305978|FG001|Lab Session 2|Withdrawal by Subject|0|||
105903626|NCT00734656|365305979|FG002|Lab Session 2|Withdrawal by Subject|0|||
105903627|NCT00734656|365305980|FG003|Lab Session 2|Withdrawal by Subject|1|||
105903628|NCT00734656|365305977|FG000|Washout 2|Withdrawal by Subject|1|||
105903629|NCT00734656|365305978|FG001|Washout 2|Withdrawal by Subject|1|||
105903630|NCT00734656|365305979|FG002|Washout 2|Withdrawal by Subject|1|||
105998236|NCT01463306|365654887|FG000|Overall Study|Withdrawal by Subject|19|||
105998237|NCT01463306|365654888|FG001|Overall Study|Withdrawal by Subject|9|||
106125279|NCT00507026|366115901|FG002|Overall Study|Other|0|||
106125280|NCT02372058|366115902|FG000|Overall Study|Withdrawal by Subject|3|||
106125281|NCT02788006|366115903|FG000|Overall Study|Patient not treated|1|||
106125282|NCT03050398|366115904|FG000|Overall Study|Study terminated by sponsor|8|||
106125283|NCT00598481|366115905|FG000|Treatment|Physician Decision|1|||
106125284|NCT01461993|366115906|FG000|Overall Study|Withdrawal by Subject|60|||
106125285|NCT01461993|366115907|FG001|Overall Study|Withdrawal by Subject|53|||
106125286|NCT01461993|366115908|FG002|Overall Study|Withdrawal by Subject|16|||
106125287|NCT01461993|366115906|FG000|Overall Study|Lost to Follow-up|44|||
105903631|NCT00734656|365305980|FG003|Washout 2|Withdrawal by Subject|0|||
105903632|NCT00734656|365305977|FG000|Washout 3|Withdrawal by Subject|1|||
105903633|NCT00734656|365305978|FG001|Washout 3|Withdrawal by Subject|0|||
105903634|NCT00734656|365305979|FG002|Washout 3|Withdrawal by Subject|0|||
105998238|NCT01463306|365654889|FG002|Overall Study|Withdrawal by Subject|1|||
105998239|NCT01463306|365654887|FG000|Overall Study|Other|26|||
106125288|NCT01461993|366115907|FG001|Overall Study|Lost to Follow-up|48|||
106125289|NCT01461993|366115908|FG002|Overall Study|Lost to Follow-up|22|||
105903635|NCT00734656|365305980|FG003|Washout 3|Withdrawal by Subject|1|||
105903636|NCT00734656|365305977|FG000|Lab Session 4|Withdrawal by Subject|0|||
105903637|NCT00734656|365305978|FG001|Lab Session 4|Withdrawal by Subject|0|||
105998240|NCT01463306|365654888|FG001|Overall Study|Other|13|||
106125290|NCT01461993|366115906|FG000|Overall Study|Protocol Violation|10|||
106125291|NCT01461993|366115907|FG001|Overall Study|Protocol Violation|9|||
105903638|NCT00734656|365305979|FG002|Lab Session 4|Withdrawal by Subject|0|||
105903639|NCT00734656|365305980|FG003|Lab Session 4|Withdrawal by Subject|1|||
105903640|NCT03915626|365305981|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
105903641|NCT02362425|365305982|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
105903642|NCT02362425|365305983|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
105903643|NCT02362425|365305984|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
105903644|NCT02362425|365305985|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
105903645|NCT02362425|365305982|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
105903646|NCT02362425|365305983|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
105903647|NCT02362425|365305984|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
105903648|NCT02362425|365305985|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
105903649|NCT02362425|365305982|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
105903650|NCT02362425|365305983|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
105903651|NCT02362425|365305984|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
105903652|NCT02362425|365305985|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
105903653|NCT02362425|365305982|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
105903654|NCT02362425|365305983|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
105903655|NCT02362425|365305984|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
105903656|NCT02362425|365305985|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
105903657|NCT02362425|365305982|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
105903658|NCT02362425|365305983|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
105903659|NCT02362425|365305984|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
105903660|NCT02362425|365305985|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
105903661|NCT02362425|365305982|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
105903662|NCT02362425|365305983|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
105903663|NCT02362425|365305984|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
105903664|NCT02362425|365305985|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
105903665|NCT02362425|365305982|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
105903666|NCT02362425|365305983|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
105903667|NCT02362425|365305984|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
105903668|NCT02362425|365305985|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
105903669|NCT02362425|365305982|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
105903670|NCT02362425|365305983|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
105903671|NCT02362425|365305984|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
105903672|NCT02362425|365305985|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
105903673|NCT01031004|365305996|FG000|Overall Study|Protocol Violation|0|||
105903674|NCT01031004|365305997|FG001|Overall Study|Protocol Violation|1|||
105903675|NCT01031004|365305996|FG000|Overall Study|Lost to Follow-up|1|||
105903676|NCT01031004|365305997|FG001|Overall Study|Lost to Follow-up|0|||
105903677|NCT02634801|365305998|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
105903678|NCT02634801|365305999|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
105903679|NCT02634801|365306000|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
105903680|NCT02634801|365305998|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
105903681|NCT02634801|365305999|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
105903682|NCT02634801|365306000|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
105903683|NCT02634801|365305998|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
105903684|NCT02634801|365305999|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
105903685|NCT02634801|365306000|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
105669283|NCT01646177|364454021|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669284|NCT01646177|364454022|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669285|NCT01646177|364454023|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669286|NCT01646177|364454024|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
105669287|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669288|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669289|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669290|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669291|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
105669292|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
105669293|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
105903686|NCT02634801|365305998|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
105903687|NCT02634801|365305999|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
105903688|NCT02634801|365306000|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
105903689|NCT02634801|365305998|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
105669294|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
105669295|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669296|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105903690|NCT02634801|365305999|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
105903691|NCT02634801|365306000|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
105903692|NCT02634801|365305998|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
105903693|NCT02634801|365305999|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
105903694|NCT02634801|365306000|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
105903695|NCT02634801|365305998|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
105903696|NCT02634801|365305999|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
105669297|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669298|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
105669299|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669300|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105903697|NCT02634801|365306000|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
105903698|NCT02634801|365305998|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
105903699|NCT02634801|365305999|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
105903700|NCT02634801|365306000|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
105903701|NCT02634801|365305998|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
105903702|NCT02634801|365305999|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
105669301|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669302|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669303|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
105669304|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
105669305|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
105669306|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
105669307|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669308|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669309|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669310|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
105669311|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669312|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669313|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669314|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669315|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
105669316|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
105669317|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
105669318|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
105669319|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669320|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669321|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669322|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
105669323|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669324|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669325|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669326|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669327|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
105669328|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
105669329|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
105669330|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
105669331|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669332|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669333|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669334|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
105669335|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105903703|NCT02634801|365306000|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
105903704|NCT02634801|365305998|FG000|Follow-up Period|Lost to Follow-up|3|||
105903705|NCT02634801|365305999|FG001|Follow-up Period|Lost to Follow-up|1|||
105903706|NCT02634801|365306000|FG002|Follow-up Period|Lost to Follow-up|2|||
105903707|NCT02634801|365305998|FG000|Follow-up Period|Physician Decision|0|||
105903708|NCT02634801|365305999|FG001|Follow-up Period|Physician Decision|0|||
105903709|NCT02634801|365306000|FG002|Follow-up Period|Physician Decision|1|||
105903710|NCT02634801|365305998|FG000|Follow-up Period|Withdrawal by Subject|1|||
105903711|NCT02634801|365305999|FG001|Follow-up Period|Withdrawal by Subject|2|||
105903712|NCT02634801|365306000|FG002|Follow-up Period|Withdrawal by Subject|5|||
105903713|NCT02634801|365305998|FG000|Follow-up Period|Adverse Event|1|||
105903714|NCT02634801|365305999|FG001|Follow-up Period|Adverse Event|5|||
105903715|NCT02634801|365306000|FG002|Follow-up Period|Adverse Event|0|||
106125292|NCT01461993|366115908|FG002|Overall Study|Protocol Violation|7|||
105669336|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669337|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669338|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669339|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
105669340|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
105669341|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
105669342|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
105669343|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669344|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669345|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669346|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
105669347|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669348|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669349|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669350|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669351|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
105669352|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
105669353|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669354|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
105669355|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669356|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105669357|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105903716|NCT02626000|365306002|FG000|Overall Study|Decision by Sponsor|1|||
105903717|NCT02626000|365306002|FG000|Overall Study|Death|29|||
105903718|NCT00662311|365306003|FG000|Overall Study|Respiratory Infection|1|||
105903719|NCT00662311|365306004|FG001|Overall Study|Respiratory Infection|0|||
105903720|NCT00662311|365306005|FG002|Overall Study|Respiratory Infection|0|||
105903721|NCT01467271|365306006|FG000|Overall Study|Death|84|||
105903722|NCT01467271|365306006|FG000|Overall Study|Lost to Follow-up|83|||
105903723|NCT01467271|365306006|FG000|Overall Study|Retraction of patient's consent|21|||
105903724|NCT01467271|365306006|FG000|Overall Study|Other reason|14|||
106125293|NCT01461993|366115906|FG000|Overall Study|Adverse Event|9|||
106125294|NCT01461993|366115907|FG001|Overall Study|Adverse Event|11|||
106125295|NCT01461993|366115908|FG002|Overall Study|Adverse Event|3|||
106125296|NCT01461993|366115906|FG000|Overall Study|No longer met eligibility criteria|13|||
106125297|NCT01461993|366115907|FG001|Overall Study|No longer met eligibility criteria|18|||
106125298|NCT01461993|366115908|FG002|Overall Study|No longer met eligibility criteria|10|||
106125299|NCT01461993|366115906|FG000|Overall Study|Did not meet entrance criteria|2|||
106125300|NCT01461993|366115907|FG001|Overall Study|Did not meet entrance criteria|3|||
106125301|NCT01461993|366115908|FG002|Overall Study|Did not meet entrance criteria|0|||
106125302|NCT01461993|366115906|FG000|Overall Study|Other|13|||
106125303|NCT01461993|366115907|FG001|Overall Study|Other|15|||
106125304|NCT01461993|366115908|FG002|Overall Study|Other|6|||
106125305|NCT03018106|366115909|FG000|Overall Study|Lost to Follow-up|0|||
106125306|NCT03018106|366115910|FG001|Overall Study|Lost to Follow-up|1|||
106125307|NCT03055832|366115911|FG000|Week 2|Withdrawal by Subject|1|||
106125308|NCT03055832|366115912|FG001|Week 2|Withdrawal by Subject|0|||
106125309|NCT01152554|366115913|FG000|Overall Study|Withdrawal by Subject|73|||
106125310|NCT01152554|366115914|FG001|Overall Study|Withdrawal by Subject|28|||
106125311|NCT01152554|366115913|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
106125312|NCT01152554|366115914|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
106125313|NCT01152554|366115913|FG000|Overall Study|Adverse Event|67|||
106125314|NCT01152554|366115914|FG001|Overall Study|Adverse Event|14|||
106125315|NCT01152554|366115913|FG000|Overall Study|Severe non-compliance to protocol|36|||
106125316|NCT01152554|366115914|FG001|Overall Study|Severe non-compliance to protocol|14|||
106125317|NCT01152554|366115913|FG000|Overall Study|Condition under investigation worsened|5|||
106125318|NCT01152554|366115914|FG001|Overall Study|Condition under investigation worsened|2|||
106125319|NCT01152554|366115913|FG000|Overall Study|Lack of Efficacy|20|||
106125320|NCT01152554|366115914|FG001|Overall Study|Lack of Efficacy|3|||
106125321|NCT01152554|366115913|FG000|Overall Study|Study-specific withdrawal criteria|17|||
106125322|NCT01152554|366115914|FG001|Overall Study|Study-specific withdrawal criteria|8|||
106125323|NCT01152554|366115913|FG000|Overall Study|Lost to Follow-up|87|||
106125324|NCT01152554|366115914|FG001|Overall Study|Lost to Follow-up|32|||
106125325|NCT01152554|366115913|FG000|Overall Study|Other|28|||
106125326|NCT01152554|366115914|FG001|Overall Study|Other|8|||
106125327|NCT01152554|366115913|FG000|Overall Study|Death|1|||
106125328|NCT01152554|366115914|FG001|Overall Study|Death|1|||
106125329|NCT01818700|366115917|FG000|Overall Study|Adverse Event|67|||
106125330|NCT01818700|366115917|FG000|Overall Study|Lack of Efficacy|2|||
106125331|NCT01818700|366115917|FG000|Overall Study|Lost to Follow-up|5|||
106125332|NCT01818700|366115917|FG000|Overall Study|Withdrawal by Subject|27|||
106125333|NCT01818700|366115917|FG000|Overall Study|Protocol Violation|2|||
105903725|NCT03300050|365306007|FG000|Overall Study|Lost to Follow-up|2|||
105903726|NCT03300050|365306008|FG001|Overall Study|Lost to Follow-up|1|||
105903727|NCT03300050|365306009|FG002|Overall Study|Lost to Follow-up|0|||
105903728|NCT03300050|365306010|FG003|Overall Study|Lost to Follow-up|0|||
105903729|NCT03300050|365306011|FG004|Overall Study|Lost to Follow-up|1|||
105903730|NCT03300050|365306007|FG000|Overall Study|Withdrawal by Subject|1|||
105903731|NCT03300050|365306008|FG001|Overall Study|Withdrawal by Subject|1|||
105903732|NCT03300050|365306009|FG002|Overall Study|Withdrawal by Subject|1|||
105903733|NCT03300050|365306010|FG003|Overall Study|Withdrawal by Subject|0|||
105903734|NCT03300050|365306011|FG004|Overall Study|Withdrawal by Subject|0|||
105903735|NCT03300050|365306007|FG000|Overall Study|Death|0|||
105903736|NCT03300050|365306008|FG001|Overall Study|Death|0|||
105903737|NCT03300050|365306009|FG002|Overall Study|Death|1|||
105903738|NCT03300050|365306010|FG003|Overall Study|Death|0|||
105903739|NCT03300050|365306011|FG004|Overall Study|Death|0|||
105903740|NCT03300050|365306007|FG000|Overall Study|Not Eligible at Randomization|0|||
105903741|NCT03300050|365306008|FG001|Overall Study|Not Eligible at Randomization|0|||
105903742|NCT03300050|365306009|FG002|Overall Study|Not Eligible at Randomization|1|||
105903743|NCT03300050|365306010|FG003|Overall Study|Not Eligible at Randomization|1|||
105903744|NCT03300050|365306011|FG004|Overall Study|Not Eligible at Randomization|0|||
105903745|NCT03084302|365306012|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
105903746|NCT03084302|365306012|FG000|Overall Study|No valid objective monitor data|6|||
105903747|NCT01411319|365306013|FG000|Overall Study|Lost to Follow-up|1|||
105903748|NCT01214668|365306014|FG000|Overall Study|Adverse Event|0|||
105903749|NCT01214668|365306015|FG001|Overall Study|Adverse Event|1|||
105903750|NCT01214668|365306016|FG002|Overall Study|Adverse Event|0|||
105903751|NCT01214668|365306017|FG003|Overall Study|Adverse Event|2|||
105903752|NCT01214668|365306018|FG004|Overall Study|Adverse Event|1|||
105903753|NCT01214668|365306019|FG005|Overall Study|Adverse Event|1|||
105903754|NCT01214668|365306014|FG000|Overall Study|Death|0|||
105903755|NCT01214668|365306015|FG001|Overall Study|Death|0|||
105903756|NCT01214668|365306016|FG002|Overall Study|Death|1|||
105903757|NCT01214668|365306017|FG003|Overall Study|Death|0|||
105903758|NCT01214668|365306018|FG004|Overall Study|Death|0|||
105903759|NCT01214668|365306019|FG005|Overall Study|Death|0|||
105903760|NCT01214668|365306014|FG000|Overall Study|Progressive Disease|4|||
105998241|NCT01463306|365654889|FG002|Overall Study|Other|0|||
105998242|NCT01463306|365654887|FG000|Overall Study|Approval expiry at site|1|||
105998243|NCT01463306|365654888|FG001|Overall Study|Approval expiry at site|0|||
105998244|NCT01463306|365654889|FG002|Overall Study|Approval expiry at site|0|||
105903761|NCT01214668|365306015|FG001|Overall Study|Progressive Disease|2|||
105903762|NCT01214668|365306016|FG002|Overall Study|Progressive Disease|5|||
105903763|NCT01214668|365306017|FG003|Overall Study|Progressive Disease|4|||
105903764|NCT01214668|365306018|FG004|Overall Study|Progressive Disease|4|||
105998245|NCT01150097|365654892|FG000|Months 24 to 36 Post-transplantation|Death|2|||
105998246|NCT01150097|365654893|FG001|Months 24 to 36 Post-transplantation|Death|0|||
105998247|NCT01150097|365654894|FG002|Months 24 to 36 Post-transplantation|Death|0|||
105998248|NCT01150097|365654892|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
105903765|NCT01214668|365306019|FG005|Overall Study|Progressive Disease|5|||
105903766|NCT01214668|365306014|FG000|Overall Study|Withdrawal by Subject|0|||
105903767|NCT01214668|365306015|FG001|Overall Study|Withdrawal by Subject|0|||
105903768|NCT01214668|365306016|FG002|Overall Study|Withdrawal by Subject|0|||
105903769|NCT01214668|365306017|FG003|Overall Study|Withdrawal by Subject|0|||
105903770|NCT01214668|365306018|FG004|Overall Study|Withdrawal by Subject|1|||
105903771|NCT01214668|365306019|FG005|Overall Study|Withdrawal by Subject|0|||
105903772|NCT00660595|365306020|FG000|Overall Study|Lost to Follow-up|0|||
105903773|NCT00660595|365306021|FG001|Overall Study|Lost to Follow-up|1|||
105903774|NCT00660595|365306020|FG000|Overall Study|Did not consent to participate in study|12|||
105903775|NCT00660595|365306021|FG001|Overall Study|Did not consent to participate in study|8|||
105903776|NCT00660595|365306020|FG000|Overall Study|Participant left hospital|1|||
105903777|NCT00660595|365306021|FG001|Overall Study|Participant left hospital|0|||
105903778|NCT00660595|365306020|FG000|Overall Study|Non Specified reasons|5|||
105903779|NCT00660595|365306021|FG001|Overall Study|Non Specified reasons|0|||
105903780|NCT05205005|365306034|FG000|Overall Study|Withdrawal by Subject|1|||
105903781|NCT05205005|365306035|FG001|Overall Study|Withdrawal by Subject|0|||
105903782|NCT05205005|365306034|FG000|Overall Study|Adverse Event|1|||
105903783|NCT05205005|365306035|FG001|Overall Study|Adverse Event|0|||
105903784|NCT01148459|365306036|FG000|Overall Study|Serious Adverse Event|5|||
105903785|NCT01148459|365306037|FG001|Overall Study|Serious Adverse Event|4|||
105903786|NCT01148459|365306036|FG000|Overall Study|Withdrawal by Subject|1|||
105903787|NCT01148459|365306037|FG001|Overall Study|Withdrawal by Subject|0|||
105903788|NCT01148459|365306036|FG000|Overall Study|Migrated/moved from study area|3|||
105903789|NCT01148459|365306037|FG001|Overall Study|Migrated/moved from study area|6|||
105903790|NCT01148459|365306036|FG000|Overall Study|Lost to Follow-up|2|||
105903791|NCT01148459|365306037|FG001|Overall Study|Lost to Follow-up|0|||
105903792|NCT01148459|365306036|FG000|Overall Study|Refusal|1|||
105903793|NCT01148459|365306037|FG001|Overall Study|Refusal|0|||
105903794|NCT01148459|365306036|FG000|Overall Study|Failure to comply with study procedures|0|||
105903795|NCT01148459|365306037|FG001|Overall Study|Failure to comply with study procedures|1|||
105903796|NCT02187029|365306038|FG000|Overall Study|Adverse Event|0|||
105903797|NCT02187029|365306039|FG001|Overall Study|Adverse Event|1|||
105903798|NCT02187029|365306040|FG002|Overall Study|Adverse Event|1|||
105903799|NCT02187029|365306041|FG003|Overall Study|Adverse Event|0|||
105903800|NCT02187029|365306038|FG000|Overall Study|Study Terminated by Sponsor|0|||
105903801|NCT02187029|365306039|FG001|Overall Study|Study Terminated by Sponsor|0|||
105903802|NCT02187029|365306040|FG002|Overall Study|Study Terminated by Sponsor|10|||
105903803|NCT02187029|365306041|FG003|Overall Study|Study Terminated by Sponsor|3|||
105903804|NCT02187029|365306038|FG000|Overall Study|Withdrawal by Subject|1|||
105903805|NCT02187029|365306039|FG001|Overall Study|Withdrawal by Subject|0|||
105903806|NCT02187029|365306040|FG002|Overall Study|Withdrawal by Subject|0|||
105903807|NCT02187029|365306041|FG003|Overall Study|Withdrawal by Subject|0|||
105903808|NCT01066663|365306047|FG000|Overall Study|Adverse Event|0|||
105903809|NCT01066663|365306048|FG001|Overall Study|Adverse Event|0|||
105903810|NCT01066663|365306049|FG002|Overall Study|Adverse Event|1|||
105903811|NCT02985021|365306050|FG000|Overall Study|Inability to comply with study procedures|1|||
105903812|NCT01491841|365306051|FG000|Overall Study|Screen Failure|10|||
105903813|NCT01491841|365306051|FG000|Overall Study|Withdrawal by Subject|1|||
105903814|NCT03539484|365306052|FG000|Overall Study|Death|1|||
105903815|NCT03539484|365306053|FG001|Overall Study|Death|0|||
105903816|NCT03539484|365306054|FG002|Overall Study|Death|0|||
105903817|NCT03539484|365306055|FG003|Overall Study|Death|2|||
105903818|NCT03539484|365306056|FG004|Overall Study|Death|8|||
105903819|NCT03539484|365306057|FG005|Overall Study|Death|3|||
105903820|NCT03539484|365306058|FG006|Overall Study|Death|0|||
105903821|NCT03539484|365306052|FG000|Overall Study|Lost to Follow-up|0|||
105903822|NCT03539484|365306053|FG001|Overall Study|Lost to Follow-up|1|||
105903823|NCT03539484|365306054|FG002|Overall Study|Lost to Follow-up|0|||
105903824|NCT03539484|365306055|FG003|Overall Study|Lost to Follow-up|0|||
105903825|NCT03539484|365306056|FG004|Overall Study|Lost to Follow-up|1|||
105903826|NCT03539484|365306057|FG005|Overall Study|Lost to Follow-up|0|||
105903827|NCT03539484|365306058|FG006|Overall Study|Lost to Follow-up|0|||
105903828|NCT03539484|365306052|FG000|Overall Study|Withdrawal by Subject|0|||
105903829|NCT03539484|365306053|FG001|Overall Study|Withdrawal by Subject|0|||
105903830|NCT03539484|365306054|FG002|Overall Study|Withdrawal by Subject|0|||
105998249|NCT01150097|365654893|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
106125334|NCT01818700|366115917|FG000|Overall Study|Other|1|||
105903831|NCT03539484|365306055|FG003|Overall Study|Withdrawal by Subject|0|||
105903832|NCT03539484|365306056|FG004|Overall Study|Withdrawal by Subject|2|||
105903833|NCT03539484|365306057|FG005|Overall Study|Withdrawal by Subject|0|||
105903834|NCT03539484|365306058|FG006|Overall Study|Withdrawal by Subject|1|||
106125335|NCT02213055|366115918|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
105903835|NCT03539484|365306052|FG000|Overall Study|Study Terminated by Sponsor|0|||
105903836|NCT03539484|365306053|FG001|Overall Study|Study Terminated by Sponsor|0|||
105903837|NCT03539484|365306054|FG002|Overall Study|Study Terminated by Sponsor|1|||
105903838|NCT03539484|365306055|FG003|Overall Study|Study Terminated by Sponsor|1|||
105903839|NCT03539484|365306056|FG004|Overall Study|Study Terminated by Sponsor|2|||
105903840|NCT03539484|365306057|FG005|Overall Study|Study Terminated by Sponsor|2|||
105903841|NCT03539484|365306058|FG006|Overall Study|Study Terminated by Sponsor|1|||
105903842|NCT04105842|365306059|FG000|Overall Study|Withdrawal by Subject|2|||
105903843|NCT02734862|365306061|FG000|Part A|Death|3|||
105903844|NCT02734862|365306062|FG001|Part A|Death|4|||
105903845|NCT02734862|365306063|FG002|Part A|Death|6|||
105903846|NCT02734862|365306061|FG000|Part A|Lost to Follow-up|2|||
105903847|NCT02734862|365306062|FG001|Part A|Lost to Follow-up|1|||
105903848|NCT02734862|365306063|FG002|Part A|Lost to Follow-up|1|||
105903849|NCT02734862|365306061|FG000|Part A|Withdrawal by Subject|1|||
105903850|NCT02734862|365306062|FG001|Part A|Withdrawal by Subject|1|||
105903851|NCT02734862|365306063|FG002|Part A|Withdrawal by Subject|2|||
105903852|NCT02734862|365306061|FG000|Part A|Physician Decision|2|||
105903853|NCT02734862|365306062|FG001|Part A|Physician Decision|0|||
105903854|NCT02734862|365306063|FG002|Part A|Physician Decision|1|||
105903855|NCT02734862|365306061|FG000|Part A|Adverse Event|2|||
105903856|NCT02734862|365306062|FG001|Part A|Adverse Event|0|||
105903857|NCT02734862|365306063|FG002|Part A|Adverse Event|1|||
105903858|NCT02734862|365306061|FG000|Part A|Noncompliance|1|||
105903859|NCT02734862|365306062|FG001|Part A|Noncompliance|1|||
105903860|NCT02734862|365306063|FG002|Part A|Noncompliance|0|||
105903861|NCT02734862|365306061|FG000|Part A|Other|1|||
105903862|NCT02734862|365306062|FG001|Part A|Other|1|||
105903863|NCT02734862|365306063|FG002|Part A|Other|3|||
105903864|NCT02734862|365306061|FG000|Part B|Death|8|||
105903865|NCT02734862|365306062|FG001|Part B|Death|3|||
105903866|NCT02734862|365306063|FG002|Part B|Death|5|||
105903867|NCT02734862|365306061|FG000|Part B|Lost to Follow-up|2|||
105903868|NCT02734862|365306062|FG001|Part B|Lost to Follow-up|2|||
105903869|NCT02734862|365306063|FG002|Part B|Lost to Follow-up|0|||
105903870|NCT02734862|365306061|FG000|Part B|Withdrawal by Subject|3|||
105903871|NCT02734862|365306062|FG001|Part B|Withdrawal by Subject|1|||
105903872|NCT02734862|365306063|FG002|Part B|Withdrawal by Subject|0|||
105903873|NCT02734862|365306061|FG000|Part B|Other|0|||
105903874|NCT02734862|365306062|FG001|Part B|Other|1|||
105903875|NCT02734862|365306063|FG002|Part B|Other|0|||
105903876|NCT02757625|365306064|FG000|Overall Study|Investigator's discretion|0|||
105903877|NCT02757625|365306065|FG001|Overall Study|Investigator's discretion|0|||
105903878|NCT02757625|365306066|FG002|Overall Study|Investigator's discretion|1|||
105903879|NCT02757625|365306067|FG003|Overall Study|Investigator's discretion|0|||
105903880|NCT02757625|365306064|FG000|Overall Study|Adverse Event|0|||
105903881|NCT02757625|365306065|FG001|Overall Study|Adverse Event|0|||
105903882|NCT02757625|365306066|FG002|Overall Study|Adverse Event|1|||
105903883|NCT02757625|365306067|FG003|Overall Study|Adverse Event|0|||
105903884|NCT04854057|365306068|FG000|Overall Study|Adverse Event|0|||
105903885|NCT04854057|365306069|FG001|Overall Study|Adverse Event|1|||
105903886|NCT03519919|365306070|FG000|Overall Study|Withdrawal by Subject|1|||
105903887|NCT03519919|365306070|FG000|Overall Study|Lack of Efficacy|1|||
105903888|NCT03519919|365306070|FG000|Overall Study|Screen Failure|1|||
105903889|NCT00645671|365306071|FG000|Overall Study|Protocol Violation|1|||
105903890|NCT00645671|365306072|FG001|Overall Study|Protocol Violation|0|||
105903891|NCT00645671|365306071|FG000|Overall Study|Withdrawal by Subject|0|||
105903892|NCT00645671|365306072|FG001|Overall Study|Withdrawal by Subject|4|||
105903893|NCT00645671|365306071|FG000|Overall Study|Adverse Event|0|||
105903894|NCT00645671|365306072|FG001|Overall Study|Adverse Event|1|||
105903895|NCT00645671|365306071|FG000|Overall Study|Physician Decision|0|||
105903896|NCT00645671|365306072|FG001|Overall Study|Physician Decision|1|||
105903897|NCT01979523|365306073|FG000|Overall Study|Withdrawal by Subject|1|||
105903898|NCT01979523|365306074|FG001|Overall Study|Withdrawal by Subject|0|||
105903899|NCT03959527|365306075|FG000|Overall Study|Withdrawal by Subject|8|||
105903900|NCT03959527|365306076|FG001|Overall Study|Withdrawal by Subject|3|||
105903901|NCT03959527|365306075|FG000|Overall Study|Lost to Follow-up|31|||
105903902|NCT03959527|365306076|FG001|Overall Study|Lost to Follow-up|15|||
105903903|NCT03959527|365306075|FG000|Overall Study|Did not meet eligibility criteria|1|||
105903904|NCT03959527|365306076|FG001|Overall Study|Did not meet eligibility criteria|1|||
105903905|NCT03959527|365306075|FG000|Overall Study|Protocol Violation|10|||
105903906|NCT03959527|365306076|FG001|Overall Study|Protocol Violation|5|||
105903907|NCT01005901|365306078|FG000|Overall Study|Withdrawal by Subject|38|||
105903908|NCT01005901|365306079|FG001|Overall Study|Withdrawal by Subject|14|||
105903909|NCT01005901|365306078|FG000|Overall Study|Adverse Event|30|||
105903910|NCT01005901|365306079|FG001|Overall Study|Adverse Event|16|||
105903911|NCT01005901|365306078|FG000|Overall Study|Administrative problems|21|||
105903912|NCT01005901|365306079|FG001|Overall Study|Administrative problems|13|||
105903913|NCT01005901|365306078|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
105903914|NCT01005901|365306079|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
105903915|NCT01005901|365306078|FG000|Overall Study|Protocol Violation|4|||
105903916|NCT01005901|365306079|FG001|Overall Study|Protocol Violation|3|||
105903917|NCT01005901|365306078|FG000|Overall Study|Death|2|||
105903918|NCT01005901|365306079|FG001|Overall Study|Death|3|||
105903919|NCT01005901|365306078|FG000|Overall Study|Lost to Follow-up|1|||
105903920|NCT01005901|365306079|FG001|Overall Study|Lost to Follow-up|2|||
105903921|NCT01005901|365306078|FG000|Overall Study|Patient's inability to use the device|1|||
105903922|NCT01005901|365306079|FG001|Overall Study|Patient's inability to use the device|1|||
105903923|NCT01005901|365306078|FG000|Overall Study|No longer requires study drug|0|||
105903924|NCT01005901|365306079|FG001|Overall Study|No longer requires study drug|1|||
105903925|NCT00902746|365306081|FG000|Overall Study|Protocol Violation|7|||
105903926|NCT00902746|365306081|FG000|Overall Study|Withdrawal by Subject|16|||
105903927|NCT00902746|365306081|FG000|Overall Study|Adverse Event|8|||
105903928|NCT00902746|365306081|FG000|Overall Study|Lost to Follow-up|3|||
105903929|NCT00902746|365306081|FG000|Overall Study|Physician Decision|2|||
105903930|NCT02937636|365306082|FG000|Overall Study|Other (Not specified)|3|||
105903931|NCT02937636|365306083|FG001|Overall Study|Other (Not specified)|2|||
105903932|NCT00359294|365306088|FG000|Overall Study|Progressive disease|1|||
105903933|NCT00359294|365306089|FG001|Overall Study|Progressive disease|1|||
105903934|NCT00359294|365306090|FG002|Overall Study|Progressive disease|2|||
105903935|NCT00359294|365306091|FG003|Overall Study|Progressive disease|3|||
105903936|NCT00359294|365306092|FG004|Overall Study|Progressive disease|2|||
105903937|NCT00359294|365306088|FG000|Overall Study|Withdrawal by Subject|0|||
105903938|NCT00359294|365306089|FG001|Overall Study|Withdrawal by Subject|0|||
105903939|NCT00359294|365306090|FG002|Overall Study|Withdrawal by Subject|0|||
105903940|NCT00359294|365306091|FG003|Overall Study|Withdrawal by Subject|0|||
105903941|NCT00359294|365306092|FG004|Overall Study|Withdrawal by Subject|1|||
105903942|NCT00359294|365306088|FG000|Overall Study|Not treated|0|||
105903943|NCT00359294|365306089|FG001|Overall Study|Not treated|0|||
105903944|NCT00359294|365306090|FG002|Overall Study|Not treated|0|||
105903945|NCT00359294|365306091|FG003|Overall Study|Not treated|1|||
105903946|NCT00359294|365306092|FG004|Overall Study|Not treated|0|||
105903947|NCT00359294|365306088|FG000|Overall Study|Physician Decision|0|||
105903948|NCT00359294|365306089|FG001|Overall Study|Physician Decision|0|||
105903949|NCT00359294|365306090|FG002|Overall Study|Physician Decision|1|||
105903950|NCT00359294|365306091|FG003|Overall Study|Physician Decision|0|||
105903951|NCT00359294|365306092|FG004|Overall Study|Physician Decision|0|||
105903952|NCT01280682|365306097|FG000|Overall Study|Lost to Follow-up|0|||
105903953|NCT01280682|365306098|FG001|Overall Study|Lost to Follow-up|6|||
105903954|NCT01280682|365306097|FG000|Overall Study|Withdrawal by Subject|0|||
105903955|NCT01280682|365306098|FG001|Overall Study|Withdrawal by Subject|7|||
105903956|NCT00849290|365306099|FG000|Overall Study|Adverse Event|3|||
105903957|NCT00849290|365306099|FG000|Overall Study|Death|14|||
105903958|NCT00849290|365306099|FG000|Overall Study|Withdrawal by Subject|11|||
105903959|NCT00849290|365306099|FG000|Overall Study|Lost to Follow-up|2|||
105903960|NCT00849290|365306099|FG000|Overall Study|Protocol Violation|5|||
105903961|NCT00849290|365306099|FG000|Overall Study|Disease Progression|20|||
105903962|NCT01464619|365306104|FG000|Overall Study|Lost to Follow-up|3|||
105903963|NCT01464619|365306105|FG001|Overall Study|Lost to Follow-up|4|||
105903964|NCT00080483|365306106|FG000|Overall Study|Lost to Follow-up|1|||
105903965|NCT00080483|365306107|FG001|Overall Study|Lost to Follow-up|1|||
105903966|NCT00080483|365306106|FG000|Overall Study|Physician Decision|1|||
105903967|NCT00080483|365306107|FG001|Overall Study|Physician Decision|1|||
105903968|NCT01119846|365306110|FG000|Overall Study|Adverse Event|1|||
105903969|NCT01119846|365306111|FG001|Overall Study|Adverse Event|0|||
105903970|NCT01119846|365306112|FG002|Overall Study|Adverse Event|6|||
105903971|NCT01119846|365306110|FG000|Overall Study|Physician Decision|1|||
105903972|NCT01119846|365306111|FG001|Overall Study|Physician Decision|0|||
105903973|NCT01119846|365306112|FG002|Overall Study|Physician Decision|0|||
105903974|NCT01119846|365306110|FG000|Overall Study|Protocol Violation|0|||
105903975|NCT01119846|365306111|FG001|Overall Study|Protocol Violation|0|||
105903976|NCT01119846|365306112|FG002|Overall Study|Protocol Violation|1|||
105903977|NCT01119846|365306110|FG000|Overall Study|Withdrawal by Subject|0|||
105903978|NCT01119846|365306111|FG001|Overall Study|Withdrawal by Subject|0|||
105903979|NCT01119846|365306112|FG002|Overall Study|Withdrawal by Subject|4|||
105903980|NCT00845676|365306121|FG000|Overall Study|Virologic breakthrough at week 20|1|||
105903981|NCT00845676|365306121|FG000|Overall Study|Adverse Event|1|||
105903982|NCT00524173|365306122|FG000|Overall Study|Lost to Follow-up|0|||
106125336|NCT02213055|366115919|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
105669358|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
105903983|NCT00524173|365306123|FG001|Overall Study|Lost to Follow-up|1|||
105903984|NCT00524173|365306122|FG000|Overall Study|Death|1|||
105903985|NCT00524173|365306123|FG001|Overall Study|Death|0|||
105903986|NCT00524173|365306122|FG000|Overall Study|Had not reached endpoint at study close|4|||
105903987|NCT00524173|365306123|FG001|Overall Study|Had not reached endpoint at study close|1|||
105903988|NCT02070978|365306124|FG000|Overall Study|Adverse Event|6|||
106125337|NCT02213055|366115918|FG000|Overall Study|Protocol was not Followed during Study|1|||
105903989|NCT02070978|365306125|FG001|Overall Study|Adverse Event|2|||
105903990|NCT02070978|365306126|FG002|Overall Study|Adverse Event|0|||
105903991|NCT02070978|365306124|FG000|Overall Study|Lost to Follow-up|1|||
105903992|NCT02070978|365306125|FG001|Overall Study|Lost to Follow-up|3|||
105903993|NCT02070978|365306126|FG002|Overall Study|Lost to Follow-up|4|||
105903994|NCT02070978|365306124|FG000|Overall Study|Withdrawal by Subject|3|||
105903995|NCT02070978|365306125|FG001|Overall Study|Withdrawal by Subject|5|||
105903996|NCT02070978|365306126|FG002|Overall Study|Withdrawal by Subject|3|||
105903997|NCT02070978|365306124|FG000|Overall Study|Protocol Violation|1|||
105903998|NCT02070978|365306125|FG001|Overall Study|Protocol Violation|0|||
105903999|NCT02070978|365306126|FG002|Overall Study|Protocol Violation|3|||
105904000|NCT02070978|365306124|FG000|Overall Study|Lack of Efficacy|0|||
105904001|NCT02070978|365306125|FG001|Overall Study|Lack of Efficacy|1|||
105904002|NCT02070978|365306126|FG002|Overall Study|Lack of Efficacy|0|||
105904003|NCT02070978|365306124|FG000|Overall Study|Death|0|||
105904004|NCT02070978|365306125|FG001|Overall Study|Death|0|||
105904005|NCT02070978|365306126|FG002|Overall Study|Death|2|||
105904006|NCT02070978|365306124|FG000|Overall Study|Un-specified|3|||
105904007|NCT02070978|365306125|FG001|Overall Study|Un-specified|2|||
105904008|NCT02070978|365306126|FG002|Overall Study|Un-specified|2|||
105904009|NCT02070978|365306124|FG000|Overall Study|Terminated by Sponsor|33|||
105904010|NCT02070978|365306125|FG001|Overall Study|Terminated by Sponsor|40|||
105904011|NCT02070978|365306126|FG002|Overall Study|Terminated by Sponsor|39|||
105904012|NCT03951753|365306127|FG000|Overall Study|Adverse Event|1|||
105904013|NCT03951753|365306128|FG001|Overall Study|Adverse Event|0|||
105904014|NCT03951753|365306129|FG002|Overall Study|Adverse Event|3|||
105904015|NCT03951753|365306127|FG000|Overall Study|Withdrawal by Subject|3|||
105904016|NCT03951753|365306128|FG001|Overall Study|Withdrawal by Subject|1|||
105904017|NCT03951753|365306129|FG002|Overall Study|Withdrawal by Subject|0|||
105904018|NCT03951753|365306127|FG000|Overall Study|Lost to Follow-up|0|||
105904019|NCT03951753|365306128|FG001|Overall Study|Lost to Follow-up|0|||
105904020|NCT03951753|365306129|FG002|Overall Study|Lost to Follow-up|1|||
105904021|NCT01153009|365307406|FG000|Overall Study|Adverse Event|4|||
105904022|NCT01153009|365307407|FG001|Overall Study|Adverse Event|14|||
105904023|NCT01153009|365307408|FG002|Overall Study|Adverse Event|14|||
105904024|NCT01153009|365307409|FG003|Overall Study|Adverse Event|10|||
105904025|NCT01153009|365307406|FG000|Overall Study|Lack of Efficacy|9|||
105904026|NCT01153009|365307407|FG001|Overall Study|Lack of Efficacy|0|||
105904027|NCT01153009|365307408|FG002|Overall Study|Lack of Efficacy|2|||
105904028|NCT01153009|365307409|FG003|Overall Study|Lack of Efficacy|1|||
105904029|NCT01153009|365307406|FG000|Overall Study|Noncompliance with Study Medication|1|||
105904030|NCT01153009|365307407|FG001|Overall Study|Noncompliance with Study Medication|3|||
105904031|NCT01153009|365307408|FG002|Overall Study|Noncompliance with Study Medication|4|||
105904032|NCT01153009|365307409|FG003|Overall Study|Noncompliance with Study Medication|1|||
105904033|NCT01153009|365307406|FG000|Overall Study|Protocol Deviations|4|||
105904034|NCT01153009|365307407|FG001|Overall Study|Protocol Deviations|3|||
105904035|NCT01153009|365307408|FG002|Overall Study|Protocol Deviations|3|||
105904036|NCT01153009|365307409|FG003|Overall Study|Protocol Deviations|2|||
105904037|NCT01153009|365307406|FG000|Overall Study|Withdrawal of Consent|5|||
105904038|NCT01153009|365307407|FG001|Overall Study|Withdrawal of Consent|5|||
105904039|NCT01153009|365307408|FG002|Overall Study|Withdrawal of Consent|4|||
105904040|NCT01153009|365307409|FG003|Overall Study|Withdrawal of Consent|6|||
105904041|NCT01153009|365307406|FG000|Overall Study|Lost to Follow-up|8|||
105904042|NCT01153009|365307407|FG001|Overall Study|Lost to Follow-up|8|||
105904043|NCT01153009|365307408|FG002|Overall Study|Lost to Follow-up|11|||
105904044|NCT01153009|365307409|FG003|Overall Study|Lost to Follow-up|15|||
105904045|NCT01153009|365307406|FG000|Overall Study|Other|1|||
105904046|NCT01153009|365307407|FG001|Overall Study|Other|1|||
105904047|NCT01153009|365307408|FG002|Overall Study|Other|3|||
105904048|NCT01153009|365307409|FG003|Overall Study|Other|2|||
105904049|NCT00385827|365307410|FG000|Part 1|Adverse Event|1|||
105904050|NCT00385827|365307411|FG001|Part 1|Adverse Event|0|||
105904051|NCT00385827|365307412|FG002|Part 1|Adverse Event|0|||
105904052|NCT00385827|365307410|FG000|Part 1|Death|2|||
105904053|NCT00385827|365307411|FG001|Part 1|Death|0|||
105904054|NCT00385827|365307412|FG002|Part 1|Death|0|||
105904055|NCT00385827|365307410|FG000|Part 1|Lack of Efficacy|5|||
105904056|NCT00385827|365307411|FG001|Part 1|Lack of Efficacy|0|||
105904057|NCT00385827|365307412|FG002|Part 1|Lack of Efficacy|0|||
105904058|NCT00385827|365307410|FG000|Part 1|Other|1|||
105904059|NCT00385827|365307411|FG001|Part 1|Other|0|||
105904060|NCT00385827|365307412|FG002|Part 1|Other|0|||
105904061|NCT00385827|365307410|FG000|Part 2|Adverse Event|0|||
105904062|NCT00385827|365307411|FG001|Part 2|Adverse Event|6|||
105904063|NCT00385827|365307412|FG002|Part 2|Adverse Event|10|||
105904064|NCT00385827|365307410|FG000|Part 2|Death|0|||
105904065|NCT00385827|365307411|FG001|Part 2|Death|0|||
105904066|NCT00385827|365307412|FG002|Part 2|Death|2|||
105904067|NCT00385827|365307410|FG000|Part 2|Lack of Efficacy|0|||
105904068|NCT00385827|365307411|FG001|Part 2|Lack of Efficacy|14|||
105904069|NCT00385827|365307412|FG002|Part 2|Lack of Efficacy|13|||
105904070|NCT00385827|365307410|FG000|Part 2|Randomized but not treated|0|||
105904071|NCT00385827|365307411|FG001|Part 2|Randomized but not treated|2|||
105904072|NCT00385827|365307412|FG002|Part 2|Randomized but not treated|2|||
105904073|NCT00385827|365307410|FG000|Part 2|Other|0|||
105904074|NCT00385827|365307411|FG001|Part 2|Other|11|||
105904075|NCT00385827|365307412|FG002|Part 2|Other|21|||
105904076|NCT00762034|365307419|FG000|Induction Period|Protocol Violation|1|||
105904077|NCT00762034|365307420|FG001|Induction Period|Protocol Violation|2|||
105904078|NCT00762034|365307419|FG000|Induction Period|Entry Criterion Not Met|12|||
105904079|NCT00762034|365307420|FG001|Induction Period|Entry Criterion Not Met|11|||
105904080|NCT00762034|365307419|FG000|Induction Period|Adverse Event|27|||
105904081|NCT00762034|365307420|FG001|Induction Period|Adverse Event|38|||
105904082|NCT00762034|365307419|FG000|Induction Period|Lost to Follow-up|1|||
105904083|NCT00762034|365307420|FG001|Induction Period|Lost to Follow-up|1|||
105904084|NCT00762034|365307419|FG000|Induction Period|Progressive Disease|73|||
105904085|NCT00762034|365307420|FG001|Induction Period|Progressive Disease|55|||
105904086|NCT00762034|365307419|FG000|Induction Period|Physician Decision|21|||
105904087|NCT00762034|365307420|FG001|Induction Period|Physician Decision|20|||
105904088|NCT00762034|365307419|FG000|Induction Period|Withdrawal by Subject|15|||
105904089|NCT00762034|365307420|FG001|Induction Period|Withdrawal by Subject|19|||
105904090|NCT00762034|365307419|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
105904091|NCT00762034|365307420|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
105904092|NCT00762034|365307419|FG000|Induction Period|Deaths Due to Study Disease|9|||
105904093|NCT00762034|365307420|FG001|Induction Period|Deaths Due to Study Disease|9|||
105904094|NCT00762034|365307419|FG000|Maintenance Period|Protocol Violation|1|||
105904095|NCT00762034|365307420|FG001|Maintenance Period|Protocol Violation|3|||
105904096|NCT00762034|365307419|FG000|Maintenance Period|Entry Criterion Not Met|0|||
105904097|NCT00762034|365307420|FG001|Maintenance Period|Entry Criterion Not Met|2|||
105904098|NCT00762034|365307419|FG000|Maintenance Period|Adverse Event|42|||
105904099|NCT00762034|365307420|FG001|Maintenance Period|Adverse Event|26|||
105904100|NCT00762034|365307419|FG000|Maintenance Period|Progressive Disease|186|||
105904101|NCT00762034|365307420|FG001|Maintenance Period|Progressive Disease|224|||
105904102|NCT00762034|365307419|FG000|Maintenance Period|Physician Decision|25|||
105904103|NCT00762034|365307420|FG001|Maintenance Period|Physician Decision|20|||
105904104|NCT00762034|365307419|FG000|Maintenance Period|Withdrawal by Subject|34|||
105904105|NCT00762034|365307420|FG001|Maintenance Period|Withdrawal by Subject|14|||
105904106|NCT00762034|365307419|FG000|Maintenance Period|Death not due to study disease|2|||
105904107|NCT00762034|365307420|FG001|Maintenance Period|Death not due to study disease|5|||
105904108|NCT00762034|365307419|FG000|Maintenance Period|Death due to study disease|3|||
105904109|NCT00762034|365307420|FG001|Maintenance Period|Death due to study disease|3|||
105904110|NCT00762034|365307419|FG000|Maintenance Period|Other|1|||
105904111|NCT00762034|365307420|FG001|Maintenance Period|Other|1|||
105904112|NCT01964989|365307430|FG000|Overall Study|Protocol Violation|3|||
105904113|NCT01964989|365307431|FG001|Overall Study|Protocol Violation|4|||
105904114|NCT01964989|365307430|FG000|Overall Study|Administrative Reason|103|||
105904115|NCT01964989|365307431|FG001|Overall Study|Administrative Reason|95|||
105904116|NCT01964989|365307430|FG000|Overall Study|Adverse Event|0|||
105904117|NCT01964989|365307431|FG001|Overall Study|Adverse Event|1|||
105904118|NCT01964989|365307430|FG000|Overall Study|Death|1|||
105904119|NCT01964989|365307431|FG001|Overall Study|Death|3|||
105904120|NCT01964989|365307430|FG000|Overall Study|Withdrawal by Subject|156|||
105904121|NCT01964989|365307431|FG001|Overall Study|Withdrawal by Subject|160|||
105904122|NCT01964989|365307430|FG000|Overall Study|Lost to Follow-up|254|||
105904123|NCT01964989|365307431|FG001|Overall Study|Lost to Follow-up|232|||
105904124|NCT01964989|365307430|FG000|Overall Study|Other|267|||
105904125|NCT01964989|365307431|FG001|Overall Study|Other|252|||
105904126|NCT00184002|365307432|FG000|Overall Study|Adverse Event|9|||
105904127|NCT00184002|365307432|FG000|Overall Study|Death|3|||
105904128|NCT00184002|365307432|FG000|Overall Study|Physician Decision|1|||
105904129|NCT00184002|365307432|FG000|Overall Study|Withdrawal by Subject|4|||
105904130|NCT02499263|365307433|FG000|Overall Study|Lost to Follow-up|9|||
105904131|NCT02499263|365307433|FG000|Overall Study|Participant's withdrawal of consent|4|||
105904132|NCT02499263|365307433|FG000|Overall Study|Lack of Efficacy|22|||
105904133|NCT02499263|365307433|FG000|Overall Study|investigator's judgment|12|||
105904134|NCT02499263|365307433|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
105904135|NCT02499263|365307433|FG000|Overall Study|Participant's decision|3|||
105904136|NCT02499263|365307433|FG000|Overall Study|Pregnancy|1|||
105904137|NCT02496039|365307437|FG000|Overall Study|Adverse Event|3|||
105904138|NCT02496039|365307437|FG000|Overall Study|Protocol Violation|1|||
105904139|NCT04472494|365307438|FG000|Pre-treatment|Other reasons|2|||
105904140|NCT04472494|365307439|FG001|Pre-treatment|Other reasons|0|||
105904141|NCT04472494|365307438|FG000|Treatment|Death|5|||
105904142|NCT04472494|365307439|FG001|Treatment|Death|2|||
105904143|NCT04472494|365307438|FG000|Treatment|Hospital discharge|1|||
105904144|NCT04472494|365307439|FG001|Treatment|Hospital discharge|1|||
105904145|NCT01972464|365307440|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
105904146|NCT01972464|365307441|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
105904147|NCT01972464|365307440|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
105904148|NCT01972464|365307441|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
105904149|NCT01972464|365307440|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
105904150|NCT01972464|365307441|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
105904151|NCT01972464|365307440|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
105904152|NCT01972464|365307441|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
105904153|NCT06360588|365307449|FG000|Overall Study|Adverse Event|3|||
105904154|NCT06360588|365307449|FG000|Overall Study|Death|2|||
105904155|NCT06360588|365307449|FG000|Overall Study|Disease Progression|14|||
105904156|NCT06360588|365307449|FG000|Overall Study|Withdrawal by Subject|1|||
105904157|NCT06360588|365307449|FG000|Overall Study|Lack of Efficacy|1|||
105904158|NCT06360588|365307449|FG000|Overall Study|Ineligible|1|||
105904159|NCT00807612|365307450|FG000|Overall Study|Death|8|||
105904160|NCT00807612|365307450|FG000|Overall Study|Study early termination|5|||
105904161|NCT00807612|365307450|FG000|Overall Study|Withdrawal by Subject|1|||
105904162|NCT02476916|365307451|FG000|Core Period|Adverse Event|2|||
105904163|NCT02476916|365307452|FG001|Core Period|Adverse Event|2|||
105904164|NCT02476916|365307451|FG000|Core Period|Investigator decision|1|||
105904165|NCT02476916|365307452|FG001|Core Period|Investigator decision|1|||
105904166|NCT02476916|365307451|FG000|Core Period|Withdrawal by Subject|3|||
105904167|NCT02476916|365307452|FG001|Core Period|Withdrawal by Subject|0|||
105904168|NCT02476916|365307451|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
105904169|NCT02476916|365307452|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
105904170|NCT02476916|365307451|FG000|Extension Period|On Treatment|12|||
105904171|NCT02476916|365307452|FG001|Extension Period|On Treatment|17|||
105904172|NCT01939223|365307454|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
105904173|NCT01939223|365307455|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
105904174|NCT01939223|365307454|FG000|Overall Study|Disease recurrence (radiological)|1|||
105904175|NCT01939223|365307455|FG001|Overall Study|Disease recurrence (radiological)|3|||
105904176|NCT01939223|365307454|FG000|Overall Study|Study stopped by Sponsor|5|||
105904177|NCT01939223|365307455|FG001|Overall Study|Study stopped by Sponsor|7|||
105904178|NCT01939223|365307454|FG000|Overall Study|Withdrawal by Subject|6|||
105904179|NCT01939223|365307455|FG001|Overall Study|Withdrawal by Subject|0|||
105904180|NCT03585712|365307457|FG000|Treatment Period 1|Protocol Violation|1|||
105904181|NCT03585712|365307458|FG001|Treatment Period 1|Protocol Violation|0|||
105904182|NCT03585712|365307459|FG002|Treatment Period 1|Protocol Violation|0|||
105904183|NCT03585712|365307457|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
105904184|NCT03585712|365307458|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
105904185|NCT03585712|365307459|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
105904186|NCT03585712|365307457|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
105904187|NCT03585712|365307458|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
105904188|NCT03585712|365307459|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
105904189|NCT03585712|365307457|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
105904190|NCT03585712|365307458|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
105904191|NCT03585712|365307459|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
105904192|NCT02347072|365307464|FG000|Overall Study|Adverse Event|2|||
105904193|NCT02347072|365307464|FG000|Overall Study|Withdrawal by Subject|6|||
105904194|NCT02347072|365307464|FG000|Overall Study|Physician Decision|1|||
105904195|NCT02347072|365307464|FG000|Overall Study|Lost to Follow-up|2|||
105904196|NCT02347072|365307464|FG000|Overall Study|Protocol Violation|1|||
105904197|NCT02347072|365307464|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
105904198|NCT01658904|365307465|FG000|Overall Study|Principal Investigator discretion|2|||
105904199|NCT01658904|365307466|FG001|Overall Study|Principal Investigator discretion|0|||
105904200|NCT01658904|365307467|FG002|Overall Study|Principal Investigator discretion|0|||
105904201|NCT01808222|365307468|FG000|Overall Study|mpMR scan was not performed|1|||
105904202|NCT03762681|365307469|FG000|Part 1|Withdrawal by Subject|0|||
105904203|NCT03762681|365307470|FG001|Part 1|Withdrawal by Subject|0|||
105904204|NCT03762681|365307471|FG002|Part 1|Withdrawal by Subject|0|||
105904205|NCT03762681|365307472|FG003|Part 1|Withdrawal by Subject|1|||
105904206|NCT03762681|365307473|FG004|Part 1|Withdrawal by Subject|0|||
105904207|NCT03762681|365307474|FG005|Part 1|Withdrawal by Subject|0|||
105904208|NCT03762681|365307475|FG006|Part 1|Withdrawal by Subject|0|||
105904209|NCT03762681|365307476|FG007|Part 1|Withdrawal by Subject|0|||
105904210|NCT03762681|365307469|FG000|Part 2a|Pandemic Travel Restrictions|0|||
105904211|NCT03762681|365307470|FG001|Part 2a|Pandemic Travel Restrictions|0|||
105904212|NCT03762681|365307471|FG002|Part 2a|Pandemic Travel Restrictions|0|||
105904213|NCT03762681|365307472|FG003|Part 2a|Pandemic Travel Restrictions|0|||
105904214|NCT03762681|365307473|FG004|Part 2a|Pandemic Travel Restrictions|0|||
105904215|NCT03762681|365307474|FG005|Part 2a|Pandemic Travel Restrictions|0|||
105904216|NCT03762681|365307475|FG006|Part 2a|Pandemic Travel Restrictions|0|||
105904217|NCT03762681|365307476|FG007|Part 2a|Pandemic Travel Restrictions|1|||
105904218|NCT02137226|365307479|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
105904219|NCT02137226|365307480|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
105904220|NCT02137226|365307481|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
105904221|NCT02137226|365307482|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
105904222|NCT02137226|365307483|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
105904223|NCT02137226|365307479|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
105904224|NCT02137226|365307480|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
105904225|NCT02137226|365307481|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
105904226|NCT02137226|365307482|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
105904227|NCT02137226|365307483|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
105904228|NCT02137226|365307479|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
105904229|NCT02137226|365307480|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
105904230|NCT02137226|365307481|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
105904231|NCT02137226|365307482|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
105904232|NCT02137226|365307483|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
105904233|NCT02137226|365307479|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
105904234|NCT02137226|365307480|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
105904235|NCT02137226|365307481|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
105904236|NCT02137226|365307482|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
105904237|NCT02137226|365307483|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
105904238|NCT02137226|365307479|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
105904239|NCT02137226|365307480|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
105904240|NCT02137226|365307481|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
105904241|NCT02137226|365307482|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
105904242|NCT02137226|365307483|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
105904243|NCT02137226|365307479|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
105904244|NCT02137226|365307480|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
105904245|NCT02137226|365307481|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
105904246|NCT02137226|365307482|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
105904247|NCT02137226|365307483|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
105904248|NCT02137226|365307479|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
105904249|NCT02137226|365307480|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
105904250|NCT02137226|365307481|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
105904251|NCT02137226|365307482|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
105904252|NCT02137226|365307483|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
105904253|NCT02137226|365307479|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
105904254|NCT02137226|365307480|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
105904255|NCT02137226|365307481|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
105904256|NCT02137226|365307482|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
105904257|NCT02137226|365307483|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
105904258|NCT02137226|365307479|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
105904259|NCT02137226|365307480|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
105904260|NCT02137226|365307481|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
105904261|NCT02137226|365307482|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
105904262|NCT02137226|365307483|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
105904263|NCT02137226|365307479|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
105904264|NCT02137226|365307480|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
105904265|NCT02137226|365307481|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
105904266|NCT02137226|365307482|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
105904267|NCT02137226|365307483|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
105904268|NCT02137226|365307479|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
105904269|NCT02137226|365307480|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
105904270|NCT02137226|365307481|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
105904271|NCT02137226|365307482|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
105904272|NCT02137226|365307483|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
105904273|NCT02137226|365307479|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
105904274|NCT02137226|365307480|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
105904275|NCT02137226|365307481|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
105904276|NCT02137226|365307482|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
105904277|NCT02137226|365307483|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
105904278|NCT01398358|365307484|FG000|Overall Study|Lost to Follow-up|11|||
105904279|NCT01398358|365307485|FG001|Overall Study|Lost to Follow-up|21|||
105904280|NCT01398358|365307486|FG002|Overall Study|Lost to Follow-up|18|||
105904281|NCT01398358|365307484|FG000|Overall Study|Withdrawal by Subject|3|||
105904282|NCT01398358|365307485|FG001|Overall Study|Withdrawal by Subject|2|||
105904283|NCT01398358|365307486|FG002|Overall Study|Withdrawal by Subject|2|||
105904284|NCT01398358|365307484|FG000|Overall Study|no longer eligible|1|||
105904285|NCT01398358|365307485|FG001|Overall Study|no longer eligible|0|||
105904286|NCT01398358|365307486|FG002|Overall Study|no longer eligible|1|||
105904287|NCT01607346|365307494|FG000|Overall Study|Adverse Event|3|||
105904288|NCT03301831|365307498|FG000|Overall Study|Lost to Follow-up|5|||
105904289|NCT03301831|365307499|FG001|Overall Study|Lost to Follow-up|3|||
105904290|NCT03301831|365307498|FG000|Overall Study|Protocol Violation|4|||
105904291|NCT03301831|365307499|FG001|Overall Study|Protocol Violation|0|||
105904292|NCT03301831|365307498|FG000|Overall Study|Withdrawal by Subject|11|||
105904293|NCT03301831|365307499|FG001|Overall Study|Withdrawal by Subject|0|||
105904294|NCT00585325|365307500|FG000|Overall Study|Withdrawal by Subject|1|||
105904295|NCT00585325|365307501|FG001|Overall Study|Withdrawal by Subject|1|||
105904296|NCT03383692|365307503|FG000|Overall Study|Progressive disease as per RECIST|3|||
105904297|NCT03383692|365307504|FG001|Overall Study|Progressive disease as per RECIST|3|||
105904298|NCT03383692|365307503|FG000|Overall Study|Clinical progression|0|||
105904299|NCT03383692|365307504|FG001|Overall Study|Clinical progression|1|||
105904300|NCT03383692|365307503|FG000|Overall Study|Adverse Event|3|||
105904301|NCT03383692|365307504|FG001|Overall Study|Adverse Event|0|||
105904302|NCT03268005|365307505|FG000|Overall Study|Death|2|||
105904303|NCT03268005|365307506|FG001|Overall Study|Death|1|||
105904304|NCT03268005|365307505|FG000|Overall Study|Lost to Follow-up|2|||
105904305|NCT03268005|365307506|FG001|Overall Study|Lost to Follow-up|2|||
105904306|NCT03268005|365307505|FG000|Overall Study|Withdrawal by Subject|11|||
105904307|NCT03268005|365307506|FG001|Overall Study|Withdrawal by Subject|11|||
105904308|NCT03628716|365307507|FG000|Overall Study|Adverse Event|1|||
105904309|NCT03628716|365307508|FG001|Overall Study|Adverse Event|1|||
105904310|NCT03628716|365307507|FG000|Overall Study|Death|1|||
105904311|NCT03628716|365307508|FG001|Overall Study|Death|0|||
105904312|NCT03628716|365307507|FG000|Overall Study|Lack of Efficacy|15|||
105904313|NCT03628716|365307508|FG001|Overall Study|Lack of Efficacy|20|||
105904314|NCT03628716|365307507|FG000|Overall Study|Withdrawal by Subject|1|||
105904315|NCT03628716|365307508|FG001|Overall Study|Withdrawal by Subject|2|||
105904316|NCT03628716|365307507|FG000|Overall Study|Study Terminated by Sponsor|1|||
105904317|NCT03628716|365307508|FG001|Overall Study|Study Terminated by Sponsor|0|||
105904318|NCT00492232|365307509|FG000|Placebo Run-in|Adverse Event|0|||
105998250|NCT01150097|365654894|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
105904319|NCT00492232|365307510|FG001|Placebo Run-in|Adverse Event|2|||
105904320|NCT00492232|365307509|FG000|Placebo Run-in|Protocol Violation|0|||
105904321|NCT00492232|365307510|FG001|Placebo Run-in|Protocol Violation|3|||
105904322|NCT00492232|365307509|FG000|Placebo Run-in|Lost to Follow-up|0|||
105904323|NCT00492232|365307510|FG001|Placebo Run-in|Lost to Follow-up|3|||
105904324|NCT00492232|365307509|FG000|Placebo Run-in|Withdrawal by Subject|0|||
105904325|NCT00492232|365307510|FG001|Placebo Run-in|Withdrawal by Subject|8|||
105904326|NCT00492232|365307509|FG000|Placebo Run-in|Pregnancy|0|||
105904327|NCT00492232|365307510|FG001|Placebo Run-in|Pregnancy|1|||
105904328|NCT00492232|365307509|FG000|Placebo Run-in|Entrance criteria not met|0|||
105904329|NCT00492232|365307510|FG001|Placebo Run-in|Entrance criteria not met|45|||
105904330|NCT00492232|365307509|FG000|Placebo Run-in|Other|0|||
105904331|NCT00492232|365307510|FG001|Placebo Run-in|Other|6|||
105904332|NCT00492232|365307509|FG000|Placebo Run-in|Missing|0|||
105904333|NCT00492232|365307510|FG001|Placebo Run-in|Missing|2|||
105904334|NCT00492232|365307509|FG000|Double-Blind Treatment|Adverse Event|1|||
105904335|NCT00492232|365307510|FG001|Double-Blind Treatment|Adverse Event|2|||
105904336|NCT00492232|365307509|FG000|Double-Blind Treatment|Protocol Violation|3|||
105904337|NCT00492232|365307510|FG001|Double-Blind Treatment|Protocol Violation|7|||
105904338|NCT00492232|365307509|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
105904339|NCT00492232|365307510|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
105904340|NCT00492232|365307509|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
105904341|NCT00492232|365307510|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
105904342|NCT00492232|365307509|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
105904343|NCT00492232|365307510|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
105904344|NCT00492232|365307509|FG000|Double-Blind Treatment|Other|6|||
105904345|NCT00492232|365307510|FG001|Double-Blind Treatment|Other|5|||
105904346|NCT00492232|365307509|FG000|Double-Blind Treatment|Randomized not treated|1|||
105904347|NCT00492232|365307510|FG001|Double-Blind Treatment|Randomized not treated|0|||
105904348|NCT00492232|365307509|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
105904349|NCT00492232|365307510|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
105904350|NCT01216332|365307511|FG000|Overall Study|Withdrawal by Subject|4|||
105904351|NCT01216332|365307512|FG001|Overall Study|Withdrawal by Subject|0|||
105904352|NCT02655016|365307513|FG000|Overall Study|Disease progression|6|||
105904353|NCT02655016|365307514|FG001|Overall Study|Disease progression|4|||
105904354|NCT02655016|365307513|FG000|Overall Study|Site closed|0|||
105904355|NCT02655016|365307514|FG001|Overall Study|Site closed|1|||
105904356|NCT02655016|365307513|FG000|Overall Study|Death|30|||
105904357|NCT02655016|365307514|FG001|Overall Study|Death|48|||
105904358|NCT02655016|365307513|FG000|Overall Study|Lost to Follow-up|1|||
105904359|NCT02655016|365307514|FG001|Overall Study|Lost to Follow-up|1|||
105904360|NCT02655016|365307513|FG000|Overall Study|Withdrawal by Subject|18|||
105904361|NCT02655016|365307514|FG001|Overall Study|Withdrawal by Subject|36|||
105904362|NCT00481767|365307515|FG000|Overall Study|Withdrawal by Subject|16|||
105904363|NCT00481767|365307516|FG001|Overall Study|Withdrawal by Subject|11|||
105904364|NCT00481767|365307515|FG000|Overall Study|Lost to Follow-up|16|||
105904365|NCT00481767|365307516|FG001|Overall Study|Lost to Follow-up|10|||
105904366|NCT03536663|365308751|FG000|Endexo|Protocol Violation|1|||
105904367|NCT00314808|365308756|FG000|Overall Study|Disease Progression without AE|4|||
105904368|NCT00314808|365308756|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
105904369|NCT02688764|365308757|FG000|Overall Study|Adverse Event|3|||
105904370|NCT02688764|365308758|FG001|Overall Study|Adverse Event|3|||
105904371|NCT02688764|365308757|FG000|Overall Study|AE/Kidney transplant|1|||
105904372|NCT02688764|365308758|FG001|Overall Study|AE/Kidney transplant|0|||
105904373|NCT02688764|365308757|FG000|Overall Study|AE/Lack of efficacy|1|||
105904374|NCT02688764|365308758|FG001|Overall Study|AE/Lack of efficacy|0|||
105904375|NCT02688764|365308757|FG000|Overall Study|AE/Non-compl.|1|||
105904376|NCT02688764|365308758|FG001|Overall Study|AE/Non-compl.|0|||
105904377|NCT02688764|365308757|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
105904378|NCT02688764|365308758|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
105904379|NCT02688764|365308757|FG000|Overall Study|AE/Other|0|||
105904380|NCT02688764|365308758|FG001|Overall Study|AE/Other|1|||
105904381|NCT02688764|365308757|FG000|Overall Study|AE/Physician decision|1|||
105904382|NCT02688764|365308758|FG001|Overall Study|AE/Physician decision|0|||
105904383|NCT02688764|365308757|FG000|Overall Study|AE/Withd. parent|3|||
105904384|NCT02688764|365308758|FG001|Overall Study|AE/Withd. parent|0|||
105904385|NCT02688764|365308757|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
105669359|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105904386|NCT02688764|365308758|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
105904387|NCT02688764|365308757|FG000|Overall Study|AE/Withd. subject|1|||
105904388|NCT02688764|365308758|FG001|Overall Study|AE/Withd. subject|0|||
105904389|NCT02688764|365308757|FG000|Overall Study|Kidney transplant|10|||
105904390|NCT02688764|365308758|FG001|Overall Study|Kidney transplant|4|||
105904391|NCT02688764|365308757|FG000|Overall Study|Lack of Efficacy|3|||
105904392|NCT02688764|365308758|FG001|Overall Study|Lack of Efficacy|2|||
105904393|NCT02688764|365308757|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
105904394|NCT02688764|365308758|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
105904395|NCT02688764|365308757|FG000|Overall Study|Non-compliance with study drug|4|||
105904396|NCT02688764|365308758|FG001|Overall Study|Non-compliance with study drug|0|||
105904397|NCT02688764|365308757|FG000|Overall Study|Non-compl./Physician decision|2|||
105904398|NCT02688764|365308758|FG001|Overall Study|Non-compl./Physician decision|0|||
105904399|NCT02688764|365308757|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
105904400|NCT02688764|365308758|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
105904401|NCT02688764|365308757|FG000|Overall Study|Non-compl./Withd. subject|0|||
105904402|NCT02688764|365308758|FG001|Overall Study|Non-compl./Withd. subject|2|||
105904403|NCT02688764|365308757|FG000|Overall Study|Phosphorus level outside safe range|0|||
105904404|NCT02688764|365308758|FG001|Overall Study|Phosphorus level outside safe range|1|||
105904405|NCT02688764|365308757|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
105904406|NCT02688764|365308758|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
105904407|NCT02688764|365308757|FG000|Overall Study|Study drug taste/Withd. parent|1|||
105904408|NCT02688764|365308758|FG001|Overall Study|Study drug taste/Withd. parent|0|||
105904409|NCT02688764|365308757|FG000|Overall Study|Subject moving out|2|||
105904410|NCT02688764|365308758|FG001|Overall Study|Subject moving out|0|||
105904411|NCT02688764|365308757|FG000|Overall Study|Subject taken off dialysis|1|||
105904412|NCT02688764|365308758|FG001|Overall Study|Subject taken off dialysis|0|||
105904413|NCT02688764|365308757|FG000|Overall Study|Withdrawal by parent|3|||
105904414|NCT02688764|365308758|FG001|Overall Study|Withdrawal by parent|0|||
105904415|NCT00885378|365308759|FG000|Overall Study|Lack of Efficacy|2|||
105904416|NCT00885378|365308760|FG001|Overall Study|Lack of Efficacy|2|||
105904417|NCT00885378|365308759|FG000|Overall Study|Withdrawal by Subject|1|||
105904418|NCT00885378|365308760|FG001|Overall Study|Withdrawal by Subject|2|||
105904419|NCT00885378|365308759|FG000|Overall Study|Lost to Follow-up|1|||
105904420|NCT00885378|365308760|FG001|Overall Study|Lost to Follow-up|2|||
105904421|NCT00885378|365308759|FG000|Overall Study|Poor/Noncompliance|2|||
105904422|NCT00885378|365308760|FG001|Overall Study|Poor/Noncompliance|2|||
105904423|NCT00885378|365308759|FG000|Overall Study|Protocol Violation|2|||
105904424|NCT00885378|365308760|FG001|Overall Study|Protocol Violation|0|||
105904425|NCT00802672|365308761|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
105904426|NCT00802672|365308762|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
105904427|NCT00802672|365308763|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
105904428|NCT00802672|365308761|FG000|Overall Study|Adverse Event|1|||
106125338|NCT02213055|366115919|FG001|Overall Study|Protocol was not Followed during Study|0|||
106125339|NCT02213055|366115918|FG000|Overall Study|Documentation Issue at Enrollment|1|||
105904429|NCT00802672|365308762|FG001|Overall Study|Adverse Event|1|||
105904430|NCT00802672|365308763|FG002|Overall Study|Adverse Event|1|||
105904431|NCT00802672|365308761|FG000|Overall Study|Protocol Violation|2|||
105904432|NCT00802672|365308762|FG001|Overall Study|Protocol Violation|1|||
105904433|NCT00802672|365308763|FG002|Overall Study|Protocol Violation|1|||
105904434|NCT00802672|365308761|FG000|Overall Study|Lost to Follow-up|5|||
105904435|NCT00802672|365308762|FG001|Overall Study|Lost to Follow-up|5|||
105904436|NCT00802672|365308763|FG002|Overall Study|Lost to Follow-up|3|||
105904437|NCT00802672|365308761|FG000|Overall Study|Withdrawal by Subject|1|||
106125340|NCT02213055|366115919|FG001|Overall Study|Documentation Issue at Enrollment|0|||
105904438|NCT00802672|365308762|FG001|Overall Study|Withdrawal by Subject|1|||
105904439|NCT00802672|365308763|FG002|Overall Study|Withdrawal by Subject|2|||
105904440|NCT00802672|365308761|FG000|Overall Study|other|3|||
106125341|NCT02213055|366115918|FG000|Overall Study|Documentation Issue during Study|10|||
105904441|NCT00802672|365308762|FG001|Overall Study|other|1|||
105904442|NCT00802672|365308763|FG002|Overall Study|other|2|||
105904443|NCT02178358|365308768|FG000|Overall Study|Withdrawal by Subject|0|||
105904444|NCT02178358|365308769|FG001|Overall Study|Withdrawal by Subject|2|||
105904445|NCT02178358|365308770|FG002|Overall Study|Withdrawal by Subject|2|||
105904446|NCT02178358|365308768|FG000|Overall Study|Lost to Follow-up|1|||
105904447|NCT02178358|365308769|FG001|Overall Study|Lost to Follow-up|0|||
105904448|NCT02178358|365308770|FG002|Overall Study|Lost to Follow-up|0|||
105904449|NCT00264290|365308772|FG000|Intervention (8 Weeks)|Adverse Event|1|||
105904450|NCT00264290|365308773|FG001|Intervention (8 Weeks)|Adverse Event|0|||
105904451|NCT02784288|365308774|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
105904452|NCT02095197|365308775|FG000|Overall Study|Lost to Follow-up|0|||
105669360|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669361|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669362|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669363|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
105669364|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
105669365|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
105669366|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
105669367|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669368|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669369|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669370|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
105669371|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
105669372|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
105669373|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
105669374|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
105669375|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
105669376|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
105669377|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
105904453|NCT02095197|365308776|FG001|Overall Study|Lost to Follow-up|3|||
105904454|NCT03374488|365308777|FG000|Overall Study|Death|13|||
105904455|NCT03374488|365308778|FG001|Overall Study|Death|13|||
105904456|NCT03374488|365308777|FG000|Overall Study|Withdrawal by Subject|3|||
105904457|NCT03374488|365308778|FG001|Overall Study|Withdrawal by Subject|1|||
105904458|NCT03374488|365308777|FG000|Overall Study|Physician Decision|3|||
105904459|NCT03374488|365308778|FG001|Overall Study|Physician Decision|0|||
105904460|NCT01951573|365308779|FG000|Washout Period|Adverse Event|0|||
105904461|NCT01951573|365308780|FG001|Washout Period|Adverse Event|1|||
105904462|NCT01909973|365308781|FG000|Overall Study|Lost to Follow-up|1|||
105904463|NCT01909973|365308782|FG001|Overall Study|Lost to Follow-up|0|||
105904464|NCT02072941|365308783|FG000|Overall Study|Withdrawal by Subject|29|||
105904465|NCT02072941|365308784|FG001|Overall Study|Withdrawal by Subject|21|||
105904466|NCT02072941|365308783|FG000|Overall Study|Lost to Follow-up|4|||
105904467|NCT02072941|365308784|FG001|Overall Study|Lost to Follow-up|4|||
105904468|NCT02072941|365308783|FG000|Overall Study|Death|3|||
105904469|NCT02072941|365308784|FG001|Overall Study|Death|2|||
105904470|NCT02072941|365308783|FG000|Overall Study|Removed by Study Staff|2|||
105904471|NCT02072941|365308784|FG001|Overall Study|Removed by Study Staff|2|||
105904472|NCT00460239|365308785|FG000|Overall Study|Physician Decision|0|||
105904473|NCT00460239|365308786|FG001|Overall Study|Physician Decision|1|||
105904474|NCT00460239|365308787|FG002|Overall Study|Physician Decision|0|||
105904475|NCT00460239|365308788|FG003|Overall Study|Physician Decision|0|||
105904476|NCT00460239|365308789|FG004|Overall Study|Physician Decision|0|||
105904477|NCT00460239|365308790|FG005|Overall Study|Physician Decision|2|||
105904478|NCT00460239|365308791|FG006|Overall Study|Physician Decision|0|||
105904479|NCT00460239|365308792|FG007|Overall Study|Physician Decision|0|||
106125342|NCT02213055|366115919|FG001|Overall Study|Documentation Issue during Study|0|||
106125343|NCT02213055|366115918|FG000|Overall Study|Did not have Live Lice|8|||
105904480|NCT00460239|365308793|FG008|Overall Study|Physician Decision|0|||
105904481|NCT00460239|365308785|FG000|Overall Study|Withdrawal by Subject|0|||
105904482|NCT00460239|365308786|FG001|Overall Study|Withdrawal by Subject|0|||
105904483|NCT00460239|365308787|FG002|Overall Study|Withdrawal by Subject|0|||
105904484|NCT00460239|365308788|FG003|Overall Study|Withdrawal by Subject|0|||
105904485|NCT00460239|365308789|FG004|Overall Study|Withdrawal by Subject|0|||
105904486|NCT00460239|365308790|FG005|Overall Study|Withdrawal by Subject|1|||
105904487|NCT00460239|365308791|FG006|Overall Study|Withdrawal by Subject|0|||
105904488|NCT00460239|365308792|FG007|Overall Study|Withdrawal by Subject|0|||
106125344|NCT02213055|366115919|FG001|Overall Study|Did not have Live Lice|0|||
105904489|NCT00460239|365308793|FG008|Overall Study|Withdrawal by Subject|0|||
105904490|NCT02020889|365308814|FG000|Overall Study|Adverse Event|0|||
105904491|NCT02020889|365308815|FG001|Overall Study|Adverse Event|1|||
105904492|NCT02020889|365308814|FG000|Overall Study|Lack of Efficacy|1|||
105904493|NCT02020889|365308815|FG001|Overall Study|Lack of Efficacy|0|||
106125345|NCT02213055|366115918|FG000|Overall Study|Had another Treatment during the Study|3|||
105904494|NCT02020889|365308814|FG000|Overall Study|Lost to Follow-up|1|||
105998251|NCT01150097|365654892|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
105998252|NCT01150097|365654893|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
105998253|NCT01150097|365654894|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
105998254|NCT01150097|365654892|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
105998255|NCT01150097|365654893|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
105998256|NCT01150097|365654894|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
105998257|NCT01150097|365654892|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
105998258|NCT01150097|365654893|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
105998259|NCT01150097|365654894|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
105998260|NCT01150097|365654892|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
105998261|NCT01150097|365654893|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
105998262|NCT01150097|365654894|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
105998263|NCT01150097|365654892|FG000|Months 24 to 48 Post-transplantation|Death|2|||
105998264|NCT01150097|365654893|FG001|Months 24 to 48 Post-transplantation|Death|0|||
105998265|NCT01150097|365654894|FG002|Months 24 to 48 Post-transplantation|Death|0|||
105998266|NCT00992459|365654895|FG000|Overall Study|Withdrawal by Subject|0|||
105998267|NCT00992459|365654896|FG001|Overall Study|Withdrawal by Subject|1|||
105998268|NCT00992459|365654895|FG000|Overall Study|Adverse Event|1|||
105998269|NCT00992459|365654896|FG001|Overall Study|Adverse Event|0|||
105998270|NCT00940498|365654897|FG000|Overall Study|Death|2|||
105998271|NCT00940498|365654898|FG001|Overall Study|Death|0|||
105998272|NCT00940498|365654899|FG002|Overall Study|Death|0|||
105998273|NCT00940498|365654900|FG003|Overall Study|Death|1|||
105998274|NCT00940498|365654901|FG004|Overall Study|Death|5|||
105998275|NCT00940498|365654902|FG005|Overall Study|Death|0|||
105998276|NCT00940498|365654903|FG006|Overall Study|Death|1|||
105998277|NCT00940498|365654904|FG007|Overall Study|Death|0|||
105998278|NCT00940498|365654897|FG000|Overall Study|Lost to Follow-up|1|||
105998279|NCT00940498|365654898|FG001|Overall Study|Lost to Follow-up|1|||
105904495|NCT02020889|365308815|FG001|Overall Study|Lost to Follow-up|0|||
105904496|NCT02020889|365308814|FG000|Overall Study|Physician Decision|2|||
105904497|NCT02020889|365308815|FG001|Overall Study|Physician Decision|0|||
105904498|NCT02020889|365308814|FG000|Overall Study|Withdrawal by Subject|3|||
105904499|NCT02020889|365308815|FG001|Overall Study|Withdrawal by Subject|2|||
105904500|NCT00760487|365308816|FG000|Overall Study|Unilateral implantation|3|||
105904501|NCT03146741|365308818|FG000|Overall Study|Txp with non-HCV+ heart|4|||
105904502|NCT03146741|365308818|FG000|Overall Study|Listeted for MOT|2|||
105904503|NCT03146741|365308818|FG000|Overall Study|Physician Decision|2|||
105904504|NCT03146741|365308818|FG000|Overall Study|Awaiting txp|2|||
105998280|NCT00940498|365654899|FG002|Overall Study|Lost to Follow-up|2|||
105998281|NCT00940498|365654900|FG003|Overall Study|Lost to Follow-up|0|||
105998282|NCT00940498|365654901|FG004|Overall Study|Lost to Follow-up|1|||
105998283|NCT00940498|365654902|FG005|Overall Study|Lost to Follow-up|0|||
105998284|NCT00940498|365654903|FG006|Overall Study|Lost to Follow-up|0|||
105998285|NCT00940498|365654904|FG007|Overall Study|Lost to Follow-up|1|||
105904505|NCT00551525|365308819|FG000|Overall Study|Protocol Violation|5|||
105904506|NCT04865419|365308820|FG000|Overall Study|Other|1|||
105904507|NCT04865419|365308821|FG001|Overall Study|Other|2|||
105904508|NCT04865419|365308822|FG002|Overall Study|Other|2|||
105904509|NCT04865419|365308823|FG003|Overall Study|Other|1|||
105904510|NCT04865419|365308824|FG004|Overall Study|Other|3|||
105904511|NCT04865419|365308825|FG005|Overall Study|Other|0|||
105904512|NCT04865419|365308826|FG006|Overall Study|Other|0|||
105904513|NCT04865419|365308827|FG007|Overall Study|Other|1|||
105904514|NCT04865419|365308828|FG008|Overall Study|Other|0|||
105998286|NCT00940498|365654897|FG000|Overall Study|Disease Progression|0|||
105998287|NCT00940498|365654898|FG001|Overall Study|Disease Progression|0|||
105998288|NCT00940498|365654899|FG002|Overall Study|Disease Progression|1|||
105998289|NCT00940498|365654900|FG003|Overall Study|Disease Progression|1|||
105669378|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
105669379|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
105669380|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
105669381|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
105669382|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
105669383|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669384|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669385|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669386|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669387|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
105669388|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
105669389|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
105669390|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
105669391|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669392|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669393|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669394|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
105669395|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669396|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669397|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669398|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669399|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669400|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669401|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669402|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
105669403|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669404|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669405|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669406|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
105669407|NCT01646177|364454013|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669408|NCT01646177|364454014|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669409|NCT01646177|364454015|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669410|NCT01646177|364454016|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669411|NCT01646177|364454017|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669412|NCT01646177|364454018|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
105669413|NCT01646177|364454019|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
105669414|NCT01646177|364454020|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
105669415|NCT01646177|364454021|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105904515|NCT04865419|365308829|FG009|Overall Study|Other|0|||
105904516|NCT04865419|365308830|FG010|Overall Study|Other|0|||
105904517|NCT04865419|365308820|FG000|Overall Study|Withdrawal by Subject|0|||
105904518|NCT04865419|365308821|FG001|Overall Study|Withdrawal by Subject|1|||
105904519|NCT04865419|365308822|FG002|Overall Study|Withdrawal by Subject|1|||
105904520|NCT04865419|365308823|FG003|Overall Study|Withdrawal by Subject|0|||
105904521|NCT04865419|365308824|FG004|Overall Study|Withdrawal by Subject|0|||
105904522|NCT04865419|365308825|FG005|Overall Study|Withdrawal by Subject|0|||
105904523|NCT04865419|365308826|FG006|Overall Study|Withdrawal by Subject|0|||
105904524|NCT04865419|365308827|FG007|Overall Study|Withdrawal by Subject|1|||
105904525|NCT04865419|365308828|FG008|Overall Study|Withdrawal by Subject|2|||
105904526|NCT04865419|365308829|FG009|Overall Study|Withdrawal by Subject|1|||
105904527|NCT04865419|365308830|FG010|Overall Study|Withdrawal by Subject|0|||
105904528|NCT04865419|365308820|FG000|Overall Study|Study terminated by Sponsor|0|||
105904529|NCT04865419|365308821|FG001|Overall Study|Study terminated by Sponsor|0|||
105904530|NCT04865419|365308822|FG002|Overall Study|Study terminated by Sponsor|0|||
105998290|NCT00940498|365654901|FG004|Overall Study|Disease Progression|0|||
105998291|NCT00940498|365654902|FG005|Overall Study|Disease Progression|1|||
105998292|NCT00940498|365654903|FG006|Overall Study|Disease Progression|0|||
105998293|NCT00940498|365654904|FG007|Overall Study|Disease Progression|0|||
105998294|NCT00940498|365654897|FG000|Overall Study|Physician Decision|0|||
105998295|NCT00940498|365654898|FG001|Overall Study|Physician Decision|0|||
105998296|NCT00940498|365654899|FG002|Overall Study|Physician Decision|0|||
105998297|NCT00940498|365654900|FG003|Overall Study|Physician Decision|0|||
105904531|NCT04865419|365308823|FG003|Overall Study|Study terminated by Sponsor|2|||
105904532|NCT04865419|365308824|FG004|Overall Study|Study terminated by Sponsor|2|||
105904533|NCT04865419|365308825|FG005|Overall Study|Study terminated by Sponsor|0|||
105998298|NCT00940498|365654901|FG004|Overall Study|Physician Decision|2|||
105998299|NCT00940498|365654902|FG005|Overall Study|Physician Decision|0|||
105998300|NCT00940498|365654903|FG006|Overall Study|Physician Decision|0|||
105998301|NCT00940498|365654904|FG007|Overall Study|Physician Decision|0|||
105904534|NCT04865419|365308826|FG006|Overall Study|Study terminated by Sponsor|0|||
105904535|NCT04865419|365308827|FG007|Overall Study|Study terminated by Sponsor|0|||
105904536|NCT04865419|365308828|FG008|Overall Study|Study terminated by Sponsor|0|||
105904537|NCT04865419|365308829|FG009|Overall Study|Study terminated by Sponsor|0|||
105904538|NCT04865419|365308830|FG010|Overall Study|Study terminated by Sponsor|1|||
105904539|NCT04865419|365308820|FG000|Overall Study|Death|3|||
105904540|NCT04865419|365308821|FG001|Overall Study|Death|1|||
105904541|NCT04865419|365308822|FG002|Overall Study|Death|4|||
105904542|NCT04865419|365308823|FG003|Overall Study|Death|2|||
105904543|NCT04865419|365308824|FG004|Overall Study|Death|5|||
105904544|NCT04865419|365308825|FG005|Overall Study|Death|2|||
105904545|NCT04865419|365308826|FG006|Overall Study|Death|1|||
105904546|NCT04865419|365308827|FG007|Overall Study|Death|1|||
105904547|NCT04865419|365308828|FG008|Overall Study|Death|2|||
105904548|NCT04865419|365308829|FG009|Overall Study|Death|2|||
105904549|NCT04865419|365308830|FG010|Overall Study|Death|1|||
105904550|NCT04865419|365308820|FG000|Overall Study|Lost to Follow-up|0|||
105904551|NCT04865419|365308821|FG001|Overall Study|Lost to Follow-up|0|||
105904552|NCT04865419|365308822|FG002|Overall Study|Lost to Follow-up|0|||
105904553|NCT04865419|365308823|FG003|Overall Study|Lost to Follow-up|0|||
105904554|NCT04865419|365308824|FG004|Overall Study|Lost to Follow-up|0|||
105904555|NCT04865419|365308825|FG005|Overall Study|Lost to Follow-up|0|||
105904556|NCT04865419|365308826|FG006|Overall Study|Lost to Follow-up|0|||
105904557|NCT04865419|365308827|FG007|Overall Study|Lost to Follow-up|0|||
105904558|NCT04865419|365308828|FG008|Overall Study|Lost to Follow-up|0|||
105904559|NCT04865419|365308829|FG009|Overall Study|Lost to Follow-up|1|||
105904560|NCT04865419|365308830|FG010|Overall Study|Lost to Follow-up|0|||
105904561|NCT00099632|365308841|FG000|Overall Study|Lost to Follow-up|1|||
105904562|NCT00099632|365308842|FG001|Overall Study|Lost to Follow-up|0|||
105904563|NCT00099632|365308843|FG002|Overall Study|Lost to Follow-up|3|||
105904564|NCT00099632|365308844|FG003|Overall Study|Lost to Follow-up|1|||
105904565|NCT00099632|365308845|FG004|Overall Study|Lost to Follow-up|1|||
105904566|NCT00099632|365308846|FG005|Overall Study|Lost to Follow-up|0|||
105904567|NCT00099632|365308841|FG000|Overall Study|Withdrawal by Subject|0|||
105904568|NCT00099632|365308842|FG001|Overall Study|Withdrawal by Subject|1|||
105904569|NCT00099632|365308843|FG002|Overall Study|Withdrawal by Subject|0|||
105904570|NCT00099632|365308844|FG003|Overall Study|Withdrawal by Subject|0|||
105904571|NCT00099632|365308845|FG004|Overall Study|Withdrawal by Subject|0|||
105904572|NCT00099632|365308846|FG005|Overall Study|Withdrawal by Subject|1|||
105904573|NCT00099632|365308841|FG000|Overall Study|Protocol Violation|0|||
105904574|NCT00099632|365308842|FG001|Overall Study|Protocol Violation|0|||
105904575|NCT00099632|365308843|FG002|Overall Study|Protocol Violation|0|||
105904576|NCT00099632|365308844|FG003|Overall Study|Protocol Violation|0|||
105904577|NCT00099632|365308845|FG004|Overall Study|Protocol Violation|0|||
105904578|NCT00099632|365308846|FG005|Overall Study|Protocol Violation|1|||
105904579|NCT00423813|365308847|FG000|Overall Study|Adverse Event|11|||
105904580|NCT00423813|365308848|FG001|Overall Study|Adverse Event|30|||
106125346|NCT02213055|366115919|FG001|Overall Study|Had another Treatment during the Study|0|||
106125347|NCT02213055|366115918|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
106125348|NCT02213055|366115919|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
105904581|NCT00423813|365308849|FG002|Overall Study|Adverse Event|40|||
105904582|NCT00423813|365308847|FG000|Overall Study|Withdrawal by Subject|6|||
105904583|NCT00423813|365308848|FG001|Overall Study|Withdrawal by Subject|8|||
105904584|NCT00423813|365308849|FG002|Overall Study|Withdrawal by Subject|5|||
105904585|NCT00423813|365308847|FG000|Overall Study|Lost to Follow-up|5|||
105904586|NCT00423813|365308848|FG001|Overall Study|Lost to Follow-up|4|||
105904587|NCT00423813|365308849|FG002|Overall Study|Lost to Follow-up|4|||
105904588|NCT00423813|365308847|FG000|Overall Study|Lack of Efficacy|23|||
105904589|NCT00423813|365308848|FG001|Overall Study|Lack of Efficacy|18|||
105904590|NCT00423813|365308849|FG002|Overall Study|Lack of Efficacy|19|||
105904591|NCT00423813|365308847|FG000|Overall Study|Physician Decision|2|||
106125349|NCT02213055|366115918|FG000|Overall Study|Did not Return to School|5|||
106125350|NCT02213055|366115919|FG001|Overall Study|Did not Return to School|0|||
106125351|NCT01848834|366115921|FG000|Overall Study|Adverse Event|3|||
106125352|NCT01848834|366115922|FG001|Overall Study|Adverse Event|11|||
106125353|NCT01848834|366115923|FG002|Overall Study|Adverse Event|3|||
106125354|NCT01848834|366115924|FG003|Overall Study|Adverse Event|5|||
106125355|NCT01848834|366115925|FG004|Overall Study|Adverse Event|9|||
106125356|NCT01848834|366115921|FG000|Overall Study|Death|2|||
106125357|NCT01848834|366115922|FG001|Overall Study|Death|11|||
106125358|NCT01848834|366115923|FG002|Overall Study|Death|1|||
106125359|NCT01848834|366115924|FG003|Overall Study|Death|8|||
106125360|NCT01848834|366115925|FG004|Overall Study|Death|27|||
105904592|NCT00423813|365308848|FG001|Overall Study|Physician Decision|0|||
106125361|NCT01848834|366115921|FG000|Overall Study|Excluded Medication|5|||
106125362|NCT01848834|366115922|FG001|Overall Study|Excluded Medication|4|||
106125363|NCT01848834|366115923|FG002|Overall Study|Excluded Medication|3|||
105904593|NCT00423813|365308849|FG002|Overall Study|Physician Decision|0|||
105904594|NCT00423813|365308847|FG000|Overall Study|Sponsor Decision|0|||
106125364|NCT01848834|366115924|FG003|Overall Study|Excluded Medication|6|||
106125365|NCT01848834|366115925|FG004|Overall Study|Excluded Medication|6|||
105904595|NCT00423813|365308848|FG001|Overall Study|Sponsor Decision|1|||
105904596|NCT00423813|365308849|FG002|Overall Study|Sponsor Decision|0|||
105904597|NCT00423813|365308847|FG000|Overall Study|Protocol Violation|9|||
105904598|NCT00423813|365308848|FG001|Overall Study|Protocol Violation|4|||
105904599|NCT00423813|365308849|FG002|Overall Study|Protocol Violation|4|||
105904600|NCT00423813|365308847|FG000|Overall Study|Pregnancy|0|||
105904601|NCT00423813|365308848|FG001|Overall Study|Pregnancy|0|||
105904602|NCT00423813|365308849|FG002|Overall Study|Pregnancy|1|||
105904603|NCT00423813|365308847|FG000|Overall Study|Subject started night shift work|1|||
105904604|NCT00423813|365308848|FG001|Overall Study|Subject started night shift work|0|||
105904605|NCT00423813|365308849|FG002|Overall Study|Subject started night shift work|0|||
105904606|NCT00423813|365308847|FG000|Overall Study|Will start exclusionary medications|0|||
105904607|NCT00423813|365308848|FG001|Overall Study|Will start exclusionary medications|1|||
105904608|NCT00423813|365308849|FG002|Overall Study|Will start exclusionary medications|0|||
105904609|NCT00423813|365308847|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
105904610|NCT00423813|365308848|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
105904611|NCT00423813|365308849|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
105904612|NCT02383355|365308858|FG000|Overall Study|Adverse Event|2|||
105904613|NCT02383355|365308859|FG001|Overall Study|Adverse Event|0|||
105904614|NCT02588664|365308863|FG000|Overall Study|Death|56|||
105904615|NCT02588664|365308864|FG001|Overall Study|Death|55|||
105904616|NCT02588664|365308863|FG000|Overall Study|Lost to Follow-up|1305|||
105904617|NCT02588664|365308864|FG001|Overall Study|Lost to Follow-up|990|||
105904618|NCT01098162|365308865|FG000|Overall Study|Adverse Event|37|||
105904619|NCT01098162|365308865|FG000|Overall Study|Lack of Efficacy|4|||
105904620|NCT01098162|365308865|FG000|Overall Study|Wish of Patient|7|||
105904621|NCT01098162|365308865|FG000|Overall Study|Lost to Follow-up|9|||
105904622|NCT01098162|365308865|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
105904623|NCT01098162|365308865|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
105904624|NCT01098162|365308865|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
105904625|NCT01098162|365308865|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
105904626|NCT01098162|365308865|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
105904627|NCT01098162|365308865|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
105904628|NCT01098162|365308865|FG000|Overall Study|Other Reason|1|||
105904629|NCT01098162|365308865|FG000|Overall Study|Reason Unknown|26|||
105904630|NCT00282152|365308866|FG000|Overall Study|Withdrawal by Subject|1|||
105904631|NCT00282152|365308867|FG001|Overall Study|Withdrawal by Subject|0|||
105904632|NCT04318132|365308868|FG000|Overall Study|Protocol Violation|0|||
105904633|NCT04318132|365308869|FG001|Overall Study|Protocol Violation|0|||
105904634|NCT04318132|365308870|FG002|Overall Study|Protocol Violation|3|||
105904635|NCT04318132|365308871|FG003|Overall Study|Protocol Violation|0|||
105904636|NCT04424914|365308873|FG000|Overall Study|Other|0|||
105904637|NCT04424914|365308874|FG001|Overall Study|Other|0|||
105904638|NCT04424914|365308875|FG002|Overall Study|Other|28|||
105904639|NCT04424914|365308873|FG000|Overall Study|Withdrawal by Subject|3|||
105904640|NCT04424914|365308874|FG001|Overall Study|Withdrawal by Subject|0|||
105904641|NCT04424914|365308875|FG002|Overall Study|Withdrawal by Subject|0|||
105998302|NCT00940498|365654897|FG000|Overall Study|Not treated due to disease related pain|0|||
105998303|NCT00940498|365654898|FG001|Overall Study|Not treated due to disease related pain|0|||
106125366|NCT01848834|366115921|FG000|Overall Study|Lost to Follow-up|5|||
105998304|NCT00940498|365654899|FG002|Overall Study|Not treated due to disease related pain|0|||
105998305|NCT00940498|365654900|FG003|Overall Study|Not treated due to disease related pain|0|||
105998306|NCT00940498|365654901|FG004|Overall Study|Not treated due to disease related pain|1|||
105998307|NCT00940498|365654902|FG005|Overall Study|Not treated due to disease related pain|0|||
106125367|NCT01848834|366115922|FG001|Overall Study|Lost to Follow-up|5|||
106125368|NCT01848834|366115923|FG002|Overall Study|Lost to Follow-up|3|||
106125369|NCT01848834|366115924|FG003|Overall Study|Lost to Follow-up|0|||
105998308|NCT00940498|365654903|FG006|Overall Study|Not treated due to disease related pain|0|||
105998309|NCT00940498|365654904|FG007|Overall Study|Not treated due to disease related pain|0|||
105998310|NCT00549445|365654905|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
105998311|NCT00549445|365654906|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
105998312|NCT00650845|365654907|FG000|Overall Study|Withdrawal by Subject|5|||
105998313|NCT00650845|365654908|FG001|Overall Study|Withdrawal by Subject|0|||
105998314|NCT00650845|365654907|FG000|Overall Study|Protocol Violation|0|||
105998315|NCT00650845|365654908|FG001|Overall Study|Protocol Violation|13|||
105904642|NCT04424914|365308873|FG000|Overall Study|Study terminated by sponsor|23|||
106125370|NCT01848834|366115925|FG004|Overall Study|Lost to Follow-up|3|||
105904643|NCT04424914|365308874|FG001|Overall Study|Study terminated by sponsor|7|||
105904644|NCT04424914|365308875|FG002|Overall Study|Study terminated by sponsor|0|||
105904645|NCT04424914|365308873|FG000|Overall Study|Lost to Follow-up|0|||
105904646|NCT04424914|365308874|FG001|Overall Study|Lost to Follow-up|0|||
105904647|NCT04424914|365308875|FG002|Overall Study|Lost to Follow-up|1|||
106125371|NCT01848834|366115921|FG000|Overall Study|Physician Decision|1|||
106125372|NCT01848834|366115922|FG001|Overall Study|Physician Decision|3|||
105904648|NCT04424914|365308873|FG000|Overall Study|Death|3|||
105904649|NCT04424914|365308874|FG001|Overall Study|Death|1|||
105904650|NCT04424914|365308875|FG002|Overall Study|Death|0|||
105904651|NCT01778751|365308879|FG000|Overall Study|Lost to Follow-up|1|||
105904652|NCT01778751|365308880|FG001|Overall Study|Lost to Follow-up|0|||
105904653|NCT01778751|365308879|FG000|Overall Study|Withdrawal by Subject|0|||
105904654|NCT01778751|365308880|FG001|Overall Study|Withdrawal by Subject|2|||
105904655|NCT01778751|365308879|FG000|Overall Study|Transfered care|1|||
105904656|NCT01778751|365308880|FG001|Overall Study|Transfered care|0|||
105904657|NCT00792116|365308889|FG000|Overall Study|Lost to Follow-up|0|||
105904658|NCT00792116|365308890|FG001|Overall Study|Lost to Follow-up|1|||
105904659|NCT00792116|365308889|FG000|Overall Study|Discontnued intervention|1|||
105904660|NCT00792116|365308890|FG001|Overall Study|Discontnued intervention|0|||
105904661|NCT00829829|365308891|FG000|Overall Study|Protocol Violation|0|||
105904662|NCT00829829|365308892|FG001|Overall Study|Protocol Violation|3|||
105904663|NCT00829829|365308893|FG002|Overall Study|Protocol Violation|0|||
105904664|NCT00829829|365308891|FG000|Overall Study|Adverse Event|4|||
105904665|NCT00829829|365308892|FG001|Overall Study|Adverse Event|4|||
105904666|NCT00829829|365308893|FG002|Overall Study|Adverse Event|3|||
105904667|NCT00829829|365308891|FG000|Overall Study|Withdrawal by Subject|8|||
105904668|NCT00829829|365308892|FG001|Overall Study|Withdrawal by Subject|4|||
105904669|NCT00829829|365308893|FG002|Overall Study|Withdrawal by Subject|2|||
105904670|NCT00829829|365308891|FG000|Overall Study|Decision by the Sponsor|1|||
105904671|NCT00829829|365308892|FG001|Overall Study|Decision by the Sponsor|0|||
105904672|NCT00829829|365308893|FG002|Overall Study|Decision by the Sponsor|2|||
105904673|NCT00829829|365308891|FG000|Overall Study|Lost to Follow-up|7|||
105904674|NCT00829829|365308892|FG001|Overall Study|Lost to Follow-up|3|||
105904675|NCT00829829|365308893|FG002|Overall Study|Lost to Follow-up|3|||
105904676|NCT00829829|365308891|FG000|Overall Study|Other than specified above|2|||
105904677|NCT00829829|365308892|FG001|Overall Study|Other than specified above|2|||
105904678|NCT00829829|365308893|FG002|Overall Study|Other than specified above|1|||
105904679|NCT04549545|365310290|FG000|Initial Period|Withdrawal by Subject|4|||
105904680|NCT04549545|365310291|FG001|Initial Period|Withdrawal by Subject|0|||
105904681|NCT04549545|365310290|FG000|Initial Period|Additional ENT Procedure|3|||
105904682|NCT04549545|365310291|FG001|Initial Period|Additional ENT Procedure|0|||
105904683|NCT04549545|365310290|FG000|Initial Period|Lost to Follow-up|3|||
105904684|NCT04549545|365310291|FG001|Initial Period|Lost to Follow-up|1|||
105904685|NCT04549545|365310290|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
105904686|NCT04549545|365310291|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
105904687|NCT04549545|365310290|FG000|Crossover Period|Additional ENT Procedure|0|||
105904688|NCT04549545|365310291|FG001|Crossover Period|Additional ENT Procedure|6|||
105904689|NCT04549545|365310290|FG000|Crossover Period|Lost to Follow-up|0|||
105904690|NCT04549545|365310291|FG001|Crossover Period|Lost to Follow-up|1|||
105904691|NCT04549545|365310290|FG000|Crossover Period|Withdrawal by Subject|0|||
105904692|NCT04549545|365310291|FG001|Crossover Period|Withdrawal by Subject|4|||
105904693|NCT01317004|365310292|FG000|Overall Study|Withdrawal by Subject|1|||
105904694|NCT01317004|365310293|FG001|Overall Study|Withdrawal by Subject|4|||
105904695|NCT01317004|365310292|FG000|Overall Study|Protocol Violation|0|||
105904696|NCT01317004|365310293|FG001|Overall Study|Protocol Violation|2|||
105904697|NCT01317004|365310292|FG000|Overall Study|Adverse Event|3|||
105904698|NCT01317004|365310293|FG001|Overall Study|Adverse Event|3|||
105904699|NCT01859949|365310297|FG000|Overall Study|Family Matters|0|||
105904700|NCT01859949|365310298|FG001|Overall Study|Family Matters|1|||
105904701|NCT01859949|365310297|FG000|Overall Study|Physician Decision|2|||
105904702|NCT01859949|365310298|FG001|Overall Study|Physician Decision|4|||
105904703|NCT01859949|365310297|FG000|Overall Study|Withdrawal by Subject|11|||
105904704|NCT01859949|365310298|FG001|Overall Study|Withdrawal by Subject|10|||
105904705|NCT01859949|365310297|FG000|Overall Study|Protocol Violation|1|||
105904706|NCT01859949|365310298|FG001|Overall Study|Protocol Violation|1|||
105904707|NCT01859949|365310297|FG000|Overall Study|Adverse Event|0|||
105904708|NCT01859949|365310298|FG001|Overall Study|Adverse Event|1|||
105904709|NCT01890759|365310299|FG000|Overall Study|Protocol Violation|0|||
105904710|NCT01890759|365310300|FG001|Overall Study|Protocol Violation|2|||
105904711|NCT01890759|365310299|FG000|Overall Study|Lost to Follow-up|0|||
105904712|NCT01890759|365310300|FG001|Overall Study|Lost to Follow-up|2|||
105669416|NCT01646177|364454022|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669417|NCT01646177|364454023|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105669418|NCT01646177|364454024|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
105904713|NCT01890759|365310299|FG000|Overall Study|Withdrawal by Subject|2|||
105904714|NCT01890759|365310300|FG001|Overall Study|Withdrawal by Subject|8|||
105904715|NCT00398216|365310301|FG000|Overall Study|Adverse Event|4|||
105904716|NCT00398216|365310302|FG001|Overall Study|Adverse Event|2|||
105904717|NCT00398216|365310303|FG002|Overall Study|Adverse Event|5|||
105904718|NCT00398216|365310304|FG003|Overall Study|Adverse Event|7|||
105904719|NCT00398216|365310305|FG004|Overall Study|Adverse Event|2|||
105904720|NCT00398216|365310301|FG000|Overall Study|Protocol Violation|2|||
105904721|NCT00398216|365310302|FG001|Overall Study|Protocol Violation|4|||
105904722|NCT00398216|365310303|FG002|Overall Study|Protocol Violation|5|||
105904723|NCT00398216|365310304|FG003|Overall Study|Protocol Violation|7|||
105904724|NCT00398216|365310305|FG004|Overall Study|Protocol Violation|5|||
105904725|NCT00398216|365310301|FG000|Overall Study|Lost to Follow-up|1|||
105904726|NCT00398216|365310302|FG001|Overall Study|Lost to Follow-up|6|||
105904727|NCT00398216|365310303|FG002|Overall Study|Lost to Follow-up|4|||
105904728|NCT00398216|365310304|FG003|Overall Study|Lost to Follow-up|4|||
105904729|NCT00398216|365310305|FG004|Overall Study|Lost to Follow-up|1|||
105904730|NCT00398216|365310301|FG000|Overall Study|Death|0|||
105904731|NCT00398216|365310302|FG001|Overall Study|Death|3|||
105904732|NCT00398216|365310303|FG002|Overall Study|Death|0|||
105904733|NCT00398216|365310304|FG003|Overall Study|Death|0|||
105904734|NCT00398216|365310305|FG004|Overall Study|Death|0|||
105904735|NCT00398216|365310301|FG000|Overall Study|Withdrawal by Subject|1|||
105904736|NCT00398216|365310302|FG001|Overall Study|Withdrawal by Subject|0|||
105904737|NCT00398216|365310303|FG002|Overall Study|Withdrawal by Subject|3|||
105904738|NCT00398216|365310304|FG003|Overall Study|Withdrawal by Subject|1|||
105904739|NCT00398216|365310305|FG004|Overall Study|Withdrawal by Subject|2|||
105904740|NCT00398216|365310301|FG000|Overall Study|administrative reasons|3|||
105904741|NCT00398216|365310302|FG001|Overall Study|administrative reasons|4|||
105904742|NCT00398216|365310303|FG002|Overall Study|administrative reasons|4|||
105904743|NCT00398216|365310304|FG003|Overall Study|administrative reasons|3|||
105904744|NCT00398216|365310305|FG004|Overall Study|administrative reasons|3|||
105904745|NCT00398216|365310301|FG000|Overall Study|entrance criteria|0|||
105904746|NCT00398216|365310302|FG001|Overall Study|entrance criteria|0|||
105904747|NCT00398216|365310303|FG002|Overall Study|entrance criteria|0|||
105904748|NCT00398216|365310304|FG003|Overall Study|entrance criteria|0|||
105904749|NCT00398216|365310305|FG004|Overall Study|entrance criteria|2|||
105904750|NCT00410072|365310308|FG000|Day 1 to Week 48|Adverse Event|1|||
105904751|NCT00410072|365310309|FG001|Day 1 to Week 48|Adverse Event|2|||
105904752|NCT00410072|365310308|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
105904753|NCT00410072|365310309|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
105904754|NCT00410072|365310308|FG000|Day 1 to Week 48|Other|0|||
105904755|NCT00410072|365310309|FG001|Day 1 to Week 48|Other|1|||
105904756|NCT00410072|365310308|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
105904757|NCT00410072|365310309|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
105904758|NCT00410072|365310308|FG000|Day 1 to Week 48|Pregnancy|0|||
105904759|NCT00410072|365310309|FG001|Day 1 to Week 48|Pregnancy|2|||
105904760|NCT00410072|365310308|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
105904761|NCT00410072|365310309|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
105904762|NCT00410072|365310308|FG000|After Week 48 to Week 96|Adverse Event|1|||
105904763|NCT00410072|365310309|FG001|After Week 48 to Week 96|Adverse Event|2|||
105904764|NCT00410072|365310308|FG000|After Week 48 to Week 96|Death|0|||
105904765|NCT00410072|365310309|FG001|After Week 48 to Week 96|Death|1|||
105904766|NCT00410072|365310308|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
105904767|NCT00410072|365310309|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
105904768|NCT00410072|365310308|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
105904769|NCT00410072|365310309|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
105904770|NCT00410072|365310308|FG000|After Week 48 to Week 96|Other|2|||
105904771|NCT00410072|365310309|FG001|After Week 48 to Week 96|Other|0|||
105904772|NCT00410072|365310308|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
105904773|NCT00410072|365310309|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
105904774|NCT00410072|365310308|FG000|After Week 48 to Week 96|Pregnancy|0|||
105904775|NCT00410072|365310309|FG001|After Week 48 to Week 96|Pregnancy|2|||
105904776|NCT00410072|365310308|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
105904777|NCT00410072|365310309|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
105904778|NCT01048944|365310310|FG000|Overall Study|Protocol Violation|8|||
105904779|NCT01048944|365310311|FG001|Overall Study|Protocol Violation|10|||
105904780|NCT01048944|365310312|FG002|Overall Study|Protocol Violation|10|||
105904781|NCT01048944|365310313|FG003|Overall Study|Protocol Violation|2|||
105998316|NCT03932760|365654911|FG000|Overall Study|Became Ineligible|2|||
105998317|NCT03932760|365654912|FG001|Overall Study|Became Ineligible|5|||
105998318|NCT03932760|365654911|FG000|Overall Study|Withdrawal by Subject|6|||
105998319|NCT03932760|365654912|FG001|Overall Study|Withdrawal by Subject|6|||
105904782|NCT00376532|365310314|FG000|Overall Study|Lack sufficient blood sample|6|||
105904783|NCT00376532|365310315|FG001|Overall Study|Lack sufficient blood sample|6|||
105904784|NCT01616758|365310317|FG000|Overall Study|Adverse Event|1|||
105904785|NCT01616758|365310317|FG000|Overall Study|Withdrawal by Subject|2|||
105904786|NCT01616758|365310317|FG000|Overall Study|Disease progression|18|||
105904787|NCT01616758|365310317|FG000|Overall Study|Study termination by Sponsor|1|||
105904788|NCT03026283|365310318|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
105904789|NCT03026283|365310319|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
105904790|NCT03026283|365310320|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
105904791|NCT03026283|365310321|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
105904792|NCT03026283|365310322|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
105904793|NCT03026283|365310323|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
105904794|NCT03026283|365310324|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
105998320|NCT02775916|365654913|FG000|Overall Study|Adverse Event|1|||
105998321|NCT02775916|365654914|FG001|Overall Study|Adverse Event|0|||
105904795|NCT03026283|365310325|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
105904796|NCT03026283|365310318|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
105904797|NCT03026283|365310319|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
105904798|NCT03026283|365310320|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
105904799|NCT03026283|365310321|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
105904800|NCT03026283|365310322|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
105904801|NCT03026283|365310323|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
105904802|NCT03026283|365310324|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
105904803|NCT03026283|365310325|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
105904804|NCT03026283|365310318|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105904805|NCT03026283|365310319|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
105904806|NCT03026283|365310320|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105904807|NCT03026283|365310321|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105904808|NCT03026283|365310322|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105904809|NCT03026283|365310323|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105904810|NCT03026283|365310324|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105904811|NCT03026283|365310325|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
105904812|NCT03026283|365310318|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105904813|NCT03026283|365310319|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105904814|NCT03026283|365310320|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
105904815|NCT03026283|365310321|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105904816|NCT03026283|365310322|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105904817|NCT03026283|365310323|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105904818|NCT03026283|365310324|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105904819|NCT03026283|365310325|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
105904820|NCT03026283|365310318|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105904821|NCT03026283|365310319|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105904822|NCT03026283|365310320|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105904823|NCT03026283|365310321|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
105904824|NCT03026283|365310322|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
105904825|NCT03026283|365310323|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105904826|NCT03026283|365310324|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105904827|NCT03026283|365310325|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
105904828|NCT03026283|365310318|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105904829|NCT03026283|365310319|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105904830|NCT03026283|365310320|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105904831|NCT03026283|365310321|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
105904832|NCT03026283|365310322|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
105904833|NCT03026283|365310323|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
105904834|NCT03026283|365310324|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105904835|NCT03026283|365310325|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
105904836|NCT03026283|365310318|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105904837|NCT03026283|365310319|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105904838|NCT03026283|365310320|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105904839|NCT03026283|365310321|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
105904840|NCT03026283|365310322|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105904841|NCT03026283|365310323|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
105904842|NCT03026283|365310324|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105904843|NCT03026283|365310325|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
105904844|NCT03026283|365310318|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105904845|NCT03026283|365310319|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105904846|NCT03026283|365310320|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105904847|NCT03026283|365310321|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
105904848|NCT03026283|365310322|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105904849|NCT03026283|365310323|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105904850|NCT03026283|365310324|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105904851|NCT03026283|365310325|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
105904852|NCT03026283|365310318|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105904853|NCT03026283|365310319|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105904854|NCT03026283|365310320|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105904855|NCT03026283|365310321|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105904856|NCT03026283|365310322|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
105904857|NCT03026283|365310323|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
105904858|NCT03026283|365310324|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105904859|NCT03026283|365310325|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
105904860|NCT04076319|365310330|FG000|Overall Study|Withdrawal by Subject|2|||
105904861|NCT04076319|365310331|FG001|Overall Study|Withdrawal by Subject|0|||
105904862|NCT04076319|365310330|FG000|Overall Study|Death|1|||
105904863|NCT04076319|365310331|FG001|Overall Study|Death|0|||
105904864|NCT01054222|365310332|FG000|Overall Study|Lack of Efficacy|1|||
105904865|NCT01054222|365310332|FG000|Overall Study|Lost to Follow-up|4|||
105904866|NCT01054222|365310332|FG000|Overall Study|Withdrawal by Subject|6|||
105904867|NCT03782571|365310333|FG000|Period 1|Withdrawal by Subject|1|||
105904868|NCT03782571|365310334|FG001|Period 1|Withdrawal by Subject|0|||
105904869|NCT03782571|365310335|FG002|Period 1|Withdrawal by Subject|0|||
105904870|NCT03782571|365310336|FG003|Period 1|Withdrawal by Subject|0|||
105904871|NCT03782571|365310333|FG000|Period 3|Subject Unable to Attend V5|1|||
105904872|NCT03782571|365310334|FG001|Period 3|Subject Unable to Attend V5|0|||
105904873|NCT03782571|365310335|FG002|Period 3|Subject Unable to Attend V5|0|||
105904874|NCT03782571|365310336|FG003|Period 3|Subject Unable to Attend V5|0|||
105904875|NCT03782571|365310333|FG000|Period 3|Adverse Event|1|||
105904876|NCT03782571|365310334|FG001|Period 3|Adverse Event|0|||
105904877|NCT03782571|365310335|FG002|Period 3|Adverse Event|0|||
105904878|NCT03782571|365310336|FG003|Period 3|Adverse Event|0|||
105904879|NCT03504189|365310337|FG000|Overall Study|Withdrawal by Subject|1|||
105904880|NCT03504189|365310337|FG000|Overall Study|Screening Failure|1|||
105904881|NCT03504189|365310337|FG000|Overall Study|Device Failure|2|||
105904882|NCT04336475|365310338|FG000|Overall Study|pain|1|||
105904883|NCT04336475|365310339|FG001|Overall Study|pain|0|||
105904884|NCT04336475|365310338|FG000|Overall Study|upper respiratory infection|1|||
105904885|NCT04336475|365310339|FG001|Overall Study|upper respiratory infection|0|||
105904886|NCT04336475|365310338|FG000|Overall Study|Lost to Follow-up|0|||
105904887|NCT04336475|365310339|FG001|Overall Study|Lost to Follow-up|2|||
105904888|NCT00199849|365310346|FG000|Overall Study|Unrelated illness or complication|0|||
105904889|NCT00199849|365310347|FG001|Overall Study|Unrelated illness or complication|1|||
105904890|NCT00199849|365310348|FG002|Overall Study|Unrelated illness or complication|0|||
105904891|NCT00199849|365310346|FG000|Overall Study|Progressive disease requiring intervention|0|||
105904892|NCT00199849|365310347|FG001|Overall Study|Progressive disease requiring intervention|0|||
105904893|NCT00199849|365310348|FG002|Overall Study|Progressive disease requiring intervention|1|||
105904894|NCT00199849|365310346|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
105904895|NCT00199849|365310347|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
105904896|NCT00199849|365310348|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
105904897|NCT02793947|365310351|FG000|Overall Study|Death|1|||
105904898|NCT02793947|365310352|FG001|Overall Study|Death|0|||
105904899|NCT02793947|365310351|FG000|Overall Study|Physician Decision|1|||
105904900|NCT02793947|365310352|FG001|Overall Study|Physician Decision|5|||
105904901|NCT03746405|365310355|FG000|Overall Study|Withdrawal by Subject|3|||
105904902|NCT03746405|365310356|FG001|Overall Study|Withdrawal by Subject|0|||
105904903|NCT03746405|365310355|FG000|Overall Study|technical difficulties|0|||
105904904|NCT03746405|365310356|FG001|Overall Study|technical difficulties|2|||
105904905|NCT01465230|365310358|FG000|Overall Study|Withdrawal by Subject|2|||
105904906|NCT02933528|365310364|FG000|Overall Study|Lost to Follow-up|2|||
105904907|NCT01301079|365310365|FG000|Overall Study|Lost to Follow-up|2|||
105904908|NCT01301079|365310366|FG001|Overall Study|Lost to Follow-up|2|||
106125373|NCT01848834|366115923|FG002|Overall Study|Physician Decision|4|||
106125374|NCT01848834|366115924|FG003|Overall Study|Physician Decision|0|||
106125375|NCT01848834|366115925|FG004|Overall Study|Physician Decision|11|||
106125376|NCT01848834|366115921|FG000|Overall Study|Protocol Violation|0|||
106125377|NCT01848834|366115922|FG001|Overall Study|Protocol Violation|0|||
106125378|NCT01848834|366115923|FG002|Overall Study|Protocol Violation|0|||
106125379|NCT01848834|366115924|FG003|Overall Study|Protocol Violation|0|||
106125380|NCT01848834|366115925|FG004|Overall Study|Protocol Violation|1|||
106125381|NCT01848834|366115921|FG000|Overall Study|Sponsor Decision|1|||
106125382|NCT01848834|366115922|FG001|Overall Study|Sponsor Decision|1|||
106125383|NCT01848834|366115923|FG002|Overall Study|Sponsor Decision|0|||
105904909|NCT01639703|365310369|FG000|Overall Study|Withdrawal by Subject|5|||
105904910|NCT01639703|365310369|FG000|Overall Study|Other reason|7|||
106125384|NCT01848834|366115924|FG003|Overall Study|Sponsor Decision|1|||
105904911|NCT02087670|365310370|FG000|Overall Study|Withdrawal by Subject|3|||
105904912|NCT02087670|365310371|FG001|Overall Study|Withdrawal by Subject|2|||
105904913|NCT00571103|365310372|FG000|Overall Study|Withdrawal by Subject|1|||
105904914|NCT00571103|365310372|FG000|Overall Study|Lost to Follow-up|1|||
105904915|NCT01308463|365310374|FG000|Overall Study|Study Discontinued|23|||
106125385|NCT01848834|366115925|FG004|Overall Study|Sponsor Decision|1|||
105669419|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669420|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669421|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105904916|NCT01308463|365310374|FG000|Overall Study|Death|4|||
105904917|NCT01308463|365310374|FG000|Overall Study|Revision|2|||
105669422|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669423|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669424|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669425|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105669426|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
105904918|NCT02131233|365310375|FG000|Overall Study|Not Treated|2|||
105904919|NCT02131233|365310376|FG001|Overall Study|Not Treated|3|||
105904920|NCT02131233|365310375|FG000|Overall Study|Adverse Event|7|||
105904921|NCT02131233|365310376|FG001|Overall Study|Adverse Event|6|||
105904922|NCT02131233|365310375|FG000|Overall Study|Death|0|||
105904923|NCT02131233|365310376|FG001|Overall Study|Death|1|||
105904924|NCT02131233|365310375|FG000|Overall Study|Lack of Efficacy|6|||
105904925|NCT02131233|365310376|FG001|Overall Study|Lack of Efficacy|3|||
105904926|NCT02131233|365310375|FG000|Overall Study|Lost to Follow-up|14|||
105904927|NCT02131233|365310376|FG001|Overall Study|Lost to Follow-up|13|||
105904928|NCT02131233|365310375|FG000|Overall Study|Non-Compliance With Study Drug|8|||
105904929|NCT02131233|365310376|FG001|Overall Study|Non-Compliance With Study Drug|5|||
105904930|NCT02131233|365310375|FG000|Overall Study|Physician Decision|7|||
105904931|NCT02131233|365310376|FG001|Overall Study|Physician Decision|0|||
105904932|NCT02131233|365310375|FG000|Overall Study|Pregnancy|4|||
105904933|NCT02131233|365310376|FG001|Overall Study|Pregnancy|0|||
105904934|NCT02131233|365310375|FG000|Overall Study|Withdrawal by Subject|18|||
105904935|NCT02131233|365310376|FG001|Overall Study|Withdrawal by Subject|11|||
105904936|NCT00790556|365310377|FG000|Treatment Period 1|Physician Decision|1|||
105904937|NCT00790556|365310378|FG001|Treatment Period 1|Physician Decision|0|||
105904938|NCT00790556|365310377|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105904939|NCT00790556|365310378|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105904940|NCT04217317|365310379|FG000|Overall Study|Lack of Efficacy|4|||
105904941|NCT04217317|365310379|FG000|Overall Study|Physician Decision|1|||
105904942|NCT04313400|365310380|FG000|Overall Study|Withdrawal by Subject|0|||
105904943|NCT04313400|365310381|FG001|Overall Study|Withdrawal by Subject|0|||
105904944|NCT04313400|365310382|FG002|Overall Study|Withdrawal by Subject|0|||
105904945|NCT04313400|365310383|FG003|Overall Study|Withdrawal by Subject|0|||
105904946|NCT04313400|365310384|FG004|Overall Study|Withdrawal by Subject|0|||
105904947|NCT04313400|365310385|FG005|Overall Study|Withdrawal by Subject|4|||
105904948|NCT04313400|365310386|FG006|Overall Study|Withdrawal by Subject|1|||
105904949|NCT04313400|365310380|FG000|Overall Study|Adverse Event|0|||
105904950|NCT04313400|365310381|FG001|Overall Study|Adverse Event|0|||
105904951|NCT04313400|365310382|FG002|Overall Study|Adverse Event|0|||
105904952|NCT04313400|365310383|FG003|Overall Study|Adverse Event|0|||
105904953|NCT04313400|365310384|FG004|Overall Study|Adverse Event|0|||
105904954|NCT04313400|365310385|FG005|Overall Study|Adverse Event|1|||
105904955|NCT04313400|365310386|FG006|Overall Study|Adverse Event|0|||
105904956|NCT04313400|365310380|FG000|Overall Study|Lost to Follow-up|0|||
105904957|NCT04313400|365310381|FG001|Overall Study|Lost to Follow-up|0|||
105904958|NCT04313400|365310382|FG002|Overall Study|Lost to Follow-up|0|||
105904959|NCT04313400|365310383|FG003|Overall Study|Lost to Follow-up|0|||
105904960|NCT04313400|365310384|FG004|Overall Study|Lost to Follow-up|0|||
105904961|NCT04313400|365310385|FG005|Overall Study|Lost to Follow-up|1|||
105904962|NCT04313400|365310386|FG006|Overall Study|Lost to Follow-up|0|||
105904963|NCT00303472|365310389|FG000|Treatment Period|Adverse Event|0|||
105904964|NCT00303472|365310390|FG001|Treatment Period|Adverse Event|0|||
105904965|NCT00303472|365310391|FG002|Treatment Period|Adverse Event|0|||
105904966|NCT00303472|365310392|FG003|Treatment Period|Adverse Event|0|||
105904967|NCT00303472|365310393|FG004|Treatment Period|Adverse Event|1|||
105669427|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
105669428|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
105669429|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
105669430|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
105904968|NCT00303472|365310394|FG005|Treatment Period|Adverse Event|0|||
105904969|NCT00303472|365310395|FG006|Treatment Period|Adverse Event|0|||
105904970|NCT00303472|365310389|FG000|Treatment Period|Death|0|||
105904971|NCT00303472|365310390|FG001|Treatment Period|Death|0|||
105904972|NCT00303472|365310391|FG002|Treatment Period|Death|0|||
105904973|NCT00303472|365310392|FG003|Treatment Period|Death|1|||
105904974|NCT00303472|365310393|FG004|Treatment Period|Death|0|||
105904975|NCT00303472|365310394|FG005|Treatment Period|Death|0|||
105904976|NCT00303472|365310395|FG006|Treatment Period|Death|1|||
105904977|NCT00303472|365310389|FG000|Treatment Period|Withdrawal by Subject|0|||
105904978|NCT00303472|365310390|FG001|Treatment Period|Withdrawal by Subject|0|||
105904979|NCT00303472|365310391|FG002|Treatment Period|Withdrawal by Subject|0|||
105904980|NCT00303472|365310392|FG003|Treatment Period|Withdrawal by Subject|1|||
105904981|NCT00303472|365310393|FG004|Treatment Period|Withdrawal by Subject|0|||
105904982|NCT00303472|365310394|FG005|Treatment Period|Withdrawal by Subject|1|||
105904983|NCT00303472|365310395|FG006|Treatment Period|Withdrawal by Subject|0|||
105904984|NCT00303472|365310389|FG000|Treatment Period|Other|0|||
105904985|NCT00303472|365310390|FG001|Treatment Period|Other|0|||
105904986|NCT00303472|365310391|FG002|Treatment Period|Other|0|||
105904987|NCT00303472|365310392|FG003|Treatment Period|Other|0|||
105904988|NCT00303472|365310393|FG004|Treatment Period|Other|1|||
105904989|NCT00303472|365310394|FG005|Treatment Period|Other|0|||
105904990|NCT00303472|365310395|FG006|Treatment Period|Other|1|||
105904991|NCT00303472|365310389|FG000|Treatment Period|Disease Progression (to AML)|0|||
105904992|NCT00303472|365310390|FG001|Treatment Period|Disease Progression (to AML)|0|||
105904993|NCT00303472|365310391|FG002|Treatment Period|Disease Progression (to AML)|0|||
105904994|NCT00303472|365310392|FG003|Treatment Period|Disease Progression (to AML)|0|||
105904995|NCT00303472|365310393|FG004|Treatment Period|Disease Progression (to AML)|1|||
105904996|NCT00303472|365310394|FG005|Treatment Period|Disease Progression (to AML)|0|||
105904997|NCT00303472|365310395|FG006|Treatment Period|Disease Progression (to AML)|0|||
105904998|NCT00303472|365310389|FG000|Treatment Extension (Optional)|Adverse Event|1|||
105904999|NCT00303472|365310390|FG001|Treatment Extension (Optional)|Adverse Event|0|||
105905000|NCT00303472|365310391|FG002|Treatment Extension (Optional)|Adverse Event|1|||
105905001|NCT00303472|365310392|FG003|Treatment Extension (Optional)|Adverse Event|0|||
105905002|NCT00303472|365310393|FG004|Treatment Extension (Optional)|Adverse Event|0|||
105905003|NCT00303472|365310394|FG005|Treatment Extension (Optional)|Adverse Event|0|||
105905004|NCT00303472|365310395|FG006|Treatment Extension (Optional)|Adverse Event|0|||
105905005|NCT00303472|365310389|FG000|Treatment Extension (Optional)|Death|2|||
105905006|NCT00303472|365310390|FG001|Treatment Extension (Optional)|Death|0|||
105905007|NCT00303472|365310391|FG002|Treatment Extension (Optional)|Death|1|||
105669431|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669432|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669433|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105905008|NCT00303472|365310392|FG003|Treatment Extension (Optional)|Death|0|||
105905009|NCT00303472|365310393|FG004|Treatment Extension (Optional)|Death|0|||
105905010|NCT00303472|365310394|FG005|Treatment Extension (Optional)|Death|0|||
105905011|NCT00303472|365310395|FG006|Treatment Extension (Optional)|Death|0|||
105905012|NCT00303472|365310389|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
105905013|NCT00303472|365310390|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
105905014|NCT00303472|365310391|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
105905015|NCT00303472|365310392|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
105905016|NCT00303472|365310393|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
105905017|NCT00303472|365310394|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
105905018|NCT00303472|365310395|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
105905019|NCT00303472|365310389|FG000|Treatment Extension (Optional)|Physician Decision|0|||
105905020|NCT00303472|365310390|FG001|Treatment Extension (Optional)|Physician Decision|4|||
105905021|NCT00303472|365310391|FG002|Treatment Extension (Optional)|Physician Decision|2|||
105905022|NCT00303472|365310392|FG003|Treatment Extension (Optional)|Physician Decision|3|||
105905023|NCT00303472|365310393|FG004|Treatment Extension (Optional)|Physician Decision|2|||
105905024|NCT00303472|365310394|FG005|Treatment Extension (Optional)|Physician Decision|0|||
105905025|NCT00303472|365310395|FG006|Treatment Extension (Optional)|Physician Decision|0|||
105905026|NCT00303472|365310389|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
105905027|NCT00303472|365310390|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
105905028|NCT00303472|365310391|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
105905029|NCT00303472|365310392|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
105905030|NCT00303472|365310393|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
105905031|NCT00303472|365310394|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
105905032|NCT00303472|365310395|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
105905033|NCT00303472|365310389|FG000|Treatment Extension (Optional)|Other|0|||
105905034|NCT00303472|365310390|FG001|Treatment Extension (Optional)|Other|2|||
105905035|NCT00303472|365310391|FG002|Treatment Extension (Optional)|Other|4|||
105905036|NCT00303472|365310392|FG003|Treatment Extension (Optional)|Other|2|||
105905037|NCT00303472|365310393|FG004|Treatment Extension (Optional)|Other|1|||
105905038|NCT00303472|365310394|FG005|Treatment Extension (Optional)|Other|0|||
105905039|NCT00303472|365310395|FG006|Treatment Extension (Optional)|Other|0|||
105905040|NCT00303472|365310389|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
105905041|NCT00303472|365310390|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105905042|NCT00303472|365310391|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105905043|NCT00303472|365310392|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105905044|NCT00303472|365310393|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105905045|NCT00303472|365310394|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
105905046|NCT00303472|365310395|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
105905047|NCT00110357|365310399|FG000|Overall Study|Deterioration without progression|2|||
105905048|NCT00110357|365310400|FG001|Overall Study|Deterioration without progression|0|||
105905049|NCT00110357|365310399|FG000|Overall Study|Disease progression/relapse|20|||
105905050|NCT00110357|365310400|FG001|Overall Study|Disease progression/relapse|15|||
105905051|NCT00110357|365310399|FG000|Overall Study|Study Closure|1|||
105905052|NCT00110357|365310400|FG001|Overall Study|Study Closure|0|||
105905053|NCT00110357|365310399|FG000|Overall Study|Study Drug Toxicity|1|||
105905054|NCT00110357|365310400|FG001|Overall Study|Study Drug Toxicity|3|||
105669434|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669435|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669436|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669437|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669438|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
105669439|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
105669440|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
105905055|NCT00110357|365310399|FG000|Overall Study|Withdrawal by Subject|3|||
105905056|NCT00110357|365310400|FG001|Overall Study|Withdrawal by Subject|1|||
105905057|NCT03853291|365310401|FG000|Overall Study|Lost to Follow-up|1|||
105905058|NCT03853291|365310402|FG001|Overall Study|Lost to Follow-up|2|||
105669441|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
105669442|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
105669443|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669444|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669445|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105905059|NCT03853291|365310403|FG002|Overall Study|Lost to Follow-up|0|||
105905060|NCT03853291|365310404|FG003|Overall Study|Lost to Follow-up|0|||
105669446|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105905061|NCT03853291|365310405|FG004|Overall Study|Lost to Follow-up|0|||
105905062|NCT03853291|365310406|FG005|Overall Study|Lost to Follow-up|0|||
105905063|NCT03853291|365310401|FG000|Overall Study|Determined to be ineligible|1|||
105905064|NCT03853291|365310402|FG001|Overall Study|Determined to be ineligible|1|||
105905065|NCT03853291|365310403|FG002|Overall Study|Determined to be ineligible|0|||
105905066|NCT03853291|365310404|FG003|Overall Study|Determined to be ineligible|0|||
105905067|NCT03853291|365310405|FG004|Overall Study|Determined to be ineligible|0|||
105905068|NCT03853291|365310406|FG005|Overall Study|Determined to be ineligible|0|||
105905069|NCT03882957|365310407|FG000|Overall Study|Did not complete all three arms|1|||
105905070|NCT01670045|365310419|FG000|Overall Study|Withdrawal by Subject|3|||
105905071|NCT01670045|365310419|FG000|Overall Study|Adverse Event|1|||
105905072|NCT01670045|365310419|FG000|Overall Study|Death|1|||
105905073|NCT01670045|365310419|FG000|Overall Study|Lost to Follow-up|11|||
105905074|NCT01429298|365310422|FG000|Overall Study|Protocol Violation|4|||
105905075|NCT01429298|365310423|FG001|Overall Study|Protocol Violation|6|||
105905076|NCT01603407|365310424|FG000|Overall Study|Adverse Event|1|||
105905077|NCT01603407|365310425|FG001|Overall Study|Adverse Event|1|||
105905078|NCT01603407|365310426|FG002|Overall Study|Adverse Event|1|||
105905079|NCT01603407|365310424|FG000|Overall Study|Protocol Violation|2|||
105905080|NCT01603407|365310425|FG001|Overall Study|Protocol Violation|2|||
105905081|NCT01603407|365310426|FG002|Overall Study|Protocol Violation|0|||
105905082|NCT01603407|365310424|FG000|Overall Study|Withdrawal by Subject|8|||
105905083|NCT01603407|365310425|FG001|Overall Study|Withdrawal by Subject|5|||
105905084|NCT01603407|365310426|FG002|Overall Study|Withdrawal by Subject|7|||
105905085|NCT01603407|365310424|FG000|Overall Study|Lost to Follow-up|0|||
105905086|NCT01603407|365310425|FG001|Overall Study|Lost to Follow-up|3|||
105905087|NCT01603407|365310426|FG002|Overall Study|Lost to Follow-up|2|||
105905088|NCT02903420|365310427|FG000|Overall Study|Death|3|||
105905089|NCT00625183|365310428|FG000|Overall Study|Disease Progression|1|||
105905090|NCT01941537|365310431|FG000|Overall Study|Lack of Efficacy|1|||
105905091|NCT01941537|365310432|FG001|Overall Study|Lack of Efficacy|2|||
105905092|NCT01941537|365310431|FG000|Overall Study|Lost to Follow-up|1|||
105905093|NCT01941537|365310432|FG001|Overall Study|Lost to Follow-up|0|||
105905094|NCT01941537|365310431|FG000|Overall Study|Pregnancy|1|||
105905095|NCT01941537|365310432|FG001|Overall Study|Pregnancy|0|||
105905096|NCT01941537|365310431|FG000|Overall Study|Adverse Event|1|||
105905097|NCT01941537|365310432|FG001|Overall Study|Adverse Event|0|||
105905098|NCT01941537|365310431|FG000|Overall Study|Withdrawal by Subject|0|||
105905099|NCT01941537|365310432|FG001|Overall Study|Withdrawal by Subject|1|||
105905100|NCT02557516|365310434|FG000|Overall Study|Adverse Event|1|||
105905101|NCT02557516|365310435|FG001|Overall Study|Adverse Event|0|||
105905102|NCT02557516|365310436|FG002|Overall Study|Adverse Event|2|||
105905103|NCT02557516|365310437|FG003|Overall Study|Adverse Event|1|||
105905104|NCT02557516|365310434|FG000|Overall Study|Disease progression|0|||
105905105|NCT02557516|365310435|FG001|Overall Study|Disease progression|2|||
105905106|NCT02557516|365310436|FG002|Overall Study|Disease progression|0|||
105905107|NCT02557516|365310437|FG003|Overall Study|Disease progression|0|||
105905108|NCT02557516|365310434|FG000|Overall Study|Physician Decision|0|||
105905109|NCT02557516|365310435|FG001|Overall Study|Physician Decision|2|||
105905110|NCT02557516|365310436|FG002|Overall Study|Physician Decision|0|||
105905111|NCT02557516|365310437|FG003|Overall Study|Physician Decision|0|||
105905112|NCT02557516|365310434|FG000|Overall Study|Sponsor decision|0|||
105905113|NCT02557516|365310435|FG001|Overall Study|Sponsor decision|1|||
105905114|NCT02557516|365310436|FG002|Overall Study|Sponsor decision|2|||
105905115|NCT02557516|365310437|FG003|Overall Study|Sponsor decision|8|||
105905116|NCT03034135|365310438|FG000|Overall Study|Withdrawal by Subject|2|||
105905117|NCT05645432|365310439|FG000|Overall Study|Withdrawal by Subject|1|||
105905118|NCT01243177|365310440|FG000|Overall Study|Lack of Efficacy|47|||
105905119|NCT01243177|365310441|FG001|Overall Study|Lack of Efficacy|31|||
105905120|NCT01243177|365310440|FG000|Overall Study|Protocol Violation|11|||
105905121|NCT01243177|365310441|FG001|Overall Study|Protocol Violation|10|||
105905122|NCT01243177|365310440|FG000|Overall Study|Lost to Follow-up|15|||
105669447|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669448|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105905123|NCT01243177|365310441|FG001|Overall Study|Lost to Follow-up|18|||
105905124|NCT01243177|365310440|FG000|Overall Study|Withdrawal by Subject|46|||
105905125|NCT01243177|365310441|FG001|Overall Study|Withdrawal by Subject|38|||
105905126|NCT01243177|365310440|FG000|Overall Study|AE, serious fatal|0|||
105905127|NCT01243177|365310441|FG001|Overall Study|AE, serious fatal|1|||
105905128|NCT01243177|365310440|FG000|Overall Study|SAE, non-fatal|7|||
105905129|NCT01243177|365310441|FG001|Overall Study|SAE, non-fatal|9|||
105905130|NCT01243177|365310440|FG000|Overall Study|AE, non-serious non-fatal|40|||
105905131|NCT01243177|365310441|FG001|Overall Study|AE, non-serious non-fatal|58|||
105905132|NCT01243177|365310440|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
105905133|NCT01243177|365310441|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
105905134|NCT01243177|365310440|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105905135|NCT01243177|365310441|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
105905136|NCT01243177|365310440|FG000|Overall Study|Other Reason|11|||
105669449|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669450|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
105669451|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
105669452|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
105669453|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
105669454|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
105669455|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669456|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669457|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669458|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669459|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669460|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669461|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669462|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
105669463|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
105669464|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
105669465|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
105669466|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
105669467|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669468|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669469|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669470|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669471|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669472|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669473|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669474|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
105669475|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
105669476|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
105669477|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
105669478|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
105905137|NCT01243177|365310441|FG001|Overall Study|Other Reason|12|||
105905138|NCT02207400|365311982|FG000|Overall Study|Adverse Event|1|||
105905139|NCT02207400|365311983|FG001|Overall Study|Adverse Event|1|||
106125386|NCT01848834|366115921|FG000|Overall Study|Withdrawal by Subject|2|||
106125387|NCT01848834|366115922|FG001|Overall Study|Withdrawal by Subject|13|||
105905140|NCT02207400|365311982|FG000|Overall Study|Lost to Follow-up|6|||
105905141|NCT02207400|365311983|FG001|Overall Study|Lost to Follow-up|7|||
105905142|NCT02207400|365311982|FG000|Overall Study|Protocol Violation|1|||
105905143|NCT02207400|365311983|FG001|Overall Study|Protocol Violation|1|||
105905144|NCT02207400|365311982|FG000|Overall Study|Withdrawal by Subject|8|||
105905145|NCT02207400|365311983|FG001|Overall Study|Withdrawal by Subject|4|||
105905146|NCT02207400|365311982|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
105905147|NCT02207400|365311983|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
105905148|NCT03396822|365311984|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
105905149|NCT03396822|365311984|FG000|Overall Study|Physician Decision|1|||
105905150|NCT04985942|365311985|FG000|Overall Study|Adverse Event|14|||
105905151|NCT04985942|365311986|FG001|Overall Study|Adverse Event|2|||
105905152|NCT04985942|365311985|FG000|Overall Study|Lack of Efficacy|0|||
105905153|NCT04985942|365311986|FG001|Overall Study|Lack of Efficacy|3|||
105905154|NCT04985942|365311985|FG000|Overall Study|Lost to Follow-up|1|||
105905155|NCT04985942|365311986|FG001|Overall Study|Lost to Follow-up|1|||
105905156|NCT04985942|365311985|FG000|Overall Study|Protocol Violation|1|||
105905157|NCT04985942|365311986|FG001|Overall Study|Protocol Violation|1|||
105905158|NCT04985942|365311985|FG000|Overall Study|Withdrawal by Subject|5|||
105905159|NCT04985942|365311986|FG001|Overall Study|Withdrawal by Subject|4|||
105905160|NCT02849704|365311990|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
105905161|NCT02849704|365311991|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
105905162|NCT02849704|365311990|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
105905163|NCT02849704|365311991|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
105905164|NCT02849704|365311990|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
105905165|NCT02849704|365311991|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
105905166|NCT03638466|365311994|FG000|Overall Study|Early Termination|0|||
105905167|NCT03638466|365311995|FG001|Overall Study|Early Termination|1|||
105905168|NCT00497146|365311996|FG000|Treatment Period|Adverse Event|6|||
105905169|NCT00497146|365311997|FG001|Treatment Period|Adverse Event|2|||
105905170|NCT00497146|365311996|FG000|Treatment Period|Withdrawal by Subject|5|||
105905171|NCT00497146|365311997|FG001|Treatment Period|Withdrawal by Subject|9|||
105905172|NCT00497146|365311996|FG000|Treatment Period|Lost to Follow-up|1|||
105669479|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
106125388|NCT01848834|366115923|FG002|Overall Study|Withdrawal by Subject|10|||
106125389|NCT01848834|366115924|FG003|Overall Study|Withdrawal by Subject|6|||
106125390|NCT01848834|366115925|FG004|Overall Study|Withdrawal by Subject|36|||
106125391|NCT02040090|366115928|FG000|Overall Study|Adverse Event|2|||
106125392|NCT02040090|366115929|FG001|Overall Study|Adverse Event|0|||
105905173|NCT00497146|365311997|FG001|Treatment Period|Lost to Follow-up|3|||
105905174|NCT00497146|365311996|FG000|Treatment Period|Required dialysis|4|||
105905175|NCT00497146|365311997|FG001|Treatment Period|Required dialysis|1|||
105905176|NCT00497146|365311996|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
105905177|NCT00497146|365311997|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
105905178|NCT00497146|365311996|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
105905179|NCT00497146|365311997|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
105905180|NCT00497146|365311996|FG000|Treatment Period|Other Reason|2|||
105905181|NCT00497146|365311997|FG001|Treatment Period|Other Reason|3|||
105905182|NCT00497146|365311996|FG000|Long-term Follow-up Period|Adverse Event|2|||
105905183|NCT00497146|365311997|FG001|Long-term Follow-up Period|Adverse Event|2|||
105905184|NCT00497146|365311996|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
105905185|NCT00497146|365311997|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
105905186|NCT00497146|365311996|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
105905187|NCT00497146|365311997|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
105905188|NCT00497146|365311996|FG000|Long-term Follow-up Period|Other|0|||
105905189|NCT00497146|365311997|FG001|Long-term Follow-up Period|Other|1|||
105905190|NCT01471444|365311998|FG000|Overall Study|Physician Decision|3|||
105905191|NCT01471444|365311999|FG001|Overall Study|Physician Decision|2|||
105905192|NCT01471444|365311998|FG000|Overall Study|Withdrawal by Subject|0|||
105905193|NCT01471444|365311999|FG001|Overall Study|Withdrawal by Subject|1|||
105905194|NCT03251482|365312000|FG000|Overall Study|Withdrawal by Subject|0|||
105905195|NCT03251482|365312001|FG001|Overall Study|Withdrawal by Subject|1|||
105905196|NCT03251482|365312002|FG002|Overall Study|Withdrawal by Subject|0|||
105905197|NCT03251482|365312003|FG003|Overall Study|Withdrawal by Subject|0|||
105905198|NCT03251482|365312004|FG004|Overall Study|Withdrawal by Subject|0|||
105905199|NCT02107313|365312013|FG000|Overall Study|One participant did not do the FED cohor|0|||
105905200|NCT02107313|365312014|FG001|Overall Study|One participant did not do the FED cohor|1|||
105905201|NCT02542397|365312015|FG000|Overall Study|Death|2|||
105905202|NCT02542397|365312015|FG000|Overall Study|Physician Decision|6|||
105905203|NCT02542397|365312015|FG000|Overall Study|Withdrawal by Subject|6|||
105905204|NCT02542397|365312015|FG000|Overall Study|Lost to Follow-up|2|||
105905205|NCT02532257|365312016|FG000|Overall Study|Adverse Event|2|||
105905206|NCT02532257|365312016|FG000|Overall Study|Physician Decision|4|||
105905207|NCT02532257|365312016|FG000|Overall Study|Withdrawal by Subject|3|||
105905208|NCT02532257|365312016|FG000|Overall Study|Progressive Disease|10|||
105905209|NCT03474107|365312017|FG000|Overall Study|Adverse Event|42|||
105905210|NCT03474107|365312018|FG001|Overall Study|Adverse Event|46|||
105905211|NCT03474107|365312017|FG000|Overall Study|Death|2|||
105905212|NCT03474107|365312018|FG001|Overall Study|Death|2|||
105905213|NCT03474107|365312017|FG000|Overall Study|Lost to Follow-up|0|||
105905214|NCT03474107|365312018|FG001|Overall Study|Lost to Follow-up|1|||
105905215|NCT03474107|365312017|FG000|Overall Study|Progressive Disease|177|||
105905216|NCT03474107|365312018|FG001|Overall Study|Progressive Disease|180|||
105905217|NCT03474107|365312017|FG000|Overall Study|Protocol Violation|1|||
105905218|NCT03474107|365312018|FG001|Overall Study|Protocol Violation|1|||
105905219|NCT03474107|365312017|FG000|Overall Study|Withdrawal by Subject|15|||
105905220|NCT03474107|365312018|FG001|Overall Study|Withdrawal by Subject|27|||
105905221|NCT03474107|365312017|FG000|Overall Study|Physician Decision|7|||
105905222|NCT03474107|365312018|FG001|Overall Study|Physician Decision|22|||
105905223|NCT03474107|365312017|FG000|Overall Study|Miscellaneous|1|||
105905224|NCT03474107|365312018|FG001|Overall Study|Miscellaneous|6|||
105669480|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669481|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105905225|NCT02768792|365312026|FG000|Overall Study|Adverse Event|1|||
105905226|NCT00435461|365312030|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
105905227|NCT00435461|365312031|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
105669482|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105905228|NCT00435461|365312032|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
105905229|NCT00435461|365312030|FG000|Overall Study|Protocol Violation|6|||
105905230|NCT00435461|365312031|FG001|Overall Study|Protocol Violation|9|||
105905231|NCT00435461|365312032|FG002|Overall Study|Protocol Violation|10|||
105905232|NCT00435461|365312030|FG000|Overall Study|Participant randomized(inadequate score)|1|||
105905233|NCT00435461|365312031|FG001|Overall Study|Participant randomized(inadequate score)|0|||
105905234|NCT00435461|365312032|FG002|Overall Study|Participant randomized(inadequate score)|0|||
106125393|NCT02040090|366115928|FG000|Overall Study|Physician Decision|1|||
106125394|NCT02040090|366115929|FG001|Overall Study|Physician Decision|0|||
105905235|NCT00435461|365312030|FG000|Overall Study|Compliance less than 80 percent|1|||
105905236|NCT00435461|365312031|FG001|Overall Study|Compliance less than 80 percent|0|||
105905237|NCT00435461|365312032|FG002|Overall Study|Compliance less than 80 percent|0|||
105905238|NCT00435461|365312030|FG000|Overall Study|In error, two study medications switched|1|||
105669483|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669484|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669485|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105905239|NCT00435461|365312031|FG001|Overall Study|In error, two study medications switched|0|||
105905240|NCT00435461|365312032|FG002|Overall Study|In error, two study medications switched|0|||
105905241|NCT00435461|365312030|FG000|Overall Study|Lack of Efficacy|2|||
105905242|NCT00435461|365312031|FG001|Overall Study|Lack of Efficacy|1|||
105905243|NCT00435461|365312032|FG002|Overall Study|Lack of Efficacy|0|||
105905244|NCT00435461|365312030|FG000|Overall Study|Withdrawal by Subject|1|||
105905245|NCT00435461|365312031|FG001|Overall Study|Withdrawal by Subject|0|||
105905246|NCT00435461|365312032|FG002|Overall Study|Withdrawal by Subject|2|||
105905247|NCT00435461|365312030|FG000|Overall Study|Randomized in error|1|||
105905248|NCT00435461|365312031|FG001|Overall Study|Randomized in error|0|||
105905249|NCT00435461|365312032|FG002|Overall Study|Randomized in error|0|||
105905250|NCT00435461|365312030|FG000|Overall Study|Participant could not tolerate symptoms|0|||
105905251|NCT00435461|365312031|FG001|Overall Study|Participant could not tolerate symptoms|0|||
105905252|NCT00435461|365312032|FG002|Overall Study|Participant could not tolerate symptoms|1|||
105905253|NCT00435461|365312030|FG000|Overall Study|Participant could not swallow capsule|0|||
105905254|NCT00435461|365312031|FG001|Overall Study|Participant could not swallow capsule|0|||
105905255|NCT00435461|365312032|FG002|Overall Study|Participant could not swallow capsule|1|||
105905256|NCT00435461|365312030|FG000|Overall Study|Pregnancy|2|||
105905257|NCT00435461|365312031|FG001|Overall Study|Pregnancy|0|||
105905258|NCT00435461|365312032|FG002|Overall Study|Pregnancy|0|||
105905259|NCT00435461|365312030|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
105905260|NCT00435461|365312031|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
105905261|NCT00435461|365312032|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
105905262|NCT00435461|365312030|FG000|Overall Study|Participant ended study one day early|1|||
105905263|NCT00435461|365312031|FG001|Overall Study|Participant ended study one day early|0|||
105905264|NCT00435461|365312032|FG002|Overall Study|Participant ended study one day early|0|||
105905265|NCT00435461|365312030|FG000|Overall Study|Noncompliance with study requirements|1|||
105905266|NCT00435461|365312031|FG001|Overall Study|Noncompliance with study requirements|1|||
105905267|NCT00435461|365312032|FG002|Overall Study|Noncompliance with study requirements|1|||
105905268|NCT00435461|365312030|FG000|Overall Study|Adverse Event|1|||
105905269|NCT00435461|365312031|FG001|Overall Study|Adverse Event|2|||
105905270|NCT00435461|365312032|FG002|Overall Study|Adverse Event|6|||
105905271|NCT00435461|365312030|FG000|Overall Study|Non-Compliance of diary|2|||
105905272|NCT00435461|365312031|FG001|Overall Study|Non-Compliance of diary|0|||
105905273|NCT00435461|365312032|FG002|Overall Study|Non-Compliance of diary|1|||
105905274|NCT00435461|365312030|FG000|Overall Study|Lost to Follow-up|1|||
105905275|NCT00435461|365312031|FG001|Overall Study|Lost to Follow-up|1|||
105905276|NCT00435461|365312032|FG002|Overall Study|Lost to Follow-up|2|||
105905277|NCT03224624|365312033|FG000|Overall Study|Lost to Follow-up|9|||
105905278|NCT03224624|365312034|FG001|Overall Study|Lost to Follow-up|4|||
105905279|NCT03224624|365312033|FG000|Overall Study|Death|1|||
105905280|NCT03224624|365312034|FG001|Overall Study|Death|0|||
105905281|NCT01884545|365312037|FG000|Overall Study|Lost to Follow-up|6|||
105905282|NCT01884545|365312038|FG001|Overall Study|Lost to Follow-up|4|||
105905283|NCT01884545|365312039|FG002|Overall Study|Lost to Follow-up|9|||
105905284|NCT01884545|365312040|FG003|Overall Study|Lost to Follow-up|4|||
105905285|NCT01884545|365312037|FG000|Overall Study|Patient withdrawn|7|||
105905286|NCT01884545|365312038|FG001|Overall Study|Patient withdrawn|12|||
105905287|NCT01884545|365312039|FG002|Overall Study|Patient withdrawn|5|||
105905288|NCT01884545|365312040|FG003|Overall Study|Patient withdrawn|5|||
105905289|NCT01884545|365312037|FG000|Overall Study|Non-adherence|0|||
105905290|NCT01884545|365312038|FG001|Overall Study|Non-adherence|2|||
105905291|NCT01884545|365312039|FG002|Overall Study|Non-adherence|0|||
105905292|NCT01884545|365312040|FG003|Overall Study|Non-adherence|0|||
105905293|NCT01424241|365312041|FG000|Overall Study|Withdrawal by Subject|1|||
105905294|NCT01424241|365312041|FG000|Overall Study|Time constraints|2|||
105905295|NCT02609984|365312050|FG000|Overall Study|Death|29|||
105669486|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
105669487|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
105905296|NCT02609984|365312051|FG001|Overall Study|Death|26|||
105905297|NCT02609984|365312050|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
105905298|NCT02609984|365312051|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
105905299|NCT02609984|365312050|FG000|Overall Study|Lost to Follow-up|1|||
105905300|NCT02609984|365312051|FG001|Overall Study|Lost to Follow-up|2|||
105905301|NCT02609984|365312050|FG000|Overall Study|Withdrawal by Subject|0|||
105905302|NCT02609984|365312051|FG001|Overall Study|Withdrawal by Subject|1|||
105905303|NCT02609984|365312050|FG000|Overall Study|Disease Progression|2|||
105905304|NCT02609984|365312051|FG001|Overall Study|Disease Progression|0|||
105905305|NCT02521792|365312052|FG000|Overall Study|Study Terminated|6|||
106125395|NCT02040090|366115928|FG000|Overall Study|Withdrawal by Subject|0|||
105905306|NCT00398047|365312053|FG000|Overall Study|all patient progressed before completion|3|||
105905307|NCT02306850|365312054|FG000|Overall Study|Lack of Efficacy|2|||
105669488|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
105669489|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
105669490|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
105905308|NCT01188668|365312055|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
105905309|NCT01188668|365312055|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
105905310|NCT01188668|365312055|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
105905311|NCT05259917|365312056|FG000|Overall Study|Protocol Violation|0|||
105905312|NCT05259917|365312057|FG001|Overall Study|Protocol Violation|0|||
105905313|NCT05259917|365312058|FG002|Overall Study|Protocol Violation|1|||
105905314|NCT05259917|365312059|FG003|Overall Study|Protocol Violation|0|||
105905315|NCT05259917|365312060|FG004|Overall Study|Protocol Violation|0|||
105905316|NCT05259917|365312061|FG005|Overall Study|Protocol Violation|0|||
105905317|NCT05259917|365312056|FG000|Overall Study|Lost to Follow-up|0|||
105905318|NCT05259917|365312057|FG001|Overall Study|Lost to Follow-up|0|||
105905319|NCT05259917|365312058|FG002|Overall Study|Lost to Follow-up|1|||
105905320|NCT05259917|365312059|FG003|Overall Study|Lost to Follow-up|0|||
105905321|NCT05259917|365312060|FG004|Overall Study|Lost to Follow-up|0|||
105905322|NCT05259917|365312061|FG005|Overall Study|Lost to Follow-up|1|||
105905323|NCT05259917|365312056|FG000|Overall Study|Physician Decision|0|||
105905324|NCT05259917|365312057|FG001|Overall Study|Physician Decision|1|||
105905325|NCT05259917|365312058|FG002|Overall Study|Physician Decision|0|||
105905326|NCT05259917|365312059|FG003|Overall Study|Physician Decision|0|||
105905327|NCT05259917|365312060|FG004|Overall Study|Physician Decision|0|||
105905328|NCT05259917|365312061|FG005|Overall Study|Physician Decision|0|||
105905329|NCT05259917|365312056|FG000|Overall Study|Withdrawal by Subject|0|||
105905330|NCT05259917|365312057|FG001|Overall Study|Withdrawal by Subject|1|||
105905331|NCT05259917|365312058|FG002|Overall Study|Withdrawal by Subject|0|||
105905332|NCT05259917|365312059|FG003|Overall Study|Withdrawal by Subject|0|||
105905333|NCT05259917|365312060|FG004|Overall Study|Withdrawal by Subject|1|||
105905334|NCT05259917|365312061|FG005|Overall Study|Withdrawal by Subject|1|||
105905335|NCT05259917|365312056|FG000|Overall Study|Trial Termination by Sponsor|7|||
105905336|NCT05259917|365312057|FG001|Overall Study|Trial Termination by Sponsor|2|||
105905337|NCT05259917|365312058|FG002|Overall Study|Trial Termination by Sponsor|3|||
105905338|NCT05259917|365312059|FG003|Overall Study|Trial Termination by Sponsor|5|||
105905339|NCT05259917|365312060|FG004|Overall Study|Trial Termination by Sponsor|11|||
105905340|NCT05259917|365312061|FG005|Overall Study|Trial Termination by Sponsor|4|||
105905341|NCT05259917|365312056|FG000|Overall Study|Other|1|||
105905342|NCT05259917|365312057|FG001|Overall Study|Other|0|||
105905343|NCT05259917|365312058|FG002|Overall Study|Other|2|||
105905344|NCT05259917|365312059|FG003|Overall Study|Other|0|||
105905345|NCT05259917|365312060|FG004|Overall Study|Other|0|||
105905346|NCT05259917|365312061|FG005|Overall Study|Other|0|||
105905347|NCT00770913|365312062|FG000|Overall Study|Adverse Event|1|||
105905348|NCT00770913|365312063|FG001|Overall Study|Adverse Event|3|||
105905349|NCT00770913|365312064|FG002|Overall Study|Adverse Event|6|||
105905350|NCT00770913|365312062|FG000|Overall Study|Refusal to continue participation|6|||
105905351|NCT00770913|365312063|FG001|Overall Study|Refusal to continue participation|4|||
105905352|NCT00770913|365312064|FG002|Overall Study|Refusal to continue participation|5|||
105905353|NCT00770913|365312062|FG000|Overall Study|Physician Decision|0|||
105905354|NCT00770913|365312063|FG001|Overall Study|Physician Decision|1|||
105905355|NCT00770913|365312064|FG002|Overall Study|Physician Decision|1|||
105905356|NCT00770913|365312062|FG000|Overall Study|Protocol Violation|3|||
105905357|NCT00770913|365312063|FG001|Overall Study|Protocol Violation|0|||
105905358|NCT00770913|365312064|FG002|Overall Study|Protocol Violation|1|||
105905359|NCT00770913|365312062|FG000|Overall Study|Incorrect drug was allocated|1|||
105905360|NCT00770913|365312063|FG001|Overall Study|Incorrect drug was allocated|0|||
105905361|NCT00770913|365312064|FG002|Overall Study|Incorrect drug was allocated|0|||
105905362|NCT04633226|365312065|FG000|Overall Study|Withdrawal by parent/guardian|4|||
105905363|NCT04633226|365312065|FG000|Overall Study|Randomized by mistake without study treatment|1|||
105905364|NCT01151345|365312069|FG000|First Intervention Period|Protocol Violation|0|||
105905365|NCT01151345|365312070|FG001|First Intervention Period|Protocol Violation|1|||
105905366|NCT01348100|365312073|FG000|Overall Study|Subject Withdrew Consent|0|||
105905367|NCT01348100|365312074|FG001|Overall Study|Subject Withdrew Consent|0|||
105905368|NCT01348100|365312075|FG002|Overall Study|Subject Withdrew Consent|2|||
105905369|NCT01348100|365312076|FG003|Overall Study|Subject Withdrew Consent|0|||
105905370|NCT01348100|365312077|FG004|Overall Study|Subject Withdrew Consent|1|||
105905371|NCT01348100|365312078|FG005|Overall Study|Subject Withdrew Consent|0|||
105905372|NCT01348100|365312079|FG006|Overall Study|Subject Withdrew Consent|1|||
105905373|NCT01348100|365312073|FG000|Overall Study|Protocol Deviation|0|||
105905374|NCT01348100|365312074|FG001|Overall Study|Protocol Deviation|0|||
105905375|NCT01348100|365312075|FG002|Overall Study|Protocol Deviation|0|||
105905376|NCT01348100|365312076|FG003|Overall Study|Protocol Deviation|1|||
105905377|NCT01348100|365312077|FG004|Overall Study|Protocol Deviation|0|||
105905378|NCT01348100|365312078|FG005|Overall Study|Protocol Deviation|0|||
105905379|NCT01348100|365312079|FG006|Overall Study|Protocol Deviation|0|||
105905380|NCT01348100|365312073|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105905381|NCT01348100|365312074|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105905382|NCT01348100|365312075|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105905383|NCT01348100|365312076|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105905384|NCT01348100|365312077|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105905385|NCT01348100|365312078|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105905386|NCT01348100|365312079|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105905387|NCT01348100|365312073|FG000|Overall Study|Lost to Follow-up|0|||
105905388|NCT01348100|365312074|FG001|Overall Study|Lost to Follow-up|0|||
105905389|NCT01348100|365312075|FG002|Overall Study|Lost to Follow-up|0|||
105905390|NCT01348100|365312076|FG003|Overall Study|Lost to Follow-up|0|||
105905391|NCT01348100|365312077|FG004|Overall Study|Lost to Follow-up|0|||
105905392|NCT01348100|365312078|FG005|Overall Study|Lost to Follow-up|0|||
105905393|NCT01348100|365312079|FG006|Overall Study|Lost to Follow-up|1|||
105905394|NCT01348100|365312073|FG000|Overall Study|Administrative Problems|0|||
105905395|NCT01348100|365312074|FG001|Overall Study|Administrative Problems|0|||
105905396|NCT01348100|365312075|FG002|Overall Study|Administrative Problems|0|||
105905397|NCT01348100|365312076|FG003|Overall Study|Administrative Problems|0|||
105905398|NCT01348100|365312077|FG004|Overall Study|Administrative Problems|0|||
105905399|NCT01348100|365312078|FG005|Overall Study|Administrative Problems|1|||
105905400|NCT01348100|365312079|FG006|Overall Study|Administrative Problems|1|||
105905401|NCT04186221|365312082|FG000|Overall Study|Death|1|||
105905402|NCT01134393|365312083|FG000|Overall Study|Adverse Event|18|||
105905403|NCT01134393|365312083|FG000|Overall Study|Lack of Efficacy|2|||
105905404|NCT01134393|365312083|FG000|Overall Study|Protocol Violation|12|||
105905405|NCT01134393|365312083|FG000|Overall Study|Lost to Follow-up|3|||
105905406|NCT01134393|365312083|FG000|Overall Study|Withdrawal by Subject|11|||
105905407|NCT01134393|365312083|FG000|Overall Study|Other|6|||
105905408|NCT00985686|365312088|FG000|Overall Study|Lost to Follow-up|1|||
105905409|NCT00985686|365312089|FG001|Overall Study|Lost to Follow-up|1|||
105905410|NCT00985686|365312090|FG002|Overall Study|Lost to Follow-up|0|||
105905411|NCT00985686|365312091|FG003|Overall Study|Lost to Follow-up|2|||
105905412|NCT03134911|365312092|FG000|Overall Study|Screen failure|31|||
105905413|NCT03134911|365312092|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
105905414|NCT04074330|365312095|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
105905415|NCT04074330|365312096|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
105905416|NCT04074330|365312097|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
105905417|NCT04074330|365312098|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
105905418|NCT04074330|365312099|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
105905419|NCT04074330|365312100|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
105905420|NCT04074330|365312101|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
105905421|NCT04074330|365312102|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
105905422|NCT04074330|365312103|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
105905423|NCT04074330|365312104|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
105905424|NCT04074330|365312095|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
105905425|NCT04074330|365312096|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
105905426|NCT04074330|365312097|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
105905427|NCT04074330|365312098|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
105905428|NCT04074330|365312099|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
105905429|NCT04074330|365312100|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
105905430|NCT04074330|365312101|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
105905431|NCT04074330|365312102|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
105905432|NCT04074330|365312103|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
105905433|NCT04074330|365312104|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
105905434|NCT04074330|365312095|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105905435|NCT04074330|365312096|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105905436|NCT04074330|365312097|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
105905437|NCT04074330|365312098|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105905438|NCT04074330|365312099|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105905439|NCT04074330|365312100|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105905440|NCT04074330|365312101|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105905441|NCT04074330|365312102|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105998322|NCT02775916|365654913|FG000|Overall Study|Subject/Guardian Decision|2|||
105998323|NCT02775916|365654914|FG001|Overall Study|Subject/Guardian Decision|0|||
106125396|NCT02040090|366115929|FG001|Overall Study|Withdrawal by Subject|1|||
106125397|NCT02040090|366115928|FG000|Overall Study|Lost to Follow-up|0|||
106125398|NCT02040090|366115929|FG001|Overall Study|Lost to Follow-up|1|||
105905442|NCT04074330|365312103|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105905443|NCT04074330|365312104|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
105905444|NCT04074330|365312095|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105998324|NCT03310723|365656151|FG000|Overall Study|Withdrawal by Subject|0|||
106125399|NCT00776100|366115935|FG000|Overall Study|Disease Progression|1|||
106125400|NCT00776100|366115936|FG001|Overall Study|Disease Progression|0|||
105905445|NCT04074330|365312096|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105905446|NCT04074330|365312097|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105905447|NCT04074330|365312098|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105905448|NCT04074330|365312099|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105905449|NCT04074330|365312100|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
105905450|NCT04074330|365312101|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105905451|NCT04074330|365312102|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
105905452|NCT04074330|365312103|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105905453|NCT04074330|365312104|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
105905454|NCT04074330|365312095|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
105905455|NCT04074330|365312096|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
105905456|NCT04074330|365312097|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
105905457|NCT04074330|365312098|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105905458|NCT04074330|365312099|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
105905459|NCT04074330|365312100|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
105905460|NCT04074330|365312101|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105905461|NCT04074330|365312102|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105905462|NCT04074330|365312103|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105905463|NCT04074330|365312104|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
105905464|NCT04074330|365312095|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105905465|NCT04074330|365312096|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
105905466|NCT04074330|365312097|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
105905467|NCT04074330|365312098|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
105905468|NCT04074330|365312099|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105905469|NCT04074330|365312100|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
105905470|NCT04074330|365312101|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105905471|NCT04074330|365312102|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105905472|NCT04074330|365312103|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105905473|NCT04074330|365312104|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
105905474|NCT04074330|365312095|FG000|Dose Expansion (up to 42 Months)|Death|0|||
105905475|NCT04074330|365312096|FG001|Dose Expansion (up to 42 Months)|Death|0|||
105905476|NCT04074330|365312097|FG002|Dose Expansion (up to 42 Months)|Death|0|||
105905477|NCT04074330|365312098|FG003|Dose Expansion (up to 42 Months)|Death|0|||
105905478|NCT04074330|365312099|FG004|Dose Expansion (up to 42 Months)|Death|0|||
105905479|NCT04074330|365312100|FG005|Dose Expansion (up to 42 Months)|Death|0|||
105905480|NCT04074330|365312101|FG006|Dose Expansion (up to 42 Months)|Death|0|||
105905481|NCT04074330|365312102|FG007|Dose Expansion (up to 42 Months)|Death|0|||
105905482|NCT04074330|365312103|FG008|Dose Expansion (up to 42 Months)|Death|1|||
105905483|NCT04074330|365312104|FG009|Dose Expansion (up to 42 Months)|Death|0|||
105905484|NCT04074330|365312095|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105905485|NCT04074330|365312096|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105905486|NCT04074330|365312097|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105905487|NCT04074330|365312098|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105905488|NCT04074330|365312099|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105905489|NCT04074330|365312100|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105905490|NCT04074330|365312101|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105905491|NCT04074330|365312102|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
105905492|NCT04074330|365312103|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
105905493|NCT04074330|365312104|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
105905494|NCT00184093|365312105|FG000|Overall Study|Adverse Event|3|||
105905495|NCT00184093|365312105|FG000|Overall Study|Lost to Follow-up|3|||
105905496|NCT00184093|365312105|FG000|Overall Study|Physician Decision|1|||
105905497|NCT00184093|365312105|FG000|Overall Study|Withdrawal by Subject|2|||
105905498|NCT05095311|365312108|FG000|Overall Study|Lost to Follow-up|7|||
105905499|NCT05095311|365312109|FG001|Overall Study|Lost to Follow-up|0|||
105905500|NCT05095311|365312110|FG002|Overall Study|Lost to Follow-up|0|||
105905501|NCT02500719|365312116|FG000|Overall Study|Lost to Follow-up|2|||
105905502|NCT02500719|365312117|FG001|Overall Study|Lost to Follow-up|3|||
105905503|NCT02500719|365312116|FG000|Overall Study|Trauma history|1|||
105905504|NCT02500719|365312117|FG001|Overall Study|Trauma history|0|||
105905505|NCT02500719|365312116|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
105905506|NCT02500719|365312117|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
105905507|NCT02500719|365312116|FG000|Overall Study|Did not meet criteria for PTSD|0|||
106125401|NCT01163747|366115937|FG000|Overall Study|Adverse Event|0|||
106125402|NCT01163747|366115938|FG001|Overall Study|Adverse Event|5|||
106125403|NCT01163747|366115937|FG000|Overall Study|Insufficient Therapeutic Response|0|||
105905508|NCT02500719|365312117|FG001|Overall Study|Did not meet criteria for PTSD|1|||
105905509|NCT02500719|365312116|FG000|Overall Study|Claustrophobia|0|||
106125404|NCT01163747|366115938|FG001|Overall Study|Insufficient Therapeutic Response|1|||
106125405|NCT01163747|366115937|FG000|Overall Study|Protocol Violation|0|||
106125406|NCT01163747|366115938|FG001|Overall Study|Protocol Violation|1|||
106125407|NCT01163747|366115937|FG000|Overall Study|Refused Treatment|6|||
106125408|NCT01163747|366115938|FG001|Overall Study|Refused Treatment|4|||
106125409|NCT01189890|366117737|FG000|Overall Study|Adverse Event|3|||
106125410|NCT01189890|366117738|FG001|Overall Study|Adverse Event|4|||
105905510|NCT02500719|365312117|FG001|Overall Study|Claustrophobia|1|||
105905511|NCT02500719|365312116|FG000|Overall Study|History of head trauma|0|||
105905512|NCT02500719|365312117|FG001|Overall Study|History of head trauma|1|||
105905513|NCT02787083|365312118|FG000|Overall Study|Adverse Event|1|||
105905514|NCT02787083|365312119|FG001|Overall Study|Adverse Event|0|||
105905515|NCT02787083|365312118|FG000|Overall Study|Withdrawal by Subject|2|||
105905516|NCT02787083|365312119|FG001|Overall Study|Withdrawal by Subject|2|||
105905517|NCT02710084|365312122|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
105905518|NCT02710084|365312123|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
105905519|NCT05305989|365312124|FG000|Overall Study|Other|3|||
105905520|NCT05305989|365312125|FG001|Overall Study|Other|2|||
105905521|NCT05305989|365312126|FG002|Overall Study|Other|0|||
105905522|NCT05305989|365312124|FG000|Overall Study|Sponsor decision|2|||
105905523|NCT05305989|365312125|FG001|Overall Study|Sponsor decision|1|||
105905524|NCT05305989|365312126|FG002|Overall Study|Sponsor decision|0|||
105905525|NCT05305989|365312124|FG000|Overall Study|Protocol Violation|0|||
105905526|NCT05305989|365312125|FG001|Overall Study|Protocol Violation|1|||
105905527|NCT05305989|365312126|FG002|Overall Study|Protocol Violation|0|||
105905528|NCT05305989|365312124|FG000|Overall Study|Investigator decision|1|||
105905529|NCT05305989|365312125|FG001|Overall Study|Investigator decision|2|||
105905530|NCT05305989|365312126|FG002|Overall Study|Investigator decision|0|||
105905531|NCT05305989|365312124|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
105905532|NCT05305989|365312125|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
105905533|NCT05305989|365312126|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
105905534|NCT05305989|365312124|FG000|Overall Study|Adverse Event|1|||
105905535|NCT05305989|365312125|FG001|Overall Study|Adverse Event|1|||
105905536|NCT05305989|365312126|FG002|Overall Study|Adverse Event|0|||
105905537|NCT05305989|365312124|FG000|Overall Study|Enrolled but never dosed|3|||
105905538|NCT05305989|365312125|FG001|Overall Study|Enrolled but never dosed|2|||
105905539|NCT05305989|365312126|FG002|Overall Study|Enrolled but never dosed|1|||
105905540|NCT03162328|365312127|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
105905541|NCT03162328|365312128|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
105905542|NCT03162328|365312129|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
105905543|NCT03162328|365312127|FG000|Screening Period|Withdrawal by Subject|1|||
105905544|NCT03162328|365312128|FG001|Screening Period|Withdrawal by Subject|0|||
105905545|NCT03162328|365312129|FG002|Screening Period|Withdrawal by Subject|0|||
105905546|NCT03162328|365312127|FG000|Study Period|Withdrawal by Subject|0|||
105905547|NCT03162328|365312128|FG001|Study Period|Withdrawal by Subject|0|||
105905548|NCT03162328|365312129|FG002|Study Period|Withdrawal by Subject|1|||
105905549|NCT02453256|365312131|FG000|Double Blind Period|Death|1|||
105905550|NCT02453256|365312132|FG001|Double Blind Period|Death|1|||
105905551|NCT02453256|365312131|FG000|Double Blind Period|Adverse Event|3|||
105905552|NCT02453256|365312132|FG001|Double Blind Period|Adverse Event|2|||
105905553|NCT02453256|365312131|FG000|Double Blind Period|Withdrawal by Subject|9|||
105905554|NCT02453256|365312132|FG001|Double Blind Period|Withdrawal by Subject|5|||
105905555|NCT02453256|365312131|FG000|Double Blind Period|Other|0|||
105905556|NCT02453256|365312132|FG001|Double Blind Period|Other|1|||
105905557|NCT02453256|365312131|FG000|Open Label Period|Adverse Event|1|||
105905558|NCT02453256|365312132|FG001|Open Label Period|Adverse Event|3|||
105905559|NCT02453256|365312131|FG000|Open Label Period|Death|0|||
105905560|NCT02453256|365312132|FG001|Open Label Period|Death|1|||
105905561|NCT02453256|365312131|FG000|Open Label Period|Lost to Follow-up|1|||
105905562|NCT02453256|365312132|FG001|Open Label Period|Lost to Follow-up|0|||
106125411|NCT01189890|366117737|FG000|Overall Study|Lack of Efficacy|7|||
105905563|NCT02453256|365312131|FG000|Open Label Period|Other|0|||
105905564|NCT02453256|365312132|FG001|Open Label Period|Other|2|||
105905565|NCT02453256|365312131|FG000|Open Label Period|Withdrawal by Subject|5|||
105905566|NCT02453256|365312132|FG001|Open Label Period|Withdrawal by Subject|1|||
106125412|NCT01189890|366117738|FG001|Overall Study|Lack of Efficacy|2|||
106125413|NCT01189890|366117737|FG000|Overall Study|Lost to Follow-up|1|||
105905567|NCT01124292|365312133|FG000|Overall Study|Lost to Follow-up|2|||
105905568|NCT01124292|365312134|FG001|Overall Study|Lost to Follow-up|4|||
105905569|NCT01124292|365312135|FG002|Overall Study|Lost to Follow-up|3|||
105905570|NCT01124292|365312133|FG000|Overall Study|Physician Decision|0|||
105905571|NCT01124292|365312134|FG001|Overall Study|Physician Decision|3|||
105905572|NCT01124292|365312135|FG002|Overall Study|Physician Decision|2|||
105905573|NCT01124292|365312133|FG000|Overall Study|Withdrawal by Subject|0|||
106125414|NCT01189890|366117738|FG001|Overall Study|Lost to Follow-up|7|||
105905574|NCT01124292|365312134|FG001|Overall Study|Withdrawal by Subject|6|||
105905575|NCT01124292|365312135|FG002|Overall Study|Withdrawal by Subject|2|||
105905576|NCT01124292|365312133|FG000|Overall Study|medical issue unrelated to the study|0|||
105905577|NCT01124292|365312134|FG001|Overall Study|medical issue unrelated to the study|0|||
105905578|NCT01124292|365312135|FG002|Overall Study|medical issue unrelated to the study|2|||
105905579|NCT01124292|365312133|FG000|Overall Study|piercing track closed|0|||
105905580|NCT01124292|365312134|FG001|Overall Study|piercing track closed|2|||
105905581|NCT01124292|365312135|FG002|Overall Study|piercing track closed|1|||
105905582|NCT04227405|365313945|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
105905583|NCT04227405|365313946|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
105905584|NCT04227405|365313945|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
105905585|NCT04227405|365313946|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
105905586|NCT04227405|365313945|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
105905587|NCT04227405|365313946|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
105905588|NCT02447328|365313947|FG000|Overall Study|Withdrawal by Subject|1|||
105905589|NCT01128400|365313948|FG000|Overall Study|Lost to Follow-up|1|||
105905590|NCT01128400|365313949|FG001|Overall Study|Lost to Follow-up|0|||
105905591|NCT01128400|365313950|FG002|Overall Study|Lost to Follow-up|1|||
105905592|NCT01128400|365313948|FG000|Overall Study|Screening failure|1|||
105905593|NCT01128400|365313949|FG001|Overall Study|Screening failure|0|||
105905594|NCT01128400|365313950|FG002|Overall Study|Screening failure|0|||
105905595|NCT01128400|365313948|FG000|Overall Study|were not invited to participate on taste|0|||
105905596|NCT01128400|365313949|FG001|Overall Study|were not invited to participate on taste|0|||
105905597|NCT01128400|365313950|FG002|Overall Study|were not invited to participate on taste|15|||
105905598|NCT01128400|365313948|FG000|Overall Study|Excluded due to sinus problems|0|||
105905599|NCT01128400|365313949|FG001|Overall Study|Excluded due to sinus problems|1|||
105905600|NCT01128400|365313950|FG002|Overall Study|Excluded due to sinus problems|0|||
105905601|NCT04304508|365313951|FG000|Overall Study|Subject Decision|29|||
105905602|NCT04304508|365313952|FG001|Overall Study|Subject Decision|39|||
105905603|NCT04304508|365313953|FG002|Overall Study|Subject Decision|37|||
105905604|NCT04304508|365313954|FG003|Overall Study|Subject Decision|48|||
105905605|NCT04304508|365313951|FG000|Overall Study|Death|6|||
105905606|NCT04304508|365313952|FG001|Overall Study|Death|1|||
105905607|NCT04304508|365313953|FG002|Overall Study|Death|8|||
105905608|NCT04304508|365313954|FG003|Overall Study|Death|5|||
105905609|NCT04304508|365313951|FG000|Overall Study|Non-compliance With Study Drug|3|||
105905610|NCT04304508|365313952|FG001|Overall Study|Non-compliance With Study Drug|1|||
105905611|NCT04304508|365313953|FG002|Overall Study|Non-compliance With Study Drug|2|||
105905612|NCT04304508|365313954|FG003|Overall Study|Non-compliance With Study Drug|0|||
105905613|NCT04304508|365313951|FG000|Overall Study|Switching To Other Therapy|1|||
105905614|NCT04304508|365313952|FG001|Overall Study|Switching To Other Therapy|1|||
105905615|NCT04304508|365313953|FG002|Overall Study|Switching To Other Therapy|1|||
105905616|NCT04304508|365313954|FG003|Overall Study|Switching To Other Therapy|2|||
105905617|NCT04304508|365313951|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
105905618|NCT04304508|365313952|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
105905619|NCT04304508|365313953|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
105905620|NCT04304508|365313954|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
105905621|NCT04304508|365313951|FG000|Overall Study|Withdrawal by Subject|7|||
105905622|NCT04304508|365313952|FG001|Overall Study|Withdrawal by Subject|5|||
105905623|NCT04304508|365313953|FG002|Overall Study|Withdrawal by Subject|11|||
105905624|NCT04304508|365313954|FG003|Overall Study|Withdrawal by Subject|6|||
105905625|NCT04304508|365313951|FG000|Overall Study|Logistical Difficulties|2|||
105905626|NCT04304508|365313952|FG001|Overall Study|Logistical Difficulties|2|||
105905627|NCT04304508|365313953|FG002|Overall Study|Logistical Difficulties|3|||
105905628|NCT04304508|365313954|FG003|Overall Study|Logistical Difficulties|2|||
105905629|NCT04304508|365313951|FG000|Overall Study|Missing Information|1|||
105905630|NCT04304508|365313952|FG001|Overall Study|Missing Information|2|||
105905631|NCT04304508|365313953|FG002|Overall Study|Missing Information|1|||
105905632|NCT04304508|365313954|FG003|Overall Study|Missing Information|3|||
105905633|NCT04304508|365313951|FG000|Overall Study|Other|7|||
105905634|NCT04304508|365313952|FG001|Overall Study|Other|6|||
105905635|NCT04304508|365313953|FG002|Overall Study|Other|5|||
105905636|NCT04304508|365313954|FG003|Overall Study|Other|4|||
105998325|NCT03310723|365656152|FG001|Overall Study|Withdrawal by Subject|1|||
105905637|NCT04304508|365313951|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
105905638|NCT04304508|365313952|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
105905639|NCT04304508|365313953|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
105905640|NCT04304508|365313954|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
105905641|NCT04304508|365313951|FG000|Overall Study|Physician Decision|3|||
105905642|NCT04304508|365313952|FG001|Overall Study|Physician Decision|4|||
105905643|NCT04304508|365313953|FG002|Overall Study|Physician Decision|9|||
105905644|NCT04304508|365313954|FG003|Overall Study|Physician Decision|7|||
105905645|NCT04304508|365313951|FG000|Overall Study|Study drug never administered|10|||
105905646|NCT04304508|365313952|FG001|Overall Study|Study drug never administered|4|||
105669491|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669492|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669493|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669494|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669495|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669496|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669497|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669498|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669499|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
105669500|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
105669501|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
105669502|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
105669503|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669504|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669505|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105905647|NCT04304508|365313953|FG002|Overall Study|Study drug never administered|4|||
105669506|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669507|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669508|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669509|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669510|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669511|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
105669512|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
105669513|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
105669514|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
105669515|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669516|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669517|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669518|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669519|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669520|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669521|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669522|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669523|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
105669524|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
105669525|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
105669526|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
105669527|NCT01646177|364454013|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669528|NCT01646177|364454014|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669529|NCT01646177|364454015|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669530|NCT01646177|364454016|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669531|NCT01646177|364454017|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669532|NCT01646177|364454018|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669533|NCT01646177|364454019|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669534|NCT01646177|364454020|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669535|NCT01646177|364454021|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669536|NCT01646177|364454022|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
105669537|NCT01646177|364454023|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
105669538|NCT01646177|364454024|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
105669539|NCT00468143|364454028|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
105669540|NCT00468143|364454029|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
105669541|NCT00468143|364454028|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
105669542|NCT00468143|364454029|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
105669543|NCT01711853|364454030|FG000|Overall Study|Not treated|3|||
105669544|NCT01606670|364454031|FG000|Overall Study|Adverse Event|6|||
105669545|NCT01606670|364454031|FG000|Overall Study|Lack of Efficacy|2|||
105669546|NCT01606670|364454031|FG000|Overall Study|Lost to Follow-up|3|||
105669547|NCT01606670|364454031|FG000|Overall Study|Withdrawal by Subject|3|||
105669548|NCT01606670|364454031|FG000|Overall Study|Other Reason|2|||
105669549|NCT02636725|364454033|FG000|Overall Study|Adverse Event|1|||
105669550|NCT01038427|364454034|FG000|Overall Study|Lost to follow up|1|||
105669551|NCT01038427|364454035|FG001|Overall Study|Lost to follow up|1|||
105669552|NCT01038427|364454036|FG002|Overall Study|Lost to follow up|0|||
105669553|NCT01038427|364454034|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
105669554|NCT01038427|364454035|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
105669555|NCT01038427|364454036|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
105905648|NCT04304508|365313954|FG003|Overall Study|Study drug never administered|4|||
105905649|NCT04304508|365313951|FG000|Overall Study|Adverse Event|49|||
105905650|NCT04304508|365313952|FG001|Overall Study|Adverse Event|50|||
105905651|NCT04304508|365313953|FG002|Overall Study|Adverse Event|51|||
105905652|NCT04304508|365313954|FG003|Overall Study|Adverse Event|56|||
105905653|NCT04304508|365313951|FG000|Overall Study|Lost to Follow-up|1|||
105905654|NCT04304508|365313952|FG001|Overall Study|Lost to Follow-up|5|||
105905655|NCT04304508|365313953|FG002|Overall Study|Lost to Follow-up|2|||
105905656|NCT04304508|365313954|FG003|Overall Study|Lost to Follow-up|3|||
105905657|NCT02113007|365313961|FG000|Overall Study|Progressive disease|2|||
105905658|NCT04750278|365313963|FG000|Overall Study|Death|9|||
105905659|NCT04750278|365313964|FG001|Overall Study|Death|10|||
105905660|NCT04750278|365313965|FG002|Overall Study|Death|10|||
105905661|NCT04750278|365313963|FG000|Overall Study|Withdrawal by Subject|4|||
105905662|NCT04750278|365313964|FG001|Overall Study|Withdrawal by Subject|1|||
105905663|NCT04750278|365313965|FG002|Overall Study|Withdrawal by Subject|2|||
105905664|NCT04750278|365313963|FG000|Overall Study|Lost to Follow-up|1|||
105905665|NCT04750278|365313964|FG001|Overall Study|Lost to Follow-up|1|||
105905666|NCT04750278|365313965|FG002|Overall Study|Lost to Follow-up|1|||
105905667|NCT04750278|365313963|FG000|Overall Study|Pregnancy|1|||
105905668|NCT04750278|365313964|FG001|Overall Study|Pregnancy|0|||
105905669|NCT04750278|365313965|FG002|Overall Study|Pregnancy|0|||
105905670|NCT04750278|365313963|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
105905671|NCT04750278|365313964|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
105905672|NCT04750278|365313965|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
105905673|NCT04750278|365313963|FG000|Overall Study|Non-compliance|0|||
105905674|NCT04750278|365313964|FG001|Overall Study|Non-compliance|0|||
105905675|NCT04750278|365313965|FG002|Overall Study|Non-compliance|1|||
105905676|NCT04750278|365313963|FG000|Overall Study|Transfer to Outside Facility|0|||
105905677|NCT04750278|365313964|FG001|Overall Study|Transfer to Outside Facility|2|||
105905678|NCT04750278|365313965|FG002|Overall Study|Transfer to Outside Facility|1|||
105905679|NCT04750278|365313963|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
105905680|NCT04750278|365313964|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
105905681|NCT04750278|365313965|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
105905682|NCT04750278|365313963|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
105905683|NCT04750278|365313964|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
105905684|NCT04750278|365313965|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
105905685|NCT02579382|365313966|FG000|Main Study Phase|Lost to Follow-up|0|||
105905686|NCT02579382|365313967|FG001|Main Study Phase|Lost to Follow-up|0|||
105905687|NCT02579382|365313968|FG002|Main Study Phase|Lost to Follow-up|2|||
105905688|NCT02579382|365313969|FG003|Main Study Phase|Lost to Follow-up|0|||
105905689|NCT02579382|365313966|FG000|Main Study Phase|Withdrew Consent|0|||
105905690|NCT02579382|365313967|FG001|Main Study Phase|Withdrew Consent|0|||
105905691|NCT02579382|365313968|FG002|Main Study Phase|Withdrew Consent|0|||
105905692|NCT02579382|365313969|FG003|Main Study Phase|Withdrew Consent|2|||
105905693|NCT02579382|365313966|FG000|Main Study Phase|Lack of Efficacy|0|||
105905694|NCT02579382|365313967|FG001|Main Study Phase|Lack of Efficacy|0|||
105905695|NCT02579382|365313968|FG002|Main Study Phase|Lack of Efficacy|0|||
105905696|NCT02579382|365313969|FG003|Main Study Phase|Lack of Efficacy|1|||
105905697|NCT02579382|365313966|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
105905698|NCT02579382|365313967|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
105905699|NCT02579382|365313968|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
105905700|NCT02579382|365313969|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
105905701|NCT02579382|365313966|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
105905702|NCT02579382|365313967|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
105905703|NCT02579382|365313968|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
105905704|NCT02579382|365313969|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
105905705|NCT02579382|365313966|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
105905706|NCT02579382|365313967|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
105905707|NCT02579382|365313968|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
105905708|NCT02579382|365313969|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
105905709|NCT02579382|365313966|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
105905710|NCT02579382|365313967|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
105905711|NCT02579382|365313968|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
106125415|NCT01189890|366117737|FG000|Overall Study|Protocol Violation|1|||
106125416|NCT01189890|366117738|FG001|Overall Study|Protocol Violation|5|||
105905712|NCT02579382|365313969|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
105905713|NCT02579382|365313966|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
105905714|NCT02579382|365313967|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
105905715|NCT02579382|365313968|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
105998326|NCT03310723|365656151|FG000|Overall Study|Protocol Violation|0|||
105998327|NCT03310723|365656152|FG001|Overall Study|Protocol Violation|2|||
105998328|NCT02098746|365656153|FG000|Overall Study|Changes of Investigator|2|||
105998329|NCT02098746|365656153|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105998330|NCT02098746|365656153|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
105998331|NCT02098746|365656153|FG000|Overall Study|Data Not Available After Treatment|1|||
105998332|NCT01410890|365656154|FG000|Overall Study|Withdrawal by Subject|0|||
105998333|NCT01410890|365656155|FG001|Overall Study|Withdrawal by Subject|1|||
105998334|NCT00330759|365656158|FG000|Overall Study|Death|316|||
105998335|NCT00330759|365656159|FG001|Overall Study|Death|310|||
105998336|NCT00330759|365656158|FG000|Overall Study|Disease progression|104|||
105998337|NCT00330759|365656159|FG001|Overall Study|Disease progression|126|||
105998338|NCT00330759|365656158|FG000|Overall Study|Withdrawal by Subject|143|||
105998339|NCT00330759|365656159|FG001|Overall Study|Withdrawal by Subject|124|||
105998340|NCT00330759|365656158|FG000|Overall Study|Adverse Event|48|||
105998341|NCT00330759|365656159|FG001|Overall Study|Adverse Event|36|||
105998342|NCT00330759|365656158|FG000|Overall Study|Participant request|31|||
105998343|NCT00330759|365656159|FG001|Overall Study|Participant request|22|||
105998344|NCT00330759|365656158|FG000|Overall Study|Lost to Follow-up|16|||
105998345|NCT00330759|365656159|FG001|Overall Study|Lost to Follow-up|22|||
105998346|NCT00330759|365656158|FG000|Overall Study|Noncompliance|15|||
105998347|NCT00330759|365656159|FG001|Overall Study|Noncompliance|17|||
105998348|NCT00330759|365656158|FG000|Overall Study|Physician Decision|1|||
105998349|NCT00330759|365656159|FG001|Overall Study|Physician Decision|2|||
105998350|NCT00330759|365656158|FG000|Overall Study|Protocol deviation|0|||
105998351|NCT00330759|365656159|FG001|Overall Study|Protocol deviation|2|||
105998352|NCT00330759|365656158|FG000|Overall Study|Ineligibility determined|2|||
105998353|NCT00330759|365656159|FG001|Overall Study|Ineligibility determined|1|||
105998354|NCT00330759|365656158|FG000|Overall Study|Other|36|||
105998355|NCT00330759|365656159|FG001|Overall Study|Other|44|||
105998356|NCT00786799|365656163|FG000|Overall Study|Lost to Follow-up|1|||
105998357|NCT00786799|365656164|FG001|Overall Study|Lost to Follow-up|1|||
105998358|NCT03922581|365656168|FG000|Overall Study|Lost to Follow-up|20|||
105998359|NCT03922581|365656169|FG001|Overall Study|Lost to Follow-up|9|||
105998360|NCT03922581|365656168|FG000|Overall Study|Physician Decision|1|||
105998361|NCT03922581|365656169|FG001|Overall Study|Physician Decision|1|||
105998362|NCT03922581|365656168|FG000|Overall Study|Withdrawal by Subject|1|||
105998363|NCT03922581|365656169|FG001|Overall Study|Withdrawal by Subject|0|||
105998364|NCT04685798|365656170|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
105998365|NCT01745367|365656171|FG000|Overall Study|Death|1|||
105998366|NCT01745367|365656172|FG001|Overall Study|Death|0|||
105998367|NCT01745367|365656171|FG000|Overall Study|Withdrawal by Subject|1|||
105998368|NCT01745367|365656172|FG001|Overall Study|Withdrawal by Subject|2|||
105998369|NCT01745367|365656171|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
105998370|NCT01745367|365656172|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
105998371|NCT01745367|365656171|FG000|Overall Study|Other Reasons Unspecified|0|||
105998372|NCT01745367|365656172|FG001|Overall Study|Other Reasons Unspecified|2|||
105998373|NCT01544920|365656173|FG000|Overall Study|Adverse Event|0|||
105998374|NCT01544920|365656174|FG001|Overall Study|Adverse Event|3|||
105998375|NCT01544920|365656173|FG000|Overall Study|Death|0|||
105998376|NCT01544920|365656174|FG001|Overall Study|Death|1|||
105998377|NCT01544920|365656173|FG000|Overall Study|Lost to Follow-up|11|||
105998378|NCT01544920|365656174|FG001|Overall Study|Lost to Follow-up|12|||
105998379|NCT01544920|365656173|FG000|Overall Study|Protocol Violation|0|||
105998380|NCT01544920|365656174|FG001|Overall Study|Protocol Violation|2|||
105998381|NCT01544920|365656173|FG000|Overall Study|Physician Decision|4|||
105998382|NCT01544920|365656174|FG001|Overall Study|Physician Decision|1|||
105998383|NCT01544920|365656173|FG000|Overall Study|Withdrawal by Subject|4|||
105998384|NCT01544920|365656174|FG001|Overall Study|Withdrawal by Subject|4|||
105998385|NCT02640547|365656175|FG000|Overall Study|Failure to Return|1|||
105998386|NCT02640547|365656175|FG000|Overall Study|Withdrawal by Subject|1|||
105998387|NCT02640547|365656175|FG000|Overall Study|Death|6|||
105998388|NCT02640547|365656175|FG000|Overall Study|Miscellaneous|3|||
105998389|NCT01367834|365656177|FG000|Overall Study|Withdrawal by Subject|2|||
105998390|NCT01367834|365656178|FG001|Overall Study|Withdrawal by Subject|2|||
105998391|NCT01367834|365656177|FG000|Overall Study|Study was ended.|0|||
105998392|NCT01367834|365656178|FG001|Overall Study|Study was ended.|1|||
105998393|NCT00474955|365656179|FG000|Overall Study|Adverse Event|2|||
105998394|NCT00474955|365656179|FG000|Overall Study|Drug unavailability|1|||
105998395|NCT00474955|365656179|FG000|Overall Study|Personal reasons|5|||
105998396|NCT01172535|365656186|FG000|Overall Study|Death|3|||
105998397|NCT01172535|365656186|FG000|Overall Study|Withdrawal by Subject|2|||
105998398|NCT01172535|365656186|FG000|Overall Study|Lost to Follow-up|1|||
105998399|NCT01172535|365656186|FG000|Overall Study|Ineligible at study entry|1|||
105998400|NCT01172535|365656186|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
105905716|NCT02579382|365313969|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
105905717|NCT02579382|365313966|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
105905718|NCT02579382|365313967|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
105905719|NCT02579382|365313968|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
105905720|NCT02579382|365313969|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
105905721|NCT01775787|365313970|FG000|First 7-10 Days|Adverse Event|0|||
105905722|NCT01775787|365313971|FG001|First 7-10 Days|Adverse Event|1|||
105905723|NCT01775787|365313970|FG000|First 7-10 Days|family emergency|0|||
105905724|NCT01775787|365313971|FG001|First 7-10 Days|family emergency|1|||
105905725|NCT01775787|365313970|FG000|First 7-10 Days|time commitment|0|||
105905726|NCT01775787|365313971|FG001|First 7-10 Days|time commitment|2|||
105905727|NCT01775787|365313970|FG000|First 7-10 Days|concerns with using IV|1|||
105669556|NCT01038427|364454034|FG000|Overall Study|Withdrew consent|0|||
105669557|NCT01038427|364454035|FG001|Overall Study|Withdrew consent|0|||
105669558|NCT01038427|364454036|FG002|Overall Study|Withdrew consent|1|||
105669559|NCT01038427|364454034|FG000|Overall Study|Adverse Event|2|||
105669560|NCT01038427|364454035|FG001|Overall Study|Adverse Event|2|||
105669561|NCT01038427|364454036|FG002|Overall Study|Adverse Event|1|||
105669562|NCT01038427|364454034|FG000|Overall Study|Enrolled in error|0|||
105669563|NCT01038427|364454035|FG001|Overall Study|Enrolled in error|1|||
105669564|NCT01038427|364454036|FG002|Overall Study|Enrolled in error|1|||
105669565|NCT01038427|364454034|FG000|Overall Study|Other|0|||
105669566|NCT01038427|364454035|FG001|Overall Study|Other|2|||
105669567|NCT01038427|364454036|FG002|Overall Study|Other|0|||
105669568|NCT01162863|364454039|FG000|Overall Study|Lack of Efficacy|1|||
105669569|NCT01162863|364454040|FG001|Overall Study|Lack of Efficacy|0|||
105669570|NCT01162863|364454041|FG002|Overall Study|Lack of Efficacy|0|||
105669571|NCT01162863|364454039|FG000|Overall Study|Adverse Event|0|||
105669572|NCT01162863|364454040|FG001|Overall Study|Adverse Event|1|||
105669573|NCT01162863|364454041|FG002|Overall Study|Adverse Event|0|||
105669574|NCT01912404|364454042|FG000|Overall Study|Due to personal reasons|1|||
105669575|NCT01912404|364454043|FG001|Overall Study|Due to personal reasons|0|||
105669576|NCT03538938|364454045|FG000|Overall Study|Death|0|||
105669577|NCT03538938|364454046|FG001|Overall Study|Death|0|||
105669578|NCT03538938|364454047|FG002|Overall Study|Death|2|||
105669579|NCT03538938|364454048|FG003|Overall Study|Death|0|||
105669580|NCT03538938|364454049|FG004|Overall Study|Death|0|||
105669581|NCT03538938|364454050|FG005|Overall Study|Death|1|||
105669582|NCT03538938|364454051|FG006|Overall Study|Death|0|||
105669583|NCT03538938|364454052|FG007|Overall Study|Death|1|||
105669584|NCT03538938|364454053|FG008|Overall Study|Death|1|||
105669585|NCT03538938|364454054|FG009|Overall Study|Death|1|||
105669586|NCT03538938|364454055|FG010|Overall Study|Death|0|||
105669587|NCT03538938|364454056|FG011|Overall Study|Death|0|||
105669588|NCT03538938|364454057|FG012|Overall Study|Death|1|||
105669589|NCT03538938|364454058|FG013|Overall Study|Death|1|||
105669590|NCT03538938|364454059|FG014|Overall Study|Death|0|||
105669591|NCT03538938|364454060|FG015|Overall Study|Death|1|||
105669592|NCT03538938|364454045|FG000|Overall Study|Withdrawal by Subject|4|||
105669593|NCT03538938|364454046|FG001|Overall Study|Withdrawal by Subject|6|||
105669594|NCT03538938|364454047|FG002|Overall Study|Withdrawal by Subject|5|||
105905728|NCT01775787|365313971|FG001|First 7-10 Days|concerns with using IV|2|||
105905729|NCT01775787|365313970|FG000|Second 7-10 Days|time commitment|0|||
105905730|NCT01775787|365313971|FG001|Second 7-10 Days|time commitment|1|||
105905731|NCT01775787|365313970|FG000|Second 7-10 Days|concerns with using IV|0|||
105905732|NCT01775787|365313971|FG001|Second 7-10 Days|concerns with using IV|1|||
105905733|NCT01299896|365313972|FG000|Overall Study|Withdrawal by Subject|1|||
105905734|NCT01299896|365313973|FG001|Overall Study|Withdrawal by Subject|7|||
105669595|NCT03538938|364454048|FG003|Overall Study|Withdrawal by Subject|3|||
105669596|NCT03538938|364454049|FG004|Overall Study|Withdrawal by Subject|0|||
105669597|NCT03538938|364454050|FG005|Overall Study|Withdrawal by Subject|0|||
105669598|NCT03538938|364454051|FG006|Overall Study|Withdrawal by Subject|3|||
105669599|NCT03538938|364454052|FG007|Overall Study|Withdrawal by Subject|1|||
105669600|NCT03538938|364454053|FG008|Overall Study|Withdrawal by Subject|5|||
105669601|NCT03538938|364454054|FG009|Overall Study|Withdrawal by Subject|1|||
105905735|NCT01299896|365313972|FG000|Overall Study|Lost to Follow-up|0|||
105905736|NCT01299896|365313973|FG001|Overall Study|Lost to Follow-up|11|||
105669602|NCT03538938|364454055|FG010|Overall Study|Withdrawal by Subject|2|||
105669603|NCT03538938|364454056|FG011|Overall Study|Withdrawal by Subject|1|||
105786071|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
105786072|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
105905737|NCT03252145|365313974|FG000|Overall Study|Withdrawal by Subject|1|||
105905738|NCT03252145|365313975|FG001|Overall Study|Withdrawal by Subject|0|||
105786073|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
105669604|NCT03538938|364454057|FG012|Overall Study|Withdrawal by Subject|3|||
105669605|NCT03538938|364454058|FG013|Overall Study|Withdrawal by Subject|0|||
105669606|NCT03538938|364454059|FG014|Overall Study|Withdrawal by Subject|2|||
105669607|NCT03538938|364454060|FG015|Overall Study|Withdrawal by Subject|4|||
105669608|NCT03538938|364454045|FG000|Overall Study|Incarcerated|0|||
105669609|NCT03538938|364454046|FG001|Overall Study|Incarcerated|0|||
105669610|NCT03538938|364454047|FG002|Overall Study|Incarcerated|0|||
105669611|NCT03538938|364454048|FG003|Overall Study|Incarcerated|0|||
105669612|NCT03538938|364454049|FG004|Overall Study|Incarcerated|0|||
105669613|NCT03538938|364454050|FG005|Overall Study|Incarcerated|0|||
105905739|NCT03252145|365313974|FG000|Overall Study|Complicating Disease|1|||
105905740|NCT03252145|365313975|FG001|Overall Study|Complicating Disease|2|||
105905741|NCT00759655|365313998|FG000|Overall Study|Termination of the study by sponsor|1|||
105905742|NCT01310127|365314001|FG000|Overall Study|Protocol Violation|1|||
105905743|NCT01310127|365314002|FG001|Overall Study|Protocol Violation|1|||
105905744|NCT01310127|365314001|FG000|Overall Study|advanced psc cataract outlier|1|||
105905745|NCT01310127|365314002|FG001|Overall Study|advanced psc cataract outlier|0|||
105905746|NCT00412932|365314003|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
105905747|NCT00412932|365314003|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
105905748|NCT00412932|365314003|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
105905749|NCT00412932|365314003|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
105905750|NCT00412932|365314003|FG000|Olmesartan (Olm) 20 mg|Other|1|||
105905751|NCT00412932|365314003|FG000|Olmesartan 40 mg|Adverse Event|4|||
105905752|NCT00412932|365314003|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
105905753|NCT00412932|365314003|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
105905754|NCT00412932|365314003|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
105905755|NCT00412932|365314003|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
105905756|NCT00412932|365314003|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
105905757|NCT00412932|365314003|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
105905758|NCT02849171|365314010|FG000|Overall Study|Withdrawal by Subject|1|||
105905759|NCT02849171|365314010|FG000|Overall Study|Not treated|1|||
105905760|NCT02090283|365314012|FG000|Overall Study|Withdrawal by Subject|6|||
105905761|NCT02090283|365314013|FG001|Overall Study|Withdrawal by Subject|6|||
105905762|NCT02090283|365314014|FG002|Overall Study|Withdrawal by Subject|6|||
105905763|NCT02090283|365314012|FG000|Overall Study|Sponsor Terminated Study|6|||
105905764|NCT02090283|365314013|FG001|Overall Study|Sponsor Terminated Study|6|||
105905765|NCT02090283|365314014|FG002|Overall Study|Sponsor Terminated Study|1|||
105905766|NCT02090283|365314012|FG000|Overall Study|Lost to Follow-up|2|||
105905767|NCT02090283|365314013|FG001|Overall Study|Lost to Follow-up|2|||
105905768|NCT02090283|365314014|FG002|Overall Study|Lost to Follow-up|3|||
105905769|NCT02090283|365314012|FG000|Overall Study|Adverse Event|1|||
105905770|NCT02090283|365314013|FG001|Overall Study|Adverse Event|1|||
105905771|NCT02090283|365314014|FG002|Overall Study|Adverse Event|0|||
105905772|NCT02090283|365314012|FG000|Overall Study|Protocol Violation|2|||
105905773|NCT02090283|365314013|FG001|Overall Study|Protocol Violation|0|||
105905774|NCT02090283|365314014|FG002|Overall Study|Protocol Violation|0|||
105905775|NCT02372383|365314020|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
105905776|NCT02372383|365314021|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
105905777|NCT02372383|365314022|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
105905778|NCT02171429|365314026|FG000|Overall Study|Other|0|||
105905779|NCT02171429|365314027|FG001|Overall Study|Other|1|||
105905780|NCT02171429|365314028|FG002|Overall Study|Other|1|||
105905781|NCT02171429|365314026|FG000|Overall Study|Non-Compliance|0|||
105905782|NCT02171429|365314027|FG001|Overall Study|Non-Compliance|0|||
105905783|NCT02171429|365314028|FG002|Overall Study|Non-Compliance|1|||
105905784|NCT02171429|365314026|FG000|Overall Study|Physician Decision|0|||
105905785|NCT02171429|365314027|FG001|Overall Study|Physician Decision|0|||
105905786|NCT02171429|365314028|FG002|Overall Study|Physician Decision|1|||
105905787|NCT02171429|365314026|FG000|Overall Study|Withdrawal by Subject|1|||
105905788|NCT02171429|365314027|FG001|Overall Study|Withdrawal by Subject|1|||
105905789|NCT02171429|365314028|FG002|Overall Study|Withdrawal by Subject|1|||
105905790|NCT02171429|365314026|FG000|Overall Study|Lost to Follow-up|0|||
105669614|NCT03538938|364454051|FG006|Overall Study|Incarcerated|0|||
105669615|NCT03538938|364454052|FG007|Overall Study|Incarcerated|0|||
105669616|NCT03538938|364454053|FG008|Overall Study|Incarcerated|0|||
105786074|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
105905791|NCT02171429|365314027|FG001|Overall Study|Lost to Follow-up|1|||
105905792|NCT02171429|365314028|FG002|Overall Study|Lost to Follow-up|0|||
105905793|NCT02171429|365314026|FG000|Overall Study|Death|0|||
105998401|NCT01020786|365656187|FG000|Induction Period|Entry Criteria Not Met|2|||
105998402|NCT01020786|365656187|FG000|Induction Period|Adverse Event|10|||
105905794|NCT02171429|365314027|FG001|Overall Study|Death|0|||
105905795|NCT02171429|365314028|FG002|Overall Study|Death|1|||
105669617|NCT03538938|364454054|FG009|Overall Study|Incarcerated|0|||
105905796|NCT00424593|365314029|FG000|Acute Double-Blind Period|Adverse Event|16|||
105905797|NCT00424593|365314030|FG001|Acute Double-Blind Period|Adverse Event|7|||
105905798|NCT00424593|365314029|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
105905799|NCT00424593|365314030|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
105905800|NCT00424593|365314029|FG000|Acute Double-Blind Period|Protocol Violation|2|||
105905801|NCT00424593|365314030|FG001|Acute Double-Blind Period|Protocol Violation|2|||
105669618|NCT03538938|364454055|FG010|Overall Study|Incarcerated|0|||
105669619|NCT03538938|364454056|FG011|Overall Study|Incarcerated|1|||
105669620|NCT03538938|364454057|FG012|Overall Study|Incarcerated|0|||
105669621|NCT03538938|364454058|FG013|Overall Study|Incarcerated|0|||
105669622|NCT03538938|364454059|FG014|Overall Study|Incarcerated|0|||
105669623|NCT03538938|364454060|FG015|Overall Study|Incarcerated|0|||
105669624|NCT01137578|364454061|FG000|Overall Study|Participant requested to Discontinue|3|||
105669625|NCT01137578|364454062|FG001|Overall Study|Participant requested to Discontinue|0|||
105669626|NCT01137578|364454063|FG002|Overall Study|Participant requested to Discontinue|0|||
105669627|NCT01137578|364454061|FG000|Overall Study|Withdrawal by Subject|1|||
105669628|NCT01137578|364454062|FG001|Overall Study|Withdrawal by Subject|0|||
105669629|NCT01137578|364454063|FG002|Overall Study|Withdrawal by Subject|0|||
105669630|NCT01137578|364454061|FG000|Overall Study|Other|12|||
105669631|NCT01137578|364454062|FG001|Overall Study|Other|2|||
105669632|NCT01137578|364454063|FG002|Overall Study|Other|6|||
105669633|NCT01277887|364454065|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
105669634|NCT01277887|364454066|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
105669635|NCT01277887|364454065|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
105669636|NCT01277887|364454066|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
105669637|NCT01277887|364454065|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
105669638|NCT01277887|364454066|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
105669639|NCT00415051|364454068|FG000|Overall Study|Protocol Violation|1|||
105905802|NCT00424593|365314029|FG000|Acute Double-Blind Period|Physician Decision|1|||
105905803|NCT00424593|365314030|FG001|Acute Double-Blind Period|Physician Decision|2|||
105905804|NCT00424593|365314029|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
105905805|NCT00424593|365314030|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
105905806|NCT00424593|365314029|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
105905807|NCT00424593|365314030|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
105905808|NCT00424593|365314029|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
105905809|NCT00424593|365314030|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
105905810|NCT00424593|365314029|FG000|Dose-Blind Extension Period|Adverse Event|18|||
105905811|NCT00424593|365314030|FG001|Dose-Blind Extension Period|Adverse Event|0|||
105905812|NCT00424593|365314029|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
105905813|NCT00424593|365314030|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
105905814|NCT00424593|365314029|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
105905815|NCT00424593|365314030|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
105905816|NCT00424593|365314029|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
105905817|NCT00424593|365314030|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
105905818|NCT00424593|365314029|FG000|Dose-Blind Extension Period|Physician Decision|3|||
105905819|NCT00424593|365314030|FG001|Dose-Blind Extension Period|Physician Decision|0|||
105905820|NCT00667563|365314031|FG000|Overall Study|Protocol Violation|24|||
105905821|NCT02075008|365314032|FG000|Overall Study|Technical problems|1|||
105905822|NCT02075008|365314032|FG000|Overall Study|Pregnancy|1|||
105905823|NCT02075008|365314032|FG000|Overall Study|Physician Decision|1|||
105905824|NCT02075008|365314032|FG000|Overall Study|Lost to Follow-up|1|||
105905825|NCT02075008|365314032|FG000|Overall Study|Lack of Efficacy|1|||
105905826|NCT02075008|365314032|FG000|Overall Study|Death|1|||
105905827|NCT02075008|365314032|FG000|Overall Study|Adverse Event|5|||
105905828|NCT02075008|365314032|FG000|Overall Study|Withdrawal by Subject|6|||
105905829|NCT02075008|365314032|FG000|Overall Study|Study terminated by Sponsor|159|||
105905830|NCT01763203|365314033|FG000|Overall Study|Death|4|||
105905831|NCT01763203|365314034|FG001|Overall Study|Death|7|||
105905832|NCT01763203|365314033|FG000|Overall Study|Lost to Follow-up|12|||
105905833|NCT01763203|365314034|FG001|Overall Study|Lost to Follow-up|12|||
105905834|NCT01763203|365314033|FG000|Overall Study|Withdrawal by Subject|8|||
105905835|NCT01763203|365314034|FG001|Overall Study|Withdrawal by Subject|12|||
105669640|NCT00780559|364454069|FG000|Overall Study|Lost to Follow-up|2|||
105905836|NCT01763203|365314033|FG000|Overall Study|Moved out of study region|7|||
105669641|NCT00780559|364454070|FG001|Overall Study|Lost to Follow-up|7|||
105905837|NCT01763203|365314034|FG001|Overall Study|Moved out of study region|10|||
105905838|NCT01763203|365314033|FG000|Overall Study|Physician Decision|2|||
105905839|NCT01763203|365314034|FG001|Overall Study|Physician Decision|1|||
105905840|NCT02187861|365314035|FG000|Overall Study|Adverse Event|2|||
105669642|NCT00780559|364454069|FG000|Overall Study|Death|1|||
105669643|NCT00780559|364454070|FG001|Overall Study|Death|0|||
105786075|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
105905841|NCT02187861|365314036|FG001|Overall Study|Adverse Event|1|||
105905842|NCT02187861|365314037|FG002|Overall Study|Adverse Event|2|||
105905843|NCT02187861|365314038|FG003|Overall Study|Adverse Event|1|||
105998403|NCT01020786|365656187|FG000|Induction Period|Progressive Disease|31|||
105669644|NCT01399918|364454073|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
105669645|NCT04608773|364454074|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
105669646|NCT04608773|364454075|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
105905844|NCT02187861|365314035|FG000|Overall Study|Death|0|||
105905845|NCT02187861|365314036|FG001|Overall Study|Death|3|||
105905846|NCT02187861|365314037|FG002|Overall Study|Death|1|||
105998404|NCT01020786|365656187|FG000|Induction Period|Investigator Decision|3|||
105998405|NCT01020786|365656187|FG000|Induction Period|Withdrawal by Subject|3|||
105998406|NCT01020786|365656187|FG000|Maintenance Period|Adverse Event|8|||
105998407|NCT01020786|365656187|FG000|Maintenance Period|Progressive Disease|43|||
105998408|NCT01020786|365656187|FG000|Maintenance Period|Withdrawal by Subject|8|||
105998409|NCT01020786|365656187|FG000|Maintenance Period|Sponsor Decision|1|||
105998410|NCT01217463|365656190|FG000|Overall Study|Adverse Event|8|||
105998411|NCT01217463|365656191|FG001|Overall Study|Adverse Event|5|||
105998412|NCT01217463|365656190|FG000|Overall Study|Physician Decision|0|||
105998413|NCT01217463|365656191|FG001|Overall Study|Physician Decision|1|||
105998414|NCT01217463|365656190|FG000|Overall Study|Withdrawal by Subject|3|||
105998415|NCT01217463|365656191|FG001|Overall Study|Withdrawal by Subject|0|||
105998416|NCT01217463|365656190|FG000|Overall Study|Surgery on the Target Limb|0|||
105998417|NCT01217463|365656191|FG001|Overall Study|Surgery on the Target Limb|1|||
105998418|NCT01217463|365656190|FG000|Overall Study|Patient Non-compliant|1|||
105998419|NCT01217463|365656191|FG001|Overall Study|Patient Non-compliant|0|||
106125417|NCT01189890|366117737|FG000|Overall Study|Withdrawal by Subject|15|||
106125418|NCT01189890|366117738|FG001|Overall Study|Withdrawal by Subject|11|||
105905847|NCT02187861|365314038|FG003|Overall Study|Death|2|||
105905848|NCT02187861|365314035|FG000|Overall Study|Physician Decision|0|||
105905849|NCT02187861|365314036|FG001|Overall Study|Physician Decision|1|||
105905850|NCT02187861|365314037|FG002|Overall Study|Physician Decision|0|||
105905851|NCT02187861|365314038|FG003|Overall Study|Physician Decision|3|||
105905852|NCT02187861|365314035|FG000|Overall Study|Progressive Disease|4|||
105905853|NCT02187861|365314036|FG001|Overall Study|Progressive Disease|42|||
105905854|NCT02187861|365314037|FG002|Overall Study|Progressive Disease|19|||
105905855|NCT02187861|365314038|FG003|Overall Study|Progressive Disease|22|||
105905856|NCT02187861|365314035|FG000|Overall Study|Withdrawal by Subject|0|||
105905857|NCT02187861|365314036|FG001|Overall Study|Withdrawal by Subject|0|||
105905858|NCT02187861|365314037|FG002|Overall Study|Withdrawal by Subject|3|||
105905859|NCT02187861|365314038|FG003|Overall Study|Withdrawal by Subject|3|||
105905860|NCT02187861|365314035|FG000|Overall Study|Other|0|||
105905861|NCT02187861|365314036|FG001|Overall Study|Other|1|||
105905862|NCT02187861|365314037|FG002|Overall Study|Other|7|||
105905863|NCT02187861|365314038|FG003|Overall Study|Other|1|||
105905864|NCT00741598|365314039|FG000|Overall Study|Lost to Follow-up|3|||
105905865|NCT00741598|365314040|FG001|Overall Study|Lost to Follow-up|4|||
105905866|NCT00741598|365314039|FG000|Overall Study|Lack of Efficacy|1|||
105905867|NCT00741598|365314040|FG001|Overall Study|Lack of Efficacy|2|||
105905868|NCT00741598|365314039|FG000|Overall Study|Physician Decision|1|||
105905869|NCT00741598|365314040|FG001|Overall Study|Physician Decision|1|||
105905870|NCT00741598|365314039|FG000|Overall Study|Pregnancy|1|||
105905871|NCT00741598|365314040|FG001|Overall Study|Pregnancy|0|||
105905872|NCT00741598|365314039|FG000|Overall Study|Withdrawal by Subject|3|||
105905873|NCT00741598|365314040|FG001|Overall Study|Withdrawal by Subject|2|||
105905874|NCT00313586|365314041|FG000|Overall Study|Disease progression|14|||
105905875|NCT00313586|365314042|FG001|Overall Study|Disease progression|19|||
105905876|NCT00313586|365314043|FG002|Overall Study|Disease progression|10|||
105905877|NCT00313586|365314044|FG003|Overall Study|Disease progression|3|||
105905878|NCT00313586|365314041|FG000|Overall Study|Adverse Event|12|||
105905879|NCT00313586|365314042|FG001|Overall Study|Adverse Event|18|||
105905880|NCT00313586|365314043|FG002|Overall Study|Adverse Event|3|||
105905881|NCT00313586|365314044|FG003|Overall Study|Adverse Event|10|||
105905882|NCT00313586|365314041|FG000|Overall Study|Death|11|||
105905883|NCT00313586|365314042|FG001|Overall Study|Death|8|||
105905884|NCT00313586|365314043|FG002|Overall Study|Death|1|||
105905885|NCT00313586|365314044|FG003|Overall Study|Death|7|||
105905886|NCT00313586|365314041|FG000|Overall Study|Withdrawal by Subject|13|||
105905887|NCT00313586|365314042|FG001|Overall Study|Withdrawal by Subject|6|||
105905888|NCT00313586|365314043|FG002|Overall Study|Withdrawal by Subject|6|||
105905889|NCT00313586|365314044|FG003|Overall Study|Withdrawal by Subject|2|||
105905890|NCT00313586|365314041|FG000|Overall Study|Alternative therapy|3|||
105905891|NCT00313586|365314042|FG001|Overall Study|Alternative therapy|6|||
105905892|NCT00313586|365314043|FG002|Overall Study|Alternative therapy|2|||
105905893|NCT00313586|365314044|FG003|Overall Study|Alternative therapy|0|||
105905894|NCT00313586|365314041|FG000|Overall Study|Other complicating disease|2|||
105905895|NCT00313586|365314042|FG001|Overall Study|Other complicating disease|2|||
105905896|NCT00313586|365314043|FG002|Overall Study|Other complicating disease|0|||
105905897|NCT00313586|365314044|FG003|Overall Study|Other complicating disease|0|||
105905898|NCT00313586|365314041|FG000|Overall Study|Did not achieve HI-major/better response|10|||
105905899|NCT00313586|365314042|FG001|Overall Study|Did not achieve HI-major/better response|7|||
105905900|NCT00313586|365314043|FG002|Overall Study|Did not achieve HI-major/better response|2|||
105905901|NCT00313586|365314044|FG003|Overall Study|Did not achieve HI-major/better response|1|||
105905902|NCT00313586|365314041|FG000|Overall Study|Physician Decision|2|||
105905903|NCT00313586|365314042|FG001|Overall Study|Physician Decision|1|||
105905904|NCT00313586|365314043|FG002|Overall Study|Physician Decision|0|||
105905905|NCT00313586|365314044|FG003|Overall Study|Physician Decision|0|||
105998420|NCT01217463|365656190|FG000|Overall Study|Other|1|||
105998421|NCT01217463|365656191|FG001|Overall Study|Other|1|||
105669647|NCT04608773|364454074|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
105669648|NCT04608773|364454075|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
105669649|NCT04608773|364454074|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
105669650|NCT04608773|364454075|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
105669651|NCT04608773|364454074|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
105669652|NCT04608773|364454075|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
105669653|NCT04608773|364454074|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
105669654|NCT04608773|364454075|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
105669655|NCT01217437|364454089|FG000|Overall Study|Adverse Event|0|||
105669656|NCT01217437|364454090|FG001|Overall Study|Adverse Event|8|||
105669657|NCT01217437|364454089|FG000|Overall Study|Death|5|||
105669658|NCT01217437|364454090|FG001|Overall Study|Death|0|||
105669659|NCT01217437|364454089|FG000|Overall Study|Lack of Efficacy|29|||
105669660|NCT01217437|364454090|FG001|Overall Study|Lack of Efficacy|25|||
105669661|NCT01217437|364454089|FG000|Overall Study|Physician Decision|8|||
105669662|NCT01217437|364454090|FG001|Overall Study|Physician Decision|5|||
105669663|NCT01217437|364454089|FG000|Overall Study|Withdrawal by Subject|0|||
105669664|NCT01217437|364454090|FG001|Overall Study|Withdrawal by Subject|2|||
105669665|NCT01217437|364454089|FG000|Overall Study|Ineligible|1|||
105669666|NCT01217437|364454090|FG001|Overall Study|Ineligible|1|||
105669667|NCT01040169|364454093|FG000|Overall Study|Lost to Follow-up|3|||
105669668|NCT01040169|364454094|FG001|Overall Study|Lost to Follow-up|8|||
105669669|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Adverse Event|4|||
105669670|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Adverse Event|0|||
105669671|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Adverse Event|0|||
105669672|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
105905906|NCT00313586|365314041|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
105905907|NCT00313586|365314042|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
105905908|NCT00313586|365314043|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
105905909|NCT00313586|365314044|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
105905910|NCT00313586|365314041|FG000|Overall Study|Lost insurance|0|||
105905911|NCT00313586|365314042|FG001|Overall Study|Lost insurance|1|||
105905912|NCT00313586|365314043|FG002|Overall Study|Lost insurance|0|||
105905913|NCT00313586|365314044|FG003|Overall Study|Lost insurance|0|||
105905914|NCT00313586|365314041|FG000|Overall Study|Moved|0|||
105905915|NCT00313586|365314042|FG001|Overall Study|Moved|1|||
105905916|NCT00313586|365314043|FG002|Overall Study|Moved|0|||
105905917|NCT00313586|365314044|FG003|Overall Study|Moved|0|||
105905918|NCT00313586|365314041|FG000|Overall Study|Death before starting treatment|1|||
105905919|NCT00313586|365314042|FG001|Overall Study|Death before starting treatment|0|||
105905920|NCT00313586|365314043|FG002|Overall Study|Death before starting treatment|0|||
105905921|NCT00313586|365314044|FG003|Overall Study|Death before starting treatment|0|||
105905922|NCT02465437|365314045|FG000|Overall Study|Physician Decision|0|||
105905923|NCT02465437|365314046|FG001|Overall Study|Physician Decision|0|||
105905924|NCT02465437|365314047|FG002|Overall Study|Physician Decision|1|||
105905925|NCT02465437|365314048|FG003|Overall Study|Physician Decision|0|||
105905926|NCT02465437|365314045|FG000|Overall Study|Withdrawal by Subject|1|||
105905927|NCT02465437|365314046|FG001|Overall Study|Withdrawal by Subject|0|||
105905928|NCT02465437|365314047|FG002|Overall Study|Withdrawal by Subject|0|||
105905929|NCT02465437|365314048|FG003|Overall Study|Withdrawal by Subject|1|||
105905930|NCT02465437|365314045|FG000|Overall Study|Adverse Event|0|||
105905931|NCT02465437|365314046|FG001|Overall Study|Adverse Event|1|||
105905932|NCT02465437|365314047|FG002|Overall Study|Adverse Event|0|||
105905933|NCT02465437|365314048|FG003|Overall Study|Adverse Event|0|||
105905934|NCT01042392|365314049|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
105905935|NCT01042392|365314050|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
105905936|NCT01042392|365314051|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
105905937|NCT01042392|365314052|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
105905938|NCT01042392|365314049|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
105905939|NCT01042392|365314050|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
105905940|NCT01042392|365314051|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
105905941|NCT01042392|365314052|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
105669673|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
105905942|NCT01042392|365314049|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
105905943|NCT01042392|365314050|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
105998422|NCT01965704|365656198|FG000|Overall Study|Withdrawal by Subject|2|||
105905944|NCT01042392|365314051|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
105905945|NCT01042392|365314052|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
105669674|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
105669675|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Death|1|||
105669676|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Death|0|||
105669677|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Death|0|||
105669678|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Physician Decision|1|||
105905946|NCT01042392|365314049|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
105905947|NCT01042392|365314050|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
105905948|NCT01042392|365314051|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
105905949|NCT01042392|365314052|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
105905950|NCT01042392|365314049|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
105905951|NCT01042392|365314050|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
105905952|NCT01042392|365314051|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
105905953|NCT01042392|365314052|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
105905954|NCT01042392|365314049|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
105905955|NCT01042392|365314050|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
105905956|NCT01042392|365314051|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
105905957|NCT01042392|365314052|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
105905958|NCT01042392|365314049|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
105905959|NCT01042392|365314050|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
105905960|NCT01042392|365314051|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
105905961|NCT01042392|365314052|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
105905962|NCT01042392|365314049|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
105905963|NCT01042392|365314050|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
105905964|NCT01042392|365314051|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
105905965|NCT01042392|365314052|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
105905966|NCT01042392|365314049|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
105905967|NCT01042392|365314050|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
105905968|NCT01042392|365314051|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
105905969|NCT01042392|365314052|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
105905970|NCT05114564|365314055|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
105905971|NCT05114564|365314056|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
105905972|NCT05114564|365314055|FG000|First Intervention|Adverse Event|0|||
105905973|NCT05114564|365314056|FG001|First Intervention|Adverse Event|1|||
105905974|NCT03117361|365314057|FG000|Overall Study|Progressive disease|5|||
105905975|NCT03117361|365314057|FG000|Overall Study|Death|1|||
105905976|NCT03117361|365314057|FG000|Overall Study|Physician Decision|2|||
105905977|NCT03117361|365314057|FG000|Overall Study|On study treatment at the end of study|1|||
105905978|NCT03117361|365314057|FG000|Overall Study|Treatment-related adverse event|1|||
105905979|NCT00943592|365314060|FG000|Overall Study|Death|3|||
105905980|NCT01152996|365314061|FG000|Overall Study|Withdrawal by Subject|142|||
105905981|NCT01152996|365314061|FG000|Overall Study|Adverse Event|115|||
105905982|NCT01152996|365314061|FG000|Overall Study|Lost to Follow-up|112|||
105905983|NCT01152996|365314061|FG000|Overall Study|Lack of Efficacy|68|||
105905984|NCT01152996|365314061|FG000|Overall Study|Noncompliance|41|||
105905985|NCT01152996|365314061|FG000|Overall Study|Other|36|||
105905986|NCT01152996|365314061|FG000|Overall Study|Protocol Violation|22|||
105905987|NCT01152996|365314061|FG000|Overall Study|Elevated liver enzymes|1|||
105905988|NCT03465709|365314071|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
105905989|NCT03465709|365314071|FG000|Overall Study|Withdrawal by Subject|3|||
105905990|NCT00272844|365314072|FG000|Overall Study|Withdrawal by Subject|5|||
105905991|NCT01210222|365314077|FG000|Overall Study|Ineligible|2|||
105905992|NCT01210222|365314077|FG000|Overall Study|Never treated|1|||
105905993|NCT02081001|365314078|FG000|Overall Study|Adverse Event|0|||
105905994|NCT02081001|365314079|FG001|Overall Study|Adverse Event|0|||
105905995|NCT02081001|365314080|FG002|Overall Study|Adverse Event|0|||
105905996|NCT02081001|365314081|FG003|Overall Study|Adverse Event|0|||
105905997|NCT02081001|365314082|FG004|Overall Study|Adverse Event|1|||
105905998|NCT02081001|365314083|FG005|Overall Study|Adverse Event|0|||
105905999|NCT02081001|365314084|FG006|Overall Study|Adverse Event|0|||
105906000|NCT02081001|365314085|FG007|Overall Study|Adverse Event|0|||
105906001|NCT02081001|365314086|FG008|Overall Study|Adverse Event|0|||
105906002|NCT02081001|365314087|FG009|Overall Study|Adverse Event|0|||
105906003|NCT02081001|365314088|FG010|Overall Study|Adverse Event|0|||
105906004|NCT02081001|365314089|FG011|Overall Study|Adverse Event|0|||
105906005|NCT03382418|365314101|FG000|Overall Study|Withdrawal by Subject|1|||
105906006|NCT03382418|365314102|FG001|Overall Study|Withdrawal by Subject|0|||
105906007|NCT03382418|365314103|FG002|Overall Study|Withdrawal by Subject|0|||
105906008|NCT03382418|365314101|FG000|Overall Study|Lost to Follow-up|2|||
105906009|NCT03382418|365314102|FG001|Overall Study|Lost to Follow-up|3|||
105906010|NCT03382418|365314103|FG002|Overall Study|Lost to Follow-up|0|||
105906011|NCT02282163|365314104|FG000|Overall Study|Protocol Violation|1|||
105906012|NCT02182830|365314109|FG000|Overall Study|Not Treated|1|||
105906013|NCT02182830|365314110|FG001|Overall Study|Not Treated|1|||
105906014|NCT02182830|365314109|FG000|Overall Study|Trial stopped, reason missing|3|||
105906015|NCT02182830|365314110|FG001|Overall Study|Trial stopped, reason missing|3|||
105906016|NCT02182830|365314109|FG000|Overall Study|Consent withdrawn|8|||
105906017|NCT02182830|365314110|FG001|Overall Study|Consent withdrawn|8|||
105906018|NCT02182830|365314109|FG000|Overall Study|Lost to Follow-up|3|||
105906019|NCT02182830|365314110|FG001|Overall Study|Lost to Follow-up|3|||
105906020|NCT00401193|365315984|FG000|Overall Study|Adverse Event|1|||
105906021|NCT00401193|365315985|FG001|Overall Study|Adverse Event|3|||
105906022|NCT00401193|365315986|FG002|Overall Study|Adverse Event|1|||
105906023|NCT00401193|365315984|FG000|Overall Study|Protocol Violation|3|||
105906024|NCT00401193|365315985|FG001|Overall Study|Protocol Violation|1|||
105906025|NCT00401193|365315986|FG002|Overall Study|Protocol Violation|1|||
105906026|NCT00401193|365315984|FG000|Overall Study|Lost to Follow-up|6|||
105906027|NCT00401193|365315985|FG001|Overall Study|Lost to Follow-up|5|||
105906028|NCT00401193|365315986|FG002|Overall Study|Lost to Follow-up|1|||
105906029|NCT00401193|365315984|FG000|Overall Study|Withdrawal by Subject|2|||
105906030|NCT00401193|365315985|FG001|Overall Study|Withdrawal by Subject|0|||
105906031|NCT00401193|365315986|FG002|Overall Study|Withdrawal by Subject|1|||
105906032|NCT00401193|365315984|FG000|Overall Study|Other Event|3|||
105906033|NCT00401193|365315985|FG001|Overall Study|Other Event|2|||
105906034|NCT00401193|365315986|FG002|Overall Study|Other Event|2|||
105906035|NCT01133704|365315988|FG000|Overall Study|Death|44|||
105906036|NCT01133704|365315989|FG001|Overall Study|Death|26|||
105906037|NCT01133704|365315988|FG000|Overall Study|Patient refused to continue|4|||
105906038|NCT01133704|365315989|FG001|Overall Study|Patient refused to continue|0|||
105906039|NCT01133704|365315988|FG000|Overall Study|Study Closure|1|||
105906040|NCT01133704|365315989|FG001|Overall Study|Study Closure|0|||
105906041|NCT02576977|365315992|FG000|Overall Study|Adverse Event|13|||
105906042|NCT02576977|365315993|FG001|Overall Study|Adverse Event|2|||
105906043|NCT02576977|365315992|FG000|Overall Study|Death|73|||
105906044|NCT02576977|365315993|FG001|Overall Study|Death|60|||
105906045|NCT02576977|365315992|FG000|Overall Study|Screen failure|1|||
105906046|NCT02576977|365315993|FG001|Overall Study|Screen failure|0|||
105906047|NCT02576977|365315992|FG000|Overall Study|Study Terminated at Selected Sites|27|||
105906048|NCT02576977|365315993|FG001|Overall Study|Study Terminated at Selected Sites|50|||
105906049|NCT02576977|365315992|FG000|Overall Study|Withdrawal by Subject|11|||
105906050|NCT02576977|365315993|FG001|Overall Study|Withdrawal by Subject|11|||
105906051|NCT02576977|365315992|FG000|Overall Study|Final Disposition Unknown|0|||
105906052|NCT02576977|365315993|FG001|Overall Study|Final Disposition Unknown|1|||
105906053|NCT02576977|365315992|FG000|Overall Study|Lost to Follow-up|1|||
105906054|NCT02576977|365315993|FG001|Overall Study|Lost to Follow-up|0|||
105906055|NCT02576977|365315992|FG000|Overall Study|Progressive Disease|0|||
105906056|NCT02576977|365315993|FG001|Overall Study|Progressive Disease|1|||
105906057|NCT04441788|365315994|FG000|Overall Study|Voluntary Withdrawl|0|||
105906058|NCT04441788|365315995|FG001|Overall Study|Voluntary Withdrawl|1|||
105906059|NCT04441788|365315996|FG002|Overall Study|Voluntary Withdrawl|0|||
105906060|NCT04441788|365315994|FG000|Overall Study|Ineligibility|1|||
105906061|NCT04441788|365315995|FG001|Overall Study|Ineligibility|0|||
105906062|NCT04441788|365315996|FG002|Overall Study|Ineligibility|0|||
105906063|NCT04441788|365315994|FG000|Overall Study|Adverse Event|0|||
105906064|NCT04441788|365315995|FG001|Overall Study|Adverse Event|0|||
105906065|NCT04441788|365315996|FG002|Overall Study|Adverse Event|4|||
105906066|NCT04441788|365315994|FG000|Overall Study|Study Terminated by Sponsor|16|||
106125419|NCT01189890|366117737|FG000|Overall Study|Non Compliance|0|||
106125420|NCT01189890|366117738|FG001|Overall Study|Non Compliance|1|||
106125421|NCT01189890|366117737|FG000|Overall Study|Physician Decision|5|||
106125422|NCT01189890|366117738|FG001|Overall Study|Physician Decision|4|||
106125423|NCT01189890|366117737|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
106125424|NCT01189890|366117738|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
106125425|NCT02802319|366117739|FG000|Overall Study|Physician Decision|2|||
106125426|NCT02802319|366117740|FG001|Overall Study|Physician Decision|1|||
106125427|NCT02802319|366117739|FG000|Overall Study|Lost to Follow-up|0|||
106125428|NCT02802319|366117740|FG001|Overall Study|Lost to Follow-up|4|||
106125429|NCT01155388|366117741|FG000|Overall Study|Adverse Event|1|||
106125430|NCT01155388|366117742|FG001|Overall Study|Adverse Event|0|||
106125431|NCT04329104|366117743|FG000|Efficacy Study|Withdrawal by Subject|0|||
106125432|NCT04329104|366117744|FG001|Efficacy Study|Withdrawal by Subject|0|||
106125433|NCT04329104|366117745|FG002|Efficacy Study|Withdrawal by Subject|0|||
106125434|NCT04329104|366117746|FG003|Efficacy Study|Withdrawal by Subject|5|||
106125435|NCT04329104|366117747|FG004|Efficacy Study|Withdrawal by Subject|6|||
106125436|NCT04329104|366117748|FG005|Efficacy Study|Withdrawal by Subject|8|||
105906067|NCT04441788|365315995|FG001|Overall Study|Study Terminated by Sponsor|16|||
105906068|NCT04441788|365315996|FG002|Overall Study|Study Terminated by Sponsor|12|||
105906069|NCT00824655|365315997|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
105906070|NCT00824655|365315998|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
105906071|NCT00824655|365315997|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
105906072|NCT00824655|365315998|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
105906073|NCT01025284|365316002|FG000|Overall Study|Investigator Decision|0|||
105906074|NCT01025284|365316003|FG001|Overall Study|Investigator Decision|1|||
105906075|NCT01025284|365316004|FG002|Overall Study|Investigator Decision|0|||
105906076|NCT01025284|365316002|FG000|Overall Study|Withdrawal by Subject|0|||
105906077|NCT01025284|365316003|FG001|Overall Study|Withdrawal by Subject|1|||
105906078|NCT01025284|365316004|FG002|Overall Study|Withdrawal by Subject|0|||
105906079|NCT02753816|365316005|FG000|Overall Study|Protocol Violation|0|||
105906080|NCT02753816|365316006|FG001|Overall Study|Protocol Violation|1|||
105906081|NCT02753816|365316007|FG002|Overall Study|Protocol Violation|0|||
105906082|NCT00905567|365316008|FG000|Washout|Withdrawal by Subject|0|||
105906083|NCT00905567|365316009|FG001|Washout|Withdrawal by Subject|1|||
105906084|NCT01957579|365316011|FG000|Overall Study|Withdrawal of concent|0|||
105906085|NCT01957579|365316012|FG001|Overall Study|Withdrawal of concent|1|||
105906086|NCT01957579|365316013|FG002|Overall Study|Withdrawal of concent|0|||
105906087|NCT01957579|365316014|FG003|Overall Study|Withdrawal of concent|0|||
105998423|NCT01965704|365656199|FG001|Overall Study|Withdrawal by Subject|2|||
105998424|NCT01965704|365656200|FG002|Overall Study|Withdrawal by Subject|1|||
105998425|NCT01965704|365656201|FG003|Overall Study|Withdrawal by Subject|1|||
105998426|NCT01965704|365656198|FG000|Overall Study|Delivered at home|1|||
105998427|NCT01965704|365656199|FG001|Overall Study|Delivered at home|1|||
105998428|NCT01965704|365656200|FG002|Overall Study|Delivered at home|0|||
105906088|NCT01957579|365316011|FG000|Overall Study|Death|0|||
105906089|NCT01957579|365316012|FG001|Overall Study|Death|0|||
105906090|NCT01957579|365316013|FG002|Overall Study|Death|2|||
105906091|NCT01957579|365316014|FG003|Overall Study|Death|0|||
105906092|NCT01738919|365316015|FG000|Overall Study|Lost to Follow-up|1|||
105906093|NCT01738919|365316016|FG001|Overall Study|Lost to Follow-up|0|||
105906094|NCT01738919|365316015|FG000|Overall Study|Immigrated|0|||
105906095|NCT01738919|365316016|FG001|Overall Study|Immigrated|1|||
105906096|NCT01738919|365316015|FG000|Overall Study|Withdrawal by Subject|0|||
105906097|NCT01738919|365316016|FG001|Overall Study|Withdrawal by Subject|1|||
105906098|NCT01738919|365316015|FG000|Overall Study|Not treated in accordance to guidelines|0|||
105906099|NCT01738919|365316016|FG001|Overall Study|Not treated in accordance to guidelines|1|||
105906100|NCT01639144|365316019|FG000|Overall Study|Withdrawal by Subject|4|||
105906101|NCT01639144|365316020|FG001|Overall Study|Withdrawal by Subject|2|||
105906102|NCT01639144|365316019|FG000|Overall Study|Physician Decision|2|||
105906103|NCT01639144|365316020|FG001|Overall Study|Physician Decision|0|||
105906104|NCT01639144|365316019|FG000|Overall Study|Met postoperative exclusion criteria|4|||
105906105|NCT01639144|365316020|FG001|Overall Study|Met postoperative exclusion criteria|3|||
105906106|NCT02750332|365316021|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105906107|NCT02750332|365316022|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105906108|NCT01473940|365316026|FG000|Induction Therapy|Death|0|||
105906109|NCT01473940|365316027|FG001|Induction Therapy|Death|0|||
105906110|NCT01473940|365316028|FG002|Induction Therapy|Death|1|||
106125437|NCT03884231|366117749|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
106125438|NCT03884231|366117749|FG000|Overall Study|Subject Withdrew Consent|1|||
105906111|NCT01473940|365316029|FG003|Induction Therapy|Death|1|||
105906112|NCT01473940|365316026|FG000|Induction Therapy|Progressive Disease|0|||
105906113|NCT01473940|365316027|FG001|Induction Therapy|Progressive Disease|1|||
105906114|NCT01473940|365316028|FG002|Induction Therapy|Progressive Disease|1|||
105906115|NCT01473940|365316029|FG003|Induction Therapy|Progressive Disease|0|||
105906116|NCT01473940|365316026|FG000|Maintenance Therapy|Progressive Disease|1|||
106125439|NCT03884231|366117749|FG000|Overall Study|MRI Scan Not Performed|1|||
106125440|NCT01500226|366117756|FG000|Overall Study|Adverse Event|31|||
106125441|NCT01500226|366117757|FG001|Overall Study|Adverse Event|38|||
106125442|NCT01500226|366117756|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
106125443|NCT01500226|366117757|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
106125444|NCT01500226|366117756|FG000|Overall Study|Withdrawal by Subject|93|||
106125445|NCT01500226|366117757|FG001|Overall Study|Withdrawal by Subject|96|||
106125446|NCT01500226|366117756|FG000|Overall Study|Death|12|||
106125447|NCT01500226|366117757|FG001|Overall Study|Death|4|||
106125448|NCT01500226|366117756|FG000|Overall Study|Disease Progression|16|||
106125449|NCT01500226|366117757|FG001|Overall Study|Disease Progression|14|||
105906117|NCT01473940|365316027|FG001|Maintenance Therapy|Progressive Disease|2|||
105906118|NCT01473940|365316028|FG002|Maintenance Therapy|Progressive Disease|1|||
105906119|NCT01473940|365316029|FG003|Maintenance Therapy|Progressive Disease|4|||
105998429|NCT01965704|365656201|FG003|Overall Study|Delivered at home|0|||
106125450|NCT01500226|366117756|FG000|Overall Study|Protocol Violation|53|||
106125451|NCT01500226|366117757|FG001|Overall Study|Protocol Violation|39|||
106125452|NCT01500226|366117756|FG000|Overall Study|Physician Decision|17|||
105906120|NCT00547248|365316030|FG000|Overall Study|Protocol Violation|0|||
105906121|NCT00547248|365316031|FG001|Overall Study|Protocol Violation|0|||
105906122|NCT00547248|365316032|FG002|Overall Study|Protocol Violation|1|||
105906123|NCT00547248|365316033|FG003|Overall Study|Protocol Violation|1|||
105906124|NCT00547248|365316030|FG000|Overall Study|Migrated/moved from study area|0|||
105906125|NCT00547248|365316031|FG001|Overall Study|Migrated/moved from study area|0|||
105906126|NCT00547248|365316032|FG002|Overall Study|Migrated/moved from study area|2|||
105906127|NCT00547248|365316033|FG003|Overall Study|Migrated/moved from study area|0|||
105906128|NCT00547248|365316030|FG000|Overall Study|Withdrawal by Subject|0|||
105906129|NCT00547248|365316031|FG001|Overall Study|Withdrawal by Subject|0|||
105906130|NCT00547248|365316032|FG002|Overall Study|Withdrawal by Subject|7|||
105906131|NCT00547248|365316033|FG003|Overall Study|Withdrawal by Subject|1|||
105906132|NCT00534248|365316036|FG000|Overall Study|Adverse Event|19|||
105906133|NCT00534248|365316037|FG001|Overall Study|Adverse Event|29|||
105906134|NCT00534248|365316036|FG000|Overall Study|Lost to Follow-up|353|||
105906135|NCT00534248|365316037|FG001|Overall Study|Lost to Follow-up|375|||
105906136|NCT00534248|365316036|FG000|Overall Study|Other protocol specified criteria|13|||
105906137|NCT00534248|365316037|FG001|Overall Study|Other protocol specified criteria|3|||
105906138|NCT00534248|365316036|FG000|Overall Study|Physician Decision|10|||
105906139|NCT00534248|365316037|FG001|Overall Study|Physician Decision|7|||
105906140|NCT00534248|365316036|FG000|Overall Study|Protocol Violation|3|||
105906141|NCT00534248|365316037|FG001|Overall Study|Protocol Violation|4|||
105906142|NCT00534248|365316036|FG000|Overall Study|Withdrawal by Subject|263|||
105906143|NCT00534248|365316037|FG001|Overall Study|Withdrawal by Subject|255|||
105906144|NCT02028507|365316038|FG000|Overall Study|Progressive Disease|122|||
105906145|NCT02028507|365316039|FG001|Overall Study|Progressive Disease|90|||
105906146|NCT02028507|365316040|FG002|Overall Study|Progressive Disease|102|||
105906147|NCT02028507|365316041|FG003|Overall Study|Progressive Disease|89|||
105906148|NCT02028507|365316038|FG000|Overall Study|Adverse Event|8|||
105906149|NCT02028507|365316039|FG001|Overall Study|Adverse Event|25|||
105906150|NCT02028507|365316040|FG002|Overall Study|Adverse Event|3|||
105906151|NCT02028507|365316041|FG003|Overall Study|Adverse Event|16|||
105906152|NCT02028507|365316038|FG000|Overall Study|Withdrawal by Subject|6|||
105906153|NCT02028507|365316039|FG001|Overall Study|Withdrawal by Subject|8|||
105906154|NCT02028507|365316040|FG002|Overall Study|Withdrawal by Subject|5|||
105906155|NCT02028507|365316041|FG003|Overall Study|Withdrawal by Subject|9|||
105906156|NCT02028507|365316038|FG000|Overall Study|Protocol Violation|2|||
105906157|NCT02028507|365316039|FG001|Overall Study|Protocol Violation|4|||
105906158|NCT02028507|365316040|FG002|Overall Study|Protocol Violation|1|||
105906159|NCT02028507|365316041|FG003|Overall Study|Protocol Violation|3|||
105906160|NCT02028507|365316038|FG000|Overall Study|Physician Decision|0|||
105906161|NCT02028507|365316039|FG001|Overall Study|Physician Decision|4|||
105906162|NCT02028507|365316040|FG002|Overall Study|Physician Decision|0|||
105906163|NCT02028507|365316041|FG003|Overall Study|Physician Decision|0|||
105906164|NCT02028507|365316038|FG000|Overall Study|Death|1|||
105906165|NCT02028507|365316039|FG001|Overall Study|Death|0|||
105906166|NCT02028507|365316040|FG002|Overall Study|Death|1|||
105906167|NCT02028507|365316041|FG003|Overall Study|Death|3|||
105906168|NCT02028507|365316038|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
105906169|NCT02028507|365316039|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
105906170|NCT02028507|365316040|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
105906171|NCT02028507|365316041|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
105906172|NCT02028507|365316038|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
105906173|NCT02028507|365316039|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
105906174|NCT02028507|365316040|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
105906175|NCT02028507|365316041|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
105906176|NCT02028507|365316038|FG000|Overall Study|Randomized But Not Treated|3|||
105906177|NCT02028507|365316039|FG001|Overall Study|Randomized But Not Treated|6|||
105906178|NCT02028507|365316040|FG002|Overall Study|Randomized But Not Treated|0|||
105906179|NCT02028507|365316041|FG003|Overall Study|Randomized But Not Treated|4|||
105906180|NCT02028507|365316038|FG000|Overall Study|Enzyme defect|0|||
105906181|NCT02028507|365316039|FG001|Overall Study|Enzyme defect|0|||
105906182|NCT02028507|365316040|FG002|Overall Study|Enzyme defect|0|||
105906183|NCT02028507|365316041|FG003|Overall Study|Enzyme defect|1|||
105906184|NCT02028507|365316038|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
105906185|NCT02028507|365316039|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
105906186|NCT02028507|365316040|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
105906187|NCT02028507|365316041|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
105906188|NCT02028507|365316038|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
105906189|NCT02028507|365316039|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
105906190|NCT02028507|365316040|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
105906191|NCT02028507|365316041|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
105906192|NCT05980013|365316042|FG000|Overall Study|Withdrawal by Subject|0|||
105906193|NCT05980013|365316043|FG001|Overall Study|Withdrawal by Subject|1|||
105906194|NCT05980013|365316042|FG000|Overall Study|Device Error|0|||
105906195|NCT05980013|365316043|FG001|Overall Study|Device Error|1|||
105998430|NCT01965704|365656198|FG000|Overall Study|Experienced complications|0|||
105998431|NCT01965704|365656199|FG001|Overall Study|Experienced complications|0|||
105998432|NCT01965704|365656200|FG002|Overall Study|Experienced complications|2|||
105998433|NCT01965704|365656201|FG003|Overall Study|Experienced complications|2|||
105998434|NCT01965704|365656198|FG000|Overall Study|Adverse Event|0|||
105998435|NCT01965704|365656199|FG001|Overall Study|Adverse Event|0|||
105998436|NCT01965704|365656200|FG002|Overall Study|Adverse Event|1|||
105998437|NCT01965704|365656201|FG003|Overall Study|Adverse Event|1|||
105998438|NCT01965704|365656198|FG000|Overall Study|Did not meet inclusion criteria|0|||
105998439|NCT01965704|365656199|FG001|Overall Study|Did not meet inclusion criteria|0|||
105998440|NCT01965704|365656200|FG002|Overall Study|Did not meet inclusion criteria|1|||
105998441|NCT01965704|365656201|FG003|Overall Study|Did not meet inclusion criteria|1|||
105998442|NCT02519439|365656206|FG000|Overall Study|Study Termination|19|||
105998443|NCT02519439|365656206|FG000|Overall Study|Withdrawal by Subject|1|||
105906196|NCT04202965|365316046|FG000|Overall Study|Adverse Event|3|||
105906197|NCT04202965|365316046|FG000|Overall Study|Did not meet inclusion criteria|1|||
105906198|NCT01556932|365316047|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
105906199|NCT01556932|365316048|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
105906200|NCT03066778|365316049|FG000|Overall Study|Death|195|||
105906201|NCT03066778|365316050|FG001|Overall Study|Death|205|||
105906202|NCT03066778|365316049|FG000|Overall Study|Withdrawal by Subject|5|||
105998444|NCT02519439|365656206|FG000|Overall Study|Adverse Event|1|||
105998445|NCT01539759|365656209|FG000|Overall Study|Lost to Follow-up|6|||
105998446|NCT01539759|365656210|FG001|Overall Study|Lost to Follow-up|8|||
105998447|NCT02872116|365656211|FG000|Pre-Treatment|Disease Progression|0|||
105998448|NCT02872116|365656212|FG001|Pre-Treatment|Disease Progression|1|||
105998449|NCT02872116|365656213|FG002|Pre-Treatment|Disease Progression|0|||
105998450|NCT02872116|365656211|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
105998451|NCT02872116|365656212|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
105998452|NCT02872116|365656213|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
105998453|NCT02872116|365656211|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
105998454|NCT02872116|365656212|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
105998455|NCT02872116|365656213|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
105998456|NCT02872116|365656211|FG000|Pre-Treatment|Participant withdrew consent|2|||
105998457|NCT02872116|365656212|FG001|Pre-Treatment|Participant withdrew consent|20|||
105998458|NCT02872116|365656213|FG002|Pre-Treatment|Participant withdrew consent|3|||
105998459|NCT02872116|365656211|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
105998460|NCT02872116|365656212|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
105998461|NCT02872116|365656213|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
105998462|NCT02872116|365656211|FG000|Pre-Treatment|Other reasons|1|||
105998463|NCT02872116|365656212|FG001|Pre-Treatment|Other reasons|2|||
105998464|NCT02872116|365656213|FG002|Pre-Treatment|Other reasons|2|||
105998465|NCT02872116|365656211|FG000|Treatment|Death|122|||
106125453|NCT01500226|366117757|FG001|Overall Study|Physician Decision|15|||
106125454|NCT01500226|366117756|FG000|Overall Study|Lack of Efficacy|14|||
106125455|NCT01500226|366117757|FG001|Overall Study|Lack of Efficacy|30|||
106125456|NCT01500226|366117756|FG000|Overall Study|Lost to Follow-up|9|||
106125457|NCT01500226|366117757|FG001|Overall Study|Lost to Follow-up|5|||
106125458|NCT01500226|366117756|FG000|Overall Study|Other Reasons|19|||
106125459|NCT01500226|366117757|FG001|Overall Study|Other Reasons|16|||
106125460|NCT01023308|366117758|FG000|Overall Study|Abnormal test proceedure results|3|||
106125461|NCT01023308|366117759|FG001|Overall Study|Abnormal test proceedure results|8|||
106125462|NCT01023308|366117758|FG000|Overall Study|Administrative problems|2|||
106125463|NCT01023308|366117759|FG001|Overall Study|Administrative problems|1|||
106125464|NCT01023308|366117758|FG000|Overall Study|Adverse Event|130|||
106125465|NCT01023308|366117759|FG001|Overall Study|Adverse Event|66|||
106125466|NCT01023308|366117758|FG000|Overall Study|Death|21|||
106125467|NCT01023308|366117759|FG001|Overall Study|Death|17|||
106125468|NCT01023308|366117758|FG000|Overall Study|Disease progression|82|||
106125469|NCT01023308|366117759|FG001|Overall Study|Disease progression|153|||
106125470|NCT01023308|366117758|FG000|Overall Study|New Cancer therapy|4|||
106125471|NCT01023308|366117759|FG001|Overall Study|New Cancer therapy|7|||
106125472|NCT01023308|366117758|FG000|Overall Study|Protocol Violation|3|||
106125473|NCT01023308|366117759|FG001|Overall Study|Protocol Violation|4|||
106125474|NCT01023308|366117758|FG000|Overall Study|Untreated|5|||
106125475|NCT01023308|366117759|FG001|Overall Study|Untreated|5|||
105906203|NCT03066778|365316050|FG001|Overall Study|Withdrawal by Subject|7|||
105998466|NCT02872116|365656212|FG001|Treatment|Death|94|||
105906204|NCT02328937|365316051|FG000|Period 1|Lost to Follow-up|0|||
105998467|NCT02872116|365656213|FG002|Treatment|Death|68|||
105998468|NCT02872116|365656211|FG000|Treatment|Lost to Follow-up|5|||
105998469|NCT02872116|365656212|FG001|Treatment|Lost to Follow-up|7|||
105998470|NCT02872116|365656213|FG002|Treatment|Lost to Follow-up|3|||
106125476|NCT01023308|366117758|FG000|Overall Study|Lost to Follow-up|1|||
106125477|NCT01023308|366117759|FG001|Overall Study|Lost to Follow-up|0|||
106125478|NCT01023308|366117758|FG000|Overall Study|Withdrawal by Subject|34|||
106125479|NCT01023308|366117759|FG001|Overall Study|Withdrawal by Subject|18|||
105906205|NCT02328937|365316052|FG001|Period 1|Lost to Follow-up|0|||
105906206|NCT02328937|365316053|FG002|Period 1|Lost to Follow-up|0|||
105998471|NCT02872116|365656211|FG000|Treatment|Participant withdrew consent|20|||
105998472|NCT02872116|365656212|FG001|Treatment|Participant withdrew consent|40|||
105998473|NCT02872116|365656213|FG002|Treatment|Participant withdrew consent|8|||
105998474|NCT02872116|365656211|FG000|Treatment|Other reasons|12|||
105998475|NCT02872116|365656212|FG001|Treatment|Other reasons|12|||
105998476|NCT02872116|365656213|FG002|Treatment|Other reasons|5|||
105998477|NCT01329978|365656217|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
105998478|NCT01329978|365656218|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
105998479|NCT01329978|365656219|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
105998480|NCT01329978|365656220|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
105998481|NCT01329978|365656221|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
105998482|NCT01329978|365656217|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
105998483|NCT01329978|365656218|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
105998484|NCT01329978|365656219|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
105998485|NCT01329978|365656220|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
105998486|NCT01329978|365656221|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
105998487|NCT01329978|365656217|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
105998488|NCT01329978|365656218|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
105998489|NCT01329978|365656219|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
105998490|NCT01329978|365656220|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
105998491|NCT01329978|365656221|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
105998492|NCT01329978|365656217|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
105998493|NCT01329978|365656218|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
105998494|NCT01329978|365656219|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
105998495|NCT01329978|365656220|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
105998496|NCT01329978|365656221|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
105998497|NCT01329978|365656217|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
105998498|NCT01329978|365656218|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
105998499|NCT01329978|365656219|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
105998500|NCT01329978|365656220|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
105998501|NCT01329978|365656221|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
105998502|NCT01329978|365656217|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
105998503|NCT01329978|365656218|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
105998504|NCT01329978|365656219|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
105998505|NCT01329978|365656220|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
105998506|NCT01329978|365656221|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
105998507|NCT01329978|365656217|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
105998508|NCT01329978|365656218|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
105998509|NCT01329978|365656219|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
106125480|NCT00593554|366117760|FG000|Overall Study|Death|1|||
106125481|NCT00593554|366117761|FG001|Overall Study|Death|2|||
106125482|NCT00593554|366117760|FG000|Overall Study|Physician Decision|0|||
106125483|NCT00593554|366117761|FG001|Overall Study|Physician Decision|1|||
106125484|NCT00593554|366117760|FG000|Overall Study|Withdrawal by Subject|1|||
106125485|NCT00593554|366117761|FG001|Overall Study|Withdrawal by Subject|0|||
106125486|NCT00593554|366117760|FG000|Overall Study|Disease Progression|1|||
106125487|NCT00593554|366117761|FG001|Overall Study|Disease Progression|2|||
106125488|NCT03638635|366117766|FG000|Initial Hospitalization|Study terminated prematurely|0|||
106125489|NCT03638635|366117767|FG001|Initial Hospitalization|Study terminated prematurely|1|||
105906207|NCT02328937|365316054|FG003|Period 1|Lost to Follow-up|1|||
105906208|NCT02328937|365316055|FG004|Period 1|Lost to Follow-up|0|||
105906209|NCT02328937|365316056|FG005|Period 1|Lost to Follow-up|0|||
105906210|NCT02328937|365316051|FG000|Period 2|Adverse Event|0|||
105906211|NCT02328937|365316052|FG001|Period 2|Adverse Event|0|||
105906212|NCT02328937|365316053|FG002|Period 2|Adverse Event|1|||
105906213|NCT02328937|365316054|FG003|Period 2|Adverse Event|0|||
105998510|NCT01329978|365656220|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
105998511|NCT01329978|365656221|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
105998512|NCT02868554|365656222|FG000|Overall Study|Lost to Follow-up|3|||
105998513|NCT02868554|365656223|FG001|Overall Study|Lost to Follow-up|0|||
106125490|NCT03638635|366117766|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
106125491|NCT03638635|366117767|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
105906214|NCT02328937|365316055|FG004|Period 2|Adverse Event|0|||
105906215|NCT02328937|365316056|FG005|Period 2|Adverse Event|0|||
105669679|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Physician Decision|0|||
105669680|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Physician Decision|0|||
105669681|NCT00350727|364454095|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
105669682|NCT00350727|364454096|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
105669683|NCT00350727|364454097|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
105669684|NCT00350727|364454095|FG000|Phase II|Disease Progression|0|||
105669685|NCT00350727|364454096|FG001|Phase II|Disease Progression|15|||
105669686|NCT00350727|364454097|FG002|Phase II|Disease Progression|16|||
105669687|NCT00350727|364454095|FG000|Phase II|Clinical Deterioration|0|||
105669688|NCT00350727|364454096|FG001|Phase II|Clinical Deterioration|1|||
105669689|NCT00350727|364454097|FG002|Phase II|Clinical Deterioration|0|||
105669690|NCT00350727|364454095|FG000|Phase II|Withdrawal by Subject|0|||
105669691|NCT00350727|364454096|FG001|Phase II|Withdrawal by Subject|2|||
105669692|NCT00350727|364454097|FG002|Phase II|Withdrawal by Subject|1|||
105669693|NCT00350727|364454095|FG000|Phase II|Adverse Event|0|||
105669694|NCT00350727|364454096|FG001|Phase II|Adverse Event|1|||
105669695|NCT00350727|364454097|FG002|Phase II|Adverse Event|1|||
105669696|NCT00350727|364454095|FG000|Phase II|Death|0|||
105669697|NCT00350727|364454096|FG001|Phase II|Death|0|||
105669698|NCT00350727|364454097|FG002|Phase II|Death|2|||
105669699|NCT00350727|364454095|FG000|Phase II|Sponsor Terminated Study|0|||
105669700|NCT00350727|364454096|FG001|Phase II|Sponsor Terminated Study|0|||
105669701|NCT00350727|364454097|FG002|Phase II|Sponsor Terminated Study|1|||
105669702|NCT00350727|364454095|FG000|Phase II|Enrolled in Rollover Study|0|||
105669703|NCT00350727|364454096|FG001|Phase II|Enrolled in Rollover Study|0|||
105669704|NCT00350727|364454097|FG002|Phase II|Enrolled in Rollover Study|1|||
105669705|NCT03682185|364454098|FG000|Overall Study|Lost to Follow-up|4|||
105669706|NCT03682185|364454099|FG001|Overall Study|Lost to Follow-up|7|||
105669707|NCT03682185|364454100|FG002|Overall Study|Lost to Follow-up|4|||
105669708|NCT03682185|364454101|FG003|Overall Study|Lost to Follow-up|7|||
105669709|NCT03682185|364454102|FG004|Overall Study|Lost to Follow-up|1|||
105669710|NCT03682185|364454098|FG000|Overall Study|Withdrawal by Subject|7|||
105669711|NCT03682185|364454099|FG001|Overall Study|Withdrawal by Subject|3|||
105669712|NCT03682185|364454100|FG002|Overall Study|Withdrawal by Subject|7|||
105669713|NCT03682185|364454101|FG003|Overall Study|Withdrawal by Subject|3|||
105669714|NCT03682185|364454102|FG004|Overall Study|Withdrawal by Subject|0|||
105669715|NCT03548220|364454107|FG000|Overall Study|Lost to Follow-up|1|||
105669716|NCT03548220|364454108|FG001|Overall Study|Lost to Follow-up|0|||
105669717|NCT03548220|364454109|FG002|Overall Study|Lost to Follow-up|0|||
105669718|NCT03548220|364454110|FG003|Overall Study|Lost to Follow-up|0|||
105669719|NCT03551691|364454113|FG000|Overall Study|Withdrawal by Subject|3|||
105669720|NCT03551691|364454114|FG001|Overall Study|Withdrawal by Subject|3|||
105669721|NCT01123070|364456067|FG000|Part B Double Blind Period|Protocol Violation|0|||
105669722|NCT01123070|364456068|FG001|Part B Double Blind Period|Protocol Violation|0|||
105669723|NCT01123070|364456069|FG002|Part B Double Blind Period|Protocol Violation|0|||
105669724|NCT01123070|364456070|FG003|Part B Double Blind Period|Protocol Violation|1|||
105669725|NCT01123070|364456067|FG000|Part B Double Blind Period|Adverse Event|0|||
105669726|NCT01123070|364456068|FG001|Part B Double Blind Period|Adverse Event|0|||
105669727|NCT01123070|364456069|FG002|Part B Double Blind Period|Adverse Event|2|||
105669728|NCT01123070|364456070|FG003|Part B Double Blind Period|Adverse Event|0|||
105669729|NCT01123070|364456067|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
105669730|NCT01123070|364456068|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
105669731|NCT01123070|364456069|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
105669732|NCT01123070|364456070|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
105669733|NCT02706405|364456071|FG000|Overall Study|Death|3|||
105669734|NCT02706405|364456072|FG001|Overall Study|Death|2|||
105669735|NCT02706405|364456073|FG002|Overall Study|Death|0|||
105669736|NCT02706405|364456074|FG003|Overall Study|Death|1|||
105669737|NCT02706405|364456075|FG004|Overall Study|Death|0|||
105786076|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
105998514|NCT02868554|365656224|FG002|Overall Study|Lost to Follow-up|1|||
105998515|NCT03305770|365656225|FG000|Overall Study|Physician Decision - prior to dispense|0|||
105998516|NCT03305770|365656226|FG001|Overall Study|Physician Decision - prior to dispense|1|||
105998517|NCT03305770|365656225|FG000|Overall Study|Subject moved|1|||
105669738|NCT02706405|364456076|FG005|Overall Study|Death|0|||
105998518|NCT03305770|365656226|FG001|Overall Study|Subject moved|0|||
105998519|NCT00773513|365656227|FG000|Overall Study|Renal Transplant|254|||
105669739|NCT02706405|364456077|FG006|Overall Study|Death|3|||
105669740|NCT02706405|364456078|FG007|Overall Study|Death|4|||
105669741|NCT02706405|364456071|FG000|Overall Study|Disease progression|0|||
105669742|NCT02706405|364456072|FG001|Overall Study|Disease progression|0|||
105669743|NCT02706405|364456073|FG002|Overall Study|Disease progression|0|||
105669744|NCT02706405|364456074|FG003|Overall Study|Disease progression|0|||
105669745|NCT02706405|364456075|FG004|Overall Study|Disease progression|0|||
105669746|NCT02706405|364456076|FG005|Overall Study|Disease progression|0|||
105669747|NCT02706405|364456077|FG006|Overall Study|Disease progression|0|||
105669748|NCT02706405|364456078|FG007|Overall Study|Disease progression|1|||
105669749|NCT02706405|364456071|FG000|Overall Study|Pt moved to new therapy|0|||
105669750|NCT02706405|364456072|FG001|Overall Study|Pt moved to new therapy|0|||
105669751|NCT02706405|364456073|FG002|Overall Study|Pt moved to new therapy|0|||
105669752|NCT02706405|364456074|FG003|Overall Study|Pt moved to new therapy|0|||
105669753|NCT02706405|364456075|FG004|Overall Study|Pt moved to new therapy|0|||
105669754|NCT02706405|364456076|FG005|Overall Study|Pt moved to new therapy|1|||
105669755|NCT02706405|364456077|FG006|Overall Study|Pt moved to new therapy|0|||
105669756|NCT02706405|364456078|FG007|Overall Study|Pt moved to new therapy|1|||
105669757|NCT02706405|364456071|FG000|Overall Study|Physician Decision|1|||
105669758|NCT02706405|364456072|FG001|Overall Study|Physician Decision|0|||
105669759|NCT02706405|364456073|FG002|Overall Study|Physician Decision|0|||
105669760|NCT02706405|364456074|FG003|Overall Study|Physician Decision|0|||
105669761|NCT02706405|364456075|FG004|Overall Study|Physician Decision|0|||
105669762|NCT02706405|364456076|FG005|Overall Study|Physician Decision|0|||
105669763|NCT02706405|364456077|FG006|Overall Study|Physician Decision|0|||
105669764|NCT02706405|364456078|FG007|Overall Study|Physician Decision|0|||
105669765|NCT01182441|364456079|FG000|Overall Study|Patient Still in Follow-up|152|||
105669766|NCT01182441|364456080|FG001|Overall Study|Patient Still in Follow-up|72|||
105669767|NCT01182441|364456079|FG000|Overall Study|Death|37|||
105669768|NCT01182441|364456080|FG001|Overall Study|Death|25|||
105669769|NCT01182441|364456079|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
105669770|NCT01182441|364456080|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
105669771|NCT01182441|364456079|FG000|Overall Study|Lost to Follow-up|5|||
105669772|NCT01182441|364456080|FG001|Overall Study|Lost to Follow-up|8|||
105669773|NCT01182441|364456079|FG000|Overall Study|Withdrawal by Subject|6|||
105669774|NCT01182441|364456080|FG001|Overall Study|Withdrawal by Subject|13|||
105669775|NCT01182441|364456079|FG000|Overall Study|Implant Not Attempted|4|||
105669776|NCT01182441|364456080|FG001|Overall Study|Implant Not Attempted|0|||
105669777|NCT01182441|364456079|FG000|Overall Study|Adverse Event|2|||
105669778|NCT01182441|364456080|FG001|Overall Study|Adverse Event|0|||
105669779|NCT01182441|364456079|FG000|Overall Study|Physician Decision|1|||
105669780|NCT01182441|364456080|FG001|Overall Study|Physician Decision|1|||
105669781|NCT00515671|364456081|FG000|Overall Study|Lost to Follow-up|13|||
105669782|NCT00515671|364456082|FG001|Overall Study|Lost to Follow-up|10|||
105669783|NCT00515671|364456081|FG000|Overall Study|Withdrawal by Subject|3|||
105669784|NCT00515671|364456082|FG001|Overall Study|Withdrawal by Subject|5|||
105669785|NCT00515671|364456081|FG000|Overall Study|incarcerated|1|||
105669786|NCT00515671|364456082|FG001|Overall Study|incarcerated|2|||
105669787|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
105669788|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
105669789|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105669790|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
105669791|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105669792|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105669793|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
105669794|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
105669795|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105669796|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105669797|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
105669798|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105669799|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
105669800|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
105669801|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105669802|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
105669803|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
105669804|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
105669805|NCT00603525|364456083|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
105669806|NCT00603525|364456084|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
105906216|NCT02091414|365316057|FG000|Overall Study|Withdrawal by Subject|2|||
105906217|NCT02091414|365316057|FG000|Overall Study|Death|2|||
105906218|NCT03665077|365316060|FG000|Overall Study|Lost to Follow-up|2|||
105906219|NCT03665077|365316060|FG000|Overall Study|Physician Decision|2|||
105906220|NCT02959918|365316065|FG000|Overall Study|Adverse Event|1|||
105906221|NCT02959918|365316066|FG001|Overall Study|Adverse Event|1|||
105906222|NCT02959918|365316067|FG002|Overall Study|Adverse Event|2|||
105906223|NCT02959918|365316068|FG003|Overall Study|Adverse Event|0|||
105906224|NCT02959918|365316069|FG004|Overall Study|Adverse Event|0|||
105906225|NCT02959918|365316070|FG005|Overall Study|Adverse Event|2|||
105906226|NCT02959918|365316071|FG006|Overall Study|Adverse Event|2|||
105906227|NCT02959918|365316072|FG007|Overall Study|Adverse Event|1|||
105906228|NCT02959918|365316073|FG008|Overall Study|Adverse Event|2|||
105906229|NCT02959918|365316074|FG009|Overall Study|Adverse Event|1|||
105906230|NCT02959918|365316075|FG010|Overall Study|Adverse Event|1|||
105906231|NCT02959918|365316076|FG011|Overall Study|Adverse Event|3|||
105906232|NCT02959918|365316077|FG012|Overall Study|Adverse Event|2|||
105906233|NCT02959918|365316078|FG013|Overall Study|Adverse Event|4|||
105906234|NCT02959918|365316065|FG000|Overall Study|Lost to Follow-up|0|||
105669807|NCT00603525|364456085|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
105669808|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
105669809|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
105669810|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
105669811|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
105669812|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
105669813|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
105669814|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
105669815|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
105669816|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
105669817|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
105669818|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
105669819|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
105669820|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
105669821|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
105669822|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
105669823|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
105669824|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
105669825|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
105669826|NCT00603525|364456083|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
105906235|NCT02959918|365316066|FG001|Overall Study|Lost to Follow-up|0|||
105906236|NCT02959918|365316067|FG002|Overall Study|Lost to Follow-up|0|||
105906237|NCT02959918|365316068|FG003|Overall Study|Lost to Follow-up|0|||
105906238|NCT02959918|365316069|FG004|Overall Study|Lost to Follow-up|0|||
105906239|NCT02959918|365316070|FG005|Overall Study|Lost to Follow-up|0|||
105906240|NCT02959918|365316071|FG006|Overall Study|Lost to Follow-up|0|||
105906241|NCT02959918|365316072|FG007|Overall Study|Lost to Follow-up|0|||
105906242|NCT02959918|365316073|FG008|Overall Study|Lost to Follow-up|0|||
105906243|NCT02959918|365316074|FG009|Overall Study|Lost to Follow-up|1|||
105906244|NCT02959918|365316075|FG010|Overall Study|Lost to Follow-up|0|||
105906245|NCT02959918|365316076|FG011|Overall Study|Lost to Follow-up|0|||
105906246|NCT02959918|365316077|FG012|Overall Study|Lost to Follow-up|1|||
105906247|NCT02959918|365316078|FG013|Overall Study|Lost to Follow-up|0|||
105906248|NCT02959918|365316065|FG000|Overall Study|Withdrawal by Subject|0|||
105906249|NCT02959918|365316066|FG001|Overall Study|Withdrawal by Subject|0|||
105906250|NCT02959918|365316067|FG002|Overall Study|Withdrawal by Subject|1|||
105906251|NCT02959918|365316068|FG003|Overall Study|Withdrawal by Subject|2|||
105998520|NCT00773513|365656228|FG001|Overall Study|Renal Transplant|263|||
105998521|NCT00773513|365656227|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
105998522|NCT00773513|365656228|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
105998523|NCT00773513|365656227|FG000|Overall Study|Withdrew Consent|68|||
105998524|NCT00773513|365656228|FG001|Overall Study|Withdrew Consent|69|||
105998525|NCT00773513|365656227|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
105998526|NCT00773513|365656228|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
105998527|NCT00773513|365656227|FG000|Overall Study|Failure to Return|22|||
105998528|NCT00773513|365656228|FG001|Overall Study|Failure to Return|8|||
105998529|NCT00773513|365656227|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105998530|NCT00773513|365656228|FG001|Overall Study|Insufficient Therapeutic Response|18|||
105998531|NCT00773513|365656227|FG000|Overall Study|Reason Not Specified|159|||
105998532|NCT00773513|365656228|FG001|Overall Study|Reason Not Specified|126|||
105998533|NCT00773513|365656227|FG000|Overall Study|Death|531|||
105998534|NCT00773513|365656228|FG001|Overall Study|Death|545|||
105998535|NCT02905266|365656230|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
105998536|NCT02905266|365656231|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
105998537|NCT02905266|365656230|FG000|Treatment Phase Part 1|Disease Progression|6|||
105998538|NCT02905266|365656231|FG001|Treatment Phase Part 1|Disease Progression|7|||
105998539|NCT02905266|365656230|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
105998540|NCT02905266|365656231|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
105998541|NCT02905266|365656230|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
105998542|NCT02905266|365656231|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
105998543|NCT02905266|365656230|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
105998544|NCT02905266|365656231|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
105998545|NCT02905266|365656230|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
105998546|NCT02905266|365656231|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
105998547|NCT02905266|365656230|FG000|Transition From Part 1 to Part 2|Death|0|||
105998548|NCT02905266|365656231|FG001|Transition From Part 1 to Part 2|Death|1|||
105998549|NCT02905266|365656230|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
105906252|NCT02959918|365316069|FG004|Overall Study|Withdrawal by Subject|0|||
105906253|NCT02959918|365316070|FG005|Overall Study|Withdrawal by Subject|0|||
105906254|NCT02959918|365316071|FG006|Overall Study|Withdrawal by Subject|1|||
105998550|NCT02905266|365656231|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
105669827|NCT00603525|364456084|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
105669828|NCT00603525|364456085|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
105669829|NCT00603525|364456083|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
105669830|NCT00603525|364456084|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
105669831|NCT00603525|364456085|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
105669832|NCT02815579|364456086|FG000|Overall Study|Non-payment of loan down-payment|16|||
105669833|NCT02815579|364456087|FG001|Overall Study|Non-payment of loan down-payment|0|||
105669834|NCT02815579|364456086|FG000|Overall Study|Withdrawal by Subject|7|||
106125492|NCT03638635|366117766|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
106125493|NCT03638635|366117767|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
106125494|NCT00962585|366117775|FG000|Overall Study|Adverse Event|0|||
106125495|NCT00962585|366117776|FG001|Overall Study|Adverse Event|2|||
106125496|NCT00962585|366117777|FG002|Overall Study|Adverse Event|1|||
106125497|NCT00962585|366117778|FG003|Overall Study|Adverse Event|0|||
106125498|NCT00962585|366117775|FG000|Overall Study|Lost to Follow-up|3|||
106125499|NCT00962585|366117776|FG001|Overall Study|Lost to Follow-up|0|||
106125500|NCT00962585|366117777|FG002|Overall Study|Lost to Follow-up|1|||
106125501|NCT00962585|366117778|FG003|Overall Study|Lost to Follow-up|0|||
106125502|NCT00962585|366117775|FG000|Overall Study|Protocol Violation|0|||
106125503|NCT00962585|366117776|FG001|Overall Study|Protocol Violation|0|||
106125504|NCT00962585|366117777|FG002|Overall Study|Protocol Violation|1|||
106125505|NCT00962585|366117778|FG003|Overall Study|Protocol Violation|0|||
106125506|NCT00962585|366117775|FG000|Overall Study|Withdrawal by Subject|1|||
106125507|NCT00962585|366117776|FG001|Overall Study|Withdrawal by Subject|0|||
106125508|NCT00962585|366117777|FG002|Overall Study|Withdrawal by Subject|0|||
106125509|NCT00962585|366117778|FG003|Overall Study|Withdrawal by Subject|0|||
106125510|NCT00962585|366117775|FG000|Overall Study|Withdrew Consent|2|||
106125511|NCT00962585|366117776|FG001|Overall Study|Withdrew Consent|0|||
106125512|NCT00962585|366117777|FG002|Overall Study|Withdrew Consent|0|||
106125513|NCT00962585|366117778|FG003|Overall Study|Withdrew Consent|0|||
106125514|NCT03354637|366117783|FG000|Double-blind Period|Protocol Violation|2|||
106125515|NCT03354637|366117784|FG001|Double-blind Period|Protocol Violation|0|||
106125516|NCT03354637|366117785|FG002|Double-blind Period|Protocol Violation|0|||
106125517|NCT03354637|366117783|FG000|Double-blind Period|Adverse Event|1|||
106125518|NCT03354637|366117784|FG001|Double-blind Period|Adverse Event|2|||
106125519|NCT03354637|366117785|FG002|Double-blind Period|Adverse Event|0|||
106125520|NCT03354637|366117783|FG000|Double-blind Period|Lost to Follow-up|3|||
106125521|NCT03354637|366117784|FG001|Double-blind Period|Lost to Follow-up|4|||
106125522|NCT03354637|366117785|FG002|Double-blind Period|Lost to Follow-up|3|||
106125523|NCT03354637|366117783|FG000|Double-blind Period|Withdrawal by Subject|10|||
106125524|NCT03354637|366117784|FG001|Double-blind Period|Withdrawal by Subject|6|||
106125525|NCT03354637|366117785|FG002|Double-blind Period|Withdrawal by Subject|4|||
106125526|NCT03354637|366117783|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
106125527|NCT03354637|366117784|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
106125528|NCT03354637|366117785|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
106125529|NCT03354637|366117783|FG000|Open Label Extension|Adverse Event|0|||
106125530|NCT03354637|366117784|FG001|Open Label Extension|Adverse Event|0|||
106125531|NCT03354637|366117785|FG002|Open Label Extension|Adverse Event|1|||
106125532|NCT03354637|366117783|FG000|Open Label Extension|Lost to Follow-up|0|||
106125533|NCT03354637|366117784|FG001|Open Label Extension|Lost to Follow-up|0|||
106125534|NCT03354637|366117785|FG002|Open Label Extension|Lost to Follow-up|2|||
106125535|NCT03354637|366117783|FG000|Open Label Extension|Withdrawal by Subject|0|||
106125536|NCT03354637|366117784|FG001|Open Label Extension|Withdrawal by Subject|0|||
106125537|NCT03354637|366117785|FG002|Open Label Extension|Withdrawal by Subject|5|||
106125538|NCT03354637|366117783|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
106125539|NCT03354637|366117784|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
106125540|NCT03354637|366117785|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
106125541|NCT03354637|366117783|FG000|Open Label Extension|Subject Noncompliance|0|||
106125542|NCT03354637|366117784|FG001|Open Label Extension|Subject Noncompliance|0|||
106125543|NCT03354637|366117785|FG002|Open Label Extension|Subject Noncompliance|1|||
106125544|NCT03354637|366117783|FG000|Open Label Extension|Lack of Efficacy|0|||
105669835|NCT02815579|364456087|FG001|Overall Study|Withdrawal by Subject|1|||
106125545|NCT03354637|366117784|FG001|Open Label Extension|Lack of Efficacy|0|||
106125546|NCT03354637|366117785|FG002|Open Label Extension|Lack of Efficacy|1|||
106125547|NCT03354637|366117783|FG000|Open Label Extension|Physician Decision|0|||
106125548|NCT03354637|366117784|FG001|Open Label Extension|Physician Decision|0|||
106125549|NCT03354637|366117785|FG002|Open Label Extension|Physician Decision|1|||
106125550|NCT02726399|366117788|FG000|Overall Study|Participant Non-Compliance|1|||
106125551|NCT02726399|366117788|FG000|Overall Study|Adverse Event|2|||
106125552|NCT02726399|366117788|FG000|Overall Study|Progression of disease|4|||
106125553|NCT03685708|366117789|FG000|Overall Study|Withdrawal by Subject|0|||
106125554|NCT03685708|366117790|FG001|Overall Study|Withdrawal by Subject|0|||
106125555|NCT03685708|366117791|FG002|Overall Study|Withdrawal by Subject|1|||
106125556|NCT03685708|366117789|FG000|Overall Study|Screen Fail|0|||
105669836|NCT02815579|364456086|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
105669837|NCT02815579|364456087|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
105669838|NCT02815579|364456086|FG000|Overall Study|Lost to Follow-up|7|||
105669839|NCT02815579|364456087|FG001|Overall Study|Lost to Follow-up|4|||
105669840|NCT02815579|364456086|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
105669841|NCT02815579|364456087|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
105669842|NCT02815579|364456086|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
105669843|NCT02815579|364456087|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
105669844|NCT02815579|364456086|FG000|Overall Study|Death|5|||
105669845|NCT02815579|364456087|FG001|Overall Study|Death|4|||
105669846|NCT02815579|364456086|FG000|Overall Study|Imprisoned|0|||
105669847|NCT02815579|364456087|FG001|Overall Study|Imprisoned|2|||
105669848|NCT02815579|364456086|FG000|Overall Study|Did not meet enrollment criteria|0|||
105669849|NCT02815579|364456087|FG001|Overall Study|Did not meet enrollment criteria|1|||
105669850|NCT01195948|364456090|FG000|Overall Study|Lost to Follow-up|0|||
105669851|NCT01195948|364456091|FG001|Overall Study|Lost to Follow-up|1|||
105669852|NCT01195948|364456092|FG002|Overall Study|Lost to Follow-up|2|||
105669853|NCT04043143|364456093|FG000|Overall Study|Lost to Follow-up|5|||
105669854|NCT04043143|364456094|FG001|Overall Study|Lost to Follow-up|5|||
105669855|NCT04043143|364456093|FG000|Overall Study|screen failure|1|||
105669856|NCT04043143|364456094|FG001|Overall Study|screen failure|0|||
105669857|NCT03480932|364456095|FG000|Overall Study|Death|1|||
105669858|NCT03480932|364456096|FG001|Overall Study|Death|1|||
105669859|NCT03480932|364456097|FG002|Overall Study|Death|0|||
105669860|NCT03480932|364456095|FG000|Overall Study|Lost to Follow-up|0|||
105669861|NCT03480932|364456096|FG001|Overall Study|Lost to Follow-up|2|||
105669862|NCT03480932|364456097|FG002|Overall Study|Lost to Follow-up|3|||
105669863|NCT03480932|364456095|FG000|Overall Study|Incarcerated|2|||
105669864|NCT03480932|364456096|FG001|Overall Study|Incarcerated|2|||
105669865|NCT03480932|364456097|FG002|Overall Study|Incarcerated|2|||
105669866|NCT00667225|364456101|FG000|Overall Study|Subject had no more lesions to treat.|1|||
105669867|NCT00667225|364456102|FG001|Overall Study|Subject had no more lesions to treat.|0|||
105669868|NCT00667225|364456101|FG000|Overall Study|Lost to Follow-up|0|||
105669869|NCT00667225|364456102|FG001|Overall Study|Lost to Follow-up|1|||
105669870|NCT00953771|364456103|FG000|Overall Study|Death|1|||
105669871|NCT00953771|364456104|FG001|Overall Study|Death|0|||
105669872|NCT00527787|364456109|FG000|Overall Study|Adverse Event|14|||
105669873|NCT00527787|364456110|FG001|Overall Study|Adverse Event|24|||
105669874|NCT00527787|364456109|FG000|Overall Study|Withdrawal by Subject|13|||
105669875|NCT00527787|364456110|FG001|Overall Study|Withdrawal by Subject|25|||
105669876|NCT00527787|364456109|FG000|Overall Study|Lost to Follow-up|5|||
105669877|NCT00527787|364456110|FG001|Overall Study|Lost to Follow-up|2|||
105669878|NCT00527787|364456109|FG000|Overall Study|Duodenal Ulcer|1|||
105669879|NCT00527787|364456110|FG001|Overall Study|Duodenal Ulcer|10|||
105669880|NCT00527787|364456109|FG000|Overall Study|misc|5|||
105669881|NCT00527787|364456110|FG001|Overall Study|misc|2|||
105669882|NCT03433677|364456111|FG000|Period 1|Protocol Violation|1|||
105669883|NCT03433677|364456112|FG001|Period 1|Protocol Violation|0|||
105669884|NCT03433677|364456111|FG000|Period 2|Withdrawal by Subject|1|||
105669885|NCT03433677|364456112|FG001|Period 2|Withdrawal by Subject|1|||
105669886|NCT00626197|364456115|FG000|Overall Study|Did not cooperate|2|||
105669887|NCT00626197|364456116|FG001|Overall Study|Did not cooperate|6|||
105669888|NCT00626197|364456117|FG002|Overall Study|Did not cooperate|1|||
105669889|NCT00626197|364456115|FG000|Overall Study|Failure to return|6|||
105669890|NCT00626197|364456116|FG001|Overall Study|Failure to return|5|||
105669891|NCT00626197|364456117|FG002|Overall Study|Failure to return|6|||
105669892|NCT00626197|364456115|FG000|Overall Study|Adverse event, serious fatal|3|||
105906255|NCT02959918|365316072|FG007|Overall Study|Withdrawal by Subject|0|||
105669893|NCT00626197|364456116|FG001|Overall Study|Adverse event, serious fatal|6|||
105669894|NCT00626197|364456117|FG002|Overall Study|Adverse event, serious fatal|6|||
105906256|NCT02959918|365316073|FG008|Overall Study|Withdrawal by Subject|1|||
105906257|NCT02959918|365316074|FG009|Overall Study|Withdrawal by Subject|1|||
105906258|NCT02959918|365316075|FG010|Overall Study|Withdrawal by Subject|2|||
105906259|NCT02959918|365316076|FG011|Overall Study|Withdrawal by Subject|3|||
105669895|NCT00626197|364456115|FG000|Overall Study|Adverse Event|1|||
105669896|NCT00626197|364456116|FG001|Overall Study|Adverse Event|1|||
105669897|NCT00626197|364456117|FG002|Overall Study|Adverse Event|2|||
105669898|NCT00626197|364456115|FG000|Overall Study|Withdrawal by Subject|17|||
105669899|NCT00626197|364456116|FG001|Overall Study|Withdrawal by Subject|17|||
105669900|NCT00626197|364456117|FG002|Overall Study|Withdrawal by Subject|7|||
105906260|NCT02959918|365316077|FG012|Overall Study|Withdrawal by Subject|1|||
105906261|NCT02959918|365316078|FG013|Overall Study|Withdrawal by Subject|1|||
105906262|NCT02959918|365316065|FG000|Overall Study|Protocol Violation|0|||
105906263|NCT02959918|365316066|FG001|Overall Study|Protocol Violation|0|||
105669901|NCT00626197|364456115|FG000|Overall Study|Administrative reasons|15|||
105669902|NCT00626197|364456116|FG001|Overall Study|Administrative reasons|19|||
105669903|NCT00626197|364456117|FG002|Overall Study|Administrative reasons|55|||
105998551|NCT02905266|365656230|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
105998552|NCT02905266|365656231|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
106125557|NCT03685708|366117790|FG001|Overall Study|Screen Fail|1|||
106125558|NCT03685708|366117791|FG002|Overall Study|Screen Fail|1|||
106125559|NCT03685708|366117789|FG000|Overall Study|COVID 19 Pandemic|1|||
106125560|NCT03685708|366117790|FG001|Overall Study|COVID 19 Pandemic|1|||
106125561|NCT03685708|366117791|FG002|Overall Study|COVID 19 Pandemic|6|||
106125562|NCT03685708|366117789|FG000|Overall Study|Disease Progression|0|||
105998553|NCT02905266|365656230|FG000|Maintenance Phase Part 2|Disease Progression|9|||
105998554|NCT02905266|365656231|FG001|Maintenance Phase Part 2|Disease Progression|2|||
106125563|NCT03685708|366117790|FG001|Overall Study|Disease Progression|0|||
106125564|NCT03685708|366117791|FG002|Overall Study|Disease Progression|1|||
106125565|NCT04430335|366117792|FG000|Overall Study|Withdrawal by Subject|1|||
106125566|NCT01592695|366117812|FG000|Overall Study|Lost to Follow-up|8|||
106125567|NCT01592695|366117813|FG001|Overall Study|Lost to Follow-up|4|||
105998555|NCT02905266|365656230|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
105998556|NCT02905266|365656231|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
105998557|NCT02905266|365656230|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
105998558|NCT02905266|365656231|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
105998559|NCT03259555|365656238|FG000|Overall Study|Adverse Event|6|||
106125568|NCT00627042|366117814|FG000|Overall Study|Withdrawal by Subject|2|||
106125569|NCT01375959|366117815|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
106125570|NCT01375959|366117816|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
106125571|NCT01375959|366117815|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
106125572|NCT01375959|366117816|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
106125573|NCT01375959|366117815|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
106125574|NCT01375959|366117816|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
105906264|NCT02959918|365316067|FG002|Overall Study|Protocol Violation|1|||
105998560|NCT03259555|365656239|FG001|Overall Study|Adverse Event|4|||
105998561|NCT03259555|365656238|FG000|Overall Study|Lack of Efficacy|6|||
105998562|NCT03259555|365656239|FG001|Overall Study|Lack of Efficacy|4|||
105998563|NCT03259555|365656238|FG000|Overall Study|Lost to Follow-up|0|||
105998564|NCT03259555|365656239|FG001|Overall Study|Lost to Follow-up|2|||
105998565|NCT03259555|365656238|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105906265|NCT02959918|365316068|FG003|Overall Study|Protocol Violation|0|||
105906266|NCT02959918|365316069|FG004|Overall Study|Protocol Violation|0|||
105906267|NCT02959918|365316070|FG005|Overall Study|Protocol Violation|1|||
105906268|NCT02959918|365316071|FG006|Overall Study|Protocol Violation|0|||
105906269|NCT02959918|365316072|FG007|Overall Study|Protocol Violation|0|||
105906270|NCT02959918|365316073|FG008|Overall Study|Protocol Violation|2|||
105669904|NCT03559062|364456118|FG000|Overall Study|Other|0|||
105906271|NCT02959918|365316074|FG009|Overall Study|Protocol Violation|1|||
105906272|NCT02959918|365316075|FG010|Overall Study|Protocol Violation|0|||
106125575|NCT00178256|366117817|FG000|Overall Study|Adverse Event|2|||
106125576|NCT00178256|366117818|FG001|Overall Study|Adverse Event|0|||
106125577|NCT00178256|366117819|FG002|Overall Study|Adverse Event|0|||
106125578|NCT00178256|366117820|FG003|Overall Study|Adverse Event|0|||
106125579|NCT00178256|366117817|FG000|Overall Study|Death|0|||
105906273|NCT02959918|365316076|FG011|Overall Study|Protocol Violation|1|||
105906274|NCT02959918|365316077|FG012|Overall Study|Protocol Violation|1|||
105906275|NCT02959918|365316078|FG013|Overall Study|Protocol Violation|0|||
105906276|NCT02959918|365316065|FG000|Overall Study|Stopping Rule Met|1|||
105906277|NCT02959918|365316066|FG001|Overall Study|Stopping Rule Met|0|||
105906278|NCT02959918|365316067|FG002|Overall Study|Stopping Rule Met|3|||
105906279|NCT02959918|365316068|FG003|Overall Study|Stopping Rule Met|4|||
105906280|NCT02959918|365316069|FG004|Overall Study|Stopping Rule Met|5|||
105906281|NCT02959918|365316070|FG005|Overall Study|Stopping Rule Met|3|||
105906282|NCT02959918|365316071|FG006|Overall Study|Stopping Rule Met|2|||
105906283|NCT02959918|365316072|FG007|Overall Study|Stopping Rule Met|4|||
105906284|NCT02959918|365316073|FG008|Overall Study|Stopping Rule Met|1|||
105906285|NCT02959918|365316074|FG009|Overall Study|Stopping Rule Met|1|||
105906286|NCT02959918|365316075|FG010|Overall Study|Stopping Rule Met|3|||
105906287|NCT02959918|365316076|FG011|Overall Study|Stopping Rule Met|5|||
105906288|NCT02959918|365316077|FG012|Overall Study|Stopping Rule Met|2|||
105906289|NCT02959918|365316078|FG013|Overall Study|Stopping Rule Met|1|||
105906290|NCT02959918|365316065|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
105906291|NCT02959918|365316066|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
105906292|NCT02959918|365316067|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
105906293|NCT02959918|365316068|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
105906294|NCT02959918|365316069|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906295|NCT02959918|365316070|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906296|NCT02959918|365316071|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906297|NCT02959918|365316072|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906298|NCT02959918|365316073|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105998566|NCT03259555|365656239|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105998567|NCT03259555|365656238|FG000|Overall Study|Progressive Disease|0|||
105998568|NCT03259555|365656239|FG001|Overall Study|Progressive Disease|2|||
105998569|NCT03259555|365656238|FG000|Overall Study|Withdrawal by Subject|19|||
105998570|NCT03259555|365656239|FG001|Overall Study|Withdrawal by Subject|16|||
105998571|NCT03259555|365656238|FG000|Overall Study|Physician Decision|1|||
105998572|NCT03259555|365656239|FG001|Overall Study|Physician Decision|2|||
105998573|NCT03259555|365656238|FG000|Overall Study|Other|1|||
105998574|NCT03259555|365656239|FG001|Overall Study|Other|0|||
105998575|NCT00279916|365656240|FG000|Overall Study|Withdrawal by Subject|4|||
105998576|NCT00279916|365656241|FG001|Overall Study|Withdrawal by Subject|3|||
105998577|NCT00279916|365656240|FG000|Overall Study|Lost to Follow-up|3|||
105998578|NCT00279916|365656241|FG001|Overall Study|Lost to Follow-up|2|||
105998579|NCT04303559|365656242|FG000|Overall Study|Study closed due to poor enrollment.|1|||
105998580|NCT02715609|365656250|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
105998581|NCT02715609|365656251|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
105998582|NCT02715609|365656252|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
105998583|NCT02715609|365656250|FG000|Overall Study|Withdrawal by Subject|0|||
105998584|NCT02715609|365656251|FG001|Overall Study|Withdrawal by Subject|0|||
105998585|NCT02715609|365656252|FG002|Overall Study|Withdrawal by Subject|1|||
105998586|NCT00866814|365656253|FG000|Overall Study|Lost to Follow-up|12|||
105998587|NCT00866814|365656253|FG000|Overall Study|Adverse Event|2|||
105998588|NCT00866814|365656253|FG000|Overall Study|Physician Decision|1|||
105998589|NCT00866814|365656253|FG000|Overall Study|Death|1|||
105998590|NCT00866814|365656253|FG000|Overall Study|No longer wished to participate|1|||
105998591|NCT00866814|365656253|FG000|Overall Study|Unable to meet follow-up requirements|2|||
105998592|NCT00866814|365656253|FG000|Overall Study|Moved to area without study site|1|||
105906299|NCT02959918|365316074|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906300|NCT02959918|365316075|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906301|NCT02959918|365316076|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906302|NCT02959918|365316077|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906303|NCT02959918|365316078|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
105906304|NCT02959918|365316065|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906305|NCT02959918|365316066|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906306|NCT02959918|365316067|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906307|NCT02959918|365316068|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906308|NCT02959918|365316069|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906309|NCT02959918|365316070|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906310|NCT02959918|365316071|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105998593|NCT00348673|365656265|FG000|Stage 1|Randomized but not Treated|0|||
105906311|NCT02959918|365316072|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
105998594|NCT00348673|365656266|FG001|Stage 1|Randomized but not Treated|0|||
105998595|NCT00348673|365656267|FG002|Stage 1|Randomized but not Treated|1|||
105998596|NCT00348673|365656268|FG003|Stage 1|Randomized but not Treated|0|||
105998597|NCT00348673|365656269|FG004|Stage 1|Randomized but not Treated|0|||
105998598|NCT00348673|365656270|FG005|Stage 1|Randomized but not Treated|0|||
105998599|NCT00348673|365656271|FG006|Stage 1|Randomized but not Treated|0|||
105998600|NCT00348673|365656272|FG007|Stage 1|Randomized but not Treated|0|||
105998601|NCT00348673|365656273|FG008|Stage 1|Randomized but not Treated|0|||
105998602|NCT03160898|365656274|FG000|Overall Study|Adverse Event|4|||
105998603|NCT03160898|365656275|FG001|Overall Study|Adverse Event|8|||
105998604|NCT03160898|365656276|FG002|Overall Study|Adverse Event|7|||
105998605|NCT03160898|365656277|FG003|Overall Study|Adverse Event|10|||
105998606|NCT03160898|365656274|FG000|Overall Study|Death|1|||
105998607|NCT03160898|365656275|FG001|Overall Study|Death|0|||
105998608|NCT03160898|365656276|FG002|Overall Study|Death|0|||
105998609|NCT03160898|365656277|FG003|Overall Study|Death|1|||
105998610|NCT03160898|365656274|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
105998611|NCT03160898|365656275|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
105998612|NCT03160898|365656276|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
105998613|NCT03160898|365656277|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
105998614|NCT03160898|365656274|FG000|Overall Study|Lost to Follow-up|1|||
105998615|NCT03160898|365656275|FG001|Overall Study|Lost to Follow-up|1|||
105998616|NCT03160898|365656276|FG002|Overall Study|Lost to Follow-up|1|||
105998617|NCT03160898|365656277|FG003|Overall Study|Lost to Follow-up|2|||
105998618|NCT03160898|365656274|FG000|Overall Study|Physician Decision|1|||
105998619|NCT03160898|365656275|FG001|Overall Study|Physician Decision|0|||
105998620|NCT03160898|365656276|FG002|Overall Study|Physician Decision|0|||
105998621|NCT03160898|365656277|FG003|Overall Study|Physician Decision|1|||
105998622|NCT03160898|365656274|FG000|Overall Study|Progressive Disease|4|||
105998623|NCT03160898|365656275|FG001|Overall Study|Progressive Disease|1|||
105998624|NCT03160898|365656276|FG002|Overall Study|Progressive Disease|2|||
105998625|NCT03160898|365656277|FG003|Overall Study|Progressive Disease|1|||
105998626|NCT03160898|365656274|FG000|Overall Study|Protocol Violation|1|||
105998627|NCT03160898|365656275|FG001|Overall Study|Protocol Violation|0|||
105998628|NCT03160898|365656276|FG002|Overall Study|Protocol Violation|2|||
105998629|NCT03160898|365656277|FG003|Overall Study|Protocol Violation|0|||
105998630|NCT03160898|365656274|FG000|Overall Study|Sponsor Discretion|2|||
105998631|NCT03160898|365656275|FG001|Overall Study|Sponsor Discretion|0|||
105998632|NCT03160898|365656276|FG002|Overall Study|Sponsor Discretion|0|||
105998633|NCT03160898|365656277|FG003|Overall Study|Sponsor Discretion|0|||
105998634|NCT03160898|365656274|FG000|Overall Study|Withdrawal by Subject|1|||
105998635|NCT03160898|365656275|FG001|Overall Study|Withdrawal by Subject|3|||
105998636|NCT03160898|365656276|FG002|Overall Study|Withdrawal by Subject|2|||
105998637|NCT03160898|365656277|FG003|Overall Study|Withdrawal by Subject|1|||
105998638|NCT03160898|365656274|FG000|Overall Study|Other|2|||
105998639|NCT03160898|365656275|FG001|Overall Study|Other|0|||
105998640|NCT03160898|365656276|FG002|Overall Study|Other|2|||
105998641|NCT03160898|365656277|FG003|Overall Study|Other|2|||
105998642|NCT01871519|365656282|FG000|Overall Study|Death|26|||
105998643|NCT01871519|365656282|FG000|Overall Study|Lost to Follow-up|15|||
105906312|NCT02959918|365316073|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906313|NCT02959918|365316074|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906314|NCT02959918|365316075|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906315|NCT02959918|365316076|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906316|NCT02959918|365316077|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906317|NCT02959918|365316078|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
105906318|NCT02959918|365316065|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906319|NCT02959918|365316066|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105669905|NCT03559062|364456119|FG001|Overall Study|Other|1|||
105998644|NCT01871519|365656282|FG000|Overall Study|Withdrawal by Subject|49|||
105998645|NCT00320515|365656283|FG000|Overall Study|Death|33|||
105998646|NCT00320515|365656283|FG000|Overall Study|Lost to Follow-up|6|||
105998647|NCT00320515|365656283|FG000|Overall Study|Physician Decision|2|||
105998648|NCT00320515|365656283|FG000|Overall Study|Withdrawal by Subject|8|||
105998649|NCT02485704|365656284|FG000|Overall Study|Lost to Follow-up|4|||
105998650|NCT02485704|365656285|FG001|Overall Study|Lost to Follow-up|5|||
105998651|NCT02485704|365656284|FG000|Overall Study|Withdrawal by Subject|0|||
105998652|NCT02485704|365656285|FG001|Overall Study|Withdrawal by Subject|3|||
105998653|NCT02485704|365656284|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
105998654|NCT02485704|365656285|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
105998655|NCT01777776|365656286|FG000|Overall Study|Adverse Event|2|||
105998656|NCT01777776|365656287|FG001|Overall Study|Adverse Event|4|||
105998657|NCT01777776|365656288|FG002|Overall Study|Adverse Event|0|||
105998658|NCT01777776|365656289|FG003|Overall Study|Adverse Event|0|||
105998659|NCT01777776|365656286|FG000|Overall Study|Disease Progression|4|||
105906320|NCT02959918|365316067|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105998660|NCT01777776|365656287|FG001|Overall Study|Disease Progression|8|||
105998661|NCT01777776|365656288|FG002|Overall Study|Disease Progression|6|||
105998662|NCT01777776|365656289|FG003|Overall Study|Disease Progression|3|||
105998663|NCT01777776|365656286|FG000|Overall Study|Withdrawal by Subject|0|||
105998664|NCT01777776|365656287|FG001|Overall Study|Withdrawal by Subject|0|||
105998665|NCT01777776|365656288|FG002|Overall Study|Withdrawal by Subject|0|||
105906321|NCT02959918|365316068|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906322|NCT02959918|365316069|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906323|NCT02959918|365316070|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906324|NCT02959918|365316071|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906325|NCT02959918|365316072|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906326|NCT02959918|365316073|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
105906327|NCT02959918|365316074|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906328|NCT02959918|365316075|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906329|NCT02959918|365316076|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906330|NCT02959918|365316077|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906331|NCT02959918|365316078|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
105906332|NCT02959918|365316065|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906333|NCT02959918|365316066|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906334|NCT02959918|365316067|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906335|NCT02959918|365316068|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906336|NCT02959918|365316069|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906337|NCT02959918|365316070|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906338|NCT02959918|365316071|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906339|NCT02959918|365316072|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906340|NCT02959918|365316073|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906341|NCT02959918|365316074|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
105906342|NCT02959918|365316075|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906343|NCT02959918|365316076|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906344|NCT02959918|365316077|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906345|NCT02959918|365316078|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
105906346|NCT00837967|365316079|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
105906347|NCT00837967|365316080|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
105906348|NCT02782377|365316083|FG000|Overall Study|Physician Decision|5|||
105906349|NCT03883477|365316087|FG000|Overall Study|Death|1|||
105906350|NCT03883477|365316088|FG001|Overall Study|Death|0|||
105906351|NCT03883477|365316087|FG000|Overall Study|Protocol Violation|0|||
105906352|NCT03883477|365316088|FG001|Overall Study|Protocol Violation|1|||
105906353|NCT01904032|365316089|FG000|Overall Study|Adverse Event|3|||
105906354|NCT01904032|365316090|FG001|Overall Study|Adverse Event|1|||
105906355|NCT01904032|365316089|FG000|Overall Study|Lost to Follow-up|4|||
105906356|NCT01904032|365316090|FG001|Overall Study|Lost to Follow-up|2|||
105906357|NCT00531947|365316091|FG000|Overall Study|Adverse Event|5|||
105669906|NCT03559062|364456120|FG002|Overall Study|Other|0|||
105669907|NCT00022659|364456121|FG000|Overall Study|Ineligible: wrong primary|1|||
105669908|NCT00022659|364456121|FG000|Overall Study|Never treated|1|||
105669909|NCT01757197|364456122|FG000|Overall Study|Death|2|||
105669910|NCT03301155|364456129|FG000|Overall Study|Сompliance with exclusion criteria|8|||
105906358|NCT00531947|365316092|FG001|Overall Study|Adverse Event|10|||
105906359|NCT00531947|365316091|FG000|Overall Study|Lost to Follow-up|12|||
105906360|NCT00531947|365316092|FG001|Overall Study|Lost to Follow-up|9|||
105906361|NCT00531947|365316091|FG000|Overall Study|Withdrawal by Subject|14|||
105906362|NCT00531947|365316092|FG001|Overall Study|Withdrawal by Subject|19|||
105906363|NCT00531947|365316091|FG000|Overall Study|Protocol Violation|2|||
105906364|NCT00531947|365316092|FG001|Overall Study|Protocol Violation|1|||
105906365|NCT00531947|365316091|FG000|Overall Study|Non-Compliance|4|||
105906366|NCT00531947|365316092|FG001|Overall Study|Non-Compliance|7|||
105906367|NCT00531947|365316091|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
105906368|NCT00531947|365316092|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
105906369|NCT00003896|365316097|FG000|Overall Study|Adverse Event|16|||
105906370|NCT00003896|365316097|FG000|Overall Study|Withdrawal by Subject|1|||
105906371|NCT00003896|365316097|FG000|Overall Study|Lack of Efficacy|1|||
105906372|NCT00003896|365316097|FG000|Overall Study|Death|3|||
105906373|NCT00003896|365316097|FG000|Overall Study|not protocol specified|3|||
105669911|NCT03301155|364456130|FG001|Overall Study|Сompliance with exclusion criteria|7|||
105669912|NCT03510455|364456132|FG000|Overall Study|Physician Decision|1|||
105669913|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
105669914|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
105669915|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
105669916|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
105669917|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
105669918|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
105906374|NCT00003896|365316097|FG000|Overall Study|ineligible|5|||
105906375|NCT01087203|365316098|FG000|Overall Study|Lost to Follow-up|2|||
105906376|NCT01087203|365316099|FG001|Overall Study|Lost to Follow-up|0|||
105998666|NCT01777776|365656289|FG003|Overall Study|Withdrawal by Subject|1|||
106125580|NCT00178256|366117818|FG001|Overall Study|Death|1|||
105906377|NCT01087203|365316098|FG000|Overall Study|Withdrawal by Subject|2|||
105906378|NCT01087203|365316099|FG001|Overall Study|Withdrawal by Subject|6|||
105906379|NCT01087203|365316098|FG000|Overall Study|Lack of Efficacy|1|||
105906380|NCT01087203|365316099|FG001|Overall Study|Lack of Efficacy|2|||
105906381|NCT01087203|365316098|FG000|Overall Study|Study terminated by sponsor|27|||
105906382|NCT01087203|365316099|FG001|Overall Study|Study terminated by sponsor|27|||
105906383|NCT05279131|365316111|FG000|Overall Study|Lost to Follow-up|1|||
105906384|NCT05279131|365316111|FG000|Overall Study|Death|1|||
105906385|NCT05279131|365316111|FG000|Overall Study|Physician Decision|1|||
105906386|NCT01868165|365316116|FG000|Overall Study|Withdrawal by Subject|36|||
105906387|NCT01868165|365316116|FG000|Overall Study|Physician Decision|2|||
105906388|NCT01868165|365316116|FG000|Overall Study|Lost to Follow-up|3|||
105906389|NCT01868165|365316116|FG000|Overall Study|Death|4|||
105906390|NCT03092791|365316117|FG000|Overall Study|Lost to Follow-up|0|||
105906391|NCT03092791|365316118|FG001|Overall Study|Lost to Follow-up|0|||
105906392|NCT03092791|365316119|FG002|Overall Study|Lost to Follow-up|0|||
105906393|NCT03092791|365316120|FG003|Overall Study|Lost to Follow-up|0|||
105906394|NCT03092791|365316121|FG004|Overall Study|Lost to Follow-up|0|||
105906395|NCT03092791|365316122|FG005|Overall Study|Lost to Follow-up|0|||
105906396|NCT03092791|365316123|FG006|Overall Study|Lost to Follow-up|1|||
105906397|NCT03092791|365316124|FG007|Overall Study|Lost to Follow-up|0|||
105906398|NCT03092791|365316117|FG000|Overall Study|Withdrawal of Consent|0|||
105906399|NCT03092791|365316118|FG001|Overall Study|Withdrawal of Consent|0|||
105906400|NCT03092791|365316119|FG002|Overall Study|Withdrawal of Consent|0|||
105906401|NCT03092791|365316120|FG003|Overall Study|Withdrawal of Consent|0|||
105906402|NCT03092791|365316121|FG004|Overall Study|Withdrawal of Consent|4|||
105906403|NCT03092791|365316122|FG005|Overall Study|Withdrawal of Consent|12|||
105906404|NCT03092791|365316123|FG006|Overall Study|Withdrawal of Consent|6|||
105906405|NCT03092791|365316124|FG007|Overall Study|Withdrawal of Consent|4|||
105906406|NCT03092791|365316117|FG000|Overall Study|Study Termination|0|||
105906407|NCT03092791|365316118|FG001|Overall Study|Study Termination|0|||
105906408|NCT03092791|365316119|FG002|Overall Study|Study Termination|0|||
105906409|NCT03092791|365316120|FG003|Overall Study|Study Termination|0|||
105906410|NCT03092791|365316121|FG004|Overall Study|Study Termination|55|||
105906411|NCT03092791|365316122|FG005|Overall Study|Study Termination|46|||
105906412|NCT03092791|365316123|FG006|Overall Study|Study Termination|53|||
105906413|NCT03092791|365316124|FG007|Overall Study|Study Termination|55|||
105906414|NCT03092791|365316117|FG000|Overall Study|Death|0|||
105906415|NCT03092791|365316118|FG001|Overall Study|Death|0|||
105906416|NCT03092791|365316119|FG002|Overall Study|Death|0|||
105906417|NCT03092791|365316120|FG003|Overall Study|Death|0|||
105906418|NCT03092791|365316121|FG004|Overall Study|Death|0|||
105906419|NCT03092791|365316122|FG005|Overall Study|Death|1|||
105906420|NCT03092791|365316123|FG006|Overall Study|Death|0|||
105906421|NCT03092791|365316124|FG007|Overall Study|Death|1|||
105906422|NCT03092791|365316117|FG000|Overall Study|Reason Not Specified|0|||
105906423|NCT03092791|365316118|FG001|Overall Study|Reason Not Specified|0|||
105906424|NCT03092791|365316119|FG002|Overall Study|Reason Not Specified|0|||
105906425|NCT03092791|365316120|FG003|Overall Study|Reason Not Specified|0|||
105906426|NCT03092791|365316121|FG004|Overall Study|Reason Not Specified|1|||
105906427|NCT03092791|365316122|FG005|Overall Study|Reason Not Specified|1|||
105906428|NCT03092791|365316123|FG006|Overall Study|Reason Not Specified|0|||
105906429|NCT03092791|365316124|FG007|Overall Study|Reason Not Specified|0|||
105906430|NCT01990768|365316125|FG000|Intervention Started|Found to be ineligible|14|||
105906431|NCT01990768|365316126|FG001|Intervention Started|Found to be ineligible|13|||
105906432|NCT01990768|365316127|FG002|Intervention Started|Found to be ineligible|11|||
105906433|NCT01990768|365316125|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
105906434|NCT01990768|365316126|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
105906435|NCT01990768|365316127|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
105906436|NCT01990768|365316125|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
105906437|NCT01990768|365316126|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
105906438|NCT01990768|365316127|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
105906439|NCT01990768|365316125|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
105906440|NCT01990768|365316126|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
105906441|NCT01990768|365316127|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
105906442|NCT01990768|365316125|FG000|Intervention Started|Patient care priority|1|||
105906443|NCT01990768|365316126|FG001|Intervention Started|Patient care priority|2|||
105906444|NCT01990768|365316127|FG002|Intervention Started|Patient care priority|3|||
105906445|NCT01990768|365316125|FG000|Intervention Started|IV lost|2|||
105906446|NCT01990768|365316126|FG001|Intervention Started|IV lost|2|||
105906447|NCT01990768|365316127|FG002|Intervention Started|IV lost|2|||
105906448|NCT01990768|365316125|FG000|Intervention Started|Required CPR|1|||
105906449|NCT01990768|365316126|FG001|Intervention Started|Required CPR|1|||
105906450|NCT01990768|365316127|FG002|Intervention Started|Required CPR|0|||
105906451|NCT01990768|365316125|FG000|Intervention Started|Seizure or hx of seizure|0|||
105906452|NCT01990768|365316126|FG001|Intervention Started|Seizure or hx of seizure|0|||
106125581|NCT00178256|366117819|FG002|Overall Study|Death|0|||
105669919|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
105669920|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
105669921|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
105669922|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
105669923|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
105669924|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
105669925|NCT04939701|364456133|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
105669926|NCT04939701|364456134|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
105669927|NCT04939701|364456135|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
105669928|NCT04939701|364456133|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
105669929|NCT04939701|364456134|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
105669930|NCT04939701|364456135|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
105669931|NCT04939701|364456133|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
105669932|NCT04939701|364456134|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
105669933|NCT04939701|364456135|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
105669934|NCT02383940|364456140|FG000|Overall Study|Adverse Event|1|||
105669935|NCT02383940|364456141|FG001|Overall Study|Adverse Event|0|||
105669936|NCT02383940|364456140|FG000|Overall Study|Lost to Follow-up|2|||
105669937|NCT02383940|364456141|FG001|Overall Study|Lost to Follow-up|2|||
105669938|NCT02383940|364456140|FG000|Overall Study|Physician Decision|2|||
105669939|NCT02383940|364456141|FG001|Overall Study|Physician Decision|0|||
105669940|NCT02383940|364456140|FG000|Overall Study|Withdrawal by Subject|1|||
105669941|NCT02383940|364456141|FG001|Overall Study|Withdrawal by Subject|1|||
105669942|NCT02383940|364456140|FG000|Overall Study|Randomized but not treated|2|||
105669943|NCT02383940|364456141|FG001|Overall Study|Randomized but not treated|0|||
105669944|NCT02383940|364456140|FG000|Overall Study|Other than specified above|1|||
105669945|NCT02383940|364456141|FG001|Overall Study|Other than specified above|0|||
105669946|NCT00384189|364456142|FG000|Overall Study|Reason Not Specified|50|||
105669947|NCT00384189|364456143|FG001|Overall Study|Reason Not Specified|57|||
105669948|NCT00384189|364456144|FG002|Overall Study|Reason Not Specified|58|||
105669949|NCT00384189|364456145|FG003|Overall Study|Reason Not Specified|40|||
105669950|NCT02672852|364456146|FG000|Part A1|Disease Worsening|1|||
105669951|NCT02672852|364456147|FG001|Part A1|Disease Worsening|0|||
105669952|NCT02672852|364456148|FG002|Part A1|Disease Worsening|0|||
105669953|NCT02672852|364456149|FG003|Part A1|Disease Worsening|0|||
105906453|NCT01990768|365316127|FG002|Intervention Started|Seizure or hx of seizure|2|||
105906454|NCT01990768|365316125|FG000|Intervention Started|Discovered to be pregnant|0|||
105906455|NCT01990768|365316126|FG001|Intervention Started|Discovered to be pregnant|1|||
105906456|NCT01990768|365316127|FG002|Intervention Started|Discovered to be pregnant|0|||
105906457|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
105906458|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
105906459|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
105906460|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
105906461|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
105906462|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
105906463|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
105906464|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
105906465|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
105906466|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
105906467|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
105669954|NCT02672852|364456150|FG004|Part A1|Disease Worsening|0|||
105669955|NCT02672852|364456151|FG005|Part A1|Disease Worsening|0|||
105669956|NCT02672852|364456152|FG006|Part A1|Disease Worsening|0|||
105669957|NCT02672852|364456146|FG000|Part A1|Adverse Event|0|||
105906468|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
105906469|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Death|3|||
105669958|NCT02672852|364456147|FG001|Part A1|Adverse Event|1|||
105669959|NCT02672852|364456148|FG002|Part A1|Adverse Event|0|||
105669960|NCT02672852|364456149|FG003|Part A1|Adverse Event|0|||
105669961|NCT02672852|364456150|FG004|Part A1|Adverse Event|0|||
105906470|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Death|1|||
105906471|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Death|1|||
105906472|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Discharged|2|||
105906473|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Discharged|1|||
105906474|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Discharged|0|||
105906475|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
105906476|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
105906477|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
105906478|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
105906479|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
105906480|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
105906481|NCT01990768|365316125|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
105906482|NCT01990768|365316126|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
105906483|NCT01990768|365316127|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
105906484|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
105906485|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
105906486|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
105906487|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
105906488|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
105906489|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
105906490|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
105906491|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
105906492|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
105906493|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
105906494|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
105906495|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
105906496|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
105906497|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
105906498|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
105906499|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
105906500|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
105906501|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
105906502|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
105906503|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
105906504|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
105906505|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
105906506|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
105906507|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
105906508|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
105906509|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
105906510|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
105906511|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
105906512|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
105906513|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
105906514|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
105906515|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
105906516|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
105906517|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
105906518|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
105906519|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
105906520|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
105906521|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
105906522|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
105906523|NCT01990768|365316125|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
105906524|NCT01990768|365316126|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
105669962|NCT02672852|364456151|FG005|Part A1|Adverse Event|0|||
105669963|NCT02672852|364456152|FG006|Part A1|Adverse Event|0|||
105998667|NCT00851786|365656290|FG000|Overall Study|Withdrawal by Subject|0|||
105906525|NCT01990768|365316127|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
105906526|NCT01990768|365316125|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
105906527|NCT01990768|365316126|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
105906528|NCT01990768|365316127|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
105906529|NCT01990768|365316125|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
105906530|NCT01990768|365316126|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
105906531|NCT01990768|365316127|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
105906532|NCT01990768|365316125|FG000|6-Month Follow-up|No contact information|5|||
105906533|NCT01990768|365316126|FG001|6-Month Follow-up|No contact information|6|||
105906534|NCT01990768|365316127|FG002|6-Month Follow-up|No contact information|5|||
105906535|NCT01990768|365316125|FG000|6-Month Follow-up|Homeless|4|||
105906536|NCT01990768|365316126|FG001|6-Month Follow-up|Homeless|3|||
105906537|NCT01990768|365316127|FG002|6-Month Follow-up|Homeless|6|||
105906538|NCT01990768|365316125|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
105906539|NCT01990768|365316126|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
105906540|NCT01990768|365316127|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
105906541|NCT01990768|365316125|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
105906542|NCT01990768|365316126|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
105906543|NCT01990768|365316127|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
105906544|NCT01990768|365316125|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
105906545|NCT01990768|365316126|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
105906546|NCT01990768|365316127|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
105906547|NCT00154375|365316128|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
105906548|NCT00154375|365316129|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
105906549|NCT00154375|365316128|FG000|Overall Study|Adverse Event|18|||
105906550|NCT00154375|365316129|FG001|Overall Study|Adverse Event|20|||
105906551|NCT00154375|365316128|FG000|Overall Study|Withdrawal by Subject|14|||
105906552|NCT00154375|365316129|FG001|Overall Study|Withdrawal by Subject|10|||
105906553|NCT00154375|365316128|FG000|Overall Study|Death|5|||
105906554|NCT00154375|365316129|FG001|Overall Study|Death|13|||
105906555|NCT00154375|365316128|FG000|Overall Study|Study drug no longer required|5|||
105906556|NCT00154375|365316129|FG001|Overall Study|Study drug no longer required|3|||
105906557|NCT00154375|365316128|FG000|Overall Study|Lost to Follow-up|2|||
105906558|NCT00154375|365316129|FG001|Overall Study|Lost to Follow-up|1|||
105906559|NCT00154375|365316128|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105906560|NCT00154375|365316129|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105906561|NCT00154375|365316128|FG000|Overall Study|Protocol Violation|0|||
105906562|NCT00154375|365316129|FG001|Overall Study|Protocol Violation|1|||
105906563|NCT00154375|365316128|FG000|Overall Study|Suspected progression of disease|44|||
105669964|NCT02672852|364456146|FG000|Part A1|Lost to Follow-up|1|||
105906564|NCT00154375|365316129|FG001|Overall Study|Suspected progression of disease|30|||
105906565|NCT02348008|365316130|FG000|Overall Study|Adverse Event|2|||
105906566|NCT02348008|365316131|FG001|Overall Study|Adverse Event|3|||
105906567|NCT02348008|365316132|FG002|Overall Study|Adverse Event|3|||
105906568|NCT02348008|365316130|FG000|Overall Study|Disease Progression|1|||
105906569|NCT02348008|365316131|FG001|Overall Study|Disease Progression|5|||
105906570|NCT02348008|365316132|FG002|Overall Study|Disease Progression|16|||
105906571|NCT02348008|365316130|FG000|Overall Study|Withdrawal by Subject|0|||
105906572|NCT02348008|365316131|FG001|Overall Study|Withdrawal by Subject|1|||
105906573|NCT02348008|365316132|FG002|Overall Study|Withdrawal by Subject|0|||
105906574|NCT02348008|365316130|FG000|Overall Study|Symptomatic Deterioration|0|||
105906575|NCT02348008|365316131|FG001|Overall Study|Symptomatic Deterioration|1|||
105906576|NCT02348008|365316132|FG002|Overall Study|Symptomatic Deterioration|0|||
105906577|NCT06597084|365316135|FG000|Overall Study|Withdrawal by Subject|4|||
105906578|NCT06597084|365316136|FG001|Overall Study|Withdrawal by Subject|9|||
105906579|NCT06597084|365316135|FG000|Overall Study|Consent was not given by the patient until V2|0|||
105906580|NCT06597084|365316136|FG001|Overall Study|Consent was not given by the patient until V2|3|||
105669965|NCT02672852|364456147|FG001|Part A1|Lost to Follow-up|2|||
105669966|NCT02672852|364456148|FG002|Part A1|Lost to Follow-up|0|||
105669967|NCT02672852|364456149|FG003|Part A1|Lost to Follow-up|0|||
105669968|NCT02672852|364456150|FG004|Part A1|Lost to Follow-up|0|||
105669969|NCT02672852|364456151|FG005|Part A1|Lost to Follow-up|0|||
105669970|NCT02672852|364456152|FG006|Part A1|Lost to Follow-up|0|||
105669971|NCT02672852|364456146|FG000|Part A1|Withdrawal by Subject|1|||
105669972|NCT02672852|364456147|FG001|Part A1|Withdrawal by Subject|1|||
105669973|NCT02672852|364456148|FG002|Part A1|Withdrawal by Subject|0|||
105669974|NCT02672852|364456149|FG003|Part A1|Withdrawal by Subject|0|||
105669975|NCT02672852|364456150|FG004|Part A1|Withdrawal by Subject|0|||
105669976|NCT02672852|364456151|FG005|Part A1|Withdrawal by Subject|0|||
105669977|NCT02672852|364456152|FG006|Part A1|Withdrawal by Subject|0|||
105669978|NCT02672852|364456146|FG000|Part A2|Disease worsening|0|||
105669979|NCT02672852|364456147|FG001|Part A2|Disease worsening|0|||
105669980|NCT02672852|364456148|FG002|Part A2|Disease worsening|1|||
105669981|NCT02672852|364456149|FG003|Part A2|Disease worsening|0|||
105669982|NCT02672852|364456150|FG004|Part A2|Disease worsening|0|||
105669983|NCT02672852|364456151|FG005|Part A2|Disease worsening|0|||
105669984|NCT02672852|364456152|FG006|Part A2|Disease worsening|0|||
105669985|NCT02672852|364456146|FG000|Part A2|Adverse Event|0|||
105669986|NCT02672852|364456147|FG001|Part A2|Adverse Event|0|||
105669987|NCT02672852|364456148|FG002|Part A2|Adverse Event|3|||
105669988|NCT02672852|364456149|FG003|Part A2|Adverse Event|0|||
105669989|NCT02672852|364456150|FG004|Part A2|Adverse Event|0|||
105669990|NCT02672852|364456151|FG005|Part A2|Adverse Event|0|||
105669991|NCT02672852|364456152|FG006|Part A2|Adverse Event|0|||
105669992|NCT02672852|364456146|FG000|Part A2|Lost to Follow-up|0|||
105669993|NCT02672852|364456147|FG001|Part A2|Lost to Follow-up|0|||
105906581|NCT06597084|365316135|FG000|Overall Study|Physician Decision|1|||
105906582|NCT06597084|365316136|FG001|Overall Study|Physician Decision|0|||
105906583|NCT06597084|365316135|FG000|Overall Study|Adverse Event|3|||
105906584|NCT06597084|365316136|FG001|Overall Study|Adverse Event|2|||
105906585|NCT06597084|365316135|FG000|Overall Study|Death|4|||
105906586|NCT06597084|365316136|FG001|Overall Study|Death|0|||
105906587|NCT06597084|365316135|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
105906588|NCT06597084|365316136|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
105906589|NCT06597084|365316135|FG000|Overall Study|Lost to Follow-up|4|||
105906590|NCT06597084|365316136|FG001|Overall Study|Lost to Follow-up|2|||
105906591|NCT06597084|365316135|FG000|Overall Study|Other. Not specified|1|||
105906592|NCT06597084|365316136|FG001|Overall Study|Other. Not specified|0|||
105669994|NCT02672852|364456148|FG002|Part A2|Lost to Follow-up|2|||
105669995|NCT02672852|364456149|FG003|Part A2|Lost to Follow-up|0|||
105906593|NCT01588405|365316138|FG000|Overall Study|Adverse Event|1|||
105906594|NCT01588405|365316138|FG000|Overall Study|Clinical Worsening|1|||
105906595|NCT05219968|365316142|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
105906596|NCT05219968|365316143|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
105998668|NCT00851786|365656291|FG001|Overall Study|Withdrawal by Subject|1|||
105669996|NCT02672852|364456150|FG004|Part A2|Lost to Follow-up|0|||
105906597|NCT05219968|365316144|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
105998669|NCT00851786|365656290|FG000|Overall Study|Protocol Violation|0|||
105669997|NCT02672852|364456151|FG005|Part A2|Lost to Follow-up|0|||
105669998|NCT02672852|364456152|FG006|Part A2|Lost to Follow-up|0|||
105669999|NCT02672852|364456146|FG000|Part A2|Withdrawal by Subject|0|||
105670000|NCT02672852|364456147|FG001|Part A2|Withdrawal by Subject|0|||
105670001|NCT02672852|364456148|FG002|Part A2|Withdrawal by Subject|1|||
105906598|NCT05219968|365316145|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
105906599|NCT05219968|365316146|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
105906600|NCT05219968|365316142|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
105906601|NCT05219968|365316143|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
105906602|NCT05219968|365316144|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
105906603|NCT05219968|365316145|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
105906604|NCT05219968|365316146|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
105906605|NCT05219968|365316142|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
105906606|NCT05219968|365316143|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
105906607|NCT05219968|365316144|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
105906608|NCT05219968|365316145|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
105906609|NCT05219968|365316146|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
105906610|NCT05219968|365316142|FG000|Week 24 Treatment Period|Adverse Event|3|||
105906611|NCT05219968|365316143|FG001|Week 24 Treatment Period|Adverse Event|0|||
105906612|NCT05219968|365316144|FG002|Week 24 Treatment Period|Adverse Event|0|||
105906613|NCT05219968|365316145|FG003|Week 24 Treatment Period|Adverse Event|0|||
105906614|NCT05219968|365316146|FG004|Week 24 Treatment Period|Adverse Event|0|||
105906615|NCT05219968|365316142|FG000|Week 24 Treatment Period|Physician Decision|0|||
105906616|NCT05219968|365316143|FG001|Week 24 Treatment Period|Physician Decision|1|||
105906617|NCT05219968|365316144|FG002|Week 24 Treatment Period|Physician Decision|0|||
105906618|NCT05219968|365316145|FG003|Week 24 Treatment Period|Physician Decision|0|||
105906619|NCT05219968|365316146|FG004|Week 24 Treatment Period|Physician Decision|0|||
105906620|NCT05219968|365316142|FG000|Week 24 Treatment Period|Other, not specified|3|||
105906621|NCT05219968|365316143|FG001|Week 24 Treatment Period|Other, not specified|0|||
105906622|NCT05219968|365316144|FG002|Week 24 Treatment Period|Other, not specified|0|||
105906623|NCT05219968|365316145|FG003|Week 24 Treatment Period|Other, not specified|0|||
105906624|NCT05219968|365316146|FG004|Week 24 Treatment Period|Other, not specified|0|||
105906625|NCT05219968|365316142|FG000|Safety Extension Period|Treatment administration failure|0|||
105906626|NCT05219968|365316143|FG001|Safety Extension Period|Treatment administration failure|0|||
105906627|NCT05219968|365316144|FG002|Safety Extension Period|Treatment administration failure|0|||
105906628|NCT05219968|365316145|FG003|Safety Extension Period|Treatment administration failure|1|||
105906629|NCT05219968|365316146|FG004|Safety Extension Period|Treatment administration failure|4|||
105906630|NCT05219968|365316142|FG000|Safety Extension Period|Bilateral dislodgement|0|||
105906631|NCT05219968|365316143|FG001|Safety Extension Period|Bilateral dislodgement|0|||
105906632|NCT05219968|365316144|FG002|Safety Extension Period|Bilateral dislodgement|4|||
105906633|NCT05219968|365316145|FG003|Safety Extension Period|Bilateral dislodgement|0|||
105906634|NCT05219968|365316146|FG004|Safety Extension Period|Bilateral dislodgement|1|||
105906635|NCT05219968|365316142|FG000|Safety Extension Period|Withdrawal by Subject|0|||
105906636|NCT05219968|365316143|FG001|Safety Extension Period|Withdrawal by Subject|0|||
105906637|NCT05219968|365316144|FG002|Safety Extension Period|Withdrawal by Subject|2|||
105906638|NCT05219968|365316145|FG003|Safety Extension Period|Withdrawal by Subject|0|||
105906639|NCT05219968|365316146|FG004|Safety Extension Period|Withdrawal by Subject|4|||
105906640|NCT05219968|365316142|FG000|Safety Extension Period|Adverse Event|0|||
105906641|NCT05219968|365316143|FG001|Safety Extension Period|Adverse Event|0|||
105906642|NCT05219968|365316144|FG002|Safety Extension Period|Adverse Event|2|||
105906643|NCT05219968|365316145|FG003|Safety Extension Period|Adverse Event|1|||
105906644|NCT05219968|365316146|FG004|Safety Extension Period|Adverse Event|1|||
105906645|NCT05219968|365316142|FG000|Safety Extension Period|Lost to Follow-up|0|||
105906646|NCT05219968|365316143|FG001|Safety Extension Period|Lost to Follow-up|0|||
105906647|NCT05219968|365316144|FG002|Safety Extension Period|Lost to Follow-up|0|||
105906648|NCT05219968|365316145|FG003|Safety Extension Period|Lost to Follow-up|1|||
105906649|NCT05219968|365316146|FG004|Safety Extension Period|Lost to Follow-up|0|||
105906650|NCT03373461|365316147|FG000|Part 2|Adverse Event|0|||
105906651|NCT03373461|365316148|FG001|Part 2|Adverse Event|1|||
105906652|NCT03373461|365316149|FG002|Part 2|Adverse Event|0|||
105906653|NCT03373461|365316150|FG003|Part 2|Adverse Event|0|||
105906654|NCT03373461|365316151|FG004|Part 2|Adverse Event|1|||
105906655|NCT03300180|365316152|FG000|Baseline|Withdrawal by Subject|4|||
105906656|NCT03300180|365316153|FG001|Baseline|Withdrawal by Subject|6|||
105906657|NCT03300180|365316154|FG002|Baseline|Withdrawal by Subject|4|||
105906658|NCT03300180|365316152|FG000|6 Month Outcome|Withdrawal by Subject|12|||
105906659|NCT03300180|365316153|FG001|6 Month Outcome|Withdrawal by Subject|12|||
105906660|NCT03300180|365316154|FG002|6 Month Outcome|Withdrawal by Subject|19|||
105906661|NCT03300180|365316152|FG000|6 Month Outcome|Death|2|||
105906662|NCT03300180|365316153|FG001|6 Month Outcome|Death|4|||
105670002|NCT02672852|364456149|FG003|Part A2|Withdrawal by Subject|0|||
105670003|NCT02672852|364456150|FG004|Part A2|Withdrawal by Subject|0|||
105906663|NCT03300180|365316154|FG002|6 Month Outcome|Death|3|||
105906664|NCT03300180|365316152|FG000|6 Month Outcome|Missed Assessment|43|||
105906665|NCT03300180|365316153|FG001|6 Month Outcome|Missed Assessment|52|||
105906666|NCT03300180|365316154|FG002|6 Month Outcome|Missed Assessment|46|||
105906667|NCT03300180|365316152|FG000|12 Month Outcome|Withdrawal by Subject|3|||
105906668|NCT03300180|365316153|FG001|12 Month Outcome|Withdrawal by Subject|6|||
105906669|NCT03300180|365316154|FG002|12 Month Outcome|Withdrawal by Subject|6|||
105906670|NCT03300180|365316152|FG000|12 Month Outcome|Death|9|||
105906671|NCT03300180|365316153|FG001|12 Month Outcome|Death|6|||
105906672|NCT03300180|365316154|FG002|12 Month Outcome|Death|6|||
105906673|NCT03300180|365316152|FG000|12 Month Outcome|Missed Assessment|62|||
105906674|NCT03300180|365316153|FG001|12 Month Outcome|Missed Assessment|59|||
105906675|NCT03300180|365316154|FG002|12 Month Outcome|Missed Assessment|58|||
105906676|NCT03300180|365316152|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
105906677|NCT03300180|365316153|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
105906678|NCT03300180|365316154|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
105906679|NCT03300180|365316152|FG000|18 Month Outcome Assessment|Death|8|||
105906680|NCT03300180|365316153|FG001|18 Month Outcome Assessment|Death|5|||
105906681|NCT03300180|365316154|FG002|18 Month Outcome Assessment|Death|5|||
105906682|NCT03300180|365316152|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
105906683|NCT03300180|365316153|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
105906684|NCT03300180|365316154|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
105906685|NCT03300180|365316152|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
105906686|NCT03300180|365316153|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
105906687|NCT03300180|365316154|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
105906688|NCT03300180|365316152|FG000|24 Month Outcome Assessment|Death|13|||
105906689|NCT03300180|365316153|FG001|24 Month Outcome Assessment|Death|13|||
105906690|NCT03300180|365316154|FG002|24 Month Outcome Assessment|Death|3|||
105906691|NCT03300180|365316152|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
105906692|NCT03300180|365316153|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
105906693|NCT03300180|365316154|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
105906694|NCT04587336|365316157|FG000|Overall Study|Lost to Follow-up|1|||
105906695|NCT04587336|365316158|FG001|Overall Study|Lost to Follow-up|0|||
105906696|NCT02757352|365318366|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
105906697|NCT02757352|365318367|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105906698|NCT02757352|365318368|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
105906699|NCT02757352|365318369|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105906700|NCT02757352|365318370|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105906701|NCT02757352|365318371|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105906702|NCT02757352|365318372|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105906703|NCT02757352|365318373|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105906704|NCT02757352|365318374|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105906705|NCT02757352|365318375|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
105906706|NCT02757352|365318366|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906707|NCT02757352|365318367|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906708|NCT02757352|365318368|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
105906709|NCT02757352|365318369|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906710|NCT02757352|365318370|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906711|NCT02757352|365318371|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906712|NCT02757352|365318372|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906713|NCT02757352|365318373|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906714|NCT02757352|365318374|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906715|NCT02757352|365318375|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
105906716|NCT02757352|365318366|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
105906717|NCT02757352|365318367|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
105906718|NCT02757352|365318368|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
105906719|NCT02757352|365318369|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105906720|NCT02757352|365318370|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105906721|NCT02757352|365318371|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105906722|NCT02757352|365318372|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105906723|NCT02757352|365318373|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105906724|NCT02757352|365318374|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105906725|NCT02757352|365318375|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
105906726|NCT02757352|365318366|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105906727|NCT02757352|365318367|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
105906728|NCT02757352|365318368|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105906729|NCT02757352|365318369|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105906730|NCT02757352|365318370|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105786077|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
105786078|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
105786079|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
105786080|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
105786081|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
105786082|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
105786083|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
105786084|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
105786085|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
105786086|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
105786087|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
105786088|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
105786089|NCT03556202|364870444|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
105786090|NCT03556202|364870445|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
105786091|NCT03556202|364870446|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
105786092|NCT00908375|364870447|FG000|Overall Study|Withdrawal by Subject|2|||
105786093|NCT00908375|364870448|FG001|Overall Study|Withdrawal by Subject|4|||
105786094|NCT00908375|364870447|FG000|Overall Study|Lost to Follow-up|8|||
105786095|NCT00908375|364870448|FG001|Overall Study|Lost to Follow-up|6|||
105786096|NCT04095039|364870449|FG000|Overall Study|Withdrawal by Subject|2|||
105786097|NCT04095039|364870450|FG001|Overall Study|Withdrawal by Subject|16|||
105786098|NCT04095039|364870449|FG000|Overall Study|Transplanted|21|||
105786099|NCT04095039|364870450|FG001|Overall Study|Transplanted|24|||
105786100|NCT04095039|364870449|FG000|Overall Study|Transferred to Non-study Facility|47|||
105786101|NCT04095039|364870450|FG001|Overall Study|Transferred to Non-study Facility|44|||
105786102|NCT04095039|364870449|FG000|Overall Study|Withdrawal from internvention target|0|||
105786103|NCT04095039|364870450|FG001|Overall Study|Withdrawal from internvention target|2|||
105786104|NCT04095039|364870449|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
105786105|NCT04095039|364870450|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
105786106|NCT04095039|364870449|FG000|Overall Study|Cacliphylaxis|0|||
105786107|NCT04095039|364870450|FG001|Overall Study|Cacliphylaxis|1|||
105786108|NCT04095039|364870449|FG000|Overall Study|Pregnancy|1|||
105786109|NCT04095039|364870450|FG001|Overall Study|Pregnancy|0|||
105786110|NCT03635788|364870451|FG000|Step 1|Death|1|||
105786111|NCT03635788|364870452|FG001|Step 1|Death|0|||
105786112|NCT03635788|364870453|FG002|Step 1|Death|0|||
105786113|NCT03635788|364870451|FG000|Step 1|Lost to Follow-up|31|||
105786114|NCT03635788|364870452|FG001|Step 1|Lost to Follow-up|0|||
105786115|NCT03635788|364870453|FG002|Step 1|Lost to Follow-up|0|||
105786116|NCT03635788|364870451|FG000|Step 1|Pregnancy|1|||
105786117|NCT03635788|364870452|FG001|Step 1|Pregnancy|0|||
105786118|NCT03635788|364870453|FG002|Step 1|Pregnancy|0|||
105786119|NCT03635788|364870451|FG000|Step 1|Protocol Violation|8|||
105786120|NCT03635788|364870452|FG001|Step 1|Protocol Violation|0|||
105786121|NCT03635788|364870453|FG002|Step 1|Protocol Violation|0|||
105786122|NCT03635788|364870451|FG000|Step 1|Withdrawal by Subject|13|||
105786123|NCT03635788|364870452|FG001|Step 1|Withdrawal by Subject|0|||
105786124|NCT03635788|364870453|FG002|Step 1|Withdrawal by Subject|0|||
105786125|NCT03635788|364870451|FG000|Step 1|Other reasons|12|||
105786126|NCT03635788|364870452|FG001|Step 1|Other reasons|0|||
105786127|NCT03635788|364870453|FG002|Step 1|Other reasons|0|||
105786128|NCT03635788|364870451|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
105786129|NCT03635788|364870452|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
105786130|NCT03635788|364870453|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
105786131|NCT03635788|364870451|FG000|Step 2|Lost to Follow-up|0|||
105786132|NCT03635788|364870452|FG001|Step 2|Lost to Follow-up|8|||
105786133|NCT03635788|364870453|FG002|Step 2|Lost to Follow-up|15|||
105786134|NCT03635788|364870451|FG000|Step 2|Withdrawal by Subject|0|||
105786135|NCT03635788|364870452|FG001|Step 2|Withdrawal by Subject|6|||
105786136|NCT03635788|364870453|FG002|Step 2|Withdrawal by Subject|6|||
105786137|NCT03635788|364870451|FG000|Step 2|Death|0|||
105786138|NCT03635788|364870452|FG001|Step 2|Death|2|||
105786139|NCT03635788|364870453|FG002|Step 2|Death|0|||
105786140|NCT03635788|364870451|FG000|Step 2|Incarceration|0|||
105786141|NCT03635788|364870452|FG001|Step 2|Incarceration|2|||
105786142|NCT03635788|364870453|FG002|Step 2|Incarceration|0|||
105786143|NCT03635788|364870451|FG000|Step 2|Non-Compliance With Study Requirements|0|||
105786144|NCT03635788|364870452|FG001|Step 2|Non-Compliance With Study Requirements|1|||
105786145|NCT03635788|364870453|FG002|Step 2|Non-Compliance With Study Requirements|1|||
105786146|NCT03635788|364870451|FG000|Step 2|Confounding Medical Condition|0|||
105786147|NCT03635788|364870452|FG001|Step 2|Confounding Medical Condition|0|||
105786148|NCT03635788|364870453|FG002|Step 2|Confounding Medical Condition|1|||
105786149|NCT03635788|364870451|FG000|Step 2|Out Of State With No Plan To Return|0|||
105786150|NCT03635788|364870452|FG001|Step 2|Out Of State With No Plan To Return|1|||
105786151|NCT03635788|364870453|FG002|Step 2|Out Of State With No Plan To Return|0|||
105670004|NCT02672852|364456151|FG005|Part A2|Withdrawal by Subject|0|||
105670005|NCT02672852|364456152|FG006|Part A2|Withdrawal by Subject|0|||
105998670|NCT00851786|365656291|FG001|Overall Study|Protocol Violation|1|||
105998671|NCT00851786|365656290|FG000|Overall Study|Lost to Follow-up|1|||
105998672|NCT00851786|365656291|FG001|Overall Study|Lost to Follow-up|0|||
105998673|NCT00851786|365656290|FG000|Overall Study|Incarceration|1|||
105998674|NCT00851786|365656291|FG001|Overall Study|Incarceration|0|||
105998675|NCT00851786|365656290|FG000|Overall Study|Site Closure|1|||
105998676|NCT00851786|365656291|FG001|Overall Study|Site Closure|0|||
105998677|NCT00851786|365656290|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
105998678|NCT00851786|365656291|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
105998679|NCT00350844|365656294|FG000|Overall Study|Lost to Follow-up|1|||
105998680|NCT01517750|365657725|FG000|Overall Study|Lost to Follow-up|1|||
105998681|NCT01517750|365657726|FG001|Overall Study|Lost to Follow-up|2|||
105998682|NCT01517750|365657727|FG002|Overall Study|Lost to Follow-up|4|||
105998683|NCT01517750|365657728|FG003|Overall Study|Lost to Follow-up|1|||
105998684|NCT00217425|365657735|FG000|Overall Study|Never started treatment|2|||
105998685|NCT00217425|365657735|FG000|Overall Study|Patient ineligible|5|||
105998686|NCT00217425|365657735|FG000|Overall Study|Lack of Efficacy|13|||
105998687|NCT00217425|365657735|FG000|Overall Study|Adverse Event|8|||
105998688|NCT00217425|365657735|FG000|Overall Study|Withdrawal by Subject|4|||
105998689|NCT00217425|365657735|FG000|Overall Study|Other complicating disease|1|||
105998690|NCT00217425|365657735|FG000|Overall Study|Other|4|||
105998691|NCT01121146|365657736|FG000|Overall Study|Death|17|||
105998692|NCT01121146|365657737|FG001|Overall Study|Death|15|||
105998693|NCT01121146|365657736|FG000|Overall Study|Adverse Event|2|||
105998694|NCT01121146|365657737|FG001|Overall Study|Adverse Event|11|||
105998695|NCT01121146|365657736|FG000|Overall Study|Lost to Follow-up|7|||
105998696|NCT01121146|365657737|FG001|Overall Study|Lost to Follow-up|16|||
105998697|NCT00086047|365657738|FG000|Overall Study|Lost to Follow-up|7|||
105998698|NCT00086047|365657739|FG001|Overall Study|Lost to Follow-up|6|||
105998699|NCT00086047|365657738|FG000|Overall Study|Physician Decision|0|||
105998700|NCT00086047|365657739|FG001|Overall Study|Physician Decision|1|||
105998701|NCT03579940|365657741|FG000|Period 2|Withdrawal by Subject|0|||
105998702|NCT03579940|365657742|FG001|Period 2|Withdrawal by Subject|0|||
105998703|NCT03579940|365657743|FG002|Period 2|Withdrawal by Subject|1|||
105998704|NCT03579940|365657744|FG003|Period 2|Withdrawal by Subject|0|||
105998705|NCT03579940|365657745|FG004|Period 2|Withdrawal by Subject|0|||
105998706|NCT03579940|365657746|FG005|Period 2|Withdrawal by Subject|0|||
105998707|NCT03579940|365657747|FG006|Period 2|Withdrawal by Subject|0|||
105998708|NCT03579940|365657748|FG007|Period 2|Withdrawal by Subject|0|||
105998709|NCT03579940|365657749|FG008|Period 2|Withdrawal by Subject|0|||
105998710|NCT03579940|365657750|FG009|Period 2|Withdrawal by Subject|0|||
105998711|NCT03579940|365657751|FG010|Period 2|Withdrawal by Subject|0|||
105998712|NCT03654690|365657752|FG000|Overall Study|Withdrawal by Subject|1|||
105998713|NCT03654690|365657753|FG001|Overall Study|Withdrawal by Subject|0|||
105998714|NCT03654690|365657754|FG002|Overall Study|Withdrawal by Subject|0|||
105998715|NCT00742183|365657755|FG000|Overall Study|Adverse Event|2|||
105998716|NCT00742183|365657756|FG001|Overall Study|Adverse Event|2|||
105998717|NCT00742183|365657755|FG000|Overall Study|Death|1|||
105998718|NCT00742183|365657756|FG001|Overall Study|Death|0|||
105998719|NCT00742183|365657755|FG000|Overall Study|Physician Decision|0|||
105998720|NCT00742183|365657756|FG001|Overall Study|Physician Decision|2|||
105998721|NCT00742183|365657755|FG000|Overall Study|Lost to Follow-up|4|||
105998722|NCT00742183|365657756|FG001|Overall Study|Lost to Follow-up|4|||
105998723|NCT00742183|365657755|FG000|Overall Study|Required skin-graft|1|||
105998724|NCT00742183|365657756|FG001|Overall Study|Required skin-graft|1|||
105998725|NCT00742183|365657755|FG000|Overall Study|Withdrawal by Subject|1|||
105998726|NCT00742183|365657756|FG001|Overall Study|Withdrawal by Subject|0|||
105670006|NCT02672852|364456146|FG000|Part A2|Other|0|||
105670007|NCT02672852|364456147|FG001|Part A2|Other|0|||
105670008|NCT02672852|364456148|FG002|Part A2|Other|3|||
105670009|NCT02672852|364456149|FG003|Part A2|Other|0|||
105998727|NCT00742183|365657755|FG000|Overall Study|Lack of Efficacy|0|||
105998728|NCT00742183|365657756|FG001|Overall Study|Lack of Efficacy|3|||
105998729|NCT02544503|365657758|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
105998730|NCT02544503|365657759|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
105998731|NCT02544503|365657758|FG000|Overall Study|Lost to Follow-up|9|||
105998732|NCT02544503|365657759|FG001|Overall Study|Lost to Follow-up|0|||
105998733|NCT02544503|365657758|FG000|Overall Study|Withdrawal by Subject|1|||
105998734|NCT02544503|365657759|FG001|Overall Study|Withdrawal by Subject|0|||
105998735|NCT03294590|365657760|FG000|Overall Study|Lost to Follow-up|105|||
105998736|NCT03294590|365657761|FG001|Overall Study|Lost to Follow-up|107|||
105998737|NCT02576639|365657767|FG000|Overall Study|Withdrawal by Subject|1|||
105998738|NCT02576639|365657768|FG001|Overall Study|Withdrawal by Subject|2|||
105998739|NCT02576639|365657769|FG002|Overall Study|Withdrawal by Subject|1|||
105998740|NCT02576639|365657770|FG003|Overall Study|Withdrawal by Subject|0|||
105998741|NCT02576639|365657771|FG004|Overall Study|Withdrawal by Subject|1|||
105670010|NCT02672852|364456150|FG004|Part A2|Other|0|||
105670011|NCT02672852|364456151|FG005|Part A2|Other|0|||
105670012|NCT02672852|364456152|FG006|Part A2|Other|0|||
105670013|NCT02672852|364456146|FG000|Part A2|Not entered in Part B|0|||
105670014|NCT02672852|364456147|FG001|Part A2|Not entered in Part B|0|||
105670015|NCT02672852|364456148|FG002|Part A2|Not entered in Part B|0|||
105670016|NCT02672852|364456149|FG003|Part A2|Not entered in Part B|4|||
105670017|NCT02672852|364456150|FG004|Part A2|Not entered in Part B|0|||
105670018|NCT02672852|364456151|FG005|Part A2|Not entered in Part B|0|||
105670019|NCT02672852|364456152|FG006|Part A2|Not entered in Part B|0|||
105670020|NCT02672852|364456146|FG000|Part B|Disease worsening|0|||
105670021|NCT02672852|364456147|FG001|Part B|Disease worsening|0|||
105670022|NCT02672852|364456148|FG002|Part B|Disease worsening|0|||
105670023|NCT02672852|364456149|FG003|Part B|Disease worsening|0|||
105670024|NCT02672852|364456150|FG004|Part B|Disease worsening|1|||
105670025|NCT02672852|364456151|FG005|Part B|Disease worsening|0|||
105670026|NCT02672852|364456152|FG006|Part B|Disease worsening|1|||
105670027|NCT02672852|364456146|FG000|Part B|Worsening pre-existing condition|0|||
105670028|NCT02672852|364456147|FG001|Part B|Worsening pre-existing condition|0|||
105670029|NCT02672852|364456148|FG002|Part B|Worsening pre-existing condition|0|||
105670030|NCT02672852|364456149|FG003|Part B|Worsening pre-existing condition|0|||
105670031|NCT02672852|364456150|FG004|Part B|Worsening pre-existing condition|0|||
105670032|NCT02672852|364456151|FG005|Part B|Worsening pre-existing condition|1|||
105670033|NCT02672852|364456152|FG006|Part B|Worsening pre-existing condition|0|||
105670034|NCT02672852|364456146|FG000|Part B|Other adverse event|0|||
105670035|NCT02672852|364456147|FG001|Part B|Other adverse event|0|||
105670036|NCT02672852|364456148|FG002|Part B|Other adverse event|0|||
105670037|NCT02672852|364456149|FG003|Part B|Other adverse event|0|||
105670038|NCT02672852|364456150|FG004|Part B|Other adverse event|3|||
105670039|NCT02672852|364456151|FG005|Part B|Other adverse event|5|||
105670040|NCT02672852|364456152|FG006|Part B|Other adverse event|1|||
105670041|NCT02672852|364456146|FG000|Part B|Lost to Follow-up|0|||
105670042|NCT02672852|364456147|FG001|Part B|Lost to Follow-up|0|||
105670043|NCT02672852|364456148|FG002|Part B|Lost to Follow-up|0|||
105670044|NCT02672852|364456149|FG003|Part B|Lost to Follow-up|0|||
105670045|NCT02672852|364456150|FG004|Part B|Lost to Follow-up|3|||
105670046|NCT02672852|364456151|FG005|Part B|Lost to Follow-up|4|||
105670047|NCT02672852|364456152|FG006|Part B|Lost to Follow-up|1|||
105670048|NCT02672852|364456146|FG000|Part B|Withdrawal by Subject|0|||
105670049|NCT02672852|364456147|FG001|Part B|Withdrawal by Subject|0|||
105670050|NCT02672852|364456148|FG002|Part B|Withdrawal by Subject|0|||
105670051|NCT02672852|364456149|FG003|Part B|Withdrawal by Subject|0|||
105670052|NCT02672852|364456150|FG004|Part B|Withdrawal by Subject|5|||
105670053|NCT02672852|364456151|FG005|Part B|Withdrawal by Subject|0|||
105670054|NCT02672852|364456152|FG006|Part B|Withdrawal by Subject|7|||
105670055|NCT02672852|364456146|FG000|Part B|Other|0|||
105670056|NCT02672852|364456147|FG001|Part B|Other|0|||
105670057|NCT02672852|364456148|FG002|Part B|Other|0|||
105670058|NCT02672852|364456149|FG003|Part B|Other|0|||
105906731|NCT02757352|365318371|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105906732|NCT02757352|365318372|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105906733|NCT02757352|365318373|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105906734|NCT02757352|365318374|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105906735|NCT02757352|365318375|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
105906736|NCT02757352|365318366|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906737|NCT02757352|365318367|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
105906738|NCT02757352|365318368|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906739|NCT02757352|365318369|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906740|NCT02757352|365318370|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906741|NCT02757352|365318371|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906742|NCT02757352|365318372|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906743|NCT02757352|365318373|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906744|NCT02757352|365318374|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105670059|NCT02672852|364456150|FG004|Part B|Other|4|||
105670060|NCT02672852|364456151|FG005|Part B|Other|1|||
105670061|NCT02672852|364456152|FG006|Part B|Other|2|||
105670062|NCT04958642|364456153|FG000|Overall Study|Transferred to OLEX program|3|||
105670063|NCT04958642|364456154|FG001|Overall Study|Transferred to OLEX program|0|||
105906745|NCT02757352|365318375|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906746|NCT02757352|365318366|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
105998742|NCT02576639|365657767|FG000|Overall Study|Adverse Event|1|||
105670064|NCT04958642|364456155|FG002|Overall Study|Transferred to OLEX program|5|||
105670065|NCT04958642|364456153|FG000|Overall Study|Death|0|||
105670066|NCT04958642|364456154|FG001|Overall Study|Death|0|||
105670067|NCT04958642|364456155|FG002|Overall Study|Death|1|||
105670068|NCT04958642|364456153|FG000|Overall Study|Withdrawal by Subject|4|||
105670069|NCT04958642|364456154|FG001|Overall Study|Withdrawal by Subject|9|||
105670070|NCT04958642|364456155|FG002|Overall Study|Withdrawal by Subject|13|||
105670071|NCT04958642|364456153|FG000|Overall Study|Investigator's Decision|0|||
105670072|NCT04958642|364456154|FG001|Overall Study|Investigator's Decision|0|||
105786152|NCT03635788|364870451|FG000|Step 2|Switched To Injectables|0|||
105906747|NCT02757352|365318367|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
105906748|NCT02757352|365318368|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
105906749|NCT02757352|365318369|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906750|NCT02757352|365318370|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906751|NCT02757352|365318371|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906752|NCT02757352|365318372|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906753|NCT02757352|365318373|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906754|NCT02757352|365318374|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105670073|NCT04958642|364456155|FG002|Overall Study|Investigator's Decision|1|||
105670074|NCT04958642|364456153|FG000|Overall Study|Adverse Event|1|||
105906755|NCT02757352|365318375|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906756|NCT02757352|365318366|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
105906757|NCT02757352|365318367|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
105906758|NCT02757352|365318368|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
105906759|NCT02757352|365318369|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105670075|NCT04958642|364456154|FG001|Overall Study|Adverse Event|0|||
105670076|NCT04958642|364456155|FG002|Overall Study|Adverse Event|1|||
105670077|NCT04958642|364456153|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
105670078|NCT04958642|364456154|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
105670079|NCT04958642|364456155|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
105906760|NCT02757352|365318370|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105906761|NCT02757352|365318371|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105906762|NCT02757352|365318372|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105906763|NCT02757352|365318373|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105906764|NCT02757352|365318374|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105906765|NCT02757352|365318375|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
105906766|NCT02757352|365318366|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105906767|NCT02757352|365318367|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105906768|NCT02757352|365318368|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105906769|NCT02757352|365318369|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
105906770|NCT02757352|365318370|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105906771|NCT02757352|365318371|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
105906772|NCT02757352|365318372|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105906773|NCT02757352|365318373|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105906774|NCT02757352|365318374|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105906775|NCT02757352|365318375|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
105906776|NCT02757352|365318366|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906777|NCT02757352|365318367|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906778|NCT02757352|365318368|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906779|NCT02757352|365318369|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
105906780|NCT02757352|365318370|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
105906781|NCT02757352|365318371|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
105906782|NCT02757352|365318372|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906783|NCT02757352|365318373|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906784|NCT02757352|365318374|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906785|NCT02757352|365318375|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
105906786|NCT02757352|365318366|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105906787|NCT02757352|365318367|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105906788|NCT02757352|365318368|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105906789|NCT02757352|365318369|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105906790|NCT02757352|365318370|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
105906791|NCT02757352|365318371|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105906792|NCT02757352|365318372|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105906793|NCT02757352|365318373|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105906794|NCT02757352|365318374|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105670080|NCT04958642|364456153|FG000|Overall Study|Lost to Follow-up|1|||
105670081|NCT04958642|364456154|FG001|Overall Study|Lost to Follow-up|0|||
105670082|NCT04958642|364456155|FG002|Overall Study|Lost to Follow-up|0|||
105670083|NCT04958642|364456153|FG000|Overall Study|Transferred to EAP following study termination|0|||
105670084|NCT04958642|364456154|FG001|Overall Study|Transferred to EAP following study termination|0|||
105670085|NCT04958642|364456155|FG002|Overall Study|Transferred to EAP following study termination|1|||
105670086|NCT04958642|364456153|FG000|Overall Study|Transferred to Expanded Access Program|1|||
105786153|NCT03635788|364870452|FG001|Step 2|Switched To Injectables|0|||
105906795|NCT02757352|365318375|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
105786154|NCT03635788|364870453|FG002|Step 2|Switched To Injectables|1|||
105786155|NCT03635788|364870451|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
105786156|NCT03635788|364870452|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
105998743|NCT02576639|365657768|FG001|Overall Study|Adverse Event|0|||
105998744|NCT02576639|365657769|FG002|Overall Study|Adverse Event|1|||
105998745|NCT02576639|365657770|FG003|Overall Study|Adverse Event|1|||
105998746|NCT02576639|365657771|FG004|Overall Study|Adverse Event|2|||
105998747|NCT02576639|365657767|FG000|Overall Study|Physician Decision|0|||
105998748|NCT02576639|365657768|FG001|Overall Study|Physician Decision|0|||
105998749|NCT02576639|365657769|FG002|Overall Study|Physician Decision|0|||
105998750|NCT02576639|365657770|FG003|Overall Study|Physician Decision|0|||
105998751|NCT02576639|365657771|FG004|Overall Study|Physician Decision|1|||
105998752|NCT01859923|365657774|FG000|Overall Study|Adverse Event|0|||
105998753|NCT01859923|365657775|FG001|Overall Study|Adverse Event|0|||
105998754|NCT01859923|365657776|FG002|Overall Study|Adverse Event|1|||
105998755|NCT01859923|365657777|FG003|Overall Study|Adverse Event|1|||
105998756|NCT00764361|365657783|FG000|Overall Study|Withdrawal by Subject|2|||
105998757|NCT00764361|365657784|FG001|Overall Study|Withdrawal by Subject|3|||
105998758|NCT00764361|365657783|FG000|Overall Study|Adverse Event|0|||
105998759|NCT00764361|365657784|FG001|Overall Study|Adverse Event|1|||
105998760|NCT02090426|365657785|FG000|Overall Study|Lost to Follow-up|12|||
105998761|NCT02090426|365657786|FG001|Overall Study|Lost to Follow-up|6|||
105998762|NCT02079038|365657787|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
105998763|NCT02079038|365657788|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
105998764|NCT02079038|365657787|FG000|Modified Intent to Treat Population|Death|1|||
105998765|NCT02079038|365657788|FG001|Modified Intent to Treat Population|Death|0|||
105998766|NCT02079038|365657787|FG000|Completed 6 Months|Lost to Follow-up|2|||
105998767|NCT02079038|365657788|FG001|Completed 6 Months|Lost to Follow-up|1|||
105998768|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
105998769|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
105998770|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
105998771|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
105998772|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
105998773|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
105998774|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
105998775|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
105998776|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
105998777|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
105998778|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
105998779|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
105998780|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
105998781|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
105998782|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
105998783|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
105998784|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
105998785|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
105998786|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
105998787|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
105998788|NCT03573323|365657789|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
105998789|NCT03573323|365657790|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
105998790|NCT03573323|365657789|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
105998791|NCT03573323|365657790|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
105998792|NCT03573323|365657789|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
105670087|NCT04958642|364456154|FG001|Overall Study|Transferred to Expanded Access Program|0|||
105670088|NCT04958642|364456155|FG002|Overall Study|Transferred to Expanded Access Program|0|||
105670089|NCT03853551|364456161|FG000|Overall Study|Death|2|||
105670090|NCT03853551|364456161|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
105670091|NCT03338296|364456162|FG000|Overall Study|Adverse Event|0|||
105670092|NCT03338296|364456163|FG001|Overall Study|Adverse Event|1|||
105670093|NCT03338296|364456162|FG000|Overall Study|Withdrawal by Subject|14|||
105670094|NCT03338296|364456163|FG001|Overall Study|Withdrawal by Subject|13|||
105670095|NCT03338296|364456162|FG000|Overall Study|Lost to Follow-up|10|||
105670096|NCT03338296|364456163|FG001|Overall Study|Lost to Follow-up|10|||
105670097|NCT03338296|364456162|FG000|Overall Study|Study Terminated by Sponsor|77|||
105670098|NCT03338296|364456163|FG001|Overall Study|Study Terminated by Sponsor|76|||
105670099|NCT03338296|364456162|FG000|Overall Study|Other|2|||
105670100|NCT03338296|364456163|FG001|Overall Study|Other|7|||
105670101|NCT03338296|364456162|FG000|Overall Study|Missing|0|||
105670102|NCT03338296|364456163|FG001|Overall Study|Missing|1|||
105670103|NCT01923467|364456166|FG000|Overall Study|Lost to Follow-up|62|||
105670104|NCT01923467|364456166|FG000|Overall Study|Subject non-interest|479|||
105670105|NCT03921723|364456167|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
105670106|NCT03921723|364456167|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
105670107|NCT03015129|364456168|FG000|Overall Study|Death|2|||
105670108|NCT03015129|364456169|FG001|Overall Study|Death|2|||
105670109|NCT03015129|364456168|FG000|Overall Study|Lost to Follow-up|0|||
105670110|NCT03015129|364456169|FG001|Overall Study|Lost to Follow-up|1|||
105670111|NCT03015129|364456168|FG000|Overall Study|Progression of disease|38|||
105670112|NCT03015129|364456169|FG001|Overall Study|Progression of disease|33|||
105670113|NCT03015129|364456168|FG000|Overall Study|Adverse Event|0|||
105670114|NCT03015129|364456169|FG001|Overall Study|Adverse Event|4|||
105786157|NCT03635788|364870453|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
105786158|NCT04089566|364870457|FG000|Overall Study|Death|0|||
105786159|NCT04089566|364870458|FG001|Overall Study|Death|6|||
105906796|NCT02757352|365318366|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906797|NCT02757352|365318367|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906798|NCT02757352|365318368|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906799|NCT02757352|365318369|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906800|NCT02757352|365318370|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906801|NCT02757352|365318371|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
105906802|NCT02757352|365318372|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906803|NCT02757352|365318373|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906804|NCT02757352|365318374|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906805|NCT02757352|365318375|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
105906806|NCT02757352|365318366|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906807|NCT02757352|365318367|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906808|NCT02757352|365318368|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906809|NCT02757352|365318369|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
105906810|NCT02757352|365318370|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
105906811|NCT02757352|365318371|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
105906812|NCT02757352|365318372|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906813|NCT02757352|365318373|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906814|NCT02757352|365318374|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906815|NCT02757352|365318375|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
105906816|NCT02757352|365318366|FG000|Follow-Up Period|Adverse Event|0|||
105906817|NCT02757352|365318367|FG001|Follow-Up Period|Adverse Event|0|||
105906818|NCT02757352|365318368|FG002|Follow-Up Period|Adverse Event|0|||
105906819|NCT02757352|365318369|FG003|Follow-Up Period|Adverse Event|0|||
105906820|NCT02757352|365318370|FG004|Follow-Up Period|Adverse Event|0|||
105906821|NCT02757352|365318371|FG005|Follow-Up Period|Adverse Event|0|||
105906822|NCT02757352|365318372|FG006|Follow-Up Period|Adverse Event|1|||
105906823|NCT02757352|365318373|FG007|Follow-Up Period|Adverse Event|0|||
105906824|NCT02757352|365318374|FG008|Follow-Up Period|Adverse Event|2|||
105906825|NCT02757352|365318375|FG009|Follow-Up Period|Adverse Event|0|||
105906826|NCT02757352|365318366|FG000|Follow-Up Period|Lost to Follow-up|0|||
105906827|NCT02757352|365318367|FG001|Follow-Up Period|Lost to Follow-up|0|||
105906828|NCT02757352|365318368|FG002|Follow-Up Period|Lost to Follow-up|0|||
105906829|NCT02757352|365318369|FG003|Follow-Up Period|Lost to Follow-up|0|||
105906830|NCT02757352|365318370|FG004|Follow-Up Period|Lost to Follow-up|0|||
105670115|NCT04076943|364456176|FG000|Overall Study|Withdrawal by Subject|12|||
105670116|NCT04076943|364456176|FG000|Overall Study|Adverse Event|1|||
105670117|NCT04076943|364456176|FG000|Overall Study|Progressive Disease|2|||
105670118|NCT04076943|364456176|FG000|Overall Study|Death|13|||
105670119|NCT04076943|364456176|FG000|Overall Study|Other than specified|6|||
105670120|NCT01075958|364456180|FG000|Overall Study|Blood sample could not be obtained|44|||
105670121|NCT03596762|364456181|FG000|Overall Study|Protocol Violation|0|||
105670122|NCT03596762|364456182|FG001|Overall Study|Protocol Violation|0|||
105670123|NCT03596762|364456183|FG002|Overall Study|Protocol Violation|0|||
105670124|NCT03596762|364456184|FG003|Overall Study|Protocol Violation|0|||
105670125|NCT03596762|364456185|FG004|Overall Study|Protocol Violation|1|||
105670126|NCT03596762|364456181|FG000|Overall Study|Adverse Event|2|||
105670127|NCT03596762|364456182|FG001|Overall Study|Adverse Event|0|||
105670128|NCT03596762|364456183|FG002|Overall Study|Adverse Event|1|||
105670129|NCT03596762|364456184|FG003|Overall Study|Adverse Event|0|||
105670130|NCT03596762|364456185|FG004|Overall Study|Adverse Event|5|||
105670131|NCT03596762|364456181|FG000|Overall Study|Withdrawal by Subject|2|||
105670132|NCT03596762|364456182|FG001|Overall Study|Withdrawal by Subject|1|||
105670133|NCT03596762|364456183|FG002|Overall Study|Withdrawal by Subject|0|||
105670134|NCT03596762|364456184|FG003|Overall Study|Withdrawal by Subject|1|||
105670135|NCT03596762|364456185|FG004|Overall Study|Withdrawal by Subject|1|||
105670136|NCT02510040|364456186|FG000|Overall Study|Deemed no longer eligible|18|||
105906831|NCT02757352|365318371|FG005|Follow-Up Period|Lost to Follow-up|0|||
105906832|NCT02757352|365318372|FG006|Follow-Up Period|Lost to Follow-up|0|||
105906833|NCT02757352|365318373|FG007|Follow-Up Period|Lost to Follow-up|0|||
105906834|NCT02757352|365318374|FG008|Follow-Up Period|Lost to Follow-up|1|||
105906835|NCT02757352|365318375|FG009|Follow-Up Period|Lost to Follow-up|0|||
105906836|NCT02757352|365318366|FG000|Follow-Up Period|Lack of Efficacy|0|||
105906837|NCT02757352|365318367|FG001|Follow-Up Period|Lack of Efficacy|0|||
105906838|NCT02757352|365318368|FG002|Follow-Up Period|Lack of Efficacy|0|||
105906839|NCT02757352|365318369|FG003|Follow-Up Period|Lack of Efficacy|0|||
105906840|NCT02757352|365318370|FG004|Follow-Up Period|Lack of Efficacy|0|||
105906841|NCT02757352|365318371|FG005|Follow-Up Period|Lack of Efficacy|0|||
105906842|NCT02757352|365318372|FG006|Follow-Up Period|Lack of Efficacy|0|||
105906843|NCT02757352|365318373|FG007|Follow-Up Period|Lack of Efficacy|0|||
105906844|NCT02757352|365318374|FG008|Follow-Up Period|Lack of Efficacy|1|||
105906845|NCT02757352|365318375|FG009|Follow-Up Period|Lack of Efficacy|1|||
105906846|NCT02757352|365318366|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105906847|NCT02757352|365318367|FG001|Follow-Up Period|Withdrawal by Subject|0|||
105906848|NCT02757352|365318368|FG002|Follow-Up Period|Withdrawal by Subject|0|||
105906849|NCT02757352|365318369|FG003|Follow-Up Period|Withdrawal by Subject|0|||
105906850|NCT02757352|365318370|FG004|Follow-Up Period|Withdrawal by Subject|0|||
105906851|NCT02757352|365318371|FG005|Follow-Up Period|Withdrawal by Subject|0|||
105906852|NCT02757352|365318372|FG006|Follow-Up Period|Withdrawal by Subject|0|||
105906853|NCT02757352|365318373|FG007|Follow-Up Period|Withdrawal by Subject|1|||
105906854|NCT02757352|365318374|FG008|Follow-Up Period|Withdrawal by Subject|6|||
105906855|NCT02757352|365318375|FG009|Follow-Up Period|Withdrawal by Subject|2|||
105906856|NCT02155309|365318376|FG000|Overall Study|Protocol Violation|0|||
105906857|NCT02155309|365318377|FG001|Overall Study|Protocol Violation|0|||
105906858|NCT02155309|365318378|FG002|Overall Study|Protocol Violation|1|||
105906859|NCT02315664|365318382|FG000|Overall Study|Lost to Follow-up|1|||
105906860|NCT02315664|365318383|FG001|Overall Study|Lost to Follow-up|1|||
105906861|NCT02315664|365318382|FG000|Overall Study|Withdrawal by Subject|0|||
105906862|NCT02315664|365318383|FG001|Overall Study|Withdrawal by Subject|3|||
105906863|NCT03091738|365318384|FG000|Overall Study|Adverse Event|1|||
105906864|NCT03091738|365318384|FG000|Overall Study|Lost to Follow-up|1|||
105906865|NCT04727528|365318394|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
105906866|NCT04727528|365318395|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
105906867|NCT04727528|365318394|FG000|Open-label Period|Randomized who did not receive treatment|1|||
105906868|NCT04727528|365318395|FG001|Open-label Period|Randomized who did not receive treatment|0|||
105906869|NCT04727528|365318394|FG000|Double-blind Treatment Phase|Adverse Event|0|||
105906870|NCT04727528|365318395|FG001|Double-blind Treatment Phase|Adverse Event|1|||
105906871|NCT04727528|365318394|FG000|Double-blind Treatment Phase|Death|0|||
105906872|NCT04727528|365318395|FG001|Double-blind Treatment Phase|Death|1|||
105906873|NCT04727528|365318394|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
105906874|NCT04727528|365318395|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
105906875|NCT04727528|365318394|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
105906876|NCT04727528|365318395|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
105906877|NCT04727528|365318394|FG000|Double-blind Treatment Phase|Physician Decision|0|||
105670137|NCT02510040|364456187|FG001|Overall Study|Deemed no longer eligible|3|||
105670138|NCT02510040|364456188|FG002|Overall Study|Deemed no longer eligible|1|||
105786160|NCT04089566|364870459|FG002|Overall Study|Death|10|||
105786161|NCT04089566|364870460|FG003|Overall Study|Death|0|||
105906878|NCT04727528|365318395|FG001|Double-blind Treatment Phase|Physician Decision|1|||
105906879|NCT04727528|365318394|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
105906880|NCT04727528|365318395|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105906881|NCT00215644|365318396|FG000|Overall Study|Disease Progression|28|||
105906882|NCT00215644|365318397|FG001|Overall Study|Disease Progression|10|||
105906883|NCT00215644|365318396|FG000|Overall Study|Adverse Event|2|||
105906884|NCT00215644|365318397|FG001|Overall Study|Adverse Event|9|||
105906885|NCT00215644|365318396|FG000|Overall Study|Death|1|||
105786162|NCT04089566|364870461|FG004|Overall Study|Death|0|||
105786163|NCT04089566|364870462|FG005|Overall Study|Death|0|||
105786164|NCT04089566|364870457|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
105906886|NCT00215644|365318397|FG001|Overall Study|Death|2|||
105786165|NCT04089566|364870458|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
105906887|NCT00215644|365318396|FG000|Overall Study|Withdrawal by Subject|1|||
105906888|NCT00215644|365318397|FG001|Overall Study|Withdrawal by Subject|0|||
105906889|NCT00215644|365318396|FG000|Overall Study|Other|3|||
105906890|NCT00215644|365318397|FG001|Overall Study|Other|15|||
105906891|NCT00215644|365318396|FG000|Overall Study|Randomized but Not Treated|1|||
105906892|NCT00215644|365318397|FG001|Overall Study|Randomized but Not Treated|0|||
105906893|NCT01763827|365318399|FG000|Overall Study|Withdrawal by Subject|1|||
105906894|NCT01763827|365318400|FG001|Overall Study|Withdrawal by Subject|0|||
105906895|NCT01763827|365318401|FG002|Overall Study|Withdrawal by Subject|0|||
105906896|NCT01763827|365318402|FG003|Overall Study|Withdrawal by Subject|0|||
105906897|NCT01763827|365318403|FG004|Overall Study|Withdrawal by Subject|2|||
105906898|NCT01763827|365318404|FG005|Overall Study|Withdrawal by Subject|0|||
105906899|NCT01763827|365318399|FG000|Overall Study|Decision by sponsor|2|||
105906900|NCT01763827|365318400|FG001|Overall Study|Decision by sponsor|0|||
105906901|NCT01763827|365318401|FG002|Overall Study|Decision by sponsor|3|||
105906902|NCT01763827|365318402|FG003|Overall Study|Decision by sponsor|0|||
105906903|NCT01763827|365318403|FG004|Overall Study|Decision by sponsor|2|||
105906904|NCT01763827|365318404|FG005|Overall Study|Decision by sponsor|1|||
105906905|NCT01763827|365318399|FG000|Overall Study|Lost to Follow-up|0|||
105906906|NCT01763827|365318400|FG001|Overall Study|Lost to Follow-up|1|||
105906907|NCT01763827|365318401|FG002|Overall Study|Lost to Follow-up|1|||
105906908|NCT01763827|365318402|FG003|Overall Study|Lost to Follow-up|1|||
105906909|NCT01763827|365318403|FG004|Overall Study|Lost to Follow-up|2|||
105906910|NCT01763827|365318404|FG005|Overall Study|Lost to Follow-up|1|||
105906911|NCT02906579|365318405|FG000|Overall Study|Adverse Event|1|||
105906912|NCT02906579|365318405|FG000|Overall Study|Physician Decision|1|||
105906913|NCT02213380|365318414|FG000|Underwent Randomization|Withdrawal by Subject|2|||
105906914|NCT02213380|365318415|FG001|Underwent Randomization|Withdrawal by Subject|0|||
105906915|NCT02213380|365318414|FG000|Underwent Randomization|Not treated|3|||
105906916|NCT02213380|365318415|FG001|Underwent Randomization|Not treated|3|||
105906917|NCT02213380|365318414|FG000|Per-protocol Analysis|Protocol Violation|32|||
105906918|NCT02213380|365318415|FG001|Per-protocol Analysis|Protocol Violation|36|||
105906919|NCT00905632|365318417|FG000|Overall Study|Adverse Event|0|||
105906920|NCT00905632|365318418|FG001|Overall Study|Adverse Event|0|||
105906921|NCT00905632|365318419|FG002|Overall Study|Adverse Event|0|||
105906922|NCT00905632|365318420|FG003|Overall Study|Adverse Event|0|||
105906923|NCT00905632|365318421|FG004|Overall Study|Adverse Event|0|||
105906924|NCT00905632|365318422|FG005|Overall Study|Adverse Event|1|||
105906925|NCT00905632|365318423|FG006|Overall Study|Adverse Event|4|||
105906926|NCT03479008|365318424|FG000|Overall Study|Withdrawal by Subject|3|||
105906927|NCT01516736|365318432|FG000|Overall Study|Withdrawal by Subject|10|||
105906928|NCT01516736|365318433|FG001|Overall Study|Withdrawal by Subject|4|||
105906929|NCT01516736|365318432|FG000|Overall Study|Adverse Event|4|||
105906930|NCT01516736|365318433|FG001|Overall Study|Adverse Event|5|||
105906931|NCT01516736|365318432|FG000|Overall Study|Death|3|||
105906932|NCT01516736|365318433|FG001|Overall Study|Death|1|||
105906933|NCT01516736|365318432|FG000|Overall Study|Physician Decision|2|||
105906934|NCT01516736|365318433|FG001|Overall Study|Physician Decision|1|||
105906935|NCT01516736|365318432|FG000|Overall Study|Lack of Efficacy|1|||
105906936|NCT01516736|365318433|FG001|Overall Study|Lack of Efficacy|0|||
105906937|NCT01516736|365318432|FG000|Overall Study|Protocol Violation|0|||
105906938|NCT01516736|365318433|FG001|Overall Study|Protocol Violation|1|||
105906939|NCT01516736|365318432|FG000|Overall Study|Other (not specified)|0|||
105906940|NCT01516736|365318433|FG001|Overall Study|Other (not specified)|1|||
105906941|NCT01490840|365318434|FG000|Phase 1|Lost to Follow-up|1|||
105906942|NCT01490840|365318435|FG001|Phase 1|Lost to Follow-up|0|||
105906943|NCT01490840|365318434|FG000|Phase 1|Adverse Event|2|||
105906944|NCT01490840|365318435|FG001|Phase 1|Adverse Event|1|||
105906945|NCT01490840|365318434|FG000|Phase 1|Withdrawal by Subject|6|||
105906946|NCT01490840|365318435|FG001|Phase 1|Withdrawal by Subject|5|||
105906947|NCT01490840|365318434|FG000|Phase 1|Visit 6a omitted|1|||
105906948|NCT01490840|365318435|FG001|Phase 1|Visit 6a omitted|0|||
105786166|NCT04089566|364870459|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
105786167|NCT04089566|364870460|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
105906949|NCT01490840|365318434|FG000|Phase 2|Withdrawal by Subject|4|||
105906950|NCT01490840|365318435|FG001|Phase 2|Withdrawal by Subject|3|||
105906951|NCT01490840|365318434|FG000|Phase 2|Permanent interruption of fingolimod|0|||
105906952|NCT01490840|365318435|FG001|Phase 2|Permanent interruption of fingolimod|1|||
105906953|NCT01490840|365318434|FG000|Phase 2|Lost to Follow-up|1|||
105906954|NCT01490840|365318435|FG001|Phase 2|Lost to Follow-up|1|||
105906955|NCT01490840|365318434|FG000|Phase 2|Adverse Event|1|||
105906956|NCT01490840|365318435|FG001|Phase 2|Adverse Event|1|||
105906957|NCT00524771|365318439|FG000|Overall Study|Protocol Violation|220|||
105906958|NCT00524771|365318440|FG001|Overall Study|Protocol Violation|585|||
105906959|NCT02781818|365318441|FG000|Overall Study|Lost to Follow-up|4|||
105906960|NCT02781818|365318442|FG001|Overall Study|Lost to Follow-up|2|||
105670139|NCT03174431|364456189|FG000|Overall Study|Withdrawal by Subject|14|||
105670140|NCT03174431|364456190|FG001|Overall Study|Withdrawal by Subject|11|||
105670141|NCT03174431|364456189|FG000|Overall Study|alternative treatment|2|||
105670142|NCT03174431|364456190|FG001|Overall Study|alternative treatment|0|||
105670143|NCT03174431|364456189|FG000|Overall Study|Lost to Follow-up|1|||
105670144|NCT03174431|364456190|FG001|Overall Study|Lost to Follow-up|5|||
105670145|NCT01031628|364456191|FG000|Overall Study|Study terminated early|0|||
105670146|NCT01031628|364456192|FG001|Overall Study|Study terminated early|1|||
105670147|NCT01031628|364456193|FG002|Overall Study|Study terminated early|3|||
105670148|NCT01031628|364456194|FG003|Overall Study|Study terminated early|0|||
105670149|NCT00643617|364456195|FG000|Overall Study|Death|6|||
105670150|NCT00643617|364456196|FG001|Overall Study|Death|9|||
105670151|NCT00643617|364456195|FG000|Overall Study|Lost to Follow-up|42|||
105670152|NCT00643617|364456196|FG001|Overall Study|Lost to Follow-up|51|||
105670153|NCT02593123|364456199|FG000|Overall Study|Physician Decision|2|||
105670154|NCT02593123|364456200|FG001|Overall Study|Physician Decision|1|||
105670155|NCT02593123|364456199|FG000|Overall Study|Relapse|1|||
105670156|NCT02593123|364456200|FG001|Overall Study|Relapse|1|||
105670157|NCT00416195|364456201|FG000|Overall Study|Adverse Event|1|||
105670158|NCT00416195|364456202|FG001|Overall Study|Adverse Event|2|||
105670159|NCT00416195|364456201|FG000|Overall Study|Protocol Violation|1|||
105670160|NCT00416195|364456202|FG001|Overall Study|Protocol Violation|1|||
105670161|NCT00416195|364456201|FG000|Overall Study|Other|0|||
105670162|NCT00416195|364456202|FG001|Overall Study|Other|1|||
105670163|NCT01417104|364456205|FG000|Overall Study|Withdrawal by Subject|5|||
105670164|NCT01417104|364456206|FG001|Overall Study|Withdrawal by Subject|1|||
105670165|NCT01417104|364456205|FG000|Overall Study|Failure to make contact|0|||
105670166|NCT01417104|364456206|FG001|Overall Study|Failure to make contact|1|||
105670167|NCT01417104|364456205|FG000|Overall Study|Adverse Event|1|||
105670168|NCT01417104|364456206|FG001|Overall Study|Adverse Event|0|||
105670169|NCT01401153|364456208|FG000|First Test Day|Learning disabilities; illness|1|||
105670170|NCT01401153|364456209|FG001|First Test Day|Learning disabilities; illness|10|||
105670171|NCT01401153|364456208|FG000|Second Test Day|illness|0|||
105670172|NCT01401153|364456209|FG001|Second Test Day|illness|5|||
105670173|NCT01754753|364456214|FG000|Overall Study|Study close|43|||
105670174|NCT01754753|364456215|FG001|Overall Study|Study close|44|||
105670175|NCT01754753|364456214|FG000|Overall Study|Lost to Follow-up|9|||
105670176|NCT01754753|364456215|FG001|Overall Study|Lost to Follow-up|5|||
105670177|NCT01250509|364456216|FG000|Overall Study|Lost to Follow-up|5|||
105670178|NCT01250509|364456217|FG001|Overall Study|Lost to Follow-up|2|||
105670179|NCT01067846|364456221|FG000|Overall Study|Lost to Follow-up|17|||
105670180|NCT01067846|364456222|FG001|Overall Study|Lost to Follow-up|19|||
105670181|NCT01067846|364456221|FG000|Overall Study|Withdrawal by Subject|1|||
105670182|NCT01067846|364456222|FG001|Overall Study|Withdrawal by Subject|0|||
105670183|NCT01067846|364456221|FG000|Overall Study|participation in other tx study|1|||
105670184|NCT01067846|364456222|FG001|Overall Study|participation in other tx study|0|||
105670185|NCT03686423|364456223|FG000|Overall Study|Withdrawal by Subject|9|||
105670186|NCT03686423|364456223|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
105670187|NCT00387426|364457995|FG000|Overall Study|Lack of Response|7|||
105670188|NCT00387426|364457995|FG000|Overall Study|Toxicities|4|||
105670189|NCT00387426|364457995|FG000|Overall Study|Disease Progression|3|||
105670190|NCT02218606|364457996|FG000|Overall Study|Adverse Event|1|||
105670191|NCT02218606|364457997|FG001|Overall Study|Adverse Event|1|||
105670192|NCT02218606|364457996|FG000|Overall Study|Death|15|||
105670193|NCT02218606|364457997|FG001|Overall Study|Death|28|||
105670194|NCT02218606|364457996|FG000|Overall Study|Physician Decision|0|||
105670195|NCT02218606|364457997|FG001|Overall Study|Physician Decision|1|||
105670196|NCT02218606|364457996|FG000|Overall Study|Withdrawal by Subject|4|||
105670197|NCT02218606|364457997|FG001|Overall Study|Withdrawal by Subject|0|||
105670198|NCT02218606|364457996|FG000|Overall Study|Noncompliance|1|||
105670199|NCT02218606|364457997|FG001|Overall Study|Noncompliance|0|||
105670200|NCT02218606|364457996|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
105670201|NCT02218606|364457997|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
105670202|NCT02218606|364457996|FG000|Overall Study|Other|2|||
105670203|NCT02218606|364457997|FG001|Overall Study|Other|1|||
105670204|NCT02218606|364457996|FG000|Overall Study|Never started treatment|0|||
105670205|NCT02218606|364457997|FG001|Overall Study|Never started treatment|1|||
105670206|NCT03203473|364457998|FG000|Induction Phase|Never started primary treatment|2|||
105670207|NCT03203473|364457999|FG001|Induction Phase|Never started primary treatment|0|||
105670208|NCT03203473|364458000|FG002|Induction Phase|Never started primary treatment|0|||
105670209|NCT03203473|364457998|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
105670210|NCT03203473|364457999|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
105670211|NCT03203473|364458000|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
105670212|NCT03203473|364457998|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
105670213|NCT03203473|364457999|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
105670214|NCT03203473|364458000|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
105670215|NCT03203473|364457998|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
105670216|NCT03203473|364457999|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
105670217|NCT03203473|364458000|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
105670218|NCT03203473|364457998|FG000|Arm Allocation Phase|started salvage therapy|0|||
105670219|NCT03203473|364457999|FG001|Arm Allocation Phase|started salvage therapy|5|||
105670220|NCT03203473|364458000|FG002|Arm Allocation Phase|started salvage therapy|0|||
105670221|NCT03203473|364457998|FG000|Arm Allocation Phase|Disease progression|0|||
105670222|NCT03203473|364457999|FG001|Arm Allocation Phase|Disease progression|0|||
105670223|NCT03203473|364458000|FG002|Arm Allocation Phase|Disease progression|37|||
105670224|NCT03203473|364457998|FG000|Arm Allocation Phase|Adverse Event|0|||
105670225|NCT03203473|364457999|FG001|Arm Allocation Phase|Adverse Event|0|||
105670226|NCT03203473|364458000|FG002|Arm Allocation Phase|Adverse Event|11|||
105670227|NCT03203473|364457998|FG000|Arm Allocation Phase|Physician Decision|0|||
105670228|NCT03203473|364457999|FG001|Arm Allocation Phase|Physician Decision|0|||
105670229|NCT03203473|364458000|FG002|Arm Allocation Phase|Physician Decision|3|||
105670230|NCT03203473|364457998|FG000|Arm Allocation Phase|Death|0|||
105670231|NCT03203473|364457999|FG001|Arm Allocation Phase|Death|0|||
105670232|NCT03203473|364458000|FG002|Arm Allocation Phase|Death|1|||
105670233|NCT03203473|364457998|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
105670234|NCT03203473|364457999|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
105670235|NCT03203473|364458000|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
105670236|NCT03203473|364457998|FG000|Arm Allocation Phase|Intercurrent illness|0|||
105670237|NCT03203473|364457999|FG001|Arm Allocation Phase|Intercurrent illness|0|||
105670238|NCT03203473|364458000|FG002|Arm Allocation Phase|Intercurrent illness|1|||
105670239|NCT03203473|364457998|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
105670240|NCT03203473|364457999|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
105670241|NCT03203473|364458000|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
105670242|NCT03554629|364458001|FG000|Overall Study|Inadequate data|6|||
105670243|NCT00918879|364458002|FG000|Overall Study|Withdrawal by Subject|4|||
105670244|NCT00918879|364458003|FG001|Overall Study|Withdrawal by Subject|4|||
105670245|NCT00918879|364458002|FG000|Overall Study|Lost to Follow-up|1|||
105670246|NCT00918879|364458003|FG001|Overall Study|Lost to Follow-up|1|||
105670247|NCT00918879|364458002|FG000|Overall Study|Severe non-compliance to protocol|1|||
105670248|NCT00918879|364458003|FG001|Overall Study|Severe non-compliance to protocol|1|||
105670249|NCT04707664|364458006|FG000|Overall Study|Adverse Event|2|||
105670250|NCT04707664|364458007|FG001|Overall Study|Adverse Event|0|||
105670251|NCT04707664|364458006|FG000|Overall Study|Death|1|||
105670252|NCT04707664|364458007|FG001|Overall Study|Death|2|||
105670253|NCT04707664|364458006|FG000|Overall Study|Withdrawal by Subject|13|||
105670254|NCT04707664|364458007|FG001|Overall Study|Withdrawal by Subject|21|||
105670255|NCT04707664|364458006|FG000|Overall Study|Lost to Follow-up|11|||
105670256|NCT04707664|364458007|FG001|Overall Study|Lost to Follow-up|13|||
105670257|NCT04707664|364458006|FG000|Overall Study|Not treated|2|||
105670258|NCT04707664|364458007|FG001|Overall Study|Not treated|0|||
105670259|NCT02412735|364458008|FG000|Overall Study|Adverse Event|0|||
105670260|NCT02412735|364458009|FG001|Overall Study|Adverse Event|1|||
105670261|NCT02412735|364458010|FG002|Overall Study|Adverse Event|2|||
105670262|NCT02412735|364458008|FG000|Overall Study|Withdrawal by Subject|23|||
105670263|NCT02412735|364458009|FG001|Overall Study|Withdrawal by Subject|27|||
105670264|NCT02412735|364458010|FG002|Overall Study|Withdrawal by Subject|22|||
105670265|NCT02412735|364458008|FG000|Overall Study|Investigator Decision|3|||
105670266|NCT02412735|364458009|FG001|Overall Study|Investigator Decision|3|||
105670267|NCT02412735|364458010|FG002|Overall Study|Investigator Decision|2|||
105670268|NCT02412735|364458008|FG000|Overall Study|Lost to Follow-up|17|||
105670269|NCT02412735|364458009|FG001|Overall Study|Lost to Follow-up|11|||
105670270|NCT02412735|364458010|FG002|Overall Study|Lost to Follow-up|18|||
105670271|NCT02412735|364458008|FG000|Overall Study|Reason not Specified|3|||
105670272|NCT02412735|364458009|FG001|Overall Study|Reason not Specified|2|||
105670273|NCT02412735|364458010|FG002|Overall Study|Reason not Specified|2|||
105670274|NCT05602727|364458018|FG000|Overall Study|Physician Decision|0|||
105670275|NCT05602727|364458019|FG001|Overall Study|Physician Decision|1|||
105670276|NCT05602727|364458020|FG002|Overall Study|Physician Decision|0|||
105670277|NCT05602727|364458018|FG000|Overall Study|Randomized by mistake without study medication|1|||
105670278|NCT05602727|364458019|FG001|Overall Study|Randomized by mistake without study medication|0|||
105670279|NCT05602727|364458020|FG002|Overall Study|Randomized by mistake without study medication|0|||
105670280|NCT05602727|364458018|FG000|Overall Study|Study termination by Sponsor|18|||
105906961|NCT02781818|365318443|FG002|Overall Study|Lost to Follow-up|1|||
105906962|NCT02492165|365318444|FG000|Overall Study|Withdrawal by Subject|0|||
105906963|NCT02492165|365318445|FG001|Overall Study|Withdrawal by Subject|1|||
105670281|NCT05602727|364458019|FG001|Overall Study|Study termination by Sponsor|15|||
105670282|NCT05602727|364458020|FG002|Overall Study|Study termination by Sponsor|19|||
105670283|NCT05602727|364458018|FG000|Overall Study|Withdrawal by Subject|2|||
105670284|NCT05602727|364458019|FG001|Overall Study|Withdrawal by Subject|1|||
105670285|NCT05602727|364458020|FG002|Overall Study|Withdrawal by Subject|1|||
105670286|NCT05602727|364458018|FG000|Overall Study|Various reasons|1|||
105670287|NCT05602727|364458019|FG001|Overall Study|Various reasons|6|||
106125582|NCT00178256|366117820|FG003|Overall Study|Death|1|||
105670288|NCT05602727|364458020|FG002|Overall Study|Various reasons|1|||
105670289|NCT03330405|364458021|FG000|Overall Study|Other|1|||
105670290|NCT03330405|364458022|FG001|Overall Study|Other|3|||
105670291|NCT03330405|364458023|FG002|Overall Study|Other|1|||
105670292|NCT03330405|364458024|FG003|Overall Study|Other|0|||
105670293|NCT03330405|364458025|FG004|Overall Study|Other|2|||
105670294|NCT03330405|364458026|FG005|Overall Study|Other|0|||
105670295|NCT03330405|364458027|FG006|Overall Study|Other|1|||
105670296|NCT03330405|364458028|FG007|Overall Study|Other|0|||
105670297|NCT03330405|364458029|FG008|Overall Study|Other|0|||
105670298|NCT03330405|364458030|FG009|Overall Study|Other|0|||
105670299|NCT03330405|364458031|FG010|Overall Study|Other|0|||
105670300|NCT03330405|364458021|FG000|Overall Study|Progressive disease|8|||
105670301|NCT03330405|364458022|FG001|Overall Study|Progressive disease|27|||
105670302|NCT03330405|364458023|FG002|Overall Study|Progressive disease|4|||
105670303|NCT03330405|364458024|FG003|Overall Study|Progressive disease|18|||
105670304|NCT03330405|364458025|FG004|Overall Study|Progressive disease|16|||
105670305|NCT03330405|364458026|FG005|Overall Study|Progressive disease|14|||
105670306|NCT03330405|364458027|FG006|Overall Study|Progressive disease|7|||
105670307|NCT03330405|364458028|FG007|Overall Study|Progressive disease|29|||
105670308|NCT03330405|364458029|FG008|Overall Study|Progressive disease|9|||
105670309|NCT03330405|364458030|FG009|Overall Study|Progressive disease|11|||
105670310|NCT03330405|364458031|FG010|Overall Study|Progressive disease|5|||
105670311|NCT03330405|364458021|FG000|Overall Study|Withdrawal by Subject|1|||
105670312|NCT03330405|364458022|FG001|Overall Study|Withdrawal by Subject|4|||
105670313|NCT03330405|364458023|FG002|Overall Study|Withdrawal by Subject|0|||
105670314|NCT03330405|364458024|FG003|Overall Study|Withdrawal by Subject|1|||
105670315|NCT03330405|364458025|FG004|Overall Study|Withdrawal by Subject|1|||
105670316|NCT03330405|364458026|FG005|Overall Study|Withdrawal by Subject|1|||
105670317|NCT03330405|364458027|FG006|Overall Study|Withdrawal by Subject|0|||
105670318|NCT03330405|364458028|FG007|Overall Study|Withdrawal by Subject|2|||
105670319|NCT03330405|364458029|FG008|Overall Study|Withdrawal by Subject|2|||
105670320|NCT03330405|364458030|FG009|Overall Study|Withdrawal by Subject|1|||
105670321|NCT03330405|364458031|FG010|Overall Study|Withdrawal by Subject|1|||
105998793|NCT03573323|365657790|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
105998794|NCT03573323|365657789|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
105998795|NCT03573323|365657790|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
105998796|NCT03573323|365657789|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
105998797|NCT03573323|365657790|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
105998798|NCT03573323|365657789|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
105998799|NCT03573323|365657790|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
105998800|NCT03573323|365657789|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
105998801|NCT03573323|365657790|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
105998802|NCT03573323|365657789|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
105998803|NCT03573323|365657790|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
105998804|NCT03573323|365657789|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
105998805|NCT03573323|365657790|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
105998806|NCT01946139|365657797|FG000|Overall Study|Withdrawal by Subject|8|||
105998807|NCT01946139|365657797|FG000|Overall Study|ineligible|8|||
105998808|NCT01946139|365657797|FG000|Overall Study|Specimens not available|4|||
105998809|NCT00890825|365657801|FG000|Overall Study|Withdrawal by Subject|1|||
105998810|NCT00890825|365657802|FG001|Overall Study|Withdrawal by Subject|0|||
105998811|NCT00890825|365657801|FG000|Overall Study|Alive at data cut off (DCO)|13|||
105998812|NCT00890825|365657802|FG001|Overall Study|Alive at data cut off (DCO)|14|||
105998813|NCT01508169|365657803|FG000|Overall Study|Adverse Event|1|||
105998814|NCT01508169|365657804|FG001|Overall Study|Adverse Event|0|||
105998815|NCT01508169|365657803|FG000|Overall Study|Withdrawal by Subject|1|||
105998816|NCT01508169|365657804|FG001|Overall Study|Withdrawal by Subject|0|||
105998817|NCT01508169|365657803|FG000|Overall Study|Lost to Follow-up|1|||
105998818|NCT01508169|365657804|FG001|Overall Study|Lost to Follow-up|2|||
105998819|NCT04701333|365657810|FG000|Overall Study|Lost to Follow-up|3|||
105998820|NCT04701333|365657811|FG001|Overall Study|Lost to Follow-up|7|||
105998821|NCT04701333|365657810|FG000|Overall Study|Withdrawal by Subject|0|||
105998822|NCT04701333|365657811|FG001|Overall Study|Withdrawal by Subject|1|||
105998823|NCT03600740|365657814|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
105998824|NCT01814527|365657820|FG000|Overall Study|RTP greater than 30 days|6|||
105998825|NCT01814527|365657821|FG001|Overall Study|RTP greater than 30 days|1|||
105998826|NCT04524858|365657822|FG000|Overall Study|Adverse Event|1|||
105998827|NCT03901144|365657825|FG000|Overall Study|Lost to Follow-up|1|||
105998828|NCT03901144|365657826|FG001|Overall Study|Lost to Follow-up|1|||
105670322|NCT03330405|364458021|FG000|Overall Study|Global deterioration of health status|2|||
105670323|NCT03330405|364458022|FG001|Overall Study|Global deterioration of health status|3|||
105670324|NCT03330405|364458023|FG002|Overall Study|Global deterioration of health status|0|||
105670325|NCT03330405|364458024|FG003|Overall Study|Global deterioration of health status|2|||
105670326|NCT03330405|364458025|FG004|Overall Study|Global deterioration of health status|3|||
105670327|NCT03330405|364458026|FG005|Overall Study|Global deterioration of health status|3|||
105670328|NCT03330405|364458027|FG006|Overall Study|Global deterioration of health status|0|||
105670329|NCT03330405|364458028|FG007|Overall Study|Global deterioration of health status|2|||
105670330|NCT03330405|364458029|FG008|Overall Study|Global deterioration of health status|8|||
105670331|NCT03330405|364458030|FG009|Overall Study|Global deterioration of health status|4|||
105670332|NCT03330405|364458031|FG010|Overall Study|Global deterioration of health status|1|||
105670333|NCT03330405|364458021|FG000|Overall Study|Adverse Event|0|||
105670334|NCT03330405|364458022|FG001|Overall Study|Adverse Event|1|||
105670335|NCT03330405|364458023|FG002|Overall Study|Adverse Event|0|||
105670336|NCT03330405|364458024|FG003|Overall Study|Adverse Event|1|||
105670337|NCT03330405|364458025|FG004|Overall Study|Adverse Event|1|||
105670338|NCT03330405|364458026|FG005|Overall Study|Adverse Event|1|||
105670339|NCT03330405|364458027|FG006|Overall Study|Adverse Event|3|||
105670340|NCT03330405|364458028|FG007|Overall Study|Adverse Event|4|||
105670341|NCT03330405|364458029|FG008|Overall Study|Adverse Event|2|||
105670342|NCT03330405|364458030|FG009|Overall Study|Adverse Event|2|||
105670343|NCT03330405|364458031|FG010|Overall Study|Adverse Event|2|||
105670344|NCT03330405|364458021|FG000|Overall Study|Death|0|||
105670345|NCT03330405|364458022|FG001|Overall Study|Death|4|||
105670346|NCT03330405|364458023|FG002|Overall Study|Death|0|||
105670347|NCT03330405|364458024|FG003|Overall Study|Death|0|||
105670348|NCT03330405|364458025|FG004|Overall Study|Death|0|||
105670349|NCT03330405|364458026|FG005|Overall Study|Death|1|||
105670350|NCT03330405|364458027|FG006|Overall Study|Death|0|||
105670351|NCT03330405|364458028|FG007|Overall Study|Death|2|||
105670352|NCT03330405|364458029|FG008|Overall Study|Death|0|||
105670353|NCT03330405|364458030|FG009|Overall Study|Death|0|||
105670354|NCT03330405|364458031|FG010|Overall Study|Death|0|||
105670355|NCT03330405|364458021|FG000|Overall Study|Physician Decision|0|||
105670356|NCT03330405|364458022|FG001|Overall Study|Physician Decision|0|||
105670357|NCT03330405|364458023|FG002|Overall Study|Physician Decision|0|||
105906964|NCT02492165|365318446|FG002|Overall Study|Withdrawal by Subject|0|||
105906965|NCT02492165|365318447|FG003|Overall Study|Withdrawal by Subject|0|||
105906966|NCT02259400|365318448|FG000|Overall Study|Death|0|||
105906967|NCT02259400|365318449|FG001|Overall Study|Death|2|||
105906968|NCT00697593|365318453|FG000|Overall Study|Adverse Event|3|||
105906969|NCT00697593|365318453|FG000|Overall Study|Protocol Violation|1|||
105906970|NCT00697593|365318453|FG000|Overall Study|Lack of Efficacy|3|||
105906971|NCT00697593|365318453|FG000|Overall Study|Suspension of the study by sponsor|12|||
105906972|NCT03498313|365318454|FG000|Experimental Period 1|Adverse Event|1|||
105906973|NCT03498313|365318455|FG001|Experimental Period 1|Adverse Event|0|||
105906974|NCT03498313|365318456|FG002|Experimental Period 1|Adverse Event|0|||
105906975|NCT03498313|365318457|FG003|Experimental Period 1|Adverse Event|1|||
105906976|NCT03498313|365318458|FG004|Experimental Period 1|Adverse Event|0|||
105906977|NCT03498313|365318459|FG005|Experimental Period 1|Adverse Event|0|||
105906978|NCT03498313|365318454|FG000|Experimental Period 1|Withdrawal by Subject|0|||
105906979|NCT03498313|365318455|FG001|Experimental Period 1|Withdrawal by Subject|1|||
105906980|NCT03498313|365318456|FG002|Experimental Period 1|Withdrawal by Subject|0|||
105906981|NCT03498313|365318457|FG003|Experimental Period 1|Withdrawal by Subject|0|||
105906982|NCT03498313|365318458|FG004|Experimental Period 1|Withdrawal by Subject|0|||
105906983|NCT03498313|365318459|FG005|Experimental Period 1|Withdrawal by Subject|0|||
105906984|NCT03498313|365318454|FG000|Washout Period 1|Anovulation|1|||
105906985|NCT03498313|365318455|FG001|Washout Period 1|Anovulation|0|||
105906986|NCT03498313|365318456|FG002|Washout Period 1|Anovulation|0|||
105906987|NCT03498313|365318457|FG003|Washout Period 1|Anovulation|0|||
105906988|NCT03498313|365318458|FG004|Washout Period 1|Anovulation|0|||
105906989|NCT03498313|365318459|FG005|Washout Period 1|Anovulation|0|||
105906990|NCT03498313|365318454|FG000|Washout Period 1|Withdrawal by Subject|0|||
105906991|NCT03498313|365318455|FG001|Washout Period 1|Withdrawal by Subject|3|||
105906992|NCT03498313|365318456|FG002|Washout Period 1|Withdrawal by Subject|0|||
105906993|NCT03498313|365318457|FG003|Washout Period 1|Withdrawal by Subject|1|||
105906994|NCT03498313|365318458|FG004|Washout Period 1|Withdrawal by Subject|0|||
105906995|NCT03498313|365318459|FG005|Washout Period 1|Withdrawal by Subject|1|||
105906996|NCT03498313|365318454|FG000|Experimental Period 2|Adverse Event|0|||
105906997|NCT03498313|365318455|FG001|Experimental Period 2|Adverse Event|0|||
105906998|NCT03498313|365318456|FG002|Experimental Period 2|Adverse Event|0|||
105906999|NCT03498313|365318457|FG003|Experimental Period 2|Adverse Event|0|||
105907000|NCT03498313|365318458|FG004|Experimental Period 2|Adverse Event|1|||
105907001|NCT03498313|365318459|FG005|Experimental Period 2|Adverse Event|2|||
105907002|NCT03498313|365318454|FG000|Washout Period 2|Physician Decision|1|||
105907003|NCT03498313|365318455|FG001|Washout Period 2|Physician Decision|0|||
105998829|NCT03901144|365657827|FG002|Overall Study|Lost to Follow-up|1|||
105670358|NCT03330405|364458024|FG003|Overall Study|Physician Decision|0|||
105670359|NCT03330405|364458025|FG004|Overall Study|Physician Decision|0|||
105670360|NCT03330405|364458026|FG005|Overall Study|Physician Decision|0|||
105670361|NCT03330405|364458027|FG006|Overall Study|Physician Decision|0|||
105670362|NCT03330405|364458028|FG007|Overall Study|Physician Decision|1|||
105670363|NCT03330405|364458029|FG008|Overall Study|Physician Decision|0|||
105670364|NCT03330405|364458030|FG009|Overall Study|Physician Decision|0|||
105670365|NCT03330405|364458031|FG010|Overall Study|Physician Decision|0|||
105670366|NCT03139604|364458032|FG000|Overall Study|Other|7|||
105670367|NCT03139604|364458033|FG001|Overall Study|Other|3|||
105670368|NCT03139604|364458032|FG000|Overall Study|Withdrawal by Subject|16|||
105670369|NCT03139604|364458033|FG001|Overall Study|Withdrawal by Subject|17|||
105670370|NCT03139604|364458032|FG000|Overall Study|Physician Decision|1|||
105670371|NCT03139604|364458033|FG001|Overall Study|Physician Decision|2|||
105670372|NCT03139604|364458032|FG000|Overall Study|Lost to Follow-up|3|||
105670373|NCT03139604|364458033|FG001|Overall Study|Lost to Follow-up|1|||
105670374|NCT03139604|364458032|FG000|Overall Study|Death|65|||
105670375|NCT03139604|364458033|FG001|Overall Study|Death|67|||
105670376|NCT03139604|364458032|FG000|Overall Study|Study Terminated by Sponsor|122|||
105670377|NCT03139604|364458033|FG001|Overall Study|Study Terminated by Sponsor|127|||
105670378|NCT03139604|364458032|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
105670379|NCT03139604|364458033|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
105907004|NCT03498313|365318456|FG002|Washout Period 2|Physician Decision|0|||
105907005|NCT03498313|365318457|FG003|Washout Period 2|Physician Decision|1|||
105907006|NCT03498313|365318458|FG004|Washout Period 2|Physician Decision|0|||
105907007|NCT03498313|365318459|FG005|Washout Period 2|Physician Decision|1|||
105907008|NCT03498313|365318454|FG000|Washout Period 2|Withdrawal by Subject|3|||
105907009|NCT03498313|365318455|FG001|Washout Period 2|Withdrawal by Subject|2|||
105907010|NCT03498313|365318456|FG002|Washout Period 2|Withdrawal by Subject|0|||
105907011|NCT03498313|365318457|FG003|Washout Period 2|Withdrawal by Subject|0|||
105907012|NCT03498313|365318458|FG004|Washout Period 2|Withdrawal by Subject|2|||
105907013|NCT03498313|365318459|FG005|Washout Period 2|Withdrawal by Subject|0|||
105907014|NCT03498313|365318454|FG000|Washout Period 2|Anovulation|0|||
105907015|NCT03498313|365318455|FG001|Washout Period 2|Anovulation|0|||
105907016|NCT03498313|365318456|FG002|Washout Period 2|Anovulation|0|||
105907017|NCT03498313|365318457|FG003|Washout Period 2|Anovulation|0|||
105907018|NCT03498313|365318458|FG004|Washout Period 2|Anovulation|0|||
105907019|NCT03498313|365318459|FG005|Washout Period 2|Anovulation|1|||
105907020|NCT02964338|365318463|FG000|Overall Study|Sponsor terminated study for futility|12|||
105907021|NCT02964338|365318464|FG001|Overall Study|Sponsor terminated study for futility|15|||
105907022|NCT02964338|365318465|FG002|Overall Study|Sponsor terminated study for futility|14|||
105907023|NCT02964338|365318463|FG000|Overall Study|Lack of Efficacy|0|||
105907024|NCT02964338|365318464|FG001|Overall Study|Lack of Efficacy|3|||
105907025|NCT02964338|365318465|FG002|Overall Study|Lack of Efficacy|0|||
105907026|NCT02964338|365318463|FG000|Overall Study|Lost to Follow-up|1|||
105907027|NCT02964338|365318464|FG001|Overall Study|Lost to Follow-up|0|||
105907028|NCT02964338|365318465|FG002|Overall Study|Lost to Follow-up|3|||
105907029|NCT02964338|365318463|FG000|Overall Study|Protocol Violation|0|||
105907030|NCT02964338|365318464|FG001|Overall Study|Protocol Violation|1|||
105907031|NCT02964338|365318465|FG002|Overall Study|Protocol Violation|0|||
105907032|NCT02964338|365318463|FG000|Overall Study|Withdrawal by Subject|1|||
105907033|NCT02964338|365318464|FG001|Overall Study|Withdrawal by Subject|3|||
105907034|NCT02964338|365318465|FG002|Overall Study|Withdrawal by Subject|1|||
105907035|NCT02964338|365318463|FG000|Overall Study|Adverse Event|2|||
105907036|NCT02964338|365318464|FG001|Overall Study|Adverse Event|1|||
105907037|NCT02964338|365318465|FG002|Overall Study|Adverse Event|1|||
105907038|NCT02964338|365318463|FG000|Overall Study|Non-compliant with e-diary|0|||
105907039|NCT02964338|365318464|FG001|Overall Study|Non-compliant with e-diary|1|||
105907040|NCT02964338|365318465|FG002|Overall Study|Non-compliant with e-diary|0|||
105907041|NCT02964338|365318463|FG000|Overall Study|Did not meet criteria|1|||
105907042|NCT02964338|365318464|FG001|Overall Study|Did not meet criteria|0|||
105907043|NCT02964338|365318465|FG002|Overall Study|Did not meet criteria|0|||
105907044|NCT02485483|365318468|FG000|Overall Study|Depression at baseline|15|||
105907045|NCT02485483|365318469|FG001|Overall Study|Depression at baseline|0|||
105907046|NCT02485483|365318468|FG000|Overall Study|Discontinued after baseline|39|||
105670380|NCT02476175|364458036|FG000|Overall Study|Adverse Event|2|||
105670381|NCT00821587|364458037|FG000|Overall Study|Physician Decision|0|||
105907047|NCT02485483|365318469|FG001|Overall Study|Discontinued after baseline|0|||
105907048|NCT00929994|365318470|FG000|Overall Study|Withdrawal by Subject|1|||
105907049|NCT00929994|365318470|FG000|Overall Study|medical issue unrelated to intervention|4|||
105907050|NCT00929994|365318470|FG000|Overall Study|employment|1|||
105907051|NCT01724177|365318474|FG000|Overall Study|Adverse Event|8|||
105907052|NCT01724177|365318474|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
105907053|NCT01724177|365318474|FG000|Overall Study|Nervous participant|1|||
105670382|NCT00821587|364458038|FG001|Overall Study|Physician Decision|1|||
105670383|NCT02964325|364458039|FG000|Overall Study|Lost to Follow-up|3|||
105670384|NCT02964325|364458040|FG001|Overall Study|Lost to Follow-up|3|||
105670385|NCT02964325|364458039|FG000|Overall Study|Physician Decision|5|||
105907054|NCT01724177|365318474|FG000|Overall Study|Serious Adverse Event Related|1|||
105907055|NCT00206427|365318477|FG000|Overall Study|Adverse Event|2|||
105907056|NCT00587795|365318481|FG000|Overall Study|Withdrawal by Subject|1|||
105907057|NCT00587795|365318482|FG001|Overall Study|Withdrawal by Subject|0|||
105670386|NCT02964325|364458040|FG001|Overall Study|Physician Decision|4|||
105670387|NCT02964325|364458039|FG000|Overall Study|Death|1|||
105670388|NCT02964325|364458040|FG001|Overall Study|Death|3|||
105670389|NCT02964325|364458039|FG000|Overall Study|Withdrawal by Subject|2|||
105670390|NCT02964325|364458040|FG001|Overall Study|Withdrawal by Subject|1|||
105670391|NCT02964325|364458039|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
105670392|NCT02964325|364458040|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
105670393|NCT01931098|364458041|FG000|Overall Study|Withdrawal by Subject|0|||
105670394|NCT01931098|364458042|FG001|Overall Study|Withdrawal by Subject|1|||
105670395|NCT01931098|364458041|FG000|Overall Study|Enrolled in different protocol|0|||
105907058|NCT01001520|365318483|FG000|Medication Period 1|Withdrawal by Subject|2|||
105907059|NCT01001520|365318484|FG001|Medication Period 1|Withdrawal by Subject|2|||
105786168|NCT04089566|364870461|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
105786169|NCT04089566|364870462|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
105786170|NCT04089566|364870457|FG000|Overall Study|Reason not Specified|0|||
105670396|NCT01931098|364458042|FG001|Overall Study|Enrolled in different protocol|1|||
105670397|NCT01931098|364458041|FG000|Overall Study|Unable to begin trmt:active infection|0|||
105670398|NCT01931098|364458042|FG001|Overall Study|Unable to begin trmt:active infection|1|||
105670399|NCT01931098|364458041|FG000|Overall Study|Refused further treatment|0|||
105670400|NCT01931098|364458042|FG001|Overall Study|Refused further treatment|1|||
105670401|NCT01712061|364458043|FG000|Overall Study|Adverse Event|4|||
105670402|NCT01712061|364458044|FG001|Overall Study|Adverse Event|9|||
105670403|NCT01712061|364458045|FG002|Overall Study|Adverse Event|5|||
105670404|NCT01712061|364458043|FG000|Overall Study|Death|0|||
105670405|NCT01712061|364458044|FG001|Overall Study|Death|0|||
105670406|NCT01712061|364458045|FG002|Overall Study|Death|1|||
105670407|NCT01712061|364458043|FG000|Overall Study|Lost to Follow-up|1|||
105670408|NCT01712061|364458044|FG001|Overall Study|Lost to Follow-up|0|||
105670409|NCT01712061|364458045|FG002|Overall Study|Lost to Follow-up|1|||
105670410|NCT01712061|364458043|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
105670411|NCT01712061|364458044|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
105907060|NCT01001520|365318483|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
105907061|NCT01001520|365318484|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
105670412|NCT01712061|364458045|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
105670413|NCT01712061|364458043|FG000|Overall Study|Medication Error Without Associated AE|0|||
105670414|NCT01712061|364458044|FG001|Overall Study|Medication Error Without Associated AE|1|||
105670415|NCT01712061|364458045|FG002|Overall Study|Medication Error Without Associated AE|0|||
105670416|NCT01712061|364458043|FG000|Overall Study|Withdrawal by Subject|1|||
105670417|NCT01712061|364458044|FG001|Overall Study|Withdrawal by Subject|7|||
105670418|NCT01712061|364458045|FG002|Overall Study|Withdrawal by Subject|1|||
105670419|NCT01712061|364458043|FG000|Overall Study|Other|0|||
105786171|NCT04089566|364870458|FG001|Overall Study|Reason not Specified|4|||
105907062|NCT01001520|365318483|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
105907063|NCT01001520|365318484|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
105907064|NCT01001520|365318483|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
105907065|NCT01001520|365318484|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
105670420|NCT01712061|364458044|FG001|Overall Study|Other|3|||
105670421|NCT01712061|364458045|FG002|Overall Study|Other|0|||
105786172|NCT04089566|364870459|FG002|Overall Study|Reason not Specified|4|||
105786173|NCT04089566|364870460|FG003|Overall Study|Reason not Specified|1|||
105907066|NCT01001520|365318483|FG000|Washout Period|Withdrawal by Subject|2|||
105907067|NCT01001520|365318484|FG001|Washout Period|Withdrawal by Subject|1|||
105907068|NCT01001520|365318483|FG000|Medication Period 2|Withdrawal by Subject|0|||
105907069|NCT01001520|365318484|FG001|Medication Period 2|Withdrawal by Subject|3|||
105907070|NCT00141518|365318485|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
105907071|NCT00141518|365318486|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
105907072|NCT00141518|365318487|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
105670422|NCT02797080|364458046|FG000|Overall Study|Lost to Follow-up|1|||
105670423|NCT02797080|364458046|FG000|Overall Study|Withdrawal by Subject|1|||
105670424|NCT00879775|364458050|FG000|Overall Study|Lost to Follow-up|2|||
105670425|NCT00879775|364458051|FG001|Overall Study|Lost to Follow-up|1|||
105670426|NCT03819634|364458052|FG000|Overall Study|Physician Decision|2|||
105670427|NCT03019640|364458053|FG000|Overall Study|Screen Failures|4|||
105670428|NCT03019640|364458053|FG000|Overall Study|Adverse Event|3|||
105670429|NCT03019640|364458053|FG000|Overall Study|Participant Relapsed|1|||
105670430|NCT02683785|364458056|FG000|Overall Study|Withdrawal by Subject|1|||
105670431|NCT02683785|364458057|FG001|Overall Study|Withdrawal by Subject|1|||
105670432|NCT02683785|364458056|FG000|Overall Study|Lost to Follow-up|0|||
105670433|NCT02683785|364458057|FG001|Overall Study|Lost to Follow-up|1|||
105907073|NCT00141518|365318485|FG000|Overall Study|Adverse Event|7|||
105786174|NCT04089566|364870461|FG004|Overall Study|Reason not Specified|0|||
105670434|NCT02683785|364458056|FG000|Overall Study|Adverse Event|0|||
105670435|NCT02683785|364458057|FG001|Overall Study|Adverse Event|2|||
105907074|NCT00141518|365318486|FG001|Overall Study|Adverse Event|5|||
105907075|NCT00141518|365318487|FG002|Overall Study|Adverse Event|2|||
105907076|NCT00141518|365318485|FG000|Overall Study|Withdrawal by Subject|2|||
105907077|NCT00141518|365318486|FG001|Overall Study|Withdrawal by Subject|0|||
105907078|NCT00141518|365318487|FG002|Overall Study|Withdrawal by Subject|2|||
105907079|NCT00141518|365318485|FG000|Overall Study|Protocol Violation|1|||
105907080|NCT00141518|365318486|FG001|Overall Study|Protocol Violation|1|||
105907081|NCT00141518|365318487|FG002|Overall Study|Protocol Violation|2|||
105907082|NCT00141518|365318485|FG000|Overall Study|Lack of Efficacy|5|||
105907083|NCT00141518|365318486|FG001|Overall Study|Lack of Efficacy|0|||
105907084|NCT00141518|365318487|FG002|Overall Study|Lack of Efficacy|0|||
105907085|NCT01806168|365318488|FG000|Overall Study|Adverse Event|1|||
105998830|NCT03901144|365657828|FG003|Overall Study|Lost to Follow-up|1|||
105998831|NCT02728089|365657832|FG000|Overall Study|Physician Decision|2|||
105998832|NCT02728089|365657832|FG000|Overall Study|Withdrawal by Subject|1|||
105998833|NCT03359174|365657838|FG000|Overall Study|Adverse Event|1|||
105998834|NCT02800863|365657847|FG000|Overall Study|Adverse Event|14|||
105998835|NCT02800863|365657847|FG000|Overall Study|Another Device Implanted|1|||
105998836|NCT02800863|365657847|FG000|Overall Study|Device Explanted|1|||
105998837|NCT02800863|365657847|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
105998838|NCT02800863|365657847|FG000|Overall Study|Health Issues|1|||
105998839|NCT02800863|365657847|FG000|Overall Study|Insurance Denial|8|||
105998840|NCT02800863|365657847|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
105998841|NCT02800863|365657847|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
105998842|NCT02800863|365657847|FG000|Overall Study|Screen Failure|1|||
105998843|NCT02800863|365657847|FG000|Overall Study|Sponsor Request|6|||
105998844|NCT02800863|365657847|FG000|Overall Study|Death|3|||
105998845|NCT02800863|365657847|FG000|Overall Study|Subject Implant at Another Facility|1|||
105998846|NCT02800863|365657847|FG000|Overall Study|Lost to Follow-up|26|||
105998847|NCT02800863|365657847|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
105998848|NCT02800863|365657847|FG000|Overall Study|Subject and/or Family Request|64|||
105998849|NCT02800863|365657847|FG000|Overall Study|Trial Failure|81|||
105998850|NCT02800863|365657847|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
105998851|NCT00428948|365657851|FG000|Overall Study|Lost to Follow-up|15|||
105998852|NCT00428948|365657852|FG001|Overall Study|Lost to Follow-up|8|||
105998853|NCT00428948|365657851|FG000|Overall Study|Adverse Event|148|||
105998854|NCT00428948|365657852|FG001|Overall Study|Adverse Event|24|||
105998855|NCT00428948|365657851|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
105998856|NCT00428948|365657852|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
105998857|NCT00428948|365657851|FG000|Overall Study|Investigator Withdrew Subject|3|||
105998858|NCT00428948|365657852|FG001|Overall Study|Investigator Withdrew Subject|4|||
105998859|NCT00428948|365657851|FG000|Overall Study|Subject Withdrew Consent|50|||
105998860|NCT00428948|365657852|FG001|Overall Study|Subject Withdrew Consent|30|||
105998861|NCT00428948|365657851|FG000|Overall Study|Protocol Deviation|1|||
105998862|NCT00428948|365657852|FG001|Overall Study|Protocol Deviation|1|||
105998863|NCT04417361|365657853|FG000|Overall Study|Withdrawal by Subject|1|||
105998864|NCT04417361|365657854|FG001|Overall Study|Withdrawal by Subject|0|||
105998865|NCT04417361|365657853|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
105907086|NCT01806168|365318489|FG001|Overall Study|Adverse Event|0|||
105907087|NCT01806168|365318490|FG002|Overall Study|Adverse Event|0|||
105907088|NCT01806168|365318488|FG000|Overall Study|Withdrawal by Subject|0|||
105907089|NCT01806168|365318489|FG001|Overall Study|Withdrawal by Subject|1|||
105907090|NCT01806168|365318490|FG002|Overall Study|Withdrawal by Subject|2|||
105907091|NCT01806168|365318488|FG000|Overall Study|Protocol Violation|0|||
105907092|NCT01806168|365318489|FG001|Overall Study|Protocol Violation|0|||
105907093|NCT01806168|365318490|FG002|Overall Study|Protocol Violation|1|||
105907094|NCT04819438|365318491|FG000|Overall Study|Withdrawal by Subject|1|||
105907095|NCT04819438|365318492|FG001|Overall Study|Withdrawal by Subject|0|||
105907096|NCT04819438|365318491|FG000|Overall Study|Adverse Event|0|||
105907097|NCT04819438|365318492|FG001|Overall Study|Adverse Event|1|||
105907098|NCT04819438|365318491|FG000|Overall Study|Protocol Violation|0|||
105907099|NCT04819438|365318492|FG001|Overall Study|Protocol Violation|1|||
105907100|NCT02869893|365318493|FG000|Overall Study|participant aversion to IV|5|||
105907101|NCT02869893|365318493|FG000|Overall Study|participant fear of MRI scanner|2|||
105907102|NCT01563913|365318494|FG000|Overall Study|Physician Decision|1|||
105907103|NCT01563913|365318495|FG001|Overall Study|Physician Decision|0|||
105998866|NCT04417361|365657854|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
105907104|NCT01563913|365318494|FG000|Overall Study|Spouse Passed Away|1|||
105907105|NCT01563913|365318495|FG001|Overall Study|Spouse Passed Away|0|||
105907106|NCT00705341|365318496|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
105907107|NCT00705341|365318497|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
105907108|NCT00705341|365318498|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
105998867|NCT01987102|365657855|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
105998868|NCT01987102|365657856|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
105998869|NCT01987102|365657855|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
105907109|NCT00705341|365318499|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
105907110|NCT00705341|365318496|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
105907111|NCT00705341|365318497|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
105907112|NCT00705341|365318498|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
105907113|NCT00705341|365318499|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
105907114|NCT00791700|365318502|FG000|Overall Study|Insufficient clinical response|1|||
105907115|NCT00791700|365318503|FG001|Overall Study|Insufficient clinical response|4|||
105907116|NCT00791700|365318504|FG002|Overall Study|Insufficient clinical response|1|||
105907117|NCT00791700|365318505|FG003|Overall Study|Insufficient clinical response|8|||
105907118|NCT00791700|365318502|FG000|Overall Study|No longer willing to participate|1|||
105907119|NCT00791700|365318503|FG001|Overall Study|No longer willing to participate|1|||
105907120|NCT00791700|365318504|FG002|Overall Study|No longer willing to participate|0|||
105907121|NCT00791700|365318505|FG003|Overall Study|No longer willing to participate|8|||
105907122|NCT00791700|365318502|FG000|Overall Study|Non-compliance with study treatment|0|||
105907123|NCT00791700|365318503|FG001|Overall Study|Non-compliance with study treatment|2|||
105907124|NCT00791700|365318504|FG002|Overall Study|Non-compliance with study treatment|0|||
105907125|NCT00791700|365318505|FG003|Overall Study|Non-compliance with study treatment|4|||
105907126|NCT00791700|365318502|FG000|Overall Study|Withdrawn due to pregnancy|0|||
105907127|NCT00791700|365318503|FG001|Overall Study|Withdrawn due to pregnancy|0|||
105907128|NCT00791700|365318504|FG002|Overall Study|Withdrawn due to pregnancy|0|||
105907129|NCT00791700|365318505|FG003|Overall Study|Withdrawn due to pregnancy|1|||
105907130|NCT00791700|365318502|FG000|Overall Study|Other|0|||
105907131|NCT00791700|365318503|FG001|Overall Study|Other|1|||
105907132|NCT00791700|365318504|FG002|Overall Study|Other|0|||
105907133|NCT00791700|365318505|FG003|Overall Study|Other|1|||
105907134|NCT00791700|365318502|FG000|Overall Study|Death|0|||
105907135|NCT00791700|365318503|FG001|Overall Study|Death|0|||
105907136|NCT00791700|365318504|FG002|Overall Study|Death|0|||
105907137|NCT00791700|365318505|FG003|Overall Study|Death|1|||
105907138|NCT00791700|365318502|FG000|Overall Study|Lost to Follow-up|4|||
105907139|NCT00791700|365318503|FG001|Overall Study|Lost to Follow-up|3|||
105907140|NCT00791700|365318504|FG002|Overall Study|Lost to Follow-up|4|||
105907141|NCT00791700|365318505|FG003|Overall Study|Lost to Follow-up|6|||
105907142|NCT00791700|365318502|FG000|Overall Study|Adverse Event|0|||
105907143|NCT00791700|365318503|FG001|Overall Study|Adverse Event|0|||
105907144|NCT00791700|365318504|FG002|Overall Study|Adverse Event|1|||
105907145|NCT00791700|365318505|FG003|Overall Study|Adverse Event|1|||
105907146|NCT00158262|365318506|FG000|Overall Study|Lost to Follow-up|1|||
105907147|NCT00158262|365318507|FG001|Overall Study|Lost to Follow-up|1|||
105907148|NCT03231306|365318508|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
105907149|NCT03231306|365318508|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
105907150|NCT03231306|365318508|FG000|Overall Study|Treatment delay > 21 days|2|||
105907151|NCT03231306|365318508|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
105907152|NCT03231306|365318508|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
105907153|NCT03231306|365318508|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
105907154|NCT03231306|365318508|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
105907155|NCT03231306|365318508|FG000|Overall Study|More than 1 Reason|2|||
105907156|NCT00237692|365318511|FG000|Overall Study|Lost to Follow-up|9|||
105907157|NCT00237692|365318512|FG001|Overall Study|Lost to Follow-up|3|||
105907158|NCT00237692|365318513|FG002|Overall Study|Lost to Follow-up|5|||
105907159|NCT00237692|365318514|FG003|Overall Study|Lost to Follow-up|3|||
105907160|NCT00237692|365318511|FG000|Overall Study|Death|1|||
105907161|NCT00237692|365318512|FG001|Overall Study|Death|2|||
105907162|NCT00237692|365318513|FG002|Overall Study|Death|2|||
105907163|NCT00237692|365318514|FG003|Overall Study|Death|3|||
105907164|NCT00237692|365318511|FG000|Overall Study|Excluded - did not meet criteria|4|||
105907165|NCT00237692|365318512|FG001|Overall Study|Excluded - did not meet criteria|3|||
105907166|NCT00237692|365318513|FG002|Overall Study|Excluded - did not meet criteria|5|||
105907167|NCT00237692|365318514|FG003|Overall Study|Excluded - did not meet criteria|9|||
105907168|NCT00237692|365318511|FG000|Overall Study|Withdrawal by Subject|4|||
105907169|NCT00237692|365318512|FG001|Overall Study|Withdrawal by Subject|6|||
105907170|NCT00237692|365318513|FG002|Overall Study|Withdrawal by Subject|10|||
105907171|NCT00237692|365318514|FG003|Overall Study|Withdrawal by Subject|4|||
105907172|NCT00436826|365318520|FG000|Double Blind Period (DBP)|Adverse Event|2|||
105907173|NCT00436826|365318521|FG001|Double Blind Period (DBP)|Adverse Event|0|||
105907174|NCT00436826|365318522|FG002|Double Blind Period (DBP)|Adverse Event|0|||
105907175|NCT00436826|365318523|FG003|Double Blind Period (DBP)|Adverse Event|0|||
105907176|NCT00436826|365318524|FG004|Double Blind Period (DBP)|Adverse Event|0|||
105907177|NCT00436826|365318525|FG005|Double Blind Period (DBP)|Adverse Event|0|||
105907178|NCT00436826|365318520|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
105907179|NCT00436826|365318521|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
105907180|NCT00436826|365318522|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
105907181|NCT00436826|365318523|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
105907182|NCT00436826|365318524|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
105907183|NCT00436826|365318525|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
105907184|NCT00436826|365318520|FG000|Double Blind Period (DBP)|Other|10|||
105907185|NCT00436826|365318521|FG001|Double Blind Period (DBP)|Other|11|||
105907186|NCT00436826|365318522|FG002|Double Blind Period (DBP)|Other|0|||
105907187|NCT00436826|365318523|FG003|Double Blind Period (DBP)|Other|0|||
105907188|NCT00436826|365318524|FG004|Double Blind Period (DBP)|Other|0|||
105907189|NCT00436826|365318525|FG005|Double Blind Period (DBP)|Other|0|||
105907190|NCT00436826|365318520|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105907191|NCT00436826|365318521|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105907192|NCT00436826|365318522|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105907193|NCT00436826|365318523|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
105907194|NCT00436826|365318524|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105907195|NCT00436826|365318525|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
105907196|NCT00436826|365318520|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
105907197|NCT00436826|365318521|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
105907198|NCT00436826|365318522|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
105907199|NCT00436826|365318523|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
105907200|NCT00436826|365318524|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
105907201|NCT00436826|365318525|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
105907202|NCT00436826|365318520|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
105907203|NCT00436826|365318521|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
105907204|NCT00436826|365318522|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
105907205|NCT00436826|365318523|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
105907206|NCT00436826|365318524|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
105907207|NCT00436826|365318525|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
105907208|NCT00784719|365318528|FG000|Overall Study|Adverse Event|0|||
105907209|NCT00784719|365318529|FG001|Overall Study|Adverse Event|2|||
105907210|NCT00784719|365318530|FG002|Overall Study|Adverse Event|0|||
105907211|NCT00784719|365318531|FG003|Overall Study|Adverse Event|0|||
105907212|NCT00784719|365318532|FG004|Overall Study|Adverse Event|1|||
105907213|NCT00784719|365318533|FG005|Overall Study|Adverse Event|1|||
105907214|NCT00784719|365318534|FG006|Overall Study|Adverse Event|1|||
105907215|NCT00784719|365318528|FG000|Overall Study|Lost to Follow-up|0|||
105907216|NCT00784719|365318529|FG001|Overall Study|Lost to Follow-up|0|||
105907217|NCT00784719|365318530|FG002|Overall Study|Lost to Follow-up|0|||
105907218|NCT00784719|365318531|FG003|Overall Study|Lost to Follow-up|0|||
105907219|NCT00784719|365318532|FG004|Overall Study|Lost to Follow-up|1|||
105907220|NCT00784719|365318533|FG005|Overall Study|Lost to Follow-up|1|||
105907221|NCT00784719|365318534|FG006|Overall Study|Lost to Follow-up|0|||
105907222|NCT00784719|365318528|FG000|Overall Study|Other|2|||
105907223|NCT00784719|365318529|FG001|Overall Study|Other|1|||
105907224|NCT00784719|365318530|FG002|Overall Study|Other|1|||
105907225|NCT00784719|365318531|FG003|Overall Study|Other|0|||
105907226|NCT00784719|365318532|FG004|Overall Study|Other|2|||
105907227|NCT00784719|365318533|FG005|Overall Study|Other|1|||
105907228|NCT00784719|365318534|FG006|Overall Study|Other|3|||
105907229|NCT00784719|365318528|FG000|Overall Study|Withdrawal by Subject|1|||
105907230|NCT00784719|365318529|FG001|Overall Study|Withdrawal by Subject|0|||
105907231|NCT00784719|365318530|FG002|Overall Study|Withdrawal by Subject|0|||
105907232|NCT00784719|365318531|FG003|Overall Study|Withdrawal by Subject|0|||
105907233|NCT00784719|365318532|FG004|Overall Study|Withdrawal by Subject|2|||
105907234|NCT00784719|365318533|FG005|Overall Study|Withdrawal by Subject|0|||
105907235|NCT00784719|365318534|FG006|Overall Study|Withdrawal by Subject|1|||
105998870|NCT01987102|365657856|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
105998871|NCT01987102|365657855|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
105998872|NCT01987102|365657856|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
105998873|NCT01987102|365657855|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
105998874|NCT01987102|365657856|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
105998875|NCT01987102|365657855|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
105998876|NCT01987102|365657856|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
105998877|NCT01987102|365657855|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
105998878|NCT01987102|365657856|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
106125583|NCT00178256|366117817|FG000|Overall Study|Cancer progression|2|||
105907236|NCT02497404|365318535|FG000|Overall Study|Adverse Event|1|||
105907237|NCT05446142|365318538|FG000|Period 2|Adverse Event|1|||
105907238|NCT05446142|365318539|FG001|Period 2|Adverse Event|0|||
105907239|NCT05446142|365318540|FG002|Period 2|Adverse Event|0|||
105907240|NCT05446142|365318541|FG003|Period 2|Adverse Event|0|||
105907241|NCT05446142|365318542|FG004|Period 2|Adverse Event|0|||
105907242|NCT05446142|365318543|FG005|Period 2|Adverse Event|0|||
105907243|NCT02098395|365318544|FG000|Overall Study|Protocol Violation|2|||
105907244|NCT02098395|365318545|FG001|Overall Study|Protocol Violation|2|||
105998879|NCT05481359|365657862|FG000|Overall Study|Lost to Follow-up|3|||
105998880|NCT05481359|365657862|FG000|Overall Study|Withdrawal by Subject|1|||
105998881|NCT01505374|365657863|FG000|Overall Study|Lost to Follow-up|1|||
105998882|NCT01505374|365657864|FG001|Overall Study|Lost to Follow-up|0|||
105998883|NCT04158583|365657867|FG000|Overall Study|Withdrawal by Subject|1|||
105998884|NCT04158583|365657868|FG001|Overall Study|Withdrawal by Subject|1|||
105998885|NCT04158583|365657869|FG002|Overall Study|Withdrawal by Subject|0|||
105998886|NCT04158583|365657870|FG003|Overall Study|Withdrawal by Subject|0|||
105998887|NCT04158583|365657871|FG004|Overall Study|Withdrawal by Subject|1|||
105998888|NCT04158583|365657872|FG005|Overall Study|Withdrawal by Subject|0|||
105998889|NCT04158583|365657873|FG006|Overall Study|Withdrawal by Subject|0|||
105998890|NCT04158583|365657874|FG007|Overall Study|Withdrawal by Subject|0|||
105998891|NCT04158583|365657875|FG008|Overall Study|Withdrawal by Subject|2|||
105998892|NCT04158583|365657876|FG009|Overall Study|Withdrawal by Subject|0|||
105998893|NCT04158583|365657867|FG000|Overall Study|Study Terminated by Sponsor|0|||
105998894|NCT04158583|365657868|FG001|Overall Study|Study Terminated by Sponsor|0|||
105998895|NCT04158583|365657869|FG002|Overall Study|Study Terminated by Sponsor|0|||
105998896|NCT04158583|365657870|FG003|Overall Study|Study Terminated by Sponsor|1|||
105998897|NCT04158583|365657871|FG004|Overall Study|Study Terminated by Sponsor|0|||
105998898|NCT04158583|365657872|FG005|Overall Study|Study Terminated by Sponsor|0|||
105998899|NCT04158583|365657873|FG006|Overall Study|Study Terminated by Sponsor|0|||
105998900|NCT04158583|365657874|FG007|Overall Study|Study Terminated by Sponsor|0|||
105998901|NCT04158583|365657875|FG008|Overall Study|Study Terminated by Sponsor|0|||
105998902|NCT04158583|365657876|FG009|Overall Study|Study Terminated by Sponsor|0|||
105998903|NCT04158583|365657867|FG000|Overall Study|Progressive Disease|1|||
105998904|NCT04158583|365657868|FG001|Overall Study|Progressive Disease|0|||
105998905|NCT04158583|365657869|FG002|Overall Study|Progressive Disease|3|||
105998906|NCT04158583|365657870|FG003|Overall Study|Progressive Disease|5|||
105998907|NCT04158583|365657871|FG004|Overall Study|Progressive Disease|0|||
105998908|NCT04158583|365657872|FG005|Overall Study|Progressive Disease|1|||
105998909|NCT04158583|365657873|FG006|Overall Study|Progressive Disease|6|||
105998910|NCT04158583|365657874|FG007|Overall Study|Progressive Disease|2|||
105998911|NCT04158583|365657875|FG008|Overall Study|Progressive Disease|1|||
106125584|NCT00178256|366117818|FG001|Overall Study|Cancer progression|0|||
106125585|NCT00178256|366117819|FG002|Overall Study|Cancer progression|0|||
106125586|NCT00178256|366117820|FG003|Overall Study|Cancer progression|1|||
106125587|NCT00478608|366117821|FG000|Overall Study|Adverse Event|1|||
106125588|NCT00478608|366117821|FG000|Overall Study|Serious Adverse Event|14|||
106125589|NCT00478608|366117821|FG000|Overall Study|Withdrawal by Subject|2|||
106125590|NCT00478608|366117821|FG000|Overall Study|Protocol Violation|3|||
106125591|NCT03237013|366117827|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
106125592|NCT03237013|366117828|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
106125593|NCT03237013|366117829|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
106125594|NCT01567163|366117830|FG000|Overall Study|Progressive Disease|2|||
106125595|NCT01567163|366117830|FG000|Overall Study|Lost to Follow-up|2|||
106125596|NCT03405662|366117831|FG000|Overall Study|COVID-19 restriction|1|||
106125597|NCT03405662|366117832|FG001|Overall Study|COVID-19 restriction|0|||
106125598|NCT03405662|366117831|FG000|Overall Study|unblinding|0|||
106125599|NCT03405662|366117832|FG001|Overall Study|unblinding|1|||
105670436|NCT00299494|364458058|FG000|Overall Study|Withdrawal by Subject|0|||
105670437|NCT00299494|364458059|FG001|Overall Study|Withdrawal by Subject|0|||
105670438|NCT00299494|364458060|FG002|Overall Study|Withdrawal by Subject|0|||
105670439|NCT00299494|364458061|FG003|Overall Study|Withdrawal by Subject|3|||
105670440|NCT00299494|364458062|FG004|Overall Study|Withdrawal by Subject|1|||
105670441|NCT00299494|364458063|FG005|Overall Study|Withdrawal by Subject|4|||
105907245|NCT02098395|365318546|FG002|Overall Study|Protocol Violation|0|||
105907246|NCT02098395|365318547|FG003|Overall Study|Protocol Violation|7|||
105907247|NCT02098395|365318544|FG000|Overall Study|Withdrawal by Subject|10|||
105907248|NCT02098395|365318545|FG001|Overall Study|Withdrawal by Subject|10|||
105670442|NCT00299494|364458058|FG000|Overall Study|Physician Decision|0|||
105670443|NCT00299494|364458059|FG001|Overall Study|Physician Decision|0|||
105670444|NCT00299494|364458060|FG002|Overall Study|Physician Decision|0|||
105670445|NCT00299494|364458061|FG003|Overall Study|Physician Decision|0|||
105670446|NCT00299494|364458062|FG004|Overall Study|Physician Decision|1|||
105907249|NCT02098395|365318546|FG002|Overall Study|Withdrawal by Subject|5|||
105670447|NCT00299494|364458063|FG005|Overall Study|Physician Decision|0|||
105670448|NCT00299494|364458058|FG000|Overall Study|Death|3|||
105670449|NCT00299494|364458059|FG001|Overall Study|Death|1|||
105670450|NCT00299494|364458060|FG002|Overall Study|Death|4|||
105670451|NCT00299494|364458061|FG003|Overall Study|Death|6|||
105670452|NCT00299494|364458062|FG004|Overall Study|Death|18|||
105670453|NCT00299494|364458063|FG005|Overall Study|Death|19|||
105670454|NCT00299494|364458058|FG000|Overall Study|Lost to Follow-up|0|||
105670455|NCT00299494|364458059|FG001|Overall Study|Lost to Follow-up|0|||
105670456|NCT00299494|364458060|FG002|Overall Study|Lost to Follow-up|0|||
105670457|NCT00299494|364458061|FG003|Overall Study|Lost to Follow-up|0|||
105670458|NCT00299494|364458062|FG004|Overall Study|Lost to Follow-up|3|||
105670459|NCT00299494|364458063|FG005|Overall Study|Lost to Follow-up|1|||
105670460|NCT00299494|364458058|FG000|Overall Study|Other - Unspecified|0|||
105670461|NCT00299494|364458059|FG001|Overall Study|Other - Unspecified|0|||
105670462|NCT00299494|364458060|FG002|Overall Study|Other - Unspecified|0|||
105670463|NCT00299494|364458061|FG003|Overall Study|Other - Unspecified|0|||
105670464|NCT00299494|364458062|FG004|Overall Study|Other - Unspecified|3|||
105670465|NCT00299494|364458063|FG005|Overall Study|Other - Unspecified|1|||
105670466|NCT00299494|364458058|FG000|Overall Study|Other - site closure|0|||
105907250|NCT02098395|365318547|FG003|Overall Study|Withdrawal by Subject|13|||
105907251|NCT02098395|365318544|FG000|Overall Study|Adverse Event|12|||
105907252|NCT02098395|365318545|FG001|Overall Study|Adverse Event|19|||
105907253|NCT02098395|365318546|FG002|Overall Study|Adverse Event|34|||
105907254|NCT02098395|365318547|FG003|Overall Study|Adverse Event|2|||
105907255|NCT02098395|365318544|FG000|Overall Study|Lost to Follow-up|2|||
105907256|NCT02098395|365318545|FG001|Overall Study|Lost to Follow-up|1|||
105907257|NCT02098395|365318546|FG002|Overall Study|Lost to Follow-up|0|||
105907258|NCT02098395|365318547|FG003|Overall Study|Lost to Follow-up|3|||
105907259|NCT02098395|365318544|FG000|Overall Study|Unclassified|0|||
105907260|NCT02098395|365318545|FG001|Overall Study|Unclassified|0|||
105907261|NCT02098395|365318546|FG002|Overall Study|Unclassified|3|||
105670467|NCT00299494|364458059|FG001|Overall Study|Other - site closure|0|||
105670468|NCT00299494|364458060|FG002|Overall Study|Other - site closure|0|||
105670469|NCT00299494|364458061|FG003|Overall Study|Other - site closure|1|||
105670470|NCT00299494|364458062|FG004|Overall Study|Other - site closure|1|||
105670471|NCT00299494|364458063|FG005|Overall Study|Other - site closure|1|||
105670472|NCT01195623|364458064|FG000|Overall Study|Lost to Follow-up|35|||
105670473|NCT01195623|364458065|FG001|Overall Study|Lost to Follow-up|37|||
105670474|NCT00534495|364458068|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
105907262|NCT02098395|365318547|FG003|Overall Study|Unclassified|2|||
105907263|NCT01386944|365318552|FG000|Overall Study|Adverse Event|26|||
105907264|NCT01386944|365318552|FG000|Overall Study|Lack of Efficacy|14|||
105907265|NCT01386944|365318552|FG000|Overall Study|Lost to Follow-up|8|||
105907266|NCT01386944|365318552|FG000|Overall Study|Unspecified reason|8|||
105670475|NCT00534495|364458069|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
105670476|NCT00534495|364458070|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
105670477|NCT00534495|364458068|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
105670478|NCT00534495|364458069|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
105670479|NCT00534495|364458070|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
105670480|NCT00534495|364458068|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
105907267|NCT02030119|365319746|FG000|Overall Study|Withdrawal by Subject|3|||
105907268|NCT02030119|365319747|FG001|Overall Study|Withdrawal by Subject|1|||
105670481|NCT00534495|364458069|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
105670482|NCT00534495|364458070|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
105670483|NCT00534495|364458068|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
105670484|NCT00534495|364458069|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
105907269|NCT02030119|365319748|FG002|Overall Study|Withdrawal by Subject|5|||
105907270|NCT02030119|365319749|FG003|Overall Study|Withdrawal by Subject|3|||
105907271|NCT02030119|365319746|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
105907272|NCT02030119|365319747|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
105907273|NCT02030119|365319748|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
105907274|NCT02030119|365319749|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
105907275|NCT01704755|365319755|FG000|Overall Study|Adverse Event|4|||
105907276|NCT01704755|365319756|FG001|Overall Study|Adverse Event|1|||
105907277|NCT01704755|365319755|FG000|Overall Study|Lost to Follow-up|3|||
105907278|NCT01704755|365319756|FG001|Overall Study|Lost to Follow-up|4|||
105907279|NCT01704755|365319755|FG000|Overall Study|Withdrew consent|1|||
105907280|NCT01704755|365319756|FG001|Overall Study|Withdrew consent|1|||
105907281|NCT01704755|365319755|FG000|Overall Study|Other (not specified)|3|||
105907282|NCT01704755|365319756|FG001|Overall Study|Other (not specified)|1|||
105907283|NCT01704755|365319755|FG000|Overall Study|Withdrew consent and personal issues|1|||
105907284|NCT01704755|365319756|FG001|Overall Study|Withdrew consent and personal issues|0|||
105907285|NCT01535443|365319765|FG000|Overall Study|Physician Decision|3|||
105907286|NCT05359952|365319767|FG000|Overall Study|Lost to Follow-up|1|||
105907287|NCT05359952|365319768|FG001|Overall Study|Lost to Follow-up|0|||
105907288|NCT02258659|365319769|FG000|Overall Study|Withdrawal by Subject|1|||
105907289|NCT04892446|365319770|FG000|Overall Study|Death|4|||
105907290|NCT04892446|365319771|FG001|Overall Study|Death|4|||
105907291|NCT04892446|365319772|FG002|Overall Study|Death|0|||
105907292|NCT04892446|365319770|FG000|Overall Study|Withdrew consent|3|||
105907293|NCT04892446|365319771|FG001|Overall Study|Withdrew consent|0|||
105907294|NCT04892446|365319772|FG002|Overall Study|Withdrew consent|1|||
105907295|NCT04892446|365319770|FG000|Overall Study|Investigator's discretion|1|||
105907296|NCT04892446|365319771|FG001|Overall Study|Investigator's discretion|1|||
105907297|NCT04892446|365319772|FG002|Overall Study|Investigator's discretion|0|||
105907298|NCT04892446|365319770|FG000|Overall Study|Study terminated by sponsor|0|||
105907299|NCT04892446|365319771|FG001|Overall Study|Study terminated by sponsor|0|||
105907300|NCT04892446|365319772|FG002|Overall Study|Study terminated by sponsor|2|||
105907301|NCT01882803|365319773|FG000|Overall Study|Disease Progression|1|||
105907302|NCT01882803|365319773|FG000|Overall Study|Withdrawal by Subject|9|||
105907303|NCT01882803|365319773|FG000|Overall Study|Death|68|||
105907304|NCT01882803|365319773|FG000|Overall Study|Physician Decision|3|||
105907305|NCT01882803|365319773|FG000|Overall Study|Lost to Follow-up|3|||
105907306|NCT01882803|365319773|FG000|Overall Study|Follow-up Completed|39|||
105907307|NCT01882803|365319773|FG000|Overall Study|Study Terminated by the Sponsor|6|||
105907308|NCT04978337|365319776|FG000|Overall Study|Withdrawal by Subject|0|||
105907309|NCT04978337|365319777|FG001|Overall Study|Withdrawal by Subject|1|||
105907310|NCT04208412|365319781|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
105907311|NCT04208412|365319782|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
105907312|NCT04208412|365319781|FG000|Overall Study|Withdrawal by Subject|1|||
105907313|NCT04208412|365319782|FG001|Overall Study|Withdrawal by Subject|0|||
105907314|NCT04208412|365319781|FG000|Overall Study|Lost to Follow-up|0|||
105907315|NCT04208412|365319782|FG001|Overall Study|Lost to Follow-up|1|||
105907316|NCT02588092|365319783|FG000|Overall Study|Death|4|||
105907317|NCT02588092|365319784|FG001|Overall Study|Death|3|||
105907318|NCT02588092|365319785|FG002|Overall Study|Death|3|||
105907319|NCT02588092|365319786|FG003|Overall Study|Death|3|||
105907320|NCT02588092|365319787|FG004|Overall Study|Death|2|||
105907321|NCT02588092|365319788|FG005|Overall Study|Death|2|||
105907322|NCT02588092|365319789|FG006|Overall Study|Death|2|||
105907323|NCT02588092|365319790|FG007|Overall Study|Death|1|||
105907324|NCT02588092|365319791|FG008|Overall Study|Death|5|||
105907325|NCT02588092|365319792|FG009|Overall Study|Death|2|||
105907326|NCT02588092|365319783|FG000|Overall Study|Withdrawal by Subject|0|||
105907327|NCT02588092|365319784|FG001|Overall Study|Withdrawal by Subject|0|||
105907328|NCT02588092|365319785|FG002|Overall Study|Withdrawal by Subject|0|||
105907329|NCT02588092|365319786|FG003|Overall Study|Withdrawal by Subject|0|||
105907330|NCT02588092|365319787|FG004|Overall Study|Withdrawal by Subject|0|||
105907331|NCT02588092|365319788|FG005|Overall Study|Withdrawal by Subject|1|||
105907332|NCT02588092|365319789|FG006|Overall Study|Withdrawal by Subject|1|||
105907333|NCT02588092|365319790|FG007|Overall Study|Withdrawal by Subject|2|||
105907334|NCT02588092|365319791|FG008|Overall Study|Withdrawal by Subject|0|||
105907335|NCT02588092|365319792|FG009|Overall Study|Withdrawal by Subject|0|||
105907336|NCT02588092|365319783|FG000|Overall Study|Started Another Treatment|0|||
105907337|NCT02588092|365319784|FG001|Overall Study|Started Another Treatment|0|||
105907338|NCT02588092|365319785|FG002|Overall Study|Started Another Treatment|0|||
105907339|NCT02588092|365319786|FG003|Overall Study|Started Another Treatment|0|||
105907340|NCT02588092|365319787|FG004|Overall Study|Started Another Treatment|1|||
105907341|NCT02588092|365319788|FG005|Overall Study|Started Another Treatment|0|||
105907342|NCT02588092|365319789|FG006|Overall Study|Started Another Treatment|0|||
105907343|NCT02588092|365319790|FG007|Overall Study|Started Another Treatment|1|||
105907344|NCT02588092|365319791|FG008|Overall Study|Started Another Treatment|0|||
105907345|NCT02588092|365319792|FG009|Overall Study|Started Another Treatment|0|||
105907346|NCT02588092|365319783|FG000|Overall Study|Sponsor Decision|0|||
105907347|NCT02588092|365319784|FG001|Overall Study|Sponsor Decision|0|||
105907348|NCT02588092|365319785|FG002|Overall Study|Sponsor Decision|0|||
105907349|NCT02588092|365319786|FG003|Overall Study|Sponsor Decision|0|||
105907350|NCT02588092|365319787|FG004|Overall Study|Sponsor Decision|0|||
105907351|NCT02588092|365319788|FG005|Overall Study|Sponsor Decision|0|||
105907352|NCT02588092|365319789|FG006|Overall Study|Sponsor Decision|0|||
105907353|NCT02588092|365319790|FG007|Overall Study|Sponsor Decision|0|||
105907354|NCT02588092|365319791|FG008|Overall Study|Sponsor Decision|1|||
105907355|NCT02588092|365319792|FG009|Overall Study|Sponsor Decision|1|||
105907356|NCT01030718|365319793|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
105907357|NCT01030718|365319794|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
105907358|NCT01030718|365319795|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
105907359|NCT01030718|365319793|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
105907360|NCT01030718|365319794|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
105907361|NCT01030718|365319795|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
105907362|NCT01030718|365319793|FG000|Studies CA180-031 and -036 Combined|Death|0|||
105907363|NCT01030718|365319794|FG001|Studies CA180-031 and -036 Combined|Death|1|||
105907364|NCT01030718|365319795|FG002|Studies CA180-031 and -036 Combined|Death|0|||
105907365|NCT01030718|365319793|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
105907366|NCT01030718|365319794|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
105907367|NCT01030718|365319795|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
105907368|NCT01030718|365319793|FG000|Study CA180-036 Only|insufficient effect|1|||
105907369|NCT01030718|365319794|FG001|Study CA180-036 Only|insufficient effect|1|||
105907370|NCT01030718|365319795|FG002|Study CA180-036 Only|insufficient effect|5|||
105907371|NCT01030718|365319793|FG000|Study CA180-036 Only|Adverse Event|2|||
105907372|NCT01030718|365319794|FG001|Study CA180-036 Only|Adverse Event|3|||
105907373|NCT01030718|365319795|FG002|Study CA180-036 Only|Adverse Event|0|||
105907374|NCT01030718|365319793|FG000|Study CA180-036 Only|Death|0|||
105907375|NCT01030718|365319794|FG001|Study CA180-036 Only|Death|1|||
105907376|NCT01030718|365319795|FG002|Study CA180-036 Only|Death|0|||
105907377|NCT01030718|365319793|FG000|Study CA180-036 Only|Other Reasons|0|||
105907378|NCT01030718|365319794|FG001|Study CA180-036 Only|Other Reasons|2|||
105907379|NCT01030718|365319795|FG002|Study CA180-036 Only|Other Reasons|0|||
105907380|NCT03131687|365319796|FG000|Overall Study|Adverse Event|0|||
105907381|NCT03131687|365319797|FG001|Overall Study|Adverse Event|1|||
105907382|NCT03131687|365319798|FG002|Overall Study|Adverse Event|0|||
105907383|NCT03131687|365319799|FG003|Overall Study|Adverse Event|1|||
105907384|NCT03131687|365319800|FG004|Overall Study|Adverse Event|2|||
105907385|NCT03131687|365319801|FG005|Overall Study|Adverse Event|2|||
105907386|NCT03131687|365319796|FG000|Overall Study|Death|1|||
105907387|NCT03131687|365319797|FG001|Overall Study|Death|0|||
105907388|NCT03131687|365319798|FG002|Overall Study|Death|0|||
105907389|NCT03131687|365319799|FG003|Overall Study|Death|0|||
105907390|NCT03131687|365319800|FG004|Overall Study|Death|0|||
105907391|NCT03131687|365319801|FG005|Overall Study|Death|0|||
105907392|NCT03131687|365319796|FG000|Overall Study|Withdrawal by Subject|3|||
105907393|NCT03131687|365319797|FG001|Overall Study|Withdrawal by Subject|3|||
105907394|NCT03131687|365319798|FG002|Overall Study|Withdrawal by Subject|3|||
105907395|NCT03131687|365319799|FG003|Overall Study|Withdrawal by Subject|1|||
105907396|NCT03131687|365319800|FG004|Overall Study|Withdrawal by Subject|2|||
105907397|NCT03131687|365319801|FG005|Overall Study|Withdrawal by Subject|1|||
105907398|NCT03131687|365319796|FG000|Overall Study|Lost to Follow-up|1|||
105907399|NCT03131687|365319797|FG001|Overall Study|Lost to Follow-up|4|||
105907400|NCT03131687|365319798|FG002|Overall Study|Lost to Follow-up|0|||
105907401|NCT03131687|365319799|FG003|Overall Study|Lost to Follow-up|1|||
105907402|NCT03131687|365319800|FG004|Overall Study|Lost to Follow-up|4|||
105907403|NCT03131687|365319801|FG005|Overall Study|Lost to Follow-up|2|||
105907404|NCT03131687|365319796|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
105907405|NCT03131687|365319797|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
105907406|NCT03131687|365319798|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
105907407|NCT03131687|365319799|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
105907408|NCT03131687|365319800|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
105907409|NCT03131687|365319801|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
105907410|NCT03131687|365319796|FG000|Overall Study|Principle Investigator Decision|0|||
105907411|NCT03131687|365319797|FG001|Overall Study|Principle Investigator Decision|1|||
105907412|NCT03131687|365319798|FG002|Overall Study|Principle Investigator Decision|0|||
105907413|NCT03131687|365319799|FG003|Overall Study|Principle Investigator Decision|0|||
105907414|NCT03131687|365319800|FG004|Overall Study|Principle Investigator Decision|0|||
105907415|NCT03131687|365319801|FG005|Overall Study|Principle Investigator Decision|0|||
105907416|NCT03131687|365319796|FG000|Overall Study|Inadvertent Enrollment|0|||
105907417|NCT03131687|365319797|FG001|Overall Study|Inadvertent Enrollment|0|||
105907418|NCT03131687|365319798|FG002|Overall Study|Inadvertent Enrollment|0|||
105907419|NCT03131687|365319799|FG003|Overall Study|Inadvertent Enrollment|1|||
105907420|NCT03131687|365319800|FG004|Overall Study|Inadvertent Enrollment|0|||
105907421|NCT03131687|365319801|FG005|Overall Study|Inadvertent Enrollment|0|||
105907422|NCT01118663|365319814|FG000|Overall Study|Adverse Event|2|||
105907423|NCT01118663|365319815|FG001|Overall Study|Adverse Event|1|||
105907424|NCT01118663|365319814|FG000|Overall Study|Withdrawal by Subject|0|||
105907425|NCT01118663|365319815|FG001|Overall Study|Withdrawal by Subject|1|||
105907426|NCT03046953|365319816|FG000|Overall Study|Relapse/progressive disease|21|||
105907427|NCT03046953|365319816|FG000|Overall Study|Death|2|||
105907428|NCT03046953|365319816|FG000|Overall Study|Withdrawal by Subject|3|||
105907429|NCT01189461|365319817|FG000|Overall Study|Lack of Efficacy|13|||
105907430|NCT01189461|365319817|FG000|Overall Study|Lost to Follow-up|1|||
105907431|NCT01189461|365319817|FG000|Overall Study|Withdrawal by Subject|6|||
105907432|NCT01189461|365319817|FG000|Overall Study|Protocol Violation|1|||
105907433|NCT01189461|365319817|FG000|Overall Study|Adverse Event|2|||
105907434|NCT01189461|365319817|FG000|Overall Study|Did not meet entrance criteria|3|||
105907435|NCT01189461|365319817|FG000|Overall Study|Other|8|||
105907436|NCT00420628|365319818|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
105907437|NCT00420628|365319819|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
105670485|NCT00534495|364458070|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
105670486|NCT00534495|364458068|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
105670487|NCT00534495|364458069|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
105670488|NCT00534495|364458070|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
105670489|NCT00534495|364458068|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
105670490|NCT00534495|364458069|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
105670491|NCT00534495|364458070|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
105670492|NCT00534495|364458068|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
105670493|NCT00534495|364458069|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
105670494|NCT00534495|364458070|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
105670495|NCT00534495|364458068|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
105907438|NCT00420628|365319818|FG000|Overall Study|Lost to Follow-up|3|||
105998912|NCT04158583|365657876|FG009|Overall Study|Progressive Disease|2|||
105998913|NCT04158583|365657867|FG000|Overall Study|Lost to Follow-up|0|||
105907439|NCT00420628|365319819|FG001|Overall Study|Lost to Follow-up|2|||
105907440|NCT00420628|365319818|FG000|Overall Study|Adverse Event|1|||
105907441|NCT00420628|365319819|FG001|Overall Study|Adverse Event|0|||
105907442|NCT03360019|365319822|FG000|Overall Study|Withdrawal by Subject|2|||
105998914|NCT04158583|365657868|FG001|Overall Study|Lost to Follow-up|0|||
105907443|NCT03360019|365319823|FG001|Overall Study|Withdrawal by Subject|0|||
105907444|NCT03360019|365319824|FG002|Overall Study|Withdrawal by Subject|0|||
105907445|NCT03360019|365319822|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
105907446|NCT03360019|365319823|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
105907447|NCT03360019|365319824|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
105670496|NCT00534495|364458069|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
105907448|NCT01462110|365319825|FG000|Overall Study|Adverse Event|1|||
105907449|NCT01462110|365319826|FG001|Overall Study|Adverse Event|0|||
105670497|NCT00534495|364458070|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
105670498|NCT00534495|364458068|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
105670499|NCT00534495|364458069|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
105670500|NCT00534495|364458070|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
105670501|NCT01305408|364458071|FG000|Overall Study|Adverse Event|10|||
105670502|NCT01305408|364458072|FG001|Overall Study|Adverse Event|7|||
105907450|NCT00656175|365319828|FG000|Overall Study|Adverse Event|1|||
105907451|NCT00656175|365319829|FG001|Overall Study|Adverse Event|0|||
106125600|NCT03405662|366117831|FG000|Overall Study|placement in memory care facility|0|||
105907452|NCT00656175|365319828|FG000|Overall Study|Transportation issues|0|||
105907453|NCT00656175|365319829|FG001|Overall Study|Transportation issues|1|||
105907454|NCT01903993|365319832|FG000|Overall Study|Death|118|||
105907455|NCT01903993|365319833|FG001|Overall Study|Death|121|||
105907456|NCT01903993|365319832|FG000|Overall Study|Withdrawal by Subject|15|||
105907457|NCT01903993|365319833|FG001|Overall Study|Withdrawal by Subject|4|||
105907458|NCT01903993|365319832|FG000|Overall Study|Lost to Follow-up|2|||
105907459|NCT01903993|365319833|FG001|Overall Study|Lost to Follow-up|3|||
105907460|NCT01903993|365319832|FG000|Overall Study|Study Terminated by Sponsor|8|||
105907461|NCT01903993|365319833|FG001|Overall Study|Study Terminated by Sponsor|14|||
105907462|NCT01903993|365319832|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
105907463|NCT01903993|365319833|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
105907464|NCT02385110|365319837|FG000|Overall Study|Early Death|1|||
105907465|NCT02385110|365319838|FG001|Overall Study|Early Death|0|||
105907466|NCT03999749|365319847|FG000|Overall Study|Toxicity|16|||
105907467|NCT03999749|365319847|FG000|Overall Study|Withdrawal by Subject|3|||
105907468|NCT03999749|365319847|FG000|Overall Study|Disease progression|26|||
105907469|NCT03999749|365319847|FG000|Overall Study|Physician Decision|4|||
105907470|NCT03999749|365319847|FG000|Overall Study|Death|5|||
105907471|NCT03999749|365319847|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
105907472|NCT00980655|365319848|FG000|Overall Study|Adverse Event|13|||
105907473|NCT00980655|365319849|FG001|Overall Study|Adverse Event|31|||
105907474|NCT00980655|365319848|FG000|Overall Study|Death|0|||
105907475|NCT00980655|365319849|FG001|Overall Study|Death|7|||
105907476|NCT00980655|365319848|FG000|Overall Study|Protocol Violation|2|||
105907477|NCT00980655|365319849|FG001|Overall Study|Protocol Violation|7|||
105907478|NCT00980655|365319848|FG000|Overall Study|Withdrawal by Subject|0|||
105907479|NCT00980655|365319849|FG001|Overall Study|Withdrawal by Subject|4|||
105907480|NCT00980655|365319848|FG000|Overall Study|Lost to Follow-up|0|||
105907481|NCT00980655|365319849|FG001|Overall Study|Lost to Follow-up|1|||
105907482|NCT00980655|365319848|FG000|Overall Study|Parent/legal guardian request|1|||
105907483|NCT00980655|365319849|FG001|Overall Study|Parent/legal guardian request|0|||
105907484|NCT00980655|365319848|FG000|Overall Study|Other|0|||
105907485|NCT00980655|365319849|FG001|Overall Study|Other|1|||
105907486|NCT01066871|365319850|FG000|Overall Study|Lost to Follow-up|0|||
105907487|NCT01066871|365319851|FG001|Overall Study|Lost to Follow-up|2|||
105907488|NCT01066871|365319852|FG002|Overall Study|Lost to Follow-up|2|||
105907489|NCT01066871|365319853|FG003|Overall Study|Lost to Follow-up|0|||
105907490|NCT01066871|365319850|FG000|Overall Study|Protocol Violation|1|||
105907491|NCT01066871|365319851|FG001|Overall Study|Protocol Violation|0|||
105907492|NCT01066871|365319852|FG002|Overall Study|Protocol Violation|3|||
106125601|NCT03405662|366117832|FG001|Overall Study|placement in memory care facility|2|||
106125602|NCT05199233|366117833|FG000|Overall Study|Lack of Efficacy|1|||
106125603|NCT01555021|366117834|FG000|Overall Study|Lost to Follow-up|1|||
106125604|NCT01555021|366117835|FG001|Overall Study|Lost to Follow-up|2|||
106125605|NCT00065468|366117837|FG000|Overall Study|Death|172|||
106125606|NCT00065468|366117838|FG001|Overall Study|Death|169|||
106125607|NCT00065468|366117839|FG002|Overall Study|Death|171|||
106125608|NCT00065468|366117837|FG000|Overall Study|Withdrawal by Subject|3|||
106125609|NCT00065468|366117838|FG001|Overall Study|Withdrawal by Subject|4|||
106125610|NCT00065468|366117839|FG002|Overall Study|Withdrawal by Subject|5|||
106125611|NCT00065468|366117837|FG000|Overall Study|Lost to Follow-up|5|||
106125612|NCT00065468|366117838|FG001|Overall Study|Lost to Follow-up|3|||
106125613|NCT00065468|366117839|FG002|Overall Study|Lost to Follow-up|2|||
106125614|NCT00065468|366117837|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
106125615|NCT00065468|366117838|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
106125616|NCT00065468|366117839|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
106125617|NCT00065468|366117837|FG000|Overall Study|Disease progression|0|||
106125618|NCT00065468|366117838|FG001|Overall Study|Disease progression|0|||
106125619|NCT00065468|366117839|FG002|Overall Study|Disease progression|1|||
106125620|NCT00065468|366117837|FG000|Overall Study|Other|14|||
106125621|NCT00065468|366117838|FG001|Overall Study|Other|24|||
106125622|NCT00065468|366117839|FG002|Overall Study|Other|18|||
106125623|NCT01058863|366117841|FG000|Overall Study|Lost to Follow-up|1|||
106125624|NCT01058863|366117841|FG000|Overall Study|Withdrawal by Subject|1|||
106125625|NCT01058863|366117841|FG000|Overall Study|Sponsor requested withdrawal|1|||
105907493|NCT01066871|365319853|FG003|Overall Study|Protocol Violation|2|||
105907494|NCT01066871|365319850|FG000|Overall Study|Lack of Efficacy|0|||
105907495|NCT01066871|365319851|FG001|Overall Study|Lack of Efficacy|0|||
105907496|NCT01066871|365319852|FG002|Overall Study|Lack of Efficacy|0|||
105907497|NCT01066871|365319853|FG003|Overall Study|Lack of Efficacy|1|||
105907498|NCT01066871|365319850|FG000|Overall Study|Withdrawal by Subject|3|||
105907499|NCT01066871|365319851|FG001|Overall Study|Withdrawal by Subject|1|||
105907500|NCT01066871|365319852|FG002|Overall Study|Withdrawal by Subject|0|||
105907501|NCT01066871|365319853|FG003|Overall Study|Withdrawal by Subject|0|||
105907502|NCT01066871|365319850|FG000|Overall Study|Other|0|||
105907503|NCT01066871|365319851|FG001|Overall Study|Other|2|||
105907504|NCT01066871|365319852|FG002|Overall Study|Other|1|||
105907505|NCT01066871|365319853|FG003|Overall Study|Other|2|||
105907506|NCT04162795|365319854|FG000|Overall Study|Other|16|||
105907507|NCT04162795|365319854|FG000|Overall Study|Screen failures|10|||
105907508|NCT02029274|365319857|FG000|Overall Study|Adverse Event|1|||
105907509|NCT02029274|365319858|FG001|Overall Study|Adverse Event|0|||
105907510|NCT02029274|365319859|FG002|Overall Study|Adverse Event|2|||
105907511|NCT02029274|365319860|FG003|Overall Study|Adverse Event|2|||
105907512|NCT01919164|365321319|FG000|Overall Study|Adverse Event|6|||
105907513|NCT01919164|365321320|FG001|Overall Study|Adverse Event|4|||
105907514|NCT01919164|365321321|FG002|Overall Study|Adverse Event|9|||
105907515|NCT01919164|365321322|FG003|Overall Study|Adverse Event|3|||
105907516|NCT01919164|365321323|FG004|Overall Study|Adverse Event|2|||
105907517|NCT01919164|365321319|FG000|Overall Study|Lost to Follow-up|2|||
105907518|NCT01919164|365321320|FG001|Overall Study|Lost to Follow-up|2|||
105907519|NCT01919164|365321321|FG002|Overall Study|Lost to Follow-up|2|||
105907520|NCT01919164|365321322|FG003|Overall Study|Lost to Follow-up|0|||
105907521|NCT01919164|365321323|FG004|Overall Study|Lost to Follow-up|4|||
105907522|NCT01919164|365321319|FG000|Overall Study|Death|1|||
105907523|NCT01919164|365321320|FG001|Overall Study|Death|0|||
105907524|NCT01919164|365321321|FG002|Overall Study|Death|0|||
105907525|NCT01919164|365321322|FG003|Overall Study|Death|0|||
105907526|NCT01919164|365321323|FG004|Overall Study|Death|0|||
105907527|NCT01919164|365321319|FG000|Overall Study|Protocol Violation|6|||
105907528|NCT01919164|365321320|FG001|Overall Study|Protocol Violation|0|||
105907529|NCT01919164|365321321|FG002|Overall Study|Protocol Violation|3|||
105907530|NCT01919164|365321322|FG003|Overall Study|Protocol Violation|2|||
105907531|NCT01919164|365321323|FG004|Overall Study|Protocol Violation|2|||
105907532|NCT01919164|365321319|FG000|Overall Study|Disease progression|2|||
105907533|NCT01919164|365321320|FG001|Overall Study|Disease progression|2|||
105907534|NCT01919164|365321321|FG002|Overall Study|Disease progression|1|||
105907535|NCT01919164|365321322|FG003|Overall Study|Disease progression|2|||
105907536|NCT01919164|365321323|FG004|Overall Study|Disease progression|1|||
105907537|NCT01919164|365321319|FG000|Overall Study|Withdrew consent|13|||
105907538|NCT01919164|365321320|FG001|Overall Study|Withdrew consent|13|||
105907539|NCT01919164|365321321|FG002|Overall Study|Withdrew consent|14|||
105907540|NCT01919164|365321322|FG003|Overall Study|Withdrew consent|14|||
105907541|NCT01919164|365321323|FG004|Overall Study|Withdrew consent|9|||
105907542|NCT01919164|365321319|FG000|Overall Study|Other Un-specified|13|||
105907543|NCT01919164|365321320|FG001|Overall Study|Other Un-specified|9|||
105907544|NCT01919164|365321321|FG002|Overall Study|Other Un-specified|8|||
105907545|NCT01919164|365321322|FG003|Overall Study|Other Un-specified|7|||
105907546|NCT01919164|365321323|FG004|Overall Study|Other Un-specified|15|||
105907547|NCT02823470|365321325|FG000|Overall Study|Adverse Event|1|||
105907548|NCT02823470|365321326|FG001|Overall Study|Adverse Event|0|||
105907549|NCT02823470|365321325|FG000|Overall Study|Study terminated by sponsor|8|||
105907550|NCT02823470|365321326|FG001|Overall Study|Study terminated by sponsor|15|||
105907551|NCT03272347|365321327|FG000|Overall Study|Death|0|||
105907552|NCT03272347|365321328|FG001|Overall Study|Death|0|||
105907553|NCT03272347|365321329|FG002|Overall Study|Death|0|||
105907554|NCT03272347|365321330|FG003|Overall Study|Death|1|||
105907555|NCT03272347|365321327|FG000|Overall Study|Lost to Follow-up|1|||
105907556|NCT03272347|365321328|FG001|Overall Study|Lost to Follow-up|3|||
105907557|NCT03272347|365321329|FG002|Overall Study|Lost to Follow-up|5|||
105907558|NCT03272347|365321330|FG003|Overall Study|Lost to Follow-up|1|||
105907559|NCT03272347|365321327|FG000|Overall Study|Physician Decision|4|||
105907560|NCT03272347|365321328|FG001|Overall Study|Physician Decision|2|||
105907561|NCT03272347|365321329|FG002|Overall Study|Physician Decision|5|||
105907562|NCT03272347|365321330|FG003|Overall Study|Physician Decision|4|||
105907563|NCT03272347|365321327|FG000|Overall Study|Screen Failure|1|||
105907564|NCT03272347|365321328|FG001|Overall Study|Screen Failure|0|||
105907565|NCT03272347|365321329|FG002|Overall Study|Screen Failure|0|||
105907566|NCT03272347|365321330|FG003|Overall Study|Screen Failure|0|||
105907567|NCT03272347|365321327|FG000|Overall Study|Withdrawal by Subject|5|||
105907568|NCT03272347|365321328|FG001|Overall Study|Withdrawal by Subject|1|||
105907569|NCT03272347|365321329|FG002|Overall Study|Withdrawal by Subject|2|||
105907570|NCT03272347|365321330|FG003|Overall Study|Withdrawal by Subject|1|||
105907571|NCT03859648|365321331|FG000|Overall Study|Lost to Follow-up|1|||
105907572|NCT03859648|365321331|FG000|Overall Study|Adverse Event|1|||
105907573|NCT01677182|365321332|FG000|Overall Study|Adverse Event|2|||
105907574|NCT01677182|365321333|FG001|Overall Study|Adverse Event|1|||
105907575|NCT01677182|365321334|FG002|Overall Study|Adverse Event|8|||
105907576|NCT01677182|365321332|FG000|Overall Study|Protocol Violation|5|||
105907577|NCT01677182|365321333|FG001|Overall Study|Protocol Violation|1|||
105907578|NCT01677182|365321334|FG002|Overall Study|Protocol Violation|4|||
105907579|NCT01677182|365321332|FG000|Overall Study|Lost to Follow-up|4|||
105670503|NCT01305408|364458071|FG000|Overall Study|Lack of Efficacy|3|||
105670504|NCT01305408|364458072|FG001|Overall Study|Lack of Efficacy|4|||
105670505|NCT01305408|364458071|FG000|Overall Study|Withdrawal by Subject|9|||
105670506|NCT01305408|364458072|FG001|Overall Study|Withdrawal by Subject|9|||
105670507|NCT01305408|364458071|FG000|Overall Study|Protocol Violation|4|||
105670508|NCT01305408|364458072|FG001|Overall Study|Protocol Violation|6|||
105670509|NCT01305408|364458071|FG000|Overall Study|Lost to Follow-up|5|||
105670510|NCT01305408|364458072|FG001|Overall Study|Lost to Follow-up|3|||
105670511|NCT01305408|364458071|FG000|Overall Study|Noncompliance with study medication|0|||
105670512|NCT01305408|364458072|FG001|Overall Study|Noncompliance with study medication|1|||
105670513|NCT01305408|364458071|FG000|Overall Study|Noncompliance with study procedures|0|||
105670514|NCT01305408|364458072|FG001|Overall Study|Noncompliance with study procedures|1|||
105670515|NCT01305408|364458071|FG000|Overall Study|Other|1|||
105670516|NCT01305408|364458072|FG001|Overall Study|Other|0|||
105670517|NCT02440425|364458073|FG000|Overall Study|Death likely due to disease progression|1|||
105670518|NCT02440425|364458073|FG000|Overall Study|Withdrawal by Subject|2|||
105670519|NCT02440425|364458073|FG000|Overall Study|Adverse Event|1|||
105670520|NCT02440425|364458073|FG000|Overall Study|Adverse Event/Ineligible|1|||
105670521|NCT03101462|364458074|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
105670522|NCT03101462|364458075|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
105670523|NCT00214019|364458076|FG000|Overall Study|Lost to Follow-up|11|||
105670524|NCT00214019|364458076|FG000|Overall Study|Withdrawal by Subject|2|||
105670525|NCT00214019|364458076|FG000|Overall Study|Screen Failed prior to randomization|17|||
105670526|NCT01677767|364458079|FG000|Overall Study|Adverse Event|1|||
105670527|NCT01677767|364458079|FG000|Overall Study|Death|4|||
105670528|NCT01677767|364458079|FG000|Overall Study|Protocol Violation|4|||
105670529|NCT01677767|364458079|FG000|Overall Study|Withdrawal by Subject|10|||
105670530|NCT01677767|364458079|FG000|Overall Study|Non-compliance by the participants|3|||
105670531|NCT00842244|364458080|FG000|Overall Study|Death|3|||
105670532|NCT00842244|364458080|FG000|Overall Study|Withdrawal by Subject|1|||
105670533|NCT00842244|364458080|FG000|Overall Study|Other|17|||
105670534|NCT03635099|364458081|FG000|Period 1|Adverse Event|1|||
105670535|NCT03635099|364458082|FG001|Period 1|Adverse Event|0|||
105670536|NCT03635099|364458083|FG002|Period 1|Adverse Event|0|||
105670537|NCT03635099|364458084|FG003|Period 1|Adverse Event|1|||
105670538|NCT03635099|364458085|FG004|Period 1|Adverse Event|0|||
105670539|NCT03635099|364458086|FG005|Period 1|Adverse Event|0|||
105670540|NCT03635099|364458087|FG006|Period 1|Adverse Event|0|||
105670541|NCT03635099|364458088|FG007|Period 1|Adverse Event|0|||
105670542|NCT03635099|364458081|FG000|Period 1|Protocol Violation|0|||
105670543|NCT03635099|364458082|FG001|Period 1|Protocol Violation|0|||
105670544|NCT03635099|364458083|FG002|Period 1|Protocol Violation|1|||
105670545|NCT03635099|364458084|FG003|Period 1|Protocol Violation|0|||
105670546|NCT03635099|364458085|FG004|Period 1|Protocol Violation|0|||
105670547|NCT03635099|364458086|FG005|Period 1|Protocol Violation|0|||
105670548|NCT03635099|364458087|FG006|Period 1|Protocol Violation|0|||
105670549|NCT03635099|364458088|FG007|Period 1|Protocol Violation|0|||
105670550|NCT03635099|364458081|FG000|Period 1|Lost to Follow-up|0|||
105670551|NCT03635099|364458082|FG001|Period 1|Lost to Follow-up|0|||
105670552|NCT03635099|364458083|FG002|Period 1|Lost to Follow-up|1|||
105670553|NCT03635099|364458084|FG003|Period 1|Lost to Follow-up|2|||
105670554|NCT03635099|364458085|FG004|Period 1|Lost to Follow-up|1|||
105670555|NCT03635099|364458086|FG005|Period 1|Lost to Follow-up|0|||
105670556|NCT03635099|364458087|FG006|Period 1|Lost to Follow-up|1|||
105670557|NCT03635099|364458088|FG007|Period 1|Lost to Follow-up|2|||
105670558|NCT03635099|364458081|FG000|Period 1|Withdrawal by Subject|3|||
105670559|NCT03635099|364458082|FG001|Period 1|Withdrawal by Subject|3|||
105670560|NCT03635099|364458083|FG002|Period 1|Withdrawal by Subject|5|||
105670561|NCT03635099|364458084|FG003|Period 1|Withdrawal by Subject|2|||
105670562|NCT03635099|364458085|FG004|Period 1|Withdrawal by Subject|2|||
105670563|NCT03635099|364458086|FG005|Period 1|Withdrawal by Subject|0|||
105670564|NCT03635099|364458087|FG006|Period 1|Withdrawal by Subject|3|||
105670565|NCT03635099|364458088|FG007|Period 1|Withdrawal by Subject|0|||
105670566|NCT03635099|364458081|FG000|Period 1|History of suicidal ideation|0|||
105670567|NCT03635099|364458082|FG001|Period 1|History of suicidal ideation|0|||
105670568|NCT03635099|364458083|FG002|Period 1|History of suicidal ideation|1|||
105670569|NCT03635099|364458084|FG003|Period 1|History of suicidal ideation|0|||
105670570|NCT03635099|364458085|FG004|Period 1|History of suicidal ideation|0|||
105670571|NCT03635099|364458086|FG005|Period 1|History of suicidal ideation|0|||
105670572|NCT03635099|364458087|FG006|Period 1|History of suicidal ideation|0|||
105670573|NCT03635099|364458088|FG007|Period 1|History of suicidal ideation|0|||
105670574|NCT03635099|364458081|FG000|Period 1|pursue other treatment options|0|||
105670575|NCT03635099|364458082|FG001|Period 1|pursue other treatment options|0|||
105670576|NCT03635099|364458083|FG002|Period 1|pursue other treatment options|0|||
105907580|NCT01677182|365321333|FG001|Overall Study|Lost to Follow-up|0|||
105907581|NCT01677182|365321334|FG002|Overall Study|Lost to Follow-up|3|||
105907582|NCT01677182|365321332|FG000|Overall Study|Withdrawal by Subject|7|||
105670577|NCT03635099|364458084|FG003|Period 1|pursue other treatment options|0|||
105670578|NCT03635099|364458085|FG004|Period 1|pursue other treatment options|0|||
105670579|NCT03635099|364458086|FG005|Period 1|pursue other treatment options|1|||
105670580|NCT03635099|364458087|FG006|Period 1|pursue other treatment options|0|||
105670581|NCT03635099|364458088|FG007|Period 1|pursue other treatment options|0|||
105670582|NCT03635099|364458081|FG000|Not Eligible for Period 2|Pregnancy|0|||
105670583|NCT03635099|364458082|FG001|Not Eligible for Period 2|Pregnancy|0|||
105670584|NCT03635099|364458083|FG002|Not Eligible for Period 2|Pregnancy|0|||
105670585|NCT03635099|364458084|FG003|Not Eligible for Period 2|Pregnancy|1|||
105670586|NCT03635099|364458085|FG004|Not Eligible for Period 2|Pregnancy|0|||
105670587|NCT03635099|364458086|FG005|Not Eligible for Period 2|Pregnancy|0|||
105670588|NCT03635099|364458087|FG006|Not Eligible for Period 2|Pregnancy|0|||
105670589|NCT03635099|364458088|FG007|Not Eligible for Period 2|Pregnancy|0|||
105670590|NCT03635099|364458081|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
105670591|NCT03635099|364458082|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670592|NCT03635099|364458083|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670593|NCT03635099|364458084|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670594|NCT03635099|364458085|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670595|NCT03635099|364458086|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670596|NCT03635099|364458087|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670597|NCT03635099|364458088|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
105670598|NCT03635099|364458081|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670599|NCT03635099|364458082|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670600|NCT03635099|364458083|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670601|NCT03635099|364458084|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670602|NCT03635099|364458085|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
105670603|NCT03635099|364458086|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
105670604|NCT03635099|364458087|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
105670605|NCT03635099|364458088|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
105670606|NCT03635099|364458081|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
105670607|NCT03635099|364458082|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
105670608|NCT03635099|364458083|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
105670609|NCT03635099|364458084|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
105670610|NCT03635099|364458085|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
105670611|NCT03635099|364458086|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
105670612|NCT03635099|364458087|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
105670613|NCT03635099|364458088|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
105670614|NCT03635099|364458081|FG000|Period 2|Adverse Event|0|||
105670615|NCT03635099|364458082|FG001|Period 2|Adverse Event|0|||
105670616|NCT03635099|364458083|FG002|Period 2|Adverse Event|1|||
105670617|NCT03635099|364458084|FG003|Period 2|Adverse Event|0|||
105670618|NCT03635099|364458085|FG004|Period 2|Adverse Event|1|||
105670619|NCT03635099|364458086|FG005|Period 2|Adverse Event|0|||
105670620|NCT03635099|364458087|FG006|Period 2|Adverse Event|0|||
105670621|NCT03635099|364458088|FG007|Period 2|Adverse Event|0|||
105670622|NCT03635099|364458081|FG000|Period 2|Lost to Follow-up|0|||
105670623|NCT03635099|364458082|FG001|Period 2|Lost to Follow-up|0|||
105670624|NCT03635099|364458083|FG002|Period 2|Lost to Follow-up|1|||
105670625|NCT03635099|364458084|FG003|Period 2|Lost to Follow-up|0|||
105670626|NCT03635099|364458085|FG004|Period 2|Lost to Follow-up|4|||
105670627|NCT03635099|364458086|FG005|Period 2|Lost to Follow-up|0|||
105670628|NCT03635099|364458087|FG006|Period 2|Lost to Follow-up|0|||
105670629|NCT03635099|364458088|FG007|Period 2|Lost to Follow-up|0|||
105670630|NCT03635099|364458081|FG000|Period 2|Withdrawal by Subject|0|||
105670631|NCT03635099|364458082|FG001|Period 2|Withdrawal by Subject|0|||
105670632|NCT03635099|364458083|FG002|Period 2|Withdrawal by Subject|7|||
105670633|NCT03635099|364458084|FG003|Period 2|Withdrawal by Subject|4|||
105670634|NCT03635099|364458085|FG004|Period 2|Withdrawal by Subject|7|||
105670635|NCT03635099|364458086|FG005|Period 2|Withdrawal by Subject|0|||
105907583|NCT01677182|365321333|FG001|Overall Study|Withdrawal by Subject|12|||
105907584|NCT01677182|365321334|FG002|Overall Study|Withdrawal by Subject|10|||
105907585|NCT01677182|365321332|FG000|Overall Study|Study termination|12|||
105907586|NCT01677182|365321333|FG001|Overall Study|Study termination|9|||
105907587|NCT01677182|365321334|FG002|Overall Study|Study termination|11|||
105907588|NCT01677182|365321332|FG000|Overall Study|Lack of Efficacy|3|||
105907589|NCT01677182|365321333|FG001|Overall Study|Lack of Efficacy|0|||
105670636|NCT03635099|364458087|FG006|Period 2|Withdrawal by Subject|0|||
105670637|NCT03635099|364458088|FG007|Period 2|Withdrawal by Subject|0|||
105670638|NCT01068665|364458089|FG000|Overall Study|Adverse Event|5|||
105670639|NCT01068665|364458090|FG001|Overall Study|Adverse Event|4|||
105670640|NCT01068665|364458089|FG000|Overall Study|Lack of Efficacy|0|||
105670641|NCT01068665|364458090|FG001|Overall Study|Lack of Efficacy|2|||
105907590|NCT01677182|365321334|FG002|Overall Study|Lack of Efficacy|1|||
105670642|NCT01068665|364458089|FG000|Overall Study|Protocol Violation|5|||
105907591|NCT01677182|365321332|FG000|Overall Study|Other reasons|1|||
105907592|NCT01677182|365321333|FG001|Overall Study|Other reasons|5|||
105670643|NCT01068665|364458090|FG001|Overall Study|Protocol Violation|2|||
105670644|NCT01068665|364458089|FG000|Overall Study|Withdrawal Criteria|3|||
105670645|NCT01068665|364458090|FG001|Overall Study|Withdrawal Criteria|9|||
105670646|NCT01068665|364458089|FG000|Overall Study|Other|17|||
105670647|NCT01068665|364458090|FG001|Overall Study|Other|12|||
105670648|NCT02920970|364458091|FG000|First Intervention|Protocol Violation|0|||
105670649|NCT02920970|364458092|FG001|First Intervention|Protocol Violation|1|||
105670650|NCT02920970|364458091|FG000|First Intervention|Adverse Event|0|||
105670651|NCT02920970|364458092|FG001|First Intervention|Adverse Event|1|||
105670652|NCT02920970|364458091|FG000|Second Intervention|Poor Lens Fit|1|||
105670653|NCT02920970|364458092|FG001|Second Intervention|Poor Lens Fit|0|||
105670654|NCT02807272|364458094|FG000|Overall Study|Death|9|||
105670655|NCT02807272|364458095|FG001|Overall Study|Death|5|||
105670656|NCT02807272|364458096|FG002|Overall Study|Death|2|||
105670657|NCT02807272|364458097|FG003|Overall Study|Death|0|||
105670658|NCT02807272|364458098|FG004|Overall Study|Death|1|||
105670659|NCT02807272|364458094|FG000|Overall Study|Lost to Follow-up|1|||
105670660|NCT02807272|364458095|FG001|Overall Study|Lost to Follow-up|0|||
105670661|NCT02807272|364458096|FG002|Overall Study|Lost to Follow-up|0|||
105670662|NCT02807272|364458097|FG003|Overall Study|Lost to Follow-up|0|||
105670663|NCT02807272|364458098|FG004|Overall Study|Lost to Follow-up|0|||
105670664|NCT02807272|364458094|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
105670665|NCT02807272|364458095|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
105670666|NCT02807272|364458096|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
105670667|NCT02807272|364458097|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
105670668|NCT02807272|364458098|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
105670669|NCT02807272|364458094|FG000|Overall Study|Protocol-defined Disease Progression|0|||
105670670|NCT02807272|364458095|FG001|Overall Study|Protocol-defined Disease Progression|1|||
105670671|NCT02807272|364458096|FG002|Overall Study|Protocol-defined Disease Progression|0|||
105670672|NCT02807272|364458097|FG003|Overall Study|Protocol-defined Disease Progression|0|||
105670673|NCT02807272|364458098|FG004|Overall Study|Protocol-defined Disease Progression|1|||
105670674|NCT02807272|364458094|FG000|Overall Study|Study Terminated by Sponsor|1|||
105670675|NCT02807272|364458095|FG001|Overall Study|Study Terminated by Sponsor|0|||
105670676|NCT02807272|364458096|FG002|Overall Study|Study Terminated by Sponsor|0|||
105670677|NCT02807272|364458097|FG003|Overall Study|Study Terminated by Sponsor|1|||
105670678|NCT02807272|364458098|FG004|Overall Study|Study Terminated by Sponsor|0|||
105670679|NCT02807272|364458094|FG000|Overall Study|Other|1|||
105670680|NCT02807272|364458095|FG001|Overall Study|Other|0|||
105670681|NCT02807272|364458096|FG002|Overall Study|Other|0|||
105670682|NCT02807272|364458097|FG003|Overall Study|Other|0|||
105670683|NCT02807272|364458098|FG004|Overall Study|Other|1|||
105670684|NCT00757627|364458099|FG000|Overall Study|Adverse Event|15|||
105670685|NCT00757627|364458099|FG000|Overall Study|Lack of Efficacy|10|||
105670686|NCT00757627|364458099|FG000|Overall Study|Lost to Follow-up|28|||
105670687|NCT00757627|364458099|FG000|Overall Study|Withdrawal by Subject|27|||
105998915|NCT04158583|365657869|FG002|Overall Study|Lost to Follow-up|1|||
105998916|NCT04158583|365657870|FG003|Overall Study|Lost to Follow-up|1|||
105998917|NCT04158583|365657871|FG004|Overall Study|Lost to Follow-up|1|||
105998918|NCT04158583|365657872|FG005|Overall Study|Lost to Follow-up|0|||
105998919|NCT04158583|365657873|FG006|Overall Study|Lost to Follow-up|0|||
105998920|NCT04158583|365657874|FG007|Overall Study|Lost to Follow-up|0|||
105998921|NCT04158583|365657875|FG008|Overall Study|Lost to Follow-up|0|||
105998922|NCT04158583|365657876|FG009|Overall Study|Lost to Follow-up|0|||
105998923|NCT04158583|365657867|FG000|Overall Study|Due To Patient Status|0|||
105998924|NCT04158583|365657868|FG001|Overall Study|Due To Patient Status|0|||
105998925|NCT04158583|365657869|FG002|Overall Study|Due To Patient Status|0|||
105998926|NCT04158583|365657870|FG003|Overall Study|Due To Patient Status|0|||
105998927|NCT04158583|365657871|FG004|Overall Study|Due To Patient Status|0|||
105998928|NCT04158583|365657872|FG005|Overall Study|Due To Patient Status|0|||
105998929|NCT04158583|365657873|FG006|Overall Study|Due To Patient Status|0|||
105998930|NCT04158583|365657874|FG007|Overall Study|Due To Patient Status|0|||
105998931|NCT04158583|365657875|FG008|Overall Study|Due To Patient Status|1|||
105998932|NCT04158583|365657876|FG009|Overall Study|Due To Patient Status|0|||
105670688|NCT00757627|364458099|FG000|Overall Study|Other|1|||
105670689|NCT00635661|364458100|FG000|Overall Study|Withdrawal by Subject|4|||
105670690|NCT01696955|364458102|FG000|Main Study|Protocol Violation|1|||
105670691|NCT01696955|364458103|FG001|Main Study|Protocol Violation|0|||
105670692|NCT01696955|364458102|FG000|Main Study|Withdrawal by Subject|1|||
105670693|NCT01696955|364458103|FG001|Main Study|Withdrawal by Subject|1|||
105670694|NCT03653208|364458106|FG000|Overall Study|Withdrawal by Subject|0|||
105670695|NCT03653208|364458107|FG001|Overall Study|Withdrawal by Subject|0|||
105670696|NCT03653208|364458108|FG002|Overall Study|Withdrawal by Subject|0|||
105670697|NCT03653208|364458109|FG003|Overall Study|Withdrawal by Subject|0|||
105670698|NCT03653208|364458110|FG004|Overall Study|Withdrawal by Subject|1|||
105670699|NCT03653208|364458111|FG005|Overall Study|Withdrawal by Subject|0|||
105998933|NCT04158583|365657867|FG000|Overall Study|Death|3|||
105670700|NCT03653208|364458112|FG006|Overall Study|Withdrawal by Subject|0|||
105998934|NCT04158583|365657868|FG001|Overall Study|Death|4|||
105786175|NCT04089566|364870462|FG005|Overall Study|Reason not Specified|0|||
105786176|NCT01083121|364870463|FG000|Overall Study|Use of Humira outside the approved label|81|||
105786177|NCT04409262|364870466|FG000|Overall Study|Adverse Event|0|||
105786178|NCT04409262|364870467|FG001|Overall Study|Adverse Event|2|||
105786179|NCT04409262|364870466|FG000|Overall Study|Death|55|||
105786180|NCT04409262|364870467|FG001|Overall Study|Death|97|||
105786181|NCT04409262|364870466|FG000|Overall Study|Lost to Follow-up|12|||
105907593|NCT01677182|365321334|FG002|Overall Study|Other reasons|2|||
105907594|NCT02489448|365321338|FG000|Overall Study|Death|3|||
105907595|NCT02489448|365321338|FG000|Overall Study|Withdrawal by Subject|2|||
105907596|NCT02748057|365321339|FG000|Overall Study|Adverse Event|1|||
105907597|NCT02748057|365321340|FG001|Overall Study|Adverse Event|0|||
105907598|NCT02748057|365321339|FG000|Overall Study|Physician Decision|0|||
105907599|NCT02748057|365321340|FG001|Overall Study|Physician Decision|1|||
105907600|NCT02748057|365321339|FG000|Overall Study|Protocol Violation|2|||
105907601|NCT02748057|365321340|FG001|Overall Study|Protocol Violation|1|||
105907602|NCT02748057|365321339|FG000|Overall Study|Participant Moved|1|||
105907603|NCT02748057|365321340|FG001|Overall Study|Participant Moved|0|||
105907604|NCT02748057|365321339|FG000|Overall Study|Withdrawal by Subject|1|||
105907605|NCT02748057|365321340|FG001|Overall Study|Withdrawal by Subject|0|||
105907606|NCT01990573|365321341|FG000|Overall Study|Physician Decision|0|||
105907607|NCT01990573|365321342|FG001|Overall Study|Physician Decision|0|||
105907608|NCT01990573|365321343|FG002|Overall Study|Physician Decision|1|||
105907609|NCT01971567|365321344|FG000|Overall Study|Withdrawal by Subject|3|||
105786182|NCT04409262|364870467|FG001|Overall Study|Lost to Follow-up|23|||
105786183|NCT04409262|364870466|FG000|Overall Study|Lack of Staff|0|||
105786184|NCT04409262|364870467|FG001|Overall Study|Lack of Staff|1|||
105786185|NCT04409262|364870466|FG000|Overall Study|Protocol Violation|3|||
105786186|NCT04409262|364870467|FG001|Overall Study|Protocol Violation|1|||
105907610|NCT01971567|365321345|FG001|Overall Study|Withdrawal by Subject|2|||
105907611|NCT01971567|365321344|FG000|Overall Study|Lost to Follow-up|1|||
105907612|NCT01971567|365321345|FG001|Overall Study|Lost to Follow-up|0|||
105907613|NCT00391872|365321348|FG000|Overall Study|Protocol Violation|7|||
105786187|NCT04409262|364870466|FG000|Overall Study|Withdrawal by Subject|5|||
105907614|NCT00391872|365321349|FG001|Overall Study|Protocol Violation|2|||
105907615|NCT00391872|365321348|FG000|Overall Study|Withdrawal by Subject|296|||
105907616|NCT00391872|365321349|FG001|Overall Study|Withdrawal by Subject|249|||
105907617|NCT00391872|365321348|FG000|Overall Study|Reason unknown|2|||
105907618|NCT00391872|365321349|FG001|Overall Study|Reason unknown|4|||
105907619|NCT00391872|365321348|FG000|Overall Study|Lost to Follow-up|2|||
105907620|NCT00391872|365321349|FG001|Overall Study|Lost to Follow-up|0|||
105907621|NCT01239394|365321350|FG000|Overall Study|Adverse Event|1|||
105786188|NCT04409262|364870467|FG001|Overall Study|Withdrawal by Subject|10|||
105786189|NCT02500732|364870468|FG000|Overall Study|Physician Decision|0|||
105786190|NCT02500732|364870469|FG001|Overall Study|Physician Decision|1|||
105786191|NCT01958619|364870470|FG000|Overall Study|Protocol Violation|2|||
105786192|NCT01958619|364870471|FG001|Overall Study|Protocol Violation|0|||
105786193|NCT01958619|364870472|FG002|Overall Study|Protocol Violation|1|||
105998935|NCT04158583|365657869|FG002|Overall Study|Death|2|||
105907622|NCT00758498|365321352|FG000|Overall Study|Adverse Event|2|||
105907623|NCT00758498|365321353|FG001|Overall Study|Adverse Event|2|||
105907624|NCT00758498|365321354|FG002|Overall Study|Adverse Event|3|||
105907625|NCT00758498|365321352|FG000|Overall Study|Subject legally detained out of state|1|||
105907626|NCT00758498|365321353|FG001|Overall Study|Subject legally detained out of state|0|||
105907627|NCT00758498|365321354|FG002|Overall Study|Subject legally detained out of state|0|||
105907628|NCT00758498|365321352|FG000|Overall Study|Withdrawal by Subject|0|||
105907629|NCT00758498|365321353|FG001|Overall Study|Withdrawal by Subject|0|||
105907630|NCT00758498|365321354|FG002|Overall Study|Withdrawal by Subject|1|||
105907631|NCT00758498|365321352|FG000|Overall Study|Noncompliance to study procedures|0|||
105907632|NCT00758498|365321353|FG001|Overall Study|Noncompliance to study procedures|0|||
105907633|NCT00758498|365321354|FG002|Overall Study|Noncompliance to study procedures|1|||
105907634|NCT02630563|365321355|FG000|Overall Study|Administrative|1|||
105907635|NCT02239640|365321356|FG000|Overall Study|Withdrawal by Subject|3|||
105907636|NCT02239640|365321356|FG000|Overall Study|Lost to Follow-up|72|||
105907637|NCT02239640|365321356|FG000|Overall Study|Death|142|||
105907638|NCT02061813|365321357|FG000|Overall Study|Withdrawal by Subject|1|||
105907639|NCT02061813|365321357|FG000|Overall Study|Protocol Violation|2|||
105907640|NCT00169104|365321358|FG000|Overall Study|Withdrawal by Subject|2|||
105907641|NCT00169104|365321359|FG001|Overall Study|Withdrawal by Subject|0|||
105907642|NCT00169104|365321358|FG000|Overall Study|Protocol Violation|0|||
105907643|NCT00169104|365321359|FG001|Overall Study|Protocol Violation|1|||
105907644|NCT00169104|365321358|FG000|Overall Study|Physician Decision|0|||
105907645|NCT00169104|365321359|FG001|Overall Study|Physician Decision|1|||
105907646|NCT01540981|365321361|FG000|Overall Study|Withdrawal by Subject|1|||
105907647|NCT01540981|365321362|FG001|Overall Study|Withdrawal by Subject|0|||
105907648|NCT00809094|365321363|FG000|Overall Study|Lost to Follow-up|0|||
105907649|NCT00809094|365321364|FG001|Overall Study|Lost to Follow-up|1|||
105786194|NCT01958619|364870473|FG003|Overall Study|Protocol Violation|0|||
105786195|NCT02396849|364870475|FG000|Overall Study|Lost to Follow-up|1|||
105786196|NCT02396849|364870476|FG001|Overall Study|Lost to Follow-up|1|||
105786197|NCT02396849|364870475|FG000|Overall Study|Did not tolerate intervention|1|||
105786198|NCT02396849|364870476|FG001|Overall Study|Did not tolerate intervention|1|||
105907650|NCT00397189|365321366|FG000|3 Weeks Period|Lost to Follow-up|5|||
105907651|NCT00397189|365321367|FG001|3 Weeks Period|Lost to Follow-up|4|||
105907652|NCT00397189|365321366|FG000|3 Weeks Period|Adverse Event|3|||
105907653|NCT00397189|365321367|FG001|3 Weeks Period|Adverse Event|2|||
105907654|NCT00397189|365321366|FG000|3 Weeks Period|Withdrawal by Subject|13|||
105907655|NCT00397189|365321367|FG001|3 Weeks Period|Withdrawal by Subject|9|||
105998936|NCT04158583|365657870|FG003|Overall Study|Death|2|||
105998937|NCT04158583|365657871|FG004|Overall Study|Death|4|||
105907656|NCT00397189|365321366|FG000|3 Weeks Period|Physician Decision|0|||
105907657|NCT00397189|365321367|FG001|3 Weeks Period|Physician Decision|2|||
105907658|NCT00397189|365321366|FG000|3 Weeks Period|Protocol Violation|0|||
105907659|NCT00397189|365321367|FG001|3 Weeks Period|Protocol Violation|3|||
105907660|NCT00397189|365321366|FG000|3 Weeks Period|Other|0|||
105907661|NCT00397189|365321367|FG001|3 Weeks Period|Other|2|||
105907662|NCT01029262|365321372|FG000|Overall Study|Adverse Event|9|||
105907663|NCT01029262|365321373|FG001|Overall Study|Adverse Event|52|||
105907664|NCT01029262|365321372|FG000|Overall Study|Lack of therapeutic effect|57|||
105907665|NCT01029262|365321373|FG001|Overall Study|Lack of therapeutic effect|76|||
105907666|NCT01029262|365321372|FG000|Overall Study|Withdrawal by Subject|10|||
105907667|NCT01029262|365321373|FG001|Overall Study|Withdrawal by Subject|17|||
105998938|NCT04158583|365657872|FG005|Overall Study|Death|3|||
105998939|NCT04158583|365657873|FG006|Overall Study|Death|5|||
105998940|NCT04158583|365657874|FG007|Overall Study|Death|2|||
105998941|NCT04158583|365657875|FG008|Overall Study|Death|0|||
105998942|NCT04158583|365657876|FG009|Overall Study|Death|1|||
105670701|NCT03653208|364458113|FG007|Overall Study|Withdrawal by Subject|1|||
105670702|NCT03653208|364458114|FG008|Overall Study|Withdrawal by Subject|1|||
105670703|NCT00436605|364458115|FG000|Overall Study|Protocol Violation|3|||
105670704|NCT03752970|364458118|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
105670705|NCT03752970|364458119|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
105670706|NCT03752970|364458120|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
105670707|NCT03752970|364458118|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
105670708|NCT03752970|364458119|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
105670709|NCT03752970|364458120|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
105670710|NCT03752970|364458118|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
105670711|NCT03752970|364458119|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
105670712|NCT03752970|364458120|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
105670713|NCT03752970|364458118|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
105670714|NCT03752970|364458119|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
105670715|NCT03752970|364458120|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
105670716|NCT03752970|364458118|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
105670717|NCT03752970|364458119|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
105670718|NCT03752970|364458120|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
105670719|NCT00573859|364458121|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
105670720|NCT00573859|364458121|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
105670721|NCT00368927|364458122|FG000|Overall Study|Lost to Follow-up|2|||
105670722|NCT00368927|364458123|FG001|Overall Study|Lost to Follow-up|0|||
105670723|NCT00368927|364458122|FG000|Overall Study|Adverse Event|1|||
105998943|NCT04158583|365657867|FG000|Overall Study|Clinical Progression Disease|0|||
105998944|NCT04158583|365657868|FG001|Overall Study|Clinical Progression Disease|0|||
105998945|NCT04158583|365657869|FG002|Overall Study|Clinical Progression Disease|0|||
105998946|NCT04158583|365657870|FG003|Overall Study|Clinical Progression Disease|1|||
105998947|NCT04158583|365657871|FG004|Overall Study|Clinical Progression Disease|0|||
105998948|NCT04158583|365657872|FG005|Overall Study|Clinical Progression Disease|0|||
105998949|NCT04158583|365657873|FG006|Overall Study|Clinical Progression Disease|0|||
105998950|NCT04158583|365657874|FG007|Overall Study|Clinical Progression Disease|0|||
105998951|NCT04158583|365657875|FG008|Overall Study|Clinical Progression Disease|0|||
105998952|NCT04158583|365657876|FG009|Overall Study|Clinical Progression Disease|0|||
105998953|NCT04158583|365657867|FG000|Overall Study|Clinical Progression|0|||
105670724|NCT00368927|364458123|FG001|Overall Study|Adverse Event|1|||
105998954|NCT04158583|365657868|FG001|Overall Study|Clinical Progression|0|||
105998955|NCT04158583|365657869|FG002|Overall Study|Clinical Progression|0|||
105998956|NCT04158583|365657870|FG003|Overall Study|Clinical Progression|0|||
105998957|NCT04158583|365657871|FG004|Overall Study|Clinical Progression|1|||
105998958|NCT04158583|365657872|FG005|Overall Study|Clinical Progression|0|||
105998959|NCT04158583|365657873|FG006|Overall Study|Clinical Progression|2|||
105998960|NCT04158583|365657874|FG007|Overall Study|Clinical Progression|0|||
105998961|NCT04158583|365657875|FG008|Overall Study|Clinical Progression|0|||
105998962|NCT04158583|365657876|FG009|Overall Study|Clinical Progression|0|||
105998963|NCT04158583|365657867|FG000|Overall Study|Clinical Deterioration|0|||
105998964|NCT04158583|365657868|FG001|Overall Study|Clinical Deterioration|0|||
105998965|NCT04158583|365657869|FG002|Overall Study|Clinical Deterioration|0|||
105998966|NCT04158583|365657870|FG003|Overall Study|Clinical Deterioration|1|||
105998967|NCT04158583|365657871|FG004|Overall Study|Clinical Deterioration|0|||
105998968|NCT04158583|365657872|FG005|Overall Study|Clinical Deterioration|0|||
105670725|NCT00368927|364458122|FG000|Overall Study|Withdrawal by Subject|1|||
105670726|NCT00368927|364458123|FG001|Overall Study|Withdrawal by Subject|2|||
105670727|NCT00368927|364458122|FG000|Overall Study|Physician Decision|1|||
105670728|NCT00368927|364458123|FG001|Overall Study|Physician Decision|0|||
105670729|NCT01152814|364458124|FG000|Overall Study|Lost to Follow-up|2|||
105670730|NCT03541200|364458125|FG000|Overall Study|Adverse Event|19|||
105670731|NCT03541200|364458125|FG000|Overall Study|Death|1|||
105670732|NCT03541200|364458125|FG000|Overall Study|Lost to Follow-up|10|||
105670733|NCT03541200|364458125|FG000|Overall Study|Physician Decision|1|||
105670734|NCT03541200|364458125|FG000|Overall Study|Protocol Violation|51|||
105998969|NCT04158583|365657873|FG006|Overall Study|Clinical Deterioration|0|||
105998970|NCT04158583|365657874|FG007|Overall Study|Clinical Deterioration|0|||
105998971|NCT04158583|365657875|FG008|Overall Study|Clinical Deterioration|0|||
105998972|NCT04158583|365657876|FG009|Overall Study|Clinical Deterioration|1|||
105670735|NCT03541200|364458125|FG000|Overall Study|Withdrawal by Subject|23|||
105670736|NCT03541200|364458125|FG000|Overall Study|other|8|||
105670737|NCT00818779|364458126|FG000|Overall Study|Protocol Violation|1|||
105670738|NCT00818779|364458127|FG001|Overall Study|Protocol Violation|0|||
105670739|NCT00818779|364458126|FG000|Overall Study|Lost to Follow-up|1|||
105998973|NCT01114828|365657877|FG000|Overall Study|Adverse Event|1|||
105907668|NCT01029262|365321372|FG000|Overall Study|Protocol Violation|2|||
105907669|NCT01029262|365321373|FG001|Overall Study|Protocol Violation|3|||
105907670|NCT01029262|365321372|FG000|Overall Study|Miscellaneous|1|||
105907671|NCT01029262|365321373|FG001|Overall Study|Miscellaneous|9|||
105907672|NCT01029262|365321372|FG000|Overall Study|Death|0|||
105907673|NCT01029262|365321373|FG001|Overall Study|Death|3|||
105907674|NCT03904420|365321376|FG000|Overall Study|Study terminated|2|||
105907675|NCT03904420|365321377|FG001|Overall Study|Study terminated|2|||
105907676|NCT01468454|365321382|FG000|Overall Study|Did not have surgery after PET|9|||
105907677|NCT02438280|365321383|FG000|Overall Study|Physician Decision|1|||
105907678|NCT02438280|365321384|FG001|Overall Study|Physician Decision|0|||
105907679|NCT02260817|365321385|FG000|Overall Study|Lost to Follow-up|0|||
105907680|NCT02260817|365321386|FG001|Overall Study|Lost to Follow-up|14|||
105907681|NCT02260817|365321385|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
105907682|NCT02260817|365321386|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
105907683|NCT02260817|365321385|FG000|Overall Study|Observation, no biopsy|0|||
105907684|NCT02260817|365321386|FG001|Overall Study|Observation, no biopsy|1|||
105907685|NCT02260817|365321385|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
105907686|NCT02260817|365321386|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
105907687|NCT02260817|365321385|FG000|Overall Study|Protocol Violation|0|||
105907688|NCT02260817|365321386|FG001|Overall Study|Protocol Violation|14|||
105907689|NCT04435808|365321387|FG000|Overall Study|Study stopped by DSMB|0|||
105907690|NCT04435808|365321388|FG001|Overall Study|Study stopped by DSMB|1|||
105907691|NCT02620787|365321389|FG000|Overall Study|Adverse Event|1|||
105907692|NCT02620787|365321390|FG001|Overall Study|Adverse Event|0|||
105907693|NCT02620787|365321389|FG000|Overall Study|Eligibility Criteria Not Met|1|||
105907694|NCT02620787|365321390|FG001|Overall Study|Eligibility Criteria Not Met|0|||
105907695|NCT03299101|365321391|FG000|Overall Study|Lost to Follow-up|1|||
105907696|NCT03299101|365321391|FG000|Overall Study|Withdrawal by Subject|5|||
105907697|NCT03299101|365321391|FG000|Overall Study|Surgery was changed|3|||
105907698|NCT03299101|365321391|FG000|Overall Study|Not enough time to complete prehab|1|||
105907699|NCT01768559|365321394|FG000|Overall Study|Randomized but not treated|0|||
105907700|NCT01768559|365321395|FG001|Overall Study|Randomized but not treated|0|||
105907701|NCT01768559|365321396|FG002|Overall Study|Randomized but not treated|1|||
105907702|NCT01768559|365321394|FG000|Overall Study|Adverse Event|15|||
105907703|NCT01768559|365321395|FG001|Overall Study|Adverse Event|2|||
105907704|NCT01768559|365321396|FG002|Overall Study|Adverse Event|5|||
105907705|NCT01768559|365321394|FG000|Overall Study|Lack of Efficacy|6|||
105907706|NCT01768559|365321395|FG001|Overall Study|Lack of Efficacy|4|||
105907707|NCT01768559|365321396|FG002|Overall Study|Lack of Efficacy|0|||
105907708|NCT01768559|365321394|FG000|Overall Study|Poor compliance to protocol|0|||
105907709|NCT01768559|365321395|FG001|Overall Study|Poor compliance to protocol|3|||
105907710|NCT01768559|365321396|FG002|Overall Study|Poor compliance to protocol|2|||
105907711|NCT01768559|365321394|FG000|Overall Study|Other than specified|9|||
105907712|NCT01768559|365321395|FG001|Overall Study|Other than specified|8|||
105907713|NCT01768559|365321396|FG002|Overall Study|Other than specified|5|||
105907714|NCT01421641|365321397|FG000|Overall Study|Protocol Violation|2|||
105907715|NCT01421641|365321398|FG001|Overall Study|Protocol Violation|2|||
105907716|NCT04676724|365321400|FG000|Overall Study|Adverse Event|2|||
105907717|NCT04676724|365321401|FG001|Overall Study|Adverse Event|0|||
105907718|NCT04676724|365321400|FG000|Overall Study|Lost to Follow-up|1|||
105907719|NCT04676724|365321401|FG001|Overall Study|Lost to Follow-up|0|||
105907720|NCT04676724|365321400|FG000|Overall Study|Physician Decision|0|||
105907721|NCT04676724|365321401|FG001|Overall Study|Physician Decision|1|||
105907722|NCT04676724|365321400|FG000|Overall Study|Withdrawal by Subject|3|||
105907723|NCT04676724|365321401|FG001|Overall Study|Withdrawal by Subject|2|||
105907724|NCT04501952|365321406|FG000|Overall Study|Adverse Event|0|||
105907725|NCT04501952|365321407|FG001|Overall Study|Adverse Event|3|||
105907726|NCT04501952|365321406|FG000|Overall Study|Investigator's Discretion|0|||
105907727|NCT04501952|365321407|FG001|Overall Study|Investigator's Discretion|1|||
105907728|NCT04501952|365321406|FG000|Overall Study|Protocol Violation|1|||
105907729|NCT04501952|365321407|FG001|Overall Study|Protocol Violation|1|||
105907730|NCT04501952|365321406|FG000|Overall Study|Withdrew Consent|5|||
105907731|NCT04501952|365321407|FG001|Overall Study|Withdrew Consent|4|||
105998974|NCT01114828|365657878|FG001|Overall Study|Adverse Event|1|||
105907732|NCT04501952|365321406|FG000|Overall Study|Lost to Follow-up|7|||
105998975|NCT01114828|365657877|FG000|Overall Study|Lack of Efficacy|0|||
105907733|NCT04501952|365321407|FG001|Overall Study|Lost to Follow-up|2|||
105907734|NCT04501952|365321406|FG000|Overall Study|Randomized and Never Treated|13|||
105907735|NCT04501952|365321407|FG001|Overall Study|Randomized and Never Treated|9|||
105907736|NCT03061188|365321408|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
105907737|NCT03061188|365321409|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
105907738|NCT03061188|365321410|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
105907739|NCT03061188|365321411|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
105907740|NCT03061188|365321408|FG000|On Follow-up for 3 Years|Death|0|||
105907741|NCT03061188|365321409|FG001|On Follow-up for 3 Years|Death|3|||
105907742|NCT03061188|365321410|FG002|On Follow-up for 3 Years|Death|5|||
105907743|NCT03061188|365321411|FG003|On Follow-up for 3 Years|Death|4|||
105907744|NCT03061188|365321408|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
105907745|NCT03061188|365321409|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
105907746|NCT03061188|365321410|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
105670740|NCT00818779|364458127|FG001|Overall Study|Lost to Follow-up|0|||
105670741|NCT00818779|364458126|FG000|Overall Study|Adverse Event|4|||
105670742|NCT00818779|364458127|FG001|Overall Study|Adverse Event|1|||
105670743|NCT03682302|364458128|FG000|Overall Study|Lost to Follow-up|1|||
105670744|NCT03682302|364458129|FG001|Overall Study|Lost to Follow-up|2|||
105670745|NCT03682302|364458130|FG002|Overall Study|Lost to Follow-up|0|||
105907747|NCT03061188|365321411|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
105907748|NCT02080364|365321413|FG000|Baseline Period|Protocol Violation|2|||
105907749|NCT02080364|365321414|FG001|Baseline Period|Protocol Violation|1|||
105907750|NCT02080364|365321415|FG002|Baseline Period|Protocol Violation|0|||
105907751|NCT02080364|365321416|FG003|Baseline Period|Protocol Violation|0|||
105907752|NCT02080364|365321413|FG000|Baseline Period|Other|0|||
105907753|NCT02080364|365321414|FG001|Baseline Period|Other|1|||
105907754|NCT02080364|365321415|FG002|Baseline Period|Other|1|||
105907755|NCT02080364|365321416|FG003|Baseline Period|Other|0|||
105907756|NCT02080364|365321413|FG000|Treatment Period|Adverse Event|10|||
105907757|NCT02080364|365321414|FG001|Treatment Period|Adverse Event|15|||
105907758|NCT02080364|365321415|FG002|Treatment Period|Adverse Event|11|||
105907759|NCT02080364|365321416|FG003|Treatment Period|Adverse Event|14|||
105907760|NCT02080364|365321413|FG000|Treatment Period|Lost to Follow-up|2|||
105907761|NCT02080364|365321414|FG001|Treatment Period|Lost to Follow-up|3|||
105907762|NCT02080364|365321415|FG002|Treatment Period|Lost to Follow-up|5|||
105907763|NCT02080364|365321416|FG003|Treatment Period|Lost to Follow-up|0|||
105907764|NCT02080364|365321413|FG000|Treatment Period|Protocol Violation|5|||
105907765|NCT02080364|365321414|FG001|Treatment Period|Protocol Violation|3|||
105907766|NCT02080364|365321415|FG002|Treatment Period|Protocol Violation|5|||
105907767|NCT02080364|365321416|FG003|Treatment Period|Protocol Violation|1|||
105907768|NCT02080364|365321413|FG000|Treatment Period|Withdrawal by Subject|16|||
105907769|NCT02080364|365321414|FG001|Treatment Period|Withdrawal by Subject|16|||
105907770|NCT02080364|365321415|FG002|Treatment Period|Withdrawal by Subject|15|||
105907771|NCT02080364|365321416|FG003|Treatment Period|Withdrawal by Subject|10|||
105907772|NCT02080364|365321413|FG000|Treatment Period|Study Terminated by Sponsor|0|||
105907773|NCT02080364|365321414|FG001|Treatment Period|Study Terminated by Sponsor|0|||
105907774|NCT02080364|365321415|FG002|Treatment Period|Study Terminated by Sponsor|180|||
105907775|NCT02080364|365321416|FG003|Treatment Period|Study Terminated by Sponsor|183|||
105670746|NCT03682302|364458131|FG003|Overall Study|Lost to Follow-up|1|||
105907776|NCT02080364|365321413|FG000|Treatment Period|Other|14|||
105907777|NCT02080364|365321414|FG001|Treatment Period|Other|12|||
105907778|NCT02080364|365321415|FG002|Treatment Period|Other|21|||
105907779|NCT02080364|365321416|FG003|Treatment Period|Other|16|||
105907780|NCT00685360|365321420|FG000|Overall Study|Lost to Follow-up|0|||
105907781|NCT00685360|365321421|FG001|Overall Study|Lost to Follow-up|1|||
105907782|NCT00685360|365321422|FG002|Overall Study|Lost to Follow-up|2|||
105907783|NCT00685360|365321420|FG000|Overall Study|Adverse Event|4|||
105907784|NCT00685360|365321421|FG001|Overall Study|Adverse Event|6|||
105907785|NCT00685360|365321422|FG002|Overall Study|Adverse Event|4|||
105907786|NCT00685360|365321420|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
105907787|NCT00685360|365321421|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
105907788|NCT00685360|365321422|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
105907789|NCT00685360|365321420|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
105907790|NCT00685360|365321421|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
105907791|NCT00685360|365321422|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
105907792|NCT00685360|365321420|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
105907793|NCT00685360|365321421|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
105670747|NCT03682302|364458128|FG000|Overall Study|Study drug was not administered|0|||
105670748|NCT03682302|364458129|FG001|Overall Study|Study drug was not administered|0|||
105907794|NCT00685360|365321422|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
105907795|NCT00685360|365321420|FG000|Overall Study|Protocol Deviation|0|||
105907796|NCT00685360|365321421|FG001|Overall Study|Protocol Deviation|1|||
105907797|NCT00685360|365321422|FG002|Overall Study|Protocol Deviation|1|||
105907798|NCT01843803|365321423|FG000|Overall Study|not a Veteran, did not see provider|1|||
105907799|NCT01843803|365321424|FG001|Overall Study|not a Veteran, did not see provider|3|||
105670749|NCT03682302|364458130|FG002|Overall Study|Study drug was not administered|1|||
105670750|NCT03682302|364458131|FG003|Overall Study|Study drug was not administered|1|||
105670751|NCT01036438|364458132|FG000|Overall Study|Adverse Event|7|||
105670752|NCT01036438|364458133|FG001|Overall Study|Adverse Event|8|||
105907800|NCT01408901|365321425|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
105907801|NCT01408901|365321426|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
105907802|NCT01408901|365321427|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
105907803|NCT01408901|365321428|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
105907804|NCT01408901|365321425|FG000|6-Week Follow-Up|Death|1|||
105907805|NCT01408901|365321426|FG001|6-Week Follow-Up|Death|0|||
105907806|NCT01408901|365321427|FG002|6-Week Follow-Up|Death|0|||
105907807|NCT01408901|365321428|FG003|6-Week Follow-Up|Death|0|||
105907808|NCT01408901|365321425|FG000|6-Week Follow-Up|Cancelled visit|0|||
105907809|NCT01408901|365321426|FG001|6-Week Follow-Up|Cancelled visit|1|||
105907810|NCT01408901|365321427|FG002|6-Week Follow-Up|Cancelled visit|0|||
105907811|NCT01408901|365321428|FG003|6-Week Follow-Up|Cancelled visit|2|||
105907812|NCT01408901|365321425|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
105907813|NCT01408901|365321426|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
105907814|NCT01408901|365321427|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
105907815|NCT01408901|365321428|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
105907816|NCT01408901|365321425|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
105907817|NCT01408901|365321426|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
105907818|NCT01408901|365321427|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
105907819|NCT01408901|365321428|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
105907820|NCT01408901|365321425|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
105907821|NCT01408901|365321426|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
105907822|NCT01408901|365321427|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
105907823|NCT01408901|365321428|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
105907824|NCT01408901|365321425|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
105907825|NCT01408901|365321426|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
105907826|NCT01408901|365321427|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
105907827|NCT01408901|365321428|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
105907828|NCT01408901|365321425|FG000|26-Week Follow-Up|Death|0|||
105907829|NCT01408901|365321426|FG001|26-Week Follow-Up|Death|1|||
105907830|NCT01408901|365321427|FG002|26-Week Follow-Up|Death|0|||
105907831|NCT01408901|365321428|FG003|26-Week Follow-Up|Death|0|||
105907832|NCT00547157|365321429|FG000|Overall Study|Other|1|||
105907833|NCT00547157|365321430|FG001|Overall Study|Other|0|||
105907834|NCT00547157|365321429|FG000|Overall Study|Death|38|||
105907835|NCT00547157|365321430|FG001|Overall Study|Death|18|||
105907836|NCT00547157|365321429|FG000|Overall Study|Withdrawal by Subject|3|||
105907837|NCT00547157|365321430|FG001|Overall Study|Withdrawal by Subject|1|||
105907838|NCT00547157|365321429|FG000|Overall Study|Administrative decision|3|||
105907839|NCT00547157|365321430|FG001|Overall Study|Administrative decision|2|||
105907840|NCT00547157|365321429|FG000|Overall Study|Lost to Follow-up|4|||
105907841|NCT00547157|365321430|FG001|Overall Study|Lost to Follow-up|2|||
105907842|NCT02797678|365321454|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
105907843|NCT02797678|365321455|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
105907844|NCT02797678|365321456|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
105907845|NCT02797678|365321457|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
105907846|NCT02797678|365321454|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
105907847|NCT02797678|365321455|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
105907848|NCT02797678|365321456|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
105907849|NCT02797678|365321457|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
105907850|NCT02797678|365321454|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
105907851|NCT02797678|365321455|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
105907852|NCT02797678|365321456|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
105907853|NCT02797678|365321457|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
105907854|NCT00869128|365321459|FG000|Overall Study|lack of Compliance|6|||
105670753|NCT01036438|364458132|FG000|Overall Study|Death|0|||
105907855|NCT00869128|365321460|FG001|Overall Study|lack of Compliance|6|||
105907856|NCT04039204|365321464|FG000|Overall Study|Withdrawal by Subject|0|||
105907857|NCT04039204|365321465|FG001|Overall Study|Withdrawal by Subject|2|||
105670754|NCT01036438|364458133|FG001|Overall Study|Death|1|||
105907858|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
105670755|NCT01036438|364458132|FG000|Overall Study|No effect of study treatment|3|||
105907859|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
105907860|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
105907861|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
105907862|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
105907863|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
105907864|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
105998976|NCT01114828|365657878|FG001|Overall Study|Lack of Efficacy|2|||
105670756|NCT01036438|364458133|FG001|Overall Study|No effect of study treatment|1|||
105670757|NCT01896726|364458134|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
105670758|NCT01896726|364458134|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
105670759|NCT01128114|364458135|FG000|Overall Study|Treatment Withdrawn|6|||
105670760|NCT01128114|364458135|FG000|Overall Study|Screening Failed|2|||
105670761|NCT00208325|364458139|FG000|Overall Study|Death|18|||
105670762|NCT00208325|364458140|FG001|Overall Study|Death|19|||
105670763|NCT00208325|364458141|FG002|Overall Study|Death|7|||
105670764|NCT00208325|364458142|FG003|Overall Study|Death|5|||
105670765|NCT00208325|364458139|FG000|Overall Study|Withdrawal by Subject|0|||
105670766|NCT00208325|364458140|FG001|Overall Study|Withdrawal by Subject|1|||
105670767|NCT00208325|364458141|FG002|Overall Study|Withdrawal by Subject|0|||
105670768|NCT00208325|364458142|FG003|Overall Study|Withdrawal by Subject|0|||
105670769|NCT00208325|364458139|FG000|Overall Study|Revision|4|||
105670770|NCT00208325|364458140|FG001|Overall Study|Revision|1|||
105670771|NCT00208325|364458141|FG002|Overall Study|Revision|0|||
105670772|NCT00208325|364458142|FG003|Overall Study|Revision|4|||
105670773|NCT00208325|364458139|FG000|Overall Study|Lost to Follow-up|1|||
105670774|NCT00208325|364458140|FG001|Overall Study|Lost to Follow-up|0|||
105670775|NCT00208325|364458141|FG002|Overall Study|Lost to Follow-up|2|||
105670776|NCT00208325|364458142|FG003|Overall Study|Lost to Follow-up|0|||
105670777|NCT00208325|364458139|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
105670778|NCT00208325|364458140|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
105670779|NCT00208325|364458141|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
105670780|NCT00208325|364458142|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
105670781|NCT00208325|364458139|FG000|Overall Study|Does not wish to Continue in Study|5|||
105670782|NCT00208325|364458140|FG001|Overall Study|Does not wish to Continue in Study|8|||
105670783|NCT00208325|364458141|FG002|Overall Study|Does not wish to Continue in Study|3|||
105670784|NCT00208325|364458142|FG003|Overall Study|Does not wish to Continue in Study|2|||
105670785|NCT00208325|364458139|FG000|Overall Study|Other|2|||
105670786|NCT00208325|364458140|FG001|Overall Study|Other|1|||
105670787|NCT00208325|364458141|FG002|Overall Study|Other|1|||
105670788|NCT00208325|364458142|FG003|Overall Study|Other|0|||
105670789|NCT00208325|364458139|FG000|Overall Study|Mis-Randomized|17|||
105670790|NCT00208325|364458140|FG001|Overall Study|Mis-Randomized|20|||
105670791|NCT00208325|364458141|FG002|Overall Study|Mis-Randomized|0|||
105670792|NCT00208325|364458142|FG003|Overall Study|Mis-Randomized|0|||
105670793|NCT01327846|364458143|FG000|Core Phase|Subject decision (vital status: missing)|1|||
105670794|NCT01327846|364458144|FG001|Core Phase|Subject decision (vital status: missing)|2|||
105670795|NCT01327846|364458145|FG002|Core Phase|Subject decision (vital status: missing)|2|||
105670796|NCT01327846|364458146|FG003|Core Phase|Subject decision (vital status: missing)|1|||
105670797|NCT01327846|364458143|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
105670798|NCT01327846|364458144|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
105670799|NCT01327846|364458145|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
105670800|NCT01327846|364458146|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
105670801|NCT01327846|364458143|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
105670802|NCT01327846|364458144|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
105670803|NCT01327846|364458145|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
105670804|NCT01327846|364458146|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
105670805|NCT01327846|364458143|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
105670806|NCT01327846|364458144|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
105670807|NCT01327846|364458145|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
105670808|NCT01327846|364458146|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
105670809|NCT01327846|364458143|FG000|Core Phase|Lost to Follow-up|3|||
105670810|NCT01327846|364458144|FG001|Core Phase|Lost to Follow-up|3|||
105907865|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
105907866|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
105907867|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
105907868|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
105907869|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
105907870|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
105907871|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
105907872|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
105907873|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
105907874|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
105907875|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
105907876|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
105670811|NCT01327846|364458145|FG002|Core Phase|Lost to Follow-up|4|||
105670812|NCT01327846|364458146|FG003|Core Phase|Lost to Follow-up|5|||
105670813|NCT01327846|364458143|FG000|Extension Phase|Study terminated by sponsor|1073|||
105670814|NCT01327846|364458144|FG001|Extension Phase|Study terminated by sponsor|1124|||
105670815|NCT01327846|364458145|FG002|Extension Phase|Study terminated by sponsor|1067|||
105670816|NCT01327846|364458146|FG003|Extension Phase|Study terminated by sponsor|1660|||
105670817|NCT01327846|364458143|FG000|Extension Phase|Withdrawal by Subject|20|||
105670818|NCT01327846|364458144|FG001|Extension Phase|Withdrawal by Subject|13|||
105670819|NCT01327846|364458145|FG002|Extension Phase|Withdrawal by Subject|19|||
105670820|NCT01327846|364458146|FG003|Extension Phase|Withdrawal by Subject|37|||
105670821|NCT01327846|364458143|FG000|Extension Phase|Lost to Follow-up|4|||
105670822|NCT01327846|364458144|FG001|Extension Phase|Lost to Follow-up|3|||
105670823|NCT01327846|364458145|FG002|Extension Phase|Lost to Follow-up|4|||
105670824|NCT01327846|364458146|FG003|Extension Phase|Lost to Follow-up|7|||
105670825|NCT01327846|364458143|FG000|Extension Phase|Technical Problems|2|||
105670826|NCT01327846|364458144|FG001|Extension Phase|Technical Problems|4|||
105670827|NCT01327846|364458145|FG002|Extension Phase|Technical Problems|2|||
105670828|NCT01327846|364458146|FG003|Extension Phase|Technical Problems|2|||
105670829|NCT01989169|364458149|FG000|Period 2|Adverse Event|0|||
105670830|NCT01989169|364458150|FG001|Period 2|Adverse Event|1|||
105670831|NCT00203268|364458151|FG000|Early Treatment|only treated one headache|2|||
105670832|NCT00203268|364458151|FG000|Early Treatment|Lost to Follow-up|1|||
105670833|NCT00203268|364458151|FG000|Early Treatment|Withdrawal by Subject|1|||
105670834|NCT00846807|364458152|FG000|Overall Study|Adverse Event|270|||
105670835|NCT00846807|364458152|FG000|Overall Study|Lost to Follow-up|94|||
105670836|NCT00846807|364458152|FG000|Overall Study|Withdrawal by Subject|56|||
105670837|NCT00846807|364458152|FG000|Overall Study|Non compliant with European label|7|||
105670838|NCT00846807|364458152|FG000|Overall Study|Switch to other anticoagulants|89|||
105670839|NCT00846807|364458152|FG000|Overall Study|No prescription after hospital discharge|56|||
105670840|NCT00846807|364458152|FG000|Overall Study|Other|60|||
105670841|NCT00316017|364458159|FG000|Overall Study|Protocol Violation|11|||
105670842|NCT00316017|364458160|FG001|Overall Study|Protocol Violation|13|||
105670843|NCT00316017|364458161|FG002|Overall Study|Protocol Violation|19|||
105670844|NCT02592876|364458162|FG000|Overall Study|Withdrawal by Subject|3|||
105670845|NCT02592876|364458163|FG001|Overall Study|Withdrawal by Subject|3|||
105670846|NCT02592876|364458162|FG000|Overall Study|Study Termination by Sponsor|32|||
105670847|NCT02592876|364458163|FG001|Overall Study|Study Termination by Sponsor|27|||
105670848|NCT02592876|364458162|FG000|Overall Study|Lost to Follow-up|0|||
105670849|NCT02592876|364458163|FG001|Overall Study|Lost to Follow-up|1|||
105670850|NCT02592876|364458162|FG000|Overall Study|Death|6|||
105670851|NCT02592876|364458163|FG001|Overall Study|Death|9|||
105670852|NCT01133418|364458164|FG000|Overall Study|Lost to Follow-up|5|||
105670853|NCT01133418|364458165|FG001|Overall Study|Lost to Follow-up|6|||
105670854|NCT00611975|364458166|FG000|Overall Study|Withdrawal by Subject|3|||
105670855|NCT00611975|364458167|FG001|Overall Study|Withdrawal by Subject|7|||
105670856|NCT00611975|364458166|FG000|Overall Study|Pregnancy|2|||
105670857|NCT00611975|364458167|FG001|Overall Study|Pregnancy|1|||
105670858|NCT03345576|364458172|FG000|Overall Study|Withdrawal by Subject|2|||
105670859|NCT03345576|364458173|FG001|Overall Study|Withdrawal by Subject|2|||
105670860|NCT03345576|364458172|FG000|Overall Study|Adverse Event|1|||
105670861|NCT03345576|364458173|FG001|Overall Study|Adverse Event|0|||
105670862|NCT03829501|364460514|FG000|Overall Study|Withdrawal of Consent|2|||
105670863|NCT03829501|364460515|FG001|Overall Study|Withdrawal of Consent|0|||
105670864|NCT03829501|364460516|FG002|Overall Study|Withdrawal of Consent|3|||
105670865|NCT03829501|364460517|FG003|Overall Study|Withdrawal of Consent|0|||
105670866|NCT03829501|364460518|FG004|Overall Study|Withdrawal of Consent|1|||
105670867|NCT03829501|364460519|FG005|Overall Study|Withdrawal of Consent|1|||
105670868|NCT03829501|364460520|FG006|Overall Study|Withdrawal of Consent|0|||
105670869|NCT03829501|364460521|FG007|Overall Study|Withdrawal of Consent|10|||
105670870|NCT03829501|364460522|FG008|Overall Study|Withdrawal of Consent|10|||
105670871|NCT03829501|364460523|FG009|Overall Study|Withdrawal of Consent|3|||
105670872|NCT03829501|364460524|FG010|Overall Study|Withdrawal of Consent|4|||
105670873|NCT03829501|364460525|FG011|Overall Study|Withdrawal of Consent|4|||
105670874|NCT03829501|364460526|FG012|Overall Study|Withdrawal of Consent|4|||
105670875|NCT03829501|364460527|FG013|Overall Study|Withdrawal of Consent|0|||
105670876|NCT03829501|364460528|FG014|Overall Study|Withdrawal of Consent|3|||
105670877|NCT03829501|364460529|FG015|Overall Study|Withdrawal of Consent|0|||
105670878|NCT03829501|364460530|FG016|Overall Study|Withdrawal of Consent|1|||
105670879|NCT03829501|364460531|FG017|Overall Study|Withdrawal of Consent|1|||
105670880|NCT03829501|364460532|FG018|Overall Study|Withdrawal of Consent|0|||
105670881|NCT03829501|364460533|FG019|Overall Study|Withdrawal of Consent|0|||
105670882|NCT03829501|364460534|FG020|Overall Study|Withdrawal of Consent|3|||
105670883|NCT03829501|364460535|FG021|Overall Study|Withdrawal of Consent|0|||
105670884|NCT03829501|364460536|FG022|Overall Study|Withdrawal of Consent|1|||
105670885|NCT03829501|364460514|FG000|Overall Study|PD|0|||
105670886|NCT03829501|364460515|FG001|Overall Study|PD|0|||
105670887|NCT03829501|364460516|FG002|Overall Study|PD|0|||
105670888|NCT03829501|364460517|FG003|Overall Study|PD|2|||
105670889|NCT03829501|364460518|FG004|Overall Study|PD|0|||
105670890|NCT03829501|364460519|FG005|Overall Study|PD|0|||
105670891|NCT03829501|364460520|FG006|Overall Study|PD|0|||
105670892|NCT03829501|364460521|FG007|Overall Study|PD|0|||
105670893|NCT03829501|364460522|FG008|Overall Study|PD|0|||
105670894|NCT03829501|364460523|FG009|Overall Study|PD|0|||
105670895|NCT03829501|364460524|FG010|Overall Study|PD|0|||
105670896|NCT03829501|364460525|FG011|Overall Study|PD|0|||
105670897|NCT03829501|364460526|FG012|Overall Study|PD|0|||
105670898|NCT03829501|364460527|FG013|Overall Study|PD|0|||
105670899|NCT03829501|364460528|FG014|Overall Study|PD|0|||
105670900|NCT03829501|364460529|FG015|Overall Study|PD|1|||
105670901|NCT03829501|364460530|FG016|Overall Study|PD|0|||
105670902|NCT03829501|364460531|FG017|Overall Study|PD|0|||
105670903|NCT03829501|364460532|FG018|Overall Study|PD|0|||
105670904|NCT03829501|364460533|FG019|Overall Study|PD|0|||
105670905|NCT03829501|364460534|FG020|Overall Study|PD|1|||
105670906|NCT03829501|364460535|FG021|Overall Study|PD|0|||
105670907|NCT03829501|364460536|FG022|Overall Study|PD|0|||
105670908|NCT03829501|364460514|FG000|Overall Study|Study Terminated by Sponsor|0|||
105670909|NCT03829501|364460515|FG001|Overall Study|Study Terminated by Sponsor|0|||
105670910|NCT03829501|364460516|FG002|Overall Study|Study Terminated by Sponsor|0|||
105670911|NCT03829501|364460517|FG003|Overall Study|Study Terminated by Sponsor|0|||
105670912|NCT03829501|364460518|FG004|Overall Study|Study Terminated by Sponsor|0|||
105670913|NCT03829501|364460519|FG005|Overall Study|Study Terminated by Sponsor|0|||
105670914|NCT03829501|364460520|FG006|Overall Study|Study Terminated by Sponsor|0|||
105670915|NCT03829501|364460521|FG007|Overall Study|Study Terminated by Sponsor|3|||
105670916|NCT03829501|364460522|FG008|Overall Study|Study Terminated by Sponsor|1|||
105670917|NCT03829501|364460523|FG009|Overall Study|Study Terminated by Sponsor|0|||
105670918|NCT03829501|364460524|FG010|Overall Study|Study Terminated by Sponsor|0|||
105998977|NCT01114828|365657877|FG000|Overall Study|Protocol Violation|2|||
105998978|NCT01114828|365657878|FG001|Overall Study|Protocol Violation|0|||
105998979|NCT01114828|365657877|FG000|Overall Study|Withdrawal by Subject|0|||
105998980|NCT01114828|365657878|FG001|Overall Study|Withdrawal by Subject|1|||
105998981|NCT01063153|365657879|FG000|Overall Study|Found Ineligible During Screening|2|||
105998982|NCT01063153|365657880|FG001|Overall Study|Found Ineligible During Screening|0|||
105998983|NCT01063153|365657879|FG000|Overall Study|Lost to Follow-up|0|||
105998984|NCT01063153|365657880|FG001|Overall Study|Lost to Follow-up|7|||
105998985|NCT01063153|365657879|FG000|Overall Study|Withdrawal by Subject|0|||
105998986|NCT01063153|365657880|FG001|Overall Study|Withdrawal by Subject|1|||
105998987|NCT01063153|365657879|FG000|Overall Study|Physician Decision|0|||
105998988|NCT01063153|365657880|FG001|Overall Study|Physician Decision|4|||
105998989|NCT01301833|365657881|FG000|Overall Study|Adverse Event|7|||
105998990|NCT01301833|365657882|FG001|Overall Study|Adverse Event|5|||
105998991|NCT01301833|365657883|FG002|Overall Study|Adverse Event|5|||
105998992|NCT01301833|365657884|FG003|Overall Study|Adverse Event|5|||
105998993|NCT01301833|365657881|FG000|Overall Study|Lack of Efficacy|1|||
105998994|NCT01301833|365657882|FG001|Overall Study|Lack of Efficacy|1|||
105998995|NCT01301833|365657883|FG002|Overall Study|Lack of Efficacy|0|||
105998996|NCT01301833|365657884|FG003|Overall Study|Lack of Efficacy|0|||
105998997|NCT01301833|365657881|FG000|Overall Study|Physician Decision|3|||
105998998|NCT01301833|365657882|FG001|Overall Study|Physician Decision|1|||
105998999|NCT01301833|365657883|FG002|Overall Study|Physician Decision|1|||
105999000|NCT01301833|365657884|FG003|Overall Study|Physician Decision|0|||
105999001|NCT01301833|365657881|FG000|Overall Study|Withdrawal by Subject|3|||
105999002|NCT01301833|365657882|FG001|Overall Study|Withdrawal by Subject|1|||
105999003|NCT01301833|365657883|FG002|Overall Study|Withdrawal by Subject|1|||
105999004|NCT01301833|365657884|FG003|Overall Study|Withdrawal by Subject|2|||
105999005|NCT01301833|365657881|FG000|Overall Study|Personal matter|1|||
105999006|NCT01301833|365657882|FG001|Overall Study|Personal matter|0|||
105999007|NCT01301833|365657883|FG002|Overall Study|Personal matter|0|||
105999008|NCT01301833|365657884|FG003|Overall Study|Personal matter|0|||
105999009|NCT03449758|365659356|FG000|Overall Study|Major protocol deviation|1|||
105999010|NCT03449758|365659356|FG000|Overall Study|Treatment inefficacy|5|||
105999011|NCT03449758|365659356|FG000|Overall Study|Adverse Event|9|||
105999012|NCT03449758|365659356|FG000|Overall Study|Consent withdrawal|1|||
105999013|NCT03449758|365659356|FG000|Overall Study|Other unspecified reason|3|||
105999014|NCT00859547|365659359|FG000|Overall Study|Lost to Follow-up|1|||
105670919|NCT03829501|364460525|FG011|Overall Study|Study Terminated by Sponsor|0|||
105670920|NCT03829501|364460526|FG012|Overall Study|Study Terminated by Sponsor|0|||
105670921|NCT03829501|364460527|FG013|Overall Study|Study Terminated by Sponsor|0|||
105999015|NCT00859547|365659359|FG000|Overall Study|Parent withdrew consent|1|||
105999016|NCT01276639|365659362|FG000|Week 0 to 16|Death|1|||
105999017|NCT01276639|365659363|FG001|Week 0 to 16|Death|0|||
105999018|NCT01276639|365659364|FG002|Week 0 to 16|Death|0|||
105999019|NCT01276639|365659365|FG003|Week 0 to 16|Death|0|||
105999020|NCT01276639|365659366|FG004|Week 0 to 16|Death|0|||
105999021|NCT01276639|365659362|FG000|Week 0 to 16|Adverse Event|11|||
105670922|NCT03829501|364460528|FG014|Overall Study|Study Terminated by Sponsor|3|||
105999022|NCT01276639|365659363|FG001|Week 0 to 16|Adverse Event|8|||
105670923|NCT03829501|364460529|FG015|Overall Study|Study Terminated by Sponsor|2|||
105670924|NCT03829501|364460530|FG016|Overall Study|Study Terminated by Sponsor|2|||
105670925|NCT03829501|364460531|FG017|Overall Study|Study Terminated by Sponsor|0|||
105670926|NCT03829501|364460532|FG018|Overall Study|Study Terminated by Sponsor|0|||
105670927|NCT03829501|364460533|FG019|Overall Study|Study Terminated by Sponsor|0|||
105670928|NCT03829501|364460534|FG020|Overall Study|Study Terminated by Sponsor|1|||
105999023|NCT01276639|365659364|FG002|Week 0 to 16|Adverse Event|11|||
105999024|NCT01276639|365659365|FG003|Week 0 to 16|Adverse Event|0|||
105999025|NCT01276639|365659366|FG004|Week 0 to 16|Adverse Event|0|||
105999026|NCT01276639|365659362|FG000|Week 0 to 16|Lack of Efficacy|20|||
105999027|NCT01276639|365659363|FG001|Week 0 to 16|Lack of Efficacy|15|||
105999028|NCT01276639|365659364|FG002|Week 0 to 16|Lack of Efficacy|25|||
105999029|NCT01276639|365659365|FG003|Week 0 to 16|Lack of Efficacy|0|||
105670929|NCT03829501|364460535|FG021|Overall Study|Study Terminated by Sponsor|0|||
105670930|NCT03829501|364460536|FG022|Overall Study|Study Terminated by Sponsor|3|||
105670931|NCT03829501|364460514|FG000|Overall Study|Lost to Follow Up|0|||
105999030|NCT01276639|365659366|FG004|Week 0 to 16|Lack of Efficacy|0|||
105999031|NCT01276639|365659362|FG000|Week 0 to 16|Lost to Follow-up|3|||
105999032|NCT01276639|365659363|FG001|Week 0 to 16|Lost to Follow-up|5|||
105670932|NCT03829501|364460515|FG001|Overall Study|Lost to Follow Up|0|||
105670933|NCT03829501|364460516|FG002|Overall Study|Lost to Follow Up|0|||
105999033|NCT01276639|365659364|FG002|Week 0 to 16|Lost to Follow-up|3|||
105999034|NCT01276639|365659365|FG003|Week 0 to 16|Lost to Follow-up|0|||
105670934|NCT03829501|364460517|FG003|Overall Study|Lost to Follow Up|0|||
105670935|NCT03829501|364460518|FG004|Overall Study|Lost to Follow Up|1|||
105670936|NCT03829501|364460519|FG005|Overall Study|Lost to Follow Up|0|||
105670937|NCT03829501|364460520|FG006|Overall Study|Lost to Follow Up|0|||
105670938|NCT03829501|364460521|FG007|Overall Study|Lost to Follow Up|2|||
105670939|NCT03829501|364460522|FG008|Overall Study|Lost to Follow Up|2|||
105670940|NCT03829501|364460523|FG009|Overall Study|Lost to Follow Up|0|||
105670941|NCT03829501|364460524|FG010|Overall Study|Lost to Follow Up|2|||
105670942|NCT03829501|364460525|FG011|Overall Study|Lost to Follow Up|1|||
105670943|NCT03829501|364460526|FG012|Overall Study|Lost to Follow Up|0|||
105670944|NCT03829501|364460527|FG013|Overall Study|Lost to Follow Up|1|||
105670945|NCT03829501|364460528|FG014|Overall Study|Lost to Follow Up|1|||
105670946|NCT03829501|364460529|FG015|Overall Study|Lost to Follow Up|0|||
105670947|NCT03829501|364460530|FG016|Overall Study|Lost to Follow Up|0|||
105670948|NCT03829501|364460531|FG017|Overall Study|Lost to Follow Up|0|||
105670949|NCT03829501|364460532|FG018|Overall Study|Lost to Follow Up|0|||
105670950|NCT03829501|364460533|FG019|Overall Study|Lost to Follow Up|0|||
105670951|NCT03829501|364460534|FG020|Overall Study|Lost to Follow Up|0|||
105670952|NCT03829501|364460535|FG021|Overall Study|Lost to Follow Up|0|||
105670953|NCT03829501|364460536|FG022|Overall Study|Lost to Follow Up|1|||
105670954|NCT03829501|364460514|FG000|Overall Study|Death|2|||
105670955|NCT03829501|364460515|FG001|Overall Study|Death|4|||
105670956|NCT03829501|364460516|FG002|Overall Study|Death|5|||
105670957|NCT03829501|364460517|FG003|Overall Study|Death|6|||
105670958|NCT03829501|364460518|FG004|Overall Study|Death|5|||
105670959|NCT03829501|364460519|FG005|Overall Study|Death|4|||
105670960|NCT03829501|364460520|FG006|Overall Study|Death|5|||
105999035|NCT01276639|365659366|FG004|Week 0 to 16|Lost to Follow-up|0|||
105999036|NCT01276639|365659362|FG000|Week 0 to 16|Withdrawal by Subject|8|||
105999037|NCT01276639|365659363|FG001|Week 0 to 16|Withdrawal by Subject|5|||
105999038|NCT01276639|365659364|FG002|Week 0 to 16|Withdrawal by Subject|4|||
105999039|NCT01276639|365659365|FG003|Week 0 to 16|Withdrawal by Subject|0|||
105999040|NCT01276639|365659366|FG004|Week 0 to 16|Withdrawal by Subject|0|||
105999041|NCT01276639|365659362|FG000|Week 0 to 16|Other|7|||
105999042|NCT01276639|365659363|FG001|Week 0 to 16|Other|7|||
105999043|NCT01276639|365659364|FG002|Week 0 to 16|Other|2|||
105999044|NCT01276639|365659365|FG003|Week 0 to 16|Other|0|||
105999045|NCT01276639|365659366|FG004|Week 0 to 16|Other|0|||
105999046|NCT01276639|365659362|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
105999047|NCT01276639|365659363|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
105999048|NCT01276639|365659364|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
105999049|NCT01276639|365659365|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
105999050|NCT01276639|365659366|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
105999051|NCT01276639|365659362|FG000|Week 16 to 52|Death|1|||
105999052|NCT01276639|365659363|FG001|Week 16 to 52|Death|0|||
105999053|NCT01276639|365659364|FG002|Week 16 to 52|Death|0|||
105999054|NCT01276639|365659365|FG003|Week 16 to 52|Death|0|||
105999055|NCT01276639|365659366|FG004|Week 16 to 52|Death|0|||
105999056|NCT01276639|365659362|FG000|Week 16 to 52|Adverse Event|10|||
105999057|NCT01276639|365659363|FG001|Week 16 to 52|Adverse Event|13|||
105999058|NCT01276639|365659364|FG002|Week 16 to 52|Adverse Event|0|||
105999059|NCT01276639|365659365|FG003|Week 16 to 52|Adverse Event|1|||
105999060|NCT01276639|365659366|FG004|Week 16 to 52|Adverse Event|3|||
105999061|NCT01276639|365659362|FG000|Week 16 to 52|Lack of Efficacy|99|||
105999062|NCT01276639|365659363|FG001|Week 16 to 52|Lack of Efficacy|71|||
105999063|NCT01276639|365659364|FG002|Week 16 to 52|Lack of Efficacy|0|||
105670961|NCT03829501|364460521|FG007|Overall Study|Death|24|||
105670962|NCT03829501|364460522|FG008|Overall Study|Death|22|||
105670963|NCT03829501|364460523|FG009|Overall Study|Death|6|||
105670964|NCT03829501|364460524|FG010|Overall Study|Death|3|||
105670965|NCT03829501|364460525|FG011|Overall Study|Death|10|||
105670966|NCT03829501|364460526|FG012|Overall Study|Death|10|||
105670967|NCT03829501|364460527|FG013|Overall Study|Death|5|||
105670968|NCT03829501|364460528|FG014|Overall Study|Death|7|||
105670969|NCT03829501|364460529|FG015|Overall Study|Death|2|||
105670970|NCT03829501|364460530|FG016|Overall Study|Death|2|||
105907877|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
105907878|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
105907879|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
105907880|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
105907881|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
105907882|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
105907883|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
105907884|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
105907885|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
105907886|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
105907887|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
105907888|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
105907889|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
105907890|NCT03538691|365321466|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
105907891|NCT03538691|365321467|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
105907892|NCT03538691|365321468|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
105907893|NCT03538691|365321469|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
105907894|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
105907895|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
105907896|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
105907897|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
105907898|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
105907899|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
105907900|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
105907901|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
105907902|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
105907903|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
105907904|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
105907905|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
105907906|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
105907907|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
105907908|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
105907909|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
105907910|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
105907911|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
105907912|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
105907913|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
105907914|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
105907915|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
105907916|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
105907917|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
105907918|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
105907919|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
105907920|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
105907921|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
105907922|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
105907923|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
105907924|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
105907925|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
105907926|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
105907927|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
105907928|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
105907929|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
105907930|NCT03538691|365321466|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105907931|NCT03538691|365321467|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
105907932|NCT03538691|365321468|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105907933|NCT03538691|365321469|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105907934|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
105907935|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
105907936|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
106125626|NCT01058863|366117841|FG000|Overall Study|Randomized in error|1|||
105907937|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
105907938|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
105907939|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
105907940|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
105907941|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
105999064|NCT01276639|365659365|FG003|Week 16 to 52|Lack of Efficacy|14|||
105999065|NCT01276639|365659366|FG004|Week 16 to 52|Lack of Efficacy|13|||
105999066|NCT01276639|365659362|FG000|Week 16 to 52|Lost to Follow-up|3|||
105907942|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
105907943|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
105907944|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
105907945|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
105907946|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
105907947|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
105907948|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
105907949|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
105907950|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
105907951|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
105907952|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
105907953|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
105907954|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
105907955|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
105907956|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
105907957|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
105907958|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
105907959|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
105907960|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
105907961|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
105907962|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
105907963|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
105907964|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
105907965|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
105907966|NCT03538691|365321466|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105907967|NCT03538691|365321467|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
105907968|NCT03538691|365321468|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
105907969|NCT03538691|365321469|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
105907970|NCT00255164|365321470|FG000|Overall Study|Adverse Event|10|||
105907971|NCT00255164|365321471|FG001|Overall Study|Adverse Event|6|||
105907972|NCT00255164|365321472|FG002|Overall Study|Adverse Event|9|||
105907973|NCT00255164|365321470|FG000|Overall Study|Lost to Follow-up|4|||
105907974|NCT00255164|365321471|FG001|Overall Study|Lost to Follow-up|3|||
105907975|NCT00255164|365321472|FG002|Overall Study|Lost to Follow-up|4|||
105907976|NCT00255164|365321470|FG000|Overall Study|Withdrawal by Subject|18|||
105907977|NCT00255164|365321471|FG001|Overall Study|Withdrawal by Subject|17|||
105907978|NCT00255164|365321472|FG002|Overall Study|Withdrawal by Subject|8|||
105907979|NCT00255164|365321470|FG000|Overall Study|Noncompliance|0|||
105907980|NCT00255164|365321471|FG001|Overall Study|Noncompliance|1|||
105907981|NCT00255164|365321472|FG002|Overall Study|Noncompliance|2|||
105907982|NCT00255164|365321470|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
105907983|NCT00255164|365321471|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
105907984|NCT00255164|365321472|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
105907985|NCT00255164|365321470|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
105907986|NCT00255164|365321471|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
105907987|NCT00255164|365321472|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
105907988|NCT00255164|365321470|FG000|Overall Study|Possible Barrett's Esophagus|1|||
105907989|NCT00255164|365321471|FG001|Overall Study|Possible Barrett's Esophagus|3|||
105907990|NCT00255164|365321472|FG002|Overall Study|Possible Barrett's Esophagus|8|||
105907991|NCT00255164|365321470|FG000|Overall Study|Esophageal Stricture|0|||
105907992|NCT00255164|365321471|FG001|Overall Study|Esophageal Stricture|0|||
105907993|NCT00255164|365321472|FG002|Overall Study|Esophageal Stricture|1|||
105907994|NCT00255164|365321470|FG000|Overall Study|Therapeutic Failure|11|||
105907995|NCT00255164|365321471|FG001|Overall Study|Therapeutic Failure|2|||
105907996|NCT00255164|365321472|FG002|Overall Study|Therapeutic Failure|3|||
105907997|NCT00565604|365321474|FG000|Overall Study|Failure to treat|2|||
105907998|NCT00565604|365321474|FG000|Overall Study|Lost to Follow-up|2|||
105907999|NCT04265261|365321475|FG000|Overall Study|Adverse Event|2|||
105908000|NCT04265261|365321476|FG001|Overall Study|Adverse Event|0|||
105908001|NCT04265261|365321477|FG002|Overall Study|Adverse Event|0|||
105908002|NCT04265261|365321475|FG000|Overall Study|Death|1|||
105908003|NCT04265261|365321476|FG001|Overall Study|Death|0|||
105908004|NCT04265261|365321477|FG002|Overall Study|Death|0|||
105908005|NCT04265261|365321475|FG000|Overall Study|Lost to Follow-up|4|||
105908006|NCT04265261|365321476|FG001|Overall Study|Lost to Follow-up|1|||
105670971|NCT03829501|364460531|FG017|Overall Study|Death|1|||
105670972|NCT03829501|364460532|FG018|Overall Study|Death|1|||
105670973|NCT03829501|364460533|FG019|Overall Study|Death|1|||
105670974|NCT03829501|364460534|FG020|Overall Study|Death|1|||
105670975|NCT03829501|364460535|FG021|Overall Study|Death|2|||
105670976|NCT03829501|364460536|FG022|Overall Study|Death|3|||
105670977|NCT03829501|364460514|FG000|Overall Study|Miscellaneous|0|||
105670978|NCT03829501|364460515|FG001|Overall Study|Miscellaneous|0|||
105670979|NCT03829501|364460516|FG002|Overall Study|Miscellaneous|1|||
105670980|NCT03829501|364460517|FG003|Overall Study|Miscellaneous|0|||
105670981|NCT03829501|364460518|FG004|Overall Study|Miscellaneous|0|||
105670982|NCT03829501|364460519|FG005|Overall Study|Miscellaneous|0|||
105670983|NCT03829501|364460520|FG006|Overall Study|Miscellaneous|0|||
105670984|NCT03829501|364460521|FG007|Overall Study|Miscellaneous|1|||
105670985|NCT03829501|364460522|FG008|Overall Study|Miscellaneous|0|||
105670986|NCT03829501|364460523|FG009|Overall Study|Miscellaneous|0|||
105670987|NCT03829501|364460524|FG010|Overall Study|Miscellaneous|0|||
105670988|NCT03829501|364460525|FG011|Overall Study|Miscellaneous|0|||
105670989|NCT03829501|364460526|FG012|Overall Study|Miscellaneous|0|||
105670990|NCT03829501|364460527|FG013|Overall Study|Miscellaneous|0|||
105670991|NCT03829501|364460528|FG014|Overall Study|Miscellaneous|0|||
105670992|NCT03829501|364460529|FG015|Overall Study|Miscellaneous|0|||
105670993|NCT03829501|364460530|FG016|Overall Study|Miscellaneous|0|||
105670994|NCT03829501|364460531|FG017|Overall Study|Miscellaneous|0|||
105670995|NCT03829501|364460532|FG018|Overall Study|Miscellaneous|0|||
105670996|NCT03829501|364460533|FG019|Overall Study|Miscellaneous|0|||
105999067|NCT01276639|365659363|FG001|Week 16 to 52|Lost to Follow-up|1|||
105999068|NCT01276639|365659364|FG002|Week 16 to 52|Lost to Follow-up|0|||
105999069|NCT01276639|365659365|FG003|Week 16 to 52|Lost to Follow-up|0|||
105999070|NCT01276639|365659366|FG004|Week 16 to 52|Lost to Follow-up|1|||
105999071|NCT01276639|365659362|FG000|Week 16 to 52|Withdrawal by Subject|4|||
105999072|NCT01276639|365659363|FG001|Week 16 to 52|Withdrawal by Subject|4|||
105999073|NCT01276639|365659364|FG002|Week 16 to 52|Withdrawal by Subject|0|||
105670997|NCT03829501|364460534|FG020|Overall Study|Miscellaneous|0|||
105908007|NCT04265261|365321477|FG002|Overall Study|Lost to Follow-up|3|||
105908008|NCT04265261|365321475|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105908009|NCT04265261|365321476|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105908010|NCT04265261|365321477|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105908011|NCT04265261|365321475|FG000|Overall Study|Physician Decision|0|||
105999074|NCT01276639|365659365|FG003|Week 16 to 52|Withdrawal by Subject|0|||
105999075|NCT01276639|365659366|FG004|Week 16 to 52|Withdrawal by Subject|1|||
105999076|NCT01276639|365659362|FG000|Week 16 to 52|Other|10|||
105999077|NCT01276639|365659363|FG001|Week 16 to 52|Other|12|||
105999078|NCT01276639|365659364|FG002|Week 16 to 52|Other|0|||
105999079|NCT01276639|365659365|FG003|Week 16 to 52|Other|1|||
105999080|NCT01276639|365659366|FG004|Week 16 to 52|Other|3|||
105999081|NCT00936702|365659368|FG000|Overall Study|Disease progression|34|||
105999082|NCT00936702|365659368|FG000|Overall Study|Adverse Event|8|||
105999083|NCT00936702|365659368|FG000|Overall Study|Withdrawal by Subject|2|||
105908012|NCT04265261|365321476|FG001|Overall Study|Physician Decision|0|||
105908013|NCT04265261|365321477|FG002|Overall Study|Physician Decision|1|||
105908014|NCT04265261|365321475|FG000|Overall Study|Protocol Deviation|0|||
105908015|NCT04265261|365321476|FG001|Overall Study|Protocol Deviation|2|||
105908016|NCT04265261|365321477|FG002|Overall Study|Protocol Deviation|0|||
105908017|NCT04265261|365321475|FG000|Overall Study|Withdrawal by Subject|2|||
105908018|NCT04265261|365321476|FG001|Overall Study|Withdrawal by Subject|1|||
105908019|NCT04265261|365321477|FG002|Overall Study|Withdrawal by Subject|4|||
105908020|NCT03877224|365321478|FG000|Overall Study|Death|3|||
105908021|NCT03877224|365321479|FG001|Overall Study|Death|2|||
105908022|NCT03877224|365321478|FG000|Overall Study|Withdrawal by Subject|1|||
105908023|NCT03877224|365321479|FG001|Overall Study|Withdrawal by Subject|6|||
105908024|NCT03877224|365321478|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
105908025|NCT03877224|365321479|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
105999084|NCT00936702|365659368|FG000|Overall Study|Alternative Treatment|1|||
105999085|NCT00936702|365659368|FG000|Overall Study|Other|1|||
105670998|NCT03829501|364460535|FG021|Overall Study|Miscellaneous|0|||
105670999|NCT03829501|364460536|FG022|Overall Study|Miscellaneous|1|||
105999086|NCT02532465|365659369|FG000|Overall Study|Protocol Violation|1|||
105999087|NCT02532465|365659370|FG001|Overall Study|Protocol Violation|0|||
105999088|NCT02532465|365659369|FG000|Overall Study|Lack of Efficacy|0|||
105671000|NCT00747227|364460537|FG000|Overall Study|Death|3|||
105671001|NCT00747227|364460538|FG001|Overall Study|Death|1|||
105908026|NCT00447902|365321480|FG000|Overall Study|Adverse Event|0|||
105908027|NCT00447902|365321481|FG001|Overall Study|Adverse Event|3|||
105671002|NCT00747227|364460537|FG000|Overall Study|Withdrawal by Subject|1|||
105671003|NCT00747227|364460538|FG001|Overall Study|Withdrawal by Subject|0|||
105671004|NCT00747227|364460537|FG000|Overall Study|Lost to Follow-up|1|||
105671005|NCT00747227|364460538|FG001|Overall Study|Lost to Follow-up|2|||
105671006|NCT00747227|364460537|FG000|Overall Study|Illness|1|||
105671007|NCT00747227|364460538|FG001|Overall Study|Illness|1|||
105908028|NCT00447902|365321480|FG000|Overall Study|Protocol Violation|1|||
105908029|NCT00447902|365321481|FG001|Overall Study|Protocol Violation|0|||
105908030|NCT00447902|365321480|FG000|Overall Study|Withdrawal by Subject|0|||
105908031|NCT00447902|365321481|FG001|Overall Study|Withdrawal by Subject|1|||
105908032|NCT00447902|365321480|FG000|Overall Study|included patients who discontinued|1|||
105908033|NCT00447902|365321481|FG001|Overall Study|included patients who discontinued|1|||
105908034|NCT00447902|365321480|FG000|Overall Study|Lack of Efficacy|2|||
105908035|NCT00447902|365321481|FG001|Overall Study|Lack of Efficacy|1|||
105908036|NCT02526160|365323471|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
105908037|NCT02526160|365323472|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
105908038|NCT02526160|365323471|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
105908039|NCT02526160|365323472|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
105908040|NCT02526160|365323471|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
105908041|NCT02526160|365323472|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
105908042|NCT02526160|365323471|FG000|Open-Label Treatment Extension Period I|Death|0|||
105908043|NCT02526160|365323472|FG001|Open-Label Treatment Extension Period I|Death|1|||
105908044|NCT02526160|365323471|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
105908045|NCT02526160|365323472|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
105908046|NCT02526160|365323471|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
105908047|NCT02526160|365323472|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
105908048|NCT02526160|365323471|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
105908049|NCT02526160|365323472|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
105908050|NCT02526160|365323471|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
105908051|NCT02526160|365323472|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
105908052|NCT04378569|365323473|FG000|Overall Study|Adverse Event|0|||
105908053|NCT04378569|365323474|FG001|Overall Study|Adverse Event|0|||
105908054|NCT04378569|365323475|FG002|Overall Study|Adverse Event|2|||
105908055|NCT04378569|365323476|FG003|Overall Study|Adverse Event|0|||
105908056|NCT04378569|365323477|FG004|Overall Study|Adverse Event|3|||
105908057|NCT04378569|365323478|FG005|Overall Study|Adverse Event|3|||
105908058|NCT04378569|365323473|FG000|Overall Study|Lost to Follow-up|0|||
105908059|NCT04378569|365323474|FG001|Overall Study|Lost to Follow-up|3|||
105908060|NCT04378569|365323475|FG002|Overall Study|Lost to Follow-up|1|||
105908061|NCT04378569|365323476|FG003|Overall Study|Lost to Follow-up|0|||
105908062|NCT04378569|365323477|FG004|Overall Study|Lost to Follow-up|1|||
105908063|NCT04378569|365323478|FG005|Overall Study|Lost to Follow-up|1|||
105908064|NCT04378569|365323473|FG000|Overall Study|Protocol Violation|0|||
105908065|NCT04378569|365323474|FG001|Overall Study|Protocol Violation|0|||
105908066|NCT04378569|365323475|FG002|Overall Study|Protocol Violation|0|||
105908067|NCT04378569|365323476|FG003|Overall Study|Protocol Violation|0|||
105908068|NCT04378569|365323477|FG004|Overall Study|Protocol Violation|0|||
105908069|NCT04378569|365323478|FG005|Overall Study|Protocol Violation|1|||
105908070|NCT04378569|365323473|FG000|Overall Study|Withdrawal by Subject|0|||
105908071|NCT04378569|365323474|FG001|Overall Study|Withdrawal by Subject|6|||
105908072|NCT04378569|365323475|FG002|Overall Study|Withdrawal by Subject|7|||
105908073|NCT04378569|365323476|FG003|Overall Study|Withdrawal by Subject|4|||
105908074|NCT04378569|365323477|FG004|Overall Study|Withdrawal by Subject|5|||
105908075|NCT04378569|365323478|FG005|Overall Study|Withdrawal by Subject|4|||
105908076|NCT04378569|365323473|FG000|Overall Study|Lack of response|0|||
105908077|NCT04378569|365323474|FG001|Overall Study|Lack of response|0|||
105908078|NCT04378569|365323475|FG002|Overall Study|Lack of response|1|||
105908079|NCT04378569|365323476|FG003|Overall Study|Lack of response|0|||
105908080|NCT04378569|365323477|FG004|Overall Study|Lack of response|1|||
105671008|NCT00379288|364460545|FG000|Overall Study|Adverse Event|5|||
105671009|NCT00379288|364460546|FG001|Overall Study|Adverse Event|6|||
105671010|NCT00379288|364460547|FG002|Overall Study|Adverse Event|2|||
105671011|NCT00379288|364460548|FG003|Overall Study|Adverse Event|0|||
105671012|NCT00379288|364460545|FG000|Overall Study|Treatment Failure|0|||
105671013|NCT00379288|364460546|FG001|Overall Study|Treatment Failure|1|||
105671014|NCT00379288|364460547|FG002|Overall Study|Treatment Failure|0|||
105671015|NCT00379288|364460548|FG003|Overall Study|Treatment Failure|1|||
105671016|NCT00379288|364460545|FG000|Overall Study|Lost to Follow-up|3|||
105671017|NCT00379288|364460546|FG001|Overall Study|Lost to Follow-up|3|||
105671018|NCT00379288|364460547|FG002|Overall Study|Lost to Follow-up|2|||
105671019|NCT00379288|364460548|FG003|Overall Study|Lost to Follow-up|0|||
105671020|NCT00379288|364460545|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
105671021|NCT00379288|364460546|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
105671022|NCT00379288|364460547|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
105671023|NCT00379288|364460548|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
105671024|NCT00379288|364460545|FG000|Overall Study|Subject withdrew-related to study drug|1|||
105671025|NCT00379288|364460546|FG001|Overall Study|Subject withdrew-related to study drug|0|||
105671026|NCT00379288|364460547|FG002|Overall Study|Subject withdrew-related to study drug|0|||
105671027|NCT00379288|364460548|FG003|Overall Study|Subject withdrew-related to study drug|1|||
105671028|NCT00379288|364460545|FG000|Overall Study|Noncompliance with protocol|8|||
105786199|NCT00972309|364870477|FG000|Overall Study|Switched to alternative treatment|0|||
105786200|NCT00972309|364870478|FG001|Overall Study|Switched to alternative treatment|2|||
105908081|NCT04378569|365323478|FG005|Overall Study|Lack of response|1|||
105908082|NCT01962948|365323479|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
105908083|NCT01962948|365323480|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
105908084|NCT01962948|365323481|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
105908085|NCT01962948|365323482|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
105908086|NCT01844817|365323483|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
105908087|NCT01844817|365323484|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
105908088|NCT01844817|365323483|FG000|Treatment|Progressive Disease|27|||
105908089|NCT01844817|365323484|FG001|Treatment|Progressive Disease|36|||
105908090|NCT01844817|365323483|FG000|Treatment|Adverse Event|17|||
105908091|NCT01844817|365323484|FG001|Treatment|Adverse Event|9|||
105908092|NCT01844817|365323483|FG000|Treatment|Withdrawal by Subject|10|||
105908093|NCT01844817|365323484|FG001|Treatment|Withdrawal by Subject|6|||
105908094|NCT01844817|365323483|FG000|Treatment|Death|10|||
105908095|NCT01844817|365323484|FG001|Treatment|Death|8|||
105908096|NCT01844817|365323483|FG000|Treatment|Lost to Follow-up|0|||
105908097|NCT01844817|365323484|FG001|Treatment|Lost to Follow-up|1|||
105908098|NCT01844817|365323483|FG000|Treatment|Other|0|||
105908099|NCT01844817|365323484|FG001|Treatment|Other|3|||
105908100|NCT03630705|365323488|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
105908101|NCT03630705|365323489|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
105908102|NCT03630705|365323490|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
105908103|NCT03630705|365323491|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105908104|NCT03630705|365323488|FG000|Overall Study|Lost to Follow-up|1|||
105908105|NCT03630705|365323489|FG001|Overall Study|Lost to Follow-up|2|||
105908106|NCT03630705|365323490|FG002|Overall Study|Lost to Follow-up|0|||
105908107|NCT03630705|365323491|FG003|Overall Study|Lost to Follow-up|0|||
105908108|NCT03654729|365323494|FG000|Overall Study|Death|9|||
105908109|NCT03654729|365323495|FG001|Overall Study|Death|9|||
105908110|NCT03654729|365323496|FG002|Overall Study|Death|16|||
105908111|NCT03654729|365323494|FG000|Overall Study|Withdrawal by Subject|8|||
105908112|NCT03654729|365323495|FG001|Overall Study|Withdrawal by Subject|6|||
105908113|NCT03654729|365323496|FG002|Overall Study|Withdrawal by Subject|4|||
105908114|NCT03654729|365323494|FG000|Overall Study|Study terminated by Sponsor|3|||
105908115|NCT03654729|365323495|FG001|Overall Study|Study terminated by Sponsor|5|||
105908116|NCT03654729|365323496|FG002|Overall Study|Study terminated by Sponsor|4|||
105908117|NCT03654729|365323494|FG000|Overall Study|Not reported|2|||
105908118|NCT03654729|365323495|FG001|Overall Study|Not reported|4|||
105908119|NCT03654729|365323496|FG002|Overall Study|Not reported|5|||
105908120|NCT03654729|365323494|FG000|Overall Study|Progressive disease|3|||
105908121|NCT03654729|365323495|FG001|Overall Study|Progressive disease|0|||
105908122|NCT03654729|365323496|FG002|Overall Study|Progressive disease|0|||
105908123|NCT03654729|365323494|FG000|Overall Study|Lost to Follow-up|2|||
105908124|NCT03654729|365323495|FG001|Overall Study|Lost to Follow-up|0|||
105908125|NCT03654729|365323496|FG002|Overall Study|Lost to Follow-up|0|||
105908126|NCT03654729|365323494|FG000|Overall Study|Physician Decision|2|||
105908127|NCT03654729|365323495|FG001|Overall Study|Physician Decision|0|||
105908128|NCT03654729|365323496|FG002|Overall Study|Physician Decision|0|||
105908129|NCT03654729|365323494|FG000|Overall Study|Protocol Violation|1|||
105908130|NCT03654729|365323495|FG001|Overall Study|Protocol Violation|1|||
105671029|NCT00379288|364460546|FG001|Overall Study|Noncompliance with protocol|6|||
105671030|NCT00379288|364460547|FG002|Overall Study|Noncompliance with protocol|2|||
105671031|NCT00379288|364460548|FG003|Overall Study|Noncompliance with protocol|1|||
105999089|NCT02532465|365659370|FG001|Overall Study|Lack of Efficacy|1|||
105999090|NCT01272232|365659379|FG000|Weeks 0-56|Adverse Event|39|||
105999091|NCT01272232|365659380|FG001|Weeks 0-56|Adverse Event|18|||
105999092|NCT01272232|365659381|FG002|Weeks 0-56|Adverse Event|7|||
105999093|NCT01272232|365659379|FG000|Weeks 0-56|Lack of Efficacy|0|||
105999094|NCT01272232|365659380|FG001|Weeks 0-56|Lack of Efficacy|0|||
105999095|NCT01272232|365659381|FG002|Weeks 0-56|Lack of Efficacy|3|||
105999096|NCT01272232|365659379|FG000|Weeks 0-56|Protocol Violation|12|||
105999097|NCT01272232|365659380|FG001|Weeks 0-56|Protocol Violation|8|||
105999098|NCT01272232|365659381|FG002|Weeks 0-56|Protocol Violation|13|||
105999099|NCT01272232|365659379|FG000|Weeks 0-56|Withdrawal criteria|32|||
105999100|NCT01272232|365659380|FG001|Weeks 0-56|Withdrawal criteria|14|||
105999101|NCT01272232|365659381|FG002|Weeks 0-56|Withdrawal criteria|37|||
105999102|NCT01272232|365659379|FG000|Weeks 0-56|Unclassified|16|||
105999103|NCT01272232|365659380|FG001|Weeks 0-56|Unclassified|7|||
105999104|NCT01272232|365659381|FG002|Weeks 0-56|Unclassified|12|||
105999105|NCT01272232|365659379|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
105999106|NCT01272232|365659380|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
105999107|NCT01272232|365659381|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
105999108|NCT01272232|365659379|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
105999109|NCT01272232|365659380|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
105999110|NCT01272232|365659381|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
105999111|NCT01272232|365659379|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
105999112|NCT01272232|365659380|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
105999113|NCT01272232|365659381|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
105999114|NCT01272232|365659379|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
105999115|NCT01272232|365659380|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
105999116|NCT01272232|365659381|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
105999117|NCT01272232|365659379|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
105999118|NCT01272232|365659380|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
105999119|NCT01272232|365659381|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
105999120|NCT01135134|365659382|FG000|Overall Study|Adverse Event|1|||
105999121|NCT01135134|365659383|FG001|Overall Study|Adverse Event|1|||
105999122|NCT01135134|365659382|FG000|Overall Study|Did not meet protocol eligibility|1|||
105999123|NCT01135134|365659383|FG001|Overall Study|Did not meet protocol eligibility|0|||
105999124|NCT00628030|365659386|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
105999125|NCT00628030|365659387|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
105999126|NCT00628030|365659386|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
105999127|NCT00628030|365659387|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
105999128|NCT00628030|365659386|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
105999129|NCT00628030|365659387|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
105999130|NCT04537793|365659388|FG000|Part B (24 Weeks)|Adverse Event|0|||
105999131|NCT04537793|365659389|FG001|Part B (24 Weeks)|Adverse Event|1|||
105999132|NCT00988598|365659390|FG000|Overall Study|Withdrawal by Subject|2|||
105999133|NCT00988598|365659391|FG001|Overall Study|Withdrawal by Subject|0|||
105999134|NCT03367858|365659392|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
105999135|NCT03367858|365659393|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
105999136|NCT03367858|365659392|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
105999137|NCT03367858|365659393|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
105999138|NCT03367858|365659392|FG000|3 Month Follow Up|Lost to Follow-up|8|||
105999139|NCT03367858|365659393|FG001|3 Month Follow Up|Lost to Follow-up|3|||
105999140|NCT03367858|365659392|FG000|3 Month Follow Up|Moved out of study area|2|||
105999141|NCT03367858|365659393|FG001|3 Month Follow Up|Moved out of study area|6|||
105999142|NCT03367858|365659392|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
105999143|NCT03367858|365659393|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
105999144|NCT03367858|365659392|FG000|3 Month Follow Up|MRI contraindication|2|||
105999145|NCT03367858|365659393|FG001|3 Month Follow Up|MRI contraindication|1|||
105999146|NCT03367858|365659392|FG000|3 Month Follow Up|Incarcerated|0|||
105999147|NCT03367858|365659393|FG001|3 Month Follow Up|Incarcerated|1|||
105999148|NCT03367858|365659392|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
105999149|NCT03367858|365659393|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
105999150|NCT03367858|365659392|FG000|6 Month Follow Up|Lost to Follow-up|5|||
105999151|NCT03367858|365659393|FG001|6 Month Follow Up|Lost to Follow-up|2|||
105999152|NCT03367858|365659392|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
105999153|NCT03367858|365659393|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
105999154|NCT03367858|365659392|FG000|12 Month Follow Up|Lost to Follow-up|3|||
105999155|NCT03367858|365659393|FG001|12 Month Follow Up|Lost to Follow-up|3|||
105908131|NCT03654729|365323496|FG002|Overall Study|Protocol Violation|0|||
105908132|NCT03654729|365323494|FG000|Overall Study|Non-compliance with study drug|0|||
105908133|NCT03654729|365323495|FG001|Overall Study|Non-compliance with study drug|1|||
105908134|NCT03654729|365323496|FG002|Overall Study|Non-compliance with study drug|0|||
105908135|NCT03654729|365323494|FG000|Overall Study|Site terminated by Sponsor|1|||
105908136|NCT03654729|365323495|FG001|Overall Study|Site terminated by Sponsor|0|||
105908137|NCT03654729|365323496|FG002|Overall Study|Site terminated by Sponsor|0|||
105908138|NCT04530838|365323497|FG000|Overall Study|Other|2|||
105908139|NCT04530838|365323498|FG001|Overall Study|Other|1|||
105908140|NCT04530838|365323499|FG002|Overall Study|Other|0|||
105908141|NCT04530838|365323497|FG000|Overall Study|Physician Decision|0|||
105908142|NCT04530838|365323498|FG001|Overall Study|Physician Decision|0|||
105908143|NCT04530838|365323499|FG002|Overall Study|Physician Decision|1|||
105908144|NCT04530838|365323497|FG000|Overall Study|Death|0|||
105908145|NCT04530838|365323498|FG001|Overall Study|Death|0|||
105908146|NCT04530838|365323499|FG002|Overall Study|Death|1|||
105908147|NCT04530838|365323497|FG000|Overall Study|Adverse Event|0|||
105671032|NCT00379288|364460545|FG000|Overall Study|Did not meet protocol eligibility|0|||
105671033|NCT00379288|364460546|FG001|Overall Study|Did not meet protocol eligibility|1|||
105671034|NCT00379288|364460547|FG002|Overall Study|Did not meet protocol eligibility|0|||
105671035|NCT00379288|364460548|FG003|Overall Study|Did not meet protocol eligibility|2|||
105671036|NCT00379288|364460545|FG000|Overall Study|Administrative|2|||
105671037|NCT00379288|364460546|FG001|Overall Study|Administrative|2|||
105671038|NCT00379288|364460547|FG002|Overall Study|Administrative|0|||
105671039|NCT00379288|364460548|FG003|Overall Study|Administrative|1|||
105671040|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
105671041|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
105671042|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
105671043|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
105671044|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Death|13|||
105671045|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Death|12|||
105671046|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Progression|257|||
105671047|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Progression|218|||
105671048|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
105671049|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
105671050|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
105671051|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
105671052|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
105671053|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
105908148|NCT04530838|365323498|FG001|Overall Study|Adverse Event|1|||
105908149|NCT04530838|365323499|FG002|Overall Study|Adverse Event|0|||
105908150|NCT04530838|365323497|FG000|Overall Study|No longer meets eligibility criteria|1|||
105908151|NCT04530838|365323498|FG001|Overall Study|No longer meets eligibility criteria|0|||
105908152|NCT04530838|365323499|FG002|Overall Study|No longer meets eligibility criteria|2|||
105908153|NCT04530838|365323497|FG000|Overall Study|Withdrawal by parent/guardian|5|||
105908154|NCT04530838|365323498|FG001|Overall Study|Withdrawal by parent/guardian|2|||
105908155|NCT04530838|365323499|FG002|Overall Study|Withdrawal by parent/guardian|2|||
105908156|NCT00588146|365323505|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
105908157|NCT00588146|365323506|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
105908158|NCT02501161|365323513|FG000|Overall Study|Adverse Event|2|||
105908159|NCT02501161|365323514|FG001|Overall Study|Adverse Event|6|||
105908160|NCT02501161|365323513|FG000|Overall Study|Lost to Follow-up|7|||
105908161|NCT02501161|365323514|FG001|Overall Study|Lost to Follow-up|4|||
105908162|NCT02501161|365323513|FG000|Overall Study|Withdrawal by Subject|10|||
105908163|NCT02501161|365323514|FG001|Overall Study|Withdrawal by Subject|15|||
105908164|NCT02501161|365323513|FG000|Overall Study|Other|3|||
105908165|NCT02501161|365323514|FG001|Overall Study|Other|0|||
105908166|NCT00667992|365323515|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
105671054|NCT01006980|364460549|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
105671055|NCT01006980|364460550|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
105671056|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
105999156|NCT03367858|365659392|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
105999157|NCT03367858|365659393|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
105999158|NCT01176058|365659396|FG000|Overall Study|Adverse Event|1|||
105999159|NCT01176058|365659397|FG001|Overall Study|Adverse Event|0|||
105999160|NCT01176058|365659396|FG000|Overall Study|Insufficient clinical response|2|||
105999161|NCT01176058|365659397|FG001|Overall Study|Insufficient clinical response|2|||
105908167|NCT00667992|365323516|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
105908168|NCT00667992|365323515|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
105908169|NCT00667992|365323516|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
105908170|NCT00667992|365323515|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
105908171|NCT00667992|365323516|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
105999162|NCT01176058|365659396|FG000|Overall Study|Insufficient mycological response|0|||
105908172|NCT00667992|365323515|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
105999163|NCT01176058|365659397|FG001|Overall Study|Insufficient mycological response|1|||
105999164|NCT01176058|365659396|FG000|Overall Study|Withdrawal by Subject|1|||
105999165|NCT01176058|365659397|FG001|Overall Study|Withdrawal by Subject|0|||
105999166|NCT00256724|365659398|FG000|Overall Study|Physician Decision|2|||
105999167|NCT00256724|365659399|FG001|Overall Study|Physician Decision|5|||
105999168|NCT00256724|365659398|FG000|Overall Study|Protocol Violation|3|||
105999169|NCT00256724|365659399|FG001|Overall Study|Protocol Violation|3|||
105999170|NCT00057863|365659407|FG000|Overall Study|Death|1|||
105999171|NCT00057863|365659407|FG000|Overall Study|Withdrawal by Subject|2|||
105999172|NCT01521507|365659408|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
105999173|NCT01521507|365659409|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
105999174|NCT01521507|365659408|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
105999175|NCT01521507|365659409|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
105999176|NCT01521507|365659408|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
105999177|NCT01521507|365659409|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
105999178|NCT01521507|365659408|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
105999179|NCT01521507|365659409|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
105999180|NCT01521507|365659408|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
105999181|NCT01521507|365659409|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
105999182|NCT01521507|365659408|FG000|Stage 2: Observational Design|Physician Decision|1|||
105999183|NCT01521507|365659409|FG001|Stage 2: Observational Design|Physician Decision|0|||
105999184|NCT04276233|365659413|FG000|Overall Study|Adverse Event|1|||
105999185|NCT04276233|365659413|FG000|Overall Study|Lost to Follow-up|3|||
105999186|NCT04276233|365659413|FG000|Overall Study|Physician Decision|4|||
105999187|NCT04276233|365659413|FG000|Overall Study|Withdrawal by Subject|2|||
105999188|NCT00296816|365659418|FG000|Overall Study|Disease Progression|37|||
105999189|NCT00296816|365659418|FG000|Overall Study|Adverse Event|18|||
105999190|NCT00296816|365659418|FG000|Overall Study|Investigator/Participant request|5|||
105999191|NCT00296816|365659418|FG000|Overall Study|Non-compliance|1|||
105999192|NCT00296816|365659418|FG000|Overall Study|Missing for end of treatment|4|||
105999193|NCT00296816|365659418|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
105999194|NCT00296816|365659418|FG000|Overall Study|Poor performance status|1|||
105999195|NCT00296816|365659418|FG000|Overall Study|Relocation to Florida|1|||
105999196|NCT00296816|365659418|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
105999197|NCT00296816|365659418|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
105999198|NCT00296816|365659418|FG000|Overall Study|Neuropathy/patient preference|1|||
105908173|NCT00667992|365323516|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
105908174|NCT00667992|365323515|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
105908175|NCT00667992|365323516|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
105908176|NCT00667992|365323515|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
105908177|NCT00667992|365323516|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
105908178|NCT00667992|365323515|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
105908179|NCT00667992|365323516|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
105908180|NCT00667992|365323515|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
105908181|NCT00667992|365323516|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
105999199|NCT00296816|365659418|FG000|Overall Study|Proteinuria|1|||
105999200|NCT00296816|365659418|FG000|Overall Study|ineligibility due to radiation treatment|1|||
105908182|NCT00667992|365323515|FG000|Wash-out|Not within one doubling dilution|4|||
105908183|NCT00667992|365323516|FG001|Wash-out|Not within one doubling dilution|3|||
105908184|NCT00667992|365323515|FG000|Wash-out|Failure to wash-out|2|||
105908185|NCT00667992|365323516|FG001|Wash-out|Failure to wash-out|2|||
105908186|NCT00667992|365323515|FG000|Wash-out|Withdrawal by Subject|1|||
105908187|NCT00667992|365323516|FG001|Wash-out|Withdrawal by Subject|0|||
105908188|NCT00667992|365323515|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
105999201|NCT00113841|365659419|FG000|Overall Study|Disease progression|0|||
105999202|NCT00113841|365659420|FG001|Overall Study|Disease progression|2|||
105908189|NCT00667992|365323516|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
105908190|NCT00667992|365323515|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
105908191|NCT00667992|365323516|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
105908192|NCT03335813|365323517|FG000|Overall Study|Withdrawal by Subject|1|||
105908193|NCT01826981|365323518|FG000|Overall Study|Lack of Efficacy|0|||
105908194|NCT01826981|365323519|FG001|Overall Study|Lack of Efficacy|1|||
105908195|NCT01826981|365323520|FG002|Overall Study|Lack of Efficacy|0|||
105908196|NCT01826981|365323521|FG003|Overall Study|Lack of Efficacy|0|||
105908197|NCT01826981|365323522|FG004|Overall Study|Lack of Efficacy|5|||
105908198|NCT01826981|365323523|FG005|Overall Study|Lack of Efficacy|0|||
105908199|NCT01826981|365323524|FG006|Overall Study|Lack of Efficacy|0|||
105908200|NCT01826981|365323525|FG007|Overall Study|Lack of Efficacy|8|||
105908201|NCT01826981|365323526|FG008|Overall Study|Lack of Efficacy|7|||
105908202|NCT01826981|365323527|FG009|Overall Study|Lack of Efficacy|0|||
105908203|NCT01826981|365323528|FG010|Overall Study|Lack of Efficacy|1|||
105908204|NCT01826981|365323529|FG011|Overall Study|Lack of Efficacy|0|||
105908205|NCT01826981|365323530|FG012|Overall Study|Lack of Efficacy|0|||
105908206|NCT01826981|365323531|FG013|Overall Study|Lack of Efficacy|3|||
105908207|NCT01826981|365323532|FG014|Overall Study|Lack of Efficacy|0|||
105908208|NCT01826981|365323518|FG000|Overall Study|Lost to Follow-up|0|||
105908209|NCT01826981|365323519|FG001|Overall Study|Lost to Follow-up|0|||
105908210|NCT01826981|365323520|FG002|Overall Study|Lost to Follow-up|0|||
105908211|NCT01826981|365323521|FG003|Overall Study|Lost to Follow-up|0|||
105908212|NCT01826981|365323522|FG004|Overall Study|Lost to Follow-up|1|||
105908213|NCT01826981|365323523|FG005|Overall Study|Lost to Follow-up|1|||
105908214|NCT01826981|365323524|FG006|Overall Study|Lost to Follow-up|0|||
105908215|NCT01826981|365323525|FG007|Overall Study|Lost to Follow-up|1|||
105908216|NCT01826981|365323526|FG008|Overall Study|Lost to Follow-up|0|||
105908217|NCT01826981|365323527|FG009|Overall Study|Lost to Follow-up|1|||
105908218|NCT01826981|365323528|FG010|Overall Study|Lost to Follow-up|1|||
105908219|NCT01826981|365323529|FG011|Overall Study|Lost to Follow-up|1|||
105908220|NCT01826981|365323530|FG012|Overall Study|Lost to Follow-up|1|||
105908221|NCT01826981|365323531|FG013|Overall Study|Lost to Follow-up|0|||
105908222|NCT01826981|365323532|FG014|Overall Study|Lost to Follow-up|0|||
105908223|NCT01826981|365323518|FG000|Overall Study|Withdrew Consent|0|||
105908224|NCT01826981|365323519|FG001|Overall Study|Withdrew Consent|0|||
105908225|NCT01826981|365323520|FG002|Overall Study|Withdrew Consent|0|||
105908226|NCT01826981|365323521|FG003|Overall Study|Withdrew Consent|0|||
105908227|NCT01826981|365323522|FG004|Overall Study|Withdrew Consent|0|||
105908228|NCT01826981|365323523|FG005|Overall Study|Withdrew Consent|0|||
105908229|NCT01826981|365323524|FG006|Overall Study|Withdrew Consent|1|||
105908230|NCT01826981|365323525|FG007|Overall Study|Withdrew Consent|1|||
105908231|NCT01826981|365323526|FG008|Overall Study|Withdrew Consent|0|||
105908232|NCT01826981|365323527|FG009|Overall Study|Withdrew Consent|0|||
105908233|NCT01826981|365323528|FG010|Overall Study|Withdrew Consent|0|||
105908234|NCT01826981|365323529|FG011|Overall Study|Withdrew Consent|1|||
105908235|NCT01826981|365323530|FG012|Overall Study|Withdrew Consent|0|||
105908236|NCT01826981|365323531|FG013|Overall Study|Withdrew Consent|1|||
105908237|NCT01826981|365323532|FG014|Overall Study|Withdrew Consent|0|||
105908238|NCT01826981|365323518|FG000|Overall Study|Adverse Event|0|||
105908239|NCT01826981|365323519|FG001|Overall Study|Adverse Event|0|||
105908240|NCT01826981|365323520|FG002|Overall Study|Adverse Event|0|||
105908241|NCT01826981|365323521|FG003|Overall Study|Adverse Event|0|||
105908242|NCT01826981|365323522|FG004|Overall Study|Adverse Event|1|||
105908243|NCT01826981|365323523|FG005|Overall Study|Adverse Event|0|||
105908244|NCT01826981|365323524|FG006|Overall Study|Adverse Event|0|||
105908245|NCT01826981|365323525|FG007|Overall Study|Adverse Event|0|||
105908246|NCT01826981|365323526|FG008|Overall Study|Adverse Event|0|||
105908247|NCT01826981|365323527|FG009|Overall Study|Adverse Event|0|||
105671057|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
105671058|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
105671059|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
105671060|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
105671061|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
105671062|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
105671063|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
105671064|NCT01006980|364460549|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
105671065|NCT01006980|364460550|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
105671066|NCT01531673|364460553|FG000|Overall Study|Non-Compliance|0|||
105671067|NCT01531673|364460554|FG001|Overall Study|Non-Compliance|0|||
105671068|NCT01531673|364460555|FG002|Overall Study|Non-Compliance|0|||
105671069|NCT01531673|364460556|FG003|Overall Study|Non-Compliance|0|||
105671070|NCT01531673|364460557|FG004|Overall Study|Non-Compliance|0|||
105671071|NCT01531673|364460558|FG005|Overall Study|Non-Compliance|1|||
105671072|NCT01531673|364460559|FG006|Overall Study|Non-Compliance|0|||
105671073|NCT01531673|364460560|FG007|Overall Study|Non-Compliance|0|||
105671074|NCT01531673|364460561|FG008|Overall Study|Non-Compliance|0|||
105671075|NCT01531673|364460562|FG009|Overall Study|Non-Compliance|0|||
105671076|NCT01531673|364460563|FG010|Overall Study|Non-Compliance|0|||
105671077|NCT01531673|364460564|FG011|Overall Study|Non-Compliance|0|||
105671078|NCT01531673|364460565|FG012|Overall Study|Non-Compliance|0|||
105671079|NCT01531673|364460553|FG000|Overall Study|Adverse Event|0|||
105671080|NCT01531673|364460554|FG001|Overall Study|Adverse Event|1|||
105671081|NCT01531673|364460555|FG002|Overall Study|Adverse Event|0|||
105671082|NCT01531673|364460556|FG003|Overall Study|Adverse Event|0|||
105671083|NCT01531673|364460557|FG004|Overall Study|Adverse Event|0|||
105671084|NCT01531673|364460558|FG005|Overall Study|Adverse Event|0|||
105671085|NCT01531673|364460559|FG006|Overall Study|Adverse Event|0|||
105671086|NCT01531673|364460560|FG007|Overall Study|Adverse Event|0|||
105671087|NCT01531673|364460561|FG008|Overall Study|Adverse Event|0|||
105671088|NCT01531673|364460562|FG009|Overall Study|Adverse Event|0|||
105671089|NCT01531673|364460563|FG010|Overall Study|Adverse Event|0|||
105671090|NCT01531673|364460564|FG011|Overall Study|Adverse Event|0|||
105671091|NCT01531673|364460565|FG012|Overall Study|Adverse Event|0|||
105671092|NCT01531673|364460553|FG000|Overall Study|Lost to Follow-up|0|||
105671093|NCT01531673|364460554|FG001|Overall Study|Lost to Follow-up|0|||
105671094|NCT01531673|364460555|FG002|Overall Study|Lost to Follow-up|0|||
105671095|NCT01531673|364460556|FG003|Overall Study|Lost to Follow-up|0|||
105671096|NCT01531673|364460557|FG004|Overall Study|Lost to Follow-up|1|||
105671097|NCT01531673|364460558|FG005|Overall Study|Lost to Follow-up|0|||
105671098|NCT01531673|364460559|FG006|Overall Study|Lost to Follow-up|0|||
105671099|NCT01531673|364460560|FG007|Overall Study|Lost to Follow-up|0|||
105671100|NCT01531673|364460561|FG008|Overall Study|Lost to Follow-up|0|||
105671101|NCT01531673|364460562|FG009|Overall Study|Lost to Follow-up|0|||
105671102|NCT01531673|364460563|FG010|Overall Study|Lost to Follow-up|0|||
105671103|NCT01531673|364460564|FG011|Overall Study|Lost to Follow-up|0|||
105671104|NCT01531673|364460565|FG012|Overall Study|Lost to Follow-up|0|||
105671105|NCT01531673|364460553|FG000|Overall Study|Other|0|||
105671106|NCT01531673|364460554|FG001|Overall Study|Other|0|||
105786201|NCT00972309|364870477|FG000|Overall Study|Refused further treatment|0|||
105786202|NCT00972309|364870478|FG001|Overall Study|Refused further treatment|1|||
105786203|NCT00972309|364870477|FG000|Overall Study|Late determination of ineligibility|0|||
105786204|NCT00972309|364870478|FG001|Overall Study|Late determination of ineligibility|1|||
105908248|NCT01826981|365323528|FG010|Overall Study|Adverse Event|0|||
105908249|NCT01826981|365323529|FG011|Overall Study|Adverse Event|0|||
105908250|NCT01826981|365323530|FG012|Overall Study|Adverse Event|0|||
105908251|NCT01826981|365323531|FG013|Overall Study|Adverse Event|0|||
105908252|NCT01826981|365323532|FG014|Overall Study|Adverse Event|0|||
105908253|NCT01826981|365323518|FG000|Overall Study|Upper G-I Haemorrhage|0|||
105908254|NCT01826981|365323519|FG001|Overall Study|Upper G-I Haemorrhage|0|||
105671107|NCT01531673|364460555|FG002|Overall Study|Other|0|||
105671108|NCT01531673|364460556|FG003|Overall Study|Other|1|||
105671109|NCT01531673|364460557|FG004|Overall Study|Other|0|||
105671110|NCT01531673|364460558|FG005|Overall Study|Other|0|||
105671111|NCT01531673|364460559|FG006|Overall Study|Other|0|||
105671112|NCT01531673|364460560|FG007|Overall Study|Other|0|||
105671113|NCT01531673|364460561|FG008|Overall Study|Other|0|||
105671114|NCT01531673|364460562|FG009|Overall Study|Other|1|||
105908255|NCT01826981|365323520|FG002|Overall Study|Upper G-I Haemorrhage|0|||
105671115|NCT01531673|364460563|FG010|Overall Study|Other|0|||
105671116|NCT01531673|364460564|FG011|Overall Study|Other|0|||
105671117|NCT01531673|364460565|FG012|Overall Study|Other|0|||
105786205|NCT00972309|364870477|FG000|Overall Study|Second malignancy|1|||
105671118|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Physician Decision|2|||
105671119|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Physician Decision|0|||
105671120|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Physician Decision|0|||
105671121|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Adverse Event|33|||
105908256|NCT01826981|365323521|FG003|Overall Study|Upper G-I Haemorrhage|0|||
105908257|NCT01826981|365323522|FG004|Overall Study|Upper G-I Haemorrhage|0|||
105908258|NCT01826981|365323523|FG005|Overall Study|Upper G-I Haemorrhage|0|||
105908259|NCT01826981|365323524|FG006|Overall Study|Upper G-I Haemorrhage|0|||
105908260|NCT01826981|365323525|FG007|Overall Study|Upper G-I Haemorrhage|0|||
105908261|NCT01826981|365323526|FG008|Overall Study|Upper G-I Haemorrhage|0|||
105908262|NCT01826981|365323527|FG009|Overall Study|Upper G-I Haemorrhage|0|||
105908263|NCT01826981|365323528|FG010|Overall Study|Upper G-I Haemorrhage|0|||
105908264|NCT01826981|365323529|FG011|Overall Study|Upper G-I Haemorrhage|0|||
105908265|NCT01826981|365323530|FG012|Overall Study|Upper G-I Haemorrhage|0|||
105908266|NCT01826981|365323531|FG013|Overall Study|Upper G-I Haemorrhage|1|||
105908267|NCT01826981|365323532|FG014|Overall Study|Upper G-I Haemorrhage|0|||
105908268|NCT01826981|365323518|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908269|NCT01826981|365323519|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908270|NCT01826981|365323520|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908271|NCT01826981|365323521|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908272|NCT01826981|365323522|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908273|NCT01826981|365323523|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908274|NCT01826981|365323524|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908275|NCT01826981|365323525|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
105908276|NCT01826981|365323526|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908277|NCT01826981|365323527|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908278|NCT01826981|365323528|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908279|NCT01826981|365323529|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908280|NCT01826981|365323530|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908281|NCT01826981|365323531|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908282|NCT01826981|365323532|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
105908283|NCT00632125|365323538|FG000|Overall Study|Death|82|||
105908284|NCT00632125|365323538|FG000|Overall Study|Withdrawal by Subject|44|||
105908285|NCT00632125|365323538|FG000|Overall Study|Adverse Event|36|||
105671122|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Adverse Event|0|||
105908286|NCT00632125|365323538|FG000|Overall Study|Renal transplantation|17|||
105908287|NCT00632125|365323538|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
105999203|NCT00113841|365659419|FG000|Overall Study|Non-compliant|1|||
105908288|NCT00632125|365323538|FG000|Overall Study|Non-compliance|8|||
105671123|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Adverse Event|0|||
105671124|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
105671125|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
105671126|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
105671127|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
105671128|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
105671129|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
105671130|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
105671131|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
105671132|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
105671133|NCT01008553|364460568|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
105671134|NCT01008553|364460569|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
105671135|NCT01008553|364460570|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
105671136|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
105671137|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
105671138|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
105671139|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
105671140|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
105671141|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
105671142|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
105908289|NCT00632125|365323538|FG000|Overall Study|Development of uncontrolled hypertension|5|||
105908290|NCT00632125|365323538|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
105908291|NCT02384538|365323545|FG000|Overall Study|Adverse Event|1|||
105908292|NCT02384538|365323546|FG001|Overall Study|Adverse Event|4|||
105908293|NCT02384538|365323545|FG000|Overall Study|Lack of Efficacy|4|||
105908294|NCT02384538|365323546|FG001|Overall Study|Lack of Efficacy|4|||
105908295|NCT02384538|365323545|FG000|Overall Study|Withdrew Consent|0|||
105908296|NCT02384538|365323546|FG001|Overall Study|Withdrew Consent|4|||
105908297|NCT02384538|365323545|FG000|Overall Study|Other|1|||
105908298|NCT02384538|365323546|FG001|Overall Study|Other|3|||
105908299|NCT02821416|365323551|FG000|Overall Study|Adverse Event|0|||
105908300|NCT02821416|365323552|FG001|Overall Study|Adverse Event|1|||
105908301|NCT02821416|365323551|FG000|Overall Study|Withdrawal by Subject|2|||
105908302|NCT02821416|365323552|FG001|Overall Study|Withdrawal by Subject|0|||
105908303|NCT02821416|365323551|FG000|Overall Study|Lost to Follow-up|1|||
105908304|NCT02821416|365323552|FG001|Overall Study|Lost to Follow-up|0|||
105908305|NCT02256917|365323553|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
105908306|NCT02256917|365323553|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
105908307|NCT02256917|365323553|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
105908308|NCT02256917|365323553|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
105908309|NCT02256917|365323553|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
105908310|NCT04152083|365323554|FG000|Overall Study|Lost to Follow-up|2|||
105908311|NCT04152083|365323555|FG001|Overall Study|Lost to Follow-up|1|||
105908312|NCT04152083|365323554|FG000|Overall Study|Adverse Event|1|||
105908313|NCT04152083|365323555|FG001|Overall Study|Adverse Event|0|||
105908314|NCT04152083|365323554|FG000|Overall Study|Randomized but not treated|3|||
105908315|NCT04152083|365323555|FG001|Overall Study|Randomized but not treated|2|||
105908316|NCT03076996|365323558|FG000|Overall Study|Withdrawal by Subject|2|||
105908317|NCT03076996|365323558|FG000|Overall Study|Lost to Follow-up|3|||
105908318|NCT03076996|365323558|FG000|Overall Study|Literacy precluded participation|1|||
105908319|NCT00540644|365323566|FG000|Overall Study|Adverse Event|3|||
105908320|NCT00540644|365323567|FG001|Overall Study|Adverse Event|1|||
105908321|NCT00540644|365323566|FG000|Overall Study|Disease Progression|3|||
105908322|NCT00540644|365323567|FG001|Overall Study|Disease Progression|1|||
105908323|NCT00540644|365323566|FG000|Overall Study|Physician Decision|0|||
105908324|NCT00540644|365323567|FG001|Overall Study|Physician Decision|5|||
105908325|NCT00540644|365323566|FG000|Overall Study|Withdrawal by Subject|2|||
105908326|NCT00540644|365323567|FG001|Overall Study|Withdrawal by Subject|2|||
105908327|NCT00540644|365323566|FG000|Overall Study|Noncomplilance|1|||
105908328|NCT00540644|365323567|FG001|Overall Study|Noncomplilance|0|||
105908329|NCT03280056|365323570|FG000|Overall Study|Withdrawal by Subject|12|||
105908330|NCT03280056|365323571|FG001|Overall Study|Withdrawal by Subject|14|||
105908331|NCT03280056|365323570|FG000|Overall Study|Death|9|||
105908332|NCT03280056|365323571|FG001|Overall Study|Death|2|||
105908333|NCT03280056|365323570|FG000|Overall Study|Adverse Event|1|||
105908334|NCT03280056|365323571|FG001|Overall Study|Adverse Event|3|||
105671143|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
105908335|NCT03280056|365323570|FG000|Overall Study|Lost to Follow-up|1|||
105908336|NCT03280056|365323571|FG001|Overall Study|Lost to Follow-up|1|||
105908337|NCT03280056|365323570|FG000|Overall Study|Physician Decision|0|||
105908338|NCT03280056|365323571|FG001|Overall Study|Physician Decision|1|||
105908339|NCT03280056|365323570|FG000|Overall Study|Early Discontinuation|1|||
105908340|NCT03280056|365323571|FG001|Overall Study|Early Discontinuation|0|||
105908341|NCT02144077|365323572|FG000|Overall Study|Withdrawal by Subject|3|||
105908342|NCT02144077|365323573|FG001|Overall Study|Withdrawal by Subject|3|||
105908343|NCT02144077|365323572|FG000|Overall Study|Adverse Event|2|||
105908344|NCT02144077|365323573|FG001|Overall Study|Adverse Event|3|||
105908345|NCT02144077|365323572|FG000|Overall Study|Lost to Follow-up|2|||
105908346|NCT02144077|365323573|FG001|Overall Study|Lost to Follow-up|2|||
105908347|NCT02144077|365323572|FG000|Overall Study|Protocol Violation|1|||
105908348|NCT02144077|365323573|FG001|Overall Study|Protocol Violation|2|||
105671144|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
105671145|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
105671146|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
105671147|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
105671148|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
105671149|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
105671150|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
105671151|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
105671152|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
105671153|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
105671154|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
105671155|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
105671156|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
105671157|NCT01008553|364460568|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
105671158|NCT01008553|364460569|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
105671159|NCT01008553|364460570|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
105671160|NCT01283152|364460575|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
105671161|NCT01283152|364460576|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
105671162|NCT01283152|364460575|FG000|Overall Study|Refused HESA|1|||
105671163|NCT01283152|364460576|FG001|Overall Study|Refused HESA|0|||
105671164|NCT00567567|364460578|FG000|Overall Study|Adverse Event|0|||
105671165|NCT00567567|364460579|FG001|Overall Study|Adverse Event|2|||
105671166|NCT00567567|364460580|FG002|Overall Study|Adverse Event|5|||
105671167|NCT00567567|364460578|FG000|Overall Study|Death|8|||
105671168|NCT00567567|364460579|FG001|Overall Study|Death|1|||
105671169|NCT00567567|364460580|FG002|Overall Study|Death|5|||
105671170|NCT00567567|364460578|FG000|Overall Study|Lack of Efficacy|16|||
105671171|NCT00567567|364460579|FG001|Overall Study|Lack of Efficacy|17|||
105671172|NCT00567567|364460580|FG002|Overall Study|Lack of Efficacy|48|||
105671173|NCT00567567|364460578|FG000|Overall Study|Lost to Follow-up|0|||
105671174|NCT00567567|364460579|FG001|Overall Study|Lost to Follow-up|0|||
105671175|NCT00567567|364460580|FG002|Overall Study|Lost to Follow-up|1|||
105671176|NCT00567567|364460578|FG000|Overall Study|Physician Decision|16|||
105671177|NCT00567567|364460579|FG001|Overall Study|Physician Decision|18|||
105671178|NCT00567567|364460580|FG002|Overall Study|Physician Decision|84|||
105671179|NCT00567567|364460578|FG000|Overall Study|Withdrawal by Subject|0|||
105671180|NCT00567567|364460579|FG001|Overall Study|Withdrawal by Subject|0|||
105671181|NCT00567567|364460580|FG002|Overall Study|Withdrawal by Subject|2|||
105671182|NCT00567567|364460578|FG000|Overall Study|Ineligible|4|||
105671183|NCT00567567|364460579|FG001|Overall Study|Ineligible|0|||
105671184|NCT00567567|364460580|FG002|Overall Study|Ineligible|9|||
105671185|NCT00567567|364460578|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
105671186|NCT00567567|364460579|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
105671187|NCT00567567|364460580|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
105671188|NCT00567567|364460578|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
105671189|NCT00567567|364460579|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
105671190|NCT00567567|364460580|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
105908349|NCT02144077|365323572|FG000|Overall Study|Death|0|||
105908350|NCT02144077|365323573|FG001|Overall Study|Death|1|||
105908351|NCT02144077|365323572|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
105908352|NCT02144077|365323573|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
105908353|NCT00610168|365323574|FG000|Overall Study|Withdrawal by Subject|2|||
105908354|NCT00610168|365323575|FG001|Overall Study|Withdrawal by Subject|0|||
105908355|NCT00613821|365323576|FG000|Overall Study|Withdrawal by Subject|1|||
105908356|NCT00613821|365323577|FG001|Overall Study|Withdrawal by Subject|0|||
105908357|NCT00613821|365323576|FG000|Overall Study|Physician Decision|1|||
105908358|NCT00613821|365323577|FG001|Overall Study|Physician Decision|1|||
105908359|NCT03060291|365323579|FG000|3-month Follow-up|Declined to respond|8|||
105671191|NCT00567567|364460578|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
105671192|NCT00567567|364460579|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
105671193|NCT00567567|364460580|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
105908360|NCT03060291|365323580|FG001|3-month Follow-up|Declined to respond|10|||
105908361|NCT03060291|365323581|FG002|3-month Follow-up|Declined to respond|2|||
105908362|NCT03060291|365323579|FG000|6-month Follow-up|Declined to respond|7|||
105908363|NCT03060291|365323580|FG001|6-month Follow-up|Declined to respond|13|||
105671194|NCT03889704|364460583|FG000|Overall Study|Study terminated due to pandemic|1|||
105671195|NCT01736189|364460588|FG000|Overall Study|Violation of registration criteria|41|||
105671196|NCT01736189|364460588|FG000|Overall Study|Protocol Violation|4|||
105671197|NCT01736189|364460588|FG000|Overall Study|Criteria and protocol violations|1|||
105671198|NCT02591953|364460589|FG000|Overall Study|Lost to Follow-up|6|||
105671199|NCT02591953|364460590|FG001|Overall Study|Lost to Follow-up|6|||
105671200|NCT01499303|364460591|FG000|Overall Study|Ongoing|2|||
105671201|NCT01499303|364460592|FG001|Overall Study|Ongoing|1|||
105671202|NCT01499303|364460591|FG000|Overall Study|Withdrawal by Subject|0|||
105671203|NCT01499303|364460592|FG001|Overall Study|Withdrawal by Subject|1|||
105671204|NCT01499303|364460591|FG000|Overall Study|Adverse Event|1|||
105671205|NCT01499303|364460592|FG001|Overall Study|Adverse Event|4|||
105671206|NCT01499303|364460591|FG000|Overall Study|Other|0|||
105671207|NCT01499303|364460592|FG001|Overall Study|Other|1|||
105671208|NCT01896557|364460595|FG000|Clopidogrel Alone|Adverse Event|1|||
105671209|NCT01896557|364460596|FG001|Clopidogrel Alone|Adverse Event|0|||
105671210|NCT01896557|364460595|FG000|Clopidogrel + GI Protector|low adherence|1|||
105671211|NCT01896557|364460596|FG001|Clopidogrel + GI Protector|low adherence|1|||
105671212|NCT01896557|364460595|FG000|Clopidogrel + GI Protector|Reading error|1|||
105671213|NCT01896557|364460596|FG001|Clopidogrel + GI Protector|Reading error|3|||
105671214|NCT03809039|364460597|FG000|Part 1|Withdrawal by Subject|1|||
105671215|NCT03809039|364460598|FG001|Part 1|Withdrawal by Subject|0|||
105671216|NCT03809039|364460599|FG002|Part 1|Withdrawal by Subject|0|||
105671217|NCT03809039|364460600|FG003|Part 1|Withdrawal by Subject|1|||
105671218|NCT03809039|364460601|FG004|Part 1|Withdrawal by Subject|0|||
105671219|NCT03809039|364460602|FG005|Part 1|Withdrawal by Subject|0|||
105671220|NCT03809039|364460603|FG006|Part 1|Withdrawal by Subject|0|||
105671221|NCT03809039|364460604|FG007|Part 1|Withdrawal by Subject|0|||
105671222|NCT03809039|364460605|FG008|Part 1|Withdrawal by Subject|0|||
105671223|NCT03809039|364460597|FG000|Part 3|Withdrawn by study termination|0|||
105671224|NCT03809039|364460598|FG001|Part 3|Withdrawn by study termination|0|||
105671225|NCT03809039|364460599|FG002|Part 3|Withdrawn by study termination|0|||
105671226|NCT03809039|364460600|FG003|Part 3|Withdrawn by study termination|0|||
105671227|NCT03809039|364460601|FG004|Part 3|Withdrawn by study termination|0|||
105671228|NCT03809039|364460602|FG005|Part 3|Withdrawn by study termination|0|||
105671229|NCT03809039|364460603|FG006|Part 3|Withdrawn by study termination|0|||
105671230|NCT03809039|364460604|FG007|Part 3|Withdrawn by study termination|2|||
105671231|NCT03809039|364460605|FG008|Part 3|Withdrawn by study termination|6|||
105671232|NCT04798781|364460612|FG000|Overall Study|Withdrawal by Subject|1|||
105671233|NCT00702962|364460613|FG000|Overall Study|Progressive disease|0|||
105671234|NCT00702962|364460614|FG001|Overall Study|Progressive disease|1|||
105671235|NCT00702962|364460613|FG000|Overall Study|Hospitalized for other health disorder|1|||
105671236|NCT00702962|364460614|FG001|Overall Study|Hospitalized for other health disorder|0|||
105671237|NCT01252355|364460615|FG000|Overall Study|Adverse Event|9|||
105671238|NCT01252355|364460616|FG001|Overall Study|Adverse Event|17|||
105671239|NCT01252355|364460617|FG002|Overall Study|Adverse Event|22|||
105671240|NCT01252355|364460615|FG000|Overall Study|Lack of Efficacy|6|||
105671241|NCT01252355|364460616|FG001|Overall Study|Lack of Efficacy|4|||
105671242|NCT01252355|364460617|FG002|Overall Study|Lack of Efficacy|2|||
105671243|NCT01252355|364460615|FG000|Overall Study|Lost to Follow-up|0|||
105671244|NCT01252355|364460616|FG001|Overall Study|Lost to Follow-up|0|||
105671245|NCT01252355|364460617|FG002|Overall Study|Lost to Follow-up|1|||
105671246|NCT01252355|364460615|FG000|Overall Study|Poor Compliance to Protocol|1|||
105908364|NCT03060291|365323581|FG002|6-month Follow-up|Declined to respond|4|||
105908365|NCT03060291|365323579|FG000|12-month Follow-up|Declined to respond|7|||
105908366|NCT03060291|365323580|FG001|12-month Follow-up|Declined to respond|16|||
105908367|NCT03060291|365323581|FG002|12-month Follow-up|Declined to respond|6|||
105908368|NCT01720524|365323584|FG000|Part A|Insufficient Clinical Response|2|||
105908369|NCT01720524|365323585|FG001|Part A|Insufficient Clinical Response|4|||
105671247|NCT01252355|364460616|FG001|Overall Study|Poor Compliance to Protocol|1|||
105671248|NCT01252355|364460617|FG002|Overall Study|Poor Compliance to Protocol|1|||
105671249|NCT01252355|364460615|FG000|Overall Study|Progressive Disease|2|||
105671250|NCT01252355|364460616|FG001|Overall Study|Progressive Disease|0|||
105671251|NCT01252355|364460617|FG002|Overall Study|Progressive Disease|0|||
105671252|NCT01252355|364460615|FG000|Overall Study|Sponsor Early Termination of Study|149|||
105671253|NCT01252355|364460616|FG001|Overall Study|Sponsor Early Termination of Study|149|||
105671254|NCT01252355|364460617|FG002|Overall Study|Sponsor Early Termination of Study|146|||
105671255|NCT01252355|364460615|FG000|Overall Study|Randomized but not Treated|2|||
105671256|NCT01252355|364460616|FG001|Overall Study|Randomized but not Treated|0|||
105671257|NCT01252355|364460617|FG002|Overall Study|Randomized but not Treated|0|||
105671258|NCT01252355|364460615|FG000|Overall Study|Other Than Above|8|||
105671259|NCT01252355|364460616|FG001|Overall Study|Other Than Above|7|||
105671260|NCT01252355|364460617|FG002|Overall Study|Other Than Above|7|||
105671261|NCT03031496|364460619|FG000|Period 1|Adverse Event|2|||
105671262|NCT03031496|364460620|FG001|Period 1|Adverse Event|0|||
105671263|NCT03031496|364460619|FG000|Period 1|Withdrawal by Subject|0|||
105671264|NCT03031496|364460620|FG001|Period 1|Withdrawal by Subject|2|||
105908370|NCT01720524|365323584|FG000|Part A|Adverse Event|2|||
105671265|NCT03733314|364460621|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
105671266|NCT03733314|364460622|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
105671267|NCT03733314|364460621|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
105671268|NCT03733314|364460622|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
105671269|NCT03733314|364460621|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
105671270|NCT03733314|364460622|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
105671271|NCT03733314|364460621|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
105671272|NCT03733314|364460622|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
105671273|NCT03733314|364460621|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
105671274|NCT03733314|364460622|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
105671275|NCT03733314|364460621|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
105671276|NCT03733314|364460622|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
105671277|NCT02574845|364460623|FG000|Overall Study|Consent withdrawn further participation|0|||
105671278|NCT02574845|364460624|FG001|Overall Study|Consent withdrawn further participation|0|||
105671279|NCT02574845|364460625|FG002|Overall Study|Consent withdrawn further participation|0|||
105671280|NCT02574845|364460626|FG003|Overall Study|Consent withdrawn further participation|0|||
105671281|NCT02574845|364460627|FG004|Overall Study|Consent withdrawn further participation|1|||
105671282|NCT02574845|364460628|FG005|Overall Study|Consent withdrawn further participation|0|||
105671283|NCT02574845|364460623|FG000|Overall Study|Adverse Event|0|||
105671284|NCT02574845|364460624|FG001|Overall Study|Adverse Event|1|||
105671285|NCT02574845|364460625|FG002|Overall Study|Adverse Event|0|||
105671286|NCT02574845|364460626|FG003|Overall Study|Adverse Event|0|||
105671287|NCT02574845|364460627|FG004|Overall Study|Adverse Event|0|||
105671288|NCT02574845|364460628|FG005|Overall Study|Adverse Event|1|||
105671289|NCT01696045|364460630|FG000|Overall Study|Study drug toxicity|1|||
105671290|NCT01696045|364460631|FG001|Overall Study|Study drug toxicity|5|||
105671291|NCT01696045|364460630|FG000|Overall Study|Disease progression|2|||
105671292|NCT01696045|364460631|FG001|Overall Study|Disease progression|2|||
105671293|NCT04145700|364460633|FG000|Overall Study|Withdrawal by Subject|8|||
105671294|NCT04145700|364460634|FG001|Overall Study|Withdrawal by Subject|3|||
105671295|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
105671296|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
105671297|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
105671298|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
105671299|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
105671300|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
105671301|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
105671302|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671303|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
105671304|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671305|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671306|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671307|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671308|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
105671309|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
105671310|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
105671311|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
105671312|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
105671313|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
105671314|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
105671315|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
105671316|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671317|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671318|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
105671319|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671320|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671321|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671322|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
105671323|NCT02229851|364460635|FG000|Main Phase (Double-blind Phase)|Death|1|||
105671324|NCT02229851|364460636|FG001|Main Phase (Double-blind Phase)|Death|1|||
105671325|NCT02229851|364460637|FG002|Main Phase (Double-blind Phase)|Death|0|||
105671326|NCT02229851|364460638|FG003|Main Phase (Double-blind Phase)|Death|0|||
105671327|NCT02229851|364460639|FG004|Main Phase (Double-blind Phase)|Death|0|||
105671328|NCT02229851|364460640|FG005|Main Phase (Double-blind Phase)|Death|0|||
105671329|NCT02229851|364460641|FG006|Main Phase (Double-blind Phase)|Death|0|||
105671330|NCT02229851|364460635|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
105671331|NCT02229851|364460636|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
105671332|NCT02229851|364460637|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
105671333|NCT02229851|364460638|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
105671334|NCT02229851|364460639|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
105671335|NCT02229851|364460640|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
105671336|NCT02229851|364460641|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
105671337|NCT02229851|364460635|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
105671338|NCT02229851|364460636|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
105671339|NCT02229851|364460637|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
105671340|NCT02229851|364460638|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
105671341|NCT02229851|364460639|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
105671342|NCT02229851|364460640|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
105671343|NCT02229851|364460641|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
105671344|NCT02229851|364460635|FG000|Extension Phase (Open-label Phase)|Death|0|||
105671345|NCT02229851|364460636|FG001|Extension Phase (Open-label Phase)|Death|0|||
105671346|NCT02229851|364460637|FG002|Extension Phase (Open-label Phase)|Death|0|||
105671347|NCT02229851|364460638|FG003|Extension Phase (Open-label Phase)|Death|1|||
105671348|NCT02229851|364460639|FG004|Extension Phase (Open-label Phase)|Death|0|||
105671349|NCT02229851|364460640|FG005|Extension Phase (Open-label Phase)|Death|1|||
105671350|NCT02229851|364460641|FG006|Extension Phase (Open-label Phase)|Death|1|||
105671351|NCT02045875|364460643|FG000|Overall Study|Lost to Follow-up|3|||
105671352|NCT02045875|364460644|FG001|Overall Study|Lost to Follow-up|0|||
105671353|NCT02045875|364460643|FG000|Overall Study|Withdrawal by Subject|4|||
105671354|NCT02045875|364460644|FG001|Overall Study|Withdrawal by Subject|3|||
105671355|NCT00864253|364460645|FG000|Overall Study|Adverse Event|56|||
105671356|NCT00864253|364460646|FG001|Overall Study|Adverse Event|11|||
105671357|NCT00864253|364460645|FG000|Overall Study|Unrelated Adverse Event|3|||
105671358|NCT00864253|364460646|FG001|Overall Study|Unrelated Adverse Event|1|||
105671359|NCT00864253|364460645|FG000|Overall Study|Physician Decision|11|||
105671360|NCT00864253|364460646|FG001|Overall Study|Physician Decision|15|||
105671361|NCT00864253|364460645|FG000|Overall Study|Protocol Violation|0|||
105671362|NCT00864253|364460646|FG001|Overall Study|Protocol Violation|2|||
105671363|NCT00864253|364460645|FG000|Overall Study|Lost to Follow-up|1|||
105671364|NCT00864253|364460646|FG001|Overall Study|Lost to Follow-up|1|||
105671365|NCT00864253|364460645|FG000|Overall Study|Withdrawal by Subject|18|||
105671366|NCT00864253|364460646|FG001|Overall Study|Withdrawal by Subject|18|||
105671367|NCT00864253|364460645|FG000|Overall Study|Death|1|||
105671368|NCT00864253|364460646|FG001|Overall Study|Death|0|||
105671369|NCT00864253|364460645|FG000|Overall Study|Ongoing|2|||
105671370|NCT00864253|364460646|FG001|Overall Study|Ongoing|3|||
105671371|NCT00864253|364460645|FG000|Overall Study|Untreated|7|||
105671372|NCT00864253|364460646|FG001|Overall Study|Untreated|7|||
105671373|NCT02807883|364460647|FG000|Overall Study|Withdrawal by Subject|2|||
105671374|NCT02206061|364460648|FG000|Overall Study|Withdrawal by Subject|4|||
105671375|NCT02206061|364460649|FG001|Overall Study|Withdrawal by Subject|7|||
105671376|NCT02206061|364460650|FG002|Overall Study|Withdrawal by Subject|1|||
105671377|NCT02206061|364460648|FG000|Overall Study|Lost to Follow-up|14|||
105671378|NCT02206061|364460649|FG001|Overall Study|Lost to Follow-up|7|||
105671379|NCT02206061|364460650|FG002|Overall Study|Lost to Follow-up|20|||
105671380|NCT01743989|364460661|FG000|Treatment Phase|Unstable MR4.0|0|||
105671381|NCT01743989|364460662|FG001|Treatment Phase|Unstable MR4.0|6|||
105671382|NCT01743989|364460663|FG002|Treatment Phase|Unstable MR4.0|263|||
105671383|NCT01743989|364460661|FG000|Treatment Phase|Adverse Event|0|||
105671384|NCT01743989|364460662|FG001|Treatment Phase|Adverse Event|4|||
105671385|NCT01743989|364460663|FG002|Treatment Phase|Adverse Event|67|||
105671386|NCT01743989|364460661|FG000|Treatment Phase|Withdrawal by Subject|1|||
105671387|NCT01743989|364460662|FG001|Treatment Phase|Withdrawal by Subject|3|||
105671388|NCT01743989|364460663|FG002|Treatment Phase|Withdrawal by Subject|28|||
105671389|NCT01743989|364460661|FG000|Treatment Phase|Death|0|||
105671390|NCT01743989|364460662|FG001|Treatment Phase|Death|1|||
105671391|NCT01743989|364460663|FG002|Treatment Phase|Death|3|||
105671392|NCT01743989|364460661|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
105671393|NCT01743989|364460662|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
105671394|NCT01743989|364460663|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
105671395|NCT01743989|364460661|FG000|Treatment Phase|Protocol deviation|0|||
105671396|NCT01743989|364460662|FG001|Treatment Phase|Protocol deviation|0|||
105908371|NCT01720524|365323585|FG001|Part A|Adverse Event|2|||
105908372|NCT01720524|365323584|FG000|Part A|Death|2|||
105671397|NCT01743989|364460663|FG002|Treatment Phase|Protocol deviation|3|||
105671398|NCT01743989|364460661|FG000|Treatment Phase|Pregnancy|0|||
105671399|NCT01743989|364460662|FG001|Treatment Phase|Pregnancy|0|||
105908373|NCT01720524|365323585|FG001|Part A|Death|1|||
105671400|NCT01743989|364460663|FG002|Treatment Phase|Pregnancy|2|||
105671401|NCT01743989|364460661|FG000|Treatment Phase|Lost to Follow-up|0|||
105671402|NCT01743989|364460662|FG001|Treatment Phase|Lost to Follow-up|0|||
105671403|NCT01743989|364460663|FG002|Treatment Phase|Lost to Follow-up|2|||
105908374|NCT01720524|365323584|FG000|Part A|Lost to Follow-up|0|||
105908375|NCT01720524|365323585|FG001|Part A|Lost to Follow-up|1|||
105908376|NCT01720524|365323584|FG000|Part A|Missed 28 day follow-up visit|1|||
105671404|NCT01743989|364460661|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
105671405|NCT01743989|364460662|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
105671406|NCT01743989|364460663|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
105671407|NCT01743989|364460661|FG000|Treatment Phase|Administrative problems|0|||
105671408|NCT01743989|364460662|FG001|Treatment Phase|Administrative problems|0|||
105671409|NCT01743989|364460663|FG002|Treatment Phase|Administrative problems|1|||
105671410|NCT01743989|364460661|FG000|Treatment Phase|New cancer (CML) therapy|0|||
105671411|NCT01743989|364460662|FG001|Treatment Phase|New cancer (CML) therapy|1|||
105671412|NCT01743989|364460663|FG002|Treatment Phase|New cancer (CML) therapy|0|||
105671413|NCT01743989|364460661|FG000|Treatment Phase|Physician Decision|0|||
105671414|NCT01743989|364460662|FG001|Treatment Phase|Physician Decision|0|||
105671415|NCT01743989|364460663|FG002|Treatment Phase|Physician Decision|3|||
105671416|NCT01743989|364460661|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
105671417|NCT01743989|364460662|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
105671418|NCT01743989|364460663|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
105671419|NCT01743989|364460661|FG000|Treatment Phase|Not randomized by mistake|0|||
105671420|NCT01743989|364460662|FG001|Treatment Phase|Not randomized by mistake|0|||
105671421|NCT01743989|364460663|FG002|Treatment Phase|Not randomized by mistake|1|||
105671422|NCT01743989|364460661|FG000|Treatment Phase|Included by mistake|0|||
105671423|NCT01743989|364460662|FG001|Treatment Phase|Included by mistake|0|||
105671424|NCT01743989|364460663|FG002|Treatment Phase|Included by mistake|1|||
105671425|NCT01743989|364460661|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
105671426|NCT01743989|364460662|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
105671427|NCT01743989|364460663|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
105671428|NCT01743989|364460661|FG000|TFR Phase|Adverse Event|0|||
105671429|NCT01743989|364460662|FG001|TFR Phase|Adverse Event|1|||
105671430|NCT01743989|364460663|FG002|TFR Phase|Adverse Event|0|||
105671431|NCT01743989|364460661|FG000|TFR Phase|Lost to Follow-up|0|||
105671432|NCT01743989|364460662|FG001|TFR Phase|Lost to Follow-up|2|||
105671433|NCT01743989|364460663|FG002|TFR Phase|Lost to Follow-up|0|||
105671434|NCT01743989|364460661|FG000|TFR Phase|Physician Decision|0|||
105671435|NCT01743989|364460662|FG001|TFR Phase|Physician Decision|1|||
105671436|NCT01743989|364460663|FG002|TFR Phase|Physician Decision|0|||
105671437|NCT01743989|364460661|FG000|TFR Phase|Logistical problems|0|||
105671438|NCT01743989|364460662|FG001|TFR Phase|Logistical problems|2|||
105671439|NCT01743989|364460663|FG002|TFR Phase|Logistical problems|0|||
105671440|NCT01743989|364460661|FG000|TFR Phase|Protocol deviation|0|||
105671441|NCT01743989|364460662|FG001|TFR Phase|Protocol deviation|1|||
105671442|NCT01743989|364460663|FG002|TFR Phase|Protocol deviation|0|||
105671443|NCT01743989|364460661|FG000|TFR Phase|Withdrawal by Subject|0|||
105671444|NCT01743989|364460662|FG001|TFR Phase|Withdrawal by Subject|2|||
105671445|NCT01743989|364460663|FG002|TFR Phase|Withdrawal by Subject|0|||
105671446|NCT01743989|364460661|FG000|Re-treatment Phase|Adverse Event|8|||
105671447|NCT01743989|364460662|FG001|Re-treatment Phase|Adverse Event|4|||
105671448|NCT01743989|364460663|FG002|Re-treatment Phase|Adverse Event|0|||
105671449|NCT01743989|364460661|FG000|Re-treatment Phase|Death|1|||
105671450|NCT01743989|364460662|FG001|Re-treatment Phase|Death|1|||
105671451|NCT01743989|364460663|FG002|Re-treatment Phase|Death|0|||
105671452|NCT01743989|364460661|FG000|Re-treatment Phase|Administrative problems|1|||
105671453|NCT01743989|364460662|FG001|Re-treatment Phase|Administrative problems|1|||
105671454|NCT01743989|364460663|FG002|Re-treatment Phase|Administrative problems|0|||
105671455|NCT01743989|364460661|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
105671456|NCT01743989|364460662|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
105671457|NCT01743989|364460663|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
105671458|NCT01743989|364460661|FG000|Re-treatment Phase|Unstable MR|1|||
105671459|NCT01743989|364460662|FG001|Re-treatment Phase|Unstable MR|0|||
105671460|NCT01743989|364460663|FG002|Re-treatment Phase|Unstable MR|0|||
105671461|NCT01743989|364460661|FG000|Re-treatment Phase|Physician Decision|0|||
105671462|NCT01743989|364460662|FG001|Re-treatment Phase|Physician Decision|1|||
105671463|NCT01743989|364460663|FG002|Re-treatment Phase|Physician Decision|0|||
105671464|NCT01743989|364460661|FG000|Re-treatment Phase|Lost to Follow-up|0|||
105671465|NCT01743989|364460662|FG001|Re-treatment Phase|Lost to Follow-up|1|||
105671466|NCT01743989|364460663|FG002|Re-treatment Phase|Lost to Follow-up|0|||
105671467|NCT02235311|364460673|FG000|Overall Study|Lost to Follow-up|0|||
105671468|NCT02235311|364460674|FG001|Overall Study|Lost to Follow-up|1|||
105671469|NCT02235311|364460673|FG000|Overall Study|Protocol Violation|0|||
105671470|NCT02235311|364460674|FG001|Overall Study|Protocol Violation|1|||
105671471|NCT04655027|364460676|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
105671472|NCT04655027|364460677|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
105671473|NCT05543707|364460678|FG000|Overall Study|Study drug non-compliance/|5|||
105671474|NCT05543707|364460679|FG001|Overall Study|Study drug non-compliance/|0|||
105671475|NCT05543707|364460678|FG000|Overall Study|Withdrawal by Subject|1|||
105671476|NCT05543707|364460679|FG001|Overall Study|Withdrawal by Subject|1|||
105671477|NCT05543707|364460678|FG000|Overall Study|Adverse Event|1|||
105671478|NCT05543707|364460679|FG001|Overall Study|Adverse Event|0|||
105671479|NCT05543707|364460678|FG000|Overall Study|concurrent illness|0|||
105671480|NCT05543707|364460679|FG001|Overall Study|concurrent illness|1|||
105671481|NCT05543707|364460678|FG000|Overall Study|Pregnancy|1|||
105671482|NCT05543707|364460679|FG001|Overall Study|Pregnancy|1|||
105671483|NCT02108964|364460680|FG000|Overall Study|Progressive disease|15|||
105671484|NCT02108964|364460681|FG001|Overall Study|Progressive disease|31|||
105671485|NCT02108964|364460682|FG002|Overall Study|Progressive disease|54|||
105671486|NCT02108964|364460683|FG003|Overall Study|Progressive disease|7|||
105671487|NCT02108964|364460684|FG004|Overall Study|Progressive disease|20|||
105671488|NCT02108964|364460685|FG005|Overall Study|Progressive disease|4|||
105671489|NCT02108964|364460686|FG006|Overall Study|Progressive disease|6|||
105671490|NCT02108964|364460687|FG007|Overall Study|Progressive disease|33|||
105671491|NCT02108964|364460680|FG000|Overall Study|Physician Decision|1|||
105671492|NCT02108964|364460681|FG001|Overall Study|Physician Decision|5|||
105671493|NCT02108964|364460682|FG002|Overall Study|Physician Decision|7|||
105671494|NCT02108964|364460683|FG003|Overall Study|Physician Decision|1|||
105671495|NCT02108964|364460684|FG004|Overall Study|Physician Decision|2|||
105671496|NCT02108964|364460685|FG005|Overall Study|Physician Decision|1|||
105671497|NCT02108964|364460686|FG006|Overall Study|Physician Decision|1|||
105671498|NCT02108964|364460687|FG007|Overall Study|Physician Decision|3|||
105671499|NCT02108964|364460680|FG000|Overall Study|Adverse Event|0|||
105671500|NCT02108964|364460681|FG001|Overall Study|Adverse Event|0|||
105671501|NCT02108964|364460682|FG002|Overall Study|Adverse Event|4|||
105671502|NCT02108964|364460683|FG003|Overall Study|Adverse Event|0|||
105671503|NCT02108964|364460684|FG004|Overall Study|Adverse Event|1|||
105671504|NCT02108964|364460685|FG005|Overall Study|Adverse Event|0|||
105908377|NCT01720524|365323585|FG001|Part A|Missed 28 day follow-up visit|1|||
105908378|NCT01720524|365323584|FG000|Part A|Withdrawal by Subject|0|||
105908379|NCT01720524|365323585|FG001|Part A|Withdrawal by Subject|1|||
105908380|NCT01720524|365323584|FG000|Part A|Other|0|||
105908381|NCT01720524|365323585|FG001|Part A|Other|1|||
105908382|NCT01720524|365323584|FG000|Part A|Lost to Follow-up|0|||
105908383|NCT01720524|365323585|FG001|Part A|Lost to Follow-up|1|||
105908384|NCT01720524|365323584|FG000|Part B|No longer willing to participate in study|1|||
105908385|NCT01720524|365323585|FG001|Part B|No longer willing to participate in study|4|||
105908386|NCT01720524|365323584|FG000|Part B|Other|2|||
105908387|NCT01720524|365323585|FG001|Part B|Other|0|||
105908388|NCT01720524|365323584|FG000|Part B|Lost to Follow-up|2|||
105908389|NCT01720524|365323585|FG001|Part B|Lost to Follow-up|3|||
105908390|NCT01720524|365323584|FG000|Part B|Death|0|||
105908391|NCT01720524|365323585|FG001|Part B|Death|2|||
105908392|NCT00527826|365323586|FG000|Overall Study|Adverse Event|10|||
105908393|NCT00527826|365323587|FG001|Overall Study|Adverse Event|10|||
105908394|NCT00527826|365323586|FG000|Overall Study|Lost to Follow-up|3|||
105908395|NCT00527826|365323587|FG001|Overall Study|Lost to Follow-up|2|||
105908396|NCT00527826|365323586|FG000|Overall Study|Withdrawal by Subject|5|||
105908397|NCT00527826|365323587|FG001|Overall Study|Withdrawal by Subject|8|||
105908398|NCT00527826|365323586|FG000|Overall Study|Inclusion Criteria Not Met|3|||
105908399|NCT00527826|365323587|FG001|Overall Study|Inclusion Criteria Not Met|3|||
105908400|NCT00527826|365323586|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
105908401|NCT00527826|365323587|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
105908402|NCT00527826|365323586|FG000|Overall Study|Additional Intake of Viani forte|0|||
105908403|NCT00527826|365323587|FG001|Overall Study|Additional Intake of Viani forte|1|||
105908404|NCT00527826|365323586|FG000|Overall Study|Participant moved away|0|||
105908405|NCT00527826|365323587|FG001|Overall Study|Participant moved away|1|||
105908406|NCT02105285|365323588|FG000|Overall Study|Adverse Event|1|||
105908407|NCT02105285|365323589|FG001|Overall Study|Adverse Event|1|||
105908408|NCT02105285|365323590|FG002|Overall Study|Adverse Event|0|||
105908409|NCT02105285|365323588|FG000|Overall Study|Protocol Violation|0|||
105908410|NCT02105285|365323589|FG001|Overall Study|Protocol Violation|1|||
105908411|NCT02105285|365323590|FG002|Overall Study|Protocol Violation|0|||
105908412|NCT02105285|365323588|FG000|Overall Study|Withdrawal by Subject|1|||
105908413|NCT02105285|365323589|FG001|Overall Study|Withdrawal by Subject|0|||
105908414|NCT02105285|365323590|FG002|Overall Study|Withdrawal by Subject|0|||
105908415|NCT01502033|365323593|FG000|Overall Study|1 participant had scalp discomfort|1|||
105908416|NCT01502033|365323593|FG000|Overall Study|1 participant had worsening depression|1|||
105908417|NCT01502033|365323593|FG000|Overall Study|1 participant went back to school|1|||
105908418|NCT01808261|365323594|FG000|Overall Study|Physician Decision|0|||
105908419|NCT01808261|365323595|FG001|Overall Study|Physician Decision|2|||
105908420|NCT01808261|365323594|FG000|Overall Study|Study Closed/Terminated|25|||
105908421|NCT01808261|365323595|FG001|Overall Study|Study Closed/Terminated|23|||
105908422|NCT01808261|365323594|FG000|Overall Study|Adverse event, non-fatal|2|||
105908423|NCT01808261|365323595|FG001|Overall Study|Adverse event, non-fatal|0|||
105908424|NCT01808261|365323594|FG000|Overall Study|Consent withdrawn by subject|6|||
105908425|NCT01808261|365323595|FG001|Overall Study|Consent withdrawn by subject|7|||
105908426|NCT01808261|365323594|FG000|Overall Study|Lost to Follow-up|3|||
105908427|NCT01808261|365323595|FG001|Overall Study|Lost to Follow-up|1|||
105908428|NCT02585713|365323597|FG000|Overall Study|Withdrew prior to treatment|2|||
105908429|NCT02585713|365323598|FG001|Overall Study|Withdrew prior to treatment|7|||
105671505|NCT02108964|364460686|FG006|Overall Study|Adverse Event|3|||
105671506|NCT02108964|364460687|FG007|Overall Study|Adverse Event|2|||
105671507|NCT02108964|364460680|FG000|Overall Study|Death|1|||
105671508|NCT02108964|364460681|FG001|Overall Study|Death|1|||
105671509|NCT02108964|364460682|FG002|Overall Study|Death|4|||
105671510|NCT02108964|364460683|FG003|Overall Study|Death|0|||
105908430|NCT02585713|365323597|FG000|Overall Study|Other|3|||
105908431|NCT02585713|365323598|FG001|Overall Study|Other|1|||
105908432|NCT03173456|365323599|FG000|Baseline|Medication dispensing system malfunction'|0|||
105908433|NCT03173456|365323600|FG001|Baseline|Medication dispensing system malfunction'|1|||
105908434|NCT03173456|365323601|FG002|Baseline|Medication dispensing system malfunction'|0|||
105908435|NCT03173456|365323602|FG003|Baseline|Medication dispensing system malfunction'|0|||
105908436|NCT03173456|365323603|FG004|Baseline|Medication dispensing system malfunction'|2|||
105908437|NCT03173456|365323599|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
105908438|NCT03173456|365323600|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
105908439|NCT03173456|365323601|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
105908440|NCT03173456|365323602|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
105908441|NCT03173456|365323603|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
105908442|NCT01733121|365323604|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
105908443|NCT01733121|365323605|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
105908444|NCT01733121|365323604|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
105908445|NCT01733121|365323605|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
105908446|NCT01733121|365323604|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
105908447|NCT01733121|365323605|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
105908448|NCT01733121|365323604|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
105908449|NCT01733121|365323605|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
105908450|NCT02504320|365323612|FG000|Treatment Period 1|Positive Drug Screen|0|||
105908451|NCT02504320|365323613|FG001|Treatment Period 1|Positive Drug Screen|0|||
105908452|NCT02504320|365323614|FG002|Treatment Period 1|Positive Drug Screen|1|||
105908453|NCT02504320|365323615|FG003|Treatment Period 1|Positive Drug Screen|0|||
105908454|NCT02504320|365323612|FG000|Treatment Period 2|Positive Drug Screen|0|||
105908455|NCT02504320|365323613|FG001|Treatment Period 2|Positive Drug Screen|1|||
105908456|NCT02504320|365323614|FG002|Treatment Period 2|Positive Drug Screen|0|||
105908457|NCT02504320|365323615|FG003|Treatment Period 2|Positive Drug Screen|0|||
105908458|NCT02504320|365323612|FG000|Treatment Period 3|Positive Drug Screen|0|||
105908459|NCT02504320|365323613|FG001|Treatment Period 3|Positive Drug Screen|0|||
105908460|NCT02504320|365323614|FG002|Treatment Period 3|Positive Drug Screen|0|||
105908461|NCT02504320|365323615|FG003|Treatment Period 3|Positive Drug Screen|1|||
105908462|NCT02504320|365323612|FG000|Treatment Period 3|Adverse Event|0|||
105908463|NCT02504320|365323613|FG001|Treatment Period 3|Adverse Event|0|||
105908464|NCT02504320|365323614|FG002|Treatment Period 3|Adverse Event|1|||
105908465|NCT02504320|365323615|FG003|Treatment Period 3|Adverse Event|0|||
105908466|NCT01436227|365323623|FG000|Overall Study|Adverse Event|7|||
105908467|NCT01436227|365323623|FG000|Overall Study|Death|1|||
105908468|NCT01436227|365323623|FG000|Overall Study|Lack of Efficacy|1|||
105908469|NCT01436227|365323623|FG000|Overall Study|Lost to Follow-up|3|||
105908470|NCT01436227|365323623|FG000|Overall Study|Physician Decision|1|||
105908471|NCT01436227|365323623|FG000|Overall Study|Withdrawal by Subject|7|||
105908472|NCT01436227|365323623|FG000|Overall Study|Disease progression, relapse|6|||
105908473|NCT04004260|365323624|FG000|Overall Study|Withdrawal by Subject|7|||
105908474|NCT04004260|365323625|FG001|Overall Study|Withdrawal by Subject|3|||
105908475|NCT04004260|365323624|FG000|Overall Study|Lost to Follow-up|22|||
105908476|NCT04004260|365323625|FG001|Overall Study|Lost to Follow-up|12|||
105908477|NCT04004260|365323624|FG000|Overall Study|Did not engage in intervention|13|||
105908478|NCT04004260|365323625|FG001|Overall Study|Did not engage in intervention|17|||
105908479|NCT02360280|365323636|FG000|Overall Study|Withdrawal by Subject|2|||
105908480|NCT02360280|365323637|FG001|Overall Study|Withdrawal by Subject|0|||
105908481|NCT02360280|365323636|FG000|Overall Study|Adverse Event|0|||
105908482|NCT02360280|365323637|FG001|Overall Study|Adverse Event|1|||
105908483|NCT02360280|365323636|FG000|Overall Study|Lost to Follow-up|1|||
105908484|NCT02360280|365323637|FG001|Overall Study|Lost to Follow-up|0|||
105908485|NCT05464420|365323638|FG000|Overall Study|Death|0|||
105908486|NCT05464420|365323639|FG001|Overall Study|Death|0|||
105908487|NCT05464420|365323640|FG002|Overall Study|Death|0|||
105908488|NCT05464420|365323641|FG003|Overall Study|Death|1|||
105908489|NCT05464420|365323638|FG000|Overall Study|Lost to Follow-up|16|||
105908490|NCT05464420|365323639|FG001|Overall Study|Lost to Follow-up|11|||
105908491|NCT05464420|365323640|FG002|Overall Study|Lost to Follow-up|11|||
105908492|NCT05464420|365323641|FG003|Overall Study|Lost to Follow-up|11|||
105908493|NCT05464420|365323638|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
105908494|NCT05464420|365323639|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
105908495|NCT05464420|365323640|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
105908496|NCT05464420|365323641|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
105908497|NCT05464420|365323638|FG000|Overall Study|Withdrawal by Subject|4|||
105908498|NCT05464420|365323639|FG001|Overall Study|Withdrawal by Subject|8|||
105908499|NCT05464420|365323640|FG002|Overall Study|Withdrawal by Subject|3|||
105908500|NCT05464420|365323641|FG003|Overall Study|Withdrawal by Subject|1|||
105671511|NCT02108964|364460684|FG004|Overall Study|Death|3|||
105671512|NCT02108964|364460685|FG005|Overall Study|Death|0|||
105908501|NCT05464420|365323638|FG000|Overall Study|Protocol Violation|0|||
105908502|NCT05464420|365323639|FG001|Overall Study|Protocol Violation|0|||
105908503|NCT05464420|365323640|FG002|Overall Study|Protocol Violation|1|||
105908504|NCT05464420|365323641|FG003|Overall Study|Protocol Violation|1|||
105908505|NCT05464420|365323638|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
105908506|NCT05464420|365323639|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
105908507|NCT05464420|365323640|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
105908508|NCT05464420|365323641|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
105908509|NCT01383018|365323642|FG000|Overall Study|Adverse Event|14|||
105908510|NCT01383018|365323642|FG000|Overall Study|Death|10|||
105908511|NCT01383018|365323642|FG000|Overall Study|Lost to Follow-up|5|||
105908512|NCT01383018|365323642|FG000|Overall Study|Physician Decision|5|||
105908513|NCT01383018|365323642|FG000|Overall Study|Withdrawal by Subject|9|||
105908514|NCT01383018|365323642|FG000|Overall Study|Subject not implanted|76|||
105908515|NCT01383018|365323642|FG000|Overall Study|Missed Visit|247|||
105908516|NCT01383018|365323642|FG000|Overall Study|Site closed early-not compliance related|7|||
105908517|NCT01383018|365323642|FG000|Overall Study|Patient moved away from site|1|||
105908518|NCT01383018|365323642|FG000|Overall Study|Subject Incarcerated|1|||
105908519|NCT01051817|365323643|FG000|Overall Study|Adverse Event|0|||
105908520|NCT01051817|365323644|FG001|Overall Study|Adverse Event|2|||
105908521|NCT01051817|365323643|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
105908522|NCT01051817|365323644|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
105908523|NCT01051817|365323643|FG000|Overall Study|Withdrawal by Subject|3|||
105908524|NCT01051817|365323644|FG001|Overall Study|Withdrawal by Subject|5|||
105908525|NCT01051817|365323643|FG000|Overall Study|Protocol Violation|0|||
105999204|NCT00113841|365659420|FG001|Overall Study|Non-compliant|0|||
105999205|NCT01092728|365659421|FG000|Overall Study|Withdrawal by Subject|2|||
105999206|NCT01092728|365659422|FG001|Overall Study|Withdrawal by Subject|0|||
105999207|NCT01092728|365659421|FG000|Overall Study|Adverse Event|0|||
105999208|NCT01092728|365659422|FG001|Overall Study|Adverse Event|1|||
105999209|NCT01092728|365659421|FG000|Overall Study|Disease Progression|1|||
105999210|NCT01092728|365659422|FG001|Overall Study|Disease Progression|13|||
105999211|NCT01092728|365659421|FG000|Overall Study|Prohibited Concomitant Medications|1|||
105999212|NCT01092728|365659422|FG001|Overall Study|Prohibited Concomitant Medications|0|||
105999213|NCT01788566|365659429|FG000|Overall Study|Death|4|||
105999214|NCT01788566|365659429|FG000|Overall Study|Adverse Event|1|||
105999215|NCT01788566|365659429|FG000|Overall Study|Clinical Progressive Disease|3|||
105999216|NCT02721875|365659433|FG000|Overall Study|Progressive disease/relapse|1|||
105999217|NCT02721875|365659434|FG001|Overall Study|Progressive disease/relapse|0|||
105999218|NCT01332994|365659442|FG000|Overall Study|Adverse Event|34|||
105999219|NCT01332994|365659442|FG000|Overall Study|Death|1|||
105999220|NCT01332994|365659442|FG000|Overall Study|Lack of Efficacy|1|||
105999221|NCT01332994|365659442|FG000|Overall Study|Lost to Follow-up|4|||
105999222|NCT01332994|365659442|FG000|Overall Study|Protocol Violation|6|||
105671513|NCT02108964|364460686|FG006|Overall Study|Death|0|||
105908526|NCT01051817|365323644|FG001|Overall Study|Protocol Violation|1|||
105908527|NCT00320788|365323646|FG000|Overall Study|Adverse Event|0|||
105908528|NCT00320788|365323647|FG001|Overall Study|Adverse Event|0|||
105908529|NCT00320788|365323648|FG002|Overall Study|Adverse Event|0|||
105908530|NCT00320788|365323649|FG003|Overall Study|Adverse Event|1|||
105908531|NCT00320788|365323650|FG004|Overall Study|Adverse Event|0|||
105908532|NCT00320788|365323646|FG000|Overall Study|Death|0|||
105908533|NCT00320788|365323647|FG001|Overall Study|Death|0|||
105908534|NCT00320788|365323648|FG002|Overall Study|Death|1|||
105908535|NCT00320788|365323649|FG003|Overall Study|Death|0|||
105908536|NCT00320788|365323650|FG004|Overall Study|Death|1|||
105908537|NCT00320788|365323646|FG000|Overall Study|Lost to Follow-up|0|||
105908538|NCT00320788|365323647|FG001|Overall Study|Lost to Follow-up|2|||
105908539|NCT00320788|365323648|FG002|Overall Study|Lost to Follow-up|1|||
105908540|NCT00320788|365323649|FG003|Overall Study|Lost to Follow-up|0|||
105908541|NCT00320788|365323650|FG004|Overall Study|Lost to Follow-up|0|||
105908542|NCT00320788|365323646|FG000|Overall Study|Decision by the Sponsor|1|||
105908543|NCT00320788|365323647|FG001|Overall Study|Decision by the Sponsor|1|||
105908544|NCT00320788|365323648|FG002|Overall Study|Decision by the Sponsor|0|||
105908545|NCT00320788|365323649|FG003|Overall Study|Decision by the Sponsor|0|||
105908546|NCT00320788|365323650|FG004|Overall Study|Decision by the Sponsor|1|||
105908547|NCT00320788|365323646|FG000|Overall Study|Other|1|||
105908548|NCT00320788|365323647|FG001|Overall Study|Other|2|||
105908549|NCT00320788|365323648|FG002|Overall Study|Other|1|||
105908550|NCT00320788|365323649|FG003|Overall Study|Other|1|||
105908551|NCT00320788|365323650|FG004|Overall Study|Other|1|||
105908552|NCT00320788|365323646|FG000|Overall Study|Physician Decision|1|||
105908553|NCT00320788|365323647|FG001|Overall Study|Physician Decision|1|||
105908554|NCT00320788|365323648|FG002|Overall Study|Physician Decision|0|||
105999223|NCT01332994|365659442|FG000|Overall Study|Withdrawal by Subject|15|||
105999224|NCT01332994|365659442|FG000|Overall Study|Administrative Problem|2|||
105908555|NCT00320788|365323649|FG003|Overall Study|Physician Decision|0|||
105908556|NCT00320788|365323650|FG004|Overall Study|Physician Decision|0|||
105908557|NCT00320788|365323646|FG000|Overall Study|Protocol Violation|0|||
105908558|NCT00320788|365323647|FG001|Overall Study|Protocol Violation|0|||
105671514|NCT02108964|364460687|FG007|Overall Study|Death|2|||
105671515|NCT02108964|364460680|FG000|Overall Study|Subject/Guardian decision|0|||
105671516|NCT02108964|364460681|FG001|Overall Study|Subject/Guardian decision|1|||
105671517|NCT02108964|364460682|FG002|Overall Study|Subject/Guardian decision|4|||
105671518|NCT02108964|364460683|FG003|Overall Study|Subject/Guardian decision|0|||
105671519|NCT02108964|364460684|FG004|Overall Study|Subject/Guardian decision|2|||
105671520|NCT02108964|364460685|FG005|Overall Study|Subject/Guardian decision|0|||
105671521|NCT02108964|364460686|FG006|Overall Study|Subject/Guardian decision|1|||
105671522|NCT02108964|364460687|FG007|Overall Study|Subject/Guardian decision|2|||
105671523|NCT02108964|364460680|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671524|NCT02108964|364460681|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671525|NCT02108964|364460682|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671526|NCT02108964|364460683|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671527|NCT02108964|364460684|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671528|NCT02108964|364460685|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671529|NCT02108964|364460686|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
105671530|NCT02108964|364460687|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
105671531|NCT02626455|364460688|FG000|Overall Study|Other|1|||
105671532|NCT02626455|364460689|FG001|Overall Study|Other|1|||
105671533|NCT02626455|364460690|FG002|Overall Study|Other|0|||
105671534|NCT02626455|364460691|FG003|Overall Study|Other|0|||
105671535|NCT02626455|364460692|FG004|Overall Study|Other|0|||
105671536|NCT02626455|364460693|FG005|Overall Study|Other|17|||
105671537|NCT02626455|364460694|FG006|Overall Study|Other|23|||
105671538|NCT02626455|364460688|FG000|Overall Study|Withdrawal by Subject|1|||
105671539|NCT02626455|364460689|FG001|Overall Study|Withdrawal by Subject|0|||
105671540|NCT02626455|364460690|FG002|Overall Study|Withdrawal by Subject|0|||
105671541|NCT02626455|364460691|FG003|Overall Study|Withdrawal by Subject|0|||
105671542|NCT02626455|364460692|FG004|Overall Study|Withdrawal by Subject|0|||
105671543|NCT02626455|364460693|FG005|Overall Study|Withdrawal by Subject|10|||
105671544|NCT02626455|364460694|FG006|Overall Study|Withdrawal by Subject|6|||
105671545|NCT02626455|364460688|FG000|Overall Study|Physician Decision|0|||
105671546|NCT02626455|364460689|FG001|Overall Study|Physician Decision|2|||
105671547|NCT02626455|364460690|FG002|Overall Study|Physician Decision|2|||
105671548|NCT02626455|364460691|FG003|Overall Study|Physician Decision|2|||
105671549|NCT02626455|364460692|FG004|Overall Study|Physician Decision|1|||
105671550|NCT02626455|364460693|FG005|Overall Study|Physician Decision|10|||
105671551|NCT02626455|364460694|FG006|Overall Study|Physician Decision|3|||
105671552|NCT02626455|364460688|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671553|NCT02626455|364460689|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671554|NCT02626455|364460690|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671555|NCT02626455|364460691|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671556|NCT02626455|364460692|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671557|NCT02626455|364460693|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
105671558|NCT02626455|364460694|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
105671559|NCT02626455|364460688|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671560|NCT02626455|364460689|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671561|NCT02626455|364460690|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671562|NCT02626455|364460691|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671563|NCT02626455|364460692|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671564|NCT02626455|364460693|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
105671565|NCT02626455|364460694|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
105671566|NCT02626455|364460688|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671567|NCT02626455|364460689|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671568|NCT02626455|364460690|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671569|NCT02626455|364460691|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671570|NCT02626455|364460692|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
105671571|NCT02626455|364460693|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
105671572|NCT02626455|364460694|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
105671573|NCT02626455|364460688|FG000|Overall Study|Patient decision|0|||
105671574|NCT02626455|364460689|FG001|Overall Study|Patient decision|1|||
105671575|NCT02626455|364460690|FG002|Overall Study|Patient decision|0|||
105671576|NCT02626455|364460691|FG003|Overall Study|Patient decision|0|||
105671577|NCT02626455|364460692|FG004|Overall Study|Patient decision|1|||
105671578|NCT02626455|364460693|FG005|Overall Study|Patient decision|36|||
105786206|NCT00972309|364870478|FG001|Overall Study|Second malignancy|1|||
105786207|NCT00972309|364870477|FG000|Overall Study|Visa issues|0|||
105908559|NCT00320788|365323648|FG002|Overall Study|Protocol Violation|0|||
105671579|NCT02626455|364460694|FG006|Overall Study|Patient decision|22|||
105671580|NCT02626455|364460688|FG000|Overall Study|Protocol Violation|0|||
105671581|NCT02626455|364460689|FG001|Overall Study|Protocol Violation|0|||
105671582|NCT02626455|364460690|FG002|Overall Study|Protocol Violation|0|||
105671583|NCT02626455|364460691|FG003|Overall Study|Protocol Violation|0|||
105671584|NCT02626455|364460692|FG004|Overall Study|Protocol Violation|0|||
105671585|NCT02626455|364460693|FG005|Overall Study|Protocol Violation|0|||
105671586|NCT02626455|364460694|FG006|Overall Study|Protocol Violation|1|||
105671587|NCT02626455|364460688|FG000|Overall Study|Progressive disease - radiological progression|0|||
105671588|NCT02626455|364460689|FG001|Overall Study|Progressive disease - radiological progression|0|||
105671589|NCT02626455|364460690|FG002|Overall Study|Progressive disease - radiological progression|0|||
105671590|NCT02626455|364460691|FG003|Overall Study|Progressive disease - radiological progression|0|||
105671591|NCT02626455|364460692|FG004|Overall Study|Progressive disease - radiological progression|0|||
105671592|NCT02626455|364460693|FG005|Overall Study|Progressive disease - radiological progression|11|||
105671593|NCT02626455|364460694|FG006|Overall Study|Progressive disease - radiological progression|22|||
105671594|NCT02626455|364460688|FG000|Overall Study|Progressive disease - clinical progression|0|||
105671595|NCT02626455|364460689|FG001|Overall Study|Progressive disease - clinical progression|0|||
105671596|NCT02626455|364460690|FG002|Overall Study|Progressive disease - clinical progression|0|||
105671597|NCT02626455|364460691|FG003|Overall Study|Progressive disease - clinical progression|0|||
105671598|NCT02626455|364460692|FG004|Overall Study|Progressive disease - clinical progression|0|||
105671599|NCT02626455|364460693|FG005|Overall Study|Progressive disease - clinical progression|1|||
105671600|NCT02626455|364460694|FG006|Overall Study|Progressive disease - clinical progression|2|||
105671601|NCT02626455|364460688|FG000|Overall Study|Lost to Follow-up|0|||
105671602|NCT02626455|364460689|FG001|Overall Study|Lost to Follow-up|0|||
105671603|NCT02626455|364460690|FG002|Overall Study|Lost to Follow-up|0|||
105671604|NCT02626455|364460691|FG003|Overall Study|Lost to Follow-up|0|||
105671605|NCT02626455|364460692|FG004|Overall Study|Lost to Follow-up|0|||
105671606|NCT02626455|364460693|FG005|Overall Study|Lost to Follow-up|1|||
105671607|NCT02626455|364460694|FG006|Overall Study|Lost to Follow-up|0|||
105671608|NCT02626455|364460688|FG000|Overall Study|AE not associated with clinical disease progression|1|||
105671609|NCT02626455|364460689|FG001|Overall Study|AE not associated with clinical disease progression|1|||
105671610|NCT02626455|364460690|FG002|Overall Study|AE not associated with clinical disease progression|0|||
105671611|NCT02626455|364460691|FG003|Overall Study|AE not associated with clinical disease progression|2|||
105671612|NCT02626455|364460692|FG004|Overall Study|AE not associated with clinical disease progression|1|||
105671613|NCT02626455|364460693|FG005|Overall Study|AE not associated with clinical disease progression|65|||
105671614|NCT02626455|364460694|FG006|Overall Study|AE not associated with clinical disease progression|21|||
105671615|NCT02626455|364460688|FG000|Overall Study|AE associated with clinical disease progression|0|||
105671616|NCT02626455|364460689|FG001|Overall Study|AE associated with clinical disease progression|0|||
105671617|NCT02626455|364460690|FG002|Overall Study|AE associated with clinical disease progression|0|||
105671618|NCT02626455|364460691|FG003|Overall Study|AE associated with clinical disease progression|0|||
105671619|NCT02626455|364460692|FG004|Overall Study|AE associated with clinical disease progression|0|||
105671620|NCT02626455|364460693|FG005|Overall Study|AE associated with clinical disease progression|1|||
105671621|NCT02626455|364460694|FG006|Overall Study|AE associated with clinical disease progression|2|||
105671622|NCT02626455|364460688|FG000|Overall Study|Study intervention never administered|0|||
105671623|NCT02626455|364460689|FG001|Overall Study|Study intervention never administered|0|||
105671624|NCT02626455|364460690|FG002|Overall Study|Study intervention never administered|0|||
105671625|NCT02626455|364460691|FG003|Overall Study|Study intervention never administered|0|||
105671626|NCT02626455|364460692|FG004|Overall Study|Study intervention never administered|0|||
105671627|NCT02626455|364460693|FG005|Overall Study|Study intervention never administered|1|||
105671628|NCT02626455|364460694|FG006|Overall Study|Study intervention never administered|3|||
105671629|NCT00384397|364460698|FG000|Overall Study|Adverse Event|0|||
105671630|NCT00384397|364460699|FG001|Overall Study|Adverse Event|1|||
105671631|NCT00384397|364460700|FG002|Overall Study|Adverse Event|2|||
105671632|NCT00384397|364460698|FG000|Overall Study|Protocol Violation|7|||
105671633|NCT00384397|364460699|FG001|Overall Study|Protocol Violation|15|||
105671634|NCT00384397|364460700|FG002|Overall Study|Protocol Violation|13|||
105671635|NCT00384397|364460698|FG000|Overall Study|Lost to Follow-up|11|||
105671636|NCT00384397|364460699|FG001|Overall Study|Lost to Follow-up|13|||
105671637|NCT00384397|364460700|FG002|Overall Study|Lost to Follow-up|3|||
105671638|NCT00384397|364460698|FG000|Overall Study|Withdrawal by Subject|14|||
105671639|NCT00384397|364460699|FG001|Overall Study|Withdrawal by Subject|17|||
105671640|NCT00384397|364460700|FG002|Overall Study|Withdrawal by Subject|15|||
105671641|NCT01214642|364460701|FG000|Overall Study|Progressive Disease|3|||
105671642|NCT01214642|364460702|FG001|Overall Study|Progressive Disease|2|||
105671643|NCT01214642|364460703|FG002|Overall Study|Progressive Disease|3|||
105671644|NCT01214642|364460704|FG003|Overall Study|Progressive Disease|5|||
105671645|NCT01214642|364460705|FG004|Overall Study|Progressive Disease|5|||
105671646|NCT01214642|364460706|FG005|Overall Study|Progressive Disease|3|||
105671647|NCT01214642|364460707|FG006|Overall Study|Progressive Disease|5|||
105908560|NCT00320788|365323649|FG003|Overall Study|Protocol Violation|0|||
105671648|NCT01214642|364460708|FG007|Overall Study|Progressive Disease|3|||
105671649|NCT01214642|364460709|FG008|Overall Study|Progressive Disease|10|||
105671650|NCT01214642|364460710|FG009|Overall Study|Progressive Disease|2|||
105671651|NCT01214642|364460711|FG010|Overall Study|Progressive Disease|1|||
105671652|NCT01214642|364460712|FG011|Overall Study|Progressive Disease|4|||
105671653|NCT01214642|364460701|FG000|Overall Study|Adverse Event|0|||
105671654|NCT01214642|364460702|FG001|Overall Study|Adverse Event|1|||
105671655|NCT01214642|364460703|FG002|Overall Study|Adverse Event|0|||
105671656|NCT01214642|364460704|FG003|Overall Study|Adverse Event|0|||
105671657|NCT01214642|364460705|FG004|Overall Study|Adverse Event|0|||
105671658|NCT01214642|364460706|FG005|Overall Study|Adverse Event|0|||
105671659|NCT01214642|364460707|FG006|Overall Study|Adverse Event|1|||
105671660|NCT01214642|364460708|FG007|Overall Study|Adverse Event|0|||
105671661|NCT01214642|364460709|FG008|Overall Study|Adverse Event|0|||
105671662|NCT01214642|364460710|FG009|Overall Study|Adverse Event|1|||
105671663|NCT01214642|364460711|FG010|Overall Study|Adverse Event|1|||
105671664|NCT01214642|364460712|FG011|Overall Study|Adverse Event|0|||
105671665|NCT01214642|364460701|FG000|Overall Study|Death|0|||
105671666|NCT01214642|364460702|FG001|Overall Study|Death|0|||
105671667|NCT01214642|364460703|FG002|Overall Study|Death|1|||
105671668|NCT01214642|364460704|FG003|Overall Study|Death|0|||
105671669|NCT01214642|364460705|FG004|Overall Study|Death|0|||
105671670|NCT01214642|364460706|FG005|Overall Study|Death|0|||
105671671|NCT01214642|364460707|FG006|Overall Study|Death|0|||
105671672|NCT01214642|364460708|FG007|Overall Study|Death|0|||
105671673|NCT01214642|364460709|FG008|Overall Study|Death|0|||
105671674|NCT01214642|364460710|FG009|Overall Study|Death|0|||
105671675|NCT01214642|364460711|FG010|Overall Study|Death|1|||
105908561|NCT00320788|365323650|FG004|Overall Study|Protocol Violation|1|||
105908562|NCT00320788|365323646|FG000|Overall Study|Withdrawal by Subject|3|||
105908563|NCT00320788|365323647|FG001|Overall Study|Withdrawal by Subject|0|||
105908564|NCT00320788|365323648|FG002|Overall Study|Withdrawal by Subject|0|||
105908565|NCT00320788|365323649|FG003|Overall Study|Withdrawal by Subject|3|||
105908566|NCT00320788|365323650|FG004|Overall Study|Withdrawal by Subject|1|||
105908567|NCT03414229|365323651|FG000|Overall Study|Adverse Event|1|||
105908568|NCT03414229|365323652|FG001|Overall Study|Adverse Event|0|||
105671676|NCT01214642|364460712|FG011|Overall Study|Death|0|||
105671677|NCT01214642|364460701|FG000|Overall Study|Withdrawal by Subject|0|||
105671678|NCT01214642|364460702|FG001|Overall Study|Withdrawal by Subject|0|||
105671679|NCT01214642|364460703|FG002|Overall Study|Withdrawal by Subject|1|||
105671680|NCT01214642|364460704|FG003|Overall Study|Withdrawal by Subject|0|||
105671681|NCT01214642|364460705|FG004|Overall Study|Withdrawal by Subject|0|||
105671682|NCT01214642|364460706|FG005|Overall Study|Withdrawal by Subject|0|||
105671683|NCT01214642|364460707|FG006|Overall Study|Withdrawal by Subject|0|||
105671684|NCT01214642|364460708|FG007|Overall Study|Withdrawal by Subject|0|||
105671685|NCT01214642|364460709|FG008|Overall Study|Withdrawal by Subject|3|||
105786208|NCT00972309|364870478|FG001|Overall Study|Visa issues|1|||
105786209|NCT00972309|364870477|FG000|Overall Study|Secondary cancer (SCC)|0|||
105786210|NCT00972309|364870478|FG001|Overall Study|Secondary cancer (SCC)|1|||
105908569|NCT03414229|365323653|FG002|Overall Study|Adverse Event|2|||
105908570|NCT03414229|365323654|FG003|Overall Study|Adverse Event|1|||
105908571|NCT03414229|365323651|FG000|Overall Study|Lack of Efficacy|7|||
105908572|NCT03414229|365323652|FG001|Overall Study|Lack of Efficacy|4|||
105908573|NCT03414229|365323653|FG002|Overall Study|Lack of Efficacy|1|||
105908574|NCT03414229|365323654|FG003|Overall Study|Lack of Efficacy|9|||
105908575|NCT03414229|365323651|FG000|Overall Study|Change in therapy|1|||
105908576|NCT03414229|365323652|FG001|Overall Study|Change in therapy|0|||
105908577|NCT03414229|365323653|FG002|Overall Study|Change in therapy|0|||
105908578|NCT03414229|365323654|FG003|Overall Study|Change in therapy|0|||
105908579|NCT03414229|365323651|FG000|Overall Study|Pregnancy|0|||
105908580|NCT03414229|365323652|FG001|Overall Study|Pregnancy|0|||
105908581|NCT03414229|365323653|FG002|Overall Study|Pregnancy|1|||
105908582|NCT03414229|365323654|FG003|Overall Study|Pregnancy|0|||
105908583|NCT03414229|365323651|FG000|Overall Study|Withdrawal by Subject|0|||
105908584|NCT03414229|365323652|FG001|Overall Study|Withdrawal by Subject|1|||
105908585|NCT03414229|365323653|FG002|Overall Study|Withdrawal by Subject|1|||
105908586|NCT03414229|365323654|FG003|Overall Study|Withdrawal by Subject|0|||
105908587|NCT04533438|365323655|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
105908588|NCT04533438|365323656|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
105671686|NCT01214642|364460710|FG009|Overall Study|Withdrawal by Subject|1|||
105671687|NCT01214642|364460711|FG010|Overall Study|Withdrawal by Subject|1|||
105671688|NCT01214642|364460712|FG011|Overall Study|Withdrawal by Subject|0|||
105671689|NCT01214642|364460701|FG000|Overall Study|Physician Decision|0|||
105671690|NCT01214642|364460702|FG001|Overall Study|Physician Decision|0|||
105671691|NCT01214642|364460703|FG002|Overall Study|Physician Decision|1|||
105671692|NCT01214642|364460704|FG003|Overall Study|Physician Decision|1|||
105786211|NCT00972309|364870477|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
105908589|NCT03472521|365323660|FG000|Overall Study|Lost to Follow-up|3|||
105908590|NCT03472521|365323661|FG001|Overall Study|Lost to Follow-up|2|||
105908591|NCT03472521|365323660|FG000|Overall Study|Discontinued intervention|3|||
105671693|NCT01214642|364460705|FG004|Overall Study|Physician Decision|1|||
105999225|NCT01332994|365659442|FG000|Overall Study|Other|8|||
105999226|NCT04170543|365659445|FG000|Overall Study|Death|1|||
105999227|NCT04170543|365659446|FG001|Overall Study|Death|1|||
105999228|NCT04170543|365659447|FG002|Overall Study|Death|1|||
105999229|NCT04170543|365659448|FG003|Overall Study|Death|1|||
105999230|NCT04170543|365659449|FG004|Overall Study|Death|1|||
105999231|NCT04170543|365659445|FG000|Overall Study|Lost to Follow-up|3|||
105999232|NCT04170543|365659446|FG001|Overall Study|Lost to Follow-up|3|||
105999233|NCT04170543|365659447|FG002|Overall Study|Lost to Follow-up|0|||
105999234|NCT04170543|365659448|FG003|Overall Study|Lost to Follow-up|3|||
105999235|NCT04170543|365659449|FG004|Overall Study|Lost to Follow-up|1|||
105999236|NCT04170543|365659445|FG000|Overall Study|Withdrawal by Subject|13|||
105999237|NCT04170543|365659446|FG001|Overall Study|Withdrawal by Subject|6|||
105999238|NCT04170543|365659447|FG002|Overall Study|Withdrawal by Subject|5|||
105999239|NCT04170543|365659448|FG003|Overall Study|Withdrawal by Subject|4|||
105999240|NCT04170543|365659449|FG004|Overall Study|Withdrawal by Subject|9|||
105999241|NCT04170543|365659445|FG000|Overall Study|Not able to transition to phase 2b|8|||
105999242|NCT04170543|365659446|FG001|Overall Study|Not able to transition to phase 2b|0|||
105999243|NCT04170543|365659447|FG002|Overall Study|Not able to transition to phase 2b|10|||
105999244|NCT04170543|365659448|FG003|Overall Study|Not able to transition to phase 2b|0|||
105999245|NCT04170543|365659449|FG004|Overall Study|Not able to transition to phase 2b|6|||
105999246|NCT04170543|365659445|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
105999247|NCT04170543|365659446|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
105999248|NCT04170543|365659447|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
105999249|NCT04170543|365659448|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
105999250|NCT04170543|365659449|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
105999251|NCT04170543|365659445|FG000|Overall Study|Not Treated|0|||
105999252|NCT04170543|365659446|FG001|Overall Study|Not Treated|0|||
105999253|NCT04170543|365659447|FG002|Overall Study|Not Treated|0|||
105999254|NCT04170543|365659448|FG003|Overall Study|Not Treated|0|||
105999255|NCT04170543|365659449|FG004|Overall Study|Not Treated|2|||
105999256|NCT04170543|365659445|FG000|Overall Study|(CRF)|16|||
105999257|NCT04170543|365659446|FG001|Overall Study|(CRF)|15|||
105999258|NCT04170543|365659447|FG002|Overall Study|(CRF)|12|||
105999259|NCT04170543|365659448|FG003|Overall Study|(CRF)|17|||
105999260|NCT04170543|365659449|FG004|Overall Study|(CRF)|17|||
105999261|NCT04170543|365659445|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
105999262|NCT04170543|365659446|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
105999263|NCT04170543|365659447|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
105999264|NCT04170543|365659448|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
105999265|NCT04170543|365659449|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
105999266|NCT04628780|365659450|FG000|Overall Study|Death|0|||
105999267|NCT04628780|365659451|FG001|Overall Study|Death|1|||
105999268|NCT04628780|365659452|FG002|Overall Study|Death|0|||
105999269|NCT04628780|365659453|FG003|Overall Study|Death|0|||
105999270|NCT04628780|365659454|FG004|Overall Study|Death|1|||
105999271|NCT04628780|365659455|FG005|Overall Study|Death|0|||
105999272|NCT04628780|365659450|FG000|Overall Study|Physician Decision|2|||
105999273|NCT04628780|365659451|FG001|Overall Study|Physician Decision|0|||
105999274|NCT04628780|365659452|FG002|Overall Study|Physician Decision|0|||
105671694|NCT01214642|364460706|FG005|Overall Study|Physician Decision|0|||
105671695|NCT01214642|364460707|FG006|Overall Study|Physician Decision|0|||
105671696|NCT01214642|364460708|FG007|Overall Study|Physician Decision|0|||
105671697|NCT01214642|364460709|FG008|Overall Study|Physician Decision|0|||
105671698|NCT01214642|364460710|FG009|Overall Study|Physician Decision|0|||
105671699|NCT01214642|364460711|FG010|Overall Study|Physician Decision|0|||
105999275|NCT04628780|365659453|FG003|Overall Study|Physician Decision|0|||
105786212|NCT00972309|364870478|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
105786213|NCT00972309|364870477|FG000|Overall Study|Lost to Follow-up|1|||
105999276|NCT04628780|365659454|FG004|Overall Study|Physician Decision|2|||
105999277|NCT04628780|365659455|FG005|Overall Study|Physician Decision|0|||
105999278|NCT04628780|365659450|FG000|Overall Study|Progressive disease|2|||
105999279|NCT04628780|365659451|FG001|Overall Study|Progressive disease|2|||
105999280|NCT04628780|365659452|FG002|Overall Study|Progressive disease|2|||
105999281|NCT04628780|365659453|FG003|Overall Study|Progressive disease|3|||
105999282|NCT04628780|365659454|FG004|Overall Study|Progressive disease|9|||
105671700|NCT01214642|364460712|FG011|Overall Study|Physician Decision|2|||
105671701|NCT01241604|364460716|FG000|Screening Period|Screen Failure|3|||
105999283|NCT04628780|365659455|FG005|Overall Study|Progressive disease|4|||
105999284|NCT04628780|365659450|FG000|Overall Study|Withdrawal by Subject|0|||
105999285|NCT04628780|365659451|FG001|Overall Study|Withdrawal by Subject|1|||
105671702|NCT01241604|364460717|FG001|Screening Period|Screen Failure|0|||
105671703|NCT01241604|364460718|FG002|Screening Period|Screen Failure|0|||
105671704|NCT02304705|364462510|FG000|Overall Study|Withdrawal by Subject|2|||
105671705|NCT02304705|364462511|FG001|Overall Study|Withdrawal by Subject|0|||
105671706|NCT02304705|364462510|FG000|Overall Study|Physician Decision|2|||
105671707|NCT02304705|364462511|FG001|Overall Study|Physician Decision|4|||
105671708|NCT02304705|364462510|FG000|Overall Study|Death|0|||
105671709|NCT02304705|364462511|FG001|Overall Study|Death|1|||
105671710|NCT02304705|364462510|FG000|Overall Study|Lost to Follow-up|0|||
105786214|NCT00972309|364870478|FG001|Overall Study|Lost to Follow-up|1|||
105786215|NCT00972309|364870477|FG000|Overall Study|Disease progression on study|10|||
105908592|NCT03472521|365323661|FG001|Overall Study|Discontinued intervention|1|||
105908593|NCT04235504|365323663|FG000|Study Phase|Withdrawal by Subject|5|||
105908594|NCT04235504|365323664|FG001|Study Phase|Withdrawal by Subject|2|||
105908595|NCT04235504|365323665|FG002|Study Phase|Withdrawal by Subject|0|||
105908596|NCT04235504|365323666|FG003|Study Phase|Withdrawal by Subject|0|||
105908597|NCT04235504|365323663|FG000|Continuation Phase|Withdrawal by Subject|0|||
105908598|NCT04235504|365323664|FG001|Continuation Phase|Withdrawal by Subject|4|||
105908599|NCT04235504|365323665|FG002|Continuation Phase|Withdrawal by Subject|0|||
105908600|NCT04235504|365323666|FG003|Continuation Phase|Withdrawal by Subject|0|||
105908601|NCT04235504|365323663|FG000|Continuation Phase|Adverse Event|0|||
105908602|NCT04235504|365323664|FG001|Continuation Phase|Adverse Event|1|||
105908603|NCT04235504|365323665|FG002|Continuation Phase|Adverse Event|0|||
105908604|NCT04235504|365323666|FG003|Continuation Phase|Adverse Event|0|||
105908605|NCT04235504|365323663|FG000|Continuation Phase|Physician Decision|1|||
105908606|NCT04235504|365323664|FG001|Continuation Phase|Physician Decision|2|||
105908607|NCT04235504|365323665|FG002|Continuation Phase|Physician Decision|1|||
105908608|NCT04235504|365323666|FG003|Continuation Phase|Physician Decision|0|||
105908609|NCT00803712|365325190|FG000|Overall Study|Noncompliance|3|||
105908610|NCT00803712|365325191|FG001|Overall Study|Noncompliance|0|||
105908611|NCT00803712|365325190|FG000|Overall Study|Adverse Event|5|||
105908612|NCT00803712|365325191|FG001|Overall Study|Adverse Event|0|||
105908613|NCT00803712|365325190|FG000|Overall Study|Death|8|||
105908614|NCT00803712|365325191|FG001|Overall Study|Death|7|||
105908615|NCT00803712|365325190|FG000|Overall Study|Lost to Follow-up|3|||
105908616|NCT00803712|365325191|FG001|Overall Study|Lost to Follow-up|1|||
105908617|NCT00803712|365325190|FG000|Overall Study|Withdrawal by Subject|2|||
105908618|NCT00803712|365325191|FG001|Overall Study|Withdrawal by Subject|4|||
105908619|NCT00803712|365325190|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
105908620|NCT00803712|365325191|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
105908621|NCT00803712|365325190|FG000|Overall Study|Protocol criteria (other)|0|||
105908622|NCT00803712|365325191|FG001|Overall Study|Protocol criteria (other)|2|||
105908623|NCT00803712|365325190|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
105908624|NCT00803712|365325191|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
105908625|NCT00803712|365325190|FG000|Overall Study|Administrative decision|2|||
105908626|NCT00803712|365325191|FG001|Overall Study|Administrative decision|3|||
105908627|NCT00803712|365325190|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
105908628|NCT00803712|365325191|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
105908629|NCT00463801|365325193|FG000|Overall Study|Protocol Violation|1|||
105908630|NCT00463801|365325193|FG000|Overall Study|Lack of Efficacy|2|||
105908631|NCT00463801|365325193|FG000|Overall Study|Adverse Event|4|||
105908632|NCT00463801|365325193|FG000|Overall Study|Lost to Follow-up|5|||
105908633|NCT00463801|365325193|FG000|Overall Study|No longer require therapy|1|||
105908634|NCT02861664|365325196|FG000|Overall Study|Withdrawal of Consent|0|||
105908635|NCT02861664|365325197|FG001|Overall Study|Withdrawal of Consent|1|||
105908636|NCT01223404|365325199|FG000|First Intervention (1 Day)|Adverse Event|0|||
105908637|NCT01223404|365325200|FG001|First Intervention (1 Day)|Adverse Event|0|||
105908638|NCT01223404|365325201|FG002|First Intervention (1 Day)|Adverse Event|0|||
105908639|NCT01223404|365325202|FG003|First Intervention (1 Day)|Adverse Event|1|||
105908640|NCT01223404|365325203|FG004|First Intervention (1 Day)|Adverse Event|0|||
105908641|NCT01223404|365325204|FG005|First Intervention (1 Day)|Adverse Event|0|||
105908642|NCT01223404|365325199|FG000|Second Intervention (1 Day)|Adverse Event|1|||
105908643|NCT01223404|365325200|FG001|Second Intervention (1 Day)|Adverse Event|0|||
105908644|NCT01223404|365325201|FG002|Second Intervention (1 Day)|Adverse Event|0|||
105908645|NCT01223404|365325202|FG003|Second Intervention (1 Day)|Adverse Event|0|||
105908646|NCT01223404|365325203|FG004|Second Intervention (1 Day)|Adverse Event|0|||
105908647|NCT01223404|365325204|FG005|Second Intervention (1 Day)|Adverse Event|0|||
105908648|NCT01223404|365325199|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105908649|NCT01223404|365325200|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105908650|NCT01223404|365325201|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105908651|NCT01223404|365325202|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
105671711|NCT02304705|364462511|FG001|Overall Study|Lost to Follow-up|2|||
105908652|NCT01223404|365325203|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105908653|NCT01223404|365325204|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
105908654|NCT00707057|365325205|FG000|Overall Study|Withdrawal by Subject|8|||
105908655|NCT00707057|365325206|FG001|Overall Study|Withdrawal by Subject|3|||
105671712|NCT01014208|364462512|FG000|Overall Study|Lost to Follow-up|2|||
105671713|NCT01014208|364462513|FG001|Overall Study|Lost to Follow-up|5|||
105671714|NCT01014208|364462512|FG000|Overall Study|Participant Withdrew Consent|12|||
105671715|NCT01014208|364462513|FG001|Overall Study|Participant Withdrew Consent|12|||
105671716|NCT01014208|364462512|FG000|Overall Study|Did Not Receive Study Drug|2|||
105671717|NCT01014208|364462513|FG001|Overall Study|Did Not Receive Study Drug|0|||
105671718|NCT01014208|364462512|FG000|Overall Study|Study Closed/terminated|78|||
105671719|NCT01014208|364462513|FG001|Overall Study|Study Closed/terminated|83|||
105671720|NCT00770029|364462517|FG000|Overall Study|Lost to Follow-up|2|||
105671721|NCT00770029|364462518|FG001|Overall Study|Lost to Follow-up|0|||
105671722|NCT00770029|364462517|FG000|Overall Study|Withdrawal by Subject|3|||
105671723|NCT00770029|364462518|FG001|Overall Study|Withdrawal by Subject|3|||
105671724|NCT00770029|364462517|FG000|Overall Study|Adverse Event|1|||
105671725|NCT00770029|364462518|FG001|Overall Study|Adverse Event|0|||
105671726|NCT02124811|364462519|FG000|Overall Study|Early termination|2|||
105671727|NCT02124811|364462520|FG001|Overall Study|Early termination|2|||
105671728|NCT02124811|364462519|FG000|Overall Study|Withdrawal by Subject|1|||
105671729|NCT02124811|364462520|FG001|Overall Study|Withdrawal by Subject|0|||
105671730|NCT00414908|364462521|FG000|Overall Study|Protocol Violation|1|||
105671731|NCT00414908|364462522|FG001|Overall Study|Protocol Violation|1|||
105671732|NCT00818168|364462523|FG000|Overall Study|Lack of Efficacy|18|||
105671733|NCT00818168|364462523|FG000|Overall Study|Pregnancy|2|||
105671734|NCT00818168|364462523|FG000|Overall Study|Withdrawal by Subject|16|||
105671735|NCT00818168|364462523|FG000|Overall Study|Lost to Follow-up|7|||
105671736|NCT00818168|364462523|FG000|Overall Study|Adverse Event|19|||
105671737|NCT00818168|364462523|FG000|Overall Study|Reason for Non-completion Not reported|6|||
105671738|NCT00818168|364462523|FG000|Overall Study|Participant Moved|2|||
105671739|NCT03140280|364462524|FG000|Overall Study|Physician Decision|5|||
105671740|NCT04476251|364462527|FG000|Overall Study|Not treated|1|||
105671741|NCT02248818|364462530|FG000|Screening|Protocol Violation|0|||
105671742|NCT02248818|364462531|FG001|Screening|Protocol Violation|0|||
105671743|NCT02248818|364462532|FG002|Screening|Protocol Violation|0|||
105671744|NCT02248818|364462533|FG003|Screening|Protocol Violation|0|||
105671745|NCT02248818|364462534|FG004|Screening|Protocol Violation|0|||
105671746|NCT02248818|364462535|FG005|Screening|Protocol Violation|0|||
105671747|NCT02248818|364462536|FG006|Screening|Protocol Violation|0|||
105671748|NCT02248818|364462537|FG007|Screening|Protocol Violation|0|||
105671749|NCT02248818|364462538|FG008|Screening|Protocol Violation|7|||
105671750|NCT02248818|364462530|FG000|Screening|Study fully enrolled|0|||
105671751|NCT02248818|364462531|FG001|Screening|Study fully enrolled|0|||
105671752|NCT02248818|364462532|FG002|Screening|Study fully enrolled|0|||
105671753|NCT02248818|364462533|FG003|Screening|Study fully enrolled|0|||
105671754|NCT02248818|364462534|FG004|Screening|Study fully enrolled|0|||
105671755|NCT02248818|364462535|FG005|Screening|Study fully enrolled|0|||
105671756|NCT02248818|364462536|FG006|Screening|Study fully enrolled|0|||
105671757|NCT02248818|364462537|FG007|Screening|Study fully enrolled|0|||
105671758|NCT02248818|364462538|FG008|Screening|Study fully enrolled|14|||
105671759|NCT02248818|364462530|FG000|Screening|Physician Decision|0|||
105671760|NCT02248818|364462531|FG001|Screening|Physician Decision|0|||
105671761|NCT02248818|364462532|FG002|Screening|Physician Decision|0|||
105671762|NCT02248818|364462533|FG003|Screening|Physician Decision|0|||
105671763|NCT02248818|364462534|FG004|Screening|Physician Decision|0|||
105908656|NCT00707057|365325205|FG000|Overall Study|Dosed incorrectly|0|||
105908657|NCT00707057|365325206|FG001|Overall Study|Dosed incorrectly|1|||
105908658|NCT04446429|365325209|FG000|Overall Study|Lost to Follow-up|6|||
105908659|NCT04446429|365325210|FG001|Overall Study|Lost to Follow-up|0|||
105671764|NCT02248818|364462535|FG005|Screening|Physician Decision|0|||
105671765|NCT02248818|364462536|FG006|Screening|Physician Decision|0|||
105671766|NCT02248818|364462537|FG007|Screening|Physician Decision|0|||
105671767|NCT02248818|364462538|FG008|Screening|Physician Decision|73|||
105908660|NCT01247350|365325215|FG000|Overall Study|Adverse Event|0|||
105671768|NCT02248818|364462530|FG000|Screening|Withdrawal by Subject|0|||
105671769|NCT02248818|364462531|FG001|Screening|Withdrawal by Subject|0|||
105671770|NCT02248818|364462532|FG002|Screening|Withdrawal by Subject|0|||
105671771|NCT02248818|364462533|FG003|Screening|Withdrawal by Subject|0|||
105671772|NCT02248818|364462534|FG004|Screening|Withdrawal by Subject|0|||
105671773|NCT02248818|364462535|FG005|Screening|Withdrawal by Subject|0|||
105671774|NCT02248818|364462536|FG006|Screening|Withdrawal by Subject|0|||
105671775|NCT02248818|364462537|FG007|Screening|Withdrawal by Subject|0|||
105671776|NCT02248818|364462538|FG008|Screening|Withdrawal by Subject|6|||
105671777|NCT02248818|364462530|FG000|Screening|Lost to Follow-up|0|||
105671778|NCT02248818|364462531|FG001|Screening|Lost to Follow-up|0|||
105671779|NCT02248818|364462532|FG002|Screening|Lost to Follow-up|0|||
105671780|NCT02248818|364462533|FG003|Screening|Lost to Follow-up|0|||
105671781|NCT02248818|364462534|FG004|Screening|Lost to Follow-up|0|||
105908661|NCT01247350|365325216|FG001|Overall Study|Adverse Event|0|||
105671782|NCT02248818|364462535|FG005|Screening|Lost to Follow-up|0|||
105671783|NCT02248818|364462536|FG006|Screening|Lost to Follow-up|0|||
105671784|NCT02248818|364462537|FG007|Screening|Lost to Follow-up|0|||
105671785|NCT02248818|364462538|FG008|Screening|Lost to Follow-up|7|||
105908662|NCT01247350|365325217|FG002|Overall Study|Adverse Event|1|||
105908663|NCT01247350|365325218|FG003|Overall Study|Adverse Event|0|||
105908664|NCT01247350|365325219|FG004|Overall Study|Adverse Event|0|||
105908665|NCT01247350|365325215|FG000|Overall Study|Withdrawal by Subject|0|||
105908666|NCT01247350|365325216|FG001|Overall Study|Withdrawal by Subject|0|||
105908667|NCT01247350|365325217|FG002|Overall Study|Withdrawal by Subject|0|||
105908668|NCT01247350|365325218|FG003|Overall Study|Withdrawal by Subject|1|||
105908669|NCT01247350|365325219|FG004|Overall Study|Withdrawal by Subject|0|||
105908670|NCT01247350|365325215|FG000|Overall Study|Entry criteria not met|0|||
105908671|NCT01247350|365325216|FG001|Overall Study|Entry criteria not met|0|||
105908672|NCT01247350|365325217|FG002|Overall Study|Entry criteria not met|0|||
105908673|NCT01247350|365325218|FG003|Overall Study|Entry criteria not met|0|||
105908674|NCT01247350|365325219|FG004|Overall Study|Entry criteria not met|1|||
105908675|NCT01266824|365325220|FG000|Overall Study|Study terminated prior to completion|2|||
105908676|NCT01266824|365325221|FG001|Overall Study|Study terminated prior to completion|3|||
105908677|NCT02302846|365325222|FG000|Overall Study|Withdrawal by Subject|1|||
105908678|NCT00232557|365325223|FG000|Overall Study|Lost to Follow-up|3|||
105908679|NCT00232557|365325224|FG001|Overall Study|Lost to Follow-up|5|||
105908680|NCT01059773|365325225|FG000|Overall Study|Adverse Event|2|||
105908681|NCT01059773|365325226|FG001|Overall Study|Adverse Event|2|||
105908682|NCT01059773|365325225|FG000|Overall Study|Withdrawal by Subject|1|||
105908683|NCT01059773|365325226|FG001|Overall Study|Withdrawal by Subject|5|||
105908684|NCT01059773|365325225|FG000|Overall Study|Lost to Follow-up|1|||
105908685|NCT01059773|365325226|FG001|Overall Study|Lost to Follow-up|1|||
105908686|NCT01059773|365325225|FG000|Overall Study|Pregnancy|1|||
105908687|NCT01059773|365325226|FG001|Overall Study|Pregnancy|1|||
105908688|NCT01059773|365325225|FG000|Overall Study|Protocol Violation|6|||
105908689|NCT01059773|365325226|FG001|Overall Study|Protocol Violation|2|||
105671786|NCT02248818|364462530|FG000|Randomised Study|Administrative - randomization error|0|||
105671787|NCT02248818|364462531|FG001|Randomised Study|Administrative - randomization error|0|||
105671788|NCT02248818|364462532|FG002|Randomised Study|Administrative - randomization error|0|||
105671789|NCT02248818|364462533|FG003|Randomised Study|Administrative - randomization error|0|||
105671790|NCT02248818|364462534|FG004|Randomised Study|Administrative - randomization error|0|||
105671791|NCT02248818|364462535|FG005|Randomised Study|Administrative - randomization error|8|||
105671792|NCT02248818|364462536|FG006|Randomised Study|Administrative - randomization error|0|||
105671793|NCT02248818|364462537|FG007|Randomised Study|Administrative - randomization error|0|||
105671794|NCT02248818|364462538|FG008|Randomised Study|Administrative - randomization error|0|||
105671795|NCT04020185|364462542|FG000|Overall Study|Death|0|||
105671796|NCT04020185|364462543|FG001|Overall Study|Death|0|||
105671797|NCT04020185|364462544|FG002|Overall Study|Death|1|||
105671798|NCT04020185|364462545|FG003|Overall Study|Death|2|||
105671799|NCT04020185|364462546|FG004|Overall Study|Death|1|||
105671800|NCT04020185|364462547|FG005|Overall Study|Death|0|||
105671801|NCT04020185|364462548|FG006|Overall Study|Death|1|||
105671802|NCT04020185|364462549|FG007|Overall Study|Death|0|||
105671803|NCT04020185|364462542|FG000|Overall Study|Consent withdrawn|1|||
105671804|NCT04020185|364462543|FG001|Overall Study|Consent withdrawn|0|||
105671805|NCT04020185|364462544|FG002|Overall Study|Consent withdrawn|0|||
105671806|NCT04020185|364462545|FG003|Overall Study|Consent withdrawn|0|||
105671807|NCT04020185|364462546|FG004|Overall Study|Consent withdrawn|2|||
105671808|NCT04020185|364462547|FG005|Overall Study|Consent withdrawn|0|||
105671809|NCT04020185|364462548|FG006|Overall Study|Consent withdrawn|1|||
105671810|NCT04020185|364462549|FG007|Overall Study|Consent withdrawn|1|||
105671811|NCT04020185|364462542|FG000|Overall Study|Patient in hospice|0|||
105671812|NCT04020185|364462543|FG001|Overall Study|Patient in hospice|1|||
105671813|NCT04020185|364462544|FG002|Overall Study|Patient in hospice|0|||
105671814|NCT04020185|364462545|FG003|Overall Study|Patient in hospice|0|||
105671815|NCT04020185|364462546|FG004|Overall Study|Patient in hospice|0|||
105671816|NCT04020185|364462547|FG005|Overall Study|Patient in hospice|0|||
105671817|NCT04020185|364462548|FG006|Overall Study|Patient in hospice|0|||
105671818|NCT04020185|364462549|FG007|Overall Study|Patient in hospice|0|||
105671819|NCT04020185|364462542|FG000|Overall Study|Continuing on expanded access|0|||
105671820|NCT04020185|364462543|FG001|Overall Study|Continuing on expanded access|0|||
105671821|NCT04020185|364462544|FG002|Overall Study|Continuing on expanded access|0|||
105671822|NCT04020185|364462545|FG003|Overall Study|Continuing on expanded access|0|||
105671823|NCT04020185|364462546|FG004|Overall Study|Continuing on expanded access|0|||
105671824|NCT04020185|364462547|FG005|Overall Study|Continuing on expanded access|0|||
105671825|NCT04020185|364462548|FG006|Overall Study|Continuing on expanded access|1|||
105671826|NCT04020185|364462549|FG007|Overall Study|Continuing on expanded access|1|||
105671827|NCT04833127|364462550|FG000|Overall Study|Lost to Follow-up|1|||
105671828|NCT04833127|364462551|FG001|Overall Study|Lost to Follow-up|1|||
105671829|NCT04552899|364462552|FG000|Overall Study|Adverse Event|4|||
105671830|NCT04552899|364462553|FG001|Overall Study|Adverse Event|3|||
105671831|NCT04552899|364462552|FG000|Overall Study|Death|4|||
105671832|NCT04552899|364462553|FG001|Overall Study|Death|4|||
105671833|NCT04552899|364462552|FG000|Overall Study|Lost to Follow-up|8|||
105671834|NCT04552899|364462553|FG001|Overall Study|Lost to Follow-up|13|||
105671835|NCT04552899|364462552|FG000|Overall Study|Lung Transplant|4|||
105671836|NCT04552899|364462553|FG001|Overall Study|Lung Transplant|3|||
105671837|NCT04552899|364462552|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
105671838|NCT04552899|364462553|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
105671839|NCT04552899|364462552|FG000|Overall Study|Physician Decision|3|||
105671840|NCT04552899|364462553|FG001|Overall Study|Physician Decision|4|||
105671841|NCT04552899|364462552|FG000|Overall Study|Study Terminated By Sponsor|237|||
105671842|NCT04552899|364462553|FG001|Overall Study|Study Terminated By Sponsor|239|||
105908690|NCT01059773|365325225|FG000|Overall Study|Physician Decision|5|||
105908691|NCT01059773|365325226|FG001|Overall Study|Physician Decision|4|||
105671843|NCT04552899|364462552|FG000|Overall Study|Withdrawal by Subject|15|||
105671844|NCT04552899|364462553|FG001|Overall Study|Withdrawal by Subject|17|||
105671845|NCT04335591|364462554|FG000|Overall Study|Adverse Event|5|||
105908692|NCT01059773|365325225|FG000|Overall Study|Lack of Efficacy|3|||
105908693|NCT01059773|365325226|FG001|Overall Study|Lack of Efficacy|3|||
105908694|NCT01059773|365325225|FG000|Overall Study|Death|0|||
105908695|NCT01059773|365325226|FG001|Overall Study|Death|1|||
105671846|NCT04335591|364462555|FG001|Overall Study|Adverse Event|2|||
105908696|NCT01059773|365325225|FG000|Overall Study|Malignancy including squamous cell skin|0|||
105671847|NCT04335591|364462556|FG002|Overall Study|Adverse Event|3|||
105671848|NCT04335591|364462557|FG003|Overall Study|Adverse Event|2|||
105671849|NCT04335591|364462554|FG000|Overall Study|Protocol Violation|1|||
105671850|NCT04335591|364462555|FG001|Overall Study|Protocol Violation|0|||
105671851|NCT04335591|364462556|FG002|Overall Study|Protocol Violation|0|||
105671852|NCT04335591|364462557|FG003|Overall Study|Protocol Violation|0|||
105671853|NCT04335591|364462554|FG000|Overall Study|Withdrawal by Subject|8|||
105671854|NCT04335591|364462555|FG001|Overall Study|Withdrawal by Subject|4|||
105908697|NCT01059773|365325226|FG001|Overall Study|Malignancy including squamous cell skin|1|||
105671855|NCT04335591|364462556|FG002|Overall Study|Withdrawal by Subject|4|||
105671856|NCT04335591|364462557|FG003|Overall Study|Withdrawal by Subject|5|||
105671857|NCT04335591|364462554|FG000|Overall Study|Subject planning pregnancy|0|||
105671858|NCT04335591|364462555|FG001|Overall Study|Subject planning pregnancy|1|||
105671859|NCT04335591|364462556|FG002|Overall Study|Subject planning pregnancy|0|||
105671860|NCT04335591|364462557|FG003|Overall Study|Subject planning pregnancy|0|||
105671861|NCT04335591|364462554|FG000|Overall Study|Ukrainian Russian war conflict|4|||
105671862|NCT04335591|364462555|FG001|Overall Study|Ukrainian Russian war conflict|5|||
105671863|NCT04335591|364462556|FG002|Overall Study|Ukrainian Russian war conflict|2|||
105671864|NCT04335591|364462557|FG003|Overall Study|Ukrainian Russian war conflict|0|||
105671865|NCT03268603|364462558|FG000|Overall Study|Withdrawal by Subject|6|||
105671866|NCT03268603|364462558|FG000|Overall Study|Physician Decision|1|||
105671867|NCT03268603|364462558|FG000|Overall Study|Withdrawn due to disease progression|2|||
105671868|NCT00461981|364462559|FG000|Overall Study|Lost to Follow-up|9|||
105671869|NCT00461981|364462560|FG001|Overall Study|Lost to Follow-up|6|||
105671870|NCT00461981|364462559|FG000|Overall Study|Withdrawal by Subject|2|||
105671871|NCT00461981|364462560|FG001|Overall Study|Withdrawal by Subject|3|||
105671872|NCT02071290|364462561|FG000|Overall Study|Death|1|||
105671873|NCT02071290|364462562|FG001|Overall Study|Death|0|||
105671874|NCT02071290|364462561|FG000|Overall Study|Withdrawal by Subject|0|||
105671875|NCT02071290|364462562|FG001|Overall Study|Withdrawal by Subject|1|||
105671876|NCT02071290|364462561|FG000|Overall Study|Protocol Violation|3|||
105671877|NCT02071290|364462562|FG001|Overall Study|Protocol Violation|5|||
105671878|NCT02071290|364462561|FG000|Overall Study|Physician Decision|0|||
105671879|NCT02071290|364462562|FG001|Overall Study|Physician Decision|1|||
105671880|NCT01493427|364462563|FG000|Overall Study|Adverse Event|10|||
105671881|NCT01493427|364462563|FG000|Overall Study|Personal Reasons|4|||
105671882|NCT01493427|364462563|FG000|Overall Study|Lost to Follow-up|2|||
105671883|NCT01493427|364462563|FG000|Overall Study|Inability to Follow Instructions|2|||
105671884|NCT01493427|364462563|FG000|Overall Study|Other|2|||
105671885|NCT00565773|364462564|FG000|Overall Study|Withdrawal by Subject|1|||
105671886|NCT00565773|364462564|FG000|Overall Study|Physician Decision|1|||
105671887|NCT02175641|364462567|FG000|Overall Study|Death|3|||
105671888|NCT02175641|364462568|FG001|Overall Study|Death|4|||
105671889|NCT02175641|364462567|FG000|Overall Study|Lost to Follow-up|4|||
105671890|NCT02175641|364462568|FG001|Overall Study|Lost to Follow-up|4|||
105671891|NCT02175641|364462567|FG000|Overall Study|Withdrawal by Subject|7|||
105671892|NCT02175641|364462568|FG001|Overall Study|Withdrawal by Subject|4|||
105671893|NCT02175641|364462567|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
105671894|NCT02175641|364462568|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
105671895|NCT02175641|364462567|FG000|Overall Study|Developed Contraindicated Condition|8|||
105671896|NCT02175641|364462568|FG001|Overall Study|Developed Contraindicated Condition|0|||
105671897|NCT04546425|364462569|FG000|Overall Study|Protocol Violation|1|||
105671898|NCT04546425|364462570|FG001|Overall Study|Protocol Violation|1|||
105671899|NCT04546425|364462571|FG002|Overall Study|Protocol Violation|0|||
105671900|NCT04546425|364462572|FG003|Overall Study|Protocol Violation|0|||
105671901|NCT04546425|364462569|FG000|Overall Study|Adverse Event|3|||
105671902|NCT04546425|364462570|FG001|Overall Study|Adverse Event|0|||
105671903|NCT04546425|364462571|FG002|Overall Study|Adverse Event|0|||
105671904|NCT04546425|364462572|FG003|Overall Study|Adverse Event|0|||
105671905|NCT04546425|364462569|FG000|Overall Study|Lost to Follow-up|5|||
105671906|NCT04546425|364462570|FG001|Overall Study|Lost to Follow-up|4|||
105671907|NCT04546425|364462571|FG002|Overall Study|Lost to Follow-up|0|||
105671908|NCT04546425|364462572|FG003|Overall Study|Lost to Follow-up|0|||
105671909|NCT04546425|364462569|FG000|Overall Study|No Longer met eligibility criteria|3|||
105908698|NCT01059773|365325225|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
105908699|NCT01059773|365325226|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
105908700|NCT01059773|365325225|FG000|Overall Study|Other|1|||
105908701|NCT01059773|365325226|FG001|Overall Study|Other|3|||
105908702|NCT00872521|365325227|FG000|Completed PAD Induction|Patient choice|0|||
105908703|NCT00872521|365325228|FG001|Completed PAD Induction|Patient choice|1|||
105908704|NCT00872521|365325229|FG002|Completed PAD Induction|Patient choice|0|||
105908705|NCT00872521|365325227|FG000|Completed PAD Induction|Disease progression|0|||
105908706|NCT00872521|365325228|FG001|Completed PAD Induction|Disease progression|2|||
105999286|NCT04628780|365659452|FG002|Overall Study|Withdrawal by Subject|2|||
105671910|NCT04546425|364462570|FG001|Overall Study|No Longer met eligibility criteria|3|||
105671911|NCT04546425|364462571|FG002|Overall Study|No Longer met eligibility criteria|1|||
105671912|NCT04546425|364462572|FG003|Overall Study|No Longer met eligibility criteria|1|||
105671913|NCT04546425|364462569|FG000|Overall Study|Withdrawal by parent/guardian|6|||
105671914|NCT04546425|364462570|FG001|Overall Study|Withdrawal by parent/guardian|5|||
105671915|NCT04546425|364462571|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105671916|NCT04546425|364462572|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105671917|NCT01461811|364462576|FG000|Overall Study|Adverse Event|2|||
105671918|NCT01461811|364462577|FG001|Overall Study|Adverse Event|1|||
105671919|NCT01461811|364462576|FG000|Overall Study|Subject decision unrelated to an AE|1|||
105671920|NCT01461811|364462577|FG001|Overall Study|Subject decision unrelated to an AE|1|||
105671921|NCT01461811|364462576|FG000|Overall Study|Noncompliance|1|||
105671922|NCT01461811|364462577|FG001|Overall Study|Noncompliance|1|||
105671923|NCT02242097|364462579|FG000|Ibrutinib Treatment|Adverse Event|16|||
105671924|NCT02242097|364462579|FG000|Ibrutinib Treatment|Physician Decision|1|||
105671925|NCT02242097|364462579|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
105671926|NCT02242097|364462579|FG000|Ibrutinib Treatment|Death|1|||
105671927|NCT02242097|364462579|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
105671928|NCT02242097|364462579|FG000|Post Therapy Follow Up|Death|3|||
105671929|NCT02242097|364462579|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
105671930|NCT05032872|364462587|FG000|Overall Study|Adverse Event|1|||
105671931|NCT05032872|364462588|FG001|Overall Study|Adverse Event|0|||
105671932|NCT05032872|364462587|FG000|Overall Study|Lost to Follow-up|2|||
105671933|NCT05032872|364462588|FG001|Overall Study|Lost to Follow-up|4|||
105671934|NCT05032872|364462587|FG000|Overall Study|Withdrawal by Subject|4|||
105671935|NCT05032872|364462588|FG001|Overall Study|Withdrawal by Subject|3|||
105671936|NCT01232738|364462589|FG000|Overall Study|Death|3|||
105671937|NCT01232738|364462589|FG000|Overall Study|Physician Decision|2|||
105671938|NCT01232738|364462589|FG000|Overall Study|Lost to Follow-up|1|||
105671939|NCT01232738|364462589|FG000|Overall Study|Withdrawal by Subject|2|||
105671940|NCT01232738|364462589|FG000|Overall Study|Adverse Event|5|||
105671941|NCT02979249|364462590|FG000|Overall Study|Lost to Follow-up|2|||
105671942|NCT02979249|364462590|FG000|Overall Study|Withdrawal by Subject|4|||
105671943|NCT03525392|364462621|FG000|Overall Study|Adverse Event|1|||
105671944|NCT03525392|364462622|FG001|Overall Study|Adverse Event|0|||
105671945|NCT03525392|364462623|FG002|Overall Study|Adverse Event|2|||
105671946|NCT03525392|364462624|FG003|Overall Study|Adverse Event|0|||
105671947|NCT03525392|364462625|FG004|Overall Study|Adverse Event|0|||
105671948|NCT03525392|364462621|FG000|Overall Study|Progressive disease|0|||
105671949|NCT03525392|364462622|FG001|Overall Study|Progressive disease|1|||
105671950|NCT03525392|364462623|FG002|Overall Study|Progressive disease|1|||
105671951|NCT03525392|364462624|FG003|Overall Study|Progressive disease|3|||
105671952|NCT03525392|364462625|FG004|Overall Study|Progressive disease|1|||
105671953|NCT00886795|364462626|FG000|Overall Study|Lack of Efficacy|1|||
105671954|NCT03449901|364462629|FG000|Overall Study|Progression|57|||
105671955|NCT03449901|364462630|FG001|Overall Study|Progression|12|||
105671956|NCT03449901|364462629|FG000|Overall Study|Adverse Event|3|||
105671957|NCT03449901|364462630|FG001|Overall Study|Adverse Event|0|||
105671958|NCT03449901|364462629|FG000|Overall Study|Death|6|||
105671959|NCT03449901|364462630|FG001|Overall Study|Death|2|||
105671960|NCT03449901|364462629|FG000|Overall Study|Withdrawal by Subject|12|||
105671961|NCT03449901|364462630|FG001|Overall Study|Withdrawal by Subject|1|||
105671962|NCT03449901|364462629|FG000|Overall Study|Physician Decision|1|||
105671963|NCT03449901|364462630|FG001|Overall Study|Physician Decision|0|||
105671964|NCT03449901|364462629|FG000|Overall Study|Patient elected for surgical intervention|1|||
105671965|NCT03449901|364462630|FG001|Overall Study|Patient elected for surgical intervention|0|||
105671966|NCT03449901|364462629|FG000|Overall Study|Patient off for other complicating disease|1|||
105671967|NCT03449901|364462630|FG001|Overall Study|Patient off for other complicating disease|0|||
105671968|NCT00743431|364462631|FG000|Overall Study|Toxicity|6|||
105671969|NCT00743431|364462631|FG000|Overall Study|Tumor progression|56|||
105671970|NCT00743431|364462631|FG000|Overall Study|Withdrawal by Subject|13|||
105671971|NCT00743431|364462631|FG000|Overall Study|Death|9|||
105671972|NCT00743431|364462631|FG000|Overall Study|Reason for discontinuation not specified|29|||
105671973|NCT00743431|364462631|FG000|Overall Study|No documentation available|13|||
105671974|NCT04276415|364462632|FG000|Overall Study|Adverse Event|0|||
105671975|NCT04276415|364462633|FG001|Overall Study|Adverse Event|0|||
105671976|NCT04276415|364462634|FG002|Overall Study|Adverse Event|0|||
105671977|NCT04276415|364462635|FG003|Overall Study|Adverse Event|3|||
105671978|NCT04276415|364462636|FG004|Overall Study|Adverse Event|0|||
105999287|NCT04628780|365659453|FG003|Overall Study|Withdrawal by Subject|0|||
105999288|NCT04628780|365659454|FG004|Overall Study|Withdrawal by Subject|3|||
105999289|NCT04628780|365659455|FG005|Overall Study|Withdrawal by Subject|1|||
105999290|NCT04628780|365659450|FG000|Overall Study|Global deterioration of health status|0|||
105671979|NCT04276415|364462637|FG005|Overall Study|Adverse Event|0|||
105999291|NCT04628780|365659451|FG001|Overall Study|Global deterioration of health status|0|||
105671980|NCT04276415|364462632|FG000|Overall Study|Clinical progression|1|||
106125627|NCT03653416|366117842|FG000|Overall Study|Protocol Violation|6|||
105671981|NCT04276415|364462633|FG001|Overall Study|Clinical progression|1|||
105671982|NCT04276415|364462634|FG002|Overall Study|Clinical progression|0|||
105671983|NCT04276415|364462635|FG003|Overall Study|Clinical progression|0|||
105671984|NCT04276415|364462636|FG004|Overall Study|Clinical progression|1|||
105671985|NCT04276415|364462637|FG005|Overall Study|Clinical progression|0|||
105671986|NCT04276415|364462632|FG000|Overall Study|Other|0|||
105671987|NCT04276415|364462633|FG001|Overall Study|Other|0|||
105671988|NCT04276415|364462634|FG002|Overall Study|Other|0|||
105671989|NCT04276415|364462635|FG003|Overall Study|Other|1|||
105671990|NCT04276415|364462636|FG004|Overall Study|Other|0|||
105671991|NCT04276415|364462637|FG005|Overall Study|Other|0|||
105671992|NCT04276415|364462632|FG000|Overall Study|Physician Decision|0|||
105671993|NCT04276415|364462633|FG001|Overall Study|Physician Decision|0|||
105671994|NCT04276415|364462634|FG002|Overall Study|Physician Decision|1|||
105671995|NCT04276415|364462635|FG003|Overall Study|Physician Decision|3|||
105671996|NCT04276415|364462636|FG004|Overall Study|Physician Decision|2|||
105671997|NCT04276415|364462637|FG005|Overall Study|Physician Decision|0|||
105671998|NCT04276415|364462632|FG000|Overall Study|Progressive disease|3|||
105671999|NCT04276415|364462633|FG001|Overall Study|Progressive disease|3|||
105672000|NCT04276415|364462634|FG002|Overall Study|Progressive disease|4|||
105672001|NCT04276415|364462635|FG003|Overall Study|Progressive disease|5|||
105672002|NCT04276415|364462636|FG004|Overall Study|Progressive disease|1|||
105672003|NCT04276415|364462637|FG005|Overall Study|Progressive disease|2|||
105672004|NCT04276415|364462632|FG000|Overall Study|Withdrawal by patient|0|||
105672005|NCT04276415|364462633|FG001|Overall Study|Withdrawal by patient|0|||
105672006|NCT04276415|364462634|FG002|Overall Study|Withdrawal by patient|0|||
105672007|NCT04276415|364462635|FG003|Overall Study|Withdrawal by patient|1|||
105672008|NCT04276415|364462636|FG004|Overall Study|Withdrawal by patient|2|||
105672009|NCT04276415|364462637|FG005|Overall Study|Withdrawal by patient|0|||
105672010|NCT01840410|364462638|FG000|Overall Study|Physician Decision|1|||
105672011|NCT01840410|364462639|FG001|Overall Study|Physician Decision|2|||
105672012|NCT01840410|364462638|FG000|Overall Study|Pregnancy|1|||
105672013|NCT01840410|364462639|FG001|Overall Study|Pregnancy|0|||
105672014|NCT01840410|364462638|FG000|Overall Study|Protocol deviation|1|||
105672015|NCT01840410|364462639|FG001|Overall Study|Protocol deviation|0|||
105672016|NCT01840410|364462638|FG000|Overall Study|Lost to Follow-up|1|||
105672017|NCT01840410|364462639|FG001|Overall Study|Lost to Follow-up|0|||
105672018|NCT01840410|364462638|FG000|Overall Study|Withdrawal by Subject|2|||
105672019|NCT01840410|364462639|FG001|Overall Study|Withdrawal by Subject|1|||
105672020|NCT01840410|364462638|FG000|Overall Study|Adverse Event|1|||
105672021|NCT01840410|364462639|FG001|Overall Study|Adverse Event|1|||
105672022|NCT01413503|364462640|FG000|Overall Study|Lost to Follow-up|1|||
105672023|NCT02406677|364462641|FG000|Overall Study|Death|16|||
105672024|NCT02406677|364462642|FG001|Overall Study|Death|8|||
105672025|NCT02406677|364462641|FG000|Overall Study|Discharged without P2Y12|1|||
105672026|NCT02406677|364462642|FG001|Overall Study|Discharged without P2Y12|3|||
105672027|NCT02406677|364462641|FG000|Overall Study|Discharged on prasugrel|283|||
105672028|NCT02406677|364462642|FG001|Overall Study|Discharged on prasugrel|587|||
105672029|NCT02406677|364462641|FG000|Overall Study|Withdrawal by Subject|1|||
105672030|NCT02406677|364462642|FG001|Overall Study|Withdrawal by Subject|0|||
105672031|NCT01114880|364462643|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
105672032|NCT01114880|364462644|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
105672033|NCT01114880|364462643|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
105672034|NCT01114880|364462644|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
105672035|NCT01114880|364462643|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
105672036|NCT01114880|364462644|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
105672037|NCT01114880|364462643|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
105672038|NCT01114880|364462644|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
105672039|NCT01114880|364462643|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
105672040|NCT01114880|364462644|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
105672041|NCT01114880|364462643|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
105672042|NCT01114880|364462644|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
105672043|NCT02817906|364462645|FG000|Overall Study|Adverse Event|3|||
105672044|NCT02817906|364462646|FG001|Overall Study|Adverse Event|0|||
105672045|NCT02817906|364462645|FG000|Overall Study|Lack of Efficacy|1|||
105672046|NCT02817906|364462646|FG001|Overall Study|Lack of Efficacy|0|||
105672047|NCT02817906|364462645|FG000|Overall Study|Protocol Violation|1|||
105672048|NCT02817906|364462646|FG001|Overall Study|Protocol Violation|1|||
105672049|NCT02817906|364462645|FG000|Overall Study|Study Terminated by Sponsor|2|||
105672050|NCT02817906|364462646|FG001|Overall Study|Study Terminated by Sponsor|2|||
105672051|NCT02817906|364462645|FG000|Overall Study|Withdrawal by Subject|7|||
105672052|NCT02817906|364462646|FG001|Overall Study|Withdrawal by Subject|0|||
105672053|NCT02817906|364462645|FG000|Overall Study|Other|2|||
105672054|NCT02817906|364462646|FG001|Overall Study|Other|2|||
105786216|NCT00972309|364870478|FG001|Overall Study|Disease progression on study|4|||
105672055|NCT04958200|364462651|FG000|Overall Study|Withdrawal by Subject|0|||
105672056|NCT04958200|364462652|FG001|Overall Study|Withdrawal by Subject|2|||
105786217|NCT04794491|364870479|FG000|Overall Study|Adverse Event|1|||
105999292|NCT04628780|365659452|FG002|Overall Study|Global deterioration of health status|0|||
105672057|NCT04958200|364462651|FG000|Overall Study|Lost to Follow-up|3|||
105672058|NCT04958200|364462652|FG001|Overall Study|Lost to Follow-up|2|||
105672059|NCT04531098|364462653|FG000|Stage I|Adverse Event|0|||
105672060|NCT04531098|364462654|FG001|Stage I|Adverse Event|0|||
105786218|NCT04794491|364870479|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
105672061|NCT04531098|364462655|FG002|Stage I|Adverse Event|3|||
105672062|NCT04531098|364462653|FG000|Stage I|Protocol Violation|0|||
105672063|NCT04531098|364462654|FG001|Stage I|Protocol Violation|0|||
105672064|NCT04531098|364462655|FG002|Stage I|Protocol Violation|5|||
105672065|NCT04531098|364462653|FG000|Stage I|Withdrawal by Subject|0|||
105672066|NCT04531098|364462654|FG001|Stage I|Withdrawal by Subject|5|||
105672067|NCT04531098|364462655|FG002|Stage I|Withdrawal by Subject|10|||
105672068|NCT04531098|364462653|FG000|Stage II|Adverse Event|1|||
105672069|NCT04531098|364462654|FG001|Stage II|Adverse Event|2|||
105672070|NCT04531098|364462655|FG002|Stage II|Adverse Event|0|||
105672071|NCT04531098|364462653|FG000|Stage II|Protocol Violation|1|||
105672072|NCT04531098|364462654|FG001|Stage II|Protocol Violation|2|||
105672073|NCT04531098|364462655|FG002|Stage II|Protocol Violation|0|||
105672074|NCT04531098|364462653|FG000|Stage II|Withdrawal by Subject|3|||
105672075|NCT04531098|364462654|FG001|Stage II|Withdrawal by Subject|1|||
105672076|NCT04531098|364462655|FG002|Stage II|Withdrawal by Subject|0|||
105672077|NCT04531098|364462653|FG000|Stage II|Moved from study area|8|||
105672078|NCT04531098|364462654|FG001|Stage II|Moved from study area|5|||
105672079|NCT04531098|364462655|FG002|Stage II|Moved from study area|0|||
105672080|NCT02628028|364462656|FG000|Dosing Period|Withdrawal by Subject|0|||
105672081|NCT02628028|364462657|FG001|Dosing Period|Withdrawal by Subject|0|||
105672082|NCT02628028|364462658|FG002|Dosing Period|Withdrawal by Subject|1|||
105672083|NCT02628028|364462659|FG003|Dosing Period|Withdrawal by Subject|0|||
105672084|NCT02628028|364462660|FG004|Dosing Period|Withdrawal by Subject|2|||
105672085|NCT02628028|364462661|FG005|Dosing Period|Withdrawal by Subject|4|||
105672086|NCT02628028|364462662|FG006|Dosing Period|Withdrawal by Subject|1|||
105672087|NCT02628028|364462663|FG007|Dosing Period|Withdrawal by Subject|1|||
105672088|NCT02628028|364462656|FG000|Dosing Period|Adverse Event|0|||
105672089|NCT02628028|364462657|FG001|Dosing Period|Adverse Event|0|||
105672090|NCT02628028|364462658|FG002|Dosing Period|Adverse Event|0|||
105672091|NCT02628028|364462659|FG003|Dosing Period|Adverse Event|0|||
105672092|NCT02628028|364462660|FG004|Dosing Period|Adverse Event|2|||
105672093|NCT02628028|364462661|FG005|Dosing Period|Adverse Event|1|||
105672094|NCT02628028|364462662|FG006|Dosing Period|Adverse Event|3|||
105672095|NCT02628028|364462663|FG007|Dosing Period|Adverse Event|2|||
105672096|NCT02628028|364462656|FG000|Dosing Period|Death|0|||
105672097|NCT02628028|364462657|FG001|Dosing Period|Death|0|||
105672098|NCT02628028|364462658|FG002|Dosing Period|Death|0|||
105672099|NCT02628028|364462659|FG003|Dosing Period|Death|0|||
105672100|NCT02628028|364462660|FG004|Dosing Period|Death|0|||
105672101|NCT02628028|364462661|FG005|Dosing Period|Death|0|||
105672102|NCT02628028|364462662|FG006|Dosing Period|Death|0|||
105672103|NCT02628028|364462663|FG007|Dosing Period|Death|1|||
105672104|NCT02628028|364462656|FG000|Dosing Period|Lack of Efficacy|0|||
105672105|NCT02628028|364462657|FG001|Dosing Period|Lack of Efficacy|0|||
105672106|NCT02628028|364462658|FG002|Dosing Period|Lack of Efficacy|0|||
105672107|NCT02628028|364462659|FG003|Dosing Period|Lack of Efficacy|0|||
105672108|NCT02628028|364462660|FG004|Dosing Period|Lack of Efficacy|3|||
105672109|NCT02628028|364462661|FG005|Dosing Period|Lack of Efficacy|0|||
105672110|NCT02628028|364462662|FG006|Dosing Period|Lack of Efficacy|1|||
105672111|NCT02628028|364462663|FG007|Dosing Period|Lack of Efficacy|0|||
105672112|NCT02628028|364462656|FG000|Dosing Period|Study Terminated by Sponsor|0|||
105672113|NCT02628028|364462657|FG001|Dosing Period|Study Terminated by Sponsor|0|||
105672114|NCT02628028|364462658|FG002|Dosing Period|Study Terminated by Sponsor|0|||
105672115|NCT02628028|364462659|FG003|Dosing Period|Study Terminated by Sponsor|0|||
105672116|NCT02628028|364462660|FG004|Dosing Period|Study Terminated by Sponsor|7|||
105672117|NCT02628028|364462661|FG005|Dosing Period|Study Terminated by Sponsor|6|||
105672118|NCT02628028|364462662|FG006|Dosing Period|Study Terminated by Sponsor|7|||
105672119|NCT02628028|364462663|FG007|Dosing Period|Study Terminated by Sponsor|7|||
105672120|NCT02628028|364462656|FG000|Dosing Period|Physician Decision|0|||
105672121|NCT02628028|364462657|FG001|Dosing Period|Physician Decision|0|||
105672122|NCT02628028|364462658|FG002|Dosing Period|Physician Decision|0|||
105672123|NCT02628028|364462659|FG003|Dosing Period|Physician Decision|0|||
105672124|NCT02628028|364462660|FG004|Dosing Period|Physician Decision|0|||
105672125|NCT02628028|364462661|FG005|Dosing Period|Physician Decision|1|||
105672126|NCT02628028|364462662|FG006|Dosing Period|Physician Decision|0|||
105908707|NCT00872521|365325229|FG002|Completed PAD Induction|Disease progression|0|||
105672127|NCT02628028|364462663|FG007|Dosing Period|Physician Decision|0|||
105672128|NCT02628028|364462656|FG000|Dosing Period|Site Terminated by Sponsor|0|||
105672129|NCT02628028|364462657|FG001|Dosing Period|Site Terminated by Sponsor|0|||
105672130|NCT02628028|364462658|FG002|Dosing Period|Site Terminated by Sponsor|0|||
105672131|NCT02628028|364462659|FG003|Dosing Period|Site Terminated by Sponsor|0|||
105672132|NCT02628028|364462660|FG004|Dosing Period|Site Terminated by Sponsor|0|||
105672133|NCT02628028|364462661|FG005|Dosing Period|Site Terminated by Sponsor|1|||
105672134|NCT02628028|364462662|FG006|Dosing Period|Site Terminated by Sponsor|1|||
105672135|NCT02628028|364462663|FG007|Dosing Period|Site Terminated by Sponsor|0|||
105672136|NCT02628028|364462656|FG000|Dosing Period|Lost to Follow-up|0|||
105672137|NCT02628028|364462657|FG001|Dosing Period|Lost to Follow-up|0|||
105672138|NCT02628028|364462658|FG002|Dosing Period|Lost to Follow-up|0|||
105672139|NCT02628028|364462659|FG003|Dosing Period|Lost to Follow-up|0|||
105672140|NCT02628028|364462660|FG004|Dosing Period|Lost to Follow-up|0|||
105672141|NCT02628028|364462661|FG005|Dosing Period|Lost to Follow-up|0|||
105672142|NCT02628028|364462662|FG006|Dosing Period|Lost to Follow-up|1|||
105672143|NCT02628028|364462663|FG007|Dosing Period|Lost to Follow-up|0|||
105672144|NCT02628028|364462656|FG000|Dosing Period|Other|0|||
105908708|NCT00872521|365325227|FG000|Completed PAD Induction|Adverse Event|4|||
105672145|NCT02628028|364462657|FG001|Dosing Period|Other|0|||
105672146|NCT02628028|364462658|FG002|Dosing Period|Other|0|||
105672147|NCT02628028|364462659|FG003|Dosing Period|Other|0|||
105672148|NCT02628028|364462660|FG004|Dosing Period|Other|2|||
105672149|NCT02628028|364462661|FG005|Dosing Period|Other|1|||
105672150|NCT02628028|364462662|FG006|Dosing Period|Other|2|||
105672151|NCT02628028|364462663|FG007|Dosing Period|Other|4|||
105672152|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
105672153|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
105672154|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
105672155|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
105672156|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
105672157|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
105672158|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
105672159|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
105672160|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672161|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672162|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672163|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672164|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672165|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
105672166|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
105672167|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
105672168|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672169|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672170|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672171|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672172|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
105672173|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
105672174|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
105672175|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
105672176|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672177|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672178|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672179|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672180|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
105672181|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
105672182|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
105672183|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
105672184|NCT02628028|364462656|FG000|Long-term Extension (LTE) Period|Other|0|||
105672185|NCT02628028|364462657|FG001|Long-term Extension (LTE) Period|Other|0|||
105672186|NCT02628028|364462658|FG002|Long-term Extension (LTE) Period|Other|0|||
105672187|NCT02628028|364462659|FG003|Long-term Extension (LTE) Period|Other|0|||
105672188|NCT02628028|364462660|FG004|Long-term Extension (LTE) Period|Other|0|||
105672189|NCT02628028|364462661|FG005|Long-term Extension (LTE) Period|Other|3|||
105672190|NCT02628028|364462662|FG006|Long-term Extension (LTE) Period|Other|4|||
105672191|NCT02628028|364462663|FG007|Long-term Extension (LTE) Period|Other|3|||
105672192|NCT01436253|364462664|FG000|Overall Study|Lost to Follow-up|182|||
105672193|NCT01436253|364462664|FG000|Overall Study|Not meeting all eligibility criteria|117|||
105786219|NCT04794491|364870479|FG000|Overall Study|Noncompliance With Study Intervention|1|||
105908709|NCT00872521|365325228|FG001|Completed PAD Induction|Adverse Event|0|||
105908710|NCT00872521|365325229|FG002|Completed PAD Induction|Adverse Event|0|||
105908711|NCT00872521|365325227|FG000|Completed PAD Induction|Death|1|||
105908712|NCT00872521|365325228|FG001|Completed PAD Induction|Death|1|||
105908713|NCT00872521|365325229|FG002|Completed PAD Induction|Death|0|||
105908714|NCT00872521|365325227|FG000|Primary Endpoint Analysis|Other|1|||
105908715|NCT00872521|365325228|FG001|Primary Endpoint Analysis|Other|2|||
105908716|NCT00872521|365325229|FG002|Primary Endpoint Analysis|Other|0|||
105908717|NCT00872521|365325227|FG000|Primary Endpoint Analysis|Patient choice|0|||
105908718|NCT00872521|365325228|FG001|Primary Endpoint Analysis|Patient choice|1|||
105908719|NCT00872521|365325229|FG002|Primary Endpoint Analysis|Patient choice|0|||
105908720|NCT00872521|365325227|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
105908721|NCT00872521|365325228|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
105672194|NCT01803282|364462671|FG000|Overall Study|Progressive Disease|4|||
105672195|NCT01803282|364462672|FG001|Overall Study|Progressive Disease|3|||
105672196|NCT01803282|364462673|FG002|Overall Study|Progressive Disease|6|||
105672197|NCT01803282|364462674|FG003|Overall Study|Progressive Disease|22|||
105672198|NCT01803282|364462675|FG004|Overall Study|Progressive Disease|5|||
105672199|NCT01803282|364462676|FG005|Overall Study|Progressive Disease|8|||
105672200|NCT01803282|364462677|FG006|Overall Study|Progressive Disease|23|||
105908722|NCT00872521|365325229|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
105908723|NCT00872521|365325227|FG000|Primary Endpoint Analysis|Patient response missing|0|||
105672201|NCT01803282|364462678|FG007|Overall Study|Progressive Disease|24|||
105672202|NCT01803282|364462679|FG008|Overall Study|Progressive Disease|3|||
105672203|NCT01803282|364462680|FG009|Overall Study|Progressive Disease|29|||
105672204|NCT01803282|364462681|FG010|Overall Study|Progressive Disease|6|||
105672205|NCT01803282|364462682|FG011|Overall Study|Progressive Disease|11|||
105672206|NCT01803282|364462671|FG000|Overall Study|Death|0|||
105672207|NCT01803282|364462672|FG001|Overall Study|Death|0|||
105672208|NCT01803282|364462673|FG002|Overall Study|Death|0|||
105672209|NCT01803282|364462674|FG003|Overall Study|Death|0|||
105672210|NCT01803282|364462675|FG004|Overall Study|Death|2|||
105672211|NCT01803282|364462676|FG005|Overall Study|Death|1|||
105672212|NCT01803282|364462677|FG006|Overall Study|Death|1|||
105672213|NCT01803282|364462678|FG007|Overall Study|Death|5|||
105672214|NCT01803282|364462679|FG008|Overall Study|Death|1|||
105672215|NCT01803282|364462680|FG009|Overall Study|Death|1|||
105672216|NCT01803282|364462681|FG010|Overall Study|Death|0|||
105672217|NCT01803282|364462682|FG011|Overall Study|Death|0|||
105672218|NCT01803282|364462671|FG000|Overall Study|Withdrew Consent|0|||
105672219|NCT01803282|364462672|FG001|Overall Study|Withdrew Consent|0|||
105672220|NCT01803282|364462673|FG002|Overall Study|Withdrew Consent|0|||
105672221|NCT01803282|364462674|FG003|Overall Study|Withdrew Consent|6|||
105672222|NCT01803282|364462675|FG004|Overall Study|Withdrew Consent|1|||
105672223|NCT01803282|364462676|FG005|Overall Study|Withdrew Consent|0|||
105672224|NCT01803282|364462677|FG006|Overall Study|Withdrew Consent|8|||
105672225|NCT01803282|364462678|FG007|Overall Study|Withdrew Consent|3|||
105672226|NCT01803282|364462679|FG008|Overall Study|Withdrew Consent|1|||
105672227|NCT01803282|364462680|FG009|Overall Study|Withdrew Consent|5|||
105672228|NCT01803282|364462681|FG010|Overall Study|Withdrew Consent|0|||
105672229|NCT01803282|364462682|FG011|Overall Study|Withdrew Consent|1|||
105672230|NCT01803282|364462671|FG000|Overall Study|Investigator's Discretion|0|||
105672231|NCT01803282|364462672|FG001|Overall Study|Investigator's Discretion|0|||
105672232|NCT01803282|364462673|FG002|Overall Study|Investigator's Discretion|0|||
105672233|NCT01803282|364462674|FG003|Overall Study|Investigator's Discretion|7|||
105672234|NCT01803282|364462675|FG004|Overall Study|Investigator's Discretion|2|||
105672235|NCT01803282|364462676|FG005|Overall Study|Investigator's Discretion|1|||
105672236|NCT01803282|364462677|FG006|Overall Study|Investigator's Discretion|7|||
105672237|NCT01803282|364462678|FG007|Overall Study|Investigator's Discretion|10|||
105672238|NCT01803282|364462679|FG008|Overall Study|Investigator's Discretion|6|||
105672239|NCT01803282|364462680|FG009|Overall Study|Investigator's Discretion|7|||
105672240|NCT01803282|364462681|FG010|Overall Study|Investigator's Discretion|1|||
105672241|NCT01803282|364462682|FG011|Overall Study|Investigator's Discretion|0|||
105672242|NCT01803282|364462671|FG000|Overall Study|Adverse Event|0|||
105672243|NCT01803282|364462672|FG001|Overall Study|Adverse Event|0|||
105672244|NCT01803282|364462673|FG002|Overall Study|Adverse Event|0|||
105672245|NCT01803282|364462674|FG003|Overall Study|Adverse Event|0|||
105672246|NCT01803282|364462675|FG004|Overall Study|Adverse Event|0|||
105672247|NCT01803282|364462676|FG005|Overall Study|Adverse Event|0|||
105672248|NCT01803282|364462677|FG006|Overall Study|Adverse Event|1|||
105672249|NCT01803282|364462678|FG007|Overall Study|Adverse Event|2|||
105672250|NCT01803282|364462679|FG008|Overall Study|Adverse Event|0|||
105672251|NCT01803282|364462680|FG009|Overall Study|Adverse Event|1|||
105672252|NCT01803282|364462681|FG010|Overall Study|Adverse Event|0|||
105672253|NCT01803282|364462682|FG011|Overall Study|Adverse Event|3|||
105672254|NCT01803282|364462671|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105672255|NCT01803282|364462672|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105672256|NCT01803282|364462673|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105672257|NCT01803282|364462674|FG003|Overall Study|Non-Compliance with Study Drug|1|||
105672258|NCT01803282|364462675|FG004|Overall Study|Non-Compliance with Study Drug|0|||
105908724|NCT00872521|365325228|FG001|Primary Endpoint Analysis|Patient response missing|0|||
105908725|NCT00872521|365325229|FG002|Primary Endpoint Analysis|Patient response missing|1|||
105672259|NCT01803282|364462676|FG005|Overall Study|Non-Compliance with Study Drug|0|||
105672260|NCT01803282|364462677|FG006|Overall Study|Non-Compliance with Study Drug|0|||
105908726|NCT00872521|365325227|FG000|Completed 3-month Follow up|Other|0|||
105908727|NCT00872521|365325228|FG001|Completed 3-month Follow up|Other|2|||
105908728|NCT00872521|365325229|FG002|Completed 3-month Follow up|Other|0|||
105908729|NCT00872521|365325227|FG000|Completed 3-month Follow up|Physician Decision|0|||
105908730|NCT00872521|365325228|FG001|Completed 3-month Follow up|Physician Decision|1|||
105672261|NCT01803282|364462678|FG007|Overall Study|Non-Compliance with Study Drug|0|||
105672262|NCT01803282|364462679|FG008|Overall Study|Non-Compliance with Study Drug|0|||
105672263|NCT01803282|364462680|FG009|Overall Study|Non-Compliance with Study Drug|0|||
105672264|NCT01803282|364462681|FG010|Overall Study|Non-Compliance with Study Drug|0|||
105672265|NCT01803282|364462682|FG011|Overall Study|Non-Compliance with Study Drug|0|||
105672266|NCT01803282|364462671|FG000|Overall Study|Unknown Reason|0|||
105672267|NCT01803282|364462672|FG001|Overall Study|Unknown Reason|0|||
105672268|NCT01803282|364462673|FG002|Overall Study|Unknown Reason|0|||
105672269|NCT01803282|364462674|FG003|Overall Study|Unknown Reason|0|||
105786220|NCT04794491|364870479|FG000|Overall Study|Withdrawal by Subject|2|||
105908731|NCT00872521|365325229|FG002|Completed 3-month Follow up|Physician Decision|0|||
105672270|NCT01803282|364462675|FG004|Overall Study|Unknown Reason|0|||
105672271|NCT01803282|364462676|FG005|Overall Study|Unknown Reason|0|||
105672272|NCT01803282|364462677|FG006|Overall Study|Unknown Reason|0|||
105672273|NCT01803282|364462678|FG007|Overall Study|Unknown Reason|1|||
105672274|NCT01803282|364462679|FG008|Overall Study|Unknown Reason|0|||
105672275|NCT01803282|364462680|FG009|Overall Study|Unknown Reason|0|||
105672276|NCT01803282|364462681|FG010|Overall Study|Unknown Reason|0|||
105672277|NCT01803282|364462682|FG011|Overall Study|Unknown Reason|0|||
105672278|NCT01803282|364462671|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
105672279|NCT01803282|364462672|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
105672280|NCT01803282|364462673|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
105672281|NCT01803282|364462674|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
105672282|NCT01803282|364462675|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
105672283|NCT01803282|364462676|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
105672284|NCT01803282|364462677|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
105672285|NCT01803282|364462678|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
105672286|NCT01803282|364462679|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
105672287|NCT01803282|364462680|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
105672288|NCT01803282|364462681|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
105672289|NCT01803282|364462682|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
105672290|NCT01803282|364462671|FG000|Overall Study|Enrolled but Never Treated|0|||
105672291|NCT01803282|364462672|FG001|Overall Study|Enrolled but Never Treated|0|||
105672292|NCT01803282|364462673|FG002|Overall Study|Enrolled but Never Treated|0|||
105672293|NCT01803282|364462674|FG003|Overall Study|Enrolled but Never Treated|0|||
105672294|NCT01803282|364462675|FG004|Overall Study|Enrolled but Never Treated|1|||
105672295|NCT01803282|364462676|FG005|Overall Study|Enrolled but Never Treated|0|||
105672296|NCT01803282|364462677|FG006|Overall Study|Enrolled but Never Treated|1|||
105672297|NCT01803282|364462678|FG007|Overall Study|Enrolled but Never Treated|1|||
105672298|NCT01803282|364462679|FG008|Overall Study|Enrolled but Never Treated|0|||
105672299|NCT01803282|364462680|FG009|Overall Study|Enrolled but Never Treated|1|||
105672300|NCT01803282|364462681|FG010|Overall Study|Enrolled but Never Treated|0|||
105672301|NCT01803282|364462682|FG011|Overall Study|Enrolled but Never Treated|0|||
105672302|NCT01008410|364464233|FG000|Overall Study|Adverse Event|13|||
105672303|NCT01008410|364464234|FG001|Overall Study|Adverse Event|7|||
105672304|NCT01008410|364464233|FG000|Overall Study|Withdrawal by Subject|6|||
105672305|NCT01008410|364464234|FG001|Overall Study|Withdrawal by Subject|2|||
105672306|NCT01008410|364464233|FG000|Overall Study|Lost to Follow-up|1|||
105672307|NCT01008410|364464234|FG001|Overall Study|Lost to Follow-up|0|||
105672308|NCT01008410|364464233|FG000|Overall Study|Noncompliance|1|||
105672309|NCT01008410|364464234|FG001|Overall Study|Noncompliance|0|||
105672310|NCT01008410|364464233|FG000|Overall Study|Low Cortisol|2|||
105672311|NCT01008410|364464234|FG001|Overall Study|Low Cortisol|0|||
105672312|NCT01008410|364464233|FG000|Overall Study|Lack of Efficacy|2|||
105672313|NCT01008410|364464234|FG001|Overall Study|Lack of Efficacy|6|||
105672314|NCT01008410|364464233|FG000|Overall Study|Met Exclusion Criterion|0|||
105672315|NCT01008410|364464234|FG001|Overall Study|Met Exclusion Criterion|1|||
105672316|NCT01977677|364464235|FG000|Overall Study|Unrelated Adverse Event|0|||
105672317|NCT01977677|364464236|FG001|Overall Study|Unrelated Adverse Event|0|||
105672318|NCT01977677|364464237|FG002|Overall Study|Unrelated Adverse Event|1|||
105672319|NCT01498887|364464238|FG000|Overall Study|Administrative problems|1|||
105672320|NCT01498887|364464239|FG001|Overall Study|Administrative problems|0|||
105672321|NCT01498887|364464238|FG000|Overall Study|Lost to Follow-up|1|||
105672322|NCT01498887|364464239|FG001|Overall Study|Lost to Follow-up|1|||
105672323|NCT01498887|364464238|FG000|Overall Study|Withdrawal by Subject|1|||
105908732|NCT00872521|365325227|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
105908733|NCT00872521|365325228|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
105908734|NCT00872521|365325229|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
105908735|NCT03410992|365325231|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105908736|NCT03410992|365325232|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
105908737|NCT03410992|365325233|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105908738|NCT03410992|365325234|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105908739|NCT03410992|365325235|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105908740|NCT03410992|365325236|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105908741|NCT03410992|365325237|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105672324|NCT01498887|364464239|FG001|Overall Study|Withdrawal by Subject|0|||
105672325|NCT01498887|364464238|FG000|Overall Study|Protocol Violation|1|||
105672326|NCT01498887|364464239|FG001|Overall Study|Protocol Violation|3|||
105672327|NCT01498887|364464238|FG000|Overall Study|Lack of Efficacy|5|||
105908742|NCT03410992|365325238|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105672328|NCT01498887|364464239|FG001|Overall Study|Lack of Efficacy|3|||
105672329|NCT01498887|364464238|FG000|Overall Study|Abnormal result from test procedure|1|||
105672330|NCT01498887|364464239|FG001|Overall Study|Abnormal result from test procedure|1|||
105672331|NCT01498887|364464238|FG000|Overall Study|Abnormal laboratory value|2|||
105672332|NCT01498887|364464239|FG001|Overall Study|Abnormal laboratory value|2|||
105672333|NCT01498887|364464238|FG000|Overall Study|Adverse Event|4|||
105672334|NCT01498887|364464239|FG001|Overall Study|Adverse Event|1|||
105672335|NCT00574873|364464242|FG000|Overall Study|Withdrawal by Subject|18|||
105672336|NCT00574873|364464243|FG001|Overall Study|Withdrawal by Subject|19|||
105672337|NCT00574873|364464242|FG000|Overall Study|Investigator request|18|||
105672338|NCT00574873|364464243|FG001|Overall Study|Investigator request|8|||
105672339|NCT00574873|364464242|FG000|Overall Study|Death|15|||
105672340|NCT00574873|364464243|FG001|Overall Study|Death|14|||
105672341|NCT00574873|364464242|FG000|Overall Study|Lost to Follow-up|14|||
105672342|NCT00574873|364464243|FG001|Overall Study|Lost to Follow-up|5|||
105672343|NCT00574873|364464242|FG000|Overall Study|Other|40|||
105672344|NCT00574873|364464243|FG001|Overall Study|Other|4|||
105672345|NCT00574873|364464242|FG000|Overall Study|Discontinuation of study by sponsor|5|||
105672346|NCT00574873|364464243|FG001|Overall Study|Discontinuation of study by sponsor|199|||
105672347|NCT00574873|364464242|FG000|Overall Study|Blank, site closed per local regulations|2|||
105672348|NCT00574873|364464243|FG001|Overall Study|Blank, site closed per local regulations|2|||
105672349|NCT00574873|364464242|FG000|Overall Study|Extension Study|126|||
105672350|NCT00574873|364464243|FG001|Overall Study|Extension Study|0|||
105672351|NCT04996004|364464244|FG000|Phase I|Death|1|||
105672352|NCT04996004|364464245|FG001|Phase I|Death|2|||
105672353|NCT04996004|364464246|FG002|Phase I|Death|1|||
105672354|NCT04996004|364464247|FG003|Phase I|Death|0|||
105672355|NCT04996004|364464248|FG004|Phase I|Death|0|||
105672356|NCT04996004|364464249|FG005|Phase I|Death|0|||
105672357|NCT04996004|364464244|FG000|Phase I|Study terminated by sponsor|2|||
105672358|NCT04996004|364464245|FG001|Phase I|Study terminated by sponsor|1|||
105672359|NCT04996004|364464246|FG002|Phase I|Study terminated by sponsor|2|||
105672360|NCT04996004|364464247|FG003|Phase I|Study terminated by sponsor|0|||
105672361|NCT04996004|364464248|FG004|Phase I|Study terminated by sponsor|0|||
105672362|NCT04996004|364464249|FG005|Phase I|Study terminated by sponsor|0|||
105672363|NCT04996004|364464244|FG000|Phase II|Study terminated by sponsor|0|||
105672364|NCT04996004|364464245|FG001|Phase II|Study terminated by sponsor|0|||
105672365|NCT04996004|364464246|FG002|Phase II|Study terminated by sponsor|0|||
105672366|NCT04996004|364464247|FG003|Phase II|Study terminated by sponsor|20|||
105672367|NCT04996004|364464248|FG004|Phase II|Study terminated by sponsor|10|||
105672368|NCT04996004|364464249|FG005|Phase II|Study terminated by sponsor|10|||
105672369|NCT04996004|364464244|FG000|Phase II|Withdrawal by Subject|0|||
105672370|NCT04996004|364464245|FG001|Phase II|Withdrawal by Subject|0|||
105672371|NCT04996004|364464246|FG002|Phase II|Withdrawal by Subject|0|||
105672372|NCT04996004|364464247|FG003|Phase II|Withdrawal by Subject|0|||
105672373|NCT04996004|364464248|FG004|Phase II|Withdrawal by Subject|1|||
105672374|NCT04996004|364464249|FG005|Phase II|Withdrawal by Subject|2|||
105672375|NCT04996004|364464244|FG000|Phase II|Death|0|||
105672376|NCT04996004|364464245|FG001|Phase II|Death|0|||
105672377|NCT04996004|364464246|FG002|Phase II|Death|0|||
105672378|NCT04996004|364464247|FG003|Phase II|Death|12|||
105672379|NCT04996004|364464248|FG004|Phase II|Death|2|||
105672380|NCT04996004|364464249|FG005|Phase II|Death|9|||
105672381|NCT04996004|364464244|FG000|Phase II|Other|0|||
105672382|NCT04996004|364464245|FG001|Phase II|Other|0|||
105672383|NCT04996004|364464246|FG002|Phase II|Other|0|||
105672384|NCT04996004|364464247|FG003|Phase II|Other|0|||
105672385|NCT04996004|364464248|FG004|Phase II|Other|0|||
105672386|NCT04996004|364464249|FG005|Phase II|Other|1|||
105672387|NCT02993406|364464250|FG000|Overall Study|Withdrawal by Subject|170|||
105672388|NCT02993406|364464251|FG001|Overall Study|Withdrawal by Subject|196|||
105672389|NCT02993406|364464250|FG000|Overall Study|Physician Decision|3|||
105672390|NCT02993406|364464251|FG001|Overall Study|Physician Decision|5|||
105672391|NCT02993406|364464250|FG000|Overall Study|Lost to Follow-up|12|||
105672392|NCT02993406|364464251|FG001|Overall Study|Lost to Follow-up|13|||
105672393|NCT02993406|364464250|FG000|Overall Study|Unclassifiable Response|105|||
105672394|NCT02993406|364464251|FG001|Overall Study|Unclassifiable Response|139|||
105672395|NCT02993406|364464250|FG000|Overall Study|Administrative decision|1|||
105786221|NCT00931515|364870481|FG000|Overall Study|Lost to Follow-up|2|||
106125628|NCT03653416|366117843|FG001|Overall Study|Protocol Violation|1|||
105672396|NCT02993406|364464251|FG001|Overall Study|Administrative decision|0|||
105672397|NCT02993406|364464250|FG000|Overall Study|Sponsor decision|4|||
105672398|NCT02993406|364464251|FG001|Overall Study|Sponsor decision|5|||
105672399|NCT03563157|364464252|FG000|Overall Study|Progressive Disease|2|||
105672400|NCT00201643|364464253|FG000|Overall Study|Withdrawal by Subject|5|||
105672401|NCT00201643|364464254|FG001|Overall Study|Withdrawal by Subject|4|||
105672402|NCT02942277|364464256|FG000|Year 1|Withdrawal by Subject|0|||
105672403|NCT02942277|364464257|FG001|Year 1|Withdrawal by Subject|0|||
105672404|NCT02942277|364464258|FG002|Year 1|Withdrawal by Subject|0|||
105672405|NCT02942277|364464259|FG003|Year 1|Withdrawal by Subject|0|||
105672406|NCT02942277|364464260|FG004|Year 1|Withdrawal by Subject|1|||
105672407|NCT02942277|364464261|FG005|Year 1|Withdrawal by Subject|3|||
105672408|NCT02942277|364464262|FG006|Year 1|Withdrawal by Subject|0|||
105672409|NCT02942277|364464263|FG007|Year 1|Withdrawal by Subject|1|||
105672410|NCT02942277|364464264|FG008|Year 1|Withdrawal by Subject|0|||
105672411|NCT02942277|364464265|FG009|Year 1|Withdrawal by Subject|0|||
105672412|NCT02942277|364464266|FG010|Year 1|Withdrawal by Subject|3|||
105908743|NCT03410992|365325239|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105908744|NCT03410992|365325240|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105908745|NCT03410992|365325241|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
105672413|NCT02942277|364464256|FG000|Year 1|Travel|0|||
105672414|NCT02942277|364464257|FG001|Year 1|Travel|1|||
105672415|NCT02942277|364464258|FG002|Year 1|Travel|0|||
105672416|NCT02942277|364464259|FG003|Year 1|Travel|0|||
105672417|NCT02942277|364464260|FG004|Year 1|Travel|4|||
105672418|NCT02942277|364464261|FG005|Year 1|Travel|5|||
105672419|NCT02942277|364464262|FG006|Year 1|Travel|0|||
105672420|NCT02942277|364464263|FG007|Year 1|Travel|0|||
105672421|NCT02942277|364464264|FG008|Year 1|Travel|0|||
105672422|NCT02942277|364464265|FG009|Year 1|Travel|0|||
105672423|NCT02942277|364464266|FG010|Year 1|Travel|8|||
105672424|NCT02942277|364464256|FG000|Year 1|Joined Army|0|||
105786222|NCT00931515|364870482|FG001|Overall Study|Lost to Follow-up|5|||
105786223|NCT01233284|364870483|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
105786224|NCT01233284|364870484|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105908746|NCT03410992|365325231|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
105908747|NCT03410992|365325232|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
105908748|NCT03410992|365325233|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908749|NCT03410992|365325234|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908750|NCT03410992|365325235|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908751|NCT03410992|365325236|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908752|NCT03410992|365325237|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908753|NCT03410992|365325238|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908754|NCT03410992|365325239|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908755|NCT03410992|365325240|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908756|NCT03410992|365325241|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
105908757|NCT03410992|365325231|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
105908758|NCT03410992|365325232|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
105908759|NCT03410992|365325233|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908760|NCT03410992|365325234|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908761|NCT03410992|365325235|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908762|NCT03410992|365325236|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908763|NCT03410992|365325237|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908764|NCT03410992|365325238|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908765|NCT03410992|365325239|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908766|NCT03410992|365325240|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908767|NCT03410992|365325241|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
105908768|NCT03410992|365325231|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
105908769|NCT03410992|365325232|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908770|NCT03410992|365325233|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908771|NCT03410992|365325234|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908772|NCT03410992|365325235|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908773|NCT03410992|365325236|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908774|NCT03410992|365325237|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908775|NCT03410992|365325238|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908776|NCT03410992|365325239|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908777|NCT03410992|365325240|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908778|NCT03410992|365325241|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
105908779|NCT03410992|365325231|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
105908780|NCT03410992|365325232|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
105908781|NCT03410992|365325233|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908782|NCT03410992|365325234|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908783|NCT03410992|365325235|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908784|NCT03410992|365325236|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908785|NCT03410992|365325237|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908786|NCT03410992|365325238|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908787|NCT03410992|365325239|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908788|NCT03410992|365325240|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908789|NCT03410992|365325241|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
105908790|NCT03410992|365325231|FG000|Week 16 Assessment|Incorrect escapers|0|||
105908791|NCT03410992|365325232|FG001|Week 16 Assessment|Incorrect escapers|6|||
105908792|NCT03410992|365325233|FG002|Week 16 Assessment|Incorrect escapers|0|||
106125629|NCT02269943|366117845|FG000|Treatment Period|Death|0|||
105672425|NCT02942277|364464257|FG001|Year 1|Joined Army|1|||
105672426|NCT02942277|364464258|FG002|Year 1|Joined Army|0|||
105672427|NCT02942277|364464259|FG003|Year 1|Joined Army|0|||
105672428|NCT02942277|364464260|FG004|Year 1|Joined Army|0|||
105672429|NCT02942277|364464261|FG005|Year 1|Joined Army|0|||
105672430|NCT02942277|364464262|FG006|Year 1|Joined Army|0|||
105999293|NCT04628780|365659453|FG003|Overall Study|Global deterioration of health status|0|||
105999294|NCT04628780|365659454|FG004|Overall Study|Global deterioration of health status|1|||
105999295|NCT04628780|365659455|FG005|Overall Study|Global deterioration of health status|1|||
105999296|NCT01132313|365659458|FG000|Overall Study|Lack of Efficacy|1|||
105999297|NCT01132313|365659459|FG001|Overall Study|Lack of Efficacy|0|||
105999298|NCT01132313|365659460|FG002|Overall Study|Lack of Efficacy|0|||
105999299|NCT01132313|365659461|FG003|Overall Study|Lack of Efficacy|0|||
105999300|NCT01132313|365659462|FG004|Overall Study|Lack of Efficacy|0|||
105999301|NCT01132313|365659463|FG005|Overall Study|Lack of Efficacy|0|||
105999302|NCT01132313|365659464|FG006|Overall Study|Lack of Efficacy|0|||
105999303|NCT01132313|365659465|FG007|Overall Study|Lack of Efficacy|3|||
105999304|NCT01132313|365659466|FG008|Overall Study|Lack of Efficacy|14|||
105999305|NCT01132313|365659467|FG009|Overall Study|Lack of Efficacy|16|||
105999306|NCT01132313|365659468|FG010|Overall Study|Lack of Efficacy|0|||
105999307|NCT01132313|365659469|FG011|Overall Study|Lack of Efficacy|0|||
105999308|NCT01132313|365659458|FG000|Overall Study|Not treated|2|||
105999309|NCT01132313|365659459|FG001|Overall Study|Not treated|0|||
105999310|NCT01132313|365659460|FG002|Overall Study|Not treated|0|||
105999311|NCT01132313|365659461|FG003|Overall Study|Not treated|0|||
105999312|NCT01132313|365659462|FG004|Overall Study|Not treated|2|||
105999313|NCT01132313|365659463|FG005|Overall Study|Not treated|1|||
105999314|NCT01132313|365659464|FG006|Overall Study|Not treated|3|||
105999315|NCT01132313|365659465|FG007|Overall Study|Not treated|0|||
105999316|NCT01132313|365659466|FG008|Overall Study|Not treated|0|||
105999317|NCT01132313|365659467|FG009|Overall Study|Not treated|0|||
105999318|NCT01132313|365659468|FG010|Overall Study|Not treated|0|||
105999319|NCT01132313|365659469|FG011|Overall Study|Not treated|0|||
105999320|NCT01132313|365659458|FG000|Overall Study|Adverse Event|0|||
105999321|NCT01132313|365659459|FG001|Overall Study|Adverse Event|0|||
105999322|NCT01132313|365659460|FG002|Overall Study|Adverse Event|4|||
105999323|NCT01132313|365659461|FG003|Overall Study|Adverse Event|10|||
105999324|NCT01132313|365659462|FG004|Overall Study|Adverse Event|19|||
105999325|NCT01132313|365659463|FG005|Overall Study|Adverse Event|6|||
105999326|NCT01132313|365659464|FG006|Overall Study|Adverse Event|5|||
105999327|NCT01132313|365659465|FG007|Overall Study|Adverse Event|3|||
105999328|NCT01132313|365659466|FG008|Overall Study|Adverse Event|7|||
105999329|NCT01132313|365659467|FG009|Overall Study|Adverse Event|2|||
105999330|NCT01132313|365659468|FG010|Overall Study|Adverse Event|0|||
105999331|NCT01132313|365659469|FG011|Overall Study|Adverse Event|0|||
105999332|NCT01132313|365659458|FG000|Overall Study|Protocol Violation|0|||
105999333|NCT01132313|365659459|FG001|Overall Study|Protocol Violation|0|||
105999334|NCT01132313|365659460|FG002|Overall Study|Protocol Violation|0|||
105999335|NCT01132313|365659461|FG003|Overall Study|Protocol Violation|1|||
105999336|NCT01132313|365659462|FG004|Overall Study|Protocol Violation|0|||
105999337|NCT01132313|365659463|FG005|Overall Study|Protocol Violation|0|||
105999338|NCT01132313|365659464|FG006|Overall Study|Protocol Violation|0|||
105999339|NCT01132313|365659465|FG007|Overall Study|Protocol Violation|0|||
105999340|NCT01132313|365659466|FG008|Overall Study|Protocol Violation|0|||
105999341|NCT01132313|365659467|FG009|Overall Study|Protocol Violation|0|||
105999342|NCT01132313|365659468|FG010|Overall Study|Protocol Violation|0|||
105999343|NCT01132313|365659469|FG011|Overall Study|Protocol Violation|0|||
105999344|NCT01132313|365659458|FG000|Overall Study|Lost to Follow-up|0|||
105999345|NCT01132313|365659459|FG001|Overall Study|Lost to Follow-up|0|||
105999346|NCT01132313|365659460|FG002|Overall Study|Lost to Follow-up|1|||
105999347|NCT01132313|365659461|FG003|Overall Study|Lost to Follow-up|0|||
105999348|NCT01132313|365659462|FG004|Overall Study|Lost to Follow-up|0|||
105999349|NCT01132313|365659463|FG005|Overall Study|Lost to Follow-up|0|||
105999350|NCT01132313|365659464|FG006|Overall Study|Lost to Follow-up|0|||
105999351|NCT01132313|365659465|FG007|Overall Study|Lost to Follow-up|1|||
105999352|NCT01132313|365659466|FG008|Overall Study|Lost to Follow-up|0|||
105999353|NCT01132313|365659467|FG009|Overall Study|Lost to Follow-up|0|||
105999354|NCT01132313|365659468|FG010|Overall Study|Lost to Follow-up|0|||
105999355|NCT01132313|365659469|FG011|Overall Study|Lost to Follow-up|0|||
105999356|NCT01132313|365659458|FG000|Overall Study|Withdrawal by Subject|0|||
105672431|NCT02942277|364464263|FG007|Year 1|Joined Army|0|||
105672432|NCT02942277|364464264|FG008|Year 1|Joined Army|0|||
105672433|NCT02942277|364464265|FG009|Year 1|Joined Army|0|||
105672434|NCT02942277|364464266|FG010|Year 1|Joined Army|0|||
105672435|NCT02942277|364464256|FG000|Year 1|Subject met withdrawal criteria|0|||
105672436|NCT02942277|364464257|FG001|Year 1|Subject met withdrawal criteria|0|||
105672437|NCT02942277|364464258|FG002|Year 1|Subject met withdrawal criteria|0|||
105672438|NCT02942277|364464259|FG003|Year 1|Subject met withdrawal criteria|1|||
105908793|NCT03410992|365325234|FG003|Week 16 Assessment|Incorrect escapers|0|||
105672439|NCT02942277|364464260|FG004|Year 1|Subject met withdrawal criteria|0|||
105786225|NCT01233284|364870485|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105672440|NCT02942277|364464261|FG005|Year 1|Subject met withdrawal criteria|0|||
105672441|NCT02942277|364464262|FG006|Year 1|Subject met withdrawal criteria|0|||
105672442|NCT02942277|364464263|FG007|Year 1|Subject met withdrawal criteria|0|||
105672443|NCT02942277|364464264|FG008|Year 1|Subject met withdrawal criteria|0|||
105672444|NCT02942277|364464265|FG009|Year 1|Subject met withdrawal criteria|0|||
105672445|NCT02942277|364464266|FG010|Year 1|Subject met withdrawal criteria|0|||
105672446|NCT02942277|364464256|FG000|Year 1|Lost to Follow-up|0|||
105672447|NCT02942277|364464257|FG001|Year 1|Lost to Follow-up|0|||
105672448|NCT02942277|364464258|FG002|Year 1|Lost to Follow-up|0|||
105672449|NCT02942277|364464259|FG003|Year 1|Lost to Follow-up|0|||
105672450|NCT02942277|364464260|FG004|Year 1|Lost to Follow-up|1|||
105672451|NCT02942277|364464261|FG005|Year 1|Lost to Follow-up|0|||
105672452|NCT02942277|364464262|FG006|Year 1|Lost to Follow-up|0|||
105672453|NCT02942277|364464263|FG007|Year 1|Lost to Follow-up|0|||
105672454|NCT02942277|364464264|FG008|Year 1|Lost to Follow-up|0|||
106125630|NCT02269943|366117846|FG001|Treatment Period|Death|1|||
105672455|NCT02942277|364464265|FG009|Year 1|Lost to Follow-up|0|||
105672456|NCT02942277|364464266|FG010|Year 1|Lost to Follow-up|2|||
105672457|NCT02942277|364464256|FG000|Year 1|Protocol Violation|0|||
106125631|NCT02269943|366117845|FG000|Treatment Period|Adverse Event|1|||
106125632|NCT02269943|366117846|FG001|Treatment Period|Adverse Event|10|||
106125633|NCT02269943|366117845|FG000|Treatment Period|Progressive Disease|5|||
106125634|NCT02269943|366117846|FG001|Treatment Period|Progressive Disease|17|||
106125635|NCT02269943|366117845|FG000|Treatment Period|Symptomatic Deterioration|0|||
106125636|NCT02269943|366117846|FG001|Treatment Period|Symptomatic Deterioration|2|||
106125637|NCT02269943|366117845|FG000|Follow-Up Survival Period|Death|3|||
106125638|NCT02269943|366117846|FG001|Follow-Up Survival Period|Death|16|||
106125639|NCT02269943|366117845|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
106125640|NCT02269943|366117846|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
106125641|NCT02269943|366117845|FG000|Follow-Up Survival Period|Alive|2|||
106125642|NCT02269943|366117846|FG001|Follow-Up Survival Period|Alive|8|||
106125643|NCT03541642|366117849|FG000|Overall Study|Withdrawal by Subject|1|||
106125644|NCT03541642|366117850|FG001|Overall Study|Withdrawal by Subject|2|||
106125645|NCT03541642|366117849|FG000|Overall Study|Lost to Follow-up|16|||
106125646|NCT03541642|366117850|FG001|Overall Study|Lost to Follow-up|12|||
106125647|NCT03541642|366117849|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
106125648|NCT03541642|366117850|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
106125649|NCT01951092|366117851|FG000|Overall Study|Lost to Follow-up|10|||
106125650|NCT01951092|366117851|FG000|Overall Study|Incarceration|1|||
106125651|NCT01951092|366117851|FG000|Overall Study|Transfer of Care|1|||
106125652|NCT02025205|366117854|FG000|Overall Study|Withdrawal by Subject|1|||
106125653|NCT02025205|366117855|FG001|Overall Study|Withdrawal by Subject|1|||
106125654|NCT02025205|366117854|FG000|Overall Study|Protocol Violation|2|||
106125655|NCT02025205|366117855|FG001|Overall Study|Protocol Violation|1|||
106125656|NCT02025205|366117854|FG000|Overall Study|Death|0|||
106125657|NCT02025205|366117855|FG001|Overall Study|Death|1|||
106125658|NCT01767129|366117856|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
106125659|NCT01767129|366117857|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
106125660|NCT01024751|366117861|FG000|Enrolled Participants|Ineligible at baseline|3|||
106125661|NCT01024751|366117862|FG001|Enrolled Participants|Ineligible at baseline|4|||
106125662|NCT01024751|366117861|FG000|Eligible Participants|Withdrawal by Subject|0|||
106125663|NCT01024751|366117862|FG001|Eligible Participants|Withdrawal by Subject|1|||
106125664|NCT01024751|366117861|FG000|Eligible Participants|Lost to Follow-up|0|||
106125665|NCT01024751|366117862|FG001|Eligible Participants|Lost to Follow-up|1|||
106125666|NCT01024751|366117861|FG000|Eligible Participants|Ineligible|0|||
106125667|NCT01024751|366117862|FG001|Eligible Participants|Ineligible|1|||
106125668|NCT01163149|366117863|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
106125669|NCT01163149|366117864|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
106125670|NCT01163149|366117865|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
106125671|NCT01163149|366117863|FG000|Extension Treatment Period|Adverse Event|0|||
106125672|NCT01163149|366117864|FG001|Extension Treatment Period|Adverse Event|1|||
106125673|NCT01163149|366117865|FG002|Extension Treatment Period|Adverse Event|0|||
106125674|NCT01163149|366117863|FG000|Extension Treatment Period|Noncompliance|0|||
106125675|NCT01163149|366117864|FG001|Extension Treatment Period|Noncompliance|0|||
106125676|NCT01163149|366117865|FG002|Extension Treatment Period|Noncompliance|1|||
106125677|NCT02550873|366117866|FG000|Randomized Double Blind|Adverse Event|3|||
106125678|NCT02550873|366117867|FG001|Randomized Double Blind|Adverse Event|1|||
106125679|NCT02550873|366117868|FG002|Randomized Double Blind|Adverse Event|0|||
106125680|NCT02550873|366117866|FG000|Randomized Double Blind|Disease progression|1|||
106125681|NCT02550873|366117867|FG001|Randomized Double Blind|Disease progression|1|||
106125682|NCT02550873|366117868|FG002|Randomized Double Blind|Disease progression|0|||
106125683|NCT02550873|366117866|FG000|Open Label Extension|Study ongoing|0|||
106125684|NCT02550873|366117867|FG001|Open Label Extension|Study ongoing|0|||
106125685|NCT02550873|366117868|FG002|Open Label Extension|Study ongoing|111|||
106125686|NCT01822353|366117869|FG000|Overall Study|Adverse Event|1|||
106125687|NCT01822353|366117870|FG001|Overall Study|Adverse Event|3|||
105672458|NCT02942277|364464257|FG001|Year 1|Protocol Violation|0|||
105672459|NCT02942277|364464258|FG002|Year 1|Protocol Violation|0|||
105672460|NCT02942277|364464259|FG003|Year 1|Protocol Violation|0|||
105672461|NCT02942277|364464260|FG004|Year 1|Protocol Violation|1|||
105672462|NCT02942277|364464261|FG005|Year 1|Protocol Violation|1|||
105672463|NCT02942277|364464262|FG006|Year 1|Protocol Violation|0|||
105672464|NCT02942277|364464263|FG007|Year 1|Protocol Violation|0|||
105672465|NCT02942277|364464264|FG008|Year 1|Protocol Violation|0|||
105672466|NCT02942277|364464265|FG009|Year 1|Protocol Violation|0|||
105672467|NCT02942277|364464266|FG010|Year 1|Protocol Violation|2|||
105672468|NCT02942277|364464256|FG000|Year 1|Pregnancy|0|||
105672469|NCT02942277|364464257|FG001|Year 1|Pregnancy|0|||
105672470|NCT02942277|364464258|FG002|Year 1|Pregnancy|0|||
105672471|NCT02942277|364464259|FG003|Year 1|Pregnancy|0|||
105672472|NCT02942277|364464260|FG004|Year 1|Pregnancy|0|||
105672473|NCT02942277|364464261|FG005|Year 1|Pregnancy|1|||
105672474|NCT02942277|364464262|FG006|Year 1|Pregnancy|0|||
105672475|NCT02942277|364464263|FG007|Year 1|Pregnancy|0|||
105672476|NCT02942277|364464264|FG008|Year 1|Pregnancy|0|||
105672477|NCT02942277|364464265|FG009|Year 1|Pregnancy|0|||
105672478|NCT02942277|364464266|FG010|Year 1|Pregnancy|0|||
105672479|NCT02942277|364464256|FG000|Year 2|Lost to Follow-up|0|||
105672480|NCT02942277|364464257|FG001|Year 2|Lost to Follow-up|0|||
105672481|NCT02942277|364464258|FG002|Year 2|Lost to Follow-up|0|||
105672482|NCT02942277|364464259|FG003|Year 2|Lost to Follow-up|0|||
105672483|NCT02942277|364464260|FG004|Year 2|Lost to Follow-up|2|||
105672484|NCT02942277|364464261|FG005|Year 2|Lost to Follow-up|1|||
105672485|NCT02942277|364464262|FG006|Year 2|Lost to Follow-up|0|||
105672486|NCT02942277|364464263|FG007|Year 2|Lost to Follow-up|0|||
105672487|NCT02942277|364464264|FG008|Year 2|Lost to Follow-up|0|||
105672488|NCT02942277|364464265|FG009|Year 2|Lost to Follow-up|0|||
105672489|NCT02942277|364464266|FG010|Year 2|Lost to Follow-up|0|||
105672490|NCT02942277|364464256|FG000|Year 2|Did not rescreen|0|||
105672491|NCT02942277|364464257|FG001|Year 2|Did not rescreen|0|||
105786226|NCT01233284|364870486|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105786227|NCT01233284|364870487|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
105786228|NCT01233284|364870483|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105786229|NCT01233284|364870484|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
105786230|NCT01233284|364870485|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105786231|NCT01233284|364870486|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105786232|NCT01233284|364870487|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105786233|NCT01233284|364870483|FG000|Period 1 (4 Weeks)|Other|0|||
105786234|NCT01233284|364870484|FG001|Period 1 (4 Weeks)|Other|0|||
105786235|NCT01233284|364870485|FG002|Period 1 (4 Weeks)|Other|1|||
105672492|NCT02942277|364464258|FG002|Year 2|Did not rescreen|1|||
105672493|NCT02942277|364464259|FG003|Year 2|Did not rescreen|1|||
105786236|NCT01233284|364870486|FG003|Period 1 (4 Weeks)|Other|0|||
105786237|NCT01233284|364870487|FG004|Period 1 (4 Weeks)|Other|0|||
105786238|NCT01233284|364870483|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105786239|NCT01233284|364870484|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105786240|NCT01233284|364870485|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
105786241|NCT01233284|364870486|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105786242|NCT01233284|364870487|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
105786243|NCT01233284|364870483|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105786244|NCT01233284|364870484|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105786245|NCT01233284|364870485|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
105786246|NCT01233284|364870486|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105786247|NCT01233284|364870487|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105786248|NCT01233284|364870483|FG000|Period 3 (4 Weeks)|Other|0|||
105786249|NCT01233284|364870484|FG001|Period 3 (4 Weeks)|Other|0|||
105786250|NCT01233284|364870485|FG002|Period 3 (4 Weeks)|Other|0|||
105786251|NCT01233284|364870486|FG003|Period 3 (4 Weeks)|Other|1|||
105786252|NCT01233284|364870487|FG004|Period 3 (4 Weeks)|Other|0|||
105786253|NCT01233284|364870483|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
106125688|NCT01822353|366117871|FG002|Overall Study|Adverse Event|1|||
105672494|NCT02942277|364464260|FG004|Year 2|Did not rescreen|9|||
105672495|NCT02942277|364464261|FG005|Year 2|Did not rescreen|6|||
105672496|NCT02942277|364464262|FG006|Year 2|Did not rescreen|0|||
105786254|NCT01233284|364870484|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
105672497|NCT02942277|364464263|FG007|Year 2|Did not rescreen|1|||
105672498|NCT02942277|364464264|FG008|Year 2|Did not rescreen|0|||
105672499|NCT02942277|364464265|FG009|Year 2|Did not rescreen|0|||
105672500|NCT02942277|364464266|FG010|Year 2|Did not rescreen|21|||
105786255|NCT01233284|364870485|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
105786256|NCT01233284|364870486|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
105786257|NCT01233284|364870487|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
105786258|NCT01233284|364870483|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
105786259|NCT01233284|364870484|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
105672501|NCT02942277|364464256|FG000|Year 2|Met withdrawal criteria|0|||
105672502|NCT02942277|364464257|FG001|Year 2|Met withdrawal criteria|0|||
105672503|NCT02942277|364464258|FG002|Year 2|Met withdrawal criteria|0|||
105672504|NCT02942277|364464259|FG003|Year 2|Met withdrawal criteria|0|||
105672505|NCT02942277|364464260|FG004|Year 2|Met withdrawal criteria|1|||
105672506|NCT02942277|364464261|FG005|Year 2|Met withdrawal criteria|2|||
105672507|NCT02942277|364464262|FG006|Year 2|Met withdrawal criteria|0|||
105672508|NCT02942277|364464263|FG007|Year 2|Met withdrawal criteria|0|||
105672509|NCT02942277|364464264|FG008|Year 2|Met withdrawal criteria|0|||
105672510|NCT02942277|364464265|FG009|Year 2|Met withdrawal criteria|0|||
105672511|NCT02942277|364464266|FG010|Year 2|Met withdrawal criteria|1|||
105672512|NCT02942277|364464256|FG000|Year 2|Travel|0|||
105672513|NCT02942277|364464257|FG001|Year 2|Travel|1|||
105672514|NCT02942277|364464258|FG002|Year 2|Travel|0|||
105672515|NCT02942277|364464259|FG003|Year 2|Travel|0|||
105672516|NCT02942277|364464260|FG004|Year 2|Travel|0|||
105672517|NCT02942277|364464261|FG005|Year 2|Travel|1|||
105672518|NCT02942277|364464262|FG006|Year 2|Travel|0|||
105672519|NCT02942277|364464263|FG007|Year 2|Travel|0|||
105672520|NCT02942277|364464264|FG008|Year 2|Travel|0|||
105672521|NCT02942277|364464265|FG009|Year 2|Travel|1|||
105672522|NCT02942277|364464266|FG010|Year 2|Travel|3|||
105672523|NCT02942277|364464256|FG000|Year 2|Non-compliant|0|||
105672524|NCT02942277|364464257|FG001|Year 2|Non-compliant|0|||
105672525|NCT02942277|364464258|FG002|Year 2|Non-compliant|0|||
105672526|NCT02942277|364464259|FG003|Year 2|Non-compliant|0|||
105672527|NCT02942277|364464260|FG004|Year 2|Non-compliant|1|||
105672528|NCT02942277|364464261|FG005|Year 2|Non-compliant|1|||
105672529|NCT02942277|364464262|FG006|Year 2|Non-compliant|0|||
105672530|NCT02942277|364464263|FG007|Year 2|Non-compliant|0|||
105672531|NCT02942277|364464264|FG008|Year 2|Non-compliant|0|||
105672532|NCT02942277|364464265|FG009|Year 2|Non-compliant|0|||
105672533|NCT02942277|364464266|FG010|Year 2|Non-compliant|0|||
105672534|NCT02942277|364464256|FG000|Year 2|Withdrawal by Subject|0|||
105672535|NCT02942277|364464257|FG001|Year 2|Withdrawal by Subject|0|||
105672536|NCT02942277|364464258|FG002|Year 2|Withdrawal by Subject|0|||
105672537|NCT02942277|364464259|FG003|Year 2|Withdrawal by Subject|0|||
105672538|NCT02942277|364464260|FG004|Year 2|Withdrawal by Subject|0|||
105672539|NCT02942277|364464261|FG005|Year 2|Withdrawal by Subject|0|||
105672540|NCT02942277|364464262|FG006|Year 2|Withdrawal by Subject|1|||
105672541|NCT02942277|364464263|FG007|Year 2|Withdrawal by Subject|0|||
105672542|NCT02942277|364464264|FG008|Year 2|Withdrawal by Subject|0|||
105672543|NCT02942277|364464265|FG009|Year 2|Withdrawal by Subject|0|||
105672544|NCT02942277|364464266|FG010|Year 2|Withdrawal by Subject|0|||
105672545|NCT02187159|364464274|FG000|Overall Study|Protocol Violation|4|||
105672546|NCT02187159|364464275|FG001|Overall Study|Protocol Violation|6|||
105672547|NCT02187159|364464276|FG002|Overall Study|Protocol Violation|3|||
105672548|NCT02187159|364464277|FG003|Overall Study|Protocol Violation|4|||
105672549|NCT02187159|364464274|FG000|Overall Study|Lack of Efficacy|10|||
105672550|NCT02187159|364464275|FG001|Overall Study|Lack of Efficacy|5|||
105672551|NCT02187159|364464276|FG002|Overall Study|Lack of Efficacy|4|||
105672552|NCT02187159|364464277|FG003|Overall Study|Lack of Efficacy|7|||
105672553|NCT02187159|364464274|FG000|Overall Study|Adverse Event|28|||
105672554|NCT02187159|364464275|FG001|Overall Study|Adverse Event|33|||
105672555|NCT02187159|364464276|FG002|Overall Study|Adverse Event|42|||
105908794|NCT03410992|365325235|FG004|Week 16 Assessment|Incorrect escapers|0|||
105672556|NCT02187159|364464277|FG003|Overall Study|Adverse Event|50|||
105672557|NCT02187159|364464274|FG000|Overall Study|Withdrawal by Subject|24|||
105672558|NCT02187159|364464275|FG001|Overall Study|Withdrawal by Subject|28|||
105672559|NCT02187159|364464276|FG002|Overall Study|Withdrawal by Subject|25|||
105672560|NCT02187159|364464277|FG003|Overall Study|Withdrawal by Subject|26|||
105672561|NCT02187159|364464274|FG000|Overall Study|Other|3|||
105908795|NCT03410992|365325236|FG005|Week 16 Assessment|Incorrect escapers|0|||
105908796|NCT03410992|365325237|FG006|Week 16 Assessment|Incorrect escapers|0|||
105908797|NCT03410992|365325238|FG007|Week 16 Assessment|Incorrect escapers|0|||
105908798|NCT03410992|365325239|FG008|Week 16 Assessment|Incorrect escapers|0|||
105672562|NCT02187159|364464275|FG001|Overall Study|Other|7|||
105672563|NCT02187159|364464276|FG002|Overall Study|Other|3|||
105672564|NCT02187159|364464277|FG003|Overall Study|Other|9|||
105672565|NCT02787044|364464278|FG000|Overall Study|Lost to Follow-up|15|||
105672566|NCT02787044|364464279|FG001|Overall Study|Lost to Follow-up|19|||
105672567|NCT00338962|364464280|FG000|Overall Study|Lost to Follow-up|3|||
105672568|NCT00338962|364464281|FG001|Overall Study|Lost to Follow-up|3|||
105672569|NCT00338962|364464282|FG002|Overall Study|Lost to Follow-up|2|||
105908799|NCT03410992|365325240|FG009|Week 16 Assessment|Incorrect escapers|0|||
105908800|NCT03410992|365325241|FG010|Week 16 Assessment|Incorrect escapers|0|||
105908801|NCT03410992|365325231|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
106125689|NCT01822353|366117869|FG000|Overall Study|Pregnancy|0|||
105672570|NCT00338962|364464283|FG003|Overall Study|Lost to Follow-up|3|||
105672571|NCT00338962|364464280|FG000|Overall Study|Withdrawal by Subject|1|||
105672572|NCT00338962|364464281|FG001|Overall Study|Withdrawal by Subject|0|||
105672573|NCT00338962|364464282|FG002|Overall Study|Withdrawal by Subject|0|||
105672574|NCT00338962|364464283|FG003|Overall Study|Withdrawal by Subject|0|||
105672575|NCT00338962|364464280|FG000|Overall Study|No Transportation|2|||
105672576|NCT00338962|364464281|FG001|Overall Study|No Transportation|0|||
105672577|NCT00338962|364464282|FG002|Overall Study|No Transportation|0|||
105672578|NCT00338962|364464283|FG003|Overall Study|No Transportation|0|||
105672579|NCT00338962|364464280|FG000|Overall Study|Time Constraint|2|||
105672580|NCT00338962|364464281|FG001|Overall Study|Time Constraint|0|||
105672581|NCT00338962|364464282|FG002|Overall Study|Time Constraint|0|||
105672582|NCT00338962|364464283|FG003|Overall Study|Time Constraint|0|||
105672583|NCT00338962|364464280|FG000|Overall Study|Moved|0|||
105672584|NCT00338962|364464281|FG001|Overall Study|Moved|1|||
105672585|NCT00338962|364464282|FG002|Overall Study|Moved|0|||
105672586|NCT00338962|364464283|FG003|Overall Study|Moved|0|||
105672587|NCT00338962|364464280|FG000|Overall Study|Adverse Event|0|||
105672588|NCT00338962|364464281|FG001|Overall Study|Adverse Event|0|||
105672589|NCT00338962|364464282|FG002|Overall Study|Adverse Event|2|||
105672590|NCT00338962|364464283|FG003|Overall Study|Adverse Event|0|||
105672591|NCT00338962|364464280|FG000|Overall Study|Poor Compliance|0|||
105672592|NCT00338962|364464281|FG001|Overall Study|Poor Compliance|0|||
105672593|NCT00338962|364464282|FG002|Overall Study|Poor Compliance|2|||
105672594|NCT00338962|364464283|FG003|Overall Study|Poor Compliance|0|||
105672595|NCT03046121|364464284|FG000|Overall Study|Death|32|||
105672596|NCT03046121|364464285|FG001|Overall Study|Death|60|||
105672597|NCT03046121|364464284|FG000|Overall Study|Withdrawal by Subject|14|||
105672598|NCT03046121|364464285|FG001|Overall Study|Withdrawal by Subject|12|||
105672599|NCT02781090|364464286|FG000|3-Month Follow-Up|Missed Visit|20|||
105672600|NCT02781090|364464287|FG001|3-Month Follow-Up|Missed Visit|20|||
105672601|NCT02781090|364464286|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
105672602|NCT02781090|364464287|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
105672603|NCT02781090|364464286|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
105672604|NCT02781090|364464287|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
105672605|NCT02781090|364464286|FG000|3-Month Follow-Up|Death|1|||
105672606|NCT02781090|364464287|FG001|3-Month Follow-Up|Death|0|||
105672607|NCT02781090|364464286|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
105672608|NCT02781090|364464287|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
105672609|NCT02781090|364464286|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
105672610|NCT02781090|364464287|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
105672611|NCT02781090|364464286|FG000|6-Month Follow-Up|Death|0|||
105672612|NCT02781090|364464287|FG001|6-Month Follow-Up|Death|1|||
105672613|NCT03361605|364464288|FG000|Overall Study|Analyzable data not available|3|||
105672614|NCT03846453|364464294|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
105672615|NCT03846453|364464295|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
105672616|NCT03846453|364464296|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
105672617|NCT03846453|364464294|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
105672618|NCT03846453|364464295|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
105672619|NCT03846453|364464296|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
105672620|NCT03846453|364464294|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
105672621|NCT03846453|364464295|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
105672622|NCT03846453|364464296|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
105672623|NCT03846453|364464294|FG000|Placebo Run-in (14 Days)|Other|2|||
105672624|NCT03846453|364464295|FG001|Placebo Run-in (14 Days)|Other|0|||
105672625|NCT03846453|364464296|FG002|Placebo Run-in (14 Days)|Other|0|||
105672626|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
105672627|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
105672628|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
105908802|NCT03410992|365325232|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105908803|NCT03410992|365325233|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105908804|NCT03410992|365325234|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
105908805|NCT03410992|365325235|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
105908806|NCT03410992|365325236|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105908807|NCT03410992|365325237|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105908808|NCT03410992|365325238|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105908809|NCT03410992|365325239|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105908810|NCT03410992|365325240|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105908811|NCT03410992|365325241|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
105908812|NCT03410992|365325231|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105908813|NCT03410992|365325232|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105908814|NCT03410992|365325233|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105908815|NCT03410992|365325234|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
105908816|NCT03410992|365325235|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
105908817|NCT03410992|365325236|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
105908818|NCT03410992|365325237|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
106125690|NCT01822353|366117870|FG001|Overall Study|Pregnancy|1|||
105672629|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
105672630|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
105672631|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
105672632|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
105672633|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
105672634|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
105672635|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
105672636|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
105672637|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
105672638|NCT03846453|364464294|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
105672639|NCT03846453|364464295|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
105672640|NCT03846453|364464296|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
105672641|NCT04230122|364464301|FG000|Overall Study|Lost to Follow-up|1|||
105672642|NCT04230122|364464302|FG001|Overall Study|Lost to Follow-up|0|||
105672643|NCT00403767|364464303|FG000|Overall Study|Adverse Event|993|||
105672644|NCT00403767|364464304|FG001|Overall Study|Adverse Event|919|||
105672645|NCT00403767|364464303|FG000|Overall Study|Non-compliant with study medication|134|||
105672646|NCT00403767|364464304|FG001|Overall Study|Non-compliant with study medication|164|||
105672647|NCT00403767|364464303|FG000|Overall Study|Consent withdrawn|671|||
105672648|NCT00403767|364464304|FG001|Overall Study|Consent withdrawn|673|||
105672649|NCT00403767|364464303|FG000|Overall Study|Investigator dec./not protocol-related|191|||
105672650|NCT00403767|364464304|FG001|Overall Study|Investigator dec./not protocol-related|178|||
105672651|NCT00403767|364464303|FG000|Overall Study|Lost to Follow-up|6|||
105672652|NCT00403767|364464304|FG001|Overall Study|Lost to Follow-up|8|||
105672653|NCT00403767|364464303|FG000|Overall Study|Protocol Violation|142|||
105672654|NCT00403767|364464304|FG001|Overall Study|Protocol Violation|124|||
105672655|NCT00403767|364464303|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
105672656|NCT00403767|364464304|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
105672657|NCT00403767|364464303|FG000|Overall Study|Study terminated by sponsor|82|||
105672658|NCT00403767|364464304|FG001|Overall Study|Study terminated by sponsor|69|||
105672659|NCT00403767|364464303|FG000|Overall Study|Missing/incomplete data|1|||
105672660|NCT00403767|364464304|FG001|Overall Study|Missing/incomplete data|1|||
105672661|NCT01641159|364464305|FG000|Overall Study|Lost to Follow-up|2|||
105672662|NCT01641159|364464306|FG001|Overall Study|Lost to Follow-up|1|||
105672663|NCT01641159|364464305|FG000|Overall Study|Withdrawal by Subject|0|||
105786260|NCT01233284|364870485|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
105786261|NCT01233284|364870486|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
105786262|NCT01233284|364870487|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
105786263|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Death|1|||
105786264|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Death|0|||
105786265|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Death|0|||
105786266|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Death|0|||
105786267|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Death|2|||
105786268|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Death|1|||
105786269|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Death|2|||
105786270|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Death|1|||
105786271|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
105786272|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
105786273|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
105786274|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
105786275|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
105786276|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
105786277|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
105786278|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
105786279|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
105786280|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
105786281|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
105786282|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
105786283|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
105786284|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
105786285|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
105786286|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
105786287|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
105786288|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
105786289|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
105786290|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
105908819|NCT03410992|365325238|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105908820|NCT03410992|365325239|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105908821|NCT03410992|365325240|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
105908822|NCT03410992|365325241|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
106125691|NCT01822353|366117871|FG002|Overall Study|Pregnancy|0|||
105672664|NCT01641159|364464306|FG001|Overall Study|Withdrawal by Subject|1|||
105672665|NCT05330676|364464307|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
105672666|NCT05330676|364464308|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
105672667|NCT02416453|364464309|FG000|Overall Study|Adverse Event|0|||
105672668|NCT02416453|364464310|FG001|Overall Study|Adverse Event|0|||
105672669|NCT02416453|364464311|FG002|Overall Study|Adverse Event|0|||
105786291|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
105672670|NCT02416453|364464312|FG003|Overall Study|Adverse Event|2|||
105672671|NCT02416453|364464313|FG004|Overall Study|Adverse Event|0|||
105672672|NCT02416453|364464314|FG005|Overall Study|Adverse Event|1|||
105672673|NCT02416453|364464315|FG006|Overall Study|Adverse Event|0|||
105672674|NCT02416453|364464316|FG007|Overall Study|Adverse Event|0|||
105672675|NCT02416453|364464317|FG008|Overall Study|Adverse Event|0|||
105672676|NCT02416453|364464318|FG009|Overall Study|Adverse Event|0|||
105672677|NCT02416453|364464319|FG010|Overall Study|Adverse Event|0|||
105672678|NCT02416453|364464309|FG000|Overall Study|Lost to Follow-up|1|||
105672679|NCT02416453|364464310|FG001|Overall Study|Lost to Follow-up|3|||
105672680|NCT02416453|364464311|FG002|Overall Study|Lost to Follow-up|0|||
105672681|NCT02416453|364464312|FG003|Overall Study|Lost to Follow-up|8|||
105672682|NCT02416453|364464313|FG004|Overall Study|Lost to Follow-up|0|||
105672683|NCT02416453|364464314|FG005|Overall Study|Lost to Follow-up|5|||
105672684|NCT02416453|364464315|FG006|Overall Study|Lost to Follow-up|1|||
105672685|NCT02416453|364464316|FG007|Overall Study|Lost to Follow-up|3|||
105672686|NCT02416453|364464317|FG008|Overall Study|Lost to Follow-up|1|||
105672687|NCT02416453|364464318|FG009|Overall Study|Lost to Follow-up|0|||
105672688|NCT02416453|364464319|FG010|Overall Study|Lost to Follow-up|0|||
105672689|NCT02416453|364464309|FG000|Overall Study|Physician Decision|0|||
105672690|NCT02416453|364464310|FG001|Overall Study|Physician Decision|0|||
105672691|NCT02416453|364464311|FG002|Overall Study|Physician Decision|0|||
105672692|NCT02416453|364464312|FG003|Overall Study|Physician Decision|0|||
105672693|NCT02416453|364464313|FG004|Overall Study|Physician Decision|0|||
105672694|NCT02416453|364464314|FG005|Overall Study|Physician Decision|1|||
105672695|NCT02416453|364464315|FG006|Overall Study|Physician Decision|1|||
105672696|NCT02416453|364464316|FG007|Overall Study|Physician Decision|1|||
105672697|NCT02416453|364464317|FG008|Overall Study|Physician Decision|0|||
105672698|NCT02416453|364464318|FG009|Overall Study|Physician Decision|0|||
105672699|NCT02416453|364464319|FG010|Overall Study|Physician Decision|0|||
105672700|NCT02416453|364464309|FG000|Overall Study|Withdrawal by Subject|2|||
105672701|NCT02416453|364464310|FG001|Overall Study|Withdrawal by Subject|0|||
105672702|NCT02416453|364464311|FG002|Overall Study|Withdrawal by Subject|0|||
105672703|NCT02416453|364464312|FG003|Overall Study|Withdrawal by Subject|5|||
105672704|NCT02416453|364464313|FG004|Overall Study|Withdrawal by Subject|1|||
105672705|NCT02416453|364464314|FG005|Overall Study|Withdrawal by Subject|8|||
105672706|NCT02416453|364464315|FG006|Overall Study|Withdrawal by Subject|0|||
105672707|NCT02416453|364464316|FG007|Overall Study|Withdrawal by Subject|8|||
105672708|NCT02416453|364464317|FG008|Overall Study|Withdrawal by Subject|4|||
105672709|NCT02416453|364464318|FG009|Overall Study|Withdrawal by Subject|0|||
105672710|NCT02416453|364464319|FG010|Overall Study|Withdrawal by Subject|0|||
105672711|NCT02416453|364464309|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672712|NCT02416453|364464310|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672713|NCT02416453|364464311|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
105672714|NCT02416453|364464312|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672715|NCT02416453|364464313|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672716|NCT02416453|364464314|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672717|NCT02416453|364464315|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672718|NCT02416453|364464316|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672719|NCT02416453|364464317|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672720|NCT02416453|364464318|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672721|NCT02416453|364464319|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
105672722|NCT02416453|364464309|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672723|NCT02416453|364464310|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672724|NCT02416453|364464311|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105908823|NCT03410992|365325231|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908824|NCT03410992|365325232|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908825|NCT03410992|365325233|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908826|NCT03410992|365325234|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908827|NCT03410992|365325235|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908828|NCT03410992|365325236|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
105908829|NCT03410992|365325237|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908830|NCT03410992|365325238|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908831|NCT03410992|365325239|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105672725|NCT02416453|364464312|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672726|NCT02416453|364464313|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672727|NCT02416453|364464314|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
105672728|NCT02416453|364464315|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672729|NCT02416453|364464316|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672730|NCT02416453|364464317|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672731|NCT02416453|364464318|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672732|NCT02416453|364464319|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
105672733|NCT01559129|364464320|FG000|Treatment Phase|Adverse Event|0|||
105672734|NCT01559129|364464321|FG001|Treatment Phase|Adverse Event|2|||
105672735|NCT01559129|364464320|FG000|Treatment Phase|Progressive Disease|1|||
105672736|NCT01559129|364464321|FG001|Treatment Phase|Progressive Disease|1|||
105672737|NCT01559129|364464320|FG000|Treatment Phase|Lack of Efficacy|0|||
105672738|NCT01559129|364464321|FG001|Treatment Phase|Lack of Efficacy|1|||
105672739|NCT01559129|364464320|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
105672740|NCT01559129|364464321|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
105672741|NCT01559129|364464320|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
105672742|NCT01559129|364464321|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
105672743|NCT01559129|364464320|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
105672744|NCT01559129|364464321|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
105672745|NCT01559129|364464320|FG000|Open-label Extension Period|Adverse Event|1|||
105672746|NCT01559129|364464321|FG001|Open-label Extension Period|Adverse Event|0|||
105672747|NCT01559129|364464320|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
105672748|NCT01559129|364464321|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
105672749|NCT01280357|364464322|FG000|Overall Study|Excluded no internal monitoring|14|||
105672750|NCT01280357|364464322|FG000|Overall Study|IInsufficient data/No data supplied|12|||
105672751|NCT01259089|364464323|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672752|NCT01259089|364464324|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672753|NCT01259089|364464325|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672754|NCT01259089|364464326|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672755|NCT01259089|364464327|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
105672756|NCT01259089|364464328|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
105672757|NCT01259089|364464323|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
105672758|NCT01259089|364464324|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
105672759|NCT01259089|364464325|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
105672760|NCT01259089|364464326|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
105672761|NCT01259089|364464327|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
105672762|NCT01259089|364464328|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
105672763|NCT01259089|364464323|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672764|NCT01259089|364464324|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672765|NCT01259089|364464325|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672766|NCT01259089|364464326|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672767|NCT01259089|364464327|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
105672768|NCT01259089|364464328|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
105672769|NCT01259089|364464323|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
105672770|NCT01259089|364464324|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
105672771|NCT01259089|364464325|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
105786292|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
105908832|NCT03410992|365325240|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908833|NCT03410992|365325241|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
105908834|NCT03410992|365325231|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105908835|NCT03410992|365325232|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105908836|NCT03410992|365325233|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105908837|NCT03410992|365325234|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
105908838|NCT03410992|365325235|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
105908839|NCT03410992|365325236|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
105908840|NCT03410992|365325237|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105908841|NCT03410992|365325238|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105908842|NCT03410992|365325239|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105908843|NCT03410992|365325240|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105908844|NCT03410992|365325241|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
105908845|NCT03410992|365325231|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908846|NCT03410992|365325232|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908847|NCT03410992|365325233|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908848|NCT03410992|365325234|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908849|NCT03410992|365325235|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908850|NCT03410992|365325236|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908851|NCT03410992|365325237|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908852|NCT03410992|365325238|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
105908853|NCT03410992|365325239|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908854|NCT03410992|365325240|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
105908855|NCT03410992|365325241|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
106125692|NCT01822353|366117869|FG000|Overall Study|Withdrawal by Subject|3|||
105672772|NCT01259089|364464326|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
105672773|NCT01259089|364464327|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
105672774|NCT01259089|364464328|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
105908856|NCT03410992|365325231|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908857|NCT03410992|365325232|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908858|NCT03410992|365325233|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908859|NCT03410992|365325234|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908860|NCT03410992|365325235|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908861|NCT03410992|365325236|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908862|NCT03410992|365325237|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908863|NCT03410992|365325238|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908864|NCT03410992|365325239|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
105908865|NCT03410992|365325240|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908866|NCT03410992|365325241|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
105908867|NCT02982863|365325242|FG000|Overall Study|Not eligible patients|809|||
105672775|NCT01259089|364464323|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
105672776|NCT01259089|364464324|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
105672777|NCT01259089|364464325|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
105672778|NCT01259089|364464326|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
105672779|NCT01259089|364464327|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
105672780|NCT01259089|364464328|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
105672781|NCT01259089|364464323|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
105672782|NCT01259089|364464324|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672783|NCT01259089|364464325|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672784|NCT01259089|364464326|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672785|NCT01259089|364464327|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672786|NCT01259089|364464328|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
105672787|NCT01259089|364464323|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
105672788|NCT01259089|364464324|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
105908868|NCT02982863|365325243|FG001|Overall Study|Not eligible patients|4261|||
105908869|NCT02982863|365325244|FG002|Overall Study|Not eligible patients|1852|||
105908870|NCT02982863|365325245|FG003|Overall Study|Not eligible patients|1400|||
105908871|NCT02982863|365325246|FG004|Overall Study|Not eligible patients|492|||
105908872|NCT02457195|365325247|FG000|Overall Study|Adverse Event|3|||
105908873|NCT02457195|365325247|FG000|Overall Study|Protocol Violation|2|||
105908874|NCT02457195|365325247|FG000|Overall Study|Withdrawal by Subject|4|||
105908875|NCT00618826|365325251|FG000|Overall Study|Adverse Event|1|||
105908876|NCT01509664|365325252|FG000|Overall Study|Lost to Follow-up|15|||
105908877|NCT01509664|365325253|FG001|Overall Study|Lost to Follow-up|21|||
105908878|NCT00996034|365325256|FG000|Overall Study|Lost to Follow-up|2|||
105908879|NCT00996034|365325256|FG000|Overall Study|withdrawn by PI|1|||
105908880|NCT02420262|365325260|FG000|Overall Study|Adverse Event|1|||
105672789|NCT01259089|364464325|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
105672790|NCT01259089|364464326|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
105672791|NCT01259089|364464327|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
105672792|NCT01259089|364464328|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
105672793|NCT01259089|364464323|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
105672794|NCT01259089|364464324|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
105672795|NCT01259089|364464325|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
105672796|NCT01259089|364464326|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
105672797|NCT01259089|364464327|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
105672798|NCT01259089|364464328|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
105672799|NCT01259089|364464323|FG000|Survival Follow up for Two Years|Death|3|||
105672800|NCT01259089|364464324|FG001|Survival Follow up for Two Years|Death|2|||
105672801|NCT01259089|364464325|FG002|Survival Follow up for Two Years|Death|2|||
105672802|NCT01259089|364464326|FG003|Survival Follow up for Two Years|Death|3|||
105672803|NCT01259089|364464327|FG004|Survival Follow up for Two Years|Death|6|||
105672804|NCT01259089|364464328|FG005|Survival Follow up for Two Years|Death|13|||
105672805|NCT01259089|364464323|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672806|NCT01259089|364464324|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672807|NCT01259089|364464325|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672808|NCT01259089|364464326|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672809|NCT01259089|364464327|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
105672810|NCT01259089|364464328|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
105672811|NCT01259089|364464323|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672812|NCT01259089|364464324|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672813|NCT01259089|364464325|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672814|NCT01259089|364464326|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105908881|NCT02420262|365325261|FG001|Overall Study|Adverse Event|0|||
105672815|NCT01259089|364464327|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
105672816|NCT01259089|364464328|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
105672817|NCT03284203|364464329|FG000|Overall Study|Lost to Follow-up|3|||
105908882|NCT02420262|365325260|FG000|Overall Study|Withdrawal by Subject|1|||
105908883|NCT02420262|365325261|FG001|Overall Study|Withdrawal by Subject|4|||
105672818|NCT01669577|364464330|FG000|Overall Study|Death|22|||
105672819|NCT01669577|364464330|FG000|Overall Study|Lost to Follow-up|78|||
105672820|NCT01669577|364464330|FG000|Overall Study|Physician Decision|34|||
105672821|NCT01253018|364464331|FG000|Overall Study|Lost to Follow-up|1|||
105672822|NCT01253018|364464332|FG001|Overall Study|Lost to Follow-up|1|||
105672823|NCT01253018|364464331|FG000|Overall Study|Robot Repair Issues|2|||
105672824|NCT01253018|364464332|FG001|Overall Study|Robot Repair Issues|0|||
105672825|NCT01253018|364464331|FG000|Overall Study|Withdrawal by Subject|1|||
105908884|NCT02420262|365325260|FG000|Overall Study|Unclassified|0|||
105908885|NCT02420262|365325261|FG001|Overall Study|Unclassified|1|||
105908886|NCT00627926|365325262|FG000|Overall Study|Adverse Event|26|||
105672826|NCT01253018|364464332|FG001|Overall Study|Withdrawal by Subject|1|||
105672827|NCT01204710|364464336|FG000|Randomization Treatment|Lost to Follow-up|1|||
105908887|NCT00627926|365325263|FG001|Overall Study|Adverse Event|37|||
105672828|NCT01204710|364464337|FG001|Randomization Treatment|Lost to Follow-up|0|||
105672829|NCT01204710|364464336|FG000|Randomization Treatment|Withdrawal by Subject|6|||
105672830|NCT01204710|364464337|FG001|Randomization Treatment|Withdrawal by Subject|5|||
105672831|NCT01204710|364464336|FG000|Randomization Treatment|Physician Decision|3|||
105672832|NCT01204710|364464337|FG001|Randomization Treatment|Physician Decision|2|||
105672833|NCT01204710|364464336|FG000|Randomization Treatment|Entry criteria not met|0|||
105672834|NCT01204710|364464337|FG001|Randomization Treatment|Entry criteria not met|1|||
105672835|NCT01204710|364464336|FG000|Randomization Treatment|Adverse Event|4|||
105672836|NCT01204710|364464337|FG001|Randomization Treatment|Adverse Event|2|||
105672837|NCT01204710|364464336|FG000|Randomization Treatment|Sponsor Decision|0|||
105672838|NCT01204710|364464337|FG001|Randomization Treatment|Sponsor Decision|1|||
105672839|NCT01204710|364464336|FG000|Randomization Treatment|Worsening of General condition|0|||
105672840|NCT01204710|364464337|FG001|Randomization Treatment|Worsening of General condition|1|||
105672841|NCT01204710|364464336|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
105672842|NCT01204710|364464337|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
105672843|NCT01204710|364464336|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
105672844|NCT01204710|364464337|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
105672845|NCT01204710|364464336|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
105672846|NCT01204710|364464337|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
105672847|NCT01204710|364464336|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
105672848|NCT01204710|364464337|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
105672849|NCT01769326|364464338|FG000|Overall Study|Lost to Follow-up|1|||
105672850|NCT01769326|364464339|FG001|Overall Study|Lost to Follow-up|2|||
105672851|NCT01769326|364464340|FG002|Overall Study|Lost to Follow-up|0|||
105672852|NCT01769326|364464341|FG003|Overall Study|Lost to Follow-up|0|||
105672853|NCT01769326|364464338|FG000|Overall Study|unrelated injry|1|||
105672854|NCT01769326|364464339|FG001|Overall Study|unrelated injry|1|||
105672855|NCT01769326|364464340|FG002|Overall Study|unrelated injry|0|||
105672856|NCT01769326|364464341|FG003|Overall Study|unrelated injry|0|||
105672857|NCT01769326|364464338|FG000|Overall Study|got a job|0|||
105672858|NCT01769326|364464339|FG001|Overall Study|got a job|1|||
105672859|NCT01769326|364464340|FG002|Overall Study|got a job|0|||
105672860|NCT01769326|364464341|FG003|Overall Study|got a job|0|||
105672861|NCT01769326|364464338|FG000|Overall Study|Got sick and could not complete study|0|||
105672862|NCT01769326|364464339|FG001|Overall Study|Got sick and could not complete study|0|||
105672863|NCT01769326|364464340|FG002|Overall Study|Got sick and could not complete study|1|||
105672864|NCT01769326|364464341|FG003|Overall Study|Got sick and could not complete study|0|||
105672865|NCT05132127|364464342|FG000|Overall Study|Adverse Event|1|||
105672866|NCT00737698|364464348|FG000|Overall Study|Withdrawal by Subject|6|||
105672867|NCT00737698|364464349|FG001|Overall Study|Withdrawal by Subject|5|||
105672868|NCT00737698|364464350|FG002|Overall Study|Withdrawal by Subject|3|||
105672869|NCT00737698|364464348|FG000|Overall Study|Death|0|||
105672870|NCT00737698|364464349|FG001|Overall Study|Death|0|||
105672871|NCT00737698|364464350|FG002|Overall Study|Death|1|||
105672872|NCT04445987|364464351|FG000|Overall Study|Adverse Event|0|||
105672873|NCT04445987|364464352|FG001|Overall Study|Adverse Event|0|||
105672874|NCT04445987|364464353|FG002|Overall Study|Adverse Event|1|||
105908888|NCT00627926|365325264|FG002|Overall Study|Adverse Event|36|||
105908889|NCT00627926|365325262|FG000|Overall Study|Death|1|||
105908890|NCT00627926|365325263|FG001|Overall Study|Death|0|||
105908891|NCT00627926|365325264|FG002|Overall Study|Death|0|||
105908892|NCT00627926|365325262|FG000|Overall Study|Lost to Follow-up|4|||
105908893|NCT00627926|365325263|FG001|Overall Study|Lost to Follow-up|3|||
105908894|NCT00627926|365325264|FG002|Overall Study|Lost to Follow-up|4|||
105908895|NCT00627926|365325262|FG000|Overall Study|Withdrawal by Subject|2|||
105908896|NCT00627926|365325263|FG001|Overall Study|Withdrawal by Subject|1|||
105908897|NCT00627926|365325264|FG002|Overall Study|Withdrawal by Subject|0|||
105908898|NCT00627926|365325262|FG000|Overall Study|Lack of Efficacy|118|||
105908899|NCT00627926|365325263|FG001|Overall Study|Lack of Efficacy|40|||
105908900|NCT00627926|365325264|FG002|Overall Study|Lack of Efficacy|38|||
105908901|NCT00627926|365325262|FG000|Overall Study|Noncompliance/unspecified|8|||
105908902|NCT00627926|365325263|FG001|Overall Study|Noncompliance/unspecified|23|||
105908903|NCT00627926|365325264|FG002|Overall Study|Noncompliance/unspecified|17|||
105908904|NCT02401035|365325269|FG000|Overall Study|Withdrawal by Subject|1|||
105908905|NCT02401035|365325270|FG001|Overall Study|Withdrawal by Subject|0|||
105908906|NCT02998996|365325271|FG000|Overall Study|Lost to Follow-up|0|||
105908907|NCT02998996|365325272|FG001|Overall Study|Lost to Follow-up|0|||
105908908|NCT02998996|365325273|FG002|Overall Study|Lost to Follow-up|1|||
105672875|NCT04445987|364464354|FG003|Overall Study|Adverse Event|0|||
105908909|NCT02998996|365325274|FG003|Overall Study|Lost to Follow-up|0|||
105908910|NCT02998996|365325275|FG004|Overall Study|Lost to Follow-up|0|||
105908911|NCT02998996|365325276|FG005|Overall Study|Lost to Follow-up|0|||
105908912|NCT02998996|365325271|FG000|Overall Study|Pregnancy|0|||
105908913|NCT02998996|365325272|FG001|Overall Study|Pregnancy|1|||
105908914|NCT02998996|365325273|FG002|Overall Study|Pregnancy|0|||
105908915|NCT02998996|365325274|FG003|Overall Study|Pregnancy|0|||
105908916|NCT02998996|365325275|FG004|Overall Study|Pregnancy|0|||
105908917|NCT02998996|365325276|FG005|Overall Study|Pregnancy|0|||
105908918|NCT02998996|365325271|FG000|Overall Study|Family reasons|0|||
105908919|NCT02998996|365325272|FG001|Overall Study|Family reasons|0|||
105908920|NCT02998996|365325273|FG002|Overall Study|Family reasons|0|||
105908921|NCT02998996|365325274|FG003|Overall Study|Family reasons|0|||
105908922|NCT02998996|365325275|FG004|Overall Study|Family reasons|1|||
105908923|NCT02998996|365325276|FG005|Overall Study|Family reasons|0|||
105908924|NCT02716584|365325277|FG000|Overall Study|Lost to Follow-up|8|||
105908925|NCT02716584|365325278|FG001|Overall Study|Lost to Follow-up|5|||
105908926|NCT02149264|365325279|FG000|Overall Study|Withdrawal by Subject|9|||
105908927|NCT02149264|365325279|FG000|Overall Study|Adverse Event|7|||
105908928|NCT02149264|365325279|FG000|Overall Study|Physician Decision|3|||
105908929|NCT02149264|365325279|FG000|Overall Study|Protocol Violation|1|||
105908930|NCT02686164|365325283|FG000|Overall Study|Adverse Event|1|||
105908931|NCT02686164|365325283|FG000|Overall Study|Withdrawal of consent|1|||
105908932|NCT02686164|365325283|FG000|Overall Study|Clinical progression|1|||
105908933|NCT00972283|365325284|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
105908934|NCT00972283|365325285|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
105908935|NCT00972283|365325284|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
105908936|NCT00972283|365325285|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
105908937|NCT00972283|365325284|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
105908938|NCT00972283|365325285|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
105908939|NCT00972283|365325284|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
105908940|NCT00972283|365325285|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
105908941|NCT00972283|365325284|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
105908942|NCT00972283|365325285|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
105908943|NCT00972283|365325284|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
105908944|NCT00972283|365325285|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
105908945|NCT00972283|365325284|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
105908946|NCT00972283|365325285|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
105908947|NCT00972283|365325284|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
105908948|NCT00972283|365325285|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
105908949|NCT00972283|365325284|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
105908950|NCT00972283|365325285|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
105908951|NCT00972283|365325284|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
105908952|NCT00972283|365325285|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
105908953|NCT00805129|365325288|FG000|Overall Study|Not treated|1|||
105908954|NCT02824627|365325289|FG000|Overall Study|Adverse Event|1|||
105908955|NCT02824627|365325290|FG001|Overall Study|Adverse Event|2|||
105908956|NCT02824627|365325289|FG000|Overall Study|Lost to Follow-up|2|||
105908957|NCT02824627|365325290|FG001|Overall Study|Lost to Follow-up|1|||
105908958|NCT01938846|365325291|FG000|Overall Study|Progressive disease|26|||
105908959|NCT01938846|365325292|FG001|Overall Study|Progressive disease|18|||
105908960|NCT01938846|365325293|FG002|Overall Study|Progressive disease|16|||
105908961|NCT01938846|365325291|FG000|Overall Study|Adverse Event|8|||
105908962|NCT01938846|365325292|FG001|Overall Study|Adverse Event|4|||
105908963|NCT01938846|365325293|FG002|Overall Study|Adverse Event|3|||
105908964|NCT01938846|365325291|FG000|Overall Study|Withdrawal by Subject|2|||
105908965|NCT01938846|365325292|FG001|Overall Study|Withdrawal by Subject|2|||
105908966|NCT01938846|365325293|FG002|Overall Study|Withdrawal by Subject|1|||
105908967|NCT01938846|365325291|FG000|Overall Study|Other than listed|5|||
105908968|NCT01938846|365325292|FG001|Overall Study|Other than listed|1|||
105908969|NCT01938846|365325293|FG002|Overall Study|Other than listed|4|||
105908970|NCT02499120|365325299|FG000|Overall Study|Death|52|||
105908971|NCT02499120|365325300|FG001|Overall Study|Death|43|||
105908972|NCT02499120|365325299|FG000|Overall Study|Lost to Follow-up|1|||
105908973|NCT02499120|365325300|FG001|Overall Study|Lost to Follow-up|2|||
105908974|NCT02499120|365325299|FG000|Overall Study|Participant refused further follow-up|1|||
105908975|NCT02499120|365325300|FG001|Overall Study|Participant refused further follow-up|0|||
105908976|NCT02499120|365325299|FG000|Overall Study|Withdrawal by Subject|2|||
105908977|NCT02499120|365325300|FG001|Overall Study|Withdrawal by Subject|5|||
105908978|NCT02499120|365325299|FG000|Overall Study|Other|9|||
105908979|NCT02499120|365325300|FG001|Overall Study|Other|10|||
105908980|NCT02324361|365325305|FG000|Overall Study|Lost to Follow-up|5|||
105908981|NCT02324361|365325306|FG001|Overall Study|Lost to Follow-up|2|||
105908982|NCT01839916|365325310|FG000|Overall Study|Death|9|||
105908983|NCT01839916|365325310|FG000|Overall Study|Physician Decision|17|||
105908984|NCT01839916|365325310|FG000|Overall Study|Relapse|12|||
105908985|NCT01839916|365325310|FG000|Overall Study|GVHD|2|||
105908986|NCT01839916|365325310|FG000|Overall Study|Graft Failure|1|||
105908987|NCT00964028|365325311|FG000|Overall Study|Withdrawal by Subject|0|||
105908988|NCT00964028|365325312|FG001|Overall Study|Withdrawal by Subject|1|||
105672876|NCT04445987|364464355|FG004|Overall Study|Adverse Event|4|||
105672877|NCT04445987|364464356|FG005|Overall Study|Adverse Event|0|||
105672878|NCT04445987|364464351|FG000|Overall Study|Lost to Follow-up|4|||
105672879|NCT04445987|364464352|FG001|Overall Study|Lost to Follow-up|3|||
105672880|NCT04445987|364464353|FG002|Overall Study|Lost to Follow-up|1|||
105672881|NCT04445987|364464354|FG003|Overall Study|Lost to Follow-up|1|||
105672882|NCT04445987|364464355|FG004|Overall Study|Lost to Follow-up|29|||
105672883|NCT04445987|364464356|FG005|Overall Study|Lost to Follow-up|0|||
105672884|NCT04445987|364464351|FG000|Overall Study|Physician Decision|0|||
105672885|NCT04445987|364464352|FG001|Overall Study|Physician Decision|0|||
105999357|NCT01132313|365659459|FG001|Overall Study|Withdrawal by Subject|0|||
105999358|NCT01132313|365659460|FG002|Overall Study|Withdrawal by Subject|3|||
105999359|NCT01132313|365659461|FG003|Overall Study|Withdrawal by Subject|3|||
105999360|NCT01132313|365659462|FG004|Overall Study|Withdrawal by Subject|6|||
105999361|NCT01132313|365659463|FG005|Overall Study|Withdrawal by Subject|0|||
105999362|NCT01132313|365659464|FG006|Overall Study|Withdrawal by Subject|1|||
105999363|NCT01132313|365659465|FG007|Overall Study|Withdrawal by Subject|0|||
105999364|NCT01132313|365659466|FG008|Overall Study|Withdrawal by Subject|0|||
105999365|NCT01132313|365659467|FG009|Overall Study|Withdrawal by Subject|2|||
105999366|NCT01132313|365659468|FG010|Overall Study|Withdrawal by Subject|0|||
105999367|NCT01132313|365659469|FG011|Overall Study|Withdrawal by Subject|0|||
105999368|NCT01132313|365659458|FG000|Overall Study|Lack of antiviral response|0|||
105908989|NCT01931397|365325313|FG000|Overall Study|Physician Decision|2|||
105672886|NCT04445987|364464353|FG002|Overall Study|Physician Decision|0|||
105999369|NCT01132313|365659459|FG001|Overall Study|Lack of antiviral response|0|||
105908990|NCT01931397|365325313|FG000|Overall Study|Withdrawal by Subject|8|||
105908991|NCT01931397|365325313|FG000|Overall Study|moved out of state|1|||
105908992|NCT01210482|365325314|FG000|Overall Study|Protocol Violation|1|||
105908993|NCT01210482|365325314|FG000|Overall Study|Case Report Forms were not collected|18|||
105908994|NCT01210482|365325314|FG000|Overall Study|Duplicated|2|||
105908995|NCT01210482|365325314|FG000|Overall Study|No Drug Administration|28|||
105908996|NCT01223937|365325315|FG000|Overall Study|Withdrawal by Subject|3|||
105908997|NCT01223937|365325316|FG001|Overall Study|Withdrawal by Subject|2|||
105908998|NCT01223937|365325315|FG000|Overall Study|Lost to Follow-up|1|||
105908999|NCT01223937|365325316|FG001|Overall Study|Lost to Follow-up|4|||
105909000|NCT01223937|365325315|FG000|Overall Study|Adverse Event|1|||
105909001|NCT01223937|365325316|FG001|Overall Study|Adverse Event|4|||
105909002|NCT01223937|365325315|FG000|Overall Study|Protocol Violation|8|||
105909003|NCT01223937|365325316|FG001|Overall Study|Protocol Violation|7|||
105909004|NCT01223937|365325315|FG000|Overall Study|Other|4|||
105909005|NCT01223937|365325316|FG001|Overall Study|Other|1|||
105909006|NCT05176717|365325317|FG000|Overall Study|Sponsor Decision|1|||
105909007|NCT05176717|365325318|FG001|Overall Study|Sponsor Decision|2|||
105909008|NCT05176717|365325319|FG002|Overall Study|Sponsor Decision|2|||
105909009|NCT00765817|365325321|FG000|Overall Study|Adverse Event|13|||
105909010|NCT00765817|365325322|FG001|Overall Study|Adverse Event|1|||
105909011|NCT00765817|365325321|FG000|Overall Study|Death|0|||
105909012|NCT00765817|365325322|FG001|Overall Study|Death|1|||
105909013|NCT00765817|365325321|FG000|Overall Study|Entry criteria not met|2|||
105909014|NCT00765817|365325322|FG001|Overall Study|Entry criteria not met|2|||
105909015|NCT00765817|365325321|FG000|Overall Study|Loss of glucose control|0|||
105909016|NCT00765817|365325322|FG001|Overall Study|Loss of glucose control|2|||
105909017|NCT00765817|365325321|FG000|Overall Study|Lost to Follow-up|1|||
105909018|NCT00765817|365325322|FG001|Overall Study|Lost to Follow-up|3|||
105909019|NCT00765817|365325321|FG000|Overall Study|Physician Decision|2|||
105909020|NCT00765817|365325322|FG001|Overall Study|Physician Decision|1|||
105909021|NCT00765817|365325321|FG000|Overall Study|Protocol Violation|1|||
105909022|NCT00765817|365325322|FG001|Overall Study|Protocol Violation|1|||
105909023|NCT00765817|365325321|FG000|Overall Study|Subject decision|7|||
105909024|NCT00765817|365325322|FG001|Overall Study|Subject decision|11|||
105909025|NCT02058589|365325323|FG000|Overall Study|Serious Adverse Event|1|||
105672887|NCT04445987|364464354|FG003|Overall Study|Physician Decision|0|||
105672888|NCT04445987|364464355|FG004|Overall Study|Physician Decision|1|||
105672889|NCT04445987|364464356|FG005|Overall Study|Physician Decision|0|||
105909026|NCT02058589|365325324|FG001|Overall Study|Serious Adverse Event|1|||
105999370|NCT01132313|365659460|FG002|Overall Study|Lack of antiviral response|12|||
105909027|NCT02058589|365325323|FG000|Overall Study|Non-Serious Adverse Event|1|||
105909028|NCT02058589|365325324|FG001|Overall Study|Non-Serious Adverse Event|0|||
105909029|NCT02058589|365325323|FG000|Overall Study|Withdrawal by Subject|0|||
105909030|NCT02058589|365325324|FG001|Overall Study|Withdrawal by Subject|1|||
105909031|NCT02532283|365325325|FG000|Overall Study|Adverse Event|0|||
105909032|NCT02532283|365325326|FG001|Overall Study|Adverse Event|1|||
105999371|NCT01132313|365659461|FG003|Overall Study|Lack of antiviral response|18|||
105672890|NCT04445987|364464351|FG000|Overall Study|Protocol Violation|1|||
105672891|NCT04445987|364464352|FG001|Overall Study|Protocol Violation|0|||
105672892|NCT04445987|364464353|FG002|Overall Study|Protocol Violation|0|||
105909033|NCT02532283|365325325|FG000|Overall Study|Death|1|||
105909034|NCT02532283|365325326|FG001|Overall Study|Death|0|||
105909035|NCT02532283|365325325|FG000|Overall Study|Lost to Follow-up|0|||
105672893|NCT04445987|364464354|FG003|Overall Study|Protocol Violation|0|||
105672894|NCT04445987|364464355|FG004|Overall Study|Protocol Violation|2|||
105672895|NCT04445987|364464356|FG005|Overall Study|Protocol Violation|0|||
105672896|NCT04445987|364464351|FG000|Overall Study|Withdrawal by Subject|4|||
105672897|NCT04445987|364464352|FG001|Overall Study|Withdrawal by Subject|0|||
105672898|NCT04445987|364464353|FG002|Overall Study|Withdrawal by Subject|1|||
105672899|NCT04445987|364464354|FG003|Overall Study|Withdrawal by Subject|0|||
105672900|NCT04445987|364464355|FG004|Overall Study|Withdrawal by Subject|18|||
105672901|NCT04445987|364464356|FG005|Overall Study|Withdrawal by Subject|1|||
105672902|NCT04445987|364464351|FG000|Overall Study|Other reason|0|||
105672903|NCT04445987|364464352|FG001|Overall Study|Other reason|0|||
105672904|NCT04445987|364464353|FG002|Overall Study|Other reason|1|||
105672905|NCT04445987|364464354|FG003|Overall Study|Other reason|0|||
105672906|NCT04445987|364464355|FG004|Overall Study|Other reason|2|||
105672907|NCT04445987|364464356|FG005|Overall Study|Other reason|0|||
105672908|NCT02387970|364464361|FG000|Overall Study|Did not complete 1-year follow up|1|||
105672909|NCT02387970|364464362|FG001|Overall Study|Did not complete 1-year follow up|2|||
105672910|NCT04157400|364464369|FG000|Overall Study|Withdrawal by Subject|1|||
105672911|NCT04157400|364464369|FG000|Overall Study|Lost to Follow-up|3|||
105672912|NCT00623805|364464370|FG000|Overall Study|Adverse Event|9|||
105672913|NCT00623805|364464371|FG001|Overall Study|Adverse Event|6|||
105672914|NCT00623805|364464370|FG000|Overall Study|Death|2|||
105672915|NCT00623805|364464371|FG001|Overall Study|Death|0|||
105672916|NCT00623805|364464370|FG000|Overall Study|Lack of Efficacy|3|||
105672917|NCT00623805|364464371|FG001|Overall Study|Lack of Efficacy|7|||
105672918|NCT00623805|364464370|FG000|Overall Study|Lost to Follow-up|2|||
105672919|NCT00623805|364464371|FG001|Overall Study|Lost to Follow-up|2|||
105672920|NCT00623805|364464370|FG000|Overall Study|Protocol Violation|1|||
105672921|NCT00623805|364464371|FG001|Overall Study|Protocol Violation|1|||
105672922|NCT00623805|364464370|FG000|Overall Study|Reason not Specified|3|||
105672923|NCT00623805|364464371|FG001|Overall Study|Reason not Specified|6|||
105672924|NCT01200290|364464373|FG000|Treatment Period|Adverse Event|1|||
105672925|NCT01200290|364464373|FG000|Post-Treatment Follow-Up Period|Death|2|||
105672926|NCT00607724|364464375|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
105672927|NCT00607724|364464376|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
105672928|NCT00607724|364464377|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
105672929|NCT00607724|364464378|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
105672930|NCT00607724|364464379|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
105672931|NCT00607724|364464380|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
105672932|NCT00607724|364464381|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
105672933|NCT00607724|364464375|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
105672934|NCT00607724|364464376|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
105672935|NCT00607724|364464377|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
105672936|NCT00607724|364464378|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
105672937|NCT00607724|364464379|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
105672938|NCT00607724|364464380|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
105672939|NCT00607724|364464381|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
105672940|NCT00607724|364464375|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
105672941|NCT00607724|364464376|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
105672942|NCT00607724|364464377|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
105672943|NCT00607724|364464378|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
105672944|NCT00607724|364464379|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
105672945|NCT00607724|364464380|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
105672946|NCT00607724|364464381|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
105672947|NCT00607724|364464375|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
105672948|NCT00607724|364464376|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
105672949|NCT00607724|364464377|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
105672950|NCT00607724|364464378|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
105672951|NCT00607724|364464379|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
105672952|NCT00607724|364464380|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
105672953|NCT00607724|364464381|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
105672954|NCT00607724|364464375|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672955|NCT00607724|364464376|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672956|NCT00607724|364464377|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672957|NCT00607724|364464378|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
105672958|NCT00607724|364464379|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672959|NCT00607724|364464380|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672960|NCT00607724|364464381|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
105672961|NCT02336451|364464382|FG000|Overall Study|Adverse Event|1|||
105672962|NCT02336451|364464383|FG001|Overall Study|Adverse Event|2|||
105672963|NCT02336451|364464384|FG002|Overall Study|Adverse Event|0|||
105672964|NCT02336451|364464385|FG003|Overall Study|Adverse Event|6|||
105672965|NCT02336451|364464386|FG004|Overall Study|Adverse Event|4|||
105672966|NCT02336451|364464382|FG000|Overall Study|Death|6|||
105672967|NCT02336451|364464383|FG001|Overall Study|Death|2|||
105672968|NCT02336451|364464384|FG002|Overall Study|Death|3|||
105672969|NCT02336451|364464385|FG003|Overall Study|Death|6|||
105672970|NCT02336451|364464386|FG004|Overall Study|Death|6|||
105672971|NCT02336451|364464382|FG000|Overall Study|Physician Decision|9|||
105672972|NCT02336451|364464383|FG001|Overall Study|Physician Decision|6|||
105672973|NCT02336451|364464384|FG002|Overall Study|Physician Decision|7|||
105672974|NCT02336451|364464385|FG003|Overall Study|Physician Decision|16|||
105672975|NCT02336451|364464386|FG004|Overall Study|Physician Decision|3|||
105672976|NCT02336451|364464382|FG000|Overall Study|Progressive disease|23|||
105672977|NCT02336451|364464383|FG001|Overall Study|Progressive disease|26|||
105672978|NCT02336451|364464384|FG002|Overall Study|Progressive disease|2|||
105672979|NCT02336451|364464385|FG003|Overall Study|Progressive disease|14|||
105672980|NCT02336451|364464386|FG004|Overall Study|Progressive disease|4|||
105672981|NCT02336451|364464382|FG000|Overall Study|Protocol Violation|1|||
105672982|NCT02336451|364464383|FG001|Overall Study|Protocol Violation|0|||
105672983|NCT02336451|364464384|FG002|Overall Study|Protocol Violation|0|||
105672984|NCT02336451|364464385|FG003|Overall Study|Protocol Violation|0|||
105672985|NCT02336451|364464386|FG004|Overall Study|Protocol Violation|0|||
105672986|NCT02336451|364464382|FG000|Overall Study|Patient/guardian decision|2|||
105672987|NCT02336451|364464383|FG001|Overall Study|Patient/guardian decision|4|||
105672988|NCT02336451|364464384|FG002|Overall Study|Patient/guardian decision|0|||
105672989|NCT02336451|364464385|FG003|Overall Study|Patient/guardian decision|2|||
105672990|NCT02336451|364464386|FG004|Overall Study|Patient/guardian decision|1|||
105672991|NCT04372121|364464388|FG000|Overall Study|Lost to Follow-up|0|||
105672992|NCT04372121|364464389|FG001|Overall Study|Lost to Follow-up|0|||
105909036|NCT02532283|365325326|FG001|Overall Study|Lost to Follow-up|1|||
105909037|NCT02532283|365325325|FG000|Overall Study|Withdrawal by Subject|8|||
105909038|NCT02532283|365325326|FG001|Overall Study|Withdrawal by Subject|3|||
105909039|NCT02308228|365325327|FG000|Overall Study|Adverse Event|3|||
105909040|NCT02308228|365325328|FG001|Overall Study|Adverse Event|4|||
105909041|NCT02308228|365325327|FG000|Overall Study|Withdrawal by Subject|5|||
105909042|NCT02308228|365325328|FG001|Overall Study|Withdrawal by Subject|3|||
105909043|NCT00490971|365325337|FG000|Acute/Continuation|Adverse Event|62|||
105909044|NCT00490971|365325338|FG001|Acute/Continuation|Adverse Event|13|||
105909045|NCT00490971|365325339|FG002|Acute/Continuation|Adverse Event|0|||
105909046|NCT00490971|365325340|FG003|Acute/Continuation|Adverse Event|0|||
105909047|NCT00490971|365325341|FG004|Acute/Continuation|Adverse Event|0|||
105909048|NCT00490971|365325337|FG000|Acute/Continuation|Death|2|||
105909049|NCT00490971|365325338|FG001|Acute/Continuation|Death|0|||
105909050|NCT00490971|365325339|FG002|Acute/Continuation|Death|0|||
105909051|NCT00490971|365325340|FG003|Acute/Continuation|Death|0|||
105909052|NCT00490971|365325341|FG004|Acute/Continuation|Death|0|||
105909053|NCT00490971|365325337|FG000|Acute/Continuation|Lack of Efficacy|106|||
105909054|NCT00490971|365325338|FG001|Acute/Continuation|Lack of Efficacy|12|||
105909055|NCT00490971|365325339|FG002|Acute/Continuation|Lack of Efficacy|0|||
105909056|NCT00490971|365325340|FG003|Acute/Continuation|Lack of Efficacy|0|||
105909057|NCT00490971|365325341|FG004|Acute/Continuation|Lack of Efficacy|0|||
105909058|NCT00490971|365325337|FG000|Acute/Continuation|Lost to Follow-up|23|||
105909059|NCT00490971|365325338|FG001|Acute/Continuation|Lost to Follow-up|7|||
105909060|NCT00490971|365325339|FG002|Acute/Continuation|Lost to Follow-up|0|||
105909061|NCT00490971|365325340|FG003|Acute/Continuation|Lost to Follow-up|0|||
105909062|NCT00490971|365325341|FG004|Acute/Continuation|Lost to Follow-up|0|||
105909063|NCT00490971|365325337|FG000|Acute/Continuation|Protocol Violation|10|||
105909064|NCT00490971|365325338|FG001|Acute/Continuation|Protocol Violation|2|||
105909065|NCT00490971|365325339|FG002|Acute/Continuation|Protocol Violation|0|||
105909066|NCT00490971|365325340|FG003|Acute/Continuation|Protocol Violation|0|||
105909067|NCT00490971|365325341|FG004|Acute/Continuation|Protocol Violation|0|||
105909068|NCT00490971|365325337|FG000|Acute/Continuation|Withdrawal by Subject|92|||
105909069|NCT00490971|365325338|FG001|Acute/Continuation|Withdrawal by Subject|24|||
105909070|NCT00490971|365325339|FG002|Acute/Continuation|Withdrawal by Subject|0|||
105672993|NCT04372121|364464390|FG002|Overall Study|Lost to Follow-up|0|||
105672994|NCT04372121|364464391|FG003|Overall Study|Lost to Follow-up|1|||
105672995|NCT04372121|364464388|FG000|Overall Study|Protocol Violation|0|||
105672996|NCT04372121|364464389|FG001|Overall Study|Protocol Violation|0|||
105909071|NCT00490971|365325340|FG003|Acute/Continuation|Withdrawal by Subject|0|||
105909072|NCT00490971|365325341|FG004|Acute/Continuation|Withdrawal by Subject|0|||
105909073|NCT00490971|365325337|FG000|Acute/Continuation|Other|11|||
105909074|NCT00490971|365325338|FG001|Acute/Continuation|Other|4|||
105672997|NCT04372121|364464390|FG002|Overall Study|Protocol Violation|1|||
105672998|NCT04372121|364464391|FG003|Overall Study|Protocol Violation|0|||
105672999|NCT04372121|364464388|FG000|Overall Study|Withdrawal by Subject|3|||
105673000|NCT04372121|364464389|FG001|Overall Study|Withdrawal by Subject|1|||
105673001|NCT04372121|364464390|FG002|Overall Study|Withdrawal by Subject|0|||
105673002|NCT04372121|364464391|FG003|Overall Study|Withdrawal by Subject|0|||
105909075|NCT00490971|365325339|FG002|Acute/Continuation|Other|0|||
105909076|NCT00490971|365325340|FG003|Acute/Continuation|Other|0|||
105909077|NCT00490971|365325341|FG004|Acute/Continuation|Other|0|||
105909078|NCT00490971|365325337|FG000|Maintenance|Adverse Event|0|||
105673003|NCT04372121|364464388|FG000|Overall Study|Study termination|6|||
105673004|NCT04372121|364464389|FG001|Overall Study|Study termination|5|||
105673005|NCT04372121|364464390|FG002|Overall Study|Study termination|1|||
105673006|NCT04372121|364464391|FG003|Overall Study|Study termination|1|||
105673007|NCT04372121|364464388|FG000|Overall Study|Hysterectomy planned|1|||
105673008|NCT04372121|364464389|FG001|Overall Study|Hysterectomy planned|0|||
105673009|NCT04372121|364464390|FG002|Overall Study|Hysterectomy planned|0|||
105673010|NCT04372121|364464391|FG003|Overall Study|Hysterectomy planned|0|||
105673011|NCT05618912|364464392|FG000|Overall Study|Lost to Follow-up|14|||
105673012|NCT05618912|364464393|FG001|Overall Study|Lost to Follow-up|19|||
105673013|NCT04500769|364466260|FG000|Overall Study|Withdrawal by Subject|5|||
105673014|NCT05718466|364466261|FG000|Overall Study|Withdrawal by Subject|1|||
105673015|NCT05718466|364466262|FG001|Overall Study|Withdrawal by Subject|2|||
105673016|NCT05718466|364466261|FG000|Overall Study|Death|0|||
105673017|NCT05718466|364466262|FG001|Overall Study|Death|1|||
105673018|NCT01967147|364466263|FG000|Overall Study|Adverse Event|5|||
105673019|NCT01967147|364466264|FG001|Overall Study|Adverse Event|2|||
105673020|NCT01967147|364466263|FG000|Overall Study|Lack of Efficacy|1|||
105673021|NCT01967147|364466264|FG001|Overall Study|Lack of Efficacy|4|||
105673022|NCT01967147|364466263|FG000|Overall Study|Lost to Follow-up|1|||
105673023|NCT01967147|364466264|FG001|Overall Study|Lost to Follow-up|2|||
105673024|NCT01967147|364466263|FG000|Overall Study|Withdrawal by Subject|2|||
105673025|NCT01967147|364466264|FG001|Overall Study|Withdrawal by Subject|4|||
105673026|NCT01967147|364466263|FG000|Overall Study|Non-compliance with Study Drug|0|||
105673027|NCT01967147|364466264|FG001|Overall Study|Non-compliance with Study Drug|3|||
105673028|NCT01967147|364466263|FG000|Overall Study|Other|4|||
105673029|NCT01967147|364466264|FG001|Overall Study|Other|5|||
105673030|NCT01099215|364466265|FG000|Overall Study|Withdrawal by Subject|1|||
105673031|NCT01099215|364466266|FG001|Overall Study|Withdrawal by Subject|0|||
105673032|NCT01099215|364466265|FG000|Overall Study|Adverse Event|0|||
105673033|NCT01099215|364466266|FG001|Overall Study|Adverse Event|1|||
105673034|NCT00890695|364466274|FG000|Overall Study|Protocol Violation|1|||
105673035|NCT00890695|364466275|FG001|Overall Study|Protocol Violation|0|||
105673036|NCT01253135|364466276|FG000|Original Protocol|Protocol Amendment|15|||
105673037|NCT01253135|364466276|FG000|Amended Protocol|Non-compliance|1|||
105673038|NCT03284229|364466277|FG000|Overall Study|Lost to Follow-up|3|||
105673039|NCT01901432|364466280|FG000|Overall Study|Adverse Event|0|||
105673040|NCT01901432|364466281|FG001|Overall Study|Adverse Event|1|||
105673041|NCT01901432|364466282|FG002|Overall Study|Adverse Event|1|||
105673042|NCT01901432|364466283|FG003|Overall Study|Adverse Event|0|||
105673043|NCT01901432|364466284|FG004|Overall Study|Adverse Event|1|||
105673044|NCT01901432|364466280|FG000|Overall Study|Withdrawal by Subject|0|||
105673045|NCT01901432|364466281|FG001|Overall Study|Withdrawal by Subject|0|||
105673046|NCT01901432|364466282|FG002|Overall Study|Withdrawal by Subject|1|||
105673047|NCT01901432|364466283|FG003|Overall Study|Withdrawal by Subject|0|||
105673048|NCT01901432|364466284|FG004|Overall Study|Withdrawal by Subject|5|||
105673049|NCT01901432|364466280|FG000|Overall Study|Physician Decision|0|||
105673050|NCT01901432|364466281|FG001|Overall Study|Physician Decision|0|||
105673051|NCT01901432|364466282|FG002|Overall Study|Physician Decision|0|||
105673052|NCT01901432|364466283|FG003|Overall Study|Physician Decision|0|||
105673053|NCT01901432|364466284|FG004|Overall Study|Physician Decision|2|||
105673054|NCT01901432|364466280|FG000|Overall Study|Patient decision to stop study drug|0|||
105673055|NCT01901432|364466281|FG001|Overall Study|Patient decision to stop study drug|0|||
105673056|NCT01901432|364466282|FG002|Overall Study|Patient decision to stop study drug|0|||
105673057|NCT01901432|364466283|FG003|Overall Study|Patient decision to stop study drug|0|||
105673058|NCT01901432|364466284|FG004|Overall Study|Patient decision to stop study drug|1|||
105673059|NCT01015560|364466288|FG000|Overall Study|Adverse Event|1|||
105673060|NCT01015560|364466288|FG000|Overall Study|Not protocol specified|1|||
105673061|NCT01015560|364466288|FG000|Overall Study|Withdrawal by Subject|1|||
105673062|NCT01302080|364466293|FG000|Overall Study|Withdrew Consent|92|||
105673063|NCT01302080|364466294|FG001|Overall Study|Withdrew Consent|39|||
105673064|NCT01302080|364466293|FG000|Overall Study|Patient/Family Moved|28|||
105673065|NCT01302080|364466294|FG001|Overall Study|Patient/Family Moved|3|||
105673066|NCT01302080|364466293|FG000|Overall Study|Lost to Follow-up|192|||
105673067|NCT01302080|364466294|FG001|Overall Study|Lost to Follow-up|93|||
105673068|NCT01302080|364466293|FG000|Overall Study|Death|1|||
105673069|NCT01302080|364466294|FG001|Overall Study|Death|0|||
105673070|NCT01302080|364466293|FG000|Overall Study|Other|52|||
105673071|NCT01302080|364466294|FG001|Overall Study|Other|8|||
105673072|NCT01302080|364466293|FG000|Overall Study|Reason Missing For Discontinuation|1|||
105673073|NCT01302080|364466294|FG001|Overall Study|Reason Missing For Discontinuation|0|||
105786293|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
105909079|NCT00490971|365325338|FG001|Maintenance|Adverse Event|0|||
105673074|NCT00288639|364466297|FG000|Overall Study|Adverse Event|5|||
105673075|NCT00288639|364466297|FG000|Overall Study|Lack of Efficacy|4|||
105673076|NCT00288639|364466297|FG000|Overall Study|Withdrawal by Subject|2|||
105673077|NCT00288639|364466297|FG000|Overall Study|Other|1|||
105673078|NCT00264303|364466298|FG000|Overall Study|Adverse Event|4|||
105909080|NCT00490971|365325339|FG002|Maintenance|Adverse Event|4|||
105673079|NCT00264303|364466299|FG001|Overall Study|Adverse Event|3|||
105673080|NCT00264303|364466298|FG000|Overall Study|Lack of Efficacy|10|||
105673081|NCT00264303|364466299|FG001|Overall Study|Lack of Efficacy|13|||
105673082|NCT00264303|364466298|FG000|Overall Study|Lost to Follow-up|3|||
105673083|NCT00264303|364466299|FG001|Overall Study|Lost to Follow-up|3|||
105673084|NCT00264303|364466298|FG000|Overall Study|Withdrawal by Subject|2|||
105673085|NCT00264303|364466299|FG001|Overall Study|Withdrawal by Subject|3|||
105673086|NCT00264303|364466298|FG000|Overall Study|Various reasons listed in study report|6|||
105673087|NCT00264303|364466299|FG001|Overall Study|Various reasons listed in study report|7|||
105673088|NCT02389452|364466300|FG000|Overall Study|Lost to Follow-up|13|||
105673089|NCT02389452|364466300|FG000|Overall Study|Adverse Event|1|||
105673090|NCT02389452|364466300|FG000|Overall Study|Withdrawal by Subject|5|||
105673091|NCT02389452|364466300|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
105673092|NCT01076153|364466307|FG000|Overall Study|Symptoms improved/resolved|10|||
105673093|NCT01076153|364466307|FG000|Overall Study|Adverse Event|1|||
105673094|NCT00663702|364466317|FG000|Overall Study|Adverse Event|8|||
105673095|NCT00663702|364466318|FG001|Overall Study|Adverse Event|4|||
105673096|NCT00663702|364466317|FG000|Overall Study|Withdrawal by Subject|3|||
105673097|NCT00663702|364466318|FG001|Overall Study|Withdrawal by Subject|1|||
105673098|NCT00663702|364466317|FG000|Overall Study|Pregnancy|0|||
105673099|NCT00663702|364466318|FG001|Overall Study|Pregnancy|1|||
105673100|NCT00663702|364466317|FG000|Overall Study|Lost to Follow-up|3|||
105673101|NCT00663702|364466318|FG001|Overall Study|Lost to Follow-up|0|||
105673102|NCT00663702|364466317|FG000|Overall Study|Death|1|||
105673103|NCT00663702|364466318|FG001|Overall Study|Death|1|||
105673104|NCT00663702|364466317|FG000|Overall Study|Lack of Efficacy|3|||
105673105|NCT00663702|364466318|FG001|Overall Study|Lack of Efficacy|3|||
105673106|NCT00626990|364466321|FG000|Overall Study|Lack of Efficacy|6|||
105673107|NCT00626990|364466322|FG001|Overall Study|Lack of Efficacy|7|||
105673108|NCT00626990|364466323|FG002|Overall Study|Lack of Efficacy|49|||
105673109|NCT00626990|364466324|FG003|Overall Study|Lack of Efficacy|40|||
105673110|NCT00626990|364466321|FG000|Overall Study|Adverse Event|1|||
105673111|NCT00626990|364466322|FG001|Overall Study|Adverse Event|7|||
105673112|NCT00626990|364466323|FG002|Overall Study|Adverse Event|14|||
105673113|NCT00626990|364466324|FG003|Overall Study|Adverse Event|28|||
105673114|NCT00626990|364466321|FG000|Overall Study|Death|0|||
105673115|NCT00626990|364466322|FG001|Overall Study|Death|1|||
105673116|NCT00626990|364466323|FG002|Overall Study|Death|0|||
105673117|NCT00626990|364466324|FG003|Overall Study|Death|0|||
105909081|NCT00490971|365325340|FG003|Maintenance|Adverse Event|5|||
105909082|NCT00490971|365325341|FG004|Maintenance|Adverse Event|7|||
105909083|NCT00490971|365325337|FG000|Maintenance|Death|0|||
105909084|NCT00490971|365325338|FG001|Maintenance|Death|0|||
105673118|NCT00626990|364466321|FG000|Overall Study|Withdrawal by Subject|3|||
105673119|NCT00626990|364466322|FG001|Overall Study|Withdrawal by Subject|1|||
105673120|NCT00626990|364466323|FG002|Overall Study|Withdrawal by Subject|5|||
105673121|NCT00626990|364466324|FG003|Overall Study|Withdrawal by Subject|11|||
105673122|NCT00626990|364466321|FG000|Overall Study|Protocol Violation|0|||
105673123|NCT00626990|364466322|FG001|Overall Study|Protocol Violation|1|||
105673124|NCT00626990|364466323|FG002|Overall Study|Protocol Violation|1|||
105673125|NCT00626990|364466324|FG003|Overall Study|Protocol Violation|0|||
105909085|NCT00490971|365325339|FG002|Maintenance|Death|0|||
105909086|NCT00490971|365325340|FG003|Maintenance|Death|2|||
105909087|NCT00490971|365325341|FG004|Maintenance|Death|0|||
105909088|NCT00490971|365325337|FG000|Maintenance|Lost to Follow-up|0|||
105909089|NCT00490971|365325338|FG001|Maintenance|Lost to Follow-up|0|||
105909090|NCT00490971|365325339|FG002|Maintenance|Lost to Follow-up|5|||
105909091|NCT00490971|365325340|FG003|Maintenance|Lost to Follow-up|8|||
105909092|NCT00490971|365325341|FG004|Maintenance|Lost to Follow-up|10|||
105909093|NCT00490971|365325337|FG000|Maintenance|Pregnancy|0|||
105909094|NCT00490971|365325338|FG001|Maintenance|Pregnancy|0|||
105909095|NCT00490971|365325339|FG002|Maintenance|Pregnancy|1|||
105673126|NCT00626990|364466321|FG000|Overall Study|Various different reasons/missing|4|||
105673127|NCT00626990|364466322|FG001|Overall Study|Various different reasons/missing|8|||
105673128|NCT00626990|364466323|FG002|Overall Study|Various different reasons/missing|8|||
105673129|NCT00626990|364466324|FG003|Overall Study|Various different reasons/missing|16|||
105909096|NCT00490971|365325340|FG003|Maintenance|Pregnancy|0|||
105673130|NCT04138576|364466329|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
105673131|NCT00297427|364466332|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
105673132|NCT00297427|364466333|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
105673133|NCT00297427|364466332|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
105673134|NCT00297427|364466333|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
105673135|NCT00297427|364466332|FG000|Phase 1: Initial Intervention|Death|0|||
105909097|NCT00490971|365325341|FG004|Maintenance|Pregnancy|0|||
105909098|NCT00490971|365325337|FG000|Maintenance|Protocol Violation|0|||
105909099|NCT00490971|365325338|FG001|Maintenance|Protocol Violation|0|||
105909100|NCT00490971|365325339|FG002|Maintenance|Protocol Violation|4|||
105909101|NCT00490971|365325340|FG003|Maintenance|Protocol Violation|1|||
105909102|NCT00490971|365325341|FG004|Maintenance|Protocol Violation|1|||
105673136|NCT00297427|364466333|FG001|Phase 1: Initial Intervention|Death|1|||
105673137|NCT00297427|364466332|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
105673138|NCT00297427|364466333|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
105673139|NCT00297427|364466332|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
105673140|NCT00297427|364466333|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
105673141|NCT00297427|364466332|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
105673142|NCT00297427|364466333|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
105673143|NCT00297427|364466332|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
105673144|NCT00297427|364466333|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
105673145|NCT00297427|364466332|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
105673146|NCT00297427|364466333|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
105673147|NCT02898077|364466338|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
105673148|NCT02898077|364466339|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
105673149|NCT02898077|364466338|FG000|Overall Study|Lost to Follow-up|4|||
105673150|NCT02898077|364466339|FG001|Overall Study|Lost to Follow-up|3|||
105673151|NCT02898077|364466338|FG000|Overall Study|Physician Decision|0|||
105673152|NCT02898077|364466339|FG001|Overall Study|Physician Decision|2|||
105673153|NCT02898077|364466338|FG000|Overall Study|Sponsor Decision|32|||
105673154|NCT02898077|364466339|FG001|Overall Study|Sponsor Decision|13|||
105673155|NCT02898077|364466338|FG000|Overall Study|Withdrawal by Subject|6|||
105673156|NCT02898077|364466339|FG001|Overall Study|Withdrawal by Subject|3|||
105673157|NCT02898077|364466338|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
105673158|NCT02898077|364466339|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
105673159|NCT02898077|364466338|FG000|Overall Study|Ended extension period|3|||
105673160|NCT02898077|364466339|FG001|Overall Study|Ended extension period|0|||
105673161|NCT02643303|364466341|FG000|Overall Study|Progressive Disease|4|||
105673162|NCT02643303|364466342|FG001|Overall Study|Progressive Disease|4|||
105673163|NCT02643303|364466343|FG002|Overall Study|Progressive Disease|1|||
105673164|NCT02643303|364466344|FG003|Overall Study|Progressive Disease|12|||
105673165|NCT02643303|364466345|FG004|Overall Study|Progressive Disease|6|||
105673166|NCT02643303|364466346|FG005|Overall Study|Progressive Disease|4|||
105673167|NCT02643303|364466347|FG006|Overall Study|Progressive Disease|8|||
105673168|NCT02643303|364466348|FG007|Overall Study|Progressive Disease|2|||
105673169|NCT02643303|364466349|FG008|Overall Study|Progressive Disease|6|||
105673170|NCT02643303|364466341|FG000|Overall Study|Adverse Event|0|||
105673171|NCT02643303|364466342|FG001|Overall Study|Adverse Event|1|||
105673172|NCT02643303|364466343|FG002|Overall Study|Adverse Event|0|||
105673173|NCT02643303|364466344|FG003|Overall Study|Adverse Event|0|||
105673174|NCT02643303|364466345|FG004|Overall Study|Adverse Event|1|||
105673175|NCT02643303|364466346|FG005|Overall Study|Adverse Event|0|||
105673176|NCT02643303|364466347|FG006|Overall Study|Adverse Event|0|||
105673177|NCT02643303|364466348|FG007|Overall Study|Adverse Event|0|||
105673178|NCT02643303|364466349|FG008|Overall Study|Adverse Event|0|||
105673179|NCT02643303|364466341|FG000|Overall Study|Withdrawal by Subject|0|||
105673180|NCT02643303|364466342|FG001|Overall Study|Withdrawal by Subject|0|||
105673181|NCT02643303|364466343|FG002|Overall Study|Withdrawal by Subject|0|||
105673182|NCT02643303|364466344|FG003|Overall Study|Withdrawal by Subject|1|||
105673183|NCT02643303|364466345|FG004|Overall Study|Withdrawal by Subject|0|||
105673184|NCT02643303|364466346|FG005|Overall Study|Withdrawal by Subject|0|||
105673185|NCT02643303|364466347|FG006|Overall Study|Withdrawal by Subject|1|||
105673186|NCT02643303|364466348|FG007|Overall Study|Withdrawal by Subject|1|||
105673187|NCT02643303|364466349|FG008|Overall Study|Withdrawal by Subject|1|||
105673188|NCT00132873|364466353|FG000|Overall Study|Adverse Event|3|||
105673189|NCT00132873|364466353|FG000|Overall Study|Lost to Follow-up|1|||
105673190|NCT00132873|364466353|FG000|Overall Study|Lack of Efficacy|1|||
105673191|NCT00132873|364466353|FG000|Overall Study|Withdrawal by Subject|3|||
105673192|NCT00132873|364466353|FG000|Overall Study|Planned Pregnancy|1|||
105673193|NCT00283244|364466356|FG000|Overall Study|Adverse Event|0|||
105673194|NCT00283244|364466357|FG001|Overall Study|Adverse Event|8|||
105673195|NCT00283244|364466358|FG002|Overall Study|Adverse Event|11|||
105673196|NCT00283244|364466356|FG000|Overall Study|Death|4|||
105673197|NCT00283244|364466357|FG001|Overall Study|Death|3|||
105673198|NCT00283244|364466358|FG002|Overall Study|Death|2|||
105673199|NCT00283244|364466356|FG000|Overall Study|Lack of Efficacy|8|||
105673200|NCT00283244|364466357|FG001|Overall Study|Lack of Efficacy|32|||
105673201|NCT00283244|364466358|FG002|Overall Study|Lack of Efficacy|26|||
105673202|NCT00283244|364466356|FG000|Overall Study|Withdrawal by Subject|1|||
105673203|NCT00283244|364466357|FG001|Overall Study|Withdrawal by Subject|2|||
105673204|NCT00283244|364466358|FG002|Overall Study|Withdrawal by Subject|2|||
105673205|NCT00283244|364466356|FG000|Overall Study|Physician Decision|0|||
105673206|NCT00283244|364466357|FG001|Overall Study|Physician Decision|0|||
105673207|NCT00283244|364466358|FG002|Overall Study|Physician Decision|1|||
105786294|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
105909103|NCT00490971|365325337|FG000|Maintenance|Withdrawal by Subject|0|||
105909104|NCT00490971|365325338|FG001|Maintenance|Withdrawal by Subject|0|||
105673208|NCT00283244|364466356|FG000|Overall Study|Medical illness (other complicating dz)|4|||
105673209|NCT00283244|364466357|FG001|Overall Study|Medical illness (other complicating dz)|3|||
105673210|NCT00283244|364466358|FG002|Overall Study|Medical illness (other complicating dz)|6|||
105673211|NCT00283244|364466356|FG000|Overall Study|Clinical deterioration|1|||
105673212|NCT00283244|364466357|FG001|Overall Study|Clinical deterioration|3|||
105673213|NCT00283244|364466358|FG002|Overall Study|Clinical deterioration|3|||
105673214|NCT02145468|364466359|FG000|Overall Study|Withdrawal by Subject|5|||
105673215|NCT02145468|364466360|FG001|Overall Study|Withdrawal by Subject|8|||
105673216|NCT00586612|364466361|FG000|Primary Phase|Protocol Violation|1|||
105673217|NCT00586612|364466362|FG001|Primary Phase|Protocol Violation|0|||
105673218|NCT00586612|364466361|FG000|Primary Phase|Lost to Follow-up|0|||
105673219|NCT00586612|364466362|FG001|Primary Phase|Lost to Follow-up|1|||
105673220|NCT00586612|364466361|FG000|Primary Phase|Withdrawal by Subject|0|||
105673221|NCT00586612|364466362|FG001|Primary Phase|Withdrawal by Subject|2|||
105673222|NCT00586612|364466361|FG000|Booster Phase|Lost to Follow-up|3|||
105673223|NCT00586612|364466362|FG001|Booster Phase|Lost to Follow-up|1|||
105673224|NCT02001064|364466363|FG000|Overall Study|Withdrawal by Subject|2|||
105673225|NCT02001064|364466364|FG001|Overall Study|Withdrawal by Subject|1|||
105673226|NCT01609062|364466367|FG000|Extension Phase|Terminated by Sponsor|14|||
105673227|NCT01609062|364466368|FG001|Extension Phase|Terminated by Sponsor|9|||
105673228|NCT01609062|364466367|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
105673229|NCT01609062|364466368|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
105673230|NCT01609062|364466367|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
105673231|NCT01609062|364466368|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
105673232|NCT02738853|364466369|FG000|Enrollment|Inclusion/Exclusion not met|21|||
105673233|NCT02738853|364466369|FG000|Enrollment|Withdrawal by Subject|3|||
105673234|NCT02738853|364466369|FG000|Enrollment|Subject treated with commercially available device|6|||
105673235|NCT02738853|364466369|FG000|Enrollment|Study Enrollment Closed|3|||
105673236|NCT02738853|364466369|FG000|Procedure|Death|1|||
105673237|NCT02738853|364466369|FG000|1 Month|Death|2|||
105673238|NCT02738853|364466369|FG000|6 Month|Death|4|||
105673239|NCT02738853|364466369|FG000|6 Month|Withdrawal by Subject|2|||
105673240|NCT02738853|364466369|FG000|1 Year|Death|6|||
105673241|NCT02738853|364466369|FG000|1 Year|Withdrawal by Subject|1|||
105673242|NCT02738853|364466369|FG000|2 Year|Death|2|||
105673243|NCT02738853|364466369|FG000|2 Year|Lost to Follow-up|1|||
105673244|NCT02738853|364466369|FG000|3 Year|Death|2|||
105673245|NCT02738853|364466369|FG000|3 Year|Withdrawal by Subject|1|||
105673246|NCT02738853|364466369|FG000|4 Year|Death|9|||
105673247|NCT02738853|364466369|FG000|5 Year|Lost to Follow-up|4|||
105673248|NCT01585155|364466370|FG000|Overall Study|Adverse Event|1|||
105673249|NCT01585155|364466370|FG000|Overall Study|Lack of Efficacy|2|||
105673250|NCT01585155|364466370|FG000|Overall Study|Worsening ulcerative colitis|2|||
105673251|NCT01468181|364466371|FG000|Overall Study|Adverse Event|8|||
105673252|NCT01468181|364466372|FG001|Overall Study|Adverse Event|1|||
105673253|NCT01468181|364466373|FG002|Overall Study|Adverse Event|6|||
105673254|NCT01468181|364466374|FG003|Overall Study|Adverse Event|2|||
105673255|NCT01468181|364466375|FG004|Overall Study|Adverse Event|2|||
105673256|NCT01468181|364466371|FG000|Overall Study|Protocol Violation|2|||
105673257|NCT01468181|364466372|FG001|Overall Study|Protocol Violation|0|||
105673258|NCT01468181|364466373|FG002|Overall Study|Protocol Violation|1|||
105673259|NCT01468181|364466374|FG003|Overall Study|Protocol Violation|0|||
105673260|NCT01468181|364466375|FG004|Overall Study|Protocol Violation|1|||
105673261|NCT01468181|364466371|FG000|Overall Study|Physician Decision|0|||
105673262|NCT01468181|364466372|FG001|Overall Study|Physician Decision|0|||
105673263|NCT01468181|364466373|FG002|Overall Study|Physician Decision|0|||
105673264|NCT01468181|364466374|FG003|Overall Study|Physician Decision|1|||
105786295|NCT00948896|364870488|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
105786296|NCT00948896|364870489|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
105786297|NCT00948896|364870490|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
105786298|NCT00948896|364870491|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
105786299|NCT00948896|364870492|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
105786300|NCT00948896|364870493|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
105909105|NCT00490971|365325339|FG002|Maintenance|Withdrawal by Subject|26|||
105909106|NCT00490971|365325340|FG003|Maintenance|Withdrawal by Subject|28|||
105909107|NCT00490971|365325341|FG004|Maintenance|Withdrawal by Subject|18|||
105909108|NCT00490971|365325337|FG000|Maintenance|Other|0|||
105673265|NCT01468181|364466375|FG004|Overall Study|Physician Decision|1|||
105673266|NCT01468181|364466371|FG000|Overall Study|Lost to Follow-up|0|||
105673267|NCT01468181|364466372|FG001|Overall Study|Lost to Follow-up|0|||
105673268|NCT01468181|364466373|FG002|Overall Study|Lost to Follow-up|1|||
105673269|NCT01468181|364466374|FG003|Overall Study|Lost to Follow-up|0|||
105673270|NCT01468181|364466375|FG004|Overall Study|Lost to Follow-up|1|||
105673271|NCT01468181|364466371|FG000|Overall Study|Withdrawal by Subject|0|||
105673272|NCT01468181|364466372|FG001|Overall Study|Withdrawal by Subject|1|||
105673273|NCT01468181|364466373|FG002|Overall Study|Withdrawal by Subject|0|||
105673274|NCT01468181|364466374|FG003|Overall Study|Withdrawal by Subject|0|||
105673275|NCT01468181|364466375|FG004|Overall Study|Withdrawal by Subject|0|||
105673276|NCT00545753|364466376|FG000|Overall Study|Withdrawal by Subject|0|||
105673277|NCT00545753|364466377|FG001|Overall Study|Withdrawal by Subject|1|||
105673278|NCT00545753|364466378|FG002|Overall Study|Withdrawal by Subject|10|||
105673279|NCT00545753|364466376|FG000|Overall Study|Lost to Follow-up|13|||
105673280|NCT00545753|364466377|FG001|Overall Study|Lost to Follow-up|3|||
105673281|NCT00545753|364466378|FG002|Overall Study|Lost to Follow-up|12|||
105673282|NCT00545753|364466376|FG000|Overall Study|Protocol Violation|3|||
105673283|NCT00545753|364466377|FG001|Overall Study|Protocol Violation|1|||
105673284|NCT00545753|364466378|FG002|Overall Study|Protocol Violation|4|||
105673285|NCT03772587|364466379|FG000|Overall Study|COVID-19|0|||
105673286|NCT03772587|364466380|FG001|Overall Study|COVID-19|0|||
105673287|NCT03772587|364466381|FG002|Overall Study|COVID-19|1|||
105673288|NCT03772587|364466382|FG003|Overall Study|COVID-19|1|||
105673289|NCT03772587|364466383|FG004|Overall Study|COVID-19|0|||
105673290|NCT03772587|364466379|FG000|Overall Study|Withdrawal by Subject|1|||
105673291|NCT03772587|364466380|FG001|Overall Study|Withdrawal by Subject|0|||
105673292|NCT03772587|364466381|FG002|Overall Study|Withdrawal by Subject|0|||
105673293|NCT03772587|364466382|FG003|Overall Study|Withdrawal by Subject|0|||
105673294|NCT03772587|364466383|FG004|Overall Study|Withdrawal by Subject|0|||
105673295|NCT00513305|364466384|FG000|Overall Study|Adverse Event|6|||
105673296|NCT00513305|364466385|FG001|Overall Study|Adverse Event|2|||
105673297|NCT00513305|364466384|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
105673298|NCT00513305|364466385|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
105673299|NCT00513305|364466384|FG000|Overall Study|Lack of Efficacy|8|||
105673300|NCT00513305|364466385|FG001|Overall Study|Lack of Efficacy|13|||
105673301|NCT00513305|364466384|FG000|Overall Study|Withdrawal by Subject|1|||
105673302|NCT00513305|364466385|FG001|Overall Study|Withdrawal by Subject|2|||
105673303|NCT00513305|364466384|FG000|Overall Study|Disease progression|8|||
105673304|NCT00513305|364466385|FG001|Overall Study|Disease progression|5|||
105673305|NCT00513305|364466384|FG000|Overall Study|Eligible for stem cell transplant|1|||
105673306|NCT00513305|364466385|FG001|Overall Study|Eligible for stem cell transplant|0|||
105673307|NCT00513305|364466384|FG000|Overall Study|Hematologic counts did not recover|1|||
105673308|NCT00513305|364466385|FG001|Overall Study|Hematologic counts did not recover|0|||
105673309|NCT00513305|364466384|FG000|Overall Study|Physician Decision|1|||
105673310|NCT00513305|364466385|FG001|Overall Study|Physician Decision|0|||
105673311|NCT00513305|364466384|FG000|Overall Study|Persistent hypocellularity|0|||
105673312|NCT00513305|364466385|FG001|Overall Study|Persistent hypocellularity|1|||
105673313|NCT00513305|364466384|FG000|Overall Study|Sponsor Decision|0|||
105673314|NCT00513305|364466385|FG001|Overall Study|Sponsor Decision|2|||
105673315|NCT05384938|364466392|FG000|Overall Study|Withdrawal by Subject|8|||
105673316|NCT05384938|364466392|FG000|Overall Study|Lost to Follow-up|6|||
105673317|NCT05384938|364466392|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
105673318|NCT03798691|364466396|FG000|Overall Study|Lost to Follow-up|2|||
105673319|NCT03798691|364466397|FG001|Overall Study|Lost to Follow-up|2|||
105673320|NCT00552929|364466398|FG000|Overall Study|Lost to Follow-up|0|||
105673321|NCT00552929|364466399|FG001|Overall Study|Lost to Follow-up|0|||
105673322|NCT00552929|364466400|FG002|Overall Study|Lost to Follow-up|0|||
105673323|NCT00552929|364466401|FG003|Overall Study|Lost to Follow-up|0|||
105673324|NCT00552929|364466402|FG004|Overall Study|Lost to Follow-up|0|||
105673325|NCT00552929|364466403|FG005|Overall Study|Lost to Follow-up|0|||
105673326|NCT00552929|364466404|FG006|Overall Study|Lost to Follow-up|0|||
105673327|NCT00552929|364466405|FG007|Overall Study|Lost to Follow-up|0|||
105673328|NCT00552929|364466406|FG008|Overall Study|Lost to Follow-up|1|||
105673329|NCT00552929|364466407|FG009|Overall Study|Lost to Follow-up|0|||
105673330|NCT00552929|364466398|FG000|Overall Study|Not Eligible|0|||
105673331|NCT00552929|364466399|FG001|Overall Study|Not Eligible|0|||
105673332|NCT00552929|364466400|FG002|Overall Study|Not Eligible|0|||
105673333|NCT00552929|364466401|FG003|Overall Study|Not Eligible|0|||
105673334|NCT00552929|364466402|FG004|Overall Study|Not Eligible|0|||
105909109|NCT00490971|365325338|FG001|Maintenance|Other|0|||
105909110|NCT00490971|365325339|FG002|Maintenance|Other|11|||
105909111|NCT00490971|365325340|FG003|Maintenance|Other|9|||
105673335|NCT00552929|364466403|FG005|Overall Study|Not Eligible|1|||
105786301|NCT00948896|364870494|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
105786302|NCT00948896|364870495|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
105673336|NCT00552929|364466404|FG006|Overall Study|Not Eligible|0|||
105673337|NCT00552929|364466405|FG007|Overall Study|Not Eligible|0|||
105673338|NCT00552929|364466406|FG008|Overall Study|Not Eligible|0|||
105673339|NCT00552929|364466407|FG009|Overall Study|Not Eligible|0|||
105786303|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Death|0|||
105909112|NCT00490971|365325341|FG004|Maintenance|Other|3|||
105673340|NCT04577001|364466411|FG000|Overall Study|Subject became ineligible|0|||
105673341|NCT04577001|364466412|FG001|Overall Study|Subject became ineligible|1|||
105673342|NCT01593787|364466413|FG000|Overall Study|Adverse Event|1|||
105673343|NCT01593787|364466414|FG001|Overall Study|Adverse Event|0|||
105673344|NCT01593787|364466415|FG002|Overall Study|Adverse Event|0|||
105673345|NCT01865747|364466416|FG000|Overall Study (ITT)|Adverse Event|32|||
105673346|NCT01865747|364466417|FG001|Overall Study (ITT)|Adverse Event|31|||
105909113|NCT00669318|365326599|FG000|Overall Study|Withdrawal by Subject|2|||
105909114|NCT01073163|365326600|FG000|Overall Study|Adverse Event|1|||
105909115|NCT01073163|365326600|FG000|Overall Study|Disease Progression|1|||
105909116|NCT01073163|365326600|FG000|Overall Study|Early termination|1|||
105909117|NCT00703677|365326601|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
105909118|NCT00940888|365326602|FG000|Overall Study|Unsuccessful Implant|4|||
105909119|NCT00940888|365326602|FG000|Overall Study|Death|461|||
105909120|NCT00940888|365326602|FG000|Overall Study|Withdrawn - Non-Death|364|||
105909121|NCT00940888|365326602|FG000|Overall Study|Lost to Follow-up|6|||
105909122|NCT00762762|365326609|FG000|Overall Study|Did not return for appointments|6|||
105909123|NCT00762762|365326610|FG001|Overall Study|Did not return for appointments|8|||
105909124|NCT01409915|365326613|FG000|Overall Study|Adverse Event|0|||
105909125|NCT01409915|365326614|FG001|Overall Study|Adverse Event|2|||
105909126|NCT01409915|365326613|FG000|Overall Study|Withdrawal by Subject|0|||
105909127|NCT01409915|365326614|FG001|Overall Study|Withdrawal by Subject|1|||
105909128|NCT01409915|365326613|FG000|Overall Study|Protocol Violation|1|||
105909129|NCT01409915|365326614|FG001|Overall Study|Protocol Violation|0|||
105909130|NCT01302418|365326619|FG000|Overall Study|Protocol Violation|9|||
105909131|NCT01302418|365326619|FG000|Overall Study|Non-evaluable|9|||
105909132|NCT02937740|365326620|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
105909133|NCT02937740|365326621|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
105909134|NCT02937740|365326620|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
105909135|NCT02937740|365326621|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
105909136|NCT02937740|365326620|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
105909137|NCT02937740|365326621|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
105909138|NCT02937740|365326620|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
105909139|NCT02937740|365326621|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
105909140|NCT02937740|365326620|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
105909141|NCT02937740|365326621|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
105909142|NCT02937740|365326620|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
105909143|NCT02937740|365326621|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
105909144|NCT00621257|365326622|FG000|Overall Study|Lost to Follow-up|4|||
105909145|NCT00621257|365326623|FG001|Overall Study|Lost to Follow-up|0|||
105909146|NCT00621257|365326624|FG002|Overall Study|Lost to Follow-up|2|||
105909147|NCT00621257|365326625|FG003|Overall Study|Lost to Follow-up|4|||
105909148|NCT00621257|365326626|FG004|Overall Study|Lost to Follow-up|7|||
105909149|NCT00621257|365326622|FG000|Overall Study|Adverse Event|0|||
105909150|NCT00621257|365326623|FG001|Overall Study|Adverse Event|1|||
105909151|NCT00621257|365326624|FG002|Overall Study|Adverse Event|1|||
105909152|NCT00621257|365326625|FG003|Overall Study|Adverse Event|0|||
105909153|NCT00621257|365326626|FG004|Overall Study|Adverse Event|0|||
105909154|NCT00621257|365326622|FG000|Overall Study|Physician Decision|0|||
105786304|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Death|2|||
105786305|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Death|2|||
105909155|NCT00621257|365326623|FG001|Overall Study|Physician Decision|2|||
105909156|NCT00621257|365326624|FG002|Overall Study|Physician Decision|0|||
105909157|NCT00621257|365326625|FG003|Overall Study|Physician Decision|1|||
105909158|NCT00621257|365326626|FG004|Overall Study|Physician Decision|1|||
105909159|NCT00621257|365326622|FG000|Overall Study|Withdrawal by Subject|0|||
105909160|NCT00621257|365326623|FG001|Overall Study|Withdrawal by Subject|0|||
105909161|NCT00621257|365326624|FG002|Overall Study|Withdrawal by Subject|0|||
105909162|NCT00621257|365326625|FG003|Overall Study|Withdrawal by Subject|1|||
105909163|NCT00621257|365326626|FG004|Overall Study|Withdrawal by Subject|1|||
105999372|NCT01132313|365659462|FG004|Overall Study|Lack of antiviral response|18|||
105909164|NCT01705080|365326629|FG000|Overall Study|Missed visit|10|||
105909165|NCT01705080|365326630|FG001|Overall Study|Missed visit|4|||
105909166|NCT01705080|365326631|FG002|Overall Study|Missed visit|1|||
105909167|NCT01705080|365326629|FG000|Overall Study|Death|4|||
105999373|NCT01132313|365659463|FG005|Overall Study|Lack of antiviral response|18|||
105999374|NCT01132313|365659464|FG006|Overall Study|Lack of antiviral response|21|||
105999375|NCT01132313|365659465|FG007|Overall Study|Lack of antiviral response|0|||
105999376|NCT01132313|365659466|FG008|Overall Study|Lack of antiviral response|0|||
105999377|NCT01132313|365659467|FG009|Overall Study|Lack of antiviral response|0|||
105999378|NCT01132313|365659468|FG010|Overall Study|Lack of antiviral response|1|||
105999379|NCT01132313|365659469|FG011|Overall Study|Lack of antiviral response|0|||
105999380|NCT01132313|365659458|FG000|Overall Study|Other reason not defined above|0|||
105999381|NCT01132313|365659459|FG001|Overall Study|Other reason not defined above|0|||
105999382|NCT01132313|365659460|FG002|Overall Study|Other reason not defined above|0|||
105999383|NCT01132313|365659461|FG003|Overall Study|Other reason not defined above|0|||
105999384|NCT01132313|365659462|FG004|Overall Study|Other reason not defined above|0|||
105999385|NCT01132313|365659463|FG005|Overall Study|Other reason not defined above|0|||
105999386|NCT01132313|365659464|FG006|Overall Study|Other reason not defined above|0|||
105999387|NCT01132313|365659465|FG007|Overall Study|Other reason not defined above|1|||
105999388|NCT01132313|365659466|FG008|Overall Study|Other reason not defined above|0|||
105999389|NCT01132313|365659467|FG009|Overall Study|Other reason not defined above|0|||
105999390|NCT01132313|365659468|FG010|Overall Study|Other reason not defined above|0|||
105999391|NCT01132313|365659469|FG011|Overall Study|Other reason not defined above|0|||
105999392|NCT01236521|365659470|FG000|Overall Study|Withdrawal by Subject|12|||
105999393|NCT01236521|365659471|FG001|Overall Study|Withdrawal by Subject|17|||
105999394|NCT01236521|365659470|FG000|Overall Study|Death|2|||
105999395|NCT01236521|365659471|FG001|Overall Study|Death|1|||
105999396|NCT01236521|365659470|FG000|Overall Study|Lost to Follow-up|9|||
105999397|NCT01236521|365659471|FG001|Overall Study|Lost to Follow-up|7|||
105999398|NCT00165672|365659472|FG000|Overall Study|Adverse Event|0|||
105999399|NCT00165672|365659473|FG001|Overall Study|Adverse Event|1|||
105999400|NCT01670721|365659477|FG000|Overall Study|Participant's decision|15|||
105999401|NCT01670721|365659477|FG000|Overall Study|Other than specified above|38|||
105999402|NCT04965688|365659483|FG000|Overall Study|Withdrawal by Subject|2|||
105999403|NCT06172348|365659484|FG000|Treatment Period 2|Adverse Event|0|||
105999404|NCT06172348|365659485|FG001|Treatment Period 2|Adverse Event|0|||
105999405|NCT06172348|365659486|FG002|Treatment Period 2|Adverse Event|1|||
105999406|NCT06172348|365659487|FG003|Treatment Period 2|Adverse Event|0|||
105999407|NCT06172348|365659488|FG004|Treatment Period 2|Adverse Event|0|||
105999408|NCT06172348|365659489|FG005|Treatment Period 2|Adverse Event|0|||
105999409|NCT03116685|365659490|FG000|Overall Study|Physician Decision|0|||
105999410|NCT03116685|365659491|FG001|Overall Study|Physician Decision|1|||
105999411|NCT05274958|365659492|FG000|Overall Study|Only completed 1 set of PROMs|22|||
105999412|NCT05274958|365659493|FG001|Overall Study|Only completed 1 set of PROMs|35|||
105999413|NCT00452790|365659496|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
105999414|NCT00452790|365659497|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
105999415|NCT00452790|365659496|FG000|Infant Series|Parent/legal guardian request|8|||
105999416|NCT00452790|365659497|FG001|Infant Series|Parent/legal guardian request|6|||
105999417|NCT00452790|365659496|FG000|Infant Series|Failed to return|4|||
105999418|NCT00452790|365659497|FG001|Infant Series|Failed to return|1|||
105999419|NCT00452790|365659496|FG000|Infant Series|Protocol Violation|1|||
105999420|NCT00452790|365659497|FG001|Infant Series|Protocol Violation|3|||
105999421|NCT00452790|365659496|FG000|Infant Series|Lost to Follow-up|2|||
105999422|NCT00452790|365659497|FG001|Infant Series|Lost to Follow-up|2|||
105999423|NCT00452790|365659496|FG000|Infant Series|Adverse Event|1|||
105999424|NCT00452790|365659497|FG001|Infant Series|Adverse Event|2|||
105999425|NCT00452790|365659496|FG000|Infant Series|Other reasons|1|||
105999426|NCT00452790|365659497|FG001|Infant Series|Other reasons|2|||
105999427|NCT00452790|365659496|FG000|Infant Series|Investigator request|0|||
105673347|NCT01865747|364466416|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
105673348|NCT01865747|364466417|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
105673349|NCT01865747|364466416|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
105673350|NCT01865747|364466417|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
105673351|NCT01865747|364466416|FG000|Overall Study (ITT)|Protocol Violation|1|||
105673352|NCT01865747|364466417|FG001|Overall Study (ITT)|Protocol Violation|1|||
105673353|NCT01865747|364466416|FG000|Overall Study (ITT)|Physician Decision|5|||
105673354|NCT01865747|364466417|FG001|Overall Study (ITT)|Physician Decision|2|||
105673355|NCT01865747|364466416|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
105673356|NCT01865747|364466417|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
105673357|NCT01865747|364466416|FG000|Overall Study (ITT)|Sponsor Decision|0|||
105673358|NCT01865747|364466417|FG001|Overall Study (ITT)|Sponsor Decision|1|||
105673359|NCT01865747|364466416|FG000|Overall Study (ITT)|Progressive Disease|122|||
105673360|NCT01865747|364466417|FG001|Overall Study (ITT)|Progressive Disease|158|||
105673361|NCT01865747|364466416|FG000|Overall Study (ITT)|Reason Not Provided|0|||
105673362|NCT01865747|364466417|FG001|Overall Study (ITT)|Reason Not Provided|1|||
105673363|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
105673364|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
105673365|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
105673366|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
105673367|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
105673368|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
105673369|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
105673370|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
105673371|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
105673372|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
105673373|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
105673374|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
105673375|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
105673376|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
105673377|NCT01865747|364466416|FG000|Primary Intent to Treat (PITT)|Other|0|||
105673378|NCT01865747|364466417|FG001|Primary Intent to Treat (PITT)|Other|1|||
105673379|NCT01732822|364468223|FG000|Overall Study|Withdrawal by Subject|123|||
105673380|NCT01732822|364468224|FG001|Overall Study|Withdrawal by Subject|113|||
105673381|NCT03002220|364468228|FG000|Overall Study|Lack of Efficacy|2|||
105673382|NCT03002220|364468228|FG000|Overall Study|Withdrawal by Subject|3|||
105673383|NCT03002220|364468228|FG000|Overall Study|Adverse Event|2|||
105673384|NCT03002220|364468228|FG000|Overall Study|Disease progression|13|||
105673385|NCT03002220|364468228|FG000|Overall Study|Physician Decision|1|||
105673386|NCT01183260|364468229|FG000|Overall Study|Intraop screen failure|2|||
105673387|NCT01183260|364468230|FG001|Overall Study|Intraop screen failure|0|||
105673388|NCT01183260|364468229|FG000|Overall Study|Withdrawal by Subject|1|||
105673389|NCT01183260|364468230|FG001|Overall Study|Withdrawal by Subject|1|||
105673390|NCT01183260|364468229|FG000|Overall Study|Revised within 30 days|0|||
105673391|NCT01183260|364468230|FG001|Overall Study|Revised within 30 days|1|||
105673392|NCT01183260|364468229|FG000|Overall Study|Death|1|||
105673393|NCT01183260|364468230|FG001|Overall Study|Death|0|||
105673394|NCT00357110|364468233|FG000|Overall Study|Early study termination|5|||
105673395|NCT00357110|364468234|FG001|Overall Study|Early study termination|5|||
105673396|NCT01202903|364468236|FG000|Overall Study|Administrative Probelms|1|||
105673397|NCT01202903|364468237|FG001|Overall Study|Administrative Probelms|4|||
105673398|NCT01202903|364468236|FG000|Overall Study|Protocol Violation|0|||
105673399|NCT01202903|364468237|FG001|Overall Study|Protocol Violation|1|||
105673400|NCT01202903|364468236|FG000|Overall Study|Death|1|||
105673401|NCT01202903|364468237|FG001|Overall Study|Death|0|||
105673402|NCT01202903|364468236|FG000|Overall Study|Lost to Follow-up|1|||
105673403|NCT01202903|364468237|FG001|Overall Study|Lost to Follow-up|1|||
105673404|NCT01202903|364468236|FG000|Overall Study|Lack of Efficacy|1|||
105673405|NCT01202903|364468237|FG001|Overall Study|Lack of Efficacy|3|||
105673406|NCT01202903|364468236|FG000|Overall Study|Adverse Event|3|||
105673407|NCT01202903|364468237|FG001|Overall Study|Adverse Event|3|||
105909168|NCT01705080|365326630|FG001|Overall Study|Death|4|||
105909169|NCT01705080|365326631|FG002|Overall Study|Death|6|||
105673408|NCT01202903|364468236|FG000|Overall Study|Withdrawal by Subject|4|||
105673409|NCT01202903|364468237|FG001|Overall Study|Withdrawal by Subject|4|||
105673410|NCT01255631|364468239|FG000|Overall Study|poor enrollment, no data analyzed|9|||
105909170|NCT01705080|365326629|FG000|Overall Study|Withdrawal by Subject|61|||
105673411|NCT01255631|364468240|FG001|Overall Study|poor enrollment, no data analyzed|6|||
105673412|NCT00568178|364468250|FG000|Double Blind Base Study|Adverse Event|0|||
105673413|NCT00568178|364468251|FG001|Double Blind Base Study|Adverse Event|2|||
105673414|NCT00568178|364468252|FG002|Double Blind Base Study|Adverse Event|1|||
105673415|NCT00568178|364468253|FG003|Double Blind Base Study|Adverse Event|2|||
105673416|NCT00568178|364468254|FG004|Double Blind Base Study|Adverse Event|0|||
105673417|NCT00568178|364468255|FG005|Double Blind Base Study|Adverse Event|0|||
105673418|NCT00568178|364468250|FG000|Double Blind Base Study|Lost to Follow-up|1|||
105673419|NCT00568178|364468251|FG001|Double Blind Base Study|Lost to Follow-up|0|||
105673420|NCT00568178|364468252|FG002|Double Blind Base Study|Lost to Follow-up|0|||
105673421|NCT00568178|364468253|FG003|Double Blind Base Study|Lost to Follow-up|1|||
105673422|NCT00568178|364468254|FG004|Double Blind Base Study|Lost to Follow-up|0|||
105673423|NCT00568178|364468255|FG005|Double Blind Base Study|Lost to Follow-up|0|||
105673424|NCT00568178|364468250|FG000|Double Blind Base Study|Physician Decision|1|||
105673425|NCT00568178|364468251|FG001|Double Blind Base Study|Physician Decision|1|||
105673426|NCT00568178|364468252|FG002|Double Blind Base Study|Physician Decision|0|||
105673427|NCT00568178|364468253|FG003|Double Blind Base Study|Physician Decision|1|||
105673428|NCT00568178|364468254|FG004|Double Blind Base Study|Physician Decision|0|||
105673429|NCT00568178|364468255|FG005|Double Blind Base Study|Physician Decision|0|||
105673430|NCT00568178|364468250|FG000|Double Blind Base Study|Protocol Violation|3|||
105673431|NCT00568178|364468251|FG001|Double Blind Base Study|Protocol Violation|2|||
105673432|NCT00568178|364468252|FG002|Double Blind Base Study|Protocol Violation|0|||
105999428|NCT00452790|365659497|FG001|Infant Series|Investigator request|1|||
105999429|NCT00452790|365659496|FG000|Infant Series|Death|0|||
105999430|NCT00452790|365659497|FG001|Infant Series|Death|1|||
105999431|NCT00452790|365659496|FG000|After Infant Series|Investigator request|10|||
105999432|NCT00452790|365659497|FG001|After Infant Series|Investigator request|10|||
105999433|NCT00452790|365659496|FG000|After Infant Series|Adverse Event|4|||
105999434|NCT00452790|365659497|FG001|After Infant Series|Adverse Event|1|||
105999435|NCT00452790|365659496|FG000|After Infant Series|Parent/legal guardian request|1|||
105999436|NCT00452790|365659497|FG001|After Infant Series|Parent/legal guardian request|3|||
105999437|NCT00452790|365659496|FG000|After Infant Series|Lost to Follow-up|4|||
105999438|NCT00452790|365659497|FG001|After Infant Series|Lost to Follow-up|0|||
105999439|NCT00452790|365659496|FG000|After Infant Series|Failed to return|1|||
105999440|NCT00452790|365659497|FG001|After Infant Series|Failed to return|0|||
105999441|NCT00452790|365659496|FG000|After Infant Series|Other reasons|1|||
105999442|NCT00452790|365659497|FG001|After Infant Series|Other reasons|0|||
105999443|NCT00452790|365659496|FG000|Toddler Dose|Failed to return|0|||
105999444|NCT00452790|365659497|FG001|Toddler Dose|Failed to return|1|||
105999445|NCT00452790|365659496|FG000|Toddler Dose|Parent/legal guardian request|0|||
105999446|NCT00452790|365659497|FG001|Toddler Dose|Parent/legal guardian request|1|||
105999447|NCT02796677|365661122|FG000|Overall Study|Adverse Event|11|||
105999448|NCT02796677|365661123|FG001|Overall Study|Adverse Event|22|||
105999449|NCT02796677|365661124|FG002|Overall Study|Adverse Event|14|||
105999450|NCT02796677|365661125|FG003|Overall Study|Adverse Event|14|||
105673433|NCT00568178|364468253|FG003|Double Blind Base Study|Protocol Violation|0|||
105673434|NCT00568178|364468254|FG004|Double Blind Base Study|Protocol Violation|0|||
105673435|NCT00568178|364468255|FG005|Double Blind Base Study|Protocol Violation|0|||
105673436|NCT00568178|364468250|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
105673437|NCT00568178|364468251|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
105673438|NCT00568178|364468252|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
105673439|NCT00568178|364468253|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
105673440|NCT00568178|364468254|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
105673441|NCT00568178|364468255|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
105673442|NCT00568178|364468250|FG000|Double Blind Base Study|Progressive Disease|0|||
105673443|NCT00568178|364468251|FG001|Double Blind Base Study|Progressive Disease|0|||
105673444|NCT00568178|364468252|FG002|Double Blind Base Study|Progressive Disease|0|||
105673445|NCT00568178|364468253|FG003|Double Blind Base Study|Progressive Disease|1|||
105673446|NCT00568178|364468254|FG004|Double Blind Base Study|Progressive Disease|0|||
105673447|NCT00568178|364468255|FG005|Double Blind Base Study|Progressive Disease|0|||
105673448|NCT00568178|364468250|FG000|Open Label Extension|Adverse Event|0|||
105673449|NCT00568178|364468251|FG001|Open Label Extension|Adverse Event|0|||
105673450|NCT00568178|364468252|FG002|Open Label Extension|Adverse Event|0|||
105673451|NCT00568178|364468253|FG003|Open Label Extension|Adverse Event|0|||
105673452|NCT00568178|364468254|FG004|Open Label Extension|Adverse Event|11|||
105673453|NCT00568178|364468255|FG005|Open Label Extension|Adverse Event|8|||
105673454|NCT00568178|364468250|FG000|Open Label Extension|Protocol Violation|0|||
105673455|NCT00568178|364468251|FG001|Open Label Extension|Protocol Violation|0|||
105673456|NCT00568178|364468252|FG002|Open Label Extension|Protocol Violation|0|||
105673457|NCT00568178|364468253|FG003|Open Label Extension|Protocol Violation|0|||
105673458|NCT00568178|364468254|FG004|Open Label Extension|Protocol Violation|1|||
105673459|NCT00568178|364468255|FG005|Open Label Extension|Protocol Violation|0|||
105999451|NCT02796677|365661122|FG000|Overall Study|Protocol Violation|7|||
105999452|NCT02796677|365661123|FG001|Overall Study|Protocol Violation|5|||
105999453|NCT02796677|365661124|FG002|Overall Study|Protocol Violation|4|||
105673460|NCT00568178|364468250|FG000|Open Label Extension|Lost to Follow-up|0|||
105673461|NCT00568178|364468251|FG001|Open Label Extension|Lost to Follow-up|0|||
105673462|NCT00568178|364468252|FG002|Open Label Extension|Lost to Follow-up|0|||
105673463|NCT00568178|364468253|FG003|Open Label Extension|Lost to Follow-up|0|||
105673464|NCT00568178|364468254|FG004|Open Label Extension|Lost to Follow-up|6|||
105673465|NCT00568178|364468255|FG005|Open Label Extension|Lost to Follow-up|11|||
105999454|NCT02796677|365661125|FG003|Overall Study|Protocol Violation|8|||
105673466|NCT00568178|364468250|FG000|Open Label Extension|Physician Decision|0|||
105673467|NCT00568178|364468251|FG001|Open Label Extension|Physician Decision|0|||
105673468|NCT00568178|364468252|FG002|Open Label Extension|Physician Decision|0|||
105673469|NCT00568178|364468253|FG003|Open Label Extension|Physician Decision|0|||
105673470|NCT00568178|364468254|FG004|Open Label Extension|Physician Decision|9|||
105673471|NCT00568178|364468255|FG005|Open Label Extension|Physician Decision|8|||
105673472|NCT00568178|364468250|FG000|Open Label Extension|Pregnancy|0|||
105673473|NCT00568178|364468251|FG001|Open Label Extension|Pregnancy|0|||
105673474|NCT00568178|364468252|FG002|Open Label Extension|Pregnancy|0|||
105673475|NCT00568178|364468253|FG003|Open Label Extension|Pregnancy|0|||
105673476|NCT00568178|364468254|FG004|Open Label Extension|Pregnancy|0|||
105673477|NCT00568178|364468255|FG005|Open Label Extension|Pregnancy|1|||
105673478|NCT00568178|364468250|FG000|Open Label Extension|Progressive Disease|0|||
105673479|NCT00568178|364468251|FG001|Open Label Extension|Progressive Disease|0|||
105673480|NCT00568178|364468252|FG002|Open Label Extension|Progressive Disease|0|||
105673481|NCT00568178|364468253|FG003|Open Label Extension|Progressive Disease|0|||
105673482|NCT00568178|364468254|FG004|Open Label Extension|Progressive Disease|3|||
105673483|NCT00568178|364468255|FG005|Open Label Extension|Progressive Disease|1|||
105673484|NCT00568178|364468250|FG000|Open Label Extension|Termination of Trial|0|||
105673485|NCT00568178|364468251|FG001|Open Label Extension|Termination of Trial|0|||
105673486|NCT00568178|364468252|FG002|Open Label Extension|Termination of Trial|0|||
105673487|NCT00568178|364468253|FG003|Open Label Extension|Termination of Trial|0|||
105673488|NCT00568178|364468254|FG004|Open Label Extension|Termination of Trial|45|||
105673489|NCT00568178|364468255|FG005|Open Label Extension|Termination of Trial|47|||
105673490|NCT00568178|364468250|FG000|Open Label Extension|Withdrawal by Subject|0|||
105673491|NCT00568178|364468251|FG001|Open Label Extension|Withdrawal by Subject|0|||
105673492|NCT00568178|364468252|FG002|Open Label Extension|Withdrawal by Subject|0|||
105673493|NCT00568178|364468253|FG003|Open Label Extension|Withdrawal by Subject|0|||
105673494|NCT00568178|364468254|FG004|Open Label Extension|Withdrawal by Subject|4|||
105673495|NCT00568178|364468255|FG005|Open Label Extension|Withdrawal by Subject|4|||
105673496|NCT02311673|364468261|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
105673497|NCT02311673|364468262|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
105673498|NCT02311673|364468263|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
105673499|NCT02311673|364468264|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
105673500|NCT00095056|364468265|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
105673501|NCT00095056|364468266|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
105673502|NCT00095056|364468265|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
105673503|NCT00095056|364468266|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
105673504|NCT00095056|364468265|FG000|Phase A (Weeks 0-12)|Death|1|||
105673505|NCT00095056|364468266|FG001|Phase A (Weeks 0-12)|Death|0|||
105673506|NCT00095056|364468265|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
105673507|NCT00095056|364468266|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
105673508|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
105673509|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
105673510|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
105673511|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
105673512|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
105673513|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
105673514|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
105673515|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
105673516|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Death|3|||
105673517|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Death|1|||
105673518|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
105673519|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
105673520|NCT00095056|364468265|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
105673521|NCT00095056|364468266|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
105673522|NCT01332630|364468267|FG000|Overall Study|Withdrawal by Subject|3|||
105673523|NCT00490490|364468271|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
105673524|NCT00490490|364468271|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
105673525|NCT01638429|364468272|FG000|Overall Study|Withdrawal by Subject|1|||
105673526|NCT03207451|364468273|FG000|Overall Study|scheduling conflict|1|||
105673527|NCT03207451|364468274|FG001|Overall Study|scheduling conflict|0|||
105673528|NCT03207451|364468275|FG002|Overall Study|scheduling conflict|2|||
105673529|NCT03207451|364468276|FG003|Overall Study|scheduling conflict|2|||
105673530|NCT03207451|364468273|FG000|Overall Study|Adverse Event|0|||
105673531|NCT03207451|364468274|FG001|Overall Study|Adverse Event|0|||
105673532|NCT03207451|364468275|FG002|Overall Study|Adverse Event|0|||
105673533|NCT03207451|364468276|FG003|Overall Study|Adverse Event|1|||
105673534|NCT03482466|364468277|FG000|Overall Study|Protocol Violation|2|||
105673535|NCT01239043|364468278|FG000|Overall Study|Protocol Violation|2|||
105673536|NCT01239043|364468279|FG001|Overall Study|Protocol Violation|1|||
105673537|NCT05540717|364468280|FG000|Overall Study|Lost to Follow-up|2|||
105673538|NCT05540717|364468281|FG001|Overall Study|Lost to Follow-up|5|||
105673539|NCT05540717|364468280|FG000|Overall Study|Withdrawal by Subject|6|||
105673540|NCT05540717|364468281|FG001|Overall Study|Withdrawal by Subject|6|||
105673541|NCT05540717|364468280|FG000|Overall Study|Sponsor request|1|||
105673542|NCT05540717|364468281|FG001|Overall Study|Sponsor request|0|||
105673543|NCT05540717|364468280|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
105673544|NCT05540717|364468281|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
105673545|NCT05540717|364468280|FG000|Overall Study|Other|0|||
105673546|NCT05540717|364468281|FG001|Overall Study|Other|1|||
105673547|NCT01940939|364468282|FG000|Overall Study|Withdrawal by Subject|2|||
105673548|NCT01940939|364468283|FG001|Overall Study|Withdrawal by Subject|8|||
105673549|NCT01470001|364468284|FG000|Overall Study|Lost to Follow-up|1|||
105673550|NCT01470001|364468285|FG001|Overall Study|Lost to Follow-up|1|||
105673551|NCT01470001|364468284|FG000|Overall Study|Physician Decision|2|||
105673552|NCT01470001|364468285|FG001|Overall Study|Physician Decision|0|||
105673553|NCT01470001|364468284|FG000|Overall Study|Withdrawal by Subject|2|||
105673554|NCT01470001|364468285|FG001|Overall Study|Withdrawal by Subject|1|||
105673555|NCT02060370|364468288|FG000|Overall Study|Physician Decision|1|||
105673556|NCT03248882|364468289|FG000|Overall Study|Adverse Event|3|||
105673557|NCT03248882|364468290|FG001|Overall Study|Adverse Event|3|||
105673558|NCT03248882|364468291|FG002|Overall Study|Adverse Event|2|||
105673559|NCT03248882|364468292|FG003|Overall Study|Adverse Event|6|||
105673560|NCT03248882|364468293|FG004|Overall Study|Adverse Event|9|||
105673561|NCT03248882|364468289|FG000|Overall Study|Lost to Follow-up|0|||
105673562|NCT03248882|364468290|FG001|Overall Study|Lost to Follow-up|0|||
105673563|NCT03248882|364468291|FG002|Overall Study|Lost to Follow-up|0|||
105673564|NCT03248882|364468292|FG003|Overall Study|Lost to Follow-up|0|||
105673565|NCT03248882|364468293|FG004|Overall Study|Lost to Follow-up|1|||
105673566|NCT03248882|364468289|FG000|Overall Study|Protocol Violation|2|||
105673567|NCT03248882|364468290|FG001|Overall Study|Protocol Violation|0|||
105673568|NCT03248882|364468291|FG002|Overall Study|Protocol Violation|2|||
105673569|NCT03248882|364468292|FG003|Overall Study|Protocol Violation|0|||
105673570|NCT03248882|364468293|FG004|Overall Study|Protocol Violation|1|||
105673571|NCT03248882|364468289|FG000|Overall Study|Withdrawal by Subject|2|||
105673572|NCT03248882|364468290|FG001|Overall Study|Withdrawal by Subject|2|||
105673573|NCT03248882|364468291|FG002|Overall Study|Withdrawal by Subject|3|||
105673574|NCT03248882|364468292|FG003|Overall Study|Withdrawal by Subject|4|||
105673575|NCT03248882|364468293|FG004|Overall Study|Withdrawal by Subject|2|||
105673576|NCT02182947|364468294|FG000|Overall Study|Withdrawal by Subject|7|||
105673577|NCT02182947|364468294|FG000|Overall Study|Lost to Follow-up|3|||
105673578|NCT02182947|364468294|FG000|Overall Study|Failed screening activities|8|||
105673579|NCT03582943|364468295|FG000|Allocated to Groups|Withdrawal by Subject|1|||
105673580|NCT03582943|364468296|FG001|Allocated to Groups|Withdrawal by Subject|1|||
105673581|NCT03582943|364468295|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
105673582|NCT03582943|364468296|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
105673583|NCT03582943|364468295|FG000|Analyzed|Protocol Violation|4|||
105673584|NCT03582943|364468296|FG001|Analyzed|Protocol Violation|1|||
105673585|NCT01656200|364468299|FG000|Overall Study|Withdrawal by Subject|1|||
105673586|NCT02236988|364468300|FG000|Overall Study|Lost to Follow-up|0|||
105673587|NCT02236988|364468301|FG001|Overall Study|Lost to Follow-up|0|||
105673588|NCT02236988|364468302|FG002|Overall Study|Lost to Follow-up|0|||
105673589|NCT02236988|364468303|FG003|Overall Study|Lost to Follow-up|1|||
105673590|NCT02236988|364468300|FG000|Overall Study|Unable to Comply with Study Visits|0|||
105673591|NCT02236988|364468301|FG001|Overall Study|Unable to Comply with Study Visits|0|||
105673592|NCT02236988|364468302|FG002|Overall Study|Unable to Comply with Study Visits|0|||
105673593|NCT02236988|364468303|FG003|Overall Study|Unable to Comply with Study Visits|2|||
105786306|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Death|0|||
105786307|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Death|0|||
105786308|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Death|1|||
105786309|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Death|0|||
105786310|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Death|0|||
105673594|NCT00730275|364468304|FG000|Overall Study|Withdrawal by Subject|0|||
105673595|NCT00730275|364468305|FG001|Overall Study|Withdrawal by Subject|0|||
105673596|NCT00730275|364468306|FG002|Overall Study|Withdrawal by Subject|0|||
105673597|NCT00730275|364468307|FG003|Overall Study|Withdrawal by Subject|1|||
105673598|NCT00356408|364468308|FG000|Overall Study|Adverse Event|9|||
105673599|NCT00356408|364468308|FG000|Overall Study|Lack of Efficacy|36|||
105673600|NCT00356408|364468308|FG000|Overall Study|Lost to Follow-up|2|||
105673601|NCT00356408|364468308|FG000|Overall Study|Withdrawal by Subject|6|||
105673602|NCT00356408|364468308|FG000|Overall Study|Other: Principal investigator discretion|3|||
105673603|NCT00356408|364468308|FG000|Overall Study|Other: Sponsor request|1|||
105673604|NCT00356408|364468308|FG000|Overall Study|Other: Azathioprine stopped|1|||
105673605|NCT00356408|364468308|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
105909171|NCT01705080|365326630|FG001|Overall Study|Withdrawal by Subject|44|||
105909172|NCT01705080|365326631|FG002|Overall Study|Withdrawal by Subject|9|||
105673606|NCT00356408|364468308|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
105673607|NCT04032613|364468310|FG000|Overall Study|Did not complete post-program assessment|5|||
105673608|NCT04032613|364468311|FG001|Overall Study|Did not complete post-program assessment|2|||
105673609|NCT04488770|364468312|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673610|NCT04488770|364468313|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673611|NCT04488770|364468314|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673612|NCT04488770|364468315|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
105673613|NCT04488770|364468316|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673614|NCT04488770|364468317|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673615|NCT04488770|364468318|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673616|NCT04488770|364468319|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673617|NCT04488770|364468320|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673618|NCT04488770|364468321|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673619|NCT04488770|364468322|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673620|NCT04488770|364468323|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673621|NCT04488770|364468324|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
105673622|NCT04488770|364468312|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
105673623|NCT04488770|364468313|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673624|NCT04488770|364468314|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673625|NCT04488770|364468315|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673626|NCT04488770|364468316|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673627|NCT04488770|364468317|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673628|NCT04488770|364468318|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673629|NCT04488770|364468319|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673630|NCT04488770|364468320|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673631|NCT04488770|364468321|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673632|NCT04488770|364468322|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673633|NCT04488770|364468323|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673634|NCT04488770|364468324|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
105673635|NCT04488770|364468312|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673636|NCT04488770|364468313|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673637|NCT04488770|364468314|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673638|NCT04488770|364468315|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673639|NCT04488770|364468316|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673640|NCT04488770|364468317|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
105673641|NCT04488770|364468318|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
105673642|NCT04488770|364468319|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673643|NCT04488770|364468320|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673644|NCT04488770|364468321|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673645|NCT04488770|364468322|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673646|NCT04488770|364468323|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673647|NCT04488770|364468324|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
105673648|NCT04488770|364468312|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673649|NCT04488770|364468313|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673650|NCT04488770|364468314|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673651|NCT04488770|364468315|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673652|NCT04488770|364468316|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
105673653|NCT04488770|364468317|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673654|NCT04488770|364468318|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673655|NCT04488770|364468319|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673656|NCT04488770|364468320|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673657|NCT04488770|364468321|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673658|NCT04488770|364468322|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673659|NCT04488770|364468323|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673660|NCT04488770|364468324|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
105673661|NCT01867333|364468325|FG000|Overall Study|Withdrawal by Subject|1|||
105786311|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
105786312|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786313|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
105909173|NCT00113295|365326633|FG000|Overall Study|Adverse Event|4|||
105909174|NCT00113295|365326634|FG001|Overall Study|Adverse Event|1|||
105909175|NCT00113295|365326633|FG000|Overall Study|Unrelated Medical Illness|1|||
105909176|NCT00113295|365326634|FG001|Overall Study|Unrelated Medical Illness|0|||
105909177|NCT03130959|365326635|FG000|Overall Study|Disease progression|19|||
105909178|NCT03130959|365326636|FG001|Overall Study|Disease progression|7|||
105909179|NCT03130959|365326637|FG002|Overall Study|Disease progression|12|||
105909180|NCT03130959|365326638|FG003|Overall Study|Disease progression|7|||
105673662|NCT01867333|364468326|FG001|Overall Study|Withdrawal by Subject|0|||
105673663|NCT01867333|364468325|FG000|Overall Study|Adverse Event|1|||
105673664|NCT01867333|364468326|FG001|Overall Study|Adverse Event|0|||
105673665|NCT01867333|364468325|FG000|Overall Study|Participant choice|1|||
105673666|NCT01867333|364468326|FG001|Overall Study|Participant choice|2|||
105673667|NCT01867333|364468325|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
105673668|NCT01867333|364468326|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
105673669|NCT01867333|364468325|FG000|Overall Study|Death|0|||
105673670|NCT01867333|364468326|FG001|Overall Study|Death|1|||
105673671|NCT01867333|364468325|FG000|Overall Study|Physician Decision|3|||
105673672|NCT01867333|364468326|FG001|Overall Study|Physician Decision|2|||
105673673|NCT01867333|364468325|FG000|Overall Study|Switched to alternative treatment|1|||
105673674|NCT01867333|364468326|FG001|Overall Study|Switched to alternative treatment|0|||
105673675|NCT02075073|364468327|FG000|Overall Study|Withdrawal by Subject|0|||
105673676|NCT02075073|364468328|FG001|Overall Study|Withdrawal by Subject|1|||
105673677|NCT02075073|364468329|FG002|Overall Study|Withdrawal by Subject|0|||
105673678|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Adverse Event|1|||
105673679|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Adverse Event|1|||
105673680|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Adverse Event|2|||
105673681|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Adverse Event|5|||
105673682|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Adverse Event|0|||
105673683|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
105673684|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
105673685|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
105673686|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
105673687|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
105673688|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
105673689|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
105673690|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
105673691|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
105673692|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
105673693|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
105673694|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
105673695|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
105673696|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
105673697|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
105673698|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
105673699|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
105673700|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
105673701|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
105673702|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
105673703|NCT00951015|364468345|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
105673704|NCT00951015|364468346|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
105673705|NCT00951015|364468347|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
105673706|NCT00951015|364468348|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
105673707|NCT00951015|364468349|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
105673708|NCT00951015|364468345|FG000|Open-label Phase|Adverse Event|0|||
105673709|NCT00951015|364468346|FG001|Open-label Phase|Adverse Event|0|||
105673710|NCT00951015|364468347|FG002|Open-label Phase|Adverse Event|0|||
105673711|NCT00951015|364468348|FG003|Open-label Phase|Adverse Event|0|||
105673712|NCT00951015|364468349|FG004|Open-label Phase|Adverse Event|3|||
105673713|NCT00951015|364468345|FG000|Open-label Phase|Lack of Efficacy|0|||
105673714|NCT00951015|364468346|FG001|Open-label Phase|Lack of Efficacy|0|||
105673715|NCT00951015|364468347|FG002|Open-label Phase|Lack of Efficacy|0|||
105673716|NCT00951015|364468348|FG003|Open-label Phase|Lack of Efficacy|0|||
105673717|NCT00951015|364468349|FG004|Open-label Phase|Lack of Efficacy|1|||
105673718|NCT00951015|364468345|FG000|Open-label Phase|Protocol Violation|0|||
105673719|NCT00951015|364468346|FG001|Open-label Phase|Protocol Violation|0|||
105673720|NCT00951015|364468347|FG002|Open-label Phase|Protocol Violation|0|||
105673721|NCT00951015|364468348|FG003|Open-label Phase|Protocol Violation|0|||
105673722|NCT00951015|364468349|FG004|Open-label Phase|Protocol Violation|12|||
105673723|NCT00951015|364468345|FG000|Open-label Phase|Lost to Follow-up|0|||
105673724|NCT00951015|364468346|FG001|Open-label Phase|Lost to Follow-up|0|||
105673725|NCT00951015|364468347|FG002|Open-label Phase|Lost to Follow-up|0|||
105673726|NCT00951015|364468348|FG003|Open-label Phase|Lost to Follow-up|0|||
105673727|NCT00951015|364468349|FG004|Open-label Phase|Lost to Follow-up|12|||
105673728|NCT00951015|364468345|FG000|Open-label Phase|Withdrawal by Subject|0|||
105673729|NCT00951015|364468346|FG001|Open-label Phase|Withdrawal by Subject|0|||
105673730|NCT00951015|364468347|FG002|Open-label Phase|Withdrawal by Subject|0|||
105673731|NCT00951015|364468348|FG003|Open-label Phase|Withdrawal by Subject|0|||
105673732|NCT00951015|364468349|FG004|Open-label Phase|Withdrawal by Subject|14|||
105673733|NCT00951015|364468345|FG000|Open-label Phase|Physician Decision|0|||
105673734|NCT00951015|364468346|FG001|Open-label Phase|Physician Decision|0|||
105673735|NCT00951015|364468347|FG002|Open-label Phase|Physician Decision|0|||
105673736|NCT00951015|364468348|FG003|Open-label Phase|Physician Decision|0|||
105673737|NCT00951015|364468349|FG004|Open-label Phase|Physician Decision|8|||
105673738|NCT01208103|364468350|FG000|Overall Study|Adverse Event|1|||
105673739|NCT01208103|364468350|FG000|Overall Study|Withdrawal by Subject|1|||
105673740|NCT02530970|364468352|FG000|Overall Study|Adverse Event|8|||
105673741|NCT02530970|364468352|FG000|Overall Study|Lost to Follow-up|88|||
105673742|NCT02530970|364468352|FG000|Overall Study|Physician Decision|5|||
105673743|NCT02530970|364468352|FG000|Overall Study|Withdrawal by Subject|14|||
105673744|NCT02530970|364468352|FG000|Overall Study|Death|6|||
105673745|NCT02530970|364468352|FG000|Overall Study|Hospitalization|1|||
105673746|NCT02530970|364468352|FG000|Overall Study|Insurance|2|||
105673747|NCT02530970|364468352|FG000|Overall Study|Explant|2|||
105673748|NCT02530970|364468352|FG000|Overall Study|Change in Provider|5|||
105673749|NCT02530970|364468352|FG000|Overall Study|Relocation|3|||
105673750|NCT02770612|364468353|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
105673751|NCT01416389|364468354|FG000|Overall Study|Lost to Follow-up|1|||
105673752|NCT01416389|364468355|FG001|Overall Study|Lost to Follow-up|0|||
105673753|NCT01416389|364468354|FG000|Overall Study|Started New Therapy|2|||
105673754|NCT01416389|364468355|FG001|Overall Study|Started New Therapy|0|||
105673755|NCT01012414|364468372|FG000|Overall Study|Withdrawal by Subject|2|||
105673756|NCT01012414|364468372|FG000|Overall Study|Lost to Follow-up|1|||
105673757|NCT01012414|364468372|FG000|Overall Study|Trial was stopped before completed|7|||
105673758|NCT02310100|364468373|FG000|Overall Study|Physician Decision|3|||
105673759|NCT02310100|364468373|FG000|Overall Study|Withdrawal by Subject|10|||
105673760|NCT02310100|364468373|FG000|Overall Study|Enrollment closure|1|||
105673761|NCT02310100|364468373|FG000|Overall Study|Unapproved ablation operator|1|||
105673762|NCT02310100|364468373|FG000|Overall Study|Visit compliance|1|||
105673763|NCT02310100|364468373|FG000|Overall Study|Lost to Follow-up|2|||
105673764|NCT04165031|364470438|FG000|Overall Study|Adverse Event|1|||
105673765|NCT04165031|364470439|FG001|Overall Study|Adverse Event|1|||
105673766|NCT04165031|364470440|FG002|Overall Study|Adverse Event|0|||
105673767|NCT04165031|364470441|FG003|Overall Study|Adverse Event|0|||
105673768|NCT04165031|364470442|FG004|Overall Study|Adverse Event|0|||
105673769|NCT04165031|364470443|FG005|Overall Study|Adverse Event|0|||
105673770|NCT04165031|364470438|FG000|Overall Study|Withdrawal by Subject|0|||
105673771|NCT04165031|364470439|FG001|Overall Study|Withdrawal by Subject|0|||
105673772|NCT04165031|364470440|FG002|Overall Study|Withdrawal by Subject|1|||
105673773|NCT04165031|364470441|FG003|Overall Study|Withdrawal by Subject|0|||
105673774|NCT04165031|364470442|FG004|Overall Study|Withdrawal by Subject|0|||
105673775|NCT04165031|364470443|FG005|Overall Study|Withdrawal by Subject|0|||
105673776|NCT02731690|364470444|FG000|Overall Study|Adverse Event|1|||
105673777|NCT02731690|364470444|FG000|Overall Study|Withdrawal by Subject|3|||
105673778|NCT02731690|364470444|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
105909181|NCT03130959|365326639|FG004|Overall Study|Disease progression|12|||
105909182|NCT03130959|365326640|FG005|Overall Study|Disease progression|3|||
105909183|NCT03130959|365326641|FG006|Overall Study|Disease progression|6|||
105909184|NCT03130959|365326642|FG007|Overall Study|Disease progression|3|||
105909185|NCT03130959|365326643|FG008|Overall Study|Disease progression|15|||
105909186|NCT03130959|365326644|FG009|Overall Study|Disease progression|8|||
105909187|NCT03130959|365326635|FG000|Overall Study|Study drug toxicity|2|||
105909188|NCT03130959|365326636|FG001|Overall Study|Study drug toxicity|2|||
105909189|NCT03130959|365326637|FG002|Overall Study|Study drug toxicity|1|||
105909190|NCT03130959|365326638|FG003|Overall Study|Study drug toxicity|2|||
105909191|NCT03130959|365326639|FG004|Overall Study|Study drug toxicity|1|||
105909192|NCT03130959|365326640|FG005|Overall Study|Study drug toxicity|1|||
105909193|NCT03130959|365326641|FG006|Overall Study|Study drug toxicity|3|||
105909194|NCT03130959|365326642|FG007|Overall Study|Study drug toxicity|0|||
105909195|NCT03130959|365326643|FG008|Overall Study|Study drug toxicity|3|||
105909196|NCT03130959|365326644|FG009|Overall Study|Study drug toxicity|3|||
105909197|NCT03130959|365326635|FG000|Overall Study|Other reasons|0|||
105909198|NCT03130959|365326636|FG001|Overall Study|Other reasons|0|||
105909199|NCT03130959|365326637|FG002|Overall Study|Other reasons|0|||
105673779|NCT02735577|364470445|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
105909200|NCT03130959|365326638|FG003|Overall Study|Other reasons|0|||
105909201|NCT03130959|365326639|FG004|Overall Study|Other reasons|0|||
105909202|NCT03130959|365326640|FG005|Overall Study|Other reasons|1|||
105673780|NCT02735577|364470445|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
105673781|NCT02040259|364470456|FG000|Overall Study|Death|280|||
105673782|NCT02040259|364470456|FG000|Overall Study|Lost to Follow-up|76|||
105673783|NCT02040259|364470456|FG000|Overall Study|Assessment not completed|3|||
105673784|NCT02040259|364470456|FG000|Overall Study|Withdrawal by Subject|4|||
105673785|NCT00316602|364470458|FG000|Overall Study|Withdrawal by Subject|3|||
105673786|NCT00316602|364470459|FG001|Overall Study|Withdrawal by Subject|2|||
105673787|NCT00316602|364470458|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
105909203|NCT03130959|365326641|FG006|Overall Study|Other reasons|1|||
105909204|NCT03130959|365326642|FG007|Overall Study|Other reasons|0|||
105909205|NCT03130959|365326643|FG008|Overall Study|Other reasons|0|||
105909206|NCT03130959|365326644|FG009|Overall Study|Other reasons|0|||
105909207|NCT03130959|365326635|FG000|Overall Study|Subject request to discontinue therapy|0|||
105673788|NCT00316602|364470459|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
105673789|NCT00316602|364470458|FG000|Overall Study|Adverse Event|1|||
105673790|NCT00316602|364470459|FG001|Overall Study|Adverse Event|0|||
105673791|NCT00316602|364470458|FG000|Overall Study|Other|3|||
105673792|NCT00316602|364470459|FG001|Overall Study|Other|6|||
105673793|NCT01142232|364470460|FG000|Overall Study|Adverse Event|1|||
105673794|NCT01142232|364470461|FG001|Overall Study|Adverse Event|2|||
105673795|NCT01142232|364470462|FG002|Overall Study|Adverse Event|1|||
105673796|NCT01142232|364470463|FG003|Overall Study|Adverse Event|0|||
105673797|NCT01142232|364470464|FG004|Overall Study|Adverse Event|4|||
105673798|NCT01142232|364470460|FG000|Overall Study|Death|0|||
105673799|NCT01142232|364470461|FG001|Overall Study|Death|0|||
105673800|NCT01142232|364470462|FG002|Overall Study|Death|0|||
105673801|NCT01142232|364470463|FG003|Overall Study|Death|0|||
105673802|NCT01142232|364470464|FG004|Overall Study|Death|1|||
105673803|NCT01142232|364470460|FG000|Overall Study|Disease Progression|2|||
105673804|NCT01142232|364470461|FG001|Overall Study|Disease Progression|0|||
105673805|NCT01142232|364470462|FG002|Overall Study|Disease Progression|1|||
105673806|NCT01142232|364470463|FG003|Overall Study|Disease Progression|2|||
105673807|NCT01142232|364470464|FG004|Overall Study|Disease Progression|12|||
105673808|NCT01142232|364470460|FG000|Overall Study|Withdrawal by Subject|0|||
105673809|NCT01142232|364470461|FG001|Overall Study|Withdrawal by Subject|0|||
105673810|NCT01142232|364470462|FG002|Overall Study|Withdrawal by Subject|0|||
105673811|NCT01142232|364470463|FG003|Overall Study|Withdrawal by Subject|1|||
105673812|NCT01142232|364470464|FG004|Overall Study|Withdrawal by Subject|3|||
105673813|NCT01142232|364470460|FG000|Overall Study|Physician Decision|0|||
105673814|NCT01142232|364470461|FG001|Overall Study|Physician Decision|1|||
105673815|NCT01142232|364470462|FG002|Overall Study|Physician Decision|0|||
105673816|NCT01142232|364470463|FG003|Overall Study|Physician Decision|2|||
105673817|NCT01142232|364470464|FG004|Overall Study|Physician Decision|10|||
105673818|NCT01142232|364470460|FG000|Overall Study|Alternative Therapy|0|||
105673819|NCT01142232|364470461|FG001|Overall Study|Alternative Therapy|1|||
105673820|NCT01142232|364470462|FG002|Overall Study|Alternative Therapy|1|||
105673821|NCT01142232|364470463|FG003|Overall Study|Alternative Therapy|0|||
105673822|NCT01142232|364470464|FG004|Overall Study|Alternative Therapy|1|||
105673823|NCT01142232|364470460|FG000|Overall Study|Off Trt for other complicating disease|0|||
105673824|NCT01142232|364470461|FG001|Overall Study|Off Trt for other complicating disease|0|||
105673825|NCT01142232|364470462|FG002|Overall Study|Off Trt for other complicating disease|0|||
105673826|NCT01142232|364470463|FG003|Overall Study|Off Trt for other complicating disease|0|||
105673827|NCT01142232|364470464|FG004|Overall Study|Off Trt for other complicating disease|1|||
105673828|NCT01142232|364470460|FG000|Overall Study|Noncompliance|0|||
105673829|NCT01142232|364470461|FG001|Overall Study|Noncompliance|0|||
105673830|NCT01142232|364470462|FG002|Overall Study|Noncompliance|0|||
105673831|NCT01142232|364470463|FG003|Overall Study|Noncompliance|0|||
105673832|NCT01142232|364470464|FG004|Overall Study|Noncompliance|2|||
105673833|NCT05262517|364470466|FG000|Overall Study|Randomized but not treated|5|||
105673834|NCT05262517|364470467|FG001|Overall Study|Randomized but not treated|11|||
105673835|NCT01659853|364470474|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
105673836|NCT01659853|364470475|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
105673837|NCT01659853|364470474|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
105673838|NCT01659853|364470475|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
105673839|NCT03053518|364470479|FG000|Overall Study|Withdrawal by Subject|3|||
105673840|NCT03053518|364470479|FG000|Overall Study|Lost to Follow-up|2|||
105673841|NCT03053518|364470479|FG000|Overall Study|Ineligible|5|||
105673842|NCT01156376|364470480|FG000|Overall Study|Adverse Event|1|||
105673843|NCT01156376|364470481|FG001|Overall Study|Adverse Event|0|||
105673844|NCT01156376|364470482|FG002|Overall Study|Adverse Event|1|||
105673845|NCT01156376|364470480|FG000|Overall Study|Withdrawal by Subject|0|||
105673846|NCT01156376|364470481|FG001|Overall Study|Withdrawal by Subject|0|||
105673847|NCT01156376|364470482|FG002|Overall Study|Withdrawal by Subject|3|||
105673848|NCT05775991|364470483|FG000|Overall Study|Withdrawal by Subject|0|||
105673849|NCT05775991|364470484|FG001|Overall Study|Withdrawal by Subject|0|||
105673850|NCT05775991|364470485|FG002|Overall Study|Withdrawal by Subject|2|||
105673851|NCT01072630|364470486|FG000|Overall Study|Adverse Event|11|||
105673852|NCT01072630|364470487|FG001|Overall Study|Adverse Event|19|||
105673853|NCT01072630|364470488|FG002|Overall Study|Adverse Event|2|||
105673854|NCT01072630|364470486|FG000|Overall Study|Lack of Efficacy|10|||
105673855|NCT01072630|364470487|FG001|Overall Study|Lack of Efficacy|10|||
105673856|NCT01072630|364470488|FG002|Overall Study|Lack of Efficacy|1|||
105673857|NCT01072630|364470486|FG000|Overall Study|Withdrawal by Subject|8|||
105673858|NCT01072630|364470487|FG001|Overall Study|Withdrawal by Subject|7|||
105673859|NCT01072630|364470488|FG002|Overall Study|Withdrawal by Subject|2|||
105673860|NCT01072630|364470486|FG000|Overall Study|Protocol Violation|10|||
105673861|NCT01072630|364470487|FG001|Overall Study|Protocol Violation|8|||
105673862|NCT01072630|364470488|FG002|Overall Study|Protocol Violation|4|||
105673863|NCT01072630|364470486|FG000|Overall Study|Lost to Follow-up|11|||
105999455|NCT02796677|365661122|FG000|Overall Study|Lost to Follow-up|1|||
105673864|NCT01072630|364470487|FG001|Overall Study|Lost to Follow-up|11|||
105673865|NCT01072630|364470488|FG002|Overall Study|Lost to Follow-up|1|||
105673866|NCT01072630|364470486|FG000|Overall Study|Noncompliance with study medication|1|||
105673867|NCT01072630|364470487|FG001|Overall Study|Noncompliance with study medication|1|||
105673868|NCT01072630|364470488|FG002|Overall Study|Noncompliance with study medication|1|||
105673869|NCT01072630|364470486|FG000|Overall Study|Noncompliance with study procedures|1|||
105673870|NCT01072630|364470487|FG001|Overall Study|Noncompliance with study procedures|2|||
105673871|NCT01072630|364470488|FG002|Overall Study|Noncompliance with study procedures|1|||
105673872|NCT01072630|364470486|FG000|Overall Study|Other|3|||
105673873|NCT01072630|364470487|FG001|Overall Study|Other|2|||
105673874|NCT01072630|364470488|FG002|Overall Study|Other|1|||
105673875|NCT03214640|364470489|FG000|Overall Study|Protocol Violation|1|||
105673876|NCT03214640|364470490|FG001|Overall Study|Protocol Violation|2|||
105673877|NCT03214640|364470491|FG002|Overall Study|Protocol Violation|1|||
105673878|NCT03214640|364470492|FG003|Overall Study|Protocol Violation|4|||
105673879|NCT04514510|364470495|FG000|Overall Study|Lost to Follow-up|0|||
105673880|NCT04514510|364470496|FG001|Overall Study|Lost to Follow-up|1|||
105673881|NCT04514510|364470495|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
105673882|NCT04514510|364470496|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
105673883|NCT01365481|364470501|FG000|Overall Study|Adverse Event|6|||
105673884|NCT01365481|364470502|FG001|Overall Study|Adverse Event|9|||
105673885|NCT01365481|364470503|FG002|Overall Study|Adverse Event|0|||
105673886|NCT01365481|364470504|FG003|Overall Study|Adverse Event|2|||
105673887|NCT01365481|364470501|FG000|Overall Study|Withdrawal by Subject|0|||
105673888|NCT01365481|364470502|FG001|Overall Study|Withdrawal by Subject|2|||
105673889|NCT01365481|364470503|FG002|Overall Study|Withdrawal by Subject|1|||
105909208|NCT03130959|365326636|FG001|Overall Study|Subject request to discontinue therapy|0|||
105909209|NCT03130959|365326637|FG002|Overall Study|Subject request to discontinue therapy|1|||
105673890|NCT01365481|364470504|FG003|Overall Study|Withdrawal by Subject|1|||
105673891|NCT01365481|364470501|FG000|Overall Study|Lost to Follow-up|1|||
105909210|NCT03130959|365326638|FG003|Overall Study|Subject request to discontinue therapy|1|||
105909211|NCT03130959|365326639|FG004|Overall Study|Subject request to discontinue therapy|0|||
105909212|NCT03130959|365326640|FG005|Overall Study|Subject request to discontinue therapy|0|||
105909213|NCT03130959|365326641|FG006|Overall Study|Subject request to discontinue therapy|1|||
105909214|NCT03130959|365326642|FG007|Overall Study|Subject request to discontinue therapy|1|||
105909215|NCT03130959|365326643|FG008|Overall Study|Subject request to discontinue therapy|0|||
105909216|NCT03130959|365326644|FG009|Overall Study|Subject request to discontinue therapy|0|||
105909217|NCT03130959|365326635|FG000|Overall Study|Not reported|0|||
105909218|NCT03130959|365326636|FG001|Overall Study|Not reported|0|||
105909219|NCT03130959|365326637|FG002|Overall Study|Not reported|0|||
105909220|NCT03130959|365326638|FG003|Overall Study|Not reported|1|||
105909221|NCT03130959|365326639|FG004|Overall Study|Not reported|0|||
105909222|NCT03130959|365326640|FG005|Overall Study|Not reported|1|||
105909223|NCT03130959|365326641|FG006|Overall Study|Not reported|0|||
105909224|NCT03130959|365326642|FG007|Overall Study|Not reported|0|||
105909225|NCT03130959|365326643|FG008|Overall Study|Not reported|0|||
105909226|NCT03130959|365326644|FG009|Overall Study|Not reported|1|||
105909227|NCT03130959|365326635|FG000|Overall Study|Adverse Event unrelated to drug|0|||
105909228|NCT03130959|365326636|FG001|Overall Study|Adverse Event unrelated to drug|0|||
105909229|NCT03130959|365326637|FG002|Overall Study|Adverse Event unrelated to drug|1|||
105909230|NCT03130959|365326638|FG003|Overall Study|Adverse Event unrelated to drug|1|||
105909231|NCT03130959|365326639|FG004|Overall Study|Adverse Event unrelated to drug|1|||
105909232|NCT03130959|365326640|FG005|Overall Study|Adverse Event unrelated to drug|0|||
105909233|NCT03130959|365326641|FG006|Overall Study|Adverse Event unrelated to drug|1|||
105909234|NCT03130959|365326642|FG007|Overall Study|Adverse Event unrelated to drug|0|||
105909235|NCT03130959|365326643|FG008|Overall Study|Adverse Event unrelated to drug|1|||
105909236|NCT03130959|365326644|FG009|Overall Study|Adverse Event unrelated to drug|1|||
105909237|NCT03130959|365326635|FG000|Overall Study|Participant withdrew consent|0|||
105909238|NCT03130959|365326636|FG001|Overall Study|Participant withdrew consent|1|||
105909239|NCT03130959|365326637|FG002|Overall Study|Participant withdrew consent|0|||
105909240|NCT03130959|365326638|FG003|Overall Study|Participant withdrew consent|2|||
105909241|NCT03130959|365326639|FG004|Overall Study|Participant withdrew consent|1|||
105909242|NCT03130959|365326640|FG005|Overall Study|Participant withdrew consent|0|||
105909243|NCT03130959|365326641|FG006|Overall Study|Participant withdrew consent|0|||
105909244|NCT03130959|365326642|FG007|Overall Study|Participant withdrew consent|0|||
105909245|NCT03130959|365326643|FG008|Overall Study|Participant withdrew consent|0|||
105909246|NCT03130959|365326644|FG009|Overall Study|Participant withdrew consent|2|||
105909247|NCT03130959|365326635|FG000|Overall Study|Administrative reason by sponsor|1|||
105909248|NCT03130959|365326636|FG001|Overall Study|Administrative reason by sponsor|0|||
105673892|NCT01365481|364470502|FG001|Overall Study|Lost to Follow-up|1|||
105673893|NCT01365481|364470503|FG002|Overall Study|Lost to Follow-up|2|||
105673894|NCT01365481|364470504|FG003|Overall Study|Lost to Follow-up|3|||
105909249|NCT03130959|365326637|FG002|Overall Study|Administrative reason by sponsor|1|||
105909250|NCT03130959|365326638|FG003|Overall Study|Administrative reason by sponsor|0|||
105909251|NCT03130959|365326639|FG004|Overall Study|Administrative reason by sponsor|0|||
105999456|NCT02796677|365661123|FG001|Overall Study|Lost to Follow-up|5|||
105673895|NCT01365481|364470501|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105673896|NCT01365481|364470502|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105999457|NCT02796677|365661124|FG002|Overall Study|Lost to Follow-up|2|||
105999458|NCT02796677|365661125|FG003|Overall Study|Lost to Follow-up|2|||
105999459|NCT02796677|365661122|FG000|Overall Study|Lack of Efficacy|7|||
105999460|NCT02796677|365661123|FG001|Overall Study|Lack of Efficacy|9|||
105999461|NCT02796677|365661124|FG002|Overall Study|Lack of Efficacy|14|||
105999462|NCT02796677|365661125|FG003|Overall Study|Lack of Efficacy|20|||
105999463|NCT02796677|365661122|FG000|Overall Study|Withdrawal by Subject|4|||
105999464|NCT02796677|365661123|FG001|Overall Study|Withdrawal by Subject|14|||
105999465|NCT02796677|365661124|FG002|Overall Study|Withdrawal by Subject|6|||
105999466|NCT02796677|365661125|FG003|Overall Study|Withdrawal by Subject|7|||
105999467|NCT02796677|365661122|FG000|Overall Study|Progressive disease|6|||
105999468|NCT02796677|365661123|FG001|Overall Study|Progressive disease|15|||
105999469|NCT02796677|365661124|FG002|Overall Study|Progressive disease|13|||
105999470|NCT02796677|365661125|FG003|Overall Study|Progressive disease|18|||
105673897|NCT01365481|364470503|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105673898|NCT01365481|364470504|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105673899|NCT01365481|364470501|FG000|Overall Study|Administrative problems|0|||
105673900|NCT01365481|364470502|FG001|Overall Study|Administrative problems|1|||
105673901|NCT01365481|364470503|FG002|Overall Study|Administrative problems|0|||
105673902|NCT01365481|364470504|FG003|Overall Study|Administrative problems|0|||
105673903|NCT01365481|364470501|FG000|Overall Study|Protocol deviation|0|||
105673904|NCT01365481|364470502|FG001|Overall Study|Protocol deviation|1|||
105673905|NCT01365481|364470503|FG002|Overall Study|Protocol deviation|0|||
105673906|NCT01365481|364470504|FG003|Overall Study|Protocol deviation|1|||
105673907|NCT01365481|364470501|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105673908|NCT01365481|364470502|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105673909|NCT01365481|364470503|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
105673910|NCT01365481|364470504|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105673911|NCT02535091|364470511|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
105673912|NCT02535091|364470512|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
105673913|NCT02535091|364470513|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
105673914|NCT02535091|364470511|FG000|Overall Study|Withdrawal by Subject|14|||
105673915|NCT02535091|364470512|FG001|Overall Study|Withdrawal by Subject|5|||
105673916|NCT02535091|364470513|FG002|Overall Study|Withdrawal by Subject|121|||
105673917|NCT02535091|364470511|FG000|Overall Study|Adverse Event|9|||
105673918|NCT02535091|364470512|FG001|Overall Study|Adverse Event|4|||
105673919|NCT02535091|364470513|FG002|Overall Study|Adverse Event|170|||
105673920|NCT02535091|364470511|FG000|Overall Study|Other|4|||
105673921|NCT02535091|364470512|FG001|Overall Study|Other|3|||
105673922|NCT02535091|364470513|FG002|Overall Study|Other|81|||
105673923|NCT02535091|364470511|FG000|Overall Study|Lost to Follow-up|0|||
105673924|NCT02535091|364470512|FG001|Overall Study|Lost to Follow-up|1|||
105673925|NCT02535091|364470513|FG002|Overall Study|Lost to Follow-up|19|||
105673926|NCT02535091|364470511|FG000|Overall Study|Protocol Violation|0|||
105673927|NCT02535091|364470512|FG001|Overall Study|Protocol Violation|1|||
105673928|NCT02535091|364470513|FG002|Overall Study|Protocol Violation|11|||
105673929|NCT02535091|364470511|FG000|Overall Study|Pregnancy|0|||
105673930|NCT02535091|364470512|FG001|Overall Study|Pregnancy|0|||
105673931|NCT02535091|364470513|FG002|Overall Study|Pregnancy|7|||
105673932|NCT03459443|364470533|FG000|Overall Study|Lack of Efficacy|3|||
105673933|NCT03459443|364470533|FG000|Overall Study|Adverse Event|1|||
105673934|NCT03459443|364470533|FG000|Overall Study|Sponsor's decision to close the study|18|||
105673935|NCT02153073|364470534|FG000|Overall Study|Case Report Forms Uncollected|230|||
105673936|NCT02153073|364470534|FG000|Overall Study|Protocol Deviation|68|||
105673937|NCT03291288|364470535|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
105673938|NCT03291288|364470536|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
105673939|NCT03291288|364470535|FG000|Drug-drug Interaction Phase|Disease progression|1|||
105999471|NCT02796677|365661122|FG000|Overall Study|Reason not mentioned|2|||
105999472|NCT02796677|365661123|FG001|Overall Study|Reason not mentioned|3|||
105999473|NCT02796677|365661124|FG002|Overall Study|Reason not mentioned|0|||
105999474|NCT02796677|365661125|FG003|Overall Study|Reason not mentioned|5|||
105999475|NCT02544321|365661130|FG000|Overall Study|Withdrawal by Subject|1|||
105673940|NCT03291288|364470536|FG001|Drug-drug Interaction Phase|Disease progression|0|||
105673941|NCT03291288|364470535|FG000|Drug-drug Interaction Phase|Other|3|||
105673942|NCT03291288|364470536|FG001|Drug-drug Interaction Phase|Other|0|||
105673943|NCT03291288|364470535|FG000|Pexidartinib Only|Ongoing|0|||
105673944|NCT03291288|364470536|FG001|Pexidartinib Only|Ongoing|2|||
105673945|NCT01276379|364470537|FG000|Overall Study|Screening failure|40|||
105673946|NCT00287690|364470538|FG000|Overall Study|Protocol Violation|20|||
105673947|NCT00287690|364470539|FG001|Overall Study|Protocol Violation|26|||
105673948|NCT03590366|364470540|FG000|Overall Study|Adverse Event|0|||
105999476|NCT02544321|365661131|FG001|Overall Study|Withdrawal by Subject|2|||
105673949|NCT03590366|364470541|FG001|Overall Study|Adverse Event|3|||
105786314|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
105999477|NCT02544321|365661130|FG000|Overall Study|Adverse Event|1|||
105673950|NCT03590366|364470540|FG000|Overall Study|Lost to Follow-up|3|||
105673951|NCT03590366|364470541|FG001|Overall Study|Lost to Follow-up|3|||
105673952|NCT03590366|364470540|FG000|Overall Study|Withdrawal by Subject|0|||
105673953|NCT03590366|364470541|FG001|Overall Study|Withdrawal by Subject|2|||
105673954|NCT03309813|364470542|FG000|Main Randomized Study|Withdrawal by Subject|1|||
105673955|NCT03309813|364470543|FG001|Main Randomized Study|Withdrawal by Subject|0|||
105673956|NCT01081665|364470545|FG000|Overall Study|Death|41|||
105673957|NCT01081665|364470545|FG000|Overall Study|Lost to Follow-up|18|||
105673958|NCT01081665|364470545|FG000|Overall Study|Withdrawal by Subject|17|||
105673959|NCT01081665|364470545|FG000|Overall Study|Change of dialysis unit|10|||
105673960|NCT01081665|364470545|FG000|Overall Study|Regulation of iPTH|5|||
105673961|NCT01081665|364470545|FG000|Overall Study|Change in renal replacement therapy|2|||
105673962|NCT01081665|364470545|FG000|Overall Study|Adverse Event|1|||
105673963|NCT01081665|364470545|FG000|Overall Study|Lack of Efficacy|1|||
105673964|NCT01747551|364470546|FG000|Overall Study|Progressive Disease|24|||
105673965|NCT01747551|364470547|FG001|Overall Study|Progressive Disease|17|||
105673966|NCT01747551|364470546|FG000|Overall Study|Death|3|||
105673967|NCT01747551|364470547|FG001|Overall Study|Death|1|||
105673968|NCT01747551|364470546|FG000|Overall Study|Adverse Event|7|||
105673969|NCT01747551|364470547|FG001|Overall Study|Adverse Event|1|||
105673970|NCT01747551|364470546|FG000|Overall Study|Prolonged Treatment Delay|2|||
105673971|NCT01747551|364470547|FG001|Overall Study|Prolonged Treatment Delay|0|||
105673972|NCT01747551|364470546|FG000|Overall Study|Withdrawal by Subject|3|||
105673973|NCT01747551|364470547|FG001|Overall Study|Withdrawal by Subject|1|||
105673974|NCT01747551|364470546|FG000|Overall Study|Physician Decision|2|||
105673975|NCT01747551|364470547|FG001|Overall Study|Physician Decision|1|||
105673976|NCT01747551|364470546|FG000|Overall Study|Other|2|||
105673977|NCT01747551|364470547|FG001|Overall Study|Other|0|||
105673978|NCT01142115|364470548|FG000|First Intervention|Lack of Efficacy|1|||
105673979|NCT01142115|364470549|FG001|First Intervention|Lack of Efficacy|1|||
105673980|NCT01142115|364470548|FG000|First Intervention|Adverse Event|1|||
105673981|NCT01142115|364470549|FG001|First Intervention|Adverse Event|0|||
105673982|NCT03406078|364470552|FG000|Overall Study|Death|1|||
105673983|NCT03406078|364470553|FG001|Overall Study|Death|0|||
105673984|NCT03406078|364470552|FG000|Overall Study|Lost to Follow-up|0|||
105673985|NCT03406078|364470553|FG001|Overall Study|Lost to Follow-up|1|||
105673986|NCT03406078|364470552|FG000|Overall Study|Withdrawal by Subject|5|||
105673987|NCT03406078|364470553|FG001|Overall Study|Withdrawal by Subject|2|||
105673988|NCT02546921|364470554|FG000|Overall Study|Adverse Event|0|||
105673989|NCT02546921|364470555|FG001|Overall Study|Adverse Event|5|||
105673990|NCT02546921|364470556|FG002|Overall Study|Adverse Event|2|||
105673991|NCT02546921|364470557|FG003|Overall Study|Adverse Event|0|||
105673992|NCT02546921|364470558|FG004|Overall Study|Adverse Event|0|||
105909252|NCT03130959|365326640|FG005|Overall Study|Administrative reason by sponsor|0|||
105909253|NCT03130959|365326641|FG006|Overall Study|Administrative reason by sponsor|0|||
105909254|NCT03130959|365326642|FG007|Overall Study|Administrative reason by sponsor|0|||
105909255|NCT03130959|365326643|FG008|Overall Study|Administrative reason by sponsor|0|||
105909256|NCT03130959|365326644|FG009|Overall Study|Administrative reason by sponsor|0|||
105909257|NCT03130959|365326635|FG000|Overall Study|Lost to Follow-up|1|||
105909258|NCT03130959|365326636|FG001|Overall Study|Lost to Follow-up|0|||
105909259|NCT03130959|365326637|FG002|Overall Study|Lost to Follow-up|0|||
105909260|NCT03130959|365326638|FG003|Overall Study|Lost to Follow-up|0|||
105909261|NCT03130959|365326639|FG004|Overall Study|Lost to Follow-up|0|||
105909262|NCT03130959|365326640|FG005|Overall Study|Lost to Follow-up|0|||
105909263|NCT03130959|365326641|FG006|Overall Study|Lost to Follow-up|0|||
105909264|NCT03130959|365326642|FG007|Overall Study|Lost to Follow-up|0|||
105909265|NCT03130959|365326643|FG008|Overall Study|Lost to Follow-up|0|||
105909266|NCT03130959|365326644|FG009|Overall Study|Lost to Follow-up|0|||
105909267|NCT00577772|365326645|FG000|Overall Study|Lost to Follow-up|0|||
105999478|NCT02544321|365661131|FG001|Overall Study|Adverse Event|1|||
105999479|NCT02544321|365661130|FG000|Overall Study|Protocol Violation|0|||
105999480|NCT02544321|365661131|FG001|Overall Study|Protocol Violation|1|||
105999481|NCT01473732|365661142|FG000|Overall Study|Adverse Event|1|||
105673993|NCT02546921|364470559|FG005|Overall Study|Adverse Event|0|||
105673994|NCT02546921|364470560|FG006|Overall Study|Adverse Event|0|||
105673995|NCT02546921|364470554|FG000|Overall Study|Evidence of Disease Progression|1|||
105673996|NCT02546921|364470555|FG001|Overall Study|Evidence of Disease Progression|0|||
105673997|NCT02546921|364470556|FG002|Overall Study|Evidence of Disease Progression|0|||
105673998|NCT02546921|364470557|FG003|Overall Study|Evidence of Disease Progression|0|||
105673999|NCT02546921|364470558|FG004|Overall Study|Evidence of Disease Progression|1|||
105674000|NCT02546921|364470559|FG005|Overall Study|Evidence of Disease Progression|0|||
105674001|NCT02546921|364470560|FG006|Overall Study|Evidence of Disease Progression|0|||
105674002|NCT02546921|364470554|FG000|Overall Study|Patient Choice|0|||
105674003|NCT02546921|364470555|FG001|Overall Study|Patient Choice|1|||
105674004|NCT02546921|364470556|FG002|Overall Study|Patient Choice|0|||
105909268|NCT00577772|365326646|FG001|Overall Study|Lost to Follow-up|1|||
105909269|NCT04131712|365326651|FG000|Overall Study|COVID related|0|||
105909270|NCT04131712|365326652|FG001|Overall Study|COVID related|0|||
105909271|NCT04131712|365326653|FG002|Overall Study|COVID related|2|||
105909272|NCT04131712|365326654|FG003|Overall Study|COVID related|0|||
105909273|NCT04131712|365326651|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
105909274|NCT04131712|365326652|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
105909275|NCT04131712|365326653|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
105909276|NCT04131712|365326654|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
105909277|NCT02299388|365326655|FG000|Overall Study|Withdrawal by Subject|0|||
105909278|NCT02299388|365326656|FG001|Overall Study|Withdrawal by Subject|1|||
105909279|NCT00103662|365326657|FG000|Overall Study|Entered Rescue Procedure|0|||
105909280|NCT00103662|365326658|FG001|Overall Study|Entered Rescue Procedure|7|||
105909281|NCT00103662|365326657|FG000|Overall Study|Death|7|||
105909282|NCT00103662|365326658|FG001|Overall Study|Death|7|||
105909283|NCT00103662|365326657|FG000|Overall Study|Elective Withdrawal|5|||
105909284|NCT00103662|365326658|FG001|Overall Study|Elective Withdrawal|5|||
105909285|NCT00103662|365326657|FG000|Overall Study|Lost to Follow-up|0|||
105909286|NCT00103662|365326658|FG001|Overall Study|Lost to Follow-up|1|||
105909287|NCT00103662|365326657|FG000|Overall Study|Other|6|||
105909288|NCT00103662|365326658|FG001|Overall Study|Other|9|||
105909289|NCT00103662|365326657|FG000|Overall Study|Failed mobilization|0|||
105909290|NCT00103662|365326658|FG001|Overall Study|Failed mobilization|4|||
105909291|NCT00103662|365326657|FG000|Overall Study|Intercurrent illness|1|||
105909292|NCT00103662|365326658|FG001|Overall Study|Intercurrent illness|0|||
105909293|NCT03334188|365326659|FG000|Overall Study|Withdrawal by Subject|0|||
105909294|NCT03334188|365326660|FG001|Overall Study|Withdrawal by Subject|1|||
105909295|NCT03334188|365326659|FG000|Overall Study|Death|1|||
105909296|NCT03334188|365326660|FG001|Overall Study|Death|0|||
105909297|NCT03334188|365326659|FG000|Overall Study|Never had qualifying clinic visit|7|||
105909298|NCT03334188|365326660|FG001|Overall Study|Never had qualifying clinic visit|7|||
105909299|NCT03373760|365326661|FG000|Overall Study|Adverse Event|8|||
105909300|NCT03373760|365326661|FG000|Overall Study|Disease Progression|46|||
105909301|NCT03373760|365326661|FG000|Overall Study|Death|4|||
105909302|NCT00357877|365326664|FG000|Overall Study|Death|2|||
105909303|NCT00357877|365326665|FG001|Overall Study|Death|1|||
105909304|NCT00357877|365326664|FG000|Overall Study|Lost to Follow-up|20|||
105909305|NCT00357877|365326665|FG001|Overall Study|Lost to Follow-up|23|||
105909306|NCT00357877|365326664|FG000|Overall Study|Withdrawal by Subject|3|||
105909307|NCT00357877|365326665|FG001|Overall Study|Withdrawal by Subject|3|||
105909308|NCT00357877|365326664|FG000|Overall Study|Administrative withdrawal|1|||
105909309|NCT00357877|365326665|FG001|Overall Study|Administrative withdrawal|1|||
105909310|NCT00357877|365326664|FG000|Overall Study|Other|0|||
105909311|NCT00357877|365326665|FG001|Overall Study|Other|2|||
105909312|NCT00766597|365326668|FG000|Overall Study|Unexpected closure of study|4|||
105909313|NCT00766597|365326668|FG000|Overall Study|Without CCR5-tropic virus|5|||
105909314|NCT03318003|365326677|FG000|Overall Study|Withdrawal by Subject|1|||
105909315|NCT03318003|365326678|FG001|Overall Study|Withdrawal by Subject|1|||
105909316|NCT03318003|365326677|FG000|Overall Study|fetal loss|0|||
105909317|NCT03318003|365326678|FG001|Overall Study|fetal loss|1|||
105909318|NCT01711983|365326679|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
105909319|NCT01711983|365326679|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
105909320|NCT01711983|365326679|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
105909321|NCT01711983|365326679|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
105909322|NCT00735943|365326684|FG000|Overall Study|Lost to Follow-up|1|||
105909323|NCT00735943|365326684|FG000|Overall Study|Adverse Event|1|||
105909324|NCT00447772|365326690|FG000|Overall Study|Lack of Efficacy|3|||
105909325|NCT00447772|365326690|FG000|Overall Study|Insufficient compliance|6|||
105909326|NCT00447772|365326690|FG000|Overall Study|Discontinuation of drug therapy|1|||
105909327|NCT00447772|365326690|FG000|Overall Study|Lost to Follow-up|9|||
105909328|NCT00447772|365326690|FG000|Overall Study|Withdrawal by Subject|1|||
105909329|NCT00447772|365326690|FG000|Overall Study|Unable to attend all study visits|2|||
105909330|NCT00447772|365326690|FG000|Overall Study|Adverse Event|1|||
105909331|NCT00447772|365326690|FG000|Overall Study|Patient relocated|1|||
105909332|NCT00447772|365326690|FG000|Overall Study|Incomplete documentation at visit 1|1|||
105909333|NCT00447772|365326690|FG000|Overall Study|Chemotherapy for lung cancer|1|||
105909334|NCT00447772|365326690|FG000|Overall Study|Premature re-injection required|1|||
105909335|NCT01896193|365326691|FG000|Overall Study|Lack of Efficacy|20|||
105909336|NCT01896193|365326692|FG001|Overall Study|Lack of Efficacy|11|||
106125693|NCT01822353|366117870|FG001|Overall Study|Withdrawal by Subject|1|||
106125694|NCT01822353|366117871|FG002|Overall Study|Withdrawal by Subject|0|||
105909337|NCT01896193|365326691|FG000|Overall Study|Protocol Violation|0|||
105909338|NCT01896193|365326692|FG001|Overall Study|Protocol Violation|1|||
105909339|NCT01896193|365326691|FG000|Overall Study|Withdrew Consent|1|||
105909340|NCT01896193|365326692|FG001|Overall Study|Withdrew Consent|0|||
105909341|NCT01737879|365326695|FG000|Overall Study|Death|1|||
105909342|NCT01737879|365326695|FG000|Overall Study|Sponsor decision|40|||
105909343|NCT00977613|365326696|FG000|Overall Study|Lost to Follow-up|16|||
105909344|NCT05285787|365326698|FG000|Overall Study|Withdrawal by Subject|1|||
105909345|NCT05568797|365326699|FG000|Overall Study|Adverse Event|0|||
105909346|NCT05568797|365326700|FG001|Overall Study|Adverse Event|8|||
105909347|NCT05568797|365326699|FG000|Overall Study|Lost to Follow-up|2|||
105909348|NCT05568797|365326700|FG001|Overall Study|Lost to Follow-up|3|||
105909349|NCT05568797|365326699|FG000|Overall Study|Withdrawal by Subject|1|||
105909350|NCT05568797|365326700|FG001|Overall Study|Withdrawal by Subject|10|||
105909351|NCT05568797|365326699|FG000|Overall Study|Other|2|||
105909352|NCT05568797|365326700|FG001|Overall Study|Other|2|||
105909353|NCT00672633|365326701|FG000|Overall Study|Withdrawal by Subject|0|||
105909354|NCT00672633|365326702|FG001|Overall Study|Withdrawal by Subject|1|||
105909355|NCT00534638|365326703|FG000|Overall Study|Withdrawal by Subject|3|||
105909356|NCT00534638|365326704|FG001|Overall Study|Withdrawal by Subject|4|||
105909357|NCT00534638|365326703|FG000|Overall Study|Migrated/moved from study area|13|||
105909358|NCT00534638|365326704|FG001|Overall Study|Migrated/moved from study area|11|||
105909359|NCT00534638|365326703|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
105909360|NCT00534638|365326704|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
105909361|NCT00534638|365326703|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
105909362|NCT00534638|365326704|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
105909363|NCT00534638|365326703|FG000|Overall Study|Other|1685|||
105909364|NCT00534638|365326704|FG001|Overall Study|Other|902|||
105909365|NCT02106351|365326707|FG000|Treatment Cycle 1|Adverse Event|2|||
105909366|NCT02106351|365326708|FG001|Treatment Cycle 1|Adverse Event|0|||
105909367|NCT02106351|365326709|FG002|Treatment Cycle 1|Adverse Event|0|||
105909368|NCT02106351|365326707|FG000|Treatment Cycle 1|Consent withdrawn|1|||
105909369|NCT02106351|365326708|FG001|Treatment Cycle 1|Consent withdrawn|0|||
105909370|NCT02106351|365326709|FG002|Treatment Cycle 1|Consent withdrawn|2|||
105909371|NCT02106351|365326707|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
105909372|NCT02106351|365326708|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
105909373|NCT02106351|365326709|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
105909374|NCT02106351|365326707|FG000|Treatment Cycle 1|Other|0|||
105909375|NCT02106351|365326708|FG001|Treatment Cycle 1|Other|3|||
105909376|NCT02106351|365326709|FG002|Treatment Cycle 1|Other|1|||
105909377|NCT02106351|365326707|FG000|Treatment Cycle 1|Randomised but not treated|1|||
105909378|NCT02106351|365326708|FG001|Treatment Cycle 1|Randomised but not treated|0|||
105909379|NCT02106351|365326709|FG002|Treatment Cycle 1|Randomised but not treated|1|||
105909380|NCT02106351|365326707|FG000|Treatment Cycle 2|Adverse Event|0|||
105909381|NCT02106351|365326708|FG001|Treatment Cycle 2|Adverse Event|2|||
105909382|NCT02106351|365326709|FG002|Treatment Cycle 2|Adverse Event|0|||
105909383|NCT02106351|365326707|FG000|Treatment Cycle 2|Consent withdrawn|0|||
105909384|NCT02106351|365326708|FG001|Treatment Cycle 2|Consent withdrawn|1|||
105909385|NCT02106351|365326709|FG002|Treatment Cycle 2|Consent withdrawn|1|||
105909386|NCT02106351|365326707|FG000|Treatment Cycle 2|Other|0|||
105909387|NCT02106351|365326708|FG001|Treatment Cycle 2|Other|2|||
105909388|NCT02106351|365326709|FG002|Treatment Cycle 2|Other|2|||
105909389|NCT02106351|365326707|FG000|Treatment Cycle 3|Adverse Event|0|||
105909390|NCT02106351|365326708|FG001|Treatment Cycle 3|Adverse Event|1|||
105909391|NCT02106351|365326709|FG002|Treatment Cycle 3|Adverse Event|0|||
105909392|NCT02106351|365326707|FG000|Treatment Cycle 3|Consent withdrawn|0|||
105909393|NCT02106351|365326708|FG001|Treatment Cycle 3|Consent withdrawn|0|||
105909394|NCT02106351|365326709|FG002|Treatment Cycle 3|Consent withdrawn|2|||
105909395|NCT02106351|365326707|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
105909396|NCT02106351|365326708|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
105909397|NCT02106351|365326709|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
105909398|NCT02106351|365326707|FG000|Treatment Cycle 3|Other|0|||
105909399|NCT02106351|365326708|FG001|Treatment Cycle 3|Other|2|||
105909400|NCT02106351|365326709|FG002|Treatment Cycle 3|Other|3|||
105909401|NCT02106351|365326707|FG000|Treatment Cycle 4|Consent withdrawn|0|||
105909402|NCT02106351|365326708|FG001|Treatment Cycle 4|Consent withdrawn|0|||
105909403|NCT02106351|365326709|FG002|Treatment Cycle 4|Consent withdrawn|2|||
105909404|NCT02106351|365326707|FG000|Treatment Cycle 4|Other|0|||
105909405|NCT02106351|365326708|FG001|Treatment Cycle 4|Other|1|||
105909406|NCT02106351|365326709|FG002|Treatment Cycle 4|Other|0|||
105909407|NCT00069823|365326710|FG000|Overall Study|Did not have follow-up diary cards|6|||
105909408|NCT00069823|365326711|FG001|Overall Study|Did not have follow-up diary cards|3|||
105909409|NCT00520039|365326714|FG000|Overall Study|Exclusion criteria met at first visit|7|||
105909410|NCT00520039|365326715|FG001|Overall Study|Exclusion criteria met at first visit|5|||
105909411|NCT04754542|365326717|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
105909412|NCT04754542|365326718|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
105909413|NCT05259163|365328365|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
105909414|NCT05259163|365328366|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
105909415|NCT05251233|365328369|FG000|Overall Study|Disease progression - did not start treatment|0|||
105909416|NCT05251233|365328370|FG001|Overall Study|Disease progression - did not start treatment|0|||
105909417|NCT05251233|365328371|FG002|Overall Study|Disease progression - did not start treatment|5|||
105909418|NCT05251233|365328369|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
105909419|NCT05251233|365328370|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
105909420|NCT05251233|365328371|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
105909421|NCT05251233|365328369|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
105909422|NCT05251233|365328370|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
105909423|NCT05251233|365328371|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
105909424|NCT05251233|365328369|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
105909425|NCT05251233|365328370|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
105909426|NCT05251233|365328371|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
105909427|NCT05251233|365328369|FG000|Overall Study|Death - did not start treatment|3|||
105909428|NCT05251233|365328370|FG001|Overall Study|Death - did not start treatment|0|||
105909429|NCT05251233|365328371|FG002|Overall Study|Death - did not start treatment|0|||
105909430|NCT05251233|365328369|FG000|Overall Study|Withdrawal by Subject|2|||
105909431|NCT05251233|365328370|FG001|Overall Study|Withdrawal by Subject|2|||
105909432|NCT05251233|365328371|FG002|Overall Study|Withdrawal by Subject|0|||
105909433|NCT05251233|365328369|FG000|Overall Study|Other complicating disease|2|||
105909434|NCT05251233|365328370|FG001|Overall Study|Other complicating disease|1|||
105909435|NCT05251233|365328371|FG002|Overall Study|Other complicating disease|0|||
105909436|NCT05251233|365328369|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
105909437|NCT05251233|365328370|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
105909438|NCT05251233|365328371|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
105909439|NCT05251233|365328369|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
105909440|NCT05251233|365328370|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
105909441|NCT05251233|365328371|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
105909442|NCT02100839|365328381|FG000|Multiple Ascending Dose|Adverse Event|2|||
105909443|NCT02100839|365328382|FG001|Multiple Ascending Dose|Adverse Event|0|||
105909444|NCT02100839|365328381|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
105909445|NCT02100839|365328382|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
105909446|NCT01000974|365328383|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
105909447|NCT01000974|365328384|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
105909448|NCT01000974|365328385|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
105909449|NCT01000974|365328383|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
105909450|NCT01000974|365328384|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
105909451|NCT01000974|365328385|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
105909452|NCT01000974|365328383|FG000|Primary Vaccination Phase|Protocol Violation|40|||
105909453|NCT01000974|365328384|FG001|Primary Vaccination Phase|Protocol Violation|3|||
105909454|NCT01000974|365328385|FG002|Primary Vaccination Phase|Protocol Violation|2|||
105909455|NCT01000974|365328383|FG000|Primary Vaccination Phase|Adverse Event|14|||
105909456|NCT01000974|365328384|FG001|Primary Vaccination Phase|Adverse Event|2|||
105909457|NCT01000974|365328385|FG002|Primary Vaccination Phase|Adverse Event|2|||
105909458|NCT01000974|365328383|FG000|Primary Vaccination Phase|Other|4|||
105909459|NCT01000974|365328384|FG001|Primary Vaccination Phase|Other|9|||
105909460|NCT01000974|365328385|FG002|Primary Vaccination Phase|Other|12|||
105909461|NCT01000974|365328383|FG000|Booster Vaccination Phase|Protocol Violation|0|||
105909462|NCT01000974|365328384|FG001|Booster Vaccination Phase|Protocol Violation|0|||
105909463|NCT01000974|365328385|FG002|Booster Vaccination Phase|Protocol Violation|2|||
105909464|NCT01000974|365328383|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
105909465|NCT01000974|365328384|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
105909466|NCT01000974|365328385|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
105909467|NCT01000974|365328383|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
105909468|NCT01000974|365328384|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
105909469|NCT01000974|365328385|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
105909470|NCT01000974|365328383|FG000|Booster Vaccination Phase|Other|24|||
105909471|NCT01000974|365328384|FG001|Booster Vaccination Phase|Other|6|||
105909472|NCT01000974|365328385|FG002|Booster Vaccination Phase|Other|4|||
105909473|NCT00493012|365328391|FG000|Overall Study|Lost to Follow-up|18|||
105909474|NCT00493012|365328392|FG001|Overall Study|Lost to Follow-up|17|||
105909475|NCT04147247|365328393|FG000|Overall Study|Progressive disease|3|||
105909476|NCT04147247|365328394|FG001|Overall Study|Progressive disease|3|||
105909477|NCT04147247|365328395|FG002|Overall Study|Progressive disease|4|||
105909478|NCT04147247|365328396|FG003|Overall Study|Progressive disease|4|||
105909479|NCT04147247|365328397|FG004|Overall Study|Progressive disease|3|||
105909480|NCT04147247|365328393|FG000|Overall Study|Physician Decision|0|||
105909481|NCT04147247|365328394|FG001|Overall Study|Physician Decision|1|||
105909482|NCT04147247|365328395|FG002|Overall Study|Physician Decision|0|||
105909483|NCT04147247|365328396|FG003|Overall Study|Physician Decision|0|||
105909484|NCT04147247|365328397|FG004|Overall Study|Physician Decision|0|||
105909485|NCT04147247|365328393|FG000|Overall Study|Clinical Disease Progression|0|||
105909486|NCT04147247|365328394|FG001|Overall Study|Clinical Disease Progression|0|||
105909487|NCT04147247|365328395|FG002|Overall Study|Clinical Disease Progression|0|||
105909488|NCT04147247|365328396|FG003|Overall Study|Clinical Disease Progression|0|||
105909489|NCT04147247|365328397|FG004|Overall Study|Clinical Disease Progression|1|||
105909490|NCT04147247|365328393|FG000|Overall Study|Adverse Event|0|||
105909491|NCT04147247|365328394|FG001|Overall Study|Adverse Event|0|||
105909492|NCT04147247|365328395|FG002|Overall Study|Adverse Event|1|||
105909493|NCT04147247|365328396|FG003|Overall Study|Adverse Event|0|||
105909494|NCT04147247|365328397|FG004|Overall Study|Adverse Event|1|||
105909495|NCT00305227|365328402|FG000|Overall Study|Lost to Follow-up|7|||
105909496|NCT00305227|365328403|FG001|Overall Study|Lost to Follow-up|6|||
105909497|NCT02915159|365328405|FG000|Overall Study|Participant no longer meets criteria|2|||
105909498|NCT02915159|365328406|FG001|Overall Study|Participant no longer meets criteria|0|||
105909499|NCT02915159|365328405|FG000|Overall Study|poor/non-compliance|1|||
105909500|NCT02915159|365328406|FG001|Overall Study|poor/non-compliance|0|||
105909501|NCT02915159|365328405|FG000|Overall Study|Participant withdrew consent|5|||
105909502|NCT02915159|365328406|FG001|Overall Study|Participant withdrew consent|1|||
105909503|NCT02915159|365328405|FG000|Overall Study|Request to discontinue treatment|1|||
105909504|NCT02915159|365328406|FG001|Overall Study|Request to discontinue treatment|2|||
105909505|NCT02915159|365328405|FG000|Overall Study|Adverse Event|2|||
105909506|NCT02915159|365328406|FG001|Overall Study|Adverse Event|2|||
105909507|NCT02915159|365328405|FG000|Overall Study|Lack of Efficacy|0|||
105909508|NCT02915159|365328406|FG001|Overall Study|Lack of Efficacy|3|||
105909509|NCT02824224|365328407|FG000|Overall Study|Discontinued, IUS expulsion|0|||
105909510|NCT02824224|365328408|FG001|Overall Study|Discontinued, IUS expulsion|1|||
105909511|NCT02824224|365328407|FG000|Overall Study|Did not show up for allocation visit|2|||
105909512|NCT02824224|365328408|FG001|Overall Study|Did not show up for allocation visit|0|||
105909513|NCT00856999|365328411|FG000|Overall Study|Withdrawal by Subject|5|||
105909514|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
105909515|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
105909516|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
105909517|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
105909518|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
105909519|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
105909520|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
105909521|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
105909522|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
105909523|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
105909524|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
105909525|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
105909526|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
105909527|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
105909528|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Death|1|||
105909529|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Death|0|||
105909530|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
105909531|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
105909532|NCT00105989|365328412|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
105909533|NCT00105989|365328413|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
105909534|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
105909535|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
105909536|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
105909537|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
105909538|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
105909539|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
105909540|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
105909541|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
105909542|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
105909543|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
105909544|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
105909545|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
105909546|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
105909547|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
105909548|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Death|0|||
105909549|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Death|0|||
105909550|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
105909551|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
105909552|NCT00105989|365328412|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
105909553|NCT00105989|365328413|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
105786315|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786316|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786317|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786318|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
105786319|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
105786320|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786321|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
105786322|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786323|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
105786324|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786325|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786326|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
105786327|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786328|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786329|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
105786330|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786331|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786332|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
105786333|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786334|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
105786335|NCT00948896|364870488|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786336|NCT00948896|364870489|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786337|NCT00948896|364870490|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786338|NCT00948896|364870491|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
105786339|NCT00948896|364870492|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786340|NCT00948896|364870493|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786341|NCT00948896|364870494|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786342|NCT00948896|364870495|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
105786343|NCT03795233|364870496|FG000|Overall Study|Withdrawal by Subject|2|||
105786344|NCT03795233|364870497|FG001|Overall Study|Withdrawal by Subject|1|||
105786345|NCT03795233|364870496|FG000|Overall Study|Lost to Follow-up|1|||
105786346|NCT03795233|364870497|FG001|Overall Study|Lost to Follow-up|0|||
105786347|NCT03795233|364870496|FG000|Overall Study|Death|1|||
105786348|NCT03795233|364870497|FG001|Overall Study|Death|0|||
105786349|NCT05403502|364870498|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
105786350|NCT05403502|364870498|FG000|Humalog Lead-In Period|Physician Decision|2|||
105786351|NCT05403502|364870498|FG000|Humalog Lead-In Period|Protocol Violation|1|||
105786352|NCT05403502|364870498|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
105786353|NCT05403502|364870498|FG000|Lyumjev Treatment Period|Physician Decision|2|||
105786354|NCT01054443|364870499|FG000|Overall Study|Withdrawal by Subject|0|||
105786355|NCT01054443|364870500|FG001|Overall Study|Withdrawal by Subject|0|||
105786356|NCT01054443|364870501|FG002|Overall Study|Withdrawal by Subject|0|||
105786357|NCT01054443|364870502|FG003|Overall Study|Withdrawal by Subject|1|||
105786358|NCT00985114|364870504|FG000|Overall Study|Adverse Event|1|||
105786359|NCT00985114|364870505|FG001|Overall Study|Adverse Event|0|||
105786360|NCT00985114|364870504|FG000|Overall Study|Withdrawal by Subject|0|||
105786361|NCT00985114|364870505|FG001|Overall Study|Withdrawal by Subject|2|||
105786362|NCT01869959|364870508|FG000|Randomization Period|Physician Decision|0|||
105786363|NCT01869959|364870509|FG001|Randomization Period|Physician Decision|0|||
105786364|NCT01869959|364870510|FG002|Randomization Period|Physician Decision|0|||
105786365|NCT01869959|364870511|FG003|Randomization Period|Physician Decision|0|||
105786366|NCT01869959|364870512|FG004|Randomization Period|Physician Decision|1|||
105786367|NCT01869959|364870508|FG000|Treatment Period|Adverse Event|1|||
105786368|NCT01869959|364870509|FG001|Treatment Period|Adverse Event|0|||
105786369|NCT01869959|364870510|FG002|Treatment Period|Adverse Event|3|||
105909554|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
105786370|NCT01869959|364870511|FG003|Treatment Period|Adverse Event|1|||
105786371|NCT01869959|364870512|FG004|Treatment Period|Adverse Event|0|||
105786372|NCT01869959|364870508|FG000|Treatment Period|Sponsor decision|0|||
105909555|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
105909556|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
105909557|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
105909558|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
105909559|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
105909560|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
105909561|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
105909562|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
105909563|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
105909564|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
105909565|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
105909566|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
105909567|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
105909568|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
105909569|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
105909570|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
105909571|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
105909572|NCT00105989|365328412|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
105909573|NCT00105989|365328413|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
105909574|NCT03442088|365328414|FG000|Overall Study|Adverse Event|1|||
105909575|NCT03442088|365328414|FG000|Overall Study|Lack of Efficacy|2|||
105909576|NCT03442088|365328414|FG000|Overall Study|Lost to Follow-up|2|||
105909577|NCT01869777|365328419|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
105909578|NCT00613366|365328422|FG000|Overall Study|Withdrawal by Subject|3|||
105909579|NCT00613366|365328423|FG001|Overall Study|Withdrawal by Subject|2|||
105909580|NCT00130689|365328424|FG000|Overall Study|Progressive Disease|29|||
105909581|NCT00130689|365328424|FG000|Overall Study|Death|1|||
105909582|NCT00130689|365328424|FG000|Overall Study|Clinical Deterioration|4|||
105909583|NCT00130689|365328424|FG000|Overall Study|Withdrawal by Subject|3|||
105909584|NCT00130689|365328424|FG000|Overall Study|Ineligible|6|||
105909585|NCT00878800|365328425|FG000|Overall Study|Adverse Event|0|||
105909586|NCT00878800|365328426|FG001|Overall Study|Adverse Event|0|||
105909587|NCT00878800|365328427|FG002|Overall Study|Adverse Event|2|||
105909588|NCT00878800|365328428|FG003|Overall Study|Adverse Event|0|||
105909589|NCT00878800|365328429|FG004|Overall Study|Adverse Event|1|||
105909590|NCT00878800|365328425|FG000|Overall Study|Progressive disease|1|||
105909591|NCT00878800|365328426|FG001|Overall Study|Progressive disease|5|||
105909592|NCT00878800|365328427|FG002|Overall Study|Progressive disease|6|||
105909593|NCT00878800|365328428|FG003|Overall Study|Progressive disease|5|||
105909594|NCT00878800|365328429|FG004|Overall Study|Progressive disease|13|||
105909595|NCT00878800|365328425|FG000|Overall Study|Withdrew consent|1|||
105909596|NCT00878800|365328426|FG001|Overall Study|Withdrew consent|1|||
105909597|NCT00878800|365328427|FG002|Overall Study|Withdrew consent|0|||
105909598|NCT00878800|365328428|FG003|Overall Study|Withdrew consent|1|||
105909599|NCT00878800|365328429|FG004|Overall Study|Withdrew consent|1|||
105909600|NCT00878800|365328425|FG000|Overall Study|Death|0|||
105909601|NCT00878800|365328426|FG001|Overall Study|Death|0|||
105909602|NCT00878800|365328427|FG002|Overall Study|Death|1|||
105909603|NCT00878800|365328428|FG003|Overall Study|Death|0|||
105909604|NCT00878800|365328429|FG004|Overall Study|Death|0|||
105909605|NCT00878800|365328425|FG000|Overall Study|Other|1|||
105909606|NCT00878800|365328426|FG001|Overall Study|Other|1|||
105909607|NCT00878800|365328427|FG002|Overall Study|Other|0|||
105909608|NCT00878800|365328428|FG003|Overall Study|Other|0|||
105909609|NCT00878800|365328429|FG004|Overall Study|Other|1|||
105909610|NCT02907463|365328431|FG000|Overall Study|Lost to Follow-up|17|||
105909611|NCT02907463|365328431|FG000|Overall Study|Death|10|||
105909612|NCT02907463|365328431|FG000|Overall Study|Withdrawal by Subject|4|||
105909613|NCT02907463|365328431|FG000|Overall Study|MIS Approach was not used|2|||
105909614|NCT02907463|365328431|FG000|Overall Study|Not Implanted with Study Device|2|||
105909615|NCT02907463|365328431|FG000|Overall Study|Device Explanted|1|||
105909616|NCT02907463|365328431|FG000|Overall Study|Missing Exit Form|1|||
105909617|NCT00715299|365328432|FG000|Overall Study|Withdrawal by Subject|1|||
105909618|NCT00715299|365328432|FG000|Overall Study|Adverse Event|3|||
105909619|NCT00715299|365328432|FG000|Overall Study|failed the pre-screen exercise test|2|||
105909620|NCT05225558|365328433|FG000|Overall Study|Withdrawal by Subject|4|||
105909621|NCT05225558|365328434|FG001|Overall Study|Withdrawal by Subject|3|||
105909622|NCT05225558|365328433|FG000|Overall Study|Adverse Event|1|||
105909623|NCT05225558|365328434|FG001|Overall Study|Adverse Event|0|||
105909624|NCT05225558|365328433|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
105909625|NCT05225558|365328434|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
105909626|NCT05225558|365328433|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
105909627|NCT05225558|365328434|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
105909628|NCT02896569|365328436|FG000|Overall Study|Lost to Follow-up|2|||
105909629|NCT02896569|365328437|FG001|Overall Study|Lost to Follow-up|1|||
105909630|NCT02896569|365328436|FG000|Overall Study|Physician Decision|1|||
105909631|NCT02896569|365328437|FG001|Overall Study|Physician Decision|3|||
105909632|NCT02896569|365328436|FG000|Overall Study|Adverse Event|0|||
105909633|NCT02896569|365328437|FG001|Overall Study|Adverse Event|1|||
105909634|NCT02896569|365328436|FG000|Overall Study|Withdrawal by Subject|1|||
105909635|NCT02896569|365328437|FG001|Overall Study|Withdrawal by Subject|0|||
105909636|NCT01462630|365328438|FG000|Overall Study|Did not initiate therapy|3|||
105909637|NCT01462630|365328438|FG000|Overall Study|Death|1|||
105909638|NCT01462630|365328438|FG000|Overall Study|Protocol Violation|2|||
105909639|NCT01462630|365328438|FG000|Overall Study|Adverse Event|1|||
105909640|NCT02849743|365328439|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
105909641|NCT02849743|365328440|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
105909642|NCT02849743|365328439|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
105909643|NCT02849743|365328440|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
105909644|NCT03874013|365328441|FG000|Overall Study|Adverse Event|0|||
105909645|NCT03874013|365328442|FG001|Overall Study|Adverse Event|1|||
105909646|NCT01096160|365328443|FG000|Overall Study|Adverse Event|0|||
105909647|NCT01096160|365328444|FG001|Overall Study|Adverse Event|0|||
105909648|NCT01096160|365328445|FG002|Overall Study|Adverse Event|1|||
105909649|NCT01096160|365328446|FG003|Overall Study|Adverse Event|0|||
105909650|NCT01096160|365328447|FG004|Overall Study|Adverse Event|0|||
105909651|NCT01096160|365328448|FG005|Overall Study|Adverse Event|0|||
105909652|NCT01096160|365328449|FG006|Overall Study|Adverse Event|0|||
105909653|NCT01096160|365328450|FG007|Overall Study|Adverse Event|0|||
105909654|NCT01096160|365328451|FG008|Overall Study|Adverse Event|0|||
105909655|NCT01096160|365328452|FG009|Overall Study|Adverse Event|1|||
105909656|NCT01096160|365328443|FG000|Overall Study|Met stopping criteria per protocol|0|||
105909657|NCT01096160|365328444|FG001|Overall Study|Met stopping criteria per protocol|0|||
105909658|NCT01096160|365328445|FG002|Overall Study|Met stopping criteria per protocol|0|||
105909659|NCT01096160|365328446|FG003|Overall Study|Met stopping criteria per protocol|0|||
105909660|NCT01096160|365328447|FG004|Overall Study|Met stopping criteria per protocol|1|||
105909661|NCT01096160|365328448|FG005|Overall Study|Met stopping criteria per protocol|0|||
105909662|NCT01096160|365328449|FG006|Overall Study|Met stopping criteria per protocol|2|||
105909663|NCT01096160|365328450|FG007|Overall Study|Met stopping criteria per protocol|0|||
105909664|NCT01096160|365328451|FG008|Overall Study|Met stopping criteria per protocol|2|||
105909665|NCT01096160|365328452|FG009|Overall Study|Met stopping criteria per protocol|0|||
105909666|NCT00705757|365328453|FG000|Overall Study|Lack of Efficacy|5|||
105909667|NCT00705757|365328454|FG001|Overall Study|Lack of Efficacy|1|||
105909668|NCT00705757|365328455|FG002|Overall Study|Lack of Efficacy|3|||
105909669|NCT00705757|365328453|FG000|Overall Study|Lost to Follow-up|7|||
105909670|NCT00705757|365328454|FG001|Overall Study|Lost to Follow-up|6|||
105909671|NCT00705757|365328455|FG002|Overall Study|Lost to Follow-up|6|||
105909672|NCT00705757|365328453|FG000|Overall Study|Withdrawal by Subject|1|||
105909673|NCT00705757|365328454|FG001|Overall Study|Withdrawal by Subject|1|||
105909674|NCT00705757|365328455|FG002|Overall Study|Withdrawal by Subject|2|||
105909675|NCT01300247|365328456|FG000|Overall Study|Death|1|||
105909676|NCT01300247|365328457|FG001|Overall Study|Death|1|||
105909677|NCT01300247|365328456|FG000|Overall Study|Lost to Follow-up|2|||
105909678|NCT01300247|365328457|FG001|Overall Study|Lost to Follow-up|0|||
105909679|NCT01300247|365328456|FG000|Overall Study|Withdrawal by Subject|1|||
105909680|NCT01300247|365328457|FG001|Overall Study|Withdrawal by Subject|0|||
105909681|NCT01300247|365328456|FG000|Overall Study|Non-Compliance|0|||
105909682|NCT01300247|365328457|FG001|Overall Study|Non-Compliance|1|||
105909683|NCT00227539|365328460|FG000|Overall Study|Protocol Violation|1|||
105909684|NCT00426764|365328461|FG000|Overall Study|Protocol Violation|1|||
105909685|NCT00426764|365328461|FG000|Overall Study|Withdrawal by Subject|4|||
105909686|NCT00426764|365328461|FG000|Overall Study|Physician Decision|6|||
105909687|NCT00426764|365328461|FG000|Overall Study|Compassionate Use|1|||
105909688|NCT00426764|365328461|FG000|Overall Study|Progressive Disease|83|||
105909689|NCT00426764|365328461|FG000|Overall Study|Adverse Event|24|||
105909690|NCT00426764|365328461|FG000|Overall Study|Other|1|||
105909691|NCT00426764|365328461|FG000|Overall Study|Death|1|||
105909692|NCT00426764|365328461|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
105909693|NCT00379899|365328462|FG000|Overall Study|Adverse Event|7|||
105909694|NCT00379899|365328463|FG001|Overall Study|Adverse Event|3|||
105909695|NCT00379899|365328462|FG000|Overall Study|Death|10|||
105909696|NCT00379899|365328463|FG001|Overall Study|Death|10|||
105909697|NCT00379899|365328462|FG000|Overall Study|Lost to Follow-up|2|||
105999482|NCT01473732|365661143|FG001|Overall Study|Adverse Event|0|||
105909698|NCT00379899|365328463|FG001|Overall Study|Lost to Follow-up|4|||
105909699|NCT00379899|365328462|FG000|Overall Study|Physician Decision|3|||
105909700|NCT00379899|365328463|FG001|Overall Study|Physician Decision|4|||
105909701|NCT00379899|365328462|FG000|Overall Study|Withdrawal by Subject|5|||
105909702|NCT00379899|365328463|FG001|Overall Study|Withdrawal by Subject|5|||
105909703|NCT00379899|365328462|FG000|Overall Study|Ineligibility determined|0|||
105909704|NCT00379899|365328463|FG001|Overall Study|Ineligibility determined|1|||
105909705|NCT00379899|365328462|FG000|Overall Study|Noncompliance|1|||
105909706|NCT00379899|365328463|FG001|Overall Study|Noncompliance|1|||
105909707|NCT00379899|365328462|FG000|Overall Study|Parathyroidectomy|0|||
105909708|NCT00379899|365328463|FG001|Overall Study|Parathyroidectomy|2|||
105909709|NCT00379899|365328462|FG000|Overall Study|Renal transplantation|5|||
105909710|NCT00379899|365328463|FG001|Overall Study|Renal transplantation|4|||
105909711|NCT00379899|365328462|FG000|Overall Study|Coronary artery bypass graft|1|||
105909712|NCT00379899|365328463|FG001|Overall Study|Coronary artery bypass graft|1|||
105909713|NCT00379899|365328462|FG000|Overall Study|Other protocol-specified criteria|3|||
105909714|NCT00379899|365328463|FG001|Overall Study|Other protocol-specified criteria|4|||
105909715|NCT00379899|365328462|FG000|Overall Study|Other|3|||
105909716|NCT00379899|365328463|FG001|Overall Study|Other|1|||
105909717|NCT01922258|365328466|FG000|Overall Study|Lost to Follow-up|1|||
105909718|NCT01922258|365328467|FG001|Overall Study|Lost to Follow-up|1|||
105909719|NCT01922258|365328466|FG000|Overall Study|Adverse Event|9|||
105909720|NCT01922258|365328467|FG001|Overall Study|Adverse Event|2|||
105909721|NCT01922258|365328466|FG000|Overall Study|Met Withdrawal Criteria|0|||
105909722|NCT01922258|365328467|FG001|Overall Study|Met Withdrawal Criteria|4|||
105909723|NCT01922258|365328466|FG000|Overall Study|Withdrawn by the Investigator|1|||
105909724|NCT01922258|365328467|FG001|Overall Study|Withdrawn by the Investigator|4|||
105909725|NCT01922258|365328466|FG000|Overall Study|Withdrawal by participant|5|||
105909726|NCT01922258|365328467|FG001|Overall Study|Withdrawal by participant|5|||
105909727|NCT00673257|365328468|FG000|Overall Study|Withdrawal by Subject|4|||
105909728|NCT00673257|365328468|FG000|Overall Study|Unable to obtain specimen|1|||
105909729|NCT01166750|365328469|FG000|Overall Study|Lost to Follow-up|1|||
105909730|NCT01166750|365328470|FG001|Overall Study|Lost to Follow-up|0|||
105909731|NCT03804268|365328471|FG000|Overall Study|Adverse Event|2|||
105909732|NCT03804268|365328472|FG001|Overall Study|Adverse Event|2|||
105909733|NCT03804268|365328471|FG000|Overall Study|Withdrawal by Subject|2|||
105909734|NCT03804268|365328472|FG001|Overall Study|Withdrawal by Subject|0|||
105909735|NCT03804268|365328471|FG000|Overall Study|Lost to Follow-up|1|||
105909736|NCT03804268|365328472|FG001|Overall Study|Lost to Follow-up|0|||
105909737|NCT03804268|365328471|FG000|Overall Study|Physician Decision|2|||
105909738|NCT03804268|365328472|FG001|Overall Study|Physician Decision|0|||
105909739|NCT02716779|365328473|FG000|Monotherapy|Adverse Event|0|||
105909740|NCT02716779|365328474|FG001|Monotherapy|Adverse Event|1|||
105909741|NCT02716779|365328475|FG002|Monotherapy|Adverse Event|1|||
105909742|NCT02716779|365328473|FG000|Combination Therapy|Adverse Event|0|||
105909743|NCT02716779|365328474|FG001|Combination Therapy|Adverse Event|2|||
105909744|NCT02716779|365328475|FG002|Combination Therapy|Adverse Event|1|||
105909745|NCT02600923|365328476|FG000|Overall Study|Death|10|||
105909746|NCT02600923|365328476|FG000|Overall Study|Adverse Event|3|||
105909747|NCT02600923|365328476|FG000|Overall Study|Global deterioration of health status|2|||
105909748|NCT02600923|365328476|FG000|Overall Study|Insufficient clinical response|6|||
105909749|NCT02600923|365328476|FG000|Overall Study|Lost to Follow-up|1|||
105909750|NCT02600923|365328476|FG000|Overall Study|Withdrawal by Subject|5|||
105909751|NCT02600923|365328476|FG000|Overall Study|Objective progression or relapse|50|||
105909752|NCT02600923|365328476|FG000|Overall Study|Study terminated by Sponsor|53|||
105909753|NCT02600923|365328476|FG000|Overall Study|Not treated|1|||
105909754|NCT00792909|365328477|FG000|Overall Study|Withdrawal by Subject|0|||
105909755|NCT00792909|365328478|FG001|Overall Study|Withdrawal by Subject|1|||
105909756|NCT00792909|365328479|FG002|Overall Study|Withdrawal by Subject|0|||
105909757|NCT00941304|365328480|FG000|Overall Study|Lost to Follow-up|1|||
105909758|NCT00941304|365328481|FG001|Overall Study|Lost to Follow-up|0|||
105909759|NCT00941304|365328482|FG002|Overall Study|Lost to Follow-up|0|||
105909760|NCT00941304|365328483|FG003|Overall Study|Lost to Follow-up|0|||
105909761|NCT00941304|365328484|FG004|Overall Study|Lost to Follow-up|0|||
105909762|NCT03293394|365328485|FG000|Follow-up (6 Months)|Adverse Event|4|||
105909763|NCT03293394|365328486|FG001|Follow-up (6 Months)|Adverse Event|2|||
105909764|NCT01497067|365328492|FG000|Overall Study|Lost to Follow-up|56|||
105909765|NCT01497067|365328492|FG000|Overall Study|Adverse Event|3|||
105909766|NCT01497067|365328492|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
105909767|NCT01497067|365328492|FG000|Overall Study|Other|13|||
105909768|NCT01765569|365328495|FG000|Period B|Withdrawal by Subject|1|||
105909769|NCT01765569|365328495|FG000|Period C|Death|1|||
105909770|NCT05415462|365328497|FG000|Overall Study|Death|18|||
105909771|NCT05415462|365328498|FG001|Overall Study|Death|10|||
105909772|NCT05415462|365328497|FG000|Overall Study|Lost to Follow-up|72|||
105909773|NCT05415462|365328498|FG001|Overall Study|Lost to Follow-up|64|||
105909774|NCT05415462|365328497|FG000|Overall Study|Physician Decision|5|||
105909775|NCT05415462|365328498|FG001|Overall Study|Physician Decision|5|||
105909776|NCT05415462|365328497|FG000|Overall Study|Protocol Deviation|1|||
105909777|NCT05415462|365328498|FG001|Overall Study|Protocol Deviation|0|||
105909778|NCT05415462|365328497|FG000|Overall Study|Withdrawal by Subject|129|||
105909779|NCT05415462|365328498|FG001|Overall Study|Withdrawal by Subject|101|||
105909780|NCT05415462|365328497|FG000|Overall Study|Other Than Specified|8|||
105909781|NCT05415462|365328498|FG001|Overall Study|Other Than Specified|8|||
105909782|NCT00753675|365328499|FG000|Overall Study|other reason|11|||
105909783|NCT00753675|365328500|FG001|Overall Study|other reason|12|||
105909784|NCT00753675|365328501|FG002|Overall Study|other reason|13|||
105909785|NCT00753675|365328499|FG000|Overall Study|Death|1|||
105909786|NCT00753675|365328500|FG001|Overall Study|Death|2|||
105909787|NCT00753675|365328501|FG002|Overall Study|Death|4|||
105909788|NCT00753675|365328499|FG000|Overall Study|Adverse Event|11|||
105909789|NCT00753675|365328500|FG001|Overall Study|Adverse Event|9|||
105909790|NCT00753675|365328501|FG002|Overall Study|Adverse Event|4|||
105909791|NCT00753675|365328499|FG000|Overall Study|Objective progression of disease|35|||
105909792|NCT00753675|365328500|FG001|Overall Study|Objective progression of disease|35|||
105909793|NCT00753675|365328501|FG002|Overall Study|Objective progression of disease|35|||
105909794|NCT00753675|365328499|FG000|Overall Study|Withdrawal by Subject|0|||
105909795|NCT00753675|365328500|FG001|Overall Study|Withdrawal by Subject|1|||
105909796|NCT00753675|365328501|FG002|Overall Study|Withdrawal by Subject|0|||
105909797|NCT00753675|365328499|FG000|Overall Study|Lost to Follow-up|1|||
105909798|NCT00753675|365328500|FG001|Overall Study|Lost to Follow-up|0|||
105909799|NCT00753675|365328501|FG002|Overall Study|Lost to Follow-up|0|||
105909800|NCT04376515|365328506|FG000|Overall Study|Found to have been vaccinated before study start|6|||
105909801|NCT04376515|365328507|FG001|Overall Study|Found to have been vaccinated before study start|6|||
105909802|NCT03430856|365328509|FG000|Overall Study|Adverse Event|0|||
105909803|NCT03430856|365328510|FG001|Overall Study|Adverse Event|1|||
105909804|NCT03430856|365328511|FG002|Overall Study|Adverse Event|0|||
105909805|NCT03430856|365328509|FG000|Overall Study|Rescue criteria|1|||
105909806|NCT03430856|365328510|FG001|Overall Study|Rescue criteria|1|||
105909807|NCT03430856|365328511|FG002|Overall Study|Rescue criteria|0|||
105909808|NCT03430856|365328509|FG000|Overall Study|Voluntary withdrawal of consent|1|||
105909809|NCT03430856|365328510|FG001|Overall Study|Voluntary withdrawal of consent|1|||
105909810|NCT03430856|365328511|FG002|Overall Study|Voluntary withdrawal of consent|1|||
105909811|NCT01395810|365328514|FG000|Overall Study|Adverse Event|0|||
105909812|NCT01395810|365328515|FG001|Overall Study|Adverse Event|1|||
105909813|NCT01395810|365328516|FG002|Overall Study|Adverse Event|0|||
105909814|NCT01395810|365328517|FG003|Overall Study|Adverse Event|0|||
105909815|NCT01395810|365328514|FG000|Overall Study|Lack of Efficacy|0|||
105909816|NCT01395810|365328515|FG001|Overall Study|Lack of Efficacy|1|||
105909817|NCT01395810|365328516|FG002|Overall Study|Lack of Efficacy|0|||
105909818|NCT01395810|365328517|FG003|Overall Study|Lack of Efficacy|0|||
105909819|NCT01395810|365328514|FG000|Overall Study|Withdrawal criteria|0|||
105909820|NCT01395810|365328515|FG001|Overall Study|Withdrawal criteria|2|||
105909821|NCT01395810|365328516|FG002|Overall Study|Withdrawal criteria|0|||
105909822|NCT01395810|365328517|FG003|Overall Study|Withdrawal criteria|0|||
105909823|NCT01395810|365328514|FG000|Overall Study|Unclassified|2|||
105909824|NCT01395810|365328515|FG001|Overall Study|Unclassified|0|||
105909825|NCT01395810|365328516|FG002|Overall Study|Unclassified|0|||
105909826|NCT01395810|365328517|FG003|Overall Study|Unclassified|0|||
105909827|NCT04826484|365330204|FG000|Overall Study|Lost to Follow-up|2|||
105909828|NCT04826484|365330205|FG001|Overall Study|Lost to Follow-up|0|||
105909829|NCT02250300|365330206|FG000|Expansion Phase|Death|6|||
105909830|NCT02250300|365330207|FG001|Expansion Phase|Death|7|||
105909831|NCT02250300|365330208|FG002|Expansion Phase|Death|0|||
105909832|NCT02250300|365330209|FG003|Expansion Phase|Death|0|||
105909833|NCT00522548|365330217|FG000|Overall Study|Adverse Event|2|||
105909834|NCT00522548|365330218|FG001|Overall Study|Adverse Event|2|||
105909835|NCT00522548|365330217|FG000|Overall Study|Withdrawal by Subject|0|||
105909836|NCT00522548|365330218|FG001|Overall Study|Withdrawal by Subject|2|||
105909837|NCT00281697|365330219|FG000|Overall Study|> 60 days since last dose of study drug|4|||
105909838|NCT00281697|365330220|FG001|Overall Study|> 60 days since last dose of study drug|4|||
105909839|NCT00281697|365330219|FG000|Overall Study|Adverse Event|54|||
105909840|NCT00281697|365330220|FG001|Overall Study|Adverse Event|15|||
105909841|NCT00281697|365330219|FG000|Overall Study|Death|8|||
105909842|NCT00281697|365330220|FG001|Overall Study|Death|3|||
105909843|NCT00281697|365330219|FG000|Overall Study|Disease progression|279|||
105909844|NCT00281697|365330220|FG001|Overall Study|Disease progression|149|||
105909845|NCT00281697|365330219|FG000|Overall Study|Other|5|||
105909846|NCT00281697|365330220|FG001|Overall Study|Other|6|||
105909847|NCT00281697|365330219|FG000|Overall Study|Physician's decision to withdraw|15|||
105909848|NCT00281697|365330220|FG001|Overall Study|Physician's decision to withdraw|12|||
105909849|NCT00281697|365330219|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
105909850|NCT00281697|365330220|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
105909851|NCT00281697|365330219|FG000|Overall Study|Did not receive study drug|3|||
105909852|NCT00281697|365330220|FG001|Overall Study|Did not receive study drug|2|||
105909853|NCT00572455|365330221|FG000|Stage I (14 Days)|Adverse Event|0|||
105909854|NCT00572455|365330222|FG001|Stage I (14 Days)|Adverse Event|0|||
105909855|NCT00572455|365330223|FG002|Stage I (14 Days)|Adverse Event|0|||
105909856|NCT00572455|365330224|FG003|Stage I (14 Days)|Adverse Event|0|||
105909857|NCT00572455|365330225|FG004|Stage I (14 Days)|Adverse Event|0|||
105909858|NCT00572455|365330226|FG005|Stage I (14 Days)|Adverse Event|3|||
105909859|NCT00572455|365330227|FG006|Stage I (14 Days)|Adverse Event|0|||
105909860|NCT00572455|365330228|FG007|Stage I (14 Days)|Adverse Event|0|||
105909861|NCT00572455|365330229|FG008|Stage I (14 Days)|Adverse Event|0|||
105909862|NCT00572455|365330230|FG009|Stage I (14 Days)|Adverse Event|0|||
105909863|NCT00572455|365330231|FG010|Stage I (14 Days)|Adverse Event|0|||
105909864|NCT00572455|365330232|FG011|Stage I (14 Days)|Adverse Event|0|||
105909865|NCT00572455|365330233|FG012|Stage I (14 Days)|Adverse Event|0|||
105909866|NCT00572455|365330234|FG013|Stage I (14 Days)|Adverse Event|0|||
105909867|NCT00572455|365330221|FG000|Stage I (14 Days)|Other|0|||
105909868|NCT00572455|365330222|FG001|Stage I (14 Days)|Other|0|||
105909869|NCT00572455|365330223|FG002|Stage I (14 Days)|Other|0|||
105909870|NCT00572455|365330224|FG003|Stage I (14 Days)|Other|0|||
105909871|NCT00572455|365330225|FG004|Stage I (14 Days)|Other|1|||
105909872|NCT00572455|365330226|FG005|Stage I (14 Days)|Other|0|||
105909873|NCT00572455|365330227|FG006|Stage I (14 Days)|Other|0|||
105909874|NCT00572455|365330228|FG007|Stage I (14 Days)|Other|0|||
105909875|NCT00572455|365330229|FG008|Stage I (14 Days)|Other|0|||
105909876|NCT00572455|365330230|FG009|Stage I (14 Days)|Other|0|||
105909877|NCT00572455|365330231|FG010|Stage I (14 Days)|Other|0|||
105909878|NCT00572455|365330232|FG011|Stage I (14 Days)|Other|0|||
105909879|NCT00572455|365330233|FG012|Stage I (14 Days)|Other|0|||
105909880|NCT00572455|365330234|FG013|Stage I (14 Days)|Other|0|||
105909881|NCT00572455|365330221|FG000|Stage II (28 Days)|Adverse Event|0|||
105909882|NCT00572455|365330222|FG001|Stage II (28 Days)|Adverse Event|0|||
105909883|NCT00572455|365330223|FG002|Stage II (28 Days)|Adverse Event|0|||
105909884|NCT00572455|365330224|FG003|Stage II (28 Days)|Adverse Event|0|||
105909885|NCT00572455|365330225|FG004|Stage II (28 Days)|Adverse Event|0|||
105909886|NCT00572455|365330226|FG005|Stage II (28 Days)|Adverse Event|0|||
105909887|NCT00572455|365330227|FG006|Stage II (28 Days)|Adverse Event|0|||
105909888|NCT00572455|365330228|FG007|Stage II (28 Days)|Adverse Event|0|||
105909889|NCT00572455|365330229|FG008|Stage II (28 Days)|Adverse Event|1|||
105909890|NCT00572455|365330230|FG009|Stage II (28 Days)|Adverse Event|3|||
105909891|NCT00572455|365330231|FG010|Stage II (28 Days)|Adverse Event|3|||
105909892|NCT00572455|365330232|FG011|Stage II (28 Days)|Adverse Event|4|||
105909893|NCT00572455|365330233|FG012|Stage II (28 Days)|Adverse Event|5|||
105909894|NCT00572455|365330234|FG013|Stage II (28 Days)|Adverse Event|1|||
105909895|NCT00572455|365330221|FG000|Stage II (28 Days)|Death|0|||
105909896|NCT00572455|365330222|FG001|Stage II (28 Days)|Death|0|||
105909897|NCT00572455|365330223|FG002|Stage II (28 Days)|Death|0|||
105909898|NCT00572455|365330224|FG003|Stage II (28 Days)|Death|0|||
105909899|NCT00572455|365330225|FG004|Stage II (28 Days)|Death|0|||
105909900|NCT00572455|365330226|FG005|Stage II (28 Days)|Death|0|||
105909901|NCT00572455|365330227|FG006|Stage II (28 Days)|Death|0|||
105909902|NCT00572455|365330228|FG007|Stage II (28 Days)|Death|0|||
105909903|NCT00572455|365330229|FG008|Stage II (28 Days)|Death|1|||
105909904|NCT00572455|365330230|FG009|Stage II (28 Days)|Death|0|||
105909905|NCT00572455|365330231|FG010|Stage II (28 Days)|Death|0|||
105909906|NCT00572455|365330232|FG011|Stage II (28 Days)|Death|0|||
105909907|NCT00572455|365330233|FG012|Stage II (28 Days)|Death|0|||
105909908|NCT00572455|365330234|FG013|Stage II (28 Days)|Death|0|||
105909909|NCT00572455|365330221|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
105909910|NCT00572455|365330222|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
105909911|NCT00572455|365330223|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
105909912|NCT00572455|365330224|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
105909913|NCT00572455|365330225|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
105909914|NCT00572455|365330226|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
105909915|NCT00572455|365330227|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
105909916|NCT00572455|365330228|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
105909917|NCT00572455|365330229|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
105909918|NCT00572455|365330230|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
105909919|NCT00572455|365330231|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
105909920|NCT00572455|365330232|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
105909921|NCT00572455|365330233|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
105909922|NCT00572455|365330234|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
105909923|NCT00572455|365330221|FG000|Stage II (28 Days)|Other|0|||
105909924|NCT00572455|365330222|FG001|Stage II (28 Days)|Other|0|||
105909925|NCT00572455|365330223|FG002|Stage II (28 Days)|Other|0|||
105909926|NCT00572455|365330224|FG003|Stage II (28 Days)|Other|0|||
105909927|NCT00572455|365330225|FG004|Stage II (28 Days)|Other|0|||
105909928|NCT00572455|365330226|FG005|Stage II (28 Days)|Other|0|||
105909929|NCT00572455|365330227|FG006|Stage II (28 Days)|Other|0|||
105909930|NCT00572455|365330228|FG007|Stage II (28 Days)|Other|0|||
105909931|NCT00572455|365330229|FG008|Stage II (28 Days)|Other|1|||
105909932|NCT00572455|365330230|FG009|Stage II (28 Days)|Other|0|||
105909933|NCT00572455|365330231|FG010|Stage II (28 Days)|Other|0|||
105909934|NCT00572455|365330232|FG011|Stage II (28 Days)|Other|0|||
105909935|NCT00572455|365330233|FG012|Stage II (28 Days)|Other|0|||
105909936|NCT00572455|365330234|FG013|Stage II (28 Days)|Other|0|||
105909937|NCT00572455|365330221|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
105909938|NCT00572455|365330222|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
105909939|NCT00572455|365330223|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
105909940|NCT00572455|365330224|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
105909941|NCT00572455|365330225|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
105909942|NCT00572455|365330226|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
105909943|NCT00572455|365330227|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
105909944|NCT00572455|365330228|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
105909945|NCT00572455|365330229|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
105909946|NCT00572455|365330230|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
105909947|NCT00572455|365330231|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
105909948|NCT00572455|365330232|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
105909949|NCT00572455|365330233|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
105909950|NCT00572455|365330234|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
105909951|NCT04547140|365330235|FG000|Overall Study|Adverse Event|0|||
105909952|NCT04547140|365330236|FG001|Overall Study|Adverse Event|1|||
105909953|NCT04547140|365330235|FG000|Overall Study|Withdrawal by Subject|0|||
105909954|NCT04547140|365330236|FG001|Overall Study|Withdrawal by Subject|1|||
105909955|NCT04547140|365330235|FG000|Overall Study|Lost to Follow-up|3|||
105909956|NCT04547140|365330236|FG001|Overall Study|Lost to Follow-up|1|||
105909957|NCT04547140|365330235|FG000|Overall Study|Death|2|||
105909958|NCT04547140|365330236|FG001|Overall Study|Death|1|||
105909959|NCT04547140|365330235|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
105909960|NCT04547140|365330236|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
105909961|NCT04547140|365330235|FG000|Overall Study|Pregnancy|1|||
105909962|NCT04547140|365330236|FG001|Overall Study|Pregnancy|0|||
105909963|NCT04547140|365330235|FG000|Overall Study|Reason Not Specified|4|||
105909964|NCT04547140|365330236|FG001|Overall Study|Reason Not Specified|1|||
105909965|NCT00003483|365330237|FG000|Overall Study|Not evaluable|1|||
105909966|NCT02609386|365330238|FG000|Overall Study|Withdrawal by Subject|6|||
105909967|NCT02609386|365330239|FG001|Overall Study|Withdrawal by Subject|1|||
105909968|NCT02609386|365330238|FG000|Overall Study|Lost to Follow-up|3|||
105909969|NCT02609386|365330239|FG001|Overall Study|Lost to Follow-up|5|||
105909970|NCT02609386|365330238|FG000|Overall Study|Death|19|||
105909971|NCT02609386|365330239|FG001|Overall Study|Death|9|||
105909972|NCT02609386|365330238|FG000|Overall Study|Physician Decision|0|||
105909973|NCT02609386|365330239|FG001|Overall Study|Physician Decision|2|||
105909974|NCT00873730|365330240|FG000|Overall Study|Protocol Deviation|5|||
105909975|NCT00873730|365330241|FG001|Overall Study|Protocol Deviation|2|||
105909976|NCT00873730|365330240|FG000|Overall Study|Adverse Event|0|||
105909977|NCT00873730|365330241|FG001|Overall Study|Adverse Event|2|||
105909978|NCT00873730|365330240|FG000|Overall Study|Withdrawal by Subject|0|||
105909979|NCT00873730|365330241|FG001|Overall Study|Withdrawal by Subject|1|||
105909980|NCT00873730|365330240|FG000|Overall Study|Sponsor decision|1|||
105909981|NCT00873730|365330241|FG001|Overall Study|Sponsor decision|0|||
105909982|NCT01051557|365330244|FG000|Overall Study|Physician Decision|1|||
105909983|NCT01051557|365330245|FG001|Overall Study|Physician Decision|0|||
105909984|NCT01051557|365330246|FG002|Overall Study|Physician Decision|0|||
105909985|NCT01051557|365330247|FG003|Overall Study|Physician Decision|0|||
105909986|NCT01051557|365330248|FG004|Overall Study|Physician Decision|0|||
105909987|NCT01051557|365330249|FG005|Overall Study|Physician Decision|0|||
105909988|NCT01051557|365330250|FG006|Overall Study|Physician Decision|0|||
105909989|NCT01051557|365330244|FG000|Overall Study|disease progression|3|||
105909990|NCT01051557|365330245|FG001|Overall Study|disease progression|3|||
105909991|NCT01051557|365330246|FG002|Overall Study|disease progression|5|||
105909992|NCT01051557|365330247|FG003|Overall Study|disease progression|2|||
105909993|NCT01051557|365330248|FG004|Overall Study|disease progression|4|||
105909994|NCT01051557|365330249|FG005|Overall Study|disease progression|3|||
105909995|NCT01051557|365330250|FG006|Overall Study|disease progression|1|||
105909996|NCT01051557|365330244|FG000|Overall Study|Withdrawal by Subject|0|||
105909997|NCT01051557|365330245|FG001|Overall Study|Withdrawal by Subject|0|||
105909998|NCT01051557|365330246|FG002|Overall Study|Withdrawal by Subject|1|||
105909999|NCT01051557|365330247|FG003|Overall Study|Withdrawal by Subject|0|||
105910000|NCT01051557|365330248|FG004|Overall Study|Withdrawal by Subject|2|||
105910001|NCT01051557|365330249|FG005|Overall Study|Withdrawal by Subject|0|||
105910002|NCT01051557|365330250|FG006|Overall Study|Withdrawal by Subject|1|||
105910003|NCT01051557|365330244|FG000|Overall Study|Adverse Event|0|||
105910004|NCT01051557|365330245|FG001|Overall Study|Adverse Event|0|||
105910005|NCT01051557|365330246|FG002|Overall Study|Adverse Event|0|||
105910006|NCT01051557|365330247|FG003|Overall Study|Adverse Event|1|||
105910007|NCT01051557|365330248|FG004|Overall Study|Adverse Event|1|||
105910008|NCT01051557|365330249|FG005|Overall Study|Adverse Event|3|||
105910009|NCT01051557|365330250|FG006|Overall Study|Adverse Event|4|||
105910010|NCT04668209|365330251|FG000|Overall Study|Withdrawal by Subject|2|||
105910011|NCT04668209|365330252|FG001|Overall Study|Withdrawal by Subject|2|||
105910012|NCT04668209|365330251|FG000|Overall Study|Lost to Follow-up|3|||
105910013|NCT04668209|365330252|FG001|Overall Study|Lost to Follow-up|4|||
105910014|NCT04668209|365330251|FG000|Overall Study|Subject Expired|2|||
105910015|NCT04668209|365330252|FG001|Overall Study|Subject Expired|0|||
105910016|NCT04668209|365330251|FG000|Overall Study|Withdrawn from study|0|||
105910017|NCT04668209|365330252|FG001|Overall Study|Withdrawn from study|1|||
105910018|NCT04668209|365330251|FG000|Overall Study|Adverse Event|0|||
105910019|NCT04668209|365330252|FG001|Overall Study|Adverse Event|1|||
105910020|NCT00536510|365330253|FG000|Overall Study|Adverse Event|27|||
105910021|NCT00536510|365330254|FG001|Overall Study|Adverse Event|4|||
105910022|NCT00536510|365330253|FG000|Overall Study|Lost to Follow-up|11|||
105910023|NCT00536510|365330254|FG001|Overall Study|Lost to Follow-up|8|||
105910024|NCT00536510|365330253|FG000|Overall Study|Protocol Violation|4|||
105910025|NCT00536510|365330254|FG001|Overall Study|Protocol Violation|5|||
105910026|NCT00536510|365330253|FG000|Overall Study|Withdrawal by Subject|16|||
105910027|NCT00536510|365330254|FG001|Overall Study|Withdrawal by Subject|9|||
105910028|NCT00536510|365330253|FG000|Overall Study|Flushing with Product|20|||
105910029|NCT00536510|365330254|FG001|Overall Study|Flushing with Product|0|||
105910030|NCT00536510|365330253|FG000|Overall Study|Laboratory Adverse Event|2|||
105910031|NCT00536510|365330254|FG001|Overall Study|Laboratory Adverse Event|1|||
105910032|NCT00536510|365330253|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
105910033|NCT00536510|365330254|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
105910034|NCT00943397|365330255|FG000|Overall Study|Adverse Event|0|||
105910035|NCT00943397|365330256|FG001|Overall Study|Adverse Event|6|||
105910036|NCT00943397|365330255|FG000|Overall Study|Lost to Follow-up|0|||
105910037|NCT00943397|365330256|FG001|Overall Study|Lost to Follow-up|4|||
105910038|NCT00943397|365330255|FG000|Overall Study|Protocol Violation|2|||
105910039|NCT00943397|365330256|FG001|Overall Study|Protocol Violation|5|||
105910040|NCT00943397|365330255|FG000|Overall Study|Withdrawal by Subject|1|||
105910041|NCT00943397|365330256|FG001|Overall Study|Withdrawal by Subject|1|||
105910042|NCT00943397|365330255|FG000|Overall Study|Site terminated and other|12|||
105910043|NCT00943397|365330256|FG001|Overall Study|Site terminated and other|56|||
105910044|NCT04878055|365330257|FG000|Overall Study|Patient transferred in another department|0|||
105910045|NCT04878055|365330258|FG001|Overall Study|Patient transferred in another department|2|||
105910046|NCT04878055|365330257|FG000|Overall Study|Physician Decision|1|||
105910047|NCT04878055|365330258|FG001|Overall Study|Physician Decision|1|||
105910048|NCT04878055|365330257|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
105910049|NCT04878055|365330258|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
105910050|NCT04878055|365330257|FG000|Overall Study|Adverse Event|12|||
105910051|NCT04878055|365330258|FG001|Overall Study|Adverse Event|7|||
105910052|NCT04878055|365330257|FG000|Overall Study|Other|5|||
105910053|NCT04878055|365330258|FG001|Overall Study|Other|0|||
105910054|NCT04878055|365330257|FG000|Overall Study|Withdrawal by Subject|7|||
105910055|NCT04878055|365330258|FG001|Overall Study|Withdrawal by Subject|3|||
105910056|NCT04878055|365330257|FG000|Overall Study|Lost to Follow-up|10|||
105910057|NCT04878055|365330258|FG001|Overall Study|Lost to Follow-up|1|||
105910058|NCT01968811|365330259|FG000|Overall Study|Protocol Violation|4|||
105910059|NCT01968811|365330259|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
105910060|NCT00411450|365330260|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
105910061|NCT01765296|365330265|FG000|Overall Study|Protocol Violation|0|||
105910062|NCT01765296|365330266|FG001|Overall Study|Protocol Violation|5|||
105910063|NCT01765296|365330267|FG002|Overall Study|Protocol Violation|4|||
105910064|NCT01765296|365330265|FG000|Overall Study|Withdrawal by Subject|4|||
105910065|NCT01765296|365330266|FG001|Overall Study|Withdrawal by Subject|2|||
105910066|NCT01765296|365330267|FG002|Overall Study|Withdrawal by Subject|2|||
105910067|NCT01765296|365330265|FG000|Overall Study|Adverse Event|1|||
105910068|NCT01765296|365330266|FG001|Overall Study|Adverse Event|13|||
105910069|NCT01765296|365330267|FG002|Overall Study|Adverse Event|5|||
105910070|NCT01765296|365330265|FG000|Overall Study|Lack of Efficacy|0|||
105910071|NCT01765296|365330266|FG001|Overall Study|Lack of Efficacy|0|||
105910072|NCT01765296|365330267|FG002|Overall Study|Lack of Efficacy|2|||
105910073|NCT01576575|365330268|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
105910074|NCT01576575|365330268|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
105910075|NCT01576575|365330268|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
105910076|NCT03478371|365330271|FG000|Overall Study|non-compliance|1|||
105910077|NCT03478371|365330271|FG000|Overall Study|Lost to Follow-up|4|||
105910078|NCT04556760|365330272|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105910079|NCT04556760|365330273|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
105910080|NCT04556760|365330274|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105910081|NCT04556760|365330275|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105910082|NCT04556760|365330276|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105910083|NCT04556760|365330277|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
105910084|NCT04556760|365330272|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105910085|NCT04556760|365330273|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105910086|NCT04556760|365330274|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105910087|NCT04556760|365330275|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
105999483|NCT01473732|365661142|FG000|Overall Study|Death|1|||
105999484|NCT01473732|365661143|FG001|Overall Study|Death|0|||
105910088|NCT04556760|365330276|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105910089|NCT04556760|365330277|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
105786373|NCT01869959|364870509|FG001|Treatment Period|Sponsor decision|1|||
105910090|NCT01048541|365330288|FG000|Overall Study|Withdrawal by Subject|1|||
105999485|NCT00671034|365661145|FG000|Overall Study|Adverse Event|5|||
105910091|NCT01048541|365330289|FG001|Overall Study|Withdrawal by Subject|0|||
105910092|NCT00627497|365330290|FG000|Overall Study|Lost to Follow-up|1|||
105910093|NCT00627497|365330291|FG001|Overall Study|Lost to Follow-up|1|||
105910094|NCT00627497|365330292|FG002|Overall Study|Lost to Follow-up|0|||
105910095|NCT00627497|365330293|FG003|Overall Study|Lost to Follow-up|0|||
105910096|NCT06060496|365330294|FG000|Overall Study|Withdrawal by Subject|2|||
105910097|NCT06060496|365330294|FG000|Overall Study|Lost to Follow-up|2|||
105910098|NCT00186485|365330301|FG000|Overall Study|Lost to Follow-up|3|||
105910099|NCT03243305|365330305|FG000|Overall Study|Lost to Follow-up|250|||
105910100|NCT03243305|365330305|FG000|Overall Study|Withdrawal by Subject|170|||
105910101|NCT03243305|365330305|FG000|Overall Study|Pregnancy|104|||
105910102|NCT03243305|365330305|FG000|Overall Study|Non-Compliance with Study Drug|38|||
105910103|NCT03243305|365330305|FG000|Overall Study|Adverse Event|23|||
105910104|NCT03243305|365330305|FG000|Overall Study|No sexually active|26|||
105910105|NCT03243305|365330305|FG000|Overall Study|Physician Decision|22|||
105910106|NCT03243305|365330305|FG000|Overall Study|Protocol Violation|22|||
105910107|NCT03243305|365330305|FG000|Overall Study|Study method no longer primary method|12|||
105910108|NCT03243305|365330305|FG000|Overall Study|Study Terminated by Sponsor|1|||
105910109|NCT03243305|365330305|FG000|Overall Study|Early terminations|267|||
105910110|NCT00905424|365330308|FG000|Overall Study|Lost to Follow-up|3|||
105910111|NCT00905424|365330309|FG001|Overall Study|Lost to Follow-up|3|||
105910112|NCT00905424|365330308|FG000|Overall Study|Withdrawal by Subject|1|||
105910113|NCT00905424|365330309|FG001|Overall Study|Withdrawal by Subject|2|||
105910114|NCT00905424|365330308|FG000|Overall Study|Adverse Event|4|||
105910115|NCT00905424|365330309|FG001|Overall Study|Adverse Event|2|||
105910116|NCT00905424|365330308|FG000|Overall Study|Non-compliance with study medication|2|||
105910117|NCT00905424|365330309|FG001|Overall Study|Non-compliance with study medication|0|||
105910118|NCT00905424|365330308|FG000|Overall Study|Sponsor decision|1|||
105910119|NCT00905424|365330309|FG001|Overall Study|Sponsor decision|0|||
105910120|NCT00905424|365330308|FG000|Overall Study|Positive urine drug screen|0|||
105910121|NCT00905424|365330309|FG001|Overall Study|Positive urine drug screen|1|||
105910122|NCT00905424|365330308|FG000|Overall Study|Non-adherence to visit schedule|0|||
105910123|NCT00905424|365330309|FG001|Overall Study|Non-adherence to visit schedule|1|||
105910124|NCT00991289|365330310|FG000|Overall Study|Adverse Event|1|||
105910125|NCT00991289|365330310|FG000|Overall Study|Physician Decision|2|||
105910126|NCT00991289|365330310|FG000|Overall Study|Withdrawal by Subject|3|||
105910127|NCT00991289|365330310|FG000|Overall Study|Lost to Follow-up|4|||
105910128|NCT00991289|365330310|FG000|Overall Study|Protocol Violation|2|||
105910129|NCT05225389|365330311|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
105910130|NCT04552132|365330312|FG000|Overall Study|Lost to Follow-up|4|||
105910131|NCT04552132|365330313|FG001|Overall Study|Lost to Follow-up|3|||
105910132|NCT04552132|365330312|FG000|Overall Study|Protocol Violation|1|||
105910133|NCT04552132|365330313|FG001|Overall Study|Protocol Violation|0|||
105910134|NCT03311841|365330314|FG000|14-day Wash-out|Adverse Event|0|||
105910135|NCT03311841|365330315|FG001|14-day Wash-out|Adverse Event|1|||
105910136|NCT03311841|365330316|FG002|14-day Wash-out|Adverse Event|0|||
105910137|NCT03311841|365330317|FG003|14-day Wash-out|Adverse Event|0|||
105910138|NCT03311841|365330318|FG004|14-day Wash-out|Adverse Event|0|||
105910139|NCT03311841|365330314|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
105910140|NCT03311841|365330315|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
105910141|NCT03311841|365330316|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
105910142|NCT03311841|365330317|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
105910143|NCT03311841|365330318|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
105910144|NCT02472886|365330320|FG000|Overall Study|Lack of Efficacy|0|||
105910145|NCT02472886|365330321|FG001|Overall Study|Lack of Efficacy|2|||
105910146|NCT02472886|365330322|FG002|Overall Study|Lack of Efficacy|1|||
105910147|NCT05216835|365330330|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
105910148|NCT05216835|365330331|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
105910149|NCT05216835|365330332|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
105910150|NCT05216835|365330333|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
105910151|NCT05216835|365330334|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
105910152|NCT05216835|365330335|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
105910153|NCT05216835|365330336|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
105910154|NCT05216835|365330337|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
105999486|NCT00671034|365661146|FG001|Overall Study|Adverse Event|7|||
105999487|NCT00671034|365661147|FG002|Overall Study|Adverse Event|1|||
105999488|NCT00671034|365661145|FG000|Overall Study|Death|3|||
105910155|NCT05216835|365330330|FG000|Overall Study|Death|0|||
105910156|NCT05216835|365330331|FG001|Overall Study|Death|0|||
105910157|NCT05216835|365330332|FG002|Overall Study|Death|0|||
105910158|NCT05216835|365330333|FG003|Overall Study|Death|1|||
105999489|NCT00671034|365661146|FG001|Overall Study|Death|2|||
105910159|NCT05216835|365330334|FG004|Overall Study|Death|1|||
105910160|NCT05216835|365330335|FG005|Overall Study|Death|1|||
105910161|NCT05216835|365330336|FG006|Overall Study|Death|1|||
105910162|NCT05216835|365330337|FG007|Overall Study|Death|1|||
105910163|NCT05216835|365330330|FG000|Overall Study|Physician Decision|0|||
105910164|NCT05216835|365330331|FG001|Overall Study|Physician Decision|0|||
105910165|NCT05216835|365330332|FG002|Overall Study|Physician Decision|0|||
105910166|NCT05216835|365330333|FG003|Overall Study|Physician Decision|0|||
105910167|NCT05216835|365330334|FG004|Overall Study|Physician Decision|0|||
105910168|NCT05216835|365330335|FG005|Overall Study|Physician Decision|1|||
105910169|NCT05216835|365330336|FG006|Overall Study|Physician Decision|1|||
105910170|NCT05216835|365330337|FG007|Overall Study|Physician Decision|0|||
105910171|NCT05216835|365330330|FG000|Overall Study|Study terminated by Sponsor|0|||
105910172|NCT05216835|365330331|FG001|Overall Study|Study terminated by Sponsor|0|||
105910173|NCT05216835|365330332|FG002|Overall Study|Study terminated by Sponsor|0|||
105910174|NCT05216835|365330333|FG003|Overall Study|Study terminated by Sponsor|0|||
105910175|NCT05216835|365330334|FG004|Overall Study|Study terminated by Sponsor|0|||
105910176|NCT05216835|365330335|FG005|Overall Study|Study terminated by Sponsor|0|||
105910177|NCT05216835|365330336|FG006|Overall Study|Study terminated by Sponsor|0|||
105910178|NCT05216835|365330337|FG007|Overall Study|Study terminated by Sponsor|1|||
105910179|NCT05216835|365330330|FG000|Overall Study|Withdrawal by Subject|1|||
105910180|NCT05216835|365330331|FG001|Overall Study|Withdrawal by Subject|0|||
105910181|NCT05216835|365330332|FG002|Overall Study|Withdrawal by Subject|1|||
105910182|NCT05216835|365330333|FG003|Overall Study|Withdrawal by Subject|0|||
105910183|NCT05216835|365330334|FG004|Overall Study|Withdrawal by Subject|1|||
105910184|NCT05216835|365330335|FG005|Overall Study|Withdrawal by Subject|0|||
105910185|NCT05216835|365330336|FG006|Overall Study|Withdrawal by Subject|0|||
105910186|NCT05216835|365330337|FG007|Overall Study|Withdrawal by Subject|1|||
105910187|NCT05216835|365330330|FG000|Overall Study|Other|0|||
105910188|NCT05216835|365330331|FG001|Overall Study|Other|1|||
105910189|NCT05216835|365330332|FG002|Overall Study|Other|0|||
105910190|NCT05216835|365330333|FG003|Overall Study|Other|0|||
105910191|NCT05216835|365330334|FG004|Overall Study|Other|0|||
105910192|NCT05216835|365330335|FG005|Overall Study|Other|0|||
105910193|NCT05216835|365330336|FG006|Overall Study|Other|0|||
105910194|NCT05216835|365330337|FG007|Overall Study|Other|0|||
105910195|NCT00096538|365330338|FG000|Overall Study|Withdrawal by Subject|1|||
105910196|NCT03283930|365330339|FG000|Overall Study|Scheduling conflict|8|||
105910197|NCT03283930|365330340|FG001|Overall Study|Scheduling conflict|10|||
105910198|NCT03283930|365330339|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
105910199|NCT03283930|365330340|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
105910200|NCT03283930|365330339|FG000|Overall Study|Technical software issue|2|||
105910201|NCT03283930|365330340|FG001|Overall Study|Technical software issue|2|||
105910202|NCT05502302|365330343|FG000|Overall Study|Lost to Follow-up|6|||
105910203|NCT05502302|365330343|FG000|Overall Study|Death|2|||
105910204|NCT00571662|365330344|FG000|Overall Study|Withdrawal by Subject|2|||
105910205|NCT00571662|365330344|FG000|Overall Study|psychiatric instability|1|||
105910206|NCT00571662|365330344|FG000|Overall Study|Adverse Event|5|||
105910207|NCT02155985|365330345|FG000|Overall Study|Withdrawal by Subject|0|||
105910208|NCT02155985|365330346|FG001|Overall Study|Withdrawal by Subject|0|||
105910209|NCT02155985|365330347|FG002|Overall Study|Withdrawal by Subject|1|||
105910210|NCT02155985|365330345|FG000|Overall Study|Lost to Follow-up|1|||
105910211|NCT02155985|365330346|FG001|Overall Study|Lost to Follow-up|0|||
105910212|NCT02155985|365330347|FG002|Overall Study|Lost to Follow-up|0|||
105910213|NCT00101868|365330350|FG000|Overall Study|Death|10|||
105910214|NCT00101868|365330351|FG001|Overall Study|Death|10|||
105910215|NCT00101868|365330350|FG000|Overall Study|Withdrawal by Subject|8|||
105910216|NCT00101868|365330351|FG001|Overall Study|Withdrawal by Subject|9|||
105910217|NCT00101868|365330350|FG000|Overall Study|Protocol Violation|3|||
105910218|NCT00101868|365330351|FG001|Overall Study|Protocol Violation|0|||
105910219|NCT00101868|365330350|FG000|Overall Study|Lost to Follow-up|8|||
105910220|NCT00101868|365330351|FG001|Overall Study|Lost to Follow-up|13|||
105910221|NCT02329327|365330352|FG000|Overall Study|Death|78|||
105910222|NCT02329327|365330353|FG001|Overall Study|Death|0|||
105910223|NCT02329327|365330352|FG000|Overall Study|Withdrawal by Subject|3|||
105910224|NCT02329327|365330353|FG001|Overall Study|Withdrawal by Subject|0|||
105910225|NCT02329327|365330352|FG000|Overall Study|Lost to Follow-up|4|||
105910226|NCT02329327|365330353|FG001|Overall Study|Lost to Follow-up|0|||
105910227|NCT03560869|365330354|FG000|Overall Study|Withdrawal by Subject|3|||
105910228|NCT03560869|365330355|FG001|Overall Study|Withdrawal by Subject|4|||
105910229|NCT03560869|365330354|FG000|Overall Study|Screening failure|4|||
105910230|NCT03560869|365330355|FG001|Overall Study|Screening failure|4|||
105674005|NCT02546921|364470557|FG003|Overall Study|Patient Choice|0|||
105910231|NCT03560869|365330354|FG000|Overall Study|Withdrawal by PI|0|||
105910232|NCT03560869|365330355|FG001|Overall Study|Withdrawal by PI|1|||
105674006|NCT02546921|364470558|FG004|Overall Study|Patient Choice|0|||
105674007|NCT02546921|364470559|FG005|Overall Study|Patient Choice|1|||
105910233|NCT01801111|365330356|FG000|Overall Study|Adverse Event|12|||
105910234|NCT01801111|365330356|FG000|Overall Study|Death|8|||
105910235|NCT01801111|365330356|FG000|Overall Study|Physician Decision|5|||
105674008|NCT02546921|364470560|FG006|Overall Study|Patient Choice|0|||
105674009|NCT02091206|364470561|FG000|Treatment Period|Adverse Event|0|||
105910236|NCT01801111|365330356|FG000|Overall Study|Other|1|||
105910237|NCT01801111|365330356|FG000|Overall Study|Withdrawal by Subject|4|||
105674010|NCT02091206|364470562|FG001|Treatment Period|Adverse Event|1|||
105674011|NCT02091206|364470563|FG002|Treatment Period|Adverse Event|0|||
105674012|NCT02091206|364470564|FG003|Treatment Period|Adverse Event|0|||
105910238|NCT01801111|365330356|FG000|Overall Study|Study Terminated by Sponsor|27|||
105910239|NCT01801111|365330356|FG000|Overall Study|Progressive Disease|81|||
105910240|NCT05404711|365330357|FG000|Completed Study Visit|Withdrawal by Subject|1|||
105910241|NCT05404711|365330357|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
105910242|NCT05404711|365330357|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
105910243|NCT05404711|365330357|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
105910244|NCT05404711|365330357|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
105910245|NCT05404711|365330357|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
105910246|NCT03284853|365330359|FG000|Overall Study|Adverse Event|40|||
105910247|NCT03284853|365330360|FG001|Overall Study|Adverse Event|4|||
105910248|NCT03284853|365330359|FG000|Overall Study|Withdrawal by Subject|5|||
105910249|NCT03284853|365330360|FG001|Overall Study|Withdrawal by Subject|1|||
105910250|NCT03284853|365330359|FG000|Overall Study|Lost to Follow-up|1|||
105910251|NCT03284853|365330360|FG001|Overall Study|Lost to Follow-up|0|||
105910252|NCT03284853|365330359|FG000|Overall Study|Lack of Efficacy|1|||
105910253|NCT03284853|365330360|FG001|Overall Study|Lack of Efficacy|0|||
105910254|NCT03284853|365330359|FG000|Overall Study|Disallowed Concurrent Medication|1|||
105910255|NCT03284853|365330360|FG001|Overall Study|Disallowed Concurrent Medication|1|||
105910256|NCT03284853|365330359|FG000|Overall Study|Protocol Violation|3|||
105910257|NCT03284853|365330360|FG001|Overall Study|Protocol Violation|3|||
105910258|NCT03284853|365330359|FG000|Overall Study|Death|0|||
105910259|NCT03284853|365330360|FG001|Overall Study|Death|1|||
105910260|NCT03284853|365330359|FG000|Overall Study|Other - Reason not reported in CSR|4|||
105910261|NCT03284853|365330360|FG001|Overall Study|Other - Reason not reported in CSR|3|||
105910262|NCT01949142|365330363|FG000|Overall Study|Withdrawal of consent|1|||
105910263|NCT01949142|365330364|FG001|Overall Study|Withdrawal of consent|0|||
105910264|NCT01949142|365330363|FG000|Overall Study|Lost to Follow-up|1|||
105910265|NCT01949142|365330364|FG001|Overall Study|Lost to Follow-up|1|||
105910266|NCT01949142|365330363|FG000|Overall Study|Parent changed their mind|1|||
105910267|NCT01949142|365330364|FG001|Overall Study|Parent changed their mind|0|||
105910268|NCT05027815|365330367|FG000|Overall Study|Death|2|||
105910269|NCT05027815|365330368|FG001|Overall Study|Death|1|||
105910270|NCT03677869|365330372|FG000|Overall Study|Withdrawal by Subject|1|||
105910271|NCT00103285|365332550|FG000|Induction|Adverse Event|14|||
105910272|NCT00103285|365332551|FG001|Induction|Adverse Event|0|||
105910273|NCT00103285|365332552|FG002|Induction|Adverse Event|0|||
105910274|NCT00103285|365332553|FG003|Induction|Adverse Event|0|||
105910275|NCT00103285|365332554|FG004|Induction|Adverse Event|0|||
105910276|NCT00103285|365332555|FG005|Induction|Adverse Event|0|||
105910277|NCT00103285|365332556|FG006|Induction|Adverse Event|0|||
105910278|NCT00103285|365332557|FG007|Induction|Adverse Event|0|||
105910279|NCT00103285|365332550|FG000|Induction|Death|24|||
105910280|NCT00103285|365332551|FG001|Induction|Death|0|||
105910281|NCT00103285|365332552|FG002|Induction|Death|0|||
105910282|NCT00103285|365332553|FG003|Induction|Death|0|||
105910283|NCT00103285|365332554|FG004|Induction|Death|0|||
105910284|NCT00103285|365332555|FG005|Induction|Death|0|||
105910285|NCT00103285|365332556|FG006|Induction|Death|0|||
105910286|NCT00103285|365332557|FG007|Induction|Death|0|||
105910287|NCT00103285|365332550|FG000|Induction|Physician Decision|103|||
105910288|NCT00103285|365332551|FG001|Induction|Physician Decision|0|||
105910289|NCT00103285|365332552|FG002|Induction|Physician Decision|0|||
105910290|NCT00103285|365332553|FG003|Induction|Physician Decision|0|||
105910291|NCT00103285|365332554|FG004|Induction|Physician Decision|0|||
105910292|NCT00103285|365332555|FG005|Induction|Physician Decision|0|||
105910293|NCT00103285|365332556|FG006|Induction|Physician Decision|0|||
105910294|NCT00103285|365332557|FG007|Induction|Physician Decision|0|||
105910295|NCT00103285|365332550|FG000|Induction|Withdrawal by Subject|1|||
105910296|NCT00103285|365332551|FG001|Induction|Withdrawal by Subject|0|||
105910297|NCT00103285|365332552|FG002|Induction|Withdrawal by Subject|0|||
105910298|NCT00103285|365332553|FG003|Induction|Withdrawal by Subject|0|||
105910299|NCT00103285|365332554|FG004|Induction|Withdrawal by Subject|0|||
105910300|NCT00103285|365332555|FG005|Induction|Withdrawal by Subject|0|||
105910301|NCT00103285|365332556|FG006|Induction|Withdrawal by Subject|0|||
105910302|NCT00103285|365332557|FG007|Induction|Withdrawal by Subject|0|||
105910303|NCT00103285|365332550|FG000|Induction|Ineligible|43|||
105910304|NCT00103285|365332551|FG001|Induction|Ineligible|0|||
105910305|NCT00103285|365332552|FG002|Induction|Ineligible|0|||
105910306|NCT00103285|365332553|FG003|Induction|Ineligible|0|||
105910307|NCT00103285|365332554|FG004|Induction|Ineligible|0|||
105910308|NCT00103285|365332555|FG005|Induction|Ineligible|0|||
105910309|NCT00103285|365332556|FG006|Induction|Ineligible|0|||
105786374|NCT01869959|364870510|FG002|Treatment Period|Sponsor decision|0|||
105910310|NCT00103285|365332557|FG007|Induction|Ineligible|0|||
105910311|NCT00103285|365332550|FG000|Induction|Refusal|906|||
105910312|NCT00103285|365332551|FG001|Induction|Refusal|0|||
105910313|NCT00103285|365332552|FG002|Induction|Refusal|0|||
105910314|NCT00103285|365332553|FG003|Induction|Refusal|0|||
105910315|NCT00103285|365332554|FG004|Induction|Refusal|0|||
105910316|NCT00103285|365332555|FG005|Induction|Refusal|0|||
105910317|NCT00103285|365332556|FG006|Induction|Refusal|0|||
105910318|NCT00103285|365332557|FG007|Induction|Refusal|0|||
105910319|NCT00103285|365332550|FG000|Induction|Other|258|||
105910320|NCT00103285|365332551|FG001|Induction|Other|0|||
105910321|NCT00103285|365332552|FG002|Induction|Other|0|||
105910322|NCT00103285|365332553|FG003|Induction|Other|0|||
105910323|NCT00103285|365332554|FG004|Induction|Other|0|||
105910324|NCT00103285|365332555|FG005|Induction|Other|0|||
105910325|NCT00103285|365332556|FG006|Induction|Other|0|||
105910326|NCT00103285|365332557|FG007|Induction|Other|0|||
105910327|NCT00103285|365332550|FG000|Response Assignment|Adverse Event|0|||
105910328|NCT00103285|365332551|FG001|Response Assignment|Adverse Event|8|||
105910329|NCT00103285|365332552|FG002|Response Assignment|Adverse Event|3|||
105910330|NCT00103285|365332553|FG003|Response Assignment|Adverse Event|2|||
105910331|NCT00103285|365332554|FG004|Response Assignment|Adverse Event|3|||
105910332|NCT00103285|365332555|FG005|Response Assignment|Adverse Event|1|||
105910333|NCT00103285|365332556|FG006|Response Assignment|Adverse Event|1|||
105910334|NCT00103285|365332557|FG007|Response Assignment|Adverse Event|2|||
105910335|NCT00103285|365332550|FG000|Response Assignment|Death|0|||
105910336|NCT00103285|365332551|FG001|Response Assignment|Death|5|||
105910337|NCT00103285|365332552|FG002|Response Assignment|Death|2|||
105910338|NCT00103285|365332553|FG003|Response Assignment|Death|2|||
105910339|NCT00103285|365332554|FG004|Response Assignment|Death|3|||
105910340|NCT00103285|365332555|FG005|Response Assignment|Death|1|||
105910341|NCT00103285|365332556|FG006|Response Assignment|Death|0|||
105910342|NCT00103285|365332557|FG007|Response Assignment|Death|8|||
105910343|NCT00103285|365332550|FG000|Response Assignment|Lost to Follow-up|0|||
105910344|NCT00103285|365332551|FG001|Response Assignment|Lost to Follow-up|9|||
105910345|NCT00103285|365332552|FG002|Response Assignment|Lost to Follow-up|5|||
105910346|NCT00103285|365332553|FG003|Response Assignment|Lost to Follow-up|5|||
105910347|NCT00103285|365332554|FG004|Response Assignment|Lost to Follow-up|1|||
105910348|NCT00103285|365332555|FG005|Response Assignment|Lost to Follow-up|2|||
105910349|NCT00103285|365332556|FG006|Response Assignment|Lost to Follow-up|2|||
105910350|NCT00103285|365332557|FG007|Response Assignment|Lost to Follow-up|5|||
105910351|NCT00103285|365332550|FG000|Response Assignment|Physician Decision|0|||
105910352|NCT00103285|365332551|FG001|Response Assignment|Physician Decision|13|||
105910353|NCT00103285|365332552|FG002|Response Assignment|Physician Decision|14|||
105910354|NCT00103285|365332553|FG003|Response Assignment|Physician Decision|9|||
105910355|NCT00103285|365332554|FG004|Response Assignment|Physician Decision|13|||
105910356|NCT00103285|365332555|FG005|Response Assignment|Physician Decision|7|||
105910357|NCT00103285|365332556|FG006|Response Assignment|Physician Decision|4|||
105910358|NCT00103285|365332557|FG007|Response Assignment|Physician Decision|35|||
105910359|NCT00103285|365332550|FG000|Response Assignment|Protocol Violation|0|||
105910360|NCT00103285|365332551|FG001|Response Assignment|Protocol Violation|2|||
105910361|NCT00103285|365332552|FG002|Response Assignment|Protocol Violation|0|||
105910362|NCT00103285|365332553|FG003|Response Assignment|Protocol Violation|0|||
105910363|NCT00103285|365332554|FG004|Response Assignment|Protocol Violation|0|||
105910364|NCT00103285|365332555|FG005|Response Assignment|Protocol Violation|0|||
105910365|NCT00103285|365332556|FG006|Response Assignment|Protocol Violation|0|||
105910366|NCT00103285|365332557|FG007|Response Assignment|Protocol Violation|0|||
105910367|NCT00103285|365332550|FG000|Response Assignment|Withdrawal by Subject|0|||
105910368|NCT00103285|365332551|FG001|Response Assignment|Withdrawal by Subject|4|||
105910369|NCT00103285|365332552|FG002|Response Assignment|Withdrawal by Subject|1|||
105910370|NCT00103285|365332553|FG003|Response Assignment|Withdrawal by Subject|1|||
105910371|NCT00103285|365332554|FG004|Response Assignment|Withdrawal by Subject|2|||
105910372|NCT00103285|365332555|FG005|Response Assignment|Withdrawal by Subject|2|||
105910373|NCT00103285|365332556|FG006|Response Assignment|Withdrawal by Subject|0|||
105910374|NCT00103285|365332557|FG007|Response Assignment|Withdrawal by Subject|2|||
105910375|NCT00103285|365332550|FG000|Response Assignment|Ineligible|0|||
105910376|NCT00103285|365332551|FG001|Response Assignment|Ineligible|8|||
105910377|NCT00103285|365332552|FG002|Response Assignment|Ineligible|6|||
105910378|NCT00103285|365332553|FG003|Response Assignment|Ineligible|2|||
105910379|NCT00103285|365332554|FG004|Response Assignment|Ineligible|0|||
105910380|NCT00103285|365332555|FG005|Response Assignment|Ineligible|3|||
105910381|NCT00103285|365332556|FG006|Response Assignment|Ineligible|1|||
105910382|NCT00103285|365332557|FG007|Response Assignment|Ineligible|5|||
105910383|NCT00103285|365332550|FG000|Response Assignment|Refusal|0|||
105910384|NCT00103285|365332551|FG001|Response Assignment|Refusal|53|||
105910385|NCT00103285|365332552|FG002|Response Assignment|Refusal|5|||
105910386|NCT00103285|365332553|FG003|Response Assignment|Refusal|3|||
105910387|NCT00103285|365332554|FG004|Response Assignment|Refusal|25|||
105910388|NCT00103285|365332555|FG005|Response Assignment|Refusal|15|||
105910389|NCT00103285|365332556|FG006|Response Assignment|Refusal|30|||
105910390|NCT00103285|365332557|FG007|Response Assignment|Refusal|10|||
105910391|NCT00103285|365332550|FG000|Response Assignment|Other|0|||
105910392|NCT00103285|365332551|FG001|Response Assignment|Other|30|||
105910393|NCT00103285|365332552|FG002|Response Assignment|Other|48|||
105910394|NCT00103285|365332553|FG003|Response Assignment|Other|38|||
105910395|NCT00103285|365332554|FG004|Response Assignment|Other|37|||
105910396|NCT00103285|365332555|FG005|Response Assignment|Other|17|||
105910397|NCT00103285|365332556|FG006|Response Assignment|Other|11|||
105910398|NCT00103285|365332557|FG007|Response Assignment|Other|53|||
105910399|NCT02624947|365332560|FG000|Maternal Participants|Adverse Event|5|||
105910400|NCT02624947|365332561|FG001|Maternal Participants|Adverse Event|0|||
105910401|NCT02624947|365332560|FG000|Maternal Participants|Investigator Decision|5|||
105910402|NCT02624947|365332561|FG001|Maternal Participants|Investigator Decision|3|||
105910403|NCT02624947|365332560|FG000|Maternal Participants|Lost to Follow-up|54|||
105910404|NCT02624947|365332561|FG001|Maternal Participants|Lost to Follow-up|24|||
105910405|NCT02624947|365332560|FG000|Maternal Participants|Non Compliance|8|||
105910406|NCT02624947|365332561|FG001|Maternal Participants|Non Compliance|5|||
105910407|NCT02624947|365332560|FG000|Maternal Participants|Sponsor Request|1|||
105910408|NCT02624947|365332561|FG001|Maternal Participants|Sponsor Request|1|||
105910409|NCT02624947|365332560|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
105910410|NCT02624947|365332561|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
105910411|NCT02624947|365332560|FG000|Maternal Participants|Miscellaneous|23|||
105910412|NCT02624947|365332561|FG001|Maternal Participants|Miscellaneous|15|||
105910413|NCT02624947|365332560|FG000|Infant Participants|Adverse Event|18|||
105910414|NCT02624947|365332561|FG001|Infant Participants|Adverse Event|11|||
105910415|NCT02624947|365332560|FG000|Infant Participants|Investigator Decision|5|||
105910416|NCT02624947|365332561|FG001|Infant Participants|Investigator Decision|4|||
105910417|NCT02624947|365332560|FG000|Infant Participants|Lost to Follow-up|93|||
105910418|NCT02624947|365332561|FG001|Infant Participants|Lost to Follow-up|58|||
105910419|NCT02624947|365332560|FG000|Infant Participants|Non Compliance|17|||
105910420|NCT02624947|365332561|FG001|Infant Participants|Non Compliance|7|||
105910421|NCT02624947|365332560|FG000|Infant Participants|Sponsor Request|0|||
105910422|NCT02624947|365332561|FG001|Infant Participants|Sponsor Request|1|||
105910423|NCT02624947|365332560|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
105910424|NCT02624947|365332561|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
105910425|NCT02624947|365332560|FG000|Infant Participants|Miscellaneous|50|||
105910426|NCT02624947|365332561|FG001|Infant Participants|Miscellaneous|26|||
105910427|NCT03492437|365332567|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105910428|NCT03492437|365332568|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105910429|NCT03872843|365332569|FG000|Overall Study|Lost to Follow-up|5|||
105910430|NCT03872843|365332570|FG001|Overall Study|Lost to Follow-up|7|||
105910431|NCT02121795|365332571|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
105910432|NCT02121795|365332572|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
105910433|NCT02121795|365332571|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
105910434|NCT02121795|365332572|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
105910435|NCT02121795|365332571|FG000|Double-Blind Phase|Lost to Follow-up|7|||
105910436|NCT02121795|365332572|FG001|Double-Blind Phase|Lost to Follow-up|4|||
105910437|NCT02121795|365332571|FG000|Double-Blind Phase|Physician Decision|2|||
105910438|NCT02121795|365332572|FG001|Double-Blind Phase|Physician Decision|5|||
105910439|NCT02121795|365332571|FG000|Double-Blind Phase|Adverse Event|5|||
105910440|NCT02121795|365332572|FG001|Double-Blind Phase|Adverse Event|0|||
105910441|NCT02121795|365332571|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
105910442|NCT02121795|365332572|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
105910443|NCT02121795|365332571|FG000|Double-Blind Phase|Protocol Violation|0|||
105910444|NCT02121795|365332572|FG001|Double-Blind Phase|Protocol Violation|3|||
105910445|NCT02121795|365332571|FG000|Double-Blind Phase|Death|1|||
105910446|NCT02121795|365332572|FG001|Double-Blind Phase|Death|1|||
105910447|NCT02121795|365332571|FG000|Open-Label Phase|Physician Decision|8|||
105910448|NCT02121795|365332572|FG001|Open-Label Phase|Physician Decision|8|||
105910449|NCT02121795|365332571|FG000|Open-Label Phase|Withdrawal by Subject|3|||
105910450|NCT02121795|365332572|FG001|Open-Label Phase|Withdrawal by Subject|2|||
105910451|NCT02121795|365332571|FG000|Open-Label Phase|Lost to Follow-up|1|||
105910452|NCT02121795|365332572|FG001|Open-Label Phase|Lost to Follow-up|0|||
105910453|NCT05133323|365332573|FG000|Overall Study|Lack of Efficacy|0|||
105910454|NCT05133323|365332574|FG001|Overall Study|Lack of Efficacy|0|||
105910455|NCT05133323|365332575|FG002|Overall Study|Lack of Efficacy|1|||
105910456|NCT05133323|365332573|FG000|Overall Study|Withdrawal by Subject|2|||
105910457|NCT05133323|365332574|FG001|Overall Study|Withdrawal by Subject|1|||
105910458|NCT05133323|365332575|FG002|Overall Study|Withdrawal by Subject|0|||
105910459|NCT01714544|365332576|FG000|Overall Study|Lost to Follow-up|1|||
105910460|NCT01714544|365332576|FG000|Overall Study|Physician Decision|1|||
105910461|NCT01714544|365332576|FG000|Overall Study|Withdrawal by Subject|1|||
105910462|NCT00994110|365332577|FG000|Overall Study|Withdrawal by Subject|9|||
105910463|NCT00994110|365332578|FG001|Overall Study|Withdrawal by Subject|9|||
105910464|NCT00994110|365332577|FG000|Overall Study|Not Treated|4|||
105910465|NCT00994110|365332578|FG001|Overall Study|Not Treated|8|||
105910466|NCT00994110|365332577|FG000|Overall Study|Adverse Event|1|||
105910467|NCT00994110|365332578|FG001|Overall Study|Adverse Event|0|||
105910468|NCT00994110|365332577|FG000|Overall Study|Patient not resected|41|||
105910469|NCT00994110|365332578|FG001|Overall Study|Patient not resected|52|||
105910470|NCT00994110|365332577|FG000|Overall Study|Pt not eligible|10|||
105910471|NCT00994110|365332578|FG001|Overall Study|Pt not eligible|5|||
105910472|NCT00666211|365332581|FG000|Overall Study|Withdrawal by Subject|10|||
105910473|NCT00666211|365332582|FG001|Overall Study|Withdrawal by Subject|13|||
105910474|NCT00666211|365332581|FG000|Overall Study|went off medication, no more pain|1|||
105910475|NCT00666211|365332582|FG001|Overall Study|went off medication, no more pain|0|||
105910476|NCT00666211|365332581|FG000|Overall Study|patient non-compliant|6|||
105910477|NCT00666211|365332582|FG001|Overall Study|patient non-compliant|6|||
105910478|NCT00666211|365332581|FG000|Overall Study|disease progression|1|||
105910479|NCT00666211|365332582|FG001|Overall Study|disease progression|8|||
105910480|NCT00666211|365332581|FG000|Overall Study|Lost to Follow-up|2|||
105910481|NCT00666211|365332582|FG001|Overall Study|Lost to Follow-up|0|||
105910482|NCT00666211|365332581|FG000|Overall Study|toxicity|0|||
105910483|NCT00666211|365332582|FG001|Overall Study|toxicity|2|||
105910484|NCT00666211|365332581|FG000|Overall Study|hospital admission|0|||
105910485|NCT00666211|365332582|FG001|Overall Study|hospital admission|5|||
105910486|NCT00666211|365332581|FG000|Overall Study|Death|0|||
105910487|NCT00666211|365332582|FG001|Overall Study|Death|2|||
105910488|NCT00666211|365332581|FG000|Overall Study|off tx for other complicating disease|0|||
105910489|NCT00666211|365332582|FG001|Overall Study|off tx for other complicating disease|1|||
105910490|NCT00666211|365332581|FG000|Overall Study|Physician Decision|0|||
105910491|NCT00666211|365332582|FG001|Overall Study|Physician Decision|1|||
105910492|NCT01111565|365332584|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
105910493|NCT01111565|365332585|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
105910494|NCT01111565|365332586|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
105910495|NCT01111565|365332587|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
105910496|NCT01111565|365332588|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
105910497|NCT01111565|365332584|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
105910498|NCT01111565|365332585|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
105910499|NCT01111565|365332586|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
105910500|NCT01111565|365332587|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
105910501|NCT01111565|365332588|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
105910502|NCT01111565|365332584|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
105910503|NCT01111565|365332585|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
105910504|NCT01111565|365332586|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
105910505|NCT01111565|365332587|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
105910506|NCT01111565|365332588|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
105910507|NCT01111565|365332584|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
105910508|NCT01111565|365332585|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
105910509|NCT01111565|365332586|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
105910510|NCT01111565|365332587|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
105910511|NCT01111565|365332588|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
105910512|NCT01111565|365332584|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
105910513|NCT01111565|365332585|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
105910514|NCT01111565|365332586|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
105910515|NCT01111565|365332587|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
105910516|NCT01111565|365332588|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
105910517|NCT01111565|365332584|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
105910518|NCT01111565|365332585|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
105910519|NCT01111565|365332586|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
105910520|NCT01111565|365332587|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
105910521|NCT01111565|365332588|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
105910522|NCT01111565|365332584|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
105910523|NCT01111565|365332585|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
105910524|NCT01111565|365332586|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
105910525|NCT01111565|365332587|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
105910526|NCT01111565|365332588|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
105910527|NCT01111565|365332584|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105910528|NCT01111565|365332585|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105910529|NCT01111565|365332586|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105910530|NCT01111565|365332587|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
105910531|NCT01111565|365332588|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105910532|NCT01111565|365332584|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105910533|NCT01111565|365332585|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105910534|NCT01111565|365332586|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
105910535|NCT01111565|365332587|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105910536|NCT01111565|365332588|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105910537|NCT01111565|365332584|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
105910538|NCT01111565|365332585|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
105910539|NCT01111565|365332586|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
105910540|NCT01111565|365332587|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
105910541|NCT01111565|365332588|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
105674013|NCT02091206|364470561|FG000|Treatment Period|Met withdrawal criteria|0|||
105674014|NCT02091206|364470562|FG001|Treatment Period|Met withdrawal criteria|0|||
105910542|NCT01111565|365332584|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
105910543|NCT01111565|365332585|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
105910544|NCT01111565|365332586|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
105999490|NCT00671034|365661147|FG002|Overall Study|Death|1|||
105786375|NCT01869959|364870511|FG003|Treatment Period|Sponsor decision|1|||
105910545|NCT01111565|365332587|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
105910546|NCT01111565|365332588|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
105910547|NCT01111565|365332584|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
105910548|NCT01111565|365332585|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
105910549|NCT01111565|365332586|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
105910550|NCT01111565|365332587|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
105910551|NCT01111565|365332588|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
105910552|NCT02683239|365332590|FG000|Overall Study|Protocol Violation|35|||
105910553|NCT02683239|365332591|FG001|Overall Study|Protocol Violation|23|||
105910554|NCT02683239|365332592|FG002|Overall Study|Protocol Violation|26|||
105910555|NCT02683239|365332593|FG003|Overall Study|Protocol Violation|4|||
105910556|NCT02683239|365332594|FG004|Overall Study|Protocol Violation|35|||
105910557|NCT02683239|365332595|FG005|Overall Study|Protocol Violation|4|||
105910558|NCT02683239|365332596|FG006|Overall Study|Protocol Violation|5|||
105910559|NCT02683239|365332590|FG000|Overall Study|Adverse Event|64|||
105910560|NCT02683239|365332591|FG001|Overall Study|Adverse Event|39|||
105910561|NCT02683239|365332592|FG002|Overall Study|Adverse Event|42|||
105910562|NCT02683239|365332593|FG003|Overall Study|Adverse Event|16|||
105910563|NCT02683239|365332594|FG004|Overall Study|Adverse Event|189|||
105910564|NCT02683239|365332595|FG005|Overall Study|Adverse Event|9|||
105910565|NCT02683239|365332596|FG006|Overall Study|Adverse Event|9|||
105910566|NCT02683239|365332590|FG000|Overall Study|Physician Decision|38|||
105910567|NCT02683239|365332591|FG001|Overall Study|Physician Decision|19|||
105910568|NCT02683239|365332592|FG002|Overall Study|Physician Decision|14|||
105910569|NCT02683239|365332593|FG003|Overall Study|Physician Decision|73|||
105910570|NCT02683239|365332594|FG004|Overall Study|Physician Decision|143|||
105910571|NCT02683239|365332595|FG005|Overall Study|Physician Decision|14|||
105910572|NCT02683239|365332596|FG006|Overall Study|Physician Decision|15|||
105910573|NCT02683239|365332590|FG000|Overall Study|Withdrawal by Subject|187|||
105910574|NCT02683239|365332591|FG001|Overall Study|Withdrawal by Subject|99|||
105910575|NCT02683239|365332592|FG002|Overall Study|Withdrawal by Subject|91|||
105910576|NCT02683239|365332593|FG003|Overall Study|Withdrawal by Subject|18|||
105910577|NCT02683239|365332594|FG004|Overall Study|Withdrawal by Subject|248|||
105910578|NCT02683239|365332595|FG005|Overall Study|Withdrawal by Subject|22|||
105910579|NCT02683239|365332596|FG006|Overall Study|Withdrawal by Subject|28|||
105910580|NCT02683239|365332590|FG000|Overall Study|Lost to Follow-up|77|||
105910581|NCT02683239|365332591|FG001|Overall Study|Lost to Follow-up|24|||
105910582|NCT02683239|365332592|FG002|Overall Study|Lost to Follow-up|25|||
105910583|NCT02683239|365332593|FG003|Overall Study|Lost to Follow-up|7|||
105910584|NCT02683239|365332594|FG004|Overall Study|Lost to Follow-up|88|||
105910585|NCT02683239|365332595|FG005|Overall Study|Lost to Follow-up|8|||
105910586|NCT02683239|365332596|FG006|Overall Study|Lost to Follow-up|11|||
105910587|NCT02683239|365332590|FG000|Overall Study|Death|9|||
105910588|NCT02683239|365332591|FG001|Overall Study|Death|5|||
105910589|NCT02683239|365332592|FG002|Overall Study|Death|8|||
105910590|NCT02683239|365332593|FG003|Overall Study|Death|0|||
105910591|NCT02683239|365332594|FG004|Overall Study|Death|12|||
105910592|NCT02683239|365332595|FG005|Overall Study|Death|1|||
105910593|NCT02683239|365332596|FG006|Overall Study|Death|0|||
105910594|NCT02683239|365332590|FG000|Overall Study|Lack of Efficacy|50|||
105910595|NCT02683239|365332591|FG001|Overall Study|Lack of Efficacy|23|||
105910596|NCT02683239|365332592|FG002|Overall Study|Lack of Efficacy|12|||
105910597|NCT02683239|365332593|FG003|Overall Study|Lack of Efficacy|2|||
105910598|NCT02683239|365332594|FG004|Overall Study|Lack of Efficacy|29|||
105910599|NCT02683239|365332595|FG005|Overall Study|Lack of Efficacy|2|||
105910600|NCT02683239|365332596|FG006|Overall Study|Lack of Efficacy|3|||
105910601|NCT02683239|365332590|FG000|Overall Study|Missing data|0|||
105910602|NCT02683239|365332591|FG001|Overall Study|Missing data|1|||
105910603|NCT02683239|365332592|FG002|Overall Study|Missing data|1|||
105910604|NCT02683239|365332593|FG003|Overall Study|Missing data|0|||
105910605|NCT02683239|365332594|FG004|Overall Study|Missing data|1|||
105910606|NCT02683239|365332595|FG005|Overall Study|Missing data|0|||
105910607|NCT02683239|365332596|FG006|Overall Study|Missing data|0|||
105910608|NCT02169505|365332603|FG000|Overall Study|Withdrawal by Subject|1|||
105910609|NCT01135524|365332604|FG000|Overall Study|Withdrawal by Subject|14|||
105910610|NCT01135524|365332604|FG000|Overall Study|Adverse Event|20|||
105910611|NCT01135524|365332604|FG000|Overall Study|Lost to Follow-up|3|||
105910612|NCT01135524|365332604|FG000|Overall Study|Administrative|151|||
105910613|NCT01135524|365332604|FG000|Overall Study|Lack of Efficacy|8|||
105910614|NCT01254656|365332605|FG000|Overall Study|Discontinued due to termination of study|40|||
105910615|NCT01254656|365332606|FG001|Overall Study|Discontinued due to termination of study|39|||
105910616|NCT01254656|365332607|FG002|Overall Study|Discontinued due to termination of study|13|||
105910617|NCT01254656|365332605|FG000|Overall Study|Lack of Efficacy|3|||
105910618|NCT01254656|365332606|FG001|Overall Study|Lack of Efficacy|0|||
105910619|NCT01254656|365332607|FG002|Overall Study|Lack of Efficacy|0|||
105786376|NCT01869959|364870512|FG004|Treatment Period|Sponsor decision|0|||
105910620|NCT01254656|365332605|FG000|Overall Study|Lost to Follow-up|1|||
105910621|NCT01254656|365332606|FG001|Overall Study|Lost to Follow-up|0|||
105910622|NCT01254656|365332607|FG002|Overall Study|Lost to Follow-up|2|||
105910623|NCT01254656|365332605|FG000|Overall Study|Withdrawal by Subject|2|||
105910624|NCT01254656|365332606|FG001|Overall Study|Withdrawal by Subject|2|||
105910625|NCT01254656|365332607|FG002|Overall Study|Withdrawal by Subject|1|||
105910626|NCT01254656|365332605|FG000|Overall Study|Pregnancy|0|||
105910627|NCT01254656|365332606|FG001|Overall Study|Pregnancy|0|||
105910628|NCT01254656|365332607|FG002|Overall Study|Pregnancy|2|||
105910629|NCT01254656|365332605|FG000|Overall Study|Adverse Event|1|||
105910630|NCT01254656|365332606|FG001|Overall Study|Adverse Event|1|||
105910631|NCT01254656|365332607|FG002|Overall Study|Adverse Event|0|||
105910632|NCT01254656|365332605|FG000|Overall Study|Death|0|||
105910633|NCT01254656|365332606|FG001|Overall Study|Death|1|||
105910634|NCT01254656|365332607|FG002|Overall Study|Death|0|||
105910635|NCT01716663|365332620|FG000|Overall Study|Withdrawn prior to procedure|4|||
105910636|NCT01716663|365332620|FG000|Overall Study|Treated with non-study catheter|2|||
105910637|NCT01719380|365332632|FG000|Overall Study|Adverse Event|0|||
105910638|NCT01719380|365332633|FG001|Overall Study|Adverse Event|0|||
105910639|NCT01719380|365332634|FG002|Overall Study|Adverse Event|1|||
105910640|NCT01719380|365332635|FG003|Overall Study|Adverse Event|2|||
105910641|NCT01719380|365332636|FG004|Overall Study|Adverse Event|0|||
105910642|NCT01719380|365332637|FG005|Overall Study|Adverse Event|1|||
105910643|NCT01719380|365332638|FG006|Overall Study|Adverse Event|0|||
105910644|NCT01719380|365332639|FG007|Overall Study|Adverse Event|1|||
105910645|NCT01719380|365332640|FG008|Overall Study|Adverse Event|4|||
105910646|NCT01719380|365332641|FG009|Overall Study|Adverse Event|3|||
105910647|NCT01719380|365332632|FG000|Overall Study|Death|0|||
105910648|NCT01719380|365332633|FG001|Overall Study|Death|1|||
105910649|NCT01719380|365332634|FG002|Overall Study|Death|0|||
105910650|NCT01719380|365332635|FG003|Overall Study|Death|0|||
105910651|NCT01719380|365332636|FG004|Overall Study|Death|0|||
105910652|NCT01719380|365332637|FG005|Overall Study|Death|0|||
105910653|NCT01719380|365332638|FG006|Overall Study|Death|0|||
105910654|NCT01719380|365332639|FG007|Overall Study|Death|0|||
105910655|NCT01719380|365332640|FG008|Overall Study|Death|3|||
105910656|NCT01719380|365332641|FG009|Overall Study|Death|3|||
105910657|NCT01719380|365332632|FG000|Overall Study|Participant/Guardian Decision|0|||
105910658|NCT01719380|365332633|FG001|Overall Study|Participant/Guardian Decision|0|||
105910659|NCT01719380|365332634|FG002|Overall Study|Participant/Guardian Decision|1|||
105910660|NCT01719380|365332635|FG003|Overall Study|Participant/Guardian Decision|0|||
105910661|NCT01719380|365332636|FG004|Overall Study|Participant/Guardian Decision|0|||
105910662|NCT01719380|365332637|FG005|Overall Study|Participant/Guardian Decision|0|||
105910663|NCT01719380|365332638|FG006|Overall Study|Participant/Guardian Decision|0|||
105910664|NCT01719380|365332639|FG007|Overall Study|Participant/Guardian Decision|0|||
105910665|NCT01719380|365332640|FG008|Overall Study|Participant/Guardian Decision|2|||
105910666|NCT01719380|365332641|FG009|Overall Study|Participant/Guardian Decision|2|||
105910667|NCT01719380|365332632|FG000|Overall Study|Physician Decision|0|||
105910668|NCT01719380|365332633|FG001|Overall Study|Physician Decision|0|||
105910669|NCT01719380|365332634|FG002|Overall Study|Physician Decision|2|||
105910670|NCT01719380|365332635|FG003|Overall Study|Physician Decision|0|||
105910671|NCT01719380|365332636|FG004|Overall Study|Physician Decision|0|||
105910672|NCT01719380|365332637|FG005|Overall Study|Physician Decision|0|||
105910673|NCT01719380|365332638|FG006|Overall Study|Physician Decision|0|||
105910674|NCT01719380|365332639|FG007|Overall Study|Physician Decision|0|||
105910675|NCT01719380|365332640|FG008|Overall Study|Physician Decision|1|||
105910676|NCT01719380|365332641|FG009|Overall Study|Physician Decision|1|||
105910677|NCT01719380|365332632|FG000|Overall Study|Lack of Efficacy|2|||
105910678|NCT01719380|365332633|FG001|Overall Study|Lack of Efficacy|6|||
105910679|NCT01719380|365332634|FG002|Overall Study|Lack of Efficacy|5|||
105910680|NCT01719380|365332635|FG003|Overall Study|Lack of Efficacy|6|||
105910681|NCT01719380|365332636|FG004|Overall Study|Lack of Efficacy|3|||
105910682|NCT01719380|365332637|FG005|Overall Study|Lack of Efficacy|7|||
105910683|NCT01719380|365332638|FG006|Overall Study|Lack of Efficacy|10|||
105910684|NCT01719380|365332639|FG007|Overall Study|Lack of Efficacy|6|||
105910685|NCT01719380|365332640|FG008|Overall Study|Lack of Efficacy|39|||
105910686|NCT01719380|365332641|FG009|Overall Study|Lack of Efficacy|42|||
105910687|NCT01719380|365332632|FG000|Overall Study|Progressive Disease|0|||
105910688|NCT01719380|365332633|FG001|Overall Study|Progressive Disease|0|||
105910689|NCT01719380|365332634|FG002|Overall Study|Progressive Disease|0|||
105910690|NCT01719380|365332635|FG003|Overall Study|Progressive Disease|0|||
105910691|NCT01719380|365332636|FG004|Overall Study|Progressive Disease|0|||
105910692|NCT01719380|365332637|FG005|Overall Study|Progressive Disease|0|||
105910693|NCT01719380|365332638|FG006|Overall Study|Progressive Disease|0|||
105910694|NCT01719380|365332639|FG007|Overall Study|Progressive Disease|0|||
105910695|NCT01719380|365332640|FG008|Overall Study|Progressive Disease|1|||
105910696|NCT01719380|365332641|FG009|Overall Study|Progressive Disease|0|||
105910697|NCT01064414|365332642|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
105910698|NCT01064414|365332643|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
105910699|NCT01064414|365332644|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
105910700|NCT01064414|365332642|FG000|Core Period: Baseline to Week 26|Death|0|||
105910701|NCT01064414|365332643|FG001|Core Period: Baseline to Week 26|Death|1|||
105910702|NCT01064414|365332644|FG002|Core Period: Baseline to Week 26|Death|0|||
105910703|NCT01064414|365332642|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
105910704|NCT01064414|365332643|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
105910705|NCT01064414|365332644|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
105910706|NCT01064414|365332642|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
105910707|NCT01064414|365332643|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
105910708|NCT01064414|365332644|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
105910709|NCT01064414|365332642|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105910710|NCT01064414|365332643|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105910711|NCT01064414|365332644|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105910712|NCT01064414|365332642|FG000|Core Period: Baseline to Week 26|Other|4|||
105910713|NCT01064414|365332643|FG001|Core Period: Baseline to Week 26|Other|7|||
105910714|NCT01064414|365332644|FG002|Core Period: Baseline to Week 26|Other|2|||
105910715|NCT01064414|365332642|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
105910716|NCT01064414|365332643|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105910717|NCT01064414|365332644|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
105910718|NCT01064414|365332642|FG000|Extension Period: Week 26 to Week 52|Death|0|||
105910719|NCT01064414|365332643|FG001|Extension Period: Week 26 to Week 52|Death|1|||
105910720|NCT01064414|365332644|FG002|Extension Period: Week 26 to Week 52|Death|0|||
105910721|NCT01064414|365332642|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
105910722|NCT01064414|365332643|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105910723|NCT01064414|365332644|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105999491|NCT00671034|365661145|FG000|Overall Study|Physician Decision|12|||
105999492|NCT00671034|365661146|FG001|Overall Study|Physician Decision|4|||
105999493|NCT00671034|365661147|FG002|Overall Study|Physician Decision|5|||
105999494|NCT00671034|365661145|FG000|Overall Study|VHR ALL feature|8|||
105999495|NCT00671034|365661146|FG001|Overall Study|VHR ALL feature|3|||
105999496|NCT00671034|365661147|FG002|Overall Study|VHR ALL feature|5|||
105910724|NCT01064414|365332642|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
105910725|NCT01064414|365332643|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105910726|NCT01064414|365332644|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105910727|NCT01064414|365332642|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105910728|NCT01064414|365332643|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105910729|NCT01064414|365332644|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105910730|NCT01064414|365332642|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
105910731|NCT01064414|365332643|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
105910732|NCT01064414|365332644|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
105910733|NCT01064414|365332642|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105910734|NCT01064414|365332643|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105910735|NCT01064414|365332644|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105910736|NCT01064414|365332642|FG000|Extension Period: Week 26 to Week 52|Other|5|||
105910737|NCT01064414|365332643|FG001|Extension Period: Week 26 to Week 52|Other|2|||
105910738|NCT01064414|365332644|FG002|Extension Period: Week 26 to Week 52|Other|1|||
105910739|NCT03286218|365332648|FG000|Qualification Phase Period 1|Adverse Event|1|||
105910740|NCT03286218|365332649|FG001|Qualification Phase Period 1|Adverse Event|0|||
105910741|NCT03286218|365332650|FG002|Qualification Phase Period 1|Adverse Event|0|||
105910742|NCT03286218|365332651|FG003|Qualification Phase Period 1|Adverse Event|0|||
105910743|NCT03286218|365332652|FG004|Qualification Phase Period 1|Adverse Event|0|||
105910744|NCT03286218|365332653|FG005|Qualification Phase Period 1|Adverse Event|0|||
105910745|NCT03286218|365332654|FG006|Qualification Phase Period 1|Adverse Event|0|||
105910746|NCT03286218|365332655|FG007|Qualification Phase Period 1|Adverse Event|0|||
105910747|NCT03286218|365332656|FG008|Qualification Phase Period 1|Adverse Event|0|||
105910748|NCT03286218|365332657|FG009|Qualification Phase Period 1|Adverse Event|0|||
105910749|NCT03286218|365332658|FG010|Qualification Phase Period 1|Adverse Event|0|||
105910750|NCT03286218|365332659|FG011|Qualification Phase Period 1|Adverse Event|0|||
105910751|NCT03286218|365332648|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910752|NCT03286218|365332649|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
105910753|NCT03286218|365332650|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910754|NCT03286218|365332651|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910755|NCT03286218|365332652|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910756|NCT03286218|365332653|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910757|NCT03286218|365332654|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910758|NCT03286218|365332655|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
105999497|NCT00671034|365661145|FG000|Overall Study|Refusal|5|||
105999498|NCT00671034|365661146|FG001|Overall Study|Refusal|3|||
105999499|NCT00671034|365661147|FG002|Overall Study|Refusal|5|||
105999500|NCT00671034|365661145|FG000|Overall Study|includes Alternative therapy, etc.|6|||
105999501|NCT00671034|365661146|FG001|Overall Study|includes Alternative therapy, etc.|1|||
105999502|NCT00671034|365661147|FG002|Overall Study|includes Alternative therapy, etc.|7|||
105999503|NCT00997035|365661148|FG000|3-week Followup Visit|Lost to Follow-up|9|||
105999504|NCT00997035|365661149|FG001|3-week Followup Visit|Lost to Follow-up|6|||
105999505|NCT00997035|365661148|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
105999506|NCT00997035|365661149|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
105999507|NCT01169103|365661155|FG000|Overall Study|Lost to Follow-up|3|||
105999508|NCT01169103|365661156|FG001|Overall Study|Lost to Follow-up|3|||
105999509|NCT01169103|365661155|FG000|Overall Study|Withdrawal by Subject|3|||
105999510|NCT01169103|365661156|FG001|Overall Study|Withdrawal by Subject|1|||
105999511|NCT03010527|365661157|FG000|Overall Study|Death|0|||
105999512|NCT03010527|365661158|FG001|Overall Study|Death|0|||
105999513|NCT03010527|365661159|FG002|Overall Study|Death|1|||
105999514|NCT03010527|365661157|FG000|Overall Study|Adverse Event|0|||
105999515|NCT03010527|365661158|FG001|Overall Study|Adverse Event|4|||
105999516|NCT03010527|365661159|FG002|Overall Study|Adverse Event|2|||
105999517|NCT03010527|365661157|FG000|Overall Study|Protocol Violation|0|||
105999518|NCT03010527|365661158|FG001|Overall Study|Protocol Violation|1|||
105999519|NCT03010527|365661159|FG002|Overall Study|Protocol Violation|0|||
105999520|NCT03010527|365661157|FG000|Overall Study|Lost to Follow-up|0|||
105999521|NCT03010527|365661158|FG001|Overall Study|Lost to Follow-up|2|||
105999522|NCT03010527|365661159|FG002|Overall Study|Lost to Follow-up|1|||
105999523|NCT03010527|365661157|FG000|Overall Study|Withdrawal by Subject|0|||
105999524|NCT03010527|365661158|FG001|Overall Study|Withdrawal by Subject|3|||
105999525|NCT03010527|365661159|FG002|Overall Study|Withdrawal by Subject|4|||
105999526|NCT03010527|365661157|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
105999527|NCT03010527|365661158|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
105999528|NCT03010527|365661159|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
105999529|NCT03010527|365661157|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
105999530|NCT03010527|365661158|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
105999531|NCT03010527|365661159|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
105999532|NCT03010527|365661157|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
105999533|NCT03010527|365661158|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
105999534|NCT03010527|365661159|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
105999535|NCT02222558|365661164|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
105999536|NCT02222558|365661165|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
105999537|NCT02222558|365661166|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
105999538|NCT02222558|365661167|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
105999539|NCT02222558|365661168|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
105999540|NCT02222558|365661169|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
105999541|NCT02222558|365661164|FG000|Period 3|Withdrawal by Subject|0|||
105999542|NCT02222558|365661165|FG001|Period 3|Withdrawal by Subject|0|||
105999543|NCT02222558|365661166|FG002|Period 3|Withdrawal by Subject|0|||
105999544|NCT02222558|365661167|FG003|Period 3|Withdrawal by Subject|0|||
105999545|NCT02222558|365661168|FG004|Period 3|Withdrawal by Subject|0|||
105999546|NCT02222558|365661169|FG005|Period 3|Withdrawal by Subject|1|||
105999547|NCT01755234|365661172|FG000|Overall Study|Lost to Follow-up|11|||
105999548|NCT01755234|365661173|FG001|Overall Study|Lost to Follow-up|6|||
105999549|NCT01755234|365661172|FG000|Overall Study|Change in surgical case|2|||
105999550|NCT01755234|365661173|FG001|Overall Study|Change in surgical case|1|||
105999551|NCT01755234|365661172|FG000|Overall Study|case cancelled|1|||
105999552|NCT01755234|365661173|FG001|Overall Study|case cancelled|0|||
105999553|NCT01755234|365661172|FG000|Overall Study|Withdrawal by Subject|0|||
105999554|NCT01755234|365661173|FG001|Overall Study|Withdrawal by Subject|1|||
105999555|NCT01755234|365661172|FG000|Overall Study|unblinded|1|||
105999556|NCT01755234|365661173|FG001|Overall Study|unblinded|0|||
105999557|NCT02836652|365661174|FG000|Overall Study|Death|3|||
105999558|NCT02836652|365661175|FG001|Overall Study|Death|3|||
105999559|NCT02836652|365661174|FG000|Overall Study|Transplant/Explant|3|||
105999560|NCT02836652|365661175|FG001|Overall Study|Transplant/Explant|4|||
105999561|NCT02836652|365661174|FG000|Overall Study|Withdrawn|9|||
105999562|NCT02836652|365661175|FG001|Overall Study|Withdrawn|9|||
105999563|NCT02836652|365661174|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
105999564|NCT02836652|365661175|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
105999565|NCT01220167|365661179|FG000|Period 3|Urine positive for substance abuse|0|||
105999566|NCT01220167|365661180|FG001|Period 3|Urine positive for substance abuse|1|||
105999567|NCT01220167|365661181|FG002|Period 3|Urine positive for substance abuse|0|||
105999568|NCT00354679|365661184|FG000|Overall Study|Patient Not Treated|1|||
105999569|NCT03719131|365661185|FG000|Overall Study|Death|1|||
105999570|NCT03719131|365661186|FG001|Overall Study|Death|2|||
105999571|NCT02525588|365661187|FG000|Overall Study|Death|3|||
105999572|NCT02525588|365661188|FG001|Overall Study|Death|1|||
105999573|NCT02525588|365661187|FG000|Overall Study|Lost to Follow-up|2|||
105999574|NCT02525588|365661188|FG001|Overall Study|Lost to Follow-up|0|||
105999575|NCT02525588|365661187|FG000|Overall Study|Withdrawal by Subject|1|||
105999576|NCT02525588|365661188|FG001|Overall Study|Withdrawal by Subject|1|||
105999577|NCT02525588|365661187|FG000|Overall Study|Adverse Event|0|||
105999578|NCT02525588|365661188|FG001|Overall Study|Adverse Event|1|||
105999579|NCT03018691|365661189|FG000|Overall Study|Adverse Event|1|||
105999580|NCT03018691|365661190|FG001|Overall Study|Adverse Event|1|||
105999581|NCT03018691|365661191|FG002|Overall Study|Adverse Event|4|||
105999582|NCT03018691|365661189|FG000|Overall Study|Lack of Efficacy|0|||
105999583|NCT03018691|365661190|FG001|Overall Study|Lack of Efficacy|0|||
105999584|NCT03018691|365661191|FG002|Overall Study|Lack of Efficacy|1|||
105999585|NCT03018691|365661189|FG000|Overall Study|Withdrawal by Subject|0|||
105999586|NCT03018691|365661190|FG001|Overall Study|Withdrawal by Subject|0|||
105999587|NCT03018691|365661191|FG002|Overall Study|Withdrawal by Subject|1|||
105999588|NCT03018691|365661189|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105999589|NCT03018691|365661190|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105999590|NCT03018691|365661191|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105999591|NCT00743249|365661194|FG000|Overall Study|Adverse Event|0|||
105999592|NCT00743249|365661195|FG001|Overall Study|Adverse Event|4|||
105999593|NCT00743249|365661194|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
105999594|NCT00743249|365661195|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
105999595|NCT00743249|365661194|FG000|Overall Study|Unsuccessful insertion of stent|2|||
105999596|NCT00743249|365661195|FG001|Overall Study|Unsuccessful insertion of stent|1|||
105999597|NCT01147666|365661196|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
105999598|NCT01147666|365661197|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
105999599|NCT01147666|365661198|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
105999600|NCT01147666|365661199|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999601|NCT01147666|365661200|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999602|NCT01147666|365661201|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999603|NCT01147666|365661202|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999604|NCT01147666|365661203|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999605|NCT01147666|365661204|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999606|NCT01147666|365661205|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999607|NCT01147666|365661206|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999608|NCT01147666|365661207|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999609|NCT01147666|365661208|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
105999610|NCT01147666|365661209|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999611|NCT01147666|365661210|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
105999612|NCT01147666|365661196|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105999613|NCT01147666|365661197|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
105999614|NCT01147666|365661198|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105999615|NCT01147666|365661199|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105999616|NCT01147666|365661200|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
105999617|NCT01147666|365661201|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
105999618|NCT01147666|365661202|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
105999619|NCT01147666|365661203|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
105910759|NCT03286218|365332656|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910760|NCT03286218|365332657|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910761|NCT03286218|365332658|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910762|NCT03286218|365332659|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
105910763|NCT03286218|365332648|FG000|Qualification Phase Period 2|Adverse Event|0|||
105910764|NCT03286218|365332649|FG001|Qualification Phase Period 2|Adverse Event|1|||
105910765|NCT03286218|365332650|FG002|Qualification Phase Period 2|Adverse Event|0|||
105910766|NCT03286218|365332651|FG003|Qualification Phase Period 2|Adverse Event|0|||
105910767|NCT03286218|365332652|FG004|Qualification Phase Period 2|Adverse Event|0|||
105910768|NCT03286218|365332653|FG005|Qualification Phase Period 2|Adverse Event|0|||
105910769|NCT03286218|365332654|FG006|Qualification Phase Period 2|Adverse Event|0|||
105910770|NCT03286218|365332655|FG007|Qualification Phase Period 2|Adverse Event|0|||
105910771|NCT03286218|365332656|FG008|Qualification Phase Period 2|Adverse Event|0|||
105910772|NCT03286218|365332657|FG009|Qualification Phase Period 2|Adverse Event|0|||
105910773|NCT03286218|365332658|FG010|Qualification Phase Period 2|Adverse Event|0|||
105910774|NCT03286218|365332659|FG011|Qualification Phase Period 2|Adverse Event|0|||
105910775|NCT03286218|365332648|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
105910776|NCT03286218|365332649|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
105910777|NCT03286218|365332650|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910778|NCT03286218|365332651|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910779|NCT03286218|365332652|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910780|NCT03286218|365332653|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910781|NCT03286218|365332654|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105999620|NCT01147666|365661204|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105999621|NCT01147666|365661205|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
105999622|NCT01147666|365661206|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105999623|NCT01147666|365661207|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105910782|NCT03286218|365332655|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910783|NCT03286218|365332656|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910784|NCT03286218|365332657|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910785|NCT03286218|365332658|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910786|NCT03286218|365332659|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
105910787|NCT03286218|365332648|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
105910788|NCT03286218|365332649|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
105910789|NCT03286218|365332650|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
105910790|NCT03286218|365332651|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
105910791|NCT03286218|365332652|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
105910792|NCT03286218|365332653|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
105910793|NCT03286218|365332654|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
105910794|NCT03286218|365332655|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
105910795|NCT03286218|365332656|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
105910796|NCT03286218|365332657|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
105910797|NCT03286218|365332658|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
105910798|NCT03286218|365332659|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
105910799|NCT03286218|365332648|FG000|Qualification Phase Period 2|Protocol Violation|2|||
105910800|NCT03286218|365332649|FG001|Qualification Phase Period 2|Protocol Violation|0|||
105910801|NCT03286218|365332650|FG002|Qualification Phase Period 2|Protocol Violation|0|||
105910802|NCT03286218|365332651|FG003|Qualification Phase Period 2|Protocol Violation|0|||
105910803|NCT03286218|365332652|FG004|Qualification Phase Period 2|Protocol Violation|0|||
105910804|NCT03286218|365332653|FG005|Qualification Phase Period 2|Protocol Violation|0|||
105910805|NCT03286218|365332654|FG006|Qualification Phase Period 2|Protocol Violation|0|||
105910806|NCT03286218|365332655|FG007|Qualification Phase Period 2|Protocol Violation|0|||
105910807|NCT03286218|365332656|FG008|Qualification Phase Period 2|Protocol Violation|0|||
105910808|NCT03286218|365332657|FG009|Qualification Phase Period 2|Protocol Violation|0|||
105910809|NCT03286218|365332658|FG010|Qualification Phase Period 2|Protocol Violation|0|||
105910810|NCT03286218|365332659|FG011|Qualification Phase Period 2|Protocol Violation|0|||
105910811|NCT03286218|365332648|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
105910812|NCT03286218|365332649|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
105910813|NCT03286218|365332650|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910814|NCT03286218|365332651|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910815|NCT03286218|365332652|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910816|NCT03286218|365332653|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910817|NCT03286218|365332654|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910818|NCT03286218|365332655|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910819|NCT03286218|365332656|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910820|NCT03286218|365332657|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910821|NCT03286218|365332658|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910822|NCT03286218|365332659|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
105910823|NCT03286218|365332648|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
105910824|NCT03286218|365332649|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
105910825|NCT03286218|365332650|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
105910826|NCT03286218|365332651|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
105910827|NCT03286218|365332652|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
105910828|NCT03286218|365332653|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
105910829|NCT03286218|365332654|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
105910830|NCT03286218|365332655|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
105910831|NCT03286218|365332656|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
105910832|NCT03286218|365332657|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
105910833|NCT03286218|365332658|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
105910834|NCT03286218|365332659|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
105910835|NCT03286218|365332648|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910836|NCT03286218|365332649|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910837|NCT03286218|365332650|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910838|NCT03286218|365332651|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910839|NCT03286218|365332652|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910840|NCT03286218|365332653|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910841|NCT03286218|365332654|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910842|NCT03286218|365332655|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910843|NCT03286218|365332656|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910844|NCT03286218|365332657|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910845|NCT03286218|365332658|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
105910846|NCT03286218|365332659|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
105910847|NCT03131167|365332660|FG000|Overall Study|Other (Unspecified)|0|||
105910848|NCT03131167|365332661|FG001|Overall Study|Other (Unspecified)|0|||
105910849|NCT03131167|365332662|FG002|Overall Study|Other (Unspecified)|0|||
105910850|NCT03131167|365332663|FG003|Overall Study|Other (Unspecified)|0|||
105910851|NCT03131167|365332664|FG004|Overall Study|Other (Unspecified)|0|||
105910852|NCT03131167|365332665|FG005|Overall Study|Other (Unspecified)|1|||
105910853|NCT03131167|365332666|FG006|Overall Study|Other (Unspecified)|0|||
105910854|NCT03131167|365332667|FG007|Overall Study|Other (Unspecified)|0|||
105910855|NCT03131167|365332668|FG008|Overall Study|Other (Unspecified)|0|||
105910856|NCT03131167|365332669|FG009|Overall Study|Other (Unspecified)|0|||
105910857|NCT03131167|365332670|FG010|Overall Study|Other (Unspecified)|0|||
105910858|NCT03131167|365332671|FG011|Overall Study|Other (Unspecified)|0|||
105910859|NCT03131167|365332672|FG012|Overall Study|Other (Unspecified)|0|||
105910860|NCT02532374|365332675|FG000|Overall Study|Withdrawal by Subject|1|||
105910861|NCT02532374|365332675|FG000|Overall Study|Physician Decision|1|||
105910862|NCT01348139|365332676|FG000|Period 1|Adverse Event|1|||
105910863|NCT01348139|365332677|FG001|Period 1|Adverse Event|0|||
105910864|NCT01348139|365332678|FG002|Period 1|Adverse Event|0|||
105910865|NCT01348139|365332679|FG003|Period 1|Adverse Event|0|||
105910866|NCT01348139|365332680|FG004|Period 1|Adverse Event|0|||
105910867|NCT01348139|365332681|FG005|Period 1|Adverse Event|0|||
105910868|NCT02762084|365332682|FG000|Overall Study|Withdrawal by Subject|1|||
105910869|NCT02762084|365332683|FG001|Overall Study|Withdrawal by Subject|0|||
105910870|NCT02762084|365332684|FG002|Overall Study|Withdrawal by Subject|0|||
105910871|NCT02762084|365332682|FG000|Overall Study|Adverse Event|0|||
105910872|NCT02762084|365332683|FG001|Overall Study|Adverse Event|0|||
105910873|NCT02762084|365332684|FG002|Overall Study|Adverse Event|1|||
105910874|NCT02976519|365332689|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105910875|NCT02976519|365332690|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
105910876|NCT02976519|365332691|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105910877|NCT02976519|365332692|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105910878|NCT02976519|365332693|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105910879|NCT02976519|365332694|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105910880|NCT02976519|365332695|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
105910881|NCT02976519|365332689|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105910882|NCT02976519|365332690|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105910883|NCT02976519|365332691|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105910884|NCT02976519|365332692|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
105910885|NCT02976519|365332693|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105910886|NCT02976519|365332694|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105910887|NCT02976519|365332695|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
105910888|NCT02976519|365332689|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105910889|NCT02976519|365332690|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105910890|NCT02976519|365332691|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105910891|NCT02976519|365332692|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105910892|NCT02976519|365332693|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105910893|NCT02976519|365332694|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
105910894|NCT02976519|365332695|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
105910895|NCT02976519|365332689|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105910896|NCT02976519|365332690|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105910897|NCT02976519|365332691|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105910898|NCT02976519|365332692|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105910899|NCT02976519|365332693|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105910900|NCT02976519|365332694|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
105910901|NCT02976519|365332695|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
105910902|NCT02976519|365332689|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105910903|NCT02976519|365332690|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105910904|NCT02976519|365332691|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105910905|NCT02976519|365332692|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105910906|NCT02976519|365332693|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105910907|NCT02976519|365332694|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
105910908|NCT02976519|365332695|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
105910909|NCT01089127|365332696|FG000|Overall Study|Adverse Event|5|||
105910910|NCT01089127|365332697|FG001|Overall Study|Adverse Event|1|||
105910911|NCT01089127|365332698|FG002|Overall Study|Adverse Event|1|||
105910912|NCT01089127|365332699|FG003|Overall Study|Adverse Event|0|||
105910913|NCT01089127|365332700|FG004|Overall Study|Adverse Event|0|||
105910914|NCT01089127|365332701|FG005|Overall Study|Adverse Event|1|||
105910915|NCT01089127|365332696|FG000|Overall Study|Subject withdrew consent|0|||
105910916|NCT01089127|365332697|FG001|Overall Study|Subject withdrew consent|1|||
105910917|NCT01089127|365332698|FG002|Overall Study|Subject withdrew consent|1|||
105910918|NCT01089127|365332699|FG003|Overall Study|Subject withdrew consent|1|||
105910919|NCT01089127|365332700|FG004|Overall Study|Subject withdrew consent|0|||
105910920|NCT01089127|365332701|FG005|Overall Study|Subject withdrew consent|2|||
105910921|NCT01089127|365332696|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105910922|NCT01089127|365332697|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105910923|NCT01089127|365332698|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105910924|NCT01089127|365332699|FG003|Overall Study|Abnormal test procedure result(s)|0|||
105910925|NCT01089127|365332700|FG004|Overall Study|Abnormal test procedure result(s)|0|||
105910926|NCT01089127|365332701|FG005|Overall Study|Abnormal test procedure result(s)|0|||
105910927|NCT01089127|365332696|FG000|Overall Study|Lost to Follow-up|1|||
105910928|NCT01089127|365332697|FG001|Overall Study|Lost to Follow-up|1|||
105910929|NCT01089127|365332698|FG002|Overall Study|Lost to Follow-up|0|||
105910930|NCT01089127|365332699|FG003|Overall Study|Lost to Follow-up|0|||
105910931|NCT01089127|365332700|FG004|Overall Study|Lost to Follow-up|1|||
105910932|NCT01089127|365332701|FG005|Overall Study|Lost to Follow-up|0|||
105910933|NCT01089127|365332696|FG000|Overall Study|Protocol deviation|0|||
105910934|NCT01089127|365332697|FG001|Overall Study|Protocol deviation|1|||
105910935|NCT01089127|365332698|FG002|Overall Study|Protocol deviation|0|||
105910936|NCT01089127|365332699|FG003|Overall Study|Protocol deviation|0|||
105910937|NCT01089127|365332700|FG004|Overall Study|Protocol deviation|1|||
105910938|NCT01089127|365332701|FG005|Overall Study|Protocol deviation|0|||
105910939|NCT01278342|365332702|FG000|Overall Study|Physician Decision|0|||
105910940|NCT01278342|365332703|FG001|Overall Study|Physician Decision|1|||
105910941|NCT01278342|365332704|FG002|Overall Study|Physician Decision|0|||
105910942|NCT01278342|365332702|FG000|Overall Study|Lost to Follow-up|1|||
105910943|NCT01278342|365332703|FG001|Overall Study|Lost to Follow-up|0|||
105910944|NCT01278342|365332704|FG002|Overall Study|Lost to Follow-up|0|||
105910945|NCT01278342|365332702|FG000|Overall Study|Administrative problems|2|||
105910946|NCT01278342|365332703|FG001|Overall Study|Administrative problems|0|||
105910947|NCT01278342|365332704|FG002|Overall Study|Administrative problems|0|||
105910948|NCT01278342|365332702|FG000|Overall Study|Other|1|||
105910949|NCT01278342|365332703|FG001|Overall Study|Other|0|||
105910950|NCT01278342|365332704|FG002|Overall Study|Other|0|||
105910951|NCT03200548|365332707|FG000|Overall Study|Withdrawal by Subject|5|||
105910952|NCT03200548|365332708|FG001|Overall Study|Withdrawal by Subject|11|||
105910953|NCT03200548|365332709|FG002|Overall Study|Withdrawal by Subject|7|||
105910954|NCT03200548|365332710|FG003|Overall Study|Withdrawal by Subject|6|||
105910955|NCT02427841|365332713|FG000|Overall Study|Lack of Efficacy|5|||
105910956|NCT02427841|365332713|FG000|Overall Study|Physician Decision|2|||
105910957|NCT02427841|365332713|FG000|Overall Study|Withdrawal by Subject|1|||
105910958|NCT03933449|365332716|FG000|Overall Study|Adverse Event|6|||
105910959|NCT03933449|365332717|FG001|Overall Study|Adverse Event|4|||
105910960|NCT03933449|365332716|FG000|Overall Study|Death|55|||
105910961|NCT03933449|365332717|FG001|Overall Study|Death|57|||
105910962|NCT03933449|365332716|FG000|Overall Study|Sponsor Decision|1|||
105910963|NCT03933449|365332717|FG001|Overall Study|Sponsor Decision|0|||
105910964|NCT01932697|365332718|FG000|Overall Study|Received a different amount of tx|1|||
105910965|NCT01932697|365332719|FG001|Overall Study|Received a different amount of tx|0|||
105910966|NCT01932697|365332718|FG000|Overall Study|Ineligible|1|||
105910967|NCT01932697|365332719|FG001|Overall Study|Ineligible|0|||
105910968|NCT05417412|365332720|FG000|Overall Study|Lost to Follow-up|2|||
105910969|NCT01841970|365332721|FG000|Overall Study|Withdrawal by Subject|1|||
105910970|NCT01841970|365332721|FG000|Overall Study|Physician Decision|2|||
105910971|NCT01841970|365332721|FG000|Overall Study|Lost to Follow-up|8|||
105910972|NCT02592447|365332722|FG000|Overall Study|Lost to Follow-up|1|||
105910973|NCT02592447|365332723|FG001|Overall Study|Lost to Follow-up|0|||
105910974|NCT02592447|365332722|FG000|Overall Study|Ineligible after randomization|1|||
105910975|NCT02592447|365332723|FG001|Overall Study|Ineligible after randomization|0|||
105910976|NCT02592447|365332722|FG000|Overall Study|Withdrawal by Subject|0|||
105910977|NCT02592447|365332723|FG001|Overall Study|Withdrawal by Subject|1|||
105910978|NCT00922116|365332724|FG000|Overall Study|Adverse Event|4|||
105910979|NCT00922116|365332724|FG000|Overall Study|Death|1|||
105910980|NCT00922116|365332724|FG000|Overall Study|Lost to Follow-up|1|||
105910981|NCT00922116|365332724|FG000|Overall Study|Withdrawal by Subject|4|||
105910982|NCT00922116|365332724|FG000|Overall Study|Other|5|||
105910983|NCT04607135|365332725|FG000|Overall Study|Physician Decision|1|||
105910984|NCT04607135|365332725|FG000|Overall Study|Withdrawal by Subject|1|||
105910985|NCT04607135|365332725|FG000|Overall Study|Equipment not working|3|||
105910986|NCT02227784|365332726|FG000|Double-Blind Phase|Adverse Event|3|||
105910987|NCT02227784|365332727|FG001|Double-Blind Phase|Adverse Event|2|||
105910988|NCT02227784|365332728|FG002|Double-Blind Phase|Adverse Event|1|||
105910989|NCT02227784|365332729|FG003|Double-Blind Phase|Adverse Event|3|||
105910990|NCT02227784|365332730|FG004|Double-Blind Phase|Adverse Event|0|||
105910991|NCT02227784|365332726|FG000|Double-Blind Phase|Physician Decision|1|||
105910992|NCT02227784|365332727|FG001|Double-Blind Phase|Physician Decision|0|||
105910993|NCT02227784|365332728|FG002|Double-Blind Phase|Physician Decision|0|||
105910994|NCT02227784|365332729|FG003|Double-Blind Phase|Physician Decision|1|||
105910995|NCT02227784|365332730|FG004|Double-Blind Phase|Physician Decision|0|||
105910996|NCT02227784|365332726|FG000|Double-Blind Phase|Protocol Violation|0|||
105910997|NCT02227784|365332727|FG001|Double-Blind Phase|Protocol Violation|0|||
105910998|NCT02227784|365332728|FG002|Double-Blind Phase|Protocol Violation|1|||
105910999|NCT02227784|365332729|FG003|Double-Blind Phase|Protocol Violation|1|||
105911000|NCT02227784|365332730|FG004|Double-Blind Phase|Protocol Violation|0|||
105911001|NCT02227784|365332726|FG000|Double-Blind Phase|Sponsor Decision|34|||
105911002|NCT02227784|365332727|FG001|Double-Blind Phase|Sponsor Decision|15|||
105911003|NCT02227784|365332728|FG002|Double-Blind Phase|Sponsor Decision|14|||
105911004|NCT02227784|365332729|FG003|Double-Blind Phase|Sponsor Decision|32|||
105911005|NCT02227784|365332730|FG004|Double-Blind Phase|Sponsor Decision|0|||
105911006|NCT02227784|365332726|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
105911007|NCT02227784|365332727|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
105911008|NCT02227784|365332728|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
105911009|NCT02227784|365332729|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
105911010|NCT02227784|365332730|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
105911011|NCT02227784|365332726|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
105911012|NCT02227784|365332727|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
105911013|NCT02227784|365332728|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
105911014|NCT02227784|365332729|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
105911015|NCT02227784|365332730|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
105911016|NCT02227784|365332726|FG000|Open-Label Extension Phase (OLE)|Death|0|||
105911017|NCT02227784|365332727|FG001|Open-Label Extension Phase (OLE)|Death|0|||
105911018|NCT02227784|365332728|FG002|Open-Label Extension Phase (OLE)|Death|0|||
105911019|NCT02227784|365332729|FG003|Open-Label Extension Phase (OLE)|Death|0|||
105911020|NCT02227784|365332730|FG004|Open-Label Extension Phase (OLE)|Death|1|||
105911021|NCT02227784|365332726|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105911022|NCT02227784|365332727|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105911023|NCT02227784|365332728|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105911024|NCT02227784|365332729|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
105911025|NCT02227784|365332730|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
105911026|NCT02227784|365332726|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
105911027|NCT02227784|365332727|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
105911028|NCT02227784|365332728|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
105911029|NCT02227784|365332729|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
105911030|NCT02227784|365332730|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
105911031|NCT00992017|365332732|FG000|Overall Study|Lost to Follow-up|2|||
105911032|NCT00992017|365332732|FG000|Overall Study|Withdrawal by Subject|2|||
105911033|NCT00992017|365332732|FG000|Overall Study|Unable to get to clinic|5|||
105911034|NCT00992017|365332732|FG000|Overall Study|Not adhere to study requirements|1|||
105911035|NCT01827592|365332735|FG000|Overall Study|Adverse Event|11|||
105911036|NCT01827592|365332736|FG001|Overall Study|Adverse Event|9|||
105911037|NCT01827592|365332737|FG002|Overall Study|Adverse Event|2|||
105911038|NCT01827592|365332735|FG000|Overall Study|Physician Decision|0|||
105911039|NCT01827592|365332736|FG001|Overall Study|Physician Decision|2|||
105911040|NCT01827592|365332737|FG002|Overall Study|Physician Decision|1|||
105911041|NCT01827592|365332735|FG000|Overall Study|Protocol Violation|2|||
105911042|NCT01827592|365332736|FG001|Overall Study|Protocol Violation|1|||
105911043|NCT01827592|365332737|FG002|Overall Study|Protocol Violation|0|||
105911044|NCT01827592|365332735|FG000|Overall Study|Lost to Follow-up|1|||
105911045|NCT01827592|365332736|FG001|Overall Study|Lost to Follow-up|2|||
105911046|NCT01827592|365332737|FG002|Overall Study|Lost to Follow-up|2|||
105911047|NCT01827592|365332735|FG000|Overall Study|Withdrawal by Subject|12|||
105911048|NCT01827592|365332736|FG001|Overall Study|Withdrawal by Subject|11|||
105911049|NCT01827592|365332737|FG002|Overall Study|Withdrawal by Subject|11|||
105911050|NCT01827592|365332735|FG000|Overall Study|Patient's substantial non-compliance|1|||
105911051|NCT01827592|365332736|FG001|Overall Study|Patient's substantial non-compliance|1|||
105911052|NCT01827592|365332737|FG002|Overall Study|Patient's substantial non-compliance|6|||
105911053|NCT01827592|365332735|FG000|Overall Study|Trial terminated by Sponsor|47|||
105911054|NCT01827592|365332736|FG001|Overall Study|Trial terminated by Sponsor|53|||
105911055|NCT01827592|365332737|FG002|Overall Study|Trial terminated by Sponsor|51|||
105911056|NCT01827592|365332735|FG000|Overall Study|Others|0|||
105911057|NCT01827592|365332736|FG001|Overall Study|Others|1|||
105911058|NCT01827592|365332737|FG002|Overall Study|Others|3|||
105911059|NCT02998151|365332738|FG000|Overall Study|Withdrawal by Subject|3|||
105911060|NCT02998151|365332738|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
105911061|NCT02998151|365332738|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
105911062|NCT00325819|365332740|FG000|Overall Study|Study product lost in mail|2|||
105911063|NCT00325819|365332741|FG001|Overall Study|Study product lost in mail|1|||
105911064|NCT00325819|365332740|FG000|Overall Study|Did not take a dose of study product|4|||
105911065|NCT00325819|365332741|FG001|Overall Study|Did not take a dose of study product|9|||
105911066|NCT00325819|365332740|FG000|Overall Study|Lost to Follow-up|3|||
105911067|NCT00325819|365332741|FG001|Overall Study|Lost to Follow-up|3|||
105911068|NCT02143024|365332742|FG000|Overall Study|Lost to Follow-up|1|||
105911069|NCT02143024|365332743|FG001|Overall Study|Lost to Follow-up|1|||
105911070|NCT02143024|365332742|FG000|Overall Study|Withdrawal by Subject|1|||
105911071|NCT02143024|365332743|FG001|Overall Study|Withdrawal by Subject|0|||
105911072|NCT02346877|365332744|FG000|Overall Study|Adverse Event|1|||
105911073|NCT02346877|365332745|FG001|Overall Study|Adverse Event|0|||
105999624|NCT01147666|365661208|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
105911074|NCT02346877|365332744|FG000|Overall Study|Administrative Decision|1|||
105911075|NCT02346877|365332745|FG001|Overall Study|Administrative Decision|0|||
105911076|NCT02346877|365332744|FG000|Overall Study|Sponsor Decision|12|||
105911077|NCT02346877|365332745|FG001|Overall Study|Sponsor Decision|0|||
105911078|NCT02346877|365332744|FG000|Overall Study|Missing|5|||
105911079|NCT02346877|365332745|FG001|Overall Study|Missing|0|||
105911080|NCT01683604|365332748|FG000|Overall Study|Adverse Event|2|||
105911081|NCT01683604|365332748|FG000|Overall Study|Lack of Efficacy|1|||
105911082|NCT01683604|365332748|FG000|Overall Study|Other|2|||
105911083|NCT04888494|365332749|FG000|Overall Study|Lost to Follow-up|2|||
105911084|NCT04888494|365332750|FG001|Overall Study|Lost to Follow-up|3|||
105911085|NCT04888494|365332749|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
105911086|NCT04888494|365332750|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
105911087|NCT00452439|365334797|FG000|Overall Study|Lost to Follow-up|1|||
105911088|NCT00452439|365334798|FG001|Overall Study|Lost to Follow-up|1|||
105911089|NCT00452439|365334797|FG000|Overall Study|Refused Treatment|4|||
105911090|NCT00452439|365334798|FG001|Overall Study|Refused Treatment|3|||
105911091|NCT00452439|365334797|FG000|Overall Study|Death|3|||
105911092|NCT00452439|365334798|FG001|Overall Study|Death|1|||
105911093|NCT00452439|365334797|FG000|Overall Study|Bone Marrow Transplant|0|||
105911094|NCT00452439|365334798|FG001|Overall Study|Bone Marrow Transplant|1|||
105911095|NCT00452439|365334797|FG000|Overall Study|Too Ill to Continue|0|||
105911096|NCT00452439|365334798|FG001|Overall Study|Too Ill to Continue|1|||
105911097|NCT00452439|365334797|FG000|Overall Study|Failed to achieve complete response|2|||
105911098|NCT00452439|365334798|FG001|Overall Study|Failed to achieve complete response|0|||
105911099|NCT00452439|365334797|FG000|Overall Study|Relapse|3|||
105911100|NCT00452439|365334798|FG001|Overall Study|Relapse|0|||
105911101|NCT00452439|365334797|FG000|Overall Study|Fracture|1|||
105911102|NCT00452439|365334798|FG001|Overall Study|Fracture|0|||
105911103|NCT01381926|365334799|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
105911104|NCT01381926|365334800|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
105911105|NCT01381926|365334799|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
105911106|NCT01381926|365334800|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
105911107|NCT01212094|365334801|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
105911108|NCT01212094|365334802|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
105911109|NCT01212094|365334803|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
105911110|NCT01212094|365334801|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
105911111|NCT01212094|365334802|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
105911112|NCT01212094|365334803|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
105911113|NCT01212094|365334801|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
105911114|NCT01212094|365334802|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
105911115|NCT01212094|365334803|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
105911116|NCT01212094|365334801|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
105911117|NCT01212094|365334802|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
105911118|NCT01212094|365334803|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
105911119|NCT01212094|365334801|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
105911120|NCT01212094|365334802|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
105911121|NCT01212094|365334803|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
105911122|NCT01212094|365334801|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
105911123|NCT01212094|365334802|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
105911124|NCT01212094|365334803|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
105911125|NCT03512353|365334805|FG000|Overall Study|Sponsor Decision|3|||
105911126|NCT03512353|365334805|FG000|Overall Study|Death|1|||
105911127|NCT03569098|365334806|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
105911128|NCT03569098|365334807|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
105911129|NCT03569098|365334808|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
105911130|NCT03569098|365334806|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
105911131|NCT03569098|365334807|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
105911132|NCT03569098|365334808|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
105911133|NCT03569098|365334806|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
105911134|NCT03569098|365334807|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
105911135|NCT03569098|365334808|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
105911136|NCT03569098|365334806|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
105911137|NCT03569098|365334807|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
105911138|NCT03569098|365334808|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
105911139|NCT03569098|365334806|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
105911140|NCT03569098|365334807|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
105911141|NCT03569098|365334808|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
105911142|NCT03569098|365334806|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
105911143|NCT03569098|365334807|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
105911144|NCT03569098|365334808|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
105911145|NCT03569098|365334806|FG000|Double-Blind Treatment Cycle 1|Other|1|||
105911146|NCT03569098|365334807|FG001|Double-Blind Treatment Cycle 1|Other|0|||
105911147|NCT03569098|365334808|FG002|Double-Blind Treatment Cycle 1|Other|1|||
105911148|NCT03569098|365334806|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
105911149|NCT03569098|365334807|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
105911150|NCT03569098|365334808|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
105911151|NCT03569098|365334806|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
105911152|NCT03569098|365334807|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
105911153|NCT03569098|365334808|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
105911154|NCT03569098|365334806|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
105911155|NCT03569098|365334807|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
105911156|NCT03569098|365334808|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
105911157|NCT03569098|365334806|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
105911158|NCT03569098|365334807|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
105911159|NCT03569098|365334808|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
105911160|NCT03569098|365334806|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
105911161|NCT03569098|365334807|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
105911162|NCT03569098|365334808|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
105911163|NCT03569098|365334806|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
105911164|NCT03569098|365334807|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
105911165|NCT03569098|365334808|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
105911166|NCT01845597|365334809|FG000|Overall Study|Death|8|||
105911167|NCT01845597|365334809|FG000|Overall Study|Lost to Follow-up|22|||
105911168|NCT02581488|365334812|FG000|Overall Study|Adverse Event|6|||
105911169|NCT02581488|365334813|FG001|Overall Study|Adverse Event|7|||
105911170|NCT02581488|365334812|FG000|Overall Study|Lost to Follow-up|1|||
105911171|NCT02581488|365334813|FG001|Overall Study|Lost to Follow-up|0|||
105911172|NCT02581488|365334812|FG000|Overall Study|Withdrawal by Subject|1|||
105911173|NCT02581488|365334813|FG001|Overall Study|Withdrawal by Subject|0|||
105911174|NCT02581488|365334812|FG000|Overall Study|Non-Compliance|1|||
105911175|NCT02581488|365334813|FG001|Overall Study|Non-Compliance|0|||
105911176|NCT02581488|365334812|FG000|Overall Study|Protocol Violation|0|||
105911177|NCT02581488|365334813|FG001|Overall Study|Protocol Violation|4|||
105911178|NCT01877668|365334814|FG000|Overall Study|Death|0|||
105911179|NCT01877668|365334815|FG001|Overall Study|Death|0|||
105911180|NCT01877668|365334816|FG002|Overall Study|Death|0|||
105911181|NCT01877668|365334817|FG003|Overall Study|Death|1|||
105911182|NCT01877668|365334818|FG004|Overall Study|Death|0|||
105911183|NCT01877668|365334814|FG000|Overall Study|No longer met study criteria|1|||
105911184|NCT01877668|365334815|FG001|Overall Study|No longer met study criteria|0|||
105911185|NCT01877668|365334816|FG002|Overall Study|No longer met study criteria|1|||
105911186|NCT01877668|365334817|FG003|Overall Study|No longer met study criteria|0|||
105911187|NCT01877668|365334818|FG004|Overall Study|No longer met study criteria|0|||
105911188|NCT01877668|365334814|FG000|Overall Study|Insufficient clinical response|0|||
105911189|NCT01877668|365334815|FG001|Overall Study|Insufficient clinical response|1|||
105911190|NCT01877668|365334816|FG002|Overall Study|Insufficient clinical response|2|||
105911191|NCT01877668|365334817|FG003|Overall Study|Insufficient clinical response|2|||
105911192|NCT01877668|365334818|FG004|Overall Study|Insufficient clinical response|0|||
105911193|NCT01877668|365334814|FG000|Overall Study|Lost to Follow-up|0|||
105911194|NCT01877668|365334815|FG001|Overall Study|Lost to Follow-up|2|||
105911195|NCT01877668|365334816|FG002|Overall Study|Lost to Follow-up|1|||
105911196|NCT01877668|365334817|FG003|Overall Study|Lost to Follow-up|0|||
105911197|NCT01877668|365334818|FG004|Overall Study|Lost to Follow-up|0|||
105911198|NCT01877668|365334814|FG000|Overall Study|Withdrawal by Subject|2|||
105911199|NCT01877668|365334815|FG001|Overall Study|Withdrawal by Subject|0|||
105911200|NCT01877668|365334816|FG002|Overall Study|Withdrawal by Subject|3|||
105911201|NCT01877668|365334817|FG003|Overall Study|Withdrawal by Subject|2|||
105911202|NCT01877668|365334818|FG004|Overall Study|Withdrawal by Subject|2|||
105911203|NCT01877668|365334814|FG000|Overall Study|Other|1|||
105911204|NCT01877668|365334815|FG001|Overall Study|Other|1|||
105911205|NCT01877668|365334816|FG002|Overall Study|Other|1|||
105911206|NCT01877668|365334817|FG003|Overall Study|Other|1|||
105911207|NCT01877668|365334818|FG004|Overall Study|Other|3|||
105911208|NCT01877668|365334814|FG000|Overall Study|Protocol Violation|1|||
105911209|NCT01877668|365334815|FG001|Overall Study|Protocol Violation|1|||
105911210|NCT01877668|365334816|FG002|Overall Study|Protocol Violation|0|||
105911211|NCT01877668|365334817|FG003|Overall Study|Protocol Violation|0|||
105911212|NCT01877668|365334818|FG004|Overall Study|Protocol Violation|3|||
105911213|NCT01877668|365334814|FG000|Overall Study|Adverse event related to study drug|2|||
105911214|NCT01877668|365334815|FG001|Overall Study|Adverse event related to study drug|2|||
105911215|NCT01877668|365334816|FG002|Overall Study|Adverse event related to study drug|2|||
105911216|NCT01877668|365334817|FG003|Overall Study|Adverse event related to study drug|2|||
105911217|NCT01877668|365334818|FG004|Overall Study|Adverse event related to study drug|1|||
105911218|NCT01877668|365334814|FG000|Overall Study|Adverse event unrelated to study drug|4|||
105911219|NCT01877668|365334815|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105911220|NCT01877668|365334816|FG002|Overall Study|Adverse event unrelated to study drug|2|||
105911221|NCT01877668|365334817|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105911222|NCT01877668|365334818|FG004|Overall Study|Adverse event unrelated to study drug|1|||
105911223|NCT01697800|365334819|FG000|Overall Study|Death|0|||
105911224|NCT01697800|365334820|FG001|Overall Study|Death|1|||
105911225|NCT00954122|365334821|FG000|Overall Study|Withdrawal by Subject|5|||
105911226|NCT00954122|365334821|FG000|Overall Study|Adverse Event|1|||
105911227|NCT00954122|365334821|FG000|Overall Study|Safety Reason|1|||
105911228|NCT02019550|365334824|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105911229|NCT02019550|365334825|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
105911230|NCT03365934|365334827|FG000|Overall Study|Adverse Event|1|||
105911231|NCT03365934|365334827|FG000|Overall Study|Withdrawal by Subject|1|||
105911232|NCT01307891|365334828|FG000|Overall Study|Progressive Disease|3|||
105911233|NCT01307891|365334829|FG001|Overall Study|Progressive Disease|1|||
105911234|NCT04194489|365334831|FG000|Overall Study|Withdrawal by Subject|5|||
105911235|NCT04194489|365334831|FG000|Overall Study|Lost to Follow-up|48|||
105911236|NCT04771013|365334834|FG000|Overall Study|Withdrawal by Subject|2|||
105911237|NCT04771013|365334835|FG001|Overall Study|Withdrawal by Subject|0|||
105911238|NCT04771013|365334834|FG000|Overall Study|Death|0|||
105911239|NCT04771013|365334835|FG001|Overall Study|Death|5|||
105911240|NCT04771013|365334834|FG000|Overall Study|Referred to another hospital before day 20|0|||
105911241|NCT04771013|365334835|FG001|Overall Study|Referred to another hospital before day 20|1|||
105911242|NCT01255904|365334836|FG000|Overall Study|Physician Decision|1|||
105911243|NCT01255904|365334837|FG001|Overall Study|Physician Decision|4|||
105911244|NCT00377637|365334839|FG000|Induction Phase|Adverse Event|12|||
105911245|NCT00377637|365334840|FG001|Induction Phase|Adverse Event|21|||
105911246|NCT00377637|365334841|FG002|Induction Phase|Adverse Event|0|||
105911247|NCT00377637|365334842|FG003|Induction Phase|Adverse Event|0|||
105911248|NCT00377637|365334839|FG000|Induction Phase|Deterioration/serum creatinine|2|||
105911249|NCT00377637|365334840|FG001|Induction Phase|Deterioration/serum creatinine|0|||
105911250|NCT00377637|365334841|FG002|Induction Phase|Deterioration/serum creatinine|0|||
105911251|NCT00377637|365334842|FG003|Induction Phase|Deterioration/serum creatinine|0|||
105911252|NCT00377637|365334839|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
105911253|NCT00377637|365334840|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
105911254|NCT00377637|365334841|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
105911255|NCT00377637|365334842|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
105911256|NCT00377637|365334839|FG000|Induction Phase|Lost to Follow-up|2|||
105911257|NCT00377637|365334840|FG001|Induction Phase|Lost to Follow-up|1|||
105911258|NCT00377637|365334841|FG002|Induction Phase|Lost to Follow-up|0|||
105911259|NCT00377637|365334842|FG003|Induction Phase|Lost to Follow-up|0|||
105911260|NCT00377637|365334839|FG000|Induction Phase|Death|1|||
105911261|NCT00377637|365334840|FG001|Induction Phase|Death|3|||
105911262|NCT00377637|365334841|FG002|Induction Phase|Death|0|||
105911263|NCT00377637|365334842|FG003|Induction Phase|Death|0|||
105911264|NCT00377637|365334839|FG000|Induction Phase|Withdrawal by Subject|5|||
105911265|NCT00377637|365334840|FG001|Induction Phase|Withdrawal by Subject|6|||
105911266|NCT00377637|365334841|FG002|Induction Phase|Withdrawal by Subject|0|||
105911267|NCT00377637|365334842|FG003|Induction Phase|Withdrawal by Subject|0|||
105911268|NCT00377637|365334839|FG000|Induction Phase|Physician Decision|3|||
105911269|NCT00377637|365334840|FG001|Induction Phase|Physician Decision|1|||
105911270|NCT00377637|365334841|FG002|Induction Phase|Physician Decision|0|||
105911271|NCT00377637|365334842|FG003|Induction Phase|Physician Decision|0|||
105911272|NCT00377637|365334839|FG000|Induction Phase|Sponsor decision|1|||
105911273|NCT00377637|365334840|FG001|Induction Phase|Sponsor decision|2|||
105911274|NCT00377637|365334841|FG002|Induction Phase|Sponsor decision|0|||
105911275|NCT00377637|365334842|FG003|Induction Phase|Sponsor decision|0|||
105911276|NCT00377637|365334839|FG000|Induction Phase|Non-Compliance|1|||
105911277|NCT00377637|365334840|FG001|Induction Phase|Non-Compliance|0|||
105911278|NCT00377637|365334841|FG002|Induction Phase|Non-Compliance|0|||
105911279|NCT00377637|365334842|FG003|Induction Phase|Non-Compliance|0|||
105911280|NCT00377637|365334839|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
105911281|NCT00377637|365334840|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
105911282|NCT00377637|365334841|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
105911283|NCT00377637|365334842|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
105911284|NCT00377637|365334839|FG000|Maintenance Phase|Adverse Event|0|||
105911285|NCT00377637|365334840|FG001|Maintenance Phase|Adverse Event|0|||
105911286|NCT00377637|365334841|FG002|Maintenance Phase|Adverse Event|29|||
105911287|NCT00377637|365334842|FG003|Maintenance Phase|Adverse Event|43|||
105911288|NCT00377637|365334839|FG000|Maintenance Phase|Physician Decision|0|||
105911289|NCT00377637|365334840|FG001|Maintenance Phase|Physician Decision|0|||
105911290|NCT00377637|365334841|FG002|Maintenance Phase|Physician Decision|5|||
105911291|NCT00377637|365334842|FG003|Maintenance Phase|Physician Decision|4|||
105911292|NCT00377637|365334839|FG000|Maintenance Phase|Lost to Follow-up|0|||
105911293|NCT00377637|365334840|FG001|Maintenance Phase|Lost to Follow-up|0|||
105911294|NCT00377637|365334841|FG002|Maintenance Phase|Lost to Follow-up|3|||
105911295|NCT00377637|365334842|FG003|Maintenance Phase|Lost to Follow-up|1|||
105911296|NCT00377637|365334839|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105999625|NCT01147666|365661209|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
105999626|NCT01147666|365661210|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
105999627|NCT01147666|365661196|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
105999628|NCT01147666|365661197|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
105999629|NCT01147666|365661198|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
105999630|NCT01147666|365661199|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
105999631|NCT01147666|365661200|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
105999632|NCT01147666|365661201|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
105999633|NCT01147666|365661202|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
105999634|NCT01147666|365661203|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
105999635|NCT01147666|365661204|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
105999636|NCT01147666|365661205|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
105999637|NCT01147666|365661206|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
105999638|NCT01147666|365661207|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
105999639|NCT01147666|365661208|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
105999640|NCT01147666|365661209|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
105999641|NCT01147666|365661210|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
105999642|NCT01147666|365661196|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
105999643|NCT01147666|365661197|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999644|NCT01147666|365661198|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999645|NCT01147666|365661199|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
105999646|NCT01147666|365661200|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999647|NCT01147666|365661201|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999648|NCT01147666|365661202|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999649|NCT01147666|365661203|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999650|NCT01147666|365661204|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999651|NCT01147666|365661205|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999652|NCT01147666|365661206|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
105999653|NCT01147666|365661207|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999654|NCT01147666|365661208|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999655|NCT01147666|365661209|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999656|NCT01147666|365661210|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
105999657|NCT01147666|365661196|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999658|NCT01147666|365661197|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999659|NCT01147666|365661198|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999660|NCT01147666|365661199|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999661|NCT01147666|365661200|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105999662|NCT01147666|365661201|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105911297|NCT00377637|365334840|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105911298|NCT00377637|365334841|FG002|Maintenance Phase|Withdrawal by Subject|3|||
105911299|NCT00377637|365334842|FG003|Maintenance Phase|Withdrawal by Subject|3|||
105911300|NCT00377637|365334839|FG000|Maintenance Phase|Sponsor decision|0|||
105911301|NCT00377637|365334840|FG001|Maintenance Phase|Sponsor decision|0|||
105911302|NCT00377637|365334841|FG002|Maintenance Phase|Sponsor decision|2|||
105911303|NCT00377637|365334842|FG003|Maintenance Phase|Sponsor decision|3|||
105911304|NCT00377637|365334839|FG000|Maintenance Phase|Non-compliance|0|||
105911305|NCT00377637|365334840|FG001|Maintenance Phase|Non-compliance|0|||
105911306|NCT00377637|365334841|FG002|Maintenance Phase|Non-compliance|1|||
105911307|NCT00377637|365334842|FG003|Maintenance Phase|Non-compliance|1|||
105911308|NCT00377637|365334839|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
105911309|NCT00377637|365334840|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
105911310|NCT00377637|365334841|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
105911311|NCT00377637|365334842|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
105911312|NCT00377637|365334839|FG000|Maintenance Phase|Death|0|||
105911313|NCT00377637|365334840|FG001|Maintenance Phase|Death|0|||
105911314|NCT00377637|365334841|FG002|Maintenance Phase|Death|0|||
105911315|NCT00377637|365334842|FG003|Maintenance Phase|Death|1|||
105911316|NCT00368108|365334848|FG000|Overall Study|Adverse Event|38|||
105911317|NCT00368108|365334849|FG001|Overall Study|Adverse Event|26|||
105911318|NCT00368108|365334850|FG002|Overall Study|Adverse Event|44|||
105911319|NCT00368108|365334848|FG000|Overall Study|Abnormal Laboratory Value|0|||
105911320|NCT00368108|365334849|FG001|Overall Study|Abnormal Laboratory Value|0|||
105911321|NCT00368108|365334850|FG002|Overall Study|Abnormal Laboratory Value|3|||
105911322|NCT00368108|365334848|FG000|Overall Study|Protocol Violation|5|||
105911323|NCT00368108|365334849|FG001|Overall Study|Protocol Violation|9|||
105911324|NCT00368108|365334850|FG002|Overall Study|Protocol Violation|9|||
105911325|NCT00368108|365334848|FG000|Overall Study|Withdrawal by Subject|9|||
105911326|NCT00368108|365334849|FG001|Overall Study|Withdrawal by Subject|3|||
105911327|NCT00368108|365334850|FG002|Overall Study|Withdrawal by Subject|5|||
105999663|NCT01147666|365661202|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999664|NCT01147666|365661203|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105999665|NCT01147666|365661204|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999666|NCT01147666|365661205|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105999667|NCT01147666|365661206|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999668|NCT01147666|365661207|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105999669|NCT01147666|365661208|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999670|NCT01147666|365661209|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
105999671|NCT01147666|365661210|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
105999672|NCT01147666|365661196|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999673|NCT01147666|365661197|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999674|NCT01147666|365661198|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999675|NCT01147666|365661199|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
105999676|NCT01147666|365661200|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999677|NCT01147666|365661201|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999678|NCT01147666|365661202|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999679|NCT01147666|365661203|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999680|NCT01147666|365661204|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999681|NCT01147666|365661205|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999682|NCT01147666|365661206|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
105999683|NCT01147666|365661207|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999684|NCT01147666|365661208|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999685|NCT01147666|365661209|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999686|NCT01147666|365661210|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
105999687|NCT01147666|365661196|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999688|NCT01147666|365661197|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999689|NCT01147666|365661198|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999690|NCT01147666|365661199|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999691|NCT01147666|365661200|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999692|NCT01147666|365661201|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999693|NCT01147666|365661202|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999694|NCT01147666|365661203|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999695|NCT01147666|365661204|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999696|NCT01147666|365661205|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999697|NCT01147666|365661206|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999698|NCT01147666|365661207|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
105999699|NCT01147666|365661208|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
105999700|NCT01147666|365661209|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
105999701|NCT01147666|365661210|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
105999702|NCT01147666|365661196|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
105999703|NCT01147666|365661197|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
105999704|NCT01147666|365661198|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
105999705|NCT01147666|365661199|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
105999706|NCT01147666|365661200|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
105999707|NCT01147666|365661201|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
105999708|NCT01147666|365661202|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
105999709|NCT01147666|365661203|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
105999710|NCT01147666|365661204|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
105999711|NCT01147666|365661205|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
105999712|NCT01147666|365661206|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
105999713|NCT01147666|365661207|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
105999714|NCT01147666|365661208|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
105999715|NCT01147666|365661209|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
105999716|NCT01147666|365661210|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
105999717|NCT01147666|365661196|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105999718|NCT01147666|365661197|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105999719|NCT01147666|365661198|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105999720|NCT01147666|365661199|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105999721|NCT01147666|365661200|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
105999722|NCT01147666|365661201|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
105999723|NCT01147666|365661202|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
105999724|NCT01147666|365661203|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
105999725|NCT01147666|365661204|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105999726|NCT01147666|365661205|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
105999727|NCT01147666|365661206|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105999728|NCT01147666|365661207|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105999729|NCT01147666|365661208|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
105999730|NCT01147666|365661209|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
105911328|NCT00368108|365334848|FG000|Overall Study|Lack of Efficacy|7|||
105911329|NCT00368108|365334849|FG001|Overall Study|Lack of Efficacy|8|||
105911330|NCT00368108|365334850|FG002|Overall Study|Lack of Efficacy|5|||
105911331|NCT00368108|365334848|FG000|Overall Study|Physician Decision|2|||
105911332|NCT00368108|365334849|FG001|Overall Study|Physician Decision|0|||
105911333|NCT00368108|365334850|FG002|Overall Study|Physician Decision|1|||
105911334|NCT00368108|365334848|FG000|Overall Study|Other|3|||
105911335|NCT00368108|365334849|FG001|Overall Study|Other|7|||
105911336|NCT00368108|365334850|FG002|Overall Study|Other|1|||
105911337|NCT04613739|365334851|FG000|Overall Study|Lost to Follow-up|6|||
105911338|NCT04613739|365334852|FG001|Overall Study|Lost to Follow-up|9|||
105911339|NCT04613739|365334851|FG000|Overall Study|potentially duplicative/fraudulent|1|||
105911340|NCT04613739|365334852|FG001|Overall Study|potentially duplicative/fraudulent|3|||
105911341|NCT01093586|365334853|FG000|Overall Study|Failed to engraft|3|||
105911342|NCT01831427|365334854|FG000|Overall Study|Adverse Event|0|||
105911343|NCT01831427|365334855|FG001|Overall Study|Adverse Event|1|||
105911344|NCT01831427|365334856|FG002|Overall Study|Adverse Event|0|||
105911345|NCT01831427|365334857|FG003|Overall Study|Adverse Event|0|||
105911346|NCT01831427|365334858|FG004|Overall Study|Adverse Event|0|||
105911347|NCT01831427|365334859|FG005|Overall Study|Adverse Event|1|||
105911348|NCT01831427|365334860|FG006|Overall Study|Adverse Event|0|||
105911349|NCT01831427|365334861|FG007|Overall Study|Adverse Event|1|||
105911350|NCT01831427|365334862|FG008|Overall Study|Adverse Event|0|||
105911351|NCT01831427|365334863|FG009|Overall Study|Adverse Event|0|||
105911352|NCT01831427|365334864|FG010|Overall Study|Adverse Event|2|||
105911353|NCT01831427|365334854|FG000|Overall Study|Investigator's Discretion|0|||
105911354|NCT01831427|365334855|FG001|Overall Study|Investigator's Discretion|0|||
105911355|NCT01831427|365334856|FG002|Overall Study|Investigator's Discretion|0|||
105911356|NCT01831427|365334857|FG003|Overall Study|Investigator's Discretion|1|||
105911357|NCT01831427|365334858|FG004|Overall Study|Investigator's Discretion|0|||
105911358|NCT01831427|365334859|FG005|Overall Study|Investigator's Discretion|0|||
105911359|NCT01831427|365334860|FG006|Overall Study|Investigator's Discretion|0|||
105911360|NCT01831427|365334861|FG007|Overall Study|Investigator's Discretion|0|||
105911361|NCT01831427|365334862|FG008|Overall Study|Investigator's Discretion|0|||
105911362|NCT01831427|365334863|FG009|Overall Study|Investigator's Discretion|0|||
105911363|NCT01831427|365334864|FG010|Overall Study|Investigator's Discretion|0|||
105911364|NCT01831427|365334854|FG000|Overall Study|Withdrew Consent|0|||
105911365|NCT01831427|365334855|FG001|Overall Study|Withdrew Consent|0|||
105911366|NCT01831427|365334856|FG002|Overall Study|Withdrew Consent|0|||
105911367|NCT01831427|365334857|FG003|Overall Study|Withdrew Consent|0|||
105911368|NCT01831427|365334858|FG004|Overall Study|Withdrew Consent|0|||
105911369|NCT01831427|365334859|FG005|Overall Study|Withdrew Consent|0|||
105911370|NCT01831427|365334860|FG006|Overall Study|Withdrew Consent|2|||
105911371|NCT01831427|365334861|FG007|Overall Study|Withdrew Consent|0|||
105911372|NCT01831427|365334862|FG008|Overall Study|Withdrew Consent|0|||
105911373|NCT01831427|365334863|FG009|Overall Study|Withdrew Consent|1|||
105911374|NCT01831427|365334864|FG010|Overall Study|Withdrew Consent|1|||
105911375|NCT02035553|365334865|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
105911376|NCT02035553|365334866|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
105911377|NCT02035553|365334865|FG000|Overall Study|Adverse Event|10|||
105911378|NCT02035553|365334866|FG001|Overall Study|Adverse Event|6|||
105911379|NCT02035553|365334865|FG000|Overall Study|Physician Decision|3|||
105911380|NCT02035553|365334866|FG001|Overall Study|Physician Decision|2|||
105911381|NCT02035553|365334865|FG000|Overall Study|Lack of Efficacy|1|||
105911382|NCT02035553|365334866|FG001|Overall Study|Lack of Efficacy|1|||
105911383|NCT02035553|365334865|FG000|Overall Study|Withdrawal by Subject|4|||
105911384|NCT02035553|365334866|FG001|Overall Study|Withdrawal by Subject|7|||
105911385|NCT02035553|365334865|FG000|Overall Study|Non-compliance with Study Drug|0|||
105911386|NCT02035553|365334866|FG001|Overall Study|Non-compliance with Study Drug|1|||
105911387|NCT02035553|365334865|FG000|Overall Study|Lost to Follow-up|0|||
105911388|NCT02035553|365334866|FG001|Overall Study|Lost to Follow-up|1|||
105911389|NCT02035553|365334865|FG000|Overall Study|Other Reason|0|||
105911390|NCT02035553|365334866|FG001|Overall Study|Other Reason|4|||
105911391|NCT01854697|365334867|FG000|Overall Study|Adverse Event|1|||
105911392|NCT01854697|365334868|FG001|Overall Study|Adverse Event|0|||
105911393|NCT01854697|365334869|FG002|Overall Study|Adverse Event|0|||
105911394|NCT01854697|365334870|FG003|Overall Study|Adverse Event|0|||
105911395|NCT01854697|365334871|FG004|Overall Study|Adverse Event|1|||
105911396|NCT01854697|365334867|FG000|Overall Study|Lost to Follow-up|4|||
105911397|NCT01854697|365334868|FG001|Overall Study|Lost to Follow-up|1|||
105911398|NCT01854697|365334869|FG002|Overall Study|Lost to Follow-up|1|||
105911399|NCT01854697|365334870|FG003|Overall Study|Lost to Follow-up|2|||
105911400|NCT01854697|365334871|FG004|Overall Study|Lost to Follow-up|0|||
105911401|NCT01854697|365334867|FG000|Overall Study|To enter another AbbVie study|1|||
105911402|NCT01854697|365334868|FG001|Overall Study|To enter another AbbVie study|0|||
105911403|NCT01854697|365334869|FG002|Overall Study|To enter another AbbVie study|0|||
105911404|NCT01854697|365334870|FG003|Overall Study|To enter another AbbVie study|0|||
105911405|NCT01854697|365334871|FG004|Overall Study|To enter another AbbVie study|1|||
105911406|NCT01854697|365334867|FG000|Overall Study|Withdrew Consent|0|||
105911407|NCT01854697|365334868|FG001|Overall Study|Withdrew Consent|1|||
105911408|NCT01854697|365334869|FG002|Overall Study|Withdrew Consent|0|||
105911409|NCT01854697|365334870|FG003|Overall Study|Withdrew Consent|1|||
105911410|NCT01854697|365334871|FG004|Overall Study|Withdrew Consent|0|||
105911411|NCT01854697|365334867|FG000|Overall Study|Other|0|||
105911412|NCT01854697|365334868|FG001|Overall Study|Other|1|||
105911413|NCT01854697|365334869|FG002|Overall Study|Other|1|||
105911414|NCT01854697|365334870|FG003|Overall Study|Other|0|||
105911415|NCT01854697|365334871|FG004|Overall Study|Other|0|||
105911416|NCT01178125|365334876|FG000|Overall Study|Lost to Follow-up|397|||
105911417|NCT01178125|365334876|FG000|Overall Study|Adverse Event|244|||
105911418|NCT01178125|365334876|FG000|Overall Study|Withdrawal by Subject|209|||
105911419|NCT01178125|365334876|FG000|Overall Study|Noncompliance|184|||
105911420|NCT01178125|365334876|FG000|Overall Study|Pregnancy|55|||
105911421|NCT01178125|365334876|FG000|Overall Study|Other Reason|39|||
105911422|NCT01178125|365334876|FG000|Overall Study|Sponsor Decision|28|||
105911423|NCT01178125|365334876|FG000|Overall Study|Protocol Violation|17|||
105911424|NCT01178125|365334876|FG000|Overall Study|Investigator Decision|5|||
105911425|NCT02948829|365334877|FG000|Overall Study|Lost to Follow-up|2|||
105911426|NCT02948829|365334877|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
105911427|NCT02948829|365334877|FG000|Overall Study|Pregnancy|1|||
105911428|NCT02948829|365334877|FG000|Overall Study|Other: Reason not Specified|8|||
105911429|NCT01004978|365334878|FG000|Overall Study|Disease progression|31|||
105911430|NCT01004978|365334879|FG001|Overall Study|Disease progression|48|||
105911431|NCT01004978|365334878|FG000|Overall Study|Adverse Event|42|||
105911432|NCT01004978|365334879|FG001|Overall Study|Adverse Event|22|||
105911433|NCT01004978|365334878|FG000|Overall Study|Death|3|||
105911434|NCT01004978|365334879|FG001|Overall Study|Death|2|||
105911435|NCT01004978|365334878|FG000|Overall Study|Withdrawal by Subject|16|||
105911436|NCT01004978|365334879|FG001|Overall Study|Withdrawal by Subject|16|||
105911437|NCT01004978|365334878|FG000|Overall Study|Alternative therapy|4|||
105911438|NCT01004978|365334879|FG001|Overall Study|Alternative therapy|8|||
105911439|NCT01004978|365334878|FG000|Overall Study|Physician Decision|6|||
105911440|NCT01004978|365334879|FG001|Overall Study|Physician Decision|3|||
105911441|NCT01004978|365334878|FG000|Overall Study|Other complicating disease|2|||
105911442|NCT01004978|365334879|FG001|Overall Study|Other complicating disease|2|||
105911443|NCT01004978|365334878|FG000|Overall Study|Protocol Violation|2|||
105911444|NCT01004978|365334879|FG001|Overall Study|Protocol Violation|3|||
105911445|NCT01004978|365334878|FG000|Overall Study|Non-compliance|3|||
105911446|NCT01004978|365334879|FG001|Overall Study|Non-compliance|2|||
105911447|NCT01004978|365334878|FG000|Overall Study|Ineligible|1|||
105911448|NCT01004978|365334879|FG001|Overall Study|Ineligible|0|||
105911449|NCT01004978|365334878|FG000|Overall Study|Unblinded|0|||
105911450|NCT01004978|365334879|FG001|Overall Study|Unblinded|1|||
105911451|NCT01004978|365334878|FG000|Overall Study|Performance status worsening|0|||
105911452|NCT01004978|365334879|FG001|Overall Study|Performance status worsening|1|||
105911453|NCT01004978|365334878|FG000|Overall Study|Never started treatment|8|||
105911454|NCT01004978|365334879|FG001|Overall Study|Never started treatment|9|||
105911455|NCT00369915|365334880|FG000|Overall Study|expected side effects|2|||
105911456|NCT00369915|365334881|FG001|Overall Study|expected side effects|1|||
105911457|NCT00369915|365334880|FG000|Overall Study|Withdrawal by Subject|4|||
105911458|NCT00369915|365334881|FG001|Overall Study|Withdrawal by Subject|1|||
105911459|NCT00369915|365334880|FG000|Overall Study|W/drawl by investigators|0|||
105911460|NCT00369915|365334881|FG001|Overall Study|W/drawl by investigators|1|||
105911461|NCT02326272|365334884|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911462|NCT02326272|365334885|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
105911463|NCT02326272|365334886|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
105911464|NCT02326272|365334887|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911465|NCT02326272|365334888|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911466|NCT02326272|365334889|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911467|NCT02326272|365334890|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911468|NCT02326272|365334891|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911469|NCT02326272|365334892|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911470|NCT02326272|365334893|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911471|NCT02326272|365334894|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911472|NCT02326272|365334895|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911473|NCT02326272|365334896|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911474|NCT02326272|365334897|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
106125695|NCT02431533|366117881|FG000|Overall Study|Withdrawal by Subject|1|||
105911475|NCT02326272|365334898|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105911476|NCT02326272|365334884|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
105911477|NCT02326272|365334885|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
105911478|NCT02326272|365334886|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911479|NCT02326272|365334887|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911480|NCT02326272|365334888|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105674015|NCT02091206|364470563|FG002|Treatment Period|Met withdrawal criteria|1|||
105674016|NCT02091206|364470564|FG003|Treatment Period|Met withdrawal criteria|0|||
105674017|NCT02091206|364470561|FG000|Taper Period|Participant refused study drug|1|||
105674018|NCT02091206|364470562|FG001|Taper Period|Participant refused study drug|0|||
105674019|NCT02091206|364470563|FG002|Taper Period|Participant refused study drug|0|||
105674020|NCT02091206|364470564|FG003|Taper Period|Participant refused study drug|1|||
105674021|NCT02091206|364470561|FG000|Taper Period|Lost to Follow-up|0|||
105674022|NCT02091206|364470562|FG001|Taper Period|Lost to Follow-up|0|||
105674023|NCT02091206|364470563|FG002|Taper Period|Lost to Follow-up|0|||
105674024|NCT02091206|364470564|FG003|Taper Period|Lost to Follow-up|1|||
105674025|NCT03381339|364470565|FG000|Overall Study|Protocol Violation|4|||
105674026|NCT03381339|364470566|FG001|Overall Study|Protocol Violation|3|||
105674027|NCT03381339|364470565|FG000|Overall Study|Lost to Follow-up|0|||
105674028|NCT03381339|364470566|FG001|Overall Study|Lost to Follow-up|1|||
105911481|NCT02326272|365334889|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911482|NCT02326272|365334890|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911483|NCT02326272|365334891|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911484|NCT02326272|365334892|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911485|NCT02326272|365334893|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911486|NCT02326272|365334894|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911487|NCT02326272|365334895|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911488|NCT02326272|365334896|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911489|NCT02326272|365334897|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911490|NCT02326272|365334898|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
105911491|NCT02326272|365334884|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
105911492|NCT02326272|365334885|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
105911493|NCT02326272|365334886|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
105911494|NCT02326272|365334887|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911495|NCT02326272|365334888|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911496|NCT02326272|365334889|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911497|NCT02326272|365334890|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911498|NCT02326272|365334891|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911499|NCT02326272|365334892|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911500|NCT02326272|365334893|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911501|NCT02326272|365334894|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911502|NCT02326272|365334895|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911503|NCT02326272|365334896|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911504|NCT02326272|365334897|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911505|NCT02326272|365334898|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105911506|NCT02326272|365334884|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911507|NCT02326272|365334885|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911508|NCT02326272|365334886|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
105911509|NCT02326272|365334887|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911510|NCT02326272|365334888|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911511|NCT02326272|365334889|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911512|NCT02326272|365334890|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911513|NCT02326272|365334891|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911514|NCT02326272|365334892|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911515|NCT02326272|365334893|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911516|NCT02326272|365334894|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911517|NCT02326272|365334895|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911518|NCT02326272|365334896|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911519|NCT02326272|365334897|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911520|NCT02326272|365334898|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
105911521|NCT02326272|365334884|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911522|NCT02326272|365334885|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911523|NCT02326272|365334886|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
105911524|NCT02326272|365334887|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911525|NCT02326272|365334888|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911526|NCT02326272|365334889|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911527|NCT02326272|365334890|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105674029|NCT04531904|364470569|FG000|Overall Study|Lost to Follow-up|1|||
105674030|NCT04531904|364470569|FG000|Overall Study|Death|14|||
105674031|NCT03117998|364470570|FG000|Overall Study|Adverse Event|1|||
105674032|NCT03117998|364470571|FG001|Overall Study|Adverse Event|0|||
105674033|NCT03117998|364470572|FG002|Overall Study|Adverse Event|0|||
105674034|NCT03117998|364470573|FG003|Overall Study|Adverse Event|0|||
105674035|NCT03117998|364470574|FG004|Overall Study|Adverse Event|0|||
105786377|NCT01869959|364870508|FG000|Treatment Period|Withdrawal by Subject|0|||
105786378|NCT01869959|364870509|FG001|Treatment Period|Withdrawal by Subject|1|||
105786379|NCT01869959|364870510|FG002|Treatment Period|Withdrawal by Subject|0|||
105786380|NCT01869959|364870511|FG003|Treatment Period|Withdrawal by Subject|0|||
105786381|NCT01869959|364870512|FG004|Treatment Period|Withdrawal by Subject|0|||
105786382|NCT01965600|364870513|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
105786383|NCT01965600|364870514|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
105786384|NCT01965600|364870515|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
105786385|NCT01965600|364870516|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
105786386|NCT01965600|364870513|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
105786387|NCT01965600|364870514|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
105786388|NCT01965600|364870515|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
105786389|NCT01965600|364870516|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
105786390|NCT01965600|364870513|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
105786391|NCT01965600|364870514|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
105911528|NCT02326272|365334891|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911529|NCT02326272|365334892|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911530|NCT02326272|365334893|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911531|NCT02326272|365334894|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911532|NCT02326272|365334895|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911533|NCT02326272|365334896|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911534|NCT02326272|365334897|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911535|NCT02326272|365334898|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
105911536|NCT02326272|365334884|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911537|NCT02326272|365334885|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911538|NCT02326272|365334886|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
105911539|NCT02326272|365334887|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911540|NCT02326272|365334888|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911541|NCT02326272|365334889|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911542|NCT02326272|365334890|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911543|NCT02326272|365334891|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911544|NCT02326272|365334892|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911545|NCT02326272|365334893|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911546|NCT02326272|365334894|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911547|NCT02326272|365334895|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911548|NCT02326272|365334896|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911549|NCT02326272|365334897|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911550|NCT02326272|365334898|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
105911551|NCT02326272|365334884|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911552|NCT02326272|365334885|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911553|NCT02326272|365334886|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
105911554|NCT02326272|365334887|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911555|NCT02326272|365334888|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911556|NCT02326272|365334889|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911557|NCT02326272|365334890|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911558|NCT02326272|365334891|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911559|NCT02326272|365334892|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911560|NCT02326272|365334893|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911561|NCT02326272|365334894|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911562|NCT02326272|365334895|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911563|NCT02326272|365334896|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911564|NCT02326272|365334897|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911565|NCT02326272|365334898|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
105911566|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911567|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911568|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911569|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911570|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
105911571|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
105911572|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
105911573|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
105911574|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
105911575|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911576|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911577|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911578|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911579|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911580|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
105911581|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911582|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911583|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911584|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911585|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911586|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
105911587|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
105911588|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911589|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
105911590|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
105911591|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911592|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911593|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911594|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911595|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
105911596|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911597|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911598|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911599|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911600|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911601|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
105911602|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911603|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
105911604|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911605|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911606|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911607|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911608|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911609|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911610|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
105911611|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911612|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911613|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911614|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105911615|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911616|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
105911617|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105999731|NCT01147666|365661210|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
105999732|NCT01147666|365661196|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
106125696|NCT02431533|366117882|FG001|Overall Study|Withdrawal by Subject|3|||
106125697|NCT02431533|366117881|FG000|Overall Study|Developed Exclusionary criteria|1|||
105911618|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105911619|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911620|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105911621|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911622|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911623|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911624|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911625|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
105911626|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911627|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911628|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911629|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911630|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911631|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911632|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911633|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
105911634|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911635|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911636|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911637|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911638|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911639|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911640|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
105911641|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911642|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911643|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911644|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911645|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911646|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911647|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
105911648|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911649|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911650|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911651|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911652|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911653|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911654|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911655|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
105911656|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911657|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911658|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911659|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911660|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911661|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911662|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911663|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911664|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
105911665|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911666|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911667|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911668|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911669|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911670|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
105911671|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911672|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911673|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911674|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911675|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911676|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
105999733|NCT01147666|365661197|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999734|NCT01147666|365661198|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105911677|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
105911678|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
105911679|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
105911680|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911681|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911682|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911683|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911684|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911685|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
105911686|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911687|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911688|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911689|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911690|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911691|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
105911692|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911693|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911694|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911695|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911696|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911697|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911698|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911699|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911700|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
105911701|NCT02326272|365334884|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911702|NCT02326272|365334885|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911703|NCT02326272|365334886|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911704|NCT02326272|365334887|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911705|NCT02326272|365334888|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911706|NCT02326272|365334889|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911707|NCT02326272|365334890|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
105911708|NCT02326272|365334891|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911709|NCT02326272|365334892|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911710|NCT02326272|365334893|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911711|NCT02326272|365334894|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911712|NCT02326272|365334895|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911713|NCT02326272|365334896|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911714|NCT02326272|365334897|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911715|NCT02326272|365334898|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
105911716|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
105911717|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
105911718|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
105911719|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
105911720|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
105911721|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
105911722|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
105911723|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
105911724|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
105911725|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
105911726|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
105911727|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
105911728|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
105911729|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
105911730|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
105911731|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911732|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911733|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911734|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911735|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911736|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911737|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911738|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911739|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911740|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911741|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
105911742|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
105911743|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
105911744|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
105911745|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
105911746|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911747|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911748|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911749|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911750|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911751|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911752|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911753|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911754|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911755|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105999735|NCT01147666|365661199|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
105999736|NCT01147666|365661200|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999737|NCT01147666|365661201|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105911756|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105911757|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911758|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
105999738|NCT01147666|365661202|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999739|NCT01147666|365661203|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999740|NCT01147666|365661204|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105911759|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911760|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
105911761|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911762|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911763|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911764|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911765|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911766|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911767|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911768|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911769|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911770|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911771|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911772|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
105911773|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911774|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911775|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
105911776|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911777|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911778|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911779|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911780|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911781|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911782|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911783|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911784|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911785|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911786|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
105911787|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105911788|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
105911789|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
105999741|NCT01147666|365661205|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999742|NCT01147666|365661206|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999743|NCT01147666|365661207|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105674036|NCT03117998|364470575|FG005|Overall Study|Adverse Event|0|||
105674037|NCT03117998|364470570|FG000|Overall Study|Withdrawal by Subject|0|||
105674038|NCT03117998|364470571|FG001|Overall Study|Withdrawal by Subject|0|||
105674039|NCT03117998|364470572|FG002|Overall Study|Withdrawal by Subject|2|||
105911790|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
105911791|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911792|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911793|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911794|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911795|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911796|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911797|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911798|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911799|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911800|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911801|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911802|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
105911803|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911804|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
105911805|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
105911806|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911807|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911808|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911809|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911810|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911811|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911812|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911813|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911814|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911815|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911816|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911817|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
105911818|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
105911819|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
105911820|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
105911821|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911822|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911823|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911824|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911825|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911826|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911827|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911828|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911829|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911830|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911831|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911832|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
105911833|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911834|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911835|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
105911836|NCT02326272|365334884|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911837|NCT02326272|365334885|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911838|NCT02326272|365334886|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911839|NCT02326272|365334887|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911840|NCT02326272|365334888|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911841|NCT02326272|365334889|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911842|NCT02326272|365334890|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911843|NCT02326272|365334891|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911844|NCT02326272|365334892|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911845|NCT02326272|365334893|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911846|NCT02326272|365334894|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911847|NCT02326272|365334895|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911848|NCT02326272|365334896|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
105911849|NCT02326272|365334897|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911850|NCT02326272|365334898|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
105911851|NCT00917124|365334902|FG000|Overall Study|Protocol Violation|4|||
105911852|NCT00917124|365334903|FG001|Overall Study|Protocol Violation|6|||
105911853|NCT00974311|365334904|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
105911854|NCT00974311|365334905|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
105911855|NCT00974311|365334904|FG000|DB Phase (up to 24 Months)|Death|561|||
105911856|NCT00974311|365334905|FG001|DB Phase (up to 24 Months)|Death|298|||
105911857|NCT00974311|365334904|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
105911858|NCT00974311|365334905|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
105911859|NCT00974311|365334904|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
105911860|NCT00974311|365334905|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
105911861|NCT00974311|365334904|FG000|DB Phase (up to 24 Months)|Other|1|||
105911862|NCT00974311|365334905|FG001|DB Phase (up to 24 Months)|Other|0|||
105911863|NCT00974311|365334904|FG000|OLE Phase (up to 77 Months)|Death|14|||
105911864|NCT00974311|365334905|FG001|OLE Phase (up to 77 Months)|Death|21|||
105911865|NCT00974311|365334904|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
105911866|NCT00974311|365334905|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
105911867|NCT00974311|365334904|FG000|OLE Phase (up to 77 Months)|Other|15|||
105911868|NCT00974311|365334905|FG001|OLE Phase (up to 77 Months)|Other|2|||
105911869|NCT00974311|365334904|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
105911870|NCT00974311|365334905|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
105911871|NCT00165503|365334908|FG000|Overall Study|Death|1|||
105911872|NCT00165503|365334908|FG000|Overall Study|Lost to Follow-up|12|||
105911873|NCT00165503|365334908|FG000|Overall Study|Unresectable|3|||
105911874|NCT02254772|365334909|FG000|Overall Study|Ineligible|1|||
105911875|NCT02254772|365334909|FG000|Overall Study|Withdrawal by Subject|1|||
105911876|NCT02346708|365334910|FG000|Overall Study|Adverse Event|2|||
105911877|NCT02346708|365334911|FG001|Overall Study|Adverse Event|0|||
105911878|NCT02346708|365334910|FG000|Overall Study|Protocol Violation|0|||
105911879|NCT02346708|365334911|FG001|Overall Study|Protocol Violation|1|||
105911880|NCT00928434|365334914|FG000|Overall Study|Adverse Event|14|||
105911881|NCT00928434|365334915|FG001|Overall Study|Adverse Event|5|||
105911882|NCT00928434|365334916|FG002|Overall Study|Adverse Event|18|||
105911883|NCT00928434|365334914|FG000|Overall Study|Protocol Violation|5|||
105911884|NCT00928434|365334915|FG001|Overall Study|Protocol Violation|0|||
105911885|NCT00928434|365334916|FG002|Overall Study|Protocol Violation|8|||
105911886|NCT00928434|365334914|FG000|Overall Study|Physician Decision|2|||
105911887|NCT00928434|365334915|FG001|Overall Study|Physician Decision|0|||
105911888|NCT00928434|365334916|FG002|Overall Study|Physician Decision|3|||
105911889|NCT00928434|365334914|FG000|Overall Study|Lost to Follow-up|1|||
105911890|NCT00928434|365334915|FG001|Overall Study|Lost to Follow-up|0|||
105911891|NCT00928434|365334916|FG002|Overall Study|Lost to Follow-up|3|||
105911892|NCT00928434|365334914|FG000|Overall Study|Withdrawal by Subject|5|||
105911893|NCT00928434|365334915|FG001|Overall Study|Withdrawal by Subject|3|||
105911894|NCT00928434|365334916|FG002|Overall Study|Withdrawal by Subject|2|||
105911895|NCT00928434|365334914|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
105911896|NCT00928434|365334915|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
105911897|NCT00928434|365334916|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
105911898|NCT00928434|365334914|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
105911899|NCT00928434|365334915|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
105911900|NCT00928434|365334916|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
105911901|NCT00928434|365334914|FG000|Overall Study|Other (not meeting above criteria)|5|||
105911902|NCT00928434|365334915|FG001|Overall Study|Other (not meeting above criteria)|1|||
105911903|NCT00928434|365334916|FG002|Overall Study|Other (not meeting above criteria)|2|||
105911904|NCT01781962|365334917|FG000|Overall Study|Other Miscellaneous Reasons|5|||
105911905|NCT03006562|365334918|FG000|Overall Study|Lost to Follow-up|0|||
105911906|NCT03006562|365334919|FG001|Overall Study|Lost to Follow-up|1|||
105911907|NCT01001910|365334920|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
105911908|NCT00614874|365334921|FG000|Overall Study|Protocol Violation|1|||
105911909|NCT00614874|365334921|FG000|Overall Study|Withdrawal by Subject|1|||
105911910|NCT00321906|365334924|FG000|Overall Study|Adverse Event|36|||
105911911|NCT00321906|365334925|FG001|Overall Study|Adverse Event|44|||
105911912|NCT00321906|365334924|FG000|Overall Study|Death|9|||
105911913|NCT00321906|365334925|FG001|Overall Study|Death|6|||
105911914|NCT00321906|365334924|FG000|Overall Study|Lost to Follow-up|1|||
105911915|NCT00321906|365334925|FG001|Overall Study|Lost to Follow-up|2|||
105911916|NCT00321906|365334924|FG000|Overall Study|Withdrawal by Subject|0|||
105911917|NCT00321906|365334925|FG001|Overall Study|Withdrawal by Subject|4|||
105911918|NCT02420119|365334926|FG000|Overall Study|insufficient laboratory data|5|||
105911919|NCT00810069|365334927|FG000|Lead-in Period I|Adverse Event|43|||
105911920|NCT00810069|365334928|FG001|Lead-in Period I|Adverse Event|0|||
105911921|NCT00810069|365334929|FG002|Lead-in Period I|Adverse Event|0|||
105786392|NCT01965600|364870515|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
105911922|NCT00810069|365334927|FG000|Lead-in Period I|Lack of Efficacy|1|||
105911923|NCT00810069|365334928|FG001|Lead-in Period I|Lack of Efficacy|0|||
105911924|NCT00810069|365334929|FG002|Lead-in Period I|Lack of Efficacy|0|||
105911925|NCT00810069|365334927|FG000|Lead-in Period I|Lost to Follow-up|19|||
105911926|NCT00810069|365334928|FG001|Lead-in Period I|Lost to Follow-up|0|||
105911927|NCT00810069|365334929|FG002|Lead-in Period I|Lost to Follow-up|0|||
105911928|NCT00810069|365334927|FG000|Lead-in Period I|Physician Decision|1|||
105911929|NCT00810069|365334928|FG001|Lead-in Period I|Physician Decision|0|||
105911930|NCT00810069|365334929|FG002|Lead-in Period I|Physician Decision|0|||
105911931|NCT00810069|365334927|FG000|Lead-in Period I|Protocol Violation|1|||
105911932|NCT00810069|365334928|FG001|Lead-in Period I|Protocol Violation|0|||
105911933|NCT00810069|365334929|FG002|Lead-in Period I|Protocol Violation|0|||
105911934|NCT00810069|365334927|FG000|Lead-in Period I|Withdrawal by Subject|46|||
105911935|NCT00810069|365334928|FG001|Lead-in Period I|Withdrawal by Subject|0|||
105911936|NCT00810069|365334929|FG002|Lead-in Period I|Withdrawal by Subject|0|||
105911937|NCT00810069|365334927|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
105911938|NCT00810069|365334928|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
105911939|NCT00810069|365334929|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
105911940|NCT00810069|365334927|FG000|Lead-in Period I|Randomization criteria not met|158|||
105911941|NCT00810069|365334928|FG001|Lead-in Period I|Randomization criteria not met|0|||
105911942|NCT00810069|365334929|FG002|Lead-in Period I|Randomization criteria not met|0|||
105911943|NCT00810069|365334927|FG000|Double-Blind Period II|Adverse Event|0|||
105911944|NCT00810069|365334928|FG001|Double-Blind Period II|Adverse Event|9|||
105911945|NCT00810069|365334929|FG002|Double-Blind Period II|Adverse Event|8|||
105911946|NCT00810069|365334927|FG000|Double-Blind Period II|Lack of Efficacy|0|||
105911947|NCT00810069|365334928|FG001|Double-Blind Period II|Lack of Efficacy|7|||
105911948|NCT00810069|365334929|FG002|Double-Blind Period II|Lack of Efficacy|12|||
105911949|NCT00810069|365334927|FG000|Double-Blind Period II|Lost to Follow-up|0|||
105911950|NCT00810069|365334928|FG001|Double-Blind Period II|Lost to Follow-up|9|||
105911951|NCT00810069|365334929|FG002|Double-Blind Period II|Lost to Follow-up|9|||
105911952|NCT00810069|365334927|FG000|Double-Blind Period II|Physician Decision|0|||
105911953|NCT00810069|365334928|FG001|Double-Blind Period II|Physician Decision|0|||
105911954|NCT00810069|365334929|FG002|Double-Blind Period II|Physician Decision|1|||
105911955|NCT00810069|365334927|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
105911956|NCT00810069|365334928|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
105911957|NCT00810069|365334929|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
105911958|NCT00810069|365334927|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
105911959|NCT00810069|365334928|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
105911960|NCT00810069|365334929|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
105911961|NCT00810069|365334927|FG000|Double-Blind Period II|Clinical relapse|0|||
105911962|NCT00810069|365334928|FG001|Double-Blind Period II|Clinical relapse|3|||
105911963|NCT00810069|365334929|FG002|Double-Blind Period II|Clinical relapse|0|||
105911964|NCT00810069|365334927|FG000|Double-Blind Period II|Protocol Violation|0|||
105911965|NCT00810069|365334928|FG001|Double-Blind Period II|Protocol Violation|7|||
105911966|NCT00810069|365334929|FG002|Double-Blind Period II|Protocol Violation|6|||
105911967|NCT01630135|365334932|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
105911968|NCT01630135|365334933|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
105911969|NCT01585246|365334936|FG000|Overall Study|Lost to Follow-up|0|||
105911970|NCT01585246|365334937|FG001|Overall Study|Lost to Follow-up|0|||
105911971|NCT01585246|365334938|FG002|Overall Study|Lost to Follow-up|2|||
105911972|NCT01585246|365334939|FG003|Overall Study|Lost to Follow-up|1|||
105911973|NCT01585246|365334940|FG004|Overall Study|Lost to Follow-up|0|||
105911974|NCT01585246|365334936|FG000|Overall Study|Protocol Violation|0|||
105911975|NCT01585246|365334937|FG001|Overall Study|Protocol Violation|0|||
105911976|NCT01585246|365334938|FG002|Overall Study|Protocol Violation|0|||
105911977|NCT01585246|365334939|FG003|Overall Study|Protocol Violation|0|||
105911978|NCT01585246|365334940|FG004|Overall Study|Protocol Violation|1|||
105911979|NCT01585246|365334936|FG000|Overall Study|Withdrawal by Subject|0|||
105911980|NCT01585246|365334937|FG001|Overall Study|Withdrawal by Subject|0|||
105911981|NCT01585246|365334938|FG002|Overall Study|Withdrawal by Subject|1|||
105911982|NCT01585246|365334939|FG003|Overall Study|Withdrawal by Subject|2|||
105911983|NCT01585246|365334940|FG004|Overall Study|Withdrawal by Subject|1|||
105911984|NCT01585246|365334936|FG000|Overall Study|Other|0|||
105911985|NCT01585246|365334937|FG001|Overall Study|Other|1|||
105911986|NCT01585246|365334938|FG002|Overall Study|Other|1|||
105911987|NCT01585246|365334939|FG003|Overall Study|Other|1|||
105911988|NCT01585246|365334940|FG004|Overall Study|Other|0|||
105911989|NCT03113968|365334943|FG000|Overall Study|Withdrawal by Subject|31|||
105911990|NCT03113968|365334944|FG001|Overall Study|Withdrawal by Subject|4|||
105911991|NCT02111174|365334945|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
105911992|NCT02111174|365334946|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
105911993|NCT02111174|365334945|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
105911994|NCT02111174|365334946|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
106125698|NCT02431533|366117882|FG001|Overall Study|Developed Exclusionary criteria|0|||
105911995|NCT02111174|365334945|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
105911996|NCT02111174|365334946|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
105911997|NCT02111174|365334945|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
105911998|NCT02111174|365334946|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
105911999|NCT01657162|365334947|FG000|Overall Study|Adverse Event|26|||
105912000|NCT01657162|365334948|FG001|Overall Study|Adverse Event|36|||
105912001|NCT01657162|365334947|FG000|Overall Study|Withdrawal by Subject|13|||
105912002|NCT01657162|365334948|FG001|Overall Study|Withdrawal by Subject|13|||
105912003|NCT01657162|365334947|FG000|Overall Study|Continuing Significant Deterioration|9|||
105912004|NCT01657162|365334948|FG001|Overall Study|Continuing Significant Deterioration|3|||
105912005|NCT01657162|365334947|FG000|Overall Study|Refusal of Treatment|4|||
105912006|NCT01657162|365334948|FG001|Overall Study|Refusal of Treatment|6|||
105912007|NCT01657162|365334947|FG000|Overall Study|Lost to Follow-up|3|||
105912008|NCT01657162|365334948|FG001|Overall Study|Lost to Follow-up|4|||
105912009|NCT01657162|365334947|FG000|Overall Study|Death|2|||
105912010|NCT01657162|365334948|FG001|Overall Study|Death|3|||
105912011|NCT01657162|365334947|FG000|Overall Study|Inability to Complete Study Procedures|1|||
105912012|NCT01657162|365334948|FG001|Overall Study|Inability to Complete Study Procedures|7|||
105912013|NCT01657162|365334947|FG000|Overall Study|Protocol Violation|1|||
105912014|NCT01657162|365334948|FG001|Overall Study|Protocol Violation|0|||
105912015|NCT01657162|365334947|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
105912016|NCT01657162|365334948|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
105912017|NCT01657162|365334947|FG000|Overall Study|Other than Specified|0|||
105912018|NCT01657162|365334948|FG001|Overall Study|Other than Specified|2|||
105912019|NCT00871234|365334949|FG000|Overall Study|Adverse Event|2|||
105912020|NCT00871234|365334949|FG000|Overall Study|Lost to Follow-up|3|||
105912021|NCT03380377|365334950|FG000|Overall Study|Physician Decision|1|||
105912022|NCT03380377|365334950|FG000|Overall Study|Withdrawal by Subject|1|||
105912023|NCT00128661|365334951|FG000|Overall Study|Adverse Event|14|||
105912024|NCT00128661|365334952|FG001|Overall Study|Adverse Event|11|||
105912025|NCT00128661|365334951|FG000|Overall Study|Lost to Follow-up|10|||
105912026|NCT00128661|365334952|FG001|Overall Study|Lost to Follow-up|7|||
105912027|NCT00128661|365334951|FG000|Overall Study|Withdrawal by Subject|243|||
105912028|NCT00128661|365334952|FG001|Overall Study|Withdrawal by Subject|232|||
105912029|NCT00128661|365334951|FG000|Overall Study|Other|7|||
105912030|NCT00128661|365334952|FG001|Overall Study|Other|8|||
105912031|NCT03421379|365334954|FG000|Period 1|Withdrawal by Subject|0|||
105912032|NCT03421379|365334955|FG001|Period 1|Withdrawal by Subject|1|||
105912033|NCT03421379|365334954|FG000|Period 1|Physician Decision|1|||
105912034|NCT03421379|365334955|FG001|Period 1|Physician Decision|1|||
105912035|NCT03421379|365334954|FG000|Period 1|Did not receive treatment|1|||
105912036|NCT03421379|365334955|FG001|Period 1|Did not receive treatment|2|||
105912037|NCT02782741|365334956|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
105912038|NCT02782741|365334957|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
105912039|NCT02782741|365334958|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
105912040|NCT02782741|365334956|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
105912041|NCT02782741|365334957|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
105912042|NCT02782741|365334958|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
105912043|NCT02782741|365334956|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
105912044|NCT02782741|365334957|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
105912045|NCT02782741|365334958|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
105912046|NCT02782741|365334956|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
105912047|NCT02782741|365334957|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
105912048|NCT02782741|365334958|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
105912049|NCT02782741|365334956|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
105912050|NCT02782741|365334957|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
105912051|NCT02782741|365334958|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
105912052|NCT04001803|365334960|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
105912053|NCT04001803|365334960|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
105912054|NCT04001803|365334960|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
105912055|NCT04001803|365334960|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
105912056|NCT04001803|365334960|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
105912057|NCT04001803|365334960|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
105912058|NCT04001803|365334960|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
105912059|NCT04001803|365334960|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
105912060|NCT04001803|365334960|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
105912061|NCT04001803|365334960|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
105912062|NCT01945944|365334963|FG000|Overall Study|Adverse Event|0|||
105912063|NCT01945944|365334964|FG001|Overall Study|Adverse Event|2|||
105912064|NCT01945944|365334963|FG000|Overall Study|Physician Decision|1|||
105912065|NCT01945944|365334964|FG001|Overall Study|Physician Decision|0|||
105912066|NCT01945944|365334963|FG000|Overall Study|Withdrawal by Subject|0|||
105912067|NCT01945944|365334964|FG001|Overall Study|Withdrawal by Subject|1|||
105912068|NCT01817075|365334965|FG000|Overall Study|Adverse Event|7|||
105912069|NCT01817075|365334966|FG001|Overall Study|Adverse Event|5|||
105912070|NCT01817075|365334965|FG000|Overall Study|Physician Decision|9|||
105912071|NCT01817075|365334966|FG001|Overall Study|Physician Decision|12|||
105912072|NCT01817075|365334965|FG000|Overall Study|Withdrawal by Subject|31|||
105912073|NCT01817075|365334966|FG001|Overall Study|Withdrawal by Subject|15|||
105912074|NCT01817075|365334965|FG000|Overall Study|Received Sorafenib after enrollment|0|||
105912075|NCT01817075|365334966|FG001|Overall Study|Received Sorafenib after enrollment|1|||
105912076|NCT01817075|365334965|FG000|Overall Study|Ineligible|0|||
105912077|NCT01817075|365334966|FG001|Overall Study|Ineligible|2|||
105952042|NCT00527618|365488181|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
105952043|NCT03314935|365488184|FG000|Phase 1|Death|4|||
105952044|NCT03314935|365488185|FG001|Phase 1|Death|2|||
105952045|NCT03314935|365488186|FG002|Phase 1|Death|5|||
105952046|NCT03314935|365488187|FG003|Phase 1|Death|4|||
105952047|NCT03314935|365488188|FG004|Phase 1|Death|3|||
105952048|NCT03314935|365488189|FG005|Phase 1|Death|4|||
105952049|NCT03314935|365488190|FG006|Phase 1|Death|5|||
105952050|NCT03314935|365488191|FG007|Phase 1|Death|4|||
105952051|NCT03314935|365488192|FG008|Phase 1|Death|3|||
105952052|NCT03314935|365488193|FG009|Phase 1|Death|0|||
105952053|NCT03314935|365488194|FG010|Phase 1|Death|0|||
105952054|NCT03314935|365488195|FG011|Phase 1|Death|0|||
105674040|NCT03117998|364470573|FG003|Overall Study|Withdrawal by Subject|3|||
105674041|NCT03117998|364470574|FG004|Overall Study|Withdrawal by Subject|3|||
105674042|NCT03117998|364470575|FG005|Overall Study|Withdrawal by Subject|0|||
105674043|NCT03117998|364470570|FG000|Overall Study|Physician Decision|0|||
105674044|NCT03117998|364470571|FG001|Overall Study|Physician Decision|1|||
105674045|NCT03117998|364470572|FG002|Overall Study|Physician Decision|1|||
105674046|NCT03117998|364470573|FG003|Overall Study|Physician Decision|0|||
105674047|NCT03117998|364470574|FG004|Overall Study|Physician Decision|0|||
105674048|NCT03117998|364470575|FG005|Overall Study|Physician Decision|0|||
105674049|NCT03117998|364470570|FG000|Overall Study|Lost to Follow-up|0|||
105674050|NCT03117998|364470571|FG001|Overall Study|Lost to Follow-up|0|||
105674051|NCT03117998|364470572|FG002|Overall Study|Lost to Follow-up|0|||
105674052|NCT03117998|364470573|FG003|Overall Study|Lost to Follow-up|1|||
105674053|NCT03117998|364470574|FG004|Overall Study|Lost to Follow-up|4|||
105674054|NCT03117998|364470575|FG005|Overall Study|Lost to Follow-up|0|||
105674055|NCT03117998|364470570|FG000|Overall Study|Subject noncompliance|0|||
105674056|NCT03117998|364470571|FG001|Overall Study|Subject noncompliance|0|||
105674057|NCT03117998|364470572|FG002|Overall Study|Subject noncompliance|1|||
105674058|NCT03117998|364470573|FG003|Overall Study|Subject noncompliance|0|||
105674059|NCT03117998|364470574|FG004|Overall Study|Subject noncompliance|0|||
105674060|NCT03117998|364470575|FG005|Overall Study|Subject noncompliance|2|||
105674061|NCT03117998|364470570|FG000|Overall Study|Protocol Violation|0|||
105674062|NCT03117998|364470571|FG001|Overall Study|Protocol Violation|0|||
105674063|NCT03117998|364470572|FG002|Overall Study|Protocol Violation|0|||
105674064|NCT03117998|364470573|FG003|Overall Study|Protocol Violation|0|||
105674065|NCT03117998|364470574|FG004|Overall Study|Protocol Violation|0|||
105674066|NCT03117998|364470575|FG005|Overall Study|Protocol Violation|1|||
105674067|NCT00293059|364470576|FG000|Overall Study|Adverse Event|12|||
105674068|NCT00293059|364470577|FG001|Overall Study|Adverse Event|4|||
105674069|NCT00293059|364470576|FG000|Overall Study|Lack of Efficacy|2|||
105674070|NCT00293059|364470577|FG001|Overall Study|Lack of Efficacy|0|||
105674071|NCT00293059|364470576|FG000|Overall Study|Lost to Follow-up|2|||
105674072|NCT00293059|364470577|FG001|Overall Study|Lost to Follow-up|3|||
105674073|NCT00293059|364470576|FG000|Overall Study|Pregnancy|1|||
105674074|NCT00293059|364470577|FG001|Overall Study|Pregnancy|1|||
105674075|NCT00293059|364470576|FG000|Overall Study|Protocol Violation|2|||
105674076|NCT00293059|364470577|FG001|Overall Study|Protocol Violation|0|||
105674077|NCT00293059|364470576|FG000|Overall Study|Withdrawal by Subject|11|||
105674078|NCT00293059|364470577|FG001|Overall Study|Withdrawal by Subject|5|||
105674079|NCT00293059|364470576|FG000|Overall Study|Participant moved out of state|1|||
105674080|NCT00293059|364470577|FG001|Overall Study|Participant moved out of state|0|||
105952055|NCT03314935|365488196|FG012|Phase 1|Death|0|||
105952056|NCT03314935|365488197|FG013|Phase 1|Death|0|||
105674081|NCT00293059|364470576|FG000|Overall Study|Participant stopped study drug|1|||
105674082|NCT00293059|364470577|FG001|Overall Study|Participant stopped study drug|0|||
105674083|NCT00293059|364470576|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
105674084|NCT00293059|364470577|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
105674085|NCT00293059|364470576|FG000|Overall Study|missing|3|||
105674086|NCT00293059|364470577|FG001|Overall Study|missing|5|||
105674087|NCT00438672|364470579|FG000|Overall Study|Lost to Follow-up|7|||
105674088|NCT00438672|364470580|FG001|Overall Study|Lost to Follow-up|9|||
105674089|NCT00680992|364470581|FG000|Overall Study|Complete Resection (as per protocol)|25|||
105674090|NCT00680992|364470582|FG001|Overall Study|Complete Resection (as per protocol)|121|||
105674091|NCT00680992|364470583|FG002|Overall Study|Complete Resection (as per protocol)|0|||
105674092|NCT00680992|364470581|FG000|Overall Study|Administrative Decision|83|||
105674093|NCT00680992|364470582|FG001|Overall Study|Administrative Decision|42|||
105952057|NCT03314935|365488198|FG014|Phase 1|Death|0|||
105952058|NCT03314935|365488184|FG000|Phase 1|Withdrawal by Subject|2|||
105952059|NCT03314935|365488185|FG001|Phase 1|Withdrawal by Subject|1|||
105674094|NCT00680992|364470583|FG002|Overall Study|Administrative Decision|5|||
105674095|NCT00680992|364470581|FG000|Overall Study|End of Trial|32|||
105674096|NCT00680992|364470582|FG001|Overall Study|End of Trial|12|||
105674097|NCT00680992|364470583|FG002|Overall Study|End of Trial|3|||
105674098|NCT00680992|364470581|FG000|Overall Study|Withdrawal by Subject|33|||
105952060|NCT03314935|365488186|FG002|Phase 1|Withdrawal by Subject|1|||
105952061|NCT03314935|365488187|FG003|Phase 1|Withdrawal by Subject|2|||
105674099|NCT00680992|364470582|FG001|Overall Study|Withdrawal by Subject|11|||
105674100|NCT00680992|364470583|FG002|Overall Study|Withdrawal by Subject|1|||
105674101|NCT00680992|364470581|FG000|Overall Study|Adverse Event|21|||
105674102|NCT00680992|364470582|FG001|Overall Study|Adverse Event|19|||
105674103|NCT00680992|364470583|FG002|Overall Study|Adverse Event|1|||
105674104|NCT00680992|364470581|FG000|Overall Study|Other|19|||
105674105|NCT00680992|364470582|FG001|Overall Study|Other|14|||
105674106|NCT00680992|364470583|FG002|Overall Study|Other|1|||
105674107|NCT00680992|364470581|FG000|Overall Study|Disease Progression|21|||
105674108|NCT00680992|364470582|FG001|Overall Study|Disease Progression|9|||
105674109|NCT00680992|364470583|FG002|Overall Study|Disease Progression|0|||
105674110|NCT00680992|364470581|FG000|Overall Study|Lost to Follow-up|12|||
105674111|NCT00680992|364470582|FG001|Overall Study|Lost to Follow-up|14|||
105674112|NCT00680992|364470583|FG002|Overall Study|Lost to Follow-up|0|||
105674113|NCT00680992|364470581|FG000|Overall Study|Noncompliance|4|||
105674114|NCT00680992|364470582|FG001|Overall Study|Noncompliance|6|||
105674115|NCT00680992|364470583|FG002|Overall Study|Noncompliance|0|||
105674116|NCT00680992|364470581|FG000|Overall Study|Requirement for Alternative Therapy|8|||
105674117|NCT00680992|364470582|FG001|Overall Study|Requirement for Alternative Therapy|2|||
105674118|NCT00680992|364470583|FG002|Overall Study|Requirement for Alternative Therapy|0|||
105674119|NCT00680992|364470581|FG000|Overall Study|Pregnancy|5|||
105674120|NCT00680992|364470582|FG001|Overall Study|Pregnancy|0|||
105674121|NCT00680992|364470583|FG002|Overall Study|Pregnancy|1|||
105674122|NCT00680992|364470581|FG000|Overall Study|Death|5|||
105674123|NCT00680992|364470582|FG001|Overall Study|Death|1|||
105674124|NCT00680992|364470583|FG002|Overall Study|Death|0|||
105674125|NCT00680992|364470581|FG000|Overall Study|Ineligibility Determined|0|||
105674126|NCT00680992|364470582|FG001|Overall Study|Ineligibility Determined|1|||
105674127|NCT00680992|364470583|FG002|Overall Study|Ineligibility Determined|0|||
105674128|NCT04828837|364470584|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
105674129|NCT04828837|364470585|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
105674130|NCT04828837|364470584|FG000|Overall Study|Lost to Follow-up|2|||
105674131|NCT04828837|364470585|FG001|Overall Study|Lost to Follow-up|6|||
105674132|NCT04828837|364470584|FG000|Overall Study|Lack of Efficacy|1|||
105674133|NCT04828837|364470585|FG001|Overall Study|Lack of Efficacy|0|||
105674134|NCT04828837|364470584|FG000|Overall Study|Admitted due to pneumothorax.|1|||
105674135|NCT04828837|364470585|FG001|Overall Study|Admitted due to pneumothorax.|0|||
105674136|NCT04828837|364470584|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
105674137|NCT04828837|364470585|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
105674138|NCT00320528|364470586|FG000|Study Period II|Adverse Event|3|||
105674139|NCT00320528|364470587|FG001|Study Period II|Adverse Event|4|||
105674140|NCT00320528|364470588|FG002|Study Period II|Adverse Event|8|||
105674141|NCT00320528|364470586|FG000|Study Period II|Parent/Caregiver Decision|8|||
105674142|NCT00320528|364470587|FG001|Study Period II|Parent/Caregiver Decision|3|||
105674143|NCT00320528|364470588|FG002|Study Period II|Parent/Caregiver Decision|11|||
105674144|NCT00320528|364470586|FG000|Study Period II|Withdrawal by Subject|0|||
105674145|NCT00320528|364470587|FG001|Study Period II|Withdrawal by Subject|1|||
105674146|NCT00320528|364470588|FG002|Study Period II|Withdrawal by Subject|1|||
105674147|NCT00320528|364470586|FG000|Study Period II|Entry Criteria Exclusion|0|||
105674148|NCT00320528|364470587|FG001|Study Period II|Entry Criteria Exclusion|2|||
105674149|NCT00320528|364470588|FG002|Study Period II|Entry Criteria Exclusion|2|||
105674150|NCT00320528|364470586|FG000|Study Period III|Adverse Event|1|||
105674151|NCT00320528|364470587|FG001|Study Period III|Adverse Event|0|||
105674152|NCT00320528|364470588|FG002|Study Period III|Adverse Event|0|||
105674153|NCT00320528|364470586|FG000|Study Period III|Lost to Follow-up|1|||
105674154|NCT00320528|364470587|FG001|Study Period III|Lost to Follow-up|0|||
105674155|NCT00320528|364470588|FG002|Study Period III|Lost to Follow-up|0|||
105674156|NCT00320528|364470586|FG000|Study Period III|Withdrawal by Subject|1|||
105674157|NCT00320528|364470587|FG001|Study Period III|Withdrawal by Subject|1|||
105674158|NCT00320528|364470588|FG002|Study Period III|Withdrawal by Subject|2|||
105674159|NCT00320528|364470586|FG000|Study Period III|Lack of Efficacy|2|||
105674160|NCT00320528|364470587|FG001|Study Period III|Lack of Efficacy|0|||
105674161|NCT00320528|364470588|FG002|Study Period III|Lack of Efficacy|0|||
105674162|NCT00320528|364470586|FG000|Study Period III|Parent/Caregiver Decision|14|||
105674163|NCT00320528|364470587|FG001|Study Period III|Parent/Caregiver Decision|3|||
105674164|NCT00320528|364470588|FG002|Study Period III|Parent/Caregiver Decision|11|||
105674165|NCT00320528|364470586|FG000|Study Period III|Protocol Violation|0|||
105674166|NCT00320528|364470587|FG001|Study Period III|Protocol Violation|1|||
105674167|NCT00320528|364470588|FG002|Study Period III|Protocol Violation|0|||
105674168|NCT00320528|364470586|FG000|Study Period III|Physician Decision|0|||
105674169|NCT00320528|364470587|FG001|Study Period III|Physician Decision|1|||
105674170|NCT00320528|364470588|FG002|Study Period III|Physician Decision|2|||
105674171|NCT00320528|364470586|FG000|Study Period III|Sponsor Decision|0|||
105674172|NCT00320528|364470587|FG001|Study Period III|Sponsor Decision|0|||
105674173|NCT00320528|364470588|FG002|Study Period III|Sponsor Decision|1|||
105674174|NCT00320528|364470586|FG000|Study Period III|Atomoxetine Commercially Available|68|||
105674175|NCT00320528|364470587|FG001|Study Period III|Atomoxetine Commercially Available|25|||
105674176|NCT00320528|364470588|FG002|Study Period III|Atomoxetine Commercially Available|90|||
105674177|NCT00925353|364470589|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
105674178|NCT01022112|364470590|FG000|Overall Study|Adverse Event|1|||
105674179|NCT01022112|364470591|FG001|Overall Study|Adverse Event|2|||
105674180|NCT01022112|364470592|FG002|Overall Study|Adverse Event|0|||
105674181|NCT01022112|364470593|FG003|Overall Study|Adverse Event|1|||
105674182|NCT01022112|364470594|FG004|Overall Study|Adverse Event|0|||
105674183|NCT01022112|364470590|FG000|Overall Study|Lack of Efficacy|1|||
105674184|NCT01022112|364470591|FG001|Overall Study|Lack of Efficacy|0|||
105674185|NCT01022112|364470592|FG002|Overall Study|Lack of Efficacy|0|||
105674186|NCT01022112|364470593|FG003|Overall Study|Lack of Efficacy|0|||
105674187|NCT01022112|364470594|FG004|Overall Study|Lack of Efficacy|1|||
105674188|NCT01022112|364470590|FG000|Overall Study|Physician Decision|0|||
105674189|NCT01022112|364470591|FG001|Overall Study|Physician Decision|0|||
105674190|NCT01022112|364470592|FG002|Overall Study|Physician Decision|1|||
105674191|NCT01022112|364470593|FG003|Overall Study|Physician Decision|0|||
105674192|NCT01022112|364470594|FG004|Overall Study|Physician Decision|1|||
105674193|NCT01022112|364470590|FG000|Overall Study|Withdrawal by Subject|0|||
105674194|NCT01022112|364470591|FG001|Overall Study|Withdrawal by Subject|1|||
105674195|NCT01022112|364470592|FG002|Overall Study|Withdrawal by Subject|2|||
105674196|NCT01022112|364470593|FG003|Overall Study|Withdrawal by Subject|2|||
105674197|NCT01022112|364470594|FG004|Overall Study|Withdrawal by Subject|1|||
105674198|NCT01022112|364470590|FG000|Overall Study|Fasting plasma glucose level increased|1|||
105674199|NCT01022112|364470591|FG001|Overall Study|Fasting plasma glucose level increased|0|||
105674200|NCT01022112|364470592|FG002|Overall Study|Fasting plasma glucose level increased|0|||
105674201|NCT01022112|364470593|FG003|Overall Study|Fasting plasma glucose level increased|0|||
105674202|NCT01022112|364470594|FG004|Overall Study|Fasting plasma glucose level increased|7|||
105674203|NCT04664400|364470595|FG000|Overall Study|Withdrawal by Subject|2|||
105674204|NCT00515853|364470596|FG000|Overall Study|Lost to Follow-up|9|||
105674205|NCT00515853|364470597|FG001|Overall Study|Lost to Follow-up|13|||
105674206|NCT00515853|364470596|FG000|Overall Study|Withdrawal by Subject|6|||
105674207|NCT00515853|364470597|FG001|Overall Study|Withdrawal by Subject|4|||
105674208|NCT03014479|364470599|FG000|Overall Study|Adverse Event|0|||
105674209|NCT03014479|364470600|FG001|Overall Study|Adverse Event|1|||
105674210|NCT03014479|364470599|FG000|Overall Study|Voluntary Withdrawal|0|||
105674211|NCT03014479|364470600|FG001|Overall Study|Voluntary Withdrawal|2|||
105674212|NCT03014479|364470599|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
105674213|NCT03014479|364470600|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
105674214|NCT00653523|364470601|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
105674215|NCT00653523|364470601|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
105674216|NCT00653523|364470601|FG000|Overall Study|Adverse Event|7|||
105674217|NCT00653523|364470601|FG000|Overall Study|Withdrawal by Subject|6|||
105674218|NCT00653523|364470601|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
105674219|NCT00653523|364470601|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
105674220|NCT01942785|364470605|FG000|Overall Study|Adverse Event|2|||
105674221|NCT01942785|364470605|FG000|Overall Study|Withdrawal by Subject|1|||
105674222|NCT01942785|364470605|FG000|Overall Study|Protocol Violation|1|||
105674223|NCT05597787|364470606|FG000|Overall Study|Withdrawal by Subject|0|||
105674224|NCT05597787|364470607|FG001|Overall Study|Withdrawal by Subject|0|||
105674225|NCT05597787|364470608|FG002|Overall Study|Withdrawal by Subject|1|||
105674226|NCT05148962|364470609|FG000|Overall Study|Withdrawal by Subject|1|||
105674227|NCT05148962|364470610|FG001|Overall Study|Withdrawal by Subject|1|||
105674228|NCT05148962|364470611|FG002|Overall Study|Withdrawal by Subject|0|||
105674229|NCT05148962|364470612|FG003|Overall Study|Withdrawal by Subject|1|||
105674230|NCT05148962|364470613|FG004|Overall Study|Withdrawal by Subject|0|||
105674231|NCT05148962|364470609|FG000|Overall Study|Participant was early terminated per protocol|0|||
105674232|NCT05148962|364470610|FG001|Overall Study|Participant was early terminated per protocol|0|||
105674233|NCT05148962|364470611|FG002|Overall Study|Participant was early terminated per protocol|3|||
105674234|NCT05148962|364470612|FG003|Overall Study|Participant was early terminated per protocol|5|||
105674235|NCT05148962|364470613|FG004|Overall Study|Participant was early terminated per protocol|2|||
105674236|NCT05148962|364470609|FG000|Overall Study|Miscellaneous|0|||
105674237|NCT05148962|364470610|FG001|Overall Study|Miscellaneous|0|||
105674238|NCT05148962|364470611|FG002|Overall Study|Miscellaneous|0|||
105674239|NCT05148962|364470612|FG003|Overall Study|Miscellaneous|1|||
105674240|NCT05148962|364470613|FG004|Overall Study|Miscellaneous|0|||
105674241|NCT01144377|364470616|FG000|52 Week Treatment Period|Adverse Event|0|||
105674242|NCT01144377|364470617|FG001|52 Week Treatment Period|Adverse Event|0|||
105912078|NCT04534517|365336939|FG000|Overall Study|Adverse Event|1|||
105912079|NCT04534517|365336939|FG000|Overall Study|Withdrawal by Subject|1|||
105912080|NCT04534517|365336939|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
105912081|NCT04534517|365336939|FG000|Overall Study|COVID-19 Related|1|||
105912082|NCT01128296|365336940|FG000|Overall Study|Physician Decision|0|||
105674243|NCT01144377|364470618|FG002|52 Week Treatment Period|Adverse Event|3|||
105674244|NCT01144377|364470619|FG003|52 Week Treatment Period|Adverse Event|2|||
105674245|NCT01144377|364470620|FG004|52 Week Treatment Period|Adverse Event|1|||
105674246|NCT01144377|364470616|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
105674247|NCT01144377|364470617|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
105674248|NCT01144377|364470618|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
105674249|NCT01144377|364470619|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
105674250|NCT01144377|364470620|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
105674251|NCT01144377|364470616|FG000|52 Week Treatment Period|Protocol Violation|0|||
105674252|NCT01144377|364470617|FG001|52 Week Treatment Period|Protocol Violation|0|||
105674253|NCT01144377|364470618|FG002|52 Week Treatment Period|Protocol Violation|0|||
105674254|NCT01144377|364470619|FG003|52 Week Treatment Period|Protocol Violation|0|||
105674255|NCT01144377|364470620|FG004|52 Week Treatment Period|Protocol Violation|1|||
105674256|NCT01144377|364470616|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
105674257|NCT01144377|364470617|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
105674258|NCT01144377|364470618|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
105674259|NCT01144377|364470619|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
105674260|NCT01144377|364470620|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
105674261|NCT01144377|364470616|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
105674262|NCT01144377|364470617|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
105674263|NCT01144377|364470618|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
105674264|NCT01144377|364470619|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
105674265|NCT01144377|364470620|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
105674266|NCT01144377|364470616|FG000|52 Week Treatment Period|Sponsor Decision|0|||
105674267|NCT01144377|364470617|FG001|52 Week Treatment Period|Sponsor Decision|0|||
105674268|NCT01144377|364470618|FG002|52 Week Treatment Period|Sponsor Decision|0|||
105674269|NCT01144377|364470619|FG003|52 Week Treatment Period|Sponsor Decision|0|||
105674270|NCT01144377|364470620|FG004|52 Week Treatment Period|Sponsor Decision|1|||
105674271|NCT01144377|364470616|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
105674272|NCT01144377|364470617|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
105674273|NCT01144377|364470618|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
105674274|NCT01144377|364470619|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
105674275|NCT01144377|364470620|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
105674276|NCT01144377|364470616|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
105674277|NCT01144377|364470617|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
105674278|NCT01144377|364470618|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
105674279|NCT01144377|364470619|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
105912083|NCT01128296|365336941|FG001|Overall Study|Physician Decision|0|||
105912084|NCT01128296|365336942|FG002|Overall Study|Physician Decision|0|||
105912085|NCT01128296|365336943|FG003|Overall Study|Physician Decision|0|||
105912086|NCT01128296|365336944|FG004|Overall Study|Physician Decision|0|||
105912087|NCT01128296|365336945|FG005|Overall Study|Physician Decision|3|||
105912088|NCT01128296|365336940|FG000|Overall Study|Withdrawal by Subject|0|||
105912089|NCT01128296|365336941|FG001|Overall Study|Withdrawal by Subject|0|||
105912090|NCT01128296|365336942|FG002|Overall Study|Withdrawal by Subject|0|||
105912091|NCT01128296|365336943|FG003|Overall Study|Withdrawal by Subject|0|||
105912092|NCT01128296|365336944|FG004|Overall Study|Withdrawal by Subject|0|||
105912093|NCT01128296|365336945|FG005|Overall Study|Withdrawal by Subject|2|||
105912094|NCT00823264|365336946|FG000|Overall Study|Protocol Violation|2|||
105912095|NCT00823264|365336947|FG001|Overall Study|Protocol Violation|0|||
105912096|NCT04155463|365336948|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
105912097|NCT04155463|365336949|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
105912098|NCT01914393|365336956|FG000|Overall Study|Protocol Violation|11|||
105912099|NCT01914393|365336957|FG001|Overall Study|Protocol Violation|3|||
105912100|NCT01914393|365336958|FG002|Overall Study|Protocol Violation|19|||
105912101|NCT01914393|365336956|FG000|Overall Study|Lack of Efficacy|11|||
105912102|NCT01914393|365336957|FG001|Overall Study|Lack of Efficacy|16|||
105912103|NCT01914393|365336958|FG002|Overall Study|Lack of Efficacy|5|||
105912104|NCT01914393|365336956|FG000|Overall Study|no reason given|14|||
105912105|NCT01914393|365336957|FG001|Overall Study|no reason given|8|||
105912106|NCT01914393|365336958|FG002|Overall Study|no reason given|16|||
105912107|NCT01914393|365336956|FG000|Overall Study|Adverse Event|29|||
105912108|NCT01914393|365336957|FG001|Overall Study|Adverse Event|18|||
105912109|NCT01914393|365336958|FG002|Overall Study|Adverse Event|31|||
105674280|NCT01144377|364470620|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
105674281|NCT01144377|364470616|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
105786393|NCT01965600|364870516|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
105786394|NCT01965600|364870513|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
105786395|NCT01965600|364870514|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
105912110|NCT01914393|365336956|FG000|Overall Study|Withdrawal by Subject|38|||
105912111|NCT01914393|365336957|FG001|Overall Study|Withdrawal by Subject|20|||
105912112|NCT01914393|365336958|FG002|Overall Study|Withdrawal by Subject|47|||
105912113|NCT01914393|365336956|FG000|Overall Study|Lost to Follow-up|12|||
106125699|NCT02107443|366117887|FG000|Overall Study|Death|42|||
105674282|NCT01144377|364470617|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
105674283|NCT01144377|364470618|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
105674284|NCT01144377|364470619|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
105674285|NCT01144377|364470620|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
105674286|NCT01147536|364470621|FG000|Overall Study|Administrative study close|2|||
105674287|NCT01147536|364470621|FG000|Overall Study|Death|1|||
105674288|NCT02489968|364470622|FG000|Open-label Treatment Period|Adverse Event|14|||
105674289|NCT02489968|364470623|FG001|Open-label Treatment Period|Adverse Event|7|||
105674290|NCT02489968|364470624|FG002|Open-label Treatment Period|Adverse Event|0|||
105674291|NCT02489968|364470625|FG003|Open-label Treatment Period|Adverse Event|0|||
105674292|NCT02489968|364470626|FG004|Open-label Treatment Period|Adverse Event|0|||
105674293|NCT02489968|364470627|FG005|Open-label Treatment Period|Adverse Event|0|||
105674294|NCT02489968|364470622|FG000|Open-label Treatment Period|Protocol Violation|2|||
105674295|NCT02489968|364470623|FG001|Open-label Treatment Period|Protocol Violation|2|||
105674296|NCT02489968|364470624|FG002|Open-label Treatment Period|Protocol Violation|0|||
105674297|NCT02489968|364470625|FG003|Open-label Treatment Period|Protocol Violation|0|||
105674298|NCT02489968|364470626|FG004|Open-label Treatment Period|Protocol Violation|0|||
105674299|NCT02489968|364470627|FG005|Open-label Treatment Period|Protocol Violation|0|||
105674300|NCT02489968|364470622|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105674301|NCT02489968|364470623|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
105674302|NCT02489968|364470624|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
105674303|NCT02489968|364470625|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
105674304|NCT02489968|364470626|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
105912114|NCT01914393|365336957|FG001|Overall Study|Lost to Follow-up|6|||
105674305|NCT02489968|364470627|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
105674306|NCT02489968|364470622|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
105674307|NCT02489968|364470623|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
105674308|NCT02489968|364470624|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
105674309|NCT02489968|364470625|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
105674310|NCT02489968|364470626|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
105674311|NCT02489968|364470627|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
105674312|NCT02489968|364470622|FG000|Open-label Treatment Period|Other than specified above|204|||
105674313|NCT02489968|364470623|FG001|Open-label Treatment Period|Other than specified above|189|||
105674314|NCT02489968|364470624|FG002|Open-label Treatment Period|Other than specified above|0|||
105674315|NCT02489968|364470625|FG003|Open-label Treatment Period|Other than specified above|0|||
105674316|NCT02489968|364470626|FG004|Open-label Treatment Period|Other than specified above|0|||
105674317|NCT02489968|364470627|FG005|Open-label Treatment Period|Other than specified above|0|||
105674318|NCT02489968|364470622|FG000|Double-blind Treatment Period|Adverse Event|0|||
105674319|NCT02489968|364470623|FG001|Double-blind Treatment Period|Adverse Event|0|||
105674320|NCT02489968|364470624|FG002|Double-blind Treatment Period|Adverse Event|2|||
105674321|NCT02489968|364470625|FG003|Double-blind Treatment Period|Adverse Event|6|||
105674322|NCT02489968|364470626|FG004|Double-blind Treatment Period|Adverse Event|4|||
105674323|NCT02489968|364470627|FG005|Double-blind Treatment Period|Adverse Event|5|||
105674324|NCT02489968|364470622|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105674325|NCT02489968|364470623|FG001|Double-blind Treatment Period|Protocol Violation|0|||
105674326|NCT02489968|364470624|FG002|Double-blind Treatment Period|Protocol Violation|0|||
105674327|NCT02489968|364470625|FG003|Double-blind Treatment Period|Protocol Violation|0|||
105674328|NCT02489968|364470626|FG004|Double-blind Treatment Period|Protocol Violation|1|||
105674329|NCT02489968|364470627|FG005|Double-blind Treatment Period|Protocol Violation|1|||
105674330|NCT02489968|364470622|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
105674331|NCT02489968|364470623|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
105674332|NCT02489968|364470624|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105674333|NCT02489968|364470625|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
105674334|NCT02489968|364470626|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
105674335|NCT02489968|364470627|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
105674336|NCT02489968|364470622|FG000|Double-blind Treatment Period|Other than specified above|0|||
105674337|NCT02489968|364470623|FG001|Double-blind Treatment Period|Other than specified above|0|||
105674338|NCT02489968|364470624|FG002|Double-blind Treatment Period|Other than specified above|0|||
105674339|NCT02489968|364470625|FG003|Double-blind Treatment Period|Other than specified above|0|||
105674340|NCT02489968|364470626|FG004|Double-blind Treatment Period|Other than specified above|1|||
105674341|NCT02489968|364470627|FG005|Double-blind Treatment Period|Other than specified above|0|||
105674342|NCT01525238|364470628|FG000|Overall Study|Withdrawal by Subject|1|||
105674343|NCT01525238|364470629|FG001|Overall Study|Withdrawal by Subject|0|||
105674344|NCT01525238|364470630|FG002|Overall Study|Withdrawal by Subject|0|||
105674345|NCT03446781|364471891|FG000|Overall Study|Lost to Follow-up|11|||
105674346|NCT03446781|364471892|FG001|Overall Study|Lost to Follow-up|5|||
105674347|NCT03446781|364471891|FG000|Overall Study|Withdrawal by Subject|9|||
105674348|NCT03446781|364471892|FG001|Overall Study|Withdrawal by Subject|7|||
105674349|NCT03446781|364471891|FG000|Overall Study|Adverse Event|8|||
105674350|NCT03446781|364471892|FG001|Overall Study|Adverse Event|2|||
105674351|NCT03446781|364471891|FG000|Overall Study|Protocol Violation|0|||
105674352|NCT03446781|364471892|FG001|Overall Study|Protocol Violation|3|||
105674353|NCT00836745|364471893|FG000|Overall Study|Death|2|||
105674354|NCT00836745|364471893|FG000|Overall Study|Lost to Follow-up|10|||
105674355|NCT00836745|364471893|FG000|Overall Study|Adverse Event|3|||
105674356|NCT00836745|364471893|FG000|Overall Study|Objective progression or relapse|4|||
105674357|NCT00836745|364471893|FG000|Overall Study|Other|2|||
105674358|NCT01552603|364471897|FG000|Overall Study|Physician Decision|1|||
105674359|NCT00224887|364471901|FG000|Overall Study|Pregnancy|6|||
105674360|NCT00224887|364471902|FG001|Overall Study|Pregnancy|6|||
105674361|NCT05560243|364471905|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
105674362|NCT00939822|364471906|FG000|Overall Study|Lost to Follow-up|1|||
105674363|NCT00939822|364471907|FG001|Overall Study|Lost to Follow-up|0|||
105674364|NCT00939822|364471906|FG000|Overall Study|withdrew from study due to busy schedule|1|||
105674365|NCT00939822|364471907|FG001|Overall Study|withdrew from study due to busy schedule|1|||
105674366|NCT00939822|364471906|FG000|Overall Study|Mental health issues|0|||
105674367|NCT00939822|364471907|FG001|Overall Study|Mental health issues|2|||
105674368|NCT00910039|364471908|FG000|Overall Study|Physician Decision|1|||
105674369|NCT03231800|364471912|FG000|Overall Study|Lost to Follow-up|0|||
105674370|NCT03231800|364471913|FG001|Overall Study|Lost to Follow-up|2|||
105674371|NCT03231800|364471912|FG000|Overall Study|Protocol Violation|1|||
105674372|NCT03231800|364471913|FG001|Overall Study|Protocol Violation|1|||
105674373|NCT03231800|364471912|FG000|Overall Study|reason not provided|2|||
105674374|NCT03231800|364471913|FG001|Overall Study|reason not provided|0|||
105674375|NCT00859222|364471915|FG000|Overall Study|Adverse Event|2|||
105674376|NCT00859222|364471916|FG001|Overall Study|Adverse Event|3|||
105674377|NCT00859222|364471917|FG002|Overall Study|Adverse Event|6|||
105674378|NCT00859222|364471918|FG003|Overall Study|Adverse Event|24|||
105786396|NCT01965600|364870515|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
105912115|NCT01914393|365336958|FG002|Overall Study|Lost to Follow-up|19|||
105999744|NCT01147666|365661208|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999745|NCT01147666|365661209|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999746|NCT01147666|365661210|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
105999747|NCT01147666|365661196|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105674379|NCT00859222|364471919|FG004|Overall Study|Adverse Event|15|||
105674380|NCT00859222|364471915|FG000|Overall Study|DLT|1|||
105674381|NCT00859222|364471916|FG001|Overall Study|DLT|0|||
105674382|NCT00859222|364471917|FG002|Overall Study|DLT|0|||
105674383|NCT00859222|364471918|FG003|Overall Study|DLT|0|||
105674384|NCT00859222|364471919|FG004|Overall Study|DLT|0|||
105674385|NCT00488475|364471920|FG000|Overall Study|Other|1754|||
105674386|NCT01941719|364471927|FG000|Overall Study|Lost to Follow-up|20|||
105674387|NCT01941719|364471928|FG001|Overall Study|Lost to Follow-up|19|||
105674388|NCT00958841|364471929|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105674389|NCT00958841|364471929|FG000|Overall Study|Abnormal test procedure result(s)|3|||
105674390|NCT00958841|364471929|FG000|Overall Study|Administrative problems|1|||
105674391|NCT00958841|364471929|FG000|Overall Study|Adverse Event|8|||
105674392|NCT00958841|364471929|FG000|Overall Study|New cancer therapy|5|||
105674393|NCT00958841|364471929|FG000|Overall Study|Withdrawal by Subject|1|||
105674394|NCT00958841|364471929|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
105674395|NCT00958841|364471929|FG000|Overall Study|Completed M6/did not enter extension|27|||
105674396|NCT00958841|364471929|FG000|Overall Study|Discontinued prior to M*|28|||
105674397|NCT01125514|364471930|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
105674398|NCT01125514|364471930|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
105674399|NCT01125514|364471930|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
105674400|NCT01125514|364471930|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
105674401|NCT01125514|364471930|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
105674402|NCT01125514|364471930|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
105674403|NCT01163292|364471932|FG000|Overall Study|Lack of Efficacy|9|||
105674404|NCT01163292|364471933|FG001|Overall Study|Lack of Efficacy|0|||
105674405|NCT01163292|364471932|FG000|Overall Study|Adverse Event|6|||
105674406|NCT01163292|364471933|FG001|Overall Study|Adverse Event|0|||
105674407|NCT01163292|364471932|FG000|Overall Study|Initiation of biological therapy|0|||
105674408|NCT01163292|364471933|FG001|Overall Study|Initiation of biological therapy|15|||
105674409|NCT01163292|364471932|FG000|Overall Study|Sufficient response to adalimumab|8|||
105674410|NCT01163292|364471933|FG001|Overall Study|Sufficient response to adalimumab|0|||
105674411|NCT01163292|364471932|FG000|Overall Study|Refusal to receive adalimumab|7|||
105674412|NCT01163292|364471933|FG001|Overall Study|Refusal to receive adalimumab|0|||
105674413|NCT01163292|364471932|FG000|Overall Study|Economic reasons|6|||
105674414|NCT01163292|364471933|FG001|Overall Study|Economic reasons|0|||
105674415|NCT01163292|364471932|FG000|Overall Study|No further visits|5|||
105674416|NCT01163292|364471933|FG001|Overall Study|No further visits|7|||
105674417|NCT00506441|364471934|FG000|Period 1; Open-label Period|Adverse Event|21|||
105674418|NCT00506441|364471935|FG001|Period 1; Open-label Period|Adverse Event|0|||
105674419|NCT00506441|364471934|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
105674420|NCT00506441|364471935|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
105674421|NCT00506441|364471934|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
105674422|NCT00506441|364471935|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
105674423|NCT00506441|364471934|FG000|Period 1; Open-label Period|Physician Decision|5|||
105674424|NCT00506441|364471935|FG001|Period 1; Open-label Period|Physician Decision|0|||
105674425|NCT00506441|364471934|FG000|Period 1; Open-label Period|Protocol Violation|9|||
105674426|NCT00506441|364471935|FG001|Period 1; Open-label Period|Protocol Violation|0|||
105674427|NCT00506441|364471934|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
105674428|NCT00506441|364471935|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
105674429|NCT00506441|364471934|FG000|Period 1; Open-label Period|Other Reasons|13|||
105674430|NCT00506441|364471935|FG001|Period 1; Open-label Period|Other Reasons|0|||
105674431|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Adverse Event|0|||
105674432|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Adverse Event|1|||
105674433|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
105674434|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
105674435|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Physician Decision|1|||
105674436|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Physician Decision|1|||
105674437|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
105912116|NCT01914393|365336956|FG000|Overall Study|subject never dosed|0|||
105912117|NCT01914393|365336957|FG001|Overall Study|subject never dosed|0|||
105912118|NCT01914393|365336958|FG002|Overall Study|subject never dosed|1|||
105912119|NCT00716456|365336963|FG000|Overall Study|Adverse Event|0|||
105912120|NCT00716456|365336964|FG001|Overall Study|Adverse Event|2|||
105912121|NCT00716456|365336965|FG002|Overall Study|Adverse Event|0|||
105912122|NCT01619852|365336966|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
105912123|NCT01619852|365336967|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
105912124|NCT01619852|365336966|FG000|3 Month Follow up|Lost to Follow-up|31|||
105912125|NCT01619852|365336967|FG001|3 Month Follow up|Lost to Follow-up|34|||
105912126|NCT00970489|365336968|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
105912127|NCT00970489|365336969|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
105912128|NCT02087774|365336970|FG000|Overall Study|Were absent day of data collection|8|||
105912129|NCT02087774|365336971|FG001|Overall Study|Were absent day of data collection|20|||
105912130|NCT01723072|365336972|FG000|Overall Study|Withdrawal by Subject|7|||
105999748|NCT01147666|365661197|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105999749|NCT01147666|365661198|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105674438|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
105674439|NCT00506441|364471934|FG000|Period 2; Double-blind Period|Other Reason|1|||
105674440|NCT00506441|364471935|FG001|Period 2; Double-blind Period|Other Reason|1|||
105674441|NCT01215188|364471936|FG000|Overall Study|Lost to Follow-up|22|||
105674442|NCT01215188|364471937|FG001|Overall Study|Lost to Follow-up|22|||
105674443|NCT01215188|364471938|FG002|Overall Study|Lost to Follow-up|16|||
105674444|NCT01215188|364471936|FG000|Overall Study|Adverse Event|1|||
105674445|NCT01215188|364471937|FG001|Overall Study|Adverse Event|1|||
105999750|NCT01147666|365661199|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105999751|NCT01147666|365661200|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105999752|NCT01147666|365661201|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105999753|NCT01147666|365661202|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105999754|NCT01147666|365661203|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105999755|NCT01147666|365661204|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105999756|NCT01147666|365661205|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105999757|NCT01147666|365661206|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105999758|NCT01147666|365661207|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105999759|NCT01147666|365661208|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105999760|NCT01147666|365661209|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
105999761|NCT01147666|365661210|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
105999762|NCT01147666|365661196|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999763|NCT01147666|365661197|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105674446|NCT01215188|364471938|FG002|Overall Study|Adverse Event|3|||
105674447|NCT01215188|364471936|FG000|Overall Study|Physician Decision|2|||
105674448|NCT01215188|364471937|FG001|Overall Study|Physician Decision|1|||
105674449|NCT01215188|364471938|FG002|Overall Study|Physician Decision|0|||
105674450|NCT01215188|364471936|FG000|Overall Study|Lack of Efficacy|0|||
105674451|NCT01215188|364471937|FG001|Overall Study|Lack of Efficacy|0|||
105674452|NCT01215188|364471938|FG002|Overall Study|Lack of Efficacy|1|||
105674453|NCT01215188|364471936|FG000|Overall Study|Protocol Violation|1|||
105674454|NCT01215188|364471937|FG001|Overall Study|Protocol Violation|1|||
105674455|NCT01215188|364471938|FG002|Overall Study|Protocol Violation|1|||
105674456|NCT01215188|364471936|FG000|Overall Study|Withdrawal by Subject|32|||
105674457|NCT01215188|364471937|FG001|Overall Study|Withdrawal by Subject|34|||
105674458|NCT01215188|364471938|FG002|Overall Study|Withdrawal by Subject|31|||
105674459|NCT01127763|364471941|FG000|Overall Study|Adverse Event|2|||
105674460|NCT01127763|364471941|FG000|Overall Study|Withdrawal by Subject|1|||
105674461|NCT01127763|364471941|FG000|Overall Study|Physician Decision|2|||
105674462|NCT00831129|364471942|FG000|Overall Study|Adverse Event|0|||
105674463|NCT00831129|364471943|FG001|Overall Study|Adverse Event|1|||
105674464|NCT00831129|364471942|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
105674465|NCT00831129|364471943|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
105674466|NCT01877239|364471944|FG000|Overall Study|Adverse Event|4|||
105674467|NCT01877239|364471944|FG000|Overall Study|Disease Remission|1|||
105674468|NCT01877239|364471944|FG000|Overall Study|Withdrawal by Subject|4|||
105674469|NCT01877239|364471944|FG000|Overall Study|Other|2|||
105674470|NCT01877239|364471944|FG000|Overall Study|Lack of Efficacy|4|||
105674471|NCT01877239|364471944|FG000|Overall Study|Data not available|35|||
105674472|NCT03466073|364471946|FG000|Overall Study|Death|1|||
105674473|NCT03466073|364471947|FG001|Overall Study|Death|0|||
105674474|NCT03466073|364471948|FG002|Overall Study|Death|0|||
105674475|NCT03466073|364471949|FG003|Overall Study|Death|0|||
105674476|NCT03466073|364471950|FG004|Overall Study|Death|0|||
105999764|NCT01147666|365661198|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999765|NCT01147666|365661199|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
105999766|NCT01147666|365661200|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999767|NCT01147666|365661201|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999768|NCT01147666|365661202|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105674477|NCT03466073|364471951|FG005|Overall Study|Death|1|||
105674478|NCT01283516|364471952|FG000|Overall Study|Adverse Event|0|||
105674479|NCT01283516|364471953|FG001|Overall Study|Adverse Event|0|||
105674480|NCT01283516|364471954|FG002|Overall Study|Adverse Event|0|||
106125700|NCT02107443|366117888|FG001|Overall Study|Death|30|||
106125701|NCT02107443|366117887|FG000|Overall Study|Study Protocol Violation|3|||
105674481|NCT01283516|364471955|FG003|Overall Study|Adverse Event|0|||
105674482|NCT01283516|364471956|FG004|Overall Study|Adverse Event|0|||
105674483|NCT01283516|364471957|FG005|Overall Study|Adverse Event|0|||
105674484|NCT01283516|364471958|FG006|Overall Study|Adverse Event|2|||
105674485|NCT01283516|364471959|FG007|Overall Study|Adverse Event|0|||
105674486|NCT01283516|364471960|FG008|Overall Study|Adverse Event|28|||
105674487|NCT01283516|364471952|FG000|Overall Study|Death|0|||
105674488|NCT01283516|364471953|FG001|Overall Study|Death|0|||
105674489|NCT01283516|364471954|FG002|Overall Study|Death|0|||
105674490|NCT01283516|364471955|FG003|Overall Study|Death|0|||
105674491|NCT01283516|364471956|FG004|Overall Study|Death|0|||
105674492|NCT01283516|364471957|FG005|Overall Study|Death|1|||
105674493|NCT01283516|364471958|FG006|Overall Study|Death|0|||
105674494|NCT01283516|364471959|FG007|Overall Study|Death|1|||
105674495|NCT01283516|364471960|FG008|Overall Study|Death|12|||
105674496|NCT01283516|364471952|FG000|Overall Study|Disease Progression|2|||
105674497|NCT01283516|364471953|FG001|Overall Study|Disease Progression|2|||
105674498|NCT01283516|364471954|FG002|Overall Study|Disease Progression|3|||
105674499|NCT01283516|364471955|FG003|Overall Study|Disease Progression|3|||
105674500|NCT01283516|364471956|FG004|Overall Study|Disease Progression|13|||
105674501|NCT01283516|364471957|FG005|Overall Study|Disease Progression|8|||
105674502|NCT01283516|364471958|FG006|Overall Study|Disease Progression|6|||
105674503|NCT01283516|364471959|FG007|Overall Study|Disease Progression|3|||
105674504|NCT01283516|364471960|FG008|Overall Study|Disease Progression|139|||
105674505|NCT01283516|364471952|FG000|Overall Study|Withdrawal by Subject|0|||
105674506|NCT01283516|364471953|FG001|Overall Study|Withdrawal by Subject|0|||
105674507|NCT01283516|364471954|FG002|Overall Study|Withdrawal by Subject|0|||
105912131|NCT01723072|365336973|FG001|Overall Study|Withdrawal by Subject|13|||
105912132|NCT01723072|365336972|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
105912133|NCT01723072|365336973|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
105912134|NCT01723072|365336972|FG000|Overall Study|Other|4|||
105912135|NCT01723072|365336973|FG001|Overall Study|Other|3|||
105912136|NCT03428100|365336974|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
105912137|NCT03428100|365336975|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912138|NCT03428100|365336976|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
105912139|NCT03428100|365336977|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
105912140|NCT03428100|365336978|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912141|NCT03428100|365336979|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912142|NCT03428100|365336980|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912143|NCT03428100|365336981|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912144|NCT03428100|365336982|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912145|NCT03428100|365336983|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912146|NCT03428100|365336984|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912147|NCT03428100|365336985|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912148|NCT03428100|365336986|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912149|NCT03428100|365336987|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912150|NCT03428100|365336988|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912151|NCT03428100|365336989|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912152|NCT03428100|365336990|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912153|NCT03428100|365336991|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912154|NCT03428100|365336992|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
105912155|NCT03428100|365336974|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
105912156|NCT03428100|365336975|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
105912157|NCT03428100|365336976|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
105912158|NCT03428100|365336977|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
105912159|NCT03428100|365336978|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912160|NCT03428100|365336979|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912161|NCT03428100|365336980|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912162|NCT03428100|365336981|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912163|NCT03428100|365336982|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912164|NCT03428100|365336983|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912165|NCT03428100|365336984|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912166|NCT03428100|365336985|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912167|NCT03428100|365336986|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912168|NCT03428100|365336987|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912169|NCT03428100|365336988|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912170|NCT03428100|365336989|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912171|NCT03428100|365336990|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912172|NCT03428100|365336991|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912173|NCT03428100|365336992|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
105912174|NCT03428100|365336974|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912175|NCT03428100|365336975|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
105912176|NCT03428100|365336976|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
105912177|NCT03428100|365336977|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912178|NCT03428100|365336978|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912179|NCT03428100|365336979|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912180|NCT03428100|365336980|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912181|NCT03428100|365336981|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105674508|NCT01283516|364471955|FG003|Overall Study|Withdrawal by Subject|0|||
105674509|NCT01283516|364471956|FG004|Overall Study|Withdrawal by Subject|1|||
105674510|NCT01283516|364471957|FG005|Overall Study|Withdrawal by Subject|0|||
105674511|NCT01283516|364471958|FG006|Overall Study|Withdrawal by Subject|1|||
105674512|NCT01283516|364471959|FG007|Overall Study|Withdrawal by Subject|0|||
105674513|NCT01283516|364471960|FG008|Overall Study|Withdrawal by Subject|36|||
105674514|NCT01283516|364471952|FG000|Overall Study|Administrative problems|0|||
105674515|NCT01283516|364471953|FG001|Overall Study|Administrative problems|0|||
105674516|NCT01283516|364471954|FG002|Overall Study|Administrative problems|0|||
105674517|NCT01283516|364471955|FG003|Overall Study|Administrative problems|0|||
105674518|NCT01283516|364471956|FG004|Overall Study|Administrative problems|0|||
105674519|NCT01283516|364471957|FG005|Overall Study|Administrative problems|1|||
105674520|NCT01283516|364471958|FG006|Overall Study|Administrative problems|1|||
105674521|NCT01283516|364471959|FG007|Overall Study|Administrative problems|1|||
105674522|NCT01283516|364471960|FG008|Overall Study|Administrative problems|39|||
105674523|NCT01283516|364471952|FG000|Overall Study|Lost to Follow-up|0|||
105674524|NCT01283516|364471953|FG001|Overall Study|Lost to Follow-up|0|||
105674525|NCT01283516|364471954|FG002|Overall Study|Lost to Follow-up|0|||
105674526|NCT01283516|364471955|FG003|Overall Study|Lost to Follow-up|0|||
105674527|NCT01283516|364471956|FG004|Overall Study|Lost to Follow-up|0|||
105674528|NCT01283516|364471957|FG005|Overall Study|Lost to Follow-up|0|||
105674529|NCT01283516|364471958|FG006|Overall Study|Lost to Follow-up|0|||
105674530|NCT01283516|364471959|FG007|Overall Study|Lost to Follow-up|0|||
105674531|NCT01283516|364471960|FG008|Overall Study|Lost to Follow-up|1|||
105674532|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
105674533|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
105674534|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
105674535|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
105674536|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
105674537|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
105674538|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
105674539|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
105674540|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
105674541|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
105674542|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Adverse Event|0|||
105674543|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Adverse Event|0|||
105674544|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Adverse Event|3|||
105674545|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Adverse Event|2|||
105674546|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Adverse Event|13|||
105674547|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
105674548|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
105674549|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
105674550|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
105674551|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
105674552|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Patient's wish|0|||
105674553|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Patient's wish|0|||
105674554|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Patient's wish|19|||
105674555|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Patient's wish|9|||
105674556|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Patient's wish|20|||
105674557|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
105674558|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
105674559|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
105674560|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
105674561|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
105674562|NCT00444275|364471961|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
105674563|NCT00444275|364471962|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
105674564|NCT00444275|364471963|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
105674565|NCT00444275|364471964|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
105674566|NCT00444275|364471965|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
106125702|NCT02107443|366117888|FG001|Overall Study|Study Protocol Violation|1|||
105674567|NCT00658788|364471966|FG000|Overall Study|Adverse Event|11|||
105674568|NCT00658788|364471966|FG000|Overall Study|Withdrawal by Subject|13|||
105674569|NCT00658788|364471966|FG000|Overall Study|Lost to Follow-up|18|||
105674570|NCT00658788|364471966|FG000|Overall Study|Treatment Discontinuation|32|||
105674571|NCT02297139|364471967|FG000|Overall Study|Disease progression|0|||
105674572|NCT02297139|364471968|FG001|Overall Study|Disease progression|1|||
105674573|NCT02297139|364471967|FG000|Overall Study|Study drug toxicity|0|||
105674574|NCT02297139|364471968|FG001|Overall Study|Study drug toxicity|4|||
105674575|NCT02297139|364471967|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105674576|NCT02297139|364471968|FG001|Overall Study|Participant request to discontinue study treatment|1|||
105674577|NCT02297139|364471967|FG000|Overall Study|Maximum clinical benefit|1|||
105674578|NCT02297139|364471968|FG001|Overall Study|Maximum clinical benefit|0|||
105674579|NCT02297139|364471967|FG000|Overall Study|Administrative reason by sponsor|0|||
105999769|NCT01147666|365661203|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999770|NCT01147666|365661204|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999771|NCT01147666|365661205|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999772|NCT01147666|365661206|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
105999773|NCT01147666|365661207|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999774|NCT01147666|365661208|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999775|NCT01147666|365661209|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999776|NCT01147666|365661210|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
105999777|NCT01147666|365661196|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999778|NCT01147666|365661197|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999779|NCT01147666|365661198|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999780|NCT01147666|365661199|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999781|NCT01147666|365661200|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999782|NCT01147666|365661201|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999783|NCT01147666|365661202|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999784|NCT01147666|365661203|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999785|NCT01147666|365661204|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999786|NCT01147666|365661205|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999787|NCT01147666|365661206|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999788|NCT01147666|365661207|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999789|NCT01147666|365661208|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
105999790|NCT01147666|365661209|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999791|NCT01147666|365661210|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
105999792|NCT01147666|365661196|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105999793|NCT01147666|365661197|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105999794|NCT01147666|365661198|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105912182|NCT03428100|365336982|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912183|NCT03428100|365336983|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912184|NCT03428100|365336984|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912185|NCT03428100|365336985|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912186|NCT03428100|365336986|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912187|NCT03428100|365336987|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912188|NCT03428100|365336988|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912189|NCT03428100|365336989|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912190|NCT03428100|365336990|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912191|NCT03428100|365336991|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912192|NCT03428100|365336992|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
105912193|NCT03428100|365336974|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
105912194|NCT03428100|365336975|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912195|NCT03428100|365336976|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912196|NCT03428100|365336977|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912197|NCT03428100|365336978|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912198|NCT03428100|365336979|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912199|NCT03428100|365336980|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912200|NCT03428100|365336981|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912201|NCT03428100|365336982|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912202|NCT03428100|365336983|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912203|NCT03428100|365336984|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912204|NCT03428100|365336985|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912205|NCT03428100|365336986|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912206|NCT03428100|365336987|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912207|NCT03428100|365336988|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912208|NCT03428100|365336989|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912209|NCT03428100|365336990|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912210|NCT03428100|365336991|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912211|NCT03428100|365336992|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
105912212|NCT03428100|365336974|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912213|NCT03428100|365336975|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
105912214|NCT03428100|365336976|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912215|NCT03428100|365336977|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912216|NCT03428100|365336978|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912217|NCT03428100|365336979|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105999795|NCT01147666|365661199|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105999796|NCT01147666|365661200|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105674580|NCT02297139|364471968|FG001|Overall Study|Administrative reason by sponsor|2|||
105674581|NCT02297139|364471967|FG000|Overall Study|Other reasons|0|||
105674582|NCT02297139|364471968|FG001|Overall Study|Other reasons|8|||
105674583|NCT05038163|364471969|FG000|Stage 1|Did not complete survey|374|||
105674584|NCT05038163|364471970|FG001|Stage 1|Did not complete survey|0|||
105674585|NCT05038163|364471971|FG002|Stage 1|Did not complete survey|0|||
105674586|NCT05038163|364471972|FG003|Stage 1|Did not complete survey|0|||
105674587|NCT05038163|364471973|FG004|Stage 1|Did not complete survey|0|||
105674588|NCT05038163|364471974|FG005|Stage 1|Did not complete survey|0|||
105674589|NCT05038163|364471969|FG000|Stage 2|Did not complete Stage 2 survey|0|||
105674590|NCT05038163|364471970|FG001|Stage 2|Did not complete Stage 2 survey|29|||
105674591|NCT05038163|364471971|FG002|Stage 2|Did not complete Stage 2 survey|30|||
105674592|NCT05038163|364471972|FG003|Stage 2|Did not complete Stage 2 survey|24|||
105674593|NCT05038163|364471973|FG004|Stage 2|Did not complete Stage 2 survey|21|||
105674594|NCT05038163|364471974|FG005|Stage 2|Did not complete Stage 2 survey|100|||
105674595|NCT05453201|364471975|FG000|Overall Study|Withdrawal by Subject|1|||
105674596|NCT01934790|364471976|FG000|Treatment|Adverse Event|3|||
105674597|NCT01934790|364471976|FG000|Treatment|Clinical progression|6|||
105674598|NCT01934790|364471976|FG000|Treatment|Radiological progression|4|||
105674599|NCT01934790|364471976|FG000|Treatment|Withdrawal by Subject|2|||
105674600|NCT01934790|364471976|FG000|Treatment|Study drug never administered|1|||
105674601|NCT01934790|364471976|FG000|Active Follow up|Death|20|||
105674602|NCT01934790|364471976|FG000|Active Follow up|Physician Decision|2|||
105674603|NCT01934790|364471976|FG000|Active Follow up|Progressive disease|1|||
105674604|NCT01934790|364471976|FG000|Active Follow up|Other reason|1|||
105674605|NCT03762200|364471984|FG000|Overall Study|Death|2|||
105674606|NCT02631577|364471985|FG000|Overall Study|Death|1|||
105674607|NCT02631577|364471986|FG001|Overall Study|Death|7|||
105674608|NCT02631577|364471985|FG000|Overall Study|Withdrawal by Subject|0|||
105674609|NCT02631577|364471986|FG001|Overall Study|Withdrawal by Subject|3|||
105674610|NCT03738423|364471987|FG000|Overall Study|Withdrawal by Subject|9|||
105674611|NCT03738423|364471988|FG001|Overall Study|Withdrawal by Subject|12|||
105674612|NCT03738423|364471989|FG002|Overall Study|Withdrawal by Subject|9|||
105674613|NCT03738423|364471990|FG003|Overall Study|Withdrawal by Subject|12|||
105674614|NCT03738423|364471991|FG004|Overall Study|Withdrawal by Subject|10|||
105674615|NCT03738423|364471987|FG000|Overall Study|Lack of Efficacy|3|||
105674616|NCT03738423|364471988|FG001|Overall Study|Lack of Efficacy|1|||
105674617|NCT03738423|364471989|FG002|Overall Study|Lack of Efficacy|1|||
105674618|NCT03738423|364471990|FG003|Overall Study|Lack of Efficacy|1|||
105674619|NCT03738423|364471991|FG004|Overall Study|Lack of Efficacy|2|||
105674620|NCT03738423|364471987|FG000|Overall Study|Lost to Follow-up|1|||
105674621|NCT03738423|364471988|FG001|Overall Study|Lost to Follow-up|0|||
105674622|NCT03738423|364471989|FG002|Overall Study|Lost to Follow-up|1|||
105674623|NCT03738423|364471990|FG003|Overall Study|Lost to Follow-up|1|||
105674624|NCT03738423|364471991|FG004|Overall Study|Lost to Follow-up|0|||
105674625|NCT03738423|364471987|FG000|Overall Study|Protocol Violation|1|||
105674626|NCT03738423|364471988|FG001|Overall Study|Protocol Violation|0|||
105674627|NCT03738423|364471989|FG002|Overall Study|Protocol Violation|0|||
105674628|NCT03738423|364471990|FG003|Overall Study|Protocol Violation|0|||
105674629|NCT03738423|364471991|FG004|Overall Study|Protocol Violation|1|||
105674630|NCT03738423|364471987|FG000|Overall Study|Physician Decision|0|||
105674631|NCT03738423|364471988|FG001|Overall Study|Physician Decision|0|||
105674632|NCT03738423|364471989|FG002|Overall Study|Physician Decision|1|||
105674633|NCT03738423|364471990|FG003|Overall Study|Physician Decision|0|||
105674634|NCT03738423|364471991|FG004|Overall Study|Physician Decision|1|||
105674635|NCT03738423|364471987|FG000|Overall Study|Death|0|||
105912218|NCT03428100|365336980|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105952062|NCT03314935|365488188|FG004|Phase 1|Withdrawal by Subject|1|||
105674636|NCT03738423|364471988|FG001|Overall Study|Death|0|||
105674637|NCT03738423|364471989|FG002|Overall Study|Death|0|||
105674638|NCT03738423|364471990|FG003|Overall Study|Death|0|||
105674639|NCT03738423|364471991|FG004|Overall Study|Death|1|||
105674640|NCT03738423|364471987|FG000|Overall Study|Randomized but never treated|0|||
105674641|NCT03738423|364471988|FG001|Overall Study|Randomized but never treated|0|||
105674642|NCT03738423|364471989|FG002|Overall Study|Randomized but never treated|1|||
105674643|NCT03738423|364471990|FG003|Overall Study|Randomized but never treated|1|||
105674644|NCT03738423|364471991|FG004|Overall Study|Randomized but never treated|0|||
105674645|NCT05110690|364471994|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
105674646|NCT05110690|364471994|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
105674647|NCT05110690|364471994|FG000|Completion of Intervention|Lost to Follow-up|1|||
105674648|NCT05110690|364471994|FG000|Completion of Intervention|Death|1|||
105674649|NCT05110690|364471994|FG000|Completion of Intervention|Withdrawal by Subject|2|||
105674650|NCT03992846|364471997|FG000|Overall Study|Adverse Event|8|||
105674651|NCT03992846|364471998|FG001|Overall Study|Adverse Event|6|||
105674652|NCT03992846|364471999|FG002|Overall Study|Adverse Event|3|||
105674653|NCT03992846|364471997|FG000|Overall Study|Lost to Follow-up|0|||
105674654|NCT03992846|364471998|FG001|Overall Study|Lost to Follow-up|1|||
105674655|NCT03992846|364471999|FG002|Overall Study|Lost to Follow-up|1|||
105674656|NCT03992846|364471997|FG000|Overall Study|Pregnancy|2|||
105674657|NCT03992846|364471998|FG001|Overall Study|Pregnancy|0|||
105674658|NCT03992846|364471999|FG002|Overall Study|Pregnancy|1|||
105674659|NCT03992846|364471997|FG000|Overall Study|Protocol Violation|1|||
105674660|NCT03992846|364471998|FG001|Overall Study|Protocol Violation|2|||
105674661|NCT03992846|364471999|FG002|Overall Study|Protocol Violation|0|||
105674662|NCT03992846|364471997|FG000|Overall Study|Withdrawal by Subject|8|||
105674663|NCT03992846|364471998|FG001|Overall Study|Withdrawal by Subject|10|||
105674664|NCT03992846|364471999|FG002|Overall Study|Withdrawal by Subject|20|||
105674665|NCT03992846|364471997|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
105674666|NCT03992846|364471998|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
105912219|NCT03428100|365336981|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912220|NCT03428100|365336982|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912221|NCT03428100|365336983|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912222|NCT03428100|365336984|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912223|NCT03428100|365336985|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912224|NCT03428100|365336986|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912225|NCT03428100|365336987|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912226|NCT03428100|365336988|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912227|NCT03428100|365336989|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912228|NCT03428100|365336990|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912229|NCT03428100|365336991|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912230|NCT03428100|365336992|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
105912231|NCT03428100|365336974|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912232|NCT03428100|365336975|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912233|NCT03428100|365336976|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912234|NCT03428100|365336977|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912235|NCT03428100|365336978|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912236|NCT03428100|365336979|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
105912237|NCT03428100|365336980|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105912238|NCT03428100|365336981|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
105912239|NCT03428100|365336982|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105912240|NCT03428100|365336983|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912241|NCT03428100|365336984|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105912242|NCT03428100|365336985|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912243|NCT03428100|365336986|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
105912244|NCT03428100|365336987|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105912245|NCT03428100|365336988|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105912246|NCT03428100|365336989|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
105912247|NCT03428100|365336990|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
105912248|NCT03428100|365336991|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912249|NCT03428100|365336992|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
105912250|NCT03428100|365336974|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
105912251|NCT03428100|365336975|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
105912252|NCT03428100|365336976|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
105912253|NCT03428100|365336977|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
105912254|NCT03428100|365336978|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
105912255|NCT03428100|365336979|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
105912256|NCT03428100|365336980|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
105912257|NCT03428100|365336981|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
105912258|NCT03428100|365336982|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
105912259|NCT03428100|365336983|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
105912260|NCT03428100|365336984|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
105912261|NCT03428100|365336985|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
105912262|NCT03428100|365336986|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
105912263|NCT03428100|365336987|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
105912264|NCT03428100|365336988|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
105912265|NCT03428100|365336989|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
105912266|NCT03428100|365336990|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
105912267|NCT03428100|365336991|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
105912268|NCT03428100|365336992|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
105912269|NCT03428100|365336974|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105912270|NCT03428100|365336975|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105999797|NCT01147666|365661201|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105999798|NCT01147666|365661202|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105674667|NCT03992846|364471999|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
105674668|NCT00215137|364473480|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
105674669|NCT00215137|364473481|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
105674670|NCT00215137|364473482|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
105674671|NCT00215137|364473480|FG000|Randomization Period|Lost to Follow-up|0|||
105674672|NCT00215137|364473481|FG001|Randomization Period|Lost to Follow-up|1|||
105674673|NCT00215137|364473482|FG002|Randomization Period|Lost to Follow-up|0|||
105674674|NCT00215137|364473480|FG000|Randomization Period|Withdrawal by Subject|0|||
105674675|NCT00215137|364473481|FG001|Randomization Period|Withdrawal by Subject|1|||
105674676|NCT00215137|364473482|FG002|Randomization Period|Withdrawal by Subject|0|||
105674677|NCT00166712|364473484|FG000|Overall Study|Death|0|||
105674678|NCT00166712|364473485|FG001|Overall Study|Death|1|||
105674679|NCT00166712|364473484|FG000|Overall Study|Adverse Event|1|||
105674680|NCT00166712|364473485|FG001|Overall Study|Adverse Event|0|||
105674681|NCT00166712|364473484|FG000|Overall Study|Withdrawal by Subject|1|||
105674682|NCT00166712|364473485|FG001|Overall Study|Withdrawal by Subject|2|||
105674683|NCT00166712|364473484|FG000|Overall Study|Physician Decision|0|||
105674684|NCT00166712|364473485|FG001|Overall Study|Physician Decision|2|||
105674685|NCT03986944|364473486|FG000|Overall Study|Adverse Event|1|||
105674686|NCT03986944|364473487|FG001|Overall Study|Adverse Event|2|||
105674687|NCT03986944|364473488|FG002|Overall Study|Adverse Event|3|||
105674688|NCT03986944|364473486|FG000|Overall Study|Protocol Violation|0|||
105674689|NCT03986944|364473487|FG001|Overall Study|Protocol Violation|1|||
105674690|NCT03986944|364473488|FG002|Overall Study|Protocol Violation|1|||
105674691|NCT03986944|364473486|FG000|Overall Study|Withdrawal by Subject|3|||
105674692|NCT03986944|364473487|FG001|Overall Study|Withdrawal by Subject|5|||
105674693|NCT03986944|364473488|FG002|Overall Study|Withdrawal by Subject|5|||
105674694|NCT03986944|364473486|FG000|Overall Study|Study termination|10|||
105674695|NCT03986944|364473487|FG001|Overall Study|Study termination|10|||
105674696|NCT03986944|364473488|FG002|Overall Study|Study termination|10|||
105674697|NCT03986944|364473486|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
105674698|NCT03986944|364473487|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
105674699|NCT03986944|364473488|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
105674700|NCT03986944|364473486|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
105674701|NCT03986944|364473487|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
105674702|NCT03986944|364473488|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
105674703|NCT00833261|364473492|FG000|Overall Study|Withdrawal by Subject|4|||
105674704|NCT00503139|364473496|FG000|Overall Study|Case Report Forms were not collected|4|||
105674705|NCT00503139|364473496|FG000|Overall Study|Protocol Violation|4|||
105674706|NCT00616902|364473497|FG000|Overall Study|Termination of study|6|||
105674707|NCT00616902|364473498|FG001|Overall Study|Termination of study|6|||
105674708|NCT01262677|364473499|FG000|Overall Study|Does not meet entrance criteria|0|||
105674709|NCT01262677|364473500|FG001|Overall Study|Does not meet entrance criteria|2|||
105674710|NCT01262677|364473501|FG002|Overall Study|Does not meet entrance criteria|0|||
105674711|NCT01262677|364473499|FG000|Overall Study|Insufficient clinical response|0|||
105674712|NCT01262677|364473500|FG001|Overall Study|Insufficient clinical response|0|||
105674713|NCT01262677|364473501|FG002|Overall Study|Insufficient clinical response|1|||
105674714|NCT01262677|364473499|FG000|Overall Study|Lost to Follow-up|1|||
105674715|NCT01262677|364473500|FG001|Overall Study|Lost to Follow-up|0|||
105674716|NCT01262677|364473501|FG002|Overall Study|Lost to Follow-up|2|||
105674717|NCT01262677|364473499|FG000|Overall Study|No longer willing to participate|3|||
105674718|NCT01262677|364473500|FG001|Overall Study|No longer willing to participate|3|||
105674719|NCT01262677|364473501|FG002|Overall Study|No longer willing to participate|2|||
105674720|NCT01262677|364473499|FG000|Overall Study|Reason not provided|2|||
105674721|NCT01262677|364473500|FG001|Overall Study|Reason not provided|1|||
105674722|NCT01262677|364473501|FG002|Overall Study|Reason not provided|3|||
105674723|NCT01262677|364473499|FG000|Overall Study|Protocol Violation|0|||
105674724|NCT01262677|364473500|FG001|Overall Study|Protocol Violation|1|||
105674725|NCT01262677|364473501|FG002|Overall Study|Protocol Violation|1|||
105674726|NCT01262677|364473499|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
105674727|NCT01262677|364473500|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
105674728|NCT01262677|364473501|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
105674729|NCT03056300|364473502|FG000|Overall Study|Surgical reason per study protocol|3|||
105674730|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Adverse Event|6|||
105674731|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Adverse Event|6|||
105674732|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Death|1|||
105999799|NCT01147666|365661203|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105999800|NCT01147666|365661204|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105674733|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Death|1|||
105674734|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105674735|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105674736|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
105674737|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
105674738|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Physician Decision|1|||
105674739|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Physician Decision|4|||
105674740|NCT03828747|364473506|FG000|Double-Blind Treatment Period|Various reasons|5|||
105674741|NCT03828747|364473507|FG001|Double-Blind Treatment Period|Various reasons|3|||
105674742|NCT03828747|364473506|FG000|Open-Label Extension|Adverse Event|9|||
105674743|NCT03828747|364473507|FG001|Open-Label Extension|Adverse Event|7|||
105674744|NCT03828747|364473506|FG000|Open-Label Extension|Death|0|||
105674745|NCT03828747|364473507|FG001|Open-Label Extension|Death|2|||
105674746|NCT03828747|364473506|FG000|Open-Label Extension|Lost to Follow-up|4|||
105674747|NCT03828747|364473507|FG001|Open-Label Extension|Lost to Follow-up|0|||
105674748|NCT03828747|364473506|FG000|Open-Label Extension|Withdrawal by Subject|31|||
105674749|NCT03828747|364473507|FG001|Open-Label Extension|Withdrawal by Subject|30|||
105674750|NCT03828747|364473506|FG000|Open-Label Extension|Various reasons|4|||
105674751|NCT03828747|364473507|FG001|Open-Label Extension|Various reasons|4|||
105674752|NCT03828747|364473506|FG000|Open-Label Extension|Physician Decision|6|||
105674753|NCT03828747|364473507|FG001|Open-Label Extension|Physician Decision|2|||
105674754|NCT03900416|364473508|FG000|Six Week Follow-up|Lost to Follow-up|1|||
105674755|NCT03900416|364473509|FG001|Six Week Follow-up|Lost to Follow-up|0|||
105674756|NCT03900416|364473508|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
105674757|NCT03900416|364473509|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
105674758|NCT03900416|364473508|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
105674759|NCT03900416|364473509|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
105674760|NCT03900416|364473508|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
105674761|NCT03900416|364473509|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
105674762|NCT03900416|364473508|FG000|Twelve Week Follow-up|Adverse Event|1|||
105674763|NCT03900416|364473509|FG001|Twelve Week Follow-up|Adverse Event|1|||
105674764|NCT03900416|364473508|FG000|Six Month Follow-up|Lost to Follow-up|4|||
105674765|NCT03900416|364473509|FG001|Six Month Follow-up|Lost to Follow-up|3|||
105674766|NCT03900416|364473508|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
105674767|NCT03900416|364473509|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
105674768|NCT04797650|364473510|FG000|Overall Study|Reason Not Specified|5|||
105674769|NCT04797650|364473511|FG001|Overall Study|Reason Not Specified|12|||
105674770|NCT04797650|364473512|FG002|Overall Study|Reason Not Specified|5|||
105674771|NCT04797650|364473510|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
105674772|NCT04797650|364473511|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
105674773|NCT04797650|364473512|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
105674774|NCT04797650|364473510|FG000|Overall Study|Lack of Efficacy|1|||
105674775|NCT04797650|364473511|FG001|Overall Study|Lack of Efficacy|0|||
105674776|NCT04797650|364473512|FG002|Overall Study|Lack of Efficacy|1|||
105674777|NCT04797650|364473510|FG000|Overall Study|Non-compliance with Study Drug|0|||
105674778|NCT04797650|364473511|FG001|Overall Study|Non-compliance with Study Drug|0|||
105674779|NCT04797650|364473512|FG002|Overall Study|Non-compliance with Study Drug|2|||
105674780|NCT04797650|364473510|FG000|Overall Study|Lost to Follow-up|4|||
105674781|NCT04797650|364473511|FG001|Overall Study|Lost to Follow-up|6|||
105674782|NCT04797650|364473512|FG002|Overall Study|Lost to Follow-up|1|||
105674783|NCT02040584|364473514|FG000|Overall Study|Adverse Event|13|||
105674784|NCT02040584|364473515|FG001|Overall Study|Adverse Event|6|||
105674785|NCT02040584|364473514|FG000|Overall Study|Protocol Violation|9|||
105674786|NCT02040584|364473515|FG001|Overall Study|Protocol Violation|11|||
105674787|NCT02040584|364473514|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105674788|NCT02040584|364473515|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105674789|NCT02040584|364473514|FG000|Overall Study|Death|6|||
105674790|NCT02040584|364473515|FG001|Overall Study|Death|3|||
105674791|NCT02040584|364473514|FG000|Overall Study|Transplant rejection/retransplant|0|||
105674792|NCT02040584|364473515|FG001|Overall Study|Transplant rejection/retransplant|1|||
105674793|NCT02040584|364473514|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
105674794|NCT02040584|364473515|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
105674795|NCT02121301|364473518|FG000|Overall Study|Protocol Violation|1|||
105674796|NCT02121301|364473519|FG001|Overall Study|Protocol Violation|4|||
105912271|NCT03428100|365336976|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105912272|NCT03428100|365336977|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105912273|NCT03428100|365336978|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
105912274|NCT03428100|365336979|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
105912275|NCT03428100|365336980|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
105912276|NCT03428100|365336981|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105912277|NCT03428100|365336982|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105912278|NCT03428100|365336983|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105674797|NCT02121301|364473520|FG002|Overall Study|Protocol Violation|1|||
105674798|NCT01802567|364473521|FG000|Overall Study|Withdrawal by Subject|2|||
105674799|NCT01802567|364473521|FG000|Overall Study|Physician Decision|1|||
105674800|NCT01802567|364473521|FG000|Overall Study|Lack of Efficacy|7|||
105674801|NCT01802567|364473521|FG000|Overall Study|Consented but did not start therapy|7|||
105674802|NCT01802567|364473521|FG000|Overall Study|Protocol Violation|1|||
105674803|NCT00309959|364473525|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
105674804|NCT01895101|364473526|FG000|Overall Study|OPCAB procedure|1|||
105674805|NCT01895101|364473527|FG001|Overall Study|OPCAB procedure|1|||
105674806|NCT01895101|364473528|FG002|Overall Study|OPCAB procedure|3|||
105674807|NCT01895101|364473526|FG000|Overall Study|Withdrawal by Subject|0|||
105674808|NCT01895101|364473527|FG001|Overall Study|Withdrawal by Subject|1|||
105674809|NCT01895101|364473528|FG002|Overall Study|Withdrawal by Subject|2|||
105674810|NCT01895101|364473526|FG000|Overall Study|another study, enrolled in other study|0|||
105674811|NCT01895101|364473527|FG001|Overall Study|another study, enrolled in other study|1|||
105674812|NCT01895101|364473528|FG002|Overall Study|another study, enrolled in other study|0|||
105674813|NCT01895101|364473526|FG000|Overall Study|Death|0|||
105674814|NCT01895101|364473527|FG001|Overall Study|Death|1|||
105674815|NCT01895101|364473528|FG002|Overall Study|Death|0|||
105674816|NCT01895101|364473526|FG000|Overall Study|coagulation disorder|0|||
105674817|NCT01895101|364473527|FG001|Overall Study|coagulation disorder|1|||
105674818|NCT01895101|364473528|FG002|Overall Study|coagulation disorder|0|||
105674819|NCT01144052|364473529|FG000|Overall Study|Withdrawal by Subject|1|||
105674820|NCT01144052|364473530|FG001|Overall Study|Withdrawal by Subject|1|||
105674821|NCT03896152|364473531|FG000|Overall Study|Patient/guardian decision|1|||
105674822|NCT03896152|364473532|FG001|Overall Study|Patient/guardian decision|1|||
105674823|NCT03896152|364473531|FG000|Overall Study|Adverse Event|0|||
105674824|NCT03896152|364473532|FG001|Overall Study|Adverse Event|1|||
105674825|NCT03896152|364473531|FG000|Overall Study|Physician Decision|1|||
105674826|NCT03896152|364473532|FG001|Overall Study|Physician Decision|0|||
105674827|NCT03896152|364473531|FG000|Overall Study|Technical problems|1|||
105674828|NCT03896152|364473532|FG001|Overall Study|Technical problems|0|||
105674829|NCT00436852|364473533|FG000|Overall Study|Death|23|||
105674830|NCT00436852|364473534|FG001|Overall Study|Death|34|||
105674831|NCT00436852|364473533|FG000|Overall Study|Lack of Efficacy|9|||
105674832|NCT00436852|364473534|FG001|Overall Study|Lack of Efficacy|7|||
105674833|NCT00436852|364473533|FG000|Overall Study|Withdrawal by Subject|2|||
105674834|NCT00436852|364473534|FG001|Overall Study|Withdrawal by Subject|4|||
105674835|NCT00436852|364473533|FG000|Overall Study|Ineligible|1|||
105674836|NCT00436852|364473534|FG001|Overall Study|Ineligible|0|||
105674837|NCT00370682|364473535|FG000|Overall Study|Moved from area|0|||
105674838|NCT00370682|364473536|FG001|Overall Study|Moved from area|2|||
105674839|NCT00370682|364473537|FG002|Overall Study|Moved from area|0|||
105674840|NCT00370682|364473535|FG000|Overall Study|Lost to Follow-up|0|||
105674841|NCT00370682|364473536|FG001|Overall Study|Lost to Follow-up|1|||
105674842|NCT00370682|364473537|FG002|Overall Study|Lost to Follow-up|1|||
105674843|NCT03167359|364473538|FG000|Overall Study|Physician Decision|1|||
105674844|NCT03167359|364473538|FG000|Overall Study|Lost to Follow-up|1|||
105674845|NCT03339583|364473539|FG000|First Intervention (14 Days)|Adverse Event|1|||
105674846|NCT03339583|364473540|FG001|First Intervention (14 Days)|Adverse Event|0|||
105674847|NCT03339583|364473539|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
105674848|NCT03339583|364473540|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
105674849|NCT03339583|364473539|FG000|Second Intervention (14 Days)|Adverse Event|0|||
105674850|NCT03339583|364473540|FG001|Second Intervention (14 Days)|Adverse Event|1|||
105674851|NCT03339583|364473539|FG000|Follow-up (14 Days)|Physician Decision|6|||
105674852|NCT03339583|364473540|FG001|Follow-up (14 Days)|Physician Decision|3|||
105674853|NCT00943852|364473541|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674854|NCT00943852|364473542|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674855|NCT00943852|364473543|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674856|NCT00943852|364473544|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
105674857|NCT00943852|364473545|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674858|NCT00943852|364473546|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674859|NCT00943852|364473547|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674860|NCT00943852|364473548|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674861|NCT00943852|364473549|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674862|NCT00943852|364473550|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
105674863|NCT00943852|364473541|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674864|NCT00943852|364473542|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674865|NCT00943852|364473543|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105912279|NCT03428100|365336984|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105912280|NCT03428100|365336985|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
105912281|NCT03428100|365336986|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
105912282|NCT03428100|365336987|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
105912283|NCT03428100|365336988|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
105912284|NCT03428100|365336989|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
105912285|NCT03428100|365336990|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105912286|NCT03428100|365336991|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
105912287|NCT03428100|365336992|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
105912288|NCT03428100|365336974|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912289|NCT03428100|365336975|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912290|NCT03428100|365336976|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912291|NCT03428100|365336977|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912292|NCT03428100|365336978|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912293|NCT03428100|365336979|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105674866|NCT00943852|364473544|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674867|NCT00943852|364473545|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674868|NCT00943852|364473546|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
105674869|NCT00943852|364473547|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674870|NCT00943852|364473548|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674871|NCT00943852|364473549|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105674872|NCT00943852|364473550|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
105912294|NCT03428100|365336980|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912295|NCT03428100|365336981|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
105912296|NCT03428100|365336982|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105674873|NCT00943852|364473541|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674874|NCT00943852|364473542|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674875|NCT00943852|364473543|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674876|NCT00943852|364473544|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674877|NCT00943852|364473545|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674878|NCT00943852|364473546|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674879|NCT00943852|364473547|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
105674880|NCT00943852|364473548|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674881|NCT00943852|364473549|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674882|NCT00943852|364473550|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
105674883|NCT00943852|364473541|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674884|NCT00943852|364473542|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674885|NCT00943852|364473543|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674886|NCT00943852|364473544|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674887|NCT00943852|364473545|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674888|NCT00943852|364473546|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674889|NCT00943852|364473547|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674890|NCT00943852|364473548|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
105674891|NCT00943852|364473549|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674892|NCT00943852|364473550|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
105674893|NCT00943852|364473541|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
105674894|NCT00943852|364473542|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674895|NCT00943852|364473543|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
105674896|NCT00943852|364473544|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
105674897|NCT00943852|364473545|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674898|NCT00943852|364473546|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674899|NCT00943852|364473547|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
105674900|NCT00943852|364473548|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674901|NCT00943852|364473549|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674902|NCT00943852|364473550|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
105674903|NCT02141620|364473551|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
105674904|NCT02141620|364473552|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
105674905|NCT00772330|364473553|FG000|Overall Study|Lost to Follow-up|3|||
105674906|NCT01519089|364473554|FG000|Overall Study|Adverse Event|4|||
105674907|NCT01519089|364473555|FG001|Overall Study|Adverse Event|4|||
105674908|NCT01519089|364473554|FG000|Overall Study|Lack of Efficacy|0|||
105674909|NCT01519089|364473555|FG001|Overall Study|Lack of Efficacy|2|||
105674910|NCT01519089|364473554|FG000|Overall Study|Lost to Follow-up|1|||
105674911|NCT01519089|364473555|FG001|Overall Study|Lost to Follow-up|0|||
105674912|NCT01519089|364473554|FG000|Overall Study|Withdrawal by Subject|0|||
105674913|NCT01519089|364473555|FG001|Overall Study|Withdrawal by Subject|2|||
105674914|NCT01519089|364473554|FG000|Overall Study|Other|2|||
105674915|NCT01519089|364473555|FG001|Overall Study|Other|6|||
105674916|NCT01519089|364473554|FG000|Overall Study|Not received study drug|0|||
105674917|NCT01519089|364473555|FG001|Overall Study|Not received study drug|1|||
105674918|NCT00127205|364473556|FG000|Overall Study|Adverse Event|228|||
105674919|NCT00127205|364473557|FG001|Overall Study|Adverse Event|387|||
105674920|NCT00127205|364473558|FG002|Overall Study|Adverse Event|273|||
105674921|NCT00127205|364473556|FG000|Overall Study|Death|8|||
105674922|NCT00127205|364473557|FG001|Overall Study|Death|6|||
105674923|NCT00127205|364473558|FG002|Overall Study|Death|5|||
105674924|NCT00127205|364473556|FG000|Overall Study|Withdrawal by Subject|318|||
105674925|NCT00127205|364473557|FG001|Overall Study|Withdrawal by Subject|310|||
105674926|NCT00127205|364473558|FG002|Overall Study|Withdrawal by Subject|172|||
105674927|NCT00127205|364473556|FG000|Overall Study|Other-non protocol specified|142|||
105674928|NCT00127205|364473557|FG001|Overall Study|Other-non protocol specified|129|||
105674929|NCT00127205|364473558|FG002|Overall Study|Other-non protocol specified|77|||
105674930|NCT00127205|364473556|FG000|Overall Study|Data not reported|6|||
105674931|NCT00127205|364473557|FG001|Overall Study|Data not reported|10|||
105674932|NCT00127205|364473558|FG002|Overall Study|Data not reported|1|||
105674933|NCT00127205|364473556|FG000|Overall Study|Progression|127|||
105674934|NCT00127205|364473557|FG001|Overall Study|Progression|131|||
105674935|NCT00127205|364473558|FG002|Overall Study|Progression|84|||
105674936|NCT00734591|364473559|FG000|Screening for Prospective Period|Site did not participate|1604|||
105674937|NCT00734591|364473560|FG001|Screening for Prospective Period|Site did not participate|1488|||
105674938|NCT00734591|364473559|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
105952063|NCT03314935|365488189|FG005|Phase 1|Withdrawal by Subject|0|||
105674939|NCT00734591|364473560|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
105674940|NCT00734591|364473559|FG000|Prospective Period|Withdrawal by Subject|11|||
105674941|NCT00734591|364473560|FG001|Prospective Period|Withdrawal by Subject|9|||
105674942|NCT00734591|364473559|FG000|Prospective Period|Lost to Follow-up|37|||
105674943|NCT00734591|364473560|FG001|Prospective Period|Lost to Follow-up|33|||
105674944|NCT00734591|364473559|FG000|Prospective Period|Study Terminated|1|||
105674945|NCT00734591|364473560|FG001|Prospective Period|Study Terminated|0|||
105674946|NCT00734591|364473559|FG000|Prospective Period|Other|2|||
105674947|NCT00734591|364473560|FG001|Prospective Period|Other|2|||
105674948|NCT03377699|364473561|FG000|Overall Study|Withdrawal by Subject|2|||
105674949|NCT03377699|364473562|FG001|Overall Study|Withdrawal by Subject|9|||
105674950|NCT03377699|364473561|FG000|Overall Study|Lost to Follow-up|1|||
105674951|NCT03377699|364473562|FG001|Overall Study|Lost to Follow-up|1|||
105674952|NCT03377699|364473561|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
105674953|NCT03377699|364473562|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
105674954|NCT03377699|364473561|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
105674955|NCT03377699|364473562|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
105674956|NCT03377699|364473561|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
105674957|NCT03377699|364473562|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
105674958|NCT03377699|364473561|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
105674959|NCT03377699|364473562|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
105674960|NCT01353859|364473563|FG000|Overall Study|Adverse Event|3|||
105674961|NCT01353859|364473563|FG000|Overall Study|Lack of Efficacy|1|||
105674962|NCT04155047|364473568|FG000|Overall Study|Adverse Event|1|||
105674963|NCT04155047|364473569|FG001|Overall Study|Adverse Event|0|||
105674964|NCT04155047|364473568|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
105674965|NCT04155047|364473569|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
105674966|NCT00406692|364473570|FG000|Overall Study|Withdrawal by Subject|4|||
105674967|NCT00406692|364473570|FG000|Overall Study|Physician Decision|1|||
105674968|NCT00406692|364473570|FG000|Overall Study|Adverse Event|1|||
105674969|NCT00406692|364473570|FG000|Overall Study|Lack of Efficacy|1|||
105674970|NCT00941070|364473573|FG000|Overall Study|Patient non-compliant|1|||
105674971|NCT00400725|364473574|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
105674972|NCT00400725|364473575|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
105674973|NCT00400725|364473576|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
105674974|NCT00400725|364473574|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
105674975|NCT00400725|364473575|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
105674976|NCT00400725|364473576|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
105674977|NCT00400725|364473574|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
105674978|NCT00400725|364473575|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
105674979|NCT00400725|364473576|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
105674980|NCT00400725|364473574|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
105674981|NCT00400725|364473575|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
105674982|NCT00400725|364473576|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
105674983|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
105674984|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
105674985|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
105674986|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
105674987|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
105674988|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
105674989|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
105674990|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
105674991|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
105674992|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
105674993|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
105674994|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
105674995|NCT00400725|364473574|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
105674996|NCT00400725|364473575|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
105674997|NCT00400725|364473576|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
105674998|NCT01145898|364473579|FG000|3-year Treatment|medication change by treating physician|3|||
105674999|NCT01145898|364473580|FG001|3-year Treatment|medication change by treating physician|16|||
105675000|NCT00858364|364473583|FG000|Overall Study|Administrative Decision|3|||
105675001|NCT00858364|364473584|FG001|Overall Study|Administrative Decision|2|||
105675002|NCT00858364|364473583|FG000|Overall Study|Adverse Event|5|||
105675003|NCT00858364|364473584|FG001|Overall Study|Adverse Event|2|||
105675004|NCT00858364|364473583|FG000|Overall Study|Withdrawal by Subject|44|||
105675005|NCT00858364|364473584|FG001|Overall Study|Withdrawal by Subject|118|||
105675006|NCT00858364|364473583|FG000|Overall Study|Ineligibility Determined|1|||
105675007|NCT00858364|364473584|FG001|Overall Study|Ineligibility Determined|10|||
105675008|NCT00858364|364473583|FG000|Overall Study|Lost to Follow-up|24|||
105675009|NCT00858364|364473584|FG001|Overall Study|Lost to Follow-up|54|||
105675010|NCT00858364|364473583|FG000|Overall Study|Noncompliance|3|||
105675011|NCT00858364|364473584|FG001|Overall Study|Noncompliance|4|||
105675012|NCT00858364|364473583|FG000|Overall Study|Protocol Deviation|0|||
105675013|NCT00858364|364473584|FG001|Overall Study|Protocol Deviation|2|||
105675014|NCT00858364|364473583|FG000|Overall Study|Other|9|||
105675015|NCT00858364|364473584|FG001|Overall Study|Other|17|||
105675016|NCT00858364|364473583|FG000|Overall Study|Missing|1|||
105786397|NCT01965600|364870516|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
105786398|NCT01965600|364870513|FG000|Second Intervention|Study terminated by Sponsor|0|||
105912297|NCT03428100|365336983|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912298|NCT03428100|365336984|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912299|NCT03428100|365336985|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
105912300|NCT03428100|365336986|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
105912301|NCT03428100|365336987|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912302|NCT03428100|365336988|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
105912303|NCT03428100|365336989|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912304|NCT03428100|365336990|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105999801|NCT01147666|365661205|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105675017|NCT00858364|364473584|FG001|Overall Study|Missing|1|||
105675018|NCT00858364|364473583|FG000|Overall Study|Still on-study|114|||
105675019|NCT00858364|364473584|FG001|Overall Study|Still on-study|247|||
105786399|NCT01965600|364870514|FG001|Second Intervention|Study terminated by Sponsor|0|||
105912305|NCT03428100|365336991|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
105675020|NCT03980808|364473585|FG000|Overall Study|Lost to Follow-up|2|||
105675021|NCT03980808|364473586|FG001|Overall Study|Lost to Follow-up|2|||
105675022|NCT01655693|364473589|FG000|Overall Study|Progression of Disease|92|||
105675023|NCT01655693|364473590|FG001|Overall Study|Progression of Disease|76|||
105675024|NCT01655693|364473591|FG002|Overall Study|Progression of Disease|58|||
105675025|NCT01655693|364473589|FG000|Overall Study|Death|8|||
105675026|NCT01655693|364473590|FG001|Overall Study|Death|9|||
105675027|NCT01655693|364473591|FG002|Overall Study|Death|12|||
105675028|NCT01655693|364473589|FG000|Overall Study|Serious Adverse Event|3|||
105675029|NCT01655693|364473590|FG001|Overall Study|Serious Adverse Event|15|||
105675030|NCT01655693|364473591|FG002|Overall Study|Serious Adverse Event|11|||
105675031|NCT01655693|364473589|FG000|Overall Study|Withdrawal by Subject|3|||
105675032|NCT01655693|364473590|FG001|Overall Study|Withdrawal by Subject|2|||
105675033|NCT01655693|364473591|FG002|Overall Study|Withdrawal by Subject|20|||
105675034|NCT01655693|364473589|FG000|Overall Study|Adverse Event|3|||
105675035|NCT01655693|364473590|FG001|Overall Study|Adverse Event|11|||
105675036|NCT01655693|364473591|FG002|Overall Study|Adverse Event|3|||
105675037|NCT01655693|364473589|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
105675038|NCT01655693|364473590|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
105675039|NCT01655693|364473591|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
105675040|NCT01655693|364473589|FG000|Overall Study|Non-Compliance|0|||
105675041|NCT01655693|364473590|FG001|Overall Study|Non-Compliance|0|||
105675042|NCT01655693|364473591|FG002|Overall Study|Non-Compliance|7|||
105675043|NCT01655693|364473589|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
105675044|NCT01655693|364473590|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
105675045|NCT01655693|364473591|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
105675046|NCT01655693|364473589|FG000|Overall Study|Protocol Violation|1|||
105675047|NCT01655693|364473590|FG001|Overall Study|Protocol Violation|0|||
105675048|NCT01655693|364473591|FG002|Overall Study|Protocol Violation|3|||
105675049|NCT01655693|364473589|FG000|Overall Study|Lost to Follow-up|1|||
105675050|NCT01655693|364473590|FG001|Overall Study|Lost to Follow-up|0|||
105675051|NCT01655693|364473591|FG002|Overall Study|Lost to Follow-up|1|||
105675052|NCT01655693|364473589|FG000|Overall Study|Screening Failure|1|||
105675053|NCT01655693|364473590|FG001|Overall Study|Screening Failure|0|||
105675054|NCT01655693|364473591|FG002|Overall Study|Screening Failure|0|||
105675055|NCT01655693|364473589|FG000|Overall Study|Other|8|||
105675056|NCT01655693|364473590|FG001|Overall Study|Other|6|||
105675057|NCT01655693|364473591|FG002|Overall Study|Other|15|||
105675058|NCT02755818|364473592|FG000|Overall Study|Withdrawal by Subject|0|||
105675059|NCT02755818|364473593|FG001|Overall Study|Withdrawal by Subject|0|||
105675060|NCT02755818|364473594|FG002|Overall Study|Withdrawal by Subject|0|||
105675061|NCT02755818|364473595|FG003|Overall Study|Withdrawal by Subject|2|||
105675062|NCT02755818|364473592|FG000|Overall Study|withdrawal by PI|0|||
105675063|NCT02755818|364473593|FG001|Overall Study|withdrawal by PI|0|||
105675064|NCT02755818|364473594|FG002|Overall Study|withdrawal by PI|1|||
105675065|NCT02755818|364473595|FG003|Overall Study|withdrawal by PI|1|||
105912306|NCT03428100|365336992|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
105912307|NCT03428100|365336974|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
105912308|NCT03428100|365336975|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
105912309|NCT03428100|365336976|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
105675066|NCT03014011|364473596|FG000|First Intervention|Withdrawal by Subject|1|||
105675067|NCT03014011|364473597|FG001|First Intervention|Withdrawal by Subject|0|||
105675068|NCT03014011|364473596|FG000|Washout|Withdrawal by Subject|1|||
105675069|NCT03014011|364473597|FG001|Washout|Withdrawal by Subject|0|||
105675070|NCT02643472|364473598|FG000|Overall Study|Death|2|||
105675071|NCT02643472|364473599|FG001|Overall Study|Death|5|||
105675072|NCT02643472|364473598|FG000|Overall Study|Withdrawal by Subject|3|||
105675073|NCT02643472|364473599|FG001|Overall Study|Withdrawal by Subject|2|||
105675074|NCT02643472|364473598|FG000|Overall Study|Protocol Violation|0|||
105675075|NCT02643472|364473599|FG001|Overall Study|Protocol Violation|1|||
105912310|NCT03428100|365336977|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
105912311|NCT03428100|365336978|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
105675076|NCT02643472|364473598|FG000|Overall Study|Lost to Follow-up|22|||
105675077|NCT02643472|364473599|FG001|Overall Study|Lost to Follow-up|26|||
105675078|NCT00528931|364473603|FG000|Overall Study|Lost to Follow-up|1|||
105675079|NCT00688870|364473604|FG000|Infant Series|Parent or legal guardian request|4|||
105675080|NCT00688870|364473605|FG001|Infant Series|Parent or legal guardian request|0|||
105675081|NCT00291642|364473607|FG000|Overall Study|Adverse Event|1|||
105675082|NCT00291642|364473608|FG001|Overall Study|Adverse Event|0|||
105675083|NCT00291642|364473609|FG002|Overall Study|Adverse Event|1|||
105675084|NCT00291642|364473610|FG003|Overall Study|Adverse Event|0|||
105675085|NCT00291642|364473611|FG004|Overall Study|Adverse Event|1|||
105675086|NCT00291642|364473607|FG000|Overall Study|Patient missed visit|0|||
106125703|NCT02107443|366117887|FG000|Overall Study|Registered but Not Eligible|0|||
105675087|NCT00291642|364473608|FG001|Overall Study|Patient missed visit|0|||
105675088|NCT00291642|364473609|FG002|Overall Study|Patient missed visit|1|||
105675089|NCT00291642|364473610|FG003|Overall Study|Patient missed visit|0|||
105675090|NCT00291642|364473611|FG004|Overall Study|Patient missed visit|0|||
105675091|NCT00291642|364473607|FG000|Overall Study|Intake of prohibited medication|1|||
105675092|NCT00291642|364473608|FG001|Overall Study|Intake of prohibited medication|0|||
105675093|NCT00291642|364473609|FG002|Overall Study|Intake of prohibited medication|0|||
105675094|NCT00291642|364473610|FG003|Overall Study|Intake of prohibited medication|0|||
105675095|NCT00291642|364473611|FG004|Overall Study|Intake of prohibited medication|0|||
105675096|NCT01278173|364473612|FG000|Overall Study|Lack of Efficacy|13|||
105675097|NCT01278173|364473612|FG000|Overall Study|Adverse Event|8|||
105675098|NCT01278173|364473612|FG000|Overall Study|Administrative or other reason|4|||
105675099|NCT01278173|364473612|FG000|Overall Study|Protocol Violation|1|||
105675100|NCT01278173|364473612|FG000|Overall Study|Withdrawal by Subject|1|||
105675101|NCT03973931|364473613|FG000|Overall Study|Lost to Follow-up|47|||
105675102|NCT03973931|364473614|FG001|Overall Study|Lost to Follow-up|63|||
105675103|NCT03973931|364473615|FG002|Overall Study|Lost to Follow-up|51|||
105675104|NCT03973931|364473616|FG003|Overall Study|Lost to Follow-up|54|||
105675105|NCT03973931|364473613|FG000|Overall Study|opted out|6|||
105675106|NCT03973931|364473614|FG001|Overall Study|opted out|5|||
105675107|NCT03973931|364473615|FG002|Overall Study|opted out|5|||
105675108|NCT03973931|364473616|FG003|Overall Study|opted out|1|||
105675109|NCT00744757|364475537|FG000|Overall Study|Objective disease progression|7|||
105675110|NCT00744757|364475537|FG000|Overall Study|Physician Decision|5|||
105675111|NCT00744757|364475537|FG000|Overall Study|Withdrawal by Subject|1|||
105675112|NCT00744757|364475537|FG000|Overall Study|Death|6|||
105675113|NCT00744757|364475537|FG000|Overall Study|Adverse Event|2|||
105675114|NCT00948766|364475540|FG000|Core Study|Adverse Event|73|||
105675115|NCT00948766|364475541|FG001|Core Study|Adverse Event|51|||
105675116|NCT00948766|364475540|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
105675117|NCT00948766|364475541|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
105675118|NCT00948766|364475540|FG000|Core Study|Patient Withdrew Consent|27|||
105912312|NCT03428100|365336979|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
105912313|NCT03428100|365336980|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
105912314|NCT03428100|365336981|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
105912315|NCT03428100|365336982|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
105912316|NCT03428100|365336983|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
105912317|NCT03428100|365336984|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
105912318|NCT03428100|365336985|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
105912319|NCT03428100|365336986|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
105912320|NCT03428100|365336987|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
105912321|NCT03428100|365336988|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
105912322|NCT03428100|365336989|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
105912323|NCT03428100|365336990|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
105912324|NCT03428100|365336991|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
105912325|NCT03428100|365336992|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
105912326|NCT03428100|365336974|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912327|NCT03428100|365336975|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912328|NCT03428100|365336976|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912329|NCT03428100|365336977|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912330|NCT03428100|365336978|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912331|NCT03428100|365336979|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912332|NCT03428100|365336980|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
105912333|NCT03428100|365336981|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912334|NCT03428100|365336982|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912335|NCT03428100|365336983|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912336|NCT03428100|365336984|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912337|NCT03428100|365336985|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912338|NCT03428100|365336986|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912339|NCT03428100|365336987|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912340|NCT03428100|365336988|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912341|NCT03428100|365336989|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912342|NCT03428100|365336990|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912343|NCT03428100|365336991|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
105912344|NCT03428100|365336992|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
105912345|NCT03428100|365336974|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
105675119|NCT00948766|364475541|FG001|Core Study|Patient Withdrew Consent|46|||
105912346|NCT03428100|365336975|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
105675120|NCT00948766|364475540|FG000|Core Study|Lost to Follow-up|3|||
105675121|NCT00948766|364475541|FG001|Core Study|Lost to Follow-up|2|||
105675122|NCT00948766|364475540|FG000|Core Study|Administrative Problems|2|||
105675123|NCT00948766|364475541|FG001|Core Study|Administrative Problems|2|||
105675124|NCT00948766|364475540|FG000|Core Study|Death|1|||
105675125|NCT00948766|364475541|FG001|Core Study|Death|1|||
105675126|NCT00948766|364475540|FG000|Core Study|Protocol Deviation|8|||
105675127|NCT00948766|364475541|FG001|Core Study|Protocol Deviation|10|||
105675128|NCT00948766|364475540|FG000|Extension Study|Adverse Event|43|||
105675129|NCT00948766|364475541|FG001|Extension Study|Adverse Event|0|||
105675130|NCT00948766|364475540|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
105675131|NCT00948766|364475541|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
105675132|NCT00948766|364475540|FG000|Extension Study|Study Drug No Longer Required|1|||
105675133|NCT00948766|364475541|FG001|Extension Study|Study Drug No Longer Required|0|||
105675134|NCT00948766|364475540|FG000|Extension Study|Patient Withdrew Consent|32|||
105675135|NCT00948766|364475541|FG001|Extension Study|Patient Withdrew Consent|0|||
105675136|NCT00948766|364475540|FG000|Extension Study|Lost to Follow-up|8|||
105675137|NCT00948766|364475541|FG001|Extension Study|Lost to Follow-up|0|||
105675138|NCT00948766|364475540|FG000|Extension Study|Administrative Problems|1|||
105675139|NCT00948766|364475541|FG001|Extension Study|Administrative Problems|0|||
105675140|NCT00948766|364475540|FG000|Extension Study|Death|4|||
105675141|NCT00948766|364475541|FG001|Extension Study|Death|0|||
105675142|NCT00888927|364475542|FG000|Overall Study|Adverse Event|0|||
105675143|NCT00888927|364475543|FG001|Overall Study|Adverse Event|0|||
105675144|NCT00888927|364475544|FG002|Overall Study|Adverse Event|0|||
105675145|NCT00888927|364475545|FG003|Overall Study|Adverse Event|1|||
105675146|NCT00888927|364475542|FG000|Overall Study|Withdrawal of consent|0|||
105675147|NCT00888927|364475543|FG001|Overall Study|Withdrawal of consent|0|||
105675148|NCT00888927|364475544|FG002|Overall Study|Withdrawal of consent|0|||
105675149|NCT00888927|364475545|FG003|Overall Study|Withdrawal of consent|1|||
105675150|NCT01080716|364475546|FG000|Part 1|Physician Decision|1|||
105675151|NCT01080716|364475547|FG001|Part 1|Physician Decision|0|||
105675152|NCT01080716|364475548|FG002|Part 1|Physician Decision|0|||
105675153|NCT01080716|364475549|FG003|Part 1|Physician Decision|0|||
105675154|NCT01056718|364475550|FG000|Overall Study|Withdrawal by Subject|2|||
105675155|NCT01056718|364475550|FG000|Overall Study|Ischemia on baseline stress test|1|||
105675156|NCT03189745|364475551|FG000|Overall Study|Conflict in work schedule of participant|1|||
105675157|NCT03189745|364475552|FG001|Overall Study|Conflict in work schedule of participant|1|||
105675158|NCT05086276|364475553|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
105675159|NCT05086276|364475554|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
105675160|NCT00895154|364475555|FG000|Overall Study|Lost to Follow-up|1|||
105675161|NCT00895154|364475556|FG001|Overall Study|Lost to Follow-up|1|||
105675162|NCT00895154|364475555|FG000|Overall Study|Withdrawal by Subject|0|||
105675163|NCT00895154|364475556|FG001|Overall Study|Withdrawal by Subject|1|||
105675164|NCT03702231|364475557|FG000|Overall Study|Withdrawal by Subject|1|||
105675165|NCT03702231|364475558|FG001|Overall Study|Withdrawal by Subject|0|||
105675166|NCT03702231|364475559|FG002|Overall Study|Withdrawal by Subject|0|||
105675167|NCT03702231|364475557|FG000|Overall Study|Protocol Violation|0|||
105675168|NCT03702231|364475558|FG001|Overall Study|Protocol Violation|0|||
105675169|NCT03702231|364475559|FG002|Overall Study|Protocol Violation|1|||
105675170|NCT03702231|364475557|FG000|Overall Study|Change in CLL Treatment|0|||
105675171|NCT03702231|364475558|FG001|Overall Study|Change in CLL Treatment|0|||
105675172|NCT03702231|364475559|FG002|Overall Study|Change in CLL Treatment|1|||
105675173|NCT03702231|364475557|FG000|Overall Study|COVID Pandemic|1|||
105675174|NCT03702231|364475558|FG001|Overall Study|COVID Pandemic|4|||
105675175|NCT03702231|364475559|FG002|Overall Study|COVID Pandemic|1|||
105675176|NCT03702231|364475557|FG000|Overall Study|Non-compliance|0|||
105675177|NCT03702231|364475558|FG001|Overall Study|Non-compliance|0|||
105675178|NCT03702231|364475559|FG002|Overall Study|Non-compliance|1|||
105675179|NCT00777088|364475560|FG000|Overall Study|PED Treatment not attempted|1|||
105675180|NCT03592745|364475561|FG000|Overall Study|Adverse Event|0|||
105675181|NCT03592745|364475562|FG001|Overall Study|Adverse Event|2|||
105675182|NCT03592745|364475561|FG000|Overall Study|Lost to Follow-up|2|||
105786400|NCT01965600|364870515|FG002|Second Intervention|Study terminated by Sponsor|2|||
105786401|NCT01965600|364870516|FG003|Second Intervention|Study terminated by Sponsor|2|||
105786402|NCT03145207|364870518|FG000|Overall Study|volunteer started taking allergy shots|1|||
105786403|NCT03145207|364870518|FG000|Overall Study|baseline blood pressure high|1|||
105786404|NCT01302366|364871383|FG000|Overall Study|patient choice or noncompliance|5|||
105675183|NCT03592745|364475562|FG001|Overall Study|Lost to Follow-up|0|||
105675184|NCT03592745|364475561|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
105675185|NCT03592745|364475562|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
105675186|NCT00738894|364475566|FG000|Overall Study|Lost to Follow-up|23|||
105675187|NCT00738894|364475567|FG001|Overall Study|Lost to Follow-up|13|||
105675188|NCT00738894|364475566|FG000|Overall Study|Withdrawal by Subject|10|||
105786405|NCT02957149|364871386|FG000|Overall Study|Withdrawal by Subject|5|||
105675189|NCT00738894|364475567|FG001|Overall Study|Withdrawal by Subject|15|||
105675190|NCT00738894|364475566|FG000|Overall Study|Physician Decision|4|||
105675191|NCT00738894|364475567|FG001|Overall Study|Physician Decision|5|||
105675192|NCT00738894|364475566|FG000|Overall Study|Death|2|||
105675193|NCT00738894|364475567|FG001|Overall Study|Death|0|||
105675194|NCT05017103|364475568|FG000|Overall Study|Death|2|||
105675195|NCT02656329|364475569|FG000|Overall Study|Lost to Follow-up|2|||
105675196|NCT02656329|364475570|FG001|Overall Study|Lost to Follow-up|3|||
105675197|NCT02656329|364475569|FG000|Overall Study|Withdrawal by Subject|7|||
105675198|NCT02656329|364475570|FG001|Overall Study|Withdrawal by Subject|6|||
105675199|NCT02656329|364475569|FG000|Overall Study|Study termination by Sponsor|150|||
105675200|NCT02656329|364475570|FG001|Overall Study|Study termination by Sponsor|142|||
105675201|NCT02656329|364475569|FG000|Overall Study|Other than specified above|5|||
105675202|NCT02656329|364475570|FG001|Overall Study|Other than specified above|6|||
105675203|NCT01139580|364475571|FG000|Overall Study|Adverse Event|5|||
105675204|NCT01139580|364475572|FG001|Overall Study|Adverse Event|4|||
105675205|NCT01139580|364475571|FG000|Overall Study|Lost to Follow-up|9|||
105675206|NCT01139580|364475572|FG001|Overall Study|Lost to Follow-up|1|||
105675207|NCT01139580|364475571|FG000|Overall Study|Lack of Efficacy|0|||
105675208|NCT01139580|364475572|FG001|Overall Study|Lack of Efficacy|2|||
105675209|NCT01139580|364475571|FG000|Overall Study|Withdrawal by Subject|6|||
105675210|NCT01139580|364475572|FG001|Overall Study|Withdrawal by Subject|9|||
105675211|NCT01139580|364475571|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
105675212|NCT01139580|364475572|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
105675213|NCT01139580|364475571|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
105675214|NCT01139580|364475572|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
105675215|NCT01139580|364475571|FG000|Overall Study|Misrandomized|1|||
105675216|NCT01139580|364475572|FG001|Overall Study|Misrandomized|0|||
105675217|NCT01139580|364475571|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
105675218|NCT01139580|364475572|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
105675219|NCT01139580|364475571|FG000|Overall Study|Participant Randomization in Error|0|||
105675220|NCT01139580|364475572|FG001|Overall Study|Participant Randomization in Error|1|||
105675221|NCT00911768|364475581|FG000|Overall Study|Protocol Violation|5|||
105675222|NCT00911768|364475582|FG001|Overall Study|Protocol Violation|4|||
105675223|NCT00911768|364475581|FG000|Overall Study|Withdrawal by Subject|1|||
105675224|NCT00911768|364475582|FG001|Overall Study|Withdrawal by Subject|0|||
105675225|NCT00633880|364475583|FG000|Open Label Titration|Lack of Efficacy|1|||
105675226|NCT00633880|364475584|FG001|Open Label Titration|Lack of Efficacy|0|||
105675227|NCT00633880|364475585|FG002|Open Label Titration|Lack of Efficacy|0|||
105675228|NCT00633880|364475583|FG000|Open Label Titration|Adverse Event|13|||
105675229|NCT00633880|364475584|FG001|Open Label Titration|Adverse Event|0|||
105675230|NCT00633880|364475585|FG002|Open Label Titration|Adverse Event|0|||
105912347|NCT03428100|365336976|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
105912348|NCT03428100|365336977|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
105912349|NCT03428100|365336978|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
105912350|NCT03428100|365336979|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
105912351|NCT03428100|365336980|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
105912352|NCT03428100|365336981|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
105675231|NCT00633880|364475583|FG000|Open Label Titration|Treatment Failure|55|||
105675232|NCT00633880|364475584|FG001|Open Label Titration|Treatment Failure|0|||
105675233|NCT00633880|364475585|FG002|Open Label Titration|Treatment Failure|0|||
105675234|NCT00633880|364475583|FG000|Open Label Titration|Protocol Violation|6|||
105675235|NCT00633880|364475584|FG001|Open Label Titration|Protocol Violation|0|||
105912353|NCT03428100|365336982|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
105912354|NCT03428100|365336983|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
105912355|NCT03428100|365336984|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
105912356|NCT03428100|365336985|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
105912357|NCT03428100|365336986|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
105912358|NCT03428100|365336987|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
105912359|NCT03428100|365336988|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
105912360|NCT03428100|365336989|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
105912361|NCT03428100|365336990|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
105912362|NCT03428100|365336991|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
105912363|NCT03428100|365336992|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
105912364|NCT03428100|365336974|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105912365|NCT03428100|365336975|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105912366|NCT03428100|365336976|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105912367|NCT03428100|365336977|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105912368|NCT03428100|365336978|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
105912369|NCT03428100|365336979|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105912370|NCT03428100|365336980|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
105912371|NCT03428100|365336981|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
105912372|NCT03428100|365336982|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105912373|NCT03428100|365336983|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
105912374|NCT03428100|365336984|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
105912375|NCT03428100|365336985|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
105912376|NCT03428100|365336986|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
105912377|NCT03428100|365336987|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
105912378|NCT03428100|365336988|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
105912379|NCT03428100|365336989|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105912380|NCT03428100|365336990|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
105912381|NCT03428100|365336991|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
105912382|NCT03428100|365336992|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
105912383|NCT02168491|365336996|FG000|Overall Study|Withdrawal by Subject|1|||
105912384|NCT00676403|365336997|FG000|Overall Study|Adverse Event|1|||
105912385|NCT00676403|365336998|FG001|Overall Study|Adverse Event|2|||
105912386|NCT00676403|365336999|FG002|Overall Study|Adverse Event|0|||
105912387|NCT00676403|365337000|FG003|Overall Study|Adverse Event|5|||
105912388|NCT00676403|365337001|FG004|Overall Study|Adverse Event|1|||
105912389|NCT00676403|365337002|FG005|Overall Study|Adverse Event|2|||
105912390|NCT00676403|365336997|FG000|Overall Study|Lost to Follow-up|0|||
105912391|NCT00676403|365336998|FG001|Overall Study|Lost to Follow-up|0|||
105912392|NCT00676403|365336999|FG002|Overall Study|Lost to Follow-up|0|||
105912393|NCT00676403|365337000|FG003|Overall Study|Lost to Follow-up|0|||
105912394|NCT00676403|365337001|FG004|Overall Study|Lost to Follow-up|0|||
105912395|NCT00676403|365337002|FG005|Overall Study|Lost to Follow-up|1|||
105912396|NCT00676403|365336997|FG000|Overall Study|Reason Unspecified|1|||
105912397|NCT00676403|365336998|FG001|Overall Study|Reason Unspecified|0|||
105912398|NCT00676403|365336999|FG002|Overall Study|Reason Unspecified|1|||
105912399|NCT00676403|365337000|FG003|Overall Study|Reason Unspecified|0|||
105912400|NCT00676403|365337001|FG004|Overall Study|Reason Unspecified|0|||
105912401|NCT00676403|365337002|FG005|Overall Study|Reason Unspecified|1|||
105912402|NCT00676403|365336997|FG000|Overall Study|Withdrawal by Subject|0|||
105912403|NCT00676403|365336998|FG001|Overall Study|Withdrawal by Subject|0|||
105912404|NCT00676403|365336999|FG002|Overall Study|Withdrawal by Subject|0|||
105912405|NCT00676403|365337000|FG003|Overall Study|Withdrawal by Subject|0|||
105912406|NCT00676403|365337001|FG004|Overall Study|Withdrawal by Subject|0|||
105912407|NCT00676403|365337002|FG005|Overall Study|Withdrawal by Subject|1|||
105912408|NCT01610037|365337003|FG000|All Patients|Adverse Event|27|||
105912409|NCT01610037|365337004|FG001|All Patients|Adverse Event|22|||
105912410|NCT01610037|365337005|FG002|All Patients|Adverse Event|26|||
105912411|NCT01610037|365337003|FG000|All Patients|Withdrawal by Subject|12|||
105912412|NCT01610037|365337004|FG001|All Patients|Withdrawal by Subject|10|||
105912413|NCT01610037|365337005|FG002|All Patients|Withdrawal by Subject|20|||
105912414|NCT01610037|365337003|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
105912415|NCT01610037|365337004|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
105912416|NCT01610037|365337005|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
105912417|NCT01610037|365337003|FG000|All Patients|Death|4|||
105912418|NCT01610037|365337004|FG001|All Patients|Death|2|||
105912419|NCT01610037|365337005|FG002|All Patients|Death|1|||
105999802|NCT01147666|365661206|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105999803|NCT01147666|365661207|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105999804|NCT01147666|365661208|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
105786406|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Adverse Event|4|||
105912420|NCT01610037|365337003|FG000|All Patients|Protocol deviation|4|||
105675236|NCT00633880|364475585|FG002|Open Label Titration|Protocol Violation|0|||
105675237|NCT00633880|364475583|FG000|Open Label Titration|Physician Decision|1|||
105675238|NCT00633880|364475584|FG001|Open Label Titration|Physician Decision|0|||
105675239|NCT00633880|364475585|FG002|Open Label Titration|Physician Decision|0|||
105675240|NCT00633880|364475583|FG000|Open Label Titration|Withdrawal by Subject|4|||
105675241|NCT00633880|364475584|FG001|Open Label Titration|Withdrawal by Subject|0|||
105675242|NCT00633880|364475585|FG002|Open Label Titration|Withdrawal by Subject|0|||
105675243|NCT00700778|364475586|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
105675244|NCT01373151|364475587|FG000|Period 1|Lack of Efficacy|3|||
105675245|NCT01373151|364475588|FG001|Period 1|Lack of Efficacy|0|||
105675246|NCT01373151|364475589|FG002|Period 1|Lack of Efficacy|0|||
105675247|NCT01373151|364475590|FG003|Period 1|Lack of Efficacy|0|||
105675248|NCT01373151|364475591|FG004|Period 1|Lack of Efficacy|1|||
105675249|NCT01373151|364475592|FG005|Period 1|Lack of Efficacy|0|||
105675250|NCT01373151|364475593|FG006|Period 1|Lack of Efficacy|0|||
105675251|NCT01373151|364475587|FG000|Period 1|Adverse Event|0|||
105675252|NCT01373151|364475588|FG001|Period 1|Adverse Event|0|||
105675253|NCT01373151|364475589|FG002|Period 1|Adverse Event|1|||
105675254|NCT01373151|364475590|FG003|Period 1|Adverse Event|0|||
105675255|NCT01373151|364475591|FG004|Period 1|Adverse Event|4|||
105675256|NCT01373151|364475592|FG005|Period 1|Adverse Event|3|||
105675257|NCT01373151|364475593|FG006|Period 1|Adverse Event|0|||
105675258|NCT01373151|364475587|FG000|Period 1|Withdrawal by Subject|2|||
105912421|NCT01610037|365337004|FG001|All Patients|Protocol deviation|3|||
105912422|NCT01610037|365337005|FG002|All Patients|Protocol deviation|3|||
105912423|NCT01610037|365337003|FG000|All Patients|Abnormal laboratory value|1|||
105675259|NCT01373151|364475588|FG001|Period 1|Withdrawal by Subject|0|||
105675260|NCT01373151|364475589|FG002|Period 1|Withdrawal by Subject|3|||
105675261|NCT01373151|364475590|FG003|Period 1|Withdrawal by Subject|1|||
105675262|NCT01373151|364475591|FG004|Period 1|Withdrawal by Subject|0|||
105675263|NCT01373151|364475592|FG005|Period 1|Withdrawal by Subject|1|||
105675264|NCT01373151|364475593|FG006|Period 1|Withdrawal by Subject|0|||
105675265|NCT01373151|364475587|FG000|Period 2|Lack of Efficacy|9|||
105675266|NCT01373151|364475588|FG001|Period 2|Lack of Efficacy|0|||
105675267|NCT01373151|364475589|FG002|Period 2|Lack of Efficacy|0|||
105675268|NCT01373151|364475590|FG003|Period 2|Lack of Efficacy|1|||
105675269|NCT01373151|364475591|FG004|Period 2|Lack of Efficacy|2|||
105675270|NCT01373151|364475592|FG005|Period 2|Lack of Efficacy|0|||
105675271|NCT01373151|364475593|FG006|Period 2|Lack of Efficacy|3|||
105675272|NCT01373151|364475587|FG000|Period 2|Adverse Event|0|||
105675273|NCT01373151|364475588|FG001|Period 2|Adverse Event|0|||
105675274|NCT01373151|364475589|FG002|Period 2|Adverse Event|3|||
105675275|NCT01373151|364475590|FG003|Period 2|Adverse Event|3|||
105675276|NCT01373151|364475591|FG004|Period 2|Adverse Event|0|||
105912424|NCT01610037|365337004|FG001|All Patients|Abnormal laboratory value|1|||
105912425|NCT01610037|365337005|FG002|All Patients|Abnormal laboratory value|0|||
105912426|NCT01610037|365337003|FG000|All Patients|Administrative problems|1|||
105912427|NCT01610037|365337004|FG001|All Patients|Administrative problems|4|||
105912428|NCT01610037|365337005|FG002|All Patients|Administrative problems|4|||
105912429|NCT01610037|365337003|FG000|All Patients|Lost to Follow-up|1|||
105912430|NCT01610037|365337004|FG001|All Patients|Lost to Follow-up|0|||
105912431|NCT01610037|365337005|FG002|All Patients|Lost to Follow-up|0|||
105912432|NCT01610037|365337003|FG000|All Patients|Abnormal test procedure result(s)|0|||
105912433|NCT01610037|365337004|FG001|All Patients|Abnormal test procedure result(s)|1|||
105912434|NCT01610037|365337005|FG002|All Patients|Abnormal test procedure result(s)|3|||
105912435|NCT01610037|365337003|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
105912436|NCT01610037|365337004|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
105912437|NCT01610037|365337005|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
105912438|NCT01610037|365337003|FG000|Treatment and Follow up Period|Death|10|||
105912439|NCT01610037|365337004|FG001|Treatment and Follow up Period|Death|5|||
105912440|NCT01610037|365337005|FG002|Treatment and Follow up Period|Death|4|||
105912441|NCT01610037|365337003|FG000|Treatment and Follow up Period|Administrative problems|1|||
105912442|NCT01610037|365337004|FG001|Treatment and Follow up Period|Administrative problems|3|||
105912443|NCT01610037|365337005|FG002|Treatment and Follow up Period|Administrative problems|2|||
105912444|NCT01610037|365337003|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
105675277|NCT01373151|364475592|FG005|Period 2|Adverse Event|0|||
105675278|NCT01373151|364475593|FG006|Period 2|Adverse Event|1|||
105675279|NCT01373151|364475587|FG000|Period 2|subject request to discontinue|0|||
105675280|NCT01373151|364475588|FG001|Period 2|subject request to discontinue|1|||
105675281|NCT01373151|364475589|FG002|Period 2|subject request to discontinue|0|||
105675282|NCT01373151|364475590|FG003|Period 2|subject request to discontinue|0|||
105675283|NCT01373151|364475591|FG004|Period 2|subject request to discontinue|0|||
105912445|NCT01610037|365337004|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
105912446|NCT01610037|365337005|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
105675284|NCT01373151|364475592|FG005|Period 2|subject request to discontinue|0|||
105675285|NCT01373151|364475593|FG006|Period 2|subject request to discontinue|0|||
105675286|NCT01373151|364475587|FG000|Period 2|Withdrawal by Subject|0|||
105675287|NCT01373151|364475588|FG001|Period 2|Withdrawal by Subject|0|||
105675288|NCT01373151|364475589|FG002|Period 2|Withdrawal by Subject|0|||
105675289|NCT01373151|364475590|FG003|Period 2|Withdrawal by Subject|1|||
105675290|NCT01373151|364475591|FG004|Period 2|Withdrawal by Subject|0|||
105675291|NCT01373151|364475592|FG005|Period 2|Withdrawal by Subject|0|||
105675292|NCT01373151|364475593|FG006|Period 2|Withdrawal by Subject|0|||
105675293|NCT01373151|364475587|FG000|Period 2|Other|0|||
105675294|NCT01373151|364475588|FG001|Period 2|Other|0|||
105675295|NCT01373151|364475589|FG002|Period 2|Other|1|||
105675296|NCT01373151|364475590|FG003|Period 2|Other|0|||
105675297|NCT01373151|364475591|FG004|Period 2|Other|0|||
105675298|NCT01373151|364475592|FG005|Period 2|Other|0|||
105675299|NCT01373151|364475593|FG006|Period 2|Other|1|||
105675300|NCT03026075|364475597|FG000|Overall Study|Physician Decision|1|||
105675301|NCT04927247|364475598|FG000|Overall Study|Other|2|||
105675302|NCT04927247|364475599|FG001|Overall Study|Other|1|||
105675303|NCT04927247|364475598|FG000|Overall Study|Physician Decision|0|||
105675304|NCT04927247|364475599|FG001|Overall Study|Physician Decision|1|||
105675305|NCT04927247|364475598|FG000|Overall Study|Adverse Event|1|||
105675306|NCT04927247|364475599|FG001|Overall Study|Adverse Event|0|||
105675307|NCT00350103|364475603|FG000|Overall Study|Adverse Event|12|||
105675308|NCT00350103|364475604|FG001|Overall Study|Adverse Event|29|||
105675309|NCT00350103|364475605|FG002|Overall Study|Adverse Event|17|||
105675310|NCT00350103|364475603|FG000|Overall Study|Lack of Efficacy|5|||
105675311|NCT00350103|364475604|FG001|Overall Study|Lack of Efficacy|1|||
105675312|NCT00350103|364475605|FG002|Overall Study|Lack of Efficacy|3|||
105675313|NCT00350103|364475603|FG000|Overall Study|Withdrawal by Subject|6|||
105675314|NCT00350103|364475604|FG001|Overall Study|Withdrawal by Subject|6|||
105675315|NCT00350103|364475605|FG002|Overall Study|Withdrawal by Subject|8|||
105675316|NCT00350103|364475603|FG000|Overall Study|Protocol Violation|0|||
105675317|NCT00350103|364475604|FG001|Overall Study|Protocol Violation|0|||
105675318|NCT00350103|364475605|FG002|Overall Study|Protocol Violation|1|||
105675319|NCT00350103|364475603|FG000|Overall Study|Unsatisfactory Compliance|2|||
105675320|NCT00350103|364475604|FG001|Overall Study|Unsatisfactory Compliance|2|||
105675321|NCT00350103|364475605|FG002|Overall Study|Unsatisfactory Compliance|1|||
105675322|NCT00350103|364475603|FG000|Overall Study|Investigator´s decision|1|||
105675323|NCT00350103|364475604|FG001|Overall Study|Investigator´s decision|1|||
105675324|NCT00350103|364475605|FG002|Overall Study|Investigator´s decision|0|||
105675325|NCT00350103|364475603|FG000|Overall Study|Exclusion criteria met|0|||
105675326|NCT00350103|364475604|FG001|Overall Study|Exclusion criteria met|0|||
105675327|NCT00350103|364475605|FG002|Overall Study|Exclusion criteria met|1|||
105675328|NCT00350103|364475603|FG000|Overall Study|Patient relocated|0|||
105675329|NCT00350103|364475604|FG001|Overall Study|Patient relocated|0|||
105675330|NCT00350103|364475605|FG002|Overall Study|Patient relocated|1|||
105675331|NCT00350103|364475603|FG000|Overall Study|Need for prohibited medication|1|||
105675332|NCT00350103|364475604|FG001|Overall Study|Need for prohibited medication|0|||
105675333|NCT00350103|364475605|FG002|Overall Study|Need for prohibited medication|0|||
105675334|NCT00350103|364475603|FG000|Overall Study|Personal reasons|0|||
105675335|NCT00350103|364475604|FG001|Overall Study|Personal reasons|0|||
105675336|NCT00350103|364475605|FG002|Overall Study|Personal reasons|1|||
105675337|NCT00350103|364475603|FG000|Overall Study|Patient stopped feeling pain|1|||
105675338|NCT00350103|364475604|FG001|Overall Study|Patient stopped feeling pain|0|||
105675339|NCT00350103|364475605|FG002|Overall Study|Patient stopped feeling pain|0|||
105675340|NCT00350103|364475603|FG000|Overall Study|PR greater than 250ms|0|||
105675341|NCT00350103|364475604|FG001|Overall Study|PR greater than 250ms|0|||
105675342|NCT00350103|364475605|FG002|Overall Study|PR greater than 250ms|1|||
105675343|NCT00350103|364475603|FG000|Overall Study|Wrong calculation of QT interval|0|||
105675344|NCT00350103|364475604|FG001|Overall Study|Wrong calculation of QT interval|0|||
105675345|NCT00350103|364475605|FG002|Overall Study|Wrong calculation of QT interval|1|||
105999805|NCT01147666|365661209|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
105999806|NCT01147666|365661210|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
105675346|NCT00350103|364475603|FG000|Overall Study|Sponsor mistake|1|||
105675347|NCT00350103|364475604|FG001|Overall Study|Sponsor mistake|0|||
105675348|NCT00350103|364475605|FG002|Overall Study|Sponsor mistake|0|||
105675349|NCT00350103|364475603|FG000|Overall Study|Randomization mistake|0|||
105675350|NCT00350103|364475604|FG001|Overall Study|Randomization mistake|1|||
105999807|NCT02748863|365661211|FG000|Treatment Period 1|Adverse Event|0|||
105999808|NCT02748863|365661212|FG001|Treatment Period 1|Adverse Event|1|||
105999809|NCT02748863|365661213|FG002|Treatment Period 1|Adverse Event|0|||
105675351|NCT00350103|364475605|FG002|Overall Study|Randomization mistake|1|||
106125704|NCT02107443|366117888|FG001|Overall Study|Registered but Not Eligible|1|||
105675352|NCT00350103|364475603|FG000|Overall Study|Sponsor´s decision|0|||
105675353|NCT00350103|364475604|FG001|Overall Study|Sponsor´s decision|1|||
105675354|NCT00350103|364475605|FG002|Overall Study|Sponsor´s decision|0|||
105675355|NCT00350103|364475603|FG000|Overall Study|Lost, Reason unknown|1|||
105675356|NCT00350103|364475604|FG001|Overall Study|Lost, Reason unknown|1|||
105675357|NCT00350103|364475605|FG002|Overall Study|Lost, Reason unknown|0|||
105675358|NCT02712905|364475606|FG000|Monotherapy|Death|2|||
105675359|NCT02712905|364475607|FG001|Monotherapy|Death|5|||
105675360|NCT02712905|364475608|FG002|Monotherapy|Death|0|||
105675361|NCT02712905|364475609|FG003|Monotherapy|Death|3|||
105675362|NCT02712905|364475610|FG004|Monotherapy|Death|15|||
105675363|NCT02712905|364475611|FG005|Monotherapy|Death|1|||
105675364|NCT02712905|364475612|FG006|Monotherapy|Death|3|||
105675365|NCT02712905|364475613|FG007|Monotherapy|Death|3|||
105675366|NCT02712905|364475614|FG008|Monotherapy|Death|0|||
105675367|NCT02712905|364475615|FG009|Monotherapy|Death|27|||
105675368|NCT02712905|364475616|FG010|Monotherapy|Death|2|||
105912447|NCT06400238|365337006|FG000|Overall Study|Started Protocol Therapy|2|||
105912448|NCT06400238|365337006|FG000|Overall Study|Adverse Event|1|||
105912449|NCT06400238|365337006|FG000|Overall Study|Death|1|||
105912450|NCT06400238|365337006|FG000|Overall Study|Disease Progression|27|||
105912451|NCT06400238|365337006|FG000|Overall Study|Withdrawal by Subject|2|||
105912452|NCT06400238|365337006|FG000|Overall Study|Physician Decision|2|||
105912453|NCT05209880|365337007|FG000|1-Month Follow-up|Spoke with Doctor|5|||
105912454|NCT05209880|365337008|FG001|1-Month Follow-up|Spoke with Doctor|5|||
105912455|NCT05209880|365337007|FG000|1-Month Follow-up|Lost to Follow-up|7|||
105912456|NCT05209880|365337008|FG001|1-Month Follow-up|Lost to Follow-up|9|||
105912457|NCT05209880|365337007|FG000|1-Month Follow-up|Discontinued|0|||
105912458|NCT05209880|365337008|FG001|1-Month Follow-up|Discontinued|1|||
105912459|NCT05209880|365337007|FG000|3-Month Follow-up|Spoke with Doctor|17|||
105912460|NCT05209880|365337008|FG001|3-Month Follow-up|Spoke with Doctor|7|||
105912461|NCT05209880|365337007|FG000|3-Month Follow-up|Lost to Follow-up|8|||
105912462|NCT05209880|365337008|FG001|3-Month Follow-up|Lost to Follow-up|10|||
105912463|NCT05209880|365337007|FG000|3-Month Follow-up|Discontinued|1|||
105912464|NCT05209880|365337008|FG001|3-Month Follow-up|Discontinued|3|||
105912465|NCT05209880|365337007|FG000|6-Month Follow-up|Spoke with Doctor|25|||
105912466|NCT05209880|365337008|FG001|6-Month Follow-up|Spoke with Doctor|14|||
105912467|NCT05209880|365337007|FG000|6-Month Follow-up|Lost to Follow-up|9|||
105912468|NCT05209880|365337008|FG001|6-Month Follow-up|Lost to Follow-up|14|||
105912469|NCT05209880|365337007|FG000|6-Month Follow-up|Discontinued|1|||
105912470|NCT05209880|365337008|FG001|6-Month Follow-up|Discontinued|3|||
105912471|NCT03990051|365337009|FG000|Masked Period|Lost to Follow-up|1|||
105912472|NCT03990051|365337010|FG001|Masked Period|Lost to Follow-up|0|||
105912473|NCT03990051|365337009|FG000|Long Term Period|Death|1|||
105912474|NCT03990051|365337010|FG001|Long Term Period|Death|1|||
105912475|NCT03990051|365337009|FG000|Long Term Period|Lost to Follow-up|7|||
105912476|NCT03990051|365337010|FG001|Long Term Period|Lost to Follow-up|2|||
105912477|NCT01411852|365337011|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
105912478|NCT01411852|365337012|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
105912479|NCT01411852|365337011|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
105912480|NCT01411852|365337012|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
105912481|NCT01411852|365337011|FG000|Prehospital Intervention Phase|Found to be under age|0|||
105912482|NCT01411852|365337012|FG001|Prehospital Intervention Phase|Found to be under age|1|||
105912483|NCT01411852|365337011|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
105912484|NCT01411852|365337012|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
105912485|NCT01411852|365337011|FG000|Hospital Intervention Phase|Severe head injury|5|||
105912486|NCT01411852|365337012|FG001|Hospital Intervention Phase|Severe head injury|4|||
105912487|NCT01411852|365337011|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
105912488|NCT01411852|365337012|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
105912489|NCT01411852|365337011|FG000|Hospital Intervention Phase|Miscommunication error|1|||
105912490|NCT01411852|365337012|FG001|Hospital Intervention Phase|Miscommunication error|2|||
105912491|NCT01411852|365337011|FG000|Hospital Intervention Phase|CPR administered|3|||
105912492|NCT01411852|365337012|FG001|Hospital Intervention Phase|CPR administered|1|||
105912493|NCT01411852|365337011|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
105912494|NCT01411852|365337012|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
105912495|NCT01411852|365337011|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
105912496|NCT01411852|365337012|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
105912497|NCT01411852|365337011|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
105912498|NCT01411852|365337012|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
105912499|NCT01411852|365337011|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
105912500|NCT01411852|365337012|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
105912501|NCT01411852|365337011|FG000|Hospital Intervention Phase|Other ineligible|2|||
105675369|NCT02712905|364475617|FG011|Monotherapy|Death|5|||
105786407|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Adverse Event|3|||
105786408|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Adverse Event|0|||
105912502|NCT01411852|365337012|FG001|Hospital Intervention Phase|Other ineligible|2|||
105912503|NCT01411852|365337011|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
105912504|NCT01411852|365337012|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
105675370|NCT02712905|364475618|FG012|Monotherapy|Death|0|||
105912505|NCT01411852|365337011|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
105912506|NCT01411852|365337012|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
105675371|NCT02712905|364475619|FG013|Monotherapy|Death|0|||
105675372|NCT02712905|364475620|FG014|Monotherapy|Death|0|||
105675373|NCT02712905|364475621|FG015|Monotherapy|Death|0|||
105912507|NCT01411852|365337011|FG000|Hospital Intervention Phase|Vascular access failed|1|||
105912508|NCT01411852|365337012|FG001|Hospital Intervention Phase|Vascular access failed|0|||
105912509|NCT03193047|365337013|FG000|Overall Study|Physician Decision|1|||
105912510|NCT03193047|365337014|FG001|Overall Study|Physician Decision|0|||
105912511|NCT03193047|365337013|FG000|Overall Study|Participant Left State|1|||
105912512|NCT03193047|365337014|FG001|Overall Study|Participant Left State|0|||
105912513|NCT05200845|365337015|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
105912514|NCT05200845|365337016|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
105912515|NCT05200845|365337017|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
105912516|NCT05200845|365337018|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
105912517|NCT05200845|365337015|FG000|Overall Study|Withdrawal by Subject|0|||
105912518|NCT05200845|365337016|FG001|Overall Study|Withdrawal by Subject|1|||
105912519|NCT05200845|365337017|FG002|Overall Study|Withdrawal by Subject|1|||
105912520|NCT05200845|365337018|FG003|Overall Study|Withdrawal by Subject|0|||
105912521|NCT03743025|365337019|FG000|Overall Study|Surgery was cancelled|2|||
105912522|NCT03743025|365337020|FG001|Overall Study|Surgery was cancelled|1|||
105675374|NCT02712905|364475622|FG016|Monotherapy|Death|0|||
105675375|NCT02712905|364475623|FG017|Monotherapy|Death|0|||
105675376|NCT02712905|364475606|FG000|Monotherapy|Lost to Follow-up|0|||
105675377|NCT02712905|364475607|FG001|Monotherapy|Lost to Follow-up|1|||
105675378|NCT02712905|364475608|FG002|Monotherapy|Lost to Follow-up|0|||
105675379|NCT02712905|364475609|FG003|Monotherapy|Lost to Follow-up|1|||
105675380|NCT02712905|364475610|FG004|Monotherapy|Lost to Follow-up|0|||
105675381|NCT02712905|364475611|FG005|Monotherapy|Lost to Follow-up|0|||
105675382|NCT02712905|364475612|FG006|Monotherapy|Lost to Follow-up|0|||
105675383|NCT02712905|364475613|FG007|Monotherapy|Lost to Follow-up|0|||
105675384|NCT02712905|364475614|FG008|Monotherapy|Lost to Follow-up|0|||
105675385|NCT02712905|364475615|FG009|Monotherapy|Lost to Follow-up|2|||
105675386|NCT02712905|364475616|FG010|Monotherapy|Lost to Follow-up|0|||
105675387|NCT02712905|364475617|FG011|Monotherapy|Lost to Follow-up|0|||
105675388|NCT02712905|364475618|FG012|Monotherapy|Lost to Follow-up|0|||
105675389|NCT02712905|364475619|FG013|Monotherapy|Lost to Follow-up|0|||
105675390|NCT02712905|364475620|FG014|Monotherapy|Lost to Follow-up|0|||
105675391|NCT02712905|364475621|FG015|Monotherapy|Lost to Follow-up|0|||
105675392|NCT02712905|364475622|FG016|Monotherapy|Lost to Follow-up|0|||
105675393|NCT02712905|364475623|FG017|Monotherapy|Lost to Follow-up|0|||
105675394|NCT02712905|364475606|FG000|Monotherapy|Physician Decision|1|||
105675395|NCT02712905|364475607|FG001|Monotherapy|Physician Decision|0|||
105675396|NCT02712905|364475608|FG002|Monotherapy|Physician Decision|0|||
105675397|NCT02712905|364475609|FG003|Monotherapy|Physician Decision|1|||
105675398|NCT02712905|364475610|FG004|Monotherapy|Physician Decision|0|||
105675399|NCT02712905|364475611|FG005|Monotherapy|Physician Decision|0|||
105675400|NCT02712905|364475612|FG006|Monotherapy|Physician Decision|0|||
105675401|NCT02712905|364475613|FG007|Monotherapy|Physician Decision|0|||
105675402|NCT02712905|364475614|FG008|Monotherapy|Physician Decision|0|||
105675403|NCT02712905|364475615|FG009|Monotherapy|Physician Decision|1|||
105675404|NCT02712905|364475616|FG010|Monotherapy|Physician Decision|0|||
105675405|NCT02712905|364475617|FG011|Monotherapy|Physician Decision|0|||
105675406|NCT02712905|364475618|FG012|Monotherapy|Physician Decision|0|||
105675407|NCT02712905|364475619|FG013|Monotherapy|Physician Decision|0|||
105675408|NCT02712905|364475620|FG014|Monotherapy|Physician Decision|0|||
105675409|NCT02712905|364475621|FG015|Monotherapy|Physician Decision|0|||
105675410|NCT02712905|364475622|FG016|Monotherapy|Physician Decision|0|||
105675411|NCT02712905|364475623|FG017|Monotherapy|Physician Decision|0|||
105675412|NCT02712905|364475606|FG000|Monotherapy|Study Terminated by Sponsor|0|||
105675413|NCT02712905|364475607|FG001|Monotherapy|Study Terminated by Sponsor|0|||
105675414|NCT02712905|364475608|FG002|Monotherapy|Study Terminated by Sponsor|0|||
105675415|NCT02712905|364475609|FG003|Monotherapy|Study Terminated by Sponsor|0|||
105675416|NCT02712905|364475610|FG004|Monotherapy|Study Terminated by Sponsor|1|||
105675417|NCT02712905|364475611|FG005|Monotherapy|Study Terminated by Sponsor|0|||
105675418|NCT02712905|364475612|FG006|Monotherapy|Study Terminated by Sponsor|0|||
105675419|NCT02712905|364475613|FG007|Monotherapy|Study Terminated by Sponsor|0|||
105675420|NCT02712905|364475614|FG008|Monotherapy|Study Terminated by Sponsor|0|||
105675421|NCT02712905|364475615|FG009|Monotherapy|Study Terminated by Sponsor|2|||
105675422|NCT02712905|364475616|FG010|Monotherapy|Study Terminated by Sponsor|0|||
105675423|NCT02712905|364475617|FG011|Monotherapy|Study Terminated by Sponsor|0|||
105675424|NCT02712905|364475618|FG012|Monotherapy|Study Terminated by Sponsor|0|||
105912523|NCT01272908|365337021|FG000|Initial Treatment Period|Adverse Event|1|||
105912524|NCT01272908|365337021|FG000|Initial Treatment Period|Lack of Efficacy|5|||
105912525|NCT01272908|365337021|FG000|Initial Treatment Period|Protocol Violation|1|||
105912526|NCT01272908|365337021|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
105912527|NCT01272908|365337021|FG000|Re-Treatment Period|Adverse Event|2|||
105912528|NCT01272908|365337021|FG000|Re-Treatment Period|Lack of Efficacy|3|||
105912529|NCT01272908|365337021|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
105912530|NCT02221648|365337022|FG000|Overall Study|Withdrawal by Subject|3|||
105912531|NCT02221648|365337023|FG001|Overall Study|Withdrawal by Subject|3|||
105912532|NCT00149396|365337028|FG000|Overall Study|Death|15|||
105912533|NCT00149396|365337028|FG000|Overall Study|Withdrawal by Subject|1|||
105912534|NCT00149396|365337028|FG000|Overall Study|Subject noncompliance|2|||
105675425|NCT02712905|364475619|FG013|Monotherapy|Study Terminated by Sponsor|0|||
105912535|NCT00149396|365337028|FG000|Overall Study|other treatment|5|||
105675426|NCT02712905|364475620|FG014|Monotherapy|Study Terminated by Sponsor|0|||
105912536|NCT00807885|365337029|FG000|Overall Study|Lost to Follow-up|0|||
105675427|NCT02712905|364475621|FG015|Monotherapy|Study Terminated by Sponsor|0|||
105675428|NCT02712905|364475622|FG016|Monotherapy|Study Terminated by Sponsor|0|||
105675429|NCT02712905|364475623|FG017|Monotherapy|Study Terminated by Sponsor|0|||
105675430|NCT02712905|364475606|FG000|Monotherapy|Withdrawal by Subject|0|||
105675431|NCT02712905|364475607|FG001|Monotherapy|Withdrawal by Subject|0|||
105912537|NCT00807885|365337030|FG001|Overall Study|Lost to Follow-up|0|||
105675432|NCT02712905|364475608|FG002|Monotherapy|Withdrawal by Subject|1|||
105675433|NCT02712905|364475609|FG003|Monotherapy|Withdrawal by Subject|0|||
105675434|NCT02712905|364475610|FG004|Monotherapy|Withdrawal by Subject|2|||
105675435|NCT02712905|364475611|FG005|Monotherapy|Withdrawal by Subject|0|||
105675436|NCT02712905|364475612|FG006|Monotherapy|Withdrawal by Subject|0|||
105675437|NCT02712905|364475613|FG007|Monotherapy|Withdrawal by Subject|0|||
105675438|NCT02712905|364475614|FG008|Monotherapy|Withdrawal by Subject|0|||
105675439|NCT02712905|364475615|FG009|Monotherapy|Withdrawal by Subject|4|||
105675440|NCT02712905|364475616|FG010|Monotherapy|Withdrawal by Subject|1|||
105675441|NCT02712905|364475617|FG011|Monotherapy|Withdrawal by Subject|2|||
105675442|NCT02712905|364475618|FG012|Monotherapy|Withdrawal by Subject|0|||
105675443|NCT02712905|364475619|FG013|Monotherapy|Withdrawal by Subject|0|||
105675444|NCT02712905|364475620|FG014|Monotherapy|Withdrawal by Subject|0|||
105675445|NCT02712905|364475621|FG015|Monotherapy|Withdrawal by Subject|0|||
105675446|NCT02712905|364475622|FG016|Monotherapy|Withdrawal by Subject|0|||
105675447|NCT02712905|364475623|FG017|Monotherapy|Withdrawal by Subject|0|||
105675448|NCT02712905|364475606|FG000|Monotherapy|Started New Cancer Drug|0|||
105675449|NCT02712905|364475607|FG001|Monotherapy|Started New Cancer Drug|0|||
105675450|NCT02712905|364475608|FG002|Monotherapy|Started New Cancer Drug|0|||
105675451|NCT02712905|364475609|FG003|Monotherapy|Started New Cancer Drug|0|||
105675452|NCT02712905|364475610|FG004|Monotherapy|Started New Cancer Drug|0|||
105675453|NCT02712905|364475611|FG005|Monotherapy|Started New Cancer Drug|1|||
105675454|NCT02712905|364475612|FG006|Monotherapy|Started New Cancer Drug|0|||
105675455|NCT02712905|364475613|FG007|Monotherapy|Started New Cancer Drug|0|||
105675456|NCT02712905|364475614|FG008|Monotherapy|Started New Cancer Drug|0|||
105675457|NCT02712905|364475615|FG009|Monotherapy|Started New Cancer Drug|0|||
105675458|NCT02712905|364475616|FG010|Monotherapy|Started New Cancer Drug|0|||
105675459|NCT02712905|364475617|FG011|Monotherapy|Started New Cancer Drug|0|||
105675460|NCT02712905|364475618|FG012|Monotherapy|Started New Cancer Drug|0|||
105675461|NCT02712905|364475619|FG013|Monotherapy|Started New Cancer Drug|0|||
105675462|NCT02712905|364475620|FG014|Monotherapy|Started New Cancer Drug|0|||
105675463|NCT02712905|364475621|FG015|Monotherapy|Started New Cancer Drug|0|||
105675464|NCT02712905|364475622|FG016|Monotherapy|Started New Cancer Drug|0|||
105675465|NCT02712905|364475623|FG017|Monotherapy|Started New Cancer Drug|0|||
105675466|NCT02712905|364475606|FG000|Monotherapy|Adverse Event|0|||
105675467|NCT02712905|364475607|FG001|Monotherapy|Adverse Event|0|||
105675468|NCT02712905|364475608|FG002|Monotherapy|Adverse Event|0|||
105675469|NCT02712905|364475609|FG003|Monotherapy|Adverse Event|0|||
105675470|NCT02712905|364475610|FG004|Monotherapy|Adverse Event|0|||
105675471|NCT02712905|364475611|FG005|Monotherapy|Adverse Event|0|||
105675472|NCT02712905|364475612|FG006|Monotherapy|Adverse Event|0|||
105675473|NCT02712905|364475613|FG007|Monotherapy|Adverse Event|0|||
105675474|NCT02712905|364475614|FG008|Monotherapy|Adverse Event|1|||
105675475|NCT02712905|364475615|FG009|Monotherapy|Adverse Event|0|||
105675476|NCT02712905|364475616|FG010|Monotherapy|Adverse Event|0|||
105675477|NCT02712905|364475617|FG011|Monotherapy|Adverse Event|0|||
105675478|NCT02712905|364475618|FG012|Monotherapy|Adverse Event|0|||
105675479|NCT02712905|364475619|FG013|Monotherapy|Adverse Event|0|||
105675480|NCT02712905|364475620|FG014|Monotherapy|Adverse Event|0|||
105912538|NCT00807885|365337031|FG002|Overall Study|Lost to Follow-up|0|||
105912539|NCT00807885|365337032|FG003|Overall Study|Lost to Follow-up|0|||
105912540|NCT00807885|365337033|FG004|Overall Study|Lost to Follow-up|0|||
105912541|NCT00807885|365337034|FG005|Overall Study|Lost to Follow-up|1|||
105912542|NCT00807885|365337035|FG006|Overall Study|Lost to Follow-up|0|||
105912543|NCT00807885|365337036|FG007|Overall Study|Lost to Follow-up|0|||
105912544|NCT00807885|365337037|FG008|Overall Study|Lost to Follow-up|0|||
105912545|NCT03489343|365337041|FG000|Overall Study|Documented progressive disease|1|||
105912546|NCT03489343|365337042|FG001|Overall Study|Documented progressive disease|0|||
105912547|NCT03489343|365337043|FG002|Overall Study|Documented progressive disease|3|||
105912548|NCT03489343|365337044|FG003|Overall Study|Documented progressive disease|1|||
105912549|NCT03489343|365337045|FG004|Overall Study|Documented progressive disease|3|||
105912550|NCT03489343|365337046|FG005|Overall Study|Documented progressive disease|5|||
105912551|NCT03489343|365337047|FG006|Overall Study|Documented progressive disease|4|||
105912552|NCT03489343|365337041|FG000|Overall Study|Adverse Event|0|||
105912553|NCT03489343|365337042|FG001|Overall Study|Adverse Event|1|||
105912554|NCT03489343|365337043|FG002|Overall Study|Adverse Event|0|||
105912555|NCT03489343|365337044|FG003|Overall Study|Adverse Event|0|||
105912556|NCT03489343|365337045|FG004|Overall Study|Adverse Event|0|||
105675481|NCT02712905|364475621|FG015|Monotherapy|Adverse Event|0|||
105675482|NCT02712905|364475622|FG016|Monotherapy|Adverse Event|0|||
105786409|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Adverse Event|0|||
105786410|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Death|24|||
105786411|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Death|9|||
105912557|NCT03489343|365337046|FG005|Overall Study|Adverse Event|1|||
105912558|NCT03489343|365337047|FG006|Overall Study|Adverse Event|0|||
105912559|NCT03489343|365337041|FG000|Overall Study|Withdrawal by Subject|0|||
105912560|NCT03489343|365337042|FG001|Overall Study|Withdrawal by Subject|0|||
105675483|NCT02712905|364475623|FG017|Monotherapy|Adverse Event|0|||
105675484|NCT02712905|364475606|FG000|Combination Therapy|Death|0|||
105675485|NCT02712905|364475607|FG001|Combination Therapy|Death|0|||
105675486|NCT02712905|364475608|FG002|Combination Therapy|Death|0|||
105675487|NCT02712905|364475609|FG003|Combination Therapy|Death|0|||
105675488|NCT02712905|364475610|FG004|Combination Therapy|Death|0|||
105675489|NCT02712905|364475611|FG005|Combination Therapy|Death|0|||
105675490|NCT02712905|364475612|FG006|Combination Therapy|Death|0|||
105675491|NCT02712905|364475613|FG007|Combination Therapy|Death|0|||
105786412|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Death|0|||
105675492|NCT02712905|364475614|FG008|Combination Therapy|Death|0|||
105675493|NCT02712905|364475615|FG009|Combination Therapy|Death|0|||
105675494|NCT02712905|364475616|FG010|Combination Therapy|Death|0|||
105675495|NCT02712905|364475617|FG011|Combination Therapy|Death|0|||
105675496|NCT02712905|364475618|FG012|Combination Therapy|Death|5|||
105675497|NCT02712905|364475619|FG013|Combination Therapy|Death|6|||
105675498|NCT02712905|364475620|FG014|Combination Therapy|Death|1|||
105675499|NCT02712905|364475621|FG015|Combination Therapy|Death|3|||
105675500|NCT02712905|364475622|FG016|Combination Therapy|Death|1|||
105786413|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Death|0|||
105786414|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
105786415|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
105999810|NCT02748863|365661214|FG003|Treatment Period 1|Adverse Event|0|||
105999811|NCT02748863|365661215|FG004|Treatment Period 1|Adverse Event|0|||
105999812|NCT02748863|365661211|FG000|Treatment Period 1|Lack of Efficacy|0|||
105999813|NCT02748863|365661212|FG001|Treatment Period 1|Lack of Efficacy|0|||
105999814|NCT02748863|365661213|FG002|Treatment Period 1|Lack of Efficacy|1|||
105999815|NCT02748863|365661214|FG003|Treatment Period 1|Lack of Efficacy|0|||
105786416|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
105675501|NCT02712905|364475623|FG017|Combination Therapy|Death|3|||
105675502|NCT02712905|364475606|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
105786417|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
105675503|NCT02712905|364475607|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
105675504|NCT02712905|364475608|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
105675505|NCT02712905|364475609|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
105675506|NCT02712905|364475610|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
105912561|NCT03489343|365337043|FG002|Overall Study|Withdrawal by Subject|0|||
105675507|NCT02712905|364475611|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
105675508|NCT02712905|364475612|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
105675509|NCT02712905|364475613|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
105675510|NCT02712905|364475614|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
105675511|NCT02712905|364475615|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
105675512|NCT02712905|364475616|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
105675513|NCT02712905|364475617|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
105675514|NCT02712905|364475618|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
105675515|NCT02712905|364475619|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
105675516|NCT02712905|364475620|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
105675517|NCT02712905|364475621|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
105675518|NCT02712905|364475622|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
105675519|NCT02712905|364475623|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
105675520|NCT02712905|364475606|FG000|Combination Therapy|Withdrawal by Subject|0|||
105675521|NCT02712905|364475607|FG001|Combination Therapy|Withdrawal by Subject|0|||
105675522|NCT02712905|364475608|FG002|Combination Therapy|Withdrawal by Subject|0|||
105675523|NCT02712905|364475609|FG003|Combination Therapy|Withdrawal by Subject|0|||
105675524|NCT02712905|364475610|FG004|Combination Therapy|Withdrawal by Subject|0|||
105675525|NCT02712905|364475611|FG005|Combination Therapy|Withdrawal by Subject|0|||
105675526|NCT02712905|364475612|FG006|Combination Therapy|Withdrawal by Subject|0|||
105912562|NCT03489343|365337044|FG003|Overall Study|Withdrawal by Subject|1|||
105912563|NCT03489343|365337045|FG004|Overall Study|Withdrawal by Subject|0|||
105912564|NCT03489343|365337046|FG005|Overall Study|Withdrawal by Subject|1|||
105912565|NCT03489343|365337047|FG006|Overall Study|Withdrawal by Subject|1|||
105675527|NCT02712905|364475613|FG007|Combination Therapy|Withdrawal by Subject|0|||
105675528|NCT02712905|364475614|FG008|Combination Therapy|Withdrawal by Subject|0|||
105675529|NCT02712905|364475615|FG009|Combination Therapy|Withdrawal by Subject|0|||
105675530|NCT02712905|364475616|FG010|Combination Therapy|Withdrawal by Subject|0|||
105675531|NCT02712905|364475617|FG011|Combination Therapy|Withdrawal by Subject|0|||
105675532|NCT02712905|364475618|FG012|Combination Therapy|Withdrawal by Subject|0|||
105675533|NCT02712905|364475619|FG013|Combination Therapy|Withdrawal by Subject|0|||
105675534|NCT02712905|364475620|FG014|Combination Therapy|Withdrawal by Subject|0|||
105675535|NCT02712905|364475621|FG015|Combination Therapy|Withdrawal by Subject|1|||
105675536|NCT02712905|364475622|FG016|Combination Therapy|Withdrawal by Subject|0|||
105675537|NCT02712905|364475623|FG017|Combination Therapy|Withdrawal by Subject|2|||
105675538|NCT02712905|364475606|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675539|NCT02712905|364475607|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675540|NCT02712905|364475608|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675541|NCT02712905|364475609|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675542|NCT02712905|364475610|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675543|NCT02712905|364475611|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675544|NCT02712905|364475612|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675545|NCT02712905|364475613|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675546|NCT02712905|364475614|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675547|NCT02712905|364475615|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675548|NCT02712905|364475616|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675549|NCT02712905|364475617|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675550|NCT02712905|364475618|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675551|NCT02712905|364475619|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675552|NCT02712905|364475620|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675553|NCT02712905|364475621|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
105675554|NCT02712905|364475622|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675555|NCT02712905|364475623|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
105675556|NCT01397422|364475624|FG000|Overall Study|Adverse Event|0|||
105675557|NCT01397422|364475625|FG001|Overall Study|Adverse Event|3|||
105675558|NCT01397422|364475626|FG002|Overall Study|Adverse Event|3|||
105675559|NCT01397422|364475627|FG003|Overall Study|Adverse Event|8|||
105675560|NCT01397422|364475624|FG000|Overall Study|Withdrawal by Subject|1|||
105675561|NCT01397422|364475625|FG001|Overall Study|Withdrawal by Subject|0|||
105675562|NCT01397422|364475626|FG002|Overall Study|Withdrawal by Subject|0|||
105675563|NCT01397422|364475627|FG003|Overall Study|Withdrawal by Subject|0|||
105675564|NCT01397422|364475624|FG000|Overall Study|Increased bradykinesia related to PD|1|||
105675565|NCT01397422|364475625|FG001|Overall Study|Increased bradykinesia related to PD|0|||
105675566|NCT01397422|364475626|FG002|Overall Study|Increased bradykinesia related to PD|0|||
105675567|NCT01397422|364475627|FG003|Overall Study|Increased bradykinesia related to PD|0|||
105675568|NCT00760474|364475628|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
105675569|NCT00760474|364475629|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
105675570|NCT00760474|364475628|FG000|Placebo Washout Period|Other|0|||
105675571|NCT00760474|364475629|FG001|Placebo Washout Period|Other|1|||
105675572|NCT00760474|364475628|FG000|Period 2 (P2)|Lost to Follow-up|1|||
105675573|NCT00760474|364475629|FG001|Period 2 (P2)|Lost to Follow-up|0|||
105675574|NCT00760474|364475628|FG000|Period 2 (P2)|Adverse Event|0|||
105675575|NCT00760474|364475629|FG001|Period 2 (P2)|Adverse Event|1|||
105675576|NCT01011153|364475634|FG000|Overall Study|Less than 78 cases completed|8|||
105675577|NCT01011153|364475635|FG001|Overall Study|Less than 78 cases completed|11|||
105675578|NCT01011153|364475636|FG002|Overall Study|Less than 78 cases completed|9|||
105675579|NCT02217501|364475647|FG000|Overall Study|Death|3|||
105675580|NCT02217501|364475648|FG001|Overall Study|Death|4|||
105675581|NCT01394978|364475649|FG000|Overall Study|Withdrawal by Subject|2|||
105675582|NCT01394978|364475650|FG001|Overall Study|Withdrawal by Subject|4|||
105675583|NCT01394978|364475649|FG000|Overall Study|Lost to Follow-up|13|||
105675584|NCT01394978|364475650|FG001|Overall Study|Lost to Follow-up|20|||
105675585|NCT01394978|364475649|FG000|Overall Study|Death|6|||
105675586|NCT01394978|364475650|FG001|Overall Study|Death|7|||
105675587|NCT01081132|364475651|FG000|Overall Study|Lack of Efficacy|25|||
105675588|NCT01081132|364475652|FG001|Overall Study|Lack of Efficacy|9|||
105675589|NCT01081132|364475651|FG000|Overall Study|Withdrawal by Subject|13|||
105675590|NCT01081132|364475652|FG001|Overall Study|Withdrawal by Subject|16|||
105675591|NCT01081132|364475651|FG000|Overall Study|Lost to Follow-up|4|||
105675592|NCT01081132|364475652|FG001|Overall Study|Lost to Follow-up|11|||
105675593|NCT01081132|364475651|FG000|Overall Study|Adverse Event|3|||
105675594|NCT01081132|364475652|FG001|Overall Study|Adverse Event|9|||
105675595|NCT01081132|364475651|FG000|Overall Study|Non Compliance|4|||
105675596|NCT01081132|364475652|FG001|Overall Study|Non Compliance|2|||
105675597|NCT01081132|364475651|FG000|Overall Study|Lack Of Compliance|0|||
105675598|NCT01081132|364475652|FG001|Overall Study|Lack Of Compliance|1|||
105675599|NCT01081132|364475651|FG000|Overall Study|Missed Visits|1|||
105675600|NCT01081132|364475652|FG001|Overall Study|Missed Visits|1|||
105675601|NCT01081132|364475651|FG000|Overall Study|Stopped Taking Meds|2|||
105675602|NCT01081132|364475652|FG001|Overall Study|Stopped Taking Meds|0|||
105675603|NCT01081132|364475651|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
105675604|NCT01081132|364475652|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
105675605|NCT01081132|364475651|FG000|Overall Study|Declined Taper Phase|0|||
105675606|NCT01081132|364475652|FG001|Overall Study|Declined Taper Phase|1|||
105675607|NCT01081132|364475651|FG000|Overall Study|Protocol Violation|3|||
105675608|NCT01081132|364475652|FG001|Overall Study|Protocol Violation|1|||
105675609|NCT02019667|364475653|FG000|First Intervention (6 Months)|Adverse Event|0|||
105675610|NCT02019667|364475654|FG001|First Intervention (6 Months)|Adverse Event|1|||
105675611|NCT02019667|364475653|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
105675612|NCT02019667|364475654|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
105675613|NCT02019667|364475653|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
105675614|NCT02019667|364475654|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
105675615|NCT02101385|364475658|FG000|Study Treatment|Disease Progression|9|||
105675616|NCT02101385|364475659|FG001|Study Treatment|Disease Progression|3|||
105675617|NCT02101385|364475658|FG000|Study Treatment|Alternative therapy|0|||
105675618|NCT02101385|364475659|FG001|Study Treatment|Alternative therapy|1|||
105675619|NCT02101385|364475658|FG000|Study Treatment|No treatment, per protocol criteria|0|||
105675620|NCT02101385|364475659|FG001|Study Treatment|No treatment, per protocol criteria|4|||
105675621|NCT02101385|364475658|FG000|Study Treatment|Patient Non compliance|0|||
105675622|NCT02101385|364475659|FG001|Study Treatment|Patient Non compliance|2|||
105675623|NCT02101385|364475658|FG000|Study Treatment|Withdrawal by Subject|5|||
105675624|NCT02101385|364475659|FG001|Study Treatment|Withdrawal by Subject|2|||
105675625|NCT02101385|364475658|FG000|Study Treatment|screen failure|1|||
105675626|NCT02101385|364475659|FG001|Study Treatment|screen failure|0|||
105675627|NCT02101385|364475658|FG000|Study Treatment|AE/Side Effects/Complications|8|||
105675628|NCT02101385|364475659|FG001|Study Treatment|AE/Side Effects/Complications|0|||
105675629|NCT02101385|364475658|FG000|Study Treatment|Lost to Follow-up|1|||
105675630|NCT02101385|364475659|FG001|Study Treatment|Lost to Follow-up|0|||
105675631|NCT02101385|364475658|FG000|Study Treatment|Disease Progression before treatment|1|||
105675632|NCT02101385|364475659|FG001|Study Treatment|Disease Progression before treatment|0|||
105912566|NCT03489343|365337041|FG000|Overall Study|Clinical progression|0|||
105675633|NCT02101385|364475658|FG000|Study Treatment|Death|1|||
105675634|NCT02101385|364475659|FG001|Study Treatment|Death|0|||
105675635|NCT02101385|364475658|FG000|Follow up|Lost to Follow-up|4|||
105675636|NCT02101385|364475659|FG001|Follow up|Lost to Follow-up|9|||
105675637|NCT02101385|364475658|FG000|Follow up|Refused to follow up|5|||
105786418|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Physician Decision|4|||
105675638|NCT02101385|364475659|FG001|Follow up|Refused to follow up|4|||
105675639|NCT02101385|364475658|FG000|Follow up|Death|21|||
105675640|NCT02101385|364475659|FG001|Follow up|Death|39|||
105675641|NCT02101385|364475658|FG000|Follow up|study completed|33|||
105675642|NCT02101385|364475659|FG001|Follow up|study completed|52|||
105675643|NCT02101385|364475658|FG000|Follow up|screen failure|2|||
105675644|NCT02101385|364475659|FG001|Follow up|screen failure|0|||
105675645|NCT02101385|364475658|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
105675646|NCT02101385|364475659|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
105675647|NCT02101385|364475658|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
105675648|NCT02101385|364475659|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
105675649|NCT02101385|364475658|FG000|Follow up|Withdrawal by Subject|2|||
105675650|NCT02101385|364475659|FG001|Follow up|Withdrawal by Subject|2|||
105675651|NCT02101385|364475658|FG000|Follow up|PI requested closure of site|0|||
105675652|NCT02101385|364475659|FG001|Follow up|PI requested closure of site|5|||
105675653|NCT00847808|364475660|FG000|Overall Study|Adverse Event|7|||
105675654|NCT00847808|364475660|FG000|Overall Study|Protocol Violation|1|||
105675655|NCT00847808|364475660|FG000|Overall Study|Lost to Follow-up|1|||
105675656|NCT00847808|364475660|FG000|Overall Study|Withdrawal by Subject|4|||
105675657|NCT00847808|364475660|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
105675658|NCT00847808|364475660|FG000|Overall Study|Participant Took Excluded Medication|1|||
105675659|NCT02432196|364475661|FG000|Overall Study|Exit - did not receive study device|1|||
105675660|NCT02432196|364475661|FG000|Overall Study|Death|2|||
105675661|NCT02432196|364475661|FG000|Overall Study|Reoperation|3|||
105675662|NCT02227199|364475668|FG000|Overall Study|Physician Decision|0|||
105675663|NCT02227199|364475669|FG001|Overall Study|Physician Decision|0|||
105675664|NCT02227199|364475670|FG002|Overall Study|Physician Decision|1|||
105675665|NCT02227199|364475668|FG000|Overall Study|Adverse Event|0|||
105675666|NCT02227199|364475669|FG001|Overall Study|Adverse Event|0|||
105675667|NCT02227199|364475670|FG002|Overall Study|Adverse Event|3|||
105675668|NCT01905150|364475674|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
105675669|NCT01905150|364475675|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
105675670|NCT05000931|364475676|FG000|Overall Study|Lost to Follow-up|1|||
105675671|NCT01892540|364475680|FG000|Overall Study|Did not complete PET/MRI|0|||
105675672|NCT01892540|364475681|FG001|Overall Study|Did not complete PET/MRI|0|||
105675673|NCT01892540|364475682|FG002|Overall Study|Did not complete PET/MRI|2|||
105675674|NCT01892540|364475680|FG000|Overall Study|Did not fit in scanner|0|||
105675675|NCT01892540|364475681|FG001|Overall Study|Did not fit in scanner|0|||
105675676|NCT01892540|364475682|FG002|Overall Study|Did not fit in scanner|1|||
105675677|NCT01370590|364475683|FG000|Period 1|Adverse Event|8|||
105675678|NCT01370590|364475684|FG001|Period 1|Adverse Event|4|||
105675679|NCT01370590|364475683|FG000|Period 1|Lost to Follow-up|2|||
105675680|NCT01370590|364475684|FG001|Period 1|Lost to Follow-up|2|||
105675681|NCT01370590|364475683|FG000|Period 1|Protocol Violation|2|||
105675682|NCT01370590|364475684|FG001|Period 1|Protocol Violation|2|||
105675683|NCT01370590|364475683|FG000|Period 1|Withdrawal by Subject|4|||
105675684|NCT01370590|364475684|FG001|Period 1|Withdrawal by Subject|2|||
105675685|NCT01370590|364475683|FG000|Period 1|Could not access randomization system|0|||
105675686|NCT01370590|364475684|FG001|Period 1|Could not access randomization system|1|||
105675687|NCT01370590|364475683|FG000|Crossover Washout Period|Adverse Event|1|||
105675688|NCT01370590|364475684|FG001|Crossover Washout Period|Adverse Event|4|||
105675689|NCT01370590|364475683|FG000|Crossover Washout Period|Lost to Follow-up|2|||
105675690|NCT01370590|364475684|FG001|Crossover Washout Period|Lost to Follow-up|0|||
105912567|NCT03489343|365337042|FG001|Overall Study|Clinical progression|0|||
105675691|NCT01370590|364475683|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
105675692|NCT01370590|364475684|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
105675693|NCT01370590|364475683|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
105675694|NCT01370590|364475684|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
105675695|NCT01370590|364475683|FG000|Period 2|Adverse Event|0|||
105675696|NCT01370590|364475684|FG001|Period 2|Adverse Event|1|||
105912568|NCT03489343|365337043|FG002|Overall Study|Clinical progression|0|||
105912569|NCT03489343|365337044|FG003|Overall Study|Clinical progression|1|||
105912570|NCT03489343|365337045|FG004|Overall Study|Clinical progression|0|||
105675697|NCT01370590|364475683|FG000|Period 2|Withdrawal by Subject|1|||
105675698|NCT01370590|364475684|FG001|Period 2|Withdrawal by Subject|1|||
105675699|NCT05172050|364475685|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
105675700|NCT05172050|364475686|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
105675701|NCT05172050|364475687|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
105675702|NCT05172050|364475685|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
105675703|NCT05172050|364475686|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
105675704|NCT05172050|364475687|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
105675705|NCT05172050|364475685|FG000|Overall Study|Other|2|||
105675706|NCT05172050|364475686|FG001|Overall Study|Other|2|||
105999816|NCT02748863|365661215|FG004|Treatment Period 1|Lack of Efficacy|0|||
105999817|NCT02748863|365661211|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105999818|NCT02748863|365661212|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105999819|NCT02748863|365661213|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105999820|NCT02748863|365661214|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105999821|NCT02748863|365661215|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105999822|NCT02748863|365661211|FG000|Treatment Period 2|Lost to Follow-up|2|||
105675707|NCT05172050|364475687|FG002|Overall Study|Other|1|||
105675708|NCT00151281|364475695|FG000|Overall Study|Not evaluable|3|||
105675709|NCT00604825|364475698|FG000|Overall Study|Adverse Event|2|||
105675710|NCT00604825|364475699|FG001|Overall Study|Adverse Event|6|||
105675711|NCT00604825|364475700|FG002|Overall Study|Adverse Event|7|||
105675712|NCT00604825|364475701|FG003|Overall Study|Adverse Event|4|||
105675713|NCT00604825|364475698|FG000|Overall Study|Lost to Follow-up|0|||
105675714|NCT00604825|364475699|FG001|Overall Study|Lost to Follow-up|3|||
105675715|NCT00604825|364475700|FG002|Overall Study|Lost to Follow-up|1|||
105675716|NCT00604825|364475701|FG003|Overall Study|Lost to Follow-up|0|||
105675717|NCT00604825|364475698|FG000|Overall Study|Protocol Violation|0|||
105675718|NCT00604825|364475699|FG001|Overall Study|Protocol Violation|1|||
105675719|NCT00604825|364475700|FG002|Overall Study|Protocol Violation|0|||
105675720|NCT00604825|364475701|FG003|Overall Study|Protocol Violation|0|||
105675721|NCT00604825|364475698|FG000|Overall Study|Withdrawal by Subject|4|||
105675722|NCT00604825|364475699|FG001|Overall Study|Withdrawal by Subject|3|||
105675723|NCT00604825|364475700|FG002|Overall Study|Withdrawal by Subject|5|||
105675724|NCT00604825|364475701|FG003|Overall Study|Withdrawal by Subject|5|||
105675725|NCT00604825|364475698|FG000|Overall Study|Lack of Efficacy|3|||
105675726|NCT00604825|364475699|FG001|Overall Study|Lack of Efficacy|2|||
105675727|NCT00604825|364475700|FG002|Overall Study|Lack of Efficacy|1|||
105675728|NCT00604825|364475701|FG003|Overall Study|Lack of Efficacy|0|||
105675729|NCT00604825|364475698|FG000|Overall Study|Did not meet eligibility criteria|0|||
105675730|NCT00604825|364475699|FG001|Overall Study|Did not meet eligibility criteria|0|||
105675731|NCT00604825|364475700|FG002|Overall Study|Did not meet eligibility criteria|2|||
105675732|NCT00604825|364475701|FG003|Overall Study|Did not meet eligibility criteria|0|||
105675733|NCT00604825|364475698|FG000|Overall Study|Physician Decision|0|||
105675734|NCT00604825|364475699|FG001|Overall Study|Physician Decision|0|||
105675735|NCT00604825|364475700|FG002|Overall Study|Physician Decision|0|||
105675736|NCT00604825|364475701|FG003|Overall Study|Physician Decision|1|||
105675737|NCT00604825|364475698|FG000|Overall Study|Exclusion criterion met|0|||
105675738|NCT00604825|364475699|FG001|Overall Study|Exclusion criterion met|0|||
105675739|NCT00604825|364475700|FG002|Overall Study|Exclusion criterion met|0|||
105675740|NCT00604825|364475701|FG003|Overall Study|Exclusion criterion met|1|||
105675741|NCT04617275|364475702|FG000|Treatment Period|Adverse Event|1|||
105675742|NCT04617275|364475703|FG001|Treatment Period|Adverse Event|6|||
105675743|NCT04617275|364475704|FG002|Treatment Period|Adverse Event|4|||
105675744|NCT04617275|364475705|FG003|Treatment Period|Adverse Event|6|||
105675745|NCT04617275|364475706|FG004|Treatment Period|Adverse Event|7|||
105675746|NCT04617275|364475707|FG005|Treatment Period|Adverse Event|8|||
105675747|NCT04617275|364475708|FG006|Treatment Period|Adverse Event|0|||
105675748|NCT04617275|364475709|FG007|Treatment Period|Adverse Event|12|||
105675749|NCT04617275|364475702|FG000|Treatment Period|Lost to Follow-up|0|||
105675750|NCT04617275|364475703|FG001|Treatment Period|Lost to Follow-up|0|||
105675751|NCT04617275|364475704|FG002|Treatment Period|Lost to Follow-up|2|||
105675752|NCT04617275|364475705|FG003|Treatment Period|Lost to Follow-up|0|||
105675753|NCT04617275|364475706|FG004|Treatment Period|Lost to Follow-up|0|||
105675754|NCT04617275|364475707|FG005|Treatment Period|Lost to Follow-up|3|||
105675755|NCT04617275|364475708|FG006|Treatment Period|Lost to Follow-up|0|||
105675756|NCT04617275|364475709|FG007|Treatment Period|Lost to Follow-up|2|||
105675757|NCT04617275|364475702|FG000|Treatment Period|No longer meets eligibility criteria|0|||
105675758|NCT04617275|364475703|FG001|Treatment Period|No longer meets eligibility criteria|0|||
105675759|NCT04617275|364475704|FG002|Treatment Period|No longer meets eligibility criteria|0|||
105675760|NCT04617275|364475705|FG003|Treatment Period|No longer meets eligibility criteria|1|||
105675761|NCT04617275|364475706|FG004|Treatment Period|No longer meets eligibility criteria|0|||
105675762|NCT04617275|364475707|FG005|Treatment Period|No longer meets eligibility criteria|0|||
105675763|NCT04617275|364475708|FG006|Treatment Period|No longer meets eligibility criteria|0|||
105675764|NCT04617275|364475709|FG007|Treatment Period|No longer meets eligibility criteria|0|||
105675765|NCT04617275|364475702|FG000|Treatment Period|Other|0|||
105675766|NCT04617275|364475703|FG001|Treatment Period|Other|1|||
105675767|NCT04617275|364475704|FG002|Treatment Period|Other|0|||
105675768|NCT04617275|364475705|FG003|Treatment Period|Other|0|||
105675769|NCT04617275|364475706|FG004|Treatment Period|Other|0|||
105912571|NCT03489343|365337046|FG005|Overall Study|Clinical progression|0|||
105675770|NCT04617275|364475707|FG005|Treatment Period|Other|0|||
105675771|NCT04617275|364475708|FG006|Treatment Period|Other|0|||
105675772|NCT04617275|364475709|FG007|Treatment Period|Other|0|||
105675773|NCT04617275|364475702|FG000|Treatment Period|Withdrawal by Subject|2|||
105675774|NCT04617275|364475703|FG001|Treatment Period|Withdrawal by Subject|0|||
105675775|NCT04617275|364475704|FG002|Treatment Period|Withdrawal by Subject|0|||
105675776|NCT04617275|364475705|FG003|Treatment Period|Withdrawal by Subject|2|||
105675777|NCT04617275|364475706|FG004|Treatment Period|Withdrawal by Subject|2|||
105675778|NCT04617275|364475707|FG005|Treatment Period|Withdrawal by Subject|0|||
105675779|NCT04617275|364475708|FG006|Treatment Period|Withdrawal by Subject|1|||
105675780|NCT04617275|364475709|FG007|Treatment Period|Withdrawal by Subject|2|||
105999823|NCT02748863|365661212|FG001|Treatment Period 2|Lost to Follow-up|0|||
105999824|NCT02748863|365661213|FG002|Treatment Period 2|Lost to Follow-up|0|||
105999825|NCT02748863|365661214|FG003|Treatment Period 2|Lost to Follow-up|0|||
105999826|NCT02748863|365661215|FG004|Treatment Period 2|Lost to Follow-up|0|||
105999827|NCT02748863|365661211|FG000|Treatment Period 2|Adverse Event|3|||
105999828|NCT02748863|365661212|FG001|Treatment Period 2|Adverse Event|2|||
105912572|NCT03489343|365337047|FG006|Overall Study|Clinical progression|1|||
105912573|NCT02364388|365337048|FG000|Overall Study|Protocol Violation|1|||
105912574|NCT02364388|365337048|FG000|Overall Study|Technical Failure|3|||
105912575|NCT02364388|365337048|FG000|Overall Study|No OA/US data|2|||
105912576|NCT02364388|365337048|FG000|Overall Study|No Biopsy|2|||
105912577|NCT00327717|365337049|FG000|Overall Study|Adverse Event|6|||
105912578|NCT00327717|365337050|FG001|Overall Study|Adverse Event|6|||
105912579|NCT00327717|365337049|FG000|Overall Study|Lack of Efficacy|0|||
105912580|NCT00327717|365337050|FG001|Overall Study|Lack of Efficacy|1|||
105999829|NCT02748863|365661213|FG002|Treatment Period 2|Adverse Event|0|||
105912581|NCT00327717|365337049|FG000|Overall Study|Withdrawal by Subject|3|||
105912582|NCT00327717|365337050|FG001|Overall Study|Withdrawal by Subject|7|||
105912583|NCT01158261|365337051|FG000|Overall Study|Lost to Follow-up|9|||
105912584|NCT01158261|365337051|FG000|Overall Study|Death|7|||
105999830|NCT02748863|365661214|FG003|Treatment Period 2|Adverse Event|2|||
105999831|NCT02748863|365661215|FG004|Treatment Period 2|Adverse Event|0|||
105999832|NCT02748863|365661211|FG000|Treatment Period 2|Lack of Efficacy|0|||
105999833|NCT02748863|365661212|FG001|Treatment Period 2|Lack of Efficacy|1|||
105999834|NCT02748863|365661213|FG002|Treatment Period 2|Lack of Efficacy|0|||
105912585|NCT01158261|365337051|FG000|Overall Study|Withdrawal by Subject|1|||
105912586|NCT03143101|365337052|FG000|Overall Study|Withdrawal by Subject|0|||
105912587|NCT03143101|365337053|FG001|Overall Study|Withdrawal by Subject|1|||
105912588|NCT03143101|365337054|FG002|Overall Study|Withdrawal by Subject|0|||
105912589|NCT03143101|365337052|FG000|Overall Study|Lost to Follow-up|2|||
105912590|NCT03143101|365337053|FG001|Overall Study|Lost to Follow-up|2|||
105912591|NCT03143101|365337054|FG002|Overall Study|Lost to Follow-up|0|||
105912592|NCT02899065|365337055|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
105912593|NCT02899065|365337056|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
105912594|NCT02899065|365337055|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
105912595|NCT02899065|365337056|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
105912596|NCT02899065|365337055|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
105912597|NCT02899065|365337056|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
105912598|NCT00593918|365337059|FG000|Overall Study|Withdrawal by Subject|5|||
105912599|NCT00593918|365337060|FG001|Overall Study|Withdrawal by Subject|24|||
105912600|NCT01601496|365337062|FG000|Overall Study|Physician Decision|1|||
105912601|NCT01601496|365337062|FG000|Overall Study|Withdrawal by Subject|1|||
105912602|NCT01601496|365337062|FG000|Overall Study|Lost to Follow-up|6|||
105912603|NCT01601496|365337062|FG000|Overall Study|Death|4|||
105912604|NCT01601496|365337062|FG000|Overall Study|Other: patient refusal to continue|3|||
105912605|NCT04157088|365337066|FG000|Overall Study|Study terminated by sponsor|23|||
105999835|NCT02748863|365661214|FG003|Treatment Period 2|Lack of Efficacy|0|||
105999836|NCT02748863|365661215|FG004|Treatment Period 2|Lack of Efficacy|0|||
105999837|NCT02748863|365661211|FG000|Treatment Period 2|Pregnancy|0|||
105999838|NCT02748863|365661212|FG001|Treatment Period 2|Pregnancy|0|||
105675781|NCT04617275|364475702|FG000|Follow-up Period|Adverse Event|1|||
105675782|NCT04617275|364475703|FG001|Follow-up Period|Adverse Event|1|||
105675783|NCT04617275|364475704|FG002|Follow-up Period|Adverse Event|2|||
105675784|NCT04617275|364475705|FG003|Follow-up Period|Adverse Event|3|||
105675785|NCT04617275|364475706|FG004|Follow-up Period|Adverse Event|4|||
105675786|NCT04617275|364475707|FG005|Follow-up Period|Adverse Event|3|||
105675787|NCT04617275|364475708|FG006|Follow-up Period|Adverse Event|0|||
105675788|NCT04617275|364475709|FG007|Follow-up Period|Adverse Event|3|||
105675789|NCT04617275|364475702|FG000|Follow-up Period|Lost to Follow-up|0|||
105675790|NCT04617275|364475703|FG001|Follow-up Period|Lost to Follow-up|1|||
105675791|NCT04617275|364475704|FG002|Follow-up Period|Lost to Follow-up|2|||
105675792|NCT04617275|364475705|FG003|Follow-up Period|Lost to Follow-up|0|||
105675793|NCT04617275|364475706|FG004|Follow-up Period|Lost to Follow-up|0|||
105675794|NCT04617275|364475707|FG005|Follow-up Period|Lost to Follow-up|4|||
105675795|NCT04617275|364475708|FG006|Follow-up Period|Lost to Follow-up|0|||
105675796|NCT04617275|364475709|FG007|Follow-up Period|Lost to Follow-up|3|||
105675797|NCT04617275|364475702|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
105675798|NCT04617275|364475703|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
105675799|NCT04617275|364475704|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
105675800|NCT04617275|364475705|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
105675801|NCT04617275|364475706|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
105675802|NCT04617275|364475707|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
105675803|NCT04617275|364475708|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
105675804|NCT04617275|364475709|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
105675805|NCT04617275|364475702|FG000|Follow-up Period|Other|0|||
105675806|NCT04617275|364475703|FG001|Follow-up Period|Other|1|||
105675807|NCT04617275|364475704|FG002|Follow-up Period|Other|0|||
105675808|NCT04617275|364475705|FG003|Follow-up Period|Other|0|||
105675809|NCT04617275|364475706|FG004|Follow-up Period|Other|0|||
105675810|NCT04617275|364475707|FG005|Follow-up Period|Other|0|||
105675811|NCT04617275|364475708|FG006|Follow-up Period|Other|0|||
105675812|NCT04617275|364475709|FG007|Follow-up Period|Other|0|||
105675813|NCT04617275|364475702|FG000|Follow-up Period|Withdrawal by Subject|2|||
105675814|NCT04617275|364475703|FG001|Follow-up Period|Withdrawal by Subject|0|||
105675815|NCT04617275|364475704|FG002|Follow-up Period|Withdrawal by Subject|0|||
105675816|NCT04617275|364475705|FG003|Follow-up Period|Withdrawal by Subject|2|||
105675817|NCT04617275|364475706|FG004|Follow-up Period|Withdrawal by Subject|2|||
105675818|NCT04617275|364475707|FG005|Follow-up Period|Withdrawal by Subject|0|||
105675819|NCT04617275|364475708|FG006|Follow-up Period|Withdrawal by Subject|1|||
105675820|NCT04617275|364475709|FG007|Follow-up Period|Withdrawal by Subject|2|||
105675821|NCT03465904|364475710|FG000|Overall Study|Withdrawal by Subject|9|||
105675822|NCT03465904|364475711|FG001|Overall Study|Withdrawal by Subject|5|||
105675823|NCT03465904|364475710|FG000|Overall Study|Lost to Follow-up|11|||
105675824|NCT03465904|364475711|FG001|Overall Study|Lost to Follow-up|9|||
105675825|NCT03465904|364475710|FG000|Overall Study|Protocol Violation|20|||
105675826|NCT03465904|364475711|FG001|Overall Study|Protocol Violation|15|||
105675827|NCT00727311|364475712|FG000|Overall Study|Did not receive drug|316|||
105675828|NCT00727311|364475712|FG000|Overall Study|Missing end of therapy data|205|||
105675829|NCT00727311|364475712|FG000|Overall Study|Adverse Event|58|||
105675830|NCT00727311|364475712|FG000|Overall Study|Lack of Efficacy|242|||
105675831|NCT00727311|364475712|FG000|Overall Study|Lost to Follow-up|73|||
105912606|NCT04157088|365337066|FG000|Overall Study|Withdrawal by Subject|4|||
105912607|NCT04157088|365337066|FG000|Overall Study|Lost to Follow-up|2|||
105912608|NCT04157088|365337066|FG000|Overall Study|Death|1|||
105912609|NCT02421419|365337067|FG000|Overall Study|Physician Decision|0|||
105912610|NCT02421419|365337068|FG001|Overall Study|Physician Decision|0|||
105912611|NCT02421419|365337069|FG002|Overall Study|Physician Decision|1|||
105912612|NCT04863872|365337072|FG000|Overall Study|Withdrawal by Subject|4|||
105912613|NCT04863872|365337073|FG001|Overall Study|Withdrawal by Subject|15|||
105912614|NCT04863872|365337072|FG000|Overall Study|Death|5|||
105912615|NCT04863872|365337073|FG001|Overall Study|Death|2|||
105912616|NCT04863872|365337072|FG000|Overall Study|Lost to Follow-up|2|||
105912617|NCT04863872|365337073|FG001|Overall Study|Lost to Follow-up|1|||
105912618|NCT04058028|365337077|FG000|Overall Study|Withdrawal of Consent from Study|12|||
105912619|NCT04058028|365337078|FG001|Overall Study|Withdrawal of Consent from Study|8|||
105912620|NCT04058028|365337079|FG002|Overall Study|Withdrawal of Consent from Study|6|||
105912621|NCT04058028|365337080|FG003|Overall Study|Withdrawal of Consent from Study|7|||
105912622|NCT04058028|365337077|FG000|Overall Study|Decision by Sponsor|13|||
105912623|NCT04058028|365337078|FG001|Overall Study|Decision by Sponsor|4|||
105675832|NCT00727311|364475712|FG000|Overall Study|Withdrawal by Subject|77|||
105675833|NCT00727311|364475712|FG000|Overall Study|Other|97|||
105675834|NCT00727311|364475712|FG000|Overall Study|Multiple reasons|39|||
105675835|NCT02314780|364477105|FG000|Overall Study|organizational reasons|0|||
105675836|NCT02314780|364477106|FG001|Overall Study|organizational reasons|2|||
105675837|NCT02314780|364477107|FG002|Overall Study|organizational reasons|0|||
105675838|NCT02314780|364477105|FG000|Overall Study|Adverse Event|0|||
105675839|NCT02314780|364477106|FG001|Overall Study|Adverse Event|1|||
105675840|NCT02314780|364477107|FG002|Overall Study|Adverse Event|0|||
105675841|NCT03333876|364477108|FG000|Screening Period|Screen Failure|4|||
105675842|NCT03333876|364477108|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
105675843|NCT03333876|364477108|FG000|Mandibular Advancement|Adverse Event|2|||
105675844|NCT03333876|364477108|FG000|Mandibular Advancement|Product Damage|2|||
105675845|NCT00640133|364477109|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
105675846|NCT00640133|364477110|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
105675847|NCT00640133|364477109|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
105675848|NCT00640133|364477110|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
105675849|NCT00640133|364477109|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
105675850|NCT00640133|364477110|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
105675851|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
105675852|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
105675853|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
105675854|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
105675855|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
105675856|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
105675857|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
105675858|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675859|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675860|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675861|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675862|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
105675863|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Death|1|||
105675864|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Death|2|||
105675865|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Death|2|||
105675866|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Death|0|||
105675867|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Death|0|||
105675868|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Death|0|||
105675869|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
105675870|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
105675871|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
105675872|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
105675873|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
105675874|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
105675875|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
105675876|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675877|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675878|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675879|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675880|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
105675881|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
105675882|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675883|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675884|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675885|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675886|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
105675887|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
105675888|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675889|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675890|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675891|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675892|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
105675893|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675894|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
105675895|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675896|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675897|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675898|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
105675899|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675900|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675901|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
105675902|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675903|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675904|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
105675905|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675906|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675907|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
105675908|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675909|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105675910|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
105912624|NCT04058028|365337079|FG002|Overall Study|Decision by Sponsor|1|||
105912625|NCT04058028|365337080|FG003|Overall Study|Decision by Sponsor|35|||
105912626|NCT04058028|365337077|FG000|Overall Study|Lost to Follow-up|1|||
105912627|NCT04058028|365337078|FG001|Overall Study|Lost to Follow-up|1|||
105912628|NCT04058028|365337079|FG002|Overall Study|Lost to Follow-up|1|||
105912629|NCT04058028|365337080|FG003|Overall Study|Lost to Follow-up|0|||
105912630|NCT04058028|365337077|FG000|Overall Study|Death|0|||
105912631|NCT04058028|365337078|FG001|Overall Study|Death|1|||
105912632|NCT04058028|365337079|FG002|Overall Study|Death|0|||
105912633|NCT04058028|365337080|FG003|Overall Study|Death|0|||
105912634|NCT01598610|365337081|FG000|Overall Study|Adverse Event|1|||
105912635|NCT02039778|365337086|FG000|Overall Study|Death|2|||
105912636|NCT02039778|365337086|FG000|Overall Study|Withdrawal by Subject|1|||
105675911|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Site closure|0|||
105675912|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Site closure|0|||
105675913|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Site closure|1|||
105675914|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Site closure|0|||
105675915|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Site closure|0|||
105675916|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Site closure|0|||
105675917|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
105675918|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
105675919|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
105675920|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
105675921|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
105675922|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
105675923|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
105675924|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675925|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675926|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675927|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
105675928|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
105912637|NCT02039778|365337086|FG000|Overall Study|Never started the protocol treatment|1|||
105912638|NCT04622969|365337087|FG000|Overall Study|Withdrawal by Subject|2|||
105912639|NCT04622969|365337088|FG001|Overall Study|Withdrawal by Subject|3|||
105912640|NCT04391842|365337089|FG000|Overall Study|Withdrawal by Subject|2|||
105912641|NCT00810199|365337097|FG000|Overall Study|Adverse Event|24|||
105912642|NCT00810199|365337098|FG001|Overall Study|Adverse Event|26|||
105912643|NCT00810199|365337097|FG000|Overall Study|Death|4|||
105912644|NCT00810199|365337098|FG001|Overall Study|Death|6|||
105912645|NCT00810199|365337097|FG000|Overall Study|Withdrew consent|9|||
105912646|NCT00810199|365337098|FG001|Overall Study|Withdrew consent|12|||
105912647|NCT00810199|365337097|FG000|Overall Study|Insufficient therapeutic response|5|||
105912648|NCT00810199|365337098|FG001|Overall Study|Insufficient therapeutic response|14|||
105912649|NCT00810199|365337097|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
105912650|NCT00810199|365337098|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
105912651|NCT00810199|365337097|FG000|Overall Study|Administrative/Other|5|||
105912652|NCT00810199|365337098|FG001|Overall Study|Administrative/Other|6|||
105912653|NCT00810199|365337097|FG000|Overall Study|Protocol Violation|2|||
105912654|NCT00810199|365337098|FG001|Overall Study|Protocol Violation|6|||
105912655|NCT00810199|365337097|FG000|Overall Study|Failure to return|1|||
105912656|NCT00810199|365337098|FG001|Overall Study|Failure to return|4|||
105912657|NCT00810199|365337097|FG000|Overall Study|Did not receive study drug|2|||
105912658|NCT00810199|365337098|FG001|Overall Study|Did not receive study drug|1|||
105912659|NCT02864407|365337106|FG000|Overall Study|Protocol Violation|3|||
105912660|NCT02864407|365337106|FG000|Overall Study|Lost to Follow-up|115|||
105912661|NCT02864407|365337106|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
105912662|NCT02864407|365337106|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
105912663|NCT02864407|365337106|FG000|Overall Study|Consent prior to the contract date|1|||
105912664|NCT01691378|365337108|FG000|Overall Study|Withdrawal by Subject|2|||
105912665|NCT01691378|365337109|FG001|Overall Study|Withdrawal by Subject|0|||
105912666|NCT01691378|365337108|FG000|Overall Study|Lost to Follow-up|5|||
105912667|NCT01691378|365337109|FG001|Overall Study|Lost to Follow-up|2|||
105675929|NCT03439254|364477111|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
105675930|NCT03439254|364477112|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
105675931|NCT03439254|364477113|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
105999839|NCT02748863|365661213|FG002|Treatment Period 2|Pregnancy|0|||
105999840|NCT02748863|365661214|FG003|Treatment Period 2|Pregnancy|0|||
105999841|NCT02748863|365661215|FG004|Treatment Period 2|Pregnancy|1|||
105999842|NCT02653326|365661216|FG000|Overall Study|Lost to Follow-up|10|||
105999843|NCT02653326|365661217|FG001|Overall Study|Lost to Follow-up|7|||
105999844|NCT00300755|365661219|FG000|Overall Study|Adverse Event|1|||
105999845|NCT00300755|365661220|FG001|Overall Study|Adverse Event|2|||
105999846|NCT00300755|365661221|FG002|Overall Study|Adverse Event|1|||
105999847|NCT00300755|365661219|FG000|Overall Study|Withdrawal by Subject|0|||
105999848|NCT00300755|365661220|FG001|Overall Study|Withdrawal by Subject|2|||
105999849|NCT00300755|365661221|FG002|Overall Study|Withdrawal by Subject|0|||
105999850|NCT00300755|365661219|FG000|Overall Study|Protocol Violation|0|||
105999851|NCT00300755|365661220|FG001|Overall Study|Protocol Violation|0|||
105999852|NCT00300755|365661221|FG002|Overall Study|Protocol Violation|1|||
105999853|NCT00985465|365661224|FG000|Overall Study|Withdrawal by Subject|1|||
105999854|NCT00985465|365661225|FG001|Overall Study|Withdrawal by Subject|2|||
105999855|NCT00985465|365661224|FG000|Overall Study|Considered to be part of the other group|0|||
105999856|NCT00985465|365661225|FG001|Overall Study|Considered to be part of the other group|1|||
105999857|NCT01695135|365661226|FG000|Double-blind Treatment Phase|Progressive disease|50|||
105999858|NCT01695135|365661227|FG001|Double-blind Treatment Phase|Progressive disease|110|||
105999859|NCT01695135|365661228|FG002|Double-blind Treatment Phase|Progressive disease|0|||
105999860|NCT01695135|365661229|FG003|Double-blind Treatment Phase|Progressive disease|0|||
105999861|NCT01695135|365661226|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
105999862|NCT01695135|365661227|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
105675932|NCT03439254|364477114|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
105675933|NCT03439254|364477115|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
105675934|NCT03439254|364477116|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
105675935|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
105675936|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
105675937|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
105675938|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
105675939|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
105675940|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
105675941|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
105675942|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
105675943|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
105675944|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
105675945|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
105675946|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
105675947|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675948|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675949|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675950|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675951|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
105675952|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
105675953|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675954|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675955|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675956|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675957|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
105675958|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
105675959|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675960|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675961|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675962|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675963|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
105675964|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
105675965|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675966|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675967|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675968|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675969|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
105675970|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
105675971|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675972|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675973|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675974|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
105675975|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675976|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
105675977|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
105675978|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
105675979|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
105675980|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
105675981|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
105675982|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
105675983|NCT03439254|364477111|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
105675984|NCT03439254|364477112|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
105675985|NCT03439254|364477113|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
105675986|NCT03439254|364477114|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
105675987|NCT03439254|364477115|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
105675988|NCT03439254|364477116|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
105675989|NCT00128102|364477117|FG000|Overall Study|Site Discontinued|3|||
105675990|NCT00128102|364477118|FG001|Overall Study|Site Discontinued|6|||
105675991|NCT00128102|364477117|FG000|Overall Study|Other|0|||
105675992|NCT00128102|364477118|FG001|Overall Study|Other|1|||
105675993|NCT00128102|364477117|FG000|Overall Study|Progressive Disease|255|||
105912668|NCT02849080|365337112|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
105912669|NCT02849080|365337113|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
105912670|NCT02849080|365337114|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
105952064|NCT03314935|365488190|FG006|Phase 1|Withdrawal by Subject|1|||
105675994|NCT00128102|364477118|FG001|Overall Study|Progressive Disease|285|||
105675995|NCT00128102|364477117|FG000|Overall Study|Adverse Event|34|||
105675996|NCT00128102|364477118|FG001|Overall Study|Adverse Event|11|||
105675997|NCT00128102|364477117|FG000|Overall Study|Death|12|||
105675998|NCT00128102|364477118|FG001|Overall Study|Death|13|||
105675999|NCT00128102|364477117|FG000|Overall Study|Physician Decision|3|||
105676000|NCT00128102|364477118|FG001|Overall Study|Physician Decision|3|||
105676001|NCT00128102|364477117|FG000|Overall Study|Withdrawal by Subject|19|||
105676002|NCT00128102|364477118|FG001|Overall Study|Withdrawal by Subject|11|||
105676003|NCT00128102|364477117|FG000|Overall Study|Protocol Violation|2|||
105676004|NCT00128102|364477118|FG001|Overall Study|Protocol Violation|2|||
105676005|NCT03339245|364477119|FG000|Overall Study|Adverse Event|1|||
105676006|NCT03339245|364477120|FG001|Overall Study|Adverse Event|1|||
105676007|NCT03339245|364477119|FG000|Overall Study|Withdrawal by Subject|1|||
105676008|NCT03339245|364477120|FG001|Overall Study|Withdrawal by Subject|0|||
105676009|NCT01342341|364477121|FG000|Overall Study|Lost to Follow-up|4|||
105676010|NCT01342341|364477122|FG001|Overall Study|Lost to Follow-up|4|||
105676011|NCT02075476|364477123|FG000|Overall Study|Death|2|||
105676012|NCT02075476|364477124|FG001|Overall Study|Death|2|||
105676013|NCT02075476|364477123|FG000|Overall Study|Lost to Follow-up|1|||
105676014|NCT02075476|364477124|FG001|Overall Study|Lost to Follow-up|3|||
105676015|NCT00837694|364477125|FG000|Overall Study|Lost to Follow-up|2|||
105676016|NCT00837694|364477126|FG001|Overall Study|Lost to Follow-up|0|||
105676017|NCT00837694|364477127|FG002|Overall Study|Lost to Follow-up|2|||
105676018|NCT00837694|364477128|FG003|Overall Study|Lost to Follow-up|1|||
105676019|NCT00837694|364477129|FG004|Overall Study|Lost to Follow-up|1|||
105676020|NCT00837694|364477130|FG005|Overall Study|Lost to Follow-up|1|||
105676021|NCT00306670|364477142|FG000|Overall Study|patients recruited; Genentech, the st|0|||
105676022|NCT00306670|364477143|FG001|Overall Study|patients recruited; Genentech, the st|2|||
105676023|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
105676024|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
105676025|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
105676026|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
105676027|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
105676028|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
105676029|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
105676030|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
105676031|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
105676032|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
105676033|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676034|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676035|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
105676036|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
105676037|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
105676038|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
105676039|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
105676040|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
105676041|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
105676042|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
105676043|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
105676044|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
105676045|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
105676046|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
105676047|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
105676048|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676049|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
105676050|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676051|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676052|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676053|NCT00833833|364477149|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
105676054|NCT00833833|364477150|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
105676055|NCT00833833|364477151|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
105676056|NCT00833833|364477152|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
105676057|NCT00833833|364477153|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
105676058|NCT00833833|364477154|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
105676059|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
105676060|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
105676061|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
105952065|NCT03314935|365488191|FG007|Phase 1|Withdrawal by Subject|0|||
105952066|NCT03314935|365488192|FG008|Phase 1|Withdrawal by Subject|1|||
105952067|NCT03314935|365488193|FG009|Phase 1|Withdrawal by Subject|0|||
105952068|NCT03314935|365488194|FG010|Phase 1|Withdrawal by Subject|0|||
105952069|NCT03314935|365488195|FG011|Phase 1|Withdrawal by Subject|0|||
105676062|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
105676063|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
105676064|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
105676065|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
105676066|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
105676067|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
105676068|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
105676069|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
105676070|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
105676071|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
105676072|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
105676073|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
105676074|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
105676075|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
105676076|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
105676077|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676078|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676079|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676080|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
105676081|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
105676082|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
105676083|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676084|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676085|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676086|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
105676087|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
105676088|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
105676089|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
105676090|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
105676091|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
105676092|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
105676093|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
105676094|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
105676095|NCT00833833|364477149|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676096|NCT00833833|364477150|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676097|NCT00833833|364477151|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676098|NCT00833833|364477152|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676099|NCT00833833|364477153|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
105676100|NCT00833833|364477154|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
105676101|NCT01994837|364477155|FG000|Overall Study|Progressive disease per protocol|23|||
105676102|NCT01994837|364477155|FG000|Overall Study|Adv event related to progressive disease|3|||
105676103|NCT01994837|364477155|FG000|Overall Study|Fatal progressive disease|2|||
105676104|NCT01994837|364477155|FG000|Overall Study|Adverse event not related to progression|1|||
105676105|NCT01994837|364477155|FG000|Overall Study|Chose palliative care|1|||
105676106|NCT01994837|364477155|FG000|Overall Study|Proceeded to transplant|1|||
105676107|NCT01994837|364477155|FG000|Overall Study|Removed from study due to no response|1|||
105676108|NCT01302067|364477156|FG000|Overall Study|Death|0|||
105676109|NCT01302067|364477157|FG001|Overall Study|Death|0|||
105676110|NCT01302067|364477158|FG002|Overall Study|Death|1|||
105676111|NCT01302067|364477156|FG000|Overall Study|Physician Decision|9|||
105676112|NCT01302067|364477157|FG001|Overall Study|Physician Decision|5|||
105676113|NCT01302067|364477158|FG002|Overall Study|Physician Decision|14|||
105676114|NCT01302067|364477156|FG000|Overall Study|Lack of Efficacy|8|||
105676115|NCT01302067|364477157|FG001|Overall Study|Lack of Efficacy|4|||
105676116|NCT01302067|364477158|FG002|Overall Study|Lack of Efficacy|2|||
105676117|NCT01302067|364477156|FG000|Overall Study|Lost to Follow-up|9|||
105676118|NCT01302067|364477157|FG001|Overall Study|Lost to Follow-up|4|||
105676119|NCT01302067|364477158|FG002|Overall Study|Lost to Follow-up|15|||
105676120|NCT01302067|364477156|FG000|Overall Study|Withdrawal by Subject|13|||
105676121|NCT01302067|364477157|FG001|Overall Study|Withdrawal by Subject|6|||
105676122|NCT01302067|364477158|FG002|Overall Study|Withdrawal by Subject|10|||
105676123|NCT01302067|364477156|FG000|Overall Study|Other|1|||
105912671|NCT02849080|365337115|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
105676124|NCT01302067|364477157|FG001|Overall Study|Other|1|||
105676125|NCT01302067|364477158|FG002|Overall Study|Other|3|||
105676126|NCT01302067|364477156|FG000|Overall Study|Protocol Violation|11|||
105676127|NCT01302067|364477157|FG001|Overall Study|Protocol Violation|0|||
105676128|NCT01302067|364477158|FG002|Overall Study|Protocol Violation|8|||
105676129|NCT01302067|364477156|FG000|Overall Study|Adverse Event|27|||
105676130|NCT01302067|364477157|FG001|Overall Study|Adverse Event|14|||
105676131|NCT01302067|364477158|FG002|Overall Study|Adverse Event|45|||
105676132|NCT02738203|364477160|FG000|Overall Study|Failed IUD Insertion|2|||
105676133|NCT02738203|364477161|FG001|Overall Study|Failed IUD Insertion|2|||
105999863|NCT01695135|365661228|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105999864|NCT01695135|365661229|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105999865|NCT01695135|365661226|FG000|Double-blind Treatment Phase|Adverse Event|7|||
105999866|NCT01695135|365661227|FG001|Double-blind Treatment Phase|Adverse Event|7|||
105999867|NCT01695135|365661228|FG002|Double-blind Treatment Phase|Adverse Event|0|||
105999868|NCT01695135|365661229|FG003|Double-blind Treatment Phase|Adverse Event|0|||
105999869|NCT01695135|365661226|FG000|Double-blind Treatment Phase|Other|1|||
105999870|NCT01695135|365661227|FG001|Double-blind Treatment Phase|Other|3|||
105999871|NCT01695135|365661228|FG002|Double-blind Treatment Phase|Other|0|||
105999872|NCT01695135|365661229|FG003|Double-blind Treatment Phase|Other|0|||
105999873|NCT01695135|365661226|FG000|Double-blind Treatment Phase|Physician Decision|6|||
105999874|NCT01695135|365661227|FG001|Double-blind Treatment Phase|Physician Decision|3|||
105999875|NCT01695135|365661228|FG002|Double-blind Treatment Phase|Physician Decision|0|||
105999876|NCT01695135|365661229|FG003|Double-blind Treatment Phase|Physician Decision|0|||
105676134|NCT02738203|364477160|FG000|Overall Study|Protocol Violation|0|||
105676135|NCT02738203|364477161|FG001|Overall Study|Protocol Violation|1|||
105676136|NCT03241927|364477162|FG000|Overall Study|study terminated|1|||
105676137|NCT03241927|364477163|FG001|Overall Study|study terminated|0|||
105999877|NCT01695135|365661226|FG000|Double-blind Treatment Phase|Death|1|||
105999878|NCT01695135|365661227|FG001|Double-blind Treatment Phase|Death|1|||
105676138|NCT01198756|364477164|FG000|Overall Study|Adverse Event|0|||
105676139|NCT01198756|364477165|FG001|Overall Study|Adverse Event|0|||
105676140|NCT01198756|364477166|FG002|Overall Study|Adverse Event|0|||
105676141|NCT01198756|364477167|FG003|Overall Study|Adverse Event|1|||
105676142|NCT01198756|364477164|FG000|Overall Study|Protocol Violation|0|||
105676143|NCT01198756|364477165|FG001|Overall Study|Protocol Violation|0|||
105676144|NCT01198756|364477166|FG002|Overall Study|Protocol Violation|0|||
105676145|NCT01198756|364477167|FG003|Overall Study|Protocol Violation|2|||
105676146|NCT01198756|364477164|FG000|Overall Study|Withdrawal by Subject|9|||
105676147|NCT01198756|364477165|FG001|Overall Study|Withdrawal by Subject|4|||
105676148|NCT01198756|364477166|FG002|Overall Study|Withdrawal by Subject|7|||
105676149|NCT01198756|364477167|FG003|Overall Study|Withdrawal by Subject|5|||
105676150|NCT01198756|364477164|FG000|Overall Study|Lost to Follow-up|29|||
105676151|NCT01198756|364477165|FG001|Overall Study|Lost to Follow-up|36|||
105676152|NCT01198756|364477166|FG002|Overall Study|Lost to Follow-up|23|||
105676153|NCT01198756|364477167|FG003|Overall Study|Lost to Follow-up|18|||
105676154|NCT01127893|364477168|FG000|Overall Study|Study Termination by the Sponsor|1|||
105676155|NCT02704754|364477169|FG000|Overall Study|Lost to Follow-up|1|||
105999879|NCT01695135|365661228|FG002|Double-blind Treatment Phase|Death|0|||
105999880|NCT01695135|365661229|FG003|Double-blind Treatment Phase|Death|0|||
105999881|NCT01695135|365661226|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
105999882|NCT01695135|365661227|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
105999883|NCT01695135|365661228|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
105999884|NCT01695135|365661229|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
105999885|NCT01695135|365661226|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
105999886|NCT01695135|365661227|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
105676156|NCT02704754|364477170|FG001|Overall Study|Lost to Follow-up|1|||
105676157|NCT02704754|364477169|FG000|Overall Study|Lack of Efficacy|1|||
105676158|NCT02704754|364477170|FG001|Overall Study|Lack of Efficacy|0|||
105676159|NCT02704754|364477169|FG000|Overall Study|Withdrawal by Subject|1|||
105676160|NCT02704754|364477170|FG001|Overall Study|Withdrawal by Subject|0|||
105676161|NCT00423943|364477171|FG000|Overall Study|Withdrawal by Subject|3|||
105676162|NCT00423943|364477172|FG001|Overall Study|Withdrawal by Subject|1|||
105676163|NCT05816330|364477176|FG000|Overall Study|Withdrawal by Subject|4|||
105999887|NCT01695135|365661228|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
105676164|NCT05816330|364477177|FG001|Overall Study|Withdrawal by Subject|1|||
105676165|NCT03245151|364477178|FG000|Overall Study|Withdrawal by Subject|2|||
105676166|NCT03245151|364477179|FG001|Overall Study|Withdrawal by Subject|0|||
105676167|NCT03245151|364477180|FG002|Overall Study|Withdrawal by Subject|0|||
105999888|NCT01695135|365661229|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
105999889|NCT01695135|365661226|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
105999890|NCT01695135|365661227|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
105999891|NCT01695135|365661228|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
105999892|NCT01695135|365661229|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
105676168|NCT03245151|364477181|FG003|Overall Study|Withdrawal by Subject|2|||
105676169|NCT03245151|364477182|FG004|Overall Study|Withdrawal by Subject|1|||
105676170|NCT03245151|364477178|FG000|Overall Study|Death|3|||
105676171|NCT03245151|364477179|FG001|Overall Study|Death|14|||
105676172|NCT03245151|364477180|FG002|Overall Study|Death|9|||
105676173|NCT03245151|364477181|FG003|Overall Study|Death|16|||
105676174|NCT03245151|364477182|FG004|Overall Study|Death|7|||
105676175|NCT03245151|364477178|FG000|Overall Study|Sponsor's decision|0|||
105676176|NCT03245151|364477179|FG001|Overall Study|Sponsor's decision|1|||
105676177|NCT03245151|364477180|FG002|Overall Study|Sponsor's decision|0|||
105676178|NCT03245151|364477181|FG003|Overall Study|Sponsor's decision|0|||
105676179|NCT03245151|364477182|FG004|Overall Study|Sponsor's decision|0|||
105676180|NCT00621777|364477183|FG000|Open Phase|Adverse Event|20|||
105676181|NCT00621777|364477184|FG001|Open Phase|Adverse Event|0|||
105676182|NCT00621777|364477183|FG000|Open Phase|Did not abstain during open phase|56|||
105676183|NCT00621777|364477184|FG001|Open Phase|Did not abstain during open phase|0|||
105676184|NCT00621777|364477183|FG000|Open Phase|Withdrawal by Subject|17|||
105676185|NCT00621777|364477184|FG001|Open Phase|Withdrawal by Subject|0|||
105676186|NCT00621777|364477183|FG000|Open Phase|administrative|13|||
105676187|NCT00621777|364477184|FG001|Open Phase|administrative|0|||
105676188|NCT00621777|364477183|FG000|Open Phase|Lost to Follow-up|10|||
105676189|NCT00621777|364477184|FG001|Open Phase|Lost to Follow-up|0|||
105676190|NCT00621777|364477183|FG000|Randomized Phase|Adverse Event|3|||
105676191|NCT00621777|364477184|FG001|Randomized Phase|Adverse Event|3|||
105676192|NCT00621777|364477183|FG000|Randomized Phase|Lost to Follow-up|3|||
105676193|NCT00621777|364477184|FG001|Randomized Phase|Lost to Follow-up|3|||
105676194|NCT00621777|364477183|FG000|Randomized Phase|Withdrawal by Subject|1|||
105676195|NCT00621777|364477184|FG001|Randomized Phase|Withdrawal by Subject|9|||
105676196|NCT00621777|364477183|FG000|Randomized Phase|administrative|0|||
105676197|NCT00621777|364477184|FG001|Randomized Phase|administrative|3|||
105676198|NCT00621777|364477183|FG000|Randomized Phase|Death|0|||
105676199|NCT00621777|364477184|FG001|Randomized Phase|Death|1|||
105676200|NCT00996476|364477185|FG000|Overall Study|Withdrawal by Subject|1|||
105676201|NCT00996476|364477186|FG001|Overall Study|Withdrawal by Subject|2|||
105676202|NCT00996476|364477187|FG002|Overall Study|Withdrawal by Subject|1|||
105676203|NCT00996476|364477188|FG003|Overall Study|Withdrawal by Subject|0|||
105676204|NCT00996476|364477189|FG004|Overall Study|Withdrawal by Subject|1|||
105676205|NCT00996476|364477185|FG000|Overall Study|Adverse Event|0|||
105676206|NCT00996476|364477186|FG001|Overall Study|Adverse Event|1|||
105676207|NCT00996476|364477187|FG002|Overall Study|Adverse Event|0|||
105676208|NCT00996476|364477188|FG003|Overall Study|Adverse Event|0|||
105676209|NCT00996476|364477189|FG004|Overall Study|Adverse Event|1|||
105676210|NCT01517295|364477195|FG000|Overall Study|Physician Decision|1|||
105676211|NCT01517295|364477196|FG001|Overall Study|Physician Decision|0|||
105676212|NCT00307684|364477197|FG000|Open Label Phase|Lack of Efficacy|0|||
105676213|NCT00307684|364477198|FG001|Open Label Phase|Lack of Efficacy|0|||
105676214|NCT00307684|364477199|FG002|Open Label Phase|Lack of Efficacy|3|||
105676215|NCT00307684|364477197|FG000|Open Label Phase|Adverse Event|0|||
105676216|NCT00307684|364477198|FG001|Open Label Phase|Adverse Event|0|||
105676217|NCT00307684|364477199|FG002|Open Label Phase|Adverse Event|16|||
105676218|NCT00307684|364477197|FG000|Open Label Phase|Withdrawal by Subject|0|||
105676219|NCT00307684|364477198|FG001|Open Label Phase|Withdrawal by Subject|0|||
105676220|NCT00307684|364477199|FG002|Open Label Phase|Withdrawal by Subject|15|||
105676221|NCT00307684|364477197|FG000|Open Label Phase|Lost to Follow-up|0|||
105676222|NCT00307684|364477198|FG001|Open Label Phase|Lost to Follow-up|0|||
105676223|NCT00307684|364477199|FG002|Open Label Phase|Lost to Follow-up|11|||
105676224|NCT00307684|364477197|FG000|Open Label Phase|non compliance|0|||
105676225|NCT00307684|364477198|FG001|Open Label Phase|non compliance|0|||
105676226|NCT00307684|364477199|FG002|Open Label Phase|non compliance|5|||
105676227|NCT00307684|364477197|FG000|Open Label Phase|other|0|||
105676228|NCT00307684|364477198|FG001|Open Label Phase|other|0|||
105676229|NCT00307684|364477199|FG002|Open Label Phase|other|6|||
105676230|NCT00307684|364477197|FG000|Double Blind Phase|Lack of Efficacy|2|||
105676231|NCT00307684|364477198|FG001|Double Blind Phase|Lack of Efficacy|5|||
105676232|NCT00307684|364477199|FG002|Double Blind Phase|Lack of Efficacy|0|||
105676233|NCT02580305|364477200|FG000|Overall Study|Adverse Event|15|||
105786419|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Physician Decision|1|||
105786420|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Physician Decision|0|||
105912672|NCT02849080|365337112|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
105912673|NCT02849080|365337113|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
105912674|NCT02849080|365337114|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
105676234|NCT02580305|364477201|FG001|Overall Study|Adverse Event|19|||
105676235|NCT02580305|364477202|FG002|Overall Study|Adverse Event|10|||
105676236|NCT02580305|364477200|FG000|Overall Study|Lack of Efficacy|5|||
105676237|NCT02580305|364477201|FG001|Overall Study|Lack of Efficacy|0|||
105676238|NCT02580305|364477202|FG002|Overall Study|Lack of Efficacy|2|||
105676239|NCT02580305|364477200|FG000|Overall Study|Protocol Violation|4|||
105676240|NCT02580305|364477201|FG001|Overall Study|Protocol Violation|9|||
105676241|NCT02580305|364477202|FG002|Overall Study|Protocol Violation|6|||
105676242|NCT02580305|364477200|FG000|Overall Study|Lost to Follow-up|4|||
105676243|NCT02580305|364477201|FG001|Overall Study|Lost to Follow-up|4|||
105676244|NCT02580305|364477202|FG002|Overall Study|Lost to Follow-up|2|||
105676245|NCT02580305|364477200|FG000|Overall Study|Withdrawal by Subject|11|||
105676246|NCT02580305|364477201|FG001|Overall Study|Withdrawal by Subject|9|||
105786421|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Physician Decision|0|||
105786422|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Progressive disease|1|||
105676247|NCT02580305|364477202|FG002|Overall Study|Withdrawal by Subject|7|||
105786423|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Progressive disease|0|||
105912675|NCT02849080|365337115|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
105912676|NCT02849080|365337112|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
105912677|NCT02849080|365337113|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
105912678|NCT02849080|365337114|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
105912679|NCT02849080|365337115|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
105912680|NCT02849080|365337112|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
105912681|NCT02849080|365337113|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
105912682|NCT02849080|365337114|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
105912683|NCT02849080|365337115|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
105912684|NCT02849080|365337112|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
105912685|NCT02849080|365337113|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
105912686|NCT02849080|365337114|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
105912687|NCT02849080|365337115|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
105912688|NCT02849080|365337112|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
105912689|NCT02849080|365337113|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
105912690|NCT02849080|365337114|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
105912691|NCT02849080|365337115|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
105912692|NCT01819727|365337116|FG000|Overall Study|Adverse Event|8|||
105912693|NCT01819727|365337117|FG001|Overall Study|Adverse Event|9|||
105912694|NCT01819727|365337116|FG000|Overall Study|Death|1|||
105912695|NCT01819727|365337117|FG001|Overall Study|Death|0|||
105912696|NCT01819727|365337116|FG000|Overall Study|Lost to Follow-up|1|||
105912697|NCT01819727|365337117|FG001|Overall Study|Lost to Follow-up|1|||
105912698|NCT01819727|365337116|FG000|Overall Study|Physician Decision|3|||
105912699|NCT01819727|365337117|FG001|Overall Study|Physician Decision|2|||
105912700|NCT01819727|365337116|FG000|Overall Study|Pregnancy|1|||
105912701|NCT01819727|365337117|FG001|Overall Study|Pregnancy|0|||
105912702|NCT01819727|365337116|FG000|Overall Study|Protocol Violation|0|||
105912703|NCT01819727|365337117|FG001|Overall Study|Protocol Violation|2|||
105912704|NCT01819727|365337116|FG000|Overall Study|Study Terminated by Sponsor|0|||
105912705|NCT01819727|365337117|FG001|Overall Study|Study Terminated by Sponsor|1|||
105912706|NCT01819727|365337116|FG000|Overall Study|Withdrawal by Subject|6|||
105912707|NCT01819727|365337117|FG001|Overall Study|Withdrawal by Subject|11|||
105912708|NCT01819727|365337116|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
105912709|NCT01819727|365337117|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
105912710|NCT01819727|365337116|FG000|Overall Study|Quit due to lack of health benifits|0|||
105912711|NCT01819727|365337117|FG001|Overall Study|Quit due to lack of health benifits|1|||
105912712|NCT00181883|365337121|FG000|Overall Study|Lack of Efficacy|2|||
105912713|NCT00181883|365337121|FG000|Overall Study|Treatment Limiting AEs|3|||
105912714|NCT00181883|365337121|FG000|Overall Study|Withdrawal by Subject|4|||
105912715|NCT00181883|365337121|FG000|Overall Study|Lost to Follow-up|1|||
105912716|NCT01367249|365337123|FG000|Overall Study|Withdrawal by Subject|6|||
105912717|NCT01367249|365337124|FG001|Overall Study|Withdrawal by Subject|6|||
105912718|NCT01367249|365337123|FG000|Overall Study|Other|3|||
105912719|NCT01367249|365337124|FG001|Overall Study|Other|10|||
105912720|NCT01519817|365338853|FG000|Overall Study|Withdrawal by Subject|1|||
105912721|NCT01519817|365338854|FG001|Overall Study|Withdrawal by Subject|0|||
105912722|NCT01519817|365338855|FG002|Overall Study|Withdrawal by Subject|0|||
105912723|NCT01519817|365338856|FG003|Overall Study|Withdrawal by Subject|0|||
105912724|NCT01519817|365338853|FG000|Overall Study|Off study due to infection|0|||
105912725|NCT01519817|365338854|FG001|Overall Study|Off study due to infection|0|||
105912726|NCT01519817|365338855|FG002|Overall Study|Off study due to infection|0|||
105912727|NCT01519817|365338856|FG003|Overall Study|Off study due to infection|1|||
105912728|NCT02922153|365338857|FG000|Overall Study|Death|8|||
105912729|NCT02922153|365338858|FG001|Overall Study|Death|1|||
105912730|NCT02922153|365338857|FG000|Overall Study|Lost to Follow-up|1|||
105912731|NCT02922153|365338858|FG001|Overall Study|Lost to Follow-up|0|||
105912732|NCT02922153|365338857|FG000|Overall Study|Physician Decision|1|||
105912733|NCT02922153|365338858|FG001|Overall Study|Physician Decision|1|||
105912734|NCT04085601|365338861|FG000|Overall Study|Lost to Follow-up|1|||
105676248|NCT02580305|364477200|FG000|Overall Study|Randomized in error and never treated|4|||
105676249|NCT02580305|364477201|FG001|Overall Study|Randomized in error and never treated|8|||
105676250|NCT02580305|364477202|FG002|Overall Study|Randomized in error and never treated|5|||
105676251|NCT04075994|364477207|FG000|Overall Study|Withdrawal by Subject|8|||
105676252|NCT04075994|364477208|FG001|Overall Study|Withdrawal by Subject|9|||
105676253|NCT04075994|364477207|FG000|Overall Study|Adverse Event|2|||
105676254|NCT04075994|364477208|FG001|Overall Study|Adverse Event|2|||
105676255|NCT04075994|364477207|FG000|Overall Study|Investigator withdrew|3|||
105676256|NCT04075994|364477208|FG001|Overall Study|Investigator withdrew|1|||
105676257|NCT00929110|364477209|FG000|Overall Study|Adverse Event|40|||
105676258|NCT00929110|364477210|FG001|Overall Study|Adverse Event|29|||
105676259|NCT00929110|364477211|FG002|Overall Study|Adverse Event|18|||
105676260|NCT00929110|364477209|FG000|Overall Study|Subject withdrew consent|40|||
105676261|NCT00929110|364477210|FG001|Overall Study|Subject withdrew consent|23|||
105676262|NCT00929110|364477211|FG002|Overall Study|Subject withdrew consent|26|||
105676263|NCT00929110|364477209|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
105676264|NCT00929110|364477210|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
105676265|NCT00929110|364477211|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
105676266|NCT00929110|364477209|FG000|Overall Study|Lost to Follow-up|7|||
105676267|NCT00929110|364477210|FG001|Overall Study|Lost to Follow-up|7|||
105676268|NCT00929110|364477211|FG002|Overall Study|Lost to Follow-up|3|||
105676269|NCT00929110|364477209|FG000|Overall Study|Protocol deviation|5|||
105676270|NCT00929110|364477210|FG001|Overall Study|Protocol deviation|2|||
105676271|NCT00929110|364477211|FG002|Overall Study|Protocol deviation|4|||
105676272|NCT00929110|364477209|FG000|Overall Study|Administrative problems|4|||
105676273|NCT00929110|364477210|FG001|Overall Study|Administrative problems|1|||
105676274|NCT00929110|364477211|FG002|Overall Study|Administrative problems|2|||
105676275|NCT00929110|364477209|FG000|Overall Study|Death|2|||
105676276|NCT00929110|364477210|FG001|Overall Study|Death|2|||
105676277|NCT00929110|364477211|FG002|Overall Study|Death|2|||
105676278|NCT00929110|364477209|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105676279|NCT00929110|364477210|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105676280|NCT00929110|364477211|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105676281|NCT00929110|364477209|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105676282|NCT00929110|364477210|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105676283|NCT00929110|364477211|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105676284|NCT00929110|364477209|FG000|Overall Study|Patient inability to use the device|0|||
105676285|NCT00929110|364477210|FG001|Overall Study|Patient inability to use the device|1|||
105676286|NCT00929110|364477211|FG002|Overall Study|Patient inability to use the device|0|||
105676287|NCT00992225|364477212|FG000|Overall Study|Entry Criteria Not Met|8|||
105676288|NCT00992225|364477212|FG000|Overall Study|Adverse Event|2|||
105676289|NCT03122223|364477213|FG000|Overall Study|Withdrawal by Subject|2|||
105676290|NCT03122223|364477214|FG001|Overall Study|Withdrawal by Subject|2|||
105676291|NCT03122223|364477215|FG002|Overall Study|Withdrawal by Subject|1|||
105676292|NCT03122223|364477216|FG003|Overall Study|Withdrawal by Subject|0|||
105676293|NCT03122223|364477213|FG000|Overall Study|Lost to Follow-up|0|||
105676294|NCT03122223|364477214|FG001|Overall Study|Lost to Follow-up|2|||
105676295|NCT03122223|364477215|FG002|Overall Study|Lost to Follow-up|2|||
105676296|NCT03122223|364477216|FG003|Overall Study|Lost to Follow-up|0|||
105676297|NCT03122223|364477213|FG000|Overall Study|Participant unable to adhere|1|||
105676298|NCT03122223|364477214|FG001|Overall Study|Participant unable to adhere|1|||
105676299|NCT03122223|364477215|FG002|Overall Study|Participant unable to adhere|1|||
105676300|NCT03122223|364477216|FG003|Overall Study|Participant unable to adhere|0|||
105676301|NCT02624791|364477220|FG000|Overall Study|Withdrawal by Subject|2|||
105676302|NCT02624791|364477221|FG001|Overall Study|Withdrawal by Subject|0|||
105676303|NCT02624791|364477222|FG002|Overall Study|Withdrawal by Subject|0|||
105676304|NCT02624791|364477223|FG003|Overall Study|Withdrawal by Subject|0|||
105676305|NCT02624791|364477224|FG004|Overall Study|Withdrawal by Subject|0|||
105676306|NCT02624791|364477225|FG005|Overall Study|Withdrawal by Subject|0|||
105676307|NCT00844532|364477228|FG000|Overall Study|Death|16|||
105676308|NCT00844532|364477228|FG000|Overall Study|Withdrawal by Subject|16|||
105912735|NCT04085601|365338862|FG001|Overall Study|Lost to Follow-up|0|||
105676309|NCT00844532|364477228|FG000|Overall Study|Lost to Follow-up|7|||
105676310|NCT02576587|364477229|FG000|Baseline|Equipment failure|0|||
105676311|NCT02576587|364477230|FG001|Baseline|Equipment failure|1|||
105676312|NCT02576587|364477229|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
105676313|NCT02576587|364477230|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
105676314|NCT02576587|364477229|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
105676315|NCT02576587|364477230|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
105912736|NCT04085601|365338861|FG000|Overall Study|Death|1|||
105676316|NCT02576587|364477229|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
105676317|NCT02576587|364477230|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
105676318|NCT00532493|364477231|FG000|Overall Study|Death|1|||
105912737|NCT04085601|365338862|FG001|Overall Study|Death|1|||
105912738|NCT01716806|365338865|FG000|Overall Study|Patient withdrawal of consent|4|||
105676319|NCT00532493|364477232|FG001|Overall Study|Death|1|||
105676320|NCT00532493|364477231|FG000|Overall Study|Lost to Follow-up|10|||
105676321|NCT00532493|364477232|FG001|Overall Study|Lost to Follow-up|7|||
105676322|NCT00532493|364477231|FG000|Overall Study|Withdrawal by Subject|7|||
105676323|NCT00532493|364477232|FG001|Overall Study|Withdrawal by Subject|9|||
105676324|NCT00532493|364477231|FG000|Overall Study|Physician Decision|1|||
105676325|NCT00532493|364477232|FG001|Overall Study|Physician Decision|6|||
105676326|NCT00532493|364477231|FG000|Overall Study|Adverse Event|6|||
105676327|NCT00532493|364477232|FG001|Overall Study|Adverse Event|5|||
105676328|NCT00532493|364477231|FG000|Overall Study|Protocol Deviation|1|||
105676329|NCT00532493|364477232|FG001|Overall Study|Protocol Deviation|0|||
105676330|NCT00532493|364477231|FG000|Overall Study|Subject Moved Away|3|||
105676331|NCT00532493|364477232|FG001|Overall Study|Subject Moved Away|1|||
105676332|NCT00532493|364477231|FG000|Overall Study|Contraindicative Medication|1|||
105676333|NCT00532493|364477232|FG001|Overall Study|Contraindicative Medication|0|||
105676334|NCT05917470|364477234|FG000|Overall Study|Progressive Disease|1|||
105676335|NCT05917470|364477235|FG001|Overall Study|Progressive Disease|1|||
105676336|NCT05917470|364477236|FG002|Overall Study|Progressive Disease|2|||
105676337|NCT05917470|364477237|FG003|Overall Study|Progressive Disease|3|||
105676338|NCT05917470|364477238|FG004|Overall Study|Progressive Disease|1|||
105676339|NCT05917470|364477239|FG005|Overall Study|Progressive Disease|1|||
105676340|NCT05917470|364477240|FG006|Overall Study|Progressive Disease|0|||
105676341|NCT05917470|364477241|FG007|Overall Study|Progressive Disease|0|||
105676342|NCT05917470|364477234|FG000|Overall Study|Withdrawal by Subject|0|||
105676343|NCT05917470|364477235|FG001|Overall Study|Withdrawal by Subject|0|||
105912739|NCT01716806|365338866|FG001|Overall Study|Patient withdrawal of consent|2|||
105912740|NCT01716806|365338867|FG002|Overall Study|Patient withdrawal of consent|4|||
105676344|NCT05917470|364477236|FG002|Overall Study|Withdrawal by Subject|1|||
105676345|NCT05917470|364477237|FG003|Overall Study|Withdrawal by Subject|0|||
105676346|NCT05917470|364477238|FG004|Overall Study|Withdrawal by Subject|0|||
105676347|NCT05917470|364477239|FG005|Overall Study|Withdrawal by Subject|0|||
105912741|NCT01716806|365338868|FG003|Overall Study|Patient withdrawal of consent|3|||
105912742|NCT01716806|365338869|FG004|Overall Study|Patient withdrawal of consent|2|||
105912743|NCT01716806|365338870|FG005|Overall Study|Patient withdrawal of consent|0|||
105912744|NCT01716806|365338865|FG000|Overall Study|Lost to Follow-up|3|||
105912745|NCT01716806|365338866|FG001|Overall Study|Lost to Follow-up|3|||
105912746|NCT01716806|365338867|FG002|Overall Study|Lost to Follow-up|0|||
105912747|NCT01716806|365338868|FG003|Overall Study|Lost to Follow-up|2|||
105912748|NCT01716806|365338869|FG004|Overall Study|Lost to Follow-up|1|||
105912749|NCT01716806|365338870|FG005|Overall Study|Lost to Follow-up|0|||
105912750|NCT01716806|365338865|FG000|Overall Study|Death|13|||
105912751|NCT01716806|365338866|FG001|Overall Study|Death|9|||
105912752|NCT01716806|365338867|FG002|Overall Study|Death|12|||
105912753|NCT01716806|365338868|FG003|Overall Study|Death|4|||
105912754|NCT01716806|365338869|FG004|Overall Study|Death|10|||
105912755|NCT01716806|365338870|FG005|Overall Study|Death|5|||
105912756|NCT01716806|365338865|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
105912757|NCT01716806|365338866|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
105912758|NCT01716806|365338867|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
105912759|NCT01716806|365338868|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
105912760|NCT01716806|365338869|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
105912761|NCT01716806|365338870|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
105912762|NCT01716806|365338865|FG000|Overall Study|PI decision|0|||
105912763|NCT01716806|365338866|FG001|Overall Study|PI decision|0|||
105912764|NCT01716806|365338867|FG002|Overall Study|PI decision|0|||
105912765|NCT01716806|365338868|FG003|Overall Study|PI decision|0|||
105912766|NCT01716806|365338869|FG004|Overall Study|PI decision|1|||
105912767|NCT01716806|365338870|FG005|Overall Study|PI decision|0|||
105912768|NCT01716806|365338865|FG000|Overall Study|Change in performance status|1|||
105912769|NCT01716806|365338866|FG001|Overall Study|Change in performance status|0|||
105912770|NCT01716806|365338867|FG002|Overall Study|Change in performance status|0|||
105912771|NCT01716806|365338868|FG003|Overall Study|Change in performance status|0|||
105912772|NCT01716806|365338869|FG004|Overall Study|Change in performance status|0|||
105912773|NCT01716806|365338870|FG005|Overall Study|Change in performance status|0|||
105912774|NCT01716806|365338865|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
105912775|NCT01716806|365338866|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
105912776|NCT01716806|365338867|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
105676348|NCT05917470|364477240|FG006|Overall Study|Withdrawal by Subject|0|||
105912777|NCT01716806|365338868|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
105676349|NCT05917470|364477241|FG007|Overall Study|Withdrawal by Subject|0|||
105676350|NCT05917470|364477234|FG000|Overall Study|Sponsor Decision|0|||
105676351|NCT05917470|364477235|FG001|Overall Study|Sponsor Decision|0|||
105676352|NCT05917470|364477236|FG002|Overall Study|Sponsor Decision|1|||
105912778|NCT01716806|365338869|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
105912779|NCT01716806|365338870|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
105912780|NCT01716806|365338865|FG000|Overall Study|Sponsor direction|7|||
105912781|NCT01716806|365338866|FG001|Overall Study|Sponsor direction|8|||
105912782|NCT01716806|365338867|FG002|Overall Study|Sponsor direction|5|||
105912783|NCT01716806|365338868|FG003|Overall Study|Sponsor direction|12|||
105912784|NCT01716806|365338869|FG004|Overall Study|Sponsor direction|16|||
105912785|NCT01716806|365338870|FG005|Overall Study|Sponsor direction|1|||
105912786|NCT02692586|365338871|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
105912787|NCT02692586|365338871|FG000|Overall Study|Received adjunctive thrombolytics|2|||
105912788|NCT03506438|365338873|FG000|Overall Study|Lost to Follow-up|8|||
105912789|NCT03506438|365338874|FG001|Overall Study|Lost to Follow-up|7|||
105912790|NCT03506438|365338875|FG002|Overall Study|Lost to Follow-up|8|||
105912791|NCT03506438|365338876|FG003|Overall Study|Lost to Follow-up|7|||
105912792|NCT03506438|365338877|FG004|Overall Study|Lost to Follow-up|0|||
105912793|NCT03506438|365338878|FG005|Overall Study|Lost to Follow-up|0|||
105912794|NCT05137717|365338879|FG000|Overall Study|Death|2|||
105912795|NCT05137717|365338879|FG000|Overall Study|Withdrawal by Subject|6|||
105912796|NCT00737100|365338885|FG000|Overall Study|Adverse Event|6|||
105912797|NCT00737100|365338886|FG001|Overall Study|Adverse Event|5|||
105912798|NCT00737100|365338887|FG002|Overall Study|Adverse Event|3|||
105912799|NCT00737100|365338885|FG000|Overall Study|Lost to Follow-up|0|||
105912800|NCT00737100|365338886|FG001|Overall Study|Lost to Follow-up|1|||
105912801|NCT00737100|365338887|FG002|Overall Study|Lost to Follow-up|0|||
105912802|NCT00737100|365338885|FG000|Overall Study|Withdrawal by Subject|0|||
105912803|NCT00737100|365338886|FG001|Overall Study|Withdrawal by Subject|0|||
105912804|NCT00737100|365338887|FG002|Overall Study|Withdrawal by Subject|3|||
105912805|NCT00737100|365338885|FG000|Overall Study|Reason discontinued not explained above|1|||
105912806|NCT00737100|365338886|FG001|Overall Study|Reason discontinued not explained above|1|||
105912807|NCT00737100|365338887|FG002|Overall Study|Reason discontinued not explained above|1|||
105912808|NCT01265394|365338888|FG000|Overall Study|Subjects withdrawn|37|||
105912809|NCT00115778|365338891|FG000|Overall Study|Withdrawal by Subject|0|||
105912810|NCT00115778|365338892|FG001|Overall Study|Withdrawal by Subject|1|||
105912811|NCT00268983|365338893|FG000|Overall Study|Death|3|||
105912812|NCT00268983|365338894|FG001|Overall Study|Death|0|||
105912813|NCT03713684|365338897|FG000|Overall Study|Adverse Event|1|||
105912814|NCT03713684|365338898|FG001|Overall Study|Adverse Event|3|||
105912815|NCT03713684|365338899|FG002|Overall Study|Adverse Event|1|||
105912816|NCT03713684|365338900|FG003|Overall Study|Adverse Event|0|||
105912817|NCT03713684|365338897|FG000|Overall Study|Poor compliance to protocol|2|||
105912818|NCT03713684|365338898|FG001|Overall Study|Poor compliance to protocol|1|||
105912819|NCT03713684|365338899|FG002|Overall Study|Poor compliance to protocol|0|||
105912820|NCT03713684|365338900|FG003|Overall Study|Poor compliance to protocol|1|||
105912821|NCT03713684|365338897|FG000|Overall Study|Withdrawal by Subject|14|||
105912822|NCT03713684|365338898|FG001|Overall Study|Withdrawal by Subject|6|||
105912823|NCT03713684|365338899|FG002|Overall Study|Withdrawal by Subject|14|||
105912824|NCT03713684|365338900|FG003|Overall Study|Withdrawal by Subject|16|||
105912825|NCT03713684|365338897|FG000|Overall Study|Other than specified|69|||
105912826|NCT03713684|365338898|FG001|Overall Study|Other than specified|77|||
105912827|NCT03713684|365338899|FG002|Overall Study|Other than specified|73|||
105912828|NCT03713684|365338900|FG003|Overall Study|Other than specified|70|||
105912829|NCT00249873|365338901|FG000|Overall Study|Not treated|7|||
105912830|NCT00249873|365338902|FG001|Overall Study|Not treated|8|||
105912831|NCT00249873|365338901|FG000|Overall Study|Significant thrombocytopenia|9|||
105912832|NCT00249873|365338902|FG001|Overall Study|Significant thrombocytopenia|8|||
105912833|NCT00249873|365338901|FG000|Overall Study|Severe allergic reaction|8|||
105912834|NCT00249873|365338902|FG001|Overall Study|Severe allergic reaction|1|||
105912835|NCT00249873|365338901|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
105912836|NCT00249873|365338902|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
105912837|NCT00249873|365338901|FG000|Overall Study|Other Serious Adverse Event|86|||
105912838|NCT00249873|365338902|FG001|Overall Study|Other Serious Adverse Event|97|||
105912839|NCT00249873|365338901|FG000|Overall Study|Qualifying condition not present|20|||
105912840|NCT00249873|365338902|FG001|Overall Study|Qualifying condition not present|23|||
105912841|NCT00249873|365338901|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
105912842|NCT00249873|365338902|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
105912843|NCT00249873|365338901|FG000|Overall Study|Withdrawal by Subject|504|||
105912844|NCT00249873|365338902|FG001|Overall Study|Withdrawal by Subject|466|||
105912845|NCT00249873|365338901|FG000|Overall Study|Lost to Follow-up|4|||
105912846|NCT00249873|365338902|FG001|Overall Study|Lost to Follow-up|7|||
105912847|NCT00249873|365338901|FG000|Overall Study|Minor bleeding|99|||
105912848|NCT00249873|365338902|FG001|Overall Study|Minor bleeding|37|||
105912849|NCT00249873|365338901|FG000|Overall Study|Non-compliance|41|||
105912850|NCT00249873|365338902|FG001|Overall Study|Non-compliance|46|||
105912851|NCT00249873|365338901|FG000|Overall Study|Other non serious Adverse Event|112|||
105912852|NCT00249873|365338902|FG001|Overall Study|Other non serious Adverse Event|108|||
105912853|NCT00249873|365338901|FG000|Overall Study|Other contraindicated medication|1|||
105912854|NCT00249873|365338902|FG001|Overall Study|Other contraindicated medication|0|||
105912855|NCT00249873|365338901|FG000|Overall Study|Patient not wish to continue after May08|3|||
105912856|NCT00249873|365338902|FG001|Overall Study|Patient not wish to continue after May08|4|||
105912857|NCT00249873|365338901|FG000|Overall Study|Physician withdrew consent|59|||
105912858|NCT00249873|365338902|FG001|Overall Study|Physician withdrew consent|60|||
105912859|NCT00249873|365338901|FG000|Overall Study|Open label clopidogrel required|31|||
105912860|NCT00249873|365338902|FG001|Overall Study|Open label clopidogrel required|42|||
105912861|NCT00249873|365338901|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
105912862|NCT00249873|365338902|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
105912863|NCT00249873|365338901|FG000|Overall Study|Oral anticoagulant required|159|||
105912864|NCT00249873|365338902|FG001|Overall Study|Oral anticoagulant required|157|||
105912865|NCT00249873|365338901|FG000|Overall Study|Study drug intolerance|5|||
105912866|NCT00249873|365338902|FG001|Overall Study|Study drug intolerance|0|||
105912867|NCT00249873|365338901|FG000|Overall Study|Surgery/ procedure|9|||
105912868|NCT00249873|365338902|FG001|Overall Study|Surgery/ procedure|9|||
105912869|NCT00249873|365338901|FG000|Overall Study|Event related to cardiac condition|12|||
105912870|NCT00249873|365338902|FG001|Overall Study|Event related to cardiac condition|21|||
105912871|NCT00249873|365338901|FG000|Overall Study|Thromboembolic/outcome event|82|||
105912872|NCT00249873|365338902|FG001|Overall Study|Thromboembolic/outcome event|122|||
105912873|NCT02595502|365338905|FG000|Period 1|Adverse Event|0|||
105912874|NCT02595502|365338906|FG001|Period 1|Adverse Event|1|||
105912875|NCT02595502|365338905|FG000|Period 1|Withdrawal by Subject|1|||
105912876|NCT02595502|365338906|FG001|Period 1|Withdrawal by Subject|0|||
105912877|NCT02595502|365338905|FG000|Period 1|Lost to Follow-up|0|||
105912878|NCT02595502|365338906|FG001|Period 1|Lost to Follow-up|1|||
105912879|NCT02595502|365338905|FG000|Period 2|Adverse Event|1|||
105912880|NCT02595502|365338906|FG001|Period 2|Adverse Event|1|||
105912881|NCT02595502|365338905|FG000|Period 2|Received incorrect lens at Period 1|0|||
105912882|NCT02595502|365338906|FG001|Period 2|Received incorrect lens at Period 1|1|||
105912883|NCT02595502|365338905|FG000|Period 3|Protocol Violation|0|||
105912884|NCT02595502|365338906|FG001|Period 3|Protocol Violation|1|||
105912885|NCT02595502|365338905|FG000|Period 3|Lost to Follow-up|1|||
105912886|NCT02595502|365338906|FG001|Period 3|Lost to Follow-up|0|||
105912887|NCT02595502|365338905|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
105912888|NCT02595502|365338906|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
105912889|NCT05556148|365338907|FG000|Overall Study|Early Termination|29|||
105912890|NCT05556148|365338907|FG000|Overall Study|Baseline Tasks Expired|4|||
105912891|NCT05556148|365338907|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
105912892|NCT05556148|365338907|FG000|Overall Study|No Longer Wished to Participate|1|||
105912893|NCT05556148|365338907|FG000|Overall Study|Bacterial Conjunctivitis|1|||
105912894|NCT00458003|365338908|FG000|Overall Study|Non protocol spinal anesthesia|1|||
105912895|NCT00458003|365338909|FG001|Overall Study|Non protocol spinal anesthesia|1|||
105912896|NCT00875563|365338916|FG000|Overall Study|Death|4|||
105912897|NCT00875563|365338916|FG000|Overall Study|Withdrawal by Subject|7|||
105912898|NCT00875563|365338916|FG000|Overall Study|No long-term (3-5 year) consent|6|||
105912899|NCT00875563|365338916|FG000|Overall Study|Still be eligible for follow-up|7|||
105912900|NCT00468585|365338917|FG000|Overall Study|Patient not treated|1|||
105912901|NCT00468585|365338918|FG001|Overall Study|Patient not treated|0|||
105912902|NCT00468585|365338919|FG002|Overall Study|Patient not treated|1|||
105912903|NCT00468585|365338920|FG003|Overall Study|Patient not treated|0|||
105912904|NCT00468585|365338917|FG000|Overall Study|Patient found to be ineligible|0|||
105912905|NCT00468585|365338918|FG001|Overall Study|Patient found to be ineligible|0|||
105912906|NCT00468585|365338919|FG002|Overall Study|Patient found to be ineligible|1|||
105912907|NCT00468585|365338920|FG003|Overall Study|Patient found to be ineligible|0|||
105912908|NCT00468585|365338917|FG000|Overall Study|Adverse Event|0|||
105912909|NCT00468585|365338918|FG001|Overall Study|Adverse Event|0|||
105912910|NCT00468585|365338919|FG002|Overall Study|Adverse Event|1|||
105912911|NCT00468585|365338920|FG003|Overall Study|Adverse Event|0|||
105912912|NCT00468585|365338917|FG000|Overall Study|Withdrawal by Subject|0|||
105912913|NCT00468585|365338918|FG001|Overall Study|Withdrawal by Subject|0|||
105912914|NCT00468585|365338919|FG002|Overall Study|Withdrawal by Subject|2|||
105786424|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Progressive disease|0|||
105912915|NCT00468585|365338920|FG003|Overall Study|Withdrawal by Subject|1|||
105912916|NCT00511810|365338923|FG000|Overall Study|Lost to Follow-up|1|||
105912917|NCT00511810|365338924|FG001|Overall Study|Lost to Follow-up|2|||
105912918|NCT00511810|365338923|FG000|Overall Study|Lack of Efficacy|0|||
105912919|NCT00511810|365338924|FG001|Overall Study|Lack of Efficacy|2|||
105912920|NCT00511810|365338923|FG000|Overall Study|Refused second scn|0|||
105676353|NCT05917470|364477237|FG003|Overall Study|Sponsor Decision|0|||
105676354|NCT05917470|364477238|FG004|Overall Study|Sponsor Decision|2|||
105676355|NCT05917470|364477239|FG005|Overall Study|Sponsor Decision|1|||
105676356|NCT05917470|364477240|FG006|Overall Study|Sponsor Decision|3|||
105676357|NCT05917470|364477241|FG007|Overall Study|Sponsor Decision|3|||
105676358|NCT05917470|364477234|FG000|Overall Study|Adverse Event|0|||
105676359|NCT05917470|364477235|FG001|Overall Study|Adverse Event|0|||
105676360|NCT05917470|364477236|FG002|Overall Study|Adverse Event|0|||
105676361|NCT05917470|364477237|FG003|Overall Study|Adverse Event|0|||
105676362|NCT05917470|364477238|FG004|Overall Study|Adverse Event|0|||
105676363|NCT05917470|364477239|FG005|Overall Study|Adverse Event|1|||
105676364|NCT05917470|364477240|FG006|Overall Study|Adverse Event|0|||
105676365|NCT05917470|364477241|FG007|Overall Study|Adverse Event|0|||
105676366|NCT05593445|364477244|FG000|12-Week DBVC Period|Adverse Event|1|||
105676367|NCT05593445|364477245|FG001|12-Week DBVC Period|Adverse Event|0|||
105676368|NCT05593445|364477246|FG002|12-Week DBVC Period|Adverse Event|0|||
105676369|NCT05593445|364477247|FG003|12-Week DBVC Period|Adverse Event|0|||
105676370|NCT05593445|364477244|FG000|12-Week DBVC Period|Physician Decision|0|||
105676371|NCT05593445|364477245|FG001|12-Week DBVC Period|Physician Decision|1|||
105676372|NCT05593445|364477246|FG002|12-Week DBVC Period|Physician Decision|0|||
105676373|NCT05593445|364477247|FG003|12-Week DBVC Period|Physician Decision|0|||
105676374|NCT05593445|364477244|FG000|12-Week DBVC Period|Protocol Violation|0|||
105676375|NCT05593445|364477245|FG001|12-Week DBVC Period|Protocol Violation|1|||
105676376|NCT05593445|364477246|FG002|12-Week DBVC Period|Protocol Violation|0|||
105676377|NCT05593445|364477247|FG003|12-Week DBVC Period|Protocol Violation|0|||
105676378|NCT05593445|364477244|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
105676379|NCT05593445|364477245|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
105676380|NCT05593445|364477246|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
105676381|NCT05593445|364477247|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
105676382|NCT05593445|364477244|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
105676383|NCT05593445|364477245|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
105676384|NCT05593445|364477246|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
105676385|NCT05593445|364477247|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
105676386|NCT05593445|364477244|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
105676387|NCT05593445|364477245|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
105676388|NCT05593445|364477246|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
105676389|NCT05593445|364477247|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
105676390|NCT05593445|364477244|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
105676391|NCT05593445|364477245|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
105676392|NCT05593445|364477246|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
105676393|NCT05593445|364477247|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
105676394|NCT05593445|364477244|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105676395|NCT05593445|364477245|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105676396|NCT05593445|364477246|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
105676397|NCT05593445|364477247|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
105676398|NCT03981861|364477248|FG000|Overall Study|Withdrawal by Subject|3|||
105676399|NCT00095498|364479330|FG000|Overall Study|Physician Decision|9|||
105676400|NCT00095498|364479331|FG001|Overall Study|Physician Decision|10|||
105676401|NCT00095498|364479332|FG002|Overall Study|Physician Decision|8|||
105676402|NCT00095498|364479330|FG000|Overall Study|Adverse Event|1|||
105676403|NCT00095498|364479331|FG001|Overall Study|Adverse Event|0|||
105676404|NCT00095498|364479332|FG002|Overall Study|Adverse Event|1|||
105676405|NCT00095498|364479330|FG000|Overall Study|Withdrawal by Subject|15|||
105676406|NCT00095498|364479331|FG001|Overall Study|Withdrawal by Subject|16|||
105676407|NCT00095498|364479332|FG002|Overall Study|Withdrawal by Subject|15|||
105676408|NCT00095498|364479330|FG000|Overall Study|Disease progression|0|||
105676409|NCT00095498|364479331|FG001|Overall Study|Disease progression|1|||
105676410|NCT00095498|364479332|FG002|Overall Study|Disease progression|1|||
105912921|NCT00511810|365338924|FG001|Overall Study|Refused second scn|1|||
105912922|NCT00313846|365338925|FG000|Overall Study|Withdrawal by Subject|2|||
105912923|NCT00313846|365338926|FG001|Overall Study|Withdrawal by Subject|0|||
105912924|NCT00313846|365338925|FG000|Overall Study|Adverse Event|1|||
105912925|NCT00313846|365338926|FG001|Overall Study|Adverse Event|8|||
105912926|NCT00313846|365338925|FG000|Overall Study|Administrative|2|||
105912927|NCT00313846|365338926|FG001|Overall Study|Administrative|3|||
105912928|NCT03257436|365338928|FG000|Overall Study|Withdrawal by Subject|76|||
105912929|NCT03257436|365338928|FG000|Overall Study|Death|19|||
105676411|NCT00095498|364479330|FG000|Overall Study|Ineligibility determined|3|||
105676412|NCT00095498|364479331|FG001|Overall Study|Ineligibility determined|0|||
105676413|NCT00095498|364479332|FG002|Overall Study|Ineligibility determined|2|||
105676414|NCT00095498|364479330|FG000|Overall Study|Lost to Follow-up|1|||
105676415|NCT00095498|364479331|FG001|Overall Study|Lost to Follow-up|1|||
105676416|NCT00095498|364479332|FG002|Overall Study|Lost to Follow-up|2|||
105912930|NCT02659943|365338929|FG000|Overall Study|Switched to alternative treatment|1|||
105676417|NCT00095498|364479330|FG000|Overall Study|Noncompliance|1|||
105912931|NCT02659943|365338930|FG001|Overall Study|Switched to alternative treatment|1|||
105676418|NCT00095498|364479331|FG001|Overall Study|Noncompliance|0|||
105676419|NCT00095498|364479332|FG002|Overall Study|Noncompliance|1|||
105676420|NCT00095498|364479330|FG000|Overall Study|Other|6|||
105676421|NCT00095498|364479331|FG001|Overall Study|Other|7|||
105676422|NCT00095498|364479332|FG002|Overall Study|Other|6|||
105676423|NCT00095498|364479330|FG000|Overall Study|Protocol Violation|0|||
105676424|NCT00095498|364479331|FG001|Overall Study|Protocol Violation|0|||
105676425|NCT00095498|364479332|FG002|Overall Study|Protocol Violation|1|||
105676426|NCT00095498|364479330|FG000|Overall Study|Requirement for alternative therapy|1|||
105676427|NCT00095498|364479331|FG001|Overall Study|Requirement for alternative therapy|0|||
105676428|NCT00095498|364479332|FG002|Overall Study|Requirement for alternative therapy|2|||
105676429|NCT05020327|364479333|FG000|Overall Study|Physician Decision|3|||
105676430|NCT05020327|364479334|FG001|Overall Study|Physician Decision|0|||
105676431|NCT05020327|364479335|FG002|Overall Study|Physician Decision|0|||
105676432|NCT05020327|364479333|FG000|Overall Study|Withdrawal by Subject|1|||
105676433|NCT05020327|364479334|FG001|Overall Study|Withdrawal by Subject|1|||
105676434|NCT05020327|364479335|FG002|Overall Study|Withdrawal by Subject|0|||
105676435|NCT05020327|364479333|FG000|Overall Study|personal/cultural, ineligible|12|||
105676436|NCT05020327|364479334|FG001|Overall Study|personal/cultural, ineligible|0|||
105676437|NCT05020327|364479335|FG002|Overall Study|personal/cultural, ineligible|0|||
105676438|NCT04684394|364479336|FG000|Overall Study|Death|1|||
105676439|NCT04684394|364479337|FG001|Overall Study|Death|2|||
105676440|NCT04684394|364479336|FG000|Overall Study|Lost to Follow-up|1|||
105676441|NCT04684394|364479337|FG001|Overall Study|Lost to Follow-up|0|||
105676442|NCT04684394|364479336|FG000|Overall Study|Withdrawal by Subject|2|||
105676443|NCT04684394|364479337|FG001|Overall Study|Withdrawal by Subject|0|||
105676444|NCT04684394|364479336|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
105676445|NCT04684394|364479337|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
105676446|NCT03037931|364479338|FG000|Overall Study|Death|354|||
105676447|NCT03037931|364479339|FG001|Overall Study|Death|367|||
105676448|NCT03037931|364479338|FG000|Overall Study|Lost to Follow-up|7|||
105676449|NCT03037931|364479339|FG001|Overall Study|Lost to Follow-up|4|||
105676450|NCT03037931|364479338|FG000|Overall Study|Withdrawal by Subject|48|||
105676451|NCT03037931|364479339|FG001|Overall Study|Withdrawal by Subject|41|||
105676452|NCT01775475|364479340|FG000|Overall Study|Death|3|||
105912932|NCT02659943|365338931|FG002|Overall Study|Switched to alternative treatment|0|||
105912933|NCT02659943|365338932|FG003|Overall Study|Switched to alternative treatment|2|||
105912934|NCT02659943|365338933|FG004|Overall Study|Switched to alternative treatment|1|||
105912935|NCT02659943|365338934|FG005|Overall Study|Switched to alternative treatment|0|||
105912936|NCT02659943|365338935|FG006|Overall Study|Switched to alternative treatment|1|||
105912937|NCT02659943|365338929|FG000|Overall Study|Disease progression on study|0|||
105912938|NCT02659943|365338930|FG001|Overall Study|Disease progression on study|1|||
105912939|NCT02659943|365338931|FG002|Overall Study|Disease progression on study|1|||
105912940|NCT02659943|365338932|FG003|Overall Study|Disease progression on study|1|||
105912941|NCT02659943|365338933|FG004|Overall Study|Disease progression on study|1|||
105912942|NCT02659943|365338934|FG005|Overall Study|Disease progression on study|4|||
105912943|NCT02659943|365338935|FG006|Overall Study|Disease progression on study|0|||
105912944|NCT02659943|365338929|FG000|Overall Study|Patient's condition per principal investigator|0|||
105912945|NCT02659943|365338930|FG001|Overall Study|Patient's condition per principal investigator|0|||
105912946|NCT02659943|365338931|FG002|Overall Study|Patient's condition per principal investigator|0|||
105912947|NCT02659943|365338932|FG003|Overall Study|Patient's condition per principal investigator|0|||
105912948|NCT02659943|365338933|FG004|Overall Study|Patient's condition per principal investigator|0|||
105912949|NCT02659943|365338934|FG005|Overall Study|Patient's condition per principal investigator|1|||
105912950|NCT02659943|365338935|FG006|Overall Study|Patient's condition per principal investigator|0|||
105912951|NCT02659943|365338929|FG000|Overall Study|Ineligible|0|||
105912952|NCT02659943|365338930|FG001|Overall Study|Ineligible|0|||
105912953|NCT02659943|365338931|FG002|Overall Study|Ineligible|0|||
105912954|NCT02659943|365338932|FG003|Overall Study|Ineligible|0|||
105912955|NCT02659943|365338933|FG004|Overall Study|Ineligible|0|||
105912956|NCT02659943|365338934|FG005|Overall Study|Ineligible|0|||
105912957|NCT02659943|365338935|FG006|Overall Study|Ineligible|1|||
105912958|NCT02659943|365338929|FG000|Overall Study|No longer meets eligibility|0|||
105912959|NCT02659943|365338930|FG001|Overall Study|No longer meets eligibility|0|||
105676453|NCT01775475|364479341|FG001|Overall Study|Death|3|||
105676454|NCT04410523|364479345|FG000|Overall Study|Study terminated by sponsor|1|||
105676455|NCT04410523|364479346|FG001|Overall Study|Study terminated by sponsor|3|||
105676456|NCT04410523|364479347|FG002|Overall Study|Study terminated by sponsor|2|||
105676457|NCT04410523|364479348|FG003|Overall Study|Study terminated by sponsor|6|||
105676458|NCT04410523|364479349|FG004|Overall Study|Study terminated by sponsor|3|||
105912960|NCT02659943|365338931|FG002|Overall Study|No longer meets eligibility|0|||
105912961|NCT02659943|365338932|FG003|Overall Study|No longer meets eligibility|0|||
105912962|NCT02659943|365338933|FG004|Overall Study|No longer meets eligibility|0|||
105676459|NCT04410523|364479350|FG005|Overall Study|Study terminated by sponsor|4|||
105676460|NCT04410523|364479345|FG000|Overall Study|Adverse Event|1|||
105676461|NCT04410523|364479346|FG001|Overall Study|Adverse Event|0|||
105999893|NCT01695135|365661226|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
105999894|NCT01695135|365661227|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
105999895|NCT01695135|365661228|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
105999896|NCT01695135|365661229|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
105999897|NCT01695135|365661226|FG000|Open Label Extension Treatment Phase|Other|0|||
105999898|NCT01695135|365661227|FG001|Open Label Extension Treatment Phase|Other|0|||
105999899|NCT01695135|365661228|FG002|Open Label Extension Treatment Phase|Other|4|||
105999900|NCT01695135|365661229|FG003|Open Label Extension Treatment Phase|Other|7|||
105999901|NCT01695135|365661226|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
105999902|NCT01695135|365661227|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
105999903|NCT01695135|365661228|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
105999904|NCT01695135|365661229|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
105999905|NCT01695135|365661226|FG000|Open Label Extension Treatment Phase|Death|0|||
105999906|NCT01695135|365661227|FG001|Open Label Extension Treatment Phase|Death|0|||
105999907|NCT01695135|365661228|FG002|Open Label Extension Treatment Phase|Death|2|||
105999908|NCT01695135|365661229|FG003|Open Label Extension Treatment Phase|Death|7|||
105999909|NCT01695135|365661226|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
105999910|NCT01695135|365661227|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
105999911|NCT01695135|365661228|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
105999912|NCT01695135|365661229|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
105999913|NCT00148759|365661230|FG000|Overall Study|Withdrawal by Subject|1|||
105676462|NCT04410523|364479347|FG002|Overall Study|Adverse Event|0|||
105999914|NCT00148759|365661231|FG001|Overall Study|Withdrawal by Subject|1|||
105912963|NCT02659943|365338934|FG005|Overall Study|No longer meets eligibility|0|||
105912964|NCT02659943|365338935|FG006|Overall Study|No longer meets eligibility|1|||
105912965|NCT02659943|365338929|FG000|Overall Study|No treatment, per protocol|0|||
105912966|NCT02659943|365338930|FG001|Overall Study|No treatment, per protocol|0|||
105912967|NCT02659943|365338931|FG002|Overall Study|No treatment, per protocol|0|||
105912968|NCT02659943|365338932|FG003|Overall Study|No treatment, per protocol|0|||
105912969|NCT02659943|365338933|FG004|Overall Study|No treatment, per protocol|0|||
105912970|NCT02659943|365338934|FG005|Overall Study|No treatment, per protocol|0|||
105912971|NCT02659943|365338935|FG006|Overall Study|No treatment, per protocol|3|||
105912972|NCT05227118|365338946|FG000|Overall Study|Adverse Event|0|||
105912973|NCT05227118|365338947|FG001|Overall Study|Adverse Event|0|||
105676463|NCT04410523|364479348|FG003|Overall Study|Adverse Event|0|||
105676464|NCT04410523|364479349|FG004|Overall Study|Adverse Event|0|||
105676465|NCT04410523|364479350|FG005|Overall Study|Adverse Event|2|||
105676466|NCT04410523|364479345|FG000|Overall Study|Lost to Follow-up|0|||
105676467|NCT04410523|364479346|FG001|Overall Study|Lost to Follow-up|1|||
105676468|NCT04410523|364479347|FG002|Overall Study|Lost to Follow-up|0|||
105676469|NCT04410523|364479348|FG003|Overall Study|Lost to Follow-up|0|||
105676470|NCT04410523|364479349|FG004|Overall Study|Lost to Follow-up|0|||
105676471|NCT04410523|364479350|FG005|Overall Study|Lost to Follow-up|0|||
105676472|NCT04410523|364479345|FG000|Overall Study|Physician Decision|0|||
105676473|NCT04410523|364479346|FG001|Overall Study|Physician Decision|1|||
105676474|NCT04410523|364479347|FG002|Overall Study|Physician Decision|0|||
105676475|NCT04410523|364479348|FG003|Overall Study|Physician Decision|0|||
105676476|NCT04410523|364479349|FG004|Overall Study|Physician Decision|0|||
105676477|NCT04410523|364479350|FG005|Overall Study|Physician Decision|0|||
105676478|NCT04410523|364479345|FG000|Overall Study|Pregnancy|0|||
105676479|NCT04410523|364479346|FG001|Overall Study|Pregnancy|0|||
105676480|NCT04410523|364479347|FG002|Overall Study|Pregnancy|0|||
105676481|NCT04410523|364479348|FG003|Overall Study|Pregnancy|0|||
105676482|NCT04410523|364479349|FG004|Overall Study|Pregnancy|0|||
105676483|NCT04410523|364479350|FG005|Overall Study|Pregnancy|1|||
105676484|NCT04410523|364479345|FG000|Overall Study|Protocol deviation|0|||
105676485|NCT04410523|364479346|FG001|Overall Study|Protocol deviation|0|||
105676486|NCT04410523|364479347|FG002|Overall Study|Protocol deviation|0|||
105676487|NCT04410523|364479348|FG003|Overall Study|Protocol deviation|0|||
105676488|NCT04410523|364479349|FG004|Overall Study|Protocol deviation|0|||
105676489|NCT04410523|364479350|FG005|Overall Study|Protocol deviation|2|||
105676490|NCT04410523|364479345|FG000|Overall Study|Subject decision|2|||
105676491|NCT04410523|364479346|FG001|Overall Study|Subject decision|0|||
105676492|NCT04410523|364479347|FG002|Overall Study|Subject decision|0|||
105676493|NCT04410523|364479348|FG003|Overall Study|Subject decision|1|||
105676494|NCT04410523|364479349|FG004|Overall Study|Subject decision|0|||
105676495|NCT04410523|364479350|FG005|Overall Study|Subject decision|1|||
105676496|NCT00657020|364479351|FG000|PERIOD 1|Adverse Event|0|||
105676497|NCT00657020|364479352|FG001|PERIOD 1|Adverse Event|1|||
105912974|NCT05227118|365338948|FG002|Overall Study|Adverse Event|1|||
105912975|NCT05227118|365338949|FG003|Overall Study|Adverse Event|0|||
105912976|NCT05227118|365338946|FG000|Overall Study|Withdrawal by Subject|0|||
105912977|NCT05227118|365338947|FG001|Overall Study|Withdrawal by Subject|0|||
105912978|NCT05227118|365338948|FG002|Overall Study|Withdrawal by Subject|2|||
105912979|NCT05227118|365338949|FG003|Overall Study|Withdrawal by Subject|0|||
105912980|NCT03727841|365338952|FG000|Overall Study|Physician Decision|3|||
105912981|NCT03727841|365338953|FG001|Overall Study|Physician Decision|1|||
105912982|NCT03126786|365338954|FG000|Overall Study|Adverse Event|3|||
105912983|NCT03126786|365338955|FG001|Overall Study|Adverse Event|0|||
105912984|NCT03126786|365338954|FG000|Overall Study|Lost to Follow-up|0|||
105912985|NCT03126786|365338955|FG001|Overall Study|Lost to Follow-up|1|||
105912986|NCT03126786|365338954|FG000|Overall Study|Withdrawal by Subject|3|||
105912987|NCT03126786|365338955|FG001|Overall Study|Withdrawal by Subject|1|||
105912988|NCT02689804|365338956|FG000|Overall Study|Withdrawal by Subject|2|||
105912989|NCT02689804|365338957|FG001|Overall Study|Withdrawal by Subject|0|||
105912990|NCT01211145|365338958|FG000|Overall Study|Reason not specified|3|||
105912991|NCT01211145|365338959|FG001|Overall Study|Reason not specified|2|||
105912992|NCT01211145|365338960|FG002|Overall Study|Reason not specified|2|||
105912993|NCT01211145|365338961|FG003|Overall Study|Reason not specified|1|||
105912994|NCT01211145|365338958|FG000|Overall Study|Lost to Follow-up|3|||
105912995|NCT01211145|365338959|FG001|Overall Study|Lost to Follow-up|2|||
105912996|NCT01211145|365338960|FG002|Overall Study|Lost to Follow-up|1|||
105676498|NCT00473265|364479353|FG000|Overall Study|Unrelated adverse event|5|||
105676499|NCT00473265|364479353|FG000|Overall Study|Off treatment early|15|||
105676500|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Death|0|||
105676501|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Death|0|||
105676502|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Death|1|||
105676503|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Death|0|||
105676504|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Death|0|||
105676505|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Death|0|||
105912997|NCT01211145|365338961|FG003|Overall Study|Lost to Follow-up|2|||
105912998|NCT01211145|365338958|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105676506|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Death|0|||
105676507|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Death|0|||
105676508|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Death|0|||
105676509|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Death|0|||
105676510|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Death|0|||
105676511|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Death|0|||
105676512|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Death|0|||
105676513|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Death|0|||
105676514|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676515|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676516|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
105676517|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676518|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676519|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676520|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676521|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676522|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676523|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676524|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676525|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676526|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676527|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
105676528|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
105676529|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
105676530|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
105676531|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
105676532|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105786425|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Progressive disease|0|||
105786426|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
105786427|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
105912999|NCT01211145|365338959|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105913000|NCT01211145|365338960|FG002|Overall Study|Study-specific withdrawal criteria|0|||
105913001|NCT01211145|365338961|FG003|Overall Study|Study-specific withdrawal criteria|0|||
105913002|NCT01211145|365338958|FG000|Overall Study|Severe noncompliance to protocol|1|||
105913003|NCT01211145|365338959|FG001|Overall Study|Severe noncompliance to protocol|0|||
105913004|NCT01211145|365338960|FG002|Overall Study|Severe noncompliance to protocol|0|||
105913005|NCT01211145|365338961|FG003|Overall Study|Severe noncompliance to protocol|0|||
105913006|NCT01211145|365338958|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
105913007|NCT01211145|365338959|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
105913008|NCT01211145|365338960|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
105913009|NCT01211145|365338961|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
105913010|NCT01211145|365338958|FG000|Overall Study|Patient decision|2|||
105913011|NCT01211145|365338959|FG001|Overall Study|Patient decision|1|||
105913012|NCT01211145|365338960|FG002|Overall Study|Patient decision|0|||
105913013|NCT01211145|365338961|FG003|Overall Study|Patient decision|2|||
105913014|NCT04396626|365338963|FG000|Overall Study|Premature termination of study|975|||
105913015|NCT02417753|365338964|FG000|Overall Study|Death|1|||
105913016|NCT04805671|365338967|FG000|Overall Study|Death|2|||
105913017|NCT04805671|365338968|FG001|Overall Study|Death|7|||
105913018|NCT04805671|365338967|FG000|Overall Study|Lost to Follow-up|1|||
105913019|NCT04805671|365338968|FG001|Overall Study|Lost to Follow-up|0|||
105913020|NCT04805671|365338967|FG000|Overall Study|Withdrawal by Subject|9|||
105913021|NCT04805671|365338968|FG001|Overall Study|Withdrawal by Subject|7|||
105913022|NCT04805671|365338967|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
105913023|NCT04805671|365338968|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
105913024|NCT00901342|365338975|FG000|Overall Study|Adverse Event|1|||
105913025|NCT00901342|365338975|FG000|Overall Study|Death|4|||
105913026|NCT00901342|365338975|FG000|Overall Study|Disease progression|1|||
105913027|NCT00901342|365338975|FG000|Overall Study|Withdrawal by Subject|9|||
105913028|NCT00838097|365338978|FG000|Overall Study|Ineligibility determined|6|||
105913029|NCT00838097|365338978|FG000|Overall Study|Adverse Event|2|||
105913030|NCT00838097|365338978|FG000|Overall Study|Withdrawal by Subject|3|||
105913031|NCT00838097|365338978|FG000|Overall Study|Requirement for alternative therapy|2|||
105913032|NCT00838097|365338978|FG000|Overall Study|Physician Decision|4|||
105913033|NCT00838097|365338978|FG000|Overall Study|Lost to Follow-up|11|||
105913034|NCT00838097|365338978|FG000|Overall Study|Death|6|||
105913035|NCT00838097|365338978|FG000|Overall Study|Protocol-specified criteria|142|||
105676533|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105786428|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
105913036|NCT01261390|365338982|FG000|Overall Study|Significant Concurrent Illness|1|||
105913037|NCT01261390|365338983|FG001|Overall Study|Significant Concurrent Illness|0|||
105913038|NCT01261390|365338984|FG002|Overall Study|Significant Concurrent Illness|1|||
105913039|NCT01261390|365338985|FG003|Overall Study|Significant Concurrent Illness|0|||
105913040|NCT01261390|365338982|FG000|Overall Study|Dissatisfaction with Treatment|2|||
105676534|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676535|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676536|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676537|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676538|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676539|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676540|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676541|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
105676542|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
105676543|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676544|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
105676545|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
105676546|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676547|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676548|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676549|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676550|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676551|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676552|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676553|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676554|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676555|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
105676556|NCT02663518|364479358|FG000|Part 1: Phase 1a Escalation|Other|0|||
105676557|NCT02663518|364479359|FG001|Part 1: Phase 1a Escalation|Other|0|||
105676558|NCT02663518|364479360|FG002|Part 1: Phase 1a Escalation|Other|2|||
105676559|NCT02663518|364479361|FG003|Part 1: Phase 1a Escalation|Other|0|||
105676560|NCT02663518|364479362|FG004|Part 1: Phase 1a Escalation|Other|0|||
105676561|NCT02663518|364479363|FG005|Part 1: Phase 1a Escalation|Other|0|||
105676562|NCT02663518|364479364|FG006|Part 1: Phase 1a Escalation|Other|0|||
105676563|NCT02663518|364479365|FG007|Part 1: Phase 1a Escalation|Other|0|||
105676564|NCT02663518|364479366|FG008|Part 1: Phase 1a Escalation|Other|0|||
105676565|NCT02663518|364479367|FG009|Part 1: Phase 1a Escalation|Other|0|||
105676566|NCT02663518|364479368|FG010|Part 1: Phase 1a Escalation|Other|0|||
105676567|NCT02663518|364479369|FG011|Part 1: Phase 1a Escalation|Other|0|||
105676568|NCT02663518|364479370|FG012|Part 1: Phase 1a Escalation|Other|0|||
105676569|NCT02663518|364479371|FG013|Part 1: Phase 1a Escalation|Other|0|||
105676570|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676571|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676572|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676573|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676574|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
105676575|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676576|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
105676577|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
105676578|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676579|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676580|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676581|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676582|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676583|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
105676584|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676585|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676586|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676587|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676588|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
105676589|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676590|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
105676591|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
105913041|NCT01261390|365338983|FG001|Overall Study|Dissatisfaction with Treatment|1|||
105913042|NCT01261390|365338984|FG002|Overall Study|Dissatisfaction with Treatment|1|||
105913043|NCT01261390|365338985|FG003|Overall Study|Dissatisfaction with Treatment|2|||
105913044|NCT01261390|365338982|FG000|Overall Study|Relocation|0|||
105913045|NCT01261390|365338983|FG001|Overall Study|Relocation|1|||
105913046|NCT01261390|365338984|FG002|Overall Study|Relocation|0|||
105676592|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676593|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676594|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676595|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676596|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105913047|NCT01261390|365338985|FG003|Overall Study|Relocation|0|||
105913048|NCT01261390|365338982|FG000|Overall Study|Loss of Interest in the Study|3|||
105913049|NCT01261390|365338983|FG001|Overall Study|Loss of Interest in the Study|1|||
105676597|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
105676598|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676599|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676600|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676601|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676602|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
105676603|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676604|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676605|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676606|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676607|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676608|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676609|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676610|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676611|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
105676612|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676613|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676614|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676615|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676616|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
105676617|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
105676618|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
105676619|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
105676620|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676621|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676622|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676623|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676624|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676625|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
105676626|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676627|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676628|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676629|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676630|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
105676631|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676632|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
105676633|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676634|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676635|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676636|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676637|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676638|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676639|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
105676640|NCT02663518|364479358|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676641|NCT02663518|364479359|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676642|NCT02663518|364479360|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676643|NCT02663518|364479361|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676644|NCT02663518|364479362|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676645|NCT02663518|364479363|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676646|NCT02663518|364479364|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
105676647|NCT02663518|364479365|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676648|NCT02663518|364479366|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676649|NCT02663518|364479367|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676650|NCT02663518|364479368|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676651|NCT02663518|364479369|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105913050|NCT01261390|365338984|FG002|Overall Study|Loss of Interest in the Study|0|||
105913051|NCT01261390|365338985|FG003|Overall Study|Loss of Interest in the Study|0|||
105913052|NCT01261390|365338982|FG000|Overall Study|Lost to Follow-up|1|||
105913053|NCT01261390|365338983|FG001|Overall Study|Lost to Follow-up|6|||
105913054|NCT01261390|365338984|FG002|Overall Study|Lost to Follow-up|5|||
105913055|NCT01261390|365338985|FG003|Overall Study|Lost to Follow-up|6|||
105913056|NCT01951417|365339001|FG000|Overall Study|Withdrawal by Subject|1|||
105913057|NCT01951417|365339001|FG000|Overall Study|Protocol Violation|2|||
105913058|NCT01951417|365339001|FG000|Overall Study|Lost to Follow-up|6|||
105913059|NCT00196105|365339002|FG000|Overall Study|Lost to Follow-up|4|||
105913060|NCT00196105|365339003|FG001|Overall Study|Lost to Follow-up|5|||
105913061|NCT00196105|365339004|FG002|Overall Study|Lost to Follow-up|7|||
105676652|NCT02663518|364479370|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676653|NCT02663518|364479371|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
105676654|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
105676655|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
105676656|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
105676657|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
105676658|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
105676659|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
105676660|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
105676661|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
105676662|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
105676663|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
105676664|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
105913062|NCT04346199|365339007|FG000|Overall Study|Death|8|||
105676665|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
105676666|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
105676667|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
105676668|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676669|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676670|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676671|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676672|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676673|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676674|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676675|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676676|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676677|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676678|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676679|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676680|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
105676681|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
105676682|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676683|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676684|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676685|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676686|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676687|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676688|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676689|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676690|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676691|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676692|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676693|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
105676694|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676695|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
105676696|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676697|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676698|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676699|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676700|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676701|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676702|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676703|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676704|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676705|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
105676706|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
105676707|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
105676708|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
105676709|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
105676710|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
105676711|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
105676712|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
105676713|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
105676714|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
105676715|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
105676716|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
105676717|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
105676718|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
105676719|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
105676720|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
105676721|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
105676722|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
105676723|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
105676724|NCT02663518|364479358|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676725|NCT02663518|364479359|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676726|NCT02663518|364479360|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676727|NCT02663518|364479361|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676728|NCT02663518|364479362|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676729|NCT02663518|364479363|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105913063|NCT04346199|365339008|FG001|Overall Study|Death|9|||
105913064|NCT04346199|365339007|FG000|Overall Study|Lost to Follow-up|0|||
105913065|NCT04346199|365339008|FG001|Overall Study|Lost to Follow-up|1|||
105952070|NCT03314935|365488196|FG012|Phase 1|Withdrawal by Subject|0|||
105676730|NCT02663518|364479364|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676731|NCT02663518|364479365|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676732|NCT02663518|364479366|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676733|NCT02663518|364479367|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676734|NCT02663518|364479368|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676735|NCT02663518|364479369|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676736|NCT02663518|364479370|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
105676737|NCT02663518|364479371|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
105676738|NCT01004848|364479377|FG000|Overall Study|Lost to Follow-up|55|||
105676739|NCT01004848|364479378|FG001|Overall Study|Lost to Follow-up|45|||
105676740|NCT00774930|364479379|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
105676741|NCT00774930|364479380|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
105676742|NCT00774930|364479379|FG000|DB Phase|Adverse Event|1|||
105676743|NCT00774930|364479380|FG001|DB Phase|Adverse Event|2|||
105676744|NCT00774930|364479379|FG000|DB Phase|Subject Decision|1|||
105676745|NCT00774930|364479380|FG001|DB Phase|Subject Decision|5|||
105676746|NCT00774930|364479379|FG000|DB Phase|Sponsor Decision|0|||
105676747|NCT00774930|364479380|FG001|DB Phase|Sponsor Decision|1|||
105676748|NCT00774930|364479379|FG000|DB Phase|Disease Progression|1|||
105676749|NCT00774930|364479380|FG001|DB Phase|Disease Progression|1|||
105676750|NCT00774930|364479379|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
105676751|NCT00774930|364479380|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
105676752|NCT00774930|364479379|FG000|IOL Phase|Adverse Event|1|||
105676753|NCT00774930|364479380|FG001|IOL Phase|Adverse Event|1|||
105676754|NCT00774930|364479379|FG000|IOL Phase|Subject Decision|4|||
105676755|NCT00774930|364479380|FG001|IOL Phase|Subject Decision|3|||
105676756|NCT00774930|364479379|FG000|IOL Phase|Physician Decision|3|||
105676757|NCT00774930|364479380|FG001|IOL Phase|Physician Decision|2|||
105676758|NCT00774930|364479379|FG000|IOL Phase|Sponsor Decision|1|||
105676759|NCT00774930|364479380|FG001|IOL Phase|Sponsor Decision|0|||
105676760|NCT00774930|364479379|FG000|IOL Phase|Disease Progression|2|||
105676761|NCT00774930|364479380|FG001|IOL Phase|Disease Progression|1|||
105676762|NCT00774930|364479379|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
105676763|NCT00774930|364479380|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
105676764|NCT00774930|364479379|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
105676765|NCT00774930|364479380|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
105676766|NCT00774930|364479379|FG000|IOL Phase|Other|1|||
105676767|NCT00774930|364479380|FG001|IOL Phase|Other|0|||
105676768|NCT00774930|364479379|FG000|IOL Phase|Brain radiation|0|||
105676769|NCT00774930|364479380|FG001|IOL Phase|Brain radiation|1|||
105676770|NCT00774930|364479379|FG000|LTOLE Phase|Adverse Event|7|||
105676771|NCT00774930|364479380|FG001|LTOLE Phase|Adverse Event|3|||
105676772|NCT00774930|364479379|FG000|LTOLE Phase|Subject decision|0|||
105676773|NCT00774930|364479380|FG001|LTOLE Phase|Subject decision|5|||
105676774|NCT00774930|364479379|FG000|LTOLE Phase|Physician Decision|4|||
105913066|NCT04346199|365339007|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
105913067|NCT04346199|365339008|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
105913068|NCT04346199|365339007|FG000|Overall Study|Withdrawal by Subject|5|||
105913069|NCT04346199|365339008|FG001|Overall Study|Withdrawal by Subject|1|||
105913070|NCT01026948|365339009|FG000|Overall Study|Physician Decision|8|||
105913071|NCT01705977|365339010|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
105913072|NCT01705977|365339011|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
105913073|NCT01705977|365339010|FG000|Treatment Period (Year 1)|Adverse Event|57|||
105913074|NCT01705977|365339011|FG001|Treatment Period (Year 1)|Adverse Event|49|||
105913075|NCT01705977|365339010|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
105676775|NCT00774930|364479380|FG001|LTOLE Phase|Physician Decision|1|||
105676776|NCT00774930|364479379|FG000|LTOLE Phase|Sponsor decision|2|||
105676777|NCT00774930|364479380|FG001|LTOLE Phase|Sponsor decision|1|||
105676778|NCT00774930|364479379|FG000|LTOLE Phase|Disease Progression|2|||
105676779|NCT00774930|364479380|FG001|LTOLE Phase|Disease Progression|5|||
105676780|NCT00774930|364479379|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
105676781|NCT00774930|364479380|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
105676782|NCT00774930|364479379|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
105676783|NCT00774930|364479380|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
105676784|NCT00766363|364479381|FG000|Overall Study|Withdrawal by Subject|1|||
105676785|NCT00766363|364479382|FG001|Overall Study|Withdrawal by Subject|0|||
105676786|NCT00766363|364479383|FG002|Overall Study|Withdrawal by Subject|0|||
105676787|NCT00766363|364479384|FG003|Overall Study|Withdrawal by Subject|0|||
105913076|NCT01705977|365339011|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
105913077|NCT01705977|365339010|FG000|Treatment Period (Year 1)|Site closure|3|||
105913078|NCT01705977|365339011|FG001|Treatment Period (Year 1)|Site closure|2|||
106125705|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
105676788|NCT00766363|364479381|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
106125706|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
105913079|NCT01705977|365339010|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
105913080|NCT01705977|365339011|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
105913081|NCT01705977|365339010|FG000|Treatment Period (Year 1)|Physician Decision|48|||
105913082|NCT01705977|365339011|FG001|Treatment Period (Year 1)|Physician Decision|38|||
105913083|NCT01705977|365339010|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
105913084|NCT01705977|365339011|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
105913085|NCT01705977|365339010|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
105913086|NCT01705977|365339011|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
105913087|NCT01705977|365339010|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
105913088|NCT01705977|365339011|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
105913089|NCT01705977|365339010|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
105913090|NCT01705977|365339011|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
105913091|NCT01705977|365339010|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
105913092|NCT01705977|365339011|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
105913093|NCT01705977|365339010|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
105913094|NCT01705977|365339011|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
105913095|NCT03014206|365339012|FG000|Overall Study|Registration Violation|12|||
105913096|NCT00003471|365339015|FG000|Overall Study|Not evaluable|4|||
105913097|NCT04877990|365339018|FG000|Treatment|Other reasons|3|||
105913098|NCT04877990|365339019|FG001|Treatment|Other reasons|1|||
105913099|NCT04877990|365339018|FG000|Treatment|Administrative reasons by sponsor|17|||
105913100|NCT04877990|365339019|FG001|Treatment|Administrative reasons by sponsor|33|||
105913101|NCT04877990|365339018|FG000|Treatment|Withdrawal by Subject|2|||
105913102|NCT04877990|365339019|FG001|Treatment|Withdrawal by Subject|6|||
105913103|NCT04877990|365339018|FG000|Treatment|Adverse Event|2|||
105913104|NCT04877990|365339019|FG001|Treatment|Adverse Event|1|||
105913105|NCT03839394|365339020|FG000|Overall Study|Lost to Follow-up|6|||
105913106|NCT03839394|365339021|FG001|Overall Study|Lost to Follow-up|8|||
105913107|NCT03839394|365339020|FG000|Overall Study|Withdrawal by Subject|0|||
105913108|NCT03839394|365339021|FG001|Overall Study|Withdrawal by Subject|2|||
105913109|NCT05212168|365339022|FG000|Overall Study|Lost to Follow-up|0|||
105913110|NCT05212168|365339023|FG001|Overall Study|Lost to Follow-up|3|||
105913111|NCT05212168|365339022|FG000|Overall Study|Study terminated by sponsor|30|||
105913112|NCT05212168|365339023|FG001|Overall Study|Study terminated by sponsor|27|||
105913113|NCT05212168|365339022|FG000|Overall Study|Other|4|||
105913114|NCT05212168|365339023|FG001|Overall Study|Other|7|||
105913115|NCT04614324|365339024|FG000|Overall Study|Lost to Follow-up|3|||
105913116|NCT04614324|365339024|FG000|Overall Study|Physician Decision|1|||
105913117|NCT04614324|365339024|FG000|Overall Study|Withdrawal by Subject|2|||
105913118|NCT04614324|365339024|FG000|Overall Study|Remaining in Follow up|123|||
105913119|NCT00823134|365341112|FG000|Overall Study|Invalid measurement|1|||
105913120|NCT01165307|365341114|FG000|Overall Study|Lost to Follow-up|11|||
105913121|NCT01165307|365341115|FG001|Overall Study|Lost to Follow-up|3|||
105913122|NCT01165307|365341114|FG000|Overall Study|Withdrawal by Subject|2|||
105913123|NCT01165307|365341115|FG001|Overall Study|Withdrawal by Subject|0|||
105913124|NCT01165307|365341114|FG000|Overall Study|Subject not available for contact|1|||
105913125|NCT01165307|365341115|FG001|Overall Study|Subject not available for contact|0|||
105913126|NCT03234036|365341116|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
105913127|NCT03234036|365341117|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
105913128|NCT03234036|365341118|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
105913129|NCT03234036|365341119|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
105913130|NCT02999789|365341122|FG000|Overall Study|Withdrawal by Subject|0|||
105913131|NCT02999789|365341123|FG001|Overall Study|Withdrawal by Subject|1|||
105913132|NCT02999789|365341122|FG000|Overall Study|Became ineligible|1|||
105913133|NCT02999789|365341123|FG001|Overall Study|Became ineligible|2|||
105913134|NCT00521365|365341126|FG000|Overall Study|Adverse Event|3|||
105913135|NCT00521365|365341126|FG000|Overall Study|Lost to Follow-up|6|||
105913136|NCT00521365|365341126|FG000|Overall Study|Protocol deviation|2|||
105913137|NCT00521365|365341126|FG000|Overall Study|Drug compliance|3|||
105913138|NCT00521365|365341126|FG000|Overall Study|Usage of not allowed drugs|6|||
105913139|NCT04110314|365341127|FG000|Overall Study|Did not meet inclusion criteria|35255|||
105913140|NCT04110314|365341128|FG001|Overall Study|Did not meet inclusion criteria|35104|||
105913141|NCT04110314|365341129|FG002|Overall Study|Did not meet inclusion criteria|35636|||
105913142|NCT04110314|365341130|FG003|Overall Study|Did not meet inclusion criteria|35135|||
105913143|NCT04110314|365341131|FG004|Overall Study|Did not meet inclusion criteria|35247|||
105913144|NCT04110314|365341132|FG005|Overall Study|Did not meet inclusion criteria|35727|||
105913145|NCT02185417|365341137|FG000|Overall Study|Death|448|||
105913146|NCT02185417|365341138|FG001|Overall Study|Death|446|||
105913147|NCT02185417|365341139|FG002|Overall Study|Death|0|||
105913148|NCT02185417|365341137|FG000|Overall Study|Withdrawal by Subject|7|||
105913149|NCT02185417|365341138|FG001|Overall Study|Withdrawal by Subject|12|||
105913150|NCT02185417|365341139|FG002|Overall Study|Withdrawal by Subject|0|||
105913151|NCT02154139|365341142|FG000|Overall Study|Injection not administered|2|||
105913152|NCT02154139|365341142|FG000|Overall Study|Other|2|||
105913153|NCT02154139|365341142|FG000|Overall Study|Investigator transferred|3|||
105913154|NCT01290718|365341143|FG000|Overall Study|Early termination of the study|4|||
105913155|NCT02157519|365341153|FG000|Overall Study|Death|3|||
105913156|NCT02157519|365341154|FG001|Overall Study|Death|1|||
105913157|NCT02157519|365341153|FG000|Overall Study|Withdrawal by Subject|7|||
105913158|NCT02157519|365341154|FG001|Overall Study|Withdrawal by Subject|0|||
105913159|NCT02157519|365341153|FG000|Overall Study|Lost to Follow-up|1|||
105913160|NCT02157519|365341154|FG001|Overall Study|Lost to Follow-up|0|||
105913161|NCT03075267|365341155|FG000|Overall Study|Protocol Violation|1|||
105913162|NCT03075267|365341156|FG001|Overall Study|Protocol Violation|0|||
105913163|NCT03075267|365341157|FG002|Overall Study|Protocol Violation|0|||
105913164|NCT00809445|365341158|FG000|1 Month Follow-up|Lost contact|1|||
105913165|NCT00809445|365341159|FG001|1 Month Follow-up|Lost contact|2|||
105913166|NCT00809445|365341160|FG002|1 Month Follow-up|Lost contact|1|||
105913167|NCT00809445|365341158|FG000|1 Month Follow-up|Withdrew consent|1|||
105913168|NCT00809445|365341159|FG001|1 Month Follow-up|Withdrew consent|1|||
105913169|NCT00809445|365341160|FG002|1 Month Follow-up|Withdrew consent|1|||
105913170|NCT00809445|365341158|FG000|1 Month Follow-up|Death|0|||
105913171|NCT00809445|365341159|FG001|1 Month Follow-up|Death|1|||
105913172|NCT00809445|365341160|FG002|1 Month Follow-up|Death|1|||
105913173|NCT00809445|365341158|FG000|1 Month Follow-up|Incarcerated|0|||
105913174|NCT00809445|365341159|FG001|1 Month Follow-up|Incarcerated|0|||
105913175|NCT00809445|365341160|FG002|1 Month Follow-up|Incarcerated|1|||
105913176|NCT00809445|365341158|FG000|6 Month Follow-up|Lost contact|16|||
105913177|NCT00809445|365341159|FG001|6 Month Follow-up|Lost contact|14|||
105913178|NCT00809445|365341160|FG002|6 Month Follow-up|Lost contact|14|||
105913179|NCT00809445|365341158|FG000|6 Month Follow-up|Death|2|||
105913180|NCT00809445|365341159|FG001|6 Month Follow-up|Death|1|||
105913181|NCT00809445|365341160|FG002|6 Month Follow-up|Death|1|||
105913182|NCT00809445|365341158|FG000|6 Month Follow-up|Incarcerated|6|||
105913183|NCT00809445|365341159|FG001|6 Month Follow-up|Incarcerated|8|||
105913184|NCT00809445|365341160|FG002|6 Month Follow-up|Incarcerated|8|||
105913185|NCT00809445|365341158|FG000|6 Month Follow-up|Withdrew consent|0|||
105913186|NCT00809445|365341159|FG001|6 Month Follow-up|Withdrew consent|0|||
105913187|NCT00809445|365341160|FG002|6 Month Follow-up|Withdrew consent|1|||
105913188|NCT02048722|365341167|FG000|2 Cycles of Treatment|Adverse Event|2|||
105913189|NCT02048722|365341167|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
105913190|NCT02048722|365341167|FG000|2 Cycles of Treatment|Progressive Disease|2|||
105913191|NCT02048722|365341167|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
105913192|NCT02048722|365341167|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
105913193|NCT02048722|365341167|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
105913194|NCT01529606|365341168|FG000|Overall Study|Lost to Follow-up|21|||
105913195|NCT01529606|365341169|FG001|Overall Study|Lost to Follow-up|18|||
105913196|NCT01825200|365341171|FG000|Overall Study|Lost to Follow-up|5|||
105913197|NCT01825200|365341172|FG001|Overall Study|Lost to Follow-up|6|||
105913198|NCT01825200|365341171|FG000|Overall Study|Withdrawal by Subject|0|||
105913199|NCT01825200|365341172|FG001|Overall Study|Withdrawal by Subject|1|||
105913200|NCT05358821|365341175|FG000|Overall Study|Withdrawal by Subject|0|||
105913201|NCT05358821|365341176|FG001|Overall Study|Withdrawal by Subject|1|||
105913202|NCT05358821|365341177|FG002|Overall Study|Withdrawal by Subject|0|||
105913203|NCT05358821|365341175|FG000|Overall Study|Withdrawal of Consent|0|||
105913204|NCT05358821|365341176|FG001|Overall Study|Withdrawal of Consent|0|||
105913205|NCT05358821|365341177|FG002|Overall Study|Withdrawal of Consent|1|||
105913206|NCT04073303|365341181|FG000|Overall Study|Adverse Event|0|||
105913207|NCT04073303|365341182|FG001|Overall Study|Adverse Event|2|||
105913208|NCT04073303|365341181|FG000|Overall Study|Withdrawal by Subject|16|||
105913209|NCT04073303|365341182|FG001|Overall Study|Withdrawal by Subject|36|||
105913210|NCT04073303|365341181|FG000|Overall Study|Lost to Follow-up|6|||
105913211|NCT04073303|365341182|FG001|Overall Study|Lost to Follow-up|1|||
105913212|NCT04073303|365341181|FG000|Overall Study|Protocol Deviation|0|||
105913213|NCT04073303|365341182|FG001|Overall Study|Protocol Deviation|4|||
105913214|NCT04073303|365341181|FG000|Overall Study|Other|1|||
105913215|NCT04073303|365341182|FG001|Overall Study|Other|1|||
105913216|NCT04144322|365341183|FG000|Overall Study|Lack of Efficacy|2|||
105913217|NCT04144322|365341184|FG001|Overall Study|Lack of Efficacy|2|||
105913218|NCT04795466|365341185|FG000|Overall Study|Adverse Event|3|||
105913219|NCT04795466|365341186|FG001|Overall Study|Adverse Event|1|||
105913220|NCT04795466|365341185|FG000|Overall Study|Physician Decision|1|||
105913221|NCT04795466|365341186|FG001|Overall Study|Physician Decision|0|||
105913222|NCT04795466|365341185|FG000|Overall Study|Withdrawal by Subject|2|||
105913223|NCT04795466|365341186|FG001|Overall Study|Withdrawal by Subject|1|||
105913224|NCT02131064|365341187|FG000|Overall Study|Death|5|||
105913225|NCT02131064|365341188|FG001|Overall Study|Death|6|||
105676789|NCT00766363|364479382|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
105676790|NCT00766363|364479383|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
105676791|NCT00766363|364479384|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
105676792|NCT01153321|364479385|FG000|Overall Study|Development of study withdrawal criteria|0|||
105676793|NCT01153321|364479386|FG001|Overall Study|Development of study withdrawal criteria|1|||
105676794|NCT01153321|364479385|FG000|Overall Study|Withdrawal by Subject|0|||
105676795|NCT01153321|364479386|FG001|Overall Study|Withdrawal by Subject|1|||
105676796|NCT01153321|364479385|FG000|Overall Study|Adverse Event|1|||
105676797|NCT01153321|364479386|FG001|Overall Study|Adverse Event|1|||
105676798|NCT03527550|364479387|FG000|Overall Study|Lost to Follow-up|4|||
105676799|NCT03527550|364479388|FG001|Overall Study|Lost to Follow-up|2|||
105676800|NCT03527550|364479387|FG000|Overall Study|Withdrawal by Subject|4|||
105676801|NCT03527550|364479388|FG001|Overall Study|Withdrawal by Subject|1|||
105676802|NCT03527550|364479387|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
105676803|NCT03527550|364479388|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
105676804|NCT03212989|364479389|FG000|Overall Study|Physician Decision|8|||
105676805|NCT00993668|364479390|FG000|Single-Blind Period|Adverse Event|1|||
105676806|NCT00993668|364479391|FG001|Single-Blind Period|Adverse Event|1|||
105676807|NCT00993668|364479390|FG000|Single-Blind Period|Lack of Efficacy|0|||
105676808|NCT00993668|364479391|FG001|Single-Blind Period|Lack of Efficacy|1|||
105676809|NCT00993668|364479390|FG000|Single-Blind Period|Lost to Follow-up|3|||
105676810|NCT00993668|364479391|FG001|Single-Blind Period|Lost to Follow-up|1|||
105676811|NCT00993668|364479390|FG000|Open-Label Period|Adverse Event|9|||
105676812|NCT00993668|364479391|FG001|Open-Label Period|Adverse Event|8|||
105676813|NCT00993668|364479390|FG000|Open-Label Period|Lack of Efficacy|4|||
105676814|NCT00993668|364479391|FG001|Open-Label Period|Lack of Efficacy|3|||
105676815|NCT00993668|364479390|FG000|Open-Label Period|Withdrawal by Subject|4|||
105676816|NCT00993668|364479391|FG001|Open-Label Period|Withdrawal by Subject|3|||
105676817|NCT00993668|364479390|FG000|Open-Label Period|Lost to Follow-up|6|||
105676818|NCT00993668|364479391|FG001|Open-Label Period|Lost to Follow-up|1|||
105676819|NCT01014143|364479400|FG000|Second Intervention|Lost to Follow-up|2|||
105676820|NCT01014143|364479401|FG001|Second Intervention|Lost to Follow-up|0|||
105676821|NCT01014143|364479402|FG002|Second Intervention|Lost to Follow-up|0|||
105676822|NCT00424385|364479405|FG000|Cohort 0|Withdrawal by Subject|5|||
105676823|NCT00424385|364479405|FG000|Cohort 0|Physician Decision|1|||
105676824|NCT00424385|364479405|FG000|Cohort 1|Withdrawal by Subject|1|||
105676825|NCT04638920|364479412|FG000|Overall Study|Withdrawal by Subject|5|||
105676826|NCT00141219|364479417|FG000|Overall Study|Protocol violations|5|||
105676827|NCT00141219|364479418|FG001|Overall Study|Protocol violations|4|||
105676828|NCT00141219|364479417|FG000|Overall Study|Adverse Event|8|||
105676829|NCT00141219|364479418|FG001|Overall Study|Adverse Event|6|||
105676830|NCT00141219|364479417|FG000|Overall Study|Lack of Efficacy|5|||
105676831|NCT00141219|364479418|FG001|Overall Study|Lack of Efficacy|4|||
105676832|NCT00141219|364479417|FG000|Overall Study|Withdrawal by Subject|6|||
105676833|NCT00141219|364479418|FG001|Overall Study|Withdrawal by Subject|2|||
105676834|NCT02224690|364479419|FG000|Overall Study|Adverse Event|8|||
105676835|NCT02224690|364479420|FG001|Overall Study|Adverse Event|1|||
105676836|NCT02224690|364479419|FG000|Overall Study|Met Withdrawal Criteria|4|||
105676837|NCT02224690|364479420|FG001|Overall Study|Met Withdrawal Criteria|0|||
105676838|NCT02224690|364479419|FG000|Overall Study|Use of G-tube|1|||
105676839|NCT02224690|364479420|FG001|Overall Study|Use of G-tube|0|||
105676840|NCT02224690|364479419|FG000|Overall Study|Did not meet eligibility criteria|1|||
105913226|NCT02131064|365341187|FG000|Overall Study|Lost to Follow-up|4|||
105913227|NCT02131064|365341188|FG001|Overall Study|Lost to Follow-up|8|||
105913228|NCT02131064|365341187|FG000|Overall Study|Withdrawal by Subject|14|||
105913229|NCT02131064|365341188|FG001|Overall Study|Withdrawal by Subject|18|||
105913230|NCT02131064|365341187|FG000|Overall Study|Other|2|||
105913231|NCT02131064|365341188|FG001|Overall Study|Other|2|||
105676841|NCT02224690|364479420|FG001|Overall Study|Did not meet eligibility criteria|0|||
105676842|NCT00122460|364479421|FG000|Overall Study|investigational study phase ongoing|7|||
105676843|NCT00122460|364479422|FG001|Overall Study|investigational study phase ongoing|1|||
105676844|NCT02595073|364479425|FG000|Overall Study|Progressive Disease|0|||
105676845|NCT02595073|364479426|FG001|Overall Study|Progressive Disease|1|||
105676846|NCT02595073|364479425|FG000|Overall Study|Protocol Violation|2|||
105913232|NCT04613518|365341189|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
105913233|NCT04613518|365341190|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
106125707|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
105676847|NCT02595073|364479426|FG001|Overall Study|Protocol Violation|0|||
105676848|NCT02884908|364479427|FG000|Overall Study|Lost to Follow-up|13|||
105676849|NCT02884908|364479428|FG001|Overall Study|Lost to Follow-up|18|||
105676850|NCT01801735|364479432|FG000|Overall Study|Adverse Event|79|||
105676851|NCT01801735|364479432|FG000|Overall Study|Lack of Efficacy|28|||
105676852|NCT01801735|364479432|FG000|Overall Study|Withdrawal by Subject|27|||
105676853|NCT01801735|364479432|FG000|Overall Study|Protocol Violation|25|||
105913234|NCT04613518|365341191|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
105913235|NCT04613518|365341189|FG000|Double-Blind Treatment Period|Adverse Event|2|||
105676854|NCT01801735|364479432|FG000|Overall Study|Lost to Follow-up|15|||
105676855|NCT01801735|364479432|FG000|Overall Study|Non-compliance with Trial Drug|13|||
105676856|NCT01801735|364479432|FG000|Overall Study|Physician Decision|3|||
105676857|NCT01801735|364479432|FG000|Overall Study|Death|1|||
105676858|NCT01801735|364479432|FG000|Overall Study|Other, including site closure|19|||
105676859|NCT00560066|364479433|FG000|Overall Study|Death|2|||
105676860|NCT00560066|364479434|FG001|Overall Study|Death|1|||
105676861|NCT00560066|364479433|FG000|Overall Study|Withdrawal by Subject|0|||
105676862|NCT00560066|364479434|FG001|Overall Study|Withdrawal by Subject|3|||
105676863|NCT00560066|364479433|FG000|Overall Study|Lost to Follow-up|4|||
105676864|NCT00560066|364479434|FG001|Overall Study|Lost to Follow-up|10|||
105676865|NCT00560066|364479433|FG000|Overall Study|Protocol Violation|0|||
105676866|NCT00560066|364479434|FG001|Overall Study|Protocol Violation|1|||
105676867|NCT00560066|364479433|FG000|Overall Study|Administrative reason|0|||
105676868|NCT00560066|364479434|FG001|Overall Study|Administrative reason|5|||
105676869|NCT00560066|364479433|FG000|Overall Study|Missing primary reason|0|||
105676870|NCT00560066|364479434|FG001|Overall Study|Missing primary reason|2|||
105676871|NCT01605019|364479435|FG000|Overall Study|pt did not meet transplant endpoint|3|||
105676872|NCT01605019|364479436|FG001|Overall Study|pt did not meet transplant endpoint|0|||
105676873|NCT04860297|364479437|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
105676874|NCT04860297|364479438|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
105676875|NCT04860297|364479439|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
105676876|NCT04860297|364479440|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
105676877|NCT04860297|364479441|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
105676878|NCT04860297|364479442|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
105676879|NCT04860297|364479443|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
105676880|NCT04860297|364479444|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
105676881|NCT04860297|364479437|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
105676882|NCT04860297|364479438|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
105676883|NCT04860297|364479439|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
105676884|NCT04860297|364479440|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
105676885|NCT04860297|364479441|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
105676886|NCT04860297|364479442|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
105676887|NCT04860297|364479443|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
105676888|NCT04860297|364479444|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
105676889|NCT04860297|364479437|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
105676890|NCT04860297|364479438|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
105676891|NCT04860297|364479439|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
105676892|NCT04860297|364479440|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
105913236|NCT04613518|365341190|FG001|Double-Blind Treatment Period|Adverse Event|0|||
105999915|NCT00148759|365661230|FG000|Overall Study|Lost to Follow-up|1|||
105913237|NCT04613518|365341191|FG002|Double-Blind Treatment Period|Adverse Event|1|||
105913238|NCT04613518|365341189|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
105913239|NCT04613518|365341190|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
105913240|NCT04613518|365341191|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
105913241|NCT04613518|365341189|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
105913242|NCT04613518|365341190|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
105913243|NCT04613518|365341191|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
105913244|NCT04613518|365341189|FG000|Double-Blind Treatment Period|Other Reasons|2|||
105913245|NCT04613518|365341190|FG001|Double-Blind Treatment Period|Other Reasons|0|||
105913246|NCT04613518|365341191|FG002|Double-Blind Treatment Period|Other Reasons|0|||
105913247|NCT04613518|365341189|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
105913248|NCT04613518|365341190|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
105913249|NCT04613518|365341191|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
105913250|NCT04613518|365341189|FG000|Open-Label Treatment Period|Adverse Event|1|||
105913251|NCT04613518|365341190|FG001|Open-Label Treatment Period|Adverse Event|0|||
105913252|NCT04613518|365341191|FG002|Open-Label Treatment Period|Adverse Event|3|||
105913253|NCT04613518|365341189|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
105913254|NCT04613518|365341190|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
105913255|NCT04613518|365341191|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
105913256|NCT04613518|365341189|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
105913257|NCT04613518|365341190|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
105676893|NCT04860297|364479441|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
105676894|NCT04860297|364479442|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
105913258|NCT04613518|365341191|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
105913259|NCT04613518|365341189|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
105676895|NCT04860297|364479443|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
105676896|NCT04860297|364479444|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
105913260|NCT04613518|365341190|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
105913261|NCT04613518|365341191|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
105913262|NCT04613518|365341189|FG000|Open-Label Treatment Period|Other reasons|1|||
105676897|NCT04860297|364479437|FG000|Part B (Booster Dose)|Other Than Specified|0|||
105676898|NCT04860297|364479438|FG001|Part B (Booster Dose)|Other Than Specified|0|||
105676899|NCT04860297|364479439|FG002|Part B (Booster Dose)|Other Than Specified|0|||
105676900|NCT04860297|364479440|FG003|Part B (Booster Dose)|Other Than Specified|0|||
105676901|NCT04860297|364479441|FG004|Part B (Booster Dose)|Other Than Specified|0|||
105676902|NCT04860297|364479442|FG005|Part B (Booster Dose)|Other Than Specified|1|||
105676903|NCT04860297|364479443|FG006|Part B (Booster Dose)|Other Than Specified|1|||
105676904|NCT04860297|364479444|FG007|Part B (Booster Dose)|Other Than Specified|0|||
105676905|NCT04860297|364479437|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676906|NCT04860297|364479438|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676907|NCT04860297|364479439|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676908|NCT04860297|364479440|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676909|NCT04860297|364479441|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676910|NCT04860297|364479442|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
105676911|NCT04860297|364479443|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
105676912|NCT04860297|364479444|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
105676913|NCT04860297|364479437|FG000|Part B (Booster Dose)|Death|0|||
105676914|NCT04860297|364479438|FG001|Part B (Booster Dose)|Death|0|||
105676915|NCT04860297|364479439|FG002|Part B (Booster Dose)|Death|0|||
105676916|NCT04860297|364479440|FG003|Part B (Booster Dose)|Death|0|||
105676917|NCT04860297|364479441|FG004|Part B (Booster Dose)|Death|1|||
105676918|NCT04860297|364479442|FG005|Part B (Booster Dose)|Death|2|||
105676919|NCT04860297|364479443|FG006|Part B (Booster Dose)|Death|1|||
105676920|NCT04860297|364479444|FG007|Part B (Booster Dose)|Death|0|||
105676921|NCT04860297|364479437|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
105676922|NCT04860297|364479438|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
105676923|NCT04860297|364479439|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
105676924|NCT04860297|364479440|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
105676925|NCT04860297|364479441|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
105676926|NCT04860297|364479442|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
105676927|NCT04860297|364479443|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
105676928|NCT04860297|364479444|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
105676929|NCT04811131|364479445|FG000|Overall Study|Adverse Event|0|||
105676930|NCT04811131|364479446|FG001|Overall Study|Adverse Event|0|||
105676931|NCT04811131|364479447|FG002|Overall Study|Adverse Event|1|||
105676932|NCT04811131|364479448|FG003|Overall Study|Adverse Event|0|||
105676933|NCT04811131|364479445|FG000|Overall Study|Lack of Efficacy|0|||
105676934|NCT04811131|364479446|FG001|Overall Study|Lack of Efficacy|0|||
105676935|NCT04811131|364479447|FG002|Overall Study|Lack of Efficacy|0|||
105676936|NCT04811131|364479448|FG003|Overall Study|Lack of Efficacy|1|||
105676937|NCT04811131|364479445|FG000|Overall Study|Lost to Follow-up|0|||
105676938|NCT04811131|364479446|FG001|Overall Study|Lost to Follow-up|1|||
105676939|NCT04811131|364479447|FG002|Overall Study|Lost to Follow-up|0|||
105676940|NCT04811131|364479448|FG003|Overall Study|Lost to Follow-up|0|||
105676941|NCT04811131|364479445|FG000|Overall Study|Sponsor request|31|||
105676942|NCT04811131|364479446|FG001|Overall Study|Sponsor request|35|||
105676943|NCT04811131|364479447|FG002|Overall Study|Sponsor request|27|||
105676944|NCT04811131|364479448|FG003|Overall Study|Sponsor request|10|||
105676945|NCT04811131|364479445|FG000|Overall Study|Withdrawal by Subject|3|||
105676946|NCT04811131|364479446|FG001|Overall Study|Withdrawal by Subject|1|||
105676947|NCT04811131|364479447|FG002|Overall Study|Withdrawal by Subject|3|||
105676948|NCT04811131|364479448|FG003|Overall Study|Withdrawal by Subject|1|||
105676949|NCT00798590|364479449|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
105676950|NCT00798590|364479450|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
105676951|NCT03223662|364479453|FG000|Overall Study|Physician Decision|1|||
105676952|NCT03223662|364479453|FG000|Overall Study|Study closure|1|||
105913263|NCT04613518|365341190|FG001|Open-Label Treatment Period|Other reasons|0|||
105913264|NCT04613518|365341191|FG002|Open-Label Treatment Period|Other reasons|0|||
105913265|NCT03589807|365341194|FG000|Overall Study|Lost to Follow-up|0|||
105913266|NCT03589807|365341195|FG001|Overall Study|Lost to Follow-up|2|||
105913267|NCT03589807|365341196|FG002|Overall Study|Lost to Follow-up|2|||
105913268|NCT03589807|365341197|FG003|Overall Study|Lost to Follow-up|3|||
105913269|NCT03589807|365341198|FG004|Overall Study|Lost to Follow-up|1|||
105913270|NCT03589807|365341199|FG005|Overall Study|Lost to Follow-up|1|||
105676953|NCT01258595|364479454|FG000|Overall Study|Lost to Follow-up|1|||
105676954|NCT01258595|364479455|FG001|Overall Study|Lost to Follow-up|0|||
105676955|NCT01258595|364479454|FG000|Overall Study|Withdrawal by Subject|0|||
105676956|NCT01258595|364479455|FG001|Overall Study|Withdrawal by Subject|1|||
105676957|NCT01528345|364479456|FG000|Overall Study|Adverse Event|10|||
105676958|NCT01528345|364479457|FG001|Overall Study|Adverse Event|1|||
105676959|NCT01528345|364479456|FG000|Overall Study|Death|1|||
105676960|NCT01528345|364479457|FG001|Overall Study|Death|1|||
105676961|NCT01528345|364479456|FG000|Overall Study|Non-compliance with study treatment|1|||
105676962|NCT01528345|364479457|FG001|Overall Study|Non-compliance with study treatment|0|||
105676963|NCT01528345|364479456|FG000|Overall Study|Progressive Disease|26|||
105913271|NCT03589807|365341194|FG000|Overall Study|Withdrawal by Subject|0|||
105913272|NCT03589807|365341195|FG001|Overall Study|Withdrawal by Subject|5|||
105676964|NCT01528345|364479457|FG001|Overall Study|Progressive Disease|40|||
105676965|NCT01528345|364479456|FG000|Overall Study|Study Terminated by Sponsor|4|||
105676966|NCT01528345|364479457|FG001|Overall Study|Study Terminated by Sponsor|8|||
105676967|NCT01528345|364479456|FG000|Overall Study|Subject/Guardian Decision|5|||
105676968|NCT01528345|364479457|FG001|Overall Study|Subject/Guardian Decision|0|||
105676969|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Death|1|||
105676970|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Death|1|||
105676971|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
105676972|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
105676973|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
105676974|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
105676975|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
105676976|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
105676977|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
105676978|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
105676979|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
105676980|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
105676981|NCT00371683|364479458|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
105676982|NCT00371683|364479459|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
105676983|NCT00371683|364479458|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
105676984|NCT00371683|364479459|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
105676985|NCT00371683|364479458|FG000|Follow-Up Period - Randomized Patients|Death|0|||
105676986|NCT00371683|364479459|FG001|Follow-Up Period - Randomized Patients|Death|2|||
105676987|NCT00371683|364479458|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
105676988|NCT00371683|364479459|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
105676989|NCT00371683|364479458|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
105676990|NCT00371683|364479459|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
105676991|NCT02971761|364479460|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
105676992|NCT03181789|364479461|FG000|Overall Study|Withdrawal by Subject|0|||
105676993|NCT03181789|364479462|FG001|Overall Study|Withdrawal by Subject|1|||
105676994|NCT03181789|364479463|FG002|Overall Study|Withdrawal by Subject|1|||
105676995|NCT03181789|364479464|FG003|Overall Study|Withdrawal by Subject|0|||
105676996|NCT03181789|364479461|FG000|Overall Study|Lost to Follow-up|7|||
105676997|NCT03181789|364479462|FG001|Overall Study|Lost to Follow-up|1|||
105676998|NCT03181789|364479463|FG002|Overall Study|Lost to Follow-up|0|||
105676999|NCT03181789|364479464|FG003|Overall Study|Lost to Follow-up|0|||
105677000|NCT03181789|364479461|FG000|Overall Study|Participant unable to adhere to visit|0|||
105786429|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
105913273|NCT03589807|365341196|FG002|Overall Study|Withdrawal by Subject|0|||
105913274|NCT03589807|365341197|FG003|Overall Study|Withdrawal by Subject|0|||
105913275|NCT03589807|365341198|FG004|Overall Study|Withdrawal by Subject|0|||
105913276|NCT03589807|365341199|FG005|Overall Study|Withdrawal by Subject|0|||
105913277|NCT03589807|365341194|FG000|Overall Study|Protocol Violation|0|||
105913278|NCT03589807|365341195|FG001|Overall Study|Protocol Violation|0|||
105913279|NCT03589807|365341196|FG002|Overall Study|Protocol Violation|0|||
105913280|NCT03589807|365341197|FG003|Overall Study|Protocol Violation|1|||
105677001|NCT03181789|364479462|FG001|Overall Study|Participant unable to adhere to visit|1|||
105677002|NCT03181789|364479463|FG002|Overall Study|Participant unable to adhere to visit|0|||
105677003|NCT03181789|364479464|FG003|Overall Study|Participant unable to adhere to visit|0|||
105677004|NCT00735475|364479465|FG000|Overall Study|Adverse Event|0|||
105677005|NCT00735475|364479466|FG001|Overall Study|Adverse Event|1|||
105677006|NCT00735475|364479465|FG000|Overall Study|Death|1|||
105677007|NCT00735475|364479466|FG001|Overall Study|Death|1|||
105677008|NCT00735475|364479465|FG000|Overall Study|Lost to Follow-up|3|||
105677009|NCT00735475|364479466|FG001|Overall Study|Lost to Follow-up|3|||
105786430|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
105913281|NCT03589807|365341198|FG004|Overall Study|Protocol Violation|0|||
105913282|NCT03589807|365341199|FG005|Overall Study|Protocol Violation|0|||
105913283|NCT03589807|365341194|FG000|Overall Study|Enrolled but treatment not administered|0|||
105913284|NCT03589807|365341195|FG001|Overall Study|Enrolled but treatment not administered|0|||
105913285|NCT03589807|365341196|FG002|Overall Study|Enrolled but treatment not administered|0|||
105913286|NCT03589807|365341197|FG003|Overall Study|Enrolled but treatment not administered|0|||
105913287|NCT03589807|365341198|FG004|Overall Study|Enrolled but treatment not administered|1|||
105913288|NCT03589807|365341199|FG005|Overall Study|Enrolled but treatment not administered|0|||
105677010|NCT00735475|364479465|FG000|Overall Study|Physician Decision|0|||
105677011|NCT00735475|364479466|FG001|Overall Study|Physician Decision|1|||
105786431|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
105913289|NCT01534273|365341200|FG000|Period 1|Physician Decision|0|||
105913290|NCT01534273|365341201|FG001|Period 1|Physician Decision|0|||
106125708|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
106125709|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Changed Mind|2|||
105999916|NCT00148759|365661231|FG001|Overall Study|Lost to Follow-up|0|||
105999917|NCT02753946|365661232|FG000|Overall Study|Adverse Event|7|||
105999918|NCT02753946|365661233|FG001|Overall Study|Adverse Event|6|||
105999919|NCT02753946|365661232|FG000|Overall Study|Withdrawal by Subject|6|||
105999920|NCT02753946|365661233|FG001|Overall Study|Withdrawal by Subject|1|||
105999921|NCT02753946|365661232|FG000|Overall Study|Lack of Efficacy|1|||
105999922|NCT02753946|365661233|FG001|Overall Study|Lack of Efficacy|0|||
105999923|NCT02753946|365661232|FG000|Overall Study|Physician Decision|0|||
105999924|NCT02753946|365661233|FG001|Overall Study|Physician Decision|2|||
105999925|NCT00430716|365661234|FG000|Double Blind Phase|Death|1|||
105999926|NCT00430716|365661235|FG001|Double Blind Phase|Death|0|||
105999927|NCT00430716|365661236|FG002|Double Blind Phase|Death|0|||
105999928|NCT00430716|365661234|FG000|Double Blind Phase|No longer willing to participate|2|||
105999929|NCT00430716|365661235|FG001|Double Blind Phase|No longer willing to participate|1|||
105999930|NCT00430716|365661236|FG002|Double Blind Phase|No longer willing to participate|1|||
105999931|NCT00430716|365661234|FG000|Double Blind Phase|Other|0|||
105677012|NCT00735475|364479465|FG000|Overall Study|Withdrawal by Subject|4|||
105999932|NCT00430716|365661235|FG001|Double Blind Phase|Other|2|||
105999933|NCT00430716|365661236|FG002|Double Blind Phase|Other|0|||
105999934|NCT00430716|365661234|FG000|Double Blind Phase|Study terminated by sponsor|1|||
105677013|NCT00735475|364479466|FG001|Overall Study|Withdrawal by Subject|5|||
105677014|NCT00548262|364479467|FG000|Overall Study|Death|21|||
105677015|NCT00548262|364479467|FG000|Overall Study|Adverse Event|2|||
105677016|NCT00548262|364479467|FG000|Overall Study|Lack of Efficacy|4|||
105677017|NCT00548262|364479467|FG000|Overall Study|Lost to Follow-up|1|||
105677018|NCT00548262|364479467|FG000|Overall Study|Other|3|||
105677019|NCT00548262|364479467|FG000|Overall Study|Withdrawal by Subject|1|||
105677020|NCT02285153|364479468|FG000|Overall Study|Adverse Event|1|||
105677021|NCT02285153|364479469|FG001|Overall Study|Adverse Event|0|||
105677022|NCT02442336|364479476|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
105677023|NCT02442336|364479476|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
105677024|NCT02442336|364479476|FG000|Overall Study|Lost to Follow-up|11|||
105677025|NCT00998790|364479477|FG000|Overall Study|Withdrawal by Subject|21|||
105677026|NCT04602221|364479479|FG000|Overall Study|Discontinuation of trial treatment|0|||
105677027|NCT04602221|364479480|FG001|Overall Study|Discontinuation of trial treatment|0|||
105677028|NCT04602221|364479481|FG002|Overall Study|Discontinuation of trial treatment|1|||
105677029|NCT04602221|364479482|FG003|Overall Study|Discontinuation of trial treatment|0|||
105677030|NCT04602221|364479483|FG004|Overall Study|Discontinuation of trial treatment|0|||
105677031|NCT04602221|364479484|FG005|Overall Study|Discontinuation of trial treatment|0|||
105677032|NCT04602221|364479485|FG006|Overall Study|Discontinuation of trial treatment|0|||
105677033|NCT04602221|364479486|FG007|Overall Study|Discontinuation of trial treatment|0|||
105677034|NCT04602221|364479487|FG008|Overall Study|Discontinuation of trial treatment|0|||
105677035|NCT04602221|364479488|FG009|Overall Study|Discontinuation of trial treatment|0|||
105677036|NCT04602221|364479489|FG010|Overall Study|Discontinuation of trial treatment|0|||
105677037|NCT04602221|364479490|FG011|Overall Study|Discontinuation of trial treatment|0|||
105677038|NCT04602221|364479491|FG012|Overall Study|Discontinuation of trial treatment|0|||
105677039|NCT04602221|364479492|FG013|Overall Study|Discontinuation of trial treatment|0|||
105677040|NCT04602221|364479493|FG014|Overall Study|Discontinuation of trial treatment|0|||
105677041|NCT04602221|364479494|FG015|Overall Study|Discontinuation of trial treatment|0|||
105677042|NCT04602221|364479495|FG016|Overall Study|Discontinuation of trial treatment|0|||
105677043|NCT04602221|364479496|FG017|Overall Study|Discontinuation of trial treatment|0|||
105677044|NCT04602221|364479479|FG000|Overall Study|Other than listed|0|||
105677045|NCT04602221|364479480|FG001|Overall Study|Other than listed|0|||
105677046|NCT04602221|364479481|FG002|Overall Study|Other than listed|0|||
105677047|NCT04602221|364479482|FG003|Overall Study|Other than listed|0|||
105677048|NCT04602221|364479483|FG004|Overall Study|Other than listed|0|||
105677049|NCT04602221|364479484|FG005|Overall Study|Other than listed|0|||
105677050|NCT04602221|364479485|FG006|Overall Study|Other than listed|0|||
105677051|NCT04602221|364479486|FG007|Overall Study|Other than listed|0|||
105677052|NCT04602221|364479487|FG008|Overall Study|Other than listed|0|||
105677053|NCT04602221|364479488|FG009|Overall Study|Other than listed|0|||
105677054|NCT04602221|364479489|FG010|Overall Study|Other than listed|0|||
105677055|NCT04602221|364479490|FG011|Overall Study|Other than listed|0|||
105677056|NCT04602221|364479491|FG012|Overall Study|Other than listed|0|||
105677057|NCT04602221|364479492|FG013|Overall Study|Other than listed|0|||
105677058|NCT04602221|364479493|FG014|Overall Study|Other than listed|0|||
105677059|NCT04602221|364479494|FG015|Overall Study|Other than listed|1|||
105677060|NCT04602221|364479495|FG016|Overall Study|Other than listed|0|||
105677061|NCT04602221|364479496|FG017|Overall Study|Other than listed|1|||
105677062|NCT04602221|364479479|FG000|Overall Study|Withdrawal by Subject|0|||
105677063|NCT04602221|364479480|FG001|Overall Study|Withdrawal by Subject|0|||
105677064|NCT04602221|364479481|FG002|Overall Study|Withdrawal by Subject|0|||
105677065|NCT04602221|364479482|FG003|Overall Study|Withdrawal by Subject|0|||
105677066|NCT04602221|364479483|FG004|Overall Study|Withdrawal by Subject|0|||
105677067|NCT04602221|364479484|FG005|Overall Study|Withdrawal by Subject|0|||
105677068|NCT04602221|364479485|FG006|Overall Study|Withdrawal by Subject|0|||
105913291|NCT01534273|365341202|FG002|Period 1|Physician Decision|0|||
105677069|NCT04602221|364479486|FG007|Overall Study|Withdrawal by Subject|0|||
105677070|NCT04602221|364479487|FG008|Overall Study|Withdrawal by Subject|0|||
105913292|NCT01534273|365341203|FG003|Period 1|Physician Decision|1|||
105913293|NCT01534273|365341204|FG004|Period 1|Physician Decision|0|||
105913294|NCT01534273|365341205|FG005|Period 1|Physician Decision|0|||
105913295|NCT01534273|365341206|FG006|Period 1|Physician Decision|0|||
105913296|NCT01619865|365341209|FG000|Overall Study|Adverse Event|1|||
105913297|NCT01619865|365341209|FG000|Overall Study|Death|2|||
105913298|NCT01619865|365341209|FG000|Overall Study|subject not able to comply|1|||
105913299|NCT03586050|365341210|FG000|Overall Study|Death|3|||
105913300|NCT03586050|365341210|FG000|Overall Study|Withdrawal by Subject|2|||
105677071|NCT04602221|364479488|FG009|Overall Study|Withdrawal by Subject|0|||
105677072|NCT04602221|364479489|FG010|Overall Study|Withdrawal by Subject|0|||
105677073|NCT04602221|364479490|FG011|Overall Study|Withdrawal by Subject|0|||
105677074|NCT04602221|364479491|FG012|Overall Study|Withdrawal by Subject|1|||
105677075|NCT04602221|364479492|FG013|Overall Study|Withdrawal by Subject|0|||
105913301|NCT04767373|365341211|FG000|Overall Study|Death|6|||
105913302|NCT04767373|365341212|FG001|Overall Study|Death|3|||
105913303|NCT04767373|365341211|FG000|Overall Study|Lost to Follow-up|67|||
105913304|NCT04767373|365341212|FG001|Overall Study|Lost to Follow-up|35|||
105913305|NCT04767373|365341211|FG000|Overall Study|Physician Decision|15|||
105913306|NCT04767373|365341212|FG001|Overall Study|Physician Decision|4|||
105913307|NCT04767373|365341211|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105677076|NCT04602221|364479493|FG014|Overall Study|Withdrawal by Subject|0|||
105677077|NCT04602221|364479494|FG015|Overall Study|Withdrawal by Subject|0|||
105677078|NCT04602221|364479495|FG016|Overall Study|Withdrawal by Subject|0|||
105677079|NCT04602221|364479496|FG017|Overall Study|Withdrawal by Subject|0|||
105677080|NCT04602221|364479479|FG000|Overall Study|Lost to Follow-up|0|||
105677081|NCT04602221|364479480|FG001|Overall Study|Lost to Follow-up|0|||
105677082|NCT04602221|364479481|FG002|Overall Study|Lost to Follow-up|0|||
105677083|NCT04602221|364479482|FG003|Overall Study|Lost to Follow-up|0|||
105677084|NCT04602221|364479483|FG004|Overall Study|Lost to Follow-up|0|||
105677085|NCT04602221|364479484|FG005|Overall Study|Lost to Follow-up|1|||
105677086|NCT04602221|364479485|FG006|Overall Study|Lost to Follow-up|0|||
105677087|NCT04602221|364479486|FG007|Overall Study|Lost to Follow-up|0|||
105677088|NCT04602221|364479487|FG008|Overall Study|Lost to Follow-up|0|||
105677089|NCT04602221|364479488|FG009|Overall Study|Lost to Follow-up|0|||
105677090|NCT04602221|364479489|FG010|Overall Study|Lost to Follow-up|0|||
105677091|NCT04602221|364479490|FG011|Overall Study|Lost to Follow-up|0|||
105913308|NCT04767373|365341212|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105913309|NCT04767373|365341211|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
105913310|NCT04767373|365341212|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
105913311|NCT04767373|365341211|FG000|Overall Study|Other|1|||
105913312|NCT04767373|365341212|FG001|Overall Study|Other|2|||
105913313|NCT02658669|365341213|FG000|Overall Study|Lost to Follow-up|7|||
105913314|NCT02658669|365341214|FG001|Overall Study|Lost to Follow-up|5|||
105913315|NCT01435759|365341215|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
105913316|NCT01435759|365341216|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
105913317|NCT01435759|365341217|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
105913318|NCT01435759|365341218|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
105913319|NCT01435759|365341219|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
105913320|NCT01435759|365341220|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
105913321|NCT01435759|365341215|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
105913322|NCT01435759|365341216|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
105913323|NCT01435759|365341217|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
105913324|NCT01435759|365341218|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
105913325|NCT01435759|365341219|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
105913326|NCT01435759|365341220|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
105913327|NCT01435759|365341215|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
105913328|NCT01435759|365341216|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105913329|NCT01435759|365341217|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105913330|NCT01435759|365341218|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105913331|NCT01435759|365341219|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105913332|NCT01435759|365341220|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
105913333|NCT01435759|365341215|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
105913334|NCT01435759|365341216|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105913335|NCT01435759|365341217|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105913336|NCT01435759|365341218|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105913337|NCT01435759|365341219|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105913338|NCT01435759|365341220|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
105913339|NCT01435759|365341215|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
105913340|NCT01435759|365341216|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105913341|NCT01435759|365341217|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105913342|NCT01435759|365341218|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105913343|NCT01435759|365341219|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105913344|NCT01435759|365341220|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105913345|NCT01435759|365341215|FG000|Antidepressant Lead-in Phase|Other|119|||
105913346|NCT01435759|365341216|FG001|Antidepressant Lead-in Phase|Other|0|||
105913347|NCT01435759|365341217|FG002|Antidepressant Lead-in Phase|Other|0|||
105913348|NCT01435759|365341218|FG003|Antidepressant Lead-in Phase|Other|0|||
105913349|NCT01435759|365341219|FG004|Antidepressant Lead-in Phase|Other|0|||
105913350|NCT01435759|365341220|FG005|Antidepressant Lead-in Phase|Other|0|||
105913351|NCT01435759|365341215|FG000|Double-blind Phase|Adverse Event|7|||
105913352|NCT01435759|365341216|FG001|Double-blind Phase|Adverse Event|0|||
105913353|NCT01435759|365341217|FG002|Double-blind Phase|Adverse Event|1|||
105677092|NCT04602221|364479491|FG012|Overall Study|Lost to Follow-up|0|||
105913354|NCT01435759|365341218|FG003|Double-blind Phase|Adverse Event|1|||
105913355|NCT01435759|365341219|FG004|Double-blind Phase|Adverse Event|1|||
105913356|NCT01435759|365341220|FG005|Double-blind Phase|Adverse Event|3|||
105677093|NCT04602221|364479492|FG013|Overall Study|Lost to Follow-up|0|||
105677094|NCT04602221|364479493|FG014|Overall Study|Lost to Follow-up|0|||
105913357|NCT01435759|365341215|FG000|Double-blind Phase|Protocol Violation|2|||
105913358|NCT01435759|365341216|FG001|Double-blind Phase|Protocol Violation|0|||
105913359|NCT01435759|365341217|FG002|Double-blind Phase|Protocol Violation|1|||
105677095|NCT04602221|364479494|FG015|Overall Study|Lost to Follow-up|0|||
105677096|NCT04602221|364479495|FG016|Overall Study|Lost to Follow-up|0|||
105677097|NCT04602221|364479496|FG017|Overall Study|Lost to Follow-up|0|||
105677098|NCT01942590|364479498|FG000|Overall Study|Withdrawal by Subject|0|||
105677099|NCT01942590|364479499|FG001|Overall Study|Withdrawal by Subject|1|||
105677100|NCT01942590|364479498|FG000|Overall Study|Adverse Event|1|||
105677101|NCT01942590|364479499|FG001|Overall Study|Adverse Event|0|||
105677102|NCT01879553|364479500|FG000|Overall Study|Withdrawal by Subject|1|||
105677103|NCT01879553|364479501|FG001|Overall Study|Withdrawal by Subject|0|||
105677104|NCT04927884|364479508|FG000|Overall Study|Progressive Disease|2|||
105677105|NCT00591370|364481598|FG000|Overall Study|Not Treated|2|||
105677106|NCT01879722|364481599|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105677107|NCT01879722|364481600|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105677108|NCT01879722|364481601|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105677109|NCT01879722|364481602|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
105677110|NCT01879722|364481603|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
105677111|NCT01879722|364481604|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
105677112|NCT01879722|364481605|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
105677113|NCT01879722|364481606|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
105677114|NCT01879722|364481607|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
105677115|NCT01879722|364481608|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
105677116|NCT01879722|364481599|FG000|Overall Study|Voluntary Withdrawal|0|||
105677117|NCT01879722|364481600|FG001|Overall Study|Voluntary Withdrawal|0|||
105677118|NCT01879722|364481601|FG002|Overall Study|Voluntary Withdrawal|0|||
105677119|NCT01879722|364481602|FG003|Overall Study|Voluntary Withdrawal|0|||
105677120|NCT01879722|364481603|FG004|Overall Study|Voluntary Withdrawal|0|||
105677121|NCT01879722|364481604|FG005|Overall Study|Voluntary Withdrawal|0|||
105677122|NCT01879722|364481605|FG006|Overall Study|Voluntary Withdrawal|0|||
105677123|NCT01879722|364481606|FG007|Overall Study|Voluntary Withdrawal|0|||
105677124|NCT01879722|364481607|FG008|Overall Study|Voluntary Withdrawal|1|||
105677125|NCT01879722|364481608|FG009|Overall Study|Voluntary Withdrawal|0|||
105677126|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
105677127|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677128|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677129|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677130|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677131|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
105677132|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
105677133|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677134|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105913360|NCT01435759|365341218|FG003|Double-blind Phase|Protocol Violation|2|||
105677135|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677136|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677137|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
105677138|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
105677139|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677140|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677141|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677142|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105913361|NCT01435759|365341219|FG004|Double-blind Phase|Protocol Violation|0|||
105913362|NCT01435759|365341220|FG005|Double-blind Phase|Protocol Violation|1|||
105913363|NCT01435759|365341215|FG000|Double-blind Phase|Withdrawal by Subject|17|||
105913364|NCT01435759|365341216|FG001|Double-blind Phase|Withdrawal by Subject|4|||
105677143|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
105677144|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
105677145|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677146|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677147|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677148|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677149|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
105677150|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
105677151|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677152|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677153|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677154|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677155|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
105677156|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
105677157|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105913365|NCT01435759|365341217|FG002|Double-blind Phase|Withdrawal by Subject|3|||
105913366|NCT01435759|365341218|FG003|Double-blind Phase|Withdrawal by Subject|4|||
105913367|NCT01435759|365341219|FG004|Double-blind Phase|Withdrawal by Subject|2|||
105913368|NCT01435759|365341220|FG005|Double-blind Phase|Withdrawal by Subject|2|||
105677158|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677159|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677160|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677161|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
105677162|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
105677163|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677164|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677165|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677166|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677167|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
105677168|NCT01160289|364481609|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
105677169|NCT01160289|364481610|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677170|NCT01160289|364481611|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677171|NCT01160289|364481612|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677172|NCT01160289|364481613|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677173|NCT01160289|364481614|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
105677174|NCT01160289|364481609|FG000|Post-Randomization Period|Adverse Event|0|||
105677175|NCT01160289|364481610|FG001|Post-Randomization Period|Adverse Event|4|||
105677176|NCT01160289|364481611|FG002|Post-Randomization Period|Adverse Event|4|||
105677177|NCT01160289|364481612|FG003|Post-Randomization Period|Adverse Event|2|||
105677178|NCT01160289|364481613|FG004|Post-Randomization Period|Adverse Event|0|||
105677179|NCT01160289|364481614|FG005|Post-Randomization Period|Adverse Event|0|||
105677180|NCT01160289|364481609|FG000|Post-Randomization Period|Death|0|||
105677181|NCT01160289|364481610|FG001|Post-Randomization Period|Death|0|||
105677182|NCT01160289|364481611|FG002|Post-Randomization Period|Death|0|||
105677183|NCT01160289|364481612|FG003|Post-Randomization Period|Death|1|||
105677184|NCT01160289|364481613|FG004|Post-Randomization Period|Death|0|||
105677185|NCT01160289|364481614|FG005|Post-Randomization Period|Death|0|||
105677186|NCT01160289|364481609|FG000|Post-Randomization Period|Lack of Efficacy|0|||
105677187|NCT01160289|364481610|FG001|Post-Randomization Period|Lack of Efficacy|1|||
105677188|NCT01160289|364481611|FG002|Post-Randomization Period|Lack of Efficacy|0|||
105677189|NCT01160289|364481612|FG003|Post-Randomization Period|Lack of Efficacy|3|||
105677190|NCT01160289|364481613|FG004|Post-Randomization Period|Lack of Efficacy|0|||
105677191|NCT01160289|364481614|FG005|Post-Randomization Period|Lack of Efficacy|0|||
105677192|NCT01160289|364481609|FG000|Post-Randomization Period|Lost to Follow-up|0|||
105677193|NCT01160289|364481610|FG001|Post-Randomization Period|Lost to Follow-up|3|||
105677194|NCT01160289|364481611|FG002|Post-Randomization Period|Lost to Follow-up|2|||
105677195|NCT01160289|364481612|FG003|Post-Randomization Period|Lost to Follow-up|5|||
105677196|NCT01160289|364481613|FG004|Post-Randomization Period|Lost to Follow-up|3|||
105677197|NCT01160289|364481614|FG005|Post-Randomization Period|Lost to Follow-up|4|||
105677198|NCT01160289|364481609|FG000|Post-Randomization Period|Physician Decision|0|||
105677199|NCT01160289|364481610|FG001|Post-Randomization Period|Physician Decision|0|||
105677200|NCT01160289|364481611|FG002|Post-Randomization Period|Physician Decision|1|||
105677201|NCT01160289|364481612|FG003|Post-Randomization Period|Physician Decision|0|||
105677202|NCT01160289|364481613|FG004|Post-Randomization Period|Physician Decision|0|||
105677203|NCT01160289|364481614|FG005|Post-Randomization Period|Physician Decision|0|||
105677204|NCT01160289|364481609|FG000|Post-Randomization Period|Protocol Violation|0|||
105677205|NCT01160289|364481610|FG001|Post-Randomization Period|Protocol Violation|4|||
105677206|NCT01160289|364481611|FG002|Post-Randomization Period|Protocol Violation|2|||
105677207|NCT01160289|364481612|FG003|Post-Randomization Period|Protocol Violation|0|||
105677208|NCT01160289|364481613|FG004|Post-Randomization Period|Protocol Violation|1|||
105677209|NCT01160289|364481614|FG005|Post-Randomization Period|Protocol Violation|3|||
105677210|NCT01160289|364481609|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
105677211|NCT01160289|364481610|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
105677212|NCT01160289|364481611|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
105677213|NCT01160289|364481612|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
105677214|NCT01160289|364481613|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
105677215|NCT01160289|364481614|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
105913369|NCT01435759|365341215|FG000|Double-blind Phase|Lost to Follow-up|31|||
105913370|NCT01435759|365341216|FG001|Double-blind Phase|Lost to Follow-up|1|||
105913371|NCT01435759|365341217|FG002|Double-blind Phase|Lost to Follow-up|2|||
105913372|NCT01435759|365341218|FG003|Double-blind Phase|Lost to Follow-up|0|||
105913373|NCT01435759|365341219|FG004|Double-blind Phase|Lost to Follow-up|3|||
105913374|NCT01435759|365341220|FG005|Double-blind Phase|Lost to Follow-up|3|||
105913375|NCT01435759|365341215|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
105913376|NCT01435759|365341216|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
105913377|NCT01435759|365341217|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
105913378|NCT01435759|365341218|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
105913379|NCT01435759|365341219|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
105677216|NCT01160289|364481609|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
105677217|NCT01160289|364481610|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
105677218|NCT01160289|364481611|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
105677219|NCT01160289|364481612|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
105677220|NCT01160289|364481613|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
105677221|NCT01160289|364481614|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
105677222|NCT01160289|364481609|FG000|Post-Randomization Period|Sponsor Decision|0|||
105677223|NCT01160289|364481610|FG001|Post-Randomization Period|Sponsor Decision|1|||
105677224|NCT01160289|364481611|FG002|Post-Randomization Period|Sponsor Decision|0|||
105677225|NCT01160289|364481612|FG003|Post-Randomization Period|Sponsor Decision|0|||
105677226|NCT01160289|364481613|FG004|Post-Randomization Period|Sponsor Decision|0|||
105677227|NCT01160289|364481614|FG005|Post-Randomization Period|Sponsor Decision|0|||
105677228|NCT01631227|364481618|FG000|Overall Study|withdrawn consent|27|||
105677229|NCT01631227|364481619|FG001|Overall Study|withdrawn consent|21|||
105677230|NCT01631227|364481618|FG000|Overall Study|Adverse Event|1|||
105677231|NCT01631227|364481619|FG001|Overall Study|Adverse Event|0|||
105677232|NCT01631227|364481618|FG000|Overall Study|administrative|2|||
105677233|NCT01631227|364481619|FG001|Overall Study|administrative|1|||
105677234|NCT01097707|364481620|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105677235|NCT01097707|364481621|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105677236|NCT01097707|364481622|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105677237|NCT01097707|364481623|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105677238|NCT01097707|364481624|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105913380|NCT01435759|365341220|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
105677239|NCT01097707|364481620|FG000|Overall Study|Adverse Event|4|||
105677240|NCT01097707|364481621|FG001|Overall Study|Adverse Event|2|||
105677241|NCT01097707|364481622|FG002|Overall Study|Adverse Event|3|||
105677242|NCT01097707|364481623|FG003|Overall Study|Adverse Event|1|||
105677243|NCT01097707|364481624|FG004|Overall Study|Adverse Event|3|||
105677244|NCT01097707|364481620|FG000|Overall Study|Entry Criteria Not Met|2|||
105677245|NCT01097707|364481621|FG001|Overall Study|Entry Criteria Not Met|1|||
105677246|NCT01097707|364481622|FG002|Overall Study|Entry Criteria Not Met|1|||
105677247|NCT01097707|364481623|FG003|Overall Study|Entry Criteria Not Met|0|||
105677248|NCT01097707|364481624|FG004|Overall Study|Entry Criteria Not Met|1|||
105677249|NCT01097707|364481620|FG000|Overall Study|Lack of Efficacy|1|||
105677250|NCT01097707|364481621|FG001|Overall Study|Lack of Efficacy|0|||
105677251|NCT01097707|364481622|FG002|Overall Study|Lack of Efficacy|0|||
105677252|NCT01097707|364481623|FG003|Overall Study|Lack of Efficacy|1|||
105677253|NCT01097707|364481624|FG004|Overall Study|Lack of Efficacy|0|||
105677254|NCT01097707|364481620|FG000|Overall Study|Lost to Follow-up|1|||
105677255|NCT01097707|364481621|FG001|Overall Study|Lost to Follow-up|1|||
105677256|NCT01097707|364481622|FG002|Overall Study|Lost to Follow-up|2|||
105677257|NCT01097707|364481623|FG003|Overall Study|Lost to Follow-up|0|||
105677258|NCT01097707|364481624|FG004|Overall Study|Lost to Follow-up|3|||
105677259|NCT01097707|364481620|FG000|Overall Study|Protocol Violation|2|||
105677260|NCT01097707|364481621|FG001|Overall Study|Protocol Violation|2|||
105677261|NCT01097707|364481622|FG002|Overall Study|Protocol Violation|3|||
105677262|NCT01097707|364481623|FG003|Overall Study|Protocol Violation|2|||
105677263|NCT01097707|364481624|FG004|Overall Study|Protocol Violation|2|||
105677264|NCT01097707|364481620|FG000|Overall Study|Sponsor Decision|31|||
105677265|NCT01097707|364481621|FG001|Overall Study|Sponsor Decision|31|||
105913381|NCT01435759|365341215|FG000|Double-blind Phase|Other|8|||
105913382|NCT01435759|365341216|FG001|Double-blind Phase|Other|2|||
105913383|NCT01435759|365341217|FG002|Double-blind Phase|Other|0|||
105913384|NCT01435759|365341218|FG003|Double-blind Phase|Other|2|||
105913385|NCT01435759|365341219|FG004|Double-blind Phase|Other|0|||
105913386|NCT01435759|365341220|FG005|Double-blind Phase|Other|0|||
105913387|NCT00385918|365341226|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
105913388|NCT00385918|365341227|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
105913389|NCT00385918|365341228|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
105913390|NCT00385918|365341226|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
105913391|NCT00385918|365341227|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
105913392|NCT00385918|365341228|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
105913393|NCT00385918|365341226|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
105913394|NCT00385918|365341227|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
105913395|NCT00385918|365341228|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
105913396|NCT00385918|365341226|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
105913397|NCT00385918|365341227|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
105913398|NCT00385918|365341228|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
105913399|NCT00385918|365341226|FG000|Intervention Phase After Randomization|Physician Decision|1|||
105913400|NCT00385918|365341227|FG001|Intervention Phase After Randomization|Physician Decision|0|||
105677266|NCT01097707|364481622|FG002|Overall Study|Sponsor Decision|34|||
105677267|NCT01097707|364481623|FG003|Overall Study|Sponsor Decision|35|||
105999935|NCT00430716|365661235|FG001|Double Blind Phase|Study terminated by sponsor|1|||
105999936|NCT00430716|365661236|FG002|Double Blind Phase|Study terminated by sponsor|2|||
105999937|NCT00430716|365661234|FG000|Double Blind Phase|Adverse Event|1|||
105999938|NCT00430716|365661235|FG001|Double Blind Phase|Adverse Event|1|||
105999939|NCT00430716|365661236|FG002|Double Blind Phase|Adverse Event|3|||
105999940|NCT00430716|365661234|FG000|Double Blind Phase|Not treated|1|||
105999941|NCT00430716|365661235|FG001|Double Blind Phase|Not treated|0|||
105999942|NCT00430716|365661236|FG002|Double Blind Phase|Not treated|0|||
105999943|NCT00430716|365661234|FG000|Open Label Phase|Lost to Follow-up|1|||
105999944|NCT00430716|365661235|FG001|Open Label Phase|Lost to Follow-up|0|||
105677268|NCT01097707|364481624|FG004|Overall Study|Sponsor Decision|36|||
105999945|NCT00430716|365661236|FG002|Open Label Phase|Lost to Follow-up|1|||
105999946|NCT00430716|365661234|FG000|Open Label Phase|No longer willing to participate|0|||
105999947|NCT00430716|365661235|FG001|Open Label Phase|No longer willing to participate|1|||
105999948|NCT00430716|365661236|FG002|Open Label Phase|No longer willing to participate|1|||
105999949|NCT00430716|365661234|FG000|Open Label Phase|Other|3|||
105999950|NCT00430716|365661235|FG001|Open Label Phase|Other|1|||
105999951|NCT00430716|365661236|FG002|Open Label Phase|Other|1|||
105999952|NCT00430716|365661234|FG000|Open Label Phase|Protocol Violation|1|||
105999953|NCT00430716|365661235|FG001|Open Label Phase|Protocol Violation|0|||
105999954|NCT00430716|365661236|FG002|Open Label Phase|Protocol Violation|0|||
105999955|NCT00430716|365661234|FG000|Open Label Phase|Study terminated by sponsor|4|||
105999956|NCT00430716|365661235|FG001|Open Label Phase|Study terminated by sponsor|5|||
105999957|NCT00430716|365661236|FG002|Open Label Phase|Study terminated by sponsor|4|||
105999958|NCT03087513|365661241|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
105999959|NCT03064490|365661251|FG000|Overall Study|Physician Decision|5|||
105999960|NCT05579977|365661253|FG000|Treatment Phase|Other|0|||
105999961|NCT05579977|365661254|FG001|Treatment Phase|Other|0|||
105999962|NCT05579977|365661255|FG002|Treatment Phase|Other|0|||
105999963|NCT05579977|365661256|FG003|Treatment Phase|Other|2|||
105999964|NCT05579977|365661257|FG004|Treatment Phase|Other|1|||
105999965|NCT05579977|365661258|FG005|Treatment Phase|Other|2|||
105999966|NCT05579977|365661259|FG006|Treatment Phase|Other|1|||
105999967|NCT05579977|365661260|FG007|Treatment Phase|Other|2|||
105999968|NCT05579977|365661261|FG008|Treatment Phase|Other|2|||
105999969|NCT05579977|365661262|FG009|Treatment Phase|Other|1|||
105999970|NCT05579977|365661263|FG010|Treatment Phase|Other|0|||
105999971|NCT05579977|365661264|FG011|Treatment Phase|Other|0|||
105999972|NCT05579977|365661265|FG012|Treatment Phase|Other|3|||
105999973|NCT05579977|365661253|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
105999974|NCT05579977|365661254|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
105677269|NCT01097707|364481620|FG000|Overall Study|Withdrawal by Subject|3|||
105999975|NCT05579977|365661255|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
105999976|NCT05579977|365661256|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
105999977|NCT05579977|365661257|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
105677270|NCT01097707|364481621|FG001|Overall Study|Withdrawal by Subject|6|||
105677271|NCT01097707|364481622|FG002|Overall Study|Withdrawal by Subject|1|||
105677272|NCT01097707|364481623|FG003|Overall Study|Withdrawal by Subject|4|||
105677273|NCT01097707|364481624|FG004|Overall Study|Withdrawal by Subject|3|||
105677274|NCT01097707|364481620|FG000|Overall Study|Reason unknown|0|||
105677275|NCT01097707|364481621|FG001|Overall Study|Reason unknown|0|||
105677276|NCT01097707|364481622|FG002|Overall Study|Reason unknown|0|||
105677277|NCT01097707|364481623|FG003|Overall Study|Reason unknown|0|||
105677278|NCT01097707|364481624|FG004|Overall Study|Reason unknown|1|||
105677279|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
105677280|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
105786432|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
105786433|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
105786434|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
105786435|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
105999978|NCT05579977|365661258|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
105999979|NCT05579977|365661259|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
105999980|NCT05579977|365661260|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
105999981|NCT05579977|365661261|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
105999982|NCT05579977|365661262|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
105999983|NCT05579977|365661263|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
105999984|NCT05579977|365661264|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
105999985|NCT05579977|365661265|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
105999986|NCT05579977|365661253|FG000|Treatment Phase|Withdrawal by Subject|2|||
105999987|NCT05579977|365661254|FG001|Treatment Phase|Withdrawal by Subject|0|||
105999988|NCT05579977|365661255|FG002|Treatment Phase|Withdrawal by Subject|0|||
105999989|NCT05579977|365661256|FG003|Treatment Phase|Withdrawal by Subject|1|||
105999990|NCT05579977|365661257|FG004|Treatment Phase|Withdrawal by Subject|2|||
105999991|NCT05579977|365661258|FG005|Treatment Phase|Withdrawal by Subject|0|||
105999992|NCT05579977|365661259|FG006|Treatment Phase|Withdrawal by Subject|1|||
105999993|NCT05579977|365661260|FG007|Treatment Phase|Withdrawal by Subject|8|||
105999994|NCT05579977|365661261|FG008|Treatment Phase|Withdrawal by Subject|3|||
105999995|NCT05579977|365661262|FG009|Treatment Phase|Withdrawal by Subject|3|||
105999996|NCT05579977|365661263|FG010|Treatment Phase|Withdrawal by Subject|5|||
105999997|NCT05579977|365661264|FG011|Treatment Phase|Withdrawal by Subject|1|||
105999998|NCT05579977|365661265|FG012|Treatment Phase|Withdrawal by Subject|3|||
105999999|NCT05579977|365661253|FG000|Treatment Phase|Study terminated by sponsor|70|||
106000000|NCT05579977|365661254|FG001|Treatment Phase|Study terminated by sponsor|70|||
106000001|NCT05579977|365661255|FG002|Treatment Phase|Study terminated by sponsor|61|||
106000002|NCT05579977|365661256|FG003|Treatment Phase|Study terminated by sponsor|59|||
105677281|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
105677282|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
105786436|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
105786437|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
105786438|NCT04579666|364871387|FG000|RTP (Up to Week 52)|Other|2|||
105786439|NCT04579666|364871388|FG001|RTP (Up to Week 52)|Other|0|||
105786440|NCT04579666|364871389|FG002|RTP (Up to Week 52)|Other|0|||
105913401|NCT00385918|365341228|FG002|Intervention Phase After Randomization|Physician Decision|0|||
105913402|NCT00385918|365341226|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
105913403|NCT00385918|365341227|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
105913404|NCT00385918|365341228|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
105913405|NCT02256839|365341229|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
105913406|NCT02256839|365341230|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
105913407|NCT04202497|365341231|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
105913408|NCT04202497|365341232|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
105913409|NCT04202497|365341233|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
105913410|NCT04202497|365341234|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
105913411|NCT03066830|365341235|FG000|Overall Study|At the Participant's own Request|16|||
105913412|NCT03066830|365341236|FG001|Overall Study|At the Participant's own Request|17|||
105913413|NCT03066830|365341235|FG000|Overall Study|Other|3|||
105913414|NCT03066830|365341236|FG001|Overall Study|Other|0|||
105913415|NCT03066830|365341235|FG000|Overall Study|Poor Compliance to Protocol|1|||
105913416|NCT03066830|365341236|FG001|Overall Study|Poor Compliance to Protocol|0|||
105913417|NCT03066830|365341235|FG000|Overall Study|Adverse Event|2|||
105913418|NCT03066830|365341236|FG001|Overall Study|Adverse Event|2|||
105913419|NCT03066830|365341235|FG000|Overall Study|Lost to Follow-up|11|||
105913420|NCT03066830|365341236|FG001|Overall Study|Lost to Follow-up|3|||
105913421|NCT00248651|365341239|FG000|Overall Study|Withdrawal by Subject|28|||
105913422|NCT00248651|365341240|FG001|Overall Study|Withdrawal by Subject|40|||
105913423|NCT00248651|365341241|FG002|Overall Study|Withdrawal by Subject|32|||
105913424|NCT00828113|365341242|FG000|Overall Study|Withdrawal by Subject|27|||
105913425|NCT00828113|365341243|FG001|Overall Study|Withdrawal by Subject|26|||
105913426|NCT00828113|365341242|FG000|Overall Study|Lost to Follow-up|3|||
105677283|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
105677284|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
105677285|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
105677286|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
105677287|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
105677288|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
105677289|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
105677290|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
105677291|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
105677292|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
105677293|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
105677294|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
105677295|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
105677296|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
105677297|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
105677298|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
105677299|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
105677300|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
105677301|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
105677302|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
105677303|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
105677304|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
105677305|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
105677306|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
105677307|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
105677308|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
105677309|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
105677310|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
105677311|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
105677312|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
105677313|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
105677314|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
105677315|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
105677316|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
105677317|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
105677318|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
105677319|NCT00700427|364481628|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
105677320|NCT00700427|364481629|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
105677321|NCT00700427|364481630|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
105677322|NCT00700427|364481631|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
105677323|NCT00700427|364481632|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
105677324|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
105677325|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
105677326|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
105677327|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
105677328|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
105677329|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
105677330|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
105677331|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
105677332|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
105677333|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
105677334|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
105677335|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
105677336|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
105677337|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
105913427|NCT00828113|365341243|FG001|Overall Study|Lost to Follow-up|5|||
105913428|NCT01091246|365341254|FG000|Overall Study|Lost to Follow-up|23|||
105913429|NCT01091246|365341255|FG001|Overall Study|Lost to Follow-up|11|||
105913430|NCT01091246|365341256|FG002|Overall Study|Lost to Follow-up|7|||
105913431|NCT01091246|365341254|FG000|Overall Study|Adverse Event|1|||
105913432|NCT01091246|365341255|FG001|Overall Study|Adverse Event|0|||
105913433|NCT01091246|365341256|FG002|Overall Study|Adverse Event|1|||
105913434|NCT01091246|365341254|FG000|Overall Study|Withdrawal by Subject|9|||
105677338|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
105677339|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
105677340|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
105677341|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
105677342|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
105677343|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
105677344|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
105677345|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
105677346|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
105677347|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
105677348|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
105677349|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
105677350|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
105677351|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
105677352|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
105677353|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
105677354|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
105677355|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
105677356|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
105677357|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
105677358|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
105677359|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
105677360|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
105677361|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
105677362|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
105677363|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
105677364|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
105677365|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
105677366|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
105677367|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
105677368|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
105677369|NCT00700427|364481628|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
105677370|NCT00700427|364481629|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
105677371|NCT00700427|364481630|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
105677372|NCT00700427|364481631|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
105677373|NCT00700427|364481632|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
105677374|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
105677375|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
105677376|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
105677377|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
105677378|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
105677379|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
105677380|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
105677381|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
105677382|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
105677383|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
105677384|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
105677385|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
105677386|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
105677387|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
105677388|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
105677389|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
105677390|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
105677391|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
105677392|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
105677393|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
105677394|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
105677395|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
105677396|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
105677397|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
105677398|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
105677399|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
105913435|NCT01091246|365341255|FG001|Overall Study|Withdrawal by Subject|5|||
105913436|NCT01091246|365341256|FG002|Overall Study|Withdrawal by Subject|4|||
106000003|NCT05579977|365661257|FG004|Treatment Phase|Study terminated by sponsor|63|||
106000004|NCT05579977|365661258|FG005|Treatment Phase|Study terminated by sponsor|53|||
106000005|NCT05579977|365661259|FG006|Treatment Phase|Study terminated by sponsor|66|||
106000006|NCT05579977|365661260|FG007|Treatment Phase|Study terminated by sponsor|48|||
105677400|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
105913437|NCT01091246|365341254|FG000|Overall Study|Subject not dosed|2|||
105913438|NCT01091246|365341255|FG001|Overall Study|Subject not dosed|0|||
105913439|NCT01091246|365341256|FG002|Overall Study|Subject not dosed|1|||
105913440|NCT03528551|365341276|FG000|Overall Study|Lost to Follow-up|0|||
105913441|NCT03528551|365341277|FG001|Overall Study|Lost to Follow-up|1|||
105913442|NCT03528551|365341278|FG002|Overall Study|Lost to Follow-up|0|||
105913443|NCT03528551|365341276|FG000|Overall Study|Transferred to other arm/group|2|||
105913444|NCT03528551|365341277|FG001|Overall Study|Transferred to other arm/group|3|||
105913445|NCT03528551|365341278|FG002|Overall Study|Transferred to other arm/group|0|||
105913446|NCT03528551|365341276|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105913447|NCT03528551|365341277|FG001|Overall Study|Withdrawal by parent/guardian|5|||
105913448|NCT03528551|365341278|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105913449|NCT03528551|365341276|FG000|Overall Study|Protocol Violation|0|||
105913450|NCT03528551|365341277|FG001|Overall Study|Protocol Violation|3|||
105913451|NCT03528551|365341278|FG002|Overall Study|Protocol Violation|0|||
105913452|NCT03528551|365341276|FG000|Overall Study|Withdrawal by Subject|0|||
105913453|NCT03528551|365341277|FG001|Overall Study|Withdrawal by Subject|7|||
105913454|NCT03528551|365341278|FG002|Overall Study|Withdrawal by Subject|0|||
105913455|NCT00808067|365341279|FG000|Overall Study|Major/minor bleed|30|||
105913456|NCT00808067|365341280|FG001|Overall Study|Major/minor bleed|44|||
105913457|NCT00808067|365341279|FG000|Overall Study|Outcome event - other|33|||
105913458|NCT00808067|365341280|FG001|Overall Study|Outcome event - other|25|||
105913459|NCT00808067|365341279|FG000|Overall Study|Adverse Event|111|||
105913460|NCT00808067|365341280|FG001|Overall Study|Adverse Event|121|||
105913461|NCT00808067|365341279|FG000|Overall Study|Hospitalization (not including surgery)|18|||
105913462|NCT00808067|365341280|FG001|Overall Study|Hospitalization (not including surgery)|17|||
105913463|NCT00808067|365341279|FG000|Overall Study|Hospitalization due to surgery|37|||
105913464|NCT00808067|365341280|FG001|Overall Study|Hospitalization due to surgery|40|||
105913465|NCT00808067|365341279|FG000|Overall Study|Reduced creatinine clearance|53|||
105913466|NCT00808067|365341280|FG001|Overall Study|Reduced creatinine clearance|55|||
105913467|NCT00808067|365341279|FG000|Overall Study|Elevated LFT results|7|||
105913468|NCT00808067|365341280|FG001|Overall Study|Elevated LFT results|3|||
105913469|NCT00808067|365341279|FG000|Overall Study|Patient refused to take study medication|65|||
105913470|NCT00808067|365341280|FG001|Overall Study|Patient refused to take study medication|76|||
105913471|NCT00808067|365341279|FG000|Overall Study|Missing|1|||
105913472|NCT00808067|365341280|FG001|Overall Study|Missing|0|||
105913473|NCT00808067|365341279|FG000|Overall Study|Death|1|||
105913474|NCT00808067|365341280|FG001|Overall Study|Death|1|||
105913475|NCT00808067|365341279|FG000|Overall Study|Procedure|6|||
105913476|NCT00808067|365341280|FG001|Overall Study|Procedure|7|||
105913477|NCT00808067|365341279|FG000|Overall Study|Withdrawal by Subject|21|||
105913478|NCT00808067|365341280|FG001|Overall Study|Withdrawal by Subject|25|||
105913479|NCT00808067|365341279|FG000|Overall Study|Site closed|4|||
105913480|NCT00808067|365341280|FG001|Overall Study|Site closed|3|||
105913481|NCT00808067|365341279|FG000|Overall Study|Physician Decision|47|||
105913482|NCT00808067|365341280|FG001|Overall Study|Physician Decision|38|||
105913483|NCT00808067|365341279|FG000|Overall Study|Protocol Violation|3|||
105913484|NCT00808067|365341280|FG001|Overall Study|Protocol Violation|11|||
105913485|NCT00808067|365341279|FG000|Overall Study|Patient elected|7|||
105913486|NCT00808067|365341280|FG001|Overall Study|Patient elected|9|||
105913487|NCT00808067|365341279|FG000|Overall Study|Site closed for cause|19|||
105913488|NCT00808067|365341280|FG001|Overall Study|Site closed for cause|19|||
105913489|NCT00808067|365341279|FG000|Overall Study|Other reason not defined above|5|||
105913490|NCT00808067|365341280|FG001|Overall Study|Other reason not defined above|5|||
105913491|NCT00808067|365341279|FG000|Overall Study|Excluded from analysis|13|||
105913492|NCT00808067|365341280|FG001|Overall Study|Excluded from analysis|19|||
105913493|NCT02104895|365341281|FG000|Overall Study|Withdrawal by Subject|0|||
105913494|NCT02104895|365341282|FG001|Overall Study|Withdrawal by Subject|14|||
105913495|NCT03718429|365341286|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
105913496|NCT03718429|365341287|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
105913497|NCT03718429|365341288|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
105913498|NCT03718429|365341289|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
105913499|NCT01190813|365341290|FG000|Overall Study|Lost to Follow-up|1|||
105913500|NCT01190813|365341291|FG001|Overall Study|Lost to Follow-up|2|||
105913501|NCT01190813|365341290|FG000|Overall Study|Withdrawal by Subject|2|||
105913502|NCT01190813|365341291|FG001|Overall Study|Withdrawal by Subject|1|||
105913503|NCT01190813|365341290|FG000|Overall Study|Refused study treatment after randomized|1|||
105913504|NCT01190813|365341291|FG001|Overall Study|Refused study treatment after randomized|0|||
105677401|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
105913505|NCT01190813|365341290|FG000|Overall Study|Adverse Event|0|||
105913506|NCT01190813|365341291|FG001|Overall Study|Adverse Event|1|||
105677402|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
105913507|NCT04632225|365341292|FG000|Overall Study|Withdrawal by Subject|2|||
105913508|NCT04632225|365341293|FG001|Overall Study|Withdrawal by Subject|2|||
105913509|NCT02317991|365342695|FG000|Overall Study|Adverse Event|12|||
105913510|NCT02317991|365342695|FG000|Overall Study|Death|4|||
105913511|NCT02317991|365342695|FG000|Overall Study|Withdrawal by Subject|8|||
105913512|NCT02317991|365342695|FG000|Overall Study|Progressive Disease|41|||
105913513|NCT02291029|365342698|FG000|Overall Study|Withdrawal by Subject|0|||
105913514|NCT02291029|365342699|FG001|Overall Study|Withdrawal by Subject|0|||
105913515|NCT02291029|365342700|FG002|Overall Study|Withdrawal by Subject|1|||
105913516|NCT02291029|365342701|FG003|Overall Study|Withdrawal by Subject|0|||
105913517|NCT02291029|365342702|FG004|Overall Study|Withdrawal by Subject|0|||
105913518|NCT02291029|365342703|FG005|Overall Study|Withdrawal by Subject|0|||
105913519|NCT02291029|365342698|FG000|Overall Study|Adverse Event|0|||
105913520|NCT02291029|365342699|FG001|Overall Study|Adverse Event|1|||
105913521|NCT02291029|365342700|FG002|Overall Study|Adverse Event|0|||
105913522|NCT02291029|365342701|FG003|Overall Study|Adverse Event|0|||
105913523|NCT02291029|365342702|FG004|Overall Study|Adverse Event|0|||
105913524|NCT02291029|365342703|FG005|Overall Study|Adverse Event|0|||
105913525|NCT00419757|365342707|FG000|Overall Study|Adverse Event|1|||
105913526|NCT00419757|365342708|FG001|Overall Study|Adverse Event|4|||
105913527|NCT00419757|365342707|FG000|Overall Study|Lost to Follow-up|1|||
105913528|NCT00419757|365342708|FG001|Overall Study|Lost to Follow-up|4|||
105913529|NCT00419757|365342707|FG000|Overall Study|Withdrawal by Subject|7|||
105913530|NCT00419757|365342708|FG001|Overall Study|Withdrawal by Subject|1|||
105913531|NCT00419757|365342707|FG000|Overall Study|Protocol Violation|2|||
105913532|NCT00419757|365342708|FG001|Overall Study|Protocol Violation|3|||
105913533|NCT00419757|365342707|FG000|Overall Study|Study specific discontinuation criteria|4|||
105913534|NCT00419757|365342708|FG001|Overall Study|Study specific discontinuation criteria|8|||
105913535|NCT00419757|365342707|FG000|Overall Study|Multiple reasons|3|||
105913536|NCT00419757|365342708|FG001|Overall Study|Multiple reasons|1|||
105913537|NCT00379834|365342709|FG000|Overall Study|Time constraints|2|||
105913538|NCT01325350|365342712|FG000|Overall Study|Adverse Event|3|||
105913539|NCT01325350|365342713|FG001|Overall Study|Adverse Event|3|||
105913540|NCT01325350|365342714|FG002|Overall Study|Adverse Event|3|||
105913541|NCT01325350|365342715|FG003|Overall Study|Adverse Event|1|||
105913542|NCT01325350|365342716|FG004|Overall Study|Adverse Event|2|||
105913543|NCT01325350|365342712|FG000|Overall Study|Pregnancy|0|||
105913544|NCT01325350|365342713|FG001|Overall Study|Pregnancy|0|||
105913545|NCT01325350|365342714|FG002|Overall Study|Pregnancy|1|||
105913546|NCT01325350|365342715|FG003|Overall Study|Pregnancy|0|||
105913547|NCT01325350|365342716|FG004|Overall Study|Pregnancy|1|||
105913548|NCT01325350|365342712|FG000|Overall Study|Lost to Follow-up|1|||
105913549|NCT01325350|365342713|FG001|Overall Study|Lost to Follow-up|0|||
105913550|NCT01325350|365342714|FG002|Overall Study|Lost to Follow-up|5|||
105913551|NCT01325350|365342715|FG003|Overall Study|Lost to Follow-up|1|||
105913552|NCT01325350|365342716|FG004|Overall Study|Lost to Follow-up|5|||
105913553|NCT01325350|365342712|FG000|Overall Study|Personal Reasons|2|||
105913554|NCT01325350|365342713|FG001|Overall Study|Personal Reasons|1|||
105913555|NCT01325350|365342714|FG002|Overall Study|Personal Reasons|6|||
105913556|NCT01325350|365342715|FG003|Overall Study|Personal Reasons|5|||
105913557|NCT01325350|365342716|FG004|Overall Study|Personal Reasons|3|||
105913558|NCT01325350|365342712|FG000|Overall Study|Protocol Violation|0|||
105913559|NCT01325350|365342713|FG001|Overall Study|Protocol Violation|0|||
105913560|NCT01325350|365342714|FG002|Overall Study|Protocol Violation|0|||
105913561|NCT01325350|365342715|FG003|Overall Study|Protocol Violation|1|||
105913562|NCT01325350|365342716|FG004|Overall Study|Protocol Violation|0|||
105913563|NCT01325350|365342712|FG000|Overall Study|Withdrawal by Subject|0|||
105913564|NCT01325350|365342713|FG001|Overall Study|Withdrawal by Subject|0|||
105913565|NCT01325350|365342714|FG002|Overall Study|Withdrawal by Subject|1|||
105913566|NCT01325350|365342715|FG003|Overall Study|Withdrawal by Subject|1|||
105913567|NCT01325350|365342716|FG004|Overall Study|Withdrawal by Subject|0|||
105913568|NCT01325350|365342712|FG000|Overall Study|Did Not Receive Treatment|0|||
105913569|NCT01325350|365342713|FG001|Overall Study|Did Not Receive Treatment|1|||
105913570|NCT01325350|365342714|FG002|Overall Study|Did Not Receive Treatment|1|||
105913571|NCT01325350|365342715|FG003|Overall Study|Did Not Receive Treatment|0|||
105913572|NCT01325350|365342716|FG004|Overall Study|Did Not Receive Treatment|1|||
105913573|NCT01298700|365342720|FG000|Overall Study|Adverse Event|50|||
105913574|NCT01298700|365342721|FG001|Overall Study|Adverse Event|51|||
105913575|NCT01298700|365342720|FG000|Overall Study|Lack of Efficacy|9|||
105913576|NCT01298700|365342721|FG001|Overall Study|Lack of Efficacy|14|||
105677403|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
105913577|NCT01298700|365342720|FG000|Overall Study|Lost to Follow-up|5|||
105913578|NCT01298700|365342721|FG001|Overall Study|Lost to Follow-up|2|||
105913579|NCT01298700|365342720|FG000|Overall Study|Withdrawal by Subject|12|||
105913580|NCT01298700|365342721|FG001|Overall Study|Withdrawal by Subject|9|||
105913581|NCT01298700|365342720|FG000|Overall Study|Protocol Violation|6|||
105913582|NCT01298700|365342721|FG001|Overall Study|Protocol Violation|4|||
105677404|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
105677405|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
105677406|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
105677407|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
105677408|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
105677409|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
105677410|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
105677411|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
105677412|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
105677413|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
105677414|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
105677415|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
105677416|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
105677417|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
105677418|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
105677419|NCT00700427|364481628|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
105677420|NCT00700427|364481629|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
105677421|NCT00700427|364481630|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
105677422|NCT00700427|364481631|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
105677423|NCT00700427|364481632|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
105677424|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
105677425|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
105677426|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
105677427|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
105677428|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
105677429|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
105677430|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
105677431|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
105677432|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
105677433|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
105913583|NCT01298700|365342720|FG000|Overall Study|Other Miscellaneous Reasons|16|||
105913584|NCT01298700|365342721|FG001|Overall Study|Other Miscellaneous Reasons|15|||
105913585|NCT01298700|365342720|FG000|Overall Study|Did not Receive Study Drug|3|||
105913586|NCT01298700|365342721|FG001|Overall Study|Did not Receive Study Drug|5|||
105913587|NCT00956839|365342724|FG000|Overall Study|Lost to Follow-up|3|||
105913588|NCT00956839|365342725|FG001|Overall Study|Lost to Follow-up|0|||
105913589|NCT00956839|365342726|FG002|Overall Study|Lost to Follow-up|3|||
105913590|NCT03934216|365342727|FG000|Overall Study|Other Reasons|5|||
105913591|NCT03934216|365342728|FG001|Overall Study|Other Reasons|5|||
105913592|NCT03934216|365342727|FG000|Overall Study|Adverse Event|22|||
105913593|NCT03934216|365342728|FG001|Overall Study|Adverse Event|11|||
105913594|NCT03934216|365342727|FG000|Overall Study|Lack of Efficacy|8|||
105913595|NCT03934216|365342728|FG001|Overall Study|Lack of Efficacy|7|||
105913596|NCT03934216|365342727|FG000|Overall Study|Lost to Follow-up|2|||
105913597|NCT03934216|365342728|FG001|Overall Study|Lost to Follow-up|0|||
105913598|NCT03934216|365342727|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105913599|NCT03934216|365342728|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105913600|NCT03934216|365342727|FG000|Overall Study|Pregnancy|1|||
105913601|NCT03934216|365342728|FG001|Overall Study|Pregnancy|0|||
105913602|NCT03934216|365342727|FG000|Overall Study|Withdrawal by Subject|18|||
105913603|NCT03934216|365342728|FG001|Overall Study|Withdrawal by Subject|6|||
105913604|NCT03934216|365342727|FG000|Overall Study|Randomized but not treated|1|||
105913605|NCT03934216|365342728|FG001|Overall Study|Randomized but not treated|1|||
105913606|NCT01063855|365342729|FG000|Overall Study|Adverse Event|4|||
105913607|NCT01063855|365342730|FG001|Overall Study|Adverse Event|4|||
105913608|NCT01063855|365342729|FG000|Overall Study|Death|0|||
105913609|NCT01063855|365342730|FG001|Overall Study|Death|1|||
105913610|NCT01063855|365342729|FG000|Overall Study|Lost to Follow-up|8|||
105913611|NCT01063855|365342730|FG001|Overall Study|Lost to Follow-up|4|||
106000007|NCT05579977|365661261|FG008|Treatment Phase|Study terminated by sponsor|47|||
106000008|NCT05579977|365661262|FG009|Treatment Phase|Study terminated by sponsor|37|||
106000009|NCT05579977|365661263|FG010|Treatment Phase|Study terminated by sponsor|44|||
106000010|NCT05579977|365661264|FG011|Treatment Phase|Study terminated by sponsor|36|||
106000011|NCT05579977|365661265|FG012|Treatment Phase|Study terminated by sponsor|32|||
105677434|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
105677435|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
105913612|NCT01063855|365342729|FG000|Overall Study|Pregnancy|1|||
105913613|NCT01063855|365342730|FG001|Overall Study|Pregnancy|0|||
105913614|NCT01063855|365342729|FG000|Overall Study|Lack of Efficacy|0|||
105913615|NCT01063855|365342730|FG001|Overall Study|Lack of Efficacy|1|||
105913616|NCT01063855|365342729|FG000|Overall Study|Withdrawal by Subject|11|||
105913617|NCT01063855|365342730|FG001|Overall Study|Withdrawal by Subject|8|||
105913618|NCT01063855|365342729|FG000|Overall Study|Reason not specified|13|||
105913619|NCT01063855|365342730|FG001|Overall Study|Reason not specified|11|||
105913620|NCT02806713|365342731|FG000|Overall Study|Urethral injury during procedure|1|||
105913621|NCT02806713|365342732|FG001|Overall Study|Urethral injury during procedure|0|||
105913622|NCT02806713|365342731|FG000|Overall Study|cancelled surgery|1|||
105913623|NCT02806713|365342732|FG001|Overall Study|cancelled surgery|2|||
105913624|NCT02163395|365342733|FG000|Overall Study|Withdrawal by Subject|1|||
105913625|NCT02163395|365342733|FG000|Overall Study|Lost to Follow-up|3|||
105913626|NCT02163395|365342733|FG000|Overall Study|Adverse Event|1|||
105913627|NCT03627832|365342734|FG000|Overall Study|Withdrawal by Subject|10|||
105913628|NCT03627832|365342735|FG001|Overall Study|Withdrawal by Subject|1|||
105913629|NCT01718483|365342736|FG000|Overall Study|Withdrawal by Subject|14|||
105913630|NCT01718483|365342737|FG001|Overall Study|Withdrawal by Subject|12|||
105913631|NCT01718483|365342736|FG000|Overall Study|Adverse Event|5|||
105913632|NCT01718483|365342737|FG001|Overall Study|Adverse Event|12|||
105913633|NCT01718483|365342736|FG000|Overall Study|Lost to Follow-up|8|||
105786441|NCT04579666|364871390|FG003|RTP (Up to Week 52)|Other|0|||
105913634|NCT01718483|365342737|FG001|Overall Study|Lost to Follow-up|3|||
105913635|NCT01718483|365342736|FG000|Overall Study|Protocol Violation|4|||
105913636|NCT01718483|365342737|FG001|Overall Study|Protocol Violation|2|||
105913637|NCT01718483|365342736|FG000|Overall Study|Other|1|||
105913638|NCT01718483|365342737|FG001|Overall Study|Other|4|||
105677436|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
105677437|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
105677438|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
105677439|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
105677440|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
105677441|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
105677442|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
105677443|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
105677444|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
105677445|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
105677446|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
105677447|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
105677448|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
105677449|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
105677450|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
105677451|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
105677452|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
105677453|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
105677454|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
105677455|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
105677456|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
105677457|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
105677458|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
105677459|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
105677460|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
105677461|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
105677462|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
105677463|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
105677464|NCT00700427|364481628|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
105677465|NCT00700427|364481629|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
105677466|NCT00700427|364481630|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
105677467|NCT00700427|364481631|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
105677468|NCT00700427|364481632|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
105677469|NCT05383508|364481633|FG000|Overall Study|Withdrawal by Subject|1|||
105677470|NCT05383508|364481634|FG001|Overall Study|Withdrawal by Subject|0|||
105677471|NCT05383508|364481635|FG002|Overall Study|Withdrawal by Subject|1|||
105677472|NCT05383508|364481636|FG003|Overall Study|Withdrawal by Subject|1|||
105677473|NCT05383508|364481637|FG004|Overall Study|Withdrawal by Subject|2|||
105677474|NCT05383508|364481638|FG005|Overall Study|Withdrawal by Subject|0|||
105677475|NCT03775434|364481639|FG000|Overall Study|Adverse Event|2|||
105677476|NCT03775434|364481639|FG000|Overall Study|Withdrawal by Subject|1|||
105677477|NCT03047395|364481640|FG000|Overall Study|Adverse Event|142|||
105677478|NCT03047395|364481640|FG000|Overall Study|Withdrawal by Subject|155|||
105677479|NCT03047395|364481640|FG000|Overall Study|Lost to Follow-up|144|||
105677480|NCT03047395|364481640|FG000|Overall Study|COVID-19 Infection|2|||
105677481|NCT03047395|364481640|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
105677482|NCT03047395|364481640|FG000|Overall Study|Other, Not Specified|117|||
105677483|NCT01859988|364481641|FG000|Overall Study|Withdrawal by Subject|6|||
105677484|NCT01859988|364481642|FG001|Overall Study|Withdrawal by Subject|3|||
105677485|NCT01859988|364481643|FG002|Overall Study|Withdrawal by Subject|4|||
105677486|NCT01859988|364481644|FG003|Overall Study|Withdrawal by Subject|3|||
105677487|NCT01859988|364481645|FG004|Overall Study|Withdrawal by Subject|2|||
105677488|NCT01859988|364481646|FG005|Overall Study|Withdrawal by Subject|2|||
105677489|NCT01859988|364481641|FG000|Overall Study|Lack of Efficacy|1|||
105677490|NCT01859988|364481642|FG001|Overall Study|Lack of Efficacy|1|||
105677491|NCT01859988|364481643|FG002|Overall Study|Lack of Efficacy|5|||
105677492|NCT01859988|364481644|FG003|Overall Study|Lack of Efficacy|0|||
105677493|NCT01859988|364481645|FG004|Overall Study|Lack of Efficacy|7|||
105677494|NCT01859988|364481646|FG005|Overall Study|Lack of Efficacy|9|||
105677495|NCT01859988|364481641|FG000|Overall Study|Physician Decision|1|||
105677496|NCT01859988|364481642|FG001|Overall Study|Physician Decision|3|||
105677497|NCT01859988|364481643|FG002|Overall Study|Physician Decision|1|||
105677498|NCT01859988|364481644|FG003|Overall Study|Physician Decision|3|||
105677499|NCT01859988|364481645|FG004|Overall Study|Physician Decision|4|||
105677500|NCT01859988|364481646|FG005|Overall Study|Physician Decision|1|||
105677501|NCT01859988|364481641|FG000|Overall Study|Adverse Event|2|||
105677502|NCT01859988|364481642|FG001|Overall Study|Adverse Event|1|||
105913639|NCT01718483|365342736|FG000|Overall Study|Pregnancy|1|||
105913640|NCT01718483|365342737|FG001|Overall Study|Pregnancy|1|||
105913641|NCT01718483|365342736|FG000|Overall Study|Lack of Efficacy|1|||
105913642|NCT01718483|365342737|FG001|Overall Study|Lack of Efficacy|0|||
106000012|NCT05579977|365661253|FG000|Treatment Phase|Pregnancy|0|||
105913643|NCT00003537|365342738|FG000|Overall Study|Not evalauable|1|||
105913644|NCT00048035|365342739|FG000|Core Period|Early Withdrawals|4|||
105913645|NCT00048035|365342740|FG001|Core Period|Early Withdrawals|2|||
105913646|NCT00048035|365342741|FG002|Core Period|Early Withdrawals|1|||
105913647|NCT00048035|365342742|FG003|Core Period|Early Withdrawals|1|||
105913648|NCT00048035|365342743|FG004|Core Period|Early Withdrawals|1|||
105677503|NCT01859988|364481643|FG002|Overall Study|Adverse Event|3|||
105677504|NCT01859988|364481644|FG003|Overall Study|Adverse Event|1|||
105677505|NCT01859988|364481645|FG004|Overall Study|Adverse Event|2|||
105677506|NCT01859988|364481646|FG005|Overall Study|Adverse Event|2|||
105677507|NCT01859988|364481641|FG000|Overall Study|Lost to Follow-up|1|||
105677508|NCT01859988|364481642|FG001|Overall Study|Lost to Follow-up|2|||
105677509|NCT01859988|364481643|FG002|Overall Study|Lost to Follow-up|3|||
105677510|NCT01859988|364481644|FG003|Overall Study|Lost to Follow-up|0|||
105677511|NCT01859988|364481645|FG004|Overall Study|Lost to Follow-up|3|||
105677512|NCT01859988|364481646|FG005|Overall Study|Lost to Follow-up|2|||
105677513|NCT01859988|364481641|FG000|Overall Study|Protocol Violation|0|||
105677514|NCT01859988|364481642|FG001|Overall Study|Protocol Violation|0|||
105677515|NCT01859988|364481643|FG002|Overall Study|Protocol Violation|1|||
105677516|NCT01859988|364481644|FG003|Overall Study|Protocol Violation|0|||
106000013|NCT05579977|365661254|FG001|Treatment Phase|Pregnancy|0|||
106000014|NCT05579977|365661255|FG002|Treatment Phase|Pregnancy|0|||
106000015|NCT05579977|365661256|FG003|Treatment Phase|Pregnancy|0|||
106000016|NCT05579977|365661257|FG004|Treatment Phase|Pregnancy|0|||
106000017|NCT05579977|365661258|FG005|Treatment Phase|Pregnancy|0|||
106000018|NCT05579977|365661259|FG006|Treatment Phase|Pregnancy|0|||
106000019|NCT05579977|365661260|FG007|Treatment Phase|Pregnancy|0|||
106000020|NCT05579977|365661261|FG008|Treatment Phase|Pregnancy|0|||
106000021|NCT05579977|365661262|FG009|Treatment Phase|Pregnancy|1|||
106000022|NCT05579977|365661263|FG010|Treatment Phase|Pregnancy|0|||
106000023|NCT05579977|365661264|FG011|Treatment Phase|Pregnancy|0|||
106000024|NCT05579977|365661265|FG012|Treatment Phase|Pregnancy|0|||
106000025|NCT05579977|365661253|FG000|Treatment Phase|Physician Decision|0|||
106000026|NCT05579977|365661254|FG001|Treatment Phase|Physician Decision|0|||
106000027|NCT05579977|365661255|FG002|Treatment Phase|Physician Decision|0|||
106000028|NCT05579977|365661256|FG003|Treatment Phase|Physician Decision|0|||
106000029|NCT05579977|365661257|FG004|Treatment Phase|Physician Decision|0|||
106000030|NCT05579977|365661258|FG005|Treatment Phase|Physician Decision|0|||
106000031|NCT05579977|365661259|FG006|Treatment Phase|Physician Decision|0|||
106000032|NCT05579977|365661260|FG007|Treatment Phase|Physician Decision|0|||
106000033|NCT05579977|365661261|FG008|Treatment Phase|Physician Decision|0|||
106000034|NCT05579977|365661262|FG009|Treatment Phase|Physician Decision|0|||
106000035|NCT05579977|365661263|FG010|Treatment Phase|Physician Decision|0|||
106000036|NCT05579977|365661264|FG011|Treatment Phase|Physician Decision|1|||
106000037|NCT05579977|365661265|FG012|Treatment Phase|Physician Decision|0|||
106000038|NCT05579977|365661253|FG000|Treatment Phase|Lost to Follow-up|0|||
106000039|NCT05579977|365661254|FG001|Treatment Phase|Lost to Follow-up|0|||
106000040|NCT05579977|365661255|FG002|Treatment Phase|Lost to Follow-up|0|||
105913649|NCT00048035|365342744|FG005|Core Period|Early Withdrawals|1|||
105677517|NCT01859988|364481645|FG004|Overall Study|Protocol Violation|0|||
105677518|NCT01859988|364481646|FG005|Overall Study|Protocol Violation|0|||
105677519|NCT01859988|364481641|FG000|Overall Study|Other than specified above|0|||
105677520|NCT01859988|364481642|FG001|Overall Study|Other than specified above|2|||
105677521|NCT01859988|364481643|FG002|Overall Study|Other than specified above|11|||
105677522|NCT01859988|364481644|FG003|Overall Study|Other than specified above|3|||
106000041|NCT05579977|365661256|FG003|Treatment Phase|Lost to Follow-up|1|||
106000042|NCT05579977|365661257|FG004|Treatment Phase|Lost to Follow-up|1|||
105913650|NCT00048035|365342745|FG006|Core Period|Early Withdrawals|0|||
105677523|NCT01859988|364481645|FG004|Overall Study|Other than specified above|5|||
105677524|NCT01859988|364481646|FG005|Overall Study|Other than specified above|3|||
105677525|NCT02334423|364481647|FG000|Overall Study|Protocol Violation|10|||
105677526|NCT02334423|364481648|FG001|Overall Study|Protocol Violation|3|||
105786442|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
105677527|NCT00652327|364481649|FG000|Overall Study|Adverse Event|0|||
105677528|NCT00652327|364481650|FG001|Overall Study|Adverse Event|2|||
105677529|NCT00652327|364481649|FG000|Overall Study|Lost to Follow-up|0|||
105786443|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
105913651|NCT00048035|365342746|FG007|Core Period|Early Withdrawals|0|||
106000043|NCT05579977|365661258|FG005|Treatment Phase|Lost to Follow-up|1|||
106000044|NCT05579977|365661259|FG006|Treatment Phase|Lost to Follow-up|0|||
106000045|NCT05579977|365661260|FG007|Treatment Phase|Lost to Follow-up|1|||
106000046|NCT05579977|365661261|FG008|Treatment Phase|Lost to Follow-up|2|||
106000047|NCT05579977|365661262|FG009|Treatment Phase|Lost to Follow-up|2|||
106000048|NCT05579977|365661263|FG010|Treatment Phase|Lost to Follow-up|1|||
106000049|NCT05579977|365661264|FG011|Treatment Phase|Lost to Follow-up|4|||
106000050|NCT05579977|365661265|FG012|Treatment Phase|Lost to Follow-up|3|||
105677530|NCT00652327|364481650|FG001|Overall Study|Lost to Follow-up|3|||
105677531|NCT01076647|364481651|FG000|Overall Study|Adverse Event|4|||
106000051|NCT05579977|365661253|FG000|Treatment Phase|Death|1|||
106000052|NCT05579977|365661254|FG001|Treatment Phase|Death|0|||
106000053|NCT05579977|365661255|FG002|Treatment Phase|Death|0|||
105913652|NCT00048035|365342739|FG000|Extension Year 1|Early Withdrawals|0|||
105913653|NCT00048035|365342740|FG001|Extension Year 1|Early Withdrawals|0|||
105913654|NCT00048035|365342741|FG002|Extension Year 1|Early Withdrawals|0|||
105913655|NCT00048035|365342742|FG003|Extension Year 1|Early Withdrawals|0|||
105913656|NCT00048035|365342743|FG004|Extension Year 1|Early Withdrawals|0|||
105913657|NCT00048035|365342744|FG005|Extension Year 1|Early Withdrawals|0|||
105913658|NCT00048035|365342745|FG006|Extension Year 1|Early Withdrawals|11|||
105913659|NCT00048035|365342746|FG007|Extension Year 1|Early Withdrawals|11|||
105913660|NCT00048035|365342739|FG000|Extension Year 2|Early Withdrawals|0|||
105913661|NCT00048035|365342740|FG001|Extension Year 2|Early Withdrawals|0|||
105913662|NCT00048035|365342741|FG002|Extension Year 2|Early Withdrawals|0|||
105913663|NCT00048035|365342742|FG003|Extension Year 2|Early Withdrawals|0|||
105913664|NCT00048035|365342743|FG004|Extension Year 2|Early Withdrawals|0|||
105913665|NCT00048035|365342744|FG005|Extension Year 2|Early Withdrawals|0|||
105913666|NCT00048035|365342745|FG006|Extension Year 2|Early Withdrawals|3|||
105913667|NCT00048035|365342746|FG007|Extension Year 2|Early Withdrawals|3|||
105913668|NCT02619617|365342747|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
105913669|NCT02619617|365342748|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
105913670|NCT02619617|365342747|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
105913671|NCT02619617|365342748|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
105913672|NCT02735980|365342749|FG000|Overall Study|Adverse Event|0|||
105913673|NCT02735980|365342750|FG001|Overall Study|Adverse Event|4|||
105913674|NCT02735980|365342751|FG002|Overall Study|Adverse Event|1|||
105913675|NCT02735980|365342749|FG000|Overall Study|Death|5|||
105913676|NCT02735980|365342750|FG001|Overall Study|Death|4|||
105913677|NCT02735980|365342751|FG002|Overall Study|Death|0|||
105913678|NCT02735980|365342749|FG000|Overall Study|Physician Decision|3|||
105913679|NCT02735980|365342750|FG001|Overall Study|Physician Decision|1|||
105913680|NCT02735980|365342751|FG002|Overall Study|Physician Decision|0|||
105913681|NCT02735980|365342749|FG000|Overall Study|Screen failure|1|||
105913682|NCT02735980|365342750|FG001|Overall Study|Screen failure|0|||
105913683|NCT02735980|365342751|FG002|Overall Study|Screen failure|0|||
105913684|NCT02735980|365342749|FG000|Overall Study|Withdrawal by Subject|1|||
105913685|NCT02735980|365342750|FG001|Overall Study|Withdrawal by Subject|2|||
105913686|NCT02735980|365342751|FG002|Overall Study|Withdrawal by Subject|0|||
105913687|NCT00509899|365342752|FG000|Overall Study|Progressive disease|1|||
105913688|NCT00509899|365342753|FG001|Overall Study|Progressive disease|3|||
105913689|NCT00509899|365342754|FG002|Overall Study|Progressive disease|5|||
105913690|NCT00509899|365342755|FG003|Overall Study|Progressive disease|1|||
105913691|NCT00509899|365342756|FG004|Overall Study|Progressive disease|0|||
105913692|NCT00509899|365342757|FG005|Overall Study|Progressive disease|1|||
105913693|NCT00509899|365342758|FG006|Overall Study|Progressive disease|0|||
105913694|NCT00509899|365342759|FG007|Overall Study|Progressive disease|0|||
105913695|NCT00509899|365342752|FG000|Overall Study|Unacceptable Toxicity|1|||
105913696|NCT00509899|365342753|FG001|Overall Study|Unacceptable Toxicity|0|||
105913697|NCT00509899|365342754|FG002|Overall Study|Unacceptable Toxicity|0|||
105913698|NCT00509899|365342755|FG003|Overall Study|Unacceptable Toxicity|2|||
105913699|NCT00509899|365342756|FG004|Overall Study|Unacceptable Toxicity|0|||
105913700|NCT00509899|365342757|FG005|Overall Study|Unacceptable Toxicity|0|||
105913701|NCT00509899|365342758|FG006|Overall Study|Unacceptable Toxicity|0|||
105913702|NCT00509899|365342759|FG007|Overall Study|Unacceptable Toxicity|0|||
105913703|NCT00509899|365342752|FG000|Overall Study|Withdrawal by Subject|6|||
105913704|NCT00509899|365342753|FG001|Overall Study|Withdrawal by Subject|2|||
105913705|NCT00509899|365342754|FG002|Overall Study|Withdrawal by Subject|3|||
105913706|NCT00509899|365342755|FG003|Overall Study|Withdrawal by Subject|0|||
105913707|NCT00509899|365342756|FG004|Overall Study|Withdrawal by Subject|3|||
105913708|NCT00509899|365342757|FG005|Overall Study|Withdrawal by Subject|2|||
105913709|NCT00509899|365342758|FG006|Overall Study|Withdrawal by Subject|0|||
105913710|NCT00509899|365342759|FG007|Overall Study|Withdrawal by Subject|0|||
105913711|NCT00509899|365342752|FG000|Overall Study|Physician Decision|4|||
105913712|NCT00509899|365342753|FG001|Overall Study|Physician Decision|2|||
105913713|NCT00509899|365342754|FG002|Overall Study|Physician Decision|7|||
105913714|NCT00509899|365342755|FG003|Overall Study|Physician Decision|0|||
105913715|NCT00509899|365342756|FG004|Overall Study|Physician Decision|1|||
105913716|NCT00509899|365342757|FG005|Overall Study|Physician Decision|4|||
105913717|NCT00509899|365342758|FG006|Overall Study|Physician Decision|0|||
105913718|NCT00509899|365342759|FG007|Overall Study|Physician Decision|0|||
105913719|NCT00509899|365342752|FG000|Overall Study|Intercurrent Illness|1|||
105913720|NCT00509899|365342753|FG001|Overall Study|Intercurrent Illness|0|||
105913721|NCT00509899|365342754|FG002|Overall Study|Intercurrent Illness|0|||
105913722|NCT00509899|365342755|FG003|Overall Study|Intercurrent Illness|1|||
105913723|NCT00509899|365342756|FG004|Overall Study|Intercurrent Illness|0|||
105913724|NCT00509899|365342757|FG005|Overall Study|Intercurrent Illness|1|||
105913725|NCT00509899|365342758|FG006|Overall Study|Intercurrent Illness|0|||
105913726|NCT00509899|365342759|FG007|Overall Study|Intercurrent Illness|0|||
105913727|NCT00509899|365342752|FG000|Overall Study|Death|2|||
105913728|NCT00509899|365342753|FG001|Overall Study|Death|2|||
106000054|NCT05579977|365661256|FG003|Treatment Phase|Death|0|||
105677532|NCT01076647|364481652|FG001|Overall Study|Adverse Event|1|||
105677533|NCT01076647|364481651|FG000|Overall Study|Lack of Efficacy|0|||
105677534|NCT01076647|364481652|FG001|Overall Study|Lack of Efficacy|1|||
105677535|NCT01076647|364481651|FG000|Overall Study|Protocol Violation|7|||
106000055|NCT05579977|365661257|FG004|Treatment Phase|Death|0|||
106000056|NCT05579977|365661258|FG005|Treatment Phase|Death|0|||
106000057|NCT05579977|365661259|FG006|Treatment Phase|Death|0|||
106000058|NCT05579977|365661260|FG007|Treatment Phase|Death|0|||
106000059|NCT05579977|365661261|FG008|Treatment Phase|Death|0|||
106000060|NCT05579977|365661262|FG009|Treatment Phase|Death|0|||
106000061|NCT05579977|365661263|FG010|Treatment Phase|Death|0|||
106000062|NCT05579977|365661264|FG011|Treatment Phase|Death|0|||
106000063|NCT05579977|365661265|FG012|Treatment Phase|Death|0|||
106000064|NCT05579977|365661253|FG000|Treatment Phase|Adverse Event|0|||
106000065|NCT05579977|365661254|FG001|Treatment Phase|Adverse Event|3|||
106000066|NCT05579977|365661255|FG002|Treatment Phase|Adverse Event|11|||
106000067|NCT05579977|365661256|FG003|Treatment Phase|Adverse Event|10|||
106000068|NCT05579977|365661257|FG004|Treatment Phase|Adverse Event|5|||
106000069|NCT05579977|365661258|FG005|Treatment Phase|Adverse Event|17|||
105913729|NCT00509899|365342754|FG002|Overall Study|Death|3|||
105913730|NCT00509899|365342755|FG003|Overall Study|Death|0|||
105913731|NCT00509899|365342756|FG004|Overall Study|Death|1|||
105913732|NCT00509899|365342757|FG005|Overall Study|Death|1|||
105677536|NCT01076647|364481652|FG001|Overall Study|Protocol Violation|9|||
105677537|NCT01076647|364481651|FG000|Overall Study|Withdrawal criteria|2|||
106000070|NCT05579977|365661259|FG006|Treatment Phase|Adverse Event|5|||
105913733|NCT00509899|365342758|FG006|Overall Study|Death|1|||
105913734|NCT00509899|365342759|FG007|Overall Study|Death|1|||
105913735|NCT00509899|365342752|FG000|Overall Study|Lack of Efficacy|1|||
105913736|NCT00509899|365342753|FG001|Overall Study|Lack of Efficacy|0|||
105913737|NCT00509899|365342754|FG002|Overall Study|Lack of Efficacy|2|||
105913738|NCT00509899|365342755|FG003|Overall Study|Lack of Efficacy|0|||
105913739|NCT00509899|365342756|FG004|Overall Study|Lack of Efficacy|0|||
105913740|NCT00509899|365342757|FG005|Overall Study|Lack of Efficacy|1|||
105913741|NCT00509899|365342758|FG006|Overall Study|Lack of Efficacy|0|||
105913742|NCT00509899|365342759|FG007|Overall Study|Lack of Efficacy|0|||
105913743|NCT01447407|365342760|FG000|Overall Study|Withdrawal by Subject|2|||
105913744|NCT01447407|365342761|FG001|Overall Study|Withdrawal by Subject|0|||
105913745|NCT01447407|365342762|FG002|Overall Study|Withdrawal by Subject|0|||
105913746|NCT01447407|365342763|FG003|Overall Study|Withdrawal by Subject|1|||
105913747|NCT01447407|365342760|FG000|Overall Study|Physician Decision|0|||
105913748|NCT01447407|365342761|FG001|Overall Study|Physician Decision|0|||
105913749|NCT01447407|365342762|FG002|Overall Study|Physician Decision|1|||
105913750|NCT01447407|365342763|FG003|Overall Study|Physician Decision|1|||
105913751|NCT00528424|365342766|FG000|Overall Study|Lost to Follow-up|13|||
105913752|NCT00528424|365342766|FG000|Overall Study|Withdrew consent|2|||
105913753|NCT00528424|365342766|FG000|Overall Study|Administrative reason|2|||
105913754|NCT00528424|365342766|FG000|Overall Study|Other|12|||
105913755|NCT02771275|365342767|FG000|Overall Study|Reoperation|3|||
105913756|NCT02771275|365342767|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
105913757|NCT00483652|365342768|FG000|Double-blind Treatment Period|Protocol Violation|2|||
105913758|NCT00483652|365342769|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105913759|NCT00483652|365342768|FG000|Double-blind Treatment Period|Adverse Event|3|||
105913760|NCT00483652|365342769|FG001|Double-blind Treatment Period|Adverse Event|4|||
105913761|NCT00483652|365342768|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
106000071|NCT05579977|365661260|FG007|Treatment Phase|Adverse Event|5|||
105913762|NCT00483652|365342769|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
105913763|NCT00483652|365342768|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
105913764|NCT00483652|365342769|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
105913765|NCT00490035|365342770|FG000|Overall Study|AE, non-serious non-fatal|3|||
105913766|NCT00490035|365342771|FG001|Overall Study|AE, non-serious non-fatal|4|||
105913767|NCT00490035|365342772|FG002|Overall Study|AE, non-serious non-fatal|4|||
105913768|NCT00490035|365342773|FG003|Overall Study|AE, non-serious non-fatal|5|||
105913769|NCT00490035|365342770|FG000|Overall Study|Lost to Follow-up|2|||
105913770|NCT00490035|365342771|FG001|Overall Study|Lost to Follow-up|0|||
105913771|NCT00490035|365342772|FG002|Overall Study|Lost to Follow-up|1|||
105913772|NCT00490035|365342773|FG003|Overall Study|Lost to Follow-up|0|||
106000072|NCT05579977|365661261|FG008|Treatment Phase|Adverse Event|12|||
105913773|NCT00490035|365342770|FG000|Overall Study|Withdrawal by Subject|2|||
106000073|NCT05579977|365661262|FG009|Treatment Phase|Adverse Event|20|||
105913774|NCT00490035|365342771|FG001|Overall Study|Withdrawal by Subject|1|||
105913775|NCT00490035|365342772|FG002|Overall Study|Withdrawal by Subject|1|||
105913776|NCT00490035|365342773|FG003|Overall Study|Withdrawal by Subject|0|||
105913777|NCT00490035|365342770|FG000|Overall Study|Other reason|0|||
105913778|NCT00490035|365342771|FG001|Overall Study|Other reason|1|||
105913779|NCT00490035|365342772|FG002|Overall Study|Other reason|3|||
105913780|NCT00490035|365342773|FG003|Overall Study|Other reason|1|||
105913781|NCT00490035|365342770|FG000|Overall Study|AE, serious fatal|1|||
105913782|NCT00490035|365342771|FG001|Overall Study|AE, serious fatal|0|||
105913783|NCT00490035|365342772|FG002|Overall Study|AE, serious fatal|0|||
105913784|NCT00490035|365342773|FG003|Overall Study|AE, serious fatal|0|||
105913785|NCT00490035|365342770|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
105913786|NCT00490035|365342771|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
105913787|NCT00490035|365342772|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
105913788|NCT00490035|365342773|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
105913789|NCT00490035|365342770|FG000|Overall Study|AE of unknown type|0|||
105913790|NCT00490035|365342771|FG001|Overall Study|AE of unknown type|0|||
105913791|NCT00490035|365342772|FG002|Overall Study|AE of unknown type|2|||
105913792|NCT00490035|365342773|FG003|Overall Study|AE of unknown type|0|||
105913793|NCT00971867|365342778|FG000|Overall Study|Adverse Event|4|||
105913794|NCT00971867|365342778|FG000|Overall Study|Participant Withdrew Consent|1|||
105913795|NCT00971867|365342778|FG000|Overall Study|Disease Progression|6|||
105913796|NCT01676701|365342787|FG000|Overall Study|Protocol Violation|1|||
105913797|NCT01676701|365342788|FG001|Overall Study|Protocol Violation|0|||
105913798|NCT01676701|365342787|FG000|Overall Study|Sponsor Decision|3|||
105913799|NCT01676701|365342788|FG001|Overall Study|Sponsor Decision|4|||
105913800|NCT02115607|365342792|FG000|Overall Study|Withdrawal by Subject|1|||
105913801|NCT05490771|365342794|FG000|Overall Study|Disease progression|18|||
105913802|NCT05490771|365342794|FG000|Overall Study|Adverse Event|3|||
105913803|NCT05490771|365342794|FG000|Overall Study|Other complicating disease|1|||
105913804|NCT05490771|365342794|FG000|Overall Study|Withdrawal by Subject|3|||
105913805|NCT05490771|365342794|FG000|Overall Study|Physician Decision|1|||
105913806|NCT05490771|365342794|FG000|Overall Study|Still on treatment|2|||
105913807|NCT05490771|365342794|FG000|Overall Study|Never start protocol therapy|5|||
105913808|NCT05490771|365342794|FG000|Overall Study|Ineligible|2|||
105913809|NCT00549549|365342795|FG000|Overall Study|Adverse Event|5|||
105913810|NCT00549549|365342796|FG001|Overall Study|Adverse Event|3|||
105913811|NCT00549549|365342797|FG002|Overall Study|Adverse Event|1|||
105913812|NCT00549549|365342798|FG003|Overall Study|Adverse Event|9|||
105913813|NCT00549549|365342795|FG000|Overall Study|Lack of Efficacy|9|||
105913814|NCT00549549|365342796|FG001|Overall Study|Lack of Efficacy|6|||
105913815|NCT00549549|365342797|FG002|Overall Study|Lack of Efficacy|4|||
105913816|NCT00549549|365342798|FG003|Overall Study|Lack of Efficacy|2|||
105913817|NCT00549549|365342795|FG000|Overall Study|Lost to Follow-up|1|||
105913818|NCT00549549|365342796|FG001|Overall Study|Lost to Follow-up|0|||
105913819|NCT00549549|365342797|FG002|Overall Study|Lost to Follow-up|1|||
105913820|NCT00549549|365342798|FG003|Overall Study|Lost to Follow-up|2|||
105913821|NCT00549549|365342795|FG000|Overall Study|Withdrawal by Subject|0|||
105913822|NCT00549549|365342796|FG001|Overall Study|Withdrawal by Subject|4|||
105913823|NCT00549549|365342797|FG002|Overall Study|Withdrawal by Subject|1|||
105913824|NCT00549549|365342798|FG003|Overall Study|Withdrawal by Subject|0|||
105913825|NCT00549549|365342795|FG000|Overall Study|Other|9|||
105913826|NCT00549549|365342796|FG001|Overall Study|Other|9|||
105913827|NCT00549549|365342797|FG002|Overall Study|Other|9|||
105913828|NCT00549549|365342798|FG003|Overall Study|Other|11|||
105913829|NCT00549549|365342795|FG000|Overall Study|Randomized but not treated|0|||
105913830|NCT00549549|365342796|FG001|Overall Study|Randomized but not treated|0|||
105913831|NCT00549549|365342797|FG002|Overall Study|Randomized but not treated|1|||
105913832|NCT00549549|365342798|FG003|Overall Study|Randomized but not treated|1|||
105913833|NCT01365130|365342799|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
105913834|NCT05607576|365342803|FG000|Overall Study|immediate sensor error|2|||
105913835|NCT05607576|365342803|FG000|Overall Study|Physician Decision|2|||
105913836|NCT02573259|365342804|FG000|Overall Study|Death|1|||
105913837|NCT02573259|365342805|FG001|Overall Study|Death|6|||
105913838|NCT02573259|365342806|FG002|Overall Study|Death|5|||
105913839|NCT02573259|365342807|FG003|Overall Study|Death|6|||
105913840|NCT02573259|365342808|FG004|Overall Study|Death|9|||
105913841|NCT02573259|365342809|FG005|Overall Study|Death|32|||
105913842|NCT02573259|365342810|FG006|Overall Study|Death|21|||
105913843|NCT02573259|365342804|FG000|Overall Study|Lost to Follow-up|0|||
105913844|NCT02573259|365342805|FG001|Overall Study|Lost to Follow-up|0|||
105913845|NCT02573259|365342806|FG002|Overall Study|Lost to Follow-up|0|||
105913846|NCT02573259|365342807|FG003|Overall Study|Lost to Follow-up|0|||
105913847|NCT02573259|365342808|FG004|Overall Study|Lost to Follow-up|0|||
105913848|NCT02573259|365342809|FG005|Overall Study|Lost to Follow-up|2|||
105913849|NCT02573259|365342810|FG006|Overall Study|Lost to Follow-up|1|||
105913850|NCT02573259|365342804|FG000|Overall Study|Participant refused further follow-up|0|||
105913851|NCT02573259|365342805|FG001|Overall Study|Participant refused further follow-up|2|||
105913852|NCT02573259|365342806|FG002|Overall Study|Participant refused further follow-up|1|||
105677538|NCT01076647|364481652|FG001|Overall Study|Withdrawal criteria|2|||
105677539|NCT01076647|364481651|FG000|Overall Study|Unclassified|12|||
105677540|NCT01076647|364481652|FG001|Overall Study|Unclassified|12|||
105677541|NCT01871805|364481657|FG000|Phase I|Death|7|||
105677542|NCT01871805|364481658|FG001|Phase I|Death|4|||
105677543|NCT01871805|364481659|FG002|Phase I|Death|6|||
105677544|NCT01871805|364481660|FG003|Phase I|Death|2|||
105677545|NCT01871805|364481661|FG004|Phase I|Death|9|||
105677546|NCT01871805|364481662|FG005|Phase I|Death|0|||
105677547|NCT01871805|364481657|FG000|Phase I|Alive in Survival Follow-up|0|||
105677548|NCT01871805|364481658|FG001|Phase I|Alive in Survival Follow-up|2|||
105677549|NCT01871805|364481659|FG002|Phase I|Alive in Survival Follow-up|4|||
105677550|NCT01871805|364481660|FG003|Phase I|Alive in Survival Follow-up|5|||
105677551|NCT01871805|364481661|FG004|Phase I|Alive in Survival Follow-up|4|||
105677552|NCT01871805|364481662|FG005|Phase I|Alive in Survival Follow-up|0|||
105677553|NCT01871805|364481657|FG000|Phase I|Lost to Follow-up|0|||
105677554|NCT01871805|364481658|FG001|Phase I|Lost to Follow-up|1|||
105677555|NCT01871805|364481659|FG002|Phase I|Lost to Follow-up|3|||
105677556|NCT01871805|364481660|FG003|Phase I|Lost to Follow-up|0|||
105677557|NCT01871805|364481661|FG004|Phase I|Lost to Follow-up|0|||
105677558|NCT01871805|364481662|FG005|Phase I|Lost to Follow-up|0|||
105677559|NCT01871805|364481657|FG000|Phase II|Death|0|||
105677560|NCT01871805|364481658|FG001|Phase II|Death|0|||
105677561|NCT01871805|364481659|FG002|Phase II|Death|0|||
105677562|NCT01871805|364481660|FG003|Phase II|Death|0|||
105677563|NCT01871805|364481661|FG004|Phase II|Death|0|||
105677564|NCT01871805|364481662|FG005|Phase II|Death|45|||
105677565|NCT01871805|364481657|FG000|Phase II|Alive in Survival Follow-up|0|||
105677566|NCT01871805|364481658|FG001|Phase II|Alive in Survival Follow-up|0|||
105677567|NCT01871805|364481659|FG002|Phase II|Alive in Survival Follow-up|0|||
105677568|NCT01871805|364481660|FG003|Phase II|Alive in Survival Follow-up|0|||
105677569|NCT01871805|364481661|FG004|Phase II|Alive in Survival Follow-up|0|||
105677570|NCT01871805|364481662|FG005|Phase II|Alive in Survival Follow-up|29|||
105677571|NCT01871805|364481657|FG000|Phase II|Lost to Follow-up|0|||
105677572|NCT01871805|364481658|FG001|Phase II|Lost to Follow-up|0|||
105677573|NCT01871805|364481659|FG002|Phase II|Lost to Follow-up|0|||
105677574|NCT01871805|364481660|FG003|Phase II|Lost to Follow-up|0|||
105677575|NCT01871805|364481661|FG004|Phase II|Lost to Follow-up|0|||
105677576|NCT01871805|364481662|FG005|Phase II|Lost to Follow-up|13|||
105677577|NCT00635427|364481665|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
105677578|NCT00635427|364481666|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
105677579|NCT00635427|364481667|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
105677580|NCT00635427|364481668|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
105677581|NCT00635427|364481669|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
105677582|NCT00635427|364481665|FG000|Overall Study|Death|0|||
105677583|NCT00635427|364481666|FG001|Overall Study|Death|0|||
105677584|NCT00635427|364481667|FG002|Overall Study|Death|0|||
105677585|NCT00635427|364481668|FG003|Overall Study|Death|1|||
105677586|NCT00635427|364481669|FG004|Overall Study|Death|0|||
105677587|NCT00635427|364481665|FG000|Overall Study|Termination Of Study By Sponsor|12|||
105677588|NCT00635427|364481666|FG001|Overall Study|Termination Of Study By Sponsor|6|||
105677589|NCT00635427|364481667|FG002|Overall Study|Termination Of Study By Sponsor|10|||
105913853|NCT02573259|365342807|FG003|Overall Study|Participant refused further follow-up|0|||
105913854|NCT02573259|365342808|FG004|Overall Study|Participant refused further follow-up|3|||
105913855|NCT02573259|365342809|FG005|Overall Study|Participant refused further follow-up|20|||
105913856|NCT02573259|365342810|FG006|Overall Study|Participant refused further follow-up|7|||
105913857|NCT02573259|365342804|FG000|Overall Study|Other|0|||
105913858|NCT02573259|365342805|FG001|Overall Study|Other|0|||
105913859|NCT02573259|365342806|FG002|Overall Study|Other|0|||
105913860|NCT02573259|365342807|FG003|Overall Study|Other|0|||
105913861|NCT02573259|365342808|FG004|Overall Study|Other|1|||
105913862|NCT02573259|365342809|FG005|Overall Study|Other|4|||
105913863|NCT02573259|365342810|FG006|Overall Study|Other|5|||
105913864|NCT00751140|365342811|FG000|Overall Study|benign angioma excluded from analysis|1|||
105913865|NCT02667301|365342812|FG000|Overall Study|Adverse Event|1|||
105677590|NCT00635427|364481668|FG003|Overall Study|Termination Of Study By Sponsor|6|||
105677591|NCT00635427|364481669|FG004|Overall Study|Termination Of Study By Sponsor|6|||
105677592|NCT00635427|364481665|FG000|Overall Study|Withdrawal Of Consent|0|||
105677593|NCT00635427|364481666|FG001|Overall Study|Withdrawal Of Consent|0|||
105677594|NCT00635427|364481667|FG002|Overall Study|Withdrawal Of Consent|0|||
105677595|NCT00635427|364481668|FG003|Overall Study|Withdrawal Of Consent|2|||
105677596|NCT00635427|364481669|FG004|Overall Study|Withdrawal Of Consent|2|||
105677597|NCT04510090|364481680|FG000|FE-HS|Withdrawal by Subject|0|||
105913866|NCT02667301|365342812|FG000|Overall Study|Lack of Efficacy|1|||
105913867|NCT02895295|365342815|FG000|Overall Study|Survey Non-response|71|||
105677598|NCT04510090|364481681|FG001|FE-HS|Withdrawal by Subject|0|||
105677599|NCT04510090|364481682|FG002|FE-HS|Withdrawal by Subject|0|||
105677600|NCT04510090|364481683|FG003|FE-HS|Withdrawal by Subject|0|||
105677601|NCT04510090|364481684|FG004|FE-HS|Withdrawal by Subject|1|||
105677602|NCT04510090|364481685|FG005|FE-HS|Withdrawal by Subject|0|||
105677603|NCT04510090|364481686|FG006|FE-HS|Withdrawal by Subject|0|||
105677604|NCT04510090|364481687|FG007|FE-HS|Withdrawal by Subject|0|||
105913868|NCT02895295|365342816|FG001|Overall Study|Survey Non-response|94|||
105913869|NCT02895295|365342817|FG002|Overall Study|Survey Non-response|92|||
105913870|NCT02493517|365342818|FG000|Overall Study|Protocol Violation|1|||
105913871|NCT02493517|365342819|FG001|Overall Study|Protocol Violation|2|||
105913872|NCT02493517|365342818|FG000|Overall Study|Withdrawal by Subject|1|||
105913873|NCT02493517|365342819|FG001|Overall Study|Withdrawal by Subject|2|||
105913874|NCT02493517|365342818|FG000|Overall Study|Adverse Event|0|||
105913875|NCT02493517|365342819|FG001|Overall Study|Adverse Event|2|||
105913876|NCT02493517|365342818|FG000|Overall Study|Missed study visit|0|||
105913877|NCT02493517|365342819|FG001|Overall Study|Missed study visit|1|||
105913878|NCT03811821|365342830|FG000|Overall Study|Adverse Event|1|||
105913879|NCT03811821|365342831|FG001|Overall Study|Adverse Event|1|||
105913880|NCT03811821|365342830|FG000|Overall Study|Withdrawal by Subject|5|||
105913881|NCT03811821|365342831|FG001|Overall Study|Withdrawal by Subject|4|||
105913882|NCT03811821|365342830|FG000|Overall Study|Lost to Follow-up|2|||
105913883|NCT03811821|365342831|FG001|Overall Study|Lost to Follow-up|2|||
105913884|NCT03811821|365342830|FG000|Overall Study|Contraindication for treatment|0|||
105913885|NCT03811821|365342831|FG001|Overall Study|Contraindication for treatment|1|||
105913886|NCT03811821|365342830|FG000|Overall Study|Tolerability|0|||
105913887|NCT03811821|365342831|FG001|Overall Study|Tolerability|3|||
105913888|NCT03811821|365342830|FG000|Overall Study|Comorbidities|0|||
105913889|NCT03811821|365342831|FG001|Overall Study|Comorbidities|2|||
105913890|NCT00919633|365342832|FG000|Overall Study|Adverse Event|1|||
105913891|NCT00919633|365342833|FG001|Overall Study|Adverse Event|9|||
105913892|NCT00919633|365342834|FG002|Overall Study|Adverse Event|12|||
105913893|NCT00919633|365342835|FG003|Overall Study|Adverse Event|10|||
105913894|NCT00919633|365342832|FG000|Overall Study|Death|0|||
105913895|NCT00919633|365342833|FG001|Overall Study|Death|0|||
105913896|NCT00919633|365342834|FG002|Overall Study|Death|2|||
105913897|NCT00919633|365342835|FG003|Overall Study|Death|0|||
105913898|NCT00919633|365342832|FG000|Overall Study|Lack of Efficacy|17|||
105913899|NCT00919633|365342833|FG001|Overall Study|Lack of Efficacy|3|||
105913900|NCT00919633|365342834|FG002|Overall Study|Lack of Efficacy|2|||
105913901|NCT00919633|365342835|FG003|Overall Study|Lack of Efficacy|3|||
105913902|NCT00919633|365342832|FG000|Overall Study|Withdrawal by Subject|1|||
105913903|NCT00919633|365342833|FG001|Overall Study|Withdrawal by Subject|2|||
105913904|NCT00919633|365342834|FG002|Overall Study|Withdrawal by Subject|4|||
105913905|NCT00919633|365342835|FG003|Overall Study|Withdrawal by Subject|3|||
105913906|NCT00919633|365342832|FG000|Overall Study|Lost to Follow-up|3|||
105913907|NCT00919633|365342833|FG001|Overall Study|Lost to Follow-up|1|||
105913908|NCT00919633|365342834|FG002|Overall Study|Lost to Follow-up|0|||
105913909|NCT00919633|365342835|FG003|Overall Study|Lost to Follow-up|2|||
105913910|NCT00919633|365342832|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
105913911|NCT00919633|365342833|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
105913912|NCT00919633|365342834|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
105913913|NCT00919633|365342835|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
105913914|NCT00919633|365342832|FG000|Overall Study|Protocol Violation|0|||
105913915|NCT00919633|365342833|FG001|Overall Study|Protocol Violation|0|||
105677605|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
105913916|NCT00919633|365342834|FG002|Overall Study|Protocol Violation|0|||
105913917|NCT00919633|365342835|FG003|Overall Study|Protocol Violation|1|||
105913918|NCT00919633|365342832|FG000|Overall Study|Physician Decision|0|||
105913919|NCT00919633|365342833|FG001|Overall Study|Physician Decision|0|||
105913920|NCT00919633|365342834|FG002|Overall Study|Physician Decision|0|||
105913921|NCT00919633|365342835|FG003|Overall Study|Physician Decision|1|||
105913922|NCT00919633|365342832|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
105913923|NCT00919633|365342833|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
105913924|NCT00919633|365342834|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
105913925|NCT00919633|365342835|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
105913926|NCT00919633|365342832|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
105913927|NCT00919633|365342833|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
105677606|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
105677607|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
105677608|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
105677609|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
105677610|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
105677611|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
105677612|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
105677613|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
105677614|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
105677615|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
105677616|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
105677617|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
105677618|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
105677619|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
105677620|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
105677621|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
105677622|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
105677623|NCT03412747|364481688|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
105677624|NCT03412747|364481689|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
105677625|NCT03412747|364481690|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
105677626|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
105677627|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
105677628|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
105677629|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
105677630|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
105677631|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
105677632|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
105677633|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
105677634|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
105677635|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
105677636|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
105677637|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
105677638|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
105677639|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
105677640|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
105677641|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
105677642|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
105677643|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
105677644|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
105677645|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
105677646|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
105677647|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
105677648|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
105677649|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
105677650|NCT03412747|364481688|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
105677651|NCT03412747|364481689|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
105677652|NCT03412747|364481690|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
105677653|NCT02081417|364481693|FG000|Overall Study|Lost to Follow-up|26|||
105677654|NCT02081417|364481694|FG001|Overall Study|Lost to Follow-up|23|||
105677655|NCT02081417|364481693|FG000|Overall Study|Moved Away|1|||
105677656|NCT02081417|364481694|FG001|Overall Study|Moved Away|2|||
105677657|NCT02081417|364481693|FG000|Overall Study|Incarcerated|2|||
105677658|NCT02081417|364481694|FG001|Overall Study|Incarcerated|2|||
105677659|NCT02081417|364481693|FG000|Overall Study|Death|4|||
105677660|NCT02081417|364481694|FG001|Overall Study|Death|3|||
105677661|NCT02081417|364481693|FG000|Overall Study|Withdrawal by Subject|4|||
105677662|NCT02081417|364481694|FG001|Overall Study|Withdrawal by Subject|0|||
105677663|NCT02081417|364481693|FG000|Overall Study|Admitted to Residential Treatment|2|||
105677664|NCT02081417|364481694|FG001|Overall Study|Admitted to Residential Treatment|0|||
105677665|NCT02081417|364481693|FG000|Overall Study|Did not start treatment|17|||
105677666|NCT02081417|364481694|FG001|Overall Study|Did not start treatment|21|||
105677667|NCT01157676|364481697|FG000|Randomization|Death|1|||
105677668|NCT01157676|364481698|FG001|Randomization|Death|1|||
105677669|NCT01157676|364481697|FG000|Randomization|unresectable|2|||
105677670|NCT01157676|364481698|FG001|Randomization|unresectable|3|||
105677671|NCT01157676|364481697|FG000|Randomization|Withdrawal by Subject|17|||
105913928|NCT00919633|365342834|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
105913929|NCT00919633|365342835|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
105677672|NCT01157676|364481698|FG001|Randomization|Withdrawal by Subject|13|||
105913930|NCT00490919|365342838|FG000|Open-label Run-in Period|Adverse Event|239|||
105913931|NCT00490919|365342839|FG001|Open-label Run-in Period|Adverse Event|0|||
105913932|NCT00490919|365342840|FG002|Open-label Run-in Period|Adverse Event|0|||
105913933|NCT00490919|365342838|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
105913934|NCT00490919|365342839|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
105913935|NCT00490919|365342840|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
105913936|NCT00490919|365342838|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
105913937|NCT00490919|365342839|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
105913938|NCT00490919|365342840|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
105913939|NCT00490919|365342838|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
105913940|NCT00490919|365342839|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
105913941|NCT00490919|365342840|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
105913942|NCT00490919|365342838|FG000|Open-label Run-in Period|Administrative|40|||
105913943|NCT00490919|365342839|FG001|Open-label Run-in Period|Administrative|0|||
105677673|NCT01157676|364481697|FG000|Randomization|Physician Decision|1|||
105677674|NCT01157676|364481698|FG001|Randomization|Physician Decision|0|||
105677675|NCT01157676|364481697|FG000|Surgery|underwent open cystectomy|0|||
105677676|NCT01157676|364481698|FG001|Surgery|underwent open cystectomy|4|||
105677677|NCT01157676|364481697|FG000|Surgery|converted to open procedure|0|||
105677678|NCT01157676|364481698|FG001|Surgery|converted to open procedure|5|||
105677679|NCT01157676|364481697|FG000|Surgery|underwent robotic cystectomy|1|||
105677680|NCT01157676|364481698|FG001|Surgery|underwent robotic cystectomy|0|||
105677681|NCT01263665|364481702|FG000|Overall Study|Withdrew Consent|1|||
105677682|NCT01263665|364481702|FG000|Overall Study|Lost to Follow-up|3|||
105677683|NCT01263665|364481702|FG000|Overall Study|Death|2|||
105677684|NCT01263665|364481702|FG000|Overall Study|Amputation above the ankle|1|||
105677685|NCT01263665|364481702|FG000|Overall Study|Surgical Bypass|2|||
105677686|NCT01506609|364481705|FG000|Overall Study|Adverse Event Related to Progression|0|||
105677687|NCT01506609|364481706|FG001|Overall Study|Adverse Event Related to Progression|0|||
105677688|NCT01506609|364481707|FG002|Overall Study|Adverse Event Related to Progression|0|||
105677689|NCT01506609|364481708|FG003|Overall Study|Adverse Event Related to Progression|3|||
105677690|NCT01506609|364481709|FG004|Overall Study|Adverse Event Related to Progression|7|||
105677691|NCT01506609|364481710|FG005|Overall Study|Adverse Event Related to Progression|3|||
105677692|NCT01506609|364481705|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
105677693|NCT01506609|364481706|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
105677694|NCT01506609|364481707|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
105677695|NCT01506609|364481708|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
105677696|NCT01506609|364481709|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
105677697|NCT01506609|364481710|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
105677698|NCT01506609|364481705|FG000|Overall Study|Withdrawal by Subject|0|||
105677699|NCT01506609|364481706|FG001|Overall Study|Withdrawal by Subject|0|||
105677700|NCT01506609|364481707|FG002|Overall Study|Withdrawal by Subject|0|||
105677701|NCT01506609|364481708|FG003|Overall Study|Withdrawal by Subject|9|||
105677702|NCT01506609|364481709|FG004|Overall Study|Withdrawal by Subject|7|||
105677703|NCT01506609|364481710|FG005|Overall Study|Withdrawal by Subject|7|||
105677704|NCT01506609|364481705|FG000|Overall Study|Lost to Follow-up|0|||
105677705|NCT01506609|364481706|FG001|Overall Study|Lost to Follow-up|0|||
105677706|NCT01506609|364481707|FG002|Overall Study|Lost to Follow-up|0|||
105677707|NCT01506609|364481708|FG003|Overall Study|Lost to Follow-up|1|||
105677708|NCT01506609|364481709|FG004|Overall Study|Lost to Follow-up|2|||
105677709|NCT01506609|364481710|FG005|Overall Study|Lost to Follow-up|0|||
105677710|NCT01506609|364481705|FG000|Overall Study|Sponsor Discontinued Study|0|||
105677711|NCT01506609|364481706|FG001|Overall Study|Sponsor Discontinued Study|0|||
105677712|NCT01506609|364481707|FG002|Overall Study|Sponsor Discontinued Study|0|||
105677713|NCT01506609|364481708|FG003|Overall Study|Sponsor Discontinued Study|2|||
105677714|NCT01506609|364481709|FG004|Overall Study|Sponsor Discontinued Study|2|||
105677715|NCT01506609|364481710|FG005|Overall Study|Sponsor Discontinued Study|0|||
105677716|NCT01506609|364481705|FG000|Overall Study|Progressive Disease per Protocol|1|||
105677717|NCT01506609|364481706|FG001|Overall Study|Progressive Disease per Protocol|0|||
105677718|NCT01506609|364481707|FG002|Overall Study|Progressive Disease per Protocol|0|||
105677719|NCT01506609|364481708|FG003|Overall Study|Progressive Disease per Protocol|64|||
105677720|NCT01506609|364481709|FG004|Overall Study|Progressive Disease per Protocol|57|||
105677721|NCT01506609|364481710|FG005|Overall Study|Progressive Disease per Protocol|74|||
105677722|NCT01506609|364481705|FG000|Overall Study|Other, Not Specified|0|||
105677723|NCT01506609|364481706|FG001|Overall Study|Other, Not Specified|0|||
105677724|NCT01506609|364481707|FG002|Overall Study|Other, Not Specified|0|||
105677725|NCT01506609|364481708|FG003|Overall Study|Other, Not Specified|10|||
105677726|NCT01506609|364481709|FG004|Overall Study|Other, Not Specified|7|||
105677727|NCT01506609|364481710|FG005|Overall Study|Other, Not Specified|3|||
105677728|NCT01506609|364481705|FG000|Overall Study|Missing / Unknown Reason|1|||
105677729|NCT01506609|364481706|FG001|Overall Study|Missing / Unknown Reason|0|||
105786444|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
105913944|NCT00490919|365342840|FG002|Open-label Run-in Period|Administrative|0|||
105913945|NCT00490919|365342838|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
105913946|NCT00490919|365342839|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
105913947|NCT00490919|365342840|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
105913948|NCT00490919|365342838|FG000|Double-blind Phase|Adverse Event|0|||
105913949|NCT00490919|365342839|FG001|Double-blind Phase|Adverse Event|40|||
105677730|NCT01506609|364481707|FG002|Overall Study|Missing / Unknown Reason|1|||
105677731|NCT01506609|364481708|FG003|Overall Study|Missing / Unknown Reason|4|||
105677732|NCT01506609|364481709|FG004|Overall Study|Missing / Unknown Reason|4|||
105677733|NCT01506609|364481710|FG005|Overall Study|Missing / Unknown Reason|2|||
105677734|NCT00252577|364481711|FG000|Overall Study|Lost to Follow-up|20|||
105677735|NCT02962960|364481714|FG000|Overall Study|Withdrawal by Subject|1|||
105677736|NCT02962960|364481715|FG001|Overall Study|Withdrawal by Subject|1|||
105677737|NCT02962960|364481716|FG002|Overall Study|Withdrawal by Subject|0|||
105786445|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
105913950|NCT00490919|365342840|FG002|Double-blind Phase|Adverse Event|20|||
105677738|NCT02962960|364481714|FG000|Overall Study|Adverse Event|1|||
105677739|NCT02962960|364481715|FG001|Overall Study|Adverse Event|1|||
105677740|NCT02962960|364481716|FG002|Overall Study|Adverse Event|0|||
105677741|NCT02962960|364481714|FG000|Overall Study|Protocol Violation|1|||
105677742|NCT02962960|364481715|FG001|Overall Study|Protocol Violation|0|||
105677743|NCT02962960|364481716|FG002|Overall Study|Protocol Violation|0|||
105677744|NCT01744392|364481717|FG000|Overall Study|Physician Decision|1|||
105677745|NCT01435616|364481718|FG000|Overall Study|Adverse Event|39|||
105913951|NCT00490919|365342838|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105913952|NCT00490919|365342839|FG001|Double-blind Phase|Withdrawal by Subject|10|||
105913953|NCT00490919|365342840|FG002|Double-blind Phase|Withdrawal by Subject|11|||
105913954|NCT00490919|365342838|FG000|Double-blind Phase|Lost to Follow-up|0|||
105677746|NCT01435616|364481719|FG001|Overall Study|Adverse Event|21|||
105677747|NCT01435616|364481718|FG000|Overall Study|Death|7|||
105677748|NCT01435616|364481719|FG001|Overall Study|Death|2|||
105677749|NCT01435616|364481718|FG000|Overall Study|Lost to Follow-up|22|||
105677750|NCT01435616|364481719|FG001|Overall Study|Lost to Follow-up|13|||
105677751|NCT01435616|364481718|FG000|Overall Study|Protocol Violation|16|||
105677752|NCT01435616|364481719|FG001|Overall Study|Protocol Violation|13|||
105677753|NCT01435616|364481718|FG000|Overall Study|Withdrawal by Subject|66|||
105677754|NCT01435616|364481719|FG001|Overall Study|Withdrawal by Subject|24|||
105677755|NCT01435616|364481718|FG000|Overall Study|Physician Decision|20|||
105677756|NCT01435616|364481719|FG001|Overall Study|Physician Decision|7|||
105677757|NCT01435616|364481718|FG000|Overall Study|Sponsor Decision|1|||
105677758|NCT01435616|364481719|FG001|Overall Study|Sponsor Decision|0|||
105677759|NCT00468559|364481726|FG000|Open-label Treatment Phase|Adverse Event|5|||
105677760|NCT00468559|364481727|FG001|Open-label Treatment Phase|Adverse Event|0|||
105677761|NCT00468559|364481728|FG002|Open-label Treatment Phase|Adverse Event|0|||
105677762|NCT00468559|364481726|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
105677763|NCT00468559|364481727|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
105677764|NCT00468559|364481728|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
105677765|NCT00468559|364481726|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
105677766|NCT00468559|364481727|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
105677767|NCT00468559|364481728|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
105677768|NCT00468559|364481726|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
105677769|NCT00468559|364481727|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
105677770|NCT00468559|364481728|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
105677771|NCT00468559|364481726|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
105677772|NCT00468559|364481727|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
105677773|NCT00468559|364481728|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
105677774|NCT00862719|364481729|FG000|Overall Study|Disease Progression|5|||
105677775|NCT00862719|364481730|FG001|Overall Study|Disease Progression|0|||
105677776|NCT00862719|364481731|FG002|Overall Study|Disease Progression|1|||
105677777|NCT00862719|364481732|FG003|Overall Study|Disease Progression|0|||
105677778|NCT00862719|364481729|FG000|Overall Study|Death|5|||
105677779|NCT00862719|364481730|FG001|Overall Study|Death|6|||
105677780|NCT00862719|364481731|FG002|Overall Study|Death|1|||
105677781|NCT00862719|364481732|FG003|Overall Study|Death|1|||
105677782|NCT00862719|364481729|FG000|Overall Study|Engraftment failure|0|||
105677783|NCT00862719|364481730|FG001|Overall Study|Engraftment failure|0|||
105677784|NCT00862719|364481731|FG002|Overall Study|Engraftment failure|1|||
105677785|NCT00862719|364481732|FG003|Overall Study|Engraftment failure|0|||
105677786|NCT00862719|364481729|FG000|Overall Study|Veno-Occlusive Disease|0|||
105677787|NCT00862719|364481730|FG001|Overall Study|Veno-Occlusive Disease|0|||
105913955|NCT00490919|365342839|FG001|Double-blind Phase|Lost to Follow-up|8|||
105913956|NCT00490919|365342840|FG002|Double-blind Phase|Lost to Follow-up|11|||
105913957|NCT00490919|365342838|FG000|Double-blind Phase|Lack of Efficacy|0|||
105913958|NCT00490919|365342839|FG001|Double-blind Phase|Lack of Efficacy|22|||
105913959|NCT00490919|365342840|FG002|Double-blind Phase|Lack of Efficacy|36|||
105913960|NCT00490919|365342838|FG000|Double-blind Phase|Administrative|0|||
105913961|NCT00490919|365342839|FG001|Double-blind Phase|Administrative|6|||
105677788|NCT00862719|364481731|FG002|Overall Study|Veno-Occlusive Disease|1|||
105677789|NCT00862719|364481732|FG003|Overall Study|Veno-Occlusive Disease|0|||
105677790|NCT00324116|364481733|FG000|Overall Study|Adverse Event|5|||
105677791|NCT00324116|364481733|FG000|Overall Study|Lack of Efficacy|17|||
105677792|NCT00324116|364481733|FG000|Overall Study|Withdrawal by Subject|5|||
105677793|NCT00324116|364481733|FG000|Overall Study|Other|5|||
105677794|NCT01806623|364481736|FG000|Overall Study|Withdrawal by Subject|1|||
105677795|NCT01806623|364481736|FG000|Overall Study|Adverse Event|1|||
105677796|NCT01806623|364481736|FG000|Overall Study|Did not meet the inclusion criteria|56|||
105677797|NCT01451827|364481743|FG000|Overall Study|Adverse Event|2|||
105677798|NCT01451827|364481744|FG001|Overall Study|Adverse Event|0|||
105677799|NCT01451827|364481745|FG002|Overall Study|Adverse Event|1|||
105677800|NCT01451827|364481746|FG003|Overall Study|Adverse Event|1|||
105677801|NCT01451827|364481743|FG000|Overall Study|Protocol deviation|1|||
105913962|NCT00490919|365342840|FG002|Double-blind Phase|Administrative|6|||
105677802|NCT01451827|364481744|FG001|Overall Study|Protocol deviation|0|||
105786446|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
105786447|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
105677803|NCT01451827|364481745|FG002|Overall Study|Protocol deviation|0|||
105677804|NCT01451827|364481746|FG003|Overall Study|Protocol deviation|0|||
105677805|NCT01451827|364481743|FG000|Overall Study|Lost to Follow-up|0|||
105677806|NCT01451827|364481744|FG001|Overall Study|Lost to Follow-up|3|||
105677807|NCT01451827|364481745|FG002|Overall Study|Lost to Follow-up|0|||
105677808|NCT01451827|364481746|FG003|Overall Study|Lost to Follow-up|2|||
105677809|NCT01451827|364481743|FG000|Overall Study|Participant met withdrawal criteria|0|||
105677810|NCT01451827|364481744|FG001|Overall Study|Participant met withdrawal criteria|2|||
105677811|NCT01451827|364481745|FG002|Overall Study|Participant met withdrawal criteria|0|||
105677812|NCT01451827|364481746|FG003|Overall Study|Participant met withdrawal criteria|0|||
105677813|NCT01451827|364481743|FG000|Overall Study|Withdrawal by Subject|0|||
105677814|NCT01451827|364481744|FG001|Overall Study|Withdrawal by Subject|0|||
105677815|NCT01451827|364481745|FG002|Overall Study|Withdrawal by Subject|1|||
105677816|NCT01451827|364481746|FG003|Overall Study|Withdrawal by Subject|1|||
105677817|NCT00620282|364481747|FG000|Overall Study|Adverse Event|0|||
105677818|NCT00620282|364481748|FG001|Overall Study|Adverse Event|1|||
105677819|NCT00620282|364481749|FG002|Overall Study|Adverse Event|0|||
105677820|NCT00620282|364481747|FG000|Overall Study|Arterial line unable to be placed|0|||
105677821|NCT00620282|364481748|FG001|Overall Study|Arterial line unable to be placed|0|||
105677822|NCT00620282|364481749|FG002|Overall Study|Arterial line unable to be placed|1|||
105677823|NCT00620282|364481747|FG000|Overall Study|Withdrawal by Subject|0|||
105677824|NCT00620282|364481748|FG001|Overall Study|Withdrawal by Subject|1|||
105677825|NCT00620282|364481749|FG002|Overall Study|Withdrawal by Subject|0|||
105677826|NCT01964924|364481750|FG000|Trametinib Monotherapy|Progression|19|||
105677827|NCT01964924|364481751|FG001|Trametinib Monotherapy|Progression|0|||
105677828|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
105677829|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
105677830|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
105677831|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
105677832|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
105677833|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
105677834|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
105677835|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
105677836|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
105677837|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
105677838|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
105677839|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
105677840|NCT02217475|364481752|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
105677841|NCT02217475|364481753|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
105677842|NCT02217475|364481754|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
105677843|NCT02217475|364481752|FG000|Discontinued After Period 1|Adverse Event|1|||
105677844|NCT02217475|364481753|FG001|Discontinued After Period 1|Adverse Event|2|||
105677845|NCT02217475|364481754|FG002|Discontinued After Period 1|Adverse Event|0|||
105677846|NCT02217475|364481752|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
105677847|NCT02217475|364481753|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
105677848|NCT02217475|364481754|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
105677849|NCT02217475|364481752|FG000|Discontinued After Period 1|Physician Decision|0|||
105677850|NCT02217475|364481753|FG001|Discontinued After Period 1|Physician Decision|0|||
105913963|NCT03527277|365345238|FG000|Overall Study|Withdrawal by Subject|5|||
105913964|NCT03527277|365345239|FG001|Overall Study|Withdrawal by Subject|0|||
105913965|NCT03527277|365345238|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
105913966|NCT03527277|365345239|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
105913967|NCT03527277|365345238|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
105913968|NCT03527277|365345239|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
105913969|NCT03316586|365345240|FG000|Overall Study|Adverse Event|2|||
105913970|NCT03316586|365345240|FG000|Overall Study|Physician Decision|3|||
105913971|NCT03316586|365345240|FG000|Overall Study|Lack of Efficacy|10|||
105913972|NCT03316586|365345240|FG000|Overall Study|still on treatment|1|||
105913973|NCT03316586|365345240|FG000|Overall Study|Patient needed radiation therapy|1|||
105677851|NCT02217475|364481754|FG002|Discontinued After Period 1|Physician Decision|1|||
105677852|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
105677853|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
105677854|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
105677855|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
105677856|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
105677857|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
105913974|NCT03316586|365345240|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
105677858|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
105913975|NCT00643760|365345243|FG000|Overall Study|Adverse Event|11|||
105677859|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
105677860|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
105677861|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
105677862|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
105677863|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
105677864|NCT02217475|364481752|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
105677865|NCT02217475|364481753|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
105677866|NCT02217475|364481754|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
105677867|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
105677868|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
105677869|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
105677870|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
105677871|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
105677872|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
105677873|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
105677874|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
105677875|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
105677876|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
105677877|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
105677878|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
105677879|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
105677880|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
105677881|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
105677882|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
105677883|NCT02544451|364481759|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
105677884|NCT02544451|364481760|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
105677885|NCT02544451|364481761|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
105677886|NCT02544451|364481762|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
105677887|NCT02544451|364481759|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
105677888|NCT02544451|364481760|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
105677889|NCT02544451|364481761|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
105677890|NCT02544451|364481762|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
105677891|NCT03001076|364481764|FG000|Overall Study|Withdrawal by patient|2|||
105677892|NCT03001076|364481765|FG001|Overall Study|Withdrawal by patient|0|||
105677893|NCT03001076|364481764|FG000|Overall Study|Other|1|||
105677894|NCT03001076|364481765|FG001|Overall Study|Other|0|||
105677895|NCT03001076|364481764|FG000|Overall Study|Adverse Event|3|||
105677896|NCT03001076|364481765|FG001|Overall Study|Adverse Event|3|||
105677897|NCT03001076|364481764|FG000|Overall Study|Sponsor decision|1|||
105677898|NCT03001076|364481765|FG001|Overall Study|Sponsor decision|0|||
105677899|NCT03001076|364481764|FG000|Overall Study|Lost to Follow-up|0|||
105677900|NCT03001076|364481765|FG001|Overall Study|Lost to Follow-up|2|||
105913976|NCT00643760|365345244|FG001|Overall Study|Adverse Event|5|||
105913977|NCT00643760|365345245|FG002|Overall Study|Adverse Event|12|||
105913978|NCT00643760|365345246|FG003|Overall Study|Adverse Event|21|||
105913979|NCT00643760|365345247|FG004|Overall Study|Adverse Event|6|||
105913980|NCT00643760|365345243|FG000|Overall Study|Lack of Efficacy|3|||
105913981|NCT00643760|365345244|FG001|Overall Study|Lack of Efficacy|1|||
105913982|NCT00643760|365345245|FG002|Overall Study|Lack of Efficacy|0|||
105913983|NCT00643760|365345246|FG003|Overall Study|Lack of Efficacy|4|||
105913984|NCT00643760|365345247|FG004|Overall Study|Lack of Efficacy|3|||
105913985|NCT00643760|365345243|FG000|Overall Study|Protocol Violation|7|||
105913986|NCT00643760|365345244|FG001|Overall Study|Protocol Violation|6|||
105913987|NCT00643760|365345245|FG002|Overall Study|Protocol Violation|4|||
105913988|NCT00643760|365345246|FG003|Overall Study|Protocol Violation|4|||
105913989|NCT00643760|365345247|FG004|Overall Study|Protocol Violation|6|||
105913990|NCT00643760|365345243|FG000|Overall Study|Lost to Follow-up|6|||
105913991|NCT00643760|365345244|FG001|Overall Study|Lost to Follow-up|2|||
105913992|NCT00643760|365345245|FG002|Overall Study|Lost to Follow-up|1|||
105913993|NCT00643760|365345246|FG003|Overall Study|Lost to Follow-up|3|||
105913994|NCT00643760|365345247|FG004|Overall Study|Lost to Follow-up|3|||
105913995|NCT00643760|365345243|FG000|Overall Study|Investigator Discretion|0|||
105913996|NCT00643760|365345244|FG001|Overall Study|Investigator Discretion|0|||
105913997|NCT00643760|365345245|FG002|Overall Study|Investigator Discretion|0|||
105677901|NCT02842151|364481772|FG000|Overall Study|Adverse Event|1|||
105677902|NCT02842151|364481772|FG000|Overall Study|Subject moved too far away|1|||
105913998|NCT00643760|365345246|FG003|Overall Study|Investigator Discretion|2|||
105913999|NCT00643760|365345247|FG004|Overall Study|Investigator Discretion|0|||
105914000|NCT00643760|365345243|FG000|Overall Study|Withdrawal by Subject|3|||
105914001|NCT00643760|365345244|FG001|Overall Study|Withdrawal by Subject|1|||
105914002|NCT00643760|365345245|FG002|Overall Study|Withdrawal by Subject|2|||
105914003|NCT00643760|365345246|FG003|Overall Study|Withdrawal by Subject|4|||
105914004|NCT00643760|365345247|FG004|Overall Study|Withdrawal by Subject|1|||
105677903|NCT01262027|364481773|FG000|Overall Study|Adverse Event|1|||
105677904|NCT01262027|364481773|FG000|Overall Study|Withdrawal by Subject|3|||
105677905|NCT01262027|364481773|FG000|Overall Study|Protocol Violation|1|||
105677906|NCT03562975|364481783|FG000|Overall Study|Death|1|||
105677907|NCT03562975|364481783|FG000|Overall Study|Lost to Follow-up|1|||
105677908|NCT03562975|364481783|FG000|Overall Study|Withdrawal by Subject|1|||
105677909|NCT03149549|364481784|FG000|Study Discontinuation--Treatment Period|Death|0|||
105677910|NCT03149549|364481785|FG001|Study Discontinuation--Treatment Period|Death|0|||
105677911|NCT03149549|364481786|FG002|Study Discontinuation--Treatment Period|Death|0|||
105677912|NCT03149549|364481787|FG003|Study Discontinuation--Treatment Period|Death|1|||
105677913|NCT03149549|364481788|FG004|Study Discontinuation--Treatment Period|Death|2|||
105677914|NCT03149549|364481789|FG005|Study Discontinuation--Treatment Period|Death|1|||
105677915|NCT03149549|364481790|FG006|Study Discontinuation--Treatment Period|Death|1|||
105677916|NCT03149549|364481791|FG007|Study Discontinuation--Treatment Period|Death|2|||
105677917|NCT03149549|364481792|FG008|Study Discontinuation--Treatment Period|Death|4|||
105677918|NCT03149549|364481793|FG009|Study Discontinuation--Treatment Period|Death|1|||
105677919|NCT03149549|364481794|FG010|Study Discontinuation--Treatment Period|Death|0|||
105677920|NCT03149549|364481795|FG011|Study Discontinuation--Treatment Period|Death|0|||
105677921|NCT03149549|364481796|FG012|Study Discontinuation--Treatment Period|Death|1|||
105677922|NCT03149549|364481784|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677923|NCT03149549|364481785|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677924|NCT03149549|364481786|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677925|NCT03149549|364481787|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677926|NCT03149549|364481788|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677927|NCT03149549|364481789|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677928|NCT03149549|364481790|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677929|NCT03149549|364481791|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
105677930|NCT03149549|364481792|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677931|NCT03149549|364481793|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677932|NCT03149549|364481794|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677933|NCT03149549|364481795|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
105677934|NCT03149549|364481796|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
105677935|NCT03149549|364481784|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677936|NCT03149549|364481785|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677937|NCT03149549|364481786|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677938|NCT03149549|364481787|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
105677939|NCT03149549|364481788|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
105677940|NCT03149549|364481789|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
105677941|NCT03149549|364481790|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
105677942|NCT03149549|364481791|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677943|NCT03149549|364481792|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
105677944|NCT03149549|364481793|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677945|NCT03149549|364481794|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677946|NCT03149549|364481795|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677947|NCT03149549|364481796|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
105677948|NCT03149549|364481784|FG000|Study Discontinuation--Treatment Period|Other|0|||
105677949|NCT03149549|364481785|FG001|Study Discontinuation--Treatment Period|Other|0|||
105677950|NCT03149549|364481786|FG002|Study Discontinuation--Treatment Period|Other|0|||
105677951|NCT03149549|364481787|FG003|Study Discontinuation--Treatment Period|Other|0|||
105677952|NCT03149549|364481788|FG004|Study Discontinuation--Treatment Period|Other|0|||
105677953|NCT03149549|364481789|FG005|Study Discontinuation--Treatment Period|Other|0|||
105677954|NCT03149549|364481790|FG006|Study Discontinuation--Treatment Period|Other|0|||
105677955|NCT03149549|364481791|FG007|Study Discontinuation--Treatment Period|Other|1|||
105677956|NCT03149549|364481792|FG008|Study Discontinuation--Treatment Period|Other|0|||
105677957|NCT03149549|364481793|FG009|Study Discontinuation--Treatment Period|Other|1|||
105914005|NCT02063672|365345248|FG000|Overall Study|Ongoing Follow-up|27|||
105914006|NCT02063672|365345249|FG001|Overall Study|Ongoing Follow-up|14|||
105914007|NCT02063672|365345248|FG000|Overall Study|Death|5|||
105914008|NCT02063672|365345249|FG001|Overall Study|Death|3|||
105914009|NCT02063672|365345248|FG000|Overall Study|Lost to Follow-up|1|||
105914010|NCT02063672|365345249|FG001|Overall Study|Lost to Follow-up|3|||
105914011|NCT02063672|365345248|FG000|Overall Study|Withdrawal by Subject|2|||
105677958|NCT03149549|364481794|FG010|Study Discontinuation--Treatment Period|Other|0|||
105677959|NCT03149549|364481795|FG011|Study Discontinuation--Treatment Period|Other|0|||
105914012|NCT02063672|365345249|FG001|Overall Study|Withdrawal by Subject|2|||
105914013|NCT01396083|365345252|FG000|Overall Study|Adverse Event|2|||
105677960|NCT03149549|364481796|FG012|Study Discontinuation--Treatment Period|Other|0|||
105677961|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677962|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677963|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677964|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677965|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677966|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
105677967|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
105677968|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677969|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
105677970|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677971|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677972|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677973|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
105677974|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677975|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677976|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677977|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677978|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
105677979|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677980|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677981|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
105677982|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
105677983|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677984|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
105677985|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
105677986|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
105786448|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
105786449|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
105786450|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
105786451|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
105786452|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
105786453|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
105786454|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
105786455|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
105786456|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
105786457|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
105786458|NCT04579666|364871387|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
105786459|NCT04579666|364871388|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
105786460|NCT04579666|364871389|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
105786461|NCT04579666|364871390|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
105786462|NCT00643006|364871392|FG000|Overall Study|Lost to Follow-up|5|||
105786463|NCT00643006|364871393|FG001|Overall Study|Lost to Follow-up|4|||
105786464|NCT02506101|364871394|FG000|Overall Study|Transportation issues|1|||
105786465|NCT02506101|364871395|FG001|Overall Study|Transportation issues|0|||
105786466|NCT02506101|364871394|FG000|Overall Study|No enrollment and staff unavailability|1|||
105914014|NCT01396083|365345253|FG001|Overall Study|Adverse Event|28|||
105914015|NCT01396083|365345252|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105914016|NCT01396083|365345253|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
105914017|NCT01396083|365345252|FG000|Overall Study|Consent withdrawn|4|||
105914018|NCT01396083|365345253|FG001|Overall Study|Consent withdrawn|5|||
105914019|NCT01396083|365345252|FG000|Overall Study|Protocol deviation(s)|0|||
105914020|NCT01396083|365345253|FG001|Overall Study|Protocol deviation(s)|1|||
105914021|NCT01396083|365345252|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105914022|NCT01396083|365345253|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105914023|NCT01396083|365345252|FG000|Overall Study|Administrative problems|1|||
105914024|NCT01396083|365345253|FG001|Overall Study|Administrative problems|0|||
105914025|NCT01396083|365345252|FG000|Overall Study|Lost to Follow-up|1|||
105914026|NCT01396083|365345253|FG001|Overall Study|Lost to Follow-up|0|||
105914027|NCT00735709|365345254|FG000|Overall Study|Adverse Event|2|||
105914028|NCT00735709|365345255|FG001|Overall Study|Adverse Event|3|||
105914029|NCT00735709|365345256|FG002|Overall Study|Adverse Event|1|||
105914030|NCT00735709|365345257|FG003|Overall Study|Adverse Event|5|||
105914031|NCT00735709|365345254|FG000|Overall Study|Lack of Efficacy|8|||
105914032|NCT00735709|365345255|FG001|Overall Study|Lack of Efficacy|4|||
106000074|NCT05579977|365661263|FG010|Treatment Phase|Adverse Event|15|||
105677987|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105786467|NCT02506101|364871395|FG001|Overall Study|No enrollment and staff unavailability|0|||
105786468|NCT03605758|364871396|FG000|Overall Study|Lost to Follow-up|2|||
105914033|NCT00735709|365345256|FG002|Overall Study|Lack of Efficacy|2|||
105914034|NCT00735709|365345257|FG003|Overall Study|Lack of Efficacy|3|||
105914035|NCT00735709|365345254|FG000|Overall Study|Noncompliance|0|||
105914036|NCT00735709|365345255|FG001|Overall Study|Noncompliance|0|||
105914037|NCT00735709|365345256|FG002|Overall Study|Noncompliance|1|||
105914038|NCT00735709|365345257|FG003|Overall Study|Noncompliance|0|||
105914039|NCT00735709|365345254|FG000|Overall Study|Protocol deviations|1|||
105914040|NCT00735709|365345255|FG001|Overall Study|Protocol deviations|2|||
105914041|NCT00735709|365345256|FG002|Overall Study|Protocol deviations|1|||
105914042|NCT00735709|365345257|FG003|Overall Study|Protocol deviations|1|||
105914043|NCT00735709|365345254|FG000|Overall Study|Voluntary Withdrawal|1|||
105914044|NCT00735709|365345255|FG001|Overall Study|Voluntary Withdrawal|3|||
105914045|NCT00735709|365345256|FG002|Overall Study|Voluntary Withdrawal|5|||
105914046|NCT00735709|365345257|FG003|Overall Study|Voluntary Withdrawal|7|||
105914047|NCT00735709|365345254|FG000|Overall Study|Lost to Follow-up|0|||
105914048|NCT00735709|365345255|FG001|Overall Study|Lost to Follow-up|1|||
105914049|NCT00735709|365345256|FG002|Overall Study|Lost to Follow-up|1|||
105914050|NCT00735709|365345257|FG003|Overall Study|Lost to Follow-up|1|||
105914051|NCT00735709|365345254|FG000|Overall Study|Excluded medication|1|||
105914052|NCT00735709|365345255|FG001|Overall Study|Excluded medication|0|||
105914053|NCT00735709|365345256|FG002|Overall Study|Excluded medication|0|||
105914054|NCT00735709|365345257|FG003|Overall Study|Excluded medication|1|||
105914055|NCT00104052|365345258|FG000|Overall Study|Adverse Event|1|||
105914056|NCT00104052|365345258|FG000|Overall Study|Lack of Efficacy|26|||
105914057|NCT00104052|365345258|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
105914058|NCT03150082|365345275|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
105914059|NCT03150082|365345276|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
105914060|NCT01249417|365345281|FG000|Randomised Population|Study treatment not received|0|||
105914061|NCT01249417|365345282|FG001|Randomised Population|Study treatment not received|0|||
105914062|NCT01249417|365345283|FG002|Randomised Population|Study treatment not received|2|||
105677988|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677989|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677990|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105914063|NCT01249417|365345281|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
105914064|NCT01249417|365345282|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
105914065|NCT01249417|365345283|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
105914066|NCT01249417|365345281|FG000|Treatment Phase - ITT Population|Other|0|||
105914067|NCT01249417|365345282|FG001|Treatment Phase - ITT Population|Other|0|||
105914068|NCT01249417|365345283|FG002|Treatment Phase - ITT Population|Other|1|||
105914069|NCT01249417|365345281|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
105677991|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
105677992|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677993|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677994|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
105677995|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
105677996|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
105677997|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
105677998|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
105677999|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
105678000|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
105678001|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
105678002|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
105678003|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
105678004|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
105678005|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
105678006|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
105678007|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
105678008|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
105678009|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
105678010|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
105678011|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
105678012|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
105678013|NCT03149549|364481784|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
105678014|NCT03149549|364481785|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
105678015|NCT03149549|364481786|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
105678016|NCT03149549|364481787|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
105678017|NCT03149549|364481788|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
105678018|NCT03149549|364481789|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
105678019|NCT03149549|364481790|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
105678020|NCT03149549|364481791|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
105678021|NCT03149549|364481792|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
105678022|NCT03149549|364481793|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
105678023|NCT03149549|364481794|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
105678024|NCT03149549|364481795|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
105678025|NCT03149549|364481796|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
105678026|NCT01758900|364481799|FG000|Overall Study|difficulty for further intubation|7|||
105678027|NCT01758900|364481800|FG001|Overall Study|difficulty for further intubation|8|||
105678028|NCT00935818|364481801|FG000|Overall Study|Withdrawal by Subject|45|||
105678029|NCT00935818|364481802|FG001|Overall Study|Withdrawal by Subject|50|||
105678030|NCT00935818|364481801|FG000|Overall Study|Lost to Follow-up|40|||
105678031|NCT00935818|364481802|FG001|Overall Study|Lost to Follow-up|42|||
105678032|NCT00935818|364481801|FG000|Overall Study|Adverse Event|6|||
105678033|NCT00935818|364481802|FG001|Overall Study|Adverse Event|7|||
105678034|NCT00935818|364481801|FG000|Overall Study|Physician Decision|0|||
105678035|NCT00935818|364481802|FG001|Overall Study|Physician Decision|1|||
105678036|NCT01305200|364481804|FG000|Overall Study|Physician Decision|4|||
105678037|NCT01305200|364481805|FG001|Overall Study|Physician Decision|6|||
105678038|NCT01305200|364481806|FG002|Overall Study|Physician Decision|1|||
105914070|NCT01249417|365345282|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
105914071|NCT01249417|365345283|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
105914072|NCT01249417|365345281|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
105914073|NCT01249417|365345282|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
105914074|NCT01249417|365345283|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
105914075|NCT01249417|365345281|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
105914076|NCT01249417|365345282|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
105914077|NCT01249417|365345283|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
105914078|NCT02515630|365345284|FG000|Overall Study|Withdrawal by Subject|5|||
105914079|NCT02515630|365345284|FG000|Overall Study|Adverse Event|4|||
106000075|NCT05579977|365661264|FG011|Treatment Phase|Adverse Event|24|||
106000076|NCT05579977|365661265|FG012|Treatment Phase|Adverse Event|23|||
105678039|NCT01305200|364481804|FG000|Overall Study|Withdrawal by Subject|24|||
105678040|NCT01305200|364481805|FG001|Overall Study|Withdrawal by Subject|21|||
105678041|NCT01305200|364481806|FG002|Overall Study|Withdrawal by Subject|1|||
105678042|NCT01305200|364481804|FG000|Overall Study|Ineligible|1|||
105678043|NCT01305200|364481805|FG001|Overall Study|Ineligible|2|||
105678044|NCT01305200|364481806|FG002|Overall Study|Ineligible|1|||
105678045|NCT01305200|364481804|FG000|Overall Study|Death|0|||
105678046|NCT01305200|364481805|FG001|Overall Study|Death|2|||
105678047|NCT01305200|364481806|FG002|Overall Study|Death|0|||
105678048|NCT02317432|364481807|FG000|Overall Study|Death|4|||
105678049|NCT02317432|364481808|FG001|Overall Study|Death|1|||
105678050|NCT02317432|364481807|FG000|Overall Study|Lost to Follow-up|0|||
105678051|NCT02317432|364481808|FG001|Overall Study|Lost to Follow-up|5|||
105678052|NCT02317432|364481807|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
105678053|NCT02317432|364481808|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
105678054|NCT00923260|364483399|FG000|Overall Study|Lost to Follow-up|1|||
105678055|NCT00923260|364483400|FG001|Overall Study|Lost to Follow-up|1|||
105678056|NCT02233543|364483402|FG000|Period 1|Withdrawal by Subject|1|||
105678057|NCT02233543|364483403|FG001|Period 1|Withdrawal by Subject|0|||
105678058|NCT02233543|364483402|FG000|Period 1|Participants required other treatment.|2|||
105678059|NCT02233543|364483403|FG001|Period 1|Participants required other treatment.|3|||
105678060|NCT02233543|364483402|FG000|Period 2|Adverse Event|1|||
105678061|NCT02233543|364483403|FG001|Period 2|Adverse Event|0|||
105678062|NCT02233543|364483402|FG000|Period 2|Participant required other treatment.|0|||
105678063|NCT02233543|364483403|FG001|Period 2|Participant required other treatment.|1|||
105678064|NCT02233543|364483402|FG000|Period 2|COPD exacerbation|1|||
105678065|NCT02233543|364483403|FG001|Period 2|COPD exacerbation|0|||
105678066|NCT02349425|364483404|FG000|Period 1|Adverse Event|1|||
105678067|NCT02349425|364483405|FG001|Period 1|Adverse Event|1|||
105678068|NCT02349425|364483406|FG002|Period 1|Adverse Event|0|||
105678069|NCT02349425|364483407|FG003|Period 1|Adverse Event|0|||
105678070|NCT02349425|364483404|FG000|Period 2|Adverse Event|0|||
105678071|NCT02349425|364483405|FG001|Period 2|Adverse Event|1|||
105678072|NCT02349425|364483406|FG002|Period 2|Adverse Event|1|||
105678073|NCT02349425|364483407|FG003|Period 2|Adverse Event|0|||
105678074|NCT03573583|364483408|FG000|Overall Study|Lost to Follow-up|1|||
105678075|NCT03573583|364483409|FG001|Overall Study|Lost to Follow-up|0|||
105678076|NCT03573583|364483408|FG000|Overall Study|Withdrawal by Subject|1|||
105678077|NCT03573583|364483409|FG001|Overall Study|Withdrawal by Subject|1|||
105678078|NCT04343872|364483414|FG000|Overall Study|Lost to Follow-up|6|||
105678079|NCT04343872|364483415|FG001|Overall Study|Lost to Follow-up|3|||
105678080|NCT00591721|364483416|FG000|Overall Study|Withdrawal by Subject|10|||
105914080|NCT02515630|365345284|FG000|Overall Study|Physician Decision|4|||
105914081|NCT02515630|365345284|FG000|Overall Study|Death|2|||
105914082|NCT02515630|365345284|FG000|Overall Study|Disease Progression|1|||
105914083|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Death|20|||
105914084|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Death|26|||
105914085|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
105914086|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
105914087|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
105914088|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
105914089|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
105914090|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
105914091|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
105914092|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
105914093|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
105914094|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
105914095|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
105914096|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
105914097|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
105914098|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
105914099|NCT00643201|365345285|FG000|Randomized, Completed 6 Months of Study|Other|107|||
105914100|NCT00643201|365345286|FG001|Randomized, Completed 6 Months of Study|Other|107|||
105914101|NCT00643201|365345285|FG000|Completed Study Follow Up|Death|28|||
105914102|NCT00643201|365345286|FG001|Completed Study Follow Up|Death|34|||
105914103|NCT00643201|365345285|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
105914104|NCT00643201|365345286|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
105914105|NCT00643201|365345285|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
105914106|NCT00643201|365345286|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
105678081|NCT00591721|364483417|FG001|Overall Study|Withdrawal by Subject|10|||
105678082|NCT00591721|364483416|FG000|Overall Study|Lost to Follow-up|1|||
105786469|NCT03605758|364871397|FG001|Overall Study|Lost to Follow-up|1|||
105914107|NCT00643201|365345285|FG000|Completed Study Follow Up|non-specified|1|||
105914108|NCT00643201|365345286|FG001|Completed Study Follow Up|non-specified|0|||
105914109|NCT01232790|365345287|FG000|Randomization|Withdrawal by Subject|2|||
105914110|NCT01232790|365345288|FG001|Randomization|Withdrawal by Subject|0|||
105914111|NCT01232790|365345287|FG000|Randomization|Protocol Violation|0|||
105678083|NCT00591721|364483417|FG001|Overall Study|Lost to Follow-up|4|||
105678084|NCT00591721|364483416|FG000|Overall Study|Intervention not received|10|||
105678085|NCT00591721|364483417|FG001|Overall Study|Intervention not received|8|||
105678086|NCT03730480|364483418|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
105678087|NCT01119105|364483423|FG000|Overall Study|Withdrawal by Subject|1|||
105678088|NCT01119105|364483424|FG001|Overall Study|Withdrawal by Subject|1|||
105678089|NCT01119105|364483425|FG002|Overall Study|Withdrawal by Subject|1|||
105678090|NCT01119105|364483423|FG000|Overall Study|Lost to Follow-up|0|||
105678091|NCT01119105|364483424|FG001|Overall Study|Lost to Follow-up|2|||
105678092|NCT01119105|364483425|FG002|Overall Study|Lost to Follow-up|5|||
105678093|NCT01119105|364483423|FG000|Overall Study|Adverse Event|1|||
105678094|NCT01119105|364483424|FG001|Overall Study|Adverse Event|0|||
105678095|NCT01119105|364483425|FG002|Overall Study|Adverse Event|1|||
105678096|NCT01119105|364483423|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
105678097|NCT01119105|364483424|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
105678098|NCT01119105|364483425|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
105678099|NCT01119105|364483423|FG000|Overall Study|Other|1|||
105678100|NCT01119105|364483424|FG001|Overall Study|Other|1|||
105678101|NCT01119105|364483425|FG002|Overall Study|Other|0|||
105678102|NCT02383056|364483426|FG000|Overall Study|Adverse Event|1|||
105678103|NCT02383056|364483427|FG001|Overall Study|Adverse Event|0|||
105678104|NCT02383056|364483426|FG000|Overall Study|Lost to Follow-up|0|||
105914112|NCT01232790|365345288|FG001|Randomization|Protocol Violation|1|||
105914113|NCT01232790|365345287|FG000|Randomization|Physician Decision|0|||
105914114|NCT01232790|365345288|FG001|Randomization|Physician Decision|1|||
105914115|NCT01232790|365345287|FG000|Initial Assessment|Withdrawal by Subject|0|||
105914116|NCT01232790|365345288|FG001|Initial Assessment|Withdrawal by Subject|1|||
105914117|NCT01232790|365345287|FG000|First Crossover|Withdrawal by Subject|1|||
105914118|NCT01232790|365345288|FG001|First Crossover|Withdrawal by Subject|0|||
105914119|NCT01232790|365345287|FG000|Second Crossover|Withdrawal by Subject|1|||
105914120|NCT01232790|365345288|FG001|Second Crossover|Withdrawal by Subject|2|||
105914121|NCT02456727|365345297|FG000|Overall Study|Lost to Follow-up|63|||
105914122|NCT02456727|365345298|FG001|Overall Study|Lost to Follow-up|65|||
105914123|NCT02456727|365345297|FG000|Overall Study|Death|2|||
105914124|NCT02456727|365345298|FG001|Overall Study|Death|1|||
105914125|NCT02456727|365345297|FG000|Overall Study|Withdrawal by Subject|1|||
105914126|NCT02456727|365345298|FG001|Overall Study|Withdrawal by Subject|10|||
105914127|NCT02456727|365345297|FG000|Overall Study|Never Initiated Treatment|43|||
105914128|NCT02456727|365345298|FG001|Overall Study|Never Initiated Treatment|30|||
105914129|NCT05081388|365345299|FG000|Overall Study|Adverse Event|1|||
105914130|NCT05081388|365345300|FG001|Overall Study|Adverse Event|0|||
105914131|NCT05081388|365345301|FG002|Overall Study|Adverse Event|0|||
105914132|NCT05081388|365345302|FG003|Overall Study|Adverse Event|0|||
105914133|NCT05081388|365345303|FG004|Overall Study|Adverse Event|0|||
105914134|NCT05081388|365345299|FG000|Overall Study|Lost to Follow-up|0|||
105914135|NCT05081388|365345300|FG001|Overall Study|Lost to Follow-up|1|||
105914136|NCT05081388|365345301|FG002|Overall Study|Lost to Follow-up|0|||
105914137|NCT05081388|365345302|FG003|Overall Study|Lost to Follow-up|0|||
105914138|NCT05081388|365345303|FG004|Overall Study|Lost to Follow-up|0|||
105914139|NCT05081388|365345299|FG000|Overall Study|Subject decision|0|||
105914140|NCT05081388|365345300|FG001|Overall Study|Subject decision|0|||
105914141|NCT05081388|365345301|FG002|Overall Study|Subject decision|0|||
105914142|NCT05081388|365345302|FG003|Overall Study|Subject decision|1|||
105914143|NCT05081388|365345303|FG004|Overall Study|Subject decision|0|||
105914144|NCT00243919|365345304|FG000|Overall Study|Death|3|||
105914145|NCT00243919|365345305|FG001|Overall Study|Death|4|||
105914146|NCT00243919|365345306|FG002|Overall Study|Death|6|||
105678105|NCT02383056|364483427|FG001|Overall Study|Lost to Follow-up|2|||
105678106|NCT00581555|364483428|FG000|Overall Study|Adverse Event|4|||
105678107|NCT00581555|364483429|FG001|Overall Study|Adverse Event|3|||
105914147|NCT00243919|365345304|FG000|Overall Study|Withdrawal by Subject|6|||
105914148|NCT00243919|365345305|FG001|Overall Study|Withdrawal by Subject|6|||
105914149|NCT00243919|365345306|FG002|Overall Study|Withdrawal by Subject|2|||
105914150|NCT00243919|365345304|FG000|Overall Study|Lost to Follow-up|6|||
105914151|NCT00243919|365345305|FG001|Overall Study|Lost to Follow-up|7|||
105914152|NCT00243919|365345306|FG002|Overall Study|Lost to Follow-up|3|||
105914153|NCT00243919|365345304|FG000|Overall Study|Administrative Error|1|||
105914154|NCT00243919|365345305|FG001|Overall Study|Administrative Error|0|||
105678108|NCT00581555|364483428|FG000|Overall Study|Physician Decision|3|||
105678109|NCT00581555|364483429|FG001|Overall Study|Physician Decision|2|||
105678110|NCT00581555|364483428|FG000|Overall Study|Withdrawal by Subject|18|||
105914155|NCT00243919|365345306|FG002|Overall Study|Administrative Error|0|||
105914156|NCT00243919|365345304|FG000|Overall Study|Physician Decision|1|||
105914157|NCT00243919|365345305|FG001|Overall Study|Physician Decision|1|||
105914158|NCT00243919|365345306|FG002|Overall Study|Physician Decision|0|||
105914159|NCT00192114|365345307|FG000|Overall Study|Objective Tumor Progression|19|||
105914160|NCT00192114|365345307|FG000|Overall Study|Adverse Event|2|||
105914161|NCT00192114|365345307|FG000|Overall Study|Clinical Progression|2|||
105914162|NCT00192114|365345307|FG000|Overall Study|Death|1|||
105914163|NCT01656395|365345313|FG000|Overall Study|Adverse Event|1|||
105914164|NCT01656395|365345314|FG001|Overall Study|Adverse Event|14|||
105914165|NCT01656395|365345315|FG002|Overall Study|Adverse Event|5|||
105914166|NCT01656395|365345316|FG003|Overall Study|Adverse Event|4|||
105678111|NCT00581555|364483429|FG001|Overall Study|Withdrawal by Subject|9|||
105678112|NCT00581555|364483428|FG000|Overall Study|Lost to Follow-up|2|||
105914167|NCT01656395|365345317|FG004|Overall Study|Adverse Event|5|||
105914168|NCT01656395|365345318|FG005|Overall Study|Adverse Event|7|||
105914169|NCT01656395|365345319|FG006|Overall Study|Adverse Event|0|||
105914170|NCT01656395|365345320|FG007|Overall Study|Adverse Event|0|||
105914171|NCT01656395|365345313|FG000|Overall Study|Lack of Efficacy|1|||
105914172|NCT01656395|365345314|FG001|Overall Study|Lack of Efficacy|8|||
105914173|NCT01656395|365345315|FG002|Overall Study|Lack of Efficacy|6|||
105914174|NCT01656395|365345316|FG003|Overall Study|Lack of Efficacy|1|||
105914175|NCT01656395|365345317|FG004|Overall Study|Lack of Efficacy|1|||
105914176|NCT01656395|365345318|FG005|Overall Study|Lack of Efficacy|6|||
105914177|NCT01656395|365345319|FG006|Overall Study|Lack of Efficacy|0|||
105914178|NCT01656395|365345320|FG007|Overall Study|Lack of Efficacy|0|||
105914179|NCT01656395|365345313|FG000|Overall Study|Lost to Follow-up|1|||
105914180|NCT01656395|365345314|FG001|Overall Study|Lost to Follow-up|0|||
105914181|NCT01656395|365345315|FG002|Overall Study|Lost to Follow-up|0|||
105914182|NCT01656395|365345316|FG003|Overall Study|Lost to Follow-up|0|||
105914183|NCT01656395|365345317|FG004|Overall Study|Lost to Follow-up|0|||
105914184|NCT01656395|365345318|FG005|Overall Study|Lost to Follow-up|0|||
105914185|NCT01656395|365345319|FG006|Overall Study|Lost to Follow-up|0|||
105914186|NCT01656395|365345320|FG007|Overall Study|Lost to Follow-up|0|||
105914187|NCT01656395|365345313|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105914188|NCT01656395|365345314|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105914189|NCT01656395|365345315|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105914190|NCT01656395|365345316|FG003|Overall Study|Non-Compliance with Study Drug|0|||
105914191|NCT01656395|365345317|FG004|Overall Study|Non-Compliance with Study Drug|1|||
105914192|NCT01656395|365345318|FG005|Overall Study|Non-Compliance with Study Drug|1|||
105914193|NCT01656395|365345319|FG006|Overall Study|Non-Compliance with Study Drug|0|||
105914194|NCT01656395|365345320|FG007|Overall Study|Non-Compliance with Study Drug|0|||
105914195|NCT01656395|365345313|FG000|Overall Study|Other|0|||
105914196|NCT01656395|365345314|FG001|Overall Study|Other|0|||
105914197|NCT01656395|365345315|FG002|Overall Study|Other|1|||
105914198|NCT01656395|365345316|FG003|Overall Study|Other|0|||
105914199|NCT01656395|365345317|FG004|Overall Study|Other|0|||
105914200|NCT01656395|365345318|FG005|Overall Study|Other|1|||
105914201|NCT01656395|365345319|FG006|Overall Study|Other|0|||
105914202|NCT01656395|365345320|FG007|Overall Study|Other|0|||
105914203|NCT01656395|365345313|FG000|Overall Study|Physician Decision|2|||
105914204|NCT01656395|365345314|FG001|Overall Study|Physician Decision|3|||
105914205|NCT01656395|365345315|FG002|Overall Study|Physician Decision|3|||
105914206|NCT01656395|365345316|FG003|Overall Study|Physician Decision|2|||
105914207|NCT01656395|365345317|FG004|Overall Study|Physician Decision|3|||
105914208|NCT01656395|365345318|FG005|Overall Study|Physician Decision|3|||
105914209|NCT01656395|365345319|FG006|Overall Study|Physician Decision|0|||
105914210|NCT01656395|365345320|FG007|Overall Study|Physician Decision|0|||
105914211|NCT01656395|365345313|FG000|Overall Study|Pregnancy|0|||
105914212|NCT01656395|365345314|FG001|Overall Study|Pregnancy|0|||
105914213|NCT01656395|365345315|FG002|Overall Study|Pregnancy|1|||
105914214|NCT01656395|365345316|FG003|Overall Study|Pregnancy|0|||
105914215|NCT01656395|365345317|FG004|Overall Study|Pregnancy|0|||
105914216|NCT01656395|365345318|FG005|Overall Study|Pregnancy|0|||
105914217|NCT01656395|365345319|FG006|Overall Study|Pregnancy|0|||
105914218|NCT01656395|365345320|FG007|Overall Study|Pregnancy|0|||
105914219|NCT01656395|365345313|FG000|Overall Study|Progressive Disease|0|||
105914220|NCT01656395|365345314|FG001|Overall Study|Progressive Disease|0|||
105914221|NCT01656395|365345315|FG002|Overall Study|Progressive Disease|0|||
105914222|NCT01656395|365345316|FG003|Overall Study|Progressive Disease|0|||
105914223|NCT01656395|365345317|FG004|Overall Study|Progressive Disease|0|||
105914224|NCT01656395|365345318|FG005|Overall Study|Progressive Disease|1|||
105914225|NCT01656395|365345319|FG006|Overall Study|Progressive Disease|0|||
105914226|NCT01656395|365345320|FG007|Overall Study|Progressive Disease|0|||
105914227|NCT01656395|365345313|FG000|Overall Study|Protocol Violation|6|||
105914228|NCT01656395|365345314|FG001|Overall Study|Protocol Violation|6|||
105914229|NCT01656395|365345315|FG002|Overall Study|Protocol Violation|9|||
105914230|NCT01656395|365345316|FG003|Overall Study|Protocol Violation|2|||
105914231|NCT01656395|365345317|FG004|Overall Study|Protocol Violation|4|||
105914232|NCT01656395|365345318|FG005|Overall Study|Protocol Violation|10|||
105914233|NCT01656395|365345319|FG006|Overall Study|Protocol Violation|0|||
105914234|NCT01656395|365345320|FG007|Overall Study|Protocol Violation|0|||
105914235|NCT01656395|365345313|FG000|Overall Study|Screen Failure|2|||
105914236|NCT01656395|365345314|FG001|Overall Study|Screen Failure|1|||
105914237|NCT01656395|365345315|FG002|Overall Study|Screen Failure|7|||
105914238|NCT01656395|365345316|FG003|Overall Study|Screen Failure|1|||
105914239|NCT01656395|365345317|FG004|Overall Study|Screen Failure|0|||
106000077|NCT05579977|365661253|FG000|Treatment Phase|Randomized not treated|0|||
106000078|NCT05579977|365661254|FG001|Treatment Phase|Randomized not treated|0|||
105914240|NCT01656395|365345318|FG005|Overall Study|Screen Failure|8|||
105914241|NCT01656395|365345319|FG006|Overall Study|Screen Failure|0|||
105914242|NCT01656395|365345320|FG007|Overall Study|Screen Failure|0|||
105914243|NCT01656395|365345313|FG000|Overall Study|Withdrawal by Subject|3|||
105914244|NCT01656395|365345314|FG001|Overall Study|Withdrawal by Subject|1|||
105914245|NCT01656395|365345315|FG002|Overall Study|Withdrawal by Subject|4|||
105914246|NCT01656395|365345316|FG003|Overall Study|Withdrawal by Subject|2|||
105914247|NCT01656395|365345317|FG004|Overall Study|Withdrawal by Subject|0|||
105914248|NCT01656395|365345318|FG005|Overall Study|Withdrawal by Subject|3|||
105914249|NCT01656395|365345319|FG006|Overall Study|Withdrawal by Subject|0|||
105914250|NCT01656395|365345320|FG007|Overall Study|Withdrawal by Subject|0|||
105914251|NCT03669549|365345321|FG000|Overall Study|Adverse Event|4|||
105914252|NCT03669549|365345321|FG000|Overall Study|Withdrawal by Subject|1|||
105914253|NCT03669549|365345321|FG000|Overall Study|Study terminated by the Sponsor|1|||
105914254|NCT02053493|365345323|FG000|Overall Study|Withdrawal by Subject|1|||
105914255|NCT02053493|365345324|FG001|Overall Study|Withdrawal by Subject|1|||
105914256|NCT01076543|365345325|FG000|Overall Study|Withdrawal by Subject|2|||
105914257|NCT01076543|365345326|FG001|Overall Study|Withdrawal by Subject|0|||
105914258|NCT01076543|365345327|FG002|Overall Study|Withdrawal by Subject|0|||
105678113|NCT00581555|364483429|FG001|Overall Study|Lost to Follow-up|2|||
105678114|NCT00581555|364483428|FG000|Overall Study|Other reasons|16|||
105678115|NCT00581555|364483429|FG001|Overall Study|Other reasons|4|||
105678116|NCT03507777|364483430|FG000|Overall Study|Lost to Follow-up|5|||
105678117|NCT03507777|364483431|FG001|Overall Study|Lost to Follow-up|7|||
105678118|NCT03507777|364483430|FG000|Overall Study|Withdrawal by Subject|6|||
105678119|NCT03507777|364483431|FG001|Overall Study|Withdrawal by Subject|11|||
105678120|NCT03507777|364483430|FG000|Overall Study|Death|30|||
105678121|NCT03507777|364483431|FG001|Overall Study|Death|44|||
105678122|NCT03507777|364483430|FG000|Overall Study|Other Reasons|3|||
105678123|NCT03507777|364483431|FG001|Overall Study|Other Reasons|8|||
105678124|NCT02245737|364483433|FG000|Overall Study|Adverse Event|23|||
105678125|NCT02245737|364483434|FG001|Overall Study|Adverse Event|26|||
105678126|NCT02245737|364483435|FG002|Overall Study|Adverse Event|33|||
105678127|NCT02245737|364483433|FG000|Overall Study|Condition Worsened|9|||
105678128|NCT02245737|364483434|FG001|Overall Study|Condition Worsened|10|||
105678129|NCT02245737|364483435|FG002|Overall Study|Condition Worsened|9|||
105678130|NCT02245737|364483433|FG000|Overall Study|Death|2|||
105678131|NCT02245737|364483434|FG001|Overall Study|Death|4|||
105678132|NCT02245737|364483435|FG002|Overall Study|Death|4|||
105678133|NCT02245737|364483433|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
105678134|NCT02245737|364483434|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
105678135|NCT02245737|364483435|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
105678136|NCT02245737|364483433|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
105678137|NCT02245737|364483434|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
105678138|NCT02245737|364483435|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
105678139|NCT02245737|364483433|FG000|Overall Study|Lost to Follow-up|2|||
105678140|NCT02245737|364483434|FG001|Overall Study|Lost to Follow-up|5|||
105678141|NCT02245737|364483435|FG002|Overall Study|Lost to Follow-up|4|||
105678142|NCT02245737|364483433|FG000|Overall Study|Other-determined by Investigator|9|||
105678143|NCT02245737|364483434|FG001|Overall Study|Other-determined by Investigator|10|||
105678144|NCT02245737|364483435|FG002|Overall Study|Other-determined by Investigator|10|||
105678145|NCT02245737|364483433|FG000|Overall Study|Physician Decision|6|||
105678146|NCT02245737|364483434|FG001|Overall Study|Physician Decision|3|||
105678147|NCT02245737|364483435|FG002|Overall Study|Physician Decision|6|||
105678148|NCT02245737|364483433|FG000|Overall Study|Protocol Violation|3|||
105678149|NCT02245737|364483434|FG001|Overall Study|Protocol Violation|2|||
105678150|NCT02245737|364483435|FG002|Overall Study|Protocol Violation|3|||
105678151|NCT02245737|364483433|FG000|Overall Study|Withdrawal by Subject|40|||
105678152|NCT02245737|364483434|FG001|Overall Study|Withdrawal by Subject|41|||
105678153|NCT02245737|364483435|FG002|Overall Study|Withdrawal by Subject|44|||
105678154|NCT02245737|364483433|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
105678155|NCT02245737|364483434|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
105678156|NCT02245737|364483435|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
105678157|NCT02245737|364483433|FG000|Overall Study|Sponsor Decision|445|||
105678158|NCT02245737|364483434|FG001|Overall Study|Sponsor Decision|430|||
105678159|NCT02245737|364483435|FG002|Overall Study|Sponsor Decision|432|||
105678160|NCT02929329|364483440|FG000|Overall Study|Withdrawal by Subject|24|||
105678161|NCT02929329|364483441|FG001|Overall Study|Withdrawal by Subject|21|||
105678162|NCT02929329|364483440|FG000|Overall Study|Lost to Follow-up|26|||
105678163|NCT02929329|364483441|FG001|Overall Study|Lost to Follow-up|20|||
105678164|NCT02929329|364483440|FG000|Overall Study|Death|1054|||
105678165|NCT02929329|364483441|FG001|Overall Study|Death|1051|||
105678166|NCT04772898|364483442|FG000|Overall Study|Withdrawal by Subject|0|||
105678167|NCT04772898|364483443|FG001|Overall Study|Withdrawal by Subject|1|||
105678168|NCT02947087|364483448|FG000|Overall Study|Withdrawal by Subject|3|||
105678169|NCT02947087|364483449|FG001|Overall Study|Withdrawal by Subject|2|||
105914259|NCT01076543|365345328|FG003|Overall Study|Withdrawal by Subject|0|||
105678170|NCT00037830|364483452|FG000|Overall Study|Adverse Event|2|||
105678171|NCT00037830|364483453|FG001|Overall Study|Adverse Event|0|||
105678172|NCT00037830|364483454|FG002|Overall Study|Adverse Event|0|||
105786470|NCT03605758|364871396|FG000|Overall Study|Illness|0|||
105786471|NCT03605758|364871397|FG001|Overall Study|Illness|1|||
105678173|NCT00037830|364483452|FG000|Overall Study|Withdrawal by Subject|4|||
105678174|NCT00037830|364483453|FG001|Overall Study|Withdrawal by Subject|5|||
105678175|NCT00037830|364483454|FG002|Overall Study|Withdrawal by Subject|1|||
105914260|NCT01076543|365345329|FG004|Overall Study|Withdrawal by Subject|0|||
105678176|NCT00037830|364483452|FG000|Overall Study|Protocol Violation|2|||
105678177|NCT00037830|364483453|FG001|Overall Study|Protocol Violation|2|||
105678178|NCT00037830|364483454|FG002|Overall Study|Protocol Violation|0|||
105678179|NCT00037830|364483452|FG000|Overall Study|Unrelated Medical Problem|2|||
105678180|NCT00037830|364483453|FG001|Overall Study|Unrelated Medical Problem|0|||
105678181|NCT00037830|364483454|FG002|Overall Study|Unrelated Medical Problem|0|||
105678182|NCT03651622|364483455|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
105914261|NCT01076543|365345330|FG005|Overall Study|Withdrawal by Subject|0|||
105914262|NCT02155699|365345339|FG000|Overall Study|Withdrawal by Subject|0|||
105914263|NCT02155699|365345340|FG001|Overall Study|Withdrawal by Subject|3|||
105914264|NCT02155699|365345341|FG002|Overall Study|Withdrawal by Subject|6|||
105678183|NCT03651622|364483456|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
105678184|NCT03651622|364483457|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
105678185|NCT03651622|364483455|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
105678186|NCT03651622|364483456|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
105678187|NCT03651622|364483457|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
105678188|NCT03651622|364483455|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
105678189|NCT03651622|364483456|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
105678190|NCT03651622|364483457|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
105678191|NCT03651622|364483455|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
105678192|NCT03651622|364483456|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
105678193|NCT03651622|364483457|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
105678194|NCT03651622|364483455|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
105678195|NCT03651622|364483456|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
105678196|NCT03651622|364483457|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
105678197|NCT00006011|364483459|FG000|Overall Study|Disease progression|13|||
105914265|NCT02155699|365345342|FG003|Overall Study|Withdrawal by Subject|1|||
105678198|NCT00006011|364483460|FG001|Overall Study|Disease progression|6|||
105678199|NCT00006011|364483461|FG002|Overall Study|Disease progression|26|||
105678200|NCT00006011|364483459|FG000|Overall Study|Refused further treatment|15|||
105678201|NCT00006011|364483460|FG001|Overall Study|Refused further treatment|13|||
105678202|NCT00006011|364483461|FG002|Overall Study|Refused further treatment|26|||
105678203|NCT00006011|364483459|FG000|Overall Study|Adverse Event|15|||
105678204|NCT00006011|364483460|FG001|Overall Study|Adverse Event|39|||
105678205|NCT00006011|364483461|FG002|Overall Study|Adverse Event|5|||
105678206|NCT00006011|364483459|FG000|Overall Study|Death|0|||
105678207|NCT00006011|364483460|FG001|Overall Study|Death|1|||
105678208|NCT00006011|364483461|FG002|Overall Study|Death|2|||
105678209|NCT00006011|364483459|FG000|Overall Study|Other|4|||
105678210|NCT00006011|364483460|FG001|Overall Study|Other|2|||
105678211|NCT00006011|364483461|FG002|Overall Study|Other|5|||
105678212|NCT00006011|364483459|FG000|Overall Study|Ineligible|18|||
105914266|NCT02155699|365345339|FG000|Overall Study|Lost to Follow-up|0|||
105914267|NCT02155699|365345340|FG001|Overall Study|Lost to Follow-up|0|||
105914268|NCT02155699|365345341|FG002|Overall Study|Lost to Follow-up|0|||
105914269|NCT02155699|365345342|FG003|Overall Study|Lost to Follow-up|3|||
105914270|NCT02155699|365345339|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
105914271|NCT02155699|365345340|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
105914272|NCT02155699|365345341|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
105914273|NCT02155699|365345342|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
105914274|NCT03771963|365345343|FG000|Overall Study|Lost to Follow-up|22|||
105914275|NCT03771963|365345343|FG000|Overall Study|Withdrawal of Consent|10|||
105914276|NCT00102596|365345344|FG000|Part A|Screen failures|6|||
105914277|NCT00102596|365345345|FG001|Part A|Screen failures|0|||
105914278|NCT00102596|365345344|FG000|Part A|Adverse Event|1|||
105914279|NCT00102596|365345345|FG001|Part A|Adverse Event|0|||
105914280|NCT00485069|365345346|FG000|Overall Study|Adverse Event|10|||
105914281|NCT00485069|365345347|FG001|Overall Study|Adverse Event|4|||
105914282|NCT00485069|365345346|FG000|Overall Study|Lack of Efficacy|2|||
105914283|NCT00485069|365345347|FG001|Overall Study|Lack of Efficacy|1|||
105914284|NCT00485069|365345346|FG000|Overall Study|Protocol Violation|0|||
105914285|NCT00485069|365345347|FG001|Overall Study|Protocol Violation|1|||
105914286|NCT00485069|365345346|FG000|Overall Study|Withdrawal by Subject|6|||
105678213|NCT00006011|364483460|FG001|Overall Study|Ineligible|16|||
105914287|NCT00485069|365345347|FG001|Overall Study|Withdrawal by Subject|6|||
105678214|NCT00006011|364483461|FG002|Overall Study|Ineligible|9|||
105914288|NCT02989402|365345350|FG000|Overall Study|Adverse event, or serious adverse event|4|||
105914289|NCT02989402|365345350|FG000|Overall Study|Death|2|||
105914290|NCT02989402|365345350|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
105678215|NCT03292432|364483468|FG000|Overall Study|Lost to Follow-up|11|||
105678216|NCT03292432|364483469|FG001|Overall Study|Lost to Follow-up|8|||
105678217|NCT03292432|364483468|FG000|Overall Study|Death|2|||
105678218|NCT03292432|364483469|FG001|Overall Study|Death|1|||
105678219|NCT03292432|364483468|FG000|Overall Study|Withdrawal by Subject|1|||
105678220|NCT03292432|364483469|FG001|Overall Study|Withdrawal by Subject|2|||
105678221|NCT03292432|364483468|FG000|Overall Study|Site closed before any data collected|1|||
105678222|NCT03292432|364483469|FG001|Overall Study|Site closed before any data collected|0|||
105678223|NCT00911937|364483471|FG000|Overall Study|Death|1|||
105678224|NCT00911937|364483472|FG001|Overall Study|Death|0|||
105678225|NCT00911937|364483471|FG000|Overall Study|Lost to Follow-up|8|||
105678226|NCT00911937|364483472|FG001|Overall Study|Lost to Follow-up|5|||
105678227|NCT00911937|364483471|FG000|Overall Study|Withdrawal by Subject|10|||
105678228|NCT00911937|364483472|FG001|Overall Study|Withdrawal by Subject|7|||
105678229|NCT00911937|364483471|FG000|Overall Study|Withdrawn due to pregnancy|1|||
105678230|NCT00911937|364483472|FG001|Overall Study|Withdrawn due to pregnancy|0|||
105678231|NCT00911937|364483471|FG000|Overall Study|Adverse Event|11|||
105678232|NCT00911937|364483472|FG001|Overall Study|Adverse Event|25|||
105678233|NCT00911937|364483471|FG000|Overall Study|Lack of Efficacy|11|||
105678234|NCT00911937|364483472|FG001|Overall Study|Lack of Efficacy|6|||
105678235|NCT00911937|364483471|FG000|Overall Study|Did not meet inclusion criteria|9|||
105678236|NCT00911937|364483472|FG001|Overall Study|Did not meet inclusion criteria|11|||
105678237|NCT00911937|364483471|FG000|Overall Study|Protocol Violation|14|||
105678238|NCT00911937|364483472|FG001|Overall Study|Protocol Violation|23|||
105914291|NCT02989402|365345350|FG000|Overall Study|Lost to Follow-up|8|||
105914292|NCT02989402|365345350|FG000|Overall Study|Patient no longer on monotherapy|1|||
105914293|NCT02989402|365345350|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
105914294|NCT02989402|365345350|FG000|Overall Study|Withdrawal by Subject|7|||
105914295|NCT02989402|365345350|FG000|Overall Study|Other|2|||
105914296|NCT02688933|365345351|FG000|Overall Study|Adverse Event|3|||
105914297|NCT02688933|365345352|FG001|Overall Study|Adverse Event|1|||
105914298|NCT02688933|365345351|FG000|Overall Study|Lack of Efficacy|2|||
105914299|NCT02688933|365345352|FG001|Overall Study|Lack of Efficacy|2|||
105914300|NCT02688933|365345351|FG000|Overall Study|Poor compliance to protocol|7|||
105914301|NCT02688933|365345352|FG001|Overall Study|Poor compliance to protocol|4|||
105914302|NCT02688933|365345351|FG000|Overall Study|Hypoglycemia|2|||
105678239|NCT00911937|364483471|FG000|Overall Study|Randomized but not treated|13|||
105678240|NCT00911937|364483472|FG001|Overall Study|Randomized but not treated|13|||
105678241|NCT00911937|364483471|FG000|Overall Study|Other|9|||
105678242|NCT00911937|364483472|FG001|Overall Study|Other|5|||
105678243|NCT02207569|364483480|FG000|1-Month|Death|6|||
105678244|NCT02207569|364483480|FG000|1-Month|Withdrawal by Subject|2|||
105678245|NCT02207569|364483480|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
105914303|NCT02688933|365345352|FG001|Overall Study|Hypoglycemia|0|||
105914304|NCT02688933|365345351|FG000|Overall Study|Other than Specified|14|||
105914305|NCT02688933|365345352|FG001|Overall Study|Other than Specified|25|||
105914306|NCT02688933|365345351|FG000|Overall Study|Lost to Follow-up|1|||
105914307|NCT02688933|365345352|FG001|Overall Study|Lost to Follow-up|5|||
105914308|NCT01275144|365345353|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
105678246|NCT02207569|364483480|FG000|6-Month|Death|8|||
105678247|NCT02207569|364483480|FG000|6-Month|Withdrawal by Subject|2|||
105678248|NCT02207569|364483480|FG000|12-Month|Death|14|||
105678249|NCT02207569|364483480|FG000|12-Month|Withdrawal by Subject|2|||
105678250|NCT02207569|364483480|FG000|24-Month|Death|23|||
105678251|NCT02207569|364483480|FG000|24-Month|Withdrawal by Subject|3|||
105678252|NCT02207569|364483480|FG000|36-Month|Death|23|||
105678253|NCT02207569|364483480|FG000|36-Month|Withdrawal by Subject|4|||
105678254|NCT02207569|364483480|FG000|48-Month|Death|25|||
105678255|NCT02207569|364483480|FG000|48-Month|Withdrawal by Subject|2|||
105678256|NCT02207569|364483480|FG000|48-Month|Lost to Follow-up|4|||
105678257|NCT02207569|364483480|FG000|60-Month|Death|1|||
105678258|NCT02207569|364483480|FG000|60-Month|Lost to Follow-up|1|||
105678259|NCT02207569|364483480|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
105678260|NCT02207569|364483480|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
105678261|NCT02683876|364483481|FG000|Overall Study|samples damaged during shipping|2|||
105678262|NCT02683876|364483482|FG001|Overall Study|samples damaged during shipping|0|||
105678263|NCT02930226|364483483|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678264|NCT02930226|364483484|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678265|NCT02930226|364483485|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678266|NCT02930226|364483486|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678267|NCT02930226|364483487|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
105678268|NCT02930226|364483488|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
105678269|NCT04738292|364483491|FG000|Overall Study|Death|1|||
105914309|NCT01275144|365345354|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
105914310|NCT04467515|365345356|FG000|Overall Study|Lost to Follow-up|1|||
105914311|NCT04467515|365345357|FG001|Overall Study|Lost to Follow-up|0|||
105914312|NCT04467515|365345358|FG002|Overall Study|Lost to Follow-up|0|||
105914313|NCT04467515|365345356|FG000|Overall Study|Withdrawal by Subject|1|||
105914314|NCT04467515|365345357|FG001|Overall Study|Withdrawal by Subject|0|||
105678270|NCT01151410|364483492|FG000|Overall Study|Withdrawal by Subject|3|||
105678271|NCT01151410|364483493|FG001|Overall Study|Withdrawal by Subject|5|||
105678272|NCT01151410|364483492|FG000|Overall Study|Lost to Follow-up|3|||
105678273|NCT01151410|364483493|FG001|Overall Study|Lost to Follow-up|4|||
106000079|NCT05579977|365661255|FG002|Treatment Phase|Randomized not treated|0|||
106000080|NCT05579977|365661256|FG003|Treatment Phase|Randomized not treated|0|||
106000081|NCT05579977|365661257|FG004|Treatment Phase|Randomized not treated|1|||
106000082|NCT05579977|365661258|FG005|Treatment Phase|Randomized not treated|0|||
106000083|NCT05579977|365661259|FG006|Treatment Phase|Randomized not treated|0|||
106000084|NCT05579977|365661260|FG007|Treatment Phase|Randomized not treated|0|||
106000085|NCT05579977|365661261|FG008|Treatment Phase|Randomized not treated|0|||
106000086|NCT05579977|365661262|FG009|Treatment Phase|Randomized not treated|0|||
106000087|NCT05579977|365661263|FG010|Treatment Phase|Randomized not treated|0|||
106000088|NCT05579977|365661264|FG011|Treatment Phase|Randomized not treated|0|||
106000089|NCT05579977|365661265|FG012|Treatment Phase|Randomized not treated|0|||
106000090|NCT05579977|365661253|FG000|Follow up|Death|1|||
106000091|NCT05579977|365661254|FG001|Follow up|Death|0|||
106000092|NCT05579977|365661255|FG002|Follow up|Death|0|||
106000093|NCT05579977|365661256|FG003|Follow up|Death|0|||
106000094|NCT05579977|365661257|FG004|Follow up|Death|0|||
106000095|NCT05579977|365661258|FG005|Follow up|Death|0|||
106000096|NCT05579977|365661259|FG006|Follow up|Death|0|||
106000097|NCT05579977|365661260|FG007|Follow up|Death|0|||
106000098|NCT05579977|365661261|FG008|Follow up|Death|0|||
105678274|NCT01151410|364483492|FG000|Overall Study|Adverse Event|1|||
105678275|NCT01151410|364483493|FG001|Overall Study|Adverse Event|2|||
105678276|NCT01151410|364483492|FG000|Overall Study|Protocol deviation|2|||
105678277|NCT01151410|364483493|FG001|Overall Study|Protocol deviation|1|||
105678278|NCT01151410|364483492|FG000|Overall Study|Administrative problems|1|||
105678279|NCT01151410|364483493|FG001|Overall Study|Administrative problems|1|||
105678280|NCT01151410|364483492|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105678281|NCT01151410|364483493|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105678282|NCT01151410|364483492|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105678283|NCT01151410|364483493|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105678284|NCT01131182|364483494|FG000|Overall Study|Withdrawal by Subject|1|||
105678285|NCT01131182|364483495|FG001|Overall Study|Withdrawal by Subject|1|||
105678286|NCT01131182|364483494|FG000|Overall Study|Lost to Follow-up|14|||
105678287|NCT01131182|364483495|FG001|Overall Study|Lost to Follow-up|15|||
106000099|NCT05579977|365661262|FG009|Follow up|Death|0|||
106000100|NCT05579977|365661263|FG010|Follow up|Death|0|||
106000101|NCT05579977|365661264|FG011|Follow up|Death|0|||
106000102|NCT05579977|365661265|FG012|Follow up|Death|0|||
106000103|NCT05579977|365661253|FG000|Follow up|Lost to Follow-up|0|||
106000104|NCT05579977|365661254|FG001|Follow up|Lost to Follow-up|0|||
106000105|NCT05579977|365661255|FG002|Follow up|Lost to Follow-up|0|||
106000106|NCT05579977|365661256|FG003|Follow up|Lost to Follow-up|1|||
106000107|NCT05579977|365661257|FG004|Follow up|Lost to Follow-up|1|||
106000108|NCT05579977|365661258|FG005|Follow up|Lost to Follow-up|2|||
106000109|NCT05579977|365661259|FG006|Follow up|Lost to Follow-up|1|||
106000110|NCT05579977|365661260|FG007|Follow up|Lost to Follow-up|1|||
106000111|NCT05579977|365661261|FG008|Follow up|Lost to Follow-up|3|||
106000112|NCT05579977|365661262|FG009|Follow up|Lost to Follow-up|2|||
106000113|NCT05579977|365661263|FG010|Follow up|Lost to Follow-up|2|||
106000114|NCT05579977|365661264|FG011|Follow up|Lost to Follow-up|4|||
106000115|NCT05579977|365661265|FG012|Follow up|Lost to Follow-up|4|||
106000116|NCT05579977|365661253|FG000|Follow up|Withdrawal by Subject|2|||
106000117|NCT05579977|365661254|FG001|Follow up|Withdrawal by Subject|0|||
106000118|NCT05579977|365661255|FG002|Follow up|Withdrawal by Subject|0|||
106000119|NCT05579977|365661256|FG003|Follow up|Withdrawal by Subject|0|||
106000120|NCT05579977|365661257|FG004|Follow up|Withdrawal by Subject|1|||
106000121|NCT05579977|365661258|FG005|Follow up|Withdrawal by Subject|0|||
106000122|NCT05579977|365661259|FG006|Follow up|Withdrawal by Subject|1|||
106000123|NCT05579977|365661260|FG007|Follow up|Withdrawal by Subject|4|||
106000124|NCT05579977|365661261|FG008|Follow up|Withdrawal by Subject|2|||
106000125|NCT05579977|365661262|FG009|Follow up|Withdrawal by Subject|3|||
106000126|NCT05579977|365661263|FG010|Follow up|Withdrawal by Subject|3|||
106000127|NCT05579977|365661264|FG011|Follow up|Withdrawal by Subject|1|||
106000128|NCT05579977|365661265|FG012|Follow up|Withdrawal by Subject|3|||
105678288|NCT01131182|364483494|FG000|Overall Study|Other Reason|1|||
105678289|NCT01131182|364483495|FG001|Overall Study|Other Reason|0|||
106000129|NCT00794950|365661268|FG000|BCG Induction|Withdrawal by Subject|2|||
106000130|NCT00794950|365661268|FG000|BCG Induction|ineligible|3|||
106000131|NCT00794950|365661268|FG000|BCG Induction|noncompliant w. BCG|1|||
106000132|NCT00794950|365661268|FG000|BCG Induction|Adverse Event|1|||
106000133|NCT00794950|365661268|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
106000134|NCT00794950|365661268|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
106000135|NCT00794950|365661268|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
106000136|NCT00794950|365661268|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
106000137|NCT01420926|365661269|FG000|Overall Study|Adverse Event|6|||
106000138|NCT01420926|365661270|FG001|Overall Study|Adverse Event|4|||
106000139|NCT01420926|365661269|FG000|Overall Study|Death|18|||
106000140|NCT01420926|365661270|FG001|Overall Study|Death|17|||
106000141|NCT01420926|365661269|FG000|Overall Study|Withdrawal by Subject|11|||
106000142|NCT01420926|365661270|FG001|Overall Study|Withdrawal by Subject|17|||
106000143|NCT01420926|365661269|FG000|Overall Study|Non-protocol treatment|17|||
105914315|NCT04467515|365345358|FG002|Overall Study|Withdrawal by Subject|1|||
105914316|NCT04467515|365345356|FG000|Overall Study|Progressive Disease|0|||
105914317|NCT04467515|365345357|FG001|Overall Study|Progressive Disease|1|||
105914318|NCT04467515|365345358|FG002|Overall Study|Progressive Disease|3|||
105914319|NCT04467515|365345356|FG000|Overall Study|Death|0|||
105914320|NCT04467515|365345357|FG001|Overall Study|Death|1|||
105914321|NCT04467515|365345358|FG002|Overall Study|Death|0|||
105914322|NCT05067972|365345359|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
105914323|NCT05067972|365345360|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
105914324|NCT05067972|365345361|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
105914325|NCT05067972|365345362|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
105914326|NCT05067972|365345363|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
105678290|NCT01820585|364483496|FG000|Overall Study|Adverse Event|9|||
105678291|NCT01820585|364483497|FG001|Overall Study|Adverse Event|13|||
105678292|NCT01820585|364483498|FG002|Overall Study|Adverse Event|23|||
105678293|NCT01820585|364483499|FG003|Overall Study|Adverse Event|34|||
105678294|NCT01820585|364483496|FG000|Overall Study|Lack of Efficacy|9|||
105678295|NCT01820585|364483497|FG001|Overall Study|Lack of Efficacy|7|||
105678296|NCT01820585|364483498|FG002|Overall Study|Lack of Efficacy|5|||
105678297|NCT01820585|364483499|FG003|Overall Study|Lack of Efficacy|1|||
105678298|NCT01820585|364483496|FG000|Overall Study|Withdrawal by Subject|3|||
105678299|NCT01820585|364483497|FG001|Overall Study|Withdrawal by Subject|7|||
105678300|NCT01820585|364483498|FG002|Overall Study|Withdrawal by Subject|3|||
105914327|NCT05067972|365345364|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
105914328|NCT05067972|365345365|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
105914329|NCT05067972|365345359|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
105914330|NCT05067972|365345360|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
105914331|NCT05067972|365345361|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
105914332|NCT05067972|365345362|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
105914333|NCT05067972|365345363|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
105914334|NCT05067972|365345364|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
105914335|NCT05067972|365345365|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
105914336|NCT05067972|365345359|FG000|Part 1: Treatment|Progressive Disease|3|||
105914337|NCT05067972|365345360|FG001|Part 1: Treatment|Progressive Disease|3|||
105914338|NCT05067972|365345361|FG002|Part 1: Treatment|Progressive Disease|4|||
105914339|NCT05067972|365345362|FG003|Part 1: Treatment|Progressive Disease|2|||
105914340|NCT05067972|365345363|FG004|Part 1: Treatment|Progressive Disease|3|||
105914341|NCT05067972|365345364|FG005|Part 1: Treatment|Progressive Disease|0|||
105914342|NCT05067972|365345365|FG006|Part 1: Treatment|Progressive Disease|2|||
105914343|NCT05067972|365345359|FG000|Part 1: Treatment|Physician Decision|0|||
105914344|NCT05067972|365345360|FG001|Part 1: Treatment|Physician Decision|0|||
105914345|NCT05067972|365345361|FG002|Part 1: Treatment|Physician Decision|0|||
105914346|NCT05067972|365345362|FG003|Part 1: Treatment|Physician Decision|1|||
105914347|NCT05067972|365345363|FG004|Part 1: Treatment|Physician Decision|0|||
105914348|NCT05067972|365345364|FG005|Part 1: Treatment|Physician Decision|0|||
105914349|NCT05067972|365345365|FG006|Part 1: Treatment|Physician Decision|0|||
105914350|NCT05067972|365345359|FG000|Part 1: Treatment|Death|0|||
105914351|NCT05067972|365345360|FG001|Part 1: Treatment|Death|0|||
105914352|NCT05067972|365345361|FG002|Part 1: Treatment|Death|0|||
105914353|NCT05067972|365345362|FG003|Part 1: Treatment|Death|2|||
105914354|NCT05067972|365345363|FG004|Part 1: Treatment|Death|0|||
105914355|NCT05067972|365345364|FG005|Part 1: Treatment|Death|0|||
105914356|NCT05067972|365345365|FG006|Part 1: Treatment|Death|0|||
105914357|NCT05067972|365345359|FG000|Part 1: Treatment|Adverse Event|0|||
105914358|NCT05067972|365345360|FG001|Part 1: Treatment|Adverse Event|0|||
105914359|NCT05067972|365345361|FG002|Part 1: Treatment|Adverse Event|0|||
105914360|NCT05067972|365345362|FG003|Part 1: Treatment|Adverse Event|0|||
105914361|NCT05067972|365345363|FG004|Part 1: Treatment|Adverse Event|0|||
105914362|NCT05067972|365345364|FG005|Part 1: Treatment|Adverse Event|2|||
105678301|NCT01820585|364483499|FG003|Overall Study|Withdrawal by Subject|8|||
105678302|NCT01820585|364483496|FG000|Overall Study|Lost to Follow-up|3|||
105914363|NCT05067972|365345365|FG006|Part 1: Treatment|Adverse Event|1|||
105914364|NCT05067972|365345359|FG000|Part 1: Follow-up|Adverse Event|0|||
105914365|NCT05067972|365345360|FG001|Part 1: Follow-up|Adverse Event|0|||
105678303|NCT01820585|364483497|FG001|Overall Study|Lost to Follow-up|3|||
105914366|NCT05067972|365345361|FG002|Part 1: Follow-up|Adverse Event|0|||
105914367|NCT05067972|365345362|FG003|Part 1: Follow-up|Adverse Event|0|||
105914368|NCT05067972|365345363|FG004|Part 1: Follow-up|Adverse Event|0|||
105914369|NCT05067972|365345364|FG005|Part 1: Follow-up|Adverse Event|1|||
105914370|NCT05067972|365345365|FG006|Part 1: Follow-up|Adverse Event|0|||
105914371|NCT05067972|365345359|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
105914372|NCT05067972|365345360|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
105914373|NCT05067972|365345361|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
105914374|NCT05067972|365345362|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
105914375|NCT05067972|365345363|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
105914376|NCT05067972|365345364|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
105914377|NCT05067972|365345365|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
105914378|NCT05067972|365345359|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105914379|NCT05067972|365345360|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105914380|NCT05067972|365345361|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105914381|NCT05067972|365345362|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105914382|NCT05067972|365345363|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105914383|NCT05067972|365345364|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
105914384|NCT05067972|365345365|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
105914385|NCT05067972|365345359|FG000|Part 1: Follow-up|Physician Decision|0|||
105914386|NCT05067972|365345360|FG001|Part 1: Follow-up|Physician Decision|0|||
105914387|NCT05067972|365345361|FG002|Part 1: Follow-up|Physician Decision|0|||
105914388|NCT05067972|365345362|FG003|Part 1: Follow-up|Physician Decision|1|||
105914389|NCT05067972|365345363|FG004|Part 1: Follow-up|Physician Decision|0|||
105914390|NCT05067972|365345364|FG005|Part 1: Follow-up|Physician Decision|0|||
105914391|NCT05067972|365345365|FG006|Part 1: Follow-up|Physician Decision|0|||
105914392|NCT05067972|365345359|FG000|Part 1: Follow-up|Death|1|||
105914393|NCT05067972|365345360|FG001|Part 1: Follow-up|Death|2|||
105914394|NCT05067972|365345361|FG002|Part 1: Follow-up|Death|1|||
105914395|NCT05067972|365345362|FG003|Part 1: Follow-up|Death|0|||
105914396|NCT05067972|365345363|FG004|Part 1: Follow-up|Death|1|||
105914397|NCT05067972|365345364|FG005|Part 1: Follow-up|Death|0|||
105914398|NCT05067972|365345365|FG006|Part 1: Follow-up|Death|1|||
105914399|NCT04577794|365345367|FG000|Overall Study|Adverse Event|1|||
105914400|NCT04577794|365345368|FG001|Overall Study|Adverse Event|1|||
105914401|NCT01676012|365345369|FG000|Overall Study|Adverse Event|2|||
105914402|NCT01676012|365345369|FG000|Overall Study|incomplete set of videos|1|||
105914403|NCT01628848|365345375|FG000|Overall Study|Adverse Event|9|||
105914404|NCT01628848|365345376|FG001|Overall Study|Adverse Event|7|||
105914405|NCT01628848|365345375|FG000|Overall Study|Lack of Efficacy|0|||
105914406|NCT01628848|365345376|FG001|Overall Study|Lack of Efficacy|4|||
105914407|NCT01628848|365345375|FG000|Overall Study|Withdrawal by Subject|0|||
105914408|NCT01628848|365345376|FG001|Overall Study|Withdrawal by Subject|2|||
105914409|NCT01628848|365345375|FG000|Overall Study|Physician Decision|3|||
105914410|NCT01628848|365345376|FG001|Overall Study|Physician Decision|1|||
105914411|NCT00689338|365345377|FG000|Overall Study|Death|65|||
105914412|NCT00689338|365345377|FG000|Overall Study|Adverse Event|13|||
105914413|NCT00689338|365345377|FG000|Overall Study|Insufficient Clinical Response|1|||
105914414|NCT00689338|365345377|FG000|Overall Study|Lack of Efficacy|6|||
106000144|NCT01420926|365661270|FG001|Overall Study|Non-protocol treatment|20|||
106000145|NCT01420926|365661269|FG000|Overall Study|Physician Decision|8|||
106000146|NCT01420926|365661270|FG001|Overall Study|Physician Decision|5|||
106000147|NCT00961181|365663289|FG000|Overall Study|Death|2|||
106000148|NCT00961181|365663289|FG000|Overall Study|Withdrawal by Subject|2|||
106000149|NCT00961181|365663289|FG000|Overall Study|Lost to Follow-up|1|||
106000150|NCT01045967|365663290|FG000|Second Intervention|Protocol Violation|0|||
105914415|NCT00689338|365345377|FG000|Overall Study|Other|8|||
105914416|NCT00689338|365345377|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
105914417|NCT00689338|365345377|FG000|Overall Study|Lost to Follow-up|5|||
105914418|NCT00689338|365345377|FG000|Overall Study|Withdrawal by Subject|3|||
105914419|NCT00689338|365345377|FG000|Overall Study|Protocol Violation|15|||
105678304|NCT01820585|364483498|FG002|Overall Study|Lost to Follow-up|0|||
105678305|NCT01820585|364483499|FG003|Overall Study|Lost to Follow-up|3|||
105678306|NCT01820585|364483496|FG000|Overall Study|Protocol Violation|3|||
105914420|NCT02700048|365345378|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
105914421|NCT02700048|365345379|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
105914422|NCT02175225|365345380|FG000|Overall Study|Withdrawal by Subject|1|||
105914423|NCT02175225|365345381|FG001|Overall Study|Withdrawal by Subject|2|||
105914424|NCT02175225|365345380|FG000|Overall Study|Lost to Follow-up|6|||
105914425|NCT02175225|365345381|FG001|Overall Study|Lost to Follow-up|7|||
105914426|NCT02175225|365345380|FG000|Overall Study|Study drug not administered|1|||
105914427|NCT02175225|365345381|FG001|Overall Study|Study drug not administered|2|||
105914428|NCT02340000|365345382|FG000|Time Period 1|Withdrawal by Subject|6|||
105914429|NCT02340000|365345383|FG001|Time Period 1|Withdrawal by Subject|8|||
105914430|NCT02340000|365345382|FG000|Time Period 1|Lost to Follow-up|6|||
105678307|NCT01820585|364483497|FG001|Overall Study|Protocol Violation|1|||
105678308|NCT01820585|364483498|FG002|Overall Study|Protocol Violation|1|||
105678309|NCT01820585|364483499|FG003|Overall Study|Protocol Violation|1|||
105914431|NCT02340000|365345383|FG001|Time Period 1|Lost to Follow-up|7|||
105678310|NCT01820585|364483496|FG000|Overall Study|Subject non-compliance|0|||
106000151|NCT01045967|365663291|FG001|Second Intervention|Protocol Violation|1|||
105678311|NCT01820585|364483497|FG001|Overall Study|Subject non-compliance|0|||
105914432|NCT02340000|365345382|FG000|Time Period 2|Withdrawal by Subject|9|||
105914433|NCT02340000|365345383|FG001|Time Period 2|Withdrawal by Subject|7|||
105914434|NCT02340000|365345382|FG000|Time Period 2|Lost to Follow-up|10|||
105678312|NCT01820585|364483498|FG002|Overall Study|Subject non-compliance|1|||
105914435|NCT02340000|365345383|FG001|Time Period 2|Lost to Follow-up|8|||
105914436|NCT01107925|365345384|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
105914437|NCT01107925|365345385|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
106000152|NCT02252146|365663292|FG000|Overall Study|Lack of Efficacy|4|||
105914438|NCT01107925|365345386|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
105914439|NCT01107925|365345387|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
105914440|NCT01107925|365345388|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
105914441|NCT01107925|365345389|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
105914442|NCT01107925|365345384|FG000|Period 2|Withdrawal by Subject|0|||
105914443|NCT01107925|365345385|FG001|Period 2|Withdrawal by Subject|1|||
105914444|NCT01107925|365345386|FG002|Period 2|Withdrawal by Subject|0|||
105914445|NCT01107925|365345387|FG003|Period 2|Withdrawal by Subject|0|||
105914446|NCT01107925|365345388|FG004|Period 2|Withdrawal by Subject|0|||
105914447|NCT01107925|365345389|FG005|Period 2|Withdrawal by Subject|1|||
105914448|NCT01619878|365345391|FG000|6 Week Follow-up Phase|Adverse Event|1|||
105914449|NCT01619878|365345391|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
105914450|NCT01619878|365345391|FG000|Follow-up at 12 Months of Age|Death|2|||
105914451|NCT00369343|365345392|FG000|Double-blind Phase|Adverse Event|19|||
105914452|NCT00369343|365345393|FG001|Double-blind Phase|Adverse Event|4|||
105914453|NCT00369343|365345392|FG000|Double-blind Phase|Failed to return|2|||
105914454|NCT00369343|365345393|FG001|Double-blind Phase|Failed to return|0|||
105914455|NCT00369343|365345392|FG000|Double-blind Phase|Lost to Follow-up|9|||
105914456|NCT00369343|365345393|FG001|Double-blind Phase|Lost to Follow-up|2|||
105914457|NCT00369343|365345392|FG000|Double-blind Phase|Protocol Violation|2|||
105914458|NCT00369343|365345393|FG001|Double-blind Phase|Protocol Violation|0|||
105914459|NCT00369343|365345392|FG000|Double-blind Phase|Withdrawal by Subject|8|||
105914460|NCT00369343|365345393|FG001|Double-blind Phase|Withdrawal by Subject|6|||
105914461|NCT00369343|365345392|FG000|Double-blind Phase|Lack of Efficacy|0|||
105914462|NCT00369343|365345393|FG001|Double-blind Phase|Lack of Efficacy|4|||
105914463|NCT00369343|365345392|FG000|Double-blind Phase|Protocol deviation|4|||
105914464|NCT00369343|365345393|FG001|Double-blind Phase|Protocol deviation|0|||
105914465|NCT00369343|365345392|FG000|Open-label Phase|Adverse Event|19|||
105914466|NCT00369343|365345393|FG001|Open-label Phase|Adverse Event|7|||
105914467|NCT00369343|365345392|FG000|Open-label Phase|Failed to return|4|||
105678313|NCT01820585|364483499|FG003|Overall Study|Subject non-compliance|2|||
105678314|NCT01820585|364483496|FG000|Overall Study|at sponsor request|0|||
105678315|NCT01820585|364483497|FG001|Overall Study|at sponsor request|0|||
105678316|NCT01820585|364483498|FG002|Overall Study|at sponsor request|1|||
105678317|NCT01820585|364483499|FG003|Overall Study|at sponsor request|0|||
105678318|NCT01820585|364483496|FG000|Overall Study|Pregnancy|0|||
105678319|NCT01820585|364483497|FG001|Overall Study|Pregnancy|1|||
105678320|NCT01820585|364483498|FG002|Overall Study|Pregnancy|0|||
105678321|NCT01820585|364483499|FG003|Overall Study|Pregnancy|0|||
105678322|NCT01712659|364483500|FG000|Dose Escalation|Physician Decision|0|||
105678323|NCT01712659|364483501|FG001|Dose Escalation|Physician Decision|1|||
105678324|NCT01712659|364483502|FG002|Dose Escalation|Physician Decision|0|||
105678325|NCT01712659|364483503|FG003|Dose Escalation|Physician Decision|0|||
105678326|NCT01712659|364483504|FG004|Dose Escalation|Physician Decision|0|||
105914468|NCT00369343|365345393|FG001|Open-label Phase|Failed to return|0|||
105914469|NCT00369343|365345392|FG000|Open-label Phase|Physician Decision|2|||
105914470|NCT00369343|365345393|FG001|Open-label Phase|Physician Decision|0|||
105914471|NCT00369343|365345392|FG000|Open-label Phase|Lost to Follow-up|5|||
105914472|NCT00369343|365345393|FG001|Open-label Phase|Lost to Follow-up|3|||
105914473|NCT00369343|365345392|FG000|Open-label Phase|inadvertently reported study completers|3|||
105914474|NCT00369343|365345393|FG001|Open-label Phase|inadvertently reported study completers|2|||
105914475|NCT00369343|365345392|FG000|Open-label Phase|Protocol Violation|1|||
105914476|NCT00369343|365345393|FG001|Open-label Phase|Protocol Violation|3|||
105914477|NCT00369343|365345392|FG000|Open-label Phase|Withdrawal by Subject|15|||
105914478|NCT00369343|365345393|FG001|Open-label Phase|Withdrawal by Subject|6|||
105914479|NCT00369343|365345392|FG000|Open-label Phase|Lack of Efficacy|4|||
105914480|NCT00369343|365345393|FG001|Open-label Phase|Lack of Efficacy|3|||
105914481|NCT00369343|365345392|FG000|Open-label Phase|Lack of continuance tolerability|3|||
105914482|NCT00369343|365345393|FG001|Open-label Phase|Lack of continuance tolerability|4|||
105914483|NCT00369343|365345392|FG000|Open-label Phase|did not take study drug|1|||
105914484|NCT00369343|365345393|FG001|Open-label Phase|did not take study drug|2|||
105914485|NCT02370511|365345396|FG000|Overall Study|Death|10|||
105914486|NCT02370511|365345397|FG001|Overall Study|Death|7|||
105914487|NCT02370511|365345398|FG002|Overall Study|Death|1|||
105914488|NCT02370511|365345396|FG000|Overall Study|Withdrawal by Subject|2|||
105914489|NCT02370511|365345397|FG001|Overall Study|Withdrawal by Subject|0|||
105914490|NCT02370511|365345398|FG002|Overall Study|Withdrawal by Subject|0|||
105914491|NCT02370511|365345396|FG000|Overall Study|Lost to Follow-up|0|||
105914492|NCT02370511|365345397|FG001|Overall Study|Lost to Follow-up|4|||
105914493|NCT02370511|365345398|FG002|Overall Study|Lost to Follow-up|0|||
105914494|NCT00807365|365345403|FG000|Overall Study|Study Terminated|5|||
105914495|NCT00960804|365345409|FG000|Overall Study|Adverse Event|1|||
105914496|NCT00960804|365345410|FG001|Overall Study|Adverse Event|0|||
105914497|NCT00960804|365345411|FG002|Overall Study|Adverse Event|0|||
105914498|NCT00960804|365345409|FG000|Overall Study|Withdrawal by Subject|1|||
105914499|NCT00960804|365345410|FG001|Overall Study|Withdrawal by Subject|0|||
105914500|NCT00960804|365345411|FG002|Overall Study|Withdrawal by Subject|0|||
105914501|NCT00960804|365345409|FG000|Overall Study|Study terminated by the sponsor|5|||
105914502|NCT00960804|365345410|FG001|Overall Study|Study terminated by the sponsor|4|||
105914503|NCT00960804|365345411|FG002|Overall Study|Study terminated by the sponsor|10|||
105914504|NCT01121263|365345412|FG000|Overall Study|Death|3|||
105914505|NCT01121263|365345413|FG001|Overall Study|Death|2|||
105914506|NCT01121263|365345412|FG000|Overall Study|Lost to Follow-up|22|||
105914507|NCT01121263|365345413|FG001|Overall Study|Lost to Follow-up|12|||
105914508|NCT01121263|365345412|FG000|Overall Study|Withdrawal by Subject|0|||
105914509|NCT01121263|365345413|FG001|Overall Study|Withdrawal by Subject|1|||
105914510|NCT03810456|365345414|FG000|Treatment|Urgent Family Matters|3|||
105914511|NCT03810456|365345415|FG001|Treatment|Urgent Family Matters|0|||
105914512|NCT03810456|365345416|FG002|Treatment|Urgent Family Matters|0|||
105914513|NCT03810456|365345414|FG000|Treatment|Scheduling Conflicts|0|||
105914514|NCT03810456|365345415|FG001|Treatment|Scheduling Conflicts|11|||
105914515|NCT03810456|365345416|FG002|Treatment|Scheduling Conflicts|0|||
105914516|NCT03810456|365345414|FG000|Treatment|No Longer Interested|0|||
105914517|NCT03810456|365345415|FG001|Treatment|No Longer Interested|12|||
105914518|NCT03810456|365345416|FG002|Treatment|No Longer Interested|0|||
105914519|NCT03810456|365345414|FG000|Treatment|Transportation Issues|0|||
105914520|NCT03810456|365345415|FG001|Treatment|Transportation Issues|1|||
105914521|NCT03810456|365345416|FG002|Treatment|Transportation Issues|0|||
105914522|NCT03810456|365345414|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
105678327|NCT01712659|364483500|FG000|Dose Escalation|Unable to take study drug|0|||
105678328|NCT01712659|364483501|FG001|Dose Escalation|Unable to take study drug|1|||
105678329|NCT01712659|364483502|FG002|Dose Escalation|Unable to take study drug|0|||
105678330|NCT01712659|364483503|FG003|Dose Escalation|Unable to take study drug|0|||
105678331|NCT01712659|364483504|FG004|Dose Escalation|Unable to take study drug|0|||
105678332|NCT01712659|364483500|FG000|Dose Expansion|Early disease progression|1|||
105914523|NCT03810456|365345415|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
105914524|NCT03810456|365345416|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
105914525|NCT03810456|365345414|FG000|1 Month Follow-Up|Relocated to Different State|1|||
105914526|NCT03810456|365345415|FG001|1 Month Follow-Up|Relocated to Different State|0|||
105914527|NCT03810456|365345416|FG002|1 Month Follow-Up|Relocated to Different State|1|||
105914528|NCT03810456|365345414|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
105914529|NCT03810456|365345415|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
105914530|NCT03810456|365345416|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
105914531|NCT03810456|365345414|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
105914532|NCT03810456|365345415|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
105914533|NCT03810456|365345416|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
105914534|NCT03810456|365345414|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
105914535|NCT03810456|365345415|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
105914536|NCT03810456|365345416|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
105914537|NCT03810456|365345414|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
105914538|NCT03810456|365345415|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
105914539|NCT03810456|365345416|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
105914540|NCT03810456|365345414|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
105914541|NCT03810456|365345415|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
105914542|NCT03810456|365345416|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
105914543|NCT02007720|365345417|FG000|Overall Study|Withdrawal by Subject|9|||
105914544|NCT02007720|365345418|FG001|Overall Study|Withdrawal by Subject|11|||
105914545|NCT02007720|365345417|FG000|Overall Study|study terminated by sponsor|58|||
105914546|NCT02007720|365345418|FG001|Overall Study|study terminated by sponsor|54|||
105914547|NCT02007720|365345417|FG000|Overall Study|technical problem|4|||
105914548|NCT02007720|365345418|FG001|Overall Study|technical problem|2|||
105914549|NCT02007720|365345417|FG000|Overall Study|patient followd less than 165 days|11|||
105914550|NCT02007720|365345418|FG001|Overall Study|patient followd less than 165 days|5|||
105914551|NCT01419535|365345419|FG000|Overall Study|could not maintain iv line|1|||
105914552|NCT01419535|365345420|FG001|Overall Study|could not maintain iv line|1|||
105914553|NCT01419535|365345419|FG000|Overall Study|Withdrawal by Subject|0|||
105914554|NCT01419535|365345420|FG001|Overall Study|Withdrawal by Subject|1|||
105914555|NCT04809974|365346826|FG000|Lead-in Phase|Withdrawal by Subject|3|||
105914556|NCT04809974|365346827|FG001|Lead-in Phase|Withdrawal by Subject|0|||
105914557|NCT04809974|365346828|FG002|Lead-in Phase|Withdrawal by Subject|0|||
105914558|NCT04809974|365346826|FG000|Lead-in Phase|No longer eligible|11|||
105914559|NCT04809974|365346827|FG001|Lead-in Phase|No longer eligible|0|||
105914560|NCT04809974|365346828|FG002|Lead-in Phase|No longer eligible|0|||
105914561|NCT04809974|365346826|FG000|Randomized Phase|Lost to Follow-up|0|||
105914562|NCT04809974|365346827|FG001|Randomized Phase|Lost to Follow-up|1|||
105914563|NCT04809974|365346828|FG002|Randomized Phase|Lost to Follow-up|5|||
105914564|NCT04809974|365346826|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
105914565|NCT04809974|365346827|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
105914566|NCT04809974|365346828|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
105914567|NCT04809974|365346826|FG000|Randomized Phase|Adverse Event|0|||
105914568|NCT04809974|365346827|FG001|Randomized Phase|Adverse Event|1|||
105914569|NCT04809974|365346828|FG002|Randomized Phase|Adverse Event|4|||
105914570|NCT04809974|365346826|FG000|Randomized Phase|Withdrawal by Subject|0|||
105914571|NCT04809974|365346827|FG001|Randomized Phase|Withdrawal by Subject|0|||
105914572|NCT04809974|365346828|FG002|Randomized Phase|Withdrawal by Subject|5|||
105914573|NCT02358031|365346829|FG000|Overall Study|Death|253|||
105914574|NCT02358031|365346830|FG001|Overall Study|Death|237|||
105914575|NCT02358031|365346831|FG002|Overall Study|Death|266|||
105678333|NCT01712659|364483501|FG001|Dose Expansion|Early disease progression|0|||
105914576|NCT02358031|365346829|FG000|Overall Study|Lost to Follow-up|1|||
105914577|NCT02358031|365346830|FG001|Overall Study|Lost to Follow-up|1|||
105914578|NCT02358031|365346831|FG002|Overall Study|Lost to Follow-up|0|||
105914579|NCT02358031|365346829|FG000|Overall Study|Withdrawal by Subject|19|||
105914580|NCT02358031|365346830|FG001|Overall Study|Withdrawal by Subject|14|||
105914581|NCT02358031|365346831|FG002|Overall Study|Withdrawal by Subject|18|||
105914582|NCT02358031|365346829|FG000|Overall Study|Sponsor Decision|26|||
105914583|NCT02358031|365346830|FG001|Overall Study|Sponsor Decision|28|||
105914584|NCT02358031|365346831|FG002|Overall Study|Sponsor Decision|16|||
105914585|NCT03246347|365346832|FG000|Overall Study|On Study|23|||
105914586|NCT05664581|365346833|FG000|Overall Study|Withdrawal by Subject|2|||
105914587|NCT03101150|365346836|FG000|Overall Study|Lost to Follow-up|2|||
105914588|NCT03101150|365346837|FG001|Overall Study|Lost to Follow-up|4|||
105914589|NCT03101150|365346836|FG000|Overall Study|Miscarriage|3|||
105914590|NCT03101150|365346837|FG001|Overall Study|Miscarriage|6|||
105914591|NCT01022203|365346838|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
105914592|NCT01022203|365346839|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
105914593|NCT01022203|365346838|FG000|Post Treatment Assessment|Physician Decision|2|||
105914594|NCT01022203|365346839|FG001|Post Treatment Assessment|Physician Decision|0|||
105914595|NCT01022203|365346838|FG000|Post Treatment Assessment|Adverse Event|0|||
105914596|NCT01022203|365346839|FG001|Post Treatment Assessment|Adverse Event|2|||
105914597|NCT01022203|365346838|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
105914598|NCT01022203|365346839|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
105914599|NCT03163446|365346840|FG000|Overall Study|Unable to return for Day 180 visit|2|||
105914600|NCT03163446|365346841|FG001|Overall Study|Unable to return for Day 180 visit|0|||
105914601|NCT03163446|365346840|FG000|Overall Study|Withdrawal by Subject|2|||
105914602|NCT03163446|365346841|FG001|Overall Study|Withdrawal by Subject|6|||
105914603|NCT03163446|365346840|FG000|Overall Study|Death|16|||
105914604|NCT03163446|365346841|FG001|Overall Study|Death|5|||
105914605|NCT03163446|365346840|FG000|Overall Study|Lost to Follow-up|6|||
105914606|NCT03163446|365346841|FG001|Overall Study|Lost to Follow-up|5|||
105914607|NCT03163446|365346840|FG000|Overall Study|Physician Decision|1|||
105914608|NCT03163446|365346841|FG001|Overall Study|Physician Decision|1|||
105914609|NCT03163446|365346840|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
105914610|NCT03163446|365346841|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
105914611|NCT01317940|365346844|FG000|Overall Study|Death|1|||
105914612|NCT01317940|365346845|FG001|Overall Study|Death|0|||
105914613|NCT01317940|365346846|FG002|Overall Study|Death|1|||
105914614|NCT01317940|365346847|FG003|Overall Study|Death|0|||
105914615|NCT01317940|365346848|FG004|Overall Study|Death|0|||
105914616|NCT01317940|365346849|FG005|Overall Study|Death|0|||
105914617|NCT01317940|365346844|FG000|Overall Study|Lost to Follow-up|0|||
105914618|NCT01317940|365346845|FG001|Overall Study|Lost to Follow-up|0|||
105914619|NCT01317940|365346846|FG002|Overall Study|Lost to Follow-up|1|||
105914620|NCT01317940|365346847|FG003|Overall Study|Lost to Follow-up|1|||
105914621|NCT01317940|365346848|FG004|Overall Study|Lost to Follow-up|1|||
105914622|NCT01317940|365346849|FG005|Overall Study|Lost to Follow-up|0|||
105914623|NCT01317940|365346844|FG000|Overall Study|Change in therapy plan|0|||
105914624|NCT01317940|365346845|FG001|Overall Study|Change in therapy plan|0|||
105914625|NCT01317940|365346846|FG002|Overall Study|Change in therapy plan|3|||
105914626|NCT01317940|365346847|FG003|Overall Study|Change in therapy plan|0|||
105914627|NCT01317940|365346848|FG004|Overall Study|Change in therapy plan|0|||
105914628|NCT01317940|365346849|FG005|Overall Study|Change in therapy plan|0|||
105914629|NCT04152200|365346851|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
105914630|NCT04152200|365346852|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
105914631|NCT02699996|365346853|FG000|Overall Study|Withdrawal by Subject|5|||
105914632|NCT02699996|365346854|FG001|Overall Study|Withdrawal by Subject|2|||
105914633|NCT01921517|365346855|FG000|Overall Study|Lost to Follow-up|5|||
105914634|NCT01921517|365346856|FG001|Overall Study|Lost to Follow-up|0|||
105914635|NCT01921517|365346855|FG000|Overall Study|Newly diagnosed health concern|2|||
105914636|NCT01921517|365346856|FG001|Overall Study|Newly diagnosed health concern|0|||
105914637|NCT01921517|365346855|FG000|Overall Study|Physician Decision|0|||
105914638|NCT01921517|365346856|FG001|Overall Study|Physician Decision|2|||
105914639|NCT01921517|365346855|FG000|Overall Study|Withdrawal by Subject|7|||
105786472|NCT03605758|364871396|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
105786473|NCT03605758|364871397|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
105914640|NCT01921517|365346856|FG001|Overall Study|Withdrawal by Subject|3|||
105914641|NCT01921517|365346855|FG000|Overall Study|Subject missed final imaging|1|||
105914642|NCT01921517|365346856|FG001|Overall Study|Subject missed final imaging|4|||
105914643|NCT04069715|365346859|FG000|Overall Study|Lost to Follow-up|1|||
105914644|NCT04069715|365346860|FG001|Overall Study|Lost to Follow-up|1|||
105914645|NCT04069715|365346859|FG000|Overall Study|Physician Decision|1|||
105914646|NCT04069715|365346860|FG001|Overall Study|Physician Decision|1|||
105914647|NCT04069715|365346859|FG000|Overall Study|Withdrawal by Subject|3|||
105914648|NCT04069715|365346860|FG001|Overall Study|Withdrawal by Subject|3|||
105914649|NCT01095835|365346863|FG000|Overall Study|Adverse Event|8|||
105914650|NCT01095835|365346864|FG001|Overall Study|Adverse Event|6|||
105914651|NCT01095835|365346865|FG002|Overall Study|Adverse Event|6|||
105914652|NCT01095835|365346863|FG000|Overall Study|Lack of Efficacy|0|||
105678334|NCT01712659|364483502|FG002|Dose Expansion|Early disease progression|0|||
105678335|NCT01712659|364483503|FG003|Dose Expansion|Early disease progression|0|||
105678336|NCT01712659|364483504|FG004|Dose Expansion|Early disease progression|0|||
105678337|NCT01712659|364483500|FG000|Dose Expansion|Physician Decision|1|||
105678338|NCT01712659|364483501|FG001|Dose Expansion|Physician Decision|0|||
105678339|NCT01712659|364483502|FG002|Dose Expansion|Physician Decision|0|||
105678340|NCT01712659|364483503|FG003|Dose Expansion|Physician Decision|0|||
105678341|NCT01712659|364483504|FG004|Dose Expansion|Physician Decision|0|||
105678342|NCT01489891|364483506|FG000|Overall Study|Endoscopy failure|1|||
105678343|NCT01489891|364483507|FG001|Overall Study|Endoscopy failure|0|||
105678344|NCT02270515|364483508|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
105678345|NCT02270515|364483508|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
105678346|NCT02270515|364483508|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
105678347|NCT02270515|364483508|FG000|Intervention Period 1: 0-6 Months|Death|7|||
105678348|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
105678349|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
105678350|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
105678351|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|Death|5|||
105678352|NCT02270515|364483508|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
105678353|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
105678354|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
105678355|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
105678356|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|Death|3|||
105678357|NCT02270515|364483508|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
105678358|NCT01853644|364483509|FG000|Registration and Treatment Start|Did not start treatment|1|||
105678359|NCT01853644|364483509|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
105914653|NCT01095835|365346864|FG001|Overall Study|Lack of Efficacy|1|||
105914654|NCT01095835|365346865|FG002|Overall Study|Lack of Efficacy|0|||
105914655|NCT01095835|365346863|FG000|Overall Study|Physician Decision|0|||
105914656|NCT01095835|365346864|FG001|Overall Study|Physician Decision|0|||
105914657|NCT01095835|365346865|FG002|Overall Study|Physician Decision|1|||
105914658|NCT01095835|365346863|FG000|Overall Study|Withdrawal by Subject|1|||
105914659|NCT01095835|365346864|FG001|Overall Study|Withdrawal by Subject|3|||
105914660|NCT01095835|365346865|FG002|Overall Study|Withdrawal by Subject|0|||
105914661|NCT01095835|365346863|FG000|Overall Study|Non study compliance|0|||
105914662|NCT01095835|365346864|FG001|Overall Study|Non study compliance|0|||
105914663|NCT01095835|365346865|FG002|Overall Study|Non study compliance|1|||
105914664|NCT01095835|365346863|FG000|Overall Study|Protocol Violation|1|||
105914665|NCT01095835|365346864|FG001|Overall Study|Protocol Violation|2|||
105914666|NCT01095835|365346865|FG002|Overall Study|Protocol Violation|0|||
105914667|NCT00327340|365346870|FG000|Overall Study|Withdrawal by Subject|1|||
105914668|NCT00327340|365346871|FG001|Overall Study|Withdrawal by Subject|5|||
105914669|NCT00327340|365346870|FG000|Overall Study|Physician Decision|1|||
105914670|NCT00327340|365346871|FG001|Overall Study|Physician Decision|1|||
105914671|NCT00327340|365346870|FG000|Overall Study|Disease Progression|10|||
105914672|NCT00327340|365346871|FG001|Overall Study|Disease Progression|19|||
105914673|NCT00327340|365346870|FG000|Overall Study|Symptomatic Disease|0|||
105914674|NCT00327340|365346871|FG001|Overall Study|Symptomatic Disease|2|||
105914675|NCT00327340|365346870|FG000|Overall Study|Adverse Event|3|||
105914676|NCT00327340|365346871|FG001|Overall Study|Adverse Event|3|||
105914677|NCT00126594|365346872|FG000|Overall Study|Ineligible|2|||
105914678|NCT00126594|365346873|FG001|Overall Study|Ineligible|0|||
105914679|NCT00126594|365346872|FG000|Overall Study|Withdrawal by Subject|0|||
105914680|NCT00126594|365346873|FG001|Overall Study|Withdrawal by Subject|4|||
105914681|NCT00126594|365346872|FG000|Overall Study|Physician Decision|1|||
105914682|NCT00126594|365346873|FG001|Overall Study|Physician Decision|3|||
105914683|NCT00126594|365346872|FG000|Overall Study|Adverse Event|7|||
105914684|NCT00126594|365346873|FG001|Overall Study|Adverse Event|5|||
105914685|NCT00126594|365346872|FG000|Overall Study|Non-compliance|0|||
105914686|NCT00126594|365346873|FG001|Overall Study|Non-compliance|1|||
105914687|NCT00126594|365346872|FG000|Overall Study|Disease Progression|29|||
105914688|NCT00126594|365346873|FG001|Overall Study|Disease Progression|24|||
105914689|NCT01249131|365346875|FG000|Washout Period of 10 Days|Adverse Event|0|||
105914690|NCT01249131|365346876|FG001|Washout Period of 10 Days|Adverse Event|0|||
105914691|NCT01249131|365346877|FG002|Washout Period of 10 Days|Adverse Event|0|||
105914692|NCT01249131|365346878|FG003|Washout Period of 10 Days|Adverse Event|0|||
105678360|NCT01853644|364483509|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
105678361|NCT01853644|364483509|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
105914693|NCT01249131|365346879|FG004|Washout Period of 10 Days|Adverse Event|1|||
105914694|NCT01249131|365346880|FG005|Washout Period of 10 Days|Adverse Event|0|||
105914695|NCT02219685|365346886|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
105914696|NCT02219685|365346887|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
105914697|NCT02219685|365346886|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
105914698|NCT02219685|365346887|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
105914699|NCT02974868|365346888|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
105914700|NCT02974868|365346889|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
105914701|NCT02974868|365346890|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
105914702|NCT02974868|365346891|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
105914703|NCT02974868|365346888|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
105914704|NCT02974868|365346889|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
105914705|NCT02974868|365346890|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
105914706|NCT02974868|365346891|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
105914707|NCT02974868|365346888|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
105914708|NCT02974868|365346889|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
105914709|NCT02974868|365346890|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
105914710|NCT02974868|365346891|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
105914711|NCT02974868|365346888|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
105914712|NCT02974868|365346889|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
105914713|NCT02974868|365346890|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
105914714|NCT02974868|365346891|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
105914715|NCT02869789|365346892|FG000|Overall Study|Disease progression|184|||
105914716|NCT02869789|365346893|FG001|Overall Study|Disease progression|109|||
105914717|NCT02869789|365346894|FG002|Overall Study|Disease progression|260|||
105914718|NCT02869789|365346895|FG003|Overall Study|Disease progression|19|||
105914719|NCT02869789|365346892|FG000|Overall Study|Study drug toxicity|90|||
105914720|NCT02869789|365346893|FG001|Overall Study|Study drug toxicity|32|||
105914721|NCT02869789|365346894|FG002|Overall Study|Study drug toxicity|55|||
105914722|NCT02869789|365346895|FG003|Overall Study|Study drug toxicity|14|||
105914723|NCT02869789|365346892|FG000|Overall Study|Death|7|||
105914724|NCT02869789|365346893|FG001|Overall Study|Death|3|||
105914725|NCT02869789|365346894|FG002|Overall Study|Death|5|||
105914726|NCT02869789|365346895|FG003|Overall Study|Death|1|||
105914727|NCT02869789|365346892|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
105914728|NCT02869789|365346893|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
105914729|NCT02869789|365346894|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
105914730|NCT02869789|365346895|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
105914731|NCT02869789|365346892|FG000|Overall Study|Participant request to discontinue study treatment|10|||
105914732|NCT02869789|365346893|FG001|Overall Study|Participant request to discontinue study treatment|5|||
105914733|NCT02869789|365346894|FG002|Overall Study|Participant request to discontinue study treatment|5|||
105914734|NCT02869789|365346895|FG003|Overall Study|Participant request to discontinue study treatment|3|||
105914735|NCT02869789|365346892|FG000|Overall Study|Withdrawal by Subject|5|||
105914736|NCT02869789|365346893|FG001|Overall Study|Withdrawal by Subject|2|||
105914737|NCT02869789|365346894|FG002|Overall Study|Withdrawal by Subject|7|||
105914738|NCT02869789|365346895|FG003|Overall Study|Withdrawal by Subject|2|||
105914739|NCT02869789|365346892|FG000|Overall Study|Lost to Follow-up|0|||
105914740|NCT02869789|365346893|FG001|Overall Study|Lost to Follow-up|0|||
105914741|NCT02869789|365346894|FG002|Overall Study|Lost to Follow-up|2|||
105914742|NCT02869789|365346895|FG003|Overall Study|Lost to Follow-up|0|||
105914743|NCT02869789|365346892|FG000|Overall Study|Maximum clinical benefit|5|||
105914744|NCT02869789|365346893|FG001|Overall Study|Maximum clinical benefit|2|||
105914745|NCT02869789|365346894|FG002|Overall Study|Maximum clinical benefit|1|||
105914746|NCT02869789|365346895|FG003|Overall Study|Maximum clinical benefit|0|||
105914747|NCT02869789|365346892|FG000|Overall Study|Poor/Non-compliance|0|||
105914748|NCT02869789|365346893|FG001|Overall Study|Poor/Non-compliance|2|||
105914749|NCT02869789|365346894|FG002|Overall Study|Poor/Non-compliance|1|||
105914750|NCT02869789|365346895|FG003|Overall Study|Poor/Non-compliance|0|||
105678362|NCT01853644|364483509|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
105914751|NCT02869789|365346892|FG000|Overall Study|Participant no longer meets study criteria|0|||
105914752|NCT02869789|365346893|FG001|Overall Study|Participant no longer meets study criteria|1|||
105914753|NCT02869789|365346894|FG002|Overall Study|Participant no longer meets study criteria|1|||
105914754|NCT02869789|365346895|FG003|Overall Study|Participant no longer meets study criteria|0|||
105914755|NCT02869789|365346892|FG000|Overall Study|Administrative reason by sponsor|0|||
105914756|NCT02869789|365346893|FG001|Overall Study|Administrative reason by sponsor|0|||
105914757|NCT02869789|365346894|FG002|Overall Study|Administrative reason by sponsor|1|||
105914758|NCT02869789|365346895|FG003|Overall Study|Administrative reason by sponsor|0|||
105914759|NCT02869789|365346892|FG000|Overall Study|Other reasons|4|||
105914760|NCT02869789|365346893|FG001|Overall Study|Other reasons|8|||
105914761|NCT02869789|365346894|FG002|Overall Study|Other reasons|6|||
105914762|NCT02869789|365346895|FG003|Overall Study|Other reasons|0|||
105914763|NCT01746862|365346915|FG000|Overall Study|Withdrawal by Subject|1|||
105914764|NCT01746862|365346916|FG001|Overall Study|Withdrawal by Subject|1|||
105914765|NCT01746862|365346915|FG000|Overall Study|Protocol Violation|1|||
105914766|NCT01746862|365346916|FG001|Overall Study|Protocol Violation|0|||
105914767|NCT01746862|365346915|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
105914768|NCT01746862|365346916|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
105914769|NCT01746862|365346915|FG000|Overall Study|Entered puberty during the study|1|||
105914770|NCT01746862|365346916|FG001|Overall Study|Entered puberty during the study|0|||
105914771|NCT04742673|365346917|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
105914772|NCT04742673|365346918|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
105914773|NCT01900444|365346919|FG000|Overall Study|Protocol Violation|2|||
105914774|NCT01900444|365346919|FG000|Overall Study|Lost to Follow-up|1|||
105914775|NCT06058390|365346924|FG000|Overall Study|Lost to Follow-up|0|||
105914776|NCT06058390|365346925|FG001|Overall Study|Lost to Follow-up|0|||
105914777|NCT06058390|365346926|FG002|Overall Study|Lost to Follow-up|2|||
105914778|NCT06058390|365346927|FG003|Overall Study|Lost to Follow-up|1|||
105914779|NCT06058390|365346924|FG000|Overall Study|Physician Decision|0|||
105914780|NCT06058390|365346925|FG001|Overall Study|Physician Decision|0|||
105914781|NCT06058390|365346926|FG002|Overall Study|Physician Decision|0|||
105914782|NCT06058390|365346927|FG003|Overall Study|Physician Decision|1|||
105914783|NCT06058390|365346924|FG000|Overall Study|Participants did not receive any study intervention|0|||
105914784|NCT06058390|365346925|FG001|Overall Study|Participants did not receive any study intervention|0|||
105914785|NCT06058390|365346926|FG002|Overall Study|Participants did not receive any study intervention|0|||
105914786|NCT06058390|365346927|FG003|Overall Study|Participants did not receive any study intervention|1|||
105914787|NCT03361306|365346928|FG000|Overall Study|Death|6|||
105914788|NCT04817332|365346931|FG000|Overall Study|Lost to Follow-up|3|||
105914789|NCT04817332|365346932|FG001|Overall Study|Lost to Follow-up|3|||
105914790|NCT04817332|365346931|FG000|Overall Study|Protocol Violation|2|||
105914791|NCT04817332|365346932|FG001|Overall Study|Protocol Violation|0|||
105914792|NCT05635045|365346936|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
105914793|NCT05635045|365346937|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
105914794|NCT05635045|365346938|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
105914795|NCT05635045|365346939|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
105914796|NCT02983045|365346940|FG000|Overall Study|Withdrawal by Subject|0|||
105914797|NCT02983045|365346941|FG001|Overall Study|Withdrawal by Subject|1|||
105914798|NCT02983045|365346942|FG002|Overall Study|Withdrawal by Subject|0|||
105914799|NCT02983045|365346943|FG003|Overall Study|Withdrawal by Subject|5|||
105914800|NCT02983045|365346944|FG004|Overall Study|Withdrawal by Subject|0|||
105914801|NCT02983045|365346945|FG005|Overall Study|Withdrawal by Subject|72|||
105914802|NCT02983045|365346946|FG006|Overall Study|Withdrawal by Subject|0|||
105914803|NCT02983045|365346947|FG007|Overall Study|Withdrawal by Subject|0|||
105678363|NCT01853644|364483509|FG000|Continued Treatment After First Response|Adverse Event|2|||
105678364|NCT01853644|364483509|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
105678365|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
105678366|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
105678367|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
105678368|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
105678369|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
105914804|NCT02983045|365346948|FG008|Overall Study|Withdrawal by Subject|0|||
105914805|NCT02983045|365346949|FG009|Overall Study|Withdrawal by Subject|2|||
105914806|NCT02983045|365346940|FG000|Overall Study|Lost to Follow-up|0|||
105914807|NCT02983045|365346941|FG001|Overall Study|Lost to Follow-up|0|||
105914808|NCT02983045|365346942|FG002|Overall Study|Lost to Follow-up|0|||
105914809|NCT02983045|365346943|FG003|Overall Study|Lost to Follow-up|0|||
105914810|NCT02983045|365346944|FG004|Overall Study|Lost to Follow-up|0|||
105914811|NCT02983045|365346945|FG005|Overall Study|Lost to Follow-up|10|||
105914812|NCT02983045|365346946|FG006|Overall Study|Lost to Follow-up|0|||
105914813|NCT02983045|365346947|FG007|Overall Study|Lost to Follow-up|0|||
105678370|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
105678371|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
105914814|NCT02983045|365346948|FG008|Overall Study|Lost to Follow-up|0|||
105914815|NCT02983045|365346949|FG009|Overall Study|Lost to Follow-up|0|||
105914816|NCT02616783|365346952|FG000|Overall Study|Randomized but Not Treated|1|||
105914817|NCT02616783|365346953|FG001|Overall Study|Randomized but Not Treated|0|||
105914818|NCT02616783|365346952|FG000|Overall Study|Adverse Event|1|||
105914819|NCT02616783|365346953|FG001|Overall Study|Adverse Event|0|||
105914820|NCT02616783|365346952|FG000|Overall Study|Death|1|||
105678372|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
105678373|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
105678374|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
105678375|NCT01237587|364483510|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
105678376|NCT01237587|364483511|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
105678377|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
105678378|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
105678379|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
105678380|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
105678381|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
105678382|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
105678383|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
105678384|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
105678385|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
105678386|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
105678387|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
105678388|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
105678389|NCT01237587|364483510|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
105678390|NCT01237587|364483511|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
105678391|NCT01237587|364483510|FG000|Taper Phase|Adverse Event|0|||
105914821|NCT02616783|365346953|FG001|Overall Study|Death|0|||
105914822|NCT02616783|365346952|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105914823|NCT02616783|365346953|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105914824|NCT02616783|365346952|FG000|Overall Study|Protocol Violation|1|||
105914825|NCT02616783|365346953|FG001|Overall Study|Protocol Violation|1|||
105914826|NCT02616783|365346952|FG000|Overall Study|Withdrew Consent|1|||
105914827|NCT02616783|365346953|FG001|Overall Study|Withdrew Consent|1|||
105914828|NCT03473743|365346954|FG000|Overall Study|Withdrawal by Subject|0|||
105914829|NCT03473743|365346955|FG001|Overall Study|Withdrawal by Subject|0|||
105914830|NCT03473743|365346956|FG002|Overall Study|Withdrawal by Subject|0|||
105914831|NCT03473743|365346957|FG003|Overall Study|Withdrawal by Subject|0|||
105914832|NCT03473743|365346958|FG004|Overall Study|Withdrawal by Subject|0|||
105914833|NCT03473743|365346959|FG005|Overall Study|Withdrawal by Subject|0|||
105914834|NCT03473743|365346960|FG006|Overall Study|Withdrawal by Subject|0|||
105914835|NCT03473743|365346961|FG007|Overall Study|Withdrawal by Subject|3|||
105914836|NCT03473743|365346954|FG000|Overall Study|Other|0|||
105914837|NCT03473743|365346955|FG001|Overall Study|Other|0|||
105914838|NCT03473743|365346956|FG002|Overall Study|Other|0|||
105914839|NCT03473743|365346957|FG003|Overall Study|Other|1|||
105914840|NCT03473743|365346958|FG004|Overall Study|Other|0|||
105914841|NCT03473743|365346959|FG005|Overall Study|Other|0|||
105914842|NCT03473743|365346960|FG006|Overall Study|Other|0|||
105914843|NCT03473743|365346961|FG007|Overall Study|Other|0|||
105914844|NCT03473743|365346954|FG000|Overall Study|Ongoing|0|||
105914845|NCT03473743|365346955|FG001|Overall Study|Ongoing|0|||
105914846|NCT03473743|365346956|FG002|Overall Study|Ongoing|6|||
105914847|NCT03473743|365346957|FG003|Overall Study|Ongoing|8|||
105914848|NCT03473743|365346958|FG004|Overall Study|Ongoing|1|||
105914849|NCT03473743|365346959|FG005|Overall Study|Ongoing|1|||
105914850|NCT03473743|365346960|FG006|Overall Study|Ongoing|22|||
105914851|NCT03473743|365346961|FG007|Overall Study|Ongoing|24|||
105914852|NCT03473743|365346954|FG000|Overall Study|Randomized but not treated|0|||
105914853|NCT03473743|365346955|FG001|Overall Study|Randomized but not treated|0|||
105914854|NCT03473743|365346956|FG002|Overall Study|Randomized but not treated|0|||
105914855|NCT03473743|365346957|FG003|Overall Study|Randomized but not treated|0|||
105914856|NCT03473743|365346958|FG004|Overall Study|Randomized but not treated|0|||
105914857|NCT03473743|365346959|FG005|Overall Study|Randomized but not treated|0|||
105914858|NCT03473743|365346960|FG006|Overall Study|Randomized but not treated|1|||
105914859|NCT03473743|365346961|FG007|Overall Study|Randomized but not treated|1|||
105914860|NCT05214118|365346971|FG000|Overall Study|Lost to Follow-up|0|||
105914861|NCT05214118|365346972|FG001|Overall Study|Lost to Follow-up|2|||
105914862|NCT05214118|365346971|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
105678392|NCT01237587|364483511|FG001|Taper Phase|Adverse Event|2|||
105678393|NCT01237587|364483510|FG000|Taper Phase|Protocol Violation|2|||
105914863|NCT05214118|365346972|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
105914864|NCT05214118|365346971|FG000|Overall Study|moved|1|||
105914865|NCT05214118|365346972|FG001|Overall Study|moved|0|||
105914866|NCT03462719|365346973|FG000|Overall Study|Withdrawal by Subject|4|||
105914867|NCT03462719|365346974|FG001|Overall Study|Withdrawal by Subject|3|||
105914868|NCT03462719|365346973|FG000|Overall Study|Ongoing|87|||
105914869|NCT03462719|365346974|FG001|Overall Study|Ongoing|72|||
105914870|NCT02283658|365346977|FG000|Overall Study|Withdrawal by Subject|1|||
105914871|NCT03311945|365346978|FG000|Overall Study|Adverse Event|2|||
105914872|NCT03311945|365346978|FG000|Overall Study|Lack of Efficacy|1|||
105914873|NCT04414787|365346979|FG000|Overall Study|Patient Death|18|||
105914874|NCT04414787|365346980|FG001|Overall Study|Patient Death|18|||
105914875|NCT04414787|365346981|FG002|Overall Study|Patient Death|15|||
105914876|NCT04414787|365346982|FG003|Overall Study|Patient Death|15|||
105914877|NCT04414787|365346979|FG000|Overall Study|Patient Hospitalization|1|||
105914878|NCT04414787|365346980|FG001|Overall Study|Patient Hospitalization|1|||
105914879|NCT04414787|365346981|FG002|Overall Study|Patient Hospitalization|2|||
105914880|NCT04414787|365346982|FG003|Overall Study|Patient Hospitalization|2|||
105914881|NCT04414787|365346979|FG000|Overall Study|Lost to Follow-up|7|||
105914882|NCT04414787|365346980|FG001|Overall Study|Lost to Follow-up|7|||
105914883|NCT04414787|365346981|FG002|Overall Study|Lost to Follow-up|5|||
105914884|NCT04414787|365346982|FG003|Overall Study|Lost to Follow-up|5|||
105914885|NCT04414787|365346979|FG000|Overall Study|Residence in post-acute care facility|3|||
105914886|NCT04414787|365346980|FG001|Overall Study|Residence in post-acute care facility|3|||
105914887|NCT04414787|365346981|FG002|Overall Study|Residence in post-acute care facility|5|||
105914888|NCT04414787|365346982|FG003|Overall Study|Residence in post-acute care facility|5|||
105914889|NCT04821830|365346983|FG000|Overall Study|Withdrawal by Subject|1|||
105914890|NCT04821830|365346984|FG001|Overall Study|Withdrawal by Subject|0|||
105914891|NCT01526785|365346985|FG000|Overall Study|Study Terminated by Sponsor|8|||
105914892|NCT01526785|365346985|FG000|Overall Study|Death|2|||
105914893|NCT01526785|365346985|FG000|Overall Study|Physician Decision|1|||
105914894|NCT01526785|365346985|FG000|Overall Study|Withdrawal by Subject|2|||
105914895|NCT02059239|365348007|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
105914896|NCT02059239|365348008|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
105914897|NCT02059239|365348007|FG000|Overall Study|Physician Decision|1|||
105914898|NCT02059239|365348008|FG001|Overall Study|Physician Decision|0|||
105914899|NCT04176939|365348009|FG000|Overall Study|Withdrawal by Subject|5|||
105914900|NCT04176939|365348009|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
105914901|NCT04176939|365348009|FG000|Overall Study|Lost to Follow-up|2|||
105914902|NCT04176939|365348009|FG000|Overall Study|Unspecified reason|4|||
105914903|NCT04176939|365348009|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
105914904|NCT03225170|365348010|FG000|Overall Study|Lost to Follow-up|4|||
105914905|NCT03225170|365348011|FG001|Overall Study|Lost to Follow-up|4|||
105914906|NCT03225170|365348012|FG002|Overall Study|Lost to Follow-up|0|||
105914907|NCT03225170|365348010|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
105914908|NCT03225170|365348011|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
105914909|NCT03225170|365348012|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
105914910|NCT04003103|365348018|FG000|Overall Study|Death|1|||
105914911|NCT04003103|365348019|FG001|Overall Study|Death|0|||
105914912|NCT04003103|365348020|FG002|Overall Study|Death|0|||
105914913|NCT04003103|365348018|FG000|Overall Study|Lost to Follow-up|4|||
105914914|NCT04003103|365348019|FG001|Overall Study|Lost to Follow-up|3|||
105914915|NCT04003103|365348020|FG002|Overall Study|Lost to Follow-up|2|||
105914916|NCT04003103|365348018|FG000|Overall Study|Withdrawal by Subject|10|||
105914917|NCT04003103|365348019|FG001|Overall Study|Withdrawal by Subject|1|||
105914918|NCT04003103|365348020|FG002|Overall Study|Withdrawal by Subject|1|||
105914919|NCT04003103|365348018|FG000|Overall Study|Status not recorded|0|||
105914920|NCT04003103|365348019|FG001|Overall Study|Status not recorded|2|||
105914921|NCT04003103|365348020|FG002|Overall Study|Status not recorded|0|||
105914922|NCT03829462|365348021|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
105914923|NCT03829462|365348022|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
105914924|NCT03829462|365348021|FG000|Overall Study|No treatment due to progression disease|0|||
105914925|NCT03829462|365348022|FG001|Overall Study|No treatment due to progression disease|1|||
105914926|NCT05547386|365348028|FG000|Overall Study|Withdrawal by Subject|7|||
105914927|NCT03976375|365348029|FG000|Overall Study|Death|147|||
105914928|NCT03976375|365348030|FG001|Overall Study|Death|150|||
105914929|NCT03976375|365348031|FG002|Overall Study|Death|38|||
105914930|NCT03976375|365348029|FG000|Overall Study|Lost to Follow-up|1|||
105914931|NCT03976375|365348030|FG001|Overall Study|Lost to Follow-up|1|||
105914932|NCT03976375|365348031|FG002|Overall Study|Lost to Follow-up|1|||
105914933|NCT03976375|365348029|FG000|Overall Study|Withdrawal by Subject|4|||
105914934|NCT03976375|365348030|FG001|Overall Study|Withdrawal by Subject|9|||
105914935|NCT03976375|365348031|FG002|Overall Study|Withdrawal by Subject|4|||
105914936|NCT03976375|365348029|FG000|Overall Study|Ongoing|33|||
105914937|NCT03976375|365348030|FG001|Overall Study|Ongoing|29|||
105914938|NCT03976375|365348031|FG002|Overall Study|Ongoing|5|||
105914939|NCT05616013|365348032|FG000|Overall Study|Adverse Event|6|||
105914940|NCT05616013|365348033|FG001|Overall Study|Adverse Event|12|||
105914941|NCT05616013|365348034|FG002|Overall Study|Adverse Event|8|||
105914942|NCT05616013|365348035|FG003|Overall Study|Adverse Event|4|||
105914943|NCT05616013|365348036|FG004|Overall Study|Adverse Event|6|||
105914944|NCT05616013|365348037|FG005|Overall Study|Adverse Event|8|||
105914945|NCT05616013|365348038|FG006|Overall Study|Adverse Event|3|||
105914946|NCT05616013|365348039|FG007|Overall Study|Adverse Event|6|||
105914947|NCT05616013|365348040|FG008|Overall Study|Adverse Event|1|||
105914948|NCT05616013|365348032|FG000|Overall Study|Lost to Follow-up|5|||
105914949|NCT05616013|365348033|FG001|Overall Study|Lost to Follow-up|4|||
105914950|NCT05616013|365348034|FG002|Overall Study|Lost to Follow-up|3|||
105914951|NCT05616013|365348035|FG003|Overall Study|Lost to Follow-up|2|||
105914952|NCT05616013|365348036|FG004|Overall Study|Lost to Follow-up|0|||
105914953|NCT05616013|365348037|FG005|Overall Study|Lost to Follow-up|5|||
105914954|NCT05616013|365348038|FG006|Overall Study|Lost to Follow-up|2|||
105914955|NCT05616013|365348039|FG007|Overall Study|Lost to Follow-up|1|||
105914956|NCT05616013|365348040|FG008|Overall Study|Lost to Follow-up|2|||
105914957|NCT05616013|365348032|FG000|Overall Study|Non-compliance with study requirements|2|||
105914958|NCT05616013|365348033|FG001|Overall Study|Non-compliance with study requirements|2|||
105914959|NCT05616013|365348034|FG002|Overall Study|Non-compliance with study requirements|2|||
105914960|NCT05616013|365348035|FG003|Overall Study|Non-compliance with study requirements|3|||
105914961|NCT05616013|365348036|FG004|Overall Study|Non-compliance with study requirements|0|||
105914962|NCT05616013|365348037|FG005|Overall Study|Non-compliance with study requirements|2|||
105914963|NCT05616013|365348038|FG006|Overall Study|Non-compliance with study requirements|1|||
105914964|NCT05616013|365348039|FG007|Overall Study|Non-compliance with study requirements|1|||
105914965|NCT05616013|365348040|FG008|Overall Study|Non-compliance with study requirements|4|||
105914966|NCT05616013|365348032|FG000|Overall Study|Withdrawal by Subject|11|||
105914967|NCT05616013|365348033|FG001|Overall Study|Withdrawal by Subject|9|||
105914968|NCT05616013|365348034|FG002|Overall Study|Withdrawal by Subject|8|||
105914969|NCT05616013|365348035|FG003|Overall Study|Withdrawal by Subject|6|||
105914970|NCT05616013|365348036|FG004|Overall Study|Withdrawal by Subject|3|||
105914971|NCT05616013|365348037|FG005|Overall Study|Withdrawal by Subject|4|||
105914972|NCT05616013|365348038|FG006|Overall Study|Withdrawal by Subject|6|||
105914973|NCT05616013|365348039|FG007|Overall Study|Withdrawal by Subject|5|||
105914974|NCT05616013|365348040|FG008|Overall Study|Withdrawal by Subject|4|||
105914975|NCT05616013|365348032|FG000|Overall Study|Physician Decision|0|||
105914976|NCT05616013|365348033|FG001|Overall Study|Physician Decision|0|||
105914977|NCT05616013|365348034|FG002|Overall Study|Physician Decision|1|||
105914978|NCT05616013|365348035|FG003|Overall Study|Physician Decision|0|||
105914979|NCT05616013|365348036|FG004|Overall Study|Physician Decision|0|||
105678394|NCT01237587|364483511|FG001|Taper Phase|Protocol Violation|0|||
105678395|NCT01237587|364483510|FG000|Taper Phase|Lack of Efficacy|2|||
105678396|NCT01237587|364483511|FG001|Taper Phase|Lack of Efficacy|5|||
105678397|NCT01237587|364483510|FG000|Taper Phase|Parent/Guardian Decision|0|||
105914980|NCT05616013|365348037|FG005|Overall Study|Physician Decision|1|||
105914981|NCT05616013|365348038|FG006|Overall Study|Physician Decision|3|||
105914982|NCT05616013|365348039|FG007|Overall Study|Physician Decision|0|||
105914983|NCT05616013|365348040|FG008|Overall Study|Physician Decision|0|||
105914984|NCT05616013|365348032|FG000|Overall Study|Protocol Violation|0|||
105914985|NCT05616013|365348033|FG001|Overall Study|Protocol Violation|0|||
105914986|NCT05616013|365348034|FG002|Overall Study|Protocol Violation|0|||
105914987|NCT05616013|365348035|FG003|Overall Study|Protocol Violation|0|||
105914988|NCT05616013|365348036|FG004|Overall Study|Protocol Violation|0|||
105914989|NCT05616013|365348037|FG005|Overall Study|Protocol Violation|0|||
105914990|NCT05616013|365348038|FG006|Overall Study|Protocol Violation|1|||
105914991|NCT05616013|365348039|FG007|Overall Study|Protocol Violation|0|||
105914992|NCT05616013|365348040|FG008|Overall Study|Protocol Violation|2|||
105914993|NCT05616013|365348032|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
106125710|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Changed Mind|0|||
106125711|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
106125712|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
106125713|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
106125714|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
106125715|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
106125716|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
106125717|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
106125718|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
106125719|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Other Medical|9|||
106125720|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Other Medical|5|||
106125721|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Disease Progression|4|||
106125722|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Disease Progression|2|||
105914994|NCT05616013|365348033|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
105914995|NCT05616013|365348034|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
105914996|NCT05616013|365348035|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
106125723|NCT02107443|366117887|FG000|Overall Study|Withdrawal: Personal Issues|0|||
106125724|NCT02107443|366117888|FG001|Overall Study|Withdrawal: Personal Issues|3|||
106125725|NCT02285595|366117893|FG000|Overall Study|Lost to Follow-up|14|||
106125726|NCT02285595|366117893|FG000|Overall Study|Withdrawal by Subject|1|||
106125727|NCT01987830|366117894|FG000|Overall Study|Never received baseline scan|1|||
106125728|NCT03990363|366117895|FG000|Overall Study|Withdrawal by Subject|10|||
106125729|NCT03990363|366117896|FG001|Overall Study|Withdrawal by Subject|9|||
106125730|NCT03990363|366117897|FG002|Overall Study|Withdrawal by Subject|18|||
106125731|NCT03990363|366117898|FG003|Overall Study|Withdrawal by Subject|11|||
106125732|NCT03990363|366117899|FG004|Overall Study|Withdrawal by Subject|9|||
106125733|NCT03990363|366117895|FG000|Overall Study|Physician Decision|1|||
105678398|NCT01237587|364483511|FG001|Taper Phase|Parent/Guardian Decision|2|||
106000153|NCT02252146|365663292|FG000|Overall Study|Entered hospice care|1|||
106000154|NCT02252146|365663292|FG000|Overall Study|Inability to travel to study site|1|||
106000155|NCT00404651|365663293|FG000|Overall Study|Serious Adverse Event|0|||
106000156|NCT00404651|365663294|FG001|Overall Study|Serious Adverse Event|0|||
106000157|NCT00404651|365663295|FG002|Overall Study|Serious Adverse Event|2|||
106000158|NCT00404651|365663296|FG003|Overall Study|Serious Adverse Event|0|||
106000159|NCT00404651|365663293|FG000|Overall Study|Protocol Violation|10|||
106000160|NCT00404651|365663294|FG001|Overall Study|Protocol Violation|5|||
106000161|NCT00404651|365663295|FG002|Overall Study|Protocol Violation|14|||
106000162|NCT00404651|365663296|FG003|Overall Study|Protocol Violation|5|||
106000163|NCT00404651|365663293|FG000|Overall Study|Lost to Follow-up|15|||
106000164|NCT00404651|365663294|FG001|Overall Study|Lost to Follow-up|11|||
106000165|NCT00404651|365663295|FG002|Overall Study|Lost to Follow-up|13|||
106000166|NCT00404651|365663296|FG003|Overall Study|Lost to Follow-up|10|||
106000167|NCT00404651|365663293|FG000|Overall Study|Withdrawal by Subject|14|||
106000168|NCT00404651|365663294|FG001|Overall Study|Withdrawal by Subject|12|||
106000169|NCT00404651|365663295|FG002|Overall Study|Withdrawal by Subject|16|||
106000170|NCT00404651|365663296|FG003|Overall Study|Withdrawal by Subject|6|||
106000171|NCT01132807|365663297|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
106000172|NCT01132807|365663298|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
106000173|NCT01132807|365663299|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
106000174|NCT01132807|365663297|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
106000175|NCT01132807|365663298|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
106000176|NCT01132807|365663299|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
106000177|NCT04073186|365663300|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
106000178|NCT04073186|365663300|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
106000179|NCT04073186|365663300|FG000|First Wearing Cycle|Protocol Violation|1|||
106000180|NCT04073186|365663300|FG000|First Wearing Cycle|Lens Discomfort|2|||
106000181|NCT04073186|365663300|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
106000182|NCT04073186|365663300|FG000|Second Wearing Cycle|Adverse Event|1|||
106000183|NCT03001557|365663301|FG000|Core Phase|Randomized but not treated|0|||
106000184|NCT03001557|365663302|FG001|Core Phase|Randomized but not treated|0|||
106000185|NCT03001557|365663303|FG002|Core Phase|Randomized but not treated|1|||
106000186|NCT03001557|365663304|FG003|Core Phase|Randomized but not treated|0|||
106000187|NCT03001557|365663305|FG004|Core Phase|Randomized but not treated|0|||
106000188|NCT03001557|365663306|FG005|Core Phase|Randomized but not treated|0|||
106000189|NCT03001557|365663307|FG006|Core Phase|Randomized but not treated|0|||
106000190|NCT03001557|365663308|FG007|Core Phase|Randomized but not treated|0|||
106000191|NCT03001557|365663301|FG000|Extension Phase|Adverse Event|0|||
106000192|NCT03001557|365663302|FG001|Extension Phase|Adverse Event|0|||
106000193|NCT03001557|365663303|FG002|Extension Phase|Adverse Event|0|||
106000194|NCT03001557|365663304|FG003|Extension Phase|Adverse Event|0|||
106000195|NCT03001557|365663305|FG004|Extension Phase|Adverse Event|0|||
106000196|NCT03001557|365663306|FG005|Extension Phase|Adverse Event|2|||
106000197|NCT03001557|365663307|FG006|Extension Phase|Adverse Event|0|||
106000198|NCT03001557|365663308|FG007|Extension Phase|Adverse Event|0|||
106000199|NCT03001557|365663301|FG000|Extension Phase|Withdrawal by Subject|0|||
106000200|NCT03001557|365663302|FG001|Extension Phase|Withdrawal by Subject|0|||
106000201|NCT03001557|365663303|FG002|Extension Phase|Withdrawal by Subject|0|||
106000202|NCT03001557|365663304|FG003|Extension Phase|Withdrawal by Subject|0|||
106000203|NCT03001557|365663305|FG004|Extension Phase|Withdrawal by Subject|0|||
106000204|NCT03001557|365663306|FG005|Extension Phase|Withdrawal by Subject|1|||
106000205|NCT03001557|365663307|FG006|Extension Phase|Withdrawal by Subject|5|||
106000206|NCT03001557|365663308|FG007|Extension Phase|Withdrawal by Subject|2|||
106000207|NCT03001557|365663301|FG000|Extension Phase|Lost to Follow-up|0|||
106000208|NCT03001557|365663302|FG001|Extension Phase|Lost to Follow-up|0|||
106000209|NCT03001557|365663303|FG002|Extension Phase|Lost to Follow-up|0|||
106000210|NCT03001557|365663304|FG003|Extension Phase|Lost to Follow-up|0|||
106000211|NCT03001557|365663305|FG004|Extension Phase|Lost to Follow-up|0|||
106000212|NCT03001557|365663306|FG005|Extension Phase|Lost to Follow-up|0|||
106000213|NCT03001557|365663307|FG006|Extension Phase|Lost to Follow-up|2|||
106000214|NCT03001557|365663308|FG007|Extension Phase|Lost to Follow-up|1|||
106000215|NCT03001557|365663301|FG000|Extension Phase|Administrative Reason|0|||
106000216|NCT03001557|365663302|FG001|Extension Phase|Administrative Reason|0|||
106000217|NCT03001557|365663303|FG002|Extension Phase|Administrative Reason|0|||
106000218|NCT03001557|365663304|FG003|Extension Phase|Administrative Reason|0|||
106000219|NCT03001557|365663305|FG004|Extension Phase|Administrative Reason|0|||
106000220|NCT03001557|365663306|FG005|Extension Phase|Administrative Reason|1|||
106000221|NCT03001557|365663307|FG006|Extension Phase|Administrative Reason|3|||
106000222|NCT03001557|365663308|FG007|Extension Phase|Administrative Reason|3|||
106000223|NCT03001557|365663301|FG000|Extension Phase|Loss of caregiver|0|||
106000224|NCT03001557|365663302|FG001|Extension Phase|Loss of caregiver|0|||
106000225|NCT03001557|365663303|FG002|Extension Phase|Loss of caregiver|0|||
106125734|NCT03990363|366117896|FG001|Overall Study|Physician Decision|0|||
106125735|NCT03990363|366117897|FG002|Overall Study|Physician Decision|0|||
106125736|NCT03990363|366117898|FG003|Overall Study|Physician Decision|0|||
106125737|NCT03990363|366117899|FG004|Overall Study|Physician Decision|0|||
106125738|NCT03990363|366117895|FG000|Overall Study|Adverse Event|1|||
106125739|NCT03990363|366117896|FG001|Overall Study|Adverse Event|3|||
106125740|NCT03990363|366117897|FG002|Overall Study|Adverse Event|2|||
106125741|NCT03990363|366117898|FG003|Overall Study|Adverse Event|2|||
106125742|NCT03990363|366117899|FG004|Overall Study|Adverse Event|0|||
106125743|NCT03990363|366117895|FG000|Overall Study|Death|14|||
106125744|NCT03990363|366117896|FG001|Overall Study|Death|8|||
106125745|NCT03990363|366117897|FG002|Overall Study|Death|14|||
106125746|NCT03990363|366117898|FG003|Overall Study|Death|10|||
106125747|NCT03990363|366117899|FG004|Overall Study|Death|11|||
106125748|NCT03990363|366117895|FG000|Overall Study|Failure to meet randomization criteria|0|||
106125749|NCT03990363|366117896|FG001|Overall Study|Failure to meet randomization criteria|1|||
106125750|NCT03990363|366117897|FG002|Overall Study|Failure to meet randomization criteria|1|||
106125751|NCT03990363|366117898|FG003|Overall Study|Failure to meet randomization criteria|0|||
106125752|NCT03990363|366117899|FG004|Overall Study|Failure to meet randomization criteria|0|||
106125753|NCT03990363|366117895|FG000|Overall Study|Lost to Follow-up|0|||
106125754|NCT03990363|366117896|FG001|Overall Study|Lost to Follow-up|0|||
106125755|NCT03990363|366117897|FG002|Overall Study|Lost to Follow-up|0|||
106125756|NCT03990363|366117898|FG003|Overall Study|Lost to Follow-up|1|||
106125757|NCT03990363|366117899|FG004|Overall Study|Lost to Follow-up|2|||
105914997|NCT05616013|365348036|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
105914998|NCT05616013|365348037|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
105914999|NCT05616013|365348038|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
105915000|NCT05616013|365348039|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
105915001|NCT05616013|365348040|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
105915002|NCT05616013|365348032|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
105915003|NCT05616013|365348033|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105915004|NCT05616013|365348034|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
106125758|NCT03990363|366117895|FG000|Overall Study|Non-compliance with study drug|2|||
106125759|NCT03990363|366117896|FG001|Overall Study|Non-compliance with study drug|1|||
105915005|NCT05616013|365348035|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105915006|NCT05616013|365348036|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105915007|NCT05616013|365348037|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
106000226|NCT03001557|365663304|FG003|Extension Phase|Loss of caregiver|0|||
106125760|NCT03990363|366117897|FG002|Overall Study|Non-compliance with study drug|2|||
106125761|NCT03990363|366117898|FG003|Overall Study|Non-compliance with study drug|0|||
106125762|NCT03990363|366117899|FG004|Overall Study|Non-compliance with study drug|0|||
106125763|NCT03990363|366117895|FG000|Overall Study|Study terminated by sponsor|0|||
106125764|NCT03990363|366117896|FG001|Overall Study|Study terminated by sponsor|1|||
106125765|NCT03990363|366117897|FG002|Overall Study|Study terminated by sponsor|0|||
106125766|NCT03990363|366117898|FG003|Overall Study|Study terminated by sponsor|0|||
106125767|NCT03990363|366117899|FG004|Overall Study|Study terminated by sponsor|0|||
106125768|NCT03990363|366117895|FG000|Overall Study|Site terminated by sponsor|2|||
105678399|NCT01237587|364483510|FG000|Taper Phase|Sponsor Decision|1|||
105678400|NCT01237587|364483511|FG001|Taper Phase|Sponsor Decision|0|||
106000227|NCT03001557|365663305|FG004|Extension Phase|Loss of caregiver|0|||
106000228|NCT03001557|365663306|FG005|Extension Phase|Loss of caregiver|0|||
106000229|NCT03001557|365663307|FG006|Extension Phase|Loss of caregiver|1|||
106000230|NCT03001557|365663308|FG007|Extension Phase|Loss of caregiver|0|||
106000231|NCT03001557|365663301|FG000|Extension Phase|Others|0|||
106000232|NCT03001557|365663302|FG001|Extension Phase|Others|0|||
106000233|NCT03001557|365663303|FG002|Extension Phase|Others|0|||
106000234|NCT03001557|365663304|FG003|Extension Phase|Others|0|||
106000235|NCT03001557|365663305|FG004|Extension Phase|Others|0|||
106000236|NCT03001557|365663306|FG005|Extension Phase|Others|1|||
106000237|NCT03001557|365663307|FG006|Extension Phase|Others|3|||
106125769|NCT03990363|366117896|FG001|Overall Study|Site terminated by sponsor|1|||
106125770|NCT03990363|366117897|FG002|Overall Study|Site terminated by sponsor|2|||
106125771|NCT03990363|366117898|FG003|Overall Study|Site terminated by sponsor|0|||
106125772|NCT03990363|366117899|FG004|Overall Study|Site terminated by sponsor|2|||
106125773|NCT03990363|366117895|FG000|Overall Study|Not categorized|5|||
106125774|NCT03990363|366117896|FG001|Overall Study|Not categorized|5|||
105678401|NCT01237587|364483510|FG000|Taper Phase|Withdrawal by Subject|0|||
105678402|NCT01237587|364483511|FG001|Taper Phase|Withdrawal by Subject|1|||
106000238|NCT03001557|365663308|FG007|Extension Phase|Others|0|||
106000239|NCT04033367|365663309|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
106000240|NCT04033367|365663310|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
106000241|NCT04033367|365663309|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
106125775|NCT03990363|366117897|FG002|Overall Study|Not categorized|3|||
106125776|NCT03990363|366117898|FG003|Overall Study|Not categorized|2|||
106125777|NCT03990363|366117899|FG004|Overall Study|Not categorized|2|||
105678403|NCT02549196|364483512|FG000|Overall Study|Protocol Violation|0|||
105678404|NCT02549196|364483513|FG001|Overall Study|Protocol Violation|0|||
105678405|NCT02549196|364483514|FG002|Overall Study|Protocol Violation|0|||
105678406|NCT02549196|364483515|FG003|Overall Study|Protocol Violation|1|||
105678407|NCT02549196|364483512|FG000|Overall Study|Withdrawal by Subject|1|||
105678408|NCT02549196|364483513|FG001|Overall Study|Withdrawal by Subject|0|||
105678409|NCT02549196|364483514|FG002|Overall Study|Withdrawal by Subject|1|||
105678410|NCT02549196|364483515|FG003|Overall Study|Withdrawal by Subject|0|||
105678411|NCT00196976|364483518|FG000|Primary Study|Migrated from study area|0|||
105678412|NCT00196976|364483519|FG001|Primary Study|Migrated from study area|0|||
105678413|NCT00196976|364483520|FG002|Primary Study|Migrated from study area|0|||
105678414|NCT00196976|364483521|FG003|Primary Study|Migrated from study area|0|||
105678415|NCT00196976|364483522|FG004|Primary Study|Migrated from study area|0|||
105678416|NCT00196976|364483523|FG005|Primary Study|Migrated from study area|0|||
105678417|NCT00196976|364483524|FG006|Primary Study|Migrated from study area|0|||
105678418|NCT00196976|364483525|FG007|Primary Study|Migrated from study area|1|||
105678419|NCT00196976|364483526|FG008|Primary Study|Migrated from study area|0|||
105678420|NCT00196976|364483527|FG009|Primary Study|Migrated from study area|0|||
105678421|NCT00196976|364483528|FG010|Primary Study|Migrated from study area|0|||
105678422|NCT00196976|364483529|FG011|Primary Study|Migrated from study area|0|||
105678423|NCT00196976|364483530|FG012|Primary Study|Migrated from study area|0|||
105678424|NCT00196976|364483531|FG013|Primary Study|Migrated from study area|0|||
105678425|NCT00196976|364483518|FG000|Primary Study|Protocol Violation|0|||
105678426|NCT00196976|364483519|FG001|Primary Study|Protocol Violation|1|||
105678427|NCT00196976|364483520|FG002|Primary Study|Protocol Violation|1|||
105678428|NCT00196976|364483521|FG003|Primary Study|Protocol Violation|0|||
105678429|NCT00196976|364483522|FG004|Primary Study|Protocol Violation|0|||
105915008|NCT05616013|365348038|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105915009|NCT05616013|365348039|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105915010|NCT05616013|365348040|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
105915011|NCT05616013|365348032|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
105915012|NCT05616013|365348033|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105915013|NCT05616013|365348034|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105915014|NCT05616013|365348035|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105915015|NCT05616013|365348036|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105915016|NCT05616013|365348037|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105915017|NCT05616013|365348038|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105915018|NCT05616013|365348039|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105915019|NCT05616013|365348040|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
105915020|NCT05616013|365348032|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105915021|NCT05616013|365348033|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
105915022|NCT05616013|365348034|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105915023|NCT05616013|365348035|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105915024|NCT05616013|365348036|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105915025|NCT05616013|365348037|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105915026|NCT05616013|365348038|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105915027|NCT05616013|365348039|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105915028|NCT05616013|365348040|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
105915029|NCT05616013|365348032|FG000|Overall Study|Participant Decision, Time Constraints|0|||
105915030|NCT05616013|365348033|FG001|Overall Study|Participant Decision, Time Constraints|1|||
105915031|NCT05616013|365348034|FG002|Overall Study|Participant Decision, Time Constraints|0|||
105915032|NCT05616013|365348035|FG003|Overall Study|Participant Decision, Time Constraints|0|||
105915033|NCT05616013|365348036|FG004|Overall Study|Participant Decision, Time Constraints|0|||
105915034|NCT05616013|365348037|FG005|Overall Study|Participant Decision, Time Constraints|0|||
105915035|NCT05616013|365348038|FG006|Overall Study|Participant Decision, Time Constraints|0|||
105915036|NCT05616013|365348039|FG007|Overall Study|Participant Decision, Time Constraints|0|||
105915037|NCT05616013|365348040|FG008|Overall Study|Participant Decision, Time Constraints|0|||
105915038|NCT05616013|365348032|FG000|Overall Study|Prohibited Concomitant Medication|0|||
105915039|NCT05616013|365348033|FG001|Overall Study|Prohibited Concomitant Medication|0|||
106000242|NCT04033367|365663310|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
105678430|NCT00196976|364483523|FG005|Primary Study|Protocol Violation|0|||
105678431|NCT00196976|364483524|FG006|Primary Study|Protocol Violation|0|||
105678432|NCT00196976|364483525|FG007|Primary Study|Protocol Violation|0|||
105678433|NCT00196976|364483526|FG008|Primary Study|Protocol Violation|0|||
105678434|NCT00196976|364483527|FG009|Primary Study|Protocol Violation|0|||
105678435|NCT00196976|364483528|FG010|Primary Study|Protocol Violation|0|||
105678436|NCT00196976|364483529|FG011|Primary Study|Protocol Violation|0|||
105678437|NCT00196976|364483530|FG012|Primary Study|Protocol Violation|0|||
105678438|NCT00196976|364483531|FG013|Primary Study|Protocol Violation|0|||
105678439|NCT00196976|364483518|FG000|Primary Study|Withdrawal by Subject|1|||
105678440|NCT00196976|364483519|FG001|Primary Study|Withdrawal by Subject|0|||
105678441|NCT00196976|364483520|FG002|Primary Study|Withdrawal by Subject|1|||
105678442|NCT00196976|364483521|FG003|Primary Study|Withdrawal by Subject|1|||
105678443|NCT00196976|364483522|FG004|Primary Study|Withdrawal by Subject|2|||
105678444|NCT00196976|364483523|FG005|Primary Study|Withdrawal by Subject|1|||
105678445|NCT00196976|364483524|FG006|Primary Study|Withdrawal by Subject|0|||
105678446|NCT00196976|364483525|FG007|Primary Study|Withdrawal by Subject|0|||
105678447|NCT00196976|364483526|FG008|Primary Study|Withdrawal by Subject|0|||
105678448|NCT00196976|364483527|FG009|Primary Study|Withdrawal by Subject|1|||
105678449|NCT00196976|364483528|FG010|Primary Study|Withdrawal by Subject|0|||
105678450|NCT00196976|364483529|FG011|Primary Study|Withdrawal by Subject|0|||
105678451|NCT00196976|364483530|FG012|Primary Study|Withdrawal by Subject|0|||
105678452|NCT00196976|364483531|FG013|Primary Study|Withdrawal by Subject|0|||
105678453|NCT00196976|364483518|FG000|Primary Study|Lost to Follow-up|0|||
105678454|NCT00196976|364483519|FG001|Primary Study|Lost to Follow-up|0|||
105678455|NCT00196976|364483520|FG002|Primary Study|Lost to Follow-up|0|||
105678456|NCT00196976|364483521|FG003|Primary Study|Lost to Follow-up|0|||
106125778|NCT01349660|366117903|FG000|Overall Study|Still Receiving Study Treatment|0|||
106125779|NCT01349660|366117904|FG001|Overall Study|Still Receiving Study Treatment|0|||
106125780|NCT01349660|366117905|FG002|Overall Study|Still Receiving Study Treatment|1|||
106125781|NCT01349660|366117903|FG000|Overall Study|Disease Progression|2|||
106125782|NCT01349660|366117904|FG001|Overall Study|Disease Progression|4|||
106125783|NCT01349660|366117905|FG002|Overall Study|Disease Progression|50|||
106125784|NCT01349660|366117903|FG000|Overall Study|Adverse Event|1|||
106125785|NCT01349660|366117904|FG001|Overall Study|Adverse Event|1|||
106125786|NCT01349660|366117905|FG002|Overall Study|Adverse Event|12|||
106125787|NCT01349660|366117903|FG000|Overall Study|Withdrawal by Subject|2|||
106125788|NCT01349660|366117904|FG001|Overall Study|Withdrawal by Subject|0|||
106125789|NCT01349660|366117905|FG002|Overall Study|Withdrawal by Subject|9|||
105678457|NCT00196976|364483522|FG004|Primary Study|Lost to Follow-up|1|||
105678458|NCT00196976|364483523|FG005|Primary Study|Lost to Follow-up|1|||
105678459|NCT00196976|364483524|FG006|Primary Study|Lost to Follow-up|0|||
105678460|NCT00196976|364483525|FG007|Primary Study|Lost to Follow-up|2|||
105678461|NCT00196976|364483526|FG008|Primary Study|Lost to Follow-up|0|||
105678462|NCT00196976|364483527|FG009|Primary Study|Lost to Follow-up|0|||
105678463|NCT00196976|364483528|FG010|Primary Study|Lost to Follow-up|0|||
105678464|NCT00196976|364483529|FG011|Primary Study|Lost to Follow-up|0|||
105678465|NCT00196976|364483530|FG012|Primary Study|Lost to Follow-up|0|||
106125790|NCT01349660|366117903|FG000|Overall Study|Death|1|||
106125791|NCT01349660|366117904|FG001|Overall Study|Death|1|||
106125792|NCT01349660|366117905|FG002|Overall Study|Death|0|||
106125793|NCT01349660|366117903|FG000|Overall Study|Non-Permitted Interventions|0|||
106125794|NCT01349660|366117904|FG001|Overall Study|Non-Permitted Interventions|0|||
106125795|NCT01349660|366117905|FG002|Overall Study|Non-Permitted Interventions|2|||
106125796|NCT01349660|366117903|FG000|Overall Study|Study Compliance|0|||
106125797|NCT01349660|366117904|FG001|Overall Study|Study Compliance|0|||
106125798|NCT01349660|366117905|FG002|Overall Study|Study Compliance|1|||
106125799|NCT01349660|366117903|FG000|Overall Study|Declining Performance Status|0|||
106125800|NCT01349660|366117904|FG001|Overall Study|Declining Performance Status|0|||
106125801|NCT01349660|366117905|FG002|Overall Study|Declining Performance Status|1|||
106125802|NCT05764239|366117907|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
106125803|NCT05764239|366117907|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
106125804|NCT05764239|366117907|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
106125805|NCT05764239|366117907|FG000|DEP (Part 1)|Adverse Event|1|||
106125806|NCT05764239|366117907|FG000|DEP (Part 1)|Lost to Follow-up|1|||
106125807|NCT05764239|366117907|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
105678466|NCT00196976|364483531|FG013|Primary Study|Lost to Follow-up|0|||
105678467|NCT00196976|364483518|FG000|Primary Study|Other|0|||
105678468|NCT00196976|364483519|FG001|Primary Study|Other|0|||
105678469|NCT00196976|364483520|FG002|Primary Study|Other|2|||
105678470|NCT00196976|364483521|FG003|Primary Study|Other|0|||
105678471|NCT00196976|364483522|FG004|Primary Study|Other|0|||
105678472|NCT00196976|364483523|FG005|Primary Study|Other|0|||
105678473|NCT00196976|364483524|FG006|Primary Study|Other|0|||
105678474|NCT00196976|364483525|FG007|Primary Study|Other|0|||
105678475|NCT00196976|364483526|FG008|Primary Study|Other|0|||
105678476|NCT00196976|364483527|FG009|Primary Study|Other|0|||
105678477|NCT00196976|364483528|FG010|Primary Study|Other|0|||
105678478|NCT00196976|364483529|FG011|Primary Study|Other|0|||
106125808|NCT05764239|366117907|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
106125809|NCT05764239|366117907|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
106125810|NCT05764239|366117907|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
106125811|NCT00057811|366117908|FG000|Overall Study|Lack of Efficacy|1|||
106125812|NCT00057811|366117909|FG001|Overall Study|Lack of Efficacy|4|||
106125813|NCT00057811|366117908|FG000|Overall Study|Physician Decision|1|||
106125814|NCT00057811|366117909|FG001|Overall Study|Physician Decision|0|||
106125815|NCT00057811|366117908|FG000|Overall Study|Withdrawal by Subject|3|||
106125816|NCT00057811|366117909|FG001|Overall Study|Withdrawal by Subject|4|||
106125817|NCT00057811|366117908|FG000|Overall Study|Ineligible|4|||
106125818|NCT00057811|366117909|FG001|Overall Study|Ineligible|2|||
106125819|NCT00057811|366117908|FG000|Overall Study|Inevaluable|1|||
106125820|NCT00057811|366117909|FG001|Overall Study|Inevaluable|2|||
106125821|NCT00663962|366117912|FG000|Overall Study|somnolence|1|||
106125822|NCT00663962|366117913|FG001|Overall Study|somnolence|0|||
106125823|NCT02218489|366117914|FG000|Overall Study|Withdrawal by Subject|4|||
106125824|NCT02218489|366117915|FG001|Overall Study|Withdrawal by Subject|3|||
106125825|NCT02218489|366117914|FG000|Overall Study|Lost to Follow-up|1|||
106125826|NCT02218489|366117915|FG001|Overall Study|Lost to Follow-up|0|||
106125827|NCT02102464|366117916|FG000|Randomized Study|Withdrawal by Subject|0|||
106125828|NCT02102464|366117917|FG001|Randomized Study|Withdrawal by Subject|1|||
106125829|NCT02102464|366117918|FG002|Randomized Study|Withdrawal by Subject|0|||
106125830|NCT02846558|366117922|FG000|Overall Study|Adverse Event|1|||
106125831|NCT02846558|366117923|FG001|Overall Study|Adverse Event|0|||
106125832|NCT02846558|366117924|FG002|Overall Study|Adverse Event|0|||
106125833|NCT02846558|366117925|FG003|Overall Study|Adverse Event|0|||
106125834|NCT02846558|366117922|FG000|Overall Study|Withdrawal by Subject|5|||
105915040|NCT05616013|365348034|FG002|Overall Study|Prohibited Concomitant Medication|1|||
105915041|NCT05616013|365348035|FG003|Overall Study|Prohibited Concomitant Medication|0|||
105915042|NCT05616013|365348036|FG004|Overall Study|Prohibited Concomitant Medication|0|||
105915043|NCT05616013|365348037|FG005|Overall Study|Prohibited Concomitant Medication|0|||
105915044|NCT05616013|365348038|FG006|Overall Study|Prohibited Concomitant Medication|0|||
105915045|NCT05616013|365348039|FG007|Overall Study|Prohibited Concomitant Medication|0|||
105915046|NCT05616013|365348040|FG008|Overall Study|Prohibited Concomitant Medication|0|||
105915047|NCT05616013|365348032|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
105915048|NCT05616013|365348033|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
105915049|NCT05616013|365348034|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
105915050|NCT05616013|365348035|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
105915051|NCT05616013|365348036|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
105915052|NCT05616013|365348037|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
105915053|NCT05616013|365348038|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
105915054|NCT05616013|365348039|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
105915055|NCT05616013|365348040|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
105915056|NCT05616013|365348032|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105915057|NCT05616013|365348033|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105915058|NCT05616013|365348034|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105915059|NCT05616013|365348035|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
105915060|NCT05616013|365348036|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105915061|NCT05616013|365348037|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105915062|NCT05616013|365348038|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105915063|NCT05616013|365348039|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105915064|NCT05616013|365348040|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
105915065|NCT05616013|365348032|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105915066|NCT05616013|365348033|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105915067|NCT05616013|365348034|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105915068|NCT05616013|365348035|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105915069|NCT05616013|365348036|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105915070|NCT05616013|365348037|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105915071|NCT05616013|365348038|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
105915072|NCT05616013|365348039|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105915073|NCT05616013|365348040|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
105915074|NCT05616013|365348032|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105915075|NCT05616013|365348033|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105915076|NCT05616013|365348034|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105915077|NCT05616013|365348035|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
106000243|NCT04033367|365663309|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
106000244|NCT04033367|365663310|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
106125835|NCT02846558|366117923|FG001|Overall Study|Withdrawal by Subject|4|||
106125836|NCT02846558|366117924|FG002|Overall Study|Withdrawal by Subject|2|||
106125837|NCT02846558|366117925|FG003|Overall Study|Withdrawal by Subject|2|||
105678479|NCT00196976|364483530|FG012|Primary Study|Other|0|||
105678480|NCT00196976|364483531|FG013|Primary Study|Other|0|||
106125838|NCT02846558|366117922|FG000|Overall Study|Lost to Follow-up|2|||
106125839|NCT02846558|366117923|FG001|Overall Study|Lost to Follow-up|0|||
106125840|NCT02846558|366117924|FG002|Overall Study|Lost to Follow-up|0|||
106125841|NCT02846558|366117925|FG003|Overall Study|Lost to Follow-up|0|||
106125842|NCT01040780|366119834|FG000|Overall Study|Protocol Violation|1|||
106125843|NCT01040780|366119835|FG001|Overall Study|Protocol Violation|3|||
106125844|NCT03681639|366119836|FG000|Overall Study|Death|4|||
106125845|NCT03681639|366119836|FG000|Overall Study|Lost to Follow-up|2|||
106125846|NCT03681639|366119836|FG000|Overall Study|Withdrawal by Subject|1|||
106125847|NCT03681639|366119836|FG000|Overall Study|Adverse Event|2|||
106125848|NCT00654940|366119837|FG000|Period 1|Adverse Event|0|||
106125849|NCT00654940|366119838|FG001|Period 1|Adverse Event|1|||
106125850|NCT00654940|366119837|FG000|Period 1|Intolerable Pain Level|1|||
105678481|NCT00196976|364483518|FG000|Booster Study|Withdrawal by Subject|0|||
105678482|NCT00196976|364483519|FG001|Booster Study|Withdrawal by Subject|0|||
105678483|NCT00196976|364483520|FG002|Booster Study|Withdrawal by Subject|0|||
105678484|NCT00196976|364483521|FG003|Booster Study|Withdrawal by Subject|0|||
105678485|NCT00196976|364483522|FG004|Booster Study|Withdrawal by Subject|0|||
105678486|NCT00196976|364483523|FG005|Booster Study|Withdrawal by Subject|0|||
105678487|NCT00196976|364483524|FG006|Booster Study|Withdrawal by Subject|0|||
105678488|NCT00196976|364483525|FG007|Booster Study|Withdrawal by Subject|0|||
105678489|NCT00196976|364483526|FG008|Booster Study|Withdrawal by Subject|0|||
105678490|NCT00196976|364483527|FG009|Booster Study|Withdrawal by Subject|0|||
105678491|NCT00196976|364483528|FG010|Booster Study|Withdrawal by Subject|1|||
105678492|NCT00196976|364483529|FG011|Booster Study|Withdrawal by Subject|0|||
105678493|NCT00196976|364483530|FG012|Booster Study|Withdrawal by Subject|0|||
105678494|NCT00196976|364483531|FG013|Booster Study|Withdrawal by Subject|0|||
105678495|NCT00196976|364483518|FG000|Booster Study|Lost to Follow-up|0|||
105678496|NCT00196976|364483519|FG001|Booster Study|Lost to Follow-up|0|||
105678497|NCT00196976|364483520|FG002|Booster Study|Lost to Follow-up|0|||
105678498|NCT00196976|364483521|FG003|Booster Study|Lost to Follow-up|0|||
105678499|NCT00196976|364483522|FG004|Booster Study|Lost to Follow-up|0|||
105678500|NCT00196976|364483523|FG005|Booster Study|Lost to Follow-up|0|||
105678501|NCT00196976|364483524|FG006|Booster Study|Lost to Follow-up|0|||
105678502|NCT00196976|364483525|FG007|Booster Study|Lost to Follow-up|0|||
105678503|NCT00196976|364483526|FG008|Booster Study|Lost to Follow-up|0|||
105678504|NCT00196976|364483527|FG009|Booster Study|Lost to Follow-up|0|||
105678505|NCT00196976|364483528|FG010|Booster Study|Lost to Follow-up|1|||
105678506|NCT00196976|364483529|FG011|Booster Study|Lost to Follow-up|2|||
105678507|NCT00196976|364483530|FG012|Booster Study|Lost to Follow-up|0|||
105678508|NCT00196976|364483531|FG013|Booster Study|Lost to Follow-up|0|||
105678509|NCT03208036|364483532|FG000|Baseline Assessment|Withdrawal by Subject|1|||
105678510|NCT03208036|364483533|FG001|Baseline Assessment|Withdrawal by Subject|1|||
105678511|NCT03208036|364483532|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
105678512|NCT03208036|364483533|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
105678513|NCT03208036|364483532|FG000|Intervention|Withdrawal by Subject|3|||
105678514|NCT03208036|364483533|FG001|Intervention|Withdrawal by Subject|2|||
105678515|NCT03208036|364483532|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
105678516|NCT03208036|364483533|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
105678517|NCT00591851|364483534|FG000|Overall Study|Withdrawal by Subject|3|||
105678518|NCT00591851|364483534|FG000|Overall Study|Adverse Event|2|||
105678519|NCT00591851|364483534|FG000|Overall Study|Progressive Disease|1|||
105678520|NCT02495792|364483538|FG000|Overall Study|Lost to Follow-up|5|||
105678521|NCT02495792|364483539|FG001|Overall Study|Lost to Follow-up|9|||
105678522|NCT02495792|364483538|FG000|Overall Study|Protocol Violation|32|||
105678523|NCT02495792|364483539|FG001|Overall Study|Protocol Violation|31|||
105678524|NCT00867308|364483540|FG000|Overall Study|Death|1|||
105678525|NCT00867308|364483541|FG001|Overall Study|Death|0|||
105678526|NCT00867308|364483540|FG000|Overall Study|Adverse Event|1|||
105678527|NCT00867308|364483541|FG001|Overall Study|Adverse Event|4|||
105678528|NCT00867308|364483540|FG000|Overall Study|Lack of Efficacy|6|||
105678529|NCT00867308|364483541|FG001|Overall Study|Lack of Efficacy|12|||
105678530|NCT00867308|364483540|FG000|Overall Study|Withdrawal by Subject|1|||
105678531|NCT00867308|364483541|FG001|Overall Study|Withdrawal by Subject|2|||
105678532|NCT01775124|364483544|FG000|Core Period|Disease Progression|0|||
105678533|NCT01775124|364483545|FG001|Core Period|Disease Progression|1|||
105678534|NCT01775124|364483544|FG000|Core Period|Physician Decision|1|||
105678535|NCT01775124|364483545|FG001|Core Period|Physician Decision|1|||
105678536|NCT01775124|364483544|FG000|Core Period|Death|0|||
105678537|NCT01775124|364483545|FG001|Core Period|Death|1|||
105678538|NCT01775124|364483544|FG000|Core Period|Administrative problems|1|||
105678539|NCT01775124|364483545|FG001|Core Period|Administrative problems|0|||
105678540|NCT01775124|364483544|FG000|Core Period|Withdrawal by Subject|4|||
105678541|NCT01775124|364483545|FG001|Core Period|Withdrawal by Subject|2|||
105678542|NCT01775124|364483544|FG000|Core Period|Adverse Event|5|||
105678543|NCT01775124|364483545|FG001|Core Period|Adverse Event|5|||
105678544|NCT01775124|364483544|FG000|Extension Period|Adverse Event|3|||
105678545|NCT01775124|364483545|FG001|Extension Period|Adverse Event|2|||
105678546|NCT01775124|364483544|FG000|Extension Period|Physician Decision|0|||
106125851|NCT00654940|366119838|FG001|Period 1|Intolerable Pain Level|0|||
105678547|NCT01775124|364483545|FG001|Extension Period|Physician Decision|2|||
105678548|NCT01775124|364483544|FG000|Extension Period|Administrative problems|0|||
105678549|NCT01775124|364483545|FG001|Extension Period|Administrative problems|1|||
105678550|NCT01775124|364483544|FG000|Extension Period|Lost to Follow-up|0|||
105678551|NCT01775124|364483545|FG001|Extension Period|Lost to Follow-up|1|||
105678552|NCT01775124|364483544|FG000|Extension Period|Withdrawal by Subject|9|||
105678553|NCT01775124|364483545|FG001|Extension Period|Withdrawal by Subject|12|||
105678554|NCT05559476|364483546|FG000|Overall Study|Adverse Event|2|||
105678555|NCT05559476|364483547|FG001|Overall Study|Adverse Event|0|||
105678556|NCT05559476|364483546|FG000|Overall Study|Lost to Follow-up|13|||
105678557|NCT05559476|364483547|FG001|Overall Study|Lost to Follow-up|12|||
105678558|NCT05559476|364483546|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
105678559|NCT05559476|364483547|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
105678560|NCT05559476|364483546|FG000|Overall Study|Other|0|||
105678561|NCT05559476|364483547|FG001|Overall Study|Other|2|||
105678562|NCT03647488|364485008|FG000|Overall Study|Progressive disease|10|||
105678563|NCT03647488|364485009|FG001|Overall Study|Progressive disease|0|||
105678564|NCT03647488|364485010|FG002|Overall Study|Progressive disease|0|||
105678565|NCT03647488|364485008|FG000|Overall Study|Adverse Event|5|||
105678566|NCT03647488|364485009|FG001|Overall Study|Adverse Event|0|||
105678567|NCT03647488|364485010|FG002|Overall Study|Adverse Event|0|||
105678568|NCT03647488|364485008|FG000|Overall Study|Clinical progression|2|||
105678569|NCT03647488|364485009|FG001|Overall Study|Clinical progression|0|||
105678570|NCT03647488|364485010|FG002|Overall Study|Clinical progression|0|||
105678571|NCT03647488|364485008|FG000|Overall Study|Participant refused to take investigational product|1|||
105678572|NCT03647488|364485009|FG001|Overall Study|Participant refused to take investigational product|0|||
105678573|NCT03647488|364485010|FG002|Overall Study|Participant refused to take investigational product|0|||
105678574|NCT00565851|364485011|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
105678575|NCT00565851|364485012|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
105678576|NCT00565851|364485013|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
105678577|NCT00565851|364485014|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
105678578|NCT00565851|364485015|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
105678579|NCT00565851|364485016|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
105678580|NCT00565851|364485017|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
105678581|NCT00565851|364485018|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
105678582|NCT00565851|364485011|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
105678583|NCT00565851|364485012|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
105678584|NCT00565851|364485013|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
105678585|NCT00565851|364485014|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
105678586|NCT00565851|364485015|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
105678587|NCT00565851|364485016|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
105678588|NCT00565851|364485017|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
105678589|NCT00565851|364485018|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
105678590|NCT01077271|364485019|FG000|Overall Study|Parental desire|8|||
105678591|NCT01077271|364485019|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
105678592|NCT01077271|364485019|FG000|Overall Study|Noncompliance|2|||
105678593|NCT01077271|364485019|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
105678594|NCT01077271|364485019|FG000|Overall Study|Changed doctors|2|||
105678595|NCT01077271|364485019|FG000|Overall Study|Parents thought too many injections|2|||
105678596|NCT01077271|364485019|FG000|Overall Study|End of RSV season nearly reached|1|||
105678597|NCT01077271|364485019|FG000|Overall Study|Mother unconvinced of the necessity|1|||
105678598|NCT00969709|364485020|FG000|Overall Study|Adverse Event|3|||
105678599|NCT00969709|364485021|FG001|Overall Study|Adverse Event|13|||
105678600|NCT00969709|364485022|FG002|Overall Study|Adverse Event|26|||
105678601|NCT00969709|364485023|FG003|Overall Study|Adverse Event|12|||
105678602|NCT00969709|364485020|FG000|Overall Study|Lack of Efficacy|7|||
105678603|NCT00969709|364485021|FG001|Overall Study|Lack of Efficacy|4|||
105678604|NCT00969709|364485022|FG002|Overall Study|Lack of Efficacy|1|||
105678605|NCT00969709|364485023|FG003|Overall Study|Lack of Efficacy|3|||
105678606|NCT00969709|364485020|FG000|Overall Study|Protocol Violation|9|||
106000245|NCT04033367|365663309|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
106000246|NCT04033367|365663310|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
106125852|NCT02906683|366119839|FG000|Overall Study|Adverse Event|0|||
106125853|NCT02906683|366119840|FG001|Overall Study|Adverse Event|1|||
105678607|NCT00969709|364485021|FG001|Overall Study|Protocol Violation|5|||
105678608|NCT00969709|364485022|FG002|Overall Study|Protocol Violation|9|||
105678609|NCT00969709|364485023|FG003|Overall Study|Protocol Violation|10|||
105678610|NCT00969709|364485020|FG000|Overall Study|Withdrawal by Subject|9|||
105678611|NCT00969709|364485021|FG001|Overall Study|Withdrawal by Subject|12|||
105678612|NCT00969709|364485022|FG002|Overall Study|Withdrawal by Subject|11|||
106125854|NCT02906683|366119841|FG002|Overall Study|Adverse Event|0|||
106125855|NCT02906683|366119839|FG000|Overall Study|Physician Decision|0|||
106125856|NCT02906683|366119840|FG001|Overall Study|Physician Decision|1|||
105678613|NCT00969709|364485023|FG003|Overall Study|Withdrawal by Subject|23|||
105678614|NCT00969709|364485020|FG000|Overall Study|Lost to Follow-up|10|||
105678615|NCT00969709|364485021|FG001|Overall Study|Lost to Follow-up|14|||
105678616|NCT00969709|364485022|FG002|Overall Study|Lost to Follow-up|8|||
105678617|NCT00969709|364485023|FG003|Overall Study|Lost to Follow-up|15|||
105678618|NCT00969709|364485020|FG000|Overall Study|Other reasons|0|||
105678619|NCT00969709|364485021|FG001|Overall Study|Other reasons|0|||
105678620|NCT00969709|364485022|FG002|Overall Study|Other reasons|3|||
105678621|NCT00969709|364485023|FG003|Overall Study|Other reasons|0|||
105678622|NCT02980731|364485024|FG000|Overall Study|Death|63|||
105678623|NCT02980731|364485024|FG000|Overall Study|Withdrawal by Subject|6|||
105678624|NCT02980731|364485024|FG000|Overall Study|Lost to Follow-up|5|||
105678625|NCT02980731|364485024|FG000|Overall Study|Study terminated by Sponsor|4|||
105678626|NCT02980731|364485024|FG000|Overall Study|Completed survival follow-up period|65|||
105678627|NCT02980731|364485024|FG000|Overall Study|COVID-19 infection|1|||
105678628|NCT02980731|364485024|FG000|Overall Study|Other, not specified|66|||
105678629|NCT02516332|364485025|FG000|Overall Study|Withdrawal by Subject|2|||
105678630|NCT02516332|364485026|FG001|Overall Study|Withdrawal by Subject|1|||
105678631|NCT02516332|364485027|FG002|Overall Study|Withdrawal by Subject|2|||
105678632|NCT02217332|364485028|FG000|Overall Study|Adverse Event|3|||
105678633|NCT02217332|364485028|FG000|Overall Study|Dose interruption >1 month|1|||
105678634|NCT02217332|364485028|FG000|Overall Study|Protocol Violation (eligibility)|1|||
105678635|NCT02217332|364485028|FG000|Overall Study|Withdrawal by Subject|1|||
105678636|NCT02217332|364485028|FG000|Overall Study|Lost to Follow-up|1|||
105678637|NCT04058366|364485039|FG000|Overall Study|Adverse Event|14|||
105678638|NCT04058366|364485039|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
105678639|NCT04058366|364485039|FG000|Overall Study|Commercial drug is available for participants|6|||
105678640|NCT04058366|364485039|FG000|Overall Study|Death|1|||
105678641|NCT04058366|364485039|FG000|Overall Study|Other non-compliance|2|||
105678642|NCT04058366|364485039|FG000|Overall Study|Other|6|||
105678643|NCT01789567|364485040|FG000|Overall Study|Death|6|||
105678644|NCT02914275|364485041|FG000|Overall Study|Lost to Follow-up|84|||
105678645|NCT02914275|364485042|FG001|Overall Study|Lost to Follow-up|29|||
105678646|NCT02914275|364485041|FG000|Overall Study|Withdrawal by Subject|26|||
105678647|NCT02914275|364485042|FG001|Overall Study|Withdrawal by Subject|10|||
105678648|NCT02914275|364485041|FG000|Overall Study|Protocol Violation|1|||
105678649|NCT02914275|364485042|FG001|Overall Study|Protocol Violation|1|||
105678650|NCT02914275|364485041|FG000|Overall Study|Physician Decision|3|||
105678651|NCT02914275|364485042|FG001|Overall Study|Physician Decision|1|||
105678652|NCT02914275|364485041|FG000|Overall Study|Other|4|||
105678653|NCT02914275|364485042|FG001|Overall Study|Other|1|||
105678654|NCT02914275|364485041|FG000|Overall Study|Excluded due to invalid informed consent|3|||
105678655|NCT02914275|364485042|FG001|Overall Study|Excluded due to invalid informed consent|0|||
105678656|NCT00872989|364485043|FG000|Overall Study|Adverse Event|7|||
105678657|NCT00872989|364485044|FG001|Overall Study|Adverse Event|15|||
105678658|NCT00872989|364485043|FG000|Overall Study|Withdrawal by Subject|8|||
105678659|NCT00872989|364485044|FG001|Overall Study|Withdrawal by Subject|5|||
105678660|NCT00872989|364485043|FG000|Overall Study|Progression/relapse|47|||
105678661|NCT00872989|364485044|FG001|Overall Study|Progression/relapse|35|||
105678662|NCT00872989|364485043|FG000|Overall Study|Not protocol specified|3|||
105678663|NCT00872989|364485044|FG001|Overall Study|Not protocol specified|8|||
105678664|NCT01238900|364485047|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
105678665|NCT01238900|364485047|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
105678666|NCT00603304|364485056|FG000|Overall Study|Lost to Follow-up|5|||
105678667|NCT00603304|364485057|FG001|Overall Study|Lost to Follow-up|7|||
105678668|NCT00603304|364485056|FG000|Overall Study|Withdrawal by Subject|8|||
105678669|NCT00603304|364485057|FG001|Overall Study|Withdrawal by Subject|5|||
105678670|NCT00603304|364485056|FG000|Overall Study|Protocol Violation|1|||
105678671|NCT00603304|364485057|FG001|Overall Study|Protocol Violation|0|||
105678672|NCT00603304|364485056|FG000|Overall Study|Adverse Event|4|||
105678673|NCT00603304|364485057|FG001|Overall Study|Adverse Event|2|||
105678674|NCT00603304|364485056|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
105678675|NCT00603304|364485057|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
105678676|NCT00603304|364485056|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
105678677|NCT00603304|364485057|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
105678678|NCT00603304|364485056|FG000|Overall Study|Exclusionary Medication|2|||
105678679|NCT00603304|364485057|FG001|Overall Study|Exclusionary Medication|3|||
105678680|NCT00603304|364485056|FG000|Overall Study|Non-Compliant|0|||
105678681|NCT00603304|364485057|FG001|Overall Study|Non-Compliant|1|||
105678682|NCT00603304|364485056|FG000|Overall Study|Moved Away|0|||
105678683|NCT00603304|364485057|FG001|Overall Study|Moved Away|2|||
105678684|NCT00603304|364485056|FG000|Overall Study|Other|2|||
105678685|NCT00603304|364485057|FG001|Overall Study|Other|0|||
105678686|NCT00603304|364485056|FG000|Overall Study|Patient Decision|2|||
105678687|NCT00603304|364485057|FG001|Overall Study|Patient Decision|0|||
105678688|NCT01290315|364485060|FG000|Overall Study|Adverse Event|0|||
105678689|NCT01290315|364485061|FG001|Overall Study|Adverse Event|0|||
105678690|NCT01290315|364485062|FG002|Overall Study|Adverse Event|0|||
105678691|NCT01290315|364485063|FG003|Overall Study|Adverse Event|3|||
105678692|NCT01290315|364485060|FG000|Overall Study|Selection criteria/compliance|2|||
105678693|NCT01290315|364485061|FG001|Overall Study|Selection criteria/compliance|1|||
105678694|NCT01290315|364485062|FG002|Overall Study|Selection criteria/compliance|0|||
105678695|NCT01290315|364485063|FG003|Overall Study|Selection criteria/compliance|2|||
105678696|NCT01290315|364485060|FG000|Overall Study|Lost to Follow-up|0|||
105678697|NCT01290315|364485061|FG001|Overall Study|Lost to Follow-up|1|||
105678698|NCT01290315|364485062|FG002|Overall Study|Lost to Follow-up|0|||
105678699|NCT01290315|364485063|FG003|Overall Study|Lost to Follow-up|0|||
105678700|NCT01290315|364485060|FG000|Overall Study|Withdrawal by Subject|1|||
105678701|NCT01290315|364485061|FG001|Overall Study|Withdrawal by Subject|1|||
105678702|NCT01290315|364485062|FG002|Overall Study|Withdrawal by Subject|0|||
105678703|NCT01290315|364485063|FG003|Overall Study|Withdrawal by Subject|0|||
105678704|NCT03725085|364485068|FG000|Overall Study|Lost to Follow-up|2|||
105678705|NCT03809429|364485069|FG000|Overall Study|Withdrawal by Subject|7|||
105678706|NCT03809429|364485070|FG001|Overall Study|Withdrawal by Subject|3|||
105678707|NCT03809429|364485069|FG000|Overall Study|Adverse Event|6|||
105678708|NCT03809429|364485070|FG001|Overall Study|Adverse Event|9|||
105678709|NCT03809429|364485069|FG000|Overall Study|COVID-19|3|||
105678710|NCT03809429|364485070|FG001|Overall Study|COVID-19|1|||
105678711|NCT03809429|364485069|FG000|Overall Study|Participant was discontinued by investigator|12|||
105678712|NCT03809429|364485070|FG001|Overall Study|Participant was discontinued by investigator|7|||
105678713|NCT00901186|364485071|FG000|Overall Study|Lack of Efficacy|0|||
105678714|NCT00901186|364485072|FG001|Overall Study|Lack of Efficacy|1|||
105678715|NCT00901186|364485071|FG000|Overall Study|Abnormal laboratory values|0|||
105678716|NCT00901186|364485072|FG001|Overall Study|Abnormal laboratory values|1|||
105678717|NCT00901186|364485071|FG000|Overall Study|Lost to Follow-up|2|||
105678718|NCT00901186|364485072|FG001|Overall Study|Lost to Follow-up|0|||
105678719|NCT00901186|364485071|FG000|Overall Study|Adverse Event|2|||
105678720|NCT00901186|364485072|FG001|Overall Study|Adverse Event|4|||
105678721|NCT00901186|364485071|FG000|Overall Study|Administration problems|0|||
105678722|NCT00901186|364485072|FG001|Overall Study|Administration problems|1|||
105678723|NCT00901186|364485071|FG000|Overall Study|Protocol deviations|5|||
105678724|NCT00901186|364485072|FG001|Overall Study|Protocol deviations|4|||
105678725|NCT04214600|364485073|FG000|Overall Study|Lost to Follow-up|9|||
105678726|NCT04214600|364485074|FG001|Overall Study|Lost to Follow-up|14|||
105678727|NCT01901341|364485075|FG000|Overall Study|Adverse Event|4|||
105678728|NCT01901341|364485076|FG001|Overall Study|Adverse Event|2|||
105678729|NCT01901341|364485075|FG000|Overall Study|Lack of Efficacy|0|||
105678730|NCT01901341|364485076|FG001|Overall Study|Lack of Efficacy|2|||
105678731|NCT01901341|364485075|FG000|Overall Study|Lost to Follow-up|0|||
105678732|NCT01901341|364485076|FG001|Overall Study|Lost to Follow-up|1|||
105678733|NCT01901341|364485075|FG000|Overall Study|Protocol Violation|2|||
105678734|NCT01901341|364485076|FG001|Overall Study|Protocol Violation|0|||
105678735|NCT01901341|364485075|FG000|Overall Study|Study Terminated by Sponsor|13|||
105678736|NCT01901341|364485076|FG001|Overall Study|Study Terminated by Sponsor|15|||
105678737|NCT01901341|364485075|FG000|Overall Study|Withdrawal by Subject|1|||
105678738|NCT01901341|364485076|FG001|Overall Study|Withdrawal by Subject|1|||
105678739|NCT01183234|364485077|FG000|First Intervention|Adverse Event|1|||
105678740|NCT01183234|364485078|FG001|First Intervention|Adverse Event|0|||
105678741|NCT01983254|364485079|FG000|Overall Study|Death|6|||
105678742|NCT01983254|364485080|FG001|Overall Study|Death|6|||
105678743|NCT01983254|364485079|FG000|Overall Study|Lost to Follow-up|17|||
105678744|NCT01983254|364485080|FG001|Overall Study|Lost to Follow-up|16|||
105678745|NCT01983254|364485079|FG000|Overall Study|too ill|11|||
105678746|NCT01983254|364485080|FG001|Overall Study|too ill|8|||
105678747|NCT00434213|364485083|FG000|Overall Study|Adverse Event|12|||
105678748|NCT00434213|364485083|FG000|Overall Study|Lack of Efficacy|9|||
105678749|NCT00434213|364485083|FG000|Overall Study|Lost to Follow-up|14|||
105678750|NCT00434213|364485083|FG000|Overall Study|Withdrawal by Subject|7|||
105678751|NCT00434213|364485083|FG000|Overall Study|Protocol Violation|3|||
105678752|NCT00434213|364485083|FG000|Overall Study|Unable to comply with study visit window|2|||
105678753|NCT00434213|364485083|FG000|Overall Study|Application site reaction|1|||
105678754|NCT00434213|364485083|FG000|Overall Study|Non-compliant to study schedule|1|||
105678755|NCT05398237|364485084|FG000|Overall Study|Withdrawal by Subject|1|||
105678756|NCT04988867|364485085|FG000|Overall Study|Study terminated by Sponsor|12|||
105678757|NCT04988867|364485085|FG000|Overall Study|Adverse Event|2|||
105678758|NCT04988867|364485085|FG000|Overall Study|Study drug noncompliance|1|||
105678759|NCT01327495|364485086|FG000|Overall Study|Adverse Event|2|||
105678760|NCT01327495|364485087|FG001|Overall Study|Adverse Event|1|||
105678761|NCT01327495|364485088|FG002|Overall Study|Adverse Event|1|||
105678762|NCT01327495|364485089|FG003|Overall Study|Adverse Event|0|||
105678763|NCT01327495|364485090|FG004|Overall Study|Adverse Event|0|||
105678764|NCT01327495|364485091|FG005|Overall Study|Adverse Event|2|||
105678765|NCT01327495|364485086|FG000|Overall Study|Withdrawal by Subject|0|||
105678766|NCT01327495|364485087|FG001|Overall Study|Withdrawal by Subject|1|||
105678767|NCT01327495|364485088|FG002|Overall Study|Withdrawal by Subject|1|||
105678768|NCT01327495|364485089|FG003|Overall Study|Withdrawal by Subject|0|||
105678769|NCT01327495|364485090|FG004|Overall Study|Withdrawal by Subject|1|||
105678770|NCT01327495|364485091|FG005|Overall Study|Withdrawal by Subject|0|||
105678771|NCT01327495|364485086|FG000|Overall Study|Physician Decision|0|||
105678772|NCT01327495|364485087|FG001|Overall Study|Physician Decision|0|||
105678773|NCT01327495|364485088|FG002|Overall Study|Physician Decision|0|||
105678774|NCT01327495|364485089|FG003|Overall Study|Physician Decision|0|||
105678775|NCT01327495|364485090|FG004|Overall Study|Physician Decision|2|||
105678776|NCT01327495|364485091|FG005|Overall Study|Physician Decision|0|||
105678777|NCT01699503|364485094|FG000|Overall Study|Death|31|||
105678778|NCT01699503|364485095|FG001|Overall Study|Death|40|||
105678779|NCT01699503|364485094|FG000|Overall Study|Withdrawal by Subject|65|||
105678780|NCT01699503|364485095|FG001|Overall Study|Withdrawal by Subject|57|||
105678781|NCT01699503|364485094|FG000|Overall Study|Lost to Follow-up|121|||
105678782|NCT01699503|364485095|FG001|Overall Study|Lost to Follow-up|117|||
105678783|NCT01699503|364485094|FG000|Overall Study|Excluded due to quality|783|||
105678784|NCT01699503|364485095|FG001|Overall Study|Excluded due to quality|791|||
105678785|NCT01888900|364485097|FG000|Overall Study|failed treatment|0|||
105678786|NCT01888900|364485098|FG001|Overall Study|failed treatment|2|||
105678787|NCT01639560|364485099|FG000|Overall Study|Withdrawal by Subject|9|||
105678788|NCT01639560|364485100|FG001|Overall Study|Withdrawal by Subject|14|||
105678789|NCT01639560|364485099|FG000|Overall Study|Lack of Efficacy|1|||
105678790|NCT01639560|364485100|FG001|Overall Study|Lack of Efficacy|2|||
105678791|NCT01639560|364485099|FG000|Overall Study|Lost to Follow-up|9|||
105678792|NCT01639560|364485100|FG001|Overall Study|Lost to Follow-up|11|||
105678793|NCT01639560|364485099|FG000|Overall Study|Adverse Event|0|||
105678794|NCT01639560|364485100|FG001|Overall Study|Adverse Event|2|||
105678795|NCT03545503|364485101|FG000|Overall Study|Protocol Violation|14|||
105678796|NCT03545503|364485102|FG001|Overall Study|Protocol Violation|16|||
105678797|NCT00468104|364485103|FG000|First Intervention|Protocol Violation|2|||
105678798|NCT00468104|364485104|FG001|First Intervention|Protocol Violation|1|||
105678799|NCT00468104|364485103|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
105678800|NCT00468104|364485104|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
105678801|NCT00468104|364485103|FG000|First Intervention|died within 3 weeks|1|||
105678802|NCT00468104|364485104|FG001|First Intervention|died within 3 weeks|0|||
105678803|NCT00468104|364485103|FG000|First Intervention|malposition/blocked chest tube tube|2|||
105678804|NCT00468104|364485104|FG001|First Intervention|malposition/blocked chest tube tube|0|||
105678805|NCT00468104|364485103|FG000|First Intervention|large lung mass with minimal effusion|1|||
105678806|NCT00468104|364485104|FG001|First Intervention|large lung mass with minimal effusion|0|||
105678807|NCT00468104|364485103|FG000|First Intervention|associated prolonged pneumothorax|1|||
105678808|NCT00468104|364485104|FG001|First Intervention|associated prolonged pneumothorax|0|||
105678809|NCT00468104|364485103|FG000|First Intervention|trapped lung|1|||
105678810|NCT00468104|364485104|FG001|First Intervention|trapped lung|0|||
105678811|NCT00468104|364485103|FG000|Second Intervention|Withdrawal by Subject|5|||
105678812|NCT00468104|364485104|FG001|Second Intervention|Withdrawal by Subject|2|||
105678813|NCT00468104|364485103|FG000|Second Intervention|discarded for malposition of chest tube|0|||
105678814|NCT00468104|364485104|FG001|Second Intervention|discarded for malposition of chest tube|2|||
105678815|NCT00324675|364485106|FG000|Overall Study|Adverse Event|1|||
105915078|NCT05616013|365348036|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105915079|NCT05616013|365348037|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105915080|NCT05616013|365348038|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105915081|NCT05616013|365348039|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
105952071|NCT03314935|365488197|FG013|Phase 1|Withdrawal by Subject|0|||
105678816|NCT00324675|364485107|FG001|Overall Study|Adverse Event|0|||
105678817|NCT00381615|364485108|FG000|Overall Study|Withdrawal by Subject|1|||
105678818|NCT00381615|364485109|FG001|Overall Study|Withdrawal by Subject|3|||
105678819|NCT00381615|364485110|FG002|Overall Study|Withdrawal by Subject|0|||
105678820|NCT00381615|364485111|FG003|Overall Study|Withdrawal by Subject|1|||
105678821|NCT00381615|364485108|FG000|Overall Study|Lost to Follow-up|3|||
105678822|NCT00381615|364485109|FG001|Overall Study|Lost to Follow-up|2|||
105678823|NCT00381615|364485110|FG002|Overall Study|Lost to Follow-up|0|||
105678824|NCT00381615|364485111|FG003|Overall Study|Lost to Follow-up|1|||
105678825|NCT00381615|364485108|FG000|Overall Study|Protocol Violation|0|||
105678826|NCT00381615|364485109|FG001|Overall Study|Protocol Violation|0|||
105678827|NCT00381615|364485110|FG002|Overall Study|Protocol Violation|1|||
105678828|NCT00381615|364485111|FG003|Overall Study|Protocol Violation|0|||
105678829|NCT02703259|364485112|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
105678830|NCT02703259|364485113|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
105678831|NCT02703259|364485112|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
105678832|NCT02703259|364485113|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
105678833|NCT02703259|364485112|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
105678834|NCT02703259|364485113|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
105678835|NCT02601300|364485114|FG000|Induction Phase|Lack of Efficacy|2|||
105678836|NCT02601300|364485114|FG000|Induction Phase|Protocol Violation|1|||
105678837|NCT02601300|364485114|FG000|Extension Phase|Withdrawal by Subject|3|||
105678838|NCT02601300|364485114|FG000|Extension Phase|Adverse Event|4|||
105678839|NCT02601300|364485114|FG000|Extension Phase|Lack of Efficacy|10|||
105678840|NCT01200589|364485115|FG000|Overall Study|Withdrawal by Subject|13|||
105678841|NCT01200589|364485116|FG001|Overall Study|Withdrawal by Subject|11|||
105678842|NCT01200589|364485115|FG000|Overall Study|Physician Decision|2|||
105678843|NCT01200589|364485116|FG001|Overall Study|Physician Decision|2|||
105678844|NCT01200589|364485115|FG000|Overall Study|Lost to Follow-up|5|||
105678845|NCT01200589|364485116|FG001|Overall Study|Lost to Follow-up|4|||
105678846|NCT01200589|364485115|FG000|Overall Study|Study terminated|170|||
105678847|NCT01200589|364485116|FG001|Overall Study|Study terminated|172|||
105678848|NCT00439231|364485117|FG000|Overall Study|Lack of Efficacy|28|||
105678849|NCT01993927|364485121|FG000|Overall Study|Case Report Forms Uncollected|18|||
105678850|NCT01993927|364485121|FG000|Overall Study|Protocol Violation|11|||
105678851|NCT00598273|364485122|FG000|Overall Study|Adverse Event|4|||
105678852|NCT00598273|364485123|FG001|Overall Study|Adverse Event|5|||
105678853|NCT00598273|364485124|FG002|Overall Study|Adverse Event|2|||
105678854|NCT00598273|364485122|FG000|Overall Study|Death|6|||
105678855|NCT00598273|364485123|FG001|Overall Study|Death|12|||
105678856|NCT00598273|364485124|FG002|Overall Study|Death|8|||
105678857|NCT00598273|364485122|FG000|Overall Study|Lost to Follow-up|8|||
105678858|NCT00598273|364485123|FG001|Overall Study|Lost to Follow-up|3|||
105678859|NCT00598273|364485124|FG002|Overall Study|Lost to Follow-up|5|||
105678860|NCT00598273|364485122|FG000|Overall Study|Physician Decision|0|||
105678861|NCT00598273|364485123|FG001|Overall Study|Physician Decision|0|||
105678862|NCT00598273|364485124|FG002|Overall Study|Physician Decision|1|||
105678863|NCT00598273|364485122|FG000|Overall Study|Withdrawal by Subject|12|||
105678864|NCT00598273|364485123|FG001|Overall Study|Withdrawal by Subject|10|||
105678865|NCT00598273|364485124|FG002|Overall Study|Withdrawal by Subject|10|||
105678866|NCT00598273|364485122|FG000|Overall Study|Noncompliance|3|||
105678867|NCT00598273|364485123|FG001|Overall Study|Noncompliance|2|||
105678868|NCT00598273|364485124|FG002|Overall Study|Noncompliance|3|||
105678869|NCT00598273|364485122|FG000|Overall Study|Relocation|0|||
105678870|NCT00598273|364485123|FG001|Overall Study|Relocation|2|||
105678871|NCT00598273|364485124|FG002|Overall Study|Relocation|4|||
105678872|NCT00598273|364485122|FG000|Overall Study|Renal transplant|1|||
105678873|NCT00598273|364485123|FG001|Overall Study|Renal transplant|0|||
105678874|NCT00598273|364485124|FG002|Overall Study|Renal transplant|1|||
105678875|NCT00598273|364485122|FG000|Overall Study|Site elected to close|1|||
105678876|NCT00598273|364485123|FG001|Overall Study|Site elected to close|0|||
105678877|NCT00598273|364485124|FG002|Overall Study|Site elected to close|0|||
105678878|NCT00598273|364485122|FG000|Overall Study|Started dialysis|6|||
105678879|NCT00598273|364485123|FG001|Overall Study|Started dialysis|4|||
105678880|NCT00598273|364485124|FG002|Overall Study|Started dialysis|5|||
105678881|NCT02729831|364485125|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
105678882|NCT02729831|364485126|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
105678883|NCT02729831|364485127|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
105678884|NCT02729831|364485128|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
105678885|NCT02729831|364485125|FG000|1 Week Post-visit|Lost to Follow-up|43|||
105678886|NCT02729831|364485126|FG001|1 Week Post-visit|Lost to Follow-up|40|||
105678887|NCT02729831|364485127|FG002|1 Week Post-visit|Lost to Follow-up|38|||
105678888|NCT02729831|364485128|FG003|1 Week Post-visit|Lost to Follow-up|36|||
105678889|NCT02729831|364485125|FG000|6 Month Follow-up|Lost to Follow-up|54|||
105678890|NCT02729831|364485126|FG001|6 Month Follow-up|Lost to Follow-up|51|||
105678891|NCT02729831|364485127|FG002|6 Month Follow-up|Lost to Follow-up|48|||
105678892|NCT02729831|364485128|FG003|6 Month Follow-up|Lost to Follow-up|42|||
105678893|NCT02729831|364485125|FG000|6 Month Follow-up|Death|1|||
105678894|NCT02729831|364485126|FG001|6 Month Follow-up|Death|3|||
105678895|NCT02729831|364485127|FG002|6 Month Follow-up|Death|0|||
105915082|NCT05616013|365348040|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
105915083|NCT05616013|365348032|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
106125857|NCT02906683|366119841|FG002|Overall Study|Physician Decision|1|||
105915084|NCT05616013|365348033|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
105915085|NCT05616013|365348034|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
105915086|NCT05616013|365348035|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
105678896|NCT02729831|364485128|FG003|6 Month Follow-up|Death|1|||
105678897|NCT02996474|364485129|FG000|Overall Study|Physician Decision|5|||
105678898|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
105678899|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
105678900|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
105678901|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
105678902|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
105678903|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
105678904|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
105678905|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
105678906|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
106125858|NCT02906683|366119839|FG000|Overall Study|Withdrawal by Subject|0|||
106125859|NCT02906683|366119840|FG001|Overall Study|Withdrawal by Subject|2|||
106125860|NCT02906683|366119841|FG002|Overall Study|Withdrawal by Subject|1|||
106125861|NCT02906683|366119839|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
106125862|NCT02906683|366119840|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
106125863|NCT02906683|366119841|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
106125864|NCT02906683|366119839|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
106125865|NCT02906683|366119840|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
106125866|NCT02906683|366119841|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
106000247|NCT01156480|365663316|FG000|Overall Study|change in diagnosis|0|||
106000248|NCT01156480|365663317|FG001|Overall Study|change in diagnosis|1|||
105678907|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
105678908|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
105678909|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
105678910|NCT04493502|364485130|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
105678911|NCT04493502|364485131|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
105678912|NCT04493502|364485130|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
105678913|NCT04493502|364485131|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
105678914|NCT04493502|364485130|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
105678915|NCT04493502|364485131|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
105678916|NCT04493502|364485130|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
105678917|NCT04493502|364485131|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
105678918|NCT04493502|364485130|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
105678919|NCT04493502|364485131|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
105678920|NCT04493502|364485130|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
105678921|NCT04493502|364485131|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
105678922|NCT04493502|364485130|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
105678923|NCT04493502|364485131|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
105678924|NCT00540046|364485132|FG000|Overall Study|Lost to Follow-up|33|||
105678925|NCT00540046|364485133|FG001|Overall Study|Lost to Follow-up|23|||
105678926|NCT03965351|364485135|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
105678927|NCT03965351|364485136|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
105678928|NCT03965351|364485135|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
105678929|NCT03965351|364485136|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
105678930|NCT02665338|364485137|FG000|Overall Study|Withdrawal by Subject|0|||
105678931|NCT02665338|364485138|FG001|Overall Study|Withdrawal by Subject|1|||
105678932|NCT02412371|364485139|FG000|Overall Study|Withdrawal by Subject|0|||
105678933|NCT02412371|364485140|FG001|Overall Study|Withdrawal by Subject|2|||
105678934|NCT02412371|364485141|FG002|Overall Study|Withdrawal by Subject|0|||
105678935|NCT02412371|364485142|FG003|Overall Study|Withdrawal by Subject|1|||
105678936|NCT02412371|364485143|FG004|Overall Study|Withdrawal by Subject|1|||
105678937|NCT02412371|364485144|FG005|Overall Study|Withdrawal by Subject|0|||
105678938|NCT02412371|364485139|FG000|Overall Study|Sponsor Discontinued Study|1|||
105678939|NCT02412371|364485140|FG001|Overall Study|Sponsor Discontinued Study|4|||
105678940|NCT02412371|364485141|FG002|Overall Study|Sponsor Discontinued Study|6|||
105678941|NCT02412371|364485142|FG003|Overall Study|Sponsor Discontinued Study|4|||
105678942|NCT02412371|364485143|FG004|Overall Study|Sponsor Discontinued Study|5|||
105678943|NCT02412371|364485144|FG005|Overall Study|Sponsor Discontinued Study|0|||
105678944|NCT02412371|364485139|FG000|Overall Study|Death|4|||
105678945|NCT02412371|364485140|FG001|Overall Study|Death|2|||
105678946|NCT02412371|364485141|FG002|Overall Study|Death|1|||
105678947|NCT02412371|364485142|FG003|Overall Study|Death|3|||
105678948|NCT02412371|364485143|FG004|Overall Study|Death|5|||
105678949|NCT02412371|364485144|FG005|Overall Study|Death|2|||
105678950|NCT02412371|364485139|FG000|Overall Study|Other|2|||
105678951|NCT02412371|364485140|FG001|Overall Study|Other|1|||
105678952|NCT02412371|364485141|FG002|Overall Study|Other|0|||
105678953|NCT02412371|364485142|FG003|Overall Study|Other|0|||
105678954|NCT02412371|364485143|FG004|Overall Study|Other|1|||
105678955|NCT02412371|364485144|FG005|Overall Study|Other|3|||
105678956|NCT00903682|364485145|FG000|Overall Study|Adverse Event|6|||
105678957|NCT00903682|364485146|FG001|Overall Study|Adverse Event|13|||
105678958|NCT00903682|364485145|FG000|Overall Study|Lost to Follow-up|1|||
105678959|NCT00903682|364485146|FG001|Overall Study|Lost to Follow-up|0|||
105678960|NCT00903682|364485145|FG000|Overall Study|Withdrawal by Subject|5|||
105678961|NCT00903682|364485146|FG001|Overall Study|Withdrawal by Subject|0|||
105678962|NCT00903682|364485145|FG000|Overall Study|Pregnancy|0|||
105678963|NCT00903682|364485146|FG001|Overall Study|Pregnancy|1|||
105678964|NCT00903682|364485145|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
105678965|NCT00903682|364485146|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
105678966|NCT00903682|364485145|FG000|Overall Study|Subject Non-Compliant|1|||
105786474|NCT01748162|364871401|FG000|Overall Study|no additional croup episodes to evaluate|2|||
105678967|NCT00903682|364485146|FG001|Overall Study|Subject Non-Compliant|0|||
105786475|NCT01748162|364871402|FG001|Overall Study|no additional croup episodes to evaluate|2|||
105915087|NCT05616013|365348036|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
105678968|NCT00903682|364485145|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
105678969|NCT00903682|364485146|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
105678970|NCT00903682|364485145|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
105678971|NCT00903682|364485146|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
105678972|NCT02053792|364485147|FG000|Overall Study|Physician Decision|0|||
105678973|NCT02053792|364485148|FG001|Overall Study|Physician Decision|1|||
105678974|NCT02053792|364485147|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
105678975|NCT02053792|364485148|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
105678976|NCT02053792|364485147|FG000|Overall Study|Lack of Efficacy|1|||
105678977|NCT02053792|364485148|FG001|Overall Study|Lack of Efficacy|0|||
105678978|NCT02053792|364485147|FG000|Overall Study|Adverse Event|1|||
105678979|NCT02053792|364485148|FG001|Overall Study|Adverse Event|0|||
105678980|NCT02053792|364485147|FG000|Overall Study|Withdrawal by Subject|2|||
105678981|NCT02053792|364485148|FG001|Overall Study|Withdrawal by Subject|2|||
105678982|NCT02053792|364485147|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
105678983|NCT02053792|364485148|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
105678984|NCT02053792|364485147|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
105678985|NCT02053792|364485148|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
105678986|NCT01028027|364485149|FG000|Overall Study|Lost to Follow-up|4|||
105678987|NCT01028027|364485150|FG001|Overall Study|Lost to Follow-up|1|||
105678988|NCT01028027|364485149|FG000|Overall Study|Withdrawal by Subject|5|||
105678989|NCT01028027|364485150|FG001|Overall Study|Withdrawal by Subject|3|||
105678990|NCT01028027|364485149|FG000|Overall Study|Adverse Event|4|||
105678991|NCT01028027|364485150|FG001|Overall Study|Adverse Event|7|||
105678992|NCT01028027|364485149|FG000|Overall Study|Protocol Violation|3|||
105678993|NCT01028027|364485150|FG001|Overall Study|Protocol Violation|1|||
105678994|NCT01028027|364485149|FG000|Overall Study|Lack of Efficacy|0|||
105678995|NCT01028027|364485150|FG001|Overall Study|Lack of Efficacy|1|||
105678996|NCT00529958|364485151|FG000|2-Year Follow-up|Lost to Follow-up|1|||
105678997|NCT00529958|364485152|FG001|2-Year Follow-up|Lost to Follow-up|2|||
105678998|NCT00529958|364485153|FG002|2-Year Follow-up|Lost to Follow-up|2|||
105678999|NCT00529958|364485151|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
105679000|NCT00529958|364485152|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
105679001|NCT00529958|364485153|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
105679002|NCT00529958|364485151|FG000|5-Year Follow-up|Lost to Follow-up|2|||
105679003|NCT00529958|364485152|FG001|5-Year Follow-up|Lost to Follow-up|3|||
105679004|NCT00529958|364485153|FG002|5-Year Follow-up|Lost to Follow-up|1|||
105679005|NCT00529958|364485151|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
105679006|NCT00529958|364485152|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
105679007|NCT00529958|364485153|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
105679008|NCT03141905|364485156|FG000|Overall Study|Death|3|||
105679009|NCT03141905|364485157|FG001|Overall Study|Death|2|||
105679010|NCT03141905|364485156|FG000|Overall Study|Withdrawal by Subject|1|||
105679011|NCT03141905|364485157|FG001|Overall Study|Withdrawal by Subject|0|||
105679012|NCT03141905|364485156|FG000|Overall Study|Lost to Follow-up|3|||
105679013|NCT03141905|364485157|FG001|Overall Study|Lost to Follow-up|7|||
105679014|NCT03141905|364485156|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
105679015|NCT03141905|364485157|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
105679016|NCT05180500|364485158|FG000|Overall Study|Adverse Event|1|||
105679017|NCT05180500|364485159|FG001|Overall Study|Adverse Event|0|||
105679018|NCT05180500|364485158|FG000|Overall Study|Withdrawal by Subject|2|||
105679019|NCT05180500|364485159|FG001|Overall Study|Withdrawal by Subject|0|||
105679020|NCT00432666|364486869|FG000|Main Period|Adverse Event|1|||
105679021|NCT00432666|364486870|FG001|Main Period|Adverse Event|1|||
105679022|NCT00432666|364486869|FG000|Main Period|Consent Withdrawn|1|||
105679023|NCT00432666|364486870|FG001|Main Period|Consent Withdrawn|0|||
105679024|NCT00432666|364486869|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
105679025|NCT00432666|364486870|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
105679026|NCT00432666|364486869|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
105679027|NCT00432666|364486870|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
105679028|NCT00432666|364486869|FG000|Open-Label Extension Period|Adverse Event|5|||
105679029|NCT00432666|364486870|FG001|Open-Label Extension Period|Adverse Event|0|||
105679030|NCT00432666|364486869|FG000|Open-Label Extension Period|Consent withdrawn|10|||
105679031|NCT00432666|364486870|FG001|Open-Label Extension Period|Consent withdrawn|0|||
105679032|NCT00432666|364486869|FG000|Open-Label Extension Period|Physician Decision|3|||
105679033|NCT00432666|364486870|FG001|Open-Label Extension Period|Physician Decision|0|||
105679034|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
105679035|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
105679036|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
105679037|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
105679038|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
106125867|NCT04714216|366119842|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
105679039|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
105679040|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
105679041|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
105679042|NCT00978627|364486871|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
105915088|NCT05616013|365348037|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
105915089|NCT05616013|365348038|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
105915090|NCT05616013|365348039|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
106125868|NCT04714216|366119842|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
106125869|NCT00619476|366119845|FG000|Overall Study|Adverse Event|12|||
105915091|NCT05616013|365348040|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
105679043|NCT00978627|364486872|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
105679044|NCT00978627|364486871|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
105679045|NCT00978627|364486872|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
105679046|NCT00978627|364486871|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
105679047|NCT00978627|364486872|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
105679048|NCT00978627|364486871|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
105679049|NCT00978627|364486872|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
105679050|NCT00978627|364486871|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
105679051|NCT00978627|364486872|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
105679052|NCT00605215|364486875|FG000|Overall Study|Death|0|||
105679053|NCT00605215|364486876|FG001|Overall Study|Death|0|||
105679054|NCT00605215|364486877|FG002|Overall Study|Death|1|||
105679055|NCT00605215|364486875|FG000|Overall Study|Adverse Event|19|||
105679056|NCT00605215|364486876|FG001|Overall Study|Adverse Event|21|||
105679057|NCT00605215|364486877|FG002|Overall Study|Adverse Event|26|||
105679058|NCT00605215|364486875|FG000|Overall Study|Refusal to sign the re-consent form|8|||
105679059|NCT00605215|364486876|FG001|Overall Study|Refusal to sign the re-consent form|3|||
105679060|NCT00605215|364486877|FG002|Overall Study|Refusal to sign the re-consent form|3|||
105679061|NCT00605215|364486875|FG000|Overall Study|Withdrawal by Subject|39|||
105679062|NCT00605215|364486876|FG001|Overall Study|Withdrawal by Subject|37|||
105679063|NCT00605215|364486877|FG002|Overall Study|Withdrawal by Subject|27|||
105679064|NCT00605215|364486875|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
105679065|NCT00605215|364486876|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
105679066|NCT00605215|364486877|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
105679067|NCT00605215|364486875|FG000|Overall Study|Protocol Violation|3|||
105679068|NCT00605215|364486876|FG001|Overall Study|Protocol Violation|4|||
105679069|NCT00605215|364486877|FG002|Overall Study|Protocol Violation|1|||
105679070|NCT00605215|364486875|FG000|Overall Study|Pregnancy|8|||
105679071|NCT00605215|364486876|FG001|Overall Study|Pregnancy|5|||
105679072|NCT00605215|364486877|FG002|Overall Study|Pregnancy|4|||
105679073|NCT00605215|364486875|FG000|Overall Study|Lost to Follow-up|8|||
105679074|NCT00605215|364486876|FG001|Overall Study|Lost to Follow-up|5|||
105679075|NCT00605215|364486877|FG002|Overall Study|Lost to Follow-up|2|||
105679076|NCT00605215|364486875|FG000|Overall Study|Other than specified|0|||
105679077|NCT00605215|364486876|FG001|Overall Study|Other than specified|2|||
105679078|NCT00605215|364486877|FG002|Overall Study|Other than specified|1|||
105679079|NCT00091169|364486878|FG000|Overall Study|Disease progression|3|||
105679080|NCT00091169|364486879|FG001|Overall Study|Disease progression|1|||
105679081|NCT00091169|364486878|FG000|Overall Study|Adverse Event|11|||
105679082|NCT00091169|364486879|FG001|Overall Study|Adverse Event|17|||
105679083|NCT00091169|364486878|FG000|Overall Study|Death|4|||
105679084|NCT00091169|364486879|FG001|Overall Study|Death|1|||
105679085|NCT00091169|364486878|FG000|Overall Study|Withdrawal by Subject|10|||
105679086|NCT00091169|364486879|FG001|Overall Study|Withdrawal by Subject|13|||
105679087|NCT00091169|364486878|FG000|Overall Study|Other|3|||
105679088|NCT00091169|364486879|FG001|Overall Study|Other|4|||
105679089|NCT00091169|364486878|FG000|Overall Study|Not start protocol therapy|26|||
105679090|NCT00091169|364486879|FG001|Overall Study|Not start protocol therapy|17|||
105679091|NCT02407990|364486880|FG000|Overall Study|Death|2|||
105679092|NCT02407990|364486881|FG001|Overall Study|Death|22|||
105679093|NCT02407990|364486882|FG002|Overall Study|Death|23|||
105679094|NCT02407990|364486883|FG003|Overall Study|Death|7|||
105679095|NCT02407990|364486884|FG004|Overall Study|Death|17|||
105679096|NCT02407990|364486885|FG005|Overall Study|Death|16|||
105679097|NCT02407990|364486886|FG006|Overall Study|Death|10|||
105679098|NCT02407990|364486887|FG007|Overall Study|Death|248|||
105679099|NCT02407990|364486880|FG000|Overall Study|Lost to Follow-up|0|||
105679100|NCT02407990|364486881|FG001|Overall Study|Lost to Follow-up|1|||
105679101|NCT02407990|364486882|FG002|Overall Study|Lost to Follow-up|0|||
105679102|NCT02407990|364486883|FG003|Overall Study|Lost to Follow-up|0|||
105786476|NCT01748162|364871401|FG000|Overall Study|participant consented but did not begin|0|||
106125870|NCT00619476|366119846|FG001|Overall Study|Adverse Event|6|||
105679103|NCT02407990|364486884|FG004|Overall Study|Lost to Follow-up|0|||
105679104|NCT02407990|364486885|FG005|Overall Study|Lost to Follow-up|0|||
105915092|NCT02287038|365348041|FG000|Overall Study|Stopped attending appointments|3|||
105915093|NCT02287038|365348042|FG001|Overall Study|Stopped attending appointments|2|||
105679105|NCT02407990|364486886|FG006|Overall Study|Lost to Follow-up|0|||
105679106|NCT02407990|364486887|FG007|Overall Study|Lost to Follow-up|17|||
105679107|NCT02407990|364486880|FG000|Overall Study|Progressive Disease|0|||
105679108|NCT02407990|364486881|FG001|Overall Study|Progressive Disease|0|||
105679109|NCT02407990|364486882|FG002|Overall Study|Progressive Disease|0|||
105679110|NCT02407990|364486883|FG003|Overall Study|Progressive Disease|0|||
105679111|NCT02407990|364486884|FG004|Overall Study|Progressive Disease|0|||
105679112|NCT02407990|364486885|FG005|Overall Study|Progressive Disease|0|||
105679113|NCT02407990|364486886|FG006|Overall Study|Progressive Disease|0|||
105679114|NCT02407990|364486887|FG007|Overall Study|Progressive Disease|1|||
105679115|NCT02407990|364486880|FG000|Overall Study|Withdrawal by Subject|0|||
105915094|NCT02287038|365348041|FG000|Overall Study|Anxiety after starting medication|0|||
105915095|NCT02287038|365348042|FG001|Overall Study|Anxiety after starting medication|1|||
105915096|NCT02287038|365348041|FG000|Overall Study|Nausea after starting medication|1|||
105915097|NCT02287038|365348042|FG001|Overall Study|Nausea after starting medication|0|||
105915098|NCT02287038|365348041|FG000|Overall Study|Abnormal ECG after starting medication|1|||
105915099|NCT02287038|365348042|FG001|Overall Study|Abnormal ECG after starting medication|0|||
105915100|NCT00492726|365348043|FG000|Overall Study|Adverse Event|10|||
105915101|NCT00492726|365348044|FG001|Overall Study|Adverse Event|6|||
105915102|NCT00492726|365348043|FG000|Overall Study|Death|7|||
105915103|NCT00492726|365348044|FG001|Overall Study|Death|2|||
105915104|NCT00492726|365348043|FG000|Overall Study|Lack of Efficacy|0|||
105915105|NCT00492726|365348044|FG001|Overall Study|Lack of Efficacy|2|||
105915106|NCT00492726|365348043|FG000|Overall Study|Lost to Follow-up|27|||
105915107|NCT00492726|365348044|FG001|Overall Study|Lost to Follow-up|19|||
105915108|NCT00492726|365348043|FG000|Overall Study|Physician Decision|0|||
105915109|NCT00492726|365348044|FG001|Overall Study|Physician Decision|1|||
105679116|NCT02407990|364486881|FG001|Overall Study|Withdrawal by Subject|0|||
105915110|NCT00492726|365348043|FG000|Overall Study|Withdrawal by Subject|6|||
105915111|NCT00492726|365348044|FG001|Overall Study|Withdrawal by Subject|3|||
105679117|NCT02407990|364486882|FG002|Overall Study|Withdrawal by Subject|0|||
105679118|NCT02407990|364486883|FG003|Overall Study|Withdrawal by Subject|0|||
105952072|NCT03314935|365488198|FG014|Phase 1|Withdrawal by Subject|0|||
106125871|NCT00619476|366119847|FG002|Overall Study|Adverse Event|12|||
106125872|NCT00619476|366119848|FG003|Overall Study|Adverse Event|16|||
106125873|NCT00619476|366119845|FG000|Overall Study|Lack of Efficacy|6|||
106125874|NCT00619476|366119846|FG001|Overall Study|Lack of Efficacy|1|||
106125875|NCT00619476|366119847|FG002|Overall Study|Lack of Efficacy|1|||
106125876|NCT00619476|366119848|FG003|Overall Study|Lack of Efficacy|4|||
106125877|NCT00619476|366119845|FG000|Overall Study|Protocol Violation|5|||
106125878|NCT00619476|366119846|FG001|Overall Study|Protocol Violation|4|||
106125879|NCT00619476|366119847|FG002|Overall Study|Protocol Violation|4|||
106125880|NCT00619476|366119848|FG003|Overall Study|Protocol Violation|9|||
106125881|NCT00619476|366119845|FG000|Overall Study|Lost to Follow-up|1|||
106125882|NCT00619476|366119846|FG001|Overall Study|Lost to Follow-up|2|||
106125883|NCT00619476|366119847|FG002|Overall Study|Lost to Follow-up|0|||
106125884|NCT00619476|366119848|FG003|Overall Study|Lost to Follow-up|1|||
106125885|NCT00619476|366119845|FG000|Overall Study|Investigator Discretion|2|||
106125886|NCT00619476|366119846|FG001|Overall Study|Investigator Discretion|2|||
106125887|NCT00619476|366119847|FG002|Overall Study|Investigator Discretion|2|||
106125888|NCT00619476|366119848|FG003|Overall Study|Investigator Discretion|0|||
106125889|NCT00619476|366119845|FG000|Overall Study|Withdrawal by Subject|5|||
106125890|NCT00619476|366119846|FG001|Overall Study|Withdrawal by Subject|7|||
106125891|NCT00619476|366119847|FG002|Overall Study|Withdrawal by Subject|5|||
106125892|NCT00619476|366119848|FG003|Overall Study|Withdrawal by Subject|4|||
106125893|NCT03204695|366119851|FG000|Overall Study|Death|1|||
106125894|NCT03204695|366119851|FG000|Overall Study|Participant was treated with another device|1|||
106125895|NCT03204695|366119851|FG000|Overall Study|Physician Decision|2|||
106125896|NCT04834362|366119852|FG000|Overall Study|Death|1|||
106125897|NCT04834362|366119853|FG001|Overall Study|Death|2|||
106125898|NCT03095599|366119856|FG000|Overall Study|Withdrawal by Subject|1|||
106125899|NCT03095599|366119857|FG001|Overall Study|Withdrawal by Subject|0|||
106125900|NCT03095599|366119856|FG000|Overall Study|Lost to Follow-up|1|||
106125901|NCT03095599|366119857|FG001|Overall Study|Lost to Follow-up|0|||
106125902|NCT03095599|366119856|FG000|Overall Study|Withdrawal prior to vaccination|1|||
106125903|NCT03095599|366119857|FG001|Overall Study|Withdrawal prior to vaccination|0|||
106125904|NCT02959138|366119858|FG000|Overall Study|Enrolled but Never Treated|0|||
106125905|NCT02959138|366119859|FG001|Overall Study|Enrolled but Never Treated|1|||
106125906|NCT02959138|366119860|FG002|Overall Study|Enrolled but Never Treated|0|||
106125907|NCT02391038|366119861|FG000|Overall Study|Progressive disease|3|||
106125908|NCT02391038|366119862|FG001|Overall Study|Progressive disease|3|||
106125909|NCT02391038|366119863|FG002|Overall Study|Progressive disease|6|||
106125910|NCT01811563|366119869|FG000|Overall Study|Lost to Follow-up|5|||
106125911|NCT01811563|366119870|FG001|Overall Study|Lost to Follow-up|2|||
106125912|NCT01811563|366119869|FG000|Overall Study|Incorrect Randomization procedure|0|||
106125913|NCT01811563|366119870|FG001|Overall Study|Incorrect Randomization procedure|1|||
106125914|NCT02930122|366119875|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
106125915|NCT02930122|366119876|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
106125916|NCT01004250|366119877|FG000|Induction Therapy Period|Adverse Event|10|||
106125917|NCT01004250|366119877|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
106125918|NCT01004250|366119877|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
106125919|NCT01004250|366119877|FG000|Induction Therapy Period|Physician Decision|2|||
106125920|NCT01004250|366119877|FG000|Maintenance Therapy Period|Adverse Event|15|||
106125921|NCT01004250|366119877|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
106125922|NCT01004250|366119877|FG000|Maintenance Therapy Period|Protocol Violation|1|||
106125923|NCT01004250|366119877|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
106125924|NCT01004250|366119877|FG000|Maintenance Therapy Period|Physician Decision|4|||
106125925|NCT01004250|366119877|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
106125926|NCT01853254|366119878|FG000|Overall Study|Abnormal Laboratory Test|1|||
106125927|NCT01853254|366119878|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
106125928|NCT01853254|366119878|FG000|Overall Study|Death|1|||
106125929|NCT01853254|366119878|FG000|Overall Study|Failure to Return|43|||
106125930|NCT01853254|366119878|FG000|Overall Study|Insufficient Therapeutic Response|22|||
106125931|NCT01853254|366119878|FG000|Overall Study|Refusal of Treatment|1|||
106125932|NCT01853254|366119878|FG000|Overall Study|Other Protocol Violation|1|||
105952073|NCT03314935|365488184|FG000|Phase 1|Progressive Disease|2|||
105952074|NCT03314935|365488185|FG001|Phase 1|Progressive Disease|0|||
105952075|NCT03314935|365488186|FG002|Phase 1|Progressive Disease|0|||
105952076|NCT03314935|365488187|FG003|Phase 1|Progressive Disease|1|||
105952077|NCT03314935|365488188|FG004|Phase 1|Progressive Disease|0|||
105952078|NCT03314935|365488189|FG005|Phase 1|Progressive Disease|0|||
105952079|NCT03314935|365488190|FG006|Phase 1|Progressive Disease|0|||
105952080|NCT03314935|365488191|FG007|Phase 1|Progressive Disease|0|||
105952081|NCT03314935|365488192|FG008|Phase 1|Progressive Disease|0|||
105952082|NCT03314935|365488193|FG009|Phase 1|Progressive Disease|0|||
105952083|NCT03314935|365488194|FG010|Phase 1|Progressive Disease|0|||
105952084|NCT03314935|365488195|FG011|Phase 1|Progressive Disease|0|||
106125933|NCT01853254|366119878|FG000|Overall Study|Withdrawal of Consent|16|||
106125934|NCT01853254|366119878|FG000|Overall Study|Administrative/Other|16|||
106125935|NCT00373295|366119879|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
106125936|NCT00373295|366119880|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
106125937|NCT00373295|366119881|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
106125938|NCT00373295|366119882|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
106125939|NCT00373295|366119883|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
106125940|NCT00373295|366119884|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
106125941|NCT03525574|366119885|FG000|Overall Study|Adverse Event|15|||
106125942|NCT03525574|366119886|FG001|Overall Study|Adverse Event|0|||
106125943|NCT03525574|366119885|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
106125944|NCT03525574|366119886|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
106125945|NCT03525574|366119885|FG000|Overall Study|Lost to Follow-up|4|||
106125946|NCT03525574|366119886|FG001|Overall Study|Lost to Follow-up|0|||
106125947|NCT03525574|366119885|FG000|Overall Study|Commercial drug is Available for participant|48|||
106125948|NCT03525574|366119886|FG001|Overall Study|Commercial drug is Available for participant|0|||
106125949|NCT03525574|366119885|FG000|Overall Study|Death|1|||
106125950|NCT03525574|366119886|FG001|Overall Study|Death|0|||
106125951|NCT03525574|366119885|FG000|Overall Study|Other non-compliance|2|||
106125952|NCT03525574|366119886|FG001|Overall Study|Other non-compliance|0|||
106125953|NCT03525574|366119885|FG000|Overall Study|Physician Decision|6|||
106125954|NCT03525574|366119886|FG001|Overall Study|Physician Decision|0|||
106125955|NCT03525574|366119885|FG000|Overall Study|Other|58|||
106125956|NCT03525574|366119886|FG001|Overall Study|Other|0|||
106125957|NCT03525574|366119885|FG000|Overall Study|Enrolled but never dosed|1|||
106125958|NCT03525574|366119886|FG001|Overall Study|Enrolled but never dosed|0|||
106125959|NCT03525574|366119885|FG000|Overall Study|Not enrolled in 105 study|0|||
106125960|NCT03525574|366119886|FG001|Overall Study|Not enrolled in 105 study|3|||
106125961|NCT03772314|366119889|FG000|Overall Study|Adverse Event|7|||
106125962|NCT03772314|366119890|FG001|Overall Study|Adverse Event|2|||
106125963|NCT00579982|366119893|FG000|Overall Study|Adverse Event|4|||
106125964|NCT00579982|366119893|FG000|Overall Study|Protocol Violation|4|||
106125965|NCT00088205|366119894|FG000|Overall Study|Adverse Event|4|||
106125966|NCT00088205|366119894|FG000|Overall Study|Progressive Disease|51|||
106125967|NCT00088205|366119894|FG000|Overall Study|Physician Decision|1|||
106125968|NCT00088205|366119894|FG000|Overall Study|Death Due to Study Disease|4|||
106125969|NCT03192215|366119895|FG000|Overall Study|Death|28|||
106125970|NCT03192215|366119896|FG001|Overall Study|Death|23|||
106125971|NCT03192215|366119895|FG000|Overall Study|Lost to Follow-up|10|||
106125972|NCT03192215|366119896|FG001|Overall Study|Lost to Follow-up|15|||
106125973|NCT03192215|366119895|FG000|Overall Study|Withdrawal by Subject|49|||
106125974|NCT03192215|366119896|FG001|Overall Study|Withdrawal by Subject|48|||
106125975|NCT03192215|366119895|FG000|Overall Study|Other as reported in analysis|4|||
106125976|NCT03192215|366119896|FG001|Overall Study|Other as reported in analysis|1|||
106125977|NCT01364727|366119901|FG000|Overall Study|Not Eligible|2|||
106125978|NCT01558674|366119903|FG000|Part 1|Study Terminated by Sponsor|10|||
106125979|NCT01558674|366119904|FG001|Part 1|Study Terminated by Sponsor|0|||
106125980|NCT01558674|366119903|FG000|Part 1|Withdrawal by Subject|1|||
106125981|NCT01558674|366119904|FG001|Part 1|Withdrawal by Subject|0|||
106125982|NCT04147260|366119905|FG000|Overall Study|Adverse Event|1|||
106125983|NCT04147260|366119906|FG001|Overall Study|Adverse Event|0|||
106125984|NCT04147260|366119907|FG002|Overall Study|Adverse Event|1|||
106125985|NCT04147260|366119908|FG003|Overall Study|Adverse Event|2|||
106125986|NCT04147260|366119909|FG004|Overall Study|Adverse Event|0|||
106125987|NCT04147260|366119905|FG000|Overall Study|Withdrawal by Subject|0|||
106125988|NCT04147260|366119906|FG001|Overall Study|Withdrawal by Subject|0|||
106125989|NCT04147260|366119907|FG002|Overall Study|Withdrawal by Subject|1|||
106125990|NCT04147260|366119908|FG003|Overall Study|Withdrawal by Subject|1|||
106125991|NCT04147260|366119909|FG004|Overall Study|Withdrawal by Subject|0|||
106125992|NCT02411591|366119910|FG000|Overall Study|Adverse Event|0|||
106125993|NCT02411591|366119911|FG001|Overall Study|Adverse Event|4|||
106125994|NCT02411591|366119912|FG002|Overall Study|Adverse Event|2|||
106125995|NCT02411591|366119910|FG000|Overall Study|Withdrawal by Subject|0|||
106125996|NCT02411591|366119911|FG001|Overall Study|Withdrawal by Subject|3|||
106125997|NCT02411591|366119912|FG002|Overall Study|Withdrawal by Subject|0|||
106125998|NCT02411591|366119910|FG000|Overall Study|Physician Decision|0|||
106125999|NCT02411591|366119911|FG001|Overall Study|Physician Decision|3|||
106126000|NCT02411591|366119912|FG002|Overall Study|Physician Decision|1|||
106126001|NCT02954575|366119913|FG000|Overall Study|Withdrawal by Subject|2|||
106126002|NCT02954575|366119913|FG000|Overall Study|Adverse Event|1|||
106126003|NCT02204293|366119917|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
106000249|NCT01582061|365663318|FG000|Overall Study|Lack of Efficacy|3|||
106000250|NCT01582061|365663319|FG001|Overall Study|Lack of Efficacy|23|||
106000251|NCT01582061|365663318|FG000|Overall Study|Adverse Event|12|||
106000252|NCT01582061|365663319|FG001|Overall Study|Adverse Event|8|||
106000253|NCT01582061|365663318|FG000|Overall Study|Withdrawal by Subject|10|||
106000254|NCT01582061|365663319|FG001|Overall Study|Withdrawal by Subject|4|||
106000255|NCT01582061|365663318|FG000|Overall Study|Abnormal laboratory value(s)|1|||
106000256|NCT01582061|365663319|FG001|Overall Study|Abnormal laboratory value(s)|0|||
106000257|NCT01582061|365663318|FG000|Overall Study|Death|0|||
106000258|NCT01582061|365663319|FG001|Overall Study|Death|1|||
106000259|NCT01582061|365663318|FG000|Overall Study|condition no longer requires study drug|1|||
106000260|NCT01582061|365663319|FG001|Overall Study|condition no longer requires study drug|0|||
106000261|NCT01582061|365663318|FG000|Overall Study|Lost to Follow-up|1|||
106000262|NCT01582061|365663319|FG001|Overall Study|Lost to Follow-up|0|||
106000263|NCT01569841|365663320|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
106000264|NCT01569841|365663321|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
106000265|NCT01308736|365663329|FG000|Overall Study|Did not attend a single session|6|||
106000266|NCT01308736|365663330|FG001|Overall Study|Did not attend a single session|5|||
106000267|NCT03634085|365663331|FG000|Overall Study|Adverse Event|1|||
106000268|NCT03634085|365663332|FG001|Overall Study|Adverse Event|0|||
106000269|NCT03634085|365663331|FG000|Overall Study|Withdrawal by Subject|0|||
106000270|NCT03634085|365663332|FG001|Overall Study|Withdrawal by Subject|2|||
106000271|NCT00867165|365663339|FG000|Overall Study|Adverse Event|3|||
106126004|NCT02204293|366119918|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
106126005|NCT02204293|366119919|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
106126006|NCT02204293|366119920|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
106126007|NCT02204293|366119921|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
106126008|NCT02204293|366119922|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
106126009|NCT02204293|366119917|FG000|Core Study Part I|Adverse Event|1|||
106126010|NCT02204293|366119918|FG001|Core Study Part I|Adverse Event|0|||
106126011|NCT02204293|366119919|FG002|Core Study Part I|Adverse Event|0|||
106126012|NCT02204293|366119920|FG003|Core Study Part I|Adverse Event|0|||
106126013|NCT02204293|366119921|FG004|Core Study Part I|Adverse Event|0|||
106126014|NCT02204293|366119922|FG005|Core Study Part I|Adverse Event|0|||
106126015|NCT02204293|366119917|FG000|Core Study Part I|Physician Decision|0|||
106126016|NCT02204293|366119918|FG001|Core Study Part I|Physician Decision|3|||
106126017|NCT02204293|366119919|FG002|Core Study Part I|Physician Decision|0|||
106126018|NCT02204293|366119920|FG003|Core Study Part I|Physician Decision|0|||
106126019|NCT02204293|366119921|FG004|Core Study Part I|Physician Decision|0|||
106126020|NCT02204293|366119922|FG005|Core Study Part I|Physician Decision|0|||
106126021|NCT02204293|366119917|FG000|LTE Phase|Study Suspended|0|||
106000272|NCT00867165|365663340|FG001|Overall Study|Adverse Event|0|||
106000273|NCT00867165|365663339|FG000|Overall Study|Withdrawal by Subject|1|||
106000274|NCT00867165|365663340|FG001|Overall Study|Withdrawal by Subject|0|||
106000275|NCT03275740|365663341|FG000|Overall Study|Adverse Event|0|||
106000276|NCT03275740|365663342|FG001|Overall Study|Adverse Event|0|||
106000277|NCT03275740|365663343|FG002|Overall Study|Adverse Event|0|||
106000278|NCT03275740|365663344|FG003|Overall Study|Adverse Event|0|||
106000279|NCT03275740|365663345|FG004|Overall Study|Adverse Event|1|||
106000280|NCT03275740|365663346|FG005|Overall Study|Adverse Event|0|||
106000281|NCT03275740|365663347|FG006|Overall Study|Adverse Event|0|||
106000282|NCT03275740|365663348|FG007|Overall Study|Adverse Event|0|||
106000283|NCT03275740|365663349|FG008|Overall Study|Adverse Event|0|||
106000284|NCT03275740|365663350|FG009|Overall Study|Adverse Event|0|||
106000285|NCT03275740|365663351|FG010|Overall Study|Adverse Event|0|||
106000286|NCT03275740|365663352|FG011|Overall Study|Adverse Event|0|||
106126022|NCT02204293|366119918|FG001|LTE Phase|Study Suspended|0|||
106126023|NCT02204293|366119919|FG002|LTE Phase|Study Suspended|0|||
106126024|NCT02204293|366119920|FG003|LTE Phase|Study Suspended|0|||
106126025|NCT02204293|366119921|FG004|LTE Phase|Study Suspended|0|||
106126026|NCT02204293|366119922|FG005|LTE Phase|Study Suspended|7|||
106126027|NCT02420327|366119923|FG000|Overall Study|Adverse Event|7|||
106126028|NCT02420327|366119923|FG000|Overall Study|Pregnancy|1|||
106126029|NCT02420327|366119923|FG000|Overall Study|Withdrawal by Subject|6|||
106126030|NCT02420327|366119923|FG000|Overall Study|Lost to Follow-up|1|||
106000287|NCT03275740|365663341|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000288|NCT03275740|365663342|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000289|NCT03275740|365663343|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000290|NCT03275740|365663344|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000291|NCT03275740|365663345|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106126031|NCT02420327|366119923|FG000|Overall Study|Protocol Violation|1|||
106126032|NCT02589392|366119930|FG000|Overall Study|Adverse Event|1|||
106126033|NCT02589392|366119931|FG001|Overall Study|Adverse Event|1|||
106126034|NCT02589392|366119930|FG000|Overall Study|Withdrawal by Subject|1|||
106126035|NCT02589392|366119931|FG001|Overall Study|Withdrawal by Subject|2|||
106126036|NCT02589392|366119930|FG000|Overall Study|Protocol Violation|1|||
106126037|NCT02589392|366119931|FG001|Overall Study|Protocol Violation|1|||
105679119|NCT02407990|364486884|FG004|Overall Study|Withdrawal by Subject|1|||
105915112|NCT00492726|365348043|FG000|Overall Study|Non compliant with study medication|0|||
105679120|NCT02407990|364486885|FG005|Overall Study|Withdrawal by Subject|0|||
106126038|NCT02589392|366119930|FG000|Overall Study|Lost to Follow-up|2|||
106126039|NCT02589392|366119931|FG001|Overall Study|Lost to Follow-up|2|||
106126040|NCT02589392|366119930|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
106126041|NCT02589392|366119931|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
106126042|NCT04230980|366119934|FG000|Overall Study|Lost to Follow-up|1|||
106126043|NCT04230980|366119935|FG001|Overall Study|Lost to Follow-up|2|||
106126044|NCT04230980|366119934|FG000|Overall Study|Adverse Event|0|||
105915113|NCT00492726|365348044|FG001|Overall Study|Non compliant with study medication|3|||
105915114|NCT03390504|365348045|FG000|Overall Study|Lost to Follow-up|2|||
106126045|NCT04230980|366119935|FG001|Overall Study|Adverse Event|1|||
106126046|NCT04894903|366119944|FG000|Overall Study|Death|1|||
106126047|NCT04894903|366119945|FG001|Overall Study|Death|0|||
106126048|NCT04894903|366119944|FG000|Overall Study|Pregnancy|1|||
106126049|NCT04894903|366119945|FG001|Overall Study|Pregnancy|0|||
106126050|NCT04894903|366119944|FG000|Overall Study|Withdrawal by Subject|1|||
106126051|NCT04894903|366119945|FG001|Overall Study|Withdrawal by Subject|1|||
106126052|NCT04894903|366119944|FG000|Overall Study|moved or exited health system|1|||
106126053|NCT04894903|366119945|FG001|Overall Study|moved or exited health system|3|||
106126054|NCT04320615|366119946|FG000|Overall Study|Withdrawal by Subject|4|||
106126055|NCT04320615|366119947|FG001|Overall Study|Withdrawal by Subject|10|||
106126056|NCT04320615|366119946|FG000|Overall Study|Physician Decision|2|||
106126057|NCT04320615|366119947|FG001|Overall Study|Physician Decision|0|||
106126058|NCT04320615|366119946|FG000|Overall Study|Other|2|||
105915115|NCT03390504|365348046|FG001|Overall Study|Lost to Follow-up|4|||
105915116|NCT03390504|365348047|FG002|Overall Study|Lost to Follow-up|0|||
105915117|NCT03390504|365348048|FG003|Overall Study|Lost to Follow-up|1|||
105915118|NCT03390504|365348045|FG000|Overall Study|Withdrawal by Subject|3|||
105915119|NCT03390504|365348046|FG001|Overall Study|Withdrawal by Subject|15|||
105915120|NCT03390504|365348047|FG002|Overall Study|Withdrawal by Subject|5|||
106126059|NCT04320615|366119947|FG001|Overall Study|Other|0|||
106126060|NCT04320615|366119946|FG000|Overall Study|Lost to Follow-up|5|||
106126061|NCT04320615|366119947|FG001|Overall Study|Lost to Follow-up|23|||
105679121|NCT02407990|364486886|FG006|Overall Study|Withdrawal by Subject|0|||
105915121|NCT03390504|365348048|FG003|Overall Study|Withdrawal by Subject|2|||
105915122|NCT03390504|365348045|FG000|Overall Study|Other|1|||
105915123|NCT03390504|365348046|FG001|Overall Study|Other|2|||
105915124|NCT03390504|365348047|FG002|Overall Study|Other|2|||
105915125|NCT03390504|365348048|FG003|Overall Study|Other|6|||
105915126|NCT03492177|365348053|FG000|Overall Study|Adverse Event|1|||
105915127|NCT03492177|365348054|FG001|Overall Study|Adverse Event|0|||
105915128|NCT03492177|365348055|FG002|Overall Study|Adverse Event|0|||
105915129|NCT03492177|365348053|FG000|Overall Study|Death|3|||
105915130|NCT03492177|365348054|FG001|Overall Study|Death|0|||
105915131|NCT03492177|365348055|FG002|Overall Study|Death|3|||
105915132|NCT03492177|365348053|FG000|Overall Study|Lack of Efficacy|1|||
105915133|NCT03492177|365348054|FG001|Overall Study|Lack of Efficacy|2|||
105915134|NCT03492177|365348055|FG002|Overall Study|Lack of Efficacy|0|||
105915135|NCT03492177|365348053|FG000|Overall Study|Other|1|||
105915136|NCT03492177|365348054|FG001|Overall Study|Other|0|||
105915137|NCT03492177|365348055|FG002|Overall Study|Other|0|||
105915138|NCT03492177|365348053|FG000|Overall Study|Ongoing|16|||
105915139|NCT03492177|365348054|FG001|Overall Study|Ongoing|19|||
105915140|NCT03492177|365348055|FG002|Overall Study|Ongoing|17|||
105915141|NCT05158140|365348058|FG000|Overall Study|Death|0|||
105915142|NCT05158140|365348059|FG001|Overall Study|Death|0|||
105915143|NCT05158140|365348060|FG002|Overall Study|Death|0|||
105915144|NCT05158140|365348061|FG003|Overall Study|Death|1|||
105915145|NCT05158140|365348058|FG000|Overall Study|Lost to Follow-up|3|||
105915146|NCT05158140|365348059|FG001|Overall Study|Lost to Follow-up|6|||
106126062|NCT04320615|366119946|FG000|Overall Study|Death|35|||
106126063|NCT04320615|366119947|FG001|Overall Study|Death|71|||
106126064|NCT00895843|366119948|FG000|Overall Study|Protocol Violation|12|||
105915147|NCT05158140|365348060|FG002|Overall Study|Lost to Follow-up|4|||
105915148|NCT05158140|365348061|FG003|Overall Study|Lost to Follow-up|3|||
105915149|NCT05158140|365348058|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105915150|NCT05158140|365348059|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105915151|NCT05158140|365348060|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
105915152|NCT05158140|365348061|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105915153|NCT05158140|365348058|FG000|Overall Study|Withdrawal by Subject|3|||
105915154|NCT05158140|365348059|FG001|Overall Study|Withdrawal by Subject|7|||
106126065|NCT00895843|366119949|FG001|Overall Study|Protocol Violation|12|||
105679122|NCT02407990|364486887|FG007|Overall Study|Withdrawal by Subject|30|||
105915155|NCT05158140|365348060|FG002|Overall Study|Withdrawal by Subject|3|||
105915156|NCT05158140|365348061|FG003|Overall Study|Withdrawal by Subject|7|||
106126066|NCT04963062|366119950|FG000|Overall Study|withdrew by the study team|4|||
106126067|NCT04963062|366119951|FG001|Overall Study|withdrew by the study team|2|||
106126068|NCT01857323|366119952|FG000|Overall Study|Adverse Event|1|||
106126069|NCT01857323|366119952|FG000|Overall Study|Withdrawal by Subject|3|||
106126070|NCT01857323|366119952|FG000|Overall Study|Non-compliance|1|||
106126071|NCT01857323|366119952|FG000|Overall Study|Protocol Violation|6|||
106126072|NCT01857323|366119952|FG000|Overall Study|Lost to Follow-up|1|||
106126073|NCT01857323|366119952|FG000|Overall Study|Other|4|||
106126074|NCT01857323|366119952|FG000|Overall Study|Did not complete 180 doses|48|||
106126075|NCT01815736|366119953|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
106126076|NCT01815736|366119954|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
106126077|NCT01815736|366119953|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
106126078|NCT01815736|366119954|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
106126079|NCT01815736|366119953|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
105915157|NCT03882918|365348062|FG000|Overall Study|Study terminated by sponsor|98|||
105915158|NCT03882918|365348062|FG000|Overall Study|Protocol Violation|1|||
105915159|NCT03882918|365348062|FG000|Overall Study|Other|9|||
105915160|NCT03882918|365348062|FG000|Overall Study|Lack of Efficacy|14|||
105915161|NCT03882918|365348062|FG000|Overall Study|Adverse Event|13|||
105915162|NCT03882918|365348062|FG000|Overall Study|Withdrawal by Subject|5|||
105915163|NCT03141359|365348063|FG000|Overall Study|Death|32|||
105915164|NCT03141359|365348063|FG000|Overall Study|Still On Study (in follow up)|29|||
105915165|NCT04647253|365348064|FG000|Overall Study|Death ≤ 365 Days|16|||
105915166|NCT04647253|365348065|FG001|Overall Study|Death ≤ 365 Days|7|||
105915167|NCT04647253|365348064|FG000|Overall Study|Physician Decision|0|||
106000292|NCT03275740|365663346|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
106000293|NCT03275740|365663347|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106126080|NCT01815736|366119954|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
106126081|NCT01815736|366119953|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
106126082|NCT01815736|366119954|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
106126083|NCT01815736|366119953|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
106126084|NCT01815736|366119954|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
106126085|NCT01815736|366119953|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
106126086|NCT01815736|366119954|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
106126087|NCT01815736|366119953|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
106126088|NCT01815736|366119954|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
105915168|NCT04647253|365348065|FG001|Overall Study|Physician Decision|1|||
105915169|NCT04647253|365348064|FG000|Overall Study|Withdrawal by Subject|7|||
105915170|NCT04647253|365348065|FG001|Overall Study|Withdrawal by Subject|2|||
105915171|NCT04647253|365348064|FG000|Overall Study|Missed 12-Month Visit|9|||
105915172|NCT04647253|365348065|FG001|Overall Study|Missed 12-Month Visit|7|||
105679123|NCT02407990|364486880|FG000|Overall Study|Study Terminated by Sponsor|1|||
105679124|NCT02407990|364486881|FG001|Overall Study|Study Terminated by Sponsor|3|||
106000294|NCT03275740|365663348|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000295|NCT03275740|365663349|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000296|NCT03275740|365663350|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000297|NCT03275740|365663351|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000298|NCT03275740|365663352|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
106000299|NCT03275740|365663341|FG000|Overall Study|Withdrawal by Subject|0|||
106000300|NCT03275740|365663342|FG001|Overall Study|Withdrawal by Subject|0|||
106000301|NCT03275740|365663343|FG002|Overall Study|Withdrawal by Subject|0|||
106000302|NCT03275740|365663344|FG003|Overall Study|Withdrawal by Subject|0|||
106000303|NCT03275740|365663345|FG004|Overall Study|Withdrawal by Subject|0|||
106000304|NCT03275740|365663346|FG005|Overall Study|Withdrawal by Subject|0|||
106000305|NCT03275740|365663347|FG006|Overall Study|Withdrawal by Subject|0|||
105679125|NCT02407990|364486882|FG002|Overall Study|Study Terminated by Sponsor|3|||
105679126|NCT02407990|364486883|FG003|Overall Study|Study Terminated by Sponsor|0|||
105679127|NCT02407990|364486884|FG004|Overall Study|Study Terminated by Sponsor|3|||
105679128|NCT02407990|364486885|FG005|Overall Study|Study Terminated by Sponsor|4|||
106000306|NCT03275740|365663348|FG007|Overall Study|Withdrawal by Subject|0|||
106126089|NCT01815736|366119953|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
106126090|NCT01815736|366119954|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
106000307|NCT03275740|365663349|FG008|Overall Study|Withdrawal by Subject|1|||
106000308|NCT03275740|365663350|FG009|Overall Study|Withdrawal by Subject|1|||
106000309|NCT03275740|365663351|FG010|Overall Study|Withdrawal by Subject|0|||
106000310|NCT03275740|365663352|FG011|Overall Study|Withdrawal by Subject|0|||
106000311|NCT02920892|365663353|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
106000312|NCT02920892|365663354|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
106000313|NCT02920892|365663355|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
106000314|NCT02920892|365663353|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
106000315|NCT02920892|365663354|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
106000316|NCT02920892|365663355|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
106000317|NCT02920892|365663353|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
106000318|NCT02920892|365663354|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
106000319|NCT02920892|365663355|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
106000320|NCT02920892|365663353|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
106000321|NCT02920892|365663354|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
106000322|NCT02920892|365663355|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
106000323|NCT02920892|365663353|FG000|Placebo-Controlled Period|Physician Decision|0|||
106000324|NCT02920892|365663354|FG001|Placebo-Controlled Period|Physician Decision|0|||
106000325|NCT02920892|365663355|FG002|Placebo-Controlled Period|Physician Decision|1|||
106000326|NCT02920892|365663353|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
106000327|NCT02920892|365663354|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
106000328|NCT02920892|365663355|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
106000329|NCT02920892|365663353|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
106000330|NCT02920892|365663354|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
106000331|NCT02920892|365663355|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
106000332|NCT02920892|365663353|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
106000333|NCT02920892|365663354|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
106000334|NCT02920892|365663355|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
106000335|NCT02336607|365663356|FG000|Overall Study|Physician Decision|1|||
106000336|NCT02336607|365663357|FG001|Overall Study|Physician Decision|4|||
106000337|NCT02336607|365663358|FG002|Overall Study|Physician Decision|3|||
106000338|NCT02336607|365663359|FG003|Overall Study|Physician Decision|15|||
106000339|NCT02336607|365663356|FG000|Overall Study|Lack of Efficacy|1|||
106000340|NCT02336607|365663357|FG001|Overall Study|Lack of Efficacy|0|||
106000341|NCT02336607|365663358|FG002|Overall Study|Lack of Efficacy|0|||
106000342|NCT02336607|365663359|FG003|Overall Study|Lack of Efficacy|2|||
106000343|NCT02336607|365663356|FG000|Overall Study|Lost to Follow-up|2|||
106000344|NCT02336607|365663357|FG001|Overall Study|Lost to Follow-up|1|||
106000345|NCT02336607|365663358|FG002|Overall Study|Lost to Follow-up|0|||
106000346|NCT02336607|365663359|FG003|Overall Study|Lost to Follow-up|21|||
106000347|NCT02336607|365663356|FG000|Overall Study|Protocol Violation|0|||
106000348|NCT02336607|365663357|FG001|Overall Study|Protocol Violation|1|||
106000349|NCT02336607|365663358|FG002|Overall Study|Protocol Violation|1|||
106000350|NCT02336607|365663359|FG003|Overall Study|Protocol Violation|3|||
106000351|NCT02336607|365663356|FG000|Overall Study|Adverse Event|0|||
106000352|NCT02336607|365663357|FG001|Overall Study|Adverse Event|2|||
106000353|NCT02336607|365663358|FG002|Overall Study|Adverse Event|2|||
106000354|NCT02336607|365663359|FG003|Overall Study|Adverse Event|26|||
106000355|NCT02336607|365663356|FG000|Overall Study|Withdrawal by Subject|0|||
106000356|NCT02336607|365663357|FG001|Overall Study|Withdrawal by Subject|2|||
106000357|NCT02336607|365663358|FG002|Overall Study|Withdrawal by Subject|0|||
106000358|NCT02336607|365663359|FG003|Overall Study|Withdrawal by Subject|20|||
106000359|NCT00721396|365663361|FG000|Overall Study|Adverse Event|4|||
106000360|NCT00721396|365663362|FG001|Overall Study|Adverse Event|7|||
106000361|NCT00721396|365663363|FG002|Overall Study|Adverse Event|2|||
106000362|NCT00721396|365663364|FG003|Overall Study|Adverse Event|0|||
106000363|NCT00721396|365663361|FG000|Overall Study|Withdrawal by Subject|12|||
106000364|NCT00721396|365663362|FG001|Overall Study|Withdrawal by Subject|15|||
106000365|NCT00721396|365663363|FG002|Overall Study|Withdrawal by Subject|3|||
106000366|NCT00721396|365663364|FG003|Overall Study|Withdrawal by Subject|7|||
106000367|NCT00721396|365663361|FG000|Overall Study|Lost to Follow-up|7|||
106000368|NCT00721396|365663362|FG001|Overall Study|Lost to Follow-up|9|||
106000369|NCT00721396|365663363|FG002|Overall Study|Lost to Follow-up|3|||
106000370|NCT00721396|365663364|FG003|Overall Study|Lost to Follow-up|3|||
106000371|NCT00721396|365663361|FG000|Overall Study|Protocol Violation|4|||
106126091|NCT01815736|366119953|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
106126092|NCT01815736|366119954|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
106126093|NCT01815736|366119953|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
106000372|NCT00721396|365663362|FG001|Overall Study|Protocol Violation|3|||
106000373|NCT00721396|365663363|FG002|Overall Study|Protocol Violation|1|||
106000374|NCT00721396|365663364|FG003|Overall Study|Protocol Violation|0|||
106000375|NCT00721396|365663361|FG000|Overall Study|Inappropriate enrollment|0|||
106000376|NCT00721396|365663362|FG001|Overall Study|Inappropriate enrollment|2|||
106000377|NCT00721396|365663363|FG002|Overall Study|Inappropriate enrollment|0|||
106126094|NCT01815736|366119954|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
106126095|NCT01815736|366119953|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
106126096|NCT01815736|366119954|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
106126097|NCT01815736|366119953|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
106126098|NCT01815736|366119954|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
106126099|NCT01815736|366119953|FG000|Extension Treatment Phase- After Week 96|Death|1|||
106126100|NCT01815736|366119954|FG001|Extension Treatment Phase- After Week 96|Death|0|||
106126101|NCT03040687|366119955|FG000|Overall Study|Withdrawal by Subject|1|||
106126102|NCT03040687|366119956|FG001|Overall Study|Withdrawal by Subject|0|||
106126103|NCT03040687|366119957|FG002|Overall Study|Withdrawal by Subject|0|||
106126104|NCT00550173|366119958|FG000|Overall Study|Death|45|||
106126105|NCT00550173|366119959|FG001|Overall Study|Death|38|||
106126106|NCT00550173|366119960|FG002|Overall Study|Death|50|||
106126107|NCT00550173|366119958|FG000|Overall Study|Physician Decision|1|||
106126108|NCT00550173|366119959|FG001|Overall Study|Physician Decision|2|||
106126109|NCT00550173|366119960|FG002|Overall Study|Physician Decision|2|||
106126110|NCT00550173|366119958|FG000|Overall Study|Withdrawal by Subject|9|||
106126111|NCT00550173|366119959|FG001|Overall Study|Withdrawal by Subject|12|||
106126112|NCT00550173|366119960|FG002|Overall Study|Withdrawal by Subject|17|||
106126113|NCT00550173|366119958|FG000|Overall Study|Sponsor Decision|13|||
106126114|NCT00550173|366119959|FG001|Overall Study|Sponsor Decision|7|||
106126115|NCT00550173|366119960|FG002|Overall Study|Sponsor Decision|1|||
106126116|NCT00550173|366119958|FG000|Overall Study|Lost to Follow-up|4|||
106126117|NCT00550173|366119959|FG001|Overall Study|Lost to Follow-up|4|||
106126118|NCT00550173|366119960|FG002|Overall Study|Lost to Follow-up|3|||
106126119|NCT00810641|366119961|FG000|Overall Study|Withdrawal by Subject|0|||
106126120|NCT00810641|366119962|FG001|Overall Study|Withdrawal by Subject|1|||
106126121|NCT00810641|366119963|FG002|Overall Study|Withdrawal by Subject|2|||
106126122|NCT02325713|366119964|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126123|NCT02325713|366119965|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126124|NCT02325713|366119966|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126125|NCT02325713|366119967|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126126|NCT02325713|366119968|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126127|NCT02325713|366119969|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126128|NCT02325713|366119970|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126129|NCT02325713|366119971|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126130|NCT02325713|366119972|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126131|NCT02325713|366119973|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126132|NCT02325713|366119974|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
106126133|NCT02325713|366119975|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126134|NCT02325713|366119976|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126135|NCT02325713|366119977|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126136|NCT02325713|366119978|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126137|NCT02325713|366119979|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
106126138|NCT02325713|366119964|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
106126139|NCT02325713|366119965|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126140|NCT02325713|366119966|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126141|NCT02325713|366119967|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126142|NCT02325713|366119968|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126143|NCT02325713|366119969|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126144|NCT02325713|366119970|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126145|NCT02325713|366119971|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126146|NCT02325713|366119972|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126147|NCT02325713|366119973|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126148|NCT02325713|366119974|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126149|NCT02325713|366119975|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
105952085|NCT03314935|365488196|FG012|Phase 1|Progressive Disease|0|||
105952086|NCT03314935|365488197|FG013|Phase 1|Progressive Disease|0|||
105952087|NCT03314935|365488198|FG014|Phase 1|Progressive Disease|0|||
105952088|NCT03314935|365488184|FG000|Phase 1|Study Terminated by Sponsor|0|||
105952089|NCT03314935|365488185|FG001|Phase 1|Study Terminated by Sponsor|1|||
105952090|NCT03314935|365488186|FG002|Phase 1|Study Terminated by Sponsor|0|||
105952091|NCT03314935|365488187|FG003|Phase 1|Study Terminated by Sponsor|0|||
105952092|NCT03314935|365488188|FG004|Phase 1|Study Terminated by Sponsor|0|||
105952093|NCT03314935|365488189|FG005|Phase 1|Study Terminated by Sponsor|0|||
105952094|NCT03314935|365488190|FG006|Phase 1|Study Terminated by Sponsor|0|||
105952095|NCT03314935|365488191|FG007|Phase 1|Study Terminated by Sponsor|0|||
105952096|NCT03314935|365488192|FG008|Phase 1|Study Terminated by Sponsor|1|||
105952097|NCT03314935|365488193|FG009|Phase 1|Study Terminated by Sponsor|0|||
106126150|NCT02325713|366119976|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126151|NCT02325713|366119977|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126152|NCT02325713|366119978|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126153|NCT02325713|366119979|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
106126154|NCT02325713|366119964|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126155|NCT02325713|366119965|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126156|NCT02325713|366119966|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126157|NCT02325713|366119967|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126158|NCT02325713|366119968|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126159|NCT02325713|366119969|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126160|NCT02325713|366119970|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126161|NCT02325713|366119971|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126162|NCT02325713|366119972|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126163|NCT02325713|366119973|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
106126164|NCT02325713|366119974|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126165|NCT02325713|366119975|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126166|NCT02325713|366119976|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126167|NCT02325713|366119977|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126168|NCT02325713|366119978|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126169|NCT02325713|366119979|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
106126170|NCT01213173|366119981|FG000|Overall Study|Protocol Violation|2|||
106126171|NCT01213173|366119982|FG001|Overall Study|Protocol Violation|0|||
106126172|NCT01213173|366119981|FG000|Overall Study|Adverse Event|4|||
106126173|NCT01213173|366119982|FG001|Overall Study|Adverse Event|8|||
106000378|NCT00721396|365663364|FG003|Overall Study|Inappropriate enrollment|0|||
106000379|NCT00721396|365663361|FG000|Overall Study|Administrative reason|3|||
106000380|NCT00721396|365663362|FG001|Overall Study|Administrative reason|0|||
106000381|NCT00721396|365663363|FG002|Overall Study|Administrative reason|1|||
106000382|NCT00721396|365663364|FG003|Overall Study|Administrative reason|0|||
106000383|NCT00580723|365663365|FG000|Overall Study|Did not want to participate in extension|3|||
106000384|NCT00580723|365663365|FG000|Overall Study|Lost to Follow-up|5|||
106000385|NCT05202418|365663366|FG000|Overall Study|Withdrawal by Subject|2|||
106000386|NCT05202418|365663367|FG001|Overall Study|Withdrawal by Subject|1|||
106000387|NCT05202418|365663366|FG000|Overall Study|Lost to Follow-up|1|||
106000388|NCT05202418|365663367|FG001|Overall Study|Lost to Follow-up|1|||
106000389|NCT01454596|365663368|FG000|Overall Study|Death|0|||
106000390|NCT01454596|365663369|FG001|Overall Study|Death|0|||
106000391|NCT01454596|365663370|FG002|Overall Study|Death|0|||
106000392|NCT01454596|365663371|FG003|Overall Study|Death|0|||
106000393|NCT01454596|365663372|FG004|Overall Study|Death|0|||
106000394|NCT01454596|365663373|FG005|Overall Study|Death|0|||
106000395|NCT01454596|365663374|FG006|Overall Study|Death|0|||
106000396|NCT01454596|365663375|FG007|Overall Study|Death|0|||
106000397|NCT01454596|365663376|FG008|Overall Study|Death|0|||
106000398|NCT01454596|365663377|FG009|Overall Study|Death|1|||
106000399|NCT01454596|365663378|FG010|Overall Study|Death|1|||
106000400|NCT01454596|365663379|FG011|Overall Study|Death|0|||
106000401|NCT00857285|365663387|FG000|Overall Study|Adverse Event|4|||
106000402|NCT00857285|365663388|FG001|Overall Study|Adverse Event|2|||
106000403|NCT00857285|365663387|FG000|Overall Study|Lack of Efficacy|0|||
106000404|NCT00857285|365663388|FG001|Overall Study|Lack of Efficacy|2|||
106000405|NCT00857285|365663387|FG000|Overall Study|Protocol Violation|3|||
106000406|NCT00857285|365663388|FG001|Overall Study|Protocol Violation|1|||
106000407|NCT00857285|365663387|FG000|Overall Study|Withdrawal by Subject|4|||
106000408|NCT00857285|365663388|FG001|Overall Study|Withdrawal by Subject|0|||
106000409|NCT00857285|365663387|FG000|Overall Study|Randomization criteria not met|1|||
106000410|NCT00857285|365663388|FG001|Overall Study|Randomization criteria not met|1|||
106000411|NCT00880698|365663389|FG000|Overall Study|Death|0|||
106000412|NCT00880698|365663390|FG001|Overall Study|Death|0|||
106126174|NCT01213173|366119981|FG000|Overall Study|Withdrawal by Subject|5|||
106126175|NCT01213173|366119982|FG001|Overall Study|Withdrawal by Subject|5|||
106126176|NCT01213173|366119981|FG000|Overall Study|Incorrect Enrollment|1|||
105679129|NCT02407990|364486886|FG006|Overall Study|Study Terminated by Sponsor|3|||
105679130|NCT02407990|364486887|FG007|Overall Study|Study Terminated by Sponsor|37|||
105679131|NCT02407990|364486880|FG000|Overall Study|Logistics|0|||
105679132|NCT02407990|364486881|FG001|Overall Study|Logistics|0|||
106000413|NCT00880698|365663391|FG002|Overall Study|Death|1|||
106000414|NCT00880698|365663392|FG003|Overall Study|Death|2|||
106000415|NCT00880698|365663389|FG000|Overall Study|Lost to Follow-up|1|||
106000416|NCT00880698|365663390|FG001|Overall Study|Lost to Follow-up|3|||
106000417|NCT00880698|365663391|FG002|Overall Study|Lost to Follow-up|0|||
106000418|NCT00880698|365663392|FG003|Overall Study|Lost to Follow-up|1|||
106000419|NCT02021565|365663406|FG000|Baseline Through Intervention|Death|0|||
106000420|NCT02021565|365663407|FG001|Baseline Through Intervention|Death|1|||
106126177|NCT01213173|366119982|FG001|Overall Study|Incorrect Enrollment|3|||
106126178|NCT02353832|366119985|FG000|Overall Study|Ineligible after enrollment|1|||
106126179|NCT02353832|366119985|FG000|Overall Study|Lost to Follow-up|1|||
106126180|NCT02684903|366119986|FG000|Overall Study|COVID-19 shutdown of lab|4|||
106126181|NCT02684903|366119987|FG001|Overall Study|COVID-19 shutdown of lab|6|||
106126182|NCT02684903|366119986|FG000|Overall Study|Lost to Follow-up|31|||
106126183|NCT02684903|366119987|FG001|Overall Study|Lost to Follow-up|41|||
106126184|NCT04880161|366119988|FG000|Overall Study|Withdrawal by Subject|1|||
106126185|NCT04880161|366119989|FG001|Overall Study|Withdrawal by Subject|0|||
106126186|NCT04880161|366119988|FG000|Overall Study|Lack of Compliance|1|||
106126187|NCT04880161|366119989|FG001|Overall Study|Lack of Compliance|1|||
106126188|NCT04880161|366119988|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
106126189|NCT04880161|366119989|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
106126190|NCT04880161|366119988|FG000|Overall Study|Screen Failure|0|||
106126191|NCT04880161|366119989|FG001|Overall Study|Screen Failure|1|||
106126192|NCT00904150|366119990|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
106126193|NCT00904150|366119991|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
106126194|NCT00904150|366119990|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
106126195|NCT00904150|366119991|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
106126196|NCT01354106|366119992|FG000|Overall Study|Withdrawal by Subject|2|||
106126197|NCT01475786|366119994|FG000|Overall Study|Adverse Event|0|||
106126198|NCT01475786|366119995|FG001|Overall Study|Adverse Event|1|||
106126199|NCT01475786|366119996|FG002|Overall Study|Adverse Event|0|||
106126200|NCT01475786|366119994|FG000|Overall Study|Lost to Follow-up|1|||
106126201|NCT01475786|366119995|FG001|Overall Study|Lost to Follow-up|2|||
106126202|NCT01475786|366119996|FG002|Overall Study|Lost to Follow-up|1|||
106126203|NCT01475786|366119994|FG000|Overall Study|Withdrawal by Subject|0|||
106126204|NCT01475786|366119995|FG001|Overall Study|Withdrawal by Subject|1|||
106126205|NCT01475786|366119996|FG002|Overall Study|Withdrawal by Subject|1|||
106126206|NCT01475786|366119994|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
106126207|NCT01475786|366119995|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
106126208|NCT01475786|366119996|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
106126209|NCT00802737|366121885|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
106126210|NCT00802737|366121886|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
106126211|NCT00802737|366121887|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
106126212|NCT00802737|366121885|FG000|Overall Study|Death|6|||
106126213|NCT00802737|366121886|FG001|Overall Study|Death|5|||
106126214|NCT00802737|366121887|FG002|Overall Study|Death|1|||
106126215|NCT00802737|366121885|FG000|Overall Study|Adverse Event|1|||
106126216|NCT00802737|366121886|FG001|Overall Study|Adverse Event|0|||
106126217|NCT00802737|366121887|FG002|Overall Study|Adverse Event|0|||
106126218|NCT00802737|366121885|FG000|Overall Study|Received Prohibited Therapy|1|||
105915173|NCT04647253|365348064|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
105915174|NCT04647253|365348065|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
105915175|NCT05079321|365348066|FG000|Overall Study|Withdrawal by Subject|2|||
105915176|NCT05079321|365348067|FG001|Overall Study|Withdrawal by Subject|2|||
106126219|NCT00802737|366121886|FG001|Overall Study|Received Prohibited Therapy|0|||
106126220|NCT00802737|366121887|FG002|Overall Study|Received Prohibited Therapy|0|||
106126221|NCT00802737|366121885|FG000|Overall Study|Ongoing CLL-Treatment|0|||
106126222|NCT00802737|366121886|FG001|Overall Study|Ongoing CLL-Treatment|1|||
106126223|NCT00802737|366121887|FG002|Overall Study|Ongoing CLL-Treatment|0|||
106126224|NCT00802737|366121885|FG000|Overall Study|Participant too Unwell|0|||
106126225|NCT00802737|366121886|FG001|Overall Study|Participant too Unwell|2|||
105915177|NCT05079321|365348066|FG000|Overall Study|Lost to Follow-up|0|||
105915178|NCT05079321|365348067|FG001|Overall Study|Lost to Follow-up|1|||
105915179|NCT00473655|365349236|FG000|Overall Study|Lost to Follow-up|9|||
105915180|NCT00473655|365349237|FG001|Overall Study|Lost to Follow-up|5|||
105915181|NCT00473655|365349238|FG002|Overall Study|Lost to Follow-up|8|||
105915182|NCT03439137|365349239|FG000|Overall Study|Adverse Event|16|||
105915183|NCT03439137|365349240|FG001|Overall Study|Adverse Event|12|||
105915184|NCT03439137|365349239|FG000|Overall Study|Physician Decision|0|||
105915185|NCT03439137|365349240|FG001|Overall Study|Physician Decision|5|||
106000421|NCT02021565|365663406|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
106000422|NCT02021565|365663407|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
106000423|NCT02021565|365663406|FG000|Baseline Through Intervention|Protocol Violation|0|||
105915186|NCT03439137|365349239|FG000|Overall Study|Withdrawal by Subject|14|||
105915187|NCT03439137|365349240|FG001|Overall Study|Withdrawal by Subject|4|||
106126226|NCT00802737|366121887|FG002|Overall Study|Participant too Unwell|0|||
106126227|NCT01349829|366121888|FG000|Overall Study|Lost to Follow-up|4|||
106126228|NCT01349829|366121889|FG001|Overall Study|Lost to Follow-up|8|||
106126229|NCT01349829|366121888|FG000|Overall Study|Consent withdrawal|3|||
106126230|NCT01349829|366121889|FG001|Overall Study|Consent withdrawal|8|||
106126231|NCT01349829|366121888|FG000|Overall Study|Migrated/moved|2|||
106126232|NCT01349829|366121889|FG001|Overall Study|Migrated/moved|7|||
106126233|NCT01625910|366121891|FG000|Overall Study|Lost to Follow-up|3|||
106126234|NCT01625910|366121892|FG001|Overall Study|Lost to Follow-up|4|||
106126235|NCT01327547|366121893|FG000|Overall Study|Adverse Event|4|||
106126236|NCT01327547|366121894|FG001|Overall Study|Adverse Event|1|||
106126237|NCT01327547|366121893|FG000|Overall Study|Death|1|||
106126238|NCT01327547|366121894|FG001|Overall Study|Death|2|||
106126239|NCT01327547|366121893|FG000|Overall Study|Lost to Follow-up|6|||
106126240|NCT01327547|366121894|FG001|Overall Study|Lost to Follow-up|6|||
106126241|NCT01327547|366121893|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
106126242|NCT01327547|366121894|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
106126243|NCT01327547|366121893|FG000|Overall Study|Withdrawal by Subject|3|||
106126244|NCT01327547|366121894|FG001|Overall Study|Withdrawal by Subject|7|||
106126245|NCT01327547|366121893|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
106126246|NCT01327547|366121894|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
106126247|NCT01327547|366121893|FG000|Overall Study|Protocol Violation|1|||
106126248|NCT01327547|366121894|FG001|Overall Study|Protocol Violation|0|||
106126249|NCT01327547|366121893|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
106126250|NCT01327547|366121894|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
106126251|NCT01327547|366121893|FG000|Overall Study|Required prohibited medication|2|||
106126252|NCT01327547|366121894|FG001|Overall Study|Required prohibited medication|0|||
106126253|NCT01327547|366121893|FG000|Overall Study|Non-compliance with study procedures|1|||
106126254|NCT01327547|366121894|FG001|Overall Study|Non-compliance with study procedures|0|||
106126255|NCT01327547|366121893|FG000|Overall Study|By investigator in subject's interest|0|||
106126256|NCT01327547|366121894|FG001|Overall Study|By investigator in subject's interest|1|||
106126257|NCT03943589|366121898|FG000|Overall Study|Death|1|||
106126258|NCT03943589|366121898|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
106126259|NCT00900627|366121899|FG000|Overall Study|Condition under investigation worsened|4|||
106126260|NCT00900627|366121900|FG001|Overall Study|Condition under investigation worsened|0|||
106126261|NCT00900627|366121901|FG002|Overall Study|Condition under investigation worsened|5|||
106126262|NCT00900627|366121902|FG003|Overall Study|Condition under investigation worsened|3|||
106126263|NCT00900627|366121903|FG004|Overall Study|Condition under investigation worsened|0|||
106126264|NCT00900627|366121904|FG005|Overall Study|Condition under investigation worsened|0|||
106126265|NCT00900627|366121899|FG000|Overall Study|Withdrawal by Subject|1|||
106126266|NCT00900627|366121900|FG001|Overall Study|Withdrawal by Subject|0|||
106126267|NCT00900627|366121901|FG002|Overall Study|Withdrawal by Subject|1|||
106126268|NCT00900627|366121902|FG003|Overall Study|Withdrawal by Subject|0|||
106126269|NCT00900627|366121903|FG004|Overall Study|Withdrawal by Subject|1|||
106126270|NCT00900627|366121904|FG005|Overall Study|Withdrawal by Subject|2|||
106126271|NCT00900627|366121899|FG000|Overall Study|Adverse Event|1|||
106126272|NCT00900627|366121900|FG001|Overall Study|Adverse Event|2|||
106126273|NCT00900627|366121901|FG002|Overall Study|Adverse Event|0|||
106126274|NCT00900627|366121902|FG003|Overall Study|Adverse Event|3|||
106126275|NCT00900627|366121903|FG004|Overall Study|Adverse Event|0|||
106126276|NCT00900627|366121904|FG005|Overall Study|Adverse Event|0|||
106126277|NCT00900627|366121899|FG000|Overall Study|Death|0|||
106126278|NCT00900627|366121900|FG001|Overall Study|Death|0|||
106126279|NCT00900627|366121901|FG002|Overall Study|Death|0|||
106126280|NCT00900627|366121902|FG003|Overall Study|Death|0|||
105915188|NCT03439137|365349239|FG000|Overall Study|Conducting rescue therapy|2|||
105915189|NCT03439137|365349240|FG001|Overall Study|Conducting rescue therapy|1|||
105915190|NCT03439137|365349239|FG000|Overall Study|Difficult to control Hb|10|||
105915191|NCT03439137|365349240|FG001|Overall Study|Difficult to control Hb|2|||
105915192|NCT03439137|365349239|FG000|Overall Study|Initiation of a renal transplant|0|||
105915193|NCT03439137|365349240|FG001|Overall Study|Initiation of a renal transplant|2|||
105915194|NCT01240382|365349241|FG000|Overall Study|Adverse Event|2|||
105915195|NCT01240382|365349242|FG001|Overall Study|Adverse Event|1|||
105915196|NCT01240382|365349241|FG000|Overall Study|Lack of Efficacy|0|||
105915197|NCT01240382|365349242|FG001|Overall Study|Lack of Efficacy|2|||
105915198|NCT01240382|365349241|FG000|Overall Study|Fear of adverse events|0|||
105915199|NCT01240382|365349242|FG001|Overall Study|Fear of adverse events|1|||
105915200|NCT01408706|365349247|FG000|Overall Study|Physician Decision|1|||
105915201|NCT01408706|365349248|FG001|Overall Study|Physician Decision|0|||
105915202|NCT01268267|365349249|FG000|Overall Study|Protocol Violation|1|||
105915203|NCT04919317|365349253|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
105915204|NCT04919317|365349254|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
105915205|NCT04919317|365349253|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
105915206|NCT04919317|365349254|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
106126281|NCT00900627|366121903|FG004|Overall Study|Death|28|||
106126282|NCT00900627|366121904|FG005|Overall Study|Death|24|||
106126283|NCT00506285|366121911|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
106126284|NCT00506285|366121912|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
106126285|NCT00506285|366121911|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
106126286|NCT00506285|366121912|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
106126287|NCT00506285|366121911|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
105915207|NCT00698815|365349255|FG000|Overall Study|Death|1|||
105915208|NCT00698815|365349256|FG001|Overall Study|Death|2|||
105915209|NCT00698815|365349257|FG002|Overall Study|Death|4|||
105915210|NCT00698815|365349255|FG000|Overall Study|Withdrawal by Subject|6|||
105915211|NCT00698815|365349256|FG001|Overall Study|Withdrawal by Subject|3|||
105915212|NCT00698815|365349257|FG002|Overall Study|Withdrawal by Subject|2|||
105915213|NCT00698815|365349255|FG000|Overall Study|MD discretion|2|||
105915214|NCT00698815|365349256|FG001|Overall Study|MD discretion|7|||
105915215|NCT00698815|365349257|FG002|Overall Study|MD discretion|2|||
105915216|NCT00698815|365349255|FG000|Overall Study|Did not receive protocol treatment|1|||
105915217|NCT00698815|365349256|FG001|Overall Study|Did not receive protocol treatment|2|||
105915218|NCT00698815|365349257|FG002|Overall Study|Did not receive protocol treatment|2|||
105915219|NCT00230048|365349258|FG000|Overall Study|Lost to Follow-up|13|||
105915220|NCT00230048|365349259|FG001|Overall Study|Lost to Follow-up|18|||
105915221|NCT01566604|365349264|FG000|Overall Study|Patient's inability to use the device|1|||
105915222|NCT01566604|365349265|FG001|Overall Study|Patient's inability to use the device|0|||
105915223|NCT01566604|365349264|FG000|Overall Study|Administrative problems|1|||
105915224|NCT01566604|365349265|FG001|Overall Study|Administrative problems|0|||
106000424|NCT02021565|365663407|FG001|Baseline Through Intervention|Protocol Violation|7|||
106000425|NCT02021565|365663406|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
106000426|NCT02021565|365663407|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
106000427|NCT02021565|365663406|FG000|3-month Follow-up|Death|3|||
106000428|NCT02021565|365663407|FG001|3-month Follow-up|Death|0|||
106000429|NCT02021565|365663406|FG000|3-month Follow-up|Withdrawal by Subject|4|||
106000430|NCT02021565|365663407|FG001|3-month Follow-up|Withdrawal by Subject|0|||
106000431|NCT02021565|365663406|FG000|3-month Follow-up|Protocol Violation|3|||
106000432|NCT02021565|365663407|FG001|3-month Follow-up|Protocol Violation|2|||
106000433|NCT01188772|365663408|FG000|Overall Study|Randomized but Not Treated|0|||
106126288|NCT00506285|366121912|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
106126289|NCT00506285|366121911|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
105915225|NCT01566604|365349264|FG000|Overall Study|Lack of Efficacy|1|||
105915226|NCT01566604|365349265|FG001|Overall Study|Lack of Efficacy|2|||
105915227|NCT01566604|365349264|FG000|Overall Study|Protocol deviation|2|||
105915228|NCT01566604|365349265|FG001|Overall Study|Protocol deviation|0|||
105915229|NCT01566604|365349264|FG000|Overall Study|Abnormal laboratory value|2|||
105915230|NCT01566604|365349265|FG001|Overall Study|Abnormal laboratory value|0|||
105915231|NCT01566604|365349264|FG000|Overall Study|Death|4|||
105915232|NCT01566604|365349265|FG001|Overall Study|Death|1|||
105915233|NCT01566604|365349264|FG000|Overall Study|Adverse Event|4|||
105915234|NCT01566604|365349265|FG001|Overall Study|Adverse Event|2|||
105915235|NCT01566604|365349264|FG000|Overall Study|Withdrawal by Subject|9|||
105915236|NCT01566604|365349265|FG001|Overall Study|Withdrawal by Subject|6|||
105915237|NCT01663402|365349267|FG000|Overall Study|Randomized but not treated|19|||
105915238|NCT01663402|365349268|FG001|Overall Study|Randomized but not treated|11|||
105915239|NCT01663402|365349267|FG000|Overall Study|Adverse Event|347|||
106126290|NCT00506285|366121912|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
106126291|NCT00506285|366121911|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
106126292|NCT00506285|366121912|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
106126293|NCT01089556|366121913|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
106126294|NCT01089556|366121914|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
106126295|NCT01089556|366121915|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
106126296|NCT01089556|366121916|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
106126297|NCT01089556|366121917|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
106126298|NCT01089556|366121918|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
106126299|NCT01089556|366121913|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
106126300|NCT01089556|366121914|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
106126301|NCT01089556|366121915|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
106126302|NCT01089556|366121916|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
106126303|NCT01089556|366121917|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
106126304|NCT01089556|366121918|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
106126305|NCT01089556|366121913|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
106126306|NCT01089556|366121914|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
105915240|NCT01663402|365349268|FG001|Overall Study|Adverse Event|362|||
105915241|NCT01663402|365349267|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
106126307|NCT01089556|366121915|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
105679133|NCT02407990|364486882|FG002|Overall Study|Logistics|0|||
105915242|NCT01663402|365349268|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
105915243|NCT01663402|365349267|FG000|Overall Study|Poor compliance to protocol|529|||
106000434|NCT01188772|365663409|FG001|Overall Study|Randomized but Not Treated|1|||
106000435|NCT01188772|365663410|FG002|Overall Study|Randomized but Not Treated|0|||
106000436|NCT01188772|365663411|FG003|Overall Study|Randomized but Not Treated|0|||
106126308|NCT01089556|366121916|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
106126309|NCT01089556|366121917|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
106126310|NCT01089556|366121918|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
106126311|NCT01089556|366121913|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
106126312|NCT01089556|366121914|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
106126313|NCT01089556|366121915|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
106126314|NCT01089556|366121916|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
106126315|NCT01089556|366121917|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
106126316|NCT01089556|366121918|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
106126317|NCT01089556|366121913|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
106126318|NCT01089556|366121914|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
106126319|NCT01089556|366121915|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
106126320|NCT01089556|366121916|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
106126321|NCT01089556|366121917|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
106126322|NCT01089556|366121918|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
106126323|NCT01089556|366121913|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
106126324|NCT01089556|366121914|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
106126325|NCT01089556|366121915|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
106126326|NCT01089556|366121916|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
106126327|NCT01089556|366121917|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
106126328|NCT01089556|366121918|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
106126329|NCT01089556|366121913|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
106126330|NCT01089556|366121914|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
106126331|NCT01089556|366121915|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
106126332|NCT01089556|366121916|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
106126333|NCT01089556|366121917|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
106126334|NCT01089556|366121918|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
106126335|NCT01089556|366121913|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
106126336|NCT01089556|366121914|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
106126337|NCT01089556|366121915|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
106126338|NCT01089556|366121916|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
106126339|NCT01089556|366121917|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
106126340|NCT01089556|366121918|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
106126341|NCT01089556|366121913|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
106126342|NCT01089556|366121914|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
106126343|NCT01089556|366121915|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
106126344|NCT01089556|366121916|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
106126345|NCT01089556|366121917|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
106126346|NCT01089556|366121918|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
106126347|NCT01089556|366121913|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
106126348|NCT01089556|366121914|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
106126349|NCT01089556|366121915|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
106126350|NCT01089556|366121916|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
106126351|NCT01089556|366121917|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
106126352|NCT01089556|366121918|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
106126353|NCT01089556|366121913|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
106126354|NCT01089556|366121914|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
106126355|NCT01089556|366121915|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
106126356|NCT01089556|366121916|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
106000437|NCT01188772|365663408|FG000|Overall Study|Adverse Event|0|||
106000438|NCT01188772|365663409|FG001|Overall Study|Adverse Event|1|||
106000439|NCT01188772|365663410|FG002|Overall Study|Adverse Event|2|||
106000440|NCT01188772|365663411|FG003|Overall Study|Adverse Event|0|||
106000441|NCT01188772|365663408|FG000|Overall Study|Lost to Follow-up|4|||
106000442|NCT01188772|365663409|FG001|Overall Study|Lost to Follow-up|1|||
106000443|NCT01188772|365663410|FG002|Overall Study|Lost to Follow-up|1|||
106000444|NCT01188772|365663411|FG003|Overall Study|Lost to Follow-up|1|||
106000445|NCT01188772|365663408|FG000|Overall Study|Non-responder|0|||
106000446|NCT01188772|365663409|FG001|Overall Study|Non-responder|0|||
106000447|NCT01188772|365663410|FG002|Overall Study|Non-responder|3|||
106000448|NCT01188772|365663411|FG003|Overall Study|Non-responder|0|||
106000449|NCT01188772|365663408|FG000|Overall Study|Physician Decision|0|||
105679134|NCT02407990|364486883|FG003|Overall Study|Logistics|0|||
105679135|NCT02407990|364486884|FG004|Overall Study|Logistics|0|||
106000450|NCT01188772|365663409|FG001|Overall Study|Physician Decision|0|||
106000451|NCT01188772|365663410|FG002|Overall Study|Physician Decision|1|||
106000452|NCT01188772|365663411|FG003|Overall Study|Physician Decision|0|||
106000453|NCT01188772|365663408|FG000|Overall Study|Terminated by Sponsor|0|||
106126357|NCT01089556|366121917|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
106126358|NCT01089556|366121918|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
106126359|NCT01089556|366121913|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
106126360|NCT01089556|366121914|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
106126361|NCT01089556|366121915|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
106126362|NCT01089556|366121916|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
106126363|NCT01089556|366121917|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
106126364|NCT01089556|366121918|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
106126365|NCT01089556|366121913|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
106126366|NCT01089556|366121914|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
106126367|NCT01089556|366121915|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
106126368|NCT01089556|366121916|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
106126369|NCT01089556|366121917|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
106126370|NCT01089556|366121918|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
106126371|NCT01089556|366121913|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
106126372|NCT01089556|366121914|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
106126373|NCT01089556|366121915|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
106126374|NCT01089556|366121916|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
106126375|NCT01089556|366121917|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
106126376|NCT01089556|366121918|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
106126377|NCT01089556|366121913|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
106126378|NCT01089556|366121914|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
106126379|NCT01089556|366121915|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
106126380|NCT01089556|366121916|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
106126381|NCT01089556|366121917|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
106126382|NCT01089556|366121918|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
106126383|NCT00551213|366121919|FG000|Overall Study|Adverse Event|6|||
106126384|NCT00551213|366121920|FG001|Overall Study|Adverse Event|3|||
106126385|NCT00551213|366121919|FG000|Overall Study|Progressive Disease|41|||
106126386|NCT00551213|366121920|FG001|Overall Study|Progressive Disease|12|||
106126387|NCT00551213|366121919|FG000|Overall Study|Withdrawal by Subject|2|||
106126388|NCT00551213|366121920|FG001|Overall Study|Withdrawal by Subject|0|||
106126389|NCT00551213|366121919|FG000|Overall Study|Not Treated|1|||
106126390|NCT00551213|366121920|FG001|Overall Study|Not Treated|2|||
106126391|NCT01383993|366121921|FG000|Overall Study|Adverse Event|1|||
106126392|NCT01383993|366121922|FG001|Overall Study|Adverse Event|1|||
106126393|NCT01383993|366121923|FG002|Overall Study|Adverse Event|0|||
106126394|NCT01383993|366121921|FG000|Overall Study|Withdrawal by Subject|0|||
106126395|NCT01383993|366121922|FG001|Overall Study|Withdrawal by Subject|0|||
106000454|NCT01188772|365663409|FG001|Overall Study|Terminated by Sponsor|0|||
106126396|NCT01383993|366121923|FG002|Overall Study|Withdrawal by Subject|1|||
106126397|NCT01383993|366121921|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
106126398|NCT01383993|366121922|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
106126399|NCT01383993|366121923|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
106126400|NCT03583541|366121928|FG000|Overall Study|Lost to Follow-up|31|||
106126401|NCT03583541|366121929|FG001|Overall Study|Lost to Follow-up|65|||
106126402|NCT04102540|366121930|FG000|Overall Study|Withdrawn by PI|2|||
106126403|NCT04102540|366121930|FG000|Overall Study|Lost to Follow-up|6|||
106126404|NCT01477749|366121933|FG000|Overall Study|Physician Decision|4|||
106126405|NCT00280293|366121934|FG000|Overall Study|Protocol Violation|3|||
106126406|NCT00280293|366121935|FG001|Overall Study|Protocol Violation|0|||
106126407|NCT00280293|366121934|FG000|Overall Study|Physician Decision|5|||
106126408|NCT00280293|366121935|FG001|Overall Study|Physician Decision|4|||
106126409|NCT00280293|366121934|FG000|Overall Study|Lost to Follow-up|14|||
106126410|NCT00280293|366121935|FG001|Overall Study|Lost to Follow-up|12|||
106126411|NCT00280293|366121934|FG000|Overall Study|Withdrawal by Subject|3|||
106126412|NCT00280293|366121935|FG001|Overall Study|Withdrawal by Subject|5|||
106126413|NCT00280293|366121934|FG000|Overall Study|Incarceration/Legal Reasons|1|||
106126414|NCT00280293|366121935|FG001|Overall Study|Incarceration/Legal Reasons|1|||
106126415|NCT00280293|366121934|FG000|Overall Study|Adverse Event|0|||
106126416|NCT00280293|366121935|FG001|Overall Study|Adverse Event|1|||
106126417|NCT01177813|366121936|FG000|Overall Study|Adverse Event|8|||
106126418|NCT01177813|366121937|FG001|Overall Study|Adverse Event|2|||
106126419|NCT01177813|366121938|FG002|Overall Study|Adverse Event|4|||
106126420|NCT01177813|366121939|FG003|Overall Study|Adverse Event|6|||
106126421|NCT01177813|366121940|FG004|Overall Study|Adverse Event|3|||
106126422|NCT01177813|366121936|FG000|Overall Study|Lack of Efficacy|1|||
106126423|NCT01177813|366121937|FG001|Overall Study|Lack of Efficacy|0|||
106126424|NCT01177813|366121938|FG002|Overall Study|Lack of Efficacy|0|||
106126425|NCT01177813|366121939|FG003|Overall Study|Lack of Efficacy|0|||
106126426|NCT01177813|366121940|FG004|Overall Study|Lack of Efficacy|0|||
106126427|NCT01177813|366121936|FG000|Overall Study|Protocol Violation|3|||
106126428|NCT01177813|366121937|FG001|Overall Study|Protocol Violation|2|||
106126429|NCT01177813|366121938|FG002|Overall Study|Protocol Violation|2|||
106126430|NCT01177813|366121939|FG003|Overall Study|Protocol Violation|0|||
106126431|NCT01177813|366121940|FG004|Overall Study|Protocol Violation|1|||
106126432|NCT01177813|366121936|FG000|Overall Study|Lost to Follow-up|12|||
106126433|NCT01177813|366121937|FG001|Overall Study|Lost to Follow-up|5|||
106126434|NCT01177813|366121938|FG002|Overall Study|Lost to Follow-up|6|||
106000455|NCT01188772|365663410|FG002|Overall Study|Terminated by Sponsor|1|||
106000456|NCT01188772|365663411|FG003|Overall Study|Terminated by Sponsor|0|||
106000457|NCT01188772|365663408|FG000|Overall Study|Treatment Failure|0|||
106000458|NCT01188772|365663409|FG001|Overall Study|Treatment Failure|0|||
106000459|NCT01188772|365663410|FG002|Overall Study|Treatment Failure|1|||
106000460|NCT01188772|365663411|FG003|Overall Study|Treatment Failure|0|||
106000461|NCT01188772|365663408|FG000|Overall Study|Virologic Failure|1|||
106000462|NCT01188772|365663409|FG001|Overall Study|Virologic Failure|0|||
106000463|NCT01188772|365663410|FG002|Overall Study|Virologic Failure|0|||
106000464|NCT01188772|365663411|FG003|Overall Study|Virologic Failure|0|||
106000465|NCT01188772|365663408|FG000|Overall Study|Withdrawal by Subject|0|||
106000466|NCT01188772|365663409|FG001|Overall Study|Withdrawal by Subject|0|||
106000467|NCT01188772|365663410|FG002|Overall Study|Withdrawal by Subject|2|||
106000468|NCT01188772|365663411|FG003|Overall Study|Withdrawal by Subject|0|||
106126435|NCT01177813|366121939|FG003|Overall Study|Lost to Follow-up|3|||
106126436|NCT01177813|366121940|FG004|Overall Study|Lost to Follow-up|0|||
105915244|NCT01663402|365349268|FG001|Overall Study|Poor compliance to protocol|454|||
105915245|NCT01663402|365349267|FG000|Overall Study|Physician Decision|77|||
105915246|NCT01663402|365349268|FG001|Overall Study|Physician Decision|62|||
105915247|NCT01663402|365349267|FG000|Overall Study|Site terminated by sponsor|1|||
105915248|NCT01663402|365349268|FG001|Overall Study|Site terminated by sponsor|3|||
105915249|NCT01663402|365349267|FG000|Overall Study|Participant moved|139|||
105915250|NCT01663402|365349268|FG001|Overall Study|Participant moved|104|||
105915251|NCT01663402|365349267|FG000|Overall Study|Withdrawal by Subject|118|||
105915252|NCT01663402|365349268|FG001|Overall Study|Withdrawal by Subject|91|||
105915253|NCT01663402|365349267|FG000|Overall Study|Related to study drug administration|96|||
105915254|NCT01663402|365349268|FG001|Overall Study|Related to study drug administration|105|||
105915255|NCT01663402|365349267|FG000|Overall Study|Lost to Follow-up|17|||
106000469|NCT03318549|365663412|FG000|Overall Study|Withdrawal by Subject|5|||
106000470|NCT03318549|365663413|FG001|Overall Study|Withdrawal by Subject|19|||
106000471|NCT03318549|365663414|FG002|Overall Study|Withdrawal by Subject|2|||
106000472|NCT03318549|365663415|FG003|Overall Study|Withdrawal by Subject|0|||
106000473|NCT03318549|365663416|FG004|Overall Study|Withdrawal by Subject|0|||
106000474|NCT03318549|365663417|FG005|Overall Study|Withdrawal by Subject|0|||
106000475|NCT03318549|365663418|FG006|Overall Study|Withdrawal by Subject|0|||
106000476|NCT03318549|365663412|FG000|Overall Study|Physician Decision|0|||
105915256|NCT01663402|365349268|FG001|Overall Study|Lost to Follow-up|15|||
105915257|NCT01663402|365349267|FG000|Overall Study|Other than specified above|172|||
105915258|NCT01663402|365349268|FG001|Overall Study|Other than specified above|147|||
105915259|NCT02666222|365349269|FG000|Overall Study|Death|2|||
105915260|NCT00072384|365349272|FG000|Overall Study|Physician Decision|1|||
105915261|NCT00072384|365349272|FG000|Overall Study|Ineligible|8|||
105915262|NCT05817669|365349274|FG000|Overall Study|Prohibited medication used|1|||
105915263|NCT05817669|365349275|FG001|Overall Study|Prohibited medication used|2|||
105915264|NCT05817669|365349274|FG000|Overall Study|Adverse Event|1|||
105915265|NCT05817669|365349275|FG001|Overall Study|Adverse Event|0|||
105915266|NCT05817669|365349274|FG000|Overall Study|Withdrawal by Subject|1|||
106000477|NCT03318549|365663413|FG001|Overall Study|Physician Decision|4|||
106000478|NCT03318549|365663414|FG002|Overall Study|Physician Decision|1|||
106000479|NCT03318549|365663415|FG003|Overall Study|Physician Decision|0|||
106000480|NCT03318549|365663416|FG004|Overall Study|Physician Decision|0|||
106000481|NCT03318549|365663417|FG005|Overall Study|Physician Decision|0|||
106000482|NCT03318549|365663418|FG006|Overall Study|Physician Decision|0|||
106000483|NCT03318549|365663412|FG000|Overall Study|Lost to Follow-up|0|||
106000484|NCT03318549|365663413|FG001|Overall Study|Lost to Follow-up|3|||
106000485|NCT03318549|365663414|FG002|Overall Study|Lost to Follow-up|3|||
106000486|NCT03318549|365663415|FG003|Overall Study|Lost to Follow-up|0|||
106126437|NCT01177813|366121936|FG000|Overall Study|Withdrawal by Subject|12|||
106126438|NCT01177813|366121937|FG001|Overall Study|Withdrawal by Subject|7|||
106126439|NCT01177813|366121938|FG002|Overall Study|Withdrawal by Subject|6|||
106126440|NCT01177813|366121939|FG003|Overall Study|Withdrawal by Subject|5|||
105915267|NCT05817669|365349275|FG001|Overall Study|Withdrawal by Subject|2|||
105915268|NCT04083976|365349281|FG000|Overall Study|Lost to Follow-up|3|||
105915269|NCT04083976|365349282|FG001|Overall Study|Lost to Follow-up|0|||
105915270|NCT04083976|365349283|FG002|Overall Study|Lost to Follow-up|0|||
105915271|NCT04083976|365349284|FG003|Overall Study|Lost to Follow-up|1|||
105915272|NCT04083976|365349281|FG000|Overall Study|Withdrawal by Subject|16|||
105915273|NCT04083976|365349282|FG001|Overall Study|Withdrawal by Subject|1|||
106000487|NCT03318549|365663416|FG004|Overall Study|Lost to Follow-up|0|||
106000488|NCT03318549|365663417|FG005|Overall Study|Lost to Follow-up|0|||
106000489|NCT03318549|365663418|FG006|Overall Study|Lost to Follow-up|0|||
106000490|NCT00920855|365663419|FG000|Overall Study|Adverse Event|1|||
106000491|NCT00920855|365663420|FG001|Overall Study|Adverse Event|1|||
106000492|NCT00920855|365663421|FG002|Overall Study|Adverse Event|4|||
106000493|NCT00920855|365663419|FG000|Overall Study|Withdrawal by Subject|2|||
106000494|NCT00920855|365663420|FG001|Overall Study|Withdrawal by Subject|1|||
106000495|NCT00920855|365663421|FG002|Overall Study|Withdrawal by Subject|6|||
106000496|NCT00920855|365663419|FG000|Overall Study|Disease progression|2|||
106000497|NCT00920855|365663420|FG001|Overall Study|Disease progression|1|||
106000498|NCT00920855|365663421|FG002|Overall Study|Disease progression|10|||
106000499|NCT00920855|365663419|FG000|Overall Study|Noncompliance to study medication|0|||
106000500|NCT00920855|365663420|FG001|Overall Study|Noncompliance to study medication|0|||
106000501|NCT00920855|365663421|FG002|Overall Study|Noncompliance to study medication|1|||
106000502|NCT00920855|365663419|FG000|Overall Study|Response plateau; started maintenance|0|||
106000503|NCT00920855|365663420|FG001|Overall Study|Response plateau; started maintenance|0|||
106000504|NCT00920855|365663421|FG002|Overall Study|Response plateau; started maintenance|1|||
106000505|NCT01894607|365663422|FG000|Overall Study|Ineligible|1|||
106000506|NCT00539994|365663423|FG000|Overall Study|Lost to Follow-up|2|||
106000507|NCT00539994|365663424|FG001|Overall Study|Lost to Follow-up|1|||
106000508|NCT00539994|365663425|FG002|Overall Study|Lost to Follow-up|0|||
106000509|NCT00539994|365663423|FG000|Overall Study|Withdrawal by Subject|1|||
106000510|NCT00539994|365663424|FG001|Overall Study|Withdrawal by Subject|0|||
106000511|NCT00539994|365663425|FG002|Overall Study|Withdrawal by Subject|1|||
106000512|NCT00539994|365663423|FG000|Overall Study|Physician Decision|0|||
106000513|NCT00539994|365663424|FG001|Overall Study|Physician Decision|0|||
105915274|NCT04083976|365349283|FG002|Overall Study|Withdrawal by Subject|9|||
105915275|NCT04083976|365349284|FG003|Overall Study|Withdrawal by Subject|0|||
105915276|NCT04083976|365349281|FG000|Overall Study|Sponsor Decision|14|||
105915277|NCT04083976|365349282|FG001|Overall Study|Sponsor Decision|0|||
105915278|NCT04083976|365349283|FG002|Overall Study|Sponsor Decision|0|||
105915279|NCT04083976|365349284|FG003|Overall Study|Sponsor Decision|7|||
105915280|NCT04083976|365349281|FG000|Overall Study|Other|1|||
105915281|NCT04083976|365349282|FG001|Overall Study|Other|0|||
105915282|NCT04083976|365349283|FG002|Overall Study|Other|1|||
105915283|NCT04083976|365349284|FG003|Overall Study|Other|0|||
105915284|NCT02127658|365349285|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
105915285|NCT02127658|365349286|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
105915286|NCT02127658|365349285|FG000|Overall Study|Withdrawal by Subject|0|||
105915287|NCT02127658|365349286|FG001|Overall Study|Withdrawal by Subject|2|||
105915288|NCT02127658|365349285|FG000|Overall Study|Physician Decision|0|||
105915289|NCT02127658|365349286|FG001|Overall Study|Physician Decision|1|||
105915290|NCT01802385|365349287|FG000|Overall Study|Death|106|||
105915291|NCT01802385|365349288|FG001|Overall Study|Death|120|||
105915292|NCT01443858|365349289|FG000|Overall Study|Withdrawal by Subject|9|||
105915293|NCT01443858|365349290|FG001|Overall Study|Withdrawal by Subject|8|||
105915294|NCT01443858|365349291|FG002|Overall Study|Withdrawal by Subject|5|||
105915295|NCT01443858|365349289|FG000|Overall Study|Lack of Efficacy|1|||
105915296|NCT01443858|365349290|FG001|Overall Study|Lack of Efficacy|0|||
105915297|NCT01443858|365349291|FG002|Overall Study|Lack of Efficacy|0|||
105915298|NCT01443858|365349289|FG000|Overall Study|Lost to Follow-up|5|||
105915299|NCT01443858|365349290|FG001|Overall Study|Lost to Follow-up|5|||
105915300|NCT01443858|365349291|FG002|Overall Study|Lost to Follow-up|2|||
105915301|NCT03834493|365349292|FG000|Overall Study|Participants Ongoing|311|||
105915302|NCT03834493|365349293|FG001|Overall Study|Participants Ongoing|324|||
105915303|NCT03834493|365349292|FG000|Overall Study|Withdrawal by Subject|20|||
105915304|NCT03834493|365349293|FG001|Overall Study|Withdrawal by Subject|17|||
105915305|NCT03834493|365349292|FG000|Overall Study|Physician Decision|1|||
105915306|NCT03834493|365349293|FG001|Overall Study|Physician Decision|0|||
105915307|NCT03834493|365349292|FG000|Overall Study|Death|289|||
105915308|NCT03834493|365349293|FG001|Overall Study|Death|282|||
105915309|NCT05559905|365349294|FG000|Overall Study|Withdrawal by Subject|1|||
105915310|NCT05559905|365349295|FG001|Overall Study|Withdrawal by Subject|0|||
105915311|NCT05559905|365349296|FG002|Overall Study|Withdrawal by Subject|0|||
105915312|NCT05559905|365349294|FG000|Overall Study|Not Reported|1|||
105915313|NCT05559905|365349295|FG001|Overall Study|Not Reported|0|||
105915314|NCT05559905|365349296|FG002|Overall Study|Not Reported|0|||
105915315|NCT02718911|365349299|FG000|Overall Study|Adverse Event|0|||
105915316|NCT02718911|365349300|FG001|Overall Study|Adverse Event|0|||
105915317|NCT02718911|365349301|FG002|Overall Study|Adverse Event|0|||
105915318|NCT02718911|365349302|FG003|Overall Study|Adverse Event|0|||
105915319|NCT02718911|365349303|FG004|Overall Study|Adverse Event|0|||
105915320|NCT02718911|365349304|FG005|Overall Study|Adverse Event|0|||
105915321|NCT02718911|365349305|FG006|Overall Study|Adverse Event|0|||
106000514|NCT00539994|365663425|FG002|Overall Study|Physician Decision|1|||
106126441|NCT01177813|366121940|FG004|Overall Study|Withdrawal by Subject|3|||
105915322|NCT02718911|365349306|FG007|Overall Study|Adverse Event|0|||
105915323|NCT02718911|365349307|FG008|Overall Study|Adverse Event|0|||
105915324|NCT02718911|365349308|FG009|Overall Study|Adverse Event|2|||
105915325|NCT02718911|365349299|FG000|Overall Study|Death|2|||
105915326|NCT02718911|365349300|FG001|Overall Study|Death|3|||
105915327|NCT02718911|365349301|FG002|Overall Study|Death|1|||
105915328|NCT02718911|365349302|FG003|Overall Study|Death|0|||
105915329|NCT02718911|365349303|FG004|Overall Study|Death|1|||
105915330|NCT02718911|365349304|FG005|Overall Study|Death|3|||
105915331|NCT02718911|365349305|FG006|Overall Study|Death|1|||
105915332|NCT02718911|365349306|FG007|Overall Study|Death|1|||
106000515|NCT05470985|365663428|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
106000516|NCT05470985|365663429|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
106126442|NCT01177813|366121936|FG000|Overall Study|Other reason not defined above|5|||
106126443|NCT01177813|366121937|FG001|Overall Study|Other reason not defined above|2|||
106126444|NCT01177813|366121938|FG002|Overall Study|Other reason not defined above|2|||
106126445|NCT01177813|366121939|FG003|Overall Study|Other reason not defined above|3|||
106126446|NCT01177813|366121940|FG004|Overall Study|Other reason not defined above|2|||
106126447|NCT02056119|366121945|FG000|Overall Study|Death|1|||
106126448|NCT02056119|366121946|FG001|Overall Study|Death|2|||
106126449|NCT02056119|366121945|FG000|Overall Study|Intubated for less than 24 hrs|2|||
106126450|NCT02056119|366121946|FG001|Overall Study|Intubated for less than 24 hrs|7|||
106126451|NCT02056119|366121945|FG000|Overall Study|No aerosol treatments were given.|3|||
106126452|NCT02056119|366121946|FG001|Overall Study|No aerosol treatments were given.|2|||
106126453|NCT02056119|366121945|FG000|Overall Study|Received Metaneb treatment|0|||
106126454|NCT02056119|366121946|FG001|Overall Study|Received Metaneb treatment|2|||
106126455|NCT02056119|366121945|FG000|Overall Study|Protocol Violation|4|||
106126456|NCT02056119|366121946|FG001|Overall Study|Protocol Violation|7|||
106126457|NCT01348854|366121947|FG000|Overall Study|Lost to Follow-up|2|||
106126458|NCT01348854|366121948|FG001|Overall Study|Lost to Follow-up|1|||
106126459|NCT01348854|366121947|FG000|Overall Study|Withdrawal by Subject|1|||
106126460|NCT01348854|366121948|FG001|Overall Study|Withdrawal by Subject|0|||
106126461|NCT03220737|366121949|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
106126462|NCT03220737|366121950|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
106126463|NCT03220737|366121951|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
106126464|NCT03220737|366121952|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
106126465|NCT03220737|366121953|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
106126466|NCT03220737|366121954|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
106126467|NCT03220737|366121955|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
106126468|NCT03220737|366121949|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
106126469|NCT03220737|366121950|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
106126470|NCT03220737|366121951|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
106126471|NCT03220737|366121952|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
106126472|NCT03220737|366121953|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
106126473|NCT03220737|366121954|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
106126474|NCT03220737|366121955|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
106126475|NCT03220737|366121949|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
106126476|NCT03220737|366121950|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
106000517|NCT05470985|365663428|FG000|Double Blind Treatment Period|Physician Decision|0|||
106000518|NCT05470985|365663429|FG001|Double Blind Treatment Period|Physician Decision|1|||
106000519|NCT05470985|365663428|FG000|Long Term Extension|Adverse Event|0|||
106000520|NCT05470985|365663429|FG001|Long Term Extension|Adverse Event|1|||
106000521|NCT05470985|365663428|FG000|Long Term Extension|Study terminated by sponsor|2|||
106126477|NCT03220737|366121951|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
106126478|NCT03220737|366121952|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
106126479|NCT03220737|366121953|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
106126480|NCT03220737|366121954|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
106000522|NCT05470985|365663429|FG001|Long Term Extension|Study terminated by sponsor|0|||
106000523|NCT01787461|365663434|FG000|Overall Study|Adverse Event|4|||
106000524|NCT01787461|365663435|FG001|Overall Study|Adverse Event|3|||
106000525|NCT01787461|365663434|FG000|Overall Study|Lost to Follow-up|3|||
106000526|NCT01787461|365663435|FG001|Overall Study|Lost to Follow-up|2|||
106000527|NCT01787461|365663434|FG000|Overall Study|No longer met eligibility criteria|1|||
106000528|NCT01787461|365663435|FG001|Overall Study|No longer met eligibility criteria|0|||
106000529|NCT01787461|365663434|FG000|Overall Study|Withdrawal by Subject|3|||
106000530|NCT01787461|365663435|FG001|Overall Study|Withdrawal by Subject|4|||
106000531|NCT01787461|365663434|FG000|Overall Study|Protocol Violation|3|||
106000532|NCT01787461|365663435|FG001|Overall Study|Protocol Violation|0|||
106000533|NCT00607087|365663436|FG000|Overall Study|Withdrawal by Subject|9|||
106000534|NCT00607087|365663437|FG001|Overall Study|Withdrawal by Subject|4|||
106000535|NCT00607087|365663438|FG002|Overall Study|Withdrawal by Subject|4|||
106126481|NCT03220737|366121955|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
106126482|NCT03220737|366121949|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
106126483|NCT03220737|366121950|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
106126484|NCT03220737|366121951|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
106126485|NCT03220737|366121952|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
106126486|NCT03220737|366121953|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
106126487|NCT03220737|366121954|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
106126488|NCT03220737|366121955|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
106126489|NCT03220737|366121949|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
105679136|NCT02407990|364486885|FG005|Overall Study|Logistics|0|||
106000536|NCT00607087|365663436|FG000|Overall Study|Adverse Event|3|||
106000537|NCT00607087|365663437|FG001|Overall Study|Adverse Event|2|||
106000538|NCT00607087|365663438|FG002|Overall Study|Adverse Event|3|||
106000539|NCT00607087|365663436|FG000|Overall Study|Other reason|1|||
106126490|NCT03220737|366121950|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
106126491|NCT03220737|366121951|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
106126492|NCT03220737|366121952|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
106126493|NCT03220737|366121953|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
106126494|NCT03220737|366121954|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
106126495|NCT03220737|366121955|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
106126496|NCT03220737|366121949|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
106126497|NCT03220737|366121950|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
106126498|NCT03220737|366121951|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
106126499|NCT03220737|366121952|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
106126500|NCT03220737|366121953|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
105915333|NCT02718911|365349307|FG008|Overall Study|Death|4|||
105915334|NCT02718911|365349308|FG009|Overall Study|Death|3|||
105915335|NCT02718911|365349299|FG000|Overall Study|Lost to Follow-up|0|||
106126501|NCT03220737|366121954|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
106126502|NCT03220737|366121955|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
106126503|NCT03220737|366121949|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
106126504|NCT03220737|366121950|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
106126505|NCT03220737|366121951|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
106126506|NCT03220737|366121952|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
106126507|NCT03220737|366121953|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
106126508|NCT03220737|366121954|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
106126509|NCT03220737|366121955|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
106126510|NCT03220737|366121949|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
106126511|NCT03220737|366121950|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
106126512|NCT03220737|366121951|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
106126513|NCT03220737|366121952|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
106126514|NCT03220737|366121953|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
106126515|NCT03220737|366121954|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
106126516|NCT03220737|366121955|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
106126517|NCT01720797|366121956|FG000|Overall Study|Withdrawal by Subject|3|||
105915336|NCT02718911|365349300|FG001|Overall Study|Lost to Follow-up|0|||
106126518|NCT01720797|366121957|FG001|Overall Study|Withdrawal by Subject|0|||
106126519|NCT00983619|366121967|FG000|Overall Study|Lost to Follow-up|0|||
106126520|NCT00983619|366121968|FG001|Overall Study|Lost to Follow-up|1|||
106126521|NCT00983619|366121969|FG002|Overall Study|Lost to Follow-up|0|||
106126522|NCT00983619|366121970|FG003|Overall Study|Lost to Follow-up|0|||
106126523|NCT00983619|366121971|FG004|Overall Study|Lost to Follow-up|0|||
106126524|NCT00983619|366121972|FG005|Overall Study|Lost to Follow-up|2|||
106126525|NCT00983619|366121973|FG006|Overall Study|Lost to Follow-up|0|||
106126526|NCT00983619|366121974|FG007|Overall Study|Lost to Follow-up|0|||
106126527|NCT00983619|366121975|FG008|Overall Study|Lost to Follow-up|0|||
105915337|NCT02718911|365349301|FG002|Overall Study|Lost to Follow-up|0|||
105915338|NCT02718911|365349302|FG003|Overall Study|Lost to Follow-up|0|||
105915339|NCT02718911|365349303|FG004|Overall Study|Lost to Follow-up|0|||
105915340|NCT02718911|365349304|FG005|Overall Study|Lost to Follow-up|0|||
105915341|NCT02718911|365349305|FG006|Overall Study|Lost to Follow-up|0|||
105915342|NCT02718911|365349306|FG007|Overall Study|Lost to Follow-up|0|||
105915343|NCT02718911|365349307|FG008|Overall Study|Lost to Follow-up|1|||
105915344|NCT02718911|365349308|FG009|Overall Study|Lost to Follow-up|0|||
105915345|NCT02718911|365349299|FG000|Overall Study|Physician Decision|2|||
105915346|NCT02718911|365349300|FG001|Overall Study|Physician Decision|0|||
105915347|NCT02718911|365349301|FG002|Overall Study|Physician Decision|1|||
105915348|NCT02718911|365349302|FG003|Overall Study|Physician Decision|1|||
105915349|NCT02718911|365349303|FG004|Overall Study|Physician Decision|0|||
105915350|NCT02718911|365349304|FG005|Overall Study|Physician Decision|0|||
105915351|NCT02718911|365349305|FG006|Overall Study|Physician Decision|0|||
105915352|NCT02718911|365349306|FG007|Overall Study|Physician Decision|1|||
105915353|NCT02718911|365349307|FG008|Overall Study|Physician Decision|2|||
105915354|NCT02718911|365349308|FG009|Overall Study|Physician Decision|1|||
105915355|NCT02718911|365349299|FG000|Overall Study|Withdrawal by Subject|0|||
106126528|NCT00983619|366121976|FG009|Overall Study|Lost to Follow-up|0|||
106126529|NCT00983619|366121977|FG010|Overall Study|Lost to Follow-up|0|||
106126530|NCT00983619|366121978|FG011|Overall Study|Lost to Follow-up|2|||
106126531|NCT00983619|366121967|FG000|Overall Study|Withdrawal by Subject|2|||
106126532|NCT00983619|366121968|FG001|Overall Study|Withdrawal by Subject|1|||
105915356|NCT02718911|365349300|FG001|Overall Study|Withdrawal by Subject|0|||
105915357|NCT02718911|365349301|FG002|Overall Study|Withdrawal by Subject|0|||
105915358|NCT02718911|365349302|FG003|Overall Study|Withdrawal by Subject|0|||
105915359|NCT02718911|365349303|FG004|Overall Study|Withdrawal by Subject|1|||
105915360|NCT02718911|365349304|FG005|Overall Study|Withdrawal by Subject|0|||
106126533|NCT00983619|366121969|FG002|Overall Study|Withdrawal by Subject|1|||
106126534|NCT00983619|366121970|FG003|Overall Study|Withdrawal by Subject|3|||
106126535|NCT00983619|366121971|FG004|Overall Study|Withdrawal by Subject|1|||
106126536|NCT00983619|366121972|FG005|Overall Study|Withdrawal by Subject|23|||
106126537|NCT00983619|366121973|FG006|Overall Study|Withdrawal by Subject|0|||
106126538|NCT00983619|366121974|FG007|Overall Study|Withdrawal by Subject|0|||
106126539|NCT00983619|366121975|FG008|Overall Study|Withdrawal by Subject|0|||
106126540|NCT00983619|366121976|FG009|Overall Study|Withdrawal by Subject|0|||
106126541|NCT00983619|366121977|FG010|Overall Study|Withdrawal by Subject|1|||
106126542|NCT00983619|366121978|FG011|Overall Study|Withdrawal by Subject|1|||
106126543|NCT00983619|366121967|FG000|Overall Study|Death|0|||
106126544|NCT00983619|366121968|FG001|Overall Study|Death|2|||
106126545|NCT00983619|366121969|FG002|Overall Study|Death|2|||
106126546|NCT00983619|366121970|FG003|Overall Study|Death|1|||
106126547|NCT00983619|366121971|FG004|Overall Study|Death|2|||
106126548|NCT00983619|366121972|FG005|Overall Study|Death|30|||
106126549|NCT00983619|366121973|FG006|Overall Study|Death|1|||
106126550|NCT00983619|366121974|FG007|Overall Study|Death|0|||
106126551|NCT00983619|366121975|FG008|Overall Study|Death|1|||
106126552|NCT00983619|366121976|FG009|Overall Study|Death|2|||
106126553|NCT00983619|366121977|FG010|Overall Study|Death|9|||
106126554|NCT00983619|366121978|FG011|Overall Study|Death|8|||
106126555|NCT00983619|366121967|FG000|Overall Study|Other|1|||
106126556|NCT00983619|366121968|FG001|Overall Study|Other|0|||
106126557|NCT00983619|366121969|FG002|Overall Study|Other|0|||
106126558|NCT00983619|366121970|FG003|Overall Study|Other|1|||
106126559|NCT00983619|366121971|FG004|Overall Study|Other|0|||
106126560|NCT00983619|366121972|FG005|Overall Study|Other|12|||
106126561|NCT00983619|366121973|FG006|Overall Study|Other|2|||
106126562|NCT00983619|366121974|FG007|Overall Study|Other|2|||
106126563|NCT00983619|366121975|FG008|Overall Study|Other|0|||
106126564|NCT00983619|366121976|FG009|Overall Study|Other|1|||
106126565|NCT00983619|366121977|FG010|Overall Study|Other|1|||
106126566|NCT00983619|366121978|FG011|Overall Study|Other|0|||
106126567|NCT04011384|366121979|FG000|Overall Study|Withdrawal by Subject|2|||
106126568|NCT04011384|366121980|FG001|Overall Study|Withdrawal by Subject|0|||
106126569|NCT00688259|366121982|FG000|Overall Study|Lost to Follow-up|2|||
106126570|NCT00688259|366121983|FG001|Overall Study|Lost to Follow-up|4|||
106126571|NCT00688259|366121982|FG000|Overall Study|Physician Decision|1|||
106126572|NCT00688259|366121983|FG001|Overall Study|Physician Decision|0|||
106126573|NCT00688259|366121982|FG000|Overall Study|Withdrawal by Subject|2|||
106126574|NCT00688259|366121983|FG001|Overall Study|Withdrawal by Subject|0|||
106126575|NCT00688259|366121982|FG000|Overall Study|Declined Interview|2|||
106126576|NCT00688259|366121983|FG001|Overall Study|Declined Interview|3|||
106126577|NCT00688259|366121982|FG000|Overall Study|Hospitalized at Follow-up|0|||
106126578|NCT00688259|366121983|FG001|Overall Study|Hospitalized at Follow-up|1|||
106126579|NCT01676220|366121985|FG000|Overall Study|Randomized But Not Treated|4|||
106126580|NCT01676220|366121986|FG001|Overall Study|Randomized But Not Treated|1|||
106126581|NCT01676220|366121985|FG000|Overall Study|Adverse Event|10|||
106126582|NCT01676220|366121986|FG001|Overall Study|Adverse Event|8|||
105915361|NCT02718911|365349305|FG006|Overall Study|Withdrawal by Subject|0|||
105915362|NCT02718911|365349306|FG007|Overall Study|Withdrawal by Subject|0|||
105915363|NCT02718911|365349307|FG008|Overall Study|Withdrawal by Subject|1|||
105915364|NCT02718911|365349308|FG009|Overall Study|Withdrawal by Subject|4|||
106126583|NCT01676220|366121985|FG000|Overall Study|Lack of Efficacy|2|||
106126584|NCT01676220|366121986|FG001|Overall Study|Lack of Efficacy|5|||
106126585|NCT01676220|366121985|FG000|Overall Study|Protocol Violation|11|||
105915365|NCT02718911|365349299|FG000|Overall Study|Reason Not Collected|0|||
105915366|NCT02718911|365349300|FG001|Overall Study|Reason Not Collected|0|||
105915367|NCT02718911|365349301|FG002|Overall Study|Reason Not Collected|1|||
106126586|NCT01676220|366121986|FG001|Overall Study|Protocol Violation|12|||
106126587|NCT01676220|366121985|FG000|Overall Study|Received Rescue Therapy|14|||
106126588|NCT01676220|366121986|FG001|Overall Study|Received Rescue Therapy|22|||
106126589|NCT01676220|366121985|FG000|Overall Study|Personal Reason|34|||
106126590|NCT01676220|366121986|FG001|Overall Study|Personal Reason|45|||
106126591|NCT01676220|366121985|FG000|Overall Study|Lost to Follow-up|11|||
106126592|NCT01676220|366121986|FG001|Overall Study|Lost to Follow-up|18|||
106126593|NCT01676220|366121985|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
106126594|NCT01676220|366121986|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
106126595|NCT01676220|366121985|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
106126596|NCT01676220|366121986|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
106126597|NCT01676220|366121985|FG000|Overall Study|Perceived Lack of Efficacy|3|||
106126598|NCT01676220|366121986|FG001|Overall Study|Perceived Lack of Efficacy|1|||
106126599|NCT01676220|366121985|FG000|Overall Study|Non Serious Hypoglycemia|2|||
106126600|NCT01676220|366121986|FG001|Overall Study|Non Serious Hypoglycemia|0|||
106126601|NCT01676220|366121985|FG000|Overall Study|No More Need of Insulin|1|||
106126602|NCT01676220|366121986|FG001|Overall Study|No More Need of Insulin|0|||
106126603|NCT01310868|366121987|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
106126604|NCT04227340|366121989|FG000|Overall Study|Withdrawal by Subject|3|||
106126605|NCT01734382|366121990|FG000|Part 1|Adverse Event|2|||
106126606|NCT01734382|366121991|FG001|Part 1|Adverse Event|0|||
106126607|NCT01734382|366121992|FG002|Part 1|Adverse Event|0|||
106126608|NCT01734382|366121990|FG000|Part 2|Adverse Event|0|||
106126609|NCT01734382|366121991|FG001|Part 2|Adverse Event|0|||
106126610|NCT01734382|366121992|FG002|Part 2|Adverse Event|1|||
106126611|NCT01734382|366121990|FG000|Part 2|Lack of Efficacy|0|||
106126612|NCT01734382|366121991|FG001|Part 2|Lack of Efficacy|1|||
106126613|NCT01734382|366121992|FG002|Part 2|Lack of Efficacy|1|||
106126614|NCT01734382|366121990|FG000|Part 2|Other|0|||
106126615|NCT01734382|366121991|FG001|Part 2|Other|0|||
106126616|NCT01734382|366121992|FG002|Part 2|Other|1|||
106126617|NCT01734382|366121990|FG000|Part 2|Physician Decision|0|||
106126618|NCT01734382|366121991|FG001|Part 2|Physician Decision|0|||
106126619|NCT01734382|366121992|FG002|Part 2|Physician Decision|3|||
106126620|NCT01734382|366121990|FG000|Part 2|Protocol Violation|0|||
106126621|NCT01734382|366121991|FG001|Part 2|Protocol Violation|1|||
106126622|NCT01734382|366121992|FG002|Part 2|Protocol Violation|0|||
106126623|NCT01734382|366121990|FG000|Part 2|Withdrawal by Subject|0|||
106126624|NCT01734382|366121991|FG001|Part 2|Withdrawal by Subject|0|||
106126625|NCT01734382|366121992|FG002|Part 2|Withdrawal by Subject|1|||
106126626|NCT02019602|366121998|FG000|Screening Period|Ineligibility|4|||
106126627|NCT02019602|366121999|FG001|Screening Period|Ineligibility|0|||
106126628|NCT02019602|366121998|FG000|Screening Period|Adverse Event|1|||
106126629|NCT02019602|366121999|FG001|Screening Period|Adverse Event|0|||
106126630|NCT01083160|366122000|FG000|Overall Study|Adverse Event|1|||
106126631|NCT00918749|366122001|FG000|Overall Study|Adverse Event|1|||
106126632|NCT00918749|366122002|FG001|Overall Study|Adverse Event|0|||
106126633|NCT00918749|366122003|FG002|Overall Study|Adverse Event|1|||
106126634|NCT00918749|366122001|FG000|Overall Study|Lost to Follow-up|0|||
106126635|NCT00918749|366122002|FG001|Overall Study|Lost to Follow-up|0|||
106126636|NCT00918749|366122003|FG002|Overall Study|Lost to Follow-up|1|||
106126637|NCT00918749|366122001|FG000|Overall Study|Withdrawal by Subject|5|||
106126638|NCT00918749|366122002|FG001|Overall Study|Withdrawal by Subject|3|||
106126639|NCT00918749|366122003|FG002|Overall Study|Withdrawal by Subject|5|||
106126640|NCT00918749|366122001|FG000|Overall Study|No Study Medication Taken|1|||
106126641|NCT00918749|366122002|FG001|Overall Study|No Study Medication Taken|0|||
106126642|NCT00918749|366122003|FG002|Overall Study|No Study Medication Taken|0|||
106126643|NCT01712789|366122004|FG000|Overall Study|Lack of Efficacy|2|||
106126644|NCT01712789|366122004|FG000|Overall Study|Lost to Follow-up|1|||
106126645|NCT01712789|366122004|FG000|Overall Study|Progressive Disease|504|||
106126646|NCT01712789|366122004|FG000|Overall Study|Death|57|||
106126647|NCT01712789|366122004|FG000|Overall Study|Adverse Event|52|||
106126648|NCT01712789|366122004|FG000|Overall Study|Miscellaneous|31|||
106126649|NCT01712789|366122004|FG000|Overall Study|Withdrawal by Subject|21|||
106126650|NCT01712789|366122004|FG000|Overall Study|Transition to Commercial Treatment|8|||
106126651|NCT01712789|366122004|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
106126652|NCT01708187|366122005|FG000|Overall Study|Lost to Follow-up|0|||
106126653|NCT01708187|366122006|FG001|Overall Study|Lost to Follow-up|1|||
106126654|NCT00873093|366122007|FG000|Overall Study|Adverse Event|0|||
106126655|NCT00873093|366122008|FG001|Overall Study|Adverse Event|2|||
106126656|NCT00873093|366122009|FG002|Overall Study|Adverse Event|0|||
106126657|NCT00873093|366122010|FG003|Overall Study|Adverse Event|0|||
106126658|NCT00873093|366122011|FG004|Overall Study|Adverse Event|0|||
106126659|NCT00873093|366122007|FG000|Overall Study|Death|0|||
106126660|NCT00873093|366122008|FG001|Overall Study|Death|3|||
106126661|NCT00873093|366122009|FG002|Overall Study|Death|2|||
106126662|NCT00873093|366122010|FG003|Overall Study|Death|0|||
106126663|NCT00873093|366122011|FG004|Overall Study|Death|0|||
106126664|NCT00873093|366122007|FG000|Overall Study|Physician Decision|0|||
106126665|NCT00873093|366122008|FG001|Overall Study|Physician Decision|17|||
106126666|NCT00873093|366122009|FG002|Overall Study|Physician Decision|10|||
106126667|NCT00873093|366122010|FG003|Overall Study|Physician Decision|10|||
106126668|NCT00873093|366122011|FG004|Overall Study|Physician Decision|2|||
106126669|NCT00873093|366122007|FG000|Overall Study|Withdrawal by Subject|1|||
106126670|NCT00873093|366122008|FG001|Overall Study|Withdrawal by Subject|4|||
106126671|NCT00873093|366122009|FG002|Overall Study|Withdrawal by Subject|4|||
106126672|NCT00873093|366122010|FG003|Overall Study|Withdrawal by Subject|0|||
106126673|NCT00873093|366122011|FG004|Overall Study|Withdrawal by Subject|0|||
106126674|NCT00873093|366122007|FG000|Overall Study|Ineligible|0|||
106126675|NCT00873093|366122008|FG001|Overall Study|Ineligible|1|||
106126676|NCT00873093|366122009|FG002|Overall Study|Ineligible|0|||
106126677|NCT00873093|366122010|FG003|Overall Study|Ineligible|1|||
106126678|NCT00873093|366122011|FG004|Overall Study|Ineligible|0|||
106126679|NCT01994720|366122014|FG000|Overall Study|Withdrawal by Subject|46|||
106126680|NCT01994720|366122015|FG001|Overall Study|Withdrawal by Subject|56|||
106126681|NCT03619174|366122016|FG000|Overall Study|Lost to Follow-up|3|||
106126682|NCT03619174|366122017|FG001|Overall Study|Lost to Follow-up|0|||
106126683|NCT03619174|366122016|FG000|Overall Study|Withdrawal by Subject|4|||
106126684|NCT03619174|366122017|FG001|Overall Study|Withdrawal by Subject|3|||
106126685|NCT03619174|366122016|FG000|Overall Study|Pregnancy|1|||
105915368|NCT02718911|365349302|FG003|Overall Study|Reason Not Collected|0|||
105915369|NCT02718911|365349303|FG004|Overall Study|Reason Not Collected|0|||
105915370|NCT02718911|365349304|FG005|Overall Study|Reason Not Collected|0|||
105915371|NCT02718911|365349305|FG006|Overall Study|Reason Not Collected|2|||
105915372|NCT02718911|365349306|FG007|Overall Study|Reason Not Collected|1|||
105915373|NCT02718911|365349307|FG008|Overall Study|Reason Not Collected|4|||
106126686|NCT03619174|366122017|FG001|Overall Study|Pregnancy|1|||
106126687|NCT03619174|366122016|FG000|Overall Study|Discomfort during treatment|1|||
106126688|NCT03619174|366122017|FG001|Overall Study|Discomfort during treatment|0|||
106126689|NCT01012973|366122018|FG000|Overall Study|Adverse Event|5|||
106126690|NCT01012973|366122019|FG001|Overall Study|Adverse Event|5|||
106126691|NCT01012973|366122018|FG000|Overall Study|Lack of Efficacy|0|||
106126692|NCT01012973|366122019|FG001|Overall Study|Lack of Efficacy|5|||
106126693|NCT01012973|366122018|FG000|Overall Study|Lost to Follow-up|1|||
106126694|NCT01012973|366122019|FG001|Overall Study|Lost to Follow-up|0|||
106126695|NCT01012973|366122018|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
106126696|NCT01012973|366122019|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
106126697|NCT01012973|366122018|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
106126698|NCT01012973|366122019|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
106126699|NCT01012973|366122018|FG000|Overall Study|Protocol Violation|5|||
106126700|NCT01012973|366122019|FG001|Overall Study|Protocol Violation|2|||
106126701|NCT01012973|366122018|FG000|Overall Study|Withdrawal by Subject|4|||
106126702|NCT01012973|366122019|FG001|Overall Study|Withdrawal by Subject|6|||
106126703|NCT01232556|366122020|FG000|Overall Study|Withdrawal by Subject|21|||
106126704|NCT01232556|366122021|FG001|Overall Study|Withdrawal by Subject|17|||
106126705|NCT01232556|366122020|FG000|Overall Study|Death|97|||
106126706|NCT01232556|366122021|FG001|Overall Study|Death|97|||
106126707|NCT01232556|366122020|FG000|Overall Study|Lost to Follow-up|0|||
106126708|NCT01232556|366122021|FG001|Overall Study|Lost to Follow-up|2|||
106126709|NCT01232556|366122020|FG000|Overall Study|Terminated by Sponsor|35|||
105915374|NCT02718911|365349308|FG009|Overall Study|Reason Not Collected|9|||
105915375|NCT05002972|365349309|FG000|Overall Study|Withdrawal by Subject|2|||
105915376|NCT01172873|365349310|FG000|Overall Study|Withdrawal by Subject|3|||
105915377|NCT01172873|365349311|FG001|Overall Study|Withdrawal by Subject|2|||
105915378|NCT05518539|365349314|FG000|Overall Study|Lost to Follow-up|6|||
105915379|NCT05116202|365349319|FG000|Overall Study|Study Terminated by Sponsor|21|||
105915380|NCT05116202|365349320|FG001|Overall Study|Study Terminated by Sponsor|38|||
105915381|NCT05116202|365349321|FG002|Overall Study|Study Terminated by Sponsor|17|||
105915382|NCT05116202|365349322|FG003|Overall Study|Study Terminated by Sponsor|18|||
105915383|NCT05116202|365349323|FG004|Overall Study|Study Terminated by Sponsor|0|||
105915384|NCT05116202|365349319|FG000|Overall Study|Withdrawal by Subject|0|||
105915385|NCT05116202|365349320|FG001|Overall Study|Withdrawal by Subject|1|||
105915386|NCT05116202|365349321|FG002|Overall Study|Withdrawal by Subject|1|||
105915387|NCT05116202|365349322|FG003|Overall Study|Withdrawal by Subject|1|||
105915388|NCT05116202|365349323|FG004|Overall Study|Withdrawal by Subject|1|||
105915389|NCT05116202|365349319|FG000|Overall Study|Lost to Follow-up|0|||
105915390|NCT05116202|365349320|FG001|Overall Study|Lost to Follow-up|0|||
105915391|NCT05116202|365349321|FG002|Overall Study|Lost to Follow-up|0|||
105915392|NCT05116202|365349322|FG003|Overall Study|Lost to Follow-up|0|||
105915393|NCT05116202|365349323|FG004|Overall Study|Lost to Follow-up|2|||
105915394|NCT05116202|365349319|FG000|Overall Study|Death|1|||
106126710|NCT01232556|366122021|FG001|Overall Study|Terminated by Sponsor|51|||
106126711|NCT01232556|366122020|FG000|Overall Study|Other|6|||
106126712|NCT01232556|366122021|FG001|Overall Study|Other|4|||
106126713|NCT02448719|366122022|FG000|Overall Study|Withdrawal by Subject|0|||
106126714|NCT02448719|366122023|FG001|Overall Study|Withdrawal by Subject|0|||
106126715|NCT02448719|366122024|FG002|Overall Study|Withdrawal by Subject|0|||
106126716|NCT02448719|366122025|FG003|Overall Study|Withdrawal by Subject|0|||
106126717|NCT02448719|366122026|FG004|Overall Study|Withdrawal by Subject|1|||
105915395|NCT05116202|365349320|FG001|Overall Study|Death|1|||
105915396|NCT05116202|365349321|FG002|Overall Study|Death|2|||
105915397|NCT05116202|365349322|FG003|Overall Study|Death|1|||
105915398|NCT05116202|365349323|FG004|Overall Study|Death|5|||
105915399|NCT03834506|365349324|FG000|Overall Study|Death|336|||
105915400|NCT03834506|365349325|FG001|Overall Study|Death|326|||
106126718|NCT02448719|366122027|FG005|Overall Study|Withdrawal by Subject|0|||
106126719|NCT02448719|366122028|FG006|Overall Study|Withdrawal by Subject|0|||
106126720|NCT02448719|366122029|FG007|Overall Study|Withdrawal by Subject|0|||
106126721|NCT02448719|366122030|FG008|Overall Study|Withdrawal by Subject|0|||
106126722|NCT02448719|366122031|FG009|Overall Study|Withdrawal by Subject|0|||
106126723|NCT02448719|366122032|FG010|Overall Study|Withdrawal by Subject|0|||
106126724|NCT01141660|366122037|FG000|Overall Study|Physician Decision|0|||
105679137|NCT02407990|364486886|FG006|Overall Study|Logistics|0|||
105915401|NCT03834506|365349324|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105915402|NCT03834506|365349325|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105915403|NCT03834506|365349324|FG000|Overall Study|Withdrawal by Subject|10|||
105915404|NCT03834506|365349325|FG001|Overall Study|Withdrawal by Subject|8|||
105915405|NCT03834506|365349324|FG000|Overall Study|Sponsor decision|165|||
105915406|NCT03834506|365349325|FG001|Overall Study|Sponsor decision|178|||
105915407|NCT03834506|365349324|FG000|Overall Study|Physician Decision|3|||
105915408|NCT03834506|365349325|FG001|Overall Study|Physician Decision|1|||
105915409|NCT03834506|365349324|FG000|Overall Study|Lost to Follow-up|0|||
105915410|NCT03834506|365349325|FG001|Overall Study|Lost to Follow-up|1|||
105915411|NCT00606307|365349330|FG000|Overall Study|Adverse Event|2|||
105915412|NCT00606307|365349330|FG000|Overall Study|Withdrawal by Subject|2|||
105915413|NCT00606307|365349330|FG000|Overall Study|Disease progression|6|||
105915414|NCT00606307|365349330|FG000|Overall Study|QTc prolongation|1|||
105915415|NCT03669588|365349338|FG000|Overall Study|Adverse Event|1|||
105915416|NCT03669588|365349339|FG001|Overall Study|Adverse Event|0|||
105915417|NCT03669588|365349338|FG000|Overall Study|Physician Decision|0|||
105915418|NCT03669588|365349339|FG001|Overall Study|Physician Decision|1|||
105915419|NCT03669588|365349338|FG000|Overall Study|Protocol Violation|1|||
105915420|NCT03669588|365349339|FG001|Overall Study|Protocol Violation|0|||
105915421|NCT03669588|365349338|FG000|Overall Study|Sponsor Decision|1|||
105915422|NCT03669588|365349339|FG001|Overall Study|Sponsor Decision|1|||
105915423|NCT03669588|365349338|FG000|Overall Study|Withdrawal by Subject|1|||
105915424|NCT03669588|365349339|FG001|Overall Study|Withdrawal by Subject|4|||
105915425|NCT03669588|365349338|FG000|Overall Study|Rescue Therapy Needed|0|||
105915426|NCT03669588|365349339|FG001|Overall Study|Rescue Therapy Needed|1|||
105915427|NCT02008526|365349346|FG000|Overall Study|Death|0|||
105915428|NCT02008526|365349347|FG001|Overall Study|Death|2|||
105915429|NCT02008526|365349348|FG002|Overall Study|Death|1|||
105915430|NCT02008526|365349346|FG000|Overall Study|Withdrawal by Subject|3|||
105915431|NCT02008526|365349347|FG001|Overall Study|Withdrawal by Subject|3|||
105915432|NCT02008526|365349348|FG002|Overall Study|Withdrawal by Subject|2|||
105915433|NCT02008526|365349346|FG000|Overall Study|Lost to Follow-up|5|||
105915434|NCT02008526|365349347|FG001|Overall Study|Lost to Follow-up|9|||
105915435|NCT02008526|365349348|FG002|Overall Study|Lost to Follow-up|6|||
105915436|NCT01883895|365349349|FG000|Overall Study|Lost to Follow-up|2|||
105915437|NCT04386902|365349350|FG000|Overall Study|Withdrawal by Subject|5|||
105915438|NCT04386902|365349350|FG000|Overall Study|Technical problems in the recording|5|||
106126725|NCT01141660|366122038|FG001|Overall Study|Physician Decision|12|||
106126726|NCT00209027|366122039|FG000|Overall Study|study terminated|10|||
106126727|NCT00209027|366122040|FG001|Overall Study|study terminated|0|||
106126728|NCT02555371|366123757|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
106126729|NCT02555371|366123758|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
106126730|NCT02555371|366123759|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
105679138|NCT02407990|364486887|FG007|Overall Study|Logistics|1|||
105679139|NCT02407990|364486880|FG000|Overall Study|Rolled into long-term extension study|0|||
105915439|NCT02322749|365349351|FG000|Period 2|Adverse Event|0|||
105915440|NCT02322749|365349352|FG001|Period 2|Adverse Event|0|||
105915441|NCT02322749|365349353|FG002|Period 2|Adverse Event|0|||
105915442|NCT02322749|365349354|FG003|Period 2|Adverse Event|1|||
105915443|NCT02322749|365349355|FG004|Period 2|Adverse Event|0|||
105915444|NCT02322749|365349356|FG005|Period 2|Adverse Event|0|||
105915445|NCT02322749|365349351|FG000|Period 2|Withdrawal by Subject|0|||
105915446|NCT02322749|365349352|FG001|Period 2|Withdrawal by Subject|0|||
105915447|NCT02322749|365349353|FG002|Period 2|Withdrawal by Subject|0|||
105915448|NCT02322749|365349354|FG003|Period 2|Withdrawal by Subject|1|||
105915449|NCT02322749|365349355|FG004|Period 2|Withdrawal by Subject|0|||
105915450|NCT02322749|365349356|FG005|Period 2|Withdrawal by Subject|0|||
105915451|NCT02322749|365349351|FG000|Period 3|Withdrawal by Subject|0|||
105915452|NCT02322749|365349352|FG001|Period 3|Withdrawal by Subject|0|||
105915453|NCT02322749|365349353|FG002|Period 3|Withdrawal by Subject|1|||
105915454|NCT02322749|365349354|FG003|Period 3|Withdrawal by Subject|0|||
105915455|NCT02322749|365349355|FG004|Period 3|Withdrawal by Subject|0|||
105915456|NCT02322749|365349356|FG005|Period 3|Withdrawal by Subject|0|||
105915457|NCT05965752|365349361|FG000|Overall Study|Adverse Event|0|||
106126731|NCT02555371|366123760|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
106126732|NCT02555371|366123761|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
105679140|NCT02407990|364486881|FG001|Overall Study|Rolled into long-term extension study|0|||
105679141|NCT02407990|364486882|FG002|Overall Study|Rolled into long-term extension study|0|||
105679142|NCT02407990|364486883|FG003|Overall Study|Rolled into long-term extension study|0|||
105915458|NCT05965752|365349362|FG001|Overall Study|Adverse Event|1|||
105915459|NCT05965752|365349363|FG002|Overall Study|Adverse Event|0|||
105915460|NCT05965752|365349364|FG003|Overall Study|Adverse Event|1|||
106144092|NCT01317420|366186950|FG001|Overall Study|Non-compliant with protocol|0|||
105915461|NCT05965752|365349365|FG004|Overall Study|Adverse Event|3|||
105915462|NCT05965752|365349361|FG000|Overall Study|Lost to Follow-up|2|||
105915463|NCT05965752|365349362|FG001|Overall Study|Lost to Follow-up|0|||
105915464|NCT05965752|365349363|FG002|Overall Study|Lost to Follow-up|1|||
106126733|NCT02555371|366123757|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
106126734|NCT02555371|366123758|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
106126735|NCT02555371|366123759|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
106126736|NCT02555371|366123760|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
106126737|NCT02555371|366123761|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
106126738|NCT02555371|366123757|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
106126739|NCT02555371|366123758|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
106126740|NCT02555371|366123759|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
106126741|NCT02555371|366123760|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
106126742|NCT02555371|366123761|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
106126743|NCT02555371|366123757|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
106126744|NCT02555371|366123758|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
106126745|NCT02555371|366123759|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
106126746|NCT02555371|366123760|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
105679143|NCT02407990|364486884|FG004|Overall Study|Rolled into long-term extension study|0|||
105679144|NCT02407990|364486885|FG005|Overall Study|Rolled into long-term extension study|0|||
105679145|NCT02407990|364486886|FG006|Overall Study|Rolled into long-term extension study|0|||
105679146|NCT02407990|364486887|FG007|Overall Study|Rolled into long-term extension study|1|||
105679147|NCT00852540|364486890|FG000|Overall Study|Adverse Event|10|||
106126747|NCT02555371|366123761|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
106126748|NCT02555371|366123757|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
106126749|NCT02555371|366123758|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
106126750|NCT02555371|366123759|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
106126751|NCT02555371|366123760|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
106126752|NCT02555371|366123761|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
106126753|NCT02555371|366123757|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
106126754|NCT02555371|366123758|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
106126755|NCT02555371|366123759|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
106126756|NCT02555371|366123760|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
106126757|NCT02555371|366123761|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
106126758|NCT02555371|366123757|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
106126759|NCT02555371|366123758|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
106126760|NCT02555371|366123759|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
106126761|NCT02555371|366123760|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
106126762|NCT02555371|366123761|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
106126763|NCT02555371|366123757|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
106126764|NCT02555371|366123758|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
105915465|NCT05965752|365349364|FG003|Overall Study|Lost to Follow-up|1|||
106126765|NCT02555371|366123759|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
106126766|NCT02555371|366123760|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
106126767|NCT02555371|366123761|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
106126768|NCT02555371|366123757|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
106126769|NCT02555371|366123758|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
106126770|NCT02555371|366123759|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
106126771|NCT02555371|366123760|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
106126772|NCT02555371|366123761|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
106126773|NCT02555371|366123757|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
106126774|NCT02555371|366123758|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
106126775|NCT02555371|366123759|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
106126776|NCT02555371|366123760|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
106126777|NCT02555371|366123761|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
106126778|NCT02555371|366123757|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
106126779|NCT02555371|366123758|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
106126780|NCT02555371|366123759|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
106126781|NCT02555371|366123760|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
106126782|NCT02555371|366123761|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
106126783|NCT02555371|366123757|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
106126784|NCT02555371|366123758|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
106126785|NCT02555371|366123759|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
106126786|NCT02555371|366123760|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
106126787|NCT02555371|366123761|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
106126788|NCT02555371|366123757|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
106126789|NCT02555371|366123758|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
106126790|NCT02555371|366123759|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
106126791|NCT02555371|366123760|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
106126792|NCT02555371|366123761|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
106126793|NCT02555371|366123757|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
106126794|NCT02555371|366123758|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
106126795|NCT02555371|366123759|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
106126796|NCT02555371|366123760|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
106126797|NCT02555371|366123761|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
106126798|NCT00513019|366123762|FG000|Overall Study|Adverse Event|1|||
106126799|NCT00513019|366123763|FG001|Overall Study|Adverse Event|0|||
106126800|NCT00513019|366123762|FG000|Overall Study|Withdrawal by Subject|4|||
106126801|NCT00513019|366123763|FG001|Overall Study|Withdrawal by Subject|5|||
106126802|NCT01154036|366123764|FG000|Phase I|Physician Decision|0|||
106126803|NCT01154036|366123765|FG001|Phase I|Physician Decision|1|||
106126804|NCT01154036|366123766|FG002|Phase I|Physician Decision|0|||
106126805|NCT01154036|366123767|FG003|Phase I|Physician Decision|0|||
106126806|NCT01154036|366123768|FG004|Phase I|Physician Decision|0|||
106126807|NCT01154036|366123769|FG005|Phase I|Physician Decision|0|||
106126808|NCT01154036|366123770|FG006|Phase I|Physician Decision|0|||
106126809|NCT01154036|366123771|FG007|Phase I|Physician Decision|0|||
106126810|NCT01154036|366123764|FG000|Phase I|Lost to Follow-up|0|||
106126811|NCT01154036|366123765|FG001|Phase I|Lost to Follow-up|3|||
106126812|NCT01154036|366123766|FG002|Phase I|Lost to Follow-up|6|||
106126813|NCT01154036|366123767|FG003|Phase I|Lost to Follow-up|0|||
106126814|NCT01154036|366123768|FG004|Phase I|Lost to Follow-up|0|||
106126815|NCT01154036|366123769|FG005|Phase I|Lost to Follow-up|0|||
106126816|NCT01154036|366123770|FG006|Phase I|Lost to Follow-up|0|||
106126817|NCT01154036|366123771|FG007|Phase I|Lost to Follow-up|0|||
106126818|NCT01154036|366123764|FG000|Phase I|Protocol Violation|0|||
106126819|NCT01154036|366123765|FG001|Phase I|Protocol Violation|3|||
106126820|NCT01154036|366123766|FG002|Phase I|Protocol Violation|9|||
106126821|NCT01154036|366123767|FG003|Phase I|Protocol Violation|0|||
106126822|NCT01154036|366123768|FG004|Phase I|Protocol Violation|0|||
106126823|NCT01154036|366123769|FG005|Phase I|Protocol Violation|0|||
106126824|NCT01154036|366123770|FG006|Phase I|Protocol Violation|0|||
106126825|NCT01154036|366123771|FG007|Phase I|Protocol Violation|0|||
106126826|NCT01154036|366123764|FG000|Phase I|Withdrawal by Subject|2|||
106126827|NCT01154036|366123765|FG001|Phase I|Withdrawal by Subject|10|||
106126828|NCT01154036|366123766|FG002|Phase I|Withdrawal by Subject|29|||
106126829|NCT01154036|366123767|FG003|Phase I|Withdrawal by Subject|0|||
106126830|NCT01154036|366123768|FG004|Phase I|Withdrawal by Subject|0|||
106126831|NCT01154036|366123769|FG005|Phase I|Withdrawal by Subject|0|||
106126832|NCT01154036|366123770|FG006|Phase I|Withdrawal by Subject|0|||
106126833|NCT01154036|366123771|FG007|Phase I|Withdrawal by Subject|0|||
106126834|NCT01154036|366123764|FG000|Phase I|Adverse Event|1|||
106126835|NCT01154036|366123765|FG001|Phase I|Adverse Event|11|||
106126836|NCT01154036|366123766|FG002|Phase I|Adverse Event|12|||
106126837|NCT01154036|366123767|FG003|Phase I|Adverse Event|0|||
106126838|NCT01154036|366123768|FG004|Phase I|Adverse Event|0|||
106126839|NCT01154036|366123769|FG005|Phase I|Adverse Event|0|||
106126840|NCT01154036|366123770|FG006|Phase I|Adverse Event|0|||
106126841|NCT01154036|366123771|FG007|Phase I|Adverse Event|0|||
106126842|NCT01154036|366123764|FG000|Phase II|Adverse Event|0|||
106126843|NCT01154036|366123765|FG001|Phase II|Adverse Event|0|||
106126844|NCT01154036|366123766|FG002|Phase II|Adverse Event|0|||
106126845|NCT01154036|366123767|FG003|Phase II|Adverse Event|0|||
106126846|NCT01154036|366123768|FG004|Phase II|Adverse Event|1|||
106126847|NCT01154036|366123769|FG005|Phase II|Adverse Event|1|||
106126848|NCT01154036|366123770|FG006|Phase II|Adverse Event|1|||
106126849|NCT01154036|366123771|FG007|Phase II|Adverse Event|1|||
106126850|NCT01154036|366123764|FG000|Phase II|Physician Decision|0|||
106126851|NCT01154036|366123765|FG001|Phase II|Physician Decision|0|||
106126852|NCT01154036|366123766|FG002|Phase II|Physician Decision|0|||
106126853|NCT01154036|366123767|FG003|Phase II|Physician Decision|0|||
106126854|NCT01154036|366123768|FG004|Phase II|Physician Decision|0|||
106126855|NCT01154036|366123769|FG005|Phase II|Physician Decision|0|||
106126856|NCT01154036|366123770|FG006|Phase II|Physician Decision|1|||
106126857|NCT01154036|366123771|FG007|Phase II|Physician Decision|0|||
106126858|NCT01154036|366123764|FG000|Phase II|Lost to Follow-up|0|||
106126859|NCT01154036|366123765|FG001|Phase II|Lost to Follow-up|0|||
106126860|NCT01154036|366123766|FG002|Phase II|Lost to Follow-up|0|||
106126861|NCT01154036|366123767|FG003|Phase II|Lost to Follow-up|1|||
106126862|NCT01154036|366123768|FG004|Phase II|Lost to Follow-up|2|||
106126863|NCT01154036|366123769|FG005|Phase II|Lost to Follow-up|0|||
106126864|NCT01154036|366123770|FG006|Phase II|Lost to Follow-up|2|||
106126865|NCT01154036|366123771|FG007|Phase II|Lost to Follow-up|1|||
106126866|NCT01154036|366123764|FG000|Phase II|Protocol Violation|0|||
106126867|NCT01154036|366123765|FG001|Phase II|Protocol Violation|0|||
106126868|NCT01154036|366123766|FG002|Phase II|Protocol Violation|0|||
106126869|NCT01154036|366123767|FG003|Phase II|Protocol Violation|0|||
106126870|NCT01154036|366123768|FG004|Phase II|Protocol Violation|1|||
106126871|NCT01154036|366123769|FG005|Phase II|Protocol Violation|2|||
106126872|NCT01154036|366123770|FG006|Phase II|Protocol Violation|0|||
106126873|NCT01154036|366123771|FG007|Phase II|Protocol Violation|0|||
106126874|NCT01154036|366123764|FG000|Phase II|Withdrawal by Subject|0|||
106126875|NCT01154036|366123765|FG001|Phase II|Withdrawal by Subject|0|||
106126876|NCT01154036|366123766|FG002|Phase II|Withdrawal by Subject|0|||
106126877|NCT01154036|366123767|FG003|Phase II|Withdrawal by Subject|0|||
106126878|NCT01154036|366123768|FG004|Phase II|Withdrawal by Subject|4|||
106126879|NCT01154036|366123769|FG005|Phase II|Withdrawal by Subject|2|||
106126880|NCT01154036|366123770|FG006|Phase II|Withdrawal by Subject|5|||
106126881|NCT01154036|366123771|FG007|Phase II|Withdrawal by Subject|4|||
106126882|NCT02206152|366123774|FG000|Pre-Randomization|Withdrawal by Subject|2|||
106126883|NCT00322374|366123780|FG000|Starting Dose|Physician Decision|2|||
106126884|NCT00322374|366123781|FG001|Starting Dose|Physician Decision|0|||
106126885|NCT00322374|366123782|FG002|Starting Dose|Physician Decision|0|||
106126886|NCT00322374|366123783|FG003|Starting Dose|Physician Decision|0|||
106126887|NCT00322374|366123780|FG000|Starting Dose|Study Drug Toxicity|4|||
106126888|NCT00322374|366123781|FG001|Starting Dose|Study Drug Toxicity|0|||
106126889|NCT00322374|366123782|FG002|Starting Dose|Study Drug Toxicity|0|||
106126890|NCT00322374|366123783|FG003|Starting Dose|Study Drug Toxicity|0|||
106126891|NCT00322374|366123780|FG000|First Escalation|Documented Disease Progression|0|||
106126892|NCT00322374|366123781|FG001|First Escalation|Documented Disease Progression|6|||
106126893|NCT00322374|366123782|FG002|First Escalation|Documented Disease Progression|0|||
106126894|NCT00322374|366123783|FG003|First Escalation|Documented Disease Progression|0|||
106126895|NCT00322374|366123780|FG000|First Escalation|Physician Decision|0|||
106126896|NCT00322374|366123781|FG001|First Escalation|Physician Decision|12|||
106126897|NCT00322374|366123782|FG002|First Escalation|Physician Decision|0|||
106126898|NCT00322374|366123783|FG003|First Escalation|Physician Decision|0|||
106126899|NCT00322374|366123780|FG000|First Escalation|Study Drug Toxicity|0|||
106126900|NCT00322374|366123781|FG001|First Escalation|Study Drug Toxicity|11|||
106126901|NCT00322374|366123782|FG002|First Escalation|Study Drug Toxicity|0|||
106126902|NCT00322374|366123783|FG003|First Escalation|Study Drug Toxicity|0|||
106126903|NCT00322374|366123780|FG000|First Escalation|Participant Request|0|||
106126904|NCT00322374|366123781|FG001|First Escalation|Participant Request|1|||
106126905|NCT00322374|366123782|FG002|First Escalation|Participant Request|0|||
106126906|NCT00322374|366123783|FG003|First Escalation|Participant Request|0|||
106126907|NCT00322374|366123780|FG000|Second Escalation|Physician Decision|0|||
106126908|NCT00322374|366123781|FG001|Second Escalation|Physician Decision|0|||
106126909|NCT00322374|366123782|FG002|Second Escalation|Physician Decision|5|||
106000540|NCT00607087|365663437|FG001|Overall Study|Other reason|5|||
106000541|NCT00607087|365663438|FG002|Overall Study|Other reason|2|||
106000542|NCT00607087|365663436|FG000|Overall Study|Poor compliance to protocol|1|||
106000543|NCT00607087|365663437|FG001|Overall Study|Poor compliance to protocol|0|||
106000544|NCT00607087|365663438|FG002|Overall Study|Poor compliance to protocol|1|||
106000545|NCT00607087|365663436|FG000|Overall Study|Lost to Follow-up|1|||
106000546|NCT00607087|365663437|FG001|Overall Study|Lost to Follow-up|0|||
106000547|NCT00607087|365663438|FG002|Overall Study|Lost to Follow-up|0|||
106000548|NCT00607087|365663436|FG000|Period 1|Withdrawal by Subject|7|||
106000549|NCT00607087|365663437|FG001|Period 1|Withdrawal by Subject|2|||
106000550|NCT00607087|365663438|FG002|Period 1|Withdrawal by Subject|3|||
106000551|NCT00607087|365663436|FG000|Period 1|Adverse Event|3|||
106000552|NCT00607087|365663437|FG001|Period 1|Adverse Event|0|||
106000553|NCT00607087|365663438|FG002|Period 1|Adverse Event|0|||
106000554|NCT00607087|365663436|FG000|Period 1|Poor compliance to protocol|1|||
106000555|NCT00607087|365663437|FG001|Period 1|Poor compliance to protocol|0|||
106000556|NCT00607087|365663438|FG002|Period 1|Poor compliance to protocol|0|||
106000557|NCT00607087|365663436|FG000|Period 1|Lost to Follow-up|1|||
106000558|NCT00607087|365663437|FG001|Period 1|Lost to Follow-up|0|||
106000559|NCT00607087|365663438|FG002|Period 1|Lost to Follow-up|0|||
106000560|NCT00607087|365663436|FG000|Period 1|Other reason|0|||
106000561|NCT00607087|365663437|FG001|Period 1|Other reason|4|||
106000562|NCT00607087|365663438|FG002|Period 1|Other reason|2|||
106000563|NCT00607087|365663436|FG000|Period 2|Withdrawal by Subject|0|||
106000564|NCT00607087|365663437|FG001|Period 2|Withdrawal by Subject|1|||
106000565|NCT00607087|365663438|FG002|Period 2|Withdrawal by Subject|1|||
106126910|NCT00322374|366123783|FG003|Second Escalation|Physician Decision|0|||
106126911|NCT00322374|366123780|FG000|Second Escalation|Study Drug Toxicity|0|||
106126912|NCT00322374|366123781|FG001|Second Escalation|Study Drug Toxicity|0|||
106126913|NCT00322374|366123782|FG002|Second Escalation|Study Drug Toxicity|1|||
106126914|NCT00322374|366123783|FG003|Second Escalation|Study Drug Toxicity|0|||
106126915|NCT00683449|366123784|FG000|Overall Study|Lost to Follow-up|0|||
106126916|NCT00683449|366123785|FG001|Overall Study|Lost to Follow-up|1|||
106126917|NCT00683449|366123786|FG002|Overall Study|Lost to Follow-up|0|||
106126918|NCT00683449|366123787|FG003|Overall Study|Lost to Follow-up|0|||
106126919|NCT00683449|366123788|FG004|Overall Study|Lost to Follow-up|0|||
106000566|NCT00607087|365663436|FG000|Period 2|Other reason|1|||
106000567|NCT00607087|365663437|FG001|Period 2|Other reason|1|||
106126920|NCT00479674|366123789|FG000|Overall Study|Adverse Event|18|||
106126921|NCT00479674|366123789|FG000|Overall Study|Withdrawal by Subject|6|||
106126922|NCT00479674|366123789|FG000|Overall Study|Physician Decision|14|||
106000568|NCT00607087|365663438|FG002|Period 2|Other reason|0|||
106000569|NCT00607087|365663436|FG000|Period 2|Adverse Event|0|||
106000570|NCT00607087|365663437|FG001|Period 2|Adverse Event|1|||
106000571|NCT00607087|365663438|FG002|Period 2|Adverse Event|3|||
106000572|NCT00607087|365663436|FG000|Period 2|Poor compliance to protocol|0|||
106000573|NCT00607087|365663437|FG001|Period 2|Poor compliance to protocol|0|||
106000574|NCT00607087|365663438|FG002|Period 2|Poor compliance to protocol|1|||
106000575|NCT00607087|365663436|FG000|Period 3|Withdrawal by Subject|2|||
106000576|NCT00607087|365663437|FG001|Period 3|Withdrawal by Subject|1|||
106000577|NCT00607087|365663438|FG002|Period 3|Withdrawal by Subject|0|||
106000578|NCT00607087|365663436|FG000|Period 3|Adverse Event|0|||
106000579|NCT00607087|365663437|FG001|Period 3|Adverse Event|1|||
106000580|NCT00607087|365663438|FG002|Period 3|Adverse Event|0|||
106000581|NCT04393493|365663442|FG000|First 4 Days of Intervention|Early improvement|5|||
106000582|NCT04393493|365663443|FG001|First 4 Days of Intervention|Early improvement|7|||
106000583|NCT02910466|365663444|FG000|Overall Study|Adverse Event|1|||
106000584|NCT02910466|365663444|FG000|Overall Study|Withdrawal by Subject|3|||
106000585|NCT02910466|365663444|FG000|Overall Study|Lost to Follow-up|5|||
106000586|NCT02910466|365663444|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
106000587|NCT02910466|365663444|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
106000588|NCT01125800|365663445|FG000|Phase I|Protocol Violation|0|||
106000589|NCT01125800|365663446|FG001|Phase I|Protocol Violation|3|||
106000590|NCT01125800|365663447|FG002|Phase I|Protocol Violation|1|||
106000591|NCT01125800|365663448|FG003|Phase I|Protocol Violation|1|||
106000592|NCT01125800|365663449|FG004|Phase I|Protocol Violation|0|||
106000593|NCT01125800|365663445|FG000|Phase I|Adverse Event|2|||
106000594|NCT01125800|365663446|FG001|Phase I|Adverse Event|2|||
106000595|NCT01125800|365663447|FG002|Phase I|Adverse Event|1|||
106000596|NCT01125800|365663448|FG003|Phase I|Adverse Event|7|||
106000597|NCT01125800|365663449|FG004|Phase I|Adverse Event|0|||
106000598|NCT01125800|365663445|FG000|Phase I|Administrative problems|1|||
106000599|NCT01125800|365663446|FG001|Phase I|Administrative problems|0|||
106000600|NCT01125800|365663447|FG002|Phase I|Administrative problems|0|||
106000601|NCT01125800|365663448|FG003|Phase I|Administrative problems|0|||
106000602|NCT01125800|365663449|FG004|Phase I|Administrative problems|0|||
106000603|NCT01125800|365663445|FG000|Phase I|Withdrawal by Subject|0|||
106000604|NCT01125800|365663446|FG001|Phase I|Withdrawal by Subject|0|||
106000605|NCT01125800|365663447|FG002|Phase I|Withdrawal by Subject|1|||
106000606|NCT01125800|365663448|FG003|Phase I|Withdrawal by Subject|0|||
106000607|NCT01125800|365663449|FG004|Phase I|Withdrawal by Subject|0|||
106000608|NCT01125800|365663445|FG000|Phase I|Disease progression|5|||
106000609|NCT01125800|365663446|FG001|Phase I|Disease progression|4|||
106000610|NCT01125800|365663447|FG002|Phase I|Disease progression|1|||
106000611|NCT01125800|365663448|FG003|Phase I|Disease progression|3|||
106000612|NCT01125800|365663449|FG004|Phase I|Disease progression|0|||
106000613|NCT01125800|365663445|FG000|Phase II|Protocol Violation|0|||
106000614|NCT01125800|365663446|FG001|Phase II|Protocol Violation|0|||
106000615|NCT01125800|365663447|FG002|Phase II|Protocol Violation|0|||
106000616|NCT01125800|365663448|FG003|Phase II|Protocol Violation|0|||
106000617|NCT01125800|365663449|FG004|Phase II|Protocol Violation|1|||
106000618|NCT01125800|365663445|FG000|Phase II|Adverse Event|0|||
106000619|NCT01125800|365663446|FG001|Phase II|Adverse Event|0|||
106000620|NCT01125800|365663447|FG002|Phase II|Adverse Event|0|||
106000621|NCT01125800|365663448|FG003|Phase II|Adverse Event|0|||
106000622|NCT01125800|365663449|FG004|Phase II|Adverse Event|2|||
106000623|NCT01125800|365663445|FG000|Phase II|Disease progression|0|||
106000624|NCT01125800|365663446|FG001|Phase II|Disease progression|0|||
106000625|NCT01125800|365663447|FG002|Phase II|Disease progression|0|||
106000626|NCT01125800|365663448|FG003|Phase II|Disease progression|1|||
105679148|NCT00852540|364486891|FG001|Overall Study|Adverse Event|3|||
105679149|NCT00852540|364486890|FG000|Overall Study|Lack of Efficacy|15|||
105679150|NCT00852540|364486891|FG001|Overall Study|Lack of Efficacy|3|||
105679151|NCT00852540|364486890|FG000|Overall Study|Protocol Violation|1|||
105679152|NCT00852540|364486891|FG001|Overall Study|Protocol Violation|2|||
105679153|NCT00852540|364486890|FG000|Overall Study|Lost to Follow-up|2|||
106000627|NCT01125800|365663449|FG004|Phase II|Disease progression|8|||
106000628|NCT03446313|365663455|FG000|Overall Study|Lost to Follow-up|1|||
106000629|NCT03446313|365663456|FG001|Overall Study|Lost to Follow-up|2|||
106000630|NCT03446313|365663455|FG000|Overall Study|Failed primary screening|3|||
106000631|NCT03446313|365663456|FG001|Overall Study|Failed primary screening|0|||
106000632|NCT03446313|365663455|FG000|Overall Study|Diagnosed with terminal cancer|1|||
106000633|NCT03446313|365663456|FG001|Overall Study|Diagnosed with terminal cancer|0|||
106000634|NCT03446313|365663455|FG000|Overall Study|Excluded from analysis|1|||
106000635|NCT03446313|365663456|FG001|Overall Study|Excluded from analysis|1|||
106000636|NCT00410956|365663457|FG000|Overall Study|Adverse Event|1|||
106000637|NCT00410956|365663457|FG000|Overall Study|Death|2|||
106000638|NCT00410956|365663457|FG000|Overall Study|Lack of Efficacy|10|||
106000639|NCT00410956|365663457|FG000|Overall Study|Physician Decision|6|||
106000640|NCT01650194|365663458|FG000|Overall Study|Progressive Disease (PD)|35|||
106000641|NCT01650194|365663458|FG000|Overall Study|Withdrawal by Subject|2|||
106000642|NCT01650194|365663458|FG000|Overall Study|Miscellaneous|10|||
105915466|NCT05965752|365349365|FG004|Overall Study|Lost to Follow-up|1|||
105915467|NCT05965752|365349361|FG000|Overall Study|Withdrawal by Subject|2|||
105915468|NCT05965752|365349362|FG001|Overall Study|Withdrawal by Subject|2|||
105915469|NCT05965752|365349363|FG002|Overall Study|Withdrawal by Subject|1|||
105915470|NCT05965752|365349364|FG003|Overall Study|Withdrawal by Subject|5|||
105915471|NCT05965752|365349365|FG004|Overall Study|Withdrawal by Subject|0|||
105915472|NCT05965752|365349361|FG000|Overall Study|Disease Relapse|1|||
105915473|NCT05965752|365349362|FG001|Overall Study|Disease Relapse|0|||
105915474|NCT05965752|365349363|FG002|Overall Study|Disease Relapse|1|||
105915475|NCT05965752|365349364|FG003|Overall Study|Disease Relapse|0|||
105915476|NCT05965752|365349365|FG004|Overall Study|Disease Relapse|0|||
105915477|NCT05965752|365349361|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
105915478|NCT05965752|365349362|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
105915479|NCT05965752|365349363|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
105915480|NCT05965752|365349364|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
105915481|NCT05965752|365349365|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
105915482|NCT05965752|365349361|FG000|Overall Study|Unable to Return for Study Visits|0|||
105915483|NCT05965752|365349362|FG001|Overall Study|Unable to Return for Study Visits|1|||
105915484|NCT05965752|365349363|FG002|Overall Study|Unable to Return for Study Visits|0|||
105915485|NCT05965752|365349364|FG003|Overall Study|Unable to Return for Study Visits|3|||
105915486|NCT05965752|365349365|FG004|Overall Study|Unable to Return for Study Visits|1|||
105915487|NCT05965752|365349361|FG000|Overall Study|Early Termination|0|||
105915488|NCT05965752|365349362|FG001|Overall Study|Early Termination|0|||
105915489|NCT05965752|365349363|FG002|Overall Study|Early Termination|1|||
105915490|NCT05965752|365349364|FG003|Overall Study|Early Termination|0|||
105915491|NCT05965752|365349365|FG004|Overall Study|Early Termination|0|||
105915492|NCT05965752|365349361|FG000|Overall Study|Reported Unwanted Symptoms|0|||
105915493|NCT05965752|365349362|FG001|Overall Study|Reported Unwanted Symptoms|0|||
105915494|NCT05965752|365349363|FG002|Overall Study|Reported Unwanted Symptoms|0|||
105915495|NCT05965752|365349364|FG003|Overall Study|Reported Unwanted Symptoms|0|||
105915496|NCT05965752|365349365|FG004|Overall Study|Reported Unwanted Symptoms|1|||
105915497|NCT05965752|365349361|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
105915498|NCT05965752|365349362|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
105915499|NCT05965752|365349363|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
105915500|NCT05965752|365349364|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
105915501|NCT05965752|365349365|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
105915502|NCT04194814|365349367|FG000|Overall Study|Physician Decision|3|||
105915503|NCT04194814|365349368|FG001|Overall Study|Physician Decision|0|||
105915504|NCT04194814|365349367|FG000|Overall Study|Withdrawal by Subject|0|||
105915505|NCT04194814|365349368|FG001|Overall Study|Withdrawal by Subject|2|||
105915506|NCT03638128|365351089|FG000|Overall Study|Withdrawal by Subject|1|||
105915507|NCT03638128|365351090|FG001|Overall Study|Withdrawal by Subject|7|||
105915508|NCT03638128|365351091|FG002|Overall Study|Withdrawal by Subject|6|||
105915509|NCT03638128|365351089|FG000|Overall Study|Sponsor Decision|15|||
105915510|NCT03638128|365351090|FG001|Overall Study|Sponsor Decision|12|||
105915511|NCT03638128|365351091|FG002|Overall Study|Sponsor Decision|19|||
105915512|NCT03638128|365351089|FG000|Overall Study|Lost to Follow-up|0|||
105915513|NCT03638128|365351090|FG001|Overall Study|Lost to Follow-up|0|||
105915514|NCT03638128|365351091|FG002|Overall Study|Lost to Follow-up|1|||
105915515|NCT01317641|365351092|FG000|Overall Study|Not treated|0|||
105915516|NCT01317641|365351093|FG001|Overall Study|Not treated|0|||
105915517|NCT01317641|365351094|FG002|Overall Study|Not treated|0|||
105915518|NCT01317641|365351095|FG003|Overall Study|Not treated|0|||
105915519|NCT01317641|365351096|FG004|Overall Study|Not treated|0|||
105915520|NCT01317641|365351097|FG005|Overall Study|Not treated|0|||
105915521|NCT01317641|365351098|FG006|Overall Study|Not treated|0|||
105915522|NCT01317641|365351099|FG007|Overall Study|Not treated|1|||
105915523|NCT01317641|365351100|FG008|Overall Study|Not treated|1|||
105915524|NCT01317641|365351092|FG000|Overall Study|Adverse Event|0|||
105915525|NCT01317641|365351093|FG001|Overall Study|Adverse Event|1|||
105915526|NCT01317641|365351094|FG002|Overall Study|Adverse Event|0|||
105915527|NCT01317641|365351095|FG003|Overall Study|Adverse Event|1|||
105915528|NCT01317641|365351096|FG004|Overall Study|Adverse Event|0|||
106000643|NCT01611194|365663459|FG000|Overall Study|Lost to Follow-up|0|||
106000644|NCT01611194|365663460|FG001|Overall Study|Lost to Follow-up|1|||
105915529|NCT01317641|365351097|FG005|Overall Study|Adverse Event|0|||
105915530|NCT01317641|365351098|FG006|Overall Study|Adverse Event|2|||
105915531|NCT01317641|365351099|FG007|Overall Study|Adverse Event|1|||
105915532|NCT01317641|365351100|FG008|Overall Study|Adverse Event|0|||
105915533|NCT01317641|365351092|FG000|Overall Study|Protocol Violation|1|||
105915534|NCT01317641|365351093|FG001|Overall Study|Protocol Violation|0|||
105915535|NCT01317641|365351094|FG002|Overall Study|Protocol Violation|0|||
105915536|NCT01317641|365351095|FG003|Overall Study|Protocol Violation|0|||
105915537|NCT01317641|365351096|FG004|Overall Study|Protocol Violation|0|||
105915538|NCT01317641|365351097|FG005|Overall Study|Protocol Violation|0|||
106126923|NCT00479674|366123789|FG000|Overall Study|none provided|3|||
106000645|NCT01611194|365663459|FG000|Overall Study|Withdrawal by Subject|0|||
105915539|NCT01317641|365351098|FG006|Overall Study|Protocol Violation|0|||
105915540|NCT01317641|365351099|FG007|Overall Study|Protocol Violation|0|||
105915541|NCT01317641|365351100|FG008|Overall Study|Protocol Violation|0|||
105915542|NCT01317641|365351092|FG000|Overall Study|Disease progression|0|||
105915543|NCT01317641|365351093|FG001|Overall Study|Disease progression|0|||
105915544|NCT01317641|365351094|FG002|Overall Study|Disease progression|0|||
105915545|NCT01317641|365351095|FG003|Overall Study|Disease progression|0|||
105915546|NCT01317641|365351096|FG004|Overall Study|Disease progression|0|||
105915547|NCT01317641|365351097|FG005|Overall Study|Disease progression|0|||
105915548|NCT01317641|365351098|FG006|Overall Study|Disease progression|0|||
105915549|NCT01317641|365351099|FG007|Overall Study|Disease progression|3|||
105915550|NCT01317641|365351100|FG008|Overall Study|Disease progression|4|||
106126924|NCT02117544|366123790|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
106126925|NCT02117544|366123791|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
106126926|NCT01991197|366123793|FG000|Overall Study|Lost to Follow-up|1|||
106126927|NCT01991197|366123794|FG001|Overall Study|Lost to Follow-up|1|||
106126928|NCT01991197|366123793|FG000|Overall Study|Physician Decision|0|||
106126929|NCT01991197|366123794|FG001|Overall Study|Physician Decision|2|||
106126930|NCT01991197|366123793|FG000|Overall Study|Withdrawal by Subject|2|||
106126931|NCT01991197|366123794|FG001|Overall Study|Withdrawal by Subject|0|||
106126932|NCT01010217|366123795|FG000|Overall Study|Lost to Follow-up|4|||
106126933|NCT01010217|366123796|FG001|Overall Study|Lost to Follow-up|5|||
106126934|NCT01010217|366123797|FG002|Overall Study|Lost to Follow-up|1|||
106126935|NCT01010217|366123798|FG003|Overall Study|Lost to Follow-up|0|||
106126936|NCT01010217|366123799|FG004|Overall Study|Lost to Follow-up|0|||
106126937|NCT01010217|366123795|FG000|Overall Study|Withdrawal by Subject|1|||
106126938|NCT01010217|366123796|FG001|Overall Study|Withdrawal by Subject|0|||
106126939|NCT01010217|366123797|FG002|Overall Study|Withdrawal by Subject|0|||
106126940|NCT01010217|366123798|FG003|Overall Study|Withdrawal by Subject|0|||
106126941|NCT01010217|366123799|FG004|Overall Study|Withdrawal by Subject|0|||
106126942|NCT01010217|366123795|FG000|Overall Study|Physician Decision|0|||
106126943|NCT01010217|366123796|FG001|Overall Study|Physician Decision|0|||
106126944|NCT01010217|366123797|FG002|Overall Study|Physician Decision|0|||
106126945|NCT01010217|366123798|FG003|Overall Study|Physician Decision|6|||
106126946|NCT01010217|366123799|FG004|Overall Study|Physician Decision|3|||
106126947|NCT01439711|366123800|FG000|Overall Study|Ineligible|13|||
106126948|NCT01439711|366123800|FG000|Overall Study|Cancel|3|||
106126949|NCT01439711|366123800|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
106126950|NCT01439711|366123800|FG000|Overall Study|Adverse Event|5|||
106126951|NCT01439711|366123800|FG000|Overall Study|Withdrawal by Subject|3|||
106126952|NCT01439711|366123800|FG000|Overall Study|Progression During Active Tx|3|||
106126953|NCT01439711|366123800|FG000|Overall Study|Noncompliance|3|||
106126954|NCT01439711|366123800|FG000|Overall Study|No MRI|9|||
106126955|NCT03389893|366123801|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
106126956|NCT03389893|366123802|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
106126957|NCT03389893|366123803|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
106126958|NCT03389893|366123804|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
106126959|NCT03389893|366123801|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
106126960|NCT03389893|366123802|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
106126961|NCT03389893|366123803|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
106126962|NCT03389893|366123804|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
106126963|NCT03389893|366123801|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
106126964|NCT03389893|366123802|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
106126965|NCT03389893|366123803|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
106126966|NCT03389893|366123804|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
106126967|NCT03389893|366123801|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
106126968|NCT03389893|366123802|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
106126969|NCT03389893|366123803|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
106126970|NCT03389893|366123804|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
105679154|NCT00852540|364486891|FG001|Overall Study|Lost to Follow-up|3|||
105679155|NCT00852540|364486890|FG000|Overall Study|Investigator Discretion|2|||
105679156|NCT00852540|364486891|FG001|Overall Study|Investigator Discretion|3|||
105679157|NCT00852540|364486890|FG000|Overall Study|Withdrawal by Subject|3|||
105679158|NCT00852540|364486891|FG001|Overall Study|Withdrawal by Subject|1|||
105679159|NCT00852540|364486890|FG000|Overall Study|Did Not Receive Study Drug|3|||
105915551|NCT01317641|365351092|FG000|Overall Study|Withdrawal by Subject|0|||
105915552|NCT01317641|365351093|FG001|Overall Study|Withdrawal by Subject|0|||
105915553|NCT01317641|365351094|FG002|Overall Study|Withdrawal by Subject|0|||
105915554|NCT01317641|365351095|FG003|Overall Study|Withdrawal by Subject|0|||
106126971|NCT00388362|366123821|FG000|Enrolled|Ineligible|1|||
106126972|NCT00388362|366123821|FG000|Enrolled|Adverse Event|9|||
106126973|NCT00388362|366123821|FG000|Enrolled|Death|1|||
106126974|NCT00388362|366123821|FG000|Enrolled|Loss insurance|1|||
106126975|NCT00388362|366123821|FG000|Enrolled|Withdrawal by Subject|1|||
106126976|NCT00388362|366123821|FG000|Remained on Study Median of 514 Days|Death|2|||
106144093|NCT01317420|366186951|FG002|Overall Study|Non-compliant with protocol|0|||
106126977|NCT03259373|366123826|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
106126978|NCT03259373|366123827|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
106126979|NCT03259373|366123826|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
106126980|NCT03259373|366123827|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
106126981|NCT03259373|366123826|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
106126982|NCT03259373|366123827|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
106126983|NCT03259373|366123826|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
106126984|NCT03259373|366123827|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
106126985|NCT03259373|366123826|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
106126986|NCT03259373|366123827|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
106126987|NCT03259373|366123826|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
106126988|NCT03259373|366123827|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
106126989|NCT01923428|366123834|FG000|Overall Study|Adverse Event|8|||
106126990|NCT01923428|366123835|FG001|Overall Study|Adverse Event|6|||
106126991|NCT01923428|366123836|FG002|Overall Study|Adverse Event|3|||
106126992|NCT01923428|366123837|FG003|Overall Study|Adverse Event|3|||
105915555|NCT01317641|365351096|FG004|Overall Study|Withdrawal by Subject|0|||
105915556|NCT01317641|365351097|FG005|Overall Study|Withdrawal by Subject|0|||
105915557|NCT01317641|365351098|FG006|Overall Study|Withdrawal by Subject|1|||
105915558|NCT01317641|365351099|FG007|Overall Study|Withdrawal by Subject|0|||
105915559|NCT01317641|365351100|FG008|Overall Study|Withdrawal by Subject|0|||
105915560|NCT00611806|365351101|FG000|Overall Study|Withdrawal by Subject|8|||
105915561|NCT00611806|365351102|FG001|Overall Study|Withdrawal by Subject|2|||
105915562|NCT00611806|365351101|FG000|Overall Study|Adverse Event|2|||
105915563|NCT00611806|365351102|FG001|Overall Study|Adverse Event|1|||
105915564|NCT00611806|365351101|FG000|Overall Study|Lost to Follow-up|6|||
105915565|NCT00611806|365351102|FG001|Overall Study|Lost to Follow-up|0|||
105915566|NCT02611882|365351103|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
105915567|NCT02611882|365351104|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
105915568|NCT02611882|365351105|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
105915569|NCT00715559|365351107|FG000|Overall Study|medication not tolerated - nausea|1|||
105915570|NCT01051921|365351108|FG000|Overall Study|Physician Decision|9|||
105915571|NCT01051921|365351108|FG000|Overall Study|Adverse Event|8|||
105915572|NCT01051921|365351108|FG000|Overall Study|Withdrawal by Subject|7|||
105915573|NCT01051921|365351108|FG000|Overall Study|Lost to Follow-up|4|||
105915574|NCT01051921|365351108|FG000|Overall Study|virological failure|1|||
105915575|NCT01051921|365351108|FG000|Overall Study|patient moved|1|||
105915576|NCT02486692|365351113|FG000|Overall Study|did not login for randomization|4|||
105915577|NCT02486692|365351114|FG001|Overall Study|did not login for randomization|7|||
105915578|NCT00010257|365351115|FG000|Overall Study|Withdrawal by Subject|1|||
105915579|NCT00010257|365351116|FG001|Overall Study|Withdrawal by Subject|0|||
105915580|NCT01053741|365351119|FG000|2nd Study Intervention|Physician Decision|0|||
105915581|NCT01053741|365351120|FG001|2nd Study Intervention|Physician Decision|1|||
105915582|NCT02498678|365351121|FG000|Overall Study|interference from the surgical team|0|||
105915583|NCT02498678|365351122|FG001|Overall Study|interference from the surgical team|2|||
105915584|NCT01811732|365351132|FG000|Overall Study|Lost to Follow-up|24|||
105915585|NCT01811732|365351133|FG001|Overall Study|Lost to Follow-up|30|||
105915586|NCT01811732|365351132|FG000|Overall Study|Withdrawal by Subject|16|||
105915587|NCT01811732|365351133|FG001|Overall Study|Withdrawal by Subject|10|||
105915588|NCT01811732|365351132|FG000|Overall Study|Adverse Event|3|||
105915589|NCT01811732|365351133|FG001|Overall Study|Adverse Event|9|||
105915590|NCT01811732|365351132|FG000|Overall Study|Lack of Efficacy|3|||
105915591|NCT01811732|365351133|FG001|Overall Study|Lack of Efficacy|1|||
105915592|NCT01811732|365351132|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
105915593|NCT01811732|365351133|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
105915594|NCT01811732|365351132|FG000|Overall Study|Physician Decision|2|||
105915595|NCT01811732|365351133|FG001|Overall Study|Physician Decision|0|||
105915596|NCT01811732|365351132|FG000|Overall Study|Death|1|||
105915597|NCT01811732|365351133|FG001|Overall Study|Death|1|||
105915598|NCT01811732|365351132|FG000|Overall Study|Insufficient venous access|0|||
105915599|NCT01811732|365351133|FG001|Overall Study|Insufficient venous access|1|||
105915600|NCT01811732|365351132|FG000|Overall Study|Protocol Violation|0|||
106126993|NCT01923428|366123834|FG000|Overall Study|Withdrawal by Subject|5|||
105915601|NCT01811732|365351133|FG001|Overall Study|Protocol Violation|1|||
105915602|NCT01811732|365351132|FG000|Overall Study|Subject incarcerated|1|||
105915603|NCT01811732|365351133|FG001|Overall Study|Subject incarcerated|2|||
105915604|NCT01811732|365351132|FG000|Overall Study|Admitted to another facility|1|||
105915605|NCT01811732|365351133|FG001|Overall Study|Admitted to another facility|0|||
105915606|NCT01811732|365351132|FG000|Overall Study|Correct study drug not available on site|1|||
106000646|NCT01611194|365663460|FG001|Overall Study|Withdrawal by Subject|1|||
106000647|NCT01611194|365663459|FG000|Overall Study|drug use|0|||
106000648|NCT01611194|365663460|FG001|Overall Study|drug use|1|||
106000649|NCT03790111|365665084|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
106000650|NCT02831764|365665085|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
106000651|NCT02831764|365665086|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
106000652|NCT02831764|365665087|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
106000653|NCT02831764|365665088|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
106000654|NCT02831764|365665089|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
106000655|NCT02831764|365665085|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
106000656|NCT02831764|365665086|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
106000657|NCT02831764|365665087|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
106000658|NCT02831764|365665088|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
106000659|NCT02831764|365665089|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
106000660|NCT02831764|365665085|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
106000661|NCT02831764|365665086|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
106000662|NCT02831764|365665087|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
106000663|NCT02831764|365665088|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
106000664|NCT02831764|365665089|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
106000665|NCT02831764|365665085|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
106000666|NCT02831764|365665086|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
106000667|NCT02831764|365665087|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
106000668|NCT02831764|365665088|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
106000669|NCT02831764|365665089|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
106000670|NCT02831764|365665085|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
106000671|NCT02831764|365665086|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
106000672|NCT02831764|365665087|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
106000673|NCT02831764|365665088|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
106000674|NCT02831764|365665089|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
106000675|NCT02831764|365665085|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
106000676|NCT02831764|365665086|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
106000677|NCT02831764|365665087|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
106000678|NCT02831764|365665088|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
106000679|NCT02831764|365665089|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
106000680|NCT02831764|365665085|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
106000681|NCT02831764|365665086|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
106000682|NCT02831764|365665087|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
106000683|NCT02831764|365665088|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
106000684|NCT02831764|365665089|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
106000685|NCT02831764|365665085|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
106000686|NCT02831764|365665086|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
106000687|NCT02831764|365665087|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
106000688|NCT02831764|365665088|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
106000689|NCT02831764|365665089|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
106000690|NCT02831764|365665085|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
106000691|NCT02831764|365665086|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
106000692|NCT02831764|365665087|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
106000693|NCT02831764|365665088|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
106000694|NCT02831764|365665089|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
106000695|NCT02831764|365665085|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
106000696|NCT02831764|365665086|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
106000697|NCT02831764|365665087|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
106000698|NCT02831764|365665088|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
106000699|NCT02831764|365665089|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
106000700|NCT02831764|365665085|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
106000701|NCT02831764|365665086|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
106000702|NCT02831764|365665087|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
106000703|NCT02831764|365665088|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
106126994|NCT01923428|366123835|FG001|Overall Study|Withdrawal by Subject|3|||
106126995|NCT01923428|366123836|FG002|Overall Study|Withdrawal by Subject|0|||
106126996|NCT01923428|366123837|FG003|Overall Study|Withdrawal by Subject|4|||
106126997|NCT01923428|366123834|FG000|Overall Study|Lost to Follow-up|2|||
106126998|NCT01923428|366123835|FG001|Overall Study|Lost to Follow-up|1|||
106126999|NCT01923428|366123836|FG002|Overall Study|Lost to Follow-up|5|||
106127000|NCT01923428|366123837|FG003|Overall Study|Lost to Follow-up|0|||
106127001|NCT01923428|366123834|FG000|Overall Study|Protocol Violation|3|||
106127002|NCT01923428|366123835|FG001|Overall Study|Protocol Violation|0|||
106127003|NCT01923428|366123836|FG002|Overall Study|Protocol Violation|2|||
106127004|NCT01923428|366123837|FG003|Overall Study|Protocol Violation|1|||
106127005|NCT01923428|366123834|FG000|Overall Study|Non Compliance to treatment|1|||
106127006|NCT01923428|366123835|FG001|Overall Study|Non Compliance to treatment|2|||
106127007|NCT01923428|366123836|FG002|Overall Study|Non Compliance to treatment|0|||
106127008|NCT01923428|366123837|FG003|Overall Study|Non Compliance to treatment|1|||
106127009|NCT01923428|366123834|FG000|Overall Study|Lack of Efficacy|0|||
106127010|NCT01923428|366123835|FG001|Overall Study|Lack of Efficacy|0|||
106127011|NCT01923428|366123836|FG002|Overall Study|Lack of Efficacy|1|||
106127012|NCT01923428|366123837|FG003|Overall Study|Lack of Efficacy|1|||
106127013|NCT00946647|366123838|FG000|Phase 1 Part|Adverse Event|2|||
106127014|NCT00946647|366123839|FG001|Phase 1 Part|Adverse Event|5|||
106127015|NCT00946647|366123840|FG002|Phase 1 Part|Adverse Event|3|||
106127016|NCT00946647|366123841|FG003|Phase 1 Part|Adverse Event|0|||
106127017|NCT00946647|366123842|FG004|Phase 1 Part|Adverse Event|0|||
106127018|NCT00946647|366123838|FG000|Phase 1 Part|Disease progression|3|||
106127019|NCT00946647|366123839|FG001|Phase 1 Part|Disease progression|6|||
106127020|NCT00946647|366123840|FG002|Phase 1 Part|Disease progression|1|||
106127021|NCT00946647|366123841|FG003|Phase 1 Part|Disease progression|0|||
106127022|NCT00946647|366123842|FG004|Phase 1 Part|Disease progression|0|||
106127023|NCT00946647|366123838|FG000|Phase 1 Part|Withdrawal by Subject|1|||
106127024|NCT00946647|366123839|FG001|Phase 1 Part|Withdrawal by Subject|4|||
106127025|NCT00946647|366123840|FG002|Phase 1 Part|Withdrawal by Subject|3|||
106127026|NCT00946647|366123841|FG003|Phase 1 Part|Withdrawal by Subject|0|||
105915607|NCT01811732|365351133|FG001|Overall Study|Correct study drug not available on site|0|||
105915608|NCT01405560|365351134|FG000|Overall Study|Physician Decision|1|||
105915609|NCT01484951|365351135|FG000|Overall Study|Adverse Event|3|||
105915610|NCT01484951|365351135|FG000|Overall Study|Personal Reasons|1|||
105915611|NCT01484951|365351135|FG000|Overall Study|Non-Compliance|1|||
105915612|NCT03102762|365351137|FG000|Overall Study|Lost to Follow-up|1|||
105915613|NCT03102762|365351138|FG001|Overall Study|Lost to Follow-up|0|||
105915614|NCT00728494|365351153|FG000|Overall Study|Adverse Event|7|||
105915615|NCT00728494|365351154|FG001|Overall Study|Adverse Event|0|||
105915616|NCT00728494|365351153|FG000|Overall Study|Withdrawal by Subject|0|||
105915617|NCT00728494|365351154|FG001|Overall Study|Withdrawal by Subject|2|||
105915618|NCT00728494|365351153|FG000|Overall Study|Lack of Efficacy|2|||
105915619|NCT00728494|365351154|FG001|Overall Study|Lack of Efficacy|4|||
105915620|NCT00728494|365351153|FG000|Overall Study|No data available|0|||
105915621|NCT00728494|365351154|FG001|Overall Study|No data available|1|||
105915622|NCT03769649|365351155|FG000|Overall Study|Lost to Follow-up|4|||
105915623|NCT03903172|365351160|FG000|Overall Study|screen fail|4|||
105915624|NCT03903172|365351161|FG001|Overall Study|screen fail|1|||
105915625|NCT00661089|365351162|FG000|Overall Study|1 subject withdrawal|0|||
105915626|NCT00661089|365351163|FG001|Overall Study|1 subject withdrawal|1|||
105915627|NCT00661089|365351162|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
105915628|NCT00661089|365351163|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
105915629|NCT01701245|365351165|FG000|Overall Study|Protocol Violation|1|||
105915630|NCT01701245|365351166|FG001|Overall Study|Protocol Violation|3|||
106127027|NCT00946647|366123842|FG004|Phase 1 Part|Withdrawal by Subject|0|||
105915631|NCT01701245|365351165|FG000|Overall Study|Did not complete the open label period|11|||
105915632|NCT01701245|365351166|FG001|Overall Study|Did not complete the open label period|12|||
105915633|NCT00274742|365351167|FG000|Overall Study|Adverse Event|0|||
105915634|NCT00274742|365351168|FG001|Overall Study|Adverse Event|4|||
105915635|NCT00274742|365351169|FG002|Overall Study|Adverse Event|1|||
105915636|NCT00274742|365351170|FG003|Overall Study|Adverse Event|4|||
105915637|NCT00274742|365351171|FG004|Overall Study|Adverse Event|12|||
106127028|NCT00946647|366123838|FG000|Phase 1 Part|Abnormal values|0|||
106127029|NCT00946647|366123839|FG001|Phase 1 Part|Abnormal values|2|||
106127030|NCT00946647|366123840|FG002|Phase 1 Part|Abnormal values|0|||
106127031|NCT00946647|366123841|FG003|Phase 1 Part|Abnormal values|0|||
106127032|NCT00946647|366123842|FG004|Phase 1 Part|Abnormal values|0|||
106127033|NCT00946647|366123838|FG000|Phase 1 Part|Reason missing|0|||
106127034|NCT00946647|366123839|FG001|Phase 1 Part|Reason missing|1|||
106127035|NCT00946647|366123840|FG002|Phase 1 Part|Reason missing|0|||
106127036|NCT00946647|366123841|FG003|Phase 1 Part|Reason missing|0|||
106127037|NCT00946647|366123842|FG004|Phase 1 Part|Reason missing|0|||
106127038|NCT00946647|366123838|FG000|Phase ll Part|Untreated|0|||
106127039|NCT00946647|366123839|FG001|Phase ll Part|Untreated|0|||
106127040|NCT00946647|366123840|FG002|Phase ll Part|Untreated|0|||
106127041|NCT00946647|366123841|FG003|Phase ll Part|Untreated|0|||
106000704|NCT02831764|365665089|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
106000705|NCT02831764|365665085|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
106000706|NCT02831764|365665086|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
106000707|NCT02831764|365665087|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
106000708|NCT02831764|365665088|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
106000709|NCT02831764|365665089|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
106000710|NCT02831764|365665085|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
106000711|NCT02831764|365665086|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
106127042|NCT00946647|366123842|FG004|Phase ll Part|Untreated|2|||
106127043|NCT00946647|366123838|FG000|Phase ll Part|Adverse Event|0|||
106127044|NCT00946647|366123839|FG001|Phase ll Part|Adverse Event|0|||
106127045|NCT00946647|366123840|FG002|Phase ll Part|Adverse Event|0|||
106127046|NCT00946647|366123841|FG003|Phase ll Part|Adverse Event|10|||
106127047|NCT00946647|366123842|FG004|Phase ll Part|Adverse Event|6|||
106127048|NCT00946647|366123838|FG000|Phase ll Part|Withdrawal by Subject|0|||
106127049|NCT00946647|366123839|FG001|Phase ll Part|Withdrawal by Subject|0|||
106127050|NCT00946647|366123840|FG002|Phase ll Part|Withdrawal by Subject|0|||
106127051|NCT00946647|366123841|FG003|Phase ll Part|Withdrawal by Subject|8|||
106127052|NCT00946647|366123842|FG004|Phase ll Part|Withdrawal by Subject|6|||
106127053|NCT00946647|366123838|FG000|Phase ll Part|Administrative problems|0|||
106127054|NCT00946647|366123839|FG001|Phase ll Part|Administrative problems|0|||
106127055|NCT00946647|366123840|FG002|Phase ll Part|Administrative problems|0|||
106127056|NCT00946647|366123841|FG003|Phase ll Part|Administrative problems|3|||
106127057|NCT00946647|366123842|FG004|Phase ll Part|Administrative problems|8|||
106000712|NCT02831764|365665087|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
106000713|NCT02831764|365665088|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
106000714|NCT02831764|365665089|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
106000715|NCT02831764|365665085|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
106000716|NCT02831764|365665086|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
106000717|NCT02831764|365665087|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
106000718|NCT02831764|365665088|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
106000719|NCT02831764|365665089|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
106000720|NCT02831764|365665085|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
106000721|NCT02831764|365665086|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
106000722|NCT02831764|365665087|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
106000723|NCT02831764|365665088|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
106000724|NCT02831764|365665089|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
106000725|NCT02831764|365665085|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
106000726|NCT02831764|365665086|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
106000727|NCT02831764|365665087|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
106000728|NCT02831764|365665088|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
106000729|NCT02831764|365665089|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
106000730|NCT02831764|365665085|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
106000731|NCT02831764|365665086|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
106127058|NCT00946647|366123838|FG000|Phase ll Part|Death|0|||
106127059|NCT00946647|366123839|FG001|Phase ll Part|Death|0|||
106127060|NCT00946647|366123840|FG002|Phase ll Part|Death|0|||
106127061|NCT00946647|366123841|FG003|Phase ll Part|Death|7|||
105679160|NCT00852540|364486891|FG001|Overall Study|Did Not Receive Study Drug|3|||
105679161|NCT00446043|364486894|FG000|Overall Study|Adverse Event|9|||
105679162|NCT00446043|364486894|FG000|Overall Study|Withdrawal by Subject|70|||
105679163|NCT00446043|364486894|FG000|Overall Study|Protocol Violation|2|||
106127062|NCT00946647|366123842|FG004|Phase ll Part|Death|4|||
105679164|NCT00446043|364486894|FG000|Overall Study|Lost to Follow-up|42|||
105679165|NCT00446043|364486894|FG000|Overall Study|Pregnancy|2|||
105679166|NCT01253304|364486902|FG000|Overall Study|Adverse Event|0|||
105679167|NCT01253304|364486903|FG001|Overall Study|Adverse Event|0|||
106127063|NCT00946647|366123838|FG000|Phase ll Part|Disease progression|0|||
106127064|NCT00946647|366123839|FG001|Phase ll Part|Disease progression|0|||
106127065|NCT00946647|366123840|FG002|Phase ll Part|Disease progression|0|||
106127066|NCT00946647|366123841|FG003|Phase ll Part|Disease progression|6|||
106127067|NCT00946647|366123842|FG004|Phase ll Part|Disease progression|14|||
106127068|NCT00946647|366123838|FG000|Phase ll Part|Protocol Violation|0|||
106127069|NCT00946647|366123839|FG001|Phase ll Part|Protocol Violation|0|||
106127070|NCT00946647|366123840|FG002|Phase ll Part|Protocol Violation|0|||
106127071|NCT00946647|366123841|FG003|Phase ll Part|Protocol Violation|4|||
106127072|NCT00946647|366123842|FG004|Phase ll Part|Protocol Violation|2|||
106127073|NCT00946647|366123838|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
106127074|NCT00946647|366123839|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
106127075|NCT00946647|366123840|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
106127076|NCT00946647|366123841|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
106127077|NCT00946647|366123842|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
106127078|NCT01368211|366123843|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
106127079|NCT01368211|366123844|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
106127080|NCT01960790|366123845|FG000|Overall Study|Survey forms could not be recovered|3|||
106127081|NCT01960790|366123845|FG000|Overall Study|Treat with Humira outside survey period|3|||
106127082|NCT01960790|366123845|FG000|Overall Study|Transferred to another hospital|4|||
106127083|NCT01960790|366123845|FG000|Overall Study|Unevaluable for safety|1|||
106127084|NCT01563978|366123849|FG000|Overall Study|Physician Decision|1|||
106127085|NCT01563978|366123850|FG001|Overall Study|Physician Decision|0|||
106127086|NCT01563978|366123849|FG000|Overall Study|Lost to Follow-up|1|||
106127087|NCT01563978|366123850|FG001|Overall Study|Lost to Follow-up|0|||
106127088|NCT01563978|366123849|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
106127089|NCT01563978|366123850|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
106127090|NCT01563978|366123849|FG000|Overall Study|Adverse Event|1|||
106127091|NCT01563978|366123850|FG001|Overall Study|Adverse Event|2|||
106127092|NCT05593211|366123854|FG000|Overall Study|Withdrawal by Subject|1|||
106127093|NCT03077620|366123858|FG000|Overall Study|Unable to place lumbar catheter|1|||
106127094|NCT03077620|366123859|FG001|Overall Study|Unable to place lumbar catheter|0|||
106127095|NCT03077620|366123860|FG002|Overall Study|Unable to place lumbar catheter|1|||
106127096|NCT03077620|366123861|FG003|Overall Study|Unable to place lumbar catheter|0|||
106127097|NCT03077620|366123858|FG000|Overall Study|Withdrawal by Subject|0|||
106127098|NCT03077620|366123859|FG001|Overall Study|Withdrawal by Subject|1|||
106127099|NCT03077620|366123860|FG002|Overall Study|Withdrawal by Subject|0|||
106127100|NCT03077620|366123861|FG003|Overall Study|Withdrawal by Subject|0|||
106127101|NCT03077620|366123858|FG000|Overall Study|Physician Decision|0|||
106127102|NCT03077620|366123859|FG001|Overall Study|Physician Decision|0|||
106127103|NCT03077620|366123860|FG002|Overall Study|Physician Decision|1|||
106127104|NCT03077620|366123861|FG003|Overall Study|Physician Decision|0|||
106127105|NCT03225846|366123862|FG000|Overall Study|Adverse Event|0|||
106127106|NCT03225846|366123863|FG001|Overall Study|Adverse Event|0|||
106127107|NCT03225846|366123864|FG002|Overall Study|Adverse Event|0|||
106127108|NCT03225846|366123865|FG003|Overall Study|Adverse Event|0|||
106127109|NCT03225846|366123866|FG004|Overall Study|Adverse Event|0|||
106127110|NCT03225846|366123867|FG005|Overall Study|Adverse Event|0|||
106127111|NCT03225846|366123868|FG006|Overall Study|Adverse Event|6|||
106127112|NCT03225846|366123862|FG000|Overall Study|Withdrawal by Subject|0|||
106127113|NCT03225846|366123863|FG001|Overall Study|Withdrawal by Subject|1|||
106127114|NCT03225846|366123864|FG002|Overall Study|Withdrawal by Subject|0|||
106127115|NCT03225846|366123865|FG003|Overall Study|Withdrawal by Subject|0|||
106127116|NCT03225846|366123866|FG004|Overall Study|Withdrawal by Subject|0|||
106127117|NCT03225846|366123867|FG005|Overall Study|Withdrawal by Subject|0|||
106127118|NCT03225846|366123868|FG006|Overall Study|Withdrawal by Subject|0|||
106127119|NCT03225846|366123862|FG000|Overall Study|Death|0|||
106127120|NCT03225846|366123863|FG001|Overall Study|Death|1|||
106127121|NCT03225846|366123864|FG002|Overall Study|Death|0|||
106127122|NCT03225846|366123865|FG003|Overall Study|Death|0|||
106127123|NCT03225846|366123866|FG004|Overall Study|Death|0|||
106127124|NCT03225846|366123867|FG005|Overall Study|Death|0|||
106127125|NCT03225846|366123868|FG006|Overall Study|Death|0|||
106127126|NCT03225846|366123862|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
106127127|NCT03225846|366123863|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
106127128|NCT03225846|366123864|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
106127129|NCT03225846|366123865|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
106127130|NCT03225846|366123866|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
106127131|NCT03225846|366123867|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
106127132|NCT03225846|366123868|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
106127133|NCT03225846|366123862|FG000|Overall Study|Patient decision|0|||
106127134|NCT03225846|366123863|FG001|Overall Study|Patient decision|0|||
105915638|NCT00274742|365351172|FG005|Overall Study|Adverse Event|3|||
105915639|NCT00274742|365351167|FG000|Overall Study|Lost to Follow-up|0|||
105915640|NCT00274742|365351168|FG001|Overall Study|Lost to Follow-up|0|||
105915641|NCT00274742|365351169|FG002|Overall Study|Lost to Follow-up|0|||
105915642|NCT00274742|365351170|FG003|Overall Study|Lost to Follow-up|0|||
105915643|NCT00274742|365351171|FG004|Overall Study|Lost to Follow-up|1|||
105915644|NCT00274742|365351172|FG005|Overall Study|Lost to Follow-up|0|||
105915645|NCT00274742|365351167|FG000|Overall Study|End of Study|0|||
105915646|NCT00274742|365351168|FG001|Overall Study|End of Study|0|||
105915647|NCT00274742|365351169|FG002|Overall Study|End of Study|0|||
105915648|NCT00274742|365351170|FG003|Overall Study|End of Study|1|||
105915649|NCT00274742|365351171|FG004|Overall Study|End of Study|0|||
105915650|NCT00274742|365351172|FG005|Overall Study|End of Study|0|||
105915651|NCT00274742|365351167|FG000|Overall Study|Disease Progression|0|||
105915652|NCT00274742|365351168|FG001|Overall Study|Disease Progression|1|||
105915653|NCT00274742|365351169|FG002|Overall Study|Disease Progression|1|||
105915654|NCT00274742|365351170|FG003|Overall Study|Disease Progression|0|||
105915655|NCT00274742|365351171|FG004|Overall Study|Disease Progression|1|||
106127135|NCT03225846|366123864|FG002|Overall Study|Patient decision|0|||
106127136|NCT03225846|366123865|FG003|Overall Study|Patient decision|0|||
106127137|NCT03225846|366123866|FG004|Overall Study|Patient decision|0|||
106127138|NCT03225846|366123867|FG005|Overall Study|Patient decision|0|||
106127139|NCT03225846|366123868|FG006|Overall Study|Patient decision|1|||
106127140|NCT00996580|366123869|FG000|Overall Study|Adverse Event|466|||
106127141|NCT00996580|366123869|FG000|Overall Study|Lost to Follow-up|480|||
106127142|NCT00996580|366123869|FG000|Overall Study|Noncompliance with the protocol|137|||
106127143|NCT00996580|366123869|FG000|Overall Study|Physician Decision|5|||
106127144|NCT00996580|366123869|FG000|Overall Study|Pregnancy|68|||
106127145|NCT00996580|366123869|FG000|Overall Study|Protocol Violation|16|||
106127146|NCT00996580|366123869|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
106127147|NCT00996580|366123869|FG000|Overall Study|Withdrawal by Subject|217|||
106127148|NCT00996580|366123869|FG000|Overall Study|Other|29|||
106127149|NCT05708846|366123872|FG000|Overall Study|Death|5|||
106127150|NCT05708846|366123872|FG000|Overall Study|Withdrawal by Subject|20|||
106127151|NCT02036515|366123873|FG000|Overall Study|Adverse Event|1|||
106127152|NCT02036515|366123874|FG001|Overall Study|Adverse Event|1|||
106127153|NCT02036515|366123875|FG002|Overall Study|Adverse Event|2|||
106127154|NCT02036515|366123873|FG000|Overall Study|Lost to Follow-up|0|||
106127155|NCT02036515|366123874|FG001|Overall Study|Lost to Follow-up|2|||
106127156|NCT02036515|366123875|FG002|Overall Study|Lost to Follow-up|0|||
106127157|NCT02036515|366123873|FG000|Overall Study|Non-compliance with study drug|0|||
106127158|NCT02036515|366123874|FG001|Overall Study|Non-compliance with study drug|0|||
106127159|NCT02036515|366123875|FG002|Overall Study|Non-compliance with study drug|2|||
106127160|NCT02036515|366123873|FG000|Overall Study|Screen failure|0|||
106127161|NCT02036515|366123874|FG001|Overall Study|Screen failure|2|||
106127162|NCT02036515|366123875|FG002|Overall Study|Screen failure|0|||
106127163|NCT02036515|366123873|FG000|Overall Study|Withdrawal by Subject|4|||
106127164|NCT02036515|366123874|FG001|Overall Study|Withdrawal by Subject|7|||
106127165|NCT02036515|366123875|FG002|Overall Study|Withdrawal by Subject|9|||
106127166|NCT02036515|366123873|FG000|Overall Study|Hyperglycemia|0|||
106127167|NCT02036515|366123874|FG001|Overall Study|Hyperglycemia|0|||
106127168|NCT02036515|366123875|FG002|Overall Study|Hyperglycemia|1|||
106127169|NCT00238420|366123876|FG000|Overall Study|Protocol Violation|1|||
106127170|NCT00238420|366123877|FG001|Overall Study|Protocol Violation|1|||
106127171|NCT03428815|366123880|FG000|Overall Study|Lost to Follow-up|2|||
106127172|NCT03428815|366123881|FG001|Overall Study|Lost to Follow-up|2|||
106127173|NCT03428815|366123880|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
106127174|NCT03428815|366123881|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
106127175|NCT03428815|366123880|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
106127176|NCT03428815|366123881|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
106127177|NCT01700348|366123882|FG000|Overall Study|Withdrawal by Subject|22|||
106127178|NCT01700348|366123882|FG000|Overall Study|Lost to Follow-up|1|||
106127179|NCT04140890|366123883|FG000|Overall Study|Withdrawal by Subject|0|||
106127180|NCT04140890|366123884|FG001|Overall Study|Withdrawal by Subject|1|||
106127181|NCT00209274|366123887|FG000|Overall Study|Missed visit|3|||
106127182|NCT00209274|366123888|FG001|Overall Study|Missed visit|2|||
106127183|NCT00209274|366123887|FG000|Overall Study|Death|32|||
106127184|NCT00209274|366123888|FG001|Overall Study|Death|15|||
106127185|NCT00209274|366123887|FG000|Overall Study|Withdrawal by Subject|30|||
106127186|NCT00209274|366123888|FG001|Overall Study|Withdrawal by Subject|15|||
106127187|NCT00209274|366123887|FG000|Overall Study|Randomized not treated (RNT)|6|||
106127188|NCT00209274|366123888|FG001|Overall Study|Randomized not treated (RNT)|15|||
106127189|NCT01824472|366123891|FG000|Overall Study|Lost to Follow-up|0|||
106127190|NCT01824472|366123892|FG001|Overall Study|Lost to Follow-up|0|||
106127191|NCT01824472|366123893|FG002|Overall Study|Lost to Follow-up|1|||
106127192|NCT01824472|366123891|FG000|Overall Study|Withdrawal by Subject|1|||
106127193|NCT01824472|366123892|FG001|Overall Study|Withdrawal by Subject|5|||
106127194|NCT01824472|366123893|FG002|Overall Study|Withdrawal by Subject|3|||
106127195|NCT01824472|366123891|FG000|Overall Study|Ineligible post randomization&screening|0|||
106127196|NCT01824472|366123892|FG001|Overall Study|Ineligible post randomization&screening|2|||
106127197|NCT01824472|366123893|FG002|Overall Study|Ineligible post randomization&screening|0|||
106127198|NCT03387514|366123897|FG000|Overall Study|Withdrawal by Subject|2|||
106127199|NCT03387514|366123897|FG000|Overall Study|Physician Decision|1|||
106127200|NCT03387514|366123897|FG000|Overall Study|Lost to Follow-up|2|||
106127201|NCT00245011|366123902|FG000|Overall Study|Lack of Efficacy|1|||
106127202|NCT03317379|366123903|FG000|Overall Study|Lost to Follow-up|0|||
106127203|NCT03317379|366123904|FG001|Overall Study|Lost to Follow-up|3|||
106127204|NCT03317379|366123905|FG002|Overall Study|Lost to Follow-up|2|||
106127205|NCT04445155|366123906|FG000|Overall Study|Lost to Follow-up|11|||
106127206|NCT04445155|366123907|FG001|Overall Study|Lost to Follow-up|2|||
106127207|NCT04445155|366123908|FG002|Overall Study|Lost to Follow-up|3|||
106127208|NCT04445155|366123909|FG003|Overall Study|Lost to Follow-up|0|||
106127209|NCT04445155|366123906|FG000|Overall Study|Withdrawal by Subject|8|||
106127210|NCT04445155|366123907|FG001|Overall Study|Withdrawal by Subject|0|||
106127211|NCT04445155|366123908|FG002|Overall Study|Withdrawal by Subject|0|||
106127212|NCT04445155|366123909|FG003|Overall Study|Withdrawal by Subject|0|||
106127213|NCT04445155|366123906|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
106127214|NCT04445155|366123907|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
106127215|NCT04445155|366123908|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
106127216|NCT04445155|366123909|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
106127217|NCT04445155|366123906|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
106127218|NCT04445155|366123907|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
106127219|NCT04445155|366123908|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
106127220|NCT04445155|366123909|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
106127221|NCT00742885|366125481|FG000|Overall Study|Lost to Follow-up|1|||
106127222|NCT00742885|366125482|FG001|Overall Study|Lost to Follow-up|0|||
106127223|NCT01755689|366125483|FG000|Overall Study|Withdrawal by Subject|1|||
106127224|NCT01755689|366125484|FG001|Overall Study|Withdrawal by Subject|3|||
106127225|NCT01755689|366125485|FG002|Overall Study|Withdrawal by Subject|2|||
106127226|NCT01755689|366125486|FG003|Overall Study|Withdrawal by Subject|1|||
106127227|NCT01755689|366125487|FG004|Overall Study|Withdrawal by Subject|1|||
106127228|NCT01755689|366125483|FG000|Overall Study|Migrated/moved from study area|0|||
106127229|NCT01755689|366125484|FG001|Overall Study|Migrated/moved from study area|1|||
106127230|NCT01755689|366125485|FG002|Overall Study|Migrated/moved from study area|1|||
106127231|NCT01755689|366125486|FG003|Overall Study|Migrated/moved from study area|1|||
106127232|NCT01755689|366125487|FG004|Overall Study|Migrated/moved from study area|1|||
106127233|NCT01755689|366125483|FG000|Overall Study|Lost to Follow-up|1|||
106127234|NCT01755689|366125484|FG001|Overall Study|Lost to Follow-up|0|||
106127235|NCT01755689|366125485|FG002|Overall Study|Lost to Follow-up|1|||
106127236|NCT01755689|366125486|FG003|Overall Study|Lost to Follow-up|0|||
106127237|NCT01755689|366125487|FG004|Overall Study|Lost to Follow-up|2|||
106127238|NCT01755689|366125483|FG000|Overall Study|Pregnancy|1|||
106127239|NCT01755689|366125484|FG001|Overall Study|Pregnancy|1|||
106127240|NCT01755689|366125485|FG002|Overall Study|Pregnancy|2|||
106127241|NCT01755689|366125486|FG003|Overall Study|Pregnancy|4|||
106127242|NCT01755689|366125487|FG004|Overall Study|Pregnancy|2|||
106127243|NCT00329719|366125488|FG000|Overall Study|Lost to Follow-up|0|||
106127244|NCT00329719|366125489|FG001|Overall Study|Lost to Follow-up|0|||
106127245|NCT00329719|366125490|FG002|Overall Study|Lost to Follow-up|0|||
106127246|NCT00329719|366125491|FG003|Overall Study|Lost to Follow-up|1|||
106127247|NCT01681368|366125492|FG000|Overall Study|Refused further treatment|1|||
106127248|NCT01681368|366125492|FG000|Overall Study|Refused further follow up|1|||
105915656|NCT00274742|365351172|FG005|Overall Study|Disease Progression|0|||
106127249|NCT02692235|366125493|FG000|Overall Study|Withdrawal by Subject|2|||
106127250|NCT02692235|366125494|FG001|Overall Study|Withdrawal by Subject|1|||
106127251|NCT02692235|366125493|FG000|Overall Study|Adverse Event|1|||
106127252|NCT02692235|366125494|FG001|Overall Study|Adverse Event|2|||
106127253|NCT00830947|366125495|FG000|Overall Study|Lost to Follow-up|4|||
106127254|NCT00830947|366125496|FG001|Overall Study|Lost to Follow-up|4|||
106127255|NCT04212169|366125497|FG000|Overall Study|Adverse Event|0|||
106127256|NCT04212169|366125498|FG001|Overall Study|Adverse Event|0|||
106127257|NCT04212169|366125499|FG002|Overall Study|Adverse Event|0|||
106127258|NCT04212169|366125500|FG003|Overall Study|Adverse Event|2|||
105679168|NCT01253304|364486904|FG002|Overall Study|Adverse Event|0|||
105915657|NCT00274742|365351167|FG000|Overall Study|Other|0|||
105915658|NCT00274742|365351168|FG001|Overall Study|Other|3|||
105915659|NCT00274742|365351169|FG002|Overall Study|Other|0|||
105915660|NCT00274742|365351170|FG003|Overall Study|Other|0|||
105915661|NCT00274742|365351171|FG004|Overall Study|Other|2|||
105915662|NCT00274742|365351172|FG005|Overall Study|Other|0|||
105915663|NCT02567188|365351173|FG000|Overall Study|Death|10|||
105915664|NCT02567188|365351173|FG000|Overall Study|Terminated Mircera Treatment|9|||
105915665|NCT02567188|365351173|FG000|Overall Study|Lost to Follow-up|5|||
105915666|NCT02567188|365351173|FG000|Overall Study|Adverse Event|1|||
105915667|NCT02567188|365351173|FG000|Overall Study|Withdrawal by Subject|1|||
105915668|NCT02567188|365351173|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
106000732|NCT02831764|365665087|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
106000733|NCT02831764|365665088|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
106000734|NCT02831764|365665089|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
106127259|NCT04212169|366125497|FG000|Overall Study|Lost to Follow-up|1|||
106127260|NCT04212169|366125498|FG001|Overall Study|Lost to Follow-up|0|||
106127261|NCT04212169|366125499|FG002|Overall Study|Lost to Follow-up|0|||
106127262|NCT04212169|366125500|FG003|Overall Study|Lost to Follow-up|2|||
106127263|NCT04212169|366125497|FG000|Overall Study|Withdrawal by Subject|10|||
106127264|NCT04212169|366125498|FG001|Overall Study|Withdrawal by Subject|2|||
106127265|NCT04212169|366125499|FG002|Overall Study|Withdrawal by Subject|5|||
106127266|NCT04212169|366125500|FG003|Overall Study|Withdrawal by Subject|7|||
106127267|NCT04212169|366125497|FG000|Overall Study|Other reason, unspecified|3|||
106127268|NCT04212169|366125498|FG001|Overall Study|Other reason, unspecified|1|||
106127269|NCT04212169|366125499|FG002|Overall Study|Other reason, unspecified|0|||
106127270|NCT04212169|366125500|FG003|Overall Study|Other reason, unspecified|2|||
106127271|NCT02176928|366125501|FG000|Overall Study|Lost to Follow-up|2|||
106127272|NCT02176928|366125502|FG001|Overall Study|Lost to Follow-up|4|||
106127273|NCT02018861|366125510|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
106127274|NCT02018861|366125511|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
106127275|NCT02018861|366125512|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
106127276|NCT02018861|366125513|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
106127277|NCT02018861|366125514|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
106127278|NCT02018861|366125515|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
106127279|NCT02018861|366125516|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
106127280|NCT02018861|366125517|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
106127281|NCT02018861|366125518|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
106127282|NCT02018861|366125519|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
106127283|NCT02018861|366125510|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
106127284|NCT02018861|366125511|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
106127285|NCT02018861|366125512|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
106127286|NCT02018861|366125513|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
106127287|NCT02018861|366125514|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
106127288|NCT02018861|366125515|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
106127289|NCT02018861|366125516|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
106127290|NCT02018861|366125517|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
106127291|NCT02018861|366125518|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
106127292|NCT02018861|366125519|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
105915669|NCT02567188|365351173|FG000|Overall Study|Moved and Changed Clinic|1|||
105915670|NCT02567188|365351173|FG000|Overall Study|Started Hemodialysis|2|||
105915671|NCT02567188|365351173|FG000|Overall Study|Protocol Violation|5|||
105915672|NCT02495389|365351181|FG000|Overall Study|Withdrawal by Subject|40|||
105915673|NCT04233879|365351182|FG000|Overall Study|Death|2|||
105915674|NCT04233879|365351183|FG001|Overall Study|Death|0|||
105915675|NCT04233879|365351182|FG000|Overall Study|Lost to Follow-up|3|||
105915676|NCT04233879|365351183|FG001|Overall Study|Lost to Follow-up|8|||
106127293|NCT02018861|366125510|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
106127294|NCT02018861|366125511|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
106127295|NCT02018861|366125512|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
106127296|NCT02018861|366125513|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
106127297|NCT02018861|366125514|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
106127298|NCT02018861|366125515|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
106127299|NCT02018861|366125516|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
106127300|NCT02018861|366125517|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
106127301|NCT02018861|366125518|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
106127302|NCT02018861|366125519|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
106127303|NCT02018861|366125510|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
106127304|NCT02018861|366125511|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
106127305|NCT02018861|366125512|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
106127306|NCT02018861|366125513|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
106127307|NCT02018861|366125514|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
106127308|NCT02018861|366125515|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
106127309|NCT02018861|366125516|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
106127310|NCT02018861|366125517|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
106127311|NCT02018861|366125518|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
106127312|NCT02018861|366125519|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
106127313|NCT02018861|366125510|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
106127314|NCT02018861|366125511|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
106127315|NCT02018861|366125512|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
106127316|NCT02018861|366125513|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
106127317|NCT02018861|366125514|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
106127318|NCT02018861|366125515|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
106127319|NCT02018861|366125516|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
106127320|NCT02018861|366125517|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
106127321|NCT02018861|366125518|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105915677|NCT04233879|365351182|FG000|Overall Study|Physician Decision|4|||
105915678|NCT04233879|365351183|FG001|Overall Study|Physician Decision|4|||
105915679|NCT04233879|365351182|FG000|Overall Study|Withdrawal by Subject|7|||
105915680|NCT04233879|365351183|FG001|Overall Study|Withdrawal by Subject|10|||
105915681|NCT04233879|365351182|FG000|Overall Study|Other|281|||
105915682|NCT04233879|365351183|FG001|Overall Study|Other|279|||
105915683|NCT02277028|365351189|FG000|Overall Study|Lost to Follow-up|1|||
105915684|NCT02277028|365351190|FG001|Overall Study|Lost to Follow-up|0|||
105915685|NCT02277028|365351189|FG000|Overall Study|Withdrawal by Subject|0|||
106127322|NCT02018861|366125519|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
105915686|NCT02277028|365351190|FG001|Overall Study|Withdrawal by Subject|1|||
105915687|NCT01038687|365351192|FG000|Overall Study|Adverse Event|0|||
105915688|NCT01038687|365351193|FG001|Overall Study|Adverse Event|2|||
105915689|NCT01038687|365351194|FG002|Overall Study|Adverse Event|1|||
106000735|NCT02831764|365665085|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
106000736|NCT02831764|365665086|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
106127323|NCT02018861|366125510|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
106127324|NCT02018861|366125511|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
106127325|NCT02018861|366125512|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
105679169|NCT01253304|364486905|FG003|Overall Study|Adverse Event|1|||
105679170|NCT03932812|364486906|FG000|Overall Study|Lost to Follow-up|12|||
105679171|NCT03932812|364486907|FG001|Overall Study|Lost to Follow-up|14|||
106127326|NCT02018861|366125513|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
106127327|NCT02018861|366125514|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
106127328|NCT02018861|366125515|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
106127329|NCT02018861|366125516|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
106127330|NCT02018861|366125517|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
106127331|NCT02018861|366125518|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
106127332|NCT02018861|366125519|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
106127333|NCT02018861|366125510|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
106127334|NCT02018861|366125511|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
106127335|NCT02018861|366125512|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
106127336|NCT02018861|366125513|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
106127337|NCT02018861|366125514|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
106127338|NCT02018861|366125515|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
106127339|NCT02018861|366125516|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
106127340|NCT02018861|366125517|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
106127341|NCT02018861|366125518|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
106127342|NCT02018861|366125519|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
106127343|NCT02018861|366125510|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
106127344|NCT02018861|366125511|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
106127345|NCT02018861|366125512|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
106127346|NCT02018861|366125513|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
106127347|NCT02018861|366125514|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
106127348|NCT02018861|366125515|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
105915690|NCT00570401|365351199|FG000|Overall Study|Adverse Event|2|||
105915691|NCT02849587|365351200|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
105915692|NCT02849587|365351201|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
105915693|NCT02849587|365351202|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
105915694|NCT02849587|365351200|FG000|Overall Study|Withdrawal by Subject|0|||
105915695|NCT02849587|365351201|FG001|Overall Study|Withdrawal by Subject|1|||
105915696|NCT02849587|365351202|FG002|Overall Study|Withdrawal by Subject|0|||
105915697|NCT00617357|365351203|FG000|Overall Study|Lost to Follow-up|7|||
105915698|NCT00617357|365351203|FG000|Overall Study|Death|5|||
105915699|NCT00617357|365351203|FG000|Overall Study|insurance concerns|2|||
105915700|NCT00617357|365351203|FG000|Overall Study|Withdrawal by Subject|1|||
105915701|NCT00617357|365351203|FG000|Overall Study|Physician Decision|1|||
105915702|NCT01710020|365351204|FG000|Period 1|Protocol Violation|1|||
105915703|NCT00427908|365351205|FG000|Primary Phase|Lost to Follow-up|4|||
105915704|NCT00427908|365351206|FG001|Primary Phase|Lost to Follow-up|0|||
105915705|NCT00427908|365351207|FG002|Primary Phase|Lost to Follow-up|2|||
105915706|NCT00427908|365351208|FG003|Primary Phase|Lost to Follow-up|0|||
105915707|NCT00427908|365351205|FG000|Primary Phase|Withdrawal by Subject|1|||
105915708|NCT00427908|365351206|FG001|Primary Phase|Withdrawal by Subject|2|||
105915709|NCT00427908|365351207|FG002|Primary Phase|Withdrawal by Subject|1|||
105915710|NCT00427908|365351208|FG003|Primary Phase|Withdrawal by Subject|0|||
105915711|NCT00427908|365351205|FG000|Primary Phase|Adverse Event|0|||
105915712|NCT00427908|365351206|FG001|Primary Phase|Adverse Event|1|||
105915713|NCT00427908|365351207|FG002|Primary Phase|Adverse Event|0|||
105915714|NCT00427908|365351208|FG003|Primary Phase|Adverse Event|0|||
105915715|NCT02984982|365351209|FG000|Overall Study|Adverse Event|2|||
105915716|NCT02984982|365351210|FG001|Overall Study|Adverse Event|5|||
105915717|NCT02984982|365351209|FG000|Overall Study|Poor Compliance to Protocol|4|||
105915718|NCT02984982|365351210|FG001|Overall Study|Poor Compliance to Protocol|4|||
105915719|NCT02984982|365351209|FG000|Overall Study|Withdrawal by Subject|2|||
105915720|NCT02984982|365351210|FG001|Overall Study|Withdrawal by Subject|0|||
105915721|NCT02984982|365351209|FG000|Overall Study|Randomized but not treated|0|||
105915722|NCT02984982|365351210|FG001|Overall Study|Randomized but not treated|1|||
105915723|NCT04344301|365351211|FG000|Overall Study|Withdrawal by Subject|1|||
106000737|NCT02831764|365665087|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105915724|NCT04344301|365351212|FG001|Overall Study|Withdrawal by Subject|0|||
105915725|NCT04344301|365351211|FG000|Overall Study|Death|0|||
105679172|NCT03932812|364486906|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
105679173|NCT03932812|364486907|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
105915726|NCT04344301|365351212|FG001|Overall Study|Death|1|||
105915727|NCT02314728|365351213|FG000|Overall Study|Protocol Violation|1|||
105915728|NCT02314728|365351214|FG001|Overall Study|Protocol Violation|0|||
105915729|NCT02314728|365351213|FG000|Overall Study|Lost to Follow-up|0|||
105915730|NCT02314728|365351214|FG001|Overall Study|Lost to Follow-up|1|||
105915731|NCT03177148|365351218|FG000|Overall Study|Lost to Follow-up|50|||
105915732|NCT03177148|365351219|FG001|Overall Study|Lost to Follow-up|1|||
105915733|NCT03177148|365351218|FG000|Overall Study|Death|1|||
105915734|NCT03177148|365351219|FG001|Overall Study|Death|0|||
105915735|NCT01419314|365351220|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
105915736|NCT01419314|365351221|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
105915737|NCT01419314|365351220|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
105915738|NCT01419314|365351221|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
105915739|NCT01419314|365351220|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
105915740|NCT01419314|365351221|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
105915741|NCT01405898|365351222|FG000|Overall Study|Withdrawal by Subject|2|||
105915742|NCT01405898|365351223|FG001|Overall Study|Withdrawal by Subject|2|||
105915743|NCT00846586|365351224|FG000|Overall Study|Adverse Event|20|||
105915744|NCT00846586|365351225|FG001|Overall Study|Adverse Event|10|||
105915745|NCT00846586|365351224|FG000|Overall Study|Subject withdrew consent|8|||
105915746|NCT00846586|365351225|FG001|Overall Study|Subject withdrew consent|10|||
105915747|NCT00846586|365351224|FG000|Overall Study|Administrative problems|5|||
105915748|NCT00846586|365351225|FG001|Overall Study|Administrative problems|4|||
105915749|NCT00846586|365351224|FG000|Overall Study|Death|2|||
105915750|NCT00846586|365351225|FG001|Overall Study|Death|0|||
105915751|NCT00846586|365351224|FG000|Overall Study|Protocol deviation|2|||
105915752|NCT00846586|365351225|FG001|Overall Study|Protocol deviation|6|||
105915753|NCT00846586|365351224|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105915754|NCT00846586|365351225|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105915755|NCT00846586|365351224|FG000|Overall Study|Lost to Follow-up|1|||
105915756|NCT00846586|365351225|FG001|Overall Study|Lost to Follow-up|4|||
105915757|NCT00846586|365351224|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105915758|NCT00846586|365351225|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105915759|NCT01939314|365351230|FG000|Overall Study|Withdrawal by Subject|3|||
105915760|NCT01939314|365351231|FG001|Overall Study|Withdrawal by Subject|1|||
105915761|NCT01939314|365351230|FG000|Overall Study|Protocol Violation|1|||
105915762|NCT01939314|365351231|FG001|Overall Study|Protocol Violation|0|||
105915763|NCT01939314|365351230|FG000|Overall Study|Pregnancy|0|||
105915764|NCT01939314|365351231|FG001|Overall Study|Pregnancy|1|||
105915765|NCT01939314|365351230|FG000|Overall Study|Lost to Follow-up|5|||
105915766|NCT01939314|365351231|FG001|Overall Study|Lost to Follow-up|6|||
105915767|NCT01061606|365351232|FG000|Overall Study|Adverse Event|1|||
105915768|NCT01061606|365351232|FG000|Overall Study|Death|1|||
105915769|NCT01061606|365351232|FG000|Overall Study|Disease Progression|4|||
105915770|NCT01061606|365351232|FG000|Overall Study|alternative therapy|2|||
105915771|NCT00735007|365351234|FG000|Overall Study|Adverse Event|4|||
105915772|NCT00735007|365351234|FG000|Overall Study|Protocol Violation|1|||
105915773|NCT03044314|365351235|FG000|Overall Study|Physician Decision|2|||
105915774|NCT03044314|365351235|FG000|Overall Study|Withdrawal by Subject|1|||
105915775|NCT03044314|365351235|FG000|Overall Study|Connector tubing not available|1|||
105915776|NCT00715403|365351236|FG000|Overall Study|Progressive disease|0|||
105915777|NCT00715403|365351237|FG001|Overall Study|Progressive disease|1|||
105915778|NCT00715403|365351238|FG002|Overall Study|Progressive disease|3|||
105915779|NCT00715403|365351239|FG003|Overall Study|Progressive disease|9|||
106127349|NCT02018861|366125516|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
106127350|NCT02018861|366125517|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
106127351|NCT02018861|366125518|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
106127352|NCT02018861|366125519|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
106127353|NCT02018861|366125510|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
106127354|NCT02018861|366125511|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
106127355|NCT02018861|366125512|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
106127356|NCT02018861|366125513|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
106127357|NCT02018861|366125514|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
106127358|NCT02018861|366125515|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
106127359|NCT02018861|366125516|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
106127360|NCT02018861|366125517|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
105679174|NCT01156792|364486917|FG000|Overall Study|Adverse Event|1|||
105915780|NCT00715403|365351240|FG004|Overall Study|Progressive disease|5|||
105915781|NCT00715403|365351241|FG005|Overall Study|Progressive disease|14|||
105915782|NCT00715403|365351242|FG006|Overall Study|Progressive disease|1|||
105915783|NCT00715403|365351236|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
105915784|NCT00715403|365351237|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
106127361|NCT02018861|366125518|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
106127362|NCT02018861|366125519|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
106127363|NCT02018861|366125510|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
106127364|NCT02018861|366125511|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
106127365|NCT02018861|366125512|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
106127366|NCT02018861|366125513|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
106127367|NCT02018861|366125514|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
106127368|NCT02018861|366125515|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
106127369|NCT02018861|366125516|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
106127370|NCT02018861|366125517|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
106127371|NCT02018861|366125518|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
106127372|NCT02018861|366125519|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
106127373|NCT02018861|366125510|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127374|NCT02018861|366125511|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127375|NCT02018861|366125512|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127376|NCT02018861|366125513|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127377|NCT02018861|366125514|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127378|NCT02018861|366125515|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127379|NCT02018861|366125516|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127380|NCT02018861|366125517|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127381|NCT02018861|366125518|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
106127382|NCT02018861|366125519|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
106127383|NCT02018861|366125510|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
106127384|NCT02018861|366125511|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
105679175|NCT01156792|364486917|FG000|Overall Study|Lack of Efficacy|36|||
106127385|NCT02018861|366125512|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
106127386|NCT02018861|366125513|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
106127387|NCT02018861|366125514|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
106127388|NCT02018861|366125515|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
106127389|NCT02018861|366125516|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
106127390|NCT02018861|366125517|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
106127391|NCT02018861|366125518|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
106127392|NCT02018861|366125519|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
106127393|NCT02018861|366125510|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
105679176|NCT01156792|364486917|FG000|Overall Study|Protocol Violation|6|||
105679177|NCT01156792|364486917|FG000|Overall Study|Lost to Follow-up|3|||
106000738|NCT02831764|365665088|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
106000739|NCT02831764|365665089|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
106000740|NCT02831764|365665085|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
106000741|NCT02831764|365665086|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
106000742|NCT02831764|365665087|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
106000743|NCT02831764|365665088|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
106127394|NCT02018861|366125511|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
106127395|NCT02018861|366125512|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
106127396|NCT02018861|366125513|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
106127397|NCT02018861|366125514|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
106127398|NCT02018861|366125515|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
106127399|NCT02018861|366125516|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
106127400|NCT02018861|366125517|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
106127401|NCT02018861|366125518|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
106127402|NCT02018861|366125519|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
106127403|NCT01809210|366125520|FG000|Overall Study|Withdrawal by Subject|0|||
106127404|NCT01809210|366125521|FG001|Overall Study|Withdrawal by Subject|0|||
106127405|NCT01809210|366125522|FG002|Overall Study|Withdrawal by Subject|1|||
106127406|NCT01809210|366125523|FG003|Overall Study|Withdrawal by Subject|1|||
106127407|NCT01809210|366125524|FG004|Overall Study|Withdrawal by Subject|1|||
106127408|NCT01809210|366125525|FG005|Overall Study|Withdrawal by Subject|0|||
106127409|NCT01809210|366125526|FG006|Overall Study|Withdrawal by Subject|4|||
106127410|NCT01809210|366125520|FG000|Overall Study|Death|1|||
106127411|NCT01809210|366125521|FG001|Overall Study|Death|1|||
106127412|NCT01809210|366125522|FG002|Overall Study|Death|2|||
106127413|NCT01809210|366125523|FG003|Overall Study|Death|0|||
106127414|NCT01809210|366125524|FG004|Overall Study|Death|1|||
106127415|NCT01809210|366125525|FG005|Overall Study|Death|3|||
106127416|NCT01809210|366125526|FG006|Overall Study|Death|1|||
106127417|NCT01668147|366125527|FG000|Overall Study|Withdrawal by Subject|6|||
106127418|NCT01474512|366125531|FG000|Induction Period|Adverse Event|6|||
106127419|NCT01474512|366125532|FG001|Induction Period|Adverse Event|10|||
106127420|NCT01474512|366125533|FG002|Induction Period|Adverse Event|10|||
106127421|NCT01474512|366125534|FG003|Induction Period|Adverse Event|0|||
106127422|NCT01474512|366125535|FG004|Induction Period|Adverse Event|0|||
106127423|NCT01474512|366125536|FG005|Induction Period|Adverse Event|0|||
106127424|NCT01474512|366125537|FG006|Induction Period|Adverse Event|0|||
106127425|NCT01474512|366125538|FG007|Induction Period|Adverse Event|0|||
106127426|NCT01474512|366125539|FG008|Induction Period|Adverse Event|0|||
106127427|NCT01474512|366125540|FG009|Induction Period|Adverse Event|0|||
106127428|NCT01474512|366125541|FG010|Induction Period|Adverse Event|0|||
106127429|NCT01474512|366125542|FG011|Induction Period|Adverse Event|0|||
106127430|NCT01474512|366125543|FG012|Induction Period|Adverse Event|0|||
106127431|NCT01474512|366125544|FG013|Induction Period|Adverse Event|0|||
106127432|NCT01474512|366125545|FG014|Induction Period|Adverse Event|0|||
106127433|NCT01474512|366125546|FG015|Induction Period|Adverse Event|0|||
106127434|NCT01474512|366125547|FG016|Induction Period|Adverse Event|0|||
106127435|NCT01474512|366125548|FG017|Induction Period|Adverse Event|0|||
106000744|NCT02831764|365665089|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
106000745|NCT03798717|365665091|FG000|Overall Study|Failed Screening|0|||
106000746|NCT03798717|365665092|FG001|Overall Study|Failed Screening|0|||
106000747|NCT03798717|365665093|FG002|Overall Study|Failed Screening|0|||
106000748|NCT03798717|365665094|FG003|Overall Study|Failed Screening|0|||
106000749|NCT03798717|365665095|FG004|Overall Study|Failed Screening|0|||
106000750|NCT03798717|365665096|FG005|Overall Study|Failed Screening|1|||
106000751|NCT03798717|365665091|FG000|Overall Study|Physician Decision|1|||
106000752|NCT03798717|365665092|FG001|Overall Study|Physician Decision|0|||
106000753|NCT03798717|365665093|FG002|Overall Study|Physician Decision|1|||
106000754|NCT03798717|365665094|FG003|Overall Study|Physician Decision|0|||
106000755|NCT03798717|365665095|FG004|Overall Study|Physician Decision|0|||
106000756|NCT03798717|365665096|FG005|Overall Study|Physician Decision|0|||
106000757|NCT03798717|365665091|FG000|Overall Study|Withdrawal by Subject|0|||
106000758|NCT03798717|365665092|FG001|Overall Study|Withdrawal by Subject|0|||
106127436|NCT01474512|366125531|FG000|Induction Period|Lack of Efficacy|7|||
106127437|NCT01474512|366125532|FG001|Induction Period|Lack of Efficacy|1|||
106127438|NCT01474512|366125533|FG002|Induction Period|Lack of Efficacy|0|||
106127439|NCT01474512|366125534|FG003|Induction Period|Lack of Efficacy|0|||
106127440|NCT01474512|366125535|FG004|Induction Period|Lack of Efficacy|0|||
106127441|NCT01474512|366125536|FG005|Induction Period|Lack of Efficacy|0|||
106127442|NCT01474512|366125537|FG006|Induction Period|Lack of Efficacy|0|||
106127443|NCT01474512|366125538|FG007|Induction Period|Lack of Efficacy|0|||
106000759|NCT03798717|365665093|FG002|Overall Study|Withdrawal by Subject|0|||
106000760|NCT03798717|365665094|FG003|Overall Study|Withdrawal by Subject|1|||
106000761|NCT03798717|365665095|FG004|Overall Study|Withdrawal by Subject|0|||
106000762|NCT03798717|365665096|FG005|Overall Study|Withdrawal by Subject|0|||
106127444|NCT01474512|366125539|FG008|Induction Period|Lack of Efficacy|0|||
106127445|NCT01474512|366125540|FG009|Induction Period|Lack of Efficacy|0|||
105915785|NCT00715403|365351238|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
105915786|NCT00715403|365351239|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
105915787|NCT00715403|365351240|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
105915788|NCT00715403|365351241|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
105915789|NCT00715403|365351242|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
105915790|NCT00715403|365351236|FG000|Overall Study|Other Adverse Event than DLT|1|||
105915791|NCT00715403|365351237|FG001|Overall Study|Other Adverse Event than DLT|0|||
105915792|NCT00715403|365351238|FG002|Overall Study|Other Adverse Event than DLT|0|||
105915793|NCT00715403|365351239|FG003|Overall Study|Other Adverse Event than DLT|0|||
105915794|NCT00715403|365351240|FG004|Overall Study|Other Adverse Event than DLT|0|||
105915795|NCT00715403|365351241|FG005|Overall Study|Other Adverse Event than DLT|2|||
105915796|NCT00715403|365351242|FG006|Overall Study|Other Adverse Event than DLT|0|||
105915797|NCT00715403|365351236|FG000|Overall Study|Protocol Violation|0|||
105915798|NCT00715403|365351237|FG001|Overall Study|Protocol Violation|0|||
105915799|NCT00715403|365351238|FG002|Overall Study|Protocol Violation|0|||
105915800|NCT00715403|365351239|FG003|Overall Study|Protocol Violation|0|||
105915801|NCT00715403|365351240|FG004|Overall Study|Protocol Violation|0|||
105915802|NCT00715403|365351241|FG005|Overall Study|Protocol Violation|1|||
105915803|NCT00715403|365351242|FG006|Overall Study|Protocol Violation|0|||
105915804|NCT00715403|365351236|FG000|Overall Study|Other reason not defined above|0|||
105915805|NCT00715403|365351237|FG001|Overall Study|Other reason not defined above|0|||
105915806|NCT00715403|365351238|FG002|Overall Study|Other reason not defined above|1|||
105915807|NCT00715403|365351239|FG003|Overall Study|Other reason not defined above|0|||
105915808|NCT00715403|365351240|FG004|Overall Study|Other reason not defined above|1|||
105915809|NCT00715403|365351241|FG005|Overall Study|Other reason not defined above|1|||
105915810|NCT00715403|365351242|FG006|Overall Study|Other reason not defined above|0|||
105915811|NCT01789047|365351243|FG000|Overall Study|Adverse Event|3|||
105915812|NCT01789047|365351244|FG001|Overall Study|Adverse Event|2|||
105915813|NCT01789047|365351243|FG000|Overall Study|Withdrawal by Subject|1|||
105915814|NCT01789047|365351244|FG001|Overall Study|Withdrawal by Subject|2|||
105915815|NCT03644017|365351245|FG000|Overall Study|Access Abandonment|5|||
105915816|NCT03644017|365351245|FG000|Overall Study|Kidney Transplant|2|||
105915817|NCT02668640|365351246|FG000|Overall Study|Lost to Follow-up|13|||
105915818|NCT02668640|365351246|FG000|Overall Study|Other, not specified|1|||
105915819|NCT02563899|365351247|FG000|Overall Study|Protocol Violation|1|||
105915820|NCT02563899|365351248|FG001|Overall Study|Protocol Violation|0|||
105915821|NCT02563899|365351249|FG002|Overall Study|Protocol Violation|0|||
105915822|NCT02563899|365351250|FG003|Overall Study|Protocol Violation|0|||
105915823|NCT02563899|365351247|FG000|Overall Study|Withdrawal by Subject|0|||
105915824|NCT02563899|365351248|FG001|Overall Study|Withdrawal by Subject|0|||
105915825|NCT02563899|365351249|FG002|Overall Study|Withdrawal by Subject|1|||
105915826|NCT02563899|365351250|FG003|Overall Study|Withdrawal by Subject|0|||
105915827|NCT01100502|365351253|FG000|Overall Study|Withdrawal by Subject|18|||
105915828|NCT01100502|365351254|FG001|Overall Study|Withdrawal by Subject|25|||
105915829|NCT01100502|365351253|FG000|Overall Study|Lost to Follow-up|13|||
105915830|NCT01100502|365351254|FG001|Overall Study|Lost to Follow-up|28|||
105915831|NCT01100502|365351253|FG000|Overall Study|Site request to end participation in study|0|||
105915832|NCT01100502|365351254|FG001|Overall Study|Site request to end participation in study|1|||
105915833|NCT01100502|365351253|FG000|Overall Study|Death|45|||
105915834|NCT01100502|365351254|FG001|Overall Study|Death|40|||
105915835|NCT00073918|365351255|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
105915836|NCT00073918|365351255|FG000|Overall Study|Rapid disease progression|2|||
105915837|NCT00073918|365351255|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
105915838|NCT02100124|365351256|FG000|Overall Study|Lost to Follow-up|5|||
105915839|NCT02100124|365351257|FG001|Overall Study|Lost to Follow-up|11|||
106127446|NCT01474512|366125541|FG010|Induction Period|Lack of Efficacy|0|||
106127447|NCT01474512|366125542|FG011|Induction Period|Lack of Efficacy|0|||
106127448|NCT01474512|366125543|FG012|Induction Period|Lack of Efficacy|0|||
106127449|NCT01474512|366125544|FG013|Induction Period|Lack of Efficacy|0|||
106127450|NCT01474512|366125545|FG014|Induction Period|Lack of Efficacy|0|||
106127451|NCT01474512|366125546|FG015|Induction Period|Lack of Efficacy|0|||
106127452|NCT01474512|366125547|FG016|Induction Period|Lack of Efficacy|0|||
106127453|NCT01474512|366125548|FG017|Induction Period|Lack of Efficacy|0|||
106127454|NCT01474512|366125531|FG000|Induction Period|Withdrawal by Subject|6|||
106127455|NCT01474512|366125532|FG001|Induction Period|Withdrawal by Subject|6|||
106127456|NCT01474512|366125533|FG002|Induction Period|Withdrawal by Subject|5|||
106127457|NCT01474512|366125534|FG003|Induction Period|Withdrawal by Subject|0|||
106127458|NCT01474512|366125535|FG004|Induction Period|Withdrawal by Subject|0|||
106127459|NCT01474512|366125536|FG005|Induction Period|Withdrawal by Subject|0|||
106127460|NCT01474512|366125537|FG006|Induction Period|Withdrawal by Subject|0|||
106127461|NCT01474512|366125538|FG007|Induction Period|Withdrawal by Subject|0|||
106127462|NCT01474512|366125539|FG008|Induction Period|Withdrawal by Subject|0|||
106127463|NCT01474512|366125540|FG009|Induction Period|Withdrawal by Subject|0|||
106127464|NCT01474512|366125541|FG010|Induction Period|Withdrawal by Subject|0|||
106127465|NCT01474512|366125542|FG011|Induction Period|Withdrawal by Subject|0|||
106127466|NCT01474512|366125543|FG012|Induction Period|Withdrawal by Subject|0|||
105915840|NCT02100124|365351258|FG002|Overall Study|Lost to Follow-up|3|||
105915841|NCT02100124|365351256|FG000|Overall Study|Withdrawal by Subject|1|||
105915842|NCT02100124|365351257|FG001|Overall Study|Withdrawal by Subject|0|||
105915843|NCT02100124|365351258|FG002|Overall Study|Withdrawal by Subject|0|||
105915844|NCT01094288|365352819|FG000|Overall Study|Adverse Event|0|||
105915845|NCT01094288|365352820|FG001|Overall Study|Adverse Event|3|||
105915846|NCT01094288|365352821|FG002|Overall Study|Adverse Event|1|||
105915847|NCT01094288|365352822|FG003|Overall Study|Adverse Event|1|||
106127467|NCT01474512|366125544|FG013|Induction Period|Withdrawal by Subject|0|||
106127468|NCT01474512|366125545|FG014|Induction Period|Withdrawal by Subject|0|||
106127469|NCT01474512|366125546|FG015|Induction Period|Withdrawal by Subject|0|||
106127470|NCT01474512|366125547|FG016|Induction Period|Withdrawal by Subject|0|||
106127471|NCT01474512|366125548|FG017|Induction Period|Withdrawal by Subject|0|||
106127472|NCT01474512|366125531|FG000|Induction Period|Protocol Violation|3|||
106127473|NCT01474512|366125532|FG001|Induction Period|Protocol Violation|6|||
106127474|NCT01474512|366125533|FG002|Induction Period|Protocol Violation|0|||
106127475|NCT01474512|366125534|FG003|Induction Period|Protocol Violation|0|||
106127476|NCT01474512|366125535|FG004|Induction Period|Protocol Violation|0|||
106127477|NCT01474512|366125536|FG005|Induction Period|Protocol Violation|0|||
106127478|NCT01474512|366125537|FG006|Induction Period|Protocol Violation|0|||
106127479|NCT01474512|366125538|FG007|Induction Period|Protocol Violation|0|||
106127480|NCT01474512|366125539|FG008|Induction Period|Protocol Violation|0|||
106127481|NCT01474512|366125540|FG009|Induction Period|Protocol Violation|0|||
106127482|NCT01474512|366125541|FG010|Induction Period|Protocol Violation|0|||
106127483|NCT01474512|366125542|FG011|Induction Period|Protocol Violation|0|||
106127484|NCT01474512|366125543|FG012|Induction Period|Protocol Violation|0|||
106127485|NCT01474512|366125544|FG013|Induction Period|Protocol Violation|0|||
106127486|NCT01474512|366125545|FG014|Induction Period|Protocol Violation|0|||
106127487|NCT01474512|366125546|FG015|Induction Period|Protocol Violation|0|||
106127488|NCT01474512|366125547|FG016|Induction Period|Protocol Violation|0|||
106127489|NCT01474512|366125548|FG017|Induction Period|Protocol Violation|0|||
106127490|NCT01474512|366125531|FG000|Induction Period|Sponsor Decision|1|||
106127491|NCT01474512|366125532|FG001|Induction Period|Sponsor Decision|1|||
106127492|NCT01474512|366125533|FG002|Induction Period|Sponsor Decision|1|||
106127493|NCT01474512|366125534|FG003|Induction Period|Sponsor Decision|0|||
106127494|NCT01474512|366125535|FG004|Induction Period|Sponsor Decision|0|||
106127495|NCT01474512|366125536|FG005|Induction Period|Sponsor Decision|0|||
106127496|NCT01474512|366125537|FG006|Induction Period|Sponsor Decision|0|||
106127497|NCT01474512|366125538|FG007|Induction Period|Sponsor Decision|0|||
106127498|NCT01474512|366125539|FG008|Induction Period|Sponsor Decision|0|||
106127499|NCT01474512|366125540|FG009|Induction Period|Sponsor Decision|0|||
106127500|NCT01474512|366125541|FG010|Induction Period|Sponsor Decision|0|||
106127501|NCT01474512|366125542|FG011|Induction Period|Sponsor Decision|0|||
106127502|NCT01474512|366125543|FG012|Induction Period|Sponsor Decision|0|||
106127503|NCT01474512|366125544|FG013|Induction Period|Sponsor Decision|0|||
106127504|NCT01474512|366125545|FG014|Induction Period|Sponsor Decision|0|||
106127505|NCT01474512|366125546|FG015|Induction Period|Sponsor Decision|0|||
106127506|NCT01474512|366125547|FG016|Induction Period|Sponsor Decision|0|||
106127507|NCT01474512|366125548|FG017|Induction Period|Sponsor Decision|0|||
106127508|NCT01474512|366125531|FG000|Induction Period|Lost to Follow-up|1|||
106127509|NCT01474512|366125532|FG001|Induction Period|Lost to Follow-up|0|||
106127510|NCT01474512|366125533|FG002|Induction Period|Lost to Follow-up|2|||
105915848|NCT01094288|365352823|FG004|Overall Study|Adverse Event|0|||
105915849|NCT01094288|365352824|FG005|Overall Study|Adverse Event|0|||
105915850|NCT01094288|365352825|FG006|Overall Study|Adverse Event|0|||
105915851|NCT01094288|365352826|FG007|Overall Study|Adverse Event|0|||
105915852|NCT01094288|365352819|FG000|Overall Study|Withdrawal by Subject|0|||
105915853|NCT01094288|365352820|FG001|Overall Study|Withdrawal by Subject|1|||
105915854|NCT01094288|365352821|FG002|Overall Study|Withdrawal by Subject|2|||
105915855|NCT01094288|365352822|FG003|Overall Study|Withdrawal by Subject|0|||
106127511|NCT01474512|366125534|FG003|Induction Period|Lost to Follow-up|0|||
105915856|NCT01094288|365352823|FG004|Overall Study|Withdrawal by Subject|0|||
105915857|NCT01094288|365352824|FG005|Overall Study|Withdrawal by Subject|0|||
105915858|NCT01094288|365352825|FG006|Overall Study|Withdrawal by Subject|0|||
105915859|NCT01094288|365352826|FG007|Overall Study|Withdrawal by Subject|2|||
105915860|NCT01094288|365352819|FG000|Overall Study|Initiation of Alternative Therapy|0|||
105679178|NCT01156792|364486917|FG000|Overall Study|Physician Decision|3|||
105679179|NCT01156792|364486917|FG000|Overall Study|Withdrawal by Subject|9|||
105915861|NCT01094288|365352820|FG001|Overall Study|Initiation of Alternative Therapy|0|||
105915862|NCT01094288|365352821|FG002|Overall Study|Initiation of Alternative Therapy|1|||
105915863|NCT01094288|365352822|FG003|Overall Study|Initiation of Alternative Therapy|0|||
105915864|NCT01094288|365352823|FG004|Overall Study|Initiation of Alternative Therapy|0|||
105915865|NCT01094288|365352824|FG005|Overall Study|Initiation of Alternative Therapy|0|||
105915866|NCT01094288|365352825|FG006|Overall Study|Initiation of Alternative Therapy|0|||
105915867|NCT01094288|365352826|FG007|Overall Study|Initiation of Alternative Therapy|0|||
105915868|NCT01094288|365352819|FG000|Overall Study|Reason not Specified|2|||
105915869|NCT01094288|365352820|FG001|Overall Study|Reason not Specified|3|||
105915870|NCT01094288|365352821|FG002|Overall Study|Reason not Specified|0|||
105915871|NCT01094288|365352822|FG003|Overall Study|Reason not Specified|1|||
105915872|NCT01094288|365352823|FG004|Overall Study|Reason not Specified|0|||
105915873|NCT01094288|365352824|FG005|Overall Study|Reason not Specified|0|||
105915874|NCT01094288|365352825|FG006|Overall Study|Reason not Specified|0|||
105915875|NCT01094288|365352826|FG007|Overall Study|Reason not Specified|0|||
105915876|NCT01094288|365352819|FG000|Overall Study|Ongoing Participants|0|||
105915877|NCT01094288|365352820|FG001|Overall Study|Ongoing Participants|3|||
105915878|NCT01094288|365352821|FG002|Overall Study|Ongoing Participants|0|||
105915879|NCT01094288|365352822|FG003|Overall Study|Ongoing Participants|0|||
105915880|NCT01094288|365352823|FG004|Overall Study|Ongoing Participants|0|||
105915881|NCT01094288|365352824|FG005|Overall Study|Ongoing Participants|0|||
105915882|NCT01094288|365352825|FG006|Overall Study|Ongoing Participants|0|||
105915883|NCT01094288|365352826|FG007|Overall Study|Ongoing Participants|0|||
105915884|NCT01228591|365352827|FG000|Baseline|Lack of Efficacy|1|||
106127512|NCT01474512|366125535|FG004|Induction Period|Lost to Follow-up|0|||
106127513|NCT01474512|366125536|FG005|Induction Period|Lost to Follow-up|0|||
106127514|NCT01474512|366125537|FG006|Induction Period|Lost to Follow-up|0|||
106127515|NCT01474512|366125538|FG007|Induction Period|Lost to Follow-up|0|||
106127516|NCT01474512|366125539|FG008|Induction Period|Lost to Follow-up|0|||
106127517|NCT01474512|366125540|FG009|Induction Period|Lost to Follow-up|0|||
106127518|NCT01474512|366125541|FG010|Induction Period|Lost to Follow-up|0|||
106127519|NCT01474512|366125542|FG011|Induction Period|Lost to Follow-up|0|||
106127520|NCT01474512|366125543|FG012|Induction Period|Lost to Follow-up|0|||
106127521|NCT01474512|366125544|FG013|Induction Period|Lost to Follow-up|0|||
106127522|NCT01474512|366125545|FG014|Induction Period|Lost to Follow-up|0|||
106127523|NCT01474512|366125546|FG015|Induction Period|Lost to Follow-up|0|||
106127524|NCT01474512|366125547|FG016|Induction Period|Lost to Follow-up|0|||
106127525|NCT01474512|366125548|FG017|Induction Period|Lost to Follow-up|0|||
106127526|NCT01474512|366125531|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127527|NCT01474512|366125532|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127528|NCT01474512|366125533|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127529|NCT01474512|366125534|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
106127530|NCT01474512|366125535|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
106127531|NCT01474512|366125536|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
106127532|NCT01474512|366125537|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
106127533|NCT01474512|366125538|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127534|NCT01474512|366125539|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127535|NCT01474512|366125540|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127536|NCT01474512|366125541|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127537|NCT01474512|366125542|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127538|NCT01474512|366125543|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127539|NCT01474512|366125544|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127540|NCT01474512|366125545|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127541|NCT01474512|366125546|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127542|NCT01474512|366125547|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127543|NCT01474512|366125548|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
106127544|NCT01474512|366125531|FG000|Maintenance Period|Adverse Event|0|||
106127545|NCT01474512|366125532|FG001|Maintenance Period|Adverse Event|0|||
106127546|NCT01474512|366125533|FG002|Maintenance Period|Adverse Event|0|||
106127547|NCT01474512|366125534|FG003|Maintenance Period|Adverse Event|4|||
106127548|NCT01474512|366125535|FG004|Maintenance Period|Adverse Event|2|||
106127549|NCT01474512|366125536|FG005|Maintenance Period|Adverse Event|7|||
106127550|NCT01474512|366125537|FG006|Maintenance Period|Adverse Event|0|||
106127551|NCT01474512|366125538|FG007|Maintenance Period|Adverse Event|19|||
106127552|NCT01474512|366125539|FG008|Maintenance Period|Adverse Event|1|||
106127553|NCT01474512|366125540|FG009|Maintenance Period|Adverse Event|3|||
106127554|NCT01474512|366125541|FG010|Maintenance Period|Adverse Event|0|||
106127555|NCT01474512|366125542|FG011|Maintenance Period|Adverse Event|0|||
106127556|NCT01474512|366125543|FG012|Maintenance Period|Adverse Event|0|||
106127557|NCT01474512|366125544|FG013|Maintenance Period|Adverse Event|0|||
106127558|NCT01474512|366125545|FG014|Maintenance Period|Adverse Event|0|||
105679180|NCT01156792|364486917|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
105915885|NCT01228591|365352828|FG001|Baseline|Lack of Efficacy|2|||
105915886|NCT04980014|365352829|FG000|Overall Study|Participants who are Duplicated|1|||
105915887|NCT04980014|365352829|FG000|Overall Study|Follow-up Failure|13|||
106127559|NCT01474512|366125546|FG015|Maintenance Period|Adverse Event|0|||
106127560|NCT01474512|366125547|FG016|Maintenance Period|Adverse Event|0|||
106127561|NCT01474512|366125548|FG017|Maintenance Period|Adverse Event|0|||
106127562|NCT01474512|366125531|FG000|Maintenance Period|Withdrawal by Subject|0|||
106127563|NCT01474512|366125532|FG001|Maintenance Period|Withdrawal by Subject|0|||
106127564|NCT01474512|366125533|FG002|Maintenance Period|Withdrawal by Subject|0|||
106127565|NCT01474512|366125534|FG003|Maintenance Period|Withdrawal by Subject|6|||
106127566|NCT01474512|366125535|FG004|Maintenance Period|Withdrawal by Subject|2|||
106127567|NCT01474512|366125536|FG005|Maintenance Period|Withdrawal by Subject|3|||
106127568|NCT01474512|366125537|FG006|Maintenance Period|Withdrawal by Subject|1|||
106127569|NCT01474512|366125538|FG007|Maintenance Period|Withdrawal by Subject|6|||
106127570|NCT01474512|366125539|FG008|Maintenance Period|Withdrawal by Subject|3|||
106127571|NCT01474512|366125540|FG009|Maintenance Period|Withdrawal by Subject|1|||
106127572|NCT01474512|366125541|FG010|Maintenance Period|Withdrawal by Subject|0|||
106127573|NCT01474512|366125542|FG011|Maintenance Period|Withdrawal by Subject|0|||
106127574|NCT01474512|366125543|FG012|Maintenance Period|Withdrawal by Subject|0|||
106127575|NCT01474512|366125544|FG013|Maintenance Period|Withdrawal by Subject|0|||
106127576|NCT01474512|366125545|FG014|Maintenance Period|Withdrawal by Subject|0|||
106127577|NCT01474512|366125546|FG015|Maintenance Period|Withdrawal by Subject|0|||
106127578|NCT01474512|366125547|FG016|Maintenance Period|Withdrawal by Subject|0|||
106127579|NCT01474512|366125548|FG017|Maintenance Period|Withdrawal by Subject|0|||
106127580|NCT01474512|366125531|FG000|Maintenance Period|Lost to Follow-up|0|||
106127581|NCT01474512|366125532|FG001|Maintenance Period|Lost to Follow-up|0|||
106127582|NCT01474512|366125533|FG002|Maintenance Period|Lost to Follow-up|0|||
106127583|NCT01474512|366125534|FG003|Maintenance Period|Lost to Follow-up|3|||
106127584|NCT01474512|366125535|FG004|Maintenance Period|Lost to Follow-up|3|||
106127585|NCT01474512|366125536|FG005|Maintenance Period|Lost to Follow-up|0|||
106127586|NCT01474512|366125537|FG006|Maintenance Period|Lost to Follow-up|0|||
106127587|NCT01474512|366125538|FG007|Maintenance Period|Lost to Follow-up|2|||
106127588|NCT01474512|366125539|FG008|Maintenance Period|Lost to Follow-up|1|||
106127589|NCT01474512|366125540|FG009|Maintenance Period|Lost to Follow-up|1|||
106127590|NCT01474512|366125541|FG010|Maintenance Period|Lost to Follow-up|0|||
106127591|NCT01474512|366125542|FG011|Maintenance Period|Lost to Follow-up|0|||
106127592|NCT01474512|366125543|FG012|Maintenance Period|Lost to Follow-up|0|||
106127593|NCT01474512|366125544|FG013|Maintenance Period|Lost to Follow-up|0|||
106127594|NCT01474512|366125545|FG014|Maintenance Period|Lost to Follow-up|0|||
106127595|NCT01474512|366125546|FG015|Maintenance Period|Lost to Follow-up|0|||
106127596|NCT01474512|366125547|FG016|Maintenance Period|Lost to Follow-up|0|||
106127597|NCT01474512|366125548|FG017|Maintenance Period|Lost to Follow-up|0|||
106127598|NCT01474512|366125531|FG000|Maintenance Period|Death|0|||
106127599|NCT01474512|366125532|FG001|Maintenance Period|Death|0|||
106127600|NCT01474512|366125533|FG002|Maintenance Period|Death|0|||
106127601|NCT01474512|366125534|FG003|Maintenance Period|Death|0|||
106127602|NCT01474512|366125535|FG004|Maintenance Period|Death|0|||
106127603|NCT01474512|366125536|FG005|Maintenance Period|Death|2|||
106127604|NCT01474512|366125537|FG006|Maintenance Period|Death|0|||
106127605|NCT01474512|366125538|FG007|Maintenance Period|Death|0|||
106127606|NCT01474512|366125539|FG008|Maintenance Period|Death|0|||
106127607|NCT01474512|366125540|FG009|Maintenance Period|Death|0|||
106127608|NCT01474512|366125541|FG010|Maintenance Period|Death|0|||
106127609|NCT01474512|366125542|FG011|Maintenance Period|Death|0|||
106127610|NCT01474512|366125543|FG012|Maintenance Period|Death|0|||
106127611|NCT01474512|366125544|FG013|Maintenance Period|Death|0|||
106127612|NCT01474512|366125545|FG014|Maintenance Period|Death|0|||
106127613|NCT01474512|366125546|FG015|Maintenance Period|Death|0|||
106127614|NCT01474512|366125547|FG016|Maintenance Period|Death|0|||
106127615|NCT01474512|366125548|FG017|Maintenance Period|Death|0|||
106127616|NCT01474512|366125531|FG000|Maintenance Period|Physician Decision|0|||
106127617|NCT01474512|366125532|FG001|Maintenance Period|Physician Decision|0|||
106127618|NCT01474512|366125533|FG002|Maintenance Period|Physician Decision|0|||
106127619|NCT01474512|366125534|FG003|Maintenance Period|Physician Decision|0|||
106127620|NCT01474512|366125535|FG004|Maintenance Period|Physician Decision|0|||
106127621|NCT01474512|366125536|FG005|Maintenance Period|Physician Decision|1|||
106127622|NCT01474512|366125537|FG006|Maintenance Period|Physician Decision|0|||
106127623|NCT01474512|366125538|FG007|Maintenance Period|Physician Decision|2|||
106127624|NCT01474512|366125539|FG008|Maintenance Period|Physician Decision|0|||
106127625|NCT01474512|366125540|FG009|Maintenance Period|Physician Decision|0|||
106127626|NCT01474512|366125541|FG010|Maintenance Period|Physician Decision|0|||
106127627|NCT01474512|366125542|FG011|Maintenance Period|Physician Decision|0|||
106127628|NCT01474512|366125543|FG012|Maintenance Period|Physician Decision|0|||
106127629|NCT01474512|366125544|FG013|Maintenance Period|Physician Decision|0|||
106127630|NCT01474512|366125545|FG014|Maintenance Period|Physician Decision|0|||
106127631|NCT01474512|366125546|FG015|Maintenance Period|Physician Decision|0|||
106127632|NCT01474512|366125547|FG016|Maintenance Period|Physician Decision|0|||
106127633|NCT01474512|366125548|FG017|Maintenance Period|Physician Decision|0|||
106127634|NCT01474512|366125531|FG000|Maintenance Period|Clinical Relapse|0|||
106127635|NCT01474512|366125532|FG001|Maintenance Period|Clinical Relapse|0|||
106127636|NCT01474512|366125533|FG002|Maintenance Period|Clinical Relapse|0|||
105915888|NCT04980014|365352829|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
105915889|NCT04980014|365352829|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
105915890|NCT04980014|365352829|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
105915891|NCT02787304|365352830|FG000|Overall Study|Adverse Event|9|||
106000763|NCT03798717|365665091|FG000|Overall Study|Lost to Follow-up|1|||
105915892|NCT02787304|365352831|FG001|Overall Study|Adverse Event|3|||
105915893|NCT02787304|365352832|FG002|Overall Study|Adverse Event|8|||
105915894|NCT02787304|365352833|FG003|Overall Study|Adverse Event|1|||
105915895|NCT02787304|365352830|FG000|Overall Study|Withdrawal by Subject|1|||
105915896|NCT02787304|365352831|FG001|Overall Study|Withdrawal by Subject|4|||
105915897|NCT02787304|365352832|FG002|Overall Study|Withdrawal by Subject|0|||
105915898|NCT02787304|365352833|FG003|Overall Study|Withdrawal by Subject|0|||
106000764|NCT03798717|365665092|FG001|Overall Study|Lost to Follow-up|0|||
106000765|NCT03798717|365665093|FG002|Overall Study|Lost to Follow-up|0|||
106000766|NCT03798717|365665094|FG003|Overall Study|Lost to Follow-up|1|||
106000767|NCT03798717|365665095|FG004|Overall Study|Lost to Follow-up|0|||
106000768|NCT03798717|365665096|FG005|Overall Study|Lost to Follow-up|0|||
106000769|NCT03798717|365665091|FG000|Overall Study|Adverse Event|0|||
106000770|NCT03798717|365665092|FG001|Overall Study|Adverse Event|1|||
106000771|NCT03798717|365665093|FG002|Overall Study|Adverse Event|0|||
106000772|NCT03798717|365665094|FG003|Overall Study|Adverse Event|0|||
106000773|NCT03798717|365665095|FG004|Overall Study|Adverse Event|0|||
106000774|NCT03798717|365665096|FG005|Overall Study|Adverse Event|0|||
106000775|NCT03798717|365665091|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
106000776|NCT03798717|365665092|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
106000777|NCT03798717|365665093|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
106000778|NCT03798717|365665094|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
106000779|NCT03798717|365665095|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
106000780|NCT03798717|365665096|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
106000781|NCT04002960|365665098|FG000|Overall Study|Withdrawn prior to Completion|2|||
106000782|NCT03811340|365665101|FG000|Overall Study|subjects did not complete the survey.|90|||
106000783|NCT00865345|365665107|FG000|Overall Study|Withdrawal by Subject|2|||
106000784|NCT02219464|365665108|FG000|Overall Study|Withdrawal by Subject|1|||
106000785|NCT02219464|365665109|FG001|Overall Study|Withdrawal by Subject|0|||
106000786|NCT02219464|365665108|FG000|Overall Study|case cancelled|1|||
106000787|NCT02219464|365665109|FG001|Overall Study|case cancelled|0|||
106000788|NCT02219464|365665108|FG000|Overall Study|catheter malfunction|1|||
106000789|NCT02219464|365665109|FG001|Overall Study|catheter malfunction|0|||
106000790|NCT00984256|365665110|FG000|Overall Study|Withdrawal by Subject|0|||
106000791|NCT00984256|365665111|FG001|Overall Study|Withdrawal by Subject|1|||
106000792|NCT02038153|365665117|FG000|Overall Study|Withdrawal by Subject|1|||
106000793|NCT01329263|365665126|FG000|Overall Study|Lost to Follow-up|4|||
106000794|NCT01329263|365665127|FG001|Overall Study|Lost to Follow-up|21|||
106000795|NCT01329263|365665126|FG000|Overall Study|Withdrawal by Subject|1|||
106000796|NCT01329263|365665127|FG001|Overall Study|Withdrawal by Subject|2|||
106000797|NCT01421017|365665128|FG000|Overall Study|Withdrawal by Subject|2|||
106000798|NCT01421017|365665129|FG001|Overall Study|Withdrawal by Subject|0|||
106000799|NCT01421017|365665130|FG002|Overall Study|Withdrawal by Subject|0|||
106000800|NCT01421017|365665128|FG000|Overall Study|POD|0|||
106000801|NCT01421017|365665129|FG001|Overall Study|POD|6|||
106000802|NCT01421017|365665130|FG002|Overall Study|POD|3|||
106000803|NCT02313766|365665135|FG000|Overall Study|surgery cancelled|1|||
106000804|NCT02313766|365665136|FG001|Overall Study|surgery cancelled|0|||
106000805|NCT02313766|365665137|FG002|Overall Study|surgery cancelled|0|||
106000806|NCT02313766|365665135|FG000|Overall Study|Lost to Follow-up|0|||
106000807|NCT02313766|365665136|FG001|Overall Study|Lost to Follow-up|2|||
106000808|NCT02313766|365665137|FG002|Overall Study|Lost to Follow-up|0|||
106000809|NCT02313766|365665135|FG000|Overall Study|Adverse Event|0|||
106000810|NCT02313766|365665136|FG001|Overall Study|Adverse Event|1|||
106000811|NCT02313766|365665137|FG002|Overall Study|Adverse Event|0|||
106000812|NCT00248495|365665147|FG000|Overall Study|Withdrawal by Subject|1|||
105915899|NCT02787304|365352830|FG000|Overall Study|Lost to Follow-up|1|||
105915900|NCT02787304|365352831|FG001|Overall Study|Lost to Follow-up|0|||
106000813|NCT03812380|365665149|FG000|Overall Study|Protocol Violation|3|||
106000814|NCT03812380|365665150|FG001|Overall Study|Protocol Violation|3|||
106000815|NCT03812380|365665149|FG000|Overall Study|Withdrawal by Subject|5|||
106127637|NCT01474512|366125534|FG003|Maintenance Period|Clinical Relapse|1|||
106127638|NCT01474512|366125535|FG004|Maintenance Period|Clinical Relapse|0|||
106000816|NCT03812380|365665150|FG001|Overall Study|Withdrawal by Subject|4|||
106000817|NCT03812380|365665149|FG000|Overall Study|Early termination of study|14|||
106000818|NCT03812380|365665150|FG001|Overall Study|Early termination of study|14|||
106000819|NCT00473434|365665151|FG000|Overall Study|Physician Decision|3|||
106000820|NCT00473434|365665151|FG000|Overall Study|Withdrawal by Subject|9|||
106000821|NCT00473434|365665151|FG000|Overall Study|Compliance|3|||
106000822|NCT00473434|365665151|FG000|Overall Study|Lack of Efficacy|3|||
106000823|NCT00473434|365665151|FG000|Overall Study|Adverse Event|3|||
105915901|NCT02787304|365352832|FG002|Overall Study|Lost to Follow-up|0|||
106127639|NCT01474512|366125536|FG005|Maintenance Period|Clinical Relapse|0|||
106127640|NCT01474512|366125537|FG006|Maintenance Period|Clinical Relapse|0|||
106127641|NCT01474512|366125538|FG007|Maintenance Period|Clinical Relapse|0|||
106127642|NCT01474512|366125539|FG008|Maintenance Period|Clinical Relapse|0|||
106127643|NCT01474512|366125540|FG009|Maintenance Period|Clinical Relapse|0|||
106127644|NCT01474512|366125541|FG010|Maintenance Period|Clinical Relapse|0|||
106127645|NCT01474512|366125542|FG011|Maintenance Period|Clinical Relapse|0|||
106127646|NCT01474512|366125543|FG012|Maintenance Period|Clinical Relapse|0|||
106127647|NCT01474512|366125544|FG013|Maintenance Period|Clinical Relapse|0|||
106127648|NCT01474512|366125545|FG014|Maintenance Period|Clinical Relapse|0|||
106127649|NCT01474512|366125546|FG015|Maintenance Period|Clinical Relapse|0|||
106127650|NCT01474512|366125547|FG016|Maintenance Period|Clinical Relapse|0|||
106127651|NCT01474512|366125548|FG017|Maintenance Period|Clinical Relapse|0|||
106127652|NCT01474512|366125531|FG000|Maintenance Period|Lack of Efficacy|0|||
106127653|NCT01474512|366125532|FG001|Maintenance Period|Lack of Efficacy|0|||
106127654|NCT01474512|366125533|FG002|Maintenance Period|Lack of Efficacy|0|||
106127655|NCT01474512|366125534|FG003|Maintenance Period|Lack of Efficacy|1|||
106127656|NCT01474512|366125535|FG004|Maintenance Period|Lack of Efficacy|0|||
106127657|NCT01474512|366125536|FG005|Maintenance Period|Lack of Efficacy|0|||
106127658|NCT01474512|366125537|FG006|Maintenance Period|Lack of Efficacy|0|||
106127659|NCT01474512|366125538|FG007|Maintenance Period|Lack of Efficacy|11|||
106127660|NCT01474512|366125539|FG008|Maintenance Period|Lack of Efficacy|11|||
106127661|NCT01474512|366125540|FG009|Maintenance Period|Lack of Efficacy|12|||
106127662|NCT01474512|366125541|FG010|Maintenance Period|Lack of Efficacy|0|||
106127663|NCT01474512|366125542|FG011|Maintenance Period|Lack of Efficacy|0|||
106127664|NCT01474512|366125543|FG012|Maintenance Period|Lack of Efficacy|0|||
106127665|NCT01474512|366125544|FG013|Maintenance Period|Lack of Efficacy|0|||
106127666|NCT01474512|366125545|FG014|Maintenance Period|Lack of Efficacy|0|||
106127667|NCT01474512|366125546|FG015|Maintenance Period|Lack of Efficacy|0|||
106127668|NCT01474512|366125547|FG016|Maintenance Period|Lack of Efficacy|0|||
106127669|NCT01474512|366125548|FG017|Maintenance Period|Lack of Efficacy|0|||
106127670|NCT01474512|366125531|FG000|Maintenance Period|Protocol Violation|0|||
106127671|NCT01474512|366125532|FG001|Maintenance Period|Protocol Violation|0|||
106127672|NCT01474512|366125533|FG002|Maintenance Period|Protocol Violation|0|||
106127673|NCT01474512|366125534|FG003|Maintenance Period|Protocol Violation|1|||
106127674|NCT01474512|366125535|FG004|Maintenance Period|Protocol Violation|0|||
106127675|NCT01474512|366125536|FG005|Maintenance Period|Protocol Violation|0|||
106127676|NCT01474512|366125537|FG006|Maintenance Period|Protocol Violation|0|||
106127677|NCT01474512|366125538|FG007|Maintenance Period|Protocol Violation|1|||
106127678|NCT01474512|366125539|FG008|Maintenance Period|Protocol Violation|0|||
106127679|NCT01474512|366125540|FG009|Maintenance Period|Protocol Violation|1|||
106127680|NCT01474512|366125541|FG010|Maintenance Period|Protocol Violation|0|||
106127681|NCT01474512|366125542|FG011|Maintenance Period|Protocol Violation|0|||
106127682|NCT01474512|366125543|FG012|Maintenance Period|Protocol Violation|0|||
106127683|NCT01474512|366125544|FG013|Maintenance Period|Protocol Violation|0|||
106127684|NCT01474512|366125545|FG014|Maintenance Period|Protocol Violation|0|||
106127685|NCT01474512|366125546|FG015|Maintenance Period|Protocol Violation|0|||
106127686|NCT01474512|366125547|FG016|Maintenance Period|Protocol Violation|0|||
106127687|NCT01474512|366125548|FG017|Maintenance Period|Protocol Violation|0|||
106127688|NCT01474512|366125531|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
106127689|NCT01474512|366125532|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
106127690|NCT01474512|366125533|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
106127691|NCT01474512|366125534|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
106127692|NCT01474512|366125535|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
106127693|NCT01474512|366125536|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
106127694|NCT01474512|366125537|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
106127695|NCT01474512|366125538|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
106127696|NCT01474512|366125539|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
106127697|NCT01474512|366125540|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
106127698|NCT01474512|366125541|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
106127699|NCT01474512|366125542|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
106127700|NCT01474512|366125543|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
106127701|NCT01474512|366125544|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
106127702|NCT01474512|366125545|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
105915902|NCT02787304|365352833|FG003|Overall Study|Lost to Follow-up|1|||
106127703|NCT01474512|366125546|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
106127704|NCT01474512|366125547|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
106127705|NCT01474512|366125548|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
106127706|NCT01474512|366125531|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
106127707|NCT01474512|366125532|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
106127708|NCT01474512|366125533|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
105915903|NCT02787304|365352830|FG000|Overall Study|Noncompliance with study drug|0|||
105915904|NCT02787304|365352831|FG001|Overall Study|Noncompliance with study drug|0|||
105679181|NCT00768079|364486918|FG000|Overall Study|Lost to Follow-up|2|||
105679182|NCT00768079|364486919|FG001|Overall Study|Lost to Follow-up|0|||
105679183|NCT00768079|364486920|FG002|Overall Study|Lost to Follow-up|4|||
105679184|NCT00768079|364486918|FG000|Overall Study|Participant incarcerated|0|||
105679185|NCT00768079|364486919|FG001|Overall Study|Participant incarcerated|1|||
105679186|NCT00768079|364486920|FG002|Overall Study|Participant incarcerated|0|||
105679187|NCT01177800|364486921|FG000|Overall Study|Adverse Event|9|||
105679188|NCT01177800|364486922|FG001|Overall Study|Adverse Event|3|||
105679189|NCT01177800|364486921|FG000|Overall Study|Protocol Violation|0|||
105679190|NCT01177800|364486922|FG001|Overall Study|Protocol Violation|1|||
105679191|NCT01177800|364486921|FG000|Overall Study|Physician Decision|1|||
105679192|NCT01177800|364486922|FG001|Overall Study|Physician Decision|0|||
105679193|NCT01177800|364486921|FG000|Overall Study|Withdrawal of informed consent|0|||
105679194|NCT01177800|364486922|FG001|Overall Study|Withdrawal of informed consent|1|||
105679195|NCT01844687|364486925|FG000|Visit 1|Protocol Violation|3|||
105679196|NCT01844687|364486925|FG000|Visit 1|Lost to Follow-up|5|||
105679197|NCT01844687|364486925|FG000|Visit 2|Withdrawal by Subject|1|||
105679198|NCT01844687|364486925|FG000|Visit 2|Protocol Violation|1|||
105679199|NCT01844687|364486925|FG000|Visit 3|Lost to Follow-up|1|||
105679200|NCT01844687|364486925|FG000|Visit 3|Withdrawal by Subject|3|||
105679201|NCT01844687|364486925|FG000|Visit 3|child care problems|1|||
105679202|NCT01844687|364486925|FG000|Visit 4|Pregnancy|1|||
105679203|NCT01844687|364486925|FG000|Visit 4|Lost to Follow-up|1|||
105679204|NCT01844687|364486925|FG000|Visit 4|Withdrawal by Subject|2|||
105679205|NCT00986973|364486931|FG000|Overall Study|Withdrawn by study team|1|||
105679206|NCT01146782|364486932|FG000|Screening Cohort|Screen Failure|187|||
105679207|NCT01146782|364486932|FG000|Screening Cohort|Lost to Follow-up|4|||
105679208|NCT01146782|364486932|FG000|Screening Cohort|Physician Decision|1|||
105679209|NCT01146782|364486932|FG000|Screening Cohort|Withdrawal by Subject|29|||
106127709|NCT01474512|366125534|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
106127710|NCT01474512|366125535|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
106127711|NCT01474512|366125536|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
106127712|NCT01474512|366125537|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
106127713|NCT01474512|366125538|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
105679210|NCT01146782|364486932|FG000|Safety Cohort|Screen Failure|61|||
105679211|NCT01146782|364486932|FG000|Safety Cohort|Withdrawal by Subject|4|||
105679212|NCT01146782|364486932|FG000|Safety Cohort|Control AHI <5|4|||
105679213|NCT01146782|364486932|FG000|Safety Cohort|TST <4 hrs|14|||
105679214|NCT01146782|364486932|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
105679215|NCT01146782|364486932|FG000|Primary Endpoint Cohort|Physician Decision|1|||
105679216|NCT01605916|364486933|FG000|Overall Study|Adverse Event|1|||
105679217|NCT01605916|364486934|FG001|Overall Study|Adverse Event|0|||
105679218|NCT01605916|364486935|FG002|Overall Study|Adverse Event|0|||
105679219|NCT01605916|364486936|FG003|Overall Study|Adverse Event|1|||
105679220|NCT01605916|364486937|FG004|Overall Study|Adverse Event|0|||
105679221|NCT01605916|364486933|FG000|Overall Study|Lack of Efficacy|2|||
105679222|NCT01605916|364486934|FG001|Overall Study|Lack of Efficacy|3|||
105679223|NCT01605916|364486935|FG002|Overall Study|Lack of Efficacy|3|||
105679224|NCT01605916|364486936|FG003|Overall Study|Lack of Efficacy|5|||
105679225|NCT01605916|364486937|FG004|Overall Study|Lack of Efficacy|4|||
105679226|NCT01605916|364486933|FG000|Overall Study|Withdrawal by Subject|1|||
105679227|NCT01605916|364486934|FG001|Overall Study|Withdrawal by Subject|1|||
105679228|NCT01605916|364486935|FG002|Overall Study|Withdrawal by Subject|0|||
105679229|NCT01605916|364486936|FG003|Overall Study|Withdrawal by Subject|0|||
105679230|NCT01605916|364486937|FG004|Overall Study|Withdrawal by Subject|2|||
105915905|NCT02787304|365352832|FG002|Overall Study|Noncompliance with study drug|1|||
105915906|NCT02787304|365352833|FG003|Overall Study|Noncompliance with study drug|0|||
105915907|NCT02787304|365352830|FG000|Overall Study|Physician Decision|0|||
105915908|NCT02787304|365352831|FG001|Overall Study|Physician Decision|0|||
105915909|NCT02787304|365352832|FG002|Overall Study|Physician Decision|1|||
105915910|NCT02787304|365352833|FG003|Overall Study|Physician Decision|0|||
105915911|NCT02787304|365352830|FG000|Overall Study|Study terminated by sponsor|25|||
105915912|NCT02787304|365352831|FG001|Overall Study|Study terminated by sponsor|31|||
105915913|NCT02787304|365352832|FG002|Overall Study|Study terminated by sponsor|31|||
105915914|NCT02787304|365352833|FG003|Overall Study|Study terminated by sponsor|32|||
105915915|NCT03028142|365352834|FG000|Overall Study|Adverse Event|1|||
105915916|NCT03028142|365352835|FG001|Overall Study|Adverse Event|1|||
105915917|NCT03028142|365352836|FG002|Overall Study|Adverse Event|0|||
105915918|NCT03028142|365352837|FG003|Overall Study|Adverse Event|0|||
105915919|NCT03028142|365352838|FG004|Overall Study|Adverse Event|0|||
105915920|NCT03028142|365352839|FG005|Overall Study|Adverse Event|1|||
106127714|NCT01474512|366125539|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
105915921|NCT03028142|365352834|FG000|Overall Study|Withdrawal by Subject|0|||
105915922|NCT03028142|365352835|FG001|Overall Study|Withdrawal by Subject|0|||
105679231|NCT00470366|364486938|FG000|Overall Study|Adverse Event|3|||
105679232|NCT00470366|364486938|FG000|Overall Study|Poor compliance|1|||
105679233|NCT02751320|364486940|FG000|Overall Study|Adverse Event|2|||
105915923|NCT03028142|365352836|FG002|Overall Study|Withdrawal by Subject|0|||
105679234|NCT02751320|364486940|FG000|Overall Study|Withdrawal by Subject|1|||
105679235|NCT03426605|364486941|FG000|Overall Study|AML relapse or progression|2|||
105915924|NCT03028142|365352837|FG003|Overall Study|Withdrawal by Subject|0|||
105679236|NCT03426605|364486942|FG001|Overall Study|AML relapse or progression|1|||
105679237|NCT03426605|364486943|FG002|Overall Study|AML relapse or progression|2|||
105679238|NCT03426605|364486944|FG003|Overall Study|AML relapse or progression|2|||
105679239|NCT03426605|364486941|FG000|Overall Study|Treatment failure|3|||
105679240|NCT03426605|364486942|FG001|Overall Study|Treatment failure|2|||
105679241|NCT03426605|364486943|FG002|Overall Study|Treatment failure|0|||
105679242|NCT03426605|364486944|FG003|Overall Study|Treatment failure|0|||
105679243|NCT03426605|364486941|FG000|Overall Study|Adverse Event|1|||
105679244|NCT03426605|364486942|FG001|Overall Study|Adverse Event|0|||
105679245|NCT03426605|364486943|FG002|Overall Study|Adverse Event|1|||
105679246|NCT03426605|364486944|FG003|Overall Study|Adverse Event|1|||
105679247|NCT03426605|364486941|FG000|Overall Study|Withdrawal by Subject|0|||
105679248|NCT03426605|364486942|FG001|Overall Study|Withdrawal by Subject|0|||
105679249|NCT03426605|364486943|FG002|Overall Study|Withdrawal by Subject|1|||
105679250|NCT03426605|364486944|FG003|Overall Study|Withdrawal by Subject|1|||
105679251|NCT01103362|364486945|FG000|Overall Study|study terminated|596|||
105679252|NCT02047903|364486946|FG000|Overall Study|Adverse Event|14|||
105679253|NCT02047903|364486946|FG000|Overall Study|Serious adverse event|10|||
105679254|NCT02047903|364486946|FG000|Overall Study|Withdrawal by Subject|16|||
105679255|NCT02047903|364486946|FG000|Overall Study|Lost to Follow-up|4|||
105679256|NCT02047903|364486946|FG000|Overall Study|Reason not listed|6|||
105679257|NCT02047903|364486946|FG000|Overall Study|Not Treated|9|||
105679258|NCT01014533|364486947|FG000|Overall Study|Protocol Violation|3|||
105679259|NCT01014533|364486948|FG001|Overall Study|Protocol Violation|2|||
105679260|NCT01014533|364486947|FG000|Overall Study|Withdrawal by Subject|2|||
105679261|NCT01014533|364486948|FG001|Overall Study|Withdrawal by Subject|0|||
105679262|NCT01014533|364486947|FG000|Overall Study|unable to come to appointment|0|||
105679263|NCT01014533|364486948|FG001|Overall Study|unable to come to appointment|3|||
105679264|NCT00296400|364486949|FG000|Overall Study|Adverse Event|7|||
105679265|NCT00296400|364486950|FG001|Overall Study|Adverse Event|7|||
105679266|NCT00296400|364486951|FG002|Overall Study|Adverse Event|7|||
105679267|NCT00296400|364486949|FG000|Overall Study|Withdrawal by Subject|5|||
105679268|NCT00296400|364486950|FG001|Overall Study|Withdrawal by Subject|6|||
105679269|NCT00296400|364486951|FG002|Overall Study|Withdrawal by Subject|2|||
105679270|NCT00296400|364486949|FG000|Overall Study|Incorrect enrollment|2|||
105679271|NCT00296400|364486950|FG001|Overall Study|Incorrect enrollment|0|||
105679272|NCT00296400|364486951|FG002|Overall Study|Incorrect enrollment|0|||
105679273|NCT00296400|364486949|FG000|Overall Study|Protocol Violation|1|||
105679274|NCT00296400|364486950|FG001|Overall Study|Protocol Violation|1|||
105679275|NCT00296400|364486951|FG002|Overall Study|Protocol Violation|1|||
105679276|NCT00296400|364486949|FG000|Overall Study|Lost to Follow-up|1|||
105679277|NCT00296400|364486950|FG001|Overall Study|Lost to Follow-up|1|||
105679278|NCT00296400|364486951|FG002|Overall Study|Lost to Follow-up|2|||
105915925|NCT03028142|365352838|FG004|Overall Study|Withdrawal by Subject|1|||
105915926|NCT03028142|365352839|FG005|Overall Study|Withdrawal by Subject|0|||
105915927|NCT00116688|365352842|FG000|Overall Study|Protocol deviation|1|||
105915928|NCT00116688|365352843|FG001|Overall Study|Protocol deviation|0|||
105915929|NCT00116688|365352842|FG000|Overall Study|Noncompliance|3|||
105915930|NCT00116688|365352843|FG001|Overall Study|Noncompliance|1|||
105915931|NCT00116688|365352842|FG000|Overall Study|Adverse Event|11|||
105915932|NCT00116688|365352843|FG001|Overall Study|Adverse Event|0|||
105915933|NCT00116688|365352842|FG000|Overall Study|Withdrawal by Subject|26|||
105915934|NCT00116688|365352843|FG001|Overall Study|Withdrawal by Subject|2|||
105915935|NCT00116688|365352842|FG000|Overall Study|Requirement for alternative therapy|11|||
105915936|NCT00116688|365352843|FG001|Overall Study|Requirement for alternative therapy|1|||
105915937|NCT00116688|365352842|FG000|Overall Study|Physician Decision|7|||
105915938|NCT00116688|365352843|FG001|Overall Study|Physician Decision|0|||
105915939|NCT00116688|365352842|FG000|Overall Study|Lost to Follow-up|3|||
105915940|NCT00116688|365352843|FG001|Overall Study|Lost to Follow-up|0|||
105915941|NCT00116688|365352842|FG000|Overall Study|Death|15|||
105915942|NCT00116688|365352843|FG001|Overall Study|Death|0|||
105915943|NCT00116688|365352842|FG000|Overall Study|Protocol-specified criteria|3|||
105915944|NCT00116688|365352843|FG001|Overall Study|Protocol-specified criteria|0|||
105915945|NCT00116688|365352842|FG000|Overall Study|Pregnancy|1|||
105915946|NCT00116688|365352843|FG001|Overall Study|Pregnancy|0|||
105915947|NCT00116688|365352842|FG000|Overall Study|Other|11|||
105679279|NCT00296400|364486949|FG000|Overall Study|Study specific discontinuation criteria|0|||
105915948|NCT00116688|365352843|FG001|Overall Study|Other|0|||
105679280|NCT00296400|364486950|FG001|Overall Study|Study specific discontinuation criteria|0|||
105679281|NCT00296400|364486951|FG002|Overall Study|Study specific discontinuation criteria|1|||
105679282|NCT00296400|364486949|FG000|Overall Study|Visit 10 was performed earlier|0|||
105679283|NCT00296400|364486950|FG001|Overall Study|Visit 10 was performed earlier|1|||
105679284|NCT00296400|364486951|FG002|Overall Study|Visit 10 was performed earlier|0|||
105679285|NCT00296400|364486949|FG000|Overall Study|Pregnancy|1|||
105915949|NCT02224625|365352844|FG000|Irritation|Adverse Event|6|||
105915950|NCT02224625|365352844|FG000|Sensitization|Adverse Event|55|||
105915951|NCT01775670|365352845|FG000|Overall Study|Lost to Follow-up|1|||
105915952|NCT01775670|365352846|FG001|Overall Study|Lost to Follow-up|1|||
105679286|NCT00296400|364486950|FG001|Overall Study|Pregnancy|2|||
105679287|NCT00296400|364486951|FG002|Overall Study|Pregnancy|0|||
105679288|NCT00412061|364486954|FG000|Double Blind Phase|Disease Progression|101|||
105679289|NCT00412061|364486955|FG001|Double Blind Phase|Disease Progression|154|||
105679290|NCT00412061|364486954|FG000|Double Blind Phase|Adverse Event|61|||
105679291|NCT00412061|364486955|FG001|Double Blind Phase|Adverse Event|16|||
105679292|NCT00412061|364486954|FG000|Double Blind Phase|Final Primary Analysis|26|||
105679293|NCT00412061|364486955|FG001|Double Blind Phase|Final Primary Analysis|14|||
105679294|NCT00412061|364486954|FG000|Double Blind Phase|Withdrawal by Subject|18|||
105679295|NCT00412061|364486955|FG001|Double Blind Phase|Withdrawal by Subject|20|||
105679296|NCT00412061|364486954|FG000|Double Blind Phase|Death|6|||
105679297|NCT00412061|364486955|FG001|Double Blind Phase|Death|3|||
105679298|NCT00412061|364486954|FG000|Double Blind Phase|Protocol Violation|3|||
105679299|NCT00412061|364486955|FG001|Double Blind Phase|Protocol Violation|4|||
105679300|NCT00412061|364486954|FG000|Double Blind Phase|New Cander Therapy|1|||
105679301|NCT00412061|364486955|FG001|Double Blind Phase|New Cander Therapy|1|||
105679302|NCT00412061|364486954|FG000|Double Blind Phase|Lost to Follow-up|0|||
105679303|NCT00412061|364486955|FG001|Double Blind Phase|Lost to Follow-up|1|||
105679304|NCT00412061|364486954|FG000|Open Label Phase|Disease Progression|0|||
105679305|NCT00412061|364486955|FG001|Open Label Phase|Disease Progression|86|||
105679306|NCT00412061|364486954|FG000|Open Label Phase|Adverse Event|0|||
105679307|NCT00412061|364486955|FG001|Open Label Phase|Adverse Event|46|||
105679308|NCT00412061|364486954|FG000|Open Label Phase|Withdrawal by Subject|0|||
105679309|NCT00412061|364486955|FG001|Open Label Phase|Withdrawal by Subject|15|||
105679310|NCT00412061|364486954|FG000|Open Label Phase|Administrative Problems|0|||
105679311|NCT00412061|364486955|FG001|Open Label Phase|Administrative Problems|13|||
105679312|NCT00412061|364486954|FG000|Open Label Phase|Death|0|||
105679313|NCT00412061|364486955|FG001|Open Label Phase|Death|7|||
105679314|NCT00412061|364486954|FG000|Open Label Phase|Lost to Follow-up|0|||
105679315|NCT00412061|364486955|FG001|Open Label Phase|Lost to Follow-up|2|||
106127715|NCT01474512|366125540|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
106127716|NCT01474512|366125541|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
106127717|NCT01474512|366125542|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
106127718|NCT01474512|366125543|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
106127719|NCT01474512|366125544|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
106127720|NCT01474512|366125545|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
105679316|NCT00412061|364486954|FG000|Open Label Phase|New Cancer Therapy|0|||
105679317|NCT00412061|364486955|FG001|Open Label Phase|New Cancer Therapy|1|||
105679318|NCT00825825|364486958|FG000|First Medication Period (14 Days)|Adverse Event|1|||
105679319|NCT00825825|364486959|FG001|First Medication Period (14 Days)|Adverse Event|0|||
105679320|NCT00825825|364486960|FG002|First Medication Period (14 Days)|Adverse Event|0|||
105679321|NCT00825825|364486961|FG003|First Medication Period (14 Days)|Adverse Event|0|||
105679322|NCT00825825|364486962|FG004|First Medication Period (14 Days)|Adverse Event|0|||
105679323|NCT00825825|364486963|FG005|First Medication Period (14 Days)|Adverse Event|1|||
105679324|NCT00825825|364486958|FG000|First Medication Period (14 Days)|Physician Decision|2|||
105679325|NCT00825825|364486959|FG001|First Medication Period (14 Days)|Physician Decision|0|||
105915953|NCT04006145|365352847|FG000|Overall Study|Lost to Follow-up|0|||
105915954|NCT04006145|365352848|FG001|Overall Study|Lost to Follow-up|1|||
105915955|NCT04006145|365352847|FG000|Overall Study|Other|1|||
105915956|NCT04006145|365352848|FG001|Overall Study|Other|2|||
105915957|NCT01001429|365352849|FG000|Overall Study|surgery cancelled|0|||
105915958|NCT01001429|365352850|FG001|Overall Study|surgery cancelled|1|||
105915959|NCT00619827|365352865|FG000|Overall Study|Adverse Event|1|||
105915960|NCT00619827|365352866|FG001|Overall Study|Adverse Event|2|||
105915961|NCT00619827|365352865|FG000|Overall Study|Withdrawal by Subject|2|||
105915962|NCT00619827|365352866|FG001|Overall Study|Withdrawal by Subject|2|||
105915963|NCT00744939|365352873|FG000|Overall Study|Withdrawal by Subject|9|||
105915964|NCT00744939|365352873|FG000|Overall Study|Protocol Violation|13|||
105915965|NCT00744939|365352873|FG000|Overall Study|Death|24|||
105915966|NCT00744939|365352873|FG000|Overall Study|distance|4|||
105915967|NCT00744939|365352873|FG000|Overall Study|Lost to Follow-up|12|||
105915968|NCT00744939|365352873|FG000|Overall Study|Medical history exclusionary|1|||
105915969|NCT00744939|365352873|FG000|Overall Study|Did not receive Magnevist|7|||
105915970|NCT00744939|365352873|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
105915971|NCT00744939|365352873|FG000|Overall Study|coma|1|||
105915972|NCT00744939|365352873|FG000|Overall Study|incorrect race|1|||
106127721|NCT01474512|366125546|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
105679326|NCT00825825|364486960|FG002|First Medication Period (14 Days)|Physician Decision|1|||
105679327|NCT00825825|364486961|FG003|First Medication Period (14 Days)|Physician Decision|0|||
105679328|NCT00825825|364486962|FG004|First Medication Period (14 Days)|Physician Decision|0|||
105679329|NCT00825825|364486963|FG005|First Medication Period (14 Days)|Physician Decision|1|||
105915973|NCT01587885|365352874|FG000|Treatment Period 1|Failure to Return|0|||
105915974|NCT01587885|365352875|FG001|Treatment Period 1|Failure to Return|1|||
105915975|NCT01587885|365352874|FG000|Treatment Period 1|Protocol Violation|0|||
105915976|NCT01587885|365352875|FG001|Treatment Period 1|Protocol Violation|2|||
105915977|NCT02643693|365352876|FG000|Overall Study|Physician Decision|0|||
105679330|NCT00825825|364486958|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
105679331|NCT00825825|364486959|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
105679332|NCT00825825|364486960|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
105679333|NCT00825825|364486961|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
105679334|NCT00825825|364486962|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
105679335|NCT00825825|364486963|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
105679336|NCT00825825|364486958|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
105679337|NCT00825825|364486959|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
105679338|NCT00825825|364486960|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
105679339|NCT00825825|364486961|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
105679340|NCT00825825|364486962|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
105679341|NCT00825825|364486963|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
105679342|NCT00825825|364486958|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
105679343|NCT00825825|364486959|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
105679344|NCT00825825|364486960|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
105679345|NCT00825825|364486961|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
105679346|NCT00825825|364486962|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
105679347|NCT00825825|364486963|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
105679348|NCT00825825|364486958|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
105679349|NCT00825825|364486959|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
105679350|NCT00825825|364486960|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
105679351|NCT00825825|364486961|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
105679352|NCT00825825|364486962|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
105679353|NCT00825825|364486963|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
105679354|NCT00825825|364486958|FG000|Third Medication Period (14 Days)|poor data quality|0|||
105679355|NCT00825825|364486959|FG001|Third Medication Period (14 Days)|poor data quality|1|||
105679356|NCT00825825|364486960|FG002|Third Medication Period (14 Days)|poor data quality|0|||
105679357|NCT00825825|364486961|FG003|Third Medication Period (14 Days)|poor data quality|0|||
105679358|NCT00825825|364486962|FG004|Third Medication Period (14 Days)|poor data quality|0|||
105679359|NCT00825825|364486963|FG005|Third Medication Period (14 Days)|poor data quality|0|||
105679360|NCT01011387|364486966|FG000|Overall Study|Withdrawal by Subject|3|||
105679361|NCT01011387|364486966|FG000|Overall Study|Adverse Event|2|||
105679362|NCT01011387|364486966|FG000|Overall Study|Protocol Violation|1|||
105679363|NCT01178385|364486967|FG000|Overall Study|Withdrawal by Subject|2|||
105679364|NCT01178385|364486968|FG001|Overall Study|Withdrawal by Subject|0|||
105679365|NCT01226095|364486969|FG000|Overall Study|Poor compliance|1|||
105679366|NCT02679508|364486975|FG000|Healing Phase|Protocol Violation|1|||
105679367|NCT02679508|364486976|FG001|Healing Phase|Protocol Violation|1|||
105679368|NCT02679508|364486975|FG000|Healing Phase|Lost to Follow-up|1|||
105679369|NCT02679508|364486976|FG001|Healing Phase|Lost to Follow-up|0|||
105679370|NCT02679508|364486975|FG000|Maintenance Phase|Adverse Event|12|||
105679371|NCT02679508|364486976|FG001|Maintenance Phase|Adverse Event|2|||
106127722|NCT01474512|366125547|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
106127723|NCT01474512|366125548|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
106127724|NCT01474512|366125531|FG000|Long-Term Extension Period|Adverse Event|0|||
106127725|NCT01474512|366125532|FG001|Long-Term Extension Period|Adverse Event|0|||
106127726|NCT01474512|366125533|FG002|Long-Term Extension Period|Adverse Event|0|||
106127727|NCT01474512|366125534|FG003|Long-Term Extension Period|Adverse Event|0|||
106127728|NCT01474512|366125535|FG004|Long-Term Extension Period|Adverse Event|0|||
105679372|NCT02679508|364486975|FG000|Maintenance Phase|Lost to Follow-up|0|||
105679373|NCT02679508|364486976|FG001|Maintenance Phase|Lost to Follow-up|1|||
105679374|NCT02679508|364486975|FG000|Maintenance Phase|Withdrawal by Subject|15|||
105679375|NCT02679508|364486976|FG001|Maintenance Phase|Withdrawal by Subject|8|||
105679376|NCT02679508|364486975|FG000|Maintenance Phase|Other|5|||
105915978|NCT02643693|365352877|FG001|Overall Study|Physician Decision|1|||
105915979|NCT02643693|365352878|FG002|Overall Study|Physician Decision|0|||
105915980|NCT02643693|365352879|FG003|Overall Study|Physician Decision|0|||
105915981|NCT02643693|365352880|FG004|Overall Study|Physician Decision|0|||
105915982|NCT02643693|365352881|FG005|Overall Study|Physician Decision|0|||
105915983|NCT02643693|365352876|FG000|Overall Study|Withdrawal by Subject|0|||
105915984|NCT02643693|365352877|FG001|Overall Study|Withdrawal by Subject|1|||
105915985|NCT02643693|365352878|FG002|Overall Study|Withdrawal by Subject|0|||
105915986|NCT02643693|365352879|FG003|Overall Study|Withdrawal by Subject|0|||
105915987|NCT02643693|365352880|FG004|Overall Study|Withdrawal by Subject|0|||
105915988|NCT02643693|365352881|FG005|Overall Study|Withdrawal by Subject|0|||
106127729|NCT01474512|366125536|FG005|Long-Term Extension Period|Adverse Event|0|||
105679377|NCT02679508|364486976|FG001|Maintenance Phase|Other|4|||
105679378|NCT03538301|364486977|FG000|Overall Study|Adverse Event|1|||
106127730|NCT01474512|366125537|FG006|Long-Term Extension Period|Adverse Event|0|||
105915989|NCT02643693|365352876|FG000|Overall Study|Protocol Adherence Issues|2|||
106127731|NCT01474512|366125538|FG007|Long-Term Extension Period|Adverse Event|0|||
106127732|NCT01474512|366125539|FG008|Long-Term Extension Period|Adverse Event|0|||
106000824|NCT00473434|365665151|FG000|Overall Study|Patient was selling medication to others|1|||
106000825|NCT00473434|365665151|FG000|Overall Study|Safety evaluation|1|||
106000826|NCT00473434|365665151|FG000|Overall Study|Reason not specified|6|||
106000827|NCT00473434|365665151|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
106000828|NCT00473434|365665151|FG000|Overall Study|Switching to trial medication|1|||
105679379|NCT03538301|364486978|FG001|Overall Study|Adverse Event|4|||
105679380|NCT03538301|364486979|FG002|Overall Study|Adverse Event|4|||
105679381|NCT03538301|364486977|FG000|Overall Study|Death|1|||
105679382|NCT03538301|364486978|FG001|Overall Study|Death|1|||
105679383|NCT03538301|364486979|FG002|Overall Study|Death|0|||
105679384|NCT03538301|364486977|FG000|Overall Study|Physician Decision|0|||
105679385|NCT03538301|364486978|FG001|Overall Study|Physician Decision|1|||
105679386|NCT03538301|364486979|FG002|Overall Study|Physician Decision|0|||
105679387|NCT03538301|364486977|FG000|Overall Study|Protocol Violation|0|||
105679388|NCT03538301|364486978|FG001|Overall Study|Protocol Violation|0|||
105679389|NCT03538301|364486979|FG002|Overall Study|Protocol Violation|1|||
105679390|NCT03538301|364486977|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
105679391|NCT03538301|364486978|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
105679392|NCT03538301|364486979|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
105679393|NCT05326815|364486986|FG000|Overall Study|Withdrawal by Subject|3|||
105915990|NCT02643693|365352877|FG001|Overall Study|Protocol Adherence Issues|0|||
105915991|NCT02643693|365352878|FG002|Overall Study|Protocol Adherence Issues|1|||
105915992|NCT02643693|365352879|FG003|Overall Study|Protocol Adherence Issues|0|||
105915993|NCT02643693|365352880|FG004|Overall Study|Protocol Adherence Issues|0|||
105915994|NCT02643693|365352881|FG005|Overall Study|Protocol Adherence Issues|1|||
105915995|NCT00297648|365352882|FG000|Overall Study|Adverse Event|13|||
105915996|NCT00297648|365352882|FG000|Overall Study|Lack of Efficacy|18|||
105915997|NCT00297648|365352882|FG000|Overall Study|Lost to Follow-up|1|||
105915998|NCT00297648|365352882|FG000|Overall Study|Withdrawal by Subject|3|||
105915999|NCT00297648|365352882|FG000|Overall Study|Other: Incompliance|1|||
105916000|NCT01255163|365352883|FG000|Overall Study|Withdrawal by Subject|1|||
105916001|NCT01255163|365352884|FG001|Overall Study|Withdrawal by Subject|0|||
105916002|NCT01255163|365352883|FG000|Overall Study|Lost to Follow-up|2|||
105916003|NCT01255163|365352884|FG001|Overall Study|Lost to Follow-up|0|||
105916004|NCT01255163|365352883|FG000|Overall Study|Adverse Event|0|||
105916005|NCT01255163|365352884|FG001|Overall Study|Adverse Event|2|||
105916006|NCT01255163|365352883|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
105916007|NCT01255163|365352884|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
105916008|NCT00731822|365352889|FG000|Overall Study|Adverse Event|2|||
105916009|NCT00731822|365352890|FG001|Overall Study|Adverse Event|1|||
105916010|NCT00731822|365352889|FG000|Overall Study|Protocol Violation|1|||
105916011|NCT00731822|365352890|FG001|Overall Study|Protocol Violation|0|||
105916012|NCT00731822|365352889|FG000|Overall Study|Lost to Follow-up|1|||
105916013|NCT00731822|365352890|FG001|Overall Study|Lost to Follow-up|0|||
105916014|NCT03585270|365352891|FG000|Overall Study|Withdrawal by Subject|2|||
105916015|NCT03585270|365352892|FG001|Overall Study|Withdrawal by Subject|6|||
105916016|NCT03585270|365352891|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
105916017|NCT03585270|365352892|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
105916018|NCT03585270|365352891|FG000|Overall Study|Adverse Event|5|||
105916019|NCT03585270|365352892|FG001|Overall Study|Adverse Event|2|||
105916020|NCT03585270|365352891|FG000|Overall Study|Lost to Follow-up|1|||
105916021|NCT03585270|365352892|FG001|Overall Study|Lost to Follow-up|4|||
105916022|NCT03585270|365352891|FG000|Overall Study|Death|5|||
105916023|NCT03585270|365352892|FG001|Overall Study|Death|3|||
105916024|NCT03585270|365352891|FG000|Overall Study|Other reasons|2|||
105916025|NCT03585270|365352892|FG001|Overall Study|Other reasons|2|||
105916026|NCT03292016|365352893|FG000|Second Washout|Adverse Event|0|||
105916027|NCT03292016|365352894|FG001|Second Washout|Adverse Event|1|||
105916028|NCT03292016|365352895|FG002|Second Washout|Adverse Event|0|||
105916029|NCT03292016|365352896|FG003|Second Washout|Adverse Event|0|||
105916030|NCT03292016|365352897|FG004|Second Washout|Adverse Event|0|||
105916031|NCT03292016|365352898|FG005|Second Washout|Adverse Event|0|||
105916032|NCT01867008|365352899|FG000|Overall Study|Withdrawal by Subject|1|||
105916033|NCT00983372|365352904|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
105916034|NCT00983372|365352904|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
105916035|NCT00983372|365352904|FG000|Diltiazem ER Alone|Adverse Event|1|||
105916036|NCT00338741|365352905|FG000|Overall Study|Lost to Follow-up|2|||
105916037|NCT00338741|365352906|FG001|Overall Study|Lost to Follow-up|0|||
105916038|NCT01747499|365352908|FG000|Overall Study|Steroid refractory aGvHD|1|||
105916039|NCT01747499|365352909|FG001|Overall Study|Steroid refractory aGvHD|0|||
105916040|NCT01747499|365352910|FG002|Overall Study|Steroid refractory aGvHD|0|||
105916041|NCT01747499|365352911|FG003|Overall Study|Steroid refractory aGvHD|1|||
105916042|NCT01747499|365352912|FG004|Overall Study|Steroid refractory aGvHD|4|||
105916043|NCT01747499|365352908|FG000|Overall Study|Physician Decision|0|||
105916044|NCT01747499|365352909|FG001|Overall Study|Physician Decision|1|||
105916045|NCT01747499|365352910|FG002|Overall Study|Physician Decision|0|||
105916046|NCT01747499|365352911|FG003|Overall Study|Physician Decision|0|||
105916047|NCT01747499|365352912|FG004|Overall Study|Physician Decision|2|||
105679394|NCT05326815|364486986|FG000|Overall Study|Did not complete required labs|6|||
105679395|NCT05326815|364486986|FG000|Overall Study|Screen fail- abnormal labs|5|||
105679396|NCT00925132|364486987|FG000|Overall Study|Withdrawal by Subject|2|||
105916048|NCT01747499|365352908|FG000|Overall Study|Death|0|||
105916049|NCT01747499|365352909|FG001|Overall Study|Death|0|||
105679397|NCT00925132|364486988|FG001|Overall Study|Withdrawal by Subject|0|||
105679398|NCT00925132|364486989|FG002|Overall Study|Withdrawal by Subject|0|||
105679399|NCT00925132|364486990|FG003|Overall Study|Withdrawal by Subject|0|||
105679400|NCT00925132|364486991|FG004|Overall Study|Withdrawal by Subject|1|||
105679401|NCT00925132|364486987|FG000|Overall Study|Removed due to disease progression|0|||
105679402|NCT00925132|364486988|FG001|Overall Study|Removed due to disease progression|0|||
105679403|NCT00925132|364486989|FG002|Overall Study|Removed due to disease progression|0|||
105679404|NCT00925132|364486990|FG003|Overall Study|Removed due to disease progression|0|||
105679405|NCT00925132|364486991|FG004|Overall Study|Removed due to disease progression|4|||
105679406|NCT02545933|364486992|FG000|Overall Study|Adverse Event|3|||
105679407|NCT02545933|364486993|FG001|Overall Study|Adverse Event|0|||
105679408|NCT02545933|364486994|FG002|Overall Study|Adverse Event|0|||
105679409|NCT02545933|364486992|FG000|Overall Study|Withdrawal by Subject|2|||
105679410|NCT02545933|364486993|FG001|Overall Study|Withdrawal by Subject|3|||
105679411|NCT02545933|364486994|FG002|Overall Study|Withdrawal by Subject|3|||
105679412|NCT02545933|364486992|FG000|Overall Study|Protocol Violation|1|||
105679413|NCT02545933|364486993|FG001|Overall Study|Protocol Violation|0|||
105679414|NCT02545933|364486994|FG002|Overall Study|Protocol Violation|1|||
105679415|NCT00979134|364486995|FG000|Overall Study|Disease progression|18|||
105679416|NCT00979134|364486996|FG001|Overall Study|Disease progression|2|||
105679417|NCT00979134|364486997|FG002|Overall Study|Disease progression|5|||
105679418|NCT00979134|364486995|FG000|Overall Study|Adverse Event|0|||
105679419|NCT00979134|364486996|FG001|Overall Study|Adverse Event|0|||
105679420|NCT00979134|364486997|FG002|Overall Study|Adverse Event|2|||
105679421|NCT00979134|364486995|FG000|Overall Study|Withdrawal by Subject|1|||
105679422|NCT00979134|364486996|FG001|Overall Study|Withdrawal by Subject|1|||
105679423|NCT00979134|364486997|FG002|Overall Study|Withdrawal by Subject|2|||
105679424|NCT00979134|364486995|FG000|Overall Study|Lost to Follow-up|2|||
105679425|NCT00979134|364486996|FG001|Overall Study|Lost to Follow-up|2|||
105679426|NCT00979134|364486997|FG002|Overall Study|Lost to Follow-up|0|||
105679427|NCT00979134|364486995|FG000|Overall Study|Death|4|||
105679428|NCT00979134|364486996|FG001|Overall Study|Death|0|||
105679429|NCT00979134|364486997|FG002|Overall Study|Death|26|||
105916050|NCT01747499|365352910|FG002|Overall Study|Death|0|||
105916051|NCT01747499|365352911|FG003|Overall Study|Death|1|||
105916052|NCT01747499|365352912|FG004|Overall Study|Death|1|||
105916053|NCT01747499|365352908|FG000|Overall Study|Withdrawal by Subject|0|||
105916054|NCT01747499|365352909|FG001|Overall Study|Withdrawal by Subject|0|||
105916055|NCT01747499|365352910|FG002|Overall Study|Withdrawal by Subject|0|||
105916056|NCT01747499|365352911|FG003|Overall Study|Withdrawal by Subject|0|||
105916057|NCT01747499|365352912|FG004|Overall Study|Withdrawal by Subject|6|||
105916058|NCT01747499|365352908|FG000|Overall Study|Developed AML and death|0|||
105916059|NCT01747499|365352909|FG001|Overall Study|Developed AML and death|0|||
105916060|NCT01747499|365352910|FG002|Overall Study|Developed AML and death|0|||
105916061|NCT01747499|365352911|FG003|Overall Study|Developed AML and death|0|||
105916062|NCT01747499|365352912|FG004|Overall Study|Developed AML and death|1|||
105916063|NCT01747499|365352908|FG000|Overall Study|Determined not to be eligible|0|||
105916064|NCT01747499|365352909|FG001|Overall Study|Determined not to be eligible|0|||
105916065|NCT01747499|365352910|FG002|Overall Study|Determined not to be eligible|0|||
105916066|NCT01747499|365352911|FG003|Overall Study|Determined not to be eligible|0|||
105916067|NCT01747499|365352912|FG004|Overall Study|Determined not to be eligible|1|||
105916068|NCT00372424|365352913|FG000|Overall Study|Adverse Event|2|||
105916069|NCT00372424|365352913|FG000|Overall Study|Withdrawal by Subject|1|||
105916070|NCT00372424|365352913|FG000|Overall Study|Death|1|||
105916071|NCT00372424|365352913|FG000|Overall Study|Objective Progression or Relapse|14|||
105916072|NCT00372424|365352913|FG000|Overall Study|Other|7|||
105916073|NCT00372424|365352913|FG000|Overall Study|Enrolled, Not Treated|1|||
105916074|NCT00072410|365352914|FG000|Overall Study|Progressive disease|0|||
105916075|NCT00072410|365352915|FG001|Overall Study|Progressive disease|3|||
105916076|NCT04010461|365352918|FG000|Overall Study|COVID based withdrawal|5|||
105916077|NCT04010461|365352918|FG000|Overall Study|Withdrawal by Subject|5|||
105916078|NCT04010461|365352918|FG000|Overall Study|Adverse Event|1|||
105916079|NCT04010461|365352918|FG000|Overall Study|No Motor Threshold obtainable|1|||
105679430|NCT00979134|364486995|FG000|Overall Study|Other|8|||
105679431|NCT00979134|364486996|FG001|Overall Study|Other|1|||
105916080|NCT04010461|365352918|FG000|Overall Study|Physician Decision|1|||
105916081|NCT03797898|365352922|FG000|Overall Study|Lost to Follow-up|60|||
105916082|NCT03797898|365352923|FG001|Overall Study|Lost to Follow-up|69|||
105916083|NCT03797898|365352922|FG000|Overall Study|Withdrawal by Subject|9|||
105679432|NCT00979134|364486997|FG002|Overall Study|Other|5|||
105679433|NCT03694275|364489645|FG000|Overall Study|Adverse Event|0|||
105679434|NCT03694275|364489646|FG001|Overall Study|Adverse Event|1|||
105679435|NCT03694275|364489645|FG000|Overall Study|Reason not Specified|0|||
105679436|NCT03694275|364489646|FG001|Overall Study|Reason not Specified|1|||
105679437|NCT00266227|364489651|FG000|Initial Treatment|Adverse Event|0|||
105916084|NCT03797898|365352923|FG001|Overall Study|Withdrawal by Subject|7|||
105916085|NCT03797898|365352922|FG000|Overall Study|Became ineligible|5|||
105916086|NCT03797898|365352923|FG001|Overall Study|Became ineligible|2|||
105679438|NCT00266227|364489652|FG001|Initial Treatment|Adverse Event|0|||
105679439|NCT00266227|364489653|FG002|Initial Treatment|Adverse Event|13|||
105679440|NCT00266227|364489651|FG000|Initial Treatment|Lost to Follow-up|0|||
105679441|NCT00266227|364489652|FG001|Initial Treatment|Lost to Follow-up|0|||
106000829|NCT00473434|365665151|FG000|Overall Study|No longer required|1|||
106000830|NCT02322281|365665152|FG000|Overall Study|Progressive Disease|42|||
105679442|NCT00266227|364489653|FG002|Initial Treatment|Lost to Follow-up|6|||
105679443|NCT00266227|364489651|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
105679444|NCT00266227|364489652|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
106000831|NCT02322281|365665153|FG001|Overall Study|Progressive Disease|14|||
106000832|NCT02322281|365665154|FG002|Overall Study|Progressive Disease|49|||
106000833|NCT02322281|365665152|FG000|Overall Study|Adverse Event|3|||
106000834|NCT02322281|365665153|FG001|Overall Study|Adverse Event|4|||
106000835|NCT02322281|365665154|FG002|Overall Study|Adverse Event|6|||
106000836|NCT02322281|365665152|FG000|Overall Study|Death|3|||
105679445|NCT00266227|364489653|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
105679446|NCT00266227|364489651|FG000|Initial Treatment|Physician decision to withdraw|0|||
105679447|NCT00266227|364489652|FG001|Initial Treatment|Physician decision to withdraw|0|||
105679448|NCT00266227|364489653|FG002|Initial Treatment|Physician decision to withdraw|12|||
106000837|NCT02322281|365665153|FG001|Overall Study|Death|3|||
106000838|NCT02322281|365665154|FG002|Overall Study|Death|3|||
106000839|NCT02322281|365665152|FG000|Overall Study|Withdrawal by Subject|1|||
106000840|NCT02322281|365665153|FG001|Overall Study|Withdrawal by Subject|1|||
106000841|NCT02322281|365665154|FG002|Overall Study|Withdrawal by Subject|6|||
106000842|NCT02322281|365665152|FG000|Overall Study|Physician Decision|2|||
106000843|NCT02322281|365665153|FG001|Overall Study|Physician Decision|0|||
105679449|NCT00266227|364489651|FG000|Initial Treatment|Pregnancy|0|||
105679450|NCT00266227|364489652|FG001|Initial Treatment|Pregnancy|0|||
105679451|NCT00266227|364489653|FG002|Initial Treatment|Pregnancy|1|||
105679452|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Death|1|||
105679453|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Death|0|||
105679454|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Death|0|||
105679455|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
105679456|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
105679457|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
105679458|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
105679459|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
105679460|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
105679461|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
105679462|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
105679463|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
105679464|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
105679465|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
105679466|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
105679467|NCT00266227|364489651|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
105679468|NCT00266227|364489652|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
105679469|NCT00266227|364489653|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
105679470|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Death|1|||
105679471|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Death|1|||
105679472|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Death|0|||
105679473|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
105679474|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
105679475|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
105679476|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
105679477|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
106000844|NCT02322281|365665154|FG002|Overall Study|Physician Decision|5|||
106000845|NCT02322281|365665152|FG000|Overall Study|Study Terminated by Sponsor|2|||
106000846|NCT02322281|365665153|FG001|Overall Study|Study Terminated by Sponsor|0|||
106000847|NCT02322281|365665154|FG002|Overall Study|Study Terminated by Sponsor|0|||
106000848|NCT02322281|365665152|FG000|Overall Study|Missing|0|||
106000849|NCT02322281|365665153|FG001|Overall Study|Missing|0|||
106000850|NCT02322281|365665154|FG002|Overall Study|Missing|1|||
106000851|NCT02322281|365665152|FG000|Overall Study|Miscellaneous|0|||
106000852|NCT02322281|365665153|FG001|Overall Study|Miscellaneous|0|||
106127733|NCT01474512|366125540|FG009|Long-Term Extension Period|Adverse Event|0|||
106000853|NCT02322281|365665154|FG002|Overall Study|Miscellaneous|4|||
105679478|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
105679479|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
106000854|NCT01285401|365665155|FG000|Overall Study|Prematurely withdrawn from the study|17|||
106000855|NCT01285401|365665156|FG001|Overall Study|Prematurely withdrawn from the study|29|||
106000856|NCT02366312|365665160|FG000|Overall Study|Lost to Follow-up|0|||
106000857|NCT02366312|365665161|FG001|Overall Study|Lost to Follow-up|1|||
106000858|NCT04581824|365665162|FG000|Overall Study|Ongoing|75|||
106000859|NCT04581824|365665163|FG001|Overall Study|Ongoing|69|||
106127734|NCT01474512|366125541|FG010|Long-Term Extension Period|Adverse Event|0|||
105679480|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
105679481|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
105679482|NCT00266227|364489651|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
105679483|NCT00266227|364489652|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
105679484|NCT00266227|364489653|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
105679485|NCT01850446|364489654|FG000|Overall Study|Lack of Efficacy|1|||
105679486|NCT01850446|364489655|FG001|Overall Study|Lack of Efficacy|0|||
105679487|NCT01850446|364489654|FG000|Overall Study|Withdrawal by Subject|4|||
105679488|NCT01850446|364489655|FG001|Overall Study|Withdrawal by Subject|0|||
105679489|NCT01850446|364489654|FG000|Overall Study|Protocol Violation|0|||
105679490|NCT01850446|364489655|FG001|Overall Study|Protocol Violation|2|||
105679491|NCT00705679|364489656|FG000|Overall Study|Adverse Event|1|||
105679492|NCT00705679|364489657|FG001|Overall Study|Adverse Event|1|||
105679493|NCT00705679|364489658|FG002|Overall Study|Adverse Event|0|||
105679494|NCT00705679|364489659|FG003|Overall Study|Adverse Event|0|||
105679495|NCT00705679|364489660|FG004|Overall Study|Adverse Event|0|||
105679496|NCT00705679|364489656|FG000|Overall Study|Death|0|||
105679497|NCT00705679|364489657|FG001|Overall Study|Death|0|||
105679498|NCT00705679|364489658|FG002|Overall Study|Death|3|||
105679499|NCT00705679|364489659|FG003|Overall Study|Death|2|||
105679500|NCT00705679|364489660|FG004|Overall Study|Death|1|||
105679501|NCT00705679|364489656|FG000|Overall Study|Lost to Follow-up|32|||
105679502|NCT00705679|364489657|FG001|Overall Study|Lost to Follow-up|60|||
105679503|NCT00705679|364489658|FG002|Overall Study|Lost to Follow-up|44|||
105679504|NCT00705679|364489659|FG003|Overall Study|Lost to Follow-up|30|||
105679505|NCT00705679|364489660|FG004|Overall Study|Lost to Follow-up|35|||
105679506|NCT00705679|364489656|FG000|Overall Study|Physician Decision|0|||
105679507|NCT00705679|364489657|FG001|Overall Study|Physician Decision|1|||
105679508|NCT00705679|364489658|FG002|Overall Study|Physician Decision|0|||
105679509|NCT00705679|364489659|FG003|Overall Study|Physician Decision|1|||
105679510|NCT00705679|364489660|FG004|Overall Study|Physician Decision|0|||
105679511|NCT00705679|364489656|FG000|Overall Study|Withdrawal by Subject|32|||
105679512|NCT00705679|364489657|FG001|Overall Study|Withdrawal by Subject|77|||
105679513|NCT00705679|364489658|FG002|Overall Study|Withdrawal by Subject|68|||
105679514|NCT00705679|364489659|FG003|Overall Study|Withdrawal by Subject|47|||
105679515|NCT00705679|364489660|FG004|Overall Study|Withdrawal by Subject|33|||
105679516|NCT00759915|364489661|FG000|Overall Study|Withdrawal by Subject|1|||
105679517|NCT00759915|364489662|FG001|Overall Study|Withdrawal by Subject|0|||
105679518|NCT00759915|364489661|FG000|Overall Study|Adverse Event|0|||
105679519|NCT00759915|364489662|FG001|Overall Study|Adverse Event|1|||
105679520|NCT00512317|364489663|FG000|Overall Study|Insufficient clinical response|36|||
105679521|NCT00512317|364489663|FG000|Overall Study|Withdrawal by Subject|23|||
105679522|NCT00512317|364489663|FG000|Overall Study|Sponsor closure of study|21|||
105679523|NCT00512317|364489663|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
105679524|NCT00512317|364489663|FG000|Overall Study|Adverse Event|13|||
105679525|NCT00512317|364489663|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
105679526|NCT00512317|364489663|FG000|Overall Study|Lost to Follow-up|2|||
105679527|NCT00512317|364489663|FG000|Overall Study|Other|2|||
105679528|NCT01639495|364489664|FG000|Overall Study|Lost to Follow-up|6|||
105679529|NCT01639495|364489664|FG000|Overall Study|Consented but didn't have study catheter|4|||
105679530|NCT01639495|364489664|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
105679531|NCT01639495|364489664|FG000|Overall Study|No radiofrequency energy applied|2|||
105679532|NCT00007345|364489669|FG000|Overall Study|Refused further treatment|0|||
105916087|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
105916088|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105916089|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105916090|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105916091|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105916092|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105916093|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
105916094|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
105916095|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105916096|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105916097|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
106000860|NCT04581824|365665162|FG000|Overall Study|Withdrawal by Subject|3|||
106000861|NCT04581824|365665163|FG001|Overall Study|Withdrawal by Subject|5|||
105679533|NCT00007345|364489670|FG001|Overall Study|Refused further treatment|7|||
105679534|NCT00007345|364489669|FG000|Overall Study|Switched to alternative treatment|0|||
105679535|NCT00007345|364489670|FG001|Overall Study|Switched to alternative treatment|3|||
105679536|NCT00007345|364489669|FG000|Overall Study|Intercurrent illness|1|||
105679537|NCT00007345|364489670|FG001|Overall Study|Intercurrent illness|0|||
105679538|NCT00007345|364489669|FG000|Overall Study|Death on study|1|||
105679539|NCT00007345|364489670|FG001|Overall Study|Death on study|1|||
105679540|NCT00618618|364489671|FG000|Overall Study|Patient Request|0|||
105916098|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105679541|NCT00618618|364489672|FG001|Overall Study|Patient Request|0|||
105679542|NCT00618618|364489673|FG002|Overall Study|Patient Request|2|||
105679543|NCT00618618|364489674|FG003|Overall Study|Patient Request|0|||
105679544|NCT00618618|364489671|FG000|Overall Study|Inability to Complete Study Procedures|0|||
105679545|NCT00618618|364489672|FG001|Overall Study|Inability to Complete Study Procedures|1|||
105679546|NCT00618618|364489673|FG002|Overall Study|Inability to Complete Study Procedures|0|||
105679547|NCT00618618|364489674|FG003|Overall Study|Inability to Complete Study Procedures|0|||
105679548|NCT00618618|364489671|FG000|Overall Study|Lost to Follow-up|3|||
105679549|NCT00618618|364489672|FG001|Overall Study|Lost to Follow-up|0|||
105679550|NCT00618618|364489673|FG002|Overall Study|Lost to Follow-up|0|||
105679551|NCT00618618|364489674|FG003|Overall Study|Lost to Follow-up|1|||
105679552|NCT00618618|364489671|FG000|Overall Study|Non-compliance|1|||
105679553|NCT00618618|364489672|FG001|Overall Study|Non-compliance|1|||
106127735|NCT01474512|366125542|FG011|Long-Term Extension Period|Adverse Event|1|||
106127736|NCT01474512|366125543|FG012|Long-Term Extension Period|Adverse Event|57|||
105679554|NCT00618618|364489673|FG002|Overall Study|Non-compliance|0|||
105679555|NCT00618618|364489674|FG003|Overall Study|Non-compliance|0|||
105679556|NCT00618618|364489671|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
105679557|NCT00618618|364489672|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
105679558|NCT00618618|364489673|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
105679559|NCT00618618|364489674|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
105679560|NCT00618618|364489671|FG000|Overall Study|Death|0|||
105916099|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105916100|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
105916101|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105916102|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
105916103|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105916104|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105916105|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105916106|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105916107|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
105916108|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105916109|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105916110|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
105916111|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105916112|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105916113|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105916114|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
105916115|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105916116|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105916117|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
105916118|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105916119|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105916120|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105916121|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
105916122|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105916123|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105916124|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
105916125|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105916126|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105916127|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105916128|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
105916129|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105916130|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105916131|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105916132|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
105916133|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105916134|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105916135|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
105916136|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105916137|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105916138|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105916139|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
106127737|NCT01474512|366125544|FG013|Long-Term Extension Period|Adverse Event|58|||
105679561|NCT00618618|364489672|FG001|Overall Study|Death|1|||
105679562|NCT00618618|364489673|FG002|Overall Study|Death|0|||
105679563|NCT00618618|364489674|FG003|Overall Study|Death|0|||
105679564|NCT01171807|364489675|FG000|Overall Study|Treatment failure|2|||
105679565|NCT01171807|364489676|FG001|Overall Study|Treatment failure|4|||
105679566|NCT01171807|364489675|FG000|Overall Study|Non compliance|1|||
105679567|NCT01171807|364489676|FG001|Overall Study|Non compliance|0|||
105679568|NCT01171807|364489675|FG000|Overall Study|Lost to Follow-up|3|||
105679569|NCT01171807|364489676|FG001|Overall Study|Lost to Follow-up|0|||
105679570|NCT04101318|364489680|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
105679571|NCT04101318|364489681|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
105679572|NCT04101318|364489680|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
105679573|NCT04101318|364489681|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
105679574|NCT04101318|364489680|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
105679575|NCT04101318|364489681|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
105679576|NCT04289051|364489682|FG000|Overall Study|Lost to Follow-up|0|||
105679577|NCT04289051|364489683|FG001|Overall Study|Lost to Follow-up|0|||
105679578|NCT04289051|364489684|FG002|Overall Study|Lost to Follow-up|2|||
105679579|NCT01052103|364489686|FG000|Overall Study|Adverse Event|10|||
105679580|NCT01052103|364489687|FG001|Overall Study|Adverse Event|6|||
105679581|NCT01052103|364489686|FG000|Overall Study|Entry Criteria Not Met|3|||
105679582|NCT01052103|364489687|FG001|Overall Study|Entry Criteria Not Met|1|||
105679583|NCT01052103|364489686|FG000|Overall Study|Lost to Follow-up|3|||
105679584|NCT01052103|364489687|FG001|Overall Study|Lost to Follow-up|5|||
105679585|NCT01052103|364489686|FG000|Overall Study|Protocol Violation|10|||
105679586|NCT01052103|364489687|FG001|Overall Study|Protocol Violation|4|||
105679587|NCT01052103|364489686|FG000|Overall Study|Scheduling conflict|2|||
105679588|NCT01052103|364489687|FG001|Overall Study|Scheduling conflict|1|||
105679589|NCT01052103|364489686|FG000|Overall Study|Sponsor Decision|2|||
105679590|NCT01052103|364489687|FG001|Overall Study|Sponsor Decision|0|||
105679591|NCT01052103|364489686|FG000|Overall Study|Withdrawal by Subject|3|||
105679592|NCT01052103|364489687|FG001|Overall Study|Withdrawal by Subject|6|||
105679593|NCT01052103|364489686|FG000|Overall Study|Perceived Lack of Efficacy|1|||
105679594|NCT01052103|364489687|FG001|Overall Study|Perceived Lack of Efficacy|0|||
105679595|NCT03836716|364489688|FG000|Overall Study|Adverse Event|3|||
105679596|NCT03836716|364489688|FG000|Overall Study|Death|22|||
105679597|NCT03836716|364489688|FG000|Overall Study|Withdrawal by Subject|8|||
105679598|NCT03836716|364489688|FG000|Overall Study|Study terminated by sponsor|87|||
105679599|NCT03020576|364489691|FG000|Overall Study|Withdrawal by Subject|1|||
105679600|NCT03020576|364489692|FG001|Overall Study|Withdrawal by Subject|2|||
105679601|NCT01474434|364489696|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
105679602|NCT01474434|364489697|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
105679603|NCT01474434|364489698|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
105679604|NCT01474434|364489699|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
105679605|NCT01474434|364489696|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
105679606|NCT01474434|364489697|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
105679607|NCT01474434|364489698|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
105679608|NCT01474434|364489699|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
105679609|NCT01474434|364489696|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
105679610|NCT01474434|364489697|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
105679611|NCT01474434|364489698|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
105679612|NCT01474434|364489699|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
105679613|NCT01236534|364489701|FG000|Overall Study|Adverse Event|3|||
105679614|NCT01236534|364489702|FG001|Overall Study|Adverse Event|0|||
105679615|NCT04275089|364489703|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
105916140|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105916141|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105916142|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
105916143|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105916144|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105916145|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105916146|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105916147|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
105916148|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105916149|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
105916150|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105679616|NCT01153958|364489704|FG000|Overall Study|Study Terminated|36|||
105679617|NCT01153958|364489705|FG001|Overall Study|Study Terminated|32|||
105679618|NCT01034163|364489710|FG000|Overall Study|Treatment completed as per protocol|8|||
105679619|NCT01034163|364489711|FG001|Overall Study|Treatment completed as per protocol|7|||
105679620|NCT01034163|364489710|FG000|Overall Study|Withdrawal by Subject|8|||
105916151|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105916152|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105916153|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105916154|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
105916155|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105916156|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
105679621|NCT01034163|364489711|FG001|Overall Study|Withdrawal by Subject|2|||
105679622|NCT01034163|364489710|FG000|Overall Study|Protocol deviation|1|||
105916157|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105916158|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105916159|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105916160|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105679623|NCT01034163|364489711|FG001|Overall Study|Protocol deviation|0|||
105679624|NCT01034163|364489710|FG000|Overall Study|Disease progression|3|||
105679625|NCT01034163|364489711|FG001|Overall Study|Disease progression|4|||
105679626|NCT01034163|364489710|FG000|Overall Study|Adverse Event|6|||
105679627|NCT01034163|364489711|FG001|Overall Study|Adverse Event|0|||
105679628|NCT01034163|364489710|FG000|Overall Study|Administrative problems|0|||
105679629|NCT01034163|364489711|FG001|Overall Study|Administrative problems|1|||
105679630|NCT01034163|364489710|FG000|Overall Study|Abnormal laboratory value|1|||
105679631|NCT01034163|364489711|FG001|Overall Study|Abnormal laboratory value|0|||
105679632|NCT00752557|364489712|FG000|Overall Study|Withdrawal by Subject|4|||
105679633|NCT00752557|364489713|FG001|Overall Study|Withdrawal by Subject|3|||
105679634|NCT00752557|364489714|FG002|Overall Study|Withdrawal by Subject|3|||
105679635|NCT00752557|364489712|FG000|Overall Study|Unspecified resaons|0|||
105679636|NCT00752557|364489713|FG001|Overall Study|Unspecified resaons|2|||
105679637|NCT00752557|364489714|FG002|Overall Study|Unspecified resaons|2|||
105679638|NCT00752557|364489712|FG000|Overall Study|Lost to Follow-up|1|||
105679639|NCT00752557|364489713|FG001|Overall Study|Lost to Follow-up|0|||
105679640|NCT00752557|364489714|FG002|Overall Study|Lost to Follow-up|1|||
105679641|NCT02150343|364489715|FG000|Overall Study|Adverse Event|2|||
105679642|NCT02150343|364489716|FG001|Overall Study|Adverse Event|0|||
105679643|NCT02150343|364489717|FG002|Overall Study|Adverse Event|1|||
105679644|NCT02150343|364489718|FG003|Overall Study|Adverse Event|1|||
105679645|NCT02150343|364489715|FG000|Overall Study|Withdrawal by Subject|13|||
105679646|NCT02150343|364489716|FG001|Overall Study|Withdrawal by Subject|10|||
105679647|NCT02150343|364489717|FG002|Overall Study|Withdrawal by Subject|9|||
105679648|NCT02150343|364489718|FG003|Overall Study|Withdrawal by Subject|4|||
105679649|NCT02150343|364489715|FG000|Overall Study|Lost to Follow-up|4|||
105679650|NCT02150343|364489716|FG001|Overall Study|Lost to Follow-up|4|||
105679651|NCT02150343|364489717|FG002|Overall Study|Lost to Follow-up|2|||
105679652|NCT02150343|364489718|FG003|Overall Study|Lost to Follow-up|3|||
105679653|NCT02150343|364489715|FG000|Overall Study|Other|2|||
105679654|NCT02150343|364489716|FG001|Overall Study|Other|6|||
105679655|NCT02150343|364489717|FG002|Overall Study|Other|0|||
105679656|NCT02150343|364489718|FG003|Overall Study|Other|2|||
105679657|NCT00190749|364489719|FG000|Overall Study|Lost to Follow-up|8|||
105679658|NCT00190749|364489720|FG001|Overall Study|Lost to Follow-up|11|||
105679659|NCT00190749|364489719|FG000|Overall Study|Withdrawal by Subject|10|||
105679660|NCT00190749|364489720|FG001|Overall Study|Withdrawal by Subject|6|||
105679661|NCT00190749|364489719|FG000|Overall Study|Protocol Violation|5|||
105679662|NCT00190749|364489720|FG001|Overall Study|Protocol Violation|4|||
105679663|NCT00190749|364489719|FG000|Overall Study|Adverse Event|0|||
105679664|NCT00190749|364489720|FG001|Overall Study|Adverse Event|5|||
105679665|NCT00190749|364489719|FG000|Overall Study|Lack of Efficacy|2|||
105679666|NCT00190749|364489720|FG001|Overall Study|Lack of Efficacy|3|||
105679667|NCT00190749|364489719|FG000|Overall Study|Reason Not Specified|0|||
105679668|NCT00190749|364489720|FG001|Overall Study|Reason Not Specified|2|||
105679669|NCT00190749|364489719|FG000|Overall Study|Sponsor Decision|1|||
105679670|NCT00190749|364489720|FG001|Overall Study|Sponsor Decision|0|||
105679671|NCT02729753|364489721|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
105679672|NCT02729753|364489722|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
105679673|NCT01154010|364489723|FG000|Overall Study|Lost to Follow-up|0|||
105679674|NCT01154010|364489724|FG001|Overall Study|Lost to Follow-up|1|||
105679675|NCT02413333|364489727|FG000|Period 1|Adverse Event|1|||
105679676|NCT02413333|364489728|FG001|Period 1|Adverse Event|0|||
105679677|NCT02413333|364489727|FG000|Period 1|Reason Not Specified|0|||
105679678|NCT02413333|364489728|FG001|Period 1|Reason Not Specified|1|||
105679679|NCT02413333|364489727|FG000|Period 2|Protocol Deviation|1|||
105679680|NCT02413333|364489728|FG001|Period 2|Protocol Deviation|0|||
105679681|NCT02414932|364489729|FG000|Overall Study|Withdrawal by Subject|2|||
105679682|NCT02414932|364489730|FG001|Overall Study|Withdrawal by Subject|3|||
105679683|NCT02414932|364489729|FG000|Overall Study|Adverse Event|1|||
105679684|NCT02414932|364489730|FG001|Overall Study|Adverse Event|0|||
105679685|NCT01771107|364489731|FG000|Overall Study|Adverse Event|1|||
105679686|NCT01771107|364489732|FG001|Overall Study|Adverse Event|3|||
105679687|NCT01771107|364489731|FG000|Overall Study|Withdrawal by Subject|0|||
106000862|NCT04581824|365665162|FG000|Overall Study|Lost to Follow-up|1|||
105679688|NCT01771107|364489732|FG001|Overall Study|Withdrawal by Subject|2|||
105679689|NCT01771107|364489731|FG000|Overall Study|Lost to Follow-up|0|||
105679690|NCT01771107|364489732|FG001|Overall Study|Lost to Follow-up|1|||
105679691|NCT01771107|364489731|FG000|Overall Study|participant moved|0|||
105679692|NCT01771107|364489732|FG001|Overall Study|participant moved|1|||
105679693|NCT01771107|364489731|FG000|Overall Study|Other|0|||
105679694|NCT01771107|364489732|FG001|Overall Study|Other|1|||
105679695|NCT02891837|364489734|FG000|Overall Study|Lost to Follow-up|2|||
105679696|NCT02891837|364489735|FG001|Overall Study|Lost to Follow-up|0|||
105679697|NCT02891837|364489734|FG000|Overall Study|Withdrawal by Subject|1|||
105679698|NCT02891837|364489735|FG001|Overall Study|Withdrawal by Subject|0|||
105679699|NCT00709852|364489736|FG000|Period 1|Adverse Event|2|||
105679700|NCT00709852|364489737|FG001|Period 1|Adverse Event|0|||
105679701|NCT00709852|364489736|FG000|Period 1|Withdrawal by Subject|4|||
105679702|NCT00709852|364489737|FG001|Period 1|Withdrawal by Subject|2|||
106000863|NCT04581824|365665163|FG001|Overall Study|Lost to Follow-up|0|||
106000864|NCT00619515|365665164|FG000|Overall Study|Study Termination by IRB|73|||
106000865|NCT02420093|365665167|FG000|Overall Study|Withdrawal by Subject|1|||
106000866|NCT02420093|365665168|FG001|Overall Study|Withdrawal by Subject|1|||
106000867|NCT04862065|365665169|FG000|Screening|Protocol Violation|54|||
105679703|NCT00709852|364489736|FG000|Period 1|Protocol Violation|1|||
105679704|NCT00709852|364489737|FG001|Period 1|Protocol Violation|0|||
105679705|NCT00709852|364489736|FG000|Period 1|Defective scanner|0|||
105679706|NCT00709852|364489737|FG001|Period 1|Defective scanner|1|||
105679707|NCT00709852|364489736|FG000|Period 1|Lost to Follow-up|1|||
105679708|NCT00709852|364489737|FG001|Period 1|Lost to Follow-up|0|||
105679709|NCT00709852|364489736|FG000|Period 2|Protocol Violation|4|||
105679710|NCT00709852|364489737|FG001|Period 2|Protocol Violation|1|||
105679711|NCT00709852|364489736|FG000|Period 2|Adverse Event|1|||
105679712|NCT00709852|364489737|FG001|Period 2|Adverse Event|1|||
105679713|NCT00709852|364489736|FG000|Period 2|Lost to Follow-up|1|||
105679714|NCT00709852|364489737|FG001|Period 2|Lost to Follow-up|0|||
105679715|NCT00709852|364489736|FG000|Period 2|No 72-hour follow-up|3|||
105679716|NCT00709852|364489737|FG001|Period 2|No 72-hour follow-up|0|||
105679717|NCT01021215|364489744|FG000|Overall Study|Lost to Follow-up|3|||
105679718|NCT01021215|364489745|FG001|Overall Study|Lost to Follow-up|0|||
105679719|NCT00185965|364489746|FG000|Overall Study|Adverse Event|0|||
105679720|NCT00185965|364489747|FG001|Overall Study|Adverse Event|1|||
105679721|NCT02533531|364489748|FG000|Overall Study|Device did not turn on|1|||
105679722|NCT02689518|364489749|FG000|Overall Study|Withdrawal by Subject|3|||
105679723|NCT02433340|364489750|FG000|Overall Study|Adverse Event|0|||
105679724|NCT02433340|364489751|FG001|Overall Study|Adverse Event|0|||
105679725|NCT02433340|364489752|FG002|Overall Study|Adverse Event|1|||
105679726|NCT02433340|364489753|FG003|Overall Study|Adverse Event|0|||
105679727|NCT02433340|364489750|FG000|Overall Study|Withdrawal by Subject|1|||
105679728|NCT02433340|364489751|FG001|Overall Study|Withdrawal by Subject|0|||
105679729|NCT02433340|364489752|FG002|Overall Study|Withdrawal by Subject|1|||
105679730|NCT02433340|364489753|FG003|Overall Study|Withdrawal by Subject|2|||
105679731|NCT02433340|364489750|FG000|Overall Study|Lost to Follow-up|0|||
105679732|NCT02433340|364489751|FG001|Overall Study|Lost to Follow-up|1|||
105679733|NCT02433340|364489752|FG002|Overall Study|Lost to Follow-up|0|||
105679734|NCT02433340|364489753|FG003|Overall Study|Lost to Follow-up|0|||
105679735|NCT02433340|364489750|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
105679736|NCT02433340|364489751|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
105679737|NCT02433340|364489752|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
105679738|NCT02433340|364489753|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
105679739|NCT02433340|364489750|FG000|Overall Study|Other|0|||
105679740|NCT02433340|364489751|FG001|Overall Study|Other|1|||
105679741|NCT02433340|364489752|FG002|Overall Study|Other|0|||
105679742|NCT02433340|364489753|FG003|Overall Study|Other|0|||
105679743|NCT01285609|364489754|FG000|Randomized|Progressive Disease|41|||
105679744|NCT01285609|364489755|FG001|Randomized|Progressive Disease|61|||
105679745|NCT01285609|364489754|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
105679746|NCT01285609|364489755|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
105679747|NCT01285609|364489754|FG000|Randomized|Study Drug Toxicity|13|||
105679748|NCT01285609|364489755|FG001|Randomized|Study Drug Toxicity|14|||
105679749|NCT01285609|364489754|FG000|Randomized|Death|5|||
105679750|NCT01285609|364489755|FG001|Randomized|Death|7|||
105679751|NCT01285609|364489754|FG000|Randomized|Withdrawal by Subject|8|||
105679752|NCT01285609|364489755|FG001|Randomized|Withdrawal by Subject|11|||
105679753|NCT01285609|364489754|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
105679754|NCT01285609|364489755|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
105679755|NCT01285609|364489754|FG000|Randomized|Undisclosed Reasons|1|||
105679756|NCT01285609|364489755|FG001|Randomized|Undisclosed Reasons|0|||
106000868|NCT04862065|365665170|FG001|Screening|Protocol Violation|0|||
106000869|NCT04862065|365665171|FG002|Screening|Protocol Violation|0|||
106127738|NCT01474512|366125545|FG014|Long-Term Extension Period|Adverse Event|0|||
106127739|NCT01474512|366125546|FG015|Long-Term Extension Period|Adverse Event|0|||
105679757|NCT01285609|364489754|FG000|Randomized|Randomized but not Treated|4|||
105679758|NCT01285609|364489755|FG001|Randomized|Randomized but not Treated|4|||
105679759|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
105679760|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
105679761|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
105679762|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
105679763|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
105679764|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
105679765|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
105679766|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
105679767|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Death|11|||
106000870|NCT04862065|365665169|FG000|Screening|Insufficient Sample|1|||
105679768|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Death|3|||
105679769|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
105679770|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
105679771|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Not Reported|0|||
105679772|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Not Reported|2|||
105679773|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
105679774|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
105679775|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
105679776|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
105679777|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
105679778|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
105679779|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
105679780|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
105679781|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
105679782|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
105679783|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
105679784|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
105679785|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
105679786|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
105679787|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
105679788|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
105679789|NCT01285609|364489754|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
105679790|NCT01285609|364489755|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
105679791|NCT01285609|364489754|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
105679792|NCT01285609|364489755|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
105679793|NCT03616977|364489761|FG000|Period 1|Physician Decision|0|||
105679794|NCT03616977|364489762|FG001|Period 1|Physician Decision|1|||
105679795|NCT03616977|364489761|FG000|Period 3|Adverse Event|1|||
105679796|NCT03616977|364489762|FG001|Period 3|Adverse Event|1|||
105679797|NCT02559895|364489763|FG000|Overall Study|Adverse Event|3|||
105679798|NCT02559895|364489764|FG001|Overall Study|Adverse Event|3|||
105679799|NCT02559895|364489765|FG002|Overall Study|Adverse Event|2|||
105679800|NCT02559895|364489766|FG003|Overall Study|Adverse Event|1|||
105679801|NCT02559895|364489763|FG000|Overall Study|Lack of Efficacy|2|||
105679802|NCT02559895|364489764|FG001|Overall Study|Lack of Efficacy|3|||
105679803|NCT02559895|364489765|FG002|Overall Study|Lack of Efficacy|2|||
105679804|NCT02559895|364489766|FG003|Overall Study|Lack of Efficacy|8|||
105679805|NCT02559895|364489763|FG000|Overall Study|Lost to Follow-up|22|||
105679806|NCT02559895|364489764|FG001|Overall Study|Lost to Follow-up|16|||
105679807|NCT02559895|364489765|FG002|Overall Study|Lost to Follow-up|12|||
105679808|NCT02559895|364489766|FG003|Overall Study|Lost to Follow-up|17|||
105679809|NCT02559895|364489763|FG000|Overall Study|Physician Decision|1|||
105679810|NCT02559895|364489764|FG001|Overall Study|Physician Decision|1|||
105679811|NCT02559895|364489765|FG002|Overall Study|Physician Decision|3|||
105679812|NCT02559895|364489766|FG003|Overall Study|Physician Decision|0|||
105679813|NCT02559895|364489763|FG000|Overall Study|Withdrawal by Subject|16|||
105679814|NCT02559895|364489764|FG001|Overall Study|Withdrawal by Subject|9|||
105679815|NCT02559895|364489765|FG002|Overall Study|Withdrawal by Subject|20|||
105679816|NCT02559895|364489766|FG003|Overall Study|Withdrawal by Subject|9|||
105679817|NCT02559895|364489763|FG000|Overall Study|Study Burden|10|||
105679818|NCT02559895|364489764|FG001|Overall Study|Study Burden|16|||
105679819|NCT02559895|364489765|FG002|Overall Study|Study Burden|12|||
105679820|NCT02559895|364489766|FG003|Overall Study|Study Burden|22|||
105679821|NCT02559895|364489763|FG000|Overall Study|Other|1|||
105679822|NCT02559895|364489764|FG001|Overall Study|Other|5|||
105679823|NCT02559895|364489765|FG002|Overall Study|Other|3|||
105679824|NCT02559895|364489766|FG003|Overall Study|Other|3|||
105679825|NCT03683823|364489772|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
105679826|NCT03683823|364489773|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
105679827|NCT03683823|364489772|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
105679828|NCT03683823|364489773|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
105679829|NCT03683823|364489772|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
105679830|NCT03683823|364489773|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
105679831|NCT01049217|364489782|FG000|Overall Study|Adverse Event|2|||
105679832|NCT01049217|364489783|FG001|Overall Study|Adverse Event|1|||
105679833|NCT01049217|364489782|FG000|Overall Study|Lack of Efficacy|1|||
105679834|NCT01049217|364489783|FG001|Overall Study|Lack of Efficacy|1|||
105679835|NCT01049217|364489782|FG000|Overall Study|Lost to Follow-up|3|||
106127740|NCT01474512|366125547|FG016|Long-Term Extension Period|Adverse Event|0|||
106127741|NCT01474512|366125548|FG017|Long-Term Extension Period|Adverse Event|0|||
105679836|NCT01049217|364489783|FG001|Overall Study|Lost to Follow-up|8|||
105679837|NCT01049217|364489782|FG000|Overall Study|Withdrawal by Subject|4|||
105679838|NCT01049217|364489783|FG001|Overall Study|Withdrawal by Subject|3|||
105679839|NCT01049217|364489782|FG000|Overall Study|Protocol Violation|1|||
105679840|NCT01049217|364489783|FG001|Overall Study|Protocol Violation|3|||
105679841|NCT01049217|364489782|FG000|Overall Study|Pregnancy|1|||
105679842|NCT01049217|364489783|FG001|Overall Study|Pregnancy|0|||
105679843|NCT01049217|364489782|FG000|Overall Study|Study Terminated by Sponsor|43|||
105679844|NCT01049217|364489783|FG001|Overall Study|Study Terminated by Sponsor|43|||
105679845|NCT01049217|364489782|FG000|Overall Study|Other|1|||
105679846|NCT01049217|364489783|FG001|Overall Study|Other|2|||
105679847|NCT01049217|364489782|FG000|Overall Study|Randomized but not Treated|0|||
105679848|NCT01049217|364489783|FG001|Overall Study|Randomized but not Treated|2|||
105679849|NCT00589121|364489784|FG000|Overall Study|Protocol Violation|2|||
105679850|NCT00589121|364489785|FG001|Overall Study|Protocol Violation|6|||
105679851|NCT00589121|364489784|FG000|Overall Study|No protocol treatment received|0|||
105679852|NCT00589121|364489785|FG001|Overall Study|No protocol treatment received|1|||
105679853|NCT00112047|364489790|FG000|Randomized Phase|Lost to Follow-up|26|||
105679854|NCT00112047|364489791|FG001|Randomized Phase|Lost to Follow-up|33|||
105679855|NCT00112047|364489790|FG000|Randomized Phase|Adverse Event|10|||
105679856|NCT00112047|364489791|FG001|Randomized Phase|Adverse Event|10|||
105679857|NCT00112047|364489790|FG000|Randomized Phase|Withrawal of consent|10|||
105679858|NCT00112047|364489791|FG001|Randomized Phase|Withrawal of consent|18|||
105679859|NCT00112047|364489790|FG000|Randomized Phase|Sub-optimal virological response|3|||
105679860|NCT00112047|364489791|FG001|Randomized Phase|Sub-optimal virological response|13|||
105679861|NCT00112047|364489790|FG000|Randomized Phase|Noncompliance|8|||
105679862|NCT00112047|364489791|FG001|Randomized Phase|Noncompliance|4|||
105679863|NCT00112047|364489790|FG000|Randomized Phase|Protocol Violation|2|||
105679864|NCT00112047|364489791|FG001|Randomized Phase|Protocol Violation|0|||
105679865|NCT00112047|364489790|FG000|Randomized Phase|Pregnancy|3|||
105679866|NCT00112047|364489791|FG001|Randomized Phase|Pregnancy|1|||
105679867|NCT00112047|364489790|FG000|Randomized Phase|Death|1|||
105679868|NCT00112047|364489791|FG001|Randomized Phase|Death|3|||
106127742|NCT01474512|366125531|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
106127743|NCT01474512|366125532|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
106127744|NCT01474512|366125533|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
106127745|NCT01474512|366125534|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
106127746|NCT01474512|366125535|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
106127747|NCT01474512|366125536|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
106127748|NCT01474512|366125537|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
106127749|NCT01474512|366125538|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
106127750|NCT01474512|366125539|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
106127751|NCT01474512|366125540|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
106127752|NCT01474512|366125541|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
106127753|NCT01474512|366125542|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
106127754|NCT01474512|366125543|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
106127755|NCT01474512|366125544|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
106127756|NCT01474512|366125545|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
106127757|NCT01474512|366125546|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
106127758|NCT01474512|366125547|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
106127759|NCT01474512|366125548|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
106127760|NCT01474512|366125531|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
106127761|NCT01474512|366125532|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
106127762|NCT01474512|366125533|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
106127763|NCT01474512|366125534|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
106127764|NCT01474512|366125535|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
106127765|NCT01474512|366125536|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
106127766|NCT01474512|366125537|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
106127767|NCT01474512|366125538|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
106127768|NCT01474512|366125539|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
106127769|NCT01474512|366125540|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
106127770|NCT01474512|366125541|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
106127771|NCT01474512|366125542|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
106127772|NCT01474512|366125543|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
106127773|NCT01474512|366125544|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
106127774|NCT01474512|366125545|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
106127775|NCT01474512|366125546|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
105679869|NCT00112047|364489790|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
105679870|NCT00112047|364489791|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
105679871|NCT00112047|364489790|FG000|Randomized Phase|Inability to swallow pills|0|||
105679872|NCT00112047|364489791|FG001|Randomized Phase|Inability to swallow pills|1|||
105679873|NCT00112047|364489790|FG000|Randomized Phase|Incarceration|3|||
105679874|NCT00112047|364489791|FG001|Randomized Phase|Incarceration|2|||
105679875|NCT00112047|364489790|FG000|Randomized Phase|Moved out of State|0|||
106127776|NCT01474512|366125547|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
106127777|NCT01474512|366125548|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
105679876|NCT00112047|364489791|FG001|Randomized Phase|Moved out of State|1|||
105679877|NCT00112047|364489790|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
105679878|NCT00112047|364489791|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
105679879|NCT00112047|364489790|FG000|Randomized Phase|High Hepatitis B DNA|0|||
105679880|NCT00112047|364489791|FG001|Randomized Phase|High Hepatitis B DNA|1|||
106000871|NCT04862065|365665170|FG001|Screening|Insufficient Sample|0|||
106000872|NCT04862065|365665171|FG002|Screening|Insufficient Sample|0|||
106000873|NCT04862065|365665169|FG000|Follow-Up|Lost to Follow-up|3|||
106000874|NCT04862065|365665170|FG001|Follow-Up|Lost to Follow-up|0|||
106000875|NCT04862065|365665171|FG002|Follow-Up|Lost to Follow-up|0|||
106000876|NCT03244917|365665172|FG000|Overall Study|Lost to Follow-up|2|||
105679881|NCT00112047|364489790|FG000|Atripla Phase|Adverse Event|2|||
105679882|NCT00112047|364489791|FG001|Atripla Phase|Adverse Event|1|||
105679883|NCT00112047|364489790|FG000|Atripla Phase|Lost to Follow-up|5|||
105679884|NCT00112047|364489791|FG001|Atripla Phase|Lost to Follow-up|7|||
105916161|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
105916162|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105916163|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
105916164|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105916165|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105916166|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105916167|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105916168|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
105916169|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105916170|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
105916171|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105916172|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105916173|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105916174|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105916175|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105916176|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
105916177|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
105916178|NCT01791595|365352924|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105916179|NCT01791595|365352925|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105916180|NCT01791595|365352926|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105916181|NCT01791595|365352927|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105916182|NCT01791595|365352928|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105916183|NCT01791595|365352929|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
105916184|NCT01791595|365352930|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
105916185|NCT01791595|365352924|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105916186|NCT01791595|365352925|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105916187|NCT01791595|365352926|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105916188|NCT01791595|365352927|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105916189|NCT01791595|365352928|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105916190|NCT01791595|365352929|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
105916191|NCT01791595|365352930|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
105916192|NCT01791595|365352924|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105916193|NCT01791595|365352925|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105916194|NCT01791595|365352926|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105916195|NCT01791595|365352927|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105916196|NCT01791595|365352928|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105916197|NCT01791595|365352929|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
105916198|NCT01791595|365352930|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
105916199|NCT01791595|365352924|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105916200|NCT01791595|365352925|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105916201|NCT01791595|365352926|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105916202|NCT01791595|365352927|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105916203|NCT01791595|365352928|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
105916204|NCT01791595|365352929|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
106000877|NCT03244917|365665173|FG001|Overall Study|Lost to Follow-up|2|||
106000878|NCT00255190|365665174|FG000|Overall Study|Adverse Event|17|||
106000879|NCT00255190|365665175|FG001|Overall Study|Adverse Event|36|||
106000880|NCT00255190|365665174|FG000|Overall Study|Protocol Violation|2|||
105679885|NCT00112047|364489790|FG000|Atripla Phase|Pregnancy|0|||
105679886|NCT00112047|364489791|FG001|Atripla Phase|Pregnancy|1|||
105679887|NCT00112047|364489790|FG000|Atripla Phase|Death|0|||
105679888|NCT00112047|364489791|FG001|Atripla Phase|Death|2|||
105679889|NCT00112047|364489790|FG000|Atripla Phase|Withdrew consent|7|||
106127778|NCT01474512|366125531|FG000|Long-Term Extension Period|Physician Decision|0|||
105679890|NCT00112047|364489791|FG001|Atripla Phase|Withdrew consent|7|||
105679891|NCT00112047|364489790|FG000|Atripla Phase|Sub-optimal virological response|0|||
105679892|NCT00112047|364489791|FG001|Atripla Phase|Sub-optimal virological response|1|||
105679893|NCT00112047|364489790|FG000|Atripla Phase|Non-compliance|1|||
105679894|NCT00112047|364489791|FG001|Atripla Phase|Non-compliance|0|||
105679895|NCT00112047|364489790|FG000|Atripla Phase|Other|3|||
105679896|NCT00112047|364489791|FG001|Atripla Phase|Other|1|||
105679897|NCT01307579|364489792|FG000|Overall Study|Death|3|||
105679898|NCT01307579|364489793|FG001|Overall Study|Death|6|||
105679899|NCT01307579|364489792|FG000|Overall Study|Physician Decision|26|||
105679900|NCT01307579|364489793|FG001|Overall Study|Physician Decision|29|||
105679901|NCT01307579|364489792|FG000|Overall Study|Withdrawal by Subject|7|||
105679902|NCT01307579|364489793|FG001|Overall Study|Withdrawal by Subject|3|||
105679903|NCT01307579|364489792|FG000|Overall Study|Institutional diagnosis of IFD|21|||
105679904|NCT01307579|364489793|FG001|Overall Study|Institutional diagnosis of IFD|36|||
105679905|NCT01307579|364489792|FG000|Overall Study|Begin conditioning for HSCT|42|||
105679906|NCT01307579|364489793|FG001|Overall Study|Begin conditioning for HSCT|44|||
105679907|NCT01307579|364489792|FG000|Overall Study|Refractory or relapsed AML|38|||
105679908|NCT01307579|364489793|FG001|Overall Study|Refractory or relapsed AML|23|||
105679909|NCT01307579|364489792|FG000|Overall Study|Ineligible|3|||
105679910|NCT01307579|364489793|FG001|Overall Study|Ineligible|4|||
105679911|NCT00812331|364491355|FG000|Overall Study|Adverse Event|1|||
105679912|NCT00812331|364491356|FG001|Overall Study|Adverse Event|0|||
105679913|NCT00812331|364491357|FG002|Overall Study|Adverse Event|0|||
105679914|NCT00812331|364491358|FG003|Overall Study|Adverse Event|0|||
105679915|NCT00812331|364491359|FG004|Overall Study|Adverse Event|0|||
105679916|NCT01034176|364491360|FG000|Overall Study|Physician Decision|2|||
105679917|NCT01034176|364491361|FG001|Overall Study|Physician Decision|0|||
105679918|NCT01034176|364491360|FG000|Overall Study|Withdrawal by Subject|0|||
105679919|NCT01034176|364491361|FG001|Overall Study|Withdrawal by Subject|1|||
105679920|NCT01034176|364491360|FG000|Overall Study|Lost to Follow-up|0|||
105679921|NCT01034176|364491361|FG001|Overall Study|Lost to Follow-up|1|||
105679922|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
105679923|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
105679924|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
105679925|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
105679926|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
105679927|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
105679928|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
105679929|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
105679930|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
105679931|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
105679932|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
105679933|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
105679934|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
105916205|NCT01791595|365352930|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
105916206|NCT01791595|365352924|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105916207|NCT01791595|365352925|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105916208|NCT01791595|365352926|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105916209|NCT01791595|365352927|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105916210|NCT01791595|365352928|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105916211|NCT01791595|365352929|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
105916212|NCT01791595|365352930|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
105916213|NCT03118934|365352931|FG000|Overall Study|Adverse Event|0|||
105916214|NCT03118934|365352932|FG001|Overall Study|Adverse Event|0|||
105916215|NCT03118934|365352933|FG002|Overall Study|Adverse Event|0|||
105916216|NCT03118934|365352934|FG003|Overall Study|Adverse Event|0|||
105916217|NCT03118934|365352935|FG004|Overall Study|Adverse Event|0|||
106127779|NCT01474512|366125532|FG001|Long-Term Extension Period|Physician Decision|0|||
106127780|NCT01474512|366125533|FG002|Long-Term Extension Period|Physician Decision|0|||
106127781|NCT01474512|366125534|FG003|Long-Term Extension Period|Physician Decision|0|||
106127782|NCT01474512|366125535|FG004|Long-Term Extension Period|Physician Decision|0|||
105679935|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
105679936|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
105679937|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
105679938|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
105679939|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
105679940|NCT02480153|364491367|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
105679941|NCT02480153|364491368|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
105679942|NCT02480153|364491369|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
105679943|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
106000881|NCT00255190|365665175|FG001|Overall Study|Protocol Violation|2|||
106000882|NCT00255190|365665174|FG000|Overall Study|Lost to Follow-up|10|||
106000883|NCT00255190|365665175|FG001|Overall Study|Lost to Follow-up|27|||
106000884|NCT00255190|365665174|FG000|Overall Study|Withdrew Consent|17|||
106000885|NCT00255190|365665175|FG001|Overall Study|Withdrew Consent|48|||
106000886|NCT00255190|365665174|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
106000887|NCT00255190|365665175|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
106000888|NCT00255190|365665174|FG000|Overall Study|Erosive esophagitis not healed|0|||
106000889|NCT00255190|365665175|FG001|Overall Study|Erosive esophagitis not healed|20|||
106000890|NCT00255190|365665174|FG000|Overall Study|Various|4|||
106000891|NCT00255190|365665175|FG001|Overall Study|Various|23|||
106000892|NCT02903914|365665176|FG000|Overall Study|Adverse Event|0|||
106000893|NCT02903914|365665177|FG001|Overall Study|Adverse Event|0|||
106000894|NCT02903914|365665178|FG002|Overall Study|Adverse Event|1|||
106000895|NCT02903914|365665179|FG003|Overall Study|Adverse Event|0|||
106000896|NCT02903914|365665180|FG004|Overall Study|Adverse Event|0|||
106000897|NCT02903914|365665181|FG005|Overall Study|Adverse Event|0|||
106000898|NCT02903914|365665182|FG006|Overall Study|Adverse Event|2|||
106000899|NCT02903914|365665183|FG007|Overall Study|Adverse Event|0|||
106000900|NCT02903914|365665176|FG000|Overall Study|Withdrawal by Subject|3|||
106000901|NCT02903914|365665177|FG001|Overall Study|Withdrawal by Subject|1|||
106000902|NCT02903914|365665178|FG002|Overall Study|Withdrawal by Subject|28|||
106000903|NCT02903914|365665179|FG003|Overall Study|Withdrawal by Subject|0|||
106000904|NCT02903914|365665180|FG004|Overall Study|Withdrawal by Subject|1|||
106000905|NCT02903914|365665181|FG005|Overall Study|Withdrawal by Subject|2|||
106000906|NCT02903914|365665182|FG006|Overall Study|Withdrawal by Subject|12|||
106000907|NCT02903914|365665183|FG007|Overall Study|Withdrawal by Subject|0|||
106000908|NCT02903914|365665176|FG000|Overall Study|Progressive Disease|1|||
106000909|NCT02903914|365665177|FG001|Overall Study|Progressive Disease|0|||
106000910|NCT02903914|365665178|FG002|Overall Study|Progressive Disease|4|||
106000911|NCT02903914|365665179|FG003|Overall Study|Progressive Disease|0|||
106000912|NCT02903914|365665180|FG004|Overall Study|Progressive Disease|0|||
106000913|NCT02903914|365665181|FG005|Overall Study|Progressive Disease|0|||
106000914|NCT02903914|365665182|FG006|Overall Study|Progressive Disease|2|||
106000915|NCT02903914|365665183|FG007|Overall Study|Progressive Disease|0|||
106000916|NCT02903914|365665176|FG000|Overall Study|Death|0|||
106000917|NCT02903914|365665177|FG001|Overall Study|Death|0|||
106000918|NCT02903914|365665178|FG002|Overall Study|Death|9|||
106000919|NCT02903914|365665179|FG003|Overall Study|Death|0|||
106000920|NCT02903914|365665180|FG004|Overall Study|Death|1|||
106000921|NCT02903914|365665181|FG005|Overall Study|Death|3|||
106000922|NCT02903914|365665182|FG006|Overall Study|Death|24|||
106000923|NCT02903914|365665183|FG007|Overall Study|Death|2|||
106000924|NCT02903914|365665176|FG000|Overall Study|Lost to Follow-up|0|||
106000925|NCT02903914|365665177|FG001|Overall Study|Lost to Follow-up|1|||
106000926|NCT02903914|365665178|FG002|Overall Study|Lost to Follow-up|0|||
106000927|NCT02903914|365665179|FG003|Overall Study|Lost to Follow-up|0|||
106000928|NCT02903914|365665180|FG004|Overall Study|Lost to Follow-up|2|||
106000929|NCT02903914|365665181|FG005|Overall Study|Lost to Follow-up|0|||
106000930|NCT02903914|365665182|FG006|Overall Study|Lost to Follow-up|1|||
106127783|NCT01474512|366125536|FG005|Long-Term Extension Period|Physician Decision|0|||
106127784|NCT01474512|366125537|FG006|Long-Term Extension Period|Physician Decision|0|||
106127785|NCT01474512|366125538|FG007|Long-Term Extension Period|Physician Decision|0|||
106127786|NCT01474512|366125539|FG008|Long-Term Extension Period|Physician Decision|0|||
106127787|NCT01474512|366125540|FG009|Long-Term Extension Period|Physician Decision|0|||
106127788|NCT01474512|366125541|FG010|Long-Term Extension Period|Physician Decision|0|||
106127789|NCT01474512|366125542|FG011|Long-Term Extension Period|Physician Decision|0|||
106127790|NCT01474512|366125543|FG012|Long-Term Extension Period|Physician Decision|21|||
106127791|NCT01474512|366125544|FG013|Long-Term Extension Period|Physician Decision|21|||
106127792|NCT01474512|366125545|FG014|Long-Term Extension Period|Physician Decision|0|||
106000931|NCT02903914|365665183|FG007|Overall Study|Lost to Follow-up|0|||
106000932|NCT02903914|365665176|FG000|Overall Study|Physician Decision|0|||
106000933|NCT02903914|365665177|FG001|Overall Study|Physician Decision|0|||
106127793|NCT01474512|366125546|FG015|Long-Term Extension Period|Physician Decision|0|||
106000934|NCT02903914|365665178|FG002|Overall Study|Physician Decision|1|||
106000935|NCT02903914|365665179|FG003|Overall Study|Physician Decision|0|||
106000936|NCT02903914|365665180|FG004|Overall Study|Physician Decision|0|||
106000937|NCT02903914|365665181|FG005|Overall Study|Physician Decision|0|||
106000938|NCT02903914|365665182|FG006|Overall Study|Physician Decision|1|||
106000939|NCT02903914|365665183|FG007|Overall Study|Physician Decision|0|||
106000940|NCT02903914|365665176|FG000|Overall Study|Symptomatic Deterioration|0|||
106000941|NCT02903914|365665177|FG001|Overall Study|Symptomatic Deterioration|0|||
106000942|NCT02903914|365665178|FG002|Overall Study|Symptomatic Deterioration|1|||
105679944|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
105679945|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
105679946|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
105679947|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
105679948|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
105679949|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
105679950|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
105679951|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
105679952|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
105679953|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
105679954|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
105679955|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
105679956|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
105679957|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
105679958|NCT02480153|364491367|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
105679959|NCT02480153|364491368|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
105679960|NCT02480153|364491369|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
105679961|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
105679962|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
105679963|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
105679964|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
105679965|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
105679966|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
105679967|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
105679968|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
105679969|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
105679970|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
105679971|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
105679972|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
105679973|NCT02480153|364491367|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
105679974|NCT02480153|364491368|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
105679975|NCT02480153|364491369|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
105679976|NCT00297232|364491374|FG000|Overall Study|Lack of Efficacy|7|||
105679977|NCT00297232|364491374|FG000|Overall Study|Lost to Follow-up|10|||
105679978|NCT00297232|364491374|FG000|Overall Study|Adverse Event|63|||
105679979|NCT00297232|364491374|FG000|Overall Study|Voluntary Withdrawal|120|||
105679980|NCT00297232|364491374|FG000|Overall Study|Subject was Noncompliant|9|||
105679981|NCT00297232|364491374|FG000|Overall Study|Death|9|||
105679982|NCT00297232|364491374|FG000|Overall Study|Anti-natalizumab Positive|8|||
105679983|NCT00297232|364491374|FG000|Overall Study|Switched to Commercial Tysabri|22|||
105679984|NCT00297232|364491374|FG000|Overall Study|Disease Progression|8|||
105679985|NCT00297232|364491374|FG000|Overall Study|Fear of PML|10|||
105679986|NCT00297232|364491374|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
105679987|NCT00297232|364491374|FG000|Overall Study|Miscellaneous|5|||
105679988|NCT00297232|364491374|FG000|Overall Study|Sponsor Decision|34|||
105679989|NCT00297232|364491374|FG000|Overall Study|Subject Relocated|7|||
105679990|NCT00297232|364491374|FG000|Overall Study|Subject Withdrew Consent|37|||
105679991|NCT00297232|364491374|FG000|Overall Study|Persistently Positive Antibodies|11|||
105679992|NCT00297232|364491374|FG000|Overall Study|Investigator Withdrew From Program|19|||
105679993|NCT00297232|364491374|FG000|Overall Study|Did Not Enroll to Week 264|34|||
105679994|NCT00297232|364491374|FG000|Overall Study|Did Not Enroll to Week 480|17|||
105679995|NCT00297232|364491374|FG000|Overall Study|No data available after Week 264|161|||
105679996|NCT00297232|364491374|FG000|Overall Study|Other|1|||
105679997|NCT02257567|364491375|FG000|Overall Study|Adverse Event|0|||
105679998|NCT02257567|364491376|FG001|Overall Study|Adverse Event|0|||
105679999|NCT02257567|364491377|FG002|Overall Study|Adverse Event|0|||
105680000|NCT02257567|364491378|FG003|Overall Study|Adverse Event|1|||
105680001|NCT02257567|364491379|FG004|Overall Study|Adverse Event|1|||
105680002|NCT02257567|364491380|FG005|Overall Study|Adverse Event|0|||
105680003|NCT02257567|364491381|FG006|Overall Study|Adverse Event|0|||
105680004|NCT02257567|364491382|FG007|Overall Study|Adverse Event|0|||
105916218|NCT03118934|365352936|FG005|Overall Study|Adverse Event|1|||
105680005|NCT02257567|364491383|FG008|Overall Study|Adverse Event|1|||
105680006|NCT02257567|364491384|FG009|Overall Study|Adverse Event|0|||
105680007|NCT02257567|364491385|FG010|Overall Study|Adverse Event|0|||
105916219|NCT03118934|365352931|FG000|Overall Study|Physician Decision|0|||
105680008|NCT02257567|364491375|FG000|Overall Study|Death|2|||
105680009|NCT02257567|364491376|FG001|Overall Study|Death|2|||
105916220|NCT03118934|365352932|FG001|Overall Study|Physician Decision|0|||
105680010|NCT02257567|364491377|FG002|Overall Study|Death|2|||
105680011|NCT02257567|364491378|FG003|Overall Study|Death|4|||
105680012|NCT02257567|364491379|FG004|Overall Study|Death|15|||
105680013|NCT02257567|364491380|FG005|Overall Study|Death|11|||
105680014|NCT02257567|364491381|FG006|Overall Study|Death|26|||
105680015|NCT02257567|364491382|FG007|Overall Study|Death|30|||
105680016|NCT02257567|364491383|FG008|Overall Study|Death|2|||
105680017|NCT02257567|364491384|FG009|Overall Study|Death|18|||
105680018|NCT02257567|364491385|FG010|Overall Study|Death|65|||
105680019|NCT02257567|364491375|FG000|Overall Study|Lost to Follow-up|0|||
105680020|NCT02257567|364491376|FG001|Overall Study|Lost to Follow-up|0|||
105680021|NCT02257567|364491377|FG002|Overall Study|Lost to Follow-up|0|||
105680022|NCT02257567|364491378|FG003|Overall Study|Lost to Follow-up|0|||
105680023|NCT02257567|364491379|FG004|Overall Study|Lost to Follow-up|2|||
105680024|NCT02257567|364491380|FG005|Overall Study|Lost to Follow-up|2|||
105680025|NCT02257567|364491381|FG006|Overall Study|Lost to Follow-up|0|||
105680026|NCT02257567|364491382|FG007|Overall Study|Lost to Follow-up|0|||
105680027|NCT02257567|364491383|FG008|Overall Study|Lost to Follow-up|0|||
105680028|NCT02257567|364491384|FG009|Overall Study|Lost to Follow-up|1|||
105680029|NCT02257567|364491385|FG010|Overall Study|Lost to Follow-up|1|||
105680030|NCT02257567|364491375|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680031|NCT02257567|364491376|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680032|NCT02257567|364491377|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680033|NCT02257567|364491378|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680034|NCT02257567|364491379|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
105680035|NCT02257567|364491380|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680036|NCT02257567|364491381|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
105680037|NCT02257567|364491382|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680038|NCT02257567|364491383|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680039|NCT02257567|364491384|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680040|NCT02257567|364491385|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
105680041|NCT02257567|364491375|FG000|Overall Study|Physician Decision|0|||
105680042|NCT02257567|364491376|FG001|Overall Study|Physician Decision|0|||
105680043|NCT02257567|364491377|FG002|Overall Study|Physician Decision|0|||
105680044|NCT02257567|364491378|FG003|Overall Study|Physician Decision|0|||
105680045|NCT02257567|364491379|FG004|Overall Study|Physician Decision|0|||
105680046|NCT02257567|364491380|FG005|Overall Study|Physician Decision|0|||
105680047|NCT02257567|364491381|FG006|Overall Study|Physician Decision|0|||
105680048|NCT02257567|364491382|FG007|Overall Study|Physician Decision|2|||
105680049|NCT02257567|364491383|FG008|Overall Study|Physician Decision|0|||
105680050|NCT02257567|364491384|FG009|Overall Study|Physician Decision|1|||
105680051|NCT02257567|364491385|FG010|Overall Study|Physician Decision|0|||
105680052|NCT02257567|364491375|FG000|Overall Study|Withdrawal by Subject|0|||
105680053|NCT02257567|364491376|FG001|Overall Study|Withdrawal by Subject|0|||
105680054|NCT02257567|364491377|FG002|Overall Study|Withdrawal by Subject|2|||
105680055|NCT02257567|364491378|FG003|Overall Study|Withdrawal by Subject|0|||
105680056|NCT02257567|364491379|FG004|Overall Study|Withdrawal by Subject|0|||
105680057|NCT02257567|364491380|FG005|Overall Study|Withdrawal by Subject|6|||
105680058|NCT02257567|364491381|FG006|Overall Study|Withdrawal by Subject|6|||
105680059|NCT02257567|364491382|FG007|Overall Study|Withdrawal by Subject|6|||
105680060|NCT02257567|364491383|FG008|Overall Study|Withdrawal by Subject|1|||
105680061|NCT02257567|364491384|FG009|Overall Study|Withdrawal by Subject|1|||
105680062|NCT02257567|364491385|FG010|Overall Study|Withdrawal by Subject|10|||
105680063|NCT02313233|364491386|FG000|Overall Study|Withdrawal by Subject|1|||
105680064|NCT02313233|364491387|FG001|Overall Study|Withdrawal by Subject|2|||
105680065|NCT02313233|364491386|FG000|Overall Study|Administrative reason|1|||
105680066|NCT02313233|364491387|FG001|Overall Study|Administrative reason|1|||
105680067|NCT00964886|364491388|FG000|Overall Study|Lost to Follow-up|2|||
105680068|NCT00964886|364491389|FG001|Overall Study|Lost to Follow-up|2|||
105680069|NCT00964886|364491390|FG002|Overall Study|Lost to Follow-up|6|||
105680070|NCT00964886|364491391|FG003|Overall Study|Lost to Follow-up|4|||
105680071|NCT00964886|364491388|FG000|Overall Study|Withdrawal by Subject|6|||
105680072|NCT00964886|364491389|FG001|Overall Study|Withdrawal by Subject|2|||
105680073|NCT00964886|364491390|FG002|Overall Study|Withdrawal by Subject|5|||
105680074|NCT00964886|364491391|FG003|Overall Study|Withdrawal by Subject|3|||
105680075|NCT00964886|364491388|FG000|Overall Study|Adverse Event|3|||
105680076|NCT00964886|364491389|FG001|Overall Study|Adverse Event|1|||
105680077|NCT00964886|364491390|FG002|Overall Study|Adverse Event|5|||
105916221|NCT03118934|365352933|FG002|Overall Study|Physician Decision|0|||
105916222|NCT03118934|365352934|FG003|Overall Study|Physician Decision|0|||
105916223|NCT03118934|365352935|FG004|Overall Study|Physician Decision|0|||
105916224|NCT03118934|365352936|FG005|Overall Study|Physician Decision|1|||
105916225|NCT03118934|365352931|FG000|Overall Study|Discontinued prior to exposure|0|||
105680078|NCT00964886|364491391|FG003|Overall Study|Adverse Event|2|||
105680079|NCT00964886|364491388|FG000|Overall Study|Protocol Violation|0|||
105680080|NCT00964886|364491389|FG001|Overall Study|Protocol Violation|2|||
105680081|NCT00964886|364491390|FG002|Overall Study|Protocol Violation|0|||
105680082|NCT00964886|364491391|FG003|Overall Study|Protocol Violation|0|||
105680083|NCT00523640|364491393|FG000|Overall Study|Death|1|||
105680084|NCT00564889|364491397|FG000|Overall Study|Death|7|||
105680085|NCT00564889|364491397|FG000|Overall Study|Adverse Event|12|||
105680086|NCT00564889|364491397|FG000|Overall Study|Alternative treatment|3|||
105680087|NCT00564889|364491397|FG000|Overall Study|Disease progression|3|||
105680088|NCT00564889|364491397|FG000|Overall Study|Other, not specified|4|||
105680089|NCT03484273|364491402|FG000|Overall Study|Equipment Malfunction|1|||
105680090|NCT03484273|364491402|FG000|Overall Study|Data excluded from analysis|1|||
105680091|NCT00069108|364491403|FG000|Overall Study|Withdrawal by Subject|5|||
105680092|NCT00069108|364491404|FG001|Overall Study|Withdrawal by Subject|9|||
105680093|NCT00069108|364491403|FG000|Overall Study|Adverse Event|64|||
105680094|NCT00069108|364491404|FG001|Overall Study|Adverse Event|42|||
105680095|NCT00069108|364491403|FG000|Overall Study|Death|6|||
105680096|NCT00069108|364491404|FG001|Overall Study|Death|6|||
105680097|NCT00069108|364491403|FG000|Overall Study|Administration|15|||
105680098|NCT00069108|364491404|FG001|Overall Study|Administration|4|||
105680099|NCT00069108|364491403|FG000|Overall Study|Insufficient therapy|117|||
105680100|NCT00069108|364491404|FG001|Overall Study|Insufficient therapy|144|||
105680101|NCT00069108|364491403|FG000|Overall Study|Violation criteria|1|||
105680102|NCT00069108|364491404|FG001|Overall Study|Violation criteria|4|||
105680103|NCT00069108|364491403|FG000|Overall Study|Refused treatment|5|||
105680104|NCT00069108|364491404|FG001|Overall Study|Refused treatment|10|||
105680105|NCT01065844|364491405|FG000|Overall Study|Adverse Event|5|||
105680106|NCT00552240|364491408|FG000|Overall Study|Adverse Event|9|||
105680107|NCT00552240|364491409|FG001|Overall Study|Adverse Event|9|||
105680108|NCT00552240|364491408|FG000|Overall Study|Protocol Violation|1|||
105680109|NCT00552240|364491409|FG001|Overall Study|Protocol Violation|1|||
105680110|NCT00552240|364491408|FG000|Overall Study|Lost to Follow-up|5|||
105680111|NCT00552240|364491409|FG001|Overall Study|Lost to Follow-up|6|||
105680112|NCT00552240|364491408|FG000|Overall Study|Withdrawal by Subject|2|||
105680113|NCT00552240|364491409|FG001|Overall Study|Withdrawal by Subject|2|||
105680114|NCT00552240|364491408|FG000|Overall Study|Lack of Efficacy|6|||
105680115|NCT00552240|364491409|FG001|Overall Study|Lack of Efficacy|0|||
105680116|NCT00552240|364491408|FG000|Overall Study|Other|1|||
105680117|NCT00552240|364491409|FG001|Overall Study|Other|0|||
105680118|NCT02476279|364491413|FG000|Overall Study|Lost to Follow-up|1|||
105680119|NCT02476279|364491414|FG001|Overall Study|Lost to Follow-up|1|||
105680120|NCT01415531|364491419|FG000|Overall Study|Adverse Event|7|||
105680121|NCT01415531|364491420|FG001|Overall Study|Adverse Event|10|||
105680122|NCT01415531|364491419|FG000|Overall Study|Lack of Efficacy|3|||
105680123|NCT01415531|364491420|FG001|Overall Study|Lack of Efficacy|2|||
105680124|NCT01415531|364491419|FG000|Overall Study|Protocol Violation|0|||
105680125|NCT01415531|364491420|FG001|Overall Study|Protocol Violation|1|||
105680126|NCT01415531|364491419|FG000|Overall Study|Withdrawal by Subject|5|||
105680127|NCT01415531|364491420|FG001|Overall Study|Withdrawal by Subject|4|||
105680128|NCT01415531|364491419|FG000|Overall Study|Lost to Follow-up|6|||
105916226|NCT03118934|365352932|FG001|Overall Study|Discontinued prior to exposure|1|||
105916227|NCT03118934|365352933|FG002|Overall Study|Discontinued prior to exposure|1|||
105916228|NCT03118934|365352934|FG003|Overall Study|Discontinued prior to exposure|1|||
105916229|NCT03118934|365352935|FG004|Overall Study|Discontinued prior to exposure|2|||
105916230|NCT03118934|365352936|FG005|Overall Study|Discontinued prior to exposure|0|||
105916231|NCT03080935|365352937|FG000|Overall Study|Death|34|||
105916232|NCT03080935|365352938|FG001|Overall Study|Death|50|||
105916233|NCT03080935|365352937|FG000|Overall Study|Lost to Follow-up|5|||
105916234|NCT03080935|365352938|FG001|Overall Study|Lost to Follow-up|4|||
105916235|NCT03080935|365352937|FG000|Overall Study|Withdrawal by Subject|11|||
106000943|NCT02903914|365665179|FG003|Overall Study|Symptomatic Deterioration|0|||
106000944|NCT02903914|365665180|FG004|Overall Study|Symptomatic Deterioration|0|||
106000945|NCT02903914|365665181|FG005|Overall Study|Symptomatic Deterioration|0|||
106000946|NCT02903914|365665182|FG006|Overall Study|Symptomatic Deterioration|0|||
106127794|NCT01474512|366125547|FG016|Long-Term Extension Period|Physician Decision|0|||
105680129|NCT01415531|364491420|FG001|Overall Study|Lost to Follow-up|14|||
105680130|NCT01415531|364491419|FG000|Overall Study|Lack of Compliance|1|||
105680131|NCT01415531|364491420|FG001|Overall Study|Lack of Compliance|4|||
105680132|NCT01415531|364491419|FG000|Overall Study|Other Reasons|3|||
105680133|NCT01415531|364491420|FG001|Overall Study|Other Reasons|2|||
105680134|NCT02706899|364491422|FG000|Overall Study|Withdrawal by Subject|1|||
105680135|NCT02706899|364491423|FG001|Overall Study|Withdrawal by Subject|0|||
105916236|NCT03080935|365352938|FG001|Overall Study|Withdrawal by Subject|15|||
105916237|NCT02848664|365352942|FG000|Overall Study|Withdrawal by Subject|2|||
106127795|NCT01474512|366125548|FG017|Long-Term Extension Period|Physician Decision|0|||
105680136|NCT02706899|364491422|FG000|Overall Study|Death|8|||
105680137|NCT02706899|364491423|FG001|Overall Study|Death|0|||
105680138|NCT02706899|364491422|FG000|Overall Study|Study Termination by Sponsor|4|||
105680139|NCT02706899|364491423|FG001|Overall Study|Study Termination by Sponsor|6|||
105680140|NCT00577473|364491426|FG000|Overall Study|Protocol Violation|1|||
105680141|NCT00577473|364491427|FG001|Overall Study|Protocol Violation|4|||
105680142|NCT00577473|364491426|FG000|Overall Study|Adverse Event|8|||
105680143|NCT00577473|364491427|FG001|Overall Study|Adverse Event|5|||
105680144|NCT00577473|364491426|FG000|Overall Study|Withdrawal by Subject|2|||
105680145|NCT00577473|364491427|FG001|Overall Study|Withdrawal by Subject|6|||
105680146|NCT00577473|364491426|FG000|Overall Study|Physician Decision|2|||
105680147|NCT00577473|364491427|FG001|Overall Study|Physician Decision|2|||
105680148|NCT00577473|364491426|FG000|Overall Study|Lack of Efficacy|8|||
105680149|NCT00577473|364491427|FG001|Overall Study|Lack of Efficacy|7|||
105680150|NCT01737827|364491436|FG000|Overall Study|Adverse Event|3|||
105680151|NCT01737827|364491437|FG001|Overall Study|Adverse Event|6|||
105680152|NCT01737827|364491438|FG002|Overall Study|Adverse Event|0|||
105680153|NCT01737827|364491436|FG000|Overall Study|Lost to Follow-up|0|||
105680154|NCT01737827|364491437|FG001|Overall Study|Lost to Follow-up|1|||
105680155|NCT01737827|364491438|FG002|Overall Study|Lost to Follow-up|0|||
105680156|NCT01737827|364491436|FG000|Overall Study|Physician Decision|0|||
105680157|NCT01737827|364491437|FG001|Overall Study|Physician Decision|2|||
105680158|NCT01737827|364491438|FG002|Overall Study|Physician Decision|0|||
105680159|NCT01737827|364491436|FG000|Overall Study|Progressive Disease|5|||
105680160|NCT01737827|364491437|FG001|Overall Study|Progressive Disease|16|||
105680161|NCT01737827|364491438|FG002|Overall Study|Progressive Disease|2|||
105680162|NCT01737827|364491436|FG000|Overall Study|Study Terminated by Sponsor|0|||
105680163|NCT01737827|364491437|FG001|Overall Study|Study Terminated by Sponsor|1|||
105680164|NCT01737827|364491438|FG002|Overall Study|Study Terminated by Sponsor|0|||
105680165|NCT01737827|364491436|FG000|Overall Study|Subject/Guardian Decision|0|||
105680166|NCT01737827|364491437|FG001|Overall Study|Subject/Guardian Decision|2|||
105680167|NCT01737827|364491438|FG002|Overall Study|Subject/Guardian Decision|0|||
105680168|NCT00528645|364491441|FG000|Overall Study|Adverse Event|3|||
105680169|NCT01642251|364491442|FG000|Overall Study|Progressive disease|0|||
105680170|NCT01642251|364491443|FG001|Overall Study|Progressive disease|0|||
105680171|NCT01642251|364491444|FG002|Overall Study|Progressive disease|3|||
105680172|NCT01642251|364491445|FG003|Overall Study|Progressive disease|3|||
105680173|NCT01642251|364491442|FG000|Overall Study|Adverse Event|0|||
105680174|NCT01642251|364491443|FG001|Overall Study|Adverse Event|0|||
105680175|NCT01642251|364491444|FG002|Overall Study|Adverse Event|5|||
105680176|NCT01642251|364491445|FG003|Overall Study|Adverse Event|4|||
105680177|NCT01642251|364491442|FG000|Overall Study|Death|0|||
105680178|NCT01642251|364491443|FG001|Overall Study|Death|0|||
105680179|NCT01642251|364491444|FG002|Overall Study|Death|1|||
105680180|NCT01642251|364491445|FG003|Overall Study|Death|3|||
105680181|NCT01642251|364491442|FG000|Overall Study|Withdrawal by Subject|0|||
105680182|NCT01642251|364491443|FG001|Overall Study|Withdrawal by Subject|0|||
105680183|NCT01642251|364491444|FG002|Overall Study|Withdrawal by Subject|1|||
105680184|NCT01642251|364491445|FG003|Overall Study|Withdrawal by Subject|3|||
105680185|NCT01642251|364491442|FG000|Overall Study|Alternative therapy|0|||
105680186|NCT01642251|364491443|FG001|Overall Study|Alternative therapy|0|||
105680187|NCT01642251|364491444|FG002|Overall Study|Alternative therapy|0|||
105680188|NCT01642251|364491445|FG003|Overall Study|Alternative therapy|2|||
105680189|NCT01642251|364491442|FG000|Overall Study|Other complicating disease|0|||
105680190|NCT01642251|364491443|FG001|Overall Study|Other complicating disease|0|||
105680191|NCT01642251|364491444|FG002|Overall Study|Other complicating disease|1|||
105680192|NCT01642251|364491445|FG003|Overall Study|Other complicating disease|0|||
105680193|NCT01642251|364491442|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
105680194|NCT01642251|364491443|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
105680195|NCT01642251|364491444|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
105680196|NCT01642251|364491445|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
105680197|NCT01445301|364491446|FG000|Overall Study|Adverse Event|15|||
105680198|NCT01445301|364491447|FG001|Overall Study|Adverse Event|25|||
105680199|NCT01445301|364491448|FG002|Overall Study|Adverse Event|4|||
105680200|NCT01445301|364491446|FG000|Overall Study|Lack of Efficacy|0|||
105680201|NCT01445301|364491447|FG001|Overall Study|Lack of Efficacy|1|||
105680202|NCT01445301|364491448|FG002|Overall Study|Lack of Efficacy|0|||
105680203|NCT01445301|364491446|FG000|Overall Study|Protocol Violation|1|||
105680204|NCT01445301|364491447|FG001|Overall Study|Protocol Violation|0|||
105680205|NCT01445301|364491448|FG002|Overall Study|Protocol Violation|0|||
105680206|NCT01445301|364491446|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
105680207|NCT01445301|364491447|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
105680208|NCT01445301|364491448|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
105680209|NCT01445301|364491446|FG000|Overall Study|Physician Decision|0|||
105680210|NCT01445301|364491447|FG001|Overall Study|Physician Decision|2|||
105680211|NCT01445301|364491448|FG002|Overall Study|Physician Decision|0|||
105916238|NCT02848664|365352942|FG000|Overall Study|Adverse Event|1|||
105680212|NCT01445301|364491446|FG000|Overall Study|Withdrawal by Subject|5|||
105680213|NCT01445301|364491447|FG001|Overall Study|Withdrawal by Subject|6|||
105916239|NCT02848664|365352942|FG000|Overall Study|no assistance for device training|1|||
105916240|NCT03160716|365352948|FG000|Overall Study|Lost to Follow-up|1|||
105680214|NCT01445301|364491448|FG002|Overall Study|Withdrawal by Subject|4|||
105680215|NCT03143166|364491454|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
105680216|NCT02112708|364491455|FG000|Baseline|Physician Decision|16|||
105680217|NCT02112708|364491456|FG001|Baseline|Physician Decision|11|||
105680218|NCT02112708|364491455|FG000|Baseline|Lost to Follow-up|12|||
105680219|NCT02112708|364491456|FG001|Baseline|Lost to Follow-up|0|||
105680220|NCT02112708|364491455|FG000|4 Month|Death|0|||
105680221|NCT02112708|364491456|FG001|4 Month|Death|1|||
105680222|NCT02112708|364491455|FG000|4 Month|Withdrawal by Subject|12|||
105680223|NCT02112708|364491456|FG001|4 Month|Withdrawal by Subject|0|||
105680224|NCT04540887|364491459|FG000|Overall Study|Withdrawal by Subject|2|||
105680225|NCT02232243|364491460|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
105680226|NCT02232243|364491461|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
105680227|NCT02232243|364491462|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
105680228|NCT00490724|364491463|FG000|Period I|Physician Decision|0|||
105680229|NCT00490724|364491464|FG001|Period I|Physician Decision|0|||
105680230|NCT00490724|364491465|FG002|Period I|Physician Decision|1|||
105680231|NCT00490724|364491463|FG000|Period II|Treatment Discontinuation|3|||
105680232|NCT00490724|364491464|FG001|Period II|Treatment Discontinuation|1|||
105680233|NCT00490724|364491465|FG002|Period II|Treatment Discontinuation|3|||
105680234|NCT01323972|364491466|FG000|Overall Study|Withdrawal by Subject|1|||
105680235|NCT01323972|364491467|FG001|Overall Study|Withdrawal by Subject|0|||
105680236|NCT01323972|364491468|FG002|Overall Study|Withdrawal by Subject|1|||
105680237|NCT01323972|364491469|FG003|Overall Study|Withdrawal by Subject|0|||
105680238|NCT01323972|364491466|FG000|Overall Study|Migrated/moved from study area|1|||
105680239|NCT01323972|364491467|FG001|Overall Study|Migrated/moved from study area|2|||
105680240|NCT01323972|364491468|FG002|Overall Study|Migrated/moved from study area|0|||
105680241|NCT01323972|364491469|FG003|Overall Study|Migrated/moved from study area|0|||
105680242|NCT01323972|364491466|FG000|Overall Study|Lost to Follow-up|0|||
105680243|NCT01323972|364491467|FG001|Overall Study|Lost to Follow-up|1|||
105680244|NCT01323972|364491468|FG002|Overall Study|Lost to Follow-up|1|||
105680245|NCT01323972|364491469|FG003|Overall Study|Lost to Follow-up|1|||
105680246|NCT02008877|364491470|FG000|Overall Study|Inevaluable|0|||
105680247|NCT02008877|364491471|FG001|Overall Study|Inevaluable|1|||
105680248|NCT02008877|364491472|FG002|Overall Study|Inevaluable|0|||
105680249|NCT00126503|364491473|FG000|Overall Study|disease progression|23|||
105680250|NCT00126503|364491474|FG001|Overall Study|disease progression|14|||
105680251|NCT00126503|364491473|FG000|Overall Study|Withdrawal by Subject|0|||
105680252|NCT00126503|364491474|FG001|Overall Study|Withdrawal by Subject|1|||
105680253|NCT00126503|364491473|FG000|Overall Study|alternative therapy|1|||
105680254|NCT00126503|364491474|FG001|Overall Study|alternative therapy|1|||
105680255|NCT00126503|364491473|FG000|Overall Study|other complicating disease|4|||
105680256|NCT00126503|364491474|FG001|Overall Study|other complicating disease|1|||
105680257|NCT00126503|364491473|FG000|Overall Study|Death|3|||
105680258|NCT00126503|364491474|FG001|Overall Study|Death|0|||
105680259|NCT00126503|364491473|FG000|Overall Study|Adverse Event|13|||
105680260|NCT00126503|364491474|FG001|Overall Study|Adverse Event|3|||
105680261|NCT00126503|364491473|FG000|Overall Study|non-compliant|1|||
105680262|NCT00126503|364491474|FG001|Overall Study|non-compliant|0|||
105680263|NCT00126503|364491473|FG000|Overall Study|Physician Decision|2|||
105680264|NCT00126503|364491474|FG001|Overall Study|Physician Decision|1|||
105680265|NCT02523599|364491476|FG000|Overall Study|Adverse Event|1|||
105680266|NCT02523599|364491477|FG001|Overall Study|Adverse Event|0|||
105680267|NCT02523599|364491476|FG000|Overall Study|Physician Decision|1|||
105680268|NCT02523599|364491477|FG001|Overall Study|Physician Decision|0|||
105680269|NCT02523599|364491476|FG000|Overall Study|Lost to Follow-up|4|||
105680270|NCT02523599|364491477|FG001|Overall Study|Lost to Follow-up|1|||
105680271|NCT02523599|364491476|FG000|Overall Study|Did not return for Day 30 visit|2|||
105680272|NCT02523599|364491477|FG001|Overall Study|Did not return for Day 30 visit|0|||
105680273|NCT01078454|364491478|FG000|Overall Study|Adverse Event|1|||
105680274|NCT01078454|364491479|FG001|Overall Study|Adverse Event|1|||
105680275|NCT01078454|364491478|FG000|Overall Study|Death|0|||
105680276|NCT01078454|364491479|FG001|Overall Study|Death|1|||
105680277|NCT04227704|364491480|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
105680278|NCT04227704|364491481|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
105680279|NCT04227704|364491482|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
105680280|NCT04227704|364491480|FG000|Overall Study|due to C/S being cancelled|1|||
105680281|NCT04227704|364491481|FG001|Overall Study|due to C/S being cancelled|0|||
105680282|NCT04227704|364491482|FG002|Overall Study|due to C/S being cancelled|0|||
105916241|NCT00780975|365352963|FG000|Overall Study|Progressive disease|3|||
105680283|NCT01880528|364491487|FG000|Overall Study|Other|1|||
105680284|NCT01880528|364491488|FG001|Overall Study|Other|1|||
105680285|NCT00775463|364493857|FG000|Overall Study|Withdrawal by Subject|0|||
105680286|NCT00775463|364493858|FG001|Overall Study|Withdrawal by Subject|1|||
105680287|NCT00775463|364493857|FG000|Overall Study|Adverse Event|7|||
105680288|NCT00775463|364493858|FG001|Overall Study|Adverse Event|9|||
105680289|NCT00775463|364493857|FG000|Overall Study|Protocol Violation|2|||
105680290|NCT00775463|364493858|FG001|Overall Study|Protocol Violation|2|||
105680291|NCT00775463|364493857|FG000|Overall Study|Lost to Follow-up|1|||
105680292|NCT00775463|364493858|FG001|Overall Study|Lost to Follow-up|0|||
105680293|NCT00775463|364493857|FG000|Overall Study|Lack of Efficacy|1|||
105680294|NCT00775463|364493858|FG001|Overall Study|Lack of Efficacy|1|||
105680295|NCT03695237|364493859|FG000|Overall Study|Withdrawal by Subject|1|||
105680296|NCT03695237|364493860|FG001|Overall Study|Withdrawal by Subject|3|||
105680297|NCT03695237|364493859|FG000|Overall Study|Lost to Follow-up|1|||
105680298|NCT03695237|364493860|FG001|Overall Study|Lost to Follow-up|2|||
105680299|NCT03695237|364493859|FG000|Overall Study|Other, Not Specified|8|||
105680300|NCT03695237|364493860|FG001|Overall Study|Other, Not Specified|2|||
105680301|NCT04375761|364493861|FG000|Overall Study|Death|1|||
105680302|NCT04375761|364493862|FG001|Overall Study|Death|2|||
105680303|NCT04375761|364493861|FG000|Overall Study|Lost to Follow-up|203|||
105680304|NCT04375761|364493862|FG001|Overall Study|Lost to Follow-up|380|||
105680305|NCT04375761|364493861|FG000|Overall Study|Withdrawal by Subject|47|||
105680306|NCT04375761|364493862|FG001|Overall Study|Withdrawal by Subject|98|||
105680307|NCT04375761|364493861|FG000|Overall Study|Noncompliance with study procedure|121|||
105680308|NCT04375761|364493862|FG001|Overall Study|Noncompliance with study procedure|251|||
105680309|NCT04375761|364493861|FG000|Overall Study|Reimbursement not enough|1|||
105680310|NCT04375761|364493862|FG001|Overall Study|Reimbursement not enough|2|||
105680311|NCT04375761|364493861|FG000|Overall Study|Unforeseen family circumstances|1|||
105680312|NCT04375761|364493862|FG001|Overall Study|Unforeseen family circumstances|3|||
105680313|NCT04375761|364493861|FG000|Overall Study|Test too painful|1|||
105680314|NCT04375761|364493862|FG001|Overall Study|Test too painful|1|||
105680315|NCT04375761|364493861|FG000|Overall Study|Moved|0|||
105680316|NCT04375761|364493862|FG001|Overall Study|Moved|2|||
105680317|NCT04375761|364493861|FG000|Overall Study|Nonresponsive|0|||
105680318|NCT04375761|364493862|FG001|Overall Study|Nonresponsive|5|||
105680319|NCT03541174|364493863|FG000|Part 1 Double-Blind|Adverse Event|6|||
105680320|NCT03541174|364493864|FG001|Part 1 Double-Blind|Adverse Event|5|||
105680321|NCT03541174|364493865|FG002|Part 1 Double-Blind|Adverse Event|2|||
105680322|NCT03541174|364493866|FG003|Part 1 Double-Blind|Adverse Event|0|||
105680323|NCT03541174|364493867|FG004|Part 1 Double-Blind|Adverse Event|0|||
105680324|NCT03541174|364493868|FG005|Part 1 Double-Blind|Adverse Event|0|||
105680325|NCT03541174|364493863|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
105680326|NCT03541174|364493864|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
105680327|NCT03541174|364493865|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
105680328|NCT03541174|364493866|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
105680329|NCT03541174|364493867|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
105680330|NCT03541174|364493868|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
105680331|NCT03541174|364493863|FG000|Part 1 Double-Blind|Other reasons|3|||
105680332|NCT03541174|364493864|FG001|Part 1 Double-Blind|Other reasons|2|||
105680333|NCT03541174|364493865|FG002|Part 1 Double-Blind|Other reasons|3|||
105680334|NCT03541174|364493866|FG003|Part 1 Double-Blind|Other reasons|0|||
105680335|NCT03541174|364493867|FG004|Part 1 Double-Blind|Other reasons|0|||
105680336|NCT03541174|364493868|FG005|Part 1 Double-Blind|Other reasons|0|||
105680337|NCT03541174|364493863|FG000|Part 2 Single-Blind|Adverse Event|0|||
105680338|NCT03541174|364493864|FG001|Part 2 Single-Blind|Adverse Event|0|||
105680339|NCT03541174|364493865|FG002|Part 2 Single-Blind|Adverse Event|0|||
105680340|NCT03541174|364493866|FG003|Part 2 Single-Blind|Adverse Event|25|||
105680341|NCT03541174|364493867|FG004|Part 2 Single-Blind|Adverse Event|0|||
105680342|NCT03541174|364493868|FG005|Part 2 Single-Blind|Adverse Event|0|||
105680343|NCT03541174|364493863|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
105680344|NCT03541174|364493864|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
105680345|NCT03541174|364493865|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
105680346|NCT03541174|364493866|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
105680347|NCT03541174|364493867|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
105680348|NCT03541174|364493868|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
105680349|NCT03541174|364493863|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680350|NCT03541174|364493864|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680351|NCT03541174|364493865|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680352|NCT03541174|364493866|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
105680353|NCT03541174|364493867|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
105916242|NCT00780975|365352963|FG000|Overall Study|Toxicity|5|||
105916243|NCT00449163|365352964|FG000|Overall Study|Physician Decision|3|||
105916244|NCT00969228|365352965|FG000|Overall Study|Adverse Event|1|||
105916245|NCT00969228|365352966|FG001|Overall Study|Adverse Event|0|||
105680354|NCT03541174|364493868|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
105680355|NCT03541174|364493863|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
105680356|NCT03541174|364493864|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
105680357|NCT03541174|364493865|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
105680358|NCT03541174|364493866|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
105680359|NCT03541174|364493867|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
105680360|NCT03541174|364493868|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
105680361|NCT03541174|364493863|FG000|Part 2 Single-Blind|Death|0|||
105680362|NCT03541174|364493864|FG001|Part 2 Single-Blind|Death|0|||
105680363|NCT03541174|364493865|FG002|Part 2 Single-Blind|Death|0|||
105916246|NCT00969228|365352965|FG000|Overall Study|Withdrawal by Subject|4|||
105680364|NCT03541174|364493866|FG003|Part 2 Single-Blind|Death|5|||
105680365|NCT03541174|364493867|FG004|Part 2 Single-Blind|Death|0|||
105680366|NCT03541174|364493868|FG005|Part 2 Single-Blind|Death|0|||
105680367|NCT03541174|364493863|FG000|Part 2 Single-Blind|Pregnancy|0|||
105680368|NCT03541174|364493864|FG001|Part 2 Single-Blind|Pregnancy|0|||
105680369|NCT03541174|364493865|FG002|Part 2 Single-Blind|Pregnancy|0|||
105680370|NCT03541174|364493866|FG003|Part 2 Single-Blind|Pregnancy|1|||
105680371|NCT03541174|364493867|FG004|Part 2 Single-Blind|Pregnancy|0|||
105680372|NCT03541174|364493868|FG005|Part 2 Single-Blind|Pregnancy|0|||
105680373|NCT03541174|364493863|FG000|Part 2 Single-Blind|Other reasons|0|||
105680374|NCT03541174|364493864|FG001|Part 2 Single-Blind|Other reasons|0|||
105680375|NCT03541174|364493865|FG002|Part 2 Single-Blind|Other reasons|0|||
105680376|NCT03541174|364493866|FG003|Part 2 Single-Blind|Other reasons|32|||
105680377|NCT03541174|364493867|FG004|Part 2 Single-Blind|Other reasons|0|||
105680378|NCT03541174|364493868|FG005|Part 2 Single-Blind|Other reasons|0|||
105680379|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
105680380|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
105680381|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
105680382|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
105680383|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
105680384|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
105680385|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
105680386|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
105680387|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
105680388|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
105680389|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
105680390|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
105680391|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680392|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680393|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680394|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680395|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
105680396|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
105680397|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
105680398|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
105680399|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
105680400|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
105680401|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
105680402|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
105680403|NCT03541174|364493863|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680404|NCT03541174|364493864|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680405|NCT03541174|364493865|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680406|NCT03541174|364493866|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680407|NCT03541174|364493867|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
105680408|NCT03541174|364493868|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
105680409|NCT00484289|364493870|FG000|Long Term Phase|Adverse Event|1|||
105680410|NCT00484289|364493871|FG001|Long Term Phase|Adverse Event|17|||
105680411|NCT00484289|364493872|FG002|Long Term Phase|Adverse Event|5|||
105680412|NCT00484289|364493870|FG000|Long Term Phase|Withdrawal by Subject|0|||
105680413|NCT00484289|364493871|FG001|Long Term Phase|Withdrawal by Subject|7|||
105680414|NCT00484289|364493872|FG002|Long Term Phase|Withdrawal by Subject|6|||
105680415|NCT00484289|364493870|FG000|Long Term Phase|Inadequate response|2|||
105680416|NCT00484289|364493871|FG001|Long Term Phase|Inadequate response|7|||
105680417|NCT00484289|364493872|FG002|Long Term Phase|Inadequate response|4|||
105680418|NCT00484289|364493870|FG000|Long Term Phase|Other Reason|0|||
105680419|NCT00484289|364493871|FG001|Long Term Phase|Other Reason|5|||
105680420|NCT00484289|364493872|FG002|Long Term Phase|Other Reason|1|||
105680421|NCT00484289|364493870|FG000|Post Marketing Phase|Adverse Event|0|||
105680422|NCT00484289|364493871|FG001|Post Marketing Phase|Adverse Event|1|||
105680423|NCT00484289|364493872|FG002|Post Marketing Phase|Adverse Event|0|||
105680424|NCT00192647|364493873|FG000|Overall Study|Death|1|||
105680425|NCT00192647|364493874|FG001|Overall Study|Death|1|||
105680426|NCT00192647|364493873|FG000|Overall Study|Adverse Event|35|||
105680427|NCT00192647|364493874|FG001|Overall Study|Adverse Event|29|||
105680428|NCT00192647|364493873|FG000|Overall Study|Laboratory Test Abnormality|4|||
105680429|NCT00192647|364493874|FG001|Overall Study|Laboratory Test Abnormality|2|||
105680430|NCT00192647|364493873|FG000|Overall Study|Insufficient Therapeutic Response|53|||
105680431|NCT00192647|364493874|FG001|Overall Study|Insufficient Therapeutic Response|83|||
105680432|NCT00192647|364493873|FG000|Overall Study|Entry Criteria Violation|6|||
105680433|NCT00192647|364493874|FG001|Overall Study|Entry Criteria Violation|6|||
105680434|NCT00192647|364493873|FG000|Overall Study|Protocol Violation|3|||
105680435|NCT00192647|364493874|FG001|Overall Study|Protocol Violation|1|||
105680436|NCT00192647|364493873|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
105680437|NCT00192647|364493874|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
105680438|NCT00192647|364493873|FG000|Overall Study|Failure to Return|11|||
105680439|NCT00192647|364493874|FG001|Overall Study|Failure to Return|13|||
105680440|NCT00192647|364493873|FG000|Overall Study|Other/Administrative|5|||
105680441|NCT00192647|364493874|FG001|Overall Study|Other/Administrative|3|||
105680442|NCT03207009|364493875|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
105680443|NCT01227577|364493876|FG000|Overall Study|Protocol deviation|3|||
105680444|NCT01227577|364493876|FG000|Overall Study|Death|3|||
105680445|NCT01227577|364493876|FG000|Overall Study|Administrative problems|2|||
105680446|NCT01227577|364493876|FG000|Overall Study|Lost to Follow-up|1|||
105680447|NCT01227577|364493876|FG000|Overall Study|Withdrawal by Subject|4|||
105680448|NCT01227577|364493876|FG000|Overall Study|Lack of Efficacy|5|||
105680449|NCT01227577|364493876|FG000|Overall Study|Adverse Event|17|||
105680450|NCT01190514|364493877|FG000|First Intervention (Period 1)|Adverse Event|1|||
105680451|NCT01190514|364493878|FG001|First Intervention (Period 1)|Adverse Event|0|||
105680452|NCT01190514|364493879|FG002|First Intervention (Period 1)|Adverse Event|0|||
105680453|NCT01190514|364493880|FG003|First Intervention (Period 1)|Adverse Event|0|||
105680454|NCT01190514|364493877|FG000|Third Intervention (Period 3)|Adverse Event|1|||
105680455|NCT01190514|364493878|FG001|Third Intervention (Period 3)|Adverse Event|0|||
105680456|NCT01190514|364493879|FG002|Third Intervention (Period 3)|Adverse Event|0|||
105680457|NCT01190514|364493880|FG003|Third Intervention (Period 3)|Adverse Event|0|||
105680458|NCT00194987|364493881|FG000|Overall Study|Withdrawal by Subject|0|||
105680459|NCT00194987|364493882|FG001|Overall Study|Withdrawal by Subject|3|||
105680460|NCT04875676|364493883|FG000|Overall Study|Lost to Follow-up|1|||
105680461|NCT04875676|364493884|FG001|Overall Study|Lost to Follow-up|0|||
105680462|NCT04875676|364493885|FG002|Overall Study|Lost to Follow-up|0|||
105680463|NCT01981473|364493887|FG000|Overall Study|Incorrect diagnosis of RA|0|||
105680464|NCT01981473|364493888|FG001|Overall Study|Incorrect diagnosis of RA|0|||
105680465|NCT01981473|364493889|FG002|Overall Study|Incorrect diagnosis of RA|1|||
105680466|NCT01981473|364493887|FG000|Overall Study|Received treatment for < 6 months|0|||
105680467|NCT01981473|364493888|FG001|Overall Study|Received treatment for < 6 months|0|||
105680468|NCT01981473|364493889|FG002|Overall Study|Received treatment for < 6 months|1|||
105680469|NCT01981473|364493887|FG000|Overall Study|Received treatment for >24 months|2|||
105680470|NCT01981473|364493888|FG001|Overall Study|Received treatment for >24 months|0|||
105680471|NCT01981473|364493889|FG002|Overall Study|Received treatment for >24 months|6|||
105680472|NCT02937454|364493890|FG000|Overall Study|Adverse Event|0|||
105680473|NCT02937454|364493891|FG001|Overall Study|Adverse Event|1|||
105680474|NCT02937454|364493890|FG000|Overall Study|Death|98|||
105680475|NCT02937454|364493891|FG001|Overall Study|Death|95|||
105680476|NCT02937454|364493890|FG000|Overall Study|Lost to Follow-up|1|||
105680477|NCT02937454|364493891|FG001|Overall Study|Lost to Follow-up|1|||
105680478|NCT02937454|364493890|FG000|Overall Study|Physician Decision|0|||
105680479|NCT02937454|364493891|FG001|Overall Study|Physician Decision|1|||
105680480|NCT02937454|364493890|FG000|Overall Study|Protocol Violation|6|||
105680481|NCT02937454|364493891|FG001|Overall Study|Protocol Violation|10|||
105680482|NCT02937454|364493890|FG000|Overall Study|Withdrawal by Subject|27|||
105680483|NCT02937454|364493891|FG001|Overall Study|Withdrawal by Subject|15|||
105680484|NCT02937454|364493890|FG000|Overall Study|Other|8|||
105680485|NCT02937454|364493891|FG001|Overall Study|Other|5|||
105680486|NCT02630693|364493894|FG000|Overall Study|No receive treatment|0|||
105680487|NCT02630693|364493895|FG001|Overall Study|No receive treatment|1|||
105680488|NCT05062759|364493901|FG000|Overall Study|Death|0|||
105680489|NCT05062759|364493902|FG001|Overall Study|Death|1|||
105680490|NCT05062759|364493901|FG000|Overall Study|Lost to Follow-up|1|||
105680491|NCT05062759|364493902|FG001|Overall Study|Lost to Follow-up|0|||
105680492|NCT00903006|364493903|FG000|Overall Study|Withdrawal by Subject|2|||
105680493|NCT00903006|364493904|FG001|Overall Study|Withdrawal by Subject|0|||
105680494|NCT00903006|364493905|FG002|Overall Study|Withdrawal by Subject|0|||
105680495|NCT00903006|364493906|FG003|Overall Study|Withdrawal by Subject|0|||
106127796|NCT01474512|366125531|FG000|Long-Term Extension Period|Clinical Relapse|0|||
106127797|NCT01474512|366125532|FG001|Long-Term Extension Period|Clinical Relapse|0|||
106127798|NCT01474512|366125533|FG002|Long-Term Extension Period|Clinical Relapse|0|||
106127799|NCT01474512|366125534|FG003|Long-Term Extension Period|Clinical Relapse|0|||
106127800|NCT01474512|366125535|FG004|Long-Term Extension Period|Clinical Relapse|0|||
105680496|NCT00903006|364493903|FG000|Overall Study|Progressive Disease|0|||
105680497|NCT00903006|364493904|FG001|Overall Study|Progressive Disease|3|||
105680498|NCT00903006|364493905|FG002|Overall Study|Progressive Disease|1|||
105680499|NCT00903006|364493906|FG003|Overall Study|Progressive Disease|0|||
105680500|NCT01383499|364493907|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
105680501|NCT01383499|364493908|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105680502|NCT01383499|364493909|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
106127801|NCT01474512|366125536|FG005|Long-Term Extension Period|Clinical Relapse|0|||
105680503|NCT01383499|364493910|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
105680504|NCT03606668|364493914|FG000|Overall Study|Screen Failure|1|||
106127802|NCT01474512|366125537|FG006|Long-Term Extension Period|Clinical Relapse|0|||
105680505|NCT03606668|364493914|FG000|Overall Study|Lost to Follow-up|1|||
105680506|NCT01079663|364493915|FG000|Overall Study|Adverse Event|0|||
105680507|NCT01079663|364493916|FG001|Overall Study|Adverse Event|2|||
105680508|NCT01079663|364493915|FG000|Overall Study|Protocol Violation|0|||
105680509|NCT01079663|364493916|FG001|Overall Study|Protocol Violation|2|||
105680510|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
105680511|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
105680512|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
105680513|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
105680514|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
105680515|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
105680516|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
105680517|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
105680518|NCT01029652|364493920|FG000|Core Study (0-12 Weeks)|Death|0|||
105680519|NCT01029652|364493921|FG001|Core Study (0-12 Weeks)|Death|1|||
105680520|NCT01029652|364493920|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
105680521|NCT01029652|364493921|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
105680522|NCT01029652|364493920|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
105680523|NCT01029652|364493921|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
105680524|NCT01029652|364493920|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
105680525|NCT01029652|364493921|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
105680526|NCT01029652|364493920|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
105680527|NCT01029652|364493921|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
105680528|NCT01029652|364493920|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
105680529|NCT01029652|364493921|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
105680530|NCT01029652|364493920|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
105680531|NCT01029652|364493921|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
105680532|NCT01029652|364493920|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
105680533|NCT01029652|364493921|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
105680534|NCT02399254|364493925|FG000|Overall Study|Physician Decision|2|||
105680535|NCT02084056|364493928|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
105680536|NCT02084056|364493929|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105680537|NCT02084056|364493930|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105680538|NCT02084056|364493931|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105680539|NCT02084056|364493928|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
105680540|NCT02084056|364493929|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105680541|NCT02084056|364493930|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105680542|NCT02084056|364493931|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
105680543|NCT01293487|364493932|FG000|Overall Study|Lost to Follow-up|0|||
105680544|NCT01293487|364493933|FG001|Overall Study|Lost to Follow-up|0|||
105680545|NCT01293487|364493934|FG002|Overall Study|Lost to Follow-up|0|||
105680546|NCT01293487|364493935|FG003|Overall Study|Lost to Follow-up|1|||
105680547|NCT01293487|364493936|FG004|Overall Study|Lost to Follow-up|0|||
105680548|NCT01293487|364493937|FG005|Overall Study|Lost to Follow-up|0|||
105680549|NCT01293487|364493938|FG006|Overall Study|Lost to Follow-up|0|||
105680550|NCT01293487|364493939|FG007|Overall Study|Lost to Follow-up|0|||
105680551|NCT01293487|364493932|FG000|Overall Study|Withdrawal by Subject|0|||
105680552|NCT01293487|364493933|FG001|Overall Study|Withdrawal by Subject|0|||
105680553|NCT01293487|364493934|FG002|Overall Study|Withdrawal by Subject|0|||
105680554|NCT01293487|364493935|FG003|Overall Study|Withdrawal by Subject|0|||
105680555|NCT01293487|364493936|FG004|Overall Study|Withdrawal by Subject|0|||
105680556|NCT01293487|364493937|FG005|Overall Study|Withdrawal by Subject|0|||
105680557|NCT01293487|364493938|FG006|Overall Study|Withdrawal by Subject|0|||
105680558|NCT01293487|364493939|FG007|Overall Study|Withdrawal by Subject|2|||
105680559|NCT00577577|364493941|FG000|Overall Study|Adverse Event|3|||
105680560|NCT00577577|364493942|FG001|Overall Study|Adverse Event|2|||
105680561|NCT00577577|364493941|FG000|Overall Study|Lost to Follow-up|1|||
105680562|NCT00577577|364493942|FG001|Overall Study|Lost to Follow-up|0|||
105680563|NCT00577577|364493941|FG000|Overall Study|Protocol Violation|0|||
105680564|NCT00577577|364493942|FG001|Overall Study|Protocol Violation|3|||
105916247|NCT00969228|365352966|FG001|Overall Study|Withdrawal by Subject|0|||
105916248|NCT00969228|365352965|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
105916249|NCT00969228|365352966|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
105916250|NCT01274533|365352969|FG000|Overall Study|Withdrawal by Subject|1|||
105916251|NCT01274533|365352969|FG000|Overall Study|Non-compliance|1|||
105680565|NCT00577577|364493941|FG000|Overall Study|Transportation|1|||
105680566|NCT00577577|364493942|FG001|Overall Study|Transportation|0|||
105680567|NCT02424734|364493943|FG000|Overall Study|Treatment stopped to be discharged home|2|||
105680568|NCT02424734|364493944|FG001|Overall Study|Treatment stopped to be discharged home|2|||
105680569|NCT02424734|364493945|FG002|Overall Study|Treatment stopped to be discharged home|0|||
105680570|NCT00116753|364493946|FG000|Overall Study|Adverse Event|16|||
105680571|NCT00116753|364493947|FG001|Overall Study|Adverse Event|10|||
105680572|NCT00116753|364493948|FG002|Overall Study|Adverse Event|7|||
105680573|NCT00116753|364493946|FG000|Overall Study|Withdrawal by Subject|11|||
105680574|NCT00116753|364493947|FG001|Overall Study|Withdrawal by Subject|12|||
105680575|NCT00116753|364493948|FG002|Overall Study|Withdrawal by Subject|8|||
105680576|NCT00116753|364493946|FG000|Overall Study|Lost to Follow-up|0|||
105680577|NCT00116753|364493947|FG001|Overall Study|Lost to Follow-up|2|||
105680578|NCT00116753|364493948|FG002|Overall Study|Lost to Follow-up|1|||
106127803|NCT01474512|366125538|FG007|Long-Term Extension Period|Clinical Relapse|0|||
106127804|NCT01474512|366125539|FG008|Long-Term Extension Period|Clinical Relapse|0|||
106127805|NCT01474512|366125540|FG009|Long-Term Extension Period|Clinical Relapse|0|||
106127806|NCT01474512|366125541|FG010|Long-Term Extension Period|Clinical Relapse|0|||
106127807|NCT01474512|366125542|FG011|Long-Term Extension Period|Clinical Relapse|0|||
106127808|NCT01474512|366125543|FG012|Long-Term Extension Period|Clinical Relapse|9|||
106127809|NCT01474512|366125544|FG013|Long-Term Extension Period|Clinical Relapse|9|||
106127810|NCT01474512|366125545|FG014|Long-Term Extension Period|Clinical Relapse|0|||
106127811|NCT01474512|366125546|FG015|Long-Term Extension Period|Clinical Relapse|0|||
106127812|NCT01474512|366125547|FG016|Long-Term Extension Period|Clinical Relapse|0|||
106127813|NCT01474512|366125548|FG017|Long-Term Extension Period|Clinical Relapse|0|||
106127814|NCT01474512|366125531|FG000|Long-Term Extension Period|Death|0|||
105680579|NCT00116753|364493946|FG000|Overall Study|Protocol Violation|0|||
105680580|NCT00116753|364493947|FG001|Overall Study|Protocol Violation|0|||
105680581|NCT00116753|364493948|FG002|Overall Study|Protocol Violation|1|||
105680582|NCT00116753|364493946|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
105680583|NCT00116753|364493947|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
105680584|NCT00116753|364493948|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
105680585|NCT00116753|364493946|FG000|Overall Study|Disease Progression|3|||
105680586|NCT00116753|364493947|FG001|Overall Study|Disease Progression|4|||
105680587|NCT00116753|364493948|FG002|Overall Study|Disease Progression|3|||
105680588|NCT00116753|364493946|FG000|Overall Study|Abnormal Echocardiogram|0|||
105680589|NCT00116753|364493947|FG001|Overall Study|Abnormal Echocardiogram|0|||
105680590|NCT00116753|364493948|FG002|Overall Study|Abnormal Echocardiogram|1|||
105680591|NCT00116753|364493946|FG000|Overall Study|Progressive Parkinson's Disease|1|||
105680592|NCT00116753|364493947|FG001|Overall Study|Progressive Parkinson's Disease|0|||
105680593|NCT00116753|364493948|FG002|Overall Study|Progressive Parkinson's Disease|0|||
105680594|NCT00116753|364493946|FG000|Overall Study|Dosing Error|0|||
105680595|NCT00116753|364493947|FG001|Overall Study|Dosing Error|1|||
105680596|NCT00116753|364493948|FG002|Overall Study|Dosing Error|0|||
105680597|NCT01090427|364493949|FG000|After Controlled Period|Death|0|||
105680598|NCT01090427|364493950|FG001|After Controlled Period|Death|0|||
105680599|NCT01090427|364493951|FG002|After Controlled Period|Death|0|||
105680600|NCT01090427|364493952|FG003|After Controlled Period|Death|0|||
105680601|NCT01090427|364493953|FG004|After Controlled Period|Death|0|||
105680602|NCT01090427|364493954|FG005|After Controlled Period|Death|1|||
105680603|NCT01090427|364493955|FG006|After Controlled Period|Death|0|||
105680604|NCT01090427|364493949|FG000|After Controlled Period|Lack of Efficacy|0|||
105680605|NCT01090427|364493950|FG001|After Controlled Period|Lack of Efficacy|0|||
105680606|NCT01090427|364493951|FG002|After Controlled Period|Lack of Efficacy|0|||
105680607|NCT01090427|364493952|FG003|After Controlled Period|Lack of Efficacy|0|||
105680608|NCT01090427|364493953|FG004|After Controlled Period|Lack of Efficacy|0|||
105680609|NCT01090427|364493954|FG005|After Controlled Period|Lack of Efficacy|3|||
105680610|NCT01090427|364493955|FG006|After Controlled Period|Lack of Efficacy|2|||
105680611|NCT01090427|364493949|FG000|After Controlled Period|Adverse Event|0|||
105680612|NCT01090427|364493950|FG001|After Controlled Period|Adverse Event|0|||
105680613|NCT01090427|364493951|FG002|After Controlled Period|Adverse Event|0|||
105680614|NCT01090427|364493952|FG003|After Controlled Period|Adverse Event|2|||
105680615|NCT01090427|364493953|FG004|After Controlled Period|Adverse Event|0|||
105680616|NCT01090427|364493954|FG005|After Controlled Period|Adverse Event|1|||
105680617|NCT01090427|364493955|FG006|After Controlled Period|Adverse Event|0|||
105680618|NCT01465347|364493956|FG000|Overall Study|Withdrawal by Subject|1|||
105680619|NCT01465347|364493957|FG001|Overall Study|Withdrawal by Subject|1|||
105680620|NCT01465347|364493956|FG000|Overall Study|Physician Decision|0|||
105680621|NCT01465347|364493957|FG001|Overall Study|Physician Decision|1|||
105680622|NCT01465347|364493956|FG000|Overall Study|Admitted to hospice|0|||
105680623|NCT01465347|364493957|FG001|Overall Study|Admitted to hospice|1|||
105680624|NCT01210664|364493959|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
105680625|NCT01210664|364493960|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
105680626|NCT01210664|364493961|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
106127815|NCT01474512|366125532|FG001|Long-Term Extension Period|Death|0|||
105680627|NCT01210664|364493962|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
105680628|NCT01210664|364493959|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680629|NCT01210664|364493960|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680630|NCT01210664|364493961|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
106127816|NCT01474512|366125533|FG002|Long-Term Extension Period|Death|0|||
105680631|NCT01210664|364493962|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
106127817|NCT01474512|366125534|FG003|Long-Term Extension Period|Death|0|||
105680632|NCT01210664|364493959|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680633|NCT01210664|364493960|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680634|NCT01210664|364493961|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
105680635|NCT01210664|364493962|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
105680636|NCT02649946|364493963|FG000|Overall Study|Withdrawal by Subject|1|||
105680637|NCT02649946|364493964|FG001|Overall Study|Withdrawal by Subject|1|||
105680638|NCT02649946|364493963|FG000|Overall Study|Death|7|||
105680639|NCT02649946|364493964|FG001|Overall Study|Death|9|||
105680640|NCT02649946|364493963|FG000|Overall Study|Physician Decision|1|||
105680641|NCT02649946|364493964|FG001|Overall Study|Physician Decision|0|||
105680642|NCT02649946|364493963|FG000|Overall Study|Lost to Follow-up|2|||
105680643|NCT02649946|364493964|FG001|Overall Study|Lost to Follow-up|1|||
105680644|NCT02649946|364493963|FG000|Overall Study|Erroneously enrolled|1|||
105680645|NCT02649946|364493964|FG001|Overall Study|Erroneously enrolled|0|||
105680646|NCT02649946|364493963|FG000|Overall Study|Missed 6-month follow-up visit|0|||
105680647|NCT02649946|364493964|FG001|Overall Study|Missed 6-month follow-up visit|4|||
105680648|NCT01920854|364493965|FG000|Overall Study|Withdrawal by Subject|1|||
105680649|NCT01920854|364493966|FG001|Overall Study|Withdrawal by Subject|0|||
105680650|NCT01920854|364493967|FG002|Overall Study|Withdrawal by Subject|0|||
105680651|NCT01920854|364493968|FG003|Overall Study|Withdrawal by Subject|0|||
105680652|NCT01920854|364493969|FG004|Overall Study|Withdrawal by Subject|1|||
105680653|NCT01920854|364493970|FG005|Overall Study|Withdrawal by Subject|0|||
105680654|NCT01920854|364493971|FG006|Overall Study|Withdrawal by Subject|1|||
105680655|NCT02372136|364493975|FG000|Overall Study|Death|3|||
105680656|NCT02372136|364493976|FG001|Overall Study|Death|1|||
105680657|NCT01688830|364493977|FG000|Overall Study|Lost to Follow-up|0|||
105680658|NCT01688830|364493978|FG001|Overall Study|Lost to Follow-up|0|||
105680659|NCT01688830|364493979|FG002|Overall Study|Lost to Follow-up|0|||
105680660|NCT01688830|364493980|FG003|Overall Study|Lost to Follow-up|0|||
105680661|NCT01688830|364493981|FG004|Overall Study|Lost to Follow-up|0|||
105680662|NCT01688830|364493982|FG005|Overall Study|Lost to Follow-up|0|||
105680663|NCT01688830|364493983|FG006|Overall Study|Lost to Follow-up|0|||
105680664|NCT01688830|364493984|FG007|Overall Study|Lost to Follow-up|0|||
105680665|NCT01688830|364493985|FG008|Overall Study|Lost to Follow-up|0|||
105680666|NCT01688830|364493986|FG009|Overall Study|Lost to Follow-up|0|||
105680667|NCT01688830|364493987|FG010|Overall Study|Lost to Follow-up|1|||
105680668|NCT01688830|364493988|FG011|Overall Study|Lost to Follow-up|0|||
105680669|NCT01688830|364493989|FG012|Overall Study|Lost to Follow-up|0|||
105680670|NCT01688830|364493990|FG013|Overall Study|Lost to Follow-up|0|||
105680671|NCT01688830|364493991|FG014|Overall Study|Lost to Follow-up|0|||
105680672|NCT01688830|364493992|FG015|Overall Study|Lost to Follow-up|0|||
105680673|NCT01688830|364493993|FG016|Overall Study|Lost to Follow-up|0|||
105680674|NCT01688830|364493994|FG017|Overall Study|Lost to Follow-up|0|||
105680675|NCT01688830|364493995|FG018|Overall Study|Lost to Follow-up|0|||
105680676|NCT01688830|364493996|FG019|Overall Study|Lost to Follow-up|0|||
105680677|NCT01688830|364493997|FG020|Overall Study|Lost to Follow-up|0|||
105680678|NCT02318797|364493998|FG000|Overall Study|Death|3|||
105680679|NCT02318797|364493999|FG001|Overall Study|Death|6|||
105680680|NCT02318797|364493998|FG000|Overall Study|Lost to Follow-up|85|||
105680681|NCT02318797|364493999|FG001|Overall Study|Lost to Follow-up|96|||
105680682|NCT00511472|364494000|FG000|Overall Study|Clinical Adverse Event|1|||
105680683|NCT00511472|364494001|FG001|Overall Study|Clinical Adverse Event|2|||
105680684|NCT00511472|364494000|FG000|Overall Study|Laboratory Adverse Event|0|||
105680685|NCT00511472|364494001|FG001|Overall Study|Laboratory Adverse Event|2|||
105680686|NCT00511472|364494000|FG000|Overall Study|Not reported|2|||
105680687|NCT00511472|364494001|FG001|Overall Study|Not reported|2|||
105680688|NCT02709096|364494002|FG000|Overall Study|non-compliance|1|||
105680689|NCT02709096|364494003|FG001|Overall Study|non-compliance|1|||
105680690|NCT02308020|364494005|FG000|Overall Study|Lost to Follow-up|1|||
105680691|NCT02308020|364494006|FG001|Overall Study|Lost to Follow-up|7|||
105680692|NCT02308020|364494007|FG002|Overall Study|Lost to Follow-up|0|||
105680693|NCT02308020|364494008|FG003|Overall Study|Lost to Follow-up|0|||
105916252|NCT01274533|365352969|FG000|Overall Study|Disease progression|2|||
105916253|NCT01118052|365352970|FG000|Overall Study|Never treated|2|||
105916254|NCT02949947|365352971|FG000|Overall Study|Non Compliance|0|||
105916255|NCT02949947|365352972|FG001|Overall Study|Non Compliance|1|||
105680694|NCT02308020|364494009|FG004|Overall Study|Lost to Follow-up|1|||
105680695|NCT02308020|364494010|FG005|Overall Study|Lost to Follow-up|2|||
105680696|NCT02308020|364494005|FG000|Overall Study|Sponsor Decision|0|||
105680697|NCT02308020|364494006|FG001|Overall Study|Sponsor Decision|8|||
105680698|NCT02308020|364494007|FG002|Overall Study|Sponsor Decision|0|||
105680699|NCT02308020|364494008|FG003|Overall Study|Sponsor Decision|2|||
105680700|NCT02308020|364494009|FG004|Overall Study|Sponsor Decision|2|||
105680701|NCT02308020|364494010|FG005|Overall Study|Sponsor Decision|1|||
105680702|NCT02308020|364494005|FG000|Overall Study|Withdrawal by Subject|3|||
105680703|NCT02308020|364494006|FG001|Overall Study|Withdrawal by Subject|5|||
105680704|NCT02308020|364494007|FG002|Overall Study|Withdrawal by Subject|3|||
105916256|NCT02949947|365352971|FG000|Overall Study|Insurance change|1|||
105680705|NCT02308020|364494008|FG003|Overall Study|Withdrawal by Subject|2|||
105916257|NCT02949947|365352972|FG001|Overall Study|Insurance change|0|||
105680706|NCT02308020|364494009|FG004|Overall Study|Withdrawal by Subject|1|||
105680707|NCT02308020|364494010|FG005|Overall Study|Withdrawal by Subject|2|||
105680708|NCT00505284|364494011|FG000|Overall Study|Adverse Event|3|||
105680709|NCT00505284|364494012|FG001|Overall Study|Adverse Event|7|||
105680710|NCT00505284|364494013|FG002|Overall Study|Adverse Event|9|||
105680711|NCT00505284|364494014|FG003|Overall Study|Adverse Event|14|||
105680712|NCT00505284|364494015|FG004|Overall Study|Adverse Event|22|||
105680713|NCT00505284|364494011|FG000|Overall Study|Protocol Violation|0|||
105680714|NCT00505284|364494012|FG001|Overall Study|Protocol Violation|1|||
105680715|NCT00505284|364494013|FG002|Overall Study|Protocol Violation|1|||
105680716|NCT00505284|364494014|FG003|Overall Study|Protocol Violation|0|||
105680717|NCT00505284|364494015|FG004|Overall Study|Protocol Violation|0|||
105680718|NCT00505284|364494011|FG000|Overall Study|Withdrawal by Subject|2|||
105680719|NCT00505284|364494012|FG001|Overall Study|Withdrawal by Subject|6|||
105680720|NCT00505284|364494013|FG002|Overall Study|Withdrawal by Subject|1|||
105680721|NCT00505284|364494014|FG003|Overall Study|Withdrawal by Subject|0|||
105680722|NCT00505284|364494015|FG004|Overall Study|Withdrawal by Subject|6|||
105680723|NCT00505284|364494011|FG000|Overall Study|Lack of Efficacy|0|||
105680724|NCT00505284|364494012|FG001|Overall Study|Lack of Efficacy|1|||
105680725|NCT00505284|364494013|FG002|Overall Study|Lack of Efficacy|1|||
105680726|NCT00505284|364494014|FG003|Overall Study|Lack of Efficacy|1|||
105680727|NCT00505284|364494015|FG004|Overall Study|Lack of Efficacy|1|||
105680728|NCT00505284|364494011|FG000|Overall Study|Physician Decision|0|||
105680729|NCT00505284|364494012|FG001|Overall Study|Physician Decision|1|||
105680730|NCT00505284|364494013|FG002|Overall Study|Physician Decision|0|||
105680731|NCT00505284|364494014|FG003|Overall Study|Physician Decision|0|||
105680732|NCT00505284|364494015|FG004|Overall Study|Physician Decision|0|||
105680733|NCT00505284|364494011|FG000|Overall Study|Other|5|||
105680734|NCT00505284|364494012|FG001|Overall Study|Other|0|||
105680735|NCT00505284|364494013|FG002|Overall Study|Other|0|||
105680736|NCT00505284|364494014|FG003|Overall Study|Other|4|||
105680737|NCT00505284|364494015|FG004|Overall Study|Other|4|||
105680738|NCT03265938|364494016|FG000|Overall Study|Withdrawal by Subject|1|||
105680739|NCT03265938|364494016|FG000|Overall Study|Physician Decision|1|||
105680740|NCT03265938|364494016|FG000|Overall Study|friable mass|6|||
105680741|NCT01211288|364494017|FG000|Overall Study|Lost to Follow-up|1|||
105680742|NCT01211288|364494018|FG001|Overall Study|Lost to Follow-up|1|||
105680743|NCT02471833|364494020|FG000|Overall Study|Lost to Follow-up|1|||
105680744|NCT02471833|364494021|FG001|Overall Study|Lost to Follow-up|0|||
105680745|NCT02471833|364494022|FG002|Overall Study|Lost to Follow-up|0|||
105680746|NCT02471833|364494020|FG000|Overall Study|Withdrawal by Subject|2|||
105680747|NCT02471833|364494021|FG001|Overall Study|Withdrawal by Subject|1|||
105680748|NCT02471833|364494022|FG002|Overall Study|Withdrawal by Subject|5|||
105680749|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
105680750|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
105680751|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
105680752|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
105680753|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
105680754|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
105680755|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
105680756|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
105680757|NCT00953745|364494036|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
105680758|NCT00953745|364494037|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
105680759|NCT00953745|364494036|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
105680760|NCT00953745|364494037|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
105680761|NCT00994682|364494038|FG000|Double Bilnd|Withdrawal by Subject|5|||
105680762|NCT00994682|364494039|FG001|Double Bilnd|Withdrawal by Subject|6|||
105680763|NCT00994682|364494038|FG000|Double Bilnd|Lost to Follow-up|3|||
105680764|NCT00994682|364494039|FG001|Double Bilnd|Lost to Follow-up|3|||
105680765|NCT00994682|364494038|FG000|Double Bilnd|Adverse Event|1|||
105680766|NCT00994682|364494039|FG001|Double Bilnd|Adverse Event|0|||
105680767|NCT00994682|364494038|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
105680768|NCT00994682|364494039|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
105680769|NCT00994682|364494038|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
105680770|NCT00994682|364494039|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
105680771|NCT00994682|364494038|FG000|Pioglitazone Open Label|Physician Decision|6|||
105680772|NCT00994682|364494039|FG001|Pioglitazone Open Label|Physician Decision|1|||
105680773|NCT00704405|364494042|FG000|Overall Study (NC Population)|Adverse Event|1|||
105680774|NCT00704405|364494043|FG001|Overall Study (NC Population)|Adverse Event|0|||
105680775|NCT00704405|364494044|FG002|Overall Study (NC Population)|Adverse Event|0|||
105680776|NCT00704405|364494045|FG003|Overall Study (NC Population)|Adverse Event|0|||
105680777|NCT00704405|364494046|FG004|Overall Study (NC Population)|Adverse Event|0|||
105680778|NCT00704405|364494042|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
105680779|NCT00704405|364494043|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
105680780|NCT00704405|364494044|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
105680781|NCT00704405|364494045|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
105680782|NCT00704405|364494046|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
105680783|NCT00704405|364494042|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
105680784|NCT00704405|364494043|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
105680785|NCT00704405|364494044|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
105680786|NCT00704405|364494045|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
105680787|NCT00704405|364494046|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
105680788|NCT00704405|364494042|FG000|Overall Study (NC Population)|Other|0|||
105680789|NCT00704405|364494043|FG001|Overall Study (NC Population)|Other|0|||
105680790|NCT00704405|364494044|FG002|Overall Study (NC Population)|Other|0|||
105680791|NCT00704405|364494045|FG003|Overall Study (NC Population)|Other|0|||
105680792|NCT00704405|364494046|FG004|Overall Study (NC Population)|Other|1|||
105680793|NCT00704405|364494042|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
105680794|NCT00704405|364494043|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
105680795|NCT00704405|364494044|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
105680796|NCT00704405|364494045|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
105680797|NCT00704405|364494046|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
105680798|NCT00704405|364494042|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
105680799|NCT00704405|364494043|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
105680800|NCT00704405|364494044|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
105680801|NCT00704405|364494045|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
105680802|NCT00704405|364494046|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
105680803|NCT02859324|364494047|FG000|Overall Study|Death|4|||
105680804|NCT02859324|364494048|FG001|Overall Study|Death|6|||
105680805|NCT02859324|364494049|FG002|Overall Study|Death|5|||
105680806|NCT02859324|364494047|FG000|Overall Study|Other reasons|3|||
105680807|NCT02859324|364494048|FG001|Overall Study|Other reasons|3|||
105680808|NCT02859324|364494049|FG002|Overall Study|Other reasons|0|||
105680809|NCT01946438|364494050|FG000|Overall Study|Adverse Event|0|||
105680810|NCT01946438|364494051|FG001|Overall Study|Adverse Event|0|||
105680811|NCT01946438|364494052|FG002|Overall Study|Adverse Event|0|||
105680812|NCT01946438|364494053|FG003|Overall Study|Adverse Event|1|||
105680813|NCT01946438|364494050|FG000|Overall Study|Serious Adverse event|1|||
105680814|NCT01946438|364494051|FG001|Overall Study|Serious Adverse event|0|||
105680815|NCT01946438|364494052|FG002|Overall Study|Serious Adverse event|0|||
105680816|NCT01946438|364494053|FG003|Overall Study|Serious Adverse event|0|||
105680817|NCT01946438|364494050|FG000|Overall Study|Protocol Violation|0|||
105680818|NCT01946438|364494051|FG001|Overall Study|Protocol Violation|0|||
105680819|NCT01946438|364494052|FG002|Overall Study|Protocol Violation|1|||
105680820|NCT01946438|364494053|FG003|Overall Study|Protocol Violation|0|||
105680821|NCT01946438|364494050|FG000|Overall Study|Withdrawal by Subject|1|||
105680822|NCT01946438|364494051|FG001|Overall Study|Withdrawal by Subject|0|||
105680823|NCT01946438|364494052|FG002|Overall Study|Withdrawal by Subject|0|||
105680824|NCT01946438|364494053|FG003|Overall Study|Withdrawal by Subject|0|||
105680825|NCT01679405|364494054|FG000|Overall Study|Death|2|||
105680826|NCT01679405|364494055|FG001|Overall Study|Death|5|||
105680827|NCT03316300|364494058|FG000|Overall Study|Withdrawal by Subject|3|||
105680828|NCT03316300|364494059|FG001|Overall Study|Withdrawal by Subject|2|||
105680829|NCT03316300|364494058|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
105916258|NCT00794664|365352973|FG000|Treatment Period|Withdrawal by Subject|0|||
105916259|NCT00794664|365352974|FG001|Treatment Period|Withdrawal by Subject|2|||
105916260|NCT00794664|365352973|FG000|Treatment Period|Protocol non-compliance|0|||
105916261|NCT00794664|365352974|FG001|Treatment Period|Protocol non-compliance|1|||
105916262|NCT00794664|365352973|FG000|Treatment Period|Other|0|||
105916263|NCT00794664|365352974|FG001|Treatment Period|Other|1|||
105916264|NCT00794664|365352973|FG000|Treatment Period|Adverse Event|1|||
105916265|NCT00794664|365352974|FG001|Treatment Period|Adverse Event|8|||
105916266|NCT00794664|365352973|FG000|Follow-up Period|Other|1|||
105916267|NCT00794664|365352974|FG001|Follow-up Period|Other|2|||
105916268|NCT00794664|365352973|FG000|Follow-up Period|Withdrawal by Subject|0|||
105680830|NCT03316300|364494059|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
105680831|NCT03316300|364494058|FG000|Overall Study|Adverse Event|1|||
105680832|NCT03316300|364494059|FG001|Overall Study|Adverse Event|0|||
105680833|NCT03316300|364494058|FG000|Overall Study|COVID-19|0|||
105680834|NCT03316300|364494059|FG001|Overall Study|COVID-19|1|||
105680835|NCT01439360|364494060|FG000|Overall Study|Adverse Event|4|||
105680836|NCT01439360|364494061|FG001|Overall Study|Adverse Event|16|||
105680837|NCT01439360|364494060|FG000|Overall Study|Lost to Follow-up|43|||
105786477|NCT01748162|364871402|FG001|Overall Study|participant consented but did not begin|1|||
105916269|NCT00794664|365352974|FG001|Follow-up Period|Withdrawal by Subject|2|||
105916270|NCT00794664|365352973|FG000|Follow-up Period|Protocol non-compliance|0|||
105916271|NCT00794664|365352974|FG001|Follow-up Period|Protocol non-compliance|1|||
105916272|NCT01618968|365352975|FG000|Overall Study|Adverse Event|1|||
105916273|NCT01618968|365352976|FG001|Overall Study|Adverse Event|0|||
105916274|NCT01618968|365352977|FG002|Overall Study|Adverse Event|0|||
105916275|NCT01618968|365352978|FG003|Overall Study|Adverse Event|0|||
105916276|NCT01618968|365352975|FG000|Overall Study|Death|0|||
105680838|NCT01439360|364494061|FG001|Overall Study|Lost to Follow-up|58|||
105680839|NCT01439360|364494060|FG000|Overall Study|Others|10|||
105680840|NCT01439360|364494061|FG001|Overall Study|Others|5|||
105680841|NCT01439360|364494060|FG000|Overall Study|Protocol Violation|1|||
105680842|NCT01439360|364494061|FG001|Overall Study|Protocol Violation|0|||
105680843|NCT01439360|364494060|FG000|Overall Study|Withdrawal by Subject|140|||
105680844|NCT01439360|364494061|FG001|Overall Study|Withdrawal by Subject|129|||
105680845|NCT01506453|364495778|FG000|Overall Study|Withdrawal prior to treatment|0|||
105680846|NCT01506453|364495779|FG001|Overall Study|Withdrawal prior to treatment|2|||
105680847|NCT00734097|364495783|FG000|Screening|Protocol Violation|12|||
105680848|NCT00734097|364495783|FG000|Screening|Withdrawal by Subject|5|||
105680849|NCT00734097|364495783|FG000|Screening|Lost to Follow-up|2|||
105680850|NCT00734097|364495783|FG000|Screening|Unconfirmed pregnancy|1|||
105680851|NCT00734097|364495783|FG000|Open Label|Lost to Follow-up|7|||
105680852|NCT00734097|364495783|FG000|Open Label|Withdrawal by Subject|5|||
105680853|NCT00734097|364495783|FG000|Open Label|Protocol Violation|4|||
105680854|NCT01346475|364495791|FG000|First Intervention|Lost to Follow-up|4|||
106000947|NCT02903914|365665183|FG007|Overall Study|Symptomatic Deterioration|0|||
106000948|NCT02903914|365665176|FG000|Overall Study|New Cancer Therapy|2|||
106000949|NCT02903914|365665177|FG001|Overall Study|New Cancer Therapy|2|||
106000950|NCT02903914|365665178|FG002|Overall Study|New Cancer Therapy|21|||
106000951|NCT02903914|365665179|FG003|Overall Study|New Cancer Therapy|4|||
106000952|NCT02903914|365665180|FG004|Overall Study|New Cancer Therapy|3|||
106000953|NCT02903914|365665181|FG005|Overall Study|New Cancer Therapy|6|||
106000954|NCT02903914|365665182|FG006|Overall Study|New Cancer Therapy|56|||
106000955|NCT02903914|365665183|FG007|Overall Study|New Cancer Therapy|3|||
106000956|NCT02903914|365665176|FG000|Overall Study|Didn't Return to Site|1|||
106000957|NCT02903914|365665177|FG001|Overall Study|Didn't Return to Site|0|||
106000958|NCT02903914|365665178|FG002|Overall Study|Didn't Return to Site|1|||
106000959|NCT02903914|365665179|FG003|Overall Study|Didn't Return to Site|1|||
106000960|NCT02903914|365665180|FG004|Overall Study|Didn't Return to Site|0|||
106000961|NCT02903914|365665181|FG005|Overall Study|Didn't Return to Site|0|||
106000962|NCT02903914|365665182|FG006|Overall Study|Didn't Return to Site|2|||
106000963|NCT02903914|365665183|FG007|Overall Study|Didn't Return to Site|0|||
106000964|NCT02903914|365665176|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
106000965|NCT02903914|365665177|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
106000966|NCT02903914|365665178|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
106000967|NCT02903914|365665179|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
106000968|NCT02903914|365665180|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
106000969|NCT02903914|365665181|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
106000970|NCT02903914|365665182|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
106000971|NCT02903914|365665183|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
106000972|NCT02903914|365665176|FG000|Overall Study|Follow-up Did Not Occur|0|||
106000973|NCT02903914|365665177|FG001|Overall Study|Follow-up Did Not Occur|1|||
106000974|NCT02903914|365665178|FG002|Overall Study|Follow-up Did Not Occur|1|||
106000975|NCT02903914|365665179|FG003|Overall Study|Follow-up Did Not Occur|0|||
106000976|NCT02903914|365665180|FG004|Overall Study|Follow-up Did Not Occur|2|||
106000977|NCT02903914|365665181|FG005|Overall Study|Follow-up Did Not Occur|0|||
106000978|NCT02903914|365665182|FG006|Overall Study|Follow-up Did Not Occur|8|||
106000979|NCT02903914|365665183|FG007|Overall Study|Follow-up Did Not Occur|0|||
106000980|NCT02903914|365665176|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
106000981|NCT02903914|365665177|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
106000982|NCT02903914|365665178|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
105680855|NCT01346475|364495792|FG001|First Intervention|Lost to Follow-up|3|||
105680856|NCT02366468|364495793|FG000|Overall Study|Adverse Event|2|||
105680857|NCT02366468|364495794|FG001|Overall Study|Adverse Event|0|||
105680858|NCT02366468|364495793|FG000|Overall Study|Withdrawal by Subject|1|||
105680859|NCT02366468|364495794|FG001|Overall Study|Withdrawal by Subject|5|||
105680860|NCT02366468|364495793|FG000|Overall Study|Lost to Follow-up|2|||
105680861|NCT02366468|364495794|FG001|Overall Study|Lost to Follow-up|0|||
105680862|NCT02366468|364495793|FG000|Overall Study|Death|1|||
105680863|NCT02366468|364495794|FG001|Overall Study|Death|2|||
106000983|NCT02903914|365665179|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
106000984|NCT02903914|365665180|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
106000985|NCT02903914|365665181|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
106000986|NCT02903914|365665182|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
106000987|NCT02903914|365665183|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
106000988|NCT02903914|365665176|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
105680864|NCT02366468|364495793|FG000|Overall Study|Other|0|||
106000989|NCT02903914|365665177|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
106000990|NCT02903914|365665178|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
106000991|NCT02903914|365665179|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
105680865|NCT02366468|364495794|FG001|Overall Study|Other|2|||
105680866|NCT01776541|364495795|FG000|Overall Study|Administrative Reason|6|||
105680867|NCT01776541|364495796|FG001|Overall Study|Administrative Reason|2|||
105680868|NCT01776541|364495795|FG000|Overall Study|Death|4|||
105680869|NCT01776541|364495796|FG001|Overall Study|Death|0|||
105680870|NCT01776541|364495795|FG000|Overall Study|Lost to Follow-up|27|||
105680871|NCT01776541|364495796|FG001|Overall Study|Lost to Follow-up|48|||
105680872|NCT01776541|364495795|FG000|Overall Study|Unclassified|5|||
105680873|NCT01776541|364495796|FG001|Overall Study|Unclassified|4|||
105680874|NCT01776541|364495795|FG000|Overall Study|Protocol Violation|2|||
105680875|NCT01776541|364495796|FG001|Overall Study|Protocol Violation|1|||
105680876|NCT01776541|364495795|FG000|Overall Study|Withdrawal by Subject|12|||
105680877|NCT01776541|364495796|FG001|Overall Study|Withdrawal by Subject|20|||
105680878|NCT04279392|364495797|FG000|Overall Study|Physician Decision|1|||
105680879|NCT04279392|364495798|FG001|Overall Study|Physician Decision|0|||
105680880|NCT00700258|364495803|FG000|Overall Study|Premature discontinuation of documentation|136|||
105680881|NCT00700258|364495803|FG000|Overall Study|Type of study end not documented|1|||
105680882|NCT00700258|364495803|FG000|Overall Study|Lost to Follow-up|81|||
105680883|NCT00700258|364495803|FG000|Overall Study|Premature discontinuation of therapy|1013|||
105680884|NCT00370331|364495805|FG000|Overall Study|Adverse Event|4|||
105680885|NCT00370331|364495806|FG001|Overall Study|Adverse Event|13|||
105680886|NCT00370331|364495805|FG000|Overall Study|Withdrawal by Subject|2|||
105680887|NCT00370331|364495806|FG001|Overall Study|Withdrawal by Subject|4|||
105680888|NCT00370331|364495805|FG000|Overall Study|Lost to Follow-up|0|||
105680889|NCT00370331|364495806|FG001|Overall Study|Lost to Follow-up|3|||
105680890|NCT00370331|364495805|FG000|Overall Study|Lack of Efficacy|0|||
105680891|NCT00370331|364495806|FG001|Overall Study|Lack of Efficacy|1|||
105680892|NCT00370331|364495805|FG000|Overall Study|Non-compliance|0|||
105680893|NCT00370331|364495806|FG001|Overall Study|Non-compliance|1|||
105680894|NCT00370331|364495805|FG000|Overall Study|Protocol Violation|1|||
105680895|NCT00370331|364495806|FG001|Overall Study|Protocol Violation|1|||
105680896|NCT01874431|364495807|FG000|Overall Study|Physician Decision|0|||
105680897|NCT01874431|364495808|FG001|Overall Study|Physician Decision|0|||
105680898|NCT01874431|364495809|FG002|Overall Study|Physician Decision|1|||
105680899|NCT01874431|364495810|FG003|Overall Study|Physician Decision|0|||
105680900|NCT01874431|364495811|FG004|Overall Study|Physician Decision|0|||
105680901|NCT01874431|364495812|FG005|Overall Study|Physician Decision|0|||
105680902|NCT01874431|364495813|FG006|Overall Study|Physician Decision|0|||
105680903|NCT01874431|364495814|FG007|Overall Study|Physician Decision|0|||
105680904|NCT01874431|364495807|FG000|Overall Study|Adverse Event|5|||
105680905|NCT01874431|364495808|FG001|Overall Study|Adverse Event|4|||
105680906|NCT01874431|364495809|FG002|Overall Study|Adverse Event|6|||
105680907|NCT01874431|364495810|FG003|Overall Study|Adverse Event|5|||
105680908|NCT01874431|364495811|FG004|Overall Study|Adverse Event|2|||
105680909|NCT01874431|364495812|FG005|Overall Study|Adverse Event|8|||
105680910|NCT01874431|364495813|FG006|Overall Study|Adverse Event|2|||
105680911|NCT01874431|364495814|FG007|Overall Study|Adverse Event|3|||
105680912|NCT01874431|364495807|FG000|Overall Study|Protocol Violation|1|||
105680913|NCT01874431|364495808|FG001|Overall Study|Protocol Violation|1|||
105680914|NCT01874431|364495809|FG002|Overall Study|Protocol Violation|1|||
105680915|NCT01874431|364495810|FG003|Overall Study|Protocol Violation|0|||
105680916|NCT01874431|364495811|FG004|Overall Study|Protocol Violation|3|||
105680917|NCT01874431|364495812|FG005|Overall Study|Protocol Violation|2|||
105680918|NCT01874431|364495813|FG006|Overall Study|Protocol Violation|1|||
105680919|NCT01874431|364495814|FG007|Overall Study|Protocol Violation|1|||
105680920|NCT01874431|364495807|FG000|Overall Study|Non-compliance|0|||
105680921|NCT01874431|364495808|FG001|Overall Study|Non-compliance|0|||
105680922|NCT01874431|364495809|FG002|Overall Study|Non-compliance|0|||
105680923|NCT01874431|364495810|FG003|Overall Study|Non-compliance|0|||
105680924|NCT01874431|364495811|FG004|Overall Study|Non-compliance|1|||
105680925|NCT01874431|364495812|FG005|Overall Study|Non-compliance|0|||
105680926|NCT01874431|364495813|FG006|Overall Study|Non-compliance|1|||
105680927|NCT01874431|364495814|FG007|Overall Study|Non-compliance|0|||
105680928|NCT01874431|364495807|FG000|Overall Study|Logistical difficulties|0|||
105680929|NCT01874431|364495808|FG001|Overall Study|Logistical difficulties|0|||
105680930|NCT01874431|364495809|FG002|Overall Study|Logistical difficulties|0|||
105680931|NCT01874431|364495810|FG003|Overall Study|Logistical difficulties|0|||
105680932|NCT01874431|364495811|FG004|Overall Study|Logistical difficulties|0|||
105680933|NCT01874431|364495812|FG005|Overall Study|Logistical difficulties|0|||
105680934|NCT01874431|364495813|FG006|Overall Study|Logistical difficulties|1|||
105680935|NCT01874431|364495814|FG007|Overall Study|Logistical difficulties|0|||
105680936|NCT01874431|364495807|FG000|Overall Study|Withdrawal by Subject|0|||
105680937|NCT01874431|364495808|FG001|Overall Study|Withdrawal by Subject|0|||
105680938|NCT01874431|364495809|FG002|Overall Study|Withdrawal by Subject|1|||
105680939|NCT01874431|364495810|FG003|Overall Study|Withdrawal by Subject|2|||
105680940|NCT01874431|364495811|FG004|Overall Study|Withdrawal by Subject|1|||
105680941|NCT01874431|364495812|FG005|Overall Study|Withdrawal by Subject|1|||
105680942|NCT01874431|364495813|FG006|Overall Study|Withdrawal by Subject|3|||
105680943|NCT01874431|364495814|FG007|Overall Study|Withdrawal by Subject|0|||
105680944|NCT01874431|364495807|FG000|Overall Study|Sponsor decision|0|||
105680945|NCT01874431|364495808|FG001|Overall Study|Sponsor decision|0|||
105680946|NCT01874431|364495809|FG002|Overall Study|Sponsor decision|0|||
105916277|NCT01618968|365352976|FG001|Overall Study|Death|0|||
105916278|NCT01618968|365352977|FG002|Overall Study|Death|0|||
105916279|NCT01618968|365352978|FG003|Overall Study|Death|1|||
105916280|NCT02230891|365352979|FG000|Baseline|Did not meet inclusion|0|||
105916281|NCT02230891|365352980|FG001|Baseline|Did not meet inclusion|1|||
105916282|NCT02230891|365352981|FG002|Baseline|Did not meet inclusion|1|||
105680947|NCT01874431|364495810|FG003|Overall Study|Sponsor decision|0|||
105680948|NCT01874431|364495811|FG004|Overall Study|Sponsor decision|1|||
105680949|NCT01874431|364495812|FG005|Overall Study|Sponsor decision|0|||
105680950|NCT01874431|364495813|FG006|Overall Study|Sponsor decision|0|||
105680951|NCT01874431|364495814|FG007|Overall Study|Sponsor decision|0|||
105680952|NCT01874431|364495807|FG000|Overall Study|Lost to Follow-up|0|||
105680953|NCT01874431|364495808|FG001|Overall Study|Lost to Follow-up|0|||
105680954|NCT01874431|364495809|FG002|Overall Study|Lost to Follow-up|1|||
105680955|NCT01874431|364495810|FG003|Overall Study|Lost to Follow-up|0|||
105680956|NCT01874431|364495811|FG004|Overall Study|Lost to Follow-up|0|||
105680957|NCT01874431|364495812|FG005|Overall Study|Lost to Follow-up|0|||
105680958|NCT01874431|364495813|FG006|Overall Study|Lost to Follow-up|0|||
105680959|NCT01874431|364495814|FG007|Overall Study|Lost to Follow-up|0|||
105680960|NCT00738582|364495816|FG000|Combination Therapy|Completed Combination Therapy|1|||
105680961|NCT00738582|364495817|FG001|Combination Therapy|Completed Combination Therapy|0|||
105680962|NCT00738582|364495816|FG000|Combination Therapy|Physician Decision|1|||
105680963|NCT00738582|364495817|FG001|Combination Therapy|Physician Decision|0|||
105680964|NCT00738582|364495816|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
105680965|NCT00738582|364495817|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
105680966|NCT00738582|364495816|FG000|Combination Therapy|Other|5|||
105680967|NCT00738582|364495817|FG001|Combination Therapy|Other|0|||
105680968|NCT00738582|364495816|FG000|Combination Therapy|Adverse Event|16|||
105680969|NCT00738582|364495817|FG001|Combination Therapy|Adverse Event|0|||
105680970|NCT00738582|364495816|FG000|Combination Therapy|Progressive Disease|9|||
105680971|NCT00738582|364495817|FG001|Combination Therapy|Progressive Disease|0|||
105680972|NCT00738582|364495816|FG000|Maintenance Therapy|Other|0|||
105680973|NCT00738582|364495817|FG001|Maintenance Therapy|Other|2|||
105680974|NCT00738582|364495816|FG000|Maintenance Therapy|Adverse Event|0|||
105680975|NCT00738582|364495817|FG001|Maintenance Therapy|Adverse Event|6|||
105680976|NCT00738582|364495816|FG000|Maintenance Therapy|Progressive Disease|0|||
105680977|NCT00738582|364495817|FG001|Maintenance Therapy|Progressive Disease|47|||
105680978|NCT00738582|364495816|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
105680979|NCT00738582|364495817|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
105680980|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
105680981|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
105680982|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
105680983|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
105680984|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
105680985|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
105680986|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
105680987|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
105680988|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
105680989|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
105680990|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
105680991|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
105680992|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
105680993|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
105680994|NCT00757588|364495818|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
105680995|NCT00757588|364495819|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
105680996|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
105680997|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
105680998|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
105680999|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
105681000|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
105681001|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
105681002|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
105681003|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
105681004|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
105681005|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
105681006|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
105681007|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
105681008|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
105681009|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
105681010|NCT00757588|364495818|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
105681011|NCT00757588|364495819|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
105681012|NCT01498679|364495821|FG000|Overall Study|Adverse Event|1|||
105681013|NCT01498679|364495822|FG001|Overall Study|Adverse Event|4|||
105681014|NCT01498679|364495821|FG000|Overall Study|Lack of Efficacy|72|||
105681015|NCT01498679|364495822|FG001|Overall Study|Lack of Efficacy|12|||
105681016|NCT01498679|364495821|FG000|Overall Study|Protocol Violation|4|||
105681017|NCT01498679|364495822|FG001|Overall Study|Protocol Violation|0|||
105681018|NCT01498679|364495821|FG000|Overall Study|Physician Decision|0|||
105681019|NCT01498679|364495822|FG001|Overall Study|Physician Decision|2|||
105681020|NCT01498679|364495821|FG000|Overall Study|Withdrawal by Subject|12|||
105681021|NCT01498679|364495822|FG001|Overall Study|Withdrawal by Subject|4|||
105681022|NCT02585232|364495823|FG000|Overall Study|Lost to Follow-up|8|||
105681023|NCT02585232|364495824|FG001|Overall Study|Lost to Follow-up|8|||
105681024|NCT02585232|364495823|FG000|Overall Study|Withdrawal by Subject|4|||
105681025|NCT02585232|364495824|FG001|Overall Study|Withdrawal by Subject|8|||
105681026|NCT01621568|364495830|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
105681027|NCT01621568|364495831|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
105681028|NCT01621568|364495830|FG000|Week 5-6 No Treatment|Death|1|||
105681029|NCT01621568|364495831|FG001|Week 5-6 No Treatment|Death|0|||
105681030|NCT00682890|364495833|FG000|Overall Study|Lost to Follow-up|1|||
105681031|NCT00682890|364495834|FG001|Overall Study|Lost to Follow-up|1|||
105681032|NCT00682890|364495833|FG000|Overall Study|subject moved away|0|||
105681033|NCT00682890|364495834|FG001|Overall Study|subject moved away|1|||
105681034|NCT00682890|364495833|FG000|Overall Study|heavy menstrual bleeding|1|||
105681035|NCT00682890|364495834|FG001|Overall Study|heavy menstrual bleeding|0|||
105681036|NCT01323647|364495835|FG000|Overall Study|Migrated/moved from study area|2|||
105681037|NCT01323647|364495836|FG001|Overall Study|Migrated/moved from study area|0|||
105681038|NCT01323647|364495835|FG000|Overall Study|Withdrawal by Subject|5|||
105681039|NCT01323647|364495836|FG001|Overall Study|Withdrawal by Subject|0|||
105681040|NCT01323647|364495835|FG000|Overall Study|Lost to Follow-up|2|||
105681041|NCT01323647|364495836|FG001|Overall Study|Lost to Follow-up|0|||
105681042|NCT01577745|364495839|FG000|Overall Study|Withdrawal by Subject|0|||
105681043|NCT01577745|364495840|FG001|Overall Study|Withdrawal by Subject|1|||
105681044|NCT01577745|364495841|FG002|Overall Study|Withdrawal by Subject|0|||
105681045|NCT01577745|364495842|FG003|Overall Study|Withdrawal by Subject|3|||
105681046|NCT01577745|364495843|FG004|Overall Study|Withdrawal by Subject|2|||
105681047|NCT01577745|364495844|FG005|Overall Study|Withdrawal by Subject|0|||
105681048|NCT01577745|364495839|FG000|Overall Study|Death|3|||
105681049|NCT01577745|364495840|FG001|Overall Study|Death|2|||
105681050|NCT01577745|364495841|FG002|Overall Study|Death|2|||
105681051|NCT01577745|364495842|FG003|Overall Study|Death|1|||
105681052|NCT01577745|364495843|FG004|Overall Study|Death|1|||
105681053|NCT01577745|364495844|FG005|Overall Study|Death|3|||
105681054|NCT01577745|364495839|FG000|Overall Study|Physician Decision|0|||
105681055|NCT01577745|364495840|FG001|Overall Study|Physician Decision|0|||
105681056|NCT01577745|364495841|FG002|Overall Study|Physician Decision|0|||
105681057|NCT01577745|364495842|FG003|Overall Study|Physician Decision|1|||
105681058|NCT01577745|364495843|FG004|Overall Study|Physician Decision|1|||
105681059|NCT01577745|364495844|FG005|Overall Study|Physician Decision|0|||
105681060|NCT01577745|364495839|FG000|Overall Study|Lost to Follow-up|0|||
105681061|NCT01577745|364495840|FG001|Overall Study|Lost to Follow-up|0|||
105681062|NCT01577745|364495841|FG002|Overall Study|Lost to Follow-up|0|||
105681063|NCT01577745|364495842|FG003|Overall Study|Lost to Follow-up|0|||
105681064|NCT01577745|364495843|FG004|Overall Study|Lost to Follow-up|0|||
105681065|NCT01577745|364495844|FG005|Overall Study|Lost to Follow-up|1|||
105681066|NCT01577745|364495839|FG000|Overall Study|Alternative Therapy|0|||
105681067|NCT01577745|364495840|FG001|Overall Study|Alternative Therapy|0|||
105681068|NCT01577745|364495841|FG002|Overall Study|Alternative Therapy|0|||
105681069|NCT01577745|364495842|FG003|Overall Study|Alternative Therapy|1|||
105681070|NCT01577745|364495843|FG004|Overall Study|Alternative Therapy|1|||
105681071|NCT01577745|364495844|FG005|Overall Study|Alternative Therapy|0|||
105681072|NCT00262951|364495845|FG000|Overall Study|Progressive disease/relapse|3|||
105681073|NCT00262951|364495845|FG000|Overall Study|Adverse Event|7|||
105681074|NCT00262951|364495845|FG000|Overall Study|Death|1|||
105681075|NCT00262951|364495845|FG000|Overall Study|Withdrawal by Subject|1|||
105681076|NCT00262951|364495845|FG000|Overall Study|Alternative treatment|3|||
105681077|NCT00262951|364495845|FG000|Overall Study|Off treatment for other disease|1|||
105681078|NCT01590082|364495846|FG000|Overall Study|Withdrawal by Subject|1|||
105681079|NCT01590082|364495847|FG001|Overall Study|Withdrawal by Subject|0|||
105681080|NCT01590082|364495846|FG000|Overall Study|Ineligible|1|||
105681081|NCT01590082|364495847|FG001|Overall Study|Ineligible|0|||
105681082|NCT02891408|364495848|FG000|Overall Study|Lost to Follow-up|0|||
105681083|NCT02891408|364495849|FG001|Overall Study|Lost to Follow-up|0|||
105681084|NCT02891408|364495850|FG002|Overall Study|Lost to Follow-up|1|||
105681085|NCT02891408|364495851|FG003|Overall Study|Lost to Follow-up|0|||
105681086|NCT02891408|364495852|FG004|Overall Study|Lost to Follow-up|0|||
105681087|NCT02891408|364495853|FG005|Overall Study|Lost to Follow-up|0|||
105681088|NCT02891408|364495854|FG006|Overall Study|Lost to Follow-up|0|||
105681089|NCT03814187|364495855|FG000|Overall Study|Sponsor's Administrative Decision|0|||
105681090|NCT03814187|364495856|FG001|Overall Study|Sponsor's Administrative Decision|0|||
105681091|NCT03814187|364495857|FG002|Overall Study|Sponsor's Administrative Decision|272|||
105681092|NCT03814187|364495855|FG000|Overall Study|Death|80|||
105681093|NCT03814187|364495856|FG001|Overall Study|Death|81|||
105681094|NCT03814187|364495857|FG002|Overall Study|Death|4|||
105681095|NCT03814187|364495855|FG000|Overall Study|Withdrew Consent|77|||
105681096|NCT03814187|364495856|FG001|Overall Study|Withdrew Consent|78|||
105681097|NCT03814187|364495857|FG002|Overall Study|Withdrew Consent|2|||
105681098|NCT03814187|364495855|FG000|Overall Study|Lost to Follow-up|47|||
105681099|NCT03814187|364495856|FG001|Overall Study|Lost to Follow-up|52|||
105681100|NCT03814187|364495857|FG002|Overall Study|Lost to Follow-up|1|||
105681101|NCT03814187|364495855|FG000|Overall Study|Adverse Event|22|||
105681102|NCT03814187|364495856|FG001|Overall Study|Adverse Event|23|||
105681103|NCT03814187|364495857|FG002|Overall Study|Adverse Event|0|||
105681104|NCT03814187|364495855|FG000|Overall Study|Physician Decision|7|||
105681105|NCT03814187|364495856|FG001|Overall Study|Physician Decision|4|||
105681106|NCT03814187|364495857|FG002|Overall Study|Physician Decision|2|||
105681107|NCT03814187|364495855|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
105681108|NCT03814187|364495856|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
105681109|NCT03814187|364495857|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
105681110|NCT03814187|364495855|FG000|Overall Study|Other reasons|34|||
105681111|NCT03814187|364495856|FG001|Overall Study|Other reasons|40|||
105681112|NCT03814187|364495857|FG002|Overall Study|Other reasons|2|||
105681113|NCT01535560|364495858|FG000|Overall Study|Adverse Event|12|||
105681114|NCT01535560|364495859|FG001|Overall Study|Adverse Event|7|||
105681115|NCT01535560|364495858|FG000|Overall Study|Lost to Follow-up|1|||
105681116|NCT01535560|364495859|FG001|Overall Study|Lost to Follow-up|3|||
105681117|NCT01535560|364495858|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
105681118|NCT01535560|364495859|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
105681119|NCT01535560|364495858|FG000|Overall Study|Treatment Failure|21|||
105681120|NCT01535560|364495859|FG001|Overall Study|Treatment Failure|83|||
105681121|NCT01535560|364495858|FG000|Overall Study|Other|0|||
105681122|NCT01535560|364495859|FG001|Overall Study|Other|1|||
105681123|NCT01535560|364495858|FG000|Overall Study|Randomized in Error|0|||
105681124|NCT01535560|364495859|FG001|Overall Study|Randomized in Error|1|||
105681125|NCT00950950|364495865|FG000|Overall Study|Adverse Event|1|||
105681126|NCT00950950|364495866|FG001|Overall Study|Adverse Event|0|||
105681127|NCT00950950|364495865|FG000|Overall Study|Withdrawal by Subject|0|||
105681128|NCT00950950|364495866|FG001|Overall Study|Withdrawal by Subject|1|||
105681129|NCT01047293|364495867|FG000|Overall Study|DLT criteria not fulfilled|1|||
105681130|NCT01047293|364495868|FG001|Overall Study|DLT criteria not fulfilled|1|||
105681131|NCT01047293|364495869|FG002|Overall Study|DLT criteria not fulfilled|0|||
105681132|NCT01047293|364495870|FG003|Overall Study|DLT criteria not fulfilled|0|||
105681133|NCT02054520|364495876|FG000|Overall Study|Adverse Event|1|||
105681134|NCT02054520|364495877|FG001|Overall Study|Adverse Event|4|||
105681135|NCT02054520|364495878|FG002|Overall Study|Adverse Event|2|||
105681136|NCT02054520|364495879|FG003|Overall Study|Adverse Event|1|||
105681137|NCT02054520|364495880|FG004|Overall Study|Adverse Event|1|||
105681138|NCT02054520|364495881|FG005|Overall Study|Adverse Event|0|||
105681139|NCT02054520|364495876|FG000|Overall Study|Lack of Efficacy|7|||
105681140|NCT02054520|364495877|FG001|Overall Study|Lack of Efficacy|0|||
105681141|NCT02054520|364495878|FG002|Overall Study|Lack of Efficacy|2|||
105681142|NCT02054520|364495879|FG003|Overall Study|Lack of Efficacy|1|||
105681143|NCT02054520|364495880|FG004|Overall Study|Lack of Efficacy|3|||
105681144|NCT02054520|364495881|FG005|Overall Study|Lack of Efficacy|2|||
105681145|NCT02054520|364495876|FG000|Overall Study|Withdrawal by Subject|1|||
105681146|NCT02054520|364495877|FG001|Overall Study|Withdrawal by Subject|0|||
105681147|NCT02054520|364495878|FG002|Overall Study|Withdrawal by Subject|0|||
105681148|NCT02054520|364495879|FG003|Overall Study|Withdrawal by Subject|2|||
105681149|NCT02054520|364495880|FG004|Overall Study|Withdrawal by Subject|1|||
105681150|NCT02054520|364495881|FG005|Overall Study|Withdrawal by Subject|0|||
105681151|NCT02054520|364495876|FG000|Overall Study|Physician Decision|0|||
105681152|NCT02054520|364495877|FG001|Overall Study|Physician Decision|1|||
105681153|NCT02054520|364495878|FG002|Overall Study|Physician Decision|0|||
105681154|NCT02054520|364495879|FG003|Overall Study|Physician Decision|1|||
105681155|NCT02054520|364495880|FG004|Overall Study|Physician Decision|0|||
105681156|NCT02054520|364495881|FG005|Overall Study|Physician Decision|1|||
105681157|NCT02054520|364495876|FG000|Overall Study|Study terminated by Sponsor|0|||
105681158|NCT02054520|364495877|FG001|Overall Study|Study terminated by Sponsor|0|||
105681159|NCT02054520|364495878|FG002|Overall Study|Study terminated by Sponsor|2|||
105681160|NCT02054520|364495879|FG003|Overall Study|Study terminated by Sponsor|1|||
105681161|NCT02054520|364495880|FG004|Overall Study|Study terminated by Sponsor|0|||
105681162|NCT02054520|364495881|FG005|Overall Study|Study terminated by Sponsor|0|||
105681163|NCT00985946|364495882|FG000|Overall Study|Lost to Follow-up|6|||
105681164|NCT00985946|364495882|FG000|Overall Study|Withdrawal by Subject|1|||
106127818|NCT01474512|366125535|FG004|Long-Term Extension Period|Death|0|||
105681165|NCT01395888|364495887|FG000|2-week Run-in Period|Adverse Event|2|||
106127819|NCT01474512|366125536|FG005|Long-Term Extension Period|Death|0|||
105681166|NCT01395888|364495888|FG001|2-week Run-in Period|Adverse Event|0|||
105681167|NCT01395888|364495889|FG002|2-week Run-in Period|Adverse Event|0|||
105681168|NCT01395888|364495887|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
105681169|NCT01395888|364495888|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
105681170|NCT01395888|364495889|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
105681171|NCT01395888|364495887|FG000|2-week Run-in Period|Lost to Follow-up|1|||
106127820|NCT01474512|366125537|FG006|Long-Term Extension Period|Death|0|||
105681172|NCT01395888|364495888|FG001|2-week Run-in Period|Lost to Follow-up|0|||
106127821|NCT01474512|366125538|FG007|Long-Term Extension Period|Death|0|||
105681173|NCT01395888|364495889|FG002|2-week Run-in Period|Lost to Follow-up|0|||
105681174|NCT01395888|364495887|FG000|2-week Run-in Period|Protocol Violation|2|||
105681175|NCT01395888|364495888|FG001|2-week Run-in Period|Protocol Violation|0|||
106000992|NCT02903914|365665180|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
106000993|NCT02903914|365665181|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
106000994|NCT02903914|365665182|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
106000995|NCT02903914|365665183|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
106000996|NCT02903914|365665176|FG000|Overall Study|Clinical Disease Progression|0|||
106000997|NCT02903914|365665177|FG001|Overall Study|Clinical Disease Progression|0|||
106000998|NCT02903914|365665178|FG002|Overall Study|Clinical Disease Progression|2|||
106000999|NCT02903914|365665179|FG003|Overall Study|Clinical Disease Progression|0|||
106001000|NCT02903914|365665180|FG004|Overall Study|Clinical Disease Progression|0|||
106001001|NCT02903914|365665181|FG005|Overall Study|Clinical Disease Progression|0|||
106001002|NCT02903914|365665182|FG006|Overall Study|Clinical Disease Progression|0|||
106001003|NCT02903914|365665183|FG007|Overall Study|Clinical Disease Progression|0|||
106001004|NCT02903914|365665176|FG000|Overall Study|Completed Follow-up Period|0|||
106001005|NCT02903914|365665177|FG001|Overall Study|Completed Follow-up Period|0|||
106001006|NCT02903914|365665178|FG002|Overall Study|Completed Follow-up Period|6|||
106001007|NCT02903914|365665179|FG003|Overall Study|Completed Follow-up Period|2|||
106001008|NCT02903914|365665180|FG004|Overall Study|Completed Follow-up Period|1|||
106001009|NCT02903914|365665181|FG005|Overall Study|Completed Follow-up Period|0|||
106001010|NCT02903914|365665182|FG006|Overall Study|Completed Follow-up Period|9|||
106001011|NCT02903914|365665183|FG007|Overall Study|Completed Follow-up Period|1|||
106001012|NCT02903914|365665176|FG000|Overall Study|Taken off Treatment per Protocol|0|||
106001013|NCT02903914|365665177|FG001|Overall Study|Taken off Treatment per Protocol|0|||
106001014|NCT02903914|365665178|FG002|Overall Study|Taken off Treatment per Protocol|0|||
106001015|NCT02903914|365665179|FG003|Overall Study|Taken off Treatment per Protocol|0|||
106001016|NCT02903914|365665180|FG004|Overall Study|Taken off Treatment per Protocol|0|||
106001017|NCT02903914|365665181|FG005|Overall Study|Taken off Treatment per Protocol|1|||
106001018|NCT02903914|365665182|FG006|Overall Study|Taken off Treatment per Protocol|0|||
106001019|NCT02903914|365665183|FG007|Overall Study|Taken off Treatment per Protocol|0|||
106001020|NCT02903914|365665176|FG000|Overall Study|Refused Further Treatment/Contact|0|||
106001021|NCT02903914|365665177|FG001|Overall Study|Refused Further Treatment/Contact|0|||
106001022|NCT02903914|365665178|FG002|Overall Study|Refused Further Treatment/Contact|0|||
106001023|NCT02903914|365665179|FG003|Overall Study|Refused Further Treatment/Contact|0|||
106001024|NCT02903914|365665180|FG004|Overall Study|Refused Further Treatment/Contact|0|||
106001025|NCT02903914|365665181|FG005|Overall Study|Refused Further Treatment/Contact|0|||
106001026|NCT02903914|365665182|FG006|Overall Study|Refused Further Treatment/Contact|1|||
106001027|NCT02903914|365665183|FG007|Overall Study|Refused Further Treatment/Contact|0|||
106001028|NCT02903914|365665176|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
106001029|NCT02903914|365665177|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
106001030|NCT02903914|365665178|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
106001031|NCT02903914|365665179|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
106001032|NCT02903914|365665180|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
106001033|NCT02903914|365665181|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
106001034|NCT02903914|365665182|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
106001035|NCT02903914|365665183|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
106001036|NCT01255423|365665184|FG000|Overall Study|Abnormal Laboratory value|3|||
106001037|NCT01255423|365665185|FG001|Overall Study|Abnormal Laboratory value|2|||
106001038|NCT01255423|365665184|FG000|Overall Study|Use of prohibited medications|0|||
106001039|NCT01255423|365665185|FG001|Overall Study|Use of prohibited medications|1|||
106001040|NCT05470387|365665186|FG000|Overall Study|Protocol Violation|0|||
106001041|NCT05470387|365665187|FG001|Overall Study|Protocol Violation|3|||
106001042|NCT00657046|365665188|FG000|Overall Study|Adverse Event|1|||
106001043|NCT00657046|365665189|FG001|Overall Study|Adverse Event|1|||
106001044|NCT00657046|365665190|FG002|Overall Study|Adverse Event|0|||
106001045|NCT00657046|365665188|FG000|Overall Study|Protocol Violation|2|||
106001046|NCT00657046|365665189|FG001|Overall Study|Protocol Violation|2|||
105681176|NCT01395888|364495889|FG002|2-week Run-in Period|Protocol Violation|0|||
105681177|NCT01395888|364495887|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
106001047|NCT00657046|365665190|FG002|Overall Study|Protocol Violation|0|||
106001048|NCT00657046|365665188|FG000|Overall Study|Withdrawal by Subject|1|||
106001049|NCT00657046|365665189|FG001|Overall Study|Withdrawal by Subject|0|||
106001050|NCT00657046|365665190|FG002|Overall Study|Withdrawal by Subject|0|||
106001051|NCT00657046|365665188|FG000|Overall Study|Death|0|||
106001052|NCT00657046|365665189|FG001|Overall Study|Death|0|||
106001053|NCT00657046|365665190|FG002|Overall Study|Death|1|||
106001054|NCT00657046|365665188|FG000|Overall Study|Surgery|0|||
106001055|NCT00657046|365665189|FG001|Overall Study|Surgery|0|||
105681178|NCT01395888|364495888|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105681179|NCT01395888|364495889|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105681180|NCT01395888|364495887|FG000|Treatment Period (TP)|Adverse Event|0|||
105681181|NCT01395888|364495888|FG001|Treatment Period (TP)|Adverse Event|7|||
105681182|NCT01395888|364495889|FG002|Treatment Period (TP)|Adverse Event|6|||
105681183|NCT01395888|364495887|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
105681184|NCT01395888|364495888|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
105681185|NCT01395888|364495889|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
105681186|NCT01395888|364495887|FG000|Treatment Period (TP)|Protocol Violation|0|||
105681187|NCT01395888|364495888|FG001|Treatment Period (TP)|Protocol Violation|1|||
105681188|NCT01395888|364495889|FG002|Treatment Period (TP)|Protocol Violation|5|||
105681189|NCT01395888|364495887|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
105681190|NCT01395888|364495888|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
105681191|NCT01395888|364495889|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
105681192|NCT01395888|364495887|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
105681193|NCT01395888|364495888|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
105681194|NCT01395888|364495889|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
105681195|NCT00928018|364495890|FG000|Overall Study|Withdrawal by Subject|1|||
105681196|NCT00928018|364495891|FG001|Overall Study|Withdrawal by Subject|0|||
105681197|NCT03218397|364495892|FG000|Overall Study|Prior positive blood culture|8|||
105681198|NCT03218397|364495893|FG001|Overall Study|Prior positive blood culture|13|||
105681199|NCT03218397|364495892|FG000|Overall Study|Comfort care|8|||
105681200|NCT03218397|364495893|FG001|Overall Study|Comfort care|5|||
105681201|NCT03218397|364495892|FG000|Overall Study|Comfort care and positive blood culture|1|||
105681202|NCT03218397|364495893|FG001|Overall Study|Comfort care and positive blood culture|0|||
105681203|NCT03218397|364495892|FG000|Overall Study|Comfort care and mixed culture|0|||
105681204|NCT03218397|364495893|FG001|Overall Study|Comfort care and mixed culture|1|||
105681205|NCT03218397|364495892|FG000|Overall Study|Mixed culture|2|||
105681206|NCT03218397|364495893|FG001|Overall Study|Mixed culture|2|||
105681207|NCT03218397|364495892|FG000|Overall Study|Inaccessible hospital records|2|||
105681208|NCT03218397|364495893|FG001|Overall Study|Inaccessible hospital records|5|||
105681209|NCT03218397|364495892|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
105681210|NCT03218397|364495893|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
105681211|NCT03218397|364495892|FG000|Overall Study|Randomized during laboratory off hours|2|||
105681212|NCT03218397|364495893|FG001|Overall Study|Randomized during laboratory off hours|1|||
105681213|NCT01796548|364495894|FG000|Overall Study|Lost to Follow-up|1|||
105681214|NCT01796548|364495894|FG000|Overall Study|Other|2|||
105681215|NCT02457559|364495895|FG000|Overall Study|Progressive Disease|1|||
105681216|NCT02457559|364495896|FG001|Overall Study|Progressive Disease|2|||
105681217|NCT02457559|364495897|FG002|Overall Study|Progressive Disease|3|||
105681218|NCT02457559|364495898|FG003|Overall Study|Progressive Disease|0|||
106001056|NCT00657046|365665190|FG002|Overall Study|Surgery|1|||
105681219|NCT02457559|364495899|FG004|Overall Study|Progressive Disease|0|||
105681220|NCT02457559|364495900|FG005|Overall Study|Progressive Disease|2|||
105681221|NCT02457559|364495901|FG006|Overall Study|Progressive Disease|1|||
105681222|NCT02457559|364495902|FG007|Overall Study|Progressive Disease|0|||
105681223|NCT02457559|364495903|FG008|Overall Study|Progressive Disease|1|||
105681224|NCT02457559|364495904|FG009|Overall Study|Progressive Disease|1|||
105681225|NCT02457559|364495905|FG010|Overall Study|Progressive Disease|1|||
105681226|NCT02457559|364495895|FG000|Overall Study|Investigator's Discretion|0|||
105681227|NCT02457559|364495896|FG001|Overall Study|Investigator's Discretion|0|||
105681228|NCT02457559|364495897|FG002|Overall Study|Investigator's Discretion|2|||
105681229|NCT02457559|364495898|FG003|Overall Study|Investigator's Discretion|0|||
105681230|NCT02457559|364495899|FG004|Overall Study|Investigator's Discretion|1|||
105681231|NCT02457559|364495900|FG005|Overall Study|Investigator's Discretion|0|||
106001057|NCT01858363|365665195|FG000|Overall Study|Death|35|||
106001058|NCT01858363|365665196|FG001|Overall Study|Death|9|||
106001059|NCT01858363|365665195|FG000|Overall Study|Withdrawal by Subject|28|||
106001060|NCT01858363|365665196|FG001|Overall Study|Withdrawal by Subject|14|||
106001061|NCT01858363|365665195|FG000|Overall Study|Lost to Follow-up|13|||
106001062|NCT01858363|365665196|FG001|Overall Study|Lost to Follow-up|3|||
106001063|NCT00088530|365665197|FG000|Overall Study|Progressive/Relapsed Disease|28|||
106001064|NCT00088530|365665198|FG001|Overall Study|Progressive/Relapsed Disease|39|||
105681232|NCT02457559|364495901|FG006|Overall Study|Investigator's Discretion|1|||
105681233|NCT02457559|364495902|FG007|Overall Study|Investigator's Discretion|0|||
105681234|NCT02457559|364495903|FG008|Overall Study|Investigator's Discretion|1|||
105681235|NCT02457559|364495904|FG009|Overall Study|Investigator's Discretion|0|||
105681236|NCT02457559|364495905|FG010|Overall Study|Investigator's Discretion|1|||
105681237|NCT02457559|364495895|FG000|Overall Study|Adverse Event|0|||
105681238|NCT02457559|364495896|FG001|Overall Study|Adverse Event|1|||
105681239|NCT02457559|364495897|FG002|Overall Study|Adverse Event|2|||
105681240|NCT02457559|364495898|FG003|Overall Study|Adverse Event|0|||
105681241|NCT02457559|364495899|FG004|Overall Study|Adverse Event|0|||
105681242|NCT02457559|364495900|FG005|Overall Study|Adverse Event|0|||
105681243|NCT02457559|364495901|FG006|Overall Study|Adverse Event|0|||
105681244|NCT02457559|364495902|FG007|Overall Study|Adverse Event|0|||
105681245|NCT02457559|364495903|FG008|Overall Study|Adverse Event|0|||
105681246|NCT02457559|364495904|FG009|Overall Study|Adverse Event|0|||
105681247|NCT02457559|364495905|FG010|Overall Study|Adverse Event|0|||
105681248|NCT02457559|364495895|FG000|Overall Study|Reason not Specified|1|||
105681249|NCT02457559|364495896|FG001|Overall Study|Reason not Specified|0|||
105681250|NCT02457559|364495897|FG002|Overall Study|Reason not Specified|0|||
105681251|NCT02457559|364495898|FG003|Overall Study|Reason not Specified|0|||
105681252|NCT02457559|364495899|FG004|Overall Study|Reason not Specified|0|||
105681253|NCT02457559|364495900|FG005|Overall Study|Reason not Specified|0|||
105916283|NCT02230891|365352979|FG000|2 Week|Withdrawal by Subject|2|||
105916284|NCT02230891|365352980|FG001|2 Week|Withdrawal by Subject|2|||
105916285|NCT02230891|365352981|FG002|2 Week|Withdrawal by Subject|0|||
105916286|NCT02230891|365352979|FG000|2 Week|Consent withdrawn|1|||
105916287|NCT02230891|365352980|FG001|2 Week|Consent withdrawn|0|||
105916288|NCT02230891|365352981|FG002|2 Week|Consent withdrawn|0|||
105916289|NCT02230891|365352979|FG000|6 Month|Withdrawal by Subject|1|||
105916290|NCT02230891|365352980|FG001|6 Month|Withdrawal by Subject|1|||
105916291|NCT02230891|365352981|FG002|6 Month|Withdrawal by Subject|1|||
105916292|NCT02230891|365352979|FG000|6 Month|Physician Decision|0|||
105916293|NCT02230891|365352980|FG001|6 Month|Physician Decision|2|||
105916294|NCT02230891|365352981|FG002|6 Month|Physician Decision|0|||
105916295|NCT02230891|365352979|FG000|12 Month|Death|1|||
105916296|NCT02230891|365352980|FG001|12 Month|Death|0|||
105916297|NCT02230891|365352981|FG002|12 Month|Death|0|||
105916298|NCT02230891|365352979|FG000|12 Month|Lost to Follow-up|0|||
105916299|NCT02230891|365352980|FG001|12 Month|Lost to Follow-up|1|||
105916300|NCT02230891|365352981|FG002|12 Month|Lost to Follow-up|0|||
105916301|NCT02230891|365352979|FG000|12 Month|Withdrawal by Subject|0|||
105916302|NCT02230891|365352980|FG001|12 Month|Withdrawal by Subject|2|||
105916303|NCT02230891|365352981|FG002|12 Month|Withdrawal by Subject|0|||
105916304|NCT02230891|365352979|FG000|18 Month End of Study|Death|0|||
105916305|NCT02230891|365352980|FG001|18 Month End of Study|Death|0|||
105916306|NCT02230891|365352981|FG002|18 Month End of Study|Death|1|||
105916307|NCT02230891|365352979|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
105916308|NCT02230891|365352980|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
105916309|NCT02230891|365352981|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
105916310|NCT03641508|365352982|FG000|First Injection|Lost to Follow-up|2|||
105916311|NCT03641508|365352983|FG001|First Injection|Lost to Follow-up|0|||
105916312|NCT02404545|365352984|FG000|Overall Study|Sponsor Termination|6|||
105916313|NCT02404545|365352985|FG001|Overall Study|Sponsor Termination|6|||
105916314|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
105916315|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
105916316|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
105916317|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
105916318|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
105916319|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
105916320|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
105916321|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105916322|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105916323|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
105916324|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
105916325|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
105916326|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
105916327|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
105916328|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
105916329|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
105916330|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
105916331|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
105916332|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
105916333|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
105916334|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
105916335|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
105916336|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
105916337|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
105916338|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
105681254|NCT02457559|364495901|FG006|Overall Study|Reason not Specified|0|||
105681255|NCT02457559|364495902|FG007|Overall Study|Reason not Specified|0|||
105916339|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
105916340|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
105916341|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
105681256|NCT02457559|364495903|FG008|Overall Study|Reason not Specified|0|||
105916342|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
105681257|NCT02457559|364495904|FG009|Overall Study|Reason not Specified|2|||
105681258|NCT02457559|364495905|FG010|Overall Study|Reason not Specified|0|||
105681259|NCT02457559|364495895|FG000|Overall Study|Death|0|||
105681260|NCT02457559|364495896|FG001|Overall Study|Death|0|||
105681261|NCT02457559|364495897|FG002|Overall Study|Death|0|||
105681262|NCT02457559|364495898|FG003|Overall Study|Death|0|||
105681263|NCT02457559|364495899|FG004|Overall Study|Death|0|||
105681264|NCT02457559|364495900|FG005|Overall Study|Death|0|||
105681265|NCT02457559|364495901|FG006|Overall Study|Death|0|||
105681266|NCT02457559|364495902|FG007|Overall Study|Death|0|||
105681267|NCT02457559|364495903|FG008|Overall Study|Death|1|||
105681268|NCT02457559|364495904|FG009|Overall Study|Death|1|||
105681269|NCT02457559|364495905|FG010|Overall Study|Death|0|||
105681270|NCT03075410|364495910|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
105681271|NCT03075410|364495911|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681272|NCT03075410|364495912|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
105681273|NCT03075410|364495913|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681274|NCT03075410|364495914|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681275|NCT03075410|364495915|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681276|NCT03075410|364495916|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681277|NCT03075410|364495917|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681278|NCT03075410|364495918|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
105681279|NCT03075410|364495910|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
105681280|NCT03075410|364495911|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681281|NCT03075410|364495912|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681282|NCT03075410|364495913|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681283|NCT03075410|364495914|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681284|NCT03075410|364495915|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681285|NCT03075410|364495916|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681286|NCT03075410|364495917|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681287|NCT03075410|364495918|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
105681288|NCT01427751|364495919|FG000|Overall Study|Adverse Event|18|||
105681289|NCT01427751|364495920|FG001|Overall Study|Adverse Event|2|||
105681290|NCT01427751|364495919|FG000|Overall Study|No further treatment benefit expected|5|||
105681291|NCT01427751|364495920|FG001|Overall Study|No further treatment benefit expected|1|||
105681292|NCT01427751|364495919|FG000|Overall Study|Lost to Follow-up|3|||
105681293|NCT01427751|364495920|FG001|Overall Study|Lost to Follow-up|1|||
105681294|NCT01427751|364495919|FG000|Overall Study|Withdrawal of consent|2|||
105681295|NCT01427751|364495920|FG001|Overall Study|Withdrawal of consent|2|||
105681296|NCT01427751|364495919|FG000|Overall Study|Protocol Violation|6|||
105681297|NCT01427751|364495920|FG001|Overall Study|Protocol Violation|4|||
105681298|NCT01427751|364495919|FG000|Overall Study|Death|2|||
105681299|NCT01427751|364495920|FG001|Overall Study|Death|0|||
105681300|NCT01427751|364495919|FG000|Overall Study|Other miscellaneous reasons|6|||
105681301|NCT01427751|364495920|FG001|Overall Study|Other miscellaneous reasons|4|||
105681302|NCT00790751|364495929|FG000|Overall Study|Protocol non-compliance|16|||
105681303|NCT00790751|364495930|FG001|Overall Study|Protocol non-compliance|16|||
105681304|NCT00790751|364495931|FG002|Overall Study|Protocol non-compliance|10|||
105681305|NCT00790751|364495932|FG003|Overall Study|Protocol non-compliance|11|||
105681306|NCT00790751|364495929|FG000|Overall Study|Lost to Follow-up|4|||
105681307|NCT00790751|364495930|FG001|Overall Study|Lost to Follow-up|9|||
105681308|NCT00790751|364495931|FG002|Overall Study|Lost to Follow-up|4|||
105681309|NCT00790751|364495932|FG003|Overall Study|Lost to Follow-up|5|||
105681310|NCT00790751|364495929|FG000|Overall Study|Adverse Event|5|||
105681311|NCT00790751|364495930|FG001|Overall Study|Adverse Event|3|||
105681312|NCT00790751|364495931|FG002|Overall Study|Adverse Event|5|||
105681313|NCT00790751|364495932|FG003|Overall Study|Adverse Event|4|||
105681314|NCT00790751|364495929|FG000|Overall Study|Requirement for restricted medication|0|||
105681315|NCT00790751|364495930|FG001|Overall Study|Requirement for restricted medication|2|||
105681316|NCT00790751|364495931|FG002|Overall Study|Requirement for restricted medication|0|||
105681317|NCT00790751|364495932|FG003|Overall Study|Requirement for restricted medication|0|||
105681318|NCT00790751|364495929|FG000|Overall Study|Death|0|||
105681319|NCT00790751|364495930|FG001|Overall Study|Death|0|||
105681320|NCT00790751|364495931|FG002|Overall Study|Death|1|||
105681321|NCT00790751|364495932|FG003|Overall Study|Death|0|||
105681322|NCT00790751|364495929|FG000|Overall Study|Physician Decision|0|||
105681323|NCT00790751|364495930|FG001|Overall Study|Physician Decision|0|||
105681324|NCT00790751|364495931|FG002|Overall Study|Physician Decision|0|||
105681325|NCT00790751|364495932|FG003|Overall Study|Physician Decision|1|||
105681326|NCT04002401|364495933|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
105681327|NCT04002401|364495933|FG000|Overall Study|Death|10|||
105681328|NCT04002401|364495933|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
105681329|NCT04002401|364495933|FG000|Overall Study|Enrolled but Never Treated|1|||
105681330|NCT04002401|364495933|FG000|Overall Study|Lost to Follow-up|1|||
105681331|NCT03035201|364495938|FG000|Overall Study|Death|9|||
105681332|NCT03035201|364495939|FG001|Overall Study|Death|12|||
105681333|NCT03035201|364495940|FG002|Overall Study|Death|9|||
105681334|NCT03035201|364495941|FG003|Overall Study|Death|10|||
105681335|NCT03035201|364495938|FG000|Overall Study|Withdrawal by Subject|51|||
105681336|NCT03035201|364495939|FG001|Overall Study|Withdrawal by Subject|49|||
105681337|NCT03035201|364495940|FG002|Overall Study|Withdrawal by Subject|37|||
105681338|NCT03035201|364495941|FG003|Overall Study|Withdrawal by Subject|46|||
105681339|NCT03035201|364495938|FG000|Overall Study|Lost to Follow-up|67|||
105681340|NCT03035201|364495939|FG001|Overall Study|Lost to Follow-up|51|||
105681341|NCT03035201|364495940|FG002|Overall Study|Lost to Follow-up|64|||
105681342|NCT03035201|364495941|FG003|Overall Study|Lost to Follow-up|69|||
105681343|NCT03432260|364495942|FG000|Overall Study|Lost to Follow-up|1|||
105681344|NCT03432260|364495943|FG001|Overall Study|Lost to Follow-up|1|||
105681345|NCT03432260|364495944|FG002|Overall Study|Lost to Follow-up|0|||
105681346|NCT03432260|364495945|FG003|Overall Study|Lost to Follow-up|0|||
105681347|NCT03432260|364495946|FG004|Overall Study|Lost to Follow-up|1|||
105681348|NCT03319849|364495947|FG000|Overall Study|Adverse Event|1|||
105681349|NCT03319849|364495948|FG001|Overall Study|Adverse Event|0|||
105681350|NCT03319849|364495947|FG000|Overall Study|Physician Decision|0|||
105681351|NCT03319849|364495948|FG001|Overall Study|Physician Decision|1|||
105681352|NCT03319849|364495947|FG000|Overall Study|Withdrawal by Subject|0|||
105681353|NCT03319849|364495948|FG001|Overall Study|Withdrawal by Subject|1|||
105681354|NCT03319849|364495947|FG000|Overall Study|COVID-19|0|||
105681355|NCT03319849|364495948|FG001|Overall Study|COVID-19|1|||
105681356|NCT03319849|364495947|FG000|Overall Study|Other|1|||
105681357|NCT03319849|364495948|FG001|Overall Study|Other|2|||
105681358|NCT03319849|364495947|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
105681359|NCT03319849|364495948|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
105681360|NCT03319849|364495947|FG000|Overall Study|Lost to Follow-up|0|||
105681361|NCT03319849|364495948|FG001|Overall Study|Lost to Follow-up|2|||
105681362|NCT02924428|364497842|FG000|Overall Study|Adverse Event|1|||
105681363|NCT02924428|364497843|FG001|Overall Study|Adverse Event|0|||
105681364|NCT02924428|364497842|FG000|Overall Study|Physician Decision|1|||
105681365|NCT02924428|364497843|FG001|Overall Study|Physician Decision|0|||
105681366|NCT02924428|364497842|FG000|Overall Study|Lost to Follow-up|2|||
105681367|NCT02924428|364497843|FG001|Overall Study|Lost to Follow-up|4|||
105681368|NCT02924428|364497842|FG000|Overall Study|Pregnancy|0|||
105681369|NCT02924428|364497843|FG001|Overall Study|Pregnancy|1|||
105681370|NCT02134977|364497844|FG000|Overall Study|Protocol Deviation|102|||
105681371|NCT01773291|364497845|FG000|Overall Study|Protocol Violation|1|||
105681372|NCT01773291|364497846|FG001|Overall Study|Protocol Violation|0|||
105681373|NCT01773291|364497847|FG002|Overall Study|Protocol Violation|0|||
105681374|NCT01773291|364497845|FG000|Overall Study|Withdrawal by Subject|0|||
105681375|NCT01773291|364497846|FG001|Overall Study|Withdrawal by Subject|0|||
105681376|NCT01773291|364497847|FG002|Overall Study|Withdrawal by Subject|1|||
105681377|NCT00203476|364497848|FG000|Overall Study|Lost to Follow-up|1|||
105681378|NCT00203476|364497849|FG001|Overall Study|Lost to Follow-up|0|||
105681379|NCT00203476|364497850|FG002|Overall Study|Lost to Follow-up|0|||
105681380|NCT00203476|364497848|FG000|Overall Study|Withdrawal by Subject|0|||
105681381|NCT00203476|364497849|FG001|Overall Study|Withdrawal by Subject|1|||
105681382|NCT00203476|364497850|FG002|Overall Study|Withdrawal by Subject|0|||
105681383|NCT01635920|364497851|FG000|Overall Study|Adverse Event|1|||
105916343|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
105916344|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
105916345|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
105916346|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
105916347|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
105916348|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
105916349|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
105916350|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
105916351|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
105916352|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
106001065|NCT00088530|365665197|FG000|Overall Study|Adverse Event|15|||
106001066|NCT00088530|365665198|FG001|Overall Study|Adverse Event|9|||
106001067|NCT00088530|365665197|FG000|Overall Study|Withdrawal by Subject|2|||
105681384|NCT01635920|364497852|FG001|Overall Study|Adverse Event|0|||
105681385|NCT01635920|364497851|FG000|Overall Study|Lost to Follow-up|0|||
105681386|NCT01635920|364497852|FG001|Overall Study|Lost to Follow-up|1|||
106001068|NCT00088530|365665198|FG001|Overall Study|Withdrawal by Subject|5|||
105681387|NCT01635920|364497851|FG000|Overall Study|Subject decision|2|||
105681388|NCT01635920|364497852|FG001|Overall Study|Subject decision|0|||
105681389|NCT04433585|364497853|FG000|Overall Study|Withdrawal by Subject|15|||
105681390|NCT04433585|364497854|FG001|Overall Study|Withdrawal by Subject|3|||
105681391|NCT04433585|364497855|FG002|Overall Study|Withdrawal by Subject|15|||
105681392|NCT04433585|364497856|FG003|Overall Study|Withdrawal by Subject|6|||
105681393|NCT04433585|364497853|FG000|Overall Study|Adverse Event|10|||
105681394|NCT04433585|364497854|FG001|Overall Study|Adverse Event|4|||
105681395|NCT04433585|364497855|FG002|Overall Study|Adverse Event|1|||
105681396|NCT04433585|364497856|FG003|Overall Study|Adverse Event|0|||
105681397|NCT04433585|364497853|FG000|Overall Study|Due to the conflict in Ukraine|2|||
105681398|NCT04433585|364497854|FG001|Overall Study|Due to the conflict in Ukraine|1|||
105681399|NCT04433585|364497855|FG002|Overall Study|Due to the conflict in Ukraine|1|||
105681400|NCT04433585|364497856|FG003|Overall Study|Due to the conflict in Ukraine|2|||
105681401|NCT04433585|364497853|FG000|Overall Study|Physician Decision|1|||
105681402|NCT04433585|364497854|FG001|Overall Study|Physician Decision|2|||
105681403|NCT04433585|364497855|FG002|Overall Study|Physician Decision|0|||
105681404|NCT04433585|364497856|FG003|Overall Study|Physician Decision|0|||
105681405|NCT04433585|364497853|FG000|Overall Study|Lost to Follow-up|1|||
105681406|NCT04433585|364497854|FG001|Overall Study|Lost to Follow-up|1|||
105681407|NCT04433585|364497855|FG002|Overall Study|Lost to Follow-up|1|||
105681408|NCT04433585|364497856|FG003|Overall Study|Lost to Follow-up|0|||
105681409|NCT04433585|364497853|FG000|Overall Study|Lack of Efficacy|0|||
105681410|NCT04433585|364497854|FG001|Overall Study|Lack of Efficacy|1|||
105681411|NCT04433585|364497855|FG002|Overall Study|Lack of Efficacy|1|||
105681412|NCT04433585|364497856|FG003|Overall Study|Lack of Efficacy|1|||
105681413|NCT04433585|364497853|FG000|Overall Study|Death|0|||
105681414|NCT04433585|364497854|FG001|Overall Study|Death|1|||
105681415|NCT04433585|364497855|FG002|Overall Study|Death|0|||
105681416|NCT04433585|364497856|FG003|Overall Study|Death|0|||
105681417|NCT01658150|364497857|FG000|Overall Study|Withdrawal by Subject|1|||
105681418|NCT03602066|364497858|FG000|Overall Study|Withdrawal by Subject|2|||
105681419|NCT03602066|364497859|FG001|Overall Study|Withdrawal by Subject|0|||
105681420|NCT03602066|364497858|FG000|Overall Study|Physician Decision|1|||
105681421|NCT03602066|364497859|FG001|Overall Study|Physician Decision|0|||
105916353|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
105916354|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
105916355|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
105916356|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
105916357|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
105916358|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
105916359|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
105916360|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
105916361|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
105916362|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
105916363|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
105916364|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
105916365|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
105916366|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
105916367|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
105916368|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
105916369|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
105916370|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
105916371|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
105916372|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
105916373|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
105916374|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
105916375|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
105916376|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
105916377|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
105916378|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
105916379|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
105916380|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
105916381|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
105916382|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
105916383|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
105916384|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
105916385|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
105916386|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
105916387|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
105916388|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
105916389|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
105681422|NCT00092495|364497860|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
105681423|NCT00092495|364497861|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
105681424|NCT00092495|364497862|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105681425|NCT00092495|364497863|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
105681426|NCT00092495|364497864|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105681427|NCT00092495|364497860|FG000|Base Study Vaccination Period|Extended|0|||
105681428|NCT00092495|364497861|FG001|Base Study Vaccination Period|Extended|0|||
105681429|NCT00092495|364497862|FG002|Base Study Vaccination Period|Extended|0|||
105681430|NCT00092495|364497863|FG003|Base Study Vaccination Period|Extended|1|||
105681431|NCT00092495|364497864|FG004|Base Study Vaccination Period|Extended|0|||
105681432|NCT00092495|364497860|FG000|Base Study Vaccination Period|*Clinical AE|1|||
105681433|NCT00092495|364497861|FG001|Base Study Vaccination Period|*Clinical AE|0|||
105681434|NCT00092495|364497862|FG002|Base Study Vaccination Period|*Clinical AE|1|||
105681435|NCT00092495|364497863|FG003|Base Study Vaccination Period|*Clinical AE|2|||
105681436|NCT00092495|364497864|FG004|Base Study Vaccination Period|*Clinical AE|0|||
105681437|NCT00092495|364497860|FG000|Base Study Vaccination Period|*Other reasons|1|||
105681438|NCT00092495|364497861|FG001|Base Study Vaccination Period|*Other reasons|0|||
105681439|NCT00092495|364497862|FG002|Base Study Vaccination Period|*Other reasons|0|||
105681440|NCT00092495|364497863|FG003|Base Study Vaccination Period|*Other reasons|1|||
105681441|NCT00092495|364497864|FG004|Base Study Vaccination Period|*Other reasons|0|||
105681442|NCT00092495|364497860|FG000|Base Study Vaccination Period|*Pregnancy|0|||
105681443|NCT00092495|364497861|FG001|Base Study Vaccination Period|*Pregnancy|2|||
105681444|NCT00092495|364497862|FG002|Base Study Vaccination Period|*Pregnancy|5|||
105681445|NCT00092495|364497863|FG003|Base Study Vaccination Period|*Pregnancy|7|||
105681446|NCT00092495|364497864|FG004|Base Study Vaccination Period|*Pregnancy|0|||
105681447|NCT00092495|364497860|FG000|Base Study Vaccination Period|Adverse Event|1|||
105681448|NCT00092495|364497861|FG001|Base Study Vaccination Period|Adverse Event|0|||
106001069|NCT00088530|365665197|FG000|Overall Study|Lost to Follow-up|2|||
106001070|NCT00088530|365665198|FG001|Overall Study|Lost to Follow-up|0|||
105681449|NCT00092495|364497862|FG002|Base Study Vaccination Period|Adverse Event|0|||
106001071|NCT00088530|365665197|FG000|Overall Study|Physician Decision|2|||
105681450|NCT00092495|364497863|FG003|Base Study Vaccination Period|Adverse Event|3|||
105681451|NCT00092495|364497864|FG004|Base Study Vaccination Period|Adverse Event|0|||
105681452|NCT00092495|364497860|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
105681453|NCT00092495|364497861|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
105681454|NCT00092495|364497862|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
105681455|NCT00092495|364497863|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
105681456|NCT00092495|364497864|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
105681457|NCT00092495|364497860|FG000|Base Study Vaccination Period|Moved|3|||
106001072|NCT00088530|365665198|FG001|Overall Study|Physician Decision|0|||
106001073|NCT00088530|365665197|FG000|Overall Study|Sponsor decision|0|||
106001074|NCT00088530|365665198|FG001|Overall Study|Sponsor decision|1|||
106001075|NCT00088530|365665197|FG000|Overall Study|Patient never treated|1|||
105681458|NCT00092495|364497861|FG001|Base Study Vaccination Period|Moved|1|||
105681459|NCT00092495|364497862|FG002|Base Study Vaccination Period|Moved|2|||
105681460|NCT00092495|364497863|FG003|Base Study Vaccination Period|Moved|2|||
105681461|NCT00092495|364497864|FG004|Base Study Vaccination Period|Moved|0|||
105681462|NCT00092495|364497860|FG000|Base Study Vaccination Period|Other|1|||
105681463|NCT00092495|364497861|FG001|Base Study Vaccination Period|Other|1|||
105681464|NCT00092495|364497862|FG002|Base Study Vaccination Period|Other|0|||
105681465|NCT00092495|364497863|FG003|Base Study Vaccination Period|Other|2|||
105681466|NCT00092495|364497864|FG004|Base Study Vaccination Period|Other|0|||
105681467|NCT00092495|364497860|FG000|Base Study Vaccination Period|Pregnancy|2|||
106001076|NCT00088530|365665198|FG001|Overall Study|Patient never treated|0|||
105681468|NCT00092495|364497861|FG001|Base Study Vaccination Period|Pregnancy|0|||
105681469|NCT00092495|364497862|FG002|Base Study Vaccination Period|Pregnancy|0|||
105681470|NCT00092495|364497863|FG003|Base Study Vaccination Period|Pregnancy|0|||
105681471|NCT00092495|364497864|FG004|Base Study Vaccination Period|Pregnancy|0|||
105681472|NCT00092495|364497860|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
105681473|NCT00092495|364497861|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
105681474|NCT00092495|364497862|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
105681475|NCT00092495|364497863|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
105681476|NCT00092495|364497864|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
105681477|NCT00092495|364497860|FG000|Base Study Vaccination Period|Protocol Violation|1|||
105681478|NCT00092495|364497861|FG001|Base Study Vaccination Period|Protocol Violation|0|||
105681479|NCT00092495|364497862|FG002|Base Study Vaccination Period|Protocol Violation|0|||
105681480|NCT00092495|364497863|FG003|Base Study Vaccination Period|Protocol Violation|0|||
105681481|NCT00092495|364497864|FG004|Base Study Vaccination Period|Protocol Violation|0|||
105681482|NCT00092495|364497860|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
105681483|NCT00092495|364497861|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
105681484|NCT00092495|364497862|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
105681485|NCT00092495|364497863|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
105681486|NCT00092495|364497864|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
105681487|NCT00092495|364497860|FG000|Base Study Follow-up Period|Extended|0|||
105681488|NCT00092495|364497861|FG001|Base Study Follow-up Period|Extended|0|||
105681489|NCT00092495|364497862|FG002|Base Study Follow-up Period|Extended|1|||
105681490|NCT00092495|364497863|FG003|Base Study Follow-up Period|Extended|2|||
105681491|NCT00092495|364497864|FG004|Base Study Follow-up Period|Extended|0|||
105681492|NCT00092495|364497860|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
105681493|NCT00092495|364497861|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
105681494|NCT00092495|364497862|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
105681495|NCT00092495|364497863|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
105681496|NCT00092495|364497864|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
105681497|NCT00092495|364497860|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
105681498|NCT00092495|364497861|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
105681499|NCT00092495|364497862|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
105681500|NCT00092495|364497863|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
105681501|NCT00092495|364497864|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
105681502|NCT00938470|364497865|FG000|Overall Study|Disease Progression|3|||
105681503|NCT00938470|364497866|FG001|Overall Study|Disease Progression|0|||
105681504|NCT00938470|364497865|FG000|Overall Study|Alternate Treatment|1|||
105681505|NCT00938470|364497866|FG001|Overall Study|Alternate Treatment|0|||
105681506|NCT00938470|364497865|FG000|Overall Study|Death|3|||
105681507|NCT00938470|364497866|FG001|Overall Study|Death|2|||
105681508|NCT00938470|364497865|FG000|Overall Study|Other Reason|0|||
105681509|NCT00938470|364497866|FG001|Overall Study|Other Reason|1|||
105681510|NCT01970345|364497867|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
105681511|NCT01970345|364497868|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
105681512|NCT01970345|364497867|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
105681513|NCT01970345|364497868|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
105681514|NCT00558259|364497869|FG000|Overall Study|Adverse Event|50|||
105681515|NCT00558259|364497870|FG001|Overall Study|Adverse Event|81|||
105681516|NCT00558259|364497869|FG000|Overall Study|Protocol Violation|9|||
105681517|NCT00558259|364497870|FG001|Overall Study|Protocol Violation|5|||
105681518|NCT00558259|364497869|FG000|Overall Study|Withdrawal by Subject|12|||
105681519|NCT00558259|364497870|FG001|Overall Study|Withdrawal by Subject|13|||
105681520|NCT02874924|364497871|FG000|Overall Study|Adverse Event|2|||
105681521|NCT02874924|364497872|FG001|Overall Study|Adverse Event|0|||
105681522|NCT02874924|364497873|FG002|Overall Study|Adverse Event|0|||
105681523|NCT02874924|364497871|FG000|Overall Study|Withdrawal by Subject|1|||
105681524|NCT02874924|364497872|FG001|Overall Study|Withdrawal by Subject|0|||
105681525|NCT02874924|364497873|FG002|Overall Study|Withdrawal by Subject|0|||
105681526|NCT00156819|364497874|FG000|Overall Study|Lost to Follow-up|1|||
105786478|NCT01748162|364871401|FG000|Overall Study|reasons not available|3|||
105786479|NCT01748162|364871402|FG001|Overall Study|reasons not available|2|||
105786480|NCT02743117|364871403|FG000|Overall Study|Lost to Follow-up|0|||
105786481|NCT02743117|364871404|FG001|Overall Study|Lost to Follow-up|1|||
105786482|NCT02743117|364871403|FG000|Overall Study|Other|1|||
105681527|NCT00156819|364497875|FG001|Overall Study|Lost to Follow-up|1|||
105681528|NCT00156819|364497876|FG002|Overall Study|Lost to Follow-up|3|||
105786483|NCT02743117|364871404|FG001|Overall Study|Other|0|||
106127822|NCT01474512|366125539|FG008|Long-Term Extension Period|Death|0|||
105681529|NCT00717067|364497877|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
105681530|NCT00717067|364497878|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
105681531|NCT00717067|364497879|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
105681532|NCT00717067|364497880|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
105786484|NCT01207219|364871405|FG000|Overall Study|changed diagnosis during study period|5|||
105786485|NCT01207219|364871406|FG001|Overall Study|changed diagnosis during study period|3|||
105681533|NCT00717067|364497881|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
105681534|NCT02090959|364497882|FG000|Overall Study|Withdrawal by Subject|10|||
105681535|NCT02090959|364497882|FG000|Overall Study|Adverse Event|1|||
105681536|NCT02090959|364497882|FG000|Overall Study|Investigator decision|2|||
105681537|NCT02090959|364497882|FG000|Overall Study|Study termination|6|||
105681538|NCT02090959|364497882|FG000|Overall Study|Enrolled but not treated|1|||
105681539|NCT02090959|364497882|FG000|Overall Study|Transfer for compassionate use medicine|4|||
105681540|NCT02090959|364497882|FG000|Overall Study|Move to medical need program|3|||
105681541|NCT02090959|364497882|FG000|Overall Study|Entered in to other study|34|||
105681542|NCT02090959|364497882|FG000|Overall Study|Switched to commercial supply|88|||
105681543|NCT02090959|364497882|FG000|Overall Study|Other than specified|2|||
105681544|NCT00522873|364497883|FG000|Overall Study|Adverse Event|41|||
105681545|NCT00522873|364497884|FG001|Overall Study|Adverse Event|26|||
105681546|NCT00522873|364497883|FG000|Overall Study|Withdrawal by Subject|20|||
105681547|NCT00522873|364497884|FG001|Overall Study|Withdrawal by Subject|9|||
105681548|NCT00522873|364497883|FG000|Overall Study|Protocol Violation|14|||
105681549|NCT00522873|364497884|FG001|Overall Study|Protocol Violation|4|||
105681550|NCT00522873|364497883|FG000|Overall Study|Lost to Follow-up|11|||
105681551|NCT00522873|364497884|FG001|Overall Study|Lost to Follow-up|3|||
105681552|NCT00522873|364497883|FG000|Overall Study|Personal Reasons|8|||
105681553|NCT00522873|364497884|FG001|Overall Study|Personal Reasons|1|||
105681554|NCT00522873|364497883|FG000|Overall Study|Medication Errors|1|||
105681555|NCT00522873|364497884|FG001|Overall Study|Medication Errors|1|||
105681556|NCT00522873|364497883|FG000|Overall Study|Never Received Medication|1|||
105681557|NCT00522873|364497884|FG001|Overall Study|Never Received Medication|0|||
105681558|NCT02029846|364497887|FG000|Overall Study|n=1 each arm|1|||
105681559|NCT02029846|364497888|FG001|Overall Study|n=1 each arm|1|||
105681560|NCT02966301|364497889|FG000|Overall Study|Death|2|||
105681561|NCT02966301|364497889|FG000|Overall Study|Withdrawal by Subject|1|||
105681562|NCT00250679|364497890|FG000|Overall Study|Adverse Event|12|||
105681563|NCT00250679|364497891|FG001|Overall Study|Adverse Event|15|||
105681564|NCT00250679|364497892|FG002|Overall Study|Adverse Event|16|||
105681565|NCT00250679|364497890|FG000|Overall Study|Protocol Violation|2|||
105681566|NCT00250679|364497891|FG001|Overall Study|Protocol Violation|4|||
105681567|NCT00250679|364497892|FG002|Overall Study|Protocol Violation|3|||
105681568|NCT00250679|364497890|FG000|Overall Study|Withdrawal by Subject|15|||
105681569|NCT00250679|364497891|FG001|Overall Study|Withdrawal by Subject|18|||
105681570|NCT00250679|364497892|FG002|Overall Study|Withdrawal by Subject|15|||
105681571|NCT00250679|364497890|FG000|Overall Study|Lost to Follow-up|3|||
105681572|NCT00250679|364497891|FG001|Overall Study|Lost to Follow-up|4|||
105916390|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
105916391|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
105916392|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
105916393|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
105916394|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
106001077|NCT01141712|365665199|FG000|Overall Study|Disease progression|3|||
105681573|NCT00250679|364497892|FG002|Overall Study|Lost to Follow-up|2|||
105916395|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
105916396|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
105916397|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
105916398|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
105916399|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
105916400|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
105916401|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
105916402|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
105916403|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
105916404|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
105916405|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
105916406|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
105916407|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
105916408|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
105916409|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
106001078|NCT00101686|365665200|FG000|Overall Study|Progressive Disease|37|||
106001079|NCT00101686|365665201|FG001|Overall Study|Progressive Disease|28|||
105681574|NCT00250679|364497890|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
105681575|NCT00250679|364497891|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
105681576|NCT00250679|364497892|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
105681577|NCT00250679|364497890|FG000|Overall Study|Lack of Efficacy|0|||
105681578|NCT00250679|364497891|FG001|Overall Study|Lack of Efficacy|1|||
105681579|NCT00250679|364497892|FG002|Overall Study|Lack of Efficacy|3|||
105681580|NCT00250679|364497890|FG000|Overall Study|Technical Holter issues|1|||
105681581|NCT00250679|364497891|FG001|Overall Study|Technical Holter issues|0|||
105681582|NCT00250679|364497892|FG002|Overall Study|Technical Holter issues|2|||
105681583|NCT00250679|364497890|FG000|Overall Study|Moved|1|||
105681584|NCT00250679|364497891|FG001|Overall Study|Moved|1|||
105681585|NCT00250679|364497892|FG002|Overall Study|Moved|0|||
105681586|NCT00250679|364497890|FG000|Overall Study|Non-compliance|1|||
105681587|NCT00250679|364497891|FG001|Overall Study|Non-compliance|1|||
105681588|NCT00250679|364497892|FG002|Overall Study|Non-compliance|0|||
105681589|NCT00250679|364497890|FG000|Overall Study|various single events: hip surgery,diary|3|||
105681590|NCT00250679|364497891|FG001|Overall Study|various single events: hip surgery,diary|1|||
105681591|NCT00250679|364497892|FG002|Overall Study|various single events: hip surgery,diary|1|||
105681592|NCT00822172|364497893|FG000|Overall Study|Adverse Event|10|||
105681593|NCT00822172|364497894|FG001|Overall Study|Adverse Event|12|||
105681594|NCT00822172|364497893|FG000|Overall Study|Death|1|||
105681595|NCT00822172|364497894|FG001|Overall Study|Death|0|||
105681596|NCT00822172|364497893|FG000|Overall Study|Lost to Follow-up|3|||
105681597|NCT00822172|364497894|FG001|Overall Study|Lost to Follow-up|1|||
105681598|NCT00822172|364497893|FG000|Overall Study|Withdrawal by Subject|1|||
105681599|NCT00822172|364497894|FG001|Overall Study|Withdrawal by Subject|4|||
105681600|NCT00822172|364497893|FG000|Overall Study|site closed|0|||
105681601|NCT00822172|364497894|FG001|Overall Study|site closed|1|||
105681602|NCT00822172|364497893|FG000|Overall Study|Other|0|||
105681603|NCT00822172|364497894|FG001|Overall Study|Other|1|||
105681604|NCT00448279|364497895|FG000|Overall Study|Lost to Follow-up|2|||
105681605|NCT00448279|364497896|FG001|Overall Study|Lost to Follow-up|2|||
105681606|NCT00448279|364497895|FG000|Overall Study|Adverse Event|1|||
105681607|NCT00448279|364497896|FG001|Overall Study|Adverse Event|1|||
105681608|NCT00448279|364497895|FG000|Overall Study|Disease progression|16|||
105681609|NCT00448279|364497896|FG001|Overall Study|Disease progression|18|||
105681610|NCT00448279|364497895|FG000|Overall Study|Withdrawal by Subject|4|||
105681611|NCT00448279|364497896|FG001|Overall Study|Withdrawal by Subject|3|||
105681612|NCT00448279|364497895|FG000|Overall Study|Other|6|||
105681613|NCT00448279|364497896|FG001|Overall Study|Other|4|||
105681614|NCT00448279|364497895|FG000|Overall Study|Protocol Violation|0|||
105681615|NCT00448279|364497896|FG001|Overall Study|Protocol Violation|1|||
105681616|NCT00642772|364497898|FG000|Overall Study|Lost to Follow-up|3|||
105681617|NCT00642772|364497898|FG000|Overall Study|Withdrawal by Subject|7|||
105681618|NCT00545051|364497901|FG000|Overall Study|Adverse Event|7|||
105681619|NCT00545051|364497902|FG001|Overall Study|Adverse Event|3|||
105681620|NCT00545051|364497901|FG000|Overall Study|Death|1|||
105681621|NCT00545051|364497902|FG001|Overall Study|Death|0|||
105681622|NCT00545051|364497901|FG000|Overall Study|Violation of inclusion/exclusion|0|||
105681623|NCT00545051|364497902|FG001|Overall Study|Violation of inclusion/exclusion|2|||
105681624|NCT00545051|364497901|FG000|Overall Study|Protocol Violation|1|||
105681625|NCT00545051|364497902|FG001|Overall Study|Protocol Violation|0|||
105681626|NCT00545051|364497901|FG000|Overall Study|Withdrawal by Subject|0|||
105681627|NCT00545051|364497902|FG001|Overall Study|Withdrawal by Subject|1|||
105681628|NCT00545051|364497901|FG000|Overall Study|Administrative reasons|0|||
105681629|NCT00545051|364497902|FG001|Overall Study|Administrative reasons|1|||
105681630|NCT02781844|364497905|FG000|Treatment Period 1|Adverse Event|0|||
105681631|NCT02781844|364497906|FG001|Treatment Period 1|Adverse Event|0|||
105681632|NCT02781844|364497907|FG002|Treatment Period 1|Adverse Event|0|||
105681633|NCT02781844|364497908|FG003|Treatment Period 1|Adverse Event|0|||
105681634|NCT02781844|364497909|FG004|Treatment Period 1|Adverse Event|0|||
105681635|NCT02781844|364497910|FG005|Treatment Period 1|Adverse Event|1|||
105681636|NCT02781844|364497911|FG006|Treatment Period 1|Adverse Event|0|||
105681637|NCT02781844|364497912|FG007|Treatment Period 1|Adverse Event|0|||
105681638|NCT04256629|364497915|FG000|Overall Study|Adverse Event|0|||
105681639|NCT04256629|364497916|FG001|Overall Study|Adverse Event|0|||
105681640|NCT04256629|364497917|FG002|Overall Study|Adverse Event|0|||
105681641|NCT04256629|364497918|FG003|Overall Study|Adverse Event|0|||
105681642|NCT04256629|364497919|FG004|Overall Study|Adverse Event|0|||
105681643|NCT04256629|364497920|FG005|Overall Study|Adverse Event|1|||
105681644|NCT04256629|364497915|FG000|Overall Study|Protocol Violation|0|||
105681645|NCT04256629|364497916|FG001|Overall Study|Protocol Violation|1|||
105681646|NCT04256629|364497917|FG002|Overall Study|Protocol Violation|0|||
105681647|NCT04256629|364497918|FG003|Overall Study|Protocol Violation|0|||
105681648|NCT04256629|364497919|FG004|Overall Study|Protocol Violation|0|||
105681649|NCT04256629|364497920|FG005|Overall Study|Protocol Violation|0|||
105681650|NCT00321373|364497921|FG000|Overall Study|Adverse Event|0|||
105681651|NCT00321373|364497922|FG001|Overall Study|Adverse Event|0|||
105681652|NCT00321373|364497923|FG002|Overall Study|Adverse Event|1|||
105681653|NCT00321373|364497921|FG000|Overall Study|Lost to Follow-up|1|||
105681654|NCT00321373|364497922|FG001|Overall Study|Lost to Follow-up|0|||
105681655|NCT00321373|364497923|FG002|Overall Study|Lost to Follow-up|1|||
105681656|NCT00321373|364497921|FG000|Overall Study|Withdrawal by Subject|1|||
105681657|NCT00321373|364497922|FG001|Overall Study|Withdrawal by Subject|0|||
105681658|NCT00321373|364497923|FG002|Overall Study|Withdrawal by Subject|0|||
105681659|NCT00321373|364497921|FG000|Overall Study|Other|0|||
105681660|NCT00321373|364497922|FG001|Overall Study|Other|0|||
105681661|NCT00321373|364497923|FG002|Overall Study|Other|1|||
106001080|NCT00101686|365665202|FG002|Overall Study|Progressive Disease|37|||
106001081|NCT00101686|365665203|FG003|Overall Study|Progressive Disease|38|||
106001082|NCT00101686|365665204|FG004|Overall Study|Progressive Disease|28|||
106001083|NCT00101686|365665205|FG005|Overall Study|Progressive Disease|25|||
106001084|NCT00101686|365665206|FG006|Overall Study|Progressive Disease|5|||
106001085|NCT00101686|365665207|FG007|Overall Study|Progressive Disease|7|||
106001086|NCT00101686|365665208|FG008|Overall Study|Progressive Disease|10|||
106127823|NCT01474512|366125540|FG009|Long-Term Extension Period|Death|0|||
106127824|NCT01474512|366125541|FG010|Long-Term Extension Period|Death|0|||
106127825|NCT01474512|366125542|FG011|Long-Term Extension Period|Death|0|||
106127826|NCT01474512|366125543|FG012|Long-Term Extension Period|Death|9|||
106127827|NCT01474512|366125544|FG013|Long-Term Extension Period|Death|9|||
106127828|NCT01474512|366125545|FG014|Long-Term Extension Period|Death|0|||
106127829|NCT01474512|366125546|FG015|Long-Term Extension Period|Death|0|||
106127830|NCT01474512|366125547|FG016|Long-Term Extension Period|Death|0|||
106127831|NCT01474512|366125548|FG017|Long-Term Extension Period|Death|0|||
106127832|NCT01474512|366125531|FG000|Long-Term Extension Period|Sponsor Decision|0|||
106127833|NCT01474512|366125532|FG001|Long-Term Extension Period|Sponsor Decision|0|||
106127834|NCT01474512|366125533|FG002|Long-Term Extension Period|Sponsor Decision|0|||
106127835|NCT01474512|366125534|FG003|Long-Term Extension Period|Sponsor Decision|0|||
106127836|NCT01474512|366125535|FG004|Long-Term Extension Period|Sponsor Decision|0|||
106127837|NCT01474512|366125536|FG005|Long-Term Extension Period|Sponsor Decision|0|||
106127838|NCT01474512|366125537|FG006|Long-Term Extension Period|Sponsor Decision|0|||
106127839|NCT01474512|366125538|FG007|Long-Term Extension Period|Sponsor Decision|0|||
106127840|NCT01474512|366125539|FG008|Long-Term Extension Period|Sponsor Decision|0|||
106127841|NCT01474512|366125540|FG009|Long-Term Extension Period|Sponsor Decision|0|||
106127842|NCT01474512|366125541|FG010|Long-Term Extension Period|Sponsor Decision|0|||
106127843|NCT01474512|366125542|FG011|Long-Term Extension Period|Sponsor Decision|0|||
106127844|NCT01474512|366125543|FG012|Long-Term Extension Period|Sponsor Decision|6|||
106127845|NCT01474512|366125544|FG013|Long-Term Extension Period|Sponsor Decision|6|||
106127846|NCT01474512|366125545|FG014|Long-Term Extension Period|Sponsor Decision|0|||
106127847|NCT01474512|366125546|FG015|Long-Term Extension Period|Sponsor Decision|0|||
106127848|NCT01474512|366125547|FG016|Long-Term Extension Period|Sponsor Decision|0|||
106127849|NCT01474512|366125548|FG017|Long-Term Extension Period|Sponsor Decision|0|||
106127850|NCT01474512|366125531|FG000|Long-Term Extension Period|Protocol Violation|0|||
106127851|NCT01474512|366125532|FG001|Long-Term Extension Period|Protocol Violation|0|||
106127852|NCT01474512|366125533|FG002|Long-Term Extension Period|Protocol Violation|0|||
106127853|NCT01474512|366125534|FG003|Long-Term Extension Period|Protocol Violation|0|||
106127854|NCT01474512|366125535|FG004|Long-Term Extension Period|Protocol Violation|0|||
106127855|NCT01474512|366125536|FG005|Long-Term Extension Period|Protocol Violation|0|||
106127856|NCT01474512|366125537|FG006|Long-Term Extension Period|Protocol Violation|0|||
106127857|NCT01474512|366125538|FG007|Long-Term Extension Period|Protocol Violation|0|||
106127858|NCT01474512|366125539|FG008|Long-Term Extension Period|Protocol Violation|0|||
106127859|NCT01474512|366125540|FG009|Long-Term Extension Period|Protocol Violation|0|||
106127860|NCT01474512|366125541|FG010|Long-Term Extension Period|Protocol Violation|0|||
106127861|NCT01474512|366125542|FG011|Long-Term Extension Period|Protocol Violation|0|||
106127862|NCT01474512|366125543|FG012|Long-Term Extension Period|Protocol Violation|5|||
106127863|NCT01474512|366125544|FG013|Long-Term Extension Period|Protocol Violation|5|||
106127864|NCT01474512|366125545|FG014|Long-Term Extension Period|Protocol Violation|0|||
106127865|NCT01474512|366125546|FG015|Long-Term Extension Period|Protocol Violation|0|||
106127866|NCT01474512|366125547|FG016|Long-Term Extension Period|Protocol Violation|0|||
106127867|NCT01474512|366125548|FG017|Long-Term Extension Period|Protocol Violation|0|||
106127868|NCT01474512|366125531|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127869|NCT01474512|366125532|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127870|NCT01474512|366125533|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127871|NCT01474512|366125534|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127872|NCT01474512|366125535|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127873|NCT01474512|366125536|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127874|NCT01474512|366125537|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127875|NCT01474512|366125538|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127876|NCT01474512|366125539|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127877|NCT01474512|366125540|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127878|NCT01474512|366125541|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127879|NCT01474512|366125542|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127880|NCT01474512|366125543|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
106127881|NCT01474512|366125544|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
106127882|NCT01474512|366125545|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127883|NCT01474512|366125546|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127884|NCT01474512|366125547|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127885|NCT01474512|366125548|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
106127886|NCT01474512|366125531|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105681662|NCT01774487|364497924|FG000|Overall Study|Did not tolerate taste|4|||
105681663|NCT01774487|364497925|FG001|Overall Study|Did not tolerate taste|4|||
105681664|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
105681665|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
105681666|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
105681667|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
105681668|NCT00918580|364497926|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
105681669|NCT00918580|364497926|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
105681670|NCT00918580|364497926|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
105681671|NCT02572882|364497927|FG000|Overall Study|Withdrawal by Subject|1|||
105681672|NCT02572882|364497927|FG000|Overall Study|Participant received kidney transplant|1|||
105681673|NCT02354508|364497931|FG000|Period 1: Core Phase|Adverse Event|1|||
105681674|NCT02354508|364497932|FG001|Period 1: Core Phase|Adverse Event|1|||
105681675|NCT02354508|364497933|FG002|Period 1: Core Phase|Adverse Event|2|||
105681676|NCT02354508|364497931|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
105681677|NCT02354508|364497932|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
105681678|NCT02354508|364497933|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
105681679|NCT02354508|364497931|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
105681680|NCT02354508|364497932|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
105681681|NCT02354508|364497933|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
105681682|NCT02354508|364497931|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
105681683|NCT02354508|364497932|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
105681684|NCT02354508|364497933|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
105681685|NCT02354508|364497931|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
105681686|NCT02354508|364497932|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
105681687|NCT02354508|364497933|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
105681688|NCT02354508|364497931|FG000|Period 2: Extension Phase|Physician Decision|5|||
105681689|NCT02354508|364497932|FG001|Period 2: Extension Phase|Physician Decision|0|||
105681690|NCT02354508|364497933|FG002|Period 2: Extension Phase|Physician Decision|1|||
105681691|NCT02354508|364497931|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
105681692|NCT02354508|364497932|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
105681693|NCT02354508|364497933|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
105681694|NCT02354508|364497931|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
105681695|NCT02354508|364497932|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
105681696|NCT02354508|364497933|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
105681697|NCT02354508|364497931|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
105681698|NCT02354508|364497932|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
105681699|NCT02354508|364497933|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
105681700|NCT04371198|364497938|FG000|Overall Study|inadequate sample|4|||
105681701|NCT00946101|364497939|FG000|Overall Study|Lost to Follow-up|2|||
105681702|NCT00946101|364497940|FG001|Overall Study|Lost to Follow-up|1|||
105681703|NCT00946101|364497939|FG000|Overall Study|Withdrawal of consent|2|||
105681704|NCT00946101|364497940|FG001|Overall Study|Withdrawal of consent|0|||
105681705|NCT00946101|364497939|FG000|Overall Study|Physician Decision|0|||
105681706|NCT00946101|364497940|FG001|Overall Study|Physician Decision|1|||
105681707|NCT00495586|364497941|FG000|Overall Study|Withdrawal by Subject|4|||
105681708|NCT00495586|364497942|FG001|Overall Study|Withdrawal by Subject|4|||
105681709|NCT03038438|364497943|FG000|Overall Study|Death|3|||
105681710|NCT03038438|364497943|FG000|Overall Study|Lost to Follow-up|8|||
105681711|NCT03038438|364497943|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
105681712|NCT03038438|364497943|FG000|Overall Study|Withdrawal by Subject|5|||
105681713|NCT03038438|364497943|FG000|Overall Study|No 36-Month Follow-Up|18|||
105681714|NCT03215810|364497944|FG000|Overall Study|Still responding to nivolumab|1|||
105916410|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
105916411|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
105916412|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
105916413|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
105916414|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
105916415|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
105916416|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
105916417|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
105916418|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
105681715|NCT03215810|364497944|FG000|Overall Study|Insufficient TIL growth|1|||
105681716|NCT03215810|364497944|FG000|Overall Study|Decline in performance status|1|||
105916419|NCT02717195|365352986|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
105681717|NCT03215810|364497944|FG000|Overall Study|Withdrawal by Subject|1|||
105681718|NCT00158860|364497947|FG000|Overall Study|Adverse Event|3|||
105681719|NCT00158860|364497948|FG001|Overall Study|Adverse Event|6|||
105681720|NCT00158860|364497947|FG000|Overall Study|Lost to Follow-up|11|||
105681721|NCT00158860|364497948|FG001|Overall Study|Lost to Follow-up|17|||
105681722|NCT00158860|364497947|FG000|Overall Study|Protocol Violation|8|||
105681723|NCT00158860|364497948|FG001|Overall Study|Protocol Violation|23|||
105681724|NCT00158860|364497947|FG000|Overall Study|Withdrawal by Subject|7|||
105681725|NCT00158860|364497948|FG001|Overall Study|Withdrawal by Subject|17|||
105681726|NCT00158860|364497947|FG000|Overall Study|MOVING OUT OF STATE|1|||
105681727|NCT00158860|364497948|FG001|Overall Study|MOVING OUT OF STATE|0|||
105681728|NCT00158860|364497947|FG000|Overall Study|Pregnancy|3|||
105681729|NCT00158860|364497948|FG001|Overall Study|Pregnancy|3|||
105681730|NCT00158860|364497947|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
105681731|NCT00158860|364497948|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
105681732|NCT00158860|364497947|FG000|Overall Study|SPONSOR REQUEST|0|||
105681733|NCT00158860|364497948|FG001|Overall Study|SPONSOR REQUEST|1|||
105681734|NCT00158860|364497947|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
105681735|NCT00158860|364497948|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
105681736|NCT00158860|364497947|FG000|Overall Study|Closed per sponsor|0|||
105681737|NCT00158860|364497948|FG001|Overall Study|Closed per sponsor|1|||
105681738|NCT02095951|364497949|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
105681739|NCT02095951|364497950|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
105681740|NCT03618823|364497951|FG000|Overall Study|Lost to Follow-up|63|||
105681741|NCT03618823|364497952|FG001|Overall Study|Lost to Follow-up|61|||
105681742|NCT00440999|364497953|FG000|Overall Study|Adverse Event|0|||
105681743|NCT00440999|364497954|FG001|Overall Study|Adverse Event|2|||
105681744|NCT00440999|364497953|FG000|Overall Study|Lack of Efficacy|6|||
105681745|NCT00440999|364497954|FG001|Overall Study|Lack of Efficacy|7|||
105681746|NCT00440999|364497953|FG000|Overall Study|Lost to Follow-up|19|||
105916420|NCT02717195|365352987|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
105916421|NCT02717195|365352988|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
105916422|NCT02717195|365352989|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
105916423|NCT02717195|365352990|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
105916424|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
105916425|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
105916426|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
105916427|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
105916428|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
105916429|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
105916430|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
105916431|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
105916432|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
105916433|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
105916434|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
105916435|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
105916436|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
105916437|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
105916438|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
105916439|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
105916440|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
105916441|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
105916442|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
105916443|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
105916444|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105916445|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105916446|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
105916447|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
105916448|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
105916449|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
105916450|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
105916451|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
105916452|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
105681747|NCT00440999|364497954|FG001|Overall Study|Lost to Follow-up|12|||
105681748|NCT00440999|364497953|FG000|Overall Study|Protocol Violation|1|||
105681749|NCT00440999|364497954|FG001|Overall Study|Protocol Violation|0|||
105681750|NCT00440999|364497953|FG000|Overall Study|Withdrawal by Subject|2|||
105681751|NCT00440999|364497954|FG001|Overall Study|Withdrawal by Subject|5|||
105681752|NCT00440999|364497953|FG000|Overall Study|Subjets missed the visit|1|||
105681753|NCT00440999|364497954|FG001|Overall Study|Subjets missed the visit|0|||
105681754|NCT00440999|364497953|FG000|Overall Study|Mixed infection at entry|1|||
105681755|NCT00440999|364497954|FG001|Overall Study|Mixed infection at entry|0|||
105681756|NCT00440999|364497953|FG000|Overall Study|P. falciparum malaria|5|||
105681757|NCT00440999|364497954|FG001|Overall Study|P. falciparum malaria|14|||
105681758|NCT00440999|364497953|FG000|Overall Study|Subj left hosp without inform staff|0|||
105681759|NCT00440999|364497954|FG001|Overall Study|Subj left hosp without inform staff|1|||
105681760|NCT01205152|364497955|FG000|Overall Study|Death|1|||
105681761|NCT03500159|364497956|FG000|Overall Study|Study Terminated|2|||
105681762|NCT03500159|364497957|FG001|Overall Study|Study Terminated|1|||
105681763|NCT01656733|364497961|FG000|Overall Study|No permission to collect birth outcomes|0|||
105681764|NCT01656733|364497962|FG001|Overall Study|No permission to collect birth outcomes|1|||
105681765|NCT01656733|364497961|FG000|Overall Study|Delivery at another hospital|0|||
105681766|NCT01656733|364497962|FG001|Overall Study|Delivery at another hospital|2|||
105681767|NCT01656733|364497961|FG000|Overall Study|Spontaneous abortion|0|||
105681768|NCT01656733|364497962|FG001|Overall Study|Spontaneous abortion|1|||
105681769|NCT00249002|364497963|FG000|Overall Study|Adverse Event|2|||
105681770|NCT00249002|364497963|FG000|Overall Study|Study cancellation|3|||
105681771|NCT00249002|364497963|FG000|Overall Study|Other|2|||
105681772|NCT03625895|364497964|FG000|Overall Study|Protocol Violation|585|||
105681773|NCT01488487|364497970|FG000|Overall Study|Adverse Event|6|||
105681774|NCT01488487|364497970|FG000|Overall Study|Death|1|||
105681775|NCT01488487|364497970|FG000|Overall Study|Withdrawal by Subject|2|||
105681776|NCT00395460|364497971|FG000|Overall Study|Withdrawal by Subject|1|||
105681777|NCT00395460|364497972|FG001|Overall Study|Withdrawal by Subject|0|||
105681778|NCT05208866|364497973|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
105681779|NCT00232544|364497977|FG000|Overall Study|Lost to Follow-up|20|||
105681780|NCT00232544|364497978|FG001|Overall Study|Lost to Follow-up|15|||
105681781|NCT02581631|364497979|FG000|Overall Study|Disease progression|29|||
105681782|NCT02581631|364497980|FG001|Overall Study|Disease progression|19|||
105681783|NCT02581631|364497981|FG002|Overall Study|Disease progression|13|||
105681784|NCT02581631|364497982|FG003|Overall Study|Disease progression|5|||
105681785|NCT02581631|364497983|FG004|Overall Study|Disease progression|8|||
105681786|NCT02581631|364497979|FG000|Overall Study|Study drug toxicity|4|||
105681787|NCT02581631|364497980|FG001|Overall Study|Study drug toxicity|6|||
105681788|NCT02581631|364497981|FG002|Overall Study|Study drug toxicity|7|||
105681789|NCT02581631|364497982|FG003|Overall Study|Study drug toxicity|0|||
105681790|NCT02581631|364497983|FG004|Overall Study|Study drug toxicity|3|||
105681791|NCT02581631|364497979|FG000|Overall Study|AE unrelated to study drug|3|||
105681792|NCT02581631|364497980|FG001|Overall Study|AE unrelated to study drug|1|||
105681793|NCT02581631|364497981|FG002|Overall Study|AE unrelated to study drug|1|||
105681794|NCT02581631|364497982|FG003|Overall Study|AE unrelated to study drug|0|||
105681795|NCT02581631|364497983|FG004|Overall Study|AE unrelated to study drug|2|||
105681796|NCT02581631|364497979|FG000|Overall Study|Request to discontinue|1|||
105681797|NCT02581631|364497980|FG001|Overall Study|Request to discontinue|0|||
105681798|NCT02581631|364497981|FG002|Overall Study|Request to discontinue|3|||
105681799|NCT02581631|364497982|FG003|Overall Study|Request to discontinue|0|||
105681800|NCT02581631|364497983|FG004|Overall Study|Request to discontinue|1|||
105681801|NCT02581631|364497979|FG000|Overall Study|participant withdrew consent|3|||
105681802|NCT02581631|364497980|FG001|Overall Study|participant withdrew consent|0|||
105681803|NCT02581631|364497981|FG002|Overall Study|participant withdrew consent|1|||
105681804|NCT02581631|364497982|FG003|Overall Study|participant withdrew consent|0|||
105681805|NCT02581631|364497983|FG004|Overall Study|participant withdrew consent|0|||
105681806|NCT02581631|364497979|FG000|Overall Study|Maximum clinical benefit|1|||
105681807|NCT02581631|364497980|FG001|Overall Study|Maximum clinical benefit|7|||
105681808|NCT02581631|364497981|FG002|Overall Study|Maximum clinical benefit|1|||
105681809|NCT02581631|364497982|FG003|Overall Study|Maximum clinical benefit|3|||
105681810|NCT02581631|364497983|FG004|Overall Study|Maximum clinical benefit|13|||
105681811|NCT02581631|364497979|FG000|Overall Study|Other Reasons|1|||
105681812|NCT02581631|364497980|FG001|Overall Study|Other Reasons|0|||
105681813|NCT02581631|364497981|FG002|Overall Study|Other Reasons|2|||
105681814|NCT02581631|364497982|FG003|Overall Study|Other Reasons|2|||
105681815|NCT02581631|364497983|FG004|Overall Study|Other Reasons|3|||
105916453|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
105916454|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
105916455|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
105916456|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
105916457|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
105916458|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
105681816|NCT02581631|364497979|FG000|Overall Study|Poor/Non-Compliance|0|||
105681817|NCT02581631|364497980|FG001|Overall Study|Poor/Non-Compliance|0|||
105681818|NCT02581631|364497981|FG002|Overall Study|Poor/Non-Compliance|1|||
105681819|NCT02581631|364497982|FG003|Overall Study|Poor/Non-Compliance|0|||
105681820|NCT02581631|364497983|FG004|Overall Study|Poor/Non-Compliance|0|||
105681821|NCT01191268|364497984|FG000|Overall Study|Withdrawal by Subject|19|||
105681822|NCT01191268|364497985|FG001|Overall Study|Withdrawal by Subject|25|||
105681823|NCT01191268|364497986|FG002|Overall Study|Withdrawal by Subject|21|||
105681824|NCT01191268|364497984|FG000|Overall Study|Adverse Event|21|||
105681825|NCT01191268|364497985|FG001|Overall Study|Adverse Event|13|||
105681826|NCT01191268|364497986|FG002|Overall Study|Adverse Event|8|||
105681827|NCT01191268|364497984|FG000|Overall Study|Physician Decision|6|||
105681828|NCT01191268|364497985|FG001|Overall Study|Physician Decision|8|||
105681829|NCT01191268|364497986|FG002|Overall Study|Physician Decision|9|||
105681830|NCT01191268|364497984|FG000|Overall Study|Lost to Follow-up|8|||
105681831|NCT01191268|364497985|FG001|Overall Study|Lost to Follow-up|5|||
105681832|NCT01191268|364497986|FG002|Overall Study|Lost to Follow-up|9|||
105681833|NCT01191268|364497984|FG000|Overall Study|Entry Criteria Not Met|3|||
105681834|NCT01191268|364497985|FG001|Overall Study|Entry Criteria Not Met|1|||
105681835|NCT01191268|364497986|FG002|Overall Study|Entry Criteria Not Met|1|||
105681836|NCT01191268|364497984|FG000|Overall Study|Death|0|||
105681837|NCT01191268|364497985|FG001|Overall Study|Death|1|||
105681838|NCT01191268|364497986|FG002|Overall Study|Death|3|||
105681839|NCT01191268|364497984|FG000|Overall Study|Protocol Violation|1|||
105681840|NCT01191268|364497985|FG001|Overall Study|Protocol Violation|0|||
105681841|NCT01191268|364497986|FG002|Overall Study|Protocol Violation|1|||
105681842|NCT01191268|364497984|FG000|Overall Study|Sponsor Decision|0|||
105681843|NCT01191268|364497985|FG001|Overall Study|Sponsor Decision|2|||
105681844|NCT01191268|364497986|FG002|Overall Study|Sponsor Decision|0|||
105681845|NCT02951767|364497987|FG000|Overall Study|Study Terminated By Sponsor|9|||
105681846|NCT02951767|364497987|FG000|Overall Study|Withdrawal by Subject|11|||
105681847|NCT02951767|364497987|FG000|Overall Study|Death|96|||
105681848|NCT02951767|364497987|FG000|Overall Study|Lost to Follow-up|2|||
105681849|NCT02951767|364497987|FG000|Overall Study|Physician Decision|1|||
105681850|NCT00513604|364497988|FG000|Overall Study|Not treated|2|||
105681851|NCT00513604|364497989|FG001|Overall Study|Not treated|0|||
105681852|NCT00513604|364497990|FG002|Overall Study|Not treated|1|||
105681853|NCT00513604|364497991|FG003|Overall Study|Not treated|0|||
105681854|NCT00513604|364497992|FG004|Overall Study|Not treated|0|||
105681855|NCT00513604|364497988|FG000|Overall Study|Death during treatment|0|||
105681856|NCT00513604|364497989|FG001|Overall Study|Death during treatment|3|||
105681857|NCT00513604|364497990|FG002|Overall Study|Death during treatment|2|||
105681858|NCT00513604|364497991|FG003|Overall Study|Death during treatment|0|||
105681859|NCT00513604|364497992|FG004|Overall Study|Death during treatment|0|||
105681860|NCT01242800|364498000|FG000|Overall Study|Patient refusal|0|||
105681861|NCT01242800|364498001|FG001|Overall Study|Patient refusal|10|||
105681862|NCT01242800|364498000|FG000|Overall Study|Physician Decision|0|||
105681863|NCT01242800|364498001|FG001|Overall Study|Physician Decision|1|||
105681864|NCT01242800|364498000|FG000|Overall Study|Disease progression|0|||
105681865|NCT01242800|364498001|FG001|Overall Study|Disease progression|3|||
105681866|NCT01242800|364498000|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
105681867|NCT01242800|364498001|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
105681868|NCT01242800|364498000|FG000|Overall Study|Reasons not reported|0|||
105681869|NCT01242800|364498001|FG001|Overall Study|Reasons not reported|4|||
105681870|NCT00943111|364498003|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
105681871|NCT00943111|364498004|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
105681872|NCT00943111|364498005|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
105681873|NCT00943111|364498003|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
105681874|NCT00943111|364498004|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
105681875|NCT00943111|364498005|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
105681876|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
105681877|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
105681878|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
105681879|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
105681880|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
105681881|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
105681882|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
105681883|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
105681884|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
105681885|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
105681886|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
105916459|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
105916460|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
105681887|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
105681888|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
105681889|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
105916461|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
105681890|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
105681891|NCT00943111|364498003|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
105681892|NCT00943111|364498004|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
105681893|NCT00943111|364498005|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
105681894|NCT00055601|364499444|FG000|Overall Study|Protocol Violation|1|||
105681895|NCT00055601|364499445|FG001|Overall Study|Protocol Violation|1|||
105681896|NCT00055601|364499444|FG000|Overall Study|No protocol treatment received|1|||
105681897|NCT00055601|364499445|FG001|Overall Study|No protocol treatment received|1|||
105681898|NCT02680002|364499446|FG000|Overall Study|Lost to Follow-up|5|||
105681899|NCT02680002|364499447|FG001|Overall Study|Lost to Follow-up|1|||
105681900|NCT02680002|364499448|FG002|Overall Study|Lost to Follow-up|4|||
105681901|NCT02680002|364499449|FG003|Overall Study|Lost to Follow-up|2|||
105681902|NCT02680002|364499450|FG004|Overall Study|Lost to Follow-up|0|||
105681903|NCT02680002|364499451|FG005|Overall Study|Lost to Follow-up|2|||
105681904|NCT02680002|364499446|FG000|Overall Study|Physician Decision|5|||
105681905|NCT02680002|364499447|FG001|Overall Study|Physician Decision|1|||
105681906|NCT02680002|364499448|FG002|Overall Study|Physician Decision|1|||
105681907|NCT02680002|364499449|FG003|Overall Study|Physician Decision|1|||
105681908|NCT02680002|364499450|FG004|Overall Study|Physician Decision|1|||
105681909|NCT02680002|364499451|FG005|Overall Study|Physician Decision|1|||
105681910|NCT02680002|364499446|FG000|Overall Study|Protocol Violation|1|||
105681911|NCT02680002|364499447|FG001|Overall Study|Protocol Violation|0|||
105681912|NCT02680002|364499448|FG002|Overall Study|Protocol Violation|1|||
105681913|NCT02680002|364499449|FG003|Overall Study|Protocol Violation|0|||
105681914|NCT02680002|364499450|FG004|Overall Study|Protocol Violation|1|||
105681915|NCT02680002|364499451|FG005|Overall Study|Protocol Violation|2|||
105681916|NCT02680002|364499446|FG000|Overall Study|Withdrawal by Subject|0|||
105681917|NCT02680002|364499447|FG001|Overall Study|Withdrawal by Subject|0|||
105681918|NCT02680002|364499448|FG002|Overall Study|Withdrawal by Subject|1|||
105681919|NCT02680002|364499449|FG003|Overall Study|Withdrawal by Subject|0|||
105681920|NCT02680002|364499450|FG004|Overall Study|Withdrawal by Subject|2|||
105681921|NCT02680002|364499451|FG005|Overall Study|Withdrawal by Subject|2|||
105681922|NCT02680002|364499446|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
105681923|NCT02680002|364499447|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
105681924|NCT02680002|364499448|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
105681925|NCT02680002|364499449|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
105681926|NCT02680002|364499450|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
105681927|NCT02680002|364499451|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
105681928|NCT02680002|364499446|FG000|Overall Study|Other|0|||
105681929|NCT02680002|364499447|FG001|Overall Study|Other|1|||
105681930|NCT02680002|364499448|FG002|Overall Study|Other|0|||
105681931|NCT02680002|364499449|FG003|Overall Study|Other|0|||
105681932|NCT02680002|364499450|FG004|Overall Study|Other|1|||
105681933|NCT02680002|364499451|FG005|Overall Study|Other|0|||
105681934|NCT02680002|364499446|FG000|Overall Study|Adverse Event|0|||
105681935|NCT02680002|364499447|FG001|Overall Study|Adverse Event|0|||
105681936|NCT02680002|364499448|FG002|Overall Study|Adverse Event|0|||
105681937|NCT02680002|364499449|FG003|Overall Study|Adverse Event|0|||
105681938|NCT02680002|364499450|FG004|Overall Study|Adverse Event|1|||
105681939|NCT02680002|364499451|FG005|Overall Study|Adverse Event|2|||
105681940|NCT01248780|364499452|FG000|Overall Study|Lack of Efficacy|2|||
105681941|NCT01248780|364499453|FG001|Overall Study|Lack of Efficacy|0|||
105681942|NCT01248780|364499452|FG000|Overall Study|Lost to Follow-up|0|||
105681943|NCT01248780|364499453|FG001|Overall Study|Lost to Follow-up|1|||
105681944|NCT01248780|364499452|FG000|Overall Study|Death|0|||
105681945|NCT01248780|364499453|FG001|Overall Study|Death|1|||
105681946|NCT01248780|364499452|FG000|Overall Study|Adverse Event|2|||
105681947|NCT01248780|364499453|FG001|Overall Study|Adverse Event|7|||
105681948|NCT01248780|364499452|FG000|Overall Study|Protocol Violation|1|||
105681949|NCT01248780|364499453|FG001|Overall Study|Protocol Violation|1|||
105681950|NCT01248780|364499452|FG000|Overall Study|Withdrawal by Subject|4|||
105681951|NCT01248780|364499453|FG001|Overall Study|Withdrawal by Subject|4|||
105681952|NCT01248780|364499452|FG000|Overall Study|Not treated|0|||
105681953|NCT01248780|364499453|FG001|Overall Study|Not treated|1|||
105681954|NCT04097301|364499454|FG000|Overall Study|Death|1|||
105681955|NCT04097301|364499454|FG000|Overall Study|Withdrawal by Subject|1|||
105916462|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
105681956|NCT04097301|364499454|FG000|Overall Study|Screening Failure|5|||
105681957|NCT03241225|364499455|FG000|Overall Study|Lost to Follow-up|2|||
105681958|NCT03241225|364499456|FG001|Overall Study|Lost to Follow-up|1|||
105681959|NCT03241225|364499455|FG000|Overall Study|Protocol Violation|4|||
105681960|NCT03241225|364499456|FG001|Overall Study|Protocol Violation|1|||
105681961|NCT03241225|364499455|FG000|Overall Study|Withdrawal by Subject|1|||
105681962|NCT03241225|364499456|FG001|Overall Study|Withdrawal by Subject|0|||
105681963|NCT01813929|364499457|FG000|Overall Study|Withdrawal by Subject|0|||
105681964|NCT01813929|364499458|FG001|Overall Study|Withdrawal by Subject|1|||
105681965|NCT02074553|364499459|FG000|Intervention Period 1|Family Emergency|0|||
105681966|NCT02074553|364499460|FG001|Intervention Period 1|Family Emergency|0|||
105681967|NCT02074553|364499461|FG002|Intervention Period 1|Family Emergency|0|||
105681968|NCT02074553|364499462|FG003|Intervention Period 1|Family Emergency|1|||
105681969|NCT02074553|364499463|FG004|Intervention Period 1|Family Emergency|0|||
105681970|NCT02074553|364499464|FG005|Intervention Period 1|Family Emergency|0|||
105681971|NCT02074553|364499465|FG006|Intervention Period 1|Family Emergency|0|||
105681972|NCT02074553|364499466|FG007|Intervention Period 1|Family Emergency|0|||
105681973|NCT02074553|364499459|FG000|Washout Period 1|Adverse Event|1|||
105681974|NCT02074553|364499460|FG001|Washout Period 1|Adverse Event|0|||
105681975|NCT02074553|364499461|FG002|Washout Period 1|Adverse Event|0|||
105681976|NCT02074553|364499462|FG003|Washout Period 1|Adverse Event|0|||
105681977|NCT02074553|364499463|FG004|Washout Period 1|Adverse Event|0|||
105681978|NCT02074553|364499464|FG005|Washout Period 1|Adverse Event|0|||
105681979|NCT02074553|364499465|FG006|Washout Period 1|Adverse Event|0|||
105681980|NCT02074553|364499466|FG007|Washout Period 1|Adverse Event|0|||
105681981|NCT02074553|364499459|FG000|Washout Period 1|Physician Decision|0|||
105681982|NCT02074553|364499460|FG001|Washout Period 1|Physician Decision|0|||
105681983|NCT02074553|364499461|FG002|Washout Period 1|Physician Decision|0|||
105681984|NCT02074553|364499462|FG003|Washout Period 1|Physician Decision|1|||
105681985|NCT02074553|364499463|FG004|Washout Period 1|Physician Decision|0|||
105681986|NCT02074553|364499464|FG005|Washout Period 1|Physician Decision|0|||
105681987|NCT02074553|364499465|FG006|Washout Period 1|Physician Decision|0|||
105681988|NCT02074553|364499466|FG007|Washout Period 1|Physician Decision|0|||
105681989|NCT02074553|364499459|FG000|Washout Period 1|Other|0|||
105681990|NCT02074553|364499460|FG001|Washout Period 1|Other|0|||
105681991|NCT02074553|364499461|FG002|Washout Period 1|Other|0|||
105681992|NCT02074553|364499462|FG003|Washout Period 1|Other|0|||
105681993|NCT02074553|364499463|FG004|Washout Period 1|Other|0|||
105681994|NCT02074553|364499464|FG005|Washout Period 1|Other|1|||
105681995|NCT02074553|364499465|FG006|Washout Period 1|Other|0|||
105681996|NCT02074553|364499466|FG007|Washout Period 1|Other|0|||
105681997|NCT02074553|364499459|FG000|Washout Period 2|Adverse Event|0|||
105681998|NCT02074553|364499460|FG001|Washout Period 2|Adverse Event|0|||
105681999|NCT02074553|364499461|FG002|Washout Period 2|Adverse Event|0|||
105916463|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
105916464|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
105916465|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
105916466|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
105916467|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
105916468|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
105916469|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
105916470|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
105916471|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
105916472|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
105916473|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
105916474|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
105916475|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
105916476|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
105916477|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
105916478|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
105916479|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
105916480|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
105916481|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
105916482|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
105916483|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
105916484|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
105916485|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
105916486|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
105916487|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
105916488|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
105916489|NCT02717195|365352986|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
105916490|NCT02717195|365352987|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
105916491|NCT02717195|365352988|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
105916492|NCT02717195|365352989|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
105916493|NCT02717195|365352990|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
105916494|NCT02033759|365352991|FG000|Overall Study|Withdrawal by Subject|2|||
105682000|NCT02074553|364499462|FG003|Washout Period 2|Adverse Event|0|||
105682001|NCT02074553|364499463|FG004|Washout Period 2|Adverse Event|0|||
105682002|NCT02074553|364499464|FG005|Washout Period 2|Adverse Event|0|||
105682003|NCT02074553|364499465|FG006|Washout Period 2|Adverse Event|1|||
105916495|NCT02033759|365352992|FG001|Overall Study|Withdrawal by Subject|1|||
105916496|NCT02033759|365352991|FG000|Overall Study|Protocol Violation|1|||
105916497|NCT02033759|365352992|FG001|Overall Study|Protocol Violation|1|||
105682004|NCT02074553|364499466|FG007|Washout Period 2|Adverse Event|0|||
105682005|NCT02074553|364499459|FG000|Washout Period 2|Physician Decision|0|||
105682006|NCT02074553|364499460|FG001|Washout Period 2|Physician Decision|0|||
105682007|NCT02074553|364499461|FG002|Washout Period 2|Physician Decision|0|||
105682008|NCT02074553|364499462|FG003|Washout Period 2|Physician Decision|0|||
105916498|NCT01081626|365352995|FG000|Overall Study|Dosing error|1|||
105916499|NCT01081626|365352996|FG001|Overall Study|Dosing error|1|||
105916500|NCT01081626|365352995|FG000|Overall Study|Missing Estradiol|25|||
105916501|NCT01081626|365352996|FG001|Overall Study|Missing Estradiol|28|||
105916502|NCT01081626|365352995|FG000|Overall Study|Low antral follicle count|1|||
105916503|NCT01081626|365352996|FG001|Overall Study|Low antral follicle count|0|||
105916504|NCT01081626|365352995|FG000|Overall Study|Overstimulation|0|||
105916505|NCT01081626|365352996|FG001|Overall Study|Overstimulation|1|||
105916506|NCT01081626|365352995|FG000|Overall Study|Lost to Follow-up|0|||
105916507|NCT01081626|365352996|FG001|Overall Study|Lost to Follow-up|1|||
105916508|NCT01081626|365352995|FG000|Overall Study|Other|33|||
105916509|NCT01081626|365352996|FG001|Overall Study|Other|30|||
105916510|NCT02003144|365352997|FG000|Open Label Maintenance Phase|Other than specified|2|||
105916511|NCT02003144|365352998|FG001|Open Label Maintenance Phase|Other than specified|4|||
105916512|NCT02003144|365352997|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
105916513|NCT02003144|365352998|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
105916514|NCT02003144|365352997|FG000|Open Label Maintenance Phase|Pregnancy|0|||
105916515|NCT02003144|365352998|FG001|Open Label Maintenance Phase|Pregnancy|2|||
105916516|NCT02003144|365352997|FG000|Open Label Maintenance Phase|Physician Decision|1|||
105916517|NCT02003144|365352998|FG001|Open Label Maintenance Phase|Physician Decision|1|||
105916518|NCT02003144|365352997|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
105916519|NCT02003144|365352998|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
105916520|NCT02003144|365352997|FG000|Open Label Maintenance Phase|Adverse Event|2|||
105916521|NCT02003144|365352998|FG001|Open Label Maintenance Phase|Adverse Event|1|||
105916522|NCT02812186|365354765|FG000|Period 1|Post randomization screen failure|5|||
105916523|NCT02812186|365354766|FG001|Period 1|Post randomization screen failure|9|||
105916524|NCT02812186|365354765|FG000|Period 1|nonevaluable data sets|6|||
105916525|NCT02812186|365354766|FG001|Period 1|nonevaluable data sets|6|||
105916526|NCT03964207|365354769|FG000|First Treatment|Withdrawal by Subject|1|||
105916527|NCT03964207|365354770|FG001|First Treatment|Withdrawal by Subject|2|||
105916528|NCT03964207|365354769|FG000|First Treatment|Protocol Violation|1|||
105916529|NCT03964207|365354770|FG001|First Treatment|Protocol Violation|0|||
105916530|NCT03964207|365354769|FG000|First Treatment|Lost to Follow-up|1|||
105916531|NCT03964207|365354770|FG001|First Treatment|Lost to Follow-up|0|||
105916532|NCT03964207|365354769|FG000|Second Treatment|Lost to Follow-up|0|||
105916533|NCT03964207|365354770|FG001|Second Treatment|Lost to Follow-up|1|||
105916534|NCT03964207|365354769|FG000|Second Treatment|Adverse Event|1|||
105916535|NCT03964207|365354770|FG001|Second Treatment|Adverse Event|2|||
105916536|NCT01699750|365354781|FG000|Overall Study|Withdrew Consent|0|||
105916537|NCT01699750|365354782|FG001|Overall Study|Withdrew Consent|1|||
105916538|NCT01699750|365354781|FG000|Overall Study|Other|0|||
105916539|NCT01699750|365354782|FG001|Overall Study|Other|2|||
105916540|NCT04635839|365354783|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
105916541|NCT04635839|365354784|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
105916542|NCT02737358|365354785|FG000|Overall Study|Withdrawal by Subject|7|||
105916543|NCT02737358|365354786|FG001|Overall Study|Withdrawal by Subject|12|||
105916544|NCT02737358|365354785|FG000|Overall Study|Lost to Follow-up|2|||
105916545|NCT02737358|365354786|FG001|Overall Study|Lost to Follow-up|3|||
105916546|NCT00896493|365354787|FG000|Overall Study|Early disease relapse|3|||
105916547|NCT02452047|365354788|FG000|Overall Study|Adverse Event|0|||
105916548|NCT02452047|365354789|FG001|Overall Study|Adverse Event|1|||
105916549|NCT02452047|365354790|FG002|Overall Study|Adverse Event|1|||
105916550|NCT02452047|365354788|FG000|Overall Study|Death|1|||
105916551|NCT02452047|365354789|FG001|Overall Study|Death|3|||
105916552|NCT02452047|365354790|FG002|Overall Study|Death|1|||
105916553|NCT02452047|365354788|FG000|Overall Study|Physician Decision|1|||
105916554|NCT02452047|365354789|FG001|Overall Study|Physician Decision|0|||
105916555|NCT02452047|365354790|FG002|Overall Study|Physician Decision|0|||
105916556|NCT02452047|365354788|FG000|Overall Study|Lost to Follow-up|1|||
105916557|NCT02452047|365354789|FG001|Overall Study|Lost to Follow-up|1|||
105916558|NCT02452047|365354790|FG002|Overall Study|Lost to Follow-up|0|||
105916559|NCT02452047|365354788|FG000|Overall Study|Withdrawal by Subject|1|||
105916560|NCT02452047|365354789|FG001|Overall Study|Withdrawal by Subject|0|||
105916561|NCT02452047|365354790|FG002|Overall Study|Withdrawal by Subject|0|||
106001087|NCT00101686|365665209|FG009|Overall Study|Progressive Disease|8|||
106001088|NCT00101686|365665200|FG000|Overall Study|initiation other anti-cancer treatment|4|||
105916562|NCT01868646|365354791|FG000|Overall Study|Do not meet inclusion criteria|3|||
105916563|NCT01868646|365354792|FG001|Overall Study|Do not meet inclusion criteria|5|||
105916564|NCT02026141|365354795|FG000|Overall Study|Protocol Violation|0|||
105916565|NCT02026141|365354796|FG001|Overall Study|Protocol Violation|1|||
105916566|NCT01218308|365354797|FG000|Overall Study|Adverse Event|1|||
105916567|NCT01218308|365354798|FG001|Overall Study|Adverse Event|2|||
105916568|NCT01218308|365354797|FG000|Overall Study|Protocol Violation|0|||
105916569|NCT01218308|365354798|FG001|Overall Study|Protocol Violation|2|||
105916570|NCT01218308|365354797|FG000|Overall Study|Withdrawal by Subject|61|||
105916571|NCT01218308|365354798|FG001|Overall Study|Withdrawal by Subject|64|||
105916572|NCT01218308|365354797|FG000|Overall Study|Lost to Follow-up|27|||
105682009|NCT02074553|364499463|FG004|Washout Period 2|Physician Decision|0|||
105682010|NCT02074553|364499464|FG005|Washout Period 2|Physician Decision|1|||
105916573|NCT01218308|365354798|FG001|Overall Study|Lost to Follow-up|31|||
105916574|NCT01218308|365354797|FG000|Overall Study|Other|14|||
105916575|NCT01218308|365354798|FG001|Overall Study|Other|21|||
105916576|NCT01450813|365354799|FG000|Overall Study|Physician Decision|1|||
105916577|NCT01450813|365354800|FG001|Overall Study|Physician Decision|1|||
105916578|NCT01450813|365354801|FG002|Overall Study|Physician Decision|0|||
105916579|NCT01450813|365354802|FG003|Overall Study|Physician Decision|3|||
105916580|NCT00960193|365354803|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
105916581|NCT02051296|365354815|FG000|Overall Study|Lost to Follow-up|1|||
105682011|NCT02074553|364499465|FG006|Washout Period 2|Physician Decision|0|||
105682012|NCT02074553|364499466|FG007|Washout Period 2|Physician Decision|0|||
105916582|NCT02051296|365354816|FG001|Overall Study|Lost to Follow-up|2|||
105682013|NCT02074553|364499459|FG000|Washout Period 2|Lost to Follow-up|0|||
105682014|NCT02074553|364499460|FG001|Washout Period 2|Lost to Follow-up|0|||
105682015|NCT02074553|364499461|FG002|Washout Period 2|Lost to Follow-up|1|||
105682016|NCT02074553|364499462|FG003|Washout Period 2|Lost to Follow-up|0|||
105682017|NCT02074553|364499463|FG004|Washout Period 2|Lost to Follow-up|0|||
105682018|NCT02074553|364499464|FG005|Washout Period 2|Lost to Follow-up|0|||
105682019|NCT02074553|364499465|FG006|Washout Period 2|Lost to Follow-up|0|||
105682020|NCT02074553|364499466|FG007|Washout Period 2|Lost to Follow-up|0|||
105682021|NCT02074553|364499459|FG000|Washout Period 3|Physician Decision|0|||
105682022|NCT02074553|364499460|FG001|Washout Period 3|Physician Decision|0|||
105682023|NCT02074553|364499461|FG002|Washout Period 3|Physician Decision|0|||
105682024|NCT02074553|364499462|FG003|Washout Period 3|Physician Decision|0|||
105682025|NCT02074553|364499463|FG004|Washout Period 3|Physician Decision|0|||
105682026|NCT02074553|364499464|FG005|Washout Period 3|Physician Decision|0|||
105682027|NCT02074553|364499465|FG006|Washout Period 3|Physician Decision|0|||
105682028|NCT02074553|364499466|FG007|Washout Period 3|Physician Decision|1|||
105682029|NCT01664598|364499467|FG000|Overall Study|Sponsor Decision|1|||
105682030|NCT01664598|364499467|FG000|Overall Study|Withdrawal of Informed Consent|4|||
105682031|NCT01664598|364499467|FG000|Overall Study|Adverse Event|1|||
105682032|NCT04187989|364499468|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
105682033|NCT04187989|364499469|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
105682034|NCT04187989|364499468|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
105682035|NCT04187989|364499469|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
105682036|NCT04882995|364499477|FG000|Overall Study|Withdrawal by Subject|1|||
105682037|NCT04882995|364499478|FG001|Overall Study|Withdrawal by Subject|2|||
105682038|NCT04882995|364499477|FG000|Overall Study|Protocol Violation|4|||
105682039|NCT04882995|364499478|FG001|Overall Study|Protocol Violation|4|||
105682040|NCT04882995|364499477|FG000|Overall Study|Surgery postponed due to COVID|1|||
105682041|NCT04882995|364499478|FG001|Overall Study|Surgery postponed due to COVID|1|||
105682042|NCT00461032|364499479|FG000|Overall Study|Adverse Event|5|||
105682043|NCT00461032|364499480|FG001|Overall Study|Adverse Event|6|||
105682044|NCT00461032|364499479|FG000|Overall Study|Lack of Efficacy|5|||
105682045|NCT00461032|364499480|FG001|Overall Study|Lack of Efficacy|1|||
105682046|NCT00461032|364499479|FG000|Overall Study|Lost to Follow-up|7|||
105682047|NCT00461032|364499480|FG001|Overall Study|Lost to Follow-up|12|||
105682048|NCT00461032|364499479|FG000|Overall Study|Protocol Violation|4|||
105682049|NCT00461032|364499480|FG001|Overall Study|Protocol Violation|4|||
105682050|NCT00461032|364499479|FG000|Overall Study|Withdrawal by Subject|7|||
105682051|NCT00461032|364499480|FG001|Overall Study|Withdrawal by Subject|15|||
105682052|NCT00461032|364499479|FG000|Overall Study|Patient Moved or Relocated|2|||
105682053|NCT00461032|364499480|FG001|Overall Study|Patient Moved or Relocated|1|||
105682054|NCT00461032|364499479|FG000|Overall Study|Other|7|||
105682055|NCT00461032|364499480|FG001|Overall Study|Other|5|||
105682056|NCT04447846|364499481|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
105682057|NCT03536143|364499482|FG000|Overall Study|Early termination, Sponsor decision|1|||
105682058|NCT01878214|364499483|FG000|Overall Study|Withdrawal by Subject|18|||
105682059|NCT01878214|364499484|FG001|Overall Study|Withdrawal by Subject|7|||
105682060|NCT01878214|364499483|FG000|Overall Study|Death|0|||
105682061|NCT01878214|364499484|FG001|Overall Study|Death|1|||
105682062|NCT01878214|364499483|FG000|Overall Study|Lost to Follow-up|35|||
105682063|NCT01878214|364499484|FG001|Overall Study|Lost to Follow-up|36|||
105682064|NCT02057523|364499487|FG000|Overall Study|Withdrawal by Subject|1|||
105682065|NCT02057523|364499487|FG000|Overall Study|Lack of Efficacy|1|||
105682066|NCT02783768|364499491|FG000|Overall Study|Lost to Follow-up|1|||
105682067|NCT02783768|364499492|FG001|Overall Study|Lost to Follow-up|0|||
105682068|NCT02344004|364499493|FG000|Overall Study|Adverse Event|11|||
105682069|NCT02344004|364499494|FG001|Overall Study|Adverse Event|1|||
105682070|NCT02344004|364499493|FG000|Overall Study|Death|9|||
105682071|NCT02344004|364499494|FG001|Overall Study|Death|7|||
105916583|NCT02051296|365354815|FG000|Overall Study|withdraw prior to treatment|7|||
105916584|NCT02051296|365354816|FG001|Overall Study|withdraw prior to treatment|7|||
105916585|NCT00473083|365354817|FG000|Overall Study|Adverse Event|1|||
105916586|NCT00473083|365354818|FG001|Overall Study|Adverse Event|0|||
105916587|NCT00473083|365354819|FG002|Overall Study|Adverse Event|0|||
105916588|NCT00748241|365354820|FG000|Overall Study|Implant failure|1|||
105682072|NCT02344004|364499493|FG000|Overall Study|Physician Decision|4|||
105682073|NCT02344004|364499494|FG001|Overall Study|Physician Decision|1|||
105682074|NCT02344004|364499493|FG000|Overall Study|Withdrawal by Subject|22|||
105682075|NCT02344004|364499494|FG001|Overall Study|Withdrawal by Subject|5|||
105682076|NCT02344004|364499493|FG000|Overall Study|Rescue Medication|2|||
105682077|NCT02344004|364499494|FG001|Overall Study|Rescue Medication|0|||
105682078|NCT02344004|364499493|FG000|Overall Study|Other Not Specified|12|||
105682079|NCT02344004|364499494|FG001|Overall Study|Other Not Specified|0|||
105682080|NCT02344004|364499493|FG000|Overall Study|Protocol Violation|1|||
105682081|NCT02344004|364499494|FG001|Overall Study|Protocol Violation|0|||
105682082|NCT02924064|364499495|FG000|Overall Study|Adverse Event|2|||
105682083|NCT02924064|364499496|FG001|Overall Study|Adverse Event|2|||
105682084|NCT02924064|364499495|FG000|Overall Study|Lost to Follow-up|0|||
105682085|NCT02924064|364499496|FG001|Overall Study|Lost to Follow-up|2|||
105682086|NCT02924064|364499495|FG000|Overall Study|Physician Decision|0|||
105682087|NCT02924064|364499496|FG001|Overall Study|Physician Decision|2|||
105682088|NCT02924064|364499495|FG000|Overall Study|Protocol Violation|1|||
105682089|NCT02924064|364499496|FG001|Overall Study|Protocol Violation|3|||
105682090|NCT02924064|364499495|FG000|Overall Study|Withdrawal by Subject|4|||
105682091|NCT02924064|364499496|FG001|Overall Study|Withdrawal by Subject|5|||
105682092|NCT02924064|364499495|FG000|Overall Study|Other|17|||
105682093|NCT02924064|364499496|FG001|Overall Study|Other|29|||
105682094|NCT01502631|364499497|FG000|Overall Study|Adverse Event|5|||
105682095|NCT01502631|364499498|FG001|Overall Study|Adverse Event|8|||
105682096|NCT01502631|364499497|FG000|Overall Study|Lost to Follow-up|2|||
105682097|NCT01502631|364499498|FG001|Overall Study|Lost to Follow-up|2|||
105682098|NCT01502631|364499497|FG000|Overall Study|Participant withdrew consent|2|||
105682099|NCT01502631|364499498|FG001|Overall Study|Participant withdrew consent|4|||
105682100|NCT01502631|364499497|FG000|Overall Study|Participant non-compliant|1|||
105682101|NCT01502631|364499498|FG001|Overall Study|Participant non-compliant|0|||
105682102|NCT01502631|364499497|FG000|Overall Study|Investigator's decision|0|||
105682103|NCT01502631|364499498|FG001|Overall Study|Investigator's decision|1|||
105682104|NCT01502631|364499497|FG000|Overall Study|Other|10|||
105682105|NCT01502631|364499498|FG001|Overall Study|Other|5|||
105682106|NCT01945060|364499499|FG000|Overall Study|Lost to follow up|1|||
105682107|NCT01945060|364499500|FG001|Overall Study|Lost to follow up|0|||
105682108|NCT01945060|364499499|FG000|Overall Study|Distress related to IV access|0|||
105682109|NCT01945060|364499500|FG001|Overall Study|Distress related to IV access|1|||
105682110|NCT00966277|364499501|FG000|Overall Study|Withdrawal by Subject|3|||
105682111|NCT00966277|364499502|FG001|Overall Study|Withdrawal by Subject|0|||
105682112|NCT00966277|364499501|FG000|Overall Study|Ineligible|1|||
105682113|NCT00966277|364499502|FG001|Overall Study|Ineligible|3|||
105682114|NCT00966277|364499501|FG000|Overall Study|Treatment Plan Changed|0|||
105682115|NCT00966277|364499502|FG001|Overall Study|Treatment Plan Changed|1|||
105682116|NCT00819390|364499509|FG000|Overall Study|Lost to Follow-up|1|||
105682117|NCT00819390|364499510|FG001|Overall Study|Lost to Follow-up|1|||
105682118|NCT00819390|364499511|FG002|Overall Study|Lost to Follow-up|0|||
105682119|NCT00819390|364499512|FG003|Overall Study|Lost to Follow-up|0|||
105682120|NCT00819390|364499509|FG000|Overall Study|Withdrawal by Subject|2|||
105682121|NCT00819390|364499510|FG001|Overall Study|Withdrawal by Subject|0|||
105682122|NCT00819390|364499511|FG002|Overall Study|Withdrawal by Subject|0|||
105682123|NCT00819390|364499512|FG003|Overall Study|Withdrawal by Subject|0|||
105682124|NCT00819390|364499509|FG000|Overall Study|Adverse Event|0|||
105682125|NCT00819390|364499510|FG001|Overall Study|Adverse Event|0|||
105682126|NCT00819390|364499511|FG002|Overall Study|Adverse Event|1|||
105682127|NCT00819390|364499512|FG003|Overall Study|Adverse Event|0|||
105682128|NCT00998335|364499515|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
105682129|NCT00998335|364499516|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
105682130|NCT03169101|364499517|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
105682131|NCT03169101|364499518|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
105682132|NCT03169101|364499519|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
105682133|NCT03169101|364499520|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
105682134|NCT02641496|364499521|FG000|Overall Study|Lost to Follow-up|13|||
105682135|NCT02641496|364499522|FG001|Overall Study|Lost to Follow-up|12|||
105682136|NCT02641496|364499521|FG000|Overall Study|Withdrawal by Subject|1|||
105682137|NCT02641496|364499522|FG001|Overall Study|Withdrawal by Subject|0|||
105682138|NCT01204398|364499525|FG000|Overall Study|Adverse Event|1|||
105682139|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
105682140|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
105682141|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
105682142|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
105682143|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
105916589|NCT00748241|365354820|FG000|Overall Study|Lost to Follow-up|5|||
105916590|NCT00748241|365354820|FG000|Overall Study|Death|2|||
105916591|NCT00492297|365354824|FG000|Treatment|Death|2|||
105916592|NCT00492297|365354824|FG000|Treatment|Study terminated by sponsor|3|||
105916593|NCT00492297|365354824|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
105682144|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
105682145|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
105682146|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
105682147|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
105682148|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
105682149|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
105682150|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
105916594|NCT00492297|365354824|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
105682151|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
105682152|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
105682153|NCT00600886|364499526|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
105682154|NCT00600886|364499527|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
105682155|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
105682156|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
105682157|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
105682158|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
105682159|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
105682160|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
105682161|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
105682162|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
105682163|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
105682164|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
105682165|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
105682166|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
105682167|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Death|1|||
105682168|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Death|1|||
105682169|NCT00600886|364499526|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
105682170|NCT00600886|364499527|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
105682171|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
105682172|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
105682173|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
105682174|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
105682175|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
105682176|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
105786486|NCT01207219|364871407|FG002|Overall Study|changed diagnosis during study period|1|||
105786487|NCT01207219|364871405|FG000|Overall Study|Lost to Follow-up|6|||
105786488|NCT01207219|364871406|FG001|Overall Study|Lost to Follow-up|8|||
105786489|NCT01207219|364871407|FG002|Overall Study|Lost to Follow-up|6|||
105786490|NCT04629534|364871414|FG000|Overall Study|Physician Decision|1|||
105786491|NCT04629534|364871415|FG001|Overall Study|Physician Decision|0|||
105682177|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
105682178|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
105682179|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
105682180|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
105682181|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
105682182|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
105682183|NCT00600886|364499526|FG000|Extension - After Crossover (CAS)|Death|1|||
105682184|NCT00600886|364499527|FG001|Extension - After Crossover (CAS)|Death|0|||
105682185|NCT01575028|364499528|FG000|Overall Study|Physician Decision|0|||
105682186|NCT01575028|364499529|FG001|Overall Study|Physician Decision|1|||
105682187|NCT01182194|364499531|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
105682188|NCT01182194|364499532|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
105682189|NCT02533570|364499538|FG000|Overall Study|Adverse Event|0|||
105682190|NCT02533570|364499539|FG001|Overall Study|Adverse Event|1|||
105682191|NCT02533570|364499540|FG002|Overall Study|Adverse Event|1|||
105682192|NCT05330312|364499542|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
105682193|NCT05330312|364499543|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
105682194|NCT05330312|364499544|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
105682195|NCT05330312|364499542|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
105682196|NCT05330312|364499543|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
105682197|NCT05330312|364499544|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
105682198|NCT05330312|364499542|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
105682199|NCT05330312|364499543|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
105682200|NCT05330312|364499544|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
105682201|NCT05330312|364499542|FG000|Pivotal Investigation - Part 2|Death|1|||
105682202|NCT05330312|364499543|FG001|Pivotal Investigation - Part 2|Death|4|||
105682203|NCT05330312|364499544|FG002|Pivotal Investigation - Part 2|Death|0|||
105682204|NCT03534284|364499545|FG000|Overall Study|Death|2|||
105682205|NCT03534284|364499546|FG001|Overall Study|Death|3|||
105682206|NCT03534284|364499547|FG002|Overall Study|Death|3|||
105682207|NCT03534284|364499545|FG000|Overall Study|Withdrawal by Subject|5|||
105682208|NCT03534284|364499546|FG001|Overall Study|Withdrawal by Subject|0|||
105682209|NCT03534284|364499547|FG002|Overall Study|Withdrawal by Subject|0|||
105682210|NCT03705832|364499550|FG000|Overall Study|Physician Decision|0|||
105786492|NCT04629534|364871414|FG000|Overall Study|Protocol Violation|0|||
105786493|NCT04629534|364871415|FG001|Overall Study|Protocol Violation|2|||
105682211|NCT03705832|364499551|FG001|Overall Study|Physician Decision|1|||
105682212|NCT03705832|364499550|FG000|Overall Study|Withdrawal by Subject|1|||
105682213|NCT03705832|364499551|FG001|Overall Study|Withdrawal by Subject|0|||
105786494|NCT04585906|364871422|FG000|Overall Study|Lost to Follow-up|8|||
105786495|NCT04585906|364871423|FG001|Overall Study|Lost to Follow-up|5|||
105682214|NCT01050790|364499552|FG000|Overall Study|Adverse Event|1|||
105682215|NCT02502799|364501263|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
105682216|NCT02502799|364501264|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
105682217|NCT02502799|364501265|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
105682218|NCT02502799|364501266|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
105682219|NCT02502799|364501263|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
105682220|NCT02502799|364501264|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
105682221|NCT02502799|364501265|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
105682222|NCT02502799|364501266|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
105682223|NCT02502799|364501263|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
105682224|NCT02502799|364501264|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
105682225|NCT02502799|364501265|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
105682226|NCT02502799|364501266|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
105682227|NCT02502799|364501263|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
105682228|NCT02502799|364501264|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
105682229|NCT02502799|364501265|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
105682230|NCT02502799|364501266|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
105682231|NCT02502799|364501263|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
105682232|NCT02502799|364501264|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
105682233|NCT02502799|364501265|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
105682234|NCT02502799|364501266|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
105682235|NCT00031551|364501267|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
105682236|NCT00031551|364501268|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
105682237|NCT00189488|364501271|FG000|Overall Study|Ineligibility determined|1|||
105682238|NCT00189488|364501272|FG001|Overall Study|Ineligibility determined|0|||
106001089|NCT00101686|365665201|FG001|Overall Study|initiation other anti-cancer treatment|3|||
106001090|NCT00101686|365665202|FG002|Overall Study|initiation other anti-cancer treatment|4|||
106001091|NCT00101686|365665203|FG003|Overall Study|initiation other anti-cancer treatment|3|||
106001092|NCT00101686|365665204|FG004|Overall Study|initiation other anti-cancer treatment|1|||
106001093|NCT00101686|365665205|FG005|Overall Study|initiation other anti-cancer treatment|1|||
106001094|NCT00101686|365665206|FG006|Overall Study|initiation other anti-cancer treatment|2|||
105682239|NCT00189488|364501271|FG000|Overall Study|Protocol deviation|2|||
105682240|NCT00189488|364501272|FG001|Overall Study|Protocol deviation|1|||
105682241|NCT00189488|364501271|FG000|Overall Study|Adverse Event|2|||
105682242|NCT00189488|364501272|FG001|Overall Study|Adverse Event|1|||
105682243|NCT00189488|364501271|FG000|Overall Study|Withdrawal by Subject|2|||
105682244|NCT00189488|364501272|FG001|Overall Study|Withdrawal by Subject|6|||
105682245|NCT00189488|364501271|FG000|Overall Study|Disease progression|2|||
105682246|NCT00189488|364501272|FG001|Overall Study|Disease progression|4|||
105682247|NCT00189488|364501271|FG000|Overall Study|Administrative Decision|0|||
105682248|NCT00189488|364501272|FG001|Overall Study|Administrative Decision|2|||
105682249|NCT00189488|364501271|FG000|Overall Study|Death|5|||
105682250|NCT00189488|364501272|FG001|Overall Study|Death|8|||
105682251|NCT00189488|364501271|FG000|Overall Study|Other|1|||
105682252|NCT00189488|364501272|FG001|Overall Study|Other|0|||
105682253|NCT03527173|364501274|FG000|Overall Study|Lost to Follow-up|4|||
105682254|NCT03527173|364501275|FG001|Overall Study|Lost to Follow-up|2|||
105682255|NCT03527173|364501274|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
105682256|NCT03527173|364501275|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
105682257|NCT03527173|364501274|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
105682258|NCT03527173|364501275|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
105682259|NCT03527173|364501274|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
105682260|NCT03527173|364501275|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105682261|NCT02342743|364501288|FG000|Baseline Period|Withdrawal by Subject|3|||
105682262|NCT02342743|364501288|FG000|Baseline Period|Lost to Follow-up|2|||
105682263|NCT02342743|364501288|FG000|Baseline Period|Change in prophylactic medication|3|||
105682264|NCT02342743|364501288|FG000|Baseline Period|Screening failure regarding baseline|7|||
105682265|NCT02342743|364501288|FG000|Treatment Period|Withdrawal by Subject|2|||
105682266|NCT02342743|364501288|FG000|Treatment Period|Lost to Follow-up|8|||
105682267|NCT02342743|364501288|FG000|Treatment Period|Change in prophylactic medication|1|||
105682268|NCT00686725|364501289|FG000|Overall Study|Adverse Event|1|||
105682269|NCT00686725|364501290|FG001|Overall Study|Adverse Event|1|||
105682270|NCT00686725|364501289|FG000|Overall Study|Progressive Disease|17|||
105682271|NCT00686725|364501290|FG001|Overall Study|Progressive Disease|23|||
105682272|NCT00686725|364501289|FG000|Overall Study|Lost to Follow-up|7|||
105682273|NCT00686725|364501290|FG001|Overall Study|Lost to Follow-up|5|||
105682274|NCT00686725|364501289|FG000|Overall Study|Death|6|||
105682275|NCT00686725|364501290|FG001|Overall Study|Death|3|||
105682276|NCT00686725|364501289|FG000|Overall Study|Withdrawal by Subject|13|||
105682277|NCT00686725|364501290|FG001|Overall Study|Withdrawal by Subject|4|||
105682278|NCT00686725|364501289|FG000|Overall Study|Protocol Violation|1|||
105682279|NCT00686725|364501290|FG001|Overall Study|Protocol Violation|3|||
105682280|NCT00686725|364501289|FG000|Overall Study|Other|1|||
105682281|NCT00686725|364501290|FG001|Overall Study|Other|3|||
105682282|NCT03064035|364501293|FG000|Overall Study|Did not receive allocated intervention|4|||
105682283|NCT03064035|364501294|FG001|Overall Study|Did not receive allocated intervention|2|||
105682284|NCT03064035|364501293|FG000|Overall Study|Lost to Follow-up|1|||
105682285|NCT03064035|364501294|FG001|Overall Study|Lost to Follow-up|1|||
105682286|NCT03646656|364501295|FG000|Overall Study|Lost to Follow-up|1|||
105682287|NCT03646656|364501296|FG001|Overall Study|Lost to Follow-up|0|||
105682288|NCT03646656|364501295|FG000|Overall Study|Withdrawal by Subject|2|||
105682289|NCT03646656|364501296|FG001|Overall Study|Withdrawal by Subject|0|||
105682290|NCT03103763|364501303|FG000|Overall Study|Death|15|||
105682291|NCT03103763|364501304|FG001|Overall Study|Death|5|||
105682292|NCT03103763|364501305|FG002|Overall Study|Death|5|||
105682293|NCT03103763|364501303|FG000|Overall Study|Withdrawal by Subject|0|||
105682294|NCT03103763|364501304|FG001|Overall Study|Withdrawal by Subject|3|||
105682295|NCT03103763|364501305|FG002|Overall Study|Withdrawal by Subject|2|||
105682296|NCT01143038|364501306|FG000|Overall Study|Withdrawal by Subject|4|||
105682297|NCT01143038|364501306|FG000|Overall Study|Requirement for alternative therapy|5|||
105682298|NCT01143038|364501306|FG000|Overall Study|Adverse Event|3|||
105682299|NCT01143038|364501306|FG000|Overall Study|Lost to Follow-up|2|||
105682300|NCT01143038|364501306|FG000|Overall Study|Protocol Deviation|1|||
105682301|NCT01143038|364501306|FG000|Overall Study|Death|1|||
105682302|NCT00618982|364501307|FG000|Overall Study|Adverse Event|23|||
105682303|NCT00618982|364501307|FG000|Overall Study|Withdrawal by Subject|1|||
105682304|NCT00618982|364501307|FG000|Overall Study|Protocol Violation|1|||
105682305|NCT00618982|364501307|FG000|Overall Study|ongoing, still treated with study med.|25|||
105682306|NCT01236365|364501308|FG000|Overall Study|Lost to Follow-up|0|||
105682307|NCT01236365|364501309|FG001|Overall Study|Lost to Follow-up|2|||
105682308|NCT01236365|364501308|FG000|Overall Study|Moved Out of State|1|||
105682309|NCT01236365|364501309|FG001|Overall Study|Moved Out of State|0|||
105682310|NCT01236365|364501308|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
105682311|NCT01236365|364501309|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
105682312|NCT00799513|364501310|FG000|Overall Study|Physician Decision|1|||
105682313|NCT00799513|364501310|FG000|Overall Study|Adverse Event|1|||
105682314|NCT01248065|364501313|FG000|Overall Study|Lost to Follow-up|3|||
105682315|NCT01248065|364501314|FG001|Overall Study|Lost to Follow-up|5|||
105682316|NCT01248065|364501313|FG000|Overall Study|Withdrawal by Subject|14|||
105682317|NCT01248065|364501314|FG001|Overall Study|Withdrawal by Subject|11|||
105682318|NCT01248065|364501313|FG000|Overall Study|Adverse Event|3|||
105682319|NCT01248065|364501314|FG001|Overall Study|Adverse Event|0|||
105916595|NCT00492297|365354824|FG000|Survival Only Follow-up|Death|46|||
105916596|NCT00492297|365354824|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
105916597|NCT00492297|365354824|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
105916598|NCT00113607|365354825|FG000|Overall Study|Adverse Event|40|||
105916599|NCT00113607|365354826|FG001|Overall Study|Adverse Event|71|||
105916600|NCT00113607|365354825|FG000|Overall Study|Death|8|||
105916601|NCT00113607|365354826|FG001|Overall Study|Death|8|||
105916602|NCT00113607|365354825|FG000|Overall Study|Withdrawal by Subject|50|||
105916603|NCT00113607|365354826|FG001|Overall Study|Withdrawal by Subject|58|||
106127887|NCT01474512|366125532|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127888|NCT01474512|366125533|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127889|NCT01474512|366125534|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127890|NCT01474512|366125535|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127891|NCT01474512|366125536|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127892|NCT01474512|366125537|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127893|NCT01474512|366125538|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127894|NCT01474512|366125539|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105682320|NCT01248065|364501313|FG000|Overall Study|Third treatment failure event|3|||
105682321|NCT01248065|364501314|FG001|Overall Study|Third treatment failure event|1|||
105682322|NCT01248065|364501313|FG000|Overall Study|Other|3|||
105916604|NCT00113607|365354825|FG000|Overall Study|Lost to Follow-up|0|||
105916605|NCT00113607|365354826|FG001|Overall Study|Lost to Follow-up|2|||
105682323|NCT01248065|364501314|FG001|Overall Study|Other|5|||
105682324|NCT03271021|364501316|FG000|Overall Study|Adverse Event|3|||
105682325|NCT03271021|364501317|FG001|Overall Study|Adverse Event|2|||
105682326|NCT03271021|364501316|FG000|Overall Study|Withdrawal by Subject|36|||
105682327|NCT03271021|364501317|FG001|Overall Study|Withdrawal by Subject|53|||
105682328|NCT03271021|364501316|FG000|Overall Study|Lost to Follow-up|34|||
105682329|NCT03271021|364501317|FG001|Overall Study|Lost to Follow-up|39|||
105682330|NCT03271021|364501316|FG000|Overall Study|Protocol Violation|6|||
105682331|NCT03271021|364501317|FG001|Overall Study|Protocol Violation|4|||
105682332|NCT03271021|364501316|FG000|Overall Study|Abnormal Lab Results|1|||
105682333|NCT03271021|364501317|FG001|Overall Study|Abnormal Lab Results|0|||
105682334|NCT03271021|364501316|FG000|Overall Study|Miscellaneous|9|||
106127895|NCT01474512|366125540|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
105682335|NCT03271021|364501317|FG001|Overall Study|Miscellaneous|8|||
105682336|NCT03010176|364501320|FG000|Overall Study|Death|21|||
105682337|NCT03010176|364501321|FG001|Overall Study|Death|35|||
105682338|NCT03010176|364501322|FG002|Overall Study|Death|19|||
105682339|NCT03010176|364501323|FG003|Overall Study|Death|19|||
105682340|NCT03010176|364501324|FG004|Overall Study|Death|14|||
105682341|NCT03010176|364501325|FG005|Overall Study|Death|0|||
105682342|NCT03010176|364501320|FG000|Overall Study|Lost to Follow-up|0|||
105682343|NCT03010176|364501321|FG001|Overall Study|Lost to Follow-up|0|||
105682344|NCT03010176|364501322|FG002|Overall Study|Lost to Follow-up|0|||
105682345|NCT03010176|364501323|FG003|Overall Study|Lost to Follow-up|0|||
105682346|NCT03010176|364501324|FG004|Overall Study|Lost to Follow-up|1|||
105682347|NCT03010176|364501325|FG005|Overall Study|Lost to Follow-up|0|||
105682348|NCT03010176|364501320|FG000|Overall Study|Physician Decision|0|||
105682349|NCT03010176|364501321|FG001|Overall Study|Physician Decision|4|||
105682350|NCT03010176|364501322|FG002|Overall Study|Physician Decision|0|||
105682351|NCT03010176|364501323|FG003|Overall Study|Physician Decision|1|||
105682352|NCT03010176|364501324|FG004|Overall Study|Physician Decision|0|||
105682353|NCT03010176|364501325|FG005|Overall Study|Physician Decision|0|||
105682354|NCT03010176|364501320|FG000|Overall Study|Sponsor Decision|0|||
105682355|NCT03010176|364501321|FG001|Overall Study|Sponsor Decision|4|||
105682356|NCT03010176|364501322|FG002|Overall Study|Sponsor Decision|4|||
105682357|NCT03010176|364501323|FG003|Overall Study|Sponsor Decision|1|||
105682358|NCT03010176|364501324|FG004|Overall Study|Sponsor Decision|6|||
105682359|NCT03010176|364501325|FG005|Overall Study|Sponsor Decision|0|||
105682360|NCT03010176|364501320|FG000|Overall Study|Withdrawal by Subject|11|||
105682361|NCT03010176|364501321|FG001|Overall Study|Withdrawal by Subject|9|||
105682362|NCT03010176|364501322|FG002|Overall Study|Withdrawal by Subject|3|||
105682363|NCT03010176|364501323|FG003|Overall Study|Withdrawal by Subject|0|||
105682364|NCT03010176|364501324|FG004|Overall Study|Withdrawal by Subject|4|||
105682365|NCT03010176|364501325|FG005|Overall Study|Withdrawal by Subject|0|||
105682366|NCT00346632|364501326|FG000|Overall Study|Progressive Disease|2|||
105682367|NCT00346632|364501327|FG001|Overall Study|Progressive Disease|2|||
105682368|NCT00346632|364501328|FG002|Overall Study|Progressive Disease|4|||
105682369|NCT00346632|364501329|FG003|Overall Study|Progressive Disease|3|||
105682370|NCT00346632|364501330|FG004|Overall Study|Progressive Disease|3|||
105682371|NCT00346632|364501331|FG005|Overall Study|Progressive Disease|1|||
105682372|NCT00346632|364501332|FG006|Overall Study|Progressive Disease|2|||
105682373|NCT00346632|364501333|FG007|Overall Study|Progressive Disease|2|||
105682374|NCT00346632|364501334|FG008|Overall Study|Progressive Disease|2|||
105682375|NCT00346632|364501335|FG009|Overall Study|Progressive Disease|2|||
105682376|NCT00346632|364501326|FG000|Overall Study|Adverse Event|0|||
105682377|NCT00346632|364501327|FG001|Overall Study|Adverse Event|0|||
105682378|NCT00346632|364501328|FG002|Overall Study|Adverse Event|0|||
105682379|NCT00346632|364501329|FG003|Overall Study|Adverse Event|0|||
105682380|NCT00346632|364501330|FG004|Overall Study|Adverse Event|1|||
105682381|NCT00346632|364501331|FG005|Overall Study|Adverse Event|1|||
105682382|NCT00346632|364501332|FG006|Overall Study|Adverse Event|1|||
105682383|NCT00346632|364501333|FG007|Overall Study|Adverse Event|0|||
105682384|NCT00346632|364501334|FG008|Overall Study|Adverse Event|0|||
105682385|NCT00346632|364501335|FG009|Overall Study|Adverse Event|0|||
105682386|NCT00346632|364501326|FG000|Overall Study|Death|0|||
105682387|NCT00346632|364501327|FG001|Overall Study|Death|0|||
105682388|NCT00346632|364501328|FG002|Overall Study|Death|1|||
106127896|NCT01474512|366125541|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127897|NCT01474512|366125542|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
106127898|NCT01474512|366125543|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127899|NCT01474512|366125544|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127900|NCT01474512|366125545|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127901|NCT01474512|366125546|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127902|NCT01474512|366125547|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127903|NCT01474512|366125548|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
106127904|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
105682389|NCT00346632|364501329|FG003|Overall Study|Death|0|||
105682390|NCT00346632|364501330|FG004|Overall Study|Death|0|||
105682391|NCT00346632|364501331|FG005|Overall Study|Death|0|||
105682392|NCT00346632|364501332|FG006|Overall Study|Death|0|||
105682393|NCT00346632|364501333|FG007|Overall Study|Death|0|||
105682394|NCT00346632|364501334|FG008|Overall Study|Death|0|||
105682395|NCT00346632|364501335|FG009|Overall Study|Death|0|||
105682396|NCT00346632|364501326|FG000|Overall Study|Protocol Violation|0|||
105682397|NCT00346632|364501327|FG001|Overall Study|Protocol Violation|0|||
105682398|NCT00346632|364501328|FG002|Overall Study|Protocol Violation|0|||
105682399|NCT00346632|364501329|FG003|Overall Study|Protocol Violation|0|||
106127905|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
106127906|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
106127907|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
105682400|NCT00346632|364501330|FG004|Overall Study|Protocol Violation|0|||
105682401|NCT00346632|364501331|FG005|Overall Study|Protocol Violation|0|||
105682402|NCT00346632|364501332|FG006|Overall Study|Protocol Violation|1|||
105682403|NCT00346632|364501333|FG007|Overall Study|Protocol Violation|0|||
105682404|NCT00346632|364501334|FG008|Overall Study|Protocol Violation|0|||
105682405|NCT00346632|364501335|FG009|Overall Study|Protocol Violation|0|||
105682406|NCT00346632|364501326|FG000|Overall Study|Withdrawal by Subject|0|||
105682407|NCT00346632|364501327|FG001|Overall Study|Withdrawal by Subject|0|||
105682408|NCT00346632|364501328|FG002|Overall Study|Withdrawal by Subject|0|||
105682409|NCT00346632|364501329|FG003|Overall Study|Withdrawal by Subject|0|||
105682410|NCT00346632|364501330|FG004|Overall Study|Withdrawal by Subject|0|||
105682411|NCT00346632|364501331|FG005|Overall Study|Withdrawal by Subject|0|||
105682412|NCT00346632|364501332|FG006|Overall Study|Withdrawal by Subject|1|||
105682413|NCT00346632|364501333|FG007|Overall Study|Withdrawal by Subject|0|||
105682414|NCT00346632|364501334|FG008|Overall Study|Withdrawal by Subject|0|||
105682415|NCT00346632|364501335|FG009|Overall Study|Withdrawal by Subject|0|||
105682416|NCT00346632|364501326|FG000|Overall Study|Switched to alternative treatment|0|||
105682417|NCT00346632|364501327|FG001|Overall Study|Switched to alternative treatment|0|||
105682418|NCT00346632|364501328|FG002|Overall Study|Switched to alternative treatment|1|||
105682419|NCT00346632|364501329|FG003|Overall Study|Switched to alternative treatment|0|||
105682420|NCT00346632|364501330|FG004|Overall Study|Switched to alternative treatment|0|||
105682421|NCT00346632|364501331|FG005|Overall Study|Switched to alternative treatment|0|||
105682422|NCT00346632|364501332|FG006|Overall Study|Switched to alternative treatment|0|||
105682423|NCT00346632|364501333|FG007|Overall Study|Switched to alternative treatment|0|||
105682424|NCT00346632|364501334|FG008|Overall Study|Switched to alternative treatment|0|||
105682425|NCT00346632|364501335|FG009|Overall Study|Switched to alternative treatment|0|||
105682426|NCT00346632|364501326|FG000|Overall Study|Not Stated|1|||
105682427|NCT00346632|364501327|FG001|Overall Study|Not Stated|1|||
105682428|NCT00346632|364501328|FG002|Overall Study|Not Stated|0|||
105682429|NCT00346632|364501329|FG003|Overall Study|Not Stated|0|||
105682430|NCT00346632|364501330|FG004|Overall Study|Not Stated|0|||
105682431|NCT00346632|364501331|FG005|Overall Study|Not Stated|0|||
105682432|NCT00346632|364501332|FG006|Overall Study|Not Stated|0|||
105682433|NCT00346632|364501333|FG007|Overall Study|Not Stated|2|||
105682434|NCT00346632|364501334|FG008|Overall Study|Not Stated|2|||
105682435|NCT00346632|364501335|FG009|Overall Study|Not Stated|1|||
105682436|NCT02038543|364501337|FG000|Overall Study|Screen Failure|0|||
105682437|NCT02038543|364501338|FG001|Overall Study|Screen Failure|0|||
105682438|NCT02038543|364501339|FG002|Overall Study|Screen Failure|0|||
105682439|NCT02038543|364501340|FG003|Overall Study|Screen Failure|1|||
105682440|NCT02038543|364501337|FG000|Overall Study|Withdrawal by Subject|0|||
105682441|NCT02038543|364501338|FG001|Overall Study|Withdrawal by Subject|0|||
106127908|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
106127909|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
106127910|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
106127911|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
106127912|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
106127913|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
106127914|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
106127915|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
106127916|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
106127917|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
106127918|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
105682442|NCT02038543|364501339|FG002|Overall Study|Withdrawal by Subject|0|||
105916606|NCT00113607|365354825|FG000|Overall Study|Disease Progression|180|||
105916607|NCT00113607|365354826|FG001|Overall Study|Disease Progression|142|||
105916608|NCT00113607|365354825|FG000|Overall Study|Complete Response (Confirmed)|14|||
105916609|NCT00113607|365354826|FG001|Overall Study|Complete Response (Confirmed)|24|||
105916610|NCT00113607|365354825|FG000|Overall Study|Other|43|||
105916611|NCT00113607|365354826|FG001|Overall Study|Other|32|||
105916612|NCT01222104|365354827|FG000|Overall Study|Lost to Follow-up|37|||
105916613|NCT01222104|365354827|FG000|Overall Study|Death|10|||
105916614|NCT03885908|365354829|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
105916615|NCT03885908|365354830|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
105916616|NCT03885908|365354829|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
105682443|NCT02038543|364501340|FG003|Overall Study|Withdrawal by Subject|1|||
105682444|NCT02292927|364501343|FG000|Overall Study|Protocol Violation|13|||
105682445|NCT02292927|364501344|FG001|Overall Study|Protocol Violation|7|||
105916617|NCT03885908|365354830|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
105916618|NCT03885908|365354829|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
106127919|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
106127920|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
105682446|NCT02679573|364501345|FG000|Overall Study|Adverse Event|13|||
105682447|NCT02679573|364501346|FG001|Overall Study|Adverse Event|6|||
105682448|NCT02679573|364501345|FG000|Overall Study|Lack of Efficacy|12|||
106127921|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
105682449|NCT02679573|364501346|FG001|Overall Study|Lack of Efficacy|15|||
105682450|NCT02679573|364501345|FG000|Overall Study|Could not complete required study visits|6|||
105682451|NCT02679573|364501346|FG001|Overall Study|Could not complete required study visits|2|||
105682452|NCT02679573|364501345|FG000|Overall Study|Withdrawal by Subject|2|||
105682453|NCT02679573|364501346|FG001|Overall Study|Withdrawal by Subject|9|||
105682454|NCT02679573|364501345|FG000|Overall Study|Death|2|||
105682455|NCT02679573|364501346|FG001|Overall Study|Death|0|||
105682456|NCT02679573|364501345|FG000|Overall Study|Physician Decision|2|||
105682457|NCT02679573|364501346|FG001|Overall Study|Physician Decision|4|||
105682458|NCT02679573|364501345|FG000|Overall Study|Lost to Follow-up|0|||
105682459|NCT02679573|364501346|FG001|Overall Study|Lost to Follow-up|3|||
105682460|NCT02128542|364501347|FG000|Overall Study|Lost to Follow-up|3|||
105682461|NCT02128542|364501348|FG001|Overall Study|Lost to Follow-up|0|||
105682462|NCT02128542|364501347|FG000|Overall Study|Withdrew Consent|1|||
105682463|NCT02128542|364501348|FG001|Overall Study|Withdrew Consent|0|||
105682464|NCT00402597|364501354|FG000|Overall Study|Death|15|||
105682465|NCT00402597|364501355|FG001|Overall Study|Death|7|||
105682466|NCT00402597|364501356|FG002|Overall Study|Death|6|||
105682467|NCT00402597|364501357|FG003|Overall Study|Death|4|||
105682468|NCT00402597|364501358|FG004|Overall Study|Death|6|||
105682469|NCT00402597|364501354|FG000|Overall Study|Adverse Event|81|||
105682470|NCT00402597|364501355|FG001|Overall Study|Adverse Event|18|||
105682471|NCT00402597|364501356|FG002|Overall Study|Adverse Event|106|||
105682472|NCT00402597|364501357|FG003|Overall Study|Adverse Event|39|||
105682473|NCT00402597|364501358|FG004|Overall Study|Adverse Event|71|||
105682474|NCT00402597|364501354|FG000|Overall Study|Lost to Follow-up|8|||
105682475|NCT00402597|364501355|FG001|Overall Study|Lost to Follow-up|1|||
105682476|NCT00402597|364501356|FG002|Overall Study|Lost to Follow-up|8|||
105682477|NCT00402597|364501357|FG003|Overall Study|Lost to Follow-up|2|||
105682478|NCT00402597|364501358|FG004|Overall Study|Lost to Follow-up|3|||
105682479|NCT00402597|364501354|FG000|Overall Study|Withdrawal by Subject|57|||
105682480|NCT00402597|364501355|FG001|Overall Study|Withdrawal by Subject|16|||
105682481|NCT00402597|364501356|FG002|Overall Study|Withdrawal by Subject|65|||
105682482|NCT00402597|364501357|FG003|Overall Study|Withdrawal by Subject|15|||
105682483|NCT00402597|364501358|FG004|Overall Study|Withdrawal by Subject|24|||
105682484|NCT00402597|364501354|FG000|Overall Study|reason not specified|30|||
105682485|NCT00402597|364501355|FG001|Overall Study|reason not specified|4|||
105682486|NCT00402597|364501356|FG002|Overall Study|reason not specified|27|||
105682487|NCT00402597|364501357|FG003|Overall Study|reason not specified|14|||
105682488|NCT00402597|364501358|FG004|Overall Study|reason not specified|20|||
105682489|NCT05249829|364501363|FG000|Overall Study|Participant Relocation|0|||
105682490|NCT05249829|364501364|FG001|Overall Study|Participant Relocation|1|||
105682491|NCT05249829|364501365|FG002|Overall Study|Participant Relocation|2|||
105682492|NCT05249829|364501366|FG003|Overall Study|Participant Relocation|2|||
105682493|NCT05249829|364501363|FG000|Overall Study|Withdrawal by Subject|9|||
105682494|NCT05249829|364501364|FG001|Overall Study|Withdrawal by Subject|17|||
105682495|NCT05249829|364501365|FG002|Overall Study|Withdrawal by Subject|40|||
105682496|NCT05249829|364501366|FG003|Overall Study|Withdrawal by Subject|35|||
105682497|NCT05249829|364501363|FG000|Overall Study|Physician Decision|1|||
105682498|NCT05249829|364501364|FG001|Overall Study|Physician Decision|0|||
105682499|NCT05249829|364501365|FG002|Overall Study|Physician Decision|0|||
105682500|NCT05249829|364501366|FG003|Overall Study|Physician Decision|0|||
105682501|NCT05249829|364501363|FG000|Overall Study|Lost to Follow-up|16|||
105682502|NCT05249829|364501364|FG001|Overall Study|Lost to Follow-up|16|||
105682503|NCT05249829|364501365|FG002|Overall Study|Lost to Follow-up|57|||
105682504|NCT05249829|364501366|FG003|Overall Study|Lost to Follow-up|60|||
105682505|NCT05249829|364501363|FG000|Overall Study|Adverse Event|2|||
105682506|NCT05249829|364501364|FG001|Overall Study|Adverse Event|2|||
105682507|NCT05249829|364501365|FG002|Overall Study|Adverse Event|2|||
105682508|NCT05249829|364501366|FG003|Overall Study|Adverse Event|2|||
105682509|NCT05249829|364501363|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
105682510|NCT05249829|364501364|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
105682511|NCT05249829|364501365|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
105682512|NCT05249829|364501366|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
105682513|NCT05249829|364501363|FG000|Overall Study|Protocol Violation|2|||
105682514|NCT05249829|364501364|FG001|Overall Study|Protocol Violation|0|||
106001095|NCT00101686|365665207|FG007|Overall Study|initiation other anti-cancer treatment|2|||
106001096|NCT00101686|365665208|FG008|Overall Study|initiation other anti-cancer treatment|3|||
105682515|NCT05249829|364501365|FG002|Overall Study|Protocol Violation|5|||
105682516|NCT05249829|364501366|FG003|Overall Study|Protocol Violation|3|||
105682517|NCT05249829|364501363|FG000|Overall Study|Death|0|||
105682518|NCT05249829|364501364|FG001|Overall Study|Death|1|||
105682519|NCT05249829|364501365|FG002|Overall Study|Death|2|||
105682520|NCT05249829|364501366|FG003|Overall Study|Death|4|||
105682521|NCT02842827|364501370|FG000|Overall Study|Adverse Event|0|||
105682522|NCT02842827|364501371|FG001|Overall Study|Adverse Event|1|||
105682523|NCT02842827|364501372|FG002|Overall Study|Adverse Event|0|||
105682524|NCT02842827|364501373|FG003|Overall Study|Adverse Event|1|||
105682525|NCT02842827|364501374|FG004|Overall Study|Adverse Event|0|||
105682526|NCT02842827|364501375|FG005|Overall Study|Adverse Event|1|||
105682527|NCT02842827|364501376|FG006|Overall Study|Adverse Event|0|||
105682528|NCT02842827|364501377|FG007|Overall Study|Adverse Event|0|||
105682529|NCT02842827|364501370|FG000|Overall Study|Death|1|||
105682530|NCT02842827|364501371|FG001|Overall Study|Death|0|||
105682531|NCT02842827|364501372|FG002|Overall Study|Death|2|||
105682532|NCT02842827|364501373|FG003|Overall Study|Death|3|||
105682533|NCT02842827|364501374|FG004|Overall Study|Death|2|||
105682534|NCT02842827|364501375|FG005|Overall Study|Death|1|||
105682535|NCT02842827|364501376|FG006|Overall Study|Death|0|||
105682536|NCT02842827|364501377|FG007|Overall Study|Death|4|||
105682537|NCT02842827|364501370|FG000|Overall Study|Physician Decision|1|||
105682538|NCT02842827|364501371|FG001|Overall Study|Physician Decision|3|||
105682539|NCT02842827|364501372|FG002|Overall Study|Physician Decision|0|||
105682540|NCT02842827|364501373|FG003|Overall Study|Physician Decision|0|||
105682541|NCT02842827|364501374|FG004|Overall Study|Physician Decision|1|||
105682542|NCT02842827|364501375|FG005|Overall Study|Physician Decision|4|||
105682543|NCT02842827|364501376|FG006|Overall Study|Physician Decision|2|||
105682544|NCT02842827|364501377|FG007|Overall Study|Physician Decision|1|||
105682545|NCT02842827|364501370|FG000|Overall Study|Protocol Defined Disease Progression|0|||
105682546|NCT02842827|364501371|FG001|Overall Study|Protocol Defined Disease Progression|0|||
105682547|NCT02842827|364501372|FG002|Overall Study|Protocol Defined Disease Progression|0|||
105682548|NCT02842827|364501373|FG003|Overall Study|Protocol Defined Disease Progression|0|||
105682549|NCT02842827|364501374|FG004|Overall Study|Protocol Defined Disease Progression|0|||
105682550|NCT02842827|364501375|FG005|Overall Study|Protocol Defined Disease Progression|1|||
105682551|NCT02842827|364501376|FG006|Overall Study|Protocol Defined Disease Progression|0|||
105682552|NCT02842827|364501377|FG007|Overall Study|Protocol Defined Disease Progression|0|||
105682553|NCT02842827|364501370|FG000|Overall Study|Participant Withdrawal of Consent|1|||
105682554|NCT02842827|364501371|FG001|Overall Study|Participant Withdrawal of Consent|2|||
105682555|NCT02842827|364501372|FG002|Overall Study|Participant Withdrawal of Consent|2|||
105682556|NCT02842827|364501373|FG003|Overall Study|Participant Withdrawal of Consent|2|||
105682557|NCT02842827|364501374|FG004|Overall Study|Participant Withdrawal of Consent|2|||
105682558|NCT02842827|364501375|FG005|Overall Study|Participant Withdrawal of Consent|1|||
105682559|NCT02842827|364501376|FG006|Overall Study|Participant Withdrawal of Consent|2|||
106001097|NCT00101686|365665209|FG009|Overall Study|initiation other anti-cancer treatment|3|||
105682560|NCT02842827|364501377|FG007|Overall Study|Participant Withdrawal of Consent|1|||
105682561|NCT00609765|364501380|FG000|Overall Study|Study ended prior to 12 months|1|||
105682562|NCT01636960|364501386|FG000|Induction Phase|Adverse Event|2|||
105682563|NCT01636960|364501386|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
105682564|NCT01636960|364501386|FG000|Maintenance Phase|Adverse Event|3|||
105682565|NCT01636960|364501386|FG000|Maintenance Phase|Progressive disease|1|||
105682566|NCT01580969|364501389|FG000|Overall Study|Physician Decision|3|||
105682567|NCT01580969|364501390|FG001|Overall Study|Physician Decision|0|||
105682568|NCT01580969|364501391|FG002|Overall Study|Physician Decision|0|||
105916619|NCT03885908|365354830|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
105916620|NCT03885908|365354829|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
105916621|NCT03885908|365354830|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
105916622|NCT00909844|365354831|FG000|Overall Study|Adverse Event|1|||
105916623|NCT00909844|365354831|FG000|Overall Study|Withdrawal by Subject|1|||
105916624|NCT00909844|365354831|FG000|Overall Study|Lost to Follow-up|2|||
105916625|NCT00706004|365354832|FG000|Overall Study|Did not meet eligibility criteria|2|||
105916626|NCT03575702|365354833|FG000|Overall Study|Withdrawal by Subject|1|||
105916627|NCT03575702|365354834|FG001|Overall Study|Withdrawal by Subject|1|||
105916628|NCT03575702|365354833|FG000|Overall Study|Lost to Follow-up|1|||
105916629|NCT03575702|365354834|FG001|Overall Study|Lost to Follow-up|2|||
105916630|NCT03575702|365354833|FG000|Overall Study|Protocol Violation|0|||
105916631|NCT03575702|365354834|FG001|Overall Study|Protocol Violation|1|||
105916632|NCT03575702|365354833|FG000|Overall Study|Patient non compliance|4|||
105916633|NCT03575702|365354834|FG001|Overall Study|Patient non compliance|0|||
105916634|NCT01545388|365354835|FG000|Overall Study|Adverse Event|2|||
105916635|NCT01545388|365354836|FG001|Overall Study|Adverse Event|4|||
105916636|NCT01545388|365354837|FG002|Overall Study|Adverse Event|1|||
105916637|NCT01545388|365354835|FG000|Overall Study|Lack of Efficacy|3|||
106001098|NCT00101686|365665200|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
106001099|NCT00101686|365665201|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
106001100|NCT00101686|365665202|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
106001101|NCT00101686|365665203|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
105916638|NCT01545388|365354836|FG001|Overall Study|Lack of Efficacy|2|||
106001102|NCT00101686|365665204|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
106001103|NCT00101686|365665205|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
105682569|NCT00757783|364501392|FG000|Overall Study|Adverse Event|0|||
105682570|NCT00757783|364501393|FG001|Overall Study|Adverse Event|2|||
105682571|NCT00757783|364501392|FG000|Overall Study|Lost to Follow-up|1|||
105682572|NCT00757783|364501393|FG001|Overall Study|Lost to Follow-up|1|||
105682573|NCT00757783|364501392|FG000|Overall Study|Protocol Violation|1|||
105682574|NCT00757783|364501393|FG001|Overall Study|Protocol Violation|0|||
105916639|NCT01545388|365354837|FG002|Overall Study|Lack of Efficacy|5|||
105916640|NCT01545388|365354835|FG000|Overall Study|Participant moved or relocated|1|||
105916641|NCT01545388|365354836|FG001|Overall Study|Participant moved or relocated|0|||
105682575|NCT00757783|364501392|FG000|Overall Study|Withdrawal by Subject|2|||
105682576|NCT00757783|364501393|FG001|Overall Study|Withdrawal by Subject|1|||
105682577|NCT00757783|364501392|FG000|Overall Study|Other|1|||
105682578|NCT00757783|364501393|FG001|Overall Study|Other|2|||
105682579|NCT03801915|364501394|FG000|Overall Study|Screen failure|0|||
105682580|NCT03801915|364501395|FG001|Overall Study|Screen failure|0|||
105682581|NCT03801915|364501396|FG002|Overall Study|Screen failure|1|||
105682582|NCT03801915|364501394|FG000|Overall Study|Ineligible|1|||
105682583|NCT03801915|364501395|FG001|Overall Study|Ineligible|0|||
105682584|NCT03801915|364501396|FG002|Overall Study|Ineligible|0|||
105682585|NCT03801915|364501394|FG000|Overall Study|Physician Decision|2|||
105682586|NCT03801915|364501395|FG001|Overall Study|Physician Decision|1|||
105682587|NCT03801915|364501396|FG002|Overall Study|Physician Decision|0|||
105682588|NCT04822597|364501397|FG000|Overall Study|Withdrawal by Subject|0|||
105682589|NCT04822597|364501398|FG001|Overall Study|Withdrawal by Subject|1|||
105682590|NCT04822597|364501399|FG002|Overall Study|Withdrawal by Subject|1|||
105682591|NCT04822597|364501400|FG003|Overall Study|Withdrawal by Subject|0|||
105682592|NCT04822597|364501397|FG000|Overall Study|Physician Decision|0|||
105682593|NCT04822597|364501398|FG001|Overall Study|Physician Decision|0|||
105682594|NCT04822597|364501399|FG002|Overall Study|Physician Decision|1|||
105682595|NCT04822597|364501400|FG003|Overall Study|Physician Decision|1|||
105682596|NCT04822597|364501397|FG000|Overall Study|Subject withdrawn after enrollment|0|||
105682597|NCT04822597|364501398|FG001|Overall Study|Subject withdrawn after enrollment|1|||
105682598|NCT04822597|364501399|FG002|Overall Study|Subject withdrawn after enrollment|0|||
105682599|NCT04822597|364501400|FG003|Overall Study|Subject withdrawn after enrollment|1|||
105682600|NCT04822597|364501397|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
105682601|NCT04822597|364501398|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
105682602|NCT04822597|364501399|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
105682603|NCT04822597|364501400|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
105682604|NCT00731120|364501405|FG000|Overall Study|Adverse Event|7|||
105682605|NCT00731120|364501406|FG001|Overall Study|Adverse Event|6|||
105682606|NCT00731120|364501407|FG002|Overall Study|Adverse Event|8|||
105682607|NCT00731120|364501405|FG000|Overall Study|Lack of Efficacy|4|||
105682608|NCT00731120|364501406|FG001|Overall Study|Lack of Efficacy|5|||
105682609|NCT00731120|364501407|FG002|Overall Study|Lack of Efficacy|4|||
105682610|NCT00731120|364501405|FG000|Overall Study|Noncompliance with Study Drug|3|||
105682611|NCT00731120|364501406|FG001|Overall Study|Noncompliance with Study Drug|3|||
105682612|NCT00731120|364501407|FG002|Overall Study|Noncompliance with Study Drug|1|||
105682613|NCT00731120|364501405|FG000|Overall Study|Protocol Deviations|1|||
105682614|NCT00731120|364501406|FG001|Overall Study|Protocol Deviations|6|||
105682615|NCT00731120|364501407|FG002|Overall Study|Protocol Deviations|1|||
105682616|NCT00731120|364501405|FG000|Overall Study|Withdrawal of Consent|13|||
105682617|NCT00731120|364501406|FG001|Overall Study|Withdrawal of Consent|8|||
105682618|NCT00731120|364501407|FG002|Overall Study|Withdrawal of Consent|4|||
105682619|NCT00731120|364501405|FG000|Overall Study|Lost to Follow-up|10|||
105682620|NCT00731120|364501406|FG001|Overall Study|Lost to Follow-up|15|||
105682621|NCT00731120|364501407|FG002|Overall Study|Lost to Follow-up|17|||
105682622|NCT00731120|364501405|FG000|Overall Study|Other|4|||
105682623|NCT00731120|364501406|FG001|Overall Study|Other|0|||
105682624|NCT00731120|364501407|FG002|Overall Study|Other|1|||
105682625|NCT02673515|364501409|FG000|Overall Study|Lack of motivation|2|||
105682626|NCT02673515|364501410|FG001|Overall Study|Lack of motivation|1|||
105682627|NCT04737187|364501411|FG000|Overall Study|Switched to marketed drug|32|||
105682628|NCT04737187|364501412|FG001|Overall Study|Switched to marketed drug|4|||
105682629|NCT04737187|364501411|FG000|Overall Study|Radiological Progressive Disease|145|||
105682630|NCT04737187|364501412|FG001|Overall Study|Radiological Progressive Disease|146|||
105682631|NCT04737187|364501411|FG000|Overall Study|Clinical Progressive Disease|20|||
105682632|NCT04737187|364501412|FG001|Overall Study|Clinical Progressive Disease|20|||
105682633|NCT04737187|364501411|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
105682634|NCT04737187|364501412|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
105682635|NCT04737187|364501411|FG000|Overall Study|Adverse Event|16|||
105682636|NCT04737187|364501412|FG001|Overall Study|Adverse Event|16|||
105682637|NCT04737187|364501411|FG000|Overall Study|Physician Decision|2|||
105682638|NCT04737187|364501412|FG001|Overall Study|Physician Decision|0|||
105682639|NCT04737187|364501411|FG000|Overall Study|Withdrawal by Subject|5|||
105682640|NCT04737187|364501412|FG001|Overall Study|Withdrawal by Subject|8|||
105682641|NCT00423930|364501413|FG000|Overall Study|Withdrawal by Subject|2|||
105682642|NCT02337751|364501414|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
105682643|NCT02337751|364501415|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
105682644|NCT02337751|364501414|FG000|Overall Study|Voluntary Withdrawal|6|||
105682645|NCT02337751|364501415|FG001|Overall Study|Voluntary Withdrawal|8|||
105682646|NCT02337751|364501414|FG000|Overall Study|Lack of Efficacy|2|||
105682647|NCT02337751|364501415|FG001|Overall Study|Lack of Efficacy|5|||
105682648|NCT02337751|364501414|FG000|Overall Study|Investigator's Judgement|1|||
105682649|NCT02337751|364501415|FG001|Overall Study|Investigator's Judgement|0|||
105682650|NCT01315353|364501421|FG000|Overall Study|Death|2|||
105916642|NCT01545388|365354837|FG002|Overall Study|Participant moved or relocated|0|||
105916643|NCT01545388|365354835|FG000|Overall Study|Withdrawal by Subject|1|||
105916644|NCT01545388|365354836|FG001|Overall Study|Withdrawal by Subject|4|||
105916645|NCT01545388|365354837|FG002|Overall Study|Withdrawal by Subject|2|||
105916646|NCT01545388|365354835|FG000|Overall Study|Other|1|||
105916647|NCT01545388|365354836|FG001|Overall Study|Other|1|||
105916648|NCT01545388|365354837|FG002|Overall Study|Other|0|||
105916649|NCT03555149|365354838|FG000|Overall Study|Death|18|||
105916650|NCT03555149|365354839|FG001|Overall Study|Death|15|||
105916651|NCT03555149|365354840|FG002|Overall Study|Death|15|||
105916652|NCT03555149|365354841|FG003|Overall Study|Death|4|||
105916653|NCT03555149|365354842|FG004|Overall Study|Death|4|||
105916654|NCT03555149|365354843|FG005|Overall Study|Death|11|||
105916655|NCT03555149|365354844|FG006|Overall Study|Death|12|||
105916656|NCT03555149|365354845|FG007|Overall Study|Death|1|||
105916657|NCT03555149|365354838|FG000|Overall Study|Lost to Follow-up|1|||
105916658|NCT03555149|365354839|FG001|Overall Study|Lost to Follow-up|0|||
105916659|NCT03555149|365354840|FG002|Overall Study|Lost to Follow-up|0|||
105916660|NCT03555149|365354841|FG003|Overall Study|Lost to Follow-up|0|||
105916661|NCT03555149|365354842|FG004|Overall Study|Lost to Follow-up|0|||
105916662|NCT03555149|365354843|FG005|Overall Study|Lost to Follow-up|1|||
105916663|NCT03555149|365354844|FG006|Overall Study|Lost to Follow-up|0|||
105916664|NCT03555149|365354845|FG007|Overall Study|Lost to Follow-up|0|||
106001104|NCT00101686|365665206|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
106001105|NCT00101686|365665207|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
105786496|NCT02686749|364871424|FG000|Overall Study|terminated for poor enrollment|2|||
105916665|NCT03555149|365354838|FG000|Overall Study|Physician Decision|1|||
105916666|NCT03555149|365354839|FG001|Overall Study|Physician Decision|0|||
105916667|NCT03555149|365354840|FG002|Overall Study|Physician Decision|0|||
105916668|NCT03555149|365354841|FG003|Overall Study|Physician Decision|0|||
105916669|NCT03555149|365354842|FG004|Overall Study|Physician Decision|0|||
105916670|NCT03555149|365354843|FG005|Overall Study|Physician Decision|0|||
105916671|NCT03555149|365354844|FG006|Overall Study|Physician Decision|0|||
105916672|NCT03555149|365354845|FG007|Overall Study|Physician Decision|0|||
105916673|NCT03555149|365354838|FG000|Overall Study|Study Terminated By Sponsor|1|||
105682651|NCT01315353|364501422|FG001|Overall Study|Death|1|||
105682652|NCT01315353|364501423|FG002|Overall Study|Death|0|||
105682653|NCT01315353|364501421|FG000|Overall Study|Withdrawal by Subject|2|||
105682654|NCT01315353|364501422|FG001|Overall Study|Withdrawal by Subject|6|||
105682655|NCT01315353|364501423|FG002|Overall Study|Withdrawal by Subject|1|||
105682656|NCT01315353|364501421|FG000|Overall Study|Lost to Follow-up|13|||
105682657|NCT01315353|364501422|FG001|Overall Study|Lost to Follow-up|6|||
105682658|NCT01315353|364501423|FG002|Overall Study|Lost to Follow-up|6|||
105682659|NCT01315353|364501421|FG000|Overall Study|Unwilling to adhere to requirements|5|||
105682660|NCT01315353|364501422|FG001|Overall Study|Unwilling to adhere to requirements|5|||
105682661|NCT01315353|364501423|FG002|Overall Study|Unwilling to adhere to requirements|4|||
105682662|NCT01315353|364501421|FG000|Overall Study|Site closing|7|||
105682663|NCT01315353|364501422|FG001|Overall Study|Site closing|4|||
105682664|NCT01315353|364501423|FG002|Overall Study|Site closing|0|||
105682665|NCT01315353|364501421|FG000|Overall Study|Taken off study by site in error|0|||
105682666|NCT01315353|364501422|FG001|Overall Study|Taken off study by site in error|1|||
105682667|NCT01315353|364501423|FG002|Overall Study|Taken off study by site in error|0|||
105682668|NCT01315353|364501421|FG000|Overall Study|Inadvertent randomization/assignment|0|||
105682669|NCT01315353|364501422|FG001|Overall Study|Inadvertent randomization/assignment|0|||
105682670|NCT01315353|364501423|FG002|Overall Study|Inadvertent randomization/assignment|2|||
105682671|NCT02390245|364501428|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
105682672|NCT02390245|364501429|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
105682673|NCT02390245|364501430|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
105682674|NCT02390245|364501428|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
105682675|NCT02390245|364501429|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
105682676|NCT02390245|364501430|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
105682677|NCT00959647|364501432|FG000|Overall Study|Adverse Event|2|||
105682678|NCT00959647|364501432|FG000|Overall Study|Progressive disease|6|||
105682679|NCT00959647|364501432|FG000|Overall Study|Study terminated by sponsor|4|||
105682680|NCT00959647|364501432|FG000|Overall Study|Withdrawal by Subject|7|||
105682681|NCT03727438|364501433|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
105682682|NCT03727438|364501434|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
105682683|NCT03727438|364501433|FG000|Intervention Period|Excluded (health)|1|||
105682684|NCT03727438|364501434|FG001|Intervention Period|Excluded (health)|0|||
105682685|NCT03727438|364501433|FG000|Intervention Period|Withdrawal by Subject|3|||
105682686|NCT03727438|364501434|FG001|Intervention Period|Withdrawal by Subject|1|||
105682687|NCT03727438|364501433|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
105682688|NCT03727438|364501434|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
105682689|NCT03727438|364501433|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
105682690|NCT03727438|364501434|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
105682691|NCT03727438|364501433|FG000|8 Week Assessment|Withdrawal by Subject|6|||
105682692|NCT03727438|364501434|FG001|8 Week Assessment|Withdrawal by Subject|1|||
105682693|NCT03727438|364501433|FG000|6 mo Assessment|did not complete assessment|10|||
105682694|NCT03727438|364501434|FG001|6 mo Assessment|did not complete assessment|11|||
105682695|NCT00924027|364501435|FG000|Overall Study|Lost to Further Follow-Up|4|||
105682696|NCT00924027|364501436|FG001|Overall Study|Lost to Further Follow-Up|0|||
105682697|NCT00924027|364501437|FG002|Overall Study|Lost to Further Follow-Up|0|||
105682698|NCT00924027|364501438|FG003|Overall Study|Lost to Further Follow-Up|0|||
105682699|NCT00924027|364501435|FG000|Overall Study|Physician Decision|1|||
105682700|NCT00924027|364501436|FG001|Overall Study|Physician Decision|0|||
105682701|NCT00924027|364501437|FG002|Overall Study|Physician Decision|0|||
105682702|NCT00924027|364501438|FG003|Overall Study|Physician Decision|1|||
105682703|NCT00924027|364501435|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
105682704|NCT00924027|364501436|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
105682705|NCT00924027|364501437|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
105682706|NCT00924027|364501438|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
105682707|NCT00924027|364501435|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
105682708|NCT00924027|364501436|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
105682709|NCT00924027|364501437|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
105682710|NCT00924027|364501438|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
105682711|NCT00924027|364501435|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
105682712|NCT00924027|364501436|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
105682713|NCT00924027|364501437|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
105916674|NCT03555149|365354839|FG001|Overall Study|Study Terminated By Sponsor|0|||
105682714|NCT00924027|364501438|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
105682715|NCT01589237|364503064|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
105682716|NCT01589237|364503065|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
105682717|NCT01589237|364503066|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
105682718|NCT01589237|364503067|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
105682719|NCT01589237|364503064|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
105682720|NCT01589237|364503065|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
105682721|NCT01589237|364503066|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
105682722|NCT01589237|364503067|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
105682723|NCT01589237|364503064|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
105682724|NCT01589237|364503065|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
105682725|NCT01589237|364503066|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
105682726|NCT01589237|364503067|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
105682727|NCT01589237|364503064|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
105682728|NCT01589237|364503065|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
105682729|NCT01589237|364503066|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
105682730|NCT01589237|364503067|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
105682731|NCT01672723|364503068|FG000|First Intervention|Adverse Event|3|||
105682732|NCT01672723|364503069|FG001|First Intervention|Adverse Event|0|||
105682733|NCT01022268|364503070|FG000|Overall Study|Withdrawal by Subject|1|||
105682734|NCT01022268|364503071|FG001|Overall Study|Withdrawal by Subject|0|||
105682735|NCT01022268|364503070|FG000|Overall Study|Withdrawal by Subject|1|||
105682736|NCT01022268|364503071|FG001|Overall Study|Withdrawal by Subject|0|||
105682737|NCT00910689|364503072|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
105682738|NCT00910689|364503073|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
105682739|NCT00910689|364503074|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
105682740|NCT00910689|364503075|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
105682741|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
105682742|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
105682743|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
106127922|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127923|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105682744|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
105682745|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
105682746|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
105682747|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
105682748|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
105682749|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
105682750|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
105682751|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
105682752|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
105682753|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
105682754|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
105682755|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
105682756|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
105682757|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
105682758|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
105682759|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
105682760|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
105682761|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
105682762|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
105682763|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
105682764|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
105682765|NCT00910689|364503072|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
105682766|NCT00910689|364503073|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
105682767|NCT00910689|364503074|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
105682768|NCT00910689|364503075|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
105682769|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
105682770|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
105682771|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
105682772|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
105682773|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
105682774|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
105682775|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
105682776|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
105682777|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
105682778|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
105682779|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
105682780|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
105682781|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
105682782|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
106127924|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127925|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105682783|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
105682784|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
105682785|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
105682786|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
105682787|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
105682788|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
105682789|NCT00910689|364503072|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
105682790|NCT00910689|364503073|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
105682791|NCT00910689|364503074|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
105682792|NCT00910689|364503075|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
105682793|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
105682794|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
105682795|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
105682796|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
105682797|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
105682798|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
105682799|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
105682800|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
105682801|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
105682802|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
105682803|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
105682804|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
105682805|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
105682806|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
105682807|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
105682808|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
105682809|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
105682810|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
105682811|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
105682812|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
105682813|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
105682814|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
105682815|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
105682816|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
105682817|NCT00910689|364503072|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
105682818|NCT00910689|364503073|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
105682819|NCT00910689|364503074|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
105682820|NCT00910689|364503075|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
105682821|NCT01290029|364503076|FG000|Overall Study|Other|2|||
105682822|NCT03938545|364503077|FG000|Overall Study|Lost to Follow-up|0|||
105682823|NCT03938545|364503078|FG001|Overall Study|Lost to Follow-up|0|||
105682824|NCT03938545|364503079|FG002|Overall Study|Lost to Follow-up|0|||
105682825|NCT03938545|364503080|FG003|Overall Study|Lost to Follow-up|1|||
105682826|NCT03938545|364503077|FG000|Overall Study|Non-compliance with study drug|0|||
105682827|NCT03938545|364503078|FG001|Overall Study|Non-compliance with study drug|0|||
105682828|NCT03938545|364503079|FG002|Overall Study|Non-compliance with study drug|1|||
105682829|NCT03938545|364503080|FG003|Overall Study|Non-compliance with study drug|0|||
105682830|NCT03938545|364503077|FG000|Overall Study|Pregnancy|1|||
105682831|NCT03938545|364503078|FG001|Overall Study|Pregnancy|0|||
105682832|NCT03938545|364503079|FG002|Overall Study|Pregnancy|0|||
105682833|NCT03938545|364503080|FG003|Overall Study|Pregnancy|0|||
105682834|NCT03938545|364503077|FG000|Overall Study|Study terminated by sponsor|6|||
105682835|NCT03938545|364503078|FG001|Overall Study|Study terminated by sponsor|4|||
105682836|NCT03938545|364503079|FG002|Overall Study|Study terminated by sponsor|2|||
105682837|NCT03938545|364503080|FG003|Overall Study|Study terminated by sponsor|4|||
105682838|NCT03938545|364503077|FG000|Overall Study|Withdrawal by Subject|0|||
105682839|NCT03938545|364503078|FG001|Overall Study|Withdrawal by Subject|1|||
105682840|NCT03938545|364503079|FG002|Overall Study|Withdrawal by Subject|0|||
105682841|NCT03938545|364503080|FG003|Overall Study|Withdrawal by Subject|0|||
105682842|NCT03938545|364503077|FG000|Overall Study|Adverse Event|1|||
105682843|NCT03938545|364503078|FG001|Overall Study|Adverse Event|0|||
105682844|NCT03938545|364503079|FG002|Overall Study|Adverse Event|0|||
105682845|NCT03938545|364503080|FG003|Overall Study|Adverse Event|0|||
105916675|NCT03555149|365354840|FG002|Overall Study|Study Terminated By Sponsor|0|||
105916676|NCT03555149|365354841|FG003|Overall Study|Study Terminated By Sponsor|0|||
105682846|NCT05087979|364503081|FG000|Overall Study|Converted to general anesthesia|1|||
105682847|NCT05087979|364503082|FG001|Overall Study|Converted to general anesthesia|0|||
105682848|NCT00477334|364503083|FG000|Overall Study|Discontinued prior to taking study drug|106|||
105682849|NCT00477334|364503084|FG001|Overall Study|Discontinued prior to taking study drug|53|||
105682850|NCT00477334|364503083|FG000|Overall Study|Adverse Event|1|||
105786497|NCT02686749|364871425|FG001|Overall Study|terminated for poor enrollment|2|||
105916677|NCT03555149|365354842|FG004|Overall Study|Study Terminated By Sponsor|0|||
105916678|NCT03555149|365354843|FG005|Overall Study|Study Terminated By Sponsor|2|||
105916679|NCT03555149|365354844|FG006|Overall Study|Study Terminated By Sponsor|3|||
105916680|NCT03555149|365354845|FG007|Overall Study|Study Terminated By Sponsor|1|||
105916681|NCT03555149|365354838|FG000|Overall Study|Withdrawal by Subject|3|||
105916682|NCT03555149|365354839|FG001|Overall Study|Withdrawal by Subject|0|||
105916683|NCT03555149|365354840|FG002|Overall Study|Withdrawal by Subject|0|||
105916684|NCT03555149|365354841|FG003|Overall Study|Withdrawal by Subject|2|||
105916685|NCT03555149|365354842|FG004|Overall Study|Withdrawal by Subject|0|||
105916686|NCT03555149|365354843|FG005|Overall Study|Withdrawal by Subject|1|||
105916687|NCT03555149|365354844|FG006|Overall Study|Withdrawal by Subject|0|||
105916688|NCT03555149|365354845|FG007|Overall Study|Withdrawal by Subject|0|||
105916689|NCT01614470|365354846|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
105916690|NCT01614470|365354847|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105916691|NCT01614470|365354848|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105916692|NCT01614470|365354846|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
105916693|NCT01614470|365354847|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
105916694|NCT01614470|365354848|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
105916695|NCT00086190|365354849|FG000|Overall Study|Adverse Event|6|||
105916696|NCT00086190|365354850|FG001|Overall Study|Adverse Event|2|||
105916697|NCT00086190|365354851|FG002|Overall Study|Adverse Event|2|||
105916698|NCT00086190|365354849|FG000|Overall Study|Withdrawal by Subject|0|||
105916699|NCT00086190|365354850|FG001|Overall Study|Withdrawal by Subject|2|||
105916700|NCT00086190|365354851|FG002|Overall Study|Withdrawal by Subject|2|||
105916701|NCT00086190|365354849|FG000|Overall Study|Protocol Violation|1|||
105916702|NCT00086190|365354850|FG001|Overall Study|Protocol Violation|0|||
105916703|NCT00086190|365354851|FG002|Overall Study|Protocol Violation|0|||
105916704|NCT00086190|365354849|FG000|Overall Study|Moved|1|||
105916705|NCT00086190|365354850|FG001|Overall Study|Moved|0|||
105916706|NCT00086190|365354851|FG002|Overall Study|Moved|0|||
105916707|NCT00086190|365354849|FG000|Overall Study|Worsening depression|0|||
105916708|NCT00086190|365354850|FG001|Overall Study|Worsening depression|0|||
105916709|NCT00086190|365354851|FG002|Overall Study|Worsening depression|2|||
105916710|NCT02175121|365354852|FG000|Overall Study|Lack of Efficacy|1|||
105916711|NCT02175121|365354853|FG001|Overall Study|Lack of Efficacy|0|||
105916712|NCT02175121|365354854|FG002|Overall Study|Lack of Efficacy|0|||
105916713|NCT02175121|365354855|FG003|Overall Study|Lack of Efficacy|0|||
105916714|NCT02175121|365354856|FG004|Overall Study|Lack of Efficacy|0|||
105916715|NCT02175121|365354852|FG000|Overall Study|Lost to Follow-up|0|||
105916716|NCT02175121|365354853|FG001|Overall Study|Lost to Follow-up|1|||
105916717|NCT02175121|365354854|FG002|Overall Study|Lost to Follow-up|0|||
105916718|NCT02175121|365354855|FG003|Overall Study|Lost to Follow-up|1|||
105916719|NCT02175121|365354856|FG004|Overall Study|Lost to Follow-up|0|||
105916720|NCT02175121|365354852|FG000|Overall Study|Personal emergency|0|||
105916721|NCT02175121|365354853|FG001|Overall Study|Personal emergency|0|||
105916722|NCT02175121|365354854|FG002|Overall Study|Personal emergency|0|||
105916723|NCT02175121|365354855|FG003|Overall Study|Personal emergency|0|||
105916724|NCT02175121|365354856|FG004|Overall Study|Personal emergency|1|||
105916725|NCT02175121|365354852|FG000|Overall Study|Schedule conflict|0|||
105916726|NCT02175121|365354853|FG001|Overall Study|Schedule conflict|0|||
105916727|NCT02175121|365354854|FG002|Overall Study|Schedule conflict|1|||
105916728|NCT02175121|365354855|FG003|Overall Study|Schedule conflict|0|||
105916729|NCT02175121|365354856|FG004|Overall Study|Schedule conflict|0|||
105916730|NCT02175121|365354852|FG000|Overall Study|Time issues|0|||
105916731|NCT02175121|365354853|FG001|Overall Study|Time issues|0|||
105916732|NCT02175121|365354854|FG002|Overall Study|Time issues|1|||
105916733|NCT02175121|365354855|FG003|Overall Study|Time issues|0|||
105916734|NCT02175121|365354856|FG004|Overall Study|Time issues|0|||
105916735|NCT03902613|365354857|FG000|Overall Study|Physician Decision|1|||
105916736|NCT02027025|365354862|FG000|Overall Study|Adverse Event|0|||
105916737|NCT02027025|365354863|FG001|Overall Study|Adverse Event|1|||
105916738|NCT02027025|365354864|FG002|Overall Study|Adverse Event|1|||
105916739|NCT02027025|365354862|FG000|Overall Study|Protocol Violation|1|||
105916740|NCT02027025|365354863|FG001|Overall Study|Protocol Violation|0|||
105916741|NCT02027025|365354864|FG002|Overall Study|Protocol Violation|0|||
105916742|NCT02027025|365354862|FG000|Overall Study|Lost to Follow-up|0|||
105916743|NCT02027025|365354863|FG001|Overall Study|Lost to Follow-up|2|||
105916744|NCT02027025|365354864|FG002|Overall Study|Lost to Follow-up|0|||
105916745|NCT02027025|365354862|FG000|Overall Study|Withdrawal by Subject|0|||
105916746|NCT02027025|365354863|FG001|Overall Study|Withdrawal by Subject|1|||
105916747|NCT02027025|365354864|FG002|Overall Study|Withdrawal by Subject|0|||
105916748|NCT02027025|365354862|FG000|Overall Study|Sponsor's decision|0|||
105916749|NCT02027025|365354863|FG001|Overall Study|Sponsor's decision|1|||
105916750|NCT02027025|365354864|FG002|Overall Study|Sponsor's decision|0|||
105916751|NCT00069264|365354865|FG000|Overall Study|Adverse Event|3|||
105916752|NCT00069264|365354865|FG000|Overall Study|Progressive Disease|23|||
105916753|NCT00069264|365354865|FG000|Overall Study|Withdrawal by Subject|3|||
105916754|NCT00069264|365354865|FG000|Overall Study|Discon Therapy|3|||
105916755|NCT04249427|365354866|FG000|Overall Study|Adverse Event|3|||
105682851|NCT00477334|364503084|FG001|Overall Study|Adverse Event|2|||
105682852|NCT00477334|364503083|FG000|Overall Study|Withdrawal by Subject|2|||
105682853|NCT00477334|364503084|FG001|Overall Study|Withdrawal by Subject|1|||
105682854|NCT00477334|364503083|FG000|Overall Study|Lost to Follow-up|15|||
105682855|NCT00477334|364503084|FG001|Overall Study|Lost to Follow-up|4|||
105682856|NCT00477334|364503083|FG000|Overall Study|Administrative Problems|39|||
105682857|NCT00477334|364503084|FG001|Overall Study|Administrative Problems|15|||
105682858|NCT00477334|364503083|FG000|Overall Study|Protocol Violation|7|||
105682859|NCT00477334|364503084|FG001|Overall Study|Protocol Violation|1|||
105682860|NCT00372229|364503085|FG000|Study Phase|Graft loss|0|||
105682861|NCT00372229|364503086|FG001|Study Phase|Graft loss|3|||
105682862|NCT00372229|364503085|FG000|Study Phase|Protocol Violation|3|||
105682863|NCT00372229|364503086|FG001|Study Phase|Protocol Violation|4|||
105682864|NCT00372229|364503085|FG000|Study Phase|Consent withdrawn|16|||
105682865|NCT00372229|364503086|FG001|Study Phase|Consent withdrawn|14|||
105682866|NCT00372229|364503085|FG000|Study Phase|Refused treatment/did not cooperate|3|||
105682867|NCT00372229|364503086|FG001|Study Phase|Refused treatment/did not cooperate|1|||
105682868|NCT00372229|364503085|FG000|Study Phase|Death|3|||
105682869|NCT00372229|364503086|FG001|Study Phase|Death|2|||
105682870|NCT00372229|364503085|FG000|Study Phase|Reason not specified|3|||
105682871|NCT00372229|364503086|FG001|Study Phase|Reason not specified|2|||
105682872|NCT00372229|364503085|FG000|Study Phase|Lost to Follow-up|3|||
105682873|NCT00372229|364503086|FG001|Study Phase|Lost to Follow-up|3|||
105682874|NCT00372229|364503085|FG000|Follow-Up Phase|Graft loss|8|||
105682875|NCT00372229|364503086|FG001|Follow-Up Phase|Graft loss|7|||
105682876|NCT00372229|364503085|FG000|Follow-Up Phase|Consent withdrawn|13|||
105682877|NCT00372229|364503086|FG001|Follow-Up Phase|Consent withdrawn|19|||
105682878|NCT00372229|364503085|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
105682879|NCT00372229|364503086|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
105682880|NCT00372229|364503085|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
105682881|NCT00372229|364503086|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
105682882|NCT00372229|364503085|FG000|Follow-Up Phase|Death|9|||
105682883|NCT00372229|364503086|FG001|Follow-Up Phase|Death|12|||
105682884|NCT00372229|364503085|FG000|Follow-Up Phase|Administrative|1|||
105682885|NCT00372229|364503086|FG001|Follow-Up Phase|Administrative|0|||
105682886|NCT00372229|364503085|FG000|Follow-Up Phase|Reason not specified|2|||
105682887|NCT00372229|364503086|FG001|Follow-Up Phase|Reason not specified|3|||
105682888|NCT00372229|364503085|FG000|Follow-Up Phase|Lost to Follow-up|12|||
105682889|NCT00372229|364503086|FG001|Follow-Up Phase|Lost to Follow-up|10|||
105682890|NCT03235284|364503087|FG000|Overall Study|Adverse Event|1|||
105682891|NCT03235284|364503088|FG001|Overall Study|Adverse Event|2|||
105682892|NCT03235284|364503089|FG002|Overall Study|Adverse Event|1|||
105682893|NCT01236339|364503096|FG000|Overall Study|Termination of study by sponsor|11|||
105682894|NCT01236339|364503097|FG001|Overall Study|Termination of study by sponsor|13|||
105682895|NCT02054741|364503098|FG000|Overall Study|Protocol Violation|13|||
105682896|NCT02054741|364503099|FG001|Overall Study|Protocol Violation|2|||
105682897|NCT02054741|364503098|FG000|Overall Study|Withdrawal by Subject|10|||
105682898|NCT02054741|364503099|FG001|Overall Study|Withdrawal by Subject|5|||
105682899|NCT02054741|364503098|FG000|Overall Study|Death|94|||
105682900|NCT02054741|364503099|FG001|Overall Study|Death|90|||
105682901|NCT02054741|364503098|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
105682902|NCT02054741|364503099|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
105682903|NCT01098097|364503100|FG000|Overall Study|Adverse Event|17|||
105682904|NCT01098097|364503100|FG000|Overall Study|Lost to Follow-up|18|||
105682905|NCT01098097|364503100|FG000|Overall Study|Status unknown|16|||
105682906|NCT01098097|364503100|FG000|Overall Study|No reason reported|31|||
105682907|NCT01411215|364503101|FG000|Overall Study|Adverse Event|1|||
105682908|NCT01411215|364503102|FG001|Overall Study|Adverse Event|2|||
105682909|NCT01411215|364503101|FG000|Overall Study|Lack of Efficacy|2|||
105916756|NCT04249427|365354867|FG001|Overall Study|Adverse Event|1|||
105916757|NCT04249427|365354866|FG000|Overall Study|Lack of Efficacy|0|||
105916758|NCT04249427|365354867|FG001|Overall Study|Lack of Efficacy|1|||
105682910|NCT01411215|364503102|FG001|Overall Study|Lack of Efficacy|4|||
105682911|NCT01411215|364503101|FG000|Overall Study|Lost to Follow-up|12|||
105682912|NCT01411215|364503102|FG001|Overall Study|Lost to Follow-up|18|||
105682913|NCT01411215|364503101|FG000|Overall Study|Did not meet entrance criteria|0|||
105682914|NCT01411215|364503102|FG001|Overall Study|Did not meet entrance criteria|1|||
105916759|NCT04249427|365354866|FG000|Overall Study|Withdrawal by Subject|1|||
105682915|NCT01411215|364503101|FG000|Overall Study|Study terminated by sponsor|2|||
105682916|NCT01411215|364503102|FG001|Overall Study|Study terminated by sponsor|15|||
105682917|NCT01411215|364503101|FG000|Overall Study|Protocol Violation|3|||
105682918|NCT01411215|364503102|FG001|Overall Study|Protocol Violation|5|||
105682919|NCT01411215|364503101|FG000|Overall Study|Withdrawal by Subject|34|||
105682920|NCT01411215|364503102|FG001|Overall Study|Withdrawal by Subject|21|||
105682921|NCT01411215|364503101|FG000|Overall Study|Other|12|||
105682922|NCT01411215|364503102|FG001|Overall Study|Other|17|||
105682923|NCT01411215|364503101|FG000|Overall Study|Screen failure|0|||
105916760|NCT04249427|365354867|FG001|Overall Study|Withdrawal by Subject|2|||
105682924|NCT01411215|364503102|FG001|Overall Study|Screen failure|1|||
105916761|NCT02895347|365354868|FG000|Overall Study|Withdrawal by Subject|3|||
105916762|NCT02895347|365354869|FG001|Overall Study|Withdrawal by Subject|1|||
105916763|NCT01673178|365354870|FG000|Overall Study|Lost to Follow-up|0|||
105916764|NCT01673178|365354871|FG001|Overall Study|Lost to Follow-up|1|||
105916765|NCT01673178|365354872|FG002|Overall Study|Lost to Follow-up|0|||
105916766|NCT01673178|365354873|FG003|Overall Study|Lost to Follow-up|0|||
105916767|NCT01673178|365354874|FG004|Overall Study|Lost to Follow-up|0|||
105916768|NCT01673178|365354870|FG000|Overall Study|Withdrawal by Subject|0|||
105916769|NCT01673178|365354871|FG001|Overall Study|Withdrawal by Subject|0|||
105916770|NCT01673178|365354872|FG002|Overall Study|Withdrawal by Subject|1|||
105916771|NCT01673178|365354873|FG003|Overall Study|Withdrawal by Subject|4|||
105916772|NCT01673178|365354874|FG004|Overall Study|Withdrawal by Subject|2|||
105916773|NCT01673178|365354870|FG000|Overall Study|Protocol Violation|1|||
105916774|NCT01673178|365354871|FG001|Overall Study|Protocol Violation|1|||
105916775|NCT01673178|365354872|FG002|Overall Study|Protocol Violation|0|||
105916776|NCT01673178|365354873|FG003|Overall Study|Protocol Violation|1|||
105916777|NCT01673178|365354874|FG004|Overall Study|Protocol Violation|0|||
105916778|NCT01673178|365354870|FG000|Overall Study|Adverse Event|1|||
105916779|NCT01673178|365354871|FG001|Overall Study|Adverse Event|0|||
105916780|NCT01673178|365354872|FG002|Overall Study|Adverse Event|0|||
105916781|NCT01673178|365354873|FG003|Overall Study|Adverse Event|2|||
105916782|NCT01673178|365354874|FG004|Overall Study|Adverse Event|0|||
105916783|NCT01673178|365354870|FG000|Overall Study|Other|1|||
105916784|NCT01673178|365354871|FG001|Overall Study|Other|0|||
105916785|NCT01673178|365354872|FG002|Overall Study|Other|2|||
105916786|NCT01673178|365354873|FG003|Overall Study|Other|1|||
105916787|NCT01673178|365354874|FG004|Overall Study|Other|0|||
105916788|NCT02557399|365354875|FG000|Overall Study|Adverse Event|6|||
105916789|NCT02557399|365354876|FG001|Overall Study|Adverse Event|5|||
105916790|NCT02557399|365354875|FG000|Overall Study|Protocol Violation|0|||
105916791|NCT02557399|365354876|FG001|Overall Study|Protocol Violation|1|||
105916792|NCT02557399|365354875|FG000|Overall Study|Protocol-defined stopping criteria|0|||
105916793|NCT02557399|365354876|FG001|Overall Study|Protocol-defined stopping criteria|1|||
105916794|NCT02557399|365354875|FG000|Overall Study|Withdrawal by Subject|1|||
105916795|NCT02557399|365354876|FG001|Overall Study|Withdrawal by Subject|1|||
105916796|NCT00931632|365354882|FG000|Overall Study|Withdrawal by Subject|2|||
105916797|NCT00931632|365354883|FG001|Overall Study|Withdrawal by Subject|3|||
105916798|NCT00931632|365354882|FG000|Overall Study|Adverse Event|19|||
105916799|NCT00931632|365354883|FG001|Overall Study|Adverse Event|15|||
105916800|NCT00732069|365354887|FG000|Washout After First Study Drug|Adverse Event|1|||
105916801|NCT00732069|365354888|FG001|Washout After First Study Drug|Adverse Event|0|||
105916802|NCT00732069|365354889|FG002|Washout After First Study Drug|Adverse Event|0|||
105916803|NCT00732069|365354890|FG003|Washout After First Study Drug|Adverse Event|0|||
105916804|NCT00732069|365354891|FG004|Washout After First Study Drug|Adverse Event|0|||
105916805|NCT00732069|365354892|FG005|Washout After First Study Drug|Adverse Event|0|||
105916806|NCT00402727|365354893|FG000|Overall Study|Adverse Event|10|||
105916807|NCT00402727|365354894|FG001|Overall Study|Adverse Event|6|||
105916808|NCT00402727|365354893|FG000|Overall Study|Death|1|||
105916809|NCT00402727|365354894|FG001|Overall Study|Death|0|||
105916810|NCT00402727|365354893|FG000|Overall Study|Lack of Efficacy|1|||
105916811|NCT00402727|365354894|FG001|Overall Study|Lack of Efficacy|3|||
105916812|NCT00402727|365354893|FG000|Overall Study|Lost to Follow-up|24|||
105916813|NCT00402727|365354894|FG001|Overall Study|Lost to Follow-up|11|||
105916814|NCT00402727|365354893|FG000|Overall Study|Physician Decision|1|||
105916815|NCT00402727|365354894|FG001|Overall Study|Physician Decision|1|||
105916816|NCT00402727|365354893|FG000|Overall Study|Protocol Violation|0|||
105916817|NCT00402727|365354894|FG001|Overall Study|Protocol Violation|4|||
105916818|NCT00402727|365354893|FG000|Overall Study|Withdrawal by Subject|3|||
105916819|NCT00402727|365354894|FG001|Overall Study|Withdrawal by Subject|7|||
105916820|NCT00402727|365354893|FG000|Overall Study|supply problems|2|||
105916821|NCT00402727|365354894|FG001|Overall Study|supply problems|1|||
105916822|NCT00402727|365354893|FG000|Overall Study|non-compliance|0|||
105916823|NCT00402727|365354894|FG001|Overall Study|non-compliance|1|||
105916824|NCT04460326|365354895|FG000|Completed at Least 4 Meals|Early discharge|5|||
105916825|NCT04460326|365354896|FG001|Completed at Least 4 Meals|Early discharge|5|||
105916826|NCT04460326|365354895|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
105682925|NCT00848926|364503105|FG000|Treatment Period|Progressive disease|45|||
105682926|NCT00848926|364503105|FG000|Treatment Period|Adverse Event|20|||
105916827|NCT04460326|365354896|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
105916828|NCT04460326|365354895|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
105916829|NCT04460326|365354896|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
105916830|NCT04460326|365354895|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
105916831|NCT04460326|365354896|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
106127926|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127927|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105916832|NCT04460326|365354895|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
105682927|NCT00848926|364503105|FG000|Treatment Period|Physician Decision|12|||
105682928|NCT00848926|364503105|FG000|Treatment Period|Withdrawal by Subject|7|||
105682929|NCT00848926|364503105|FG000|Follow-up Period|Lost to Follow-up|7|||
105682930|NCT00848926|364503105|FG000|Follow-up Period|Withdrawal by Subject|3|||
105682931|NCT00848926|364503105|FG000|Follow-up Period|Other|2|||
105682932|NCT00394082|364503106|FG000|Overall Study|Unacceptable toxicity|15|||
105682933|NCT00394082|364503106|FG000|Overall Study|Adverse Event|4|||
105682934|NCT00394082|364503106|FG000|Overall Study|Physician Decision|4|||
105682935|NCT00394082|364503106|FG000|Overall Study|Withdrawal by Subject|2|||
105682936|NCT00394082|364503106|FG000|Overall Study|Other|1|||
105682937|NCT04025580|364503107|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
105682938|NCT04025580|364503108|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
105682939|NCT04025580|364503109|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
105682940|NCT02325557|364503110|FG000|Overall Study|Progressive disease|1|||
105682941|NCT02325557|364503111|FG001|Overall Study|Progressive disease|0|||
105682942|NCT02325557|364503112|FG002|Overall Study|Progressive disease|0|||
105682943|NCT02325557|364503113|FG003|Overall Study|Progressive disease|0|||
105682944|NCT02325557|364503110|FG000|Overall Study|Withdrawal by Subject|4|||
105682945|NCT02325557|364503111|FG001|Overall Study|Withdrawal by Subject|0|||
105682946|NCT02325557|364503112|FG002|Overall Study|Withdrawal by Subject|0|||
105682947|NCT02325557|364503113|FG003|Overall Study|Withdrawal by Subject|15|||
105682948|NCT02325557|364503110|FG000|Overall Study|Death|5|||
105682949|NCT02325557|364503111|FG001|Overall Study|Death|1|||
105682950|NCT02325557|364503112|FG002|Overall Study|Death|1|||
105682951|NCT02325557|364503113|FG003|Overall Study|Death|16|||
105682952|NCT02325557|364503110|FG000|Overall Study|Lost to Follow-up|0|||
105682953|NCT02325557|364503111|FG001|Overall Study|Lost to Follow-up|0|||
105682954|NCT02325557|364503112|FG002|Overall Study|Lost to Follow-up|1|||
105682955|NCT02325557|364503113|FG003|Overall Study|Lost to Follow-up|1|||
105682956|NCT02325557|364503110|FG000|Overall Study|Other|0|||
105682957|NCT02325557|364503111|FG001|Overall Study|Other|0|||
105682958|NCT02325557|364503112|FG002|Overall Study|Other|0|||
105682959|NCT02325557|364503113|FG003|Overall Study|Other|5|||
105916833|NCT04460326|365354896|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
105916834|NCT04460326|365354895|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
105916835|NCT04460326|365354896|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
105916836|NCT00577317|365354897|FG000|Overall Study|Study Terminated|0|||
105682964|NCT01768117|364503116|FG000|Overall Study|Lost to Follow-up|1|||
105682965|NCT01768117|364503116|FG000|Overall Study|Withdrawal by Subject|2|||
105682966|NCT01768117|364503116|FG000|Overall Study|Protocol Violation|3|||
105682967|NCT02752074|364503117|FG000|Overall Study|Lost to Follow-up|1|||
105682968|NCT02752074|364503118|FG001|Overall Study|Lost to Follow-up|4|||
105682969|NCT02752074|364503117|FG000|Overall Study|Death|146|||
105682970|NCT02752074|364503118|FG001|Overall Study|Death|129|||
105682971|NCT02752074|364503117|FG000|Overall Study|Withdrawal by Subject|9|||
105682972|NCT02752074|364503118|FG001|Overall Study|Withdrawal by Subject|10|||
105682973|NCT00938860|364503121|FG000|Overall Study|Adverse Event|2|||
105682974|NCT00938860|364503122|FG001|Overall Study|Adverse Event|1|||
105682975|NCT00938860|364503121|FG000|Overall Study|Abnormal laboratory values|2|||
105682976|NCT00938860|364503122|FG001|Overall Study|Abnormal laboratory values|2|||
105682977|NCT00938860|364503121|FG000|Overall Study|Withdrawal by Subject|11|||
105682978|NCT00938860|364503122|FG001|Overall Study|Withdrawal by Subject|8|||
105682979|NCT00938860|364503121|FG000|Overall Study|Lost to Follow-up|4|||
105682980|NCT00938860|364503122|FG001|Overall Study|Lost to Follow-up|4|||
105682981|NCT00938860|364503121|FG000|Overall Study|Administration problems|2|||
105682982|NCT00938860|364503122|FG001|Overall Study|Administration problems|0|||
105682983|NCT00938860|364503121|FG000|Overall Study|Death|1|||
105682984|NCT00938860|364503122|FG001|Overall Study|Death|1|||
105682985|NCT00938860|364503121|FG000|Overall Study|Protocol Violation|3|||
105682986|NCT00938860|364503122|FG001|Overall Study|Protocol Violation|1|||
105682987|NCT01477333|364503123|FG000|Overall Study|Adverse Event|1|||
105682988|NCT01477333|364503123|FG000|Overall Study|Withdrawal by Subject|1|||
105682989|NCT01477333|364503123|FG000|Overall Study|Clinical Deterioration|1|||
105682990|NCT02004353|364503126|FG000|Overall Study|Voluntary participation|1334|||
105682991|NCT01691768|364503127|FG000|Overall Study|Death|0|||
105682992|NCT01691768|364503128|FG001|Overall Study|Death|2|||
105682993|NCT01691768|364503127|FG000|Overall Study|Lost to Follow-up|4|||
105682994|NCT01691768|364503128|FG001|Overall Study|Lost to Follow-up|3|||
105682995|NCT01691768|364503127|FG000|Overall Study|Withdrawal by Subject|10|||
105682996|NCT01691768|364503128|FG001|Overall Study|Withdrawal by Subject|9|||
105682997|NCT01691768|364503127|FG000|Overall Study|Relocated|0|||
105682998|NCT01691768|364503128|FG001|Overall Study|Relocated|1|||
105682999|NCT01691768|364503127|FG000|Overall Study|Investigator decision|1|||
105683000|NCT01691768|364503128|FG001|Overall Study|Investigator decision|1|||
105683001|NCT00336895|364503129|FG000|Overall Study|diarrhea|1|||
105683002|NCT00336895|364503129|FG000|Overall Study|nausea and upset stomach|1|||
105683003|NCT00336895|364503129|FG000|Overall Study|Physician Decision|1|||
105683004|NCT00336895|364503129|FG000|Overall Study|screen failed|1|||
105916837|NCT00577317|365354898|FG001|Overall Study|Study Terminated|2|||
105916838|NCT04794751|365354901|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
105916839|NCT04794751|365354902|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
105916840|NCT04794751|365354901|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
105916841|NCT04794751|365354902|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
105916842|NCT04794751|365354901|FG000|Period 1|Protocol Violation|0|||
105916843|NCT04794751|365354902|FG001|Period 1|Protocol Violation|2|||
105916844|NCT04794751|365354901|FG000|Period 1|Withdrawal by Subject|0|||
105916845|NCT04794751|365354902|FG001|Period 1|Withdrawal by Subject|1|||
105916846|NCT04794751|365354901|FG000|Period 2|Withdrawal by Subject|0|||
105916847|NCT04794751|365354902|FG001|Period 2|Withdrawal by Subject|1|||
105916848|NCT04794751|365354901|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
105916849|NCT04794751|365354902|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
105916850|NCT04794751|365354901|FG000|Period 2|Protocol Violation|1|||
105916851|NCT04794751|365354902|FG001|Period 2|Protocol Violation|0|||
105916852|NCT03139552|365354908|FG000|Overall Study|unable to attend tasting due to schedule|3|||
105916853|NCT00887484|365354909|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
105916854|NCT00887484|365354909|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
105916855|NCT00887484|365354909|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
105916856|NCT03106077|365354912|FG000|Overall Study|Screen Failure|94|||
105916857|NCT03106077|365354913|FG001|Overall Study|Screen Failure|0|||
105916858|NCT01305564|365354917|FG000|Overall Study|Death|21|||
105916859|NCT01305564|365354917|FG000|Overall Study|Lost to Follow-up|12|||
105916860|NCT01305564|365354917|FG000|Overall Study|Withdrawal by Subject|1|||
105916861|NCT01305564|365354917|FG000|Overall Study|Physician Decision|3|||
105916862|NCT00828711|365354919|FG000|Overall Study|Lost to Follow-up|1|||
105916863|NCT00828711|365354920|FG001|Overall Study|Lost to Follow-up|0|||
105916864|NCT00828711|365354921|FG002|Overall Study|Lost to Follow-up|0|||
105916865|NCT01814007|365354926|FG000|Overall Study|Withdrawal by Subject|1|||
105916866|NCT04350827|365354927|FG000|Overall Study|Lost to Follow-up|1|||
105916867|NCT04350827|365354928|FG001|Overall Study|Lost to Follow-up|2|||
105916868|NCT02481050|365356703|FG000|Overall Study|Adverse Event|1|||
105916869|NCT02481050|365356703|FG000|Overall Study|Disease Progression|47|||
105916870|NCT02481050|365356703|FG000|Overall Study|Withdrawal by Subject|7|||
105916871|NCT02481050|365356703|FG000|Overall Study|Other|3|||
105916872|NCT01386606|365356704|FG000|Overall Study|Adverse Event|0|||
105916873|NCT01386606|365356705|FG001|Overall Study|Adverse Event|1|||
105916874|NCT01386606|365356706|FG002|Overall Study|Adverse Event|0|||
105916875|NCT01386606|365356707|FG003|Overall Study|Adverse Event|0|||
105916876|NCT01386606|365356704|FG000|Overall Study|Withdrawal by Subject|0|||
105916877|NCT01386606|365356705|FG001|Overall Study|Withdrawal by Subject|1|||
105916878|NCT01386606|365356706|FG002|Overall Study|Withdrawal by Subject|1|||
105916879|NCT01386606|365356707|FG003|Overall Study|Withdrawal by Subject|0|||
105916880|NCT01386606|365356704|FG000|Overall Study|Protocol Violation|1|||
105916881|NCT01386606|365356705|FG001|Overall Study|Protocol Violation|0|||
105916882|NCT01386606|365356706|FG002|Overall Study|Protocol Violation|1|||
105916883|NCT01386606|365356707|FG003|Overall Study|Protocol Violation|1|||
105916884|NCT01386606|365356704|FG000|Overall Study|Lost to Follow-up|2|||
105916885|NCT01386606|365356705|FG001|Overall Study|Lost to Follow-up|0|||
105916886|NCT01386606|365356706|FG002|Overall Study|Lost to Follow-up|0|||
105916887|NCT01386606|365356707|FG003|Overall Study|Lost to Follow-up|0|||
105916888|NCT01386606|365356704|FG000|Overall Study|Subject incarcerated|0|||
105916889|NCT01386606|365356705|FG001|Overall Study|Subject incarcerated|1|||
105916890|NCT01386606|365356706|FG002|Overall Study|Subject incarcerated|0|||
105916891|NCT01386606|365356707|FG003|Overall Study|Subject incarcerated|0|||
105916892|NCT01386606|365356704|FG000|Overall Study|Unable to draw PK|1|||
105916893|NCT01386606|365356705|FG001|Overall Study|Unable to draw PK|0|||
105916894|NCT01386606|365356706|FG002|Overall Study|Unable to draw PK|0|||
105916895|NCT01386606|365356707|FG003|Overall Study|Unable to draw PK|0|||
105916896|NCT01386606|365356704|FG000|Overall Study|T levels too high|0|||
105916897|NCT01386606|365356705|FG001|Overall Study|T levels too high|1|||
105916898|NCT01386606|365356706|FG002|Overall Study|T levels too high|1|||
106127928|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127929|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127930|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127931|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105916899|NCT01386606|365356707|FG003|Overall Study|T levels too high|0|||
106127932|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127933|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127934|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
106127935|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
105916900|NCT01548599|365356708|FG000|Overall Study|Lost to Follow-up|0|||
105916901|NCT01548599|365356709|FG001|Overall Study|Lost to Follow-up|1|||
105916902|NCT01548599|365356708|FG000|Overall Study|Withdrawal by Subject|4|||
105916903|NCT01548599|365356709|FG001|Overall Study|Withdrawal by Subject|0|||
105916904|NCT01548599|365356708|FG000|Overall Study|Death|2|||
105916905|NCT01548599|365356709|FG001|Overall Study|Death|1|||
106001106|NCT00101686|365665208|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
106001107|NCT00101686|365665209|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
106001108|NCT00101686|365665200|FG000|Overall Study|unacceptable toxicity|3|||
106001109|NCT00101686|365665201|FG001|Overall Study|unacceptable toxicity|9|||
106001110|NCT00101686|365665202|FG002|Overall Study|unacceptable toxicity|10|||
106001111|NCT00101686|365665203|FG003|Overall Study|unacceptable toxicity|6|||
106001112|NCT00101686|365665204|FG004|Overall Study|unacceptable toxicity|16|||
106001113|NCT00101686|365665205|FG005|Overall Study|unacceptable toxicity|10|||
106001114|NCT00101686|365665206|FG006|Overall Study|unacceptable toxicity|4|||
106001115|NCT00101686|365665207|FG007|Overall Study|unacceptable toxicity|2|||
106001116|NCT00101686|365665208|FG008|Overall Study|unacceptable toxicity|1|||
106001117|NCT00101686|365665209|FG009|Overall Study|unacceptable toxicity|4|||
106001118|NCT00101686|365665200|FG000|Overall Study|Randomized but did not receive treament|1|||
106001119|NCT00101686|365665201|FG001|Overall Study|Randomized but did not receive treament|6|||
106001120|NCT00101686|365665202|FG002|Overall Study|Randomized but did not receive treament|2|||
106001121|NCT00101686|365665203|FG003|Overall Study|Randomized but did not receive treament|2|||
106001122|NCT00101686|365665204|FG004|Overall Study|Randomized but did not receive treament|2|||
106127936|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
106127937|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
106127938|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
106127939|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
106127940|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127941|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127942|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127943|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127944|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127945|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127946|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127947|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127948|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127949|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127950|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127951|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127952|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127953|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
106127954|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
106127955|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
106127956|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
106127957|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
106127958|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127959|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127960|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127961|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127962|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127963|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127964|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127965|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127966|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127967|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127968|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127969|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127970|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127971|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127972|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127973|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
106127974|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
106127975|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
106127976|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
106127977|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
106127978|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
106127979|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
106127980|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
106127981|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
106127982|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
106127983|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
106127984|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
106127985|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
106127986|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
106127987|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
106127988|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
106001123|NCT00101686|365665205|FG005|Overall Study|Randomized but did not receive treament|2|||
105683005|NCT00906945|364503130|FG000|Overall Study|Found to be not eligible|0|||
105683006|NCT00906945|364503131|FG001|Overall Study|Found to be not eligible|0|||
105683007|NCT00906945|364503132|FG002|Overall Study|Found to be not eligible|0|||
105683008|NCT00906945|364503133|FG003|Overall Study|Found to be not eligible|1|||
105683009|NCT00906945|364503134|FG004|Overall Study|Found to be not eligible|1|||
105683010|NCT00906945|364503135|FG005|Overall Study|Found to be not eligible|1|||
105683011|NCT00906945|364503130|FG000|Overall Study|Physician Decision|0|||
105683012|NCT00906945|364503131|FG001|Overall Study|Physician Decision|0|||
105683013|NCT00906945|364503132|FG002|Overall Study|Physician Decision|0|||
105683014|NCT00906945|364503133|FG003|Overall Study|Physician Decision|0|||
105683015|NCT00906945|364503134|FG004|Overall Study|Physician Decision|0|||
105683016|NCT00906945|364503135|FG005|Overall Study|Physician Decision|1|||
105683017|NCT01768637|364503136|FG000|Overall Study|Lost to Follow-up|2|||
105683018|NCT01768637|364503137|FG001|Overall Study|Lost to Follow-up|7|||
105683019|NCT01768637|364503136|FG000|Overall Study|Difficult blood draw|1|||
105683020|NCT01768637|364503137|FG001|Overall Study|Difficult blood draw|0|||
105683021|NCT02481947|364503138|FG000|Overall Study|Withdrawal by Subject|24|||
105683022|NCT02481947|364503139|FG001|Overall Study|Withdrawal by Subject|10|||
105683023|NCT02481947|364503138|FG000|Overall Study|Lost to Follow-up|11|||
105683024|NCT02481947|364503139|FG001|Overall Study|Lost to Follow-up|5|||
105683025|NCT02481947|364503138|FG000|Overall Study|Adverse Event|6|||
105683026|NCT02481947|364503139|FG001|Overall Study|Adverse Event|11|||
105683027|NCT02481947|364503138|FG000|Overall Study|Physician Decision|4|||
105683028|NCT02481947|364503139|FG001|Overall Study|Physician Decision|5|||
105683029|NCT02481947|364503138|FG000|Overall Study|Protocol Violation|1|||
105683030|NCT02481947|364503139|FG001|Overall Study|Protocol Violation|5|||
105683031|NCT01054170|364503140|FG000|Overall Study|Protocol Violation|1|||
105683032|NCT01054170|364503141|FG001|Overall Study|Protocol Violation|0|||
105683033|NCT01054170|364503140|FG000|Overall Study|Withdrawal by Subject|3|||
105683034|NCT01054170|364503141|FG001|Overall Study|Withdrawal by Subject|2|||
105683035|NCT01054170|364503140|FG000|Overall Study|Adverse Event|0|||
105683036|NCT01054170|364503141|FG001|Overall Study|Adverse Event|4|||
105916906|NCT02873689|365356710|FG000|Overall Study|Lack of Efficacy|1|||
105916907|NCT02873689|365356711|FG001|Overall Study|Lack of Efficacy|0|||
105916908|NCT02873689|365356710|FG000|Overall Study|Withdrawal by Subject|2|||
105916909|NCT02873689|365356711|FG001|Overall Study|Withdrawal by Subject|2|||
105916910|NCT02873689|365356710|FG000|Overall Study|Protocol Violation|1|||
105916911|NCT02873689|365356711|FG001|Overall Study|Protocol Violation|0|||
105916912|NCT02873689|365356710|FG000|Overall Study|Adverse Event|2|||
105916913|NCT02873689|365356711|FG001|Overall Study|Adverse Event|2|||
105916914|NCT02873689|365356710|FG000|Overall Study|Randomized but not Treated|1|||
105916915|NCT02873689|365356711|FG001|Overall Study|Randomized but not Treated|1|||
105916916|NCT04113694|365356712|FG000|Overall Study|Adverse Event|2|||
105916917|NCT04113694|365356712|FG000|Overall Study|Lost to Follow-up|2|||
105916918|NCT04113694|365356712|FG000|Overall Study|Withdrawal by Subject|6|||
105916919|NCT04113694|365356712|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
105916920|NCT05630196|365356713|FG000|Overall Study|Adverse Event|2|||
105916921|NCT05630196|365356714|FG001|Overall Study|Adverse Event|1|||
105916922|NCT05630196|365356713|FG000|Overall Study|Lost to Follow-up|1|||
105916923|NCT05630196|365356714|FG001|Overall Study|Lost to Follow-up|1|||
105916924|NCT05630196|365356713|FG000|Overall Study|Protocol Violation|2|||
105916925|NCT05630196|365356714|FG001|Overall Study|Protocol Violation|3|||
105916926|NCT05630196|365356713|FG000|Overall Study|Physician Decision|1|||
105916927|NCT05630196|365356714|FG001|Overall Study|Physician Decision|0|||
105916928|NCT05630196|365356713|FG000|Overall Study|Withdrawal by Subject|3|||
105916929|NCT05630196|365356714|FG001|Overall Study|Withdrawal by Subject|4|||
105916930|NCT00352118|365356715|FG000|Overall Study|Physician Decision|4|||
105916931|NCT00903201|365356716|FG000|Overall Study|Adverse Event|1|||
105916932|NCT00903201|365356717|FG001|Overall Study|Adverse Event|4|||
105916933|NCT00903201|365356718|FG002|Overall Study|Adverse Event|0|||
105916934|NCT00903201|365356716|FG000|Overall Study|Protocol Violation|2|||
105916935|NCT00903201|365356717|FG001|Overall Study|Protocol Violation|1|||
105916936|NCT00903201|365356718|FG002|Overall Study|Protocol Violation|0|||
105916937|NCT00903201|365356716|FG000|Overall Study|Lost to Follow-up|0|||
105683037|NCT01442779|364503142|FG000|Overall Study|Withdrawal by Subject|3|||
105683038|NCT01442779|364503142|FG000|Overall Study|Death|3|||
105683039|NCT01442779|364503142|FG000|Overall Study|Non-compliance|1|||
105683040|NCT01048671|364503143|FG000|Overall Study|Protocol Violation|0|||
105683041|NCT01048671|364503144|FG001|Overall Study|Protocol Violation|1|||
105683042|NCT01048671|364503145|FG002|Overall Study|Protocol Violation|1|||
105916938|NCT00903201|365356717|FG001|Overall Study|Lost to Follow-up|1|||
105916939|NCT00903201|365356718|FG002|Overall Study|Lost to Follow-up|0|||
105683043|NCT02009761|364503146|FG000|Overall Study|Adverse Event|4|||
105683044|NCT01815138|364503147|FG000|Overall Study|Withdrawal by Subject|0|||
105683045|NCT01815138|364503148|FG001|Overall Study|Withdrawal by Subject|1|||
105916940|NCT00903201|365356716|FG000|Overall Study|Physician Decision|1|||
105916941|NCT00903201|365356717|FG001|Overall Study|Physician Decision|0|||
105916942|NCT00903201|365356718|FG002|Overall Study|Physician Decision|1|||
105916943|NCT00903201|365356716|FG000|Overall Study|Withdrawal by Subject|1|||
105916944|NCT00903201|365356717|FG001|Overall Study|Withdrawal by Subject|0|||
105916945|NCT00903201|365356718|FG002|Overall Study|Withdrawal by Subject|1|||
105916946|NCT01389232|365356719|FG000|Overall Study|Had scaffold removed|15|||
105916947|NCT01389232|365356719|FG000|Overall Study|Personal reasons|2|||
105916948|NCT01389232|365356719|FG000|Overall Study|Adverse Event|1|||
105916949|NCT01389232|365356719|FG000|Overall Study|Death|1|||
105916950|NCT02990000|365356720|FG000|Overall Study|Failed to provide data beyond baseline|36|||
105916951|NCT02990000|365356721|FG001|Overall Study|Failed to provide data beyond baseline|34|||
105916952|NCT04969289|365356722|FG000|Overall Study|Lost to Follow-up|13|||
105916953|NCT04969289|365356723|FG001|Overall Study|Lost to Follow-up|9|||
105916954|NCT00593814|365356724|FG000|Overall Study|Death|7|||
105916955|NCT00593814|365356725|FG001|Overall Study|Death|0|||
105916956|NCT00593814|365356724|FG000|Overall Study|Withdrawal by Subject|7|||
105916957|NCT00593814|365356725|FG001|Overall Study|Withdrawal by Subject|0|||
105916958|NCT00593814|365356724|FG000|Overall Study|Lost to Follow-up|7|||
105916959|NCT00593814|365356725|FG001|Overall Study|Lost to Follow-up|0|||
105916960|NCT00593814|365356724|FG000|Overall Study|Physician Decision|3|||
105916961|NCT00593814|365356725|FG001|Overall Study|Physician Decision|0|||
105916962|NCT00557466|365356726|FG000|Overall Study|Adverse Event|3|||
105916963|NCT00557466|365356727|FG001|Overall Study|Adverse Event|1|||
105916964|NCT00557466|365356728|FG002|Overall Study|Adverse Event|4|||
105916965|NCT00557466|365356729|FG003|Overall Study|Adverse Event|1|||
105916966|NCT00557466|365356730|FG004|Overall Study|Adverse Event|2|||
105916967|NCT00557466|365356731|FG005|Overall Study|Adverse Event|4|||
105916968|NCT00557466|365356726|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105916969|NCT00557466|365356727|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105916970|NCT00557466|365356728|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105916971|NCT00557466|365356729|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105916972|NCT00557466|365356730|FG004|Overall Study|Abnormal laboratory value(s)|0|||
105916973|NCT00557466|365356731|FG005|Overall Study|Abnormal laboratory value(s)|0|||
105916974|NCT00557466|365356726|FG000|Overall Study|Protocol deviation|0|||
105916975|NCT00557466|365356727|FG001|Overall Study|Protocol deviation|1|||
105916976|NCT00557466|365356728|FG002|Overall Study|Protocol deviation|0|||
105916977|NCT00557466|365356729|FG003|Overall Study|Protocol deviation|2|||
105916978|NCT00557466|365356730|FG004|Overall Study|Protocol deviation|0|||
105916979|NCT00557466|365356731|FG005|Overall Study|Protocol deviation|0|||
105916980|NCT00557466|365356726|FG000|Overall Study|Subject withdrew consent|0|||
105916981|NCT00557466|365356727|FG001|Overall Study|Subject withdrew consent|0|||
105916982|NCT00557466|365356728|FG002|Overall Study|Subject withdrew consent|0|||
105916983|NCT00557466|365356729|FG003|Overall Study|Subject withdrew consent|0|||
105916984|NCT00557466|365356730|FG004|Overall Study|Subject withdrew consent|1|||
105916985|NCT00557466|365356731|FG005|Overall Study|Subject withdrew consent|2|||
105916986|NCT00557466|365356726|FG000|Overall Study|Administrative problems|0|||
105916987|NCT00557466|365356727|FG001|Overall Study|Administrative problems|1|||
105916988|NCT00557466|365356728|FG002|Overall Study|Administrative problems|1|||
105916989|NCT00557466|365356729|FG003|Overall Study|Administrative problems|0|||
105916990|NCT00557466|365356730|FG004|Overall Study|Administrative problems|0|||
105916991|NCT00557466|365356731|FG005|Overall Study|Administrative problems|0|||
105916992|NCT00557466|365356726|FG000|Overall Study|Abnormal test procedure results|0|||
105916993|NCT00557466|365356727|FG001|Overall Study|Abnormal test procedure results|0|||
105916994|NCT00557466|365356728|FG002|Overall Study|Abnormal test procedure results|1|||
105916995|NCT00557466|365356729|FG003|Overall Study|Abnormal test procedure results|0|||
105916996|NCT00557466|365356730|FG004|Overall Study|Abnormal test procedure results|0|||
105916997|NCT00557466|365356731|FG005|Overall Study|Abnormal test procedure results|0|||
105916998|NCT00557466|365356726|FG000|Overall Study|Lost to Follow-up|0|||
105916999|NCT00557466|365356727|FG001|Overall Study|Lost to Follow-up|0|||
105917000|NCT00557466|365356728|FG002|Overall Study|Lost to Follow-up|0|||
105917001|NCT00557466|365356729|FG003|Overall Study|Lost to Follow-up|1|||
105917002|NCT00557466|365356730|FG004|Overall Study|Lost to Follow-up|0|||
105917003|NCT00557466|365356731|FG005|Overall Study|Lost to Follow-up|0|||
105917004|NCT03205150|365356732|FG000|Overall Study|Protocol deviation|1|||
105917005|NCT03205150|365356733|FG001|Overall Study|Protocol deviation|3|||
105917006|NCT03205150|365356734|FG002|Overall Study|Protocol deviation|0|||
105917007|NCT03205150|365356732|FG000|Overall Study|Patient/guardian decision|0|||
105917008|NCT03205150|365356733|FG001|Overall Study|Patient/guardian decision|3|||
105917009|NCT03205150|365356734|FG002|Overall Study|Patient/guardian decision|0|||
105917010|NCT03205150|365356732|FG000|Overall Study|Adverse Event|1|||
105917011|NCT03205150|365356733|FG001|Overall Study|Adverse Event|1|||
105917012|NCT03205150|365356734|FG002|Overall Study|Adverse Event|1|||
105917013|NCT03205150|365356732|FG000|Overall Study|Lost to Follow-up|0|||
105917014|NCT03205150|365356733|FG001|Overall Study|Lost to Follow-up|0|||
105917015|NCT03205150|365356734|FG002|Overall Study|Lost to Follow-up|1|||
105917016|NCT02723188|365356735|FG000|Overall Study|Withdrawal by Subject|1|||
105917017|NCT02723188|365356736|FG001|Overall Study|Withdrawal by Subject|0|||
105917018|NCT02723188|365356737|FG002|Overall Study|Withdrawal by Subject|0|||
105917019|NCT01251952|365356738|FG000|Overall Study|Adverse Event|1|||
106001124|NCT00101686|365665206|FG006|Overall Study|Randomized but did not receive treament|0|||
106001125|NCT00101686|365665207|FG007|Overall Study|Randomized but did not receive treament|1|||
106001126|NCT00101686|365665208|FG008|Overall Study|Randomized but did not receive treament|0|||
106001127|NCT00101686|365665209|FG009|Overall Study|Randomized but did not receive treament|1|||
106001128|NCT00101686|365665200|FG000|Overall Study|intercurrent non-cancer related illness|0|||
106001129|NCT00101686|365665201|FG001|Overall Study|intercurrent non-cancer related illness|0|||
106001130|NCT00101686|365665202|FG002|Overall Study|intercurrent non-cancer related illness|2|||
106001131|NCT00101686|365665203|FG003|Overall Study|intercurrent non-cancer related illness|0|||
106001132|NCT00101686|365665204|FG004|Overall Study|intercurrent non-cancer related illness|1|||
106001133|NCT00101686|365665205|FG005|Overall Study|intercurrent non-cancer related illness|3|||
106001134|NCT00101686|365665206|FG006|Overall Study|intercurrent non-cancer related illness|1|||
106001135|NCT00101686|365665207|FG007|Overall Study|intercurrent non-cancer related illness|0|||
106001136|NCT00101686|365665208|FG008|Overall Study|intercurrent non-cancer related illness|1|||
106001137|NCT00101686|365665209|FG009|Overall Study|intercurrent non-cancer related illness|1|||
106001138|NCT00101686|365665200|FG000|Overall Study|Physician Decision|10|||
106001139|NCT00101686|365665201|FG001|Overall Study|Physician Decision|13|||
106001140|NCT00101686|365665202|FG002|Overall Study|Physician Decision|6|||
106001141|NCT00101686|365665203|FG003|Overall Study|Physician Decision|7|||
106001142|NCT00101686|365665204|FG004|Overall Study|Physician Decision|8|||
106001143|NCT00101686|365665205|FG005|Overall Study|Physician Decision|9|||
106001144|NCT00101686|365665206|FG006|Overall Study|Physician Decision|5|||
106001145|NCT00101686|365665207|FG007|Overall Study|Physician Decision|5|||
106001146|NCT00101686|365665208|FG008|Overall Study|Physician Decision|1|||
106001147|NCT00101686|365665209|FG009|Overall Study|Physician Decision|1|||
106001148|NCT00101686|365665200|FG000|Overall Study|Other|1|||
106001149|NCT00101686|365665201|FG001|Overall Study|Other|4|||
106001150|NCT00101686|365665202|FG002|Overall Study|Other|1|||
106001151|NCT00101686|365665203|FG003|Overall Study|Other|6|||
106001152|NCT00101686|365665204|FG004|Overall Study|Other|2|||
105683046|NCT01815138|364503147|FG000|Overall Study|Physician Decision|8|||
106001153|NCT00101686|365665205|FG005|Overall Study|Other|12|||
106001154|NCT00101686|365665206|FG006|Overall Study|Other|1|||
106001155|NCT00101686|365665207|FG007|Overall Study|Other|5|||
106001156|NCT00101686|365665208|FG008|Overall Study|Other|3|||
106001157|NCT00101686|365665209|FG009|Overall Study|Other|3|||
106001158|NCT00101686|365665200|FG000|Overall Study|Withdrawal by Subject|9|||
106001159|NCT00101686|365665201|FG001|Overall Study|Withdrawal by Subject|8|||
106001160|NCT00101686|365665202|FG002|Overall Study|Withdrawal by Subject|6|||
106001161|NCT00101686|365665203|FG003|Overall Study|Withdrawal by Subject|8|||
106001162|NCT00101686|365665204|FG004|Overall Study|Withdrawal by Subject|8|||
106001163|NCT00101686|365665205|FG005|Overall Study|Withdrawal by Subject|7|||
106001164|NCT00101686|365665206|FG006|Overall Study|Withdrawal by Subject|7|||
105683047|NCT01815138|364503148|FG001|Overall Study|Physician Decision|5|||
105683048|NCT03426267|364503151|FG000|Overall Study|Physician Decision|1|||
105683049|NCT03426267|364503152|FG001|Overall Study|Physician Decision|4|||
105683050|NCT03426267|364503151|FG000|Overall Study|Lost to Follow-up|1|||
105683051|NCT03426267|364503152|FG001|Overall Study|Lost to Follow-up|0|||
106001165|NCT00101686|365665207|FG007|Overall Study|Withdrawal by Subject|7|||
106001166|NCT00101686|365665208|FG008|Overall Study|Withdrawal by Subject|8|||
105683052|NCT03426267|364503151|FG000|Overall Study|Withdrawal by Subject|4|||
105683053|NCT03426267|364503152|FG001|Overall Study|Withdrawal by Subject|10|||
105683054|NCT03426267|364503151|FG000|Overall Study|Protocol Violation|1|||
105683055|NCT03426267|364503152|FG001|Overall Study|Protocol Violation|3|||
105683056|NCT03426267|364503151|FG000|Overall Study|Adverse Event|9|||
105683057|NCT03426267|364503152|FG001|Overall Study|Adverse Event|27|||
105683058|NCT03426267|364503151|FG000|Overall Study|Prohibited Treatment Intake|2|||
105683059|NCT03426267|364503152|FG001|Overall Study|Prohibited Treatment Intake|3|||
105683060|NCT03426267|364503151|FG000|Overall Study|Lack of Efficacy|0|||
105683061|NCT03426267|364503152|FG001|Overall Study|Lack of Efficacy|25|||
106001167|NCT00101686|365665209|FG009|Overall Study|Withdrawal by Subject|9|||
106001168|NCT01358825|365665210|FG000|Overall Study|Blood sample not drawn|0|||
106001169|NCT01358825|365665211|FG001|Overall Study|Blood sample not drawn|1|||
106001170|NCT01623115|365665212|FG000|Overall Study|Randomized but not treated|0|||
105683062|NCT03426267|364503151|FG000|Overall Study|other|3|||
106001171|NCT01623115|365665213|FG001|Overall Study|Randomized but not treated|1|||
106001172|NCT01623115|365665212|FG000|Overall Study|Physician Decision|1|||
106127989|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
106127990|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
105683063|NCT03426267|364503152|FG001|Overall Study|other|0|||
105683064|NCT01209780|364503153|FG000|Overall Study|Adverse Event|0|||
105683065|NCT01209780|364503154|FG001|Overall Study|Adverse Event|1|||
105683066|NCT01209780|364503155|FG002|Overall Study|Adverse Event|0|||
105683067|NCT01209780|364503156|FG003|Overall Study|Adverse Event|0|||
106001173|NCT01623115|365665213|FG001|Overall Study|Physician Decision|0|||
106001174|NCT01623115|365665212|FG000|Overall Study|Participants moved|1|||
106001175|NCT01623115|365665213|FG001|Overall Study|Participants moved|5|||
106001176|NCT01623115|365665212|FG000|Overall Study|Adverse Event|10|||
105917020|NCT00496769|365356739|FG000|Double Blind|>=1 reason assigned per patient|558|||
105917021|NCT00496769|365356740|FG001|Double Blind|>=1 reason assigned per patient|649|||
105917022|NCT00496769|365356741|FG002|Double Blind|>=1 reason assigned per patient|0|||
105917023|NCT00496769|365356739|FG000|Open Label|>=1 reason assigned per patient|0|||
105917024|NCT00496769|365356740|FG001|Open Label|>=1 reason assigned per patient|0|||
105917025|NCT00496769|365356741|FG002|Open Label|>=1 reason assigned per patient|1011|||
105917026|NCT03110354|365356742|FG000|Overall Study|Death|1|||
105917027|NCT03110354|365356743|FG001|Overall Study|Death|0|||
105917028|NCT03110354|365356744|FG002|Overall Study|Death|0|||
105917029|NCT03110354|365356745|FG003|Overall Study|Death|1|||
105917030|NCT03110354|365356746|FG004|Overall Study|Death|0|||
105917031|NCT03110354|365356742|FG000|Overall Study|Start of new therapy|0|||
105917032|NCT03110354|365356743|FG001|Overall Study|Start of new therapy|0|||
105917033|NCT03110354|365356744|FG002|Overall Study|Start of new therapy|0|||
105917034|NCT03110354|365356745|FG003|Overall Study|Start of new therapy|0|||
105917035|NCT03110354|365356746|FG004|Overall Study|Start of new therapy|1|||
105917036|NCT03110354|365356742|FG000|Overall Study|Failure to achieve response|2|||
105917037|NCT03110354|365356743|FG001|Overall Study|Failure to achieve response|3|||
105917038|NCT03110354|365356744|FG002|Overall Study|Failure to achieve response|0|||
105917039|NCT03110354|365356745|FG003|Overall Study|Failure to achieve response|2|||
105917040|NCT03110354|365356746|FG004|Overall Study|Failure to achieve response|1|||
105917041|NCT03110354|365356742|FG000|Overall Study|Progressive disease|1|||
105917042|NCT03110354|365356743|FG001|Overall Study|Progressive disease|1|||
105917043|NCT03110354|365356744|FG002|Overall Study|Progressive disease|3|||
105917044|NCT03110354|365356745|FG003|Overall Study|Progressive disease|4|||
106127991|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
106127992|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
106127993|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
106127994|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
106127995|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
106127996|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
106127997|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
106127998|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
106127999|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128000|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128001|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128002|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128003|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128004|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128005|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128006|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128007|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128008|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128009|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
106128010|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
106128011|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
106128012|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
106128013|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
106128014|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
106128015|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
105683068|NCT01209780|364503157|FG004|Overall Study|Adverse Event|0|||
105683069|NCT01209780|364503153|FG000|Overall Study|Withdrawal by Subject|9|||
105917045|NCT03110354|365356746|FG004|Overall Study|Progressive disease|2|||
105917046|NCT03110354|365356742|FG000|Overall Study|Adverse Event|0|||
105917047|NCT03110354|365356743|FG001|Overall Study|Adverse Event|0|||
106128016|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
106128017|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
106128018|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
106128019|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
106128020|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
106128021|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
106128022|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
106128023|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
106128024|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
106128025|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
106128026|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
106128027|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
105683070|NCT01209780|364503154|FG001|Overall Study|Withdrawal by Subject|2|||
105917048|NCT03110354|365356744|FG002|Overall Study|Adverse Event|0|||
105917049|NCT03110354|365356745|FG003|Overall Study|Adverse Event|2|||
105917050|NCT03110354|365356746|FG004|Overall Study|Adverse Event|2|||
105917051|NCT03110354|365356742|FG000|Overall Study|Other|0|||
105917052|NCT03110354|365356743|FG001|Overall Study|Other|0|||
105917053|NCT03110354|365356744|FG002|Overall Study|Other|0|||
105917054|NCT03110354|365356745|FG003|Overall Study|Other|1|||
105917055|NCT03110354|365356746|FG004|Overall Study|Other|1|||
105917056|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
105917057|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
105917058|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
105917059|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
105917060|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
105917061|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
105917062|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
105917063|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
105917064|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
105917065|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
105917066|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
105917067|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
105917068|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
105917069|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
105917070|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
105917071|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
105917072|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
105917073|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
106128028|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
106128029|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
106128030|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128031|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
105683071|NCT01209780|364503155|FG002|Overall Study|Withdrawal by Subject|1|||
105683072|NCT01209780|364503156|FG003|Overall Study|Withdrawal by Subject|1|||
105683073|NCT01209780|364503157|FG004|Overall Study|Withdrawal by Subject|0|||
105683074|NCT01209780|364503153|FG000|Overall Study|Lost to Follow-up|17|||
105683075|NCT01209780|364503154|FG001|Overall Study|Lost to Follow-up|12|||
105683076|NCT01209780|364503155|FG002|Overall Study|Lost to Follow-up|3|||
105683077|NCT01209780|364503156|FG003|Overall Study|Lost to Follow-up|9|||
105683078|NCT01209780|364503157|FG004|Overall Study|Lost to Follow-up|4|||
105683079|NCT01209780|364503153|FG000|Overall Study|Protocol Violation|0|||
105683080|NCT01209780|364503154|FG001|Overall Study|Protocol Violation|1|||
105683081|NCT01209780|364503155|FG002|Overall Study|Protocol Violation|0|||
105683082|NCT01209780|364503156|FG003|Overall Study|Protocol Violation|0|||
105683083|NCT01209780|364503157|FG004|Overall Study|Protocol Violation|0|||
105683084|NCT01209780|364503153|FG000|Overall Study|Inappropriate enrollment|0|||
105683085|NCT01209780|364503154|FG001|Overall Study|Inappropriate enrollment|2|||
105683086|NCT01209780|364503155|FG002|Overall Study|Inappropriate enrollment|0|||
105683087|NCT01209780|364503156|FG003|Overall Study|Inappropriate enrollment|0|||
105683088|NCT01209780|364503157|FG004|Overall Study|Inappropriate enrollment|1|||
105683089|NCT01272804|364503162|FG000|Overall Study|Adverse Event|1|||
105683090|NCT01272804|364503163|FG001|Overall Study|Adverse Event|0|||
105683091|NCT01272804|364503164|FG002|Overall Study|Adverse Event|0|||
105683092|NCT01272804|364503165|FG003|Overall Study|Adverse Event|0|||
105683093|NCT01272804|364503166|FG004|Overall Study|Adverse Event|2|||
105683094|NCT01272804|364503167|FG005|Overall Study|Adverse Event|1|||
105683095|NCT02076178|364503168|FG000|Oral Phase|Adverse Event|0|||
105683096|NCT02076178|364503169|FG001|Oral Phase|Adverse Event|7|||
105683097|NCT02076178|364503168|FG000|Oral Phase|Withdrawal by Subject|0|||
105683098|NCT02076178|364503169|FG001|Oral Phase|Withdrawal by Subject|4|||
105683099|NCT02076178|364503168|FG000|Oral Phase|Physician Decision|0|||
105683100|NCT02076178|364503169|FG001|Oral Phase|Physician Decision|1|||
105683101|NCT02076178|364503168|FG000|Injection Phase|Protocol defined stopping criteria|1|||
105683102|NCT02076178|364503169|FG001|Injection Phase|Protocol defined stopping criteria|0|||
105683103|NCT02076178|364503168|FG000|Injection Phase|Withdrawal by Subject|0|||
105683104|NCT02076178|364503169|FG001|Injection Phase|Withdrawal by Subject|3|||
105683105|NCT02076178|364503168|FG000|Injection Phase|Physician Decision|0|||
105683106|NCT02076178|364503169|FG001|Injection Phase|Physician Decision|3|||
105683107|NCT02076178|364503168|FG000|Injection Phase|Lost to Follow-up|0|||
105683108|NCT02076178|364503169|FG001|Injection Phase|Lost to Follow-up|1|||
105683109|NCT00705523|364503170|FG000|Overall Study|Lost to Follow-up|2|||
105683110|NCT00705523|364503171|FG001|Overall Study|Lost to Follow-up|3|||
105683111|NCT02640157|364503172|FG000|Overall Study|Adverse Event|2|||
105683112|NCT02640157|364503173|FG001|Overall Study|Adverse Event|2|||
105683113|NCT02640157|364503174|FG002|Overall Study|Adverse Event|1|||
105683114|NCT02640157|364503172|FG000|Overall Study|Withdrew consent|2|||
105683115|NCT02640157|364503173|FG001|Overall Study|Withdrew consent|0|||
105683116|NCT02640157|364503174|FG002|Overall Study|Withdrew consent|2|||
105683117|NCT02640157|364503172|FG000|Overall Study|Lost to Follow-up|9|||
105683118|NCT02640157|364503173|FG001|Overall Study|Lost to Follow-up|2|||
105683119|NCT02640157|364503174|FG002|Overall Study|Lost to Follow-up|7|||
105683120|NCT02640157|364503172|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
105683121|NCT02640157|364503173|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
105683122|NCT02640157|364503174|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
105683123|NCT00710021|364503175|FG000|Overall Study|Lost to Follow-up|1|||
105683124|NCT00710021|364503176|FG001|Overall Study|Lost to Follow-up|0|||
105683125|NCT00710021|364503177|FG002|Overall Study|Lost to Follow-up|0|||
105683126|NCT00710021|364503175|FG000|Overall Study|Subject's Decision|0|||
105683127|NCT00710021|364503176|FG001|Overall Study|Subject's Decision|1|||
105683128|NCT00710021|364503177|FG002|Overall Study|Subject's Decision|0|||
105683129|NCT00710021|364503175|FG000|Overall Study|Subject misrandomized|0|||
105683130|NCT00710021|364503176|FG001|Overall Study|Subject misrandomized|1|||
105683131|NCT00710021|364503177|FG002|Overall Study|Subject misrandomized|1|||
105683132|NCT00710021|364503175|FG000|Overall Study|Physician Decision|0|||
105683133|NCT00710021|364503176|FG001|Overall Study|Physician Decision|1|||
105683134|NCT00710021|364503177|FG002|Overall Study|Physician Decision|0|||
105683135|NCT04677179|364503179|FG000|Induction Treatment Period|Adverse Event|1|||
105683136|NCT04677179|364503180|FG001|Induction Treatment Period|Adverse Event|0|||
105683137|NCT04677179|364503181|FG002|Induction Treatment Period|Adverse Event|0|||
105683138|NCT04677179|364503182|FG003|Induction Treatment Period|Adverse Event|0|||
105683139|NCT04677179|364503183|FG004|Induction Treatment Period|Adverse Event|0|||
105683140|NCT04677179|364503184|FG005|Induction Treatment Period|Adverse Event|0|||
105683141|NCT04677179|364503185|FG006|Induction Treatment Period|Adverse Event|0|||
105683142|NCT04677179|364503186|FG007|Induction Treatment Period|Adverse Event|0|||
105683143|NCT04677179|364503187|FG008|Induction Treatment Period|Adverse Event|0|||
105917074|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
106001177|NCT01623115|365665213|FG001|Overall Study|Adverse Event|13|||
105683144|NCT04677179|364503188|FG009|Induction Treatment Period|Adverse Event|0|||
105683145|NCT04677179|364503179|FG000|Induction Treatment Period|Physician Decision|1|||
105683146|NCT04677179|364503180|FG001|Induction Treatment Period|Physician Decision|0|||
105683147|NCT04677179|364503181|FG002|Induction Treatment Period|Physician Decision|1|||
105683148|NCT04677179|364503182|FG003|Induction Treatment Period|Physician Decision|0|||
105683149|NCT04677179|364503183|FG004|Induction Treatment Period|Physician Decision|0|||
105683150|NCT04677179|364503184|FG005|Induction Treatment Period|Physician Decision|0|||
105683151|NCT04677179|364503185|FG006|Induction Treatment Period|Physician Decision|0|||
105683152|NCT04677179|364503186|FG007|Induction Treatment Period|Physician Decision|0|||
105683153|NCT04677179|364503187|FG008|Induction Treatment Period|Physician Decision|0|||
105683154|NCT04677179|364503188|FG009|Induction Treatment Period|Physician Decision|0|||
105683155|NCT04677179|364503179|FG000|Induction Treatment Period|Protocol Violation|0|||
105683156|NCT04677179|364503180|FG001|Induction Treatment Period|Protocol Violation|1|||
105683157|NCT04677179|364503181|FG002|Induction Treatment Period|Protocol Violation|0|||
105683158|NCT04677179|364503182|FG003|Induction Treatment Period|Protocol Violation|0|||
105683159|NCT04677179|364503183|FG004|Induction Treatment Period|Protocol Violation|0|||
105683160|NCT04677179|364503184|FG005|Induction Treatment Period|Protocol Violation|0|||
105683161|NCT04677179|364503185|FG006|Induction Treatment Period|Protocol Violation|0|||
105683162|NCT04677179|364503186|FG007|Induction Treatment Period|Protocol Violation|0|||
105683163|NCT04677179|364503187|FG008|Induction Treatment Period|Protocol Violation|0|||
105683164|NCT04677179|364503188|FG009|Induction Treatment Period|Protocol Violation|0|||
105683165|NCT04677179|364503179|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
105683166|NCT04677179|364503180|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
105683167|NCT04677179|364503181|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
105683168|NCT04677179|364503182|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
105683169|NCT04677179|364503183|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
105683170|NCT04677179|364503184|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
105683171|NCT04677179|364503185|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
105683172|NCT04677179|364503186|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
105683173|NCT04677179|364503187|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
105683174|NCT04677179|364503188|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
105683175|NCT04677179|364503179|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
105683176|NCT04677179|364503180|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
105683177|NCT04677179|364503181|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
105683178|NCT04677179|364503182|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
105683179|NCT04677179|364503183|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
105683180|NCT04677179|364503184|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
105683181|NCT04677179|364503185|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
105683182|NCT04677179|364503186|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
105683183|NCT04677179|364503187|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
105683184|NCT04677179|364503188|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
105683185|NCT04677179|364503179|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
105683186|NCT04677179|364503180|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
105683187|NCT04677179|364503181|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
105683188|NCT04677179|364503182|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
105683189|NCT04677179|364503183|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
105683190|NCT04677179|364503184|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
105683191|NCT04677179|364503185|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
105683192|NCT04677179|364503186|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
105683193|NCT04677179|364503187|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
105683194|NCT04677179|364503188|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
105683195|NCT04677179|364503179|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683196|NCT04677179|364503180|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683197|NCT04677179|364503181|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683198|NCT04677179|364503182|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
105683199|NCT04677179|364503183|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683200|NCT04677179|364503184|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683201|NCT04677179|364503185|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683202|NCT04677179|364503186|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683203|NCT04677179|364503187|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683204|NCT04677179|364503188|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
105683205|NCT04677179|364503179|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683206|NCT04677179|364503180|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683207|NCT04677179|364503181|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683208|NCT04677179|364503182|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
105683209|NCT04677179|364503183|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
105683210|NCT04677179|364503184|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
105683211|NCT04677179|364503185|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
105917075|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
105917076|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
105917077|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
105683212|NCT04677179|364503186|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683213|NCT04677179|364503187|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683214|NCT04677179|364503188|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
105683215|NCT04677179|364503179|FG000|Extension Treatment Period|Lack of Efficacy|0|||
105683216|NCT04677179|364503180|FG001|Extension Treatment Period|Lack of Efficacy|0|||
105683217|NCT04677179|364503181|FG002|Extension Treatment Period|Lack of Efficacy|0|||
105683218|NCT04677179|364503182|FG003|Extension Treatment Period|Lack of Efficacy|0|||
105683219|NCT04677179|364503183|FG004|Extension Treatment Period|Lack of Efficacy|0|||
105683220|NCT04677179|364503184|FG005|Extension Treatment Period|Lack of Efficacy|0|||
105683221|NCT04677179|364503185|FG006|Extension Treatment Period|Lack of Efficacy|6|||
105683222|NCT04677179|364503186|FG007|Extension Treatment Period|Lack of Efficacy|0|||
105683223|NCT04677179|364503187|FG008|Extension Treatment Period|Lack of Efficacy|0|||
105683224|NCT04677179|364503188|FG009|Extension Treatment Period|Lack of Efficacy|0|||
105683225|NCT04677179|364503179|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
105683226|NCT04677179|364503180|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105683227|NCT04677179|364503181|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
105683228|NCT04677179|364503182|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
105683229|NCT04677179|364503183|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
105683230|NCT04677179|364503184|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
105683231|NCT04677179|364503185|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
105683232|NCT04677179|364503186|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
105683233|NCT04677179|364503187|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
105683234|NCT04677179|364503188|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
105683235|NCT04677179|364503179|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
105683236|NCT04677179|364503180|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
105683237|NCT04677179|364503181|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
105683238|NCT04677179|364503182|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
105683239|NCT04677179|364503183|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
105683240|NCT04677179|364503184|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
105683241|NCT04677179|364503185|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
105683242|NCT04677179|364503186|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
105683243|NCT04677179|364503187|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
105683244|NCT04677179|364503188|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
105683245|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
105683246|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
105683247|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
105683248|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
105683249|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
105683250|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
105683251|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
105683252|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
105683253|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
105683254|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
105683255|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683256|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683257|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683258|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683259|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683260|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683261|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
105683262|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
105917078|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
105917079|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
105917080|NCT01198002|365356747|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
105917081|NCT01198002|365356748|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
105917082|NCT01198002|365356749|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
105917083|NCT01198002|365356747|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
105917084|NCT01198002|365356748|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
105917085|NCT01198002|365356749|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
105917086|NCT01198002|365356747|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
105917087|NCT01198002|365356748|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
105917088|NCT01198002|365356749|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
105917089|NCT01198002|365356747|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
105917090|NCT01198002|365356748|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
105917091|NCT01198002|365356749|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
106128032|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
105683263|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
105683264|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
106128033|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
105683265|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683266|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683267|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683268|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683269|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683270|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683271|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683272|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
105683273|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683274|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105683275|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683276|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683277|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683278|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683279|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683280|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683281|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683282|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
105683283|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
105683284|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105683285|NCT04677179|364503179|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683286|NCT04677179|364503180|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683287|NCT04677179|364503181|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683288|NCT04677179|364503182|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683289|NCT04677179|364503183|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683290|NCT04677179|364503184|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683291|NCT04677179|364503185|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
105683292|NCT04677179|364503186|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
105683293|NCT04677179|364503187|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
105683294|NCT04677179|364503188|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
105683295|NCT01536015|364503189|FG000|Overall Study|Adverse Event|1|||
105683296|NCT01536015|364503190|FG001|Overall Study|Adverse Event|4|||
105683297|NCT01536015|364503189|FG000|Overall Study|Lost to Follow-up|0|||
105683298|NCT01536015|364503190|FG001|Overall Study|Lost to Follow-up|1|||
105683299|NCT01536015|364503189|FG000|Overall Study|Inclusion Criterion not met|2|||
105683300|NCT01536015|364503190|FG001|Overall Study|Inclusion Criterion not met|0|||
105683301|NCT01536015|364503189|FG000|Overall Study|Study closure|5|||
105683302|NCT01536015|364503190|FG001|Overall Study|Study closure|5|||
105683303|NCT02374671|364503191|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
105683304|NCT02374671|364503192|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
105683305|NCT02374671|364503193|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
105683306|NCT02374671|364503191|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
105683307|NCT02374671|364503192|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
105683308|NCT02374671|364503193|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
105683309|NCT02374671|364503191|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
105683310|NCT02374671|364503192|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
105683311|NCT02374671|364503193|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
105683312|NCT02374671|364503191|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
105683313|NCT02374671|364503192|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
105683314|NCT02374671|364503193|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
105683315|NCT02374671|364503191|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
105683316|NCT02374671|364503192|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
105683317|NCT02374671|364503193|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
105683318|NCT03110185|364503195|FG000|Overall Study|Death|0|||
105683319|NCT03110185|364503196|FG001|Overall Study|Death|1|||
105683320|NCT03110185|364503195|FG000|Overall Study|Withdrawal by Subject|2|||
105683321|NCT03110185|364503196|FG001|Overall Study|Withdrawal by Subject|7|||
105683322|NCT03110185|364503195|FG000|Overall Study|Time Constraints|0|||
105683323|NCT03110185|364503196|FG001|Overall Study|Time Constraints|6|||
105683324|NCT03110185|364503195|FG000|Overall Study|Conflict with care|5|||
105683325|NCT03110185|364503196|FG001|Overall Study|Conflict with care|12|||
105683326|NCT03110185|364503195|FG000|Overall Study|Protocol Violation|1|||
105683327|NCT03110185|364503196|FG001|Overall Study|Protocol Violation|4|||
105683328|NCT03110185|364503195|FG000|Overall Study|MRI Incompatible|2|||
105683329|NCT03110185|364503196|FG001|Overall Study|MRI Incompatible|0|||
105683330|NCT03110185|364503195|FG000|Overall Study|Patient Refusal|0|||
105683331|NCT03110185|364503196|FG001|Overall Study|Patient Refusal|1|||
105683332|NCT00178126|364503197|FG000|Overall Study|Lost to Follow-up|21|||
105683333|NCT00178126|364503198|FG001|Overall Study|Lost to Follow-up|21|||
105683334|NCT00178126|364503197|FG000|Overall Study|did not receive intervention|4|||
105683335|NCT00178126|364503198|FG001|Overall Study|did not receive intervention|6|||
105683336|NCT02796560|364503201|FG000|Overall Study|Adverse Event|2|||
105683337|NCT02796560|364503202|FG001|Overall Study|Adverse Event|0|||
105683338|NCT02796560|364503201|FG000|Overall Study|Withdrawal by Subject|2|||
105683339|NCT02796560|364503202|FG001|Overall Study|Withdrawal by Subject|2|||
105683340|NCT03756129|364503204|FG000|Overall Study|Adverse Event|1|||
105683341|NCT03756129|364503205|FG001|Overall Study|Adverse Event|1|||
105683342|NCT03756129|364503206|FG002|Overall Study|Adverse Event|0|||
105683343|NCT03756129|364503207|FG003|Overall Study|Adverse Event|2|||
105683344|NCT03756129|364503208|FG004|Overall Study|Adverse Event|0|||
105683345|NCT03756129|364503209|FG005|Overall Study|Adverse Event|0|||
105683346|NCT03756129|364503204|FG000|Overall Study|Withdrawal by Subject|2|||
105683347|NCT03756129|364503205|FG001|Overall Study|Withdrawal by Subject|1|||
105683348|NCT03756129|364503206|FG002|Overall Study|Withdrawal by Subject|3|||
105683349|NCT03756129|364503207|FG003|Overall Study|Withdrawal by Subject|1|||
105683350|NCT03756129|364503208|FG004|Overall Study|Withdrawal by Subject|1|||
105683351|NCT03756129|364503209|FG005|Overall Study|Withdrawal by Subject|3|||
105683352|NCT03756129|364503204|FG000|Overall Study|Lost to Follow-up|0|||
105683353|NCT03756129|364503205|FG001|Overall Study|Lost to Follow-up|0|||
105683354|NCT03756129|364503206|FG002|Overall Study|Lost to Follow-up|0|||
105683355|NCT03756129|364503207|FG003|Overall Study|Lost to Follow-up|0|||
105683356|NCT03756129|364503208|FG004|Overall Study|Lost to Follow-up|0|||
105683357|NCT03756129|364503209|FG005|Overall Study|Lost to Follow-up|1|||
105683358|NCT03756129|364503204|FG000|Overall Study|Physician Decision|0|||
105683359|NCT03756129|364503205|FG001|Overall Study|Physician Decision|0|||
105683360|NCT03756129|364503206|FG002|Overall Study|Physician Decision|0|||
105683361|NCT03756129|364503207|FG003|Overall Study|Physician Decision|0|||
105683362|NCT03756129|364503208|FG004|Overall Study|Physician Decision|0|||
105683363|NCT03756129|364503209|FG005|Overall Study|Physician Decision|1|||
105683364|NCT03567434|364503210|FG000|Overall Study|Lost to Follow-up|1|||
105683365|NCT03567434|364503211|FG001|Overall Study|Lost to Follow-up|3|||
105683366|NCT00081497|364503215|FG000|Overall Study|Adverse Event|2|||
105683367|NCT00081497|364503216|FG001|Overall Study|Adverse Event|0|||
105683368|NCT00081497|364503215|FG000|Overall Study|Death|0|||
105683369|NCT00081497|364503216|FG001|Overall Study|Death|1|||
105683370|NCT00081497|364503215|FG000|Overall Study|Withdrawal by Subject|1|||
105683371|NCT00081497|364503216|FG001|Overall Study|Withdrawal by Subject|0|||
105683372|NCT00081497|364503215|FG000|Overall Study|Non-compliance|0|||
105683373|NCT00081497|364503216|FG001|Overall Study|Non-compliance|1|||
105683374|NCT00345293|364503217|FG000|Overall Study|Unable to access line for sample|1|||
105683375|NCT00345293|364503218|FG001|Overall Study|Unable to access line for sample|0|||
105683376|NCT00345293|364503217|FG000|Overall Study|Withdrawal by Subject|1|||
105683377|NCT00345293|364503218|FG001|Overall Study|Withdrawal by Subject|0|||
105683378|NCT01036763|364504886|FG000|Overall Study|Adverse Event|25|||
105683379|NCT01036763|364504886|FG000|Overall Study|Lost to Follow-up|28|||
105683380|NCT01036763|364504886|FG000|Overall Study|Other reason (not specified)|40|||
105683381|NCT00743275|364504887|FG000|Overall Study|Protocol Violation|0|||
105683382|NCT00743275|364504888|FG001|Overall Study|Protocol Violation|1|||
105683383|NCT01076192|364504896|FG000|Overall Study|Other|197|||
105683384|NCT00596427|364504897|FG000|Overall Study|Withdrawal by Subject|2|||
105683385|NCT00596427|364504898|FG001|Overall Study|Withdrawal by Subject|2|||
105683386|NCT00596427|364504897|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
105683387|NCT00596427|364504898|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
105683388|NCT00596427|364504897|FG000|Overall Study|Protocol Violation|1|||
105683389|NCT00596427|364504898|FG001|Overall Study|Protocol Violation|0|||
105683390|NCT02401867|364504899|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
105683391|NCT02401867|364504899|FG000|Analysis|Cervical assay could not be conducted|9|||
105683392|NCT02502097|364504900|FG000|Period 1|Adverse Event|0|||
105683393|NCT02502097|364504901|FG001|Period 1|Adverse Event|0|||
105683394|NCT02502097|364504902|FG002|Period 1|Adverse Event|1|||
105683395|NCT02502097|364504903|FG003|Period 1|Adverse Event|0|||
105683396|NCT02502097|364504900|FG000|Wash Out Period|Adverse Event|0|||
105683397|NCT02502097|364504901|FG001|Wash Out Period|Adverse Event|1|||
105683398|NCT02502097|364504902|FG002|Wash Out Period|Adverse Event|1|||
105683399|NCT02502097|364504903|FG003|Wash Out Period|Adverse Event|1|||
105683400|NCT02502097|364504900|FG000|Period 2|Adverse Event|0|||
105683401|NCT02502097|364504901|FG001|Period 2|Adverse Event|0|||
105683402|NCT02502097|364504902|FG002|Period 2|Adverse Event|1|||
105683403|NCT02502097|364504903|FG003|Period 2|Adverse Event|0|||
105683404|NCT02186223|364504904|FG000|Overall Study|Not eligible for device placement|6|||
105683405|NCT02186223|364504904|FG000|Overall Study|Unable to obtain femoral access|3|||
105683406|NCT02186223|364504904|FG000|Overall Study|Death|3|||
105683407|NCT02186223|364504904|FG000|Overall Study|Device in place less than 48 hours|9|||
105683408|NCT01491672|364504906|FG000|Overall Study|Lost to Follow-up|0|||
105683409|NCT01491672|364504907|FG001|Overall Study|Lost to Follow-up|4|||
105683410|NCT01491672|364504908|FG002|Overall Study|Lost to Follow-up|1|||
105683411|NCT01491672|364504906|FG000|Overall Study|Withdrawal by Subject|6|||
105683412|NCT01491672|364504907|FG001|Overall Study|Withdrawal by Subject|7|||
105683413|NCT01491672|364504908|FG002|Overall Study|Withdrawal by Subject|0|||
105683414|NCT01491672|364504906|FG000|Overall Study|Adverse Event|8|||
105683415|NCT01491672|364504907|FG001|Overall Study|Adverse Event|10|||
105683416|NCT01491672|364504908|FG002|Overall Study|Adverse Event|4|||
105683417|NCT01491672|364504906|FG000|Overall Study|Disease progression|42|||
105683418|NCT01491672|364504907|FG001|Overall Study|Disease progression|34|||
105683419|NCT01491672|364504908|FG002|Overall Study|Disease progression|6|||
105683420|NCT01491672|364504906|FG000|Overall Study|Protocol deviation|0|||
105683421|NCT01491672|364504907|FG001|Overall Study|Protocol deviation|1|||
105683422|NCT01491672|364504908|FG002|Overall Study|Protocol deviation|0|||
105683423|NCT01491672|364504906|FG000|Overall Study|Death|0|||
105683424|NCT01491672|364504907|FG001|Overall Study|Death|4|||
105683425|NCT01491672|364504908|FG002|Overall Study|Death|0|||
105683426|NCT00107120|364504909|FG000|Overall Study|Adverse Event|4|||
105683427|NCT00107120|364504910|FG001|Overall Study|Adverse Event|1|||
105683428|NCT00107120|364504909|FG000|Overall Study|Lack of Efficacy|5|||
105683429|NCT00107120|364504910|FG001|Overall Study|Lack of Efficacy|5|||
105683430|NCT00107120|364504909|FG000|Overall Study|Protocol Violation|3|||
105683431|NCT00107120|364504910|FG001|Overall Study|Protocol Violation|0|||
105683432|NCT00107120|364504909|FG000|Overall Study|Withdrawal by Subject|8|||
105683433|NCT00107120|364504910|FG001|Overall Study|Withdrawal by Subject|9|||
105683434|NCT00107120|364504909|FG000|Overall Study|Lost to Follow-up|8|||
105683435|NCT00107120|364504910|FG001|Overall Study|Lost to Follow-up|6|||
105683436|NCT00107120|364504909|FG000|Overall Study|Pregnancy|0|||
105683437|NCT00107120|364504910|FG001|Overall Study|Pregnancy|1|||
105683438|NCT00107120|364504909|FG000|Overall Study|moving away from site|1|||
105683439|NCT00107120|364504910|FG001|Overall Study|moving away from site|1|||
105683440|NCT00107120|364504909|FG000|Overall Study|death of parent|0|||
105683441|NCT00107120|364504910|FG001|Overall Study|death of parent|1|||
105683442|NCT00896051|364504911|FG000|Overall Study|Adverse Event|2|||
105683443|NCT00896051|364504912|FG001|Overall Study|Adverse Event|1|||
105683444|NCT00896051|364504911|FG000|Overall Study|Lost to Follow-up|3|||
105683445|NCT00896051|364504912|FG001|Overall Study|Lost to Follow-up|2|||
105683446|NCT00896051|364504911|FG000|Overall Study|Withdrawal by Subject|3|||
105683447|NCT00896051|364504912|FG001|Overall Study|Withdrawal by Subject|2|||
105683448|NCT00896051|364504911|FG000|Overall Study|Subject noncompliant|1|||
105683449|NCT00896051|364504912|FG001|Overall Study|Subject noncompliant|3|||
105683450|NCT00896051|364504911|FG000|Overall Study|Other|1|||
105683451|NCT00896051|364504912|FG001|Overall Study|Other|1|||
105683452|NCT02935452|364504913|FG000|Overall Study|work and life commintment|3|||
105683453|NCT02935452|364504914|FG001|Overall Study|work and life commintment|1|||
105683454|NCT00876928|364504915|FG000|Overall Study|Lost to Follow-up|2|||
105683455|NCT00876928|364504916|FG001|Overall Study|Lost to Follow-up|5|||
105683456|NCT00876928|364504915|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
105683457|NCT00876928|364504916|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
105683458|NCT00701779|364504919|FG000|Overall Study|Adverse Event|6|||
105683459|NCT00701779|364504919|FG000|Overall Study|Lost to Follow-up|1|||
105683460|NCT00701779|364504919|FG000|Overall Study|Withdrawal by Subject|2|||
105683461|NCT02079610|364504920|FG000|Overall Study|Withdrawal by Subject|1|||
105683462|NCT02079610|364504921|FG001|Overall Study|Withdrawal by Subject|1|||
105683463|NCT01111474|364504922|FG000|Overall Study|Lost to Follow-up|12|||
105683464|NCT01016977|364504923|FG000|Overall Study|Lost to Follow-up|1|||
105683465|NCT01016977|364504924|FG001|Overall Study|Lost to Follow-up|0|||
105683466|NCT01016977|364504923|FG000|Overall Study|Withdrawal by Subject|2|||
105683467|NCT01016977|364504924|FG001|Overall Study|Withdrawal by Subject|2|||
105683468|NCT02808143|364504928|FG000|Maintenance Phase|Disease recurrence|1|||
105683469|NCT02808143|364504929|FG001|Maintenance Phase|Disease recurrence|3|||
105683470|NCT02808143|364504928|FG000|Maintenance Phase|Disease progression|1|||
105683471|NCT02808143|364504929|FG001|Maintenance Phase|Disease progression|2|||
105683472|NCT02808143|364504928|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
105683473|NCT02808143|364504929|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
105683474|NCT02808143|364504928|FG000|Survival Follow-Up|Disease recurrence|0|||
105683475|NCT02808143|364504929|FG001|Survival Follow-Up|Disease recurrence|2|||
105683476|NCT02808143|364504928|FG000|Survival Follow-Up|Adverse Event|0|||
105683477|NCT02808143|364504929|FG001|Survival Follow-Up|Adverse Event|1|||
105683478|NCT02808143|364504928|FG000|Survival Follow-Up|Death|1|||
105683479|NCT02808143|364504929|FG001|Survival Follow-Up|Death|0|||
106001178|NCT01623115|365665212|FG000|Overall Study|Poor compliance to protocol|4|||
106001179|NCT01623115|365665213|FG001|Overall Study|Poor compliance to protocol|10|||
106001180|NCT01623115|365665212|FG000|Overall Study|Consent withdrawn by participant|2|||
106001181|NCT01623115|365665213|FG001|Overall Study|Consent withdrawn by participant|6|||
106001182|NCT01623115|365665212|FG000|Overall Study|Related to study drug administration|0|||
106001183|NCT01623115|365665213|FG001|Overall Study|Related to study drug administration|2|||
106001184|NCT01623115|365665212|FG000|Overall Study|Last visit outside protocol visit window|14|||
106001185|NCT01623115|365665213|FG001|Overall Study|Last visit outside protocol visit window|26|||
106001186|NCT01623115|365665212|FG000|Overall Study|Site closure|1|||
106001187|NCT01623115|365665213|FG001|Overall Study|Site closure|7|||
106001188|NCT01623115|365665212|FG000|Overall Study|Death|0|||
106001189|NCT01623115|365665213|FG001|Overall Study|Death|4|||
106001190|NCT01623115|365665212|FG000|Overall Study|Other than specified above|0|||
106001191|NCT01623115|365665213|FG001|Overall Study|Other than specified above|3|||
106001192|NCT00687401|365665216|FG000|Overall Study|Protocol Violation|7|||
106001193|NCT00687401|365665216|FG000|Overall Study|Adverse Event|6|||
106001194|NCT00687401|365665216|FG000|Overall Study|Lack of Efficacy|6|||
106001195|NCT00687401|365665216|FG000|Overall Study|Withdrawal by Subject|4|||
106001196|NCT00687401|365665216|FG000|Overall Study|Did not return for visit|3|||
106001197|NCT00687401|365665216|FG000|Overall Study|For reasons different from those above|4|||
106001198|NCT01363700|365665217|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
106001199|NCT01363700|365665218|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
106001200|NCT01363700|365665219|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
106001201|NCT01363700|365665220|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
106001202|NCT01363700|365665221|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
106001203|NCT03827655|365665228|FG000|Overall Study|Death|0|||
106001204|NCT03827655|365665229|FG001|Overall Study|Death|0|||
106001205|NCT03827655|365665230|FG002|Overall Study|Death|0|||
106001206|NCT03827655|365665231|FG003|Overall Study|Death|0|||
106001207|NCT03827655|365665232|FG004|Overall Study|Death|1|||
106001208|NCT03827655|365665228|FG000|Overall Study|Protocol Deviation|1|||
106001209|NCT03827655|365665229|FG001|Overall Study|Protocol Deviation|0|||
106001210|NCT03827655|365665230|FG002|Overall Study|Protocol Deviation|1|||
106001211|NCT03827655|365665231|FG003|Overall Study|Protocol Deviation|1|||
106001212|NCT03827655|365665232|FG004|Overall Study|Protocol Deviation|0|||
106001213|NCT03827655|365665228|FG000|Overall Study|Withdrawal by Subject|3|||
106001214|NCT03827655|365665229|FG001|Overall Study|Withdrawal by Subject|2|||
106001215|NCT03827655|365665230|FG002|Overall Study|Withdrawal by Subject|2|||
106001216|NCT03827655|365665231|FG003|Overall Study|Withdrawal by Subject|0|||
105683480|NCT00824161|364504934|FG000|Overall Study|Withdrawal by Subject|1|||
105683481|NCT00824161|364504934|FG000|Overall Study|Screen Failure|1|||
105683482|NCT02518490|364504935|FG000|Overall Study|Withdrawal by Subject|1|||
105683483|NCT02518490|364504936|FG001|Overall Study|Withdrawal by Subject|1|||
105683484|NCT03587974|364504937|FG000|Overall Study|caregiver demented, care recipient died|3|||
105683485|NCT03587974|364504938|FG001|Overall Study|caregiver demented, care recipient died|3|||
105683486|NCT03587974|364504937|FG000|Overall Study|Withdrawal by Subject|2|||
105683487|NCT03587974|364504938|FG001|Overall Study|Withdrawal by Subject|1|||
105683488|NCT01174160|364504939|FG000|Overall Study|Adverse Event|1|||
105683489|NCT01174160|364504940|FG001|Overall Study|Adverse Event|0|||
105683490|NCT01174160|364504939|FG000|Overall Study|Lost to Follow-up|1|||
105683491|NCT01174160|364504940|FG001|Overall Study|Lost to Follow-up|0|||
105683492|NCT01174160|364504939|FG000|Overall Study|Physician Decision|1|||
105683493|NCT01174160|364504940|FG001|Overall Study|Physician Decision|0|||
105683494|NCT01174160|364504939|FG000|Overall Study|Protocol Violation|4|||
105683495|NCT01174160|364504940|FG001|Overall Study|Protocol Violation|6|||
105683496|NCT01174160|364504939|FG000|Overall Study|Withdrawal by Subject|1|||
105683497|NCT01174160|364504940|FG001|Overall Study|Withdrawal by Subject|0|||
105683498|NCT01590017|364504941|FG000|Overall Study|Adverse Event|1|||
105683499|NCT01590017|364504941|FG000|Overall Study|Withdrawal by Subject|1|||
105683500|NCT01590017|364504941|FG000|Overall Study|Lack of Efficacy|1|||
105683501|NCT01590017|364504941|FG000|Overall Study|Physician Decision|1|||
105683502|NCT02647866|364504942|FG000|Overall Study|Adverse Event|0|||
105683503|NCT02647866|364504943|FG001|Overall Study|Adverse Event|0|||
105683504|NCT02647866|364504944|FG002|Overall Study|Adverse Event|2|||
105683505|NCT02647866|364504945|FG003|Overall Study|Adverse Event|2|||
105683506|NCT02647866|364504946|FG004|Overall Study|Adverse Event|1|||
105683507|NCT02647866|364504942|FG000|Overall Study|Disease Worsening|3|||
105683508|NCT02647866|364504943|FG001|Overall Study|Disease Worsening|1|||
105683509|NCT02647866|364504944|FG002|Overall Study|Disease Worsening|0|||
105683510|NCT02647866|364504945|FG003|Overall Study|Disease Worsening|0|||
105683511|NCT02647866|364504946|FG004|Overall Study|Disease Worsening|1|||
105683512|NCT02647866|364504942|FG000|Overall Study|Withdrawal by Subject|1|||
105683513|NCT02647866|364504943|FG001|Overall Study|Withdrawal by Subject|1|||
105683514|NCT02647866|364504944|FG002|Overall Study|Withdrawal by Subject|2|||
105683515|NCT02647866|364504945|FG003|Overall Study|Withdrawal by Subject|4|||
105683516|NCT02647866|364504946|FG004|Overall Study|Withdrawal by Subject|4|||
105917092|NCT01198002|365356747|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
105917093|NCT01198002|365356748|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
105917094|NCT01198002|365356749|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
105917095|NCT01198002|365356747|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
105917096|NCT01198002|365356748|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
105917097|NCT01198002|365356749|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
105917098|NCT01198002|365356747|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
105917099|NCT01198002|365356748|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
105917100|NCT01198002|365356749|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
105917101|NCT02810418|365356750|FG000|Arm A Dose Escalation|Adverse Event|2|||
105917102|NCT02810418|365356751|FG001|Arm A Dose Escalation|Adverse Event|1|||
105917103|NCT02810418|365356752|FG002|Arm A Dose Escalation|Adverse Event|0|||
105917104|NCT02810418|365356753|FG003|Arm A Dose Escalation|Adverse Event|0|||
105917105|NCT02810418|365356754|FG004|Arm A Dose Escalation|Adverse Event|0|||
105917106|NCT02810418|365356755|FG005|Arm A Dose Escalation|Adverse Event|0|||
105917107|NCT02810418|365356756|FG006|Arm A Dose Escalation|Adverse Event|0|||
105917108|NCT02810418|365356750|FG000|Dose Expansion|Adverse Event|0|||
105917109|NCT02810418|365356751|FG001|Dose Expansion|Adverse Event|1|||
105917110|NCT02810418|365356752|FG002|Dose Expansion|Adverse Event|1|||
105917111|NCT02810418|365356753|FG003|Dose Expansion|Adverse Event|0|||
105917112|NCT02810418|365356754|FG004|Dose Expansion|Adverse Event|0|||
105917113|NCT02810418|365356755|FG005|Dose Expansion|Adverse Event|0|||
105917114|NCT02810418|365356756|FG006|Dose Expansion|Adverse Event|0|||
105917115|NCT02810418|365356750|FG000|Dose Expansion|Physician Decision|0|||
105917116|NCT02810418|365356751|FG001|Dose Expansion|Physician Decision|0|||
105917117|NCT02810418|365356752|FG002|Dose Expansion|Physician Decision|2|||
105917118|NCT02810418|365356753|FG003|Dose Expansion|Physician Decision|0|||
105917119|NCT02810418|365356754|FG004|Dose Expansion|Physician Decision|0|||
105917120|NCT02810418|365356755|FG005|Dose Expansion|Physician Decision|0|||
105917121|NCT02810418|365356756|FG006|Dose Expansion|Physician Decision|0|||
105917122|NCT02810418|365356750|FG000|Arm B Dose Escalation|Adverse Event|0|||
105683517|NCT02647866|364504942|FG000|Overall Study|Physician Decision|0|||
105683518|NCT02647866|364504943|FG001|Overall Study|Physician Decision|1|||
105683519|NCT02647866|364504944|FG002|Overall Study|Physician Decision|1|||
105683520|NCT02647866|364504945|FG003|Overall Study|Physician Decision|0|||
105683521|NCT02647866|364504946|FG004|Overall Study|Physician Decision|2|||
105683522|NCT02647866|364504942|FG000|Overall Study|Death|0|||
105683523|NCT02647866|364504943|FG001|Overall Study|Death|1|||
105683524|NCT02647866|364504944|FG002|Overall Study|Death|0|||
105683525|NCT02647866|364504945|FG003|Overall Study|Death|0|||
105683526|NCT02647866|364504946|FG004|Overall Study|Death|0|||
105683527|NCT02647866|364504942|FG000|Overall Study|Subject moved to different country|1|||
105683528|NCT02647866|364504943|FG001|Overall Study|Subject moved to different country|0|||
105683529|NCT02647866|364504944|FG002|Overall Study|Subject moved to different country|0|||
105683530|NCT02647866|364504945|FG003|Overall Study|Subject moved to different country|0|||
105683531|NCT02647866|364504946|FG004|Overall Study|Subject moved to different country|0|||
105683532|NCT00701220|364504947|FG000|Overall Study|Withdrawal by Subject|0|||
105683533|NCT00701220|364504948|FG001|Overall Study|Withdrawal by Subject|2|||
105683534|NCT00701220|364504947|FG000|Overall Study|Protocol Violation|2|||
105683535|NCT00701220|364504948|FG001|Overall Study|Protocol Violation|0|||
105683536|NCT00319839|364504949|FG000|Overall Study|Adverse Event|5|||
105683537|NCT00319839|364504949|FG000|Overall Study|Withdrawal by Subject|1|||
105683538|NCT01853137|364504952|FG000|Overall Study|Lost to Follow-up|4|||
105683539|NCT01853137|364504953|FG001|Overall Study|Lost to Follow-up|1|||
105683540|NCT02483585|364504954|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
105683541|NCT02483585|364504955|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
105683542|NCT02483585|364504954|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
105683543|NCT02483585|364504955|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
105683544|NCT02483585|364504954|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
105683545|NCT02483585|364504955|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
105683546|NCT02483585|364504954|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
105683547|NCT02483585|364504955|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
105683548|NCT02483585|364504954|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
105683549|NCT02483585|364504955|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
105683550|NCT02483585|364504954|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
105683551|NCT02483585|364504955|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
105683552|NCT02483585|364504954|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
105683553|NCT02483585|364504955|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
105683554|NCT00842985|364504957|FG000|Screening|Did not meet entrance requirements|27|||
105683555|NCT00842985|364504957|FG000|First Intervention|Withdrawal by Subject|3|||
105683556|NCT00842985|364504957|FG000|First Intervention|Protocol Violation|3|||
105683557|NCT00842985|364504957|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
105683558|NCT00842985|364504957|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
105683559|NCT01037244|364504958|FG000|Overall Study|Adverse Event|3|||
105683560|NCT01037244|364504959|FG001|Overall Study|Adverse Event|2|||
105683561|NCT01037244|364504960|FG002|Overall Study|Adverse Event|6|||
105683562|NCT01037244|364504961|FG003|Overall Study|Adverse Event|3|||
105683563|NCT01037244|364504958|FG000|Overall Study|Lack of Efficacy|1|||
105683564|NCT01037244|364504959|FG001|Overall Study|Lack of Efficacy|1|||
105683565|NCT01037244|364504960|FG002|Overall Study|Lack of Efficacy|0|||
105683566|NCT01037244|364504961|FG003|Overall Study|Lack of Efficacy|1|||
105683567|NCT01037244|364504958|FG000|Overall Study|Lost to Follow-up|3|||
105683568|NCT01037244|364504959|FG001|Overall Study|Lost to Follow-up|3|||
105683569|NCT01037244|364504960|FG002|Overall Study|Lost to Follow-up|4|||
105683570|NCT01037244|364504961|FG003|Overall Study|Lost to Follow-up|4|||
105683571|NCT01037244|364504958|FG000|Overall Study|Withdrawal by Subject|1|||
105683572|NCT01037244|364504959|FG001|Overall Study|Withdrawal by Subject|5|||
105683573|NCT01037244|364504960|FG002|Overall Study|Withdrawal by Subject|3|||
105683574|NCT01037244|364504961|FG003|Overall Study|Withdrawal by Subject|5|||
105683575|NCT01037244|364504958|FG000|Overall Study|Partner Withdrew Consent|2|||
105683576|NCT01037244|364504959|FG001|Overall Study|Partner Withdrew Consent|1|||
105683577|NCT01037244|364504960|FG002|Overall Study|Partner Withdrew Consent|0|||
105683578|NCT01037244|364504961|FG003|Overall Study|Partner Withdrew Consent|0|||
105683579|NCT01037244|364504958|FG000|Overall Study|Various|3|||
105683580|NCT01037244|364504959|FG001|Overall Study|Various|2|||
105683581|NCT01037244|364504960|FG002|Overall Study|Various|1|||
105683582|NCT01037244|364504961|FG003|Overall Study|Various|1|||
105683583|NCT01990560|364504965|FG000|Overall Study|Withdrawal by Subject|1|||
105683584|NCT01778023|364504966|FG000|Overall Study|Withdrawal by Subject|0|||
105683585|NCT01778023|364504967|FG001|Overall Study|Withdrawal by Subject|3|||
105683586|NCT01324440|364504968|FG000|Overall Study|Subject moved|0|||
105683587|NCT01324440|364504969|FG001|Overall Study|Subject moved|1|||
105683588|NCT00903630|364504975|FG000|Phase 2|Adverse Event|0|||
105683589|NCT00903630|364504976|FG001|Phase 2|Adverse Event|0|||
105917123|NCT02810418|365356751|FG001|Arm B Dose Escalation|Adverse Event|0|||
105917124|NCT02810418|365356752|FG002|Arm B Dose Escalation|Adverse Event|0|||
105683590|NCT00903630|364504977|FG002|Phase 2|Adverse Event|1|||
105683591|NCT00138671|364504979|FG000|Overall Study|Death|0|||
105683592|NCT00138671|364504980|FG001|Overall Study|Death|3|||
105683593|NCT00138671|364504979|FG000|Overall Study|Adverse Event|6|||
105683594|NCT00138671|364504980|FG001|Overall Study|Adverse Event|3|||
105683595|NCT00138671|364504979|FG000|Overall Study|Lost to Follow-up|1|||
105683596|NCT00138671|364504980|FG001|Overall Study|Lost to Follow-up|2|||
105683597|NCT00138671|364504979|FG000|Overall Study|Withdrawal by Subject|3|||
105683598|NCT00138671|364504980|FG001|Overall Study|Withdrawal by Subject|5|||
105683599|NCT00138671|364504979|FG000|Overall Study|Other|3|||
105683600|NCT00138671|364504980|FG001|Overall Study|Other|3|||
105683601|NCT03305731|364504981|FG000|Overall Study|Protocol Violation|1|||
105683602|NCT01959516|364504982|FG000|Epoch 1|Adverse Event|4|||
105683603|NCT01959516|364504983|FG001|Epoch 1|Adverse Event|1|||
105683604|NCT01959516|364504982|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
105683605|NCT01959516|364504983|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
105683606|NCT01959516|364504982|FG000|Epoch 1|Subject withdrew consent|3|||
105683607|NCT01959516|364504983|FG001|Epoch 1|Subject withdrew consent|2|||
105683608|NCT01959516|364504982|FG000|Epoch 1|Administrative problems|1|||
105683609|NCT01959516|364504983|FG001|Epoch 1|Administrative problems|0|||
105683610|NCT01959516|364504982|FG000|Epoch 1|Use of prohibited treatment|1|||
105683611|NCT01959516|364504983|FG001|Epoch 1|Use of prohibited treatment|0|||
105683612|NCT01959516|364504982|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
105683613|NCT01959516|364504983|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
105683614|NCT01959516|364504982|FG000|Epoch 1|Protocol deviation|0|||
105683615|NCT01959516|364504983|FG001|Epoch 1|Protocol deviation|1|||
105683616|NCT01959516|364504982|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
105683617|NCT01959516|364504983|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
105683618|NCT01959516|364504982|FG000|Epoch 2|Subject withdrew consent|1|||
105683619|NCT01959516|364504983|FG001|Epoch 2|Subject withdrew consent|0|||
105683620|NCT01959516|364504982|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
105683621|NCT01959516|364504983|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
105683622|NCT05116046|364504988|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105683623|NCT05116046|364504989|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105683624|NCT05116046|364504990|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105683625|NCT05116046|364504988|FG000|Overall Study|Study terminated by sponsor|14|||
105683626|NCT05116046|364504989|FG001|Overall Study|Study terminated by sponsor|16|||
105683627|NCT05116046|364504990|FG002|Overall Study|Study terminated by sponsor|1|||
105683628|NCT04223830|364504992|FG000|Overall Study|Lost to Follow-up|9|||
105683629|NCT04223830|364504992|FG000|Overall Study|Adverse Event|1|||
105683630|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
105683631|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
105683632|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
105683633|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
105683634|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
105683635|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
105683636|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
105683637|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
105683638|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
105683639|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
105683640|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
105683641|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
105683642|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
105683643|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
105683644|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
105683645|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
105683646|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
105683647|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
105683648|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
105683649|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
105683650|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
105683651|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
105683652|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
105683653|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
105683654|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
105683655|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
105683656|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
105683657|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
105683658|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
105683659|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
105683660|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Other|10|||
105917125|NCT02810418|365356753|FG003|Arm B Dose Escalation|Adverse Event|0|||
105917126|NCT02810418|365356754|FG004|Arm B Dose Escalation|Adverse Event|1|||
105917127|NCT02810418|365356755|FG005|Arm B Dose Escalation|Adverse Event|2|||
105917128|NCT02810418|365356756|FG006|Arm B Dose Escalation|Adverse Event|0|||
105917129|NCT00789321|365356762|FG000|Overall Study|Adverse Event|0|||
105917130|NCT00789321|365356763|FG001|Overall Study|Adverse Event|1|||
105683661|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Other|7|||
105683662|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Other|8|||
105683663|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Other|8|||
105683664|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Other|0|||
105683665|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
105683666|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
105683667|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
105683668|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
105683669|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
105683670|NCT00615836|364504994|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
105683671|NCT00615836|364504995|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
105683672|NCT00615836|364504996|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
105683673|NCT00615836|364504997|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
105683674|NCT00615836|364504998|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
105683675|NCT01759368|364504999|FG000|Overall Study|Lost to Follow-up|1|||
105683676|NCT01759368|364505000|FG001|Overall Study|Lost to Follow-up|0|||
105683677|NCT01959334|364505007|FG000|Second Dose|Adverse Event|1|||
105683678|NCT01959334|364505008|FG001|Second Dose|Adverse Event|0|||
105683679|NCT01959334|364505007|FG000|Third Dose|Adverse Event|0|||
105683680|NCT01959334|364505008|FG001|Third Dose|Adverse Event|1|||
105683681|NCT01745848|364505011|FG000|Overall Study|Adverse Event|6|||
105683682|NCT00679627|364505012|FG000|Overall Study|Death|41|||
105683683|NCT00679627|364505013|FG001|Overall Study|Death|29|||
105683684|NCT00679627|364505012|FG000|Overall Study|Adverse Event|43|||
105683685|NCT00679627|364505013|FG001|Overall Study|Adverse Event|53|||
105683686|NCT00679627|364505012|FG000|Overall Study|Withdrawal by Subject|168|||
105683687|NCT00679627|364505013|FG001|Overall Study|Withdrawal by Subject|172|||
105683688|NCT00679627|364505012|FG000|Overall Study|Lost to Follow-up|22|||
105683689|NCT00679627|364505013|FG001|Overall Study|Lost to Follow-up|26|||
105683690|NCT00679627|364505012|FG000|Overall Study|Early Study Closure|425|||
105683691|NCT00679627|364505013|FG001|Overall Study|Early Study Closure|405|||
105683692|NCT00448123|364505014|FG000|Overall Study|Lost to Follow-up|9|||
105683693|NCT00448123|364505015|FG001|Overall Study|Lost to Follow-up|6|||
105683694|NCT00448123|364505014|FG000|Overall Study|Physician Decision|6|||
105683695|NCT00448123|364505015|FG001|Overall Study|Physician Decision|6|||
105683696|NCT01588496|364505017|FG000|Overall Study|Withdrawal by Subject|0|||
105683697|NCT01588496|364505018|FG001|Overall Study|Withdrawal by Subject|1|||
105683698|NCT01588496|364505019|FG002|Overall Study|Withdrawal by Subject|0|||
105683699|NCT03581825|364505022|FG000|Period 1|Lens Discomfort|1|||
105683700|NCT03581825|364505023|FG001|Period 1|Lens Discomfort|0|||
105683701|NCT03581825|364505022|FG000|Period 2|Unsatisfactory Vision to Test|0|||
105683702|NCT03581825|364505023|FG001|Period 2|Unsatisfactory Vision to Test|1|||
105683703|NCT00511901|364505024|FG000|Overall Study|Withdrawal by Subject|1|||
105683704|NCT00511901|364505025|FG001|Overall Study|Withdrawal by Subject|3|||
105683705|NCT02447172|364505026|FG000|Overall Study|Adverse Event|11|||
105917131|NCT01965327|365356766|FG000|Overall Study|Physician Decision|2|||
105917132|NCT03342001|365356767|FG000|Overall Study|Adverse Event|1|||
105917133|NCT03342001|365356767|FG000|Overall Study|Lost to Follow-up|1|||
105917134|NCT01100853|365356772|FG000|Overall Study|Lost to Follow-up|11|||
105917135|NCT01100853|365356773|FG001|Overall Study|Lost to Follow-up|6|||
105917136|NCT01100853|365356772|FG000|Overall Study|Received <4 study injections|10|||
105917137|NCT01100853|365356773|FG001|Overall Study|Received <4 study injections|13|||
105917138|NCT01100853|365356772|FG000|Overall Study|Withdrawal by Subject|6|||
105917139|NCT01100853|365356773|FG001|Overall Study|Withdrawal by Subject|4|||
105917140|NCT04161391|365356776|FG000|Overall Study|Adverse Event|0|||
105917141|NCT04161391|365356777|FG001|Overall Study|Adverse Event|1|||
105917142|NCT04161391|365356778|FG002|Overall Study|Adverse Event|0|||
105917143|NCT04161391|365356779|FG003|Overall Study|Adverse Event|1|||
105917144|NCT04161391|365356780|FG004|Overall Study|Adverse Event|0|||
105917145|NCT04161391|365356781|FG005|Overall Study|Adverse Event|0|||
105917146|NCT04161391|365356782|FG006|Overall Study|Adverse Event|0|||
105917147|NCT04161391|365356783|FG007|Overall Study|Adverse Event|3|||
105917148|NCT04161391|365356784|FG008|Overall Study|Adverse Event|0|||
105917149|NCT04161391|365356776|FG000|Overall Study|Death|0|||
105917150|NCT04161391|365356777|FG001|Overall Study|Death|0|||
105917151|NCT04161391|365356778|FG002|Overall Study|Death|0|||
105917152|NCT04161391|365356779|FG003|Overall Study|Death|0|||
106128034|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
105683706|NCT02447172|364505027|FG001|Overall Study|Adverse Event|8|||
105683707|NCT02447172|364505028|FG002|Overall Study|Adverse Event|7|||
105683708|NCT02447172|364505026|FG000|Overall Study|Death|3|||
105683709|NCT02447172|364505027|FG001|Overall Study|Death|1|||
105683710|NCT02447172|364505028|FG002|Overall Study|Death|0|||
105683711|NCT02447172|364505026|FG000|Overall Study|Protocol Violation|2|||
105683712|NCT02447172|364505027|FG001|Overall Study|Protocol Violation|1|||
105683713|NCT02447172|364505028|FG002|Overall Study|Protocol Violation|2|||
105917153|NCT04161391|365356780|FG004|Overall Study|Death|0|||
105917154|NCT04161391|365356781|FG005|Overall Study|Death|0|||
105917155|NCT04161391|365356782|FG006|Overall Study|Death|0|||
105683714|NCT02447172|364505026|FG000|Overall Study|Lost to Follow-up|7|||
105683715|NCT02447172|364505027|FG001|Overall Study|Lost to Follow-up|4|||
105917156|NCT04161391|365356783|FG007|Overall Study|Death|1|||
105917157|NCT04161391|365356784|FG008|Overall Study|Death|0|||
106128035|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128036|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128037|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128038|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128039|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128040|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128041|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128042|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128043|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128044|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
106128045|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128046|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
106128047|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
106128048|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128049|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128050|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128051|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128052|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128053|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128054|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128055|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128056|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128057|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128058|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128059|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128060|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128061|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128062|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
106128063|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128064|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
106128065|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
106128066|NCT01474512|366125531|FG000|Post-Treatment Follow-Up|Death|0|||
106128067|NCT01474512|366125532|FG001|Post-Treatment Follow-Up|Death|0|||
106128068|NCT01474512|366125533|FG002|Post-Treatment Follow-Up|Death|0|||
106128069|NCT01474512|366125534|FG003|Post-Treatment Follow-Up|Death|0|||
106128070|NCT01474512|366125535|FG004|Post-Treatment Follow-Up|Death|0|||
106128071|NCT01474512|366125536|FG005|Post-Treatment Follow-Up|Death|0|||
106128072|NCT01474512|366125537|FG006|Post-Treatment Follow-Up|Death|0|||
106128073|NCT01474512|366125538|FG007|Post-Treatment Follow-Up|Death|0|||
106128074|NCT01474512|366125539|FG008|Post-Treatment Follow-Up|Death|0|||
106128075|NCT01474512|366125540|FG009|Post-Treatment Follow-Up|Death|0|||
106128076|NCT01474512|366125541|FG010|Post-Treatment Follow-Up|Death|0|||
106128077|NCT01474512|366125542|FG011|Post-Treatment Follow-Up|Death|0|||
106128078|NCT01474512|366125543|FG012|Post-Treatment Follow-Up|Death|0|||
106128079|NCT01474512|366125544|FG013|Post-Treatment Follow-Up|Death|0|||
106128080|NCT01474512|366125545|FG014|Post-Treatment Follow-Up|Death|0|||
106128081|NCT01474512|366125546|FG015|Post-Treatment Follow-Up|Death|0|||
106128082|NCT01474512|366125547|FG016|Post-Treatment Follow-Up|Death|1|||
106128083|NCT01474512|366125548|FG017|Post-Treatment Follow-Up|Death|0|||
106128084|NCT04466618|366125551|FG000|Overall Study|Withdrawal by Subject|0|||
106128085|NCT04466618|366125552|FG001|Overall Study|Withdrawal by Subject|1|||
106128086|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
106128087|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
106128088|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
106128089|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
106128090|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
106128091|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
106128092|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
106128093|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
106128094|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
106128095|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
106128096|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
106128097|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
105683716|NCT02447172|364505028|FG002|Overall Study|Lost to Follow-up|4|||
105683717|NCT02447172|364505026|FG000|Overall Study|Withdrawal by Subject|5|||
105683718|NCT02447172|364505027|FG001|Overall Study|Withdrawal by Subject|1|||
106128098|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
106128099|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
106128100|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
106128101|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
105786498|NCT01683565|364871432|FG000|Overall Study|Lost to Follow-up|2|||
105786499|NCT01683565|364871433|FG001|Overall Study|Lost to Follow-up|0|||
106128102|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
106128103|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
106128104|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
106128105|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
106128106|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
106128107|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
106128108|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
106128109|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
106128110|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
106128111|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
106128112|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
106128113|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
106128114|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
106128115|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
106128116|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
106128117|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
106128118|NCT03890120|366125553|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
106128119|NCT03890120|366125554|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
106128120|NCT03890120|366125555|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
106128121|NCT03890120|366125556|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
106128122|NCT03890120|366125553|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
106128123|NCT03890120|366125554|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
106128124|NCT03890120|366125555|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
106128125|NCT03890120|366125556|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
106128126|NCT03890120|366125553|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
106128127|NCT03890120|366125554|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
106128128|NCT03890120|366125555|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
106128129|NCT03890120|366125556|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
106128130|NCT03890120|366125553|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
106128131|NCT03890120|366125554|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
106128132|NCT03890120|366125555|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
106128133|NCT03890120|366125556|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
106128134|NCT03890120|366125553|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
106128135|NCT03890120|366125554|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
106128136|NCT03890120|366125555|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
106128137|NCT03890120|366125556|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
106128138|NCT00146640|366125557|FG000|Overall Study|Adverse Event|12|||
106128139|NCT00146640|366125558|FG001|Overall Study|Adverse Event|10|||
106128140|NCT00146640|366125557|FG000|Overall Study|Medical Reasons|3|||
106128141|NCT00146640|366125558|FG001|Overall Study|Medical Reasons|0|||
106128142|NCT00146640|366125557|FG000|Overall Study|Non-Medical Reasons|8|||
106128143|NCT00146640|366125558|FG001|Overall Study|Non-Medical Reasons|4|||
106128144|NCT04242875|366125559|FG000|Overall Study|Adverse Event|2|||
106128145|NCT00231894|366125560|FG000|Overall Study|Withdrawal by Subject|1|||
106128146|NCT00231894|366125561|FG001|Overall Study|Withdrawal by Subject|1|||
106128147|NCT01473420|366125562|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
106128148|NCT01473420|366125563|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
106128149|NCT01473420|366125562|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
106128150|NCT01473420|366125563|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
106128151|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
106128152|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
106128153|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
106128154|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
106128155|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
106128156|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
106128157|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
106128158|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
106128159|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
106128160|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
106128161|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
106128162|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
106128163|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
105786500|NCT01683565|364871432|FG000|Overall Study|Discontinued Intervention|1|||
105786501|NCT01683565|364871433|FG001|Overall Study|Discontinued Intervention|1|||
105786502|NCT00859313|364871434|FG000|Overall Study|Lack of Efficacy|2|||
105683719|NCT02447172|364505028|FG002|Overall Study|Withdrawal by Subject|3|||
105683720|NCT02447172|364505026|FG000|Overall Study|protocol specific treatment unrelated|3|||
105683721|NCT02447172|364505027|FG001|Overall Study|protocol specific treatment unrelated|0|||
105683722|NCT02447172|364505028|FG002|Overall Study|protocol specific treatment unrelated|2|||
105683723|NCT00421707|364505029|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
105683724|NCT00421707|364505030|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
105683725|NCT00421707|364505029|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
105683726|NCT00421707|364505030|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
105683727|NCT00421707|364505029|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
105683728|NCT00421707|364505030|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
105683729|NCT00421707|364505029|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
105683730|NCT00421707|364505030|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
105683731|NCT00421707|364505029|FG000|Period 2: Washout|Adverse Event|1|||
105683732|NCT00421707|364505030|FG001|Period 2: Washout|Adverse Event|1|||
105683733|NCT00421707|364505029|FG000|Period 2: Washout|Withdrawal by Subject|0|||
105683734|NCT00421707|364505030|FG001|Period 2: Washout|Withdrawal by Subject|1|||
105683735|NCT00421707|364505029|FG000|Period 2: Washout|Lost to Follow-up|0|||
105683736|NCT00421707|364505030|FG001|Period 2: Washout|Lost to Follow-up|1|||
105683737|NCT00421707|364505029|FG000|Period 2: Washout|Other: Pregnancy|0|||
105683738|NCT00421707|364505030|FG001|Period 2: Washout|Other: Pregnancy|1|||
105683739|NCT00421707|364505029|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
105683740|NCT00421707|364505030|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
105683741|NCT00421707|364505029|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
105683742|NCT00421707|364505030|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
105683743|NCT00421707|364505029|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
105683744|NCT00421707|364505030|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
105683745|NCT01209143|364505031|FG000|Overall Study|Adverse Event|2|||
105683746|NCT01209143|364505032|FG001|Overall Study|Adverse Event|1|||
105683747|NCT01209143|364505031|FG000|Overall Study|Death|0|||
105683748|NCT01209143|364505032|FG001|Overall Study|Death|1|||
105683749|NCT01209143|364505031|FG000|Overall Study|Physician Decision|3|||
105683750|NCT01209143|364505032|FG001|Overall Study|Physician Decision|1|||
105683751|NCT01209143|364505031|FG000|Overall Study|Lost to Follow-up|1|||
105683752|NCT01209143|364505032|FG001|Overall Study|Lost to Follow-up|0|||
105683753|NCT01209143|364505031|FG000|Overall Study|Withdrawal by Subject|2|||
105683754|NCT01209143|364505032|FG001|Overall Study|Withdrawal by Subject|1|||
105683755|NCT01209143|364505031|FG000|Overall Study|Disease progression|11|||
105683756|NCT01209143|364505032|FG001|Overall Study|Disease progression|16|||
105683757|NCT00585195|364505033|FG000|Overall Study|Adverse Event|0|||
105683758|NCT00585195|364505034|FG001|Overall Study|Adverse Event|0|||
105683759|NCT00585195|364505035|FG002|Overall Study|Adverse Event|0|||
105683760|NCT00585195|364505036|FG003|Overall Study|Adverse Event|0|||
105683761|NCT00585195|364505037|FG004|Overall Study|Adverse Event|2|||
105683762|NCT00585195|364505038|FG005|Overall Study|Adverse Event|1|||
105683763|NCT00585195|364505039|FG006|Overall Study|Adverse Event|0|||
105683764|NCT00585195|364505040|FG007|Overall Study|Adverse Event|1|||
105683765|NCT00585195|364505041|FG008|Overall Study|Adverse Event|0|||
105683766|NCT00585195|364505042|FG009|Overall Study|Adverse Event|0|||
105683767|NCT00585195|364505043|FG010|Overall Study|Adverse Event|3|||
105683768|NCT00585195|364505044|FG011|Overall Study|Adverse Event|0|||
105683769|NCT00585195|364505045|FG012|Overall Study|Adverse Event|8|||
105683770|NCT00585195|364505046|FG013|Overall Study|Adverse Event|6|||
105683771|NCT00585195|364505047|FG014|Overall Study|Adverse Event|4|||
105683772|NCT00585195|364505048|FG015|Overall Study|Adverse Event|1|||
105683773|NCT00585195|364505049|FG016|Overall Study|Adverse Event|14|||
105683774|NCT00585195|364505050|FG017|Overall Study|Adverse Event|9|||
105683775|NCT00585195|364505051|FG018|Overall Study|Adverse Event|2|||
105683776|NCT00585195|364505052|FG019|Overall Study|Adverse Event|3|||
105683777|NCT00585195|364505053|FG020|Overall Study|Adverse Event|1|||
105683778|NCT00585195|364505033|FG000|Overall Study|Progressive Disease|2|||
105683779|NCT00585195|364505034|FG001|Overall Study|Progressive Disease|2|||
105683780|NCT00585195|364505035|FG002|Overall Study|Progressive Disease|5|||
105683781|NCT00585195|364505036|FG003|Overall Study|Progressive Disease|4|||
105683782|NCT00585195|364505037|FG004|Overall Study|Progressive Disease|6|||
105683783|NCT00585195|364505038|FG005|Overall Study|Progressive Disease|4|||
105683784|NCT00585195|364505039|FG006|Overall Study|Progressive Disease|6|||
105683785|NCT00585195|364505040|FG007|Overall Study|Progressive Disease|3|||
105683786|NCT00585195|364505041|FG008|Overall Study|Progressive Disease|0|||
105683787|NCT00585195|364505042|FG009|Overall Study|Progressive Disease|5|||
105683788|NCT00585195|364505043|FG010|Overall Study|Progressive Disease|2|||
105683789|NCT00585195|364505044|FG011|Overall Study|Progressive Disease|25|||
105683790|NCT00585195|364505045|FG012|Overall Study|Progressive Disease|29|||
105683791|NCT00585195|364505046|FG013|Overall Study|Progressive Disease|26|||
105683792|NCT00585195|364505047|FG014|Overall Study|Progressive Disease|21|||
105683793|NCT00585195|364505048|FG015|Overall Study|Progressive Disease|12|||
105683794|NCT00585195|364505049|FG016|Overall Study|Progressive Disease|94|||
105683795|NCT00585195|364505050|FG017|Overall Study|Progressive Disease|42|||
105786503|NCT00859313|364871434|FG000|Overall Study|Adverse Event|1|||
105786504|NCT00859313|364871434|FG000|Overall Study|staff error|1|||
105786505|NCT00071006|364871435|FG000|Overall Study|Lack of Efficacy|7|||
105786506|NCT00071006|364871435|FG000|Overall Study|Adverse Event|1|||
105786507|NCT00071006|364871435|FG000|Overall Study|Withdrawal by Subject|1|||
105786508|NCT00071006|364871435|FG000|Overall Study|Other|3|||
105786509|NCT03792633|364871436|FG000|Overall Study|Alternative Treatment|17|||
105786510|NCT03792633|364871437|FG001|Overall Study|Alternative Treatment|19|||
105786511|NCT03792633|364871436|FG000|Overall Study|Death|2|||
105786512|NCT03792633|364871437|FG001|Overall Study|Death|0|||
105786513|NCT03792633|364871436|FG000|Overall Study|Disease progression|8|||
105683796|NCT00585195|364505051|FG018|Overall Study|Progressive Disease|4|||
105683797|NCT00585195|364505052|FG019|Overall Study|Progressive Disease|9|||
105683798|NCT00585195|364505053|FG020|Overall Study|Progressive Disease|8|||
105683799|NCT00585195|364505033|FG000|Overall Study|Withdrawal by Subject|1|||
105683800|NCT00585195|364505034|FG001|Overall Study|Withdrawal by Subject|1|||
105683801|NCT00585195|364505035|FG002|Overall Study|Withdrawal by Subject|2|||
105683802|NCT00585195|364505036|FG003|Overall Study|Withdrawal by Subject|2|||
105683803|NCT00585195|364505037|FG004|Overall Study|Withdrawal by Subject|0|||
105683804|NCT00585195|364505038|FG005|Overall Study|Withdrawal by Subject|0|||
105683805|NCT00585195|364505039|FG006|Overall Study|Withdrawal by Subject|0|||
105683806|NCT00585195|364505040|FG007|Overall Study|Withdrawal by Subject|1|||
105683807|NCT00585195|364505041|FG008|Overall Study|Withdrawal by Subject|0|||
105683808|NCT00585195|364505042|FG009|Overall Study|Withdrawal by Subject|0|||
105683809|NCT00585195|364505043|FG010|Overall Study|Withdrawal by Subject|3|||
105683810|NCT00585195|364505044|FG011|Overall Study|Withdrawal by Subject|8|||
105683811|NCT00585195|364505045|FG012|Overall Study|Withdrawal by Subject|15|||
105683812|NCT00585195|364505046|FG013|Overall Study|Withdrawal by Subject|0|||
105683813|NCT00585195|364505047|FG014|Overall Study|Withdrawal by Subject|3|||
105683814|NCT00585195|364505048|FG015|Overall Study|Withdrawal by Subject|0|||
105683815|NCT00585195|364505049|FG016|Overall Study|Withdrawal by Subject|7|||
105683816|NCT00585195|364505050|FG017|Overall Study|Withdrawal by Subject|1|||
105683817|NCT00585195|364505051|FG018|Overall Study|Withdrawal by Subject|2|||
105683818|NCT00585195|364505052|FG019|Overall Study|Withdrawal by Subject|2|||
105683819|NCT00585195|364505053|FG020|Overall Study|Withdrawal by Subject|0|||
105683820|NCT00585195|364505033|FG000|Overall Study|Other|0|||
105683821|NCT00585195|364505034|FG001|Overall Study|Other|1|||
105683822|NCT00585195|364505035|FG002|Overall Study|Other|1|||
105683823|NCT00585195|364505036|FG003|Overall Study|Other|1|||
105683824|NCT00585195|364505037|FG004|Overall Study|Other|0|||
105683825|NCT00585195|364505038|FG005|Overall Study|Other|1|||
105683826|NCT00585195|364505039|FG006|Overall Study|Other|0|||
105683827|NCT00585195|364505040|FG007|Overall Study|Other|0|||
105683828|NCT00585195|364505041|FG008|Overall Study|Other|2|||
105683829|NCT00585195|364505042|FG009|Overall Study|Other|1|||
105683830|NCT00585195|364505043|FG010|Overall Study|Other|0|||
105683831|NCT00585195|364505044|FG011|Overall Study|Other|19|||
105683832|NCT00585195|364505045|FG012|Overall Study|Other|24|||
105683833|NCT00585195|364505046|FG013|Overall Study|Other|7|||
105683834|NCT00585195|364505047|FG014|Overall Study|Other|11|||
105786514|NCT03792633|364871437|FG001|Overall Study|Disease progression|9|||
105786515|NCT03792633|364871436|FG000|Overall Study|Lost to Follow-up|1|||
105786516|NCT03792633|364871437|FG001|Overall Study|Lost to Follow-up|1|||
105786517|NCT03792633|364871436|FG000|Overall Study|Screen fail|1|||
105786518|NCT03792633|364871437|FG001|Overall Study|Screen fail|0|||
105786519|NCT03792633|364871436|FG000|Overall Study|Second malignancy|0|||
105786520|NCT03792633|364871437|FG001|Overall Study|Second malignancy|1|||
105786521|NCT03901274|364871438|FG000|Overall Study|Lost to Follow-up|120|||
105786522|NCT03901274|364871439|FG001|Overall Study|Lost to Follow-up|124|||
105786523|NCT03901274|364871438|FG000|Overall Study|Withdrawal by Subject|0|||
105786524|NCT03901274|364871439|FG001|Overall Study|Withdrawal by Subject|6|||
105786525|NCT04527380|364871442|FG000|Overall Study|Lack of Efficacy|0|||
105786526|NCT04527380|364871443|FG001|Overall Study|Lack of Efficacy|1|||
106128164|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
105683835|NCT00585195|364505048|FG015|Overall Study|Other|3|||
105683836|NCT00585195|364505049|FG016|Overall Study|Other|28|||
105683837|NCT00585195|364505050|FG017|Overall Study|Other|12|||
105683838|NCT00585195|364505051|FG018|Overall Study|Other|10|||
105683839|NCT00585195|364505052|FG019|Overall Study|Other|4|||
105683840|NCT00585195|364505053|FG020|Overall Study|Other|2|||
105786527|NCT04527380|364871442|FG000|Overall Study|Withdrawal by Subject|1|||
105683841|NCT00585195|364505033|FG000|Overall Study|Randomized not treated|0|||
105683842|NCT00585195|364505034|FG001|Overall Study|Randomized not treated|0|||
105683843|NCT00585195|364505035|FG002|Overall Study|Randomized not treated|1|||
105786528|NCT04527380|364871443|FG001|Overall Study|Withdrawal by Subject|0|||
105786529|NCT05048875|364871448|FG000|Overall Study|Withdrawal by Subject|1|||
105917158|NCT04161391|365356776|FG000|Overall Study|Physician Decision|0|||
105917159|NCT04161391|365356777|FG001|Overall Study|Physician Decision|0|||
105917160|NCT04161391|365356778|FG002|Overall Study|Physician Decision|1|||
105917161|NCT04161391|365356779|FG003|Overall Study|Physician Decision|2|||
105917162|NCT04161391|365356780|FG004|Overall Study|Physician Decision|0|||
105917163|NCT04161391|365356781|FG005|Overall Study|Physician Decision|0|||
105917164|NCT04161391|365356782|FG006|Overall Study|Physician Decision|2|||
105917165|NCT04161391|365356783|FG007|Overall Study|Physician Decision|0|||
105917166|NCT04161391|365356784|FG008|Overall Study|Physician Decision|0|||
105917167|NCT04161391|365356776|FG000|Overall Study|Progressive Disease|4|||
105917168|NCT04161391|365356777|FG001|Overall Study|Progressive Disease|3|||
105917169|NCT04161391|365356778|FG002|Overall Study|Progressive Disease|3|||
105917170|NCT04161391|365356779|FG003|Overall Study|Progressive Disease|5|||
105917171|NCT04161391|365356780|FG004|Overall Study|Progressive Disease|3|||
105917172|NCT04161391|365356781|FG005|Overall Study|Progressive Disease|3|||
105683844|NCT00585195|364505036|FG003|Overall Study|Randomized not treated|0|||
105683845|NCT00585195|364505037|FG004|Overall Study|Randomized not treated|1|||
105683846|NCT00585195|364505038|FG005|Overall Study|Randomized not treated|0|||
105683847|NCT00585195|364505039|FG006|Overall Study|Randomized not treated|1|||
105683848|NCT00585195|364505040|FG007|Overall Study|Randomized not treated|0|||
105683849|NCT00585195|364505041|FG008|Overall Study|Randomized not treated|0|||
105683850|NCT00585195|364505042|FG009|Overall Study|Randomized not treated|0|||
105683851|NCT00585195|364505043|FG010|Overall Study|Randomized not treated|2|||
105683852|NCT00585195|364505044|FG011|Overall Study|Randomized not treated|0|||
105683853|NCT00585195|364505045|FG012|Overall Study|Randomized not treated|0|||
105683854|NCT00585195|364505046|FG013|Overall Study|Randomized not treated|0|||
105683855|NCT00585195|364505047|FG014|Overall Study|Randomized not treated|0|||
105683856|NCT00585195|364505048|FG015|Overall Study|Randomized not treated|1|||
105683857|NCT00585195|364505049|FG016|Overall Study|Randomized not treated|0|||
105683858|NCT00585195|364505050|FG017|Overall Study|Randomized not treated|1|||
105683859|NCT00585195|364505051|FG018|Overall Study|Randomized not treated|3|||
105683860|NCT00585195|364505052|FG019|Overall Study|Randomized not treated|0|||
105683861|NCT00585195|364505053|FG020|Overall Study|Randomized not treated|2|||
105683862|NCT00585195|364505033|FG000|Overall Study|Death|0|||
105683863|NCT00585195|364505034|FG001|Overall Study|Death|0|||
105683864|NCT00585195|364505035|FG002|Overall Study|Death|0|||
105683865|NCT00585195|364505036|FG003|Overall Study|Death|0|||
105683866|NCT00585195|364505037|FG004|Overall Study|Death|0|||
105683867|NCT00585195|364505038|FG005|Overall Study|Death|0|||
105683868|NCT00585195|364505039|FG006|Overall Study|Death|0|||
105683869|NCT00585195|364505040|FG007|Overall Study|Death|0|||
105683870|NCT00585195|364505041|FG008|Overall Study|Death|1|||
105917173|NCT04161391|365356782|FG006|Overall Study|Progressive Disease|5|||
105917174|NCT04161391|365356783|FG007|Overall Study|Progressive Disease|2|||
105917175|NCT04161391|365356784|FG008|Overall Study|Progressive Disease|2|||
105917176|NCT01162343|365356785|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
105917177|NCT01162343|365356785|FG000|Overall Study|Refused psychiatrist assessment|12|||
105917178|NCT01930539|365356787|FG000|Overall Study|Withdrawal by Subject|2|||
105917179|NCT01930539|365356788|FG001|Overall Study|Withdrawal by Subject|2|||
105917180|NCT02579629|365356789|FG000|Overall Study|Withdrawal by Subject|0|||
105917181|NCT02579629|365356790|FG001|Overall Study|Withdrawal by Subject|1|||
106001217|NCT03827655|365665232|FG004|Overall Study|Withdrawal by Subject|1|||
105683871|NCT00585195|364505042|FG009|Overall Study|Death|0|||
105683872|NCT00585195|364505043|FG010|Overall Study|Death|1|||
105683873|NCT00585195|364505044|FG011|Overall Study|Death|1|||
105683874|NCT00585195|364505045|FG012|Overall Study|Death|7|||
105683875|NCT00585195|364505046|FG013|Overall Study|Death|2|||
105683876|NCT00585195|364505047|FG014|Overall Study|Death|8|||
105683877|NCT00585195|364505048|FG015|Overall Study|Death|2|||
105683878|NCT00585195|364505049|FG016|Overall Study|Death|11|||
105683879|NCT00585195|364505050|FG017|Overall Study|Death|0|||
105683880|NCT00585195|364505051|FG018|Overall Study|Death|0|||
105683881|NCT00585195|364505052|FG019|Overall Study|Death|0|||
105683882|NCT00585195|364505053|FG020|Overall Study|Death|1|||
105683883|NCT00585195|364505033|FG000|Overall Study|Lost to Follow-up|0|||
105683884|NCT00585195|364505034|FG001|Overall Study|Lost to Follow-up|0|||
105683885|NCT00585195|364505035|FG002|Overall Study|Lost to Follow-up|0|||
105683886|NCT00585195|364505036|FG003|Overall Study|Lost to Follow-up|0|||
105683887|NCT00585195|364505037|FG004|Overall Study|Lost to Follow-up|0|||
105683888|NCT00585195|364505038|FG005|Overall Study|Lost to Follow-up|0|||
105683889|NCT00585195|364505039|FG006|Overall Study|Lost to Follow-up|0|||
105683890|NCT00585195|364505040|FG007|Overall Study|Lost to Follow-up|0|||
105683891|NCT00585195|364505041|FG008|Overall Study|Lost to Follow-up|0|||
105683892|NCT00585195|364505042|FG009|Overall Study|Lost to Follow-up|0|||
105683893|NCT00585195|364505043|FG010|Overall Study|Lost to Follow-up|0|||
105683894|NCT00585195|364505044|FG011|Overall Study|Lost to Follow-up|0|||
105683895|NCT00585195|364505045|FG012|Overall Study|Lost to Follow-up|1|||
105683896|NCT00585195|364505046|FG013|Overall Study|Lost to Follow-up|0|||
105683897|NCT00585195|364505047|FG014|Overall Study|Lost to Follow-up|0|||
105917182|NCT02579629|365356791|FG002|Overall Study|Withdrawal by Subject|0|||
106001218|NCT03827655|365665228|FG000|Overall Study|Reason not Specified|3|||
105683898|NCT00585195|364505048|FG015|Overall Study|Lost to Follow-up|0|||
105683899|NCT00585195|364505049|FG016|Overall Study|Lost to Follow-up|0|||
105683900|NCT00585195|364505050|FG017|Overall Study|Lost to Follow-up|2|||
105683901|NCT00585195|364505051|FG018|Overall Study|Lost to Follow-up|0|||
105683902|NCT00585195|364505052|FG019|Overall Study|Lost to Follow-up|0|||
105683903|NCT00585195|364505053|FG020|Overall Study|Lost to Follow-up|0|||
105683904|NCT00585195|364505033|FG000|Overall Study|Site Terminated by Sponsor|0|||
105683905|NCT00585195|364505034|FG001|Overall Study|Site Terminated by Sponsor|0|||
105917183|NCT02579629|365356789|FG000|Overall Study|Screen Failure|2|||
106001219|NCT03827655|365665229|FG001|Overall Study|Reason not Specified|1|||
105683906|NCT00585195|364505035|FG002|Overall Study|Site Terminated by Sponsor|0|||
105683907|NCT00585195|364505036|FG003|Overall Study|Site Terminated by Sponsor|0|||
105683908|NCT00585195|364505037|FG004|Overall Study|Site Terminated by Sponsor|0|||
105683909|NCT00585195|364505038|FG005|Overall Study|Site Terminated by Sponsor|0|||
105683910|NCT00585195|364505039|FG006|Overall Study|Site Terminated by Sponsor|0|||
105683911|NCT00585195|364505040|FG007|Overall Study|Site Terminated by Sponsor|0|||
105683912|NCT00585195|364505041|FG008|Overall Study|Site Terminated by Sponsor|0|||
105683913|NCT00585195|364505042|FG009|Overall Study|Site Terminated by Sponsor|0|||
105683914|NCT00585195|364505043|FG010|Overall Study|Site Terminated by Sponsor|0|||
105683915|NCT00585195|364505044|FG011|Overall Study|Site Terminated by Sponsor|0|||
105683916|NCT00585195|364505045|FG012|Overall Study|Site Terminated by Sponsor|1|||
105683917|NCT00585195|364505046|FG013|Overall Study|Site Terminated by Sponsor|0|||
105683918|NCT00585195|364505047|FG014|Overall Study|Site Terminated by Sponsor|0|||
105683919|NCT00585195|364505048|FG015|Overall Study|Site Terminated by Sponsor|0|||
105683920|NCT00585195|364505049|FG016|Overall Study|Site Terminated by Sponsor|0|||
105683921|NCT00585195|364505050|FG017|Overall Study|Site Terminated by Sponsor|0|||
105683922|NCT00585195|364505051|FG018|Overall Study|Site Terminated by Sponsor|0|||
105683923|NCT00585195|364505052|FG019|Overall Study|Site Terminated by Sponsor|0|||
105683924|NCT00585195|364505053|FG020|Overall Study|Site Terminated by Sponsor|0|||
105683925|NCT00585195|364505033|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
105683926|NCT00585195|364505034|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
105683927|NCT00585195|364505035|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
105683928|NCT00585195|364505036|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
105683929|NCT00585195|364505037|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
105683930|NCT00585195|364505038|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
105683931|NCT00585195|364505039|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
105683932|NCT00585195|364505040|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
105683933|NCT00585195|364505041|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
105683934|NCT00585195|364505042|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
105683935|NCT00585195|364505043|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
105683936|NCT00585195|364505044|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
105683937|NCT00585195|364505045|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
105683938|NCT00585195|364505046|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
105683939|NCT00585195|364505047|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
105683940|NCT00585195|364505048|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
105683941|NCT00585195|364505049|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
105683942|NCT00585195|364505050|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
105683943|NCT00585195|364505051|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
105683944|NCT00585195|364505052|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
105683945|NCT00585195|364505053|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
105683946|NCT02594163|364506685|FG000|Treatment Period|Progressive disease|2|||
105683947|NCT02594163|364506686|FG001|Treatment Period|Progressive disease|3|||
105683948|NCT02594163|364506685|FG000|Treatment Period|Adverse Event|1|||
105683949|NCT02594163|364506686|FG001|Treatment Period|Adverse Event|5|||
105683950|NCT02594163|364506685|FG000|Treatment Period|Physician Decision|1|||
105683951|NCT02594163|364506686|FG001|Treatment Period|Physician Decision|3|||
105683952|NCT02594163|364506685|FG000|Treatment Period|Study termination by sponsor|2|||
105683953|NCT02594163|364506686|FG001|Treatment Period|Study termination by sponsor|1|||
105683954|NCT02594163|364506685|FG000|Treatment Period|Other, Non-AE|1|||
105683955|NCT02594163|364506686|FG001|Treatment Period|Other, Non-AE|0|||
105683956|NCT02594163|364506685|FG000|Follow-up Period|Withdrawal by Subject|0|||
105683957|NCT02594163|364506686|FG001|Follow-up Period|Withdrawal by Subject|1|||
105683958|NCT02594163|364506685|FG000|Follow-up Period|Study Termination by Sponsor|6|||
105683959|NCT02594163|364506686|FG001|Follow-up Period|Study Termination by Sponsor|4|||
105683960|NCT02594163|364506685|FG000|Follow-up Period|Lost to Follow-up|1|||
105683961|NCT02594163|364506686|FG001|Follow-up Period|Lost to Follow-up|0|||
105683962|NCT02594163|364506685|FG000|Follow-up Period|Death|2|||
105683963|NCT02594163|364506686|FG001|Follow-up Period|Death|5|||
105683964|NCT02594163|364506685|FG000|Follow-up Period|Adverse Event|0|||
105683965|NCT02594163|364506686|FG001|Follow-up Period|Adverse Event|1|||
105683966|NCT02594163|364506685|FG000|Follow-up Period|Progressive Disease|2|||
105683967|NCT02594163|364506686|FG001|Follow-up Period|Progressive Disease|0|||
105683968|NCT02594163|364506685|FG000|Follow-up Period|Physician Decision|0|||
105683969|NCT02594163|364506686|FG001|Follow-up Period|Physician Decision|1|||
105683970|NCT00117845|364506689|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
105683971|NCT01877837|364506694|FG000|Overall Study|Lost to Follow-up|1|||
105683972|NCT01877837|364506694|FG000|Overall Study|Ineligible|4|||
105683973|NCT00320541|364506696|FG000|Overall Study|Adverse Event|21|||
105683974|NCT00320541|364506697|FG001|Overall Study|Adverse Event|19|||
105683975|NCT00320541|364506696|FG000|Overall Study|Protocol Violation|0|||
105683976|NCT00320541|364506697|FG001|Overall Study|Protocol Violation|1|||
105683977|NCT00320541|364506696|FG000|Overall Study|Withdrawal by Subject|12|||
105683978|NCT00320541|364506697|FG001|Overall Study|Withdrawal by Subject|16|||
105683979|NCT00320541|364506696|FG000|Overall Study|Physician Decision|9|||
105683980|NCT00320541|364506697|FG001|Overall Study|Physician Decision|13|||
105683981|NCT00320541|364506696|FG000|Overall Study|Other|3|||
105683982|NCT00320541|364506697|FG001|Overall Study|Other|4|||
105683983|NCT00320541|364506696|FG000|Overall Study|Sponsor Decision|2|||
105683984|NCT00320541|364506697|FG001|Overall Study|Sponsor Decision|1|||
105683985|NCT00320541|364506696|FG000|Overall Study|Death due to Study Disease|1|||
105683986|NCT00320541|364506697|FG001|Overall Study|Death due to Study Disease|3|||
105683987|NCT00320541|364506696|FG000|Overall Study|Death due to Adverse Event(s)|1|||
105683988|NCT00320541|364506697|FG001|Overall Study|Death due to Adverse Event(s)|0|||
105683989|NCT00320541|364506696|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
105683990|NCT00320541|364506697|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
105683991|NCT01403610|364506698|FG000|Overall Study|Withdrawal by Subject|2|||
105683992|NCT01403610|364506699|FG001|Overall Study|Withdrawal by Subject|0|||
105683993|NCT01403610|364506700|FG002|Overall Study|Withdrawal by Subject|0|||
105683994|NCT01403610|364506701|FG003|Overall Study|Withdrawal by Subject|0|||
105683995|NCT01403610|364506698|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
105683996|NCT01403610|364506699|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
105683997|NCT01403610|364506700|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
105683998|NCT01403610|364506701|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
105683999|NCT01350336|364506702|FG000|Overall Study|Lost to Follow-up|31|||
105684000|NCT01350336|364506702|FG000|Overall Study|Withdrawal by Subject|14|||
105684001|NCT01350336|364506702|FG000|Overall Study|Physician Decision|8|||
105684002|NCT01350336|364506702|FG000|Overall Study|Death|4|||
105684003|NCT01689337|364506708|FG000|Overall Study|Study Discontinuation|1|||
105684004|NCT03718533|364506710|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
105684005|NCT03718533|364506710|FG000|Overall Study|Protocol deviation|1|||
105684006|NCT03718533|364506710|FG000|Overall Study|Disease progression|1|||
105684007|NCT03718533|364506710|FG000|Overall Study|Relapse|1|||
105684008|NCT03718533|364506710|FG000|Overall Study|Physician Decision|2|||
105684009|NCT03718533|364506710|FG000|Overall Study|Physician Decision and Adverse Event|1|||
105684010|NCT00666679|364506711|FG000|First Intervention|Lost to Follow-up|1|||
105684011|NCT00666679|364506712|FG001|First Intervention|Lost to Follow-up|0|||
105684012|NCT00666679|364506711|FG000|First Intervention|Protocol Violation|1|||
105684013|NCT00666679|364506712|FG001|First Intervention|Protocol Violation|0|||
105684014|NCT00666679|364506711|FG000|First Intervention|Withdrawal by Subject|1|||
105684015|NCT00666679|364506712|FG001|First Intervention|Withdrawal by Subject|0|||
105684016|NCT00666679|364506711|FG000|First Intervention|Randomized did not start treatment|1|||
105684017|NCT00666679|364506712|FG001|First Intervention|Randomized did not start treatment|1|||
105684018|NCT00666679|364506711|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
105684019|NCT00666679|364506712|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
105684020|NCT00666679|364506711|FG000|Washout Period of 1 Week|Protocol Violation|0|||
105684021|NCT00666679|364506712|FG001|Washout Period of 1 Week|Protocol Violation|1|||
105684022|NCT00666679|364506711|FG000|Second Intervention|Adverse Event|1|||
105684023|NCT00666679|364506712|FG001|Second Intervention|Adverse Event|0|||
105684024|NCT00666679|364506711|FG000|Second Intervention|Death|0|||
105684025|NCT00666679|364506712|FG001|Second Intervention|Death|1|||
105684026|NCT01347762|364506713|FG000|Overall Study|Lost to Follow-up|0|||
105684027|NCT01347762|364506714|FG001|Overall Study|Lost to Follow-up|1|||
105684028|NCT01347762|364506715|FG002|Overall Study|Lost to Follow-up|6|||
105684029|NCT01347762|364506716|FG003|Overall Study|Lost to Follow-up|5|||
105684030|NCT01347762|364506713|FG000|Overall Study|Withdrawal by Subject|4|||
105684031|NCT01347762|364506714|FG001|Overall Study|Withdrawal by Subject|1|||
105684032|NCT01347762|364506715|FG002|Overall Study|Withdrawal by Subject|3|||
105684033|NCT01347762|364506716|FG003|Overall Study|Withdrawal by Subject|3|||
105684034|NCT00093808|364506717|FG000|Overall Study|Cancel participation before receiving tx|1|||
105684035|NCT00093808|364506717|FG000|Overall Study|Protocol Violation|1|||
105684036|NCT00871780|364506718|FG000|Overall Study|Enrolled But Not Treated|6|||
105684037|NCT00871780|364506718|FG000|Overall Study|Withdrawal by Subject|9|||
105684038|NCT00871780|364506718|FG000|Overall Study|Adverse Event|6|||
105684039|NCT00871780|364506718|FG000|Overall Study|Voluntary Discontinuation|4|||
105684040|NCT00871780|364506718|FG000|Overall Study|Death|1|||
105684041|NCT00871780|364506718|FG000|Overall Study|Physician Decision|1|||
105786530|NCT05048875|364871449|FG001|Overall Study|Withdrawal by Subject|0|||
105786531|NCT05048875|364871450|FG002|Overall Study|Withdrawal by Subject|0|||
105786532|NCT05048875|364871451|FG003|Overall Study|Withdrawal by Subject|0|||
105917184|NCT02579629|365356790|FG001|Overall Study|Screen Failure|0|||
105917185|NCT02579629|365356791|FG002|Overall Study|Screen Failure|2|||
105917186|NCT00830219|365356792|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105917187|NCT00830219|365356793|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105917188|NCT01241279|365356794|FG000|Overall Study|Lost to Follow-up|0|||
105917189|NCT01241279|365356795|FG001|Overall Study|Lost to Follow-up|1|||
105917190|NCT02683109|365356798|FG000|Overall Study|Adverse Event|1|||
105917191|NCT02683109|365356799|FG001|Overall Study|Adverse Event|0|||
105786533|NCT05048875|364871452|FG004|Overall Study|Withdrawal by Subject|0|||
105917192|NCT04400318|365356808|FG000|Overall Study|Adverse Event|1|||
106001220|NCT03827655|365665230|FG002|Overall Study|Reason not Specified|1|||
105684042|NCT03406260|364506719|FG000|Period 1|Adverse Event|0|||
105684043|NCT03406260|364506720|FG001|Period 1|Adverse Event|0|||
105684044|NCT03406260|364506721|FG002|Period 1|Adverse Event|0|||
105684045|NCT03406260|364506722|FG003|Period 1|Adverse Event|0|||
105917193|NCT04400318|365356809|FG001|Overall Study|Adverse Event|0|||
105684046|NCT03406260|364506723|FG004|Period 1|Adverse Event|1|||
105917194|NCT04400318|365356808|FG000|Overall Study|Withdrawal by Subject|1|||
105684047|NCT03406260|364506724|FG005|Period 1|Adverse Event|0|||
105684048|NCT02208999|364506726|FG000|Overall Study|Lost to Follow-up|1|||
105684049|NCT01136772|364506727|FG000|Overall Study|Adverse Event|15|||
105684050|NCT01136772|364506728|FG001|Overall Study|Adverse Event|14|||
105684051|NCT01136772|364506727|FG000|Overall Study|Lack of Efficacy|42|||
105684052|NCT01136772|364506728|FG001|Overall Study|Lack of Efficacy|39|||
105684053|NCT01136772|364506727|FG000|Overall Study|Administrative|14|||
105684054|NCT01136772|364506728|FG001|Overall Study|Administrative|12|||
105684055|NCT01136772|364506727|FG000|Overall Study|Withdrawal by Subject|33|||
105684056|NCT01136772|364506728|FG001|Overall Study|Withdrawal by Subject|36|||
105684057|NCT01136772|364506727|FG000|Overall Study|Did not receive injection|10|||
105684058|NCT01136772|364506728|FG001|Overall Study|Did not receive injection|7|||
105684059|NCT01136772|364506727|FG000|Overall Study|Did not follow up after first injection|2|||
105684060|NCT01136772|364506728|FG001|Overall Study|Did not follow up after first injection|2|||
105684061|NCT01831856|364506729|FG000|Overall Study|Adverse Event|5|||
105684062|NCT01831856|364506730|FG001|Overall Study|Adverse Event|8|||
105684063|NCT01831856|364506729|FG000|Overall Study|Lack of Efficacy|13|||
105684064|NCT01831856|364506730|FG001|Overall Study|Lack of Efficacy|11|||
105684065|NCT01831856|364506729|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
105684066|NCT01831856|364506730|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
105684067|NCT01498653|364506731|FG000|Overall Study|Adverse Event|2|||
105684068|NCT01498653|364506732|FG001|Overall Study|Adverse Event|2|||
105684069|NCT01498653|364506731|FG000|Overall Study|Lack of Efficacy|12|||
105684070|NCT01498653|364506732|FG001|Overall Study|Lack of Efficacy|26|||
105684071|NCT01498653|364506731|FG000|Overall Study|Protocol Violation|0|||
105684072|NCT01498653|364506732|FG001|Overall Study|Protocol Violation|4|||
105684073|NCT01498653|364506731|FG000|Overall Study|Lost to Follow-up|1|||
105684074|NCT01498653|364506732|FG001|Overall Study|Lost to Follow-up|0|||
105684075|NCT01498653|364506731|FG000|Overall Study|Physician Decision|2|||
105684076|NCT01498653|364506732|FG001|Overall Study|Physician Decision|0|||
105684077|NCT01498653|364506731|FG000|Overall Study|Withdrawal by Subject|2|||
105684078|NCT01498653|364506732|FG001|Overall Study|Withdrawal by Subject|3|||
105684079|NCT02070588|364506733|FG000|Overall Study|Withdrawal by Subject|29|||
105684080|NCT02070588|364506734|FG001|Overall Study|Withdrawal by Subject|1|||
105684081|NCT02070588|364506735|FG002|Overall Study|Withdrawal by Subject|0|||
105684082|NCT02070588|364506733|FG000|Overall Study|Writhdrawal due to early termination|9|||
105684083|NCT02070588|364506734|FG001|Overall Study|Writhdrawal due to early termination|0|||
105684084|NCT02070588|364506735|FG002|Overall Study|Writhdrawal due to early termination|0|||
105684085|NCT02070588|364506733|FG000|Overall Study|Adverse Event|1|||
105684086|NCT02070588|364506734|FG001|Overall Study|Adverse Event|0|||
105684087|NCT02070588|364506735|FG002|Overall Study|Adverse Event|0|||
105684088|NCT00836095|364506740|FG000|Overall Study|Physician Decision|0|||
105684089|NCT00836095|364506741|FG001|Overall Study|Physician Decision|3|||
105684090|NCT02319525|364506742|FG000|Overall Study|Withdrawal by Subject|2|||
105684091|NCT02319525|364506743|FG001|Overall Study|Withdrawal by Subject|1|||
105684092|NCT01602562|364506744|FG000|Overall Study|Adverse Event|3|||
105684093|NCT01602562|364506745|FG001|Overall Study|Adverse Event|1|||
105684094|NCT01602562|364506744|FG000|Overall Study|Physician Decision|1|||
105684095|NCT01602562|364506745|FG001|Overall Study|Physician Decision|1|||
105684096|NCT01602562|364506744|FG000|Overall Study|Withdrawal by Subject|1|||
105684097|NCT01602562|364506745|FG001|Overall Study|Withdrawal by Subject|1|||
105684098|NCT03881553|364506746|FG000|Overall Study|Discharged prior to participation|1|||
105684099|NCT03881553|364506747|FG001|Overall Study|Discharged prior to participation|1|||
105684100|NCT03881553|364506748|FG002|Overall Study|Discharged prior to participation|0|||
105684101|NCT03881553|364506746|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
105684102|NCT03881553|364506747|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
105684103|NCT03881553|364506748|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
105684104|NCT01718353|364506749|FG000|Overall Study|Lost to Follow-up|0|||
105684105|NCT01718353|364506750|FG001|Overall Study|Lost to Follow-up|1|||
105684106|NCT01718353|364506749|FG000|Overall Study|Principal Investigator's Decision|10|||
105684107|NCT01718353|364506750|FG001|Overall Study|Principal Investigator's Decision|4|||
105684108|NCT01718353|364506749|FG000|Overall Study|Randomized but not treated|2|||
105684109|NCT01718353|364506750|FG001|Overall Study|Randomized but not treated|0|||
105684110|NCT01078675|364506751|FG000|Overall Study|Withdrawal by Subject|7|||
106001221|NCT03827655|365665231|FG003|Overall Study|Reason not Specified|1|||
106001222|NCT03827655|365665232|FG004|Overall Study|Reason not Specified|1|||
105684111|NCT01078675|364506752|FG001|Overall Study|Withdrawal by Subject|3|||
105684112|NCT01078675|364506751|FG000|Overall Study|Protocol Violation|56|||
105684113|NCT01078675|364506752|FG001|Overall Study|Protocol Violation|0|||
105684114|NCT01078675|364506751|FG000|Overall Study|Provided in CRF for specific reasons|2|||
105684115|NCT01078675|364506752|FG001|Overall Study|Provided in CRF for specific reasons|3|||
105684116|NCT01078675|364506751|FG000|Overall Study|Adverse Event|3|||
105684117|NCT01078675|364506752|FG001|Overall Study|Adverse Event|0|||
105684118|NCT00928746|364506753|FG000|Overall Study|Adverse Event|2|||
105684119|NCT00928746|364506753|FG000|Overall Study|Protocol Violation|1|||
105684120|NCT00928746|364506753|FG000|Overall Study|Withdrawal by Subject|1|||
105684121|NCT00928746|364506753|FG000|Overall Study|Other|2|||
105684122|NCT01337115|364506754|FG000|Overall Study|Protocol Violation|2|||
105684123|NCT01337115|364506755|FG001|Overall Study|Protocol Violation|0|||
105684124|NCT01079741|364506757|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
105684125|NCT01079741|364506758|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
105684126|NCT01079741|364506759|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
105684127|NCT01079741|364506760|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
105684128|NCT01079741|364506761|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
105684129|NCT01079741|364506757|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
105684130|NCT01079741|364506758|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
105684131|NCT01079741|364506759|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
105684132|NCT01079741|364506760|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
105684133|NCT01079741|364506761|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
105684134|NCT01275131|364506763|FG000|Period 1|Withdrawal by Subject|1|||
105684135|NCT01275131|364506764|FG001|Period 1|Withdrawal by Subject|0|||
105684136|NCT01275131|364506765|FG002|Period 1|Withdrawal by Subject|3|||
105684137|NCT01275131|364506766|FG003|Period 1|Withdrawal by Subject|2|||
105684138|NCT01275131|364506763|FG000|Period 1|Physician Decision|1|||
105684139|NCT01275131|364506764|FG001|Period 1|Physician Decision|0|||
105684140|NCT01275131|364506765|FG002|Period 1|Physician Decision|0|||
105684141|NCT01275131|364506766|FG003|Period 1|Physician Decision|0|||
105684142|NCT01275131|364506763|FG000|Period 2 (Crossover)|Adverse Event|0|||
105684143|NCT01275131|364506764|FG001|Period 2 (Crossover)|Adverse Event|1|||
105684144|NCT01275131|364506765|FG002|Period 2 (Crossover)|Adverse Event|0|||
105684145|NCT01275131|364506766|FG003|Period 2 (Crossover)|Adverse Event|0|||
105684146|NCT01275131|364506763|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
105684147|NCT01275131|364506764|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
105684148|NCT01275131|364506765|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
105684149|NCT01275131|364506766|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
105684150|NCT01270971|364506767|FG000|Overall Study|Withdrawal by Subject|24|||
105684151|NCT01270971|364506768|FG001|Overall Study|Withdrawal by Subject|11|||
105684152|NCT01270971|364506767|FG000|Overall Study|Lost to Follow-up|18|||
105684153|NCT01270971|364506768|FG001|Overall Study|Lost to Follow-up|5|||
105684154|NCT01270971|364506767|FG000|Overall Study|Adverse Event|1|||
105684155|NCT01270971|364506768|FG001|Overall Study|Adverse Event|2|||
105684156|NCT01270971|364506767|FG000|Overall Study|Non compliance|2|||
105684157|NCT01270971|364506768|FG001|Overall Study|Non compliance|2|||
105684158|NCT01270971|364506767|FG000|Overall Study|Non-specific|7|||
105684159|NCT01270971|364506768|FG001|Overall Study|Non-specific|3|||
105684160|NCT01142596|364506769|FG000|Overall Study|Withdrawal by Subject|9|||
105684161|NCT01142596|364506770|FG001|Overall Study|Withdrawal by Subject|35|||
105684162|NCT01142596|364506769|FG000|Overall Study|Adverse Event|8|||
105684163|NCT01142596|364506770|FG001|Overall Study|Adverse Event|35|||
105684164|NCT01142596|364506769|FG000|Overall Study|Lack of Efficacy|5|||
105684165|NCT01142596|364506770|FG001|Overall Study|Lack of Efficacy|9|||
105684166|NCT01142596|364506769|FG000|Overall Study|Lost to Follow-up|2|||
105684167|NCT01142596|364506770|FG001|Overall Study|Lost to Follow-up|3|||
105684168|NCT01142596|364506769|FG000|Overall Study|Other reason (not specified)|5|||
105684169|NCT01142596|364506770|FG001|Overall Study|Other reason (not specified)|4|||
105684170|NCT03333837|364506774|FG000|Overall Study|Adverse Event|2|||
105684171|NCT03333837|364506775|FG001|Overall Study|Adverse Event|1|||
105684172|NCT03333837|364506776|FG002|Overall Study|Adverse Event|1|||
105684173|NCT03333837|364506777|FG003|Overall Study|Adverse Event|1|||
105684174|NCT03333837|364506778|FG004|Overall Study|Adverse Event|0|||
105684175|NCT03333837|364506774|FG000|Overall Study|Caregiver withdrew|0|||
105684176|NCT03333837|364506775|FG001|Overall Study|Caregiver withdrew|2|||
105684177|NCT03333837|364506776|FG002|Overall Study|Caregiver withdrew|1|||
105684178|NCT03333837|364506777|FG003|Overall Study|Caregiver withdrew|0|||
105684179|NCT03333837|364506778|FG004|Overall Study|Caregiver withdrew|0|||
105684180|NCT03333837|364506774|FG000|Overall Study|Withdrawal by Subject|0|||
105684181|NCT03333837|364506775|FG001|Overall Study|Withdrawal by Subject|0|||
105917195|NCT04400318|365356809|FG001|Overall Study|Withdrawal by Subject|1|||
105917196|NCT04400318|365356808|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
105684182|NCT03333837|364506776|FG002|Overall Study|Withdrawal by Subject|1|||
105684183|NCT03333837|364506777|FG003|Overall Study|Withdrawal by Subject|1|||
105684184|NCT03333837|364506778|FG004|Overall Study|Withdrawal by Subject|3|||
105684185|NCT03333837|364506774|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
105684186|NCT03333837|364506775|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
105684187|NCT03333837|364506776|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
105684188|NCT03333837|364506777|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
105684189|NCT03333837|364506778|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
105684190|NCT04217590|364506779|FG000|Overall Study|Other|1|||
105684191|NCT04217590|364506780|FG001|Overall Study|Other|1|||
105684192|NCT04217590|364506779|FG000|Overall Study|Withdrawal by Subject|3|||
105684193|NCT04217590|364506780|FG001|Overall Study|Withdrawal by Subject|1|||
105684194|NCT04217590|364506779|FG000|Overall Study|Death|0|||
105684195|NCT04217590|364506780|FG001|Overall Study|Death|1|||
105684196|NCT03353350|364506781|FG000|30-week Core Treatment Period|Protocol Violation|1|||
105684197|NCT03353350|364506782|FG001|30-week Core Treatment Period|Protocol Violation|1|||
105684198|NCT03353350|364506783|FG002|30-week Core Treatment Period|Protocol Violation|1|||
105684199|NCT03353350|364506784|FG003|30-week Core Treatment Period|Protocol Violation|0|||
105684200|NCT03353350|364506781|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
105684201|NCT03353350|364506782|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
105684202|NCT03353350|364506783|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
105684203|NCT03353350|364506784|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
105684204|NCT03353350|364506781|FG000|30-week Core Treatment Period|Adverse Event|0|||
105684205|NCT03353350|364506782|FG001|30-week Core Treatment Period|Adverse Event|4|||
105684206|NCT03353350|364506783|FG002|30-week Core Treatment Period|Adverse Event|2|||
105684207|NCT03353350|364506784|FG003|30-week Core Treatment Period|Adverse Event|3|||
105684208|NCT03353350|364506781|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
105684209|NCT03353350|364506782|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
105684210|NCT03353350|364506783|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
105684211|NCT03353350|364506784|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
105684212|NCT03353350|364506781|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
105684213|NCT03353350|364506782|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
105684214|NCT03353350|364506783|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
105684215|NCT03353350|364506784|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
105684216|NCT03353350|364506781|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
105684217|NCT03353350|364506782|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
105684218|NCT03353350|364506783|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
105684219|NCT03353350|364506784|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
105684220|NCT03353350|364506781|FG000|26-week Treatment Extension Period|Adverse Event|1|||
105684221|NCT03353350|364506782|FG001|26-week Treatment Extension Period|Adverse Event|0|||
105684222|NCT03353350|364506783|FG002|26-week Treatment Extension Period|Adverse Event|0|||
105684223|NCT03353350|364506784|FG003|26-week Treatment Extension Period|Adverse Event|1|||
105684224|NCT03353350|364506781|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
105684225|NCT03353350|364506782|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
105684226|NCT03353350|364506783|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
105684227|NCT03353350|364506784|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
105684228|NCT02003573|364506785|FG000|Overall Study|Progressive disease|2|||
105684229|NCT02003573|364506786|FG001|Overall Study|Progressive disease|0|||
105684230|NCT02003573|364506787|FG002|Overall Study|Progressive disease|1|||
105684231|NCT02003573|364506785|FG000|Overall Study|Other Adverse event|0|||
105684232|NCT02003573|364506786|FG001|Overall Study|Other Adverse event|1|||
105684233|NCT02003573|364506787|FG002|Overall Study|Other Adverse event|1|||
105684234|NCT02003573|364506785|FG000|Overall Study|Refuse to take trial medication|0|||
105684235|NCT02003573|364506786|FG001|Overall Study|Refuse to take trial medication|1|||
105684236|NCT02003573|364506787|FG002|Overall Study|Refuse to take trial medication|1|||
105684237|NCT02003573|364506785|FG000|Overall Study|Other than specified|1|||
105684238|NCT02003573|364506786|FG001|Overall Study|Other than specified|2|||
105684239|NCT02003573|364506787|FG002|Overall Study|Other than specified|3|||
105684240|NCT02988622|364506788|FG000|Overall Study|Lost to Follow-up|17|||
105684241|NCT03261700|364506789|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
105684242|NCT03261700|364506790|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
105684243|NCT03562247|364506791|FG000|Overall Study|Lost to Follow-up|3|||
105684244|NCT03562247|364506792|FG001|Overall Study|Lost to Follow-up|1|||
105684245|NCT03562247|364506793|FG002|Overall Study|Lost to Follow-up|1|||
105786534|NCT05048875|364871453|FG005|Overall Study|Withdrawal by Subject|0|||
105786535|NCT05048875|364871454|FG006|Overall Study|Withdrawal by Subject|0|||
105786536|NCT05048875|364871455|FG007|Overall Study|Withdrawal by Subject|0|||
105786537|NCT05048875|364871448|FG000|Overall Study|Adverse Event|0|||
105786538|NCT05048875|364871449|FG001|Overall Study|Adverse Event|0|||
105684246|NCT00983931|364506794|FG000|14 Day Washout Period|Physician Decision|1|||
105684247|NCT02513745|364506802|FG000|Overall Study|Criteria at time of surgery not met.|3|||
105684248|NCT02513745|364506803|FG001|Overall Study|Criteria at time of surgery not met.|3|||
105684249|NCT00427895|364506804|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684250|NCT00427895|364506805|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684251|NCT00427895|364506806|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105786539|NCT05048875|364871450|FG002|Overall Study|Adverse Event|0|||
105786540|NCT05048875|364871451|FG003|Overall Study|Adverse Event|1|||
105684252|NCT00427895|364506807|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
105684253|NCT00427895|364506808|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684254|NCT00427895|364506809|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684255|NCT00427895|364506810|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684256|NCT00427895|364506811|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
105684257|NCT00427895|364506804|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684258|NCT00427895|364506805|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684259|NCT00427895|364506806|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684260|NCT00427895|364506807|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684261|NCT00427895|364506808|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684262|NCT00427895|364506809|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684263|NCT00427895|364506810|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
105684264|NCT00427895|364506811|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
105684265|NCT00427895|364506804|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684266|NCT00427895|364506805|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684267|NCT00427895|364506806|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684268|NCT00427895|364506807|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684269|NCT00427895|364506808|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684270|NCT00427895|364506809|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684271|NCT00427895|364506810|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
105684272|NCT00427895|364506811|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
105684273|NCT00427895|364506804|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
105684274|NCT00427895|364506805|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
105684275|NCT00427895|364506806|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
105684276|NCT00427895|364506807|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
105684277|NCT00427895|364506808|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
105684278|NCT00427895|364506809|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
105684279|NCT00427895|364506810|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
105684280|NCT00427895|364506811|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
105684281|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684282|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
105684283|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
105684284|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
105684285|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684286|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684287|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684288|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
105684289|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
105684290|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684291|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
105684292|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
105684293|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684294|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684295|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684296|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
105684297|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
105684298|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
105684299|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684300|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684301|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684302|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684303|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684304|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
105684305|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
105684306|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
105684307|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
105684308|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
105684309|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
105684310|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
105684311|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
105684312|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
105684313|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
106001223|NCT03550378|365665233|FG000|Overall Study|Death|0|||
105684314|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684315|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684316|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
105684317|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684318|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684319|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684320|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
105684321|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
105684322|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
105684323|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
105684324|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
105684325|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
105684326|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
105684327|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
105684328|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
105684329|NCT00427895|364506804|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684330|NCT00427895|364506805|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684331|NCT00427895|364506806|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
105684332|NCT00427895|364506807|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
105684333|NCT00427895|364506808|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684334|NCT00427895|364506809|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684335|NCT00427895|364506810|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684336|NCT00427895|364506811|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
105684337|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684338|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
105684339|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
105684340|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
105684341|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684342|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684343|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684344|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
105684345|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
105684346|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
105684347|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684348|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
105684349|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684350|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684351|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684352|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
105684353|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
105684354|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
105684355|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
105684356|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
105684357|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
105684358|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
105684359|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
105684360|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
105684361|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684362|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
105684363|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684364|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684365|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684366|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684367|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684368|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
105684369|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Death|1|||
105684370|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Death|0|||
105684371|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Death|0|||
105684372|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Death|0|||
105684373|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Death|0|||
105684374|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Death|0|||
105684375|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Death|0|||
105684376|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Death|0|||
105684377|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105917197|NCT04400318|365356809|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
105917198|NCT01239797|365356810|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
105684378|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684379|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
105684380|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
105684381|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684382|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684383|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
105684384|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
106001224|NCT03550378|365665234|FG001|Overall Study|Death|1|||
105684385|NCT00427895|364506804|FG000|Vax 1/Year 1 Follow-up|Other|0|||
105684386|NCT00427895|364506805|FG001|Vax 1/Year 1 Follow-up|Other|0|||
105684387|NCT00427895|364506806|FG002|Vax 1/Year 1 Follow-up|Other|0|||
105684388|NCT00427895|364506807|FG003|Vax 1/Year 1 Follow-up|Other|2|||
105684389|NCT00427895|364506808|FG004|Vax 1/Year 1 Follow-up|Other|0|||
105684390|NCT00427895|364506809|FG005|Vax 1/Year 1 Follow-up|Other|0|||
105684391|NCT00427895|364506810|FG006|Vax 1/Year 1 Follow-up|Other|0|||
105684392|NCT00427895|364506811|FG007|Vax 1/Year 1 Follow-up|Other|0|||
105684393|NCT00427895|364506804|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
105684394|NCT00427895|364506805|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
105684395|NCT00427895|364506806|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
105684396|NCT00427895|364506807|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
105684397|NCT00427895|364506808|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
105684398|NCT00427895|364506809|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
105684399|NCT00427895|364506810|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
105684400|NCT00427895|364506811|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
105684401|NCT02730598|364506824|FG000|Overall Study|Withdrawal by Subject|3|||
105684402|NCT02730598|364506825|FG001|Overall Study|Withdrawal by Subject|3|||
105684403|NCT02730598|364506824|FG000|Overall Study|Protocol Violation|0|||
105684404|NCT02730598|364506825|FG001|Overall Study|Protocol Violation|1|||
105684405|NCT02730598|364506824|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
105684406|NCT02730598|364506825|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
105684407|NCT03282240|364506826|FG000|Overall Study|Adverse Event|2|||
105684408|NCT03282240|364506827|FG001|Overall Study|Adverse Event|2|||
105684409|NCT03282240|364506828|FG002|Overall Study|Adverse Event|0|||
105684410|NCT03282240|364506826|FG000|Overall Study|Lost to Follow-up|3|||
105684411|NCT03282240|364506827|FG001|Overall Study|Lost to Follow-up|0|||
105684412|NCT03282240|364506828|FG002|Overall Study|Lost to Follow-up|0|||
105684413|NCT03282240|364506826|FG000|Overall Study|Protocol Deviation|4|||
105684414|NCT03282240|364506827|FG001|Overall Study|Protocol Deviation|1|||
105684415|NCT03282240|364506828|FG002|Overall Study|Protocol Deviation|2|||
105684416|NCT03282240|364506826|FG000|Overall Study|Withdrawal by Subject|1|||
105684417|NCT03282240|364506827|FG001|Overall Study|Withdrawal by Subject|0|||
105684418|NCT03282240|364506828|FG002|Overall Study|Withdrawal by Subject|1|||
105684419|NCT01675479|364506829|FG000|Overall Study|Lost to Follow-up|11|||
105684420|NCT02146326|364506830|FG000|Overall Study|Lost to Follow-up|3|||
105684421|NCT02146326|364506831|FG001|Overall Study|Lost to Follow-up|3|||
105684422|NCT02146326|364506832|FG002|Overall Study|Lost to Follow-up|11|||
105684423|NCT02146326|364506833|FG003|Overall Study|Lost to Follow-up|19|||
105684424|NCT02146326|364506830|FG000|Overall Study|Withdrawal by Subject|2|||
105684425|NCT02146326|364506831|FG001|Overall Study|Withdrawal by Subject|1|||
105684426|NCT02146326|364506832|FG002|Overall Study|Withdrawal by Subject|15|||
105684427|NCT02146326|364506833|FG003|Overall Study|Withdrawal by Subject|11|||
105684428|NCT02146326|364506830|FG000|Overall Study|Separated from mental health center|23|||
105684429|NCT02146326|364506831|FG001|Overall Study|Separated from mental health center|33|||
105684430|NCT02146326|364506832|FG002|Overall Study|Separated from mental health center|0|||
105684431|NCT02146326|364506833|FG003|Overall Study|Separated from mental health center|0|||
105684432|NCT02146326|364506830|FG000|Overall Study|Incarcerated|0|||
105684433|NCT02146326|364506831|FG001|Overall Study|Incarcerated|0|||
105684434|NCT02146326|364506832|FG002|Overall Study|Incarcerated|3|||
105684435|NCT02146326|364506833|FG003|Overall Study|Incarcerated|8|||
105684436|NCT02146326|364506830|FG000|Overall Study|Death|0|||
105684437|NCT02146326|364506831|FG001|Overall Study|Death|0|||
105684438|NCT02146326|364506832|FG002|Overall Study|Death|4|||
105684439|NCT02146326|364506833|FG003|Overall Study|Death|4|||
105684440|NCT02146326|364506830|FG000|Overall Study|Unable to complete interview|0|||
105684441|NCT02146326|364506831|FG001|Overall Study|Unable to complete interview|0|||
105684442|NCT02146326|364506832|FG002|Overall Study|Unable to complete interview|10|||
105684443|NCT02146326|364506833|FG003|Overall Study|Unable to complete interview|6|||
105684444|NCT01910181|364506834|FG000|Overall Study|Death|37|||
105684445|NCT01910181|364506834|FG000|Overall Study|Lost to Follow-up|3|||
105684446|NCT01910181|364506834|FG000|Overall Study|Study Terminated by Sponsor|6|||
105684447|NCT01328717|364509251|FG000|Overall Study|Adverse Event|1|||
105684448|NCT00346268|364509252|FG000|Overall Study|Adverse Event|1|||
105684449|NCT00346268|364509253|FG001|Overall Study|Adverse Event|0|||
105684450|NCT00346268|364509252|FG000|Overall Study|Protocol Violation|1|||
105684451|NCT00346268|364509253|FG001|Overall Study|Protocol Violation|0|||
105684452|NCT00346268|364509252|FG000|Overall Study|Participant refused|0|||
105684453|NCT00346268|364509253|FG001|Overall Study|Participant refused|3|||
105684454|NCT01177722|364509256|FG000|Overall Study|Serious Adverse Event|0|||
105684455|NCT01177722|364509257|FG001|Overall Study|Serious Adverse Event|0|||
105684456|NCT01177722|364509258|FG002|Overall Study|Serious Adverse Event|1|||
105684457|NCT01177722|364509259|FG003|Overall Study|Serious Adverse Event|0|||
105684458|NCT01177722|364509256|FG000|Overall Study|Protocol Violation|0|||
105684459|NCT01177722|364509257|FG001|Overall Study|Protocol Violation|0|||
105684460|NCT01177722|364509258|FG002|Overall Study|Protocol Violation|1|||
105684461|NCT01177722|364509259|FG003|Overall Study|Protocol Violation|0|||
105684462|NCT01177722|364509256|FG000|Overall Study|Lost to Follow-up|3|||
105684463|NCT01177722|364509257|FG001|Overall Study|Lost to Follow-up|4|||
105684464|NCT01177722|364509258|FG002|Overall Study|Lost to Follow-up|3|||
105684465|NCT01177722|364509259|FG003|Overall Study|Lost to Follow-up|1|||
105684466|NCT01177722|364509256|FG000|Overall Study|Withdrawal by Subject|10|||
105684467|NCT01177722|364509257|FG001|Overall Study|Withdrawal by Subject|6|||
105684468|NCT01177722|364509258|FG002|Overall Study|Withdrawal by Subject|4|||
105684469|NCT01177722|364509259|FG003|Overall Study|Withdrawal by Subject|6|||
105684470|NCT02831387|364509260|FG000|Overall Study|Withdrawal by Subject|1|||
105684471|NCT02831387|364509261|FG001|Overall Study|Withdrawal by Subject|1|||
105684472|NCT02831387|364509260|FG000|Overall Study|Discontinued due to stock recovery|0|||
105684473|NCT02831387|364509261|FG001|Overall Study|Discontinued due to stock recovery|1|||
105684474|NCT01828073|364509262|FG000|Overall Study|Lost to Follow-up|1|||
105684475|NCT01828073|364509263|FG001|Overall Study|Lost to Follow-up|2|||
105684476|NCT02915302|364509264|FG000|Overall Study|Adverse Event|3|||
105684477|NCT02915302|364509265|FG001|Overall Study|Adverse Event|0|||
105684478|NCT02915302|364509264|FG000|Overall Study|Protocol Violation|20|||
105684479|NCT02915302|364509265|FG001|Overall Study|Protocol Violation|27|||
105684480|NCT02915302|364509264|FG000|Overall Study|Lost to Follow-up|19|||
105684481|NCT02915302|364509265|FG001|Overall Study|Lost to Follow-up|22|||
105684482|NCT02915302|364509264|FG000|Overall Study|Withdrawal by Subject|22|||
105684483|NCT02915302|364509265|FG001|Overall Study|Withdrawal by Subject|29|||
105684484|NCT02915302|364509264|FG000|Overall Study|Other|1|||
105684485|NCT02915302|364509265|FG001|Overall Study|Other|0|||
105684486|NCT00690443|364509270|FG000|Overall Study|Adverse Event|1|||
105684487|NCT00690443|364509271|FG001|Overall Study|Adverse Event|2|||
105684488|NCT00645801|364509272|FG000|Overall Study|unclear if patient took all the medication.|1|||
105684489|NCT00645801|364509273|FG001|Overall Study|unclear if patient took all the medication.|0|||
105684490|NCT00645801|364509272|FG000|Overall Study|Lost to Follow-up|19|||
105684491|NCT00645801|364509273|FG001|Overall Study|Lost to Follow-up|15|||
105684492|NCT00932113|364509274|FG000|Overall Study|Lost to Follow-up|1|||
105684493|NCT00932113|364509275|FG001|Overall Study|Lost to Follow-up|0|||
105684494|NCT01386788|364509280|FG000|Overall Study|Lost to Follow-up|2|||
105684495|NCT00706433|364509283|FG000|Overall Study|Lost to Follow-up|3|||
105684496|NCT00706433|364509284|FG001|Overall Study|Lost to Follow-up|1|||
105684497|NCT00706433|364509285|FG002|Overall Study|Lost to Follow-up|6|||
105684498|NCT00706433|364509286|FG003|Overall Study|Lost to Follow-up|0|||
105684499|NCT00706433|364509283|FG000|Overall Study|Withdrawal by Subject|1|||
105684500|NCT00706433|364509284|FG001|Overall Study|Withdrawal by Subject|2|||
105684501|NCT00706433|364509285|FG002|Overall Study|Withdrawal by Subject|3|||
105684502|NCT00706433|364509286|FG003|Overall Study|Withdrawal by Subject|1|||
105684503|NCT00706433|364509283|FG000|Overall Study|Adverse Event|0|||
105684504|NCT00706433|364509284|FG001|Overall Study|Adverse Event|0|||
105684505|NCT00706433|364509285|FG002|Overall Study|Adverse Event|1|||
105684506|NCT00706433|364509286|FG003|Overall Study|Adverse Event|0|||
105684507|NCT00706433|364509283|FG000|Overall Study|Protocol Violation|1|||
105684508|NCT00706433|364509284|FG001|Overall Study|Protocol Violation|0|||
105684509|NCT00706433|364509285|FG002|Overall Study|Protocol Violation|0|||
105684510|NCT00706433|364509286|FG003|Overall Study|Protocol Violation|0|||
105684511|NCT00706433|364509283|FG000|Overall Study|new job|0|||
105684512|NCT00706433|364509284|FG001|Overall Study|new job|0|||
105684513|NCT00706433|364509285|FG002|Overall Study|new job|0|||
105684514|NCT00706433|364509286|FG003|Overall Study|new job|1|||
105684515|NCT04964388|364509291|FG000|Overall Study|Lost to Follow-up|3|||
105684516|NCT04964388|364509292|FG001|Overall Study|Lost to Follow-up|2|||
105684517|NCT03486457|364509293|FG000|Up to Month 3|Adverse Event|2|||
105684518|NCT03486457|364509294|FG001|Up to Month 3|Adverse Event|5|||
105917199|NCT01239797|365356811|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
105917200|NCT01239797|365356810|FG000|Randomized Participants|Participant withdrew consent|1|||
105917201|NCT01239797|365356811|FG001|Randomized Participants|Participant withdrew consent|7|||
105917202|NCT01239797|365356810|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
105917203|NCT01239797|365356811|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
105917204|NCT01239797|365356810|FG000|Treated Participants|Disease progression|185|||
105917205|NCT01239797|365356811|FG001|Treated Participants|Disease progression|185|||
105917206|NCT01239797|365356810|FG000|Treated Participants|Study drug toxicity|39|||
105917207|NCT01239797|365356811|FG001|Treated Participants|Study drug toxicity|45|||
105917208|NCT01239797|365356810|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
105684519|NCT03486457|364509293|FG000|Up to Month 3|Lack of Efficacy|1|||
105684520|NCT03486457|364509294|FG001|Up to Month 3|Lack of Efficacy|0|||
105684521|NCT03486457|364509293|FG000|Up to Month 3|Withdrawal by Subject|1|||
105684522|NCT03486457|364509294|FG001|Up to Month 3|Withdrawal by Subject|0|||
105684523|NCT03486457|364509293|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
105684524|NCT03486457|364509294|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
105684525|NCT03486457|364509293|FG000|Up to Month 3|Other|1|||
105684526|NCT03486457|364509294|FG001|Up to Month 3|Other|0|||
105684527|NCT03486457|364509293|FG000|Month 3 to Month 6|Adverse Event|2|||
105684528|NCT03486457|364509294|FG001|Month 3 to Month 6|Adverse Event|0|||
105684529|NCT03486457|364509293|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
105684530|NCT03486457|364509294|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
105684531|NCT03486457|364509293|FG000|Month 3 to Month 6|Pregnancy|0|||
105684532|NCT03486457|364509294|FG001|Month 3 to Month 6|Pregnancy|1|||
105684533|NCT03486457|364509293|FG000|Month 3 to Month 6|Other|1|||
105684534|NCT03486457|364509294|FG001|Month 3 to Month 6|Other|0|||
106128165|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
106128166|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
106128167|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
106128168|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
106128169|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
106128170|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
106128171|NCT01473420|366125562|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
106128172|NCT01473420|366125563|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
106128173|NCT03246672|366125565|FG000|Overall Study|Lost to Follow-up|2|||
106128174|NCT02806336|366125566|FG000|Overall Study|Physician Decision|1|||
106128175|NCT02806336|366125567|FG001|Overall Study|Physician Decision|0|||
106128176|NCT02806336|366125566|FG000|Overall Study|Withdrawal by Subject|2|||
106128177|NCT02806336|366125567|FG001|Overall Study|Withdrawal by Subject|4|||
106128178|NCT02806336|366125566|FG000|Overall Study|COVID-19 research shut down|3|||
106128179|NCT02806336|366125567|FG001|Overall Study|COVID-19 research shut down|4|||
106128180|NCT02806336|366125566|FG000|Overall Study|Lack of Efficacy|0|||
105684535|NCT02527343|364509295|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
105684536|NCT02527343|364509296|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
106128181|NCT02806336|366125567|FG001|Overall Study|Lack of Efficacy|1|||
106128182|NCT01670500|366125572|FG000|Overall Study|Withdrawal by Subject|1|||
106128183|NCT01670500|366125573|FG001|Overall Study|Withdrawal by Subject|0|||
106128184|NCT03714022|366125574|FG000|Overall Study|Adverse Event|1|||
106128185|NCT03714022|366125575|FG001|Overall Study|Adverse Event|0|||
106128186|NCT03714022|366125574|FG000|Overall Study|Consent withdrawal|0|||
106128187|NCT03714022|366125575|FG001|Overall Study|Consent withdrawal|1|||
106128188|NCT03714022|366125574|FG000|Overall Study|Lost to Follow-up|3|||
106128189|NCT03714022|366125575|FG001|Overall Study|Lost to Follow-up|2|||
106128190|NCT02148718|366125576|FG000|Overall Study|Protocol Violation|26|||
105684537|NCT02527343|364509297|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105684538|NCT02527343|364509298|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105684539|NCT02527343|364509299|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105684540|NCT02527343|364509300|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
105684541|NCT02527343|364509295|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
105684542|NCT02527343|364509296|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
106128191|NCT02148718|366125576|FG000|Overall Study|Discontinued Study Prematurely|5|||
106128192|NCT04793464|366125577|FG000|Overall Study|Lost to Follow-up|458|||
105684543|NCT02527343|364509297|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105684544|NCT02527343|364509298|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105684545|NCT02527343|364509299|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105684546|NCT02527343|364509300|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
105684547|NCT02527343|364509295|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105684548|NCT02527343|364509296|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
106128193|NCT04793464|366125578|FG001|Overall Study|Lost to Follow-up|168|||
105684549|NCT02527343|364509297|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105684550|NCT02527343|364509298|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
106128194|NCT04793464|366125579|FG002|Overall Study|Lost to Follow-up|5|||
106128195|NCT04793464|366125577|FG000|Overall Study|Withdrawal by Subject|43|||
106128196|NCT04793464|366125578|FG001|Overall Study|Withdrawal by Subject|15|||
105684551|NCT02527343|364509299|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105684552|NCT02527343|364509300|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105684553|NCT02527343|364509295|FG000|RT Period: Weeks 1 to 52|Other|4|||
105684554|NCT02527343|364509296|FG001|RT Period: Weeks 1 to 52|Other|3|||
105684555|NCT02527343|364509297|FG002|RT Period: Weeks 1 to 52|Other|0|||
106128197|NCT04793464|366125579|FG002|Overall Study|Withdrawal by Subject|0|||
106128198|NCT00003509|366125580|FG000|Overall Study|Not evaluable|5|||
106128199|NCT03873246|366125581|FG000|Overall Study|Adverse Event|1|||
106128200|NCT03873246|366125582|FG001|Overall Study|Adverse Event|3|||
106128201|NCT03873246|366125583|FG002|Overall Study|Adverse Event|3|||
105684556|NCT02527343|364509298|FG003|RT Period: Weeks 1 to 52|Other|0|||
105684557|NCT02527343|364509299|FG004|RT Period: Weeks 1 to 52|Other|0|||
105684558|NCT02527343|364509300|FG005|RT Period: Weeks 1 to 52|Other|0|||
105684559|NCT02527343|364509295|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105684560|NCT02527343|364509296|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
106128202|NCT03873246|366125581|FG000|Overall Study|Lost to Follow-up|4|||
106128203|NCT03873246|366125582|FG001|Overall Study|Lost to Follow-up|4|||
106128204|NCT03873246|366125583|FG002|Overall Study|Lost to Follow-up|5|||
106128205|NCT03873246|366125581|FG000|Overall Study|Protocol Violation|0|||
105684561|NCT02527343|364509297|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
105684562|NCT02527343|364509298|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105684563|NCT02527343|364509299|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105684564|NCT02527343|364509300|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
105684565|NCT02527343|364509295|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684566|NCT02527343|364509296|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684567|NCT02527343|364509297|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684568|NCT02527343|364509298|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
105684569|NCT02527343|364509299|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684570|NCT02527343|364509300|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
105684571|NCT02527343|364509295|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684572|NCT02527343|364509296|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684573|NCT02527343|364509297|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684574|NCT02527343|364509298|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684575|NCT02527343|364509299|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
105684576|NCT02527343|364509300|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
105684577|NCT02527343|364509295|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
105684578|NCT02527343|364509296|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
105684579|NCT02527343|364509297|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
105684580|NCT02527343|364509298|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
105684581|NCT02527343|364509299|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
105684582|NCT02527343|364509300|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
105684583|NCT02527343|364509295|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
105684584|NCT02527343|364509296|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
105684585|NCT02527343|364509297|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
105684586|NCT02527343|364509298|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
105684587|NCT02527343|364509299|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
105684588|NCT02527343|364509300|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
105684589|NCT02527343|364509295|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
105684590|NCT02527343|364509296|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
105684591|NCT02527343|364509297|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
105684592|NCT02527343|364509298|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
105684593|NCT02527343|364509299|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
105684594|NCT02527343|364509300|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
105684595|NCT02527343|364509295|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
105684596|NCT02527343|364509296|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
105684597|NCT02527343|364509297|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
105684598|NCT02527343|364509298|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
105684599|NCT02527343|364509299|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
105684600|NCT02527343|364509300|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
105684601|NCT02527343|364509295|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684602|NCT02527343|364509296|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684603|NCT02527343|364509297|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684604|NCT02527343|364509298|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684605|NCT02527343|364509299|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
105684606|NCT02527343|364509300|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
105684607|NCT02527343|364509295|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
105684608|NCT02527343|364509296|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
105684609|NCT02527343|364509297|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
105684610|NCT02527343|364509298|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
105684611|NCT02527343|364509299|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
105684612|NCT02527343|364509300|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
105684613|NCT05041101|364509303|FG000|Overall Study|Adverse Event|1|||
105684614|NCT05041101|364509304|FG001|Overall Study|Adverse Event|0|||
105684615|NCT05041101|364509305|FG002|Overall Study|Adverse Event|0|||
105684616|NCT05041101|364509303|FG000|Overall Study|Diease Progression|5|||
105684617|NCT05041101|364509304|FG001|Overall Study|Diease Progression|0|||
105684618|NCT05041101|364509305|FG002|Overall Study|Diease Progression|0|||
105684619|NCT00211185|364509306|FG000|Overall Study|Death|2|||
105684620|NCT00211185|364509306|FG000|Overall Study|Disease progression|7|||
105917209|NCT01239797|365356811|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
105917210|NCT01239797|365356810|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
105917211|NCT01239797|365356811|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
105917212|NCT01239797|365356810|FG000|Treated Participants|Administrative reason by sponsor|13|||
105917213|NCT01239797|365356811|FG001|Treated Participants|Administrative reason by sponsor|4|||
105917214|NCT01239797|365356810|FG000|Treated Participants|Other reasons|14|||
105917215|NCT01239797|365356811|FG001|Treated Participants|Other reasons|14|||
105917216|NCT01239797|365356810|FG000|Treated Participants|Participant withdrew consent|6|||
105917217|NCT01239797|365356811|FG001|Treated Participants|Participant withdrew consent|11|||
105917218|NCT01239797|365356810|FG000|Treated Participants|Death|1|||
105917219|NCT01239797|365356811|FG001|Treated Participants|Death|1|||
105917220|NCT01239797|365356810|FG000|Treated Participants|Participant no longer meets study criteria|1|||
105917221|NCT01239797|365356811|FG001|Treated Participants|Participant no longer meets study criteria|1|||
105684621|NCT00211185|364509306|FG000|Overall Study|Withdrawal by Subject|6|||
105684622|NCT00211185|364509306|FG000|Overall Study|Physician Decision|5|||
105684623|NCT03256851|364509307|FG000|Overall Study|Withdrawal by Subject|1|||
105684624|NCT03256851|364509308|FG001|Overall Study|Withdrawal by Subject|0|||
105684625|NCT03451162|364509310|FG000|Overall Study|Lost to Follow-up|1|||
105684626|NCT03451162|364509311|FG001|Overall Study|Lost to Follow-up|0|||
105684627|NCT03451162|364509312|FG002|Overall Study|Lost to Follow-up|0|||
105684628|NCT03451162|364509313|FG003|Overall Study|Lost to Follow-up|0|||
105684629|NCT03451162|364509314|FG004|Overall Study|Lost to Follow-up|0|||
105684630|NCT03451162|364509310|FG000|Overall Study|Physician Decision|0|||
105684631|NCT03451162|364509311|FG001|Overall Study|Physician Decision|1|||
105684632|NCT03451162|364509312|FG002|Overall Study|Physician Decision|0|||
105684633|NCT03451162|364509313|FG003|Overall Study|Physician Decision|0|||
105684634|NCT03451162|364509314|FG004|Overall Study|Physician Decision|0|||
105684635|NCT03451162|364509310|FG000|Overall Study|Withdrawal by Subject|1|||
105684636|NCT03451162|364509311|FG001|Overall Study|Withdrawal by Subject|1|||
105684637|NCT03451162|364509312|FG002|Overall Study|Withdrawal by Subject|0|||
105684638|NCT03451162|364509313|FG003|Overall Study|Withdrawal by Subject|0|||
105684639|NCT03451162|364509314|FG004|Overall Study|Withdrawal by Subject|0|||
105684640|NCT01952054|364509315|FG000|Overall Study|Physician Decision|1|||
105684641|NCT01127139|364509316|FG000|Overall Study|Adverse Event|40|||
105684642|NCT01127139|364509316|FG000|Overall Study|Incompliance|12|||
105684643|NCT01127139|364509316|FG000|Overall Study|Lack of Efficacy|4|||
105684644|NCT01127139|364509316|FG000|Overall Study|Reason not specified|1|||
105684645|NCT02294227|364509322|FG000|Overall Study|Death|0|||
105684646|NCT02294227|364509323|FG001|Overall Study|Death|0|||
105684647|NCT02294227|364509324|FG002|Overall Study|Death|1|||
105684648|NCT02294227|364509322|FG000|Overall Study|Subject/Guardian Decision|6|||
105684649|NCT02294227|364509323|FG001|Overall Study|Subject/Guardian Decision|3|||
105684650|NCT02294227|364509324|FG002|Overall Study|Subject/Guardian Decision|7|||
105684651|NCT02294227|364509322|FG000|Overall Study|Physician Decision|1|||
105684652|NCT02294227|364509323|FG001|Overall Study|Physician Decision|2|||
105684653|NCT02294227|364509324|FG002|Overall Study|Physician Decision|1|||
105684654|NCT02294227|364509322|FG000|Overall Study|Lost to Follow-up|1|||
105684655|NCT02294227|364509323|FG001|Overall Study|Lost to Follow-up|0|||
105684656|NCT02294227|364509324|FG002|Overall Study|Lost to Follow-up|0|||
105684657|NCT02294227|364509322|FG000|Overall Study|Lack of Efficacy|11|||
105684658|NCT02294227|364509323|FG001|Overall Study|Lack of Efficacy|12|||
105684659|NCT02294227|364509324|FG002|Overall Study|Lack of Efficacy|8|||
105684660|NCT02294227|364509322|FG000|Overall Study|Adverse Event|6|||
105684661|NCT02294227|364509323|FG001|Overall Study|Adverse Event|8|||
105684662|NCT02294227|364509324|FG002|Overall Study|Adverse Event|2|||
105684663|NCT00687973|364509325|FG000|Overall Study|Adverse Event|18|||
105684664|NCT00687973|364509326|FG001|Overall Study|Adverse Event|28|||
105684665|NCT00687973|364509325|FG000|Overall Study|Lack of Efficacy|2|||
105684666|NCT00687973|364509326|FG001|Overall Study|Lack of Efficacy|3|||
105684667|NCT00687973|364509325|FG000|Overall Study|Protocol Violation|1|||
105684668|NCT00687973|364509326|FG001|Overall Study|Protocol Violation|2|||
105684669|NCT00687973|364509325|FG000|Overall Study|Administrative Reasons|0|||
105684670|NCT00687973|364509326|FG001|Overall Study|Administrative Reasons|2|||
105684671|NCT00687973|364509325|FG000|Overall Study|Withdrawal by Subject|3|||
105684672|NCT00687973|364509326|FG001|Overall Study|Withdrawal by Subject|3|||
105684673|NCT01007448|364509327|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
105684674|NCT01007448|364509328|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
105684675|NCT01007448|364509327|FG000|Overall Study|Staph Skin Infection Flare|1|||
105684676|NCT01007448|364509328|FG001|Overall Study|Staph Skin Infection Flare|0|||
105684677|NCT01007448|364509327|FG000|Overall Study|Participant Leaving the Country|1|||
105684678|NCT01007448|364509328|FG001|Overall Study|Participant Leaving the Country|0|||
105684679|NCT01007448|364509327|FG000|Overall Study|Participant Given Prohibited Medication|1|||
105684680|NCT01007448|364509328|FG001|Overall Study|Participant Given Prohibited Medication|0|||
105684681|NCT01007448|364509327|FG000|Overall Study|Progressive Disease|1|||
105684682|NCT01007448|364509328|FG001|Overall Study|Progressive Disease|2|||
105684683|NCT01007448|364509327|FG000|Overall Study|Lack of Efficacy|2|||
105684684|NCT01007448|364509328|FG001|Overall Study|Lack of Efficacy|0|||
105684685|NCT01007448|364509327|FG000|Overall Study|Withdrawal by Subject|2|||
105684686|NCT01007448|364509328|FG001|Overall Study|Withdrawal by Subject|3|||
105684687|NCT01007448|364509327|FG000|Overall Study|Adverse Event|1|||
105684688|NCT01007448|364509328|FG001|Overall Study|Adverse Event|4|||
105684689|NCT00887432|364509329|FG000|Overall Study|Start Excluded Therapy|3|||
105684690|NCT00887432|364509330|FG001|Overall Study|Start Excluded Therapy|0|||
105684691|NCT00887432|364509329|FG000|Overall Study|Did not complete treatment|6|||
105684692|NCT00887432|364509330|FG001|Overall Study|Did not complete treatment|8|||
105684693|NCT00887432|364509329|FG000|Overall Study|Protocol Violation|2|||
105684694|NCT00887432|364509330|FG001|Overall Study|Protocol Violation|3|||
105684695|NCT00887432|364509329|FG000|Overall Study|Withdrawal by Subject|3|||
106001225|NCT00468299|365665238|FG000|Overall Study|Withdrawal by Subject|0|||
106001226|NCT00468299|365665239|FG001|Overall Study|Withdrawal by Subject|1|||
106001227|NCT03649217|365665240|FG000|Overall Study|subject had severe ataxia not initially found|1|||
106001228|NCT03649217|365665240|FG000|Overall Study|subject had cognitive issues not initially found|1|||
106001229|NCT02520726|365665241|FG000|Overall Study|Lost to Follow-up|3|||
106001230|NCT02520726|365665242|FG001|Overall Study|Lost to Follow-up|2|||
106001231|NCT01362348|365665243|FG000|Overall Study|Protocol-defined stopping criteria|9|||
106001232|NCT01362348|365665243|FG000|Overall Study|Study closed/terminated|5|||
105684696|NCT00887432|364509330|FG001|Overall Study|Withdrawal by Subject|2|||
105684697|NCT00887432|364509329|FG000|Overall Study|Lost to Follow-up|1|||
105684698|NCT00887432|364509330|FG001|Overall Study|Lost to Follow-up|0|||
105684699|NCT00887432|364509329|FG000|Overall Study|No reason provided|0|||
105684700|NCT00887432|364509330|FG001|Overall Study|No reason provided|1|||
105684701|NCT00899548|364509331|FG000|Overall Study|Physician Decision|3|||
105684702|NCT01886378|364509337|FG000|Overall Study|Adverse Event|1|||
105684703|NCT01886378|364509337|FG000|Overall Study|Withdrawal by Subject|4|||
105684704|NCT00446992|364509346|FG000|Overall Study|Adverse Event|11|||
105684705|NCT00446992|364509346|FG000|Overall Study|Lost to Follow-up|5|||
105684706|NCT00406653|364509347|FG000|Induction Period|Adverse Event|1|||
105684707|NCT00406653|364509348|FG001|Induction Period|Adverse Event|10|||
105684708|NCT00406653|364509349|FG002|Induction Period|Adverse Event|4|||
105684709|NCT00406653|364509350|FG003|Induction Period|Adverse Event|11|||
105684710|NCT00406653|364509351|FG004|Induction Period|Adverse Event|0|||
105684711|NCT00406653|364509352|FG005|Induction Period|Adverse Event|0|||
105684712|NCT00406653|364509353|FG006|Induction Period|Adverse Event|0|||
105684713|NCT00406653|364509347|FG000|Induction Period|Lack of Efficacy|11|||
105684714|NCT00406653|364509348|FG001|Induction Period|Lack of Efficacy|14|||
105684715|NCT00406653|364509349|FG002|Induction Period|Lack of Efficacy|8|||
105684716|NCT00406653|364509350|FG003|Induction Period|Lack of Efficacy|10|||
105684717|NCT00406653|364509351|FG004|Induction Period|Lack of Efficacy|0|||
105684718|NCT00406653|364509352|FG005|Induction Period|Lack of Efficacy|0|||
105684719|NCT00406653|364509353|FG006|Induction Period|Lack of Efficacy|0|||
105684720|NCT00406653|364509347|FG000|Induction Period|Lost to Follow-up|0|||
105684721|NCT00406653|364509348|FG001|Induction Period|Lost to Follow-up|2|||
105684722|NCT00406653|364509349|FG002|Induction Period|Lost to Follow-up|0|||
105684723|NCT00406653|364509350|FG003|Induction Period|Lost to Follow-up|0|||
105684724|NCT00406653|364509351|FG004|Induction Period|Lost to Follow-up|0|||
105684725|NCT00406653|364509352|FG005|Induction Period|Lost to Follow-up|0|||
105684726|NCT00406653|364509353|FG006|Induction Period|Lost to Follow-up|0|||
105684727|NCT00406653|364509347|FG000|Induction Period|Withdrawal of Consent|2|||
105684728|NCT00406653|364509348|FG001|Induction Period|Withdrawal of Consent|5|||
105684729|NCT00406653|364509349|FG002|Induction Period|Withdrawal of Consent|1|||
105684730|NCT00406653|364509350|FG003|Induction Period|Withdrawal of Consent|2|||
105684731|NCT00406653|364509351|FG004|Induction Period|Withdrawal of Consent|0|||
105684732|NCT00406653|364509352|FG005|Induction Period|Withdrawal of Consent|0|||
105684733|NCT00406653|364509353|FG006|Induction Period|Withdrawal of Consent|0|||
105684734|NCT00406653|364509347|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684735|NCT00406653|364509348|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684736|NCT00406653|364509349|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684737|NCT00406653|364509350|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
105684738|NCT00406653|364509351|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684739|NCT00406653|364509352|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684740|NCT00406653|364509353|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
105684741|NCT00406653|364509347|FG000|Induction Period|Pregnancy|1|||
105684742|NCT00406653|364509348|FG001|Induction Period|Pregnancy|0|||
105684743|NCT00406653|364509349|FG002|Induction Period|Pregnancy|0|||
105917222|NCT01239797|365356810|FG000|Treated Participants|Poor/non-compliance|0|||
105917223|NCT01239797|365356811|FG001|Treated Participants|Poor/non-compliance|1|||
105917224|NCT02000921|365356812|FG000|Overall Study|Withdrawal by Subject|3|||
105917225|NCT02000921|365356813|FG001|Overall Study|Withdrawal by Subject|10|||
105917226|NCT02000921|365356814|FG002|Overall Study|Withdrawal by Subject|5|||
105917227|NCT02000921|365356812|FG000|Overall Study|Lost to Follow-up|2|||
105917228|NCT02000921|365356813|FG001|Overall Study|Lost to Follow-up|4|||
105917229|NCT02000921|365356814|FG002|Overall Study|Lost to Follow-up|5|||
105684744|NCT00406653|364509350|FG003|Induction Period|Pregnancy|0|||
105684745|NCT00406653|364509351|FG004|Induction Period|Pregnancy|0|||
105917230|NCT02000921|365356812|FG000|Overall Study|Physician Decision|0|||
105917231|NCT02000921|365356813|FG001|Overall Study|Physician Decision|2|||
105917232|NCT02000921|365356814|FG002|Overall Study|Physician Decision|0|||
105684746|NCT00406653|364509352|FG005|Induction Period|Pregnancy|0|||
105684747|NCT00406653|364509353|FG006|Induction Period|Pregnancy|0|||
105684748|NCT00406653|364509347|FG000|Induction Period|Declined participation but followup done|0|||
105684749|NCT00406653|364509348|FG001|Induction Period|Declined participation but followup done|2|||
105917233|NCT01418339|365356815|FG000|Overall Study|Adverse Event|5|||
105917234|NCT01418339|365356816|FG001|Overall Study|Adverse Event|2|||
106001233|NCT04816214|365665244|FG000|Overall Study|Progressive Disease|4|||
105684750|NCT00406653|364509349|FG002|Induction Period|Declined participation but followup done|1|||
105684751|NCT00406653|364509350|FG003|Induction Period|Declined participation but followup done|1|||
105684752|NCT00406653|364509351|FG004|Induction Period|Declined participation but followup done|0|||
105684753|NCT00406653|364509352|FG005|Induction Period|Declined participation but followup done|0|||
105684754|NCT00406653|364509353|FG006|Induction Period|Declined participation but followup done|0|||
105684755|NCT00406653|364509347|FG000|Induction Period|Given prohibited drug|0|||
105684756|NCT00406653|364509348|FG001|Induction Period|Given prohibited drug|1|||
105684757|NCT00406653|364509349|FG002|Induction Period|Given prohibited drug|2|||
105684758|NCT00406653|364509350|FG003|Induction Period|Given prohibited drug|0|||
105684759|NCT00406653|364509351|FG004|Induction Period|Given prohibited drug|0|||
105684760|NCT00406653|364509352|FG005|Induction Period|Given prohibited drug|0|||
105684761|NCT00406653|364509353|FG006|Induction Period|Given prohibited drug|0|||
105684762|NCT00406653|364509347|FG000|Induction Period|Incarcerated|0|||
105684763|NCT00406653|364509348|FG001|Induction Period|Incarcerated|0|||
105684764|NCT00406653|364509349|FG002|Induction Period|Incarcerated|1|||
105684765|NCT00406653|364509350|FG003|Induction Period|Incarcerated|0|||
105684766|NCT00406653|364509351|FG004|Induction Period|Incarcerated|0|||
105684767|NCT00406653|364509352|FG005|Induction Period|Incarcerated|0|||
105684768|NCT00406653|364509353|FG006|Induction Period|Incarcerated|0|||
105684769|NCT00406653|364509347|FG000|Induction Period|Patient relocated|0|||
105684770|NCT00406653|364509348|FG001|Induction Period|Patient relocated|0|||
105684771|NCT00406653|364509349|FG002|Induction Period|Patient relocated|1|||
105684772|NCT00406653|364509350|FG003|Induction Period|Patient relocated|0|||
105684773|NCT00406653|364509351|FG004|Induction Period|Patient relocated|0|||
105684774|NCT00406653|364509352|FG005|Induction Period|Patient relocated|0|||
105684775|NCT00406653|364509353|FG006|Induction Period|Patient relocated|0|||
105684776|NCT00406653|364509347|FG000|Maintenance Period|Adverse Event|0|||
105684777|NCT00406653|364509348|FG001|Maintenance Period|Adverse Event|0|||
105684778|NCT00406653|364509349|FG002|Maintenance Period|Adverse Event|0|||
105684779|NCT00406653|364509350|FG003|Maintenance Period|Adverse Event|0|||
105684780|NCT00406653|364509351|FG004|Maintenance Period|Adverse Event|1|||
105684781|NCT00406653|364509352|FG005|Maintenance Period|Adverse Event|1|||
105684782|NCT00406653|364509353|FG006|Maintenance Period|Adverse Event|0|||
105684783|NCT00406653|364509347|FG000|Maintenance Period|Lack of Efficacy|0|||
105684784|NCT00406653|364509348|FG001|Maintenance Period|Lack of Efficacy|0|||
105684785|NCT00406653|364509349|FG002|Maintenance Period|Lack of Efficacy|0|||
105684786|NCT00406653|364509350|FG003|Maintenance Period|Lack of Efficacy|0|||
105684787|NCT00406653|364509351|FG004|Maintenance Period|Lack of Efficacy|20|||
105684788|NCT00406653|364509352|FG005|Maintenance Period|Lack of Efficacy|26|||
105684789|NCT00406653|364509353|FG006|Maintenance Period|Lack of Efficacy|0|||
105684790|NCT00406653|364509347|FG000|Maintenance Period|Lost to Follow-up|0|||
105684791|NCT00406653|364509348|FG001|Maintenance Period|Lost to Follow-up|0|||
105684792|NCT00406653|364509349|FG002|Maintenance Period|Lost to Follow-up|0|||
105684793|NCT00406653|364509350|FG003|Maintenance Period|Lost to Follow-up|0|||
105684794|NCT00406653|364509351|FG004|Maintenance Period|Lost to Follow-up|2|||
105684795|NCT00406653|364509352|FG005|Maintenance Period|Lost to Follow-up|1|||
105684796|NCT00406653|364509353|FG006|Maintenance Period|Lost to Follow-up|0|||
105684797|NCT00406653|364509347|FG000|Maintenance Period|Withdrawal of Consent|0|||
105684798|NCT00406653|364509348|FG001|Maintenance Period|Withdrawal of Consent|0|||
105684799|NCT00406653|364509349|FG002|Maintenance Period|Withdrawal of Consent|0|||
105684800|NCT00406653|364509350|FG003|Maintenance Period|Withdrawal of Consent|0|||
105684801|NCT00406653|364509351|FG004|Maintenance Period|Withdrawal of Consent|2|||
105684802|NCT00406653|364509352|FG005|Maintenance Period|Withdrawal of Consent|0|||
105684803|NCT00406653|364509353|FG006|Maintenance Period|Withdrawal of Consent|0|||
105684804|NCT00406653|364509347|FG000|Maintenance Period|Pregnancy|0|||
105684805|NCT00406653|364509348|FG001|Maintenance Period|Pregnancy|0|||
105684806|NCT00406653|364509349|FG002|Maintenance Period|Pregnancy|0|||
105684807|NCT00406653|364509350|FG003|Maintenance Period|Pregnancy|0|||
105684808|NCT00406653|364509351|FG004|Maintenance Period|Pregnancy|0|||
105684809|NCT00406653|364509352|FG005|Maintenance Period|Pregnancy|1|||
105684810|NCT00406653|364509353|FG006|Maintenance Period|Pregnancy|0|||
105786541|NCT05048875|364871452|FG004|Overall Study|Adverse Event|0|||
105917235|NCT01418339|365356815|FG000|Overall Study|Subject Withdrew Consent|1|||
105917236|NCT01418339|365356816|FG001|Overall Study|Subject Withdrew Consent|2|||
105917237|NCT01418339|365356815|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
105917238|NCT01418339|365356816|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
105917239|NCT00749398|365356817|FG000|Overall Study|Lack of Efficacy|7|||
105786542|NCT05048875|364871453|FG005|Overall Study|Adverse Event|0|||
105917240|NCT00749398|365356817|FG000|Overall Study|Adverse Event|4|||
105786543|NCT05048875|364871454|FG006|Overall Study|Adverse Event|0|||
105684811|NCT00406653|364509347|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
105684812|NCT00406653|364509348|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
105684813|NCT00406653|364509349|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
105786544|NCT05048875|364871455|FG007|Overall Study|Adverse Event|0|||
105786545|NCT01802281|364871458|FG000|Overall Study|Death|1|||
105684814|NCT00406653|364509350|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
105684815|NCT00406653|364509351|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
105684816|NCT00406653|364509352|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
105684817|NCT00406653|364509353|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
105684818|NCT00406653|364509347|FG000|Maintenance Period|Error in disease score evaluation|0|||
105684819|NCT00406653|364509348|FG001|Maintenance Period|Error in disease score evaluation|0|||
105684820|NCT00406653|364509349|FG002|Maintenance Period|Error in disease score evaluation|0|||
105684821|NCT00406653|364509350|FG003|Maintenance Period|Error in disease score evaluation|0|||
105684822|NCT00406653|364509351|FG004|Maintenance Period|Error in disease score evaluation|1|||
105684823|NCT00406653|364509352|FG005|Maintenance Period|Error in disease score evaluation|0|||
105684824|NCT00406653|364509353|FG006|Maintenance Period|Error in disease score evaluation|0|||
105684825|NCT00406653|364509347|FG000|Open-Label Period|Death|0|||
105684826|NCT00406653|364509348|FG001|Open-Label Period|Death|0|||
105684827|NCT00406653|364509349|FG002|Open-Label Period|Death|0|||
105684828|NCT00406653|364509350|FG003|Open-Label Period|Death|0|||
105684829|NCT00406653|364509351|FG004|Open-Label Period|Death|0|||
105684830|NCT00406653|364509352|FG005|Open-Label Period|Death|0|||
105684831|NCT00406653|364509353|FG006|Open-Label Period|Death|1|||
105684832|NCT00406653|364509347|FG000|Open-Label Period|Adverse Event|0|||
105684833|NCT00406653|364509348|FG001|Open-Label Period|Adverse Event|0|||
105684834|NCT00406653|364509349|FG002|Open-Label Period|Adverse Event|0|||
105684835|NCT00406653|364509350|FG003|Open-Label Period|Adverse Event|0|||
105684836|NCT00406653|364509351|FG004|Open-Label Period|Adverse Event|0|||
105684837|NCT00406653|364509352|FG005|Open-Label Period|Adverse Event|0|||
105684838|NCT00406653|364509353|FG006|Open-Label Period|Adverse Event|18|||
105684839|NCT00406653|364509347|FG000|Open-Label Period|Lack of Efficacy|0|||
105684840|NCT00406653|364509348|FG001|Open-Label Period|Lack of Efficacy|0|||
105684841|NCT00406653|364509349|FG002|Open-Label Period|Lack of Efficacy|0|||
105684842|NCT00406653|364509350|FG003|Open-Label Period|Lack of Efficacy|0|||
105684843|NCT00406653|364509351|FG004|Open-Label Period|Lack of Efficacy|0|||
105684844|NCT00406653|364509352|FG005|Open-Label Period|Lack of Efficacy|0|||
105684845|NCT00406653|364509353|FG006|Open-Label Period|Lack of Efficacy|160|||
105684846|NCT00406653|364509347|FG000|Open-Label Period|Lost to Follow-up|0|||
105684847|NCT00406653|364509348|FG001|Open-Label Period|Lost to Follow-up|0|||
105684848|NCT00406653|364509349|FG002|Open-Label Period|Lost to Follow-up|0|||
105684849|NCT00406653|364509350|FG003|Open-Label Period|Lost to Follow-up|0|||
105684850|NCT00406653|364509351|FG004|Open-Label Period|Lost to Follow-up|0|||
105684851|NCT00406653|364509352|FG005|Open-Label Period|Lost to Follow-up|0|||
105684852|NCT00406653|364509353|FG006|Open-Label Period|Lost to Follow-up|6|||
105684853|NCT00406653|364509347|FG000|Open-Label Period|Withdrawal of Consent|0|||
105684854|NCT00406653|364509348|FG001|Open-Label Period|Withdrawal of Consent|0|||
105684855|NCT00406653|364509349|FG002|Open-Label Period|Withdrawal of Consent|0|||
105684856|NCT00406653|364509350|FG003|Open-Label Period|Withdrawal of Consent|0|||
105684857|NCT00406653|364509351|FG004|Open-Label Period|Withdrawal of Consent|0|||
105684858|NCT00406653|364509352|FG005|Open-Label Period|Withdrawal of Consent|0|||
105684859|NCT00406653|364509353|FG006|Open-Label Period|Withdrawal of Consent|11|||
105684860|NCT00406653|364509347|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684861|NCT00406653|364509348|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684862|NCT00406653|364509349|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684863|NCT00406653|364509350|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684864|NCT00406653|364509351|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684865|NCT00406653|364509352|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
105684866|NCT00406653|364509353|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
105684867|NCT00406653|364509347|FG000|Open-Label Period|Pregnancy|0|||
105684868|NCT00406653|364509348|FG001|Open-Label Period|Pregnancy|0|||
105684869|NCT00406653|364509349|FG002|Open-Label Period|Pregnancy|0|||
105684870|NCT00406653|364509350|FG003|Open-Label Period|Pregnancy|0|||
105684871|NCT00406653|364509351|FG004|Open-Label Period|Pregnancy|0|||
105684872|NCT00406653|364509352|FG005|Open-Label Period|Pregnancy|0|||
105684873|NCT00406653|364509353|FG006|Open-Label Period|Pregnancy|2|||
105684874|NCT00406653|364509347|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
105684875|NCT00406653|364509348|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
105786546|NCT01802281|364871459|FG001|Overall Study|Death|2|||
105917241|NCT00749398|365356817|FG000|Overall Study|Serious adverse event|11|||
105917242|NCT00749398|365356817|FG000|Overall Study|Withdrawal by Subject|17|||
105917243|NCT00749398|365356817|FG000|Overall Study|Lost to Follow-up|11|||
105917244|NCT00749398|365356817|FG000|Overall Study|Reason not specified|2|||
106128206|NCT03873246|366125582|FG001|Overall Study|Protocol Violation|1|||
106128207|NCT03873246|366125583|FG002|Overall Study|Protocol Violation|0|||
105684876|NCT00406653|364509349|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
105684877|NCT00406653|364509350|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
105684878|NCT00406653|364509351|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
105786547|NCT01802281|364871458|FG000|Overall Study|Withdrawal by Subject|2|||
105786548|NCT01802281|364871459|FG001|Overall Study|Withdrawal by Subject|1|||
105684879|NCT00406653|364509352|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
105684880|NCT00406653|364509353|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
105684881|NCT00406653|364509347|FG000|Open-Label Period|Declined participation but followup done|0|||
105684882|NCT00406653|364509348|FG001|Open-Label Period|Declined participation but followup done|0|||
105684883|NCT00406653|364509349|FG002|Open-Label Period|Declined participation but followup done|0|||
105684884|NCT00406653|364509350|FG003|Open-Label Period|Declined participation but followup done|0|||
105684885|NCT00406653|364509351|FG004|Open-Label Period|Declined participation but followup done|0|||
105684886|NCT00406653|364509352|FG005|Open-Label Period|Declined participation but followup done|0|||
105684887|NCT00406653|364509353|FG006|Open-Label Period|Declined participation but followup done|8|||
105684888|NCT00406653|364509347|FG000|Open-Label Period|Discontinued by Sponsor|0|||
105684889|NCT00406653|364509348|FG001|Open-Label Period|Discontinued by Sponsor|0|||
105684890|NCT00406653|364509349|FG002|Open-Label Period|Discontinued by Sponsor|0|||
105684891|NCT00406653|364509350|FG003|Open-Label Period|Discontinued by Sponsor|0|||
105684892|NCT00406653|364509351|FG004|Open-Label Period|Discontinued by Sponsor|0|||
105684893|NCT00406653|364509352|FG005|Open-Label Period|Discontinued by Sponsor|0|||
105684894|NCT00406653|364509353|FG006|Open-Label Period|Discontinued by Sponsor|1|||
105684895|NCT00406653|364509347|FG000|Open-Label Period|Refused followup|0|||
105684896|NCT00406653|364509348|FG001|Open-Label Period|Refused followup|0|||
105684897|NCT00406653|364509349|FG002|Open-Label Period|Refused followup|0|||
105684898|NCT00406653|364509350|FG003|Open-Label Period|Refused followup|0|||
105684899|NCT00406653|364509351|FG004|Open-Label Period|Refused followup|0|||
105684900|NCT00406653|364509352|FG005|Open-Label Period|Refused followup|0|||
105684901|NCT00406653|364509353|FG006|Open-Label Period|Refused followup|1|||
105684902|NCT00818649|364509354|FG000|Overall Study|Declining performance status|2|||
105684903|NCT00818649|364509354|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
105684904|NCT00818649|364509354|FG000|Overall Study|Adverse Event|1|||
105684905|NCT03513588|364509355|FG000|Overall Study|Lost to Follow-up|0|||
105684906|NCT03513588|364509356|FG001|Overall Study|Lost to Follow-up|1|||
105684907|NCT03513588|364509357|FG002|Overall Study|Lost to Follow-up|1|||
105684908|NCT03513588|364509355|FG000|Overall Study|Study dosing paused by sponsor|1|||
105684909|NCT03513588|364509356|FG001|Overall Study|Study dosing paused by sponsor|1|||
105684910|NCT03513588|364509357|FG002|Overall Study|Study dosing paused by sponsor|0|||
105684911|NCT03513588|364509355|FG000|Overall Study|Death|0|||
105684912|NCT03513588|364509356|FG001|Overall Study|Death|0|||
105684913|NCT03513588|364509357|FG002|Overall Study|Death|1|||
105684914|NCT00940108|364509358|FG000|Overall Study|Adverse Event|2|||
105684915|NCT00940108|364509359|FG001|Overall Study|Adverse Event|4|||
105684916|NCT00940108|364509360|FG002|Overall Study|Adverse Event|0|||
105684917|NCT00940108|364509361|FG003|Overall Study|Adverse Event|2|||
105684918|NCT00940108|364509358|FG000|Overall Study|Withdrew Consent|2|||
105684919|NCT00940108|364509359|FG001|Overall Study|Withdrew Consent|1|||
105684920|NCT00940108|364509360|FG002|Overall Study|Withdrew Consent|0|||
105684921|NCT00940108|364509361|FG003|Overall Study|Withdrew Consent|1|||
105684922|NCT00940108|364509358|FG000|Overall Study|Dose 2 contraindicated|1|||
105684923|NCT00940108|364509359|FG001|Overall Study|Dose 2 contraindicated|1|||
105684924|NCT00940108|364509360|FG002|Overall Study|Dose 2 contraindicated|0|||
105684925|NCT00940108|364509361|FG003|Overall Study|Dose 2 contraindicated|1|||
105684926|NCT00940108|364509358|FG000|Overall Study|Declined further vaccination|0|||
105684927|NCT00940108|364509359|FG001|Overall Study|Declined further vaccination|1|||
105684928|NCT00940108|364509360|FG002|Overall Study|Declined further vaccination|3|||
105684929|NCT00940108|364509361|FG003|Overall Study|Declined further vaccination|0|||
105684930|NCT00940108|364509358|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
105684931|NCT00940108|364509359|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
105684932|NCT00940108|364509360|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
105684933|NCT00940108|364509361|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
105684934|NCT00940108|364509358|FG000|Overall Study|Viral illness after Dose 1|0|||
105684935|NCT00940108|364509359|FG001|Overall Study|Viral illness after Dose 1|1|||
105684936|NCT00940108|364509360|FG002|Overall Study|Viral illness after Dose 1|0|||
105684937|NCT00940108|364509361|FG003|Overall Study|Viral illness after Dose 1|0|||
105684938|NCT00940108|364509358|FG000|Overall Study|Diagnosed with H1N1|0|||
105684939|NCT00940108|364509359|FG001|Overall Study|Diagnosed with H1N1|0|||
105684940|NCT00940108|364509360|FG002|Overall Study|Diagnosed with H1N1|0|||
105684941|NCT00940108|364509361|FG003|Overall Study|Diagnosed with H1N1|1|||
105684942|NCT02075541|364509362|FG000|Overall Study|Serious Adverse Event|1|||
105684943|NCT02075541|364509363|FG001|Overall Study|Serious Adverse Event|4|||
105684944|NCT02075541|364509362|FG000|Overall Study|Protocol Violation|1|||
105684945|NCT02075541|364509363|FG001|Overall Study|Protocol Violation|0|||
105684946|NCT02075541|364509362|FG000|Overall Study|Withdrawal by Subject|1|||
105684947|NCT02075541|364509363|FG001|Overall Study|Withdrawal by Subject|3|||
105684948|NCT02075541|364509362|FG000|Overall Study|Sponsor study termination|0|||
105684949|NCT02075541|364509363|FG001|Overall Study|Sponsor study termination|1|||
105684950|NCT02075541|364509362|FG000|Overall Study|Other- unable to perform study procedure|1|||
105684951|NCT02075541|364509363|FG001|Overall Study|Other- unable to perform study procedure|0|||
105684952|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
105684953|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
105684954|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Death|0|||
105684955|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Death|2|||
105684956|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
105684957|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
105684958|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
105684959|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
105684960|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
105684961|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
105684962|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
105684963|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
105684964|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
105684965|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
105684966|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
105684967|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
105684968|NCT00343252|364509364|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
105684969|NCT00343252|364509365|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
105684970|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
105684971|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
105684972|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Death|3|||
105684973|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Death|3|||
105684974|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
105684975|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
105684976|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
105684977|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
105684978|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
105684979|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
105684980|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
105684981|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
105684982|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
105684983|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
105684984|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
105684985|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
105684986|NCT00343252|364509364|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
105684987|NCT00343252|364509365|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
105684988|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
105684989|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
105684990|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Death|4|||
105684991|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Death|5|||
105684992|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
105684993|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
105684994|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
105684995|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
105684996|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
105684997|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
105684998|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
105684999|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
105685000|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
105685001|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
105685002|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
105685003|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
105685004|NCT00343252|364509364|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
105685005|NCT00343252|364509365|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
105685006|NCT03945825|364509375|FG000|Overall Study|Enrolled but treatment not administered|0|||
105685007|NCT03945825|364509376|FG001|Overall Study|Enrolled but treatment not administered|0|||
105685008|NCT03945825|364509377|FG002|Overall Study|Enrolled but treatment not administered|0|||
105685009|NCT03945825|364509378|FG003|Overall Study|Enrolled but treatment not administered|0|||
105685010|NCT03945825|364509379|FG004|Overall Study|Enrolled but treatment not administered|1|||
105685011|NCT03945825|364509380|FG005|Overall Study|Enrolled but treatment not administered|0|||
105685012|NCT03945825|364509375|FG000|Overall Study|Lost to Follow-up|1|||
105685013|NCT03945825|364509376|FG001|Overall Study|Lost to Follow-up|5|||
105685014|NCT03945825|364509377|FG002|Overall Study|Lost to Follow-up|0|||
105685015|NCT03945825|364509378|FG003|Overall Study|Lost to Follow-up|1|||
105685016|NCT03945825|364509379|FG004|Overall Study|Lost to Follow-up|2|||
105685017|NCT03945825|364509380|FG005|Overall Study|Lost to Follow-up|2|||
105685018|NCT03945825|364509375|FG000|Overall Study|Withdrawal by Subject|1|||
105685019|NCT03945825|364509376|FG001|Overall Study|Withdrawal by Subject|0|||
106128208|NCT03873246|366125581|FG000|Overall Study|Withdrawal by Subject|0|||
106128209|NCT03873246|366125582|FG001|Overall Study|Withdrawal by Subject|4|||
106128210|NCT03873246|366125583|FG002|Overall Study|Withdrawal by Subject|1|||
106128211|NCT03285711|366125584|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
106128212|NCT03285711|366125585|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
106128213|NCT03285711|366125586|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
106128214|NCT03285711|366125587|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
106128215|NCT03285711|366125584|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
106128216|NCT03285711|366125585|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
106128217|NCT03285711|366125586|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
106128218|NCT03285711|366125587|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
106128219|NCT03285711|366125584|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
106128220|NCT03285711|366125585|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
106128221|NCT03285711|366125586|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
106128222|NCT03285711|366125587|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
106128223|NCT03285711|366125584|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
106128224|NCT03285711|366125585|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
106128225|NCT03285711|366125586|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
106128226|NCT03285711|366125587|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
106128227|NCT03658811|366125588|FG000|Overall Study|Lost to Follow-up|3|||
106128228|NCT02169219|366125593|FG000|Overall Study|Lack of Efficacy|6|||
106128229|NCT02886936|366125597|FG000|Overall Study|Lost to Follow-up|4|||
106128230|NCT02886936|366125598|FG001|Overall Study|Lost to Follow-up|3|||
106128231|NCT02886936|366125599|FG002|Overall Study|Lost to Follow-up|0|||
106128232|NCT02507219|366125600|FG000|Overall Study|Physician Decision|1|||
106128233|NCT02507219|366125601|FG001|Overall Study|Physician Decision|0|||
106128234|NCT02507219|366125602|FG002|Overall Study|Physician Decision|0|||
106128235|NCT02507219|366125603|FG003|Overall Study|Physician Decision|0|||
106128236|NCT02507219|366125604|FG004|Overall Study|Physician Decision|0|||
106128237|NCT02507219|366125605|FG005|Overall Study|Physician Decision|0|||
106128238|NCT02507219|366125600|FG000|Overall Study|Withdrawal by Subject|0|||
106128239|NCT02507219|366125601|FG001|Overall Study|Withdrawal by Subject|0|||
106128240|NCT02507219|366125602|FG002|Overall Study|Withdrawal by Subject|0|||
106128241|NCT02507219|366125603|FG003|Overall Study|Withdrawal by Subject|0|||
106128242|NCT02507219|366125604|FG004|Overall Study|Withdrawal by Subject|1|||
106128243|NCT02507219|366125605|FG005|Overall Study|Withdrawal by Subject|0|||
106128244|NCT04562779|366125606|FG000|Overall Study|Lost to Follow-up|7|||
106128245|NCT04562779|366125607|FG001|Overall Study|Lost to Follow-up|5|||
106128246|NCT04562779|366125608|FG002|Overall Study|Lost to Follow-up|10|||
106128247|NCT04562779|366125606|FG000|Overall Study|Protocol Violation|2|||
106128248|NCT04562779|366125607|FG001|Overall Study|Protocol Violation|2|||
106128249|NCT04562779|366125608|FG002|Overall Study|Protocol Violation|0|||
106128250|NCT00333138|366125609|FG000|Core Study (6 Months)|Adverse Event|4|||
106128251|NCT00333138|366125610|FG001|Core Study (6 Months)|Adverse Event|5|||
106128252|NCT00333138|366125611|FG002|Core Study (6 Months)|Adverse Event|8|||
106128253|NCT00333138|366125609|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
106128254|NCT00333138|366125610|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
106128255|NCT00333138|366125611|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
106128256|NCT00333138|366125609|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
106128257|NCT00333138|366125610|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
106128258|NCT00333138|366125611|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
106128259|NCT00333138|366125609|FG000|Core Study (6 Months)|Protocol Violation|1|||
106128260|NCT00333138|366125610|FG001|Core Study (6 Months)|Protocol Violation|0|||
106128261|NCT00333138|366125611|FG002|Core Study (6 Months)|Protocol Violation|1|||
106128262|NCT00333138|366125609|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
106128263|NCT00333138|366125610|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
106128264|NCT00333138|366125611|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
106128265|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
106128266|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
106128267|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
106128268|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
106128269|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
106128270|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
106128271|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
106128272|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
106128273|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
106128274|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
106128275|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
106128276|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
106128277|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
105685020|NCT03945825|364509377|FG002|Overall Study|Withdrawal by Subject|1|||
105685021|NCT03945825|364509378|FG003|Overall Study|Withdrawal by Subject|1|||
105685022|NCT03945825|364509379|FG004|Overall Study|Withdrawal by Subject|0|||
105685023|NCT03945825|364509380|FG005|Overall Study|Withdrawal by Subject|1|||
105685024|NCT01551212|364509381|FG000|Overall Study|Graft loss/Retransplantation|0|||
105685025|NCT01551212|364509382|FG001|Overall Study|Graft loss/Retransplantation|1|||
105685026|NCT01551212|364509381|FG000|Overall Study|Administrative problems|1|||
105685027|NCT01551212|364509382|FG001|Overall Study|Administrative problems|2|||
105685028|NCT01551212|364509381|FG000|Overall Study|Lost to Follow-up|0|||
105685029|NCT01551212|364509382|FG001|Overall Study|Lost to Follow-up|1|||
105685030|NCT01551212|364509381|FG000|Overall Study|Protocol Violation|0|||
105685031|NCT01551212|364509382|FG001|Overall Study|Protocol Violation|1|||
105685032|NCT01551212|364509381|FG000|Overall Study|Withdrawal by Subject|0|||
105685033|NCT01551212|364509382|FG001|Overall Study|Withdrawal by Subject|7|||
105685034|NCT01551212|364509381|FG000|Overall Study|Death|2|||
105685035|NCT01551212|364509382|FG001|Overall Study|Death|4|||
105685036|NCT01551212|364509381|FG000|Overall Study|Never Received Study Treatment|2|||
105685037|NCT01551212|364509382|FG001|Overall Study|Never Received Study Treatment|4|||
105685038|NCT01013285|364509384|FG000|Overall Study|Death|48|||
105685039|NCT01013285|364509385|FG001|Overall Study|Death|89|||
105685040|NCT00807235|364509388|FG000|Overall Study|Adverse Event|1|||
105685041|NCT00807235|364509389|FG001|Overall Study|Adverse Event|0|||
105685042|NCT01012713|364509390|FG000|Overall Study|Lack of Efficacy|3|||
105685043|NCT02571049|364509391|FG000|Screening|Did not meet entry criteria|2|||
105685044|NCT02571049|364509392|FG001|Screening|Did not meet entry criteria|2|||
105685045|NCT02571049|364509391|FG000|Randomization|No migraine attack|0|||
105685046|NCT02571049|364509392|FG001|Randomization|No migraine attack|1|||
105685047|NCT02571049|364509391|FG000|Randomization|Adverse Event|0|||
105685048|NCT02571049|364509392|FG001|Randomization|Adverse Event|1|||
105685049|NCT04161495|364509393|FG000|Overall Study|Withdrawal by Subject|3|||
105685050|NCT04161495|364509394|FG001|Overall Study|Withdrawal by Subject|0|||
105685051|NCT04161495|364509393|FG000|Overall Study|Protocol Violation|1|||
105685052|NCT04161495|364509394|FG001|Overall Study|Protocol Violation|0|||
105685053|NCT04161495|364509393|FG000|Overall Study|Prohibited concomitant medication|3|||
105685054|NCT04161495|364509394|FG001|Overall Study|Prohibited concomitant medication|0|||
105685055|NCT04161495|364509393|FG000|Overall Study|Adverse Event|1|||
105685056|NCT04161495|364509394|FG001|Overall Study|Adverse Event|0|||
105685057|NCT04161495|364509393|FG000|Overall Study|Other - Unspecified|1|||
105685058|NCT04161495|364509394|FG001|Overall Study|Other - Unspecified|0|||
105685059|NCT04161495|364509393|FG000|Overall Study|Death|0|||
105685060|NCT04161495|364509394|FG001|Overall Study|Death|1|||
105685061|NCT03866473|364509395|FG000|Phase 1|Death|1|||
105685062|NCT03866473|364509396|FG001|Phase 1|Death|0|||
105685063|NCT03866473|364509395|FG000|Phase 2|Death|0|||
105685064|NCT03866473|364509396|FG001|Phase 2|Death|2|||
105685065|NCT03866473|364509395|FG000|Phase 2|Dropped|1|||
105685066|NCT03866473|364509396|FG001|Phase 2|Dropped|1|||
105685067|NCT03866473|364509395|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
105685068|NCT03866473|364509396|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
105685069|NCT01257425|364509402|FG000|Overall Study|Lack of Efficacy|3|||
105685070|NCT01257425|364509403|FG001|Overall Study|Lack of Efficacy|3|||
105685071|NCT01257425|364509402|FG000|Overall Study|Adverse Event|1|||
105685072|NCT01257425|364509403|FG001|Overall Study|Adverse Event|1|||
105685073|NCT01257425|364509402|FG000|Overall Study|Protocol Violation|1|||
105685074|NCT01257425|364509403|FG001|Overall Study|Protocol Violation|1|||
105685075|NCT01257425|364509402|FG000|Overall Study|Withdrawal by Subject|0|||
105685076|NCT01257425|364509403|FG001|Overall Study|Withdrawal by Subject|1|||
105685077|NCT01257425|364509402|FG000|Overall Study|Death|1|||
105685078|NCT01257425|364509403|FG001|Overall Study|Death|0|||
105685079|NCT00368992|364509404|FG000|Overall Study|Ineligible|5|||
105685080|NCT00368992|364509404|FG000|Overall Study|Refused treatment|3|||
105685081|NCT00368992|364509404|FG000|Overall Study|Lack of Efficacy|63|||
105685082|NCT00368992|364509404|FG000|Overall Study|Adverse Event|26|||
105786549|NCT01802281|364871458|FG000|Overall Study|Ineligible|5|||
105786550|NCT01802281|364871459|FG001|Overall Study|Ineligible|3|||
105685083|NCT00368992|364509404|FG000|Overall Study|Death|4|||
105685084|NCT00368992|364509404|FG000|Overall Study|Other|9|||
105685085|NCT00723021|364509409|FG000|Intervention Period 4|Adverse Event|0|||
105685086|NCT00723021|364509410|FG001|Intervention Period 4|Adverse Event|0|||
105685087|NCT00723021|364509411|FG002|Intervention Period 4|Adverse Event|0|||
105685088|NCT00723021|364509412|FG003|Intervention Period 4|Adverse Event|0|||
105786551|NCT02161380|364871464|FG000|Overall Study|Lost to Follow-up|0|||
105917245|NCT00749398|365356817|FG000|Overall Study|Unknown reason|1|||
105685089|NCT00723021|364509413|FG004|Intervention Period 4|Adverse Event|1|||
105685090|NCT00971243|364509414|FG000|Double Blind Period|Adverse Event|2|||
105685091|NCT00971243|364509415|FG001|Double Blind Period|Adverse Event|3|||
105685092|NCT00971243|364509416|FG002|Double Blind Period|Adverse Event|2|||
105685093|NCT00971243|364509417|FG003|Double Blind Period|Adverse Event|2|||
105917246|NCT03786380|365356818|FG000|Overall Study|Adverse Event|1|||
105685094|NCT00971243|364509418|FG004|Double Blind Period|Adverse Event|3|||
105685095|NCT00971243|364509414|FG000|Double Blind Period|Lost to Follow-up|0|||
105685096|NCT00971243|364509415|FG001|Double Blind Period|Lost to Follow-up|1|||
105685097|NCT00971243|364509416|FG002|Double Blind Period|Lost to Follow-up|1|||
105685098|NCT00971243|364509417|FG003|Double Blind Period|Lost to Follow-up|0|||
105685099|NCT00971243|364509418|FG004|Double Blind Period|Lost to Follow-up|1|||
105685100|NCT00971243|364509414|FG000|Double Blind Period|Physician Decision|10|||
105685101|NCT00971243|364509415|FG001|Double Blind Period|Physician Decision|6|||
105685102|NCT00971243|364509416|FG002|Double Blind Period|Physician Decision|7|||
105685103|NCT00971243|364509417|FG003|Double Blind Period|Physician Decision|6|||
105685104|NCT00971243|364509418|FG004|Double Blind Period|Physician Decision|7|||
105685105|NCT00971243|364509414|FG000|Double Blind Period|Protocol Violation|2|||
105685106|NCT00971243|364509415|FG001|Double Blind Period|Protocol Violation|0|||
105685107|NCT00971243|364509416|FG002|Double Blind Period|Protocol Violation|3|||
105685108|NCT00971243|364509417|FG003|Double Blind Period|Protocol Violation|2|||
105685109|NCT00971243|364509418|FG004|Double Blind Period|Protocol Violation|2|||
105685110|NCT00971243|364509414|FG000|Double Blind Period|Withdrawal by Subject|4|||
105685111|NCT00971243|364509415|FG001|Double Blind Period|Withdrawal by Subject|1|||
105685112|NCT00971243|364509416|FG002|Double Blind Period|Withdrawal by Subject|4|||
105685113|NCT00971243|364509417|FG003|Double Blind Period|Withdrawal by Subject|4|||
105685114|NCT00971243|364509418|FG004|Double Blind Period|Withdrawal by Subject|4|||
105685115|NCT00971243|364509414|FG000|Double Blind Period|Other reasons|1|||
105685116|NCT00971243|364509415|FG001|Double Blind Period|Other reasons|0|||
105685117|NCT00971243|364509416|FG002|Double Blind Period|Other reasons|2|||
105685118|NCT00971243|364509417|FG003|Double Blind Period|Other reasons|0|||
105685119|NCT00971243|364509418|FG004|Double Blind Period|Other reasons|1|||
105685120|NCT00971243|364509414|FG000|Open-label Period|Adverse Event|1|||
105685121|NCT00971243|364509415|FG001|Open-label Period|Adverse Event|0|||
105685122|NCT00971243|364509416|FG002|Open-label Period|Adverse Event|1|||
105685123|NCT00971243|364509417|FG003|Open-label Period|Adverse Event|1|||
105685124|NCT00971243|364509418|FG004|Open-label Period|Adverse Event|0|||
105685125|NCT00971243|364509414|FG000|Open-label Period|Physician Decision|5|||
105685126|NCT00971243|364509415|FG001|Open-label Period|Physician Decision|9|||
105685127|NCT00971243|364509416|FG002|Open-label Period|Physician Decision|3|||
105685128|NCT00971243|364509417|FG003|Open-label Period|Physician Decision|7|||
105685129|NCT00971243|364509418|FG004|Open-label Period|Physician Decision|2|||
105685130|NCT00971243|364509414|FG000|Open-label Period|Protocol Violation|1|||
105685131|NCT00971243|364509415|FG001|Open-label Period|Protocol Violation|1|||
105685132|NCT00971243|364509416|FG002|Open-label Period|Protocol Violation|1|||
105685133|NCT00971243|364509417|FG003|Open-label Period|Protocol Violation|0|||
105685134|NCT00971243|364509418|FG004|Open-label Period|Protocol Violation|1|||
105685135|NCT00971243|364509414|FG000|Open-label Period|Withdrawal by Subject|1|||
105685136|NCT00971243|364509415|FG001|Open-label Period|Withdrawal by Subject|0|||
105685137|NCT00971243|364509416|FG002|Open-label Period|Withdrawal by Subject|0|||
105685138|NCT00971243|364509417|FG003|Open-label Period|Withdrawal by Subject|2|||
105685139|NCT00971243|364509418|FG004|Open-label Period|Withdrawal by Subject|1|||
105685140|NCT00971243|364509414|FG000|Open-label Period|Other reason|0|||
105685141|NCT00971243|364509415|FG001|Open-label Period|Other reason|0|||
105685142|NCT00971243|364509416|FG002|Open-label Period|Other reason|0|||
105685143|NCT00971243|364509417|FG003|Open-label Period|Other reason|0|||
105685144|NCT00971243|364509418|FG004|Open-label Period|Other reason|2|||
105685145|NCT00770341|364509419|FG000|Overall Study|Did not meet eligibility criteria|1|||
105685146|NCT00770341|364509420|FG001|Overall Study|Did not meet eligibility criteria|0|||
105685147|NCT00770341|364509421|FG002|Overall Study|Did not meet eligibility criteria|0|||
105685148|NCT00770341|364509419|FG000|Overall Study|Withdrawal by Subject|0|||
105685149|NCT00770341|364509420|FG001|Overall Study|Withdrawal by Subject|1|||
105685150|NCT00770341|364509421|FG002|Overall Study|Withdrawal by Subject|0|||
105685151|NCT00770341|364509419|FG000|Overall Study|Clinical Adverse Event|3|||
105685152|NCT00770341|364509420|FG001|Overall Study|Clinical Adverse Event|1|||
105917247|NCT03786380|365356819|FG001|Overall Study|Adverse Event|0|||
105917248|NCT03786380|365356820|FG002|Overall Study|Adverse Event|0|||
105917249|NCT03786380|365356821|FG003|Overall Study|Adverse Event|3|||
105917250|NCT03786380|365356822|FG004|Overall Study|Adverse Event|1|||
105917251|NCT03786380|365356818|FG000|Overall Study|Lack of Efficacy|0|||
105917252|NCT03786380|365356819|FG001|Overall Study|Lack of Efficacy|0|||
105685153|NCT00770341|364509421|FG002|Overall Study|Clinical Adverse Event|2|||
105685154|NCT00770341|364509419|FG000|Overall Study|Laboratory adverse event|3|||
105685155|NCT00770341|364509420|FG001|Overall Study|Laboratory adverse event|3|||
105685156|NCT00770341|364509421|FG002|Overall Study|Laboratory adverse event|0|||
105685157|NCT00770341|364509419|FG000|Overall Study|Lack of Efficacy|3|||
105685158|NCT00770341|364509420|FG001|Overall Study|Lack of Efficacy|0|||
105685159|NCT00770341|364509421|FG002|Overall Study|Lack of Efficacy|1|||
105685160|NCT00770341|364509419|FG000|Overall Study|Other|1|||
105685161|NCT00770341|364509420|FG001|Overall Study|Other|0|||
105685162|NCT00770341|364509421|FG002|Overall Study|Other|0|||
105685163|NCT00770341|364509419|FG000|Overall Study|Not treated|1|||
105685164|NCT00770341|364509420|FG001|Overall Study|Not treated|0|||
105685165|NCT00770341|364509421|FG002|Overall Study|Not treated|0|||
105917253|NCT03786380|365356820|FG002|Overall Study|Lack of Efficacy|0|||
105917254|NCT03786380|365356821|FG003|Overall Study|Lack of Efficacy|0|||
105917255|NCT03786380|365356822|FG004|Overall Study|Lack of Efficacy|1|||
105917256|NCT03786380|365356818|FG000|Overall Study|Withdrawal by Subject|1|||
105917257|NCT03786380|365356819|FG001|Overall Study|Withdrawal by Subject|2|||
105917258|NCT03786380|365356820|FG002|Overall Study|Withdrawal by Subject|2|||
105917259|NCT03786380|365356821|FG003|Overall Study|Withdrawal by Subject|1|||
105917260|NCT03786380|365356822|FG004|Overall Study|Withdrawal by Subject|2|||
105917261|NCT03786380|365356818|FG000|Overall Study|Lost to Follow-up|3|||
105917262|NCT03786380|365356819|FG001|Overall Study|Lost to Follow-up|0|||
105917263|NCT03786380|365356820|FG002|Overall Study|Lost to Follow-up|1|||
105917264|NCT03786380|365356821|FG003|Overall Study|Lost to Follow-up|2|||
105917265|NCT03786380|365356822|FG004|Overall Study|Lost to Follow-up|0|||
105917266|NCT03786380|365356818|FG000|Overall Study|Physician Decision|0|||
106001234|NCT04816214|365665245|FG001|Overall Study|Progressive Disease|0|||
105917267|NCT03786380|365356819|FG001|Overall Study|Physician Decision|0|||
105917268|NCT03786380|365356820|FG002|Overall Study|Physician Decision|1|||
105917269|NCT03786380|365356821|FG003|Overall Study|Physician Decision|0|||
105917270|NCT03786380|365356822|FG004|Overall Study|Physician Decision|0|||
106001235|NCT04816214|365665246|FG002|Overall Study|Progressive Disease|0|||
106001236|NCT04816214|365665244|FG000|Overall Study|Death|1|||
105917271|NCT03786380|365356818|FG000|Overall Study|Study Terminated by the Sponsor|30|||
106001237|NCT04816214|365665245|FG001|Overall Study|Death|0|||
105685166|NCT00960531|364509422|FG000|Overall Study|Lack of Efficacy|1|||
105685167|NCT00960531|364509423|FG001|Overall Study|Lack of Efficacy|0|||
105685168|NCT00960531|364509424|FG002|Overall Study|Lack of Efficacy|0|||
105685169|NCT00960531|364509425|FG003|Overall Study|Lack of Efficacy|0|||
105685170|NCT00960531|364509426|FG004|Overall Study|Lack of Efficacy|0|||
105685171|NCT00960531|364509427|FG005|Overall Study|Lack of Efficacy|0|||
105685172|NCT00960531|364509428|FG006|Overall Study|Lack of Efficacy|0|||
105685173|NCT00960531|364509429|FG007|Overall Study|Lack of Efficacy|0|||
105685174|NCT00960531|364509430|FG008|Overall Study|Lack of Efficacy|0|||
105685175|NCT00960531|364509431|FG009|Overall Study|Lack of Efficacy|0|||
105685176|NCT00960531|364509422|FG000|Overall Study|Withdrawal by Subject|1|||
105685177|NCT00960531|364509423|FG001|Overall Study|Withdrawal by Subject|0|||
105685178|NCT00960531|364509424|FG002|Overall Study|Withdrawal by Subject|5|||
105685179|NCT00960531|364509425|FG003|Overall Study|Withdrawal by Subject|2|||
105685180|NCT00960531|364509426|FG004|Overall Study|Withdrawal by Subject|0|||
105685181|NCT00960531|364509427|FG005|Overall Study|Withdrawal by Subject|0|||
105685182|NCT00960531|364509428|FG006|Overall Study|Withdrawal by Subject|2|||
105685183|NCT00960531|364509429|FG007|Overall Study|Withdrawal by Subject|0|||
105685184|NCT00960531|364509430|FG008|Overall Study|Withdrawal by Subject|1|||
105685185|NCT00960531|364509431|FG009|Overall Study|Withdrawal by Subject|0|||
105685186|NCT00960531|364509422|FG000|Overall Study|Caregiver Request|2|||
105685187|NCT00960531|364509423|FG001|Overall Study|Caregiver Request|0|||
105685188|NCT00960531|364509424|FG002|Overall Study|Caregiver Request|6|||
105685189|NCT00960531|364509425|FG003|Overall Study|Caregiver Request|5|||
105685190|NCT00960531|364509426|FG004|Overall Study|Caregiver Request|0|||
105685191|NCT00960531|364509427|FG005|Overall Study|Caregiver Request|2|||
105685192|NCT00960531|364509428|FG006|Overall Study|Caregiver Request|3|||
105685193|NCT00960531|364509429|FG007|Overall Study|Caregiver Request|1|||
105685194|NCT00960531|364509430|FG008|Overall Study|Caregiver Request|3|||
105685195|NCT00960531|364509431|FG009|Overall Study|Caregiver Request|0|||
105685196|NCT00960531|364509422|FG000|Overall Study|Investigator Request|0|||
105685197|NCT00960531|364509423|FG001|Overall Study|Investigator Request|0|||
105685198|NCT00960531|364509424|FG002|Overall Study|Investigator Request|1|||
105685199|NCT00960531|364509425|FG003|Overall Study|Investigator Request|0|||
105685200|NCT00960531|364509426|FG004|Overall Study|Investigator Request|0|||
105685201|NCT00960531|364509427|FG005|Overall Study|Investigator Request|0|||
105685202|NCT00960531|364509428|FG006|Overall Study|Investigator Request|0|||
105685203|NCT00960531|364509429|FG007|Overall Study|Investigator Request|0|||
105685204|NCT00960531|364509430|FG008|Overall Study|Investigator Request|0|||
105685205|NCT00960531|364509431|FG009|Overall Study|Investigator Request|0|||
105685206|NCT00960531|364509422|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
105685207|NCT00960531|364509423|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105685208|NCT00960531|364509424|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
105685209|NCT00960531|364509425|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
105685210|NCT00960531|364509426|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
105685211|NCT00960531|364509427|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
105917272|NCT03786380|365356819|FG001|Overall Study|Study Terminated by the Sponsor|20|||
105917273|NCT03786380|365356820|FG002|Overall Study|Study Terminated by the Sponsor|50|||
105917274|NCT03786380|365356821|FG003|Overall Study|Study Terminated by the Sponsor|57|||
105917275|NCT03786380|365356822|FG004|Overall Study|Study Terminated by the Sponsor|23|||
105917276|NCT03786380|365356818|FG000|Overall Study|Reason Not Specified|0|||
105917277|NCT03786380|365356819|FG001|Overall Study|Reason Not Specified|0|||
105917278|NCT03786380|365356820|FG002|Overall Study|Reason Not Specified|0|||
105917279|NCT03786380|365356821|FG003|Overall Study|Reason Not Specified|0|||
105917280|NCT03786380|365356822|FG004|Overall Study|Reason Not Specified|1|||
105917281|NCT01909804|365356823|FG000|Overall Study|Randomized but Never Treated|0|||
105917282|NCT01909804|365356824|FG001|Overall Study|Randomized but Never Treated|0|||
105917283|NCT01909804|365356825|FG002|Overall Study|Randomized but Never Treated|0|||
105917284|NCT01909804|365356826|FG003|Overall Study|Randomized but Never Treated|0|||
105917285|NCT01909804|365356827|FG004|Overall Study|Randomized but Never Treated|0|||
105917286|NCT01909804|365356828|FG005|Overall Study|Randomized but Never Treated|0|||
105917287|NCT01909804|365356829|FG006|Overall Study|Randomized but Never Treated|1|||
105917288|NCT01909804|365356830|FG007|Overall Study|Randomized but Never Treated|0|||
105917289|NCT01909804|365356831|FG008|Overall Study|Randomized but Never Treated|0|||
105917290|NCT01909804|365356832|FG009|Overall Study|Randomized but Never Treated|0|||
105685212|NCT00960531|364509428|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
105685213|NCT00960531|364509429|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
105685214|NCT00960531|364509430|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
105917291|NCT01909804|365356833|FG010|Overall Study|Randomized but Never Treated|0|||
105685215|NCT00960531|364509431|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
105685216|NCT00960531|364509422|FG000|Overall Study|Lost to Follow-up|0|||
105685217|NCT00960531|364509423|FG001|Overall Study|Lost to Follow-up|0|||
105685218|NCT00960531|364509424|FG002|Overall Study|Lost to Follow-up|1|||
105685219|NCT00960531|364509425|FG003|Overall Study|Lost to Follow-up|0|||
105685220|NCT00960531|364509426|FG004|Overall Study|Lost to Follow-up|0|||
105685221|NCT00960531|364509427|FG005|Overall Study|Lost to Follow-up|0|||
105685222|NCT00960531|364509428|FG006|Overall Study|Lost to Follow-up|1|||
105685223|NCT00960531|364509429|FG007|Overall Study|Lost to Follow-up|0|||
105685224|NCT00960531|364509430|FG008|Overall Study|Lost to Follow-up|0|||
105685225|NCT00960531|364509431|FG009|Overall Study|Lost to Follow-up|0|||
105685226|NCT00960531|364509422|FG000|Overall Study|Failed to Return|2|||
105685227|NCT00960531|364509423|FG001|Overall Study|Failed to Return|0|||
105685228|NCT00960531|364509424|FG002|Overall Study|Failed to Return|0|||
105685229|NCT00960531|364509425|FG003|Overall Study|Failed to Return|0|||
105685230|NCT00960531|364509426|FG004|Overall Study|Failed to Return|0|||
105685231|NCT00960531|364509427|FG005|Overall Study|Failed to Return|0|||
105685232|NCT00960531|364509428|FG006|Overall Study|Failed to Return|0|||
105685233|NCT00960531|364509429|FG007|Overall Study|Failed to Return|2|||
105685234|NCT00960531|364509430|FG008|Overall Study|Failed to Return|0|||
105685235|NCT00960531|364509431|FG009|Overall Study|Failed to Return|0|||
105685236|NCT00960531|364509422|FG000|Overall Study|Adverse Event (AE)|2|||
105685237|NCT00960531|364509423|FG001|Overall Study|Adverse Event (AE)|0|||
105685238|NCT00960531|364509424|FG002|Overall Study|Adverse Event (AE)|0|||
105685239|NCT00960531|364509425|FG003|Overall Study|Adverse Event (AE)|0|||
105685240|NCT00960531|364509426|FG004|Overall Study|Adverse Event (AE)|0|||
105685241|NCT00960531|364509427|FG005|Overall Study|Adverse Event (AE)|1|||
105685242|NCT00960531|364509428|FG006|Overall Study|Adverse Event (AE)|2|||
105685243|NCT00960531|364509429|FG007|Overall Study|Adverse Event (AE)|0|||
105685244|NCT00960531|364509430|FG008|Overall Study|Adverse Event (AE)|2|||
105685245|NCT00960531|364509431|FG009|Overall Study|Adverse Event (AE)|0|||
105685246|NCT00960531|364509422|FG000|Overall Study|Reason not Specified|2|||
105685247|NCT00960531|364509423|FG001|Overall Study|Reason not Specified|1|||
105685248|NCT00960531|364509424|FG002|Overall Study|Reason not Specified|13|||
105685249|NCT00960531|364509425|FG003|Overall Study|Reason not Specified|1|||
105685250|NCT00960531|364509426|FG004|Overall Study|Reason not Specified|2|||
105685251|NCT00960531|364509427|FG005|Overall Study|Reason not Specified|0|||
105685252|NCT00960531|364509428|FG006|Overall Study|Reason not Specified|16|||
105685253|NCT00960531|364509429|FG007|Overall Study|Reason not Specified|0|||
105685254|NCT00960531|364509430|FG008|Overall Study|Reason not Specified|8|||
105685255|NCT00960531|364509431|FG009|Overall Study|Reason not Specified|1|||
105685256|NCT00409773|364510857|FG000|Overall Study|Adverse Event|3|||
105685257|NCT00409773|364510858|FG001|Overall Study|Adverse Event|4|||
105685258|NCT00409773|364510859|FG002|Overall Study|Adverse Event|4|||
105685259|NCT00409773|364510860|FG003|Overall Study|Adverse Event|2|||
105685260|NCT00409773|364510861|FG004|Overall Study|Adverse Event|6|||
105685261|NCT00409773|364510857|FG000|Overall Study|Lost to Follow-up|6|||
105685262|NCT00409773|364510858|FG001|Overall Study|Lost to Follow-up|1|||
105685263|NCT00409773|364510859|FG002|Overall Study|Lost to Follow-up|2|||
105685264|NCT00409773|364510860|FG003|Overall Study|Lost to Follow-up|3|||
105685265|NCT00409773|364510861|FG004|Overall Study|Lost to Follow-up|1|||
105685266|NCT00409773|364510857|FG000|Overall Study|Physician Decision|0|||
105685267|NCT00409773|364510858|FG001|Overall Study|Physician Decision|0|||
105685268|NCT00409773|364510859|FG002|Overall Study|Physician Decision|0|||
105685269|NCT00409773|364510860|FG003|Overall Study|Physician Decision|2|||
105685270|NCT00409773|364510861|FG004|Overall Study|Physician Decision|0|||
105685271|NCT00409773|364510857|FG000|Overall Study|Protocol Violation|0|||
105685272|NCT00409773|364510858|FG001|Overall Study|Protocol Violation|2|||
105685273|NCT00409773|364510859|FG002|Overall Study|Protocol Violation|3|||
105685274|NCT00409773|364510860|FG003|Overall Study|Protocol Violation|3|||
105685275|NCT00409773|364510861|FG004|Overall Study|Protocol Violation|1|||
105685276|NCT00409773|364510857|FG000|Overall Study|Withdrawal by Subject|0|||
105685277|NCT00409773|364510858|FG001|Overall Study|Withdrawal by Subject|0|||
105685278|NCT00409773|364510859|FG002|Overall Study|Withdrawal by Subject|0|||
105685279|NCT00409773|364510860|FG003|Overall Study|Withdrawal by Subject|2|||
105685280|NCT00409773|364510861|FG004|Overall Study|Withdrawal by Subject|1|||
105685281|NCT00409773|364510857|FG000|Overall Study|Lack of Eligibility|0|||
105685282|NCT00409773|364510858|FG001|Overall Study|Lack of Eligibility|0|||
105685283|NCT00409773|364510859|FG002|Overall Study|Lack of Eligibility|0|||
105685284|NCT00409773|364510860|FG003|Overall Study|Lack of Eligibility|0|||
105685285|NCT00409773|364510861|FG004|Overall Study|Lack of Eligibility|1|||
105685286|NCT00153062|364510862|FG000|Overall Study|Death|360|||
105685287|NCT00153062|364510863|FG001|Overall Study|Death|352|||
105685288|NCT00153062|364510864|FG002|Overall Study|Death|369|||
105685289|NCT00153062|364510865|FG003|Overall Study|Death|365|||
105685290|NCT00153062|364510862|FG000|Overall Study|Withdrawal by Subject|14|||
105685291|NCT00153062|364510863|FG001|Overall Study|Withdrawal by Subject|30|||
105685292|NCT00153062|364510864|FG002|Overall Study|Withdrawal by Subject|27|||
105917292|NCT01909804|365356834|FG011|Overall Study|Randomized but Never Treated|1|||
105685293|NCT00153062|364510865|FG003|Overall Study|Withdrawal by Subject|28|||
105685294|NCT00153062|364510862|FG000|Overall Study|Lost to Follow-up|12|||
105685295|NCT00153062|364510863|FG001|Overall Study|Lost to Follow-up|20|||
105685296|NCT00153062|364510864|FG002|Overall Study|Lost to Follow-up|15|||
105685297|NCT00153062|364510865|FG003|Overall Study|Lost to Follow-up|16|||
105685298|NCT00153062|364510862|FG000|Overall Study|Adverse Event|0|||
105685299|NCT00153062|364510863|FG001|Overall Study|Adverse Event|1|||
105685300|NCT00153062|364510864|FG002|Overall Study|Adverse Event|1|||
105685301|NCT00153062|364510865|FG003|Overall Study|Adverse Event|0|||
105685302|NCT00153062|364510862|FG000|Overall Study|Protocol Violation|0|||
105685303|NCT00153062|364510863|FG001|Overall Study|Protocol Violation|2|||
105685304|NCT00153062|364510864|FG002|Overall Study|Protocol Violation|1|||
105685305|NCT00153062|364510865|FG003|Overall Study|Protocol Violation|1|||
105685306|NCT00153062|364510862|FG000|Overall Study|No disposition data available|1|||
105685307|NCT00153062|364510863|FG001|Overall Study|No disposition data available|1|||
105685308|NCT00153062|364510864|FG002|Overall Study|No disposition data available|1|||
105685309|NCT00153062|364510865|FG003|Overall Study|No disposition data available|1|||
105685310|NCT00153062|364510862|FG000|Overall Study|Other|0|||
105685311|NCT00153062|364510863|FG001|Overall Study|Other|0|||
105685312|NCT00153062|364510864|FG002|Overall Study|Other|1|||
105685313|NCT00153062|364510865|FG003|Overall Study|Other|0|||
105685314|NCT02359877|364510866|FG000|Overall Study|Withdrawal by Subject|1|||
105685315|NCT02359877|364510867|FG001|Overall Study|Withdrawal by Subject|0|||
105685316|NCT02359877|364510868|FG002|Overall Study|Withdrawal by Subject|0|||
105685317|NCT02359877|364510869|FG003|Overall Study|Withdrawal by Subject|2|||
105685318|NCT02359877|364510866|FG000|Overall Study|Adverse Event|0|||
105685319|NCT02359877|364510867|FG001|Overall Study|Adverse Event|0|||
105685320|NCT02359877|364510868|FG002|Overall Study|Adverse Event|0|||
105685321|NCT02359877|364510869|FG003|Overall Study|Adverse Event|1|||
105685322|NCT01919814|364510870|FG000|Overall Study|Adverse Event|1|||
105685323|NCT01919814|364510871|FG001|Overall Study|Adverse Event|0|||
105685324|NCT01919814|364510870|FG000|Overall Study|Protocol Violation|1|||
105685325|NCT01919814|364510871|FG001|Overall Study|Protocol Violation|0|||
105685326|NCT01919814|364510870|FG000|Overall Study|Withdrawal by Subject|1|||
105685327|NCT01919814|364510871|FG001|Overall Study|Withdrawal by Subject|0|||
105685328|NCT00275262|364510872|FG000|Overall Study|Adverse Event|2|||
105685329|NCT00275262|364510873|FG001|Overall Study|Adverse Event|0|||
105685330|NCT00275262|364510872|FG000|Overall Study|Disease progression|2|||
105685331|NCT00275262|364510873|FG001|Overall Study|Disease progression|5|||
105685332|NCT00275262|364510872|FG000|Overall Study|Lost to Follow-up|0|||
105685333|NCT00275262|364510873|FG001|Overall Study|Lost to Follow-up|2|||
105685334|NCT00275262|364510872|FG000|Overall Study|Protocol Violation|0|||
105685335|NCT00275262|364510873|FG001|Overall Study|Protocol Violation|2|||
105685336|NCT00275262|364510872|FG000|Overall Study|Death|1|||
105685337|NCT00275262|364510873|FG001|Overall Study|Death|0|||
105685338|NCT00275262|364510872|FG000|Overall Study|Started Chemotherapy|1|||
105685339|NCT00275262|364510873|FG001|Overall Study|Started Chemotherapy|0|||
105685340|NCT00001962|364510876|FG000|Overall Study|Lack of Efficacy|18|||
105685341|NCT00001962|364510876|FG000|Overall Study|Lack of Accrual|6|||
105685342|NCT00001962|364510876|FG000|Overall Study|Death|1|||
105685343|NCT00001962|364510876|FG000|Overall Study|Lost to Follow-up|2|||
105685344|NCT00001962|364510876|FG000|Overall Study|Adverse Event|1|||
105685345|NCT01201317|364510886|FG000|Overall Study|Withdrawal by Subject|5|||
105685346|NCT01201317|364510887|FG001|Overall Study|Withdrawal by Subject|0|||
105685347|NCT01201317|364510888|FG002|Overall Study|Withdrawal by Subject|3|||
105685348|NCT01201317|364510886|FG000|Overall Study|Adverse Event|2|||
105685349|NCT01201317|364510887|FG001|Overall Study|Adverse Event|2|||
105685350|NCT01201317|364510888|FG002|Overall Study|Adverse Event|2|||
105685351|NCT01201317|364510886|FG000|Overall Study|Screen failure|1|||
105685352|NCT01201317|364510887|FG001|Overall Study|Screen failure|1|||
105685353|NCT01201317|364510888|FG002|Overall Study|Screen failure|0|||
105685354|NCT01201317|364510886|FG000|Overall Study|Protocol Violation|0|||
105685355|NCT01201317|364510887|FG001|Overall Study|Protocol Violation|1|||
105685356|NCT01201317|364510888|FG002|Overall Study|Protocol Violation|1|||
105685357|NCT01201317|364510886|FG000|Overall Study|Death|0|||
105685358|NCT01201317|364510887|FG001|Overall Study|Death|1|||
105685359|NCT01201317|364510888|FG002|Overall Study|Death|0|||
105685360|NCT01201317|364510886|FG000|Overall Study|Study-specific withdrawal criteria|0|||
105685361|NCT01201317|364510887|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105685362|NCT01201317|364510888|FG002|Overall Study|Study-specific withdrawal criteria|1|||
105685363|NCT01201317|364510886|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
105685364|NCT01201317|364510887|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
105685365|NCT01201317|364510888|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
105685366|NCT01201317|364510886|FG000|Overall Study|Decrease in renal function|0|||
105685367|NCT01201317|364510887|FG001|Overall Study|Decrease in renal function|1|||
105685368|NCT01201317|364510888|FG002|Overall Study|Decrease in renal function|0|||
105685369|NCT01201317|364510886|FG000|Overall Study|Lack of Efficacy|1|||
105685370|NCT01201317|364510887|FG001|Overall Study|Lack of Efficacy|0|||
105685371|NCT01201317|364510888|FG002|Overall Study|Lack of Efficacy|0|||
105685372|NCT01201317|364510886|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
105685373|NCT01201317|364510887|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
105685374|NCT01201317|364510888|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
105685375|NCT02795429|364510889|FG000|Overall Study|Adverse Event|1|||
105685376|NCT02795429|364510890|FG001|Overall Study|Adverse Event|2|||
105685377|NCT02795429|364510891|FG002|Overall Study|Adverse Event|1|||
105685378|NCT02795429|364510892|FG003|Overall Study|Adverse Event|2|||
105685379|NCT02795429|364510893|FG004|Overall Study|Adverse Event|1|||
105685380|NCT02795429|364510889|FG000|Overall Study|Death|1|||
105685381|NCT02795429|364510890|FG001|Overall Study|Death|0|||
105685382|NCT02795429|364510891|FG002|Overall Study|Death|1|||
105685383|NCT02795429|364510892|FG003|Overall Study|Death|2|||
105685384|NCT02795429|364510893|FG004|Overall Study|Death|1|||
105685385|NCT02795429|364510889|FG000|Overall Study|Physician Decision|0|||
105685386|NCT02795429|364510890|FG001|Overall Study|Physician Decision|0|||
105685387|NCT02795429|364510891|FG002|Overall Study|Physician Decision|2|||
105685388|NCT02795429|364510892|FG003|Overall Study|Physician Decision|1|||
105685389|NCT02795429|364510893|FG004|Overall Study|Physician Decision|5|||
105685390|NCT02795429|364510889|FG000|Overall Study|Progressive disease|3|||
105685391|NCT02795429|364510890|FG001|Overall Study|Progressive disease|7|||
105685392|NCT02795429|364510891|FG002|Overall Study|Progressive disease|6|||
105685393|NCT02795429|364510892|FG003|Overall Study|Progressive disease|26|||
105685394|NCT02795429|364510893|FG004|Overall Study|Progressive disease|20|||
105685395|NCT02795429|364510889|FG000|Overall Study|Subject/guardian decision|1|||
105685396|NCT02795429|364510890|FG001|Overall Study|Subject/guardian decision|1|||
105685397|NCT02795429|364510891|FG002|Overall Study|Subject/guardian decision|1|||
105685398|NCT02795429|364510892|FG003|Overall Study|Subject/guardian decision|1|||
105685399|NCT02795429|364510893|FG004|Overall Study|Subject/guardian decision|3|||
105685400|NCT03628898|364510894|FG000|Overall Study|Device deficiency|1|||
105685401|NCT03645057|364510899|FG000|Randomization to Baseline|Lost to Follow-up|1|||
105685402|NCT03645057|364510900|FG001|Randomization to Baseline|Lost to Follow-up|0|||
105685403|NCT03645057|364510901|FG002|Randomization to Baseline|Lost to Follow-up|1|||
105685404|NCT03645057|364510902|FG003|Randomization to Baseline|Lost to Follow-up|0|||
105685405|NCT03645057|364510899|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
105685406|NCT03645057|364510900|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
105685407|NCT03645057|364510901|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
105685408|NCT03645057|364510902|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
105685409|NCT03645057|364510899|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
105685410|NCT03645057|364510900|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
105685411|NCT03645057|364510901|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
105685412|NCT03645057|364510902|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
105685413|NCT03645057|364510899|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
105685414|NCT03645057|364510900|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
105685415|NCT03645057|364510901|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
105685416|NCT03645057|364510902|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
105685417|NCT01873495|364510903|FG000|Overall Study|Withdrawal by Subject|1|||
105685418|NCT01873495|364510903|FG000|Overall Study|Physician Decision|3|||
105685419|NCT01873495|364510903|FG000|Overall Study|Adverse Event|1|||
105685420|NCT01873495|364510903|FG000|Overall Study|Removed for Transplantation|1|||
105685421|NCT01873495|364510903|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
105685422|NCT02080221|364510904|FG000|Overall Study|Withdrawal by Subject|1|||
105685423|NCT02080221|364510904|FG000|Overall Study|Clinical Progression of Disease|1|||
105685424|NCT03907410|364510905|FG000|Overall Study|Lost to Follow-up|4|||
105685425|NCT03907410|364510906|FG001|Overall Study|Lost to Follow-up|1|||
105685426|NCT03907410|364510907|FG002|Overall Study|Lost to Follow-up|1|||
105685427|NCT03907410|364510905|FG000|Overall Study|Lost to follow-up and research burden|0|||
105685428|NCT03907410|364510906|FG001|Overall Study|Lost to follow-up and research burden|0|||
105685429|NCT03907410|364510907|FG002|Overall Study|Lost to follow-up and research burden|1|||
105685430|NCT01295034|364510908|FG000|Overall Study|Lost to Follow-up|5|||
105685431|NCT01295034|364510909|FG001|Overall Study|Lost to Follow-up|5|||
105685432|NCT04754477|364510911|FG000|Overall Study|Withdrawal by Subject|1|||
105917293|NCT01909804|365356823|FG000|Overall Study|Death|0|||
105917294|NCT01909804|365356824|FG001|Overall Study|Death|0|||
105917295|NCT01909804|365356825|FG002|Overall Study|Death|0|||
105917296|NCT01909804|365356826|FG003|Overall Study|Death|0|||
105917297|NCT01909804|365356827|FG004|Overall Study|Death|0|||
105917298|NCT01909804|365356828|FG005|Overall Study|Death|0|||
105917299|NCT01909804|365356829|FG006|Overall Study|Death|0|||
105685433|NCT00986674|364510912|FG000|Overall Study|Lack of Efficacy|28|||
105685434|NCT00986674|364510913|FG001|Overall Study|Lack of Efficacy|25|||
105685435|NCT00986674|364510914|FG002|Overall Study|Lack of Efficacy|23|||
105917300|NCT01909804|365356830|FG007|Overall Study|Death|0|||
105685436|NCT00986674|364510912|FG000|Overall Study|Adverse Event|4|||
105685437|NCT00986674|364510913|FG001|Overall Study|Adverse Event|8|||
105685438|NCT00986674|364510914|FG002|Overall Study|Adverse Event|9|||
105685439|NCT00986674|364510912|FG000|Overall Study|Death|5|||
105685440|NCT00986674|364510913|FG001|Overall Study|Death|0|||
105685441|NCT00986674|364510914|FG002|Overall Study|Death|4|||
105685442|NCT00986674|364510912|FG000|Overall Study|Withdrawal by Subject|6|||
105917301|NCT01909804|365356831|FG008|Overall Study|Death|0|||
105685443|NCT00986674|364510913|FG001|Overall Study|Withdrawal by Subject|2|||
105685444|NCT00986674|364510914|FG002|Overall Study|Withdrawal by Subject|1|||
105685445|NCT00986674|364510912|FG000|Overall Study|alternative therapy|0|||
105917302|NCT01909804|365356832|FG009|Overall Study|Death|0|||
105685446|NCT00986674|364510913|FG001|Overall Study|alternative therapy|0|||
105685447|NCT00986674|364510914|FG002|Overall Study|alternative therapy|1|||
105685448|NCT00986674|364510912|FG000|Overall Study|not start protocol therapy|4|||
105685449|NCT00986674|364510913|FG001|Overall Study|not start protocol therapy|3|||
105685450|NCT00986674|364510914|FG002|Overall Study|not start protocol therapy|1|||
105685451|NCT00986674|364510912|FG000|Overall Study|unknown/not specify|0|||
105685452|NCT00986674|364510913|FG001|Overall Study|unknown/not specify|7|||
105685453|NCT00986674|364510914|FG002|Overall Study|unknown/not specify|9|||
105685454|NCT00825916|364510917|FG000|Overall Study|Lost to Follow-up|4|||
105685455|NCT00825916|364510918|FG001|Overall Study|Lost to Follow-up|2|||
105685456|NCT00825916|364510919|FG002|Overall Study|Lost to Follow-up|1|||
105685457|NCT03421431|364510927|FG000|Overall Study|Adverse Event|2|||
105685458|NCT03421431|364510928|FG001|Overall Study|Adverse Event|1|||
105685459|NCT03421431|364510929|FG002|Overall Study|Adverse Event|12|||
105685460|NCT03421431|364510927|FG000|Overall Study|Lost to Follow-up|1|||
105685461|NCT03421431|364510928|FG001|Overall Study|Lost to Follow-up|1|||
105685462|NCT03421431|364510929|FG002|Overall Study|Lost to Follow-up|1|||
105685463|NCT03421431|364510927|FG000|Overall Study|Withdrawal by Subject|3|||
105685464|NCT03421431|364510928|FG001|Overall Study|Withdrawal by Subject|2|||
105685465|NCT03421431|364510929|FG002|Overall Study|Withdrawal by Subject|1|||
105685466|NCT03421431|364510927|FG000|Overall Study|Protocol Violation|0|||
105685467|NCT03421431|364510928|FG001|Overall Study|Protocol Violation|1|||
105685468|NCT03421431|364510929|FG002|Overall Study|Protocol Violation|0|||
105685469|NCT03421431|364510927|FG000|Overall Study|Participant met Stopping Rules|0|||
105685470|NCT03421431|364510928|FG001|Overall Study|Participant met Stopping Rules|1|||
105685471|NCT03421431|364510929|FG002|Overall Study|Participant met Stopping Rules|0|||
105685472|NCT02216357|364510930|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
105685473|NCT02216357|364510931|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
105685474|NCT04964414|364510932|FG000|Overall Study|Lost to Follow-up|10|||
105685475|NCT04964414|364510933|FG001|Overall Study|Lost to Follow-up|8|||
105685476|NCT04964414|364510932|FG000|Overall Study|Withdrawal by Subject|1|||
105685477|NCT04964414|364510933|FG001|Overall Study|Withdrawal by Subject|1|||
105685478|NCT00051363|364510940|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
105685479|NCT00051363|364510941|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
105685480|NCT00051363|364510940|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
105685481|NCT00051363|364510941|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
105685482|NCT00051363|364510940|FG000|Overall Study|Death|2|||
105685483|NCT00051363|364510941|FG001|Overall Study|Death|2|||
105685484|NCT00051363|364510940|FG000|Overall Study|Excluded Pre-Randomization|2|||
105685485|NCT00051363|364510941|FG001|Overall Study|Excluded Pre-Randomization|5|||
105685486|NCT01596621|364510942|FG000|Overall Study|Death|4|||
105685487|NCT01596621|364510942|FG000|Overall Study|Withdrawal by Subject|9|||
105685488|NCT01596621|364510942|FG000|Overall Study|Disease Progression|49|||
105917303|NCT01909804|365356833|FG010|Overall Study|Death|1|||
105917304|NCT01909804|365356834|FG011|Overall Study|Death|0|||
106128278|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
106128279|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
106128280|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
106128281|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
106128282|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
106128283|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
106128284|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
106128285|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
106128286|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
105685489|NCT01596621|364510942|FG000|Overall Study|Lost to Follow-up|3|||
105917305|NCT01909804|365356823|FG000|Overall Study|Lack of Efficacy|4|||
105917306|NCT01909804|365356824|FG001|Overall Study|Lack of Efficacy|1|||
105917307|NCT01909804|365356825|FG002|Overall Study|Lack of Efficacy|0|||
105917308|NCT01909804|365356826|FG003|Overall Study|Lack of Efficacy|0|||
105917309|NCT01909804|365356827|FG004|Overall Study|Lack of Efficacy|7|||
105917310|NCT01909804|365356828|FG005|Overall Study|Lack of Efficacy|3|||
105917311|NCT01909804|365356829|FG006|Overall Study|Lack of Efficacy|1|||
105917312|NCT01909804|365356830|FG007|Overall Study|Lack of Efficacy|1|||
105685490|NCT01596621|364510942|FG000|Overall Study|Other than specified|13|||
105685491|NCT00388154|364510948|FG000|Overall Study|Withdrawal by Subject|1|||
105685492|NCT01201265|364510949|FG000|Overall Study|Death|14|||
105685493|NCT01201265|364510949|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105917313|NCT01909804|365356831|FG008|Overall Study|Lack of Efficacy|0|||
105917314|NCT01909804|365356832|FG009|Overall Study|Lack of Efficacy|1|||
105685494|NCT01201265|364510949|FG000|Overall Study|Lost to Follow-up|10|||
105685495|NCT01201265|364510949|FG000|Overall Study|Withdrawal by Subject|7|||
105685496|NCT01201265|364510949|FG000|Overall Study|Disease Progression|4|||
105685497|NCT03737474|364510950|FG000|Overall Study|Adverse Event|18|||
105685498|NCT03737474|364510951|FG001|Overall Study|Adverse Event|48|||
105685499|NCT03737474|364510950|FG000|Overall Study|Lack of Efficacy|1|||
106128287|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
106128288|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
106128289|NCT00333138|366125609|FG000|Extension Study (Month6 to End of Study)|Death|0|||
106128290|NCT00333138|366125610|FG001|Extension Study (Month6 to End of Study)|Death|1|||
106128291|NCT00333138|366125611|FG002|Extension Study (Month6 to End of Study)|Death|0|||
106128292|NCT02320721|366125613|FG000|Overall Study|Adverse Event|6|||
106128293|NCT02320721|366125614|FG001|Overall Study|Adverse Event|6|||
106128294|NCT02320721|366125613|FG000|Overall Study|Lack of Efficacy|2|||
106128295|NCT02320721|366125614|FG001|Overall Study|Lack of Efficacy|0|||
106128296|NCT02320721|366125613|FG000|Overall Study|Poor compliance to protocol|3|||
106128297|NCT02320721|366125614|FG001|Overall Study|Poor compliance to protocol|7|||
106128298|NCT02320721|366125613|FG000|Overall Study|Randomized but not treated|0|||
106128299|NCT02320721|366125614|FG001|Overall Study|Randomized but not treated|1|||
106128300|NCT02320721|366125613|FG000|Overall Study|Hypoglycemia|1|||
106128301|NCT02320721|366125614|FG001|Overall Study|Hypoglycemia|0|||
105685500|NCT03737474|364510951|FG001|Overall Study|Lack of Efficacy|3|||
105685501|NCT03737474|364510950|FG000|Overall Study|Protocol Violation|0|||
105685502|NCT03737474|364510951|FG001|Overall Study|Protocol Violation|8|||
105685503|NCT03737474|364510950|FG000|Overall Study|Withdrawal by Subject|5|||
105685504|NCT03737474|364510951|FG001|Overall Study|Withdrawal by Subject|20|||
105685505|NCT03737474|364510950|FG000|Overall Study|Non-compliance With Study Drug|0|||
106128302|NCT02320721|366125613|FG000|Overall Study|Other than specified above|15|||
106128303|NCT02320721|366125614|FG001|Overall Study|Other than specified above|20|||
106128304|NCT04630756|366125619|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
106128305|NCT04630756|366125620|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
106128306|NCT04630756|366125621|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
106128307|NCT04131907|366125622|FG000|Overall Study|Adverse Event|2|||
106128308|NCT04131907|366125623|FG001|Overall Study|Adverse Event|0|||
106128309|NCT04131907|366125624|FG002|Overall Study|Adverse Event|0|||
106128310|NCT04131907|366125622|FG000|Overall Study|Physician Decision|4|||
105685506|NCT03737474|364510951|FG001|Overall Study|Non-compliance With Study Drug|1|||
105685507|NCT03737474|364510950|FG000|Overall Study|Physician Decision|1|||
105786552|NCT02161380|364871465|FG001|Overall Study|Lost to Follow-up|1|||
105786553|NCT02161380|364871466|FG002|Overall Study|Lost to Follow-up|0|||
106128311|NCT04131907|366125623|FG001|Overall Study|Physician Decision|22|||
106128312|NCT04131907|366125624|FG002|Overall Study|Physician Decision|0|||
106128313|NCT04131907|366125622|FG000|Overall Study|Withdrawal by Subject|2|||
106128314|NCT04131907|366125623|FG001|Overall Study|Withdrawal by Subject|0|||
106128315|NCT04131907|366125624|FG002|Overall Study|Withdrawal by Subject|1|||
106128316|NCT04131907|366125622|FG000|Overall Study|Treatment failure|2|||
106128317|NCT04131907|366125623|FG001|Overall Study|Treatment failure|0|||
106128318|NCT04131907|366125624|FG002|Overall Study|Treatment failure|1|||
106128319|NCT00847301|366125625|FG000|Overall Study|Adverse Event|35|||
106128320|NCT00847301|366125625|FG000|Overall Study|Switch to other anticoagulants|16|||
106128321|NCT00847301|366125625|FG000|Overall Study|Lost to Follow-up|1|||
106128322|NCT00847301|366125625|FG000|Overall Study|No prescription after hospital discharge|1|||
106128323|NCT00847301|366125625|FG000|Overall Study|Other reason not defined above|1|||
106128324|NCT04248465|366125626|FG000|Randomized-Controlled Period|Death|12|||
106128325|NCT04248465|366125627|FG001|Randomized-Controlled Period|Death|5|||
106128326|NCT04248465|366125626|FG000|Randomized-Controlled Period|Adverse Event|2|||
106128327|NCT04248465|366125627|FG001|Randomized-Controlled Period|Adverse Event|0|||
106128328|NCT04248465|366125626|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
106128329|NCT04248465|366125627|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
106128330|NCT04248465|366125626|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
106128331|NCT04248465|366125627|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
106128332|NCT04248465|366125626|FG000|Randomized-Controlled Period|Physician Decision|1|||
106128333|NCT04248465|366125627|FG001|Randomized-Controlled Period|Physician Decision|1|||
106128334|NCT04248465|366125626|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
106128335|NCT04248465|366125627|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
106128336|NCT04248465|366125626|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
106128337|NCT04248465|366125627|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
106128338|NCT04248465|366125626|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
106128339|NCT04248465|366125627|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
105786554|NCT02161380|364871467|FG003|Overall Study|Lost to Follow-up|0|||
105786555|NCT01945034|364872824|FG000|Overall Study|Medication Error|0|||
106128340|NCT01342887|366125628|FG000|Overall Study|Death|2|||
106128341|NCT01544582|366125629|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
106128342|NCT01544582|366125630|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
105685508|NCT03737474|364510951|FG001|Overall Study|Physician Decision|4|||
105685509|NCT01145755|364510952|FG000|Overall Study|Adverse Event|2|||
105685510|NCT01145755|364510953|FG001|Overall Study|Adverse Event|4|||
105786556|NCT01945034|364872825|FG001|Overall Study|Medication Error|1|||
105786557|NCT01945034|364872826|FG002|Overall Study|Medication Error|0|||
106128343|NCT01544582|366125631|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
106128344|NCT01544582|366125632|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
106128345|NCT01544582|366125629|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
106128346|NCT01544582|366125630|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
106128347|NCT01544582|366125631|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
106128348|NCT01544582|366125632|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
106128349|NCT01544582|366125629|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
106128350|NCT01544582|366125630|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
106128351|NCT01544582|366125631|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
106128352|NCT01544582|366125632|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
106128353|NCT01544582|366125629|FG000|Analysis Population|Physician Decision|0|||
106128354|NCT01544582|366125630|FG001|Analysis Population|Physician Decision|13|||
106128355|NCT01544582|366125631|FG002|Analysis Population|Physician Decision|10|||
106128356|NCT01544582|366125632|FG003|Analysis Population|Physician Decision|9|||
106128357|NCT01544582|366125629|FG000|Analysis Population|Safety Reason|0|||
106128358|NCT01544582|366125630|FG001|Analysis Population|Safety Reason|33|||
106128359|NCT01544582|366125631|FG002|Analysis Population|Safety Reason|31|||
106128360|NCT01544582|366125632|FG003|Analysis Population|Safety Reason|8|||
106128361|NCT01544582|366125629|FG000|Analysis Population|Effectiveness Reason|0|||
106128362|NCT01544582|366125630|FG001|Analysis Population|Effectiveness Reason|48|||
106128363|NCT01544582|366125631|FG002|Analysis Population|Effectiveness Reason|29|||
106128364|NCT01544582|366125632|FG003|Analysis Population|Effectiveness Reason|12|||
106128365|NCT01544582|366125629|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
106128366|NCT01544582|366125630|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
106128367|NCT01544582|366125631|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
106128368|NCT01544582|366125632|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
106128369|NCT01544582|366125629|FG000|Analysis Population|Lost to Follow-up|0|||
106128370|NCT01544582|366125630|FG001|Analysis Population|Lost to Follow-up|6|||
106128371|NCT01544582|366125631|FG002|Analysis Population|Lost to Follow-up|6|||
105685511|NCT01145755|364510954|FG002|Overall Study|Adverse Event|2|||
105685512|NCT01145755|364510952|FG000|Overall Study|Withdrawal by Subject|2|||
105685513|NCT01145755|364510953|FG001|Overall Study|Withdrawal by Subject|2|||
105685514|NCT01145755|364510954|FG002|Overall Study|Withdrawal by Subject|2|||
105685515|NCT01145755|364510952|FG000|Overall Study|Lost to Follow-up|2|||
105685516|NCT01145755|364510953|FG001|Overall Study|Lost to Follow-up|3|||
105685517|NCT01145755|364510954|FG002|Overall Study|Lost to Follow-up|1|||
105685518|NCT01145755|364510952|FG000|Overall Study|Protocol Violation|0|||
105685519|NCT01145755|364510953|FG001|Overall Study|Protocol Violation|3|||
105685520|NCT01145755|364510954|FG002|Overall Study|Protocol Violation|1|||
105685521|NCT01145755|364510952|FG000|Overall Study|Study Closure|14|||
105685522|NCT01145755|364510953|FG001|Overall Study|Study Closure|14|||
105685523|NCT01145755|364510954|FG002|Overall Study|Study Closure|17|||
105685524|NCT01145755|364510952|FG000|Overall Study|Lack of Efficacy|0|||
105685525|NCT01145755|364510953|FG001|Overall Study|Lack of Efficacy|1|||
105685526|NCT01145755|364510954|FG002|Overall Study|Lack of Efficacy|0|||
105685527|NCT01145755|364510952|FG000|Overall Study|Patient could not swollow medication|0|||
105685528|NCT01145755|364510953|FG001|Overall Study|Patient could not swollow medication|0|||
105685529|NCT01145755|364510954|FG002|Overall Study|Patient could not swollow medication|1|||
105685530|NCT01145755|364510952|FG000|Overall Study|Withdrawal by Subject|0|||
105685531|NCT01145755|364510953|FG001|Overall Study|Withdrawal by Subject|0|||
105685532|NCT01145755|364510954|FG002|Overall Study|Withdrawal by Subject|1|||
105917315|NCT01909804|365356833|FG010|Overall Study|Lack of Efficacy|0|||
105917316|NCT01909804|365356834|FG011|Overall Study|Lack of Efficacy|1|||
105917317|NCT01909804|365356823|FG000|Overall Study|Withdrew Consent|0|||
105917318|NCT01909804|365356824|FG001|Overall Study|Withdrew Consent|0|||
105917319|NCT01909804|365356825|FG002|Overall Study|Withdrew Consent|0|||
105917320|NCT01909804|365356826|FG003|Overall Study|Withdrew Consent|0|||
105917321|NCT01909804|365356827|FG004|Overall Study|Withdrew Consent|1|||
105917322|NCT01909804|365356828|FG005|Overall Study|Withdrew Consent|1|||
105917323|NCT01909804|365356829|FG006|Overall Study|Withdrew Consent|0|||
105917324|NCT01909804|365356830|FG007|Overall Study|Withdrew Consent|0|||
105917325|NCT01909804|365356831|FG008|Overall Study|Withdrew Consent|0|||
105917326|NCT01909804|365356832|FG009|Overall Study|Withdrew Consent|0|||
105917327|NCT01909804|365356833|FG010|Overall Study|Withdrew Consent|0|||
105917328|NCT01909804|365356834|FG011|Overall Study|Withdrew Consent|0|||
105917329|NCT01909804|365356823|FG000|Overall Study|Protocol Violation|0|||
105917330|NCT01909804|365356824|FG001|Overall Study|Protocol Violation|0|||
105917331|NCT01909804|365356825|FG002|Overall Study|Protocol Violation|0|||
105917332|NCT01909804|365356826|FG003|Overall Study|Protocol Violation|0|||
105917333|NCT01909804|365356827|FG004|Overall Study|Protocol Violation|0|||
105917334|NCT01909804|365356828|FG005|Overall Study|Protocol Violation|0|||
105917335|NCT01909804|365356829|FG006|Overall Study|Protocol Violation|0|||
105917336|NCT01909804|365356830|FG007|Overall Study|Protocol Violation|0|||
105917337|NCT01909804|365356831|FG008|Overall Study|Protocol Violation|0|||
105917338|NCT01909804|365356832|FG009|Overall Study|Protocol Violation|0|||
105917339|NCT01909804|365356833|FG010|Overall Study|Protocol Violation|0|||
105685533|NCT01145755|364510952|FG000|Overall Study|Positive urine ethanol|0|||
105685534|NCT01145755|364510953|FG001|Overall Study|Positive urine ethanol|1|||
105685535|NCT01145755|364510954|FG002|Overall Study|Positive urine ethanol|0|||
105685536|NCT02739360|364510956|FG000|Overall Study|Adverse Event|1|||
105685537|NCT02739360|364510956|FG000|Overall Study|Study terminated by Sponsor|2|||
105685538|NCT00883051|364510957|FG000|Overall Study|Lost to Follow-up|0|||
105685539|NCT00883051|364510958|FG001|Overall Study|Lost to Follow-up|0|||
105685540|NCT00883051|364510959|FG002|Overall Study|Lost to Follow-up|0|||
105685541|NCT00883051|364510960|FG003|Overall Study|Lost to Follow-up|0|||
105685542|NCT00883051|364510961|FG004|Overall Study|Lost to Follow-up|1|||
105685543|NCT00883051|364510957|FG000|Overall Study|Did not use study medication|24|||
105685544|NCT00883051|364510958|FG001|Overall Study|Did not use study medication|22|||
105685545|NCT00883051|364510959|FG002|Overall Study|Did not use study medication|29|||
105685546|NCT00883051|364510960|FG003|Overall Study|Did not use study medication|29|||
105685547|NCT00883051|364510961|FG004|Overall Study|Did not use study medication|17|||
105685548|NCT03604523|364510962|FG000|Overall Study|Physician Decision|1|||
105685549|NCT03604523|364510963|FG001|Overall Study|Physician Decision|0|||
105685550|NCT02910739|364510968|FG000|Overall Study|Adverse Event|1|||
105685551|NCT02910739|364510969|FG001|Overall Study|Adverse Event|0|||
105685552|NCT02910739|364510970|FG002|Overall Study|Adverse Event|0|||
105685553|NCT02910739|364510971|FG003|Overall Study|Adverse Event|0|||
105685554|NCT02656823|364510972|FG000|Overall Study|Adverse Event|3|||
105685555|NCT02656823|364510972|FG000|Overall Study|Lost to Follow-up|2|||
105685556|NCT04675151|364510974|FG000|Overall Study|Protocol Violation|1|||
105685557|NCT04675151|364510975|FG001|Overall Study|Protocol Violation|0|||
105685558|NCT04675151|364510976|FG002|Overall Study|Protocol Violation|0|||
105685559|NCT04675151|364510977|FG003|Overall Study|Protocol Violation|1|||
105685560|NCT01340651|364510978|FG000|Overall Study|Adverse Event|3|||
105685561|NCT01340651|364510978|FG000|Overall Study|Consent Withdrawn|2|||
105917340|NCT01909804|365356834|FG011|Overall Study|Protocol Violation|1|||
105917341|NCT05222880|365356837|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
105917342|NCT05222880|365356837|FG000|Overall Study|Withdrew Consent during Study|1|||
105917343|NCT05222880|365356837|FG000|Overall Study|COVID-19 Related|1|||
105917344|NCT00791999|365356838|FG000|Overall Study|Protocol planed withdrawal|14|||
105917345|NCT00791999|365356839|FG001|Overall Study|Protocol planed withdrawal|11|||
105917346|NCT00791999|365356840|FG002|Overall Study|Protocol planed withdrawal|11|||
105917347|NCT00791999|365356841|FG003|Overall Study|Protocol planed withdrawal|45|||
105917348|NCT00791999|365356838|FG000|Overall Study|Withdrawal by Subject|0|||
105917349|NCT00791999|365356839|FG001|Overall Study|Withdrawal by Subject|1|||
105917350|NCT00791999|365356840|FG002|Overall Study|Withdrawal by Subject|0|||
105917351|NCT00791999|365356841|FG003|Overall Study|Withdrawal by Subject|2|||
105917352|NCT00791999|365356838|FG000|Overall Study|Protocol Violation|3|||
105917353|NCT00791999|365356839|FG001|Overall Study|Protocol Violation|0|||
105917354|NCT00791999|365356840|FG002|Overall Study|Protocol Violation|1|||
105917355|NCT00791999|365356841|FG003|Overall Study|Protocol Violation|0|||
105917356|NCT00791999|365356838|FG000|Overall Study|Adverse Event|3|||
105917357|NCT00791999|365356839|FG001|Overall Study|Adverse Event|3|||
105917358|NCT00791999|365356840|FG002|Overall Study|Adverse Event|7|||
105917359|NCT00791999|365356841|FG003|Overall Study|Adverse Event|3|||
105917360|NCT00791999|365356838|FG000|Overall Study|Lack of Efficacy|0|||
105917361|NCT00791999|365356839|FG001|Overall Study|Lack of Efficacy|1|||
105917362|NCT00791999|365356840|FG002|Overall Study|Lack of Efficacy|0|||
105917363|NCT00791999|365356841|FG003|Overall Study|Lack of Efficacy|2|||
105917364|NCT00791999|365356838|FG000|Overall Study|Reason other than those above|1|||
105917365|NCT00791999|365356839|FG001|Overall Study|Reason other than those above|0|||
105917366|NCT00791999|365356840|FG002|Overall Study|Reason other than those above|1|||
105917367|NCT00791999|365356841|FG003|Overall Study|Reason other than those above|0|||
105917368|NCT01077323|365356842|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
105917369|NCT01077323|365356843|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
105917370|NCT01077323|365356844|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
105917371|NCT01077323|365356842|FG000|Overall Study|Dispensing of drug in baseline period|0|||
105917372|NCT01077323|365356843|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
105917373|NCT01077323|365356844|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
105917374|NCT01077323|365356842|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
105917375|NCT01077323|365356843|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
105917376|NCT01077323|365356844|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
105917377|NCT02153918|365356845|FG000|Overall Study|Refused further treatment|1|||
105917378|NCT01764841|365356846|FG000|Overall Study|Logistical Difficulties|0|||
105917379|NCT01764841|365356847|FG001|Overall Study|Logistical Difficulties|1|||
105917380|NCT01764841|365356848|FG002|Overall Study|Logistical Difficulties|0|||
105917381|NCT01764841|365356849|FG003|Overall Study|Logistical Difficulties|0|||
105917382|NCT01764841|365356846|FG000|Overall Study|Death|3|||
105917383|NCT01764841|365356847|FG001|Overall Study|Death|0|||
105917384|NCT01764841|365356848|FG002|Overall Study|Death|1|||
106128372|NCT01544582|366125632|FG003|Analysis Population|Lost to Follow-up|5|||
106128373|NCT01544582|366125629|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
106128374|NCT01544582|366125630|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
106128375|NCT01544582|366125631|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
106128376|NCT01544582|366125632|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
106128377|NCT01544582|366125629|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
106128378|NCT01544582|366125630|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
106128379|NCT01544582|366125631|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
105917385|NCT01764841|365356849|FG003|Overall Study|Death|4|||
105917386|NCT01764841|365356846|FG000|Overall Study|No Follow Up|1|||
106128380|NCT01544582|366125632|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
106128381|NCT01544582|366125629|FG000|Analysis Population|Intolerance|0|||
106128382|NCT01544582|366125630|FG001|Analysis Population|Intolerance|1|||
106128383|NCT01544582|366125631|FG002|Analysis Population|Intolerance|0|||
106128384|NCT01544582|366125632|FG003|Analysis Population|Intolerance|0|||
106128385|NCT01544582|366125629|FG000|Analysis Population|Liver Transplantation|0|||
106128386|NCT01544582|366125630|FG001|Analysis Population|Liver Transplantation|0|||
106128387|NCT01544582|366125631|FG002|Analysis Population|Liver Transplantation|1|||
106128388|NCT01544582|366125632|FG003|Analysis Population|Liver Transplantation|0|||
106128389|NCT01544582|366125629|FG000|Analysis Population|No Social Insurance|0|||
105685562|NCT01340651|364510978|FG000|Overall Study|Commercial Supply per Sponsor|12|||
105685563|NCT01009580|364510979|FG000|Overall Study|Adverse Event|4|||
105685564|NCT01009580|364510980|FG001|Overall Study|Adverse Event|4|||
105685565|NCT01009580|364510979|FG000|Overall Study|Lack of Efficacy|0|||
105685566|NCT01009580|364510980|FG001|Overall Study|Lack of Efficacy|1|||
105685567|NCT01009580|364510979|FG000|Overall Study|Protocol Violation|2|||
105685568|NCT01009580|364510980|FG001|Overall Study|Protocol Violation|3|||
105685569|NCT01009580|364510979|FG000|Overall Study|Withdrawal Criteria|4|||
105685570|NCT01009580|364510980|FG001|Overall Study|Withdrawal Criteria|6|||
105685571|NCT01009580|364510979|FG000|Overall Study|Unclassified|17|||
105917387|NCT01764841|365356847|FG001|Overall Study|No Follow Up|0|||
105917388|NCT01764841|365356848|FG002|Overall Study|No Follow Up|1|||
105917389|NCT01764841|365356849|FG003|Overall Study|No Follow Up|0|||
105917390|NCT01764841|365356846|FG000|Overall Study|Protocol Violation|0|||
105917391|NCT01764841|365356847|FG001|Overall Study|Protocol Violation|1|||
105917392|NCT01764841|365356848|FG002|Overall Study|Protocol Violation|0|||
106128390|NCT01544582|366125630|FG001|Analysis Population|No Social Insurance|0|||
106128391|NCT01544582|366125631|FG002|Analysis Population|No Social Insurance|1|||
106128392|NCT01544582|366125632|FG003|Analysis Population|No Social Insurance|0|||
106128393|NCT01544582|366125629|FG000|Analysis Population|Poor Adherence|0|||
106128394|NCT01544582|366125630|FG001|Analysis Population|Poor Adherence|0|||
106128395|NCT01544582|366125631|FG002|Analysis Population|Poor Adherence|1|||
106128396|NCT01544582|366125632|FG003|Analysis Population|Poor Adherence|0|||
106128397|NCT01544582|366125629|FG000|Analysis Population|Poor Participant Compliance|0|||
106128398|NCT01544582|366125630|FG001|Analysis Population|Poor Participant Compliance|1|||
106128399|NCT01544582|366125631|FG002|Analysis Population|Poor Participant Compliance|0|||
106128400|NCT01544582|366125632|FG003|Analysis Population|Poor Participant Compliance|0|||
106128401|NCT01544582|366125629|FG000|Analysis Population|Programmed Surgery|0|||
106128402|NCT01544582|366125630|FG001|Analysis Population|Programmed Surgery|1|||
106128403|NCT01544582|366125631|FG002|Analysis Population|Programmed Surgery|0|||
106128404|NCT01544582|366125632|FG003|Analysis Population|Programmed Surgery|0|||
106128405|NCT01544582|366125629|FG000|Analysis Population|Participant in Jail|0|||
106128406|NCT01544582|366125630|FG001|Analysis Population|Participant in Jail|0|||
106128407|NCT01544582|366125631|FG002|Analysis Population|Participant in Jail|1|||
106128408|NCT01544582|366125632|FG003|Analysis Population|Participant in Jail|0|||
106128409|NCT01778062|366125633|FG000|Overall Study|Adverse Event|1|||
105685572|NCT01009580|364510980|FG001|Overall Study|Unclassified|21|||
105685573|NCT00658684|364510981|FG000|Overall Study|Adverse Event|10|||
105917393|NCT01764841|365356849|FG003|Overall Study|Protocol Violation|0|||
106128410|NCT01778062|366125634|FG001|Overall Study|Adverse Event|3|||
105685574|NCT00658684|364510982|FG001|Overall Study|Adverse Event|8|||
105685575|NCT00658684|364510983|FG002|Overall Study|Adverse Event|2|||
106128411|NCT01778062|366125633|FG000|Overall Study|Consent Withdrawal|1|||
106128412|NCT01778062|366125634|FG001|Overall Study|Consent Withdrawal|5|||
106128413|NCT01778062|366125633|FG000|Overall Study|major protocol deviation|4|||
105685576|NCT00658684|364510984|FG003|Overall Study|Adverse Event|0|||
105685577|NCT00658684|364510981|FG000|Overall Study|Withdrawal by Subject|6|||
105685578|NCT00658684|364510982|FG001|Overall Study|Withdrawal by Subject|4|||
105685579|NCT00658684|364510983|FG002|Overall Study|Withdrawal by Subject|1|||
105917394|NCT01764841|365356846|FG000|Overall Study|Withdrawal by Subject|16|||
106128414|NCT01778062|366125634|FG001|Overall Study|major protocol deviation|3|||
106128415|NCT03958630|366125635|FG000|Overall Study|Withdrawal by Subject|0|||
106128416|NCT03958630|366125636|FG001|Overall Study|Withdrawal by Subject|0|||
106128417|NCT03958630|366125637|FG002|Overall Study|Withdrawal by Subject|1|||
105917395|NCT01764841|365356847|FG001|Overall Study|Withdrawal by Subject|24|||
105685580|NCT00658684|364510984|FG003|Overall Study|Withdrawal by Subject|1|||
105685581|NCT00658684|364510981|FG000|Overall Study|Lack of Efficacy|1|||
105685582|NCT00658684|364510982|FG001|Overall Study|Lack of Efficacy|1|||
105685583|NCT00658684|364510983|FG002|Overall Study|Lack of Efficacy|0|||
105685584|NCT00658684|364510984|FG003|Overall Study|Lack of Efficacy|0|||
105685585|NCT00658684|364510981|FG000|Overall Study|Protocol Violation|1|||
105685586|NCT00658684|364510982|FG001|Overall Study|Protocol Violation|1|||
105685587|NCT00658684|364510983|FG002|Overall Study|Protocol Violation|0|||
105685588|NCT00658684|364510984|FG003|Overall Study|Protocol Violation|0|||
105685589|NCT00658684|364510981|FG000|Overall Study|Pregnancy|1|||
105685590|NCT00658684|364510982|FG001|Overall Study|Pregnancy|1|||
105685591|NCT00658684|364510983|FG002|Overall Study|Pregnancy|0|||
105685592|NCT00658684|364510984|FG003|Overall Study|Pregnancy|0|||
105685593|NCT04646005|364510985|FG000|Overall Study|Adverse Event|1|||
105685594|NCT04646005|364510985|FG000|Overall Study|Progressive Disease|71|||
105685595|NCT04646005|364510985|FG000|Overall Study|Death|20|||
105685596|NCT04646005|364510985|FG000|Overall Study|Withdrawal by Subject|12|||
105685597|NCT04646005|364510985|FG000|Overall Study|Sponsor Request|9|||
105685598|NCT03226275|364510986|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
105685599|NCT03226275|364510987|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
105917396|NCT01764841|365356848|FG002|Overall Study|Withdrawal by Subject|11|||
105917397|NCT01764841|365356849|FG003|Overall Study|Withdrawal by Subject|15|||
105917398|NCT01764841|365356846|FG000|Overall Study|Lost to Follow-up|3|||
105917399|NCT01764841|365356847|FG001|Overall Study|Lost to Follow-up|0|||
105917400|NCT01764841|365356848|FG002|Overall Study|Lost to Follow-up|1|||
105917401|NCT01764841|365356849|FG003|Overall Study|Lost to Follow-up|0|||
105917402|NCT02144701|365356850|FG000|Overall Study|development of relapse, GVHD or death|9|||
105917403|NCT02144701|365356851|FG001|Overall Study|development of relapse, GVHD or death|3|||
106001238|NCT04816214|365665246|FG002|Overall Study|Death|0|||
106001239|NCT04816214|365665244|FG000|Overall Study|Study Terminated by Sponsor|1|||
106001240|NCT04816214|365665245|FG001|Overall Study|Study Terminated by Sponsor|0|||
105917404|NCT03327324|365356852|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917405|NCT03327324|365356853|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
105917406|NCT03327324|365356854|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917407|NCT03327324|365356855|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
105917408|NCT03327324|365356856|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917409|NCT03327324|365356857|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
105917410|NCT03327324|365356852|FG000|Baseline (Month 0-Month 3)|Refused|0|||
105917411|NCT03327324|365356853|FG001|Baseline (Month 0-Month 3)|Refused|0|||
105917412|NCT03327324|365356854|FG002|Baseline (Month 0-Month 3)|Refused|0|||
105917413|NCT03327324|365356855|FG003|Baseline (Month 0-Month 3)|Refused|0|||
105917414|NCT03327324|365356856|FG004|Baseline (Month 0-Month 3)|Refused|1|||
105917415|NCT03327324|365356857|FG005|Baseline (Month 0-Month 3)|Refused|0|||
105917416|NCT03327324|365356852|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105917417|NCT03327324|365356853|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
105917418|NCT03327324|365356854|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105917419|NCT03327324|365356855|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105917420|NCT03327324|365356856|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105917421|NCT03327324|365356857|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
105917422|NCT03327324|365356852|FG000|Baseline (Month 0-Month 3)|Death|0|||
105917423|NCT03327324|365356853|FG001|Baseline (Month 0-Month 3)|Death|0|||
105917424|NCT03327324|365356854|FG002|Baseline (Month 0-Month 3)|Death|0|||
105917425|NCT03327324|365356855|FG003|Baseline (Month 0-Month 3)|Death|0|||
105917426|NCT03327324|365356856|FG004|Baseline (Month 0-Month 3)|Death|1|||
105917427|NCT03327324|365356857|FG005|Baseline (Month 0-Month 3)|Death|0|||
105917428|NCT03327324|365356852|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917429|NCT03327324|365356853|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917430|NCT03327324|365356854|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917431|NCT03327324|365356855|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917432|NCT03327324|365356856|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
106001241|NCT04816214|365665246|FG002|Overall Study|Study Terminated by Sponsor|0|||
105685600|NCT03226275|364510988|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
105685601|NCT03226275|364510989|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
105685602|NCT03226275|364510986|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
105685603|NCT03226275|364510987|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
105685604|NCT03226275|364510988|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
105685605|NCT03226275|364510989|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
105685606|NCT00816400|364512783|FG000|Overall Study|Death|2|||
105685607|NCT00816400|364512784|FG001|Overall Study|Death|3|||
105685608|NCT00816400|364512785|FG002|Overall Study|Death|3|||
105685609|NCT00816400|364512786|FG003|Overall Study|Death|3|||
105685610|NCT00816400|364512787|FG004|Overall Study|Death|2|||
105685611|NCT00816400|364512788|FG005|Overall Study|Death|3|||
105685612|NCT00816400|364512789|FG006|Overall Study|Death|2|||
106001242|NCT00550407|365665247|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
106001243|NCT00550407|365665248|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
106001244|NCT00550407|365665249|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
106001245|NCT00550407|365665247|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
106001246|NCT00550407|365665248|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
106001247|NCT00550407|365665249|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
106001248|NCT00550407|365665247|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
106001249|NCT00550407|365665248|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
106001250|NCT00550407|365665249|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
106001251|NCT00550407|365665247|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
106001252|NCT00550407|365665248|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
106001253|NCT00550407|365665249|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
106001254|NCT00550407|365665247|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
106001255|NCT00550407|365665248|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
106001256|NCT00550407|365665249|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
106001257|NCT00550407|365665247|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
106001258|NCT00550407|365665248|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
106001259|NCT00550407|365665249|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
106001260|NCT00550407|365665247|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
106001261|NCT00550407|365665248|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
106001262|NCT00550407|365665249|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
106001263|NCT00550407|365665247|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
106001264|NCT00550407|365665248|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
106001265|NCT00550407|365665249|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
106001266|NCT00550407|365665247|FG000|26-Week Randomized Phase|Adverse Event|0|||
106001267|NCT00550407|365665248|FG001|26-Week Randomized Phase|Adverse Event|5|||
106001268|NCT00550407|365665249|FG002|26-Week Randomized Phase|Adverse Event|2|||
106001269|NCT00550407|365665247|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
106001270|NCT00550407|365665248|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
106001271|NCT00550407|365665249|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
106001272|NCT00550407|365665247|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
106001273|NCT00550407|365665248|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
106001274|NCT00550407|365665249|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
106001275|NCT00550407|365665247|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
106001276|NCT00550407|365665248|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
106001277|NCT00550407|365665249|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
106001278|NCT00556894|365665250|FG000|Overall Study|Adverse Event|2|||
106001279|NCT00556894|365665251|FG001|Overall Study|Adverse Event|3|||
106001280|NCT00556894|365665252|FG002|Overall Study|Adverse Event|3|||
106001281|NCT00556894|365665250|FG000|Overall Study|Death|1|||
106001282|NCT00556894|365665251|FG001|Overall Study|Death|0|||
106001283|NCT00556894|365665252|FG002|Overall Study|Death|0|||
106001284|NCT00556894|365665250|FG000|Overall Study|regulatory decision in Bulgaria|10|||
106001285|NCT00556894|365665251|FG001|Overall Study|regulatory decision in Bulgaria|14|||
106001286|NCT00556894|365665252|FG002|Overall Study|regulatory decision in Bulgaria|13|||
106001287|NCT00556894|365665250|FG000|Overall Study|Change in therapy|2|||
106001288|NCT00556894|365665251|FG001|Overall Study|Change in therapy|1|||
106001289|NCT00556894|365665252|FG002|Overall Study|Change in therapy|2|||
106001290|NCT00556894|365665250|FG000|Overall Study|Withdrawal by Subject|1|||
106128418|NCT03958630|366125635|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
106128419|NCT03958630|366125636|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
106128420|NCT03958630|366125637|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
106128421|NCT00394095|366127161|FG000|Screening|Withdrawal by Subject|1|||
106128422|NCT00394095|366127162|FG001|Screening|Withdrawal by Subject|0|||
106128423|NCT00394095|366127161|FG000|Randomized|Withdrawal by Subject|5|||
106128424|NCT00394095|366127162|FG001|Randomized|Withdrawal by Subject|1|||
106128425|NCT00394095|366127161|FG000|Randomized|Adverse Event|1|||
106128426|NCT00394095|366127162|FG001|Randomized|Adverse Event|1|||
106128427|NCT00394095|366127161|FG000|Randomized|Overdose|1|||
106128428|NCT00394095|366127162|FG001|Randomized|Overdose|0|||
106128429|NCT00394095|366127161|FG000|Randomized|Lost to Follow-up|1|||
106128430|NCT00394095|366127162|FG001|Randomized|Lost to Follow-up|2|||
105685613|NCT00816400|364512790|FG007|Overall Study|Death|5|||
105685614|NCT00816400|364512791|FG008|Overall Study|Death|6|||
105685615|NCT00816400|364512783|FG000|Overall Study|In hospice care at the end of the study|0|||
105685616|NCT00816400|364512784|FG001|Overall Study|In hospice care at the end of the study|0|||
105685617|NCT00816400|364512785|FG002|Overall Study|In hospice care at the end of the study|2|||
105685618|NCT00816400|364512786|FG003|Overall Study|In hospice care at the end of the study|0|||
105685619|NCT00816400|364512787|FG004|Overall Study|In hospice care at the end of the study|0|||
105685620|NCT00816400|364512788|FG005|Overall Study|In hospice care at the end of the study|0|||
106001291|NCT00556894|365665251|FG001|Overall Study|Withdrawal by Subject|1|||
106128431|NCT02169830|366127163|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
106128432|NCT02169830|366127164|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
106128433|NCT02169830|366127165|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
106128434|NCT02169830|366127163|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
106128435|NCT02169830|366127164|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
106128436|NCT02169830|366127165|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
106128437|NCT02169830|366127163|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
106128438|NCT02169830|366127164|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
106128439|NCT02169830|366127165|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
106128440|NCT02169830|366127163|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
106128441|NCT02169830|366127164|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
106128442|NCT02169830|366127165|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
106128443|NCT02169830|366127163|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
106128444|NCT02169830|366127164|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
106128445|NCT02169830|366127165|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
106128446|NCT00777803|366127166|FG000|Overall Study|Lost to Follow-up|12|||
106128447|NCT00777803|366127167|FG001|Overall Study|Lost to Follow-up|5|||
106128448|NCT00777803|366127166|FG000|Overall Study|Adverse Event|1|||
106128449|NCT00777803|366127167|FG001|Overall Study|Adverse Event|0|||
106128450|NCT00777803|366127166|FG000|Overall Study|Non-compliance|2|||
106128451|NCT00777803|366127167|FG001|Overall Study|Non-compliance|2|||
106128452|NCT04129580|366127171|FG000|Overall Study|Lost to Follow-up|14|||
106128453|NCT04129580|366127172|FG001|Overall Study|Lost to Follow-up|25|||
106128454|NCT02462083|366127173|FG000|Overall Study|Sponsor request|39|||
106128455|NCT02462083|366127173|FG000|Overall Study|Withdrawal by Subject|87|||
106128456|NCT02462083|366127173|FG000|Overall Study|Lost to Follow-up|41|||
106128457|NCT02462083|366127173|FG000|Overall Study|Lack of Efficacy|151|||
106128458|NCT02462083|366127173|FG000|Overall Study|Pregnancy|1|||
106128459|NCT02462083|366127173|FG000|Overall Study|Protocol Violation|6|||
106128460|NCT02462083|366127173|FG000|Overall Study|Adverse Event|33|||
106128461|NCT02462083|366127173|FG000|Overall Study|Worsening condition|16|||
105786558|NCT01945034|364872824|FG000|Overall Study|Withdrawal by Subject|0|||
105917433|NCT03327324|365356857|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
106128462|NCT02462083|366127173|FG000|Overall Study|Other than specified|45|||
105786559|NCT01945034|364872825|FG001|Overall Study|Withdrawal by Subject|3|||
106128463|NCT00802841|366127174|FG000|Overall Study|Administrative problems|1|||
106128464|NCT00802841|366127175|FG001|Overall Study|Administrative problems|0|||
106128465|NCT00802841|366127174|FG000|Overall Study|Lost to Follow-up|2|||
106128466|NCT00802841|366127175|FG001|Overall Study|Lost to Follow-up|1|||
106128467|NCT00802841|366127174|FG000|Overall Study|Death|1|||
106128468|NCT00802841|366127175|FG001|Overall Study|Death|2|||
106128469|NCT00802841|366127174|FG000|Overall Study|Adverse Event|8|||
106128470|NCT00802841|366127175|FG001|Overall Study|Adverse Event|2|||
106128471|NCT00802841|366127174|FG000|Overall Study|Disease progression|7|||
106128472|NCT00802841|366127175|FG001|Overall Study|Disease progression|3|||
106128473|NCT00802841|366127174|FG000|Overall Study|Withdrawal by Subject|9|||
106128474|NCT00802841|366127175|FG001|Overall Study|Withdrawal by Subject|5|||
106128475|NCT00802841|366127174|FG000|Overall Study|Protocol deviation|2|||
106128476|NCT00802841|366127175|FG001|Overall Study|Protocol deviation|6|||
106128477|NCT00802841|366127174|FG000|Overall Study|Treatment duration completed|66|||
105952098|NCT03314935|365488194|FG010|Phase 1|Study Terminated by Sponsor|0|||
106128478|NCT00802841|366127175|FG001|Overall Study|Treatment duration completed|76|||
106128479|NCT02711995|366127176|FG000|Washout (90 Days)|Conflicting medication|1|||
106128480|NCT00322868|366127179|FG000|Overall Study|disease progression|1|||
106128481|NCT03615482|366127180|FG000|Overall Study|Death|1|||
106128482|NCT03615482|366127181|FG001|Overall Study|Death|0|||
106128483|NCT03615482|366127180|FG000|Overall Study|Lost to Follow-up|7|||
106128484|NCT03615482|366127181|FG001|Overall Study|Lost to Follow-up|7|||
106128485|NCT03615482|366127180|FG000|Overall Study|Physician Decision|2|||
106128486|NCT03615482|366127181|FG001|Overall Study|Physician Decision|3|||
106128487|NCT03615482|366127180|FG000|Overall Study|Withdrawal by Subject|7|||
106128488|NCT03615482|366127181|FG001|Overall Study|Withdrawal by Subject|7|||
106128489|NCT02955277|366127184|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
106128490|NCT02955277|366127185|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
106128491|NCT02955277|366127184|FG000|Post to Follow-up|Lost to Follow-up|8|||
106128492|NCT02955277|366127185|FG001|Post to Follow-up|Lost to Follow-up|11|||
106128493|NCT00107380|366127188|FG000|Overall Study|Adverse Event|7|||
106128494|NCT00107380|366127188|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
106128495|NCT00107380|366127188|FG000|Overall Study|Progression/relapse|4|||
106128496|NCT00107380|366127188|FG000|Overall Study|Death|3|||
106128497|NCT00107380|366127188|FG000|Overall Study|Other - not protocol specified|7|||
106128498|NCT00107380|366127188|FG000|Overall Study|Ineligible|2|||
106128499|NCT01642186|366127196|FG000|Overall Study|Death|0|||
106128500|NCT01642186|366127197|FG001|Overall Study|Death|2|||
106128501|NCT01642186|366127198|FG002|Overall Study|Death|2|||
106128502|NCT01642186|366127196|FG000|Overall Study|Lost to Follow-up|0|||
106128503|NCT01642186|366127197|FG001|Overall Study|Lost to Follow-up|0|||
106128504|NCT01642186|366127198|FG002|Overall Study|Lost to Follow-up|1|||
106128505|NCT00590980|366127199|FG000|Overall Study|Did not meet all inclusion criteria|10|||
106128506|NCT02819479|366127200|FG000|Overall Study|Adverse Event|2|||
106128507|NCT00504348|366127201|FG000|Overall Study|Adverse Event|3|||
106128508|NCT00504348|366127201|FG000|Overall Study|Lack of Efficacy|4|||
106128509|NCT00504348|366127201|FG000|Overall Study|Physician Decision|1|||
106128510|NCT00224133|366127202|FG000|Overall Study|Adverse Event|93|||
106128511|NCT00224133|366127202|FG000|Overall Study|Protocol Violation|6|||
106128512|NCT00224133|366127202|FG000|Overall Study|Withdrawal by Subject|33|||
106128513|NCT00224133|366127202|FG000|Overall Study|Lack of Efficacy|58|||
106128514|NCT00224133|366127202|FG000|Overall Study|Lost to Follow-up|21|||
105917434|NCT03327324|365356852|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105685621|NCT00816400|364512789|FG006|Overall Study|In hospice care at the end of the study|0|||
106128515|NCT00224133|366127202|FG000|Overall Study|Physician Decision|1|||
106128516|NCT00224133|366127202|FG000|Overall Study|Other|14|||
106128517|NCT02718417|366127203|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
106128518|NCT02718417|366127204|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
106128519|NCT02718417|366127205|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
106128520|NCT02718417|366127203|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
106128521|NCT02718417|366127204|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
106128522|NCT02718417|366127205|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
106128523|NCT02718417|366127203|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
106128524|NCT02718417|366127204|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
106128525|NCT02718417|366127205|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
106128526|NCT02718417|366127203|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
106128527|NCT02718417|366127204|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
105952099|NCT03314935|365488195|FG011|Phase 1|Study Terminated by Sponsor|0|||
106128528|NCT02718417|366127205|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
106128529|NCT02718417|366127203|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
106128530|NCT02718417|366127204|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
106128531|NCT02718417|366127205|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
106128532|NCT02718417|366127203|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
105685622|NCT00816400|364512790|FG007|Overall Study|In hospice care at the end of the study|0|||
105685623|NCT00816400|364512791|FG008|Overall Study|In hospice care at the end of the study|0|||
105685624|NCT01222507|364512792|FG000|Overall Study|Physician Decision|1|||
105685625|NCT01222507|364512792|FG000|Overall Study|Withdrawal by Subject|1|||
105685626|NCT03057977|364512797|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
105685627|NCT03057977|364512798|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
106128533|NCT02718417|366127204|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
106128534|NCT02718417|366127205|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
106128535|NCT02718417|366127203|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
106128536|NCT02718417|366127204|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
106128537|NCT02718417|366127205|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
106128538|NCT02718417|366127203|FG000|Chemotherapy Phase (CP)|Other|2|||
106128539|NCT02718417|366127204|FG001|Chemotherapy Phase (CP)|Other|0|||
106128540|NCT02718417|366127205|FG002|Chemotherapy Phase (CP)|Other|1|||
106128541|NCT02718417|366127203|FG000|Maintenance Phase (MP)|Adverse Event|21|||
106128542|NCT02718417|366127204|FG001|Maintenance Phase (MP)|Adverse Event|26|||
106128543|NCT02718417|366127205|FG002|Maintenance Phase (MP)|Adverse Event|0|||
106128544|NCT02718417|366127203|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
106128545|NCT02718417|366127204|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
106128546|NCT02718417|366127205|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
106128547|NCT02718417|366127203|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
106128548|NCT02718417|366127204|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
106128549|NCT02718417|366127205|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
106128550|NCT02718417|366127203|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
106128551|NCT02718417|366127204|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
106128552|NCT02718417|366127205|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
106128553|NCT02718417|366127203|FG000|Maintenance Phase (MP)|Physician's decision|6|||
106128554|NCT02718417|366127204|FG001|Maintenance Phase (MP)|Physician's decision|7|||
106128555|NCT02718417|366127205|FG002|Maintenance Phase (MP)|Physician's decision|0|||
106128556|NCT02718417|366127203|FG000|Maintenance Phase (MP)|Progressive disease|100|||
106128557|NCT02718417|366127204|FG001|Maintenance Phase (MP)|Progressive disease|88|||
106128558|NCT02718417|366127205|FG002|Maintenance Phase (MP)|Progressive disease|0|||
106128559|NCT02718417|366127203|FG000|Maintenance Phase (MP)|Other|2|||
106128560|NCT02718417|366127204|FG001|Maintenance Phase (MP)|Other|1|||
106128561|NCT02718417|366127205|FG002|Maintenance Phase (MP)|Other|0|||
106128562|NCT02718417|366127203|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
106128563|NCT02718417|366127204|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
106128564|NCT02718417|366127205|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
106128565|NCT02718417|366127203|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
106128566|NCT02718417|366127204|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
106128567|NCT02718417|366127205|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
106128568|NCT02718417|366127203|FG000|Observation Phase (OP)|Adverse Event|0|||
106128569|NCT02718417|366127204|FG001|Observation Phase (OP)|Adverse Event|0|||
106128570|NCT02718417|366127205|FG002|Observation Phase (OP)|Adverse Event|1|||
106128571|NCT02718417|366127203|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
106128572|NCT02718417|366127204|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
106128573|NCT02718417|366127205|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
106128574|NCT02718417|366127203|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
106128575|NCT02718417|366127204|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
106128576|NCT02718417|366127205|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
106128577|NCT02718417|366127203|FG000|Observation Phase (OP)|Physician Decision|0|||
106128578|NCT02718417|366127204|FG001|Observation Phase (OP)|Physician Decision|0|||
106128579|NCT02718417|366127205|FG002|Observation Phase (OP)|Physician Decision|9|||
106128580|NCT02718417|366127203|FG000|Observation Phase (OP)|Progressive disease|0|||
106128581|NCT02718417|366127204|FG001|Observation Phase (OP)|Progressive disease|0|||
106128582|NCT02718417|366127205|FG002|Observation Phase (OP)|Progressive disease|92|||
106128583|NCT02718417|366127203|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
106128584|NCT02718417|366127204|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
106128585|NCT02718417|366127205|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
106128586|NCT02718417|366127203|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
106128587|NCT02718417|366127204|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
106128588|NCT02718417|366127205|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
106128589|NCT02718417|366127203|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
106128590|NCT02718417|366127204|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
106128591|NCT02718417|366127205|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
106128592|NCT02718417|366127203|FG000|Observation Phase (OP)|Other|0|||
106128593|NCT02718417|366127204|FG001|Observation Phase (OP)|Other|0|||
106128594|NCT02718417|366127205|FG002|Observation Phase (OP)|Other|7|||
106128595|NCT02718417|366127203|FG000|Follow-up Phase|Adverse Event|3|||
106128596|NCT02718417|366127204|FG001|Follow-up Phase|Adverse Event|1|||
106128597|NCT02718417|366127205|FG002|Follow-up Phase|Adverse Event|1|||
106128598|NCT02718417|366127203|FG000|Follow-up Phase|Other|4|||
106128599|NCT02718417|366127204|FG001|Follow-up Phase|Other|6|||
106128600|NCT02718417|366127205|FG002|Follow-up Phase|Other|4|||
106128601|NCT02718417|366127203|FG000|Follow-up Phase|Withdrawal by Subject|19|||
106128602|NCT02718417|366127204|FG001|Follow-up Phase|Withdrawal by Subject|17|||
106128603|NCT02718417|366127205|FG002|Follow-up Phase|Withdrawal by Subject|5|||
106128604|NCT02718417|366127203|FG000|Follow-up Phase|Study terminated by sponsor|100|||
106128605|NCT02718417|366127204|FG001|Follow-up Phase|Study terminated by sponsor|138|||
106128606|NCT02718417|366127205|FG002|Follow-up Phase|Study terminated by sponsor|6|||
106128607|NCT02718417|366127203|FG000|Follow-up Phase|Lost to Follow-up|2|||
106128608|NCT02718417|366127204|FG001|Follow-up Phase|Lost to Follow-up|3|||
106128609|NCT02718417|366127205|FG002|Follow-up Phase|Lost to Follow-up|0|||
106128610|NCT02718417|366127203|FG000|Follow-up Phase|Death leading to discontinuation|7|||
106128611|NCT02718417|366127204|FG001|Follow-up Phase|Death leading to discontinuation|7|||
106128612|NCT02718417|366127205|FG002|Follow-up Phase|Death leading to discontinuation|3|||
106128613|NCT02718417|366127203|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
106128614|NCT02718417|366127204|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
106128615|NCT02718417|366127205|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
106128616|NCT02718417|366127203|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
106128617|NCT02718417|366127204|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
106128618|NCT02718417|366127205|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
106001292|NCT00556894|365665252|FG002|Overall Study|Withdrawal by Subject|1|||
106128619|NCT02718417|366127203|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
105917435|NCT03327324|365356853|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917436|NCT03327324|365356854|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
106128620|NCT02718417|366127204|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
106128621|NCT02718417|366127205|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
106128622|NCT02718417|366127203|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
106128623|NCT02718417|366127204|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
106128624|NCT02718417|366127205|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
106128625|NCT02718417|366127203|FG000|Long-term Follow-up Phase|Other|0|||
106128626|NCT02718417|366127204|FG001|Long-term Follow-up Phase|Other|2|||
106128627|NCT02718417|366127205|FG002|Long-term Follow-up Phase|Other|0|||
105786560|NCT01945034|364872826|FG002|Overall Study|Withdrawal by Subject|1|||
105786561|NCT01945034|364872824|FG000|Overall Study|Other|0|||
105786562|NCT01945034|364872825|FG001|Overall Study|Other|1|||
105786563|NCT01945034|364872826|FG002|Overall Study|Other|3|||
105786564|NCT01945034|364872824|FG000|Overall Study|Lost to Follow-up|0|||
105786565|NCT01945034|364872825|FG001|Overall Study|Lost to Follow-up|0|||
105786566|NCT01945034|364872826|FG002|Overall Study|Lost to Follow-up|2|||
105786567|NCT01945034|364872824|FG000|Overall Study|Protocol Violation|1|||
105786568|NCT01945034|364872825|FG001|Overall Study|Protocol Violation|0|||
105786569|NCT01945034|364872826|FG002|Overall Study|Protocol Violation|1|||
105786570|NCT03053102|364872827|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
105786571|NCT03053102|364872827|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
105917437|NCT03327324|365356855|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105952100|NCT03314935|365488196|FG012|Phase 1|Study Terminated by Sponsor|0|||
106128628|NCT01890967|366127206|FG000|Overall Study|Adverse Event|3|||
106128629|NCT01890967|366127207|FG001|Overall Study|Adverse Event|3|||
106128630|NCT01890967|366127208|FG002|Overall Study|Adverse Event|3|||
106128631|NCT01890967|366127209|FG003|Overall Study|Adverse Event|2|||
106128632|NCT01890967|366127210|FG004|Overall Study|Adverse Event|1|||
106128633|NCT01890967|366127211|FG005|Overall Study|Adverse Event|7|||
106128634|NCT01890967|366127206|FG000|Overall Study|Death|1|||
106128635|NCT01890967|366127207|FG001|Overall Study|Death|0|||
106128636|NCT01890967|366127208|FG002|Overall Study|Death|0|||
106128637|NCT01890967|366127209|FG003|Overall Study|Death|0|||
106128638|NCT01890967|366127210|FG004|Overall Study|Death|0|||
106128639|NCT01890967|366127211|FG005|Overall Study|Death|0|||
106128640|NCT01890967|366127206|FG000|Overall Study|Lost to Follow-up|1|||
106128641|NCT01890967|366127207|FG001|Overall Study|Lost to Follow-up|1|||
106128642|NCT01890967|366127208|FG002|Overall Study|Lost to Follow-up|1|||
106128643|NCT01890967|366127209|FG003|Overall Study|Lost to Follow-up|1|||
106128644|NCT01890967|366127210|FG004|Overall Study|Lost to Follow-up|0|||
105685628|NCT03057977|364512797|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
105685629|NCT03057977|364512798|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
105685630|NCT03057977|364512797|FG000|Discontinuation From Treatment|Protocol Violation|6|||
105685631|NCT03057977|364512798|FG001|Discontinuation From Treatment|Protocol Violation|5|||
105685632|NCT03057977|364512797|FG000|Discontinuation From Treatment|Not treated|4|||
105685633|NCT03057977|364512798|FG001|Discontinuation From Treatment|Not treated|0|||
105685634|NCT03057977|364512797|FG000|Discontinuation From Treatment|Adverse Event|343|||
105685635|NCT03057977|364512798|FG001|Discontinuation From Treatment|Adverse Event|337|||
105685636|NCT03057977|364512797|FG000|Discontinuation From Treatment|Reason Unknown|0|||
105685637|NCT03057977|364512798|FG001|Discontinuation From Treatment|Reason Unknown|1|||
105685638|NCT03057977|364512797|FG000|Discontinuation From Treatment|Personal Reasons|1|||
105685639|NCT03057977|364512798|FG001|Discontinuation From Treatment|Personal Reasons|1|||
105685640|NCT03057977|364512797|FG000|Discontinuation From Treatment|Unblinded medication|1|||
105685641|NCT03057977|364512798|FG001|Discontinuation From Treatment|Unblinded medication|0|||
105685642|NCT03057977|364512797|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
106128645|NCT01890967|366127211|FG005|Overall Study|Lost to Follow-up|1|||
105685643|NCT03057977|364512798|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
106128646|NCT01890967|366127206|FG000|Overall Study|Protocol Violation|0|||
106128647|NCT01890967|366127207|FG001|Overall Study|Protocol Violation|3|||
106128648|NCT01890967|366127208|FG002|Overall Study|Protocol Violation|3|||
106128649|NCT01890967|366127209|FG003|Overall Study|Protocol Violation|2|||
106128650|NCT01890967|366127210|FG004|Overall Study|Protocol Violation|4|||
106128651|NCT01890967|366127211|FG005|Overall Study|Protocol Violation|1|||
106128652|NCT01890967|366127206|FG000|Overall Study|Sponsor Decision|2|||
106128653|NCT01890967|366127207|FG001|Overall Study|Sponsor Decision|0|||
106128654|NCT01890967|366127208|FG002|Overall Study|Sponsor Decision|1|||
106128655|NCT01890967|366127209|FG003|Overall Study|Sponsor Decision|3|||
106128656|NCT01890967|366127210|FG004|Overall Study|Sponsor Decision|2|||
106128657|NCT01890967|366127211|FG005|Overall Study|Sponsor Decision|3|||
106128658|NCT01890967|366127206|FG000|Overall Study|Withdrawal by Subject|3|||
106128659|NCT01890967|366127207|FG001|Overall Study|Withdrawal by Subject|4|||
106128660|NCT01890967|366127208|FG002|Overall Study|Withdrawal by Subject|2|||
106128661|NCT01890967|366127209|FG003|Overall Study|Withdrawal by Subject|3|||
106128662|NCT01890967|366127210|FG004|Overall Study|Withdrawal by Subject|3|||
106128663|NCT01890967|366127211|FG005|Overall Study|Withdrawal by Subject|1|||
106128664|NCT01646320|366127217|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
106128665|NCT01646320|366127218|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
106128666|NCT01646320|366127217|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
106128667|NCT01646320|366127218|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
106128668|NCT01646320|366127217|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
106128669|NCT01646320|366127218|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
106128670|NCT01646320|366127217|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
106128671|NCT01646320|366127218|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
106128672|NCT01646320|366127217|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
106128673|NCT01646320|366127218|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
106128674|NCT01646320|366127217|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
106128675|NCT01646320|366127218|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
106128676|NCT01646320|366127217|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
106128677|NCT01646320|366127218|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
106128678|NCT01646320|366127217|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
106128679|NCT01646320|366127218|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
106128680|NCT01646320|366127217|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
106128681|NCT01646320|366127218|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
106128682|NCT01646320|366127217|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
106128683|NCT01646320|366127218|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
106128684|NCT01646320|366127217|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
106128685|NCT01646320|366127218|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
106128686|NCT01489020|366127219|FG000|Overall Study|Withdrawal by Subject|1|||
106128687|NCT01489020|366127220|FG001|Overall Study|Withdrawal by Subject|0|||
106128688|NCT01489020|366127221|FG002|Overall Study|Withdrawal by Subject|0|||
106128689|NCT01489020|366127222|FG003|Overall Study|Withdrawal by Subject|0|||
106128690|NCT01489020|366127223|FG004|Overall Study|Withdrawal by Subject|0|||
106128691|NCT01489020|366127224|FG005|Overall Study|Withdrawal by Subject|0|||
106128692|NCT01489020|366127219|FG000|Overall Study|Adverse Event|0|||
106128693|NCT01489020|366127220|FG001|Overall Study|Adverse Event|0|||
106128694|NCT01489020|366127221|FG002|Overall Study|Adverse Event|3|||
106128695|NCT01489020|366127222|FG003|Overall Study|Adverse Event|0|||
106128696|NCT01489020|366127223|FG004|Overall Study|Adverse Event|3|||
106128697|NCT01489020|366127224|FG005|Overall Study|Adverse Event|0|||
106128698|NCT01489020|366127219|FG000|Overall Study|Concomitant disease|0|||
106128699|NCT01489020|366127220|FG001|Overall Study|Concomitant disease|0|||
106128700|NCT01489020|366127221|FG002|Overall Study|Concomitant disease|0|||
106128701|NCT01489020|366127222|FG003|Overall Study|Concomitant disease|0|||
106128702|NCT01489020|366127223|FG004|Overall Study|Concomitant disease|3|||
106128703|NCT01489020|366127224|FG005|Overall Study|Concomitant disease|0|||
106128704|NCT02561455|366127226|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
106128705|NCT02561455|366127227|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
106128706|NCT02561455|366127228|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
106128707|NCT02561455|366127229|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
106128708|NCT02561455|366127226|FG000|Overall Study|Withdrawal by Subject|1|||
106128709|NCT02561455|366127227|FG001|Overall Study|Withdrawal by Subject|0|||
106128710|NCT02561455|366127228|FG002|Overall Study|Withdrawal by Subject|1|||
106128711|NCT02561455|366127229|FG003|Overall Study|Withdrawal by Subject|0|||
106128712|NCT02561455|366127226|FG000|Overall Study|Disease Progression|0|||
106128713|NCT02561455|366127227|FG001|Overall Study|Disease Progression|1|||
106128714|NCT02561455|366127228|FG002|Overall Study|Disease Progression|0|||
106128715|NCT02561455|366127229|FG003|Overall Study|Disease Progression|0|||
106128716|NCT05406791|366127230|FG000|Overall Study|Lost to Follow-up|13|||
106128717|NCT05406791|366127231|FG001|Overall Study|Lost to Follow-up|10|||
106128718|NCT01625338|366127232|FG000|Overall Study|Enrolled but not Treated|0|||
106128719|NCT01625338|366127233|FG001|Overall Study|Enrolled but not Treated|0|||
106128720|NCT01625338|366127234|FG002|Overall Study|Enrolled but not Treated|1|||
106128721|NCT01625338|366127232|FG000|Overall Study|Efficacy Failure|27|||
106128722|NCT01625338|366127233|FG001|Overall Study|Efficacy Failure|39|||
106128723|NCT01625338|366127234|FG002|Overall Study|Efficacy Failure|31|||
106128724|NCT01625338|366127232|FG000|Overall Study|Lost to Follow-up|3|||
106128725|NCT01625338|366127233|FG001|Overall Study|Lost to Follow-up|3|||
106128726|NCT01625338|366127234|FG002|Overall Study|Lost to Follow-up|2|||
106128727|NCT01625338|366127232|FG000|Overall Study|Investigator Decision|0|||
106128728|NCT01625338|366127233|FG001|Overall Study|Investigator Decision|2|||
106128729|NCT01625338|366127234|FG002|Overall Study|Investigator Decision|1|||
106128730|NCT01625338|366127232|FG000|Overall Study|Subject Withdrew Consent|1|||
106128731|NCT01625338|366127233|FG001|Overall Study|Subject Withdrew Consent|0|||
106128732|NCT01625338|366127234|FG002|Overall Study|Subject Withdrew Consent|2|||
106128733|NCT01625338|366127232|FG000|Overall Study|Adverse Event|1|||
106128734|NCT01625338|366127233|FG001|Overall Study|Adverse Event|0|||
106128735|NCT01625338|366127234|FG002|Overall Study|Adverse Event|1|||
106128736|NCT01625338|366127232|FG000|Overall Study|Study Discontinued by Sponsor|0|||
106128737|NCT01625338|366127233|FG001|Overall Study|Study Discontinued by Sponsor|0|||
106128738|NCT01625338|366127234|FG002|Overall Study|Study Discontinued by Sponsor|1|||
106128739|NCT02451930|366127238|FG000|Overall Study|Death|0|||
106128740|NCT02451930|366127239|FG001|Overall Study|Death|15|||
106128741|NCT02451930|366127238|FG000|Overall Study|Lost to Follow-up|0|||
106128742|NCT02451930|366127239|FG001|Overall Study|Lost to Follow-up|3|||
106128743|NCT02451930|366127238|FG000|Overall Study|Sponsor Decision|2|||
106128744|NCT02451930|366127239|FG001|Overall Study|Sponsor Decision|10|||
105685644|NCT03057977|364512797|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
105685645|NCT03057977|364512798|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
105685646|NCT03057977|364512797|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
105685647|NCT03057977|364512798|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
105685648|NCT03057977|364512797|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
105685649|NCT03057977|364512798|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
105685650|NCT03057977|364512797|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
105685651|NCT03057977|364512798|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
105685652|NCT03057977|364512797|FG000|Discontinuation From Treatment|Not attending study visit|3|||
105685653|NCT03057977|364512798|FG001|Discontinuation From Treatment|Not attending study visit|10|||
105685654|NCT03057977|364512797|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
105685655|NCT03057977|364512798|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
105685656|NCT03057977|364512797|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
105685657|NCT03057977|364512798|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
105685658|NCT03057977|364512797|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
105685659|NCT03057977|364512798|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
105685660|NCT03057977|364512797|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
105685661|NCT03057977|364512798|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
105685662|NCT03057977|364512797|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
105685663|NCT03057977|364512798|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
105685664|NCT01650246|364512801|FG000|Overall Study|Adverse Event|23|||
105685665|NCT01650246|364512801|FG000|Overall Study|Protocol Violation|5|||
105685666|NCT01650246|364512801|FG000|Overall Study|Sponsor terminated study|53|||
105685667|NCT01650246|364512801|FG000|Overall Study|Lost to Follow-up|5|||
105685668|NCT01650246|364512801|FG000|Overall Study|Withdrawal by Subject|26|||
105685669|NCT01650246|364512801|FG000|Overall Study|Death|1|||
105685670|NCT01650246|364512801|FG000|Overall Study|Lack of Efficacy|30|||
105685671|NCT00953407|364512802|FG000|Overall Study|Failed inclusion criteria|1|||
105685672|NCT00953407|364512803|FG001|Overall Study|Failed inclusion criteria|1|||
105685673|NCT00953407|364512804|FG002|Overall Study|Failed inclusion criteria|1|||
105685674|NCT00953407|364512805|FG003|Overall Study|Failed inclusion criteria|1|||
105685675|NCT00953407|364512806|FG004|Overall Study|Failed inclusion criteria|1|||
105685676|NCT00953407|364512802|FG000|Overall Study|Lost to Follow-up|0|||
105685677|NCT00953407|364512803|FG001|Overall Study|Lost to Follow-up|0|||
105685678|NCT00953407|364512804|FG002|Overall Study|Lost to Follow-up|0|||
105685679|NCT00953407|364512805|FG003|Overall Study|Lost to Follow-up|1|||
105685680|NCT00953407|364512806|FG004|Overall Study|Lost to Follow-up|0|||
105685681|NCT00288509|364512823|FG000|Treatment Cycle 1|Adverse Event|1|||
105685682|NCT00288509|364512823|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
105685683|NCT00288509|364512823|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
106128745|NCT02451930|366127238|FG000|Overall Study|Withdrawal by Subject|0|||
106128746|NCT02451930|366127239|FG001|Overall Study|Withdrawal by Subject|1|||
106128747|NCT02451930|366127238|FG000|Overall Study|Other|0|||
106128748|NCT02451930|366127239|FG001|Overall Study|Other|1|||
106128749|NCT04006366|366127245|FG000|Overall Study|Withdrawal by Subject|1|||
106128750|NCT01254305|366127246|FG000|Overall Study|Adverse Event|6|||
106128751|NCT01254305|366127247|FG001|Overall Study|Adverse Event|3|||
106128752|NCT01254305|366127248|FG002|Overall Study|Adverse Event|2|||
106128753|NCT01254305|366127246|FG000|Overall Study|Lack of Efficacy|1|||
106128754|NCT01254305|366127247|FG001|Overall Study|Lack of Efficacy|0|||
106128755|NCT01254305|366127248|FG002|Overall Study|Lack of Efficacy|1|||
106128756|NCT01254305|366127246|FG000|Overall Study|Protocol Violation|1|||
106128757|NCT01254305|366127247|FG001|Overall Study|Protocol Violation|7|||
106128758|NCT01254305|366127248|FG002|Overall Study|Protocol Violation|3|||
106128759|NCT01254305|366127246|FG000|Overall Study|Withdrawal by Subject|4|||
106128760|NCT01254305|366127247|FG001|Overall Study|Withdrawal by Subject|2|||
106128761|NCT01254305|366127248|FG002|Overall Study|Withdrawal by Subject|4|||
106128762|NCT01254305|366127246|FG000|Overall Study|Lost to Follow-up|10|||
106128763|NCT01254305|366127247|FG001|Overall Study|Lost to Follow-up|6|||
106128764|NCT01254305|366127248|FG002|Overall Study|Lost to Follow-up|5|||
106128765|NCT01254305|366127246|FG000|Overall Study|Other Reasons|0|||
106128766|NCT01254305|366127247|FG001|Overall Study|Other Reasons|0|||
106128767|NCT01254305|366127248|FG002|Overall Study|Other Reasons|2|||
106128768|NCT03019458|366127252|FG000|Overall Study|Death|0|||
106128769|NCT03019458|366127253|FG001|Overall Study|Death|1|||
106128770|NCT00997243|366127254|FG000|Overall Study|Early termination of study by sponsor|7|||
106128771|NCT02800928|366127257|FG000|Overall Study|Withdrawal by Subject|1|||
106128772|NCT02800928|366127258|FG001|Overall Study|Withdrawal by Subject|1|||
106128773|NCT02800928|366127257|FG000|Overall Study|Protocol Violation|1|||
106128774|NCT02800928|366127258|FG001|Overall Study|Protocol Violation|1|||
106128775|NCT02491892|366127263|FG000|Overall Study|Adverse Event|1|||
106128776|NCT02491892|366127264|FG001|Overall Study|Adverse Event|1|||
106128777|NCT02491892|366127263|FG000|Overall Study|Death|1|||
106128778|NCT02491892|366127264|FG001|Overall Study|Death|1|||
106128779|NCT02491892|366127263|FG000|Overall Study|Lack of Efficacy|37|||
106128780|NCT02491892|366127264|FG001|Overall Study|Lack of Efficacy|36|||
106128781|NCT02491892|366127263|FG000|Overall Study|Refused Treatment|1|||
106128782|NCT02491892|366127264|FG001|Overall Study|Refused Treatment|0|||
106128783|NCT02491892|366127263|FG000|Overall Study|Lost to Follow-up|1|||
106128784|NCT02491892|366127264|FG001|Overall Study|Lost to Follow-up|0|||
106128785|NCT00661258|366127265|FG000|Overall Study|Death|1|||
106128786|NCT00661258|366127266|FG001|Overall Study|Death|0|||
106128787|NCT00661258|366127265|FG000|Overall Study|caught by police and in detox center|2|||
106128788|NCT00661258|366127266|FG001|Overall Study|caught by police and in detox center|1|||
106128789|NCT04496167|366127267|FG000|Overall Study|Adverse Event|6|||
106128790|NCT04496167|366127268|FG001|Overall Study|Adverse Event|2|||
106128791|NCT04496167|366127267|FG000|Overall Study|Withdrawal by Subject|7|||
106128792|NCT04496167|366127268|FG001|Overall Study|Withdrawal by Subject|6|||
106128793|NCT04496167|366127267|FG000|Overall Study|Lost to Follow-up|3|||
106128794|NCT04496167|366127268|FG001|Overall Study|Lost to Follow-up|5|||
106128795|NCT04496167|366127267|FG000|Overall Study|Not Treated|1|||
106128796|NCT04496167|366127268|FG001|Overall Study|Not Treated|2|||
106128797|NCT04496167|366127267|FG000|Overall Study|Other Than Specified|1|||
106128798|NCT04496167|366127268|FG001|Overall Study|Other Than Specified|1|||
106128799|NCT03523871|366127269|FG000|Overall Study|Death|1|||
106128800|NCT00994279|366127275|FG000|Overall Study|Withdrawal by Subject|2|||
106128801|NCT00994279|366127276|FG001|Overall Study|Withdrawal by Subject|2|||
106128802|NCT00994279|366127275|FG000|Overall Study|Toxicity|1|||
106128803|NCT00994279|366127276|FG001|Overall Study|Toxicity|0|||
106128804|NCT00994279|366127275|FG000|Overall Study|Multiple reasons|1|||
106128805|NCT00994279|366127276|FG001|Overall Study|Multiple reasons|3|||
106128806|NCT03785340|366127277|FG000|Overall Study|Lost to Follow-up|2|||
106128807|NCT03785340|366127278|FG001|Overall Study|Lost to Follow-up|0|||
106128808|NCT03785340|366127277|FG000|Overall Study|Adverse Event|1|||
106128809|NCT03785340|366127278|FG001|Overall Study|Adverse Event|0|||
106128810|NCT03008122|366127280|FG000|Overall Study|Physician Decision|3|||
106128811|NCT03008122|366127281|FG001|Overall Study|Physician Decision|2|||
106128812|NCT03008122|366127282|FG002|Overall Study|Physician Decision|0|||
106128813|NCT03008122|366127280|FG000|Overall Study|Withdrawal by Subject|1|||
106128814|NCT03008122|366127281|FG001|Overall Study|Withdrawal by Subject|3|||
106128815|NCT03008122|366127282|FG002|Overall Study|Withdrawal by Subject|0|||
106128816|NCT03008122|366127280|FG000|Overall Study|Lost to Follow-up|4|||
106128817|NCT03008122|366127281|FG001|Overall Study|Lost to Follow-up|8|||
106128818|NCT03008122|366127282|FG002|Overall Study|Lost to Follow-up|3|||
106128819|NCT03008122|366127280|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
106128820|NCT03008122|366127281|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
106128821|NCT03008122|366127282|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
106128822|NCT03008122|366127280|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
106128823|NCT03008122|366127281|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
106128824|NCT03008122|366127282|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
106128825|NCT03008122|366127280|FG000|Overall Study|Death|0|||
106128826|NCT03008122|366127281|FG001|Overall Study|Death|0|||
106128827|NCT03008122|366127282|FG002|Overall Study|Death|1|||
106128828|NCT04159896|366127283|FG000|Overall Study|Lack of Efficacy|7|||
106128829|NCT04159896|366127283|FG000|Overall Study|Withdrawal by Subject|1|||
105685684|NCT00288509|364512823|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
105685685|NCT00288509|364512823|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
106128830|NCT04159896|366127283|FG000|Overall Study|Adverse Event|1|||
106128831|NCT04159896|366127283|FG000|Overall Study|A transient ischaemic attack|1|||
106128832|NCT03473756|366127284|FG000|Overall Study|Withdrawal by Subject|1|||
106128833|NCT03473756|366127285|FG001|Overall Study|Withdrawal by Subject|4|||
106128834|NCT03473756|366127284|FG000|Overall Study|Adverse Event|6|||
106128835|NCT03473756|366127285|FG001|Overall Study|Adverse Event|7|||
106128836|NCT03473756|366127284|FG000|Overall Study|Lack of Efficacy|3|||
106128837|NCT03473756|366127285|FG001|Overall Study|Lack of Efficacy|10|||
106128838|NCT03473756|366127284|FG000|Overall Study|Physician Decision|0|||
106128839|NCT03473756|366127285|FG001|Overall Study|Physician Decision|2|||
106128840|NCT03473756|366127284|FG000|Overall Study|End of study treatment|0|||
106128841|NCT03473756|366127285|FG001|Overall Study|End of study treatment|2|||
106128842|NCT03473756|366127284|FG000|Overall Study|Lost to Follow-up|0|||
106128843|NCT03473756|366127285|FG001|Overall Study|Lost to Follow-up|1|||
106128844|NCT01449721|366127286|FG000|Overall Study|Physician Decision|0|||
106128845|NCT01449721|366127287|FG001|Overall Study|Physician Decision|1|||
106128846|NCT01449721|366127286|FG000|Overall Study|Physician Decision|0|||
106128847|NCT01449721|366127287|FG001|Overall Study|Physician Decision|1|||
106128848|NCT00885495|366127288|FG000|Overall Study|Adverse Event|1|||
106128849|NCT00885495|366127289|FG001|Overall Study|Adverse Event|2|||
106128850|NCT00885495|366127288|FG000|Overall Study|Protocol Violation|0|||
106128851|NCT00885495|366127289|FG001|Overall Study|Protocol Violation|1|||
106128852|NCT00885495|366127288|FG000|Overall Study|Withdrawal by Subject|1|||
106128853|NCT00885495|366127289|FG001|Overall Study|Withdrawal by Subject|0|||
106128854|NCT01400893|366127290|FG000|Overall Study|Death|27|||
106128855|NCT01400893|366127291|FG001|Overall Study|Death|21|||
106128856|NCT01400893|366127290|FG000|Overall Study|Lost to Follow-up|0|||
106128857|NCT01400893|366127291|FG001|Overall Study|Lost to Follow-up|6|||
106128858|NCT01513967|366127292|FG000|Overall Study|Pregnancy|0|||
106128859|NCT01513967|366127293|FG001|Overall Study|Pregnancy|0|||
106128860|NCT01513967|366127294|FG002|Overall Study|Pregnancy|0|||
106128861|NCT01513967|366127295|FG003|Overall Study|Pregnancy|0|||
106128862|NCT01513967|366127296|FG004|Overall Study|Pregnancy|0|||
106128863|NCT01513967|366127297|FG005|Overall Study|Pregnancy|0|||
106128864|NCT01513967|366127298|FG006|Overall Study|Pregnancy|1|||
106128865|NCT01513967|366127299|FG007|Overall Study|Pregnancy|0|||
106128866|NCT01513967|366127292|FG000|Overall Study|missed a study visit|0|||
106128867|NCT01513967|366127293|FG001|Overall Study|missed a study visit|0|||
105685686|NCT00288509|364512823|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
105685687|NCT00288509|364512823|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
105685688|NCT00288509|364512823|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
105685689|NCT00288509|364512823|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
105685690|NCT00288509|364512823|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
105685691|NCT00288509|364512823|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
105685692|NCT00288509|364512823|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
105685693|NCT00288509|364512823|FG000|Treatment Cycle 4|Physician Decision|4|||
105685694|NCT00288509|364512823|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
105685695|NCT02336178|364512830|FG000|Overall Study|Lost to Follow-up|1|||
105685696|NCT02336178|364512830|FG000|Overall Study|Protocol Violation|1|||
105685697|NCT02336178|364512830|FG000|Overall Study|Withdrawal by Subject|1|||
105685698|NCT02336178|364512830|FG000|Overall Study|Other|1|||
105685699|NCT03310268|364512833|FG000|Overall Study|(Not specified)|1|||
105685700|NCT03310268|364512834|FG001|Overall Study|(Not specified)|5|||
105685701|NCT03310268|364512835|FG002|Overall Study|(Not specified)|0|||
105685702|NCT02986334|364512836|FG000|Overall Study|Withdrawal by Subject|0|||
106128868|NCT01513967|366127294|FG002|Overall Study|missed a study visit|0|||
106128869|NCT01513967|366127295|FG003|Overall Study|missed a study visit|0|||
105685703|NCT02986334|364512837|FG001|Overall Study|Withdrawal by Subject|1|||
105685704|NCT02986334|364512838|FG002|Overall Study|Withdrawal by Subject|2|||
105685705|NCT02986334|364512836|FG000|Overall Study|Lost to Follow-up|1|||
106128870|NCT01513967|366127296|FG004|Overall Study|missed a study visit|0|||
106128871|NCT01513967|366127297|FG005|Overall Study|missed a study visit|0|||
106128872|NCT01513967|366127298|FG006|Overall Study|missed a study visit|1|||
106128873|NCT01513967|366127299|FG007|Overall Study|missed a study visit|0|||
106128874|NCT01513967|366127292|FG000|Overall Study|excluded due to positive drug screen|0|||
106128875|NCT01513967|366127293|FG001|Overall Study|excluded due to positive drug screen|0|||
106128876|NCT01513967|366127294|FG002|Overall Study|excluded due to positive drug screen|0|||
106128877|NCT01513967|366127295|FG003|Overall Study|excluded due to positive drug screen|0|||
105685706|NCT02986334|364512837|FG001|Overall Study|Lost to Follow-up|2|||
106128878|NCT01513967|366127296|FG004|Overall Study|excluded due to positive drug screen|0|||
106128879|NCT01513967|366127297|FG005|Overall Study|excluded due to positive drug screen|0|||
106128880|NCT01513967|366127298|FG006|Overall Study|excluded due to positive drug screen|0|||
106128881|NCT01513967|366127299|FG007|Overall Study|excluded due to positive drug screen|2|||
106128882|NCT01513967|366127292|FG000|Overall Study|Physician Decision|0|||
106128883|NCT01513967|366127293|FG001|Overall Study|Physician Decision|0|||
106128884|NCT01513967|366127294|FG002|Overall Study|Physician Decision|0|||
106128885|NCT01513967|366127295|FG003|Overall Study|Physician Decision|0|||
106128886|NCT01513967|366127296|FG004|Overall Study|Physician Decision|0|||
106128887|NCT01513967|366127297|FG005|Overall Study|Physician Decision|1|||
106128888|NCT01513967|366127298|FG006|Overall Study|Physician Decision|0|||
106128889|NCT01513967|366127299|FG007|Overall Study|Physician Decision|0|||
106128890|NCT02322775|366127300|FG000|Overall Study|Adverse Event|1|||
106128891|NCT02322775|366127301|FG001|Overall Study|Adverse Event|0|||
106128892|NCT02322775|366127300|FG000|Overall Study|Lost to Follow-up|0|||
106128893|NCT02322775|366127301|FG001|Overall Study|Lost to Follow-up|1|||
106128894|NCT02322775|366127300|FG000|Overall Study|Protocol Violation|1|||
106128895|NCT02322775|366127301|FG001|Overall Study|Protocol Violation|0|||
106128896|NCT02322775|366127300|FG000|Overall Study|Withdrawal by Subject|3|||
106128897|NCT02322775|366127301|FG001|Overall Study|Withdrawal by Subject|4|||
106128898|NCT02322775|366127300|FG000|Overall Study|Not willing to perform all FU visits|0|||
106128899|NCT02322775|366127301|FG001|Overall Study|Not willing to perform all FU visits|1|||
106128900|NCT02711826|366127302|FG000|Overall Study|Physician Decision|0|||
106128901|NCT02711826|366127303|FG001|Overall Study|Physician Decision|0|||
106128902|NCT02711826|366127304|FG002|Overall Study|Physician Decision|0|||
106128903|NCT02711826|366127305|FG003|Overall Study|Physician Decision|1|||
106128904|NCT02711826|366127306|FG004|Overall Study|Physician Decision|0|||
106128905|NCT02711826|366127302|FG000|Overall Study|Withdrawal by Subject|0|||
106128906|NCT02711826|366127303|FG001|Overall Study|Withdrawal by Subject|1|||
106128907|NCT02711826|366127304|FG002|Overall Study|Withdrawal by Subject|0|||
106128908|NCT02711826|366127305|FG003|Overall Study|Withdrawal by Subject|4|||
105685707|NCT02986334|364512838|FG002|Overall Study|Lost to Follow-up|1|||
105685708|NCT02986334|364512836|FG000|Overall Study|Adverse Event|0|||
105685709|NCT02986334|364512837|FG001|Overall Study|Adverse Event|2|||
105685710|NCT02986334|364512838|FG002|Overall Study|Adverse Event|1|||
105685711|NCT02986334|364512836|FG000|Overall Study|non compliance in phone ratings|2|||
105685712|NCT02986334|364512837|FG001|Overall Study|non compliance in phone ratings|1|||
105685713|NCT02986334|364512838|FG002|Overall Study|non compliance in phone ratings|2|||
105685714|NCT02986334|364512836|FG000|Overall Study|undisclosed comorbidities|0|||
105685715|NCT02986334|364512837|FG001|Overall Study|undisclosed comorbidities|1|||
105685716|NCT02986334|364512838|FG002|Overall Study|undisclosed comorbidities|1|||
105685717|NCT00120406|364512839|FG000|Overall Study|Death|9|||
105685718|NCT00120406|364512840|FG001|Overall Study|Death|4|||
105685719|NCT00120406|364512839|FG000|Overall Study|Withdrawal by Subject|5|||
105685720|NCT00120406|364512840|FG001|Overall Study|Withdrawal by Subject|7|||
105685721|NCT00120406|364512839|FG000|Overall Study|Lost to Follow-up|5|||
105685722|NCT00120406|364512840|FG001|Overall Study|Lost to Follow-up|2|||
105685723|NCT00120406|364512839|FG000|Overall Study|received non-study stent|0|||
105685724|NCT00120406|364512840|FG001|Overall Study|received non-study stent|2|||
105685725|NCT00120406|364512839|FG000|Overall Study|patient moved but has not withdrawn|0|||
105685726|NCT00120406|364512840|FG001|Overall Study|patient moved but has not withdrawn|1|||
105685727|NCT03658668|364512843|FG000|Overall Study|Time Commitment|1|||
105685728|NCT03658668|364512844|FG001|Overall Study|Time Commitment|1|||
105685729|NCT04634825|364512845|FG000|Overall Study|Death|10|||
105685730|NCT04634825|364512846|FG001|Overall Study|Death|3|||
105685731|NCT04634825|364512845|FG000|Overall Study|Lost to Follow-up|1|||
105685732|NCT04634825|364512846|FG001|Overall Study|Lost to Follow-up|0|||
105685733|NCT04634825|364512845|FG000|Overall Study|Study terminated by sponsor|35|||
105685734|NCT04634825|364512846|FG001|Overall Study|Study terminated by sponsor|11|||
105685735|NCT04634825|364512845|FG000|Overall Study|Withdrawal by Subject|2|||
105685736|NCT04634825|364512846|FG001|Overall Study|Withdrawal by Subject|0|||
105685737|NCT00235326|364512847|FG000|Overall Study|Lost to Follow-up|746|||
105685738|NCT00235326|364512848|FG001|Overall Study|Lost to Follow-up|1400|||
105685739|NCT01790126|364512849|FG000|Overall Study|PSA Progression|12|||
106128909|NCT02711826|366127306|FG004|Overall Study|Withdrawal by Subject|0|||
106128910|NCT02711826|366127302|FG000|Overall Study|Failure to manufacture cellular product|0|||
106128911|NCT02711826|366127303|FG001|Overall Study|Failure to manufacture cellular product|0|||
106128912|NCT02711826|366127304|FG002|Overall Study|Failure to manufacture cellular product|5|||
106128913|NCT02711826|366127305|FG003|Overall Study|Failure to manufacture cellular product|0|||
106128914|NCT02711826|366127306|FG004|Overall Study|Failure to manufacture cellular product|0|||
105685740|NCT01790126|364512850|FG001|Overall Study|PSA Progression|16|||
105685741|NCT01790126|364512851|FG002|Overall Study|PSA Progression|16|||
105685742|NCT01790126|364512849|FG000|Overall Study|Other|5|||
105685743|NCT01790126|364512850|FG001|Overall Study|Other|4|||
105685744|NCT01790126|364512851|FG002|Overall Study|Other|8|||
105685745|NCT01790126|364512849|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
105685746|NCT01790126|364512850|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
105685747|NCT01790126|364512851|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
105685748|NCT01790126|364512849|FG000|Overall Study|Withdrawal by Physician|1|||
105685749|NCT01790126|364512850|FG001|Overall Study|Withdrawal by Physician|1|||
105685750|NCT01790126|364512851|FG002|Overall Study|Withdrawal by Physician|2|||
105685751|NCT01790126|364512849|FG000|Overall Study|Withdrawal by Subject|3|||
105685752|NCT01790126|364512850|FG001|Overall Study|Withdrawal by Subject|1|||
105685753|NCT01790126|364512851|FG002|Overall Study|Withdrawal by Subject|2|||
105685754|NCT01790126|364512849|FG000|Overall Study|Lost to Follow-up|1|||
105917438|NCT03327324|365356856|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917439|NCT03327324|365356857|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917440|NCT03327324|365356852|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
105917441|NCT03327324|365356853|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
106128915|NCT02711826|366127302|FG000|Overall Study|Infusion canceled for active infection|0|||
106128916|NCT02711826|366127303|FG001|Overall Study|Infusion canceled for active infection|1|||
106128917|NCT02711826|366127304|FG002|Overall Study|Infusion canceled for active infection|0|||
106128918|NCT02711826|366127305|FG003|Overall Study|Infusion canceled for active infection|0|||
106128919|NCT02711826|366127306|FG004|Overall Study|Infusion canceled for active infection|0|||
106128920|NCT02711826|366127302|FG000|Overall Study|Screen failures|0|||
106128921|NCT02711826|366127303|FG001|Overall Study|Screen failures|0|||
106128922|NCT02711826|366127304|FG002|Overall Study|Screen failures|0|||
106128923|NCT02711826|366127305|FG003|Overall Study|Screen failures|4|||
106128924|NCT02711826|366127306|FG004|Overall Study|Screen failures|0|||
106128925|NCT02906202|366127307|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
106128926|NCT00729690|366127310|FG000|Overall Study|IT Catheter Malfunction|0|||
106128927|NCT00729690|366127311|FG001|Overall Study|IT Catheter Malfunction|2|||
105917442|NCT03327324|365356854|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
105917443|NCT03327324|365356855|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
105917444|NCT03327324|365356856|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
105917445|NCT03327324|365356857|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
105917446|NCT03327324|365356852|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
105917447|NCT03327324|365356853|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105917448|NCT03327324|365356854|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
106128928|NCT00729690|366127312|FG002|Overall Study|IT Catheter Malfunction|2|||
106128929|NCT00442286|366127313|FG000|Overall Study|Death|2|||
106128930|NCT00442286|366127314|FG001|Overall Study|Death|2|||
106128931|NCT00442286|366127313|FG000|Overall Study|Lost to Follow-up|1|||
106128932|NCT00442286|366127314|FG001|Overall Study|Lost to Follow-up|0|||
106128933|NCT00442286|366127313|FG000|Overall Study|Withdrawal by Subject|2|||
106128934|NCT00442286|366127314|FG001|Overall Study|Withdrawal by Subject|0|||
106128935|NCT00442286|366127313|FG000|Overall Study|System explanted|1|||
106128936|NCT00442286|366127314|FG001|Overall Study|System explanted|0|||
106128937|NCT00442286|366127313|FG000|Overall Study|Patient Injury|1|||
106128938|NCT00442286|366127314|FG001|Overall Study|Patient Injury|0|||
105917449|NCT03327324|365356855|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105917450|NCT03327324|365356856|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105917451|NCT03327324|365356857|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
105917452|NCT03327324|365356852|FG000|Intervention (Month 3-Month 6)|Death|1|||
105917453|NCT03327324|365356853|FG001|Intervention (Month 3-Month 6)|Death|0|||
106128939|NCT01388543|366127315|FG000|Day 14|Adverse Event|1|||
106128940|NCT01388543|366127316|FG001|Day 14|Adverse Event|4|||
106128941|NCT00163215|366129089|FG000|Overall Study|Lack of Efficacy|3|||
106128942|NCT00163215|366129089|FG000|Overall Study|Withdrawal by Subject|5|||
106128943|NCT00163215|366129089|FG000|Overall Study|Other|7|||
106128944|NCT01268059|366129094|FG000|Overall Study|Lost to Follow-up|0|||
106128945|NCT01268059|366129095|FG001|Overall Study|Lost to Follow-up|1|||
106128946|NCT01268059|366129096|FG002|Overall Study|Lost to Follow-up|0|||
106128947|NCT01268059|366129097|FG003|Overall Study|Lost to Follow-up|0|||
106128948|NCT01268059|366129094|FG000|Overall Study|Withdrawal by Subject|7|||
105917454|NCT03327324|365356854|FG002|Intervention (Month 3-Month 6)|Death|1|||
105917455|NCT03327324|365356855|FG003|Intervention (Month 3-Month 6)|Death|1|||
105917456|NCT03327324|365356856|FG004|Intervention (Month 3-Month 6)|Death|1|||
105917457|NCT03327324|365356857|FG005|Intervention (Month 3-Month 6)|Death|0|||
106128949|NCT01268059|366129095|FG001|Overall Study|Withdrawal by Subject|4|||
106128950|NCT01268059|366129096|FG002|Overall Study|Withdrawal by Subject|0|||
106128951|NCT01268059|366129097|FG003|Overall Study|Withdrawal by Subject|0|||
106128952|NCT01268059|366129094|FG000|Overall Study|Death|20|||
105685755|NCT01790126|364512850|FG001|Overall Study|Lost to Follow-up|0|||
105685756|NCT01790126|364512851|FG002|Overall Study|Lost to Follow-up|1|||
105685757|NCT01790126|364512849|FG000|Overall Study|Adverse Event|0|||
105685758|NCT01790126|364512850|FG001|Overall Study|Adverse Event|2|||
106128953|NCT01268059|366129095|FG001|Overall Study|Death|30|||
106128954|NCT01268059|366129096|FG002|Overall Study|Death|3|||
106128955|NCT01268059|366129097|FG003|Overall Study|Death|5|||
106128956|NCT01268059|366129094|FG000|Overall Study|Progression of disease|1|||
106128957|NCT01268059|366129095|FG001|Overall Study|Progression of disease|0|||
106128958|NCT01268059|366129096|FG002|Overall Study|Progression of disease|0|||
106128959|NCT01268059|366129097|FG003|Overall Study|Progression of disease|0|||
106128960|NCT01155726|366129104|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
106128961|NCT01155726|366129105|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
106128962|NCT01155726|366129106|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
106128963|NCT01155726|366129107|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
106128964|NCT02424344|366129108|FG000|Overall Study|Lack of Efficacy|0|||
106128965|NCT02424344|366129109|FG001|Overall Study|Lack of Efficacy|1|||
106128966|NCT02424344|366129108|FG000|Overall Study|Withdrawal by Subject|2|||
106128967|NCT02424344|366129109|FG001|Overall Study|Withdrawal by Subject|1|||
106128968|NCT02424344|366129108|FG000|Overall Study|Lost to Follow-up|1|||
106128969|NCT02424344|366129109|FG001|Overall Study|Lost to Follow-up|0|||
106128970|NCT02424344|366129108|FG000|Overall Study|Adverse Event|4|||
106128971|NCT02424344|366129109|FG001|Overall Study|Adverse Event|8|||
106128972|NCT05257837|366129113|FG000|Overall Study|Excluded (did not find the guns)|4|||
106128973|NCT05257837|366129114|FG001|Overall Study|Excluded (did not find the guns)|2|||
106128974|NCT05257837|366129115|FG002|Overall Study|Excluded (did not find the guns)|4|||
106128975|NCT05257837|366129116|FG003|Overall Study|Excluded (did not find the guns)|0|||
106128976|NCT04822298|366129117|FG000|Overall Study|Death|3|||
106128977|NCT01781611|366129118|FG000|Overall Study|Adverse Event|4|||
106128978|NCT01781611|366129119|FG001|Overall Study|Adverse Event|0|||
106128979|NCT01333943|366129120|FG000|Overall Study|Known neuropathy|1|||
106128980|NCT01333943|366129121|FG001|Overall Study|Known neuropathy|0|||
106128981|NCT03639675|366129122|FG000|Overall Study|Withdrawal by Subject|1|||
106128982|NCT00262743|366129125|FG000|Overall Study|Adverse Event|0|||
106128983|NCT00262743|366129126|FG001|Overall Study|Adverse Event|9|||
106128984|NCT00262743|366129125|FG000|Overall Study|Disease progression|0|||
106128985|NCT00262743|366129126|FG001|Overall Study|Disease progression|3|||
106128986|NCT02373813|366129129|FG000|Run-In Period|Other, Not Specified|5|||
106128987|NCT02373813|366129130|FG001|Run-In Period|Other, Not Specified|0|||
106128988|NCT02373813|366129131|FG002|Run-In Period|Other, Not Specified|0|||
106128989|NCT02373813|366129132|FG003|Run-In Period|Other, Not Specified|0|||
106128990|NCT02373813|366129129|FG000|Run-In Period|Withdrawal by Subject|16|||
106128991|NCT02373813|366129130|FG001|Run-In Period|Withdrawal by Subject|0|||
106128992|NCT02373813|366129131|FG002|Run-In Period|Withdrawal by Subject|0|||
106128993|NCT02373813|366129132|FG003|Run-In Period|Withdrawal by Subject|0|||
106128994|NCT02373813|366129129|FG000|Run-In Period|Decision by Sponsor|11|||
106128995|NCT02373813|366129130|FG001|Run-In Period|Decision by Sponsor|0|||
106128996|NCT02373813|366129131|FG002|Run-In Period|Decision by Sponsor|0|||
106128997|NCT02373813|366129132|FG003|Run-In Period|Decision by Sponsor|0|||
106128998|NCT02373813|366129129|FG000|Run-In Period|Protocol Violation|75|||
106128999|NCT02373813|366129130|FG001|Run-In Period|Protocol Violation|0|||
106129000|NCT02373813|366129131|FG002|Run-In Period|Protocol Violation|0|||
106129001|NCT02373813|366129132|FG003|Run-In Period|Protocol Violation|0|||
106129002|NCT02373813|366129129|FG000|Run-In Period|Lost to Follow-up|2|||
106129003|NCT02373813|366129130|FG001|Run-In Period|Lost to Follow-up|0|||
106129004|NCT02373813|366129131|FG002|Run-In Period|Lost to Follow-up|0|||
106129005|NCT02373813|366129132|FG003|Run-In Period|Lost to Follow-up|0|||
106129006|NCT02373813|366129129|FG000|Run-In Period|Adverse Event|3|||
106129007|NCT02373813|366129130|FG001|Run-In Period|Adverse Event|0|||
106129008|NCT02373813|366129131|FG002|Run-In Period|Adverse Event|0|||
106129009|NCT02373813|366129132|FG003|Run-In Period|Adverse Event|0|||
106129010|NCT02373813|366129129|FG000|Run-In Period|Noncompliance|1|||
106129011|NCT02373813|366129130|FG001|Run-In Period|Noncompliance|0|||
106129012|NCT02373813|366129131|FG002|Run-In Period|Noncompliance|0|||
106129013|NCT02373813|366129132|FG003|Run-In Period|Noncompliance|0|||
106129014|NCT02373813|366129129|FG000|Run-In Period|Ineligibility Determined|3|||
106129015|NCT02373813|366129130|FG001|Run-In Period|Ineligibility Determined|0|||
106129016|NCT02373813|366129131|FG002|Run-In Period|Ineligibility Determined|0|||
106129017|NCT02373813|366129132|FG003|Run-In Period|Ineligibility Determined|0|||
106129018|NCT02373813|366129129|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
106129019|NCT02373813|366129130|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
106129020|NCT02373813|366129131|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
105917458|NCT03327324|365356852|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
106129021|NCT02373813|366129132|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
106129022|NCT02373813|366129129|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
106129023|NCT02373813|366129130|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
106129024|NCT02373813|366129131|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
106129025|NCT02373813|366129132|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
106129026|NCT02373813|366129129|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
106129027|NCT02373813|366129130|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
106129028|NCT02373813|366129131|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
106129029|NCT02373813|366129132|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
106129030|NCT02373813|366129129|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106129031|NCT02373813|366129130|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
106129032|NCT02373813|366129131|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
106129033|NCT02373813|366129132|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
106129034|NCT00826280|366129133|FG000|Overall Study|Randomized but drug not received|1|||
106129035|NCT00826280|366129134|FG001|Overall Study|Randomized but drug not received|0|||
106129036|NCT00826280|366129135|FG002|Overall Study|Randomized but drug not received|1|||
106129037|NCT00826280|366129133|FG000|Overall Study|Adverse Event|1|||
106129038|NCT00826280|366129134|FG001|Overall Study|Adverse Event|3|||
106129039|NCT00826280|366129135|FG002|Overall Study|Adverse Event|0|||
106129040|NCT00826280|366129133|FG000|Overall Study|Lost to Follow-up|0|||
106129041|NCT00826280|366129134|FG001|Overall Study|Lost to Follow-up|1|||
106129042|NCT00826280|366129135|FG002|Overall Study|Lost to Follow-up|0|||
106129043|NCT00826280|366129133|FG000|Overall Study|Sponsor discontinued subject or study|1|||
106129044|NCT00826280|366129134|FG001|Overall Study|Sponsor discontinued subject or study|0|||
106129045|NCT00826280|366129135|FG002|Overall Study|Sponsor discontinued subject or study|0|||
106129046|NCT00826280|366129133|FG000|Overall Study|Reversible ischemic defect not present|43|||
106129047|NCT00826280|366129134|FG001|Overall Study|Reversible ischemic defect not present|40|||
106129048|NCT00826280|366129135|FG002|Overall Study|Reversible ischemic defect not present|44|||
106129049|NCT00826280|366129133|FG000|Overall Study|Interpretation Failure|1|||
106129050|NCT00826280|366129134|FG001|Overall Study|Interpretation Failure|0|||
106129051|NCT00826280|366129135|FG002|Overall Study|Interpretation Failure|0|||
106129052|NCT00826280|366129133|FG000|Overall Study|Machine Failure|1|||
106129053|NCT00826280|366129134|FG001|Overall Study|Machine Failure|1|||
106129054|NCT00826280|366129135|FG002|Overall Study|Machine Failure|0|||
106129055|NCT00826280|366129133|FG000|Overall Study|One or more non-interpretable scan|0|||
106129056|NCT00826280|366129134|FG001|Overall Study|One or more non-interpretable scan|1|||
106129057|NCT00826280|366129135|FG002|Overall Study|One or more non-interpretable scan|1|||
106129058|NCT01440049|366129140|FG000|Overall Study|Adverse Event|5|||
106129059|NCT02268552|366129142|FG000|Part 1|Death|1|||
106129060|NCT02268552|366129143|FG001|Part 1|Death|1|||
106129061|NCT02268552|366129144|FG002|Part 1|Death|1|||
106129062|NCT02268552|366129145|FG003|Part 1|Death|2|||
106129063|NCT02268552|366129146|FG004|Part 1|Death|0|||
106129064|NCT02268552|366129147|FG005|Part 1|Death|0|||
106129065|NCT02268552|366129148|FG006|Part 1|Death|0|||
106129066|NCT02268552|366129142|FG000|Part 1|Subject/guardian decision|0|||
106129067|NCT02268552|366129143|FG001|Part 1|Subject/guardian decision|0|||
106129068|NCT02268552|366129144|FG002|Part 1|Subject/guardian decision|0|||
106129069|NCT02268552|366129145|FG003|Part 1|Subject/guardian decision|1|||
106129070|NCT02268552|366129146|FG004|Part 1|Subject/guardian decision|0|||
106129071|NCT02268552|366129147|FG005|Part 1|Subject/guardian decision|0|||
106129072|NCT02268552|366129148|FG006|Part 1|Subject/guardian decision|0|||
106129073|NCT02268552|366129142|FG000|Part 2|Death|0|||
106129074|NCT02268552|366129143|FG001|Part 2|Death|0|||
106129075|NCT02268552|366129144|FG002|Part 2|Death|0|||
106129076|NCT02268552|366129145|FG003|Part 2|Death|0|||
106129077|NCT02268552|366129146|FG004|Part 2|Death|0|||
106129078|NCT02268552|366129147|FG005|Part 2|Death|0|||
106129079|NCT02268552|366129148|FG006|Part 2|Death|2|||
106129080|NCT02268552|366129142|FG000|Part 2|Subject/guardian decision|0|||
106129081|NCT02268552|366129143|FG001|Part 2|Subject/guardian decision|0|||
106129082|NCT02268552|366129144|FG002|Part 2|Subject/guardian decision|0|||
106129083|NCT02268552|366129145|FG003|Part 2|Subject/guardian decision|0|||
106129084|NCT02268552|366129146|FG004|Part 2|Subject/guardian decision|0|||
106129085|NCT02268552|366129147|FG005|Part 2|Subject/guardian decision|0|||
106129086|NCT02268552|366129148|FG006|Part 2|Subject/guardian decision|1|||
106129087|NCT02268552|366129142|FG000|Part 3 Extension|Death|0|||
106129088|NCT02268552|366129143|FG001|Part 3 Extension|Death|1|||
106129089|NCT02268552|366129144|FG002|Part 3 Extension|Death|1|||
106129090|NCT02268552|366129145|FG003|Part 3 Extension|Death|1|||
106129091|NCT02268552|366129146|FG004|Part 3 Extension|Death|1|||
106129092|NCT02268552|366129147|FG005|Part 3 Extension|Death|1|||
106129093|NCT02268552|366129148|FG006|Part 3 Extension|Death|0|||
106129094|NCT02268552|366129142|FG000|Part 3 Extension|Early termination of trial|1|||
105685759|NCT01790126|364512851|FG002|Overall Study|Adverse Event|0|||
106129095|NCT02268552|366129143|FG001|Part 3 Extension|Early termination of trial|0|||
106129096|NCT02268552|366129144|FG002|Part 3 Extension|Early termination of trial|0|||
106129097|NCT02268552|366129145|FG003|Part 3 Extension|Early termination of trial|0|||
106129098|NCT02268552|366129146|FG004|Part 3 Extension|Early termination of trial|2|||
106129099|NCT02268552|366129147|FG005|Part 3 Extension|Early termination of trial|9|||
106129100|NCT02268552|366129148|FG006|Part 3 Extension|Early termination of trial|11|||
106129101|NCT02268552|366129142|FG000|Part 3 Extension|Subject/guardian decision|0|||
106129102|NCT02268552|366129143|FG001|Part 3 Extension|Subject/guardian decision|0|||
106129103|NCT02268552|366129144|FG002|Part 3 Extension|Subject/guardian decision|0|||
106129104|NCT02268552|366129145|FG003|Part 3 Extension|Subject/guardian decision|0|||
106129105|NCT02268552|366129146|FG004|Part 3 Extension|Subject/guardian decision|0|||
106129106|NCT02268552|366129147|FG005|Part 3 Extension|Subject/guardian decision|0|||
106129107|NCT02268552|366129148|FG006|Part 3 Extension|Subject/guardian decision|1|||
106129108|NCT02703532|366129149|FG000|Overall Study|Withdrawal by Subject|0|||
106129109|NCT02703532|366129150|FG001|Overall Study|Withdrawal by Subject|1|||
106129110|NCT02703532|366129151|FG002|Overall Study|Withdrawal by Subject|0|||
106129111|NCT02703532|366129152|FG003|Overall Study|Withdrawal by Subject|1|||
106129112|NCT02703532|366129149|FG000|Overall Study|Lost to Follow-up|2|||
106129113|NCT02703532|366129150|FG001|Overall Study|Lost to Follow-up|0|||
106129114|NCT02703532|366129151|FG002|Overall Study|Lost to Follow-up|2|||
106129115|NCT02703532|366129152|FG003|Overall Study|Lost to Follow-up|0|||
106129116|NCT00031447|366129153|FG000|Overall Study|Lost to Follow-up|0|||
106129117|NCT00031447|366129154|FG001|Overall Study|Lost to Follow-up|1|||
106129118|NCT00031447|366129153|FG000|Overall Study|Non-compliant|1|||
106129119|NCT00031447|366129154|FG001|Overall Study|Non-compliant|1|||
106129120|NCT00031447|366129153|FG000|Overall Study|Re-activation of Disease|2|||
106129121|NCT00031447|366129154|FG001|Overall Study|Re-activation of Disease|1|||
106129122|NCT00031447|366129153|FG000|Overall Study|Disruption of blinded study drug supply|7|||
106129123|NCT00031447|366129154|FG001|Overall Study|Disruption of blinded study drug supply|4|||
106129124|NCT01636362|366129155|FG000|Overall Study|Physician Decision|6|||
106129125|NCT01636362|366129155|FG000|Overall Study|Subject healed, not returning|1|||
106129126|NCT01636362|366129155|FG000|Overall Study|Withdrawal by Subject|1|||
106129127|NCT02264574|366129156|FG000|Overall Study|Death|21|||
106129128|NCT02264574|366129157|FG001|Overall Study|Death|21|||
106129129|NCT02264574|366129156|FG000|Overall Study|Withdrawal by Subject|8|||
106129130|NCT02264574|366129157|FG001|Overall Study|Withdrawal by Subject|6|||
106129131|NCT02264574|366129156|FG000|Overall Study|Other, Not Specified|0|||
106129132|NCT02264574|366129157|FG001|Overall Study|Other, Not Specified|3|||
106129133|NCT03415022|366129160|FG000|Overall Study|Withdrawal by Subject|1|||
106129134|NCT03415022|366129161|FG001|Overall Study|Withdrawal by Subject|2|||
106129135|NCT03415022|366129160|FG000|Overall Study|COVID-19 Suspension|2|||
106129136|NCT03415022|366129161|FG001|Overall Study|COVID-19 Suspension|3|||
106129137|NCT03415022|366129160|FG000|Overall Study|Lost to Follow-up|2|||
106129138|NCT03415022|366129161|FG001|Overall Study|Lost to Follow-up|0|||
106129139|NCT00884286|366129163|FG000|Overall Study|Progressive disease|21|||
106129140|NCT00884286|366129164|FG001|Overall Study|Progressive disease|28|||
106129141|NCT00884286|366129163|FG000|Overall Study|Toxicity|4|||
106129142|NCT00884286|366129164|FG001|Overall Study|Toxicity|1|||
106129143|NCT00884286|366129163|FG000|Overall Study|Death|2|||
106129144|NCT00884286|366129164|FG001|Overall Study|Death|2|||
106129145|NCT00884286|366129163|FG000|Overall Study|Physician Decision|1|||
106129146|NCT00884286|366129164|FG001|Overall Study|Physician Decision|0|||
106129147|NCT00884286|366129163|FG000|Overall Study|Septic shock|1|||
106129148|NCT00884286|366129164|FG001|Overall Study|Septic shock|0|||
106129149|NCT00884286|366129163|FG000|Overall Study|Thrombus in right auricle|1|||
106129150|NCT00884286|366129164|FG001|Overall Study|Thrombus in right auricle|0|||
106129151|NCT00884286|366129163|FG000|Overall Study|Not treated|2|||
106129152|NCT00884286|366129164|FG001|Overall Study|Not treated|1|||
106129153|NCT00884286|366129163|FG000|Overall Study|Comprised lung carcinoma|0|||
106129154|NCT00884286|366129164|FG001|Overall Study|Comprised lung carcinoma|1|||
106129155|NCT01094171|366129169|FG000|Overall Study|Lost to Follow-up|2|||
106129156|NCT01094171|366129169|FG000|Overall Study|Informed consent withdrawal|4|||
106129157|NCT01094171|366129169|FG000|Overall Study|Migration from the study area|3|||
106129158|NCT01094171|366129169|FG000|Overall Study|Other|1|||
106129159|NCT01686932|366129170|FG000|Period 1|Adverse Event|1|||
106129160|NCT01686932|366129171|FG001|Period 1|Adverse Event|1|||
106129161|NCT02118714|366129172|FG000|Overall Study|Lost to Follow-up|2|||
106129162|NCT02118714|366129172|FG000|Overall Study|Protocol Violation|1|||
106129163|NCT01628874|366129173|FG000|Overall Study|Physician Decision|1|||
106129164|NCT01628874|366129174|FG001|Overall Study|Physician Decision|1|||
106129165|NCT01628874|366129173|FG000|Overall Study|Age >4 months|4|||
106129166|NCT01628874|366129174|FG001|Overall Study|Age >4 months|2|||
106129167|NCT01113463|366129180|FG000|Overall Study|Physician Decision|5|||
106129168|NCT00136916|366129181|FG000|Overall Study|Never received study treatment|3|||
106129169|NCT00136916|366129182|FG001|Overall Study|Never received study treatment|5|||
106129170|NCT00136916|366129181|FG000|Overall Study|Death|1|||
106129171|NCT00136916|366129182|FG001|Overall Study|Death|3|||
106129172|NCT00136916|366129181|FG000|Overall Study|Adverse Event|27|||
106129173|NCT00136916|366129182|FG001|Overall Study|Adverse Event|8|||
106129174|NCT00136916|366129181|FG000|Overall Study|Laboratory abnormality|0|||
106129175|NCT00136916|366129182|FG001|Overall Study|Laboratory abnormality|1|||
106129176|NCT00136916|366129181|FG000|Overall Study|Lack of Efficacy|13|||
106129177|NCT00136916|366129182|FG001|Overall Study|Lack of Efficacy|3|||
106129178|NCT00136916|366129181|FG000|Overall Study|Lost to Follow-up|12|||
106129179|NCT00136916|366129182|FG001|Overall Study|Lost to Follow-up|14|||
106129180|NCT00136916|366129181|FG000|Overall Study|Withdrawal by Subject|44|||
106129181|NCT00136916|366129182|FG001|Overall Study|Withdrawal by Subject|46|||
106129182|NCT00136916|366129181|FG000|Overall Study|Other|22|||
106129183|NCT00136916|366129182|FG001|Overall Study|Other|24|||
106129184|NCT00136916|366129181|FG000|Overall Study|Discontinued in follow up period|3|||
106129185|NCT00136916|366129182|FG001|Overall Study|Discontinued in follow up period|0|||
106129186|NCT02059161|366129183|FG000|Overall Study|Pregnancy|0|||
106129187|NCT02059161|366129184|FG001|Overall Study|Pregnancy|2|||
106129188|NCT02059161|366129183|FG000|Overall Study|Adverse Event|2|||
106001293|NCT04332107|365665255|FG000|Day 3|Lost to Follow-up|23|||
106001294|NCT04332107|365665256|FG001|Day 3|Lost to Follow-up|14|||
106129189|NCT02059161|366129184|FG001|Overall Study|Adverse Event|6|||
106001295|NCT04332107|365665255|FG000|Day 3|Missing outcome data|3|||
106001296|NCT04332107|365665256|FG001|Day 3|Missing outcome data|6|||
106001297|NCT04332107|365665255|FG000|Day 14|Lost to Follow-up|13|||
106001298|NCT04332107|365665256|FG001|Day 14|Lost to Follow-up|4|||
106001299|NCT04332107|365665255|FG000|Day 14|Missing outcome data|4|||
106129190|NCT02059161|366129183|FG000|Overall Study|Lost to Follow-up|20|||
106129191|NCT02059161|366129184|FG001|Overall Study|Lost to Follow-up|12|||
106129192|NCT02059161|366129183|FG000|Overall Study|Physician Decision|4|||
106129193|NCT02059161|366129184|FG001|Overall Study|Physician Decision|4|||
106129194|NCT02059161|366129183|FG000|Overall Study|Protocol Violation|1|||
106129195|NCT02059161|366129184|FG001|Overall Study|Protocol Violation|1|||
106129196|NCT02059161|366129183|FG000|Overall Study|Withdrawal by Subject|16|||
106129197|NCT02059161|366129184|FG001|Overall Study|Withdrawal by Subject|13|||
106129198|NCT02059161|366129183|FG000|Overall Study|Randomized in error, no study drug|0|||
106129199|NCT02059161|366129184|FG001|Overall Study|Randomized in error, no study drug|1|||
106129200|NCT02059161|366129183|FG000|Overall Study|Non-compliance with study drug|6|||
106129201|NCT02059161|366129184|FG001|Overall Study|Non-compliance with study drug|2|||
106129202|NCT03293485|366129185|FG000|Overall Study|Death|1|||
106129203|NCT03293485|366129185|FG000|Overall Study|Screen Failure|2|||
106129204|NCT03293485|366129185|FG000|Overall Study|Withdrawal by Subject|2|||
106129205|NCT03486899|366129186|FG000|Overall Study|Lost to Follow-up|4|||
106129206|NCT03486899|366129187|FG001|Overall Study|Lost to Follow-up|1|||
106129207|NCT03486899|366129188|FG002|Overall Study|Lost to Follow-up|4|||
106129208|NCT03486899|366129189|FG003|Overall Study|Lost to Follow-up|3|||
106129209|NCT03486899|366129186|FG000|Overall Study|Death|1|||
106001300|NCT04332107|365665256|FG001|Day 14|Missing outcome data|4|||
106129210|NCT03486899|366129187|FG001|Overall Study|Death|0|||
106129211|NCT03486899|366129188|FG002|Overall Study|Death|0|||
106129212|NCT03486899|366129189|FG003|Overall Study|Death|1|||
106129213|NCT03486899|366129186|FG000|Overall Study|Adverse Event|0|||
106129214|NCT03486899|366129187|FG001|Overall Study|Adverse Event|2|||
106129215|NCT03486899|366129188|FG002|Overall Study|Adverse Event|0|||
106129216|NCT03486899|366129189|FG003|Overall Study|Adverse Event|2|||
106129217|NCT03486899|366129186|FG000|Overall Study|Withdrawal by Subject|3|||
106129218|NCT03486899|366129187|FG001|Overall Study|Withdrawal by Subject|7|||
106129219|NCT03486899|366129188|FG002|Overall Study|Withdrawal by Subject|4|||
106129220|NCT03486899|366129189|FG003|Overall Study|Withdrawal by Subject|3|||
106129221|NCT03486899|366129186|FG000|Overall Study|Other Reasons|0|||
106129222|NCT03486899|366129187|FG001|Overall Study|Other Reasons|1|||
106129223|NCT03486899|366129188|FG002|Overall Study|Other Reasons|0|||
106129224|NCT03486899|366129189|FG003|Overall Study|Other Reasons|1|||
106129225|NCT01723826|366129192|FG000|Overall Study|Adverse Event|4|||
106129226|NCT01723826|366129193|FG001|Overall Study|Adverse Event|1|||
106129227|NCT01723826|366129194|FG002|Overall Study|Adverse Event|4|||
106129228|NCT01723826|366129195|FG003|Overall Study|Adverse Event|5|||
106129229|NCT01723826|366129192|FG000|Overall Study|Death according to AE eCRF|2|||
106129230|NCT01723826|366129193|FG001|Overall Study|Death according to AE eCRF|3|||
106129231|NCT01723826|366129194|FG002|Overall Study|Death according to AE eCRF|3|||
106001301|NCT04332107|365665255|FG000|Day 21|Lost to Follow-up|10|||
106129232|NCT01723826|366129195|FG003|Overall Study|Death according to AE eCRF|7|||
106129233|NCT01723826|366129192|FG000|Overall Study|Lost to Follow-up|1|||
106129234|NCT01723826|366129193|FG001|Overall Study|Lost to Follow-up|3|||
106129235|NCT01723826|366129194|FG002|Overall Study|Lost to Follow-up|1|||
106129236|NCT01723826|366129195|FG003|Overall Study|Lost to Follow-up|1|||
106129237|NCT01723826|366129192|FG000|Overall Study|Non-compliance|0|||
106129238|NCT01723826|366129193|FG001|Overall Study|Non-compliance|1|||
106129239|NCT01723826|366129194|FG002|Overall Study|Non-compliance|3|||
106129240|NCT01723826|366129195|FG003|Overall Study|Non-compliance|3|||
106129241|NCT01723826|366129192|FG000|Overall Study|Non-compliance With Study Drug|0|||
106129242|NCT01723826|366129193|FG001|Overall Study|Non-compliance With Study Drug|1|||
106129243|NCT01723826|366129194|FG002|Overall Study|Non-compliance With Study Drug|0|||
106129244|NCT01723826|366129195|FG003|Overall Study|Non-compliance With Study Drug|0|||
106129245|NCT01723826|366129192|FG000|Overall Study|Other Reason|8|||
106129246|NCT01723826|366129193|FG001|Overall Study|Other Reason|6|||
106129247|NCT01723826|366129194|FG002|Overall Study|Other Reason|12|||
106129248|NCT01723826|366129195|FG003|Overall Study|Other Reason|14|||
106129249|NCT01723826|366129192|FG000|Overall Study|Physician Decision|1|||
106001302|NCT04332107|365665256|FG001|Day 21|Lost to Follow-up|2|||
106001303|NCT00717249|365665261|FG000|Overall Study|Lens Discomfort|4|||
106129250|NCT01723826|366129193|FG001|Overall Study|Physician Decision|3|||
106129251|NCT01723826|366129194|FG002|Overall Study|Physician Decision|4|||
106129252|NCT01723826|366129195|FG003|Overall Study|Physician Decision|11|||
106129253|NCT01723826|366129192|FG000|Overall Study|Protocol Violation|1|||
106129254|NCT01723826|366129193|FG001|Overall Study|Protocol Violation|1|||
106129255|NCT01723826|366129194|FG002|Overall Study|Protocol Violation|3|||
106129256|NCT01723826|366129195|FG003|Overall Study|Protocol Violation|1|||
106129257|NCT01723826|366129192|FG000|Overall Study|Withdrawal by Subject|10|||
106129258|NCT01723826|366129193|FG001|Overall Study|Withdrawal by Subject|17|||
106129259|NCT01723826|366129194|FG002|Overall Study|Withdrawal by Subject|27|||
106129260|NCT01723826|366129195|FG003|Overall Study|Withdrawal by Subject|48|||
106129261|NCT03023332|366129196|FG000|Overall Study|Withdrawal by Subject|10|||
106129262|NCT03023332|366129197|FG001|Overall Study|Withdrawal by Subject|5|||
106129263|NCT03023332|366129198|FG002|Overall Study|Withdrawal by Subject|4|||
106129264|NCT03023332|366129199|FG003|Overall Study|Withdrawal by Subject|7|||
106129265|NCT03023332|366129196|FG000|Overall Study|Lost to Follow-up|13|||
106129266|NCT03023332|366129197|FG001|Overall Study|Lost to Follow-up|16|||
106129267|NCT03023332|366129198|FG002|Overall Study|Lost to Follow-up|8|||
106129268|NCT03023332|366129199|FG003|Overall Study|Lost to Follow-up|13|||
106129269|NCT03023332|366129196|FG000|Overall Study|Death|1|||
106129270|NCT03023332|366129197|FG001|Overall Study|Death|0|||
106129271|NCT03023332|366129198|FG002|Overall Study|Death|0|||
106129272|NCT03023332|366129199|FG003|Overall Study|Death|0|||
106129273|NCT02408549|366129200|FG000|Overall Study|Adverse Event|15|||
106129274|NCT02408549|366129200|FG000|Overall Study|Death|4|||
106129275|NCT02408549|366129200|FG000|Overall Study|Lack of Efficacy|17|||
106129276|NCT02408549|366129200|FG000|Overall Study|Protocol Violation|4|||
106129277|NCT02408549|366129200|FG000|Overall Study|Lost to Follow-up|6|||
106129278|NCT02408549|366129200|FG000|Overall Study|Consent withdrawn|30|||
106129279|NCT02408549|366129200|FG000|Overall Study|Neurology research program closing at site|1|||
106129280|NCT02408549|366129200|FG000|Overall Study|Site closure|1|||
106129281|NCT02408549|366129200|FG000|Overall Study|Pregnancy|1|||
106129282|NCT02408549|366129200|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
106129283|NCT02408549|366129200|FG000|Overall Study|Subject moved to another place, far from site|1|||
106129284|NCT02408549|366129200|FG000|Overall Study|Study terminated at site|1|||
106129285|NCT02013687|366129201|FG000|Overall Study|Lost to Follow-up|0|||
106129286|NCT02013687|366129202|FG001|Overall Study|Lost to Follow-up|0|||
106129287|NCT02013687|366129203|FG002|Overall Study|Lost to Follow-up|1|||
106129288|NCT02013687|366129204|FG003|Overall Study|Lost to Follow-up|0|||
106129289|NCT02013687|366129201|FG000|Overall Study|Protocol Violation|0|||
106129290|NCT02013687|366129202|FG001|Overall Study|Protocol Violation|0|||
106129291|NCT02013687|366129203|FG002|Overall Study|Protocol Violation|0|||
106129292|NCT02013687|366129204|FG003|Overall Study|Protocol Violation|1|||
106129293|NCT02013687|366129201|FG000|Overall Study|Withdrawal by Subject|0|||
106129294|NCT02013687|366129202|FG001|Overall Study|Withdrawal by Subject|0|||
106129295|NCT02013687|366129203|FG002|Overall Study|Withdrawal by Subject|0|||
106129296|NCT02013687|366129204|FG003|Overall Study|Withdrawal by Subject|1|||
106129297|NCT02013687|366129201|FG000|Overall Study|Missed visits due to patient travel|0|||
106129298|NCT02013687|366129202|FG001|Overall Study|Missed visits due to patient travel|0|||
106129299|NCT02013687|366129203|FG002|Overall Study|Missed visits due to patient travel|1|||
106129300|NCT02013687|366129204|FG003|Overall Study|Missed visits due to patient travel|0|||
106129301|NCT01657032|366129205|FG000|Overall Study|Lost to Follow-up|0|||
106129302|NCT01657032|366129206|FG001|Overall Study|Lost to Follow-up|7|||
106129303|NCT01782326|366129207|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
106129304|NCT01782326|366129208|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
106129305|NCT01782326|366129207|FG000|Planned Treatment Epoch|Death|29|||
106129306|NCT01782326|366129208|FG001|Planned Treatment Epoch|Death|30|||
106129307|NCT01782326|366129207|FG000|Planned Treatment Epoch|Physician Decision|18|||
106129308|NCT01782326|366129208|FG001|Planned Treatment Epoch|Physician Decision|16|||
106129309|NCT01782326|366129207|FG000|Planned Treatment Epoch|Protocol deviation|2|||
106129310|NCT01782326|366129208|FG001|Planned Treatment Epoch|Protocol deviation|3|||
106129311|NCT01782326|366129207|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
106129312|NCT01782326|366129208|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
106129313|NCT01782326|366129207|FG000|Planned Treatment Epoch|Technical problems|0|||
105917459|NCT03327324|365356853|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
106129314|NCT01782326|366129208|FG001|Planned Treatment Epoch|Technical problems|4|||
106129315|NCT01782326|366129207|FG000|Double-blind Treatment|Adverse Event|129|||
106129316|NCT01782326|366129208|FG001|Double-blind Treatment|Adverse Event|145|||
106129317|NCT01782326|366129207|FG000|Double-blind Treatment|Subject/guardian decision|111|||
106129318|NCT01782326|366129208|FG001|Double-blind Treatment|Subject/guardian decision|125|||
106129319|NCT01782326|366129207|FG000|Double-blind Treatment|Lack of Efficacy|17|||
106129320|NCT01782326|366129208|FG001|Double-blind Treatment|Lack of Efficacy|22|||
106001304|NCT00717249|365665262|FG001|Overall Study|Lens Discomfort|1|||
106129321|NCT01782326|366129207|FG000|Double-blind Treatment|Physician Decision|13|||
106129322|NCT01782326|366129208|FG001|Double-blind Treatment|Physician Decision|16|||
106129323|NCT01782326|366129207|FG000|Double-blind Treatment|Protocol deviation|8|||
106129324|NCT01782326|366129208|FG001|Double-blind Treatment|Protocol deviation|7|||
106129325|NCT01782326|366129207|FG000|Double-blind Treatment|Technical problems|0|||
106129326|NCT01782326|366129208|FG001|Double-blind Treatment|Technical problems|5|||
106129327|NCT05968482|366129209|FG000|First Crossover Period|Withdrawal by Subject|0|||
106129328|NCT05968482|366129210|FG001|First Crossover Period|Withdrawal by Subject|0|||
106129329|NCT05968482|366129211|FG002|First Crossover Period|Withdrawal by Subject|1|||
106129330|NCT05968482|366129212|FG003|First Crossover Period|Withdrawal by Subject|0|||
106129331|NCT05968482|366129213|FG004|First Crossover Period|Withdrawal by Subject|0|||
106129332|NCT05968482|366129214|FG005|First Crossover Period|Withdrawal by Subject|0|||
106129333|NCT05968482|366129209|FG000|First Crossover Period|Adverse Event|0|||
106129334|NCT05968482|366129210|FG001|First Crossover Period|Adverse Event|0|||
106129335|NCT05968482|366129211|FG002|First Crossover Period|Adverse Event|0|||
106129336|NCT05968482|366129212|FG003|First Crossover Period|Adverse Event|0|||
106129337|NCT05968482|366129213|FG004|First Crossover Period|Adverse Event|0|||
106129338|NCT05968482|366129214|FG005|First Crossover Period|Adverse Event|1|||
106129339|NCT05968482|366129209|FG000|Second Crossover Period|Withdrawal by Subject|0|||
106129340|NCT05968482|366129210|FG001|Second Crossover Period|Withdrawal by Subject|0|||
106129341|NCT05968482|366129211|FG002|Second Crossover Period|Withdrawal by Subject|0|||
106129342|NCT05968482|366129212|FG003|Second Crossover Period|Withdrawal by Subject|0|||
106129343|NCT05968482|366129213|FG004|Second Crossover Period|Withdrawal by Subject|1|||
106129344|NCT05968482|366129214|FG005|Second Crossover Period|Withdrawal by Subject|0|||
106129345|NCT05968482|366129209|FG000|Third Crossover Period|Adverse Event|0|||
106129346|NCT05968482|366129210|FG001|Third Crossover Period|Adverse Event|0|||
106129347|NCT05968482|366129211|FG002|Third Crossover Period|Adverse Event|0|||
106129348|NCT05968482|366129212|FG003|Third Crossover Period|Adverse Event|0|||
106129349|NCT05968482|366129213|FG004|Third Crossover Period|Adverse Event|1|||
106129350|NCT05968482|366129214|FG005|Third Crossover Period|Adverse Event|0|||
106129351|NCT05968482|366129209|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
106129352|NCT05968482|366129210|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
106129353|NCT05968482|366129211|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
106129354|NCT05968482|366129212|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
106129355|NCT05968482|366129213|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
106129356|NCT05968482|366129214|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
106129357|NCT02559817|366129215|FG000|Treatment Period|Adverse Event|1|||
106129358|NCT02559817|366129216|FG001|Treatment Period|Adverse Event|0|||
106129359|NCT02559817|366129217|FG002|Treatment Period|Adverse Event|1|||
106129360|NCT02559817|366129218|FG003|Treatment Period|Adverse Event|0|||
106129361|NCT02559817|366129219|FG004|Treatment Period|Adverse Event|0|||
106129362|NCT02559817|366129215|FG000|Treatment Period|Lack of Efficacy|0|||
106129363|NCT02559817|366129216|FG001|Treatment Period|Lack of Efficacy|1|||
106129364|NCT02559817|366129217|FG002|Treatment Period|Lack of Efficacy|0|||
106129365|NCT02559817|366129218|FG003|Treatment Period|Lack of Efficacy|0|||
106129366|NCT02559817|366129219|FG004|Treatment Period|Lack of Efficacy|0|||
106129367|NCT02559817|366129215|FG000|Treatment Period|Lost to Follow-up|0|||
106129368|NCT02559817|366129216|FG001|Treatment Period|Lost to Follow-up|1|||
106129369|NCT02559817|366129217|FG002|Treatment Period|Lost to Follow-up|0|||
106129370|NCT02559817|366129218|FG003|Treatment Period|Lost to Follow-up|1|||
106129371|NCT02559817|366129219|FG004|Treatment Period|Lost to Follow-up|0|||
106129372|NCT02559817|366129215|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
106001305|NCT00717249|365665261|FG000|Overall Study|Unsatisfactory visual Response|0|||
106001306|NCT00717249|365665262|FG001|Overall Study|Unsatisfactory visual Response|2|||
106001307|NCT00717249|365665261|FG000|Overall Study|Adverse Event|4|||
106129373|NCT02559817|366129216|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
105685760|NCT01790126|364512849|FG000|Overall Study|Death|2|||
105685761|NCT01790126|364512850|FG001|Overall Study|Death|0|||
105685762|NCT01790126|364512851|FG002|Overall Study|Death|0|||
106129374|NCT02559817|366129217|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
106129375|NCT02559817|366129218|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
106129376|NCT02559817|366129219|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
106129377|NCT02559817|366129215|FG000|Treatment Period|Protocol Violation|0|||
106129378|NCT02559817|366129216|FG001|Treatment Period|Protocol Violation|0|||
106129379|NCT02559817|366129217|FG002|Treatment Period|Protocol Violation|0|||
106129380|NCT02559817|366129218|FG003|Treatment Period|Protocol Violation|1|||
106129381|NCT02559817|366129219|FG004|Treatment Period|Protocol Violation|0|||
106129382|NCT04172987|366129222|FG000|Lead In Period|Adverse Event|1|||
106129383|NCT04172987|366129222|FG000|Lead In Period|Protocol Violation|1|||
106129384|NCT04172987|366129222|FG000|Period 1|Physician Decision|1|||
105685763|NCT01790126|364512849|FG000|Overall Study|Radiographic Progression|3|||
105685764|NCT01790126|364512850|FG001|Overall Study|Radiographic Progression|1|||
106129385|NCT04172987|366129222|FG000|Period 2|Adverse Event|5|||
106129386|NCT04172987|366129222|FG000|Period 2|Dosing Termination by Sponsor|4|||
105685765|NCT01790126|364512851|FG002|Overall Study|Radiographic Progression|0|||
105917460|NCT03327324|365356854|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917461|NCT03327324|365356855|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917462|NCT03327324|365356856|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917463|NCT03327324|365356857|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
105952101|NCT03314935|365488197|FG013|Phase 1|Study Terminated by Sponsor|0|||
106129387|NCT01603121|366129224|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
106129388|NCT01603121|366129225|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
106129389|NCT00577720|366129226|FG000|Overall Study|Adverse Event|2|||
106129390|NCT00577720|366129227|FG001|Overall Study|Adverse Event|1|||
106129391|NCT00577720|366129228|FG002|Overall Study|Adverse Event|0|||
106129392|NCT00577720|366129229|FG003|Overall Study|Adverse Event|4|||
106129393|NCT00577720|366129226|FG000|Overall Study|Lost to Follow-up|0|||
106129394|NCT00577720|366129227|FG001|Overall Study|Lost to Follow-up|0|||
106129395|NCT00577720|366129228|FG002|Overall Study|Lost to Follow-up|1|||
106129396|NCT00577720|366129229|FG003|Overall Study|Lost to Follow-up|0|||
106129397|NCT00577720|366129226|FG000|Overall Study|Protocol Violation|0|||
106129398|NCT00577720|366129227|FG001|Overall Study|Protocol Violation|0|||
106129399|NCT00577720|366129228|FG002|Overall Study|Protocol Violation|0|||
106129400|NCT00577720|366129229|FG003|Overall Study|Protocol Violation|1|||
106129401|NCT00577720|366129226|FG000|Overall Study|Withdrawal by Subject|2|||
106129402|NCT00577720|366129227|FG001|Overall Study|Withdrawal by Subject|0|||
106129403|NCT00577720|366129228|FG002|Overall Study|Withdrawal by Subject|0|||
106129404|NCT00577720|366129229|FG003|Overall Study|Withdrawal by Subject|2|||
106129405|NCT02839681|366129232|FG000|Overall Study|Death|2|||
106129406|NCT00738530|366129233|FG000|Overall Study|Death|220|||
106129407|NCT00738530|366129234|FG001|Overall Study|Death|224|||
106129408|NCT00738530|366129233|FG000|Overall Study|Lost to Follow-up|8|||
106129409|NCT00738530|366129234|FG001|Overall Study|Lost to Follow-up|6|||
106129410|NCT00738530|366129233|FG000|Overall Study|Withdrawal by Subject|6|||
106129411|NCT00738530|366129234|FG001|Overall Study|Withdrawal by Subject|8|||
106129412|NCT01628510|366129235|FG000|Overall Study|Withdrawal by Subject|0|||
106129413|NCT01628510|366129236|FG001|Overall Study|Withdrawal by Subject|4|||
106129414|NCT01628510|366129235|FG000|Overall Study|Death|3|||
106129415|NCT01628510|366129236|FG001|Overall Study|Death|1|||
106129416|NCT02687919|366129237|FG000|Overall Study|Withdrawal by Subject|6|||
106129417|NCT02687919|366129238|FG001|Overall Study|Withdrawal by Subject|6|||
106129418|NCT02687919|366129237|FG000|Overall Study|Protocol Violation|2|||
106129419|NCT02687919|366129238|FG001|Overall Study|Protocol Violation|0|||
106129420|NCT04179461|366129239|FG000|Overall Study|Lost to Follow-up|4|||
106129421|NCT00772928|366129240|FG000|Overall Study|Lost to Follow-up|9|||
106129422|NCT00772928|366129241|FG001|Overall Study|Lost to Follow-up|6|||
106129423|NCT00772928|366129240|FG000|Overall Study|Protocol Violation|10|||
106129424|NCT00772928|366129241|FG001|Overall Study|Protocol Violation|12|||
106129425|NCT00772928|366129240|FG000|Overall Study|Withdrawal by Subject|25|||
106129426|NCT00772928|366129241|FG001|Overall Study|Withdrawal by Subject|22|||
106129427|NCT00772928|366129240|FG000|Overall Study|Did not receive vaccine|0|||
106129428|NCT00772928|366129241|FG001|Overall Study|Did not receive vaccine|1|||
106129429|NCT01653847|366129242|FG000|Overall Study|Withdrawal by Subject|1|||
106129430|NCT01653847|366129243|FG001|Overall Study|Withdrawal by Subject|0|||
106129431|NCT03100838|366129244|FG000|Overall Study|Adverse Event|1|||
106129432|NCT03100838|366129245|FG001|Overall Study|Adverse Event|0|||
106129433|NCT03100838|366129246|FG002|Overall Study|Adverse Event|0|||
106129434|NCT03100838|366129247|FG003|Overall Study|Adverse Event|0|||
106129435|NCT03100838|366129244|FG000|Overall Study|Physician Decision|1|||
106129436|NCT03100838|366129245|FG001|Overall Study|Physician Decision|1|||
106129437|NCT03100838|366129246|FG002|Overall Study|Physician Decision|1|||
106129438|NCT03100838|366129247|FG003|Overall Study|Physician Decision|1|||
106129439|NCT03100838|366129244|FG000|Overall Study|Pregnancy|0|||
106129440|NCT03100838|366129245|FG001|Overall Study|Pregnancy|1|||
106129441|NCT03100838|366129246|FG002|Overall Study|Pregnancy|0|||
106129442|NCT03100838|366129247|FG003|Overall Study|Pregnancy|0|||
106129443|NCT03100838|366129244|FG000|Overall Study|Lost to Follow-up|0|||
106129444|NCT03100838|366129245|FG001|Overall Study|Lost to Follow-up|0|||
106129445|NCT03100838|366129246|FG002|Overall Study|Lost to Follow-up|1|||
106129446|NCT03100838|366129247|FG003|Overall Study|Lost to Follow-up|0|||
105786572|NCT02147132|364872828|FG000|Overall Study|Lost to Follow-up|1|||
106129447|NCT00801242|366129248|FG000|Overall Study|Adverse Event|10|||
106129448|NCT00801242|366129248|FG000|Overall Study|Withdrawal by Subject|13|||
106129449|NCT00801242|366129248|FG000|Overall Study|Protocol Violation|5|||
106129450|NCT00801242|366129248|FG000|Overall Study|Physician Decision|3|||
106129451|NCT00801242|366129248|FG000|Overall Study|Lost to Follow-up|1|||
106129452|NCT00801242|366129248|FG000|Overall Study|Miscellaneous reasons|20|||
106129453|NCT04707391|366129249|FG000|Overall Study|Adverse Event|5|||
106129454|NCT04707391|366129250|FG001|Overall Study|Adverse Event|8|||
106129455|NCT04707391|366129249|FG000|Overall Study|Lost to Follow-up|44|||
106129456|NCT04707391|366129250|FG001|Overall Study|Lost to Follow-up|31|||
106129457|NCT04707391|366129249|FG000|Overall Study|Protocol Violation|1|||
106129458|NCT04707391|366129250|FG001|Overall Study|Protocol Violation|5|||
106129459|NCT04707391|366129249|FG000|Overall Study|Withdrawal by Subject|27|||
106129460|NCT04707391|366129250|FG001|Overall Study|Withdrawal by Subject|25|||
106129461|NCT04707391|366129249|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
106129462|NCT04707391|366129250|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
106129463|NCT04707391|366129249|FG000|Overall Study|Other|0|||
106129464|NCT04707391|366129250|FG001|Overall Study|Other|2|||
106129465|NCT01347645|366129253|FG000|Overall Study|Death|1|||
106129466|NCT01347645|366129254|FG001|Overall Study|Death|5|||
106129467|NCT01347645|366129255|FG002|Overall Study|Death|2|||
106129468|NCT01347645|366129256|FG003|Overall Study|Death|7|||
105685766|NCT01128738|364512852|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
105685767|NCT01128738|364512853|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
105685768|NCT01128738|364512852|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
105685769|NCT01128738|364512853|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
105685770|NCT01128738|364512852|FG000|Second TP|Lost to Follow-up|0|||
105685771|NCT01128738|364512853|FG001|Second TP|Lost to Follow-up|1|||
105685772|NCT01128738|364512852|FG000|Second TP|Withdrawal by Subject|0|||
105685773|NCT01128738|364512853|FG001|Second TP|Withdrawal by Subject|2|||
105685774|NCT00455325|364512854|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
105685775|NCT00455325|364512855|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
105685776|NCT00455325|364512856|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
105685777|NCT00455325|364512857|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
105685778|NCT00455325|364512854|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
105685779|NCT00455325|364512855|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
105685780|NCT00455325|364512856|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
105685781|NCT00455325|364512857|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
105685782|NCT00455325|364512854|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
105685783|NCT00455325|364512855|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
105685784|NCT00455325|364512856|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
105685785|NCT00455325|364512857|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
105685786|NCT00455325|364512854|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
105685787|NCT00455325|364512855|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
105685788|NCT00455325|364512856|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
105685789|NCT00455325|364512857|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
105685790|NCT00455325|364512854|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
105685791|NCT00455325|364512855|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
106129469|NCT01347645|366129257|FG004|Overall Study|Death|7|||
105685792|NCT00455325|364512856|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
105685793|NCT00455325|364512857|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
105685794|NCT00455325|364512854|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
105685795|NCT00455325|364512855|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
105685796|NCT00455325|364512856|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
105685797|NCT00455325|364512857|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
106129470|NCT01347645|366129253|FG000|Overall Study|Lost to Follow-up|1|||
106129471|NCT01347645|366129254|FG001|Overall Study|Lost to Follow-up|1|||
106129472|NCT01347645|366129255|FG002|Overall Study|Lost to Follow-up|0|||
106129473|NCT01347645|366129256|FG003|Overall Study|Lost to Follow-up|1|||
106129474|NCT01347645|366129257|FG004|Overall Study|Lost to Follow-up|1|||
106129475|NCT01347645|366129253|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
106129476|NCT01347645|366129254|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
106129477|NCT01347645|366129255|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
106129478|NCT01347645|366129256|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
106129479|NCT01347645|366129257|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
106129480|NCT01347645|366129253|FG000|Overall Study|Other|1|||
106129481|NCT01347645|366129254|FG001|Overall Study|Other|0|||
106129482|NCT01347645|366129255|FG002|Overall Study|Other|0|||
106129483|NCT01347645|366129256|FG003|Overall Study|Other|0|||
106129484|NCT01347645|366129257|FG004|Overall Study|Other|1|||
106129485|NCT01347645|366129253|FG000|Overall Study|Withdrawal by Subject|0|||
106129486|NCT01347645|366129254|FG001|Overall Study|Withdrawal by Subject|0|||
106129487|NCT01347645|366129255|FG002|Overall Study|Withdrawal by Subject|0|||
106129488|NCT01347645|366129256|FG003|Overall Study|Withdrawal by Subject|3|||
106129489|NCT01347645|366129257|FG004|Overall Study|Withdrawal by Subject|3|||
106129490|NCT01347645|366129253|FG000|Overall Study|Physician Decision|0|||
106129491|NCT01347645|366129254|FG001|Overall Study|Physician Decision|0|||
105685798|NCT00455325|364512854|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
105685799|NCT00455325|364512855|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
105685800|NCT00455325|364512856|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
106129492|NCT01347645|366129255|FG002|Overall Study|Physician Decision|0|||
106129493|NCT01347645|366129256|FG003|Overall Study|Physician Decision|0|||
106129494|NCT01347645|366129257|FG004|Overall Study|Physician Decision|1|||
105685801|NCT00455325|364512857|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
105685802|NCT04620811|364512858|FG000|Overall Study|Withdrawal by Subject|18|||
105685803|NCT04620811|364512859|FG001|Overall Study|Withdrawal by Subject|15|||
105685804|NCT04620811|364512858|FG000|Overall Study|Adverse Event|6|||
105685805|NCT04620811|364512859|FG001|Overall Study|Adverse Event|11|||
105685806|NCT04620811|364512858|FG000|Overall Study|Lost to Follow-up|4|||
105685807|NCT04620811|364512859|FG001|Overall Study|Lost to Follow-up|8|||
105685808|NCT04620811|364512858|FG000|Overall Study|Physician Decision|1|||
105685809|NCT04620811|364512859|FG001|Overall Study|Physician Decision|4|||
105685810|NCT04620811|364512858|FG000|Overall Study|Sponsor Decision|0|||
105685811|NCT04620811|364512859|FG001|Overall Study|Sponsor Decision|1|||
105685812|NCT04620811|364512858|FG000|Overall Study|Elevation of ALT or AST|1|||
105685813|NCT04620811|364512859|FG001|Overall Study|Elevation of ALT or AST|0|||
105685814|NCT04620811|364512858|FG000|Overall Study|Other|3|||
105685815|NCT04620811|364512859|FG001|Overall Study|Other|5|||
105685816|NCT02683941|364512862|FG000|Double-blind Phase|Adverse Event|0|||
105685817|NCT02683941|364512863|FG001|Double-blind Phase|Adverse Event|1|||
105685818|NCT02683941|364512862|FG000|Double-blind Phase|Withdrawal by Subject|4|||
105685819|NCT02683941|364512863|FG001|Double-blind Phase|Withdrawal by Subject|2|||
105685820|NCT02683941|364512862|FG000|Double-blind Phase|Lost to Follow-up|1|||
105685821|NCT02683941|364512863|FG001|Double-blind Phase|Lost to Follow-up|0|||
105685822|NCT02683941|364512862|FG000|Double-blind Phase|Disease Progression|5|||
105685823|NCT02683941|364512863|FG001|Double-blind Phase|Disease Progression|2|||
105685824|NCT02683941|364512862|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
105685825|NCT02683941|364512863|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
105685826|NCT02683941|364512862|FG000|Open-label Treatment Phase|Disease Progression|1|||
105685827|NCT02683941|364512863|FG001|Open-label Treatment Phase|Disease Progression|2|||
105685828|NCT02683941|364512862|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
105685829|NCT02683941|364512863|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
105685830|NCT02683941|364512862|FG000|Open-label Treatment Phase|Other|1|||
105685831|NCT02683941|364512863|FG001|Open-label Treatment Phase|Other|0|||
105685832|NCT02683941|364512862|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
105685833|NCT02683941|364512863|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
105685834|NCT02683941|364512862|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
105685835|NCT02683941|364512863|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
105685836|NCT02683941|364512862|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
105685837|NCT02683941|364512863|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
105685838|NCT02683941|364512862|FG000|Open-label Follow-up Phase|Other|8|||
105685839|NCT02683941|364512863|FG001|Open-label Follow-up Phase|Other|1|||
105685840|NCT02168842|364512865|FG000|Overall Study|Withdrawal by Subject|5|||
105685841|NCT02168842|364512866|FG001|Overall Study|Withdrawal by Subject|3|||
105685842|NCT02168842|364512865|FG000|Overall Study|Lost to Follow-up|0|||
105685843|NCT02168842|364512866|FG001|Overall Study|Lost to Follow-up|2|||
105685844|NCT02168842|364512865|FG000|Overall Study|Death|2|||
105685845|NCT02168842|364512866|FG001|Overall Study|Death|1|||
105685846|NCT02168842|364512865|FG000|Overall Study|Physician Decision|1|||
105685847|NCT02168842|364512866|FG001|Overall Study|Physician Decision|2|||
105685848|NCT02745392|364512867|FG000|Overall Study|Lost to Follow-up|0|||
105917464|NCT03327324|365356852|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
105917465|NCT03327324|365356853|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917466|NCT03327324|365356854|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917467|NCT03327324|365356855|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917468|NCT03327324|365356856|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917469|NCT03327324|365356857|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
105917470|NCT03327324|365356852|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
105917471|NCT03327324|365356853|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
105917472|NCT03327324|365356854|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
105917473|NCT03327324|365356855|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
105917474|NCT03327324|365356856|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
106129495|NCT01347645|366129253|FG000|Overall Study|Adverse Event|0|||
106129496|NCT01347645|366129254|FG001|Overall Study|Adverse Event|0|||
106129497|NCT01347645|366129255|FG002|Overall Study|Adverse Event|0|||
106129498|NCT01347645|366129256|FG003|Overall Study|Adverse Event|1|||
105786573|NCT02147132|364872829|FG001|Overall Study|Lost to Follow-up|0|||
106129499|NCT01347645|366129257|FG004|Overall Study|Adverse Event|1|||
105685849|NCT02745392|364512868|FG001|Overall Study|Lost to Follow-up|1|||
105685850|NCT02745392|364512869|FG002|Overall Study|Lost to Follow-up|0|||
105786574|NCT02147132|364872830|FG002|Overall Study|Lost to Follow-up|0|||
105786575|NCT02147132|364872831|FG003|Overall Study|Lost to Follow-up|0|||
105786576|NCT01013207|364872832|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
105685851|NCT02745392|364512870|FG003|Overall Study|Lost to Follow-up|0|||
105685852|NCT02974088|364512871|FG000|Overall Study|Lost to Follow-up|0|||
105685853|NCT02974088|364512872|FG001|Overall Study|Lost to Follow-up|2|||
105685854|NCT02974088|364512871|FG000|Overall Study|Adverse Event|0|||
105685855|NCT02974088|364512872|FG001|Overall Study|Adverse Event|1|||
105685856|NCT00150969|364512875|FG000|24 Month Main Study|Adverse Event|3|||
105685857|NCT00150969|364512876|FG001|24 Month Main Study|Adverse Event|4|||
105685858|NCT00150969|364512875|FG000|24 Month Main Study|Death|1|||
105685859|NCT00150969|364512876|FG001|24 Month Main Study|Death|1|||
105685860|NCT00150969|364512875|FG000|24 Month Main Study|Lack of Efficacy|1|||
105685861|NCT00150969|364512876|FG001|24 Month Main Study|Lack of Efficacy|8|||
105685862|NCT00150969|364512875|FG000|24 Month Main Study|Lost to Follow-up|3|||
105685863|NCT00150969|364512876|FG001|24 Month Main Study|Lost to Follow-up|2|||
105685864|NCT00150969|364512875|FG000|24 Month Main Study|Protocol Violation|4|||
105685865|NCT00150969|364512876|FG001|24 Month Main Study|Protocol Violation|2|||
105685866|NCT00150969|364512875|FG000|24 Month Main Study|Withdrawal by Subject|7|||
105685867|NCT00150969|364512876|FG001|24 Month Main Study|Withdrawal by Subject|4|||
105685868|NCT00150969|364512875|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
105685869|NCT00150969|364512876|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
105685870|NCT00150969|364512875|FG000|24-48 Month Extension|Lack of Efficacy|0|||
105685871|NCT00150969|364512876|FG001|24-48 Month Extension|Lack of Efficacy|1|||
105685872|NCT00150969|364512875|FG000|24-48 Month Extension|Adverse Event|1|||
105685873|NCT00150969|364512876|FG001|24-48 Month Extension|Adverse Event|3|||
105685874|NCT00150969|364512875|FG000|24-48 Month Extension|Other Reason|81|||
105685875|NCT00150969|364512876|FG001|24-48 Month Extension|Other Reason|91|||
105685876|NCT01313689|364512880|FG000|24-Week Randomization 1|Adverse Event|10|||
105685877|NCT01313689|364512881|FG001|24-Week Randomization 1|Adverse Event|5|||
105685878|NCT01313689|364512882|FG002|24-Week Randomization 1|Adverse Event|0|||
105685879|NCT01313689|364512883|FG003|24-Week Randomization 1|Adverse Event|0|||
105685880|NCT01313689|364512884|FG004|24-Week Randomization 1|Adverse Event|0|||
105685881|NCT01313689|364512880|FG000|24-Week Randomization 1|Physician Decision|4|||
105917475|NCT03327324|365356857|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
105917476|NCT03327324|365356852|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
105917477|NCT03327324|365356853|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
105917478|NCT03327324|365356854|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
105917479|NCT03327324|365356855|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
106129500|NCT01192295|366129258|FG000|Overall Study|Adverse Event|3|||
106129501|NCT01192295|366129259|FG001|Overall Study|Adverse Event|7|||
106129502|NCT01192295|366129258|FG000|Overall Study|Withdrawal by Subject|3|||
106129503|NCT01192295|366129259|FG001|Overall Study|Withdrawal by Subject|4|||
106129504|NCT01192295|366129258|FG000|Overall Study|Lost to Follow-up|0|||
106129505|NCT01192295|366129259|FG001|Overall Study|Lost to Follow-up|1|||
106129506|NCT01192295|366129258|FG000|Overall Study|Lack of Efficacy|0|||
106129507|NCT01192295|366129259|FG001|Overall Study|Lack of Efficacy|5|||
106129508|NCT01192295|366129258|FG000|Overall Study|Administrative|4|||
106129509|NCT01192295|366129259|FG001|Overall Study|Administrative|6|||
106129510|NCT03673098|366131182|FG000|Overall Study|Lost to Follow-up|2|||
106129511|NCT03673098|366131183|FG001|Overall Study|Lost to Follow-up|3|||
106129512|NCT03673098|366131182|FG000|Overall Study|Withdrawal by Subject|6|||
106129513|NCT03673098|366131183|FG001|Overall Study|Withdrawal by Subject|1|||
106129514|NCT03673098|366131182|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
106129515|NCT03673098|366131183|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
106129516|NCT03850444|366131184|FG000|Overall Study|Adverse Event|16|||
106129517|NCT03850444|366131185|FG001|Overall Study|Adverse Event|10|||
106129518|NCT03850444|366131184|FG000|Overall Study|Death|87|||
106129519|NCT03850444|366131185|FG001|Overall Study|Death|107|||
106129520|NCT03850444|366131184|FG000|Overall Study|Lost to Follow-up|1|||
106129521|NCT03850444|366131185|FG001|Overall Study|Lost to Follow-up|1|||
106129522|NCT03850444|366131184|FG000|Overall Study|Withdrawal by Subject|1|||
106129523|NCT03850444|366131185|FG001|Overall Study|Withdrawal by Subject|5|||
106129524|NCT03850444|366131184|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
106129525|NCT03850444|366131185|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
106129526|NCT01118962|366131186|FG000|Overall Study|Adverse Event|2|||
106129527|NCT01118962|366131186|FG000|Overall Study|Lack of Efficacy|1|||
106129528|NCT01118962|366131186|FG000|Overall Study|Protocol Violation|1|||
106129529|NCT01118962|366131186|FG000|Overall Study|Withdrawal by Subject|4|||
106129530|NCT01118962|366131186|FG000|Overall Study|Pregnancy|1|||
106129531|NCT01118962|366131186|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
106129532|NCT00795132|366131187|FG000|Overall Study|Death|1|||
105685882|NCT01313689|364512881|FG001|24-Week Randomization 1|Physician Decision|5|||
105685883|NCT01313689|364512882|FG002|24-Week Randomization 1|Physician Decision|0|||
105685884|NCT01313689|364512883|FG003|24-Week Randomization 1|Physician Decision|0|||
105685885|NCT01313689|364512884|FG004|24-Week Randomization 1|Physician Decision|0|||
105685886|NCT01313689|364512880|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
105685887|NCT01313689|364512881|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
105685888|NCT01313689|364512882|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
105685889|NCT01313689|364512883|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
105685890|NCT01313689|364512884|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
105685891|NCT01313689|364512880|FG000|24-Week Randomization 2|Adverse Event|0|||
105685892|NCT01313689|364512881|FG001|24-Week Randomization 2|Adverse Event|0|||
105685893|NCT01313689|364512882|FG002|24-Week Randomization 2|Adverse Event|2|||
105685894|NCT01313689|364512883|FG003|24-Week Randomization 2|Adverse Event|0|||
105685895|NCT01313689|364512884|FG004|24-Week Randomization 2|Adverse Event|8|||
105685896|NCT01313689|364512880|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
105685897|NCT01313689|364512881|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
105685898|NCT01313689|364512882|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
105685899|NCT01313689|364512883|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
105685900|NCT01313689|364512884|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
105685901|NCT01313689|364512880|FG000|24-Week Randomization 2|Physician Decision|0|||
105685902|NCT01313689|364512881|FG001|24-Week Randomization 2|Physician Decision|0|||
105685903|NCT01313689|364512882|FG002|24-Week Randomization 2|Physician Decision|0|||
105685904|NCT01313689|364512883|FG003|24-Week Randomization 2|Physician Decision|0|||
105685905|NCT01313689|364512884|FG004|24-Week Randomization 2|Physician Decision|4|||
105685906|NCT02121834|364512885|FG000|Overall Study|Protocol Violation|0|||
105685907|NCT02121834|364512886|FG001|Overall Study|Protocol Violation|1|||
105685908|NCT02121834|364512887|FG002|Overall Study|Protocol Violation|0|||
105685909|NCT02121834|364512888|FG003|Overall Study|Protocol Violation|0|||
105685910|NCT02121834|364512889|FG004|Overall Study|Protocol Violation|0|||
105685911|NCT02121834|364512890|FG005|Overall Study|Protocol Violation|0|||
105685912|NCT02121834|364512891|FG006|Overall Study|Protocol Violation|0|||
105685913|NCT02121834|364512885|FG000|Overall Study|Withdrawal by Subject|0|||
105685914|NCT02121834|364512886|FG001|Overall Study|Withdrawal by Subject|1|||
105685915|NCT02121834|364512887|FG002|Overall Study|Withdrawal by Subject|1|||
105685916|NCT02121834|364512888|FG003|Overall Study|Withdrawal by Subject|0|||
105685917|NCT02121834|364512889|FG004|Overall Study|Withdrawal by Subject|0|||
105685918|NCT02121834|364512890|FG005|Overall Study|Withdrawal by Subject|0|||
105685919|NCT02121834|364512891|FG006|Overall Study|Withdrawal by Subject|0|||
105685920|NCT02121834|364512885|FG000|Overall Study|Lost to Follow-up|0|||
105685921|NCT02121834|364512886|FG001|Overall Study|Lost to Follow-up|0|||
105685922|NCT02121834|364512887|FG002|Overall Study|Lost to Follow-up|1|||
105685923|NCT02121834|364512888|FG003|Overall Study|Lost to Follow-up|0|||
105685924|NCT02121834|364512889|FG004|Overall Study|Lost to Follow-up|0|||
105685925|NCT02121834|364512890|FG005|Overall Study|Lost to Follow-up|0|||
105685926|NCT02121834|364512891|FG006|Overall Study|Lost to Follow-up|0|||
105685927|NCT00551460|364512892|FG000|Overall Study|Adverse Event|1|||
105685928|NCT00551460|364512892|FG000|Overall Study|Withdrawal by Subject|1|||
105685929|NCT00551460|364512892|FG000|Overall Study|Physician Decision|1|||
105685930|NCT00551460|364512892|FG000|Overall Study|Death|7|||
105685931|NCT00551460|364512892|FG000|Overall Study|Ineligible|4|||
105685932|NCT00551460|364512892|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
105685933|NCT02578862|364512893|FG000|Overall Study|Withdrawal by Subject|0|||
105685934|NCT02578862|364512894|FG001|Overall Study|Withdrawal by Subject|1|||
105685935|NCT02578862|364512893|FG000|Overall Study|Unplanned unilateral procedure|0|||
105685936|NCT02578862|364512894|FG001|Overall Study|Unplanned unilateral procedure|1|||
105685937|NCT02027623|364512895|FG000|Overall Study|Lost to Follow-up|3|||
105685938|NCT02027623|364512896|FG001|Overall Study|Lost to Follow-up|3|||
105685939|NCT02027623|364512895|FG000|Overall Study|Withdrawal by Subject|6|||
105685940|NCT02027623|364512896|FG001|Overall Study|Withdrawal by Subject|9|||
105685941|NCT02019927|364512897|FG000|Overall Study|Lost to Follow-up|2|||
105685942|NCT02019927|364512898|FG001|Overall Study|Lost to Follow-up|4|||
105685943|NCT02019927|364512899|FG002|Overall Study|Lost to Follow-up|1|||
105685944|NCT02019927|364512900|FG003|Overall Study|Lost to Follow-up|2|||
105685945|NCT02019927|364512901|FG004|Overall Study|Lost to Follow-up|3|||
105685946|NCT02019927|364512902|FG005|Overall Study|Lost to Follow-up|1|||
105685947|NCT02434939|364512905|FG000|Overall Study|Lack of Efficacy|34|||
105685948|NCT02434939|364512906|FG001|Overall Study|Lack of Efficacy|48|||
105685949|NCT02434939|364512905|FG000|Overall Study|Withdrawal by Subject|3|||
105685950|NCT02434939|364512906|FG001|Overall Study|Withdrawal by Subject|0|||
105685951|NCT02434939|364512905|FG000|Overall Study|Adverse Event|0|||
105685952|NCT02434939|364512906|FG001|Overall Study|Adverse Event|1|||
105685953|NCT00928447|364512909|FG000|Overall Study|Withdrawal by Subject|1|||
105685954|NCT00928447|364512909|FG000|Overall Study|Investigator's decision|1|||
105685955|NCT03021954|364512912|FG000|Overall Study|Lost to Follow-up|10|||
105685956|NCT03021954|364512913|FG001|Overall Study|Lost to Follow-up|43|||
105685957|NCT03021954|364512912|FG000|Overall Study|Subjects had avulsion trauma|4|||
105685958|NCT03021954|364512913|FG001|Overall Study|Subjects had avulsion trauma|1|||
105685959|NCT00069238|364512914|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
105685960|NCT00069238|364512915|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
105685961|NCT00069238|364512916|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
105685962|NCT00069238|364512914|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
105685963|NCT00069238|364512915|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
105685964|NCT00069238|364512916|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
105685965|NCT00069238|364512914|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
105685966|NCT00069238|364512915|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
105685967|NCT00069238|364512916|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
105685968|NCT01001832|364512917|FG000|Short-term Period|Adverse Event|2|||
105685969|NCT01001832|364512918|FG001|Short-term Period|Adverse Event|3|||
105685970|NCT01001832|364512917|FG000|Long-term Period|Adverse Event|2|||
105685971|NCT01001832|364512918|FG001|Long-term Period|Adverse Event|1|||
105685972|NCT01001832|364512917|FG000|Long-term Period|Withdrawal by Subject|1|||
105685973|NCT01001832|364512918|FG001|Long-term Period|Withdrawal by Subject|0|||
105685974|NCT01001832|364512917|FG000|Long-term Period|Lack of Efficacy|0|||
105685975|NCT01001832|364512918|FG001|Long-term Period|Lack of Efficacy|2|||
105685976|NCT01001832|364512917|FG000|Long-term Period|Other|1|||
105685977|NCT01001832|364512918|FG001|Long-term Period|Other|2|||
105685978|NCT01001832|364512917|FG000|Follow-up Period|Withdrawal by Subject|1|||
105685979|NCT01001832|364512918|FG001|Follow-up Period|Withdrawal by Subject|0|||
105685980|NCT01001832|364512917|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
105685981|NCT01001832|364512918|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
105685982|NCT01001832|364512917|FG000|Follow-up Period|Other|2|||
105685983|NCT01001832|364512918|FG001|Follow-up Period|Other|1|||
105685984|NCT00412971|364512922|FG000|Overall Study|Lost to Follow-up|17|||
105685985|NCT00412971|364512923|FG001|Overall Study|Lost to Follow-up|9|||
105685986|NCT00412971|364512922|FG000|Overall Study|Protocol Violation|13|||
105685987|NCT00412971|364512923|FG001|Overall Study|Protocol Violation|1|||
105685988|NCT00985153|364512924|FG000|Overall Study|Lost to Follow-up|16|||
105685989|NCT00985153|364512925|FG001|Overall Study|Lost to Follow-up|19|||
105685990|NCT00985153|364512926|FG002|Overall Study|Lost to Follow-up|17|||
105685991|NCT00985153|364512927|FG003|Overall Study|Lost to Follow-up|20|||
105685992|NCT00985153|364512924|FG000|Overall Study|Protocol Violation|3|||
105685993|NCT00985153|364512925|FG001|Overall Study|Protocol Violation|2|||
105685994|NCT00985153|364512926|FG002|Overall Study|Protocol Violation|4|||
105685995|NCT00985153|364512927|FG003|Overall Study|Protocol Violation|3|||
105685996|NCT00985153|364512924|FG000|Overall Study|Withdrawal by Subject|6|||
105685997|NCT00985153|364512925|FG001|Overall Study|Withdrawal by Subject|11|||
105685998|NCT00985153|364512926|FG002|Overall Study|Withdrawal by Subject|11|||
105685999|NCT00985153|364512927|FG003|Overall Study|Withdrawal by Subject|10|||
105686000|NCT00985153|364512924|FG000|Overall Study|Missed One or More Bleeds|7|||
105686001|NCT00985153|364512925|FG001|Overall Study|Missed One or More Bleeds|7|||
105686002|NCT00985153|364512926|FG002|Overall Study|Missed One or More Bleeds|8|||
105686003|NCT00985153|364512927|FG003|Overall Study|Missed One or More Bleeds|10|||
105686004|NCT00985153|364512924|FG000|Overall Study|Incomplete Safety Follow-up|3|||
105686005|NCT00985153|364512925|FG001|Overall Study|Incomplete Safety Follow-up|5|||
105686006|NCT00985153|364512926|FG002|Overall Study|Incomplete Safety Follow-up|4|||
105686007|NCT00985153|364512927|FG003|Overall Study|Incomplete Safety Follow-up|4|||
105686008|NCT00561951|364512929|FG000|Overall Study|Adverse Event|11|||
105686009|NCT00561951|364512930|FG001|Overall Study|Adverse Event|14|||
105686010|NCT00561951|364512931|FG002|Overall Study|Adverse Event|14|||
105686011|NCT00561951|364512929|FG000|Overall Study|Lack of Efficacy|5|||
105686012|NCT00561951|364512930|FG001|Overall Study|Lack of Efficacy|3|||
105686013|NCT00561951|364512931|FG002|Overall Study|Lack of Efficacy|2|||
105686014|NCT00561951|364512929|FG000|Overall Study|Lost to Follow-up|1|||
105686015|NCT00561951|364512930|FG001|Overall Study|Lost to Follow-up|1|||
105686016|NCT00561951|364512931|FG002|Overall Study|Lost to Follow-up|0|||
105686017|NCT00561951|364512929|FG000|Overall Study|Withdrawal by Subject|10|||
105686018|NCT00561951|364512930|FG001|Overall Study|Withdrawal by Subject|9|||
105686019|NCT00561951|364512931|FG002|Overall Study|Withdrawal by Subject|10|||
105686020|NCT00561951|364512929|FG000|Overall Study|Protocol Violation|4|||
105686021|NCT00561951|364512930|FG001|Overall Study|Protocol Violation|3|||
105686022|NCT00561951|364512931|FG002|Overall Study|Protocol Violation|4|||
105686023|NCT00561951|364512929|FG000|Overall Study|Physician Decision|1|||
106129533|NCT00795132|366131187|FG000|Overall Study|Relapse|2|||
106129534|NCT00765362|366131190|FG000|Overall Study|Death|9|||
106129535|NCT00765362|366131190|FG000|Overall Study|Adverse Event|2|||
106129536|NCT00765362|366131190|FG000|Overall Study|Protocol Violation|18|||
105686024|NCT00561951|364512930|FG001|Overall Study|Physician Decision|0|||
105686025|NCT00561951|364512931|FG002|Overall Study|Physician Decision|0|||
105686026|NCT00561951|364512929|FG000|Overall Study|Pregnancy|0|||
105686027|NCT00561951|364512930|FG001|Overall Study|Pregnancy|1|||
105686028|NCT00561951|364512931|FG002|Overall Study|Pregnancy|0|||
106129537|NCT00765362|366131190|FG000|Overall Study|Withdrawal by Subject|13|||
105686029|NCT00561951|364512929|FG000|Overall Study|Meet Withdrawal Criterion|0|||
105686030|NCT00561951|364512930|FG001|Overall Study|Meet Withdrawal Criterion|1|||
105686031|NCT00561951|364512931|FG002|Overall Study|Meet Withdrawal Criterion|1|||
105686032|NCT00561951|364512929|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
105686033|NCT00561951|364512930|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
105686034|NCT00561951|364512931|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
105686035|NCT04508023|364512932|FG000|Overall Study|Withdrawal by Subject|1|||
105686036|NCT04508023|364512933|FG001|Overall Study|Withdrawal by Subject|2|||
105686037|NCT02668185|364512936|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
105686038|NCT02668185|364512937|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
105686039|NCT02668185|364512936|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
105686040|NCT02668185|364512937|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
105686041|NCT02668185|364512936|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
105686042|NCT02668185|364512937|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
105686043|NCT02668185|364512936|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
105686044|NCT02668185|364512937|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
105686045|NCT01013597|364512938|FG000|Overall Study|Withdrawal by Subject|1|||
105686046|NCT02678247|364512939|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
105686047|NCT02678247|364512940|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
105686048|NCT02678247|364512939|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
105686049|NCT02678247|364512940|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
105686050|NCT02678247|364512939|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
105686051|NCT02678247|364512940|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
105686052|NCT02678247|364512939|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
105686053|NCT02678247|364512940|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
105686054|NCT02678247|364512939|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
105686055|NCT02678247|364512940|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
105686056|NCT02678247|364512939|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
105686057|NCT02678247|364512940|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
105686058|NCT01313117|364512941|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
105686059|NCT01313117|364512941|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
105686060|NCT03440320|364514571|FG000|Overall Study|Withdrawal by Subject|0|||
105686061|NCT03440320|364514572|FG001|Overall Study|Withdrawal by Subject|1|||
105686062|NCT01912456|364514573|FG000|Period 1|Physician Decision|0|||
105686063|NCT01912456|364514574|FG001|Period 1|Physician Decision|0|||
105686064|NCT01912456|364514575|FG002|Period 1|Physician Decision|1|||
105686065|NCT01912456|364514576|FG003|Period 1|Physician Decision|0|||
105686066|NCT01912456|364514573|FG000|Period 1|non-compliance|1|||
105686067|NCT01912456|364514574|FG001|Period 1|non-compliance|0|||
105686068|NCT01912456|364514575|FG002|Period 1|non-compliance|0|||
105686069|NCT01912456|364514576|FG003|Period 1|non-compliance|1|||
105686070|NCT01912456|364514573|FG000|Period 1|Adverse Event|1|||
105686071|NCT01912456|364514574|FG001|Period 1|Adverse Event|0|||
105686072|NCT01912456|364514575|FG002|Period 1|Adverse Event|0|||
105686073|NCT01912456|364514576|FG003|Period 1|Adverse Event|1|||
105686074|NCT01912456|364514573|FG000|Period 1|Withdrawal by Subject|0|||
105686075|NCT01912456|364514574|FG001|Period 1|Withdrawal by Subject|1|||
105686076|NCT01912456|364514575|FG002|Period 1|Withdrawal by Subject|1|||
105686077|NCT01912456|364514576|FG003|Period 1|Withdrawal by Subject|1|||
105686078|NCT01912456|364514573|FG000|Period 2|Lack of Efficacy|0|||
105686079|NCT01912456|364514574|FG001|Period 2|Lack of Efficacy|2|||
105686080|NCT01912456|364514575|FG002|Period 2|Lack of Efficacy|0|||
105686081|NCT01912456|364514576|FG003|Period 2|Lack of Efficacy|0|||
105686082|NCT01912456|364514573|FG000|Period 2|Adverse Event|0|||
105686083|NCT01912456|364514574|FG001|Period 2|Adverse Event|0|||
105686084|NCT01912456|364514575|FG002|Period 2|Adverse Event|0|||
105686085|NCT01912456|364514576|FG003|Period 2|Adverse Event|1|||
105686086|NCT00252733|364514585|FG000|Overall Study|Withdrawal by Subject|73|||
105686087|NCT00252733|364514586|FG001|Overall Study|Withdrawal by Subject|67|||
105686088|NCT00252733|364514585|FG000|Overall Study|Death|7|||
106129538|NCT00765362|366131190|FG000|Overall Study|Lost to Follow-up|95|||
106129539|NCT00664521|366131199|FG000|Overall Study|Adverse Event|4|||
105686089|NCT00252733|364514586|FG001|Overall Study|Death|5|||
105686090|NCT00252733|364514585|FG000|Overall Study|Lost to Follow-up|12|||
105686091|NCT00252733|364514586|FG001|Overall Study|Lost to Follow-up|6|||
105686092|NCT00252733|364514585|FG000|Overall Study|Multiple Reasons|14|||
105917480|NCT03327324|365356856|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
105917481|NCT03327324|365356857|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
105917482|NCT03327324|365356852|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917483|NCT03327324|365356853|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917484|NCT03327324|365356854|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917485|NCT03327324|365356855|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
105917486|NCT03327324|365356856|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
105952102|NCT03314935|365488198|FG014|Phase 1|Study Terminated by Sponsor|0|||
106129540|NCT00664521|366131200|FG001|Overall Study|Adverse Event|1|||
106129541|NCT00664521|366131199|FG000|Overall Study|Lost to Follow-up|1|||
105686093|NCT00252733|364514586|FG001|Overall Study|Multiple Reasons|14|||
105686094|NCT05220254|364514588|FG000|Overall Study|Withdrawal by Subject|4|||
105686095|NCT05220254|364514588|FG000|Overall Study|Removed due to ineligibility|1|||
105686096|NCT05220254|364514588|FG000|Overall Study|Lost to Follow-up|7|||
105686097|NCT01211197|364514590|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686098|NCT01211197|364514591|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686099|NCT01211197|364514592|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105686100|NCT01211197|364514593|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686101|NCT01211197|364514594|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686102|NCT01211197|364514595|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105686103|NCT01211197|364514590|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
105686104|NCT01211197|364514591|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
105686105|NCT01211197|364514592|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
105686106|NCT01211197|364514593|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
105686107|NCT01211197|364514594|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
105686108|NCT01211197|364514595|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
105686109|NCT00261846|364514596|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
105686110|NCT00261846|364514597|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
105686111|NCT00261846|364514598|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
105686112|NCT00261846|364514599|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686113|NCT00261846|364514600|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686114|NCT00261846|364514601|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686115|NCT00261846|364514602|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686116|NCT00261846|364514603|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686117|NCT00261846|364514604|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686118|NCT00261846|364514605|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686119|NCT00261846|364514606|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686120|NCT00261846|364514607|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
105686121|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686122|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686123|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686124|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
105686125|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686126|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686127|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686128|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686129|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
105686130|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686131|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686132|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
105686133|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686134|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686135|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686136|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
105686137|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
105686138|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
105686139|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
105686140|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
105686141|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686142|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
105686143|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686144|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
105686145|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686146|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686147|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686148|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
105686149|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
105686150|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686151|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
105686152|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686153|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
105917487|NCT03327324|365356857|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
105917488|NCT03327324|365356852|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
105917489|NCT03327324|365356853|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105917490|NCT03327324|365356854|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105917491|NCT03327324|365356855|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105917492|NCT03327324|365356856|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105686154|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
105686155|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
105686156|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
105686157|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
105917493|NCT03327324|365356857|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
105917494|NCT03327324|365356852|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
105917495|NCT03327324|365356853|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105917496|NCT03327324|365356854|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105917497|NCT03327324|365356855|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105917498|NCT03327324|365356856|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105917499|NCT03327324|365356857|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
105917500|NCT01103323|365356858|FG000|Without/Before Drug Switch|Adverse Event|50|||
105917501|NCT01103323|365356859|FG001|Without/Before Drug Switch|Adverse Event|7|||
105917502|NCT01103323|365356858|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
105917503|NCT01103323|365356859|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
105917504|NCT01103323|365356858|FG000|Without/Before Drug Switch|Protocol Violation|2|||
105917505|NCT01103323|365356859|FG001|Without/Before Drug Switch|Protocol Violation|0|||
105917506|NCT01103323|365356858|FG000|Without/Before Drug Switch|Physician Decision|2|||
105917507|NCT01103323|365356859|FG001|Without/Before Drug Switch|Physician Decision|0|||
105917508|NCT01103323|365356858|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
105917509|NCT01103323|365356859|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
105686158|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
105917510|NCT01103323|365356858|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
105917511|NCT01103323|365356859|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
105917512|NCT01103323|365356858|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
105917513|NCT01103323|365356859|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
105917514|NCT03217591|365356870|FG000|Overall Study|Adverse Event|1|||
105917515|NCT03217591|365356871|FG001|Overall Study|Adverse Event|2|||
105917516|NCT03217591|365356872|FG002|Overall Study|Adverse Event|6|||
105917517|NCT03217591|365356870|FG000|Overall Study|Withdrawal by Subject|0|||
105917518|NCT03217591|365356871|FG001|Overall Study|Withdrawal by Subject|1|||
105917519|NCT03217591|365356872|FG002|Overall Study|Withdrawal by Subject|3|||
105917520|NCT03217591|365356870|FG000|Overall Study|Lost to Follow-up|1|||
105917521|NCT03217591|365356871|FG001|Overall Study|Lost to Follow-up|0|||
105917522|NCT03217591|365356872|FG002|Overall Study|Lost to Follow-up|0|||
105917523|NCT03217591|365356870|FG000|Overall Study|Protocol Violation|1|||
105917524|NCT03217591|365356871|FG001|Overall Study|Protocol Violation|0|||
105917525|NCT03217591|365356872|FG002|Overall Study|Protocol Violation|1|||
105917526|NCT02475369|365356873|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
105917527|NCT02475369|365356874|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
105917528|NCT03372798|365356877|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
105917529|NCT03372798|365356878|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
105917530|NCT03372798|365356877|FG000|Overall Study|Failure of imaging probe|0|||
105917531|NCT03372798|365356878|FG001|Overall Study|Failure of imaging probe|1|||
105917532|NCT03188055|365356879|FG000|Overall Study|Unavailable for training|0|||
105917533|NCT03188055|365356880|FG001|Overall Study|Unavailable for training|0|||
105917534|NCT03188055|365356881|FG002|Overall Study|Unavailable for training|19|||
106001308|NCT00717249|365665262|FG001|Overall Study|Adverse Event|2|||
105686159|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
105686160|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
105686161|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
105686162|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
105686163|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
105686164|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
105686165|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
105686166|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
105686167|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
105686168|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
105686169|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
105686170|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
105686171|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
105686172|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
105686173|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
105686174|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
105686175|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
105686176|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
105686177|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
105686178|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
105686179|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
105686180|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
105786577|NCT01541644|364872838|FG000|Overall Study|Withdrawal by Subject|3|||
105917535|NCT03188055|365356882|FG003|Overall Study|Unavailable for training|0|||
105917536|NCT03188055|365356883|FG004|Overall Study|Unavailable for training|0|||
105917537|NCT03188055|365356884|FG005|Overall Study|Unavailable for training|0|||
105686181|NCT00261846|364514596|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
105686182|NCT00261846|364514597|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
105686183|NCT00261846|364514598|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
105686184|NCT00261846|364514599|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
105686185|NCT00261846|364514600|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
105686186|NCT00261846|364514601|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
105686187|NCT00261846|364514602|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
105686188|NCT00261846|364514603|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
105686189|NCT00261846|364514604|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
105686190|NCT00261846|364514605|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
105686191|NCT00261846|364514606|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
105686192|NCT00261846|364514607|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
105686193|NCT00325039|364514610|FG000|Overall Study|Lost to Follow-up|18|||
105686194|NCT00325039|364514611|FG001|Overall Study|Lost to Follow-up|14|||
105686195|NCT01009203|364514613|FG000|Overall Study|Withdrawal by Subject|1|||
105686196|NCT01009203|364514613|FG000|Overall Study|Adverse Event|5|||
105686197|NCT01009203|364514613|FG000|Overall Study|Treatment-unrelated death|1|||
105686198|NCT00892723|364514614|FG000|Overall Study|Lost to Follow-up|1|||
105686199|NCT00892723|364514615|FG001|Overall Study|Lost to Follow-up|3|||
105686200|NCT00892723|364514616|FG002|Overall Study|Lost to Follow-up|1|||
105686201|NCT00892723|364514614|FG000|Overall Study|Withdrawal by Subject|1|||
105686202|NCT00892723|364514615|FG001|Overall Study|Withdrawal by Subject|1|||
105686203|NCT00892723|364514616|FG002|Overall Study|Withdrawal by Subject|1|||
105686204|NCT01740323|364514624|FG000|Overall Study|Adverse Event|1|||
105686205|NCT01740323|364514625|FG001|Overall Study|Adverse Event|0|||
105686206|NCT01740323|364514624|FG000|Overall Study|Randomized but did not take study drug|1|||
105686207|NCT01740323|364514625|FG001|Overall Study|Randomized but did not take study drug|0|||
105686208|NCT02893930|364514626|FG000|Overall Study|Adverse Event|3|||
105686209|NCT02893930|364514626|FG000|Overall Study|Death|1|||
105686210|NCT02893930|364514626|FG000|Overall Study|Disease progression|5|||
105686211|NCT02893930|364514626|FG000|Overall Study|Withdrawal by Subject|2|||
105686212|NCT02893930|364514626|FG000|Overall Study|Physician Decision|1|||
105686213|NCT02893930|364514626|FG000|Overall Study|Ineligible|1|||
105686214|NCT01054846|364514627|FG000|Overall Study|Lost to Follow-up|76|||
105686215|NCT01054846|364514628|FG001|Overall Study|Lost to Follow-up|17|||
105686216|NCT02446886|364514629|FG000|Overall Study|Adverse Event|1|||
105686217|NCT02446886|364514630|FG001|Overall Study|Adverse Event|3|||
105686218|NCT02446886|364514629|FG000|Overall Study|Withdrawal by Subject|1|||
105686219|NCT02446886|364514630|FG001|Overall Study|Withdrawal by Subject|1|||
105686220|NCT01259284|364514631|FG000|Overall Study|Study Termination|2|||
105686221|NCT01259284|364514632|FG001|Overall Study|Study Termination|0|||
105786578|NCT02389621|364872839|FG000|Treatment Period|Withdrawal by Subject|1|||
105786579|NCT02389621|364872840|FG001|Treatment Period|Withdrawal by Subject|1|||
105786580|NCT02389621|364872839|FG000|Posttreatment Period|Adverse Event|3|||
105786581|NCT02389621|364872840|FG001|Posttreatment Period|Adverse Event|1|||
105917538|NCT03188055|365356879|FG000|Overall Study|Lost to Follow-up|0|||
105917539|NCT03188055|365356880|FG001|Overall Study|Lost to Follow-up|18|||
105917540|NCT03188055|365356881|FG002|Overall Study|Lost to Follow-up|0|||
105917541|NCT03188055|365356882|FG003|Overall Study|Lost to Follow-up|11|||
105917542|NCT03188055|365356883|FG004|Overall Study|Lost to Follow-up|0|||
105917543|NCT03188055|365356884|FG005|Overall Study|Lost to Follow-up|0|||
105917544|NCT03188055|365356879|FG000|Overall Study|Withdrawal by Subject|0|||
105917545|NCT03188055|365356880|FG001|Overall Study|Withdrawal by Subject|1|||
105917546|NCT03188055|365356881|FG002|Overall Study|Withdrawal by Subject|0|||
105917547|NCT03188055|365356882|FG003|Overall Study|Withdrawal by Subject|1|||
105917548|NCT03188055|365356883|FG004|Overall Study|Withdrawal by Subject|0|||
105917549|NCT03188055|365356884|FG005|Overall Study|Withdrawal by Subject|0|||
105917550|NCT00875810|365356885|FG000|Overall Study|Withdrawal by Subject|1|||
105917551|NCT00875810|365356885|FG000|Overall Study|Physician Decision|3|||
105917552|NCT00875810|365356885|FG000|Overall Study|Lost to Follow-up|39|||
105917553|NCT00875810|365356885|FG000|Overall Study|Patient enroled but not implanted|2|||
105917554|NCT00875810|365356885|FG000|Overall Study|Device explanted|1|||
105917555|NCT01204671|365356890|FG000|Overall Study|Adverse Event|4|||
105917556|NCT01204671|365356891|FG001|Overall Study|Adverse Event|3|||
105917557|NCT01204671|365356892|FG002|Overall Study|Adverse Event|3|||
105917558|NCT01204671|365356893|FG003|Overall Study|Adverse Event|3|||
105917559|NCT01204671|365356894|FG004|Overall Study|Adverse Event|1|||
105917560|NCT01204671|365356890|FG000|Overall Study|Withdrawal by Subject|2|||
105917561|NCT01204671|365356891|FG001|Overall Study|Withdrawal by Subject|3|||
106129542|NCT00664521|366131200|FG001|Overall Study|Lost to Follow-up|0|||
106129543|NCT00664521|366131199|FG000|Overall Study|Other|1|||
105686222|NCT01259284|364514633|FG002|Overall Study|Study Termination|0|||
105686223|NCT01668667|364514634|FG000|Overall Study|Adverse Event|3|||
105686224|NCT01668667|364514635|FG001|Overall Study|Adverse Event|6|||
105686225|NCT01668667|364514636|FG002|Overall Study|Adverse Event|4|||
105686226|NCT01668667|364514637|FG003|Overall Study|Adverse Event|4|||
105686227|NCT01668667|364514634|FG000|Overall Study|Lack of Efficacy|3|||
105686228|NCT01668667|364514635|FG001|Overall Study|Lack of Efficacy|2|||
105686229|NCT01668667|364514636|FG002|Overall Study|Lack of Efficacy|2|||
105686230|NCT01668667|364514637|FG003|Overall Study|Lack of Efficacy|3|||
105686231|NCT01668667|364514634|FG000|Overall Study|Protocol Violation|6|||
105686232|NCT01668667|364514635|FG001|Overall Study|Protocol Violation|10|||
105917562|NCT01204671|365356892|FG002|Overall Study|Withdrawal by Subject|4|||
105917563|NCT01204671|365356893|FG003|Overall Study|Withdrawal by Subject|5|||
105917564|NCT01204671|365356894|FG004|Overall Study|Withdrawal by Subject|3|||
105917565|NCT01204671|365356890|FG000|Overall Study|Lost to Follow-up|7|||
105917566|NCT01204671|365356891|FG001|Overall Study|Lost to Follow-up|8|||
105917567|NCT01204671|365356892|FG002|Overall Study|Lost to Follow-up|6|||
106129544|NCT00664521|366131200|FG001|Overall Study|Other|0|||
106129545|NCT02459964|366131201|FG000|Overall Study|Withdrawal by Subject|0|||
106129546|NCT02459964|366131202|FG001|Overall Study|Withdrawal by Subject|0|||
106129547|NCT02459964|366131203|FG002|Overall Study|Withdrawal by Subject|1|||
106129548|NCT02459964|366131201|FG000|Overall Study|Abnormal EKG changes|0|||
106129549|NCT02459964|366131202|FG001|Overall Study|Abnormal EKG changes|0|||
106129550|NCT02459964|366131203|FG002|Overall Study|Abnormal EKG changes|1|||
106129551|NCT00367237|366131204|FG000|Overall Study|Adverse Event|7|||
106129552|NCT00367237|366131205|FG001|Overall Study|Adverse Event|2|||
106129553|NCT00367237|366131204|FG000|Overall Study|Lost to Follow-up|1|||
106129554|NCT00367237|366131205|FG001|Overall Study|Lost to Follow-up|0|||
106129555|NCT00367237|366131204|FG000|Overall Study|Withdrawal by Subject|0|||
106129556|NCT00367237|366131205|FG001|Overall Study|Withdrawal by Subject|4|||
106129557|NCT00367237|366131204|FG000|Overall Study|Protocol Violation|2|||
106129558|NCT00367237|366131205|FG001|Overall Study|Protocol Violation|5|||
106129559|NCT02886728|366131207|FG000|Overall Study|Withdrew Consent|31|||
106129560|NCT02886728|366131208|FG001|Overall Study|Withdrew Consent|13|||
106129561|NCT02886728|366131209|FG002|Overall Study|Withdrew Consent|11|||
106129562|NCT02886728|366131210|FG003|Overall Study|Withdrew Consent|47|||
106129563|NCT02886728|366131207|FG000|Overall Study|Lost to Follow-up|12|||
106129564|NCT02886728|366131208|FG001|Overall Study|Lost to Follow-up|6|||
106129565|NCT02886728|366131209|FG002|Overall Study|Lost to Follow-up|13|||
106129566|NCT02886728|366131210|FG003|Overall Study|Lost to Follow-up|12|||
106129567|NCT02886728|366131207|FG000|Overall Study|Adverse Event|13|||
106129568|NCT02886728|366131208|FG001|Overall Study|Adverse Event|5|||
106129569|NCT02886728|366131209|FG002|Overall Study|Adverse Event|5|||
106129570|NCT02886728|366131210|FG003|Overall Study|Adverse Event|11|||
106129571|NCT02886728|366131207|FG000|Overall Study|Investigator's Discretion|11|||
106129572|NCT02886728|366131208|FG001|Overall Study|Investigator's Discretion|7|||
106129573|NCT02886728|366131209|FG002|Overall Study|Investigator's Discretion|5|||
106129574|NCT02886728|366131210|FG003|Overall Study|Investigator's Discretion|11|||
106129575|NCT02886728|366131207|FG000|Overall Study|Death|3|||
106129576|NCT02886728|366131208|FG001|Overall Study|Death|1|||
106129577|NCT02886728|366131209|FG002|Overall Study|Death|0|||
106129578|NCT02886728|366131210|FG003|Overall Study|Death|0|||
106129579|NCT02886728|366131207|FG000|Overall Study|Protocol Violation|0|||
106129580|NCT02886728|366131208|FG001|Overall Study|Protocol Violation|0|||
106129581|NCT02886728|366131209|FG002|Overall Study|Protocol Violation|0|||
106129582|NCT02886728|366131210|FG003|Overall Study|Protocol Violation|4|||
106129583|NCT02886728|366131207|FG000|Overall Study|Non-Compliance with Study Drug|1|||
106129584|NCT02886728|366131208|FG001|Overall Study|Non-Compliance with Study Drug|0|||
106129585|NCT02886728|366131209|FG002|Overall Study|Non-Compliance with Study Drug|1|||
106129586|NCT02886728|366131210|FG003|Overall Study|Non-Compliance with Study Drug|0|||
106129587|NCT02886728|366131207|FG000|Overall Study|Pregnancy|0|||
106129588|NCT02886728|366131208|FG001|Overall Study|Pregnancy|0|||
106129589|NCT02886728|366131209|FG002|Overall Study|Pregnancy|1|||
106129590|NCT02886728|366131210|FG003|Overall Study|Pregnancy|0|||
106129591|NCT02886728|366131207|FG000|Overall Study|Randomized but Not Dosed|1|||
106129592|NCT02886728|366131208|FG001|Overall Study|Randomized but Not Dosed|0|||
106129593|NCT02886728|366131209|FG002|Overall Study|Randomized but Not Dosed|0|||
106129594|NCT02886728|366131210|FG003|Overall Study|Randomized but Not Dosed|2|||
106129595|NCT04004208|366131217|FG000|Overall Study|Withdrawal by parent/guardian|1|||
106129596|NCT04004208|366131218|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106129597|NCT04004208|366131217|FG000|Overall Study|Death|3|||
106129598|NCT04004208|366131218|FG001|Overall Study|Death|0|||
106129599|NCT04004208|366131217|FG000|Overall Study|COVID-19 pandemic|1|||
106129600|NCT04004208|366131218|FG001|Overall Study|COVID-19 pandemic|0|||
106129601|NCT04004208|366131217|FG000|Overall Study|Physician Decision|1|||
106129602|NCT04004208|366131218|FG001|Overall Study|Physician Decision|0|||
106129603|NCT04004208|366131217|FG000|Overall Study|Adverse Event|1|||
106129604|NCT04004208|366131218|FG001|Overall Study|Adverse Event|1|||
106129605|NCT01458249|366131220|FG000|Overall Study|Not treated|1|||
106129606|NCT01458249|366131220|FG000|Overall Study|Adverse Event|4|||
106129607|NCT01458249|366131220|FG000|Overall Study|Other|2|||
106129608|NCT01458249|366131220|FG000|Overall Study|Ongoing|1|||
105917568|NCT01204671|365356893|FG003|Overall Study|Lost to Follow-up|4|||
105917569|NCT01204671|365356894|FG004|Overall Study|Lost to Follow-up|0|||
106129609|NCT04990440|366131221|FG000|Overall Study|Sponsor's Decision|0|||
106129610|NCT04990440|366131222|FG001|Overall Study|Sponsor's Decision|0|||
105917570|NCT01204671|365356890|FG000|Overall Study|Unknown Completion Status|1|||
106129611|NCT04990440|366131223|FG002|Overall Study|Sponsor's Decision|1|||
106129612|NCT03712098|366131224|FG000|Overall Study|Lost to Follow-up|3|||
106129613|NCT03712098|366131225|FG001|Overall Study|Lost to Follow-up|7|||
106129614|NCT03712098|366131224|FG000|Overall Study|Withdrawal by Subject|9|||
106129615|NCT03712098|366131225|FG001|Overall Study|Withdrawal by Subject|4|||
105686233|NCT01668667|364514636|FG002|Overall Study|Protocol Violation|12|||
105686234|NCT01668667|364514637|FG003|Overall Study|Protocol Violation|5|||
105686235|NCT01668667|364514634|FG000|Overall Study|Lost to Follow-up|9|||
105686236|NCT01668667|364514635|FG001|Overall Study|Lost to Follow-up|4|||
105686237|NCT01668667|364514636|FG002|Overall Study|Lost to Follow-up|7|||
105686238|NCT01668667|364514637|FG003|Overall Study|Lost to Follow-up|6|||
105686239|NCT01668667|364514634|FG000|Overall Study|Physician Decision|3|||
105686240|NCT01668667|364514635|FG001|Overall Study|Physician Decision|0|||
105686241|NCT01668667|364514636|FG002|Overall Study|Physician Decision|1|||
105686242|NCT01668667|364514637|FG003|Overall Study|Physician Decision|0|||
105686243|NCT01668667|364514634|FG000|Overall Study|Withdrawal by Subject|7|||
105686244|NCT01668667|364514635|FG001|Overall Study|Withdrawal by Subject|4|||
105686245|NCT01668667|364514636|FG002|Overall Study|Withdrawal by Subject|5|||
105686246|NCT01668667|364514637|FG003|Overall Study|Withdrawal by Subject|5|||
105686247|NCT01281969|364514641|FG000|Overall Study|not randomized didn't meet criteria|0|||
105686248|NCT01281969|364514642|FG001|Overall Study|not randomized didn't meet criteria|0|||
105686249|NCT01281969|364514643|FG002|Overall Study|not randomized didn't meet criteria|7|||
105686250|NCT01281969|364514641|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
105686251|NCT01281969|364514642|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
105686252|NCT01281969|364514643|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
105686253|NCT01281969|364514641|FG000|Overall Study|not randomized, child consent not given|0|||
105686254|NCT01281969|364514642|FG001|Overall Study|not randomized, child consent not given|0|||
105686255|NCT01281969|364514643|FG002|Overall Study|not randomized, child consent not given|2|||
105686256|NCT01074216|364514644|FG000|Overall Study|Physician Decision|1|||
105686257|NCT01074216|364514644|FG000|Overall Study|Not Treated|12|||
105686258|NCT01723254|364514645|FG000|Overall Study|Conflict with work schedule|0|||
105686259|NCT01723254|364514646|FG001|Overall Study|Conflict with work schedule|0|||
105686260|NCT01723254|364514647|FG002|Overall Study|Conflict with work schedule|0|||
105686261|NCT01723254|364514648|FG003|Overall Study|Conflict with work schedule|0|||
105686262|NCT01723254|364514649|FG004|Overall Study|Conflict with work schedule|0|||
105686263|NCT01723254|364514650|FG005|Overall Study|Conflict with work schedule|0|||
105686264|NCT01723254|364514651|FG006|Overall Study|Conflict with work schedule|0|||
105686265|NCT01723254|364514652|FG007|Overall Study|Conflict with work schedule|1|||
105686266|NCT01723254|364514645|FG000|Overall Study|Personal issues|0|||
105686267|NCT01723254|364514646|FG001|Overall Study|Personal issues|0|||
105686268|NCT01723254|364514647|FG002|Overall Study|Personal issues|0|||
105686269|NCT01723254|364514648|FG003|Overall Study|Personal issues|0|||
105686270|NCT01723254|364514649|FG004|Overall Study|Personal issues|0|||
105686271|NCT01723254|364514650|FG005|Overall Study|Personal issues|1|||
105686272|NCT01723254|364514651|FG006|Overall Study|Personal issues|0|||
105686273|NCT01723254|364514652|FG007|Overall Study|Personal issues|0|||
105686274|NCT01723254|364514645|FG000|Overall Study|No longer have time to participate|0|||
105686275|NCT01723254|364514646|FG001|Overall Study|No longer have time to participate|0|||
105686276|NCT01723254|364514647|FG002|Overall Study|No longer have time to participate|0|||
105686277|NCT01723254|364514648|FG003|Overall Study|No longer have time to participate|1|||
105686278|NCT01723254|364514649|FG004|Overall Study|No longer have time to participate|0|||
105686279|NCT01723254|364514650|FG005|Overall Study|No longer have time to participate|0|||
105686280|NCT01723254|364514651|FG006|Overall Study|No longer have time to participate|0|||
105686281|NCT01723254|364514652|FG007|Overall Study|No longer have time to participate|0|||
105686282|NCT01723254|364514645|FG000|Overall Study|Move/Left to another country/city|0|||
105686283|NCT01723254|364514646|FG001|Overall Study|Move/Left to another country/city|0|||
105686284|NCT01723254|364514647|FG002|Overall Study|Move/Left to another country/city|2|||
105686285|NCT01723254|364514648|FG003|Overall Study|Move/Left to another country/city|1|||
105686286|NCT01723254|364514649|FG004|Overall Study|Move/Left to another country/city|1|||
105686287|NCT01723254|364514650|FG005|Overall Study|Move/Left to another country/city|0|||
105686288|NCT01723254|364514651|FG006|Overall Study|Move/Left to another country/city|0|||
105686289|NCT01723254|364514652|FG007|Overall Study|Move/Left to another country/city|0|||
105686290|NCT01723254|364514645|FG000|Overall Study|Protocol Violation|0|||
105686291|NCT01723254|364514646|FG001|Overall Study|Protocol Violation|1|||
105686292|NCT01723254|364514647|FG002|Overall Study|Protocol Violation|0|||
105686293|NCT01723254|364514648|FG003|Overall Study|Protocol Violation|0|||
106129616|NCT03712098|366131224|FG000|Overall Study|Protocol Violation|2|||
105686294|NCT01723254|364514649|FG004|Overall Study|Protocol Violation|0|||
105686295|NCT01723254|364514650|FG005|Overall Study|Protocol Violation|0|||
106129617|NCT03712098|366131225|FG001|Overall Study|Protocol Violation|1|||
105686296|NCT01723254|364514651|FG006|Overall Study|Protocol Violation|0|||
105686297|NCT01723254|364514652|FG007|Overall Study|Protocol Violation|0|||
105686298|NCT01723254|364514645|FG000|Overall Study|Withdrawal by Subject|1|||
105686299|NCT01723254|364514646|FG001|Overall Study|Withdrawal by Subject|2|||
105686300|NCT01723254|364514647|FG002|Overall Study|Withdrawal by Subject|1|||
105686301|NCT01723254|364514648|FG003|Overall Study|Withdrawal by Subject|0|||
105686302|NCT01723254|364514649|FG004|Overall Study|Withdrawal by Subject|1|||
105686303|NCT01723254|364514650|FG005|Overall Study|Withdrawal by Subject|1|||
105686304|NCT01723254|364514651|FG006|Overall Study|Withdrawal by Subject|1|||
105686305|NCT01723254|364514652|FG007|Overall Study|Withdrawal by Subject|2|||
106129618|NCT02724020|366131232|FG000|Overall Study|Death|16|||
105686306|NCT01323634|364514653|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
105686307|NCT01323634|364514654|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
105686308|NCT01323634|364514655|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
106001309|NCT00717249|365665261|FG000|Overall Study|Lost to Follow-up|2|||
106129619|NCT02724020|366131233|FG001|Overall Study|Death|18|||
106129620|NCT02724020|366131234|FG002|Overall Study|Death|19|||
106129621|NCT02724020|366131232|FG000|Overall Study|Lost to Follow-up|0|||
106129622|NCT02724020|366131233|FG001|Overall Study|Lost to Follow-up|3|||
106129623|NCT02724020|366131234|FG002|Overall Study|Lost to Follow-up|0|||
106129624|NCT02724020|366131232|FG000|Overall Study|Site Terminated by Sponsor|15|||
106129625|NCT02724020|366131233|FG001|Overall Study|Site Terminated by Sponsor|8|||
106129626|NCT02724020|366131234|FG002|Overall Study|Site Terminated by Sponsor|8|||
106129627|NCT02724020|366131232|FG000|Overall Study|Withdrawal by Subject|1|||
106129628|NCT02724020|366131233|FG001|Overall Study|Withdrawal by Subject|3|||
106129629|NCT02724020|366131234|FG002|Overall Study|Withdrawal by Subject|5|||
106129630|NCT00425503|366131235|FG000|Overall Study|Adverse Event|2|||
106129631|NCT00425503|366131235|FG000|Overall Study|Protocol Violation|1|||
106129632|NCT00594932|366131236|FG000|First 3 Months|Withdrawal by Subject|1|||
106129633|NCT00594932|366131237|FG001|First 3 Months|Withdrawal by Subject|3|||
106129634|NCT00594932|366131236|FG000|Final 3 Months|Withdrawal by Subject|4|||
106129635|NCT00594932|366131237|FG001|Final 3 Months|Withdrawal by Subject|3|||
106129636|NCT01052662|366131242|FG000|Overall Study|Lost to Follow-up|15|||
106129637|NCT01052662|366131243|FG001|Overall Study|Lost to Follow-up|13|||
106129638|NCT01052662|366131244|FG002|Overall Study|Lost to Follow-up|18|||
106129639|NCT01052662|366131242|FG000|Overall Study|Withdrawal by Subject|3|||
106129640|NCT01052662|366131243|FG001|Overall Study|Withdrawal by Subject|2|||
106129641|NCT01052662|366131244|FG002|Overall Study|Withdrawal by Subject|1|||
106129642|NCT01052662|366131242|FG000|Overall Study|Pharmacy issue|1|||
106129643|NCT01052662|366131243|FG001|Overall Study|Pharmacy issue|3|||
106129644|NCT01052662|366131244|FG002|Overall Study|Pharmacy issue|3|||
106129645|NCT01052662|366131242|FG000|Overall Study|Adverse Event|1|||
106129646|NCT01052662|366131243|FG001|Overall Study|Adverse Event|1|||
106129647|NCT01052662|366131244|FG002|Overall Study|Adverse Event|0|||
106129648|NCT01052662|366131242|FG000|Overall Study|Legal Problem|2|||
106129649|NCT01052662|366131243|FG001|Overall Study|Legal Problem|0|||
106129650|NCT01052662|366131244|FG002|Overall Study|Legal Problem|0|||
106129651|NCT01052662|366131242|FG000|Overall Study|Administrative|0|||
106129652|NCT01052662|366131243|FG001|Overall Study|Administrative|3|||
106129653|NCT01052662|366131244|FG002|Overall Study|Administrative|0|||
106129654|NCT02015663|366131245|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
106129655|NCT02015663|366131246|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
106129656|NCT02015663|366131245|FG000|Overall Study|Withdrawal by Subject|1|||
106129657|NCT02015663|366131246|FG001|Overall Study|Withdrawal by Subject|0|||
106129658|NCT02015663|366131245|FG000|Overall Study|Protocol Violation|0|||
106129659|NCT02015663|366131246|FG001|Overall Study|Protocol Violation|1|||
106129660|NCT02015663|366131245|FG000|Overall Study|Adverse Event|3|||
106129661|NCT02015663|366131246|FG001|Overall Study|Adverse Event|0|||
106129662|NCT02015663|366131245|FG000|Overall Study|Administrative problems|10|||
106129663|NCT02015663|366131246|FG001|Overall Study|Administrative problems|11|||
106129664|NCT02015195|366131249|FG000|Overall Study|Adverse Event|0|||
106129665|NCT02015195|366131250|FG001|Overall Study|Adverse Event|0|||
106129666|NCT02015195|366131251|FG002|Overall Study|Adverse Event|0|||
106129667|NCT02015195|366131252|FG003|Overall Study|Adverse Event|1|||
106129668|NCT02015195|366131253|FG004|Overall Study|Adverse Event|0|||
106129669|NCT02015195|366131254|FG005|Overall Study|Adverse Event|0|||
106129670|NCT02015195|366131255|FG006|Overall Study|Adverse Event|0|||
106129671|NCT01318811|366131256|FG000|Overall Study|Physician Decision|1|||
106129672|NCT01318811|366131257|FG001|Overall Study|Physician Decision|1|||
106129673|NCT01318811|366131256|FG000|Overall Study|CRRT stopped for head CT|0|||
106129674|NCT01318811|366131257|FG001|Overall Study|CRRT stopped for head CT|1|||
106129675|NCT01318811|366131256|FG000|Overall Study|Death|0|||
106129676|NCT01318811|366131257|FG001|Overall Study|Death|1|||
106129677|NCT01318811|366131256|FG000|Overall Study|CRRT stopped for head MRI|0|||
106129678|NCT01318811|366131257|FG001|Overall Study|CRRT stopped for head MRI|1|||
106001310|NCT00717249|365665262|FG001|Overall Study|Lost to Follow-up|0|||
106001311|NCT00717249|365665261|FG000|Overall Study|Withdrawal by Subject|1|||
106129679|NCT00131911|366131258|FG000|Overall Study|Withdrawal by Subject|1|||
106129680|NCT00131911|366131259|FG001|Overall Study|Withdrawal by Subject|0|||
106129681|NCT00162942|366131261|FG000|Overall Study|Adverse Event|10|||
106129682|NCT00162942|366131262|FG001|Overall Study|Adverse Event|6|||
106129683|NCT00162942|366131261|FG000|Overall Study|Death|1|||
106129684|NCT00162942|366131262|FG001|Overall Study|Death|0|||
106129685|NCT00162942|366131261|FG000|Overall Study|Withdrawal by Subject|3|||
106129686|NCT00162942|366131262|FG001|Overall Study|Withdrawal by Subject|6|||
106129687|NCT00162942|366131261|FG000|Overall Study|Physician Decision|1|||
106129688|NCT00162942|366131262|FG001|Overall Study|Physician Decision|0|||
106129689|NCT00162942|366131261|FG000|Overall Study|Enter Open-Label Study|76|||
106129690|NCT00162942|366131262|FG001|Overall Study|Enter Open-Label Study|35|||
105686309|NCT01323634|364514653|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
105686310|NCT01323634|364514654|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
105686311|NCT01323634|364514655|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
105686312|NCT01323634|364514653|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
105686313|NCT01323634|364514654|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105686314|NCT01323634|364514655|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105686315|NCT01323634|364514653|FG000|2-week Run-in Period|Physician Decision|5|||
105686316|NCT01323634|364514654|FG001|2-week Run-in Period|Physician Decision|0|||
105686317|NCT01323634|364514655|FG002|2-week Run-in Period|Physician Decision|0|||
105686318|NCT01323634|364514653|FG000|2-week Run-in Period|Protocol Violation|1|||
105686319|NCT01323634|364514654|FG001|2-week Run-in Period|Protocol Violation|0|||
105686320|NCT01323634|364514655|FG002|2-week Run-in Period|Protocol Violation|0|||
105686321|NCT01323634|364514653|FG000|2-week Run-in Period|Adverse Event|1|||
105686322|NCT01323634|364514654|FG001|2-week Run-in Period|Adverse Event|0|||
105686323|NCT01323634|364514655|FG002|2-week Run-in Period|Adverse Event|0|||
105686324|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105686325|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
105686326|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
105686327|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105686328|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105686329|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
105686330|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105686331|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
105686332|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
105686333|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105686334|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
105686335|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
105686336|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
105686337|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
105686338|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
105686339|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105686340|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
105686341|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
105686342|NCT01323634|364514653|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
105686343|NCT01323634|364514654|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
105686344|NCT01323634|364514655|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
105686345|NCT04640077|364514656|FG000|Period 1|Withdrawal by Subject|4|||
105686346|NCT04640077|364514657|FG001|Period 1|Withdrawal by Subject|5|||
105686347|NCT04640077|364514658|FG002|Period 1|Withdrawal by Subject|0|||
105686348|NCT04640077|364514656|FG000|Period 1|Adverse Event|1|||
105686349|NCT04640077|364514657|FG001|Period 1|Adverse Event|1|||
105686350|NCT04640077|364514658|FG002|Period 1|Adverse Event|0|||
105686351|NCT04640077|364514656|FG000|Period 1|Screen Failure|2|||
105686352|NCT04640077|364514657|FG001|Period 1|Screen Failure|0|||
105686353|NCT04640077|364514658|FG002|Period 1|Screen Failure|0|||
105686354|NCT04640077|364514656|FG000|Period 2|Withdrawal by Subject|0|||
105686355|NCT04640077|364514657|FG001|Period 2|Withdrawal by Subject|0|||
105686356|NCT04640077|364514658|FG002|Period 2|Withdrawal by Subject|18|||
105686357|NCT04640077|364514656|FG000|Period 2|Adverse Event|0|||
105686358|NCT04640077|364514657|FG001|Period 2|Adverse Event|0|||
105686359|NCT04640077|364514658|FG002|Period 2|Adverse Event|6|||
105686360|NCT04640077|364514656|FG000|Period 2|Lost to Follow-up|0|||
105686361|NCT04640077|364514657|FG001|Period 2|Lost to Follow-up|0|||
105686362|NCT04640077|364514658|FG002|Period 2|Lost to Follow-up|2|||
105686363|NCT04640077|364514656|FG000|Period 2|Death|0|||
105686364|NCT04640077|364514657|FG001|Period 2|Death|0|||
105686365|NCT04640077|364514658|FG002|Period 2|Death|2|||
105686366|NCT04640077|364514656|FG000|Period 2|Progressive Disease|0|||
105686367|NCT04640077|364514657|FG001|Period 2|Progressive Disease|0|||
105686368|NCT04640077|364514658|FG002|Period 2|Progressive Disease|1|||
105686369|NCT04640077|364514656|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
105686370|NCT04640077|364514657|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
105686371|NCT04640077|364514658|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
105686372|NCT05056987|364514659|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
105686373|NCT05056987|364514660|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
105686374|NCT05056987|364514659|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
105686375|NCT05056987|364514660|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
105686376|NCT01759407|364514662|FG000|Overall Study|Protocol Violation|0|||
105686377|NCT01759407|364514663|FG001|Overall Study|Protocol Violation|2|||
105686378|NCT00753272|364514670|FG000|Overall Study|Adverse Event|878|||
105686379|NCT00753272|364514671|FG001|Overall Study|Adverse Event|869|||
105686380|NCT00753272|364514670|FG000|Overall Study|Protocol Violation|28|||
105686381|NCT00753272|364514671|FG001|Overall Study|Protocol Violation|46|||
105686382|NCT00753272|364514670|FG000|Overall Study|Withdrawal by Subject|2481|||
105917571|NCT01204671|365356891|FG001|Overall Study|Unknown Completion Status|1|||
105686383|NCT00753272|364514671|FG001|Overall Study|Withdrawal by Subject|2407|||
105686384|NCT00753272|364514670|FG000|Overall Study|Lost to Follow-up|491|||
105686385|NCT00753272|364514671|FG001|Overall Study|Lost to Follow-up|497|||
105686386|NCT00753272|364514670|FG000|Overall Study|Other|1104|||
105686387|NCT00753272|364514671|FG001|Overall Study|Other|1088|||
105686388|NCT02092220|364514674|FG000|Period 1|Unrelated Illness|0|||
105686389|NCT02092220|364514675|FG001|Period 1|Unrelated Illness|2|||
105686390|NCT02092220|364514674|FG000|Period 2|Severe Hypoglycaemia|1|||
105686391|NCT02092220|364514675|FG001|Period 2|Severe Hypoglycaemia|0|||
105686392|NCT02092220|364514674|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
105686393|NCT02092220|364514675|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
105686394|NCT02225353|364514676|FG000|Overall Study|Lost to Follow-up|0|||
105686395|NCT02225353|364514677|FG001|Overall Study|Lost to Follow-up|1|||
105686396|NCT02225353|364514678|FG002|Overall Study|Lost to Follow-up|3|||
105686397|NCT02225353|364514676|FG000|Overall Study|Protocol Violation|4|||
105686398|NCT02225353|364514677|FG001|Overall Study|Protocol Violation|5|||
105686399|NCT02225353|364514678|FG002|Overall Study|Protocol Violation|12|||
105686400|NCT01117857|364514679|FG000|Overall Study|Lost to Follow-up|4|||
105686401|NCT01117857|364514679|FG000|Overall Study|Withdrawal by Subject|4|||
105686402|NCT01117857|364514679|FG000|Overall Study|Physician Decision|1|||
105686403|NCT01119001|364514680|FG000|Overall Study|Withdrawal by Subject|2|||
105686404|NCT00633061|364514681|FG000|Overall Study|Study closed|86|||
105686405|NCT00633061|364514682|FG001|Overall Study|Study closed|0|||
105686406|NCT05245097|364514683|FG000|Overall Study|Adverse Event|13|||
105686407|NCT05245097|364514684|FG001|Overall Study|Adverse Event|2|||
105686408|NCT05245097|364514683|FG000|Overall Study|Protocol Violation|8|||
105686409|NCT05245097|364514684|FG001|Overall Study|Protocol Violation|6|||
105686410|NCT05245097|364514683|FG000|Overall Study|Withdrawal by Subject|18|||
105686411|NCT05245097|364514684|FG001|Overall Study|Withdrawal by Subject|0|||
105686412|NCT05245097|364514683|FG000|Overall Study|Death|6|||
105686413|NCT05245097|364514684|FG001|Overall Study|Death|7|||
105686414|NCT05245097|364514683|FG000|Overall Study|Physician Decision|6|||
105686415|NCT05245097|364514684|FG001|Overall Study|Physician Decision|0|||
105686416|NCT05245097|364514683|FG000|Overall Study|Relocation|4|||
105686417|NCT05245097|364514684|FG001|Overall Study|Relocation|3|||
105686418|NCT05543187|364514685|FG000|Overall Study|Ongoing|3|||
105686419|NCT05543187|364514686|FG001|Overall Study|Ongoing|2|||
105686420|NCT03254485|364514692|FG000|Overall Study|Adverse Event|3|||
105786582|NCT02389621|364872839|FG000|Posttreatment Period|Withdrawal by Subject|3|||
105917572|NCT01204671|365356892|FG002|Overall Study|Unknown Completion Status|0|||
105917573|NCT01204671|365356893|FG003|Overall Study|Unknown Completion Status|0|||
105917574|NCT01204671|365356894|FG004|Overall Study|Unknown Completion Status|0|||
105917575|NCT01204671|365356890|FG000|Overall Study|Physician Decision|0|||
105917576|NCT01204671|365356891|FG001|Overall Study|Physician Decision|0|||
105917577|NCT01204671|365356892|FG002|Overall Study|Physician Decision|0|||
105917578|NCT01204671|365356893|FG003|Overall Study|Physician Decision|1|||
105917579|NCT01204671|365356894|FG004|Overall Study|Physician Decision|0|||
106129691|NCT00162942|366131261|FG000|Overall Study|Alternate Therapy|6|||
106129692|NCT00162942|366131262|FG001|Overall Study|Alternate Therapy|2|||
106129693|NCT00162942|366131261|FG000|Overall Study|Lack of Efficacy|1|||
106129694|NCT00162942|366131262|FG001|Overall Study|Lack of Efficacy|0|||
106129695|NCT00162942|366131261|FG000|Overall Study|Flare During Active Treatment|7|||
106129696|NCT00162942|366131262|FG001|Overall Study|Flare During Active Treatment|3|||
106129697|NCT00162942|366131261|FG000|Overall Study|2 or more consecutive treatments missed|1|||
106129698|NCT00162942|366131262|FG001|Overall Study|2 or more consecutive treatments missed|0|||
106129699|NCT01253200|366131263|FG000|Overall Study|Death|1|||
106129700|NCT01253200|366131264|FG001|Overall Study|Death|0|||
106129701|NCT01253200|366131265|FG002|Overall Study|Death|0|||
106129702|NCT01253200|366131266|FG003|Overall Study|Death|0|||
106129703|NCT01253200|366131267|FG004|Overall Study|Death|0|||
106129704|NCT01253200|366131263|FG000|Overall Study|Lost to Follow-up|1|||
106129705|NCT01253200|366131264|FG001|Overall Study|Lost to Follow-up|1|||
106129706|NCT01253200|366131265|FG002|Overall Study|Lost to Follow-up|0|||
105917580|NCT01316224|365356895|FG000|Overall Study|Protocol Violation|3|||
105917581|NCT01316224|365356895|FG000|Overall Study|Adverse Event|3|||
105917582|NCT01316224|365356895|FG000|Overall Study|Lack of Efficacy|1|||
105686421|NCT03254485|364514693|FG001|Overall Study|Adverse Event|0|||
105686422|NCT03254485|364514694|FG002|Overall Study|Adverse Event|0|||
105686423|NCT03254485|364514695|FG003|Overall Study|Adverse Event|6|||
105686424|NCT03254485|364514692|FG000|Overall Study|Protocol Violation|6|||
105686425|NCT03254485|364514693|FG001|Overall Study|Protocol Violation|0|||
105686426|NCT03254485|364514694|FG002|Overall Study|Protocol Violation|0|||
105686427|NCT03254485|364514695|FG003|Overall Study|Protocol Violation|2|||
105686428|NCT03254485|364514692|FG000|Overall Study|Withdrawal by Subject|1|||
105686429|NCT03254485|364514693|FG001|Overall Study|Withdrawal by Subject|0|||
106129707|NCT01253200|366131266|FG003|Overall Study|Lost to Follow-up|0|||
106129708|NCT01253200|366131267|FG004|Overall Study|Lost to Follow-up|0|||
106129709|NCT01253200|366131263|FG000|Overall Study|Withdrawal by Subject|2|||
106001312|NCT00717249|365665262|FG001|Overall Study|Withdrawal by Subject|2|||
106001313|NCT00717249|365665261|FG000|Overall Study|Pregnancy|6|||
106001314|NCT00717249|365665262|FG001|Overall Study|Pregnancy|3|||
106001315|NCT00717249|365665261|FG000|Overall Study|Protocol Violation|0|||
105686430|NCT03254485|364514694|FG002|Overall Study|Withdrawal by Subject|0|||
105686431|NCT03254485|364514695|FG003|Overall Study|Withdrawal by Subject|4|||
105686432|NCT03254485|364514692|FG000|Overall Study|Death|0|||
105686433|NCT03254485|364514693|FG001|Overall Study|Death|0|||
105686434|NCT03254485|364514694|FG002|Overall Study|Death|0|||
105686435|NCT03254485|364514695|FG003|Overall Study|Death|1|||
105686436|NCT03254485|364514692|FG000|Overall Study|Lost to Follow-up|1|||
105686437|NCT03254485|364514693|FG001|Overall Study|Lost to Follow-up|0|||
105686438|NCT03254485|364514694|FG002|Overall Study|Lost to Follow-up|0|||
105686439|NCT03254485|364514695|FG003|Overall Study|Lost to Follow-up|0|||
105686440|NCT03254485|364514692|FG000|Overall Study|Other|1|||
105686441|NCT03254485|364514693|FG001|Overall Study|Other|0|||
105686442|NCT03254485|364514694|FG002|Overall Study|Other|0|||
105686443|NCT03254485|364514695|FG003|Overall Study|Other|2|||
105686444|NCT00777946|364514698|FG000|Overall Study|Adverse Event|11|||
105686445|NCT00777946|364514699|FG001|Overall Study|Adverse Event|1|||
105686446|NCT00777946|364514700|FG002|Overall Study|Adverse Event|3|||
105686447|NCT00777946|364514698|FG000|Overall Study|Lack of Efficacy|0|||
105686448|NCT00777946|364514699|FG001|Overall Study|Lack of Efficacy|0|||
105686449|NCT00777946|364514700|FG002|Overall Study|Lack of Efficacy|9|||
105686450|NCT00777946|364514698|FG000|Overall Study|Condition no longer required study drug|1|||
105686451|NCT00777946|364514699|FG001|Overall Study|Condition no longer required study drug|0|||
105686452|NCT00777946|364514700|FG002|Overall Study|Condition no longer required study drug|0|||
105686453|NCT00777946|364514698|FG000|Overall Study|Patient withdrew consent|3|||
105686454|NCT00777946|364514699|FG001|Overall Study|Patient withdrew consent|2|||
105686455|NCT00777946|364514700|FG002|Overall Study|Patient withdrew consent|3|||
105686456|NCT00777946|364514698|FG000|Overall Study|Lost to Follow-up|3|||
105686457|NCT00777946|364514699|FG001|Overall Study|Lost to Follow-up|1|||
105686458|NCT00777946|364514700|FG002|Overall Study|Lost to Follow-up|0|||
105686459|NCT00777946|364514698|FG000|Overall Study|Protocol deviation|2|||
106001316|NCT00717249|365665262|FG001|Overall Study|Protocol Violation|2|||
106001317|NCT00717249|365665261|FG000|Overall Study|Subject became Ineligible|1|||
106001318|NCT00717249|365665262|FG001|Overall Study|Subject became Ineligible|1|||
106001319|NCT00717249|365665261|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
106001320|NCT00717249|365665262|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
106001321|NCT00717249|365665261|FG000|Overall Study|Gastric Surgery|0|||
106001322|NCT00717249|365665262|FG001|Overall Study|Gastric Surgery|1|||
106001323|NCT00717249|365665261|FG000|Overall Study|Diagnosed with Diabetes|1|||
106001324|NCT00717249|365665262|FG001|Overall Study|Diagnosed with Diabetes|0|||
106001325|NCT00717249|365665261|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
106001326|NCT00717249|365665262|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
106001327|NCT00717249|365665261|FG000|Overall Study|Subject relocated|1|||
106001328|NCT00717249|365665262|FG001|Overall Study|Subject relocated|0|||
106001329|NCT00717249|365665261|FG000|Overall Study|Headaches|1|||
106001330|NCT00717249|365665262|FG001|Overall Study|Headaches|0|||
106001331|NCT03370718|365665263|FG000|Overall Study|Withdrawal by Subject|1|||
106001332|NCT02719171|365667707|FG000|Overall Study|Adverse Event|1|||
106001333|NCT02719171|365667708|FG001|Overall Study|Adverse Event|2|||
106001334|NCT02719171|365667709|FG002|Overall Study|Adverse Event|0|||
106001335|NCT02719171|365667710|FG003|Overall Study|Adverse Event|0|||
106001336|NCT02719171|365667711|FG004|Overall Study|Adverse Event|2|||
106001337|NCT02719171|365667707|FG000|Overall Study|Lost to Follow-up|0|||
106001338|NCT02719171|365667708|FG001|Overall Study|Lost to Follow-up|0|||
106001339|NCT02719171|365667709|FG002|Overall Study|Lost to Follow-up|1|||
106001340|NCT02719171|365667710|FG003|Overall Study|Lost to Follow-up|0|||
106001341|NCT02719171|365667711|FG004|Overall Study|Lost to Follow-up|0|||
106001342|NCT02719171|365667707|FG000|Overall Study|Subject Withdrawal|0|||
106001343|NCT02719171|365667708|FG001|Overall Study|Subject Withdrawal|2|||
106001344|NCT02719171|365667709|FG002|Overall Study|Subject Withdrawal|2|||
106001345|NCT02719171|365667710|FG003|Overall Study|Subject Withdrawal|1|||
106001346|NCT02719171|365667711|FG004|Overall Study|Subject Withdrawal|0|||
106001347|NCT02719171|365667707|FG000|Overall Study|Other|0|||
105686460|NCT00777946|364514699|FG001|Overall Study|Protocol deviation|1|||
105686461|NCT00777946|364514700|FG002|Overall Study|Protocol deviation|1|||
105686462|NCT00777946|364514698|FG000|Overall Study|Randomized in error|1|||
105686463|NCT00777946|364514699|FG001|Overall Study|Randomized in error|1|||
105686464|NCT00777946|364514700|FG002|Overall Study|Randomized in error|0|||
105686465|NCT02684357|364514701|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
105686466|NCT02684357|364514702|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
105686467|NCT02684357|364514703|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
105686468|NCT02684357|364514704|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
106001348|NCT02719171|365667708|FG001|Overall Study|Other|0|||
106001349|NCT02719171|365667709|FG002|Overall Study|Other|0|||
106001350|NCT02719171|365667710|FG003|Overall Study|Other|1|||
106001351|NCT02719171|365667711|FG004|Overall Study|Other|0|||
105686469|NCT02684357|364514705|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
105686470|NCT02684357|364514706|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
105686471|NCT02684357|364514701|FG000|Part A|Lost to Follow-up|0|||
105686472|NCT02684357|364514702|FG001|Part A|Lost to Follow-up|2|||
105686473|NCT02684357|364514703|FG002|Part A|Lost to Follow-up|2|||
105686474|NCT02684357|364514704|FG003|Part A|Lost to Follow-up|0|||
105686475|NCT02684357|364514705|FG004|Part A|Lost to Follow-up|0|||
105686476|NCT02684357|364514706|FG005|Part A|Lost to Follow-up|0|||
105686477|NCT02684357|364514701|FG000|Part A|Withdrawal by Subject|3|||
105686478|NCT02684357|364514702|FG001|Part A|Withdrawal by Subject|0|||
105686479|NCT02684357|364514703|FG002|Part A|Withdrawal by Subject|0|||
105686480|NCT02684357|364514704|FG003|Part A|Withdrawal by Subject|0|||
105686481|NCT02684357|364514705|FG004|Part A|Withdrawal by Subject|0|||
105686482|NCT02684357|364514706|FG005|Part A|Withdrawal by Subject|0|||
105686483|NCT02684357|364514701|FG000|Part A|Other|0|||
105686484|NCT02684357|364514702|FG001|Part A|Other|1|||
105686485|NCT02684357|364514703|FG002|Part A|Other|0|||
105686486|NCT02684357|364514704|FG003|Part A|Other|0|||
105686487|NCT02684357|364514705|FG004|Part A|Other|0|||
105686488|NCT02684357|364514706|FG005|Part A|Other|0|||
105686489|NCT02684357|364514701|FG000|Part B|Adverse Event (Other)|0|||
105686490|NCT02684357|364514702|FG001|Part B|Adverse Event (Other)|0|||
105686491|NCT02684357|364514703|FG002|Part B|Adverse Event (Other)|0|||
105686492|NCT02684357|364514704|FG003|Part B|Adverse Event (Other)|1|||
105686493|NCT02684357|364514705|FG004|Part B|Adverse Event (Other)|1|||
105686494|NCT02684357|364514706|FG005|Part B|Adverse Event (Other)|1|||
105686495|NCT02684357|364514701|FG000|Part B|Lost to Follow-up|0|||
105686496|NCT02684357|364514702|FG001|Part B|Lost to Follow-up|0|||
105686497|NCT02684357|364514703|FG002|Part B|Lost to Follow-up|0|||
105686498|NCT02684357|364514704|FG003|Part B|Lost to Follow-up|1|||
105686499|NCT02684357|364514705|FG004|Part B|Lost to Follow-up|1|||
105686500|NCT02684357|364514706|FG005|Part B|Lost to Follow-up|7|||
105686501|NCT02684357|364514701|FG000|Part B|Withdrawal by Subject|0|||
105686502|NCT02684357|364514702|FG001|Part B|Withdrawal by Subject|0|||
105686503|NCT02684357|364514703|FG002|Part B|Withdrawal by Subject|0|||
105686504|NCT02684357|364514704|FG003|Part B|Withdrawal by Subject|0|||
105686505|NCT02684357|364514705|FG004|Part B|Withdrawal by Subject|2|||
105686506|NCT02684357|364514706|FG005|Part B|Withdrawal by Subject|4|||
105686507|NCT02684357|364514701|FG000|Part B|Other|0|||
105686508|NCT02684357|364514702|FG001|Part B|Other|0|||
105686509|NCT02684357|364514703|FG002|Part B|Other|0|||
105686510|NCT02684357|364514704|FG003|Part B|Other|1|||
105686511|NCT02684357|364514705|FG004|Part B|Other|0|||
105686512|NCT02684357|364514706|FG005|Part B|Other|1|||
105686513|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
105686514|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
105686515|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
105686516|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
105686517|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
105686518|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
105686519|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
105686520|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
105686521|NCT01658826|364514713|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
105686522|NCT01658826|364514714|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
105686523|NCT01658826|364514713|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
105686524|NCT01658826|364514714|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
105686525|NCT01658826|364514713|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
105686526|NCT01658826|364514714|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
105686527|NCT01658826|364514713|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
105686528|NCT01658826|364514714|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
105786583|NCT02389621|364872840|FG001|Posttreatment Period|Withdrawal by Subject|2|||
105786584|NCT02389621|364872839|FG000|Posttreatment Period|Lost to Follow-up|1|||
105686529|NCT01658826|364514713|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
105686530|NCT01658826|364514714|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
105686531|NCT01696942|364514715|FG000|Overall Study|Withdrawal by Subject|1|||
105686532|NCT01696942|364514716|FG001|Overall Study|Withdrawal by Subject|0|||
105686533|NCT01696942|364514715|FG000|Overall Study|Protocol Violation|1|||
105686534|NCT01696942|364514716|FG001|Overall Study|Protocol Violation|2|||
105686535|NCT01696942|364514715|FG000|Overall Study|screen failure|0|||
105686536|NCT01696942|364514716|FG001|Overall Study|screen failure|1|||
105686537|NCT02881957|364514718|FG000|Overall Study|Comfort care|0|||
105686538|NCT02881957|364514719|FG001|Overall Study|Comfort care|1|||
105686539|NCT02881957|364514718|FG000|Overall Study|Concurrent trial enrollment|0|||
105686540|NCT02881957|364514719|FG001|Overall Study|Concurrent trial enrollment|1|||
105686541|NCT02881957|364514718|FG000|Overall Study|Discharged within 48 hours|0|||
105686542|NCT02881957|364514719|FG001|Overall Study|Discharged within 48 hours|1|||
105686543|NCT02881957|364514718|FG000|Overall Study|Withdrawal by Subject|2|||
105686544|NCT02881957|364514719|FG001|Overall Study|Withdrawal by Subject|1|||
105686545|NCT02881957|364514718|FG000|Overall Study|Protocol Violation|1|||
105686546|NCT02881957|364514719|FG001|Overall Study|Protocol Violation|0|||
105686547|NCT05269355|364514724|FG000|Overall Study|Progressive Disease|104|||
105686548|NCT05269355|364514725|FG001|Overall Study|Progressive Disease|68|||
105686549|NCT05269355|364514724|FG000|Overall Study|Study Terminated by Sponsor|87|||
105686550|NCT05269355|364514725|FG001|Overall Study|Study Terminated by Sponsor|29|||
105686551|NCT05269355|364514724|FG000|Overall Study|Adverse Event|15|||
105686552|NCT05269355|364514725|FG001|Overall Study|Adverse Event|8|||
105686553|NCT05269355|364514724|FG000|Overall Study|Withdrawal by Subject|18|||
105686554|NCT05269355|364514725|FG001|Overall Study|Withdrawal by Subject|5|||
105686555|NCT05269355|364514724|FG000|Overall Study|Physician Decision|6|||
105686556|NCT05269355|364514725|FG001|Overall Study|Physician Decision|4|||
105686557|NCT05269355|364514724|FG000|Overall Study|Death|3|||
105686558|NCT05269355|364514725|FG001|Overall Study|Death|5|||
105686559|NCT05269355|364514724|FG000|Overall Study|Other Than Specified|5|||
105686560|NCT05269355|364514725|FG001|Overall Study|Other Than Specified|1|||
105686561|NCT05269355|364514724|FG000|Overall Study|Randomized But Not Treated|1|||
105686562|NCT05269355|364514725|FG001|Overall Study|Randomized But Not Treated|0|||
105686563|NCT01598311|364514726|FG000|Overall Study|Physician Decision|4|||
105686564|NCT01598311|364514727|FG001|Overall Study|Physician Decision|5|||
105686565|NCT01598311|364514726|FG000|Overall Study|Adverse Event|9|||
105686566|NCT01598311|364514727|FG001|Overall Study|Adverse Event|13|||
105686567|NCT01598311|364514726|FG000|Overall Study|Lost to Follow-up|7|||
105686568|NCT01598311|364514727|FG001|Overall Study|Lost to Follow-up|12|||
105686569|NCT01598311|364514726|FG000|Overall Study|Withdrawal by Subject|9|||
105686570|NCT01598311|364514727|FG001|Overall Study|Withdrawal by Subject|13|||
105686571|NCT01598311|364514726|FG000|Overall Study|No reason provided.|0|||
105686572|NCT01598311|364514727|FG001|Overall Study|No reason provided.|5|||
105686573|NCT01598311|364514726|FG000|Overall Study|Randomized but never treated|8|||
105686574|NCT01598311|364514727|FG001|Overall Study|Randomized but never treated|5|||
105686575|NCT01598311|364514726|FG000|Overall Study|Treated but no confirmed CDAD|9|||
105686576|NCT01598311|364514727|FG001|Overall Study|Treated but no confirmed CDAD|8|||
105686577|NCT01598311|364514726|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
105686578|NCT01598311|364514727|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
105686579|NCT03442114|364514728|FG000|Overall Study|Lost to Follow-up|13|||
105686580|NCT03442114|364514729|FG001|Overall Study|Lost to Follow-up|13|||
105686581|NCT03442114|364514728|FG000|Overall Study|Physician Decision|2|||
105686582|NCT03442114|364514729|FG001|Overall Study|Physician Decision|2|||
105686583|NCT03442114|364514728|FG000|Overall Study|Protocol Violation|0|||
105686584|NCT03442114|364514729|FG001|Overall Study|Protocol Violation|2|||
105686585|NCT03442114|364514728|FG000|Overall Study|Withdrawal by Subject|1|||
105686586|NCT03442114|364514729|FG001|Overall Study|Withdrawal by Subject|3|||
105686587|NCT03442114|364514728|FG000|Overall Study|Guardianship Change|0|||
105686588|NCT03442114|364514729|FG001|Overall Study|Guardianship Change|1|||
105686589|NCT01201343|364516326|FG000|Overall Study|Adverse Event|6|||
105686590|NCT01201343|364516326|FG000|Overall Study|Withdrawal by Subject|5|||
105686591|NCT01201343|364516326|FG000|Overall Study|Lost to Follow-up|2|||
105686592|NCT01201343|364516326|FG000|Overall Study|Lack of Efficacy|2|||
105686593|NCT01201343|364516326|FG000|Overall Study|Participant wrongly included in trial|1|||
105686594|NCT01201343|364516326|FG000|Overall Study|Randomized, not treated|3|||
105686595|NCT02164383|364516327|FG000|Overall Study|Lost to Follow-up|1|||
105686596|NCT02164383|364516328|FG001|Overall Study|Lost to Follow-up|0|||
105686597|NCT01440374|364516333|FG000|Part 1: Open-label Phase|Adverse Event|5|||
105686598|NCT01440374|364516334|FG001|Part 1: Open-label Phase|Adverse Event|0|||
105686599|NCT01440374|364516335|FG002|Part 1: Open-label Phase|Adverse Event|0|||
105686600|NCT01440374|364516336|FG003|Part 1: Open-label Phase|Adverse Event|0|||
105686601|NCT01440374|364516333|FG000|Part 1: Open-label Phase|Physician Decision|1|||
105686602|NCT01440374|364516334|FG001|Part 1: Open-label Phase|Physician Decision|0|||
105686603|NCT01440374|364516335|FG002|Part 1: Open-label Phase|Physician Decision|0|||
105686604|NCT01440374|364516336|FG003|Part 1: Open-label Phase|Physician Decision|0|||
105686605|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
105686606|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
105686607|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
105686608|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
105686609|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
105686610|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
105686611|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
105686612|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
105686613|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
105686614|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
105686615|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
105686616|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
105686617|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
105686618|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
105686619|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
105686620|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
105686621|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
106129710|NCT01253200|366131264|FG001|Overall Study|Withdrawal by Subject|0|||
106129711|NCT01253200|366131265|FG002|Overall Study|Withdrawal by Subject|0|||
106129712|NCT01253200|366131266|FG003|Overall Study|Withdrawal by Subject|0|||
106129713|NCT01253200|366131267|FG004|Overall Study|Withdrawal by Subject|0|||
106129714|NCT01253200|366131263|FG000|Overall Study|Protocol Violation|1|||
106129715|NCT01253200|366131264|FG001|Overall Study|Protocol Violation|4|||
106129716|NCT01253200|366131265|FG002|Overall Study|Protocol Violation|0|||
106129717|NCT01253200|366131266|FG003|Overall Study|Protocol Violation|0|||
106129718|NCT01253200|366131267|FG004|Overall Study|Protocol Violation|5|||
106129719|NCT01253200|366131263|FG000|Overall Study|intents|10|||
106129720|NCT01253200|366131264|FG001|Overall Study|intents|10|||
106129721|NCT01253200|366131265|FG002|Overall Study|intents|1|||
106129722|NCT01253200|366131266|FG003|Overall Study|intents|3|||
106129723|NCT01253200|366131267|FG004|Overall Study|intents|0|||
106129724|NCT01253200|366131263|FG000|Overall Study|Attempts|6|||
106129725|NCT01253200|366131264|FG001|Overall Study|Attempts|4|||
106129726|NCT01253200|366131265|FG002|Overall Study|Attempts|1|||
106129727|NCT01253200|366131266|FG003|Overall Study|Attempts|2|||
106129728|NCT01253200|366131267|FG004|Overall Study|Attempts|0|||
106129729|NCT01700530|366131271|FG000|Overall Study|Withdrawal by Subject|0|||
106129730|NCT01700530|366131272|FG001|Overall Study|Withdrawal by Subject|3|||
106129731|NCT01700530|366131273|FG002|Overall Study|Withdrawal by Subject|1|||
106129732|NCT04833855|366131279|FG000|Overall Study|Decision by sponsor|0|||
106129733|NCT04833855|366131280|FG001|Overall Study|Decision by sponsor|1|||
106129734|NCT04833855|366131281|FG002|Overall Study|Decision by sponsor|0|||
106129735|NCT04833855|366131282|FG003|Overall Study|Decision by sponsor|0|||
106129736|NCT04833855|366131279|FG000|Overall Study|Withdrawal by Subject|4|||
106129737|NCT04833855|366131280|FG001|Overall Study|Withdrawal by Subject|1|||
106129738|NCT04833855|366131281|FG002|Overall Study|Withdrawal by Subject|3|||
106129739|NCT04833855|366131282|FG003|Overall Study|Withdrawal by Subject|1|||
106129740|NCT04833855|366131279|FG000|Overall Study|Lost to Follow-up|1|||
106129741|NCT04833855|366131280|FG001|Overall Study|Lost to Follow-up|0|||
106129742|NCT04833855|366131281|FG002|Overall Study|Lost to Follow-up|2|||
106129743|NCT04833855|366131282|FG003|Overall Study|Lost to Follow-up|2|||
106129744|NCT04833855|366131279|FG000|Overall Study|Protocol specified criteria|0|||
106129745|NCT04833855|366131280|FG001|Overall Study|Protocol specified criteria|0|||
106129746|NCT04833855|366131281|FG002|Overall Study|Protocol specified criteria|2|||
106129747|NCT04833855|366131282|FG003|Overall Study|Protocol specified criteria|1|||
106129748|NCT03682536|366131284|FG000|Randomization|Withdrawal by Subject|0|||
106129749|NCT03682536|366131285|FG001|Randomization|Withdrawal by Subject|2|||
106129750|NCT03682536|366131284|FG000|Treatment|Other Reasons|8|||
106129751|NCT03682536|366131285|FG001|Treatment|Other Reasons|7|||
106129752|NCT03682536|366131284|FG000|Treatment|Physician Decision|5|||
106129753|NCT03682536|366131285|FG001|Treatment|Physician Decision|5|||
106129754|NCT03682536|366131284|FG000|Treatment|Protocol Violation|1|||
106129755|NCT03682536|366131285|FG001|Treatment|Protocol Violation|0|||
106129756|NCT03682536|366131284|FG000|Treatment|Study Terminated by Sponsor|1|||
106129757|NCT03682536|366131285|FG001|Treatment|Study Terminated by Sponsor|2|||
106129758|NCT03682536|366131284|FG000|Treatment|Lost to Follow-up|0|||
106129759|NCT03682536|366131285|FG001|Treatment|Lost to Follow-up|1|||
106129760|NCT03682536|366131284|FG000|Treatment|Withdrawal by Subject|16|||
106129761|NCT03682536|366131285|FG001|Treatment|Withdrawal by Subject|18|||
106129762|NCT03682536|366131284|FG000|Treatment|Lack of Efficacy|41|||
106129763|NCT03682536|366131285|FG001|Treatment|Lack of Efficacy|68|||
106129764|NCT03682536|366131284|FG000|Treatment|Disease Progression|9|||
106129765|NCT03682536|366131285|FG001|Treatment|Disease Progression|7|||
106129766|NCT03682536|366131284|FG000|Treatment|Adverse Event|9|||
106129767|NCT03682536|366131285|FG001|Treatment|Adverse Event|5|||
106129768|NCT03682536|366131284|FG000|Treatment|Death|14|||
106129769|NCT03682536|366131285|FG001|Treatment|Death|13|||
106129770|NCT02234310|366131295|FG000|Overall Study|Physician Decision|1|||
106129771|NCT02234310|366131295|FG000|Overall Study|Adverse Event|1|||
106129772|NCT02234310|366131295|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
106129773|NCT02234310|366131295|FG000|Overall Study|Withdrawal by Subject|2|||
106129774|NCT02192359|366131297|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
106129775|NCT02192359|366131298|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
106129776|NCT02192359|366131299|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
106129777|NCT02192359|366131300|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
106129778|NCT02192359|366131297|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
106129779|NCT02192359|366131298|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
106129780|NCT02192359|366131299|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
106129781|NCT02192359|366131300|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
106129782|NCT02192359|366131297|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
106129783|NCT02192359|366131298|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
106144094|NCT01317420|366186952|FG003|Overall Study|Non-compliant with protocol|0|||
105686622|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
105686623|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
105686624|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
105686625|NCT01440374|364516333|FG000|Part 2; Double-blind Phase|Not treated|0|||
105686626|NCT01440374|364516334|FG001|Part 2; Double-blind Phase|Not treated|0|||
105686627|NCT01440374|364516335|FG002|Part 2; Double-blind Phase|Not treated|1|||
105686628|NCT01440374|364516336|FG003|Part 2; Double-blind Phase|Not treated|0|||
105686629|NCT01440374|364516333|FG000|Part 3: Extension|Withdrawal by Subject|0|||
105686630|NCT01440374|364516334|FG001|Part 3: Extension|Withdrawal by Subject|0|||
105686631|NCT01440374|364516335|FG002|Part 3: Extension|Withdrawal by Subject|0|||
105686632|NCT01440374|364516336|FG003|Part 3: Extension|Withdrawal by Subject|5|||
105686633|NCT01440374|364516333|FG000|Part 3: Extension|Adverse Event|0|||
105686634|NCT01440374|364516334|FG001|Part 3: Extension|Adverse Event|0|||
105686635|NCT01440374|364516335|FG002|Part 3: Extension|Adverse Event|0|||
105686636|NCT01440374|364516336|FG003|Part 3: Extension|Adverse Event|13|||
105686637|NCT01440374|364516333|FG000|Part 3: Extension|Physician Decision|0|||
105686638|NCT01440374|364516334|FG001|Part 3: Extension|Physician Decision|0|||
105686639|NCT01440374|364516335|FG002|Part 3: Extension|Physician Decision|0|||
105686640|NCT01440374|364516336|FG003|Part 3: Extension|Physician Decision|14|||
105686641|NCT00171704|364516339|FG000|Overall Study|Adverse Event|24|||
105686642|NCT00171704|364516340|FG001|Overall Study|Adverse Event|33|||
105686643|NCT00171704|364516339|FG000|Overall Study|Disease Progression|14|||
105686644|NCT00171704|364516340|FG001|Overall Study|Disease Progression|9|||
105686645|NCT00171704|364516339|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
105686646|NCT00171704|364516340|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
105686647|NCT00171704|364516339|FG000|Overall Study|Administrative Problems|2|||
105686648|NCT00171704|364516340|FG001|Overall Study|Administrative Problems|1|||
105686649|NCT00171704|364516339|FG000|Overall Study|Death|2|||
105686650|NCT00171704|364516340|FG001|Overall Study|Death|2|||
105686651|NCT00171704|364516339|FG000|Overall Study|Withdrawal by Subject|1|||
105686652|NCT00171704|364516340|FG001|Overall Study|Withdrawal by Subject|3|||
105686653|NCT00171704|364516339|FG000|Overall Study|Protocol Violation|0|||
105686654|NCT00171704|364516340|FG001|Overall Study|Protocol Violation|1|||
105686655|NCT03435497|364516343|FG000|Overall Study|Lost to Follow-up|1|||
105686656|NCT03435497|364516344|FG001|Overall Study|Lost to Follow-up|0|||
105686657|NCT03435497|364516343|FG000|Overall Study|Death|1|||
105686658|NCT03435497|364516344|FG001|Overall Study|Death|0|||
105686659|NCT03435497|364516343|FG000|Overall Study|Withdrawal by Subject|0|||
105686660|NCT03435497|364516344|FG001|Overall Study|Withdrawal by Subject|4|||
105686661|NCT03435497|364516343|FG000|Overall Study|Wrong survey administered|0|||
105686662|NCT03435497|364516344|FG001|Overall Study|Wrong survey administered|2|||
105686663|NCT00601419|364516346|FG000|Overall Study|Lost to Follow-up|3|||
105686664|NCT00601419|364516346|FG000|Overall Study|Missed Visits|1|||
105686665|NCT01786174|364516347|FG000|Overall Study|Discontinued Study Drug|2|||
105686666|NCT01786174|364516348|FG001|Overall Study|Discontinued Study Drug|0|||
105686667|NCT03442985|364516349|FG000|Overall Study|Sponsor Request|55|||
105686668|NCT03442985|364516350|FG001|Overall Study|Sponsor Request|60|||
105686669|NCT03442985|364516351|FG002|Overall Study|Sponsor Request|54|||
105686670|NCT03442985|364516349|FG000|Overall Study|Lost to Follow-up|5|||
105686671|NCT03442985|364516350|FG001|Overall Study|Lost to Follow-up|2|||
105686672|NCT03442985|364516351|FG002|Overall Study|Lost to Follow-up|7|||
105686673|NCT03442985|364516349|FG000|Overall Study|Withdrawal by Subject|2|||
105686674|NCT03442985|364516350|FG001|Overall Study|Withdrawal by Subject|3|||
105686675|NCT03442985|364516351|FG002|Overall Study|Withdrawal by Subject|4|||
105686676|NCT03442985|364516349|FG000|Overall Study|Adverse Event|0|||
105686677|NCT03442985|364516350|FG001|Overall Study|Adverse Event|1|||
105686678|NCT03442985|364516351|FG002|Overall Study|Adverse Event|0|||
105686679|NCT01217957|364516352|FG000|Phase 1|Withdrawal by Patient|1|||
105686680|NCT01217957|364516353|FG001|Phase 1|Withdrawal by Patient|0|||
105917583|NCT01316224|365356895|FG000|Overall Study|Withdrawal by Subject|1|||
105917584|NCT01316224|365356895|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
105917585|NCT01316224|365356895|FG000|Overall Study|Other|1|||
105917586|NCT00264147|365356896|FG000|Treatment I Period|Adverse Event|3|||
105917587|NCT00264147|365356897|FG001|Treatment I Period|Adverse Event|6|||
106129784|NCT02192359|366131299|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
105686681|NCT01217957|364516354|FG002|Phase 1|Withdrawal by Patient|1|||
105686682|NCT01217957|364516355|FG003|Phase 1|Withdrawal by Patient|1|||
105686683|NCT01217957|364516356|FG004|Phase 1|Withdrawal by Patient|0|||
105686684|NCT01217957|364516352|FG000|Phase 2|Withdrawal by Patient|0|||
105686685|NCT01217957|364516353|FG001|Phase 2|Withdrawal by Patient|0|||
105686686|NCT01217957|364516354|FG002|Phase 2|Withdrawal by Patient|0|||
105686687|NCT01217957|364516355|FG003|Phase 2|Withdrawal by Patient|0|||
105917588|NCT00264147|365356898|FG002|Treatment I Period|Adverse Event|3|||
105686688|NCT01217957|364516356|FG004|Phase 2|Withdrawal by Patient|1|||
105686689|NCT01620255|364516362|FG000|Overall Study|Withdrawal by Subject|4|||
105686690|NCT01620255|364516363|FG001|Overall Study|Withdrawal by Subject|1|||
105917589|NCT00264147|365356899|FG003|Treatment I Period|Adverse Event|5|||
105686691|NCT01620255|364516364|FG002|Overall Study|Withdrawal by Subject|1|||
105686692|NCT01620255|364516365|FG003|Overall Study|Withdrawal by Subject|2|||
105686693|NCT01620255|364516366|FG004|Overall Study|Withdrawal by Subject|4|||
105686694|NCT01620255|364516362|FG000|Overall Study|Participant underwent fecal transplant|0|||
105686695|NCT01620255|364516363|FG001|Overall Study|Participant underwent fecal transplant|0|||
105686696|NCT01620255|364516364|FG002|Overall Study|Participant underwent fecal transplant|1|||
105686697|NCT01620255|364516365|FG003|Overall Study|Participant underwent fecal transplant|0|||
105686698|NCT01620255|364516366|FG004|Overall Study|Participant underwent fecal transplant|0|||
105686699|NCT01620255|364516362|FG000|Overall Study|Non-compliance|0|||
105686700|NCT01620255|364516363|FG001|Overall Study|Non-compliance|1|||
105686701|NCT01620255|364516364|FG002|Overall Study|Non-compliance|0|||
105686702|NCT01620255|364516365|FG003|Overall Study|Non-compliance|0|||
105686703|NCT01620255|364516366|FG004|Overall Study|Non-compliance|0|||
105686704|NCT01620255|364516362|FG000|Overall Study|Adverse Event|0|||
105686705|NCT01620255|364516363|FG001|Overall Study|Adverse Event|4|||
105686706|NCT01620255|364516364|FG002|Overall Study|Adverse Event|0|||
105686707|NCT01620255|364516365|FG003|Overall Study|Adverse Event|1|||
105686708|NCT01620255|364516366|FG004|Overall Study|Adverse Event|1|||
105686709|NCT01620255|364516362|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
105686710|NCT01620255|364516363|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
105686711|NCT01620255|364516364|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
105686712|NCT01620255|364516365|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
105686713|NCT01620255|364516366|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
105686714|NCT01716117|364516367|FG000|Overall Study|Death|5|||
105686715|NCT01716117|364516368|FG001|Overall Study|Death|2|||
105686716|NCT01716117|364516367|FG000|Overall Study|Withdrawal by Subject|2|||
105686717|NCT01716117|364516368|FG001|Overall Study|Withdrawal by Subject|0|||
105686718|NCT01557283|364516369|FG000|Overall Study|Lost to Follow-up|7|||
105686719|NCT01557283|364516369|FG000|Overall Study|Non-responder|19|||
105686720|NCT01557283|364516369|FG000|Overall Study|Adverse Event|7|||
105686721|NCT01557283|364516369|FG000|Overall Study|Lack of Efficacy|1|||
105686722|NCT01557283|364516369|FG000|Overall Study|Non-compliance|1|||
105686723|NCT01557283|364516369|FG000|Overall Study|Withdrawal by Subject|1|||
105686724|NCT01557283|364516369|FG000|Overall Study|Participant's weight too high for dose|1|||
105686725|NCT01557283|364516369|FG000|Overall Study|Worsening of psoriasis|1|||
105686726|NCT01557283|364516369|FG000|Overall Study|Other|6|||
105686727|NCT01765192|364516370|FG000|Treatment Period 1|Adverse Event|0|||
105686728|NCT01765192|364516371|FG001|Treatment Period 1|Adverse Event|1|||
105686729|NCT01765192|364516370|FG000|Washout Period|Voluntary Withdrawal|1|||
105686730|NCT01765192|364516371|FG001|Washout Period|Voluntary Withdrawal|1|||
105686731|NCT01765192|364516370|FG000|Washout Period|Reason not specified|1|||
105686732|NCT01765192|364516371|FG001|Washout Period|Reason not specified|0|||
105686733|NCT01765192|364516370|FG000|Treatment Period 2|Reason not specified|0|||
105686734|NCT01765192|364516371|FG001|Treatment Period 2|Reason not specified|2|||
105686735|NCT01765192|364516370|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
105686736|NCT01765192|364516371|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
105686737|NCT04335812|364516377|FG000|Overall Study|Withdrawal by Subject|1|||
105686738|NCT04335812|364516378|FG001|Overall Study|Withdrawal by Subject|3|||
105686739|NCT04335812|364516377|FG000|Overall Study|Lost to Follow-up|12|||
105686740|NCT04335812|364516378|FG001|Overall Study|Lost to Follow-up|12|||
105686741|NCT04335812|364516377|FG000|Overall Study|Did not engage in the intervention|22|||
105686742|NCT04335812|364516378|FG001|Overall Study|Did not engage in the intervention|18|||
105686743|NCT01480674|364516379|FG000|Overall Study|Death|23|||
105686744|NCT01480674|364516379|FG000|Overall Study|Lost to Follow-up|2|||
105686745|NCT01480674|364516379|FG000|Overall Study|visit not done|10|||
105686746|NCT00975507|364516380|FG000|Overall Study|Adverse Event|1|||
105686747|NCT00975507|364516381|FG001|Overall Study|Adverse Event|0|||
105686748|NCT00975507|364516380|FG000|Overall Study|Lost to Follow-up|7|||
105686749|NCT00975507|364516381|FG001|Overall Study|Lost to Follow-up|1|||
105686750|NCT00975507|364516380|FG000|Overall Study|Protocol Violation|2|||
105686751|NCT00975507|364516381|FG001|Overall Study|Protocol Violation|0|||
105686752|NCT00975507|364516380|FG000|Overall Study|Withdrawal by Subject|10|||
105686753|NCT00975507|364516381|FG001|Overall Study|Withdrawal by Subject|3|||
105686754|NCT03864146|364516382|FG000|Overall Study|Lost to Follow-up|14|||
105686755|NCT03864146|364516383|FG001|Overall Study|Lost to Follow-up|23|||
105686756|NCT03864146|364516382|FG000|Overall Study|Withdrawal by Subject|3|||
105686757|NCT03864146|364516383|FG001|Overall Study|Withdrawal by Subject|2|||
105686758|NCT00655863|364516390|FG000|Overall Study|Lost to Follow-up|0|||
105686759|NCT00655863|364516391|FG001|Overall Study|Lost to Follow-up|0|||
105686760|NCT00655863|364516392|FG002|Overall Study|Lost to Follow-up|1|||
105686761|NCT04745026|364516393|FG000|Overall Study|Physician Decision|1|||
105686762|NCT04745026|364516394|FG001|Overall Study|Physician Decision|0|||
105686763|NCT04745026|364516393|FG000|Overall Study|Adverse Event|2|||
105917590|NCT00264147|365356900|FG004|Treatment I Period|Adverse Event|7|||
105686764|NCT04745026|364516394|FG001|Overall Study|Adverse Event|2|||
105686765|NCT04745026|364516393|FG000|Overall Study|Protocol Violation|1|||
105686766|NCT04745026|364516394|FG001|Overall Study|Protocol Violation|3|||
105686767|NCT04745026|364516393|FG000|Overall Study|Lost to Follow-up|4|||
105686768|NCT04745026|364516394|FG001|Overall Study|Lost to Follow-up|3|||
105686769|NCT04745026|364516393|FG000|Overall Study|Withdrawal by Subject|5|||
105686770|NCT04745026|364516394|FG001|Overall Study|Withdrawal by Subject|5|||
105686771|NCT04426851|364516395|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
105686772|NCT04426851|364516396|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
105686773|NCT04426851|364516395|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
105686774|NCT04426851|364516396|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
105686775|NCT05580588|364516397|FG000|Overall Study|Lack of Efficacy|12|||
105686776|NCT00712673|364516400|FG000|Overall Study|Adverse Event|3|||
105686777|NCT00712673|364516401|FG001|Overall Study|Adverse Event|3|||
105686778|NCT00712673|364516402|FG002|Overall Study|Adverse Event|21|||
105686779|NCT00712673|364516403|FG003|Overall Study|Adverse Event|26|||
105686780|NCT00712673|364516400|FG000|Overall Study|Lack of Efficacy|2|||
105686781|NCT00712673|364516401|FG001|Overall Study|Lack of Efficacy|8|||
105686782|NCT00712673|364516402|FG002|Overall Study|Lack of Efficacy|8|||
105686783|NCT00712673|364516403|FG003|Overall Study|Lack of Efficacy|6|||
105686784|NCT00712673|364516400|FG000|Overall Study|Poor Compliance to Protocol|3|||
105686785|NCT00712673|364516401|FG001|Overall Study|Poor Compliance to Protocol|3|||
105686786|NCT00712673|364516402|FG002|Overall Study|Poor Compliance to Protocol|4|||
105686787|NCT00712673|364516403|FG003|Overall Study|Poor Compliance to Protocol|16|||
105686788|NCT00712673|364516400|FG000|Overall Study|Lost to Follow-up|1|||
105686789|NCT00712673|364516401|FG001|Overall Study|Lost to Follow-up|0|||
105686790|NCT00712673|364516402|FG002|Overall Study|Lost to Follow-up|2|||
105686791|NCT00712673|364516403|FG003|Overall Study|Lost to Follow-up|0|||
105686792|NCT00712673|364516400|FG000|Overall Study|Withdrawal by Subject|6|||
105686793|NCT00712673|364516401|FG001|Overall Study|Withdrawal by Subject|7|||
105686794|NCT00712673|364516402|FG002|Overall Study|Withdrawal by Subject|15|||
105686795|NCT00712673|364516403|FG003|Overall Study|Withdrawal by Subject|20|||
105686796|NCT00712673|364516400|FG000|Overall Study|Familial and Personal Reasons|5|||
105686797|NCT00712673|364516401|FG001|Overall Study|Familial and Personal Reasons|0|||
105686798|NCT00712673|364516402|FG002|Overall Study|Familial and Personal Reasons|5|||
105686799|NCT00712673|364516403|FG003|Overall Study|Familial and Personal Reasons|2|||
105686800|NCT00712673|364516400|FG000|Overall Study|Investigator's Decision|1|||
105686801|NCT00712673|364516401|FG001|Overall Study|Investigator's Decision|0|||
105686802|NCT00712673|364516402|FG002|Overall Study|Investigator's Decision|0|||
105686803|NCT00712673|364516403|FG003|Overall Study|Investigator's Decision|0|||
105686804|NCT00712673|364516400|FG000|Overall Study|Protocol Violation|0|||
105686805|NCT00712673|364516401|FG001|Overall Study|Protocol Violation|0|||
105686806|NCT00712673|364516402|FG002|Overall Study|Protocol Violation|2|||
105686807|NCT00712673|364516403|FG003|Overall Study|Protocol Violation|0|||
105686808|NCT03603028|364516404|FG000|Overall Study|Withdrawal by Subject|1|||
105686809|NCT02768870|364516407|FG000|Overall Study|Death|1|||
105686810|NCT02768870|364516407|FG000|Overall Study|Reoperation|6|||
105686811|NCT02768870|364516407|FG000|Overall Study|Lost to Follow-up|1|||
105686812|NCT02768870|364516407|FG000|Overall Study|Exit|4|||
105686813|NCT03401229|364516409|FG000|Overall Study|Lost to Follow-up|2|||
105686814|NCT03401229|364516410|FG001|Overall Study|Lost to Follow-up|1|||
105686815|NCT03401229|364516409|FG000|Overall Study|Other|1|||
105686816|NCT03401229|364516410|FG001|Overall Study|Other|3|||
105686817|NCT03401229|364516409|FG000|Overall Study|Adverse Event|8|||
105686818|NCT03401229|364516410|FG001|Overall Study|Adverse Event|6|||
105686819|NCT03401229|364516409|FG000|Overall Study|Withdrawal by Subject|29|||
105686820|NCT03401229|364516410|FG001|Overall Study|Withdrawal by Subject|26|||
105686821|NCT03401229|364516409|FG000|Overall Study|COVID-19|0|||
105686822|NCT03401229|364516410|FG001|Overall Study|COVID-19|1|||
105686823|NCT02963610|364516411|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
105686824|NCT01122862|364516412|FG000|Period 1|Protocol Violation|0|||
105686825|NCT01122862|364516413|FG001|Period 1|Protocol Violation|1|||
105686826|NCT01122862|364516414|FG002|Period 1|Protocol Violation|0|||
105686827|NCT01122862|364516412|FG000|Period 2|Adverse Event|0|||
105686828|NCT01122862|364516413|FG001|Period 2|Adverse Event|0|||
105917591|NCT00264147|365356901|FG005|Treatment I Period|Adverse Event|0|||
105917592|NCT00264147|365356896|FG000|Treatment I Period|Laboratory Adverse Event|0|||
106129785|NCT02192359|366131300|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
105686829|NCT01122862|364516414|FG002|Period 2|Adverse Event|1|||
105686830|NCT01249274|364516416|FG000|Overall Study|Lost to Follow-up|3|||
105686831|NCT01249274|364516417|FG001|Overall Study|Lost to Follow-up|4|||
105686832|NCT01249274|364516416|FG000|Overall Study|Received inpatient substance treatment|1|||
105686833|NCT01249274|364516417|FG001|Overall Study|Received inpatient substance treatment|2|||
105686834|NCT01000636|364516418|FG000|Overall Study|Withdrawal by Subject|1|||
105686835|NCT01000636|364516418|FG000|Overall Study|Adverse Event|1|||
105686836|NCT01100034|364516419|FG000|Overall Study|Lost to Follow-up|11|||
105686837|NCT01100034|364516419|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
105686838|NCT01100034|364516419|FG000|Overall Study|Withdrawal by Subject|4|||
105917593|NCT00264147|365356897|FG001|Treatment I Period|Laboratory Adverse Event|0|||
106129786|NCT00114959|366131301|FG000|Overall Study|Lack of Efficacy|6|||
105686839|NCT01100034|364516419|FG000|Overall Study|Sponsor decision|21|||
105686840|NCT01100034|364516419|FG000|Overall Study|Participated in another clinical trial|1|||
105686841|NCT01100034|364516419|FG000|Overall Study|Participants moved to another hospital|4|||
105686842|NCT01100034|364516419|FG000|Overall Study|Site closed due to non-responsiveness|1|||
105686843|NCT01259726|364516420|FG000|Overall Study|Death|1|||
105686844|NCT01259726|364516421|FG001|Overall Study|Death|0|||
105686845|NCT01259726|364516422|FG002|Overall Study|Death|0|||
105686846|NCT01259726|364516423|FG003|Overall Study|Death|0|||
105686847|NCT01259726|364516420|FG000|Overall Study|Physician Decision|2|||
105686848|NCT01259726|364516421|FG001|Overall Study|Physician Decision|0|||
105686849|NCT01259726|364516422|FG002|Overall Study|Physician Decision|1|||
105686850|NCT01259726|364516423|FG003|Overall Study|Physician Decision|1|||
105686851|NCT01259726|364516420|FG000|Overall Study|Withdrawal by Subject|1|||
105686852|NCT01259726|364516421|FG001|Overall Study|Withdrawal by Subject|3|||
105686853|NCT01259726|364516422|FG002|Overall Study|Withdrawal by Subject|2|||
105686854|NCT01259726|364516423|FG003|Overall Study|Withdrawal by Subject|1|||
105686855|NCT01259726|364516420|FG000|Overall Study|Lost to Follow-up|1|||
105686856|NCT01259726|364516421|FG001|Overall Study|Lost to Follow-up|1|||
105686857|NCT01259726|364516422|FG002|Overall Study|Lost to Follow-up|1|||
105686858|NCT01259726|364516423|FG003|Overall Study|Lost to Follow-up|3|||
105686859|NCT01978262|364516424|FG000|Overall Study|Withdrawal by Subject|9|||
105686860|NCT01978262|364516424|FG000|Overall Study|Lost to Follow-up|2|||
105686861|NCT00141726|364516427|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
105686862|NCT02435966|364516428|FG000|Overall Study|Withdrawal by Subject|0|||
105686863|NCT02435966|364516429|FG001|Overall Study|Withdrawal by Subject|1|||
105686864|NCT02435966|364516430|FG002|Overall Study|Withdrawal by Subject|0|||
105686865|NCT02147353|364516431|FG000|Overall Study|Lost to Follow-up|2|||
105686866|NCT02147353|364516432|FG001|Overall Study|Lost to Follow-up|0|||
105686867|NCT02147353|364516431|FG000|Overall Study|unable to make visits|4|||
105686868|NCT02147353|364516432|FG001|Overall Study|unable to make visits|0|||
105686869|NCT02147353|364516431|FG000|Overall Study|medication noncompliance|3|||
105686870|NCT02147353|364516432|FG001|Overall Study|medication noncompliance|0|||
105686871|NCT02349360|364516433|FG000|Overall Study|Withdrawal by Subject|0|||
105686872|NCT02349360|364516434|FG001|Overall Study|Withdrawal by Subject|1|||
105686873|NCT02196714|364516439|FG000|Overall Study|Protocol Violation|0|||
105686874|NCT02196714|364516440|FG001|Overall Study|Protocol Violation|0|||
105686875|NCT02196714|364516441|FG002|Overall Study|Protocol Violation|1|||
105686876|NCT02196714|364516442|FG003|Overall Study|Protocol Violation|0|||
105686877|NCT01106404|364516452|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
105686878|NCT01106404|364516453|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
105686879|NCT01106404|364516452|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
105686880|NCT01106404|364516453|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
105686881|NCT01106404|364516452|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
105686882|NCT01106404|364516453|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
105686883|NCT01106404|364516452|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
105686884|NCT01106404|364516453|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
105686885|NCT02409368|364516456|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
105686886|NCT02409368|364516457|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
105686887|NCT02409368|364516458|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
105686888|NCT02409368|364516459|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
105686889|NCT02409368|364516456|FG000|ECOG Reclassification|Death|1|||
105686890|NCT02409368|364516457|FG001|ECOG Reclassification|Death|5|||
105686891|NCT02409368|364516458|FG002|ECOG Reclassification|Death|0|||
105686892|NCT02409368|364516459|FG003|ECOG Reclassification|Death|0|||
105686893|NCT02409368|364516456|FG000|ECOG Reclassification|Disease Progression|113|||
105686894|NCT02409368|364516457|FG001|ECOG Reclassification|Disease Progression|382|||
105686895|NCT02409368|364516458|FG002|ECOG Reclassification|Disease Progression|70|||
105686896|NCT02409368|364516459|FG003|ECOG Reclassification|Disease Progression|1|||
105686897|NCT02409368|364516456|FG000|ECOG Reclassification|Lost to Follow-up|1|||
105686898|NCT02409368|364516457|FG001|ECOG Reclassification|Lost to Follow-up|5|||
105686899|NCT02409368|364516458|FG002|ECOG Reclassification|Lost to Follow-up|0|||
105686900|NCT02409368|364516459|FG003|ECOG Reclassification|Lost to Follow-up|0|||
105686901|NCT02409368|364516456|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
105686902|NCT02409368|364516457|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
105686903|NCT02409368|364516458|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
105686904|NCT02409368|364516459|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
105686905|NCT02409368|364516456|FG000|ECOG Reclassification|Poor/non-compliance|0|||
105686906|NCT02409368|364516457|FG001|ECOG Reclassification|Poor/non-compliance|3|||
105686907|NCT02409368|364516458|FG002|ECOG Reclassification|Poor/non-compliance|2|||
105686908|NCT02409368|364516459|FG003|ECOG Reclassification|Poor/non-compliance|0|||
105686909|NCT02409368|364516456|FG000|ECOG Reclassification|Study drug toxicity|17|||
105686910|NCT02409368|364516457|FG001|ECOG Reclassification|Study drug toxicity|42|||
105686911|NCT02409368|364516458|FG002|ECOG Reclassification|Study drug toxicity|7|||
105686912|NCT02409368|364516459|FG003|ECOG Reclassification|Study drug toxicity|0|||
105686913|NCT02409368|364516456|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
105686914|NCT02409368|364516457|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
105686915|NCT02409368|364516458|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
105686916|NCT02409368|364516459|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
105686917|NCT02409368|364516456|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
106129787|NCT00114959|366131301|FG000|Overall Study|Physician Decision|1|||
106129788|NCT00114959|366131301|FG000|Overall Study|Death|1|||
105686918|NCT02409368|364516457|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
105686919|NCT02409368|364516458|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
106129789|NCT04951479|366131302|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
106129790|NCT03251378|366131303|FG000|Overall Study|Death|3|||
106129791|NCT03251378|366131304|FG001|Overall Study|Death|2|||
106129792|NCT03251378|366131305|FG002|Overall Study|Death|3|||
106129793|NCT03251378|366131306|FG003|Overall Study|Death|30|||
106129794|NCT03251378|366131307|FG004|Overall Study|Death|24|||
106129795|NCT03251378|366131308|FG005|Overall Study|Death|12|||
106129796|NCT03251378|366131309|FG006|Overall Study|Death|12|||
106129797|NCT03251378|366131303|FG000|Overall Study|Lost to Follow-up|0|||
106129798|NCT03251378|366131304|FG001|Overall Study|Lost to Follow-up|0|||
106129799|NCT03251378|366131305|FG002|Overall Study|Lost to Follow-up|1|||
106129800|NCT03251378|366131306|FG003|Overall Study|Lost to Follow-up|3|||
106129801|NCT03251378|366131307|FG004|Overall Study|Lost to Follow-up|0|||
106129802|NCT03251378|366131308|FG005|Overall Study|Lost to Follow-up|0|||
106129803|NCT03251378|366131309|FG006|Overall Study|Lost to Follow-up|0|||
106129804|NCT03251378|366131303|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
106129805|NCT03251378|366131304|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
106129806|NCT03251378|366131305|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
106129807|NCT03251378|366131306|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
106129808|NCT03251378|366131307|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
106129809|NCT03251378|366131308|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
106129810|NCT03251378|366131309|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
105686920|NCT02409368|364516459|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
105686921|NCT02409368|364516456|FG000|ECOG Reclassification|Participant withdrew consent|2|||
105686922|NCT02409368|364516457|FG001|ECOG Reclassification|Participant withdrew consent|3|||
105686923|NCT02409368|364516458|FG002|ECOG Reclassification|Participant withdrew consent|4|||
105686924|NCT02409368|364516459|FG003|ECOG Reclassification|Participant withdrew consent|0|||
106129811|NCT03251378|366131303|FG000|Overall Study|Progressive disease|2|||
106129812|NCT03251378|366131304|FG001|Overall Study|Progressive disease|0|||
105686925|NCT02409368|364516456|FG000|ECOG Reclassification|Other Reasons|5|||
105686926|NCT02409368|364516457|FG001|ECOG Reclassification|Other Reasons|26|||
106129813|NCT03251378|366131305|FG002|Overall Study|Progressive disease|0|||
106129814|NCT03251378|366131306|FG003|Overall Study|Progressive disease|1|||
106129815|NCT03251378|366131307|FG004|Overall Study|Progressive disease|0|||
106129816|NCT03251378|366131308|FG005|Overall Study|Progressive disease|0|||
106129817|NCT03251378|366131309|FG006|Overall Study|Progressive disease|0|||
106129818|NCT03251378|366131303|FG000|Overall Study|Physician Decision|0|||
106129819|NCT03251378|366131304|FG001|Overall Study|Physician Decision|2|||
106129820|NCT03251378|366131305|FG002|Overall Study|Physician Decision|0|||
106129821|NCT03251378|366131306|FG003|Overall Study|Physician Decision|0|||
105686927|NCT02409368|364516458|FG002|ECOG Reclassification|Other Reasons|2|||
105686928|NCT02409368|364516459|FG003|ECOG Reclassification|Other Reasons|0|||
105686929|NCT02409368|364516456|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
105686930|NCT02409368|364516457|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
105686931|NCT02409368|364516458|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
105686932|NCT02409368|364516459|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
105686933|NCT03343301|364516460|FG000|Overall Study|Withdrawal by Subject|1|||
105686934|NCT03343301|364516461|FG001|Overall Study|Withdrawal by Subject|1|||
105686935|NCT03343301|364516460|FG000|Overall Study|Death|0|||
105686936|NCT03343301|364516461|FG001|Overall Study|Death|2|||
105686937|NCT03343301|364516460|FG000|Overall Study|Other|0|||
105686938|NCT03343301|364516461|FG001|Overall Study|Other|6|||
105686939|NCT03343301|364516460|FG000|Overall Study|Missing|2|||
105686940|NCT03343301|364516461|FG001|Overall Study|Missing|0|||
105686941|NCT00494481|364516462|FG000|Overall Study|Condition under investigation worsened|11|||
105686942|NCT00494481|364516463|FG001|Overall Study|Condition under investigation worsened|13|||
105686943|NCT00494481|364516462|FG000|Overall Study|Adverse Event|15|||
105686944|NCT00494481|364516463|FG001|Overall Study|Adverse Event|11|||
105917594|NCT00264147|365356898|FG002|Treatment I Period|Laboratory Adverse Event|0|||
105917595|NCT00264147|365356899|FG003|Treatment I Period|Laboratory Adverse Event|1|||
106129822|NCT03251378|366131307|FG004|Overall Study|Physician Decision|0|||
106129823|NCT03251378|366131308|FG005|Overall Study|Physician Decision|0|||
106129824|NCT03251378|366131309|FG006|Overall Study|Physician Decision|0|||
106129825|NCT03251378|366131303|FG000|Overall Study|Other|2|||
106129826|NCT03251378|366131304|FG001|Overall Study|Other|3|||
106129827|NCT03251378|366131305|FG002|Overall Study|Other|2|||
105686945|NCT00494481|364516462|FG000|Overall Study|Other|1|||
105686946|NCT00494481|364516463|FG001|Overall Study|Other|0|||
105686947|NCT00494481|364516462|FG000|Overall Study|Never received IP|2|||
106129828|NCT03251378|366131306|FG003|Overall Study|Other|0|||
106129829|NCT03251378|366131307|FG004|Overall Study|Other|1|||
106129830|NCT03251378|366131308|FG005|Overall Study|Other|1|||
106129831|NCT03251378|366131309|FG006|Overall Study|Other|1|||
106129832|NCT03251378|366131303|FG000|Overall Study|Other|0|||
106129833|NCT03251378|366131304|FG001|Overall Study|Other|0|||
106129834|NCT03251378|366131305|FG002|Overall Study|Other|0|||
105686948|NCT00494481|364516463|FG001|Overall Study|Never received IP|0|||
105686949|NCT01193920|364516464|FG000|Overall Study|Withdrawal by Subject|1|||
105686950|NCT01193920|364516465|FG001|Overall Study|Withdrawal by Subject|0|||
105686951|NCT01193920|364516466|FG002|Overall Study|Withdrawal by Subject|5|||
105686952|NCT01193920|364516467|FG003|Overall Study|Withdrawal by Subject|1|||
105686953|NCT01193920|364516468|FG004|Overall Study|Withdrawal by Subject|3|||
105686954|NCT01193920|364516469|FG005|Overall Study|Withdrawal by Subject|1|||
105686955|NCT01193920|364516470|FG006|Overall Study|Withdrawal by Subject|3|||
105686956|NCT01193920|364516471|FG007|Overall Study|Withdrawal by Subject|0|||
105686957|NCT01193920|364516472|FG008|Overall Study|Withdrawal by Subject|1|||
105686958|NCT01193920|364516473|FG009|Overall Study|Withdrawal by Subject|0|||
105686959|NCT01193920|364516464|FG000|Overall Study|Lost to Follow-up|1|||
105686960|NCT01193920|364516465|FG001|Overall Study|Lost to Follow-up|0|||
105686961|NCT01193920|364516466|FG002|Overall Study|Lost to Follow-up|1|||
105686962|NCT01193920|364516467|FG003|Overall Study|Lost to Follow-up|1|||
105686963|NCT01193920|364516468|FG004|Overall Study|Lost to Follow-up|3|||
105686964|NCT01193920|364516469|FG005|Overall Study|Lost to Follow-up|3|||
105686965|NCT01193920|364516470|FG006|Overall Study|Lost to Follow-up|1|||
105686966|NCT01193920|364516471|FG007|Overall Study|Lost to Follow-up|0|||
105686967|NCT01193920|364516472|FG008|Overall Study|Lost to Follow-up|2|||
105686968|NCT01193920|364516473|FG009|Overall Study|Lost to Follow-up|3|||
105686969|NCT01193920|364516464|FG000|Overall Study|Protocol Violation|1|||
105686970|NCT01193920|364516465|FG001|Overall Study|Protocol Violation|0|||
105686971|NCT01193920|364516466|FG002|Overall Study|Protocol Violation|0|||
105686972|NCT01193920|364516467|FG003|Overall Study|Protocol Violation|0|||
105686973|NCT01193920|364516468|FG004|Overall Study|Protocol Violation|0|||
105686974|NCT01193920|364516469|FG005|Overall Study|Protocol Violation|0|||
105686975|NCT01193920|364516470|FG006|Overall Study|Protocol Violation|0|||
105686976|NCT01193920|364516471|FG007|Overall Study|Protocol Violation|0|||
105686977|NCT01193920|364516472|FG008|Overall Study|Protocol Violation|0|||
105686978|NCT01193920|364516473|FG009|Overall Study|Protocol Violation|0|||
105686979|NCT01193920|364516464|FG000|Overall Study|Death|0|||
105686980|NCT01193920|364516465|FG001|Overall Study|Death|0|||
105686981|NCT01193920|364516466|FG002|Overall Study|Death|0|||
105686982|NCT01193920|364516467|FG003|Overall Study|Death|1|||
105686983|NCT01193920|364516468|FG004|Overall Study|Death|0|||
105686984|NCT01193920|364516469|FG005|Overall Study|Death|0|||
105686985|NCT01193920|364516470|FG006|Overall Study|Death|2|||
105686986|NCT01193920|364516471|FG007|Overall Study|Death|3|||
106129835|NCT03251378|366131306|FG003|Overall Study|Other|4|||
105786585|NCT02389621|364872840|FG001|Posttreatment Period|Lost to Follow-up|1|||
105917596|NCT00264147|365356900|FG004|Treatment I Period|Laboratory Adverse Event|0|||
105917597|NCT00264147|365356901|FG005|Treatment I Period|Laboratory Adverse Event|0|||
105917598|NCT00264147|365356896|FG000|Treatment I Period|Lack of Efficacy|6|||
106129836|NCT03251378|366131307|FG004|Overall Study|Other|13|||
106129837|NCT03251378|366131308|FG005|Overall Study|Other|0|||
106129838|NCT03251378|366131309|FG006|Overall Study|Other|0|||
105686987|NCT01193920|364516472|FG008|Overall Study|Death|2|||
105917599|NCT00264147|365356897|FG001|Treatment I Period|Lack of Efficacy|2|||
106129839|NCT01007552|366131320|FG000|Overall Study|Withdrawal by Subject|1|||
106129840|NCT05174065|366131322|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
105686988|NCT01193920|364516473|FG009|Overall Study|Death|4|||
105686989|NCT01193920|364516464|FG000|Overall Study|Unable to classify|0|||
105686990|NCT01193920|364516465|FG001|Overall Study|Unable to classify|0|||
105686991|NCT01193920|364516466|FG002|Overall Study|Unable to classify|0|||
105686992|NCT01193920|364516467|FG003|Overall Study|Unable to classify|1|||
105686993|NCT01193920|364516468|FG004|Overall Study|Unable to classify|0|||
105686994|NCT01193920|364516469|FG005|Overall Study|Unable to classify|0|||
106129841|NCT05174065|366131323|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
105686995|NCT01193920|364516470|FG006|Overall Study|Unable to classify|0|||
105686996|NCT01193920|364516471|FG007|Overall Study|Unable to classify|1|||
105686997|NCT01193920|364516472|FG008|Overall Study|Unable to classify|0|||
105686998|NCT01193920|364516473|FG009|Overall Study|Unable to classify|0|||
105686999|NCT00332189|364516474|FG000|Overall Study|Adverse Event|3|||
105687000|NCT00332189|364516474|FG000|Overall Study|Uncooperative/Noncompliant|3|||
105687001|NCT00332189|364516474|FG000|Overall Study|Withdrawal by Subject|9|||
105687002|NCT00332189|364516474|FG000|Overall Study|Lack of Efficacy|4|||
105687003|NCT00332189|364516474|FG000|Overall Study|Moved out of country|2|||
105687004|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
105687005|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
105687006|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
105687007|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
105687008|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
105687009|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
105687010|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
105687011|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
105687012|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
105687013|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
105687014|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
105687015|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
105687016|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
105687017|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
105687018|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
105687019|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
105687020|NCT01231516|364516475|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
105687021|NCT01231516|364516476|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
105687022|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
105687023|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
105687024|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
105687025|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
105687026|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
105687027|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
105687028|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
105687029|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
105687030|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
105687031|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
105687032|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
105687033|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
105687034|NCT01231516|364516475|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
105687035|NCT01231516|364516476|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
105687036|NCT01163916|364516477|FG000|Overall Study|Withdrawal by Subject|2|||
105687037|NCT01163916|364516478|FG001|Overall Study|Withdrawal by Subject|0|||
105687038|NCT01163916|364516479|FG002|Overall Study|Withdrawal by Subject|2|||
105687039|NCT01163916|364516477|FG000|Overall Study|Adverse Event|2|||
105687040|NCT01163916|364516478|FG001|Overall Study|Adverse Event|0|||
105687041|NCT01163916|364516479|FG002|Overall Study|Adverse Event|1|||
105687042|NCT01163916|364516477|FG000|Overall Study|Lack of Efficacy|2|||
105687043|NCT01163916|364516478|FG001|Overall Study|Lack of Efficacy|0|||
105687044|NCT01163916|364516479|FG002|Overall Study|Lack of Efficacy|1|||
105687045|NCT01163916|364516477|FG000|Overall Study|Other|24|||
105786586|NCT02389621|364872839|FG000|Posttreatment Period|Other - Miscellaneous|2|||
105786587|NCT02389621|364872840|FG001|Posttreatment Period|Other - Miscellaneous|0|||
105786588|NCT03323034|364872841|FG000|Overall Study|Lack of Efficacy|5|||
105786589|NCT03323034|364872842|FG001|Overall Study|Lack of Efficacy|5|||
105786590|NCT03323034|364872843|FG002|Overall Study|Lack of Efficacy|6|||
105786591|NCT03323034|364872844|FG003|Overall Study|Lack of Efficacy|5|||
105786592|NCT03323034|364872845|FG004|Overall Study|Lack of Efficacy|5|||
105786593|NCT03323034|364872841|FG000|Overall Study|Physician Decision|0|||
105786594|NCT03323034|364872842|FG001|Overall Study|Physician Decision|0|||
106129842|NCT05174065|366131324|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
106129843|NCT05174065|366131322|FG000|Placebo-controlled Period|Other|0|||
106129844|NCT05174065|366131323|FG001|Placebo-controlled Period|Other|1|||
106129845|NCT05174065|366131324|FG002|Placebo-controlled Period|Other|0|||
106129846|NCT05174065|366131322|FG000|Placebo-controlled Period|Adverse Event|1|||
106129847|NCT05174065|366131323|FG001|Placebo-controlled Period|Adverse Event|1|||
105786595|NCT03323034|364872843|FG002|Overall Study|Physician Decision|0|||
105786596|NCT03323034|364872844|FG003|Overall Study|Physician Decision|0|||
105786597|NCT03323034|364872845|FG004|Overall Study|Physician Decision|1|||
105786598|NCT03323034|364872841|FG000|Overall Study|Withdrawal by Subject|1|||
106129848|NCT05174065|366131324|FG002|Placebo-controlled Period|Adverse Event|0|||
106129849|NCT05174065|366131322|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
105687046|NCT01163916|364516478|FG001|Overall Study|Other|4|||
105687047|NCT01163916|364516479|FG002|Overall Study|Other|16|||
105687048|NCT00026208|364516480|FG000|Overall Study|Complications of auto accident|1|||
105687049|NCT00026208|364516481|FG001|Overall Study|Complications of auto accident|0|||
105687050|NCT03170154|364516482|FG000|Overall Study|Lost to Follow-up|4|||
105687051|NCT03170154|364516482|FG000|Overall Study|Death|2|||
105687052|NCT03170154|364516482|FG000|Overall Study|Withdrawal by Subject|2|||
105687053|NCT02279862|364516483|FG000|Overall Study|Study drug toxicity|3|||
105687054|NCT02279862|364516484|FG001|Overall Study|Study drug toxicity|6|||
105687055|NCT02279862|364516483|FG000|Overall Study|No longer meets criteria|0|||
105687056|NCT02279862|364516484|FG001|Overall Study|No longer meets criteria|1|||
105687057|NCT02279862|364516483|FG000|Overall Study|Administrative reason by sponsor|0|||
105687058|NCT02279862|364516484|FG001|Overall Study|Administrative reason by sponsor|1|||
105687059|NCT02279862|364516483|FG000|Overall Study|Disease progression|5|||
105687060|NCT02279862|364516484|FG001|Overall Study|Disease progression|2|||
105687061|NCT02279862|364516483|FG000|Overall Study|Study closed by sponsor|16|||
105687062|NCT02279862|364516484|FG001|Overall Study|Study closed by sponsor|13|||
105687063|NCT02279862|364516483|FG000|Overall Study|Other|1|||
105687064|NCT02279862|364516484|FG001|Overall Study|Other|2|||
105687065|NCT02279862|364516483|FG000|Overall Study|Withdrawal by Subject|1|||
105687066|NCT02279862|364516484|FG001|Overall Study|Withdrawal by Subject|0|||
105687067|NCT05266586|364516485|FG000|Overall Study|Adverse Event|2|||
105687068|NCT05266586|364516486|FG001|Overall Study|Adverse Event|2|||
105687069|NCT05266586|364516487|FG002|Overall Study|Adverse Event|1|||
105687070|NCT05266586|364516485|FG000|Overall Study|Withdrawal by Subject|1|||
105687071|NCT05266586|364516486|FG001|Overall Study|Withdrawal by Subject|0|||
105687072|NCT05266586|364516487|FG002|Overall Study|Withdrawal by Subject|1|||
105687073|NCT05266586|364516485|FG000|Overall Study|Non-compliance with study drug|0|||
105687074|NCT05266586|364516486|FG001|Overall Study|Non-compliance with study drug|1|||
105687075|NCT05266586|364516487|FG002|Overall Study|Non-compliance with study drug|0|||
105687076|NCT05266586|364516485|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
105687077|NCT05266586|364516486|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
105687078|NCT05266586|364516487|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
105687079|NCT03707925|364516488|FG000|Overall Study|Inevaluable|1|||
105687080|NCT00688181|364516489|FG000|Overall Study|Lost to Follow-up|17|||
105687081|NCT00688181|364516489|FG000|Overall Study|Unknown Reason|4|||
105687082|NCT00688181|364516489|FG000|Overall Study|Non-clinical Reason|2|||
105687083|NCT00467285|364516493|FG000|Overall Study|Lost to Follow-up|4|||
105687084|NCT00467285|364516494|FG001|Overall Study|Lost to Follow-up|4|||
105687085|NCT00688103|364516495|FG000|Overall Study|Adverse Event|4|||
105687086|NCT00688103|364516496|FG001|Overall Study|Adverse Event|1|||
105687087|NCT00688103|364516495|FG000|Overall Study|Lack of Efficacy|11|||
105687088|NCT00688103|364516496|FG001|Overall Study|Lack of Efficacy|1|||
105687089|NCT00688103|364516495|FG000|Overall Study|Withdrawal by Subject|4|||
105687090|NCT00688103|364516496|FG001|Overall Study|Withdrawal by Subject|2|||
105687091|NCT00688103|364516495|FG000|Overall Study|complex reasons|11|||
105687092|NCT00688103|364516496|FG001|Overall Study|complex reasons|9|||
105687093|NCT01060540|364518882|FG000|Overall Study|Withdrawal by Subject|10|||
105687094|NCT01060540|364518883|FG001|Overall Study|Withdrawal by Subject|20|||
105687095|NCT01060540|364518882|FG000|Overall Study|Lost to Follow-up|52|||
105687096|NCT01060540|364518883|FG001|Overall Study|Lost to Follow-up|43|||
105687097|NCT01060540|364518882|FG000|Overall Study|Death|2|||
105687098|NCT01060540|364518883|FG001|Overall Study|Death|1|||
105687099|NCT01060540|364518882|FG000|Overall Study|Physician Decision|0|||
105917600|NCT00264147|365356898|FG002|Treatment I Period|Lack of Efficacy|8|||
105917601|NCT00264147|365356899|FG003|Treatment I Period|Lack of Efficacy|0|||
105786599|NCT03323034|364872842|FG001|Overall Study|Withdrawal by Subject|1|||
105687100|NCT01060540|364518883|FG001|Overall Study|Physician Decision|1|||
105786600|NCT03323034|364872843|FG002|Overall Study|Withdrawal by Subject|0|||
105687101|NCT02647320|364518884|FG000|Overall Study|Adverse Event|0|||
105687102|NCT02647320|364518885|FG001|Overall Study|Adverse Event|1|||
105687103|NCT02647320|364518886|FG002|Overall Study|Adverse Event|3|||
105687104|NCT02647320|364518887|FG003|Overall Study|Adverse Event|2|||
105687105|NCT02647320|364518888|FG004|Overall Study|Adverse Event|1|||
105687106|NCT02647320|364518884|FG000|Overall Study|Protocol Violation|0|||
105687107|NCT02647320|364518885|FG001|Overall Study|Protocol Violation|0|||
105687108|NCT02647320|364518886|FG002|Overall Study|Protocol Violation|3|||
105687109|NCT02647320|364518887|FG003|Overall Study|Protocol Violation|0|||
105687110|NCT02647320|364518888|FG004|Overall Study|Protocol Violation|0|||
105687111|NCT02647320|364518884|FG000|Overall Study|Withdrawal by Subject|7|||
105687112|NCT02647320|364518885|FG001|Overall Study|Withdrawal by Subject|4|||
105687113|NCT02647320|364518886|FG002|Overall Study|Withdrawal by Subject|2|||
105687114|NCT02647320|364518887|FG003|Overall Study|Withdrawal by Subject|2|||
105687115|NCT02647320|364518888|FG004|Overall Study|Withdrawal by Subject|7|||
105687116|NCT02647320|364518884|FG000|Overall Study|Persistent hyperglycemia|0|||
105687117|NCT02647320|364518885|FG001|Overall Study|Persistent hyperglycemia|1|||
105687118|NCT02647320|364518886|FG002|Overall Study|Persistent hyperglycemia|1|||
105687119|NCT02647320|364518887|FG003|Overall Study|Persistent hyperglycemia|1|||
105687120|NCT02647320|364518888|FG004|Overall Study|Persistent hyperglycemia|1|||
105687121|NCT02647320|364518884|FG000|Overall Study|Study terminated by sponsor|1|||
105687122|NCT02647320|364518885|FG001|Overall Study|Study terminated by sponsor|1|||
105687123|NCT02647320|364518886|FG002|Overall Study|Study terminated by sponsor|1|||
105687124|NCT02647320|364518887|FG003|Overall Study|Study terminated by sponsor|1|||
105687125|NCT02647320|364518888|FG004|Overall Study|Study terminated by sponsor|2|||
105687126|NCT02647320|364518884|FG000|Overall Study|Reason not provided|0|||
105687127|NCT02647320|364518885|FG001|Overall Study|Reason not provided|0|||
105687128|NCT02647320|364518886|FG002|Overall Study|Reason not provided|1|||
105687129|NCT02647320|364518887|FG003|Overall Study|Reason not provided|0|||
105687130|NCT02647320|364518888|FG004|Overall Study|Reason not provided|2|||
105687131|NCT02647320|364518884|FG000|Overall Study|Lost to Follow-up|1|||
105687132|NCT02647320|364518885|FG001|Overall Study|Lost to Follow-up|1|||
105687133|NCT02647320|364518886|FG002|Overall Study|Lost to Follow-up|0|||
105687134|NCT02647320|364518887|FG003|Overall Study|Lost to Follow-up|0|||
105687135|NCT02647320|364518888|FG004|Overall Study|Lost to Follow-up|0|||
105687136|NCT02647320|364518884|FG000|Overall Study|Develop anemia|1|||
105687137|NCT02647320|364518885|FG001|Overall Study|Develop anemia|0|||
105687138|NCT02647320|364518886|FG002|Overall Study|Develop anemia|0|||
105687139|NCT02647320|364518887|FG003|Overall Study|Develop anemia|0|||
105687140|NCT02647320|364518888|FG004|Overall Study|Develop anemia|0|||
105687141|NCT02647320|364518884|FG000|Overall Study|Lack of Efficacy|0|||
105687142|NCT02647320|364518885|FG001|Overall Study|Lack of Efficacy|0|||
105687143|NCT02647320|364518886|FG002|Overall Study|Lack of Efficacy|0|||
105687144|NCT02647320|364518887|FG003|Overall Study|Lack of Efficacy|1|||
105687145|NCT02647320|364518888|FG004|Overall Study|Lack of Efficacy|0|||
105687146|NCT02647320|364518884|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
105687147|NCT02647320|364518885|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
105687148|NCT02647320|364518886|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
105687149|NCT02647320|364518887|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
105687150|NCT02647320|364518888|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
105687151|NCT00081770|364518889|FG000|Overall Study|Adverse Event|130|||
105687152|NCT00081770|364518890|FG001|Overall Study|Adverse Event|98|||
105687153|NCT00081770|364518891|FG002|Overall Study|Adverse Event|136|||
105687154|NCT00081770|364518889|FG000|Overall Study|Lack of Efficacy|262|||
105687155|NCT00081770|364518890|FG001|Overall Study|Lack of Efficacy|357|||
105687156|NCT00081770|364518891|FG002|Overall Study|Lack of Efficacy|211|||
105687157|NCT00081770|364518889|FG000|Overall Study|Lost to Follow-up|45|||
105687158|NCT00081770|364518890|FG001|Overall Study|Lost to Follow-up|34|||
105687159|NCT00081770|364518891|FG002|Overall Study|Lost to Follow-up|45|||
105687160|NCT00081770|364518889|FG000|Overall Study|Protocol Violation|15|||
105687161|NCT00081770|364518890|FG001|Overall Study|Protocol Violation|10|||
105687162|NCT00081770|364518891|FG002|Overall Study|Protocol Violation|10|||
105687163|NCT00081770|364518889|FG000|Overall Study|Withdrawal by Subject|45|||
105687164|NCT00081770|364518890|FG001|Overall Study|Withdrawal by Subject|40|||
105687165|NCT00081770|364518891|FG002|Overall Study|Withdrawal by Subject|42|||
105687166|NCT00081770|364518889|FG000|Overall Study|Did not meet protocol eligibility|2|||
105687167|NCT00081770|364518890|FG001|Overall Study|Did not meet protocol eligibility|0|||
105687168|NCT00081770|364518891|FG002|Overall Study|Did not meet protocol eligibility|3|||
105687169|NCT00081770|364518889|FG000|Overall Study|Administrative|1|||
105687170|NCT00081770|364518890|FG001|Overall Study|Administrative|0|||
105687171|NCT00081770|364518891|FG002|Overall Study|Administrative|1|||
105687172|NCT00081770|364518889|FG000|Overall Study|Other|2|||
105687173|NCT00081770|364518890|FG001|Overall Study|Other|7|||
105687174|NCT00081770|364518891|FG002|Overall Study|Other|8|||
105687175|NCT01614197|364518894|FG000|Overall Study|Withdrawal by Subject|0|||
105687176|NCT01614197|364518895|FG001|Overall Study|Withdrawal by Subject|1|||
105687177|NCT01614197|364518896|FG002|Overall Study|Withdrawal by Subject|0|||
105687178|NCT01614197|364518897|FG003|Overall Study|Withdrawal by Subject|0|||
105687179|NCT04281004|364518898|FG000|Overall Study|Physician Decision|1|||
105687180|NCT04281004|364518899|FG001|Overall Study|Physician Decision|0|||
105687181|NCT00971932|364518900|FG000|Overall Study|Withdrawal by Subject|1|||
105687182|NCT00971932|364518900|FG000|Overall Study|Investigator's decision|2|||
105687183|NCT00971932|364518900|FG000|Overall Study|Ongoing|4|||
105687184|NCT01640054|364518901|FG000|Overall Study|Study-specific disc criteria|1|||
105687185|NCT01640054|364518901|FG000|Overall Study|Lack of Efficacy|3|||
105687186|NCT01640054|364518901|FG000|Overall Study|Adverse Event|2|||
105687187|NCT01206777|364518902|FG000|Overall Study|Death|1|||
105687188|NCT01206777|364518902|FG000|Overall Study|Adverse Event|1|||
105687189|NCT02544217|364518905|FG000|Overall Study|Withdrawal by Subject|1|||
105687190|NCT02544217|364518906|FG001|Overall Study|Withdrawal by Subject|1|||
105687191|NCT02544217|364518907|FG002|Overall Study|Withdrawal by Subject|0|||
105687192|NCT02544217|364518908|FG003|Overall Study|Withdrawal by Subject|0|||
105687193|NCT02544217|364518909|FG004|Overall Study|Withdrawal by Subject|0|||
105687194|NCT02544217|364518910|FG005|Overall Study|Withdrawal by Subject|0|||
105687195|NCT01155375|364518911|FG000|Overall Study|Adverse Event|1|||
105687196|NCT01155375|364518912|FG001|Overall Study|Adverse Event|0|||
105687197|NCT02901041|364518913|FG000|Overall Study|Withdrawal by PI|4|||
105687198|NCT02901041|364518914|FG001|Overall Study|Withdrawal by PI|8|||
105687199|NCT02901041|364518913|FG000|Overall Study|Withdrawal by Subject|7|||
105687200|NCT02901041|364518914|FG001|Overall Study|Withdrawal by Subject|3|||
105687201|NCT00762970|364518915|FG000|Overall Study|Withdrawal by Subject|7|||
105687202|NCT00762970|364518916|FG001|Overall Study|Withdrawal by Subject|4|||
105687203|NCT00762970|364518917|FG002|Overall Study|Withdrawal by Subject|0|||
105687204|NCT00762970|364518915|FG000|Overall Study|Protocol Violation|3|||
105687205|NCT00762970|364518916|FG001|Overall Study|Protocol Violation|1|||
105687206|NCT00762970|364518917|FG002|Overall Study|Protocol Violation|1|||
105687207|NCT00762970|364518915|FG000|Overall Study|Lost to Follow-up|1|||
105687208|NCT00762970|364518916|FG001|Overall Study|Lost to Follow-up|2|||
105687209|NCT00762970|364518917|FG002|Overall Study|Lost to Follow-up|0|||
105687210|NCT00762970|364518915|FG000|Overall Study|Difficulty of handling lens|1|||
105687211|NCT00762970|364518916|FG001|Overall Study|Difficulty of handling lens|2|||
105687212|NCT00762970|364518917|FG002|Overall Study|Difficulty of handling lens|0|||
105687213|NCT03818204|364518918|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687214|NCT03818204|364518919|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687215|NCT03818204|364518920|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687216|NCT03818204|364518921|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687217|NCT03818204|364518922|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
105687218|NCT03818204|364518923|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687219|NCT03818204|364518924|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687220|NCT03818204|364518925|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687221|NCT03818204|364518926|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687222|NCT03818204|364518927|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687223|NCT03818204|364518928|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687224|NCT03818204|364518929|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687225|NCT03818204|364518930|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687226|NCT03818204|364518931|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
105687227|NCT03818204|364518932|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687228|NCT03818204|364518933|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687229|NCT03818204|364518934|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687230|NCT03818204|364518935|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687231|NCT03818204|364518936|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
105687232|NCT03818204|364518918|FG000|Overall Study|Physician Decision|0|||
105687233|NCT03818204|364518919|FG001|Overall Study|Physician Decision|0|||
105687234|NCT03818204|364518920|FG002|Overall Study|Physician Decision|0|||
105687235|NCT03818204|364518921|FG003|Overall Study|Physician Decision|0|||
105687236|NCT03818204|364518922|FG004|Overall Study|Physician Decision|0|||
105687237|NCT03818204|364518923|FG005|Overall Study|Physician Decision|0|||
105687238|NCT03818204|364518924|FG006|Overall Study|Physician Decision|0|||
105687239|NCT03818204|364518925|FG007|Overall Study|Physician Decision|0|||
105917602|NCT00264147|365356900|FG004|Treatment I Period|Lack of Efficacy|1|||
105917603|NCT00264147|365356901|FG005|Treatment I Period|Lack of Efficacy|0|||
105917604|NCT00264147|365356896|FG000|Treatment I Period|Lost to Follow-up|1|||
105917605|NCT00264147|365356897|FG001|Treatment I Period|Lost to Follow-up|0|||
105917606|NCT00264147|365356898|FG002|Treatment I Period|Lost to Follow-up|0|||
105917607|NCT00264147|365356899|FG003|Treatment I Period|Lost to Follow-up|1|||
105917608|NCT00264147|365356900|FG004|Treatment I Period|Lost to Follow-up|1|||
105917609|NCT00264147|365356901|FG005|Treatment I Period|Lost to Follow-up|0|||
105687240|NCT03818204|364518926|FG008|Overall Study|Physician Decision|0|||
105687241|NCT03818204|364518927|FG009|Overall Study|Physician Decision|0|||
105687242|NCT03818204|364518928|FG010|Overall Study|Physician Decision|0|||
105687243|NCT03818204|364518929|FG011|Overall Study|Physician Decision|0|||
105687244|NCT03818204|364518930|FG012|Overall Study|Physician Decision|0|||
105687245|NCT03818204|364518931|FG013|Overall Study|Physician Decision|0|||
105687246|NCT03818204|364518932|FG014|Overall Study|Physician Decision|1|||
105687247|NCT03818204|364518933|FG015|Overall Study|Physician Decision|0|||
105917610|NCT00264147|365356896|FG000|Treatment I Period|Protocol Violation|2|||
105917611|NCT00264147|365356897|FG001|Treatment I Period|Protocol Violation|2|||
105687248|NCT03818204|364518934|FG016|Overall Study|Physician Decision|0|||
105687249|NCT03818204|364518935|FG017|Overall Study|Physician Decision|0|||
105687250|NCT03818204|364518936|FG018|Overall Study|Physician Decision|0|||
106129850|NCT05174065|366131323|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
106129851|NCT05174065|366131324|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
106129852|NCT05174065|366131322|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
106129853|NCT05174065|366131323|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
106129854|NCT05174065|366131324|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
105687251|NCT00887250|364518937|FG000|Overall Study|Adverse Event|3|||
105687252|NCT00887250|364518938|FG001|Overall Study|Adverse Event|0|||
105687253|NCT00887250|364518939|FG002|Overall Study|Adverse Event|7|||
105687254|NCT00887250|364518937|FG000|Overall Study|Lack of Efficacy|9|||
105687255|NCT00887250|364518938|FG001|Overall Study|Lack of Efficacy|6|||
105687256|NCT00887250|364518939|FG002|Overall Study|Lack of Efficacy|1|||
105687257|NCT00887250|364518937|FG000|Overall Study|Lost to Follow-up|2|||
105687258|NCT00887250|364518938|FG001|Overall Study|Lost to Follow-up|3|||
105687259|NCT00887250|364518939|FG002|Overall Study|Lost to Follow-up|1|||
105687260|NCT00887250|364518937|FG000|Overall Study|Protocol Violation|2|||
105687261|NCT00887250|364518938|FG001|Overall Study|Protocol Violation|2|||
105687262|NCT00887250|364518939|FG002|Overall Study|Protocol Violation|1|||
105687263|NCT00887250|364518937|FG000|Overall Study|Withdrawal by Subject|2|||
105687264|NCT00887250|364518938|FG001|Overall Study|Withdrawal by Subject|1|||
105687265|NCT00887250|364518939|FG002|Overall Study|Withdrawal by Subject|2|||
105687266|NCT00887250|364518937|FG000|Overall Study|Patient uncooperative|0|||
105687267|NCT00887250|364518938|FG001|Overall Study|Patient uncooperative|0|||
105687268|NCT00887250|364518939|FG002|Overall Study|Patient uncooperative|1|||
105687269|NCT01933113|364518942|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
105687270|NCT01313637|364518943|FG000|Overall Study|Adverse Event|17|||
105687271|NCT01313637|364518944|FG001|Overall Study|Adverse Event|24|||
105687272|NCT01313637|364518945|FG002|Overall Study|Adverse Event|25|||
105687273|NCT01313637|364518946|FG003|Overall Study|Adverse Event|18|||
105687274|NCT01313637|364518943|FG000|Overall Study|Lack of Efficacy|44|||
105687275|NCT01313637|364518944|FG001|Overall Study|Lack of Efficacy|38|||
105917612|NCT00264147|365356898|FG002|Treatment I Period|Protocol Violation|0|||
105917613|NCT00264147|365356899|FG003|Treatment I Period|Protocol Violation|0|||
105917614|NCT00264147|365356900|FG004|Treatment I Period|Protocol Violation|0|||
105917615|NCT00264147|365356901|FG005|Treatment I Period|Protocol Violation|0|||
105917616|NCT00264147|365356896|FG000|Treatment I Period|Withdrawal by Subject|2|||
105917617|NCT00264147|365356897|FG001|Treatment I Period|Withdrawal by Subject|0|||
105917618|NCT00264147|365356898|FG002|Treatment I Period|Withdrawal by Subject|0|||
105917619|NCT00264147|365356899|FG003|Treatment I Period|Withdrawal by Subject|2|||
105917620|NCT00264147|365356900|FG004|Treatment I Period|Withdrawal by Subject|2|||
105917621|NCT00264147|365356901|FG005|Treatment I Period|Withdrawal by Subject|0|||
105917622|NCT00264147|365356896|FG000|Treatment I Period|Patient out of town for an extended time|0|||
105917623|NCT00264147|365356897|FG001|Treatment I Period|Patient out of town for an extended time|1|||
105917624|NCT00264147|365356898|FG002|Treatment I Period|Patient out of town for an extended time|0|||
105917625|NCT00264147|365356899|FG003|Treatment I Period|Patient out of town for an extended time|0|||
105917626|NCT00264147|365356900|FG004|Treatment I Period|Patient out of town for an extended time|0|||
105917627|NCT00264147|365356901|FG005|Treatment I Period|Patient out of town for an extended time|0|||
105917628|NCT00264147|365356896|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105917629|NCT00264147|365356897|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105917630|NCT00264147|365356898|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
105917631|NCT00264147|365356899|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105917632|NCT00264147|365356900|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105917633|NCT00264147|365356901|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
105917634|NCT00264147|365356896|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
105917635|NCT00264147|365356897|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
105917636|NCT00264147|365356898|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
105917637|NCT00264147|365356899|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
105917638|NCT00264147|365356900|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
105917639|NCT00264147|365356901|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
105917640|NCT00264147|365356896|FG000|Treatment II Period|Adverse Event|0|||
105917641|NCT00264147|365356897|FG001|Treatment II Period|Adverse Event|0|||
105917642|NCT00264147|365356898|FG002|Treatment II Period|Adverse Event|0|||
105917643|NCT00264147|365356899|FG003|Treatment II Period|Adverse Event|0|||
105917644|NCT00264147|365356900|FG004|Treatment II Period|Adverse Event|9|||
105917645|NCT00264147|365356901|FG005|Treatment II Period|Adverse Event|9|||
105917646|NCT00264147|365356896|FG000|Treatment II Period|Laboratory Adverse Event|0|||
106129855|NCT05174065|366131322|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
106129856|NCT05174065|366131323|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
105687276|NCT01313637|364518945|FG002|Overall Study|Lack of Efficacy|37|||
105687277|NCT01313637|364518946|FG003|Overall Study|Lack of Efficacy|24|||
105687278|NCT01313637|364518943|FG000|Overall Study|Protocol Violation|4|||
105687279|NCT01313637|364518944|FG001|Overall Study|Protocol Violation|3|||
105687280|NCT01313637|364518945|FG002|Overall Study|Protocol Violation|11|||
105687281|NCT01313637|364518946|FG003|Overall Study|Protocol Violation|5|||
105687282|NCT01313637|364518943|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
105687283|NCT01313637|364518944|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
105687284|NCT01313637|364518945|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
105687285|NCT01313637|364518946|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
105687286|NCT01313637|364518943|FG000|Overall Study|Lost to Follow-up|0|||
105687287|NCT01313637|364518944|FG001|Overall Study|Lost to Follow-up|2|||
105687288|NCT01313637|364518945|FG002|Overall Study|Lost to Follow-up|1|||
105687289|NCT01313637|364518946|FG003|Overall Study|Lost to Follow-up|3|||
105687290|NCT01313637|364518943|FG000|Overall Study|Withdrawal by Subject|11|||
105687291|NCT01313637|364518944|FG001|Overall Study|Withdrawal by Subject|13|||
105687292|NCT01313637|364518945|FG002|Overall Study|Withdrawal by Subject|18|||
105687293|NCT01313637|364518946|FG003|Overall Study|Withdrawal by Subject|15|||
105687294|NCT04218084|364518947|FG000|Overall Study|Adverse Event|7|||
105687295|NCT04218084|364518948|FG001|Overall Study|Adverse Event|2|||
105687296|NCT04218084|364518947|FG000|Overall Study|Withdrawal of Consent|4|||
105687297|NCT04218084|364518948|FG001|Overall Study|Withdrawal of Consent|5|||
105687298|NCT04218084|364518947|FG000|Overall Study|Physician Decision|1|||
105687299|NCT04218084|364518948|FG001|Overall Study|Physician Decision|1|||
105687300|NCT04218084|364518947|FG000|Overall Study|Lost to Follow-up|1|||
105687301|NCT04218084|364518948|FG001|Overall Study|Lost to Follow-up|1|||
105687302|NCT04218084|364518947|FG000|Overall Study|Non-compliance with study drug|1|||
105687303|NCT04218084|364518948|FG001|Overall Study|Non-compliance with study drug|1|||
105687304|NCT04218084|364518947|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
105687305|NCT04218084|364518948|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
105687306|NCT04218084|364518947|FG000|Overall Study|Other|0|||
105687307|NCT04218084|364518948|FG001|Overall Study|Other|1|||
105687308|NCT04218084|364518947|FG000|Overall Study|Ongoing at data cut-off date|62|||
105687309|NCT04218084|364518948|FG001|Overall Study|Ongoing at data cut-off date|58|||
105687310|NCT03840486|364518949|FG000|Overall Study|Withdrawal by Subject|0|||
105687311|NCT03840486|364518950|FG001|Overall Study|Withdrawal by Subject|1|||
105687312|NCT03840486|364518951|FG002|Overall Study|Withdrawal by Subject|0|||
105687313|NCT03840486|364518952|FG003|Overall Study|Withdrawal by Subject|0|||
105687314|NCT03840486|364518953|FG004|Overall Study|Withdrawal by Subject|0|||
105687315|NCT03840486|364518954|FG005|Overall Study|Withdrawal by Subject|0|||
105687316|NCT03840486|364518955|FG006|Overall Study|Withdrawal by Subject|0|||
105687317|NCT03840486|364518956|FG007|Overall Study|Withdrawal by Subject|0|||
105687318|NCT03840486|364518957|FG008|Overall Study|Withdrawal by Subject|0|||
105687319|NCT03840486|364518958|FG009|Overall Study|Withdrawal by Subject|0|||
105687320|NCT03840486|364518959|FG010|Overall Study|Withdrawal by Subject|0|||
105687321|NCT03840486|364518960|FG011|Overall Study|Withdrawal by Subject|0|||
105687322|NCT04661878|364518961|FG000|Overall Study|Lost to Follow-up|6|||
105687323|NCT04661878|364518962|FG001|Overall Study|Lost to Follow-up|5|||
105687324|NCT00690820|364518967|FG000|Period 1|Withdrawal by Subject|0|||
105687325|NCT00690820|364518968|FG001|Period 1|Withdrawal by Subject|1|||
105687326|NCT05333224|364518969|FG000|Overall Study - Infants|Lost to Follow-up|1|||
105687327|NCT05333224|364518970|FG001|Overall Study - Infants|Lost to Follow-up|1|||
105687328|NCT01774110|364518971|FG000|Overall Study|Lost to Follow-up|7|||
105687329|NCT00846391|364518974|FG000|Overall Study|Physician Decision|0|||
105687330|NCT00846391|364518975|FG001|Overall Study|Physician Decision|0|||
105687331|NCT00846391|364518976|FG002|Overall Study|Physician Decision|1|||
105687332|NCT00846391|364518974|FG000|Overall Study|Study Terminated by Sponsor|1|||
105687333|NCT00846391|364518975|FG001|Overall Study|Study Terminated by Sponsor|2|||
105687334|NCT00846391|364518976|FG002|Overall Study|Study Terminated by Sponsor|2|||
105687335|NCT04507126|364518977|FG000|Overall Study|Withdrawal by Subject|1|||
105687336|NCT04507126|364518977|FG000|Overall Study|Protocol Violation|2|||
105687337|NCT04507126|364518977|FG000|Overall Study|Physician Decision|1|||
105687338|NCT02699983|364518978|FG000|Overall Study|Withdrawal by Subject|1|||
105687339|NCT02699983|364518979|FG001|Overall Study|Withdrawal by Subject|0|||
105687340|NCT03575143|364518980|FG000|Overall Study|Lost to Follow-up|0|||
105687341|NCT03575143|364518981|FG001|Overall Study|Lost to Follow-up|0|||
105687342|NCT03575143|364518982|FG002|Overall Study|Lost to Follow-up|4|||
106129857|NCT05174065|366131324|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
106129858|NCT00924560|366131325|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
106129859|NCT00924560|366131326|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
106129860|NCT00924560|366131327|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
105687343|NCT03575143|364518980|FG000|Overall Study|Withdrawal by Subject|0|||
105687344|NCT03575143|364518981|FG001|Overall Study|Withdrawal by Subject|0|||
105687345|NCT03575143|364518982|FG002|Overall Study|Withdrawal by Subject|5|||
105687346|NCT03575143|364518980|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
105687347|NCT03575143|364518981|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
106129861|NCT00924560|366131325|FG000|Overall Study|Non Compliance with the Protocol|20|||
105687348|NCT03575143|364518982|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
105786601|NCT03323034|364872844|FG003|Overall Study|Withdrawal by Subject|1|||
105687349|NCT01287065|364518985|FG000|Treatment Period 1|Adverse Event|0|||
106129862|NCT00924560|366131326|FG001|Overall Study|Non Compliance with the Protocol|15|||
106129863|NCT00924560|366131327|FG002|Overall Study|Non Compliance with the Protocol|4|||
106129864|NCT00924560|366131325|FG000|Overall Study|Physician Decision|2|||
106129865|NCT00924560|366131326|FG001|Overall Study|Physician Decision|3|||
106129866|NCT00924560|366131327|FG002|Overall Study|Physician Decision|4|||
106129867|NCT00924560|366131325|FG000|Overall Study|Withdrawal by Subject|50|||
106129868|NCT00924560|366131326|FG001|Overall Study|Withdrawal by Subject|44|||
106129869|NCT00924560|366131327|FG002|Overall Study|Withdrawal by Subject|18|||
106129870|NCT00924560|366131325|FG000|Overall Study|Adverse Event|39|||
106129871|NCT00924560|366131326|FG001|Overall Study|Adverse Event|33|||
105687350|NCT01287065|364518986|FG001|Treatment Period 1|Adverse Event|0|||
105687351|NCT01287065|364518987|FG002|Treatment Period 1|Adverse Event|0|||
105687352|NCT01287065|364518988|FG003|Treatment Period 1|Adverse Event|0|||
105687353|NCT01287065|364518989|FG004|Treatment Period 1|Adverse Event|1|||
105687354|NCT01287065|364518990|FG005|Treatment Period 1|Adverse Event|0|||
105687355|NCT01287065|364518985|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105687356|NCT01287065|364518986|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105687357|NCT01287065|364518987|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105687358|NCT01287065|364518988|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105687359|NCT01287065|364518989|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105687360|NCT01287065|364518990|FG005|Treatment Period 1|Withdrawal by Subject|1|||
105687361|NCT00973362|364518991|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
105687362|NCT00973362|364518992|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
105687363|NCT00973362|364518991|FG000|Baseline Evaluation|No colposcopy visit|62|||
105687364|NCT00973362|364518992|FG001|Baseline Evaluation|No colposcopy visit|0|||
105687365|NCT00973362|364518991|FG000|Baseline Evaluation|Inevaluable|686|||
105687366|NCT00973362|364518992|FG001|Baseline Evaluation|Inevaluable|223|||
105687367|NCT00973362|364518991|FG000|3-Year Follow-up|Lost to Follow-up|17|||
105687368|NCT00973362|364518992|FG001|3-Year Follow-up|Lost to Follow-up|0|||
105687369|NCT02349451|364518993|FG000|Overall Study|Withdrawal by Subject|0|||
105687370|NCT02349451|364518994|FG001|Overall Study|Withdrawal by Subject|1|||
105687371|NCT02349451|364518995|FG002|Overall Study|Withdrawal by Subject|2|||
105687372|NCT02349451|364518996|FG003|Overall Study|Withdrawal by Subject|1|||
105687373|NCT04781387|364518997|FG000|Overall Study|Withdrawal by Subject|1|||
105687374|NCT04781387|364518998|FG001|Overall Study|Withdrawal by Subject|0|||
105687375|NCT04781387|364518999|FG002|Overall Study|Withdrawal by Subject|1|||
105687376|NCT04781387|364518997|FG000|Overall Study|Lost to Follow-up|1|||
105687377|NCT04781387|364518998|FG001|Overall Study|Lost to Follow-up|0|||
105687378|NCT04781387|364518999|FG002|Overall Study|Lost to Follow-up|0|||
105687379|NCT01423253|364519005|FG000|Overall Study|Adverse Event|2|||
105687380|NCT01423253|364519005|FG000|Overall Study|Lack of Efficacy|2|||
105687381|NCT01423253|364519005|FG000|Overall Study|Lost to Follow-up|1|||
105687382|NCT01423253|364519005|FG000|Overall Study|Protocol Violation|2|||
105687383|NCT01423253|364519005|FG000|Overall Study|Withdrawal by Subject|2|||
105687384|NCT00392327|364519007|FG000|Overall Study|Death|1|||
105687385|NCT00392327|364519008|FG001|Overall Study|Death|0|||
105687386|NCT00392327|364519009|FG002|Overall Study|Death|1|||
105687387|NCT00392327|364519010|FG003|Overall Study|Death|0|||
105687388|NCT00392327|364519011|FG004|Overall Study|Death|0|||
105687389|NCT00392327|364519012|FG005|Overall Study|Death|0|||
105687390|NCT00392327|364519013|FG006|Overall Study|Death|0|||
105687391|NCT00392327|364519014|FG007|Overall Study|Death|0|||
105687392|NCT00392327|364519007|FG000|Overall Study|Lack of Efficacy|8|||
105687393|NCT00392327|364519008|FG001|Overall Study|Lack of Efficacy|8|||
105687394|NCT00392327|364519009|FG002|Overall Study|Lack of Efficacy|9|||
105687395|NCT00392327|364519010|FG003|Overall Study|Lack of Efficacy|6|||
105687396|NCT00392327|364519011|FG004|Overall Study|Lack of Efficacy|3|||
105687397|NCT00392327|364519012|FG005|Overall Study|Lack of Efficacy|3|||
105687398|NCT00392327|364519013|FG006|Overall Study|Lack of Efficacy|3|||
105687399|NCT00392327|364519014|FG007|Overall Study|Lack of Efficacy|3|||
105687400|NCT00392327|364519007|FG000|Overall Study|Physician Decision|3|||
105687401|NCT00392327|364519008|FG001|Overall Study|Physician Decision|5|||
106129872|NCT00924560|366131327|FG002|Overall Study|Adverse Event|0|||
105687402|NCT00392327|364519009|FG002|Overall Study|Physician Decision|2|||
105687403|NCT00392327|364519010|FG003|Overall Study|Physician Decision|2|||
105687404|NCT00392327|364519011|FG004|Overall Study|Physician Decision|0|||
105687405|NCT00392327|364519012|FG005|Overall Study|Physician Decision|1|||
105687406|NCT00392327|364519013|FG006|Overall Study|Physician Decision|5|||
106129873|NCT00924560|366131325|FG000|Overall Study|Pregnancy|5|||
106129874|NCT00924560|366131326|FG001|Overall Study|Pregnancy|7|||
105687407|NCT00392327|364519014|FG007|Overall Study|Physician Decision|3|||
105687408|NCT00392327|364519007|FG000|Overall Study|Protocol Violation|0|||
105687409|NCT00392327|364519008|FG001|Overall Study|Protocol Violation|0|||
105687410|NCT00392327|364519009|FG002|Overall Study|Protocol Violation|1|||
105687411|NCT00392327|364519010|FG003|Overall Study|Protocol Violation|0|||
105687412|NCT00392327|364519011|FG004|Overall Study|Protocol Violation|0|||
105687413|NCT00392327|364519012|FG005|Overall Study|Protocol Violation|0|||
106129875|NCT00924560|366131327|FG002|Overall Study|Pregnancy|1|||
106129876|NCT00924560|366131325|FG000|Overall Study|Lost to Follow-up|78|||
106129877|NCT00924560|366131326|FG001|Overall Study|Lost to Follow-up|94|||
106129878|NCT00924560|366131327|FG002|Overall Study|Lost to Follow-up|45|||
106129879|NCT00924560|366131325|FG000|Overall Study|Miscellaneous Reasons|13|||
106129880|NCT00924560|366131326|FG001|Overall Study|Miscellaneous Reasons|10|||
105687414|NCT00392327|364519013|FG006|Overall Study|Protocol Violation|0|||
105687415|NCT00392327|364519014|FG007|Overall Study|Protocol Violation|0|||
105687416|NCT00392327|364519007|FG000|Overall Study|Withdrawal by Subject|3|||
105687417|NCT00392327|364519008|FG001|Overall Study|Withdrawal by Subject|2|||
105687418|NCT00392327|364519009|FG002|Overall Study|Withdrawal by Subject|4|||
105687419|NCT00392327|364519010|FG003|Overall Study|Withdrawal by Subject|6|||
105687420|NCT00392327|364519011|FG004|Overall Study|Withdrawal by Subject|0|||
105687421|NCT00392327|364519012|FG005|Overall Study|Withdrawal by Subject|1|||
105687422|NCT00392327|364519013|FG006|Overall Study|Withdrawal by Subject|1|||
105687423|NCT00392327|364519014|FG007|Overall Study|Withdrawal by Subject|5|||
105687424|NCT00392327|364519007|FG000|Overall Study|Ineligible|0|||
105687425|NCT00392327|364519008|FG001|Overall Study|Ineligible|4|||
105687426|NCT00392327|364519009|FG002|Overall Study|Ineligible|3|||
105687427|NCT00392327|364519010|FG003|Overall Study|Ineligible|2|||
105687428|NCT00392327|364519011|FG004|Overall Study|Ineligible|0|||
105687429|NCT00392327|364519012|FG005|Overall Study|Ineligible|0|||
105687430|NCT00392327|364519013|FG006|Overall Study|Ineligible|0|||
106129881|NCT00924560|366131327|FG002|Overall Study|Miscellaneous Reasons|10|||
106129882|NCT03621982|366131328|FG000|Overall Study|Withdrawal by Subject|1|||
106129883|NCT03621982|366131329|FG001|Overall Study|Withdrawal by Subject|0|||
106129884|NCT03621982|366131330|FG002|Overall Study|Withdrawal by Subject|0|||
106129885|NCT03621982|366131331|FG003|Overall Study|Withdrawal by Subject|1|||
106129886|NCT03621982|366131332|FG004|Overall Study|Withdrawal by Subject|0|||
106129887|NCT03621982|366131333|FG005|Overall Study|Withdrawal by Subject|1|||
106129888|NCT03621982|366131334|FG006|Overall Study|Withdrawal by Subject|1|||
106129889|NCT03621982|366131335|FG007|Overall Study|Withdrawal by Subject|0|||
106129890|NCT03621982|366131336|FG008|Overall Study|Withdrawal by Subject|1|||
106129891|NCT03621982|366131337|FG009|Overall Study|Withdrawal by Subject|0|||
106129892|NCT03621982|366131338|FG010|Overall Study|Withdrawal by Subject|2|||
106129893|NCT03621982|366131339|FG011|Overall Study|Withdrawal by Subject|1|||
105687431|NCT00392327|364519014|FG007|Overall Study|Ineligible|0|||
105687432|NCT03267940|364519015|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
105687433|NCT03267940|364519016|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
105687434|NCT03267940|364519017|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
105687435|NCT03267940|364519018|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
105687436|NCT03267940|364519019|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
105687437|NCT03267940|364519020|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
105687438|NCT03267940|364519015|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105687439|NCT03267940|364519016|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
105917647|NCT00264147|365356897|FG001|Treatment II Period|Laboratory Adverse Event|0|||
105917648|NCT00264147|365356898|FG002|Treatment II Period|Laboratory Adverse Event|0|||
106129894|NCT03621982|366131340|FG012|Overall Study|Withdrawal by Subject|2|||
105687440|NCT03267940|364519017|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105687441|NCT03267940|364519018|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105687442|NCT03267940|364519019|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
106129895|NCT03621982|366131341|FG013|Overall Study|Withdrawal by Subject|2|||
106129896|NCT03621982|366131328|FG000|Overall Study|Investigator/Sponsor decision|0|||
106129897|NCT03621982|366131329|FG001|Overall Study|Investigator/Sponsor decision|0|||
105687443|NCT03267940|364519020|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
105687444|NCT03267940|364519015|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687445|NCT03267940|364519016|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
105687446|NCT03267940|364519017|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687447|NCT03267940|364519018|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687448|NCT03267940|364519019|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687449|NCT03267940|364519020|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
105687450|NCT03267940|364519015|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
105687451|NCT03267940|364519016|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
105687452|NCT03267940|364519017|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
105687453|NCT03267940|364519018|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
105687454|NCT03267940|364519019|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
105687455|NCT03267940|364519020|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
105687456|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
105687457|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
105917649|NCT00264147|365356899|FG003|Treatment II Period|Laboratory Adverse Event|0|||
105917650|NCT00264147|365356900|FG004|Treatment II Period|Laboratory Adverse Event|0|||
105917651|NCT00264147|365356901|FG005|Treatment II Period|Laboratory Adverse Event|1|||
105917652|NCT00264147|365356896|FG000|Treatment II Period|Lack of Efficacy|0|||
105917653|NCT00264147|365356897|FG001|Treatment II Period|Lack of Efficacy|0|||
105917654|NCT00264147|365356898|FG002|Treatment II Period|Lack of Efficacy|0|||
105917655|NCT00264147|365356899|FG003|Treatment II Period|Lack of Efficacy|0|||
105917656|NCT00264147|365356900|FG004|Treatment II Period|Lack of Efficacy|20|||
105917657|NCT00264147|365356901|FG005|Treatment II Period|Lack of Efficacy|19|||
105917658|NCT00264147|365356896|FG000|Treatment II Period|Lost to Follow-up|0|||
105917659|NCT00264147|365356897|FG001|Treatment II Period|Lost to Follow-up|0|||
105917660|NCT00264147|365356898|FG002|Treatment II Period|Lost to Follow-up|0|||
105917661|NCT00264147|365356899|FG003|Treatment II Period|Lost to Follow-up|0|||
105917662|NCT00264147|365356900|FG004|Treatment II Period|Lost to Follow-up|1|||
105917663|NCT00264147|365356901|FG005|Treatment II Period|Lost to Follow-up|1|||
105917664|NCT00264147|365356896|FG000|Treatment II Period|Withdrawal by Subject|0|||
105917665|NCT00264147|365356897|FG001|Treatment II Period|Withdrawal by Subject|0|||
105917666|NCT00264147|365356898|FG002|Treatment II Period|Withdrawal by Subject|0|||
105917667|NCT00264147|365356899|FG003|Treatment II Period|Withdrawal by Subject|0|||
105917668|NCT00264147|365356900|FG004|Treatment II Period|Withdrawal by Subject|3|||
105917669|NCT00264147|365356901|FG005|Treatment II Period|Withdrawal by Subject|2|||
105917670|NCT00264147|365356896|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
105917671|NCT00264147|365356897|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
105917672|NCT00264147|365356898|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
105917673|NCT00264147|365356899|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
105917674|NCT00264147|365356900|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
105917675|NCT00264147|365356901|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
105917676|NCT03234465|365356902|FG000|Overall Study|Adverse Event|4|||
105917677|NCT03234465|365356903|FG001|Overall Study|Adverse Event|2|||
105917678|NCT03234465|365356902|FG000|Overall Study|Death|0|||
105917679|NCT03234465|365356903|FG001|Overall Study|Death|1|||
105917680|NCT03234465|365356902|FG000|Overall Study|Lost to Follow-up|1|||
105917681|NCT03234465|365356903|FG001|Overall Study|Lost to Follow-up|1|||
105917682|NCT03234465|365356902|FG000|Overall Study|Withdrawal by Subject|12|||
105917683|NCT03234465|365356903|FG001|Overall Study|Withdrawal by Subject|27|||
105917684|NCT03234465|365356902|FG000|Overall Study|Symptomatic deterioration|0|||
105917685|NCT03234465|365356903|FG001|Overall Study|Symptomatic deterioration|1|||
106129898|NCT03621982|366131330|FG002|Overall Study|Investigator/Sponsor decision|0|||
106129899|NCT03621982|366131331|FG003|Overall Study|Investigator/Sponsor decision|0|||
106129900|NCT03621982|366131332|FG004|Overall Study|Investigator/Sponsor decision|0|||
106129901|NCT03621982|366131333|FG005|Overall Study|Investigator/Sponsor decision|0|||
106129902|NCT03621982|366131334|FG006|Overall Study|Investigator/Sponsor decision|0|||
106129903|NCT03621982|366131335|FG007|Overall Study|Investigator/Sponsor decision|0|||
105917686|NCT03234465|365356902|FG000|Overall Study|Non-compliance|2|||
105917687|NCT03234465|365356903|FG001|Overall Study|Non-compliance|0|||
105917688|NCT03234465|365356902|FG000|Overall Study|Other|14|||
105917689|NCT03234465|365356903|FG001|Overall Study|Other|8|||
105917690|NCT02247466|365356911|FG000|Overall Study|Procedure changed to open surgery|0|||
105917691|NCT02247466|365356912|FG001|Overall Study|Procedure changed to open surgery|3|||
105917692|NCT00721799|365356913|FG000|Overall Study|Withdrawal by Subject|7|||
106129904|NCT03621982|366131336|FG008|Overall Study|Investigator/Sponsor decision|0|||
105917693|NCT00721799|365356913|FG000|Overall Study|withdraw by subject after scan 1|1|||
105917694|NCT00764790|365356915|FG000|Overall Study|Protocol Violation|0|||
105917695|NCT00764790|365356916|FG001|Overall Study|Protocol Violation|0|||
105917696|NCT00764790|365356917|FG002|Overall Study|Protocol Violation|1|||
105687458|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
105687459|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
105687460|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
105687461|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
105687462|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
105687463|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
105687464|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
105687465|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
105687466|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
105687467|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
105687468|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
105687469|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
105687470|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
105687471|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
106129905|NCT03621982|366131337|FG009|Overall Study|Investigator/Sponsor decision|0|||
106129906|NCT03621982|366131338|FG010|Overall Study|Investigator/Sponsor decision|0|||
106129907|NCT03621982|366131339|FG011|Overall Study|Investigator/Sponsor decision|4|||
106129908|NCT03621982|366131340|FG012|Overall Study|Investigator/Sponsor decision|0|||
106129909|NCT03621982|366131341|FG013|Overall Study|Investigator/Sponsor decision|2|||
106129910|NCT03621982|366131328|FG000|Overall Study|Death|2|||
106129911|NCT03621982|366131329|FG001|Overall Study|Death|4|||
106129912|NCT03621982|366131330|FG002|Overall Study|Death|4|||
106129913|NCT03621982|366131331|FG003|Overall Study|Death|3|||
106129914|NCT03621982|366131332|FG004|Overall Study|Death|8|||
106129915|NCT03621982|366131333|FG005|Overall Study|Death|4|||
106129916|NCT03621982|366131334|FG006|Overall Study|Death|6|||
106129917|NCT03621982|366131335|FG007|Overall Study|Death|3|||
106129918|NCT03621982|366131336|FG008|Overall Study|Death|0|||
106129919|NCT03621982|366131337|FG009|Overall Study|Death|3|||
106129920|NCT03621982|366131338|FG010|Overall Study|Death|8|||
106129921|NCT03621982|366131339|FG011|Overall Study|Death|4|||
106129922|NCT03621982|366131340|FG012|Overall Study|Death|2|||
106129923|NCT03621982|366131341|FG013|Overall Study|Death|2|||
106129924|NCT03621982|366131328|FG000|Overall Study|Lost to Follow-up|0|||
106129925|NCT03621982|366131329|FG001|Overall Study|Lost to Follow-up|0|||
106129926|NCT03621982|366131330|FG002|Overall Study|Lost to Follow-up|1|||
106129927|NCT03621982|366131331|FG003|Overall Study|Lost to Follow-up|0|||
106129928|NCT03621982|366131332|FG004|Overall Study|Lost to Follow-up|0|||
106129929|NCT03621982|366131333|FG005|Overall Study|Lost to Follow-up|0|||
106129930|NCT03621982|366131334|FG006|Overall Study|Lost to Follow-up|1|||
106129931|NCT03621982|366131335|FG007|Overall Study|Lost to Follow-up|0|||
106129932|NCT03621982|366131336|FG008|Overall Study|Lost to Follow-up|0|||
106129933|NCT03621982|366131337|FG009|Overall Study|Lost to Follow-up|1|||
106129934|NCT03621982|366131338|FG010|Overall Study|Lost to Follow-up|0|||
106129935|NCT03621982|366131339|FG011|Overall Study|Lost to Follow-up|0|||
106129936|NCT03621982|366131340|FG012|Overall Study|Lost to Follow-up|0|||
106129937|NCT03621982|366131341|FG013|Overall Study|Lost to Follow-up|0|||
106129938|NCT02753530|366131342|FG000|Overall Study|Adverse Event|7|||
105687472|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
106129939|NCT02753530|366131343|FG001|Overall Study|Adverse Event|1|||
106129940|NCT02753530|366131342|FG000|Overall Study|Death|0|||
106129941|NCT02753530|366131343|FG001|Overall Study|Death|1|||
106129942|NCT02753530|366131342|FG000|Overall Study|Physician Decision|0|||
106129943|NCT02753530|366131343|FG001|Overall Study|Physician Decision|1|||
106129944|NCT02753530|366131342|FG000|Overall Study|Protocol Violation|1|||
106129945|NCT02753530|366131343|FG001|Overall Study|Protocol Violation|0|||
106129946|NCT02753530|366131342|FG000|Overall Study|Withdrawal by Subject|4|||
106129947|NCT02753530|366131343|FG001|Overall Study|Withdrawal by Subject|3|||
106129948|NCT00731042|366132869|FG000|Second Intervention|Did not meet inclusion criteria|0|||
106129949|NCT00731042|366132870|FG001|Second Intervention|Did not meet inclusion criteria|2|||
106129950|NCT00231179|366132874|FG000|Overall Study|Lost to Follow-up|21|||
106129951|NCT00231179|366132875|FG001|Overall Study|Lost to Follow-up|21|||
106129952|NCT00231179|366132874|FG000|Overall Study|Withdrawal by Subject|3|||
106129953|NCT00231179|366132875|FG001|Overall Study|Withdrawal by Subject|3|||
106129954|NCT03531905|366132879|FG000|Overall Study|Withdrawal by Subject|3|||
106129955|NCT03531905|366132880|FG001|Overall Study|Withdrawal by Subject|3|||
106129956|NCT03531905|366132881|FG002|Overall Study|Withdrawal by Subject|2|||
106129957|NCT03531905|366132879|FG000|Overall Study|Lost to Follow-up|2|||
106129958|NCT03531905|366132880|FG001|Overall Study|Lost to Follow-up|2|||
106129959|NCT03531905|366132881|FG002|Overall Study|Lost to Follow-up|1|||
106129960|NCT03531905|366132879|FG000|Overall Study|Participant was out of town|1|||
106129961|NCT03531905|366132880|FG001|Overall Study|Participant was out of town|0|||
106129962|NCT03531905|366132881|FG002|Overall Study|Participant was out of town|0|||
106129963|NCT03531905|366132879|FG000|Overall Study|Could not speak with the participant|1|||
106129964|NCT03531905|366132880|FG001|Overall Study|Could not speak with the participant|0|||
105687473|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
105687474|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
105687475|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
105687476|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
105687477|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
105687478|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
105687479|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
105687480|NCT03267940|364519015|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
105687481|NCT03267940|364519016|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
105687482|NCT03267940|364519017|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
106129965|NCT03531905|366132881|FG002|Overall Study|Could not speak with the participant|0|||
106129966|NCT01174550|366132884|FG000|Overall Study|Death|75|||
106129967|NCT01174550|366132885|FG001|Overall Study|Death|74|||
106129968|NCT01174550|366132884|FG000|Overall Study|Lost to Follow-up|652|||
106129969|NCT01174550|366132885|FG001|Overall Study|Lost to Follow-up|510|||
106129970|NCT01174550|366132884|FG000|Overall Study|Withdrawal by Subject|543|||
106129971|NCT01174550|366132885|FG001|Overall Study|Withdrawal by Subject|289|||
106129972|NCT01536262|366132886|FG000|Overall Study|Adverse Event|6|||
106129973|NCT01536262|366132887|FG001|Overall Study|Adverse Event|1|||
106129974|NCT01536262|366132888|FG002|Overall Study|Adverse Event|2|||
106129975|NCT01536262|366132886|FG000|Overall Study|Withdrawal by Subject|1|||
106129976|NCT01536262|366132887|FG001|Overall Study|Withdrawal by Subject|1|||
105917697|NCT00764790|365356915|FG000|Overall Study|Withdrawal by Subject|10|||
105917698|NCT00764790|365356916|FG001|Overall Study|Withdrawal by Subject|12|||
105917699|NCT00764790|365356917|FG002|Overall Study|Withdrawal by Subject|6|||
105917700|NCT00764790|365356915|FG000|Overall Study|Lost to Follow-up|28|||
105917701|NCT00764790|365356916|FG001|Overall Study|Lost to Follow-up|29|||
105917702|NCT00764790|365356917|FG002|Overall Study|Lost to Follow-up|23|||
105917703|NCT05117060|365356919|FG000|Overall Study|Adverse Event|3|||
105917704|NCT05117060|365356920|FG001|Overall Study|Adverse Event|5|||
105917705|NCT05117060|365356921|FG002|Overall Study|Adverse Event|6|||
105917706|NCT05117060|365356922|FG003|Overall Study|Adverse Event|1|||
105917707|NCT05117060|365356919|FG000|Overall Study|Lost to Follow-up|0|||
106001352|NCT02614729|365667712|FG000|Overall Study|Withdrawal by Subject|1|||
106001353|NCT02614729|365667713|FG001|Overall Study|Withdrawal by Subject|0|||
106001354|NCT04564846|365667714|FG000|Overall Study|Withdrawal by Subject|2|||
106001355|NCT04564846|365667715|FG001|Overall Study|Withdrawal by Subject|1|||
106001356|NCT04564846|365667714|FG000|Overall Study|Physician Decision|0|||
106001357|NCT04564846|365667715|FG001|Overall Study|Physician Decision|1|||
106001358|NCT04564846|365667714|FG000|Overall Study|Lost to Follow-up|0|||
106001359|NCT04564846|365667715|FG001|Overall Study|Lost to Follow-up|1|||
106129977|NCT01536262|366132888|FG002|Overall Study|Withdrawal by Subject|0|||
106129978|NCT01536262|366132886|FG000|Overall Study|Other than stated above|1|||
106001360|NCT04564846|365667714|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
106001361|NCT04564846|365667715|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
106001362|NCT04564846|365667714|FG000|Overall Study|Subject non-compliance|1|||
106001363|NCT04564846|365667715|FG001|Overall Study|Subject non-compliance|0|||
106001364|NCT00985673|365667718|FG000|Overall Study|Lost to Follow-up|6|||
106001365|NCT00985673|365667719|FG001|Overall Study|Lost to Follow-up|7|||
106001366|NCT00985673|365667720|FG002|Overall Study|Lost to Follow-up|6|||
106001367|NCT00985673|365667721|FG003|Overall Study|Lost to Follow-up|10|||
106001368|NCT00985673|365667722|FG004|Overall Study|Lost to Follow-up|5|||
106001369|NCT00985673|365667723|FG005|Overall Study|Lost to Follow-up|3|||
106129979|NCT01536262|366132887|FG001|Overall Study|Other than stated above|0|||
106001370|NCT00985673|365667718|FG000|Overall Study|Withdrawal by Subject|0|||
106001371|NCT00985673|365667719|FG001|Overall Study|Withdrawal by Subject|4|||
106001372|NCT00985673|365667720|FG002|Overall Study|Withdrawal by Subject|5|||
106001373|NCT00985673|365667721|FG003|Overall Study|Withdrawal by Subject|2|||
106001374|NCT00985673|365667722|FG004|Overall Study|Withdrawal by Subject|2|||
106001375|NCT00985673|365667723|FG005|Overall Study|Withdrawal by Subject|3|||
106001376|NCT00985673|365667718|FG000|Overall Study|Other|1|||
106001377|NCT00985673|365667719|FG001|Overall Study|Other|0|||
106001378|NCT00985673|365667720|FG002|Overall Study|Other|1|||
106129980|NCT01536262|366132888|FG002|Overall Study|Other than stated above|0|||
106129981|NCT02459587|366132893|FG000|3-Month Follow-up Assessment|Death|0|||
105687483|NCT03267940|364519018|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
105687484|NCT03267940|364519019|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
105917708|NCT05117060|365356920|FG001|Overall Study|Lost to Follow-up|0|||
106001379|NCT00985673|365667721|FG003|Overall Study|Other|0|||
106001380|NCT00985673|365667722|FG004|Overall Study|Other|1|||
106001381|NCT00985673|365667723|FG005|Overall Study|Other|0|||
106001382|NCT00531284|365667724|FG000|Overall Study|Progressive Disease|1|||
105917709|NCT05117060|365356921|FG002|Overall Study|Lost to Follow-up|0|||
105917710|NCT05117060|365356922|FG003|Overall Study|Lost to Follow-up|1|||
106001383|NCT00531284|365667725|FG001|Overall Study|Progressive Disease|3|||
106129982|NCT02459587|366132894|FG001|3-Month Follow-up Assessment|Death|2|||
106129983|NCT02459587|366132893|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
106129984|NCT02459587|366132894|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
106129985|NCT02459587|366132893|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
106129986|NCT02459587|366132894|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
106129987|NCT02459587|366132893|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
106129988|NCT02459587|366132894|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
106129989|NCT02459587|366132893|FG000|6-month Follow-up Assessment|Death|2|||
106129990|NCT02459587|366132894|FG001|6-month Follow-up Assessment|Death|1|||
106129991|NCT02459587|366132893|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
106129992|NCT02459587|366132894|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
106129993|NCT02459587|366132893|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
106129994|NCT02459587|366132894|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
106129995|NCT02459587|366132893|FG000|12-month Follow-up Assessment|Death|2|||
106129996|NCT02459587|366132894|FG001|12-month Follow-up Assessment|Death|0|||
106129997|NCT02459587|366132893|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
106129998|NCT02459587|366132894|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
106129999|NCT02459587|366132893|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
106130000|NCT02459587|366132894|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
106130001|NCT02459587|366132893|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
106130002|NCT02459587|366132894|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
106130003|NCT00515086|366132895|FG000|Overall Study|Adverse Event|1|||
106130004|NCT00515086|366132896|FG001|Overall Study|Adverse Event|1|||
106130005|NCT00515086|366132897|FG002|Overall Study|Adverse Event|2|||
106130006|NCT00515086|366132898|FG003|Overall Study|Adverse Event|3|||
106130007|NCT00515086|366132895|FG000|Overall Study|Administrative|1|||
106130008|NCT00515086|366132896|FG001|Overall Study|Administrative|1|||
106130009|NCT00515086|366132897|FG002|Overall Study|Administrative|0|||
106130010|NCT00515086|366132898|FG003|Overall Study|Administrative|0|||
106130011|NCT00515086|366132895|FG000|Overall Study|Withdrawal by Subject|1|||
106130012|NCT00515086|366132896|FG001|Overall Study|Withdrawal by Subject|0|||
106130013|NCT00515086|366132897|FG002|Overall Study|Withdrawal by Subject|0|||
106130014|NCT00515086|366132898|FG003|Overall Study|Withdrawal by Subject|1|||
106130015|NCT00515086|366132895|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
106130016|NCT00515086|366132896|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
106130017|NCT00515086|366132897|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
106130018|NCT00515086|366132898|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
106130019|NCT00515086|366132895|FG000|Overall Study|Lost to Follow-up|1|||
106130020|NCT00515086|366132896|FG001|Overall Study|Lost to Follow-up|0|||
106130021|NCT00515086|366132897|FG002|Overall Study|Lost to Follow-up|0|||
106130022|NCT00515086|366132898|FG003|Overall Study|Lost to Follow-up|0|||
106130023|NCT00515086|366132895|FG000|Overall Study|Study drug no longer required|0|||
106130024|NCT00515086|366132896|FG001|Overall Study|Study drug no longer required|1|||
106130025|NCT00515086|366132897|FG002|Overall Study|Study drug no longer required|0|||
106130026|NCT00515086|366132898|FG003|Overall Study|Study drug no longer required|0|||
106130027|NCT00515086|366132895|FG000|Overall Study|Death|2|||
106130028|NCT00515086|366132896|FG001|Overall Study|Death|0|||
106130029|NCT00515086|366132897|FG002|Overall Study|Death|0|||
106130030|NCT00515086|366132898|FG003|Overall Study|Death|0|||
106130031|NCT03930186|366132899|FG000|Weeks 0 to 16|Adverse Event|6|||
106130032|NCT03930186|366132899|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
106130033|NCT03930186|366132899|FG000|Weeks 16 to 32|Adverse Event|1|||
106130034|NCT03930186|366132899|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
106130035|NCT00557505|366132901|FG000|Overall Study|Death|0|||
106130036|NCT00557505|366132902|FG001|Overall Study|Death|0|||
106130037|NCT00557505|366132903|FG002|Overall Study|Death|0|||
106130038|NCT00557505|366132904|FG003|Overall Study|Death|0|||
105687485|NCT03267940|364519020|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
105687486|NCT01296347|364519029|FG000|Allocation|Withdrawal by Subject|1|||
105687487|NCT01296347|364519030|FG001|Allocation|Withdrawal by Subject|2|||
106130039|NCT00557505|366132905|FG004|Overall Study|Death|0|||
106130040|NCT00557505|366132906|FG005|Overall Study|Death|0|||
105687488|NCT01296347|364519029|FG000|Allocation|Lack of Efficacy|1|||
106130041|NCT00557505|366132907|FG006|Overall Study|Death|0|||
106130042|NCT00557505|366132908|FG007|Overall Study|Death|0|||
106130043|NCT00557505|366132909|FG008|Overall Study|Death|1|||
106130044|NCT00557505|366132901|FG000|Overall Study|Adverse Event|0|||
105687489|NCT01296347|364519030|FG001|Allocation|Lack of Efficacy|2|||
105687490|NCT01296347|364519029|FG000|Allocation|not received infusion|1|||
105687491|NCT01296347|364519030|FG001|Allocation|not received infusion|0|||
105687492|NCT01296347|364519029|FG000|6 Week Follow up|Death|0|||
106130045|NCT00557505|366132902|FG001|Overall Study|Adverse Event|0|||
106130046|NCT00557505|366132903|FG002|Overall Study|Adverse Event|1|||
106130047|NCT00557505|366132904|FG003|Overall Study|Adverse Event|0|||
106130048|NCT00557505|366132905|FG004|Overall Study|Adverse Event|0|||
105687493|NCT01296347|364519030|FG001|6 Week Follow up|Death|1|||
105687494|NCT01296347|364519029|FG000|3 Month Follow up|Death|1|||
105687495|NCT01296347|364519030|FG001|3 Month Follow up|Death|0|||
105687496|NCT01296347|364519029|FG000|3 Month Follow up|Lost to Follow-up|0|||
105687497|NCT01296347|364519030|FG001|3 Month Follow up|Lost to Follow-up|1|||
105687498|NCT01296347|364519029|FG000|6 Month Follow up|Death|2|||
105687499|NCT01296347|364519030|FG001|6 Month Follow up|Death|1|||
105687500|NCT01296347|364519029|FG000|6 Month Follow up|Lost to Follow-up|0|||
105687501|NCT01296347|364519030|FG001|6 Month Follow up|Lost to Follow-up|1|||
105687502|NCT01296347|364519029|FG000|12 Month Follow up|Lost to Follow-up|3|||
105687503|NCT01296347|364519030|FG001|12 Month Follow up|Lost to Follow-up|1|||
105687504|NCT01296347|364519029|FG000|12 Month Follow up|Death|1|||
105687505|NCT01296347|364519030|FG001|12 Month Follow up|Death|1|||
105687506|NCT01296347|364519029|FG000|12 Month Follow up|Withdrawal by Subject|0|||
105687507|NCT01296347|364519030|FG001|12 Month Follow up|Withdrawal by Subject|1|||
105687508|NCT01948908|364519031|FG000|Overall Study|Protocol Violation|1|||
105687509|NCT01948908|364519032|FG001|Overall Study|Protocol Violation|0|||
105687510|NCT01948908|364519033|FG002|Overall Study|Protocol Violation|2|||
106001384|NCT00531284|365667726|FG002|Overall Study|Progressive Disease|5|||
106001385|NCT00531284|365667727|FG003|Overall Study|Progressive Disease|42|||
106001386|NCT00531284|365667728|FG004|Overall Study|Progressive Disease|4|||
106001387|NCT00531284|365667729|FG005|Overall Study|Progressive Disease|4|||
106001388|NCT00531284|365667730|FG006|Overall Study|Progressive Disease|3|||
106001389|NCT00531284|365667731|FG007|Overall Study|Progressive Disease|8|||
106001390|NCT00531284|365667732|FG008|Overall Study|Progressive Disease|6|||
106001391|NCT00531284|365667733|FG009|Overall Study|Progressive Disease|3|||
106001392|NCT00531284|365667734|FG010|Overall Study|Progressive Disease|3|||
106001393|NCT00531284|365667735|FG011|Overall Study|Progressive Disease|14|||
106001394|NCT00531284|365667736|FG012|Overall Study|Progressive Disease|2|||
106001395|NCT00531284|365667737|FG013|Overall Study|Progressive Disease|1|||
106001396|NCT00531284|365667738|FG014|Overall Study|Progressive Disease|2|||
106001397|NCT00531284|365667739|FG015|Overall Study|Progressive Disease|11|||
106001398|NCT00531284|365667740|FG016|Overall Study|Progressive Disease|5|||
106001399|NCT00531284|365667724|FG000|Overall Study|Adverse Event|0|||
106001400|NCT00531284|365667725|FG001|Overall Study|Adverse Event|1|||
106001401|NCT00531284|365667726|FG002|Overall Study|Adverse Event|1|||
106001402|NCT00531284|365667727|FG003|Overall Study|Adverse Event|7|||
106001403|NCT00531284|365667728|FG004|Overall Study|Adverse Event|0|||
106001404|NCT00531284|365667729|FG005|Overall Study|Adverse Event|2|||
106001405|NCT00531284|365667730|FG006|Overall Study|Adverse Event|3|||
106001406|NCT00531284|365667731|FG007|Overall Study|Adverse Event|2|||
106001407|NCT00531284|365667732|FG008|Overall Study|Adverse Event|3|||
106001408|NCT00531284|365667733|FG009|Overall Study|Adverse Event|0|||
106001409|NCT00531284|365667734|FG010|Overall Study|Adverse Event|0|||
106001410|NCT00531284|365667735|FG011|Overall Study|Adverse Event|5|||
106001411|NCT00531284|365667736|FG012|Overall Study|Adverse Event|0|||
106001412|NCT00531284|365667737|FG013|Overall Study|Adverse Event|1|||
106001413|NCT00531284|365667738|FG014|Overall Study|Adverse Event|1|||
106001414|NCT00531284|365667739|FG015|Overall Study|Adverse Event|0|||
106001415|NCT00531284|365667740|FG016|Overall Study|Adverse Event|2|||
106001416|NCT00531284|365667724|FG000|Overall Study|Withdrawal by Subject|1|||
106001417|NCT00531284|365667725|FG001|Overall Study|Withdrawal by Subject|0|||
106001418|NCT00531284|365667726|FG002|Overall Study|Withdrawal by Subject|0|||
106001419|NCT00531284|365667727|FG003|Overall Study|Withdrawal by Subject|4|||
106001420|NCT00531284|365667728|FG004|Overall Study|Withdrawal by Subject|0|||
106001421|NCT00531284|365667729|FG005|Overall Study|Withdrawal by Subject|0|||
106001422|NCT00531284|365667730|FG006|Overall Study|Withdrawal by Subject|0|||
106001423|NCT00531284|365667731|FG007|Overall Study|Withdrawal by Subject|0|||
106001424|NCT00531284|365667732|FG008|Overall Study|Withdrawal by Subject|0|||
106001425|NCT00531284|365667733|FG009|Overall Study|Withdrawal by Subject|0|||
106001426|NCT00531284|365667734|FG010|Overall Study|Withdrawal by Subject|0|||
106001427|NCT00531284|365667735|FG011|Overall Study|Withdrawal by Subject|3|||
106001428|NCT00531284|365667736|FG012|Overall Study|Withdrawal by Subject|0|||
106001429|NCT00531284|365667737|FG013|Overall Study|Withdrawal by Subject|1|||
106001430|NCT00531284|365667738|FG014|Overall Study|Withdrawal by Subject|0|||
106001431|NCT00531284|365667739|FG015|Overall Study|Withdrawal by Subject|1|||
106001432|NCT00531284|365667740|FG016|Overall Study|Withdrawal by Subject|1|||
105687511|NCT02240693|364519034|FG000|Overall Study|Adverse Event|0|||
105687512|NCT02240693|364519035|FG001|Overall Study|Adverse Event|0|||
105687513|NCT02240693|364519036|FG002|Overall Study|Adverse Event|0|||
105687514|NCT02240693|364519037|FG003|Overall Study|Adverse Event|0|||
105687515|NCT02240693|364519038|FG004|Overall Study|Adverse Event|1|||
106001433|NCT00531284|365667724|FG000|Overall Study|Other|1|||
106001434|NCT00531284|365667725|FG001|Overall Study|Other|0|||
106001435|NCT00531284|365667726|FG002|Overall Study|Other|0|||
106001436|NCT00531284|365667727|FG003|Overall Study|Other|10|||
106001437|NCT00531284|365667728|FG004|Overall Study|Other|2|||
106001438|NCT00531284|365667729|FG005|Overall Study|Other|1|||
106001439|NCT00531284|365667730|FG006|Overall Study|Other|0|||
106001440|NCT00531284|365667731|FG007|Overall Study|Other|0|||
105687516|NCT02240693|364519034|FG000|Overall Study|Withdrawal by Subject|0|||
105687517|NCT02240693|364519035|FG001|Overall Study|Withdrawal by Subject|0|||
106130049|NCT00557505|366132906|FG005|Overall Study|Adverse Event|0|||
106130050|NCT00557505|366132907|FG006|Overall Study|Adverse Event|1|||
106130051|NCT00557505|366132908|FG007|Overall Study|Adverse Event|0|||
106130052|NCT00557505|366132909|FG008|Overall Study|Adverse Event|0|||
106130053|NCT00557505|366132901|FG000|Overall Study|Global deterioration of health|1|||
106130054|NCT00557505|366132902|FG001|Overall Study|Global deterioration of health|0|||
106130055|NCT00557505|366132903|FG002|Overall Study|Global deterioration of health|0|||
106130056|NCT00557505|366132904|FG003|Overall Study|Global deterioration of health|0|||
106130057|NCT00557505|366132905|FG004|Overall Study|Global deterioration of health|0|||
106130058|NCT00557505|366132906|FG005|Overall Study|Global deterioration of health|0|||
106130059|NCT00557505|366132907|FG006|Overall Study|Global deterioration of health|0|||
106130060|NCT00557505|366132908|FG007|Overall Study|Global deterioration of health|0|||
106130061|NCT00557505|366132909|FG008|Overall Study|Global deterioration of health|0|||
106130062|NCT00557505|366132901|FG000|Overall Study|Objective progression or relapse|2|||
106130063|NCT00557505|366132902|FG001|Overall Study|Objective progression or relapse|3|||
106130064|NCT00557505|366132903|FG002|Overall Study|Objective progression or relapse|3|||
105687518|NCT02240693|364519036|FG002|Overall Study|Withdrawal by Subject|2|||
105687519|NCT02240693|364519037|FG003|Overall Study|Withdrawal by Subject|1|||
105687520|NCT02240693|364519038|FG004|Overall Study|Withdrawal by Subject|0|||
105687521|NCT02240693|364519034|FG000|Overall Study|Other than specified|0|||
106130065|NCT00557505|366132904|FG003|Overall Study|Objective progression or relapse|2|||
106130066|NCT00557505|366132905|FG004|Overall Study|Objective progression or relapse|2|||
106130067|NCT00557505|366132906|FG005|Overall Study|Objective progression or relapse|3|||
106130068|NCT00557505|366132907|FG006|Overall Study|Objective progression or relapse|2|||
106130069|NCT00557505|366132908|FG007|Overall Study|Objective progression or relapse|5|||
106130070|NCT00557505|366132909|FG008|Overall Study|Objective progression or relapse|15|||
106130071|NCT00557505|366132901|FG000|Overall Study|Withdrawal by Subject|0|||
106130072|NCT00557505|366132902|FG001|Overall Study|Withdrawal by Subject|0|||
106130073|NCT00557505|366132903|FG002|Overall Study|Withdrawal by Subject|0|||
106130074|NCT00557505|366132904|FG003|Overall Study|Withdrawal by Subject|1|||
106130075|NCT00557505|366132905|FG004|Overall Study|Withdrawal by Subject|0|||
106130076|NCT00557505|366132906|FG005|Overall Study|Withdrawal by Subject|0|||
106130077|NCT00557505|366132907|FG006|Overall Study|Withdrawal by Subject|0|||
106130078|NCT00557505|366132908|FG007|Overall Study|Withdrawal by Subject|0|||
106130079|NCT00557505|366132909|FG008|Overall Study|Withdrawal by Subject|1|||
106130080|NCT01244763|366132912|FG000|Overall Study|Adverse Event|1|||
106130081|NCT01244763|366132913|FG001|Overall Study|Adverse Event|0|||
106130082|NCT01244763|366132914|FG002|Overall Study|Adverse Event|0|||
106130083|NCT01244763|366132915|FG003|Overall Study|Adverse Event|0|||
106130084|NCT01244763|366132916|FG004|Overall Study|Adverse Event|0|||
106130085|NCT01244763|366132917|FG005|Overall Study|Adverse Event|1|||
106130086|NCT01244763|366132912|FG000|Overall Study|Death|1|||
106130087|NCT01244763|366132913|FG001|Overall Study|Death|0|||
106130088|NCT01244763|366132914|FG002|Overall Study|Death|1|||
106130089|NCT01244763|366132915|FG003|Overall Study|Death|0|||
106130090|NCT01244763|366132916|FG004|Overall Study|Death|2|||
106130091|NCT01244763|366132917|FG005|Overall Study|Death|0|||
106130092|NCT01244763|366132912|FG000|Overall Study|Physician Decision|0|||
106130093|NCT01244763|366132913|FG001|Overall Study|Physician Decision|0|||
106130094|NCT01244763|366132914|FG002|Overall Study|Physician Decision|1|||
106130095|NCT01244763|366132915|FG003|Overall Study|Physician Decision|0|||
106130096|NCT01244763|366132916|FG004|Overall Study|Physician Decision|0|||
106130097|NCT01244763|366132917|FG005|Overall Study|Physician Decision|0|||
106130098|NCT01244763|366132912|FG000|Overall Study|Withdrawal by Subject|1|||
106130099|NCT01244763|366132913|FG001|Overall Study|Withdrawal by Subject|2|||
106130100|NCT01244763|366132914|FG002|Overall Study|Withdrawal by Subject|0|||
106130101|NCT01244763|366132915|FG003|Overall Study|Withdrawal by Subject|1|||
106130102|NCT01244763|366132916|FG004|Overall Study|Withdrawal by Subject|1|||
106130103|NCT01244763|366132917|FG005|Overall Study|Withdrawal by Subject|2|||
106130104|NCT01244763|366132912|FG000|Overall Study|Lost to Follow-up|0|||
106130105|NCT01244763|366132913|FG001|Overall Study|Lost to Follow-up|1|||
106130106|NCT01244763|366132914|FG002|Overall Study|Lost to Follow-up|0|||
106130107|NCT01244763|366132915|FG003|Overall Study|Lost to Follow-up|0|||
106130108|NCT01244763|366132916|FG004|Overall Study|Lost to Follow-up|0|||
105687522|NCT02240693|364519035|FG001|Overall Study|Other than specified|0|||
105687523|NCT02240693|364519036|FG002|Overall Study|Other than specified|2|||
106130109|NCT01244763|366132917|FG005|Overall Study|Lost to Follow-up|0|||
106130110|NCT01244763|366132912|FG000|Overall Study|Enrolled into the Extension Study|0|||
106130111|NCT01244763|366132913|FG001|Overall Study|Enrolled into the Extension Study|0|||
106130112|NCT01244763|366132914|FG002|Overall Study|Enrolled into the Extension Study|0|||
106130113|NCT01244763|366132915|FG003|Overall Study|Enrolled into the Extension Study|0|||
106130114|NCT01244763|366132916|FG004|Overall Study|Enrolled into the Extension Study|0|||
106130115|NCT01244763|366132917|FG005|Overall Study|Enrolled into the Extension Study|1|||
106130116|NCT03330119|366132922|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
106130117|NCT03330119|366132923|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
106001441|NCT00531284|365667732|FG008|Overall Study|Other|2|||
106001442|NCT00531284|365667733|FG009|Overall Study|Other|1|||
106001443|NCT00531284|365667734|FG010|Overall Study|Other|0|||
106001444|NCT00531284|365667735|FG011|Overall Study|Other|2|||
106001445|NCT00531284|365667736|FG012|Overall Study|Other|0|||
105687524|NCT02240693|364519037|FG003|Overall Study|Other than specified|0|||
105687525|NCT02240693|364519038|FG004|Overall Study|Other than specified|0|||
105687526|NCT01585987|364519039|FG000|Randomized|Withdrawal by Subject|0|||
105687527|NCT01585987|364519040|FG001|Randomized|Withdrawal by Subject|4|||
105917711|NCT05117060|365356919|FG000|Overall Study|Lack of Efficacy|4|||
106001446|NCT00531284|365667737|FG013|Overall Study|Other|0|||
105687528|NCT01585987|364519039|FG000|Randomized|No longer met criteria|0|||
106001447|NCT00531284|365667738|FG014|Overall Study|Other|1|||
106001448|NCT00531284|365667739|FG015|Overall Study|Other|0|||
106001449|NCT00531284|365667740|FG016|Overall Study|Other|0|||
105917712|NCT05117060|365356920|FG001|Overall Study|Lack of Efficacy|5|||
105917713|NCT05117060|365356921|FG002|Overall Study|Lack of Efficacy|2|||
105917714|NCT05117060|365356922|FG003|Overall Study|Lack of Efficacy|6|||
105917715|NCT05117060|365356919|FG000|Overall Study|Withdrawal by Subject|8|||
105917716|NCT05117060|365356920|FG001|Overall Study|Withdrawal by Subject|5|||
105917717|NCT05117060|365356921|FG002|Overall Study|Withdrawal by Subject|5|||
105917718|NCT05117060|365356922|FG003|Overall Study|Withdrawal by Subject|6|||
105917719|NCT05117060|365356919|FG000|Overall Study|Other|2|||
105917720|NCT05117060|365356920|FG001|Overall Study|Other|1|||
105917721|NCT05117060|365356921|FG002|Overall Study|Other|3|||
105917722|NCT05117060|365356922|FG003|Overall Study|Other|1|||
105917723|NCT01274351|365356923|FG000|Overall Study|Lost to Follow-up|1|||
105917724|NCT01274351|365356923|FG000|Overall Study|patient not compliant with the protocol|1|||
106001450|NCT04388111|365667741|FG000|Overall Study|Lost to Follow-up|5|||
106001451|NCT04388111|365667742|FG001|Overall Study|Lost to Follow-up|3|||
106001452|NCT04388111|365667741|FG000|Overall Study|Adverse Event|1|||
106001453|NCT04388111|365667742|FG001|Overall Study|Adverse Event|1|||
105687529|NCT01585987|364519040|FG001|Randomized|No longer met criteria|2|||
105687530|NCT01585987|364519039|FG000|Treated|Disease Progression|39|||
106001454|NCT04388111|365667741|FG000|Overall Study|Protocol Violation|2|||
105687531|NCT01585987|364519040|FG001|Treated|Disease Progression|36|||
105917725|NCT01274351|365356923|FG000|Overall Study|Pregnancy|1|||
105917726|NCT01274351|365356923|FG000|Overall Study|Death|2|||
105917727|NCT01274351|365356923|FG000|Overall Study|Withdrawal by Subject|3|||
105917728|NCT01274351|365356923|FG000|Overall Study|Adverse Event|8|||
106001455|NCT04388111|365667742|FG001|Overall Study|Protocol Violation|4|||
106001456|NCT04388111|365667741|FG000|Overall Study|Withdrawal by Subject|1|||
105917729|NCT01274351|365356923|FG000|Overall Study|progression of disease|3|||
106001457|NCT04388111|365667742|FG001|Overall Study|Withdrawal by Subject|0|||
105917730|NCT01274351|365356923|FG000|Overall Study|hospitalization|1|||
105917731|NCT02357459|365358723|FG000|Overall Study|Adverse Event|0|||
105917732|NCT02357459|365358724|FG001|Overall Study|Adverse Event|1|||
105917733|NCT02357459|365358725|FG002|Overall Study|Adverse Event|1|||
105917734|NCT02357459|365358723|FG000|Overall Study|Withdrawal by Subject|5|||
105917735|NCT02357459|365358724|FG001|Overall Study|Withdrawal by Subject|3|||
105917736|NCT02357459|365358725|FG002|Overall Study|Withdrawal by Subject|3|||
105917737|NCT02357459|365358723|FG000|Overall Study|Physician Decision|0|||
105917738|NCT02357459|365358724|FG001|Overall Study|Physician Decision|2|||
105917739|NCT02357459|365358725|FG002|Overall Study|Physician Decision|0|||
105917740|NCT02357459|365358723|FG000|Overall Study|Protocol Violation|1|||
105917741|NCT02357459|365358724|FG001|Overall Study|Protocol Violation|1|||
105917742|NCT02357459|365358725|FG002|Overall Study|Protocol Violation|0|||
105917743|NCT02357459|365358723|FG000|Overall Study|Lost to Follow-up|1|||
105917744|NCT02357459|365358724|FG001|Overall Study|Lost to Follow-up|3|||
105917745|NCT02357459|365358725|FG002|Overall Study|Lost to Follow-up|0|||
105917746|NCT02357459|365358723|FG000|Overall Study|Lack of Efficacy|7|||
105917747|NCT02357459|365358724|FG001|Overall Study|Lack of Efficacy|4|||
105917748|NCT02357459|365358725|FG002|Overall Study|Lack of Efficacy|4|||
105917749|NCT02357459|365358723|FG000|Overall Study|Patient Relocated|2|||
105917750|NCT02357459|365358724|FG001|Overall Study|Patient Relocated|0|||
105917751|NCT02357459|365358725|FG002|Overall Study|Patient Relocated|0|||
105917752|NCT02357459|365358723|FG000|Overall Study|Instruction from PCP|1|||
105917753|NCT02357459|365358724|FG001|Overall Study|Instruction from PCP|0|||
105917754|NCT02357459|365358725|FG002|Overall Study|Instruction from PCP|0|||
105917755|NCT02357459|365358723|FG000|Overall Study|Incarceration|0|||
105917756|NCT02357459|365358724|FG001|Overall Study|Incarceration|0|||
105917757|NCT02357459|365358725|FG002|Overall Study|Incarceration|1|||
105917758|NCT02357459|365358723|FG000|Overall Study|Pre-planned Knee surgery|0|||
105917759|NCT02357459|365358724|FG001|Overall Study|Pre-planned Knee surgery|0|||
105917760|NCT02357459|365358725|FG002|Overall Study|Pre-planned Knee surgery|2|||
105917761|NCT02357459|365358723|FG000|Overall Study|Job Commitments|0|||
105917762|NCT02357459|365358724|FG001|Overall Study|Job Commitments|0|||
105917763|NCT02357459|365358725|FG002|Overall Study|Job Commitments|1|||
105917764|NCT02188160|365358726|FG000|Overall Study|Adverse Event|1|||
105917765|NCT02188160|365358727|FG001|Overall Study|Adverse Event|0|||
105917766|NCT02188160|365358726|FG000|Overall Study|Use of an excluded medication|0|||
105917767|NCT02188160|365358727|FG001|Overall Study|Use of an excluded medication|1|||
105917768|NCT00916578|365358728|FG000|Overall Study|Physician Decision|2|||
105917769|NCT00916578|365358728|FG000|Overall Study|Withdrawal by Subject|3|||
105917770|NCT00916578|365358728|FG000|Overall Study|Insurance Denial|2|||
105917771|NCT00945243|365358731|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
105917772|NCT01307787|365358738|FG000|Overall Study|Withdrawal by Subject|2|||
105917773|NCT01307787|365358739|FG001|Overall Study|Withdrawal by Subject|0|||
105917774|NCT01573000|365358740|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
105917775|NCT01573000|365358741|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
105917776|NCT01573000|365358740|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
105917777|NCT01573000|365358741|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
105917778|NCT01573000|365358740|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
105917779|NCT01573000|365358741|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
105917780|NCT01573000|365358740|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
105917781|NCT01573000|365358741|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
105917782|NCT01573000|365358740|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
105917783|NCT01573000|365358741|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
105917784|NCT01573000|365358740|FG000|Crossover Phase|Lack of Efficacy|0|||
105917785|NCT01573000|365358741|FG001|Crossover Phase|Lack of Efficacy|13|||
105917786|NCT01573000|365358740|FG000|Crossover Phase|Lost to Follow-up|0|||
105917787|NCT01573000|365358741|FG001|Crossover Phase|Lost to Follow-up|2|||
105917788|NCT01573000|365358740|FG000|Crossover Phase|Death|0|||
105917789|NCT01573000|365358741|FG001|Crossover Phase|Death|3|||
105917790|NCT01573000|365358740|FG000|Long-Term Follow-Up|Death|3|||
105917791|NCT01573000|365358741|FG001|Long-Term Follow-Up|Death|0|||
105917792|NCT01573000|365358740|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
105917793|NCT01573000|365358741|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
105917794|NCT03353792|365358742|FG000|Overall Study|Lost to Follow-up|1|||
105917795|NCT03353792|365358743|FG001|Overall Study|Lost to Follow-up|0|||
105917796|NCT03353792|365358742|FG000|Overall Study|Participant Unable to Manage Device|1|||
105917797|NCT03353792|365358743|FG001|Overall Study|Participant Unable to Manage Device|0|||
105917798|NCT03652818|365358745|FG000|Overall Study|Adverse Event|1|||
105917799|NCT03652818|365358746|FG001|Overall Study|Adverse Event|0|||
105917800|NCT03652818|365358747|FG002|Overall Study|Adverse Event|0|||
105917801|NCT03652818|365358748|FG003|Overall Study|Adverse Event|0|||
105917802|NCT03652818|365358749|FG004|Overall Study|Adverse Event|0|||
105917803|NCT03652818|365358745|FG000|Overall Study|Physician Decision|1|||
105917804|NCT03652818|365358746|FG001|Overall Study|Physician Decision|0|||
105917805|NCT03652818|365358747|FG002|Overall Study|Physician Decision|0|||
105917806|NCT03652818|365358748|FG003|Overall Study|Physician Decision|0|||
105687532|NCT01585987|364519039|FG000|Treated|Study Drug Toxicity|9|||
105687533|NCT01585987|364519040|FG001|Treated|Study Drug Toxicity|5|||
105687534|NCT01585987|364519039|FG000|Treated|Adverse Event|3|||
105687535|NCT01585987|364519040|FG001|Treated|Adverse Event|0|||
105917807|NCT03652818|365358749|FG004|Overall Study|Physician Decision|0|||
105917808|NCT03652818|365358745|FG000|Overall Study|Lost to Follow-up|0|||
105917809|NCT03652818|365358746|FG001|Overall Study|Lost to Follow-up|1|||
105917810|NCT03652818|365358747|FG002|Overall Study|Lost to Follow-up|2|||
105917811|NCT03652818|365358748|FG003|Overall Study|Lost to Follow-up|1|||
105917812|NCT03652818|365358749|FG004|Overall Study|Lost to Follow-up|1|||
105917813|NCT01130272|365358752|FG000|Overall Study|Adverse Event|2|||
105917814|NCT01130272|365358753|FG001|Overall Study|Adverse Event|5|||
105917815|NCT01130272|365358754|FG002|Overall Study|Adverse Event|6|||
105917816|NCT01130272|365358755|FG003|Overall Study|Adverse Event|22|||
105917817|NCT01130272|365358756|FG004|Overall Study|Adverse Event|7|||
105917818|NCT01130272|365358752|FG000|Overall Study|IVRS-confirmed constipation|0|||
105917819|NCT01130272|365358753|FG001|Overall Study|IVRS-confirmed constipation|1|||
105917820|NCT01130272|365358754|FG002|Overall Study|IVRS-confirmed constipation|1|||
105917821|NCT01130272|365358755|FG003|Overall Study|IVRS-confirmed constipation|2|||
105917822|NCT01130272|365358756|FG004|Overall Study|IVRS-confirmed constipation|0|||
105917823|NCT01130272|365358752|FG000|Overall Study|Rescue medications due to diarrhea|3|||
105917824|NCT01130272|365358753|FG001|Overall Study|Rescue medications due to diarrhea|5|||
105917825|NCT01130272|365358754|FG002|Overall Study|Rescue medications due to diarrhea|8|||
105917826|NCT01130272|365358755|FG003|Overall Study|Rescue medications due to diarrhea|8|||
105917827|NCT01130272|365358756|FG004|Overall Study|Rescue medications due to diarrhea|6|||
105917828|NCT01130272|365358752|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
105917829|NCT01130272|365358753|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
105917830|NCT01130272|365358754|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
105917831|NCT01130272|365358755|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
105917832|NCT01130272|365358756|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
105917833|NCT01130272|365358752|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
105917834|NCT01130272|365358753|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
105917835|NCT01130272|365358754|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
105917836|NCT01130272|365358755|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
105917837|NCT01130272|365358756|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
105917838|NCT01130272|365358752|FG000|Overall Study|Protocol Violation|0|||
105917839|NCT01130272|365358753|FG001|Overall Study|Protocol Violation|0|||
105917840|NCT01130272|365358754|FG002|Overall Study|Protocol Violation|3|||
105917841|NCT01130272|365358755|FG003|Overall Study|Protocol Violation|5|||
105917842|NCT01130272|365358756|FG004|Overall Study|Protocol Violation|5|||
105917843|NCT01130272|365358752|FG000|Overall Study|Lost to Follow-up|4|||
105917844|NCT01130272|365358753|FG001|Overall Study|Lost to Follow-up|3|||
105917845|NCT01130272|365358754|FG002|Overall Study|Lost to Follow-up|4|||
105917846|NCT01130272|365358755|FG003|Overall Study|Lost to Follow-up|7|||
105917847|NCT01130272|365358756|FG004|Overall Study|Lost to Follow-up|6|||
105917848|NCT01130272|365358752|FG000|Overall Study|Withdrawal by Subject|4|||
105917849|NCT01130272|365358753|FG001|Overall Study|Withdrawal by Subject|11|||
105917850|NCT01130272|365358754|FG002|Overall Study|Withdrawal by Subject|10|||
105917851|NCT01130272|365358755|FG003|Overall Study|Withdrawal by Subject|9|||
105917852|NCT01130272|365358756|FG004|Overall Study|Withdrawal by Subject|8|||
105917853|NCT01130272|365358752|FG000|Overall Study|Physician Decision|1|||
105917854|NCT01130272|365358753|FG001|Overall Study|Physician Decision|1|||
105917855|NCT01130272|365358754|FG002|Overall Study|Physician Decision|0|||
105917856|NCT01130272|365358755|FG003|Overall Study|Physician Decision|1|||
105917857|NCT01130272|365358756|FG004|Overall Study|Physician Decision|2|||
105917858|NCT01130272|365358752|FG000|Overall Study|Sponsor decision|6|||
105917859|NCT01130272|365358753|FG001|Overall Study|Sponsor decision|15|||
105917860|NCT01130272|365358754|FG002|Overall Study|Sponsor decision|16|||
105917861|NCT01130272|365358755|FG003|Overall Study|Sponsor decision|13|||
105917862|NCT01130272|365358756|FG004|Overall Study|Sponsor decision|16|||
105917863|NCT01130272|365358752|FG000|Overall Study|Study arm discontinued|38|||
105917864|NCT01130272|365358753|FG001|Overall Study|Study arm discontinued|0|||
105917865|NCT01130272|365358754|FG002|Overall Study|Study arm discontinued|0|||
105917866|NCT01130272|365358755|FG003|Overall Study|Study arm discontinued|0|||
105917867|NCT01130272|365358756|FG004|Overall Study|Study arm discontinued|0|||
105917868|NCT01548404|365358757|FG000|Overall Study|Adverse Event|3|||
105917869|NCT01548404|365358758|FG001|Overall Study|Adverse Event|1|||
105917870|NCT01548404|365358757|FG000|Overall Study|Physician Decision|2|||
105687536|NCT01585987|364519039|FG000|Treated|Withdrawal by Subject|1|||
105687537|NCT01585987|364519040|FG001|Treated|Withdrawal by Subject|2|||
105687538|NCT01585987|364519039|FG000|Treated|Death|1|||
105917871|NCT01548404|365358758|FG001|Overall Study|Physician Decision|1|||
105917872|NCT01548404|365358757|FG000|Overall Study|Inadequate response to study treatment|23|||
105917873|NCT01548404|365358758|FG001|Overall Study|Inadequate response to study treatment|7|||
105917874|NCT01548404|365358757|FG000|Overall Study|Lost to Follow-up|2|||
105917875|NCT01548404|365358758|FG001|Overall Study|Lost to Follow-up|0|||
105917876|NCT01548404|365358757|FG000|Overall Study|Withdrawal by Subject|0|||
105917877|NCT01548404|365358758|FG001|Overall Study|Withdrawal by Subject|3|||
105917878|NCT01548404|365358757|FG000|Overall Study|Other than specified above|0|||
105917879|NCT01548404|365358758|FG001|Overall Study|Other than specified above|2|||
105917880|NCT00239720|365358759|FG000|Overall Study|Adverse Event|1|||
105917881|NCT00239720|365358760|FG001|Overall Study|Adverse Event|0|||
105917882|NCT00239720|365358759|FG000|Overall Study|Lost to Follow-up|0|||
105917883|NCT00239720|365358760|FG001|Overall Study|Lost to Follow-up|1|||
105917884|NCT00606008|365358764|FG000|Overall Study|Adverse Event|1|||
105917885|NCT00606008|365358764|FG000|Overall Study|Withdrawal by Subject|4|||
105917886|NCT04040439|365358769|FG000|Overall Study|Invalid registration|11|||
105917887|NCT04040439|365358769|FG000|Overall Study|No IC* on publication of study results|2|||
105917888|NCT00547339|365358770|FG000|Overall Study|Physician Decision|0|||
105917889|NCT00547339|365358771|FG001|Overall Study|Physician Decision|0|||
105917890|NCT00547339|365358772|FG002|Overall Study|Physician Decision|1|||
105917891|NCT00547339|365358773|FG003|Overall Study|Physician Decision|0|||
105917892|NCT01935089|365358776|FG000|Overall Study|Adverse Event|2|||
105917893|NCT01935089|365358776|FG000|Overall Study|Withdrawal by Subject|1|||
105917894|NCT01309386|365358783|FG000|Overall Study|Other|2|||
105917895|NCT01309386|365358784|FG001|Overall Study|Other|0|||
105917896|NCT01309386|365358783|FG000|Overall Study|Withdrawal by Subject|2|||
105917897|NCT01309386|365358784|FG001|Overall Study|Withdrawal by Subject|0|||
105917898|NCT01309386|365358783|FG000|Overall Study|Progressive disease|9|||
105917899|NCT01309386|365358784|FG001|Overall Study|Progressive disease|11|||
105917900|NCT01309386|365358783|FG000|Overall Study|Physician Decision|1|||
105917901|NCT01309386|365358784|FG001|Overall Study|Physician Decision|1|||
105917902|NCT01309386|365358783|FG000|Overall Study|Lack of Efficacy|3|||
105917903|NCT01309386|365358784|FG001|Overall Study|Lack of Efficacy|1|||
105917904|NCT01309386|365358783|FG000|Overall Study|Adverse Event|5|||
105917905|NCT01309386|365358784|FG001|Overall Study|Adverse Event|8|||
105917906|NCT01783743|365358785|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
105917907|NCT01783743|365358786|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
105917908|NCT01783743|365358785|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
105917909|NCT01783743|365358786|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
105917910|NCT01783743|365358785|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
105917911|NCT01783743|365358786|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
105917912|NCT01607593|365358788|FG000|Overall Study|Adverse Event|15|||
105917913|NCT01607593|365358788|FG000|Overall Study|Lack of Efficacy|16|||
105917914|NCT01607593|365358788|FG000|Overall Study|Lost to Follow-up|25|||
105917915|NCT01607593|365358788|FG000|Overall Study|Continuation|33|||
105917916|NCT01607593|365358788|FG000|Overall Study|Other|4|||
105917917|NCT02062437|365358789|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
105917918|NCT02062437|365358789|FG000|Overall Study|Patient not available for the 2y visit|18|||
105917919|NCT02062437|365358789|FG000|Overall Study|Death|2|||
105917920|NCT02062437|365358789|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
105917921|NCT02337491|365358793|FG000|Overall Study|Death|1|||
105917922|NCT02337491|365358794|FG001|Overall Study|Death|1|||
105917923|NCT02337491|365358793|FG000|Overall Study|Adverse Event|0|||
105917924|NCT02337491|365358794|FG001|Overall Study|Adverse Event|1|||
105917925|NCT02337491|365358793|FG000|Overall Study|Withdrawal by Subject|3|||
105917926|NCT02337491|365358794|FG001|Overall Study|Withdrawal by Subject|0|||
105917927|NCT02337491|365358793|FG000|Overall Study|Progressive Disease|44|||
105917928|NCT02337491|365358794|FG001|Overall Study|Progressive Disease|28|||
105917929|NCT02337491|365358793|FG000|Overall Study|On Treatment|2|||
105917930|NCT02337491|365358794|FG001|Overall Study|On Treatment|0|||
105917931|NCT00723229|365358795|FG000|First Intervention|Lost to Follow-up|7|||
105917932|NCT00723229|365358796|FG001|First Intervention|Lost to Follow-up|3|||
105917933|NCT00752089|365358801|FG000|Overall Study|Adverse Event|1|||
105917934|NCT00752089|365358801|FG000|Overall Study|Protocol Deviation|2|||
105917935|NCT00752089|365358801|FG000|Overall Study|Could not attend visit 9|1|||
105917936|NCT00752089|365358801|FG000|Overall Study|Not capable of wearing partial denture|1|||
105917937|NCT00752089|365358801|FG000|Overall Study|Cannot continue the study|1|||
105917938|NCT02900352|365358802|FG000|Overall Study|Lost to Follow-up|28|||
105917939|NCT02900352|365358803|FG001|Overall Study|Lost to Follow-up|17|||
105917940|NCT03074695|365358804|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
105917941|NCT03074695|365358805|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
105917942|NCT03074695|365358804|FG000|Overall Study|Research staff not available|1|||
105917943|NCT03074695|365358805|FG001|Overall Study|Research staff not available|2|||
105917944|NCT03074695|365358804|FG000|Overall Study|Did not receive neuraxial block|2|||
105917945|NCT03074695|365358805|FG001|Overall Study|Did not receive neuraxial block|2|||
105917946|NCT03191799|365358806|FG000|Overall Study|Withdrawal by Subject|4|||
105917947|NCT03191799|365358806|FG000|Overall Study|Physician Decision|2|||
105917948|NCT03191799|365358806|FG000|Overall Study|Lost to Follow-up|1|||
105917949|NCT03191799|365358806|FG000|Overall Study|Death|2|||
105917950|NCT01774981|365358807|FG000|Overall Study|Adverse Event|0|||
105917951|NCT01774981|365358808|FG001|Overall Study|Adverse Event|0|||
105917952|NCT01774981|365358809|FG002|Overall Study|Adverse Event|0|||
105917953|NCT01774981|365358810|FG003|Overall Study|Adverse Event|0|||
105917954|NCT01774981|365358811|FG004|Overall Study|Adverse Event|0|||
105917955|NCT01774981|365358812|FG005|Overall Study|Adverse Event|1|||
105917956|NCT01774981|365358813|FG006|Overall Study|Adverse Event|0|||
105917957|NCT01774981|365358814|FG007|Overall Study|Adverse Event|0|||
105917958|NCT01774981|365358807|FG000|Overall Study|Withdrawal by Subject|0|||
105917959|NCT01774981|365358808|FG001|Overall Study|Withdrawal by Subject|0|||
105917960|NCT01774981|365358809|FG002|Overall Study|Withdrawal by Subject|0|||
105917961|NCT01774981|365358810|FG003|Overall Study|Withdrawal by Subject|0|||
105687539|NCT01585987|364519040|FG001|Treated|Death|0|||
105687540|NCT01585987|364519039|FG000|Treated|Lost to Follow-up|0|||
105917962|NCT01774981|365358811|FG004|Overall Study|Withdrawal by Subject|0|||
105917963|NCT01774981|365358812|FG005|Overall Study|Withdrawal by Subject|0|||
105917964|NCT01774981|365358813|FG006|Overall Study|Withdrawal by Subject|0|||
105917965|NCT01774981|365358814|FG007|Overall Study|Withdrawal by Subject|1|||
105917966|NCT01774981|365358807|FG000|Overall Study|Death|0|||
105917967|NCT01774981|365358808|FG001|Overall Study|Death|0|||
105917968|NCT01774981|365358809|FG002|Overall Study|Death|0|||
105917969|NCT01774981|365358810|FG003|Overall Study|Death|0|||
105917970|NCT01774981|365358811|FG004|Overall Study|Death|1|||
105917971|NCT01774981|365358812|FG005|Overall Study|Death|0|||
105917972|NCT01774981|365358813|FG006|Overall Study|Death|0|||
105917973|NCT01774981|365358814|FG007|Overall Study|Death|0|||
105917974|NCT01324102|365358815|FG000|Overall Study|illness|1|||
105917975|NCT01324102|365358816|FG001|Overall Study|illness|6|||
105917976|NCT00386334|365358817|FG000|Double Blind Period|Adverse Event|9|||
105917977|NCT00386334|365358818|FG001|Double Blind Period|Adverse Event|14|||
105917978|NCT00386334|365358817|FG000|Double Blind Period|Protocol Violation|1|||
105917979|NCT00386334|365358818|FG001|Double Blind Period|Protocol Violation|1|||
105917980|NCT00386334|365358817|FG000|Double Blind Period|Withdrawal by Subject|9|||
105917981|NCT00386334|365358818|FG001|Double Blind Period|Withdrawal by Subject|13|||
105917982|NCT00386334|365358817|FG000|Double Blind Period|Lack of Efficacy|20|||
105917983|NCT00386334|365358818|FG001|Double Blind Period|Lack of Efficacy|11|||
105917984|NCT00386334|365358817|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
105917985|NCT00386334|365358818|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
105917986|NCT00386334|365358817|FG000|Double Blind Period|Other|3|||
106130118|NCT00278564|366132928|FG000|Overall Study|Lack of Efficacy|4|||
106130119|NCT00570661|366132931|FG000|Overall Study|Disease worsening|5|||
106130120|NCT00570661|366132931|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
106130121|NCT00570661|366132931|FG000|Overall Study|Adverse Event|1|||
106130122|NCT01066156|366132932|FG000|Overall Study|ineligible|2|||
106130123|NCT01066156|366132932|FG000|Overall Study|Lost to Follow-up|7|||
106130124|NCT01066156|366132932|FG000|Overall Study|Withdrawal by Subject|1|||
106130125|NCT02400307|366132933|FG000|Overall Study|Enrolled and Never Dosed|1|||
106130126|NCT02400307|366132934|FG001|Overall Study|Enrolled and Never Dosed|0|||
106130127|NCT03633903|366132938|FG000|Overall Study|Withdrawal by Subject|1|||
106130128|NCT03633903|366132939|FG001|Overall Study|Withdrawal by Subject|2|||
106130129|NCT03633903|366132938|FG000|Overall Study|Lost to Follow-up|5|||
106130130|NCT03633903|366132939|FG001|Overall Study|Lost to Follow-up|5|||
106130131|NCT00087490|366132940|FG000|Overall Study|Death|6|||
106130132|NCT00087490|366132941|FG001|Overall Study|Death|4|||
106130133|NCT00087490|366132940|FG000|Overall Study|Adverse Event|3|||
106130134|NCT00087490|366132941|FG001|Overall Study|Adverse Event|8|||
105687541|NCT01585987|364519040|FG001|Treated|Lost to Follow-up|1|||
105687542|NCT01585987|364519039|FG000|Treated|Maximum Clinical Benefit|0|||
105687543|NCT01585987|364519040|FG001|Treated|Maximum Clinical Benefit|1|||
105917987|NCT00386334|365358818|FG001|Double Blind Period|Other|3|||
105917988|NCT00386334|365358817|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
106130135|NCT00087490|366132940|FG000|Overall Study|Lack of Efficacy|0|||
106130136|NCT00087490|366132941|FG001|Overall Study|Lack of Efficacy|2|||
106130137|NCT00087490|366132940|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
106130138|NCT00087490|366132941|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
105917989|NCT00386334|365358818|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
105917990|NCT00902577|365358819|FG000|Overall Study|Withdrawal by Subject|6|||
105917991|NCT00902577|365358819|FG000|Overall Study|FMISO production failure|2|||
105917992|NCT00785356|365358822|FG000|Overall Study|Study prematurely terminated|8|||
105917993|NCT03238417|365358824|FG000|Overall|non-response|955|||
105917994|NCT03238417|365358825|FG001|Overall|non-response|1920|||
105917995|NCT03238417|365358824|FG000|Overall|partial completion|48|||
105917996|NCT03238417|365358825|FG001|Overall|partial completion|68|||
105917997|NCT03238417|365358824|FG000|Baseline|Partial completion|17|||
105687544|NCT01585987|364519039|FG000|Treated|Non-Specified|1|||
105687545|NCT01585987|364519040|FG001|Treated|Non-Specified|2|||
105687546|NCT01585987|364519039|FG000|Treated|Subject Request|0|||
105687547|NCT01585987|364519040|FG001|Treated|Subject Request|1|||
105687548|NCT01585987|364519039|FG000|Treated|Poor/Non-Compliance|0|||
105687549|NCT01585987|364519040|FG001|Treated|Poor/Non-Compliance|1|||
105687550|NCT02041520|364519042|FG000|Overall Study|Adverse Event|2|||
105687551|NCT02041520|364519043|FG001|Overall Study|Adverse Event|1|||
105687552|NCT02041520|364519042|FG000|Overall Study|Withdrawal by Subject|3|||
105687553|NCT02041520|364519043|FG001|Overall Study|Withdrawal by Subject|4|||
105687554|NCT02041520|364519042|FG000|Overall Study|Protocol Violation|1|||
105687555|NCT02041520|364519043|FG001|Overall Study|Protocol Violation|0|||
105687556|NCT02041520|364519042|FG000|Overall Study|Lost to Follow-up|0|||
105687557|NCT02041520|364519043|FG001|Overall Study|Lost to Follow-up|1|||
105687558|NCT02041520|364519042|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
105687559|NCT02041520|364519043|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
105687560|NCT01898923|364519047|FG000|Overall Study|Lack of Efficacy|5|||
105687561|NCT01898923|364519048|FG001|Overall Study|Lack of Efficacy|6|||
105687562|NCT01898923|364519047|FG000|Overall Study|Adverse Event|3|||
105687563|NCT01898923|364519048|FG001|Overall Study|Adverse Event|1|||
105687564|NCT01898923|364519047|FG000|Overall Study|Lost to Follow-up|0|||
105687565|NCT01898923|364519048|FG001|Overall Study|Lost to Follow-up|1|||
105687566|NCT01898923|364519047|FG000|Overall Study|Withdrawal by Subject|4|||
105687567|NCT01898923|364519048|FG001|Overall Study|Withdrawal by Subject|7|||
105687568|NCT01898923|364519047|FG000|Overall Study|Physician Decision|3|||
105687569|NCT01898923|364519048|FG001|Overall Study|Physician Decision|4|||
105687570|NCT01898923|364519047|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
105687571|NCT01898923|364519048|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
105687572|NCT04526197|364519049|FG000|Period 1|Adverse Event|0|||
105687573|NCT04526197|364519050|FG001|Period 1|Adverse Event|1|||
105687574|NCT04526197|364519049|FG000|Period 1|Withdrawal by Subject|1|||
105687575|NCT04526197|364519050|FG001|Period 1|Withdrawal by Subject|0|||
105687576|NCT04526197|364519049|FG000|Period 2|Adverse Event|0|||
105687577|NCT04526197|364519050|FG001|Period 2|Adverse Event|1|||
105687578|NCT04526197|364519049|FG000|Period 2|Withdrawal by Subject|0|||
105687579|NCT04526197|364519050|FG001|Period 2|Withdrawal by Subject|1|||
105917998|NCT03238417|365358825|FG001|Baseline|Partial completion|48|||
105917999|NCT03238417|365358824|FG000|Baseline|non-response|372|||
105918000|NCT03238417|365358825|FG001|Baseline|non-response|669|||
105918001|NCT03238417|365358824|FG000|12-month|non-response|296|||
105918002|NCT03238417|365358825|FG001|12-month|non-response|669|||
105918003|NCT03238417|365358824|FG000|12-month|partial completion|23|||
105918004|NCT03238417|365358825|FG001|12-month|partial completion|37|||
105918005|NCT03238417|365358824|FG000|24-month|non-response|287|||
105918006|NCT03238417|365358825|FG001|24-month|non-response|594|||
105918007|NCT03238417|365358824|FG000|24-month|partial completion|8|||
105918008|NCT03238417|365358825|FG001|24-month|partial completion|31|||
105918009|NCT00001566|365358826|FG000|Overall Study|patients' choice to discontinue protocol|3|||
105918010|NCT00001566|365358826|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
105918011|NCT00001566|365358826|FG000|Overall Study|Death|13|||
105918012|NCT00001566|365358826|FG000|Overall Study|Lost to Follow-up|1|||
105918013|NCT00001566|365358826|FG000|Overall Study|unable to complete initial apheresis|1|||
105918014|NCT03712280|365358827|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
105918015|NCT03712280|365358828|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
105687580|NCT00381303|364519051|FG000|Overall Study|Lost to Follow-up|25|||
105687581|NCT00381303|364519052|FG001|Overall Study|Lost to Follow-up|9|||
105687582|NCT00381303|364519051|FG000|Overall Study|AE/HIV-related event|22|||
105687583|NCT00381303|364519052|FG001|Overall Study|AE/HIV-related event|6|||
105687584|NCT00381303|364519051|FG000|Overall Study|Non-Adherence|13|||
105918016|NCT03712280|365358829|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
105687585|NCT00381303|364519052|FG001|Overall Study|Non-Adherence|6|||
105687586|NCT00381303|364519051|FG000|Overall Study|Withdrawal by Subject|13|||
105918017|NCT03712280|365358830|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
105918018|NCT03712280|365358827|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
105918019|NCT03712280|365358828|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
105687587|NCT00381303|364519052|FG001|Overall Study|Withdrawal by Subject|6|||
105687588|NCT00381303|364519051|FG000|Overall Study|Virologic failure|6|||
105687589|NCT00381303|364519052|FG001|Overall Study|Virologic failure|4|||
105918020|NCT03712280|365358829|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
105918021|NCT03712280|365358830|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
105918022|NCT03712280|365358827|FG000|Overall Study|Adverse Event|0|||
105918023|NCT03712280|365358828|FG001|Overall Study|Adverse Event|0|||
105918024|NCT03712280|365358829|FG002|Overall Study|Adverse Event|1|||
105918025|NCT03712280|365358830|FG003|Overall Study|Adverse Event|0|||
105918026|NCT00853762|365358831|FG000|Overall Study|Premature Termination|16|||
105918027|NCT00853762|365358832|FG001|Overall Study|Premature Termination|15|||
105918028|NCT00853762|365358833|FG002|Overall Study|Premature Termination|14|||
105918029|NCT00853762|365358834|FG003|Overall Study|Premature Termination|21|||
105918030|NCT00853762|365358831|FG000|Overall Study|Protocol Violation|0|||
105918031|NCT00853762|365358832|FG001|Overall Study|Protocol Violation|0|||
105918032|NCT00853762|365358833|FG002|Overall Study|Protocol Violation|0|||
105918033|NCT00853762|365358834|FG003|Overall Study|Protocol Violation|1|||
105918034|NCT00853762|365358831|FG000|Overall Study|Withdrawal by Subject|0|||
105918035|NCT00853762|365358832|FG001|Overall Study|Withdrawal by Subject|0|||
105918036|NCT00853762|365358833|FG002|Overall Study|Withdrawal by Subject|1|||
105918037|NCT00853762|365358834|FG003|Overall Study|Withdrawal by Subject|0|||
105918038|NCT00853762|365358831|FG000|Overall Study|Other|0|||
105918039|NCT00853762|365358832|FG001|Overall Study|Other|2|||
105918040|NCT00853762|365358833|FG002|Overall Study|Other|0|||
105918041|NCT00853762|365358834|FG003|Overall Study|Other|0|||
105918042|NCT00853762|365358831|FG000|Overall Study|Randomised but not Treated|0|||
105918043|NCT00853762|365358832|FG001|Overall Study|Randomised but not Treated|2|||
105918044|NCT00853762|365358833|FG002|Overall Study|Randomised but not Treated|2|||
105918045|NCT00853762|365358834|FG003|Overall Study|Randomised but not Treated|0|||
105918046|NCT02914834|365358835|FG000|Overall Study|Study halted due to COVID|1|||
105918047|NCT02914834|365358836|FG001|Overall Study|Study halted due to COVID|1|||
105918048|NCT02914834|365358835|FG000|Overall Study|1 subject withdrew|0|||
105918049|NCT02914834|365358836|FG001|Overall Study|1 subject withdrew|1|||
105918050|NCT02631941|365358843|FG000|Overall Study|Physician Decision|0|||
105918051|NCT02631941|365358844|FG001|Overall Study|Physician Decision|1|||
105918052|NCT02631941|365358845|FG002|Overall Study|Physician Decision|0|||
105918053|NCT02631941|365358846|FG003|Overall Study|Physician Decision|0|||
105918054|NCT02631941|365358847|FG004|Overall Study|Physician Decision|0|||
105918055|NCT02631941|365358848|FG005|Overall Study|Physician Decision|0|||
105918056|NCT02631941|365358849|FG006|Overall Study|Physician Decision|0|||
105918057|NCT02631941|365358850|FG007|Overall Study|Physician Decision|0|||
105918058|NCT02631941|365358851|FG008|Overall Study|Physician Decision|0|||
105918059|NCT02631941|365358852|FG009|Overall Study|Physician Decision|0|||
105918060|NCT02631941|365358843|FG000|Overall Study|Adverse Event|0|||
105918061|NCT02631941|365358844|FG001|Overall Study|Adverse Event|1|||
106130139|NCT00087490|366132940|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
106130140|NCT00087490|366132941|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
106130141|NCT00087490|366132940|FG000|Overall Study|Randomized but not treated|7|||
106130142|NCT00087490|366132941|FG001|Overall Study|Randomized but not treated|18|||
106130143|NCT03111095|366132942|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
106130144|NCT03111095|366132943|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
106130145|NCT03111095|366132942|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
106130146|NCT03111095|366132943|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
106130147|NCT01925170|366132944|FG000|Overall Study|Unverified cancer status|53|||
106130148|NCT03379233|366132945|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
106130149|NCT03379233|366132946|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
106130150|NCT02335268|366132951|FG000|Overall Study|Physician Decision|5|||
106130151|NCT02335268|366132952|FG001|Overall Study|Physician Decision|1|||
106130152|NCT02335268|366132951|FG000|Overall Study|Lack of Efficacy|2|||
106130153|NCT02335268|366132952|FG001|Overall Study|Lack of Efficacy|1|||
106130154|NCT02335268|366132951|FG000|Overall Study|Adverse Event|5|||
106130155|NCT02335268|366132952|FG001|Overall Study|Adverse Event|2|||
106130156|NCT02335268|366132951|FG000|Overall Study|increase blasts|2|||
106130157|NCT02335268|366132952|FG001|Overall Study|increase blasts|0|||
106130158|NCT02335268|366132951|FG000|Overall Study|Withdrawal by Subject|3|||
105918062|NCT02631941|365358845|FG002|Overall Study|Adverse Event|0|||
105918063|NCT02631941|365358846|FG003|Overall Study|Adverse Event|0|||
105918064|NCT02631941|365358847|FG004|Overall Study|Adverse Event|0|||
105918065|NCT02631941|365358848|FG005|Overall Study|Adverse Event|0|||
106001458|NCT02735239|365667743|FG000|Overall Study|Adverse Event|0|||
106001459|NCT02735239|365667744|FG001|Overall Study|Adverse Event|0|||
106001460|NCT02735239|365667745|FG002|Overall Study|Adverse Event|4|||
106001461|NCT02735239|365667746|FG003|Overall Study|Adverse Event|0|||
106001462|NCT02735239|365667747|FG004|Overall Study|Adverse Event|0|||
106001463|NCT02735239|365667748|FG005|Overall Study|Adverse Event|0|||
106001464|NCT02735239|365667743|FG000|Overall Study|Death|1|||
106001465|NCT02735239|365667744|FG001|Overall Study|Death|1|||
106001466|NCT02735239|365667745|FG002|Overall Study|Death|0|||
106001467|NCT02735239|365667746|FG003|Overall Study|Death|0|||
106001468|NCT02735239|365667747|FG004|Overall Study|Death|0|||
106001469|NCT02735239|365667748|FG005|Overall Study|Death|0|||
106001470|NCT02735239|365667743|FG000|Overall Study|Physician Decision|0|||
106001471|NCT02735239|365667744|FG001|Overall Study|Physician Decision|0|||
106001472|NCT02735239|365667745|FG002|Overall Study|Physician Decision|1|||
106001473|NCT02735239|365667746|FG003|Overall Study|Physician Decision|0|||
106001474|NCT02735239|365667747|FG004|Overall Study|Physician Decision|0|||
106001475|NCT02735239|365667748|FG005|Overall Study|Physician Decision|0|||
106001476|NCT02735239|365667743|FG000|Overall Study|Progressive disease|3|||
106001477|NCT02735239|365667744|FG001|Overall Study|Progressive disease|1|||
106001478|NCT02735239|365667745|FG002|Overall Study|Progressive disease|3|||
106001479|NCT02735239|365667746|FG003|Overall Study|Progressive disease|0|||
106001480|NCT02735239|365667747|FG004|Overall Study|Progressive disease|0|||
106001481|NCT02735239|365667748|FG005|Overall Study|Progressive disease|2|||
106001482|NCT02735239|365667743|FG000|Overall Study|Withdrawal by Subject|0|||
106001483|NCT02735239|365667744|FG001|Overall Study|Withdrawal by Subject|1|||
106001484|NCT02735239|365667745|FG002|Overall Study|Withdrawal by Subject|0|||
106001485|NCT02735239|365667746|FG003|Overall Study|Withdrawal by Subject|0|||
106001486|NCT02735239|365667747|FG004|Overall Study|Withdrawal by Subject|0|||
106001487|NCT02735239|365667748|FG005|Overall Study|Withdrawal by Subject|0|||
106001488|NCT01342913|365667749|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
106001489|NCT01342913|365667750|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
106001490|NCT01342913|365667751|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
106001491|NCT01342913|365667749|FG000|2-week Run-in Period|Physician Decision|6|||
106001492|NCT01342913|365667750|FG001|2-week Run-in Period|Physician Decision|0|||
106001493|NCT01342913|365667751|FG002|2-week Run-in Period|Physician Decision|0|||
106001494|NCT01342913|365667749|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
106001495|NCT01342913|365667750|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
106001496|NCT01342913|365667751|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
106001497|NCT01342913|365667749|FG000|2-week Run-in Period|Adverse Event|2|||
106001498|NCT01342913|365667750|FG001|2-week Run-in Period|Adverse Event|0|||
106001499|NCT01342913|365667751|FG002|2-week Run-in Period|Adverse Event|0|||
106001500|NCT01342913|365667749|FG000|2-week Run-in Period|Protocol Violation|5|||
106001501|NCT01342913|365667750|FG001|2-week Run-in Period|Protocol Violation|0|||
106001502|NCT01342913|365667751|FG002|2-week Run-in Period|Protocol Violation|0|||
106001503|NCT01342913|365667749|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
106001504|NCT01342913|365667750|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
106001505|NCT01342913|365667751|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
106001506|NCT01342913|365667749|FG000|Double-Blind Treatment Period|Adverse Event|0|||
106001507|NCT01342913|365667750|FG001|Double-Blind Treatment Period|Adverse Event|3|||
106001508|NCT01342913|365667751|FG002|Double-Blind Treatment Period|Adverse Event|6|||
106001509|NCT01342913|365667749|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
106001510|NCT01342913|365667750|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
106001511|NCT01342913|365667751|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
106001512|NCT01342913|365667749|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
106001513|NCT01342913|365667750|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
106001514|NCT01342913|365667751|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
106001515|NCT01342913|365667749|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105687590|NCT00381303|364519051|FG000|Overall Study|Ineligible to continue the trial|2|||
105687591|NCT00381303|364519052|FG001|Overall Study|Ineligible to continue the trial|1|||
105687592|NCT00381303|364519051|FG000|Overall Study|Pregnancy|2|||
106001516|NCT01342913|365667750|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
106001517|NCT01342913|365667751|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
106001518|NCT01342913|365667749|FG000|Double-Blind Treatment Period|Physician Decision|0|||
106001519|NCT01342913|365667750|FG001|Double-Blind Treatment Period|Physician Decision|2|||
106001520|NCT01342913|365667751|FG002|Double-Blind Treatment Period|Physician Decision|0|||
106001521|NCT01342913|365667749|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106001522|NCT01342913|365667750|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
106130159|NCT02335268|366132952|FG001|Overall Study|Withdrawal by Subject|2|||
106130160|NCT01767909|366132955|FG000|Overall Study|Withdrawal by Subject|4|||
106130161|NCT01767909|366132956|FG001|Overall Study|Withdrawal by Subject|7|||
106130162|NCT01767909|366132955|FG000|Overall Study|Adverse Event|3|||
106130163|NCT01767909|366132956|FG001|Overall Study|Adverse Event|1|||
106130164|NCT01767909|366132955|FG000|Overall Study|Withdrawal by Study Partner|3|||
106130165|NCT01767909|366132956|FG001|Overall Study|Withdrawal by Study Partner|1|||
106001523|NCT01342913|365667751|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
106001524|NCT00387881|365667755|FG000|Overall Study|Lost to Follow-up|23|||
106130166|NCT01767909|366132955|FG000|Overall Study|Non-Compliance|2|||
106130167|NCT01767909|366132956|FG001|Overall Study|Non-Compliance|0|||
106001525|NCT00387881|365667756|FG001|Overall Study|Lost to Follow-up|23|||
106001526|NCT00387881|365667755|FG000|Overall Study|Protocol Violation|2|||
106001527|NCT00387881|365667756|FG001|Overall Study|Protocol Violation|12|||
106001528|NCT00387881|365667755|FG000|Overall Study|Withdrawal by Subject|15|||
106001529|NCT00387881|365667756|FG001|Overall Study|Withdrawal by Subject|18|||
106001530|NCT00387881|365667755|FG000|Overall Study|Sponsor terminated Study|0|||
106001531|NCT00387881|365667756|FG001|Overall Study|Sponsor terminated Study|1|||
106001532|NCT00387881|365667755|FG000|Overall Study|Not eligible|6|||
106130168|NCT01767909|366132955|FG000|Overall Study|Perceived Lack of Efficacy|1|||
106130169|NCT01767909|366132956|FG001|Overall Study|Perceived Lack of Efficacy|0|||
106130170|NCT01767909|366132955|FG000|Overall Study|Investigator Recommendation|0|||
106130171|NCT01767909|366132956|FG001|Overall Study|Investigator Recommendation|1|||
106130172|NCT01767909|366132955|FG000|Overall Study|Lost to Follow-up|0|||
106130173|NCT01767909|366132956|FG001|Overall Study|Lost to Follow-up|1|||
106130174|NCT01767909|366132955|FG000|Overall Study|LP uncessessful|0|||
106130175|NCT01767909|366132956|FG001|Overall Study|LP uncessessful|1|||
106130176|NCT04529538|366132957|FG000|Overall Study|Lost to Follow-up|3|||
106130177|NCT04529538|366132958|FG001|Overall Study|Lost to Follow-up|2|||
105687593|NCT00381303|364519052|FG001|Overall Study|Pregnancy|0|||
105687594|NCT00381303|364519051|FG000|Overall Study|Physician Decision|1|||
105687595|NCT00381303|364519052|FG001|Overall Study|Physician Decision|0|||
106130178|NCT04529538|366132959|FG002|Overall Study|Lost to Follow-up|1|||
106130179|NCT04529538|366132960|FG003|Overall Study|Lost to Follow-up|0|||
106130180|NCT04529538|366132961|FG004|Overall Study|Lost to Follow-up|1|||
106130181|NCT04529538|366132962|FG005|Overall Study|Lost to Follow-up|1|||
106130182|NCT04529538|366132963|FG006|Overall Study|Lost to Follow-up|2|||
106130183|NCT04529538|366132964|FG007|Overall Study|Lost to Follow-up|0|||
106130184|NCT04529538|366132957|FG000|Overall Study|Not eligible at enrollment|0|||
106130185|NCT04529538|366132958|FG001|Overall Study|Not eligible at enrollment|1|||
106130186|NCT04529538|366132959|FG002|Overall Study|Not eligible at enrollment|2|||
106130187|NCT04529538|366132960|FG003|Overall Study|Not eligible at enrollment|1|||
106130188|NCT04529538|366132961|FG004|Overall Study|Not eligible at enrollment|0|||
106130189|NCT04529538|366132962|FG005|Overall Study|Not eligible at enrollment|0|||
106130190|NCT04529538|366132963|FG006|Overall Study|Not eligible at enrollment|0|||
106130191|NCT04529538|366132964|FG007|Overall Study|Not eligible at enrollment|1|||
106130192|NCT04529538|366132957|FG000|Overall Study|Withdrawal by Subject|0|||
106130193|NCT04529538|366132958|FG001|Overall Study|Withdrawal by Subject|1|||
106130194|NCT04529538|366132959|FG002|Overall Study|Withdrawal by Subject|1|||
106130195|NCT04529538|366132960|FG003|Overall Study|Withdrawal by Subject|2|||
106130196|NCT04529538|366132961|FG004|Overall Study|Withdrawal by Subject|0|||
106130197|NCT04529538|366132962|FG005|Overall Study|Withdrawal by Subject|2|||
106130198|NCT04529538|366132963|FG006|Overall Study|Withdrawal by Subject|3|||
106130199|NCT04529538|366132964|FG007|Overall Study|Withdrawal by Subject|0|||
106130200|NCT04529538|366132957|FG000|Overall Study|Other|0|||
106130201|NCT04529538|366132958|FG001|Overall Study|Other|1|||
106130202|NCT04529538|366132959|FG002|Overall Study|Other|0|||
106130203|NCT04529538|366132960|FG003|Overall Study|Other|0|||
106130204|NCT04529538|366132961|FG004|Overall Study|Other|0|||
106130205|NCT04529538|366132962|FG005|Overall Study|Other|0|||
106130206|NCT04529538|366132963|FG006|Overall Study|Other|0|||
106130207|NCT04529538|366132964|FG007|Overall Study|Other|0|||
106130208|NCT04529538|366132957|FG000|Overall Study|Adverse Event|0|||
106130209|NCT04529538|366132958|FG001|Overall Study|Adverse Event|0|||
106130210|NCT04529538|366132959|FG002|Overall Study|Adverse Event|0|||
106130211|NCT04529538|366132960|FG003|Overall Study|Adverse Event|1|||
106130212|NCT04529538|366132961|FG004|Overall Study|Adverse Event|0|||
106130213|NCT04529538|366132962|FG005|Overall Study|Adverse Event|0|||
106130214|NCT04529538|366132963|FG006|Overall Study|Adverse Event|0|||
106130215|NCT04529538|366132964|FG007|Overall Study|Adverse Event|0|||
106130216|NCT04529538|366132957|FG000|Overall Study|Protocol Deviation|0|||
106130217|NCT04529538|366132958|FG001|Overall Study|Protocol Deviation|0|||
106130218|NCT04529538|366132959|FG002|Overall Study|Protocol Deviation|0|||
106130219|NCT04529538|366132960|FG003|Overall Study|Protocol Deviation|1|||
106130220|NCT04529538|366132961|FG004|Overall Study|Protocol Deviation|0|||
106130221|NCT04529538|366132962|FG005|Overall Study|Protocol Deviation|0|||
106130222|NCT04529538|366132963|FG006|Overall Study|Protocol Deviation|0|||
106130223|NCT04529538|366132964|FG007|Overall Study|Protocol Deviation|0|||
106130224|NCT04529538|366132957|FG000|Overall Study|Physician Decision|0|||
106001533|NCT00387881|365667756|FG001|Overall Study|Not eligible|7|||
106001534|NCT00387881|365667755|FG000|Overall Study|No opportunity to treat headache|32|||
106001535|NCT00387881|365667756|FG001|Overall Study|No opportunity to treat headache|34|||
106001536|NCT00387881|365667755|FG000|Overall Study|Not otherwise specified|11|||
106001537|NCT00387881|365667756|FG001|Overall Study|Not otherwise specified|7|||
106130225|NCT04529538|366132958|FG001|Overall Study|Physician Decision|0|||
106130226|NCT04529538|366132959|FG002|Overall Study|Physician Decision|0|||
106130227|NCT04529538|366132960|FG003|Overall Study|Physician Decision|0|||
106130228|NCT04529538|366132961|FG004|Overall Study|Physician Decision|0|||
105918066|NCT02631941|365358849|FG006|Overall Study|Adverse Event|0|||
105918067|NCT02631941|365358850|FG007|Overall Study|Adverse Event|0|||
105918068|NCT02631941|365358851|FG008|Overall Study|Adverse Event|0|||
105918069|NCT02631941|365358852|FG009|Overall Study|Adverse Event|0|||
105918070|NCT02631941|365358843|FG000|Overall Study|Withdrawal by Subject|0|||
105918071|NCT02631941|365358844|FG001|Overall Study|Withdrawal by Subject|0|||
105918072|NCT02631941|365358845|FG002|Overall Study|Withdrawal by Subject|0|||
105918073|NCT02631941|365358846|FG003|Overall Study|Withdrawal by Subject|0|||
105918074|NCT02631941|365358847|FG004|Overall Study|Withdrawal by Subject|1|||
105918075|NCT02631941|365358848|FG005|Overall Study|Withdrawal by Subject|0|||
105918076|NCT02631941|365358849|FG006|Overall Study|Withdrawal by Subject|0|||
105918077|NCT02631941|365358850|FG007|Overall Study|Withdrawal by Subject|1|||
105918078|NCT02631941|365358851|FG008|Overall Study|Withdrawal by Subject|0|||
105918079|NCT02631941|365358852|FG009|Overall Study|Withdrawal by Subject|0|||
105918080|NCT02631941|365358843|FG000|Overall Study|Lost to Follow-up|0|||
105918081|NCT02631941|365358844|FG001|Overall Study|Lost to Follow-up|0|||
105918082|NCT02631941|365358845|FG002|Overall Study|Lost to Follow-up|0|||
105918083|NCT02631941|365358846|FG003|Overall Study|Lost to Follow-up|0|||
105918084|NCT02631941|365358847|FG004|Overall Study|Lost to Follow-up|0|||
105918085|NCT02631941|365358848|FG005|Overall Study|Lost to Follow-up|0|||
105918086|NCT02631941|365358849|FG006|Overall Study|Lost to Follow-up|0|||
105918087|NCT02631941|365358850|FG007|Overall Study|Lost to Follow-up|0|||
105918088|NCT02631941|365358851|FG008|Overall Study|Lost to Follow-up|1|||
105918089|NCT02631941|365358852|FG009|Overall Study|Lost to Follow-up|0|||
105918090|NCT02204917|365358858|FG000|Overall Study|Protocol Violation|1|||
105918091|NCT04210986|365358859|FG000|Overall Study|Lost to Follow-up|5|||
105918092|NCT04210986|365358860|FG001|Overall Study|Lost to Follow-up|2|||
105918093|NCT04210986|365358859|FG000|Overall Study|Withdrawal by Subject|3|||
105918094|NCT04210986|365358860|FG001|Overall Study|Withdrawal by Subject|1|||
105918095|NCT04210986|365358859|FG000|Overall Study|Protocol Violation|1|||
105918096|NCT04210986|365358860|FG001|Overall Study|Protocol Violation|1|||
105918097|NCT04210986|365358859|FG000|Overall Study|Physician Decision|0|||
105918098|NCT04210986|365358860|FG001|Overall Study|Physician Decision|1|||
105918099|NCT03863353|365358861|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
105918100|NCT03863353|365358862|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
105918101|NCT03810183|365358864|FG000|Overall Study|Study terminated by Sponsor|2|||
105918102|NCT03810183|365358865|FG001|Overall Study|Study terminated by Sponsor|1|||
105918103|NCT01664091|365358866|FG000|Overall Study|Death|1|||
105918104|NCT01664091|365358866|FG000|Overall Study|Disease Progression|2|||
105918105|NCT01664091|365358866|FG000|Overall Study|Lost to Follow-up|2|||
105918106|NCT01664091|365358866|FG000|Overall Study|Withdrawal by Subject|1|||
105918107|NCT01791985|365358872|FG000|Overall Study|Adverse Event|7|||
105918108|NCT01791985|365358872|FG000|Overall Study|Withdrawal by Subject|1|||
105918109|NCT01687218|365358873|FG000|Overall Study|Withdrawal by Subject|2|||
105918110|NCT01687218|365358874|FG001|Overall Study|Withdrawal by Subject|3|||
105918111|NCT01687218|365358875|FG002|Overall Study|Withdrawal by Subject|0|||
105918112|NCT01687218|365358876|FG003|Overall Study|Withdrawal by Subject|1|||
105918113|NCT01687218|365358877|FG004|Overall Study|Withdrawal by Subject|1|||
105918114|NCT01687218|365358878|FG005|Overall Study|Withdrawal by Subject|0|||
105918115|NCT01687218|365358873|FG000|Overall Study|Relocated, no follow-up planned|1|||
105918116|NCT01687218|365358874|FG001|Overall Study|Relocated, no follow-up planned|0|||
105918117|NCT01687218|365358875|FG002|Overall Study|Relocated, no follow-up planned|1|||
105918118|NCT01687218|365358876|FG003|Overall Study|Relocated, no follow-up planned|1|||
105918119|NCT01687218|365358877|FG004|Overall Study|Relocated, no follow-up planned|0|||
105918120|NCT01687218|365358878|FG005|Overall Study|Relocated, no follow-up planned|0|||
105918121|NCT01973218|365358879|FG000|Overall Study|Adverse Event|1|||
105918122|NCT01973218|365358880|FG001|Overall Study|Adverse Event|0|||
105918123|NCT01973218|365358879|FG000|Overall Study|Withdrawal by Subject|1|||
105918124|NCT01973218|365358880|FG001|Overall Study|Withdrawal by Subject|0|||
105918125|NCT03533751|365358881|FG000|Overall Study|Withdrawal by Subject|12|||
105918126|NCT03533751|365358882|FG001|Overall Study|Withdrawal by Subject|6|||
105918127|NCT03533751|365358883|FG002|Overall Study|Withdrawal by Subject|11|||
105918128|NCT03533751|365358884|FG003|Overall Study|Withdrawal by Subject|9|||
105918129|NCT03533751|365358885|FG004|Overall Study|Withdrawal by Subject|10|||
105918130|NCT03533751|365358881|FG000|Overall Study|Adverse Event|4|||
105918131|NCT03533751|365358882|FG001|Overall Study|Adverse Event|7|||
105918132|NCT03533751|365358883|FG002|Overall Study|Adverse Event|2|||
105918133|NCT03533751|365358884|FG003|Overall Study|Adverse Event|4|||
105918134|NCT03533751|365358885|FG004|Overall Study|Adverse Event|5|||
105918135|NCT03533751|365358881|FG000|Overall Study|Physician Decision|0|||
106001538|NCT03629886|365667757|FG000|Overall Study|Migrated / moved from the study area|0|||
106130229|NCT04529538|366132962|FG005|Overall Study|Physician Decision|1|||
105918136|NCT03533751|365358882|FG001|Overall Study|Physician Decision|2|||
105918137|NCT03533751|365358883|FG002|Overall Study|Physician Decision|1|||
106130230|NCT04529538|366132963|FG006|Overall Study|Physician Decision|0|||
106130231|NCT04529538|366132964|FG007|Overall Study|Physician Decision|1|||
106130232|NCT03289455|366132967|FG000|Overall Study|Death|1|||
106130233|NCT03289455|366132968|FG001|Overall Study|Death|0|||
106130234|NCT03289455|366132969|FG002|Overall Study|Death|0|||
106130235|NCT03289455|366132967|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
106130236|NCT03289455|366132968|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
106130237|NCT03289455|366132969|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
106130238|NCT03289455|366132967|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
106130239|NCT03289455|366132968|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
106130240|NCT03289455|366132969|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
106130241|NCT03289455|366132967|FG000|Overall Study|Progressive disease|3|||
106130242|NCT03289455|366132968|FG001|Overall Study|Progressive disease|4|||
106130243|NCT03289455|366132969|FG002|Overall Study|Progressive disease|5|||
106130244|NCT00333788|366132972|FG000|Overall Study|Adverse Event|44|||
106130245|NCT00333788|366132972|FG000|Overall Study|Lack of Efficacy|80|||
106130246|NCT00333788|366132972|FG000|Overall Study|Lost to Follow-up|2|||
106130247|NCT00333788|366132972|FG000|Overall Study|Withdrawal by Subject|24|||
105786602|NCT03323034|364872845|FG004|Overall Study|Withdrawal by Subject|0|||
105786603|NCT02815540|364872851|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
105786604|NCT00718809|364872862|FG000|Overall Study|Disease progression|9|||
105786605|NCT00718809|364872863|FG001|Overall Study|Disease progression|7|||
105786606|NCT00718809|364872862|FG000|Overall Study|Adverse Event|1|||
105786607|NCT00718809|364872863|FG001|Overall Study|Adverse Event|1|||
105786608|NCT00718809|364872862|FG000|Overall Study|Withdrawal by Subject|0|||
105786609|NCT00718809|364872863|FG001|Overall Study|Withdrawal by Subject|1|||
105786610|NCT00718809|364872862|FG000|Overall Study|Lost to Follow-up|1|||
105786611|NCT00718809|364872863|FG001|Overall Study|Lost to Follow-up|0|||
105786612|NCT00718809|364872862|FG000|Overall Study|Noncompliance|1|||
105786613|NCT00718809|364872863|FG001|Overall Study|Noncompliance|0|||
105786614|NCT00463385|364872864|FG000|Overall Study|Other|4|||
105918138|NCT03533751|365358884|FG003|Overall Study|Physician Decision|2|||
105918139|NCT03533751|365358885|FG004|Overall Study|Physician Decision|1|||
105918140|NCT03533751|365358881|FG000|Overall Study|Sponsor Decision|0|||
105918141|NCT03533751|365358882|FG001|Overall Study|Sponsor Decision|0|||
105918142|NCT03533751|365358883|FG002|Overall Study|Sponsor Decision|1|||
105918143|NCT03533751|365358884|FG003|Overall Study|Sponsor Decision|1|||
105918144|NCT03533751|365358885|FG004|Overall Study|Sponsor Decision|0|||
105918145|NCT03533751|365358881|FG000|Overall Study|Lost to Follow-up|3|||
105918146|NCT03533751|365358882|FG001|Overall Study|Lost to Follow-up|7|||
105918147|NCT03533751|365358883|FG002|Overall Study|Lost to Follow-up|6|||
105918148|NCT03533751|365358884|FG003|Overall Study|Lost to Follow-up|4|||
105918149|NCT03533751|365358885|FG004|Overall Study|Lost to Follow-up|3|||
105918150|NCT03533751|365358881|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
105918151|NCT03533751|365358882|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
105918152|NCT03533751|365358883|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
105918153|NCT03533751|365358884|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
105918154|NCT03533751|365358885|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
105918155|NCT03533751|365358881|FG000|Overall Study|Other|0|||
105918156|NCT03533751|365358882|FG001|Overall Study|Other|2|||
105918157|NCT03533751|365358883|FG002|Overall Study|Other|1|||
106001539|NCT03629886|365667758|FG001|Overall Study|Migrated / moved from the study area|55|||
106130248|NCT00333788|366132972|FG000|Overall Study|Other: Non-compliance|2|||
105687596|NCT00381303|364519051|FG000|Overall Study|Physician's decision to close the site|3|||
105687597|NCT00381303|364519052|FG001|Overall Study|Physician's decision to close the site|1|||
105687598|NCT00381303|364519051|FG000|Overall Study|Subject moved out of state|2|||
105687599|NCT00381303|364519052|FG001|Overall Study|Subject moved out of state|0|||
105687600|NCT00381303|364519051|FG000|Overall Study|Subject taking too many different meds|1|||
105687601|NCT00381303|364519052|FG001|Overall Study|Subject taking too many different meds|0|||
105687602|NCT00381303|364519051|FG000|Overall Study|No virologic response by week 12|1|||
105786615|NCT00463385|364872865|FG001|Overall Study|Other|3|||
105786616|NCT00463385|364872866|FG002|Overall Study|Other|6|||
105918158|NCT03533751|365358884|FG003|Overall Study|Other|0|||
105918159|NCT03533751|365358885|FG004|Overall Study|Other|3|||
105918160|NCT01499810|365358886|FG000|Overall Study|Lost to Follow-up|10|||
105918161|NCT01499810|365358886|FG000|Overall Study|Protocol Violation|1|||
105918162|NCT01499810|365358886|FG000|Overall Study|Withdrawal by Subject|1|||
105918163|NCT04158219|365358887|FG000|Overall Study|Lost to Follow-up|1|||
105918164|NCT01324947|365358888|FG000|Overall Study|Adverse Event|7|||
106130249|NCT00333788|366132972|FG000|Overall Study|Other: Moved|2|||
106130250|NCT00333788|366132972|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
106130251|NCT00333788|366132972|FG000|Overall Study|Other: Investigator decision|1|||
105786617|NCT00463385|364872867|FG003|Overall Study|Other|4|||
105786618|NCT00463385|364872864|FG000|Overall Study|Adverse Event|5|||
105918165|NCT01324947|365358888|FG000|Overall Study|Death|10|||
105918166|NCT01324947|365358888|FG000|Overall Study|Other|3|||
105687603|NCT00381303|364519052|FG001|Overall Study|No virologic response by week 12|0|||
105687604|NCT00381303|364519051|FG000|Overall Study|Subject was too busy for appointments|1|||
105687605|NCT00381303|364519052|FG001|Overall Study|Subject was too busy for appointments|0|||
105687606|NCT00381303|364519051|FG000|Overall Study|Subject did not continue visits|1|||
105687607|NCT00381303|364519052|FG001|Overall Study|Subject did not continue visits|0|||
105918167|NCT01324947|365358888|FG000|Overall Study|Progressive Disease|50|||
105918168|NCT01324947|365358888|FG000|Overall Study|Withdrawal by Subject|3|||
105918169|NCT01324947|365358888|FG000|Overall Study|1 discontinued before starting drug|1|||
105918170|NCT01655901|365360976|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
105918171|NCT01655901|365360977|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
105918172|NCT01655901|365360978|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
105918173|NCT01655901|365360979|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
105918174|NCT01655901|365360980|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
105918175|NCT01655901|365360981|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
105918176|NCT00329108|365360986|FG000|Overall Study|Adverse Event|2|||
105918177|NCT00329108|365360987|FG001|Overall Study|Adverse Event|2|||
105918178|NCT00329108|365360986|FG000|Overall Study|Lack of Efficacy|3|||
105918179|NCT00329108|365360987|FG001|Overall Study|Lack of Efficacy|3|||
106001540|NCT03629886|365667757|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
106001541|NCT03629886|365667758|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
106001542|NCT03629886|365667757|FG000|Overall Study|Study vaccine not administrated|0|||
106001543|NCT03629886|365667758|FG001|Overall Study|Study vaccine not administrated|3|||
106001544|NCT03629886|365667757|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
106001545|NCT03629886|365667758|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
106001546|NCT03629886|365667757|FG000|Overall Study|Refused vaccination step of the study|0|||
106001547|NCT03629886|365667758|FG001|Overall Study|Refused vaccination step of the study|44|||
106001548|NCT03683173|365667762|FG000|Completed Follow-up|Unavailable|235|||
106001549|NCT03683173|365667763|FG001|Completed Follow-up|Unavailable|217|||
106001550|NCT03683173|365667762|FG000|Completed Follow-up|Refused|69|||
106001551|NCT03683173|365667763|FG001|Completed Follow-up|Refused|59|||
106001552|NCT03683173|365667762|FG000|Completed Follow-up|Disconnected phone|65|||
106001553|NCT03683173|365667763|FG001|Completed Follow-up|Disconnected phone|95|||
106001554|NCT03683173|365667762|FG000|Completed Follow-up|Health issue/deceased|10|||
106001555|NCT03683173|365667763|FG001|Completed Follow-up|Health issue/deceased|4|||
106001556|NCT03683173|365667762|FG000|Completed Follow-up|Moved away|8|||
106001557|NCT03683173|365667763|FG001|Completed Follow-up|Moved away|1|||
106001558|NCT02730728|365667764|FG000|Overall Study|Withdrawal by Subject|0|||
106001559|NCT02730728|365667765|FG001|Overall Study|Withdrawal by Subject|1|||
106001560|NCT02730728|365667766|FG002|Overall Study|Withdrawal by Subject|0|||
106001561|NCT02730728|365667764|FG000|Overall Study|Lack of Efficacy|0|||
106001562|NCT02730728|365667765|FG001|Overall Study|Lack of Efficacy|1|||
106001563|NCT02730728|365667766|FG002|Overall Study|Lack of Efficacy|1|||
106001564|NCT00922623|365667767|FG000|Overall Study|Other|4|||
106001565|NCT00922623|365667767|FG000|Overall Study|Lost to Follow-up|1|||
106001566|NCT02210000|365667769|FG000|Overall Study|Study Terminated|11|||
106001567|NCT02210000|365667770|FG001|Overall Study|Study Terminated|12|||
106001568|NCT02210000|365667769|FG000|Overall Study|Withdrawal by Subject|7|||
106001569|NCT02210000|365667770|FG001|Overall Study|Withdrawal by Subject|1|||
106001570|NCT02210000|365667769|FG000|Overall Study|Adverse Event|1|||
106001571|NCT02210000|365667770|FG001|Overall Study|Adverse Event|5|||
105918180|NCT00329108|365360986|FG000|Overall Study|Withdrawal by Subject|0|||
105918181|NCT00329108|365360987|FG001|Overall Study|Withdrawal by Subject|2|||
105918182|NCT00329108|365360986|FG000|Overall Study|symptomatic deterioration|1|||
105786619|NCT00463385|364872865|FG001|Overall Study|Adverse Event|8|||
105918183|NCT00329108|365360987|FG001|Overall Study|symptomatic deterioration|1|||
105918184|NCT00329108|365360986|FG000|Overall Study|Subject no longer willing to participate|2|||
106001572|NCT02210000|365667769|FG000|Overall Study|Lost to Follow-up|0|||
106001573|NCT02210000|365667770|FG001|Overall Study|Lost to Follow-up|2|||
106001574|NCT02210000|365667769|FG000|Overall Study|Physician Decision|0|||
106001575|NCT02210000|365667770|FG001|Overall Study|Physician Decision|1|||
106001576|NCT03347123|365667776|FG000|Overall Study|Death|1|||
106001577|NCT03347123|365667777|FG001|Overall Study|Death|2|||
105687608|NCT00381303|364519051|FG000|Overall Study|Subject primary physician's decision|1|||
105687609|NCT00381303|364519052|FG001|Overall Study|Subject primary physician's decision|0|||
105687610|NCT01211522|364519054|FG000|Overall Study|Withdrawal by Subject|3|||
105687611|NCT01211522|364519055|FG001|Overall Study|Withdrawal by Subject|7|||
105687612|NCT01211522|364519056|FG002|Overall Study|Withdrawal by Subject|5|||
105687613|NCT00547365|364519057|FG000|Overall Study|Physician Decision|1|||
105687614|NCT00547365|364519057|FG000|Overall Study|Lost to Follow-up|1|||
105687615|NCT00547365|364519057|FG000|Overall Study|Protocol Violation|2|||
105687616|NCT00547365|364519057|FG000|Overall Study|death (not related to study)|4|||
105687617|NCT01777269|364519058|FG000|Overall Study|Adverse Event|24|||
105918185|NCT00329108|365360987|FG001|Overall Study|Subject no longer willing to participate|2|||
105918186|NCT00329108|365360986|FG000|Overall Study|study terminated by sponsor|1|||
105918187|NCT00329108|365360987|FG001|Overall Study|study terminated by sponsor|0|||
105918188|NCT00329108|365360986|FG000|Overall Study|withdrew patient after SAE resolved|1|||
105918189|NCT00329108|365360987|FG001|Overall Study|withdrew patient after SAE resolved|0|||
105918190|NCT00329108|365360986|FG000|Overall Study|Protocol Violation|0|||
105918191|NCT00329108|365360987|FG001|Overall Study|Protocol Violation|2|||
105918192|NCT03256578|365360988|FG000|Overall Study|Excluded Post Randomization|66|||
105918193|NCT03256578|365360989|FG001|Overall Study|Excluded Post Randomization|56|||
105918194|NCT00754741|365360990|FG000|Overall Study|Died or disenrolled|57|||
105918195|NCT00754741|365360991|FG001|Overall Study|Died or disenrolled|69|||
105918196|NCT00754741|365360992|FG002|Overall Study|Died or disenrolled|54|||
105918197|NCT00922636|365360993|FG000|Overall Study|Adverse Event|3|||
105918198|NCT00922636|365360994|FG001|Overall Study|Adverse Event|3|||
105918199|NCT00922636|365360995|FG002|Overall Study|Adverse Event|2|||
105918200|NCT00922636|365360996|FG003|Overall Study|Adverse Event|3|||
105918201|NCT00922636|365360997|FG004|Overall Study|Adverse Event|2|||
105918202|NCT00922636|365360993|FG000|Overall Study|Lack of Efficacy|1|||
105918203|NCT00922636|365360994|FG001|Overall Study|Lack of Efficacy|7|||
105918204|NCT00922636|365360995|FG002|Overall Study|Lack of Efficacy|3|||
105918205|NCT00922636|365360996|FG003|Overall Study|Lack of Efficacy|2|||
105918206|NCT00922636|365360997|FG004|Overall Study|Lack of Efficacy|4|||
105918207|NCT00922636|365360993|FG000|Overall Study|Sponsor Decision|0|||
105918208|NCT00922636|365360994|FG001|Overall Study|Sponsor Decision|0|||
105918209|NCT00922636|365360995|FG002|Overall Study|Sponsor Decision|2|||
105918210|NCT00922636|365360996|FG003|Overall Study|Sponsor Decision|0|||
105918211|NCT00922636|365360997|FG004|Overall Study|Sponsor Decision|0|||
105918212|NCT00922636|365360993|FG000|Overall Study|Withdrawal by Subject|0|||
105918213|NCT00922636|365360994|FG001|Overall Study|Withdrawal by Subject|0|||
105918214|NCT00922636|365360995|FG002|Overall Study|Withdrawal by Subject|5|||
106130252|NCT00333788|366132972|FG000|Overall Study|Other: Quality of life concern|1|||
106130253|NCT00333788|366132972|FG000|Overall Study|Other: Sponsor decision|1|||
106130254|NCT00333788|366132972|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
106130255|NCT00333788|366132972|FG000|Overall Study|Other: Medical monitor decision|1|||
106130256|NCT00333788|366132972|FG000|Overall Study|Other: Physician decision|1|||
106130257|NCT00333788|366132972|FG000|Overall Study|Other: Signed consent for another study|1|||
106130258|NCT04060680|366132975|FG000|Overall Study|Unsuccessful implant|17|||
106130259|NCT04060680|366132976|FG001|Overall Study|Unsuccessful implant|2|||
106130260|NCT04060680|366132975|FG000|Overall Study|Adverse Event|3|||
106130261|NCT04060680|366132976|FG001|Overall Study|Adverse Event|0|||
106130262|NCT04060680|366132975|FG000|Overall Study|Death|2|||
106130263|NCT04060680|366132976|FG001|Overall Study|Death|0|||
106130264|NCT04060680|366132975|FG000|Overall Study|Study product no longer in use|1|||
106130265|NCT04060680|366132976|FG001|Overall Study|Study product no longer in use|0|||
106130266|NCT04060680|366132975|FG000|Overall Study|Withdrawal by Subject|1|||
106130267|NCT04060680|366132976|FG001|Overall Study|Withdrawal by Subject|0|||
106130268|NCT02956967|366132977|FG000|Overall Study|Adverse Event|3|||
106130269|NCT02956967|366132977|FG000|Overall Study|Reason non-related to neutropenia|10|||
106130270|NCT02956967|366132977|FG000|Overall Study|Lost to Follow-up|5|||
106130271|NCT02956967|366132977|FG000|Overall Study|Missing|1|||
106130272|NCT02956967|366132977|FG000|Overall Study|Termination of Nivestim administration|29|||
106130273|NCT04426006|366132989|FG000|Inclusion|Protocol Violation|1|||
106130274|NCT04426006|366132989|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
106130275|NCT04426006|366132989|FG000|Inclusion|Blood sample at inclusion not done|1|||
105687618|NCT01777269|364519059|FG001|Overall Study|Adverse Event|33|||
105687619|NCT01777269|364519058|FG000|Overall Study|Lack of Efficacy|8|||
105687620|NCT01777269|364519059|FG001|Overall Study|Lack of Efficacy|10|||
105918215|NCT00922636|365360996|FG003|Overall Study|Withdrawal by Subject|2|||
105918216|NCT00922636|365360997|FG004|Overall Study|Withdrawal by Subject|4|||
105918217|NCT00922636|365360993|FG000|Overall Study|Protocol Violation|0|||
105918218|NCT00922636|365360994|FG001|Overall Study|Protocol Violation|0|||
106130276|NCT04426006|366132989|FG000|3 Months|Lost to Follow-up|17|||
106130277|NCT04426006|366132989|FG000|12 Months|Lost to Follow-up|38|||
106130278|NCT05114590|366132990|FG000|Overall Study|Adverse Event|1|||
105918219|NCT00922636|365360995|FG002|Overall Study|Protocol Violation|2|||
105918220|NCT00922636|365360996|FG003|Overall Study|Protocol Violation|2|||
105918221|NCT00922636|365360997|FG004|Overall Study|Protocol Violation|0|||
105918222|NCT00922636|365360993|FG000|Overall Study|Entry Criteria Not Met|0|||
105918223|NCT00922636|365360994|FG001|Overall Study|Entry Criteria Not Met|0|||
105918224|NCT00922636|365360995|FG002|Overall Study|Entry Criteria Not Met|1|||
105918225|NCT00922636|365360996|FG003|Overall Study|Entry Criteria Not Met|1|||
105918226|NCT00922636|365360997|FG004|Overall Study|Entry Criteria Not Met|0|||
105918227|NCT00922636|365360993|FG000|Overall Study|Parent/Caregiver Decision|2|||
105918228|NCT00922636|365360994|FG001|Overall Study|Parent/Caregiver Decision|4|||
105918229|NCT00922636|365360995|FG002|Overall Study|Parent/Caregiver Decision|3|||
105918230|NCT00922636|365360996|FG003|Overall Study|Parent/Caregiver Decision|5|||
105918231|NCT00922636|365360997|FG004|Overall Study|Parent/Caregiver Decision|2|||
105918232|NCT00922636|365360993|FG000|Overall Study|Lost to Follow-up|1|||
105918233|NCT00922636|365360994|FG001|Overall Study|Lost to Follow-up|2|||
106001578|NCT03347123|365667778|FG002|Overall Study|Death|0|||
106001579|NCT03347123|365667779|FG003|Overall Study|Death|0|||
106001580|NCT03347123|365667780|FG004|Overall Study|Death|0|||
106001581|NCT03347123|365667781|FG005|Overall Study|Death|0|||
106001582|NCT03347123|365667782|FG006|Overall Study|Death|0|||
106001583|NCT03347123|365667776|FG000|Overall Study|Withdrawal by Subject|1|||
106001584|NCT03347123|365667777|FG001|Overall Study|Withdrawal by Subject|0|||
106001585|NCT03347123|365667778|FG002|Overall Study|Withdrawal by Subject|0|||
106001586|NCT03347123|365667779|FG003|Overall Study|Withdrawal by Subject|0|||
106001587|NCT03347123|365667780|FG004|Overall Study|Withdrawal by Subject|0|||
106001588|NCT03347123|365667781|FG005|Overall Study|Withdrawal by Subject|0|||
106001589|NCT03347123|365667782|FG006|Overall Study|Withdrawal by Subject|0|||
106001590|NCT03347123|365667776|FG000|Overall Study|Reason not Specified|3|||
106001591|NCT03347123|365667777|FG001|Overall Study|Reason not Specified|4|||
106001592|NCT03347123|365667778|FG002|Overall Study|Reason not Specified|0|||
106001593|NCT03347123|365667779|FG003|Overall Study|Reason not Specified|0|||
106001594|NCT03347123|365667780|FG004|Overall Study|Reason not Specified|0|||
106001595|NCT03347123|365667781|FG005|Overall Study|Reason not Specified|0|||
106001596|NCT03347123|365667782|FG006|Overall Study|Reason not Specified|0|||
106001597|NCT02123134|365667783|FG000|Overall Study|Withdrawal of consent|3|||
106001598|NCT02123134|365667784|FG001|Overall Study|Withdrawal of consent|2|||
106001599|NCT02123134|365667783|FG000|Overall Study|Administrative decision|0|||
106001600|NCT02123134|365667784|FG001|Overall Study|Administrative decision|1|||
106001601|NCT02632344|365667789|FG000|Overall Study|Adverse Event|3|||
106001602|NCT02632344|365667789|FG000|Overall Study|Lack of Efficacy|3|||
106001603|NCT02632344|365667789|FG000|Overall Study|Withdrawal by Subject|2|||
106001604|NCT02469623|365667792|FG000|Overall Study|Not consented for long-term follow-up|4|||
106001605|NCT02469623|365667792|FG000|Overall Study|Lost to Follow-up|4|||
106001606|NCT02469623|365667792|FG000|Overall Study|Withdrawal by Subject|2|||
106001607|NCT02469623|365667792|FG000|Overall Study|Death|3|||
106001608|NCT03309878|365667793|FG000|Overall Study|Adverse Event|1|||
106001609|NCT03309878|365667794|FG001|Overall Study|Adverse Event|0|||
106001610|NCT03309878|365667795|FG002|Overall Study|Adverse Event|0|||
106001611|NCT03309878|365667796|FG003|Overall Study|Adverse Event|0|||
106001612|NCT03309878|365667793|FG000|Overall Study|Did not maintain eligibility|2|||
105918234|NCT00922636|365360995|FG002|Overall Study|Lost to Follow-up|2|||
105918235|NCT00922636|365360996|FG003|Overall Study|Lost to Follow-up|2|||
105918236|NCT00922636|365360997|FG004|Overall Study|Lost to Follow-up|4|||
105918237|NCT02308046|365361006|FG000|Overall Study|Negative yeast culture at Baseline|32|||
105918238|NCT02308046|365361007|FG001|Overall Study|Negative yeast culture at Baseline|33|||
106001613|NCT03309878|365667794|FG001|Overall Study|Did not maintain eligibility|1|||
106001614|NCT03309878|365667795|FG002|Overall Study|Did not maintain eligibility|0|||
106001615|NCT03309878|365667796|FG003|Overall Study|Did not maintain eligibility|0|||
105918239|NCT02308046|365361006|FG000|Overall Study|Positive for STD at Baseline|1|||
105918240|NCT02308046|365361007|FG001|Overall Study|Positive for STD at Baseline|2|||
105918241|NCT02308046|365361006|FG000|Overall Study|Lost to Follow-up|1|||
105918242|NCT02308046|365361007|FG001|Overall Study|Lost to Follow-up|3|||
105918243|NCT00161213|365361008|FG000|Overall Study|Withdrawal by Subject|1|||
105918244|NCT00161213|365361008|FG000|Overall Study|Evaluable for toxicity but not response|1|||
105918245|NCT01190891|365361011|FG000|Overall Study|Protocol Violation|1|||
105918246|NCT01190891|365361012|FG001|Overall Study|Protocol Violation|0|||
105918247|NCT01190891|365361011|FG000|Overall Study|Withdrawal by Subject|5|||
105918248|NCT01190891|365361012|FG001|Overall Study|Withdrawal by Subject|0|||
105918249|NCT01926028|365361013|FG000|Overall Study|Lost to Follow-up|7|||
105918250|NCT01926028|365361014|FG001|Overall Study|Lost to Follow-up|6|||
105918251|NCT01926028|365361015|FG002|Overall Study|Lost to Follow-up|0|||
105918252|NCT01926028|365361013|FG000|Overall Study|Physician Decision|1|||
105918253|NCT01926028|365361014|FG001|Overall Study|Physician Decision|5|||
105918254|NCT01926028|365361015|FG002|Overall Study|Physician Decision|0|||
105918255|NCT01926028|365361013|FG000|Overall Study|Withdrawal by Subject|9|||
105918256|NCT01926028|365361014|FG001|Overall Study|Withdrawal by Subject|9|||
105918257|NCT01926028|365361015|FG002|Overall Study|Withdrawal by Subject|2|||
105918258|NCT01926028|365361013|FG000|Overall Study|Non compliance or other reasons|4|||
105918259|NCT01926028|365361014|FG001|Overall Study|Non compliance or other reasons|2|||
105918260|NCT01926028|365361015|FG002|Overall Study|Non compliance or other reasons|0|||
105918261|NCT00737048|365361016|FG000|Overall Study|Physician Decision|0|||
105918262|NCT00737048|365361017|FG001|Overall Study|Physician Decision|0|||
105918263|NCT00737048|365361018|FG002|Overall Study|Physician Decision|1|||
105918264|NCT00737048|365361016|FG000|Overall Study|Adverse Event|0|||
105918265|NCT00737048|365361017|FG001|Overall Study|Adverse Event|1|||
105918266|NCT00737048|365361018|FG002|Overall Study|Adverse Event|0|||
105918267|NCT00737048|365361016|FG000|Overall Study|Worsening of the symptoms|3|||
105918268|NCT00737048|365361017|FG001|Overall Study|Worsening of the symptoms|5|||
105918269|NCT00737048|365361018|FG002|Overall Study|Worsening of the symptoms|3|||
105918270|NCT00301834|365361021|FG000|Overall Study|Death|1|||
105918271|NCT02351934|365361022|FG000|Allocation|POD weight<pre-op weight|3|||
105918272|NCT02351934|365361023|FG001|Allocation|POD weight<pre-op weight|0|||
105918273|NCT02351934|365361022|FG000|Allocation|Hypotension preventing administration|2|||
105918274|NCT02351934|365361023|FG001|Allocation|Hypotension preventing administration|0|||
105918275|NCT02351934|365361022|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
105918276|NCT02351934|365361023|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
105918277|NCT02351934|365361022|FG000|Follow-Up|POD weight<pre-op weight|3|||
105918278|NCT02351934|365361023|FG001|Follow-Up|POD weight<pre-op weight|0|||
105918279|NCT02351934|365361022|FG000|Follow-Up|Acute Kidney Injury|1|||
105918280|NCT02351934|365361023|FG001|Follow-Up|Acute Kidney Injury|0|||
105918281|NCT02351934|365361022|FG000|Follow-Up|Early dismissal|3|||
105918282|NCT02351934|365361023|FG001|Follow-Up|Early dismissal|0|||
105918283|NCT02351934|365361022|FG000|Follow-Up|Hypotension|3|||
105918284|NCT02351934|365361023|FG001|Follow-Up|Hypotension|0|||
105918285|NCT02351934|365361022|FG000|Follow-Up|No documentation|2|||
105918286|NCT02351934|365361023|FG001|Follow-Up|No documentation|0|||
105918287|NCT02351934|365361022|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
105918288|NCT02351934|365361023|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
105918289|NCT02351934|365361022|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
105918290|NCT02351934|365361023|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
105918291|NCT02870868|365361024|FG000|Overall Study|Withdrawal by Subject|2|||
105918292|NCT02870868|365361025|FG001|Overall Study|Withdrawal by Subject|1|||
105918293|NCT02119299|365361026|FG000|Overall Study|Withdrawal by Subject|7|||
105918294|NCT02119299|365361026|FG000|Overall Study|Lack of Efficacy|1|||
105918295|NCT02119299|365361026|FG000|Overall Study|Pregnancy|1|||
105918296|NCT01739335|365361027|FG000|Overall Study|Lost to Follow-up|7|||
105918297|NCT01739335|365361028|FG001|Overall Study|Lost to Follow-up|4|||
106001616|NCT03309878|365667793|FG000|Overall Study|Withdrawal by Subject|0|||
106001617|NCT03309878|365667794|FG001|Overall Study|Withdrawal by Subject|1|||
106130279|NCT05114590|366132990|FG000|Overall Study|Investigator decision|1|||
106001618|NCT03309878|365667795|FG002|Overall Study|Withdrawal by Subject|0|||
106001619|NCT03309878|365667796|FG003|Overall Study|Withdrawal by Subject|0|||
105918298|NCT01739335|365361027|FG000|Overall Study|Ineligible patient randomized|0|||
105918299|NCT01739335|365361028|FG001|Overall Study|Ineligible patient randomized|1|||
105918300|NCT00288912|365361029|FG000|Overall Study|Developed exclusion criterion|4|||
106001620|NCT01096316|365667797|FG000|Overall Study|Lost to Follow-up|15|||
105918301|NCT00288912|365361030|FG001|Overall Study|Developed exclusion criterion|6|||
105918302|NCT00288912|365361031|FG002|Overall Study|Developed exclusion criterion|7|||
105918303|NCT00288912|365361029|FG000|Overall Study|Lost to Follow-up|9|||
105918304|NCT00288912|365361030|FG001|Overall Study|Lost to Follow-up|6|||
105918305|NCT00288912|365361031|FG002|Overall Study|Lost to Follow-up|9|||
105918306|NCT00288912|365361029|FG000|Overall Study|Withdrawal by Subject|4|||
105918307|NCT00288912|365361030|FG001|Overall Study|Withdrawal by Subject|5|||
106001621|NCT01096316|365667798|FG001|Overall Study|Lost to Follow-up|9|||
106130280|NCT05114590|366132990|FG000|Overall Study|Lost to Follow-up|5|||
106001622|NCT02763644|365667799|FG000|Overall Study|Patient/guardian decision|1|||
106001623|NCT02763644|365667800|FG001|Overall Study|Patient/guardian decision|0|||
106001624|NCT02763644|365667799|FG000|Overall Study|Death|1|||
105687621|NCT01777269|364519058|FG000|Overall Study|Protocol Violation|4|||
105687622|NCT01777269|364519059|FG001|Overall Study|Protocol Violation|4|||
106001625|NCT02763644|365667800|FG001|Overall Study|Death|1|||
106001626|NCT02763644|365667799|FG000|Overall Study|Adverse Event|1|||
106001627|NCT02763644|365667800|FG001|Overall Study|Adverse Event|1|||
106001628|NCT01884077|365667801|FG000|Overall Study|screen fail|0|||
106001629|NCT01884077|365667802|FG001|Overall Study|screen fail|2|||
106001630|NCT01884077|365667801|FG000|Overall Study|canceled surgery|2|||
106001631|NCT01884077|365667802|FG001|Overall Study|canceled surgery|0|||
106001632|NCT01884077|365667801|FG000|Overall Study|Lost to Follow-up|0|||
106001633|NCT01884077|365667802|FG001|Overall Study|Lost to Follow-up|4|||
106001634|NCT01884077|365667801|FG000|Overall Study|study closed|6|||
106001635|NCT01884077|365667802|FG001|Overall Study|study closed|4|||
106001636|NCT01008943|365667803|FG000|Overall Study|Withdrawal by Subject|1|||
106001637|NCT05789745|365667805|FG000|Overall Study|Withdrawal by Subject|0|||
106001638|NCT05789745|365667806|FG001|Overall Study|Withdrawal by Subject|0|||
106001639|NCT05789745|365667807|FG002|Overall Study|Withdrawal by Subject|0|||
106001640|NCT05789745|365667808|FG003|Overall Study|Withdrawal by Subject|0|||
106001641|NCT05789745|365667809|FG004|Overall Study|Withdrawal by Subject|1|||
106001642|NCT03480152|365667815|FG000|Phase I|Signed consent. Died before treatment.|1|||
106001643|NCT03480152|365667816|FG001|Phase I|Signed consent. Died before treatment.|0|||
106001644|NCT03480152|365667817|FG002|Phase I|Signed consent. Died before treatment.|0|||
106001645|NCT02903160|365667818|FG000|Overall Study|Adverse Event|2|||
106001646|NCT02903160|365667818|FG000|Overall Study|Death|1|||
106001647|NCT02903160|365667818|FG000|Overall Study|Lost to Follow-up|2|||
106001648|NCT02903160|365667818|FG000|Overall Study|Withdrawal by Subject|1|||
106001649|NCT02903160|365667818|FG000|Overall Study|Medical Insurance Barriers|1|||
106001650|NCT02525471|365667821|FG000|Overall Study|Screen Failure|6|||
106001651|NCT02525471|365667821|FG000|Overall Study|Withdrawal by Subject|4|||
106001652|NCT02525471|365667821|FG000|Overall Study|Death|1|||
106001653|NCT01168349|365667822|FG000|Overall Study|Death|157|||
106001654|NCT01168349|365667822|FG000|Overall Study|Lost to Follow-up|34|||
106001655|NCT01168349|365667822|FG000|Overall Study|Withdrawal by Subject|9|||
106001656|NCT01168349|365667822|FG000|Overall Study|Kidney transplantation|3|||
106001657|NCT01168349|365667822|FG000|Overall Study|Other|22|||
106001658|NCT01168349|365667822|FG000|Overall Study|Protocol Violation|76|||
106001659|NCT01091675|365667827|FG000|Overall Study|Adverse Event|7|||
106001660|NCT01091675|365667827|FG000|Overall Study|Lack of Efficacy|27|||
106001661|NCT02888106|365667831|FG000|Overall Study|Withdrawal by Subject|1|||
106001662|NCT02888106|365667832|FG001|Overall Study|Withdrawal by Subject|2|||
106001663|NCT02888106|365667833|FG002|Overall Study|Withdrawal by Subject|0|||
106001664|NCT02888106|365667834|FG003|Overall Study|Withdrawal by Subject|1|||
106001665|NCT02888106|365667835|FG004|Overall Study|Withdrawal by Subject|0|||
106001666|NCT02888106|365667836|FG005|Overall Study|Withdrawal by Subject|0|||
106001667|NCT02888106|365667831|FG000|Overall Study|Lost to Follow-up|1|||
106001668|NCT02888106|365667832|FG001|Overall Study|Lost to Follow-up|0|||
106001669|NCT02888106|365667833|FG002|Overall Study|Lost to Follow-up|0|||
106001670|NCT02888106|365667834|FG003|Overall Study|Lost to Follow-up|1|||
106001671|NCT02888106|365667835|FG004|Overall Study|Lost to Follow-up|0|||
106001672|NCT02888106|365667836|FG005|Overall Study|Lost to Follow-up|1|||
106001673|NCT02888106|365667831|FG000|Overall Study|Adverse Event|2|||
106001674|NCT02888106|365667832|FG001|Overall Study|Adverse Event|0|||
106001675|NCT02888106|365667833|FG002|Overall Study|Adverse Event|0|||
106001676|NCT02888106|365667834|FG003|Overall Study|Adverse Event|0|||
105687623|NCT01777269|364519058|FG000|Overall Study|Participants reached stopping criteria|1|||
105687624|NCT01777269|364519059|FG001|Overall Study|Participants reached stopping criteria|1|||
106001677|NCT02888106|365667835|FG004|Overall Study|Adverse Event|0|||
106001678|NCT02888106|365667836|FG005|Overall Study|Adverse Event|0|||
106001679|NCT02888106|365667831|FG000|Overall Study|Withdrawal of consent|0|||
106001680|NCT02888106|365667832|FG001|Overall Study|Withdrawal of consent|0|||
106001681|NCT02888106|365667833|FG002|Overall Study|Withdrawal of consent|0|||
106001682|NCT02888106|365667834|FG003|Overall Study|Withdrawal of consent|0|||
106001683|NCT02888106|365667835|FG004|Overall Study|Withdrawal of consent|1|||
106001684|NCT02888106|365667836|FG005|Overall Study|Withdrawal of consent|0|||
106130281|NCT05114590|366132990|FG000|Overall Study|Withdrawal by Subject|5|||
106130282|NCT05114590|366132990|FG000|Overall Study|Other|2|||
106001685|NCT02888106|365667831|FG000|Overall Study|Pregnancy|1|||
106130283|NCT03590743|366132991|FG000|Overall Study|Withdrawal by Subject|0|||
106130284|NCT03590743|366132992|FG001|Overall Study|Withdrawal by Subject|1|||
106001686|NCT02888106|365667832|FG001|Overall Study|Pregnancy|0|||
106001687|NCT02888106|365667833|FG002|Overall Study|Pregnancy|0|||
106001688|NCT02888106|365667834|FG003|Overall Study|Pregnancy|0|||
106001689|NCT02888106|365667835|FG004|Overall Study|Pregnancy|0|||
106001690|NCT02888106|365667836|FG005|Overall Study|Pregnancy|0|||
106130285|NCT00604786|366133000|FG000|Overall Study|Lost to Follow-up|2|||
106130286|NCT00604786|366133001|FG001|Overall Study|Lost to Follow-up|0|||
106130287|NCT01394991|366133002|FG000|Overall Study|Adverse Event|0|||
106130288|NCT01394991|366133003|FG001|Overall Study|Adverse Event|4|||
106130289|NCT01394991|366133002|FG000|Overall Study|Lack of Efficacy|5|||
106130290|NCT01394991|366133003|FG001|Overall Study|Lack of Efficacy|7|||
106130291|NCT01394991|366133002|FG000|Overall Study|Lost to Follow-up|6|||
106130292|NCT01394991|366133003|FG001|Overall Study|Lost to Follow-up|8|||
106130293|NCT01394991|366133002|FG000|Overall Study|Physician Decision|1|||
106130294|NCT01394991|366133003|FG001|Overall Study|Physician Decision|3|||
106130295|NCT01394991|366133002|FG000|Overall Study|Protocol Violation|1|||
106130296|NCT01394991|366133003|FG001|Overall Study|Protocol Violation|1|||
106130297|NCT01394991|366133002|FG000|Overall Study|Withdrawal by Subject|20|||
106130298|NCT01394991|366133003|FG001|Overall Study|Withdrawal by Subject|17|||
106130299|NCT01394991|366133002|FG000|Overall Study|Chemotherapy Termination|10|||
105918308|NCT00288912|365361031|FG002|Overall Study|Withdrawal by Subject|12|||
105918309|NCT03312738|365361032|FG000|Overall Study|Progressive disease|58|||
105918310|NCT03312738|365361033|FG001|Overall Study|Progressive disease|67|||
105918311|NCT03312738|365361032|FG000|Overall Study|Patient/guardian decision|13|||
105918312|NCT03312738|365361033|FG001|Overall Study|Patient/guardian decision|5|||
105918313|NCT03312738|365361032|FG000|Overall Study|Adverse Event|5|||
105918314|NCT03312738|365361033|FG001|Overall Study|Adverse Event|3|||
105918315|NCT03312738|365361032|FG000|Overall Study|Protocol deviation|2|||
105918316|NCT03312738|365361033|FG001|Overall Study|Protocol deviation|0|||
105918317|NCT03312738|365361032|FG000|Overall Study|Technical problems|0|||
105918318|NCT03312738|365361033|FG001|Overall Study|Technical problems|1|||
105918319|NCT03312738|365361032|FG000|Overall Study|Physician Decision|2|||
105918320|NCT03312738|365361033|FG001|Overall Study|Physician Decision|3|||
105918321|NCT00183430|365361034|FG000|Overall Study|Adverse Event|1|||
105687625|NCT01777269|364519058|FG000|Overall Study|Lost to Follow-up|4|||
105687626|NCT01777269|364519059|FG001|Overall Study|Lost to Follow-up|0|||
105687627|NCT01777269|364519058|FG000|Overall Study|Physician Decision|5|||
105687628|NCT01777269|364519059|FG001|Overall Study|Physician Decision|2|||
105687629|NCT01777269|364519058|FG000|Overall Study|Withdrawal by Subject|9|||
105687630|NCT01777269|364519059|FG001|Overall Study|Withdrawal by Subject|9|||
105687631|NCT01966471|364519061|FG000|Overall Study|Death|44|||
105918322|NCT00183430|365361035|FG001|Overall Study|Adverse Event|0|||
105918323|NCT00183430|365361034|FG000|Overall Study|Lost to Follow-up|3|||
105918324|NCT00183430|365361035|FG001|Overall Study|Lost to Follow-up|0|||
105918325|NCT00183430|365361034|FG000|Overall Study|did not meet inclusion criteria|1|||
105918326|NCT00183430|365361035|FG001|Overall Study|did not meet inclusion criteria|0|||
105918327|NCT00183430|365361034|FG000|Overall Study|Withdrawal by Subject|1|||
105918328|NCT00183430|365361035|FG001|Overall Study|Withdrawal by Subject|0|||
105918329|NCT02466399|365361039|FG000|Overall Study|Adverse Event|1|||
105918330|NCT02466399|365361040|FG001|Overall Study|Adverse Event|0|||
105918331|NCT02466399|365361039|FG000|Overall Study|Early exit due to family emergency|1|||
105918332|NCT02466399|365361040|FG001|Overall Study|Early exit due to family emergency|0|||
105918333|NCT04539275|365361041|FG000|Overall Study|Death|2|||
105918334|NCT04539275|365361042|FG001|Overall Study|Death|4|||
105918335|NCT04539275|365361041|FG000|Overall Study|Lost to Follow-up|1|||
105918336|NCT04539275|365361042|FG001|Overall Study|Lost to Follow-up|1|||
105918337|NCT04539275|365361041|FG000|Overall Study|Withdrawal by Subject|3|||
105918338|NCT04539275|365361042|FG001|Overall Study|Withdrawal by Subject|0|||
105918339|NCT02669849|365361043|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105918340|NCT02669849|365361044|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105918341|NCT02669849|365361045|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
105918342|NCT02669849|365361043|FG000|Overall Study|Lost to Follow-up|1|||
105918343|NCT02669849|365361044|FG001|Overall Study|Lost to Follow-up|0|||
105918344|NCT02669849|365361045|FG002|Overall Study|Lost to Follow-up|3|||
105918345|NCT02669849|365361043|FG000|Overall Study|Death|1|||
105918346|NCT02669849|365361044|FG001|Overall Study|Death|1|||
105918347|NCT02669849|365361045|FG002|Overall Study|Death|2|||
105918348|NCT02669849|365361043|FG000|Overall Study|Study terminated by sponsor|16|||
105918349|NCT02669849|365361044|FG001|Overall Study|Study terminated by sponsor|1|||
105918350|NCT02669849|365361045|FG002|Overall Study|Study terminated by sponsor|14|||
105918351|NCT02669849|365361043|FG000|Overall Study|Other|0|||
105918352|NCT02669849|365361044|FG001|Overall Study|Other|0|||
105918353|NCT02669849|365361045|FG002|Overall Study|Other|2|||
105918354|NCT03098979|365361052|FG000|Overall Study|Adverse Event|1|||
105918355|NCT03098979|365361053|FG001|Overall Study|Adverse Event|0|||
105918356|NCT03098979|365361054|FG002|Overall Study|Adverse Event|1|||
105918357|NCT03098979|365361055|FG003|Overall Study|Adverse Event|4|||
105918358|NCT03098979|365361056|FG004|Overall Study|Adverse Event|6|||
106130300|NCT01394991|366133003|FG001|Overall Study|Chemotherapy Termination|15|||
105687632|NCT01966471|364519062|FG001|Overall Study|Death|56|||
105918359|NCT03098979|365361057|FG005|Overall Study|Adverse Event|1|||
105918360|NCT03098979|365361052|FG000|Overall Study|Withdrawal by Subject|2|||
105918361|NCT03098979|365361053|FG001|Overall Study|Withdrawal by Subject|1|||
105918362|NCT03098979|365361054|FG002|Overall Study|Withdrawal by Subject|1|||
106130301|NCT01394991|366133002|FG000|Overall Study|Disease Progression|7|||
106130302|NCT01394991|366133003|FG001|Overall Study|Disease Progression|7|||
106001691|NCT01391663|365667837|FG000|Overall Study|Withdrawal by Subject|0|||
106001692|NCT01391663|365667838|FG001|Overall Study|Withdrawal by Subject|0|||
106001693|NCT01391663|365667839|FG002|Overall Study|Withdrawal by Subject|1|||
106001694|NCT01391663|365667840|FG003|Overall Study|Withdrawal by Subject|0|||
106001695|NCT03515824|365667841|FG000|Overall Study|Death|3|||
106001696|NCT03515824|365667842|FG001|Overall Study|Death|2|||
106001697|NCT03515824|365667843|FG002|Overall Study|Death|6|||
106001698|NCT03515824|365667844|FG003|Overall Study|Death|0|||
106001699|NCT03515824|365667841|FG000|Overall Study|Lost to Follow-up|0|||
106001700|NCT03515824|365667842|FG001|Overall Study|Lost to Follow-up|1|||
106001701|NCT03515824|365667843|FG002|Overall Study|Lost to Follow-up|1|||
106001702|NCT03515824|365667844|FG003|Overall Study|Lost to Follow-up|0|||
106001703|NCT03515824|365667841|FG000|Overall Study|Study terminated by sponsor|0|||
106001704|NCT03515824|365667842|FG001|Overall Study|Study terminated by sponsor|1|||
106001705|NCT03515824|365667843|FG002|Overall Study|Study terminated by sponsor|6|||
106001706|NCT03515824|365667844|FG003|Overall Study|Study terminated by sponsor|0|||
106001707|NCT03515824|365667841|FG000|Overall Study|Status not recorded|0|||
106001708|NCT03515824|365667842|FG001|Overall Study|Status not recorded|0|||
106001709|NCT03515824|365667843|FG002|Overall Study|Status not recorded|2|||
106001710|NCT03515824|365667844|FG003|Overall Study|Status not recorded|0|||
106001711|NCT01384734|365667845|FG000|Overall Study|Adverse Event|0|||
106001712|NCT01384734|365667846|FG001|Overall Study|Adverse Event|3|||
106001713|NCT01384734|365667847|FG002|Overall Study|Adverse Event|0|||
106001714|NCT01384734|365667848|FG003|Overall Study|Adverse Event|2|||
106001715|NCT01384734|365667849|FG004|Overall Study|Adverse Event|7|||
106001716|NCT01384734|365667845|FG000|Overall Study|Death|1|||
106001717|NCT01384734|365667846|FG001|Overall Study|Death|0|||
106001718|NCT01384734|365667847|FG002|Overall Study|Death|1|||
106001719|NCT01384734|365667848|FG003|Overall Study|Death|0|||
106001720|NCT01384734|365667849|FG004|Overall Study|Death|0|||
106001721|NCT01384734|365667845|FG000|Overall Study|Continuation criteria not met|0|||
106001722|NCT01384734|365667846|FG001|Overall Study|Continuation criteria not met|0|||
106001723|NCT01384734|365667847|FG002|Overall Study|Continuation criteria not met|1|||
106001724|NCT01384734|365667848|FG003|Overall Study|Continuation criteria not met|1|||
106001725|NCT01384734|365667849|FG004|Overall Study|Continuation criteria not met|0|||
106001726|NCT01384734|365667845|FG000|Overall Study|Lack of Efficacy|3|||
106001727|NCT01384734|365667846|FG001|Overall Study|Lack of Efficacy|7|||
106001728|NCT01384734|365667847|FG002|Overall Study|Lack of Efficacy|4|||
106001729|NCT01384734|365667848|FG003|Overall Study|Lack of Efficacy|4|||
106001730|NCT01384734|365667849|FG004|Overall Study|Lack of Efficacy|2|||
106001731|NCT01384734|365667845|FG000|Overall Study|Lost to Follow-up|5|||
106001732|NCT01384734|365667846|FG001|Overall Study|Lost to Follow-up|3|||
106001733|NCT01384734|365667847|FG002|Overall Study|Lost to Follow-up|3|||
106001734|NCT01384734|365667848|FG003|Overall Study|Lost to Follow-up|8|||
106001735|NCT01384734|365667849|FG004|Overall Study|Lost to Follow-up|5|||
106001736|NCT01384734|365667845|FG000|Overall Study|Non-compliance with study drug|1|||
106001737|NCT01384734|365667846|FG001|Overall Study|Non-compliance with study drug|2|||
106001738|NCT01384734|365667847|FG002|Overall Study|Non-compliance with study drug|6|||
106001739|NCT01384734|365667848|FG003|Overall Study|Non-compliance with study drug|0|||
106001740|NCT01384734|365667849|FG004|Overall Study|Non-compliance with study drug|2|||
106001741|NCT01384734|365667845|FG000|Overall Study|Pregnancy|0|||
106001742|NCT01384734|365667846|FG001|Overall Study|Pregnancy|1|||
106001743|NCT01384734|365667847|FG002|Overall Study|Pregnancy|0|||
106001744|NCT01384734|365667848|FG003|Overall Study|Pregnancy|0|||
106001745|NCT01384734|365667849|FG004|Overall Study|Pregnancy|1|||
106001746|NCT01384734|365667845|FG000|Overall Study|Sponsor terminated|0|||
106001747|NCT01384734|365667846|FG001|Overall Study|Sponsor terminated|0|||
106001748|NCT01384734|365667847|FG002|Overall Study|Sponsor terminated|0|||
106001749|NCT01384734|365667848|FG003|Overall Study|Sponsor terminated|0|||
106001750|NCT01384734|365667849|FG004|Overall Study|Sponsor terminated|1|||
106130303|NCT01394991|366133002|FG000|Overall Study|Prematurely Termination of Trial|9|||
106130304|NCT01394991|366133003|FG001|Overall Study|Prematurely Termination of Trial|10|||
106001751|NCT01384734|365667845|FG000|Overall Study|Withdrawal by Subject|5|||
106001752|NCT01384734|365667846|FG001|Overall Study|Withdrawal by Subject|5|||
106001753|NCT01384734|365667847|FG002|Overall Study|Withdrawal by Subject|6|||
106001754|NCT01384734|365667848|FG003|Overall Study|Withdrawal by Subject|7|||
106001755|NCT01384734|365667849|FG004|Overall Study|Withdrawal by Subject|9|||
106001756|NCT01384734|365667845|FG000|Overall Study|Investigator relocating|0|||
106001757|NCT01384734|365667846|FG001|Overall Study|Investigator relocating|2|||
106001758|NCT01384734|365667847|FG002|Overall Study|Investigator relocating|0|||
106001759|NCT01384734|365667848|FG003|Overall Study|Investigator relocating|3|||
106001760|NCT01384734|365667849|FG004|Overall Study|Investigator relocating|1|||
106001761|NCT01384734|365667845|FG000|Overall Study|Unable to come back for visit|1|||
106001762|NCT01384734|365667846|FG001|Overall Study|Unable to come back for visit|0|||
106001763|NCT01384734|365667847|FG002|Overall Study|Unable to come back for visit|1|||
106001764|NCT01384734|365667848|FG003|Overall Study|Unable to come back for visit|1|||
106001765|NCT01384734|365667849|FG004|Overall Study|Unable to come back for visit|0|||
106001766|NCT01384734|365667845|FG000|Overall Study|Prison|0|||
106001767|NCT01384734|365667846|FG001|Overall Study|Prison|0|||
106001768|NCT01384734|365667847|FG002|Overall Study|Prison|1|||
106001769|NCT01384734|365667848|FG003|Overall Study|Prison|0|||
106001770|NCT01384734|365667849|FG004|Overall Study|Prison|0|||
106001771|NCT01384734|365667845|FG000|Overall Study|As per Exclusion criteria|0|||
106001772|NCT01384734|365667846|FG001|Overall Study|As per Exclusion criteria|1|||
106001773|NCT01384734|365667847|FG002|Overall Study|As per Exclusion criteria|0|||
106001774|NCT01384734|365667848|FG003|Overall Study|As per Exclusion criteria|0|||
106001775|NCT01384734|365667849|FG004|Overall Study|As per Exclusion criteria|0|||
106001776|NCT01384734|365667845|FG000|Overall Study|Missed End of treatment visit|0|||
106001777|NCT01384734|365667846|FG001|Overall Study|Missed End of treatment visit|0|||
106001778|NCT01384734|365667847|FG002|Overall Study|Missed End of treatment visit|0|||
106001779|NCT01384734|365667848|FG003|Overall Study|Missed End of treatment visit|1|||
106001780|NCT01384734|365667849|FG004|Overall Study|Missed End of treatment visit|0|||
106001781|NCT01384734|365667845|FG000|Overall Study|Adhesion problem|0|||
106001782|NCT01384734|365667846|FG001|Overall Study|Adhesion problem|0|||
106001783|NCT01384734|365667847|FG002|Overall Study|Adhesion problem|0|||
106001784|NCT01384734|365667848|FG003|Overall Study|Adhesion problem|1|||
106001785|NCT01384734|365667849|FG004|Overall Study|Adhesion problem|0|||
106001786|NCT01384734|365667845|FG000|Overall Study|Early termination|0|||
106001787|NCT01384734|365667846|FG001|Overall Study|Early termination|0|||
106001788|NCT01384734|365667847|FG002|Overall Study|Early termination|0|||
106001789|NCT01384734|365667848|FG003|Overall Study|Early termination|0|||
106001790|NCT01384734|365667849|FG004|Overall Study|Early termination|1|||
106001791|NCT01384734|365667845|FG000|Overall Study|Physician Decision|1|||
106001792|NCT01384734|365667846|FG001|Overall Study|Physician Decision|0|||
106001793|NCT01384734|365667847|FG002|Overall Study|Physician Decision|0|||
106001794|NCT01384734|365667848|FG003|Overall Study|Physician Decision|0|||
106001795|NCT01384734|365667849|FG004|Overall Study|Physician Decision|0|||
106001796|NCT03084796|365667850|FG000|Overall Study|Adverse Event|4|||
106001797|NCT03084796|365667851|FG001|Overall Study|Adverse Event|5|||
106001798|NCT03084796|365667852|FG002|Overall Study|Adverse Event|6|||
106001799|NCT03084796|365667853|FG003|Overall Study|Adverse Event|2|||
106001800|NCT03084796|365667854|FG004|Overall Study|Adverse Event|3|||
106001801|NCT03084796|365667855|FG005|Overall Study|Adverse Event|5|||
106001802|NCT03084796|365667850|FG000|Overall Study|Withdrawal by Subject|3|||
106001803|NCT03084796|365667851|FG001|Overall Study|Withdrawal by Subject|5|||
106001804|NCT03084796|365667852|FG002|Overall Study|Withdrawal by Subject|2|||
105786620|NCT00463385|364872866|FG002|Overall Study|Adverse Event|4|||
105786621|NCT00463385|364872867|FG003|Overall Study|Adverse Event|2|||
105786622|NCT00463385|364872864|FG000|Overall Study|Lack of Efficacy|6|||
105786623|NCT00463385|364872865|FG001|Overall Study|Lack of Efficacy|6|||
105786624|NCT00463385|364872866|FG002|Overall Study|Lack of Efficacy|7|||
105786625|NCT00463385|364872867|FG003|Overall Study|Lack of Efficacy|9|||
105786626|NCT00463385|364872864|FG000|Overall Study|Withdrawal by Subject|3|||
105786627|NCT00463385|364872865|FG001|Overall Study|Withdrawal by Subject|3|||
105786628|NCT00463385|364872866|FG002|Overall Study|Withdrawal by Subject|3|||
105786629|NCT00463385|364872867|FG003|Overall Study|Withdrawal by Subject|4|||
106001805|NCT03084796|365667853|FG003|Overall Study|Withdrawal by Subject|1|||
106001806|NCT03084796|365667854|FG004|Overall Study|Withdrawal by Subject|3|||
106001807|NCT03084796|365667855|FG005|Overall Study|Withdrawal by Subject|0|||
105786630|NCT00463385|364872864|FG000|Overall Study|Lost to Follow-up|0|||
105786631|NCT00463385|364872865|FG001|Overall Study|Lost to Follow-up|0|||
106001808|NCT03084796|365667850|FG000|Overall Study|Protocol Violation|0|||
106001809|NCT03084796|365667851|FG001|Overall Study|Protocol Violation|0|||
106001810|NCT03084796|365667852|FG002|Overall Study|Protocol Violation|1|||
106001811|NCT03084796|365667853|FG003|Overall Study|Protocol Violation|0|||
106001812|NCT03084796|365667854|FG004|Overall Study|Protocol Violation|1|||
106001813|NCT03084796|365667855|FG005|Overall Study|Protocol Violation|1|||
106001814|NCT03084796|365667850|FG000|Overall Study|Lack of Efficacy|0|||
106001815|NCT03084796|365667851|FG001|Overall Study|Lack of Efficacy|0|||
106001816|NCT03084796|365667852|FG002|Overall Study|Lack of Efficacy|1|||
106001817|NCT03084796|365667853|FG003|Overall Study|Lack of Efficacy|0|||
106001818|NCT03084796|365667854|FG004|Overall Study|Lack of Efficacy|1|||
106001819|NCT03084796|365667855|FG005|Overall Study|Lack of Efficacy|0|||
106001820|NCT03084796|365667850|FG000|Overall Study|Lost to Follow-up|0|||
106001821|NCT03084796|365667851|FG001|Overall Study|Lost to Follow-up|0|||
106001822|NCT03084796|365667852|FG002|Overall Study|Lost to Follow-up|1|||
106001823|NCT03084796|365667853|FG003|Overall Study|Lost to Follow-up|1|||
106001824|NCT03084796|365667854|FG004|Overall Study|Lost to Follow-up|3|||
106001825|NCT03084796|365667855|FG005|Overall Study|Lost to Follow-up|1|||
106001826|NCT03084796|365667850|FG000|Overall Study|Randomization error|0|||
106001827|NCT03084796|365667851|FG001|Overall Study|Randomization error|0|||
106001828|NCT03084796|365667852|FG002|Overall Study|Randomization error|1|||
106001829|NCT03084796|365667853|FG003|Overall Study|Randomization error|0|||
106001830|NCT03084796|365667854|FG004|Overall Study|Randomization error|0|||
106001831|NCT03084796|365667855|FG005|Overall Study|Randomization error|0|||
106001832|NCT00650767|365667857|FG000|Overall Study|Adverse Event|0|||
106001833|NCT00650767|365667858|FG001|Overall Study|Adverse Event|3|||
106001834|NCT00650767|365667859|FG002|Overall Study|Adverse Event|10|||
106001835|NCT00650767|365667860|FG003|Overall Study|Adverse Event|8|||
106001836|NCT00650767|365667857|FG000|Overall Study|Death|1|||
106001837|NCT00650767|365667858|FG001|Overall Study|Death|0|||
106001838|NCT00650767|365667859|FG002|Overall Study|Death|0|||
106001839|NCT00650767|365667860|FG003|Overall Study|Death|0|||
106001840|NCT00650767|365667857|FG000|Overall Study|Withdrawal by Subject|2|||
106001841|NCT00650767|365667858|FG001|Overall Study|Withdrawal by Subject|4|||
106001842|NCT00650767|365667859|FG002|Overall Study|Withdrawal by Subject|3|||
106001843|NCT00650767|365667860|FG003|Overall Study|Withdrawal by Subject|3|||
106001844|NCT00650767|365667857|FG000|Overall Study|Lost to Follow-up|1|||
106001845|NCT00650767|365667858|FG001|Overall Study|Lost to Follow-up|1|||
106001846|NCT00650767|365667859|FG002|Overall Study|Lost to Follow-up|1|||
106001847|NCT00650767|365667860|FG003|Overall Study|Lost to Follow-up|0|||
106001848|NCT00650767|365667857|FG000|Overall Study|Other|1|||
106001849|NCT00650767|365667858|FG001|Overall Study|Other|1|||
106001850|NCT00650767|365667859|FG002|Overall Study|Other|0|||
106001851|NCT00650767|365667860|FG003|Overall Study|Other|0|||
106001852|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
106001853|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
106001854|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
106001855|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
106001856|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
106001857|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
106001858|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
106001859|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
106001860|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
106001861|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
106001862|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
106001863|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
106001864|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
106001865|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
106001866|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
106001867|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
106001868|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
106001869|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
106001870|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
106001871|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
106001872|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
106001873|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
106001874|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
106001875|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
106001876|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
106001877|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
106001878|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
106001879|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
106001880|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
106001881|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
106001882|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
106001883|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
105786632|NCT00463385|364872866|FG002|Overall Study|Lost to Follow-up|0|||
106001884|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
106001885|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
106001886|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
106001887|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
106001888|NCT02586623|365667861|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
106001889|NCT02586623|365667862|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
106001890|NCT02586623|365667863|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
106001891|NCT02586623|365667861|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
105687633|NCT01966471|364519061|FG000|Overall Study|Lost to Follow-up|46|||
105687634|NCT01966471|364519062|FG001|Overall Study|Lost to Follow-up|39|||
105687635|NCT01966471|364519061|FG000|Overall Study|Various reasons|4|||
105918363|NCT03098979|365361055|FG003|Overall Study|Withdrawal by Subject|1|||
105918364|NCT03098979|365361056|FG004|Overall Study|Withdrawal by Subject|2|||
105918365|NCT03098979|365361057|FG005|Overall Study|Withdrawal by Subject|1|||
105918366|NCT03098979|365361052|FG000|Overall Study|Death|1|||
105918367|NCT03098979|365361053|FG001|Overall Study|Death|0|||
105918368|NCT03098979|365361054|FG002|Overall Study|Death|2|||
105918369|NCT03098979|365361055|FG003|Overall Study|Death|0|||
105918370|NCT03098979|365361056|FG004|Overall Study|Death|1|||
105918371|NCT03098979|365361057|FG005|Overall Study|Death|0|||
105918372|NCT03098979|365361052|FG000|Overall Study|Physician Decision|2|||
105918373|NCT03098979|365361053|FG001|Overall Study|Physician Decision|1|||
105918374|NCT03098979|365361054|FG002|Overall Study|Physician Decision|0|||
105918375|NCT03098979|365361055|FG003|Overall Study|Physician Decision|0|||
105918376|NCT03098979|365361056|FG004|Overall Study|Physician Decision|0|||
105918377|NCT03098979|365361057|FG005|Overall Study|Physician Decision|0|||
105918378|NCT03098979|365361052|FG000|Overall Study|Non-compliance|0|||
105918379|NCT03098979|365361053|FG001|Overall Study|Non-compliance|0|||
105918380|NCT03098979|365361054|FG002|Overall Study|Non-compliance|0|||
105918381|NCT03098979|365361055|FG003|Overall Study|Non-compliance|0|||
105918382|NCT03098979|365361056|FG004|Overall Study|Non-compliance|0|||
105918383|NCT03098979|365361057|FG005|Overall Study|Non-compliance|1|||
105918384|NCT03098979|365361052|FG000|Overall Study|Protocol Violation|0|||
105918385|NCT03098979|365361053|FG001|Overall Study|Protocol Violation|0|||
105918386|NCT03098979|365361054|FG002|Overall Study|Protocol Violation|0|||
105918387|NCT03098979|365361055|FG003|Overall Study|Protocol Violation|0|||
105918388|NCT03098979|365361056|FG004|Overall Study|Protocol Violation|0|||
105918389|NCT03098979|365361057|FG005|Overall Study|Protocol Violation|1|||
105918390|NCT01248455|365361058|FG000|Overall Study|switched to alternate treatment|1|||
105918391|NCT01065818|365361059|FG000|Overall Study|Withdrawal by Subject|1|||
105918392|NCT01065818|365361059|FG000|Overall Study|Not a candidate for surgery|1|||
105918393|NCT01674725|365361060|FG000|Overall Study|Adverse Event|1|||
105918394|NCT01674725|365361061|FG001|Overall Study|Adverse Event|0|||
105918395|NCT01674725|365361060|FG000|Overall Study|Did not receive study drug|1|||
105918396|NCT01674725|365361061|FG001|Overall Study|Did not receive study drug|0|||
105918397|NCT01674725|365361060|FG000|Overall Study|Withdrawal by Subject|1|||
105918398|NCT01674725|365361061|FG001|Overall Study|Withdrawal by Subject|0|||
105918399|NCT01674725|365361060|FG000|Overall Study|Lost to Follow-up|0|||
105918400|NCT01674725|365361061|FG001|Overall Study|Lost to Follow-up|1|||
105918401|NCT00958074|365361062|FG000|Overall Study|Withdrawal by Subject|0|||
105918402|NCT00958074|365361063|FG001|Overall Study|Withdrawal by Subject|1|||
105918403|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
105918404|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
105918405|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
105918406|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
105918407|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
105918408|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
105918409|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
105918410|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
105918411|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
105918412|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
106001892|NCT02586623|365667862|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
105687636|NCT01966471|364519062|FG001|Overall Study|Various reasons|4|||
105687637|NCT01966471|364519061|FG000|Overall Study|Physician Decision|7|||
105687638|NCT01966471|364519062|FG001|Overall Study|Physician Decision|5|||
105918413|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
105918414|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
105918415|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
106001893|NCT02586623|365667863|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
105687639|NCT01966471|364519061|FG000|Overall Study|Study Terminated By Sponsor|758|||
105918416|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
105918417|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
105918418|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
106001894|NCT02586623|365667861|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
106001895|NCT02586623|365667862|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
105687640|NCT01966471|364519062|FG001|Overall Study|Study Terminated By Sponsor|773|||
105687641|NCT01966471|364519061|FG000|Overall Study|Withdrawal by Subject|59|||
105918419|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
105918420|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
105918421|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
105918422|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
105918423|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
105918424|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
105918425|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
105918426|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
105918427|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
105918428|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
105918429|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
105918430|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
105918431|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
105918432|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
105918433|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
105918434|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
105918435|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
105918436|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
105918437|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
105918438|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
105918439|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
105918440|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
105918441|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
105918442|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
105918443|NCT02709746|365361064|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
105918444|NCT02709746|365361065|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
105918445|NCT02709746|365361066|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
105918446|NCT02709746|365361067|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
105918447|NCT02709746|365361068|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
105918448|NCT02709746|365361064|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
105918449|NCT02709746|365361065|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
105918450|NCT02709746|365361066|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
105918451|NCT02709746|365361067|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
105918452|NCT02709746|365361068|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
105918453|NCT02709746|365361064|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
105918454|NCT02709746|365361065|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
105918455|NCT02709746|365361066|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
105918456|NCT02709746|365361067|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
105918457|NCT02709746|365361068|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
105918458|NCT02709746|365361064|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
105918459|NCT02709746|365361065|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
105918460|NCT02709746|365361066|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
105918461|NCT02709746|365361067|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
105918462|NCT02709746|365361068|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
105918463|NCT02709746|365361064|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
105918464|NCT02709746|365361065|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
105918465|NCT02709746|365361066|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
105918466|NCT02709746|365361067|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
105918467|NCT02709746|365361068|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
105918468|NCT02709746|365361064|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
105918469|NCT02709746|365361065|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
105918470|NCT02709746|365361066|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
105918471|NCT02709746|365361067|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
105918472|NCT02709746|365361068|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
105918473|NCT02709746|365361064|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
105918474|NCT02709746|365361065|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
105918475|NCT02709746|365361066|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
105918476|NCT02709746|365361067|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
106130305|NCT02414828|366133004|FG000|Overall Study|Lost to Follow-up|0|||
106130306|NCT02414828|366133005|FG001|Overall Study|Lost to Follow-up|1|||
106130307|NCT02414828|366133006|FG002|Overall Study|Lost to Follow-up|1|||
106130308|NCT02414828|366133007|FG003|Overall Study|Lost to Follow-up|2|||
106130309|NCT03253653|366133008|FG000|Overall Study|Withdrawal by Subject|4|||
106130310|NCT03253653|366133009|FG001|Overall Study|Withdrawal by Subject|1|||
106130311|NCT03253653|366133008|FG000|Overall Study|Protocol Violation|0|||
106130312|NCT03253653|366133009|FG001|Overall Study|Protocol Violation|5|||
106144095|NCT01317420|366186953|FG004|Overall Study|Non-compliant with protocol|0|||
105687642|NCT01966471|364519062|FG001|Overall Study|Withdrawal by Subject|51|||
105687643|NCT02370043|364519063|FG000|Overall Study|Withdrawal by Subject|0|||
105918477|NCT02709746|365361068|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
106144096|NCT01317420|366186954|FG005|Overall Study|Non-compliant with protocol|0|||
106144097|NCT01317420|366186955|FG006|Overall Study|Non-compliant with protocol|0|||
106144098|NCT01317420|366186956|FG007|Overall Study|Non-compliant with protocol|0|||
106144099|NCT01317420|366186957|FG008|Overall Study|Non-compliant with protocol|0|||
106144100|NCT01317420|366186958|FG009|Overall Study|Non-compliant with protocol|0|||
106144101|NCT01317420|366186959|FG010|Overall Study|Non-compliant with protocol|0|||
106144102|NCT01317420|366186960|FG011|Overall Study|Non-compliant with protocol|0|||
106144103|NCT01317420|366186961|FG012|Overall Study|Non-compliant with protocol|1|||
106144104|NCT01317420|366186949|FG000|Overall Study|Refused to cont. taking trial medication|0|||
106144105|NCT01317420|366186950|FG001|Overall Study|Refused to cont. taking trial medication|0|||
106144106|NCT01317420|366186951|FG002|Overall Study|Refused to cont. taking trial medication|0|||
106144107|NCT01317420|366186952|FG003|Overall Study|Refused to cont. taking trial medication|0|||
106144108|NCT01317420|366186953|FG004|Overall Study|Refused to cont. taking trial medication|0|||
106144109|NCT01317420|366186954|FG005|Overall Study|Refused to cont. taking trial medication|0|||
106144110|NCT01317420|366186955|FG006|Overall Study|Refused to cont. taking trial medication|0|||
106144111|NCT01317420|366186956|FG007|Overall Study|Refused to cont. taking trial medication|0|||
106144112|NCT01317420|366186957|FG008|Overall Study|Refused to cont. taking trial medication|0|||
105918478|NCT02709746|365361064|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
105918479|NCT02709746|365361065|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
105918480|NCT02709746|365361066|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
105918481|NCT02709746|365361067|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
105918482|NCT02709746|365361068|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
105918483|NCT02709746|365361064|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
105918484|NCT02709746|365361065|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
105918485|NCT02709746|365361066|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
105918486|NCT02709746|365361067|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
105918487|NCT02709746|365361068|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
105918488|NCT03322293|365361069|FG000|Overall Study|Lost to Follow-up|0|||
105918489|NCT03322293|365361070|FG001|Overall Study|Lost to Follow-up|0|||
105918490|NCT03322293|365361071|FG002|Overall Study|Lost to Follow-up|1|||
105918491|NCT02732639|365361072|FG000|Overall Study|Lost to Follow-up|1|||
105918492|NCT01122173|365361073|FG000|Overall Study|Lost to Follow-up|3|||
105918493|NCT01122173|365361073|FG000|Overall Study|Withdrawal by Subject|3|||
105918494|NCT01122173|365361073|FG000|Overall Study|Left study for other reasons|3|||
105918495|NCT02915835|365361074|FG000|Overall Study|Physician Decision|1|||
105918496|NCT02915835|365361075|FG001|Overall Study|Physician Decision|0|||
105918497|NCT02915835|365361074|FG000|Overall Study|Withdrawal by Subject|0|||
105918498|NCT02915835|365361075|FG001|Overall Study|Withdrawal by Subject|1|||
105918499|NCT02530385|365361076|FG000|Overall Study|Withdrawal by Subject|0|||
106144113|NCT01317420|366186958|FG009|Overall Study|Refused to cont. taking trial medication|0|||
106144114|NCT01317420|366186959|FG010|Overall Study|Refused to cont. taking trial medication|0|||
106144115|NCT01317420|366186960|FG011|Overall Study|Refused to cont. taking trial medication|0|||
105786633|NCT00463385|364872867|FG003|Overall Study|Lost to Follow-up|1|||
105687644|NCT02370043|364519064|FG001|Overall Study|Withdrawal by Subject|0|||
105687645|NCT02370043|364519065|FG002|Overall Study|Withdrawal by Subject|0|||
105687646|NCT02370043|364519066|FG003|Overall Study|Withdrawal by Subject|0|||
105687647|NCT02370043|364519067|FG004|Overall Study|Withdrawal by Subject|1|||
105687648|NCT02370043|364519068|FG005|Overall Study|Withdrawal by Subject|1|||
105687649|NCT00810394|364519071|FG000|Overall Study|Withdrawal by Subject|3|||
105687650|NCT01079130|364519072|FG000|Overall Study|Adverse Event|1|||
105687651|NCT01079130|364519073|FG001|Overall Study|Adverse Event|1|||
105687652|NCT01079130|364519074|FG002|Overall Study|Adverse Event|0|||
105687653|NCT01079130|364519075|FG003|Overall Study|Adverse Event|1|||
105687654|NCT01079130|364519076|FG004|Overall Study|Adverse Event|5|||
105687655|NCT01079130|364519077|FG005|Overall Study|Adverse Event|1|||
105687656|NCT01079130|364519072|FG000|Overall Study|Administrative problems|1|||
105687657|NCT01079130|364519073|FG001|Overall Study|Administrative problems|3|||
105687658|NCT01079130|364519074|FG002|Overall Study|Administrative problems|0|||
105687659|NCT01079130|364519075|FG003|Overall Study|Administrative problems|0|||
105687660|NCT01079130|364519076|FG004|Overall Study|Administrative problems|0|||
105687661|NCT01079130|364519077|FG005|Overall Study|Administrative problems|1|||
105687662|NCT01079130|364519072|FG000|Overall Study|Withdrawal by Subject|0|||
105687663|NCT01079130|364519073|FG001|Overall Study|Withdrawal by Subject|1|||
105687664|NCT01079130|364519074|FG002|Overall Study|Withdrawal by Subject|0|||
105687665|NCT01079130|364519075|FG003|Overall Study|Withdrawal by Subject|0|||
105687666|NCT01079130|364519076|FG004|Overall Study|Withdrawal by Subject|1|||
105687667|NCT01079130|364519077|FG005|Overall Study|Withdrawal by Subject|3|||
105687668|NCT01079130|364519072|FG000|Overall Study|Protocol deviation|0|||
105786634|NCT00463385|364872864|FG000|Overall Study|Death|2|||
105687669|NCT01079130|364519073|FG001|Overall Study|Protocol deviation|2|||
105687670|NCT01079130|364519074|FG002|Overall Study|Protocol deviation|1|||
105687671|NCT01079130|364519075|FG003|Overall Study|Protocol deviation|2|||
105687672|NCT01079130|364519076|FG004|Overall Study|Protocol deviation|0|||
105687673|NCT01079130|364519077|FG005|Overall Study|Protocol deviation|0|||
105786635|NCT00463385|364872865|FG001|Overall Study|Death|1|||
105687674|NCT01079130|364519072|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105687675|NCT01079130|364519073|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105687676|NCT01079130|364519074|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105786636|NCT00463385|364872866|FG002|Overall Study|Death|2|||
105687677|NCT01079130|364519075|FG003|Overall Study|Abnormal test procedure result(s)|0|||
105918500|NCT02530385|365361077|FG001|Overall Study|Withdrawal by Subject|1|||
105687678|NCT01079130|364519076|FG004|Overall Study|Abnormal test procedure result(s)|1|||
105687679|NCT01079130|364519077|FG005|Overall Study|Abnormal test procedure result(s)|0|||
105687680|NCT01079130|364519072|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105687681|NCT01079130|364519073|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105687682|NCT01079130|364519074|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105918501|NCT01184872|365361078|FG000|Overall Study|Adverse Event|3|||
105918502|NCT01184872|365361079|FG001|Overall Study|Adverse Event|4|||
105918503|NCT01184872|365361078|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
105918504|NCT01184872|365361079|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105918505|NCT01184872|365361078|FG000|Overall Study|Withdrawal by Subject|2|||
105918506|NCT01184872|365361079|FG001|Overall Study|Withdrawal by Subject|0|||
105918507|NCT01184872|365361078|FG000|Overall Study|Lost to Follow-up|0|||
105918508|NCT01184872|365361079|FG001|Overall Study|Lost to Follow-up|1|||
105918509|NCT01184872|365361078|FG000|Overall Study|Administrative problems|1|||
105918510|NCT01184872|365361079|FG001|Overall Study|Administrative problems|1|||
105918511|NCT01184872|365361078|FG000|Overall Study|Protocol deviation|1|||
106130313|NCT01115998|366134152|FG000|Overall Study|Lost to Follow-up|6|||
106130314|NCT01115998|366134153|FG001|Overall Study|Lost to Follow-up|6|||
106130315|NCT04096365|366134154|FG000|Overall Study|Adverse Event|1|||
105687683|NCT01079130|364519075|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
105687684|NCT01079130|364519076|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
105687685|NCT01079130|364519077|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
105687686|NCT01079130|364519072|FG000|Overall Study|Lost to Follow-up|0|||
105687687|NCT01079130|364519073|FG001|Overall Study|Lost to Follow-up|0|||
105687688|NCT01079130|364519074|FG002|Overall Study|Lost to Follow-up|0|||
105687689|NCT01079130|364519075|FG003|Overall Study|Lost to Follow-up|0|||
105687690|NCT01079130|364519076|FG004|Overall Study|Lost to Follow-up|1|||
105687691|NCT01079130|364519077|FG005|Overall Study|Lost to Follow-up|0|||
105687692|NCT02141984|364520500|FG000|Overall Study|Lack of Efficacy|2|||
105687693|NCT02245672|364520501|FG000|Overall Study|Adverse Event|4|||
105687694|NCT02245672|364520502|FG001|Overall Study|Adverse Event|4|||
105687695|NCT02245672|364520503|FG002|Overall Study|Adverse Event|4|||
105687696|NCT02245672|364520501|FG000|Overall Study|Lost to Follow-up|3|||
105687697|NCT02245672|364520502|FG001|Overall Study|Lost to Follow-up|5|||
105687698|NCT02245672|364520503|FG002|Overall Study|Lost to Follow-up|1|||
105687699|NCT02245672|364520501|FG000|Overall Study|Withdrawal by Subject|6|||
105687700|NCT02245672|364520502|FG001|Overall Study|Withdrawal by Subject|3|||
105687701|NCT02245672|364520503|FG002|Overall Study|Withdrawal by Subject|0|||
106130316|NCT02107274|366134155|FG000|Treatment vs. Placebo|Adverse Event|3|||
106130317|NCT02107274|366134156|FG001|Treatment vs. Placebo|Adverse Event|0|||
106130318|NCT02107274|366134155|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
106130319|NCT02107274|366134156|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
106130320|NCT02107274|366134155|FG000|Control Phase|Lost to Follow-up|1|||
106130321|NCT02107274|366134156|FG001|Control Phase|Lost to Follow-up|1|||
106130322|NCT02107274|366134155|FG000|Control Phase|Death|2|||
106130323|NCT02107274|366134156|FG001|Control Phase|Death|0|||
106130324|NCT02107274|366134155|FG000|Control Phase|Adverse Event|0|||
106130325|NCT02107274|366134156|FG001|Control Phase|Adverse Event|1|||
106130326|NCT01036087|366134157|FG000|Overall Study|Adverse Event|2|||
106130327|NCT01036087|366134157|FG000|Overall Study|Lack of Efficacy|1|||
106130328|NCT02123966|366134160|FG000|Overall Study|Intercurrent Illness|1|||
106130329|NCT00465361|366134162|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
106130330|NCT01021332|366134163|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
106130331|NCT01021332|366134163|FG000|Overall Study|Adverse Event|43|||
106130332|NCT01021332|366134163|FG000|Overall Study|Lack of Efficacy|19|||
106130333|NCT01021332|366134163|FG000|Overall Study|Withdrawal of Consent|23|||
106130334|NCT01021332|366134163|FG000|Overall Study|Lost to Follow-up|4|||
106130335|NCT01021332|366134163|FG000|Overall Study|Protocol Violation|9|||
106130336|NCT01021332|366134163|FG000|Overall Study|Miscellaneous|3|||
106130337|NCT03487666|366134165|FG000|Overall Study|Disease progression|4|||
106130338|NCT03487666|366134166|FG001|Overall Study|Disease progression|2|||
106130339|NCT03487666|366134167|FG002|Overall Study|Disease progression|0|||
106130340|NCT03487666|366134165|FG000|Overall Study|Adverse Event|0|||
106130341|NCT03487666|366134166|FG001|Overall Study|Adverse Event|0|||
106130342|NCT03487666|366134167|FG002|Overall Study|Adverse Event|1|||
106130343|NCT00550732|366134179|FG000|Overall Study|Death|4|||
105687702|NCT02245672|364520501|FG000|Overall Study|Randomized in error (not treated)|0|||
105687703|NCT02245672|364520502|FG001|Overall Study|Randomized in error (not treated)|1|||
105687704|NCT02245672|364520503|FG002|Overall Study|Randomized in error (not treated)|0|||
105786637|NCT00463385|364872867|FG003|Overall Study|Death|0|||
106130344|NCT00550732|366134179|FG000|Overall Study|Withdrawal by Subject|2|||
106130345|NCT00550732|366134179|FG000|Overall Study|Physician Decision|2|||
105687705|NCT04981366|364520514|FG000|Overall Study|Withdrawal by Subject|5|||
105687706|NCT04981366|364520515|FG001|Overall Study|Withdrawal by Subject|4|||
105687707|NCT04981366|364520516|FG002|Overall Study|Withdrawal by Subject|8|||
106130346|NCT00550732|366134179|FG000|Overall Study|Lost to Follow-up|1|||
105918512|NCT01184872|365361079|FG001|Overall Study|Protocol deviation|0|||
105918513|NCT02133508|365361080|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
105918514|NCT02133508|365361080|FG000|Overall Study|Death|12|||
105918515|NCT02133508|365361080|FG000|Overall Study|Lost to Follow-up|2|||
105918516|NCT02446691|365361087|FG000|Overall Study|Withdrawal by Subject|2|||
105918517|NCT02446691|365361087|FG000|Overall Study|Lost to Follow-up|8|||
105918518|NCT02446691|365361087|FG000|Overall Study|Protocol Violation|1|||
105918519|NCT02497469|365361088|FG000|Overall Study|Randomized but not Treated|0|||
105918520|NCT02497469|365361089|FG001|Overall Study|Randomized but not Treated|2|||
105918521|NCT02497469|365361088|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
105918522|NCT02497469|365361089|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
105918523|NCT02497469|365361088|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
105918524|NCT02497469|365361089|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
105918525|NCT02497469|365361088|FG000|Overall Study|Significant Protocol Deviation|4|||
105918526|NCT02497469|365361089|FG001|Overall Study|Significant Protocol Deviation|5|||
105918527|NCT02497469|365361088|FG000|Overall Study|Lost to Follow-up|14|||
105918528|NCT02497469|365361089|FG001|Overall Study|Lost to Follow-up|4|||
105918529|NCT02497469|365361088|FG000|Overall Study|Voluntary Withdrawal|39|||
105918530|NCT02497469|365361089|FG001|Overall Study|Voluntary Withdrawal|41|||
105918531|NCT02497469|365361088|FG000|Overall Study|Pregnancy|1|||
105918532|NCT02497469|365361089|FG001|Overall Study|Pregnancy|1|||
105918533|NCT02497469|365361088|FG000|Overall Study|Lack of Efficacy|86|||
105918534|NCT02497469|365361089|FG001|Overall Study|Lack of Efficacy|40|||
105918535|NCT02497469|365361088|FG000|Overall Study|Reason not Specified|6|||
105918536|NCT02497469|365361089|FG001|Overall Study|Reason not Specified|6|||
105918537|NCT03093181|365361091|FG000|Overall Study|Withdrawal by Subject|2|||
105918538|NCT03093181|365361092|FG001|Overall Study|Withdrawal by Subject|1|||
105918539|NCT03093181|365361093|FG002|Overall Study|Withdrawal by Subject|2|||
105918540|NCT03093181|365361091|FG000|Overall Study|Other (Not specified)|1|||
105918541|NCT03093181|365361092|FG001|Overall Study|Other (Not specified)|0|||
105918542|NCT03093181|365361093|FG002|Overall Study|Other (Not specified)|0|||
105918543|NCT03093181|365361091|FG000|Overall Study|Adverse Event|0|||
105918544|NCT03093181|365361092|FG001|Overall Study|Adverse Event|1|||
105918545|NCT03093181|365361093|FG002|Overall Study|Adverse Event|0|||
105918546|NCT03093181|365361091|FG000|Overall Study|Other (Protocol violation)|0|||
105918547|NCT03093181|365361092|FG001|Overall Study|Other (Protocol violation)|0|||
105918548|NCT03093181|365361093|FG002|Overall Study|Other (Protocol violation)|1|||
105918549|NCT01159574|365361094|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
105918550|NCT01159574|365361094|FG000|Treatment Phase|Adverse Event|3|||
105918551|NCT01159574|365361094|FG000|Treatment Phase|Death|6|||
105918552|NCT01159574|365361094|FG000|Treatment Phase|Physician Decision|2|||
105918553|NCT01159574|365361094|FG000|Treatment Phase|Withdrawal by Subject|7|||
105687708|NCT04981366|364520514|FG000|Overall Study|Health issues unrelated to the trial|1|||
105687709|NCT04981366|364520515|FG001|Overall Study|Health issues unrelated to the trial|2|||
105687710|NCT04981366|364520516|FG002|Overall Study|Health issues unrelated to the trial|0|||
105687711|NCT03214094|364520517|FG000|Overall Study|Case Report Forms Uncollected|14|||
105687712|NCT03214094|364520517|FG000|Overall Study|Protocol Deviation|46|||
105687713|NCT00795951|364520524|FG000|Overall Study|Lost to Follow-up|1|||
105687714|NCT00795951|364520524|FG000|Overall Study|Withdrawal by Subject|1|||
105687715|NCT01180998|364520525|FG000|Overall Study|Poor Vision|0|||
105687716|NCT01180998|364520526|FG001|Overall Study|Poor Vision|2|||
105687717|NCT01180998|364520527|FG002|Overall Study|Poor Vision|2|||
105687718|NCT01180998|364520525|FG000|Overall Study|Lost to Follow-up|0|||
105687719|NCT01180998|364520526|FG001|Overall Study|Lost to Follow-up|0|||
105687720|NCT01180998|364520527|FG002|Overall Study|Lost to Follow-up|1|||
105687721|NCT01180998|364520525|FG000|Overall Study|Protocol Violation|1|||
105687722|NCT01180998|364520526|FG001|Overall Study|Protocol Violation|2|||
105687723|NCT01180998|364520527|FG002|Overall Study|Protocol Violation|0|||
105687724|NCT01180998|364520525|FG000|Overall Study|Withdrawal by Subject|0|||
105687725|NCT01180998|364520526|FG001|Overall Study|Withdrawal by Subject|0|||
105687726|NCT01180998|364520527|FG002|Overall Study|Withdrawal by Subject|1|||
105687727|NCT01180998|364520525|FG000|Overall Study|Poor comfort|3|||
105687728|NCT01180998|364520526|FG001|Overall Study|Poor comfort|0|||
105687729|NCT01180998|364520527|FG002|Overall Study|Poor comfort|4|||
105687730|NCT01180998|364520525|FG000|Overall Study|Poor lens handling|0|||
105687731|NCT01180998|364520526|FG001|Overall Study|Poor lens handling|0|||
105918554|NCT01159574|365361094|FG000|Treatment Phase|still on treatment|2|||
105918555|NCT01159574|365361094|FG000|Follow Up Phase|Lost to Follow-up|2|||
105687732|NCT01180998|364520527|FG002|Overall Study|Poor lens handling|2|||
105687733|NCT00162032|364520528|FG000|Overall Study|Lost to Follow-up|4|||
105687734|NCT00162032|364520529|FG001|Overall Study|Lost to Follow-up|2|||
105918556|NCT01159574|365361094|FG000|Follow Up Phase|still being followed for overall surviva|18|||
105918557|NCT03167242|365361103|FG000|Overall Study|Patient/Guardian Decision|0|||
105687735|NCT00162032|364520528|FG000|Overall Study|Reason not specified|1|||
105687736|NCT00162032|364520529|FG001|Overall Study|Reason not specified|0|||
105687737|NCT00655486|364520534|FG000|Overall Study|Adverse Event|10|||
106001896|NCT02586623|365667863|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
106001897|NCT02586623|365667861|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
106001898|NCT02586623|365667862|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
106001899|NCT02586623|365667863|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
106001900|NCT02586623|365667861|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
106001901|NCT02586623|365667862|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
106001902|NCT02586623|365667863|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
106001903|NCT02586623|365667861|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
106001904|NCT02586623|365667862|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
106001905|NCT02586623|365667863|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
106001906|NCT02586623|365667861|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
106001907|NCT02586623|365667862|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
106001908|NCT02586623|365667863|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
106001909|NCT02586623|365667861|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
106001910|NCT02586623|365667862|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
106001911|NCT02586623|365667863|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
106001912|NCT02586623|365667861|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
106001913|NCT02586623|365667862|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
106001914|NCT02586623|365667863|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
106001915|NCT00795704|365667864|FG000|Overall Study|Withdrawal by Subject|3|||
106001916|NCT00795704|365667865|FG001|Overall Study|Withdrawal by Subject|2|||
106001917|NCT00795704|365667864|FG000|Overall Study|Adverse Event|1|||
106001918|NCT00795704|365667865|FG001|Overall Study|Adverse Event|1|||
106001919|NCT00360412|365667868|FG000|Overall Study|Adverse Event|37|||
106001920|NCT00360412|365667869|FG001|Overall Study|Adverse Event|65|||
106001921|NCT00360412|365667868|FG000|Overall Study|Protocol Violation|2|||
106001922|NCT00360412|365667869|FG001|Overall Study|Protocol Violation|5|||
106001923|NCT00360412|365667868|FG000|Overall Study|Patient withdrew consent|27|||
106001924|NCT00360412|365667869|FG001|Overall Study|Patient withdrew consent|52|||
106001925|NCT00360412|365667868|FG000|Overall Study|Lack of therapeutic efficacy|46|||
106001926|NCT00360412|365667869|FG001|Overall Study|Lack of therapeutic efficacy|61|||
106001927|NCT00360412|365667868|FG000|Overall Study|Physician Decision|2|||
106001928|NCT00360412|365667869|FG001|Overall Study|Physician Decision|4|||
106001929|NCT00360412|365667868|FG000|Overall Study|Other|5|||
106001930|NCT00360412|365667869|FG001|Overall Study|Other|6|||
106001931|NCT00360412|365667868|FG000|Overall Study|Study termination by Sponsor|214|||
106001932|NCT00360412|365667869|FG001|Overall Study|Study termination by Sponsor|469|||
106001933|NCT00479713|365667870|FG000|Overall Study|Adverse Event|8|||
106001934|NCT00479713|365667871|FG001|Overall Study|Adverse Event|6|||
106001935|NCT00479713|365667870|FG000|Overall Study|Death|1|||
106001936|NCT00479713|365667871|FG001|Overall Study|Death|0|||
106001937|NCT00479713|365667870|FG000|Overall Study|Lost to Follow-up|0|||
106001938|NCT00479713|365667871|FG001|Overall Study|Lost to Follow-up|1|||
106001939|NCT00479713|365667870|FG000|Overall Study|Protocol Violation|0|||
106001940|NCT00479713|365667871|FG001|Overall Study|Protocol Violation|1|||
106001941|NCT00479713|365667870|FG000|Overall Study|Withdrawal by Subject|4|||
106001942|NCT00479713|365667871|FG001|Overall Study|Withdrawal by Subject|1|||
106001943|NCT01572480|365667872|FG000|Participants Enrolled|Withdrawal by Subject|1|||
106001944|NCT01572480|365667872|FG000|Drug Administration|Discontinued drug/Off Study|1|||
106130347|NCT00550732|366134179|FG000|Overall Study|Palliative care|1|||
106130348|NCT00550732|366134179|FG000|Overall Study|Adverse Event|1|||
106130349|NCT01403987|366134186|FG000|Overall Study|Residents forgot their secret PIN|18|||
106130350|NCT01403987|366134187|FG001|Overall Study|Residents forgot their secret PIN|17|||
106130351|NCT01403987|366134188|FG002|Overall Study|Residents forgot their secret PIN|18|||
105918558|NCT03167242|365361104|FG001|Overall Study|Patient/Guardian Decision|1|||
105918559|NCT03167242|365361105|FG002|Overall Study|Patient/Guardian Decision|2|||
105918560|NCT03167242|365361106|FG003|Overall Study|Patient/Guardian Decision|1|||
105918561|NCT03167242|365361107|FG004|Overall Study|Patient/Guardian Decision|1|||
105918562|NCT03167242|365361108|FG005|Overall Study|Patient/Guardian Decision|1|||
105918563|NCT03167242|365361109|FG006|Overall Study|Patient/Guardian Decision|0|||
105918564|NCT03167242|365361110|FG007|Overall Study|Patient/Guardian Decision|0|||
105918565|NCT03167242|365361111|FG008|Overall Study|Patient/Guardian Decision|0|||
105918566|NCT03167242|365361112|FG009|Overall Study|Patient/Guardian Decision|0|||
105918567|NCT03167242|365361113|FG010|Overall Study|Patient/Guardian Decision|1|||
105918568|NCT03167242|365361114|FG011|Overall Study|Patient/Guardian Decision|0|||
105918569|NCT03167242|365361103|FG000|Overall Study|Lost to Follow-up|0|||
105918570|NCT03167242|365361104|FG001|Overall Study|Lost to Follow-up|0|||
106130352|NCT03302910|366134190|FG000|Overall Study|Protocol Violation|1|||
105918571|NCT03167242|365361105|FG002|Overall Study|Lost to Follow-up|1|||
105918572|NCT03167242|365361106|FG003|Overall Study|Lost to Follow-up|0|||
106001945|NCT01572480|365667872|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
106001946|NCT01572480|365667872|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
106130353|NCT03302910|366134191|FG001|Overall Study|Protocol Violation|0|||
106001947|NCT00191334|365667873|FG000|Overall Study|Adverse Event|4|||
106001948|NCT00191334|365667873|FG000|Overall Study|Disease Progression or Relapse|8|||
106001949|NCT00191334|365667873|FG000|Overall Study|Physician Decision|1|||
106001950|NCT00191334|365667873|FG000|Overall Study|Withdrawal by Subject|4|||
106001951|NCT02429830|365667882|FG000|Overall Study|Lost to Follow-up|1|||
106001952|NCT02429830|365667882|FG000|Overall Study|Device Explant|2|||
106001953|NCT01232868|365670471|FG000|Overall Study|Lost to Follow-up|2|||
106001954|NCT01232868|365670472|FG001|Overall Study|Lost to Follow-up|4|||
106001955|NCT04481243|365670473|FG000|Overall Study|Withdrawal by Subject|4|||
106001956|NCT02539797|365670474|FG000|Overall Study|Lost to Follow-up|0|||
106001957|NCT02539797|365670475|FG001|Overall Study|Lost to Follow-up|1|||
106001958|NCT02539797|365670476|FG002|Overall Study|Lost to Follow-up|0|||
106001959|NCT01777308|365670477|FG000|Overall Study|Withdrawal by Subject|5|||
106001960|NCT01777308|365670478|FG001|Overall Study|Withdrawal by Subject|1|||
106001961|NCT01777308|365670477|FG000|Overall Study|Migrated/moved from study area|1|||
106001962|NCT01777308|365670478|FG001|Overall Study|Migrated/moved from study area|0|||
106001963|NCT01777308|365670477|FG000|Overall Study|Lost to Follow-up|7|||
106001964|NCT01777308|365670478|FG001|Overall Study|Lost to Follow-up|2|||
106001965|NCT01777308|365670477|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
106001966|NCT01777308|365670478|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
106001967|NCT03212326|365670479|FG000|Overall Study|Physician Decision|4|||
106001968|NCT00383786|365670489|FG000|Overall Study|Protocol Violation|2|||
106001969|NCT00383786|365670490|FG001|Overall Study|Protocol Violation|6|||
106001970|NCT00383786|365670489|FG000|Overall Study|Withdrawal by Subject|2|||
105918573|NCT03167242|365361107|FG004|Overall Study|Lost to Follow-up|0|||
105918574|NCT03167242|365361108|FG005|Overall Study|Lost to Follow-up|1|||
105918575|NCT03167242|365361109|FG006|Overall Study|Lost to Follow-up|2|||
105918576|NCT03167242|365361110|FG007|Overall Study|Lost to Follow-up|1|||
105918577|NCT03167242|365361111|FG008|Overall Study|Lost to Follow-up|0|||
105918578|NCT03167242|365361112|FG009|Overall Study|Lost to Follow-up|0|||
105918579|NCT03167242|365361113|FG010|Overall Study|Lost to Follow-up|1|||
105918580|NCT03167242|365361114|FG011|Overall Study|Lost to Follow-up|1|||
105918581|NCT03167242|365361103|FG000|Overall Study|Reason not provided|0|||
105918582|NCT03167242|365361104|FG001|Overall Study|Reason not provided|0|||
105918583|NCT03167242|365361105|FG002|Overall Study|Reason not provided|0|||
105918584|NCT03167242|365361106|FG003|Overall Study|Reason not provided|0|||
105918585|NCT03167242|365361107|FG004|Overall Study|Reason not provided|0|||
105918586|NCT03167242|365361108|FG005|Overall Study|Reason not provided|0|||
105918587|NCT03167242|365361109|FG006|Overall Study|Reason not provided|0|||
105918588|NCT03167242|365361110|FG007|Overall Study|Reason not provided|0|||
105918589|NCT03167242|365361111|FG008|Overall Study|Reason not provided|1|||
105918590|NCT03167242|365361112|FG009|Overall Study|Reason not provided|0|||
105918591|NCT03167242|365361113|FG010|Overall Study|Reason not provided|0|||
105918592|NCT03167242|365361114|FG011|Overall Study|Reason not provided|0|||
105918593|NCT01494818|365361115|FG000|Overall Study|Relocation|1|||
105918594|NCT01494818|365361116|FG001|Overall Study|Relocation|2|||
105918595|NCT01494818|365361115|FG000|Overall Study|Lost to Follow-up|1|||
105918596|NCT01494818|365361116|FG001|Overall Study|Lost to Follow-up|0|||
105918597|NCT01041859|365361119|FG000|Open-Label Titration|Adverse Event|69|||
105918598|NCT01041859|365361120|FG001|Open-Label Titration|Adverse Event|0|||
105918599|NCT01041859|365361121|FG002|Open-Label Titration|Adverse Event|0|||
105918600|NCT01041859|365361119|FG000|Open-Label Titration|Lack of Efficacy|3|||
105918601|NCT01041859|365361120|FG001|Open-Label Titration|Lack of Efficacy|0|||
105918602|NCT01041859|365361121|FG002|Open-Label Titration|Lack of Efficacy|0|||
105918603|NCT01041859|365361119|FG000|Open-Label Titration|Lost to Follow-up|1|||
105918604|NCT01041859|365361120|FG001|Open-Label Titration|Lost to Follow-up|0|||
105918605|NCT01041859|365361121|FG002|Open-Label Titration|Lost to Follow-up|0|||
105918606|NCT01041859|365361119|FG000|Open-Label Titration|Physician Decision|1|||
105918607|NCT01041859|365361120|FG001|Open-Label Titration|Physician Decision|0|||
105918608|NCT01041859|365361121|FG002|Open-Label Titration|Physician Decision|0|||
105918609|NCT01041859|365361119|FG000|Open-Label Titration|Protocol Violation|1|||
105918610|NCT01041859|365361120|FG001|Open-Label Titration|Protocol Violation|0|||
105918611|NCT01041859|365361121|FG002|Open-Label Titration|Protocol Violation|0|||
105918612|NCT01041859|365361119|FG000|Open-Label Titration|Other|7|||
105918613|NCT01041859|365361120|FG001|Open-Label Titration|Other|0|||
105918614|NCT01041859|365361121|FG002|Open-Label Titration|Other|0|||
106001971|NCT00383786|365670490|FG001|Overall Study|Withdrawal by Subject|5|||
106001972|NCT00383786|365670489|FG000|Overall Study|Physician Decision|0|||
106001973|NCT00383786|365670490|FG001|Overall Study|Physician Decision|1|||
105918615|NCT01041859|365361119|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
105918616|NCT01041859|365361120|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
106001974|NCT03057496|365670495|FG000|Overall Study|Withdrawal by Subject|8|||
106001975|NCT03057496|365670495|FG000|Overall Study|Lost to Follow-up|5|||
106001976|NCT03057496|365670495|FG000|Overall Study|Did not use device during home trial|3|||
106001977|NCT03057496|365670495|FG000|Overall Study|Device failure|2|||
106001978|NCT03737123|365670496|FG000|Study Treatment|Adverse Event|2|||
106001979|NCT03737123|365670497|FG001|Study Treatment|Adverse Event|0|||
106001980|NCT03737123|365670496|FG000|Study Treatment|Disease Progression|2|||
106001981|NCT03737123|365670497|FG001|Study Treatment|Disease Progression|0|||
106001982|NCT03737123|365670496|FG000|Study Treatment|Withdrawal by Subject|2|||
106001983|NCT03737123|365670497|FG001|Study Treatment|Withdrawal by Subject|0|||
106001984|NCT03737123|365670496|FG000|Follow up|Death|1|||
106001985|NCT03737123|365670497|FG001|Follow up|Death|0|||
106001986|NCT03737123|365670496|FG000|Follow up|Withdrawal by Subject|1|||
105687738|NCT00655486|364520534|FG000|Overall Study|Lack of Efficacy|8|||
105687739|NCT00655486|364520534|FG000|Overall Study|Withdrawal by Subject|4|||
105918617|NCT01041859|365361121|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
106001987|NCT03737123|365670497|FG001|Follow up|Withdrawal by Subject|0|||
106001988|NCT03737123|365670496|FG000|Follow up|Termination of study|4|||
106001989|NCT03737123|365670497|FG001|Follow up|Termination of study|0|||
106001990|NCT04617782|365670500|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
106001991|NCT04617782|365670500|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
106001992|NCT04617782|365670500|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
106001993|NCT04617782|365670500|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
106001994|NCT04617782|365670500|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
106001995|NCT04617782|365670500|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
106001996|NCT01584232|365670505|FG000|Overall Study|Adverse Event|3|||
106001997|NCT01584232|365670506|FG001|Overall Study|Adverse Event|1|||
106001998|NCT01584232|365670505|FG000|Overall Study|Withdrawal by Subject|2|||
106001999|NCT01584232|365670506|FG001|Overall Study|Withdrawal by Subject|1|||
106002000|NCT01584232|365670505|FG000|Overall Study|Physician Decision|2|||
106002001|NCT01584232|365670506|FG001|Overall Study|Physician Decision|1|||
106002002|NCT01584232|365670505|FG000|Overall Study|Lost to Follow-up|1|||
106002003|NCT01584232|365670506|FG001|Overall Study|Lost to Follow-up|0|||
106002004|NCT01307319|365670507|FG000|Overall Study|Adverse Event|2|||
106002005|NCT01307319|365670508|FG001|Overall Study|Adverse Event|2|||
106002006|NCT01307319|365670509|FG002|Overall Study|Adverse Event|1|||
106002007|NCT01307319|365670507|FG000|Overall Study|Lost to Follow-up|1|||
106002008|NCT01307319|365670508|FG001|Overall Study|Lost to Follow-up|0|||
106002009|NCT01307319|365670509|FG002|Overall Study|Lost to Follow-up|1|||
106002010|NCT01307319|365670507|FG000|Overall Study|Protocol Violation|1|||
106002011|NCT01307319|365670508|FG001|Overall Study|Protocol Violation|1|||
106002012|NCT01307319|365670509|FG002|Overall Study|Protocol Violation|0|||
106002013|NCT01307319|365670507|FG000|Overall Study|Withdrawal by Subject|0|||
106002014|NCT01307319|365670508|FG001|Overall Study|Withdrawal by Subject|1|||
105687740|NCT00655486|364520534|FG000|Overall Study|Protocol Violation|1|||
105918618|NCT01041859|365361119|FG000|Open-Label Titration|Withdrawal by Subject|11|||
105918619|NCT01041859|365361120|FG001|Open-Label Titration|Withdrawal by Subject|0|||
105918620|NCT01041859|365361121|FG002|Open-Label Titration|Withdrawal by Subject|0|||
105918621|NCT01041859|365361119|FG000|Double-Blind Maintenance|Adverse Event|0|||
105918622|NCT01041859|365361120|FG001|Double-Blind Maintenance|Adverse Event|23|||
105918623|NCT01041859|365361121|FG002|Double-Blind Maintenance|Adverse Event|13|||
105918624|NCT01041859|365361119|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
105918625|NCT01041859|365361120|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
105918626|NCT01041859|365361121|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
105918627|NCT01041859|365361119|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
105918628|NCT01041859|365361120|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
105918629|NCT01041859|365361121|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
105918630|NCT01041859|365361119|FG000|Double-Blind Maintenance|Physician Decision|0|||
105918631|NCT01041859|365361120|FG001|Double-Blind Maintenance|Physician Decision|2|||
105918632|NCT01041859|365361121|FG002|Double-Blind Maintenance|Physician Decision|1|||
105918633|NCT01041859|365361119|FG000|Double-Blind Maintenance|Protocol Violation|0|||
105918634|NCT01041859|365361120|FG001|Double-Blind Maintenance|Protocol Violation|1|||
105918635|NCT01041859|365361121|FG002|Double-Blind Maintenance|Protocol Violation|3|||
105918636|NCT01041859|365361119|FG000|Double-Blind Maintenance|Other|0|||
105918637|NCT01041859|365361120|FG001|Double-Blind Maintenance|Other|6|||
105918638|NCT01041859|365361121|FG002|Double-Blind Maintenance|Other|2|||
105918639|NCT01041859|365361119|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
105918640|NCT01041859|365361120|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
105918641|NCT01041859|365361121|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
106002015|NCT01307319|365670509|FG002|Overall Study|Withdrawal by Subject|2|||
105687741|NCT00655486|364520534|FG000|Overall Study|Unsatisfactory compliance|2|||
105918642|NCT01041859|365361119|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
105918643|NCT01041859|365361120|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
106002016|NCT01307319|365670507|FG000|Overall Study|Other|0|||
106002017|NCT01307319|365670508|FG001|Overall Study|Other|4|||
106002018|NCT01307319|365670509|FG002|Overall Study|Other|3|||
106002019|NCT04233801|365670512|FG000|Overall Study|Other than listed|0|||
106002020|NCT04233801|365670513|FG001|Overall Study|Other than listed|0|||
106002021|NCT04233801|365670514|FG002|Overall Study|Other than listed|1|||
106002022|NCT04233801|365670512|FG000|Overall Study|Withdrawal by Subject|0|||
106002023|NCT04233801|365670513|FG001|Overall Study|Withdrawal by Subject|2|||
106002024|NCT04233801|365670514|FG002|Overall Study|Withdrawal by Subject|3|||
106002025|NCT03633396|365670515|FG000|Overall Study|Withdrawal by Subject|4|||
106002026|NCT03633396|365670516|FG001|Overall Study|Withdrawal by Subject|4|||
106002027|NCT03633396|365670515|FG000|Overall Study|Adverse Event|1|||
106002028|NCT03633396|365670516|FG001|Overall Study|Adverse Event|1|||
106002029|NCT03633396|365670515|FG000|Overall Study|Lack of Efficacy|1|||
106002030|NCT03633396|365670516|FG001|Overall Study|Lack of Efficacy|0|||
106002031|NCT03633396|365670515|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
106002032|NCT03633396|365670516|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
106002033|NCT00928486|365670519|FG000|Overall Study|Adverse Event|2|||
106002034|NCT00928486|365670519|FG000|Overall Study|Disease Progression|7|||
106002035|NCT00928486|365670519|FG000|Overall Study|Withdrawal by Subject|1|||
106002036|NCT04024891|365670523|FG000|Overall Study|Pregnancy|0|||
106002037|NCT04024891|365670524|FG001|Overall Study|Pregnancy|1|||
106002038|NCT02723773|365670527|FG000|Overall Study|Adverse Event|934|||
106002039|NCT02723773|365670528|FG001|Overall Study|Adverse Event|3|||
106002040|NCT02723773|365670529|FG002|Overall Study|Adverse Event|1|||
106002041|NCT02723773|365670530|FG003|Overall Study|Adverse Event|9|||
106002042|NCT02723773|365670527|FG000|Overall Study|Protocol Violation|1|||
106002043|NCT02723773|365670528|FG001|Overall Study|Protocol Violation|0|||
106002044|NCT02723773|365670529|FG002|Overall Study|Protocol Violation|0|||
106002045|NCT02723773|365670530|FG003|Overall Study|Protocol Violation|0|||
106002046|NCT02723773|365670527|FG000|Overall Study|Withdrawal by Subject|360|||
106002047|NCT02723773|365670528|FG001|Overall Study|Withdrawal by Subject|5|||
106002048|NCT02723773|365670529|FG002|Overall Study|Withdrawal by Subject|6|||
106002049|NCT02723773|365670530|FG003|Overall Study|Withdrawal by Subject|10|||
106002050|NCT02723773|365670527|FG000|Overall Study|Migrated/moved from study area|37|||
106002051|NCT02723773|365670528|FG001|Overall Study|Migrated/moved from study area|0|||
105687742|NCT00655486|364520534|FG000|Overall Study|Other: Pregnancy|1|||
105687743|NCT00655486|364520534|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
105918644|NCT01041859|365361121|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
105918645|NCT00269152|365361124|FG000|Overall Study|Adverse Event|9|||
105918646|NCT00269152|365361125|FG001|Overall Study|Adverse Event|3|||
105918647|NCT00269152|365361124|FG000|Overall Study|Withdrawal by Subject|7|||
105918648|NCT00269152|365361125|FG001|Overall Study|Withdrawal by Subject|3|||
105918649|NCT00269152|365361124|FG000|Overall Study|Physician Decision|2|||
105918650|NCT00269152|365361125|FG001|Overall Study|Physician Decision|3|||
105918651|NCT00269152|365361124|FG000|Overall Study|Protocol Violation|0|||
105918652|NCT00269152|365361125|FG001|Overall Study|Protocol Violation|1|||
105918653|NCT03368807|365361130|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
105918654|NCT03368807|365361130|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
105918655|NCT03368807|365361130|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
105918656|NCT03368807|365361130|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
105918657|NCT00885118|365361131|FG000|Overall Study|Adverse Event|1|||
105918658|NCT00885118|365361132|FG001|Overall Study|Adverse Event|0|||
105918659|NCT00885118|365361133|FG002|Overall Study|Adverse Event|0|||
105918660|NCT00885118|365361134|FG003|Overall Study|Adverse Event|0|||
105918661|NCT00885118|365361135|FG004|Overall Study|Adverse Event|0|||
105918662|NCT00885118|365361131|FG000|Overall Study|Withdrawal by Subject|0|||
105918663|NCT00885118|365361132|FG001|Overall Study|Withdrawal by Subject|0|||
105918664|NCT00885118|365361133|FG002|Overall Study|Withdrawal by Subject|0|||
105918665|NCT00885118|365361134|FG003|Overall Study|Withdrawal by Subject|0|||
105918666|NCT00885118|365361135|FG004|Overall Study|Withdrawal by Subject|1|||
105918667|NCT00885118|365361131|FG000|Overall Study|Other reason not defined above|0|||
105918668|NCT00885118|365361132|FG001|Overall Study|Other reason not defined above|0|||
105918669|NCT00885118|365361133|FG002|Overall Study|Other reason not defined above|1|||
105918670|NCT00885118|365361134|FG003|Overall Study|Other reason not defined above|0|||
105918671|NCT00885118|365361135|FG004|Overall Study|Other reason not defined above|0|||
105918672|NCT03191552|365361136|FG000|Overall Study|Lost to Follow-up|1|||
105918673|NCT03191552|365361137|FG001|Overall Study|Lost to Follow-up|0|||
105918674|NCT03191552|365361138|FG002|Overall Study|Lost to Follow-up|0|||
105918675|NCT03191552|365361136|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
105918676|NCT03191552|365361137|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
105918677|NCT03191552|365361138|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
105918678|NCT01441973|365361139|FG000|Overall Study|Disease progression|8|||
105918679|NCT01441973|365361140|FG001|Overall Study|Disease progression|6|||
105918680|NCT01441973|365361139|FG000|Overall Study|Adverse event unrelated to study drug|3|||
105918681|NCT01441973|365361140|FG001|Overall Study|Adverse event unrelated to study drug|2|||
106002052|NCT02723773|365670529|FG002|Overall Study|Migrated/moved from study area|0|||
106002053|NCT02723773|365670530|FG003|Overall Study|Migrated/moved from study area|1|||
106002054|NCT02723773|365670527|FG000|Overall Study|Lost to Follow-up|198|||
106002055|NCT02723773|365670528|FG001|Overall Study|Lost to Follow-up|0|||
106002056|NCT02723773|365670529|FG002|Overall Study|Lost to Follow-up|0|||
106002057|NCT02723773|365670530|FG003|Overall Study|Lost to Follow-up|0|||
106002058|NCT02723773|365670527|FG000|Overall Study|Other|189|||
106002059|NCT02723773|365670528|FG001|Overall Study|Other|1|||
106002060|NCT02723773|365670529|FG002|Overall Study|Other|2|||
106002061|NCT02723773|365670530|FG003|Overall Study|Other|2|||
106002062|NCT01790594|365670536|FG000|Overall Study|Death|1|||
106002063|NCT01790594|365670537|FG001|Overall Study|Death|0|||
106002064|NCT01790594|365670538|FG002|Overall Study|Death|0|||
106002065|NCT01790594|365670536|FG000|Overall Study|Physician Decision|2|||
106002066|NCT01790594|365670537|FG001|Overall Study|Physician Decision|1|||
106002067|NCT01790594|365670538|FG002|Overall Study|Physician Decision|0|||
106002068|NCT01790594|365670536|FG000|Overall Study|Withdrawal by Subject|2|||
106002069|NCT01790594|365670537|FG001|Overall Study|Withdrawal by Subject|0|||
106002070|NCT01790594|365670538|FG002|Overall Study|Withdrawal by Subject|0|||
106002071|NCT01790594|365670536|FG000|Overall Study|Transplant was not done|0|||
106002072|NCT01790594|365670537|FG001|Overall Study|Transplant was not done|0|||
106002073|NCT01790594|365670538|FG002|Overall Study|Transplant was not done|3|||
106002074|NCT01790594|365670536|FG000|Overall Study|Terminated prior to week 76|0|||
106002075|NCT01790594|365670537|FG001|Overall Study|Terminated prior to week 76|2|||
106002076|NCT01790594|365670538|FG002|Overall Study|Terminated prior to week 76|0|||
106002077|NCT02152631|365670539|FG000|Overall Study|Adverse Event|32|||
106002078|NCT02152631|365670540|FG001|Overall Study|Adverse Event|4|||
106002079|NCT02152631|365670539|FG000|Overall Study|Withdrawal by Subject|13|||
106002080|NCT02152631|365670540|FG001|Overall Study|Withdrawal by Subject|16|||
106002081|NCT02152631|365670539|FG000|Overall Study|Noncompliance with study drug|1|||
106002082|NCT02152631|365670540|FG001|Overall Study|Noncompliance with study drug|0|||
106002083|NCT02152631|365670539|FG000|Overall Study|Physician Decision|1|||
106002084|NCT02152631|365670540|FG001|Overall Study|Physician Decision|2|||
106002085|NCT02152631|365670539|FG000|Overall Study|Lost to Follow-up|0|||
106002086|NCT02152631|365670540|FG001|Overall Study|Lost to Follow-up|1|||
106002087|NCT02152631|365670539|FG000|Overall Study|On Treatment|19|||
106002088|NCT02152631|365670540|FG001|Overall Study|On Treatment|3|||
106002089|NCT05473026|365670541|FG000|Overall Study|Lost to Follow-up|5|||
106002090|NCT05473026|365670542|FG001|Overall Study|Lost to Follow-up|2|||
106002091|NCT01050634|365670543|FG000|Overall Study|Enrolled, but Not Treated|56|||
106002092|NCT01050634|365670543|FG000|Overall Study|Death|2|||
106002093|NCT01050634|365670543|FG000|Overall Study|Adverse Event|42|||
106002094|NCT01050634|365670543|FG000|Overall Study|Lost to Follow-up|2|||
106002095|NCT01050634|365670543|FG000|Overall Study|Other|21|||
106002096|NCT01050634|365670543|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
106002097|NCT00496015|365670544|FG000|Overall Study|Other|1|||
106002098|NCT00496015|365670545|FG001|Overall Study|Other|0|||
106002099|NCT00496015|365670546|FG002|Overall Study|Other|0|||
106002100|NCT00496015|365670547|FG003|Overall Study|Other|1|||
106002101|NCT00496015|365670548|FG004|Overall Study|Other|0|||
106002102|NCT00527735|365670549|FG000|Overall Study|Disease progression|47|||
106002103|NCT00527735|365670550|FG001|Overall Study|Disease progression|61|||
106002104|NCT00527735|365670551|FG002|Overall Study|Disease progression|53|||
106002105|NCT00527735|365670549|FG000|Overall Study|Death|23|||
106130354|NCT00724061|366134204|FG000|Dose Escalation Phase|Adverse Event|2|||
106130355|NCT00724061|366134204|FG000|Dose Escalation Phase|Disease Progression|3|||
106130356|NCT00372567|366134207|FG000|Phase 3 Study|Adverse Event|5|||
106130357|NCT00372567|366134208|FG001|Phase 3 Study|Adverse Event|1|||
106130358|NCT00372567|366134209|FG002|Phase 3 Study|Adverse Event|1|||
106130359|NCT00372567|366134207|FG000|Phase 3 Study|Death|1|||
105687744|NCT00655486|364520534|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
105687745|NCT01138007|364520545|FG000|Overall Study|Adverse Event|4|||
105687746|NCT01138007|364520546|FG001|Overall Study|Adverse Event|12|||
105687747|NCT01138007|364520547|FG002|Overall Study|Adverse Event|9|||
105687748|NCT01138007|364520545|FG000|Overall Study|Lack of Efficacy|2|||
105687749|NCT01138007|364520546|FG001|Overall Study|Lack of Efficacy|0|||
106130360|NCT00372567|366134208|FG001|Phase 3 Study|Death|1|||
106130361|NCT00372567|366134209|FG002|Phase 3 Study|Death|0|||
105687750|NCT01138007|364520547|FG002|Overall Study|Lack of Efficacy|6|||
105687751|NCT01138007|364520545|FG000|Overall Study|Protocol Violation|2|||
105687752|NCT01138007|364520546|FG001|Overall Study|Protocol Violation|3|||
106002106|NCT00527735|365670550|FG001|Overall Study|Death|13|||
106002107|NCT00527735|365670551|FG002|Overall Study|Death|15|||
106002108|NCT00527735|365670549|FG000|Overall Study|Completed treatment in treatment phase|14|||
106002109|NCT00527735|365670550|FG001|Overall Study|Completed treatment in treatment phase|13|||
106002110|NCT00527735|365670551|FG002|Overall Study|Completed treatment in treatment phase|18|||
106002111|NCT00527735|365670549|FG000|Overall Study|Adverse Event|10|||
106002112|NCT00527735|365670550|FG001|Overall Study|Adverse Event|6|||
106002113|NCT00527735|365670551|FG002|Overall Study|Adverse Event|7|||
106130362|NCT00372567|366134207|FG000|Phase 3 Study|Protocol Violation|0|||
106002114|NCT00527735|365670549|FG000|Overall Study|Not identified|5|||
106002115|NCT00527735|365670550|FG001|Overall Study|Not identified|5|||
106002116|NCT00527735|365670551|FG002|Overall Study|Not identified|5|||
106002117|NCT00527735|365670549|FG000|Overall Study|Withdrawal by Subject|5|||
106002118|NCT00527735|365670550|FG001|Overall Study|Withdrawal by Subject|4|||
106002119|NCT00527735|365670551|FG002|Overall Study|Withdrawal by Subject|3|||
106002120|NCT00527735|365670549|FG000|Overall Study|No longer met study criteria|2|||
106002121|NCT00527735|365670550|FG001|Overall Study|No longer met study criteria|2|||
106002122|NCT00527735|365670551|FG002|Overall Study|No longer met study criteria|1|||
106002123|NCT00527735|365670549|FG000|Overall Study|Lost to Follow-up|0|||
106002124|NCT00527735|365670550|FG001|Overall Study|Lost to Follow-up|0|||
106002125|NCT00527735|365670551|FG002|Overall Study|Lost to Follow-up|3|||
106002126|NCT00527735|365670549|FG000|Overall Study|Poor compliance or noncompliance|0|||
106002127|NCT00527735|365670550|FG001|Overall Study|Poor compliance or noncompliance|1|||
106002128|NCT00527735|365670551|FG002|Overall Study|Poor compliance or noncompliance|1|||
106002129|NCT00527735|365670549|FG000|Overall Study|Completed treatment during maintenance|2|||
106002130|NCT00527735|365670550|FG001|Overall Study|Completed treatment during maintenance|2|||
106002131|NCT00527735|365670551|FG002|Overall Study|Completed treatment during maintenance|1|||
106002132|NCT01535807|365670552|FG000|Overall Study|Withdrawal by Subject|1|||
106002133|NCT01535807|365670553|FG001|Overall Study|Withdrawal by Subject|1|||
106002134|NCT01535807|365670552|FG000|Overall Study|Data collection error|1|||
106002135|NCT01535807|365670553|FG001|Overall Study|Data collection error|1|||
106002136|NCT01855412|365670556|FG000|Overall Study|Death|77|||
106002137|NCT01855412|365670557|FG001|Overall Study|Death|123|||
106002138|NCT01855412|365670558|FG002|Overall Study|Death|30|||
106002139|NCT01855412|365670556|FG000|Overall Study|Lost to Follow-up|28|||
106002140|NCT01855412|365670557|FG001|Overall Study|Lost to Follow-up|46|||
106002141|NCT01855412|365670558|FG002|Overall Study|Lost to Follow-up|15|||
106002142|NCT01855412|365670556|FG000|Overall Study|Withdrawal by Subject|77|||
106002143|NCT01855412|365670557|FG001|Overall Study|Withdrawal by Subject|123|||
106002144|NCT01855412|365670558|FG002|Overall Study|Withdrawal by Subject|24|||
106002145|NCT01855412|365670556|FG000|Overall Study|Physician Decision|25|||
106002146|NCT01855412|365670557|FG001|Overall Study|Physician Decision|31|||
106002147|NCT01855412|365670558|FG002|Overall Study|Physician Decision|3|||
106002148|NCT01855412|365670556|FG000|Overall Study|Site Closure|4|||
106002149|NCT01855412|365670557|FG001|Overall Study|Site Closure|18|||
106002150|NCT01855412|365670558|FG002|Overall Study|Site Closure|1|||
106002151|NCT01855412|365670556|FG000|Overall Study|Reason not Specified|1|||
106002152|NCT01855412|365670557|FG001|Overall Study|Reason not Specified|2|||
106002153|NCT01855412|365670558|FG002|Overall Study|Reason not Specified|3|||
106002154|NCT01631435|365670560|FG000|Overall Study|Adverse Event|2|||
106002155|NCT01631435|365670560|FG000|Overall Study|Withdrawal by Subject|2|||
106002156|NCT01631435|365670560|FG000|Overall Study|incomplete study procedure|5|||
106002157|NCT00308139|365670561|FG000|Overall Study|Adverse Event|20|||
106002158|NCT00308139|365670562|FG001|Overall Study|Adverse Event|14|||
106002159|NCT00308139|365670561|FG000|Overall Study|Lost to Follow-up|13|||
106002160|NCT00308139|365670562|FG001|Overall Study|Lost to Follow-up|8|||
106002161|NCT00308139|365670561|FG000|Overall Study|Protocol Violation|3|||
106002162|NCT00308139|365670562|FG001|Overall Study|Protocol Violation|2|||
106002163|NCT00308139|365670561|FG000|Overall Study|Withdrawal of Consent|40|||
106002164|NCT00308139|365670562|FG001|Overall Study|Withdrawal of Consent|42|||
106002165|NCT00308139|365670561|FG000|Overall Study|Investigator Decision|11|||
106002166|NCT00308139|365670562|FG001|Overall Study|Investigator Decision|10|||
106002167|NCT00308139|365670561|FG000|Overall Study|Loss of Glucose Control|5|||
106002168|NCT00308139|365670562|FG001|Overall Study|Loss of Glucose Control|7|||
106002169|NCT00308139|365670561|FG000|Overall Study|Administrative|1|||
106002170|NCT00308139|365670562|FG001|Overall Study|Administrative|4|||
106002171|NCT00308139|365670561|FG000|Overall Study|Other|1|||
106002172|NCT00308139|365670562|FG001|Overall Study|Other|0|||
106002173|NCT02349633|365670565|FG000|Overall Study|Death|0|||
105687753|NCT01138007|364520547|FG002|Overall Study|Protocol Violation|2|||
106002174|NCT02349633|365670566|FG001|Overall Study|Death|1|||
106002175|NCT02349633|365670567|FG002|Overall Study|Death|0|||
106002176|NCT02349633|365670568|FG003|Overall Study|Death|0|||
106002177|NCT02349633|365670569|FG004|Overall Study|Death|0|||
106002178|NCT02349633|365670570|FG005|Overall Study|Death|1|||
106002179|NCT02349633|365670571|FG006|Overall Study|Death|1|||
106002180|NCT02349633|365670572|FG007|Overall Study|Death|1|||
106002181|NCT02349633|365670573|FG008|Overall Study|Death|0|||
106002182|NCT02349633|365670574|FG009|Overall Study|Death|1|||
105687754|NCT01138007|364520545|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
106002183|NCT02349633|365670575|FG010|Overall Study|Death|0|||
106002184|NCT02349633|365670576|FG011|Overall Study|Death|0|||
106002185|NCT02349633|365670577|FG012|Overall Study|Death|0|||
106002186|NCT02349633|365670578|FG013|Overall Study|Death|0|||
106002187|NCT02349633|365670565|FG000|Overall Study|Withdrawal by Subject|0|||
106002188|NCT02349633|365670566|FG001|Overall Study|Withdrawal by Subject|0|||
106002189|NCT02349633|365670567|FG002|Overall Study|Withdrawal by Subject|0|||
106002190|NCT02349633|365670568|FG003|Overall Study|Withdrawal by Subject|1|||
106002191|NCT02349633|365670569|FG004|Overall Study|Withdrawal by Subject|0|||
106002192|NCT02349633|365670570|FG005|Overall Study|Withdrawal by Subject|0|||
106002193|NCT02349633|365670571|FG006|Overall Study|Withdrawal by Subject|0|||
106002194|NCT02349633|365670572|FG007|Overall Study|Withdrawal by Subject|2|||
106002195|NCT02349633|365670573|FG008|Overall Study|Withdrawal by Subject|2|||
106002196|NCT02349633|365670574|FG009|Overall Study|Withdrawal by Subject|1|||
106002197|NCT02349633|365670575|FG010|Overall Study|Withdrawal by Subject|0|||
106002198|NCT02349633|365670576|FG011|Overall Study|Withdrawal by Subject|0|||
106002199|NCT02349633|365670577|FG012|Overall Study|Withdrawal by Subject|0|||
106002200|NCT02349633|365670578|FG013|Overall Study|Withdrawal by Subject|0|||
106002201|NCT02349633|365670565|FG000|Overall Study|Withdrawal of informed consent|0|||
106002202|NCT02349633|365670566|FG001|Overall Study|Withdrawal of informed consent|0|||
106002203|NCT02349633|365670567|FG002|Overall Study|Withdrawal of informed consent|0|||
106002204|NCT02349633|365670568|FG003|Overall Study|Withdrawal of informed consent|1|||
106002205|NCT02349633|365670569|FG004|Overall Study|Withdrawal of informed consent|1|||
106002206|NCT02349633|365670570|FG005|Overall Study|Withdrawal of informed consent|0|||
106002207|NCT02349633|365670571|FG006|Overall Study|Withdrawal of informed consent|0|||
106002208|NCT02349633|365670572|FG007|Overall Study|Withdrawal of informed consent|3|||
106002209|NCT02349633|365670573|FG008|Overall Study|Withdrawal of informed consent|0|||
106002210|NCT02349633|365670574|FG009|Overall Study|Withdrawal of informed consent|0|||
106002211|NCT02349633|365670575|FG010|Overall Study|Withdrawal of informed consent|0|||
106002212|NCT02349633|365670576|FG011|Overall Study|Withdrawal of informed consent|0|||
106002213|NCT02349633|365670577|FG012|Overall Study|Withdrawal of informed consent|0|||
106002214|NCT02349633|365670578|FG013|Overall Study|Withdrawal of informed consent|0|||
106002215|NCT02349633|365670565|FG000|Overall Study|Transition to compassionate use|0|||
106002216|NCT02349633|365670566|FG001|Overall Study|Transition to compassionate use|0|||
106002217|NCT02349633|365670567|FG002|Overall Study|Transition to compassionate use|0|||
106002218|NCT02349633|365670568|FG003|Overall Study|Transition to compassionate use|0|||
106002219|NCT02349633|365670569|FG004|Overall Study|Transition to compassionate use|1|||
106002220|NCT02349633|365670570|FG005|Overall Study|Transition to compassionate use|0|||
106002221|NCT02349633|365670571|FG006|Overall Study|Transition to compassionate use|0|||
106002222|NCT02349633|365670572|FG007|Overall Study|Transition to compassionate use|3|||
106002223|NCT02349633|365670573|FG008|Overall Study|Transition to compassionate use|0|||
106002224|NCT02349633|365670574|FG009|Overall Study|Transition to compassionate use|1|||
106002225|NCT02349633|365670575|FG010|Overall Study|Transition to compassionate use|0|||
106002226|NCT02349633|365670576|FG011|Overall Study|Transition to compassionate use|0|||
106002227|NCT02349633|365670577|FG012|Overall Study|Transition to compassionate use|0|||
106002228|NCT02349633|365670578|FG013|Overall Study|Transition to compassionate use|0|||
106002229|NCT02349633|365670565|FG000|Overall Study|Early termination of survival follow-up|0|||
106002230|NCT02349633|365670566|FG001|Overall Study|Early termination of survival follow-up|0|||
106002231|NCT02349633|365670567|FG002|Overall Study|Early termination of survival follow-up|0|||
106002232|NCT02349633|365670568|FG003|Overall Study|Early termination of survival follow-up|0|||
106002233|NCT02349633|365670569|FG004|Overall Study|Early termination of survival follow-up|0|||
106002234|NCT02349633|365670570|FG005|Overall Study|Early termination of survival follow-up|0|||
106002235|NCT02349633|365670571|FG006|Overall Study|Early termination of survival follow-up|0|||
106002236|NCT02349633|365670572|FG007|Overall Study|Early termination of survival follow-up|4|||
106002237|NCT02349633|365670573|FG008|Overall Study|Early termination of survival follow-up|0|||
106002238|NCT02349633|365670574|FG009|Overall Study|Early termination of survival follow-up|0|||
106002239|NCT02349633|365670575|FG010|Overall Study|Early termination of survival follow-up|0|||
106002240|NCT02349633|365670576|FG011|Overall Study|Early termination of survival follow-up|0|||
106002241|NCT02349633|365670577|FG012|Overall Study|Early termination of survival follow-up|0|||
106002242|NCT02349633|365670578|FG013|Overall Study|Early termination of survival follow-up|0|||
106002243|NCT02349633|365670565|FG000|Overall Study|Termination by sponsor|0|||
106002244|NCT02349633|365670566|FG001|Overall Study|Termination by sponsor|0|||
106002245|NCT02349633|365670567|FG002|Overall Study|Termination by sponsor|0|||
106002246|NCT02349633|365670568|FG003|Overall Study|Termination by sponsor|0|||
106002247|NCT02349633|365670569|FG004|Overall Study|Termination by sponsor|0|||
106002248|NCT02349633|365670570|FG005|Overall Study|Termination by sponsor|0|||
106002249|NCT02349633|365670571|FG006|Overall Study|Termination by sponsor|0|||
106002250|NCT02349633|365670572|FG007|Overall Study|Termination by sponsor|1|||
106002251|NCT02349633|365670573|FG008|Overall Study|Termination by sponsor|0|||
106002252|NCT02349633|365670574|FG009|Overall Study|Termination by sponsor|2|||
106002253|NCT02349633|365670575|FG010|Overall Study|Termination by sponsor|0|||
106002254|NCT02349633|365670576|FG011|Overall Study|Termination by sponsor|0|||
106002255|NCT02349633|365670577|FG012|Overall Study|Termination by sponsor|0|||
105786638|NCT00463385|364872864|FG000|Overall Study|Missing|2|||
106002256|NCT02349633|365670578|FG013|Overall Study|Termination by sponsor|0|||
106002257|NCT02349633|365670565|FG000|Overall Study|Other|0|||
105786639|NCT00463385|364872865|FG001|Overall Study|Missing|0|||
106002258|NCT02349633|365670566|FG001|Overall Study|Other|0|||
106002259|NCT02349633|365670567|FG002|Overall Study|Other|0|||
106002260|NCT02349633|365670568|FG003|Overall Study|Other|0|||
106002261|NCT02349633|365670569|FG004|Overall Study|Other|0|||
106002262|NCT02349633|365670570|FG005|Overall Study|Other|0|||
106002263|NCT02349633|365670571|FG006|Overall Study|Other|0|||
106002264|NCT02349633|365670572|FG007|Overall Study|Other|2|||
106002265|NCT02349633|365670573|FG008|Overall Study|Other|0|||
106002266|NCT02349633|365670574|FG009|Overall Study|Other|0|||
106002267|NCT02349633|365670575|FG010|Overall Study|Other|0|||
106002268|NCT02349633|365670576|FG011|Overall Study|Other|0|||
106002269|NCT02349633|365670577|FG012|Overall Study|Other|0|||
106002270|NCT02349633|365670578|FG013|Overall Study|Other|0|||
106002271|NCT00981149|365670580|FG000|Overall Study|Lost to Follow-up|1|||
106002272|NCT00981149|365670581|FG001|Overall Study|Lost to Follow-up|2|||
106002273|NCT00981149|365670580|FG000|Overall Study|Withdrawal by Subject|1|||
106002274|NCT00981149|365670581|FG001|Overall Study|Withdrawal by Subject|1|||
106002275|NCT02648204|365670582|FG000|Overall Study|Withdrawal by Subject|12|||
106002276|NCT02648204|365670583|FG001|Overall Study|Withdrawal by Subject|8|||
106002277|NCT02648204|365670584|FG002|Overall Study|Withdrawal by Subject|2|||
106002278|NCT02648204|365670585|FG003|Overall Study|Withdrawal by Subject|6|||
106002279|NCT02648204|365670582|FG000|Overall Study|Lost to Follow-up|5|||
106002280|NCT02648204|365670583|FG001|Overall Study|Lost to Follow-up|8|||
106002281|NCT02648204|365670584|FG002|Overall Study|Lost to Follow-up|4|||
106002282|NCT02648204|365670585|FG003|Overall Study|Lost to Follow-up|6|||
106002283|NCT02648204|365670582|FG000|Overall Study|Missing follow-up information|4|||
106002284|NCT02648204|365670583|FG001|Overall Study|Missing follow-up information|4|||
106002285|NCT02648204|365670584|FG002|Overall Study|Missing follow-up information|4|||
106002286|NCT02648204|365670585|FG003|Overall Study|Missing follow-up information|2|||
106002287|NCT02648204|365670582|FG000|Overall Study|Death|1|||
106002288|NCT02648204|365670583|FG001|Overall Study|Death|1|||
106002289|NCT02648204|365670584|FG002|Overall Study|Death|2|||
106002290|NCT02648204|365670585|FG003|Overall Study|Death|2|||
106002291|NCT02648204|365670582|FG000|Overall Study|Adverse Event|0|||
106002292|NCT02648204|365670583|FG001|Overall Study|Adverse Event|0|||
106002293|NCT02648204|365670584|FG002|Overall Study|Adverse Event|1|||
106002294|NCT02648204|365670585|FG003|Overall Study|Adverse Event|0|||
106002295|NCT02634333|365670586|FG000|Overall Study|Completed out of Window|3|||
106002296|NCT02634333|365670587|FG001|Overall Study|Completed out of Window|2|||
106002297|NCT02634333|365670586|FG000|Overall Study|Missed Visit|5|||
106002298|NCT02634333|365670587|FG001|Overall Study|Missed Visit|2|||
106002299|NCT02634333|365670586|FG000|Overall Study|Lost to Follow-up|12|||
106002300|NCT02634333|365670587|FG001|Overall Study|Lost to Follow-up|7|||
106002301|NCT02634333|365670586|FG000|Overall Study|Withdrawal by Subject|9|||
106002302|NCT02634333|365670587|FG001|Overall Study|Withdrawal by Subject|13|||
106002303|NCT02634333|365670586|FG000|Overall Study|Death|11|||
106002304|NCT02634333|365670587|FG001|Overall Study|Death|8|||
106002305|NCT01960140|365670588|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
106002306|NCT00231777|365670589|FG000|Overall Study|Lost to Follow-up|3|||
106002307|NCT00231777|365670590|FG001|Overall Study|Lost to Follow-up|0|||
106002308|NCT00231777|365670589|FG000|Overall Study|Other|3|||
106002309|NCT00231777|365670590|FG001|Overall Study|Other|2|||
106002310|NCT04486235|365670592|FG000|Overall Study|Pregnancy|1|||
106002311|NCT04486235|365670593|FG001|Overall Study|Pregnancy|0|||
106002312|NCT04486235|365670592|FG000|Overall Study|Lost to Follow-up|1|||
106002313|NCT04486235|365670593|FG001|Overall Study|Lost to Follow-up|0|||
106002314|NCT00626275|365670594|FG000|Part A - Treatment Period 1|Adverse Event|1|||
106002315|NCT00626275|365670595|FG001|Part A - Treatment Period 1|Adverse Event|0|||
106002316|NCT00626275|365670596|FG002|Part A - Treatment Period 1|Adverse Event|0|||
106002317|NCT00626275|365670597|FG003|Part A - Treatment Period 1|Adverse Event|0|||
106002318|NCT00626275|365670598|FG004|Part A - Treatment Period 1|Adverse Event|0|||
105687755|NCT01138007|364520546|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
106002319|NCT00626275|365670599|FG005|Part A - Treatment Period 1|Adverse Event|0|||
106002320|NCT00626275|365670600|FG006|Part A - Treatment Period 1|Adverse Event|0|||
106002321|NCT00626275|365670601|FG007|Part A - Treatment Period 1|Adverse Event|0|||
106002322|NCT00626275|365670594|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
106002323|NCT00626275|365670595|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
106002324|NCT00626275|365670596|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
106002325|NCT00626275|365670597|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
106002326|NCT00626275|365670598|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
105687756|NCT01138007|364520547|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
105687757|NCT01138007|364520545|FG000|Overall Study|Lost to Follow-up|3|||
106002327|NCT00626275|365670599|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
106002328|NCT00626275|365670600|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
106002329|NCT00626275|365670601|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
106002330|NCT00626275|365670594|FG000|Part B|Lost to Follow-up|0|||
106002331|NCT00626275|365670595|FG001|Part B|Lost to Follow-up|0|||
106002332|NCT00626275|365670596|FG002|Part B|Lost to Follow-up|0|||
106002333|NCT00626275|365670597|FG003|Part B|Lost to Follow-up|0|||
106002334|NCT00626275|365670598|FG004|Part B|Lost to Follow-up|0|||
106002335|NCT00626275|365670599|FG005|Part B|Lost to Follow-up|0|||
106002336|NCT00626275|365670600|FG006|Part B|Lost to Follow-up|1|||
106002337|NCT00626275|365670601|FG007|Part B|Lost to Follow-up|0|||
106002338|NCT00626275|365670594|FG000|Part B|Withdrawal by Subject|0|||
106002339|NCT00626275|365670595|FG001|Part B|Withdrawal by Subject|0|||
106002340|NCT00626275|365670596|FG002|Part B|Withdrawal by Subject|0|||
106002341|NCT00626275|365670597|FG003|Part B|Withdrawal by Subject|0|||
106002342|NCT00626275|365670598|FG004|Part B|Withdrawal by Subject|0|||
106002343|NCT00626275|365670599|FG005|Part B|Withdrawal by Subject|0|||
106002344|NCT00626275|365670600|FG006|Part B|Withdrawal by Subject|0|||
106002345|NCT00626275|365670601|FG007|Part B|Withdrawal by Subject|1|||
106002346|NCT04590014|365670602|FG000|Overall Study|Withdrawal by Subject|1|||
106002347|NCT04590014|365670603|FG001|Overall Study|Withdrawal by Subject|0|||
106002348|NCT03546621|365670604|FG000|Overall Study|Withdrawal by Subject|0|||
106002349|NCT03546621|365670605|FG001|Overall Study|Withdrawal by Subject|1|||
106002350|NCT03546621|365670606|FG002|Overall Study|Withdrawal by Subject|2|||
106002351|NCT03546621|365670607|FG003|Overall Study|Withdrawal by Subject|1|||
106002352|NCT03546621|365670604|FG000|Overall Study|Lost to Follow-up|0|||
106002353|NCT03546621|365670605|FG001|Overall Study|Lost to Follow-up|1|||
106002354|NCT03546621|365670606|FG002|Overall Study|Lost to Follow-up|0|||
106002355|NCT03546621|365670607|FG003|Overall Study|Lost to Follow-up|0|||
106002356|NCT03546621|365670604|FG000|Overall Study|Adverse Event|0|||
106002357|NCT03546621|365670605|FG001|Overall Study|Adverse Event|1|||
106002358|NCT03546621|365670606|FG002|Overall Study|Adverse Event|0|||
106002359|NCT03546621|365670607|FG003|Overall Study|Adverse Event|1|||
106002360|NCT03546621|365670604|FG000|Overall Study|Progressive disease|0|||
106002361|NCT03546621|365670605|FG001|Overall Study|Progressive disease|0|||
106002362|NCT03546621|365670606|FG002|Overall Study|Progressive disease|0|||
106002363|NCT03546621|365670607|FG003|Overall Study|Progressive disease|1|||
106002364|NCT00377520|365670609|FG000|Overall Study|Ineligible (Prior radiation)|1|||
106002365|NCT00614380|365670614|FG000|Overall Study|Adverse Event|14|||
106002366|NCT00614380|365670615|FG001|Overall Study|Adverse Event|4|||
106002367|NCT00614380|365670616|FG002|Overall Study|Adverse Event|0|||
106002368|NCT00614380|365670617|FG003|Overall Study|Adverse Event|0|||
106002369|NCT00614380|365670614|FG000|Overall Study|Lost to Follow-up|6|||
106002370|NCT00614380|365670615|FG001|Overall Study|Lost to Follow-up|1|||
106002371|NCT00614380|365670616|FG002|Overall Study|Lost to Follow-up|0|||
106002372|NCT00614380|365670617|FG003|Overall Study|Lost to Follow-up|0|||
106002373|NCT00614380|365670614|FG000|Overall Study|Non compliant with the protocol|12|||
106002374|NCT00614380|365670615|FG001|Overall Study|Non compliant with the protocol|2|||
106002375|NCT00614380|365670616|FG002|Overall Study|Non compliant with the protocol|1|||
106002376|NCT00614380|365670617|FG003|Overall Study|Non compliant with the protocol|2|||
106002377|NCT00614380|365670614|FG000|Overall Study|Consent withdrawn|3|||
106002378|NCT00614380|365670615|FG001|Overall Study|Consent withdrawn|1|||
106002379|NCT00614380|365670616|FG002|Overall Study|Consent withdrawn|0|||
106002380|NCT00614380|365670617|FG003|Overall Study|Consent withdrawn|0|||
106002381|NCT01290523|365670622|FG000|Overall Study|Death|3|||
106002382|NCT03071263|365670623|FG000|Overall Study|Adverse Event|1|||
106002383|NCT03071263|365670624|FG001|Overall Study|Adverse Event|3|||
106002384|NCT03071263|365670623|FG000|Overall Study|Withdrawal by Subject|1|||
106002385|NCT03071263|365670624|FG001|Overall Study|Withdrawal by Subject|3|||
106002386|NCT03071263|365670623|FG000|Overall Study|Physician Decision|1|||
106002387|NCT03071263|365670624|FG001|Overall Study|Physician Decision|0|||
106002388|NCT03071263|365670623|FG000|Overall Study|Participant moved to another city|0|||
106002389|NCT03071263|365670624|FG001|Overall Study|Participant moved to another city|1|||
106002390|NCT00525512|365670625|FG000|Double-Blind Phase|Adverse Event|48|||
106002391|NCT00525512|365670626|FG001|Double-Blind Phase|Adverse Event|28|||
106002392|NCT00525512|365670627|FG002|Double-Blind Phase|Adverse Event|0|||
106002393|NCT00525512|365670628|FG003|Double-Blind Phase|Adverse Event|0|||
106002394|NCT00525512|365670625|FG000|Double-Blind Phase|Protocol Violation|3|||
106002395|NCT00525512|365670626|FG001|Double-Blind Phase|Protocol Violation|1|||
106002396|NCT00525512|365670627|FG002|Double-Blind Phase|Protocol Violation|0|||
106002397|NCT00525512|365670628|FG003|Double-Blind Phase|Protocol Violation|0|||
106002398|NCT00525512|365670625|FG000|Double-Blind Phase|Lost to Follow-up|3|||
105687758|NCT01138007|364520546|FG001|Overall Study|Lost to Follow-up|3|||
105687759|NCT01138007|364520547|FG002|Overall Study|Lost to Follow-up|5|||
106002399|NCT00525512|365670626|FG001|Double-Blind Phase|Lost to Follow-up|7|||
106002400|NCT00525512|365670627|FG002|Double-Blind Phase|Lost to Follow-up|0|||
106002401|NCT00525512|365670628|FG003|Double-Blind Phase|Lost to Follow-up|0|||
106002402|NCT00525512|365670625|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
106002403|NCT00525512|365670626|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
106002404|NCT00525512|365670627|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
106002405|NCT00525512|365670628|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
106002406|NCT00525512|365670625|FG000|Double-Blind Phase|Lack of Efficacy|13|||
106002407|NCT00525512|365670626|FG001|Double-Blind Phase|Lack of Efficacy|5|||
106002408|NCT00525512|365670627|FG002|Double-Blind Phase|Lack of Efficacy|0|||
106002409|NCT00525512|365670628|FG003|Double-Blind Phase|Lack of Efficacy|0|||
106002410|NCT00525512|365670625|FG000|Double-Blind Phase|Other reason (not specified)|12|||
106002411|NCT00525512|365670626|FG001|Double-Blind Phase|Other reason (not specified)|13|||
106002412|NCT00525512|365670627|FG002|Double-Blind Phase|Other reason (not specified)|0|||
106002413|NCT00525512|365670628|FG003|Double-Blind Phase|Other reason (not specified)|0|||
106002414|NCT00525512|365670625|FG000|Open-Label Phase|Adverse Event|0|||
106002415|NCT00525512|365670626|FG001|Open-Label Phase|Adverse Event|0|||
106002416|NCT00525512|365670627|FG002|Open-Label Phase|Adverse Event|1|||
106002417|NCT00525512|365670628|FG003|Open-Label Phase|Adverse Event|0|||
106002418|NCT00525512|365670625|FG000|Open-Label Phase|Lost to Follow-up|0|||
106002419|NCT00525512|365670626|FG001|Open-Label Phase|Lost to Follow-up|0|||
106002420|NCT00525512|365670627|FG002|Open-Label Phase|Lost to Follow-up|1|||
106002421|NCT00525512|365670628|FG003|Open-Label Phase|Lost to Follow-up|0|||
106002422|NCT00525512|365670625|FG000|Open-Label Phase|Other reason (not specified)|0|||
106002423|NCT00525512|365670626|FG001|Open-Label Phase|Other reason (not specified)|0|||
106002424|NCT00525512|365670627|FG002|Open-Label Phase|Other reason (not specified)|4|||
106002425|NCT00525512|365670628|FG003|Open-Label Phase|Other reason (not specified)|5|||
106002426|NCT00510835|365670629|FG000|Overall Study|Withdrawal by Subject|6|||
106002427|NCT00510835|365670630|FG001|Overall Study|Withdrawal by Subject|2|||
106002428|NCT00510835|365670631|FG002|Overall Study|Withdrawal by Subject|2|||
106002429|NCT00647296|365670632|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
106002430|NCT00647296|365670633|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
106002431|NCT00647296|365670634|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
106002432|NCT00647296|365670635|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
106002433|NCT00647296|365670632|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
106002434|NCT00647296|365670633|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
106002435|NCT00647296|365670634|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
106002436|NCT00647296|365670635|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
106002437|NCT00647296|365670632|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
106002438|NCT00647296|365670633|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
106002439|NCT00647296|365670634|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
106002440|NCT00647296|365670635|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
106002441|NCT00647296|365670632|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
106002442|NCT00647296|365670633|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
106002443|NCT00647296|365670634|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
106002444|NCT00647296|365670635|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
106002445|NCT00647296|365670632|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
106002446|NCT00647296|365670633|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
106002447|NCT00647296|365670634|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
106002448|NCT00647296|365670635|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
106002449|NCT00647296|365670632|FG000|Part 2: 4-week Placebo Washout|Death|3|||
106002450|NCT00647296|365670633|FG001|Part 2: 4-week Placebo Washout|Death|0|||
106002451|NCT00647296|365670634|FG002|Part 2: 4-week Placebo Washout|Death|0|||
106002452|NCT00647296|365670635|FG003|Part 2: 4-week Placebo Washout|Death|0|||
106002453|NCT00647296|365670632|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
106002454|NCT00647296|365670633|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
106002455|NCT00647296|365670634|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
106002456|NCT00647296|365670635|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
106002457|NCT00647296|365670632|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
106002458|NCT00647296|365670633|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
106002459|NCT00647296|365670634|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
106002460|NCT00647296|365670635|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
106002461|NCT00647296|365670632|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
106002462|NCT00647296|365670633|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
106002463|NCT00647296|365670634|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
106002464|NCT00647296|365670635|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
106002465|NCT00647296|365670632|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
106002466|NCT00647296|365670633|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
106002467|NCT00647296|365670634|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
106002468|NCT00647296|365670635|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
106002469|NCT00647296|365670632|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
106002470|NCT00647296|365670633|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
106002471|NCT00647296|365670634|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
106002472|NCT00647296|365670635|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
106002473|NCT01917747|365670636|FG000|Overall Study|Withdrawal by Subject|1|||
106002474|NCT01917747|365670637|FG001|Overall Study|Withdrawal by Subject|2|||
106002475|NCT01917747|365670636|FG000|Overall Study|Lost to Follow-up|18|||
106002476|NCT01917747|365670637|FG001|Overall Study|Lost to Follow-up|9|||
106002477|NCT00402168|365670638|FG000|Randomized|Lost to Follow-up|1|||
105918682|NCT01441973|365361139|FG000|Overall Study|Participant request to discontinue|1|||
105918683|NCT01441973|365361140|FG001|Overall Study|Participant request to discontinue|1|||
105918684|NCT01441973|365361139|FG000|Overall Study|Poor compliance/noncompliance|0|||
105918685|NCT01441973|365361140|FG001|Overall Study|Poor compliance/noncompliance|1|||
105918686|NCT01441973|365361139|FG000|Overall Study|Administrative reason by sponsor|3|||
105918687|NCT01441973|365361140|FG001|Overall Study|Administrative reason by sponsor|5|||
105918688|NCT01441973|365361139|FG000|Overall Study|Participant withdrew consent|0|||
105918689|NCT01441973|365361140|FG001|Overall Study|Participant withdrew consent|1|||
105918690|NCT03054428|365361141|FG000|Overall Study|Physician Decision|0|||
105918691|NCT03054428|365361142|FG001|Overall Study|Physician Decision|1|||
105918692|NCT03054428|365361143|FG002|Overall Study|Physician Decision|1|||
105918693|NCT03054428|365361141|FG000|Overall Study|Lack of Efficacy|3|||
105918694|NCT03054428|365361142|FG001|Overall Study|Lack of Efficacy|1|||
105918695|NCT03054428|365361143|FG002|Overall Study|Lack of Efficacy|0|||
105918696|NCT03054428|365361141|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
105918697|NCT03054428|365361142|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
105918698|NCT03054428|365361143|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
105918699|NCT03054428|365361141|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
105918700|NCT03054428|365361142|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
105918701|NCT03054428|365361143|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
105918702|NCT03054428|365361141|FG000|Overall Study|Transitioned to OLE study|76|||
105918703|NCT03054428|365361142|FG001|Overall Study|Transitioned to OLE study|76|||
105918704|NCT03054428|365361143|FG002|Overall Study|Transitioned to OLE study|73|||
105918705|NCT03054428|365361141|FG000|Overall Study|Withdrawal by Subject|3|||
105918706|NCT03054428|365361142|FG001|Overall Study|Withdrawal by Subject|2|||
105918707|NCT03054428|365361143|FG002|Overall Study|Withdrawal by Subject|3|||
105918708|NCT03054428|365361141|FG000|Overall Study|Lost to Follow-up|0|||
105918709|NCT03054428|365361142|FG001|Overall Study|Lost to Follow-up|0|||
105918710|NCT03054428|365361143|FG002|Overall Study|Lost to Follow-up|1|||
105918711|NCT04356937|365361144|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
105918712|NCT04356937|365361145|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
105918713|NCT04030598|365361146|FG000|Overall Study|Voluntary Withdrawal|0|||
105918714|NCT04030598|365361147|FG001|Overall Study|Voluntary Withdrawal|1|||
105918715|NCT04030598|365361148|FG002|Overall Study|Voluntary Withdrawal|0|||
105918716|NCT01884597|365361151|FG000|Overall Study|Adverse Event|0|||
105918717|NCT01884597|365361152|FG001|Overall Study|Adverse Event|0|||
105918718|NCT01884597|365361153|FG002|Overall Study|Adverse Event|1|||
105918719|NCT01884597|365361151|FG000|Overall Study|Lack of Efficacy|1|||
105918720|NCT01884597|365361152|FG001|Overall Study|Lack of Efficacy|0|||
105918721|NCT01884597|365361153|FG002|Overall Study|Lack of Efficacy|0|||
105918722|NCT01884597|365361151|FG000|Overall Study|Death|0|||
105918723|NCT01884597|365361152|FG001|Overall Study|Death|1|||
105918724|NCT01884597|365361153|FG002|Overall Study|Death|0|||
105918725|NCT02097823|365361154|FG000|Overall Study|Withdrawal by Subject|1|||
105918726|NCT02097823|365361155|FG001|Overall Study|Withdrawal by Subject|1|||
105918727|NCT02074514|365361157|FG000|Overall Study|Lack of Efficacy|3|||
105918728|NCT02074514|365361158|FG001|Overall Study|Lack of Efficacy|2|||
105918729|NCT02074514|365361157|FG000|Overall Study|Lost to Follow-up|0|||
105918730|NCT02074514|365361158|FG001|Overall Study|Lost to Follow-up|1|||
105918731|NCT02074514|365361157|FG000|Overall Study|Withdrew Consent|0|||
105918732|NCT02074514|365361158|FG001|Overall Study|Withdrew Consent|1|||
105918733|NCT01296412|365361159|FG000|Overall Study|Adverse Event|8|||
105918734|NCT01296412|365361160|FG001|Overall Study|Adverse Event|29|||
105918735|NCT01296412|365361159|FG000|Overall Study|Lack of Efficacy|1|||
105918736|NCT01296412|365361160|FG001|Overall Study|Lack of Efficacy|0|||
105918737|NCT01296412|365361159|FG000|Overall Study|Lost to Follow-up|10|||
105918738|NCT01296412|365361160|FG001|Overall Study|Lost to Follow-up|7|||
105918739|NCT01296412|365361159|FG000|Overall Study|Non-compliance with study drug|1|||
105918740|NCT01296412|365361160|FG001|Overall Study|Non-compliance with study drug|2|||
105918741|NCT01296412|365361159|FG000|Overall Study|Other reason not specified|20|||
105918742|NCT01296412|365361160|FG001|Overall Study|Other reason not specified|15|||
105918743|NCT01296412|365361159|FG000|Overall Study|Physician Decision|1|||
105918744|NCT01296412|365361160|FG001|Overall Study|Physician Decision|3|||
105918745|NCT01296412|365361159|FG000|Overall Study|Pregnancy|0|||
105918746|NCT01296412|365361160|FG001|Overall Study|Pregnancy|1|||
105918747|NCT01296412|365361159|FG000|Overall Study|Withdrawal by Subject|10|||
105918748|NCT01296412|365361160|FG001|Overall Study|Withdrawal by Subject|13|||
105918749|NCT02997163|365363399|FG000|Overall Study|Adverse Event|1|||
105918750|NCT02997163|365363400|FG001|Overall Study|Adverse Event|0|||
105687760|NCT01138007|364520545|FG000|Overall Study|Physician Decision|0|||
105687761|NCT01138007|364520546|FG001|Overall Study|Physician Decision|5|||
105918751|NCT02997163|365363401|FG002|Overall Study|Adverse Event|0|||
105918752|NCT02997163|365363402|FG003|Overall Study|Adverse Event|1|||
105918753|NCT02371616|365363403|FG000|Overall Study|Protocol Violation|2|||
105918754|NCT02371616|365363404|FG001|Overall Study|Protocol Violation|1|||
105918755|NCT02371616|365363403|FG000|Overall Study|Adverse Event|0|||
105918756|NCT02371616|365363404|FG001|Overall Study|Adverse Event|1|||
105918757|NCT02371616|365363403|FG000|Overall Study|Withdrawal of Consent|1|||
105918758|NCT02371616|365363404|FG001|Overall Study|Withdrawal of Consent|0|||
105918759|NCT02371616|365363403|FG000|Overall Study|Other (Not specified)|1|||
105918760|NCT02371616|365363404|FG001|Overall Study|Other (Not specified)|5|||
105918761|NCT01855958|365363408|FG000|Overall Study|Withdrawal by Subject|1|||
105918762|NCT01855958|365363409|FG001|Overall Study|Withdrawal by Subject|0|||
105918763|NCT00266708|365363413|FG000|Overall Study|No renal function|1|||
105918764|NCT00266708|365363414|FG001|Overall Study|No renal function|1|||
105918765|NCT00266708|365363413|FG000|Overall Study|Refused biopsy|3|||
105918766|NCT00266708|365363414|FG001|Overall Study|Refused biopsy|6|||
105918767|NCT00266708|365363413|FG000|Overall Study|Asthma|0|||
105918768|NCT00266708|365363414|FG001|Overall Study|Asthma|2|||
105918769|NCT01294423|365363415|FG000|Overall Study|Adverse Event|1|||
105918770|NCT01294423|365363416|FG001|Overall Study|Adverse Event|2|||
105918771|NCT01294423|365363417|FG002|Overall Study|Adverse Event|3|||
105918772|NCT01294423|365363415|FG000|Overall Study|Withdrawal by Subject|1|||
105918773|NCT01294423|365363416|FG001|Overall Study|Withdrawal by Subject|2|||
105918774|NCT01294423|365363417|FG002|Overall Study|Withdrawal by Subject|2|||
105918775|NCT01294423|365363415|FG000|Overall Study|subject no longer meets study criteria|2|||
105918776|NCT01294423|365363416|FG001|Overall Study|subject no longer meets study criteria|5|||
105918777|NCT01294423|365363417|FG002|Overall Study|subject no longer meets study criteria|2|||
105918778|NCT01294423|365363415|FG000|Overall Study|poor/non-compliance|1|||
105918779|NCT01294423|365363416|FG001|Overall Study|poor/non-compliance|0|||
105918780|NCT01294423|365363417|FG002|Overall Study|poor/non-compliance|1|||
105918781|NCT00641056|365363418|FG000|Overall Study|Adverse Event|12|||
105918782|NCT00641056|365363419|FG001|Overall Study|Adverse Event|2|||
105918783|NCT00641056|365363418|FG000|Overall Study|Lost to Follow-up|2|||
105918784|NCT00641056|365363419|FG001|Overall Study|Lost to Follow-up|1|||
105918785|NCT00641056|365363418|FG000|Overall Study|Physician Decision|3|||
105918786|NCT00641056|365363419|FG001|Overall Study|Physician Decision|1|||
105918787|NCT00641056|365363418|FG000|Overall Study|Protocol Violation|2|||
105918788|NCT00641056|365363419|FG001|Overall Study|Protocol Violation|0|||
105918789|NCT00641056|365363418|FG000|Overall Study|Entry Criteria Not Met|3|||
105918790|NCT00641056|365363419|FG001|Overall Study|Entry Criteria Not Met|0|||
105918791|NCT00641056|365363418|FG000|Overall Study|Subject Decision|6|||
105918792|NCT00641056|365363419|FG001|Overall Study|Subject Decision|19|||
105918793|NCT00641056|365363418|FG000|Overall Study|Sponsor Decision|1|||
105918794|NCT00641056|365363419|FG001|Overall Study|Sponsor Decision|2|||
105918795|NCT00368251|365363420|FG000|Overall Study|SAE, non-fatal|1|||
105918796|NCT00368251|365363421|FG001|Overall Study|SAE, non-fatal|0|||
105918797|NCT00368251|365363422|FG002|Overall Study|SAE, non-fatal|0|||
105918798|NCT00368251|365363420|FG000|Overall Study|AE, non-serious non-fatal|0|||
105918799|NCT00368251|365363421|FG001|Overall Study|AE, non-serious non-fatal|0|||
105918800|NCT00368251|365363422|FG002|Overall Study|AE, non-serious non-fatal|1|||
105918801|NCT01316614|365363424|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
105918802|NCT01316614|365363424|FG000|Overall Study|Cytology slides not available for review|4|||
105918803|NCT01316614|365363424|FG000|Overall Study|Cystic lesion|5|||
105918804|NCT01316614|365363424|FG000|Overall Study|Inadequate number of passes|2|||
105918805|NCT01316614|365363424|FG000|Overall Study|Medically unstable|1|||
105918806|NCT01863771|365363430|FG000|Induction Phase|Adverse Event|9|||
105918807|NCT01863771|365363431|FG001|Induction Phase|Adverse Event|0|||
105918808|NCT01863771|365363432|FG002|Induction Phase|Adverse Event|0|||
105918809|NCT01863771|365363433|FG003|Induction Phase|Adverse Event|0|||
105918810|NCT01863771|365363430|FG000|Induction Phase|Lack of Efficacy|10|||
105918811|NCT01863771|365363431|FG001|Induction Phase|Lack of Efficacy|0|||
105918812|NCT01863771|365363432|FG002|Induction Phase|Lack of Efficacy|0|||
105918813|NCT01863771|365363433|FG003|Induction Phase|Lack of Efficacy|0|||
105918814|NCT01863771|365363430|FG000|Induction Phase|Withdrawal by Subject|2|||
105918815|NCT01863771|365363431|FG001|Induction Phase|Withdrawal by Subject|0|||
105918816|NCT01863771|365363432|FG002|Induction Phase|Withdrawal by Subject|0|||
105918817|NCT01863771|365363433|FG003|Induction Phase|Withdrawal by Subject|0|||
105918818|NCT01863771|365363430|FG000|Maintenance Phase|Adverse Event|0|||
105918819|NCT01863771|365363431|FG001|Maintenance Phase|Adverse Event|0|||
105918820|NCT01863771|365363432|FG002|Maintenance Phase|Adverse Event|1|||
105918821|NCT01863771|365363433|FG003|Maintenance Phase|Adverse Event|1|||
105918822|NCT01863771|365363430|FG000|Maintenance Phase|Lack of Efficacy|0|||
105918823|NCT01863771|365363431|FG001|Maintenance Phase|Lack of Efficacy|3|||
105918824|NCT01863771|365363432|FG002|Maintenance Phase|Lack of Efficacy|7|||
105918825|NCT01863771|365363433|FG003|Maintenance Phase|Lack of Efficacy|38|||
106002478|NCT00402168|365670639|FG001|Randomized|Lost to Follow-up|0|||
105918826|NCT01863771|365363430|FG000|Maintenance Phase|Physician Decision|0|||
105918827|NCT01863771|365363431|FG001|Maintenance Phase|Physician Decision|0|||
105918828|NCT01863771|365363432|FG002|Maintenance Phase|Physician Decision|2|||
105918829|NCT01863771|365363433|FG003|Maintenance Phase|Physician Decision|1|||
105918830|NCT01863771|365363430|FG000|Maintenance Phase|Pregnancy|0|||
105918831|NCT01863771|365363431|FG001|Maintenance Phase|Pregnancy|1|||
105918832|NCT01863771|365363432|FG002|Maintenance Phase|Pregnancy|0|||
105918833|NCT01863771|365363433|FG003|Maintenance Phase|Pregnancy|0|||
105918834|NCT01863771|365363430|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105918835|NCT01863771|365363431|FG001|Maintenance Phase|Withdrawal by Subject|1|||
105918836|NCT01863771|365363432|FG002|Maintenance Phase|Withdrawal by Subject|2|||
105918837|NCT01863771|365363433|FG003|Maintenance Phase|Withdrawal by Subject|3|||
105918838|NCT03499795|365363434|FG000|Overall Study|Adverse Event|1|||
105918839|NCT03499795|365363434|FG000|Overall Study|Lost to Follow-up|1|||
105918840|NCT02089347|365363440|FG000|Overall Study|Protocol Violation|1|||
105918841|NCT02089347|365363441|FG001|Overall Study|Protocol Violation|0|||
105918842|NCT00083915|365363442|FG000|Overall Study|Death|6|||
105918843|NCT00083915|365363443|FG001|Overall Study|Death|3|||
105918844|NCT00083915|365363442|FG000|Overall Study|Physician Decision|11|||
105918845|NCT00083915|365363443|FG001|Overall Study|Physician Decision|6|||
105918846|NCT00083915|365363442|FG000|Overall Study|Withdrawal by Subject|8|||
105918847|NCT00083915|365363443|FG001|Overall Study|Withdrawal by Subject|3|||
105918848|NCT00083915|365363442|FG000|Overall Study|disease progression|18|||
105918849|NCT00083915|365363443|FG001|Overall Study|disease progression|23|||
105918850|NCT00083915|365363442|FG000|Overall Study|Failure to collect|3|||
105918851|NCT00083915|365363443|FG001|Overall Study|Failure to collect|0|||
105918852|NCT00083915|365363442|FG000|Overall Study|No response|3|||
105918853|NCT00083915|365363443|FG001|Overall Study|No response|1|||
105918854|NCT00083915|365363442|FG000|Overall Study|Insurance issues|1|||
105918855|NCT00083915|365363443|FG001|Overall Study|Insurance issues|1|||
105918856|NCT03176771|365363449|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
105918857|NCT03176771|365363450|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
105918858|NCT03176771|365363451|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
105918859|NCT03176771|365363452|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
105918860|NCT03176771|365363453|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
105918861|NCT03176771|365363449|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
105918862|NCT03176771|365363450|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
105918863|NCT03176771|365363451|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
105918864|NCT03176771|365363452|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
105918865|NCT03176771|365363453|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
105918866|NCT03176771|365363449|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
105918867|NCT03176771|365363450|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
105918868|NCT03176771|365363451|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
105918869|NCT03176771|365363452|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
105918870|NCT03176771|365363453|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
105918871|NCT03176771|365363449|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
105918872|NCT03176771|365363450|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
105918873|NCT03176771|365363451|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
105918874|NCT03176771|365363452|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
105918875|NCT03176771|365363453|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
105918876|NCT03176771|365363449|FG000|Double-Blind Extension Period|Adverse Event|0|||
105918877|NCT03176771|365363450|FG001|Double-Blind Extension Period|Adverse Event|0|||
105918878|NCT03176771|365363451|FG002|Double-Blind Extension Period|Adverse Event|0|||
105918879|NCT03176771|365363452|FG003|Double-Blind Extension Period|Adverse Event|15|||
105918880|NCT03176771|365363453|FG004|Double-Blind Extension Period|Adverse Event|18|||
105918881|NCT03176771|365363449|FG000|Double-Blind Extension Period|Death|0|||
105918882|NCT03176771|365363450|FG001|Double-Blind Extension Period|Death|0|||
105918883|NCT03176771|365363451|FG002|Double-Blind Extension Period|Death|0|||
105918884|NCT03176771|365363452|FG003|Double-Blind Extension Period|Death|3|||
105918885|NCT03176771|365363453|FG004|Double-Blind Extension Period|Death|4|||
105918886|NCT03176771|365363449|FG000|Double-Blind Extension Period|Physician Decision|0|||
105918887|NCT03176771|365363450|FG001|Double-Blind Extension Period|Physician Decision|0|||
105918888|NCT03176771|365363451|FG002|Double-Blind Extension Period|Physician Decision|0|||
105918889|NCT03176771|365363452|FG003|Double-Blind Extension Period|Physician Decision|3|||
105918890|NCT03176771|365363453|FG004|Double-Blind Extension Period|Physician Decision|1|||
105918891|NCT03176771|365363449|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
105918892|NCT03176771|365363450|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
105918893|NCT03176771|365363451|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
105918894|NCT03176771|365363452|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
105918895|NCT03176771|365363453|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
105918896|NCT03530293|365363454|FG000|Pre-randomization|Adverse Event|12|||
105918897|NCT03530293|365363455|FG001|Pre-randomization|Adverse Event|0|||
105918898|NCT03530293|365363456|FG002|Pre-randomization|Adverse Event|0|||
105918899|NCT03530293|365363454|FG000|Pre-randomization|Protocol Violation|2|||
105918900|NCT03530293|365363455|FG001|Pre-randomization|Protocol Violation|0|||
105918901|NCT03530293|365363456|FG002|Pre-randomization|Protocol Violation|0|||
105918902|NCT03530293|365363454|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
105918903|NCT03530293|365363455|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
105918904|NCT03530293|365363456|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
106002479|NCT00402168|365670638|FG000|Randomized|Withdrawal by Subject|0|||
105786640|NCT00463385|364872866|FG002|Overall Study|Missing|0|||
105786641|NCT00463385|364872867|FG003|Overall Study|Missing|2|||
105786642|NCT00463385|364872864|FG000|Overall Study|1 participant received commercial drug|0|||
105786643|NCT00463385|364872865|FG001|Overall Study|1 participant received commercial drug|1|||
105786644|NCT00463385|364872866|FG002|Overall Study|1 participant received commercial drug|0|||
105786645|NCT00463385|364872867|FG003|Overall Study|1 participant received commercial drug|0|||
105786646|NCT00449761|364872868|FG000|Overall Study|Disease progression|12|||
105786647|NCT00449761|364872868|FG000|Overall Study|Death|5|||
105786648|NCT00449761|364872868|FG000|Overall Study|New cancer therapy|1|||
105786649|NCT01422876|364872869|FG000|Week 24|Lost to Follow-up|1|||
105786650|NCT01422876|364872870|FG001|Week 24|Lost to Follow-up|1|||
105786651|NCT01422876|364872871|FG002|Week 24|Lost to Follow-up|2|||
105786652|NCT01422876|364872872|FG003|Week 24|Lost to Follow-up|4|||
105786653|NCT01422876|364872873|FG004|Week 24|Lost to Follow-up|2|||
105786654|NCT01422876|364872874|FG005|Week 24|Lost to Follow-up|0|||
105786655|NCT01422876|364872875|FG006|Week 24|Lost to Follow-up|1|||
105786656|NCT01422876|364872876|FG007|Week 24|Lost to Follow-up|3|||
105786657|NCT01422876|364872877|FG008|Week 24|Lost to Follow-up|3|||
105786658|NCT01422876|364872878|FG009|Week 24|Lost to Follow-up|4|||
105786659|NCT01422876|364872869|FG000|Week 24|Consent withdrawn|5|||
105786660|NCT01422876|364872870|FG001|Week 24|Consent withdrawn|1|||
105786661|NCT01422876|364872871|FG002|Week 24|Consent withdrawn|3|||
105786662|NCT01422876|364872872|FG003|Week 24|Consent withdrawn|4|||
105786663|NCT01422876|364872873|FG004|Week 24|Consent withdrawn|5|||
105786664|NCT01422876|364872874|FG005|Week 24|Consent withdrawn|6|||
105786665|NCT01422876|364872875|FG006|Week 24|Consent withdrawn|5|||
105786666|NCT01422876|364872876|FG007|Week 24|Consent withdrawn|4|||
105786667|NCT01422876|364872877|FG008|Week 24|Consent withdrawn|3|||
105786668|NCT01422876|364872878|FG009|Week 24|Consent withdrawn|6|||
105786669|NCT01422876|364872869|FG000|Week 24|Death|0|||
105786670|NCT01422876|364872870|FG001|Week 24|Death|1|||
105786671|NCT01422876|364872871|FG002|Week 24|Death|0|||
105786672|NCT01422876|364872872|FG003|Week 24|Death|0|||
105786673|NCT01422876|364872873|FG004|Week 24|Death|0|||
105786674|NCT01422876|364872874|FG005|Week 24|Death|0|||
105786675|NCT01422876|364872875|FG006|Week 24|Death|0|||
105786676|NCT01422876|364872876|FG007|Week 24|Death|0|||
105786677|NCT01422876|364872877|FG008|Week 24|Death|0|||
105786678|NCT01422876|364872878|FG009|Week 24|Death|0|||
105786679|NCT01422876|364872869|FG000|Week 52|Lost to Follow-up|3|||
105786680|NCT01422876|364872870|FG001|Week 52|Lost to Follow-up|5|||
105918905|NCT03530293|365363454|FG000|Pre-randomization|Withdrawal by Subject|5|||
105918906|NCT03530293|365363455|FG001|Pre-randomization|Withdrawal by Subject|0|||
105918907|NCT03530293|365363456|FG002|Pre-randomization|Withdrawal by Subject|0|||
105918908|NCT03530293|365363454|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
105918909|NCT03530293|365363455|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
105918910|NCT03530293|365363456|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
105918911|NCT03530293|365363454|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
105918912|NCT03530293|365363455|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
105918913|NCT03530293|365363456|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
105918914|NCT03530293|365363454|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
105918915|NCT03530293|365363455|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
105918916|NCT03530293|365363456|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
105918917|NCT03530293|365363454|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
105918918|NCT03530293|365363455|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
105918919|NCT03530293|365363456|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
105918920|NCT03530293|365363454|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
105918921|NCT03530293|365363455|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
105786681|NCT01422876|364872871|FG002|Week 52|Lost to Follow-up|7|||
105786682|NCT01422876|364872872|FG003|Week 52|Lost to Follow-up|5|||
105786683|NCT01422876|364872873|FG004|Week 52|Lost to Follow-up|8|||
105786684|NCT01422876|364872874|FG005|Week 52|Lost to Follow-up|5|||
105786685|NCT01422876|364872875|FG006|Week 52|Lost to Follow-up|5|||
105786686|NCT01422876|364872876|FG007|Week 52|Lost to Follow-up|8|||
105786687|NCT01422876|364872877|FG008|Week 52|Lost to Follow-up|7|||
105786688|NCT01422876|364872878|FG009|Week 52|Lost to Follow-up|8|||
105786689|NCT01422876|364872869|FG000|Week 52|Consent withdrawn|9|||
105786690|NCT01422876|364872870|FG001|Week 52|Consent withdrawn|4|||
105786691|NCT01422876|364872871|FG002|Week 52|Consent withdrawn|6|||
105786692|NCT01422876|364872872|FG003|Week 52|Consent withdrawn|12|||
105786693|NCT01422876|364872873|FG004|Week 52|Consent withdrawn|7|||
105786694|NCT01422876|364872874|FG005|Week 52|Consent withdrawn|12|||
105786695|NCT01422876|364872875|FG006|Week 52|Consent withdrawn|10|||
105786696|NCT01422876|364872876|FG007|Week 52|Consent withdrawn|12|||
105786697|NCT01422876|364872877|FG008|Week 52|Consent withdrawn|13|||
105786698|NCT01422876|364872878|FG009|Week 52|Consent withdrawn|9|||
105786699|NCT01422876|364872869|FG000|Week 52|Death|0|||
105786700|NCT01422876|364872870|FG001|Week 52|Death|1|||
105786701|NCT01422876|364872871|FG002|Week 52|Death|0|||
105786702|NCT01422876|364872872|FG003|Week 52|Death|1|||
105786703|NCT01422876|364872873|FG004|Week 52|Death|0|||
105687762|NCT01138007|364520547|FG002|Overall Study|Physician Decision|3|||
105687763|NCT01138007|364520545|FG000|Overall Study|Withdrawal by Subject|5|||
105687764|NCT01138007|364520546|FG001|Overall Study|Withdrawal by Subject|6|||
105687765|NCT01138007|364520547|FG002|Overall Study|Withdrawal by Subject|15|||
105687766|NCT00744523|364520548|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
105687767|NCT00744523|364520549|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
105687768|NCT01139021|364520552|FG000|Overall Study|Adverse Event|0|||
105687769|NCT01139021|364520553|FG001|Overall Study|Adverse Event|0|||
105687770|NCT01139021|364520554|FG002|Overall Study|Adverse Event|0|||
105687771|NCT01139021|364520555|FG003|Overall Study|Adverse Event|0|||
105687772|NCT01139021|364520556|FG004|Overall Study|Adverse Event|1|||
105786704|NCT01422876|364872874|FG005|Week 52|Death|0|||
105786705|NCT01422876|364872875|FG006|Week 52|Death|1|||
105786706|NCT01422876|364872876|FG007|Week 52|Death|3|||
105786707|NCT01422876|364872877|FG008|Week 52|Death|1|||
105786708|NCT01422876|364872878|FG009|Week 52|Death|0|||
106002480|NCT00402168|365670639|FG001|Randomized|Withdrawal by Subject|1|||
106130363|NCT00372567|366134208|FG001|Phase 3 Study|Protocol Violation|0|||
105687773|NCT01139021|364520557|FG005|Overall Study|Adverse Event|0|||
105687774|NCT01139021|364520552|FG000|Overall Study|Lost to Follow-up|0|||
105687775|NCT01139021|364520553|FG001|Overall Study|Lost to Follow-up|0|||
105687776|NCT01139021|364520554|FG002|Overall Study|Lost to Follow-up|0|||
105786709|NCT00761761|364872879|FG000|Overall Study|Lost to Follow-up|3|||
105786710|NCT00761761|364872880|FG001|Overall Study|Lost to Follow-up|1|||
106002481|NCT00402168|365670638|FG000|Treatment (up to 12 Months)|Death|0|||
106002482|NCT00402168|365670639|FG001|Treatment (up to 12 Months)|Death|1|||
106002483|NCT00402168|365670638|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
106002484|NCT00402168|365670639|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
106002485|NCT00402168|365670638|FG000|Treatment (up to 12 Months)|non-specified|0|||
106002486|NCT00402168|365670639|FG001|Treatment (up to 12 Months)|non-specified|1|||
106002487|NCT00402168|365670638|FG000|Long Term (LT)|Adverse Event|1|||
106002488|NCT00402168|365670639|FG001|Long Term (LT)|Adverse Event|5|||
106002489|NCT00402168|365670638|FG000|Long Term (LT)|Withdrawal by Subject|4|||
106002490|NCT00402168|365670639|FG001|Long Term (LT)|Withdrawal by Subject|7|||
106002491|NCT00402168|365670638|FG000|Long Term (LT)|Pregnancy|0|||
106002492|NCT00402168|365670639|FG001|Long Term (LT)|Pregnancy|1|||
106002493|NCT00402168|365670638|FG000|Long Term (LT)|Lost to Follow-up|1|||
106002494|NCT00402168|365670639|FG001|Long Term (LT)|Lost to Follow-up|0|||
106002495|NCT00402168|365670638|FG000|Long Term (LT)|Death|4|||
106002496|NCT00402168|365670639|FG001|Long Term (LT)|Death|0|||
106002497|NCT00402168|365670638|FG000|Long Term (LT)|Lack of Efficacy|0|||
106002498|NCT00402168|365670639|FG001|Long Term (LT)|Lack of Efficacy|2|||
106002499|NCT00402168|365670638|FG000|Long Term (LT)|non-specified|1|||
106002500|NCT00402168|365670639|FG001|Long Term (LT)|non-specified|2|||
106002501|NCT00402168|365670638|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
106002502|NCT00402168|365670639|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
106002503|NCT00402168|365670638|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
106002504|NCT00402168|365670639|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
106002505|NCT02922725|365670640|FG000|Overall Study|Withdrawal by Subject|1|||
106002506|NCT02922725|365670641|FG001|Overall Study|Withdrawal by Subject|0|||
106002507|NCT02922725|365670642|FG002|Overall Study|Withdrawal by Subject|0|||
106130364|NCT00372567|366134209|FG002|Phase 3 Study|Protocol Violation|1|||
106130365|NCT00372567|366134207|FG000|Phase 3 Study|Objective progression or relapse|10|||
106130366|NCT00372567|366134208|FG001|Phase 3 Study|Objective progression or relapse|13|||
106002508|NCT01300234|365670643|FG000|Overall Study|Adverse Event|1|||
106002509|NCT01300234|365670644|FG001|Overall Study|Adverse Event|1|||
106002510|NCT01300234|365670643|FG000|Overall Study|Protocol Violation|2|||
106002511|NCT01300234|365670644|FG001|Overall Study|Protocol Violation|3|||
106002512|NCT01300234|365670643|FG000|Overall Study|Withdrawal by Subject|5|||
106130367|NCT00372567|366134209|FG002|Phase 3 Study|Objective progression or relapse|4|||
105687777|NCT01139021|364520555|FG003|Overall Study|Lost to Follow-up|0|||
105687778|NCT01139021|364520556|FG004|Overall Study|Lost to Follow-up|2|||
105687779|NCT01139021|364520557|FG005|Overall Study|Lost to Follow-up|0|||
105786711|NCT00761761|364872879|FG000|Overall Study|Withdrawal by Subject|3|||
105786712|NCT00761761|364872880|FG001|Overall Study|Withdrawal by Subject|0|||
105786713|NCT00447265|364872884|FG000|Overall Study|Physician Decision|1|||
105687780|NCT01139021|364520552|FG000|Overall Study|Protocol Violation|1|||
105687781|NCT01139021|364520553|FG001|Overall Study|Protocol Violation|0|||
105786714|NCT00447265|364872885|FG001|Overall Study|Physician Decision|0|||
105786715|NCT05064436|364872886|FG000|Overall Study|Other Reasons|1|||
105687782|NCT01139021|364520554|FG002|Overall Study|Protocol Violation|0|||
105786716|NCT05064436|364872887|FG001|Overall Study|Other Reasons|0|||
106002513|NCT01300234|365670644|FG001|Overall Study|Withdrawal by Subject|9|||
106002514|NCT01300234|365670643|FG000|Overall Study|Lost to Follow-up|14|||
106002515|NCT01300234|365670644|FG001|Overall Study|Lost to Follow-up|12|||
106002516|NCT01300234|365670643|FG000|Overall Study|Pregnancy|2|||
106002517|NCT01300234|365670644|FG001|Overall Study|Pregnancy|1|||
106002518|NCT01300234|365670643|FG000|Overall Study|Participant reached stopping critera|2|||
106130368|NCT00372567|366134207|FG000|Phase 3 Study|Global deterioration of health status|0|||
106130369|NCT00372567|366134208|FG001|Phase 3 Study|Global deterioration of health status|1|||
106130370|NCT00372567|366134209|FG002|Phase 3 Study|Global deterioration of health status|0|||
106130371|NCT00372567|366134207|FG000|Phase 3 Study|Other|2|||
106130372|NCT00372567|366134208|FG001|Phase 3 Study|Other|2|||
106130373|NCT00372567|366134209|FG002|Phase 3 Study|Other|1|||
106130374|NCT00372567|366134207|FG000|Phase 3 Study|study terminated by sponsor|13|||
106130375|NCT00372567|366134208|FG001|Phase 3 Study|study terminated by sponsor|8|||
106130376|NCT00372567|366134209|FG002|Phase 3 Study|study terminated by sponsor|5|||
106130377|NCT04796935|366134212|FG000|Overall Study|Withdrawal by Subject|0|||
106130378|NCT04796935|366134213|FG001|Overall Study|Withdrawal by Subject|1|||
106130379|NCT04796935|366134212|FG000|Overall Study|Physician Decision|0|||
106130380|NCT04796935|366134213|FG001|Overall Study|Physician Decision|1|||
106130381|NCT04796935|366134212|FG000|Overall Study|Device not available|1|||
106130382|NCT04796935|366134213|FG001|Overall Study|Device not available|0|||
106130383|NCT04796935|366134212|FG000|Overall Study|Trained provider not available|1|||
106130384|NCT04796935|366134213|FG001|Overall Study|Trained provider not available|0|||
106130385|NCT00410384|366134214|FG000|Overall Study|Withdrawal by Subject|28|||
106130386|NCT00410384|366134215|FG001|Overall Study|Withdrawal by Subject|17|||
106130387|NCT00410384|366134216|FG002|Overall Study|Withdrawal by Subject|20|||
106130388|NCT00410384|366134214|FG000|Overall Study|Adverse Event|23|||
106130389|NCT00410384|366134215|FG001|Overall Study|Adverse Event|18|||
106130390|NCT00410384|366134216|FG002|Overall Study|Adverse Event|23|||
106130391|NCT00410384|366134214|FG000|Overall Study|Lack of Efficacy|20|||
105687783|NCT01139021|364520555|FG003|Overall Study|Protocol Violation|0|||
105687784|NCT01139021|364520556|FG004|Overall Study|Protocol Violation|2|||
105687785|NCT01139021|364520557|FG005|Overall Study|Protocol Violation|0|||
105687786|NCT01139021|364520552|FG000|Overall Study|Withdrawal by Subject|0|||
105687787|NCT01139021|364520553|FG001|Overall Study|Withdrawal by Subject|0|||
105687788|NCT01139021|364520554|FG002|Overall Study|Withdrawal by Subject|0|||
105687789|NCT01139021|364520555|FG003|Overall Study|Withdrawal by Subject|1|||
105687790|NCT01139021|364520556|FG004|Overall Study|Withdrawal by Subject|4|||
105687791|NCT01139021|364520557|FG005|Overall Study|Withdrawal by Subject|0|||
105687792|NCT04975438|364520558|FG000|Overall Study|Lost to Follow-up|1|||
105687793|NCT04975438|364520559|FG001|Overall Study|Lost to Follow-up|0|||
105687794|NCT04975438|364520560|FG002|Overall Study|Lost to Follow-up|1|||
105687795|NCT04975438|364520561|FG003|Overall Study|Lost to Follow-up|0|||
105687796|NCT04975438|364520558|FG000|Overall Study|Withdrawal by Subject|1|||
105687797|NCT04975438|364520559|FG001|Overall Study|Withdrawal by Subject|0|||
105687798|NCT04975438|364520560|FG002|Overall Study|Withdrawal by Subject|0|||
105687799|NCT04975438|364520561|FG003|Overall Study|Withdrawal by Subject|0|||
105687800|NCT02875977|364520562|FG000|Overall Study|Lost to Follow-up|42|||
105687801|NCT02875977|364520563|FG001|Overall Study|Lost to Follow-up|29|||
105687802|NCT00195507|364520567|FG000|Overall Study|Adverse Event|24|||
105687803|NCT00195507|364520568|FG001|Overall Study|Adverse Event|13|||
105687804|NCT00195507|364520567|FG000|Overall Study|Death|0|||
106002519|NCT01300234|365670644|FG001|Overall Study|Participant reached stopping critera|0|||
106002520|NCT01300234|365670643|FG000|Overall Study|Participant stopped medication|1|||
106002521|NCT01300234|365670644|FG001|Overall Study|Participant stopped medication|1|||
106002522|NCT01300234|365670643|FG000|Overall Study|Participant refused return to hospital|1|||
106002523|NCT01300234|365670644|FG001|Overall Study|Participant refused return to hospital|0|||
106002524|NCT03253679|365670645|FG000|Overall Study|Screen Failure|1|||
106002525|NCT01774799|365670646|FG000|Overall Study|Lost to Follow-up|1|||
106002526|NCT01774799|365670647|FG001|Overall Study|Lost to Follow-up|1|||
106002527|NCT01774799|365670648|FG002|Overall Study|Lost to Follow-up|0|||
106002528|NCT01774799|365670649|FG003|Overall Study|Lost to Follow-up|0|||
106002529|NCT00584415|365670650|FG000|Overall Study|Adverse Event|7|||
106002530|NCT02370420|365670651|FG000|Overall Study|Physician Decision|3|||
106002531|NCT02370420|365670652|FG001|Overall Study|Physician Decision|3|||
106002532|NCT02370420|365670651|FG000|Overall Study|Lost to Follow-up|11|||
106002533|NCT02370420|365670652|FG001|Overall Study|Lost to Follow-up|9|||
106002534|NCT03980730|365670653|FG000|Overall Study|Study Terminated by Sponsor|0|||
106002535|NCT03980730|365670654|FG001|Overall Study|Study Terminated by Sponsor|3|||
106002536|NCT03980730|365670653|FG000|Overall Study|Adverse Event|2|||
106002537|NCT03980730|365670654|FG001|Overall Study|Adverse Event|0|||
106002538|NCT03980730|365670653|FG000|Overall Study|Sponsor Request|0|||
106002539|NCT03980730|365670654|FG001|Overall Study|Sponsor Request|1|||
106002540|NCT05051579|365670655|FG000|Overall Study|Withdrawal by Subject|3|||
106002541|NCT05051579|365670656|FG001|Overall Study|Withdrawal by Subject|5|||
106002542|NCT05051579|365670657|FG002|Overall Study|Withdrawal by Subject|2|||
106002543|NCT05051579|365670658|FG003|Overall Study|Withdrawal by Subject|1|||
106002544|NCT05051579|365670659|FG004|Overall Study|Withdrawal by Subject|4|||
106002545|NCT05051579|365670660|FG005|Overall Study|Withdrawal by Subject|0|||
106002546|NCT05051579|365670661|FG006|Overall Study|Withdrawal by Subject|4|||
106002547|NCT05051579|365670655|FG000|Overall Study|Lost to Follow-up|1|||
106002548|NCT05051579|365670656|FG001|Overall Study|Lost to Follow-up|0|||
106002549|NCT05051579|365670657|FG002|Overall Study|Lost to Follow-up|0|||
106002550|NCT05051579|365670658|FG003|Overall Study|Lost to Follow-up|0|||
106002551|NCT05051579|365670659|FG004|Overall Study|Lost to Follow-up|1|||
106002552|NCT05051579|365670660|FG005|Overall Study|Lost to Follow-up|0|||
106002553|NCT05051579|365670661|FG006|Overall Study|Lost to Follow-up|1|||
106002554|NCT05051579|365670655|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
106002555|NCT05051579|365670656|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
106002556|NCT05051579|365670657|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
106002557|NCT05051579|365670658|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
106002558|NCT05051579|365670659|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
106002559|NCT05051579|365670660|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
106002560|NCT05051579|365670661|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
106002561|NCT05051579|365670655|FG000|Overall Study|Adverse Event|2|||
106002562|NCT05051579|365670656|FG001|Overall Study|Adverse Event|1|||
105687805|NCT00195507|364520568|FG001|Overall Study|Death|1|||
105687806|NCT00195507|364520567|FG000|Overall Study|Failed to Return|4|||
105687807|NCT00195507|364520568|FG001|Overall Study|Failed to Return|3|||
105687808|NCT00195507|364520567|FG000|Overall Study|Physician Decision|1|||
105687809|NCT00195507|364520568|FG001|Overall Study|Physician Decision|2|||
105687810|NCT00195507|364520567|FG000|Overall Study|Lost to Follow-up|3|||
106002563|NCT05051579|365670657|FG002|Overall Study|Adverse Event|0|||
106002564|NCT05051579|365670658|FG003|Overall Study|Adverse Event|4|||
106002565|NCT05051579|365670659|FG004|Overall Study|Adverse Event|1|||
106002566|NCT05051579|365670660|FG005|Overall Study|Adverse Event|2|||
106002567|NCT05051579|365670661|FG006|Overall Study|Adverse Event|0|||
105687811|NCT00195507|364520568|FG001|Overall Study|Lost to Follow-up|2|||
105687812|NCT00195507|364520567|FG000|Overall Study|Protocol Violation|5|||
105687813|NCT00195507|364520568|FG001|Overall Study|Protocol Violation|4|||
105687814|NCT00195507|364520567|FG000|Overall Study|Lack of Efficacy|40|||
105687815|NCT00195507|364520568|FG001|Overall Study|Lack of Efficacy|67|||
106130392|NCT00410384|366134215|FG001|Overall Study|Lack of Efficacy|12|||
106130393|NCT00410384|366134216|FG002|Overall Study|Lack of Efficacy|17|||
105687816|NCT00195507|364520567|FG000|Overall Study|Withdrawal by Subject|16|||
105687817|NCT00195507|364520568|FG001|Overall Study|Withdrawal by Subject|23|||
105687818|NCT00195507|364520567|FG000|Overall Study|Protocol Deviation|6|||
105687819|NCT00195507|364520568|FG001|Overall Study|Protocol Deviation|3|||
105687820|NCT01178671|364520569|FG000|Overall Study|Adverse Event|4|||
105687821|NCT01178671|364520570|FG001|Overall Study|Adverse Event|6|||
105687822|NCT01178671|364520569|FG000|Overall Study|Protocol Violation|1|||
105687823|NCT01178671|364520570|FG001|Overall Study|Protocol Violation|1|||
105687824|NCT01178671|364520569|FG000|Overall Study|Lack of Efficacy|0|||
105687825|NCT01178671|364520570|FG001|Overall Study|Lack of Efficacy|1|||
105687826|NCT01178671|364520569|FG000|Overall Study|Lost to Follow-up|3|||
105687827|NCT01178671|364520570|FG001|Overall Study|Lost to Follow-up|1|||
106130394|NCT00410384|366134214|FG000|Overall Study|Lack of Compliance|2|||
106130395|NCT00410384|366134215|FG001|Overall Study|Lack of Compliance|2|||
106130396|NCT00410384|366134216|FG002|Overall Study|Lack of Compliance|2|||
106130397|NCT00410384|366134214|FG000|Overall Study|Lost to Follow-up|4|||
106130398|NCT00410384|366134215|FG001|Overall Study|Lost to Follow-up|6|||
106130399|NCT00410384|366134216|FG002|Overall Study|Lost to Follow-up|6|||
106130400|NCT00410384|366134214|FG000|Overall Study|Protocol Violation|6|||
106130401|NCT00410384|366134215|FG001|Overall Study|Protocol Violation|6|||
106130402|NCT00410384|366134216|FG002|Overall Study|Protocol Violation|6|||
106130403|NCT00410384|366134214|FG000|Overall Study|Physician Decision|3|||
106130404|NCT00410384|366134215|FG001|Overall Study|Physician Decision|3|||
106130405|NCT00410384|366134216|FG002|Overall Study|Physician Decision|4|||
106130406|NCT00410384|366134214|FG000|Overall Study|Other|3|||
106130407|NCT00410384|366134215|FG001|Overall Study|Other|8|||
106130408|NCT00410384|366134216|FG002|Overall Study|Other|4|||
106130409|NCT00783718|366134219|FG000|Induction Phase|Adverse Event|4|||
106130410|NCT00783718|366134220|FG001|Induction Phase|Adverse Event|0|||
106130411|NCT00783718|366134221|FG002|Induction Phase|Adverse Event|7|||
106130412|NCT00783718|366134222|FG003|Induction Phase|Adverse Event|0|||
106130413|NCT00783718|366134223|FG004|Induction Phase|Adverse Event|0|||
106130414|NCT00783718|366134224|FG005|Induction Phase|Adverse Event|0|||
106130415|NCT00783718|366134225|FG006|Induction Phase|Adverse Event|0|||
106130416|NCT00783718|366134219|FG000|Induction Phase|Protocol Violation|1|||
106130417|NCT00783718|366134220|FG001|Induction Phase|Protocol Violation|1|||
106130418|NCT00783718|366134221|FG002|Induction Phase|Protocol Violation|6|||
106130419|NCT00783718|366134222|FG003|Induction Phase|Protocol Violation|0|||
106130420|NCT00783718|366134223|FG004|Induction Phase|Protocol Violation|0|||
106130421|NCT00783718|366134224|FG005|Induction Phase|Protocol Violation|0|||
106130422|NCT00783718|366134225|FG006|Induction Phase|Protocol Violation|0|||
106130423|NCT00783718|366134219|FG000|Induction Phase|Lack of Efficacy|5|||
106130424|NCT00783718|366134220|FG001|Induction Phase|Lack of Efficacy|2|||
106130425|NCT00783718|366134221|FG002|Induction Phase|Lack of Efficacy|14|||
106130426|NCT00783718|366134222|FG003|Induction Phase|Lack of Efficacy|0|||
106130427|NCT00783718|366134223|FG004|Induction Phase|Lack of Efficacy|0|||
106130428|NCT00783718|366134224|FG005|Induction Phase|Lack of Efficacy|0|||
106130429|NCT00783718|366134225|FG006|Induction Phase|Lack of Efficacy|0|||
106130430|NCT00783718|366134219|FG000|Induction Phase|Withdrawal by Subject|3|||
106130431|NCT00783718|366134220|FG001|Induction Phase|Withdrawal by Subject|4|||
106130432|NCT00783718|366134221|FG002|Induction Phase|Withdrawal by Subject|8|||
105687828|NCT01178671|364520569|FG000|Overall Study|Physician Decision|4|||
105687829|NCT01178671|364520570|FG001|Overall Study|Physician Decision|6|||
105687830|NCT02260882|364520573|FG000|Overall Study|Protocol Violation|0|||
105687831|NCT02260882|364520574|FG001|Overall Study|Protocol Violation|1|||
105687832|NCT01326533|364520575|FG000|Overall Study|Lost to Follow-up|2|||
105687833|NCT01326533|364520576|FG001|Overall Study|Lost to Follow-up|0|||
105687834|NCT01326533|364520575|FG000|Overall Study|Withdrawal by Subject|1|||
105687835|NCT01326533|364520576|FG001|Overall Study|Withdrawal by Subject|0|||
105918922|NCT03530293|365363456|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
106130433|NCT00783718|366134222|FG003|Induction Phase|Withdrawal by Subject|0|||
105687836|NCT01326533|364520575|FG000|Overall Study|Adverse Event|1|||
105687837|NCT01326533|364520576|FG001|Overall Study|Adverse Event|0|||
105687838|NCT04079803|364520577|FG000|Overall Study|Withdrawal by Subject|0|||
105687839|NCT04079803|364520578|FG001|Overall Study|Withdrawal by Subject|0|||
105687840|NCT04079803|364520579|FG002|Overall Study|Withdrawal by Subject|1|||
106130434|NCT00783718|366134223|FG004|Induction Phase|Withdrawal by Subject|0|||
106130435|NCT00783718|366134224|FG005|Induction Phase|Withdrawal by Subject|0|||
106130436|NCT00783718|366134225|FG006|Induction Phase|Withdrawal by Subject|0|||
106130437|NCT00783718|366134219|FG000|Induction Phase|Lost to Follow-up|1|||
105687841|NCT03370471|364520589|FG000|Overall Study|Withdrawal by Subject|6|||
105687842|NCT03370471|364520590|FG001|Overall Study|Withdrawal by Subject|1|||
106002568|NCT05051579|365670655|FG000|Overall Study|Inadvertent Enrollment|0|||
106002569|NCT05051579|365670656|FG001|Overall Study|Inadvertent Enrollment|0|||
106002570|NCT05051579|365670657|FG002|Overall Study|Inadvertent Enrollment|0|||
105687843|NCT03370471|364520589|FG000|Overall Study|Unable to access veins for blood draw|0|||
105687844|NCT03370471|364520590|FG001|Overall Study|Unable to access veins for blood draw|1|||
105687845|NCT03370471|364520589|FG000|Overall Study|Screen fail|1|||
105687846|NCT03370471|364520590|FG001|Overall Study|Screen fail|0|||
105687847|NCT01030198|364520597|FG000|Overall Study|Could not measure efficacy accurately|0|||
106002571|NCT05051579|365670658|FG003|Overall Study|Inadvertent Enrollment|0|||
106002572|NCT05051579|365670659|FG004|Overall Study|Inadvertent Enrollment|0|||
105687848|NCT01030198|364520598|FG001|Overall Study|Could not measure efficacy accurately|7|||
105687849|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
105687850|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
105687851|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
105687852|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
105687853|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
105687854|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
105687855|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
105687856|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
105687857|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
105687858|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
105687859|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
106002573|NCT05051579|365670660|FG005|Overall Study|Inadvertent Enrollment|0|||
106002574|NCT05051579|365670661|FG006|Overall Study|Inadvertent Enrollment|1|||
106002575|NCT05051579|365670655|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
106002576|NCT05051579|365670656|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
106002577|NCT05051579|365670657|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
106002578|NCT05051579|365670658|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
106002579|NCT05051579|365670659|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
106002580|NCT05051579|365670660|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
106002581|NCT05051579|365670661|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
106002582|NCT05051579|365670655|FG000|Overall Study|Sponsor Decision|0|||
106002583|NCT05051579|365670656|FG001|Overall Study|Sponsor Decision|0|||
106002584|NCT05051579|365670657|FG002|Overall Study|Sponsor Decision|0|||
106002585|NCT05051579|365670658|FG003|Overall Study|Sponsor Decision|0|||
105687860|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
105687861|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
105687862|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
105687863|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
105687864|NCT04908189|364520599|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
105786717|NCT01711736|364872889|FG000|Overall Study|Lost to Follow-up|4|||
105786718|NCT01711736|364872890|FG001|Overall Study|Lost to Follow-up|1|||
105786719|NCT01711736|364872889|FG000|Overall Study|Withdrawal by Subject|6|||
106002586|NCT05051579|365670659|FG004|Overall Study|Sponsor Decision|1|||
106002587|NCT05051579|365670660|FG005|Overall Study|Sponsor Decision|0|||
106002588|NCT05051579|365670661|FG006|Overall Study|Sponsor Decision|0|||
106002589|NCT05051579|365670655|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
106002590|NCT05051579|365670656|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
106002591|NCT05051579|365670657|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
106130438|NCT00783718|366134220|FG001|Induction Phase|Lost to Follow-up|0|||
106130439|NCT00783718|366134221|FG002|Induction Phase|Lost to Follow-up|1|||
106130440|NCT00783718|366134222|FG003|Induction Phase|Lost to Follow-up|0|||
106130441|NCT00783718|366134223|FG004|Induction Phase|Lost to Follow-up|0|||
106130442|NCT00783718|366134224|FG005|Induction Phase|Lost to Follow-up|0|||
106130443|NCT00783718|366134225|FG006|Induction Phase|Lost to Follow-up|0|||
106130444|NCT00783718|366134219|FG000|Maintenance Phase|Adverse Event|12|||
106130445|NCT00783718|366134220|FG001|Maintenance Phase|Adverse Event|0|||
106130446|NCT00783718|366134221|FG002|Maintenance Phase|Adverse Event|0|||
106130447|NCT00783718|366134222|FG003|Maintenance Phase|Adverse Event|15|||
106130448|NCT00783718|366134223|FG004|Maintenance Phase|Adverse Event|7|||
106130449|NCT00783718|366134224|FG005|Maintenance Phase|Adverse Event|6|||
106130450|NCT00783718|366134225|FG006|Maintenance Phase|Adverse Event|16|||
106130451|NCT00783718|366134219|FG000|Maintenance Phase|Protocol Violation|1|||
106130452|NCT00783718|366134220|FG001|Maintenance Phase|Protocol Violation|0|||
106130453|NCT00783718|366134221|FG002|Maintenance Phase|Protocol Violation|0|||
106130454|NCT00783718|366134222|FG003|Maintenance Phase|Protocol Violation|0|||
106130455|NCT00783718|366134223|FG004|Maintenance Phase|Protocol Violation|0|||
106130456|NCT00783718|366134224|FG005|Maintenance Phase|Protocol Violation|0|||
105918923|NCT01245101|365363462|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
105918924|NCT01245101|365363463|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
105918925|NCT01245101|365363462|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
105918926|NCT01245101|365363463|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
105918927|NCT01245101|365363462|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
105918928|NCT01245101|365363463|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
105918929|NCT01225549|365363464|FG000|Period 4 - Washout|Disallowed medication|0|||
105918930|NCT01225549|365363465|FG001|Period 4 - Washout|Disallowed medication|1|||
105918931|NCT01225549|365363466|FG002|Period 4 - Washout|Disallowed medication|0|||
105918932|NCT01225549|365363467|FG003|Period 4 - Washout|Disallowed medication|0|||
105918933|NCT01225549|365363468|FG004|Period 4 - Washout|Disallowed medication|0|||
105918934|NCT01225549|365363469|FG005|Period 4 - Washout|Disallowed medication|0|||
105918935|NCT01225549|365363470|FG006|Period 4 - Washout|Disallowed medication|0|||
105918936|NCT01225549|365363471|FG007|Period 4 - Washout|Disallowed medication|0|||
106130457|NCT00783718|366134225|FG006|Maintenance Phase|Protocol Violation|2|||
106130458|NCT00783718|366134219|FG000|Maintenance Phase|Lack of Efficacy|83|||
106130459|NCT00783718|366134220|FG001|Maintenance Phase|Lack of Efficacy|0|||
106130460|NCT00783718|366134221|FG002|Maintenance Phase|Lack of Efficacy|0|||
106130461|NCT00783718|366134222|FG003|Maintenance Phase|Lack of Efficacy|61|||
106130462|NCT00783718|366134223|FG004|Maintenance Phase|Lack of Efficacy|31|||
106130463|NCT00783718|366134224|FG005|Maintenance Phase|Lack of Efficacy|33|||
106130464|NCT00783718|366134225|FG006|Maintenance Phase|Lack of Efficacy|155|||
106130465|NCT00783718|366134219|FG000|Maintenance Phase|Withdrawal by Subject|6|||
106130466|NCT00783718|366134220|FG001|Maintenance Phase|Withdrawal by Subject|0|||
106130467|NCT00783718|366134221|FG002|Maintenance Phase|Withdrawal by Subject|0|||
106130468|NCT00783718|366134222|FG003|Maintenance Phase|Withdrawal by Subject|2|||
106130469|NCT00783718|366134223|FG004|Maintenance Phase|Withdrawal by Subject|5|||
106130470|NCT00783718|366134224|FG005|Maintenance Phase|Withdrawal by Subject|2|||
106130471|NCT00783718|366134225|FG006|Maintenance Phase|Withdrawal by Subject|20|||
106130472|NCT00783718|366134219|FG000|Maintenance Phase|Lost to Follow-up|3|||
106130473|NCT00783718|366134220|FG001|Maintenance Phase|Lost to Follow-up|0|||
106130474|NCT00783718|366134221|FG002|Maintenance Phase|Lost to Follow-up|0|||
106130475|NCT00783718|366134222|FG003|Maintenance Phase|Lost to Follow-up|0|||
106130476|NCT00783718|366134223|FG004|Maintenance Phase|Lost to Follow-up|2|||
106130477|NCT00783718|366134224|FG005|Maintenance Phase|Lost to Follow-up|0|||
106130478|NCT00783718|366134225|FG006|Maintenance Phase|Lost to Follow-up|2|||
106130479|NCT02223182|366134230|FG000|Double-Blind Period|Adverse Event|0|||
106130480|NCT02223182|366134231|FG001|Double-Blind Period|Adverse Event|2|||
106130481|NCT02223182|366134232|FG002|Double-Blind Period|Adverse Event|1|||
106130482|NCT02223182|366134233|FG003|Double-Blind Period|Adverse Event|0|||
106130483|NCT02223182|366134230|FG000|Double-Blind Period|Withdrawal by Subject|1|||
106130484|NCT02223182|366134231|FG001|Double-Blind Period|Withdrawal by Subject|1|||
106130485|NCT02223182|366134232|FG002|Double-Blind Period|Withdrawal by Subject|1|||
106130486|NCT02223182|366134233|FG003|Double-Blind Period|Withdrawal by Subject|0|||
106130487|NCT02223182|366134230|FG000|Double-Blind Period|Lost to Follow-up|0|||
106130488|NCT02223182|366134231|FG001|Double-Blind Period|Lost to Follow-up|1|||
106130489|NCT02223182|366134232|FG002|Double-Blind Period|Lost to Follow-up|0|||
106130490|NCT02223182|366134233|FG003|Double-Blind Period|Lost to Follow-up|0|||
106130491|NCT02223182|366134230|FG000|Double-Blind Period|Non Compliance|0|||
106130492|NCT02223182|366134231|FG001|Double-Blind Period|Non Compliance|0|||
106130493|NCT02223182|366134232|FG002|Double-Blind Period|Non Compliance|0|||
106130494|NCT02223182|366134233|FG003|Double-Blind Period|Non Compliance|1|||
106130495|NCT02223182|366134230|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
106130496|NCT02223182|366134231|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
106130497|NCT02223182|366134232|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
106130498|NCT02223182|366134233|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
106130499|NCT02223182|366134230|FG000|Open-Label 500 Period|Adverse Event|1|||
106130500|NCT02223182|366134231|FG001|Open-Label 500 Period|Adverse Event|0|||
106130501|NCT02223182|366134232|FG002|Open-Label 500 Period|Adverse Event|2|||
106130502|NCT02223182|366134233|FG003|Open-Label 500 Period|Adverse Event|1|||
106130503|NCT02223182|366134230|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
106130504|NCT02223182|366134231|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
106130505|NCT02223182|366134232|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
106130506|NCT02223182|366134233|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
106130507|NCT02223182|366134230|FG000|Open-Label 500 Period|Physician Decision|0|||
106130508|NCT02223182|366134231|FG001|Open-Label 500 Period|Physician Decision|0|||
105918937|NCT01225549|365363472|FG008|Period 4 - Washout|Disallowed medication|0|||
105918938|NCT01225549|365363473|FG009|Period 4 - Washout|Disallowed medication|0|||
105918939|NCT01225549|365363464|FG000|Period 6 - Washout|Disallowed medication|0|||
106130509|NCT02223182|366134232|FG002|Open-Label 500 Period|Physician Decision|0|||
106130510|NCT02223182|366134233|FG003|Open-Label 500 Period|Physician Decision|1|||
106130511|NCT02223182|366134230|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
106130512|NCT02223182|366134231|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
105918940|NCT01225549|365363465|FG001|Period 6 - Washout|Disallowed medication|0|||
105918941|NCT01225549|365363466|FG002|Period 6 - Washout|Disallowed medication|0|||
105918942|NCT01225549|365363467|FG003|Period 6 - Washout|Disallowed medication|1|||
105918943|NCT01225549|365363468|FG004|Period 6 - Washout|Disallowed medication|0|||
106130513|NCT02223182|366134232|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
106130514|NCT02223182|366134233|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
106130515|NCT02223182|366134230|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
106130516|NCT02223182|366134231|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
106130517|NCT02223182|366134232|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
106130518|NCT02223182|366134233|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
106130519|NCT02223182|366134230|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
105687865|NCT04908189|364520600|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
105687866|NCT04908189|364520601|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
105687867|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
105687868|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
105687869|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
105687870|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
105687871|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
105687872|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
105687873|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
105687874|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
105687875|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
105687876|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
105687877|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
105687878|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
105687879|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
105687880|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
105687881|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
105687882|NCT04908189|364520599|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
105687883|NCT04908189|364520600|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
105687884|NCT04908189|364520601|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
105687885|NCT00607022|364520602|FG000|Overall Study|Withdrawal by Subject|1|||
105687886|NCT00607022|364520603|FG001|Overall Study|Withdrawal by Subject|0|||
105687887|NCT00607022|364520604|FG002|Overall Study|Withdrawal by Subject|0|||
105687888|NCT01411839|364520607|FG000|Overall Study|Lost to Follow-up|4|||
105687889|NCT01411839|364520608|FG001|Overall Study|Lost to Follow-up|3|||
106130520|NCT02223182|366134231|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
106130521|NCT02223182|366134232|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
106130522|NCT02223182|366134233|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
106130523|NCT02223182|366134230|FG000|Open-Label 300 Period|Non Compliance|0|||
106130524|NCT02223182|366134231|FG001|Open-Label 300 Period|Non Compliance|2|||
106130525|NCT02223182|366134232|FG002|Open-Label 300 Period|Non Compliance|1|||
106130526|NCT02223182|366134233|FG003|Open-Label 300 Period|Non Compliance|0|||
106130527|NCT00235495|366134234|FG000|Overall Study|Death|52|||
105918944|NCT01225549|365363469|FG005|Period 6 - Washout|Disallowed medication|0|||
106130528|NCT00235495|366134235|FG001|Overall Study|Death|42|||
106130529|NCT00235495|366134234|FG000|Overall Study|Withdrawal by Subject|5|||
106130530|NCT00235495|366134235|FG001|Overall Study|Withdrawal by Subject|3|||
106130531|NCT00235495|366134234|FG000|Overall Study|Lost to Follow-up|11|||
106130532|NCT00235495|366134235|FG001|Overall Study|Lost to Follow-up|13|||
106130533|NCT00235495|366134234|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
105687890|NCT03330847|364520609|FG000|Overall Study|Patients ongoing study|62|||
105687891|NCT03330847|364520610|FG001|Overall Study|Patients ongoing study|65|||
105687892|NCT03330847|364520611|FG002|Overall Study|Patients ongoing study|15|||
105687893|NCT04821869|364520612|FG000|Overall Study|Adverse Event|4|||
105687894|NCT04821869|364520612|FG000|Overall Study|Withdrawal by Subject|2|||
105687895|NCT04821869|364520612|FG000|Overall Study|Did not meet FEV1 criteria|1|||
105687896|NCT03444324|364520614|FG000|Overall Study|Withdrawal by Subject|0|||
105687897|NCT03444324|364520615|FG001|Overall Study|Withdrawal by Subject|1|||
105687898|NCT03444324|364520614|FG000|Overall Study|Lost to Follow-up|4|||
105687899|NCT03444324|364520615|FG001|Overall Study|Lost to Follow-up|2|||
105687900|NCT03444324|364520614|FG000|Overall Study|Protocol Violation|0|||
105687901|NCT03444324|364520615|FG001|Overall Study|Protocol Violation|1|||
105687902|NCT03444324|364520614|FG000|Overall Study|Lack of Trial Compliance|1|||
105687903|NCT03444324|364520615|FG001|Overall Study|Lack of Trial Compliance|1|||
105687904|NCT03444324|364520614|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
105687905|NCT03444324|364520615|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
105687906|NCT02903368|364520616|FG000|Part 1|Adverse Event|3|||
105687907|NCT02903368|364520617|FG001|Part 1|Adverse Event|0|||
105687908|NCT02903368|364520618|FG002|Part 1|Adverse Event|0|||
105687909|NCT02903368|364520619|FG003|Part 1|Adverse Event|0|||
105687910|NCT02903368|364520616|FG000|Part 1|Withdrawal by Subject|1|||
105687911|NCT02903368|364520617|FG001|Part 1|Withdrawal by Subject|0|||
105687912|NCT02903368|364520618|FG002|Part 1|Withdrawal by Subject|0|||
105687913|NCT02903368|364520619|FG003|Part 1|Withdrawal by Subject|0|||
105687914|NCT02903368|364520616|FG000|Part 2|Adverse Event|0|||
105687915|NCT02903368|364520617|FG001|Part 2|Adverse Event|0|||
105687916|NCT02903368|364520618|FG002|Part 2|Adverse Event|5|||
105687917|NCT02903368|364520619|FG003|Part 2|Adverse Event|0|||
105687918|NCT02903368|364520616|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
105687919|NCT02903368|364520617|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
105687920|NCT02903368|364520618|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
105687921|NCT02903368|364520619|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
105687922|NCT02903368|364520616|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
105687923|NCT02903368|364520617|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
105687924|NCT02903368|364520618|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
105687925|NCT02903368|364520619|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
105687926|NCT02903368|364520616|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
105687927|NCT02903368|364520617|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
105687928|NCT02903368|364520618|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
105687929|NCT02903368|364520619|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
105687930|NCT01340196|364522421|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
105687931|NCT00876694|364522422|FG000|Overall Study|Adverse Event|10|||
105687932|NCT00876694|364522423|FG001|Overall Study|Adverse Event|7|||
105687933|NCT00876694|364522422|FG000|Overall Study|Subject withdrew consent|6|||
105687934|NCT00876694|364522423|FG001|Overall Study|Subject withdrew consent|4|||
105687935|NCT00876694|364522422|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105918945|NCT01225549|365363470|FG006|Period 6 - Washout|Disallowed medication|0|||
105918946|NCT01225549|365363471|FG007|Period 6 - Washout|Disallowed medication|0|||
105918947|NCT01225549|365363472|FG008|Period 6 - Washout|Disallowed medication|0|||
105918948|NCT01225549|365363473|FG009|Period 6 - Washout|Disallowed medication|0|||
105918949|NCT04456686|365363474|FG000|Overall Study|Adverse Event|2|||
105918950|NCT04456686|365363475|FG001|Overall Study|Adverse Event|1|||
105918951|NCT04456686|365363474|FG000|Overall Study|Lack of Efficacy|3|||
105918952|NCT04456686|365363475|FG001|Overall Study|Lack of Efficacy|1|||
105918953|NCT04456686|365363474|FG000|Overall Study|Withdrew consent|3|||
105918954|NCT04456686|365363475|FG001|Overall Study|Withdrew consent|1|||
105918955|NCT04456686|365363474|FG000|Overall Study|Physician Decision|2|||
105918956|NCT04456686|365363475|FG001|Overall Study|Physician Decision|2|||
105687936|NCT00876694|364522423|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105687937|NCT00876694|364522422|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105687938|NCT00876694|364522423|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105918957|NCT04456686|365363474|FG000|Overall Study|Withdrawal by Subject|5|||
105918958|NCT04456686|365363475|FG001|Overall Study|Withdrawal by Subject|1|||
105918959|NCT04456686|365363474|FG000|Overall Study|Protocol Violation|0|||
105918960|NCT04456686|365363475|FG001|Overall Study|Protocol Violation|1|||
105687939|NCT00876694|364522422|FG000|Overall Study|Administrative problems|1|||
105687940|NCT00876694|364522423|FG001|Overall Study|Administrative problems|1|||
105687941|NCT00876694|364522422|FG000|Overall Study|Death|1|||
105687942|NCT00876694|364522423|FG001|Overall Study|Death|0|||
105687943|NCT02382016|364522424|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
105687944|NCT02382016|364522425|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
105687945|NCT02382016|364522424|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
105687946|NCT02382016|364522425|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
105687947|NCT02382016|364522424|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
105687948|NCT02382016|364522425|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
105687949|NCT02382016|364522424|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
105687950|NCT02382016|364522425|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
105687951|NCT02382016|364522424|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
105687952|NCT02382016|364522425|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
105687953|NCT02382016|364522424|FG000|Open-label (OL) Treatment Period|Death|4|||
105687954|NCT02382016|364522425|FG001|Open-label (OL) Treatment Period|Death|0|||
105687955|NCT02382016|364522424|FG000|OL Extension Period|Physician Decision|3|||
105687956|NCT02382016|364522425|FG001|OL Extension Period|Physician Decision|0|||
105687957|NCT02382016|364522424|FG000|OL Extension Period|Death|2|||
105687958|NCT02382016|364522425|FG001|OL Extension Period|Death|0|||
105687959|NCT02382016|364522424|FG000|OL Extension Period|Withdrawal by Subject|1|||
105687960|NCT02382016|364522425|FG001|OL Extension Period|Withdrawal by Subject|0|||
105687961|NCT00730171|364522426|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
105687962|NCT00730171|364522426|FG000|Overall Study|Adverse Event|193|||
105687963|NCT00730171|364522426|FG000|Overall Study|Protocol Violation|48|||
105687964|NCT00730171|364522426|FG000|Overall Study|Withdrawal by Subject|202|||
105687965|NCT00730171|364522426|FG000|Overall Study|Lost to Follow-up|121|||
105687966|NCT00730171|364522426|FG000|Overall Study|Insufficient Therapeutic Response|141|||
105687967|NCT00730171|364522426|FG000|Overall Study|Other|61|||
105687968|NCT01215422|364522427|FG000|Overall Study|Relocation|1|||
105687969|NCT01215422|364522428|FG001|Overall Study|Relocation|0|||
105687970|NCT01215422|364522429|FG002|Overall Study|Relocation|0|||
105687971|NCT01215422|364522430|FG003|Overall Study|Relocation|0|||
105687972|NCT01215422|364522427|FG000|Overall Study|Failed intubations|0|||
105687973|NCT01215422|364522428|FG001|Overall Study|Failed intubations|0|||
105687974|NCT01215422|364522429|FG002|Overall Study|Failed intubations|3|||
105687975|NCT01215422|364522430|FG003|Overall Study|Failed intubations|8|||
105687976|NCT01215422|364522427|FG000|Overall Study|Did not complete all intubations|7|||
105687977|NCT01215422|364522428|FG001|Overall Study|Did not complete all intubations|0|||
105687978|NCT01215422|364522429|FG002|Overall Study|Did not complete all intubations|0|||
105687979|NCT01215422|364522430|FG003|Overall Study|Did not complete all intubations|0|||
105687980|NCT00909792|364522431|FG000|Period 1|Did not meet inclusion criteria|0|||
105687981|NCT00909792|364522432|FG001|Period 1|Did not meet inclusion criteria|1|||
105687982|NCT00909792|364522431|FG000|Period 2|Biomicroscopy|1|||
105687983|NCT00909792|364522432|FG001|Period 2|Biomicroscopy|0|||
105687984|NCT00909792|364522431|FG000|Period 2|Lost to Follow-up|0|||
105687985|NCT00909792|364522432|FG001|Period 2|Lost to Follow-up|1|||
105687986|NCT00294554|364522437|FG000|Overall Study|Lack of Efficacy|0|||
105687987|NCT00294554|364522438|FG001|Overall Study|Lack of Efficacy|1|||
105687988|NCT00294554|364522437|FG000|Overall Study|Physician Decision|0|||
105687989|NCT00294554|364522438|FG001|Overall Study|Physician Decision|1|||
105687990|NCT01717989|364522439|FG000|Overall Study|Ineligibility determined|6|||
105687991|NCT01717989|364522439|FG000|Overall Study|Protocol deviation|6|||
105687992|NCT01717989|364522439|FG000|Overall Study|Withdrawal by Subject|11|||
105687993|NCT01717989|364522439|FG000|Overall Study|Physician Decision|2|||
105687994|NCT01717989|364522439|FG000|Overall Study|Lost to Follow-up|11|||
105687995|NCT01717989|364522439|FG000|Overall Study|Death|439|||
105687996|NCT01717989|364522439|FG000|Overall Study|Protocol-specified criteria|551|||
105918961|NCT00891813|365363476|FG000|Overall Study|Adverse Event|3|||
105918962|NCT00891813|365363476|FG000|Overall Study|Withdrawal by Subject|1|||
105918963|NCT00891813|365363476|FG000|Overall Study|Patient Noncompliance|6|||
105918964|NCT00891813|365363476|FG000|Overall Study|Protocol Violation|2|||
105918965|NCT02858401|365363481|FG000|Overall Study|Withdrew Consent|0|||
105918966|NCT02858401|365363482|FG001|Overall Study|Withdrew Consent|0|||
105918967|NCT02858401|365363483|FG002|Overall Study|Withdrew Consent|0|||
105918968|NCT02858401|365363484|FG003|Overall Study|Withdrew Consent|0|||
105918969|NCT02858401|365363485|FG004|Overall Study|Withdrew Consent|0|||
105687997|NCT01717989|364522439|FG000|Overall Study|Other|40|||
105687998|NCT00462865|364522440|FG000|Overall Study|Adverse Event|1|||
105687999|NCT00792805|364522441|FG000|Overall Study|Adverse Event|12|||
105688000|NCT00792805|364522442|FG001|Overall Study|Adverse Event|10|||
105688001|NCT00792805|364522443|FG002|Overall Study|Adverse Event|10|||
105688002|NCT00792805|364522441|FG000|Overall Study|Subject withdrew consent|5|||
105688003|NCT00792805|364522442|FG001|Overall Study|Subject withdrew consent|6|||
105688004|NCT00792805|364522443|FG002|Overall Study|Subject withdrew consent|5|||
105688005|NCT00792805|364522441|FG000|Overall Study|Administrative problems|2|||
105688006|NCT00792805|364522442|FG001|Overall Study|Administrative problems|0|||
105688007|NCT00792805|364522443|FG002|Overall Study|Administrative problems|4|||
105688008|NCT00792805|364522441|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105688009|NCT00792805|364522442|FG001|Overall Study|Abnormal test procedure result(s)|2|||
105688010|NCT00792805|364522443|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105688011|NCT00792805|364522441|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105688012|NCT00792805|364522442|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
105688013|NCT00792805|364522443|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
105688014|NCT00792805|364522441|FG000|Overall Study|Lost to Follow-up|1|||
105688015|NCT00792805|364522442|FG001|Overall Study|Lost to Follow-up|1|||
105688016|NCT00792805|364522443|FG002|Overall Study|Lost to Follow-up|6|||
105688017|NCT00792805|364522441|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105688018|NCT00792805|364522442|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105688019|NCT00792805|364522443|FG002|Overall Study|Abnormal laboratory value(s)|1|||
105688020|NCT00792805|364522441|FG000|Overall Study|Protocol deviation|0|||
105688021|NCT00792805|364522442|FG001|Overall Study|Protocol deviation|1|||
105688022|NCT00792805|364522443|FG002|Overall Study|Protocol deviation|1|||
105688023|NCT03224325|364522444|FG000|Overall Study|Adverse Event|1|||
105688024|NCT03224325|364522445|FG001|Overall Study|Adverse Event|0|||
105688025|NCT03224325|364522446|FG002|Overall Study|Adverse Event|0|||
105688026|NCT03224325|364522447|FG003|Overall Study|Adverse Event|0|||
105688027|NCT03224325|364522448|FG004|Overall Study|Adverse Event|0|||
105688028|NCT03224325|364522449|FG005|Overall Study|Adverse Event|0|||
105688029|NCT03224325|364522450|FG006|Overall Study|Adverse Event|1|||
105688030|NCT03224325|364522444|FG000|Overall Study|Withdrawal by Subject|0|||
105688031|NCT03224325|364522445|FG001|Overall Study|Withdrawal by Subject|0|||
105688032|NCT03224325|364522446|FG002|Overall Study|Withdrawal by Subject|0|||
105688033|NCT03224325|364522447|FG003|Overall Study|Withdrawal by Subject|1|||
105688034|NCT03224325|364522448|FG004|Overall Study|Withdrawal by Subject|0|||
105688035|NCT03224325|364522449|FG005|Overall Study|Withdrawal by Subject|0|||
105688036|NCT03224325|364522450|FG006|Overall Study|Withdrawal by Subject|0|||
105688037|NCT00888433|364522451|FG000|Overall Study|Withdrawal by Subject|1|||
105688038|NCT00888433|364522452|FG001|Overall Study|Withdrawal by Subject|2|||
105688039|NCT00888433|364522451|FG000|Overall Study|Missed Visit|2|||
105688040|NCT00888433|364522452|FG001|Overall Study|Missed Visit|1|||
105688041|NCT04796896|364522455|FG000|Overall Study|Adverse Event|1|||
105688042|NCT04796896|364522456|FG001|Overall Study|Adverse Event|0|||
105918970|NCT02858401|365363486|FG005|Overall Study|Withdrew Consent|1|||
105918971|NCT02858401|365363487|FG006|Overall Study|Withdrew Consent|0|||
105918972|NCT02858401|365363481|FG000|Overall Study|Lost to Follow-up|0|||
105918973|NCT02858401|365363482|FG001|Overall Study|Lost to Follow-up|1|||
105918974|NCT02858401|365363483|FG002|Overall Study|Lost to Follow-up|0|||
105918975|NCT02858401|365363484|FG003|Overall Study|Lost to Follow-up|0|||
105918976|NCT02858401|365363485|FG004|Overall Study|Lost to Follow-up|0|||
105918977|NCT02858401|365363486|FG005|Overall Study|Lost to Follow-up|0|||
105918978|NCT02858401|365363487|FG006|Overall Study|Lost to Follow-up|0|||
105918979|NCT03722576|365363489|FG000|Overall Study|Withdrawal by Subject|3|||
105918980|NCT03722576|365363489|FG000|Overall Study|Adverse Event|2|||
105918981|NCT03722576|365363489|FG000|Overall Study|Physician Decision|1|||
105918982|NCT03722576|365363489|FG000|Overall Study|Lost to Follow-up|1|||
105918983|NCT01569022|365363490|FG000|First Intervention|Lost to Follow-up|2|||
105918984|NCT01569022|365363491|FG001|First Intervention|Lost to Follow-up|1|||
105918985|NCT01569022|365363490|FG000|Second Intervention|Lost to Follow-up|2|||
105918986|NCT01569022|365363491|FG001|Second Intervention|Lost to Follow-up|2|||
105918987|NCT03426345|365363496|FG000|Overall Study|Adverse Event|4|||
105918988|NCT03426345|365363497|FG001|Overall Study|Adverse Event|4|||
105918989|NCT03426345|365363496|FG000|Overall Study|Lack of Efficacy|1|||
105918990|NCT03426345|365363497|FG001|Overall Study|Lack of Efficacy|0|||
105918991|NCT03426345|365363496|FG000|Overall Study|Withdrawal by Subject|5|||
105918992|NCT03426345|365363497|FG001|Overall Study|Withdrawal by Subject|6|||
105918993|NCT03426345|365363496|FG000|Overall Study|Lost to Follow-up|3|||
105918994|NCT03426345|365363497|FG001|Overall Study|Lost to Follow-up|1|||
105918995|NCT03426345|365363496|FG000|Overall Study|Protocol Deviation|3|||
105688043|NCT04796896|364522457|FG002|Overall Study|Adverse Event|0|||
105688044|NCT04796896|364522458|FG003|Overall Study|Adverse Event|0|||
105688045|NCT04796896|364522459|FG004|Overall Study|Adverse Event|0|||
105688046|NCT04796896|364522460|FG005|Overall Study|Adverse Event|1|||
105688047|NCT04796896|364522461|FG006|Overall Study|Adverse Event|1|||
105918996|NCT03426345|365363497|FG001|Overall Study|Protocol Deviation|4|||
105918997|NCT03426345|365363496|FG000|Overall Study|Reason Not Specified|1|||
105918998|NCT03426345|365363497|FG001|Overall Study|Reason Not Specified|2|||
105688048|NCT04796896|364522462|FG007|Overall Study|Adverse Event|0|||
105918999|NCT03426345|365363496|FG000|Overall Study|Missing Completion Status|1|||
105919000|NCT03426345|365363497|FG001|Overall Study|Missing Completion Status|0|||
105919001|NCT00116142|365363498|FG000|Overall Study|Adverse Event|8|||
105919002|NCT00116142|365363499|FG001|Overall Study|Adverse Event|7|||
105688049|NCT04796896|364522463|FG008|Overall Study|Adverse Event|1|||
105688050|NCT04796896|364522464|FG009|Overall Study|Adverse Event|1|||
105688051|NCT04796896|364522465|FG010|Overall Study|Adverse Event|1|||
105688052|NCT04796896|364522466|FG011|Overall Study|Adverse Event|0|||
105688053|NCT04796896|364522455|FG000|Overall Study|Lost to Follow-up|24|||
105688054|NCT04796896|364522456|FG001|Overall Study|Lost to Follow-up|15|||
105688055|NCT04796896|364522457|FG002|Overall Study|Lost to Follow-up|6|||
105688056|NCT04796896|364522458|FG003|Overall Study|Lost to Follow-up|4|||
105688057|NCT04796896|364522459|FG004|Overall Study|Lost to Follow-up|21|||
105688058|NCT04796896|364522460|FG005|Overall Study|Lost to Follow-up|55|||
105688059|NCT04796896|364522461|FG006|Overall Study|Lost to Follow-up|237|||
105688060|NCT04796896|364522462|FG007|Overall Study|Lost to Follow-up|52|||
105919003|NCT00116142|365363498|FG000|Overall Study|Protocol Violation|2|||
105919004|NCT00116142|365363499|FG001|Overall Study|Protocol Violation|1|||
105688061|NCT04796896|364522463|FG008|Overall Study|Lost to Follow-up|221|||
105688062|NCT04796896|364522464|FG009|Overall Study|Lost to Follow-up|43|||
105688063|NCT04796896|364522465|FG010|Overall Study|Lost to Follow-up|142|||
105688064|NCT04796896|364522466|FG011|Overall Study|Lost to Follow-up|18|||
105688065|NCT04796896|364522455|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
105688066|NCT04796896|364522456|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
105688067|NCT04796896|364522457|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
105688068|NCT04796896|364522458|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
105688069|NCT04796896|364522459|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
105688070|NCT04796896|364522460|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
105688071|NCT04796896|364522461|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
105688072|NCT04796896|364522462|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
105688073|NCT04796896|364522463|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
105688074|NCT04796896|364522464|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
105919005|NCT00116142|365363498|FG000|Overall Study|Withdrawal by Subject|5|||
105919006|NCT00116142|365363499|FG001|Overall Study|Withdrawal by Subject|5|||
105919007|NCT00116142|365363498|FG000|Overall Study|Physician Decision|3|||
105919008|NCT00116142|365363499|FG001|Overall Study|Physician Decision|1|||
105919009|NCT00116142|365363498|FG000|Overall Study|Delayed Radiation Therapy|1|||
105919010|NCT00116142|365363499|FG001|Overall Study|Delayed Radiation Therapy|0|||
105919011|NCT00116142|365363498|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
105919012|NCT00116142|365363499|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
105919013|NCT00116142|365363498|FG000|Overall Study|Patient stopped due to depression|0|||
105919014|NCT00116142|365363499|FG001|Overall Study|Patient stopped due to depression|1|||
105919015|NCT00116142|365363498|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
105919016|NCT00116142|365363499|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
105919017|NCT00116142|365363498|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
105919018|NCT00116142|365363499|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
105919019|NCT00116142|365363498|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
105919020|NCT00116142|365363499|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
105919021|NCT01302899|365363500|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
105919022|NCT01302899|365363501|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
105919023|NCT01302899|365363500|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
105688075|NCT04796896|364522465|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
105688076|NCT04796896|364522466|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
105688077|NCT04796896|364522455|FG000|Overall Study|Physician Decision|1|||
105688078|NCT04796896|364522456|FG001|Overall Study|Physician Decision|0|||
105688079|NCT04796896|364522457|FG002|Overall Study|Physician Decision|0|||
105688080|NCT04796896|364522458|FG003|Overall Study|Physician Decision|0|||
105688081|NCT04796896|364522459|FG004|Overall Study|Physician Decision|0|||
105688082|NCT04796896|364522460|FG005|Overall Study|Physician Decision|3|||
105688083|NCT04796896|364522461|FG006|Overall Study|Physician Decision|18|||
105688084|NCT04796896|364522462|FG007|Overall Study|Physician Decision|1|||
105688085|NCT04796896|364522463|FG008|Overall Study|Physician Decision|7|||
105688086|NCT04796896|364522464|FG009|Overall Study|Physician Decision|0|||
105688087|NCT04796896|364522465|FG010|Overall Study|Physician Decision|5|||
105688088|NCT04796896|364522466|FG011|Overall Study|Physician Decision|0|||
105688089|NCT04796896|364522455|FG000|Overall Study|Withdrawal by Subject|36|||
105688090|NCT04796896|364522456|FG001|Overall Study|Withdrawal by Subject|31|||
105688091|NCT04796896|364522457|FG002|Overall Study|Withdrawal by Subject|11|||
105688092|NCT04796896|364522458|FG003|Overall Study|Withdrawal by Subject|8|||
105688093|NCT04796896|364522459|FG004|Overall Study|Withdrawal by Subject|16|||
105688094|NCT04796896|364522460|FG005|Overall Study|Withdrawal by Subject|162|||
105688095|NCT04796896|364522461|FG006|Overall Study|Withdrawal by Subject|299|||
105688096|NCT04796896|364522462|FG007|Overall Study|Withdrawal by Subject|149|||
105688097|NCT04796896|364522463|FG008|Overall Study|Withdrawal by Subject|303|||
105688098|NCT04796896|364522464|FG009|Overall Study|Withdrawal by Subject|94|||
105688099|NCT04796896|364522465|FG010|Overall Study|Withdrawal by Subject|192|||
105688100|NCT04796896|364522466|FG011|Overall Study|Withdrawal by Subject|16|||
105919024|NCT01302899|365363501|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
105688101|NCT04796896|364522455|FG000|Overall Study|Other Than Specified|6|||
105688102|NCT04796896|364522456|FG001|Overall Study|Other Than Specified|5|||
105688103|NCT04796896|364522457|FG002|Overall Study|Other Than Specified|3|||
105919025|NCT02513550|365363502|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
105919026|NCT02513550|365363503|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
105688104|NCT04796896|364522458|FG003|Overall Study|Other Than Specified|2|||
105688105|NCT04796896|364522459|FG004|Overall Study|Other Than Specified|6|||
105688106|NCT04796896|364522460|FG005|Overall Study|Other Than Specified|31|||
105688107|NCT04796896|364522461|FG006|Overall Study|Other Than Specified|86|||
105688108|NCT04796896|364522462|FG007|Overall Study|Other Than Specified|66|||
105688109|NCT04796896|364522463|FG008|Overall Study|Other Than Specified|388|||
105688110|NCT04796896|364522464|FG009|Overall Study|Other Than Specified|48|||
105688111|NCT04796896|364522465|FG010|Overall Study|Other Than Specified|258|||
105688112|NCT04796896|364522466|FG011|Overall Study|Other Than Specified|4|||
105688113|NCT04796896|364522455|FG000|Overall Study|Protocol Deviation|0|||
105688114|NCT04796896|364522456|FG001|Overall Study|Protocol Deviation|0|||
105688115|NCT04796896|364522457|FG002|Overall Study|Protocol Deviation|0|||
105688116|NCT04796896|364522458|FG003|Overall Study|Protocol Deviation|1|||
105688117|NCT04796896|364522459|FG004|Overall Study|Protocol Deviation|1|||
105688118|NCT04796896|364522460|FG005|Overall Study|Protocol Deviation|2|||
105688119|NCT04796896|364522461|FG006|Overall Study|Protocol Deviation|2|||
105688120|NCT04796896|364522462|FG007|Overall Study|Protocol Deviation|2|||
105688121|NCT04796896|364522463|FG008|Overall Study|Protocol Deviation|2|||
105688122|NCT04796896|364522464|FG009|Overall Study|Protocol Deviation|1|||
105688123|NCT04796896|364522465|FG010|Overall Study|Protocol Deviation|0|||
105688124|NCT04796896|364522466|FG011|Overall Study|Protocol Deviation|0|||
105688125|NCT04796896|364522455|FG000|Overall Study|Missing|0|||
105688126|NCT04796896|364522456|FG001|Overall Study|Missing|0|||
105688127|NCT04796896|364522457|FG002|Overall Study|Missing|0|||
105688128|NCT04796896|364522458|FG003|Overall Study|Missing|0|||
105688129|NCT04796896|364522459|FG004|Overall Study|Missing|0|||
105688130|NCT04796896|364522460|FG005|Overall Study|Missing|0|||
105688131|NCT04796896|364522461|FG006|Overall Study|Missing|2|||
105688132|NCT04796896|364522462|FG007|Overall Study|Missing|1|||
105688133|NCT04796896|364522463|FG008|Overall Study|Missing|2|||
105688134|NCT04796896|364522464|FG009|Overall Study|Missing|1|||
105688135|NCT04796896|364522465|FG010|Overall Study|Missing|1|||
105688136|NCT04796896|364522466|FG011|Overall Study|Missing|0|||
105688137|NCT04796896|364522455|FG000|Overall Study|Death|0|||
105688138|NCT04796896|364522456|FG001|Overall Study|Death|0|||
105688139|NCT04796896|364522457|FG002|Overall Study|Death|0|||
105688140|NCT04796896|364522458|FG003|Overall Study|Death|0|||
105688141|NCT04796896|364522459|FG004|Overall Study|Death|0|||
105688142|NCT04796896|364522460|FG005|Overall Study|Death|0|||
105688143|NCT04796896|364522461|FG006|Overall Study|Death|0|||
105688144|NCT04796896|364522462|FG007|Overall Study|Death|0|||
105688145|NCT04796896|364522463|FG008|Overall Study|Death|1|||
105688146|NCT04796896|364522464|FG009|Overall Study|Death|0|||
105688147|NCT04796896|364522465|FG010|Overall Study|Death|0|||
105688148|NCT04796896|364522466|FG011|Overall Study|Death|0|||
105688149|NCT01177787|364522469|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
105688150|NCT01177787|364522469|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
105688151|NCT01177787|364522469|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
105688152|NCT01637623|364522473|FG000|Overall Study|Lost to Follow-up|0|||
105688153|NCT01637623|364522474|FG001|Overall Study|Lost to Follow-up|0|||
105688154|NCT01637623|364522475|FG002|Overall Study|Lost to Follow-up|2|||
105688155|NCT01637623|364522473|FG000|Overall Study|Physician Decision|1|||
105688156|NCT01637623|364522474|FG001|Overall Study|Physician Decision|0|||
105688157|NCT01637623|364522475|FG002|Overall Study|Physician Decision|1|||
105688158|NCT00879762|364522476|FG000|Overall Study|Lost to Follow-up|3|||
105919027|NCT02513550|365363504|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
105919028|NCT02513550|365363505|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
105919029|NCT02513550|365363506|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
105919030|NCT02513550|365363507|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
105919031|NCT02513550|365363502|FG000|Double Blind Treatment Period|Adverse Event|5|||
105919032|NCT02513550|365363503|FG001|Double Blind Treatment Period|Adverse Event|13|||
105919033|NCT02513550|365363504|FG002|Double Blind Treatment Period|Adverse Event|17|||
105919034|NCT02513550|365363505|FG003|Double Blind Treatment Period|Adverse Event|0|||
105919035|NCT02513550|365363506|FG004|Double Blind Treatment Period|Adverse Event|1|||
105919036|NCT02513550|365363507|FG005|Double Blind Treatment Period|Adverse Event|0|||
105688159|NCT00879762|364522477|FG001|Overall Study|Lost to Follow-up|1|||
105786720|NCT01711736|364872890|FG001|Overall Study|Withdrawal by Subject|6|||
105919037|NCT02513550|365363502|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
105688160|NCT01676909|364522478|FG000|Overall Study|Withdrawal by Subject|3|||
105786721|NCT01711736|364872889|FG000|Overall Study|Migrated/moved from study area|2|||
105688161|NCT01676909|364522479|FG001|Overall Study|Withdrawal by Subject|5|||
105688162|NCT01676909|364522478|FG000|Overall Study|Lost to Follow-up|15|||
105688163|NCT01676909|364522479|FG001|Overall Study|Lost to Follow-up|9|||
105688164|NCT00881608|364522480|FG000|Overall Study|Study prematurely terminated|11|||
105688165|NCT00887679|364522481|FG000|Overall Study|Withdrawal by Subject|1|||
105688166|NCT00887679|364522481|FG000|Overall Study|Lost to Follow-up|4|||
105688167|NCT00887679|364522481|FG000|Overall Study|Physician Decision|5|||
105688168|NCT03294109|364522486|FG000|Overall Study|Withdrawal by Subject|6|||
105688169|NCT03294109|364522487|FG001|Overall Study|Withdrawal by Subject|5|||
105688170|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
105688171|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
105688172|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
105688173|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
105688174|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
105688175|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
105688176|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
105688177|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
105688178|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
105688179|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
105688180|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
105688181|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
105688182|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
105688183|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
105688184|NCT01294683|364522488|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
105688185|NCT01294683|364522489|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
105688186|NCT01294683|364522488|FG000|Post Crossover (Period III)|Adverse Event|6|||
105688187|NCT01294683|364522489|FG001|Post Crossover (Period III)|Adverse Event|6|||
105688188|NCT01294683|364522488|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
105688189|NCT01294683|364522489|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
105688190|NCT01294683|364522488|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
105688191|NCT01294683|364522489|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
105688192|NCT01294683|364522488|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
105688193|NCT01294683|364522489|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
105688194|NCT01881750|364522494|FG000|Overall Study|Changes in concomitant therapies|2|||
105688195|NCT01881750|364522495|FG001|Overall Study|Changes in concomitant therapies|3|||
105688196|NCT01881750|364522494|FG000|Overall Study|Lost to Follow-up|0|||
105688197|NCT01881750|364522495|FG001|Overall Study|Lost to Follow-up|1|||
105688198|NCT00147823|364522501|FG000|Overall Study|Lost to Follow-up|6|||
105688199|NCT00147823|364522502|FG001|Overall Study|Lost to Follow-up|12|||
105688200|NCT00147823|364522501|FG000|Overall Study|Physician Decision|1|||
105688201|NCT00147823|364522502|FG001|Overall Study|Physician Decision|0|||
105688202|NCT00147823|364522501|FG000|Overall Study|Withdrawal by Subject|0|||
105688203|NCT00147823|364522502|FG001|Overall Study|Withdrawal by Subject|1|||
105688204|NCT00147823|364522501|FG000|Overall Study|Did not receive vitoss due to infection|6|||
105688205|NCT00147823|364522502|FG001|Overall Study|Did not receive vitoss due to infection|2|||
105688206|NCT02804178|364522505|FG000|Overall Study|Adverse Event|1|||
105688207|NCT01290601|364522506|FG000|Overall Study|Adverse Event|0|||
105688208|NCT01290601|364522507|FG001|Overall Study|Adverse Event|2|||
105688209|NCT01290601|364522508|FG002|Overall Study|Adverse Event|0|||
105688210|NCT01290601|364522509|FG003|Overall Study|Adverse Event|0|||
105688211|NCT01290601|364522506|FG000|Overall Study|Lack of Efficacy|2|||
105688212|NCT01290601|364522507|FG001|Overall Study|Lack of Efficacy|1|||
105688213|NCT01290601|364522508|FG002|Overall Study|Lack of Efficacy|0|||
105688214|NCT01290601|364522509|FG003|Overall Study|Lack of Efficacy|0|||
105688215|NCT01290601|364522506|FG000|Overall Study|Lost to Follow-up|7|||
105688216|NCT01290601|364522507|FG001|Overall Study|Lost to Follow-up|2|||
105688217|NCT01290601|364522508|FG002|Overall Study|Lost to Follow-up|0|||
105688218|NCT01290601|364522509|FG003|Overall Study|Lost to Follow-up|0|||
105919038|NCT02513550|365363503|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
105919039|NCT02513550|365363504|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
105919040|NCT02513550|365363505|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
105919041|NCT02513550|365363506|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
105919042|NCT02513550|365363507|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
105919043|NCT02513550|365363502|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
105919044|NCT02513550|365363503|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
105919045|NCT02513550|365363504|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
105919046|NCT02513550|365363505|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
105919047|NCT02513550|365363506|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
105919048|NCT02513550|365363507|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
105919049|NCT02513550|365363502|FG000|Double Blind Treatment Period|Protocol Violation|1|||
106002592|NCT05051579|365670658|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
106002593|NCT05051579|365670659|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
106002594|NCT05051579|365670660|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
105688219|NCT01290601|364522506|FG000|Overall Study|Other|1|||
105688220|NCT01290601|364522507|FG001|Overall Study|Other|0|||
105688221|NCT01290601|364522508|FG002|Overall Study|Other|0|||
106130534|NCT00235495|366134235|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
105688222|NCT01290601|364522509|FG003|Overall Study|Other|0|||
105688223|NCT01290601|364522506|FG000|Overall Study|Protocol Violation|1|||
105688224|NCT01290601|364522507|FG001|Overall Study|Protocol Violation|0|||
105688225|NCT01290601|364522508|FG002|Overall Study|Protocol Violation|0|||
105919050|NCT02513550|365363503|FG001|Double Blind Treatment Period|Protocol Violation|1|||
105919051|NCT02513550|365363504|FG002|Double Blind Treatment Period|Protocol Violation|4|||
105919052|NCT02513550|365363505|FG003|Double Blind Treatment Period|Protocol Violation|0|||
105919053|NCT02513550|365363506|FG004|Double Blind Treatment Period|Protocol Violation|0|||
105919054|NCT02513550|365363507|FG005|Double Blind Treatment Period|Protocol Violation|0|||
105919055|NCT02513550|365363502|FG000|Double Blind Treatment Period|Physician Decision|2|||
105919056|NCT02513550|365363503|FG001|Double Blind Treatment Period|Physician Decision|0|||
105919057|NCT02513550|365363504|FG002|Double Blind Treatment Period|Physician Decision|4|||
105919058|NCT02513550|365363505|FG003|Double Blind Treatment Period|Physician Decision|0|||
105919059|NCT02513550|365363506|FG004|Double Blind Treatment Period|Physician Decision|0|||
105919060|NCT02513550|365363507|FG005|Double Blind Treatment Period|Physician Decision|0|||
105919061|NCT02513550|365363502|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
105919062|NCT02513550|365363503|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
105919063|NCT02513550|365363504|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
105919064|NCT02513550|365363505|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
105919065|NCT02513550|365363506|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
105919066|NCT02513550|365363507|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
105919067|NCT02513550|365363502|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105919068|NCT02513550|365363503|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
106130535|NCT04482855|366134239|FG000|Overall Study|Lost to Follow-up|1|||
105688226|NCT01290601|364522509|FG003|Overall Study|Protocol Violation|0|||
105919069|NCT02513550|365363504|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
106130536|NCT04482855|366134240|FG001|Overall Study|Lost to Follow-up|0|||
106130537|NCT04482855|366134239|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
106130538|NCT04482855|366134240|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
106130539|NCT04482855|366134239|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
106130540|NCT04482855|366134240|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
106130541|NCT02696226|366134242|FG000|Overall Study|Study terminated - lack of enrollment|1|||
106130542|NCT02696226|366134243|FG001|Overall Study|Study terminated - lack of enrollment|0|||
106130543|NCT02696226|366134244|FG002|Overall Study|Study terminated - lack of enrollment|2|||
106130544|NCT02696226|366134245|FG003|Overall Study|Study terminated - lack of enrollment|0|||
106130545|NCT02909101|366134246|FG000|Overall Study|Lost to Follow-up|1|||
106130546|NCT02909101|366134247|FG001|Overall Study|Lost to Follow-up|1|||
106130547|NCT01221181|366134248|FG000|Overall Study|Lost to Follow-up|1|||
106130548|NCT02698436|366134249|FG000|Overall Study|Adverse Event|1|||
106130549|NCT02698436|366134250|FG001|Overall Study|Adverse Event|0|||
106130550|NCT02698436|366134249|FG000|Overall Study|Withdrawal by Subject|3|||
106130551|NCT02698436|366134250|FG001|Overall Study|Withdrawal by Subject|3|||
106130552|NCT02698436|366134249|FG000|Overall Study|Lost to Follow-up|2|||
106130553|NCT02698436|366134250|FG001|Overall Study|Lost to Follow-up|4|||
106130554|NCT02698436|366134249|FG000|Overall Study|Non-compliance with study regimen|1|||
106130555|NCT02698436|366134250|FG001|Overall Study|Non-compliance with study regimen|0|||
106130556|NCT00429793|366134251|FG000|Overall Study|Improper pre-protocol treatment|3|||
106130557|NCT00429793|366134251|FG000|Overall Study|Required test not done|1|||
106130558|NCT00429793|366134251|FG000|Overall Study|Never treated|1|||
106130559|NCT00429793|366134251|FG000|Overall Study|Non-measurable|1|||
106130560|NCT00097370|366134252|FG000|Stage 1|Adverse Event|3|||
106130561|NCT00097370|366134252|FG000|Stage 1|Withdrawal by Subject|1|||
106130562|NCT00097370|366134252|FG000|Stage 1|Lack of Efficacy|2|||
106130563|NCT00097370|366134252|FG000|Stage 2|Adverse Event|5|||
106130564|NCT00097370|366134252|FG000|Stage 2|Withdrawal by Subject|1|||
106130565|NCT00097370|366134252|FG000|Stage 2|Lack of Efficacy|3|||
106130566|NCT00097370|366134252|FG000|Stage 2|Pregnancy|1|||
106130567|NCT00097370|366134252|FG000|Stage 2|Sponsor Terminated Study|2|||
106130568|NCT00097370|366134252|FG000|Stage 2|Lost to Follow-up|1|||
106130569|NCT00097370|366134252|FG000|Stage 3|Adverse Event|2|||
106130570|NCT00097370|366134252|FG000|Stage 3|Withdrawal by Subject|3|||
106130571|NCT00097370|366134252|FG000|Stage 3|Lack of Efficacy|1|||
105688227|NCT00775450|364522510|FG000|Overall Study|Serious Adverse Event|2|||
105688228|NCT00775450|364522511|FG001|Overall Study|Serious Adverse Event|0|||
105688229|NCT00775450|364522512|FG002|Overall Study|Serious Adverse Event|0|||
105688230|NCT00775450|364522513|FG003|Overall Study|Serious Adverse Event|0|||
105688231|NCT00775450|364522514|FG004|Overall Study|Serious Adverse Event|0|||
105688232|NCT00775450|364522510|FG000|Overall Study|Protocol Violation|0|||
105688233|NCT00775450|364522511|FG001|Overall Study|Protocol Violation|0|||
105688234|NCT00775450|364522512|FG002|Overall Study|Protocol Violation|0|||
105688235|NCT00775450|364522513|FG003|Overall Study|Protocol Violation|0|||
105688236|NCT00775450|364522514|FG004|Overall Study|Protocol Violation|1|||
105688237|NCT00775450|364522510|FG000|Overall Study|Withdrawal by Subject|1|||
105688238|NCT00775450|364522511|FG001|Overall Study|Withdrawal by Subject|0|||
105688239|NCT00775450|364522512|FG002|Overall Study|Withdrawal by Subject|0|||
105688240|NCT00775450|364522513|FG003|Overall Study|Withdrawal by Subject|0|||
105688241|NCT00775450|364522514|FG004|Overall Study|Withdrawal by Subject|1|||
105688242|NCT01749540|364522517|FG000|Overall Study|Protocol Violation|0|||
105688243|NCT01749540|364522518|FG001|Overall Study|Protocol Violation|0|||
105688244|NCT01749540|364522519|FG002|Overall Study|Protocol Violation|0|||
105688245|NCT01749540|364522520|FG003|Overall Study|Protocol Violation|0|||
105688246|NCT01749540|364522521|FG004|Overall Study|Protocol Violation|0|||
105688247|NCT01749540|364522522|FG005|Overall Study|Protocol Violation|1|||
105688248|NCT01749540|364522523|FG006|Overall Study|Protocol Violation|1|||
105688249|NCT01749540|364522517|FG000|Overall Study|Withdrawal by Subject|0|||
105688250|NCT01749540|364522518|FG001|Overall Study|Withdrawal by Subject|0|||
105688251|NCT01749540|364522519|FG002|Overall Study|Withdrawal by Subject|0|||
105688252|NCT01749540|364522520|FG003|Overall Study|Withdrawal by Subject|1|||
105688253|NCT01749540|364522521|FG004|Overall Study|Withdrawal by Subject|0|||
105688254|NCT01749540|364522522|FG005|Overall Study|Withdrawal by Subject|0|||
105688255|NCT01749540|364522523|FG006|Overall Study|Withdrawal by Subject|0|||
105688256|NCT01749540|364522517|FG000|Overall Study|Initiated into extension study A536-06|0|||
105688257|NCT01749540|364522518|FG001|Overall Study|Initiated into extension study A536-06|0|||
105688258|NCT01749540|364522519|FG002|Overall Study|Initiated into extension study A536-06|0|||
105688259|NCT01749540|364522520|FG003|Overall Study|Initiated into extension study A536-06|0|||
105688260|NCT01749540|364522521|FG004|Overall Study|Initiated into extension study A536-06|0|||
105688261|NCT01749540|364522522|FG005|Overall Study|Initiated into extension study A536-06|2|||
105688262|NCT01749540|364522523|FG006|Overall Study|Initiated into extension study A536-06|24|||
105688263|NCT01055262|364522524|FG000|Overall Study|Adverse Event|5|||
105688264|NCT01055262|364522524|FG000|Overall Study|Protocol Violation|3|||
105688265|NCT01055262|364522524|FG000|Overall Study|Uncooperativeness|1|||
105688266|NCT01765179|364522525|FG000|Overall Study|Adverse Event|3|||
105688267|NCT01765179|364522525|FG000|Overall Study|Lost to Follow-up|5|||
105688268|NCT01765179|364522525|FG000|Overall Study|Non-compliance with study drug|2|||
105688269|NCT01765179|364522525|FG000|Overall Study|Protocol Violation|1|||
105688270|NCT01765179|364522525|FG000|Overall Study|Withdrawal by Subject|8|||
105688271|NCT01765179|364522525|FG000|Overall Study|Hematocrit >54%|3|||
105688272|NCT01765179|364522525|FG000|Overall Study|prohibited med|1|||
105688273|NCT01765179|364522525|FG000|Overall Study|Out of country unable to finish study|1|||
105688274|NCT01765179|364522525|FG000|Overall Study|lack of venous access|1|||
105688275|NCT01765179|364522525|FG000|Overall Study|work conflict|1|||
105688276|NCT01765179|364522525|FG000|Overall Study|Ca elevated 10.6|1|||
105688277|NCT00894686|364522526|FG000|Overall Study|Withdrawal by Subject|50|||
105688278|NCT00894686|364522526|FG000|Overall Study|Physician Decision|1|||
105688279|NCT00894686|364522526|FG000|Overall Study|Other|5|||
105688280|NCT00564018|364522527|FG000|Overall Study|Withdrawal by Subject|2|||
105688281|NCT00564018|364522528|FG001|Overall Study|Withdrawal by Subject|3|||
105688282|NCT00564018|364522529|FG002|Overall Study|Withdrawal by Subject|1|||
105688283|NCT03291587|364522531|FG000|Overall Study|Lost to Follow-up|62|||
105688284|NCT03291587|364522532|FG001|Overall Study|Lost to Follow-up|43|||
105786722|NCT01711736|364872890|FG001|Overall Study|Migrated/moved from study area|1|||
105786723|NCT00750061|364872895|FG000|Overall Study|Adverse Event|2|||
105786724|NCT00750061|364872896|FG001|Overall Study|Adverse Event|0|||
105786725|NCT00750061|364872895|FG000|Overall Study|Withdrawal by Subject|0|||
105786726|NCT00750061|364872896|FG001|Overall Study|Withdrawal by Subject|1|||
105688285|NCT03291587|364522531|FG000|Overall Study|Refused to Answer|5|||
105786727|NCT00750061|364872895|FG000|Overall Study|Physician Decision|0|||
105919070|NCT02513550|365363505|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105919071|NCT02513550|365363506|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105786728|NCT00750061|364872896|FG001|Overall Study|Physician Decision|1|||
105786729|NCT04196023|364872898|FG000|Overall Study|Withdrawal by Subject|0|||
105688286|NCT03291587|364522532|FG001|Overall Study|Refused to Answer|2|||
105688287|NCT03291587|364522531|FG000|Overall Study|Death|2|||
105688288|NCT03291587|364522532|FG001|Overall Study|Death|4|||
105688289|NCT03291587|364522531|FG000|Overall Study|Not interested in participating|8|||
105688290|NCT03291587|364522532|FG001|Overall Study|Not interested in participating|6|||
105688291|NCT03291587|364522531|FG000|Overall Study|Too busy to participate|4|||
105688292|NCT03291587|364522532|FG001|Overall Study|Too busy to participate|2|||
105786730|NCT04196023|364872899|FG001|Overall Study|Withdrawal by Subject|1|||
105786731|NCT04196023|364872898|FG000|Overall Study|Adverse Event|3|||
105786732|NCT04196023|364872899|FG001|Overall Study|Adverse Event|1|||
105786733|NCT04196023|364872898|FG000|Overall Study|Lost to Follow-up|0|||
105786734|NCT04196023|364872899|FG001|Overall Study|Lost to Follow-up|1|||
105786735|NCT04359758|364872900|FG000|Overall Study|Protocol Violation|3|||
105786736|NCT04359758|364872901|FG001|Overall Study|Protocol Violation|2|||
105786737|NCT03099096|364872902|FG000|Overall Study|Adverse Event|1|||
105786738|NCT03099096|364872902|FG000|Overall Study|Physician Decision|1|||
105786739|NCT04753606|364872903|FG000|Overall Study|Adverse Event|1|||
105786740|NCT04753606|364872904|FG001|Overall Study|Adverse Event|0|||
105786741|NCT04753606|364872905|FG002|Overall Study|Adverse Event|0|||
105786742|NCT00752206|364872910|FG000|Overall Study|Disease progression|8|||
105786743|NCT00752206|364872911|FG001|Overall Study|Disease progression|11|||
105786744|NCT00752206|364872910|FG000|Overall Study|Pregnancy|1|||
105786745|NCT00752206|364872911|FG001|Overall Study|Pregnancy|0|||
105786746|NCT00678652|364872912|FG000|Overall Study|Protocol Violation|2|||
105786747|NCT00678652|364872913|FG001|Overall Study|Protocol Violation|0|||
105786748|NCT00678652|364872914|FG002|Overall Study|Protocol Violation|0|||
105786749|NCT00678652|364872915|FG003|Overall Study|Protocol Violation|0|||
105786750|NCT00678652|364872912|FG000|Overall Study|Pregnancy|0|||
105786751|NCT00678652|364872913|FG001|Overall Study|Pregnancy|0|||
105786752|NCT00678652|364872914|FG002|Overall Study|Pregnancy|1|||
105786753|NCT00678652|364872915|FG003|Overall Study|Pregnancy|0|||
105786754|NCT00678652|364872912|FG000|Overall Study|Relocation|1|||
105786755|NCT00678652|364872913|FG001|Overall Study|Relocation|0|||
105786756|NCT00678652|364872914|FG002|Overall Study|Relocation|0|||
105786757|NCT00678652|364872915|FG003|Overall Study|Relocation|0|||
105786758|NCT04365387|364872918|FG000|Overall Study|Adverse Event|4|||
105786759|NCT04365387|364872919|FG001|Overall Study|Adverse Event|2|||
105786760|NCT04365387|364872918|FG000|Overall Study|Participants request|14|||
105786761|NCT04365387|364872919|FG001|Overall Study|Participants request|14|||
105786762|NCT04365387|364872918|FG000|Overall Study|Lost to Follow-up|8|||
105786763|NCT04365387|364872919|FG001|Overall Study|Lost to Follow-up|5|||
105786764|NCT04365387|364872918|FG000|Overall Study|Protocol deviation|3|||
105786765|NCT04365387|364872919|FG001|Overall Study|Protocol deviation|4|||
105786766|NCT04365387|364872918|FG000|Overall Study|Participant compliance with visit schedule|1|||
105786767|NCT04365387|364872919|FG001|Overall Study|Participant compliance with visit schedule|0|||
105786768|NCT04365387|364872918|FG000|Overall Study|Participant incarcerated|1|||
105786769|NCT04365387|364872919|FG001|Overall Study|Participant incarcerated|0|||
105786770|NCT04365387|364872918|FG000|Overall Study|Participant moved out of town (relocated)|0|||
105786771|NCT04365387|364872919|FG001|Overall Study|Participant moved out of town (relocated)|1|||
105786772|NCT04365387|364872918|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
105919072|NCT02513550|365363507|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
105919073|NCT02513550|365363502|FG000|Double Blind Treatment Period|Due to personal business|2|||
105919074|NCT02513550|365363503|FG001|Double Blind Treatment Period|Due to personal business|0|||
105919075|NCT02513550|365363504|FG002|Double Blind Treatment Period|Due to personal business|1|||
105919076|NCT02513550|365363505|FG003|Double Blind Treatment Period|Due to personal business|0|||
105919077|NCT02513550|365363506|FG004|Double Blind Treatment Period|Due to personal business|0|||
105919078|NCT02513550|365363507|FG005|Double Blind Treatment Period|Due to personal business|0|||
105919079|NCT02513550|365363502|FG000|Double Blind Treatment Period|Death|1|||
105919080|NCT02513550|365363503|FG001|Double Blind Treatment Period|Death|0|||
105786773|NCT04365387|364872919|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
105786774|NCT04365387|364872918|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
105786775|NCT04365387|364872919|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
105786776|NCT05770401|364872920|FG000|Overall Study|Lost to Follow-up|5|||
105786777|NCT05770401|364872921|FG001|Overall Study|Lost to Follow-up|4|||
105786778|NCT00402298|364872922|FG000|Overall Study|Withdrawal by Subject|1|||
105786779|NCT00402298|364872923|FG001|Overall Study|Withdrawal by Subject|0|||
105786780|NCT04784455|364872924|FG000|Overall Study|Death|4|||
105786781|NCT05570604|364872925|FG000|Overall Study|Lost to Follow-up|1|||
105786782|NCT05570604|364872926|FG001|Overall Study|Lost to Follow-up|5|||
105786783|NCT05570604|364872925|FG000|Overall Study|Illness|2|||
105688293|NCT01116882|364522533|FG000|30-day|Lost to Follow-up|50|||
105688294|NCT01116882|364522534|FG001|30-day|Lost to Follow-up|21|||
105688295|NCT01116882|364522533|FG000|30-day|Withdrawal by Subject|2|||
105688296|NCT01116882|364522534|FG001|30-day|Withdrawal by Subject|4|||
105688297|NCT01116882|364522533|FG000|30-day|Other Reasons|16|||
105688298|NCT01116882|364522534|FG001|30-day|Other Reasons|6|||
105688299|NCT01116882|364522533|FG000|12-month|Lost to Follow-up|111|||
105688300|NCT01116882|364522534|FG001|12-month|Lost to Follow-up|42|||
105688301|NCT01116882|364522533|FG000|12-month|Other Reasons|151|||
105688302|NCT01116882|364522534|FG001|12-month|Other Reasons|49|||
105688303|NCT01116882|364522533|FG000|12-month|Withdrawal by Subject|5|||
105688304|NCT01116882|364522534|FG001|12-month|Withdrawal by Subject|8|||
105688305|NCT00372385|364522535|FG000|Overall Study|Adverse Event|6|||
105688306|NCT00372385|364522536|FG001|Overall Study|Adverse Event|11|||
105688307|NCT00372385|364522537|FG002|Overall Study|Adverse Event|9|||
105688308|NCT00372385|364522538|FG003|Overall Study|Adverse Event|7|||
105688309|NCT00372385|364522535|FG000|Overall Study|Noncompliance|0|||
105688310|NCT00372385|364522536|FG001|Overall Study|Noncompliance|1|||
105688311|NCT00372385|364522537|FG002|Overall Study|Noncompliance|1|||
105688312|NCT00372385|364522538|FG003|Overall Study|Noncompliance|1|||
105688313|NCT00372385|364522535|FG000|Overall Study|Physician Decision|1|||
105688314|NCT00372385|364522536|FG001|Overall Study|Physician Decision|0|||
105688315|NCT00372385|364522537|FG002|Overall Study|Physician Decision|0|||
105688316|NCT00372385|364522538|FG003|Overall Study|Physician Decision|0|||
105688317|NCT00372385|364522535|FG000|Overall Study|Lost to Follow-up|2|||
105688318|NCT00372385|364522536|FG001|Overall Study|Lost to Follow-up|0|||
105688319|NCT00372385|364522537|FG002|Overall Study|Lost to Follow-up|0|||
105688320|NCT00372385|364522538|FG003|Overall Study|Lost to Follow-up|0|||
105688321|NCT00372385|364522535|FG000|Overall Study|Withdrawal by Subject|2|||
105688322|NCT00372385|364522536|FG001|Overall Study|Withdrawal by Subject|1|||
105688323|NCT00372385|364522537|FG002|Overall Study|Withdrawal by Subject|0|||
105688324|NCT00372385|364522538|FG003|Overall Study|Withdrawal by Subject|0|||
105688325|NCT00372385|364522535|FG000|Overall Study|Refusal of Treatment|3|||
105688326|NCT00372385|364522536|FG001|Overall Study|Refusal of Treatment|6|||
105688327|NCT00372385|364522537|FG002|Overall Study|Refusal of Treatment|0|||
105688328|NCT00372385|364522538|FG003|Overall Study|Refusal of Treatment|0|||
105688329|NCT00372385|364522535|FG000|Overall Study|No Response|1|||
105688330|NCT00372385|364522536|FG001|Overall Study|No Response|1|||
105688331|NCT00372385|364522537|FG002|Overall Study|No Response|0|||
105688332|NCT00372385|364522538|FG003|Overall Study|No Response|0|||
105688333|NCT00372385|364522535|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
105688334|NCT00372385|364522536|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
105688335|NCT00372385|364522537|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
105688336|NCT00372385|364522538|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
105688337|NCT00372385|364522535|FG000|Overall Study|Virologic Stopping Rule|17|||
105688338|NCT00372385|364522536|FG001|Overall Study|Virologic Stopping Rule|0|||
105688339|NCT00372385|364522537|FG002|Overall Study|Virologic Stopping Rule|0|||
105688340|NCT00372385|364522538|FG003|Overall Study|Virologic Stopping Rule|0|||
105688341|NCT01139658|364522541|FG000|Overall Study|Adverse Event|10|||
105688342|NCT01139658|364522542|FG001|Overall Study|Adverse Event|27|||
105688343|NCT01139658|364522541|FG000|Overall Study|Lack of Efficacy|15|||
105688344|NCT01139658|364522542|FG001|Overall Study|Lack of Efficacy|7|||
105688345|NCT01139658|364522541|FG000|Overall Study|Withdrawal by Subject|2|||
105688346|NCT01139658|364522542|FG001|Overall Study|Withdrawal by Subject|4|||
105688347|NCT01139658|364522541|FG000|Overall Study|No documentation of treatment|1|||
105688348|NCT01139658|364522542|FG001|Overall Study|No documentation of treatment|0|||
105688349|NCT01139658|364522541|FG000|Overall Study|Other|28|||
105688350|NCT01139658|364522542|FG001|Overall Study|Other|75|||
105688351|NCT00504881|364522543|FG000|Overall Study|Lack of Efficacy|1|||
105688352|NCT00504881|364522544|FG001|Overall Study|Lack of Efficacy|5|||
105688353|NCT00504881|364522543|FG000|Overall Study|Lost to Follow-up|0|||
105688354|NCT00504881|364522544|FG001|Overall Study|Lost to Follow-up|2|||
105688355|NCT00504881|364522543|FG000|Overall Study|Withdrawal by Subject|1|||
105688356|NCT00504881|364522544|FG001|Overall Study|Withdrawal by Subject|4|||
105688357|NCT00504881|364522543|FG000|Overall Study|Non-Compliance|1|||
105688358|NCT00504881|364522544|FG001|Overall Study|Non-Compliance|0|||
105688359|NCT00504881|364522543|FG000|Overall Study|No Birth Control|0|||
105688360|NCT00504881|364522544|FG001|Overall Study|No Birth Control|1|||
105688361|NCT00504881|364522543|FG000|Overall Study|Safety Visit not performed|0|||
105688362|NCT00504881|364522544|FG001|Overall Study|Safety Visit not performed|1|||
105688363|NCT00504881|364522543|FG000|Overall Study|AE, serious fatal|0|||
105688364|NCT00504881|364522544|FG001|Overall Study|AE, serious fatal|1|||
105688365|NCT00504881|364522543|FG000|Overall Study|SAE, non-fatal|2|||
105688366|NCT00504881|364522544|FG001|Overall Study|SAE, non-fatal|6|||
105688367|NCT00504881|364522543|FG000|Overall Study|AE, non-serious non-fatal|4|||
105688368|NCT00504881|364522544|FG001|Overall Study|AE, non-serious non-fatal|14|||
105688369|NCT00504881|364522543|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105688370|NCT00504881|364522544|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
105786784|NCT05570604|364872926|FG001|Overall Study|Illness|2|||
105688371|NCT00504881|364522543|FG000|Overall Study|AE of unknown type|1|||
105688372|NCT00504881|364522544|FG001|Overall Study|AE of unknown type|0|||
105688373|NCT03240874|364522546|FG000|Overall Study|Lost to Follow-up|0|||
105688374|NCT03240874|364522547|FG001|Overall Study|Lost to Follow-up|2|||
105688375|NCT03240874|364522548|FG002|Overall Study|Lost to Follow-up|4|||
105688376|NCT03240874|364522549|FG003|Overall Study|Lost to Follow-up|1|||
105688377|NCT04223856|364522556|FG000|Overall Study|Progressive disease|153|||
105688378|NCT04223856|364522557|FG001|Overall Study|Progressive disease|73|||
105688379|NCT04223856|364522556|FG000|Overall Study|Adverse Event|97|||
105688380|NCT04223856|364522557|FG001|Overall Study|Adverse Event|62|||
105688381|NCT04223856|364522556|FG000|Overall Study|Physician Decision|9|||
105688382|NCT04223856|364522557|FG001|Overall Study|Physician Decision|28|||
105688383|NCT04223856|364522556|FG000|Overall Study|Withdrawal by Subject|22|||
105688384|NCT04223856|364522557|FG001|Overall Study|Withdrawal by Subject|24|||
105688385|NCT04223856|364522556|FG000|Overall Study|Other|7|||
105688386|NCT04223856|364522557|FG001|Overall Study|Other|2|||
105688387|NCT04223856|364522556|FG000|Overall Study|Randomized but not treated|2|||
105688388|NCT04223856|364522557|FG001|Overall Study|Randomized but not treated|11|||
105688389|NCT04223856|364522556|FG000|Overall Study|On-treatment|144|||
105688390|NCT04223856|364522557|FG001|Overall Study|On-treatment|0|||
105688391|NCT06515483|364522560|FG000|Overall Study|Subject withdraw due to family issues|1|||
105688392|NCT06515483|364522561|FG001|Overall Study|Subject withdraw due to family issues|0|||
105688393|NCT02101034|364524098|FG000|Overall Study|Enrolled but did not start treatment|0|||
105688394|NCT02101034|364524099|FG001|Overall Study|Enrolled but did not start treatment|0|||
105919081|NCT02513550|365363504|FG002|Double Blind Treatment Period|Death|2|||
105919082|NCT02513550|365363505|FG003|Double Blind Treatment Period|Death|0|||
105919083|NCT02513550|365363506|FG004|Double Blind Treatment Period|Death|0|||
105919084|NCT02513550|365363507|FG005|Double Blind Treatment Period|Death|0|||
105919085|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
105919086|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
105919087|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
105919088|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105919089|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105919090|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
105919091|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
105919092|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
105919093|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
105919094|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
105919095|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
105919096|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
105919097|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
105919098|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
105919099|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
105919100|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105919101|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105919102|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
105919103|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
105919104|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
105919105|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
105919106|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
105919107|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
105919108|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
105919109|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
105919110|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
105919111|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
105919112|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
105919113|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
105919114|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
106002595|NCT05051579|365670661|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
106002596|NCT00141102|365670662|FG000|Overall Study|Adverse Event|233|||
106002597|NCT00141102|365670663|FG001|Overall Study|Adverse Event|305|||
106002598|NCT00141102|365670662|FG000|Overall Study|Laboratory Abnormality|9|||
106002599|NCT00141102|365670663|FG001|Overall Study|Laboratory Abnormality|33|||
105688395|NCT02101034|364524100|FG002|Overall Study|Enrolled but did not start treatment|1|||
105919115|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Death|0|||
106002600|NCT00141102|365670662|FG000|Overall Study|Lack of Efficacy|21|||
105688396|NCT02101034|364524101|FG003|Overall Study|Enrolled but did not start treatment|0|||
105688397|NCT02101034|364524102|FG004|Overall Study|Enrolled but did not start treatment|0|||
105688398|NCT01101477|364524104|FG000|Overall Study|Protocol Violation|5|||
105688399|NCT01101477|364524105|FG001|Overall Study|Protocol Violation|3|||
105688400|NCT01101477|364524106|FG002|Overall Study|Protocol Violation|1|||
105688401|NCT02952001|364524107|FG000|Overall Study|Adverse Event|3|||
105688402|NCT02952001|364524108|FG001|Overall Study|Adverse Event|0|||
105688403|NCT02952001|364524107|FG000|Overall Study|Prohibited therapy|10|||
105688404|NCT02952001|364524108|FG001|Overall Study|Prohibited therapy|3|||
105688405|NCT02952001|364524107|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
105688406|NCT02952001|364524108|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
105688407|NCT02021292|364524111|FG000|Overall Study|Physician Decision|0|||
105688408|NCT02021292|364524112|FG001|Overall Study|Physician Decision|1|||
105688409|NCT02021292|364524111|FG000|Overall Study|Lost to Follow-up|0|||
105688410|NCT02021292|364524112|FG001|Overall Study|Lost to Follow-up|1|||
105688411|NCT02021292|364524111|FG000|Overall Study|Death|0|||
105688412|NCT02021292|364524112|FG001|Overall Study|Death|1|||
105688413|NCT03249714|364524115|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
105688414|NCT03249714|364524116|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
105688415|NCT03249714|364524115|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
105688416|NCT03249714|364524116|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
105688417|NCT03249714|364524115|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
105688418|NCT03249714|364524116|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
105688419|NCT03249714|364524115|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
105688420|NCT03249714|364524116|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
105688421|NCT02634346|364524119|FG000|Overall Study|Withdrawal by Subject|8|||
105688422|NCT02634346|364524120|FG001|Overall Study|Withdrawal by Subject|9|||
105688423|NCT02634346|364524121|FG002|Overall Study|Withdrawal by Subject|8|||
105688424|NCT02634346|364524119|FG000|Overall Study|Adverse Event|2|||
105688425|NCT02634346|364524120|FG001|Overall Study|Adverse Event|2|||
105688426|NCT02634346|364524121|FG002|Overall Study|Adverse Event|7|||
105688427|NCT02634346|364524119|FG000|Overall Study|Lack of Efficacy|1|||
105688428|NCT02634346|364524120|FG001|Overall Study|Lack of Efficacy|2|||
105688429|NCT02634346|364524121|FG002|Overall Study|Lack of Efficacy|8|||
105688430|NCT02634346|364524119|FG000|Overall Study|Lost to Follow-up|1|||
105688431|NCT02634346|364524120|FG001|Overall Study|Lost to Follow-up|0|||
105688432|NCT02634346|364524121|FG002|Overall Study|Lost to Follow-up|0|||
105688433|NCT02634346|364524119|FG000|Overall Study|Protocol Violation|0|||
105688434|NCT02634346|364524120|FG001|Overall Study|Protocol Violation|1|||
105688435|NCT02634346|364524121|FG002|Overall Study|Protocol Violation|0|||
105688436|NCT02170389|364524126|FG000|Overall Study|Study terminated prior to start of treat|1|||
105688437|NCT02824263|364524127|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
105688438|NCT02824263|364524128|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
105688439|NCT02824263|364524127|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
105688440|NCT02824263|364524128|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
105688441|NCT01112306|364524129|FG000|Overall Study|Death|175|||
105688442|NCT01112306|364524129|FG000|Overall Study|Lost to Follow-up|9|||
105688443|NCT01112306|364524129|FG000|Overall Study|Withdrawal by Subject|31|||
105688444|NCT01112306|364524129|FG000|Overall Study|Other|70|||
105688445|NCT02175004|364524132|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
105688446|NCT02175004|364524133|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
105688447|NCT02175004|364524132|FG000|Overall Study|Investigator Judgment|1|||
105688448|NCT02175004|364524133|FG001|Overall Study|Investigator Judgment|4|||
105688449|NCT02175004|364524132|FG000|Overall Study|Voluntary Withdrawal|6|||
105688450|NCT02175004|364524133|FG001|Overall Study|Voluntary Withdrawal|19|||
105688451|NCT02175004|364524132|FG000|Overall Study|Liver Transplant|1|||
105688452|NCT02175004|364524133|FG001|Overall Study|Liver Transplant|0|||
105688453|NCT02175004|364524132|FG000|Overall Study|Disease Progression|1|||
105688454|NCT02175004|364524133|FG001|Overall Study|Disease Progression|0|||
105688455|NCT02175004|364524132|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
105688456|NCT02175004|364524133|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
105688457|NCT02960854|364524134|FG000|Overall Study|Not Disclosed|2|||
105688458|NCT02960854|364524135|FG001|Overall Study|Not Disclosed|2|||
105688459|NCT02960854|364524134|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
105688460|NCT02960854|364524135|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
105688461|NCT02960854|364524134|FG000|Overall Study|Subject Withdrew Consent|0|||
105688462|NCT02960854|364524135|FG001|Overall Study|Subject Withdrew Consent|1|||
105919116|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Death|0|||
105919117|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Death|1|||
105688463|NCT02960854|364524134|FG000|Overall Study|Death|4|||
105688464|NCT02960854|364524135|FG001|Overall Study|Death|6|||
105688465|NCT00221195|364524136|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
105919118|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Death|0|||
105688466|NCT00221195|364524137|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
105688467|NCT00221195|364524136|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
105688468|NCT00221195|364524137|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
105688469|NCT00221195|364524136|FG000|Washout Period (Months 7-9)|Death|0|||
105688470|NCT00221195|364524137|FG001|Washout Period (Months 7-9)|Death|1|||
105688471|NCT00221195|364524136|FG000|Therapy 2 (Months 10-15)|Death|1|||
105688472|NCT00221195|364524137|FG001|Therapy 2 (Months 10-15)|Death|0|||
105688473|NCT00221195|364524136|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
105688474|NCT00221195|364524137|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
105688475|NCT01607554|364524140|FG000|Overall Study|Disease progression|2|||
105688476|NCT04442737|364524141|FG000|Overall Study|Lost to Follow-up|1|||
105688477|NCT04442737|364524142|FG001|Overall Study|Lost to Follow-up|3|||
105688478|NCT04442737|364524141|FG000|Overall Study|Withdrawal by Subject|3|||
105688479|NCT04442737|364524142|FG001|Overall Study|Withdrawal by Subject|2|||
105688480|NCT04442737|364524141|FG000|Overall Study|Adverse Event|3|||
105688481|NCT04442737|364524142|FG001|Overall Study|Adverse Event|2|||
105688482|NCT04442737|364524141|FG000|Overall Study|Death|0|||
105688483|NCT04442737|364524142|FG001|Overall Study|Death|1|||
105688484|NCT04442737|364524141|FG000|Overall Study|Protocol Violation|0|||
105688485|NCT04442737|364524142|FG001|Overall Study|Protocol Violation|2|||
105688486|NCT04442737|364524141|FG000|Overall Study|Other|1|||
105688487|NCT04442737|364524142|FG001|Overall Study|Other|1|||
105688488|NCT00820027|364524143|FG000|Overall Study|Adverse Event|15|||
105688489|NCT00820027|364524144|FG001|Overall Study|Adverse Event|8|||
105688490|NCT00820027|364524145|FG002|Overall Study|Adverse Event|10|||
105688491|NCT00820027|364524146|FG003|Overall Study|Adverse Event|5|||
105688492|NCT00820027|364524143|FG000|Overall Study|Lack of Efficacy|2|||
105688493|NCT00820027|364524144|FG001|Overall Study|Lack of Efficacy|1|||
105688494|NCT00820027|364524145|FG002|Overall Study|Lack of Efficacy|2|||
105688495|NCT00820027|364524146|FG003|Overall Study|Lack of Efficacy|2|||
105688496|NCT00820027|364524143|FG000|Overall Study|Physician Decision|0|||
105688497|NCT00820027|364524144|FG001|Overall Study|Physician Decision|1|||
105688498|NCT00820027|364524145|FG002|Overall Study|Physician Decision|1|||
105688499|NCT00820027|364524146|FG003|Overall Study|Physician Decision|0|||
105688500|NCT00820027|364524143|FG000|Overall Study|Protocol Violation|3|||
105688501|NCT00820027|364524144|FG001|Overall Study|Protocol Violation|0|||
105688502|NCT00820027|364524145|FG002|Overall Study|Protocol Violation|4|||
105688503|NCT00820027|364524146|FG003|Overall Study|Protocol Violation|0|||
105688504|NCT00820027|364524143|FG000|Overall Study|Withdrawal by Subject|6|||
105688505|NCT00820027|364524144|FG001|Overall Study|Withdrawal by Subject|4|||
105688506|NCT00820027|364524145|FG002|Overall Study|Withdrawal by Subject|4|||
105688507|NCT00820027|364524146|FG003|Overall Study|Withdrawal by Subject|6|||
105688508|NCT02982187|364524147|FG000|Overall Study|Withdrawal by Subject|0|||
105688509|NCT02982187|364524148|FG001|Overall Study|Withdrawal by Subject|0|||
105688510|NCT02982187|364524149|FG002|Overall Study|Withdrawal by Subject|0|||
105688511|NCT02982187|364524150|FG003|Overall Study|Withdrawal by Subject|0|||
105688512|NCT02982187|364524151|FG004|Overall Study|Withdrawal by Subject|0|||
105688513|NCT02982187|364524152|FG005|Overall Study|Withdrawal by Subject|0|||
105688514|NCT02982187|364524153|FG006|Overall Study|Withdrawal by Subject|1|||
105688515|NCT02982187|364524154|FG007|Overall Study|Withdrawal by Subject|0|||
105688516|NCT02604433|364524155|FG000|Overall Study|Withdrawal by Subject|37|||
105688517|NCT02604433|364524156|FG001|Overall Study|Withdrawal by Subject|16|||
105688518|NCT02604433|364524155|FG000|Overall Study|Adverse Event|4|||
105688519|NCT02604433|364524156|FG001|Overall Study|Adverse Event|0|||
105688520|NCT02604433|364524155|FG000|Overall Study|Other reasons|3|||
105688521|NCT02604433|364524156|FG001|Overall Study|Other reasons|5|||
105688522|NCT02604433|364524155|FG000|Overall Study|Death|4|||
105688523|NCT02604433|364524156|FG001|Overall Study|Death|1|||
105688524|NCT02604433|364524155|FG000|Overall Study|Transition to Rollover Protocol|169|||
105688525|NCT02604433|364524156|FG001|Overall Study|Transition to Rollover Protocol|82|||
105688526|NCT02604433|364524155|FG000|Overall Study|Physician Decision|1|||
105688527|NCT02604433|364524156|FG001|Overall Study|Physician Decision|1|||
105688528|NCT02604433|364524155|FG000|Overall Study|Lack of Efficacy|0|||
105688529|NCT02604433|364524156|FG001|Overall Study|Lack of Efficacy|1|||
105688530|NCT03285178|364524164|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
105688531|NCT03285178|364524165|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
106002601|NCT00141102|365670663|FG001|Overall Study|Lack of Efficacy|26|||
105688532|NCT03285178|364524166|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105786785|NCT05643573|364872927|FG000|Overall Study|Adverse Event|117|||
105688533|NCT03285178|364524167|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105688534|NCT03285178|364524168|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105688535|NCT03285178|364524169|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105688536|NCT03285178|364524170|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
105688537|NCT03285178|364524164|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
105688538|NCT03285178|364524165|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688539|NCT03285178|364524166|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688540|NCT03285178|364524167|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688541|NCT03285178|364524168|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688542|NCT03285178|364524169|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688543|NCT03285178|364524170|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
105688544|NCT03285178|364524164|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
105688545|NCT03285178|364524165|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
105688546|NCT03285178|364524166|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
105688547|NCT03285178|364524167|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
105688548|NCT03285178|364524168|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
105688549|NCT03285178|364524169|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
105688550|NCT03285178|364524170|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
105688551|NCT03285178|364524164|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
105688552|NCT03285178|364524165|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688553|NCT03285178|364524166|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688554|NCT03285178|364524167|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688555|NCT03285178|364524168|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688556|NCT03285178|364524169|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688557|NCT03285178|364524170|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
105688558|NCT03285178|364524164|FG000|Single-Blind Run-In Period|Physician Decision|2|||
105688559|NCT03285178|364524165|FG001|Single-Blind Run-In Period|Physician Decision|0|||
105688560|NCT03285178|364524166|FG002|Single-Blind Run-In Period|Physician Decision|0|||
105688561|NCT03285178|364524167|FG003|Single-Blind Run-In Period|Physician Decision|0|||
105688562|NCT03285178|364524168|FG004|Single-Blind Run-In Period|Physician Decision|0|||
105688563|NCT03285178|364524169|FG005|Single-Blind Run-In Period|Physician Decision|0|||
105688564|NCT03285178|364524170|FG006|Single-Blind Run-In Period|Physician Decision|0|||
105688565|NCT03285178|364524164|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688566|NCT03285178|364524165|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
105688567|NCT03285178|364524166|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
105688568|NCT03285178|364524167|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688569|NCT03285178|364524168|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688570|NCT03285178|364524169|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688571|NCT03285178|364524170|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
105688572|NCT03285178|364524164|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105688573|NCT03285178|364524165|FG001|Double-Blind Treatment Period|Adverse Event|0|||
105688574|NCT03285178|364524166|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105688575|NCT03285178|364524167|FG003|Double-Blind Treatment Period|Adverse Event|0|||
105688576|NCT03285178|364524168|FG004|Double-Blind Treatment Period|Adverse Event|0|||
105688577|NCT03285178|364524169|FG005|Double-Blind Treatment Period|Adverse Event|0|||
105688578|NCT03285178|364524170|FG006|Double-Blind Treatment Period|Adverse Event|2|||
105688579|NCT03285178|364524164|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105688580|NCT03285178|364524165|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105688581|NCT03285178|364524166|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
105688582|NCT03285178|364524167|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
105688583|NCT03285178|364524168|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
105688584|NCT03285178|364524169|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
105688585|NCT03285178|364524170|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
105786786|NCT05643573|364872928|FG001|Overall Study|Adverse Event|90|||
105786787|NCT05643573|364872927|FG000|Overall Study|Death|53|||
105786788|NCT05643573|364872928|FG001|Overall Study|Death|57|||
105786789|NCT05643573|364872927|FG000|Overall Study|Lost to Follow-up|6|||
106002602|NCT00141102|365670662|FG000|Overall Study|Lost to Follow-up|29|||
106002603|NCT00141102|365670663|FG001|Overall Study|Lost to Follow-up|32|||
106002604|NCT00141102|365670662|FG000|Overall Study|Other|87|||
106002605|NCT00141102|365670663|FG001|Overall Study|Other|76|||
106002606|NCT00141102|365670662|FG000|Overall Study|Withdrawal by Subject|112|||
106002607|NCT00141102|365670663|FG001|Overall Study|Withdrawal by Subject|142|||
106002608|NCT00141102|365670662|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
106002609|NCT00141102|365670663|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
106002610|NCT00141102|365670662|FG000|Overall Study|Death|2|||
106002611|NCT00141102|365670663|FG001|Overall Study|Death|2|||
106002612|NCT00990106|365670666|FG000|Overall Study|"too busy to continue"|1|||
106002613|NCT00990106|365670667|FG001|Overall Study|"too busy to continue"|2|||
106002614|NCT00990106|365670666|FG000|Overall Study|Lost to Follow-up|1|||
106002615|NCT00990106|365670667|FG001|Overall Study|Lost to Follow-up|3|||
106002616|NCT00990106|365670666|FG000|Overall Study|Withdrawal by Subject|2|||
106002617|NCT00990106|365670667|FG001|Overall Study|Withdrawal by Subject|1|||
106002618|NCT00990106|365670666|FG000|Overall Study|opted for open label prazosin|1|||
106130572|NCT00097370|366134252|FG000|Stage 3|Sponsor Terminated Study|52|||
106130573|NCT00097370|366134252|FG000|Stage 3|Lost to Follow-up|1|||
105786790|NCT05643573|364872928|FG001|Overall Study|Lost to Follow-up|3|||
106130574|NCT02419755|366134253|FG000|Overall Study|Death|1|||
105688586|NCT03285178|364524164|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105688587|NCT03285178|364524165|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105688588|NCT03285178|364524166|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105688589|NCT03285178|364524167|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105688590|NCT03285178|364524168|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105688591|NCT03285178|364524169|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105688592|NCT03285178|364524170|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105688593|NCT03285178|364524164|FG000|Double-Blind Treatment Period|COVID-19|0|||
105688594|NCT03285178|364524165|FG001|Double-Blind Treatment Period|COVID-19|0|||
105688595|NCT03285178|364524166|FG002|Double-Blind Treatment Period|COVID-19|1|||
105919119|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Death|0|||
105919120|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Death|0|||
105919121|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
105919122|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
105919123|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
105919124|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
105919125|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
105919126|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
105919127|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105919128|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105919129|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
105919130|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105919131|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105919132|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
105919133|NCT02513550|365363502|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
105919134|NCT02513550|365363503|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
105919135|NCT02513550|365363504|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
105919136|NCT02513550|365363505|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
105919137|NCT02513550|365363506|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
105919138|NCT02513550|365363507|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
105919139|NCT00472420|365363508|FG000|Induction Treatment Period|Physician Decision|9|||
105919140|NCT00472420|365363508|FG000|Induction Treatment Period|Adverse Event|3|||
105919141|NCT00472420|365363508|FG000|Induction Treatment Period|Non-compliance|1|||
105919142|NCT00472420|365363508|FG000|Induction Treatment Period|Death|3|||
105919143|NCT00472420|365363508|FG000|Follow-up Period|Death|5|||
105919144|NCT00472420|365363508|FG000|Follow-up Period|Physician Decision|9|||
105919145|NCT00472420|365363508|FG000|Follow-up Period|Lost to Follow-up|2|||
105919146|NCT00472420|365363508|FG000|Follow-up Period|Protocol Violation|1|||
105919147|NCT00888654|365363511|FG000|Overall Study|Problems swallowing oral meds.|1|||
105919148|NCT00888654|365363511|FG000|Overall Study|Not enough oral meds before surgery|3|||
105919149|NCT00888654|365363511|FG000|Overall Study|Surgery aborted|2|||
105919150|NCT00888654|365363511|FG000|Overall Study|Withdrawal by Subject|1|||
105919151|NCT00888654|365363511|FG000|Overall Study|Inelig. due to contraindication of med|1|||
105919152|NCT00888654|365363511|FG000|Overall Study|Change in surg date|1|||
105919153|NCT00888654|365363511|FG000|Overall Study|Stopped meds due to headaches|1|||
105919154|NCT02674516|365363512|FG000|Overall Study|Lost to Follow-up|3|||
105919155|NCT02674516|365363513|FG001|Overall Study|Lost to Follow-up|0|||
105919156|NCT02674516|365363512|FG000|Overall Study|Protocol Violation|0|||
105919157|NCT02674516|365363513|FG001|Overall Study|Protocol Violation|4|||
105919158|NCT02674516|365363512|FG000|Overall Study|Knowledge of study hypothesis|1|||
105919159|NCT02674516|365363513|FG001|Overall Study|Knowledge of study hypothesis|0|||
105919160|NCT01064479|365363514|FG000|Overall Study|Death|10|||
105919161|NCT01064479|365363515|FG001|Overall Study|Death|11|||
105919162|NCT01064479|365363514|FG000|Overall Study|Withdrawal by Subject|2|||
105919163|NCT01064479|365363515|FG001|Overall Study|Withdrawal by Subject|2|||
105919164|NCT01064479|365363514|FG000|Overall Study|Disease progression|1|||
105919165|NCT01064479|365363515|FG001|Overall Study|Disease progression|1|||
105919166|NCT01064479|365363514|FG000|Overall Study|Toxicity|1|||
105688596|NCT03285178|364524167|FG003|Double-Blind Treatment Period|COVID-19|0|||
105688597|NCT03285178|364524168|FG004|Double-Blind Treatment Period|COVID-19|0|||
105786791|NCT05643573|364872927|FG000|Overall Study|Other|18|||
105786792|NCT05643573|364872928|FG001|Overall Study|Other|15|||
105919167|NCT01064479|365363515|FG001|Overall Study|Toxicity|1|||
105919168|NCT01064479|365363514|FG000|Overall Study|Other|1|||
105919169|NCT01064479|365363515|FG001|Overall Study|Other|2|||
105919170|NCT04076917|365363518|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
105919171|NCT04076917|365363518|FG000|Overall Study|Study closure|13|||
105919172|NCT04076917|365363518|FG000|Overall Study|Physician Decision|3|||
105919173|NCT04076917|365363518|FG000|Overall Study|Death|1|||
105919174|NCT04076917|365363518|FG000|Overall Study|Lost to Follow-up|1|||
105688598|NCT03285178|364524169|FG005|Double-Blind Treatment Period|COVID-19|0|||
105786793|NCT05643573|364872927|FG000|Overall Study|Outcome event|64|||
106130575|NCT02419755|366134254|FG001|Overall Study|Death|3|||
105688599|NCT03285178|364524170|FG006|Double-Blind Treatment Period|COVID-19|0|||
105688600|NCT01388790|364524171|FG000|Overall Study|Ongoing at data cut-off date|8|||
105688601|NCT01324323|364524172|FG000|Overall Study|Withdrawal by Subject|1|||
105688602|NCT00908232|364524173|FG000|Cycle 1 to 4|Death|5|||
105688603|NCT00908232|364524174|FG001|Cycle 1 to 4|Death|0|||
105688604|NCT00908232|364524175|FG002|Cycle 1 to 4|Death|0|||
105688605|NCT00908232|364524176|FG003|Cycle 1 to 4|Death|0|||
105688606|NCT00908232|364524173|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
105688607|NCT00908232|364524174|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
105688608|NCT00908232|364524175|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
105688609|NCT00908232|364524176|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
105688610|NCT00908232|364524173|FG000|Cycle 1 to 4|Progressive Disease|6|||
105688611|NCT00908232|364524174|FG001|Cycle 1 to 4|Progressive Disease|0|||
105688612|NCT00908232|364524175|FG002|Cycle 1 to 4|Progressive Disease|0|||
105688613|NCT00908232|364524176|FG003|Cycle 1 to 4|Progressive Disease|0|||
105688614|NCT00908232|364524173|FG000|Cycle 1 to 4|Adverse Event|12|||
105688615|NCT00908232|364524174|FG001|Cycle 1 to 4|Adverse Event|0|||
105688616|NCT00908232|364524175|FG002|Cycle 1 to 4|Adverse Event|0|||
105688617|NCT00908232|364524176|FG003|Cycle 1 to 4|Adverse Event|0|||
105688618|NCT00908232|364524173|FG000|Cycle 1 to 4|Other|1|||
105688619|NCT00908232|364524174|FG001|Cycle 1 to 4|Other|0|||
105688620|NCT00908232|364524175|FG002|Cycle 1 to 4|Other|0|||
105688621|NCT00908232|364524176|FG003|Cycle 1 to 4|Other|0|||
105688622|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
105688623|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
105688624|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
105688625|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
105688626|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
105688627|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
105688628|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
105688629|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
105688630|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
105688631|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
105688632|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
105688633|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
105688634|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
105688635|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
105688636|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
105688637|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
105688638|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
105688639|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
105688640|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
105688641|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
105688642|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
105688643|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
105688644|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
105688645|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
105688646|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
105688647|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
105688648|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
105688649|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
105688650|NCT00908232|364524173|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
105688651|NCT00908232|364524174|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
105688652|NCT00908232|364524175|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
105688653|NCT00908232|364524176|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
105688654|NCT01128894|364524177|FG000|Overall Study|Adverse Event|31|||
105688655|NCT01128894|364524178|FG001|Overall Study|Adverse Event|41|||
105688656|NCT01128894|364524177|FG000|Overall Study|Protocol Violation|2|||
105688657|NCT01128894|364524178|FG001|Overall Study|Protocol Violation|1|||
105688658|NCT01128894|364524177|FG000|Overall Study|Noncompliance|4|||
105688659|NCT01128894|364524178|FG001|Overall Study|Noncompliance|5|||
105688660|NCT01128894|364524177|FG000|Overall Study|Lost to Follow-up|8|||
105688661|NCT01128894|364524178|FG001|Overall Study|Lost to Follow-up|8|||
105688662|NCT01128894|364524177|FG000|Overall Study|Withdrawal by Subject|10|||
105688663|NCT01128894|364524178|FG001|Overall Study|Withdrawal by Subject|12|||
105688664|NCT01128894|364524177|FG000|Overall Study|Physician Decision|2|||
105688665|NCT01128894|364524178|FG001|Overall Study|Physician Decision|1|||
105688666|NCT01128894|364524177|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
105688667|NCT01128894|364524178|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
105688668|NCT03437278|364524179|FG000|Overall Study|Adverse Event|0|||
105688669|NCT03437278|364524180|FG001|Overall Study|Adverse Event|0|||
105688670|NCT03437278|364524181|FG002|Overall Study|Adverse Event|1|||
105688671|NCT03437278|364524179|FG000|Overall Study|Progressive disease|1|||
105688672|NCT03437278|364524180|FG001|Overall Study|Progressive disease|0|||
105688673|NCT03437278|364524181|FG002|Overall Study|Progressive disease|0|||
105688674|NCT03437278|364524179|FG000|Overall Study|Physician Decision|1|||
105688675|NCT03437278|364524180|FG001|Overall Study|Physician Decision|0|||
105688676|NCT03437278|364524181|FG002|Overall Study|Physician Decision|1|||
105688677|NCT03093350|364524183|FG000|Overall Study|Death|1|||
105688678|NCT03093350|364524183|FG000|Overall Study|Signed consent, never began treartment|1|||
105688679|NCT01630434|364524191|FG000|Overall Study|Donor lungs turned down|1|||
105688680|NCT01630434|364524192|FG001|Overall Study|Donor lungs turned down|0|||
105688681|NCT01630434|364524191|FG000|Overall Study|Protocol Violation|9|||
105688682|NCT01630434|364524192|FG001|Overall Study|Protocol Violation|4|||
105688683|NCT01630434|364524191|FG000|Overall Study|Death|20|||
105688684|NCT01630434|364524192|FG001|Overall Study|Death|26|||
105688685|NCT01230788|364524201|FG000|Overall Study|Prescribed exclusion drug|1|||
105688686|NCT01026454|364524202|FG000|Second Intervention|Pregnancy|1|||
105688687|NCT01026454|364524203|FG001|Second Intervention|Pregnancy|1|||
105688688|NCT01176773|364524204|FG000|Overall Study|Screen Failure|2|||
105688689|NCT01176773|364524204|FG000|Overall Study|Withdrew consent|1|||
105688690|NCT03181451|364524219|FG000|Overall Study|Adverse Event|0|||
105688691|NCT03181451|364524220|FG001|Overall Study|Adverse Event|1|||
105688692|NCT03181451|364524221|FG002|Overall Study|Adverse Event|0|||
105688693|NCT03181451|364524219|FG000|Overall Study|Withdrawal by Subject|0|||
105688694|NCT03181451|364524220|FG001|Overall Study|Withdrawal by Subject|1|||
105688695|NCT03181451|364524221|FG002|Overall Study|Withdrawal by Subject|0|||
105688696|NCT01592864|364524228|FG000|Overall Study|Withdrawal by Subject|0|||
105688697|NCT01592864|364524229|FG001|Overall Study|Withdrawal by Subject|1|||
105688698|NCT01019317|364524230|FG000|Overall Study|Not Eligible|4|||
105688699|NCT00926211|364524231|FG000|Overall Study|Lost to Follow-up|1|||
105688700|NCT01032382|364524232|FG000|Overall Study|Disease dissemination|1|||
105688701|NCT01032382|364524233|FG001|Overall Study|Disease dissemination|1|||
105688702|NCT01032382|364524232|FG000|Overall Study|Treatment failure|3|||
105688703|NCT01032382|364524233|FG001|Overall Study|Treatment failure|1|||
105688704|NCT01032382|364524232|FG000|Overall Study|Index lesion relapse|1|||
105688705|NCT01032382|364524233|FG001|Overall Study|Index lesion relapse|3|||
105688706|NCT00413972|364524245|FG000|Overall Study|Adverse Event|2|||
105688707|NCT00413972|364524246|FG001|Overall Study|Adverse Event|1|||
105688708|NCT00413972|364524247|FG002|Overall Study|Adverse Event|0|||
105688709|NCT00413972|364524248|FG003|Overall Study|Adverse Event|0|||
105919175|NCT04076917|365363518|FG000|Overall Study|Withdrawal by Subject|1|||
105919176|NCT04076917|365363518|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
105919177|NCT01474486|365363520|FG000|Overall Study|Death|2|||
105919178|NCT01474486|365363520|FG000|Overall Study|Withdrawal by Subject|4|||
105919179|NCT01474486|365363520|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
105919180|NCT03504917|365363521|FG000|Blinded Treatment Period|Protocol Violation|1|||
105919181|NCT03504917|365363522|FG001|Blinded Treatment Period|Protocol Violation|0|||
105919182|NCT03504917|365363521|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
105919183|NCT03504917|365363522|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
105919184|NCT03504917|365363521|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
105919185|NCT03504917|365363522|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
105919186|NCT03504917|365363521|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
105919187|NCT03504917|365363522|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
105919188|NCT03504917|365363521|FG000|Blinded Treatment Period|Adverse Event|4|||
105919189|NCT03504917|365363522|FG001|Blinded Treatment Period|Adverse Event|4|||
105919190|NCT03504917|365363521|FG000|Blinded Treatment Period|Physician Decision|1|||
105919191|NCT03504917|365363522|FG001|Blinded Treatment Period|Physician Decision|0|||
105919192|NCT03504917|365363521|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
105919193|NCT03504917|365363522|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
105919194|NCT03504917|365363521|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
106130576|NCT02419755|366134253|FG000|Overall Study|Relapse|0|||
106130577|NCT02419755|366134254|FG001|Overall Study|Relapse|1|||
105688710|NCT00413972|364524245|FG000|Overall Study|Lost to Follow-up|1|||
105688711|NCT00413972|364524246|FG001|Overall Study|Lost to Follow-up|2|||
105688712|NCT00413972|364524247|FG002|Overall Study|Lost to Follow-up|1|||
106130578|NCT02419755|366134253|FG000|Overall Study|Ineligible|1|||
106130579|NCT02419755|366134254|FG001|Overall Study|Ineligible|0|||
105688713|NCT00413972|364524248|FG003|Overall Study|Lost to Follow-up|0|||
105688714|NCT00413972|364524245|FG000|Overall Study|Withdrawal by Subject|4|||
105688715|NCT00413972|364524246|FG001|Overall Study|Withdrawal by Subject|5|||
105688716|NCT00413972|364524247|FG002|Overall Study|Withdrawal by Subject|7|||
105688717|NCT00413972|364524248|FG003|Overall Study|Withdrawal by Subject|2|||
105688718|NCT00413972|364524245|FG000|Overall Study|Protocol Violation|0|||
105688719|NCT00413972|364524246|FG001|Overall Study|Protocol Violation|0|||
105688720|NCT00413972|364524247|FG002|Overall Study|Protocol Violation|2|||
105688721|NCT00413972|364524248|FG003|Overall Study|Protocol Violation|0|||
105688722|NCT00413972|364524245|FG000|Overall Study|Other|0|||
105688723|NCT00413972|364524246|FG001|Overall Study|Other|0|||
105688724|NCT00413972|364524247|FG002|Overall Study|Other|0|||
105688725|NCT00413972|364524248|FG003|Overall Study|Other|1|||
105688726|NCT01163721|364524253|FG000|Overall Study|Adverse Event|5|||
105688727|NCT01163721|364524254|FG001|Overall Study|Adverse Event|6|||
105688728|NCT01163721|364524253|FG000|Overall Study|Withdrawal by Subject|3|||
105688729|NCT01163721|364524254|FG001|Overall Study|Withdrawal by Subject|4|||
105688730|NCT01163721|364524253|FG000|Overall Study|Lost to Follow-up|0|||
105688731|NCT01163721|364524254|FG001|Overall Study|Lost to Follow-up|1|||
105688732|NCT01163721|364524253|FG000|Overall Study|Physician Decision|0|||
105688733|NCT01163721|364524254|FG001|Overall Study|Physician Decision|1|||
105688734|NCT01012739|364524255|FG000|Treatment Period 1|Adverse Event|0|||
105688735|NCT01012739|364524256|FG001|Treatment Period 1|Adverse Event|0|||
105688736|NCT01012739|364524257|FG002|Treatment Period 1|Adverse Event|0|||
105688737|NCT01012739|364524258|FG003|Treatment Period 1|Adverse Event|1|||
105688738|NCT01012739|364524255|FG000|Treatment Period 2|Abnormal test procedure results|0|||
105688739|NCT01012739|364524256|FG001|Treatment Period 2|Abnormal test procedure results|0|||
105688740|NCT01012739|364524257|FG002|Treatment Period 2|Abnormal test procedure results|0|||
105688741|NCT01012739|364524258|FG003|Treatment Period 2|Abnormal test procedure results|1|||
105688742|NCT01485354|364525377|FG000|Overall Study|Withdrawal by Subject|5|||
105688743|NCT01096342|364525378|FG000|Overall Study|Protocol Violation|1|||
105688744|NCT00300781|364525379|FG000|Overall Study|Disease Progression|55|||
105688745|NCT00300781|364525380|FG001|Overall Study|Disease Progression|52|||
105688746|NCT00300781|364525379|FG000|Overall Study|Adverse Event|5|||
105688747|NCT00300781|364525380|FG001|Overall Study|Adverse Event|6|||
105688748|NCT00300781|364525379|FG000|Overall Study|Withdrawal by Subject|1|||
105688749|NCT00300781|364525380|FG001|Overall Study|Withdrawal by Subject|2|||
105688750|NCT00300781|364525379|FG000|Overall Study|Physician Decision|1|||
105688751|NCT00300781|364525380|FG001|Overall Study|Physician Decision|0|||
105688752|NCT00300781|364525379|FG000|Overall Study|Not Recorded|0|||
105688753|NCT00300781|364525380|FG001|Overall Study|Not Recorded|1|||
105688754|NCT00300781|364525379|FG000|Overall Study|Symptomatic Deterioration|1|||
105688755|NCT00300781|364525380|FG001|Overall Study|Symptomatic Deterioration|0|||
105688756|NCT00300781|364525379|FG000|Overall Study|Lost to Follow-up|0|||
105688757|NCT00300781|364525380|FG001|Overall Study|Lost to Follow-up|1|||
105688758|NCT02864381|364525381|FG000|Overall Study|Death|58|||
105688759|NCT02864381|364525382|FG001|Overall Study|Death|61|||
105688760|NCT02864381|364525381|FG000|Overall Study|Withdrew Consent|5|||
105688761|NCT02864381|364525382|FG001|Overall Study|Withdrew Consent|6|||
105688762|NCT02864381|364525381|FG000|Overall Study|Reason Unknown|7|||
105688763|NCT02864381|364525382|FG001|Overall Study|Reason Unknown|3|||
105688764|NCT02864381|364525381|FG000|Overall Study|Lost to Follow-up|1|||
105688765|NCT02864381|364525382|FG001|Overall Study|Lost to Follow-up|1|||
105688766|NCT02864381|364525381|FG000|Overall Study|Investigator's Discretion|1|||
105688767|NCT02864381|364525382|FG001|Overall Study|Investigator's Discretion|0|||
105688768|NCT02864381|364525381|FG000|Overall Study|Protocol Violation|0|||
105688769|NCT02864381|364525382|FG001|Overall Study|Protocol Violation|1|||
105688770|NCT02120625|364525387|FG000|Overall Study|Physician Decision|2|||
105688771|NCT04142450|364525390|FG000|Overall Study|Screen Failure|1|||
105688772|NCT04142450|364525390|FG000|Overall Study|Lost to Follow-up|1|||
105688773|NCT03278106|364525401|FG000|Overall Study|No protocol treatment|1|||
105688774|NCT04098068|364525402|FG000|Overall Study|Disease Progression|7|||
105688775|NCT04098068|364525402|FG000|Overall Study|Withdrawal by Subject|2|||
105688776|NCT04098068|364525402|FG000|Overall Study|New Cancer Diagnosis|1|||
105688777|NCT00784693|364525403|FG000|Overall Study|Lost to Follow-up|0|||
105688778|NCT00784693|364525404|FG001|Overall Study|Lost to Follow-up|1|||
105688779|NCT00784693|364525403|FG000|Overall Study|Lack of Efficacy|1|||
105688780|NCT00784693|364525404|FG001|Overall Study|Lack of Efficacy|1|||
105688781|NCT00784693|364525403|FG000|Overall Study|Withdrawal by Subject|0|||
105688782|NCT00784693|364525404|FG001|Overall Study|Withdrawal by Subject|4|||
105688783|NCT00784693|364525403|FG000|Overall Study|Randomized but not Treated|1|||
105688784|NCT00784693|364525404|FG001|Overall Study|Randomized but not Treated|0|||
105688785|NCT00784693|364525403|FG000|Overall Study|Other|1|||
105688786|NCT00784693|364525404|FG001|Overall Study|Other|0|||
105688787|NCT00640016|364525407|FG000|Overall Study|Withdrawal by Subject|0|||
105688788|NCT00640016|364525408|FG001|Overall Study|Withdrawal by Subject|1|||
105688789|NCT00640016|364525409|FG002|Overall Study|Withdrawal by Subject|0|||
105688790|NCT00640016|364525410|FG003|Overall Study|Withdrawal by Subject|0|||
105688791|NCT00640016|364525407|FG000|Overall Study|Study termination|2|||
105688792|NCT00640016|364525408|FG001|Overall Study|Study termination|1|||
105688793|NCT00640016|364525409|FG002|Overall Study|Study termination|3|||
105688794|NCT00640016|364525410|FG003|Overall Study|Study termination|2|||
105688795|NCT00640016|364525407|FG000|Overall Study|Adverse Event|0|||
105688796|NCT00640016|364525408|FG001|Overall Study|Adverse Event|0|||
105688797|NCT00640016|364525409|FG002|Overall Study|Adverse Event|0|||
105688798|NCT00640016|364525410|FG003|Overall Study|Adverse Event|1|||
105688799|NCT03588728|364525411|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
105688800|NCT03588728|364525412|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
105688801|NCT03588728|364525413|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
105688802|NCT03588728|364525414|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
105688803|NCT03588728|364525411|FG000|Overall Study|Lab shut down due to COVID-19|0|||
105688804|NCT03588728|364525412|FG001|Overall Study|Lab shut down due to COVID-19|0|||
105688805|NCT03588728|364525413|FG002|Overall Study|Lab shut down due to COVID-19|0|||
105688806|NCT03588728|364525414|FG003|Overall Study|Lab shut down due to COVID-19|1|||
105688807|NCT03588728|364525411|FG000|Overall Study|multiple technical issues|1|||
105688808|NCT03588728|364525412|FG001|Overall Study|multiple technical issues|0|||
105688809|NCT03588728|364525413|FG002|Overall Study|multiple technical issues|0|||
105688810|NCT03588728|364525414|FG003|Overall Study|multiple technical issues|0|||
105688811|NCT03588728|364525411|FG000|Overall Study|Hospitalized for COVID|1|||
105688812|NCT03588728|364525412|FG001|Overall Study|Hospitalized for COVID|0|||
105688813|NCT03588728|364525413|FG002|Overall Study|Hospitalized for COVID|0|||
105688814|NCT03588728|364525414|FG003|Overall Study|Hospitalized for COVID|0|||
105688815|NCT03588728|364525411|FG000|Overall Study|Schedule change unable to attend sessions|1|||
105688816|NCT03588728|364525412|FG001|Overall Study|Schedule change unable to attend sessions|0|||
105688817|NCT03588728|364525413|FG002|Overall Study|Schedule change unable to attend sessions|0|||
105688818|NCT03588728|364525414|FG003|Overall Study|Schedule change unable to attend sessions|0|||
105688819|NCT02027701|364525416|FG000|Overall Study|Adverse Event|3|||
105688820|NCT02027701|364525416|FG000|Overall Study|Lack of Efficacy|8|||
105688821|NCT02027701|364525416|FG000|Overall Study|Physician Decision|2|||
105688822|NCT02027701|364525416|FG000|Overall Study|Withdrawal by Subject|3|||
105688823|NCT02202551|364525423|FG000|Overall Study|Adverse Event|8|||
105688824|NCT02202551|364525424|FG001|Overall Study|Adverse Event|19|||
105688825|NCT02202551|364525425|FG002|Overall Study|Adverse Event|5|||
105688826|NCT02202551|364525426|FG003|Overall Study|Adverse Event|9|||
105688827|NCT02202551|364525423|FG000|Overall Study|Death|3|||
105688828|NCT02202551|364525424|FG001|Overall Study|Death|2|||
105688829|NCT02202551|364525425|FG002|Overall Study|Death|1|||
105688830|NCT02202551|364525426|FG003|Overall Study|Death|1|||
105688831|NCT02202551|364525423|FG000|Overall Study|Lost to Follow-up|0|||
105688832|NCT02202551|364525424|FG001|Overall Study|Lost to Follow-up|1|||
105688833|NCT02202551|364525425|FG002|Overall Study|Lost to Follow-up|0|||
105688834|NCT02202551|364525426|FG003|Overall Study|Lost to Follow-up|1|||
105688835|NCT02202551|364525423|FG000|Overall Study|Needed to take excluded medication|0|||
105688836|NCT02202551|364525424|FG001|Overall Study|Needed to take excluded medication|2|||
105688837|NCT02202551|364525425|FG002|Overall Study|Needed to take excluded medication|0|||
105688838|NCT02202551|364525426|FG003|Overall Study|Needed to take excluded medication|1|||
105688839|NCT02202551|364525423|FG000|Overall Study|Subject moved away|0|||
105688840|NCT02202551|364525424|FG001|Overall Study|Subject moved away|1|||
105688841|NCT02202551|364525425|FG002|Overall Study|Subject moved away|0|||
105688842|NCT02202551|364525426|FG003|Overall Study|Subject moved away|0|||
105688843|NCT02202551|364525423|FG000|Overall Study|DBS surgery|3|||
105688844|NCT02202551|364525424|FG001|Overall Study|DBS surgery|0|||
105688845|NCT02202551|364525425|FG002|Overall Study|DBS surgery|0|||
105688846|NCT02202551|364525426|FG003|Overall Study|DBS surgery|0|||
105688847|NCT02202551|364525423|FG000|Overall Study|Dyskinesia upon taper|1|||
105688848|NCT02202551|364525424|FG001|Overall Study|Dyskinesia upon taper|0|||
105688849|NCT02202551|364525425|FG002|Overall Study|Dyskinesia upon taper|0|||
105688850|NCT02202551|364525426|FG003|Overall Study|Dyskinesia upon taper|0|||
105688851|NCT02202551|364525423|FG000|Overall Study|Lack of Efficacy|0|||
105688852|NCT02202551|364525424|FG001|Overall Study|Lack of Efficacy|1|||
105688853|NCT02202551|364525425|FG002|Overall Study|Lack of Efficacy|0|||
105688854|NCT02202551|364525426|FG003|Overall Study|Lack of Efficacy|0|||
105688855|NCT02202551|364525423|FG000|Overall Study|Physician Decision|1|||
105688856|NCT02202551|364525424|FG001|Overall Study|Physician Decision|0|||
105919195|NCT03504917|365363522|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
105919196|NCT03504917|365363521|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
105919197|NCT03504917|365363522|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
105919198|NCT03504917|365363521|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
105688857|NCT02202551|364525425|FG002|Overall Study|Physician Decision|0|||
105688858|NCT02202551|364525426|FG003|Overall Study|Physician Decision|0|||
105688859|NCT02202551|364525423|FG000|Overall Study|Site closure|3|||
105688860|NCT02202551|364525424|FG001|Overall Study|Site closure|0|||
105688861|NCT02202551|364525425|FG002|Overall Study|Site closure|0|||
105688862|NCT02202551|364525426|FG003|Overall Study|Site closure|1|||
105688863|NCT02202551|364525423|FG000|Overall Study|Unable to complete visits per protocol|1|||
105688864|NCT02202551|364525424|FG001|Overall Study|Unable to complete visits per protocol|0|||
105688865|NCT02202551|364525425|FG002|Overall Study|Unable to complete visits per protocol|0|||
105919199|NCT03504917|365363522|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
105919200|NCT03504917|365363521|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
105688866|NCT02202551|364525426|FG003|Overall Study|Unable to complete visits per protocol|0|||
105688867|NCT02202551|364525423|FG000|Overall Study|Worsening Dyskinesia|0|||
105688868|NCT02202551|364525424|FG001|Overall Study|Worsening Dyskinesia|0|||
105688869|NCT02202551|364525425|FG002|Overall Study|Worsening Dyskinesia|0|||
105688870|NCT02202551|364525426|FG003|Overall Study|Worsening Dyskinesia|1|||
105688871|NCT02202551|364525423|FG000|Overall Study|Protocol Violation|0|||
105688872|NCT02202551|364525424|FG001|Overall Study|Protocol Violation|1|||
105688873|NCT02202551|364525425|FG002|Overall Study|Protocol Violation|0|||
105688874|NCT02202551|364525426|FG003|Overall Study|Protocol Violation|0|||
105688875|NCT02202551|364525423|FG000|Overall Study|Sponsor's decision|2|||
105688876|NCT02202551|364525424|FG001|Overall Study|Sponsor's decision|0|||
105688877|NCT02202551|364525425|FG002|Overall Study|Sponsor's decision|0|||
105688878|NCT02202551|364525426|FG003|Overall Study|Sponsor's decision|0|||
105688879|NCT02202551|364525423|FG000|Overall Study|Subject unwilling to proceed|1|||
105688880|NCT02202551|364525424|FG001|Overall Study|Subject unwilling to proceed|5|||
105688881|NCT02202551|364525425|FG002|Overall Study|Subject unwilling to proceed|3|||
105688882|NCT02202551|364525426|FG003|Overall Study|Subject unwilling to proceed|5|||
105688883|NCT02202551|364525423|FG000|Overall Study|Subject consent withdrawn|0|||
105688884|NCT02202551|364525424|FG001|Overall Study|Subject consent withdrawn|3|||
105688885|NCT02202551|364525425|FG002|Overall Study|Subject consent withdrawn|1|||
105688886|NCT02202551|364525426|FG003|Overall Study|Subject consent withdrawn|2|||
105688887|NCT02202551|364525423|FG000|Overall Study|eGFR<50mL/min/m2|2|||
105688888|NCT02202551|364525424|FG001|Overall Study|eGFR<50mL/min/m2|2|||
105688889|NCT02202551|364525425|FG002|Overall Study|eGFR<50mL/min/m2|0|||
105688890|NCT02202551|364525426|FG003|Overall Study|eGFR<50mL/min/m2|1|||
105688891|NCT02249767|364525427|FG000|Overall Study|Did not use medication|8|||
105688892|NCT02249767|364525428|FG001|Overall Study|Did not use medication|9|||
105688893|NCT02249767|364525429|FG002|Overall Study|Did not use medication|8|||
105688894|NCT00146757|364525430|FG000|Overall Study|Death|1|||
105688895|NCT00146757|364525431|FG001|Overall Study|Death|0|||
105688896|NCT00146757|364525430|FG000|Overall Study|Adverse Event|1|||
105688897|NCT00146757|364525431|FG001|Overall Study|Adverse Event|0|||
105688898|NCT00867113|364525432|FG000|Treatment Period|Adverse Event|15|||
105688899|NCT00867113|364525432|FG000|Treatment Period|Death|2|||
106002619|NCT00990106|365670667|FG001|Overall Study|opted for open label prazosin|1|||
105688900|NCT00867113|364525432|FG000|Treatment Period|Withdrawal by Subject|19|||
105688901|NCT00867113|364525432|FG000|Treatment Period|Lost to Follow-up|3|||
105688902|NCT00867113|364525432|FG000|Treatment Period|Administrative problems|1|||
105688903|NCT00867113|364525432|FG000|Treatment Period|Disease progression/relapse|1|||
105688904|NCT00867113|364525432|FG000|Treatment Period|Protocol Violation|4|||
105688905|NCT00867113|364525432|FG000|Post Treatment After Survival Follow-up|Death|1|||
105688906|NCT00867113|364525432|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
105688907|NCT00867113|364525432|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
105688908|NCT00867113|364525432|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
105688909|NCT00394953|364525433|FG000|First Treatment Period|Adverse Event|1|||
105688910|NCT00394953|364525434|FG001|First Treatment Period|Adverse Event|2|||
105688911|NCT00394953|364525433|FG000|First Treatment Period|Death|6|||
105688912|NCT00394953|364525434|FG001|First Treatment Period|Death|7|||
105688913|NCT00394953|364525433|FG000|First Treatment Period|Lack of Efficacy|1|||
105688914|NCT00394953|364525434|FG001|First Treatment Period|Lack of Efficacy|1|||
105688915|NCT00394953|364525433|FG000|First Treatment Period|Withdrawal by Subject|6|||
105688916|NCT00394953|364525434|FG001|First Treatment Period|Withdrawal by Subject|3|||
105688917|NCT00394953|364525433|FG000|First Treatment Period|Lost to Follow-up|0|||
105688918|NCT00394953|364525434|FG001|First Treatment Period|Lost to Follow-up|1|||
105688919|NCT00394953|364525433|FG000|First Treatment Period|Renal transplant|11|||
105688920|NCT00394953|364525434|FG001|First Treatment Period|Renal transplant|7|||
105688921|NCT00394953|364525433|FG000|First Treatment Period|Not defined|4|||
105688922|NCT00394953|364525434|FG001|First Treatment Period|Not defined|1|||
105688923|NCT00394953|364525433|FG000|Second Treatment Period|Adverse Event|2|||
105688924|NCT00394953|364525434|FG001|Second Treatment Period|Adverse Event|5|||
106002620|NCT00990106|365670666|FG000|Overall Study|relocation/deployment|4|||
106002621|NCT00990106|365670667|FG001|Overall Study|relocation/deployment|1|||
106002622|NCT00990106|365670666|FG000|Overall Study|started exclusionary medication|0|||
106002623|NCT00990106|365670667|FG001|Overall Study|started exclusionary medication|1|||
106002624|NCT00990106|365670666|FG000|Overall Study|planned major surgery|0|||
105688925|NCT00394953|364525433|FG000|Second Treatment Period|Death|8|||
105688926|NCT00394953|364525434|FG001|Second Treatment Period|Death|4|||
105688927|NCT00394953|364525433|FG000|Second Treatment Period|Lack of Efficacy|9|||
105688928|NCT00394953|364525434|FG001|Second Treatment Period|Lack of Efficacy|47|||
105688929|NCT00394953|364525433|FG000|Second Treatment Period|Withdrawal by Subject|3|||
105688930|NCT00394953|364525434|FG001|Second Treatment Period|Withdrawal by Subject|3|||
106002625|NCT00990106|365670667|FG001|Overall Study|planned major surgery|1|||
106002626|NCT00990106|365670666|FG000|Overall Study|scheduling conflicts|0|||
105688931|NCT00394953|364525433|FG000|Second Treatment Period|Lost to Follow-up|0|||
105688932|NCT00394953|364525434|FG001|Second Treatment Period|Lost to Follow-up|1|||
105688933|NCT00394953|364525433|FG000|Second Treatment Period|Renal transplant|4|||
105688934|NCT00394953|364525434|FG001|Second Treatment Period|Renal transplant|6|||
105688935|NCT00394953|364525433|FG000|Second Treatment Period|Not defined|3|||
105688936|NCT00394953|364525434|FG001|Second Treatment Period|Not defined|8|||
105688937|NCT01971203|364525437|FG000|Overall Study|Protocol Violation|3|||
105688938|NCT01971203|364525438|FG001|Overall Study|Protocol Violation|2|||
105688939|NCT01971203|364525437|FG000|Overall Study|Withdrawal by Subject|5|||
105688940|NCT01971203|364525438|FG001|Overall Study|Withdrawal by Subject|6|||
105688941|NCT01971203|364525437|FG000|Overall Study|Adverse Event|1|||
105688942|NCT01971203|364525438|FG001|Overall Study|Adverse Event|0|||
105688943|NCT01498289|364525439|FG000|Overall Study|Adverse Event|16|||
105688944|NCT01498289|364525440|FG001|Overall Study|Adverse Event|18|||
105688945|NCT01498289|364525439|FG000|Overall Study|Death|6|||
105688946|NCT01498289|364525440|FG001|Overall Study|Death|8|||
105688947|NCT01498289|364525439|FG000|Overall Study|Withdrawal unrelated to AE|16|||
105688948|NCT01498289|364525440|FG001|Overall Study|Withdrawal unrelated to AE|16|||
105688949|NCT01498289|364525439|FG000|Overall Study|Progression/relapse|53|||
105688950|NCT01498289|364525440|FG001|Overall Study|Progression/relapse|59|||
105688951|NCT01498289|364525439|FG000|Overall Study|Not protocol specified|7|||
105688952|NCT01498289|364525440|FG001|Overall Study|Not protocol specified|2|||
105688953|NCT01498289|364525439|FG000|Overall Study|Reason under review|0|||
105688954|NCT01498289|364525440|FG001|Overall Study|Reason under review|1|||
105688955|NCT00307125|364525443|FG000|Screening Phase|Adverse Event|1|||
105688956|NCT00307125|364525444|FG001|Screening Phase|Adverse Event|0|||
105688957|NCT00307125|364525445|FG002|Screening Phase|Adverse Event|0|||
105688958|NCT00307125|364525443|FG000|Screening Phase|Protocol Violation|27|||
105688959|NCT00307125|364525444|FG001|Screening Phase|Protocol Violation|0|||
105688960|NCT00307125|364525445|FG002|Screening Phase|Protocol Violation|0|||
105688961|NCT00307125|364525443|FG000|Screening Phase|Lost to Follow-up|87|||
105688962|NCT00307125|364525444|FG001|Screening Phase|Lost to Follow-up|0|||
105688963|NCT00307125|364525445|FG002|Screening Phase|Lost to Follow-up|0|||
105688964|NCT00307125|364525443|FG000|Screening Phase|Death|10|||
105688965|NCT00307125|364525444|FG001|Screening Phase|Death|0|||
105688966|NCT00307125|364525445|FG002|Screening Phase|Death|0|||
105688967|NCT00307125|364525443|FG000|Screening Phase|Withdrawal by Subject|77|||
105688968|NCT00307125|364525444|FG001|Screening Phase|Withdrawal by Subject|0|||
105688969|NCT00307125|364525445|FG002|Screening Phase|Withdrawal by Subject|0|||
105688970|NCT00307125|364525443|FG000|Screening Phase|Physician Decision|26|||
105688971|NCT00307125|364525444|FG001|Screening Phase|Physician Decision|0|||
105688972|NCT00307125|364525445|FG002|Screening Phase|Physician Decision|0|||
105688973|NCT00307125|364525443|FG000|Screening Phase|Sponsor Decision|4|||
105688974|NCT00307125|364525444|FG001|Screening Phase|Sponsor Decision|0|||
105688975|NCT00307125|364525445|FG002|Screening Phase|Sponsor Decision|0|||
105688976|NCT00307125|364525443|FG000|Screening Phase|Study Terminated|17|||
105688977|NCT00307125|364525444|FG001|Screening Phase|Study Terminated|0|||
105688978|NCT00307125|364525445|FG002|Screening Phase|Study Terminated|0|||
105688979|NCT00307125|364525443|FG000|Screening Phase|Graft Loss|3|||
105688980|NCT00307125|364525444|FG001|Screening Phase|Graft Loss|0|||
106002627|NCT00990106|365670667|FG001|Overall Study|scheduling conflicts|2|||
106002628|NCT02926638|365670668|FG000|Overall Study|Progression|2|||
106002629|NCT02926638|365670669|FG001|Overall Study|Progression|5|||
106002630|NCT02926638|365670668|FG000|Overall Study|Ineligible|1|||
106002631|NCT02926638|365670669|FG001|Overall Study|Ineligible|0|||
106002632|NCT02926638|365670668|FG000|Overall Study|Not protocol specified|1|||
106002633|NCT02926638|365670669|FG001|Overall Study|Not protocol specified|0|||
106002634|NCT01928927|365670670|FG000|Overall Study|Lost to Follow-up|1|||
106002635|NCT01928927|365670671|FG001|Overall Study|Lost to Follow-up|0|||
106002636|NCT01928927|365670670|FG000|Overall Study|Withdrawal by Subject|1|||
106002637|NCT01928927|365670671|FG001|Overall Study|Withdrawal by Subject|1|||
106002638|NCT00445549|365672471|FG000|Overall Study|progressive disease|12|||
106002639|NCT00383552|365672477|FG000|Overall Study|Adverse Event|7|||
106002640|NCT00383552|365672478|FG001|Overall Study|Adverse Event|6|||
106002641|NCT00383552|365672479|FG002|Overall Study|Adverse Event|9|||
106002642|NCT00383552|365672480|FG003|Overall Study|Adverse Event|6|||
106002643|NCT00383552|365672477|FG000|Overall Study|Lack of Efficacy|4|||
105688981|NCT00307125|364525445|FG002|Screening Phase|Graft Loss|0|||
105688982|NCT00307125|364525443|FG000|Screening Phase|Graft Failure|8|||
105688983|NCT00307125|364525444|FG001|Screening Phase|Graft Failure|0|||
105688984|NCT00307125|364525445|FG002|Screening Phase|Graft Failure|0|||
105688985|NCT00307125|364525443|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
105688986|NCT00307125|364525444|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
105688987|NCT00307125|364525445|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
105688988|NCT00307125|364525443|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
105688989|NCT00307125|364525444|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
105688990|NCT00307125|364525445|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
106002644|NCT00383552|365672478|FG001|Overall Study|Lack of Efficacy|13|||
106002645|NCT00383552|365672479|FG002|Overall Study|Lack of Efficacy|29|||
106002646|NCT00383552|365672480|FG003|Overall Study|Lack of Efficacy|42|||
106002647|NCT00383552|365672477|FG000|Overall Study|Lost to Follow-up|0|||
106002648|NCT00383552|365672478|FG001|Overall Study|Lost to Follow-up|1|||
106002649|NCT00383552|365672479|FG002|Overall Study|Lost to Follow-up|5|||
106002650|NCT00383552|365672480|FG003|Overall Study|Lost to Follow-up|1|||
106002651|NCT00383552|365672477|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
106002652|NCT00383552|365672478|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
106002653|NCT00383552|365672479|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
106002654|NCT00383552|365672480|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
106002655|NCT00383552|365672477|FG000|Overall Study|Did not wish to continue (related)|1|||
106002656|NCT00383552|365672478|FG001|Overall Study|Did not wish to continue (related)|0|||
106002657|NCT00383552|365672479|FG002|Overall Study|Did not wish to continue (related)|2|||
106002658|NCT00383552|365672480|FG003|Overall Study|Did not wish to continue (related)|3|||
106002659|NCT00383552|365672477|FG000|Overall Study|Noncompliance with the protocol|11|||
106002660|NCT00383552|365672478|FG001|Overall Study|Noncompliance with the protocol|6|||
105688991|NCT00307125|364525443|FG000|Screening Phase|Moved or transferred facilities|34|||
105688992|NCT00307125|364525444|FG001|Screening Phase|Moved or transferred facilities|0|||
106002661|NCT00383552|365672479|FG002|Overall Study|Noncompliance with the protocol|8|||
106002662|NCT00383552|365672480|FG003|Overall Study|Noncompliance with the protocol|10|||
106002663|NCT00383552|365672477|FG000|Overall Study|Did not meet protocol eligibility|8|||
106002664|NCT00383552|365672478|FG001|Overall Study|Did not meet protocol eligibility|6|||
106002665|NCT00383552|365672479|FG002|Overall Study|Did not meet protocol eligibility|2|||
105688993|NCT00307125|364525445|FG002|Screening Phase|Moved or transferred facilities|0|||
105688994|NCT00307125|364525443|FG000|Screening Phase|Received Pancreas Transplant|8|||
105688995|NCT00307125|364525444|FG001|Screening Phase|Received Pancreas Transplant|0|||
105688996|NCT00307125|364525445|FG002|Screening Phase|Received Pancreas Transplant|0|||
105688997|NCT00307125|364525443|FG000|Screening Phase|Ineligible for pilot|4|||
105688998|NCT00307125|364525444|FG001|Screening Phase|Ineligible for pilot|0|||
105688999|NCT00307125|364525445|FG002|Screening Phase|Ineligible for pilot|0|||
105689000|NCT00307125|364525443|FG000|Screening Phase|Try to get pregnant|1|||
105689001|NCT00307125|364525444|FG001|Screening Phase|Try to get pregnant|0|||
105689002|NCT00307125|364525445|FG002|Screening Phase|Try to get pregnant|0|||
106002666|NCT00383552|365672480|FG003|Overall Study|Did not meet protocol eligibility|3|||
106002667|NCT00383552|365672477|FG000|Overall Study|Administrative|1|||
106002668|NCT00383552|365672478|FG001|Overall Study|Administrative|0|||
106002669|NCT00383552|365672479|FG002|Overall Study|Administrative|1|||
106002670|NCT00383552|365672480|FG003|Overall Study|Administrative|1|||
106002671|NCT00280917|365672481|FG000|Overall Study|Adverse Event|1|||
106002672|NCT00280917|365672482|FG001|Overall Study|Adverse Event|1|||
105689003|NCT00307125|364525443|FG000|Screening Phase|Developed acute leukemia|1|||
105689004|NCT00307125|364525444|FG001|Screening Phase|Developed acute leukemia|0|||
105689005|NCT00307125|364525445|FG002|Screening Phase|Developed acute leukemia|0|||
106002673|NCT00280917|365672483|FG002|Overall Study|Adverse Event|4|||
106002674|NCT00280917|365672484|FG003|Overall Study|Adverse Event|1|||
106002675|NCT00280917|365672481|FG000|Overall Study|Change Therapy|1|||
106002676|NCT00280917|365672482|FG001|Overall Study|Change Therapy|2|||
106002677|NCT00280917|365672483|FG002|Overall Study|Change Therapy|0|||
106002678|NCT00280917|365672484|FG003|Overall Study|Change Therapy|0|||
106002679|NCT00280917|365672481|FG000|Overall Study|Withdrawal by Subject|0|||
106002680|NCT00280917|365672482|FG001|Overall Study|Withdrawal by Subject|2|||
106002681|NCT00280917|365672483|FG002|Overall Study|Withdrawal by Subject|0|||
106002682|NCT00280917|365672484|FG003|Overall Study|Withdrawal by Subject|1|||
106002683|NCT00280917|365672481|FG000|Overall Study|Noncompliance|0|||
106002684|NCT00280917|365672482|FG001|Overall Study|Noncompliance|1|||
105689006|NCT00307125|364525443|FG000|Screening Phase|Metastatic colon cancer|1|||
105689007|NCT00307125|364525444|FG001|Screening Phase|Metastatic colon cancer|0|||
105689008|NCT00307125|364525445|FG002|Screening Phase|Metastatic colon cancer|0|||
105689009|NCT00307125|364525443|FG000|Screening Phase|Malignancy|1|||
105689010|NCT00307125|364525444|FG001|Screening Phase|Malignancy|0|||
105689011|NCT00307125|364525445|FG002|Screening Phase|Malignancy|0|||
105689012|NCT00307125|364525443|FG000|Screening Phase|PAK|1|||
105689013|NCT00307125|364525444|FG001|Screening Phase|PAK|0|||
105689014|NCT00307125|364525445|FG002|Screening Phase|PAK|0|||
105689015|NCT00307125|364525443|FG000|Screening Phase|Ineligible|1|||
106002685|NCT00280917|365672483|FG002|Overall Study|Noncompliance|2|||
106002686|NCT00280917|365672484|FG003|Overall Study|Noncompliance|0|||
106002687|NCT03096834|365672485|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
106002688|NCT03096834|365672486|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
106002689|NCT03096834|365672487|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
106002690|NCT03096834|365672488|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
106002691|NCT03096834|365672485|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
105689016|NCT00307125|364525444|FG001|Screening Phase|Ineligible|0|||
105689017|NCT00307125|364525445|FG002|Screening Phase|Ineligible|0|||
105689018|NCT00307125|364525443|FG000|Screening Phase|Screen Error|1|||
105689019|NCT00307125|364525444|FG001|Screening Phase|Screen Error|0|||
105689020|NCT00307125|364525445|FG002|Screening Phase|Screen Error|0|||
106002692|NCT03096834|365672486|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
105689021|NCT00307125|364525443|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
105689022|NCT00307125|364525444|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
105689023|NCT00307125|364525445|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
105689024|NCT00307125|364525443|FG000|Screening Phase|AMR and treated with rituximab|1|||
105689025|NCT00307125|364525444|FG001|Screening Phase|AMR and treated with rituximab|0|||
105689026|NCT00307125|364525445|FG002|Screening Phase|AMR and treated with rituximab|0|||
105689027|NCT00307125|364525443|FG000|Screening Phase|Coronary artery bypass|1|||
105689028|NCT00307125|364525444|FG001|Screening Phase|Coronary artery bypass|0|||
105689029|NCT00307125|364525445|FG002|Screening Phase|Coronary artery bypass|0|||
105689030|NCT00307125|364525443|FG000|Pilot Phase|Lost to Follow-up|0|||
105689031|NCT00307125|364525444|FG001|Pilot Phase|Lost to Follow-up|1|||
105689032|NCT00307125|364525445|FG002|Pilot Phase|Lost to Follow-up|0|||
105689033|NCT00307125|364525443|FG000|Pilot Phase|Withdrawal by Subject|0|||
105689034|NCT00307125|364525444|FG001|Pilot Phase|Withdrawal by Subject|1|||
105689035|NCT00307125|364525445|FG002|Pilot Phase|Withdrawal by Subject|1|||
105689036|NCT01699789|364525446|FG000|Overall Study|Withdrawal by Subject|18|||
105689037|NCT01699789|364525447|FG001|Overall Study|Withdrawal by Subject|23|||
105689038|NCT01699789|364525446|FG000|Overall Study|Death|1|||
105689039|NCT01699789|364525447|FG001|Overall Study|Death|2|||
105689040|NCT01699789|364525446|FG000|Overall Study|Lost to Follow-up|83|||
105689041|NCT01699789|364525447|FG001|Overall Study|Lost to Follow-up|101|||
105689042|NCT01050205|364525450|FG000|Overall Study|Lost to Follow-up|7|||
105689043|NCT01050205|364525451|FG001|Overall Study|Lost to Follow-up|1|||
105689044|NCT01050205|364525450|FG000|Overall Study|Withdrawal by Subject|1|||
105689045|NCT01050205|364525451|FG001|Overall Study|Withdrawal by Subject|1|||
105689046|NCT01050205|364525450|FG000|Overall Study|Relocated from area|1|||
105689047|NCT01050205|364525451|FG001|Overall Study|Relocated from area|2|||
105689048|NCT01050205|364525450|FG000|Overall Study|Discontinued Intervention|2|||
105689049|NCT01050205|364525451|FG001|Overall Study|Discontinued Intervention|0|||
105689050|NCT00954421|364525452|FG000|Screening|screen failures|3|||
105689051|NCT00954421|364525452|FG000|6 Months of DBS|Withdrawal by Subject|1|||
105689052|NCT00954421|364525452|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
105689053|NCT01557348|364525453|FG000|Overall Study|Adverse Event|6|||
105689054|NCT01557348|364525454|FG001|Overall Study|Adverse Event|16|||
105689055|NCT01557348|364525453|FG000|Overall Study|Infusion reaction event|5|||
105689056|NCT01557348|364525454|FG001|Overall Study|Infusion reaction event|5|||
105689057|NCT01557348|364525453|FG000|Overall Study|Death|7|||
105689058|NCT01557348|364525454|FG001|Overall Study|Death|4|||
105689059|NCT01557348|364525453|FG000|Overall Study|Insufficient Therapeutic Response|13|||
105689060|NCT01557348|364525454|FG001|Overall Study|Insufficient Therapeutic Response|28|||
105689061|NCT01557348|364525453|FG000|Overall Study|Withdrawal by Subject|5|||
105689062|NCT01557348|364525454|FG001|Overall Study|Withdrawal by Subject|4|||
105689063|NCT01557348|364525453|FG000|Overall Study|Lost to Follow-up|26|||
105689064|NCT01557348|364525454|FG001|Overall Study|Lost to Follow-up|22|||
105689065|NCT01557348|364525453|FG000|Overall Study|Administrative|18|||
105689066|NCT01557348|364525454|FG001|Overall Study|Administrative|11|||
105689067|NCT05125679|364525455|FG000|Overall Study|Study Terminated by Sponsor|2|||
105689068|NCT05125679|364525456|FG001|Overall Study|Study Terminated by Sponsor|5|||
105689069|NCT06132425|364525457|FG000|Overall Study|Withdrawal by Subject|3|||
105689070|NCT06132425|364525458|FG001|Overall Study|Withdrawal by Subject|0|||
105689071|NCT06132425|364525457|FG000|Overall Study|Did not follow study instructions|0|||
105689072|NCT06132425|364525458|FG001|Overall Study|Did not follow study instructions|2|||
105689073|NCT06132425|364525457|FG000|Overall Study|Lost to Follow-up|3|||
105689074|NCT06132425|364525458|FG001|Overall Study|Lost to Follow-up|5|||
105689075|NCT05393037|364525459|FG000|Part A|Death|1|||
105689076|NCT05393037|364525460|FG001|Part A|Death|0|||
105689077|NCT05393037|364525459|FG000|Part A|Lost to Follow-up|1|||
105689078|NCT05393037|364525460|FG001|Part A|Lost to Follow-up|1|||
105689079|NCT05393037|364525459|FG000|Part A|Withdrawal by Subject|2|||
105689080|NCT05393037|364525460|FG001|Part A|Withdrawal by Subject|4|||
105689081|NCT05393037|364525459|FG000|Part B|Lost to Follow-up|1|||
105689082|NCT05393037|364525460|FG001|Part B|Lost to Follow-up|0|||
105689083|NCT05461794|364525463|FG000|Overall Study|Withdrawal by Subject|1|||
105689084|NCT05461794|364525464|FG001|Overall Study|Withdrawal by Subject|1|||
105689085|NCT05461794|364525465|FG002|Overall Study|Withdrawal by Subject|3|||
105689086|NCT05461794|364525463|FG000|Overall Study|Study Terminated By Sponsor|18|||
105689087|NCT05461794|364525464|FG001|Overall Study|Study Terminated By Sponsor|13|||
105689088|NCT05461794|364525465|FG002|Overall Study|Study Terminated By Sponsor|16|||
105689089|NCT05461794|364525463|FG000|Overall Study|Death|20|||
105689090|NCT05461794|364525464|FG001|Overall Study|Death|5|||
105689091|NCT05461794|364525465|FG002|Overall Study|Death|19|||
105689092|NCT01853982|364525466|FG000|Overall Study|Withdrawal by Subject|1|||
105689093|NCT01853982|364525467|FG001|Overall Study|Withdrawal by Subject|0|||
105689094|NCT01853982|364525466|FG000|Overall Study|Death|1|||
105689095|NCT01853982|364525467|FG001|Overall Study|Death|0|||
105689096|NCT01853982|364525466|FG000|Overall Study|Lost to Follow-up|0|||
105689097|NCT01853982|364525467|FG001|Overall Study|Lost to Follow-up|1|||
105689098|NCT05066724|364525470|FG000|Overall Study|Adverse Event|1|||
105786794|NCT05643573|364872928|FG001|Overall Study|Outcome event|36|||
105689099|NCT05066724|364525470|FG000|Overall Study|Non-Compliance With Study Drug|5|||
105689100|NCT05066724|364525470|FG000|Overall Study|Withdrawal by Subject|6|||
105689101|NCT05066724|364525470|FG000|Overall Study|Physician Decision|2|||
105689102|NCT01422850|364525471|FG000|Overall Study|Physician Decision|3|||
105689103|NCT04484831|364525472|FG000|Overall Study|Withdrawal by Subject|1|||
105689104|NCT04484831|364525473|FG001|Overall Study|Withdrawal by Subject|0|||
105689105|NCT02244996|364525474|FG000|Overall Study|Lack of Efficacy|2|||
105689106|NCT02244996|364525475|FG001|Overall Study|Lack of Efficacy|6|||
105689107|NCT00447382|364525476|FG000|Overall Study|Adverse Event|1|||
105689108|NCT00447382|364525477|FG001|Overall Study|Adverse Event|1|||
105689109|NCT00447382|364525476|FG000|Overall Study|Lack of Efficacy|1|||
105689110|NCT00447382|364525477|FG001|Overall Study|Lack of Efficacy|0|||
105689111|NCT00447382|364525476|FG000|Overall Study|Protocol Violation|2|||
105689112|NCT00447382|364525477|FG001|Overall Study|Protocol Violation|0|||
105689113|NCT00447382|364525476|FG000|Overall Study|Unclassified|2|||
105689114|NCT00447382|364525477|FG001|Overall Study|Unclassified|5|||
105689115|NCT04435782|364525478|FG000|Overall Study|Study terminated by sponsor|4|||
105689116|NCT02477696|364525479|FG000|Overall Study|Death|89|||
105689117|NCT02477696|364525480|FG001|Overall Study|Death|106|||
105689118|NCT02477696|364525479|FG000|Overall Study|Lost to Follow-up|7|||
105689119|NCT02477696|364525480|FG001|Overall Study|Lost to Follow-up|5|||
105689120|NCT02477696|364525479|FG000|Overall Study|Withdrawal by Subject|37|||
105689121|NCT02477696|364525480|FG001|Overall Study|Withdrawal by Subject|34|||
105689122|NCT02477696|364525479|FG000|Overall Study|Physician Decision|7|||
105689123|NCT02477696|364525480|FG001|Overall Study|Physician Decision|9|||
105689124|NCT02477696|364525479|FG000|Overall Study|Study terminated by sponsor|103|||
105689125|NCT02477696|364525480|FG001|Overall Study|Study terminated by sponsor|99|||
105689126|NCT02477696|364525479|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
105689127|NCT02477696|364525480|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
105689128|NCT02477696|364525479|FG000|Overall Study|Missing/Unknown|2|||
105689129|NCT02477696|364525480|FG001|Overall Study|Missing/Unknown|0|||
105689130|NCT03602261|364525483|FG000|Overall Study|Adverse Event|5|||
105689131|NCT03602261|364525484|FG001|Overall Study|Adverse Event|1|||
105689132|NCT03602261|364525483|FG000|Overall Study|Physician Decision|1|||
105689133|NCT03602261|364525484|FG001|Overall Study|Physician Decision|0|||
105689134|NCT03602261|364525483|FG000|Overall Study|Withdrawal by Subject|1|||
105689135|NCT03602261|364525484|FG001|Overall Study|Withdrawal by Subject|1|||
105689136|NCT03602261|364525483|FG000|Overall Study|Lack of Efficacy|0|||
105786795|NCT05643573|364872927|FG000|Overall Study|Physician Decision|33|||
105919201|NCT03504917|365363522|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
105919202|NCT03504917|365363521|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
105919203|NCT03504917|365363522|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
105919204|NCT03504917|365363521|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
105919205|NCT03504917|365363522|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
105919206|NCT03504917|365363521|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
105919207|NCT03504917|365363522|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
105919208|NCT03504917|365363521|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
105919209|NCT03504917|365363522|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
105919210|NCT03504917|365363521|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
105919211|NCT03504917|365363522|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
105919212|NCT04219189|365363523|FG000|Overall Study|Withdrawal by Subject|1|||
105919213|NCT04219189|365363524|FG001|Overall Study|Withdrawal by Subject|2|||
105919214|NCT04219189|365363523|FG000|Overall Study|Protocol Violation|0|||
105919215|NCT04219189|365363524|FG001|Overall Study|Protocol Violation|1|||
105919216|NCT04219189|365363523|FG000|Overall Study|Lost to Follow-up|0|||
105919217|NCT04219189|365363524|FG001|Overall Study|Lost to Follow-up|1|||
105919218|NCT04219189|365363523|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
105919219|NCT04219189|365363524|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
105919220|NCT00572832|365363525|FG000|Overall Study|Lost to Follow-up|0|||
105919221|NCT00572832|365363526|FG001|Overall Study|Lost to Follow-up|11|||
105919222|NCT00572832|365363525|FG000|Overall Study|Pregnancy|0|||
105919223|NCT00572832|365363526|FG001|Overall Study|Pregnancy|1|||
105919224|NCT04079790|365363527|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
105919225|NCT04079790|365363528|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
105919226|NCT04079790|365363529|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
105919227|NCT04079790|365363530|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
105786796|NCT05643573|364872928|FG001|Overall Study|Physician Decision|19|||
106002693|NCT03096834|365672487|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
106002694|NCT03096834|365672488|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
106002695|NCT03096834|365672485|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
105689137|NCT03602261|364525484|FG001|Overall Study|Lack of Efficacy|1|||
105689138|NCT03602261|364525483|FG000|Overall Study|Subject moving out of state|1|||
105689139|NCT03602261|364525484|FG001|Overall Study|Subject moving out of state|0|||
105689140|NCT04091451|364525485|FG000|Overall Study|Adverse Event|15|||
105689141|NCT04091451|364525486|FG001|Overall Study|Adverse Event|10|||
105689142|NCT04091451|364525485|FG000|Overall Study|Lost to Follow-up|8|||
106002696|NCT03096834|365672486|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
106002697|NCT03096834|365672487|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
106002698|NCT03096834|365672488|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
105689143|NCT04091451|364525486|FG001|Overall Study|Lost to Follow-up|8|||
105689144|NCT04091451|364525485|FG000|Overall Study|Protocol Violation|5|||
105689145|NCT04091451|364525486|FG001|Overall Study|Protocol Violation|4|||
105689146|NCT04091451|364525485|FG000|Overall Study|Withdrawal by Subject|21|||
105689147|NCT04091451|364525486|FG001|Overall Study|Withdrawal by Subject|27|||
105689148|NCT04091451|364525485|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
105689149|NCT04091451|364525486|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
105689150|NCT04091451|364525485|FG000|Overall Study|Migrated/moved from the study area|3|||
105689151|NCT04091451|364525486|FG001|Overall Study|Migrated/moved from the study area|5|||
105689152|NCT04091451|364525485|FG000|Overall Study|Suspected HZ episode|1|||
105689153|NCT04091451|364525486|FG001|Overall Study|Suspected HZ episode|0|||
105689154|NCT04124614|364525488|FG000|Placebo Run-in Period|Not Randomized|34|||
105689155|NCT04124614|364525489|FG001|Placebo Run-in Period|Not Randomized|0|||
106002699|NCT03096834|365672485|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
105689156|NCT04124614|364525490|FG002|Placebo Run-in Period|Not Randomized|0|||
105689157|NCT04124614|364525488|FG000|Double Blind Treatment Period|Adverse Event|0|||
105689158|NCT04124614|364525489|FG001|Double Blind Treatment Period|Adverse Event|7|||
105689159|NCT04124614|364525490|FG002|Double Blind Treatment Period|Adverse Event|22|||
105689160|NCT04124614|364525488|FG000|Double Blind Treatment Period|Death|0|||
105689161|NCT04124614|364525489|FG001|Double Blind Treatment Period|Death|0|||
105689162|NCT04124614|364525490|FG002|Double Blind Treatment Period|Death|1|||
105689163|NCT04124614|364525488|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
105689164|NCT04124614|364525489|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
105689165|NCT04124614|364525490|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
105689166|NCT04124614|364525488|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
105689167|NCT04124614|364525489|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
105689168|NCT04124614|364525490|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
105689169|NCT04124614|364525488|FG000|Double Blind Treatment Period|Physician Decision|0|||
105689170|NCT04124614|364525489|FG001|Double Blind Treatment Period|Physician Decision|0|||
105689171|NCT04124614|364525490|FG002|Double Blind Treatment Period|Physician Decision|3|||
105689172|NCT04124614|364525488|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
105689173|NCT04124614|364525489|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
106002700|NCT03096834|365672486|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
106002701|NCT03096834|365672487|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
106002702|NCT03096834|365672488|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
106002703|NCT03096834|365672485|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
106002704|NCT03096834|365672486|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
106002705|NCT03096834|365672487|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
106002706|NCT03096834|365672488|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
106002707|NCT03096834|365672485|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
106002708|NCT03096834|365672486|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
106002709|NCT03096834|365672487|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
106002710|NCT03096834|365672488|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
106002711|NCT03096834|365672485|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
106002712|NCT03096834|365672486|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
106002713|NCT03096834|365672487|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
106002714|NCT03096834|365672488|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
106002715|NCT03096834|365672485|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
106002716|NCT03096834|365672486|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
106002717|NCT03096834|365672487|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
106002718|NCT03096834|365672488|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
106002719|NCT03096834|365672485|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
106002720|NCT03096834|365672486|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
106002721|NCT03096834|365672487|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
106002722|NCT03096834|365672488|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
106002723|NCT03096834|365672485|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
105689174|NCT04124614|364525490|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
105689175|NCT04124614|364525488|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
105689176|NCT04124614|364525489|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
105689177|NCT04124614|364525490|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
105689178|NCT04124614|364525488|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
105689179|NCT04124614|364525489|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
106002724|NCT03096834|365672486|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
106002725|NCT03096834|365672487|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
106002726|NCT03096834|365672488|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
105689180|NCT04124614|364525490|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
105689181|NCT00720941|364526619|FG000|Overall Study|Protocol Violation|1|||
105689182|NCT00720941|364526620|FG001|Overall Study|Protocol Violation|2|||
105689183|NCT00720941|364526619|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
105689184|NCT00720941|364526620|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
105689185|NCT00720941|364526619|FG000|Overall Study|Lost to Follow-up|20|||
105689186|NCT00720941|364526620|FG001|Overall Study|Lost to Follow-up|15|||
105689187|NCT00720941|364526619|FG000|Overall Study|Physician Decision|14|||
105689188|NCT00720941|364526620|FG001|Overall Study|Physician Decision|12|||
105689189|NCT00720941|364526619|FG000|Overall Study|Withdrawal by Subject|29|||
105689190|NCT00720941|364526620|FG001|Overall Study|Withdrawal by Subject|36|||
105689191|NCT02425644|364526624|FG000|Overall Study|Lost to Follow-up|2|||
105689192|NCT02425644|364526625|FG001|Overall Study|Lost to Follow-up|3|||
105689193|NCT02425644|364526624|FG000|Overall Study|Withdrawal by Subject|41|||
105689194|NCT02425644|364526625|FG001|Overall Study|Withdrawal by Subject|36|||
105689195|NCT02425644|364526624|FG000|Overall Study|Lack of Efficacy|3|||
105689196|NCT02425644|364526625|FG001|Overall Study|Lack of Efficacy|10|||
105689197|NCT02425644|364526624|FG000|Overall Study|Adverse Event|13|||
105689198|NCT02425644|364526625|FG001|Overall Study|Adverse Event|3|||
105689199|NCT02425644|364526624|FG000|Overall Study|Death|0|||
105689200|NCT02425644|364526625|FG001|Overall Study|Death|2|||
105689201|NCT02425644|364526624|FG000|Overall Study|Other|18|||
105689202|NCT02425644|364526625|FG001|Overall Study|Other|17|||
105689203|NCT01072877|364526626|FG000|Overall Study|Lost to Follow-up|1|||
105689204|NCT01072877|364526627|FG001|Overall Study|Lost to Follow-up|1|||
105689205|NCT01072877|364526628|FG002|Overall Study|Lost to Follow-up|0|||
105689206|NCT01072877|364526629|FG003|Overall Study|Lost to Follow-up|2|||
105689207|NCT01072877|364526630|FG004|Overall Study|Lost to Follow-up|0|||
105689208|NCT01929980|364526631|FG000|Overall Study|Physician Decision|1|||
105689209|NCT00995020|364526632|FG000|Overall Study|margin analysis not performed|2|||
105689210|NCT00995020|364526633|FG001|Overall Study|margin analysis not performed|5|||
105689211|NCT00995020|364526632|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
105689212|NCT00995020|364526633|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
105689213|NCT01940354|364526634|FG000|Overall Study|Withdrawal by Subject|4|||
105689214|NCT01940354|364526635|FG001|Overall Study|Withdrawal by Subject|2|||
105689215|NCT00985166|364526636|FG000|Overall Study|Lost to Follow-up|3|||
105689216|NCT00985166|364526637|FG001|Overall Study|Lost to Follow-up|2|||
105689217|NCT00985166|364526638|FG002|Overall Study|Lost to Follow-up|2|||
105689218|NCT00985166|364526636|FG000|Overall Study|Withdrawal by Subject|3|||
105689219|NCT00985166|364526637|FG001|Overall Study|Withdrawal by Subject|2|||
105689220|NCT00985166|364526638|FG002|Overall Study|Withdrawal by Subject|0|||
105689221|NCT00985166|364526636|FG000|Overall Study|Test not done|2|||
105689222|NCT00985166|364526637|FG001|Overall Study|Test not done|0|||
105689223|NCT00985166|364526638|FG002|Overall Study|Test not done|4|||
105689224|NCT00985166|364526636|FG000|Overall Study|Other|1|||
105689225|NCT00985166|364526637|FG001|Overall Study|Other|0|||
105689226|NCT00985166|364526638|FG002|Overall Study|Other|1|||
105689227|NCT01028222|364526639|FG000|Overall Study|Protocol deviation|1|||
105689228|NCT01028222|364526640|FG001|Overall Study|Protocol deviation|0|||
105689229|NCT01028222|364526639|FG000|Overall Study|Disease progression|33|||
105689230|NCT01028222|364526640|FG001|Overall Study|Disease progression|9|||
105689231|NCT01028222|364526639|FG000|Overall Study|Administrative problems|1|||
105689232|NCT01028222|364526640|FG001|Overall Study|Administrative problems|1|||
105689233|NCT01028222|364526639|FG000|Overall Study|Lost to Follow-up|0|||
105689234|NCT01028222|364526640|FG001|Overall Study|Lost to Follow-up|1|||
105689235|NCT01028222|364526639|FG000|Overall Study|Withdrawal by Subject|1|||
105689236|NCT01028222|364526640|FG001|Overall Study|Withdrawal by Subject|0|||
105689237|NCT01028222|364526639|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
105689238|NCT01028222|364526640|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
105689239|NCT01028222|364526639|FG000|Overall Study|Adverse Event|2|||
105689240|NCT01028222|364526640|FG001|Overall Study|Adverse Event|0|||
105919228|NCT04079790|365363527|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
105919229|NCT04079790|365363528|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
105919230|NCT04079790|365363529|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
105919231|NCT04079790|365363530|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
105919232|NCT04079790|365363527|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
105919233|NCT04079790|365363528|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
105689241|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
105689242|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
105689243|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
105689244|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
105689245|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
105689246|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
105689247|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
105689248|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
105689249|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
105689250|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
105689251|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
105689252|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
105689253|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Death|3|||
105689254|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Death|1|||
105689255|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
105689256|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
105689257|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Adverse Event|7|||
105689258|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Adverse Event|8|||
105689259|NCT03236246|364526647|FG000|24-Week Dose Titration Period|Captured as Other|1|||
105689260|NCT03236246|364526648|FG001|24-Week Dose Titration Period|Captured as Other|2|||
105689261|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
105689262|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
105689263|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
105689264|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
105689265|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
105689266|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
105689267|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Death|0|||
105689268|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Death|1|||
105689269|NCT03236246|364526647|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
105689270|NCT03236246|364526648|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
105689271|NCT02598557|364526649|FG000|Overall Study|Withdrawal by Subject|1|||
105689272|NCT02598557|364526650|FG001|Overall Study|Withdrawal by Subject|0|||
105689273|NCT02598557|364526651|FG002|Overall Study|Withdrawal by Subject|1|||
105689274|NCT02598557|364526649|FG000|Overall Study|Participant did not start treatment|2|||
105689275|NCT02598557|364526650|FG001|Overall Study|Participant did not start treatment|1|||
105689276|NCT02598557|364526651|FG002|Overall Study|Participant did not start treatment|1|||
105689277|NCT02598557|364526649|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
105689278|NCT02598557|364526650|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
105689279|NCT02598557|364526651|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
105689280|NCT02598557|364526649|FG000|Overall Study|Adverse Event|1|||
105689281|NCT02598557|364526650|FG001|Overall Study|Adverse Event|1|||
105689282|NCT02598557|364526651|FG002|Overall Study|Adverse Event|0|||
105689283|NCT01117454|364526652|FG000|Overall Study|Pregnancy|0|||
105689284|NCT01117454|364526653|FG001|Overall Study|Pregnancy|1|||
105689285|NCT01146054|364526658|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
105689286|NCT01146054|364526658|FG000|Overall Study|Rapid tumor progression|2|||
105689287|NCT01146054|364526658|FG000|Overall Study|Other illness precluded treatment|2|||
105689288|NCT01146054|364526658|FG000|Overall Study|Lost to Follow-up|1|||
105689289|NCT00402363|364526659|FG000|Overall Study|Adverse Event|9|||
105689290|NCT00402363|364526660|FG001|Overall Study|Adverse Event|14|||
105689291|NCT00402363|364526661|FG002|Overall Study|Adverse Event|2|||
105689292|NCT00402363|364526662|FG003|Overall Study|Adverse Event|2|||
105689293|NCT00402363|364526659|FG000|Overall Study|Withdrew Consent|10|||
105689294|NCT00402363|364526660|FG001|Overall Study|Withdrew Consent|5|||
105689295|NCT00402363|364526661|FG002|Overall Study|Withdrew Consent|2|||
105689296|NCT00402363|364526662|FG003|Overall Study|Withdrew Consent|1|||
105689297|NCT00402363|364526659|FG000|Overall Study|Protocol Violation|3|||
105689298|NCT00402363|364526660|FG001|Overall Study|Protocol Violation|5|||
105919234|NCT04079790|365363529|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
105919235|NCT04079790|365363530|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
105689299|NCT00402363|364526661|FG002|Overall Study|Protocol Violation|0|||
105689300|NCT00402363|364526662|FG003|Overall Study|Protocol Violation|3|||
105689301|NCT00402363|364526659|FG000|Overall Study|Lost to Follow-up|5|||
105689302|NCT00402363|364526660|FG001|Overall Study|Lost to Follow-up|4|||
105689303|NCT00402363|364526661|FG002|Overall Study|Lost to Follow-up|0|||
105689304|NCT00402363|364526662|FG003|Overall Study|Lost to Follow-up|2|||
105689305|NCT00402363|364526659|FG000|Overall Study|"Captured as Other"|6|||
105689306|NCT00402363|364526660|FG001|Overall Study|"Captured as Other"|2|||
105689307|NCT00402363|364526661|FG002|Overall Study|"Captured as Other"|2|||
105689308|NCT00402363|364526662|FG003|Overall Study|"Captured as Other"|2|||
105919236|NCT01253161|365363531|FG000|Overall Study|Adverse Event|1|||
105689309|NCT00293722|364526663|FG000|Overall Study|Other|427|||
105689310|NCT01008696|364526665|FG000|Overall Study|Participant's evasion of hospital visit|5|||
105689311|NCT01008696|364526666|FG001|Overall Study|Participant's evasion of hospital visit|4|||
105689312|NCT01008696|364526665|FG000|Overall Study|Withdrawal by Subject|2|||
105689313|NCT01008696|364526666|FG001|Overall Study|Withdrawal by Subject|4|||
105689314|NCT01008696|364526665|FG000|Overall Study|Physician Decision|5|||
105689315|NCT01008696|364526666|FG001|Overall Study|Physician Decision|1|||
105689316|NCT01008696|364526665|FG000|Overall Study|Adverse Event|1|||
105919237|NCT03101020|365363532|FG000|Overall Study|Lack of time to participate|1|||
105919238|NCT03101020|365363533|FG001|Overall Study|Lack of time to participate|0|||
106002727|NCT03096834|365672485|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
106002728|NCT03096834|365672486|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
106002729|NCT03096834|365672487|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
106002730|NCT03096834|365672488|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
106002731|NCT03096834|365672485|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
105689317|NCT01008696|364526666|FG001|Overall Study|Adverse Event|0|||
106002732|NCT03096834|365672486|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
106002733|NCT03096834|365672487|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
106002734|NCT03096834|365672488|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
106002735|NCT02173769|365672497|FG000|Overall Study|Protocol Violation|4|||
106002736|NCT02421172|365672500|FG000|Period 1|Adverse Event|1|||
106002737|NCT02421172|365672501|FG001|Period 1|Adverse Event|0|||
106002738|NCT02421172|365672502|FG002|Period 1|Adverse Event|0|||
106002739|NCT02421172|365672503|FG003|Period 1|Adverse Event|0|||
106002740|NCT02421172|365672504|FG004|Period 1|Adverse Event|0|||
106002741|NCT02421172|365672500|FG000|Period 1|Lost to Follow-up|3|||
106002742|NCT02421172|365672501|FG001|Period 1|Lost to Follow-up|1|||
106002743|NCT02421172|365672502|FG002|Period 1|Lost to Follow-up|0|||
106002744|NCT02421172|365672503|FG003|Period 1|Lost to Follow-up|0|||
106002745|NCT02421172|365672504|FG004|Period 1|Lost to Follow-up|0|||
106002746|NCT02421172|365672500|FG000|Period 1|Patient/guardian decision|0|||
105689318|NCT01008696|364526665|FG000|Overall Study|Participants' non-cooperation|2|||
105689319|NCT01008696|364526666|FG001|Overall Study|Participants' non-cooperation|3|||
105689320|NCT01008696|364526665|FG000|Overall Study|Other|2|||
105689321|NCT01008696|364526666|FG001|Overall Study|Other|3|||
105689322|NCT01008696|364526665|FG000|Overall Study|Other|0|||
105689323|NCT01008696|364526666|FG001|Overall Study|Other|2|||
105689324|NCT00667355|364526667|FG000|Overall Study|Adverse Event|5|||
105689325|NCT00667355|364526667|FG000|Overall Study|Lost to Follow-up|1|||
105689326|NCT00667355|364526667|FG000|Overall Study|Other reason was not specified|5|||
105689327|NCT01369511|364526669|FG000|Overall Study|Adverse Event|1|||
105689328|NCT01369511|364526670|FG001|Overall Study|Adverse Event|1|||
105689329|NCT01369511|364526671|FG002|Overall Study|Adverse Event|5|||
105689330|NCT01369511|364526672|FG003|Overall Study|Adverse Event|0|||
105689331|NCT01369511|364526669|FG000|Overall Study|Entry criteria not met|2|||
105689332|NCT01369511|364526670|FG001|Overall Study|Entry criteria not met|0|||
105689333|NCT01369511|364526671|FG002|Overall Study|Entry criteria not met|0|||
105689334|NCT01369511|364526672|FG003|Overall Study|Entry criteria not met|1|||
105689335|NCT01369511|364526669|FG000|Overall Study|Lost to Follow-up|0|||
105689336|NCT01369511|364526670|FG001|Overall Study|Lost to Follow-up|1|||
105689337|NCT01369511|364526671|FG002|Overall Study|Lost to Follow-up|1|||
105689338|NCT01369511|364526672|FG003|Overall Study|Lost to Follow-up|2|||
105689339|NCT01369511|364526669|FG000|Overall Study|Protocol Violation|0|||
105689340|NCT01369511|364526670|FG001|Overall Study|Protocol Violation|1|||
105689341|NCT01369511|364526671|FG002|Overall Study|Protocol Violation|0|||
105689342|NCT01369511|364526672|FG003|Overall Study|Protocol Violation|2|||
105689343|NCT01369511|364526669|FG000|Overall Study|Physician Decision|3|||
105689344|NCT01369511|364526670|FG001|Overall Study|Physician Decision|4|||
105689345|NCT01369511|364526671|FG002|Overall Study|Physician Decision|0|||
105689346|NCT01369511|364526672|FG003|Overall Study|Physician Decision|0|||
105689347|NCT01369511|364526669|FG000|Overall Study|Sponsor decision|2|||
105689348|NCT01369511|364526670|FG001|Overall Study|Sponsor decision|0|||
105786797|NCT05643573|364872927|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
106002747|NCT02421172|365672501|FG001|Period 1|Patient/guardian decision|1|||
106002748|NCT02421172|365672502|FG002|Period 1|Patient/guardian decision|0|||
106002749|NCT02421172|365672503|FG003|Period 1|Patient/guardian decision|0|||
106002750|NCT02421172|365672504|FG004|Period 1|Patient/guardian decision|0|||
106002751|NCT02421172|365672500|FG000|Period 2|Adverse Event|0|||
106002752|NCT02421172|365672501|FG001|Period 2|Adverse Event|0|||
106002753|NCT02421172|365672502|FG002|Period 2|Adverse Event|4|||
106002754|NCT02421172|365672503|FG003|Period 2|Adverse Event|0|||
106002755|NCT02421172|365672504|FG004|Period 2|Adverse Event|0|||
106002756|NCT02421172|365672500|FG000|Period 2|Lost to Follow-up|0|||
106002757|NCT02421172|365672501|FG001|Period 2|Lost to Follow-up|0|||
106002758|NCT02421172|365672502|FG002|Period 2|Lost to Follow-up|0|||
106002759|NCT02421172|365672503|FG003|Period 2|Lost to Follow-up|1|||
106002760|NCT02421172|365672504|FG004|Period 2|Lost to Follow-up|0|||
105689349|NCT01369511|364526671|FG002|Overall Study|Sponsor decision|1|||
105689350|NCT01369511|364526672|FG003|Overall Study|Sponsor decision|0|||
105689351|NCT01369511|364526669|FG000|Overall Study|Withdrawal by Subject|5|||
105689352|NCT01369511|364526670|FG001|Overall Study|Withdrawal by Subject|6|||
105689353|NCT01369511|364526671|FG002|Overall Study|Withdrawal by Subject|4|||
105689354|NCT01369511|364526672|FG003|Overall Study|Withdrawal by Subject|6|||
105689355|NCT00718640|364526673|FG000|Overall Study|Adverse Event|4|||
105689356|NCT00718640|364526673|FG000|Overall Study|Death|1|||
105689357|NCT00718640|364526673|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
106002761|NCT02421172|365672500|FG000|Period 2|Patient/guardian decision|0|||
106002762|NCT02421172|365672501|FG001|Period 2|Patient/guardian decision|0|||
106002763|NCT02421172|365672502|FG002|Period 2|Patient/guardian decision|3|||
106002764|NCT02421172|365672503|FG003|Period 2|Patient/guardian decision|2|||
105689358|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
105689359|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
105689360|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
105689361|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
105689362|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
105689363|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
105689364|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
105689365|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
105689366|NCT03952806|364526674|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
105689367|NCT03952806|364526675|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
105689368|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
105689369|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
105689370|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
105689371|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
105689372|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
105689373|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
105689374|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
105689375|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
105689376|NCT03952806|364526674|FG000|OLE Phase (48 Weeks)|Other|16|||
105689377|NCT03952806|364526675|FG001|OLE Phase (48 Weeks)|Other|13|||
105689378|NCT01137955|364526676|FG000|Overall Study|Withdrawal by Subject|5|||
105689379|NCT01137955|364526677|FG001|Overall Study|Withdrawal by Subject|4|||
105689380|NCT01207596|364526678|FG000|Overall Study|Physician Decision|4|||
105689381|NCT01207596|364526678|FG000|Overall Study|Lack of Efficacy|1|||
105689382|NCT01207596|364526678|FG000|Overall Study|Adverse Event|3|||
105689383|NCT01207596|364526678|FG000|Overall Study|Withdrawal by Subject|1|||
105689384|NCT03871829|364526679|FG000|Overall Study|Lost to Follow-up|0|||
105689385|NCT03871829|364526680|FG001|Overall Study|Lost to Follow-up|1|||
105689386|NCT03871829|364526679|FG000|Overall Study|Withdrawal by Subject|1|||
105689387|NCT03871829|364526680|FG001|Overall Study|Withdrawal by Subject|1|||
105689388|NCT03871829|364526679|FG000|Overall Study|Death|12|||
105689389|NCT03871829|364526680|FG001|Overall Study|Death|8|||
105689390|NCT03871829|364526679|FG000|Overall Study|Study terminated by sponsor|31|||
105689391|NCT03871829|364526680|FG001|Overall Study|Study terminated by sponsor|34|||
105689392|NCT02310672|364526681|FG000|Overall Study|Death|1|||
105689393|NCT02310672|364526681|FG000|Overall Study|Lost to Follow-up|1|||
105689394|NCT02310672|364526681|FG000|Overall Study|Withdrawal by Subject|1|||
105689395|NCT02310672|364526681|FG000|Overall Study|Sponsor's decision|12|||
105689396|NCT04288778|364526682|FG000|Overall Study|Withdrawal by Subject|2|||
105689397|NCT04288778|364526682|FG000|Overall Study|Adverse Event|5|||
105689398|NCT04288778|364526682|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105689399|NCT04288778|364526682|FG000|Overall Study|Other|1|||
105689400|NCT04288778|364526682|FG000|Overall Study|Started but not treated|2|||
105689401|NCT01106014|364526685|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
105689402|NCT01106014|364526686|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
105689403|NCT01106014|364526685|FG000|Overall Study|Adverse Event|78|||
105689404|NCT01106014|364526686|FG001|Overall Study|Adverse Event|42|||
105689405|NCT01106014|364526685|FG000|Overall Study|Withdrawal by Subject|43|||
105689406|NCT01106014|364526686|FG001|Overall Study|Withdrawal by Subject|37|||
105689407|NCT01106014|364526685|FG000|Overall Study|Administrative reason|7|||
105689408|NCT01106014|364526686|FG001|Overall Study|Administrative reason|6|||
105689409|NCT01106014|364526685|FG000|Overall Study|Lost to Follow-up|2|||
105689410|NCT01106014|364526686|FG001|Overall Study|Lost to Follow-up|3|||
105689411|NCT00063154|364526687|FG000|Overall Study|Disease progression|27|||
105689412|NCT00063154|364526687|FG000|Overall Study|Adverse Event|2|||
105689413|NCT00063154|364526687|FG000|Overall Study|Physician Decision|10|||
105689414|NCT00063154|364526687|FG000|Overall Study|Death|3|||
105689415|NCT00063154|364526687|FG000|Overall Study|Reason unspecified|1|||
105689416|NCT00063154|364526687|FG000|Overall Study|Did not receive treatment|8|||
105689417|NCT02554903|364526694|FG000|Overall Study|Death|1|||
105689418|NCT02554903|364526695|FG001|Overall Study|Death|1|||
105689419|NCT02554903|364526694|FG000|Overall Study|Physician Decision|2|||
105689420|NCT02554903|364526695|FG001|Overall Study|Physician Decision|2|||
105689421|NCT02554903|364526694|FG000|Overall Study|Heart Transplant|1|||
105689422|NCT02554903|364526695|FG001|Overall Study|Heart Transplant|2|||
105689423|NCT00364156|364526696|FG000|Overall Study|Withdrawal by Subject|73|||
105786798|NCT05643573|364872928|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
105689424|NCT00364156|364526697|FG001|Overall Study|Withdrawal by Subject|80|||
105689425|NCT00364156|364526696|FG000|Overall Study|Protocol Violation|6|||
105689426|NCT00364156|364526697|FG001|Overall Study|Protocol Violation|1|||
105689427|NCT03049735|364526704|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
105689428|NCT03049735|364526705|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
105786799|NCT05643573|364872927|FG000|Overall Study|Site terminated by sponsor|10|||
105786800|NCT05643573|364872928|FG001|Overall Study|Site terminated by sponsor|10|||
105786801|NCT05643573|364872927|FG000|Overall Study|Study terminated by sponsor|1|||
105786802|NCT05643573|364872928|FG001|Overall Study|Study terminated by sponsor|0|||
105786803|NCT05643573|364872927|FG000|Overall Study|Withdrawal by Subject|178|||
105919239|NCT03101020|365363532|FG000|Overall Study|Ran over by a car|0|||
105919240|NCT03101020|365363533|FG001|Overall Study|Ran over by a car|1|||
106130580|NCT02419755|366134253|FG000|Overall Study|Withdrawal by Subject|1|||
106130581|NCT02419755|366134254|FG001|Overall Study|Withdrawal by Subject|0|||
106130582|NCT03073005|366134255|FG000|Overall Study|Death|6|||
106130583|NCT03073005|366134256|FG001|Overall Study|Death|0|||
106130584|NCT03073005|366134257|FG002|Overall Study|Death|7|||
106130585|NCT03073005|366134258|FG003|Overall Study|Death|0|||
106130586|NCT03073005|366134255|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
106130587|NCT03073005|366134256|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
106130588|NCT03073005|366134257|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
106130589|NCT03073005|366134258|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
106130590|NCT03073005|366134255|FG000|Overall Study|Lost to Follow-up|2|||
106130591|NCT03073005|366134256|FG001|Overall Study|Lost to Follow-up|2|||
106130592|NCT03073005|366134257|FG002|Overall Study|Lost to Follow-up|1|||
106130593|NCT03073005|366134258|FG003|Overall Study|Lost to Follow-up|2|||
106130594|NCT03073005|366134255|FG000|Overall Study|Withdrawal by Subject|0|||
106130595|NCT03073005|366134256|FG001|Overall Study|Withdrawal by Subject|4|||
106130596|NCT03073005|366134257|FG002|Overall Study|Withdrawal by Subject|4|||
106130597|NCT03073005|366134258|FG003|Overall Study|Withdrawal by Subject|4|||
106130598|NCT02427646|366134259|FG000|Overall Study|Lack of Efficacy|2|||
106130599|NCT02427646|366134260|FG001|Overall Study|Lack of Efficacy|3|||
106130600|NCT02427646|366134259|FG000|Overall Study|Physician Decision|1|||
106130601|NCT02427646|366134260|FG001|Overall Study|Physician Decision|4|||
106130602|NCT02427646|366134259|FG000|Overall Study|Protocol Violation|3|||
106130603|NCT02427646|366134260|FG001|Overall Study|Protocol Violation|3|||
106130604|NCT02427646|366134259|FG000|Overall Study|Bothersome hand weakness|2|||
106130605|NCT02427646|366134260|FG001|Overall Study|Bothersome hand weakness|4|||
106130606|NCT01641861|366134261|FG000|Overall Study|Lost to Follow-up|21|||
106130607|NCT01641861|366134262|FG001|Overall Study|Lost to Follow-up|16|||
106130608|NCT01641861|366134261|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
106130609|NCT01641861|366134262|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
106130610|NCT01641861|366134261|FG000|Overall Study|Died due to drowning|0|||
106130611|NCT01641861|366134262|FG001|Overall Study|Died due to drowning|1|||
106130612|NCT01556243|366134263|FG000|Overall Study|Ineligible|34|||
106130613|NCT01556243|366134263|FG000|Overall Study|Converted to mastectomy|14|||
106130614|NCT01556243|366134263|FG000|Overall Study|Unable to achieve negative margins|2|||
106130615|NCT01556243|366134263|FG000|Overall Study|Withdrawal by Subject|16|||
106002765|NCT02421172|365672504|FG004|Period 2|Patient/guardian decision|1|||
106002766|NCT00882440|365672505|FG000|Overall Study|Adverse Event|2|||
106002767|NCT00882440|365672506|FG001|Overall Study|Adverse Event|2|||
106002768|NCT00882440|365672507|FG002|Overall Study|Adverse Event|2|||
106002769|NCT00882440|365672508|FG003|Overall Study|Adverse Event|1|||
106002770|NCT00882440|365672509|FG004|Overall Study|Adverse Event|1|||
106002771|NCT00882440|365672510|FG005|Overall Study|Adverse Event|4|||
106002772|NCT00882440|365672511|FG006|Overall Study|Adverse Event|2|||
106002773|NCT00882440|365672505|FG000|Overall Study|Lack of Efficacy|3|||
106002774|NCT00882440|365672506|FG001|Overall Study|Lack of Efficacy|5|||
106002775|NCT00882440|365672507|FG002|Overall Study|Lack of Efficacy|2|||
106002776|NCT00882440|365672508|FG003|Overall Study|Lack of Efficacy|0|||
106002777|NCT00882440|365672509|FG004|Overall Study|Lack of Efficacy|0|||
106002778|NCT00882440|365672510|FG005|Overall Study|Lack of Efficacy|3|||
106002779|NCT00882440|365672511|FG006|Overall Study|Lack of Efficacy|0|||
106002780|NCT00882440|365672505|FG000|Overall Study|Lost to Follow-up|2|||
106002781|NCT00882440|365672506|FG001|Overall Study|Lost to Follow-up|0|||
106002782|NCT00882440|365672507|FG002|Overall Study|Lost to Follow-up|1|||
106002783|NCT00882440|365672508|FG003|Overall Study|Lost to Follow-up|1|||
106002784|NCT00882440|365672509|FG004|Overall Study|Lost to Follow-up|1|||
106002785|NCT00882440|365672510|FG005|Overall Study|Lost to Follow-up|0|||
106002786|NCT00882440|365672511|FG006|Overall Study|Lost to Follow-up|1|||
106002787|NCT00882440|365672505|FG000|Overall Study|Protocol Violation|0|||
106002788|NCT00882440|365672506|FG001|Overall Study|Protocol Violation|0|||
106002789|NCT00882440|365672507|FG002|Overall Study|Protocol Violation|1|||
106002790|NCT00882440|365672508|FG003|Overall Study|Protocol Violation|1|||
106002791|NCT00882440|365672509|FG004|Overall Study|Protocol Violation|1|||
106002792|NCT00882440|365672510|FG005|Overall Study|Protocol Violation|0|||
106002793|NCT00882440|365672511|FG006|Overall Study|Protocol Violation|0|||
106002794|NCT00882440|365672505|FG000|Overall Study|Withdrawal by Subject|2|||
106002795|NCT00882440|365672506|FG001|Overall Study|Withdrawal by Subject|1|||
106002796|NCT00882440|365672507|FG002|Overall Study|Withdrawal by Subject|1|||
106002797|NCT00882440|365672508|FG003|Overall Study|Withdrawal by Subject|0|||
106130616|NCT00901485|366134264|FG000|Overall Study|Lack of Efficacy|0|||
106130617|NCT00901485|366134265|FG001|Overall Study|Lack of Efficacy|2|||
106130618|NCT00901485|366134264|FG000|Overall Study|Withdrawal by Subject|1|||
106130619|NCT00901485|366134265|FG001|Overall Study|Withdrawal by Subject|2|||
106130620|NCT01929993|366135505|FG000|Overall Study|Protocol Violation|4|||
106130621|NCT01929993|366135506|FG001|Overall Study|Protocol Violation|6|||
106130622|NCT01929993|366135505|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
106130623|NCT01929993|366135506|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
106130624|NCT01852162|366135507|FG000|Overall Study|Adverse Event|1|||
106130625|NCT01852162|366135508|FG001|Overall Study|Adverse Event|0|||
106130626|NCT01852162|366135507|FG000|Overall Study|Withdrawal by Subject|3|||
106130627|NCT01852162|366135508|FG001|Overall Study|Withdrawal by Subject|1|||
106130628|NCT02268396|366135513|FG000|Overall Study|Adverse Event|3|||
106130629|NCT02268396|366135513|FG000|Overall Study|Administrative|2|||
106130630|NCT02268396|366135513|FG000|Overall Study|Withdrawal by Subject|1|||
106130631|NCT02268396|366135513|FG000|Overall Study|Lost to Follow-up|2|||
106130632|NCT02268396|366135513|FG000|Overall Study|Protocol-Specified Criteria|2|||
106130633|NCT02268396|366135513|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
105786804|NCT05643573|364872928|FG001|Overall Study|Withdrawal by Subject|130|||
106002798|NCT00882440|365672509|FG004|Overall Study|Withdrawal by Subject|6|||
106002799|NCT00882440|365672510|FG005|Overall Study|Withdrawal by Subject|0|||
106002800|NCT00882440|365672511|FG006|Overall Study|Withdrawal by Subject|1|||
106002801|NCT00882440|365672505|FG000|Overall Study|Patient Uncooperative|2|||
106002802|NCT00882440|365672506|FG001|Overall Study|Patient Uncooperative|0|||
106002803|NCT00882440|365672507|FG002|Overall Study|Patient Uncooperative|0|||
106002804|NCT00882440|365672508|FG003|Overall Study|Patient Uncooperative|0|||
106002805|NCT00882440|365672509|FG004|Overall Study|Patient Uncooperative|1|||
106002806|NCT00882440|365672510|FG005|Overall Study|Patient Uncooperative|0|||
106002807|NCT00882440|365672511|FG006|Overall Study|Patient Uncooperative|0|||
106002808|NCT00683878|365672515|FG000|Overall Study|Lack of Efficacy|3|||
106002809|NCT00683878|365672516|FG001|Overall Study|Lack of Efficacy|0|||
106002810|NCT00683878|365672517|FG002|Overall Study|Lack of Efficacy|1|||
106002811|NCT00683878|365672515|FG000|Overall Study|Adverse Event|4|||
106002812|NCT00683878|365672516|FG001|Overall Study|Adverse Event|3|||
106130634|NCT01021878|366135516|FG000|Overall Study|Lost to Follow-up|4|||
106130635|NCT01021878|366135517|FG001|Overall Study|Lost to Follow-up|3|||
105786805|NCT05182840|364872929|FG000|Run-in Period|Not treated|0|||
105786806|NCT05182840|364872930|FG001|Run-in Period|Not treated|1|||
106002813|NCT00683878|365672517|FG002|Overall Study|Adverse Event|3|||
106002814|NCT00683878|365672515|FG000|Overall Study|Withdrawal by Subject|9|||
106002815|NCT00683878|365672516|FG001|Overall Study|Withdrawal by Subject|8|||
106002816|NCT00683878|365672517|FG002|Overall Study|Withdrawal by Subject|6|||
106002817|NCT00683878|365672515|FG000|Overall Study|Death|0|||
106130636|NCT01021878|366135516|FG000|Overall Study|Death|0|||
106130637|NCT01021878|366135517|FG001|Overall Study|Death|1|||
106002818|NCT00683878|365672516|FG001|Overall Study|Death|1|||
105689429|NCT03049735|364526706|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
105689430|NCT03049735|364526704|FG000|Overall Study|Other|5|||
105689431|NCT03049735|364526705|FG001|Overall Study|Other|3|||
105689432|NCT03049735|364526706|FG002|Overall Study|Other|1|||
105689433|NCT03049735|364526704|FG000|Overall Study|Lack of Efficacy|4|||
105689434|NCT03049735|364526705|FG001|Overall Study|Lack of Efficacy|0|||
105689435|NCT03049735|364526706|FG002|Overall Study|Lack of Efficacy|3|||
105689436|NCT03049735|364526704|FG000|Overall Study|Protocol deviation|1|||
105689437|NCT03049735|364526705|FG001|Overall Study|Protocol deviation|0|||
105689438|NCT03049735|364526706|FG002|Overall Study|Protocol deviation|0|||
105689439|NCT03049735|364526704|FG000|Overall Study|Pregnancy|0|||
105689440|NCT03049735|364526705|FG001|Overall Study|Pregnancy|0|||
105689441|NCT03049735|364526706|FG002|Overall Study|Pregnancy|1|||
105689442|NCT03049735|364526704|FG000|Overall Study|Adverse Event|7|||
105689443|NCT03049735|364526705|FG001|Overall Study|Adverse Event|18|||
105689444|NCT03049735|364526706|FG002|Overall Study|Adverse Event|5|||
105689445|NCT03049735|364526704|FG000|Overall Study|Withdrawal by Subject|10|||
105689446|NCT03049735|364526705|FG001|Overall Study|Withdrawal by Subject|3|||
105689447|NCT03049735|364526706|FG002|Overall Study|Withdrawal by Subject|7|||
105689448|NCT03049735|364526704|FG000|Overall Study|Lost to Follow-up|1|||
105689449|NCT03049735|364526705|FG001|Overall Study|Lost to Follow-up|5|||
105689450|NCT03049735|364526706|FG002|Overall Study|Lost to Follow-up|5|||
105689451|NCT03153111|364526708|FG000|Overall Study|Death|2|||
105689452|NCT03153111|364526709|FG001|Overall Study|Death|5|||
105689453|NCT03153111|364526708|FG000|Overall Study|Lost to Follow-up|1|||
105689454|NCT03153111|364526709|FG001|Overall Study|Lost to Follow-up|0|||
105689455|NCT03153111|364526708|FG000|Overall Study|Physician Decision|5|||
105689456|NCT03153111|364526709|FG001|Overall Study|Physician Decision|1|||
105689457|NCT03153111|364526708|FG000|Overall Study|Withdrawal by Subject|3|||
105689458|NCT03153111|364526709|FG001|Overall Study|Withdrawal by Subject|3|||
105689459|NCT01210118|364526710|FG000|Overall Study|Lost to Follow-up|1|||
105689460|NCT01210118|364526711|FG001|Overall Study|Lost to Follow-up|1|||
105689461|NCT01210118|364526710|FG000|Overall Study|Protocol Violation|1|||
105689462|NCT01210118|364526711|FG001|Overall Study|Protocol Violation|1|||
105689463|NCT01210118|364526710|FG000|Overall Study|Spontaneous abortion|1|||
105689464|NCT01210118|364526711|FG001|Overall Study|Spontaneous abortion|3|||
105689465|NCT02958267|364526712|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
105689466|NCT02958267|364526713|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
105689467|NCT02958267|364526712|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
105689468|NCT02958267|364526713|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
105689469|NCT02958267|364526712|FG000|Follow-up Visits|Additional treatment pursued|2|||
105689470|NCT02958267|364526713|FG001|Follow-up Visits|Additional treatment pursued|1|||
105689471|NCT00174265|364526721|FG000|Overall Study|Adverse Event|7|||
105689472|NCT00174265|364526722|FG001|Overall Study|Adverse Event|4|||
105689473|NCT00174265|364526721|FG000|Overall Study|Lack of Efficacy|2|||
105689474|NCT00174265|364526722|FG001|Overall Study|Lack of Efficacy|2|||
105689475|NCT00174265|364526721|FG000|Overall Study|Withdrawal by Subject|3|||
105689476|NCT00174265|364526722|FG001|Overall Study|Withdrawal by Subject|5|||
105689477|NCT00174265|364526721|FG000|Overall Study|Lost to Follow-up|1|||
105689478|NCT00174265|364526722|FG001|Overall Study|Lost to Follow-up|0|||
105786807|NCT05182840|364872931|FG002|Run-in Period|Not treated|0|||
105919241|NCT03101020|365363532|FG000|Overall Study|Withdrawal by Subject|0|||
105919242|NCT03101020|365363533|FG001|Overall Study|Withdrawal by Subject|2|||
105919243|NCT00323063|365363535|FG000|Overall Study|Adverse Event|1|||
105919244|NCT00323063|365363536|FG001|Overall Study|Adverse Event|0|||
105919245|NCT00323063|365363535|FG000|Overall Study|brain mets discovered prior to treatment|1|||
105919246|NCT00323063|365363536|FG001|Overall Study|brain mets discovered prior to treatment|0|||
105919247|NCT03055936|365363537|FG000|Overall Study|Adverse Event|0|||
105919248|NCT03055936|365363538|FG001|Overall Study|Adverse Event|1|||
105919249|NCT03055936|365363539|FG002|Overall Study|Adverse Event|1|||
105919250|NCT03055936|365363540|FG003|Overall Study|Adverse Event|1|||
105919251|NCT03055936|365363537|FG000|Overall Study|Personal reason|2|||
105919252|NCT03055936|365363538|FG001|Overall Study|Personal reason|0|||
105919253|NCT03055936|365363539|FG002|Overall Study|Personal reason|1|||
105919254|NCT03055936|365363540|FG003|Overall Study|Personal reason|0|||
105919255|NCT00467519|365363547|FG000|Overall Study|Protocol Violation|8|||
105919256|NCT00467519|365363548|FG001|Overall Study|Protocol Violation|4|||
105919257|NCT00467519|365363547|FG000|Overall Study|Lost to Follow-up|2|||
105919258|NCT00467519|365363548|FG001|Overall Study|Lost to Follow-up|9|||
105919259|NCT00467519|365363547|FG000|Overall Study|Withdrawal by Subject|4|||
105689479|NCT00174265|364526721|FG000|Overall Study|Other (Not specified)|16|||
105689480|NCT00174265|364526722|FG001|Overall Study|Other (Not specified)|10|||
105689481|NCT03471871|364526727|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
105689482|NCT03471871|364526728|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
105919260|NCT00467519|365363548|FG001|Overall Study|Withdrawal by Subject|10|||
105919261|NCT00249834|365363551|FG000|Overall Study|Ovarian stimulation failed|1|||
105919262|NCT00249834|365363552|FG001|Overall Study|Ovarian stimulation failed|0|||
106002819|NCT00683878|365672517|FG002|Overall Study|Death|0|||
105919263|NCT00249834|365363553|FG002|Overall Study|Ovarian stimulation failed|0|||
105689483|NCT03471871|364526729|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
105689484|NCT03471871|364526730|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
105689485|NCT03471871|364526731|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
105689486|NCT03471871|364526727|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
105689487|NCT03471871|364526728|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
105689488|NCT03471871|364526729|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
105689489|NCT03471871|364526730|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
105689490|NCT03471871|364526731|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
105689491|NCT03471871|364526727|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
105689492|NCT03471871|364526728|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
105689493|NCT03471871|364526729|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
105689494|NCT03471871|364526730|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
105689495|NCT03471871|364526731|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
105689496|NCT03471871|364526727|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
105689497|NCT03471871|364526728|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
105689498|NCT03471871|364526729|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
105689499|NCT03471871|364526730|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
105689500|NCT03471871|364526731|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
105689501|NCT03471871|364526727|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
105689502|NCT03471871|364526728|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
105689503|NCT03471871|364526729|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
105689504|NCT03471871|364526730|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
105689505|NCT03471871|364526731|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
105689506|NCT04600336|364526732|FG000|Initial Treatment|Withdrawal by Subject|1|||
105689507|NCT04600336|364526733|FG001|Initial Treatment|Withdrawal by Subject|2|||
105689508|NCT04600336|364526734|FG002|Initial Treatment|Withdrawal by Subject|0|||
105689509|NCT04600336|364526735|FG003|Initial Treatment|Withdrawal by Subject|0|||
105689510|NCT04600336|364526732|FG000|Initial Treatment|Adverse Event|0|||
105689511|NCT04600336|364526733|FG001|Initial Treatment|Adverse Event|2|||
105689512|NCT04600336|364526734|FG002|Initial Treatment|Adverse Event|0|||
105689513|NCT04600336|364526735|FG003|Initial Treatment|Adverse Event|0|||
105689514|NCT04600336|364526732|FG000|Initial Treatment|Other complicating disease|0|||
105689515|NCT04600336|364526733|FG001|Initial Treatment|Other complicating disease|0|||
105689516|NCT04600336|364526734|FG002|Initial Treatment|Other complicating disease|1|||
105689517|NCT04600336|364526735|FG003|Initial Treatment|Other complicating disease|0|||
105689518|NCT04600336|364526732|FG000|Crossover Treatment|Withdrawal by Subject|0|||
105689519|NCT04600336|364526733|FG001|Crossover Treatment|Withdrawal by Subject|0|||
105689520|NCT04600336|364526734|FG002|Crossover Treatment|Withdrawal by Subject|2|||
105689521|NCT04600336|364526735|FG003|Crossover Treatment|Withdrawal by Subject|1|||
105689522|NCT04600336|364526732|FG000|Crossover Treatment|Adverse Event|0|||
105689523|NCT04600336|364526733|FG001|Crossover Treatment|Adverse Event|0|||
105689524|NCT04600336|364526734|FG002|Crossover Treatment|Adverse Event|1|||
105689525|NCT04600336|364526735|FG003|Crossover Treatment|Adverse Event|1|||
105689526|NCT05460273|364526736|FG000|Overall Study|Death|43|||
105689527|NCT05460273|364526737|FG001|Overall Study|Death|9|||
105689528|NCT05460273|364526736|FG000|Overall Study|Lost to Follow-up|7|||
105689529|NCT05460273|364526737|FG001|Overall Study|Lost to Follow-up|0|||
105689530|NCT05460273|364526736|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
105689531|NCT05460273|364526737|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
105689532|NCT05677893|364528165|FG000|Overall Study|Withdrawal by Subject|0|||
105689533|NCT05677893|364528166|FG001|Overall Study|Withdrawal by Subject|0|||
105689534|NCT05677893|364528167|FG002|Overall Study|Withdrawal by Subject|0|||
105689535|NCT05677893|364528168|FG003|Overall Study|Withdrawal by Subject|0|||
105689536|NCT05677893|364528169|FG004|Overall Study|Withdrawal by Subject|1|||
105689537|NCT05677893|364528170|FG005|Overall Study|Withdrawal by Subject|1|||
105689538|NCT05677893|364528171|FG006|Overall Study|Withdrawal by Subject|0|||
105689539|NCT05677893|364528165|FG000|Overall Study|Others|1|||
105689540|NCT05677893|364528166|FG001|Overall Study|Others|0|||
105689541|NCT05677893|364528167|FG002|Overall Study|Others|0|||
105689542|NCT05677893|364528168|FG003|Overall Study|Others|0|||
105689543|NCT05677893|364528169|FG004|Overall Study|Others|0|||
105689544|NCT05677893|364528170|FG005|Overall Study|Others|0|||
105689545|NCT05677893|364528171|FG006|Overall Study|Others|0|||
105689546|NCT01390181|364528172|FG000|Overall Study|Lost to Follow-up|1|||
105689547|NCT01390181|364528172|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
105689548|NCT00355056|364528173|FG000|Randomization Period|Early Termination|4|||
105689549|NCT00355056|364528174|FG001|Randomization Period|Early Termination|6|||
105689550|NCT02805725|364528175|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
105689551|NCT02805725|364528176|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
105689552|NCT02805725|364528177|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
105689553|NCT02805725|364528178|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
105689554|NCT02805725|364528179|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
105689555|NCT02805725|364528175|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
105689556|NCT02805725|364528176|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
105689557|NCT02805725|364528177|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
105689558|NCT02805725|364528178|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
105689559|NCT02805725|364528179|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
105689560|NCT02805725|364528175|FG000|Phase II|Protocol Violation|0|||
105689561|NCT02805725|364528176|FG001|Phase II|Protocol Violation|0|||
105689562|NCT02805725|364528177|FG002|Phase II|Protocol Violation|0|||
105689563|NCT02805725|364528178|FG003|Phase II|Protocol Violation|0|||
105689564|NCT02805725|364528179|FG004|Phase II|Protocol Violation|6|||
105689565|NCT01195545|364528180|FG000|Overall Study|Protocol Violation|4|||
105689566|NCT00084266|364528181|FG000|Overall Study|Death|42|||
105689567|NCT00084266|364528182|FG001|Overall Study|Death|39|||
105689568|NCT00084266|364528181|FG000|Overall Study|Adverse Event|8|||
105689569|NCT00084266|364528182|FG001|Overall Study|Adverse Event|5|||
105689570|NCT00084266|364528181|FG000|Overall Study|Lack of Efficacy|2|||
105689571|NCT00084266|364528182|FG001|Overall Study|Lack of Efficacy|4|||
105689572|NCT00084266|364528181|FG000|Overall Study|Lost to Follow-up|5|||
105689573|NCT00084266|364528182|FG001|Overall Study|Lost to Follow-up|3|||
105689574|NCT00084266|364528181|FG000|Overall Study|Participant not willing to participate|3|||
105689575|NCT00084266|364528182|FG001|Overall Study|Participant not willing to participate|8|||
105689576|NCT00084266|364528181|FG000|Overall Study|Other|360|||
105689577|NCT00084266|364528182|FG001|Overall Study|Other|344|||
105689578|NCT00084266|364528181|FG000|Overall Study|Randomized not treated|21|||
105689579|NCT00084266|364528182|FG001|Overall Study|Randomized not treated|20|||
105689580|NCT01729156|364528183|FG000|Overall Study|Withdrawal by Subject|1|||
105689581|NCT01729156|364528184|FG001|Overall Study|Withdrawal by Subject|0|||
105689582|NCT01729156|364528185|FG002|Overall Study|Withdrawal by Subject|0|||
105689583|NCT00719563|364528186|FG000|Overall Study|Adverse Event|16|||
105689584|NCT00719563|364528187|FG001|Overall Study|Adverse Event|13|||
105689585|NCT00719563|364528186|FG000|Overall Study|Medical condition changed|3|||
105689586|NCT00719563|364528187|FG001|Overall Study|Medical condition changed|5|||
105689587|NCT00719563|364528186|FG000|Overall Study|Lack of Efficacy|3|||
105689588|NCT00719563|364528187|FG001|Overall Study|Lack of Efficacy|7|||
105689589|NCT00719563|364528186|FG000|Overall Study|Personal reasons|6|||
105689590|NCT00719563|364528187|FG001|Overall Study|Personal reasons|7|||
105689591|NCT00719563|364528186|FG000|Overall Study|Unknown reasons|4|||
105689592|NCT00719563|364528187|FG001|Overall Study|Unknown reasons|6|||
105689593|NCT00719563|364528186|FG000|Overall Study|Noncompliant|1|||
105689594|NCT00719563|364528187|FG001|Overall Study|Noncompliant|1|||
105689595|NCT00719563|364528186|FG000|Overall Study|Lost to Follow-up|5|||
105689596|NCT00719563|364528187|FG001|Overall Study|Lost to Follow-up|3|||
105689597|NCT00567268|364528188|FG000|Overall Study|Protocol Violation|7|||
105689598|NCT00567268|364528188|FG000|Overall Study|Lost to Follow-up|36|||
105689599|NCT00567268|364528188|FG000|Overall Study|No Visit After First Day of Treatment|2|||
105689600|NCT00567268|364528188|FG000|Overall Study|No Drug Administration|4|||
105689601|NCT00567268|364528188|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
105689602|NCT02525861|364528189|FG000|Overall Study|Adverse Event|1|||
105689603|NCT02525861|364528190|FG001|Overall Study|Adverse Event|0|||
105786808|NCT05182840|364872932|FG003|Run-in Period|Not treated|0|||
105919264|NCT00249834|365363554|FG003|Overall Study|Ovarian stimulation failed|0|||
105919265|NCT00249834|365363555|FG004|Overall Study|Ovarian stimulation failed|0|||
105919266|NCT00249834|365363556|FG005|Overall Study|Ovarian stimulation failed|0|||
105919267|NCT00249834|365363557|FG006|Overall Study|Ovarian stimulation failed|0|||
105919268|NCT00249834|365363558|FG007|Overall Study|Ovarian stimulation failed|0|||
105919269|NCT00249834|365363551|FG000|Overall Study|Failure of down-regulation|0|||
105919270|NCT00249834|365363552|FG001|Overall Study|Failure of down-regulation|0|||
105689604|NCT02525861|364528189|FG000|Overall Study|Withdrawal by Subject|0|||
105689605|NCT02525861|364528190|FG001|Overall Study|Withdrawal by Subject|1|||
105689606|NCT02525861|364528189|FG000|Overall Study|Physician Decision|0|||
105689607|NCT02525861|364528190|FG001|Overall Study|Physician Decision|1|||
105689608|NCT03942406|364528194|FG000|Overall Study|Lost to Follow-up|4|||
105689609|NCT03942406|364528195|FG001|Overall Study|Lost to Follow-up|5|||
105689610|NCT03942406|364528196|FG002|Overall Study|Lost to Follow-up|3|||
105689611|NCT03942406|364528197|FG003|Overall Study|Lost to Follow-up|7|||
105919271|NCT00249834|365363553|FG002|Overall Study|Failure of down-regulation|0|||
105689612|NCT03942406|364528198|FG004|Overall Study|Lost to Follow-up|1|||
105689613|NCT03942406|364528199|FG005|Overall Study|Lost to Follow-up|0|||
105689614|NCT03942406|364528200|FG006|Overall Study|Lost to Follow-up|0|||
105689615|NCT03942406|364528194|FG000|Overall Study|Withdrawal by Subject|3|||
105689616|NCT03942406|364528195|FG001|Overall Study|Withdrawal by Subject|1|||
105689617|NCT03942406|364528196|FG002|Overall Study|Withdrawal by Subject|1|||
105689618|NCT03942406|364528197|FG003|Overall Study|Withdrawal by Subject|3|||
105689619|NCT03942406|364528198|FG004|Overall Study|Withdrawal by Subject|0|||
105786809|NCT05182840|364872933|FG004|Run-in Period|Not treated|0|||
105786810|NCT05182840|364872934|FG005|Run-in Period|Not treated|0|||
105786811|NCT05182840|364872935|FG006|Run-in Period|Not treated|0|||
105786812|NCT05182840|364872936|FG007|Run-in Period|Not treated|0|||
105786813|NCT05182840|364872937|FG008|Run-in Period|Not treated|0|||
105689620|NCT03942406|364528199|FG005|Overall Study|Withdrawal by Subject|0|||
105689621|NCT03942406|364528200|FG006|Overall Study|Withdrawal by Subject|0|||
105689622|NCT03942406|364528194|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
105689623|NCT03942406|364528195|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
105689624|NCT03942406|364528196|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
105689625|NCT03942406|364528197|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
105689626|NCT03942406|364528198|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
105786814|NCT05182840|364872938|FG009|Run-in Period|Not treated|0|||
105786815|NCT05182840|364872929|FG000|Run-in Period|Other reason but not sponsor termination|14|||
105689627|NCT03942406|364528199|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
105689628|NCT03942406|364528200|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
105689629|NCT00818389|364528201|FG000|Overall Study|Death|1|||
105689630|NCT00818389|364528202|FG001|Overall Study|Death|3|||
105689631|NCT00818389|364528201|FG000|Overall Study|ALS Disease Progression|1|||
105689632|NCT00818389|364528202|FG001|Overall Study|ALS Disease Progression|0|||
105689633|NCT00818389|364528201|FG000|Overall Study|Withdrawal by Subject|2|||
105689634|NCT00818389|364528202|FG001|Overall Study|Withdrawal by Subject|2|||
105689635|NCT00818389|364528201|FG000|Overall Study|Adverse Event|0|||
105689636|NCT00818389|364528202|FG001|Overall Study|Adverse Event|1|||
105689637|NCT04263909|364528203|FG000|Overall Study|Physician Decision|1|||
105689638|NCT04263909|364528204|FG001|Overall Study|Physician Decision|0|||
105689639|NCT04263909|364528205|FG002|Overall Study|Physician Decision|0|||
105689640|NCT04263909|364528203|FG000|Overall Study|Adverse Event|3|||
105786816|NCT05182840|364872930|FG001|Run-in Period|Other reason but not sponsor termination|18|||
105786817|NCT05182840|364872931|FG002|Run-in Period|Other reason but not sponsor termination|0|||
105786818|NCT05182840|364872932|FG003|Run-in Period|Other reason but not sponsor termination|0|||
105786819|NCT05182840|364872933|FG004|Run-in Period|Other reason but not sponsor termination|0|||
105786820|NCT05182840|364872934|FG005|Run-in Period|Other reason but not sponsor termination|0|||
105786821|NCT05182840|364872935|FG006|Run-in Period|Other reason but not sponsor termination|0|||
105786822|NCT05182840|364872936|FG007|Run-in Period|Other reason but not sponsor termination|0|||
105786823|NCT05182840|364872937|FG008|Run-in Period|Other reason but not sponsor termination|0|||
105786824|NCT05182840|364872938|FG009|Run-in Period|Other reason but not sponsor termination|0|||
105919272|NCT00249834|365363554|FG003|Overall Study|Failure of down-regulation|0|||
105919273|NCT00249834|365363555|FG004|Overall Study|Failure of down-regulation|0|||
105919274|NCT00249834|365363556|FG005|Overall Study|Failure of down-regulation|0|||
105919275|NCT00249834|365363557|FG006|Overall Study|Failure of down-regulation|1|||
105919276|NCT00249834|365363558|FG007|Overall Study|Failure of down-regulation|0|||
105919277|NCT00249834|365363551|FG000|Overall Study|Protocol Violation|0|||
105919278|NCT00249834|365363552|FG001|Overall Study|Protocol Violation|19|||
105919279|NCT00249834|365363553|FG002|Overall Study|Protocol Violation|14|||
105919280|NCT00249834|365363554|FG003|Overall Study|Protocol Violation|8|||
105919281|NCT00249834|365363555|FG004|Overall Study|Protocol Violation|5|||
105919282|NCT00249834|365363556|FG005|Overall Study|Protocol Violation|2|||
105919283|NCT00249834|365363557|FG006|Overall Study|Protocol Violation|0|||
105919284|NCT00249834|365363558|FG007|Overall Study|Protocol Violation|0|||
105919285|NCT00171249|365363559|FG000|Overall Study|Withdrawal by Subject|2|||
105919286|NCT00171249|365363560|FG001|Overall Study|Withdrawal by Subject|0|||
105919287|NCT00171249|365363561|FG002|Overall Study|Withdrawal by Subject|0|||
105919288|NCT00171249|365363562|FG003|Overall Study|Withdrawal by Subject|6|||
105919289|NCT00171249|365363563|FG004|Overall Study|Withdrawal by Subject|0|||
105919290|NCT00171249|365363564|FG005|Overall Study|Withdrawal by Subject|0|||
105919291|NCT00171249|365363565|FG006|Overall Study|Withdrawal by Subject|0|||
105919292|NCT00171249|365363559|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
105919293|NCT00171249|365363560|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105919294|NCT00171249|365363561|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
105919295|NCT00171249|365363562|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
105786825|NCT05182840|364872929|FG000|Run-in Period|No reason available|2|||
105919296|NCT00171249|365363563|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105919297|NCT00171249|365363564|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
105919298|NCT00171249|365363565|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105919299|NCT00171249|365363559|FG000|Overall Study|Death|7|||
105919300|NCT00171249|365363560|FG001|Overall Study|Death|1|||
105919301|NCT00171249|365363561|FG002|Overall Study|Death|0|||
105919302|NCT00171249|365363562|FG003|Overall Study|Death|4|||
105689641|NCT04263909|364528204|FG001|Overall Study|Adverse Event|0|||
105689642|NCT04263909|364528205|FG002|Overall Study|Adverse Event|0|||
105689643|NCT04263909|364528203|FG000|Overall Study|Protocol Violation|5|||
105919303|NCT00171249|365363563|FG004|Overall Study|Death|0|||
105919304|NCT00171249|365363564|FG005|Overall Study|Death|3|||
105919305|NCT00171249|365363565|FG006|Overall Study|Death|1|||
105689644|NCT04263909|364528204|FG001|Overall Study|Protocol Violation|0|||
105689645|NCT04263909|364528205|FG002|Overall Study|Protocol Violation|0|||
105689646|NCT05193500|364528206|FG000|Overall Study|Withdrawal by Subject|7|||
105689647|NCT05193500|364528207|FG001|Overall Study|Withdrawal by Subject|4|||
105689648|NCT05193500|364528208|FG002|Overall Study|Withdrawal by Subject|3|||
105689649|NCT05193500|364528209|FG003|Overall Study|Withdrawal by Subject|5|||
105689650|NCT05458479|364528210|FG000|Overall Study|Lost to Follow-up|1|||
105689651|NCT00756470|364528211|FG000|Overall Study|Withdrawal by Subject|1|||
105689652|NCT00756470|364528211|FG000|Overall Study|Adverse Event|4|||
105689653|NCT00528866|364528212|FG000|Overall Study|Protocol Violation|6|||
105689654|NCT00954174|364528213|FG000|Overall Study|Adverse Event|28|||
105689655|NCT00954174|364528214|FG001|Overall Study|Adverse Event|23|||
105689656|NCT00954174|364528215|FG002|Overall Study|Adverse Event|4|||
105689657|NCT00954174|364528216|FG003|Overall Study|Adverse Event|9|||
105689658|NCT00954174|364528213|FG000|Overall Study|Death|4|||
105689659|NCT00954174|364528214|FG001|Overall Study|Death|2|||
105689660|NCT00954174|364528215|FG002|Overall Study|Death|0|||
105689661|NCT00954174|364528216|FG003|Overall Study|Death|0|||
105689662|NCT00954174|364528213|FG000|Overall Study|Lack of Efficacy|32|||
105689663|NCT00954174|364528214|FG001|Overall Study|Lack of Efficacy|22|||
105689664|NCT00954174|364528215|FG002|Overall Study|Lack of Efficacy|8|||
105689665|NCT00954174|364528216|FG003|Overall Study|Lack of Efficacy|6|||
105689666|NCT00954174|364528213|FG000|Overall Study|Withdrawal by Subject|14|||
105689667|NCT00954174|364528214|FG001|Overall Study|Withdrawal by Subject|10|||
105689668|NCT00954174|364528215|FG002|Overall Study|Withdrawal by Subject|4|||
105689669|NCT00954174|364528216|FG003|Overall Study|Withdrawal by Subject|3|||
105689670|NCT00954174|364528213|FG000|Overall Study|Medical Reason|4|||
105689671|NCT00954174|364528214|FG001|Overall Study|Medical Reason|2|||
105689672|NCT00954174|364528215|FG002|Overall Study|Medical Reason|1|||
105689673|NCT00954174|364528216|FG003|Overall Study|Medical Reason|0|||
105689674|NCT00954174|364528213|FG000|Overall Study|Ineligible|40|||
105689675|NCT00954174|364528214|FG001|Overall Study|Ineligible|47|||
105689676|NCT00954174|364528215|FG002|Overall Study|Ineligible|7|||
105689677|NCT00954174|364528216|FG003|Overall Study|Ineligible|4|||
105689678|NCT00954174|364528213|FG000|Overall Study|Never Treated|4|||
105689679|NCT00954174|364528214|FG001|Overall Study|Never Treated|17|||
105689680|NCT00954174|364528215|FG002|Overall Study|Never Treated|0|||
105689681|NCT00954174|364528216|FG003|Overall Study|Never Treated|3|||
105689682|NCT01776424|364528217|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
105689683|NCT01776424|364528218|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
105689684|NCT01776424|364528219|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
105689685|NCT01776424|364528217|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
105689686|NCT01776424|364528218|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
105689687|NCT01776424|364528219|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
105689688|NCT01776424|364528217|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
105689689|NCT01776424|364528218|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
105689690|NCT01776424|364528219|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
105689691|NCT01776424|364528217|FG000|LTOLE Part (Open Label)|Refused|5|||
105919306|NCT00171249|365363559|FG000|Overall Study|Other|10|||
105919307|NCT00171249|365363560|FG001|Overall Study|Other|0|||
105919308|NCT00171249|365363561|FG002|Overall Study|Other|0|||
105919309|NCT00171249|365363562|FG003|Overall Study|Other|43|||
105919310|NCT00171249|365363563|FG004|Overall Study|Other|0|||
105919311|NCT00171249|365363564|FG005|Overall Study|Other|2|||
105919312|NCT00171249|365363565|FG006|Overall Study|Other|0|||
105689692|NCT01776424|364528218|FG001|LTOLE Part (Open Label)|Refused|2|||
105689693|NCT01776424|364528219|FG002|LTOLE Part (Open Label)|Refused|11|||
105689694|NCT01776424|364528217|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
105689695|NCT01776424|364528218|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
105689696|NCT01776424|364528219|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
105689697|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
105786826|NCT05182840|364872930|FG001|Run-in Period|No reason available|2|||
105919313|NCT00171249|365363559|FG000|Overall Study|No Longer Requires Study Drug|4|||
105919314|NCT00171249|365363560|FG001|Overall Study|No Longer Requires Study Drug|0|||
105689698|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
105689699|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
105689700|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
105689701|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
105689702|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
105689703|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
105689704|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
105689705|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Death|1|||
105689706|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Death|1|||
105689707|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
105919315|NCT00171249|365363561|FG002|Overall Study|No Longer Requires Study Drug|0|||
106130638|NCT01021878|366135516|FG000|Overall Study|Adverse Event|6|||
105689708|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
105689709|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
105689710|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
105689711|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
105689712|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
105689713|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
105689714|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
105689715|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
105689716|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
105689717|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
105689718|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
105689719|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
105689720|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
105689721|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
105689722|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
105689723|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
105689724|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
105689725|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
105689726|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
105689727|NCT00559585|364528220|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
105689728|NCT00559585|364528221|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
105689729|NCT00559585|364528220|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
105689730|NCT00559585|364528221|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
105689731|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
105689732|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
105689733|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
105689734|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
105689735|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
105689736|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
105689737|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
105689738|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
105689739|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
105689740|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
105689741|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
105689742|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
105689743|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
105919316|NCT00171249|365363562|FG003|Overall Study|No Longer Requires Study Drug|3|||
105919317|NCT00171249|365363563|FG004|Overall Study|No Longer Requires Study Drug|0|||
105919318|NCT00171249|365363564|FG005|Overall Study|No Longer Requires Study Drug|5|||
105919319|NCT00171249|365363565|FG006|Overall Study|No Longer Requires Study Drug|0|||
105919320|NCT00171249|365363559|FG000|Overall Study|Administrative Problems|1|||
105919321|NCT00171249|365363560|FG001|Overall Study|Administrative Problems|0|||
106130639|NCT01021878|366135517|FG001|Overall Study|Adverse Event|5|||
106130640|NCT01021878|366135516|FG000|Overall Study|Transplantation|6|||
106130641|NCT01021878|366135517|FG001|Overall Study|Transplantation|1|||
106130642|NCT02652130|366135518|FG000|Overall Study|Death|1|||
106130643|NCT02403674|366135521|FG000|Base Study|Death|1|||
105919322|NCT00171249|365363561|FG002|Overall Study|Administrative Problems|0|||
105919323|NCT00171249|365363562|FG003|Overall Study|Administrative Problems|2|||
105919324|NCT00171249|365363563|FG004|Overall Study|Administrative Problems|0|||
105919325|NCT00171249|365363564|FG005|Overall Study|Administrative Problems|0|||
105919326|NCT00171249|365363565|FG006|Overall Study|Administrative Problems|0|||
105919327|NCT00171249|365363559|FG000|Overall Study|Adverse Event|3|||
105919328|NCT00171249|365363560|FG001|Overall Study|Adverse Event|1|||
105919329|NCT00171249|365363561|FG002|Overall Study|Adverse Event|0|||
105919330|NCT00171249|365363562|FG003|Overall Study|Adverse Event|15|||
105919331|NCT00171249|365363563|FG004|Overall Study|Adverse Event|0|||
105919332|NCT00171249|365363564|FG005|Overall Study|Adverse Event|2|||
105919333|NCT00171249|365363565|FG006|Overall Study|Adverse Event|0|||
105919334|NCT00171249|365363559|FG000|Overall Study|Lost to Follow-up|5|||
105919335|NCT00171249|365363560|FG001|Overall Study|Lost to Follow-up|0|||
105919336|NCT00171249|365363561|FG002|Overall Study|Lost to Follow-up|0|||
105919337|NCT00171249|365363562|FG003|Overall Study|Lost to Follow-up|9|||
106130644|NCT02403674|366135522|FG001|Base Study|Death|4|||
105689744|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
105919338|NCT00171249|365363563|FG004|Overall Study|Lost to Follow-up|0|||
105919339|NCT00171249|365363564|FG005|Overall Study|Lost to Follow-up|0|||
105919340|NCT00171249|365363565|FG006|Overall Study|Lost to Follow-up|0|||
105919341|NCT03087058|365363566|FG000|Overall Study|Withdrawal by Subject|2|||
105919342|NCT03087058|365363567|FG001|Overall Study|Withdrawal by Subject|0|||
106130645|NCT02403674|366135521|FG000|Base Study|Adverse Event|11|||
105689745|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
105689746|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
105689747|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
105689748|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
105689749|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
105689750|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
105689751|NCT00559585|364528220|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
105689752|NCT00559585|364528221|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
105689753|NCT04209621|364528222|FG000|Overall Study|Death|1|||
105689754|NCT04209621|364528222|FG000|Overall Study|Study Terminated Early|2|||
105689755|NCT01372410|364528223|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
105689756|NCT01372410|364528224|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
105689757|NCT01372410|364528225|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689758|NCT01372410|364528226|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689759|NCT01372410|364528227|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
105689760|NCT01372410|364528228|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689761|NCT01372410|364528229|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689762|NCT01372410|364528230|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
105689763|NCT01372410|364528223|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689764|NCT01372410|364528224|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
105689765|NCT01372410|364528225|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689766|NCT01372410|364528226|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689767|NCT01372410|364528227|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689768|NCT01372410|364528228|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689769|NCT01372410|364528229|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
105689770|NCT01372410|364528230|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
105689771|NCT01372410|364528223|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689772|NCT01372410|364528224|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689773|NCT01372410|364528225|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689774|NCT01372410|364528226|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689775|NCT01372410|364528227|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
105689776|NCT01372410|364528228|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689777|NCT01372410|364528229|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689778|NCT01372410|364528230|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
105689779|NCT01372410|364528223|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689780|NCT01372410|364528224|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689781|NCT01372410|364528225|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689782|NCT01372410|364528226|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689783|NCT01372410|364528227|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689784|NCT01372410|364528228|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689785|NCT01372410|364528229|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
105689786|NCT01372410|364528230|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
105689787|NCT01372410|364528223|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
105689788|NCT01372410|364528224|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689789|NCT01372410|364528225|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689790|NCT01372410|364528226|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689791|NCT01372410|364528227|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689792|NCT01372410|364528228|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689793|NCT01372410|364528229|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
105689794|NCT01372410|364528230|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
105689795|NCT01372410|364528223|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689796|NCT01372410|364528224|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689797|NCT01372410|364528225|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689798|NCT01372410|364528226|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689799|NCT01372410|364528227|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
105689800|NCT01372410|364528228|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689801|NCT01372410|364528229|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105919343|NCT03087058|365363568|FG002|Overall Study|Withdrawal by Subject|0|||
105919344|NCT02577029|365363569|FG000|Overall Study|Adverse Event|1|||
105919345|NCT02577029|365363570|FG001|Overall Study|Adverse Event|0|||
105919346|NCT02577029|365363571|FG002|Overall Study|Adverse Event|2|||
105919347|NCT02577029|365363572|FG003|Overall Study|Adverse Event|0|||
105919348|NCT02577029|365363573|FG004|Overall Study|Adverse Event|1|||
106130646|NCT02403674|366135522|FG001|Base Study|Adverse Event|26|||
105689802|NCT01372410|364528230|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
105689803|NCT01372410|364528223|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689804|NCT01372410|364528224|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689805|NCT01372410|364528225|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105919349|NCT02577029|365363574|FG005|Overall Study|Adverse Event|0|||
105689806|NCT01372410|364528226|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689807|NCT01372410|364528227|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
105689808|NCT01372410|364528228|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
105689809|NCT01372410|364528229|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
105689810|NCT01372410|364528230|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
105689811|NCT01372410|364528223|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689812|NCT01372410|364528224|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689813|NCT01372410|364528225|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689814|NCT01372410|364528226|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689815|NCT01372410|364528227|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689816|NCT01372410|364528228|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689817|NCT01372410|364528229|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
105689818|NCT01372410|364528230|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
105689819|NCT01372410|364528223|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689820|NCT01372410|364528224|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689821|NCT01372410|364528225|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
105689822|NCT01372410|364528226|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689823|NCT01372410|364528227|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689824|NCT01372410|364528228|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689825|NCT01372410|364528229|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689826|NCT01372410|364528230|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
105689827|NCT01372410|364528223|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689828|NCT01372410|364528224|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689829|NCT01372410|364528225|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689830|NCT01372410|364528226|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689831|NCT01372410|364528227|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689832|NCT01372410|364528228|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
105689833|NCT01372410|364528229|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689834|NCT01372410|364528230|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
105689835|NCT02644941|364528231|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
105689836|NCT02644941|364528232|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
105689837|NCT04585646|364528233|FG000|First Intervention|Physician Decision|1|||
105689838|NCT04585646|364528234|FG001|First Intervention|Physician Decision|0|||
105689839|NCT04585646|364528233|FG000|First Intervention|Lost to Follow-up|0|||
105689840|NCT04585646|364528234|FG001|First Intervention|Lost to Follow-up|3|||
105689841|NCT04585646|364528233|FG000|First Intervention|Withdrawal by Subject|0|||
105689842|NCT04585646|364528234|FG001|First Intervention|Withdrawal by Subject|1|||
105689843|NCT00769860|364528239|FG000|Overall Study|Withdrawal by Subject|2|||
105689844|NCT00769860|364528240|FG001|Overall Study|Withdrawal by Subject|0|||
105689845|NCT01003990|364528241|FG000|Overall Study|Adverse Event|8|||
105689846|NCT01003990|364528242|FG001|Overall Study|Adverse Event|5|||
105689847|NCT01003990|364528243|FG002|Overall Study|Adverse Event|11|||
105689848|NCT01003990|364528241|FG000|Overall Study|Death|0|||
105689849|NCT01003990|364528242|FG001|Overall Study|Death|8|||
105689850|NCT01003990|364528243|FG002|Overall Study|Death|1|||
105689851|NCT01003990|364528241|FG000|Overall Study|Lack of Efficacy|10|||
105689852|NCT01003990|364528242|FG001|Overall Study|Lack of Efficacy|2|||
105689853|NCT01003990|364528243|FG002|Overall Study|Lack of Efficacy|3|||
105689854|NCT01003990|364528241|FG000|Overall Study|Lost to Follow-up|30|||
105689855|NCT01003990|364528242|FG001|Overall Study|Lost to Follow-up|12|||
105689856|NCT01003990|364528243|FG002|Overall Study|Lost to Follow-up|7|||
105689857|NCT01003990|364528241|FG000|Overall Study|Reasons Not Identified|14|||
105689858|NCT01003990|364528242|FG001|Overall Study|Reasons Not Identified|13|||
105689859|NCT01003990|364528243|FG002|Overall Study|Reasons Not Identified|8|||
105689860|NCT01003990|364528241|FG000|Overall Study|Poor/Non-compliance|4|||
105689861|NCT01003990|364528242|FG001|Overall Study|Poor/Non-compliance|3|||
105689862|NCT01003990|364528243|FG002|Overall Study|Poor/Non-compliance|2|||
105689863|NCT01003990|364528241|FG000|Overall Study|Pregnancy|10|||
105689864|NCT01003990|364528242|FG001|Overall Study|Pregnancy|2|||
105919350|NCT02577029|365363575|FG006|Overall Study|Adverse Event|0|||
105919351|NCT02577029|365363576|FG007|Overall Study|Adverse Event|0|||
105919352|NCT02577029|365363569|FG000|Overall Study|Withdrawal by Subject|0|||
105919353|NCT02577029|365363570|FG001|Overall Study|Withdrawal by Subject|0|||
105689865|NCT01003990|364528243|FG002|Overall Study|Pregnancy|4|||
105689866|NCT01003990|364528241|FG000|Overall Study|No Longer Met Study Criteria|4|||
105689867|NCT01003990|364528242|FG001|Overall Study|No Longer Met Study Criteria|1|||
105689868|NCT01003990|364528243|FG002|Overall Study|No Longer Met Study Criteria|0|||
105689869|NCT01003990|364528241|FG000|Overall Study|Subject Withdrew Consent|12|||
105689870|NCT01003990|364528242|FG001|Overall Study|Subject Withdrew Consent|5|||
105689871|NCT01003990|364528243|FG002|Overall Study|Subject Withdrew Consent|7|||
105919354|NCT02577029|365363571|FG002|Overall Study|Withdrawal by Subject|0|||
105689872|NCT03037619|364528249|FG000|Overall Study|Lost to Follow-up|0|||
105689873|NCT03037619|364528250|FG001|Overall Study|Lost to Follow-up|1|||
105689874|NCT02030405|364528259|FG000|Overall Study|Withdrawal by Subject|1|||
105689875|NCT02030405|364528259|FG000|Overall Study|Lost to Follow-up|1|||
105689876|NCT02520284|364528260|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
105689877|NCT02520284|364528261|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
105689878|NCT02520284|364528262|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
105689879|NCT02520284|364528260|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
105689880|NCT02520284|364528261|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
105689881|NCT02520284|364528262|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
105689882|NCT02520284|364528260|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
105689883|NCT02520284|364528261|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
105689884|NCT02520284|364528262|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
105689885|NCT02520284|364528260|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
105689886|NCT02520284|364528261|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
105689887|NCT02520284|364528262|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
105689888|NCT02520284|364528260|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
105689889|NCT02520284|364528261|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
105689890|NCT02520284|364528262|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
105689891|NCT02520284|364528260|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
105689892|NCT02520284|364528261|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
105689893|NCT02520284|364528262|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
105689894|NCT02520284|364528260|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
105689895|NCT02520284|364528261|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
105919355|NCT02577029|365363572|FG003|Overall Study|Withdrawal by Subject|0|||
105919356|NCT02577029|365363573|FG004|Overall Study|Withdrawal by Subject|0|||
105689896|NCT02520284|364528262|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
105919357|NCT02577029|365363574|FG005|Overall Study|Withdrawal by Subject|1|||
105919358|NCT02577029|365363575|FG006|Overall Study|Withdrawal by Subject|0|||
105919359|NCT02577029|365363576|FG007|Overall Study|Withdrawal by Subject|0|||
105919360|NCT02577029|365363569|FG000|Overall Study|Sponsor Termination of the Study|9|||
105689897|NCT02520284|364528260|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
105689898|NCT02520284|364528261|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
105689899|NCT02520284|364528262|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
105689900|NCT02520284|364528260|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
105689901|NCT02520284|364528261|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
105689902|NCT02520284|364528262|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
105689903|NCT02520284|364528260|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
105689904|NCT02520284|364528261|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
105689905|NCT02520284|364528262|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
105689906|NCT02520284|364528260|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
105689907|NCT02520284|364528261|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
105689908|NCT02520284|364528262|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
105689909|NCT02411578|364528263|FG000|Crossover Trial Phase|Pregnancy|0|||
105689910|NCT02411578|364528264|FG001|Crossover Trial Phase|Pregnancy|1|||
105689911|NCT02973048|364528265|FG000|Overall Study|Epidural catheter insertion failure|1|||
105689912|NCT02973048|364528266|FG001|Overall Study|Epidural catheter insertion failure|0|||
105689913|NCT02973048|364528265|FG000|Overall Study|Withdrawal by Subject|0|||
105689914|NCT02973048|364528266|FG001|Overall Study|Withdrawal by Subject|3|||
105689915|NCT01472380|364528280|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
105689916|NCT01472380|364528280|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
105689917|NCT02511678|364528281|FG000|Overall Study|Withdrawal by Subject|2|||
105689918|NCT02511678|364528281|FG000|Overall Study|Lost to Follow-up|4|||
105689919|NCT02511678|364528281|FG000|Overall Study|Death|19|||
105689920|NCT02511678|364528281|FG000|Overall Study|Adverse Event|1|||
105689921|NCT02511678|364528281|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
105689922|NCT02511678|364528281|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
105689923|NCT02511678|364528281|FG000|Overall Study|Required Radiofrequency Ablation|1|||
105689924|NCT02511678|364528281|FG000|Overall Study|Biopsy was Negative|1|||
105689925|NCT02511678|364528281|FG000|Overall Study|Protocol Violation|1|||
105689926|NCT02511678|364528281|FG000|Overall Study|Received Radiation Treatment|1|||
105689927|NCT01295281|364528282|FG000|First Intervention (7 Days)|Death|0|||
105689928|NCT01295281|364528283|FG001|First Intervention (7 Days)|Death|1|||
105689929|NCT00292461|364528284|FG000|Overall Study|Adverse Event|4|||
105689930|NCT00292461|364528285|FG001|Overall Study|Adverse Event|2|||
105689931|NCT00292461|364528284|FG000|Overall Study|Lack of Efficacy|1|||
105689932|NCT00292461|364528285|FG001|Overall Study|Lack of Efficacy|0|||
105689933|NCT00292461|364528284|FG000|Overall Study|Withdrawal by Subject|0|||
105689934|NCT00292461|364528285|FG001|Overall Study|Withdrawal by Subject|1|||
105689935|NCT00292461|364528284|FG000|Overall Study|Protocol Violation|4|||
105689936|NCT00292461|364528285|FG001|Overall Study|Protocol Violation|3|||
105919361|NCT02577029|365363570|FG001|Overall Study|Sponsor Termination of the Study|2|||
105689937|NCT00292461|364528284|FG000|Overall Study|Lost to Follow-up|1|||
105689938|NCT00292461|364528285|FG001|Overall Study|Lost to Follow-up|0|||
105689939|NCT01891721|364528286|FG000|Overall Study|Lost to Follow-up|10|||
105689940|NCT01891721|364528287|FG001|Overall Study|Lost to Follow-up|5|||
105689941|NCT01891721|364528288|FG002|Overall Study|Lost to Follow-up|1|||
105689942|NCT02684279|364528289|FG000|Overall Study|Adverse Event|87|||
105689943|NCT02684279|364528289|FG000|Overall Study|Lack of Efficacy|4|||
105689944|NCT02684279|364528289|FG000|Overall Study|Lost to Follow-up|61|||
105689945|NCT02684279|364528289|FG000|Overall Study|Protocol Violation|6|||
105689946|NCT02684279|364528289|FG000|Overall Study|Pregnancy|8|||
105689947|NCT02684279|364528289|FG000|Overall Study|Withdrawal by Subject|92|||
105689948|NCT02684279|364528289|FG000|Overall Study|non-compliance with study drug|9|||
105689949|NCT02684279|364528289|FG000|Overall Study|non compliance with study visits|2|||
105689950|NCT02684279|364528289|FG000|Overall Study|subject to have surgery|1|||
105689951|NCT02684279|364528289|FG000|Overall Study|family emergency|1|||
105689952|NCT02684279|364528289|FG000|Overall Study|Site closures|7|||
105689953|NCT02684279|364528289|FG000|Overall Study|Physician Decision|1|||
105689954|NCT04683731|364528302|FG000|Overall Study|Withdrawal by Subject|1|||
105689955|NCT04683731|364528303|FG001|Overall Study|Withdrawal by Subject|0|||
105689956|NCT04683731|364528304|FG002|Overall Study|Withdrawal by Subject|3|||
105689957|NCT04683731|364528305|FG003|Overall Study|Withdrawal by Subject|2|||
105689958|NCT04683731|364528302|FG000|Overall Study|Determined patient was not eligible|3|||
105689959|NCT04683731|364528303|FG001|Overall Study|Determined patient was not eligible|3|||
105689960|NCT04683731|364528304|FG002|Overall Study|Determined patient was not eligible|12|||
105689961|NCT04683731|364528305|FG003|Overall Study|Determined patient was not eligible|3|||
105689962|NCT01839487|364528306|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
105689963|NCT01839487|364528307|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689964|NCT01839487|364528308|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689965|NCT01839487|364528309|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689966|NCT01839487|364528310|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689967|NCT01839487|364528311|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
105689968|NCT01839487|364528306|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
105689969|NCT01839487|364528307|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
105689970|NCT01839487|364528308|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
105689971|NCT01839487|364528309|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
105689972|NCT01839487|364528310|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
105689973|NCT01839487|364528311|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
105689974|NCT01839487|364528306|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689975|NCT01839487|364528307|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
105689976|NCT01839487|364528308|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689977|NCT01839487|364528309|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689978|NCT01839487|364528310|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689979|NCT01839487|364528311|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
105689980|NCT01839487|364528306|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
105689981|NCT01839487|364528307|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689982|NCT01839487|364528308|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689983|NCT01839487|364528309|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689984|NCT01839487|364528310|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689985|NCT01839487|364528311|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
105689986|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
105689987|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
105689988|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
105689989|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
105689990|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
105689991|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
105689992|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
105689993|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
105689994|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
105689995|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
105689996|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
105689997|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
105689998|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
105689999|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
105690000|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
105690001|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
105690002|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
105690003|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
105690004|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
105690005|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
105690006|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
105690007|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
105690008|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
105690009|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
105690010|NCT01839487|364528306|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
105690011|NCT01839487|364528307|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
105690012|NCT01839487|364528308|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
105690013|NCT01839487|364528309|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
105690014|NCT01839487|364528310|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
105690015|NCT01839487|364528311|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
105690016|NCT00475033|364528312|FG000|Infant Series|Failed to return|3|||
105690017|NCT00475033|364528313|FG001|Infant Series|Failed to return|4|||
105690018|NCT00475033|364528312|FG000|Infant Series|Parent or legal guardian request|1|||
105690019|NCT00475033|364528313|FG001|Infant Series|Parent or legal guardian request|5|||
105690020|NCT00475033|364528312|FG000|Infant Series|Protocol Violation|1|||
105690021|NCT00475033|364528313|FG001|Infant Series|Protocol Violation|2|||
105690022|NCT00475033|364528312|FG000|Infant Series|Lost to Follow-up|2|||
105690023|NCT00475033|364528313|FG001|Infant Series|Lost to Follow-up|0|||
105690024|NCT00475033|364528312|FG000|Infant Series|Adverse Event|0|||
105690025|NCT00475033|364528313|FG001|Infant Series|Adverse Event|2|||
105690026|NCT00475033|364528312|FG000|After the Infant Series|Adverse Event|0|||
105690027|NCT00475033|364528313|FG001|After the Infant Series|Adverse Event|4|||
105690028|NCT00475033|364528312|FG000|After the Infant Series|Parent or legal guardian request|2|||
105690029|NCT00475033|364528313|FG001|After the Infant Series|Parent or legal guardian request|2|||
105690030|NCT00475033|364528312|FG000|After the Infant Series|Failed to return|2|||
105690031|NCT00475033|364528313|FG001|After the Infant Series|Failed to return|1|||
105690032|NCT00475033|364528312|FG000|After the Infant Series|Protocol Violation|1|||
105690033|NCT00475033|364528313|FG001|After the Infant Series|Protocol Violation|0|||
105690034|NCT00475033|364528312|FG000|After the Infant Series|Lost to Follow-up|1|||
105690035|NCT00475033|364528313|FG001|After the Infant Series|Lost to Follow-up|0|||
105690036|NCT00475033|364528312|FG000|After the Infant Series|Other|0|||
105690037|NCT00475033|364528313|FG001|After the Infant Series|Other|1|||
105690038|NCT00475033|364528312|FG000|Toddler Dose|Parent or legal guardian request|2|||
105690039|NCT00475033|364528313|FG001|Toddler Dose|Parent or legal guardian request|0|||
105690040|NCT00475033|364528312|FG000|Toddler Dose|Failed to return|1|||
105690041|NCT00475033|364528313|FG001|Toddler Dose|Failed to return|0|||
105690042|NCT00475033|364528312|FG000|Toddler Dose|Lost to Follow-up|1|||
105690043|NCT00475033|364528313|FG001|Toddler Dose|Lost to Follow-up|0|||
105690044|NCT03566810|364530210|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
105690045|NCT03566810|364530211|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
105690046|NCT03566810|364530212|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
105690047|NCT03566810|364530213|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
105690048|NCT01103245|364530214|FG000|Overall Study|Withdrawal by Subject|1|||
105690049|NCT01103245|364530215|FG001|Overall Study|Withdrawal by Subject|0|||
105690050|NCT01103245|364530216|FG002|Overall Study|Withdrawal by Subject|3|||
105690051|NCT01103245|364530217|FG003|Overall Study|Withdrawal by Subject|0|||
105690052|NCT01103245|364530214|FG000|Overall Study|Inadequate IV access|1|||
105786827|NCT05182840|364872931|FG002|Run-in Period|No reason available|0|||
105786828|NCT05182840|364872932|FG003|Run-in Period|No reason available|0|||
105786829|NCT05182840|364872933|FG004|Run-in Period|No reason available|0|||
105786830|NCT05182840|364872934|FG005|Run-in Period|No reason available|0|||
105786831|NCT05182840|364872935|FG006|Run-in Period|No reason available|0|||
105786832|NCT05182840|364872936|FG007|Run-in Period|No reason available|0|||
105786833|NCT05182840|364872937|FG008|Run-in Period|No reason available|0|||
105786834|NCT05182840|364872938|FG009|Run-in Period|No reason available|0|||
105919362|NCT02577029|365363571|FG002|Overall Study|Sponsor Termination of the Study|5|||
105919363|NCT02577029|365363572|FG003|Overall Study|Sponsor Termination of the Study|12|||
105919364|NCT02577029|365363573|FG004|Overall Study|Sponsor Termination of the Study|10|||
105919365|NCT02577029|365363574|FG005|Overall Study|Sponsor Termination of the Study|12|||
105919366|NCT02577029|365363575|FG006|Overall Study|Sponsor Termination of the Study|12|||
106130647|NCT02403674|366135521|FG000|Base Study|Lack of Efficacy|31|||
106130648|NCT02403674|366135522|FG001|Base Study|Lack of Efficacy|23|||
106130649|NCT02403674|366135521|FG000|Base Study|Lost to Follow-up|6|||
106130650|NCT02403674|366135522|FG001|Base Study|Lost to Follow-up|8|||
105690053|NCT01103245|364530215|FG001|Overall Study|Inadequate IV access|0|||
105690054|NCT01103245|364530216|FG002|Overall Study|Inadequate IV access|0|||
105690055|NCT01103245|364530217|FG003|Overall Study|Inadequate IV access|0|||
105690056|NCT01103245|364530214|FG000|Overall Study|Adverse Event|0|||
105690057|NCT01103245|364530215|FG001|Overall Study|Adverse Event|2|||
105690058|NCT01103245|364530216|FG002|Overall Study|Adverse Event|1|||
105690059|NCT01103245|364530217|FG003|Overall Study|Adverse Event|0|||
105786835|NCT05182840|364872929|FG000|Run-in Period|Burden of study procedures|2|||
105919367|NCT02577029|365363576|FG007|Overall Study|Sponsor Termination of the Study|12|||
106130651|NCT02403674|366135521|FG000|Base Study|Withdrawal by Subject|10|||
105690060|NCT01103245|364530214|FG000|Overall Study|Physician Decision|1|||
105690061|NCT01103245|364530215|FG001|Overall Study|Physician Decision|0|||
105690062|NCT01103245|364530216|FG002|Overall Study|Physician Decision|0|||
105690063|NCT01103245|364530217|FG003|Overall Study|Physician Decision|0|||
105690064|NCT03078907|364530220|FG000|Overall Study|Adverse Event|2|||
105690065|NCT03078907|364530221|FG001|Overall Study|Adverse Event|0|||
105690066|NCT03078907|364530220|FG000|Overall Study|Other|1|||
105690067|NCT03078907|364530221|FG001|Overall Study|Other|0|||
105690068|NCT03078907|364530220|FG000|Overall Study|Protocol Violation|0|||
105690069|NCT03078907|364530221|FG001|Overall Study|Protocol Violation|1|||
105690070|NCT00604279|364530222|FG000|Overall Study|Lack of Efficacy|22|||
105690071|NCT00604279|364530223|FG001|Overall Study|Lack of Efficacy|9|||
105690072|NCT00604279|364530222|FG000|Overall Study|Lost to Follow-up|9|||
105690073|NCT00604279|364530223|FG001|Overall Study|Lost to Follow-up|14|||
105690074|NCT00604279|364530222|FG000|Overall Study|Pregnancy|2|||
105690075|NCT00604279|364530223|FG001|Overall Study|Pregnancy|0|||
105690076|NCT00604279|364530222|FG000|Overall Study|Protocol Violation|3|||
105690077|NCT00604279|364530223|FG001|Overall Study|Protocol Violation|1|||
105690078|NCT00604279|364530222|FG000|Overall Study|Withdrawal by Subject|16|||
105690079|NCT00604279|364530223|FG001|Overall Study|Withdrawal by Subject|5|||
105690080|NCT00604279|364530222|FG000|Overall Study|Adverse Event|4|||
105690081|NCT00604279|364530223|FG001|Overall Study|Adverse Event|5|||
105690082|NCT00604279|364530222|FG000|Overall Study|Other|8|||
105690083|NCT00604279|364530223|FG001|Overall Study|Other|4|||
105690084|NCT02720536|364530224|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
105690085|NCT02720536|364530224|FG000|Overall Study|PR - pregnancy|2|||
105690086|NCT02720536|364530224|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
105690087|NCT02720536|364530224|FG000|Overall Study|PR - death|1|||
105690088|NCT02720536|364530224|FG000|Overall Study|PR - adverse event|1|||
105690089|NCT02720536|364530224|FG000|Overall Study|PR - abnormal lab value(s)|1|||
105690090|NCT02720536|364530224|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
105690091|NCT00146328|364530225|FG000|Overall Study|Adverse Event|39|||
105690092|NCT00146328|364530226|FG001|Overall Study|Adverse Event|48|||
105690093|NCT00146328|364530227|FG002|Overall Study|Adverse Event|79|||
105690094|NCT00146328|364530225|FG000|Overall Study|Protocol Violation|11|||
105690095|NCT00146328|364530226|FG001|Overall Study|Protocol Violation|6|||
105690096|NCT00146328|364530227|FG002|Overall Study|Protocol Violation|12|||
105690097|NCT00146328|364530225|FG000|Overall Study|Lost to Follow-up|7|||
105690098|NCT00146328|364530226|FG001|Overall Study|Lost to Follow-up|4|||
105690099|NCT00146328|364530227|FG002|Overall Study|Lost to Follow-up|7|||
105690100|NCT00146328|364530225|FG000|Overall Study|Withdrawal by Subject|16|||
105690101|NCT00146328|364530226|FG001|Overall Study|Withdrawal by Subject|16|||
105690102|NCT00146328|364530227|FG002|Overall Study|Withdrawal by Subject|22|||
105690103|NCT00146328|364530225|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
105690104|NCT00146328|364530226|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
105690105|NCT00146328|364530227|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
105690106|NCT00146328|364530225|FG000|Overall Study|Trial ended/site closed|8|||
105690107|NCT00146328|364530226|FG001|Overall Study|Trial ended/site closed|2|||
105690108|NCT00146328|364530227|FG002|Overall Study|Trial ended/site closed|19|||
105690109|NCT00146328|364530225|FG000|Overall Study|Patient decision to end|0|||
105690110|NCT00146328|364530226|FG001|Overall Study|Patient decision to end|1|||
105690111|NCT00146328|364530227|FG002|Overall Study|Patient decision to end|6|||
105690112|NCT00146328|364530225|FG000|Overall Study|Enroll into other trial|2|||
105690113|NCT00146328|364530226|FG001|Overall Study|Enroll into other trial|4|||
105690114|NCT00146328|364530227|FG002|Overall Study|Enroll into other trial|2|||
105690115|NCT00146328|364530225|FG000|Overall Study|Death|0|||
105690116|NCT00146328|364530226|FG001|Overall Study|Death|1|||
105690117|NCT00146328|364530227|FG002|Overall Study|Death|1|||
105690118|NCT00146328|364530225|FG000|Overall Study|Moved|2|||
105690119|NCT00146328|364530226|FG001|Overall Study|Moved|0|||
105690120|NCT00146328|364530227|FG002|Overall Study|Moved|0|||
105690121|NCT00146328|364530225|FG000|Overall Study|Interaction with other medication|2|||
105690122|NCT00146328|364530226|FG001|Overall Study|Interaction with other medication|0|||
105690123|NCT00146328|364530227|FG002|Overall Study|Interaction with other medication|1|||
105690124|NCT01256658|364530228|FG000|Period 1|Lost to Follow-up|837|||
106130652|NCT02403674|366135522|FG001|Base Study|Withdrawal by Subject|17|||
105690125|NCT01256658|364530229|FG001|Period 1|Lost to Follow-up|661|||
105690126|NCT01256658|364530228|FG000|Period 1|Withdrawal by Subject|35|||
105690127|NCT01256658|364530229|FG001|Period 1|Withdrawal by Subject|43|||
105690128|NCT01256658|364530228|FG000|Period 1|Death|48|||
105690129|NCT01256658|364530229|FG001|Period 1|Death|44|||
105690130|NCT03434353|364530230|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
105690131|NCT03434353|364530231|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
105786836|NCT05182840|364872930|FG001|Run-in Period|Burden of study procedures|2|||
105690132|NCT03434353|364530232|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
105690133|NCT03434353|364530233|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
105690134|NCT03434353|364530234|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
105690135|NCT03434353|364530230|FG000|Overall Study|Withdrew consent|1|||
105690136|NCT03434353|364530231|FG001|Overall Study|Withdrew consent|0|||
105690137|NCT03434353|364530232|FG002|Overall Study|Withdrew consent|3|||
105690138|NCT03434353|364530233|FG003|Overall Study|Withdrew consent|0|||
105690139|NCT03434353|364530234|FG004|Overall Study|Withdrew consent|0|||
105690140|NCT03434353|364530230|FG000|Overall Study|Adverse Event|1|||
105690141|NCT03434353|364530231|FG001|Overall Study|Adverse Event|0|||
105690142|NCT03434353|364530232|FG002|Overall Study|Adverse Event|0|||
105690143|NCT03434353|364530233|FG003|Overall Study|Adverse Event|0|||
105690144|NCT03434353|364530234|FG004|Overall Study|Adverse Event|1|||
105690145|NCT03434353|364530230|FG000|Overall Study|Lost to Follow-up|2|||
105690146|NCT03434353|364530231|FG001|Overall Study|Lost to Follow-up|0|||
105690147|NCT03434353|364530232|FG002|Overall Study|Lost to Follow-up|0|||
105690148|NCT03434353|364530233|FG003|Overall Study|Lost to Follow-up|0|||
105690149|NCT03434353|364530234|FG004|Overall Study|Lost to Follow-up|0|||
105690150|NCT04906616|364530235|FG000|Overall Study|Divorce|3|||
105690151|NCT04906616|364530236|FG001|Overall Study|Divorce|2|||
105690152|NCT02072434|364530237|FG000|Overall Study|Protocol Violation|10|||
105690153|NCT02072434|364530238|FG001|Overall Study|Protocol Violation|9|||
105690154|NCT02072434|364530237|FG000|Overall Study|Physician Decision|5|||
105690155|NCT02072434|364530238|FG001|Overall Study|Physician Decision|10|||
105690156|NCT02072434|364530237|FG000|Overall Study|Adverse event, serious fatal|1|||
105690157|NCT02072434|364530238|FG001|Overall Study|Adverse event, serious fatal|6|||
105690158|NCT02072434|364530237|FG000|Overall Study|Adverse Event|7|||
105690159|NCT02072434|364530238|FG001|Overall Study|Adverse Event|6|||
105690160|NCT02072434|364530237|FG000|Overall Study|Withdrawal by Subject|17|||
105690161|NCT02072434|364530238|FG001|Overall Study|Withdrawal by Subject|29|||
105690162|NCT02072434|364530237|FG000|Overall Study|Other|14|||
105690163|NCT02072434|364530238|FG001|Overall Study|Other|29|||
105690164|NCT02072434|364530237|FG000|Overall Study|Lost to Follow-up|0|||
105690165|NCT02072434|364530238|FG001|Overall Study|Lost to Follow-up|1|||
105690166|NCT00993954|364530239|FG000|Overall Study|Protocol Violation|21|||
105690167|NCT00993954|364530240|FG001|Overall Study|Protocol Violation|2|||
105690168|NCT00234494|364530243|FG000|Overall Study|Protocol Violation|2|||
105690169|NCT03308942|364530249|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
105690170|NCT03308942|364530250|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
105690171|NCT03308942|364530251|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
105690172|NCT03308942|364530252|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
105690173|NCT03308942|364530253|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
105690174|NCT03308942|364530249|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
105690175|NCT03308942|364530250|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
105690176|NCT03308942|364530251|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
105690177|NCT03308942|364530252|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
105690178|NCT03308942|364530253|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
105690179|NCT03308942|364530249|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
105690180|NCT03308942|364530250|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
105690181|NCT03308942|364530251|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
105690182|NCT03308942|364530252|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
105690183|NCT03308942|364530253|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
105690184|NCT03308942|364530249|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
105690185|NCT03308942|364530250|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
105690186|NCT03308942|364530251|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
105690187|NCT03308942|364530252|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
105690188|NCT03308942|364530253|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
105690189|NCT03308942|364530249|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
105690190|NCT03308942|364530250|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
105690191|NCT03308942|364530251|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
105690192|NCT03308942|364530252|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
105690193|NCT03308942|364530253|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
105690194|NCT03308942|364530249|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
105690195|NCT03308942|364530250|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
105690196|NCT03308942|364530251|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
105690197|NCT03308942|364530252|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
105690198|NCT03308942|364530253|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
105690199|NCT03308942|364530249|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
105786837|NCT05182840|364872931|FG002|Run-in Period|Burden of study procedures|0|||
106002820|NCT00683878|365672515|FG000|Overall Study|Lost to Follow-up|4|||
105690200|NCT03308942|364530250|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
105690201|NCT03308942|364530251|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
105690202|NCT03308942|364530252|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
105690203|NCT03308942|364530253|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
105690204|NCT02194062|364530254|FG000|Overall Study|Lost to Follow-up|2|||
105690205|NCT02194062|364530255|FG001|Overall Study|Lost to Follow-up|2|||
105690206|NCT02194062|364530256|FG002|Overall Study|Lost to Follow-up|5|||
105690207|NCT02294682|364530257|FG000|Overall Study|Could not swallow pills|1|||
105690208|NCT02294682|364530258|FG001|Overall Study|Could not swallow pills|0|||
105690209|NCT04175808|364530259|FG000|Part A|Miscellaneous|2|||
105690210|NCT04175808|364530260|FG001|Part A|Miscellaneous|0|||
105690211|NCT04175808|364530261|FG002|Part A|Miscellaneous|0|||
105690212|NCT04175808|364530262|FG003|Part A|Miscellaneous|0|||
105690213|NCT04175808|364530263|FG004|Part A|Miscellaneous|0|||
105690214|NCT04175808|364530264|FG005|Part A|Miscellaneous|0|||
105690215|NCT04175808|364530265|FG006|Part A|Miscellaneous|0|||
105690216|NCT04982588|364530271|FG000|Overall Study|Withdrawal by Subject|2|||
105690217|NCT00568321|364530272|FG000|Overall Study|Adverse Event|1|||
105690218|NCT00568321|364530273|FG001|Overall Study|Adverse Event|0|||
105690219|NCT00568321|364530274|FG002|Overall Study|Adverse Event|0|||
105690220|NCT00568321|364530272|FG000|Overall Study|Lack of Efficacy|8|||
105690221|NCT00568321|364530273|FG001|Overall Study|Lack of Efficacy|5|||
105690222|NCT00568321|364530274|FG002|Overall Study|Lack of Efficacy|6|||
105690223|NCT00568321|364530272|FG000|Overall Study|Lost to Follow-up|0|||
105690224|NCT00568321|364530273|FG001|Overall Study|Lost to Follow-up|0|||
105690225|NCT00568321|364530274|FG002|Overall Study|Lost to Follow-up|1|||
105690226|NCT00568321|364530272|FG000|Overall Study|Withdrawal by Subject|2|||
105690227|NCT00568321|364530273|FG001|Overall Study|Withdrawal by Subject|0|||
105690228|NCT00568321|364530274|FG002|Overall Study|Withdrawal by Subject|0|||
105690229|NCT00568321|364530272|FG000|Overall Study|Protocol Violation|0|||
105690230|NCT00568321|364530273|FG001|Overall Study|Protocol Violation|0|||
105690231|NCT00568321|364530274|FG002|Overall Study|Protocol Violation|1|||
105690232|NCT00568321|364530272|FG000|Overall Study|Randomized, not treated|2|||
105690233|NCT00568321|364530273|FG001|Overall Study|Randomized, not treated|0|||
105690234|NCT00568321|364530274|FG002|Overall Study|Randomized, not treated|1|||
105690235|NCT00992511|364530275|FG000|Overall Study|Migrated/moved from study area|1|||
105690236|NCT00992511|364530276|FG001|Overall Study|Migrated/moved from study area|0|||
105690237|NCT00992511|364530277|FG002|Overall Study|Migrated/moved from study area|1|||
105690238|NCT00992511|364530278|FG003|Overall Study|Migrated/moved from study area|2|||
105690239|NCT00992511|364530275|FG000|Overall Study|Lost to Follow-up|1|||
105690240|NCT00992511|364530276|FG001|Overall Study|Lost to Follow-up|0|||
105690241|NCT00992511|364530277|FG002|Overall Study|Lost to Follow-up|0|||
105690242|NCT00992511|364530278|FG003|Overall Study|Lost to Follow-up|2|||
105690243|NCT00992511|364530275|FG000|Overall Study|Withdrawal by Subject|0|||
105690244|NCT00992511|364530276|FG001|Overall Study|Withdrawal by Subject|0|||
105690245|NCT00992511|364530277|FG002|Overall Study|Withdrawal by Subject|1|||
105690246|NCT00992511|364530278|FG003|Overall Study|Withdrawal by Subject|1|||
105690247|NCT04498169|364530279|FG000|Study Completion|Adverse Event|1|||
105690248|NCT04498169|364530280|FG001|Study Completion|Adverse Event|1|||
105690249|NCT04615247|364530281|FG000|Overall Study|Adverse Event|0|||
105690250|NCT04615247|364530282|FG001|Overall Study|Adverse Event|2|||
105690251|NCT04615247|364530281|FG000|Overall Study|Withdrawal by Subject|1|||
105690252|NCT04615247|364530282|FG001|Overall Study|Withdrawal by Subject|1|||
105690253|NCT01383161|364530288|FG000|Overall Study|Adverse Event|5|||
105690254|NCT01383161|364530289|FG001|Overall Study|Adverse Event|1|||
105690255|NCT01383161|364530288|FG000|Overall Study|Withdrawal by Subject|0|||
105690256|NCT01383161|364530289|FG001|Overall Study|Withdrawal by Subject|2|||
105690257|NCT01383161|364530288|FG000|Overall Study|Lack of Efficacy|0|||
105690258|NCT01383161|364530289|FG001|Overall Study|Lack of Efficacy|1|||
105690259|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
105690260|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
105690261|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
105690262|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
105690263|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
105690264|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
105690265|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
105690266|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
105690267|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
105690268|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
106130653|NCT02403674|366135521|FG000|Base Study|Physician Decision|2|||
106130654|NCT02403674|366135522|FG001|Base Study|Physician Decision|2|||
106130655|NCT02403674|366135521|FG000|Base Study|Pregnancy|2|||
105690269|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
105690270|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
105690271|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
105690272|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
105690273|NCT03548987|364530298|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
105690274|NCT03548987|364530299|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
105690275|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
105690276|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
105690277|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
106130656|NCT02403674|366135522|FG001|Base Study|Pregnancy|2|||
106002821|NCT00683878|365672516|FG001|Overall Study|Lost to Follow-up|2|||
105690278|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
105690279|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
105690280|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
105690281|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
105690282|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
105690283|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
105690284|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
105690285|NCT03548987|364530298|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
105690286|NCT03548987|364530299|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
105690287|NCT03153137|364530301|FG000|Overall Study|Lost to Follow-up|1|||
105690288|NCT03153137|364530302|FG001|Overall Study|Lost to Follow-up|0|||
105690289|NCT03153137|364530301|FG000|Overall Study|Withdrawal by Subject|2|||
105690290|NCT03153137|364530302|FG001|Overall Study|Withdrawal by Subject|1|||
105690291|NCT03153137|364530301|FG000|Overall Study|Physician Decision|0|||
105690292|NCT03153137|364530302|FG001|Overall Study|Physician Decision|3|||
105690293|NCT02119325|364530306|FG000|Washout Period 1|Adverse Event|0|||
105690294|NCT02119325|364530307|FG001|Washout Period 1|Adverse Event|1|||
105690295|NCT00578786|364530314|FG000|Overall Study|Adverse Event|27|||
105690296|NCT00578786|364530315|FG001|Overall Study|Adverse Event|37|||
105690297|NCT00578786|364530316|FG002|Overall Study|Adverse Event|17|||
105690298|NCT00578786|364530314|FG000|Overall Study|Lack of Efficacy|2|||
105690299|NCT00578786|364530315|FG001|Overall Study|Lack of Efficacy|5|||
105690300|NCT00578786|364530316|FG002|Overall Study|Lack of Efficacy|2|||
105690301|NCT00578786|364530314|FG000|Overall Study|Early Escape from Prior Study|2|||
105690302|NCT00578786|364530315|FG001|Overall Study|Early Escape from Prior Study|1|||
105690303|NCT00578786|364530316|FG002|Overall Study|Early Escape from Prior Study|2|||
105690304|NCT00578786|364530314|FG000|Overall Study|Withdrawal by Subject|7|||
105690305|NCT00578786|364530315|FG001|Overall Study|Withdrawal by Subject|8|||
105690306|NCT00578786|364530316|FG002|Overall Study|Withdrawal by Subject|5|||
105690307|NCT00578786|364530314|FG000|Overall Study|Protocol Violation|0|||
105690308|NCT00578786|364530315|FG001|Overall Study|Protocol Violation|3|||
105690309|NCT00578786|364530316|FG002|Overall Study|Protocol Violation|1|||
105690310|NCT00578786|364530314|FG000|Overall Study|Physician Decision|1|||
105919368|NCT02078817|365363577|FG000|Overall Study|Withdrawal by Subject|1|||
105919369|NCT00855218|365363578|FG000|Overall Study|Adverse Event|43|||
105919370|NCT00855218|365363579|FG001|Overall Study|Adverse Event|27|||
105919371|NCT00855218|365363578|FG000|Overall Study|Withdrawal by Subject|10|||
105919372|NCT00855218|365363579|FG001|Overall Study|Withdrawal by Subject|6|||
105690311|NCT00578786|364530315|FG001|Overall Study|Physician Decision|0|||
105919373|NCT00855218|365363578|FG000|Overall Study|Physician Decision|18|||
105919374|NCT00855218|365363579|FG001|Overall Study|Physician Decision|11|||
105919375|NCT00855218|365363578|FG000|Overall Study|Lost to Follow-up|0|||
105919376|NCT00855218|365363579|FG001|Overall Study|Lost to Follow-up|1|||
105919377|NCT00855218|365363578|FG000|Overall Study|Protocol Violation|5|||
105919378|NCT00855218|365363579|FG001|Overall Study|Protocol Violation|9|||
105919379|NCT00855218|365363578|FG000|Overall Study|non-compliant with study drug|3|||
105919380|NCT00855218|365363579|FG001|Overall Study|non-compliant with study drug|1|||
105919381|NCT00855218|365363578|FG000|Overall Study|patient convenience|2|||
105919382|NCT00855218|365363579|FG001|Overall Study|patient convenience|0|||
105919383|NCT00855218|365363578|FG000|Overall Study|technical problems|2|||
105919384|NCT00855218|365363579|FG001|Overall Study|technical problems|1|||
105919385|NCT00855218|365363578|FG000|Overall Study|Still treated with study medication|0|||
105919386|NCT00855218|365363579|FG001|Overall Study|Still treated with study medication|1|||
105919387|NCT00855218|365363578|FG000|Overall Study|Untreatable disease progression|54|||
105919388|NCT00855218|365363579|FG001|Overall Study|Untreatable disease progression|67|||
105919389|NCT00855218|365363578|FG000|Overall Study|Second malignancy|0|||
105919390|NCT00855218|365363579|FG001|Overall Study|Second malignancy|1|||
105919391|NCT00855218|365363578|FG000|Overall Study|Progression measurement proven|7|||
105919392|NCT00855218|365363579|FG001|Overall Study|Progression measurement proven|15|||
105919393|NCT00855218|365363578|FG000|Overall Study|Clinical endpoint reached|10|||
105919394|NCT00855218|365363579|FG001|Overall Study|Clinical endpoint reached|13|||
106130657|NCT02403674|366135521|FG000|Base Study|Protocol Violation|8|||
106130658|NCT02403674|366135522|FG001|Base Study|Protocol Violation|4|||
106130659|NCT02403674|366135521|FG000|Base Study|Non-Compliance with study drug|1|||
105690312|NCT00578786|364530316|FG002|Overall Study|Physician Decision|1|||
106130660|NCT02403674|366135522|FG001|Base Study|Non-Compliance with study drug|4|||
105690313|NCT00578786|364530314|FG000|Overall Study|Sponsor Decision|0|||
105690314|NCT00578786|364530315|FG001|Overall Study|Sponsor Decision|0|||
105690315|NCT00578786|364530316|FG002|Overall Study|Sponsor Decision|1|||
105690316|NCT00578786|364530314|FG000|Overall Study|Lost to Follow-up|0|||
105690317|NCT00578786|364530315|FG001|Overall Study|Lost to Follow-up|4|||
105919395|NCT01149655|365363584|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
105919396|NCT01149655|365363585|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
105919397|NCT01149655|365363586|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
105690318|NCT00578786|364530316|FG002|Overall Study|Lost to Follow-up|0|||
105690319|NCT00578786|364530314|FG000|Overall Study|Pregnancy|0|||
105690320|NCT00578786|364530315|FG001|Overall Study|Pregnancy|1|||
105690321|NCT00578786|364530316|FG002|Overall Study|Pregnancy|0|||
105690322|NCT00578786|364530314|FG000|Overall Study|Not Otherwise Specified|0|||
105690323|NCT00578786|364530315|FG001|Overall Study|Not Otherwise Specified|4|||
105690324|NCT00578786|364530316|FG002|Overall Study|Not Otherwise Specified|1|||
105690325|NCT00578786|364530314|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
105690326|NCT00578786|364530315|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
105690327|NCT00578786|364530316|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
105690328|NCT00866723|364530317|FG000|Overall Study|Withdrawal by Subject|1|||
105690329|NCT00866723|364530317|FG000|Overall Study|Disease Progression|4|||
105690330|NCT01603082|364530320|FG000|Overall Study|Adverse Event|0|||
105690331|NCT01603082|364530321|FG001|Overall Study|Adverse Event|1|||
105690332|NCT01603082|364530320|FG000|Overall Study|Withdrawal by Subject|1|||
105690333|NCT01603082|364530321|FG001|Overall Study|Withdrawal by Subject|0|||
105690334|NCT01603082|364530320|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
105690335|NCT01603082|364530321|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
105690336|NCT01794923|364530325|FG000|Overall Study|Adverse Event|0|||
105690337|NCT01794923|364530326|FG001|Overall Study|Adverse Event|0|||
105690338|NCT01794923|364530327|FG002|Overall Study|Adverse Event|1|||
105690339|NCT04744285|364530328|FG000|Overall Study|Withdrawal by Subject|1|||
105690340|NCT04744285|364530329|FG001|Overall Study|Withdrawal by Subject|1|||
105690341|NCT04744285|364530330|FG002|Overall Study|Withdrawal by Subject|2|||
105690342|NCT04744285|364530331|FG003|Overall Study|Withdrawal by Subject|1|||
105690343|NCT01717768|364530332|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690344|NCT01717768|364530333|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
105690345|NCT01717768|364530334|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690346|NCT01717768|364530335|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690347|NCT01717768|364530336|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690348|NCT01717768|364530337|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690349|NCT01717768|364530338|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690350|NCT01717768|364530339|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690351|NCT01717768|364530340|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690352|NCT01717768|364530341|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690353|NCT01717768|364530342|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690354|NCT01717768|364530343|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
105690355|NCT01717768|364530332|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690356|NCT01717768|364530333|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690357|NCT01717768|364530334|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690358|NCT01717768|364530335|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690359|NCT01717768|364530336|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690360|NCT01717768|364530337|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690361|NCT01717768|364530338|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690362|NCT01717768|364530339|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690363|NCT01717768|364530340|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690364|NCT01717768|364530341|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690365|NCT01717768|364530342|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
105690366|NCT01717768|364530343|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
105690367|NCT01717768|364530332|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690368|NCT01717768|364530333|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690369|NCT01717768|364530334|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690370|NCT01717768|364530335|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690371|NCT01717768|364530336|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690372|NCT01717768|364530337|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690373|NCT01717768|364530338|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105919398|NCT01149655|365363587|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
105919399|NCT01149655|365363584|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
105919400|NCT01149655|365363585|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
105690374|NCT01717768|364530339|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
105919401|NCT01149655|365363586|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
105919402|NCT01149655|365363587|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
105919403|NCT01149655|365363584|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
105919404|NCT01149655|365363585|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
105919405|NCT01149655|365363586|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
105919406|NCT01149655|365363587|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
105919407|NCT01149655|365363584|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
105690375|NCT01717768|364530340|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690376|NCT01717768|364530341|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690377|NCT01717768|364530342|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690378|NCT01717768|364530343|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
105690379|NCT01717768|364530332|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690380|NCT01717768|364530333|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690381|NCT01717768|364530334|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690382|NCT01717768|364530335|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690383|NCT01717768|364530336|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690384|NCT01717768|364530337|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690385|NCT01717768|364530338|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690386|NCT01717768|364530339|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690387|NCT01717768|364530340|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690388|NCT01717768|364530341|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
105690389|NCT01717768|364530342|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690390|NCT01717768|364530343|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
105690391|NCT01774084|364530344|FG000|Overall Study|Personal reasons|1|||
105690392|NCT01774084|364530345|FG001|Overall Study|Personal reasons|0|||
105690393|NCT01610687|364530350|FG000|Overall Study|Lack of Efficacy|26|||
105690394|NCT01610687|364530350|FG000|Overall Study|Adverse Event|18|||
105690395|NCT01610687|364530350|FG000|Overall Study|Moved out of area|6|||
105690396|NCT01610687|364530350|FG000|Overall Study|Withdrawal by Subject|7|||
105690397|NCT01610687|364530350|FG000|Overall Study|Lost to Follow-up|4|||
105690398|NCT01610687|364530350|FG000|Overall Study|Symptom control without study medication|2|||
105690399|NCT01610687|364530350|FG000|Overall Study|Unable to make journey|1|||
105690400|NCT01610687|364530350|FG000|Overall Study|Death|1|||
105690401|NCT01610687|364530350|FG000|Overall Study|Cannabis affecting job|1|||
105690402|NCT01610687|364530350|FG000|Overall Study|Felt more alter without study medication|1|||
105690403|NCT01006265|364530351|FG000|Overall Study|Lost to Follow-up|1|||
105690404|NCT01006265|364530352|FG001|Overall Study|Lost to Follow-up|0|||
105690405|NCT01006265|364530353|FG002|Overall Study|Lost to Follow-up|1|||
105690406|NCT01006265|364530354|FG003|Overall Study|Lost to Follow-up|0|||
105690407|NCT01006265|364530351|FG000|Overall Study|Withdrawal by Subject|4|||
105690408|NCT01006265|364530352|FG001|Overall Study|Withdrawal by Subject|7|||
105690409|NCT01006265|364530353|FG002|Overall Study|Withdrawal by Subject|5|||
105690410|NCT01006265|364530354|FG003|Overall Study|Withdrawal by Subject|5|||
105690411|NCT01006265|364530351|FG000|Overall Study|Administrative reason|1|||
105690412|NCT01006265|364530352|FG001|Overall Study|Administrative reason|2|||
105690413|NCT01006265|364530353|FG002|Overall Study|Administrative reason|3|||
105690414|NCT01006265|364530354|FG003|Overall Study|Administrative reason|0|||
105690415|NCT00752622|364530357|FG000|Induction Phase|Adverse Event|3|||
105690416|NCT00752622|364530357|FG000|Induction Phase|Other|3|||
105690417|NCT00752622|364530357|FG000|Induction Phase|Non-responder|14|||
105690418|NCT00752622|364530357|FG000|Induction Phase|Withdrawal by Subject|1|||
105690419|NCT00752622|364530357|FG000|Induction Phase|Premature study termination|14|||
105690420|NCT00752622|364530357|FG000|Observational Phase|Premature Study Termination|36|||
105690421|NCT00752622|364530357|FG000|Observational Phase|Non-responder|2|||
105690422|NCT00752622|364530357|FG000|Observational Phase|Withdrawal by Subject|2|||
105690423|NCT00752622|364530357|FG000|Observational Phase|Adverse Event|1|||
105690424|NCT00752622|364530357|FG000|Observational Phase|Other|2|||
105690425|NCT00752622|364530357|FG000|Interventional Phase|Non-responder|2|||
105690426|NCT00752622|364530357|FG000|Interventional Phase|Physician Decision|1|||
105690427|NCT00752622|364530357|FG000|Interventional Phase|Premature Study Termination|5|||
105690428|NCT00576836|364530358|FG000|Overall Study|Death|0|||
105690429|NCT00576836|364530359|FG001|Overall Study|Death|1|||
105690430|NCT00576836|364530358|FG000|Overall Study|Physician Decision|0|||
105690431|NCT00576836|364530359|FG001|Overall Study|Physician Decision|1|||
105690432|NCT01272947|364530360|FG000|Overall Study|Abnormal Laboratory Value|2|||
105690433|NCT01272947|364530361|FG001|Overall Study|Abnormal Laboratory Value|2|||
105690434|NCT00796120|364530363|FG000|Overall Study|Death|3|||
105690435|NCT00796120|364530364|FG001|Overall Study|Death|0|||
105690436|NCT00796120|364530363|FG000|Overall Study|Adverse Event|11|||
105690437|NCT00796120|364530364|FG001|Overall Study|Adverse Event|6|||
105690438|NCT00796120|364530363|FG000|Overall Study|Progressive disease|22|||
105690439|NCT00796120|364530364|FG001|Overall Study|Progressive disease|13|||
105690440|NCT00796120|364530363|FG000|Overall Study|Participant refusal|3|||
105690441|NCT00796120|364530364|FG001|Overall Study|Participant refusal|4|||
105690442|NCT00796120|364530363|FG000|Overall Study|Other|6|||
105690443|NCT00796120|364530364|FG001|Overall Study|Other|17|||
105690444|NCT00796120|364530363|FG000|Overall Study|Physician Decision|16|||
105690445|NCT00796120|364530364|FG001|Overall Study|Physician Decision|17|||
105690446|NCT00796120|364530363|FG000|Overall Study|Randomized but not treated|0|||
105690447|NCT00796120|364530364|FG001|Overall Study|Randomized but not treated|3|||
105690448|NCT01136811|364530365|FG000|Overall Study|Physician Decision|11|||
105690449|NCT00803270|364530371|FG000|Overall Study|Lost to Follow-up|1|||
105690450|NCT00803270|364530372|FG001|Overall Study|Lost to Follow-up|2|||
105690451|NCT04484259|364530373|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
105690452|NCT04484259|364530374|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
105690453|NCT04484259|364530375|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
105690454|NCT04484259|364530376|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
105690455|NCT04484259|364530377|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
105690456|NCT04484259|364530373|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
105690457|NCT04484259|364530374|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
105690458|NCT04484259|364530375|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
105690459|NCT04484259|364530376|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
105690460|NCT04484259|364530377|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
105690461|NCT04484259|364530373|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
105690462|NCT04484259|364530374|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
105690463|NCT04484259|364530375|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
105690464|NCT04484259|364530376|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
105690465|NCT04484259|364530377|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
105690466|NCT04484259|364530373|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
105690467|NCT04484259|364530374|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
105690468|NCT04484259|364530375|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
105690469|NCT04484259|364530376|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
105690470|NCT04484259|364530377|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
105690471|NCT04484259|364530373|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
105690472|NCT04484259|364530374|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
105690473|NCT04484259|364530375|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
105690474|NCT04484259|364530376|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
105690475|NCT04484259|364530377|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
105690476|NCT04484259|364530373|FG000|Randomized Treatment|Withdrawal by Subject|1|||
105690477|NCT04484259|364530374|FG001|Randomized Treatment|Withdrawal by Subject|0|||
105690478|NCT04484259|364530375|FG002|Randomized Treatment|Withdrawal by Subject|0|||
105690479|NCT04484259|364530376|FG003|Randomized Treatment|Withdrawal by Subject|0|||
105690480|NCT04484259|364530377|FG004|Randomized Treatment|Withdrawal by Subject|0|||
105690481|NCT01681628|364532515|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
105690482|NCT01681628|364532516|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
105690483|NCT01681628|364532515|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
105690484|NCT01681628|364532516|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
105690485|NCT01681628|364532515|FG000|19 Months Follow-up|Death|1|||
105690486|NCT01681628|364532516|FG001|19 Months Follow-up|Death|0|||
105690487|NCT01681628|364532515|FG000|19 Months Follow-up|Lost to Follow-up|61|||
105690488|NCT01681628|364532516|FG001|19 Months Follow-up|Lost to Follow-up|43|||
105690489|NCT01521897|364532517|FG000|Overall Study|Protocol Violation|18|||
105690490|NCT01521897|364532517|FG000|Overall Study|Lost to Follow-up|5|||
105690491|NCT01794520|364532526|FG000|Overall Study|Adverse events- related to progression|0|||
105690492|NCT01794520|364532527|FG001|Overall Study|Adverse events- related to progression|0|||
105690493|NCT01794520|364532528|FG002|Overall Study|Adverse events- related to progression|1|||
105690494|NCT01794520|364532529|FG003|Overall Study|Adverse events- related to progression|2|||
105690495|NCT01794520|364532530|FG004|Overall Study|Adverse events- related to progression|0|||
105690496|NCT01794520|364532531|FG005|Overall Study|Adverse events- related to progression|1|||
105690497|NCT01794520|364532532|FG006|Overall Study|Adverse events- related to progression|0|||
105690498|NCT01794520|364532526|FG000|Overall Study|Adverse event- not related to progression|1|||
105690499|NCT01794520|364532527|FG001|Overall Study|Adverse event- not related to progression|1|||
105690500|NCT01794520|364532528|FG002|Overall Study|Adverse event- not related to progression|0|||
105690501|NCT01794520|364532529|FG003|Overall Study|Adverse event- not related to progression|0|||
105786838|NCT05182840|364872932|FG003|Run-in Period|Burden of study procedures|0|||
105786839|NCT05182840|364872933|FG004|Run-in Period|Burden of study procedures|0|||
105690502|NCT01794520|364532530|FG004|Overall Study|Adverse event- not related to progression|2|||
105690503|NCT01794520|364532531|FG005|Overall Study|Adverse event- not related to progression|0|||
105690504|NCT01794520|364532532|FG006|Overall Study|Adverse event- not related to progression|0|||
105690505|NCT01794520|364532526|FG000|Overall Study|Progressive disease|5|||
105690506|NCT01794520|364532527|FG001|Overall Study|Progressive disease|6|||
105690507|NCT01794520|364532528|FG002|Overall Study|Progressive disease|2|||
105690508|NCT01794520|364532529|FG003|Overall Study|Progressive disease|5|||
105690509|NCT01794520|364532530|FG004|Overall Study|Progressive disease|27|||
105690510|NCT01794520|364532531|FG005|Overall Study|Progressive disease|18|||
105690511|NCT01794520|364532532|FG006|Overall Study|Progressive disease|0|||
105690512|NCT01794520|364532526|FG000|Overall Study|Withdrew consent|0|||
105690513|NCT01794520|364532527|FG001|Overall Study|Withdrew consent|0|||
105690514|NCT01794520|364532528|FG002|Overall Study|Withdrew consent|1|||
105690515|NCT01794520|364532529|FG003|Overall Study|Withdrew consent|1|||
105690516|NCT01794520|364532530|FG004|Overall Study|Withdrew consent|0|||
105690517|NCT01794520|364532531|FG005|Overall Study|Withdrew consent|0|||
105690518|NCT01794520|364532532|FG006|Overall Study|Withdrew consent|0|||
105690519|NCT01794520|364532526|FG000|Overall Study|Lost to Follow-up|0|||
105690520|NCT01794520|364532527|FG001|Overall Study|Lost to Follow-up|0|||
105690521|NCT01794520|364532528|FG002|Overall Study|Lost to Follow-up|0|||
105690522|NCT01794520|364532529|FG003|Overall Study|Lost to Follow-up|0|||
105690523|NCT01794520|364532530|FG004|Overall Study|Lost to Follow-up|1|||
105690524|NCT01794520|364532531|FG005|Overall Study|Lost to Follow-up|0|||
105690525|NCT01794520|364532532|FG006|Overall Study|Lost to Follow-up|0|||
105690526|NCT01794520|364532526|FG000|Overall Study|Toxicity|0|||
105690527|NCT01794520|364532527|FG001|Overall Study|Toxicity|2|||
105690528|NCT01794520|364532528|FG002|Overall Study|Toxicity|0|||
105690529|NCT01794520|364532529|FG003|Overall Study|Toxicity|0|||
105690530|NCT01794520|364532530|FG004|Overall Study|Toxicity|0|||
105690531|NCT01794520|364532531|FG005|Overall Study|Toxicity|0|||
105690532|NCT01794520|364532532|FG006|Overall Study|Toxicity|0|||
105690533|NCT01794520|364532526|FG000|Overall Study|Study terminated by sponsor|0|||
105690534|NCT01794520|364532527|FG001|Overall Study|Study terminated by sponsor|0|||
105690535|NCT01794520|364532528|FG002|Overall Study|Study terminated by sponsor|1|||
105690536|NCT01794520|364532529|FG003|Overall Study|Study terminated by sponsor|0|||
105690537|NCT01794520|364532530|FG004|Overall Study|Study terminated by sponsor|1|||
105690538|NCT01794520|364532531|FG005|Overall Study|Study terminated by sponsor|0|||
105690539|NCT01794520|364532532|FG006|Overall Study|Study terminated by sponsor|7|||
105690540|NCT01794520|364532526|FG000|Overall Study|Death|0|||
105690541|NCT01794520|364532527|FG001|Overall Study|Death|0|||
105690542|NCT01794520|364532528|FG002|Overall Study|Death|0|||
105690543|NCT01794520|364532529|FG003|Overall Study|Death|0|||
105690544|NCT01794520|364532530|FG004|Overall Study|Death|1|||
105690545|NCT01794520|364532531|FG005|Overall Study|Death|0|||
105690546|NCT01794520|364532532|FG006|Overall Study|Death|22|||
105690547|NCT01794520|364532526|FG000|Overall Study|Other, not specified|0|||
105690548|NCT01794520|364532527|FG001|Overall Study|Other, not specified|0|||
105690549|NCT01794520|364532528|FG002|Overall Study|Other, not specified|1|||
105690550|NCT01794520|364532529|FG003|Overall Study|Other, not specified|1|||
105690551|NCT01794520|364532530|FG004|Overall Study|Other, not specified|4|||
105690552|NCT01794520|364532531|FG005|Overall Study|Other, not specified|1|||
105690553|NCT01794520|364532532|FG006|Overall Study|Other, not specified|2|||
105690554|NCT02276872|364532533|FG000|Overall Study|Adverse Event|1|||
105690555|NCT02276872|364532534|FG001|Overall Study|Adverse Event|0|||
105690556|NCT02276872|364532535|FG002|Overall Study|Adverse Event|0|||
105690557|NCT04356183|364532537|FG000|Overall Study|Lost to Follow-up|1|||
105690558|NCT04356183|364532538|FG001|Overall Study|Lost to Follow-up|0|||
105690559|NCT04356183|364532537|FG000|Overall Study|Withdrawal by Subject|1|||
105690560|NCT04356183|364532538|FG001|Overall Study|Withdrawal by Subject|1|||
105690561|NCT00823901|364532541|FG000|Overall Study|Adverse Event|1|||
105919408|NCT01149655|365363585|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
105919409|NCT01149655|365363586|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
105690562|NCT00823901|364532542|FG001|Overall Study|Adverse Event|1|||
105690563|NCT00823901|364532541|FG000|Overall Study|Lack of Efficacy|1|||
105919410|NCT01149655|365363587|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
105919411|NCT01149655|365363584|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
105919412|NCT01149655|365363585|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
105690564|NCT00823901|364532542|FG001|Overall Study|Lack of Efficacy|0|||
105690565|NCT00823901|364532541|FG000|Overall Study|Lost to Follow-up|2|||
105690566|NCT00823901|364532542|FG001|Overall Study|Lost to Follow-up|1|||
105690567|NCT01176968|364532543|FG000|Overall Study|Adverse Event|10|||
105690568|NCT01176968|364532544|FG001|Overall Study|Adverse Event|11|||
105690569|NCT01176968|364532543|FG000|Overall Study|Death|2|||
105690570|NCT01176968|364532544|FG001|Overall Study|Death|3|||
105690571|NCT01176968|364532543|FG000|Overall Study|Lack of Efficacy|0|||
106002822|NCT00683878|365672517|FG002|Overall Study|Lost to Follow-up|4|||
105690572|NCT01176968|364532544|FG001|Overall Study|Lack of Efficacy|1|||
105690573|NCT01176968|364532543|FG000|Overall Study|Lost to Follow-up|16|||
105690574|NCT01176968|364532544|FG001|Overall Study|Lost to Follow-up|14|||
105690575|NCT01176968|364532543|FG000|Overall Study|Withdrawal by Subject|48|||
105690576|NCT01176968|364532544|FG001|Overall Study|Withdrawal by Subject|48|||
105690577|NCT01176968|364532543|FG000|Overall Study|Protocol Violation|2|||
105690578|NCT01176968|364532544|FG001|Overall Study|Protocol Violation|1|||
105690579|NCT01176968|364532543|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
105690580|NCT01176968|364532544|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
105690581|NCT01176968|364532543|FG000|Overall Study|Study terminated by sponsor|0|||
105690582|NCT01176968|364532544|FG001|Overall Study|Study terminated by sponsor|1|||
105690583|NCT01176968|364532543|FG000|Overall Study|Reason not defined|5|||
105690584|NCT01176968|364532544|FG001|Overall Study|Reason not defined|3|||
105786840|NCT05182840|364872934|FG005|Run-in Period|Burden of study procedures|0|||
105786841|NCT05182840|364872935|FG006|Run-in Period|Burden of study procedures|0|||
105786842|NCT05182840|364872936|FG007|Run-in Period|Burden of study procedures|0|||
105786843|NCT05182840|364872937|FG008|Run-in Period|Burden of study procedures|0|||
105786844|NCT05182840|364872938|FG009|Run-in Period|Burden of study procedures|0|||
105786845|NCT05182840|364872929|FG000|Run-in Period|Change of residence|1|||
105690585|NCT00833911|364532545|FG000|Titration|Adverse Event|18|||
105690586|NCT00833911|364532545|FG000|Titration|Withdrawal by Subject|3|||
105690587|NCT00833911|364532545|FG000|Maintenance Phase I|Adverse Event|73|||
105690588|NCT00833911|364532545|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
105690589|NCT00833911|364532545|FG000|Maintenance Phase I|Physician Decision|10|||
105690590|NCT00833911|364532545|FG000|Maintenance Phase I|Lack of Efficacy|4|||
105690591|NCT00833911|364532545|FG000|Maintenance Phase II|Adverse Event|6|||
105690592|NCT00833911|364532545|FG000|Maintenance Phase II|Physician Decision|2|||
105690593|NCT00833911|364532545|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
105690594|NCT00833911|364532545|FG000|Maintenance Phase II|Lack of Efficacy|1|||
105690595|NCT00216203|364532548|FG000|Overall Study|Withdrawal by Subject|2|||
105690596|NCT01214187|364532553|FG000|Overall Study|Adverse Event|6|||
105690597|NCT01214187|364532554|FG001|Overall Study|Adverse Event|2|||
105690598|NCT01214187|364532553|FG000|Overall Study|Death|1|||
105690599|NCT01214187|364532554|FG001|Overall Study|Death|1|||
105690600|NCT01214187|364532553|FG000|Overall Study|Withdrawal by Subject|0|||
105690601|NCT01214187|364532554|FG001|Overall Study|Withdrawal by Subject|3|||
105690602|NCT00993915|364532555|FG000|Overall Study|Insufficient clinical response|3|||
105690603|NCT00993915|364532555|FG000|Overall Study|Withdrawal by Subject|2|||
105690604|NCT00993915|364532555|FG000|Overall Study|Other|1|||
105690605|NCT00993915|364532555|FG000|Overall Study|Ongoing|3|||
105690606|NCT01386658|364532556|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
105690607|NCT01386658|364532557|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
105690608|NCT01386658|364532556|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
105690609|NCT01386658|364532557|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
105690610|NCT01601847|364532558|FG000|Overall Study|Death|1|||
105690611|NCT01601847|364532559|FG001|Overall Study|Death|0|||
105690612|NCT01601847|364532558|FG000|Overall Study|Withdrawal by Subject|11|||
105690613|NCT01601847|364532559|FG001|Overall Study|Withdrawal by Subject|7|||
105690614|NCT01601847|364532558|FG000|Overall Study|Lost to Follow-up|1|||
105690615|NCT01601847|364532559|FG001|Overall Study|Lost to Follow-up|3|||
105690616|NCT01284062|364532565|FG000|Overall Study|Adverse Event|4|||
105690617|NCT01284062|364532566|FG001|Overall Study|Adverse Event|5|||
105690618|NCT01284062|364532567|FG002|Overall Study|Adverse Event|0|||
105690619|NCT01284062|364532568|FG003|Overall Study|Adverse Event|5|||
105690620|NCT01284062|364532565|FG000|Overall Study|Lack of Efficacy|3|||
105690621|NCT01284062|364532566|FG001|Overall Study|Lack of Efficacy|2|||
105786846|NCT05182840|364872930|FG001|Run-in Period|Change of residence|0|||
105786847|NCT05182840|364872931|FG002|Run-in Period|Change of residence|0|||
105786848|NCT05182840|364872932|FG003|Run-in Period|Change of residence|0|||
105786849|NCT05182840|364872933|FG004|Run-in Period|Change of residence|0|||
105690622|NCT01284062|364532567|FG002|Overall Study|Lack of Efficacy|2|||
105690623|NCT01284062|364532568|FG003|Overall Study|Lack of Efficacy|1|||
105786850|NCT05182840|364872934|FG005|Run-in Period|Change of residence|0|||
105786851|NCT05182840|364872935|FG006|Run-in Period|Change of residence|0|||
105786852|NCT05182840|364872936|FG007|Run-in Period|Change of residence|0|||
105786853|NCT05182840|364872937|FG008|Run-in Period|Change of residence|0|||
105690624|NCT01284062|364532565|FG000|Overall Study|Medication error without adverse event|0|||
105690625|NCT01284062|364532566|FG001|Overall Study|Medication error without adverse event|0|||
105786854|NCT05182840|364872938|FG009|Run-in Period|Change of residence|0|||
105786855|NCT05182840|364872929|FG000|Run-in Period|Adverse Event|5|||
105786856|NCT05182840|364872930|FG001|Run-in Period|Adverse Event|5|||
105786857|NCT05182840|364872931|FG002|Run-in Period|Adverse Event|0|||
105786858|NCT05182840|364872932|FG003|Run-in Period|Adverse Event|0|||
105786859|NCT05182840|364872933|FG004|Run-in Period|Adverse Event|0|||
105690626|NCT01284062|364532567|FG002|Overall Study|Medication error without adverse event|1|||
105690627|NCT01284062|364532568|FG003|Overall Study|Medication error without adverse event|0|||
105690628|NCT01284062|364532565|FG000|Overall Study|Protocol Violation|1|||
105690629|NCT01284062|364532566|FG001|Overall Study|Protocol Violation|0|||
105690630|NCT01284062|364532567|FG002|Overall Study|Protocol Violation|0|||
105786860|NCT05182840|364872934|FG005|Run-in Period|Adverse Event|0|||
105786861|NCT05182840|364872935|FG006|Run-in Period|Adverse Event|0|||
105786862|NCT05182840|364872936|FG007|Run-in Period|Adverse Event|0|||
105690631|NCT01284062|364532568|FG003|Overall Study|Protocol Violation|2|||
105690632|NCT01284062|364532565|FG000|Overall Study|Withdrawal by Subject|3|||
105690633|NCT01284062|364532566|FG001|Overall Study|Withdrawal by Subject|1|||
105690634|NCT01284062|364532567|FG002|Overall Study|Withdrawal by Subject|2|||
105690635|NCT01284062|364532568|FG003|Overall Study|Withdrawal by Subject|5|||
105690636|NCT01284062|364532565|FG000|Overall Study|Other|0|||
105690637|NCT01284062|364532566|FG001|Overall Study|Other|0|||
105690638|NCT01284062|364532567|FG002|Overall Study|Other|0|||
105690639|NCT01284062|364532568|FG003|Overall Study|Other|1|||
105690640|NCT01284062|364532565|FG000|Overall Study|Site Closed|0|||
105690641|NCT01284062|364532566|FG001|Overall Study|Site Closed|0|||
105690642|NCT01284062|364532567|FG002|Overall Study|Site Closed|1|||
105690643|NCT01284062|364532568|FG003|Overall Study|Site Closed|0|||
105690644|NCT02234323|364532572|FG000|All Enrolled|Not Treated: Completed study in database|2|||
105690645|NCT02234323|364532572|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
105690646|NCT02234323|364532572|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
105690647|NCT02234323|364532572|FG000|All Treated|Death|1|||
105690648|NCT02234323|364532572|FG000|All Treated|Physician Decision|5|||
105690649|NCT02234323|364532572|FG000|All Treated|Lack of Efficacy|3|||
105690650|NCT02234323|364532572|FG000|All Treated|Exceeded lab value limit|2|||
105690651|NCT02234323|364532572|FG000|All Treated|Other|7|||
105690652|NCT02465463|364532573|FG000|Overall Study|Lost to Follow-up|2|||
105690653|NCT02465463|364532574|FG001|Overall Study|Lost to Follow-up|1|||
105690654|NCT02465463|364532573|FG000|Overall Study|Death|1|||
105690655|NCT02465463|364532574|FG001|Overall Study|Death|0|||
105690656|NCT02465463|364532573|FG000|Overall Study|Protocol Violation|1|||
105690657|NCT02465463|364532574|FG001|Overall Study|Protocol Violation|0|||
105690658|NCT05372653|364532575|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
105690659|NCT05372653|364532576|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
105690660|NCT05372653|364532575|FG000|Overall Study|Adverse Event|0|||
105690661|NCT05372653|364532576|FG001|Overall Study|Adverse Event|1|||
105690662|NCT01067326|364532577|FG000|Overall Study|Adverse Event|0|||
105690663|NCT01067326|364532578|FG001|Overall Study|Adverse Event|2|||
105690664|NCT01067326|364532577|FG000|Overall Study|Withdrawal by Subject|1|||
105690665|NCT01067326|364532578|FG001|Overall Study|Withdrawal by Subject|0|||
105690666|NCT01067326|364532577|FG000|Overall Study|Early Study Termination|1|||
105690667|NCT01067326|364532578|FG001|Overall Study|Early Study Termination|1|||
105919413|NCT01149655|365363586|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
105919414|NCT01149655|365363587|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
105919415|NCT01149655|365363584|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
105919416|NCT01149655|365363585|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
105919417|NCT01149655|365363586|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
105919418|NCT01149655|365363587|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
105919419|NCT01149655|365363584|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
105919420|NCT01149655|365363585|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
105919421|NCT01149655|365363586|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
105690668|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
105690669|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
105690670|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Death|0|||
105919422|NCT01149655|365363587|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
105919423|NCT01149655|365363584|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
105919424|NCT01149655|365363585|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
105919425|NCT01149655|365363586|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
105690671|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Death|1|||
105690672|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
105690673|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
105690674|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
105690675|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
105690676|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
105690677|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
105690678|NCT00323297|364532579|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
105690679|NCT00323297|364532580|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
105919426|NCT01149655|365363587|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
105690680|NCT00323297|364532579|FG000|Part B (Open-label)|Death|0|||
105919427|NCT01149655|365363584|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
105690681|NCT00323297|364532580|FG001|Part B (Open-label)|Death|1|||
105690682|NCT00323297|364532579|FG000|Part B (Open-label)|Reason unspecified|0|||
105690683|NCT00323297|364532580|FG001|Part B (Open-label)|Reason unspecified|1|||
105690684|NCT00323297|364532579|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
105690685|NCT00323297|364532580|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
105919428|NCT01149655|365363585|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
105690686|NCT00323297|364532579|FG000|Part B (Open-label)|Lack of Efficacy|3|||
105690687|NCT00323297|364532580|FG001|Part B (Open-label)|Lack of Efficacy|1|||
105690688|NCT00323297|364532579|FG000|Part B (Open-label)|Adverse Event|5|||
105690689|NCT00323297|364532580|FG001|Part B (Open-label)|Adverse Event|5|||
105690690|NCT00323297|364532579|FG000|Part B (Open-label)|Protocol Violation|0|||
105690691|NCT00323297|364532580|FG001|Part B (Open-label)|Protocol Violation|1|||
105690692|NCT02066051|364532583|FG000|Overall Study|Subject developed active GVHD|1|||
105690693|NCT03027557|364532584|FG000|Overall Study|Adverse Event|1|||
105690694|NCT03027557|364532585|FG001|Overall Study|Adverse Event|0|||
105690695|NCT03027557|364532586|FG002|Overall Study|Adverse Event|0|||
105690696|NCT01237340|364532587|FG000|Overall Study|Adverse Event|3|||
105690697|NCT01237340|364532587|FG000|Overall Study|Withdrawal by Subject|1|||
105690698|NCT01237340|364532587|FG000|Overall Study|Early termination of the trial|36|||
105690699|NCT02019420|364532588|FG000|Overall Study|Did not receive study drug|2|||
105690700|NCT02019420|364532589|FG001|Overall Study|Did not receive study drug|2|||
105690701|NCT02019420|364532588|FG000|Overall Study|Withdrawal by Subject|1|||
105690702|NCT02019420|364532589|FG001|Overall Study|Withdrawal by Subject|3|||
105690703|NCT02019420|364532588|FG000|Overall Study|At request of sponsor or investigator|0|||
105690704|NCT02019420|364532589|FG001|Overall Study|At request of sponsor or investigator|1|||
105690705|NCT02019420|364532588|FG000|Overall Study|Death|104|||
105690706|NCT02019420|364532589|FG001|Overall Study|Death|99|||
105690707|NCT02019420|364532588|FG000|Overall Study|Transferred to other care facility|1|||
105690708|NCT02019420|364532589|FG001|Overall Study|Transferred to other care facility|1|||
105690709|NCT00986440|364532590|FG000|Overall Study|Progressive disease|27|||
105690710|NCT00986440|364532591|FG001|Overall Study|Progressive disease|37|||
105690711|NCT00986440|364532590|FG000|Overall Study|Serious adverse event or adverse event|9|||
105690712|NCT00986440|364532591|FG001|Overall Study|Serious adverse event or adverse event|2|||
105690713|NCT00986440|364532590|FG000|Overall Study|Withdrawal by Subject|1|||
105690714|NCT00986440|364532591|FG001|Overall Study|Withdrawal by Subject|2|||
105690715|NCT00986440|364532590|FG000|Overall Study|Screen failure (not dosed)|4|||
105690716|NCT00986440|364532591|FG001|Overall Study|Screen failure (not dosed)|2|||
105690717|NCT00593957|364532592|FG000|Overall Study|Physician Decision|0|||
105690718|NCT00593957|364532593|FG001|Overall Study|Physician Decision|1|||
105690719|NCT00593957|364532594|FG002|Overall Study|Physician Decision|2|||
105690720|NCT01009554|364532595|FG000|Overall Study|Adverse Event|1|||
105690721|NCT01009554|364532596|FG001|Overall Study|Adverse Event|1|||
105690722|NCT01009554|364532595|FG000|Overall Study|Withdrawal by Subject|1|||
105690723|NCT01009554|364532596|FG001|Overall Study|Withdrawal by Subject|3|||
105690724|NCT01009554|364532595|FG000|Overall Study|Noncompliant with Study Product|0|||
105690725|NCT01009554|364532596|FG001|Overall Study|Noncompliant with Study Product|3|||
105690726|NCT01605253|364532597|FG000|Overall Study|Physician Decision|3|||
105690727|NCT01605253|364532598|FG001|Overall Study|Physician Decision|2|||
105690728|NCT01605253|364532597|FG000|Overall Study|Lost to Follow-up|3|||
105690729|NCT01605253|364532598|FG001|Overall Study|Lost to Follow-up|1|||
105690730|NCT02742766|364532599|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690731|NCT02742766|364532600|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690732|NCT02742766|364532601|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690733|NCT02742766|364532602|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690734|NCT02742766|364532603|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690735|NCT02742766|364532604|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690736|NCT02742766|364532605|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690737|NCT02742766|364532606|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690738|NCT02742766|364532607|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690739|NCT02742766|364532608|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690740|NCT02742766|364532609|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690741|NCT02742766|364532610|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690742|NCT02742766|364532611|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690743|NCT02742766|364532612|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
105690744|NCT02742766|364532613|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690745|NCT02742766|364532614|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690746|NCT02742766|364532615|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690747|NCT02742766|364532616|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690748|NCT02742766|364532617|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
105690749|NCT02742766|364532599|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690750|NCT02742766|364532600|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690751|NCT02742766|364532601|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690752|NCT02742766|364532602|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690753|NCT02742766|364532603|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690754|NCT02742766|364532604|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690755|NCT02742766|364532605|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
105786863|NCT05182840|364872937|FG008|Run-in Period|Adverse Event|0|||
105690756|NCT02742766|364532606|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690757|NCT02742766|364532607|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
105786864|NCT05182840|364872938|FG009|Run-in Period|Adverse Event|0|||
105690758|NCT02742766|364532608|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690759|NCT02742766|364532609|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690760|NCT02742766|364532610|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690761|NCT02742766|364532611|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
105690762|NCT02742766|364532612|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
105690763|NCT02742766|364532613|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690764|NCT02742766|364532614|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
105690765|NCT02742766|364532615|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690766|NCT02742766|364532616|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690767|NCT02742766|364532617|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
105690768|NCT04427501|364532618|FG000|Overall Study|Death|0|||
105690769|NCT04427501|364532619|FG001|Overall Study|Death|0|||
105690770|NCT04427501|364532620|FG002|Overall Study|Death|0|||
105690771|NCT04427501|364532621|FG003|Overall Study|Death|0|||
105690772|NCT04427501|364532622|FG004|Overall Study|Death|0|||
105690773|NCT04427501|364532623|FG005|Overall Study|Death|15|||
105690774|NCT04427501|364532624|FG006|Overall Study|Death|0|||
105690775|NCT04427501|364532625|FG007|Overall Study|Death|0|||
105690776|NCT04427501|364532626|FG008|Overall Study|Death|0|||
105690777|NCT04427501|364532627|FG009|Overall Study|Death|0|||
105690778|NCT04427501|364532628|FG010|Overall Study|Death|0|||
105690779|NCT04427501|364532629|FG011|Overall Study|Death|0|||
105690780|NCT04427501|364532618|FG000|Overall Study|Lost to Follow-up|5|||
105690781|NCT04427501|364532619|FG001|Overall Study|Lost to Follow-up|1|||
105690782|NCT04427501|364532620|FG002|Overall Study|Lost to Follow-up|2|||
105690783|NCT04427501|364532621|FG003|Overall Study|Lost to Follow-up|0|||
105690784|NCT04427501|364532622|FG004|Overall Study|Lost to Follow-up|2|||
105690785|NCT04427501|364532623|FG005|Overall Study|Lost to Follow-up|11|||
105690786|NCT04427501|364532624|FG006|Overall Study|Lost to Follow-up|10|||
105690787|NCT04427501|364532625|FG007|Overall Study|Lost to Follow-up|10|||
105690788|NCT04427501|364532626|FG008|Overall Study|Lost to Follow-up|2|||
105690789|NCT04427501|364532627|FG009|Overall Study|Lost to Follow-up|5|||
105690790|NCT04427501|364532628|FG010|Overall Study|Lost to Follow-up|2|||
105690791|NCT04427501|364532629|FG011|Overall Study|Lost to Follow-up|0|||
105690792|NCT04427501|364532618|FG000|Overall Study|Physician Decision|0|||
105690793|NCT04427501|364532619|FG001|Overall Study|Physician Decision|3|||
105690794|NCT04427501|364532620|FG002|Overall Study|Physician Decision|0|||
105690795|NCT04427501|364532621|FG003|Overall Study|Physician Decision|0|||
105690796|NCT04427501|364532622|FG004|Overall Study|Physician Decision|0|||
105690797|NCT04427501|364532623|FG005|Overall Study|Physician Decision|0|||
105690798|NCT04427501|364532624|FG006|Overall Study|Physician Decision|2|||
105690799|NCT04427501|364532625|FG007|Overall Study|Physician Decision|0|||
105919429|NCT01149655|365363586|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
105919430|NCT01149655|365363587|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
105919431|NCT01149655|365363584|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
105919432|NCT01149655|365363585|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
105919433|NCT01149655|365363586|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
105919434|NCT01149655|365363587|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
105919435|NCT01149655|365363584|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
105919436|NCT01149655|365363585|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
105919437|NCT01149655|365363586|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
105919438|NCT01149655|365363587|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
105919439|NCT01149655|365363584|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
105919440|NCT01149655|365363585|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
105919441|NCT01149655|365363586|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
105919442|NCT01149655|365363587|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
105919443|NCT01149655|365363584|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
105919444|NCT01149655|365363585|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
105919445|NCT01149655|365363586|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
105919446|NCT01149655|365363587|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
106130661|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
106130662|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
106130663|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
105690800|NCT04427501|364532626|FG008|Overall Study|Physician Decision|0|||
105690801|NCT04427501|364532627|FG009|Overall Study|Physician Decision|0|||
105690802|NCT04427501|364532628|FG010|Overall Study|Physician Decision|0|||
105690803|NCT04427501|364532629|FG011|Overall Study|Physician Decision|0|||
105690804|NCT04427501|364532618|FG000|Overall Study|Withdrawal by Subject|9|||
105690805|NCT04427501|364532619|FG001|Overall Study|Withdrawal by Subject|2|||
105690806|NCT04427501|364532620|FG002|Overall Study|Withdrawal by Subject|2|||
105690807|NCT04427501|364532621|FG003|Overall Study|Withdrawal by Subject|3|||
105919447|NCT01149655|365363584|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
106130664|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
105690808|NCT04427501|364532622|FG004|Overall Study|Withdrawal by Subject|7|||
105690809|NCT04427501|364532623|FG005|Overall Study|Withdrawal by Subject|25|||
105690810|NCT04427501|364532624|FG006|Overall Study|Withdrawal by Subject|15|||
105690811|NCT04427501|364532625|FG007|Overall Study|Withdrawal by Subject|7|||
105690812|NCT04427501|364532626|FG008|Overall Study|Withdrawal by Subject|4|||
105690813|NCT04427501|364532627|FG009|Overall Study|Withdrawal by Subject|1|||
105690814|NCT04427501|364532628|FG010|Overall Study|Withdrawal by Subject|4|||
105690815|NCT04427501|364532629|FG011|Overall Study|Withdrawal by Subject|0|||
105690816|NCT04427501|364532618|FG000|Overall Study|Other - as reported by the investigator|1|||
105690817|NCT04427501|364532619|FG001|Overall Study|Other - as reported by the investigator|0|||
105690818|NCT04427501|364532620|FG002|Overall Study|Other - as reported by the investigator|0|||
105690819|NCT04427501|364532621|FG003|Overall Study|Other - as reported by the investigator|0|||
105690820|NCT04427501|364532622|FG004|Overall Study|Other - as reported by the investigator|0|||
105690821|NCT04427501|364532623|FG005|Overall Study|Other - as reported by the investigator|6|||
105690822|NCT04427501|364532624|FG006|Overall Study|Other - as reported by the investigator|6|||
105690823|NCT04427501|364532625|FG007|Overall Study|Other - as reported by the investigator|0|||
105690824|NCT04427501|364532626|FG008|Overall Study|Other - as reported by the investigator|0|||
105690825|NCT04427501|364532627|FG009|Overall Study|Other - as reported by the investigator|0|||
105690826|NCT04427501|364532628|FG010|Overall Study|Other - as reported by the investigator|0|||
105690827|NCT04427501|364532629|FG011|Overall Study|Other - as reported by the investigator|0|||
105690828|NCT04427501|364532618|FG000|Overall Study|Other|0|||
105690829|NCT04427501|364532619|FG001|Overall Study|Other|0|||
105690830|NCT04427501|364532620|FG002|Overall Study|Other|0|||
105690831|NCT04427501|364532621|FG003|Overall Study|Other|0|||
105690832|NCT04427501|364532622|FG004|Overall Study|Other|0|||
105690833|NCT04427501|364532623|FG005|Overall Study|Other|0|||
105690834|NCT04427501|364532624|FG006|Overall Study|Other|0|||
105786865|NCT05182840|364872929|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
105786866|NCT05182840|364872930|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
105786867|NCT05182840|364872931|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786868|NCT05182840|364872932|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786869|NCT05182840|364872933|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786870|NCT05182840|364872934|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786871|NCT05182840|364872935|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786872|NCT05182840|364872936|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786873|NCT05182840|364872937|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105919448|NCT01149655|365363585|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
105690835|NCT04427501|364532625|FG007|Overall Study|Other|0|||
105690836|NCT04427501|364532626|FG008|Overall Study|Other|0|||
105690837|NCT04427501|364532627|FG009|Overall Study|Other|0|||
105690838|NCT04427501|364532628|FG010|Overall Study|Other|0|||
105690839|NCT04427501|364532629|FG011|Overall Study|Other|1|||
105690840|NCT00999713|364532630|FG000|Overall Study|Physician Decision|2|||
105690841|NCT00999713|364532631|FG001|Overall Study|Physician Decision|0|||
105690842|NCT01906346|364532634|FG000|Overall Study|AEs|1|||
105690843|NCT03431857|364532638|FG000|Overall Study|Death|6|||
105690844|NCT03431857|364532638|FG000|Overall Study|Lost to Follow-up|41|||
105690845|NCT03431857|364532638|FG000|Overall Study|Adverse Event|6|||
105690846|NCT03431857|364532638|FG000|Overall Study|Withdrawal by Subject|1|||
105690847|NCT01395316|364532639|FG000|Overall Study|Lost to Follow-up|2|||
105690848|NCT01395316|364532639|FG000|Overall Study|poor MRI quality|1|||
105690849|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
105690850|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
105690851|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
105690852|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
105690853|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
105690854|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
105919449|NCT01149655|365363586|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
105919450|NCT01149655|365363587|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
105919451|NCT01149655|365363584|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
105919452|NCT01149655|365363585|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
105690855|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
105690856|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
105690857|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
105690858|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
105690859|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
105690860|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
105690861|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
105690862|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
105690863|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
105690864|NCT01323621|364532640|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
105690865|NCT01323621|364532641|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
105690866|NCT01323621|364532642|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
105690867|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
105690868|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
105690869|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
105690870|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
105690871|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
105690872|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
105690873|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
105690874|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
105690875|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
105690876|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105690877|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105690878|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105690879|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
105690880|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
105690881|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
105690882|NCT01323621|364532640|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105690883|NCT01323621|364532641|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
105690884|NCT01323621|364532642|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
105690885|NCT03359590|364532645|FG000|First Intervention|Withdrawal by Subject|1|||
105690886|NCT03359590|364532646|FG001|First Intervention|Withdrawal by Subject|1|||
105690887|NCT03359590|364532645|FG000|First Intervention|Protocol Violation|0|||
105690888|NCT03359590|364532646|FG001|First Intervention|Protocol Violation|1|||
105690889|NCT04343248|364532652|FG000|Overall Study|Withdrawal by Subject|5|||
105690890|NCT04343248|364532653|FG001|Overall Study|Withdrawal by Subject|6|||
105690891|NCT04343248|364532652|FG000|Overall Study|Death|1|||
105690892|NCT04343248|364532653|FG001|Overall Study|Death|2|||
105690893|NCT04343248|364532652|FG000|Overall Study|Lost to Follow-up|9|||
105690894|NCT04343248|364532653|FG001|Overall Study|Lost to Follow-up|6|||
105690895|NCT04343248|364532652|FG000|Overall Study|Physician Decision|0|||
105690896|NCT04343248|364532653|FG001|Overall Study|Physician Decision|1|||
105690897|NCT04343248|364532652|FG000|Overall Study|Adverse Event|1|||
105690898|NCT04343248|364532653|FG001|Overall Study|Adverse Event|0|||
105690899|NCT02708095|364532654|FG000|Overall Study|Adverse Event|4|||
105690900|NCT02708095|364532655|FG001|Overall Study|Adverse Event|10|||
105690901|NCT02708095|364532656|FG002|Overall Study|Adverse Event|11|||
105690902|NCT02708095|364532654|FG000|Overall Study|Lack of Efficacy|9|||
105690903|NCT02708095|364532655|FG001|Overall Study|Lack of Efficacy|3|||
105690904|NCT02708095|364532656|FG002|Overall Study|Lack of Efficacy|0|||
105690905|NCT02708095|364532654|FG000|Overall Study|Lost to Follow-up|2|||
105690906|NCT02708095|364532655|FG001|Overall Study|Lost to Follow-up|0|||
105690907|NCT02708095|364532656|FG002|Overall Study|Lost to Follow-up|0|||
105690908|NCT02708095|364532654|FG000|Overall Study|Physician Decision|2|||
105690909|NCT02708095|364532655|FG001|Overall Study|Physician Decision|3|||
105690910|NCT02708095|364532656|FG002|Overall Study|Physician Decision|2|||
105690911|NCT02708095|364532654|FG000|Overall Study|Protocol Violation|0|||
105690912|NCT02708095|364532655|FG001|Overall Study|Protocol Violation|0|||
105690913|NCT02708095|364532656|FG002|Overall Study|Protocol Violation|1|||
105690914|NCT02708095|364532654|FG000|Overall Study|Withdrawal by Subject|5|||
105690915|NCT02708095|364532655|FG001|Overall Study|Withdrawal by Subject|3|||
105690916|NCT02708095|364532656|FG002|Overall Study|Withdrawal by Subject|4|||
105690917|NCT04598477|364532657|FG000|Overall Study|Adverse Event|2|||
105690918|NCT04598477|364532658|FG001|Overall Study|Adverse Event|0|||
105690919|NCT04598477|364532657|FG000|Overall Study|Death|0|||
105690920|NCT04598477|364532658|FG001|Overall Study|Death|1|||
105690921|NCT04598477|364532657|FG000|Overall Study|Lost to Follow-up|1|||
105690922|NCT04598477|364532658|FG001|Overall Study|Lost to Follow-up|0|||
105690923|NCT04598477|364532657|FG000|Overall Study|Physician Decision|7|||
105690924|NCT04598477|364532658|FG001|Overall Study|Physician Decision|2|||
105690925|NCT04598477|364532657|FG000|Overall Study|Pregnancy|0|||
105690926|NCT04598477|364532658|FG001|Overall Study|Pregnancy|1|||
105690927|NCT04598477|364532657|FG000|Overall Study|Requires Prohibited Medication|0|||
105690928|NCT04598477|364532658|FG001|Overall Study|Requires Prohibited Medication|1|||
105690929|NCT04598477|364532657|FG000|Overall Study|Study Terminated by Sponsor|18|||
105690930|NCT04598477|364532658|FG001|Overall Study|Study Terminated by Sponsor|12|||
105690931|NCT04598477|364532657|FG000|Overall Study|Withdrawal by Subject|16|||
105690932|NCT04598477|364532658|FG001|Overall Study|Withdrawal by Subject|12|||
105690933|NCT04598477|364532657|FG000|Overall Study|Other|15|||
105690934|NCT04598477|364532658|FG001|Overall Study|Other|8|||
105690935|NCT01313650|364532661|FG000|Overall Study|Adverse Event|9|||
105690936|NCT01313650|364532662|FG001|Overall Study|Adverse Event|34|||
105690937|NCT01313650|364532663|FG002|Overall Study|Adverse Event|24|||
105919453|NCT01149655|365363586|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
105690938|NCT01313650|364532664|FG003|Overall Study|Adverse Event|23|||
105690939|NCT01313650|364532661|FG000|Overall Study|Lack of Efficacy|37|||
105690940|NCT01313650|364532662|FG001|Overall Study|Lack of Efficacy|20|||
105690941|NCT01313650|364532663|FG002|Overall Study|Lack of Efficacy|32|||
105690942|NCT01313650|364532664|FG003|Overall Study|Lack of Efficacy|20|||
105690943|NCT01313650|364532661|FG000|Overall Study|Lost to Follow-up|1|||
105690944|NCT01313650|364532662|FG001|Overall Study|Lost to Follow-up|0|||
105690945|NCT01313650|364532663|FG002|Overall Study|Lost to Follow-up|3|||
105690946|NCT01313650|364532664|FG003|Overall Study|Lost to Follow-up|2|||
105690947|NCT01313650|364532661|FG000|Overall Study|Withdrawal by Subject|16|||
105690948|NCT01313650|364532662|FG001|Overall Study|Withdrawal by Subject|20|||
105690949|NCT01313650|364532663|FG002|Overall Study|Withdrawal by Subject|15|||
105690950|NCT01313650|364532664|FG003|Overall Study|Withdrawal by Subject|15|||
105690951|NCT01313650|364532661|FG000|Overall Study|Protocol Violation|4|||
105690952|NCT01313650|364532662|FG001|Overall Study|Protocol Violation|7|||
105690953|NCT01313650|364532663|FG002|Overall Study|Protocol Violation|5|||
105690954|NCT01313650|364532664|FG003|Overall Study|Protocol Violation|6|||
105690955|NCT01313650|364532661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
105690956|NCT01313650|364532662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
105690957|NCT01313650|364532663|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
105690958|NCT01313650|364532664|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
105690959|NCT00458341|364532665|FG000|Cycle 1|Adverse Event|1|||
105690960|NCT00458341|364532666|FG001|Cycle 1|Adverse Event|0|||
105690961|NCT00390910|364532669|FG000|Overall Study|Adverse Event|1|||
105690962|NCT00390910|364532670|FG001|Overall Study|Adverse Event|0|||
105690963|NCT00390910|364532671|FG002|Overall Study|Adverse Event|0|||
105690964|NCT00390910|364532669|FG000|Overall Study|Lost to Follow-up|0|||
105690965|NCT00390910|364532670|FG001|Overall Study|Lost to Follow-up|1|||
105690966|NCT00390910|364532671|FG002|Overall Study|Lost to Follow-up|5|||
105690967|NCT00390910|364532669|FG000|Overall Study|Withdrawal by Subject|1|||
105690968|NCT00390910|364532670|FG001|Overall Study|Withdrawal by Subject|3|||
105690969|NCT00390910|364532671|FG002|Overall Study|Withdrawal by Subject|2|||
105690970|NCT00390910|364532669|FG000|Overall Study|Migrated/moved from study area|0|||
105690971|NCT00390910|364532670|FG001|Overall Study|Migrated/moved from study area|0|||
105690972|NCT00390910|364532671|FG002|Overall Study|Migrated/moved from study area|3|||
105690973|NCT00835120|364532674|FG000|Overall Study|Lack of Efficacy|1|||
105690974|NCT00835120|364532674|FG000|Overall Study|Lost to Follow-up|3|||
105690975|NCT00835120|364532674|FG000|Overall Study|Adverse Event|2|||
105690976|NCT00835120|364532674|FG000|Overall Study|Withdrawal by Subject|2|||
105690977|NCT02499770|364532677|FG000|Overall Study|Death|17|||
105690978|NCT02499770|364532678|FG001|Overall Study|Death|56|||
105690979|NCT02499770|364532677|FG000|Overall Study|Study completion|1|||
105690980|NCT02499770|364532678|FG001|Overall Study|Study completion|10|||
105690981|NCT02499770|364532677|FG000|Overall Study|Withdrawal by Subject|0|||
105690982|NCT02499770|364532678|FG001|Overall Study|Withdrawal by Subject|7|||
105690983|NCT02499770|364532677|FG000|Overall Study|Lost to Follow-up|0|||
105690984|NCT02499770|364532678|FG001|Overall Study|Lost to Follow-up|2|||
105690985|NCT02499770|364532677|FG000|Overall Study|Subject declined further treatment|1|||
105690986|NCT02499770|364532678|FG001|Overall Study|Subject declined further treatment|0|||
105690987|NCT02499770|364532677|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
105690988|NCT02499770|364532678|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
105690989|NCT02499770|364532677|FG000|Overall Study|Randomized but not enrolled|0|||
105690990|NCT02499770|364532678|FG001|Overall Study|Randomized but not enrolled|1|||
105690991|NCT00232141|364532681|FG000|Overall Study|Adverse Event|9|||
105690992|NCT00232141|364532682|FG001|Overall Study|Adverse Event|4|||
105690993|NCT00232141|364532681|FG000|Overall Study|Lack of Efficacy|0|||
105690994|NCT00232141|364532682|FG001|Overall Study|Lack of Efficacy|3|||
105690995|NCT00232141|364532681|FG000|Overall Study|Lost to Follow-up|9|||
105690996|NCT00232141|364532682|FG001|Overall Study|Lost to Follow-up|6|||
105690997|NCT00232141|364532681|FG000|Overall Study|Other|8|||
105919454|NCT01149655|365363587|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
105919455|NCT01149655|365363584|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
105690998|NCT00232141|364532682|FG001|Overall Study|Other|10|||
105690999|NCT00232141|364532681|FG000|Overall Study|Withdrawal by Subject|5|||
105691000|NCT00232141|364532682|FG001|Overall Study|Withdrawal by Subject|3|||
105691001|NCT01298518|364532683|FG000|Overall Study|Withdrawal by Subject|0|||
105691002|NCT01298518|364532684|FG001|Overall Study|Withdrawal by Subject|0|||
106130665|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
106130666|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
106130667|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
105691003|NCT01298518|364532685|FG002|Overall Study|Withdrawal by Subject|1|||
105691004|NCT01019980|364532687|FG000|Overall Study|Drug not available.|2|||
105691005|NCT01019980|364532688|FG001|Overall Study|Drug not available.|0|||
105691006|NCT04275297|364532694|FG000|Overall Study|Lost to Follow-up|1|||
105691007|NCT04275297|364532695|FG001|Overall Study|Lost to Follow-up|1|||
105691008|NCT04824521|364532696|FG000|Overall Study|Lost to Follow-up|1|||
105691009|NCT01791803|364532697|FG000|Overall Study|Withdrawal by Subject|0|||
105691010|NCT01791803|364532698|FG001|Overall Study|Withdrawal by Subject|0|||
105691011|NCT01791803|364532699|FG002|Overall Study|Withdrawal by Subject|0|||
105691012|NCT01791803|364532700|FG003|Overall Study|Withdrawal by Subject|2|||
105691013|NCT01791803|364532697|FG000|Overall Study|Physician Decision|0|||
105691014|NCT01791803|364532698|FG001|Overall Study|Physician Decision|2|||
105691015|NCT01791803|364532699|FG002|Overall Study|Physician Decision|0|||
105691016|NCT01791803|364532700|FG003|Overall Study|Physician Decision|1|||
105691017|NCT01791803|364532697|FG000|Overall Study|Death|0|||
105691018|NCT01791803|364532698|FG001|Overall Study|Death|0|||
105691019|NCT01791803|364532699|FG002|Overall Study|Death|2|||
105691020|NCT01791803|364532700|FG003|Overall Study|Death|2|||
105691021|NCT03672461|364532702|FG000|Overall Study|COVID Related|4|||
105691022|NCT03672461|364532703|FG001|Overall Study|COVID Related|2|||
105691023|NCT03672461|364532702|FG000|Overall Study|Adverse Event|2|||
105691024|NCT03672461|364532703|FG001|Overall Study|Adverse Event|0|||
105691025|NCT03672461|364532702|FG000|Overall Study|Serious Adverse Event|0|||
105691026|NCT03672461|364532703|FG001|Overall Study|Serious Adverse Event|1|||
105691027|NCT03672461|364532702|FG000|Overall Study|Too Busy|3|||
105691028|NCT03672461|364532703|FG001|Overall Study|Too Busy|1|||
105691029|NCT03672461|364532702|FG000|Overall Study|Lost to Follow-up|1|||
105691030|NCT03672461|364532703|FG001|Overall Study|Lost to Follow-up|2|||
105691031|NCT03672461|364532702|FG000|Overall Study|Family|2|||
105691032|NCT03672461|364532703|FG001|Overall Study|Family|2|||
105691033|NCT03672461|364532702|FG000|Overall Study|No remote technology access|0|||
105691034|NCT03672461|364532703|FG001|Overall Study|No remote technology access|1|||
105691035|NCT03672461|364532702|FG000|Overall Study|Withdrawal by Subject|1|||
105691036|NCT03672461|364532703|FG001|Overall Study|Withdrawal by Subject|0|||
105691037|NCT03672461|364532702|FG000|Overall Study|Cannot tolerate intervention|1|||
105691038|NCT03672461|364532703|FG001|Overall Study|Cannot tolerate intervention|0|||
105691039|NCT03672461|364532702|FG000|Overall Study|Incomplete outcome data|6|||
105691040|NCT03672461|364532703|FG001|Overall Study|Incomplete outcome data|1|||
105691041|NCT03144804|364532704|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
105691042|NCT05514873|364532705|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
105691043|NCT05514873|364532705|FG000|Main Treatment Period|Adverse Event|2|||
105691044|NCT05514873|364532705|FG000|Extension Treatment Period|Lost to Follow-up|3|||
105919456|NCT01149655|365363585|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
105919457|NCT01149655|365363586|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
105919458|NCT01149655|365363587|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
105919459|NCT01265498|365363590|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
105691045|NCT04751656|364534724|FG000|Overall Study|Lost to Follow-up|1|||
105691046|NCT01306890|364534725|FG000|Overall Study|Adverse Event|2|||
105691047|NCT01306890|364534725|FG000|Overall Study|Death|1223|||
105691048|NCT01306890|364534725|FG000|Overall Study|Lost to Follow-up|58|||
105691049|NCT01306890|364534725|FG000|Overall Study|Withdrawal by Subject|88|||
105691050|NCT01306890|364534725|FG000|Overall Study|Unspecified reasons|104|||
105691051|NCT01306890|364534725|FG000|Overall Study|Study Termination|3|||
105691052|NCT01306890|364534725|FG000|Overall Study|No discontinuation documentation|41|||
105691053|NCT01955122|364534730|FG000|Overall Study|Physician Decision|5|||
105691054|NCT01955122|364534731|FG001|Overall Study|Physician Decision|5|||
105691055|NCT00826111|364534735|FG000|Overall Study|Lost to Follow-up|0|||
105691056|NCT00826111|364534736|FG001|Overall Study|Lost to Follow-up|1|||
105691057|NCT00826111|364534735|FG000|Overall Study|Protocol Violation|1|||
105691058|NCT00826111|364534736|FG001|Overall Study|Protocol Violation|0|||
105691059|NCT00826111|364534735|FG000|Overall Study|Withdrawal by Subject|5|||
105691060|NCT00826111|364534736|FG001|Overall Study|Withdrawal by Subject|0|||
105691061|NCT00826111|364534735|FG000|Overall Study|Physician Decision|1|||
105691062|NCT00826111|364534736|FG001|Overall Study|Physician Decision|1|||
105691063|NCT00440700|364534739|FG000|Overall Study|Withdrawal by Subject|8|||
105691064|NCT00440700|364534740|FG001|Overall Study|Withdrawal by Subject|8|||
105691065|NCT00440700|364534741|FG002|Overall Study|Withdrawal by Subject|4|||
105691066|NCT01990534|364534742|FG000|Overall Study|Death|22|||
105691067|NCT01990534|364534742|FG000|Overall Study|Progressive disease|3|||
105691068|NCT01990534|364534742|FG000|Overall Study|Protocol Violation|1|||
105919460|NCT01265498|365363591|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
105691069|NCT01990534|364534742|FG000|Overall Study|Withdrawal of Informed Consent|2|||
105691070|NCT01990534|364534742|FG000|Overall Study|Symptomatic Deterioration|1|||
105919461|NCT01093846|365363593|FG000|Overall Study|Adverse Event|0|||
105691071|NCT01990534|364534742|FG000|Overall Study|Withdrawal by Subject|3|||
105691072|NCT01990534|364534742|FG000|Overall Study|Reason not Specified|2|||
105691073|NCT01990534|364534742|FG000|Overall Study|Lost to Follow-up|1|||
105691074|NCT00907257|364534743|FG000|Overall Study|Adverse Event|0|||
105691075|NCT00907257|364534744|FG001|Overall Study|Adverse Event|4|||
105691076|NCT00907257|364534743|FG000|Overall Study|Protocol Violation|1|||
105919462|NCT01093846|365363594|FG001|Overall Study|Adverse Event|0|||
105691077|NCT00907257|364534744|FG001|Overall Study|Protocol Violation|2|||
105691078|NCT00907257|364534743|FG000|Overall Study|Lost to Follow-up|3|||
105691079|NCT00907257|364534744|FG001|Overall Study|Lost to Follow-up|3|||
105691080|NCT00907257|364534743|FG000|Overall Study|Withdrawal by Subject|1|||
105691081|NCT00907257|364534744|FG001|Overall Study|Withdrawal by Subject|2|||
105691082|NCT00907257|364534743|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
105691083|NCT00907257|364534744|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
105691084|NCT00907257|364534743|FG000|Overall Study|Moved|1|||
105691085|NCT00907257|364534744|FG001|Overall Study|Moved|0|||
105691086|NCT00907257|364534743|FG000|Overall Study|Personal Reasons|6|||
105691087|NCT00907257|364534744|FG001|Overall Study|Personal Reasons|1|||
105691088|NCT00937833|364534748|FG000|Overall Study|Protocol Violation|1|||
105691089|NCT00937833|364534749|FG001|Overall Study|Protocol Violation|2|||
105691090|NCT00937833|364534748|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
105691091|NCT00937833|364534749|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
105691092|NCT00937833|364534748|FG000|Overall Study|Lost to Follow-up|10|||
105691093|NCT00937833|364534749|FG001|Overall Study|Lost to Follow-up|8|||
105691094|NCT00937833|364534748|FG000|Overall Study|Withdrawal by Subject|4|||
105691095|NCT00937833|364534749|FG001|Overall Study|Withdrawal by Subject|6|||
105691096|NCT02366728|364534751|FG000|Overall Study|Death|0|||
105691097|NCT02366728|364534752|FG001|Overall Study|Death|0|||
105691098|NCT02366728|364534753|FG002|Overall Study|Death|1|||
105691099|NCT02366728|364534751|FG000|Overall Study|Adverse Event|1|||
105691100|NCT02366728|364534752|FG001|Overall Study|Adverse Event|0|||
105691101|NCT02366728|364534753|FG002|Overall Study|Adverse Event|0|||
105691102|NCT02366728|364534751|FG000|Overall Study|Screen Failure|2|||
105691103|NCT02366728|364534752|FG001|Overall Study|Screen Failure|1|||
105691104|NCT02366728|364534753|FG002|Overall Study|Screen Failure|0|||
105691105|NCT02366728|364534751|FG000|Overall Study|Only yielded 2 vaccines|1|||
105691106|NCT02366728|364534752|FG001|Overall Study|Only yielded 2 vaccines|0|||
105691107|NCT02366728|364534753|FG002|Overall Study|Only yielded 2 vaccines|0|||
105691108|NCT01376349|364534754|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
105691109|NCT01376349|364534755|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
105691110|NCT01376349|364534756|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
105691111|NCT01376349|364534754|FG000|Raondomized Treatment|Adverse Event|13|||
105691112|NCT01376349|364534755|FG001|Raondomized Treatment|Adverse Event|17|||
105691113|NCT01376349|364534756|FG002|Raondomized Treatment|Adverse Event|14|||
105691114|NCT01376349|364534754|FG000|Raondomized Treatment|Unkown|1|||
105691115|NCT01376349|364534755|FG001|Raondomized Treatment|Unkown|2|||
105691116|NCT01376349|364534756|FG002|Raondomized Treatment|Unkown|1|||
105691117|NCT01376349|364534754|FG000|Raondomized Treatment|Alternative Treatment|0|||
105691118|NCT01376349|364534755|FG001|Raondomized Treatment|Alternative Treatment|0|||
105691119|NCT01376349|364534756|FG002|Raondomized Treatment|Alternative Treatment|1|||
105691120|NCT03155373|364534759|FG000|Overall Study|No longer required surgery|1|||
105691121|NCT03155373|364534759|FG000|Overall Study|Protocol Violation|1|||
105691122|NCT03155373|364534759|FG000|Overall Study|Death|2|||
105691123|NCT03155373|364534759|FG000|Overall Study|Withdrawal by Subject|3|||
105691124|NCT03836807|364534763|FG000|Overall Study|Physician Decision|1|||
105691125|NCT03836807|364534764|FG001|Overall Study|Physician Decision|0|||
105691126|NCT00639223|364534765|FG000|Overall Study|Lost to Follow-up|0|||
105691127|NCT00639223|364534766|FG001|Overall Study|Lost to Follow-up|2|||
105691128|NCT00651157|364534767|FG000|Overall Study|Death|1|||
105691129|NCT00651157|364534767|FG000|Overall Study|Protocol Violation|1|||
105691130|NCT04226833|364534768|FG000|Overall Study|Death|0|||
105691131|NCT04226833|364534769|FG001|Overall Study|Death|0|||
105691132|NCT04226833|364534770|FG002|Overall Study|Death|1|||
105691133|NCT04226833|364534771|FG003|Overall Study|Death|0|||
105691134|NCT02876835|364534774|FG000|Treatment Period (51.1 Month)|Other|1|||
105691135|NCT02876835|364534775|FG001|Treatment Period (51.1 Month)|Other|0|||
105691136|NCT02876835|364534774|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
105691137|NCT02876835|364534775|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
105691138|NCT02876835|364534774|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
105691139|NCT02876835|364534775|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
105691140|NCT02876835|364534774|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
105691141|NCT02876835|364534775|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
105691142|NCT02374021|364534778|FG000|Overall Study|Adverse Event|1|||
105691143|NCT02374021|364534779|FG001|Overall Study|Adverse Event|0|||
105691144|NCT02374021|364534778|FG000|Overall Study|Lost to Follow-up|3|||
105691145|NCT02374021|364534779|FG001|Overall Study|Lost to Follow-up|2|||
105691146|NCT02374021|364534778|FG000|Overall Study|Physician Decision|0|||
105691147|NCT02374021|364534779|FG001|Overall Study|Physician Decision|3|||
105691148|NCT02374021|364534778|FG000|Overall Study|Withdrawal by Subject|6|||
105691149|NCT02374021|364534779|FG001|Overall Study|Withdrawal by Subject|5|||
105691150|NCT02374021|364534778|FG000|Overall Study|Poor Adherence|0|||
105691151|NCT02374021|364534779|FG001|Overall Study|Poor Adherence|1|||
105691152|NCT02374021|364534778|FG000|Overall Study|Scan protocol not followed|0|||
105691153|NCT02374021|364534779|FG001|Overall Study|Scan protocol not followed|1|||
105691154|NCT02374021|364534778|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
105691155|NCT02374021|364534779|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
105691156|NCT04029961|364534783|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
105691157|NCT04029961|364534784|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
105691158|NCT04029961|364534783|FG000|Overall Study|Change in Treatment Course|0|||
105691159|NCT04029961|364534784|FG001|Overall Study|Change in Treatment Course|1|||
105691160|NCT00403754|364534785|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
105691161|NCT00403754|364534786|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
105691162|NCT00403754|364534787|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
105691163|NCT00403754|364534788|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
105691164|NCT00403754|364534785|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
105691165|NCT00403754|364534786|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
105691166|NCT00403754|364534787|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
105691167|NCT00403754|364534788|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
105691168|NCT02000427|364534791|FG000|Overall Study|Death|22|||
105691169|NCT02846532|364534794|FG000|Overall Study|Lost to Follow-up|0|||
105691170|NCT02846532|364534795|FG001|Overall Study|Lost to Follow-up|1|||
105691171|NCT02846532|364534796|FG002|Overall Study|Lost to Follow-up|1|||
105691172|NCT02846532|364534794|FG000|Overall Study|Withdrawal by Subject|1|||
105691173|NCT02846532|364534795|FG001|Overall Study|Withdrawal by Subject|2|||
105691174|NCT02846532|364534796|FG002|Overall Study|Withdrawal by Subject|0|||
105691175|NCT04540133|364534797|FG000|Overall Study|Lost to Follow-up|1|||
105691176|NCT04540133|364534798|FG001|Overall Study|Lost to Follow-up|0|||
105691177|NCT04252287|364534799|FG000|Overall Study|Death|5|||
105691178|NCT04252287|364534800|FG001|Overall Study|Death|3|||
105691179|NCT04252287|364534799|FG000|Overall Study|Lost to Follow-up|4|||
105691180|NCT04252287|364534800|FG001|Overall Study|Lost to Follow-up|6|||
105691181|NCT04252287|364534799|FG000|Overall Study|Withdrawal by Subject|19|||
105691182|NCT04252287|364534800|FG001|Overall Study|Withdrawal by Subject|16|||
105691183|NCT04252287|364534799|FG000|Overall Study|Protocol Violation|3|||
105691184|NCT04252287|364534800|FG001|Overall Study|Protocol Violation|4|||
105691185|NCT03891524|364534801|FG000|Overall Study|Death|0|||
105691186|NCT03891524|364534802|FG001|Overall Study|Death|0|||
105691187|NCT03891524|364534803|FG002|Overall Study|Death|0|||
105691188|NCT03891524|364534804|FG003|Overall Study|Death|0|||
105691189|NCT03891524|364534805|FG004|Overall Study|Death|0|||
105691190|NCT03891524|364534806|FG005|Overall Study|Death|0|||
105691191|NCT03891524|364534807|FG006|Overall Study|Death|0|||
105691192|NCT03891524|364534808|FG007|Overall Study|Death|1|||
105691193|NCT03891524|364534801|FG000|Overall Study|Withdrawal by Subject|0|||
105691194|NCT03891524|364534802|FG001|Overall Study|Withdrawal by Subject|1|||
105691195|NCT03891524|364534803|FG002|Overall Study|Withdrawal by Subject|2|||
105691196|NCT03891524|364534804|FG003|Overall Study|Withdrawal by Subject|1|||
105691197|NCT03891524|364534805|FG004|Overall Study|Withdrawal by Subject|2|||
105691198|NCT03891524|364534806|FG005|Overall Study|Withdrawal by Subject|2|||
105691199|NCT03891524|364534807|FG006|Overall Study|Withdrawal by Subject|2|||
105691200|NCT03891524|364534808|FG007|Overall Study|Withdrawal by Subject|1|||
105691201|NCT02273726|364534809|FG000|Overall Study|Death|70|||
105691202|NCT02273726|364534810|FG001|Overall Study|Death|62|||
105691203|NCT02273726|364534809|FG000|Overall Study|Withdrawal by Subject|41|||
105691204|NCT02273726|364534810|FG001|Overall Study|Withdrawal by Subject|29|||
105691205|NCT02273726|364534809|FG000|Overall Study|Kidney transplant|31|||
105691206|NCT02273726|364534810|FG001|Overall Study|Kidney transplant|39|||
105691207|NCT02273726|364534809|FG000|Overall Study|Physician Decision|30|||
105691208|NCT02273726|364534810|FG001|Overall Study|Physician Decision|15|||
105691209|NCT02273726|364534809|FG000|Overall Study|Adverse Event|27|||
105691210|NCT02273726|364534810|FG001|Overall Study|Adverse Event|9|||
105691211|NCT02273726|364534809|FG000|Overall Study|Lost to Follow-up|6|||
105691212|NCT02273726|364534810|FG001|Overall Study|Lost to Follow-up|3|||
105691213|NCT02273726|364534809|FG000|Overall Study|Lack of Efficacy|6|||
105691214|NCT02273726|364534810|FG001|Overall Study|Lack of Efficacy|1|||
105691215|NCT02273726|364534809|FG000|Overall Study|Protocol Violation|4|||
105691216|NCT02273726|364534810|FG001|Overall Study|Protocol Violation|0|||
105691217|NCT02273726|364534809|FG000|Overall Study|Other than specified|28|||
105691218|NCT02273726|364534810|FG001|Overall Study|Other than specified|30|||
105691219|NCT03610165|364534811|FG000|Overall Study|Device didn't work|0|||
105691220|NCT03610165|364534812|FG001|Overall Study|Device didn't work|1|||
105691221|NCT02129205|364534813|FG000|Overall Study|Withdrawal by Subject|0|||
105691222|NCT02129205|364534814|FG001|Overall Study|Withdrawal by Subject|0|||
105691223|NCT02129205|364534815|FG002|Overall Study|Withdrawal by Subject|0|||
105691224|NCT02129205|364534816|FG003|Overall Study|Withdrawal by Subject|0|||
105691225|NCT02129205|364534817|FG004|Overall Study|Withdrawal by Subject|1|||
105691226|NCT02129205|364534818|FG005|Overall Study|Withdrawal by Subject|1|||
105691227|NCT02129205|364534819|FG006|Overall Study|Withdrawal by Subject|1|||
105691228|NCT02129205|364534820|FG007|Overall Study|Withdrawal by Subject|0|||
105691229|NCT02129205|364534821|FG008|Overall Study|Withdrawal by Subject|1|||
105691230|NCT02129205|364534822|FG009|Overall Study|Withdrawal by Subject|0|||
105691231|NCT02129205|364534813|FG000|Overall Study|Other|1|||
105691232|NCT02129205|364534814|FG001|Overall Study|Other|0|||
105691233|NCT02129205|364534815|FG002|Overall Study|Other|0|||
105691234|NCT02129205|364534816|FG003|Overall Study|Other|0|||
105691235|NCT02129205|364534817|FG004|Overall Study|Other|2|||
105691236|NCT02129205|364534818|FG005|Overall Study|Other|3|||
105691237|NCT02129205|364534819|FG006|Overall Study|Other|3|||
105691238|NCT02129205|364534820|FG007|Overall Study|Other|2|||
105691239|NCT02129205|364534821|FG008|Overall Study|Other|1|||
105691240|NCT02129205|364534822|FG009|Overall Study|Other|0|||
105691241|NCT00671554|364534823|FG000|Overall Study|Disease progression|3|||
105691242|NCT01479829|364534824|FG000|Overall Study|Withdrawal by Subject|8|||
105691243|NCT01479829|364534825|FG001|Overall Study|Withdrawal by Subject|10|||
105691244|NCT02877927|364534826|FG000|Overall Study|Adverse Event|1|||
105691245|NCT02877927|364534827|FG001|Overall Study|Adverse Event|0|||
105691246|NCT02877927|364534826|FG000|Overall Study|Lost to Follow-up|37|||
105691247|NCT02877927|364534827|FG001|Overall Study|Lost to Follow-up|38|||
105691248|NCT02877927|364534826|FG000|Overall Study|Withdrawal by Subject|11|||
105691249|NCT02877927|364534827|FG001|Overall Study|Withdrawal by Subject|12|||
105691250|NCT02877927|364534826|FG000|Overall Study|Physician Decision|0|||
105691251|NCT02877927|364534827|FG001|Overall Study|Physician Decision|1|||
105691252|NCT02877927|364534826|FG000|Overall Study|Missed EOT/PTE Visit|5|||
105691253|NCT02877927|364534827|FG001|Overall Study|Missed EOT/PTE Visit|6|||
105691254|NCT00601250|364534828|FG000|Overall Study|Adverse Event|3|||
105691255|NCT00601250|364534829|FG001|Overall Study|Adverse Event|9|||
105691256|NCT00601250|364534828|FG000|Overall Study|Protocol Violation|3|||
105691257|NCT00601250|364534829|FG001|Overall Study|Protocol Violation|2|||
105691258|NCT00601250|364534828|FG000|Overall Study|Lost to Follow-up|2|||
105691259|NCT00601250|364534829|FG001|Overall Study|Lost to Follow-up|6|||
105691260|NCT00601250|364534828|FG000|Overall Study|Withdrawal by Subject|4|||
105691261|NCT00601250|364534829|FG001|Overall Study|Withdrawal by Subject|13|||
105691262|NCT00601250|364534828|FG000|Overall Study|Other incl. lack of efficacy|2|||
105691263|NCT00601250|364534829|FG001|Overall Study|Other incl. lack of efficacy|9|||
105691264|NCT01810016|364534830|FG000|Overall Study|Progressive disease|1|||
105691265|NCT01810016|364534831|FG001|Overall Study|Progressive disease|1|||
105691266|NCT01810016|364534832|FG002|Overall Study|Progressive disease|0|||
105691267|NCT01810016|364534830|FG000|Overall Study|Death|0|||
105691268|NCT01810016|364534831|FG001|Overall Study|Death|0|||
105691269|NCT01810016|364534832|FG002|Overall Study|Death|1|||
105691270|NCT03231943|364534833|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691271|NCT03231943|364534834|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
105691272|NCT03231943|364534835|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
105691273|NCT03231943|364534836|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691274|NCT03231943|364534837|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691275|NCT03231943|364534838|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691276|NCT03231943|364534839|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691277|NCT03231943|364534840|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691278|NCT03231943|364534841|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691279|NCT03231943|364534842|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691280|NCT03231943|364534843|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691281|NCT03231943|364534844|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691282|NCT03231943|364534845|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
105691283|NCT03231943|364534833|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691284|NCT03231943|364534834|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
105691285|NCT03231943|364534835|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691286|NCT03231943|364534836|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691287|NCT03231943|364534837|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691288|NCT03231943|364534838|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691289|NCT03231943|364534839|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691290|NCT03231943|364534840|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691291|NCT03231943|364534841|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691292|NCT03231943|364534842|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691293|NCT03231943|364534843|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691294|NCT03231943|364534844|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691295|NCT03231943|364534845|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
105691296|NCT03231943|364534833|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
105691297|NCT03231943|364534834|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691298|NCT03231943|364534835|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691299|NCT03231943|364534836|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691300|NCT03231943|364534837|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691301|NCT03231943|364534838|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691302|NCT03231943|364534839|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691303|NCT03231943|364534840|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691304|NCT03231943|364534841|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691305|NCT03231943|364534842|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691306|NCT03231943|364534843|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691307|NCT03231943|364534844|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691308|NCT03231943|364534845|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
105691309|NCT03231943|364534833|FG000|Part 2|Adverse Event|0|||
105691310|NCT03231943|364534834|FG001|Part 2|Adverse Event|0|||
105691311|NCT03231943|364534835|FG002|Part 2|Adverse Event|0|||
105691312|NCT03231943|364534836|FG003|Part 2|Adverse Event|0|||
105691313|NCT03231943|364534837|FG004|Part 2|Adverse Event|0|||
105691314|NCT03231943|364534838|FG005|Part 2|Adverse Event|0|||
105691315|NCT03231943|364534839|FG006|Part 2|Adverse Event|0|||
105691316|NCT03231943|364534840|FG007|Part 2|Adverse Event|0|||
105691317|NCT03231943|364534841|FG008|Part 2|Adverse Event|0|||
105691318|NCT03231943|364534842|FG009|Part 2|Adverse Event|0|||
105691319|NCT03231943|364534843|FG010|Part 2|Adverse Event|1|||
105786874|NCT05182840|364872938|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
105786875|NCT05182840|364872929|FG000|Treatment Period|Reason missing|0|||
105786876|NCT05182840|364872930|FG001|Treatment Period|Reason missing|0|||
105786877|NCT05182840|364872931|FG002|Treatment Period|Reason missing|1|||
105786878|NCT05182840|364872932|FG003|Treatment Period|Reason missing|0|||
105691320|NCT03231943|364534844|FG011|Part 2|Adverse Event|0|||
105691321|NCT03231943|364534845|FG012|Part 2|Adverse Event|0|||
105691322|NCT03231943|364534833|FG000|Part 2|Withdrawal by Subject|0|||
105691323|NCT03231943|364534834|FG001|Part 2|Withdrawal by Subject|0|||
105691324|NCT03231943|364534835|FG002|Part 2|Withdrawal by Subject|0|||
105691325|NCT03231943|364534836|FG003|Part 2|Withdrawal by Subject|0|||
105691326|NCT03231943|364534837|FG004|Part 2|Withdrawal by Subject|0|||
105691327|NCT03231943|364534838|FG005|Part 2|Withdrawal by Subject|0|||
105691328|NCT03231943|364534839|FG006|Part 2|Withdrawal by Subject|0|||
105691329|NCT03231943|364534840|FG007|Part 2|Withdrawal by Subject|0|||
105691330|NCT03231943|364534841|FG008|Part 2|Withdrawal by Subject|0|||
105691331|NCT03231943|364534842|FG009|Part 2|Withdrawal by Subject|0|||
105786879|NCT05182840|364872933|FG004|Treatment Period|Reason missing|0|||
105786880|NCT05182840|364872934|FG005|Treatment Period|Reason missing|0|||
105786881|NCT05182840|364872935|FG006|Treatment Period|Reason missing|0|||
105691332|NCT03231943|364534843|FG010|Part 2|Withdrawal by Subject|0|||
105691333|NCT03231943|364534844|FG011|Part 2|Withdrawal by Subject|1|||
105691334|NCT03231943|364534845|FG012|Part 2|Withdrawal by Subject|0|||
105691335|NCT00708175|364534846|FG000|Overall Study|Adverse Event|4|||
105691336|NCT00708175|364534847|FG001|Overall Study|Adverse Event|5|||
105691337|NCT00708175|364534846|FG000|Overall Study|Protocol Violation|2|||
105691338|NCT00708175|364534847|FG001|Overall Study|Protocol Violation|3|||
105691339|NCT00708175|364534846|FG000|Overall Study|Lost to Follow-up|5|||
105691340|NCT00708175|364534847|FG001|Overall Study|Lost to Follow-up|3|||
105691341|NCT00708175|364534846|FG000|Overall Study|Withdrawal by Subject|5|||
105691342|NCT00708175|364534847|FG001|Overall Study|Withdrawal by Subject|7|||
105691343|NCT00708175|364534846|FG000|Overall Study|BMD loss >7%|2|||
105691344|NCT00708175|364534847|FG001|Overall Study|BMD loss >7%|3|||
105691345|NCT02038920|364534855|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
105691346|NCT02038920|364534856|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
105691347|NCT02038920|364534857|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
105691348|NCT02038920|364534858|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
105691349|NCT02038920|364534859|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
105691350|NCT02038920|364534860|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
105691351|NCT02038920|364534855|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
105691352|NCT02038920|364534856|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691353|NCT02038920|364534857|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691354|NCT02038920|364534858|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691355|NCT02038920|364534859|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691356|NCT02038920|364534860|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
105691357|NCT02038920|364534855|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
105691358|NCT02038920|364534856|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
105691359|NCT02038920|364534857|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
105691360|NCT02038920|364534858|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
105691361|NCT02038920|364534859|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
105786882|NCT05182840|364872936|FG007|Treatment Period|Reason missing|0|||
105786883|NCT05182840|364872937|FG008|Treatment Period|Reason missing|0|||
105919463|NCT01093846|365363595|FG002|Overall Study|Adverse Event|1|||
105919464|NCT01093846|365363593|FG000|Overall Study|Lack of Efficacy|0|||
106130668|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
106130669|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
106130670|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
105691362|NCT02038920|364534860|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
105919465|NCT01093846|365363594|FG001|Overall Study|Lack of Efficacy|0|||
106130671|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
105691363|NCT02038920|364534855|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
105691364|NCT02038920|364534856|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
105786884|NCT05182840|364872938|FG009|Treatment Period|Reason missing|0|||
105786885|NCT05182840|364872929|FG000|Treatment Period|Other but not sponsor termination|0|||
105919466|NCT01093846|365363595|FG002|Overall Study|Lack of Efficacy|4|||
105691365|NCT02038920|364534857|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
105691366|NCT02038920|364534858|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
105691367|NCT02038920|364534859|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
105691368|NCT02038920|364534860|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
105691369|NCT02038920|364534855|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691370|NCT02038920|364534856|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691371|NCT02038920|364534857|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
105691372|NCT02038920|364534858|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691373|NCT02038920|364534859|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691374|NCT02038920|364534860|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
105691375|NCT02038920|364534855|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
105691376|NCT02038920|364534856|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
105691377|NCT02038920|364534857|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
105691378|NCT02038920|364534858|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
105691379|NCT02038920|364534859|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
105691380|NCT02038920|364534860|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
105691381|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691382|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691383|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691384|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691385|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
105691386|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
105691387|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691388|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691389|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691390|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691391|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
105691392|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
105691393|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691394|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691395|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691396|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691397|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
105691398|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
105691399|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691400|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691401|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691402|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691403|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
105691404|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
105691405|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691406|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691407|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691408|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691409|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
105691410|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
105691411|NCT02038920|364534855|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691412|NCT02038920|364534856|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691413|NCT02038920|364534857|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691414|NCT02038920|364534858|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691415|NCT02038920|364534859|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
105691416|NCT02038920|364534860|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
105691417|NCT00047320|364534863|FG000|Overall Study|Lack of Efficacy|8|||
105691418|NCT00047320|364534863|FG000|Overall Study|Lost to Follow-up|1|||
105691419|NCT00047320|364534863|FG000|Overall Study|Physician Decision|8|||
105691420|NCT00047320|364534863|FG000|Overall Study|Withdrawal by Subject|9|||
105691421|NCT00047320|364534863|FG000|Overall Study|Ineligible|2|||
105691422|NCT02383589|364534864|FG000|Treatment Period|Adverse Event|1|||
105691423|NCT02383589|364534865|FG001|Treatment Period|Adverse Event|3|||
105691424|NCT02383589|364534864|FG000|Treatment Period|Lost to Follow-up|0|||
106002823|NCT00683878|365672515|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
105691425|NCT02383589|364534865|FG001|Treatment Period|Lost to Follow-up|1|||
105691426|NCT02383589|364534864|FG000|Treatment Period|Withdrawal by Subject|0|||
105691427|NCT02383589|364534865|FG001|Treatment Period|Withdrawal by Subject|5|||
105691428|NCT02383589|364534864|FG000|Treatment Period|Non-compliance with study drug|0|||
105691429|NCT02383589|364534865|FG001|Treatment Period|Non-compliance with study drug|1|||
105691430|NCT02383589|364534864|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
105691431|NCT02383589|364534865|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
105691432|NCT02383589|364534864|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
105691433|NCT02383589|364534865|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
105691434|NCT02383589|364534864|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
105691435|NCT02383589|364534865|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
105691436|NCT00866697|364534867|FG000|Overall Study|Study closed/terminated|156|||
105691437|NCT00866697|364534868|FG001|Overall Study|Study closed/terminated|138|||
105691438|NCT00866697|364534867|FG000|Overall Study|Lost to Follow-up|22|||
105691439|NCT00866697|364534868|FG001|Overall Study|Lost to Follow-up|28|||
105691440|NCT00866697|364534867|FG000|Overall Study|Physician Decision|3|||
105691441|NCT00866697|364534868|FG001|Overall Study|Physician Decision|5|||
105691442|NCT00866697|364534867|FG000|Overall Study|Withdrawal by Subject|33|||
105691443|NCT00866697|364534868|FG001|Overall Study|Withdrawal by Subject|57|||
105691444|NCT01572922|364534871|FG000|Overall Study|Adverse Event|1|||
105691445|NCT01572922|364534871|FG000|Overall Study|Protocol Violation|1|||
105691446|NCT01572922|364534871|FG000|Overall Study|Death|1|||
105691447|NCT03040622|364534872|FG000|Overall Study|unable to implant device|3|||
105691448|NCT02906787|364534873|FG000|Overall Study|Withdrawal by Subject|12|||
105691449|NCT02906787|364534874|FG001|Overall Study|Withdrawal by Subject|10|||
105691450|NCT02906787|364534873|FG000|Overall Study|Missed|24|||
105691451|NCT02906787|364534874|FG001|Overall Study|Missed|22|||
105691452|NCT04376060|364534875|FG000|Overall Study|Physician Decision|1|||
105691453|NCT01335009|364534876|FG000|Overall Study|Too ill to travel to study sites|1|||
105691454|NCT01335009|364534877|FG001|Overall Study|Too ill to travel to study sites|0|||
105691455|NCT01335009|364534876|FG000|Overall Study|Death|28|||
105691456|NCT01335009|364534877|FG001|Overall Study|Death|32|||
105691457|NCT01335009|364534876|FG000|Overall Study|Withdrawal by Subject|1|||
105691458|NCT01335009|364534877|FG001|Overall Study|Withdrawal by Subject|1|||
105691459|NCT01335009|364534876|FG000|Overall Study|Lost to Follow-up|1|||
105691460|NCT01335009|364534877|FG001|Overall Study|Lost to Follow-up|0|||
105691461|NCT02818920|364534878|FG000|Overall Study|Unresectable|4|||
105691462|NCT02818920|364534878|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
105691463|NCT02818920|364534878|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
105691464|NCT02818920|364534878|FG000|Overall Study|Adverse Event|3|||
105691465|NCT02818920|364534878|FG000|Overall Study|Developed Other Disease|1|||
105691466|NCT02818920|364534878|FG000|Overall Study|Refused Further Treatment|1|||
105691467|NCT00445068|364534879|FG000|Overall Study|Disease progression|26|||
105691468|NCT00445068|364534879|FG000|Overall Study|Adverse Event|5|||
105691469|NCT00445068|364534879|FG000|Overall Study|Abnormal laboratory value|2|||
105691470|NCT00445068|364534879|FG000|Overall Study|Withdrawal by Subject|2|||
105691471|NCT00445068|364534879|FG000|Overall Study|Death|1|||
105691472|NCT02462928|364536280|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
105691473|NCT02462928|364536281|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
105691474|NCT02462928|364536282|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
105691475|NCT02462928|364536280|FG000|Overall Study|Adverse Event|47|||
105691476|NCT02462928|364536281|FG001|Overall Study|Adverse Event|51|||
105691477|NCT02462928|364536282|FG002|Overall Study|Adverse Event|25|||
105691478|NCT02462928|364536280|FG000|Overall Study|Lack of Efficacy|3|||
105691479|NCT02462928|364536281|FG001|Overall Study|Lack of Efficacy|8|||
105691480|NCT02462928|364536282|FG002|Overall Study|Lack of Efficacy|3|||
105691481|NCT02462928|364536280|FG000|Overall Study|Lost to Follow-up|4|||
105691482|NCT02462928|364536281|FG001|Overall Study|Lost to Follow-up|4|||
105691483|NCT02462928|364536282|FG002|Overall Study|Lost to Follow-up|1|||
105691484|NCT02462928|364536280|FG000|Overall Study|Withdrawal by Patient|31|||
105691485|NCT02462928|364536281|FG001|Overall Study|Withdrawal by Patient|21|||
105691486|NCT02462928|364536282|FG002|Overall Study|Withdrawal by Patient|21|||
105691487|NCT02462928|364536280|FG000|Overall Study|Protocol Violation|0|||
105691488|NCT02462928|364536281|FG001|Overall Study|Protocol Violation|1|||
105691489|NCT02462928|364536282|FG002|Overall Study|Protocol Violation|0|||
105691490|NCT02462928|364536280|FG000|Overall Study|Reason not Specified|4|||
105691491|NCT02462928|364536281|FG001|Overall Study|Reason not Specified|6|||
105691492|NCT02462928|364536282|FG002|Overall Study|Reason not Specified|5|||
105691493|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
105691494|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
105691495|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
105691496|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
105691497|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
105691498|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
105691499|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
105786886|NCT05182840|364872930|FG001|Treatment Period|Other but not sponsor termination|0|||
105691500|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
105691501|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
105691502|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
105691503|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
105691504|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
105691505|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
105691506|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
105691507|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
105691508|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
105691509|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
105691510|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
105691511|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Early termination|0|||
105691512|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Early termination|0|||
105691513|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Early termination|34|||
105691514|NCT01493557|364536283|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
105691515|NCT01493557|364536284|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
105691516|NCT01493557|364536285|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
105691517|NCT01493557|364536283|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
105691518|NCT01493557|364536284|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
105691519|NCT01493557|364536285|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
105691520|NCT01493557|364536283|FG000|Randomized to Management Strategies|Other adverse event|8|||
105691521|NCT01493557|364536284|FG001|Randomized to Management Strategies|Other adverse event|5|||
105691522|NCT01493557|364536285|FG002|Randomized to Management Strategies|Other adverse event|0|||
105691523|NCT01493557|364536283|FG000|Randomized to Management Strategies|Protocol Violation|3|||
105691524|NCT01493557|364536284|FG001|Randomized to Management Strategies|Protocol Violation|0|||
105691525|NCT01493557|364536285|FG002|Randomized to Management Strategies|Protocol Violation|0|||
105691526|NCT01493557|364536283|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
105691527|NCT01493557|364536284|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
105691528|NCT01493557|364536285|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
105691529|NCT01493557|364536283|FG000|Randomized to Management Strategies|Other than stated above|1|||
105691530|NCT01493557|364536284|FG001|Randomized to Management Strategies|Other than stated above|3|||
105691531|NCT01493557|364536285|FG002|Randomized to Management Strategies|Other than stated above|0|||
105691532|NCT01493557|364536283|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
105691533|NCT01493557|364536284|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
105691534|NCT01493557|364536285|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
105691535|NCT01493557|364536283|FG000|Adding the Second Strategy|Other adverse event|1|||
105691536|NCT01493557|364536284|FG001|Adding the Second Strategy|Other adverse event|2|||
105691537|NCT01493557|364536285|FG002|Adding the Second Strategy|Other adverse event|0|||
105691538|NCT01493557|364536283|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
105691539|NCT01493557|364536284|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
105691540|NCT01493557|364536285|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
105691541|NCT03338192|364536288|FG000|Year One to Year Two|High Blood Pressure|7|||
105691542|NCT03338192|364536289|FG001|Year One to Year Two|High Blood Pressure|1|||
105691543|NCT03338192|364536288|FG000|Year One to Year Two|HIV +|1|||
105691544|NCT03338192|364536289|FG001|Year One to Year Two|HIV +|0|||
105691545|NCT03338192|364536288|FG000|Year Two to Year Four|High Blood Pressure|1|||
105691546|NCT03338192|364536289|FG001|Year Two to Year Four|High Blood Pressure|0|||
105691547|NCT03338192|364536288|FG000|Year Two to Year Four|HIV +|2|||
105691548|NCT03338192|364536289|FG001|Year Two to Year Four|HIV +|0|||
105691549|NCT03338192|364536288|FG000|Year Four to Year Six|High Blood Pressure|2|||
105691550|NCT03338192|364536289|FG001|Year Four to Year Six|High Blood Pressure|1|||
105691551|NCT03808688|364536290|FG000|Overall Study|Adverse Event|13|||
105691552|NCT03808688|364536291|FG001|Overall Study|Adverse Event|17|||
105691553|NCT03808688|364536290|FG000|Overall Study|Lack of Efficacy|2|||
105691554|NCT03808688|364536291|FG001|Overall Study|Lack of Efficacy|0|||
105691555|NCT03808688|364536290|FG000|Overall Study|Lost to Follow-up|0|||
105691556|NCT03808688|364536291|FG001|Overall Study|Lost to Follow-up|2|||
105691557|NCT03808688|364536290|FG000|Overall Study|Withdrawal by Subject|1|||
105691558|NCT03808688|364536291|FG001|Overall Study|Withdrawal by Subject|0|||
105691559|NCT03808688|364536290|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
105691560|NCT03808688|364536291|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
105691561|NCT03808688|364536290|FG000|Overall Study|IOP Too High|1|||
106002824|NCT00683878|365672516|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
105691562|NCT03808688|364536291|FG001|Overall Study|IOP Too High|1|||
105691563|NCT03808688|364536290|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
105691564|NCT03808688|364536291|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
105691565|NCT03808688|364536290|FG000|Overall Study|Visit Out of Window|0|||
105691566|NCT03808688|364536291|FG001|Overall Study|Visit Out of Window|1|||
105691567|NCT03808688|364536290|FG000|Overall Study|Medication Non-Compliance|0|||
105691568|NCT03808688|364536291|FG001|Overall Study|Medication Non-Compliance|1|||
105691569|NCT03329196|364536294|FG000|Overall Study|Adverse Event|10|||
105691570|NCT03329196|364536295|FG001|Overall Study|Adverse Event|5|||
105691571|NCT03329196|364536294|FG000|Overall Study|Physician Decision|2|||
105691572|NCT03329196|364536295|FG001|Overall Study|Physician Decision|2|||
105691573|NCT03329196|364536294|FG000|Overall Study|Withdrawal by Subject|11|||
105691574|NCT03329196|364536295|FG001|Overall Study|Withdrawal by Subject|3|||
105691575|NCT03329196|364536294|FG000|Overall Study|Hepatic function abnormalities|0|||
105691576|NCT03329196|364536295|FG001|Overall Study|Hepatic function abnormalities|1|||
105691577|NCT03329196|364536294|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
105786887|NCT05182840|364872931|FG002|Treatment Period|Other but not sponsor termination|8|||
105786888|NCT05182840|364872932|FG003|Treatment Period|Other but not sponsor termination|6|||
105786889|NCT05182840|364872933|FG004|Treatment Period|Other but not sponsor termination|6|||
105786890|NCT05182840|364872934|FG005|Treatment Period|Other but not sponsor termination|7|||
105786891|NCT05182840|364872935|FG006|Treatment Period|Other but not sponsor termination|5|||
105786892|NCT05182840|364872936|FG007|Treatment Period|Other but not sponsor termination|8|||
105786893|NCT05182840|364872937|FG008|Treatment Period|Other but not sponsor termination|7|||
105786894|NCT05182840|364872938|FG009|Treatment Period|Other but not sponsor termination|2|||
105786895|NCT05182840|364872929|FG000|Treatment Period|Protocol deviation|0|||
105786896|NCT05182840|364872930|FG001|Treatment Period|Protocol deviation|0|||
105691578|NCT03329196|364536295|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
105691579|NCT03329196|364536294|FG000|Overall Study|Difficult to control Hb|2|||
105691580|NCT03329196|364536295|FG001|Overall Study|Difficult to control Hb|3|||
105786897|NCT05182840|364872931|FG002|Treatment Period|Protocol deviation|0|||
105786898|NCT05182840|364872932|FG003|Treatment Period|Protocol deviation|0|||
105786899|NCT05182840|364872933|FG004|Treatment Period|Protocol deviation|0|||
105786900|NCT05182840|364872934|FG005|Treatment Period|Protocol deviation|0|||
105691581|NCT03329196|364536294|FG000|Overall Study|Dialysis or renal transplant|13|||
105691582|NCT03329196|364536295|FG001|Overall Study|Dialysis or renal transplant|15|||
105691583|NCT03511053|364536306|FG000|Overall Study|Withdrawal by Subject|1|||
105691584|NCT01128361|364536307|FG000|Overall Study|Lost to Follow-up|0|||
105691585|NCT01128361|364536308|FG001|Overall Study|Lost to Follow-up|1|||
105691586|NCT01128361|364536307|FG000|Overall Study|Withdrawal by Subject|5|||
105691587|NCT01128361|364536308|FG001|Overall Study|Withdrawal by Subject|2|||
105691588|NCT00404066|364536309|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
105691589|NCT00404066|364536309|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
105691590|NCT00059839|364536311|FG000|Overall Study|Death|1|||
105691591|NCT00059839|364536312|FG001|Overall Study|Death|1|||
105691592|NCT00059839|364536311|FG000|Overall Study|Lack of Efficacy|6|||
105691593|NCT00059839|364536312|FG001|Overall Study|Lack of Efficacy|5|||
105691594|NCT00059839|364536311|FG000|Overall Study|Lost to Follow-up|2|||
105691595|NCT00059839|364536312|FG001|Overall Study|Lost to Follow-up|0|||
105691596|NCT00059839|364536311|FG000|Overall Study|Physician Decision|1|||
105691597|NCT00059839|364536312|FG001|Overall Study|Physician Decision|2|||
105691598|NCT00059839|364536311|FG000|Overall Study|Withdrawal by Subject|1|||
105691599|NCT00059839|364536312|FG001|Overall Study|Withdrawal by Subject|6|||
105691600|NCT00059839|364536311|FG000|Overall Study|Ineligible|1|||
105691601|NCT00059839|364536312|FG001|Overall Study|Ineligible|3|||
105691602|NCT00436618|364536313|FG000|Overall Study|Withdrawal by Subject|5|||
105786901|NCT05182840|364872935|FG006|Treatment Period|Protocol deviation|0|||
105786902|NCT05182840|364872936|FG007|Treatment Period|Protocol deviation|0|||
105786903|NCT05182840|364872937|FG008|Treatment Period|Protocol deviation|1|||
105786904|NCT05182840|364872938|FG009|Treatment Period|Protocol deviation|0|||
105786905|NCT05182840|364872929|FG000|Treatment Period|No reason available|0|||
105786906|NCT05182840|364872930|FG001|Treatment Period|No reason available|0|||
105786907|NCT05182840|364872931|FG002|Treatment Period|No reason available|0|||
105786908|NCT05182840|364872932|FG003|Treatment Period|No reason available|1|||
105786909|NCT05182840|364872933|FG004|Treatment Period|No reason available|0|||
105786910|NCT05182840|364872934|FG005|Treatment Period|No reason available|2|||
105786911|NCT05182840|364872935|FG006|Treatment Period|No reason available|0|||
105786912|NCT05182840|364872936|FG007|Treatment Period|No reason available|1|||
105919467|NCT01093846|365363593|FG000|Overall Study|Condition no longer required study drug|1|||
105919468|NCT01093846|365363594|FG001|Overall Study|Condition no longer required study drug|1|||
105919469|NCT01093846|365363595|FG002|Overall Study|Condition no longer required study drug|1|||
105919470|NCT01093846|365363593|FG000|Overall Study|Administrative Problems|18|||
105919471|NCT01093846|365363594|FG001|Overall Study|Administrative Problems|17|||
105919472|NCT01093846|365363595|FG002|Overall Study|Administrative Problems|15|||
105691603|NCT00436618|364536314|FG001|Overall Study|Withdrawal by Subject|8|||
105691604|NCT00436618|364536315|FG002|Overall Study|Withdrawal by Subject|11|||
105691605|NCT00436618|364536313|FG000|Overall Study|Adverse Event|8|||
105786913|NCT05182840|364872937|FG008|Treatment Period|No reason available|0|||
105919473|NCT01181167|365365070|FG000|Overall Study|Adverse Event|11|||
105691606|NCT00436618|364536314|FG001|Overall Study|Adverse Event|8|||
105691607|NCT00436618|364536315|FG002|Overall Study|Adverse Event|9|||
105691608|NCT00436618|364536313|FG000|Overall Study|Alternate Treatment|3|||
105691609|NCT00436618|364536314|FG001|Overall Study|Alternate Treatment|4|||
105691610|NCT00436618|364536315|FG002|Overall Study|Alternate Treatment|12|||
105691611|NCT00436618|364536313|FG000|Overall Study|Other Medical Problems|3|||
105691612|NCT00436618|364536314|FG001|Overall Study|Other Medical Problems|1|||
105691613|NCT00436618|364536315|FG002|Overall Study|Other Medical Problems|7|||
105691614|NCT00436618|364536313|FG000|Overall Study|Death|4|||
105691615|NCT00436618|364536314|FG001|Overall Study|Death|2|||
105691616|NCT00436618|364536315|FG002|Overall Study|Death|3|||
105691617|NCT00436618|364536313|FG000|Overall Study|New Primary or Other Reasons|6|||
105691618|NCT00436618|364536314|FG001|Overall Study|New Primary or Other Reasons|2|||
105691619|NCT00436618|364536315|FG002|Overall Study|New Primary or Other Reasons|12|||
105691620|NCT00436618|364536313|FG000|Overall Study|Still on treatment|1|||
105691621|NCT00436618|364536314|FG001|Overall Study|Still on treatment|2|||
105691622|NCT00436618|364536315|FG002|Overall Study|Still on treatment|7|||
105691623|NCT02596620|364536316|FG000|Overall Study|Lost to Follow-up|1|||
105691624|NCT02596620|364536317|FG001|Overall Study|Lost to Follow-up|1|||
105691625|NCT01054144|364536318|FG000|Overall Study|Death|2|||
105691626|NCT00068588|364536319|FG000|Overall Study|Adverse Event|0|||
105691627|NCT00068588|364536320|FG001|Overall Study|Adverse Event|0|||
105691628|NCT00068588|364536321|FG002|Overall Study|Adverse Event|2|||
105691629|NCT00068588|364536319|FG000|Overall Study|Withdrawal by Subject|0|||
105691630|NCT00068588|364536320|FG001|Overall Study|Withdrawal by Subject|0|||
105691631|NCT00068588|364536321|FG002|Overall Study|Withdrawal by Subject|1|||
105691632|NCT00068588|364536319|FG000|Overall Study|Poor KPS|0|||
105691633|NCT00068588|364536320|FG001|Overall Study|Poor KPS|0|||
105691634|NCT00068588|364536321|FG002|Overall Study|Poor KPS|1|||
105691635|NCT03118674|364536322|FG000|Overall Study|Lost to Follow-up|2|||
105691636|NCT03118674|364536322|FG000|Overall Study|Screen Faliure|8|||
105691637|NCT03118674|364536322|FG000|Overall Study|Withdrawal by Subject|5|||
105691638|NCT01829360|364536323|FG000|Overall Study|Protocol Violation|0|||
105691639|NCT01829360|364536324|FG001|Overall Study|Protocol Violation|0|||
105691640|NCT01829360|364536325|FG002|Overall Study|Protocol Violation|1|||
105691641|NCT01829360|364536326|FG003|Overall Study|Protocol Violation|0|||
105691642|NCT02060721|364536327|FG000|Overall Study|Lost to Follow-up|1|||
105691643|NCT02060721|364536327|FG000|Overall Study|Physician Decision|2|||
105691644|NCT02060721|364536327|FG000|Overall Study|Death|14|||
105691645|NCT02060721|364536327|FG000|Overall Study|Withdrawal by Subject|2|||
105691646|NCT02060721|364536327|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
105691647|NCT00117507|364536328|FG000|Overall Study|Adverse Event|4|||
105691648|NCT00117507|364536328|FG000|Overall Study|Abnormal laboratory values|3|||
105691649|NCT00117507|364536328|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105691650|NCT00117507|364536328|FG000|Overall Study|Patient withdrew consent|4|||
105691651|NCT00117507|364536328|FG000|Overall Study|Death|3|||
105691652|NCT05105789|364536329|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
105691653|NCT00711529|364536336|FG000|Overall Study|Protocol Violation|2|||
105691654|NCT00711529|364536337|FG001|Overall Study|Protocol Violation|0|||
105691655|NCT00711529|364536336|FG000|Overall Study|Withdrawal by Subject|2|||
105691656|NCT00711529|364536337|FG001|Overall Study|Withdrawal by Subject|6|||
105691657|NCT01271803|364536338|FG000|Overall Study|Progressive disease|0|||
105691658|NCT01271803|364536339|FG001|Overall Study|Progressive disease|0|||
105691659|NCT01271803|364536340|FG002|Overall Study|Progressive disease|2|||
105691660|NCT01271803|364536338|FG000|Overall Study|Death|53|||
105691661|NCT01271803|364536339|FG001|Overall Study|Death|34|||
105691662|NCT01271803|364536340|FG002|Overall Study|Death|0|||
105691663|NCT01271803|364536338|FG000|Overall Study|Withdrawal by Subject|1|||
105691664|NCT01271803|364536339|FG001|Overall Study|Withdrawal by Subject|5|||
105691665|NCT01271803|364536340|FG002|Overall Study|Withdrawal by Subject|0|||
105691666|NCT01271803|364536338|FG000|Overall Study|Lost to Follow-up|1|||
105919474|NCT01181167|365365071|FG001|Overall Study|Adverse Event|21|||
105919475|NCT01181167|365365070|FG000|Overall Study|Lost to Follow-up|1|||
105919476|NCT01181167|365365071|FG001|Overall Study|Lost to Follow-up|0|||
105919477|NCT01181167|365365070|FG000|Overall Study|Physician Decision|2|||
105919478|NCT01181167|365365071|FG001|Overall Study|Physician Decision|3|||
105691667|NCT01271803|364536339|FG001|Overall Study|Lost to Follow-up|0|||
105691668|NCT01271803|364536340|FG002|Overall Study|Lost to Follow-up|0|||
105691669|NCT00634010|364536342|FG000|Overall Study|Adverse Event|2|||
105691670|NCT00634010|364536343|FG001|Overall Study|Adverse Event|5|||
105691671|NCT00634010|364536342|FG000|Overall Study|Withdrawal by Subject|5|||
105691672|NCT00634010|364536343|FG001|Overall Study|Withdrawal by Subject|6|||
105691673|NCT00634010|364536342|FG000|Overall Study|Physician Decision|1|||
105691674|NCT00634010|364536343|FG001|Overall Study|Physician Decision|1|||
105691675|NCT00634010|364536342|FG000|Overall Study|Disease Progression|1|||
105691676|NCT00634010|364536343|FG001|Overall Study|Disease Progression|1|||
105691677|NCT00634010|364536342|FG000|Overall Study|Non-Compliant|1|||
105691678|NCT00634010|364536343|FG001|Overall Study|Non-Compliant|1|||
105919479|NCT01181167|365365070|FG000|Overall Study|Protocol Violation|3|||
105919480|NCT01181167|365365071|FG001|Overall Study|Protocol Violation|0|||
105691679|NCT05211739|364536344|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
105691680|NCT05211739|364536345|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
105691681|NCT05211739|364536344|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
105691682|NCT05211739|364536345|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
105691683|NCT05211739|364536344|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
105691684|NCT05211739|364536345|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
105691685|NCT05211739|364536344|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
105691686|NCT05211739|364536345|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
105691687|NCT01975428|364536346|FG000|Overall Study|Lost to Follow-up|17|||
105691688|NCT01975428|364536347|FG001|Overall Study|Lost to Follow-up|4|||
105691689|NCT01975428|364536346|FG000|Overall Study|Withdrawal by Subject|3|||
105691690|NCT01975428|364536347|FG001|Overall Study|Withdrawal by Subject|10|||
105691691|NCT05085665|364536348|FG000|Overall Study|Physician Decision|2|||
105691692|NCT00778622|364536351|FG000|Overall Study|Adverse Event|5|||
105691693|NCT00778622|364536352|FG001|Overall Study|Adverse Event|4|||
105691694|NCT00778622|364536353|FG002|Overall Study|Adverse Event|7|||
105691695|NCT00778622|364536351|FG000|Overall Study|Withdrawal by Subject|4|||
105691696|NCT00778622|364536352|FG001|Overall Study|Withdrawal by Subject|5|||
105691697|NCT00778622|364536353|FG002|Overall Study|Withdrawal by Subject|5|||
105691698|NCT00778622|364536351|FG000|Overall Study|Lost to Follow-up|3|||
105691699|NCT00778622|364536352|FG001|Overall Study|Lost to Follow-up|3|||
105691700|NCT00778622|364536353|FG002|Overall Study|Lost to Follow-up|2|||
105691701|NCT00778622|364536351|FG000|Overall Study|Protocol Violation|0|||
105691702|NCT00778622|364536352|FG001|Overall Study|Protocol Violation|3|||
105691703|NCT00778622|364536353|FG002|Overall Study|Protocol Violation|0|||
105691704|NCT00778622|364536351|FG000|Overall Study|Lack of Efficacy|2|||
105691705|NCT00778622|364536352|FG001|Overall Study|Lack of Efficacy|0|||
105691706|NCT00778622|364536353|FG002|Overall Study|Lack of Efficacy|0|||
105691707|NCT00778622|364536351|FG000|Overall Study|immigration|1|||
105919481|NCT01181167|365365070|FG000|Overall Study|Withdrawal by Subject|6|||
105919482|NCT01181167|365365071|FG001|Overall Study|Withdrawal by Subject|8|||
105919483|NCT01145482|365365074|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
105919484|NCT01145482|365365075|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
105919485|NCT00499122|365365077|FG000|Overall Study|Withdrawal by Subject|2|||
105919486|NCT00076570|365365078|FG000|Overall Study|Drug intolerance|8|||
105919487|NCT00076570|365365079|FG001|Overall Study|Drug intolerance|8|||
105919488|NCT01516216|365365082|FG000|Overall Study|Adverse Event|2|||
105919489|NCT01516216|365365083|FG001|Overall Study|Adverse Event|4|||
105919490|NCT01516216|365365082|FG000|Overall Study|Disease Progression|38|||
105919491|NCT01516216|365365083|FG001|Overall Study|Disease Progression|34|||
105919492|NCT01516216|365365082|FG000|Overall Study|Withdrawal by Subject|9|||
105919493|NCT01516216|365365083|FG001|Overall Study|Withdrawal by Subject|11|||
105919494|NCT01516216|365365082|FG000|Overall Study|Potentially Curative Resection|6|||
105919495|NCT01516216|365365083|FG001|Overall Study|Potentially Curative Resection|12|||
105919496|NCT01516216|365365082|FG000|Overall Study|Nonadherence|2|||
105919497|NCT01516216|365365083|FG001|Overall Study|Nonadherence|3|||
105919498|NCT01516216|365365082|FG000|Overall Study|Physician Decision|6|||
105919499|NCT01516216|365365083|FG001|Overall Study|Physician Decision|3|||
105919500|NCT01516216|365365082|FG000|Overall Study|Prolonged Treatment Delay|5|||
105919501|NCT01516216|365365083|FG001|Overall Study|Prolonged Treatment Delay|1|||
105919502|NCT01516216|365365082|FG000|Overall Study|Intercurrent Illness|1|||
105919503|NCT01516216|365365083|FG001|Overall Study|Intercurrent Illness|0|||
105919504|NCT01516216|365365082|FG000|Overall Study|Death|1|||
105919505|NCT01516216|365365083|FG001|Overall Study|Death|1|||
105919506|NCT01117870|365365084|FG000|Overall Study|Inability to place needle|1|||
105919507|NCT01117870|365365085|FG001|Overall Study|Inability to place needle|0|||
105919508|NCT02783066|365365090|FG000|Overall Study|Withdrawal by Subject|13|||
105691708|NCT00778622|364536352|FG001|Overall Study|immigration|0|||
105691709|NCT00778622|364536353|FG002|Overall Study|immigration|0|||
105691710|NCT00778622|364536351|FG000|Overall Study|Other|1|||
105691711|NCT00778622|364536352|FG001|Overall Study|Other|0|||
105691712|NCT00778622|364536353|FG002|Overall Study|Other|1|||
105691713|NCT01251120|364536357|FG000|Overall Study|Lack of Efficacy|0|||
105691714|NCT01251120|364536358|FG001|Overall Study|Lack of Efficacy|1|||
105691715|NCT01968070|364536361|FG000|Period 1|Withdrawal by Subject|0|||
105691716|NCT01968070|364536362|FG001|Period 1|Withdrawal by Subject|1|||
105919509|NCT00551369|365365091|FG000|Overall Study|Protocol Violation|5|||
105919510|NCT00551369|365365091|FG000|Overall Study|Withdrawal by Subject|1|||
105919511|NCT00551369|365365091|FG000|Overall Study|Not treated per protocol and re|1|||
105919512|NCT00975416|365365095|FG000|Overall Study|early discharge from tx|3|||
105919513|NCT00975416|365365096|FG001|Overall Study|early discharge from tx|5|||
105691717|NCT01968070|364536363|FG002|Period 1|Withdrawal by Subject|0|||
105691718|NCT01968070|364536364|FG003|Period 1|Withdrawal by Subject|0|||
105691719|NCT01968070|364536365|FG004|Period 1|Withdrawal by Subject|0|||
105919514|NCT05379920|365365097|FG000|Overall Study|Lost to Follow-up|0|||
105919515|NCT05379920|365365098|FG001|Overall Study|Lost to Follow-up|5|||
105919516|NCT05379920|365365099|FG002|Overall Study|Lost to Follow-up|0|||
105691720|NCT01968070|364536366|FG005|Period 1|Withdrawal by Subject|0|||
105691721|NCT01968070|364536367|FG006|Period 1|Withdrawal by Subject|1|||
105691722|NCT01968070|364536368|FG007|Period 1|Withdrawal by Subject|0|||
105691723|NCT01968070|364536369|FG008|Period 1|Withdrawal by Subject|0|||
105691724|NCT01968070|364536370|FG009|Period 1|Withdrawal by Subject|0|||
105691725|NCT01968070|364536371|FG010|Period 1|Withdrawal by Subject|0|||
105919517|NCT05379920|365365100|FG003|Overall Study|Lost to Follow-up|0|||
106130672|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
105691726|NCT01968070|364536372|FG011|Period 1|Withdrawal by Subject|0|||
105919518|NCT00106002|365365105|FG000|Overall Study|Did not take any study drug|1|||
105919519|NCT00106002|365365105|FG000|Overall Study|Ineligible after Registration|1|||
105919520|NCT01663623|365365106|FG000|Overall Study|Adverse Event|3|||
105919521|NCT01663623|365365107|FG001|Overall Study|Adverse Event|7|||
105919522|NCT01663623|365365106|FG000|Overall Study|Lack of Efficacy|5|||
105919523|NCT01663623|365365107|FG001|Overall Study|Lack of Efficacy|6|||
105919524|NCT01663623|365365106|FG000|Overall Study|Protocol Violation|0|||
105919525|NCT01663623|365365107|FG001|Overall Study|Protocol Violation|1|||
105919526|NCT01663623|365365106|FG000|Overall Study|Other-Study closed/terminated|1|||
105919527|NCT01663623|365365107|FG001|Overall Study|Other-Study closed/terminated|1|||
105919528|NCT01663623|365365106|FG000|Overall Study|Physician Decision|1|||
105919529|NCT01663623|365365107|FG001|Overall Study|Physician Decision|4|||
105919530|NCT01663623|365365106|FG000|Overall Study|Withdrawal by Subject|2|||
105919531|NCT01663623|365365107|FG001|Overall Study|Withdrawal by Subject|1|||
105919532|NCT00719901|365365111|FG000|Overall Study|Adverse Event|5|||
105919533|NCT00719901|365365111|FG000|Overall Study|Withdrawal by Subject|1|||
105919534|NCT00719901|365365111|FG000|Overall Study|Alternate Treatment|1|||
105919535|NCT00719901|365365111|FG000|Overall Study|Disease Progression|3|||
105919536|NCT00719901|365365111|FG000|Overall Study|Availability of Study Drug|1|||
105919537|NCT00856180|365365114|FG000|Overall Study|Adverse Event|4|||
105919538|NCT00856180|365365114|FG000|Overall Study|Progressive Disease|16|||
105919539|NCT02265510|365365115|FG000|Overall Study|Withdrawal by Subject|1|||
105919540|NCT02265510|365365116|FG001|Overall Study|Withdrawal by Subject|1|||
105919541|NCT02265510|365365117|FG002|Overall Study|Withdrawal by Subject|2|||
105919542|NCT02265510|365365118|FG003|Overall Study|Withdrawal by Subject|1|||
105919543|NCT02265510|365365119|FG004|Overall Study|Withdrawal by Subject|0|||
105919544|NCT02265510|365365120|FG005|Overall Study|Withdrawal by Subject|2|||
105919545|NCT02265510|365365121|FG006|Overall Study|Withdrawal by Subject|0|||
105919546|NCT02265510|365365122|FG007|Overall Study|Withdrawal by Subject|2|||
105919547|NCT02265510|365365123|FG008|Overall Study|Withdrawal by Subject|0|||
105919548|NCT02265510|365365124|FG009|Overall Study|Withdrawal by Subject|0|||
105919549|NCT02265510|365365125|FG010|Overall Study|Withdrawal by Subject|0|||
105919550|NCT02265510|365365126|FG011|Overall Study|Withdrawal by Subject|0|||
105919551|NCT02265510|365365127|FG012|Overall Study|Withdrawal by Subject|1|||
105919552|NCT02265510|365365128|FG013|Overall Study|Withdrawal by Subject|0|||
105919553|NCT02265510|365365115|FG000|Overall Study|Disease Progression|0|||
105919554|NCT02265510|365365116|FG001|Overall Study|Disease Progression|1|||
105919555|NCT02265510|365365117|FG002|Overall Study|Disease Progression|2|||
105919556|NCT02265510|365365118|FG003|Overall Study|Disease Progression|1|||
105919557|NCT02265510|365365119|FG004|Overall Study|Disease Progression|1|||
105919558|NCT02265510|365365120|FG005|Overall Study|Disease Progression|0|||
105919559|NCT02265510|365365121|FG006|Overall Study|Disease Progression|0|||
105919560|NCT02265510|365365122|FG007|Overall Study|Disease Progression|0|||
105919561|NCT02265510|365365123|FG008|Overall Study|Disease Progression|0|||
105919562|NCT02265510|365365124|FG009|Overall Study|Disease Progression|0|||
105919563|NCT02265510|365365125|FG010|Overall Study|Disease Progression|0|||
105919564|NCT02265510|365365126|FG011|Overall Study|Disease Progression|0|||
105919565|NCT02265510|365365127|FG012|Overall Study|Disease Progression|0|||
105919566|NCT02265510|365365128|FG013|Overall Study|Disease Progression|0|||
105919567|NCT02265510|365365115|FG000|Overall Study|Death|2|||
105919568|NCT02265510|365365116|FG001|Overall Study|Death|0|||
105919569|NCT02265510|365365117|FG002|Overall Study|Death|2|||
106002825|NCT00683878|365672517|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
106130673|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Death|1|||
105691727|NCT01968070|364536373|FG012|Period 1|Withdrawal by Subject|0|||
105691728|NCT01968070|364536374|FG013|Period 1|Withdrawal by Subject|0|||
105691729|NCT01968070|364536375|FG014|Period 1|Withdrawal by Subject|0|||
105691730|NCT01968070|364536376|FG015|Period 1|Withdrawal by Subject|1|||
105691731|NCT01968070|364536377|FG016|Period 1|Withdrawal by Subject|0|||
105691732|NCT01968070|364536378|FG017|Period 1|Withdrawal by Subject|0|||
105919570|NCT02265510|365365118|FG003|Overall Study|Death|2|||
105919571|NCT02265510|365365119|FG004|Overall Study|Death|1|||
105919572|NCT02265510|365365120|FG005|Overall Study|Death|3|||
105919573|NCT02265510|365365121|FG006|Overall Study|Death|2|||
105919574|NCT02265510|365365122|FG007|Overall Study|Death|1|||
105919575|NCT02265510|365365123|FG008|Overall Study|Death|3|||
105919576|NCT02265510|365365124|FG009|Overall Study|Death|3|||
105919577|NCT02265510|365365125|FG010|Overall Study|Death|4|||
105919578|NCT02265510|365365126|FG011|Overall Study|Death|12|||
105919579|NCT02265510|365365127|FG012|Overall Study|Death|7|||
105919580|NCT02265510|365365128|FG013|Overall Study|Death|6|||
105691733|NCT01968070|364536361|FG000|Period 1|Protocol Violation|0|||
105691734|NCT01968070|364536362|FG001|Period 1|Protocol Violation|0|||
105691735|NCT01968070|364536363|FG002|Period 1|Protocol Violation|0|||
105691736|NCT01968070|364536364|FG003|Period 1|Protocol Violation|1|||
105691737|NCT01968070|364536365|FG004|Period 1|Protocol Violation|1|||
105691738|NCT01968070|364536366|FG005|Period 1|Protocol Violation|0|||
105691739|NCT01968070|364536367|FG006|Period 1|Protocol Violation|0|||
105691740|NCT01968070|364536368|FG007|Period 1|Protocol Violation|0|||
105691741|NCT01968070|364536369|FG008|Period 1|Protocol Violation|0|||
105691742|NCT01968070|364536370|FG009|Period 1|Protocol Violation|0|||
105691743|NCT01968070|364536371|FG010|Period 1|Protocol Violation|0|||
105691744|NCT01968070|364536372|FG011|Period 1|Protocol Violation|0|||
105786914|NCT05182840|364872938|FG009|Treatment Period|No reason available|0|||
105786915|NCT05182840|364872929|FG000|Treatment Period|Burden of study procedures|0|||
105786916|NCT05182840|364872930|FG001|Treatment Period|Burden of study procedures|0|||
105786917|NCT05182840|364872931|FG002|Treatment Period|Burden of study procedures|0|||
105691745|NCT01968070|364536373|FG012|Period 1|Protocol Violation|0|||
105691746|NCT01968070|364536374|FG013|Period 1|Protocol Violation|0|||
105786918|NCT05182840|364872932|FG003|Treatment Period|Burden of study procedures|0|||
105786919|NCT05182840|364872933|FG004|Treatment Period|Burden of study procedures|1|||
105786920|NCT05182840|364872934|FG005|Treatment Period|Burden of study procedures|0|||
105786921|NCT05182840|364872935|FG006|Treatment Period|Burden of study procedures|0|||
105786922|NCT05182840|364872936|FG007|Treatment Period|Burden of study procedures|0|||
105786923|NCT05182840|364872937|FG008|Treatment Period|Burden of study procedures|0|||
105786924|NCT05182840|364872938|FG009|Treatment Period|Burden of study procedures|0|||
105786925|NCT05182840|364872929|FG000|Treatment Period|Change of residence|0|||
105786926|NCT05182840|364872930|FG001|Treatment Period|Change of residence|0|||
105786927|NCT05182840|364872931|FG002|Treatment Period|Change of residence|0|||
105786928|NCT05182840|364872932|FG003|Treatment Period|Change of residence|0|||
105786929|NCT05182840|364872933|FG004|Treatment Period|Change of residence|0|||
105786930|NCT05182840|364872934|FG005|Treatment Period|Change of residence|1|||
105786931|NCT05182840|364872935|FG006|Treatment Period|Change of residence|0|||
105786932|NCT05182840|364872936|FG007|Treatment Period|Change of residence|0|||
105786933|NCT05182840|364872937|FG008|Treatment Period|Change of residence|0|||
105786934|NCT05182840|364872938|FG009|Treatment Period|Change of residence|0|||
105786935|NCT05182840|364872929|FG000|Treatment Period|Adverse Event|0|||
105786936|NCT05182840|364872930|FG001|Treatment Period|Adverse Event|0|||
105786937|NCT05182840|364872931|FG002|Treatment Period|Adverse Event|4|||
105786938|NCT05182840|364872932|FG003|Treatment Period|Adverse Event|16|||
105786939|NCT05182840|364872933|FG004|Treatment Period|Adverse Event|12|||
105786940|NCT05182840|364872934|FG005|Treatment Period|Adverse Event|6|||
105786941|NCT05182840|364872935|FG006|Treatment Period|Adverse Event|4|||
105786942|NCT05182840|364872936|FG007|Treatment Period|Adverse Event|8|||
105786943|NCT05182840|364872937|FG008|Treatment Period|Adverse Event|16|||
105786944|NCT05182840|364872938|FG009|Treatment Period|Adverse Event|5|||
105786945|NCT05182840|364872929|FG000|Treatment Period|Not treated with study drug|0|||
105786946|NCT05182840|364872930|FG001|Treatment Period|Not treated with study drug|0|||
105786947|NCT05182840|364872931|FG002|Treatment Period|Not treated with study drug|0|||
105786948|NCT05182840|364872932|FG003|Treatment Period|Not treated with study drug|1|||
105786949|NCT05182840|364872933|FG004|Treatment Period|Not treated with study drug|0|||
105786950|NCT05182840|364872934|FG005|Treatment Period|Not treated with study drug|0|||
105786951|NCT05182840|364872935|FG006|Treatment Period|Not treated with study drug|1|||
105786952|NCT05182840|364872936|FG007|Treatment Period|Not treated with study drug|1|||
105786953|NCT05182840|364872937|FG008|Treatment Period|Not treated with study drug|0|||
105786954|NCT05182840|364872938|FG009|Treatment Period|Not treated with study drug|0|||
105786955|NCT04342390|364872941|FG000|Overall Study|Lost to Follow-up|3|||
105786956|NCT04342390|364872942|FG001|Overall Study|Lost to Follow-up|0|||
105786957|NCT04768881|364872943|FG000|Overall Study|Completed Study Follow-up|0|||
105919581|NCT02265510|365365115|FG000|Overall Study|Lost to Follow-up|0|||
105919582|NCT02265510|365365116|FG001|Overall Study|Lost to Follow-up|0|||
105919583|NCT02265510|365365117|FG002|Overall Study|Lost to Follow-up|0|||
105919584|NCT02265510|365365118|FG003|Overall Study|Lost to Follow-up|0|||
105919585|NCT02265510|365365119|FG004|Overall Study|Lost to Follow-up|1|||
105919586|NCT02265510|365365120|FG005|Overall Study|Lost to Follow-up|0|||
105919587|NCT02265510|365365121|FG006|Overall Study|Lost to Follow-up|0|||
105919588|NCT02265510|365365122|FG007|Overall Study|Lost to Follow-up|0|||
105919589|NCT02265510|365365123|FG008|Overall Study|Lost to Follow-up|0|||
105691747|NCT01968070|364536375|FG014|Period 1|Protocol Violation|0|||
105786958|NCT04768881|364872944|FG001|Overall Study|Completed Study Follow-up|2|||
105786959|NCT04768881|364872943|FG000|Overall Study|Death|3|||
105786960|NCT04768881|364872944|FG001|Overall Study|Death|2|||
105786961|NCT04768881|364872943|FG000|Overall Study|Study Terminated by Sponsor|2|||
105786962|NCT04768881|364872944|FG001|Overall Study|Study Terminated by Sponsor|2|||
105919590|NCT02265510|365365124|FG009|Overall Study|Lost to Follow-up|2|||
105691748|NCT01968070|364536376|FG015|Period 1|Protocol Violation|0|||
105691749|NCT01968070|364536377|FG016|Period 1|Protocol Violation|0|||
105919591|NCT02265510|365365125|FG010|Overall Study|Lost to Follow-up|0|||
106002826|NCT00833040|365672519|FG000|Overall Study|Adverse Event|0|||
106002827|NCT00833040|365672520|FG001|Overall Study|Adverse Event|0|||
106002828|NCT00833040|365672521|FG002|Overall Study|Adverse Event|0|||
106002829|NCT00833040|365672522|FG003|Overall Study|Adverse Event|0|||
106002830|NCT00833040|365672523|FG004|Overall Study|Adverse Event|0|||
106002831|NCT00833040|365672524|FG005|Overall Study|Adverse Event|1|||
105691750|NCT01968070|364536378|FG017|Period 1|Protocol Violation|0|||
105691751|NCT01968070|364536361|FG000|Period 1|Lost to Follow-up|0|||
105691752|NCT01968070|364536362|FG001|Period 1|Lost to Follow-up|0|||
105691753|NCT01968070|364536363|FG002|Period 1|Lost to Follow-up|0|||
105691754|NCT01968070|364536364|FG003|Period 1|Lost to Follow-up|1|||
105691755|NCT01968070|364536365|FG004|Period 1|Lost to Follow-up|0|||
105691756|NCT01968070|364536366|FG005|Period 1|Lost to Follow-up|0|||
105691757|NCT01968070|364536367|FG006|Period 1|Lost to Follow-up|0|||
105691758|NCT01968070|364536368|FG007|Period 1|Lost to Follow-up|0|||
105691759|NCT01968070|364536369|FG008|Period 1|Lost to Follow-up|0|||
105691760|NCT01968070|364536370|FG009|Period 1|Lost to Follow-up|0|||
105691761|NCT01968070|364536371|FG010|Period 1|Lost to Follow-up|0|||
105691762|NCT01968070|364536372|FG011|Period 1|Lost to Follow-up|0|||
105691763|NCT01968070|364536373|FG012|Period 1|Lost to Follow-up|0|||
105691764|NCT01968070|364536374|FG013|Period 1|Lost to Follow-up|0|||
105691765|NCT01968070|364536375|FG014|Period 1|Lost to Follow-up|0|||
105691766|NCT01968070|364536376|FG015|Period 1|Lost to Follow-up|0|||
105691767|NCT01968070|364536377|FG016|Period 1|Lost to Follow-up|0|||
105691768|NCT01968070|364536378|FG017|Period 1|Lost to Follow-up|0|||
105691769|NCT01968070|364536361|FG000|Period 1|Adverse Event|0|||
105691770|NCT01968070|364536362|FG001|Period 1|Adverse Event|0|||
105691771|NCT01968070|364536363|FG002|Period 1|Adverse Event|0|||
105691772|NCT01968070|364536364|FG003|Period 1|Adverse Event|0|||
105691773|NCT01968070|364536365|FG004|Period 1|Adverse Event|0|||
105691774|NCT01968070|364536366|FG005|Period 1|Adverse Event|0|||
105691775|NCT01968070|364536367|FG006|Period 1|Adverse Event|1|||
105691776|NCT01968070|364536368|FG007|Period 1|Adverse Event|0|||
105691777|NCT01968070|364536369|FG008|Period 1|Adverse Event|0|||
105691778|NCT01968070|364536370|FG009|Period 1|Adverse Event|0|||
105691779|NCT01968070|364536371|FG010|Period 1|Adverse Event|0|||
105691780|NCT01968070|364536372|FG011|Period 1|Adverse Event|0|||
105691781|NCT01968070|364536373|FG012|Period 1|Adverse Event|0|||
105691782|NCT01968070|364536374|FG013|Period 1|Adverse Event|0|||
105691783|NCT01968070|364536375|FG014|Period 1|Adverse Event|0|||
105691784|NCT01968070|364536376|FG015|Period 1|Adverse Event|0|||
105691785|NCT01968070|364536377|FG016|Period 1|Adverse Event|0|||
105691786|NCT01968070|364536378|FG017|Period 1|Adverse Event|0|||
105691787|NCT01968070|364536361|FG000|Period 1|Physician Decision|0|||
105691788|NCT01968070|364536362|FG001|Period 1|Physician Decision|0|||
105691789|NCT01968070|364536363|FG002|Period 1|Physician Decision|0|||
105691790|NCT01968070|364536364|FG003|Period 1|Physician Decision|0|||
105691791|NCT01968070|364536365|FG004|Period 1|Physician Decision|0|||
105691792|NCT01968070|364536366|FG005|Period 1|Physician Decision|0|||
105691793|NCT01968070|364536367|FG006|Period 1|Physician Decision|0|||
105691794|NCT01968070|364536368|FG007|Period 1|Physician Decision|0|||
105691795|NCT01968070|364536369|FG008|Period 1|Physician Decision|0|||
105691796|NCT01968070|364536370|FG009|Period 1|Physician Decision|0|||
105691797|NCT01968070|364536371|FG010|Period 1|Physician Decision|0|||
105691798|NCT01968070|364536372|FG011|Period 1|Physician Decision|1|||
105691799|NCT01968070|364536373|FG012|Period 1|Physician Decision|0|||
105691800|NCT01968070|364536374|FG013|Period 1|Physician Decision|0|||
105691801|NCT01968070|364536375|FG014|Period 1|Physician Decision|0|||
105691802|NCT01968070|364536376|FG015|Period 1|Physician Decision|0|||
105691803|NCT01968070|364536377|FG016|Period 1|Physician Decision|0|||
105691804|NCT01968070|364536378|FG017|Period 1|Physician Decision|0|||
105691805|NCT01968070|364536361|FG000|Period 2|Withdrawal by Subject|0|||
105691806|NCT01968070|364536362|FG001|Period 2|Withdrawal by Subject|0|||
105691807|NCT01968070|364536363|FG002|Period 2|Withdrawal by Subject|0|||
105691808|NCT01968070|364536364|FG003|Period 2|Withdrawal by Subject|0|||
105691809|NCT01968070|364536365|FG004|Period 2|Withdrawal by Subject|1|||
105691810|NCT01968070|364536366|FG005|Period 2|Withdrawal by Subject|0|||
105691811|NCT01968070|364536367|FG006|Period 2|Withdrawal by Subject|0|||
105691812|NCT01968070|364536368|FG007|Period 2|Withdrawal by Subject|0|||
106002832|NCT03489863|365672525|FG000|Overall Study|Withdrawal by Subject|0|||
106002833|NCT03489863|365672526|FG001|Overall Study|Withdrawal by Subject|1|||
105691813|NCT01968070|364536369|FG008|Period 2|Withdrawal by Subject|0|||
106002834|NCT01005251|365672527|FG000|Overall Study|Withdrawal by Subject|2|||
105691814|NCT01968070|364536370|FG009|Period 2|Withdrawal by Subject|0|||
105691815|NCT01968070|364536371|FG010|Period 2|Withdrawal by Subject|0|||
105691816|NCT01968070|364536372|FG011|Period 2|Withdrawal by Subject|0|||
105691817|NCT01968070|364536373|FG012|Period 2|Withdrawal by Subject|0|||
105691818|NCT01968070|364536374|FG013|Period 2|Withdrawal by Subject|0|||
105691819|NCT01968070|364536375|FG014|Period 2|Withdrawal by Subject|0|||
105691820|NCT01968070|364536376|FG015|Period 2|Withdrawal by Subject|0|||
105691821|NCT01968070|364536377|FG016|Period 2|Withdrawal by Subject|0|||
105691822|NCT01968070|364536378|FG017|Period 2|Withdrawal by Subject|0|||
105691823|NCT00821431|364536383|FG000|Overall Study|Adverse Event|6|||
105691824|NCT00821431|364536384|FG001|Overall Study|Adverse Event|3|||
105691825|NCT00821431|364536383|FG000|Overall Study|Withdrawal by Subject|5|||
105691826|NCT00821431|364536384|FG001|Overall Study|Withdrawal by Subject|0|||
105691827|NCT00821431|364536383|FG000|Overall Study|Lost to Follow-up|1|||
105691828|NCT00821431|364536384|FG001|Overall Study|Lost to Follow-up|0|||
105691829|NCT00821431|364536383|FG000|Overall Study|Protocol Violation|3|||
105691830|NCT00821431|364536384|FG001|Overall Study|Protocol Violation|1|||
105691831|NCT00821431|364536383|FG000|Overall Study|Physician Decision|0|||
105691832|NCT00821431|364536384|FG001|Overall Study|Physician Decision|1|||
105691833|NCT01822522|364536385|FG000|Overall Study|Adverse Event|1|||
105691834|NCT01822522|364536386|FG001|Overall Study|Adverse Event|1|||
105691835|NCT01822522|364536387|FG002|Overall Study|Adverse Event|1|||
105691836|NCT01822522|364536388|FG003|Overall Study|Adverse Event|0|||
105691837|NCT01822522|364536389|FG004|Overall Study|Adverse Event|0|||
105691838|NCT01822522|364536390|FG005|Overall Study|Adverse Event|1|||
105691839|NCT01822522|364536385|FG000|Overall Study|Death|3|||
105691840|NCT01822522|364536386|FG001|Overall Study|Death|0|||
105691841|NCT01822522|364536387|FG002|Overall Study|Death|2|||
105691842|NCT01822522|364536388|FG003|Overall Study|Death|0|||
105691843|NCT01822522|364536389|FG004|Overall Study|Death|0|||
106002835|NCT01005251|365672528|FG001|Overall Study|Withdrawal by Subject|5|||
106002836|NCT01005251|365672529|FG002|Overall Study|Withdrawal by Subject|3|||
106002837|NCT01005251|365672530|FG003|Overall Study|Withdrawal by Subject|4|||
106002838|NCT01005251|365672531|FG004|Overall Study|Withdrawal by Subject|9|||
106002839|NCT01005251|365672527|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
106002840|NCT01005251|365672528|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
106002841|NCT01005251|365672529|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
106002842|NCT01005251|365672530|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
106002843|NCT01005251|365672531|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
106002844|NCT01005251|365672527|FG000|Overall Study|Adverse Event|2|||
106002845|NCT01005251|365672528|FG001|Overall Study|Adverse Event|6|||
106002846|NCT01005251|365672529|FG002|Overall Study|Adverse Event|8|||
106002847|NCT01005251|365672530|FG003|Overall Study|Adverse Event|5|||
106002848|NCT01005251|365672531|FG004|Overall Study|Adverse Event|4|||
106002849|NCT01005251|365672527|FG000|Overall Study|Protocol Violation|1|||
106002850|NCT01005251|365672528|FG001|Overall Study|Protocol Violation|0|||
106002851|NCT01005251|365672529|FG002|Overall Study|Protocol Violation|0|||
106002852|NCT01005251|365672530|FG003|Overall Study|Protocol Violation|0|||
106002853|NCT01005251|365672531|FG004|Overall Study|Protocol Violation|2|||
106002854|NCT01005251|365672527|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
106002855|NCT01005251|365672528|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
106002856|NCT01005251|365672529|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
106002857|NCT01005251|365672530|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
106002858|NCT01005251|365672531|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
106002859|NCT01005251|365672527|FG000|Overall Study|Lost to Follow-up|1|||
106002860|NCT01005251|365672528|FG001|Overall Study|Lost to Follow-up|4|||
106002861|NCT01005251|365672529|FG002|Overall Study|Lost to Follow-up|2|||
106002862|NCT01005251|365672530|FG003|Overall Study|Lost to Follow-up|0|||
106002863|NCT01005251|365672531|FG004|Overall Study|Lost to Follow-up|0|||
106002864|NCT01005251|365672527|FG000|Overall Study|Physician Decision|0|||
106002865|NCT01005251|365672528|FG001|Overall Study|Physician Decision|0|||
106002866|NCT01005251|365672529|FG002|Overall Study|Physician Decision|0|||
106002867|NCT01005251|365672530|FG003|Overall Study|Physician Decision|0|||
106002868|NCT01005251|365672531|FG004|Overall Study|Physician Decision|2|||
106002869|NCT01005251|365672527|FG000|Overall Study|Patient moved|1|||
105691844|NCT01822522|364536390|FG005|Overall Study|Death|0|||
105691845|NCT01822522|364536385|FG000|Overall Study|Lost to Follow-up|0|||
106002870|NCT01005251|365672528|FG001|Overall Study|Patient moved|0|||
106002871|NCT01005251|365672529|FG002|Overall Study|Patient moved|0|||
106002872|NCT01005251|365672530|FG003|Overall Study|Patient moved|0|||
106002873|NCT01005251|365672531|FG004|Overall Study|Patient moved|0|||
106002874|NCT01005251|365672527|FG000|Overall Study|Wrong drug dispensed|0|||
106002875|NCT01005251|365672528|FG001|Overall Study|Wrong drug dispensed|1|||
106002876|NCT01005251|365672529|FG002|Overall Study|Wrong drug dispensed|0|||
106002877|NCT01005251|365672530|FG003|Overall Study|Wrong drug dispensed|0|||
105691846|NCT01822522|364536386|FG001|Overall Study|Lost to Follow-up|0|||
105691847|NCT01822522|364536387|FG002|Overall Study|Lost to Follow-up|1|||
105691848|NCT01822522|364536388|FG003|Overall Study|Lost to Follow-up|1|||
106002878|NCT01005251|365672531|FG004|Overall Study|Wrong drug dispensed|0|||
105691849|NCT01822522|364536389|FG004|Overall Study|Lost to Follow-up|0|||
105691850|NCT01822522|364536390|FG005|Overall Study|Lost to Follow-up|1|||
106002879|NCT01005251|365672527|FG000|Overall Study|Randomized in error|0|||
106002880|NCT01005251|365672528|FG001|Overall Study|Randomized in error|0|||
106130674|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Death|0|||
106130675|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
106130676|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
106130677|NCT02403674|366135521|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
106130678|NCT02403674|366135522|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
106130679|NCT02403674|366135521|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
106130680|NCT02403674|366135522|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
106130681|NCT02403674|366135521|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
106130682|NCT02403674|366135522|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
106130683|NCT02403674|366135521|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
106130684|NCT02403674|366135522|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
106130685|NCT02403674|366135521|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
106130686|NCT02403674|366135522|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
106130687|NCT02403674|366135521|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
106130688|NCT02403674|366135522|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
106130689|NCT02403674|366135521|FG000|Study Extension 2 (Open-Label)|Death|2|||
106130690|NCT02403674|366135522|FG001|Study Extension 2 (Open-Label)|Death|2|||
106130691|NCT02403674|366135521|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
106130692|NCT02403674|366135522|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
106130693|NCT02403674|366135521|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
106130694|NCT02403674|366135522|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
106130695|NCT02403674|366135521|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
106130696|NCT02403674|366135522|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
106130697|NCT02403674|366135521|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
106130698|NCT02403674|366135522|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
106130699|NCT02403674|366135521|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
106130700|NCT02403674|366135522|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
106130701|NCT02403674|366135521|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
106130702|NCT02403674|366135522|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
106130703|NCT02403674|366135521|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
106130704|NCT02403674|366135522|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
106130705|NCT05343455|366135527|FG000|Overall Study|Withdrawal by Subject|4|||
106130706|NCT05343455|366135528|FG001|Overall Study|Withdrawal by Subject|9|||
106130707|NCT05343455|366135529|FG002|Overall Study|Withdrawal by Subject|7|||
106130708|NCT05343455|366135527|FG000|Overall Study|Adverse Event|2|||
106130709|NCT05343455|366135528|FG001|Overall Study|Adverse Event|1|||
106130710|NCT05343455|366135529|FG002|Overall Study|Adverse Event|2|||
106130711|NCT05343455|366135527|FG000|Overall Study|Lost to Follow-up|1|||
106130712|NCT05343455|366135528|FG001|Overall Study|Lost to Follow-up|1|||
106130713|NCT05343455|366135529|FG002|Overall Study|Lost to Follow-up|3|||
106130714|NCT05343455|366135527|FG000|Overall Study|Pregnancy|1|||
106130715|NCT05343455|366135528|FG001|Overall Study|Pregnancy|0|||
106130716|NCT05343455|366135529|FG002|Overall Study|Pregnancy|0|||
106130717|NCT05343455|366135527|FG000|Overall Study|Physician Decision|0|||
106130718|NCT05343455|366135528|FG001|Overall Study|Physician Decision|0|||
106130719|NCT05343455|366135529|FG002|Overall Study|Physician Decision|1|||
106130720|NCT05343455|366135527|FG000|Overall Study|Protocol Violation|0|||
106130721|NCT05343455|366135528|FG001|Overall Study|Protocol Violation|1|||
106130722|NCT05343455|366135529|FG002|Overall Study|Protocol Violation|1|||
106130723|NCT02297503|366135530|FG000|Overall Study|Withdrawal by Subject|1|||
106130724|NCT02297503|366135531|FG001|Overall Study|Withdrawal by Subject|1|||
106130725|NCT02297503|366135530|FG000|Overall Study|Protocol Violation|1|||
106130726|NCT02297503|366135531|FG001|Overall Study|Protocol Violation|0|||
106130727|NCT02297503|366135530|FG000|Overall Study|Pregnancy|0|||
106130728|NCT02297503|366135531|FG001|Overall Study|Pregnancy|1|||
106130729|NCT02297503|366135530|FG000|Overall Study|Lost to Follow-up|0|||
106130730|NCT02297503|366135531|FG001|Overall Study|Lost to Follow-up|1|||
106130731|NCT02297503|366135530|FG000|Overall Study|Medical reason|0|||
105691851|NCT01822522|364536385|FG000|Overall Study|Withdrawal by Subject|0|||
105691852|NCT01822522|364536386|FG001|Overall Study|Withdrawal by Subject|0|||
106130732|NCT02297503|366135531|FG001|Overall Study|Medical reason|1|||
106130733|NCT02748512|366135532|FG000|Overall Study|Lost to Follow-up|1|||
106002881|NCT01005251|365672529|FG002|Overall Study|Randomized in error|1|||
106002882|NCT01005251|365672530|FG003|Overall Study|Randomized in error|1|||
106002883|NCT01005251|365672531|FG004|Overall Study|Randomized in error|0|||
106002884|NCT01005251|365672527|FG000|Overall Study|Lack of Efficacy|0|||
106002885|NCT01005251|365672528|FG001|Overall Study|Lack of Efficacy|0|||
106002886|NCT01005251|365672529|FG002|Overall Study|Lack of Efficacy|1|||
106002887|NCT01005251|365672530|FG003|Overall Study|Lack of Efficacy|1|||
106002888|NCT01005251|365672531|FG004|Overall Study|Lack of Efficacy|0|||
106002889|NCT00791388|365672533|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
106002890|NCT00791388|365672534|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
106002891|NCT00791388|365672535|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
106002892|NCT00791388|365672536|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
106002893|NCT00791388|365672537|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
106002894|NCT00791388|365672533|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
106002895|NCT00791388|365672534|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
106002896|NCT00791388|365672535|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
106002897|NCT00791388|365672536|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
106002898|NCT00791388|365672537|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
106002899|NCT00791388|365672533|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
106002900|NCT00791388|365672534|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
106002901|NCT00791388|365672535|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
106002902|NCT00791388|365672536|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
106002903|NCT00791388|365672537|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
106002904|NCT00346216|365672538|FG000|Overall Study|Other|181|||
106002905|NCT00346216|365672539|FG001|Overall Study|Other|231|||
106002906|NCT00346216|365672540|FG002|Overall Study|Other|205|||
106002907|NCT00346216|365672538|FG000|Overall Study|No longer willing to participate|600|||
106002908|NCT00346216|365672539|FG001|Overall Study|No longer willing to participate|606|||
106002909|NCT00346216|365672540|FG002|Overall Study|No longer willing to participate|585|||
106002910|NCT00346216|365672538|FG000|Overall Study|Withdrawal by Subject|661|||
106002911|NCT00346216|365672539|FG001|Overall Study|Withdrawal by Subject|692|||
106002912|NCT00346216|365672540|FG002|Overall Study|Withdrawal by Subject|651|||
106002913|NCT00346216|365672538|FG000|Overall Study|Lost to Follow-up|611|||
106002914|NCT00346216|365672539|FG001|Overall Study|Lost to Follow-up|588|||
106002915|NCT00346216|365672540|FG002|Overall Study|Lost to Follow-up|542|||
106002916|NCT00346216|365672538|FG000|Overall Study|Physician Decision|80|||
106002917|NCT00346216|365672539|FG001|Overall Study|Physician Decision|76|||
106002918|NCT00346216|365672540|FG002|Overall Study|Physician Decision|59|||
106002919|NCT00346216|365672538|FG000|Overall Study|Does not meet entrance criteria|13|||
106002920|NCT00346216|365672539|FG001|Overall Study|Does not meet entrance criteria|10|||
106002921|NCT00346216|365672540|FG002|Overall Study|Does not meet entrance criteria|8|||
106002922|NCT00346216|365672538|FG000|Overall Study|Death|189|||
106002923|NCT00346216|365672539|FG001|Overall Study|Death|192|||
106002924|NCT00346216|365672540|FG002|Overall Study|Death|228|||
106002925|NCT00346216|365672538|FG000|Overall Study|Study terminated by sponsor|11|||
106002926|NCT00346216|365672539|FG001|Overall Study|Study terminated by sponsor|4|||
106002927|NCT00346216|365672540|FG002|Overall Study|Study terminated by sponsor|8|||
106002928|NCT00346216|365672538|FG000|Overall Study|Missing Subject Summary Status|62|||
106002929|NCT00346216|365672539|FG001|Overall Study|Missing Subject Summary Status|61|||
106002930|NCT00346216|365672540|FG002|Overall Study|Missing Subject Summary Status|62|||
106002931|NCT00657540|365672550|FG000|Overall Study|Lost to Follow-up|1|||
106002932|NCT00657540|365672551|FG001|Overall Study|Lost to Follow-up|4|||
105691853|NCT01822522|364536387|FG002|Overall Study|Withdrawal by Subject|0|||
105691854|NCT01822522|364536388|FG003|Overall Study|Withdrawal by Subject|1|||
105691855|NCT01822522|364536389|FG004|Overall Study|Withdrawal by Subject|0|||
105691856|NCT01822522|364536390|FG005|Overall Study|Withdrawal by Subject|0|||
106002933|NCT01731912|365672552|FG000|Overall Study|noncompliance|2|||
105691857|NCT01822522|364536385|FG000|Overall Study|Lack of Efficacy|0|||
106002934|NCT02043938|365672553|FG000|Overall Study|Withdrawal by Subject|7|||
106002935|NCT02043938|365672553|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
106002936|NCT02043938|365672553|FG000|Overall Study|No show by subject|1|||
106002937|NCT02043938|365672553|FG000|Overall Study|Investigator decision|1|||
106002938|NCT01453140|365672560|FG000|Overall Study|Adverse Event|3|||
106002939|NCT01054456|365672561|FG000|Overall Study|Other|1|||
106002940|NCT03535974|365672562|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
106002941|NCT03535974|365672563|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
106002942|NCT03535974|365672564|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
106002943|NCT03535974|365672562|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
106130734|NCT02748512|366135533|FG001|Overall Study|Lost to Follow-up|1|||
106130735|NCT03169361|366135535|FG000|Overall Study|Protocol Violation|32|||
106130736|NCT02688621|366135536|FG000|Overall Study|Pregnancy|1|||
106130737|NCT02688621|366135537|FG001|Overall Study|Pregnancy|3|||
106130738|NCT02688621|366135536|FG000|Overall Study|Lost to Follow-up|38|||
106130739|NCT02688621|366135537|FG001|Overall Study|Lost to Follow-up|15|||
106130740|NCT02688621|366135536|FG000|Overall Study|Withdrawal by Subject|1|||
106130741|NCT02688621|366135537|FG001|Overall Study|Withdrawal by Subject|0|||
106130742|NCT03239210|366135538|FG000|Overall Study|Lost to Follow-up|2|||
106130743|NCT03239210|366135539|FG001|Overall Study|Lost to Follow-up|2|||
106130744|NCT03239210|366135538|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
106130745|NCT03239210|366135539|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
106130746|NCT03239210|366135538|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
106130747|NCT03239210|366135539|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
106130748|NCT03606460|366135542|FG000|Overall Study|Lost to Follow-up|1|||
106130749|NCT03606460|366135543|FG001|Overall Study|Lost to Follow-up|8|||
106130750|NCT03836664|366135547|FG000|Overall Study|Didn't complete forms and lost drug|3|||
106130751|NCT03836664|366135548|FG001|Overall Study|Didn't complete forms and lost drug|3|||
106130752|NCT02179918|366135553|FG000|Overall Study|Death|0|||
106130753|NCT02179918|366135554|FG001|Overall Study|Death|0|||
106130754|NCT02179918|366135555|FG002|Overall Study|Death|0|||
106130755|NCT02179918|366135556|FG003|Overall Study|Death|1|||
106130756|NCT02179918|366135557|FG004|Overall Study|Death|0|||
106130757|NCT02179918|366135553|FG000|Overall Study|Lost to Follow-up|0|||
106130758|NCT02179918|366135554|FG001|Overall Study|Lost to Follow-up|0|||
106130759|NCT02179918|366135555|FG002|Overall Study|Lost to Follow-up|1|||
106130760|NCT02179918|366135556|FG003|Overall Study|Lost to Follow-up|0|||
106130761|NCT02179918|366135557|FG004|Overall Study|Lost to Follow-up|0|||
106130762|NCT02179918|366135553|FG000|Overall Study|Progressive Disease|4|||
106130763|NCT02179918|366135554|FG001|Overall Study|Progressive Disease|1|||
106130764|NCT02179918|366135555|FG002|Overall Study|Progressive Disease|1|||
106130765|NCT02179918|366135556|FG003|Overall Study|Progressive Disease|2|||
106130766|NCT02179918|366135557|FG004|Overall Study|Progressive Disease|6|||
106130767|NCT02179918|366135553|FG000|Overall Study|Other|0|||
106130768|NCT02179918|366135554|FG001|Overall Study|Other|1|||
106130769|NCT02179918|366135555|FG002|Overall Study|Other|0|||
106130770|NCT02179918|366135556|FG003|Overall Study|Other|0|||
106130771|NCT02179918|366135557|FG004|Overall Study|Other|1|||
106130772|NCT02179918|366135553|FG000|Overall Study|Subject refused further follow-up|0|||
106130773|NCT02179918|366135554|FG001|Overall Study|Subject refused further follow-up|1|||
106130774|NCT02179918|366135555|FG002|Overall Study|Subject refused further follow-up|0|||
106130775|NCT02179918|366135556|FG003|Overall Study|Subject refused further follow-up|0|||
106130776|NCT02179918|366135557|FG004|Overall Study|Subject refused further follow-up|1|||
106130777|NCT01272011|366135560|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
106130778|NCT01272011|366135561|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
106130779|NCT01272011|366135562|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
106130780|NCT01627340|366135563|FG000|Overall Study|Adverse Event|1|||
106130781|NCT01627340|366135564|FG001|Overall Study|Adverse Event|0|||
106130782|NCT01627340|366135563|FG000|Overall Study|Lost to Follow-up|8|||
106130783|NCT01627340|366135564|FG001|Overall Study|Lost to Follow-up|4|||
106130784|NCT01627340|366135563|FG000|Overall Study|Pregnancy|1|||
106130785|NCT01627340|366135564|FG001|Overall Study|Pregnancy|0|||
106130786|NCT01627340|366135563|FG000|Overall Study|Withdrawal by Subject|2|||
106130787|NCT01627340|366135564|FG001|Overall Study|Withdrawal by Subject|0|||
106130788|NCT00859014|366135567|FG000|Overall Study|Death|4|||
106130789|NCT00859014|366135567|FG000|Overall Study|Lost to Follow-up|1|||
106130790|NCT02162732|366135568|FG000|Overall Study|Biopsy not performed.|18|||
106130791|NCT04668144|366135574|FG000|Overall Study|Protocol Violation|0|||
106130792|NCT04668144|366135575|FG001|Overall Study|Protocol Violation|1|||
106130793|NCT04668144|366135576|FG002|Overall Study|Protocol Violation|2|||
106130794|NCT00577629|366135580|FG000|Treatment Period|Death|1|||
106130795|NCT00577629|366135580|FG000|Long Term Follow-Up|Death|15|||
106130796|NCT00577629|366135580|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
106130797|NCT00577629|366135580|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
106130798|NCT00577629|366135580|FG000|Long Term Follow-Up|Physician Decision|1|||
106130799|NCT01072929|366135581|FG000|Overall Study|Adverse Event|8|||
106130800|NCT01072929|366135582|FG001|Overall Study|Adverse Event|11|||
106130801|NCT01072929|366135583|FG002|Overall Study|Adverse Event|2|||
106130802|NCT01072929|366135581|FG000|Overall Study|Lack of Efficacy|7|||
106130803|NCT01072929|366135582|FG001|Overall Study|Lack of Efficacy|4|||
106130804|NCT01072929|366135583|FG002|Overall Study|Lack of Efficacy|0|||
106130805|NCT01072929|366135581|FG000|Overall Study|Withdrawal by Subject|7|||
106130806|NCT01072929|366135582|FG001|Overall Study|Withdrawal by Subject|15|||
106130807|NCT01072929|366135583|FG002|Overall Study|Withdrawal by Subject|3|||
106130808|NCT01072929|366135581|FG000|Overall Study|Protocol Violation|13|||
106130809|NCT01072929|366135582|FG001|Overall Study|Protocol Violation|11|||
106130810|NCT01072929|366135583|FG002|Overall Study|Protocol Violation|2|||
106130811|NCT01072929|366135581|FG000|Overall Study|Lost to Follow-up|8|||
106130812|NCT01072929|366135582|FG001|Overall Study|Lost to Follow-up|4|||
106130813|NCT01072929|366135583|FG002|Overall Study|Lost to Follow-up|1|||
106130814|NCT01072929|366135581|FG000|Overall Study|Noncompliance with study medication|0|||
106130815|NCT01072929|366135582|FG001|Overall Study|Noncompliance with study medication|3|||
106130816|NCT01072929|366135583|FG002|Overall Study|Noncompliance with study medication|0|||
106130817|NCT01072929|366135581|FG000|Overall Study|Noncompliance with study procedures|1|||
106130818|NCT01072929|366135582|FG001|Overall Study|Noncompliance with study procedures|0|||
106130819|NCT01072929|366135583|FG002|Overall Study|Noncompliance with study procedures|1|||
106130820|NCT01072929|366135581|FG000|Overall Study|Other|0|||
106130821|NCT01072929|366135582|FG001|Overall Study|Other|3|||
106130822|NCT01072929|366135583|FG002|Overall Study|Other|0|||
106130823|NCT02338609|366135586|FG000|Overall Study|Physician Decision|1|||
106130824|NCT02338609|366135586|FG000|Overall Study|Death|1|||
106130825|NCT00832780|366135587|FG000|Overall Study|Death|16|||
106130826|NCT00832780|366135587|FG000|Overall Study|Lost to Follow-up|4|||
106130827|NCT00832780|366135587|FG000|Overall Study|no reason given|2|||
106130828|NCT00832780|366135587|FG000|Overall Study|other complicating condition|2|||
106130829|NCT00832780|366135587|FG000|Overall Study|Physician Decision|1|||
106130830|NCT05705167|366135588|FG000|Overall Study|Randomised but not Treated|0|||
106130831|NCT05705167|366135589|FG001|Overall Study|Randomised but not Treated|2|||
106130832|NCT05705167|366135590|FG002|Overall Study|Randomised but not Treated|0|||
106130833|NCT05705167|366135591|FG003|Overall Study|Randomised but not Treated|7|||
106130834|NCT05705167|366135592|FG004|Overall Study|Randomised but not Treated|0|||
106130835|NCT05705167|366135593|FG005|Overall Study|Randomised but not Treated|0|||
106130836|NCT05705167|366135594|FG006|Overall Study|Randomised but not Treated|0|||
106130837|NCT05705167|366135588|FG000|Overall Study|Death|0|||
106130838|NCT05705167|366135589|FG001|Overall Study|Death|0|||
106130839|NCT05705167|366135590|FG002|Overall Study|Death|3|||
106130840|NCT05705167|366135591|FG003|Overall Study|Death|0|||
106130841|NCT05705167|366135592|FG004|Overall Study|Death|1|||
106130842|NCT05705167|366135593|FG005|Overall Study|Death|1|||
106130843|NCT05705167|366135594|FG006|Overall Study|Death|1|||
106130844|NCT05705167|366135588|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
106130845|NCT05705167|366135589|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
106130846|NCT05705167|366135590|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
106130847|NCT05705167|366135591|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
106130848|NCT05705167|366135592|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
106130849|NCT05705167|366135593|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
106130850|NCT05705167|366135594|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
106130851|NCT01101542|366135598|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
106130852|NCT01101542|366135598|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
106130853|NCT01101542|366135598|FG000|Year 4 Surveillance Period|Other|287|||
106130854|NCT01101542|366135598|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
106130855|NCT01101542|366135598|FG000|Year 5 Surveillance Period|Pregnancy|1|||
106130856|NCT01101542|366135598|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
106130857|NCT01101542|366135598|FG000|Year 6 Surveillance Period|Pregnancy|1|||
106130858|NCT01101542|366135598|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
106130859|NCT00701311|366135599|FG000|Overall Study|Lack of Efficacy|3|||
106130860|NCT00701311|366135599|FG000|Overall Study|Adverse Event|3|||
106130861|NCT00701311|366135599|FG000|Overall Study|Withdrawal by Subject|2|||
106130862|NCT00670540|366135602|FG000|Overall Study|ineligible|17|||
106130863|NCT00670540|366135602|FG000|Overall Study|not living in France|348|||
106130864|NCT00670540|366135602|FG000|Overall Study|refused to participate|189|||
106130865|NCT00670540|366135602|FG000|Overall Study|controls randomised for no follow up|2770|||
106130866|NCT00670540|366135602|FG000|Overall Study|missing information inclusion criteria|1|||
106130867|NCT00814489|366135603|FG000|Overall Study|Other|2|||
106130868|NCT00814489|366135604|FG001|Overall Study|Other|0|||
106130869|NCT00814489|366135605|FG002|Overall Study|Other|1|||
106130870|NCT01256476|366137577|FG000|Overall Study|Adverse Event|2|||
106130871|NCT01256476|366137578|FG001|Overall Study|Adverse Event|1|||
106130872|NCT01256476|366137577|FG000|Overall Study|Withdrawal by Subject|2|||
106130873|NCT01256476|366137578|FG001|Overall Study|Withdrawal by Subject|1|||
106130874|NCT01256476|366137577|FG000|Overall Study|Lost to Follow-up|1|||
106130875|NCT01256476|366137578|FG001|Overall Study|Lost to Follow-up|2|||
105691858|NCT01822522|364536386|FG001|Overall Study|Lack of Efficacy|0|||
105691859|NCT01822522|364536387|FG002|Overall Study|Lack of Efficacy|0|||
105691860|NCT01822522|364536388|FG003|Overall Study|Lack of Efficacy|0|||
105691861|NCT01822522|364536389|FG004|Overall Study|Lack of Efficacy|0|||
105691862|NCT01822522|364536390|FG005|Overall Study|Lack of Efficacy|2|||
105691863|NCT01807923|364536392|FG000|Overall Study|Adverse Event|2|||
105691864|NCT01807923|364536393|FG001|Overall Study|Adverse Event|1|||
105691865|NCT01807923|364536394|FG002|Overall Study|Adverse Event|2|||
105691866|NCT01807923|364536392|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
106130876|NCT01256476|366137577|FG000|Overall Study|Persistent ALT or AST elevation|1|||
105691867|NCT01807923|364536393|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
106130877|NCT01256476|366137578|FG001|Overall Study|Persistent ALT or AST elevation|0|||
106130878|NCT01256476|366137577|FG000|Overall Study|Physician Decision|0|||
105786963|NCT04768881|364872943|FG000|Overall Study|Withdrawal by Subject|2|||
105786964|NCT04768881|364872944|FG001|Overall Study|Withdrawal by Subject|0|||
105786965|NCT04768881|364872943|FG000|Overall Study|Other|2|||
105786966|NCT04768881|364872944|FG001|Overall Study|Other|0|||
105786967|NCT02146365|364872947|FG000|Overall Study|Lost to Follow-up|2|||
106002944|NCT03535974|365672563|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
106002945|NCT03535974|365672564|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
106002946|NCT04621448|365672565|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
106002947|NCT04621448|365672566|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
106002948|NCT04621448|365672567|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
106002949|NCT04621448|365672568|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
106002950|NCT04621448|365672565|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
106002951|NCT04621448|365672566|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
106002952|NCT04621448|365672567|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
106002953|NCT04621448|365672568|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
106002954|NCT04621448|365672565|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
106002955|NCT04621448|365672566|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
106002956|NCT04621448|365672567|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
106002957|NCT04621448|365672568|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
106002958|NCT04621448|365672565|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
106002959|NCT04621448|365672566|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
106002960|NCT04621448|365672567|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
106002961|NCT04621448|365672568|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
106002962|NCT03935126|365672569|FG000|Overall Study|Study termination by sponsor|3|||
106002963|NCT01721161|365672570|FG000|Overall Study|Adverse Event|2|||
106002964|NCT01721161|365672571|FG001|Overall Study|Adverse Event|3|||
106002965|NCT01721161|365672570|FG000|Overall Study|Lost to Follow-up|1|||
106002966|NCT01721161|365672571|FG001|Overall Study|Lost to Follow-up|2|||
106002967|NCT01721161|365672570|FG000|Overall Study|Withdrawal by Subject|1|||
106002968|NCT01721161|365672571|FG001|Overall Study|Withdrawal by Subject|1|||
106002969|NCT01721161|365672570|FG000|Overall Study|Other|0|||
106002970|NCT01721161|365672571|FG001|Overall Study|Other|1|||
106002971|NCT00399516|365672572|FG000|Overall Study|Lost to Follow-up|2|||
106002972|NCT02365649|365672577|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
106002973|NCT02365649|365672578|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
106002974|NCT02365649|365672579|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
106002975|NCT02365649|365672580|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
106002976|NCT02365649|365672581|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
106002977|NCT02365649|365672582|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
106002978|NCT02365649|365672583|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
106002979|NCT02365649|365672584|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
106002980|NCT02365649|365672585|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
105691868|NCT01807923|364536394|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
105691869|NCT01807923|364536392|FG000|Overall Study|Physician Decision|0|||
105691870|NCT01807923|364536393|FG001|Overall Study|Physician Decision|0|||
105691871|NCT01807923|364536394|FG002|Overall Study|Physician Decision|1|||
105691872|NCT01807923|364536392|FG000|Overall Study|Not Eligible (Genotype)|0|||
105691873|NCT01807923|364536393|FG001|Overall Study|Not Eligible (Genotype)|0|||
105691874|NCT01807923|364536394|FG002|Overall Study|Not Eligible (Genotype)|1|||
105691875|NCT01807923|364536392|FG000|Overall Study|Randomized But Not Treated|3|||
105691876|NCT01807923|364536393|FG001|Overall Study|Randomized But Not Treated|2|||
105691877|NCT01807923|364536394|FG002|Overall Study|Randomized But Not Treated|5|||
105691878|NCT00890929|364536395|FG000|Overall Study|Death before treatment|2|||
105691879|NCT00890929|364536395|FG000|Overall Study|Withdrawal by Subject|3|||
105691880|NCT00890929|364536395|FG000|Overall Study|Physician Decision|1|||
105691881|NCT00995007|364536396|FG000|Overall Study|Withdrew consent|1|||
105691882|NCT00995007|364536397|FG001|Overall Study|Withdrew consent|0|||
105691883|NCT00995007|364536396|FG000|Overall Study|Refused further treatment|8|||
105691884|NCT00995007|364536397|FG001|Overall Study|Refused further treatment|2|||
105691885|NCT00995007|364536396|FG000|Overall Study|Toxicity|8|||
105691886|NCT00995007|364536397|FG001|Overall Study|Toxicity|0|||
105786968|NCT02146365|364872948|FG001|Overall Study|Lost to Follow-up|1|||
105786969|NCT02146365|364872949|FG002|Overall Study|Lost to Follow-up|3|||
106002981|NCT02365649|365672586|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
106002982|NCT02365649|365672577|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
106002983|NCT02365649|365672578|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
105691887|NCT02469896|364536404|FG000|Overall Study|Withdrawal by Subject|2|||
106002984|NCT02365649|365672579|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
106002985|NCT02365649|365672580|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
105691888|NCT02469896|364536405|FG001|Overall Study|Withdrawal by Subject|0|||
105691889|NCT01093625|364536410|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
105691890|NCT01093625|364536411|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
105786970|NCT02146365|364872950|FG003|Overall Study|Lost to Follow-up|3|||
106002986|NCT02365649|365672581|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
106002987|NCT02365649|365672582|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
106002988|NCT02365649|365672583|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
106002989|NCT02365649|365672584|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
106002990|NCT02365649|365672585|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
106002991|NCT02365649|365672586|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
106002992|NCT02365649|365672577|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
106002993|NCT02365649|365672578|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
106002994|NCT02365649|365672579|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
106002995|NCT02365649|365672580|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
106002996|NCT02365649|365672581|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
106002997|NCT02365649|365672582|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
106002998|NCT02365649|365672583|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
106002999|NCT02365649|365672584|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
106003000|NCT02365649|365672585|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
106003001|NCT02365649|365672586|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
106003002|NCT02365649|365672577|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
106003003|NCT02365649|365672578|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
106003004|NCT02365649|365672579|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
106003005|NCT02365649|365672580|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
106003006|NCT02365649|365672581|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
106003007|NCT02365649|365672582|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
106003008|NCT02365649|365672583|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
106003009|NCT02365649|365672584|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
106003010|NCT02365649|365672585|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
106003011|NCT02365649|365672586|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
106003012|NCT02365649|365672577|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
106003013|NCT02365649|365672578|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
106003014|NCT02365649|365672579|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
106003015|NCT02365649|365672580|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
106003016|NCT02365649|365672581|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
106003017|NCT02365649|365672582|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
106003018|NCT02365649|365672583|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
106003019|NCT02365649|365672584|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
106003020|NCT02365649|365672585|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
106003021|NCT02365649|365672586|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
106003022|NCT02365649|365672577|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
106003023|NCT02365649|365672578|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
106003024|NCT02365649|365672579|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
106003025|NCT02365649|365672580|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
106003026|NCT02365649|365672581|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
106003027|NCT02365649|365672582|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
106003028|NCT02365649|365672583|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
106003029|NCT02365649|365672584|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
106003030|NCT02365649|365672585|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
106003031|NCT02365649|365672586|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
106003032|NCT02365649|365672577|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003033|NCT02365649|365672578|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003034|NCT02365649|365672579|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
106003035|NCT02365649|365672580|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003036|NCT02365649|365672581|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003037|NCT02365649|365672582|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003038|NCT02365649|365672583|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003039|NCT02365649|365672584|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003040|NCT02365649|365672585|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003041|NCT02365649|365672586|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
106003042|NCT02365649|365672577|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
106003043|NCT02365649|365672578|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
106003044|NCT02365649|365672579|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
106003045|NCT02365649|365672580|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
106003046|NCT02365649|365672581|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
106003047|NCT02365649|365672582|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
106003048|NCT02365649|365672583|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
106003049|NCT02365649|365672584|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
106003050|NCT02365649|365672585|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
105691891|NCT01093625|364536410|FG000|2-Week Visit|Withdrawal by Subject|1|||
105691892|NCT01093625|364536411|FG001|2-Week Visit|Withdrawal by Subject|0|||
106130879|NCT01256476|366137578|FG001|Overall Study|Physician Decision|1|||
106130880|NCT01256476|366137577|FG000|Overall Study|Subject non-compliance|0|||
106130881|NCT01256476|366137578|FG001|Overall Study|Subject non-compliance|1|||
106130882|NCT01256476|366137577|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
106130883|NCT01256476|366137578|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
106130884|NCT02485353|366137581|FG000|Overall Study|Death|1|||
106130885|NCT02485353|366137581|FG000|Overall Study|Disease Progression|1|||
106130886|NCT02788656|366137582|FG000|Overall Study|Withdrawal by Subject|1|||
106130887|NCT02788656|366137583|FG001|Overall Study|Withdrawal by Subject|0|||
106130888|NCT02271594|366137584|FG000|Overall Study|Study closed; recruiting failure|19|||
106130889|NCT02271594|366137585|FG001|Overall Study|Study closed; recruiting failure|12|||
106130890|NCT01561079|366137586|FG000|Overall Study|Physician Decision|17|||
106130891|NCT01561079|366137586|FG000|Overall Study|Withdrawal by Subject|59|||
106130892|NCT01561079|366137586|FG000|Overall Study|Protocol Violation|2|||
106130893|NCT01575860|366137587|FG000|Overall Study|Withdrawal by Subject|1|||
106130894|NCT01575860|366137587|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
106130895|NCT01106976|366137588|FG000|Overall Study|Lost to Follow-up|8|||
106130896|NCT00003377|366137589|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
106130897|NCT00003377|366137590|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
105691893|NCT01093625|364536410|FG000|1-Month Visit|Lost to Follow-up|2|||
105691894|NCT01093625|364536411|FG001|1-Month Visit|Lost to Follow-up|0|||
105691895|NCT01093625|364536410|FG000|3-Month Visit|Lost to Follow-up|2|||
105691896|NCT01093625|364536411|FG001|3-Month Visit|Lost to Follow-up|0|||
105691897|NCT01093625|364536410|FG000|6-Month Visit|Withdrawal by Subject|6|||
106130898|NCT00003377|366137591|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
106130899|NCT00003377|366137592|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
106130900|NCT00003377|366137593|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
106130901|NCT00003377|366137589|FG000|Period II|Ureteral stent complications|0|||
106130902|NCT00003377|366137590|FG001|Period II|Ureteral stent complications|0|||
106130903|NCT00003377|366137591|FG002|Period II|Ureteral stent complications|0|||
106130904|NCT00003377|366137592|FG003|Period II|Ureteral stent complications|0|||
106130905|NCT00003377|366137593|FG004|Period II|Ureteral stent complications|1|||
106130906|NCT01237678|366137600|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
106130907|NCT01237678|366137601|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
106130908|NCT01237678|366137602|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
106130909|NCT01237678|366137600|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
106130910|NCT01237678|366137601|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
106130911|NCT01237678|366137602|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
106130912|NCT01237678|366137600|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
106130913|NCT01237678|366137601|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
106130914|NCT01237678|366137602|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
106130915|NCT01237678|366137600|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
106130916|NCT01237678|366137601|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
106130917|NCT01237678|366137602|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
106130918|NCT01237678|366137600|FG000|Phase II|Adverse Event|0|||
106130919|NCT01237678|366137601|FG001|Phase II|Adverse Event|39|||
106130920|NCT01237678|366137602|FG002|Phase II|Adverse Event|9|||
106130921|NCT01237678|366137600|FG000|Phase II|Death|0|||
106130922|NCT01237678|366137601|FG001|Phase II|Death|0|||
106130923|NCT01237678|366137602|FG002|Phase II|Death|2|||
106130924|NCT01237678|366137600|FG000|Phase II|Lack of Efficacy|0|||
106130925|NCT01237678|366137601|FG001|Phase II|Lack of Efficacy|25|||
106130926|NCT01237678|366137602|FG002|Phase II|Lack of Efficacy|3|||
106130927|NCT01237678|366137600|FG000|Phase II|Withdrawal by Subject|0|||
106130928|NCT01237678|366137601|FG001|Phase II|Withdrawal by Subject|1|||
106130929|NCT01237678|366137602|FG002|Phase II|Withdrawal by Subject|5|||
106130930|NCT01237678|366137600|FG000|Phase II|Completed Cycles 4-6|0|||
106130931|NCT01237678|366137601|FG001|Phase II|Completed Cycles 4-6|11|||
106130932|NCT01237678|366137602|FG002|Phase II|Completed Cycles 4-6|21|||
106130933|NCT01237678|366137600|FG000|Phase II|Sponsor Decision/Study Closed|0|||
106130934|NCT01237678|366137601|FG001|Phase II|Sponsor Decision/Study Closed|18|||
106130935|NCT01237678|366137602|FG002|Phase II|Sponsor Decision/Study Closed|7|||
106130936|NCT01237678|366137600|FG000|Phase II|Randomized but were not treated|0|||
106130937|NCT01237678|366137601|FG001|Phase II|Randomized but were not treated|4|||
106130938|NCT01237678|366137602|FG002|Phase II|Randomized but were not treated|3|||
106130939|NCT00372528|366137603|FG000|Overall Study|Lack of Efficacy|1|||
106130940|NCT00372528|366137603|FG000|Overall Study|Adverse Event|1|||
105691898|NCT01093625|364536411|FG001|6-Month Visit|Withdrawal by Subject|7|||
105691899|NCT01093625|364536410|FG000|6-Month Visit|Lost to Follow-up|2|||
106130941|NCT00372528|366137603|FG000|Overall Study|Study Terminated by Sponsor|18|||
106130942|NCT00372528|366137603|FG000|Overall Study|Other|1|||
105691900|NCT01093625|364536411|FG001|6-Month Visit|Lost to Follow-up|2|||
106130943|NCT00562965|366137608|FG000|Overall Study|Withdrawal by Subject|0|||
106130944|NCT00562965|366137609|FG001|Overall Study|Withdrawal by Subject|1|||
106130945|NCT00562965|366137608|FG000|Overall Study|Death|2|||
106130946|NCT00562965|366137609|FG001|Overall Study|Death|4|||
105691901|NCT01093625|364536410|FG000|1-Year Visit|Lost to Follow-up|5|||
105691902|NCT01093625|364536411|FG001|1-Year Visit|Lost to Follow-up|3|||
105691903|NCT03684642|364536415|FG000|Overall Study|Adverse Event|6|||
105919592|NCT02265510|365365126|FG011|Overall Study|Lost to Follow-up|0|||
105919593|NCT02265510|365365127|FG012|Overall Study|Lost to Follow-up|0|||
105919594|NCT02265510|365365128|FG013|Overall Study|Lost to Follow-up|2|||
105919595|NCT02265510|365365115|FG000|Overall Study|Other|0|||
105919596|NCT02265510|365365116|FG001|Overall Study|Other|1|||
105919597|NCT02265510|365365117|FG002|Overall Study|Other|0|||
105919598|NCT02265510|365365118|FG003|Overall Study|Other|0|||
105919599|NCT02265510|365365119|FG004|Overall Study|Other|0|||
105919600|NCT02265510|365365120|FG005|Overall Study|Other|0|||
105919601|NCT02265510|365365121|FG006|Overall Study|Other|0|||
105919602|NCT02265510|365365122|FG007|Overall Study|Other|0|||
105919603|NCT02265510|365365123|FG008|Overall Study|Other|0|||
105919604|NCT02265510|365365124|FG009|Overall Study|Other|0|||
105919605|NCT02265510|365365125|FG010|Overall Study|Other|0|||
105919606|NCT02265510|365365126|FG011|Overall Study|Other|0|||
105919607|NCT02265510|365365127|FG012|Overall Study|Other|0|||
105919608|NCT02265510|365365128|FG013|Overall Study|Other|0|||
105919609|NCT02265510|365365115|FG000|Overall Study|Study Terminated by Sponsor|0|||
105919610|NCT02265510|365365116|FG001|Overall Study|Study Terminated by Sponsor|0|||
105919611|NCT02265510|365365117|FG002|Overall Study|Study Terminated by Sponsor|0|||
105919612|NCT02265510|365365118|FG003|Overall Study|Study Terminated by Sponsor|0|||
105919613|NCT02265510|365365119|FG004|Overall Study|Study Terminated by Sponsor|0|||
105919614|NCT02265510|365365120|FG005|Overall Study|Study Terminated by Sponsor|1|||
105919615|NCT02265510|365365121|FG006|Overall Study|Study Terminated by Sponsor|1|||
105919616|NCT02265510|365365122|FG007|Overall Study|Study Terminated by Sponsor|1|||
105919617|NCT02265510|365365123|FG008|Overall Study|Study Terminated by Sponsor|1|||
105919618|NCT02265510|365365124|FG009|Overall Study|Study Terminated by Sponsor|2|||
105919619|NCT02265510|365365125|FG010|Overall Study|Study Terminated by Sponsor|1|||
105919620|NCT02265510|365365126|FG011|Overall Study|Study Terminated by Sponsor|4|||
105919621|NCT02265510|365365127|FG012|Overall Study|Study Terminated by Sponsor|1|||
105919622|NCT02265510|365365128|FG013|Overall Study|Study Terminated by Sponsor|2|||
105919623|NCT01668797|365365129|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
105919624|NCT01668797|365365130|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
105919625|NCT01668797|365365131|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
105919626|NCT01668797|365365132|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
105919627|NCT01668797|365365129|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
105919628|NCT01668797|365365130|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
105919629|NCT01668797|365365131|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
105919630|NCT01668797|365365132|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
105919631|NCT01668797|365365129|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
105919632|NCT01668797|365365130|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
105919633|NCT01668797|365365131|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
105919634|NCT01668797|365365132|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
105919635|NCT01668797|365365129|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
105919636|NCT01668797|365365130|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
105919637|NCT01668797|365365131|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
105919638|NCT01668797|365365132|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
105919639|NCT01668797|365365129|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
105919640|NCT01668797|365365130|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
105919641|NCT01668797|365365131|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
105919642|NCT01668797|365365132|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
105919643|NCT01668797|365365129|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
105919644|NCT01668797|365365130|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
105919645|NCT01668797|365365131|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
105919646|NCT01668797|365365132|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
105919647|NCT01668797|365365129|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
105919648|NCT01668797|365365130|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
105691904|NCT03684642|364536416|FG001|Overall Study|Adverse Event|15|||
105919649|NCT01668797|365365131|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
105919650|NCT01668797|365365132|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
105691905|NCT03684642|364536417|FG002|Overall Study|Adverse Event|11|||
105919651|NCT01668797|365365129|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
105919652|NCT01668797|365365130|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
105919653|NCT01668797|365365131|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
105919654|NCT01668797|365365132|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
105919655|NCT01668797|365365129|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
105919656|NCT01668797|365365130|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
105919657|NCT01668797|365365131|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
105786971|NCT02146365|364872951|FG004|Overall Study|Lost to Follow-up|1|||
105919658|NCT01668797|365365132|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
106130947|NCT00562965|366137608|FG000|Overall Study|Lost to Follow-up|1|||
106003051|NCT02365649|365672586|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
106003052|NCT02365649|365672577|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
106003053|NCT02365649|365672578|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
106003054|NCT02365649|365672579|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
106003055|NCT02365649|365672580|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
106003056|NCT02365649|365672581|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
106003057|NCT02365649|365672582|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
106003058|NCT02365649|365672583|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
106003059|NCT02365649|365672584|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
106003060|NCT02365649|365672585|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
106003061|NCT02365649|365672586|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
106003062|NCT02365649|365672577|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
106003063|NCT02365649|365672578|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
106003064|NCT02365649|365672579|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
106003065|NCT02365649|365672580|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
106003066|NCT02365649|365672581|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
106003067|NCT02365649|365672582|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
106003068|NCT02365649|365672583|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
106003069|NCT02365649|365672584|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
106003070|NCT02365649|365672585|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
106003071|NCT02365649|365672586|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
106003072|NCT02365649|365672577|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
106003073|NCT02365649|365672578|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
106003074|NCT02365649|365672579|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
106003075|NCT02365649|365672580|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
106003076|NCT02365649|365672581|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
106003077|NCT02365649|365672582|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
106003078|NCT02365649|365672583|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
106003079|NCT02365649|365672584|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
106003080|NCT02365649|365672585|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
106003081|NCT02365649|365672586|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
106003082|NCT02365649|365672577|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
106003083|NCT02365649|365672578|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
106003084|NCT02365649|365672579|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
106003085|NCT02365649|365672580|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
106003086|NCT02365649|365672581|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
106003087|NCT02365649|365672582|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
106003088|NCT02365649|365672583|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
106003089|NCT02365649|365672584|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
106003090|NCT02365649|365672585|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
106003091|NCT02365649|365672586|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
106003092|NCT00689390|365672594|FG000|Overall Study|Adverse Event|19|||
106003093|NCT00689390|365672595|FG001|Overall Study|Adverse Event|0|||
106003094|NCT00689390|365672594|FG000|Overall Study|Lost to Follow-up|179|||
106003095|NCT00689390|365672595|FG001|Overall Study|Lost to Follow-up|7|||
106003096|NCT00689390|365672594|FG000|Overall Study|Withdrawal by Subject|117|||
106003097|NCT00689390|365672595|FG001|Overall Study|Withdrawal by Subject|3|||
106003098|NCT00689390|365672594|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
106003099|NCT00689390|365672595|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
106003100|NCT00689390|365672594|FG000|Overall Study|Non-Compliance With Protocol|21|||
106003101|NCT00689390|365672595|FG001|Overall Study|Non-Compliance With Protocol|0|||
106003102|NCT00689390|365672594|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
106003103|NCT00689390|365672595|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
106003104|NCT00689390|365672594|FG000|Overall Study|Administrative|37|||
106003105|NCT00689390|365672595|FG001|Overall Study|Administrative|0|||
106003106|NCT03473236|365672598|FG000|Overall Study|Withdrawal by Subject|0|||
106003107|NCT03473236|365672599|FG001|Overall Study|Withdrawal by Subject|0|||
106003108|NCT03473236|365672600|FG002|Overall Study|Withdrawal by Subject|0|||
106003109|NCT03473236|365672601|FG003|Overall Study|Withdrawal by Subject|0|||
106003110|NCT03473236|365672602|FG004|Overall Study|Withdrawal by Subject|0|||
106003111|NCT03473236|365672603|FG005|Overall Study|Withdrawal by Subject|1|||
106003112|NCT03473236|365672604|FG006|Overall Study|Withdrawal by Subject|0|||
106003113|NCT03473236|365672605|FG007|Overall Study|Withdrawal by Subject|0|||
106003114|NCT03473236|365672606|FG008|Overall Study|Withdrawal by Subject|1|||
105691906|NCT03684642|364536415|FG000|Overall Study|Withdrawal by Subject|35|||
105691907|NCT03684642|364536416|FG001|Overall Study|Withdrawal by Subject|53|||
105786972|NCT02146365|364872952|FG005|Overall Study|Lost to Follow-up|1|||
106130948|NCT00562965|366137609|FG001|Overall Study|Lost to Follow-up|0|||
106130949|NCT00562965|366137608|FG000|Overall Study|Other|0|||
106130950|NCT00562965|366137609|FG001|Overall Study|Other|1|||
106130951|NCT00761774|366137616|FG000|Overall Study|Adverse Event|17|||
106130952|NCT00761774|366137616|FG000|Overall Study|Lack of Efficacy|37|||
106130953|NCT00761774|366137616|FG000|Overall Study|Lost to Follow-up|2|||
106130954|NCT00761774|366137616|FG000|Overall Study|Withdrawal by Subject|9|||
106130955|NCT00761774|366137616|FG000|Overall Study|Non-compliance|4|||
106130956|NCT00761774|366137616|FG000|Overall Study|End of study|2|||
106130957|NCT00761774|366137616|FG000|Overall Study|Reclassification of seizures|1|||
106130958|NCT00761774|366137616|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
106130959|NCT00761774|366137616|FG000|Overall Study|Sponsor decision|1|||
106130960|NCT00761774|366137616|FG000|Overall Study|Investigator clinical judgement|1|||
106130961|NCT00761774|366137616|FG000|Overall Study|Patient moved out of study area|1|||
106130962|NCT00761774|366137616|FG000|Overall Study|Coordinator leaving site|1|||
106130963|NCT00761774|366137616|FG000|Overall Study|Subject IP non-compliance|1|||
106130964|NCT00761774|366137616|FG000|Overall Study|IP stopped by hospital physician|1|||
106130965|NCT01077024|366137617|FG000|Overall Study|Lost to Follow-up|20|||
106130966|NCT01077024|366137618|FG001|Overall Study|Lost to Follow-up|14|||
106130967|NCT01077024|366137617|FG000|Overall Study|Withdrawal by Subject|0|||
106130968|NCT01077024|366137618|FG001|Overall Study|Withdrawal by Subject|2|||
106130969|NCT01077024|366137617|FG000|Overall Study|Incarcerated|7|||
106130970|NCT01077024|366137618|FG001|Overall Study|Incarcerated|8|||
106130971|NCT01077024|366137617|FG000|Overall Study|Other|4|||
106130972|NCT01077024|366137618|FG001|Overall Study|Other|4|||
106130973|NCT02034435|366137622|FG000|Overall Study|Withdrawal by Subject|1|||
106130974|NCT02034435|366137623|FG001|Overall Study|Withdrawal by Subject|0|||
106130975|NCT02034435|366137624|FG002|Overall Study|Withdrawal by Subject|0|||
106130976|NCT02034435|366137625|FG003|Overall Study|Withdrawal by Subject|0|||
106130977|NCT02034435|366137622|FG000|Overall Study|Illness|0|||
106130978|NCT02034435|366137623|FG001|Overall Study|Illness|2|||
106130979|NCT02034435|366137624|FG002|Overall Study|Illness|0|||
106130980|NCT02034435|366137625|FG003|Overall Study|Illness|0|||
106130981|NCT02034435|366137622|FG000|Overall Study|Inadequate IV access|1|||
105691908|NCT03684642|364536417|FG002|Overall Study|Withdrawal by Subject|23|||
105691909|NCT03684642|364536415|FG000|Overall Study|Lack of Efficacy|0|||
105691910|NCT03684642|364536416|FG001|Overall Study|Lack of Efficacy|0|||
105691911|NCT03684642|364536417|FG002|Overall Study|Lack of Efficacy|1|||
105691912|NCT03684642|364536415|FG000|Overall Study|Poor compliance to protocol|0|||
105691913|NCT03684642|364536416|FG001|Overall Study|Poor compliance to protocol|4|||
105691914|NCT03684642|364536417|FG002|Overall Study|Poor compliance to protocol|1|||
105691915|NCT03684642|364536415|FG000|Overall Study|Other than specified|62|||
105691916|NCT03684642|364536416|FG001|Overall Study|Other than specified|60|||
105691917|NCT03684642|364536417|FG002|Overall Study|Other than specified|67|||
105691918|NCT03684642|364536415|FG000|Overall Study|Randomized and not treated|0|||
105691919|NCT03684642|364536416|FG001|Overall Study|Randomized and not treated|0|||
105691920|NCT03684642|364536417|FG002|Overall Study|Randomized and not treated|1|||
105691921|NCT03684642|364536415|FG000|Overall Study|Missing completion status but alive at last contact|0|||
105691922|NCT03684642|364536416|FG001|Overall Study|Missing completion status but alive at last contact|1|||
105691923|NCT03684642|364536417|FG002|Overall Study|Missing completion status but alive at last contact|2|||
105691924|NCT01431534|364536418|FG000|Treatment Phase|Adverse Event|0|||
105691925|NCT01431534|364536419|FG001|Treatment Phase|Adverse Event|0|||
105691926|NCT01431534|364536420|FG002|Treatment Phase|Adverse Event|1|||
105691927|NCT01431534|364536418|FG000|Treatment Phase|Progressive Disease|4|||
105691928|NCT01431534|364536419|FG001|Treatment Phase|Progressive Disease|3|||
105691929|NCT01431534|364536420|FG002|Treatment Phase|Progressive Disease|10|||
105691930|NCT01840605|364536421|FG000|Overall Study|Adverse Event|0|||
105691931|NCT01840605|364536422|FG001|Overall Study|Adverse Event|1|||
105691932|NCT01840605|364536421|FG000|Overall Study|Physician Decision|2|||
105691933|NCT01840605|364536422|FG001|Overall Study|Physician Decision|1|||
105691934|NCT03739437|364536423|FG000|Overall Study|Lost to Follow-up|2|||
105691935|NCT03739437|364536424|FG001|Overall Study|Lost to Follow-up|5|||
105691936|NCT04201821|364536426|FG000|Overall Study|Withdrawal by Subject|2|||
105691937|NCT01130974|364536427|FG000|Overall Study|Protocol Violation|10|||
105691938|NCT01130974|364536428|FG001|Overall Study|Protocol Violation|10|||
105691939|NCT01130974|364536427|FG000|Overall Study|Withdrawal by Subject|0|||
105691940|NCT01130974|364536428|FG001|Overall Study|Withdrawal by Subject|1|||
105691941|NCT01130974|364536427|FG000|Overall Study|Ineligibility criteria|5|||
106130982|NCT02034435|366137623|FG001|Overall Study|Inadequate IV access|0|||
106130983|NCT02034435|366137624|FG002|Overall Study|Inadequate IV access|0|||
106130984|NCT02034435|366137625|FG003|Overall Study|Inadequate IV access|1|||
106130985|NCT00965484|366137626|FG000|Overall Study|Protocol Violation|1|||
106130986|NCT00965484|366137626|FG000|Overall Study|Withdrawal by Subject|1|||
106130987|NCT02300311|366137629|FG000|Overall Study|Other than the reason specified|1|||
106130988|NCT02300311|366137630|FG001|Overall Study|Other than the reason specified|0|||
106130989|NCT02300311|366137629|FG000|Overall Study|Refused to continue taking medication|18|||
106130990|NCT02300311|366137630|FG001|Overall Study|Refused to continue taking medication|0|||
106130991|NCT00419003|366137631|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
106130992|NCT00419003|366137632|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
106130993|NCT00419003|366137631|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
106130994|NCT00419003|366137632|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
106130995|NCT01656759|366137633|FG000|Overall Study|Protocol Violation|2|||
106130996|NCT01656759|366137634|FG001|Overall Study|Protocol Violation|3|||
106130997|NCT00848211|366137635|FG000|Overall Study|Protocol Violation|0|||
106130998|NCT00848211|366137636|FG001|Overall Study|Protocol Violation|1|||
106130999|NCT00848211|366137637|FG002|Overall Study|Protocol Violation|1|||
106131000|NCT00848211|366137638|FG003|Overall Study|Protocol Violation|0|||
106131001|NCT00848211|366137635|FG000|Overall Study|Adverse Event|0|||
106131002|NCT00848211|366137636|FG001|Overall Study|Adverse Event|0|||
106131003|NCT00848211|366137637|FG002|Overall Study|Adverse Event|0|||
106131004|NCT00848211|366137638|FG003|Overall Study|Adverse Event|0|||
106131005|NCT02531438|366137639|FG000|Overall Study|Adverse Event|7|||
106131006|NCT02531438|366137640|FG001|Overall Study|Adverse Event|9|||
106131007|NCT02531438|366137639|FG000|Overall Study|Lost to Follow-up|0|||
106131008|NCT02531438|366137640|FG001|Overall Study|Lost to Follow-up|3|||
106131009|NCT02531438|366137639|FG000|Overall Study|Withdrawal by Subject|7|||
106131010|NCT02531438|366137640|FG001|Overall Study|Withdrawal by Subject|8|||
106131011|NCT02531438|366137639|FG000|Overall Study|Physician Decision|0|||
106131012|NCT02531438|366137640|FG001|Overall Study|Physician Decision|1|||
106131013|NCT02531438|366137639|FG000|Overall Study|Death|6|||
106131014|NCT02531438|366137640|FG001|Overall Study|Death|3|||
106131015|NCT02531438|366137639|FG000|Overall Study|Randomized, but Not Treated|4|||
106131016|NCT02531438|366137640|FG001|Overall Study|Randomized, but Not Treated|0|||
106131017|NCT02531438|366137639|FG000|Overall Study|Missed EOT/PTE Visit|5|||
106131018|NCT02531438|366137640|FG001|Overall Study|Missed EOT/PTE Visit|2|||
106131019|NCT02531438|366137639|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
106131020|NCT02531438|366137640|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
106131021|NCT01124617|366137641|FG000|Overall Study|Adverse Event|5|||
106131022|NCT01124617|366137642|FG001|Overall Study|Adverse Event|2|||
106131023|NCT01124617|366137641|FG000|Overall Study|Lack of Efficacy|2|||
106131024|NCT01124617|366137642|FG001|Overall Study|Lack of Efficacy|1|||
106131025|NCT01124617|366137641|FG000|Overall Study|Protocol Violation|1|||
106131026|NCT01124617|366137642|FG001|Overall Study|Protocol Violation|1|||
106131027|NCT01124617|366137641|FG000|Overall Study|Withdrawal by Subject|9|||
106131028|NCT01124617|366137642|FG001|Overall Study|Withdrawal by Subject|1|||
106131029|NCT01124617|366137641|FG000|Overall Study|Other|2|||
106131030|NCT01124617|366137642|FG001|Overall Study|Other|1|||
106131031|NCT00945477|366137643|FG000|Overall Study|Adverse Event|3|||
106131032|NCT00945477|366137643|FG000|Overall Study|Lack of Efficacy|2|||
106131033|NCT00945477|366137643|FG000|Overall Study|Withdrawal by Subject|1|||
106131034|NCT00619151|366137647|FG000|Overall Study|Study terminated prior to followup|1|||
106131035|NCT00619151|366137648|FG001|Overall Study|Study terminated prior to followup|0|||
106131036|NCT00811187|366137649|FG000|Overall Study|Unable to place device / procedure abort|3|||
106131037|NCT00811187|366137650|FG001|Overall Study|Unable to place device / procedure abort|3|||
106131038|NCT00329303|366137651|FG000|Overall Study|Lack of Efficacy|1|||
106131039|NCT00329303|366137652|FG001|Overall Study|Lack of Efficacy|0|||
106131040|NCT00329303|366137651|FG000|Overall Study|Decision of the sponsor|0|||
106131041|NCT00329303|366137652|FG001|Overall Study|Decision of the sponsor|1|||
106131042|NCT00329303|366137651|FG000|Overall Study|Patient no longer available|1|||
106131043|NCT00329303|366137652|FG001|Overall Study|Patient no longer available|0|||
106131044|NCT00329303|366137651|FG000|Overall Study|Patient relocated|0|||
106131045|NCT00329303|366137652|FG001|Overall Study|Patient relocated|1|||
106131046|NCT03582137|366137658|FG000|Overall Study|Adverse Event|1|||
106131047|NCT03582137|366137659|FG001|Overall Study|Adverse Event|0|||
106131048|NCT02554513|366137660|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
106131049|NCT02554513|366137661|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
106131050|NCT01982760|366137663|FG000|Overall Study|Physician Decision|1|||
106131051|NCT01982760|366137664|FG001|Overall Study|Physician Decision|0|||
106131052|NCT02303574|366137665|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
105919659|NCT01668797|365365129|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
106131053|NCT02303574|366137666|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
106131054|NCT02303574|366137667|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
105919660|NCT01668797|365365130|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
106131055|NCT02303574|366137668|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
106131056|NCT02303574|366137669|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
106131057|NCT02303574|366137670|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
106131058|NCT02303574|366137671|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
106131059|NCT02303574|366137672|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
106131060|NCT02303574|366137673|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
106131061|NCT02303574|366137674|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
106131062|NCT02303574|366137665|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131063|NCT02303574|366137666|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131064|NCT02303574|366137667|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131065|NCT02303574|366137668|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131066|NCT02303574|366137669|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131067|NCT02303574|366137670|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131068|NCT02303574|366137671|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131069|NCT02303574|366137672|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
106131070|NCT02303574|366137673|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131071|NCT02303574|366137674|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
106131072|NCT00184028|366137677|FG000|Overall Study|Death|1|||
106131073|NCT00184028|366137677|FG000|Overall Study|Lack of Efficacy|4|||
106131074|NCT00184028|366137677|FG000|Overall Study|Adverse Event|2|||
106131075|NCT00184028|366137677|FG000|Overall Study|Withdrawal by Subject|1|||
106131076|NCT00184028|366137677|FG000|Overall Study|Non-compliance|2|||
106131077|NCT01354938|366137678|FG000|Overall Study|Lost to Follow-up|1|||
106131078|NCT01167023|366137679|FG000|Overall Study|Lost to Follow-up|0|||
106131079|NCT01167023|366137680|FG001|Overall Study|Lost to Follow-up|1|||
106131080|NCT01167023|366137681|FG002|Overall Study|Lost to Follow-up|1|||
106131081|NCT01167023|366137679|FG000|Overall Study|Screen Failure|0|||
106131082|NCT01167023|366137680|FG001|Overall Study|Screen Failure|1|||
106131083|NCT01167023|366137681|FG002|Overall Study|Screen Failure|0|||
106131084|NCT01167023|366137679|FG000|Overall Study|Sponsor Decision|0|||
106131085|NCT01167023|366137680|FG001|Overall Study|Sponsor Decision|1|||
106131086|NCT01167023|366137681|FG002|Overall Study|Sponsor Decision|0|||
106131087|NCT01167023|366137679|FG000|Overall Study|Withdrawal by Subject|0|||
106131088|NCT01167023|366137680|FG001|Overall Study|Withdrawal by Subject|0|||
106131089|NCT01167023|366137681|FG002|Overall Study|Withdrawal by Subject|1|||
106131090|NCT02049437|366137682|FG000|Period 1|Adverse Event|1|||
106131091|NCT02049437|366137683|FG001|Period 1|Adverse Event|1|||
106131092|NCT02049437|366137682|FG000|Period 1|Adverse Event|1|||
106131093|NCT02049437|366137683|FG001|Period 1|Adverse Event|0|||
106131094|NCT00630539|366137684|FG000|Overall Study|Adverse Event|1|||
106131095|NCT00630539|366137685|FG001|Overall Study|Adverse Event|3|||
106131096|NCT00630539|366137686|FG002|Overall Study|Adverse Event|1|||
106131097|NCT00630539|366137687|FG003|Overall Study|Adverse Event|2|||
106131098|NCT00630539|366137684|FG000|Overall Study|Withdrawal by Subject|0|||
106131099|NCT00630539|366137685|FG001|Overall Study|Withdrawal by Subject|1|||
106131100|NCT00630539|366137686|FG002|Overall Study|Withdrawal by Subject|0|||
106131101|NCT00630539|366137687|FG003|Overall Study|Withdrawal by Subject|1|||
106131102|NCT00578227|366137688|FG000|Overall Study|Lost to Follow-up|0|||
106131103|NCT00578227|366137689|FG001|Overall Study|Lost to Follow-up|1|||
106131104|NCT00578227|366137690|FG002|Overall Study|Lost to Follow-up|1|||
106131105|NCT00578227|366137688|FG000|Overall Study|Withdrawal by Subject|5|||
106131106|NCT00578227|366137689|FG001|Overall Study|Withdrawal by Subject|1|||
106131107|NCT00578227|366137690|FG002|Overall Study|Withdrawal by Subject|3|||
106131108|NCT01027871|366137693|FG000|Overall Study|Physician Decision|1|||
106131109|NCT01027871|366137694|FG001|Overall Study|Physician Decision|5|||
106131110|NCT01027871|366137695|FG002|Overall Study|Physician Decision|0|||
106131111|NCT01027871|366137693|FG000|Overall Study|Protocol Violation|0|||
106131112|NCT01027871|366137694|FG001|Overall Study|Protocol Violation|2|||
106131113|NCT01027871|366137695|FG002|Overall Study|Protocol Violation|2|||
106131114|NCT01027871|366137693|FG000|Overall Study|Withdrawal by Subject|1|||
106131115|NCT01027871|366137694|FG001|Overall Study|Withdrawal by Subject|2|||
105919661|NCT01668797|365365131|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
105919662|NCT01668797|365365132|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
105919663|NCT01668797|365365129|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
105919664|NCT01668797|365365130|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
105919665|NCT01668797|365365131|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
105919666|NCT01668797|365365132|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
106131116|NCT01027871|366137695|FG002|Overall Study|Withdrawal by Subject|2|||
106131117|NCT01027871|366137693|FG000|Overall Study|Adverse Event|0|||
106131118|NCT01027871|366137694|FG001|Overall Study|Adverse Event|2|||
106131119|NCT01027871|366137695|FG002|Overall Study|Adverse Event|2|||
106131120|NCT01027871|366137693|FG000|Overall Study|Sponsor Decision|0|||
106131121|NCT01027871|366137694|FG001|Overall Study|Sponsor Decision|2|||
106131122|NCT01027871|366137695|FG002|Overall Study|Sponsor Decision|0|||
106131123|NCT01027871|366137693|FG000|Overall Study|Discontinued Prior to Treatment|0|||
106131124|NCT01027871|366137694|FG001|Overall Study|Discontinued Prior to Treatment|0|||
106131125|NCT01027871|366137695|FG002|Overall Study|Discontinued Prior to Treatment|1|||
106131126|NCT03782727|366137696|FG000|Overall Study|Lost to Follow-up|32|||
105919667|NCT01668797|365365129|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
106131127|NCT05489224|366137697|FG000|Treatment Period I|Withdrawal by Subject|6|||
105691942|NCT01130974|364536428|FG001|Overall Study|Ineligibility criteria|2|||
105691943|NCT00387764|364536429|FG000|Overall Study|Adverse Event|12|||
106131128|NCT05489224|366137698|FG001|Treatment Period I|Withdrawal by Subject|5|||
106131129|NCT05489224|366137699|FG002|Treatment Period I|Withdrawal by Subject|0|||
106131130|NCT05489224|366137697|FG000|Treatment Period I|Adverse Event|3|||
105691944|NCT00387764|364536429|FG000|Overall Study|Withdrawal by Subject|8|||
105691945|NCT00387764|364536429|FG000|Overall Study|Sponsor Terminated Study|1|||
105691946|NCT00387764|364536429|FG000|Overall Study|Physician Decision|1|||
105691947|NCT00387764|364536429|FG000|Overall Study|Other|2|||
105691948|NCT00387764|364536429|FG000|Overall Study|Death|7|||
105691949|NCT02673619|364536430|FG000|Overall Study|Lost to Follow-up|1|||
105691950|NCT02673619|364536431|FG001|Overall Study|Lost to Follow-up|0|||
105691951|NCT02673619|364536432|FG002|Overall Study|Lost to Follow-up|0|||
105691952|NCT02673619|364536433|FG003|Overall Study|Lost to Follow-up|0|||
105691953|NCT02673619|364536430|FG000|Overall Study|Withdrawal by Subject|1|||
105691954|NCT02673619|364536431|FG001|Overall Study|Withdrawal by Subject|1|||
105691955|NCT02673619|364536432|FG002|Overall Study|Withdrawal by Subject|1|||
105691956|NCT02673619|364536433|FG003|Overall Study|Withdrawal by Subject|0|||
105691957|NCT02673619|364536430|FG000|Overall Study|Adverse Event|0|||
105691958|NCT02673619|364536431|FG001|Overall Study|Adverse Event|0|||
105691959|NCT02673619|364536432|FG002|Overall Study|Adverse Event|1|||
105691960|NCT02673619|364536433|FG003|Overall Study|Adverse Event|0|||
105691961|NCT02673619|364536430|FG000|Overall Study|Lack of Efficacy|0|||
105691962|NCT02673619|364536431|FG001|Overall Study|Lack of Efficacy|0|||
105691963|NCT02673619|364536432|FG002|Overall Study|Lack of Efficacy|1|||
105691964|NCT02673619|364536433|FG003|Overall Study|Lack of Efficacy|0|||
105691965|NCT00972777|364536436|FG000|Overall Study|Adverse Event|3|||
105691966|NCT00972777|364536437|FG001|Overall Study|Adverse Event|2|||
105691967|NCT00972777|364536436|FG000|Overall Study|Lost to Follow-up|0|||
105691968|NCT00972777|364536437|FG001|Overall Study|Lost to Follow-up|4|||
105691969|NCT00972777|364536436|FG000|Overall Study|Withdrawal by Subject|4|||
105691970|NCT00972777|364536437|FG001|Overall Study|Withdrawal by Subject|5|||
105691971|NCT00972777|364536436|FG000|Overall Study|Physician Decision|4|||
105691972|NCT00972777|364536437|FG001|Overall Study|Physician Decision|0|||
105691973|NCT00972777|364536436|FG000|Overall Study|Protocol Violation|0|||
105919668|NCT01668797|365365130|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
105919669|NCT01668797|365365131|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
105919670|NCT01668797|365365132|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
105919671|NCT01668797|365365129|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
105919672|NCT01668797|365365130|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
105919673|NCT01668797|365365131|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
105919674|NCT01668797|365365132|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
105919675|NCT01668797|365365129|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
105919676|NCT01668797|365365130|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
105919677|NCT01668797|365365131|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
105919678|NCT01668797|365365132|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
105919679|NCT01668797|365365129|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
105919680|NCT01668797|365365130|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
105919681|NCT01668797|365365131|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
105919682|NCT01668797|365365132|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
105919683|NCT01668797|365365129|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
105919684|NCT01668797|365365130|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
105919685|NCT01668797|365365131|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
105919686|NCT01668797|365365132|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
105919687|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
105919688|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
105919689|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
105919690|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
105919691|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
105919692|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
105919693|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
105919694|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
105919695|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
106003115|NCT03473236|365672607|FG009|Overall Study|Withdrawal by Subject|0|||
105691974|NCT00972777|364536437|FG001|Overall Study|Protocol Violation|2|||
105691975|NCT00972777|364536436|FG000|Overall Study|Screening Failure|2|||
105691976|NCT00972777|364536437|FG001|Overall Study|Screening Failure|1|||
105691977|NCT00972777|364536436|FG000|Overall Study|Missed visit|1|||
105691978|NCT00972777|364536437|FG001|Overall Study|Missed visit|0|||
105691979|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
105691980|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
105691981|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
105691982|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
105691983|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
105691984|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
105691985|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
105691986|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
105691987|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
105691988|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
105691989|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
105691990|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
105691991|NCT00594516|364538305|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
105691992|NCT00594516|364538306|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
105691993|NCT00594516|364538307|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
105691994|NCT00594516|364538305|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
105691995|NCT00594516|364538306|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
105691996|NCT00594516|364538307|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
105691997|NCT00594516|364538305|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
105691998|NCT00594516|364538306|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
105691999|NCT00594516|364538307|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
105692000|NCT00594516|364538305|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
105692001|NCT00594516|364538306|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
105692002|NCT00594516|364538307|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
105692003|NCT00594516|364538305|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
105692004|NCT00594516|364538306|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
105692005|NCT00594516|364538307|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
105692006|NCT01890148|364538310|FG000|Overall Study|Adverse Event|1|||
105692007|NCT03872453|364538311|FG000|Overall Study|Adverse Event|1|||
105692008|NCT03872453|364538312|FG001|Overall Study|Adverse Event|1|||
105692009|NCT03872453|364538313|FG002|Overall Study|Adverse Event|0|||
105692010|NCT03872453|364538314|FG003|Overall Study|Adverse Event|0|||
105692011|NCT03872453|364538311|FG000|Overall Study|Lost to Follow-up|8|||
105692012|NCT03872453|364538312|FG001|Overall Study|Lost to Follow-up|7|||
105692013|NCT03872453|364538313|FG002|Overall Study|Lost to Follow-up|4|||
105692014|NCT03872453|364538314|FG003|Overall Study|Lost to Follow-up|4|||
105692015|NCT03872453|364538311|FG000|Overall Study|Never Treated Migraine|19|||
105692016|NCT03872453|364538312|FG001|Overall Study|Never Treated Migraine|17|||
105692017|NCT03872453|364538313|FG002|Overall Study|Never Treated Migraine|13|||
105692018|NCT03872453|364538314|FG003|Overall Study|Never Treated Migraine|12|||
105692019|NCT03872453|364538311|FG000|Overall Study|Pregnancy|1|||
105692020|NCT03872453|364538312|FG001|Overall Study|Pregnancy|0|||
105692021|NCT03872453|364538313|FG002|Overall Study|Pregnancy|0|||
105692022|NCT03872453|364538314|FG003|Overall Study|Pregnancy|0|||
105692023|NCT03872453|364538311|FG000|Overall Study|Protocol Deviation|2|||
105692024|NCT03872453|364538312|FG001|Overall Study|Protocol Deviation|0|||
105692025|NCT03872453|364538313|FG002|Overall Study|Protocol Deviation|0|||
105692026|NCT03872453|364538314|FG003|Overall Study|Protocol Deviation|2|||
105692027|NCT03872453|364538311|FG000|Overall Study|Withdrawal by Subject|0|||
105692028|NCT03872453|364538312|FG001|Overall Study|Withdrawal by Subject|1|||
105692029|NCT03872453|364538313|FG002|Overall Study|Withdrawal by Subject|2|||
105692030|NCT03872453|364538314|FG003|Overall Study|Withdrawal by Subject|0|||
105692031|NCT03872453|364538311|FG000|Overall Study|Other Than Specified|1|||
105692032|NCT03872453|364538312|FG001|Overall Study|Other Than Specified|0|||
105692033|NCT03872453|364538313|FG002|Overall Study|Other Than Specified|0|||
105692034|NCT03872453|364538314|FG003|Overall Study|Other Than Specified|0|||
105692035|NCT00352885|364538315|FG000|Overall Study|Withdrawal by Subject|0|||
105692036|NCT00352885|364538316|FG001|Overall Study|Withdrawal by Subject|3|||
105692037|NCT00352885|364538315|FG000|Overall Study|Development of major depression|0|||
105692038|NCT00352885|364538316|FG001|Overall Study|Development of major depression|1|||
105692039|NCT00352885|364538315|FG000|Overall Study|Progression of metastatic melanoma|5|||
105692040|NCT00352885|364538316|FG001|Overall Study|Progression of metastatic melanoma|3|||
105692041|NCT00352885|364538315|FG000|Overall Study|Side effects of IL-2 administration|1|||
105692042|NCT00352885|364538316|FG001|Overall Study|Side effects of IL-2 administration|0|||
105692043|NCT01678209|364538317|FG000|Overall Study|could not scan twice|1|||
105692044|NCT01678209|364538318|FG001|Overall Study|could not scan twice|1|||
105692045|NCT01678209|364538319|FG002|Overall Study|could not scan twice|1|||
105692046|NCT01678209|364538317|FG000|Overall Study|scheduling conflicts|0|||
105692047|NCT01678209|364538318|FG001|Overall Study|scheduling conflicts|0|||
105692048|NCT01678209|364538319|FG002|Overall Study|scheduling conflicts|1|||
105692049|NCT01678209|364538317|FG000|Overall Study|screen fail|16|||
105692050|NCT01678209|364538318|FG001|Overall Study|screen fail|17|||
105692051|NCT01678209|364538319|FG002|Overall Study|screen fail|16|||
105692052|NCT03873493|364538320|FG000|Overall Study|Withdrawal by Subject|1|||
105692053|NCT03873493|364538320|FG000|Overall Study|Death|9|||
105786973|NCT02146365|364872953|FG006|Overall Study|Lost to Follow-up|0|||
105786974|NCT02146365|364872954|FG007|Overall Study|Lost to Follow-up|1|||
105692054|NCT03873493|364538320|FG000|Overall Study|Lost to Follow-up|1|||
105786975|NCT02146365|364872947|FG000|Overall Study|Withdrawal by Subject|1|||
105692055|NCT03873493|364538320|FG000|Overall Study|Study Terminated by Sponsor|1|||
105692056|NCT03873493|364538320|FG000|Overall Study|Other|2|||
105692057|NCT03756350|364538325|FG000|Overall Study|Lost to Follow-up|1|||
105692058|NCT02464228|364538327|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
105692059|NCT02464228|364538328|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
105692060|NCT02464228|364538329|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
105692061|NCT02464228|364538330|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
105692062|NCT02464228|364538327|FG000|Overall Study|Physician Decision|2|||
105692063|NCT02464228|364538328|FG001|Overall Study|Physician Decision|0|||
105692064|NCT02464228|364538329|FG002|Overall Study|Physician Decision|1|||
105919696|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
105919697|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
105919698|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
105919699|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
105919700|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
105919701|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
105919702|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
105919703|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
105919704|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
105919705|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
105919706|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
105919707|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
105919708|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
105919709|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
105919710|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
105919711|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
105919712|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
105919713|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
105919714|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
105919715|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
105919716|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
105919717|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
105919718|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
105919719|NCT01668797|365365129|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
105919720|NCT01668797|365365130|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
105919721|NCT01668797|365365131|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
105919722|NCT01668797|365365132|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
105919723|NCT01004614|365365133|FG000|Washout|Withdrawal by Subject|0|||
105919724|NCT01004614|365365134|FG001|Washout|Withdrawal by Subject|1|||
105919725|NCT01004614|365365135|FG002|Washout|Withdrawal by Subject|0|||
105919726|NCT01004614|365365136|FG003|Washout|Withdrawal by Subject|0|||
105919727|NCT02834975|365365141|FG000|Overall Study|Physician Decision|2|||
105919728|NCT02834975|365365141|FG000|Overall Study|Adverse Event|1|||
105919729|NCT02834975|365365141|FG000|Overall Study|Withdrawal by Subject|1|||
105919730|NCT02834975|365365141|FG000|Overall Study|Lack of Efficacy|1|||
105919731|NCT02662569|365365143|FG000|Overall Study|Withdrawal by Subject|6|||
105919732|NCT02662569|365365144|FG001|Overall Study|Withdrawal by Subject|1|||
105919733|NCT02662569|365365145|FG002|Overall Study|Withdrawal by Subject|6|||
105919734|NCT02662569|365365146|FG003|Overall Study|Withdrawal by Subject|4|||
105919735|NCT02662569|365365143|FG000|Overall Study|Lost to Follow-up|1|||
105919736|NCT02662569|365365144|FG001|Overall Study|Lost to Follow-up|0|||
105919737|NCT02662569|365365145|FG002|Overall Study|Lost to Follow-up|0|||
105919738|NCT02662569|365365146|FG003|Overall Study|Lost to Follow-up|0|||
105919739|NCT02378662|365365149|FG000|Overall Study|Early Discontinuation|2|||
105919740|NCT02378662|365365150|FG001|Overall Study|Early Discontinuation|0|||
105692065|NCT02464228|364538330|FG003|Overall Study|Physician Decision|0|||
105692066|NCT02464228|364538327|FG000|Overall Study|Miscellaneous|1|||
105692067|NCT02464228|364538328|FG001|Overall Study|Miscellaneous|0|||
105692068|NCT02464228|364538329|FG002|Overall Study|Miscellaneous|1|||
105919741|NCT01774591|365365151|FG000|Overall Study|Physician Decision|1|||
105919742|NCT01774591|365365152|FG001|Overall Study|Physician Decision|1|||
105919743|NCT01774591|365365151|FG000|Overall Study|Withdrawal by Subject|0|||
105692069|NCT02464228|364538330|FG003|Overall Study|Miscellaneous|0|||
106131131|NCT05489224|366137698|FG001|Treatment Period I|Adverse Event|11|||
106131132|NCT05489224|366137699|FG002|Treatment Period I|Adverse Event|0|||
106131133|NCT05489224|366137697|FG000|Treatment Period I|Lost to Follow-up|0|||
106131134|NCT05489224|366137698|FG001|Treatment Period I|Lost to Follow-up|1|||
106131135|NCT05489224|366137699|FG002|Treatment Period I|Lost to Follow-up|0|||
106131136|NCT05489224|366137697|FG000|Treatment Period I|Physician Decision|0|||
106131137|NCT05489224|366137698|FG001|Treatment Period I|Physician Decision|1|||
106131138|NCT05489224|366137699|FG002|Treatment Period I|Physician Decision|0|||
106131139|NCT05489224|366137697|FG000|Treatment Period II up to Week 32|Ongoing|222|||
106131140|NCT05489224|366137698|FG001|Treatment Period II up to Week 32|Ongoing|107|||
106131141|NCT05489224|366137699|FG002|Treatment Period II up to Week 32|Ongoing|107|||
106131142|NCT05489224|366137697|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
106131143|NCT05489224|366137698|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
106131144|NCT05489224|366137699|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
106131145|NCT05489224|366137697|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
106131146|NCT05489224|366137698|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
106131147|NCT05489224|366137699|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
106131148|NCT04640571|366137701|FG000|Overall Study|Withdrawal by Subject|0|||
106131149|NCT04640571|366137702|FG001|Overall Study|Withdrawal by Subject|0|||
106131150|NCT04640571|366137703|FG002|Overall Study|Withdrawal by Subject|0|||
106131151|NCT04640571|366137704|FG003|Overall Study|Withdrawal by Subject|0|||
106131152|NCT04640571|366137705|FG004|Overall Study|Withdrawal by Subject|0|||
106131153|NCT04640571|366137706|FG005|Overall Study|Withdrawal by Subject|2|||
106131154|NCT01222247|366137711|FG000|Overall Study|Lost to Follow-up|2|||
106131155|NCT01222247|366137712|FG001|Overall Study|Lost to Follow-up|2|||
106131156|NCT04530344|366137713|FG000|Overall Study|Lost to Follow-up|3|||
106131157|NCT04530344|366137714|FG001|Overall Study|Lost to Follow-up|3|||
106131158|NCT04530344|366137715|FG002|Overall Study|Lost to Follow-up|3|||
106131159|NCT04530344|366137716|FG003|Overall Study|Lost to Follow-up|10|||
106131160|NCT04530344|366137713|FG000|Overall Study|Withdrawal by Subject|14|||
106131161|NCT04530344|366137714|FG001|Overall Study|Withdrawal by Subject|5|||
106131162|NCT04530344|366137715|FG002|Overall Study|Withdrawal by Subject|18|||
106131163|NCT04530344|366137716|FG003|Overall Study|Withdrawal by Subject|33|||
106131164|NCT04530344|366137713|FG000|Overall Study|Adverse Event|0|||
106131165|NCT04530344|366137714|FG001|Overall Study|Adverse Event|0|||
106131166|NCT04530344|366137715|FG002|Overall Study|Adverse Event|0|||
106131167|NCT04530344|366137716|FG003|Overall Study|Adverse Event|1|||
106131168|NCT04530344|366137713|FG000|Overall Study|Lack of Efficacy|0|||
105692070|NCT02464228|364538327|FG000|Overall Study|Adverse Event|9|||
105692071|NCT02464228|364538328|FG001|Overall Study|Adverse Event|0|||
105692072|NCT02464228|364538329|FG002|Overall Study|Adverse Event|3|||
105692073|NCT02464228|364538330|FG003|Overall Study|Adverse Event|0|||
105692074|NCT02464228|364538327|FG000|Overall Study|Withdrawal by Subject|1|||
105692075|NCT02464228|364538328|FG001|Overall Study|Withdrawal by Subject|1|||
105692076|NCT02464228|364538329|FG002|Overall Study|Withdrawal by Subject|1|||
105692077|NCT02464228|364538330|FG003|Overall Study|Withdrawal by Subject|0|||
105692078|NCT02464228|364538327|FG000|Overall Study|Disease Progression|22|||
106131169|NCT04530344|366137714|FG001|Overall Study|Lack of Efficacy|0|||
106131170|NCT04530344|366137715|FG002|Overall Study|Lack of Efficacy|0|||
106131171|NCT04530344|366137716|FG003|Overall Study|Lack of Efficacy|1|||
106131172|NCT04530344|366137713|FG000|Overall Study|Physician Decision|0|||
106131173|NCT04530344|366137714|FG001|Overall Study|Physician Decision|0|||
106131174|NCT04530344|366137715|FG002|Overall Study|Physician Decision|1|||
106131175|NCT04530344|366137716|FG003|Overall Study|Physician Decision|1|||
106131176|NCT04530344|366137713|FG000|Overall Study|Pregnancy|0|||
106131177|NCT04530344|366137714|FG001|Overall Study|Pregnancy|0|||
106131178|NCT04530344|366137715|FG002|Overall Study|Pregnancy|2|||
106131179|NCT04530344|366137716|FG003|Overall Study|Pregnancy|1|||
106131180|NCT04530344|366137713|FG000|Overall Study|Protocol Violation|0|||
106131181|NCT04530344|366137714|FG001|Overall Study|Protocol Violation|0|||
106131182|NCT04530344|366137715|FG002|Overall Study|Protocol Violation|0|||
106131183|NCT04530344|366137716|FG003|Overall Study|Protocol Violation|1|||
105692079|NCT02464228|364538328|FG001|Overall Study|Disease Progression|12|||
106131184|NCT04530344|366137713|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
106131185|NCT04530344|366137714|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
106131186|NCT04530344|366137715|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
106131187|NCT04530344|366137716|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
106131188|NCT04530344|366137713|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
106131189|NCT04530344|366137714|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
105692080|NCT02464228|364538329|FG002|Overall Study|Disease Progression|5|||
106131190|NCT04530344|366137715|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
106131191|NCT04530344|366137716|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
105692081|NCT02464228|364538330|FG003|Overall Study|Disease Progression|2|||
106131192|NCT04530344|366137713|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
106131193|NCT04530344|366137714|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
105692082|NCT01131351|364538331|FG000|Overall Study|Adverse Event|0|||
106131194|NCT04530344|366137715|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
106131195|NCT04530344|366137716|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
106131196|NCT04530344|366137713|FG000|Overall Study|Personal Reasons|0|||
106131197|NCT04530344|366137714|FG001|Overall Study|Personal Reasons|0|||
106131198|NCT04530344|366137715|FG002|Overall Study|Personal Reasons|0|||
106131199|NCT04530344|366137716|FG003|Overall Study|Personal Reasons|1|||
106131200|NCT04530344|366137713|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
106131201|NCT04530344|366137714|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
106131202|NCT04530344|366137715|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
106131203|NCT04530344|366137716|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
106131204|NCT04736056|366137721|FG000|Overall Study|Death|0|||
106131205|NCT04736056|366137722|FG001|Overall Study|Death|0|||
106131206|NCT04736056|366137723|FG002|Overall Study|Death|0|||
106131207|NCT04736056|366137724|FG003|Overall Study|Death|1|||
106131208|NCT04736056|366137721|FG000|Overall Study|Lost to Follow-up|1|||
106131209|NCT04736056|366137722|FG001|Overall Study|Lost to Follow-up|0|||
106131210|NCT04736056|366137723|FG002|Overall Study|Lost to Follow-up|1|||
106131211|NCT04736056|366137724|FG003|Overall Study|Lost to Follow-up|1|||
106131212|NCT04736056|366137721|FG000|Overall Study|Withdrawal by Subject|2|||
106131213|NCT04736056|366137722|FG001|Overall Study|Withdrawal by Subject|0|||
105692083|NCT01131351|364538332|FG001|Overall Study|Adverse Event|2|||
105692084|NCT01131351|364538331|FG000|Overall Study|Protocol Deviation|0|||
105692085|NCT01131351|364538332|FG001|Overall Study|Protocol Deviation|1|||
105692086|NCT00763971|364538333|FG000|Overall Study|Adverse Event|5|||
105692087|NCT00763971|364538334|FG001|Overall Study|Adverse Event|2|||
105692088|NCT00763971|364538335|FG002|Overall Study|Adverse Event|4|||
105692089|NCT00763971|364538333|FG000|Overall Study|Protocol Violation|3|||
105692090|NCT00763971|364538334|FG001|Overall Study|Protocol Violation|3|||
105692091|NCT00763971|364538335|FG002|Overall Study|Protocol Violation|2|||
105692092|NCT00763971|364538333|FG000|Overall Study|Withdrawal by Subject|4|||
105692093|NCT00763971|364538334|FG001|Overall Study|Withdrawal by Subject|5|||
105692094|NCT00763971|364538335|FG002|Overall Study|Withdrawal by Subject|5|||
105692095|NCT00763971|364538333|FG000|Overall Study|Lost to Follow-up|0|||
105692096|NCT00763971|364538334|FG001|Overall Study|Lost to Follow-up|1|||
105692097|NCT00763971|364538335|FG002|Overall Study|Lost to Follow-up|0|||
105692098|NCT00763971|364538333|FG000|Overall Study|Lack of Efficacy|11|||
105692099|NCT00763971|364538334|FG001|Overall Study|Lack of Efficacy|22|||
105692100|NCT00763971|364538335|FG002|Overall Study|Lack of Efficacy|54|||
105692101|NCT00763971|364538333|FG000|Overall Study|Unable to swallow capsule|2|||
105692102|NCT00763971|364538334|FG001|Overall Study|Unable to swallow capsule|1|||
105692103|NCT00763971|364538335|FG002|Overall Study|Unable to swallow capsule|1|||
105919744|NCT01774591|365365152|FG001|Overall Study|Withdrawal by Subject|1|||
105919745|NCT01774591|365365151|FG000|Overall Study|Adverse Event|0|||
105919746|NCT01774591|365365152|FG001|Overall Study|Adverse Event|2|||
105919747|NCT01787552|365365153|FG000|Overall Study|Withdrawal by Subject|2|||
105919748|NCT01787552|365365154|FG001|Overall Study|Withdrawal by Subject|0|||
105919749|NCT01787552|365365155|FG002|Overall Study|Withdrawal by Subject|0|||
105919750|NCT01787552|365365156|FG003|Overall Study|Withdrawal by Subject|4|||
105919751|NCT01787552|365365153|FG000|Overall Study|Physician Decision|2|||
105919752|NCT01787552|365365154|FG001|Overall Study|Physician Decision|2|||
105919753|NCT01787552|365365155|FG002|Overall Study|Physician Decision|1|||
105919754|NCT01787552|365365156|FG003|Overall Study|Physician Decision|2|||
105919755|NCT01787552|365365153|FG000|Overall Study|Death|0|||
105919756|NCT01787552|365365154|FG001|Overall Study|Death|0|||
105919757|NCT01787552|365365155|FG002|Overall Study|Death|0|||
105919758|NCT01787552|365365156|FG003|Overall Study|Death|1|||
105919759|NCT01787552|365365153|FG000|Overall Study|Adverse Event|2|||
105919760|NCT01787552|365365154|FG001|Overall Study|Adverse Event|5|||
105919761|NCT01787552|365365155|FG002|Overall Study|Adverse Event|2|||
105919762|NCT01787552|365365156|FG003|Overall Study|Adverse Event|16|||
105919763|NCT01787552|365365153|FG000|Overall Study|Study terminated by Sponsor|0|||
105692104|NCT00763971|364538333|FG000|Overall Study|Personal reason|3|||
105692105|NCT00763971|364538334|FG001|Overall Study|Personal reason|0|||
105692106|NCT00763971|364538335|FG002|Overall Study|Personal reason|0|||
105692107|NCT00763971|364538333|FG000|Overall Study|Exclusion criteria met|1|||
105692108|NCT00763971|364538334|FG001|Overall Study|Exclusion criteria met|0|||
105919764|NCT01787552|365365154|FG001|Overall Study|Study terminated by Sponsor|0|||
105692109|NCT00763971|364538335|FG002|Overall Study|Exclusion criteria met|0|||
105919765|NCT01787552|365365155|FG002|Overall Study|Study terminated by Sponsor|1|||
105919766|NCT01787552|365365156|FG003|Overall Study|Study terminated by Sponsor|3|||
105919767|NCT01787552|365365153|FG000|Overall Study|Progressive Disease|2|||
105919768|NCT01787552|365365154|FG001|Overall Study|Progressive Disease|2|||
105919769|NCT01787552|365365155|FG002|Overall Study|Progressive Disease|1|||
106131214|NCT04736056|366137723|FG002|Overall Study|Withdrawal by Subject|0|||
106131215|NCT04736056|366137724|FG003|Overall Study|Withdrawal by Subject|0|||
106131216|NCT04736056|366137721|FG000|Overall Study|Physician Decision|1|||
105692110|NCT00763971|364538333|FG000|Overall Study|Sponsor decision|1|||
105919770|NCT01787552|365365156|FG003|Overall Study|Progressive Disease|1|||
106131217|NCT04736056|366137722|FG001|Overall Study|Physician Decision|0|||
106131218|NCT04736056|366137723|FG002|Overall Study|Physician Decision|1|||
106131219|NCT04736056|366137724|FG003|Overall Study|Physician Decision|0|||
106131220|NCT04939428|366137725|FG000|Overall Study|Death|0|||
106131221|NCT04939428|366137726|FG001|Overall Study|Death|1|||
106003116|NCT00462306|365672608|FG000|Overall Study|insufficient data|0|||
106003117|NCT00462306|365672609|FG001|Overall Study|insufficient data|13|||
106003118|NCT00871871|365672611|FG000|Part I|Adverse Event|0|||
106003119|NCT00871871|365672612|FG001|Part I|Adverse Event|2|||
106003120|NCT00871871|365672613|FG002|Part I|Adverse Event|0|||
106003121|NCT00871871|365672614|FG003|Part I|Adverse Event|0|||
106131222|NCT04939428|366137727|FG002|Overall Study|Death|0|||
106131223|NCT04939428|366137725|FG000|Overall Study|Lost to Follow-up|0|||
106131224|NCT04939428|366137726|FG001|Overall Study|Lost to Follow-up|5|||
106131225|NCT04939428|366137727|FG002|Overall Study|Lost to Follow-up|0|||
106131226|NCT04939428|366137725|FG000|Overall Study|Physician Decision|1|||
106131227|NCT04939428|366137726|FG001|Overall Study|Physician Decision|0|||
106003122|NCT00871871|365672611|FG000|Part I|Withdrawal by Subject|3|||
106003123|NCT00871871|365672612|FG001|Part I|Withdrawal by Subject|0|||
106003124|NCT00871871|365672613|FG002|Part I|Withdrawal by Subject|0|||
106003125|NCT00871871|365672614|FG003|Part I|Withdrawal by Subject|0|||
106003126|NCT00871871|365672611|FG000|Part I|Laboratory abnormality|0|||
106003127|NCT00871871|365672612|FG001|Part I|Laboratory abnormality|1|||
106003128|NCT00871871|365672613|FG002|Part I|Laboratory abnormality|0|||
106003129|NCT00871871|365672614|FG003|Part I|Laboratory abnormality|0|||
106003130|NCT00871871|365672611|FG000|Part II|Lack of Efficacy|0|||
106003131|NCT00871871|365672612|FG001|Part II|Lack of Efficacy|0|||
106003132|NCT00871871|365672613|FG002|Part II|Lack of Efficacy|1|||
106003133|NCT00871871|365672614|FG003|Part II|Lack of Efficacy|0|||
106003134|NCT00871871|365672611|FG000|Part II|Withdrawal by Subject|0|||
106003135|NCT00871871|365672612|FG001|Part II|Withdrawal by Subject|0|||
106003136|NCT00871871|365672613|FG002|Part II|Withdrawal by Subject|2|||
106003137|NCT00871871|365672614|FG003|Part II|Withdrawal by Subject|1|||
106003138|NCT00871871|365672611|FG000|Part II|Adverse Event|0|||
106003139|NCT00871871|365672612|FG001|Part II|Adverse Event|0|||
106131228|NCT04939428|366137727|FG002|Overall Study|Physician Decision|0|||
106131229|NCT04939428|366137725|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
106131230|NCT04939428|366137726|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106003140|NCT00871871|365672613|FG002|Part II|Adverse Event|1|||
106003141|NCT00871871|365672614|FG003|Part II|Adverse Event|2|||
106131231|NCT04939428|366137727|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106131232|NCT04939428|366137725|FG000|Overall Study|Withdrawal by Subject|10|||
106003142|NCT00871871|365672611|FG000|Part II|Protocol Violation|0|||
106131233|NCT04939428|366137726|FG001|Overall Study|Withdrawal by Subject|11|||
106003143|NCT00871871|365672612|FG001|Part II|Protocol Violation|0|||
106003144|NCT00871871|365672613|FG002|Part II|Protocol Violation|0|||
106003145|NCT00871871|365672614|FG003|Part II|Protocol Violation|1|||
105692111|NCT00763971|364538334|FG001|Overall Study|Sponsor decision|0|||
106003146|NCT03883581|365672616|FG000|Overall Study|Withdrawal by Subject|4|||
106003147|NCT01808196|365672620|FG000|Overall Study|Lost to Follow-up|1|||
106003148|NCT04612725|365672621|FG000|Overall Study|Adverse Event|1|||
106003149|NCT04612725|365672622|FG001|Overall Study|Adverse Event|3|||
106003150|NCT04612725|365672623|FG002|Overall Study|Adverse Event|1|||
106003151|NCT04612725|365672624|FG003|Overall Study|Adverse Event|0|||
105692112|NCT00763971|364538335|FG002|Overall Study|Sponsor decision|0|||
105692113|NCT00763971|364538333|FG000|Overall Study|Due to holiday season|2|||
105692114|NCT00763971|364538334|FG001|Overall Study|Due to holiday season|0|||
105692115|NCT00763971|364538335|FG002|Overall Study|Due to holiday season|1|||
105692116|NCT00763971|364538333|FG000|Overall Study|Randomization error|0|||
105692117|NCT00763971|364538334|FG001|Overall Study|Randomization error|0|||
105692118|NCT00763971|364538335|FG002|Overall Study|Randomization error|1|||
105692119|NCT00763971|364538333|FG000|Overall Study|Medical monitor decision|0|||
105692120|NCT00763971|364538334|FG001|Overall Study|Medical monitor decision|0|||
105692121|NCT00763971|364538335|FG002|Overall Study|Medical monitor decision|1|||
105692122|NCT00763971|364538333|FG000|Overall Study|Moved to another country|0|||
105692123|NCT00763971|364538334|FG001|Overall Study|Moved to another country|1|||
105692124|NCT00763971|364538335|FG002|Overall Study|Moved to another country|0|||
105692125|NCT00763971|364538333|FG000|Overall Study|Subject wanted dose reduction|0|||
105692126|NCT00763971|364538334|FG001|Overall Study|Subject wanted dose reduction|1|||
105692127|NCT00763971|364538335|FG002|Overall Study|Subject wanted dose reduction|0|||
105692128|NCT00763971|364538333|FG000|Overall Study|Lack of availability|0|||
105692129|NCT00763971|364538334|FG001|Overall Study|Lack of availability|1|||
105692130|NCT00763971|364538335|FG002|Overall Study|Lack of availability|0|||
105692131|NCT00763971|364538333|FG000|Overall Study|Performed final visit on phone|0|||
105692132|NCT00763971|364538334|FG001|Overall Study|Performed final visit on phone|1|||
105692133|NCT00763971|364538335|FG002|Overall Study|Performed final visit on phone|0|||
105692134|NCT00763971|364538333|FG000|Overall Study|Participation in 489-326 required|1|||
105692135|NCT00763971|364538334|FG001|Overall Study|Participation in 489-326 required|0|||
105692136|NCT00763971|364538335|FG002|Overall Study|Participation in 489-326 required|0|||
105692137|NCT01524133|364538338|FG000|Treatment Phase|Withdrawal by Subject|13|||
105692138|NCT01524133|364538339|FG001|Treatment Phase|Withdrawal by Subject|28|||
105692139|NCT01524133|364538340|FG002|Treatment Phase|Withdrawal by Subject|31|||
105692140|NCT01524133|364538338|FG000|Treatment Phase|Physician Decision|6|||
105692141|NCT01524133|364538339|FG001|Treatment Phase|Physician Decision|3|||
105692142|NCT01524133|364538340|FG002|Treatment Phase|Physician Decision|3|||
105692143|NCT01524133|364538338|FG000|Treatment Phase|Lost to Follow-up|0|||
105692144|NCT01524133|364538339|FG001|Treatment Phase|Lost to Follow-up|1|||
105692145|NCT01524133|364538340|FG002|Treatment Phase|Lost to Follow-up|2|||
105692146|NCT01524133|364538338|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
105692147|NCT01524133|364538339|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
105692148|NCT01524133|364538340|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
105692149|NCT01524133|364538338|FG000|Overall Study 52 Weeks|Physician Decision|1|||
105692150|NCT01524133|364538339|FG001|Overall Study 52 Weeks|Physician Decision|0|||
105692151|NCT01524133|364538340|FG002|Overall Study 52 Weeks|Physician Decision|2|||
105692152|NCT01524133|364538338|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
105692153|NCT01524133|364538339|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
105692154|NCT01524133|364538340|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
105692155|NCT00733304|364538347|FG000|Overall Study|Adverse Event|3|||
105692156|NCT00733304|364538348|FG001|Overall Study|Adverse Event|0|||
105692157|NCT00733304|364538349|FG002|Overall Study|Adverse Event|0|||
105692158|NCT00733304|364538347|FG000|Overall Study|Lack of Efficacy|0|||
105692159|NCT00733304|364538348|FG001|Overall Study|Lack of Efficacy|0|||
105692160|NCT00733304|364538349|FG002|Overall Study|Lack of Efficacy|2|||
105692161|NCT00733304|364538347|FG000|Overall Study|Lost to Follow-up|0|||
105692162|NCT00733304|364538348|FG001|Overall Study|Lost to Follow-up|1|||
105692163|NCT00733304|364538349|FG002|Overall Study|Lost to Follow-up|0|||
105692164|NCT00733304|364538347|FG000|Overall Study|Physician Decision|3|||
105692165|NCT00733304|364538348|FG001|Overall Study|Physician Decision|1|||
106003152|NCT04612725|365672625|FG004|Overall Study|Adverse Event|1|||
106131234|NCT04939428|366137727|FG002|Overall Study|Withdrawal by Subject|0|||
105692166|NCT00733304|364538349|FG002|Overall Study|Physician Decision|3|||
105692167|NCT00733304|364538347|FG000|Overall Study|Withdrawal by Subject|1|||
105692168|NCT00733304|364538348|FG001|Overall Study|Withdrawal by Subject|1|||
105692169|NCT00733304|364538349|FG002|Overall Study|Withdrawal by Subject|0|||
105692170|NCT00129623|364538350|FG000|Overall Study|Adverse Event|3|||
105692171|NCT00129623|364538351|FG001|Overall Study|Adverse Event|7|||
105692172|NCT00129623|364538350|FG000|Overall Study|Refused Treatment|5|||
105692173|NCT00129623|364538351|FG001|Overall Study|Refused Treatment|3|||
105692174|NCT00129623|364538350|FG000|Overall Study|Failure to Return|1|||
105692175|NCT00129623|364538351|FG001|Overall Study|Failure to Return|1|||
105692176|NCT00129623|364538350|FG000|Overall Study|Relocated job out of state|1|||
105692177|NCT00129623|364538351|FG001|Overall Study|Relocated job out of state|0|||
105692178|NCT00129623|364538350|FG000|Overall Study|Uncertainty to return|0|||
106003153|NCT04612725|365672621|FG000|Overall Study|Lost to Follow-up|0|||
106003154|NCT04612725|365672622|FG001|Overall Study|Lost to Follow-up|1|||
106003155|NCT04612725|365672623|FG002|Overall Study|Lost to Follow-up|0|||
106131235|NCT04939428|366137725|FG000|Overall Study|Unkown|6|||
105692179|NCT00129623|364538351|FG001|Overall Study|Uncertainty to return|1|||
105692180|NCT03239483|364538352|FG000|Overall Study|Lost to Follow-up|1|||
105692181|NCT03239483|364538353|FG001|Overall Study|Lost to Follow-up|0|||
105692182|NCT03239483|364538352|FG000|Overall Study|Withdrawal by Subject|1|||
105692183|NCT03239483|364538353|FG001|Overall Study|Withdrawal by Subject|0|||
105692184|NCT03781323|364538354|FG000|Overall Study|Withdrawal by Subject|1|||
105692185|NCT01338415|364538355|FG000|Core + Extension|Adverse Event|8|||
105692186|NCT01338415|364538356|FG001|Core + Extension|Adverse Event|6|||
105919771|NCT04275336|365365158|FG000|Overall Study|First venipuncture failed|4|||
105919772|NCT04275336|365365159|FG001|Overall Study|First venipuncture failed|6|||
105919773|NCT04275336|365365160|FG002|Overall Study|First venipuncture failed|5|||
105919774|NCT04275336|365365158|FG000|Overall Study|Unscheduled venipuncture|9|||
105919775|NCT04275336|365365159|FG001|Overall Study|Unscheduled venipuncture|13|||
105919776|NCT04275336|365365160|FG002|Overall Study|Unscheduled venipuncture|7|||
105919777|NCT04275336|365365158|FG000|Overall Study|Failed specimen of saliva|4|||
105919778|NCT04275336|365365159|FG001|Overall Study|Failed specimen of saliva|3|||
105919779|NCT04275336|365365160|FG002|Overall Study|Failed specimen of saliva|4|||
105919780|NCT03444584|365365165|FG000|Overall Study|Withdrawal by Subject|0|||
105919781|NCT03444584|365365166|FG001|Overall Study|Withdrawal by Subject|1|||
105919782|NCT03444584|365365165|FG000|Overall Study|Other|0|||
105919783|NCT03444584|365365166|FG001|Overall Study|Other|1|||
105919784|NCT00423046|365365169|FG000|Overall Study|Other|340|||
105919785|NCT00423046|365365170|FG001|Overall Study|Other|345|||
105919786|NCT05401565|365365171|FG000|Overall Study|Lost to Follow-up|1|||
105919787|NCT05401565|365365172|FG001|Overall Study|Lost to Follow-up|0|||
105919788|NCT05401565|365365171|FG000|Overall Study|Adverse Event|2|||
105919789|NCT05401565|365365172|FG001|Overall Study|Adverse Event|0|||
105919790|NCT02783911|365365173|FG000|Overall Study|Lost to Follow-up|3|||
105919791|NCT02783911|365365174|FG001|Overall Study|Lost to Follow-up|32|||
105919792|NCT00071981|365365177|FG000|Overall Study|Lack of Efficacy|37|||
105919793|NCT00071981|365365178|FG001|Overall Study|Lack of Efficacy|29|||
105919794|NCT00071981|365365179|FG002|Overall Study|Lack of Efficacy|30|||
105919795|NCT00071981|365365180|FG003|Overall Study|Lack of Efficacy|43|||
105919796|NCT00071981|365365177|FG000|Overall Study|Adverse Event|4|||
105919797|NCT00071981|365365178|FG001|Overall Study|Adverse Event|4|||
105919798|NCT00071981|365365179|FG002|Overall Study|Adverse Event|3|||
105919799|NCT00071981|365365180|FG003|Overall Study|Adverse Event|1|||
105919800|NCT00071981|365365177|FG000|Overall Study|Death|0|||
105919801|NCT00071981|365365178|FG001|Overall Study|Death|0|||
105919802|NCT00071981|365365179|FG002|Overall Study|Death|1|||
105919803|NCT00071981|365365180|FG003|Overall Study|Death|1|||
105919804|NCT00071981|365365177|FG000|Overall Study|Withdrawal by Subject|3|||
105919805|NCT00071981|365365178|FG001|Overall Study|Withdrawal by Subject|1|||
105919806|NCT00071981|365365179|FG002|Overall Study|Withdrawal by Subject|0|||
105919807|NCT00071981|365365180|FG003|Overall Study|Withdrawal by Subject|0|||
105919808|NCT00071981|365365177|FG000|Overall Study|No protocol therapy|2|||
105919809|NCT00071981|365365178|FG001|Overall Study|No protocol therapy|5|||
105919810|NCT00071981|365365179|FG002|Overall Study|No protocol therapy|1|||
105919811|NCT00071981|365365180|FG003|Overall Study|No protocol therapy|0|||
105919812|NCT00071981|365365177|FG000|Overall Study|others (not specified in the study)|0|||
105919813|NCT00071981|365365178|FG001|Overall Study|others (not specified in the study)|2|||
105919814|NCT00071981|365365179|FG002|Overall Study|others (not specified in the study)|2|||
105919815|NCT00071981|365365180|FG003|Overall Study|others (not specified in the study)|0|||
105919816|NCT01123655|365365183|FG000|Overall Study|Medication for RA had to be changed|1|||
105919817|NCT01123655|365365184|FG001|Overall Study|Medication for RA had to be changed|0|||
105919818|NCT01123655|365365185|FG002|Overall Study|Medication for RA had to be changed|0|||
105919819|NCT01123655|365365183|FG000|Overall Study|new illness|0|||
105919820|NCT01123655|365365184|FG001|Overall Study|new illness|1|||
106003156|NCT04612725|365672624|FG003|Overall Study|Lost to Follow-up|0|||
105692187|NCT01338415|364538357|FG002|Core + Extension|Adverse Event|0|||
105692188|NCT01338415|364538355|FG000|Core + Extension|Withdrawal by Subject|1|||
105692189|NCT01338415|364538356|FG001|Core + Extension|Withdrawal by Subject|1|||
105919821|NCT01123655|365365185|FG002|Overall Study|new illness|0|||
105919822|NCT01123655|365365183|FG000|Overall Study|began prohibitive drug|0|||
105919823|NCT01123655|365365184|FG001|Overall Study|began prohibitive drug|0|||
105919824|NCT01123655|365365185|FG002|Overall Study|began prohibitive drug|1|||
105919825|NCT03608826|365365189|FG000|Overall Study|Death|3|||
105919826|NCT03608826|365365189|FG000|Overall Study|Heart Transplant|3|||
105919827|NCT03608826|365365189|FG000|Overall Study|Physician Decision|4|||
105919828|NCT00720499|365365200|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
105919829|NCT00720499|365365201|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
105919830|NCT00720499|365365200|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
106003157|NCT04612725|365672625|FG004|Overall Study|Lost to Follow-up|0|||
105786976|NCT02146365|364872948|FG001|Overall Study|Withdrawal by Subject|2|||
105919831|NCT00720499|365365201|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
105919832|NCT00720499|365365200|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
105919833|NCT00720499|365365201|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
106003158|NCT04612725|365672621|FG000|Overall Study|Physician Decision|2|||
106003159|NCT04612725|365672622|FG001|Overall Study|Physician Decision|0|||
106003160|NCT04612725|365672623|FG002|Overall Study|Physician Decision|0|||
106003161|NCT04612725|365672624|FG003|Overall Study|Physician Decision|0|||
106003162|NCT04612725|365672625|FG004|Overall Study|Physician Decision|0|||
106003163|NCT04612725|365672621|FG000|Overall Study|Study terminated by sponsor|3|||
106003164|NCT04612725|365672622|FG001|Overall Study|Study terminated by sponsor|1|||
106003165|NCT04612725|365672623|FG002|Overall Study|Study terminated by sponsor|2|||
106003166|NCT04612725|365672624|FG003|Overall Study|Study terminated by sponsor|4|||
106003167|NCT04612725|365672625|FG004|Overall Study|Study terminated by sponsor|5|||
106003168|NCT04612725|365672621|FG000|Overall Study|Withdrawal by Subject|8|||
106003169|NCT04612725|365672622|FG001|Overall Study|Withdrawal by Subject|3|||
105692190|NCT01338415|364538357|FG002|Core + Extension|Withdrawal by Subject|0|||
105692191|NCT01338415|364538355|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
105692192|NCT01338415|364538356|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
105692193|NCT01338415|364538357|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
105692194|NCT01338415|364538355|FG000|Core + Extension|Other (administrative reason)|1|||
105692195|NCT01338415|364538356|FG001|Core + Extension|Other (administrative reason)|0|||
105692196|NCT01338415|364538357|FG002|Core + Extension|Other (administrative reason)|0|||
105692197|NCT01338415|364538355|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
105692198|NCT01338415|364538356|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
105692199|NCT01338415|364538357|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
106003170|NCT04612725|365672623|FG002|Overall Study|Withdrawal by Subject|5|||
106003171|NCT04612725|365672624|FG003|Overall Study|Withdrawal by Subject|1|||
106003172|NCT04612725|365672625|FG004|Overall Study|Withdrawal by Subject|9|||
106003173|NCT04612725|365672621|FG000|Overall Study|Other|0|||
106003174|NCT04612725|365672622|FG001|Overall Study|Other|0|||
106003175|NCT04612725|365672623|FG002|Overall Study|Other|0|||
106003176|NCT04612725|365672624|FG003|Overall Study|Other|0|||
106003177|NCT04612725|365672625|FG004|Overall Study|Other|1|||
106003178|NCT03863509|365672629|FG000|Overall Study|COVID-19 shutdown period|0|||
106003179|NCT03863509|365672630|FG001|Overall Study|COVID-19 shutdown period|4|||
106003180|NCT03863509|365672631|FG002|Overall Study|COVID-19 shutdown period|0|||
106003181|NCT03863509|365672629|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
106003182|NCT03863509|365672630|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
106003183|NCT03863509|365672631|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
106003184|NCT03863509|365672629|FG000|Overall Study|Lost to Follow-up|8|||
106003185|NCT03863509|365672630|FG001|Overall Study|Lost to Follow-up|0|||
106003186|NCT03863509|365672631|FG002|Overall Study|Lost to Follow-up|2|||
106003187|NCT03863509|365672629|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
106003188|NCT03863509|365672630|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
106003189|NCT03863509|365672631|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
106003190|NCT03863509|365672629|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
106003191|NCT03863509|365672630|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
106003192|NCT03863509|365672631|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
106003193|NCT05893862|365672634|FG000|Overall Study|Physician Decision|0|||
106003194|NCT05893862|365672635|FG001|Overall Study|Physician Decision|1|||
106003195|NCT05893862|365672636|FG002|Overall Study|Physician Decision|0|||
106003196|NCT05893862|365672637|FG003|Overall Study|Physician Decision|0|||
106003197|NCT05893862|365672638|FG004|Overall Study|Physician Decision|1|||
106003198|NCT05893862|365672639|FG005|Overall Study|Physician Decision|0|||
106003199|NCT05893862|365672634|FG000|Overall Study|Withdrawal by Subject|1|||
106003200|NCT05893862|365672635|FG001|Overall Study|Withdrawal by Subject|7|||
106003201|NCT05893862|365672636|FG002|Overall Study|Withdrawal by Subject|1|||
106003202|NCT05893862|365672637|FG003|Overall Study|Withdrawal by Subject|3|||
106003203|NCT05893862|365672638|FG004|Overall Study|Withdrawal by Subject|3|||
106003204|NCT05893862|365672639|FG005|Overall Study|Withdrawal by Subject|2|||
106003205|NCT05893862|365672634|FG000|Overall Study|Adverse Event|1|||
106003206|NCT05893862|365672635|FG001|Overall Study|Adverse Event|4|||
106003207|NCT05893862|365672636|FG002|Overall Study|Adverse Event|2|||
106003208|NCT05893862|365672637|FG003|Overall Study|Adverse Event|2|||
106003209|NCT05893862|365672638|FG004|Overall Study|Adverse Event|1|||
106003210|NCT05893862|365672639|FG005|Overall Study|Adverse Event|0|||
106003211|NCT04750642|365672642|FG000|Overall Study|Adverse Event|1|||
106003212|NCT04750642|365672643|FG001|Overall Study|Adverse Event|0|||
106003213|NCT04750642|365672642|FG000|Overall Study|Withdrawal by Subject|0|||
106003214|NCT04750642|365672643|FG001|Overall Study|Withdrawal by Subject|1|||
106003215|NCT04750642|365672642|FG000|Overall Study|Protocol Violation|0|||
106003216|NCT04750642|365672643|FG001|Overall Study|Protocol Violation|1|||
106003217|NCT02919761|365672644|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
106003218|NCT02919761|365672645|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
106003219|NCT02919761|365672646|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
105692200|NCT01338415|364538355|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
106131236|NCT04939428|366137726|FG001|Overall Study|Unkown|3|||
106131237|NCT04939428|366137727|FG002|Overall Study|Unkown|0|||
106131238|NCT04939428|366137725|FG000|Overall Study|Discotinued per protocol|0|||
106131239|NCT04939428|366137726|FG001|Overall Study|Discotinued per protocol|0|||
106131240|NCT04939428|366137727|FG002|Overall Study|Discotinued per protocol|902|||
106131241|NCT02099539|366137733|FG000|Overall Study|Progressive Disease|3|||
106131242|NCT02099539|366137734|FG001|Overall Study|Progressive Disease|2|||
106131243|NCT02099539|366137735|FG002|Overall Study|Progressive Disease|2|||
106131244|NCT02099539|366137736|FG003|Overall Study|Progressive Disease|1|||
106131245|NCT02099539|366137737|FG004|Overall Study|Progressive Disease|4|||
106131246|NCT02099539|366137738|FG005|Overall Study|Progressive Disease|2|||
106131247|NCT02099539|366137739|FG006|Overall Study|Progressive Disease|0|||
106131248|NCT02099539|366137733|FG000|Overall Study|Adverse Event|0|||
106131249|NCT02099539|366137734|FG001|Overall Study|Adverse Event|0|||
106131250|NCT02099539|366137735|FG002|Overall Study|Adverse Event|1|||
106131251|NCT02099539|366137736|FG003|Overall Study|Adverse Event|1|||
106131252|NCT02099539|366137737|FG004|Overall Study|Adverse Event|0|||
106131253|NCT02099539|366137738|FG005|Overall Study|Adverse Event|0|||
106131254|NCT02099539|366137739|FG006|Overall Study|Adverse Event|0|||
106131255|NCT02099539|366137733|FG000|Overall Study|Physician Decision|0|||
106131256|NCT02099539|366137734|FG001|Overall Study|Physician Decision|0|||
106131257|NCT02099539|366137735|FG002|Overall Study|Physician Decision|0|||
106131258|NCT02099539|366137736|FG003|Overall Study|Physician Decision|0|||
106131259|NCT02099539|366137737|FG004|Overall Study|Physician Decision|0|||
106131260|NCT02099539|366137738|FG005|Overall Study|Physician Decision|1|||
106131261|NCT02099539|366137739|FG006|Overall Study|Physician Decision|0|||
106131262|NCT02696785|366137741|FG000|Blinded Treatment Period|Adverse Event|0|||
106131263|NCT02696785|366137742|FG001|Blinded Treatment Period|Adverse Event|1|||
106131264|NCT02696785|366137743|FG002|Blinded Treatment Period|Adverse Event|3|||
106131265|NCT02696785|366137744|FG003|Blinded Treatment Period|Adverse Event|0|||
106131266|NCT02696785|366137741|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
106131267|NCT02696785|366137742|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
106131268|NCT02696785|366137743|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
106131269|NCT02696785|366137744|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
106131270|NCT02696785|366137741|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
106131271|NCT02696785|366137742|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
106131272|NCT02696785|366137743|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
106131273|NCT02696785|366137744|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
106131274|NCT02696785|366137741|FG000|Blinded Treatment Period|Screen Failure|1|||
106131275|NCT02696785|366137742|FG001|Blinded Treatment Period|Screen Failure|0|||
106131276|NCT02696785|366137743|FG002|Blinded Treatment Period|Screen Failure|0|||
106131277|NCT02696785|366137744|FG003|Blinded Treatment Period|Screen Failure|0|||
106131278|NCT02696785|366137741|FG000|Washout Period|Withdrawal by Subject|0|||
106131279|NCT02696785|366137742|FG001|Washout Period|Withdrawal by Subject|1|||
106131280|NCT02696785|366137743|FG002|Washout Period|Withdrawal by Subject|0|||
106131281|NCT02696785|366137744|FG003|Washout Period|Withdrawal by Subject|0|||
106131282|NCT02696785|366137741|FG000|Washout Period|Lack of Efficacy|0|||
106131283|NCT02696785|366137742|FG001|Washout Period|Lack of Efficacy|1|||
106131284|NCT02696785|366137743|FG002|Washout Period|Lack of Efficacy|0|||
106131285|NCT02696785|366137744|FG003|Washout Period|Lack of Efficacy|0|||
106131286|NCT02696785|366137741|FG000|Extended Treatment Period|Adverse Event|2|||
106131287|NCT02696785|366137742|FG001|Extended Treatment Period|Adverse Event|3|||
106131288|NCT02696785|366137743|FG002|Extended Treatment Period|Adverse Event|2|||
106131289|NCT02696785|366137744|FG003|Extended Treatment Period|Adverse Event|1|||
106131290|NCT02696785|366137741|FG000|Extended Treatment Period|Lack of Efficacy|0|||
106131291|NCT02696785|366137742|FG001|Extended Treatment Period|Lack of Efficacy|1|||
106131292|NCT02696785|366137743|FG002|Extended Treatment Period|Lack of Efficacy|0|||
106131293|NCT02696785|366137744|FG003|Extended Treatment Period|Lack of Efficacy|0|||
105692201|NCT01338415|364538356|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
105692202|NCT01338415|364538357|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
106131294|NCT02696785|366137741|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
106131295|NCT02696785|366137742|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
106131296|NCT02696785|366137743|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
106131297|NCT02696785|366137744|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
106131298|NCT02696785|366137741|FG000|Follow-up Period|Adverse Event|0|||
106131299|NCT02696785|366137742|FG001|Follow-up Period|Adverse Event|0|||
106131300|NCT02696785|366137743|FG002|Follow-up Period|Adverse Event|8|||
106131301|NCT02696785|366137744|FG003|Follow-up Period|Adverse Event|2|||
106131302|NCT02696785|366137741|FG000|Follow-up Period|Lost to Follow-up|0|||
106131303|NCT02696785|366137742|FG001|Follow-up Period|Lost to Follow-up|0|||
106131304|NCT02696785|366137743|FG002|Follow-up Period|Lost to Follow-up|0|||
105692203|NCT01338415|364538355|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
105919834|NCT01326871|365365203|FG000|Overall Study|Major surgery|0|||
105919835|NCT01326871|365365204|FG001|Overall Study|Major surgery|1|||
105919836|NCT01326871|365365205|FG002|Overall Study|Major surgery|0|||
105919837|NCT01326871|365365203|FG000|Overall Study|SAE and death|0|||
105919838|NCT01326871|365365204|FG001|Overall Study|SAE and death|2|||
105919839|NCT01326871|365365205|FG002|Overall Study|SAE and death|0|||
105919840|NCT01326871|365365203|FG000|Overall Study|Physician decision and decreased performance status|0|||
105919841|NCT01326871|365365204|FG001|Overall Study|Physician decision and decreased performance status|1|||
105919842|NCT01326871|365365205|FG002|Overall Study|Physician decision and decreased performance status|0|||
105919843|NCT01326871|365365203|FG000|Overall Study|Disease progression|0|||
105919844|NCT01326871|365365204|FG001|Overall Study|Disease progression|11|||
105919845|NCT01326871|365365205|FG002|Overall Study|Disease progression|5|||
105919846|NCT01326871|365365203|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
105919847|NCT01326871|365365204|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
105919848|NCT01326871|365365205|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
105919849|NCT01326871|365365203|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
105919850|NCT01326871|365365204|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
105919851|NCT01326871|365365205|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
105919852|NCT01326871|365365203|FG000|Overall Study|Withdrawal by Subject|0|||
105919853|NCT01326871|365365204|FG001|Overall Study|Withdrawal by Subject|1|||
105919854|NCT01326871|365365205|FG002|Overall Study|Withdrawal by Subject|0|||
105919855|NCT01326871|365365203|FG000|Overall Study|DLT|0|||
105919856|NCT01326871|365365204|FG001|Overall Study|DLT|2|||
105919857|NCT01326871|365365205|FG002|Overall Study|DLT|0|||
105919858|NCT01326871|365365203|FG000|Overall Study|SAE, disease progression and subject decision|0|||
105919859|NCT01326871|365365204|FG001|Overall Study|SAE, disease progression and subject decision|1|||
105919860|NCT01326871|365365205|FG002|Overall Study|SAE, disease progression and subject decision|0|||
105919861|NCT01326871|365365203|FG000|Overall Study|Death|0|||
105919862|NCT01326871|365365204|FG001|Overall Study|Death|1|||
105919863|NCT01326871|365365205|FG002|Overall Study|Death|0|||
105919864|NCT01326871|365365203|FG000|Overall Study|Other|0|||
105919865|NCT01326871|365365204|FG001|Overall Study|Other|3|||
105919866|NCT01326871|365365205|FG002|Overall Study|Other|0|||
105919867|NCT01326871|365365203|FG000|Overall Study|SAE and disease progression|0|||
105919868|NCT01326871|365365204|FG001|Overall Study|SAE and disease progression|0|||
105919869|NCT01326871|365365205|FG002|Overall Study|SAE and disease progression|1|||
105919870|NCT01326871|365365203|FG000|Overall Study|SAE and physician decision|0|||
105919871|NCT01326871|365365204|FG001|Overall Study|SAE and physician decision|0|||
105919872|NCT01326871|365365205|FG002|Overall Study|SAE and physician decision|1|||
105919873|NCT01326871|365365203|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
105919874|NCT01326871|365365204|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
105919875|NCT01326871|365365205|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
105919876|NCT01326871|365365203|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
105919877|NCT01326871|365365204|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
105919878|NCT01326871|365365205|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
105919879|NCT01326871|365365203|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
105919880|NCT01326871|365365204|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
105919881|NCT01326871|365365205|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
105919882|NCT01326871|365365203|FG000|Overall Study|Physician Decision|0|||
105919883|NCT01326871|365365204|FG001|Overall Study|Physician Decision|0|||
105919884|NCT01326871|365365205|FG002|Overall Study|Physician Decision|1|||
105919885|NCT01326871|365365203|FG000|Overall Study|SAE|0|||
105919886|NCT01326871|365365204|FG001|Overall Study|SAE|0|||
105919887|NCT01326871|365365205|FG002|Overall Study|SAE|1|||
105919888|NCT01326871|365365203|FG000|Overall Study|Disease progression and death|0|||
105919889|NCT01326871|365365204|FG001|Overall Study|Disease progression and death|0|||
106131305|NCT02696785|366137744|FG003|Follow-up Period|Lost to Follow-up|1|||
105919890|NCT01326871|365365205|FG002|Overall Study|Disease progression and death|1|||
105919891|NCT01326871|365365203|FG000|Overall Study|Subject decision|0|||
105919892|NCT01326871|365365204|FG001|Overall Study|Subject decision|0|||
105919893|NCT01326871|365365205|FG002|Overall Study|Subject decision|1|||
105919894|NCT00434252|365367177|FG000|Overall Study|Lack of Efficacy|50|||
105919895|NCT00434252|365367178|FG001|Overall Study|Lack of Efficacy|100|||
105919896|NCT00434252|365367177|FG000|Overall Study|Adverse Event|6|||
105919897|NCT00434252|365367178|FG001|Overall Study|Adverse Event|13|||
105919898|NCT00434252|365367177|FG000|Overall Study|Death|1|||
105919899|NCT00434252|365367178|FG001|Overall Study|Death|2|||
105919900|NCT00434252|365367177|FG000|Overall Study|Lost to Follow-up|0|||
105919901|NCT00434252|365367178|FG001|Overall Study|Lost to Follow-up|1|||
105919902|NCT00434252|365367177|FG000|Overall Study|Physician Decision|4|||
105919903|NCT00434252|365367178|FG001|Overall Study|Physician Decision|8|||
105919904|NCT00434252|365367177|FG000|Overall Study|Withdrawal by Subject|3|||
105692204|NCT01338415|364538356|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
105692205|NCT01338415|364538357|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
105692206|NCT01338415|364538355|FG000|Exceptional Use Treatment Period|Death|0|||
105692207|NCT01338415|364538356|FG001|Exceptional Use Treatment Period|Death|0|||
105692208|NCT01338415|364538357|FG002|Exceptional Use Treatment Period|Death|1|||
105692209|NCT02308007|364538358|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
105692210|NCT02308007|364538359|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
105692211|NCT02308007|364538360|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
105692212|NCT02308007|364538358|FG000|Overall Study|Positive for STD at Baseline|7|||
105692213|NCT02308007|364538359|FG001|Overall Study|Positive for STD at Baseline|11|||
105692214|NCT02308007|364538360|FG002|Overall Study|Positive for STD at Baseline|7|||
105692215|NCT02308007|364538358|FG000|Overall Study|Lost to Follow-up|3|||
105692216|NCT02308007|364538359|FG001|Overall Study|Lost to Follow-up|0|||
105692217|NCT02308007|364538360|FG002|Overall Study|Lost to Follow-up|1|||
105692218|NCT01233869|364538361|FG000|Initial Treatment Period (24 Months)|Death|1|||
105692219|NCT01233869|364538362|FG001|Initial Treatment Period (24 Months)|Death|0|||
105692220|NCT01233869|364538363|FG002|Initial Treatment Period (24 Months)|Death|0|||
105692221|NCT01233869|364538364|FG003|Initial Treatment Period (24 Months)|Death|0|||
105692222|NCT01233869|364538361|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
105692223|NCT01233869|364538362|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
105692224|NCT01233869|364538363|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
105786977|NCT02146365|364872949|FG002|Overall Study|Withdrawal by Subject|1|||
105786978|NCT02146365|364872950|FG003|Overall Study|Withdrawal by Subject|5|||
105786979|NCT02146365|364872951|FG004|Overall Study|Withdrawal by Subject|1|||
105786980|NCT02146365|364872952|FG005|Overall Study|Withdrawal by Subject|0|||
105919905|NCT00434252|365367178|FG001|Overall Study|Withdrawal by Subject|7|||
105919906|NCT02807259|365367179|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
105919907|NCT02807259|365367180|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
105919908|NCT02807259|365367179|FG000|Midline (3 Months)|migration, refusal, not available|30|||
105919909|NCT02807259|365367180|FG001|Midline (3 Months)|migration, refusal, not available|34|||
105919910|NCT02807259|365367179|FG000|Endline (3 Months)|migration, refusal, not available|35|||
105919911|NCT02807259|365367180|FG001|Endline (3 Months)|migration, refusal, not available|87|||
105919912|NCT03861039|365367181|FG000|Overall Study|Adverse Event|2|||
105919913|NCT03861039|365367182|FG001|Overall Study|Adverse Event|5|||
105919914|NCT03861039|365367183|FG002|Overall Study|Adverse Event|11|||
105919915|NCT03861039|365367181|FG000|Overall Study|Withdrawal by Subject|1|||
105919916|NCT03861039|365367182|FG001|Overall Study|Withdrawal by Subject|3|||
105919917|NCT03861039|365367183|FG002|Overall Study|Withdrawal by Subject|4|||
105919918|NCT00720278|365367186|FG000|Overall Study|Adverse Event|5|||
105919919|NCT00720278|365367187|FG001|Overall Study|Adverse Event|3|||
105919920|NCT00720278|365367188|FG002|Overall Study|Adverse Event|4|||
105919921|NCT00720278|365367186|FG000|Overall Study|Withdrawal by Subject|0|||
105919922|NCT00720278|365367187|FG001|Overall Study|Withdrawal by Subject|1|||
105919923|NCT00720278|365367188|FG002|Overall Study|Withdrawal by Subject|0|||
105919924|NCT00720278|365367186|FG000|Overall Study|Lost to Follow-up|0|||
105919925|NCT00720278|365367187|FG001|Overall Study|Lost to Follow-up|0|||
105919926|NCT00720278|365367188|FG002|Overall Study|Lost to Follow-up|1|||
105919927|NCT00720278|365367186|FG000|Overall Study|Non-compliance|1|||
105919928|NCT00720278|365367187|FG001|Overall Study|Non-compliance|0|||
105919929|NCT00720278|365367188|FG002|Overall Study|Non-compliance|0|||
105919930|NCT00720278|365367186|FG000|Overall Study|eligibility criteria violation|1|||
105919931|NCT00720278|365367187|FG001|Overall Study|eligibility criteria violation|0|||
105919932|NCT00720278|365367188|FG002|Overall Study|eligibility criteria violation|1|||
105919933|NCT03103503|365367192|FG000|Overall Study|Death|64|||
105919934|NCT03103503|365367192|FG000|Overall Study|Physician Decision|57|||
105919935|NCT03103503|365367192|FG000|Overall Study|Withdrawal by Subject|10|||
105919936|NCT03103503|365367192|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
105919937|NCT03103503|365367192|FG000|Overall Study|Lost to Follow-up|3|||
105919938|NCT03103503|365367192|FG000|Overall Study|Study Closure|757|||
105919939|NCT01433159|365367193|FG000|Overall Study|Adverse Event|1|||
105919940|NCT01433159|365367194|FG001|Overall Study|Adverse Event|0|||
105919941|NCT01433159|365367193|FG000|Overall Study|Physician Decision|1|||
105919942|NCT01433159|365367194|FG001|Overall Study|Physician Decision|0|||
105919943|NCT01433159|365367193|FG000|Overall Study|Protocol Violation|0|||
106131306|NCT02696785|366137741|FG000|Follow-up Period|Lack of Efficacy|0|||
105692225|NCT01233869|364538364|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
105919944|NCT01433159|365367194|FG001|Overall Study|Protocol Violation|1|||
105919945|NCT01384877|365367195|FG000|Treatment 2|Lost to Follow-up|2|||
105919946|NCT01384877|365367196|FG001|Treatment 2|Lost to Follow-up|2|||
105786981|NCT02146365|364872953|FG006|Overall Study|Withdrawal by Subject|0|||
105919947|NCT03630393|365367198|FG000|Overall Study|Death|1|||
105919948|NCT03630393|365367199|FG001|Overall Study|Death|0|||
105919949|NCT01586195|365367203|FG000|Overall Study|Death|11|||
105919950|NCT01586195|365367203|FG000|Overall Study|Withdrawal of Consent|5|||
106003220|NCT02919761|365672644|FG000|Part 1: Open Label|Adverse Event|1|||
105692226|NCT01233869|364538361|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
105692227|NCT01233869|364538362|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
105692228|NCT01233869|364538363|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
105692229|NCT01233869|364538364|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
105692230|NCT01233869|364538361|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
105692231|NCT01233869|364538362|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
105692232|NCT01233869|364538363|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
105692233|NCT01233869|364538364|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
105692234|NCT01233869|364538361|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
105692235|NCT01233869|364538362|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
105692236|NCT01233869|364538363|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
105692237|NCT01233869|364538364|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
105692238|NCT01233869|364538361|FG000|Extended Treatment Period (46 Months)|Other|3|||
105692239|NCT01233869|364538362|FG001|Extended Treatment Period (46 Months)|Other|0|||
105692240|NCT01233869|364538363|FG002|Extended Treatment Period (46 Months)|Other|0|||
105692241|NCT01233869|364538364|FG003|Extended Treatment Period (46 Months)|Other|3|||
105692242|NCT01233869|364538361|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
105692243|NCT01233869|364538362|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
105692244|NCT01233869|364538363|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
105692245|NCT01233869|364538364|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
105692246|NCT03334409|364538365|FG000|Overall Study|Did not meet inclusion criteria|1|||
105692247|NCT03334409|364538366|FG001|Overall Study|Did not meet inclusion criteria|0|||
105692248|NCT03678103|364538367|FG000|Overall Study|Withdrawn prior to completion|4|||
105692249|NCT00537485|364538368|FG000|Overall Study|Adverse Event|10|||
105692250|NCT00537485|364538369|FG001|Overall Study|Adverse Event|5|||
105692251|NCT00537485|364538368|FG000|Overall Study|Withdrawal by Subject|3|||
105692252|NCT00537485|364538369|FG001|Overall Study|Withdrawal by Subject|2|||
105692253|NCT00537485|364538368|FG000|Overall Study|Withdrawal by Subject|1|||
105692254|NCT00537485|364538369|FG001|Overall Study|Withdrawal by Subject|3|||
105692255|NCT00537485|364538368|FG000|Overall Study|Physician Decision|1|||
105692256|NCT00537485|364538369|FG001|Overall Study|Physician Decision|0|||
105692257|NCT01241552|364538379|FG000|Overall Study|Lack of Efficacy|1|||
105692258|NCT01241552|364538380|FG001|Overall Study|Lack of Efficacy|0|||
105692259|NCT01241552|364538381|FG002|Overall Study|Lack of Efficacy|0|||
105692260|NCT01241552|364538382|FG003|Overall Study|Lack of Efficacy|0|||
105692261|NCT01241552|364538379|FG000|Overall Study|Death|26|||
105692262|NCT01241552|364538380|FG001|Overall Study|Death|30|||
105692263|NCT01241552|364538381|FG002|Overall Study|Death|20|||
105692264|NCT01241552|364538382|FG003|Overall Study|Death|25|||
105692265|NCT01241552|364538379|FG000|Overall Study|Adverse Event|1|||
105692266|NCT01241552|364538380|FG001|Overall Study|Adverse Event|1|||
105692267|NCT01241552|364538381|FG002|Overall Study|Adverse Event|0|||
105692268|NCT01241552|364538382|FG003|Overall Study|Adverse Event|0|||
105692269|NCT01241552|364538379|FG000|Overall Study|Technical Problems|2|||
105692270|NCT01241552|364538380|FG001|Overall Study|Technical Problems|0|||
105692271|NCT01241552|364538381|FG002|Overall Study|Technical Problems|2|||
105692272|NCT01241552|364538382|FG003|Overall Study|Technical Problems|2|||
105692273|NCT01241552|364538379|FG000|Overall Study|Progressive Disease|0|||
105692274|NCT01241552|364538380|FG001|Overall Study|Progressive Disease|0|||
105692275|NCT01241552|364538381|FG002|Overall Study|Progressive Disease|1|||
105692276|NCT01241552|364538382|FG003|Overall Study|Progressive Disease|2|||
105692277|NCT01241552|364538379|FG000|Overall Study|Protocol Violation|0|||
105692278|NCT01241552|364538380|FG001|Overall Study|Protocol Violation|2|||
105786982|NCT02146365|364872954|FG007|Overall Study|Withdrawal by Subject|0|||
105919951|NCT01586195|365367203|FG000|Overall Study|Started new anti-melanoma therapy|1|||
105919952|NCT01586195|365367203|FG000|Overall Study|Reason not specified|9|||
105919953|NCT00997334|365367204|FG000|Overall Study|still on therapy|12|||
105919954|NCT00997334|365367204|FG000|Overall Study|Adverse Event|3|||
105919955|NCT00997334|365367204|FG000|Overall Study|Patient non-compliance|1|||
105919956|NCT00997334|365367204|FG000|Overall Study|Withdrawal by Subject|3|||
105919957|NCT00997334|365367204|FG000|Overall Study|Death|2|||
105919958|NCT00997334|365367204|FG000|Overall Study|Urgent Palliative Care|2|||
105692279|NCT01241552|364538381|FG002|Overall Study|Protocol Violation|6|||
105692280|NCT01241552|364538382|FG003|Overall Study|Protocol Violation|1|||
105692281|NCT01241552|364538379|FG000|Overall Study|Withdrawal by Subject|7|||
105692282|NCT01241552|364538380|FG001|Overall Study|Withdrawal by Subject|15|||
105692283|NCT01241552|364538381|FG002|Overall Study|Withdrawal by Subject|14|||
105692284|NCT01241552|364538382|FG003|Overall Study|Withdrawal by Subject|15|||
105786983|NCT02146365|364872947|FG000|Overall Study|Unable to Comply with Protocol|0|||
105919959|NCT00997334|365367204|FG000|Overall Study|No lesion amenable|1|||
105919960|NCT00997334|365367204|FG000|Overall Study|Ineligible|1|||
105692285|NCT01241552|364538379|FG000|Overall Study|Physician Decision|2|||
105692286|NCT01241552|364538380|FG001|Overall Study|Physician Decision|4|||
105692287|NCT01241552|364538381|FG002|Overall Study|Physician Decision|2|||
105919961|NCT01287936|365367205|FG000|Overall Study|Lost to Follow-up|0|||
106131307|NCT02696785|366137742|FG001|Follow-up Period|Lack of Efficacy|0|||
106131308|NCT02696785|366137743|FG002|Follow-up Period|Lack of Efficacy|0|||
106131309|NCT02696785|366137744|FG003|Follow-up Period|Lack of Efficacy|1|||
106131310|NCT02696785|366137741|FG000|Follow-up Period|Withdrawal by Subject|1|||
106131311|NCT02696785|366137742|FG001|Follow-up Period|Withdrawal by Subject|0|||
105692288|NCT01241552|364538382|FG003|Overall Study|Physician Decision|3|||
105692289|NCT01241552|364538379|FG000|Overall Study|Lost to Follow-up|2|||
105692290|NCT01241552|364538380|FG001|Overall Study|Lost to Follow-up|11|||
105692291|NCT01241552|364538381|FG002|Overall Study|Lost to Follow-up|15|||
105692292|NCT01241552|364538382|FG003|Overall Study|Lost to Follow-up|16|||
105692293|NCT01296035|364538384|FG000|Overall Study|Withdrawal by Subject|1|||
105692294|NCT00528567|364538385|FG000|Overall Study|Death|4|||
105692295|NCT00528567|364538386|FG001|Overall Study|Death|5|||
105692296|NCT00528567|364538385|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
105692297|NCT00528567|364538386|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
105692298|NCT00528567|364538385|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
105692299|NCT00528567|364538386|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
105692300|NCT00528567|364538385|FG000|Overall Study|Violation Criteria at Entry|3|||
105692301|NCT00528567|364538386|FG001|Overall Study|Violation Criteria at Entry|17|||
105692302|NCT00528567|364538385|FG000|Overall Study|Withdrew Consent|59|||
105692303|NCT00528567|364538386|FG001|Overall Study|Withdrew Consent|55|||
105692304|NCT00528567|364538385|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
105692305|NCT00528567|364538386|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
105692306|NCT00528567|364538385|FG000|Overall Study|Failure to Return|1|||
105692307|NCT00528567|364538386|FG001|Overall Study|Failure to Return|4|||
105692308|NCT00528567|364538385|FG000|Overall Study|Other Protocol Violation|5|||
105692309|NCT00528567|364538386|FG001|Overall Study|Other Protocol Violation|21|||
105692310|NCT00528567|364538385|FG000|Overall Study|Administrative/Other|22|||
105692311|NCT00528567|364538386|FG001|Overall Study|Administrative/Other|75|||
105692312|NCT04004429|364538390|FG000|Overall Study|Protocol Violation|1|||
105692313|NCT04004429|364538391|FG001|Overall Study|Protocol Violation|0|||
105692314|NCT04004429|364538392|FG002|Overall Study|Protocol Violation|0|||
105692315|NCT04004429|364538390|FG000|Overall Study|Physician Decision|0|||
105692316|NCT04004429|364538391|FG001|Overall Study|Physician Decision|1|||
105692317|NCT04004429|364538392|FG002|Overall Study|Physician Decision|1|||
105692318|NCT04004429|364538390|FG000|Overall Study|Withdrawal by Subject|1|||
105692319|NCT04004429|364538391|FG001|Overall Study|Withdrawal by Subject|1|||
105692320|NCT04004429|364538392|FG002|Overall Study|Withdrawal by Subject|1|||
105692321|NCT03085758|364538393|FG000|Overall Study|Death|26|||
105692322|NCT03085758|364538394|FG001|Overall Study|Death|24|||
105692323|NCT03085758|364538395|FG002|Overall Study|Death|53|||
105692324|NCT03085758|364538393|FG000|Overall Study|Lost to Follow-up|1|||
105692325|NCT03085758|364538394|FG001|Overall Study|Lost to Follow-up|1|||
105692326|NCT03085758|364538395|FG002|Overall Study|Lost to Follow-up|1|||
105692327|NCT03085758|364538393|FG000|Overall Study|Withdrawal by Subject|2|||
105692328|NCT03085758|364538394|FG001|Overall Study|Withdrawal by Subject|2|||
105692329|NCT03085758|364538395|FG002|Overall Study|Withdrawal by Subject|1|||
105692330|NCT03085758|364538393|FG000|Overall Study|Refusal to recall it up to day 90|0|||
105692331|NCT03085758|364538394|FG001|Overall Study|Refusal to recall it up to day 90|0|||
105692332|NCT03085758|364538395|FG002|Overall Study|Refusal to recall it up to day 90|1|||
105692333|NCT03085758|364538393|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
105692334|NCT03085758|364538394|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
105692335|NCT03085758|364538395|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
105692336|NCT01287364|364538397|FG000|Overall Study|Adverse Event|0|||
105692337|NCT01287364|364538398|FG001|Overall Study|Adverse Event|3|||
105692338|NCT01287364|364538397|FG000|Overall Study|Protocol Violation|5|||
105692339|NCT01287364|364538398|FG001|Overall Study|Protocol Violation|5|||
105692340|NCT01287364|364538397|FG000|Overall Study|Other Reason|4|||
105692341|NCT01287364|364538398|FG001|Overall Study|Other Reason|2|||
106131312|NCT02696785|366137743|FG002|Follow-up Period|Withdrawal by Subject|5|||
105692342|NCT02187809|364538404|FG000|Overall Study|The study was terminated|3|||
105692343|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
105692344|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
105692345|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
105692346|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
105692347|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
105692348|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
105692349|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
105692350|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
105692351|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
105692352|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
105692353|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
105692354|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
105692355|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
106003221|NCT02919761|365672645|FG001|Part 1: Open Label|Adverse Event|0|||
105692356|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
105692357|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
105692358|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
105692359|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
105692360|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
105692361|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
105692362|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
105692363|NCT01641809|364538405|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
106003222|NCT02919761|365672646|FG002|Part 1: Open Label|Adverse Event|0|||
106003223|NCT02919761|365672644|FG000|Part 1: Open Label|Lost to Follow-up|1|||
106003224|NCT02919761|365672645|FG001|Part 1: Open Label|Lost to Follow-up|0|||
106003225|NCT02919761|365672646|FG002|Part 1: Open Label|Lost to Follow-up|0|||
106003226|NCT02919761|365672644|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
106003227|NCT02919761|365672645|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
106003228|NCT02919761|365672646|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
106003229|NCT02919761|365672644|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
106003230|NCT02919761|365672645|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
106003231|NCT02919761|365672646|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
106003232|NCT02919761|365672644|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
106003233|NCT02919761|365672645|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
106003234|NCT02919761|365672646|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
105692364|NCT01641809|364538406|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
105919962|NCT01287936|365367206|FG001|Overall Study|Lost to Follow-up|1|||
105919963|NCT01287936|365367207|FG002|Overall Study|Lost to Follow-up|1|||
105919964|NCT00427934|365367208|FG000|Overall Study|Adverse Event|1|||
105919965|NCT00427934|365367209|FG001|Overall Study|Adverse Event|0|||
105919966|NCT00427934|365367210|FG002|Overall Study|Adverse Event|5|||
105919967|NCT00427934|365367211|FG003|Overall Study|Adverse Event|4|||
105919968|NCT00427934|365367208|FG000|Overall Study|Lack of Efficacy|0|||
105919969|NCT00427934|365367209|FG001|Overall Study|Lack of Efficacy|0|||
105919970|NCT00427934|365367210|FG002|Overall Study|Lack of Efficacy|5|||
105919971|NCT00427934|365367211|FG003|Overall Study|Lack of Efficacy|2|||
105919972|NCT00427934|365367208|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
105919973|NCT00427934|365367209|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
105919974|NCT00427934|365367210|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
105919975|NCT00427934|365367211|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
105919976|NCT00427934|365367208|FG000|Overall Study|Other|0|||
105919977|NCT00427934|365367209|FG001|Overall Study|Other|0|||
105919978|NCT00427934|365367210|FG002|Overall Study|Other|11|||
105919979|NCT00427934|365367211|FG003|Overall Study|Other|5|||
105919980|NCT00427934|365367208|FG000|Overall Study|Withdrawal by Subject|0|||
105919981|NCT00427934|365367209|FG001|Overall Study|Withdrawal by Subject|0|||
105919982|NCT00427934|365367210|FG002|Overall Study|Withdrawal by Subject|1|||
105919983|NCT00427934|365367211|FG003|Overall Study|Withdrawal by Subject|3|||
105919984|NCT04745351|365367212|FG000|Overall Study|Death|51|||
105919985|NCT04745351|365367213|FG001|Overall Study|Death|25|||
105919986|NCT04745351|365367212|FG000|Overall Study|Lost to Follow-up|9|||
105919987|NCT04745351|365367213|FG001|Overall Study|Lost to Follow-up|3|||
105919988|NCT04745351|365367212|FG000|Overall Study|Randomized but Never Treated|3|||
105919989|NCT04745351|365367213|FG001|Overall Study|Randomized but Never Treated|3|||
105919990|NCT04745351|365367212|FG000|Overall Study|Adverse Event|4|||
105919991|NCT04745351|365367213|FG001|Overall Study|Adverse Event|0|||
105919992|NCT04745351|365367212|FG000|Overall Study|Withdrew Consent|1|||
105919993|NCT04745351|365367213|FG001|Overall Study|Withdrew Consent|2|||
105919994|NCT04745351|365367212|FG000|Overall Study|Investigator's Discretion|2|||
105919995|NCT04745351|365367213|FG001|Overall Study|Investigator's Discretion|0|||
105919996|NCT04745351|365367212|FG000|Overall Study|Protocol Violation|1|||
105919997|NCT04745351|365367213|FG001|Overall Study|Protocol Violation|0|||
105919998|NCT00883181|365367214|FG000|Overall Study|Hematological Adverse Event|26|||
105919999|NCT00883181|365367214|FG000|Overall Study|Non-hematological Adverse Event|55|||
105920000|NCT00883181|365367214|FG000|Overall Study|Disease Progression|94|||
105920001|NCT00883181|365367214|FG000|Overall Study|Administrative Reason|24|||
106003235|NCT02919761|365672644|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
106003236|NCT02919761|365672645|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
106003237|NCT02919761|365672646|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
105920002|NCT00883181|365367214|FG000|Overall Study|Withdrawal by Subject|4|||
105920003|NCT00883181|365367214|FG000|Overall Study|Death|31|||
105920004|NCT00883181|365367214|FG000|Overall Study|Other|38|||
105920005|NCT00883181|365367214|FG000|Overall Study|Protocol Deviation|3|||
105920006|NCT00883181|365367214|FG000|Overall Study|Noncompliance|3|||
105920007|NCT01715831|365367215|FG000|Overall Study|Adverse Event|1|||
105692365|NCT01641809|364538407|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
105920008|NCT02419807|365367216|FG000|Overall Study|Withdrawal by Subject|4|||
105920009|NCT02419807|365367216|FG000|Overall Study|Physician Decision|1|||
105920010|NCT02419807|365367216|FG000|Overall Study|Protocol Violation|5|||
106003238|NCT02919761|365672644|FG000|Part 1: Open Label|Termination by Sponsor|1|||
106003239|NCT02919761|365672645|FG001|Part 1: Open Label|Termination by Sponsor|0|||
106003240|NCT02919761|365672646|FG002|Part 1: Open Label|Termination by Sponsor|0|||
106003241|NCT02919761|365672644|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
106003242|NCT02919761|365672645|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
106003243|NCT02919761|365672646|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
106003244|NCT02919761|365672644|FG000|Part 2: Double-blind|Adverse Event|0|||
106003245|NCT02919761|365672645|FG001|Part 2: Double-blind|Adverse Event|1|||
106003246|NCT02919761|365672646|FG002|Part 2: Double-blind|Adverse Event|0|||
106003247|NCT02919761|365672644|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
106003248|NCT02919761|365672645|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
106003249|NCT02919761|365672646|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
106003250|NCT02919761|365672644|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
106003251|NCT02919761|365672645|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
106003252|NCT02919761|365672646|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
106003253|NCT02919761|365672644|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
106003254|NCT02919761|365672645|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
106003255|NCT02919761|365672646|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
106003256|NCT02919761|365672644|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
106003257|NCT02919761|365672645|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
106003258|NCT02919761|365672646|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
106003259|NCT02919761|365672644|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
106003260|NCT02919761|365672645|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
106003261|NCT02919761|365672646|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
105692366|NCT01641809|364538408|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
105692367|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
105692368|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
105692369|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
106003262|NCT02919761|365672644|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
106003263|NCT02919761|365672645|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
106003264|NCT02919761|365672646|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
106003265|NCT03016312|365674232|FG000|Overall Study|discontinued before the treatment started|0|||
106003266|NCT03016312|365674233|FG001|Overall Study|discontinued before the treatment started|1|||
106003267|NCT03016312|365674232|FG000|Overall Study|Withdrawal by Subject|37|||
106003268|NCT03016312|365674233|FG001|Overall Study|Withdrawal by Subject|44|||
106003269|NCT03016312|365674232|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
106003270|NCT03016312|365674233|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
106003271|NCT03016312|365674232|FG000|Overall Study|Physician Decision|1|||
106003272|NCT03016312|365674233|FG001|Overall Study|Physician Decision|3|||
106003273|NCT03016312|365674232|FG000|Overall Study|Lost to Follow-up|12|||
106003274|NCT03016312|365674233|FG001|Overall Study|Lost to Follow-up|12|||
106003275|NCT03016312|365674232|FG000|Overall Study|Death|210|||
106003276|NCT03016312|365674233|FG001|Overall Study|Death|184|||
106003277|NCT03016312|365674232|FG000|Overall Study|loss to contact|1|||
106003278|NCT03016312|365674233|FG001|Overall Study|loss to contact|0|||
106003279|NCT03016312|365674232|FG000|Overall Study|started a new cancer therapy|1|||
106003280|NCT03016312|365674233|FG001|Overall Study|started a new cancer therapy|0|||
106003281|NCT01451723|365674234|FG000|Overall Study|study halted|6|||
106003282|NCT01451723|365674235|FG001|Overall Study|study halted|5|||
106003283|NCT01702844|365674241|FG000|Overall Study|Adverse Event|9|||
106003284|NCT01702844|365674241|FG000|Overall Study|Death|1|||
106003285|NCT01702844|365674241|FG000|Overall Study|Withdrawal by Subject|3|||
106003286|NCT01702844|365674241|FG000|Overall Study|Physician Decision|6|||
106003287|NCT02193776|365674242|FG000|Overall Study|Consent withdrawn|1|||
106003288|NCT02193776|365674243|FG001|Overall Study|Consent withdrawn|0|||
106003289|NCT02193776|365674244|FG002|Overall Study|Consent withdrawn|0|||
106003290|NCT02193776|365674245|FG003|Overall Study|Consent withdrawn|0|||
105692370|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
105692371|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
105692372|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
106003291|NCT02193776|365674242|FG000|Overall Study|Failure to comply with protocol|0|||
106003292|NCT02193776|365674243|FG001|Overall Study|Failure to comply with protocol|1|||
106003293|NCT02193776|365674244|FG002|Overall Study|Failure to comply with protocol|0|||
106003294|NCT02193776|365674245|FG003|Overall Study|Failure to comply with protocol|0|||
105692373|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
105692374|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
106003295|NCT02193776|365674242|FG000|Overall Study|Investigator/Sponsor decision|1|||
106003296|NCT02193776|365674243|FG001|Overall Study|Investigator/Sponsor decision|1|||
106003297|NCT02193776|365674244|FG002|Overall Study|Investigator/Sponsor decision|0|||
106003298|NCT02193776|365674245|FG003|Overall Study|Investigator/Sponsor decision|0|||
106003299|NCT02193776|365674242|FG000|Overall Study|Death|1|||
106003300|NCT02193776|365674243|FG001|Overall Study|Death|0|||
106003301|NCT02193776|365674244|FG002|Overall Study|Death|0|||
105692375|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
105692376|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
105692377|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
105692378|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
105692379|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
105692380|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
105692381|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
105692382|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
105692383|NCT01641809|364538405|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
105692384|NCT01641809|364538406|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
105692385|NCT01641809|364538407|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
105692386|NCT01641809|364538408|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
105692387|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
105692388|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
105692389|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
105692390|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
105692391|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
105692392|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
105692393|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
105692394|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
105692395|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
105692396|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
105692397|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
105692398|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
105692399|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
105692400|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
105692401|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
105692402|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
105692403|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
105692404|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
105692405|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
105692406|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
105692407|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
105692408|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
105692409|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
105692410|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
105692411|NCT01641809|364538405|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
105692412|NCT01641809|364538406|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
105692413|NCT01641809|364538407|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
105692414|NCT01641809|364538408|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
105692415|NCT01505010|364538409|FG000|Overall Study|Protocol Violation|0|||
105920011|NCT00426270|365367217|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
105920012|NCT00426270|365367217|FG000|Overall Study|Adverse Event|5|||
105920013|NCT00095979|365367221|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
105920014|NCT01483118|365367222|FG000|Overall Study|Lost to Follow-up|12|||
105920015|NCT01483118|365367223|FG001|Overall Study|Lost to Follow-up|16|||
105920016|NCT01079780|365367226|FG000|Overall Study|Disease progression|43|||
105920017|NCT01079780|365367227|FG001|Overall Study|Disease progression|7|||
105920018|NCT01079780|365367228|FG002|Overall Study|Disease progression|31|||
105920019|NCT01079780|365367226|FG000|Overall Study|Adverse Event|13|||
105920020|NCT01079780|365367227|FG001|Overall Study|Adverse Event|5|||
105920021|NCT01079780|365367228|FG002|Overall Study|Adverse Event|7|||
105920022|NCT01079780|365367226|FG000|Overall Study|Death|2|||
105920023|NCT01079780|365367227|FG001|Overall Study|Death|0|||
105920024|NCT01079780|365367228|FG002|Overall Study|Death|2|||
105920025|NCT01079780|365367226|FG000|Overall Study|Withdrawal by Subject|6|||
105920026|NCT01079780|365367227|FG001|Overall Study|Withdrawal by Subject|4|||
105920027|NCT01079780|365367228|FG002|Overall Study|Withdrawal by Subject|4|||
105920028|NCT01079780|365367226|FG000|Overall Study|Alternative therapy|2|||
105920029|NCT01079780|365367227|FG001|Overall Study|Alternative therapy|0|||
105920030|NCT01079780|365367228|FG002|Overall Study|Alternative therapy|2|||
105920031|NCT01079780|365367226|FG000|Overall Study|Physician Decision|1|||
105920032|NCT01079780|365367227|FG001|Overall Study|Physician Decision|0|||
105920033|NCT01079780|365367228|FG002|Overall Study|Physician Decision|1|||
105920034|NCT01079780|365367226|FG000|Overall Study|Error made in lesion measurement|1|||
106131313|NCT02696785|366137744|FG003|Follow-up Period|Withdrawal by Subject|4|||
105692416|NCT01505010|364538410|FG001|Overall Study|Protocol Violation|1|||
105692417|NCT01505010|364538409|FG000|Overall Study|Lost to Follow-up|0|||
105920035|NCT01079780|365367227|FG001|Overall Study|Error made in lesion measurement|0|||
105920036|NCT01079780|365367228|FG002|Overall Study|Error made in lesion measurement|0|||
105920037|NCT01079780|365367226|FG000|Overall Study|Patient had surgery|1|||
106131314|NCT04863898|366137747|FG000|Overall Study|Away from study clinic during intervention training period|2|||
106131315|NCT04863898|366137747|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
106131316|NCT04863898|366137747|FG000|Overall Study|Lost to Follow-up|3|||
106131317|NCT04863898|366137747|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
106131318|NCT04863898|366137747|FG000|Overall Study|No longer employed at clinic|3|||
105692418|NCT01505010|364538410|FG001|Overall Study|Lost to Follow-up|1|||
105692419|NCT04195581|364538413|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
105692420|NCT04195581|364538413|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
105692421|NCT04195581|364538413|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
105692422|NCT04195581|364538413|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
105692423|NCT04195581|364538413|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
105692424|NCT04195581|364538413|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
105692425|NCT01387230|364538414|FG000|Overall Study|Adverse Event|0|||
105692426|NCT01387230|364538415|FG001|Overall Study|Adverse Event|1|||
105692427|NCT01387230|364538416|FG002|Overall Study|Adverse Event|3|||
106131319|NCT02487446|366137748|FG000|Period 1|Physician Decision|0|||
106131320|NCT02487446|366137749|FG001|Period 1|Physician Decision|1|||
106131321|NCT02487446|366137748|FG000|Period 1|Lack of Efficacy|1|||
106131322|NCT02487446|366137749|FG001|Period 1|Lack of Efficacy|0|||
106131323|NCT02487446|366137748|FG000|Period 1|Protocol deviation|3|||
106131324|NCT02487446|366137749|FG001|Period 1|Protocol deviation|2|||
106131325|NCT02487446|366137748|FG000|Period 1|Lost to Follow-up|2|||
106131326|NCT02487446|366137749|FG001|Period 1|Lost to Follow-up|0|||
106131327|NCT02487446|366137748|FG000|Period 1|Withdrawal by Subject|2|||
106131328|NCT02487446|366137749|FG001|Period 1|Withdrawal by Subject|0|||
106131329|NCT02487446|366137748|FG000|Period 1|Adverse Event|5|||
106131330|NCT02487446|366137749|FG001|Period 1|Adverse Event|5|||
106131331|NCT02487446|366137748|FG000|Washout|Lost to Follow-up|0|||
106131332|NCT02487446|366137749|FG001|Washout|Lost to Follow-up|2|||
106131333|NCT02487446|366137748|FG000|Washout|Withdrawal by Subject|1|||
106131334|NCT02487446|366137749|FG001|Washout|Withdrawal by Subject|4|||
106131335|NCT02487446|366137748|FG000|Washout|Adverse Event|2|||
106131336|NCT02487446|366137749|FG001|Washout|Adverse Event|2|||
106131337|NCT02487446|366137748|FG000|Period 2|Protocol deviation|0|||
106131338|NCT02487446|366137749|FG001|Period 2|Protocol deviation|1|||
106131339|NCT02487446|366137748|FG000|Period 2|Lost to Follow-up|1|||
106131340|NCT02487446|366137749|FG001|Period 2|Lost to Follow-up|1|||
106131341|NCT02487446|366137748|FG000|Period 2|Withdrawal by Subject|1|||
106131342|NCT02487446|366137749|FG001|Period 2|Withdrawal by Subject|1|||
106131343|NCT02487446|366137748|FG000|Period 2|Adverse Event|6|||
106131344|NCT02487446|366137749|FG001|Period 2|Adverse Event|2|||
106131345|NCT02337361|366137754|FG000|3-month Follow-up|Lost to Follow-up|19|||
106131346|NCT02337361|366137755|FG001|3-month Follow-up|Lost to Follow-up|14|||
106131347|NCT02337361|366137754|FG000|6-month Follow-up|Lost to Follow-up|2|||
106131348|NCT02337361|366137755|FG001|6-month Follow-up|Lost to Follow-up|4|||
106131349|NCT05310084|366139482|FG000|Overall Study|Withdrawal by Subject|2|||
106131350|NCT05310084|366139483|FG001|Overall Study|Withdrawal by Subject|3|||
106131351|NCT05310084|366139482|FG000|Overall Study|Participant availability|0|||
106131352|NCT05310084|366139483|FG001|Overall Study|Participant availability|4|||
106131353|NCT05310084|366139482|FG000|Overall Study|Lost to Follow-up|1|||
106131354|NCT05310084|366139483|FG001|Overall Study|Lost to Follow-up|1|||
106131355|NCT05310084|366139482|FG000|Overall Study|Adverse Event|1|||
106131356|NCT05310084|366139483|FG001|Overall Study|Adverse Event|1|||
106131357|NCT05310084|366139482|FG000|Overall Study|Randomized but not vaccinated|4|||
106131358|NCT05310084|366139483|FG001|Overall Study|Randomized but not vaccinated|2|||
106131359|NCT01598987|366139484|FG000|Baseline to Month 12|Administrative problems|2|||
106131360|NCT01598987|366139484|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
106131361|NCT01598987|366139484|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
106131362|NCT01598987|366139484|FG000|Baseline to 24 Month|Administrative problems|2|||
106131363|NCT01598987|366139484|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
106131364|NCT02892409|366139485|FG000|Overall Study|Adverse Event|1|||
105692428|NCT01387230|364538414|FG000|Overall Study|Lack of Efficacy|8|||
105692429|NCT01387230|364538415|FG001|Overall Study|Lack of Efficacy|5|||
105692430|NCT01387230|364538416|FG002|Overall Study|Lack of Efficacy|4|||
105692431|NCT01387230|364538414|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
106131365|NCT02892409|366139486|FG001|Overall Study|Adverse Event|0|||
106131366|NCT02892409|366139485|FG000|Overall Study|Withdrawal by Subject|2|||
106131367|NCT02892409|366139486|FG001|Overall Study|Withdrawal by Subject|1|||
106131368|NCT05305040|366139487|FG000|Overall Study|Not Dosed|37|||
106131369|NCT05305040|366139488|FG001|Overall Study|Not Dosed|37|||
106131370|NCT05305040|366139487|FG000|Overall Study|Study Closure|34|||
105692432|NCT01387230|364538415|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
105692433|NCT01387230|364538416|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
105692434|NCT01387230|364538414|FG000|Overall Study|Lost to Follow-up|0|||
105692435|NCT01387230|364538415|FG001|Overall Study|Lost to Follow-up|0|||
105692436|NCT01387230|364538416|FG002|Overall Study|Lost to Follow-up|1|||
105692437|NCT01387230|364538414|FG000|Overall Study|Withdrawal by Subject|4|||
105692438|NCT01387230|364538415|FG001|Overall Study|Withdrawal by Subject|1|||
105692439|NCT01387230|364538416|FG002|Overall Study|Withdrawal by Subject|0|||
105692440|NCT02558231|364538420|FG000|Overall Study|Death|4|||
105692441|NCT02558231|364538421|FG001|Overall Study|Death|12|||
105692442|NCT02558231|364538420|FG000|Overall Study|Lost to Follow-up|7|||
105692443|NCT02558231|364538421|FG001|Overall Study|Lost to Follow-up|4|||
105692444|NCT02558231|364538420|FG000|Overall Study|Withdrawal by Subject|7|||
105692445|NCT02558231|364538421|FG001|Overall Study|Withdrawal by Subject|4|||
105692446|NCT02558231|364538420|FG000|Overall Study|Physician Decision|7|||
105692447|NCT02558231|364538421|FG001|Overall Study|Physician Decision|5|||
105692448|NCT02558231|364538420|FG000|Overall Study|Sponsor Decision|0|||
105692449|NCT02558231|364538421|FG001|Overall Study|Sponsor Decision|1|||
105692450|NCT01294150|364538422|FG000|Overall Study|Physician Decision|2|||
105692451|NCT01294150|364538423|FG001|Overall Study|Physician Decision|2|||
105692452|NCT03675776|364538424|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
105692453|NCT03675776|364538425|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
105692454|NCT03675776|364538426|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
105692455|NCT03675776|364538424|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
105692456|NCT03675776|364538425|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
105692457|NCT03675776|364538426|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
105692458|NCT02401412|364538427|FG000|Overall Study|Lost to Follow-up|1|||
105692459|NCT02401412|364538428|FG001|Overall Study|Lost to Follow-up|0|||
105692460|NCT02401412|364538427|FG000|Overall Study|Discontinued Intervention|15|||
105692461|NCT02401412|364538428|FG001|Overall Study|Discontinued Intervention|21|||
105692462|NCT02401412|364538427|FG000|Overall Study|Withdrawal by Subject|4|||
105692463|NCT02401412|364538428|FG001|Overall Study|Withdrawal by Subject|4|||
105692464|NCT02401412|364538427|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
105692465|NCT02401412|364538428|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
105692466|NCT02401412|364538427|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
105920038|NCT01079780|365367227|FG001|Overall Study|Patient had surgery|0|||
105920039|NCT01079780|365367228|FG002|Overall Study|Patient had surgery|0|||
105920040|NCT01079780|365367226|FG000|Overall Study|Treatment cycle delay|0|||
105920041|NCT01079780|365367227|FG001|Overall Study|Treatment cycle delay|0|||
105920042|NCT01079780|365367228|FG002|Overall Study|Treatment cycle delay|1|||
105920043|NCT01079780|365367226|FG000|Overall Study|Never started treatment|1|||
105920044|NCT01079780|365367227|FG001|Overall Study|Never started treatment|0|||
105920045|NCT01079780|365367228|FG002|Overall Study|Never started treatment|2|||
105920046|NCT01178294|365367229|FG000|Overall Study|Adverse Event|4|||
105920047|NCT01178294|365367229|FG000|Overall Study|Lost to Follow-up|2|||
105920048|NCT01178294|365367229|FG000|Overall Study|Lack of Efficacy|1|||
105920049|NCT01178294|365367229|FG000|Overall Study|Death|1|||
105920050|NCT01178294|365367229|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
105920051|NCT01178294|365367229|FG000|Overall Study|Subject status is terminal|1|||
105920052|NCT01178294|365367229|FG000|Overall Study|Completion status could not be verified|1|||
105920053|NCT03435055|365367230|FG000|Screening|Physician Decision|2|||
105920054|NCT03435055|365367230|FG000|Received Intervention|Did not complete nitrous administration|3|||
105920055|NCT04018066|365367231|FG000|Overall Study|participants started taking medications during the study period|3|||
105920056|NCT04018066|365367231|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
105920057|NCT02111083|365367239|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
105920058|NCT02111083|365367240|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
105920059|NCT00433836|365367241|FG000|Overall Study|Adverse Event|7|||
105920060|NCT00433836|365367242|FG001|Overall Study|Adverse Event|0|||
105920061|NCT00433836|365367241|FG000|Overall Study|Lost to Follow-up|3|||
105920062|NCT00433836|365367242|FG001|Overall Study|Lost to Follow-up|0|||
105920063|NCT00433836|365367241|FG000|Overall Study|Withdrawal by Subject|2|||
105920064|NCT00433836|365367242|FG001|Overall Study|Withdrawal by Subject|1|||
105920065|NCT00433836|365367241|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105920066|NCT00433836|365367242|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
106131371|NCT05305040|366139488|FG001|Overall Study|Study Closure|46|||
106131372|NCT05305040|366139487|FG000|Overall Study|Death|14|||
106131373|NCT05305040|366139488|FG001|Overall Study|Death|13|||
105692467|NCT02401412|364538428|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
105692468|NCT02608879|364538431|FG000|Overall Study|Lost to Follow-up|1|||
105692469|NCT02608879|364538432|FG001|Overall Study|Lost to Follow-up|0|||
105692470|NCT02608879|364538433|FG002|Overall Study|Lost to Follow-up|0|||
105920067|NCT00433836|365367241|FG000|Overall Study|Protocol Violation|0|||
105920068|NCT00433836|365367242|FG001|Overall Study|Protocol Violation|2|||
105920069|NCT00433836|365367241|FG000|Overall Study|Condition no longer requires study drug|0|||
105920070|NCT00433836|365367242|FG001|Overall Study|Condition no longer requires study drug|1|||
105692471|NCT02608879|364538431|FG000|Overall Study|Did not meet continuation criteria|0|||
105786984|NCT02146365|364872948|FG001|Overall Study|Unable to Comply with Protocol|1|||
105786985|NCT02146365|364872949|FG002|Overall Study|Unable to Comply with Protocol|1|||
105786986|NCT02146365|364872950|FG003|Overall Study|Unable to Comply with Protocol|0|||
105786987|NCT02146365|364872951|FG004|Overall Study|Unable to Comply with Protocol|0|||
105786988|NCT02146365|364872952|FG005|Overall Study|Unable to Comply with Protocol|0|||
106131374|NCT05305040|366139487|FG000|Overall Study|Withdrawal by Subject|15|||
106131375|NCT05305040|366139488|FG001|Overall Study|Withdrawal by Subject|10|||
105786989|NCT02146365|364872953|FG006|Overall Study|Unable to Comply with Protocol|0|||
105786990|NCT02146365|364872954|FG007|Overall Study|Unable to Comply with Protocol|0|||
105786991|NCT02146365|364872947|FG000|Overall Study|Other|1|||
105786992|NCT02146365|364872948|FG001|Overall Study|Other|0|||
105786993|NCT02146365|364872949|FG002|Overall Study|Other|2|||
105786994|NCT02146365|364872950|FG003|Overall Study|Other|1|||
105786995|NCT02146365|364872951|FG004|Overall Study|Other|0|||
105786996|NCT02146365|364872952|FG005|Overall Study|Other|0|||
105786997|NCT02146365|364872953|FG006|Overall Study|Other|0|||
105786998|NCT02146365|364872954|FG007|Overall Study|Other|0|||
105786999|NCT01479777|364874846|FG000|Overall Study|Physician Decision|2|||
105787000|NCT00270205|364874848|FG000|Overall Study|Lost to Follow-up|1|||
105787001|NCT00270205|364874849|FG001|Overall Study|Lost to Follow-up|0|||
105787002|NCT00270205|364874850|FG002|Overall Study|Lost to Follow-up|0|||
105787003|NCT00270205|364874851|FG003|Overall Study|Lost to Follow-up|1|||
105787004|NCT00066573|364874855|FG000|Overall Study|Did not received protocol treatment|28|||
105787005|NCT00066573|364874856|FG001|Overall Study|Did not received protocol treatment|28|||
105787006|NCT01855607|364874859|FG000|Overall Study|Withdrawal by Subject|1|||
105787007|NCT01855607|364874859|FG000|Overall Study|Study was terminated|11|||
105787008|NCT01548573|364874865|FG000|Overall Study|Death|3|||
105787009|NCT01548573|364874865|FG000|Overall Study|Withdrawal by Subject|2|||
105787010|NCT01366846|364874866|FG000|Overall Study|Withdrawal by Subject|2|||
105787011|NCT01366846|364874867|FG001|Overall Study|Withdrawal by Subject|0|||
105787012|NCT01366846|364874868|FG002|Overall Study|Withdrawal by Subject|0|||
105787013|NCT01366846|364874869|FG003|Overall Study|Withdrawal by Subject|0|||
105787014|NCT01366846|364874866|FG000|Overall Study|Communication Difficulties|1|||
105787015|NCT01366846|364874867|FG001|Overall Study|Communication Difficulties|4|||
106003302|NCT02193776|365674245|FG003|Overall Study|Death|0|||
106131376|NCT05305040|366139487|FG000|Overall Study|Other|13|||
106131377|NCT05305040|366139488|FG001|Overall Study|Other|10|||
105692472|NCT02608879|364538432|FG001|Overall Study|Did not meet continuation criteria|0|||
105692473|NCT02608879|364538433|FG002|Overall Study|Did not meet continuation criteria|3|||
105692474|NCT04246801|364538434|FG000|Overall Study|Adverse Event|1|||
105692475|NCT04246801|364538435|FG001|Overall Study|Adverse Event|1|||
105692476|NCT04246801|364538434|FG000|Overall Study|Protocol Violation|1|||
105692477|NCT04246801|364538435|FG001|Overall Study|Protocol Violation|1|||
105692478|NCT04246801|364538434|FG000|Overall Study|Lack of Efficacy|0|||
105692479|NCT04246801|364538435|FG001|Overall Study|Lack of Efficacy|2|||
105692480|NCT04246801|364538434|FG000|Overall Study|Lost to Follow-up|1|||
105692481|NCT04246801|364538435|FG001|Overall Study|Lost to Follow-up|1|||
105692482|NCT04246801|364538434|FG000|Overall Study|Withdrawal by Subject|2|||
105692483|NCT04246801|364538435|FG001|Overall Study|Withdrawal by Subject|1|||
105692484|NCT01184053|364538438|FG000|Overall Study|progression while on treatment|3|||
105692485|NCT01174238|364538440|FG000|Overall Study|Lost to Follow-up|2|||
105692486|NCT02301936|364538441|FG000|Overall Study|Lost to Follow-up|1|||
105692487|NCT02301936|364538442|FG001|Overall Study|Lost to Follow-up|0|||
105692488|NCT03065023|364538443|FG000|Overall Study|Progressive Disease|0|||
105692489|NCT03065023|364538444|FG001|Overall Study|Progressive Disease|1|||
105692490|NCT03065023|364538445|FG002|Overall Study|Progressive Disease|0|||
105692491|NCT03065023|364538446|FG003|Overall Study|Progressive Disease|0|||
105692492|NCT03065023|364538447|FG004|Overall Study|Progressive Disease|0|||
105692493|NCT03065023|364538443|FG000|Overall Study|Death|2|||
105692494|NCT03065023|364538444|FG001|Overall Study|Death|0|||
105692495|NCT03065023|364538445|FG002|Overall Study|Death|1|||
106131378|NCT05305040|366139487|FG000|Overall Study|Primary Malignancy Relapse|3|||
106131379|NCT05305040|366139488|FG001|Overall Study|Primary Malignancy Relapse|4|||
105692496|NCT03065023|364538446|FG003|Overall Study|Death|1|||
106131380|NCT05305040|366139487|FG000|Overall Study|Adverse Event|3|||
105692497|NCT03065023|364538447|FG004|Overall Study|Death|0|||
105692498|NCT03065023|364538443|FG000|Overall Study|Lost to Follow-up|0|||
105692499|NCT03065023|364538444|FG001|Overall Study|Lost to Follow-up|1|||
105692500|NCT03065023|364538445|FG002|Overall Study|Lost to Follow-up|0|||
105692501|NCT03065023|364538446|FG003|Overall Study|Lost to Follow-up|0|||
105787016|NCT01366846|364874868|FG002|Overall Study|Communication Difficulties|0|||
105787017|NCT01366846|364874869|FG003|Overall Study|Communication Difficulties|1|||
105787018|NCT01366846|364874866|FG000|Overall Study|Scheduling Conflicts|0|||
105787019|NCT01366846|364874867|FG001|Overall Study|Scheduling Conflicts|0|||
105787020|NCT01366846|364874868|FG002|Overall Study|Scheduling Conflicts|1|||
105787021|NCT01366846|364874869|FG003|Overall Study|Scheduling Conflicts|0|||
105787022|NCT02204449|364874870|FG000|Overall Study|Lost to Follow-up|7|||
105787023|NCT02204449|364874871|FG001|Overall Study|Lost to Follow-up|9|||
105787024|NCT02204449|364874870|FG000|Overall Study|Death|0|||
106131381|NCT05305040|366139488|FG001|Overall Study|Adverse Event|3|||
106131382|NCT05305040|366139487|FG000|Overall Study|Lost to Follow-up|2|||
106131383|NCT05305040|366139488|FG001|Overall Study|Lost to Follow-up|1|||
106131384|NCT05305040|366139487|FG000|Overall Study|Graft versus host disease|2|||
106131385|NCT05305040|366139488|FG001|Overall Study|Graft versus host disease|0|||
106131386|NCT05305040|366139487|FG000|Overall Study|Investigator's Decision|1|||
106131387|NCT05305040|366139488|FG001|Overall Study|Investigator's Decision|1|||
106131388|NCT05305040|366139487|FG000|Overall Study|COVID-19 Reasons|1|||
106131389|NCT05305040|366139488|FG001|Overall Study|COVID-19 Reasons|0|||
106131390|NCT01876043|366139489|FG000|Overall Study|Death|1|||
106131391|NCT01876043|366139489|FG000|Overall Study|Withdrawal by Subject|1|||
106131392|NCT01616563|366139490|FG000|Overall Study|Lost to Follow-up|40|||
106131393|NCT01033643|366139493|FG000|Overall Study|Withdrew Consent|0|||
106131394|NCT01033643|366139494|FG001|Overall Study|Withdrew Consent|3|||
106131395|NCT01033643|366139495|FG002|Overall Study|Withdrew Consent|0|||
106131396|NCT01033643|366139496|FG003|Overall Study|Withdrew Consent|0|||
106131397|NCT01033643|366139497|FG004|Overall Study|Withdrew Consent|0|||
106131398|NCT01033643|366139498|FG005|Overall Study|Withdrew Consent|1|||
106131399|NCT00852475|366139507|FG000|Overall Study|Lost to Follow-up|3|||
106131400|NCT00852475|366139508|FG001|Overall Study|Lost to Follow-up|4|||
106131401|NCT02028884|366139509|FG000|Double-blind Period|Adverse Event|5|||
106131402|NCT02028884|366139510|FG001|Double-blind Period|Adverse Event|3|||
106131403|NCT02028884|366139511|FG002|Double-blind Period|Adverse Event|0|||
106131404|NCT02028884|366139509|FG000|Double-blind Period|Eligibility Violation|1|||
106131405|NCT02028884|366139510|FG001|Double-blind Period|Eligibility Violation|0|||
106131406|NCT02028884|366139511|FG002|Double-blind Period|Eligibility Violation|0|||
106131407|NCT02028884|366139509|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
106131408|NCT02028884|366139510|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
106131409|NCT02028884|366139511|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
106131410|NCT02028884|366139509|FG000|Double-blind Period|Withdrawal by Subject|2|||
106131411|NCT02028884|366139510|FG001|Double-blind Period|Withdrawal by Subject|0|||
106131412|NCT02028884|366139511|FG002|Double-blind Period|Withdrawal by Subject|0|||
106131413|NCT02028884|366139509|FG000|Open-label Extension Period|Adverse Event|3|||
106131414|NCT02028884|366139510|FG001|Open-label Extension Period|Adverse Event|1|||
106131415|NCT02028884|366139511|FG002|Open-label Extension Period|Adverse Event|0|||
105920071|NCT00433836|365367241|FG000|Overall Study|Abnormal laboratory values|0|||
105920072|NCT00433836|365367242|FG001|Overall Study|Abnormal laboratory values|1|||
105920073|NCT00644059|365367243|FG000|Overall Study|Lost to Follow-up|37|||
105920074|NCT00644059|365367244|FG001|Overall Study|Lost to Follow-up|34|||
105920075|NCT00644059|365367245|FG002|Overall Study|Lost to Follow-up|16|||
105920076|NCT00644059|365367243|FG000|Overall Study|Withdrawal by Subject|52|||
105920077|NCT00644059|365367244|FG001|Overall Study|Withdrawal by Subject|60|||
105920078|NCT00644059|365367245|FG002|Overall Study|Withdrawal by Subject|30|||
105920079|NCT00644059|365367243|FG000|Overall Study|Adverse Event|8|||
105920080|NCT00644059|365367244|FG001|Overall Study|Adverse Event|5|||
105920081|NCT00644059|365367245|FG002|Overall Study|Adverse Event|1|||
105920082|NCT00644059|365367243|FG000|Overall Study|Inappropriate Enrollment|1|||
105920083|NCT00644059|365367244|FG001|Overall Study|Inappropriate Enrollment|3|||
105920084|NCT00644059|365367245|FG002|Overall Study|Inappropriate Enrollment|0|||
105920085|NCT00644059|365367243|FG000|Overall Study|Protocol Deviation/violation|20|||
105920086|NCT00644059|365367244|FG001|Overall Study|Protocol Deviation/violation|19|||
105920087|NCT00644059|365367245|FG002|Overall Study|Protocol Deviation/violation|15|||
105920088|NCT00644059|365367243|FG000|Overall Study|Unable to classify|6|||
105920089|NCT00644059|365367244|FG001|Overall Study|Unable to classify|2|||
105920090|NCT00644059|365367245|FG002|Overall Study|Unable to classify|3|||
105920091|NCT03154086|365367250|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920092|NCT03154086|365367251|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920093|NCT03154086|365367252|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920094|NCT03154086|365367253|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
105920095|NCT03154086|365367254|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920096|NCT03154086|365367255|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920097|NCT03154086|365367256|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920098|NCT03154086|365367257|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920099|NCT03154086|365367258|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920100|NCT03154086|365367259|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920101|NCT03154086|365367260|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920102|NCT03154086|365367261|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920103|NCT03154086|365367262|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
106131416|NCT02028884|366139509|FG000|Open-label Extension Period|Lack of Efficacy|3|||
106131417|NCT02028884|366139510|FG001|Open-label Extension Period|Lack of Efficacy|0|||
106131418|NCT02028884|366139511|FG002|Open-label Extension Period|Lack of Efficacy|0|||
106131419|NCT02028884|366139509|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
105692502|NCT03065023|364538447|FG004|Overall Study|Lost to Follow-up|0|||
106131420|NCT02028884|366139510|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
106131421|NCT02028884|366139511|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
106131422|NCT02028884|366139509|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
106131423|NCT02028884|366139510|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
106131424|NCT02028884|366139511|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
106131425|NCT02028884|366139509|FG000|Open-label Extension Period|Switched to another treatment option|3|||
106131426|NCT02028884|366139510|FG001|Open-label Extension Period|Switched to another treatment option|0|||
106131427|NCT02028884|366139511|FG002|Open-label Extension Period|Switched to another treatment option|0|||
106131428|NCT00354029|366139512|FG000|Overall Study|Protocol Violation|4|||
106131429|NCT00354029|366139513|FG001|Overall Study|Protocol Violation|2|||
106131430|NCT00723294|366139514|FG000|Overall Study|Lobular histology|2|||
106131431|NCT00723294|366139514|FG000|Overall Study|>25% intraductal component|1|||
106131432|NCT00723294|366139514|FG000|Overall Study|No MRI tumor enhancement|1|||
106131433|NCT00723294|366139514|FG000|Overall Study|1.0-Tesla MRI|1|||
106131434|NCT00723294|366139514|FG000|Overall Study|No cryoabalation|2|||
106131435|NCT00723294|366139514|FG000|Overall Study|Did not undergo surgery|1|||
106131436|NCT00723294|366139514|FG000|Overall Study|Treated prior to registration|1|||
106131437|NCT00723294|366139514|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
106131438|NCT00723294|366139514|FG000|Overall Study|Benign lesion|1|||
106131439|NCT00723294|366139514|FG000|Overall Study|Withdrawal by Subject|1|||
106131440|NCT00723294|366139514|FG000|Overall Study|No treatment due to probe failure|1|||
106131441|NCT01511536|366139515|FG000|Phase 1|Other|0|||
106131442|NCT01511536|366139516|FG001|Phase 1|Other|1|||
106131443|NCT01511536|366139517|FG002|Phase 1|Other|0|||
106131444|NCT01511536|366139515|FG000|Phase 2|Other|0|||
106131445|NCT01511536|366139516|FG001|Phase 2|Other|0|||
106131446|NCT01511536|366139517|FG002|Phase 2|Other|9|||
106131447|NCT01764386|366139518|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
106131448|NCT01764386|366139519|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
106131449|NCT01764386|366139518|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
106131450|NCT01764386|366139519|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
106131451|NCT01764386|366139518|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
106131452|NCT01764386|366139519|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
106131453|NCT01764386|366139518|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
106131454|NCT01764386|366139519|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
106131455|NCT01764386|366139518|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
106131456|NCT01764386|366139519|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
106131457|NCT01764386|366139518|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
106131458|NCT01764386|366139519|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
106131459|NCT01764386|366139518|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
106131460|NCT01764386|366139519|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
106131461|NCT01764386|366139518|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
106131462|NCT01764386|366139519|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
106131463|NCT02263885|366139523|FG000|Overall Study|Withdrawal by Subject|7|||
106131464|NCT02263885|366139523|FG000|Overall Study|Alternative Treatment|3|||
106131465|NCT00088465|366139524|FG000|Overall Study|Withdrawal by Subject|290|||
105692503|NCT03065023|364538443|FG000|Overall Study|Participant Decision|0|||
105692504|NCT03065023|364538444|FG001|Overall Study|Participant Decision|0|||
105692505|NCT03065023|364538445|FG002|Overall Study|Participant Decision|0|||
105692506|NCT03065023|364538446|FG003|Overall Study|Participant Decision|1|||
105692507|NCT03065023|364538447|FG004|Overall Study|Participant Decision|0|||
105692508|NCT03065023|364538443|FG000|Overall Study|Withdrawal by Subject|0|||
105692509|NCT03065023|364538444|FG001|Overall Study|Withdrawal by Subject|0|||
105692510|NCT03065023|364538445|FG002|Overall Study|Withdrawal by Subject|0|||
105692511|NCT03065023|364538446|FG003|Overall Study|Withdrawal by Subject|1|||
105692512|NCT03065023|364538447|FG004|Overall Study|Withdrawal by Subject|0|||
105692513|NCT03427125|364538448|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
105692514|NCT03427125|364538449|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
105692515|NCT03427125|364538450|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
105692516|NCT04014361|364538451|FG000|Period 2|Physician Decision|0|||
105692517|NCT04014361|364538452|FG001|Period 2|Physician Decision|0|||
105692518|NCT04014361|364538453|FG002|Period 2|Physician Decision|0|||
105692519|NCT04014361|364538454|FG003|Period 2|Physician Decision|1|||
105787025|NCT02204449|364874871|FG001|Overall Study|Death|1|||
105787026|NCT02204449|364874870|FG000|Overall Study|Withdrawal by Subject|0|||
106131466|NCT00088465|366139524|FG000|Overall Study|Adverse Event|77|||
106131467|NCT00088465|366139524|FG000|Overall Study|Lost to Follow-up|57|||
106131468|NCT00088465|366139524|FG000|Overall Study|Physician Decision|45|||
106131469|NCT00088465|366139524|FG000|Overall Study|Sponsor Decision|37|||
106131470|NCT00088465|366139524|FG000|Overall Study|Lack of Efficacy|27|||
106131471|NCT00088465|366139524|FG000|Overall Study|Protocol Violation|17|||
106131472|NCT00088465|366139524|FG000|Overall Study|Death|11|||
106131473|NCT00519779|366139525|FG000|Overall Study|Withdrawal by Subject|0|||
106131474|NCT00519779|366139526|FG001|Overall Study|Withdrawal by Subject|1|||
106131475|NCT03929302|366139529|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
106131476|NCT03929302|366139530|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
106131477|NCT03929302|366139531|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
106131478|NCT03929302|366139529|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
106131479|NCT03929302|366139530|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
106131480|NCT03929302|366139531|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
106131481|NCT03929302|366139529|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
106131482|NCT03929302|366139530|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
106131483|NCT03929302|366139531|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
106131484|NCT04531540|366139538|FG000|Overall Study|Adverse Event|1|||
106131485|NCT04531540|366139538|FG000|Overall Study|Protocol Violation|3|||
106131486|NCT04531540|366139538|FG000|Overall Study|Withdrawal by Subject|4|||
106131487|NCT04531540|366139538|FG000|Overall Study|Found to be Ineligible|1|||
106131488|NCT00751790|366139542|FG000|Overall Study|Lost to Follow-up|1|||
106131489|NCT00751790|366139542|FG000|Overall Study|Death|3|||
106131490|NCT00751790|366139542|FG000|Overall Study|Withdrawal by Subject|1|||
106131491|NCT00180674|366139543|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
106131492|NCT00180674|366139543|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
106131493|NCT01094743|366139544|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
106131494|NCT02851511|366139545|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
106131495|NCT02851511|366139546|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
106131496|NCT02851511|366139547|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
106131497|NCT02851511|366139548|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
105692520|NCT04014361|364538455|FG004|Period 2|Physician Decision|0|||
105692521|NCT04014361|364538456|FG005|Period 2|Physician Decision|0|||
105692522|NCT04014361|364538457|FG006|Period 2|Physician Decision|0|||
105692523|NCT04014361|364538458|FG007|Period 2|Physician Decision|0|||
105692524|NCT01093326|364538465|FG000|Overall Study|Death|0|||
105692525|NCT01093326|364538466|FG001|Overall Study|Death|1|||
105692526|NCT01093326|364538467|FG002|Overall Study|Death|0|||
105692527|NCT01093326|364538465|FG000|Overall Study|Lack of Efficacy|7|||
105692528|NCT01093326|364538466|FG001|Overall Study|Lack of Efficacy|6|||
105692529|NCT01093326|364538467|FG002|Overall Study|Lack of Efficacy|3|||
105692530|NCT01093326|364538465|FG000|Overall Study|Lost to Follow-up|2|||
105692531|NCT01093326|364538466|FG001|Overall Study|Lost to Follow-up|5|||
105692532|NCT01093326|364538467|FG002|Overall Study|Lost to Follow-up|4|||
105692533|NCT01093326|364538465|FG000|Overall Study|Physician Decision|3|||
105692534|NCT01093326|364538466|FG001|Overall Study|Physician Decision|1|||
105920104|NCT03154086|365367263|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920105|NCT03154086|365367264|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
105920106|NCT03154086|365367250|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920107|NCT03154086|365367251|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
105920108|NCT03154086|365367252|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920109|NCT03154086|365367253|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920110|NCT03154086|365367254|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920111|NCT03154086|365367255|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920112|NCT03154086|365367256|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920113|NCT03154086|365367257|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920114|NCT03154086|365367258|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920115|NCT03154086|365367259|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920116|NCT03154086|365367260|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920117|NCT03154086|365367261|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920118|NCT03154086|365367262|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920119|NCT03154086|365367263|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920120|NCT03154086|365367264|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
105920121|NCT03154086|365367250|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920122|NCT03154086|365367251|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920123|NCT03154086|365367252|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
105920124|NCT03154086|365367253|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920125|NCT03154086|365367254|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920126|NCT03154086|365367255|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
106131498|NCT02851511|366139545|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
106131499|NCT02851511|366139546|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
106131500|NCT02851511|366139547|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
106131501|NCT02851511|366139548|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
105692535|NCT01093326|364538467|FG002|Overall Study|Physician Decision|3|||
105787027|NCT02204449|364874871|FG001|Overall Study|Withdrawal by Subject|1|||
105787028|NCT00503035|364874872|FG000|Overall Study|Lost to Follow-up|2|||
105787029|NCT00503035|364874872|FG000|Overall Study|Physician Decision|3|||
105787030|NCT00503035|364874872|FG000|Overall Study|Ineligible|15|||
105787031|NCT05604521|364874873|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
105787032|NCT05604521|364874874|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
105787033|NCT05604521|364874873|FG000|Overall Study|Adverse Event|1|||
105787034|NCT05604521|364874874|FG001|Overall Study|Adverse Event|0|||
105787035|NCT05028816|364874883|FG000|Overall Study|Lost to Follow-up|5|||
105787036|NCT05028816|364874884|FG001|Overall Study|Lost to Follow-up|3|||
105787037|NCT05028816|364874883|FG000|Overall Study|Withdrawal by Subject|4|||
105787038|NCT05028816|364874884|FG001|Overall Study|Withdrawal by Subject|1|||
105787039|NCT05028816|364874883|FG000|Overall Study|Physician Decision|1|||
105787040|NCT05028816|364874884|FG001|Overall Study|Physician Decision|0|||
105787041|NCT01342445|364874885|FG000|Overall Study|Experienced side effects|0|||
105787042|NCT01342445|364874886|FG001|Overall Study|Experienced side effects|2|||
105787043|NCT05299359|364874887|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
105787044|NCT05299359|364874888|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
105787045|NCT05299359|364874887|FG000|Main Part: Day 1 up to Day 366|Other|2|||
105787046|NCT05299359|364874888|FG001|Main Part: Day 1 up to Day 366|Other|0|||
105787047|NCT05299359|364874887|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
105787048|NCT05299359|364874888|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
105787049|NCT05299359|364874887|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
105787050|NCT05299359|364874888|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
106003303|NCT02193776|365674242|FG000|Overall Study|Adverse event/Specific toxicity|5|||
106003304|NCT02193776|365674243|FG001|Overall Study|Adverse event/Specific toxicity|5|||
106003305|NCT02193776|365674244|FG002|Overall Study|Adverse event/Specific toxicity|2|||
106003306|NCT02193776|365674245|FG003|Overall Study|Adverse event/Specific toxicity|2|||
106003307|NCT00768989|365674248|FG000|Prior to Week 24|Withdrawal by Subject|1|||
106003308|NCT00768989|365674249|FG001|Prior to Week 24|Withdrawal by Subject|0|||
106003309|NCT00768989|365674248|FG000|Prior to Week 24|Adverse Event|3|||
106003310|NCT00768989|365674249|FG001|Prior to Week 24|Adverse Event|0|||
106003311|NCT00768989|365674248|FG000|Prior to Week 24|Lost to Follow-up|0|||
106003312|NCT00768989|365674249|FG001|Prior to Week 24|Lost to Follow-up|1|||
106003313|NCT00768989|365674248|FG000|Prior to Week 24|Protocol Violation|0|||
106003314|NCT00768989|365674249|FG001|Prior to Week 24|Protocol Violation|2|||
106003315|NCT00768989|365674248|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
106003316|NCT00768989|365674249|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
106003317|NCT00768989|365674248|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
106003318|NCT00768989|365674249|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
106003319|NCT00768989|365674248|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
106003320|NCT00768989|365674249|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
106003321|NCT00768989|365674248|FG000|On or After Week 36|Lack of Efficacy|1|||
106003322|NCT00768989|365674249|FG001|On or After Week 36|Lack of Efficacy|0|||
106003323|NCT00768989|365674248|FG000|On or After Week 36|Adverse Event|0|||
106003324|NCT00768989|365674249|FG001|On or After Week 36|Adverse Event|1|||
106003325|NCT00768989|365674248|FG000|On or After Week 36|Lost to Follow-up|1|||
106003326|NCT00768989|365674249|FG001|On or After Week 36|Lost to Follow-up|0|||
106003327|NCT00768989|365674248|FG000|On or After Week 36|Poor Compliance|1|||
106003328|NCT00768989|365674249|FG001|On or After Week 36|Poor Compliance|0|||
106003329|NCT00768989|365674248|FG000|On or After Week 36|Protocol Violation|1|||
106003330|NCT00768989|365674249|FG001|On or After Week 36|Protocol Violation|0|||
106003331|NCT00768989|365674248|FG000|On or After Week 36|Did not attend termination visit|2|||
106003332|NCT00768989|365674249|FG001|On or After Week 36|Did not attend termination visit|0|||
106003333|NCT00768989|365674248|FG000|On or After Week 36|Sponsor Termination|45|||
106003334|NCT00768989|365674249|FG001|On or After Week 36|Sponsor Termination|26|||
106003335|NCT03431441|365674250|FG000|Overall Study|Withdrawal by Subject|2|||
106003336|NCT03431441|365674250|FG000|Overall Study|Adverse Event|2|||
106003337|NCT03431441|365674250|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
106003338|NCT03040999|365674254|FG000|Overall Study|Lost to Follow-up|1|||
106003339|NCT03040999|365674255|FG001|Overall Study|Lost to Follow-up|0|||
106003340|NCT03040999|365674254|FG000|Overall Study|Withdrawal by Subject|7|||
106003341|NCT03040999|365674255|FG001|Overall Study|Withdrawal by Subject|12|||
106003342|NCT03040999|365674254|FG000|Overall Study|Death|128|||
106003343|NCT03040999|365674255|FG001|Overall Study|Death|138|||
106003344|NCT03040999|365674254|FG000|Overall Study|Participants Ongoing in Trial|266|||
105787051|NCT05299359|364874887|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
105787052|NCT05299359|364874888|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
105787053|NCT05299359|364874887|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
105787054|NCT05299359|364874888|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
105787055|NCT05299359|364874887|FG000|Extension Part: Day 1 to Day 366|Other|0|||
105787056|NCT05299359|364874888|FG001|Extension Part: Day 1 to Day 366|Other|1|||
106131502|NCT02851511|366139545|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
106131503|NCT02851511|366139546|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
106131504|NCT02851511|366139547|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
106131505|NCT02851511|366139548|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
106131506|NCT02851511|366139545|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
106131507|NCT02851511|366139546|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
106131508|NCT02851511|366139547|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
106131509|NCT02851511|366139548|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
105692536|NCT01093326|364538465|FG000|Overall Study|Withdrawal by Subject|30|||
105692537|NCT01093326|364538466|FG001|Overall Study|Withdrawal by Subject|27|||
105692538|NCT01093326|364538467|FG002|Overall Study|Withdrawal by Subject|26|||
105692539|NCT01093326|364538465|FG000|Overall Study|Adverse Event|2|||
105692540|NCT01093326|364538466|FG001|Overall Study|Adverse Event|1|||
105692541|NCT01093326|364538467|FG002|Overall Study|Adverse Event|4|||
105692542|NCT01093326|364538465|FG000|Overall Study|Other|0|||
105692543|NCT01093326|364538466|FG001|Overall Study|Other|0|||
105692544|NCT01093326|364538467|FG002|Overall Study|Other|1|||
105692545|NCT01444456|364538468|FG000|Overall Study|Withdrawal by Subject|21|||
105692546|NCT01444456|364538468|FG000|Overall Study|Physician Decision|9|||
105692547|NCT01444456|364538468|FG000|Overall Study|Lost to Follow-up|37|||
105692548|NCT01444456|364538468|FG000|Overall Study|Death|73|||
105692549|NCT01444456|364538468|FG000|Overall Study|Ineligibility determined|23|||
105692550|NCT01444456|364538468|FG000|Overall Study|Other|18|||
105692551|NCT01444456|364538468|FG000|Overall Study|Not treated|104|||
105692552|NCT04223791|364538469|FG000|Overall Study|Lost to Follow-up|0|||
105692553|NCT04223791|364538470|FG001|Overall Study|Lost to Follow-up|4|||
105692554|NCT04223791|364538469|FG000|Overall Study|Physician Decision|5|||
105692555|NCT04223791|364538470|FG001|Overall Study|Physician Decision|1|||
105692556|NCT04223791|364538469|FG000|Overall Study|Protocol Violation|1|||
105692557|NCT04223791|364538470|FG001|Overall Study|Protocol Violation|1|||
105692558|NCT04223791|364538469|FG000|Overall Study|Withdrawal by Subject|10|||
105692559|NCT04223791|364538470|FG001|Overall Study|Withdrawal by Subject|12|||
105692560|NCT04223791|364538469|FG000|Overall Study|Pregnancy|1|||
105692561|NCT04223791|364538470|FG001|Overall Study|Pregnancy|1|||
105692562|NCT04223791|364538469|FG000|Overall Study|Ongoing in Study|305|||
105692563|NCT04223791|364538470|FG001|Overall Study|Ongoing in Study|302|||
105760668|NCT00293241|364776123|FG000|Overall Study|Withdrawal by Subject|4|||
105760669|NCT00293241|364776124|FG001|Overall Study|Withdrawal by Subject|8|||
105760670|NCT02661464|364776125|FG000|Overall Study|Lost to Follow-up|28|||
105760671|NCT02661464|364776126|FG001|Overall Study|Lost to Follow-up|0|||
105760672|NCT02661464|364776127|FG002|Overall Study|Lost to Follow-up|0|||
105760673|NCT02661464|364776128|FG003|Overall Study|Lost to Follow-up|0|||
105760674|NCT02661464|364776125|FG000|Overall Study|Withdrawal by Subject|3|||
105760675|NCT02661464|364776126|FG001|Overall Study|Withdrawal by Subject|1|||
105760676|NCT02661464|364776127|FG002|Overall Study|Withdrawal by Subject|0|||
105760677|NCT02661464|364776128|FG003|Overall Study|Withdrawal by Subject|0|||
105760678|NCT02661464|364776125|FG000|Overall Study|Participants terminated prematurely|288|||
105760679|NCT02661464|364776126|FG001|Overall Study|Participants terminated prematurely|52|||
105760680|NCT02661464|364776127|FG002|Overall Study|Participants terminated prematurely|1|||
105760681|NCT02661464|364776128|FG003|Overall Study|Participants terminated prematurely|1|||
105760682|NCT02661464|364776125|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
105760683|NCT02661464|364776126|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
105760684|NCT02661464|364776127|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
105760685|NCT02661464|364776128|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
105760686|NCT05567393|364776131|FG000|Overall Study|Voluntary Withdrawal|0|||
105760687|NCT05567393|364776132|FG001|Overall Study|Voluntary Withdrawal|0|||
105760688|NCT05567393|364776133|FG002|Overall Study|Voluntary Withdrawal|0|||
105760689|NCT05567393|364776134|FG003|Overall Study|Voluntary Withdrawal|0|||
105760690|NCT05567393|364776135|FG004|Overall Study|Voluntary Withdrawal|0|||
105760691|NCT05567393|364776136|FG005|Overall Study|Voluntary Withdrawal|0|||
105760692|NCT05567393|364776137|FG006|Overall Study|Voluntary Withdrawal|0|||
105760693|NCT05567393|364776138|FG007|Overall Study|Voluntary Withdrawal|0|||
105760694|NCT05567393|364776139|FG008|Overall Study|Voluntary Withdrawal|0|||
105760695|NCT05567393|364776140|FG009|Overall Study|Voluntary Withdrawal|0|||
105760696|NCT05567393|364776141|FG010|Overall Study|Voluntary Withdrawal|0|||
105760697|NCT05567393|364776142|FG011|Overall Study|Voluntary Withdrawal|0|||
105760698|NCT05567393|364776143|FG012|Overall Study|Voluntary Withdrawal|0|||
105760699|NCT05567393|364776144|FG013|Overall Study|Voluntary Withdrawal|1|||
105760700|NCT05567393|364776145|FG014|Overall Study|Voluntary Withdrawal|0|||
105760701|NCT05567393|364776146|FG015|Overall Study|Voluntary Withdrawal|0|||
105760702|NCT05567393|364776147|FG016|Overall Study|Voluntary Withdrawal|0|||
106131510|NCT02851511|366139545|FG000|Phase I|Physician Decision|0|||
105920127|NCT03154086|365367256|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920128|NCT03154086|365367257|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920129|NCT03154086|365367258|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105692564|NCT01310803|364540480|FG000|Overall Study|Subject terminated by Sponsor|1|||
105692565|NCT01310803|364540481|FG001|Overall Study|Subject terminated by Sponsor|0|||
105692566|NCT01444651|364540482|FG000|Overall Study|Adverse Event|3|||
105692567|NCT01444651|364540483|FG001|Overall Study|Adverse Event|2|||
105692568|NCT01444651|364540482|FG000|Overall Study|Lost to Follow-up|5|||
105692569|NCT01444651|364540483|FG001|Overall Study|Lost to Follow-up|5|||
105692570|NCT01444651|364540482|FG000|Overall Study|Non-fasting|2|||
105692571|NCT01444651|364540483|FG001|Overall Study|Non-fasting|1|||
105692572|NCT01444651|364540482|FG000|Overall Study|Missing data|1|||
105692573|NCT01444651|364540483|FG001|Overall Study|Missing data|1|||
105692574|NCT01436071|364540484|FG000|Overall Study|Adverse Event|1|||
105692575|NCT01436071|364540485|FG001|Overall Study|Adverse Event|0|||
105692576|NCT01436071|364540484|FG000|Overall Study|Lack of Efficacy|16|||
105692577|NCT01436071|364540485|FG001|Overall Study|Lack of Efficacy|7|||
105692578|NCT01436071|364540484|FG000|Overall Study|Protocol Violation|0|||
105692579|NCT01436071|364540485|FG001|Overall Study|Protocol Violation|1|||
105692580|NCT01436071|364540484|FG000|Overall Study|Lost to Follow-up|3|||
105692581|NCT01436071|364540485|FG001|Overall Study|Lost to Follow-up|1|||
105692582|NCT01436071|364540484|FG000|Overall Study|Physician Decision|1|||
105692583|NCT01436071|364540485|FG001|Overall Study|Physician Decision|0|||
105692584|NCT01436071|364540484|FG000|Overall Study|Withdrawal by Subject|2|||
105692585|NCT01436071|364540485|FG001|Overall Study|Withdrawal by Subject|2|||
105692586|NCT01436071|364540484|FG000|Overall Study|Did Not Receive Trial Medication|3|||
105692587|NCT01436071|364540485|FG001|Overall Study|Did Not Receive Trial Medication|3|||
105692588|NCT03047551|364540486|FG000|Overall Study|Did not receive TAS|1|||
105692589|NCT03047551|364540487|FG001|Overall Study|Did not receive TAS|0|||
105692590|NCT03047551|364540486|FG000|Overall Study|Physician Decision|1|||
105692591|NCT03047551|364540487|FG001|Overall Study|Physician Decision|0|||
105692592|NCT03047551|364540486|FG000|Overall Study|Withdrawal by Subject|0|||
105692593|NCT03047551|364540487|FG001|Overall Study|Withdrawal by Subject|1|||
105692594|NCT03047551|364540486|FG000|Overall Study|Probe malfunction|0|||
105692595|NCT03047551|364540487|FG001|Overall Study|Probe malfunction|1|||
105692596|NCT03047551|364540486|FG000|Overall Study|Ineligible|0|||
105692597|NCT03047551|364540487|FG001|Overall Study|Ineligible|1|||
105692598|NCT00726622|364540488|FG000|Overall Study|Withdrawal by Subject|16|||
105692599|NCT00726622|364540489|FG001|Overall Study|Withdrawal by Subject|2|||
105692600|NCT00726622|364540488|FG000|Overall Study|Physician Decision|0|||
105692601|NCT00726622|364540489|FG001|Overall Study|Physician Decision|1|||
105692602|NCT00726622|364540488|FG000|Overall Study|Metastasis|2|||
105692603|NCT00726622|364540489|FG001|Overall Study|Metastasis|0|||
105692604|NCT01672788|364540490|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
105692605|NCT01672788|364540491|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
105692606|NCT01672788|364540492|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
105692607|NCT01672788|364540493|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
105692608|NCT01215175|364540495|FG000|Overall Study|Lost to Follow-up|0|||
105692609|NCT01215175|364540496|FG001|Overall Study|Lost to Follow-up|1|||
105692610|NCT01215175|364540497|FG002|Overall Study|Lost to Follow-up|0|||
105692611|NCT01215175|364540498|FG003|Overall Study|Lost to Follow-up|1|||
105692612|NCT01215175|364540499|FG004|Overall Study|Lost to Follow-up|0|||
105692613|NCT00659529|364540500|FG000|Overall Study|Withdrawal by Subject|4|||
105692614|NCT00659529|364540500|FG000|Overall Study|Protocol Violation|3|||
105692615|NCT00659529|364540500|FG000|Overall Study|Screen failure|9|||
105692616|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
105692617|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
105692618|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
105692619|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
105692620|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
105692621|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
105692622|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
105692623|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
105692624|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
105692625|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
105692626|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
105692627|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
105692628|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
105692629|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
105692630|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
105692631|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
105920130|NCT03154086|365367259|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920131|NCT03154086|365367260|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920132|NCT03154086|365367261|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920133|NCT03154086|365367262|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105692632|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
105692633|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
105692634|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
105692635|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
105692636|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
105692637|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
105692638|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
105692639|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
105692640|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
105692641|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
105692642|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
105692643|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
106003345|NCT03040999|365674255|FG001|Overall Study|Participants Ongoing in Trial|252|||
106003346|NCT01458639|365674256|FG000|Overall Study|Physician Decision|4|||
106003347|NCT01458639|365674256|FG000|Overall Study|Equipment issue|1|||
106003348|NCT01458639|365674256|FG000|Overall Study|Inability to obtain subject blood sample|1|||
106003349|NCT00764699|365674257|FG000|Overall Study|PI left and study terminated|3|||
106003350|NCT03070392|365674258|FG000|Overall Study|Not Treated|7|||
106003351|NCT03070392|365674259|FG001|Overall Study|Not Treated|0|||
106003352|NCT03070392|365674260|FG002|Overall Study|Not Treated|3|||
106003353|NCT03070392|365674261|FG003|Overall Study|Not Treated|12|||
106003354|NCT03070392|365674258|FG000|Overall Study|Death|3|||
106003355|NCT03070392|365674259|FG001|Overall Study|Death|0|||
106003356|NCT03070392|365674260|FG002|Overall Study|Death|0|||
106003357|NCT03070392|365674261|FG003|Overall Study|Death|1|||
106003358|NCT03070392|365674258|FG000|Overall Study|Withdrawal by Subject|7|||
106003359|NCT03070392|365674259|FG001|Overall Study|Withdrawal by Subject|0|||
106003360|NCT03070392|365674260|FG002|Overall Study|Withdrawal by Subject|0|||
106003361|NCT03070392|365674261|FG003|Overall Study|Withdrawal by Subject|3|||
106003362|NCT03070392|365674258|FG000|Overall Study|Physician Decision|1|||
106003363|NCT03070392|365674259|FG001|Overall Study|Physician Decision|0|||
106003364|NCT03070392|365674260|FG002|Overall Study|Physician Decision|0|||
106003365|NCT03070392|365674261|FG003|Overall Study|Physician Decision|2|||
106003366|NCT03070392|365674258|FG000|Overall Study|Progressive Disease|154|||
106003367|NCT03070392|365674259|FG001|Overall Study|Progressive Disease|6|||
106003368|NCT03070392|365674260|FG002|Overall Study|Progressive Disease|2|||
106003369|NCT03070392|365674261|FG003|Overall Study|Progressive Disease|70|||
106003370|NCT03070392|365674258|FG000|Overall Study|Adverse Event|6|||
106003371|NCT03070392|365674259|FG001|Overall Study|Adverse Event|1|||
106003372|NCT03070392|365674260|FG002|Overall Study|Adverse Event|1|||
106003373|NCT03070392|365674261|FG003|Overall Study|Adverse Event|3|||
106003374|NCT03070392|365674258|FG000|Overall Study|Alternate anticancer treatment|1|||
106003375|NCT03070392|365674259|FG001|Overall Study|Alternate anticancer treatment|0|||
106003376|NCT03070392|365674260|FG002|Overall Study|Alternate anticancer treatment|0|||
106131511|NCT02851511|366139546|FG001|Phase I|Physician Decision|0|||
106131512|NCT02851511|366139547|FG002|Phase I|Physician Decision|0|||
106131513|NCT02851511|366139548|FG003|Phase I|Physician Decision|1|||
106131514|NCT02851511|366139545|FG000|Phase I|Withdrawal by Subject|2|||
106131515|NCT02851511|366139546|FG001|Phase I|Withdrawal by Subject|1|||
106131516|NCT02851511|366139547|FG002|Phase I|Withdrawal by Subject|0|||
106131517|NCT02851511|366139548|FG003|Phase I|Withdrawal by Subject|3|||
106131518|NCT02851511|366139545|FG000|Phase II|Physician Decision|18|||
106131519|NCT02851511|366139546|FG001|Phase II|Physician Decision|16|||
106131520|NCT02851511|366139547|FG002|Phase II|Physician Decision|0|||
106131521|NCT02851511|366139548|FG003|Phase II|Physician Decision|0|||
106131522|NCT02851511|366139545|FG000|Phase II|Withdrawal by Subject|18|||
106131523|NCT02851511|366139546|FG001|Phase II|Withdrawal by Subject|16|||
106131524|NCT02851511|366139547|FG002|Phase II|Withdrawal by Subject|0|||
106131525|NCT02851511|366139548|FG003|Phase II|Withdrawal by Subject|0|||
106131526|NCT02851511|366139545|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
106131527|NCT02851511|366139546|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
106131528|NCT02851511|366139547|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
106003377|NCT03070392|365674261|FG003|Overall Study|Alternate anticancer treatment|1|||
106003378|NCT03070392|365674258|FG000|Overall Study|Ongoing|73|||
106003379|NCT03070392|365674259|FG001|Overall Study|Ongoing|0|||
106003380|NCT03070392|365674260|FG002|Overall Study|Ongoing|0|||
106003381|NCT03070392|365674261|FG003|Overall Study|Ongoing|11|||
106003382|NCT03985761|365674263|FG000|Overall Study|Withdrawal by Subject|2|||
106003383|NCT03985761|365674264|FG001|Overall Study|Withdrawal by Subject|3|||
106131529|NCT02851511|366139548|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
106131530|NCT02851511|366139545|FG000|Phase II|Lost to Follow-up|0|||
106131531|NCT02851511|366139546|FG001|Phase II|Lost to Follow-up|1|||
106131532|NCT02851511|366139547|FG002|Phase II|Lost to Follow-up|0|||
106131533|NCT02851511|366139548|FG003|Phase II|Lost to Follow-up|0|||
106131534|NCT04170023|366139549|FG000|LTE Period|Withdrawal by Subject|1|||
106131535|NCT04170023|366139550|FG001|LTE Period|Withdrawal by Subject|0|||
105692644|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
105692645|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
105692646|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
105692647|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
105692648|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
105692649|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
105692650|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
105692651|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
105692652|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
105692653|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
105692654|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
105692655|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
105692656|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
105692657|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
105692658|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
105692659|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
105692660|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
105692661|NCT03627767|364540501|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
105692662|NCT03627767|364540502|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
105692663|NCT03627767|364540503|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
105692664|NCT03627767|364540504|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
105692665|NCT03627767|364540505|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
105692666|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
105692667|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
105692668|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
105692669|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
105692670|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
105692671|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105692672|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105692673|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
105692674|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
105692675|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
105692676|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
105692677|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
105692678|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
105692679|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
105692680|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
105692681|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
105692682|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
105692683|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
105692684|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
105692685|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
105692686|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
105692687|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
105692688|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
105692689|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
105692690|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
105692691|NCT03627767|364540501|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
105692692|NCT03627767|364540502|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
105692693|NCT03627767|364540503|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
105692694|NCT03627767|364540504|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
105692695|NCT03627767|364540505|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
105692696|NCT03627767|364540501|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
105692697|NCT03627767|364540502|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
105692698|NCT03627767|364540503|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
105692699|NCT03627767|364540504|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
105692700|NCT03627767|364540505|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
105692701|NCT03627767|364540501|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
105692702|NCT03627767|364540502|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
106003384|NCT02792231|365674269|FG000|Overall Study|Patient/guardian decision|32|||
106003385|NCT02792231|365674270|FG001|Overall Study|Patient/guardian decision|42|||
106003386|NCT02792231|365674269|FG000|Overall Study|Adverse Event|15|||
105692703|NCT03627767|364540503|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
105692704|NCT03627767|364540504|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
105692705|NCT03627767|364540505|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
105692706|NCT03627767|364540501|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
105692707|NCT03627767|364540502|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
105692708|NCT03627767|364540503|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
105692709|NCT03627767|364540504|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
105692710|NCT03627767|364540505|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
105692711|NCT03627767|364540501|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
105692712|NCT03627767|364540502|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
105692713|NCT03627767|364540503|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
105692714|NCT03627767|364540504|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
105692715|NCT03627767|364540505|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
105692716|NCT03823404|364540506|FG000|Overall Study|Lost to Follow-up|1|||
105692717|NCT03823404|364540507|FG001|Overall Study|Lost to Follow-up|2|||
105692718|NCT03823404|364540508|FG002|Overall Study|Lost to Follow-up|3|||
105692719|NCT03823404|364540506|FG000|Overall Study|Protocol Violation|2|||
106003387|NCT02792231|365674270|FG001|Overall Study|Adverse Event|11|||
106003388|NCT02792231|365674269|FG000|Overall Study|Physician Decision|14|||
106003389|NCT02792231|365674270|FG001|Overall Study|Physician Decision|12|||
106003390|NCT02792231|365674269|FG000|Overall Study|Lack of Efficacy|7|||
106003391|NCT02792231|365674270|FG001|Overall Study|Lack of Efficacy|9|||
106003392|NCT02792231|365674269|FG000|Overall Study|Lost to Follow-up|9|||
106003393|NCT02792231|365674270|FG001|Overall Study|Lost to Follow-up|5|||
106003394|NCT02792231|365674269|FG000|Overall Study|Pregnancy|1|||
106003395|NCT02792231|365674270|FG001|Overall Study|Pregnancy|3|||
106003396|NCT02792231|365674269|FG000|Overall Study|Non-compliance with study treatment|2|||
106003397|NCT02792231|365674270|FG001|Overall Study|Non-compliance with study treatment|1|||
106003398|NCT02792231|365674269|FG000|Overall Study|Protocol deviation|2|||
106003399|NCT02792231|365674270|FG001|Overall Study|Protocol deviation|0|||
106003400|NCT02792231|365674269|FG000|Overall Study|Technical problems|0|||
106003401|NCT02792231|365674270|FG001|Overall Study|Technical problems|1|||
106003402|NCT05196828|365674271|FG000|Overall Study|Withdrawal by Subject|2|||
106003403|NCT05196828|365674272|FG001|Overall Study|Withdrawal by Subject|0|||
106003404|NCT05196828|365674271|FG000|Overall Study|Lost to Follow-up|0|||
106003405|NCT05196828|365674272|FG001|Overall Study|Lost to Follow-up|4|||
106003406|NCT05196828|365674271|FG000|Overall Study|Adverse Event|1|||
106003407|NCT05196828|365674272|FG001|Overall Study|Adverse Event|0|||
106003408|NCT00667628|365674281|FG000|Overall Study|Lost to Follow-up|1|||
106003409|NCT00667628|365674282|FG001|Overall Study|Lost to Follow-up|0|||
106003410|NCT00667628|365674281|FG000|Overall Study|Death|6|||
106003411|NCT00667628|365674282|FG001|Overall Study|Death|6|||
106003412|NCT00667628|365674281|FG000|Overall Study|Investigator Considers in Best Interest|1|||
106003413|NCT00667628|365674282|FG001|Overall Study|Investigator Considers in Best Interest|0|||
106003414|NCT00667628|365674281|FG000|Overall Study|Sponsor Terminated Study|17|||
106003415|NCT00667628|365674282|FG001|Overall Study|Sponsor Terminated Study|21|||
106003416|NCT04244253|365674283|FG000|Overall Study|Adverse Event|2|||
106003417|NCT04244253|365674284|FG001|Overall Study|Adverse Event|2|||
106003418|NCT04244253|365674285|FG002|Overall Study|Adverse Event|4|||
106003419|NCT04244253|365674283|FG000|Overall Study|Protocol Violation|1|||
106003420|NCT04244253|365674284|FG001|Overall Study|Protocol Violation|2|||
106003421|NCT04244253|365674285|FG002|Overall Study|Protocol Violation|1|||
106003422|NCT04244253|365674283|FG000|Overall Study|Withdrawal by Subject|0|||
106003423|NCT04244253|365674284|FG001|Overall Study|Withdrawal by Subject|1|||
106003424|NCT04244253|365674285|FG002|Overall Study|Withdrawal by Subject|6|||
106003425|NCT04244253|365674283|FG000|Overall Study|Non-Compliance With Study Drug|0|||
106003426|NCT04244253|365674284|FG001|Overall Study|Non-Compliance With Study Drug|0|||
106003427|NCT04244253|365674285|FG002|Overall Study|Non-Compliance With Study Drug|1|||
106003428|NCT02055898|365674286|FG000|First Intervention (5 Days)|Physician Decision|2|||
106003429|NCT02055898|365674287|FG001|First Intervention (5 Days)|Physician Decision|0|||
106003430|NCT02055898|365674286|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
106003431|NCT02055898|365674287|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
105692720|NCT03823404|364540507|FG001|Overall Study|Protocol Violation|0|||
106003432|NCT02611479|365674288|FG000|Baseline Enrollment|Exited study|13|||
106003433|NCT02611479|365674288|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
106003434|NCT02611479|365674288|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
106003435|NCT02611479|365674288|FG000|Data Cleaning|No baseline function or pain metrics|2|||
106003436|NCT01794000|365674289|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
106003437|NCT01794000|365674290|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
106003438|NCT01794000|365674289|FG000|Double-Blind Phase (DBP)|Death|1|||
106003439|NCT01794000|365674290|FG001|Double-Blind Phase (DBP)|Death|2|||
106003440|NCT01794000|365674289|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
106131536|NCT04170023|366139551|FG002|LTE Period|Withdrawal by Subject|0|||
105692721|NCT03823404|364540508|FG002|Overall Study|Protocol Violation|2|||
105692722|NCT03823404|364540506|FG000|Overall Study|Adverse Event|35|||
105692723|NCT03823404|364540507|FG001|Overall Study|Adverse Event|38|||
106003441|NCT01794000|365674290|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
106003442|NCT01794000|365674289|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
106003443|NCT01794000|365674290|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
106003444|NCT01794000|365674289|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
106003445|NCT01794000|365674290|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
106003446|NCT01794000|365674289|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
106003447|NCT01794000|365674290|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
106003448|NCT01794000|365674289|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
106003449|NCT01794000|365674290|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
106003450|NCT01794000|365674289|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
106003451|NCT01794000|365674290|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
106003452|NCT02159066|365674294|FG000|Part I|Adverse Event|7|||
106003453|NCT02159066|365674295|FG001|Part I|Adverse Event|5|||
106003454|NCT02159066|365674296|FG002|Part I|Adverse Event|0|||
106003455|NCT02159066|365674297|FG003|Part I|Adverse Event|0|||
106003456|NCT02159066|365674298|FG004|Part I|Adverse Event|0|||
105692724|NCT03823404|364540508|FG002|Overall Study|Adverse Event|8|||
105692725|NCT03823404|364540506|FG000|Overall Study|Withdrawal by Subject|38|||
105692726|NCT03823404|364540507|FG001|Overall Study|Withdrawal by Subject|40|||
105692727|NCT03823404|364540508|FG002|Overall Study|Withdrawal by Subject|35|||
105692728|NCT03823404|364540506|FG000|Overall Study|Death|4|||
105692729|NCT03823404|364540507|FG001|Overall Study|Death|0|||
105692730|NCT03823404|364540508|FG002|Overall Study|Death|0|||
105692731|NCT03823404|364540506|FG000|Overall Study|Other: Various reasons provided|5|||
105692732|NCT03823404|364540507|FG001|Overall Study|Other: Various reasons provided|5|||
105692733|NCT03823404|364540508|FG002|Overall Study|Other: Various reasons provided|6|||
105692734|NCT03383289|364540511|FG000|Overall Study|Death|83|||
105692735|NCT03383289|364540512|FG001|Overall Study|Death|78|||
105692736|NCT03383289|364540511|FG000|Overall Study|discharge from facility|84|||
105692737|NCT03383289|364540512|FG001|Overall Study|discharge from facility|84|||
105692738|NCT03383289|364540511|FG000|Overall Study|Withdrawal by Subject|4|||
105692739|NCT03383289|364540512|FG001|Overall Study|Withdrawal by Subject|1|||
105692740|NCT00892177|364540513|FG000|Phase II|Ineligible|0|||
105692741|NCT00892177|364540514|FG001|Phase II|Ineligible|0|||
105692742|NCT00892177|364540515|FG002|Phase II|Ineligible|0|||
105692743|NCT00892177|364540516|FG003|Phase II|Ineligible|0|||
105692744|NCT00892177|364540517|FG004|Phase II|Ineligible|1|||
105692745|NCT00892177|364540518|FG005|Phase II|Ineligible|1|||
105692746|NCT00892177|364540513|FG000|Phase II|Withdrawal by Subject|0|||
105692747|NCT00892177|364540514|FG001|Phase II|Withdrawal by Subject|0|||
105692748|NCT00892177|364540515|FG002|Phase II|Withdrawal by Subject|0|||
105692749|NCT00892177|364540516|FG003|Phase II|Withdrawal by Subject|0|||
105692750|NCT00892177|364540517|FG004|Phase II|Withdrawal by Subject|4|||
105692751|NCT00892177|364540518|FG005|Phase II|Withdrawal by Subject|1|||
105692752|NCT02616614|364540519|FG000|Overall Study|Withdrawal by Subject|10|||
105692753|NCT02616614|364540520|FG001|Overall Study|Withdrawal by Subject|5|||
105692754|NCT02616614|364540521|FG002|Overall Study|Withdrawal by Subject|6|||
105692755|NCT02616614|364540519|FG000|Overall Study|Physician Decision|2|||
105692756|NCT02616614|364540520|FG001|Overall Study|Physician Decision|1|||
105692757|NCT02616614|364540521|FG002|Overall Study|Physician Decision|0|||
105692758|NCT02616614|364540519|FG000|Overall Study|Adverse Event|1|||
105692759|NCT02616614|364540520|FG001|Overall Study|Adverse Event|4|||
105692760|NCT02616614|364540521|FG002|Overall Study|Adverse Event|1|||
105692761|NCT02616614|364540519|FG000|Overall Study|Protocol Violation|0|||
105692762|NCT02616614|364540520|FG001|Overall Study|Protocol Violation|3|||
105692763|NCT02616614|364540521|FG002|Overall Study|Protocol Violation|1|||
105692764|NCT02616614|364540519|FG000|Overall Study|Prohibited Medication|12|||
105692765|NCT02616614|364540520|FG001|Overall Study|Prohibited Medication|9|||
105692766|NCT02616614|364540521|FG002|Overall Study|Prohibited Medication|5|||
105692767|NCT02616614|364540519|FG000|Overall Study|More than 3 applications missed|6|||
105692768|NCT02616614|364540520|FG001|Overall Study|More than 3 applications missed|8|||
105692769|NCT02616614|364540521|FG002|Overall Study|More than 3 applications missed|1|||
105692770|NCT02616614|364540519|FG000|Overall Study|Lost to Follow-up|31|||
105692771|NCT02616614|364540520|FG001|Overall Study|Lost to Follow-up|28|||
105692772|NCT02616614|364540521|FG002|Overall Study|Lost to Follow-up|13|||
105692773|NCT02616614|364540519|FG000|Overall Study|Pregnancy|2|||
105692774|NCT02616614|364540520|FG001|Overall Study|Pregnancy|0|||
105692775|NCT02616614|364540521|FG002|Overall Study|Pregnancy|1|||
105692776|NCT02616614|364540519|FG000|Overall Study|Other|1|||
105692777|NCT02616614|364540520|FG001|Overall Study|Other|2|||
105692778|NCT02616614|364540521|FG002|Overall Study|Other|1|||
105692779|NCT01674712|364540524|FG000|Overall Study|Adverse Event|5|||
105692780|NCT01674712|364540525|FG001|Overall Study|Adverse Event|6|||
105692781|NCT01674712|364540526|FG002|Overall Study|Adverse Event|3|||
105692782|NCT01674712|364540527|FG003|Overall Study|Adverse Event|4|||
105692783|NCT01674712|364540528|FG004|Overall Study|Adverse Event|6|||
105692784|NCT01674712|364540524|FG000|Overall Study|Lost to Follow-up|1|||
105692785|NCT01674712|364540525|FG001|Overall Study|Lost to Follow-up|0|||
105692786|NCT01674712|364540526|FG002|Overall Study|Lost to Follow-up|0|||
105692787|NCT01674712|364540527|FG003|Overall Study|Lost to Follow-up|0|||
105692788|NCT01674712|364540528|FG004|Overall Study|Lost to Follow-up|0|||
105692789|NCT01674712|364540524|FG000|Overall Study|Protocol Violation|2|||
105692790|NCT01674712|364540525|FG001|Overall Study|Protocol Violation|0|||
105692791|NCT01674712|364540526|FG002|Overall Study|Protocol Violation|0|||
105692792|NCT01674712|364540527|FG003|Overall Study|Protocol Violation|0|||
105692793|NCT01674712|364540528|FG004|Overall Study|Protocol Violation|0|||
105692794|NCT01674712|364540524|FG000|Overall Study|Withdrawal by Subject|2|||
105692795|NCT01674712|364540525|FG001|Overall Study|Withdrawal by Subject|2|||
105692796|NCT01674712|364540526|FG002|Overall Study|Withdrawal by Subject|5|||
105692797|NCT01674712|364540527|FG003|Overall Study|Withdrawal by Subject|4|||
105692798|NCT01674712|364540528|FG004|Overall Study|Withdrawal by Subject|3|||
105920134|NCT03154086|365367263|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920135|NCT03154086|365367264|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
105920136|NCT03154086|365367250|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
105920137|NCT03154086|365367251|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920138|NCT03154086|365367252|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920139|NCT03154086|365367253|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920140|NCT03154086|365367254|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920141|NCT03154086|365367255|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920142|NCT03154086|365367256|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920143|NCT03154086|365367257|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920144|NCT03154086|365367258|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920145|NCT03154086|365367259|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920146|NCT03154086|365367260|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920147|NCT03154086|365367261|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920148|NCT03154086|365367262|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920149|NCT03154086|365367263|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920150|NCT03154086|365367264|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
105920151|NCT03154086|365367250|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920152|NCT03154086|365367251|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920153|NCT03154086|365367252|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920154|NCT03154086|365367253|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920155|NCT03154086|365367254|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920156|NCT03154086|365367255|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920157|NCT03154086|365367256|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920158|NCT03154086|365367257|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920159|NCT03154086|365367258|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
105920160|NCT03154086|365367259|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920161|NCT03154086|365367260|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920162|NCT03154086|365367261|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920163|NCT03154086|365367262|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920164|NCT03154086|365367263|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920165|NCT03154086|365367264|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
105920166|NCT03154086|365367250|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920167|NCT03154086|365367251|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920168|NCT03154086|365367252|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920169|NCT03154086|365367253|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920170|NCT03154086|365367254|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920171|NCT03154086|365367255|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920172|NCT03154086|365367256|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920173|NCT03154086|365367257|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
105920174|NCT03154086|365367258|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920175|NCT03154086|365367259|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920176|NCT03154086|365367260|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920177|NCT03154086|365367261|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920178|NCT03154086|365367262|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920179|NCT03154086|365367263|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920180|NCT03154086|365367264|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
105920181|NCT03154086|365367250|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
105920182|NCT03154086|365367251|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
105920183|NCT03154086|365367252|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
105920184|NCT03154086|365367253|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
105920185|NCT03154086|365367254|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
105692799|NCT01674712|364540524|FG000|Overall Study|Administrative|0|||
105692800|NCT01674712|364540525|FG001|Overall Study|Administrative|1|||
105692801|NCT01674712|364540526|FG002|Overall Study|Administrative|0|||
105692802|NCT01674712|364540527|FG003|Overall Study|Administrative|0|||
106003457|NCT02159066|365674299|FG005|Part I|Adverse Event|0|||
106003458|NCT02159066|365674294|FG000|Part I|Death|11|||
106003459|NCT02159066|365674295|FG001|Part I|Death|9|||
106003460|NCT02159066|365674296|FG002|Part I|Death|0|||
106003461|NCT02159066|365674297|FG003|Part I|Death|0|||
105692803|NCT01674712|364540528|FG004|Overall Study|Administrative|1|||
105692804|NCT01674712|364540524|FG000|Overall Study|Lack of Efficacy|0|||
105692805|NCT01674712|364540525|FG001|Overall Study|Lack of Efficacy|0|||
105692806|NCT01674712|364540526|FG002|Overall Study|Lack of Efficacy|1|||
105692807|NCT01674712|364540527|FG003|Overall Study|Lack of Efficacy|0|||
105692808|NCT01674712|364540528|FG004|Overall Study|Lack of Efficacy|1|||
105692809|NCT00631189|364540529|FG000|Initial Phase|Protocol Violation|347|||
105692810|NCT00631189|364540530|FG001|Initial Phase|Protocol Violation|0|||
105692811|NCT00631189|364540531|FG002|Initial Phase|Protocol Violation|0|||
105692812|NCT00631189|364540532|FG003|Initial Phase|Protocol Violation|0|||
105692813|NCT00631189|364540529|FG000|Initial Phase|Withdrawal by Subject|4|||
105692814|NCT00631189|364540530|FG001|Initial Phase|Withdrawal by Subject|0|||
105692815|NCT00631189|364540531|FG002|Initial Phase|Withdrawal by Subject|0|||
105692816|NCT00631189|364540532|FG003|Initial Phase|Withdrawal by Subject|0|||
105692817|NCT00631189|364540529|FG000|Treatment Phase|Withdrawal by Subject|0|||
105692818|NCT00631189|364540530|FG001|Treatment Phase|Withdrawal by Subject|2|||
105692819|NCT00631189|364540531|FG002|Treatment Phase|Withdrawal by Subject|1|||
105692820|NCT00631189|364540532|FG003|Treatment Phase|Withdrawal by Subject|1|||
105692821|NCT00631189|364540529|FG000|Treatment Phase|Protocol Violation|0|||
105692822|NCT00631189|364540530|FG001|Treatment Phase|Protocol Violation|1|||
105692823|NCT00631189|364540531|FG002|Treatment Phase|Protocol Violation|6|||
105692824|NCT00631189|364540532|FG003|Treatment Phase|Protocol Violation|2|||
105692825|NCT00631189|364540529|FG000|Treatment Phase|Adverse Event|0|||
105692826|NCT00631189|364540530|FG001|Treatment Phase|Adverse Event|3|||
105692827|NCT00631189|364540531|FG002|Treatment Phase|Adverse Event|2|||
105692828|NCT00631189|364540532|FG003|Treatment Phase|Adverse Event|4|||
105692829|NCT00631189|364540529|FG000|Treatment Phase|Lost to Follow-up|0|||
105692830|NCT00631189|364540530|FG001|Treatment Phase|Lost to Follow-up|1|||
105692831|NCT00631189|364540531|FG002|Treatment Phase|Lost to Follow-up|0|||
105692832|NCT00631189|364540532|FG003|Treatment Phase|Lost to Follow-up|0|||
105692833|NCT00631189|364540529|FG000|Treatment Phase|Pregnancy|0|||
105692834|NCT00631189|364540530|FG001|Treatment Phase|Pregnancy|0|||
105692835|NCT00631189|364540531|FG002|Treatment Phase|Pregnancy|1|||
105692836|NCT00631189|364540532|FG003|Treatment Phase|Pregnancy|0|||
105692837|NCT00631189|364540529|FG000|Treatment Phase|patient did not take pravastatin|0|||
105692838|NCT00631189|364540530|FG001|Treatment Phase|patient did not take pravastatin|0|||
105692839|NCT00631189|364540531|FG002|Treatment Phase|patient did not take pravastatin|1|||
105692840|NCT00631189|364540532|FG003|Treatment Phase|patient did not take pravastatin|0|||
105692841|NCT00874770|364540533|FG000|Overall Study|Lack of Efficacy|2|||
105692842|NCT00874770|364540534|FG001|Overall Study|Lack of Efficacy|0|||
105692843|NCT00874770|364540535|FG002|Overall Study|Lack of Efficacy|0|||
105692844|NCT00874770|364540536|FG003|Overall Study|Lack of Efficacy|2|||
105692845|NCT00874770|364540533|FG000|Overall Study|Adverse Event|1|||
105692846|NCT00874770|364540534|FG001|Overall Study|Adverse Event|1|||
105692847|NCT00874770|364540535|FG002|Overall Study|Adverse Event|4|||
105692848|NCT00874770|364540536|FG003|Overall Study|Adverse Event|2|||
105692849|NCT00874770|364540533|FG000|Overall Study|Lost to Follow-up|1|||
105692850|NCT00874770|364540534|FG001|Overall Study|Lost to Follow-up|0|||
105692851|NCT00874770|364540535|FG002|Overall Study|Lost to Follow-up|0|||
105692852|NCT00874770|364540536|FG003|Overall Study|Lost to Follow-up|1|||
105692853|NCT00874770|364540533|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
105692854|NCT00874770|364540534|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
105692855|NCT00874770|364540535|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
105692856|NCT00874770|364540536|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
105692857|NCT04464265|364540537|FG000|Overall Study|Physician Decision|2|||
105692858|NCT03189862|364540542|FG000|Overall Study|Withdrawal by Subject|1|||
105692859|NCT03189862|364540543|FG001|Overall Study|Withdrawal by Subject|0|||
105692860|NCT03189862|364540542|FG000|Overall Study|Lost to Follow-up|54|||
105692861|NCT03189862|364540543|FG001|Overall Study|Lost to Follow-up|62|||
105692862|NCT00056862|364540546|FG000|Overall Study|Protocol Violation|1|||
105692863|NCT00056862|364540547|FG001|Overall Study|Protocol Violation|0|||
105692864|NCT04880447|364540548|FG000|Overall Study|No vaccination information|1|||
105692865|NCT04880447|364540548|FG000|Overall Study|No adverse event information (missing information)|1|||
105692866|NCT04880447|364540548|FG000|Overall Study|Disease not covered in this study|35|||
105692867|NCT01122576|364540549|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
106003462|NCT02159066|365674298|FG004|Part I|Death|0|||
106003463|NCT02159066|365674299|FG005|Part I|Death|0|||
106003464|NCT02159066|365674294|FG000|Part I|Progressive Disease|37|||
105692868|NCT01122576|364540550|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
105692869|NCT01122576|364540551|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
105692870|NCT01122576|364540549|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
105692871|NCT01122576|364540550|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
106003465|NCT02159066|365674295|FG001|Part I|Progressive Disease|46|||
105692872|NCT01122576|364540551|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
105692873|NCT01122576|364540549|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
105692874|NCT01122576|364540550|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
105692875|NCT01122576|364540551|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
105692876|NCT05395104|364540553|FG000|Overall Study|Met Liver Stopping Criteria|1|||
105692877|NCT05395104|364540553|FG000|Overall Study|Withdrawal by Subject|1|||
105692878|NCT01145495|364540554|FG000|Overall Study|Adverse Event|6|||
105692879|NCT01145495|364540554|FG000|Overall Study|Withdrawal by Subject|6|||
105692880|NCT01145495|364540554|FG000|Overall Study|Disease progression after respone|2|||
105692881|NCT01886313|364540556|FG000|Overall Study|Adverse Event|1|||
105692882|NCT01886313|364540557|FG001|Overall Study|Adverse Event|1|||
105692883|NCT01379573|364540562|FG000|Overall Study|Lost to Follow-up|1|||
105692884|NCT01379573|364540562|FG000|Overall Study|Screen Failure|10|||
105692885|NCT02378220|364540563|FG000|Overall Study|Death|6|||
105787057|NCT03110107|364874889|FG000|Treatment Period|Disease Progression|3|||
105787058|NCT03110107|364874890|FG001|Treatment Period|Disease Progression|9|||
105920186|NCT03154086|365367255|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
105920187|NCT03154086|365367256|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
105920188|NCT03154086|365367257|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
105920189|NCT03154086|365367258|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
105920190|NCT03154086|365367259|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
105920191|NCT03154086|365367260|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
105920192|NCT03154086|365367261|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
105920193|NCT03154086|365367262|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
105920194|NCT03154086|365367263|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
105920195|NCT03154086|365367264|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
105920196|NCT01924533|365367265|FG000|Overall Study|Death|181|||
105920197|NCT01924533|365367266|FG001|Overall Study|Death|200|||
105920198|NCT01924533|365367265|FG000|Overall Study|Lost to Follow-up|0|||
105920199|NCT01924533|365367266|FG001|Overall Study|Lost to Follow-up|1|||
105920200|NCT01924533|365367265|FG000|Overall Study|Withdrawal by Subject|7|||
105920201|NCT01924533|365367266|FG001|Overall Study|Withdrawal by Subject|3|||
105920202|NCT01924533|365367265|FG000|Overall Study|Other Eligibility criteria|1|||
105920203|NCT01924533|365367266|FG001|Overall Study|Other Eligibility criteria|1|||
105920204|NCT05412134|365367268|FG000|Overall Study|Lost to Follow-up|2|||
105920205|NCT05412134|365367269|FG001|Overall Study|Lost to Follow-up|0|||
105920206|NCT03307174|365367270|FG000|Overall Study|Unplanned ICU Administrion|5|||
105920207|NCT03307174|365367271|FG001|Overall Study|Unplanned ICU Administrion|3|||
105920208|NCT03307174|365367270|FG000|Overall Study|Aborted Surgery|1|||
105920209|NCT03307174|365367271|FG001|Overall Study|Aborted Surgery|2|||
105920210|NCT03307174|365367270|FG000|Overall Study|Hypotension|6|||
105920211|NCT03307174|365367271|FG001|Overall Study|Hypotension|0|||
105920212|NCT03307174|365367270|FG000|Overall Study|Nonfunctional epidural|1|||
105920213|NCT03307174|365367271|FG001|Overall Study|Nonfunctional epidural|1|||
105920214|NCT03307174|365367270|FG000|Overall Study|Planned epidural removal|1|||
105920215|NCT03307174|365367271|FG001|Overall Study|Planned epidural removal|0|||
105920216|NCT03307174|365367270|FG000|Overall Study|Intrathecal catheter placement|0|||
105920217|NCT03307174|365367271|FG001|Overall Study|Intrathecal catheter placement|1|||
105920218|NCT03704064|365367273|FG000|Overall Study|Lost to Follow-up|8|||
105920219|NCT03704064|365367274|FG001|Overall Study|Lost to Follow-up|4|||
105920220|NCT03704064|365367273|FG000|Overall Study|Withdrawal by Subject|1|||
105920221|NCT03704064|365367274|FG001|Overall Study|Withdrawal by Subject|1|||
105920222|NCT03704064|365367273|FG000|Overall Study|No longer available for study visits|0|||
105920223|NCT03704064|365367274|FG001|Overall Study|No longer available for study visits|1|||
105920224|NCT03704064|365367273|FG000|Overall Study|Censoring event|1|||
105920225|NCT03704064|365367274|FG001|Overall Study|Censoring event|0|||
105920226|NCT00830128|365367275|FG000|Overall Study|Adverse Event|5|||
105920227|NCT00830128|365367275|FG000|Overall Study|Lack of Efficacy|7|||
105920228|NCT00830128|365367275|FG000|Overall Study|Protocol Violation|1|||
105920229|NCT00830128|365367275|FG000|Overall Study|Withdrawal by Subject|2|||
105920230|NCT00830128|365367275|FG000|Overall Study|Family obligation|1|||
106003466|NCT02159066|365674296|FG002|Part I|Progressive Disease|0|||
105692886|NCT02378220|364540564|FG001|Overall Study|Death|1|||
105692887|NCT00962390|364540565|FG000|Overall Study|Adverse Event|0|||
105787059|NCT03110107|364874891|FG002|Treatment Period|Disease Progression|8|||
105787060|NCT03110107|364874892|FG003|Treatment Period|Disease Progression|11|||
105920231|NCT00830128|365367275|FG000|Overall Study|Relocation|1|||
105920232|NCT00830128|365367275|FG000|Overall Study|Work obligation|1|||
105920233|NCT00830128|365367275|FG000|Overall Study|Operating a vehicle|1|||
105920234|NCT00846053|365367280|FG000|Overall Study|Physician Decision|3|||
105920235|NCT00846053|365367281|FG001|Overall Study|Physician Decision|0|||
105920236|NCT00111761|365367284|FG000|Part 1|Physician Decision|0|||
105920237|NCT00111761|365367285|FG001|Part 1|Physician Decision|1|||
105692888|NCT00962390|364540566|FG001|Overall Study|Adverse Event|0|||
105920238|NCT00111761|365367284|FG000|Part 1|Death|0|||
105920239|NCT00111761|365367285|FG001|Part 1|Death|2|||
105692889|NCT00962390|364540567|FG002|Overall Study|Adverse Event|3|||
105787061|NCT03110107|364874893|FG004|Treatment Period|Disease Progression|8|||
106003467|NCT02159066|365674297|FG003|Part I|Progressive Disease|0|||
106003468|NCT02159066|365674298|FG004|Part I|Progressive Disease|0|||
105692890|NCT00962390|364540568|FG003|Overall Study|Adverse Event|1|||
105692891|NCT00962390|364540565|FG000|Overall Study|Lost to Follow-up|2|||
105692892|NCT00962390|364540566|FG001|Overall Study|Lost to Follow-up|2|||
105692893|NCT00962390|364540567|FG002|Overall Study|Lost to Follow-up|0|||
105692894|NCT00962390|364540568|FG003|Overall Study|Lost to Follow-up|0|||
105692895|NCT00962390|364540565|FG000|Overall Study|Protocol Violation|1|||
105692896|NCT00962390|364540566|FG001|Overall Study|Protocol Violation|0|||
105692897|NCT00962390|364540567|FG002|Overall Study|Protocol Violation|0|||
105692898|NCT00962390|364540568|FG003|Overall Study|Protocol Violation|0|||
105692899|NCT00962390|364540565|FG000|Overall Study|Withdrawal by Subject|1|||
105692900|NCT00962390|364540566|FG001|Overall Study|Withdrawal by Subject|1|||
105692901|NCT00962390|364540567|FG002|Overall Study|Withdrawal by Subject|1|||
105692902|NCT00962390|364540568|FG003|Overall Study|Withdrawal by Subject|0|||
105692903|NCT00312221|364540572|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
105692904|NCT00312221|364540573|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
105692905|NCT00312221|364540574|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
105692906|NCT00312221|364540575|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
105692907|NCT00312221|364540572|FG000|Open-label Run-in Period|Adverse Event|74|||
105692908|NCT00312221|364540573|FG001|Open-label Run-in Period|Adverse Event|0|||
105692909|NCT00312221|364540574|FG002|Open-label Run-in Period|Adverse Event|0|||
106003469|NCT02159066|365674299|FG005|Part I|Progressive Disease|0|||
106003470|NCT02159066|365674294|FG000|Part I|New Therapy for Study Indication|5|||
106003471|NCT02159066|365674295|FG001|Part I|New Therapy for Study Indication|4|||
105692910|NCT00312221|364540575|FG003|Open-label Run-in Period|Adverse Event|0|||
105692911|NCT00312221|364540572|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
105692912|NCT00312221|364540573|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
105692913|NCT00312221|364540574|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
105692914|NCT00312221|364540575|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
105692915|NCT00312221|364540572|FG000|Open-label Run-in Period|Administrative|42|||
105692916|NCT00312221|364540573|FG001|Open-label Run-in Period|Administrative|0|||
105692917|NCT00312221|364540574|FG002|Open-label Run-in Period|Administrative|0|||
105692918|NCT00312221|364540575|FG003|Open-label Run-in Period|Administrative|0|||
105692919|NCT00312221|364540572|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
105692920|NCT00312221|364540573|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
105692921|NCT00312221|364540574|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
105692922|NCT00312221|364540575|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
105692923|NCT00312221|364540572|FG000|Open-label Run-in Period|Did not qualify|5|||
105692924|NCT00312221|364540573|FG001|Open-label Run-in Period|Did not qualify|0|||
105692925|NCT00312221|364540574|FG002|Open-label Run-in Period|Did not qualify|0|||
105692926|NCT00312221|364540575|FG003|Open-label Run-in Period|Did not qualify|0|||
105692927|NCT00312221|364540572|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105692928|NCT00312221|364540573|FG001|Double-blind Phase|Withdrawal by Subject|6|||
105692929|NCT00312221|364540574|FG002|Double-blind Phase|Withdrawal by Subject|8|||
105692930|NCT00312221|364540575|FG003|Double-blind Phase|Withdrawal by Subject|7|||
105692931|NCT00312221|364540572|FG000|Double-blind Phase|Adverse Event|0|||
105692932|NCT00312221|364540573|FG001|Double-blind Phase|Adverse Event|10|||
105692933|NCT00312221|364540574|FG002|Double-blind Phase|Adverse Event|19|||
105692934|NCT00312221|364540575|FG003|Double-blind Phase|Adverse Event|18|||
105692935|NCT00312221|364540572|FG000|Double-blind Phase|Lost to Follow-up|0|||
105692936|NCT00312221|364540573|FG001|Double-blind Phase|Lost to Follow-up|0|||
105692937|NCT00312221|364540574|FG002|Double-blind Phase|Lost to Follow-up|2|||
105692938|NCT00312221|364540575|FG003|Double-blind Phase|Lost to Follow-up|2|||
105692939|NCT00312221|364540572|FG000|Double-blind Phase|Administrative|0|||
105692940|NCT00312221|364540573|FG001|Double-blind Phase|Administrative|26|||
105692941|NCT00312221|364540574|FG002|Double-blind Phase|Administrative|37|||
105692942|NCT00312221|364540575|FG003|Double-blind Phase|Administrative|33|||
105692943|NCT00312221|364540572|FG000|Double-blind Phase|Lack of Efficacy|0|||
105692944|NCT00312221|364540573|FG001|Double-blind Phase|Lack of Efficacy|17|||
105692945|NCT00312221|364540574|FG002|Double-blind Phase|Lack of Efficacy|6|||
105692946|NCT00312221|364540575|FG003|Double-blind Phase|Lack of Efficacy|10|||
106003472|NCT02159066|365674296|FG002|Part I|New Therapy for Study Indication|0|||
105692947|NCT03740997|364540581|FG000|Overall Study|Withdrawal by Subject|1|||
105692948|NCT03740997|364540582|FG001|Overall Study|Withdrawal by Subject|0|||
105692949|NCT03740997|364540581|FG000|Overall Study|Participant was unable to complete study procedures|1|||
105692950|NCT03740997|364540582|FG001|Overall Study|Participant was unable to complete study procedures|0|||
105692951|NCT01829425|364540583|FG000|Overall Study|Withdrawal by Subject|4|||
105692952|NCT01829425|364540584|FG001|Overall Study|Withdrawal by Subject|3|||
105692953|NCT01829425|364540583|FG000|Overall Study|Lost to Follow-up|2|||
106003473|NCT02159066|365674297|FG003|Part I|New Therapy for Study Indication|0|||
105692954|NCT01829425|364540584|FG001|Overall Study|Lost to Follow-up|1|||
105692955|NCT01862640|364540587|FG000|Overall Study|Adverse Event|4|||
105692956|NCT01862640|364540588|FG001|Overall Study|Adverse Event|10|||
105692957|NCT01862640|364540589|FG002|Overall Study|Adverse Event|6|||
105692958|NCT01862640|364540590|FG003|Overall Study|Adverse Event|8|||
105692959|NCT01862640|364540587|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
105692960|NCT01862640|364540588|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
105692961|NCT01862640|364540589|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
105692962|NCT01862640|364540590|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
105692963|NCT01862640|364540587|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
105692964|NCT01862640|364540588|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
105692965|NCT01862640|364540589|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
105692966|NCT01862640|364540590|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
105692967|NCT01862640|364540587|FG000|Overall Study|Withdrawal by Subject|2|||
105692968|NCT01862640|364540588|FG001|Overall Study|Withdrawal by Subject|4|||
105692969|NCT01862640|364540589|FG002|Overall Study|Withdrawal by Subject|8|||
105692970|NCT01862640|364540590|FG003|Overall Study|Withdrawal by Subject|5|||
105692971|NCT01862640|364540587|FG000|Overall Study|Protocol Deviation|0|||
105692972|NCT01862640|364540588|FG001|Overall Study|Protocol Deviation|0|||
105692973|NCT01862640|364540589|FG002|Overall Study|Protocol Deviation|1|||
105692974|NCT01862640|364540590|FG003|Overall Study|Protocol Deviation|0|||
105692975|NCT04178967|364540591|FG000|Induction Period|Adverse Event|4|||
105692976|NCT04178967|364540592|FG001|Induction Period|Adverse Event|6|||
105692977|NCT04178967|364540593|FG002|Induction Period|Adverse Event|0|||
105692978|NCT04178967|364540594|FG003|Induction Period|Adverse Event|0|||
105692979|NCT04178967|364540595|FG004|Induction Period|Adverse Event|0|||
105692980|NCT04178967|364540596|FG005|Induction Period|Adverse Event|0|||
105692981|NCT04178967|364540597|FG006|Induction Period|Adverse Event|0|||
105692982|NCT04178967|364540598|FG007|Induction Period|Adverse Event|0|||
105692983|NCT04178967|364540599|FG008|Induction Period|Adverse Event|0|||
105692984|NCT04178967|364540600|FG009|Induction Period|Adverse Event|0|||
105692985|NCT04178967|364540601|FG010|Induction Period|Adverse Event|0|||
105692986|NCT04178967|364540591|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
105692987|NCT04178967|364540592|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
105692988|NCT04178967|364540593|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
105692989|NCT04178967|364540594|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
105692990|NCT04178967|364540595|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
105692991|NCT04178967|364540596|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
105692992|NCT04178967|364540597|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
105692993|NCT04178967|364540598|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
105692994|NCT04178967|364540599|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
105692995|NCT04178967|364540600|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
105920240|NCT00111761|365367284|FG000|Part 1|Other|0|||
105920241|NCT00111761|365367285|FG001|Part 1|Other|1|||
105920242|NCT00111761|365367284|FG000|Part 1|Withdrawal by Subject|0|||
105920243|NCT00111761|365367285|FG001|Part 1|Withdrawal by Subject|1|||
105920244|NCT00111761|365367284|FG000|Part 2|Adverse Event|1|||
105920245|NCT00111761|365367285|FG001|Part 2|Adverse Event|0|||
105920246|NCT00111761|365367284|FG000|Part 2|Physician Decision|1|||
105920247|NCT00111761|365367285|FG001|Part 2|Physician Decision|0|||
105920248|NCT00111761|365367284|FG000|Part 2|Death|1|||
105920249|NCT00111761|365367285|FG001|Part 2|Death|0|||
105920250|NCT00111761|365367284|FG000|Part 2|Disease progression|3|||
105920251|NCT00111761|365367285|FG001|Part 2|Disease progression|0|||
105920252|NCT00111761|365367284|FG000|Part 2|Protocol-specified criteria|1|||
105920253|NCT00111761|365367285|FG001|Part 2|Protocol-specified criteria|0|||
105920254|NCT00111761|365367284|FG000|Part 2|Other|1|||
105920255|NCT00111761|365367285|FG001|Part 2|Other|0|||
105920256|NCT00726609|365367286|FG000|Overall Study|Adverse Event|10|||
105920257|NCT00726609|365367286|FG000|Overall Study|Withdrawal by Subject|2|||
105920258|NCT00726609|365367286|FG000|Overall Study|Lack of Efficacy|25|||
105920259|NCT00726609|365367286|FG000|Overall Study|Other|16|||
105920260|NCT00726609|365367286|FG000|Overall Study|Missing|42|||
105920261|NCT00726609|365367286|FG000|Overall Study|Other|3|||
105920262|NCT00746551|365367287|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
105920263|NCT00746551|365367288|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
105920264|NCT00746551|365367287|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
106003474|NCT02159066|365674298|FG004|Part I|New Therapy for Study Indication|0|||
106003475|NCT02159066|365674299|FG005|Part I|New Therapy for Study Indication|0|||
106131537|NCT04170023|366139549|FG000|LTE Period|Study Termination|11|||
105920265|NCT00746551|365367288|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
105692996|NCT04178967|364540601|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
105920266|NCT00746551|365367287|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
105692997|NCT04178967|364540591|FG000|Induction Period|Lack of Efficacy|4|||
105692998|NCT04178967|364540592|FG001|Induction Period|Lack of Efficacy|1|||
105692999|NCT04178967|364540593|FG002|Induction Period|Lack of Efficacy|0|||
105693000|NCT04178967|364540594|FG003|Induction Period|Lack of Efficacy|0|||
105693001|NCT04178967|364540595|FG004|Induction Period|Lack of Efficacy|0|||
105920267|NCT00746551|365367288|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
106131538|NCT04170023|366139550|FG001|LTE Period|Study Termination|11|||
105693002|NCT04178967|364540596|FG005|Induction Period|Lack of Efficacy|0|||
105693003|NCT04178967|364540597|FG006|Induction Period|Lack of Efficacy|0|||
105920268|NCT00062166|365367289|FG000|Overall Study|Withdrawal by Subject|6|||
105920269|NCT04609514|365367301|FG000|Overall Study|Lost to Follow-up|5|||
105920270|NCT04609514|365367302|FG001|Overall Study|Lost to Follow-up|4|||
105920271|NCT04609514|365367301|FG000|Overall Study|Withdrawal by PI|0|||
105920272|NCT04609514|365367302|FG001|Overall Study|Withdrawal by PI|2|||
105920273|NCT00909870|365367303|FG000|Overall Study|Adverse Event|13|||
105920274|NCT00909870|365367304|FG001|Overall Study|Adverse Event|7|||
105920275|NCT00909870|365367303|FG000|Overall Study|Protocol Violation|1|||
105920276|NCT00909870|365367304|FG001|Overall Study|Protocol Violation|2|||
105920277|NCT00909870|365367303|FG000|Overall Study|Withdrawal by Subject|5|||
105920278|NCT00909870|365367304|FG001|Overall Study|Withdrawal by Subject|8|||
105920279|NCT00909870|365367303|FG000|Overall Study|Lost to Follow-up|3|||
105920280|NCT00909870|365367304|FG001|Overall Study|Lost to Follow-up|3|||
105920281|NCT00909870|365367303|FG000|Overall Study|Physician Decision|0|||
105920282|NCT00909870|365367304|FG001|Overall Study|Physician Decision|2|||
105920283|NCT00909870|365367303|FG000|Overall Study|Other|1|||
105920284|NCT00909870|365367304|FG001|Overall Study|Other|5|||
105920285|NCT03122171|365367305|FG000|Overall Study|Withdrawal by Subject|1|||
105920286|NCT01114724|365367316|FG000|Overall Study|Death|8|||
105920287|NCT01114724|365367316|FG000|Overall Study|Lost to Follow-up|1|||
105920288|NCT01114724|365367316|FG000|Overall Study|Withdrawal by Subject|1|||
105920289|NCT00843492|365367320|FG000|Overall Study|Adverse Event|0|||
105920290|NCT00843492|365367321|FG001|Overall Study|Adverse Event|3|||
105920291|NCT00843492|365367320|FG000|Overall Study|Lost to Follow-up|4|||
105920292|NCT00843492|365367321|FG001|Overall Study|Lost to Follow-up|4|||
105920293|NCT00843492|365367320|FG000|Overall Study|Withdrawal by Subject|0|||
105920294|NCT00843492|365367321|FG001|Overall Study|Withdrawal by Subject|4|||
105920295|NCT00843492|365367320|FG000|Overall Study|Immobilization Stopped|1|||
105920296|NCT00843492|365367321|FG001|Overall Study|Immobilization Stopped|0|||
105920297|NCT00843492|365367320|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
105920298|NCT00843492|365367321|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
105920299|NCT00843492|365367320|FG000|Overall Study|Orthopedic Surgery|0|||
105920300|NCT00843492|365367321|FG001|Overall Study|Orthopedic Surgery|2|||
105920301|NCT00843492|365367320|FG000|Overall Study|Visit Not Performed|1|||
105920302|NCT00843492|365367321|FG001|Overall Study|Visit Not Performed|0|||
105920303|NCT00843492|365367320|FG000|Overall Study|Deep-vein Thrombosis|1|||
105920304|NCT00843492|365367321|FG001|Overall Study|Deep-vein Thrombosis|0|||
105920305|NCT01677741|365367323|FG000|Overall Study|Death|0|||
105920306|NCT01677741|365367324|FG001|Overall Study|Death|0|||
105920307|NCT01677741|365367325|FG002|Overall Study|Death|0|||
105920308|NCT01677741|365367326|FG003|Overall Study|Death|1|||
105920309|NCT01677741|365367327|FG004|Overall Study|Death|0|||
105920310|NCT01677741|365367328|FG005|Overall Study|Death|1|||
105920311|NCT01677741|365367329|FG006|Overall Study|Death|0|||
105920312|NCT01677741|365367330|FG007|Overall Study|Death|0|||
105920313|NCT01677741|365367323|FG000|Overall Study|Withdrawal by Subject|2|||
105920314|NCT01677741|365367324|FG001|Overall Study|Withdrawal by Subject|7|||
105920315|NCT01677741|365367325|FG002|Overall Study|Withdrawal by Subject|5|||
105920316|NCT01677741|365367326|FG003|Overall Study|Withdrawal by Subject|4|||
105920317|NCT01677741|365367327|FG004|Overall Study|Withdrawal by Subject|11|||
105920318|NCT01677741|365367328|FG005|Overall Study|Withdrawal by Subject|20|||
105920319|NCT01677741|365367329|FG006|Overall Study|Withdrawal by Subject|4|||
105920320|NCT01677741|365367330|FG007|Overall Study|Withdrawal by Subject|2|||
105920321|NCT01677741|365367323|FG000|Overall Study|Enrolled in a rollover study|0|||
105920322|NCT01677741|365367324|FG001|Overall Study|Enrolled in a rollover study|3|||
105920323|NCT01677741|365367325|FG002|Overall Study|Enrolled in a rollover study|2|||
105920324|NCT01677741|365367326|FG003|Overall Study|Enrolled in a rollover study|1|||
105920325|NCT01677741|365367327|FG004|Overall Study|Enrolled in a rollover study|6|||
105920326|NCT01677741|365367328|FG005|Overall Study|Enrolled in a rollover study|6|||
105920327|NCT01677741|365367329|FG006|Overall Study|Enrolled in a rollover study|7|||
105920328|NCT01677741|365367330|FG007|Overall Study|Enrolled in a rollover study|0|||
105920329|NCT01677741|365367323|FG000|Overall Study|Progressive disease|1|||
105920330|NCT01677741|365367324|FG001|Overall Study|Progressive disease|0|||
105920331|NCT01677741|365367325|FG002|Overall Study|Progressive disease|1|||
105920332|NCT01677741|365367326|FG003|Overall Study|Progressive disease|0|||
105920333|NCT01677741|365367327|FG004|Overall Study|Progressive disease|0|||
105920334|NCT01677741|365367328|FG005|Overall Study|Progressive disease|1|||
105920335|NCT01677741|365367329|FG006|Overall Study|Progressive disease|0|||
105920336|NCT01677741|365367330|FG007|Overall Study|Progressive disease|0|||
105920337|NCT03225287|365367335|FG000|Overall Study|Adverse Event|0|||
105920338|NCT03225287|365367336|FG001|Overall Study|Adverse Event|0|||
105920339|NCT03225287|365367337|FG002|Overall Study|Adverse Event|1|||
105920340|NCT03225287|365367335|FG000|Overall Study|Protocol non-compliance|0|||
106003476|NCT02159066|365674294|FG000|Part I|Termination of participants from the study|3|||
105920341|NCT03225287|365367336|FG001|Overall Study|Protocol non-compliance|0|||
105920342|NCT03225287|365367337|FG002|Overall Study|Protocol non-compliance|1|||
105920343|NCT03225287|365367335|FG000|Overall Study|Subject withdraws consent|3|||
105920344|NCT03225287|365367336|FG001|Overall Study|Subject withdraws consent|0|||
106003477|NCT02159066|365674295|FG001|Part I|Termination of participants from the study|3|||
106003478|NCT02159066|365674296|FG002|Part I|Termination of participants from the study|0|||
105693004|NCT04178967|364540598|FG007|Induction Period|Lack of Efficacy|0|||
105693005|NCT04178967|364540599|FG008|Induction Period|Lack of Efficacy|0|||
105693006|NCT04178967|364540600|FG009|Induction Period|Lack of Efficacy|0|||
106003479|NCT02159066|365674297|FG003|Part I|Termination of participants from the study|0|||
106003480|NCT02159066|365674298|FG004|Part I|Termination of participants from the study|0|||
106003481|NCT02159066|365674299|FG005|Part I|Termination of participants from the study|0|||
106003482|NCT02159066|365674294|FG000|Part I|Physician Decision|2|||
106003483|NCT02159066|365674295|FG001|Part I|Physician Decision|9|||
106003484|NCT02159066|365674296|FG002|Part I|Physician Decision|0|||
106003485|NCT02159066|365674297|FG003|Part I|Physician Decision|0|||
106003486|NCT02159066|365674298|FG004|Part I|Physician Decision|0|||
106003487|NCT02159066|365674299|FG005|Part I|Physician Decision|0|||
106003488|NCT02159066|365674294|FG000|Part I|Participant/Guardian Decision|9|||
106003489|NCT02159066|365674295|FG001|Part I|Participant/Guardian Decision|3|||
106003490|NCT02159066|365674296|FG002|Part I|Participant/Guardian Decision|0|||
106003491|NCT02159066|365674297|FG003|Part I|Participant/Guardian Decision|0|||
106003492|NCT02159066|365674298|FG004|Part I|Participant/Guardian Decision|0|||
106003493|NCT02159066|365674299|FG005|Part I|Participant/Guardian Decision|0|||
106003494|NCT02159066|365674294|FG000|Part I|Missing Data|1|||
106003495|NCT02159066|365674295|FG001|Part I|Missing Data|0|||
106003496|NCT02159066|365674296|FG002|Part I|Missing Data|0|||
106003497|NCT02159066|365674297|FG003|Part I|Missing Data|0|||
106003498|NCT02159066|365674298|FG004|Part I|Missing Data|0|||
106003499|NCT02159066|365674299|FG005|Part I|Missing Data|0|||
106003500|NCT02159066|365674294|FG000|Part II|Adverse Event|0|||
106003501|NCT02159066|365674295|FG001|Part II|Adverse Event|0|||
106003502|NCT02159066|365674296|FG002|Part II|Adverse Event|1|||
106003503|NCT02159066|365674297|FG003|Part II|Adverse Event|0|||
106003504|NCT02159066|365674298|FG004|Part II|Adverse Event|1|||
106003505|NCT02159066|365674299|FG005|Part II|Adverse Event|1|||
106003506|NCT02159066|365674294|FG000|Part II|Death|0|||
106003507|NCT02159066|365674295|FG001|Part II|Death|0|||
106003508|NCT02159066|365674296|FG002|Part II|Death|1|||
106003509|NCT02159066|365674297|FG003|Part II|Death|0|||
106003510|NCT02159066|365674298|FG004|Part II|Death|2|||
106003511|NCT02159066|365674299|FG005|Part II|Death|1|||
106003512|NCT02159066|365674294|FG000|Part II|Progressive Disease|0|||
106003513|NCT02159066|365674295|FG001|Part II|Progressive Disease|0|||
106003514|NCT02159066|365674296|FG002|Part II|Progressive Disease|35|||
106003515|NCT02159066|365674297|FG003|Part II|Progressive Disease|1|||
106003516|NCT02159066|365674298|FG004|Part II|Progressive Disease|7|||
106003517|NCT02159066|365674299|FG005|Part II|Progressive Disease|4|||
106003518|NCT02159066|365674294|FG000|Part II|New Therapy for Study Indication|0|||
106003519|NCT02159066|365674295|FG001|Part II|New Therapy for Study Indication|0|||
106003520|NCT02159066|365674296|FG002|Part II|New Therapy for Study Indication|0|||
106003521|NCT02159066|365674297|FG003|Part II|New Therapy for Study Indication|0|||
106003522|NCT02159066|365674298|FG004|Part II|New Therapy for Study Indication|1|||
106003523|NCT02159066|365674299|FG005|Part II|New Therapy for Study Indication|0|||
106003524|NCT02159066|365674294|FG000|Part II|Physician Decision|0|||
106003525|NCT02159066|365674295|FG001|Part II|Physician Decision|0|||
106003526|NCT02159066|365674296|FG002|Part II|Physician Decision|1|||
106003527|NCT02159066|365674297|FG003|Part II|Physician Decision|0|||
106003528|NCT02159066|365674298|FG004|Part II|Physician Decision|0|||
106003529|NCT02159066|365674299|FG005|Part II|Physician Decision|0|||
106003530|NCT02159066|365674294|FG000|Part II|Participant/Guardian Decision|0|||
106003531|NCT02159066|365674295|FG001|Part II|Participant/Guardian Decision|0|||
106003532|NCT02159066|365674296|FG002|Part II|Participant/Guardian Decision|0|||
106003533|NCT02159066|365674297|FG003|Part II|Participant/Guardian Decision|0|||
106003534|NCT02159066|365674298|FG004|Part II|Participant/Guardian Decision|2|||
106003535|NCT02159066|365674299|FG005|Part II|Participant/Guardian Decision|0|||
106003536|NCT00423657|365674300|FG000|Overall Study|Withdrew consent|10|||
106003537|NCT00423657|365674301|FG001|Overall Study|Withdrew consent|8|||
106003538|NCT00423657|365674300|FG000|Overall Study|Non-compliance|0|||
106003539|NCT00423657|365674301|FG001|Overall Study|Non-compliance|1|||
106003540|NCT00423657|365674300|FG000|Overall Study|Other|15|||
106003541|NCT00423657|365674301|FG001|Overall Study|Other|16|||
105693007|NCT04178967|364540601|FG010|Induction Period|Lack of Efficacy|0|||
106003542|NCT00423657|365674300|FG000|Overall Study|Request of sponsor/investigator|1|||
105693008|NCT04178967|364540591|FG000|Induction Period|Protocol Violation|0|||
106003543|NCT00423657|365674301|FG001|Overall Study|Request of sponsor/investigator|0|||
106003544|NCT02314052|365674302|FG000|Cycle One|Adverse Event|0|||
106003545|NCT02314052|365674303|FG001|Cycle One|Adverse Event|0|||
106003546|NCT02314052|365674304|FG002|Cycle One|Adverse Event|0|||
106003547|NCT02314052|365674305|FG003|Cycle One|Adverse Event|1|||
106003548|NCT02314052|365674306|FG004|Cycle One|Adverse Event|0|||
106003549|NCT02314052|365674307|FG005|Cycle One|Adverse Event|0|||
106131539|NCT04170023|366139551|FG002|LTE Period|Study Termination|5|||
106131540|NCT00953160|366139555|FG000|Overall Study|Lost to Follow-up|23|||
106131541|NCT00953160|366139555|FG000|Overall Study|Withdrawal by Subject|4|||
106131542|NCT03566680|366139557|FG000|Overall Study|Pregnancy|1|||
106131543|NCT03566680|366139557|FG000|Overall Study|Lost to Follow-up|13|||
106131544|NCT03566680|366139557|FG000|Overall Study|Withdrawal by Subject|3|||
106131545|NCT04337489|366139558|FG000|Overall Study|Withdrawal by Subject|1|||
106131546|NCT00688688|366139559|FG000|Overall Study|Eligibility criterion not met|7|||
106131547|NCT00688688|366139560|FG001|Overall Study|Eligibility criterion not met|7|||
106131548|NCT00688688|366139561|FG002|Overall Study|Eligibility criterion not met|10|||
106131549|NCT00688688|366139559|FG000|Overall Study|Adverse Event|52|||
106131550|NCT00688688|366139560|FG001|Overall Study|Adverse Event|51|||
106131551|NCT00688688|366139561|FG002|Overall Study|Adverse Event|50|||
106131552|NCT00688688|366139559|FG000|Overall Study|Lack of Efficacy|34|||
105920345|NCT03225287|365367337|FG002|Overall Study|Subject withdraws consent|0|||
105920346|NCT03225287|365367335|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
105920347|NCT03225287|365367336|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
105920348|NCT03225287|365367337|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
105920349|NCT03225287|365367335|FG000|Overall Study|Trial drug not effective|0|||
105920350|NCT03225287|365367336|FG001|Overall Study|Trial drug not effective|1|||
105920351|NCT03225287|365367337|FG002|Overall Study|Trial drug not effective|0|||
105920352|NCT03225287|365367335|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
105920353|NCT03225287|365367336|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
105920354|NCT03225287|365367337|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
105920355|NCT03225287|365367335|FG000|Overall Study|Stem cell transplantation|0|||
105920356|NCT03225287|365367336|FG001|Overall Study|Stem cell transplantation|1|||
105920357|NCT03225287|365367337|FG002|Overall Study|Stem cell transplantation|0|||
105920358|NCT03415178|365367338|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
105920359|NCT03415178|365367339|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
105920360|NCT03415178|365367338|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
105920361|NCT03415178|365367339|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
105920362|NCT00750269|365369235|FG000|Overall Study|Protocol Violation|0|||
105920363|NCT00750269|365369236|FG001|Overall Study|Protocol Violation|1|||
105920364|NCT00750269|365369237|FG002|Overall Study|Protocol Violation|1|||
105920365|NCT00750269|365369238|FG003|Overall Study|Protocol Violation|2|||
105920366|NCT00750269|365369239|FG004|Overall Study|Protocol Violation|4|||
105920367|NCT00750269|365369235|FG000|Overall Study|Withdrawal by Subject|0|||
105920368|NCT00750269|365369236|FG001|Overall Study|Withdrawal by Subject|0|||
105920369|NCT00750269|365369237|FG002|Overall Study|Withdrawal by Subject|2|||
105920370|NCT00750269|365369238|FG003|Overall Study|Withdrawal by Subject|2|||
105920371|NCT00750269|365369239|FG004|Overall Study|Withdrawal by Subject|2|||
105920372|NCT00750269|365369235|FG000|Overall Study|Physician Decision|0|||
105920373|NCT00750269|365369236|FG001|Overall Study|Physician Decision|0|||
105920374|NCT00750269|365369237|FG002|Overall Study|Physician Decision|0|||
105920375|NCT00750269|365369238|FG003|Overall Study|Physician Decision|0|||
105920376|NCT00750269|365369239|FG004|Overall Study|Physician Decision|2|||
105920377|NCT00750269|365369235|FG000|Overall Study|Patient too large for positioning|0|||
105920378|NCT00750269|365369236|FG001|Overall Study|Patient too large for positioning|0|||
105920379|NCT00750269|365369237|FG002|Overall Study|Patient too large for positioning|1|||
105920380|NCT00750269|365369238|FG003|Overall Study|Patient too large for positioning|0|||
105920381|NCT00750269|365369239|FG004|Overall Study|Patient too large for positioning|0|||
106003550|NCT02422498|365674312|FG000|Overall Study|Inevaluable|4|||
106003551|NCT03206216|365674313|FG000|Overall Study|Withdrawal by Subject|0|||
106003552|NCT03206216|365674314|FG001|Overall Study|Withdrawal by Subject|1|||
106003553|NCT01620060|365674315|FG000|Overall Study|Adverse Event|9|||
106003554|NCT01620060|365674315|FG000|Overall Study|Protocol Violation|1|||
106003555|NCT01620060|365674315|FG000|Overall Study|Withdrawal by Subject|1|||
106003556|NCT01620060|365674315|FG000|Overall Study|Did not comply with Study Produre|1|||
106003557|NCT01620060|365674315|FG000|Overall Study|Family emergency|1|||
106003558|NCT01620060|365674315|FG000|Overall Study|Per Sponsor Decision|2|||
106003559|NCT04551989|365674318|FG000|Overall Study|Adverse Event|4|||
105920382|NCT00750269|365369235|FG000|Overall Study|Site error|0|||
105920383|NCT00750269|365369236|FG001|Overall Study|Site error|0|||
105920384|NCT00750269|365369237|FG002|Overall Study|Site error|0|||
106003560|NCT04551989|365674318|FG000|Overall Study|Protocol Violation|3|||
105920385|NCT00750269|365369238|FG003|Overall Study|Site error|1|||
105920386|NCT00750269|365369239|FG004|Overall Study|Site error|0|||
106003561|NCT04551989|365674318|FG000|Overall Study|Lost to Follow-up|1|||
106131553|NCT00688688|366139560|FG001|Overall Study|Lack of Efficacy|25|||
106131554|NCT00688688|366139561|FG002|Overall Study|Lack of Efficacy|45|||
106003562|NCT04551989|365674318|FG000|Overall Study|Physician Decision|3|||
106003563|NCT04698343|365674319|FG000|Overall Study|Withdrawal by Subject|6|||
106003564|NCT04698343|365674319|FG000|Overall Study|Physician Decision|2|||
106003565|NCT04698343|365674319|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
106003566|NCT04698343|365674319|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
106003567|NCT04698343|365674319|FG000|Overall Study|Personal reasons|3|||
106003568|NCT04698343|365674319|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
106003569|NCT00730158|365674320|FG000|Overall Study|Withdrawal by Subject|1|||
106003570|NCT00730158|365674321|FG001|Overall Study|Withdrawal by Subject|1|||
106003571|NCT04678115|365674322|FG000|Overall Study|Lost to Follow-up|1|||
106003572|NCT04678115|365674323|FG001|Overall Study|Lost to Follow-up|0|||
106003573|NCT04059549|365674324|FG000|Overall Study|Withdrawal by Subject|2|||
106003574|NCT04059549|365674325|FG001|Overall Study|Withdrawal by Subject|0|||
106003575|NCT02678351|365674327|FG000|Overall Study|Withdrawal by Subject|1|||
106003576|NCT00988884|365674328|FG000|Overall Study|Adverse Event|0|||
106003577|NCT00988884|365674329|FG001|Overall Study|Adverse Event|1|||
106003578|NCT00988884|365674328|FG000|Overall Study|Lost to Follow-up|20|||
106003579|NCT00988884|365674329|FG001|Overall Study|Lost to Follow-up|16|||
106003580|NCT00988884|365674328|FG000|Overall Study|Protocol Violation|0|||
106003581|NCT00988884|365674329|FG001|Overall Study|Protocol Violation|1|||
106003582|NCT00988884|365674328|FG000|Overall Study|Withdrawal by Subject|15|||
106003583|NCT00988884|365674329|FG001|Overall Study|Withdrawal by Subject|18|||
106003584|NCT01919229|365674330|FG000|Overall Study|Subject/guardian decision|0|||
106003585|NCT01919229|365674331|FG001|Overall Study|Subject/guardian decision|0|||
106003586|NCT01919229|365674332|FG002|Overall Study|Subject/guardian decision|1|||
106003587|NCT01011673|365674333|FG000|Randomized|Secondary headache|2|||
106003588|NCT01011673|365674334|FG001|Randomized|Secondary headache|1|||
106003589|NCT01011673|365674333|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
106003590|NCT01011673|365674334|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
106003591|NCT02738008|365674336|FG000|Overall Study|Study Terminated by Sponsor|1|||
106003592|NCT02738008|365674337|FG001|Overall Study|Study Terminated by Sponsor|5|||
106003593|NCT02738008|365674338|FG002|Overall Study|Study Terminated by Sponsor|3|||
106003594|NCT02738008|365674336|FG000|Overall Study|Adverse Event|0|||
106003595|NCT02738008|365674337|FG001|Overall Study|Adverse Event|1|||
106003596|NCT02738008|365674338|FG002|Overall Study|Adverse Event|2|||
106003597|NCT02552966|365674348|FG000|Overall Study|Lost to Follow-up|2|||
106003598|NCT02552966|365674348|FG000|Overall Study|Withdrawal by Subject|3|||
106003599|NCT04999839|365674351|FG000|Overall Study|Adverse Event|1|||
106003600|NCT04999839|365674352|FG001|Overall Study|Adverse Event|1|||
106003601|NCT04999839|365674353|FG002|Overall Study|Adverse Event|1|||
106003602|NCT04999839|365674354|FG003|Overall Study|Adverse Event|1|||
106003603|NCT04999839|365674355|FG004|Overall Study|Adverse Event|1|||
106003604|NCT04999839|365674351|FG000|Overall Study|Lost to Follow-up|2|||
106003605|NCT04999839|365674352|FG001|Overall Study|Lost to Follow-up|0|||
106003606|NCT04999839|365674353|FG002|Overall Study|Lost to Follow-up|2|||
106003607|NCT04999839|365674354|FG003|Overall Study|Lost to Follow-up|4|||
106003608|NCT04999839|365674355|FG004|Overall Study|Lost to Follow-up|1|||
106003609|NCT04999839|365674351|FG000|Overall Study|Withdrawal by Subject|6|||
106003610|NCT04999839|365674352|FG001|Overall Study|Withdrawal by Subject|5|||
106003611|NCT04999839|365674353|FG002|Overall Study|Withdrawal by Subject|3|||
106003612|NCT04999839|365674354|FG003|Overall Study|Withdrawal by Subject|2|||
106003613|NCT04999839|365674355|FG004|Overall Study|Withdrawal by Subject|2|||
106003614|NCT04999839|365674351|FG000|Overall Study|Lack of Efficacy|0|||
106003615|NCT04999839|365674352|FG001|Overall Study|Lack of Efficacy|1|||
106003616|NCT04999839|365674353|FG002|Overall Study|Lack of Efficacy|0|||
106003617|NCT04999839|365674354|FG003|Overall Study|Lack of Efficacy|0|||
106003618|NCT04999839|365674355|FG004|Overall Study|Lack of Efficacy|0|||
106003619|NCT04999839|365674351|FG000|Overall Study|Physician Decision|0|||
106003620|NCT04999839|365674352|FG001|Overall Study|Physician Decision|0|||
106003621|NCT04999839|365674353|FG002|Overall Study|Physician Decision|0|||
106003622|NCT04999839|365674354|FG003|Overall Study|Physician Decision|0|||
106003623|NCT04999839|365674355|FG004|Overall Study|Physician Decision|1|||
106003624|NCT04999839|365674351|FG000|Overall Study|Sponsor request|0|||
106003625|NCT04999839|365674352|FG001|Overall Study|Sponsor request|1|||
106003626|NCT04999839|365674353|FG002|Overall Study|Sponsor request|0|||
105693009|NCT04178967|364540592|FG001|Induction Period|Protocol Violation|6|||
105693010|NCT04178967|364540593|FG002|Induction Period|Protocol Violation|0|||
105693011|NCT04178967|364540594|FG003|Induction Period|Protocol Violation|0|||
105693012|NCT04178967|364540595|FG004|Induction Period|Protocol Violation|0|||
106003627|NCT04999839|365674354|FG003|Overall Study|Sponsor request|0|||
106003628|NCT04999839|365674355|FG004|Overall Study|Sponsor request|0|||
106003629|NCT04999839|365674351|FG000|Overall Study|Other|0|||
106003630|NCT04999839|365674352|FG001|Overall Study|Other|0|||
106003631|NCT04999839|365674353|FG002|Overall Study|Other|1|||
106003632|NCT04999839|365674354|FG003|Overall Study|Other|0|||
106003633|NCT04999839|365674355|FG004|Overall Study|Other|0|||
106003634|NCT01216202|365674356|FG000|Overall Study|Withdrawal by Subject|8|||
106003635|NCT01216202|365674357|FG001|Overall Study|Withdrawal by Subject|0|||
106003636|NCT01216202|365674356|FG000|Overall Study|Death|0|||
106003637|NCT01216202|365674357|FG001|Overall Study|Death|2|||
106003638|NCT01216202|365674356|FG000|Overall Study|Lost to Follow-up|14|||
106003639|NCT01216202|365674357|FG001|Overall Study|Lost to Follow-up|0|||
106003640|NCT00660192|365674362|FG000|Overall Study|Lost to Follow-up|2|||
106003641|NCT00660192|365674363|FG001|Overall Study|Lost to Follow-up|3|||
106003642|NCT00982735|365674364|FG000|Overall Study|Lost to Follow-up|6|||
106003643|NCT00982735|365674364|FG000|Overall Study|Patient ineligible for trial|224|||
106003644|NCT00539981|365674369|FG000|Overall Study|Adverse events (AE)|3|||
106003645|NCT00539981|365674370|FG001|Overall Study|Adverse events (AE)|3|||
106003646|NCT00539981|365674369|FG000|Overall Study|Lost to Follow-up|260|||
106003647|NCT00539981|365674370|FG001|Overall Study|Lost to Follow-up|251|||
106003648|NCT00539981|365674369|FG000|Overall Study|Withdrew consent|22|||
106003649|NCT00539981|365674370|FG001|Overall Study|Withdrew consent|14|||
106003650|NCT00539981|365674369|FG000|Overall Study|Death|1|||
106003651|NCT00539981|365674370|FG001|Overall Study|Death|1|||
106003652|NCT00539981|365674369|FG000|Overall Study|Other reason-unspecified|9|||
106003653|NCT00539981|365674370|FG001|Overall Study|Other reason-unspecified|13|||
106003654|NCT02675907|365674371|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
106003655|NCT02675907|365674372|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
106003656|NCT02675907|365674371|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
106003657|NCT02675907|365674372|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
106003658|NCT02675907|365674371|FG000|Study Overall|Lack of Efficacy|1|||
106003659|NCT02675907|365674372|FG001|Study Overall|Lack of Efficacy|0|||
106003660|NCT02675907|365674371|FG000|Study Overall|Withdrawal by Subject|2|||
106003661|NCT02675907|365674372|FG001|Study Overall|Withdrawal by Subject|2|||
106003662|NCT02675907|365674371|FG000|Study Overall|Lost to Follow-up|0|||
106003663|NCT02675907|365674372|FG001|Study Overall|Lost to Follow-up|2|||
106003664|NCT03416868|365674375|FG000|Overall Study|Withdrawal by Subject|2|||
106003665|NCT03416868|365674375|FG000|Overall Study|Lost to Follow-up|1|||
106003666|NCT02898454|365674378|FG000|Overall Study|Adverse Event|4|||
106003667|NCT02898454|365674379|FG001|Overall Study|Adverse Event|1|||
106003668|NCT02898454|365674380|FG002|Overall Study|Adverse Event|2|||
106003669|NCT02898454|365674378|FG000|Overall Study|Protocol Violation|1|||
106003670|NCT02898454|365674379|FG001|Overall Study|Protocol Violation|0|||
106003671|NCT02898454|365674380|FG002|Overall Study|Protocol Violation|1|||
106003672|NCT02898454|365674378|FG000|Overall Study|Lack of Efficacy|4|||
106003673|NCT02898454|365674379|FG001|Overall Study|Lack of Efficacy|1|||
106003674|NCT02898454|365674380|FG002|Overall Study|Lack of Efficacy|0|||
106003675|NCT02898454|365674378|FG000|Overall Study|Withdrawal by Subject|6|||
106003676|NCT02898454|365674379|FG001|Overall Study|Withdrawal by Subject|3|||
106003677|NCT02898454|365674380|FG002|Overall Study|Withdrawal by Subject|3|||
106003678|NCT02898454|365674378|FG000|Overall Study|Lost to Follow-up|1|||
106003679|NCT02898454|365674379|FG001|Overall Study|Lost to Follow-up|0|||
106003680|NCT02898454|365674380|FG002|Overall Study|Lost to Follow-up|0|||
106003681|NCT02898454|365674378|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
106003682|NCT02898454|365674379|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
106003683|NCT02898454|365674380|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
106003684|NCT02782949|365674388|FG000|Overall Study|Protocol Violation|1|||
106003685|NCT02782949|365674389|FG001|Overall Study|Protocol Violation|0|||
106003686|NCT02782949|365674388|FG000|Overall Study|Withdrawal by Subject|0|||
106003687|NCT02782949|365674389|FG001|Overall Study|Withdrawal by Subject|1|||
106003688|NCT02741128|365676443|FG000|Overall Study|Protocol Violation|4|||
106003689|NCT02741128|365676444|FG001|Overall Study|Protocol Violation|1|||
106003690|NCT02741128|365676443|FG000|Overall Study|Withdrawal by Subject|2|||
106003691|NCT02741128|365676444|FG001|Overall Study|Withdrawal by Subject|0|||
106003692|NCT02741128|365676443|FG000|Overall Study|Lost to Follow-up|1|||
106003693|NCT02741128|365676444|FG001|Overall Study|Lost to Follow-up|0|||
106003694|NCT01519323|365676445|FG000|Overall Study|Death|3|||
106003695|NCT01519323|365676446|FG001|Overall Study|Death|2|||
106003696|NCT01519323|365676445|FG000|Overall Study|Study terminated by sponsor|0|||
106003697|NCT01519323|365676446|FG001|Overall Study|Study terminated by sponsor|1|||
106003698|NCT00966654|365676454|FG000|Overall Study|Study was terminated,PI left institution|12|||
105787062|NCT03110107|364874894|FG005|Treatment Period|Disease Progression|4|||
106003699|NCT04416204|365676455|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
106003700|NCT04416204|365676456|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
106003701|NCT04416204|365676457|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
106003702|NCT04416204|365676458|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
106003703|NCT03858049|365676459|FG000|Overall Study|Adverse Event|16|||
106003704|NCT03858049|365676460|FG001|Overall Study|Adverse Event|9|||
106003705|NCT03858049|365676459|FG000|Overall Study|Other|1|||
106003706|NCT03858049|365676460|FG001|Overall Study|Other|1|||
106003707|NCT00762359|365676463|FG000|Overall Study|Adverse Event|20|||
106003708|NCT00762359|365676464|FG001|Overall Study|Adverse Event|23|||
106003709|NCT00762359|365676463|FG000|Overall Study|Protocol Violation|21|||
106003710|NCT00762359|365676464|FG001|Overall Study|Protocol Violation|13|||
106003711|NCT00762359|365676463|FG000|Overall Study|Withdrawal by Subject|13|||
106003712|NCT00762359|365676464|FG001|Overall Study|Withdrawal by Subject|10|||
105920387|NCT00750269|365369235|FG000|Overall Study|SBRT plan could not be drawn|0|||
105920388|NCT00750269|365369236|FG001|Overall Study|SBRT plan could not be drawn|0|||
105920389|NCT00750269|365369237|FG002|Overall Study|SBRT plan could not be drawn|0|||
105920390|NCT00750269|365369238|FG003|Overall Study|SBRT plan could not be drawn|0|||
105920391|NCT00750269|365369239|FG004|Overall Study|SBRT plan could not be drawn|1|||
105920392|NCT00750269|365369235|FG000|Overall Study|Fiducials could not be placed|0|||
105920393|NCT00750269|365369236|FG001|Overall Study|Fiducials could not be placed|0|||
105920394|NCT00750269|365369237|FG002|Overall Study|Fiducials could not be placed|0|||
105920395|NCT00750269|365369238|FG003|Overall Study|Fiducials could not be placed|0|||
105920396|NCT00750269|365369239|FG004|Overall Study|Fiducials could not be placed|1|||
105920397|NCT02934178|365369240|FG000|Received Vaccination 2|Death|0|||
105920398|NCT02934178|365369241|FG001|Received Vaccination 2|Death|1|||
105920399|NCT02934178|365369240|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
105920400|NCT02934178|365369241|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
105920401|NCT00870727|365369243|FG000|Overall Study|Lost to Follow-up|0|||
105920402|NCT00870727|365369244|FG001|Overall Study|Lost to Follow-up|1|||
105920403|NCT00870727|365369243|FG000|Overall Study|Lack of Efficacy|1|||
105920404|NCT00870727|365369244|FG001|Overall Study|Lack of Efficacy|3|||
105920405|NCT00870727|365369243|FG000|Overall Study|Adverse Event|0|||
105920406|NCT00870727|365369244|FG001|Overall Study|Adverse Event|1|||
105920407|NCT00408499|365369251|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
105920408|NCT00408499|365369252|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
105920409|NCT00408499|365369253|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
105920410|NCT00408499|365369254|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
105920411|NCT00408499|365369255|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
105920412|NCT00408499|365369251|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
105920413|NCT00408499|365369252|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
105920414|NCT00408499|365369253|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
105920415|NCT00408499|365369254|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
105920416|NCT00408499|365369255|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
105920417|NCT00408499|365369251|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
105920418|NCT00408499|365369252|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
105920419|NCT00408499|365369253|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
105920420|NCT00408499|365369254|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
105920421|NCT00408499|365369255|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
105920422|NCT00408499|365369251|FG000|Phase II- MTD Expansion|Adverse Event|0|||
105920423|NCT00408499|365369252|FG001|Phase II- MTD Expansion|Adverse Event|0|||
105920424|NCT00408499|365369253|FG002|Phase II- MTD Expansion|Adverse Event|0|||
105920425|NCT00408499|365369254|FG003|Phase II- MTD Expansion|Adverse Event|0|||
105920426|NCT00408499|365369255|FG004|Phase II- MTD Expansion|Adverse Event|9|||
105920427|NCT00408499|365369251|FG000|Phase II- MTD Expansion|Death|0|||
105920428|NCT00408499|365369252|FG001|Phase II- MTD Expansion|Death|0|||
105920429|NCT00408499|365369253|FG002|Phase II- MTD Expansion|Death|0|||
105920430|NCT00408499|365369254|FG003|Phase II- MTD Expansion|Death|0|||
105920431|NCT00408499|365369255|FG004|Phase II- MTD Expansion|Death|2|||
105920432|NCT00408499|365369251|FG000|Phase II- MTD Expansion|Physician Decision|0|||
105920433|NCT00408499|365369252|FG001|Phase II- MTD Expansion|Physician Decision|0|||
105920434|NCT00408499|365369253|FG002|Phase II- MTD Expansion|Physician Decision|0|||
105920435|NCT00408499|365369254|FG003|Phase II- MTD Expansion|Physician Decision|0|||
105920436|NCT00408499|365369255|FG004|Phase II- MTD Expansion|Physician Decision|1|||
105920437|NCT00408499|365369251|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
105920438|NCT00408499|365369252|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
105920439|NCT00408499|365369253|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
105920440|NCT00408499|365369254|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
105920441|NCT00408499|365369255|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
105920442|NCT00408499|365369251|FG000|Phase II- MTD Expansion|treatment delay|0|||
105920443|NCT00408499|365369252|FG001|Phase II- MTD Expansion|treatment delay|0|||
105920444|NCT00408499|365369253|FG002|Phase II- MTD Expansion|treatment delay|0|||
105920445|NCT00408499|365369254|FG003|Phase II- MTD Expansion|treatment delay|0|||
105920446|NCT00408499|365369255|FG004|Phase II- MTD Expansion|treatment delay|3|||
105920447|NCT00296244|365369257|FG000|Overall Study|Underwent retransplant|0|||
105920448|NCT00296244|365369258|FG001|Overall Study|Underwent retransplant|1|||
105920449|NCT00903968|365369259|FG000|Overall Study|Adverse Event|0|||
105920450|NCT00903968|365369260|FG001|Overall Study|Adverse Event|0|||
105920451|NCT00903968|365369261|FG002|Overall Study|Adverse Event|0|||
105920452|NCT00903968|365369262|FG003|Overall Study|Adverse Event|0|||
105920453|NCT00903968|365369263|FG004|Overall Study|Adverse Event|0|||
105920454|NCT00903968|365369264|FG005|Overall Study|Adverse Event|0|||
105920455|NCT00903968|365369265|FG006|Overall Study|Adverse Event|1|||
105920456|NCT00903968|365369266|FG007|Overall Study|Adverse Event|8|||
105920457|NCT00903968|365369259|FG000|Overall Study|DLT|0|||
105920458|NCT00903968|365369260|FG001|Overall Study|DLT|0|||
105920459|NCT00903968|365369261|FG002|Overall Study|DLT|0|||
106131555|NCT00688688|366139559|FG000|Overall Study|Withdrawal by Subject|66|||
106003713|NCT00762359|365676463|FG000|Overall Study|Lack of Efficacy|0|||
106003714|NCT00762359|365676464|FG001|Overall Study|Lack of Efficacy|4|||
106003715|NCT00762359|365676463|FG000|Overall Study|Institution closed|2|||
106003716|NCT00762359|365676464|FG001|Overall Study|Institution closed|3|||
106003717|NCT00762359|365676463|FG000|Overall Study|Physician Decision|2|||
106003718|NCT00762359|365676464|FG001|Overall Study|Physician Decision|3|||
106003719|NCT00762359|365676463|FG000|Overall Study|Removal|0|||
106003720|NCT00762359|365676464|FG001|Overall Study|Removal|1|||
106003721|NCT00762359|365676463|FG000|Overall Study|Withdrew consent|1|||
106003722|NCT00762359|365676464|FG001|Overall Study|Withdrew consent|0|||
106003723|NCT02869633|365676465|FG000|Overall Study|Death|2|||
106003724|NCT02869633|365676466|FG001|Overall Study|Death|1|||
106003725|NCT02869633|365676465|FG000|Overall Study|Patient refused follow-up|1|||
106003726|NCT02869633|365676466|FG001|Overall Study|Patient refused follow-up|0|||
106003727|NCT02869633|365676465|FG000|Overall Study|Provider discretion|1|||
106003728|NCT02869633|365676466|FG001|Overall Study|Provider discretion|0|||
106003729|NCT02869633|365676465|FG000|Overall Study|Investigator decision|1|||
106003730|NCT02869633|365676466|FG001|Overall Study|Investigator decision|0|||
106003731|NCT02869633|365676465|FG000|Overall Study|Lost to Follow-up|0|||
106003732|NCT02869633|365676466|FG001|Overall Study|Lost to Follow-up|1|||
106003733|NCT02869633|365676465|FG000|Overall Study|Not eligible|6|||
106003734|NCT02869633|365676466|FG001|Overall Study|Not eligible|1|||
106003735|NCT02869633|365676465|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
106003736|NCT02869633|365676466|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
106003737|NCT02869633|365676465|FG000|Overall Study|Withdrawal by Subject|0|||
105693013|NCT04178967|364540596|FG005|Induction Period|Protocol Violation|0|||
105693014|NCT04178967|364540597|FG006|Induction Period|Protocol Violation|0|||
106003738|NCT02869633|365676466|FG001|Overall Study|Withdrawal by Subject|1|||
106003739|NCT03095651|365676469|FG000|Overall Study|Lost to Follow-up|1|||
106003740|NCT03095651|365676470|FG001|Overall Study|Lost to Follow-up|1|||
106003741|NCT03095651|365676471|FG002|Overall Study|Lost to Follow-up|0|||
106003742|NCT03095651|365676472|FG003|Overall Study|Lost to Follow-up|1|||
106003743|NCT03095651|365676473|FG004|Overall Study|Lost to Follow-up|0|||
106003744|NCT03095651|365676474|FG005|Overall Study|Lost to Follow-up|0|||
106003745|NCT03095651|365676475|FG006|Overall Study|Lost to Follow-up|0|||
106003746|NCT03095651|365676476|FG007|Overall Study|Lost to Follow-up|0|||
106003747|NCT03095651|365676469|FG000|Overall Study|Withdrawal by Subject|0|||
106003748|NCT03095651|365676470|FG001|Overall Study|Withdrawal by Subject|0|||
106003749|NCT03095651|365676471|FG002|Overall Study|Withdrawal by Subject|0|||
106003750|NCT03095651|365676472|FG003|Overall Study|Withdrawal by Subject|0|||
106003751|NCT03095651|365676473|FG004|Overall Study|Withdrawal by Subject|0|||
106003752|NCT03095651|365676474|FG005|Overall Study|Withdrawal by Subject|1|||
106003753|NCT03095651|365676475|FG006|Overall Study|Withdrawal by Subject|0|||
106003754|NCT03095651|365676476|FG007|Overall Study|Withdrawal by Subject|0|||
106003755|NCT00453154|365676477|FG000|Double BIind Maintenance|Adverse Event|0|||
106003756|NCT00453154|365676478|FG001|Double BIind Maintenance|Adverse Event|0|||
106003757|NCT00453154|365676479|FG002|Double BIind Maintenance|Adverse Event|3|||
106003758|NCT00453154|365676480|FG003|Double BIind Maintenance|Adverse Event|12|||
106003759|NCT00453154|365676477|FG000|Double BIind Maintenance|Death|0|||
106003760|NCT00453154|365676478|FG001|Double BIind Maintenance|Death|0|||
106003761|NCT00453154|365676479|FG002|Double BIind Maintenance|Death|2|||
106003762|NCT00453154|365676480|FG003|Double BIind Maintenance|Death|1|||
106003763|NCT00453154|365676477|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
106003764|NCT00453154|365676478|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
106003765|NCT00453154|365676479|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
106003766|NCT00453154|365676480|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
106003767|NCT00453154|365676477|FG000|Double BIind Maintenance|Progression|0|||
106003768|NCT00453154|365676478|FG001|Double BIind Maintenance|Progression|0|||
106003769|NCT00453154|365676479|FG002|Double BIind Maintenance|Progression|29|||
106131556|NCT00688688|366139560|FG001|Overall Study|Withdrawal by Subject|75|||
105693015|NCT04178967|364540598|FG007|Induction Period|Protocol Violation|0|||
106003770|NCT00453154|365676480|FG003|Double BIind Maintenance|Progression|26|||
105693016|NCT04178967|364540599|FG008|Induction Period|Protocol Violation|0|||
106003771|NCT00453154|365676477|FG000|Double BIind Maintenance|Medical Issues|0|||
106003772|NCT00453154|365676478|FG001|Double BIind Maintenance|Medical Issues|0|||
105693017|NCT04178967|364540600|FG009|Induction Period|Protocol Violation|0|||
105693018|NCT04178967|364540601|FG010|Induction Period|Protocol Violation|0|||
105693019|NCT04178967|364540591|FG000|Induction Period|Withdrawal by Subject|6|||
106003773|NCT00453154|365676479|FG002|Double BIind Maintenance|Medical Issues|3|||
106003774|NCT00453154|365676480|FG003|Double BIind Maintenance|Medical Issues|1|||
106003775|NCT00453154|365676477|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
106003776|NCT00453154|365676478|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
106131557|NCT00688688|366139561|FG002|Overall Study|Withdrawal by Subject|65|||
106003777|NCT00453154|365676479|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
106003778|NCT00453154|365676480|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
106131558|NCT00688688|366139559|FG000|Overall Study|Lost to Follow-up|14|||
106131559|NCT00688688|366139560|FG001|Overall Study|Lost to Follow-up|7|||
106131560|NCT00688688|366139561|FG002|Overall Study|Lost to Follow-up|7|||
106131561|NCT00688688|366139559|FG000|Overall Study|Protocol Violation|6|||
106131562|NCT00688688|366139560|FG001|Overall Study|Protocol Violation|9|||
106131563|NCT00688688|366139561|FG002|Overall Study|Protocol Violation|11|||
106131564|NCT00688688|366139559|FG000|Overall Study|Randomized but never received study drug|1|||
106131565|NCT00688688|366139560|FG001|Overall Study|Randomized but never received study drug|0|||
106131566|NCT00688688|366139561|FG002|Overall Study|Randomized but never received study drug|0|||
106131567|NCT00688688|366139559|FG000|Overall Study|Non-compliance with study procedures|5|||
106131568|NCT00688688|366139560|FG001|Overall Study|Non-compliance with study procedures|3|||
106131569|NCT00688688|366139561|FG002|Overall Study|Non-compliance with study procedures|4|||
106131570|NCT00688688|366139559|FG000|Overall Study|Taking exclusionary medications|1|||
106131571|NCT00688688|366139560|FG001|Overall Study|Taking exclusionary medications|0|||
105693020|NCT04178967|364540592|FG001|Induction Period|Withdrawal by Subject|4|||
105693021|NCT04178967|364540593|FG002|Induction Period|Withdrawal by Subject|0|||
106131572|NCT00688688|366139561|FG002|Overall Study|Taking exclusionary medications|0|||
106131573|NCT00688688|366139559|FG000|Overall Study|Site closure|0|||
106131574|NCT00688688|366139560|FG001|Overall Study|Site closure|1|||
106131575|NCT00688688|366139561|FG002|Overall Study|Site closure|0|||
106131576|NCT00688688|366139559|FG000|Overall Study|Violation of exclusion criterion|0|||
106131577|NCT00688688|366139560|FG001|Overall Study|Violation of exclusion criterion|1|||
106131578|NCT00688688|366139561|FG002|Overall Study|Violation of exclusion criterion|0|||
106131579|NCT03283553|366139562|FG000|Patient Participant Flow|Death|5|||
106131580|NCT03283553|366139563|FG001|Patient Participant Flow|Death|10|||
105693022|NCT04178967|364540594|FG003|Induction Period|Withdrawal by Subject|0|||
105693023|NCT04178967|364540595|FG004|Induction Period|Withdrawal by Subject|0|||
105693024|NCT04178967|364540596|FG005|Induction Period|Withdrawal by Subject|0|||
105693025|NCT04178967|364540597|FG006|Induction Period|Withdrawal by Subject|0|||
105693026|NCT04178967|364540598|FG007|Induction Period|Withdrawal by Subject|0|||
105693027|NCT04178967|364540599|FG008|Induction Period|Withdrawal by Subject|0|||
105693028|NCT04178967|364540600|FG009|Induction Period|Withdrawal by Subject|0|||
105693029|NCT04178967|364540601|FG010|Induction Period|Withdrawal by Subject|0|||
105693030|NCT04178967|364540591|FG000|Induction Period|Lost to Follow-up|2|||
105693031|NCT04178967|364540592|FG001|Induction Period|Lost to Follow-up|0|||
105693032|NCT04178967|364540593|FG002|Induction Period|Lost to Follow-up|0|||
105693033|NCT04178967|364540594|FG003|Induction Period|Lost to Follow-up|0|||
105693034|NCT04178967|364540595|FG004|Induction Period|Lost to Follow-up|0|||
105693035|NCT04178967|364540596|FG005|Induction Period|Lost to Follow-up|0|||
105693036|NCT04178967|364540597|FG006|Induction Period|Lost to Follow-up|0|||
105693037|NCT04178967|364540598|FG007|Induction Period|Lost to Follow-up|0|||
105693038|NCT04178967|364540599|FG008|Induction Period|Lost to Follow-up|0|||
105693039|NCT04178967|364540600|FG009|Induction Period|Lost to Follow-up|0|||
105693040|NCT04178967|364540601|FG010|Induction Period|Lost to Follow-up|0|||
105693041|NCT04178967|364540591|FG000|Induction Period|Participant Missed Study Visits|0|||
105693042|NCT04178967|364540592|FG001|Induction Period|Participant Missed Study Visits|1|||
105693043|NCT04178967|364540593|FG002|Induction Period|Participant Missed Study Visits|0|||
105693044|NCT04178967|364540594|FG003|Induction Period|Participant Missed Study Visits|0|||
105693045|NCT04178967|364540595|FG004|Induction Period|Participant Missed Study Visits|0|||
105693046|NCT04178967|364540596|FG005|Induction Period|Participant Missed Study Visits|0|||
105693047|NCT04178967|364540597|FG006|Induction Period|Participant Missed Study Visits|0|||
105693048|NCT04178967|364540598|FG007|Induction Period|Participant Missed Study Visits|0|||
105693049|NCT04178967|364540599|FG008|Induction Period|Participant Missed Study Visits|0|||
105693050|NCT04178967|364540600|FG009|Induction Period|Participant Missed Study Visits|0|||
105693051|NCT04178967|364540601|FG010|Induction Period|Participant Missed Study Visits|0|||
105693052|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693053|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693054|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693055|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693056|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693057|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
106131581|NCT03283553|366139562|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
105693058|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
105693059|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
105693060|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693061|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693062|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
105693063|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693064|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
106131582|NCT03283553|366139563|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
106131583|NCT03283553|366139562|FG000|Patient Participant Flow|Lost to Follow-up|1|||
106131584|NCT03283553|366139563|FG001|Patient Participant Flow|Lost to Follow-up|1|||
105693065|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693066|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693067|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693068|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
105693069|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693070|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693071|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693072|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105693073|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
106003779|NCT01381016|365676482|FG000|Overall Study|Lost to Follow-up|1|||
106003780|NCT01381016|365676483|FG001|Overall Study|Lost to Follow-up|1|||
106003781|NCT01381016|365676482|FG000|Overall Study|Screen Failure|2|||
106003782|NCT01381016|365676483|FG001|Overall Study|Screen Failure|2|||
106003783|NCT01381016|365676482|FG000|Overall Study|Withdrawal by Subject|0|||
106003784|NCT01381016|365676483|FG001|Overall Study|Withdrawal by Subject|1|||
106003785|NCT01381016|365676482|FG000|Overall Study|Physician Decision|0|||
106003786|NCT01381016|365676483|FG001|Overall Study|Physician Decision|2|||
106003787|NCT01693029|365676484|FG000|Overall Study|Withdrawal by Subject|15|||
106003788|NCT01693029|365676485|FG001|Overall Study|Withdrawal by Subject|22|||
106003789|NCT01693029|365676484|FG000|Overall Study|Kidney transplantation|7|||
106003790|NCT01693029|365676485|FG001|Overall Study|Kidney transplantation|7|||
106003791|NCT01693029|365676484|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
106003792|NCT01693029|365676485|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
106003793|NCT01693029|365676484|FG000|Overall Study|Protocol Violation|6|||
106003794|NCT01693029|365676485|FG001|Overall Study|Protocol Violation|7|||
106003795|NCT01693029|365676484|FG000|Overall Study|Change in dialysis modality|2|||
106003796|NCT01693029|365676485|FG001|Overall Study|Change in dialysis modality|1|||
106003797|NCT01693029|365676484|FG000|Overall Study|Physician Decision|0|||
106003798|NCT01693029|365676485|FG001|Overall Study|Physician Decision|2|||
106003799|NCT01693029|365676484|FG000|Overall Study|Lost to Follow-up|0|||
106003800|NCT01693029|365676485|FG001|Overall Study|Lost to Follow-up|1|||
106003801|NCT01693029|365676484|FG000|Overall Study|Adverse Event|1|||
106003802|NCT01693029|365676485|FG001|Overall Study|Adverse Event|6|||
106003803|NCT01693029|365676484|FG000|Overall Study|Death|5|||
106003804|NCT01693029|365676485|FG001|Overall Study|Death|8|||
106003805|NCT01693029|365676484|FG000|Overall Study|Non-compliance|2|||
106003806|NCT01693029|365676485|FG001|Overall Study|Non-compliance|1|||
106003807|NCT05801991|365676486|FG000|Overall Study|Lost to Follow-up|1|||
106003808|NCT05801991|365676487|FG001|Overall Study|Lost to Follow-up|0|||
106003809|NCT06308822|365676488|FG000|Overall Study|Mutation Status Not Confirmed|17|||
106003810|NCT06308822|365676488|FG000|Overall Study|Adverse Event|1|||
106003811|NCT06308822|365676488|FG000|Overall Study|Death|5|||
106003812|NCT06308822|365676488|FG000|Overall Study|Disease progression|8|||
106003813|NCT06308822|365676488|FG000|Overall Study|Withdrawal by Subject|1|||
106003814|NCT06308822|365676488|FG000|Overall Study|Physician Decision|3|||
106003815|NCT00962208|365676492|FG000|Overall Study|Could not achieve good vision|9|||
106003816|NCT00962208|365676493|FG001|Overall Study|Could not achieve good vision|0|||
106003817|NCT00962208|365676492|FG000|Overall Study|Contraindicated to continue study|5|||
106003818|NCT00962208|365676493|FG001|Overall Study|Contraindicated to continue study|1|||
106003819|NCT00962208|365676492|FG000|Overall Study|Lost to Follow-up|0|||
106003820|NCT00962208|365676493|FG001|Overall Study|Lost to Follow-up|9|||
106003821|NCT03924622|365676494|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
106003822|NCT03924622|365676495|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
106131585|NCT03283553|366139562|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
105693074|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105787063|NCT03110107|364874895|FG006|Treatment Period|Disease Progression|6|||
105787064|NCT03110107|364874896|FG007|Treatment Period|Disease Progression|7|||
105787065|NCT03110107|364874897|FG008|Treatment Period|Disease Progression|2|||
105787066|NCT03110107|364874898|FG009|Treatment Period|Disease Progression|10|||
106003823|NCT03924622|365676496|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
106131586|NCT03283553|366139563|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
106131587|NCT03283553|366139562|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
106131588|NCT03283553|366139563|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
106131589|NCT03283553|366139562|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
105693075|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693076|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105787067|NCT03110107|364874899|FG010|Treatment Period|Disease Progression|5|||
105787068|NCT03110107|364874900|FG011|Treatment Period|Disease Progression|2|||
106003824|NCT03924622|365676497|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
106003825|NCT03924622|365676498|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
106016888|NCT03847896|365725907|FG002|Overall Study|Withdrawal by parent/guardian|1|||
106131590|NCT03283553|366139563|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
106131591|NCT01004263|366139575|FG000|Overall Study|Adverse Event|15|||
106131592|NCT01004263|366139575|FG000|Overall Study|Withdrawal by Subject|58|||
106131593|NCT01004263|366139575|FG000|Overall Study|Protocol Violation|10|||
106131594|NCT01004263|366139575|FG000|Overall Study|Lost to Follow-up|64|||
106131595|NCT01004263|366139575|FG000|Overall Study|Lack of Efficacy|13|||
106131596|NCT01004263|366139575|FG000|Overall Study|Pregnancy|2|||
106131597|NCT01004263|366139575|FG000|Overall Study|Physician Decision|15|||
106131598|NCT01004263|366139575|FG000|Overall Study|Lack of Qualifying Event|2|||
106131599|NCT02478359|366139576|FG000|Overall Study|Disenrolled from health plan|106|||
106131600|NCT02478359|366139577|FG001|Overall Study|Disenrolled from health plan|65|||
106131601|NCT01719861|366139578|FG000|Cycle 1|Death|4|||
106131602|NCT01719861|366139578|FG000|Cycle 2|Death|1|||
106131603|NCT01606189|366139579|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
106131604|NCT01606189|366139580|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
106131605|NCT01606189|366139581|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
106131606|NCT01606189|366139582|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
106131607|NCT01606189|366139583|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
106131608|NCT01606189|366139584|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
106131609|NCT01606189|366139579|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
106131610|NCT01606189|366139580|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
106131611|NCT01606189|366139581|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
106131612|NCT01606189|366139582|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
106131613|NCT01606189|366139583|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
106131614|NCT01606189|366139584|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
106131615|NCT01605136|366139585|FG000|Study Period|Withdrawal by Subject|2|||
106131616|NCT01605136|366139586|FG001|Study Period|Withdrawal by Subject|0|||
106131617|NCT01605136|366139585|FG000|Study Period|Physician Decision|1|||
106131618|NCT01605136|366139586|FG001|Study Period|Physician Decision|1|||
106131619|NCT01605136|366139585|FG000|Study Period|Lost to Follow-up|0|||
106131620|NCT01605136|366139586|FG001|Study Period|Lost to Follow-up|2|||
106131621|NCT01605136|366139585|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
106131622|NCT01605136|366139586|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
106131623|NCT02929108|366139589|FG000|Overall Study|Hospice patient death|100|||
106131624|NCT02929108|366139590|FG001|Overall Study|Hospice patient death|64|||
106131625|NCT02929108|366139591|FG002|Overall Study|Hospice patient death|28|||
106131626|NCT02929108|366139592|FG003|Overall Study|Hospice patient death|46|||
106131627|NCT02929108|366139593|FG004|Overall Study|Hospice patient death|55|||
106131628|NCT02929108|366139594|FG005|Overall Study|Hospice patient death|28|||
106131629|NCT02929108|366139595|FG006|Overall Study|Hospice patient death|78|||
106131630|NCT01414166|366139596|FG000|Overall Study|Adverse Event|10|||
106131631|NCT01414166|366139597|FG001|Overall Study|Adverse Event|2|||
106131632|NCT01414166|366139596|FG000|Overall Study|Lost to Follow-up|4|||
106131633|NCT01414166|366139597|FG001|Overall Study|Lost to Follow-up|1|||
106131634|NCT01414166|366139596|FG000|Overall Study|Non-compliance with study drug|2|||
106131635|NCT01414166|366139597|FG001|Overall Study|Non-compliance with study drug|0|||
106131636|NCT01414166|366139596|FG000|Overall Study|Physician Decision|2|||
106131637|NCT01414166|366139597|FG001|Overall Study|Physician Decision|0|||
106131638|NCT01414166|366139596|FG000|Overall Study|Protocol Violation|2|||
106131639|NCT01414166|366139597|FG001|Overall Study|Protocol Violation|0|||
106131640|NCT01414166|366139596|FG000|Overall Study|Study terminated by Sponsor|68|||
106131641|NCT01414166|366139597|FG001|Overall Study|Study terminated by Sponsor|75|||
106131642|NCT01414166|366139596|FG000|Overall Study|Withdrawal by Subject|3|||
106131643|NCT01414166|366139597|FG001|Overall Study|Withdrawal by Subject|5|||
106131644|NCT02084082|366139600|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
106131645|NCT02084082|366139601|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
106131646|NCT02084082|366139602|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
106131647|NCT02084082|366139603|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
106131648|NCT02084082|366139600|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
106131649|NCT02084082|366139601|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
106131650|NCT02084082|366139602|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
106131651|NCT02084082|366139603|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
105693077|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
105693078|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693079|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
106131652|NCT04319094|366139609|FG000|Baseline|Lost to Follow-up|4|||
106131653|NCT04319094|366139610|FG001|Baseline|Lost to Follow-up|5|||
106131654|NCT04319094|366139609|FG000|Baseline|Protocol Violation|0|||
106131655|NCT04319094|366139610|FG001|Baseline|Protocol Violation|3|||
106131656|NCT04319094|366139609|FG000|Baseline|Withdrawal by Subject|2|||
106131657|NCT04319094|366139610|FG001|Baseline|Withdrawal by Subject|1|||
106131658|NCT04319094|366139609|FG000|Post-Intervention|Death|0|||
106131659|NCT04319094|366139610|FG001|Post-Intervention|Death|1|||
106131660|NCT04319094|366139609|FG000|Post-Intervention|Lost to Follow-up|4|||
106131661|NCT04319094|366139610|FG001|Post-Intervention|Lost to Follow-up|4|||
106131662|NCT04319094|366139609|FG000|Post-Intervention|Withdrawal by Subject|8|||
105693080|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693081|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693082|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693083|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105693084|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105920460|NCT00903968|365369262|FG003|Overall Study|DLT|0|||
105920461|NCT00903968|365369263|FG004|Overall Study|DLT|0|||
105920462|NCT00903968|365369264|FG005|Overall Study|DLT|0|||
105920463|NCT00903968|365369265|FG006|Overall Study|DLT|2|||
105920464|NCT00903968|365369266|FG007|Overall Study|DLT|0|||
105920465|NCT00903968|365369259|FG000|Overall Study|Withdrawal by Subject|1|||
105920466|NCT00903968|365369260|FG001|Overall Study|Withdrawal by Subject|0|||
105920467|NCT00903968|365369261|FG002|Overall Study|Withdrawal by Subject|1|||
105920468|NCT00903968|365369262|FG003|Overall Study|Withdrawal by Subject|0|||
105920469|NCT00903968|365369263|FG004|Overall Study|Withdrawal by Subject|1|||
105920470|NCT00903968|365369264|FG005|Overall Study|Withdrawal by Subject|1|||
105920471|NCT00903968|365369265|FG006|Overall Study|Withdrawal by Subject|0|||
105920472|NCT00903968|365369266|FG007|Overall Study|Withdrawal by Subject|4|||
105920473|NCT00903968|365369259|FG000|Overall Study|Non-Compliance|0|||
105920474|NCT00903968|365369260|FG001|Overall Study|Non-Compliance|0|||
105920475|NCT00903968|365369261|FG002|Overall Study|Non-Compliance|0|||
105920476|NCT00903968|365369262|FG003|Overall Study|Non-Compliance|0|||
105920477|NCT00903968|365369263|FG004|Overall Study|Non-Compliance|0|||
105920478|NCT00903968|365369264|FG005|Overall Study|Non-Compliance|1|||
105920479|NCT00903968|365369265|FG006|Overall Study|Non-Compliance|0|||
105920480|NCT00903968|365369266|FG007|Overall Study|Non-Compliance|0|||
105920481|NCT00903968|365369259|FG000|Overall Study|Physician Decision|0|||
105920482|NCT00903968|365369260|FG001|Overall Study|Physician Decision|0|||
105920483|NCT00903968|365369261|FG002|Overall Study|Physician Decision|0|||
105920484|NCT00903968|365369262|FG003|Overall Study|Physician Decision|0|||
105920485|NCT00903968|365369263|FG004|Overall Study|Physician Decision|0|||
105920486|NCT00903968|365369264|FG005|Overall Study|Physician Decision|1|||
105920487|NCT00903968|365369265|FG006|Overall Study|Physician Decision|0|||
105920488|NCT00903968|365369266|FG007|Overall Study|Physician Decision|0|||
105920489|NCT00903968|365369259|FG000|Overall Study|Progressive Disease|2|||
105920490|NCT00903968|365369260|FG001|Overall Study|Progressive Disease|3|||
105920491|NCT00903968|365369261|FG002|Overall Study|Progressive Disease|2|||
105920492|NCT00903968|365369262|FG003|Overall Study|Progressive Disease|3|||
105920493|NCT00903968|365369263|FG004|Overall Study|Progressive Disease|3|||
105920494|NCT00903968|365369264|FG005|Overall Study|Progressive Disease|3|||
105920495|NCT00903968|365369265|FG006|Overall Study|Progressive Disease|0|||
105920496|NCT00903968|365369266|FG007|Overall Study|Progressive Disease|18|||
105920497|NCT00903968|365369259|FG000|Overall Study|Lack of Efficacy|0|||
105920498|NCT00903968|365369260|FG001|Overall Study|Lack of Efficacy|0|||
105920499|NCT00903968|365369261|FG002|Overall Study|Lack of Efficacy|0|||
105920500|NCT00903968|365369262|FG003|Overall Study|Lack of Efficacy|0|||
105920501|NCT00903968|365369263|FG004|Overall Study|Lack of Efficacy|0|||
105920502|NCT00903968|365369264|FG005|Overall Study|Lack of Efficacy|0|||
105920503|NCT00903968|365369265|FG006|Overall Study|Lack of Efficacy|0|||
105920504|NCT00903968|365369266|FG007|Overall Study|Lack of Efficacy|3|||
105920505|NCT01373164|365369267|FG000|Overall Study|Lost to Follow-up|0|||
105920506|NCT01373164|365369268|FG001|Overall Study|Lost to Follow-up|0|||
105920507|NCT01373164|365369269|FG002|Overall Study|Lost to Follow-up|1|||
105920508|NCT01373164|365369270|FG003|Overall Study|Lost to Follow-up|2|||
105920509|NCT01373164|365369271|FG004|Overall Study|Lost to Follow-up|0|||
105920510|NCT01373164|365369267|FG000|Overall Study|Withdrawal by Subject|0|||
105920511|NCT01373164|365369268|FG001|Overall Study|Withdrawal by Subject|1|||
105920512|NCT01373164|365369269|FG002|Overall Study|Withdrawal by Subject|0|||
105920513|NCT01373164|365369270|FG003|Overall Study|Withdrawal by Subject|10|||
105920514|NCT01373164|365369271|FG004|Overall Study|Withdrawal by Subject|2|||
105920515|NCT01799941|365369276|FG000|Overall Study|Adverse Event|34|||
105920516|NCT01799941|365369276|FG000|Overall Study|Withdrawal by Subject|21|||
105920517|NCT01799941|365369276|FG000|Overall Study|Death|2|||
105920518|NCT01799941|365369276|FG000|Overall Study|Investigator Decision|4|||
105920519|NCT01799941|365369276|FG000|Overall Study|Lack of Efficacy|3|||
105920520|NCT01799941|365369276|FG000|Overall Study|Lost to Follow-up|17|||
105920521|NCT01799941|365369276|FG000|Overall Study|Other|15|||
105920522|NCT00420745|365369283|FG000|Overall Study|Adverse Event|2|||
105920523|NCT00420745|365369284|FG001|Overall Study|Adverse Event|2|||
105920524|NCT00420745|365369283|FG000|Overall Study|Lost to Follow-up|10|||
105920525|NCT00420745|365369284|FG001|Overall Study|Lost to Follow-up|2|||
106003826|NCT03924622|365676499|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
105920526|NCT00420745|365369283|FG000|Overall Study|Protocol Violation|1|||
105920527|NCT00420745|365369284|FG001|Overall Study|Protocol Violation|0|||
105920528|NCT00420745|365369283|FG000|Overall Study|Physician Decision|1|||
105920529|NCT00420745|365369284|FG001|Overall Study|Physician Decision|1|||
105920530|NCT00420745|365369283|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
105920531|NCT00420745|365369284|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
105920532|NCT00420745|365369283|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
106003827|NCT02995980|365676500|FG000|Overall Study|Lost to Follow-up|14|||
106003828|NCT00866177|365676501|FG000|Overall Study|Withdrawal by Subject|1|||
106003829|NCT00866177|365676501|FG000|Overall Study|Not Treated|151|||
106003830|NCT01706458|365676504|FG000|Overall Study|Physician Decision|3|||
106003831|NCT01706458|365676505|FG001|Overall Study|Physician Decision|4|||
106003832|NCT03192176|365676506|FG000|Overall Study|Adverse Event|1|||
106003833|NCT03192176|365676507|FG001|Overall Study|Adverse Event|0|||
106003834|NCT03192176|365676508|FG002|Overall Study|Adverse Event|4|||
106003835|NCT03192176|365676509|FG003|Overall Study|Adverse Event|5|||
106003836|NCT03192176|365676510|FG004|Overall Study|Adverse Event|3|||
106003837|NCT03192176|365676511|FG005|Overall Study|Adverse Event|2|||
106003838|NCT03192176|365676512|FG006|Overall Study|Adverse Event|3|||
106003839|NCT03192176|365676513|FG007|Overall Study|Adverse Event|3|||
106003840|NCT03192176|365676506|FG000|Overall Study|Lost to Follow-up|0|||
106003841|NCT03192176|365676507|FG001|Overall Study|Lost to Follow-up|0|||
106003842|NCT03192176|365676508|FG002|Overall Study|Lost to Follow-up|1|||
106003843|NCT03192176|365676509|FG003|Overall Study|Lost to Follow-up|2|||
106003844|NCT03192176|365676510|FG004|Overall Study|Lost to Follow-up|3|||
106003845|NCT03192176|365676511|FG005|Overall Study|Lost to Follow-up|1|||
106003846|NCT03192176|365676512|FG006|Overall Study|Lost to Follow-up|1|||
106003847|NCT03192176|365676513|FG007|Overall Study|Lost to Follow-up|1|||
106003848|NCT03192176|365676506|FG000|Overall Study|Physician Decision|1|||
106003849|NCT03192176|365676507|FG001|Overall Study|Physician Decision|0|||
106003850|NCT03192176|365676508|FG002|Overall Study|Physician Decision|0|||
106003851|NCT03192176|365676509|FG003|Overall Study|Physician Decision|0|||
106003852|NCT03192176|365676510|FG004|Overall Study|Physician Decision|0|||
106003853|NCT03192176|365676511|FG005|Overall Study|Physician Decision|2|||
106003854|NCT03192176|365676512|FG006|Overall Study|Physician Decision|1|||
106003855|NCT03192176|365676513|FG007|Overall Study|Physician Decision|0|||
106003856|NCT03192176|365676506|FG000|Overall Study|Protocol Deviation|1|||
106003857|NCT03192176|365676507|FG001|Overall Study|Protocol Deviation|1|||
106003858|NCT03192176|365676508|FG002|Overall Study|Protocol Deviation|0|||
106003859|NCT03192176|365676509|FG003|Overall Study|Protocol Deviation|0|||
106003860|NCT03192176|365676510|FG004|Overall Study|Protocol Deviation|2|||
106003861|NCT03192176|365676511|FG005|Overall Study|Protocol Deviation|0|||
106003862|NCT03192176|365676512|FG006|Overall Study|Protocol Deviation|0|||
106003863|NCT03192176|365676513|FG007|Overall Study|Protocol Deviation|0|||
106003864|NCT03192176|365676506|FG000|Overall Study|Withdrawal by Subject|3|||
106003865|NCT03192176|365676507|FG001|Overall Study|Withdrawal by Subject|4|||
106003866|NCT03192176|365676508|FG002|Overall Study|Withdrawal by Subject|0|||
106003867|NCT03192176|365676509|FG003|Overall Study|Withdrawal by Subject|4|||
106003868|NCT03192176|365676510|FG004|Overall Study|Withdrawal by Subject|3|||
106003869|NCT03192176|365676511|FG005|Overall Study|Withdrawal by Subject|4|||
106003870|NCT03192176|365676512|FG006|Overall Study|Withdrawal by Subject|4|||
106003871|NCT03192176|365676513|FG007|Overall Study|Withdrawal by Subject|2|||
106003872|NCT03192176|365676506|FG000|Overall Study|Miscellaneous|1|||
106003873|NCT03192176|365676507|FG001|Overall Study|Miscellaneous|0|||
106003874|NCT03192176|365676508|FG002|Overall Study|Miscellaneous|1|||
106003875|NCT03192176|365676509|FG003|Overall Study|Miscellaneous|1|||
106003876|NCT03192176|365676510|FG004|Overall Study|Miscellaneous|1|||
106003877|NCT03192176|365676511|FG005|Overall Study|Miscellaneous|2|||
106003878|NCT03192176|365676512|FG006|Overall Study|Miscellaneous|0|||
106003879|NCT03192176|365676513|FG007|Overall Study|Miscellaneous|1|||
106003880|NCT04349891|365676514|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
106003881|NCT04349891|365676515|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
106003882|NCT04349891|365676514|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
106003883|NCT04349891|365676515|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
106003884|NCT04349891|365676514|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
106003885|NCT04349891|365676515|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
105693085|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693086|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693087|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693088|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693089|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
106003886|NCT04349891|365676514|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
106003887|NCT04349891|365676515|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
106003888|NCT00718510|365676521|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
106003889|NCT00718510|365676522|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
106003890|NCT00718510|365676521|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
106003891|NCT00718510|365676522|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
106003892|NCT00286442|365676529|FG000|Overall Study|Hyperglycemic Rescue|19|||
105693090|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693091|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
106003893|NCT00286442|365676530|FG001|Overall Study|Hyperglycemic Rescue|17|||
106003894|NCT00286442|365676531|FG002|Overall Study|Hyperglycemic Rescue|25|||
106003895|NCT00286442|365676529|FG000|Overall Study|Adverse Event|7|||
105693092|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693093|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693094|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693095|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
105693096|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693097|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693098|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693099|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693100|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
105693101|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
105693102|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693103|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
105693104|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693105|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693106|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105693107|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693108|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693109|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
105693110|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
105920533|NCT00420745|365369284|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
105920534|NCT03408899|365369285|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
105920535|NCT01603602|365369293|FG000|Overall Study|Adverse Event|1|||
105920536|NCT01603602|365369294|FG001|Overall Study|Adverse Event|0|||
105920537|NCT01603602|365369295|FG002|Overall Study|Adverse Event|0|||
105920538|NCT01603602|365369293|FG000|Overall Study|Personal Reasons|1|||
105920539|NCT01603602|365369294|FG001|Overall Study|Personal Reasons|0|||
105920540|NCT01603602|365369295|FG002|Overall Study|Personal Reasons|1|||
105920541|NCT04748718|365369296|FG000|Overall Study|Lost to Follow-up|50|||
105920542|NCT03248037|365369298|FG000|Overall Study|Withdrawal by Subject|6|||
105920543|NCT03248037|365369299|FG001|Overall Study|Withdrawal by Subject|9|||
105920544|NCT03248037|365369298|FG000|Overall Study|Adverse Event|15|||
105920545|NCT03248037|365369299|FG001|Overall Study|Adverse Event|0|||
105920546|NCT02152007|365369307|FG000|Overall Study|Withdrawal by Subject|1|||
105920547|NCT03558516|365369308|FG000|Overall Study|Protocol Violation|2|||
105920548|NCT03558516|365369309|FG001|Overall Study|Protocol Violation|2|||
105920549|NCT02714153|365369311|FG000|Overall Study|Death|1|||
105920550|NCT00686972|365369312|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
105693111|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
105693112|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
105693113|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
105693114|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
105693115|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693116|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693117|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
105693118|NCT04178967|364540591|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693119|NCT04178967|364540592|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693120|NCT04178967|364540593|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693121|NCT04178967|364540594|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
105693122|NCT04178967|364540595|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693123|NCT04178967|364540596|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
105693124|NCT04178967|364540597|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
105693125|NCT04178967|364540598|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
105693126|NCT04178967|364540599|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693127|NCT04178967|364540600|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693128|NCT04178967|364540601|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105693129|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693130|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693131|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693132|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693133|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693134|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693135|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693136|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
105693137|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
105693138|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
105693139|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
105920551|NCT01901185|365369313|FG000|Overall Study|Withdrawal by Subject|2|||
105920552|NCT02065557|365369314|FG000|Induction Period|Withdrawal by Subject|2|||
105920553|NCT02065557|365369315|FG001|Induction Period|Withdrawal by Subject|1|||
106131663|NCT04319094|366139610|FG001|Post-Intervention|Withdrawal by Subject|5|||
106131664|NCT04319094|366139609|FG000|Post-Intervention|Incomplete Data Collection|1|||
106131665|NCT04319094|366139610|FG001|Post-Intervention|Incomplete Data Collection|3|||
106131666|NCT04319094|366139609|FG000|3-month|Death|1|||
106131667|NCT04319094|366139610|FG001|3-month|Death|0|||
106131668|NCT04319094|366139609|FG000|3-month|Lost to Follow-up|2|||
106131669|NCT04319094|366139610|FG001|3-month|Lost to Follow-up|2|||
106131670|NCT04319094|366139609|FG000|3-month|Withdrawal by Subject|0|||
106131671|NCT04319094|366139610|FG001|3-month|Withdrawal by Subject|3|||
106131672|NCT04319094|366139609|FG000|3-month|Incomplete data collection|9|||
106131673|NCT04319094|366139610|FG001|3-month|Incomplete data collection|7|||
106131674|NCT04319094|366139609|FG000|6-month|Lost to Follow-up|1|||
106131675|NCT04319094|366139610|FG001|6-month|Lost to Follow-up|1|||
106131676|NCT04319094|366139609|FG000|6-month|Withdrawal by Subject|0|||
106131677|NCT04319094|366139610|FG001|6-month|Withdrawal by Subject|3|||
106131678|NCT04319094|366139609|FG000|6-month|Incomplete data collection|14|||
106131679|NCT04319094|366139610|FG001|6-month|Incomplete data collection|9|||
106131680|NCT04319094|366139609|FG000|9-month|Lost to Follow-up|8|||
106131681|NCT04319094|366139610|FG001|9-month|Lost to Follow-up|4|||
106131682|NCT04319094|366139609|FG000|9-month|Withdrawal by Subject|0|||
106131683|NCT04319094|366139610|FG001|9-month|Withdrawal by Subject|1|||
106131684|NCT04319094|366139609|FG000|9-month|Incomplete data collection|8|||
106131685|NCT04319094|366139610|FG001|9-month|Incomplete data collection|5|||
106131686|NCT04319094|366139609|FG000|12-month|Lost to Follow-up|11|||
106131687|NCT04319094|366139610|FG001|12-month|Lost to Follow-up|8|||
106131688|NCT01321073|366139611|FG000|Overall Study|Did not attempt implant|4|||
106131689|NCT01321073|366139611|FG000|Overall Study|Death|3|||
106131690|NCT04639947|366139612|FG000|Overall Study|Screen fail|1|||
105693140|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693141|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693142|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693143|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693144|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693145|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693146|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693147|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105693148|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
106003896|NCT00286442|365676530|FG001|Overall Study|Adverse Event|6|||
106003897|NCT00286442|365676531|FG002|Overall Study|Adverse Event|1|||
106003898|NCT00286442|365676529|FG000|Overall Study|Protocol Violation|2|||
106003899|NCT00286442|365676530|FG001|Overall Study|Protocol Violation|4|||
106003900|NCT00286442|365676531|FG002|Overall Study|Protocol Violation|2|||
106003901|NCT00286442|365676529|FG000|Overall Study|Lost to Follow-up|5|||
106131691|NCT00654238|366139616|FG000|Overall Study|Screen Failures|4|||
106131692|NCT00877851|366139617|FG000|Overall Study|Lost to Follow-up|5|||
106131693|NCT00877851|366139618|FG001|Overall Study|Lost to Follow-up|5|||
105693149|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
105693150|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
105693151|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693152|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693153|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693154|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693155|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693156|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105920554|NCT02065557|365369316|FG002|Induction Period|Withdrawal by Subject|0|||
105920555|NCT02065557|365369317|FG003|Induction Period|Withdrawal by Subject|0|||
105920556|NCT02065557|365369318|FG004|Induction Period|Withdrawal by Subject|0|||
105920557|NCT02065557|365369319|FG005|Induction Period|Withdrawal by Subject|0|||
105920558|NCT02065557|365369314|FG000|Induction Period|Lack of Efficacy|2|||
105920559|NCT02065557|365369315|FG001|Induction Period|Lack of Efficacy|1|||
105920560|NCT02065557|365369316|FG002|Induction Period|Lack of Efficacy|1|||
105920561|NCT02065557|365369317|FG003|Induction Period|Lack of Efficacy|0|||
105920562|NCT02065557|365369318|FG004|Induction Period|Lack of Efficacy|0|||
106003902|NCT00286442|365676530|FG001|Overall Study|Lost to Follow-up|2|||
106131694|NCT00877851|366139617|FG000|Overall Study|computer problem|3|||
106131695|NCT00877851|366139618|FG001|Overall Study|computer problem|0|||
106131696|NCT00877851|366139617|FG000|Overall Study|no longer interested in participating|1|||
106131697|NCT00877851|366139618|FG001|Overall Study|no longer interested in participating|0|||
106131698|NCT03424239|366139619|FG000|Overall Study|Withdrawal by Subject|2|||
106131699|NCT00062868|366139629|FG000|Dose Level 1|Death|2|||
106131700|NCT00062868|366139630|FG001|Dose Level 1|Death|0|||
106131701|NCT00062868|366139631|FG002|Dose Level 1|Death|0|||
106131702|NCT00062868|366139632|FG003|Dose Level 1|Death|2|||
106131703|NCT00062868|366139633|FG004|Dose Level 1|Death|0|||
106131704|NCT00062868|366139634|FG005|Dose Level 1|Death|0|||
106131705|NCT00062868|366139635|FG006|Dose Level 1|Death|3|||
106131706|NCT00062868|366139636|FG007|Dose Level 1|Death|0|||
105693157|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693158|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693159|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693160|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
105693161|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105693162|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693163|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693164|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693165|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693166|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693167|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693168|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693169|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105693170|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
105693171|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
105693172|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
105693173|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693174|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693175|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693176|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693177|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693178|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693179|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693180|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693181|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693182|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
105693183|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
105693184|NCT04178967|364540591|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693185|NCT04178967|364540592|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693186|NCT04178967|364540593|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693187|NCT04178967|364540594|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693188|NCT04178967|364540595|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693189|NCT04178967|364540596|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693190|NCT04178967|364540597|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693191|NCT04178967|364540598|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693192|NCT04178967|364540599|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693193|NCT04178967|364540600|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
105693194|NCT04178967|364540601|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
105693195|NCT03681951|364540602|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
105693196|NCT03681951|364540603|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693197|NCT03681951|364540604|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693198|NCT03681951|364540605|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693199|NCT03681951|364540606|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693200|NCT03681951|364540607|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693201|NCT03681951|364540608|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693202|NCT03681951|364540609|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
105693203|NCT03681951|364540602|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
105693204|NCT03681951|364540603|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693205|NCT03681951|364540604|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693206|NCT03681951|364540605|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693207|NCT03681951|364540606|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693208|NCT03681951|364540607|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693209|NCT03681951|364540608|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693210|NCT03681951|364540609|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
105693211|NCT03681951|364540602|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
105693212|NCT03681951|364540603|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693213|NCT03681951|364540604|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693214|NCT03681951|364540605|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693215|NCT03681951|364540606|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693216|NCT03681951|364540607|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693217|NCT03681951|364540608|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693218|NCT03681951|364540609|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
105693219|NCT02178553|364540610|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
105693220|NCT02178553|364540611|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
105693221|NCT02178553|364540610|FG000|Overall Study|Physician Decision|0|||
105693222|NCT02178553|364540611|FG001|Overall Study|Physician Decision|4|||
105693223|NCT02178553|364540610|FG000|Overall Study|Technical problem with injection|1|||
105693224|NCT02178553|364540611|FG001|Overall Study|Technical problem with injection|3|||
105693225|NCT01020448|364540612|FG000|Pre-assignment|Adverse Event|6|||
105693226|NCT01020448|364540612|FG000|Pre-assignment|Withdrawal by Subject|5|||
105693227|NCT01020448|364540612|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
105693228|NCT01020448|364540612|FG000|Treatment|Adverse Event|11|||
105693229|NCT01020448|364540612|FG000|Treatment|Consent Withdrawn|3|||
105693230|NCT01020448|364540612|FG000|Treatment|Disease Progression|2|||
105693231|NCT01020448|364540612|FG000|Treatment|Lack of Efficacy|8|||
105693232|NCT01020448|364540612|FG000|Treatment|Lost to Follow-up|2|||
105693233|NCT00448435|364540613|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
105693234|NCT00448435|364540614|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
105693235|NCT00108069|364540617|FG000|Overall Study|Never rec'd study drug|0|||
105693236|NCT00108069|364540618|FG001|Overall Study|Never rec'd study drug|1|||
105693237|NCT00108069|364540617|FG000|Overall Study|Adverse Event|1|||
105693238|NCT00108069|364540618|FG001|Overall Study|Adverse Event|1|||
105693239|NCT00108069|364540617|FG000|Overall Study|Withdrawal by Subject|1|||
105693240|NCT00108069|364540618|FG001|Overall Study|Withdrawal by Subject|0|||
105693241|NCT00108069|364540617|FG000|Overall Study|Death|1|||
105693242|NCT00108069|364540618|FG001|Overall Study|Death|0|||
105693243|NCT00108069|364540617|FG000|Overall Study|Progessive disease|27|||
105693244|NCT00108069|364540618|FG001|Overall Study|Progessive disease|11|||
105693245|NCT03933397|364540619|FG000|Overall Study|No emergency department visit|65|||
105693246|NCT03933397|364540620|FG001|Overall Study|No emergency department visit|71|||
105693247|NCT03933397|364540619|FG000|Overall Study|Missed emergency department visit|25|||
105693248|NCT03933397|364540620|FG001|Overall Study|Missed emergency department visit|30|||
105693249|NCT03933397|364540619|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
105693250|NCT03933397|364540620|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
105693251|NCT03933397|364540619|FG000|Overall Study|Withdrawal by Subject|1|||
105693252|NCT03933397|364540620|FG001|Overall Study|Withdrawal by Subject|0|||
105693253|NCT03933397|364540619|FG000|Overall Study|Physician Decision|1|||
105693254|NCT03933397|364540620|FG001|Overall Study|Physician Decision|1|||
105693255|NCT03933397|364540619|FG000|Overall Study|missing pain score|1|||
105693256|NCT03933397|364540620|FG001|Overall Study|missing pain score|1|||
105693257|NCT03933397|364540619|FG000|Overall Study|Confirmed COVID-19|1|||
105693258|NCT03933397|364540620|FG001|Overall Study|Confirmed COVID-19|2|||
105693259|NCT01910116|364540623|FG000|Overall Study|Adverse Event|0|||
105693260|NCT01910116|364540624|FG001|Overall Study|Adverse Event|3|||
105693261|NCT01910116|364540623|FG000|Overall Study|Lack of Efficacy|3|||
105693262|NCT01910116|364540624|FG001|Overall Study|Lack of Efficacy|4|||
105693263|NCT01910116|364540623|FG000|Overall Study|Lost to Follow-up|1|||
105693264|NCT01910116|364540624|FG001|Overall Study|Lost to Follow-up|0|||
105693265|NCT01910116|364540623|FG000|Overall Study|Protocol Violation|1|||
105693266|NCT01910116|364540624|FG001|Overall Study|Protocol Violation|2|||
105693267|NCT01910116|364540623|FG000|Overall Study|Withdrawal by Subject|8|||
105693268|NCT01910116|364540624|FG001|Overall Study|Withdrawal by Subject|3|||
105693269|NCT01910116|364540623|FG000|Overall Study|uncertain allocation|1|||
105693270|NCT01910116|364540624|FG001|Overall Study|uncertain allocation|3|||
105693271|NCT01910116|364540623|FG000|Overall Study|incomplete data|0|||
105693272|NCT01910116|364540624|FG001|Overall Study|incomplete data|1|||
105693273|NCT03606980|364540625|FG000|Overall Study|Lost to Follow-up|3|||
105693274|NCT03606980|364540626|FG001|Overall Study|Lost to Follow-up|2|||
105693275|NCT03606980|364540627|FG002|Overall Study|Lost to Follow-up|3|||
105693276|NCT03606980|364540625|FG000|Overall Study|Withdrawal by Subject|1|||
105693277|NCT03606980|364540626|FG001|Overall Study|Withdrawal by Subject|0|||
105693278|NCT03606980|364540627|FG002|Overall Study|Withdrawal by Subject|4|||
105693279|NCT00132496|364540628|FG000|Overall Study|Withdrawal by Subject|1|||
105693280|NCT00132496|364540629|FG001|Overall Study|Withdrawal by Subject|2|||
105693281|NCT00132496|364540628|FG000|Overall Study|Physician Decision|1|||
105693282|NCT00132496|364540629|FG001|Overall Study|Physician Decision|0|||
105693283|NCT00307333|364540630|FG000|Overall Study|Lost to Follow-up|11|||
105693284|NCT00307333|364540631|FG001|Overall Study|Lost to Follow-up|3|||
105693285|NCT02014740|364540633|FG000|Overall Study|Lost to Follow-up|4|||
105693286|NCT02014740|364540634|FG001|Overall Study|Lost to Follow-up|4|||
105693287|NCT02014740|364540633|FG000|Overall Study|Withdrawal by Subject|2|||
105693288|NCT02014740|364540634|FG001|Overall Study|Withdrawal by Subject|1|||
105693289|NCT04936841|364540640|FG000|Overall Study|Death|1|||
105693290|NCT01351623|364540641|FG000|Overall Study|Protocol Violation|2|||
105693291|NCT01351623|364540641|FG000|Overall Study|Adverse Event|4|||
105693292|NCT01351623|364540641|FG000|Overall Study|Withdrawal by Subject|1|||
105693293|NCT01351623|364540641|FG000|Overall Study|Death|2|||
105693294|NCT01326728|364540642|FG000|Overall Study|Death|13|||
105693295|NCT01326728|364540643|FG001|Overall Study|Death|0|||
105693296|NCT01326728|364540642|FG000|Overall Study|Early closure of study|34|||
105693297|NCT01326728|364540643|FG001|Overall Study|Early closure of study|9|||
105693298|NCT04399122|364540644|FG000|Overall Study|Lost to Follow-up|2|||
106131707|NCT00062868|366139637|FG008|Dose Level 1|Death|0|||
106131708|NCT00062868|366139638|FG009|Dose Level 1|Death|0|||
106131709|NCT00062868|366139639|FG010|Dose Level 1|Death|0|||
106131710|NCT00062868|366139640|FG011|Dose Level 1|Death|0|||
105693299|NCT04399122|364540645|FG001|Overall Study|Lost to Follow-up|0|||
105693300|NCT04399122|364540644|FG000|Overall Study|Withdrawal by Subject|1|||
105693301|NCT04399122|364540645|FG001|Overall Study|Withdrawal by Subject|0|||
105693302|NCT02536755|364540647|FG000|Overall Study|Adverse Event|4|||
105693303|NCT01102803|364540649|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
105693304|NCT01102803|364540650|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
105693305|NCT01102803|364540649|FG000|Post to Follow-Up|Lost to Follow-up|1|||
105693306|NCT01102803|364540650|FG001|Post to Follow-Up|Lost to Follow-up|3|||
105693307|NCT04448756|364540653|FG000|Overall Study|Adverse Event|0|||
105693308|NCT04448756|364540654|FG001|Overall Study|Adverse Event|1|||
105693309|NCT04448756|364540655|FG002|Overall Study|Adverse Event|0|||
105693310|NCT04448756|364540653|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
105693311|NCT04448756|364540654|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
105920563|NCT02065557|365369319|FG005|Induction Period|Lack of Efficacy|0|||
105920564|NCT02065557|365369314|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
105920565|NCT02065557|365369315|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
105920566|NCT02065557|365369316|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
105920567|NCT02065557|365369317|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
105920568|NCT02065557|365369318|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
105920569|NCT02065557|365369319|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
105920570|NCT02065557|365369314|FG000|Induction Period|Non-Responder at Week 8|4|||
105920571|NCT02065557|365369315|FG001|Induction Period|Non-Responder at Week 8|4|||
105920572|NCT02065557|365369316|FG002|Induction Period|Non-Responder at Week 8|0|||
105920573|NCT02065557|365369317|FG003|Induction Period|Non-Responder at Week 8|0|||
105920574|NCT02065557|365369318|FG004|Induction Period|Non-Responder at Week 8|0|||
105693312|NCT04448756|364540655|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
105693313|NCT04448756|364540653|FG000|Overall Study|Withdrawal by Subject|0|||
105693314|NCT04448756|364540654|FG001|Overall Study|Withdrawal by Subject|3|||
105693315|NCT04448756|364540655|FG002|Overall Study|Withdrawal by Subject|1|||
105693316|NCT04448756|364540653|FG000|Overall Study|Death|2|||
105693317|NCT04448756|364540654|FG001|Overall Study|Death|1|||
105693318|NCT04448756|364540655|FG002|Overall Study|Death|0|||
105693319|NCT02733185|364540656|FG000|Overall Study|Withdrawal by Subject|12|||
105693320|NCT02733185|364540657|FG001|Overall Study|Withdrawal by Subject|10|||
105693321|NCT02733185|364540658|FG002|Overall Study|Withdrawal by Subject|17|||
105693322|NCT02733185|364540659|FG003|Overall Study|Withdrawal by Subject|21|||
105693323|NCT02733185|364540656|FG000|Overall Study|Death|46|||
105693324|NCT02733185|364540657|FG001|Overall Study|Death|34|||
105693325|NCT02733185|364540658|FG002|Overall Study|Death|35|||
105693326|NCT02733185|364540659|FG003|Overall Study|Death|43|||
105693327|NCT02733185|364540656|FG000|Overall Study|Lost to Follow-up|17|||
105693328|NCT02733185|364540657|FG001|Overall Study|Lost to Follow-up|18|||
105920575|NCT02065557|365369319|FG005|Induction Period|Non-Responder at Week 8|0|||
105920576|NCT02065557|365369314|FG000|Induction Period|Adverse Event|1|||
105920577|NCT02065557|365369315|FG001|Induction Period|Adverse Event|1|||
105920578|NCT02065557|365369316|FG002|Induction Period|Adverse Event|0|||
105920579|NCT02065557|365369317|FG003|Induction Period|Adverse Event|0|||
105920580|NCT02065557|365369318|FG004|Induction Period|Adverse Event|0|||
105920581|NCT02065557|365369319|FG005|Induction Period|Adverse Event|0|||
105920582|NCT02065557|365369314|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
105920583|NCT02065557|365369315|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
105920584|NCT02065557|365369316|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
106131711|NCT00062868|366139641|FG012|Dose Level 1|Death|0|||
106131712|NCT00062868|366139642|FG013|Dose Level 1|Death|0|||
106131713|NCT00062868|366139643|FG014|Dose Level 1|Death|0|||
106131714|NCT00062868|366139644|FG015|Dose Level 1|Death|0|||
106131715|NCT00062868|366139645|FG016|Dose Level 1|Death|0|||
106131716|NCT00062868|366139646|FG017|Dose Level 1|Death|0|||
106131717|NCT00062868|366139647|FG018|Dose Level 1|Death|7|||
105920585|NCT02065557|365369317|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
106003903|NCT00286442|365676531|FG002|Overall Study|Lost to Follow-up|1|||
106003904|NCT00286442|365676529|FG000|Overall Study|Physician Decision|1|||
106131718|NCT00062868|366139648|FG019|Dose Level 1|Death|0|||
106131719|NCT00062868|366139649|FG020|Dose Level 1|Death|1|||
106131720|NCT00062868|366139629|FG000|Dose Level 1|Lost to Follow-up|0|||
105693329|NCT02733185|364540658|FG002|Overall Study|Lost to Follow-up|16|||
105693330|NCT02733185|364540659|FG003|Overall Study|Lost to Follow-up|11|||
105693331|NCT02593786|364540660|FG000|Overall Study|Disease progression|12|||
105693332|NCT02593786|364540661|FG001|Overall Study|Disease progression|16|||
106131721|NCT00062868|366139630|FG001|Dose Level 1|Lost to Follow-up|0|||
106131722|NCT00062868|366139631|FG002|Dose Level 1|Lost to Follow-up|0|||
106131723|NCT00062868|366139632|FG003|Dose Level 1|Lost to Follow-up|0|||
106131724|NCT00062868|366139633|FG004|Dose Level 1|Lost to Follow-up|0|||
106131725|NCT00062868|366139634|FG005|Dose Level 1|Lost to Follow-up|0|||
105693333|NCT02593786|364540662|FG002|Overall Study|Disease progression|10|||
105693334|NCT02593786|364540663|FG003|Overall Study|Disease progression|7|||
105693335|NCT02593786|364540660|FG000|Overall Study|Study drug toxicity|1|||
105693336|NCT02593786|364540661|FG001|Overall Study|Study drug toxicity|0|||
105693337|NCT02593786|364540662|FG002|Overall Study|Study drug toxicity|0|||
105693338|NCT02593786|364540663|FG003|Overall Study|Study drug toxicity|0|||
105693339|NCT02593786|364540660|FG000|Overall Study|Adverse event unrelated to study drug|1|||
105693340|NCT02593786|364540661|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105693341|NCT02593786|364540662|FG002|Overall Study|Adverse event unrelated to study drug|1|||
105693342|NCT02593786|364540663|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105920586|NCT02065557|365369318|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
105920587|NCT02065557|365369319|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
106003905|NCT00286442|365676530|FG001|Overall Study|Physician Decision|1|||
106003906|NCT00286442|365676531|FG002|Overall Study|Physician Decision|1|||
105693343|NCT02593786|364540660|FG000|Overall Study|Participant request to discontinue study therapy|0|||
105693344|NCT02593786|364540661|FG001|Overall Study|Participant request to discontinue study therapy|2|||
105693345|NCT02593786|364540662|FG002|Overall Study|Participant request to discontinue study therapy|0|||
105920588|NCT02065557|365369314|FG000|Maintenance Period|Withdrawal by Subject|0|||
105920589|NCT02065557|365369315|FG001|Maintenance Period|Withdrawal by Subject|0|||
105920590|NCT02065557|365369316|FG002|Maintenance Period|Withdrawal by Subject|0|||
105920591|NCT02065557|365369317|FG003|Maintenance Period|Withdrawal by Subject|0|||
105920592|NCT02065557|365369318|FG004|Maintenance Period|Withdrawal by Subject|2|||
105920593|NCT02065557|365369319|FG005|Maintenance Period|Withdrawal by Subject|1|||
105920594|NCT02065557|365369314|FG000|Maintenance Period|Lack of Efficacy|0|||
105920595|NCT02065557|365369315|FG001|Maintenance Period|Lack of Efficacy|0|||
105920596|NCT02065557|365369316|FG002|Maintenance Period|Lack of Efficacy|0|||
105920597|NCT02065557|365369317|FG003|Maintenance Period|Lack of Efficacy|0|||
105920598|NCT02065557|365369318|FG004|Maintenance Period|Lack of Efficacy|5|||
105920599|NCT02065557|365369319|FG005|Maintenance Period|Lack of Efficacy|2|||
105920600|NCT02065557|365369314|FG000|Maintenance Period|Subject Non-Compliance|0|||
105920601|NCT02065557|365369315|FG001|Maintenance Period|Subject Non-Compliance|0|||
105920602|NCT02065557|365369316|FG002|Maintenance Period|Subject Non-Compliance|0|||
105920603|NCT02065557|365369317|FG003|Maintenance Period|Subject Non-Compliance|0|||
105920604|NCT02065557|365369318|FG004|Maintenance Period|Subject Non-Compliance|0|||
105920605|NCT02065557|365369319|FG005|Maintenance Period|Subject Non-Compliance|1|||
105920606|NCT01462942|365369323|FG000|Overall Study|Adverse Event|7|||
105920607|NCT01462942|365369324|FG001|Overall Study|Adverse Event|12|||
105920608|NCT01462942|365369325|FG002|Overall Study|Adverse Event|10|||
105920609|NCT01462942|365369326|FG003|Overall Study|Adverse Event|11|||
105920610|NCT01462942|365369327|FG004|Overall Study|Adverse Event|11|||
105920611|NCT01462942|365369323|FG000|Overall Study|Other, including COPD exacerbation|3|||
105920612|NCT01462942|365369324|FG001|Overall Study|Other, including COPD exacerbation|5|||
105920613|NCT01462942|365369325|FG002|Overall Study|Other, including COPD exacerbation|2|||
105920614|NCT01462942|365369326|FG003|Overall Study|Other, including COPD exacerbation|8|||
105920615|NCT01462942|365369327|FG004|Overall Study|Other, including COPD exacerbation|5|||
105920616|NCT01462942|365369323|FG000|Overall Study|Withdrawal by Subject|14|||
105920617|NCT01462942|365369324|FG001|Overall Study|Withdrawal by Subject|10|||
105920618|NCT01462942|365369325|FG002|Overall Study|Withdrawal by Subject|14|||
105920619|NCT01462942|365369326|FG003|Overall Study|Withdrawal by Subject|16|||
105920620|NCT01462942|365369327|FG004|Overall Study|Withdrawal by Subject|19|||
105693346|NCT02593786|364540663|FG003|Overall Study|Participant request to discontinue study therapy|0|||
105693347|NCT02593786|364540660|FG000|Overall Study|Other reasons|1|||
105693348|NCT02593786|364540661|FG001|Overall Study|Other reasons|1|||
105693349|NCT02593786|364540662|FG002|Overall Study|Other reasons|0|||
105920621|NCT01462942|365369323|FG000|Overall Study|Lack of Efficacy|6|||
105693350|NCT02593786|364540663|FG003|Overall Study|Other reasons|5|||
105693351|NCT01130051|364540664|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
105693352|NCT01130051|364540665|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
105920622|NCT01462942|365369324|FG001|Overall Study|Lack of Efficacy|0|||
105920623|NCT01462942|365369325|FG002|Overall Study|Lack of Efficacy|4|||
105920624|NCT01462942|365369326|FG003|Overall Study|Lack of Efficacy|5|||
105920625|NCT01462942|365369327|FG004|Overall Study|Lack of Efficacy|3|||
105920626|NCT01462942|365369323|FG000|Overall Study|Lost to Follow-up|0|||
105920627|NCT01462942|365369324|FG001|Overall Study|Lost to Follow-up|1|||
105920628|NCT01462942|365369325|FG002|Overall Study|Lost to Follow-up|1|||
105920629|NCT01462942|365369326|FG003|Overall Study|Lost to Follow-up|1|||
105920630|NCT01462942|365369327|FG004|Overall Study|Lost to Follow-up|1|||
105920631|NCT01462942|365369323|FG000|Overall Study|Protocol Violation|4|||
105920632|NCT01462942|365369324|FG001|Overall Study|Protocol Violation|6|||
105920633|NCT01462942|365369325|FG002|Overall Study|Protocol Violation|9|||
105920634|NCT01462942|365369326|FG003|Overall Study|Protocol Violation|9|||
105920635|NCT01462942|365369327|FG004|Overall Study|Protocol Violation|6|||
105920636|NCT01670292|365369329|FG000|Overall Study|Lost to Follow-up|14|||
105920637|NCT01603277|365369336|FG000|Overall Study|Adverse Event|1|||
105920638|NCT01603277|365369337|FG001|Overall Study|Adverse Event|2|||
105920639|NCT01603277|365369336|FG000|Overall Study|Physician Decision|0|||
105920640|NCT01603277|365369337|FG001|Overall Study|Physician Decision|1|||
105920641|NCT01603277|365369336|FG000|Overall Study|Protocol Violation|6|||
106131726|NCT00062868|366139635|FG006|Dose Level 1|Lost to Follow-up|0|||
106131727|NCT00062868|366139636|FG007|Dose Level 1|Lost to Follow-up|0|||
105693353|NCT01130051|364540664|FG000|Washout Period of 14 Days|Protocol Violation|1|||
105693354|NCT01130051|364540665|FG001|Washout Period of 14 Days|Protocol Violation|1|||
105693355|NCT04572854|364540666|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
105693356|NCT04572854|364540667|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
105693357|NCT04572854|364540668|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
105693358|NCT04572854|364540669|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
105693359|NCT04572854|364540666|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
105693360|NCT04572854|364540667|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
105693361|NCT04572854|364540668|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
105693362|NCT04572854|364540669|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
105693363|NCT01016964|364541994|FG000|Overall Study|Lost to Follow-up|3|||
105693364|NCT01016964|364541995|FG001|Overall Study|Lost to Follow-up|3|||
105693365|NCT00702845|364541996|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
105693366|NCT00702845|364541997|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
105693367|NCT00702845|364541996|FG000|Overall Study|Too high ovarian response|5|||
105693368|NCT00702845|364541997|FG001|Overall Study|Too high ovarian response|1|||
105693369|NCT00702845|364541996|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
105693370|NCT00702845|364541997|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
105693371|NCT00702845|364541996|FG000|Overall Study|Insufficient ovarian response|1|||
105693372|NCT00702845|364541997|FG001|Overall Study|Insufficient ovarian response|0|||
105693373|NCT00702845|364541996|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
105693374|NCT00702845|364541997|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
105693375|NCT00702845|364541996|FG000|Overall Study|No or abnormal fertilization|4|||
105693376|NCT00702845|364541997|FG001|Overall Study|No or abnormal fertilization|2|||
105693377|NCT00702845|364541996|FG000|Overall Study|Patient's decision|2|||
105693378|NCT00702845|364541997|FG001|Overall Study|Patient's decision|1|||
105693379|NCT00702845|364541996|FG000|Overall Study|Not randomized|0|||
105693380|NCT00702845|364541997|FG001|Overall Study|Not randomized|1|||
105693381|NCT01330914|364542004|FG000|Overall Study|Withdrawal by Subject|4|||
105693382|NCT01330914|364542004|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
105693383|NCT03503513|364542005|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
105693384|NCT03503513|364542005|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
105693385|NCT03503513|364542005|FG000|Overall Study|Physician Decision|3|||
105693386|NCT03503513|364542005|FG000|Overall Study|Withdrawal by Subject|2|||
105693387|NCT03503513|364542005|FG000|Overall Study|Lost to Follow-up|1|||
105693388|NCT00929656|364542010|FG000|Overall Study|Lost to Follow-up|0|||
105693389|NCT00929656|364542011|FG001|Overall Study|Lost to Follow-up|1|||
105693390|NCT00607880|364542012|FG000|Overall Study|Unable to place port due to occlusion|1|||
105693391|NCT00607880|364542013|FG001|Overall Study|Unable to place port due to occlusion|0|||
105693392|NCT01170039|364542014|FG000|Overall Study|Withdrawal by Subject|5|||
105693393|NCT01170039|364542015|FG001|Overall Study|Withdrawal by Subject|3|||
105693394|NCT01170039|364542014|FG000|Overall Study|Lack of funding, drug not available|3|||
105693395|NCT01170039|364542015|FG001|Overall Study|Lack of funding, drug not available|3|||
105693396|NCT00908583|364542016|FG000|Phase 1|Withdrawal by Subject|1|||
105693397|NCT00908583|364542016|FG000|Phase 1|Adverse Event|4|||
105693398|NCT00908583|364542016|FG000|Phase 2|Physician Decision|1|||
105693399|NCT00908583|364542016|FG000|Phase 2|Adverse Event|1|||
105693400|NCT00908583|364542016|FG000|Phase 3|Adverse Event|2|||
105693401|NCT00908583|364542016|FG000|Phase 4|Adverse Event|1|||
105693402|NCT00908583|364542016|FG000|Phase 4|Physician Decision|1|||
105693403|NCT00908583|364542016|FG000|Phase 5|Adverse Event|3|||
105920642|NCT01603277|365369337|FG001|Overall Study|Protocol Violation|10|||
105920643|NCT01603277|365369336|FG000|Overall Study|Withdrawal by Subject|5|||
105920644|NCT01603277|365369337|FG001|Overall Study|Withdrawal by Subject|4|||
105920645|NCT01603277|365369336|FG000|Overall Study|Non-Compliance|2|||
105920646|NCT01603277|365369337|FG001|Overall Study|Non-Compliance|1|||
105920647|NCT04494646|365369340|FG000|Overall Study|Adverse Event|0|||
106131728|NCT00062868|366139637|FG008|Dose Level 1|Lost to Follow-up|0|||
106131729|NCT00062868|366139638|FG009|Dose Level 1|Lost to Follow-up|0|||
106131730|NCT00062868|366139639|FG010|Dose Level 1|Lost to Follow-up|0|||
106131731|NCT00062868|366139640|FG011|Dose Level 1|Lost to Follow-up|0|||
106131732|NCT00062868|366139641|FG012|Dose Level 1|Lost to Follow-up|1|||
106131733|NCT00062868|366139642|FG013|Dose Level 1|Lost to Follow-up|0|||
106131734|NCT00062868|366139643|FG014|Dose Level 1|Lost to Follow-up|0|||
106131735|NCT00062868|366139644|FG015|Dose Level 1|Lost to Follow-up|0|||
106131736|NCT00062868|366139645|FG016|Dose Level 1|Lost to Follow-up|0|||
106131737|NCT00062868|366139646|FG017|Dose Level 1|Lost to Follow-up|0|||
106131738|NCT00062868|366139647|FG018|Dose Level 1|Lost to Follow-up|2|||
106131739|NCT00062868|366139648|FG019|Dose Level 1|Lost to Follow-up|0|||
106131740|NCT00062868|366139649|FG020|Dose Level 1|Lost to Follow-up|1|||
106131741|NCT00062868|366139629|FG000|Dose Level 2|Death|0|||
106131742|NCT00062868|366139630|FG001|Dose Level 2|Death|3|||
106131743|NCT00062868|366139631|FG002|Dose Level 2|Death|0|||
106131744|NCT00062868|366139632|FG003|Dose Level 2|Death|0|||
106131745|NCT00062868|366139633|FG004|Dose Level 2|Death|2|||
106131746|NCT00062868|366139634|FG005|Dose Level 2|Death|0|||
106131747|NCT00062868|366139635|FG006|Dose Level 2|Death|0|||
106131748|NCT00062868|366139636|FG007|Dose Level 2|Death|0|||
106131749|NCT00062868|366139637|FG008|Dose Level 2|Death|0|||
106131750|NCT00062868|366139638|FG009|Dose Level 2|Death|0|||
106131751|NCT00062868|366139639|FG010|Dose Level 2|Death|1|||
106131752|NCT00062868|366139640|FG011|Dose Level 2|Death|0|||
106131753|NCT00062868|366139641|FG012|Dose Level 2|Death|0|||
105693404|NCT02615470|364542017|FG000|Overall Study|Lost to Follow-up|21|||
105693405|NCT02615470|364542018|FG001|Overall Study|Lost to Follow-up|32|||
105693406|NCT00860951|364542019|FG000|Overall Study|Withdrawal by Subject|2|||
105693407|NCT00860951|364542019|FG000|Overall Study|Lost to Follow-up|5|||
105693408|NCT00727649|364542020|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
105920648|NCT04494646|365369341|FG001|Overall Study|Adverse Event|1|||
105920649|NCT04494646|365369340|FG000|Overall Study|Withdrawal by Subject|0|||
105920650|NCT04494646|365369341|FG001|Overall Study|Withdrawal by Subject|1|||
105920651|NCT02785939|365369347|FG000|Overall Study|Progression|25|||
105920652|NCT02785939|365369348|FG001|Overall Study|Progression|8|||
105920653|NCT02785939|365369347|FG000|Overall Study|Adverse Event|3|||
105920654|NCT02785939|365369348|FG001|Overall Study|Adverse Event|1|||
105920655|NCT02785939|365369347|FG000|Overall Study|Death|1|||
105693409|NCT00727649|364542021|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
105693410|NCT00727649|364542020|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
105693411|NCT00727649|364542021|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
105693412|NCT00727649|364542020|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
105693413|NCT00727649|364542021|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
105693414|NCT00727649|364542020|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
105920656|NCT02785939|365369348|FG001|Overall Study|Death|0|||
105920657|NCT02785939|365369347|FG000|Overall Study|Refusal|1|||
105920658|NCT02785939|365369348|FG001|Overall Study|Refusal|0|||
105920659|NCT02785939|365369347|FG000|Overall Study|Deteriorating health|1|||
105920660|NCT02785939|365369348|FG001|Overall Study|Deteriorating health|0|||
105920661|NCT02785939|365369347|FG000|Overall Study|Not protocol specified|0|||
105920662|NCT02785939|365369348|FG001|Overall Study|Not protocol specified|1|||
105920663|NCT02295644|365369351|FG000|Overall Study|Did not meet inclusion criterion|0|||
105920664|NCT02295644|365369352|FG001|Overall Study|Did not meet inclusion criterion|0|||
105920665|NCT02295644|365369353|FG002|Overall Study|Did not meet inclusion criterion|1|||
105920666|NCT02295644|365369354|FG003|Overall Study|Did not meet inclusion criterion|2|||
105920667|NCT01692119|365369355|FG000|Overall Study|Protocol Violation|3|||
105920668|NCT01692119|365369356|FG001|Overall Study|Protocol Violation|1|||
105920669|NCT01692119|365369355|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
105920670|NCT01692119|365369356|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
105920671|NCT01299584|365369366|FG000|Overall Study|Protocol Violation|9|||
105920672|NCT00390689|365369372|FG000|Overall Study|Adverse Event|2|||
105920673|NCT00390689|365369373|FG001|Overall Study|Adverse Event|5|||
105920674|NCT00390689|365369374|FG002|Overall Study|Adverse Event|2|||
105920675|NCT00390689|365369372|FG000|Overall Study|Lack of Efficacy|0|||
106131754|NCT00062868|366139642|FG013|Dose Level 2|Death|0|||
106131755|NCT00062868|366139643|FG014|Dose Level 2|Death|0|||
106131756|NCT00062868|366139644|FG015|Dose Level 2|Death|0|||
105693415|NCT00727649|364542021|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
105693416|NCT00727649|364542020|FG000|Second Intervention (4-weeks)|Death|1|||
105693417|NCT00727649|364542021|FG001|Second Intervention (4-weeks)|Death|0|||
105920676|NCT00390689|365369373|FG001|Overall Study|Lack of Efficacy|0|||
106131757|NCT00062868|366139645|FG016|Dose Level 2|Death|2|||
106131758|NCT00062868|366139646|FG017|Dose Level 2|Death|0|||
106131759|NCT00062868|366139647|FG018|Dose Level 2|Death|0|||
106131760|NCT00062868|366139648|FG019|Dose Level 2|Death|0|||
106131761|NCT00062868|366139649|FG020|Dose Level 2|Death|0|||
106131762|NCT00062868|366139629|FG000|Dose Level 2|Lost to Follow-up|0|||
106131763|NCT00062868|366139630|FG001|Dose Level 2|Lost to Follow-up|0|||
106131764|NCT00062868|366139631|FG002|Dose Level 2|Lost to Follow-up|0|||
106131765|NCT00062868|366139632|FG003|Dose Level 2|Lost to Follow-up|0|||
106131766|NCT00062868|366139633|FG004|Dose Level 2|Lost to Follow-up|0|||
106131767|NCT00062868|366139634|FG005|Dose Level 2|Lost to Follow-up|0|||
106131768|NCT00062868|366139635|FG006|Dose Level 2|Lost to Follow-up|0|||
106131769|NCT00062868|366139636|FG007|Dose Level 2|Lost to Follow-up|0|||
106131770|NCT00062868|366139637|FG008|Dose Level 2|Lost to Follow-up|0|||
106131771|NCT00062868|366139638|FG009|Dose Level 2|Lost to Follow-up|0|||
106131772|NCT00062868|366139639|FG010|Dose Level 2|Lost to Follow-up|0|||
106131773|NCT00062868|366139640|FG011|Dose Level 2|Lost to Follow-up|0|||
106131774|NCT00062868|366139641|FG012|Dose Level 2|Lost to Follow-up|0|||
106131775|NCT00062868|366139642|FG013|Dose Level 2|Lost to Follow-up|1|||
106131776|NCT00062868|366139643|FG014|Dose Level 2|Lost to Follow-up|0|||
106131777|NCT00062868|366139644|FG015|Dose Level 2|Lost to Follow-up|0|||
106131778|NCT00062868|366139645|FG016|Dose Level 2|Lost to Follow-up|1|||
106131779|NCT00062868|366139646|FG017|Dose Level 2|Lost to Follow-up|0|||
106131780|NCT00062868|366139647|FG018|Dose Level 2|Lost to Follow-up|0|||
106131781|NCT00062868|366139648|FG019|Dose Level 2|Lost to Follow-up|0|||
106131782|NCT00062868|366139649|FG020|Dose Level 2|Lost to Follow-up|0|||
106131783|NCT00062868|366139629|FG000|Dose Level 3|Death|0|||
106131784|NCT00062868|366139630|FG001|Dose Level 3|Death|0|||
106131785|NCT00062868|366139631|FG002|Dose Level 3|Death|0|||
106131786|NCT00062868|366139632|FG003|Dose Level 3|Death|0|||
106131787|NCT00062868|366139633|FG004|Dose Level 3|Death|0|||
106131788|NCT00062868|366139634|FG005|Dose Level 3|Death|0|||
106131789|NCT00062868|366139635|FG006|Dose Level 3|Death|0|||
106131790|NCT00062868|366139636|FG007|Dose Level 3|Death|0|||
106131791|NCT00062868|366139637|FG008|Dose Level 3|Death|0|||
106131792|NCT00062868|366139638|FG009|Dose Level 3|Death|0|||
106131793|NCT00062868|366139639|FG010|Dose Level 3|Death|0|||
106131794|NCT00062868|366139640|FG011|Dose Level 3|Death|1|||
106131795|NCT00062868|366139641|FG012|Dose Level 3|Death|0|||
106131796|NCT00062868|366139642|FG013|Dose Level 3|Death|0|||
106131797|NCT00062868|366139643|FG014|Dose Level 3|Death|0|||
106131798|NCT00062868|366139644|FG015|Dose Level 3|Death|0|||
106131799|NCT00062868|366139645|FG016|Dose Level 3|Death|0|||
106131800|NCT00062868|366139646|FG017|Dose Level 3|Death|1|||
106131801|NCT00062868|366139647|FG018|Dose Level 3|Death|0|||
106131802|NCT00062868|366139648|FG019|Dose Level 3|Death|0|||
106131803|NCT00062868|366139649|FG020|Dose Level 3|Death|0|||
106131804|NCT00062868|366139629|FG000|Dose Level 3|Lost to Follow-up|0|||
106131805|NCT00062868|366139630|FG001|Dose Level 3|Lost to Follow-up|0|||
106131806|NCT00062868|366139631|FG002|Dose Level 3|Lost to Follow-up|0|||
106131807|NCT00062868|366139632|FG003|Dose Level 3|Lost to Follow-up|0|||
106131808|NCT00062868|366139633|FG004|Dose Level 3|Lost to Follow-up|0|||
106131809|NCT00062868|366139634|FG005|Dose Level 3|Lost to Follow-up|0|||
106131810|NCT00062868|366139635|FG006|Dose Level 3|Lost to Follow-up|0|||
106131811|NCT00062868|366139636|FG007|Dose Level 3|Lost to Follow-up|0|||
106131812|NCT00062868|366139637|FG008|Dose Level 3|Lost to Follow-up|0|||
106131813|NCT00062868|366139638|FG009|Dose Level 3|Lost to Follow-up|0|||
106131814|NCT00062868|366139639|FG010|Dose Level 3|Lost to Follow-up|0|||
106131815|NCT00062868|366139640|FG011|Dose Level 3|Lost to Follow-up|0|||
106131816|NCT00062868|366139641|FG012|Dose Level 3|Lost to Follow-up|0|||
106131817|NCT00062868|366139642|FG013|Dose Level 3|Lost to Follow-up|0|||
106131818|NCT00062868|366139643|FG014|Dose Level 3|Lost to Follow-up|1|||
106131819|NCT00062868|366139644|FG015|Dose Level 3|Lost to Follow-up|0|||
106131820|NCT00062868|366139645|FG016|Dose Level 3|Lost to Follow-up|0|||
106131821|NCT00062868|366139646|FG017|Dose Level 3|Lost to Follow-up|0|||
106131822|NCT00062868|366139647|FG018|Dose Level 3|Lost to Follow-up|0|||
105787069|NCT03110107|364874901|FG012|Treatment Period|Disease Progression|0|||
105920677|NCT00390689|365369374|FG002|Overall Study|Lack of Efficacy|1|||
106131823|NCT00062868|366139648|FG019|Dose Level 3|Lost to Follow-up|0|||
106131824|NCT00062868|366139649|FG020|Dose Level 3|Lost to Follow-up|0|||
106131825|NCT00062868|366139629|FG000|Dose Level 3|Withdrew|0|||
106131826|NCT00062868|366139630|FG001|Dose Level 3|Withdrew|0|||
106131827|NCT00062868|366139631|FG002|Dose Level 3|Withdrew|2|||
106131828|NCT00062868|366139632|FG003|Dose Level 3|Withdrew|0|||
106131829|NCT00062868|366139633|FG004|Dose Level 3|Withdrew|0|||
106131830|NCT00062868|366139634|FG005|Dose Level 3|Withdrew|0|||
106131831|NCT00062868|366139635|FG006|Dose Level 3|Withdrew|0|||
106131832|NCT00062868|366139636|FG007|Dose Level 3|Withdrew|0|||
106131833|NCT00062868|366139637|FG008|Dose Level 3|Withdrew|0|||
106131834|NCT00062868|366139638|FG009|Dose Level 3|Withdrew|0|||
106131835|NCT00062868|366139639|FG010|Dose Level 3|Withdrew|0|||
106131836|NCT00062868|366139640|FG011|Dose Level 3|Withdrew|0|||
106131837|NCT00062868|366139641|FG012|Dose Level 3|Withdrew|0|||
106131838|NCT00062868|366139642|FG013|Dose Level 3|Withdrew|0|||
106131839|NCT00062868|366139643|FG014|Dose Level 3|Withdrew|0|||
106131840|NCT00062868|366139644|FG015|Dose Level 3|Withdrew|0|||
106131841|NCT00062868|366139645|FG016|Dose Level 3|Withdrew|0|||
106131842|NCT00062868|366139646|FG017|Dose Level 3|Withdrew|0|||
106131843|NCT00062868|366139647|FG018|Dose Level 3|Withdrew|0|||
106131844|NCT00062868|366139648|FG019|Dose Level 3|Withdrew|0|||
106131845|NCT00062868|366139649|FG020|Dose Level 3|Withdrew|0|||
106131846|NCT01290094|366139652|FG000|Overall Study|Withdrawal by Subject|1|||
106131847|NCT01290094|366139652|FG000|Overall Study|Lost to Follow-up|5|||
106131848|NCT01712685|366139661|FG000|Overall Study|pt declined to participate before trmt|1|||
106131849|NCT01866917|366139662|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
106131850|NCT01866917|366139663|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
106131851|NCT00432159|366141804|FG000|Overall Study|Death|0|||
106131852|NCT00432159|366141805|FG001|Overall Study|Death|1|||
106131853|NCT00432159|366141806|FG002|Overall Study|Death|0|||
106131854|NCT00432159|366141807|FG003|Overall Study|Death|0|||
106131855|NCT00432159|366141808|FG004|Overall Study|Death|0|||
106131856|NCT00432159|366141804|FG000|Overall Study|Failure|9|||
106131857|NCT00432159|366141805|FG001|Overall Study|Failure|5|||
106131858|NCT00432159|366141806|FG002|Overall Study|Failure|3|||
106131859|NCT00432159|366141807|FG003|Overall Study|Failure|2|||
106131860|NCT00432159|366141808|FG004|Overall Study|Failure|3|||
106131861|NCT00432159|366141804|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
106131862|NCT00432159|366141805|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
106131863|NCT00432159|366141806|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
106131864|NCT00432159|366141807|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
106131865|NCT00432159|366141808|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
106131866|NCT03660943|366141811|FG000|Overall Study|Adverse Event|5|||
106131867|NCT03660943|366141812|FG001|Overall Study|Adverse Event|3|||
106131868|NCT03660943|366141811|FG000|Overall Study|Death|0|||
106131869|NCT03660943|366141812|FG001|Overall Study|Death|2|||
106131870|NCT03660943|366141811|FG000|Overall Study|Lost to Follow-up|7|||
106131871|NCT03660943|366141812|FG001|Overall Study|Lost to Follow-up|3|||
105693418|NCT00727649|364542020|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
105693419|NCT00727649|364542021|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
105693420|NCT00727649|364542020|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
105693421|NCT00727649|364542021|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
106003907|NCT00286442|365676529|FG000|Overall Study|Administrative Error|1|||
106003908|NCT00286442|365676530|FG001|Overall Study|Administrative Error|1|||
106003909|NCT00286442|365676531|FG002|Overall Study|Administrative Error|0|||
106003910|NCT00286442|365676529|FG000|Overall Study|Withdrawal by Subject|2|||
106003911|NCT00286442|365676530|FG001|Overall Study|Withdrawal by Subject|14|||
106003912|NCT00286442|365676531|FG002|Overall Study|Withdrawal by Subject|2|||
106003913|NCT02756338|365676532|FG000|Overall Study|Withdrawn by Investigator|1|||
106003914|NCT02756338|365676532|FG000|Overall Study|Device Replaced with Pacemaker|4|||
106003915|NCT00667888|365676533|FG000|Overall Study|Death|1|||
106003916|NCT00667888|365676534|FG001|Overall Study|Death|1|||
106003917|NCT00667888|365676533|FG000|Overall Study|Withdrawal by Subject|6|||
106003918|NCT00667888|365676534|FG001|Overall Study|Withdrawal by Subject|3|||
106003919|NCT00667888|365676533|FG000|Overall Study|Proceed with other treatment|3|||
106003920|NCT00667888|365676534|FG001|Overall Study|Proceed with other treatment|3|||
106003921|NCT00667888|365676533|FG000|Overall Study|Ineligible after SIM|0|||
106003922|NCT00667888|365676534|FG001|Overall Study|Ineligible after SIM|2|||
106003923|NCT01945021|365676535|FG000|Overall Study|Adverse Event|1|||
106003924|NCT01945021|365676535|FG000|Overall Study|Withdrawal of consent|12|||
106003925|NCT01945021|365676535|FG000|Overall Study|Lost to Follow-up|5|||
106003926|NCT01945021|365676535|FG000|Overall Study|Death|65|||
106003927|NCT00467740|365676539|FG000|Overall Study|Adverse Event|0|||
106003928|NCT00467740|365676540|FG001|Overall Study|Adverse Event|0|||
106003929|NCT00467740|365676541|FG002|Overall Study|Adverse Event|1|||
106003930|NCT00467740|365676542|FG003|Overall Study|Adverse Event|0|||
106131872|NCT03660943|366141811|FG000|Overall Study|Protocol Violation|3|||
106131873|NCT03660943|366141812|FG001|Overall Study|Protocol Violation|5|||
105693422|NCT01650285|364542022|FG000|Overall Study|Adverse Event|1|||
106003931|NCT00467740|365676543|FG004|Overall Study|Adverse Event|0|||
106131874|NCT03660943|366141811|FG000|Overall Study|Withdrawal by Subject|8|||
106131875|NCT03660943|366141812|FG001|Overall Study|Withdrawal by Subject|15|||
106131876|NCT03660943|366141811|FG000|Overall Study|Lack of Efficacy|9|||
106131877|NCT03660943|366141812|FG001|Overall Study|Lack of Efficacy|12|||
106131878|NCT03660943|366141811|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
106131879|NCT03660943|366141812|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
106003932|NCT00467740|365676539|FG000|Overall Study|Protocol Violation|0|||
106003933|NCT00467740|365676540|FG001|Overall Study|Protocol Violation|0|||
106003934|NCT00467740|365676541|FG002|Overall Study|Protocol Violation|1|||
105920678|NCT00390689|365369372|FG000|Overall Study|Protocol Violation|1|||
105920679|NCT00390689|365369373|FG001|Overall Study|Protocol Violation|0|||
105920680|NCT00390689|365369374|FG002|Overall Study|Protocol Violation|0|||
105693423|NCT00385203|364542028|FG000|Overall Study|Adverse Event|5|||
105693424|NCT00385203|364542029|FG001|Overall Study|Adverse Event|4|||
105693425|NCT00385203|364542028|FG000|Overall Study|Death|1|||
105693426|NCT00385203|364542029|FG001|Overall Study|Death|0|||
105693427|NCT00385203|364542028|FG000|Overall Study|Condition under investigation worsened|18|||
105693428|NCT00385203|364542029|FG001|Overall Study|Condition under investigation worsened|3|||
105693429|NCT00385203|364542028|FG000|Overall Study|Incorrect enrollment|2|||
105693430|NCT00385203|364542029|FG001|Overall Study|Incorrect enrollment|0|||
105693431|NCT01186939|364542030|FG000|Overall Study|Death|7|||
105693432|NCT01186939|364542030|FG000|Overall Study|Withdrawal by Subject|2|||
105693433|NCT01186939|364542030|FG000|Overall Study|No longer receiving clinical benefit|17|||
105693434|NCT01186939|364542030|FG000|Overall Study|Program closed|5|||
105693435|NCT01186939|364542030|FG000|Overall Study|Sponsor decision|4|||
105693436|NCT01186939|364542030|FG000|Overall Study|Started additional treatment|1|||
105693437|NCT01186939|364542030|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
105693438|NCT01186939|364542030|FG000|Overall Study|Myocardial infarction|1|||
105693439|NCT01186939|364542030|FG000|Overall Study|Bone marrow transplant|1|||
105693440|NCT01186939|364542030|FG000|Overall Study|Transformation to AML|1|||
105693441|NCT03842163|364542031|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
105693442|NCT03842163|364542031|FG000|Overall Study|Scintigraphy was not performed|44|||
105693443|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
105693444|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
105693445|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
105693446|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
105693447|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
105693448|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
105693449|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
105693450|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
105693451|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
105693452|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
105693453|NCT03829241|364542035|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
105693454|NCT03829241|364542036|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
105693455|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
105693456|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
105693457|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
105693458|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
105693459|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
105693460|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
105693461|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
105693462|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
105693463|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
105693464|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
105920681|NCT00390689|365369372|FG000|Overall Study|Investigator's judgement|2|||
105920682|NCT00390689|365369373|FG001|Overall Study|Investigator's judgement|0|||
105920683|NCT00390689|365369374|FG002|Overall Study|Investigator's judgement|0|||
105920684|NCT02747927|365369375|FG000|Overall Study|Adverse Event|5|||
105920685|NCT02747927|365369376|FG001|Overall Study|Adverse Event|14|||
105920686|NCT02747927|365369375|FG000|Overall Study|Lost to Follow-up|22|||
105920687|NCT02747927|365369376|FG001|Overall Study|Lost to Follow-up|43|||
105920688|NCT02747927|365369375|FG000|Overall Study|Pregnancy|34|||
105920689|NCT02747927|365369376|FG001|Overall Study|Pregnancy|66|||
105920690|NCT02747927|365369375|FG000|Overall Study|Protocol Violation|2|||
105920691|NCT02747927|365369376|FG001|Overall Study|Protocol Violation|4|||
105920692|NCT02747927|365369375|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
105920693|NCT02747927|365369376|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
105920694|NCT02747927|365369375|FG000|Overall Study|Reason not Specified|11|||
105920695|NCT02747927|365369376|FG001|Overall Study|Reason not Specified|27|||
105920696|NCT01218802|365369380|FG000|Overall Study|Lost to Follow-up|5|||
105920697|NCT01218802|365369381|FG001|Overall Study|Lost to Follow-up|6|||
106131880|NCT02065245|366141813|FG000|Infusion 1|Lost to Follow-up|0|||
106131881|NCT02065245|366141814|FG001|Infusion 1|Lost to Follow-up|0|||
106131882|NCT02065245|366141815|FG002|Infusion 1|Lost to Follow-up|0|||
105693465|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
105693466|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
105693467|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
105693468|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
105693469|NCT03829241|364542035|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
106131883|NCT02065245|366141816|FG003|Infusion 1|Lost to Follow-up|0|||
105693470|NCT03829241|364542036|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
106003935|NCT00467740|365676542|FG003|Overall Study|Protocol Violation|0|||
106003936|NCT00467740|365676543|FG004|Overall Study|Protocol Violation|0|||
106003937|NCT00467740|365676539|FG000|Overall Study|Lost to Follow-up|0|||
106003938|NCT00467740|365676540|FG001|Overall Study|Lost to Follow-up|1|||
106003939|NCT00467740|365676541|FG002|Overall Study|Lost to Follow-up|0|||
106003940|NCT00467740|365676542|FG003|Overall Study|Lost to Follow-up|0|||
106003941|NCT00467740|365676543|FG004|Overall Study|Lost to Follow-up|0|||
106003942|NCT00467740|365676539|FG000|Overall Study|Withdrawal by Subject|1|||
106003943|NCT00467740|365676540|FG001|Overall Study|Withdrawal by Subject|1|||
106003944|NCT00467740|365676541|FG002|Overall Study|Withdrawal by Subject|0|||
106003945|NCT00467740|365676542|FG003|Overall Study|Withdrawal by Subject|1|||
106003946|NCT00467740|365676543|FG004|Overall Study|Withdrawal by Subject|0|||
106003947|NCT00467740|365676539|FG000|Overall Study|Lack of Efficacy|0|||
106003948|NCT00467740|365676540|FG001|Overall Study|Lack of Efficacy|1|||
106003949|NCT00467740|365676541|FG002|Overall Study|Lack of Efficacy|0|||
106003950|NCT00467740|365676542|FG003|Overall Study|Lack of Efficacy|0|||
106003951|NCT00467740|365676543|FG004|Overall Study|Lack of Efficacy|0|||
106003952|NCT00953667|365676544|FG000|Overall Study|Lost to Follow-up|11|||
106003953|NCT00953667|365676544|FG000|Overall Study|Physician Decision|35|||
106003954|NCT00953667|365676544|FG000|Overall Study|Withdrawal by Subject|63|||
106003955|NCT00953667|365676544|FG000|Overall Study|Adverse Event|10|||
106003956|NCT00953667|365676544|FG000|Overall Study|poor venous access,unable to draw blood|4|||
106003957|NCT04819945|365676545|FG000|Overall Study|Lost to Follow-up|1|||
106003958|NCT02004236|365676546|FG000|Overall Study|Lack of Efficacy|0|||
106003959|NCT02004236|365676547|FG001|Overall Study|Lack of Efficacy|0|||
106003960|NCT02004236|365676548|FG002|Overall Study|Lack of Efficacy|16|||
106003961|NCT00844376|365676549|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
106003962|NCT00844376|365676550|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
106003963|NCT01632020|365676551|FG000|Overall Study|Withdrawal by Subject|1|||
106003964|NCT01632020|365676552|FG001|Overall Study|Withdrawal by Subject|0|||
106003965|NCT01632020|365676551|FG000|Overall Study|Adverse Event|1|||
106003966|NCT01632020|365676552|FG001|Overall Study|Adverse Event|0|||
106003967|NCT01069484|365676554|FG000|Overall Study|Death-in-near-family|1|||
106003968|NCT01069484|365676555|FG001|Overall Study|Death-in-near-family|0|||
106003969|NCT01069484|365676554|FG000|Overall Study|No specific reason|8|||
106003970|NCT01069484|365676555|FG001|Overall Study|No specific reason|2|||
106003971|NCT01069484|365676554|FG000|Overall Study|Illness mother or child|3|||
106003972|NCT01069484|365676555|FG001|Overall Study|Illness mother or child|1|||
106003973|NCT01506271|365676556|FG000|Overall Study|Progressive disease|0|||
106003974|NCT01506271|365676557|FG001|Overall Study|Progressive disease|1|||
106003975|NCT01506271|365676558|FG002|Overall Study|Progressive disease|0|||
106003976|NCT01506271|365676556|FG000|Overall Study|Protocol Violation|3|||
106003977|NCT01506271|365676557|FG001|Overall Study|Protocol Violation|1|||
106003978|NCT01506271|365676558|FG002|Overall Study|Protocol Violation|0|||
106003979|NCT01506271|365676556|FG000|Overall Study|Death|0|||
106003980|NCT01506271|365676557|FG001|Overall Study|Death|1|||
106003981|NCT01506271|365676558|FG002|Overall Study|Death|0|||
106003982|NCT01506271|365676556|FG000|Overall Study|Adverse Event|0|||
106003983|NCT01506271|365676557|FG001|Overall Study|Adverse Event|2|||
106003984|NCT01506271|365676558|FG002|Overall Study|Adverse Event|0|||
106003985|NCT01506271|365676556|FG000|Overall Study|Insufficient supply of study drug|1|||
106003986|NCT01506271|365676557|FG001|Overall Study|Insufficient supply of study drug|0|||
106003987|NCT01506271|365676558|FG002|Overall Study|Insufficient supply of study drug|0|||
106003988|NCT01506271|365676556|FG000|Overall Study|Withdrawal by Subject|0|||
106003989|NCT01506271|365676557|FG001|Overall Study|Withdrawal by Subject|1|||
106003990|NCT01506271|365676558|FG002|Overall Study|Withdrawal by Subject|1|||
106003991|NCT01506271|365676556|FG000|Overall Study|Lost to Follow-up|0|||
106003992|NCT01506271|365676557|FG001|Overall Study|Lost to Follow-up|1|||
106003993|NCT01506271|365676558|FG002|Overall Study|Lost to Follow-up|2|||
106003994|NCT00651924|365676565|FG000|Overall Study|Withdrawal by PI|0|||
106003995|NCT00651924|365676566|FG001|Overall Study|Withdrawal by PI|2|||
106003996|NCT00651924|365676565|FG000|Overall Study|Withdrawal by Subject|0|||
106003997|NCT00651924|365676566|FG001|Overall Study|Withdrawal by Subject|5|||
106003998|NCT00960063|365676567|FG000|Overall Study|Adverse Event|1|||
106003999|NCT00960063|365676568|FG001|Overall Study|Adverse Event|0|||
106004000|NCT00960063|365676569|FG002|Overall Study|Adverse Event|0|||
106004001|NCT00960063|365676567|FG000|Overall Study|Progression of Disease|0|||
106004002|NCT00960063|365676568|FG001|Overall Study|Progression of Disease|0|||
105693471|NCT00698204|364542037|FG000|Overall Study|Withdrawal by Subject|1|||
106004003|NCT00960063|365676569|FG002|Overall Study|Progression of Disease|3|||
106004004|NCT00528957|365676570|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
105693472|NCT00698204|364542038|FG001|Overall Study|Withdrawal by Subject|0|||
106004005|NCT00528957|365676571|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
106004006|NCT00528957|365676570|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
106004007|NCT00528957|365676571|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
106004008|NCT00528957|365676570|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
106004009|NCT00528957|365676571|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
106004010|NCT00528957|365676570|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
106004011|NCT00528957|365676571|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
106004012|NCT00528957|365676570|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
106004013|NCT00528957|365676571|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
106004014|NCT00528957|365676570|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
106004015|NCT00528957|365676571|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
106004016|NCT00528957|365676570|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
106004017|NCT00528957|365676571|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
106004018|NCT00528957|365676570|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
106004019|NCT00528957|365676571|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
106004020|NCT00528957|365676570|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
106004021|NCT00528957|365676571|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
106004022|NCT00528957|365676570|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
106004023|NCT00528957|365676571|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
106004024|NCT00528957|365676570|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
106004025|NCT00528957|365676571|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
106004026|NCT00528957|365676570|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
106004027|NCT00528957|365676571|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
106004028|NCT00528957|365676570|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
106004029|NCT00528957|365676571|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
106004030|NCT00528957|365676570|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
106004031|NCT00528957|365676571|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
106004032|NCT00528957|365676570|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
106004033|NCT00528957|365676571|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
106004034|NCT00528957|365676570|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
106004035|NCT00528957|365676571|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
106004036|NCT01611792|365676575|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
106004037|NCT01611792|365676576|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
106004038|NCT01611792|365676575|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
106004039|NCT01611792|365676576|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
106004040|NCT01323582|365676578|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
106004041|NCT01323582|365676579|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
106004042|NCT01323582|365676578|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
106004043|NCT01323582|365676579|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
106004044|NCT01323582|365676578|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
106004045|NCT01323582|365676579|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
106004046|NCT01759420|365676580|FG000|Overall Study|Screen failure|5|||
106004047|NCT01759420|365676580|FG000|Overall Study|Inaccurate EKG machine readings|1|||
106004048|NCT01129622|365676581|FG000|Overall Study|Withdrawal by Subject|2|||
106004049|NCT00960375|365676582|FG000|Overall Study|Lost to Follow-up|20|||
106004050|NCT00960375|365676583|FG001|Overall Study|Lost to Follow-up|22|||
106004051|NCT01601535|365676584|FG000|Phase 1|Adverse Event|1|||
106004052|NCT01601535|365676585|FG001|Phase 1|Adverse Event|0|||
106004053|NCT01601535|365676586|FG002|Phase 1|Adverse Event|2|||
106004054|NCT01601535|365676587|FG003|Phase 1|Adverse Event|1|||
106004055|NCT01601535|365676588|FG004|Phase 1|Adverse Event|0|||
106004056|NCT01601535|365676589|FG005|Phase 1|Adverse Event|0|||
106004057|NCT01601535|365676584|FG000|Phase 1|Withdrawal by Subject|2|||
106004058|NCT01601535|365676585|FG001|Phase 1|Withdrawal by Subject|1|||
106004059|NCT01601535|365676586|FG002|Phase 1|Withdrawal by Subject|1|||
106004060|NCT01601535|365676587|FG003|Phase 1|Withdrawal by Subject|2|||
106004061|NCT01601535|365676588|FG004|Phase 1|Withdrawal by Subject|0|||
106004062|NCT01601535|365676589|FG005|Phase 1|Withdrawal by Subject|0|||
106004063|NCT01601535|365676584|FG000|Phase 1|Progressive Disease|2|||
106004064|NCT01601535|365676585|FG001|Phase 1|Progressive Disease|3|||
106004065|NCT01601535|365676586|FG002|Phase 1|Progressive Disease|2|||
106004066|NCT01601535|365676587|FG003|Phase 1|Progressive Disease|1|||
106004067|NCT01601535|365676588|FG004|Phase 1|Progressive Disease|0|||
106004068|NCT01601535|365676589|FG005|Phase 1|Progressive Disease|0|||
106004069|NCT01601535|365676584|FG000|Phase 1|Started Another Treatment|1|||
106004070|NCT01601535|365676585|FG001|Phase 1|Started Another Treatment|2|||
106004071|NCT01601535|365676586|FG002|Phase 1|Started Another Treatment|0|||
106004072|NCT01601535|365676587|FG003|Phase 1|Started Another Treatment|0|||
106004073|NCT01601535|365676588|FG004|Phase 1|Started Another Treatment|0|||
106004074|NCT01601535|365676589|FG005|Phase 1|Started Another Treatment|0|||
106004075|NCT01601535|365676584|FG000|Phase 2|Adverse Event|0|||
106004076|NCT01601535|365676585|FG001|Phase 2|Adverse Event|0|||
106131884|NCT02065245|366141817|FG004|Infusion 1|Lost to Follow-up|0|||
106131885|NCT02065245|366141818|FG005|Infusion 1|Lost to Follow-up|0|||
106131886|NCT02065245|366141819|FG006|Infusion 1|Lost to Follow-up|1|||
106131887|NCT02065245|366141813|FG000|Infusion 1|Death|0|||
106131888|NCT02065245|366141814|FG001|Infusion 1|Death|0|||
106131889|NCT02065245|366141815|FG002|Infusion 1|Death|1|||
106131890|NCT02065245|366141816|FG003|Infusion 1|Death|0|||
106131891|NCT02065245|366141817|FG004|Infusion 1|Death|1|||
106131892|NCT02065245|366141818|FG005|Infusion 1|Death|0|||
106131893|NCT02065245|366141819|FG006|Infusion 1|Death|0|||
106131894|NCT02065245|366141813|FG000|Infusion 2|Death|0|||
106131895|NCT02065245|366141814|FG001|Infusion 2|Death|0|||
106131896|NCT02065245|366141815|FG002|Infusion 2|Death|0|||
106131897|NCT02065245|366141816|FG003|Infusion 2|Death|0|||
106131898|NCT02065245|366141817|FG004|Infusion 2|Death|0|||
106131899|NCT02065245|366141818|FG005|Infusion 2|Death|0|||
106131900|NCT02065245|366141819|FG006|Infusion 2|Death|1|||
106131901|NCT02065245|366141813|FG000|Infusion 3|Lost to Follow-up|1|||
106131902|NCT02065245|366141814|FG001|Infusion 3|Lost to Follow-up|1|||
106131903|NCT02065245|366141815|FG002|Infusion 3|Lost to Follow-up|0|||
106131904|NCT02065245|366141816|FG003|Infusion 3|Lost to Follow-up|0|||
106131905|NCT02065245|366141817|FG004|Infusion 3|Lost to Follow-up|0|||
106131906|NCT02065245|366141818|FG005|Infusion 3|Lost to Follow-up|0|||
106131907|NCT02065245|366141819|FG006|Infusion 3|Lost to Follow-up|0|||
106131908|NCT00924664|366141820|FG000|Overall Study|Adverse Event|23|||
106131909|NCT00924664|366141821|FG001|Overall Study|Adverse Event|39|||
106131910|NCT00924664|366141820|FG000|Overall Study|Lack of Efficacy|10|||
106131911|NCT00924664|366141821|FG001|Overall Study|Lack of Efficacy|15|||
106131912|NCT00924664|366141820|FG000|Overall Study|Lost to Follow-up|10|||
106131913|NCT00924664|366141821|FG001|Overall Study|Lost to Follow-up|12|||
106131914|NCT00924664|366141820|FG000|Overall Study|Withdrawal by Subject|47|||
106131915|NCT00924664|366141821|FG001|Overall Study|Withdrawal by Subject|71|||
106131916|NCT00924664|366141820|FG000|Overall Study|Protocol Violation|2|||
106131917|NCT00924664|366141821|FG001|Overall Study|Protocol Violation|5|||
106131918|NCT00924664|366141820|FG000|Overall Study|Pregnancy|1|||
106131919|NCT00924664|366141821|FG001|Overall Study|Pregnancy|1|||
106131920|NCT00924664|366141820|FG000|Overall Study|Death|0|||
106131921|NCT00924664|366141821|FG001|Overall Study|Death|2|||
106131922|NCT00924664|366141820|FG000|Overall Study|Study terminated by sponsor|199|||
106131923|NCT00924664|366141821|FG001|Overall Study|Study terminated by sponsor|330|||
106131924|NCT00924664|366141820|FG000|Overall Study|Other|29|||
106131925|NCT00924664|366141821|FG001|Overall Study|Other|52|||
106131926|NCT00924664|366141820|FG000|Overall Study|Randomized but not Treated|1|||
105920698|NCT01218802|365369380|FG000|Overall Study|Withdrawal by Subject|3|||
105920699|NCT01218802|365369381|FG001|Overall Study|Withdrawal by Subject|10|||
105920700|NCT01218802|365369380|FG000|Overall Study|Adverse Event|0|||
105920701|NCT01218802|365369381|FG001|Overall Study|Adverse Event|2|||
105920702|NCT01218802|365369380|FG000|Overall Study|Incarcerated|2|||
105920703|NCT01218802|365369381|FG001|Overall Study|Incarcerated|0|||
105920704|NCT00833755|365369384|FG000|Overall Study|Physician Decision|4|||
105920705|NCT00833755|365369385|FG001|Overall Study|Physician Decision|4|||
105920706|NCT00833755|365369386|FG002|Overall Study|Physician Decision|2|||
105920707|NCT00833755|365369387|FG003|Overall Study|Physician Decision|6|||
105920708|NCT00833755|365369384|FG000|Overall Study|Subject had scheduling issues|0|||
105920709|NCT00833755|365369385|FG001|Overall Study|Subject had scheduling issues|1|||
105920710|NCT00833755|365369386|FG002|Overall Study|Subject had scheduling issues|0|||
105920711|NCT00833755|365369387|FG003|Overall Study|Subject had scheduling issues|0|||
105920712|NCT02908347|365369388|FG000|Overall Study|Adverse Event|0|||
105920713|NCT02908347|365369389|FG001|Overall Study|Adverse Event|1|||
105920714|NCT02908347|365369388|FG000|Overall Study|Lost to Follow-up|1|||
105920715|NCT02908347|365369389|FG001|Overall Study|Lost to Follow-up|0|||
105920716|NCT03329885|365369390|FG000|Overall Study|Sponsor discontinued the study early|0|||
105920717|NCT03329885|365369391|FG001|Overall Study|Sponsor discontinued the study early|0|||
105920718|NCT03329885|365369392|FG002|Overall Study|Sponsor discontinued the study early|0|||
105920719|NCT03329885|365369393|FG003|Overall Study|Sponsor discontinued the study early|0|||
106131927|NCT00924664|366141821|FG001|Overall Study|Randomized but not Treated|0|||
106131928|NCT03738241|366141822|FG000|Overall Study|Withdrawal by Subject|0|||
105693473|NCT00698451|364542039|FG000|Overall Study|Adverse Event|22|||
105693474|NCT00698451|364542039|FG000|Overall Study|Physician Decision|2|||
105920720|NCT03329885|365369394|FG004|Overall Study|Sponsor discontinued the study early|0|||
106131929|NCT03738241|366141823|FG001|Overall Study|Withdrawal by Subject|0|||
106131930|NCT03738241|366141824|FG002|Overall Study|Withdrawal by Subject|0|||
106131931|NCT03738241|366141825|FG003|Overall Study|Withdrawal by Subject|0|||
106131932|NCT03738241|366141826|FG004|Overall Study|Withdrawal by Subject|0|||
106131933|NCT03738241|366141827|FG005|Overall Study|Withdrawal by Subject|0|||
106131934|NCT03738241|366141828|FG006|Overall Study|Withdrawal by Subject|0|||
106131935|NCT03738241|366141829|FG007|Overall Study|Withdrawal by Subject|0|||
106131936|NCT03738241|366141830|FG008|Overall Study|Withdrawal by Subject|0|||
106131937|NCT03738241|366141831|FG009|Overall Study|Withdrawal by Subject|1|||
105693475|NCT00698451|364542039|FG000|Overall Study|Protocol Violation|6|||
106131938|NCT03738241|366141822|FG000|Overall Study|Physician Decision|0|||
106131939|NCT03738241|366141823|FG001|Overall Study|Physician Decision|0|||
106131940|NCT03738241|366141824|FG002|Overall Study|Physician Decision|0|||
106131941|NCT03738241|366141825|FG003|Overall Study|Physician Decision|0|||
106131942|NCT03738241|366141826|FG004|Overall Study|Physician Decision|0|||
106131943|NCT03738241|366141827|FG005|Overall Study|Physician Decision|0|||
106131944|NCT03738241|366141828|FG006|Overall Study|Physician Decision|0|||
106131945|NCT03738241|366141829|FG007|Overall Study|Physician Decision|0|||
106131946|NCT03738241|366141830|FG008|Overall Study|Physician Decision|1|||
106131947|NCT03738241|366141831|FG009|Overall Study|Physician Decision|0|||
106131948|NCT03738241|366141822|FG000|Overall Study|Adverse Event|1|||
106131949|NCT03738241|366141823|FG001|Overall Study|Adverse Event|0|||
106131950|NCT03738241|366141824|FG002|Overall Study|Adverse Event|0|||
106131951|NCT03738241|366141825|FG003|Overall Study|Adverse Event|0|||
106131952|NCT03738241|366141826|FG004|Overall Study|Adverse Event|0|||
106131953|NCT03738241|366141827|FG005|Overall Study|Adverse Event|0|||
106131954|NCT03738241|366141828|FG006|Overall Study|Adverse Event|0|||
106131955|NCT03738241|366141829|FG007|Overall Study|Adverse Event|0|||
106131956|NCT03738241|366141830|FG008|Overall Study|Adverse Event|0|||
106131957|NCT03738241|366141831|FG009|Overall Study|Adverse Event|0|||
106131958|NCT04541186|366141835|FG000|Main Study|Adverse Event|0|||
106131959|NCT04541186|366141836|FG001|Main Study|Adverse Event|0|||
106131960|NCT04541186|366141837|FG002|Main Study|Adverse Event|4|||
106131961|NCT04541186|366141838|FG003|Main Study|Adverse Event|0|||
106131962|NCT04541186|366141839|FG004|Main Study|Adverse Event|0|||
106131963|NCT04541186|366141835|FG000|Main Study|Investigator Decision|0|||
106131964|NCT04541186|366141836|FG001|Main Study|Investigator Decision|0|||
106131965|NCT04541186|366141837|FG002|Main Study|Investigator Decision|1|||
106131966|NCT04541186|366141838|FG003|Main Study|Investigator Decision|1|||
106131967|NCT04541186|366141839|FG004|Main Study|Investigator Decision|0|||
106131968|NCT04541186|366141835|FG000|Main Study|Withdrawal by Subject|1|||
106131969|NCT04541186|366141836|FG001|Main Study|Withdrawal by Subject|1|||
106131970|NCT04541186|366141837|FG002|Main Study|Withdrawal by Subject|0|||
106131971|NCT04541186|366141838|FG003|Main Study|Withdrawal by Subject|0|||
106131972|NCT04541186|366141839|FG004|Main Study|Withdrawal by Subject|0|||
106131973|NCT04541186|366141835|FG000|Main Study|COVID-19-related Dose Interruption|0|||
106131974|NCT04541186|366141836|FG001|Main Study|COVID-19-related Dose Interruption|0|||
106131975|NCT04541186|366141837|FG002|Main Study|COVID-19-related Dose Interruption|0|||
106131976|NCT04541186|366141838|FG003|Main Study|COVID-19-related Dose Interruption|0|||
106131977|NCT04541186|366141839|FG004|Main Study|COVID-19-related Dose Interruption|1|||
106131978|NCT04541186|366141835|FG000|Main Study|Randomized in Error Not Treated|0|||
106131979|NCT04541186|366141836|FG001|Main Study|Randomized in Error Not Treated|0|||
106131980|NCT04541186|366141837|FG002|Main Study|Randomized in Error Not Treated|1|||
106131981|NCT04541186|366141838|FG003|Main Study|Randomized in Error Not Treated|0|||
106131982|NCT04541186|366141839|FG004|Main Study|Randomized in Error Not Treated|0|||
106131983|NCT04541186|366141835|FG000|Fibrate Expansion Study|Other than Specified|0|||
106131984|NCT04541186|366141836|FG001|Fibrate Expansion Study|Other than Specified|0|||
106131985|NCT04541186|366141837|FG002|Fibrate Expansion Study|Other than Specified|0|||
106131986|NCT04541186|366141838|FG003|Fibrate Expansion Study|Other than Specified|0|||
106131987|NCT04541186|366141839|FG004|Fibrate Expansion Study|Other than Specified|1|||
106131988|NCT01427907|366141846|FG000|Overall Study|Withdrawal by Subject|3|||
106131989|NCT01427907|366141847|FG001|Overall Study|Withdrawal by Subject|4|||
106131990|NCT02374957|366141852|FG000|Overall Study|Patient did not complete forms correctly|1|||
106131991|NCT02374957|366141853|FG001|Overall Study|Patient did not complete forms correctly|0|||
106131992|NCT05349084|366141854|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
106131993|NCT01880554|366141855|FG000|Overall Study|Protocol Violation|14|||
106131994|NCT01880554|366141855|FG000|Overall Study|Simon's design requirements|2|||
106131995|NCT00972543|366141856|FG000|Overall Study|Adverse Event|1|||
106131996|NCT00972543|366141857|FG001|Overall Study|Adverse Event|0|||
106131997|NCT00972543|366141856|FG000|Overall Study|Early study termination by sponsor|4|||
106131998|NCT00972543|366141857|FG001|Overall Study|Early study termination by sponsor|1|||
106131999|NCT04537949|366141860|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
106132000|NCT04537949|366141861|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
106132001|NCT04537949|366141862|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
106132002|NCT04537949|366141863|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
106132003|NCT04537949|366141864|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
106132004|NCT04537949|366141865|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
106132005|NCT04537949|366141866|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
106004077|NCT01601535|365676586|FG002|Phase 2|Adverse Event|0|||
106132006|NCT04537949|366141867|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
106132007|NCT04537949|366141860|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
106132008|NCT04537949|366141861|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
106004078|NCT01601535|365676587|FG003|Phase 2|Adverse Event|0|||
106132009|NCT04537949|366141862|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
106132010|NCT04537949|366141863|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
106132011|NCT04537949|366141864|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
106132012|NCT04537949|366141865|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
105693476|NCT00698451|364542039|FG000|Overall Study|Withdrawal by Subject|6|||
105693477|NCT00698451|364542039|FG000|Overall Study|Disease progression|3|||
105693478|NCT01179672|364542040|FG000|Overall Study|Adverse Event|17|||
105693479|NCT01179672|364542041|FG001|Overall Study|Adverse Event|8|||
105693480|NCT01179672|364542040|FG000|Overall Study|Withdrawal by Subject|10|||
105693481|NCT01179672|364542041|FG001|Overall Study|Withdrawal by Subject|12|||
105693482|NCT01179672|364542040|FG000|Overall Study|Entry Criteria Not Met|0|||
105693483|NCT01179672|364542041|FG001|Overall Study|Entry Criteria Not Met|2|||
105693484|NCT01179672|364542040|FG000|Overall Study|Lost to Follow-up|0|||
105693485|NCT01179672|364542041|FG001|Overall Study|Lost to Follow-up|1|||
105693486|NCT01179672|364542040|FG000|Overall Study|Protocol Violation|2|||
105693487|NCT01179672|364542041|FG001|Overall Study|Protocol Violation|2|||
105693488|NCT01179672|364542040|FG000|Overall Study|Physician Decision|1|||
105693489|NCT01179672|364542041|FG001|Overall Study|Physician Decision|1|||
105693490|NCT02224599|364542044|FG000|Overall Study|Physician Decision|1|||
105693491|NCT02224599|364542044|FG000|Overall Study|Progression of Disease|1|||
105693492|NCT01949155|364542046|FG000|Overall Study|Lost to Follow-up|1|||
105693493|NCT01949155|364542047|FG001|Overall Study|Lost to Follow-up|0|||
105693494|NCT01949155|364542046|FG000|Overall Study|Protocol Violation|1|||
105693495|NCT01949155|364542047|FG001|Overall Study|Protocol Violation|0|||
105693496|NCT00314249|364542048|FG000|Overall Study|Adverse Event|73|||
105693497|NCT00314249|364542049|FG001|Overall Study|Adverse Event|94|||
105693498|NCT00314249|364542048|FG000|Overall Study|Lack of Efficacy|33|||
105693499|NCT00314249|364542049|FG001|Overall Study|Lack of Efficacy|24|||
105693500|NCT00314249|364542048|FG000|Overall Study|Withdrawal by Subject|21|||
105693501|NCT00314249|364542049|FG001|Overall Study|Withdrawal by Subject|28|||
105693502|NCT00314249|364542048|FG000|Overall Study|Lost to Follow-up|15|||
105693503|NCT00314249|364542049|FG001|Overall Study|Lost to Follow-up|9|||
105693504|NCT00314249|364542048|FG000|Overall Study|Physician Decision|1|||
105693505|NCT00314249|364542049|FG001|Overall Study|Physician Decision|1|||
105693506|NCT00314249|364542048|FG000|Overall Study|Withdrawn for other reasons|4|||
105693507|NCT00314249|364542049|FG001|Overall Study|Withdrawn for other reasons|1|||
105693508|NCT00314249|364542048|FG000|Overall Study|Non-Compliant|5|||
105693509|NCT00314249|364542049|FG001|Overall Study|Non-Compliant|6|||
105693510|NCT01187550|364542050|FG000|Overall Study|Protocol Violation|3|||
105693511|NCT01187550|364542051|FG001|Overall Study|Protocol Violation|1|||
105693512|NCT01187550|364542050|FG000|Overall Study|Other|3|||
105693513|NCT01187550|364542051|FG001|Overall Study|Other|0|||
105693514|NCT01187550|364542050|FG000|Overall Study|Randomized but not treated|8|||
105693515|NCT01187550|364542051|FG001|Overall Study|Randomized but not treated|0|||
105920721|NCT03329885|365369395|FG005|Overall Study|Sponsor discontinued the study early|0|||
105920722|NCT03329885|365369396|FG006|Overall Study|Sponsor discontinued the study early|1|||
105920723|NCT03329885|365369397|FG007|Overall Study|Sponsor discontinued the study early|1|||
105920724|NCT03329885|365369398|FG008|Overall Study|Sponsor discontinued the study early|0|||
105920725|NCT03886272|365369399|FG000|Period 1|Withdrawal by Subject|0|||
105920726|NCT03886272|365369400|FG001|Period 1|Withdrawal by Subject|0|||
105920727|NCT03886272|365369401|FG002|Period 1|Withdrawal by Subject|0|||
105920728|NCT03886272|365369402|FG003|Period 1|Withdrawal by Subject|0|||
105920729|NCT03886272|365369403|FG004|Period 1|Withdrawal by Subject|0|||
105920730|NCT03886272|365369404|FG005|Period 1|Withdrawal by Subject|1|||
105920731|NCT03886272|365369405|FG006|Period 1|Withdrawal by Subject|0|||
105920732|NCT02814526|365369406|FG000|Overall Study|Adverse Event|4|||
105920733|NCT02814526|365369407|FG001|Overall Study|Adverse Event|3|||
105920734|NCT02814526|365369406|FG000|Overall Study|Death|1|||
105920735|NCT02814526|365369407|FG001|Overall Study|Death|1|||
105920736|NCT02814526|365369406|FG000|Overall Study|Lost to Follow-up|3|||
105920737|NCT02814526|365369407|FG001|Overall Study|Lost to Follow-up|4|||
105920738|NCT02814526|365369406|FG000|Overall Study|non site physician decision|1|||
105920739|NCT02814526|365369407|FG001|Overall Study|non site physician decision|0|||
105920740|NCT02814526|365369406|FG000|Overall Study|participant noncompliance|1|||
105693516|NCT00596934|364542052|FG000|Overall Study|Protocol Violation|1|||
105693517|NCT00596934|364542052|FG000|Overall Study|Withdrawal by Subject|1|||
105693518|NCT00975715|364542058|FG000|Titration Period|Adverse Event|6|||
105693519|NCT00975715|364542059|FG001|Titration Period|Adverse Event|0|||
105693520|NCT00975715|364542058|FG000|Titration Period|Protocol Violation|1|||
105693521|NCT00975715|364542059|FG001|Titration Period|Protocol Violation|0|||
105693522|NCT00975715|364542058|FG000|Maintenance Period|Adverse Event|2|||
105920741|NCT02814526|365369407|FG001|Overall Study|participant noncompliance|1|||
105920742|NCT02814526|365369406|FG000|Overall Study|Withdrawal by Subject|20|||
105920743|NCT02814526|365369407|FG001|Overall Study|Withdrawal by Subject|14|||
105920744|NCT02814526|365369406|FG000|Overall Study|safety risk|2|||
105693523|NCT00975715|364542059|FG001|Maintenance Period|Adverse Event|1|||
105693524|NCT00974090|364542066|FG000|Period 1: Double Blind Period|Adverse Event|2|||
105693525|NCT00974090|364542067|FG001|Period 1: Double Blind Period|Adverse Event|1|||
105693526|NCT00974090|364542066|FG000|Period 1: Double Blind Period|Physician Decision|1|||
105693527|NCT00974090|364542067|FG001|Period 1: Double Blind Period|Physician Decision|0|||
105693528|NCT00974090|364542066|FG000|Period 2: Open-label Period|Adverse Event|4|||
105920745|NCT02814526|365369407|FG001|Overall Study|safety risk|1|||
106004079|NCT01601535|365676588|FG004|Phase 2|Adverse Event|5|||
105693529|NCT00974090|364542067|FG001|Period 2: Open-label Period|Adverse Event|6|||
105693530|NCT00974090|364542066|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
105693531|NCT00974090|364542067|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
105693532|NCT00974090|364542066|FG000|Period 2: Open-label Period|Physician Decision|0|||
105693533|NCT00974090|364542067|FG001|Period 2: Open-label Period|Physician Decision|3|||
105693534|NCT00974090|364542066|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
105693535|NCT00974090|364542067|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
105693536|NCT02606461|364542071|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105693537|NCT02606461|364542072|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
106004080|NCT01601535|365676589|FG005|Phase 2|Adverse Event|1|||
106004081|NCT01601535|365676584|FG000|Phase 2|Withdrawal by Subject|0|||
106004082|NCT01601535|365676585|FG001|Phase 2|Withdrawal by Subject|0|||
106004083|NCT01601535|365676586|FG002|Phase 2|Withdrawal by Subject|0|||
106004084|NCT01601535|365676587|FG003|Phase 2|Withdrawal by Subject|0|||
106004085|NCT01601535|365676588|FG004|Phase 2|Withdrawal by Subject|8|||
106004086|NCT01601535|365676589|FG005|Phase 2|Withdrawal by Subject|2|||
106004087|NCT01601535|365676584|FG000|Phase 2|Progressive Disease|0|||
106004088|NCT01601535|365676585|FG001|Phase 2|Progressive Disease|0|||
106004089|NCT01601535|365676586|FG002|Phase 2|Progressive Disease|0|||
106004090|NCT01601535|365676587|FG003|Phase 2|Progressive Disease|0|||
106004091|NCT01601535|365676588|FG004|Phase 2|Progressive Disease|5|||
106004092|NCT01601535|365676589|FG005|Phase 2|Progressive Disease|7|||
106004093|NCT01601535|365676584|FG000|Phase 2|Started Another Treatment|0|||
106004094|NCT01601535|365676585|FG001|Phase 2|Started Another Treatment|0|||
106004095|NCT01601535|365676586|FG002|Phase 2|Started Another Treatment|0|||
106004096|NCT01601535|365676587|FG003|Phase 2|Started Another Treatment|0|||
106004097|NCT01601535|365676588|FG004|Phase 2|Started Another Treatment|1|||
106004098|NCT01601535|365676589|FG005|Phase 2|Started Another Treatment|2|||
106004099|NCT00152503|365676595|FG000|Overall Study|Adverse Event|4|||
106004100|NCT00154297|365676596|FG000|Overall Study|Death|5|||
106004101|NCT00154297|365676597|FG001|Overall Study|Death|2|||
106004102|NCT00154297|365676596|FG000|Overall Study|Withdrawal by Subject|0|||
106004103|NCT00154297|365676597|FG001|Overall Study|Withdrawal by Subject|5|||
106004104|NCT00154297|365676596|FG000|Overall Study|Lost to Follow-up|3|||
106004105|NCT00154297|365676597|FG001|Overall Study|Lost to Follow-up|0|||
106004106|NCT03077542|365676598|FG000|Overall Study|Death|4|||
106004107|NCT03077542|365676599|FG001|Overall Study|Death|0|||
106004108|NCT03077542|365676598|FG000|Overall Study|Physician Decision|6|||
106004109|NCT03077542|365676599|FG001|Overall Study|Physician Decision|1|||
105693538|NCT02606461|364542073|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
105693539|NCT02606461|364542074|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105693540|NCT02606461|364542075|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105693541|NCT02606461|364542076|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
105693542|NCT02092350|364542077|FG000|Overall Study|Adverse Event|0|||
105693543|NCT02092350|364542078|FG001|Overall Study|Adverse Event|3|||
105693544|NCT02092350|364542077|FG000|Overall Study|Death|2|||
105693545|NCT02092350|364542078|FG001|Overall Study|Death|5|||
105693546|NCT02092350|364542077|FG000|Overall Study|Lost to Follow-up|3|||
105693547|NCT02092350|364542078|FG001|Overall Study|Lost to Follow-up|1|||
105693548|NCT02092350|364542077|FG000|Overall Study|Protocol Violation|1|||
106004110|NCT03077542|365676598|FG000|Overall Study|Withdrawal by Subject|0|||
105693549|NCT02092350|364542078|FG001|Overall Study|Protocol Violation|0|||
105693550|NCT02092350|364542077|FG000|Overall Study|Physician Decision|1|||
105693551|NCT02092350|364542078|FG001|Overall Study|Physician Decision|1|||
106004111|NCT03077542|365676599|FG001|Overall Study|Withdrawal by Subject|1|||
106004112|NCT03649074|365676600|FG000|Overall Study|Lost to Follow-up|2|||
106004113|NCT03649074|365676601|FG001|Overall Study|Lost to Follow-up|1|||
106004114|NCT03649074|365676600|FG000|Overall Study|Adverse Event|1|||
106004115|NCT03649074|365676601|FG001|Overall Study|Adverse Event|0|||
106004116|NCT03649074|365676600|FG000|Overall Study|Physician Decision|1|||
106004117|NCT03649074|365676601|FG001|Overall Study|Physician Decision|0|||
106004118|NCT03649074|365676600|FG000|Overall Study|Withdrawal by Subject|0|||
106004119|NCT03649074|365676601|FG001|Overall Study|Withdrawal by Subject|2|||
106004120|NCT03649074|365676600|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
106132013|NCT04537949|366141866|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
106132014|NCT04537949|366141867|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
106132015|NCT04537949|366141860|FG000|Follow-up Phase|Lost to Follow-up|0|||
106132016|NCT04537949|366141861|FG001|Follow-up Phase|Lost to Follow-up|3|||
106132017|NCT04537949|366141862|FG002|Follow-up Phase|Lost to Follow-up|0|||
106132018|NCT04537949|366141863|FG003|Follow-up Phase|Lost to Follow-up|0|||
106132019|NCT04537949|366141864|FG004|Follow-up Phase|Lost to Follow-up|0|||
106132020|NCT04537949|366141865|FG005|Follow-up Phase|Lost to Follow-up|0|||
106132021|NCT04537949|366141866|FG006|Follow-up Phase|Lost to Follow-up|0|||
106132022|NCT04537949|366141867|FG007|Follow-up Phase|Lost to Follow-up|0|||
106132023|NCT04537949|366141860|FG000|Follow-up Phase|personal reasons|0|||
106132024|NCT04537949|366141861|FG001|Follow-up Phase|personal reasons|0|||
106132025|NCT04537949|366141862|FG002|Follow-up Phase|personal reasons|0|||
106132026|NCT04537949|366141863|FG003|Follow-up Phase|personal reasons|1|||
106132027|NCT04537949|366141864|FG004|Follow-up Phase|personal reasons|1|||
106132028|NCT04537949|366141865|FG005|Follow-up Phase|personal reasons|0|||
106132029|NCT04537949|366141866|FG006|Follow-up Phase|personal reasons|0|||
106132030|NCT04537949|366141867|FG007|Follow-up Phase|personal reasons|0|||
106132031|NCT04537949|366141860|FG000|Follow-up Phase|Withdrawal by Subject|0|||
106132032|NCT04537949|366141861|FG001|Follow-up Phase|Withdrawal by Subject|0|||
106132033|NCT04537949|366141862|FG002|Follow-up Phase|Withdrawal by Subject|0|||
106132034|NCT04537949|366141863|FG003|Follow-up Phase|Withdrawal by Subject|0|||
106132035|NCT04537949|366141864|FG004|Follow-up Phase|Withdrawal by Subject|1|||
106132036|NCT04537949|366141865|FG005|Follow-up Phase|Withdrawal by Subject|0|||
106132037|NCT04537949|366141866|FG006|Follow-up Phase|Withdrawal by Subject|0|||
106132038|NCT04537949|366141867|FG007|Follow-up Phase|Withdrawal by Subject|0|||
106132039|NCT04003974|366141869|FG000|Overall Study|Missing|1|||
106132040|NCT04003974|366141870|FG001|Overall Study|Missing|0|||
106132041|NCT04003974|366141869|FG000|Overall Study|Withdrawal by Subject|0|||
106132042|NCT04003974|366141870|FG001|Overall Study|Withdrawal by Subject|2|||
105693552|NCT02092350|364542077|FG000|Overall Study|Screen Failure|1|||
105920746|NCT02814526|365369406|FG000|Overall Study|early termination-study terminated|1|||
105920747|NCT02814526|365369407|FG001|Overall Study|early termination-study terminated|2|||
105920748|NCT02814526|365369406|FG000|Overall Study|Other|0|||
105920749|NCT02814526|365369407|FG001|Overall Study|Other|4|||
105920750|NCT00251758|365369410|FG000|Overall Study|Adverse Event|7|||
105920751|NCT00251758|365369411|FG001|Overall Study|Adverse Event|9|||
105920752|NCT00251758|365369412|FG002|Overall Study|Adverse Event|11|||
105920753|NCT00251758|365369410|FG000|Overall Study|Lost to Follow-up|4|||
105920754|NCT00251758|365369411|FG001|Overall Study|Lost to Follow-up|2|||
105920755|NCT00251758|365369412|FG002|Overall Study|Lost to Follow-up|5|||
105920756|NCT00251758|365369410|FG000|Overall Study|Withdrawal by Subject|13|||
105920757|NCT00251758|365369411|FG001|Overall Study|Withdrawal by Subject|7|||
105920758|NCT00251758|365369412|FG002|Overall Study|Withdrawal by Subject|3|||
105920759|NCT00251758|365369410|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
105920760|NCT00251758|365369411|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
105920761|NCT00251758|365369412|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
105920762|NCT00251758|365369410|FG000|Overall Study|Lack of Efficacy|3|||
105920763|NCT00251758|365369411|FG001|Overall Study|Lack of Efficacy|0|||
105920764|NCT00251758|365369412|FG002|Overall Study|Lack of Efficacy|0|||
105920765|NCT00251758|365369410|FG000|Overall Study|Noncompliant|0|||
105920766|NCT00251758|365369411|FG001|Overall Study|Noncompliant|2|||
105920767|NCT00251758|365369412|FG002|Overall Study|Noncompliant|2|||
105920768|NCT00251758|365369410|FG000|Overall Study|Pregnancy|0|||
105920769|NCT00251758|365369411|FG001|Overall Study|Pregnancy|1|||
105920770|NCT00251758|365369412|FG002|Overall Study|Pregnancy|0|||
105920771|NCT00251758|365369410|FG000|Overall Study|Per Subject Request|0|||
105920772|NCT00251758|365369411|FG001|Overall Study|Per Subject Request|0|||
105920773|NCT00251758|365369412|FG002|Overall Study|Per Subject Request|1|||
105920774|NCT00251758|365369410|FG000|Overall Study|Per Investigator Request|1|||
105920775|NCT00251758|365369411|FG001|Overall Study|Per Investigator Request|0|||
105920776|NCT00251758|365369412|FG002|Overall Study|Per Investigator Request|0|||
106004121|NCT03649074|365676601|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
106004122|NCT03649074|365676600|FG000|Overall Study|Other|1|||
106132043|NCT04296942|366141871|FG000|Overall Study|Study closure by sponsor|1|||
106132044|NCT04296942|366141872|FG001|Overall Study|Study closure by sponsor|0|||
106132045|NCT04296942|366141873|FG002|Overall Study|Study closure by sponsor|0|||
106132046|NCT01579578|366141874|FG000|Overall Study|Death|4|||
106132047|NCT01579578|366141875|FG001|Overall Study|Death|1|||
106132048|NCT01579578|366141874|FG000|Overall Study|Lost to Follow-up|1|||
106132049|NCT01579578|366141875|FG001|Overall Study|Lost to Follow-up|1|||
106132050|NCT01579578|366141874|FG000|Overall Study|Withdrawal by Subject|2|||
105920777|NCT01200329|365369419|FG000|Overall Study|Lack of financial coverage|2|||
105920778|NCT01200329|365369419|FG000|Overall Study|Progressive disease|1|||
105920779|NCT03642990|365369422|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
106004123|NCT03649074|365676601|FG001|Overall Study|Other|0|||
106132051|NCT01579578|366141875|FG001|Overall Study|Withdrawal by Subject|1|||
106004124|NCT01300728|365676602|FG000|Overall Study|Withdrawal by Subject|1|||
106004125|NCT01300728|365676603|FG001|Overall Study|Withdrawal by Subject|1|||
106004126|NCT01300728|365676602|FG000|Overall Study|Physician Decision|1|||
106004127|NCT01300728|365676603|FG001|Overall Study|Physician Decision|0|||
106004128|NCT00880620|365676607|FG000|Overall Study|Adverse Event|4|||
106004129|NCT00880620|365676608|FG001|Overall Study|Adverse Event|5|||
106004130|NCT00880620|365676609|FG002|Overall Study|Adverse Event|15|||
106004131|NCT00880620|365676610|FG003|Overall Study|Adverse Event|15|||
106004132|NCT00880620|365676607|FG000|Overall Study|Death|0|||
106004133|NCT00880620|365676608|FG001|Overall Study|Death|0|||
106004134|NCT00880620|365676609|FG002|Overall Study|Death|1|||
106004135|NCT00880620|365676610|FG003|Overall Study|Death|0|||
106004136|NCT00880620|365676607|FG000|Overall Study|Lack of Efficacy|12|||
106004137|NCT00880620|365676608|FG001|Overall Study|Lack of Efficacy|4|||
106004138|NCT00880620|365676609|FG002|Overall Study|Lack of Efficacy|0|||
106004139|NCT00880620|365676610|FG003|Overall Study|Lack of Efficacy|1|||
106004140|NCT00880620|365676607|FG000|Overall Study|Lost to Follow-up|0|||
106004141|NCT00880620|365676608|FG001|Overall Study|Lost to Follow-up|1|||
106004142|NCT00880620|365676609|FG002|Overall Study|Lost to Follow-up|1|||
106004143|NCT00880620|365676610|FG003|Overall Study|Lost to Follow-up|0|||
106004144|NCT00880620|365676607|FG000|Overall Study|Protocol Violation|0|||
106004145|NCT00880620|365676608|FG001|Overall Study|Protocol Violation|1|||
106004146|NCT00880620|365676609|FG002|Overall Study|Protocol Violation|0|||
106004147|NCT00880620|365676610|FG003|Overall Study|Protocol Violation|2|||
106004148|NCT00880620|365676607|FG000|Overall Study|Withdrawal by Subject|4|||
106004149|NCT00880620|365676608|FG001|Overall Study|Withdrawal by Subject|3|||
106004150|NCT00880620|365676609|FG002|Overall Study|Withdrawal by Subject|1|||
106004151|NCT00880620|365676610|FG003|Overall Study|Withdrawal by Subject|3|||
106004152|NCT00880620|365676607|FG000|Overall Study|Noncompliance|0|||
106004153|NCT00880620|365676608|FG001|Overall Study|Noncompliance|0|||
106004154|NCT00880620|365676609|FG002|Overall Study|Noncompliance|1|||
106004155|NCT00880620|365676610|FG003|Overall Study|Noncompliance|1|||
106004156|NCT00880620|365676607|FG000|Overall Study|Other|1|||
106004157|NCT00880620|365676608|FG001|Overall Study|Other|1|||
106004158|NCT00880620|365676609|FG002|Overall Study|Other|2|||
106004159|NCT00880620|365676610|FG003|Overall Study|Other|2|||
106004160|NCT00301808|365676613|FG000|Overall Study|Adverse Event|5|||
106004161|NCT00301808|365676613|FG000|Overall Study|Death|3|||
106004162|NCT00301808|365676613|FG000|Overall Study|Lack of Efficacy|4|||
106004163|NCT03291067|365678161|FG000|Overall Study|Adverse Event|0|||
106004164|NCT03291067|365678162|FG001|Overall Study|Adverse Event|2|||
106004165|NCT03291067|365678163|FG002|Overall Study|Adverse Event|17|||
106004166|NCT03291067|365678164|FG003|Overall Study|Adverse Event|3|||
106004167|NCT03291067|365678161|FG000|Overall Study|Lost to Follow-up|2|||
106004168|NCT03291067|365678162|FG001|Overall Study|Lost to Follow-up|1|||
106004169|NCT03291067|365678163|FG002|Overall Study|Lost to Follow-up|0|||
106004170|NCT03291067|365678164|FG003|Overall Study|Lost to Follow-up|1|||
106004171|NCT03291067|365678161|FG000|Overall Study|Physician Decision|0|||
106004172|NCT03291067|365678162|FG001|Overall Study|Physician Decision|0|||
106004173|NCT03291067|365678163|FG002|Overall Study|Physician Decision|1|||
106004174|NCT03291067|365678164|FG003|Overall Study|Physician Decision|0|||
106004175|NCT03291067|365678161|FG000|Overall Study|Protocol Violation|5|||
106004176|NCT03291067|365678162|FG001|Overall Study|Protocol Violation|3|||
106004177|NCT03291067|365678163|FG002|Overall Study|Protocol Violation|4|||
106004178|NCT03291067|365678164|FG003|Overall Study|Protocol Violation|2|||
106004179|NCT03291067|365678161|FG000|Overall Study|Withdrawal by Subject|3|||
106132052|NCT01579578|366141874|FG000|Overall Study|Eligibility criteria|3|||
106132053|NCT01579578|366141875|FG001|Overall Study|Eligibility criteria|9|||
106132054|NCT01579578|366141874|FG000|Overall Study|Ongoing|3|||
105693553|NCT02092350|364542078|FG001|Overall Study|Screen Failure|0|||
105693554|NCT02092350|364542077|FG000|Overall Study|Withdrawal by Subject|2|||
106004180|NCT03291067|365678162|FG001|Overall Study|Withdrawal by Subject|4|||
106004181|NCT03291067|365678163|FG002|Overall Study|Withdrawal by Subject|7|||
106004182|NCT03291067|365678164|FG003|Overall Study|Withdrawal by Subject|5|||
106004183|NCT03291067|365678161|FG000|Overall Study|Other|0|||
106004184|NCT03291067|365678162|FG001|Overall Study|Other|4|||
106004185|NCT03291067|365678163|FG002|Overall Study|Other|4|||
106004186|NCT03291067|365678164|FG003|Overall Study|Other|6|||
106004187|NCT02250326|365678168|FG000|Treatment|Death|1|||
106004188|NCT02250326|365678169|FG001|Treatment|Death|13|||
106004189|NCT02250326|365678170|FG002|Treatment|Death|2|||
106004190|NCT02250326|365678168|FG000|Treatment|Adverse Event|8|||
106004191|NCT02250326|365678169|FG001|Treatment|Adverse Event|8|||
106004192|NCT02250326|365678170|FG002|Treatment|Adverse Event|9|||
105693555|NCT02092350|364542078|FG001|Overall Study|Withdrawal by Subject|2|||
106004193|NCT02250326|365678168|FG000|Treatment|Progressive Disease|42|||
106004194|NCT02250326|365678169|FG001|Treatment|Progressive Disease|40|||
106004195|NCT02250326|365678170|FG002|Treatment|Progressive Disease|47|||
106132055|NCT01579578|366141875|FG001|Overall Study|Ongoing|0|||
106004196|NCT02250326|365678168|FG000|Treatment|Symptomatic Deterioration|9|||
106004197|NCT02250326|365678169|FG001|Treatment|Symptomatic Deterioration|4|||
106004198|NCT02250326|365678170|FG002|Treatment|Symptomatic Deterioration|10|||
105920780|NCT03642990|365369422|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
105920781|NCT01420536|365369424|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
105920782|NCT01420536|365369425|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
105920783|NCT03092752|365369428|FG000|Overall Study|Aged <40 years|14209|||
105920784|NCT03092752|365369428|FG000|Overall Study|At least one claim with T2DM|61299|||
105920785|NCT03092752|365369428|FG000|Overall Study|Having no claim of study drugs|29282|||
105693556|NCT00024167|364542079|FG000|Overall Study|Death|53|||
105693557|NCT00024167|364542080|FG001|Overall Study|Death|47|||
105693558|NCT00931944|364542081|FG000|Overall Study|Adverse Event|4|||
105693559|NCT00931944|364542081|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
105693560|NCT00931944|364542081|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
105693561|NCT00931944|364542081|FG000|Overall Study|Death|28|||
105693562|NCT00931944|364542081|FG000|Overall Study|Other|2|||
105693563|NCT00006392|364542087|FG000|Overall Study|Ineligible|11|||
105693564|NCT00006392|364542088|FG001|Overall Study|Ineligible|3|||
105693565|NCT00006392|364542089|FG002|Overall Study|Ineligible|5|||
105693566|NCT00006392|364542090|FG003|Overall Study|Ineligible|5|||
105693567|NCT00006392|364542087|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
105693568|NCT00006392|364542088|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
105693569|NCT00006392|364542089|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
105693570|NCT00006392|364542090|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
105693571|NCT03838198|364542095|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
105693572|NCT03838198|364542096|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
105693573|NCT03838198|364542097|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
105693574|NCT03838198|364542098|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
105693575|NCT03838198|364542095|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
105693576|NCT03838198|364542096|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
105693577|NCT03838198|364542097|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
105693578|NCT03838198|364542098|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
105693579|NCT00770770|364542104|FG000|Overall Study|Lost to Follow-up|1|||
105693580|NCT00770770|364542105|FG001|Overall Study|Lost to Follow-up|0|||
105693581|NCT00770770|364542104|FG000|Overall Study|Withdrawal by Subject|1|||
105693582|NCT00770770|364542105|FG001|Overall Study|Withdrawal by Subject|0|||
105920786|NCT03092752|365369428|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
105920787|NCT03092752|365369428|FG000|Overall Study|<6 month history|245900|||
105920788|NCT01652690|365369430|FG000|Overall Study|Withdrawal by Subject|16|||
105920789|NCT01652690|365369431|FG001|Overall Study|Withdrawal by Subject|4|||
105920790|NCT01652690|365369430|FG000|Overall Study|Other|8|||
105920791|NCT01652690|365369431|FG001|Overall Study|Other|9|||
105920792|NCT01652690|365369430|FG000|Overall Study|Lost to Follow-up|6|||
105920793|NCT01652690|365369431|FG001|Overall Study|Lost to Follow-up|6|||
105920794|NCT01652690|365369430|FG000|Overall Study|Death|5|||
106132056|NCT00335153|366141876|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
105920795|NCT01652690|365369431|FG001|Overall Study|Death|2|||
105920796|NCT00921024|365369437|FG000|Overall Study|Lost to Follow-up|2|||
105920797|NCT00921024|365369438|FG001|Overall Study|Lost to Follow-up|0|||
105920798|NCT00921024|365369437|FG000|Overall Study|Received concomittant therapy|2|||
105920799|NCT00921024|365369438|FG001|Overall Study|Received concomittant therapy|0|||
105920800|NCT00921024|365369437|FG000|Overall Study|Withdrawal by Subject|0|||
105693583|NCT00770770|364542104|FG000|Overall Study|Death|0|||
105693584|NCT00770770|364542105|FG001|Overall Study|Death|1|||
105693585|NCT00770770|364542104|FG000|Overall Study|Study Terminated|8|||
105693586|NCT00770770|364542105|FG001|Overall Study|Study Terminated|0|||
105693587|NCT01026142|364542106|FG000|Overall Study|Death|136|||
105693588|NCT01026142|364542107|FG001|Overall Study|Death|134|||
105693589|NCT01026142|364542106|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
105693590|NCT01026142|364542107|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
105693591|NCT00628251|364542111|FG000|Randomised Part|Withdrawal by Subject|0|||
105693592|NCT00628251|364542112|FG001|Randomised Part|Withdrawal by Subject|0|||
105693593|NCT00628251|364542113|FG002|Randomised Part|Withdrawal by Subject|1|||
105693594|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
105693595|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
105693596|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
105693597|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
105693598|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
105920801|NCT00921024|365369438|FG001|Overall Study|Withdrawal by Subject|3|||
105920802|NCT00666237|365369445|FG000|Overall Study|Death|5|||
105920803|NCT00666237|365369446|FG001|Overall Study|Death|5|||
105920804|NCT00666237|365369445|FG000|Overall Study|Lost to Follow-up|29|||
105920805|NCT00666237|365369446|FG001|Overall Study|Lost to Follow-up|25|||
106132057|NCT00335153|366141876|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
106132058|NCT00335153|366141876|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
105693599|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
105693600|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
105693601|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
105693602|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
105693603|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
105693604|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
105693605|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
105693606|NCT00628251|364542111|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
105693607|NCT00628251|364542112|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
105693608|NCT00628251|364542113|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
105693609|NCT00728481|364542114|FG000|Overall Study|Withdrawal by Subject|0|||
105693610|NCT00728481|364542115|FG001|Overall Study|Withdrawal by Subject|1|||
105693611|NCT00728481|364542114|FG000|Overall Study|Adverse Event|0|||
105693612|NCT00728481|364542115|FG001|Overall Study|Adverse Event|1|||
105693613|NCT00728481|364542114|FG000|Overall Study|Study medication non-compliance|0|||
105693614|NCT00728481|364542115|FG001|Overall Study|Study medication non-compliance|2|||
105693615|NCT00728481|364542114|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
105693616|NCT00728481|364542115|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
105693617|NCT03690141|364542116|FG000|Overall Study|Adverse Event|5|||
105693618|NCT03690141|364542116|FG000|Overall Study|Withdrawal by Subject|3|||
105693619|NCT03690141|364542116|FG000|Overall Study|Physician Decision|4|||
105693620|NCT03690141|364542116|FG000|Overall Study|Disease progression|4|||
105693621|NCT02540538|364542119|FG000|Overall Study|Pregnancy|0|||
105693622|NCT02540538|364542120|FG001|Overall Study|Pregnancy|1|||
105693623|NCT02540538|364542121|FG002|Overall Study|Pregnancy|0|||
105693624|NCT00375219|364542123|FG000|Overall Study|Failure to achieve a response|16|||
105693625|NCT00375219|364542124|FG001|Overall Study|Failure to achieve a response|2|||
105693626|NCT00375219|364542125|FG002|Overall Study|Failure to achieve a response|0|||
105693627|NCT00375219|364542123|FG000|Overall Study|Adverse Event|8|||
105693628|NCT00375219|364542124|FG001|Overall Study|Adverse Event|2|||
105693629|NCT00375219|364542125|FG002|Overall Study|Adverse Event|1|||
105693630|NCT00375219|364542123|FG000|Overall Study|Protocol Violation|1|||
105693631|NCT00375219|364542124|FG001|Overall Study|Protocol Violation|0|||
105693632|NCT00375219|364542125|FG002|Overall Study|Protocol Violation|1|||
105693633|NCT00375219|364542123|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
105693634|NCT00375219|364542124|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
105693635|NCT00375219|364542125|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
105693636|NCT00375219|364542123|FG000|Overall Study|Lost to Follow-up|1|||
105693637|NCT00375219|364542124|FG001|Overall Study|Lost to Follow-up|1|||
105693638|NCT00375219|364542125|FG002|Overall Study|Lost to Follow-up|0|||
105693639|NCT00375219|364542123|FG000|Overall Study|Disease progression|18|||
105693640|NCT00375219|364542124|FG001|Overall Study|Disease progression|9|||
105693641|NCT00375219|364542125|FG002|Overall Study|Disease progression|12|||
105693642|NCT00375219|364542123|FG000|Overall Study|Death|4|||
105693643|NCT00375219|364542124|FG001|Overall Study|Death|3|||
105693644|NCT00375219|364542125|FG002|Overall Study|Death|7|||
105693645|NCT00375219|364542123|FG000|Overall Study|Hematologic resistance|1|||
105693646|NCT00375219|364542124|FG001|Overall Study|Hematologic resistance|0|||
105693647|NCT00375219|364542125|FG002|Overall Study|Hematologic resistance|0|||
105693648|NCT00375219|364542123|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
105693649|NCT00375219|364542124|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
105693650|NCT00375219|364542125|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
105693651|NCT00375219|364542123|FG000|Overall Study|Allograft|2|||
105693652|NCT00375219|364542124|FG001|Overall Study|Allograft|0|||
105693653|NCT00375219|364542125|FG002|Overall Study|Allograft|0|||
105693654|NCT00375219|364542123|FG000|Overall Study|Cord blood transplantation|1|||
105693655|NCT00375219|364542124|FG001|Overall Study|Cord blood transplantation|0|||
105693656|NCT00375219|364542125|FG002|Overall Study|Cord blood transplantation|0|||
105693657|NCT00375219|364542123|FG000|Overall Study|Withdrawal by Subject|1|||
105693658|NCT00375219|364542124|FG001|Overall Study|Withdrawal by Subject|0|||
105693659|NCT00375219|364542125|FG002|Overall Study|Withdrawal by Subject|0|||
105693660|NCT01252810|364542128|FG000|Overall Study|Withdrawal by Subject|4|||
105693661|NCT01252810|364542129|FG001|Overall Study|Withdrawal by Subject|1|||
105693662|NCT01252810|364542128|FG000|Overall Study|Lost to Follow-up|0|||
105693663|NCT01252810|364542129|FG001|Overall Study|Lost to Follow-up|1|||
105693664|NCT01252810|364542128|FG000|Overall Study|Physician Decision|2|||
105693665|NCT01252810|364542129|FG001|Overall Study|Physician Decision|1|||
105693666|NCT01252810|364542128|FG000|Overall Study|Various reasons|8|||
105693667|NCT01252810|364542129|FG001|Overall Study|Various reasons|0|||
105693668|NCT01162239|364542133|FG000|Treatment Phase|Withdrawal by Subject|1|||
105693669|NCT01162239|364542134|FG001|Treatment Phase|Withdrawal by Subject|3|||
105693670|NCT01162239|364542135|FG002|Treatment Phase|Withdrawal by Subject|2|||
105693671|NCT01162239|364542136|FG003|Treatment Phase|Withdrawal by Subject|3|||
105693672|NCT01162239|364542133|FG000|Treatment Phase|Death|0|||
105693673|NCT01162239|364542134|FG001|Treatment Phase|Death|0|||
106132059|NCT00335153|366141876|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
106132060|NCT00335153|366141876|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
106132061|NCT00335153|366141876|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
106132062|NCT00335153|366141876|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
106132063|NCT00335153|366141876|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
106132064|NCT00335153|366141876|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
106132065|NCT00335153|366141876|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
106132066|NCT02825043|366141879|FG000|Overall Study|Lost to Follow-up|4|||
106132067|NCT03704298|366141882|FG000|Overall Study|Death|3|||
106132068|NCT03704298|366141883|FG001|Overall Study|Death|1|||
106132069|NCT03704298|366141884|FG002|Overall Study|Death|1|||
106132070|NCT03704298|366141885|FG003|Overall Study|Death|0|||
106132071|NCT03704298|366141882|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
106132072|NCT03704298|366141883|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
106132073|NCT03704298|366141884|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
106132074|NCT03704298|366141885|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
106132075|NCT03704298|366141882|FG000|Overall Study|Withdrawal by Subject|1|||
106132076|NCT03704298|366141883|FG001|Overall Study|Withdrawal by Subject|0|||
106132077|NCT03704298|366141884|FG002|Overall Study|Withdrawal by Subject|0|||
105693674|NCT01162239|364542135|FG002|Treatment Phase|Death|0|||
106132078|NCT03704298|366141885|FG003|Overall Study|Withdrawal by Subject|0|||
106132079|NCT03704298|366141882|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
106132080|NCT03704298|366141883|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
106132081|NCT03704298|366141884|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
106132082|NCT03704298|366141885|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
106132083|NCT00558753|366141886|FG000|Overall Study|Lost to Follow-up|5|||
106132084|NCT00558753|366141887|FG001|Overall Study|Lost to Follow-up|7|||
106132085|NCT00821236|366141888|FG000|Overall Study|Lost to Follow-up|3|||
106132086|NCT00052962|366141889|FG000|Overall Study|Not evaluable|0|||
106132087|NCT00052962|366141890|FG001|Overall Study|Not evaluable|2|||
106132088|NCT00052962|366141889|FG000|Overall Study|Not randomized/not evaluable|1|||
106132089|NCT00052962|366141890|FG001|Overall Study|Not randomized/not evaluable|0|||
106132090|NCT04887285|366141893|FG000|Overall Study|Lost to Follow-up|0|||
106132091|NCT04887285|366141894|FG001|Overall Study|Lost to Follow-up|2|||
106132092|NCT04887285|366141895|FG002|Overall Study|Lost to Follow-up|3|||
106132093|NCT00770211|366141897|FG000|Overall Study|Lost to Follow-up|1|||
106132094|NCT00770211|366141898|FG001|Overall Study|Lost to Follow-up|0|||
106132095|NCT00770211|366141897|FG000|Overall Study|Withdrawal by Subject|0|||
106132096|NCT00770211|366141898|FG001|Overall Study|Withdrawal by Subject|2|||
106132097|NCT04739423|366141900|FG000|Overall Study|Protocol Violation|0|||
106132098|NCT04739423|366141901|FG001|Overall Study|Protocol Violation|1|||
106132099|NCT04739423|366141902|FG002|Overall Study|Protocol Violation|0|||
106132100|NCT04739423|366141903|FG003|Overall Study|Protocol Violation|0|||
106132101|NCT04739423|366141904|FG004|Overall Study|Protocol Violation|0|||
106132102|NCT04739423|366141905|FG005|Overall Study|Protocol Violation|0|||
105693675|NCT01162239|364542136|FG003|Treatment Phase|Death|1|||
105693676|NCT01162239|364542133|FG000|Treatment Phase|Lost to Follow-up|5|||
105693677|NCT01162239|364542134|FG001|Treatment Phase|Lost to Follow-up|4|||
105693678|NCT01162239|364542135|FG002|Treatment Phase|Lost to Follow-up|2|||
105693679|NCT01162239|364542136|FG003|Treatment Phase|Lost to Follow-up|1|||
105693680|NCT01162239|364542133|FG000|Extended Follow-up|Lost to Follow-up|8|||
105693681|NCT01162239|364542134|FG001|Extended Follow-up|Lost to Follow-up|13|||
105693682|NCT01162239|364542135|FG002|Extended Follow-up|Lost to Follow-up|8|||
105693683|NCT01162239|364542136|FG003|Extended Follow-up|Lost to Follow-up|6|||
105693684|NCT00228566|364542137|FG000|Overall Study|Adverse Event|31|||
105693685|NCT00228566|364542137|FG000|Overall Study|Lack of Efficacy|14|||
105693686|NCT00228566|364542137|FG000|Overall Study|Lost to Follow-up|16|||
105693687|NCT00228566|364542137|FG000|Overall Study|Physician Decision|5|||
105693688|NCT00228566|364542137|FG000|Overall Study|Withdrawal by Subject|4|||
105693689|NCT00228566|364542137|FG000|Overall Study|Miscellaneous|1|||
105693690|NCT03431350|364542140|FG000|Overall Study|ONGOING|0|||
105693691|NCT03431350|364542141|FG001|Overall Study|ONGOING|0|||
105693692|NCT03431350|364542142|FG002|Overall Study|ONGOING|2|||
105693693|NCT03431350|364542143|FG003|Overall Study|ONGOING|0|||
105693694|NCT03431350|364542144|FG004|Overall Study|ONGOING|1|||
105693695|NCT03431350|364542145|FG005|Overall Study|ONGOING|3|||
105693696|NCT03431350|364542146|FG006|Overall Study|ONGOING|0|||
105693697|NCT03431350|364542147|FG007|Overall Study|ONGOING|1|||
106132103|NCT04739423|366141900|FG000|Overall Study|Adverse Event|0|||
106132104|NCT04739423|366141901|FG001|Overall Study|Adverse Event|0|||
106132105|NCT04739423|366141902|FG002|Overall Study|Adverse Event|1|||
106132106|NCT04739423|366141903|FG003|Overall Study|Adverse Event|0|||
106132107|NCT04739423|366141904|FG004|Overall Study|Adverse Event|1|||
106132108|NCT04739423|366141905|FG005|Overall Study|Adverse Event|0|||
106132109|NCT04739423|366141900|FG000|Overall Study|Withdrawal by Subject|0|||
105693698|NCT03431350|364542148|FG008|Overall Study|ONGOING|3|||
105693699|NCT03431350|364542149|FG009|Overall Study|ONGOING|4|||
105693700|NCT03431350|364542150|FG010|Overall Study|ONGOING|2|||
105693701|NCT03431350|364542151|FG011|Overall Study|ONGOING|1|||
105693702|NCT03431350|364542140|FG000|Overall Study|Death|6|||
105693703|NCT03431350|364542141|FG001|Overall Study|Death|5|||
105693704|NCT03431350|364542142|FG002|Overall Study|Death|18|||
105693705|NCT03431350|364542143|FG003|Overall Study|Death|7|||
105693706|NCT03431350|364542144|FG004|Overall Study|Death|4|||
105693707|NCT03431350|364542145|FG005|Overall Study|Death|3|||
105693708|NCT03431350|364542146|FG006|Overall Study|Death|2|||
105693709|NCT03431350|364542147|FG007|Overall Study|Death|0|||
105693710|NCT03431350|364542148|FG008|Overall Study|Death|0|||
105693711|NCT03431350|364542149|FG009|Overall Study|Death|0|||
105693712|NCT03431350|364542150|FG010|Overall Study|Death|4|||
105693713|NCT03431350|364542151|FG011|Overall Study|Death|0|||
105693714|NCT03431350|364542140|FG000|Overall Study|Lost to Follow-up|0|||
105693715|NCT03431350|364542141|FG001|Overall Study|Lost to Follow-up|1|||
105693716|NCT03431350|364542142|FG002|Overall Study|Lost to Follow-up|0|||
105693717|NCT03431350|364542143|FG003|Overall Study|Lost to Follow-up|0|||
105693718|NCT03431350|364542144|FG004|Overall Study|Lost to Follow-up|0|||
105693719|NCT03431350|364542145|FG005|Overall Study|Lost to Follow-up|0|||
105693720|NCT03431350|364542146|FG006|Overall Study|Lost to Follow-up|0|||
105693721|NCT03431350|364542147|FG007|Overall Study|Lost to Follow-up|0|||
105693722|NCT03431350|364542148|FG008|Overall Study|Lost to Follow-up|0|||
105693723|NCT03431350|364542149|FG009|Overall Study|Lost to Follow-up|0|||
105693724|NCT03431350|364542150|FG010|Overall Study|Lost to Follow-up|0|||
105693725|NCT03431350|364542151|FG011|Overall Study|Lost to Follow-up|0|||
105693726|NCT03431350|364542140|FG000|Overall Study|Withdrawal by Subject|0|||
105693727|NCT03431350|364542141|FG001|Overall Study|Withdrawal by Subject|0|||
105693728|NCT03431350|364542142|FG002|Overall Study|Withdrawal by Subject|0|||
105693729|NCT03431350|364542143|FG003|Overall Study|Withdrawal by Subject|1|||
105693730|NCT03431350|364542144|FG004|Overall Study|Withdrawal by Subject|1|||
105693731|NCT03431350|364542145|FG005|Overall Study|Withdrawal by Subject|1|||
105693732|NCT03431350|364542146|FG006|Overall Study|Withdrawal by Subject|0|||
105693733|NCT03431350|364542147|FG007|Overall Study|Withdrawal by Subject|0|||
105693734|NCT03431350|364542148|FG008|Overall Study|Withdrawal by Subject|0|||
105693735|NCT03431350|364542149|FG009|Overall Study|Withdrawal by Subject|2|||
105693736|NCT03431350|364542150|FG010|Overall Study|Withdrawal by Subject|0|||
105693737|NCT03431350|364542151|FG011|Overall Study|Withdrawal by Subject|1|||
105693738|NCT03431350|364542140|FG000|Overall Study|Other|0|||
105693739|NCT03431350|364542141|FG001|Overall Study|Other|0|||
105693740|NCT03431350|364542142|FG002|Overall Study|Other|1|||
105693741|NCT03431350|364542143|FG003|Overall Study|Other|3|||
105693742|NCT03431350|364542144|FG004|Overall Study|Other|2|||
105693743|NCT03431350|364542145|FG005|Overall Study|Other|2|||
105693744|NCT03431350|364542146|FG006|Overall Study|Other|4|||
105693745|NCT03431350|364542147|FG007|Overall Study|Other|0|||
105693746|NCT03431350|364542148|FG008|Overall Study|Other|14|||
105693747|NCT03431350|364542149|FG009|Overall Study|Other|11|||
105693748|NCT03431350|364542150|FG010|Overall Study|Other|11|||
105693749|NCT03431350|364542151|FG011|Overall Study|Other|15|||
105693750|NCT00583024|364542152|FG000|Overall Study|Lost to Follow-up|4|||
105693751|NCT00088907|364543445|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
105693752|NCT00088907|364543446|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
105693753|NCT00088907|364543445|FG000|Randomized Study (Step 1)|Adverse Event|14|||
105693754|NCT00088907|364543446|FG001|Randomized Study (Step 1)|Adverse Event|19|||
105693755|NCT00088907|364543445|FG000|Randomized Study (Step 1)|Death|11|||
105693756|NCT00088907|364543446|FG001|Randomized Study (Step 1)|Death|12|||
105693757|NCT00088907|364543445|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
105693758|NCT00088907|364543446|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
105693759|NCT00088907|364543445|FG000|Randomized Study (Step 1)|complicating disease|3|||
105693760|NCT00088907|364543446|FG001|Randomized Study (Step 1)|complicating disease|1|||
105693761|NCT00088907|364543445|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
105693762|NCT00088907|364543446|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
105693763|NCT00088907|364543445|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
105693764|NCT00088907|364543446|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
105693765|NCT00088907|364543445|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
105693766|NCT00088907|364543446|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
105693767|NCT00088907|364543445|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
105693768|NCT00088907|364543446|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
105693769|NCT00088907|364543445|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
105693770|NCT00088907|364543446|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
105693771|NCT00088907|364543445|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
105693772|NCT00088907|364543446|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
105693773|NCT03426787|364543447|FG000|Overall Study|Withdrawal by Subject|6|||
105693774|NCT03426787|364543447|FG000|Overall Study|Lost to Follow-up|7|||
105693775|NCT03426787|364543447|FG000|Overall Study|Unrelated to intervention death|1|||
105693776|NCT00928564|364543453|FG000|Overall Study|Lost to Follow-up|6|||
105693777|NCT00928564|364543454|FG001|Overall Study|Lost to Follow-up|0|||
105693778|NCT02973425|364543455|FG000|Overall Study|Lost to Follow-up|49|||
105693779|NCT02973425|364543456|FG001|Overall Study|Lost to Follow-up|53|||
105693780|NCT02460497|364543459|FG000|Overall Study|Participant Requested Withdrawal|4|||
105693781|NCT02460497|364543459|FG000|Overall Study|Non-Compliance|1|||
105693782|NCT02460497|364543459|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
105693783|NCT02460497|364543459|FG000|Overall Study|Lost to Follow-up|2|||
105693784|NCT02460497|364543459|FG000|Overall Study|Investigator Decision|1|||
105693785|NCT01448213|364543462|FG000|Overall Study|Lost to Follow-up|12|||
105693786|NCT01448213|364543463|FG001|Overall Study|Lost to Follow-up|10|||
105693787|NCT01448213|364543462|FG000|Overall Study|Adverse Event|4|||
105693788|NCT01448213|364543463|FG001|Overall Study|Adverse Event|10|||
105693789|NCT01448213|364543462|FG000|Overall Study|Protocol Violation|1|||
105693790|NCT01448213|364543463|FG001|Overall Study|Protocol Violation|2|||
105693791|NCT03876171|364543464|FG000|Overall Study|Withdrawal by Subject|3|||
105693792|NCT03876171|364543465|FG001|Overall Study|Withdrawal by Subject|3|||
105693793|NCT03876171|364543464|FG000|Overall Study|Re-arrest|0|||
105693794|NCT03876171|364543465|FG001|Overall Study|Re-arrest|4|||
105693795|NCT02012296|364543466|FG000|Overall Study|Lack of Efficacy|0|||
105693796|NCT02012296|364543467|FG001|Overall Study|Lack of Efficacy|0|||
105693797|NCT02012296|364543468|FG002|Overall Study|Lack of Efficacy|15|||
105693798|NCT02012296|364543466|FG000|Overall Study|Adverse Event|0|||
105693799|NCT02012296|364543467|FG001|Overall Study|Adverse Event|0|||
105693800|NCT02012296|364543468|FG002|Overall Study|Adverse Event|2|||
105693801|NCT02012296|364543466|FG000|Overall Study|Early study closure|0|||
105693802|NCT02012296|364543467|FG001|Overall Study|Early study closure|0|||
105693803|NCT02012296|364543468|FG002|Overall Study|Early study closure|5|||
105693804|NCT02012296|364543466|FG000|Overall Study|Protocol Violation|0|||
105693805|NCT02012296|364543467|FG001|Overall Study|Protocol Violation|1|||
105693806|NCT02012296|364543468|FG002|Overall Study|Protocol Violation|0|||
105693807|NCT03739762|364543469|FG000|Overall Study|Lost to Follow-up|1|||
105693808|NCT03739762|364543470|FG001|Overall Study|Lost to Follow-up|1|||
105693809|NCT03739762|364543469|FG000|Overall Study|Withdrawal by Subject|2|||
105693810|NCT03739762|364543470|FG001|Overall Study|Withdrawal by Subject|6|||
105693811|NCT04163900|364543477|FG000|Overall Study|Radiological disease progression|112|||
105693812|NCT04163900|364543478|FG001|Overall Study|Radiological disease progression|127|||
105693813|NCT04163900|364543477|FG000|Overall Study|Study closure|98|||
105693814|NCT04163900|364543478|FG001|Overall Study|Study closure|133|||
105693815|NCT04163900|364543477|FG000|Overall Study|Adverse Event|78|||
105693816|NCT04163900|364543478|FG001|Overall Study|Adverse Event|32|||
105693817|NCT04163900|364543477|FG000|Overall Study|Withdrawal by Subject|37|||
105693818|NCT04163900|364543478|FG001|Overall Study|Withdrawal by Subject|34|||
105693819|NCT04163900|364543477|FG000|Overall Study|Death|29|||
105693820|NCT04163900|364543478|FG001|Overall Study|Death|16|||
105693821|NCT04163900|364543477|FG000|Overall Study|Physician Decision|17|||
105693822|NCT04163900|364543478|FG001|Overall Study|Physician Decision|25|||
105693823|NCT04163900|364543477|FG000|Overall Study|Clinical disease progression|14|||
105693824|NCT04163900|364543478|FG001|Overall Study|Clinical disease progression|13|||
105693825|NCT04163900|364543477|FG000|Overall Study|Protocol Violation|3|||
105693826|NCT04163900|364543478|FG001|Overall Study|Protocol Violation|4|||
105693827|NCT04163900|364543477|FG000|Overall Study|Lost to Follow-up|0|||
105693828|NCT04163900|364543478|FG001|Overall Study|Lost to Follow-up|1|||
105693829|NCT00283049|364543479|FG000|Overall Study|Adverse Event|6|||
105693830|NCT00283049|364543480|FG001|Overall Study|Adverse Event|1|||
105693831|NCT00283049|364543481|FG002|Overall Study|Adverse Event|4|||
105693832|NCT00283049|364543479|FG000|Overall Study|Protocol Violation|3|||
105693833|NCT00283049|364543480|FG001|Overall Study|Protocol Violation|0|||
105693834|NCT00283049|364543481|FG002|Overall Study|Protocol Violation|3|||
105693835|NCT00283049|364543479|FG000|Overall Study|Death|1|||
105693836|NCT00283049|364543480|FG001|Overall Study|Death|1|||
105693837|NCT00283049|364543481|FG002|Overall Study|Death|1|||
105693838|NCT00283049|364543479|FG000|Overall Study|Lack of Efficacy|0|||
105693839|NCT00283049|364543480|FG001|Overall Study|Lack of Efficacy|1|||
105693840|NCT00283049|364543481|FG002|Overall Study|Lack of Efficacy|1|||
105693841|NCT00283049|364543479|FG000|Overall Study|Lost to Follow-up|4|||
105693842|NCT00283049|364543480|FG001|Overall Study|Lost to Follow-up|2|||
105693843|NCT00283049|364543481|FG002|Overall Study|Lost to Follow-up|5|||
105693844|NCT00283049|364543479|FG000|Overall Study|Withdrawal by Subject|26|||
105693845|NCT00283049|364543480|FG001|Overall Study|Withdrawal by Subject|24|||
105693846|NCT00283049|364543481|FG002|Overall Study|Withdrawal by Subject|19|||
105693847|NCT00283049|364543479|FG000|Overall Study|Discontinuation of Study|18|||
105693848|NCT00283049|364543480|FG001|Overall Study|Discontinuation of Study|16|||
105693849|NCT00283049|364543481|FG002|Overall Study|Discontinuation of Study|20|||
105693850|NCT00283049|364543479|FG000|Overall Study|No longer requires study treatment|0|||
105693851|NCT00283049|364543480|FG001|Overall Study|No longer requires study treatment|0|||
105693852|NCT00283049|364543481|FG002|Overall Study|No longer requires study treatment|1|||
105693853|NCT01873417|364543482|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
105693854|NCT01873417|364543482|FG000|Overall Study|Adverse Event|24|||
105693855|NCT01873417|364543482|FG000|Overall Study|Lost to Follow-up|2|||
105693856|NCT01873417|364543482|FG000|Overall Study|Withdrawal by Subject|2|||
106132110|NCT04739423|366141901|FG001|Overall Study|Withdrawal by Subject|0|||
106132111|NCT04739423|366141902|FG002|Overall Study|Withdrawal by Subject|0|||
106132112|NCT04739423|366141903|FG003|Overall Study|Withdrawal by Subject|0|||
106132113|NCT04739423|366141904|FG004|Overall Study|Withdrawal by Subject|0|||
106132114|NCT04739423|366141905|FG005|Overall Study|Withdrawal by Subject|1|||
106132115|NCT00819234|366141906|FG000|Overall Study|Withdrawal by Subject|8|||
106132116|NCT00819234|366141907|FG001|Overall Study|Withdrawal by Subject|13|||
106132117|NCT00819234|366141908|FG002|Overall Study|Withdrawal by Subject|6|||
106132118|NCT00819234|366141909|FG003|Overall Study|Withdrawal by Subject|3|||
106132119|NCT00819234|366141910|FG004|Overall Study|Withdrawal by Subject|0|||
106132120|NCT00819234|366141911|FG005|Overall Study|Withdrawal by Subject|4|||
106132121|NCT00819234|366141912|FG006|Overall Study|Withdrawal by Subject|4|||
106132122|NCT00819234|366141913|FG007|Overall Study|Withdrawal by Subject|8|||
106132123|NCT00819234|366141914|FG008|Overall Study|Withdrawal by Subject|5|||
106132124|NCT00819234|366141915|FG009|Overall Study|Withdrawal by Subject|3|||
106132125|NCT00819234|366141906|FG000|Overall Study|Adverse Event|0|||
106132126|NCT00819234|366141907|FG001|Overall Study|Adverse Event|0|||
106132127|NCT00819234|366141908|FG002|Overall Study|Adverse Event|1|||
106132128|NCT00819234|366141909|FG003|Overall Study|Adverse Event|0|||
106132129|NCT00819234|366141910|FG004|Overall Study|Adverse Event|0|||
105693857|NCT01873417|364543482|FG000|Overall Study|Physician Decision|3|||
105693858|NCT00785044|364543483|FG000|Overall Study|Dosed at non-participating sites|152|||
105693859|NCT00785044|364543483|FG000|Overall Study|Death|77|||
105693860|NCT00785044|364543483|FG000|Overall Study|Lost to Follow-up|266|||
105693861|NCT00785044|364543483|FG000|Overall Study|Withdrawal by Subject|1|||
105693862|NCT01798992|364543485|FG000|Overall Study|Administrative withdrawal|0|||
105693863|NCT01798992|364543486|FG001|Overall Study|Administrative withdrawal|1|||
105693864|NCT01798992|364543487|FG002|Overall Study|Administrative withdrawal|0|||
105693865|NCT01798992|364543488|FG003|Overall Study|Administrative withdrawal|1|||
105693866|NCT01798992|364543485|FG000|Overall Study|Lost to Follow-up|0|||
105693867|NCT01798992|364543486|FG001|Overall Study|Lost to Follow-up|1|||
105693868|NCT01798992|364543487|FG002|Overall Study|Lost to Follow-up|1|||
105693869|NCT01798992|364543488|FG003|Overall Study|Lost to Follow-up|0|||
105693870|NCT01798992|364543485|FG000|Overall Study|Insufficient biopsy tissue|0|||
105693871|NCT01798992|364543486|FG001|Overall Study|Insufficient biopsy tissue|0|||
105693872|NCT01798992|364543487|FG002|Overall Study|Insufficient biopsy tissue|1|||
105693873|NCT01798992|364543488|FG003|Overall Study|Insufficient biopsy tissue|0|||
105693874|NCT03422172|364543489|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
105693875|NCT03422172|364543489|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
105693876|NCT03422172|364543489|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
105693877|NCT01446016|364543498|FG000|Overall Study|Lost to Follow-up|3|||
105693878|NCT01446016|364543498|FG000|Overall Study|Withdrawal by Subject|1|||
105693879|NCT01446016|364543498|FG000|Overall Study|Toxicity|3|||
105693880|NCT01087957|364543499|FG000|Overall Study|Death|2|||
105693881|NCT01087957|364543500|FG001|Overall Study|Death|2|||
105920806|NCT00350545|365371371|FG000|Overall Study|Withdrawal by Subject|2|||
105920807|NCT00753519|365371372|FG000|Overall Study|Withdrawal by Subject|0|||
105920808|NCT00753519|365371373|FG001|Overall Study|Withdrawal by Subject|2|||
105920809|NCT00959751|365371374|FG000|Overall Study|Lost to Follow-up|2|||
105920810|NCT00959751|365371375|FG001|Overall Study|Lost to Follow-up|3|||
105920811|NCT00959751|365371374|FG000|Overall Study|Consent Withdrawn|0|||
105920812|NCT00959751|365371375|FG001|Overall Study|Consent Withdrawn|1|||
106132130|NCT00819234|366141911|FG005|Overall Study|Adverse Event|2|||
106132131|NCT00819234|366141912|FG006|Overall Study|Adverse Event|0|||
106132132|NCT00819234|366141913|FG007|Overall Study|Adverse Event|0|||
105693882|NCT01087957|364543499|FG000|Overall Study|Lost to Follow-up|3|||
105693883|NCT01087957|364543500|FG001|Overall Study|Lost to Follow-up|4|||
105693884|NCT01087957|364543499|FG000|Overall Study|Protocol Violation|13|||
105693885|NCT01087957|364543500|FG001|Overall Study|Protocol Violation|25|||
106132133|NCT00819234|366141914|FG008|Overall Study|Adverse Event|0|||
106132134|NCT00819234|366141915|FG009|Overall Study|Adverse Event|0|||
106132135|NCT00819234|366141906|FG000|Overall Study|Physician Decision|0|||
105693886|NCT01087957|364543499|FG000|Overall Study|Withdrawal by Subject|18|||
105693887|NCT01087957|364543500|FG001|Overall Study|Withdrawal by Subject|15|||
105693888|NCT01087957|364543499|FG000|Overall Study|Physician Decision|5|||
106132136|NCT00819234|366141907|FG001|Overall Study|Physician Decision|0|||
106132137|NCT00819234|366141908|FG002|Overall Study|Physician Decision|0|||
106132138|NCT00819234|366141909|FG003|Overall Study|Physician Decision|1|||
105693889|NCT01087957|364543500|FG001|Overall Study|Physician Decision|9|||
105693890|NCT01509079|364543501|FG000|Overall Study|Lack of Efficacy|0|||
105920813|NCT00959751|365371374|FG000|Overall Study|Non-compliance to Study Procedures|0|||
106132139|NCT00819234|366141910|FG004|Overall Study|Physician Decision|0|||
106132140|NCT00819234|366141911|FG005|Overall Study|Physician Decision|0|||
106132141|NCT00819234|366141912|FG006|Overall Study|Physician Decision|0|||
106132142|NCT00819234|366141913|FG007|Overall Study|Physician Decision|0|||
105693891|NCT01509079|364543502|FG001|Overall Study|Lack of Efficacy|2|||
105693892|NCT01509079|364543501|FG000|Overall Study|started an excluded medication|0|||
105693893|NCT01509079|364543502|FG001|Overall Study|started an excluded medication|1|||
105693894|NCT01423812|364543505|FG000|Overall Study|Lost to Follow-up|2|||
105693895|NCT01423812|364543506|FG001|Overall Study|Lost to Follow-up|2|||
105693896|NCT01423812|364543505|FG000|Overall Study|Withdrawal by Subject|1|||
105693897|NCT01423812|364543506|FG001|Overall Study|Withdrawal by Subject|2|||
105693898|NCT01970488|364543507|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
105693899|NCT01970488|364543508|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
105693900|NCT01970488|364543509|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
105693901|NCT01970488|364543510|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
105693902|NCT01970488|364543511|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
105693903|NCT01970488|364543507|FG000|Part 1: Through Week 16|Protocol Violation|1|||
105693904|NCT01970488|364543508|FG001|Part 1: Through Week 16|Protocol Violation|2|||
105920814|NCT00959751|365371375|FG001|Overall Study|Non-compliance to Study Procedures|1|||
105920815|NCT00959751|365371374|FG000|Overall Study|No migraine headache without aura|7|||
105920816|NCT00959751|365371375|FG001|Overall Study|No migraine headache without aura|7|||
105920817|NCT03427892|365371381|FG000|Overall Study|Lost to Follow-up|2|||
105920818|NCT01673386|365371384|FG000|Overall Study|Study terminated by sponsor|16|||
105920819|NCT01673386|365371385|FG001|Overall Study|Study terminated by sponsor|22|||
105920820|NCT01673386|365371384|FG000|Overall Study|Adverse Event|5|||
105920821|NCT01673386|365371385|FG001|Overall Study|Adverse Event|2|||
105920822|NCT01673386|365371384|FG000|Overall Study|Progressive disease|4|||
105920823|NCT01673386|365371385|FG001|Overall Study|Progressive disease|1|||
105920824|NCT01673386|365371384|FG000|Overall Study|Withdrawal by Subject|0|||
105920825|NCT01673386|365371385|FG001|Overall Study|Withdrawal by Subject|2|||
105920826|NCT01799889|365371388|FG000|Overall Study|Adverse Event|4|||
105920827|NCT01799889|365371389|FG001|Overall Study|Adverse Event|4|||
105920828|NCT01799889|365371390|FG002|Overall Study|Adverse Event|5|||
105920829|NCT01799889|365371391|FG003|Overall Study|Adverse Event|1|||
105920830|NCT01799889|365371392|FG004|Overall Study|Adverse Event|11|||
105920831|NCT01799889|365371393|FG005|Overall Study|Adverse Event|1|||
105920832|NCT01799889|365371394|FG006|Overall Study|Adverse Event|5|||
105920833|NCT01799889|365371395|FG007|Overall Study|Adverse Event|2|||
105920834|NCT01799889|365371396|FG008|Overall Study|Adverse Event|3|||
105693905|NCT01970488|364543509|FG002|Part 1: Through Week 16|Protocol Violation|0|||
105693906|NCT01970488|364543510|FG003|Part 1: Through Week 16|Protocol Violation|0|||
105693907|NCT01970488|364543511|FG004|Part 1: Through Week 16|Protocol Violation|0|||
105693908|NCT01970488|364543507|FG000|Part 1: Through Week 16|Adverse Event|6|||
105693909|NCT01970488|364543508|FG001|Part 1: Through Week 16|Adverse Event|5|||
105693910|NCT01970488|364543509|FG002|Part 1: Through Week 16|Adverse Event|0|||
105693911|NCT01970488|364543510|FG003|Part 1: Through Week 16|Adverse Event|0|||
105693912|NCT01970488|364543511|FG004|Part 1: Through Week 16|Adverse Event|0|||
105693913|NCT01970488|364543507|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
105693914|NCT01970488|364543508|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
105693915|NCT01970488|364543509|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
105693916|NCT01970488|364543510|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
105693917|NCT01970488|364543511|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
105693918|NCT01970488|364543507|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
105693919|NCT01970488|364543508|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
105693920|NCT01970488|364543509|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
105693921|NCT01970488|364543510|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
105693922|NCT01970488|364543511|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
105693923|NCT01970488|364543507|FG000|Part 2: Post Week 16|Physician Decision|0|||
105693924|NCT01970488|364543508|FG001|Part 2: Post Week 16|Physician Decision|0|||
105693925|NCT01970488|364543509|FG002|Part 2: Post Week 16|Physician Decision|0|||
105693926|NCT01970488|364543510|FG003|Part 2: Post Week 16|Physician Decision|0|||
105693927|NCT01970488|364543511|FG004|Part 2: Post Week 16|Physician Decision|1|||
105693928|NCT01970488|364543507|FG000|Part 2: Post Week 16|Non-compliance|0|||
105693929|NCT01970488|364543508|FG001|Part 2: Post Week 16|Non-compliance|0|||
105693930|NCT01970488|364543509|FG002|Part 2: Post Week 16|Non-compliance|1|||
105693931|NCT01970488|364543510|FG003|Part 2: Post Week 16|Non-compliance|0|||
105693932|NCT01970488|364543511|FG004|Part 2: Post Week 16|Non-compliance|0|||
105693933|NCT01970488|364543507|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
105693934|NCT01970488|364543508|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
105693935|NCT01970488|364543509|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
105693936|NCT01970488|364543510|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
105693937|NCT01970488|364543511|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
105693938|NCT01970488|364543507|FG000|Part 2: Post Week 16|Adverse Event|0|||
105693939|NCT01970488|364543508|FG001|Part 2: Post Week 16|Adverse Event|0|||
105920835|NCT01799889|365371397|FG009|Overall Study|Adverse Event|1|||
105920836|NCT01799889|365371398|FG010|Overall Study|Adverse Event|1|||
105920837|NCT01799889|365371399|FG011|Overall Study|Adverse Event|0|||
106132143|NCT00819234|366141914|FG008|Overall Study|Physician Decision|0|||
106004199|NCT02250326|365678168|FG000|Treatment|Withdrawal by Subject|11|||
106004200|NCT02250326|365678169|FG001|Treatment|Withdrawal by Subject|6|||
106004201|NCT02250326|365678170|FG002|Treatment|Withdrawal by Subject|4|||
106004202|NCT02250326|365678168|FG000|Treatment|Other reasons|8|||
106004203|NCT02250326|365678169|FG001|Treatment|Other reasons|7|||
106004204|NCT02250326|365678170|FG002|Treatment|Other reasons|7|||
106004205|NCT02250326|365678168|FG000|Extension Period|Progressive Disease|0|||
106004206|NCT02250326|365678169|FG001|Extension Period|Progressive Disease|2|||
105693940|NCT01970488|364543509|FG002|Part 2: Post Week 16|Adverse Event|5|||
105693941|NCT01970488|364543510|FG003|Part 2: Post Week 16|Adverse Event|1|||
105693942|NCT01970488|364543511|FG004|Part 2: Post Week 16|Adverse Event|1|||
105693943|NCT01970488|364543507|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
105693944|NCT01970488|364543508|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
105693945|NCT01970488|364543509|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
105693946|NCT01970488|364543510|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
105693947|NCT01970488|364543511|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
105693948|NCT01970488|364543507|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
105693949|NCT01970488|364543508|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
105920838|NCT01799889|365371388|FG000|Overall Study|Death|1|||
105920839|NCT01799889|365371389|FG001|Overall Study|Death|0|||
105920840|NCT01799889|365371390|FG002|Overall Study|Death|5|||
105920841|NCT01799889|365371391|FG003|Overall Study|Death|3|||
105920842|NCT01799889|365371392|FG004|Overall Study|Death|1|||
105920843|NCT01799889|365371393|FG005|Overall Study|Death|0|||
105920844|NCT01799889|365371394|FG006|Overall Study|Death|0|||
105920845|NCT01799889|365371395|FG007|Overall Study|Death|0|||
105920846|NCT01799889|365371396|FG008|Overall Study|Death|1|||
105920847|NCT01799889|365371397|FG009|Overall Study|Death|0|||
105920848|NCT01799889|365371398|FG010|Overall Study|Death|1|||
105920849|NCT01799889|365371399|FG011|Overall Study|Death|0|||
105920850|NCT01799889|365371388|FG000|Overall Study|Lack of Efficacy|1|||
105920851|NCT01799889|365371389|FG001|Overall Study|Lack of Efficacy|1|||
105920852|NCT01799889|365371390|FG002|Overall Study|Lack of Efficacy|0|||
105920853|NCT01799889|365371391|FG003|Overall Study|Lack of Efficacy|1|||
105920854|NCT01799889|365371392|FG004|Overall Study|Lack of Efficacy|2|||
105920855|NCT01799889|365371393|FG005|Overall Study|Lack of Efficacy|2|||
105920856|NCT01799889|365371394|FG006|Overall Study|Lack of Efficacy|0|||
105920857|NCT01799889|365371395|FG007|Overall Study|Lack of Efficacy|0|||
105920858|NCT01799889|365371396|FG008|Overall Study|Lack of Efficacy|2|||
105920859|NCT01799889|365371397|FG009|Overall Study|Lack of Efficacy|0|||
105920860|NCT01799889|365371398|FG010|Overall Study|Lack of Efficacy|1|||
105920861|NCT01799889|365371399|FG011|Overall Study|Lack of Efficacy|0|||
105920862|NCT01799889|365371388|FG000|Overall Study|Lost to Follow-up|0|||
105920863|NCT01799889|365371389|FG001|Overall Study|Lost to Follow-up|1|||
105920864|NCT01799889|365371390|FG002|Overall Study|Lost to Follow-up|0|||
105920865|NCT01799889|365371391|FG003|Overall Study|Lost to Follow-up|0|||
105920866|NCT01799889|365371392|FG004|Overall Study|Lost to Follow-up|0|||
105920867|NCT01799889|365371393|FG005|Overall Study|Lost to Follow-up|0|||
105920868|NCT01799889|365371394|FG006|Overall Study|Lost to Follow-up|0|||
105920869|NCT01799889|365371395|FG007|Overall Study|Lost to Follow-up|0|||
105920870|NCT01799889|365371396|FG008|Overall Study|Lost to Follow-up|0|||
105920871|NCT01799889|365371397|FG009|Overall Study|Lost to Follow-up|0|||
105920872|NCT01799889|365371398|FG010|Overall Study|Lost to Follow-up|0|||
105920873|NCT01799889|365371399|FG011|Overall Study|Lost to Follow-up|0|||
105920874|NCT01799889|365371388|FG000|Overall Study|Physician Decision|3|||
105920875|NCT01799889|365371389|FG001|Overall Study|Physician Decision|2|||
105920876|NCT01799889|365371390|FG002|Overall Study|Physician Decision|4|||
105920877|NCT01799889|365371391|FG003|Overall Study|Physician Decision|4|||
105693950|NCT01970488|364543509|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
105693951|NCT01970488|364543510|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
105693952|NCT01970488|364543511|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
105693953|NCT03974334|364543512|FG000|Overall Study|Lost to Follow-up|1|||
105693954|NCT00239226|364543513|FG000|Overall Study|permAF during stabilization period|0|||
105920878|NCT01799889|365371392|FG004|Overall Study|Physician Decision|5|||
105920879|NCT01799889|365371393|FG005|Overall Study|Physician Decision|5|||
105920880|NCT01799889|365371394|FG006|Overall Study|Physician Decision|5|||
105920881|NCT01799889|365371395|FG007|Overall Study|Physician Decision|2|||
105920882|NCT01799889|365371396|FG008|Overall Study|Physician Decision|6|||
105920883|NCT01799889|365371397|FG009|Overall Study|Physician Decision|0|||
105920884|NCT01799889|365371398|FG010|Overall Study|Physician Decision|0|||
105920885|NCT01799889|365371399|FG011|Overall Study|Physician Decision|1|||
106004207|NCT02250326|365678170|FG002|Extension Period|Progressive Disease|0|||
106004208|NCT02250326|365678168|FG000|Extension Period|Withdrawal by Subject|0|||
106004209|NCT02250326|365678169|FG001|Extension Period|Withdrawal by Subject|1|||
105920886|NCT01799889|365371388|FG000|Overall Study|Progressive Disease|30|||
105920887|NCT01799889|365371389|FG001|Overall Study|Progressive Disease|26|||
105920888|NCT01799889|365371390|FG002|Overall Study|Progressive Disease|25|||
105693955|NCT00239226|364543514|FG001|Overall Study|permAF during stabilization period|0|||
105693956|NCT00239226|364543515|FG002|Overall Study|permAF during stabilization period|0|||
105920889|NCT01799889|365371391|FG003|Overall Study|Progressive Disease|30|||
105920890|NCT01799889|365371392|FG004|Overall Study|Progressive Disease|23|||
105920891|NCT01799889|365371393|FG005|Overall Study|Progressive Disease|9|||
105920892|NCT01799889|365371394|FG006|Overall Study|Progressive Disease|8|||
105693957|NCT00239226|364543516|FG003|Overall Study|permAF during stabilization period|3|||
105693958|NCT00239226|364543513|FG000|Overall Study|Lost to Follow-up|1|||
105693959|NCT00239226|364543514|FG001|Overall Study|Lost to Follow-up|0|||
105693960|NCT00239226|364543515|FG002|Overall Study|Lost to Follow-up|1|||
105693961|NCT00239226|364543516|FG003|Overall Study|Lost to Follow-up|0|||
105693962|NCT01109173|364543518|FG000|Overall Study|Adverse Event|15|||
105693963|NCT01109173|364543519|FG001|Overall Study|Adverse Event|17|||
105693964|NCT01109173|364543520|FG002|Overall Study|Adverse Event|9|||
105693965|NCT01109173|364543521|FG003|Overall Study|Adverse Event|6|||
105920893|NCT01799889|365371395|FG007|Overall Study|Progressive Disease|13|||
105920894|NCT01799889|365371396|FG008|Overall Study|Progressive Disease|18|||
105920895|NCT01799889|365371397|FG009|Overall Study|Progressive Disease|5|||
106004210|NCT02250326|365678170|FG002|Extension Period|Withdrawal by Subject|0|||
105693966|NCT01109173|364543518|FG000|Overall Study|Lost to Follow-up|0|||
105693967|NCT01109173|364543519|FG001|Overall Study|Lost to Follow-up|1|||
105693968|NCT01109173|364543520|FG002|Overall Study|Lost to Follow-up|0|||
105693969|NCT01109173|364543521|FG003|Overall Study|Lost to Follow-up|0|||
105693970|NCT01109173|364543518|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
105693971|NCT01109173|364543519|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
106004211|NCT02250326|365678168|FG000|Extension Period|Withdrawal by investigator|0|||
106004212|NCT02250326|365678169|FG001|Extension Period|Withdrawal by investigator|1|||
106004213|NCT02250326|365678170|FG002|Extension Period|Withdrawal by investigator|0|||
106004214|NCT03585660|365678177|FG000|Overall Study|operator error|1|||
105693972|NCT01109173|364543520|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
105693973|NCT01109173|364543521|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
105693974|NCT01109173|364543518|FG000|Overall Study|Noncompliance|0|||
105693975|NCT01109173|364543519|FG001|Overall Study|Noncompliance|1|||
105693976|NCT01109173|364543520|FG002|Overall Study|Noncompliance|0|||
105693977|NCT01109173|364543521|FG003|Overall Study|Noncompliance|0|||
105920896|NCT01799889|365371398|FG010|Overall Study|Progressive Disease|3|||
105920897|NCT01799889|365371399|FG011|Overall Study|Progressive Disease|1|||
105920898|NCT01799889|365371388|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
105920899|NCT01799889|365371389|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
105920900|NCT01799889|365371390|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
105920901|NCT01799889|365371391|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
105920902|NCT01799889|365371392|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
105920903|NCT01799889|365371393|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
105920904|NCT01799889|365371394|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
105920905|NCT01799889|365371395|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
105920906|NCT01799889|365371396|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
105920907|NCT01799889|365371397|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
105920908|NCT01799889|365371398|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
105920909|NCT01799889|365371399|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
105920910|NCT01799889|365371388|FG000|Overall Study|Study Terminated By Sponsor|1|||
105920911|NCT01799889|365371389|FG001|Overall Study|Study Terminated By Sponsor|0|||
105920912|NCT01799889|365371390|FG002|Overall Study|Study Terminated By Sponsor|0|||
105920913|NCT01799889|365371391|FG003|Overall Study|Study Terminated By Sponsor|0|||
105920914|NCT01799889|365371392|FG004|Overall Study|Study Terminated By Sponsor|2|||
105920915|NCT01799889|365371393|FG005|Overall Study|Study Terminated By Sponsor|1|||
105920916|NCT01799889|365371394|FG006|Overall Study|Study Terminated By Sponsor|0|||
105920917|NCT01799889|365371395|FG007|Overall Study|Study Terminated By Sponsor|2|||
105920918|NCT01799889|365371396|FG008|Overall Study|Study Terminated By Sponsor|1|||
105920919|NCT01799889|365371397|FG009|Overall Study|Study Terminated By Sponsor|1|||
105920920|NCT01799889|365371398|FG010|Overall Study|Study Terminated By Sponsor|0|||
105920921|NCT01799889|365371399|FG011|Overall Study|Study Terminated By Sponsor|0|||
105920922|NCT01799889|365371388|FG000|Overall Study|Withdrawal by Subject|1|||
105920923|NCT01799889|365371389|FG001|Overall Study|Withdrawal by Subject|6|||
105920924|NCT01799889|365371390|FG002|Overall Study|Withdrawal by Subject|4|||
105920925|NCT01799889|365371391|FG003|Overall Study|Withdrawal by Subject|0|||
105920926|NCT01799889|365371392|FG004|Overall Study|Withdrawal by Subject|5|||
105920927|NCT01799889|365371393|FG005|Overall Study|Withdrawal by Subject|1|||
105920928|NCT01799889|365371394|FG006|Overall Study|Withdrawal by Subject|3|||
105920929|NCT01799889|365371395|FG007|Overall Study|Withdrawal by Subject|1|||
106004215|NCT03585660|365678177|FG000|Overall Study|technical error|2|||
106004216|NCT03585660|365678177|FG000|Overall Study|hip prosthesis|2|||
105920930|NCT01799889|365371396|FG008|Overall Study|Withdrawal by Subject|2|||
105920931|NCT01799889|365371397|FG009|Overall Study|Withdrawal by Subject|1|||
105920932|NCT01799889|365371398|FG010|Overall Study|Withdrawal by Subject|1|||
105920933|NCT01799889|365371399|FG011|Overall Study|Withdrawal by Subject|1|||
106004217|NCT03585660|365678177|FG000|Overall Study|did not undergo biopsy|8|||
106004218|NCT03585660|365678177|FG000|Overall Study|scanner problem|2|||
105920934|NCT01799889|365371388|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105920935|NCT01799889|365371389|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105920936|NCT01799889|365371390|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105920937|NCT01799889|365371391|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105920938|NCT01799889|365371392|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105920939|NCT01799889|365371393|FG005|Overall Study|Non-Compliance With Study Drug|1|||
105920940|NCT01799889|365371394|FG006|Overall Study|Non-Compliance With Study Drug|0|||
105920941|NCT01799889|365371395|FG007|Overall Study|Non-Compliance With Study Drug|0|||
106004219|NCT04245111|365678178|FG000|Overall Study|Lost to Follow-up|5|||
106004220|NCT04245111|365678179|FG001|Overall Study|Lost to Follow-up|1|||
106004221|NCT04245111|365678180|FG002|Overall Study|Lost to Follow-up|1|||
106004222|NCT00435409|365678181|FG000|Overall Study|Protocol Violation|1|||
106004223|NCT00435409|365678182|FG001|Overall Study|Protocol Violation|2|||
106004224|NCT00435409|365678183|FG002|Overall Study|Protocol Violation|0|||
106004225|NCT00435409|365678181|FG000|Overall Study|Lost to Follow-up|1|||
106004226|NCT00435409|365678182|FG001|Overall Study|Lost to Follow-up|2|||
106004227|NCT00435409|365678183|FG002|Overall Study|Lost to Follow-up|0|||
106004228|NCT00435409|365678181|FG000|Overall Study|Death|8|||
106004229|NCT00435409|365678182|FG001|Overall Study|Death|6|||
106004230|NCT00435409|365678183|FG002|Overall Study|Death|6|||
106004231|NCT00435409|365678181|FG000|Overall Study|Objective progression or relapse|158|||
106004232|NCT00435409|365678182|FG001|Overall Study|Objective progression or relapse|93|||
106004233|NCT00435409|365678183|FG002|Overall Study|Objective progression or relapse|58|||
106004234|NCT00435409|365678181|FG000|Overall Study|Global deterioration of health status|0|||
106004235|NCT00435409|365678182|FG001|Overall Study|Global deterioration of health status|0|||
106004236|NCT00435409|365678183|FG002|Overall Study|Global deterioration of health status|4|||
106004237|NCT00435409|365678181|FG000|Overall Study|Withdrawal by Subject|8|||
106004238|NCT00435409|365678182|FG001|Overall Study|Withdrawal by Subject|7|||
106004239|NCT00435409|365678183|FG002|Overall Study|Withdrawal by Subject|1|||
106004240|NCT00435409|365678181|FG000|Overall Study|Other|45|||
106004241|NCT00435409|365678182|FG001|Overall Study|Other|30|||
106004242|NCT00435409|365678183|FG002|Overall Study|Other|1|||
106004243|NCT00435409|365678181|FG000|Overall Study|Adverse Event|0|||
106004244|NCT00435409|365678182|FG001|Overall Study|Adverse Event|0|||
106004245|NCT00435409|365678183|FG002|Overall Study|Adverse Event|8|||
106004246|NCT00435409|365678181|FG000|Overall Study|Sponsor decision|0|||
106004247|NCT00435409|365678182|FG001|Overall Study|Sponsor decision|3|||
106004248|NCT00435409|365678183|FG002|Overall Study|Sponsor decision|0|||
106004249|NCT02542865|365678186|FG000|Overall Study|Identified as screen failure|1|||
106004250|NCT02542865|365678187|FG001|Overall Study|Identified as screen failure|0|||
106004251|NCT02542865|365678186|FG000|Overall Study|Withdrawal by Subject|16|||
106004252|NCT02542865|365678187|FG001|Overall Study|Withdrawal by Subject|0|||
106004253|NCT01339689|365678190|FG000|Overall Study|Adverse Event|1|||
106004254|NCT01339689|365678191|FG001|Overall Study|Adverse Event|2|||
106004255|NCT01339689|365678190|FG000|Overall Study|Lost to Follow-up|9|||
106004256|NCT01339689|365678191|FG001|Overall Study|Lost to Follow-up|3|||
106004257|NCT01339689|365678190|FG000|Overall Study|Withdrawal by Subject|3|||
106004258|NCT01339689|365678191|FG001|Overall Study|Withdrawal by Subject|0|||
106004259|NCT01339689|365678190|FG000|Overall Study|Noncompliance|1|||
106004260|NCT01339689|365678191|FG001|Overall Study|Noncompliance|0|||
106004261|NCT01339689|365678190|FG000|Overall Study|Relocated out of area|0|||
106004262|NCT01339689|365678191|FG001|Overall Study|Relocated out of area|1|||
106004263|NCT01339689|365678190|FG000|Overall Study|Other|2|||
106004264|NCT01339689|365678191|FG001|Overall Study|Other|2|||
106004265|NCT01339689|365678190|FG000|Overall Study|multiple reasons|1|||
106004266|NCT01339689|365678191|FG001|Overall Study|multiple reasons|1|||
106004267|NCT04571944|365678194|FG000|Overall Study|Death|1|||
106004268|NCT04571944|365678195|FG001|Overall Study|Death|0|||
106004269|NCT04571944|365678194|FG000|Overall Study|Withdrawal by Subject|3|||
106004270|NCT04571944|365678195|FG001|Overall Study|Withdrawal by Subject|0|||
106004271|NCT04571944|365678194|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
105693978|NCT01109173|364543518|FG000|Overall Study|Treatment Failure|25|||
105693979|NCT01109173|364543519|FG001|Overall Study|Treatment Failure|32|||
106004272|NCT04571944|365678195|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
106004273|NCT02694744|365678196|FG000|Overall Study|Adverse Event|2|||
106004274|NCT02694744|365678197|FG001|Overall Study|Adverse Event|1|||
106004275|NCT02694744|365678196|FG000|Overall Study|Withdrawal by Subject|2|||
106004276|NCT02694744|365678197|FG001|Overall Study|Withdrawal by Subject|1|||
106004277|NCT02694744|365678196|FG000|Overall Study|Physician Decision|1|||
106004278|NCT02694744|365678197|FG001|Overall Study|Physician Decision|2|||
106004279|NCT02694744|365678196|FG000|Overall Study|Lost to Follow-up|1|||
106004280|NCT02694744|365678197|FG001|Overall Study|Lost to Follow-up|0|||
106004281|NCT02694744|365678196|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
105920942|NCT01799889|365371396|FG008|Overall Study|Non-Compliance With Study Drug|0|||
106004282|NCT02694744|365678197|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
106004283|NCT02140047|365678198|FG000|Overall Study|Withdrawal by parent/guardian|1|||
106004284|NCT02140047|365678199|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106004285|NCT02140047|365678200|FG002|Overall Study|Withdrawal by parent/guardian|0|||
106004286|NCT02174731|365678201|FG000|Overall Study|Participant decision|67|||
106004287|NCT02174731|365678202|FG001|Overall Study|Participant decision|64|||
106004288|NCT02174731|365678201|FG000|Overall Study|Incorrect enrolment before randomization|0|||
106004289|NCT02174731|365678202|FG001|Overall Study|Incorrect enrolment before randomization|1|||
106004290|NCT02174731|365678201|FG000|Overall Study|Missing|2|||
106004291|NCT02174731|365678202|FG001|Overall Study|Missing|0|||
106004292|NCT00079040|365678203|FG000|Overall Study|Withdrew before treatment|1|||
106004293|NCT00079040|365678203|FG000|Overall Study|Ineligible|1|||
106004294|NCT00739401|365678208|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
106004295|NCT00739401|365678208|FG000|Overall Study|Death|3|||
106004296|NCT00739401|365678208|FG000|Overall Study|Withdrawal by Subject|4|||
106004297|NCT04739982|365678211|FG000|Overall Study|Lost to Follow-up|176|||
106004298|NCT04739982|365678212|FG001|Overall Study|Lost to Follow-up|65|||
106132144|NCT00819234|366141915|FG009|Overall Study|Physician Decision|2|||
106132145|NCT00819234|366141906|FG000|Overall Study|Protocol Violation|0|||
106132146|NCT00819234|366141907|FG001|Overall Study|Protocol Violation|0|||
105693980|NCT01109173|364543520|FG002|Overall Study|Treatment Failure|69|||
105693981|NCT01109173|364543521|FG003|Overall Study|Treatment Failure|64|||
105693982|NCT01109173|364543518|FG000|Overall Study|Protocol Violation|4|||
105693983|NCT01109173|364543519|FG001|Overall Study|Protocol Violation|5|||
105693984|NCT01109173|364543520|FG002|Overall Study|Protocol Violation|1|||
105693985|NCT01109173|364543521|FG003|Overall Study|Protocol Violation|2|||
105693986|NCT01109173|364543518|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
105693987|NCT01109173|364543519|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
105693988|NCT01109173|364543520|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
105693989|NCT01109173|364543521|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
105693990|NCT01109173|364543518|FG000|Overall Study|Not Specifiied|5|||
105920943|NCT01799889|365371397|FG009|Overall Study|Non-Compliance With Study Drug|0|||
105920944|NCT01799889|365371398|FG010|Overall Study|Non-Compliance With Study Drug|0|||
105920945|NCT01799889|365371399|FG011|Overall Study|Non-Compliance With Study Drug|0|||
105920946|NCT04889040|365371400|FG000|Overall Study|Withdrawal by Subject|3|||
105920947|NCT04889040|365371401|FG001|Overall Study|Withdrawal by Subject|3|||
105920948|NCT04889040|365371400|FG000|Overall Study|Lost to Follow-up|0|||
105920949|NCT04889040|365371401|FG001|Overall Study|Lost to Follow-up|1|||
105920950|NCT04889040|365371400|FG000|Overall Study|Adverse Event|2|||
105920951|NCT04889040|365371401|FG001|Overall Study|Adverse Event|1|||
106132147|NCT00819234|366141908|FG002|Overall Study|Protocol Violation|1|||
106132148|NCT00819234|366141909|FG003|Overall Study|Protocol Violation|0|||
106132149|NCT00819234|366141910|FG004|Overall Study|Protocol Violation|0|||
106132150|NCT00819234|366141911|FG005|Overall Study|Protocol Violation|0|||
106132151|NCT00819234|366141912|FG006|Overall Study|Protocol Violation|0|||
106132152|NCT00819234|366141913|FG007|Overall Study|Protocol Violation|0|||
106132153|NCT00819234|366141914|FG008|Overall Study|Protocol Violation|0|||
106132154|NCT00819234|366141915|FG009|Overall Study|Protocol Violation|0|||
106132155|NCT00819234|366141906|FG000|Overall Study|Lost to Follow-up|2|||
106132156|NCT00819234|366141907|FG001|Overall Study|Lost to Follow-up|2|||
106132157|NCT00819234|366141908|FG002|Overall Study|Lost to Follow-up|0|||
106132158|NCT00819234|366141909|FG003|Overall Study|Lost to Follow-up|2|||
106132159|NCT00819234|366141910|FG004|Overall Study|Lost to Follow-up|1|||
106132160|NCT00819234|366141911|FG005|Overall Study|Lost to Follow-up|1|||
106132161|NCT00819234|366141912|FG006|Overall Study|Lost to Follow-up|1|||
106132162|NCT00819234|366141913|FG007|Overall Study|Lost to Follow-up|1|||
106132163|NCT00819234|366141914|FG008|Overall Study|Lost to Follow-up|1|||
105920952|NCT02014272|365371402|FG000|Intervention Period 1|Withdrawal by Subject|1|||
105920953|NCT02014272|365371403|FG001|Intervention Period 1|Withdrawal by Subject|0|||
105920954|NCT02014272|365371402|FG000|Intervention Period 1|Adverse Event|0|||
105920955|NCT02014272|365371403|FG001|Intervention Period 1|Adverse Event|1|||
105920956|NCT01240746|365371404|FG000|Overall Study|Adverse Event|2|||
105920957|NCT01240746|365371405|FG001|Overall Study|Adverse Event|0|||
105693991|NCT01109173|364543519|FG001|Overall Study|Not Specifiied|4|||
105693992|NCT01109173|364543520|FG002|Overall Study|Not Specifiied|9|||
105920958|NCT01240746|365371406|FG002|Overall Study|Adverse Event|10|||
105920959|NCT01240746|365371404|FG000|Overall Study|Lost to Follow-up|23|||
105920960|NCT01240746|365371405|FG001|Overall Study|Lost to Follow-up|20|||
106004299|NCT04739982|365678211|FG000|Overall Study|Withdrawal by Subject|19|||
106004300|NCT04739982|365678212|FG001|Overall Study|Withdrawal by Subject|0|||
106004301|NCT04739982|365678211|FG000|Overall Study|Protocol Violation|0|||
106132164|NCT00819234|366141915|FG009|Overall Study|Lost to Follow-up|2|||
106132165|NCT00689104|366141916|FG000|Overall Study|Eligibility criterion not met|5|||
106132166|NCT00689104|366141917|FG001|Overall Study|Eligibility criterion not met|8|||
106132167|NCT00689104|366141918|FG002|Overall Study|Eligibility criterion not met|0|||
106132168|NCT00689104|366141919|FG003|Overall Study|Eligibility criterion not met|4|||
106132169|NCT00689104|366141916|FG000|Overall Study|Adverse Event|13|||
106132170|NCT00689104|366141917|FG001|Overall Study|Adverse Event|25|||
106132171|NCT00689104|366141918|FG002|Overall Study|Adverse Event|16|||
106132172|NCT00689104|366141919|FG003|Overall Study|Adverse Event|24|||
106132173|NCT00689104|366141916|FG000|Overall Study|Lack of Efficacy|5|||
106132174|NCT00689104|366141917|FG001|Overall Study|Lack of Efficacy|6|||
106132175|NCT00689104|366141918|FG002|Overall Study|Lack of Efficacy|2|||
106132176|NCT00689104|366141919|FG003|Overall Study|Lack of Efficacy|3|||
106132177|NCT00689104|366141916|FG000|Overall Study|Withdrawal by Subject|12|||
106132178|NCT00689104|366141917|FG001|Overall Study|Withdrawal by Subject|11|||
106132179|NCT00689104|366141918|FG002|Overall Study|Withdrawal by Subject|18|||
106132180|NCT00689104|366141919|FG003|Overall Study|Withdrawal by Subject|11|||
106132181|NCT00689104|366141916|FG000|Overall Study|Lost to Follow-up|4|||
106132182|NCT00689104|366141917|FG001|Overall Study|Lost to Follow-up|3|||
106132183|NCT00689104|366141918|FG002|Overall Study|Lost to Follow-up|2|||
106132184|NCT00689104|366141919|FG003|Overall Study|Lost to Follow-up|5|||
106132185|NCT00689104|366141916|FG000|Overall Study|Protocol Violation|2|||
106132186|NCT00689104|366141917|FG001|Overall Study|Protocol Violation|3|||
106132187|NCT00689104|366141918|FG002|Overall Study|Protocol Violation|5|||
106132188|NCT00689104|366141919|FG003|Overall Study|Protocol Violation|3|||
106132189|NCT00689104|366141916|FG000|Overall Study|Randomized but never received study drug|2|||
106132190|NCT00689104|366141917|FG001|Overall Study|Randomized but never received study drug|1|||
106132191|NCT00689104|366141918|FG002|Overall Study|Randomized but never received study drug|1|||
106132192|NCT00689104|366141919|FG003|Overall Study|Randomized but never received study drug|0|||
106132193|NCT00689104|366141916|FG000|Overall Study|Physician Decision|1|||
106132194|NCT00689104|366141917|FG001|Overall Study|Physician Decision|0|||
106132195|NCT00689104|366141918|FG002|Overall Study|Physician Decision|0|||
106132196|NCT00689104|366141919|FG003|Overall Study|Physician Decision|0|||
106132197|NCT00689104|366141916|FG000|Overall Study|Non-compliance with study procedures|0|||
106132198|NCT00689104|366141917|FG001|Overall Study|Non-compliance with study procedures|0|||
106132199|NCT00689104|366141918|FG002|Overall Study|Non-compliance with study procedures|1|||
106004302|NCT04739982|365678212|FG001|Overall Study|Protocol Violation|5|||
106004303|NCT04575155|365678213|FG000|2 Month|Withdrawal by Subject|1|||
106004304|NCT04575155|365678214|FG001|2 Month|Withdrawal by Subject|1|||
106004305|NCT04575155|365678213|FG000|2 Month|Lost to Follow-up|5|||
106004306|NCT04575155|365678214|FG001|2 Month|Lost to Follow-up|3|||
106004307|NCT04575155|365678213|FG000|2 Month|Ineligible|1|||
106004308|NCT04575155|365678214|FG001|2 Month|Ineligible|0|||
106004309|NCT03915717|365678217|FG000|Overall Study|EchoMark Not Implanted|6|||
106004310|NCT01664910|365678219|FG000|Overall Study|Adverse Event|0|||
106004311|NCT01664910|365678220|FG001|Overall Study|Adverse Event|0|||
106004312|NCT01664910|365678221|FG002|Overall Study|Adverse Event|1|||
106004313|NCT00702702|365678222|FG000|Overall Study|Study prematurely terminated|56|||
106004314|NCT00475670|365678227|FG000|Overall Study|Death|0|||
106004315|NCT00475670|365678228|FG001|Overall Study|Death|1|||
106004316|NCT00475670|365678227|FG000|Overall Study|Lack of Efficacy|3|||
106004317|NCT00475670|365678228|FG001|Overall Study|Lack of Efficacy|34|||
106004318|NCT00475670|365678227|FG000|Overall Study|Refused treatment|0|||
106004319|NCT00475670|365678228|FG001|Overall Study|Refused treatment|2|||
106004320|NCT00475670|365678227|FG000|Overall Study|Failure to Return|0|||
106004321|NCT00475670|365678228|FG001|Overall Study|Failure to Return|1|||
106004322|NCT00475670|365678227|FG000|Overall Study|Other|0|||
106004323|NCT00475670|365678228|FG001|Overall Study|Other|3|||
106004324|NCT05083351|365678231|FG000|Overall Study|Adverse Event|3|||
106004325|NCT05083351|365678231|FG000|Overall Study|Did not meet data inclusion criteria|8|||
106132200|NCT00689104|366141919|FG003|Overall Study|Non-compliance with study procedures|0|||
106132201|NCT04873817|366141920|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
106132202|NCT04873817|366141920|FG000|Overall Study|Lost to Follow-up|4|||
106132203|NCT04873817|366141920|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
106132204|NCT04873817|366141920|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
106132205|NCT04873817|366141920|FG000|Overall Study|Other Reasons|3|||
106132206|NCT01836458|366141921|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
106132207|NCT01836458|366141922|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
106132208|NCT01836458|366141923|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
105693993|NCT01109173|364543521|FG003|Overall Study|Not Specifiied|14|||
105693994|NCT01132612|364543522|FG000|Overall Study|Death|0|||
106004326|NCT05083351|365678231|FG000|Overall Study|Did not meet eligibility criteria|19|||
106004327|NCT05083351|365678231|FG000|Overall Study|Study Staff Decision|19|||
106004328|NCT00591006|365678234|FG000|Overall Study|Withdrawal by Subject|0|||
106004329|NCT00591006|365678235|FG001|Overall Study|Withdrawal by Subject|0|||
106004330|NCT00591006|365678236|FG002|Overall Study|Withdrawal by Subject|0|||
106132209|NCT01836458|366141924|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
106132210|NCT02926937|366141931|FG000|Overall Study|Adverse Event|0|||
106132211|NCT02926937|366141932|FG001|Overall Study|Adverse Event|1|||
106132212|NCT02926937|366141933|FG002|Overall Study|Adverse Event|1|||
106132213|NCT02926937|366141931|FG000|Overall Study|Poor Compliance to Protocol|1|||
105693995|NCT01132612|364543523|FG001|Overall Study|Death|0|||
106004331|NCT00591006|365678237|FG003|Overall Study|Withdrawal by Subject|0|||
105693996|NCT01132612|364543524|FG002|Overall Study|Death|1|||
105693997|NCT01132612|364543522|FG000|Overall Study|Protocol deviation|0|||
105693998|NCT01132612|364543523|FG001|Overall Study|Protocol deviation|0|||
105693999|NCT01132612|364543524|FG002|Overall Study|Protocol deviation|3|||
105694000|NCT01132612|364543522|FG000|Overall Study|Lost to Follow-up|2|||
105694001|NCT01132612|364543523|FG001|Overall Study|Lost to Follow-up|2|||
105694002|NCT01132612|364543524|FG002|Overall Study|Lost to Follow-up|7|||
105694003|NCT01132612|364543522|FG000|Overall Study|Adverse Event|5|||
105694004|NCT01132612|364543523|FG001|Overall Study|Adverse Event|2|||
105694005|NCT01132612|364543524|FG002|Overall Study|Adverse Event|15|||
105694006|NCT01132612|364543522|FG000|Overall Study|Withdrawal by Subject|5|||
105920961|NCT01240746|365371406|FG002|Overall Study|Lost to Follow-up|102|||
105920962|NCT01240746|365371404|FG000|Overall Study|Protocol Violation|24|||
105920963|NCT01240746|365371405|FG001|Overall Study|Protocol Violation|15|||
105920964|NCT01240746|365371406|FG002|Overall Study|Protocol Violation|72|||
105920965|NCT01240746|365371404|FG000|Overall Study|Withdrawal by Subject|10|||
106132214|NCT02926937|366141932|FG001|Overall Study|Poor Compliance to Protocol|0|||
105694007|NCT01132612|364543523|FG001|Overall Study|Withdrawal by Subject|8|||
105694008|NCT01132612|364543524|FG002|Overall Study|Withdrawal by Subject|19|||
105920966|NCT01240746|365371405|FG001|Overall Study|Withdrawal by Subject|13|||
105920967|NCT01240746|365371406|FG002|Overall Study|Withdrawal by Subject|59|||
105920968|NCT03636256|365371407|FG000|Overall Study|Lost to Follow-up|3|||
105920969|NCT03636256|365371408|FG001|Overall Study|Lost to Follow-up|0|||
105920970|NCT03636256|365371409|FG002|Overall Study|Lost to Follow-up|2|||
105920971|NCT03636256|365371410|FG003|Overall Study|Lost to Follow-up|1|||
105920972|NCT03636256|365371411|FG004|Overall Study|Lost to Follow-up|0|||
105920973|NCT03636256|365371412|FG005|Overall Study|Lost to Follow-up|4|||
105920974|NCT03636256|365371413|FG006|Overall Study|Lost to Follow-up|2|||
105920975|NCT03636256|365371414|FG007|Overall Study|Lost to Follow-up|0|||
105920976|NCT03636256|365371415|FG008|Overall Study|Lost to Follow-up|4|||
105920977|NCT03636256|365371407|FG000|Overall Study|Withdrawal by Subject|0|||
105920978|NCT03636256|365371408|FG001|Overall Study|Withdrawal by Subject|0|||
105920979|NCT03636256|365371409|FG002|Overall Study|Withdrawal by Subject|0|||
105920980|NCT03636256|365371410|FG003|Overall Study|Withdrawal by Subject|0|||
105920981|NCT03636256|365371411|FG004|Overall Study|Withdrawal by Subject|0|||
105920982|NCT03636256|365371412|FG005|Overall Study|Withdrawal by Subject|0|||
105920983|NCT03636256|365371413|FG006|Overall Study|Withdrawal by Subject|0|||
105920984|NCT03636256|365371414|FG007|Overall Study|Withdrawal by Subject|0|||
105920985|NCT03636256|365371415|FG008|Overall Study|Withdrawal by Subject|1|||
105920986|NCT02369653|365371416|FG000|Overall Study|Lost to Follow-up|0|||
105920987|NCT02369653|365371417|FG001|Overall Study|Lost to Follow-up|1|||
105920988|NCT02369653|365371416|FG000|Overall Study|Administrative reason by sponsor|0|||
105920989|NCT02369653|365371417|FG001|Overall Study|Administrative reason by sponsor|1|||
105920990|NCT02369653|365371416|FG000|Overall Study|Death|1|||
105920991|NCT02369653|365371417|FG001|Overall Study|Death|2|||
105920992|NCT02369653|365371416|FG000|Overall Study|Participant withdrew consent|13|||
105920993|NCT02369653|365371417|FG001|Overall Study|Participant withdrew consent|3|||
105920994|NCT03587636|365371420|FG000|Overall Study|Lost to Follow-up|2|||
105920995|NCT03587636|365371421|FG001|Overall Study|Lost to Follow-up|5|||
105920996|NCT01458587|365371422|FG000|Overall Study|Withdrawal by Subject|1|||
105920997|NCT01458587|365371423|FG001|Overall Study|Withdrawal by Subject|0|||
105920998|NCT00726453|365371424|FG000|Primary Enrollment Group|Death|18|||
105920999|NCT00726453|365371425|FG001|Primary Enrollment Group|Death|0|||
105921000|NCT00726453|365371424|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
105921001|NCT00726453|365371425|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
105921002|NCT00726453|365371424|FG000|38 mm Length Group|Death|0|||
105921003|NCT00726453|365371425|FG001|38 mm Length Group|Death|3|||
105921004|NCT00250588|365371430|FG000|Overall Study|Withdrawal by Subject|3|||
105921005|NCT00250588|365371431|FG001|Overall Study|Withdrawal by Subject|6|||
105921006|NCT00250588|365371432|FG002|Overall Study|Withdrawal by Subject|0|||
105921007|NCT00250588|365371430|FG000|Overall Study|Lost to Follow-up|6|||
105921008|NCT00250588|365371431|FG001|Overall Study|Lost to Follow-up|13|||
105921009|NCT00250588|365371432|FG002|Overall Study|Lost to Follow-up|13|||
105921010|NCT00706797|365371433|FG000|Overall Study|Lack of Efficacy|3|||
105921011|NCT00706797|365371434|FG001|Overall Study|Lack of Efficacy|0|||
105921012|NCT00706797|365371433|FG000|Overall Study|Adverse Event|0|||
105921013|NCT00706797|365371434|FG001|Overall Study|Adverse Event|3|||
106004332|NCT00591006|365678238|FG004|Overall Study|Withdrawal by Subject|0|||
105921014|NCT00706797|365371433|FG000|Overall Study|Withdrawal by Subject|8|||
105921015|NCT00706797|365371434|FG001|Overall Study|Withdrawal by Subject|1|||
105921016|NCT00706797|365371433|FG000|Overall Study|Death|1|||
105921017|NCT00706797|365371434|FG001|Overall Study|Death|0|||
105921018|NCT00706797|365371433|FG000|Overall Study|Discontinuation of study by sponsor|52|||
105921019|NCT00706797|365371434|FG001|Overall Study|Discontinuation of study by sponsor|63|||
105921020|NCT00706797|365371433|FG000|Overall Study|Protocol Violation|3|||
106132215|NCT02926937|366141933|FG002|Overall Study|Poor Compliance to Protocol|0|||
106132216|NCT02926937|366141931|FG000|Overall Study|Lost to Follow-up|4|||
105694009|NCT01132612|364543522|FG000|Overall Study|Administrative problems|5|||
105921021|NCT00706797|365371434|FG001|Overall Study|Protocol Violation|2|||
105921022|NCT00706797|365371433|FG000|Overall Study|Lost to Follow-up|1|||
105921023|NCT00706797|365371434|FG001|Overall Study|Lost to Follow-up|2|||
105921024|NCT00706797|365371433|FG000|Overall Study|Other|1|||
105921025|NCT00706797|365371434|FG001|Overall Study|Other|0|||
105921026|NCT00296335|365371436|FG000|Overall Study|Recurrence|3|||
105921027|NCT00296335|365371437|FG001|Overall Study|Recurrence|51|||
105921028|NCT00296335|365371436|FG000|Overall Study|Adverse Event|17|||
105921029|NCT00296335|365371437|FG001|Overall Study|Adverse Event|27|||
105921030|NCT00296335|365371436|FG000|Overall Study|Lost to Follow-up|7|||
105921031|NCT00296335|365371437|FG001|Overall Study|Lost to Follow-up|33|||
105921032|NCT00296335|365371436|FG000|Overall Study|Physician Decision|3|||
105921033|NCT00296335|365371437|FG001|Overall Study|Physician Decision|11|||
105921034|NCT01027845|365371438|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
105921035|NCT01027845|365371439|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
105921036|NCT01027845|365371440|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
105921037|NCT01027845|365371441|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
105921038|NCT01027845|365371438|FG000|Primary Vaccination Phase|Adverse Event|1|||
105921039|NCT01027845|365371439|FG001|Primary Vaccination Phase|Adverse Event|0|||
105921040|NCT01027845|365371440|FG002|Primary Vaccination Phase|Adverse Event|0|||
105921041|NCT01027845|365371441|FG003|Primary Vaccination Phase|Adverse Event|0|||
105921042|NCT01027845|365371438|FG000|Primary Vaccination Phase|Protocol Violation|1|||
105921043|NCT01027845|365371439|FG001|Primary Vaccination Phase|Protocol Violation|0|||
105921044|NCT01027845|365371440|FG002|Primary Vaccination Phase|Protocol Violation|0|||
105921045|NCT01027845|365371441|FG003|Primary Vaccination Phase|Protocol Violation|0|||
105921046|NCT01027845|365371438|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
105921047|NCT01027845|365371439|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
105921048|NCT01027845|365371440|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
105921049|NCT01027845|365371441|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
105921050|NCT01027845|365371438|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
105921051|NCT01027845|365371439|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
105921052|NCT01027845|365371440|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
105921053|NCT01027845|365371441|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
105921054|NCT01027845|365371438|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
105921055|NCT01027845|365371439|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
105921056|NCT01027845|365371440|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
105921057|NCT01027845|365371441|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
105921058|NCT00368550|365371442|FG000|Overall Study|Adverse Event|7|||
105921059|NCT00368550|365371443|FG001|Overall Study|Adverse Event|4|||
105921060|NCT00368550|365371442|FG000|Overall Study|Lack of Efficacy|4|||
105921061|NCT00368550|365371443|FG001|Overall Study|Lack of Efficacy|9|||
105921062|NCT00368550|365371442|FG000|Overall Study|Withdrawal by Subject|17|||
105921063|NCT00368550|365371443|FG001|Overall Study|Withdrawal by Subject|10|||
105921064|NCT01401322|365371444|FG000|Overall Study|Withdrawal by Subject|1|||
105921065|NCT01401322|365371444|FG000|Overall Study|Physician Decision|1|||
105921066|NCT00486044|365371445|FG000|Overall Study|Withdrawal by Subject|2|||
105921067|NCT00486044|365371446|FG001|Overall Study|Withdrawal by Subject|1|||
105921068|NCT00486044|365371445|FG000|Overall Study|Adverse Event|0|||
105921069|NCT00486044|365371446|FG001|Overall Study|Adverse Event|1|||
105921070|NCT00486044|365371445|FG000|Overall Study|Lost to Follow-up|0|||
105921071|NCT00486044|365371446|FG001|Overall Study|Lost to Follow-up|1|||
105921072|NCT02737722|365371448|FG000|Overall Study|Physician Decision|0|||
105921073|NCT02737722|365371449|FG001|Overall Study|Physician Decision|0|||
105921074|NCT02737722|365371450|FG002|Overall Study|Physician Decision|1|||
105921075|NCT02737722|365371451|FG003|Overall Study|Physician Decision|0|||
105921076|NCT01026493|365371452|FG000|Overall Study|Protocol Violation|0|||
105921077|NCT01026493|365371453|FG001|Overall Study|Protocol Violation|1|||
105921078|NCT01026493|365371454|FG002|Overall Study|Protocol Violation|0|||
105921079|NCT01026493|365371455|FG003|Overall Study|Protocol Violation|0|||
105921080|NCT01026493|365371456|FG004|Overall Study|Protocol Violation|2|||
105921081|NCT01026493|365371457|FG005|Overall Study|Protocol Violation|3|||
105921082|NCT01026493|365371458|FG006|Overall Study|Protocol Violation|4|||
105921083|NCT01026493|365371459|FG007|Overall Study|Protocol Violation|1|||
105921084|NCT00087178|365371460|FG000|Overall Study|No follow up data|5|||
105921085|NCT00087178|365371461|FG001|Overall Study|No follow up data|15|||
105921086|NCT00087178|365371460|FG000|Overall Study|No clinical assessment|1|||
105921087|NCT00087178|365371461|FG001|Overall Study|No clinical assessment|2|||
105694010|NCT01132612|364543523|FG001|Overall Study|Administrative problems|1|||
105694011|NCT01132612|364543524|FG002|Overall Study|Administrative problems|52|||
105694012|NCT01132612|364543522|FG000|Overall Study|Lack of Efficacy|23|||
105921088|NCT00087178|365371460|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
105921089|NCT00087178|365371461|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
105921090|NCT01206764|365371462|FG000|Overall Study|Adverse Event|20|||
105921091|NCT01206764|365371462|FG000|Overall Study|Abnormal laboratory value|2|||
105921092|NCT01206764|365371462|FG000|Overall Study|Abnormal test procedure result|1|||
106004333|NCT00591006|365678239|FG005|Overall Study|Withdrawal by Subject|0|||
105694013|NCT01132612|364543523|FG001|Overall Study|Lack of Efficacy|22|||
105694014|NCT01132612|364543524|FG002|Overall Study|Lack of Efficacy|73|||
105694015|NCT02252536|364543528|FG000|Overall Study|Lost to Follow-up|5|||
105694016|NCT02252536|364543529|FG001|Overall Study|Lost to Follow-up|3|||
105694017|NCT02459769|364543532|FG000|Overall Study|Withdrawal by Subject|7|||
105694018|NCT02459769|364543533|FG001|Overall Study|Withdrawal by Subject|4|||
105694019|NCT02459769|364543534|FG002|Overall Study|Withdrawal by Subject|8|||
105694020|NCT02459769|364543535|FG003|Overall Study|Withdrawal by Subject|5|||
105694021|NCT02459769|364543532|FG000|Overall Study|Lost to Follow-up|1|||
105694022|NCT02459769|364543533|FG001|Overall Study|Lost to Follow-up|0|||
105694023|NCT02459769|364543534|FG002|Overall Study|Lost to Follow-up|1|||
105694024|NCT02459769|364543535|FG003|Overall Study|Lost to Follow-up|0|||
105694025|NCT00041067|364543541|FG000|Overall Study|Adverse Event|20|||
105694026|NCT00041067|364543541|FG000|Overall Study|Progression|19|||
105694027|NCT00041067|364543541|FG000|Overall Study|Patient refusal|12|||
105694028|NCT00041067|364543541|FG000|Overall Study|Other reasons|23|||
105694029|NCT00041067|364543541|FG000|Overall Study|Ineligible|2|||
105694030|NCT01289821|364543546|FG000|Treatment Period|Withdrawal by Subject|1|||
105694031|NCT01289821|364543546|FG000|Treatment Period|Physician Decision|3|||
105694032|NCT01289821|364543546|FG000|Treatment Period|Adverse Event|4|||
105694033|NCT01289821|364543546|FG000|Treatment Period|Radiological Progression|43|||
105694034|NCT01289821|364543546|FG000|Treatment Period|Clinical Progression|2|||
105694035|NCT01289821|364543546|FG000|Treatment Period|Therapeutic procedure required|1|||
105694036|NCT01289821|364543546|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
105694037|NCT01289821|364543546|FG000|Safety Follow-up Period|Protocol Violation|3|||
105694038|NCT01289821|364543546|FG000|Safety Follow-up Period|Unspecified reason|1|||
105694039|NCT01289821|364543546|FG000|Survival Follow-up Period|Protocol Violation|1|||
105694040|NCT01289821|364543546|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
105694041|NCT01289821|364543546|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
105694042|NCT00773136|364543549|FG000|Overall Study|Physician Decision|2|||
105694043|NCT01514136|364543553|FG000|Test Period 1; Test A|Protocol Violation|1|||
105921093|NCT01206764|365371462|FG000|Overall Study|Patient withdrew consent|5|||
105921094|NCT01206764|365371462|FG000|Overall Study|Lost to Follow-up|6|||
105921095|NCT01206764|365371462|FG000|Overall Study|Death|11|||
105921096|NCT01206764|365371462|FG000|Overall Study|New cancer therapy|2|||
105921097|NCT01206764|365371462|FG000|Overall Study|Disease progression|88|||
105694044|NCT01514136|364543554|FG001|Test Period 1; Test A|Protocol Violation|0|||
105694045|NCT01514136|364543555|FG002|Test Period 1; Test A|Protocol Violation|0|||
105921098|NCT01206764|365371462|FG000|Overall Study|Protocol deviation|3|||
105921099|NCT00630916|365371463|FG000|Overall Study|Death|110|||
106132217|NCT02926937|366141932|FG001|Overall Study|Lost to Follow-up|5|||
105694046|NCT01514136|364543556|FG003|Test Period 1; Test A|Protocol Violation|0|||
105694047|NCT01514136|364543557|FG004|Test Period 1; Test A|Protocol Violation|0|||
105694048|NCT01514136|364543558|FG005|Test Period 1; Test A|Protocol Violation|0|||
105694049|NCT01514136|364543559|FG006|Test Period 1; Test A|Protocol Violation|0|||
105694050|NCT01514136|364543560|FG007|Test Period 1; Test A|Protocol Violation|0|||
105694051|NCT01514136|364543553|FG000|Test Period 1; Test A|Break from study holiday|2|||
105694052|NCT01514136|364543554|FG001|Test Period 1; Test A|Break from study holiday|0|||
105694053|NCT01514136|364543555|FG002|Test Period 1; Test A|Break from study holiday|0|||
105694054|NCT01514136|364543556|FG003|Test Period 1; Test A|Break from study holiday|0|||
105694055|NCT01514136|364543557|FG004|Test Period 1; Test A|Break from study holiday|0|||
105694056|NCT01514136|364543558|FG005|Test Period 1; Test A|Break from study holiday|0|||
105694057|NCT01514136|364543559|FG006|Test Period 1; Test A|Break from study holiday|0|||
105694058|NCT01514136|364543560|FG007|Test Period 1; Test A|Break from study holiday|0|||
105694059|NCT01514136|364543553|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
105694060|NCT01514136|364543554|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
105694061|NCT01514136|364543555|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
105694062|NCT01514136|364543556|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
105694063|NCT01514136|364543557|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
105694064|NCT01514136|364543558|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
105694065|NCT01514136|364543559|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
105694066|NCT01514136|364543560|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
105694067|NCT01514136|364543553|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694068|NCT01514136|364543554|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694069|NCT01514136|364543555|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694070|NCT01514136|364543556|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
105694071|NCT01514136|364543557|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694072|NCT01514136|364543558|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694073|NCT01514136|364543559|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
105694074|NCT01514136|364543560|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
105921100|NCT00630916|365371463|FG000|Overall Study|Explant|8|||
105694075|NCT01514136|364543553|FG000|Test Period 2; Test A*|Adverse Event|0|||
105921101|NCT00630916|365371463|FG000|Overall Study|Lost to Follow-up|5|||
105694076|NCT01514136|364543554|FG001|Test Period 2; Test A*|Adverse Event|0|||
105694077|NCT01514136|364543555|FG002|Test Period 2; Test A*|Adverse Event|0|||
105694078|NCT01514136|364543556|FG003|Test Period 2; Test A*|Adverse Event|0|||
105694079|NCT01514136|364543557|FG004|Test Period 2; Test A*|Adverse Event|1|||
105694080|NCT01514136|364543558|FG005|Test Period 2; Test A*|Adverse Event|0|||
105694081|NCT01514136|364543559|FG006|Test Period 2; Test A*|Adverse Event|0|||
105694082|NCT01514136|364543560|FG007|Test Period 2; Test A*|Adverse Event|0|||
105694083|NCT01514136|364543553|FG000|Test Period 2; Test A*|Holiday|0|||
105694084|NCT01514136|364543554|FG001|Test Period 2; Test A*|Holiday|0|||
105694085|NCT01514136|364543555|FG002|Test Period 2; Test A*|Holiday|0|||
105694086|NCT01514136|364543556|FG003|Test Period 2; Test A*|Holiday|0|||
105694087|NCT01514136|364543557|FG004|Test Period 2; Test A*|Holiday|1|||
105694088|NCT01514136|364543558|FG005|Test Period 2; Test A*|Holiday|0|||
105694089|NCT01514136|364543559|FG006|Test Period 2; Test A*|Holiday|0|||
105694090|NCT01514136|364543560|FG007|Test Period 2; Test A*|Holiday|0|||
105694091|NCT01514136|364543553|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694092|NCT01514136|364543554|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694093|NCT01514136|364543555|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694094|NCT01514136|364543556|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694095|NCT01514136|364543557|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694096|NCT01514136|364543558|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
105694097|NCT01514136|364543559|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694098|NCT01514136|364543560|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
105694099|NCT01514136|364543553|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694100|NCT01514136|364543554|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694101|NCT01514136|364543555|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694102|NCT01514136|364543556|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694103|NCT01514136|364543557|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694104|NCT01514136|364543558|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694105|NCT01514136|364543559|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
105694106|NCT01514136|364543560|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
105694107|NCT01514136|364543553|FG000|Test Period 2; Test C*|holiday|0|||
105694108|NCT01514136|364543554|FG001|Test Period 2; Test C*|holiday|0|||
106004334|NCT00591006|365678240|FG006|Overall Study|Withdrawal by Subject|0|||
105694109|NCT01514136|364543555|FG002|Test Period 2; Test C*|holiday|0|||
105694110|NCT01514136|364543556|FG003|Test Period 2; Test C*|holiday|0|||
105694111|NCT01514136|364543557|FG004|Test Period 2; Test C*|holiday|0|||
105694112|NCT01514136|364543558|FG005|Test Period 2; Test C*|holiday|0|||
105694113|NCT01514136|364543559|FG006|Test Period 2; Test C*|holiday|1|||
105694114|NCT01514136|364543560|FG007|Test Period 2; Test C*|holiday|0|||
105694115|NCT01514136|364543553|FG000|Test Period 2; Test C*|Protocol Violation|0|||
105694116|NCT01514136|364543554|FG001|Test Period 2; Test C*|Protocol Violation|0|||
105694117|NCT01514136|364543555|FG002|Test Period 2; Test C*|Protocol Violation|0|||
105694118|NCT01514136|364543556|FG003|Test Period 2; Test C*|Protocol Violation|0|||
105694119|NCT01514136|364543557|FG004|Test Period 2; Test C*|Protocol Violation|0|||
105694120|NCT01514136|364543558|FG005|Test Period 2; Test C*|Protocol Violation|0|||
105694121|NCT01514136|364543559|FG006|Test Period 2; Test C*|Protocol Violation|1|||
105694122|NCT01514136|364543560|FG007|Test Period 2; Test C*|Protocol Violation|0|||
105694123|NCT01010633|364543561|FG000|Overall Study|Adverse Event|1|||
106004335|NCT00591006|365678241|FG007|Overall Study|Withdrawal by Subject|0|||
106004336|NCT00591006|365678242|FG008|Overall Study|Withdrawal by Subject|0|||
106004337|NCT00591006|365678243|FG009|Overall Study|Withdrawal by Subject|0|||
106004338|NCT00591006|365678244|FG010|Overall Study|Withdrawal by Subject|0|||
106004339|NCT00591006|365678245|FG011|Overall Study|Withdrawal by Subject|0|||
106004340|NCT00591006|365678246|FG012|Overall Study|Withdrawal by Subject|0|||
106004341|NCT00591006|365678247|FG013|Overall Study|Withdrawal by Subject|0|||
106004342|NCT00591006|365678248|FG014|Overall Study|Withdrawal by Subject|0|||
106004343|NCT00591006|365678249|FG015|Overall Study|Withdrawal by Subject|1|||
106004344|NCT00591006|365678250|FG016|Overall Study|Withdrawal by Subject|0|||
106004345|NCT00591006|365678251|FG017|Overall Study|Withdrawal by Subject|0|||
106004346|NCT00591006|365678252|FG018|Overall Study|Withdrawal by Subject|0|||
106004347|NCT00591006|365678253|FG019|Overall Study|Withdrawal by Subject|0|||
106132218|NCT02926937|366141933|FG002|Overall Study|Lost to Follow-up|0|||
106004348|NCT00591006|365678254|FG020|Overall Study|Withdrawal by Subject|0|||
106132219|NCT02926937|366141931|FG000|Overall Study|At the Participant's own Request|11|||
106132220|NCT02926937|366141932|FG001|Overall Study|At the Participant's own Request|5|||
106132221|NCT02926937|366141933|FG002|Overall Study|At the Participant's own Request|8|||
105694124|NCT01010633|364543562|FG001|Overall Study|Adverse Event|1|||
106004349|NCT00591006|365678255|FG021|Overall Study|Withdrawal by Subject|0|||
105694125|NCT01010633|364543561|FG000|Overall Study|Protocol Violation|1|||
105694126|NCT01010633|364543562|FG001|Overall Study|Protocol Violation|2|||
105694127|NCT01010633|364543561|FG000|Overall Study|Withdrawal by Subject|2|||
106132222|NCT02926937|366141931|FG000|Overall Study|Reason not Specified|3|||
105694128|NCT01010633|364543562|FG001|Overall Study|Withdrawal by Subject|1|||
105694129|NCT01010633|364543561|FG000|Overall Study|Investigator decision|0|||
106004350|NCT00591006|365678256|FG022|Overall Study|Withdrawal by Subject|0|||
105694130|NCT01010633|364543562|FG001|Overall Study|Investigator decision|1|||
105694131|NCT02941926|364543563|FG000|Core Phase|Progressive disease|1109|||
105694132|NCT02941926|364543563|FG000|Core Phase|Adverse Event|504|||
105694133|NCT02941926|364543563|FG000|Core Phase|Subject/guardian decision|127|||
105694134|NCT02941926|364543563|FG000|Core Phase|Physician Decision|112|||
105694135|NCT02941926|364543563|FG000|Core Phase|Death|46|||
105694136|NCT02941926|364543563|FG000|Core Phase|Protocol deviation|34|||
105694137|NCT02941926|364543563|FG000|Core Phase|Lost to Follow-up|8|||
105694138|NCT02941926|364543563|FG000|Core Phase|Technical problems|5|||
105694139|NCT02941926|364543563|FG000|Extension Phase|Physician Decision|155|||
105694140|NCT02941926|364543563|FG000|Extension Phase|Progressive disease|115|||
105694141|NCT02941926|364543563|FG000|Extension Phase|Adverse Event|13|||
105694142|NCT02941926|364543563|FG000|Extension Phase|Subject/Guardian decision|12|||
105694143|NCT02941926|364543563|FG000|Extension Phase|Death|6|||
105694144|NCT02729740|364543564|FG000|Overall Study|Early Termination|130|||
105694145|NCT02729740|364543564|FG000|Overall Study|Other|1|||
105694146|NCT00882310|364543565|FG000|Overall Study|Screen Failure|10|||
105694147|NCT00882310|364543565|FG000|Overall Study|Never received treatment|1|||
105694148|NCT00882310|364543565|FG000|Overall Study|Death|6|||
105694149|NCT00882310|364543565|FG000|Overall Study|Progression of disease|4|||
105694150|NCT00882310|364543565|FG000|Overall Study|Adverse Event|1|||
105694151|NCT01494350|364543566|FG000|Overall Study|Worsening of lesion|1|||
105694152|NCT00698932|364543567|FG000|Overall Study|Adverse Event|0|||
105694153|NCT00698932|364543568|FG001|Overall Study|Adverse Event|2|||
105694154|NCT00698932|364543567|FG000|Overall Study|Incorrect enrollment|0|||
105694155|NCT00698932|364543568|FG001|Overall Study|Incorrect enrollment|2|||
105694156|NCT00698932|364543567|FG000|Overall Study|Study specific discontinuation criteria|3|||
105694157|NCT00698932|364543568|FG001|Overall Study|Study specific discontinuation criteria|4|||
105694158|NCT00698932|364543567|FG000|Overall Study|Withdrawal by Subject|11|||
105694159|NCT00698932|364543568|FG001|Overall Study|Withdrawal by Subject|23|||
105694160|NCT00698932|364543567|FG000|Overall Study|Lost to Follow-up|6|||
105694161|NCT00698932|364543568|FG001|Overall Study|Lost to Follow-up|1|||
105694162|NCT00698932|364543567|FG000|Overall Study|Severe non-compliance to protocol|1|||
105694163|NCT00698932|364543568|FG001|Overall Study|Severe non-compliance to protocol|2|||
105694164|NCT00698932|364543567|FG000|Overall Study|Safety reasons|0|||
105694165|NCT00698932|364543568|FG001|Overall Study|Safety reasons|2|||
105694166|NCT00698932|364543567|FG000|Overall Study|Death|1|||
105694167|NCT00698932|364543568|FG001|Overall Study|Death|0|||
105694168|NCT00601705|364543571|FG000|Overall Study|Withdrawal by Subject|1|||
105694169|NCT04233164|364543572|FG000|Overall Study|Unable to obtain specimen|0|||
105694170|NCT04233164|364543573|FG001|Overall Study|Unable to obtain specimen|1|||
105694171|NCT03250832|364543591|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
105694172|NCT03250832|364543592|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
105694173|NCT03250832|364543593|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
105694174|NCT03250832|364543594|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
105694175|NCT03250832|364543595|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
105694176|NCT03250832|364543596|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
105694177|NCT03250832|364543597|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
105694178|NCT03250832|364543598|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694179|NCT03250832|364543599|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694180|NCT03250832|364543600|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694181|NCT03250832|364543601|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694182|NCT03250832|364543602|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
105694183|NCT03250832|364543591|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
105694184|NCT03250832|364543592|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
105694185|NCT03250832|364543593|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
105694186|NCT03250832|364543594|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
105694187|NCT03250832|364543595|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
105694188|NCT03250832|364543596|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
105694189|NCT03250832|364543597|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
105694190|NCT03250832|364543598|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694191|NCT03250832|364543599|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694192|NCT03250832|364543600|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694193|NCT03250832|364543601|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694194|NCT03250832|364543602|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
105694195|NCT03250832|364543591|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694196|NCT03250832|364543592|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105921102|NCT00630916|365371463|FG000|Overall Study|Withdrawal by Subject|30|||
105921103|NCT00630916|365371463|FG000|Overall Study|Protocol Violation|7|||
105921104|NCT00630916|365371463|FG000|Overall Study|Physician Decision|47|||
105921105|NCT00630916|365371463|FG000|Overall Study|Lack of Efficacy|3|||
105921106|NCT00324155|365371464|FG000|Enrolled and Randomized|No longer met study criteria|3|||
105694197|NCT03250832|364543593|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
105921107|NCT00324155|365371465|FG001|Enrolled and Randomized|No longer met study criteria|0|||
105921108|NCT00324155|365371464|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
105921109|NCT00324155|365371465|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
105921110|NCT00324155|365371464|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
105921111|NCT00324155|365371465|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
105921112|NCT00324155|365371464|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
105921113|NCT00324155|365371465|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
105921114|NCT00324155|365371464|FG000|Received Treatment in Induction Phase|Death|8|||
105921115|NCT00324155|365371465|FG001|Received Treatment in Induction Phase|Death|15|||
105921116|NCT00324155|365371464|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
105921117|NCT00324155|365371465|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
105921118|NCT00324155|365371464|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
105921119|NCT00324155|365371465|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
105921120|NCT00324155|365371464|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
105921121|NCT00324155|365371465|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
105921122|NCT00324155|365371464|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
105921123|NCT00324155|365371465|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
105921124|NCT00324155|365371464|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
105921125|NCT00324155|365371465|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
106004351|NCT00591006|365678257|FG023|Overall Study|Withdrawal by Subject|1|||
106004352|NCT00591006|365678234|FG000|Overall Study|Adverse Event|0|||
106004353|NCT00591006|365678235|FG001|Overall Study|Adverse Event|0|||
106004354|NCT00591006|365678236|FG002|Overall Study|Adverse Event|0|||
106004355|NCT00591006|365678237|FG003|Overall Study|Adverse Event|0|||
106004356|NCT00591006|365678238|FG004|Overall Study|Adverse Event|0|||
106004357|NCT00591006|365678239|FG005|Overall Study|Adverse Event|0|||
106004358|NCT00591006|365678240|FG006|Overall Study|Adverse Event|0|||
106004359|NCT00591006|365678241|FG007|Overall Study|Adverse Event|0|||
106004360|NCT00591006|365678242|FG008|Overall Study|Adverse Event|0|||
106004361|NCT00591006|365678243|FG009|Overall Study|Adverse Event|0|||
106004362|NCT00591006|365678244|FG010|Overall Study|Adverse Event|0|||
106004363|NCT00591006|365678245|FG011|Overall Study|Adverse Event|0|||
106004364|NCT00591006|365678246|FG012|Overall Study|Adverse Event|0|||
106004365|NCT00591006|365678247|FG013|Overall Study|Adverse Event|0|||
106004366|NCT00591006|365678248|FG014|Overall Study|Adverse Event|0|||
105694198|NCT03250832|364543594|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694199|NCT03250832|364543595|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694200|NCT03250832|364543596|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694201|NCT03250832|364543597|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694202|NCT03250832|364543598|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694203|NCT03250832|364543599|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694204|NCT03250832|364543600|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694205|NCT03250832|364543601|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694206|NCT03250832|364543602|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
105694207|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694208|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694209|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694210|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694211|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694212|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694213|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694214|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
105694215|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694216|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694217|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694218|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
105694219|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694220|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694221|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694222|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694223|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694224|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694225|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694226|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
106004367|NCT00591006|365678249|FG015|Overall Study|Adverse Event|0|||
106004368|NCT00591006|365678250|FG016|Overall Study|Adverse Event|0|||
106004369|NCT00591006|365678251|FG017|Overall Study|Adverse Event|0|||
106004370|NCT00591006|365678252|FG018|Overall Study|Adverse Event|0|||
105694227|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694228|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694229|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694230|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
105694231|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694232|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694233|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694234|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105921126|NCT00324155|365371464|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
105694235|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694236|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694237|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694238|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
105694239|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694240|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694241|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694242|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
105694243|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694244|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694245|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694246|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694247|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694248|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694249|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694250|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
105694251|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694252|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694253|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694254|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
105694255|NCT03250832|364543591|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694256|NCT03250832|364543592|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694257|NCT03250832|364543593|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694258|NCT03250832|364543594|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694259|NCT03250832|364543595|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694260|NCT03250832|364543596|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694261|NCT03250832|364543597|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694262|NCT03250832|364543598|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
105694263|NCT03250832|364543599|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694264|NCT03250832|364543600|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
105921127|NCT00324155|365371465|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
105921128|NCT00324155|365371464|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
105921129|NCT00324155|365371465|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
105921130|NCT00324155|365371464|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
105921131|NCT00324155|365371465|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
105921132|NCT00324155|365371464|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
105921133|NCT00324155|365371465|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
105921134|NCT00324155|365371464|FG000|Follow-up Phase|On-going participants still on drug|11|||
105921135|NCT00324155|365371465|FG001|Follow-up Phase|On-going participants still on drug|6|||
105921136|NCT03451045|365371466|FG000|Overall Study|Lack of Efficacy|3|||
105921137|NCT03451045|365371467|FG001|Overall Study|Lack of Efficacy|2|||
105921138|NCT03451045|365371468|FG002|Overall Study|Lack of Efficacy|2|||
105921139|NCT03451045|365371466|FG000|Overall Study|Physician Decision|1|||
105921140|NCT03451045|365371467|FG001|Overall Study|Physician Decision|1|||
105921141|NCT03451045|365371468|FG002|Overall Study|Physician Decision|1|||
105921142|NCT03451045|365371466|FG000|Overall Study|Withdrawal by Subject|4|||
105921143|NCT03451045|365371467|FG001|Overall Study|Withdrawal by Subject|0|||
105921144|NCT03451045|365371468|FG002|Overall Study|Withdrawal by Subject|5|||
105921145|NCT03451045|365371466|FG000|Overall Study|Pregnancy|0|||
105694265|NCT03250832|364543601|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694266|NCT03250832|364543602|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
105694267|NCT03250832|364543591|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694268|NCT03250832|364543592|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694269|NCT03250832|364543593|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694270|NCT03250832|364543594|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694271|NCT03250832|364543595|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694272|NCT03250832|364543596|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694273|NCT03250832|364543597|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694274|NCT03250832|364543598|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694275|NCT03250832|364543599|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
105694276|NCT03250832|364543600|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
105694277|NCT03250832|364543601|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694278|NCT03250832|364543602|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
105694279|NCT03250832|364543591|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
106004371|NCT00591006|365678253|FG019|Overall Study|Adverse Event|0|||
106004372|NCT00591006|365678254|FG020|Overall Study|Adverse Event|0|||
106004373|NCT00591006|365678255|FG021|Overall Study|Adverse Event|0|||
105694280|NCT03250832|364543592|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694281|NCT03250832|364543593|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694282|NCT03250832|364543594|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694283|NCT03250832|364543595|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694284|NCT03250832|364543596|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694285|NCT03250832|364543597|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694286|NCT03250832|364543598|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694287|NCT03250832|364543599|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
105694288|NCT03250832|364543600|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
105694289|NCT03250832|364543601|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694290|NCT03250832|364543602|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
105694291|NCT03250832|364543591|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694292|NCT03250832|364543592|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694293|NCT03250832|364543593|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694294|NCT03250832|364543594|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694295|NCT03250832|364543595|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
106004374|NCT00591006|365678256|FG022|Overall Study|Adverse Event|1|||
106004375|NCT00591006|365678257|FG023|Overall Study|Adverse Event|0|||
105694296|NCT03250832|364543596|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694297|NCT03250832|364543597|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694298|NCT03250832|364543598|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694299|NCT03250832|364543599|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
105694300|NCT03250832|364543600|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
105694301|NCT03250832|364543601|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694302|NCT03250832|364543602|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
105694303|NCT03250832|364543591|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694304|NCT03250832|364543592|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694305|NCT03250832|364543593|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694306|NCT03250832|364543594|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694307|NCT03250832|364543595|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694308|NCT03250832|364543596|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694309|NCT03250832|364543597|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
106004376|NCT03557970|365678258|FG000|Overall Study|Study closure|1|||
106004377|NCT03557970|365678259|FG001|Overall Study|Study closure|0|||
106004378|NCT03557970|365678258|FG000|Overall Study|Physician Decision|0|||
106004379|NCT03557970|365678259|FG001|Overall Study|Physician Decision|1|||
106004380|NCT03557970|365678258|FG000|Overall Study|Death|0|||
106004381|NCT03557970|365678259|FG001|Overall Study|Death|1|||
105694310|NCT03250832|364543598|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694311|NCT03250832|364543599|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694312|NCT03250832|364543600|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694313|NCT03250832|364543601|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
105694314|NCT03250832|364543602|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
105694315|NCT02303704|364543603|FG000|Overall Study|Protocol Violation|5|||
105694316|NCT02303704|364543604|FG001|Overall Study|Protocol Violation|9|||
105694317|NCT00705432|364543605|FG000|Treatment Period|Adverse Event|45|||
106004382|NCT00112736|365678260|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
106004383|NCT00112736|365678261|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
105694318|NCT00705432|364543606|FG001|Treatment Period|Adverse Event|37|||
105694319|NCT00705432|364543607|FG002|Treatment Period|Adverse Event|51|||
105694320|NCT00705432|364543608|FG003|Treatment Period|Adverse Event|12|||
105694321|NCT00705432|364543609|FG004|Treatment Period|Adverse Event|8|||
105694322|NCT00705432|364543610|FG005|Treatment Period|Adverse Event|9|||
105694323|NCT00705432|364543605|FG000|Treatment Period|Treatment failure|92|||
105694324|NCT00705432|364543606|FG001|Treatment Period|Treatment failure|42|||
105694325|NCT00705432|364543607|FG002|Treatment Period|Treatment failure|33|||
105694326|NCT00705432|364543608|FG003|Treatment Period|Treatment failure|25|||
106132223|NCT02926937|366141932|FG001|Overall Study|Reason not Specified|4|||
106004384|NCT05435339|365678262|FG000|Overall Study|Death|1|||
106004385|NCT05435339|365678263|FG001|Overall Study|Death|0|||
105694327|NCT00705432|364543609|FG004|Treatment Period|Treatment failure|13|||
105694328|NCT00705432|364543610|FG005|Treatment Period|Treatment failure|14|||
105694329|NCT00705432|364543605|FG000|Treatment Period|Non medical reason|26|||
105694330|NCT00705432|364543606|FG001|Treatment Period|Non medical reason|32|||
105694331|NCT00705432|364543607|FG002|Treatment Period|Non medical reason|37|||
105694332|NCT00705432|364543608|FG003|Treatment Period|Non medical reason|4|||
105694333|NCT00705432|364543609|FG004|Treatment Period|Non medical reason|7|||
105694334|NCT00705432|364543610|FG005|Treatment Period|Non medical reason|7|||
105694335|NCT00705432|364543605|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
105694336|NCT00705432|364543606|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
105694337|NCT00705432|364543607|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
105694338|NCT00705432|364543608|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
105694339|NCT00705432|364543609|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
105694340|NCT00705432|364543610|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
105694341|NCT00705432|364543605|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
105694342|NCT00705432|364543606|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
105694343|NCT00705432|364543607|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
105694344|NCT00705432|364543608|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
105694345|NCT00705432|364543609|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
105694346|NCT00705432|364543610|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
105694347|NCT00805025|364543611|FG000|Overall Study|Screened but not enrolled/treated|42|||
105694348|NCT00805025|364543611|FG000|Overall Study|Adverse Event|4|||
105694349|NCT00805025|364543611|FG000|Overall Study|Withdrawal by Subject|2|||
105694350|NCT00805025|364543611|FG000|Overall Study|Physician Decision|1|||
105694351|NCT03631667|364545029|FG000|Overall Study|Withdrawal by Subject|3|||
105694352|NCT01383096|364545036|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
105694353|NCT01383096|364545037|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
105694354|NCT01383096|364545038|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
106132224|NCT02926937|366141933|FG002|Overall Study|Reason not Specified|2|||
105694355|NCT01383096|364545036|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
105694356|NCT01383096|364545037|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
105694357|NCT01383096|364545038|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
105694358|NCT01383096|364545036|FG000|Third Intervention (8 Days)|Elevated AST|0|||
105694359|NCT01383096|364545037|FG001|Third Intervention (8 Days)|Elevated AST|1|||
105694360|NCT01383096|364545038|FG002|Third Intervention (8 Days)|Elevated AST|0|||
105694361|NCT01383096|364545036|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
105694362|NCT01383096|364545037|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
105694363|NCT01383096|364545038|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
105694364|NCT01383096|364545036|FG000|Third Intervention (8 Days)|Adverse Event|1|||
105694365|NCT01383096|364545037|FG001|Third Intervention (8 Days)|Adverse Event|0|||
105694366|NCT01383096|364545038|FG002|Third Intervention (8 Days)|Adverse Event|0|||
105694367|NCT01383096|364545036|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
105694368|NCT01383096|364545037|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
105694369|NCT01383096|364545038|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
105694370|NCT01383096|364545036|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
105694371|NCT01383096|364545037|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
105694372|NCT01383096|364545038|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
105694373|NCT01383096|364545036|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
105787070|NCT03110107|364874902|FG013|Treatment Period|Disease Progression|5|||
105787071|NCT03110107|364874903|FG014|Treatment Period|Disease Progression|14|||
105694374|NCT01383096|364545037|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
105694375|NCT01383096|364545038|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
105694376|NCT01383096|364545036|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
105787072|NCT03110107|364874904|FG015|Treatment Period|Disease Progression|14|||
105921146|NCT03451045|365371467|FG001|Overall Study|Pregnancy|0|||
105921147|NCT03451045|365371468|FG002|Overall Study|Pregnancy|2|||
105921148|NCT03451045|365371466|FG000|Overall Study|Adverse Event|7|||
105921149|NCT03451045|365371467|FG001|Overall Study|Adverse Event|1|||
105921150|NCT03451045|365371468|FG002|Overall Study|Adverse Event|3|||
105921151|NCT03451045|365371466|FG000|Overall Study|Non-compliance with study|2|||
105921152|NCT03451045|365371467|FG001|Overall Study|Non-compliance with study|0|||
105921153|NCT03451045|365371468|FG002|Overall Study|Non-compliance with study|1|||
105921154|NCT03451045|365371466|FG000|Overall Study|any other reason|10|||
105921155|NCT03451045|365371467|FG001|Overall Study|any other reason|2|||
105921156|NCT03451045|365371468|FG002|Overall Study|any other reason|13|||
105921157|NCT00863707|365371471|FG000|Overall Study|Randomized, but drug not received|4|||
105921158|NCT00863707|365371472|FG001|Overall Study|Randomized, but drug not received|3|||
105921159|NCT02722967|365371473|FG000|Overall Study|Adverse Event|1|||
105921160|NCT02722967|365371474|FG001|Overall Study|Adverse Event|0|||
105921161|NCT02722967|365371475|FG002|Overall Study|Adverse Event|0|||
105921162|NCT02722967|365371473|FG000|Overall Study|Lost to Follow-up|0|||
106004386|NCT05435339|365678264|FG002|Overall Study|Death|3|||
105787073|NCT03110107|364874905|FG016|Treatment Period|Disease Progression|4|||
106004387|NCT05435339|365678265|FG003|Overall Study|Death|1|||
106004388|NCT05435339|365678266|FG004|Overall Study|Death|3|||
106004389|NCT05435339|365678267|FG005|Overall Study|Death|2|||
106004390|NCT05435339|365678268|FG006|Overall Study|Death|4|||
106004391|NCT05435339|365678269|FG007|Overall Study|Death|6|||
106004392|NCT05435339|365678262|FG000|Overall Study|Sponsor Decision|0|||
106004393|NCT05435339|365678263|FG001|Overall Study|Sponsor Decision|1|||
106004394|NCT05435339|365678264|FG002|Overall Study|Sponsor Decision|0|||
106004395|NCT05435339|365678265|FG003|Overall Study|Sponsor Decision|0|||
106004396|NCT05435339|365678266|FG004|Overall Study|Sponsor Decision|2|||
106004397|NCT05435339|365678267|FG005|Overall Study|Sponsor Decision|1|||
106004398|NCT05435339|365678268|FG006|Overall Study|Sponsor Decision|2|||
106004399|NCT05435339|365678269|FG007|Overall Study|Sponsor Decision|2|||
106004400|NCT05435339|365678262|FG000|Overall Study|Withdrawal by Subject|0|||
106004401|NCT05435339|365678263|FG001|Overall Study|Withdrawal by Subject|0|||
106004402|NCT05435339|365678264|FG002|Overall Study|Withdrawal by Subject|0|||
106004403|NCT05435339|365678265|FG003|Overall Study|Withdrawal by Subject|0|||
106004404|NCT05435339|365678266|FG004|Overall Study|Withdrawal by Subject|1|||
106004405|NCT05435339|365678267|FG005|Overall Study|Withdrawal by Subject|0|||
106004406|NCT05435339|365678268|FG006|Overall Study|Withdrawal by Subject|1|||
106004407|NCT05435339|365678269|FG007|Overall Study|Withdrawal by Subject|1|||
106004408|NCT02343263|365678270|FG000|Overall Study|Physician Decision|5|||
106004409|NCT02343263|365678271|FG001|Overall Study|Physician Decision|3|||
106004410|NCT02343263|365678272|FG002|Overall Study|Physician Decision|1|||
106004411|NCT03040141|365678282|FG000|Overall Study|Death|1|||
106004412|NCT03040141|365678283|FG001|Overall Study|Death|2|||
106004413|NCT03040141|365678284|FG002|Overall Study|Death|3|||
106004414|NCT03040141|365678282|FG000|Overall Study|Withdrawal by Subject|3|||
106004415|NCT03040141|365678283|FG001|Overall Study|Withdrawal by Subject|1|||
106004416|NCT03040141|365678284|FG002|Overall Study|Withdrawal by Subject|1|||
106004417|NCT03040141|365678282|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
106004418|NCT03040141|365678283|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
106004419|NCT03040141|365678284|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
106004420|NCT03040141|365678282|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
106004421|NCT03040141|365678283|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
106004422|NCT03040141|365678284|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
106004423|NCT03155724|365678285|FG000|Overall Study|Death|3|||
106004424|NCT03155724|365678285|FG000|Overall Study|Physician Decision|1|||
106004425|NCT03155724|365678285|FG000|Overall Study|Study closure|7|||
106004426|NCT05135871|365678291|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
106004427|NCT05135871|365678292|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
106004428|NCT05135871|365678293|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
106004429|NCT05135871|365678294|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
106004430|NCT04258423|365678301|FG000|Overall Study|Study Closure|2|||
106004431|NCT04258423|365678302|FG001|Overall Study|Study Closure|2|||
106004432|NCT03289208|365678303|FG000|Overall Study|Adverse Event|1|||
106004433|NCT03289208|365678304|FG001|Overall Study|Adverse Event|0|||
106004434|NCT03289208|365678305|FG002|Overall Study|Adverse Event|0|||
106004435|NCT00321789|365678308|FG000|Overall Study|Lost to Follow-up|4|||
106004436|NCT00321789|365678309|FG001|Overall Study|Lost to Follow-up|7|||
106004437|NCT00321789|365678308|FG000|Overall Study|Withdrawal by Subject|6|||
106004438|NCT00321789|365678309|FG001|Overall Study|Withdrawal by Subject|6|||
106004439|NCT00321789|365678308|FG000|Overall Study|Protocol Violation|5|||
106004440|NCT00321789|365678309|FG001|Overall Study|Protocol Violation|3|||
106004441|NCT02354235|365678310|FG000|Overall Study|Adverse Event|2|||
106004442|NCT02354235|365678311|FG001|Overall Study|Adverse Event|2|||
106004443|NCT02354235|365678310|FG000|Overall Study|Physician Decision|0|||
106004444|NCT02354235|365678311|FG001|Overall Study|Physician Decision|1|||
106004445|NCT02354235|365678310|FG000|Overall Study|Withdrawal by Subject|1|||
106004446|NCT02354235|365678311|FG001|Overall Study|Withdrawal by Subject|3|||
106004447|NCT02354235|365678310|FG000|Overall Study|Conflict with the stopping criteria|0|||
106004448|NCT02354235|365678311|FG001|Overall Study|Conflict with the stopping criteria|1|||
106004449|NCT02656017|365680376|FG000|Overall Study|Study burden|3|||
106004450|NCT02656017|365680377|FG001|Overall Study|Study burden|3|||
106004451|NCT02656017|365680376|FG000|Overall Study|Adverse Event|2|||
106004452|NCT02656017|365680377|FG001|Overall Study|Adverse Event|1|||
106004453|NCT02656017|365680376|FG000|Overall Study|Unable/unwilling to take study medication|2|||
106004454|NCT02656017|365680377|FG001|Overall Study|Unable/unwilling to take study medication|1|||
106004455|NCT02656017|365680376|FG000|Overall Study|Began Tolvaptan|1|||
106004456|NCT02656017|365680377|FG001|Overall Study|Began Tolvaptan|1|||
106004457|NCT02656017|365680376|FG000|Overall Study|Withdrawal by Subject|1|||
105694377|NCT01383096|364545037|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
105921163|NCT02722967|365371474|FG001|Overall Study|Lost to Follow-up|1|||
105921164|NCT02722967|365371475|FG002|Overall Study|Lost to Follow-up|0|||
105921165|NCT02722967|365371473|FG000|Overall Study|Non-compliance with patch wearing|2|||
105921166|NCT02722967|365371474|FG001|Overall Study|Non-compliance with patch wearing|1|||
105921167|NCT02722967|365371475|FG002|Overall Study|Non-compliance with patch wearing|1|||
105921168|NCT02722967|365371473|FG000|Overall Study|Withdrawal by Subject|1|||
105921169|NCT02722967|365371474|FG001|Overall Study|Withdrawal by Subject|0|||
105921170|NCT02722967|365371475|FG002|Overall Study|Withdrawal by Subject|1|||
105921171|NCT02722967|365371473|FG000|Overall Study|Physician Decision|1|||
105921172|NCT02722967|365371474|FG001|Overall Study|Physician Decision|0|||
105921173|NCT02722967|365371475|FG002|Overall Study|Physician Decision|0|||
105921174|NCT02722967|365371473|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
105921175|NCT02722967|365371474|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
106132225|NCT01559090|366141936|FG000|Stage I|Withdrawal by Subject|2|||
106132226|NCT01559090|366141937|FG001|Stage I|Withdrawal by Subject|2|||
105694378|NCT01383096|364545038|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
105694379|NCT01383096|364545036|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
105694380|NCT01383096|364545037|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
105694381|NCT01383096|364545038|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
105694382|NCT01383096|364545036|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
105694383|NCT01383096|364545037|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
105694384|NCT01383096|364545038|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
105694385|NCT00616434|364545043|FG000|Overall Study|Adverse Event|5|||
105694386|NCT00616434|364545044|FG001|Overall Study|Adverse Event|2|||
105694387|NCT00616434|364545043|FG000|Overall Study|Physician Decision|0|||
105694388|NCT00616434|364545044|FG001|Overall Study|Physician Decision|4|||
105694389|NCT00616434|364545043|FG000|Overall Study|Withdrawal by Subject|1|||
105694390|NCT00616434|364545044|FG001|Overall Study|Withdrawal by Subject|1|||
105694391|NCT00616434|364545043|FG000|Overall Study|Protocol deviation|0|||
105694392|NCT00616434|364545044|FG001|Overall Study|Protocol deviation|1|||
105694393|NCT01754857|364545045|FG000|Overall Study|Adverse Event|7|||
105694394|NCT01754857|364545045|FG000|Overall Study|Disease progression|3|||
105694395|NCT01754857|364545045|FG000|Overall Study|Physician Decision|2|||
105694396|NCT01754857|364545045|FG000|Overall Study|Withdrawal by Subject|3|||
105694397|NCT01754857|364545045|FG000|Overall Study|other complicating disease|1|||
105694398|NCT01754857|364545045|FG000|Overall Study|ineligible to continue onto maintenance|1|||
105694399|NCT01754857|364545045|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
105694400|NCT01754857|364545045|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
105694401|NCT03945591|364545046|FG000|Overall Study|Participant not transplanted|1|||
105694402|NCT03945591|364545046|FG000|Overall Study|Change in treatment plan|3|||
105694403|NCT03945591|364545046|FG000|Overall Study|Adverse Event|1|||
105694404|NCT01399190|364545047|FG000|Overall Study|Not Eligible for Final Analysis|5|||
105694405|NCT01399190|364545047|FG000|Overall Study|Adverse Event|8|||
105694406|NCT01399190|364545047|FG000|Overall Study|Participant's Request|5|||
105694407|NCT01399190|364545047|FG000|Overall Study|Physician Decision|2|||
105694408|NCT00791258|364545048|FG000|Overall Study|Adverse Event|87|||
105694409|NCT00791258|364545048|FG000|Overall Study|Lost to Follow-up|18|||
105694410|NCT00791258|364545048|FG000|Overall Study|Protocol Violation|109|||
105694411|NCT00791258|364545048|FG000|Overall Study|Withdrawal by Subject|40|||
105694412|NCT00791258|364545048|FG000|Overall Study|Did not take medication for >3 days|1|||
105694413|NCT00791258|364545048|FG000|Overall Study|subject left area|2|||
105694414|NCT00791258|364545048|FG000|Overall Study|non-compliance|3|||
105694415|NCT00791258|364545048|FG000|Overall Study|Subject incarcerated|1|||
105694416|NCT00791258|364545048|FG000|Overall Study|Subject required restricted medication|1|||
105694417|NCT00791258|364545048|FG000|Overall Study|Lack of Efficacy|1|||
105694418|NCT00210184|364545058|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
105694419|NCT02445755|364545061|FG000|Overall Study|Withdrawal by Subject|2|||
105694420|NCT02445755|364545061|FG000|Overall Study|Protocol Violation|6|||
105694421|NCT02445755|364545061|FG000|Overall Study|Screen Failure|5|||
105694422|NCT01118325|364545063|FG000|Overall Study|Adverse Event|1|||
105694423|NCT01118325|364545064|FG001|Overall Study|Adverse Event|0|||
105694424|NCT01118325|364545065|FG002|Overall Study|Adverse Event|1|||
105694425|NCT00381563|364545070|FG000|Overall Study|Withdrawal by Subject|5|||
105694426|NCT00381563|364545071|FG001|Overall Study|Withdrawal by Subject|5|||
105694427|NCT00381563|364545070|FG000|Overall Study|Lost to Follow-up|2|||
105694428|NCT00381563|364545071|FG001|Overall Study|Lost to Follow-up|0|||
105694429|NCT00381563|364545070|FG000|Overall Study|Protocol Violation|0|||
105921176|NCT02722967|365371475|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
105921177|NCT02391337|365371476|FG000|6 Months Follow-up|Death|5|||
105921178|NCT02391337|365371477|FG001|6 Months Follow-up|Death|4|||
105921179|NCT02391337|365371476|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
105921180|NCT02391337|365371477|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
106132227|NCT01559090|366141938|FG002|Stage I|Withdrawal by Subject|3|||
106004458|NCT02656017|365680377|FG001|Overall Study|Withdrawal by Subject|0|||
105694430|NCT00381563|364545071|FG001|Overall Study|Protocol Violation|1|||
105694431|NCT01438151|364545072|FG000|Overall Study|study terminated|8|||
105694432|NCT01303965|364545075|FG000|Overall Study|Adverse Event|1|||
105694433|NCT01303965|364545076|FG001|Overall Study|Adverse Event|1|||
105694434|NCT01303965|364545075|FG000|Overall Study|Death|0|||
105694435|NCT01303965|364545076|FG001|Overall Study|Death|3|||
105694436|NCT01303965|364545075|FG000|Overall Study|Withdrawal by Subject|1|||
105694437|NCT01303965|364545076|FG001|Overall Study|Withdrawal by Subject|0|||
105694438|NCT01303965|364545075|FG000|Overall Study|Disease Progression|1|||
105694439|NCT01303965|364545076|FG001|Overall Study|Disease Progression|6|||
105694440|NCT02448225|364545077|FG000|Overall Study|Withdrawal by Subject|1|||
105694441|NCT02448225|364545077|FG000|Overall Study|Did not get FSPG scan|18|||
105694442|NCT02448225|364545077|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
105694443|NCT00851682|364545078|FG000|Overall Study|screen failure|5|||
105694444|NCT00851682|364545079|FG001|Overall Study|screen failure|0|||
105694445|NCT04060563|364545080|FG000|Overall Study|Lost to Follow-up|1|||
105694446|NCT04060563|364545081|FG001|Overall Study|Lost to Follow-up|1|||
105694447|NCT04060563|364545080|FG000|Overall Study|Physician Decision|0|||
105694448|NCT04060563|364545081|FG001|Overall Study|Physician Decision|1|||
105694449|NCT01106027|364545088|FG000|Overall Study|Lost graft early, discontinued|1|||
105694450|NCT02545322|364545089|FG000|Overall Study|Withdrawal by Subject|3|||
105694451|NCT01230554|364545091|FG000|Overall Study|Lost to Follow-up|2|||
105694452|NCT01230554|364545091|FG000|Overall Study|Inability to maintain visit schedule|1|||
105694453|NCT02653300|364545092|FG000|Overall Study|Withdrawal by Subject|2|||
105694454|NCT02678416|364545095|FG000|Part 1|Withdrawal by Subject|1|||
105694455|NCT02678416|364545095|FG000|Part 2|Adverse Event|2|||
105694456|NCT02678416|364545095|FG000|Part 2|Withdrawal by Subject|1|||
105694457|NCT04556136|364545096|FG000|Overall Study|Lost to Follow-up|6|||
105694458|NCT04556136|364545097|FG001|Overall Study|Lost to Follow-up|6|||
105694459|NCT04556136|364545096|FG000|Overall Study|Physician Decision|2|||
105694460|NCT04556136|364545097|FG001|Overall Study|Physician Decision|1|||
105694461|NCT04556136|364545096|FG000|Overall Study|Withdrawal by Subject|2|||
105694462|NCT04556136|364545097|FG001|Overall Study|Withdrawal by Subject|1|||
105694463|NCT01848353|364545098|FG000|Phase 1|Withdrawal by Subject|3|||
105694464|NCT01848353|364545099|FG001|Phase 1|Withdrawal by Subject|1|||
105694465|NCT01848353|364545100|FG002|Phase 1|Withdrawal by Subject|0|||
105694466|NCT01848353|364545101|FG003|Phase 1|Withdrawal by Subject|0|||
105694467|NCT01848353|364545098|FG000|Phase 2|Withdrawal by Subject|3|||
106004459|NCT03661723|365680383|FG000|Overall Study|Disease Progression|4|||
106004460|NCT03661723|365680384|FG001|Overall Study|Disease Progression|24|||
106004461|NCT03661723|365680385|FG002|Overall Study|Disease Progression|4|||
106004462|NCT03661723|365680386|FG003|Overall Study|Disease Progression|19|||
106004463|NCT03661723|365680383|FG000|Overall Study|Withdrawal by Subject|1|||
106004464|NCT03661723|365680384|FG001|Overall Study|Withdrawal by Subject|0|||
106004465|NCT03661723|365680385|FG002|Overall Study|Withdrawal by Subject|2|||
106004466|NCT03661723|365680386|FG003|Overall Study|Withdrawal by Subject|4|||
106004467|NCT03661723|365680383|FG000|Overall Study|Physician Decision|1|||
106004468|NCT03661723|365680384|FG001|Overall Study|Physician Decision|0|||
106004469|NCT03661723|365680385|FG002|Overall Study|Physician Decision|0|||
106004470|NCT03661723|365680386|FG003|Overall Study|Physician Decision|0|||
106004471|NCT03661723|365680383|FG000|Overall Study|Clinical Deterioration|0|||
106004472|NCT03661723|365680384|FG001|Overall Study|Clinical Deterioration|0|||
106004473|NCT03661723|365680385|FG002|Overall Study|Clinical Deterioration|0|||
106004474|NCT03661723|365680386|FG003|Overall Study|Clinical Deterioration|1|||
106004475|NCT03760029|365680387|FG000|Overall Study|Death|1|||
106004476|NCT03760029|365680388|FG001|Overall Study|Death|0|||
106004477|NCT03760029|365680389|FG002|Overall Study|Death|0|||
106004478|NCT03760029|365680387|FG000|Overall Study|Lost to Follow-up|0|||
106132228|NCT01559090|366141936|FG000|Stage II|Withdrawal by Subject|1|||
106132229|NCT01559090|366141937|FG001|Stage II|Withdrawal by Subject|0|||
106132230|NCT01559090|366141938|FG002|Stage II|Withdrawal by Subject|0|||
106132231|NCT01734811|366141939|FG000|Overall Study|Lost to Follow-up|2|||
105694468|NCT01848353|364545099|FG001|Phase 2|Withdrawal by Subject|2|||
105694469|NCT01848353|364545100|FG002|Phase 2|Withdrawal by Subject|0|||
106004479|NCT03760029|365680388|FG001|Overall Study|Lost to Follow-up|2|||
106004480|NCT03760029|365680389|FG002|Overall Study|Lost to Follow-up|1|||
106004481|NCT03760029|365680387|FG000|Overall Study|Withdrawal by Subject|1|||
106004482|NCT03760029|365680388|FG001|Overall Study|Withdrawal by Subject|4|||
106004483|NCT03760029|365680389|FG002|Overall Study|Withdrawal by Subject|1|||
106132232|NCT01734811|366141940|FG001|Overall Study|Lost to Follow-up|3|||
106132233|NCT01734811|366141939|FG000|Overall Study|Withdrawal by Subject|2|||
105694470|NCT01848353|364545101|FG003|Phase 2|Withdrawal by Subject|0|||
105694471|NCT01848353|364545098|FG000|Phase 3|Withdrawal by Subject|1|||
105694472|NCT01848353|364545099|FG001|Phase 3|Withdrawal by Subject|1|||
105694473|NCT01848353|364545100|FG002|Phase 3|Withdrawal by Subject|0|||
105694474|NCT01848353|364545101|FG003|Phase 3|Withdrawal by Subject|0|||
105694475|NCT03492554|364545108|FG000|Overall Study|Protocol Violation|0|||
105694476|NCT03492554|364545109|FG001|Overall Study|Protocol Violation|14|||
105694477|NCT02289352|364545110|FG000|Overall Study|Withdrawal by Subject|1|||
105694478|NCT02289352|364545111|FG001|Overall Study|Withdrawal by Subject|1|||
105694479|NCT02289352|364545112|FG002|Overall Study|Withdrawal by Subject|0|||
105694480|NCT04340557|364545113|FG000|Overall Study|Transferred to ICU and/or death|1|||
105694481|NCT04340557|364545114|FG001|Overall Study|Transferred to ICU and/or death|2|||
105694482|NCT00685685|364545115|FG000|Washout Period of 7 Days|Adverse Event|2|||
105694483|NCT00685685|364545116|FG001|Washout Period of 7 Days|Adverse Event|0|||
105694484|NCT00685685|364545115|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105694485|NCT00685685|364545116|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105694486|NCT04029116|364545117|FG000|Overall Study|Adverse Event|0|||
105694487|NCT04029116|364545118|FG001|Overall Study|Adverse Event|2|||
105694488|NCT04029116|364545117|FG000|Overall Study|Lost to Follow-up|3|||
105694489|NCT04029116|364545118|FG001|Overall Study|Lost to Follow-up|5|||
105694490|NCT04029116|364545117|FG000|Overall Study|Physician Decision|2|||
105694491|NCT04029116|364545118|FG001|Overall Study|Physician Decision|0|||
105694492|NCT04029116|364545117|FG000|Overall Study|Pregnancy|1|||
105694493|NCT04029116|364545118|FG001|Overall Study|Pregnancy|2|||
105694494|NCT04029116|364545117|FG000|Overall Study|Withdrawal by Subject|4|||
105694495|NCT04029116|364545118|FG001|Overall Study|Withdrawal by Subject|6|||
105694496|NCT04029116|364545117|FG000|Overall Study|Other|2|||
105694497|NCT04029116|364545118|FG001|Overall Study|Other|1|||
105694498|NCT01177384|364545119|FG000|Overall Study|Adverse Event|6|||
105694499|NCT01177384|364545120|FG001|Overall Study|Adverse Event|4|||
105694500|NCT01177384|364545119|FG000|Overall Study|Lack of Efficacy|0|||
105694501|NCT01177384|364545120|FG001|Overall Study|Lack of Efficacy|1|||
105694502|NCT01177384|364545119|FG000|Overall Study|Lost to Follow-up|3|||
105694503|NCT01177384|364545120|FG001|Overall Study|Lost to Follow-up|4|||
105694504|NCT01177384|364545119|FG000|Overall Study|Physician Decision|0|||
105694505|NCT01177384|364545120|FG001|Overall Study|Physician Decision|3|||
105921181|NCT02391337|365371476|FG000|12 Months Follow-up|Death|2|||
105921182|NCT02391337|365371477|FG001|12 Months Follow-up|Death|0|||
105921183|NCT02391337|365371476|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
105921184|NCT02391337|365371477|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
105921185|NCT02391337|365371476|FG000|12 Months Follow-up|Lost to Follow-up|0|||
105921186|NCT02391337|365371477|FG001|12 Months Follow-up|Lost to Follow-up|2|||
105921187|NCT00465517|365371478|FG000|Overall Study|Adverse Event|7|||
105921188|NCT00465517|365371479|FG001|Overall Study|Adverse Event|3|||
106004484|NCT03760029|365680387|FG000|Overall Study|Withdrawal by parent/guardian|4|||
106004485|NCT03760029|365680388|FG001|Overall Study|Withdrawal by parent/guardian|4|||
106004486|NCT03760029|365680389|FG002|Overall Study|Withdrawal by parent/guardian|1|||
106004487|NCT03760029|365680387|FG000|Overall Study|Other|2|||
105921189|NCT00465517|365371478|FG000|Overall Study|Lost to Follow-up|1|||
105921190|NCT00465517|365371479|FG001|Overall Study|Lost to Follow-up|0|||
105921191|NCT00465517|365371478|FG000|Overall Study|Withdrawal by Subject|4|||
105921192|NCT00465517|365371479|FG001|Overall Study|Withdrawal by Subject|1|||
106004488|NCT03760029|365680388|FG001|Overall Study|Other|1|||
106004489|NCT03760029|365680389|FG002|Overall Study|Other|0|||
106004490|NCT02927301|365680395|FG000|Overall Study|Death|39|||
106004491|NCT02927301|365680395|FG000|Overall Study|Lost to Follow-up|8|||
106004492|NCT02927301|365680395|FG000|Overall Study|Physician Decision|2|||
106004493|NCT02927301|365680395|FG000|Overall Study|Withdrawal by Subject|12|||
106004494|NCT02927301|365680395|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
106004495|NCT04663321|365680396|FG000|Overall Study|Study terminated by Sponsor|2|||
106004496|NCT04663321|365680397|FG001|Overall Study|Study terminated by Sponsor|1|||
106004497|NCT04663321|365680398|FG002|Overall Study|Study terminated by Sponsor|2|||
106004498|NCT04663321|365680396|FG000|Overall Study|Withdrawal by Subject|10|||
106132234|NCT01734811|366141940|FG001|Overall Study|Withdrawal by Subject|0|||
105921193|NCT00289276|365371484|FG000|Second Part of FAST Study (Expansion)|Death|0|||
105921194|NCT00289276|365371485|FG001|Second Part of FAST Study (Expansion)|Death|2|||
105921195|NCT00289276|365371484|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
106132235|NCT00725010|366141941|FG000|Overall Study|Toxicity|9|||
106132236|NCT00725010|366141941|FG000|Overall Study|Tumor Progression|7|||
106132237|NCT00725010|366141941|FG000|Overall Study|Withdrawal by Subject|2|||
106004499|NCT04663321|365680397|FG001|Overall Study|Withdrawal by Subject|3|||
106004500|NCT04663321|365680398|FG002|Overall Study|Withdrawal by Subject|2|||
106132238|NCT00725010|366141941|FG000|Overall Study|Death|1|||
105921196|NCT00289276|365371485|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
105921197|NCT01776554|365371488|FG000|Overall Study|Adverse Event|1|||
105921198|NCT01776554|365371489|FG001|Overall Study|Adverse Event|0|||
105921199|NCT01776554|365371488|FG000|Overall Study|Withdrawal by Subject|3|||
105921200|NCT01776554|365371489|FG001|Overall Study|Withdrawal by Subject|8|||
105921201|NCT01776554|365371488|FG000|Overall Study|Lost to Follow-up|6|||
106004501|NCT04663321|365680396|FG000|Overall Study|Not provided|0|||
106132239|NCT00725010|366141941|FG000|Overall Study|Lost to Follow-up|1|||
106132240|NCT00725010|366141941|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
105694506|NCT01177384|364545119|FG000|Overall Study|Protocol Violation|0|||
105694507|NCT01177384|364545120|FG001|Overall Study|Protocol Violation|2|||
105921202|NCT01776554|365371489|FG001|Overall Study|Lost to Follow-up|9|||
105921203|NCT01776554|365371488|FG000|Overall Study|Administrative Reason|2|||
105921204|NCT01776554|365371489|FG001|Overall Study|Administrative Reason|5|||
105921205|NCT01776554|365371488|FG000|Overall Study|Protocol Violation|1|||
105921206|NCT01776554|365371489|FG001|Overall Study|Protocol Violation|0|||
105921207|NCT01776554|365371488|FG000|Overall Study|Unclassified|4|||
105921208|NCT01776554|365371489|FG001|Overall Study|Unclassified|1|||
105921209|NCT01654276|365371490|FG000|Overall Study|Lack of Efficacy|1|||
106132241|NCT00725010|366141941|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
106132242|NCT00725010|366141941|FG000|Overall Study|No further documentation|1|||
106132243|NCT00725010|366141941|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
106132244|NCT00445692|366141942|FG000|Overall Study|Adverse Event|11|||
105921210|NCT01654276|365371490|FG000|Overall Study|Lost to Follow-up|4|||
105921211|NCT01654276|365371490|FG000|Overall Study|Withdrawal by Subject|1|||
105921212|NCT01155570|365371491|FG000|Overall Study|Adverse Event|39|||
105921213|NCT01155570|365371491|FG000|Overall Study|Lack of Efficacy|46|||
105921214|NCT01155570|365371491|FG000|Overall Study|Participant's Economic Reasons|17|||
105921215|NCT01155570|365371491|FG000|Overall Study|No Hospital Visits|7|||
105921216|NCT01155570|365371491|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
105921217|NCT01155570|365371491|FG000|Overall Study|Adverse Event + Other Reasons|7|||
105921218|NCT01155570|365371491|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
105921219|NCT01155570|365371491|FG000|Overall Study|Other Reasons|23|||
105921220|NCT01981616|365371492|FG000|Overall Study|Adverse Event|0|||
105921221|NCT01981616|365371493|FG001|Overall Study|Adverse Event|1|||
105921222|NCT01981616|365371492|FG000|Overall Study|Protocol Violation|1|||
105921223|NCT01981616|365371493|FG001|Overall Study|Protocol Violation|0|||
105921224|NCT01020123|365371494|FG000|Main Period|Withdrawal by Subject|6|||
105921225|NCT01020123|365371495|FG001|Main Period|Withdrawal by Subject|5|||
105921226|NCT01020123|365371496|FG002|Main Period|Withdrawal by Subject|3|||
105921227|NCT01020123|365371497|FG003|Main Period|Withdrawal by Subject|1|||
105921228|NCT01020123|365371498|FG004|Main Period|Withdrawal by Subject|6|||
105921229|NCT01020123|365371499|FG005|Main Period|Withdrawal by Subject|3|||
105921230|NCT01020123|365371500|FG006|Main Period|Withdrawal by Subject|2|||
105921231|NCT01020123|365371494|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
105921232|NCT01020123|365371495|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
105921233|NCT01020123|365371496|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
105921234|NCT01020123|365371497|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
105921235|NCT01020123|365371498|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
105921236|NCT01020123|365371499|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
105921237|NCT01020123|365371500|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
105921238|NCT01020123|365371494|FG000|Main Period|Adverse Event|5|||
105921239|NCT01020123|365371495|FG001|Main Period|Adverse Event|2|||
105921240|NCT01020123|365371496|FG002|Main Period|Adverse Event|2|||
105921241|NCT01020123|365371497|FG003|Main Period|Adverse Event|1|||
105921242|NCT01020123|365371498|FG004|Main Period|Adverse Event|1|||
105921243|NCT01020123|365371499|FG005|Main Period|Adverse Event|2|||
105921244|NCT01020123|365371500|FG006|Main Period|Adverse Event|1|||
106004502|NCT04663321|365680397|FG001|Overall Study|Not provided|0|||
106004503|NCT04663321|365680398|FG002|Overall Study|Not provided|1|||
106004504|NCT04247347|365680401|FG000|Overall Study|Withdrawal by Subject|2|||
106004505|NCT04247347|365680402|FG001|Overall Study|Withdrawal by Subject|3|||
106004506|NCT04247347|365680403|FG002|Overall Study|Withdrawal by Subject|3|||
106004507|NCT04247347|365680401|FG000|Overall Study|Lost to Follow-up|1|||
106004508|NCT04247347|365680402|FG001|Overall Study|Lost to Follow-up|1|||
106132245|NCT00445692|366141942|FG000|Overall Study|Lack of Efficacy|5|||
106132246|NCT03425539|366141945|FG000|Overall Study|Randomized but not treated|0|||
106132247|NCT03425539|366141946|FG001|Overall Study|Randomized but not treated|1|||
105694508|NCT01177384|364545119|FG000|Overall Study|Withdrawal by Subject|5|||
105694509|NCT01177384|364545120|FG001|Overall Study|Withdrawal by Subject|12|||
105694510|NCT01009034|364545129|FG000|Overall Study|Lost to Follow-up|2|||
105694511|NCT01009034|364545129|FG000|Overall Study|Withdrawal by Subject|2|||
105694512|NCT03061175|364545133|FG000|Baseline|Participant was deemed ineligible|1|||
105921245|NCT01020123|365371494|FG000|Main Period|Protocol Violation|4|||
105921246|NCT01020123|365371495|FG001|Main Period|Protocol Violation|4|||
105921247|NCT01020123|365371496|FG002|Main Period|Protocol Violation|2|||
105921248|NCT01020123|365371497|FG003|Main Period|Protocol Violation|5|||
105921249|NCT01020123|365371498|FG004|Main Period|Protocol Violation|2|||
105921250|NCT01020123|365371499|FG005|Main Period|Protocol Violation|3|||
105921251|NCT01020123|365371500|FG006|Main Period|Protocol Violation|2|||
105921252|NCT01020123|365371494|FG000|Main Period|Lost to Follow-up|0|||
105921253|NCT01020123|365371495|FG001|Main Period|Lost to Follow-up|2|||
105921254|NCT01020123|365371496|FG002|Main Period|Lost to Follow-up|0|||
106004509|NCT04247347|365680403|FG002|Overall Study|Lost to Follow-up|1|||
106132248|NCT03425539|366141945|FG000|Overall Study|Adverse Event|2|||
105694513|NCT03061175|364545134|FG001|Baseline|Participant was deemed ineligible|0|||
105921255|NCT01020123|365371497|FG003|Main Period|Lost to Follow-up|0|||
105921256|NCT01020123|365371498|FG004|Main Period|Lost to Follow-up|0|||
105921257|NCT01020123|365371499|FG005|Main Period|Lost to Follow-up|0|||
105921258|NCT01020123|365371500|FG006|Main Period|Lost to Follow-up|0|||
105921259|NCT01020123|365371494|FG000|Main Period|Unclasified|2|||
105921260|NCT01020123|365371495|FG001|Main Period|Unclasified|0|||
105921261|NCT01020123|365371496|FG002|Main Period|Unclasified|1|||
105921262|NCT01020123|365371497|FG003|Main Period|Unclasified|0|||
105921263|NCT01020123|365371498|FG004|Main Period|Unclasified|1|||
105921264|NCT01020123|365371499|FG005|Main Period|Unclasified|3|||
105921265|NCT01020123|365371500|FG006|Main Period|Unclasified|6|||
105921266|NCT01020123|365371494|FG000|Extention Period|Withdrawal by Subject|2|||
105921267|NCT01020123|365371495|FG001|Extention Period|Withdrawal by Subject|1|||
105921268|NCT01020123|365371496|FG002|Extention Period|Withdrawal by Subject|1|||
105921269|NCT01020123|365371497|FG003|Extention Period|Withdrawal by Subject|0|||
105921270|NCT01020123|365371498|FG004|Extention Period|Withdrawal by Subject|0|||
105921271|NCT01020123|365371499|FG005|Extention Period|Withdrawal by Subject|0|||
105921272|NCT01020123|365371500|FG006|Extention Period|Withdrawal by Subject|0|||
105921273|NCT01020123|365371494|FG000|Extention Period|Adverse Event|0|||
105921274|NCT01020123|365371495|FG001|Extention Period|Adverse Event|0|||
105921275|NCT01020123|365371496|FG002|Extention Period|Adverse Event|0|||
105921276|NCT01020123|365371497|FG003|Extention Period|Adverse Event|1|||
105921277|NCT01020123|365371498|FG004|Extention Period|Adverse Event|0|||
105921278|NCT01020123|365371499|FG005|Extention Period|Adverse Event|0|||
105921279|NCT01020123|365371500|FG006|Extention Period|Adverse Event|0|||
105921280|NCT01020123|365371494|FG000|Extention Period|Protocol Violation|1|||
105921281|NCT01020123|365371495|FG001|Extention Period|Protocol Violation|1|||
105921282|NCT01020123|365371496|FG002|Extention Period|Protocol Violation|1|||
105921283|NCT01020123|365371497|FG003|Extention Period|Protocol Violation|0|||
105921284|NCT01020123|365371498|FG004|Extention Period|Protocol Violation|0|||
106004510|NCT03562195|365680404|FG000|Overall Study|Adverse Event|0|||
106004511|NCT03562195|365680405|FG001|Overall Study|Adverse Event|6|||
106004512|NCT03562195|365680404|FG000|Overall Study|Lack of Efficacy|0|||
106004513|NCT03562195|365680405|FG001|Overall Study|Lack of Efficacy|5|||
106004514|NCT03562195|365680404|FG000|Overall Study|Protocol Violation|0|||
106004515|NCT03562195|365680405|FG001|Overall Study|Protocol Violation|1|||
106004516|NCT03562195|365680404|FG000|Overall Study|Lost to Follow-up|0|||
106004517|NCT03562195|365680405|FG001|Overall Study|Lost to Follow-up|1|||
106004518|NCT03562195|365680404|FG000|Overall Study|Physician Decision|1|||
106004519|NCT03562195|365680405|FG001|Overall Study|Physician Decision|0|||
106004520|NCT03562195|365680404|FG000|Overall Study|Withdrawal by Subject|3|||
106004521|NCT03562195|365680405|FG001|Overall Study|Withdrawal by Subject|0|||
106004522|NCT02529852|365680406|FG000|Overall Study|Withdrawal by Subject|2|||
106004523|NCT03532542|365680407|FG000|Overall Study|Death|1|||
106004524|NCT03532542|365680408|FG001|Overall Study|Death|0|||
106004525|NCT03532542|365680407|FG000|Overall Study|Study Terminated by Sponsor|41|||
106004526|NCT03532542|365680408|FG001|Overall Study|Study Terminated by Sponsor|65|||
106004527|NCT03532542|365680407|FG000|Overall Study|Withdrawal by Subject|6|||
106004528|NCT03532542|365680408|FG001|Overall Study|Withdrawal by Subject|5|||
106004529|NCT01962441|365680409|FG000|Randomized Period|Randomized but Never Treated|4|||
106004530|NCT01962441|365680410|FG001|Randomized Period|Randomized but Never Treated|2|||
106004531|NCT01962441|365680411|FG002|Randomized Period|Randomized but Never Treated|3|||
106004532|NCT01962441|365680409|FG000|Randomized Period|Lost to Follow-up|2|||
106004533|NCT01962441|365680410|FG001|Randomized Period|Lost to Follow-up|4|||
106004534|NCT01962441|365680411|FG002|Randomized Period|Lost to Follow-up|4|||
106004535|NCT01962441|365680409|FG000|Randomized Period|Withdrew Consent|3|||
106004536|NCT01962441|365680410|FG001|Randomized Period|Withdrew Consent|3|||
106004537|NCT01962441|365680411|FG002|Randomized Period|Withdrew Consent|2|||
106132249|NCT03425539|366141946|FG001|Overall Study|Adverse Event|2|||
106132250|NCT03425539|366141945|FG000|Overall Study|Withdrawal by Subject|3|||
106132251|NCT03425539|366141946|FG001|Overall Study|Withdrawal by Subject|0|||
106132252|NCT03425539|366141945|FG000|Overall Study|Lost to Follow-up|0|||
106132253|NCT03425539|366141946|FG001|Overall Study|Lost to Follow-up|1|||
105694514|NCT03061175|364545133|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
105694515|NCT03061175|364545134|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
105921285|NCT01020123|365371499|FG005|Extention Period|Protocol Violation|0|||
105921286|NCT01020123|365371500|FG006|Extention Period|Protocol Violation|1|||
105921287|NCT01020123|365371494|FG000|Extention Period|Lost to Follow-up|0|||
105921288|NCT01020123|365371495|FG001|Extention Period|Lost to Follow-up|0|||
105921289|NCT01020123|365371496|FG002|Extention Period|Lost to Follow-up|0|||
106004538|NCT01962441|365680409|FG000|Randomized Period|Adverse Event|1|||
106004539|NCT01962441|365680410|FG001|Randomized Period|Adverse Event|1|||
106004540|NCT01962441|365680411|FG002|Randomized Period|Adverse Event|0|||
106004541|NCT01962441|365680409|FG000|Randomized Period|Death|0|||
106004542|NCT01962441|365680410|FG001|Randomized Period|Death|0|||
106004543|NCT01962441|365680411|FG002|Randomized Period|Death|2|||
106004544|NCT01962441|365680409|FG000|Randomized Period|Protocol Violation|0|||
106004545|NCT01962441|365680410|FG001|Randomized Period|Protocol Violation|1|||
106132254|NCT00681811|366141947|FG000|Overall Study|Adverse Event|1|||
105921290|NCT01020123|365371497|FG003|Extention Period|Lost to Follow-up|0|||
105921291|NCT01020123|365371498|FG004|Extention Period|Lost to Follow-up|0|||
105921292|NCT01020123|365371499|FG005|Extention Period|Lost to Follow-up|2|||
106004546|NCT01962441|365680411|FG002|Randomized Period|Protocol Violation|0|||
106004547|NCT01962441|365680409|FG000|Retreatment Substudy|Lack of Efficacy|1|||
106004548|NCT01962441|365680410|FG001|Retreatment Substudy|Lack of Efficacy|0|||
106004549|NCT01962441|365680411|FG002|Retreatment Substudy|Lack of Efficacy|0|||
106004550|NCT01962441|365680409|FG000|Retreatment Substudy|Lost to Follow-up|1|||
106004551|NCT01962441|365680410|FG001|Retreatment Substudy|Lost to Follow-up|0|||
106004552|NCT01962441|365680411|FG002|Retreatment Substudy|Lost to Follow-up|0|||
106004553|NCT00117637|365680412|FG000|First Intervention (Period 1)|Adverse Event|11|||
106004554|NCT00117637|365680413|FG001|First Intervention (Period 1)|Adverse Event|16|||
106004555|NCT00117637|365680412|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
106004556|NCT00117637|365680413|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
106004557|NCT00117637|365680412|FG000|First Intervention (Period 1)|Protocol Violation|1|||
106004558|NCT00117637|365680413|FG001|First Intervention (Period 1)|Protocol Violation|0|||
106004559|NCT00117637|365680412|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
106004560|NCT00117637|365680413|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
106004561|NCT00117637|365680412|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
106004562|NCT00117637|365680413|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
106004563|NCT00117637|365680412|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
106004564|NCT00117637|365680413|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
106004565|NCT00117637|365680412|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
106004566|NCT00117637|365680413|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
106004567|NCT00117637|365680412|FG000|First Intervention (Period 1)|reason not reported|0|||
106004568|NCT00117637|365680413|FG001|First Intervention (Period 1)|reason not reported|1|||
106004569|NCT00117637|365680412|FG000|Second Intervention (Period 2)|Adverse Event|0|||
106004570|NCT00117637|365680413|FG001|Second Intervention (Period 2)|Adverse Event|9|||
106004571|NCT00117637|365680412|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
106004572|NCT00117637|365680413|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
106004573|NCT00117637|365680412|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
106004574|NCT00117637|365680413|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
106004575|NCT00117637|365680412|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
106004576|NCT00117637|365680413|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
106004577|NCT00117637|365680412|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
106004578|NCT00117637|365680413|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
106004579|NCT00117637|365680412|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
106004580|NCT00117637|365680413|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
106004581|NCT00117637|365680412|FG000|Second Intervention (Period 2)|reason not reported|1|||
106004582|NCT00117637|365680413|FG001|Second Intervention (Period 2)|reason not reported|0|||
106004583|NCT00097500|365680419|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
106004584|NCT00097500|365680420|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
106004585|NCT00097500|365680419|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
106004586|NCT00097500|365680420|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
106004587|NCT00097500|365680419|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
106004588|NCT00097500|365680420|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
106004589|NCT00097500|365680419|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
106004590|NCT00097500|365680420|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
106004591|NCT00097500|365680419|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
106132255|NCT00681811|366141948|FG001|Overall Study|Adverse Event|1|||
106132256|NCT00681811|366141947|FG000|Overall Study|Withdrawal by Subject|2|||
106132257|NCT00681811|366141948|FG001|Overall Study|Withdrawal by Subject|2|||
106132258|NCT00681811|366141947|FG000|Overall Study|Non-compliance|0|||
105921293|NCT01020123|365371500|FG006|Extention Period|Lost to Follow-up|0|||
105921294|NCT02318940|365371501|FG000|Overall Study|lost the record|1|||
105921295|NCT02318940|365371502|FG001|Overall Study|lost the record|0|||
105921296|NCT00617279|365371505|FG000|Overall Study|Study terminated by Sponsor|10|||
105921297|NCT00617279|365371506|FG001|Overall Study|Study terminated by Sponsor|15|||
105921298|NCT00617279|365371505|FG000|Overall Study|Graft abandonment|2|||
105921299|NCT00617279|365371506|FG001|Overall Study|Graft abandonment|0|||
105921300|NCT00617279|365371505|FG000|Overall Study|Lost to Follow-up|1|||
105921301|NCT00617279|365371506|FG001|Overall Study|Lost to Follow-up|0|||
105921302|NCT00617279|365371505|FG000|Overall Study|Death|1|||
105921303|NCT00617279|365371506|FG001|Overall Study|Death|2|||
105921304|NCT03573297|365371509|FG000|Open Label Treatment Period|Adverse Event|67|||
105921305|NCT03573297|365371510|FG001|Open Label Treatment Period|Adverse Event|0|||
106004592|NCT00097500|365680420|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
106132259|NCT00681811|366141948|FG001|Overall Study|Non-compliance|1|||
106132260|NCT01140347|366141952|FG000|Overall Study|Lost to Follow-up|5|||
105787074|NCT03110107|364874906|FG017|Treatment Period|Disease Progression|3|||
105787075|NCT03110107|364874907|FG018|Treatment Period|Disease Progression|16|||
105921306|NCT03573297|365371511|FG002|Open Label Treatment Period|Adverse Event|0|||
105921307|NCT03573297|365371512|FG003|Open Label Treatment Period|Adverse Event|0|||
106004593|NCT00097500|365680419|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
106004594|NCT00097500|365680420|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
106004595|NCT00097500|365680419|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
106004596|NCT00097500|365680420|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
106004597|NCT00642356|365680427|FG000|Overall Study|Adverse Event|1|||
106004598|NCT00642356|365680428|FG001|Overall Study|Adverse Event|0|||
106004599|NCT00642356|365680427|FG000|Overall Study|Protocol Violation|0|||
106004600|NCT00642356|365680428|FG001|Overall Study|Protocol Violation|3|||
106004601|NCT00642356|365680427|FG000|Overall Study|Lack of Efficacy|1|||
106004602|NCT00642356|365680428|FG001|Overall Study|Lack of Efficacy|0|||
106004603|NCT05106959|365680429|FG000|Overall Study|Lost to Follow-up|1|||
106004604|NCT00686777|365680432|FG000|Overall Study|Adverse Event|2|||
106004605|NCT00686777|365680432|FG000|Overall Study|Pregnancy|1|||
106004606|NCT00686777|365680432|FG000|Overall Study|Withdrawal by Subject|2|||
106004607|NCT00686777|365680432|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
106004608|NCT00686777|365680432|FG000|Overall Study|No Visit|1|||
106004609|NCT00883779|365680433|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
106004610|NCT00883779|365680434|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
106004611|NCT00883779|365680433|FG000|Primary Study Treatment Phase|Disease progression|75|||
106004612|NCT00883779|365680434|FG001|Primary Study Treatment Phase|Disease progression|59|||
106004613|NCT00883779|365680433|FG000|Primary Study Treatment Phase|Adverse Event|16|||
106004614|NCT00883779|365680434|FG001|Primary Study Treatment Phase|Adverse Event|16|||
106004615|NCT00883779|365680433|FG000|Primary Study Treatment Phase|Death|2|||
106004616|NCT00883779|365680434|FG001|Primary Study Treatment Phase|Death|3|||
106004617|NCT00883779|365680433|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
106004618|NCT00883779|365680434|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
106004619|NCT00883779|365680433|FG000|Primary Study Treatment Phase|Other|3|||
106004620|NCT00883779|365680434|FG001|Primary Study Treatment Phase|Other|0|||
106004621|NCT00883779|365680433|FG000|Post-Study Treatment Phase|Adverse Event|2|||
106004622|NCT00883779|365680434|FG001|Post-Study Treatment Phase|Adverse Event|3|||
106004623|NCT00883779|365680433|FG000|Post-Study Treatment Phase|Death|1|||
106004624|NCT00883779|365680434|FG001|Post-Study Treatment Phase|Death|3|||
106004625|NCT00883779|365680433|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
106004626|NCT00883779|365680434|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
106004627|NCT00883779|365680433|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
106004628|NCT00883779|365680434|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
106004629|NCT00883779|365680433|FG000|Post-Study Treatment Phase|Disease progression|103|||
106004630|NCT00883779|365680434|FG001|Post-Study Treatment Phase|Disease progression|122|||
106004631|NCT00883779|365680433|FG000|Post-Study Treatment Phase|Other|3|||
106004632|NCT00883779|365680434|FG001|Post-Study Treatment Phase|Other|0|||
106004633|NCT00883779|365680433|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
106004634|NCT00883779|365680434|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
106004635|NCT00883779|365680433|FG000|Off-study Phase|Death|185|||
106004636|NCT00883779|365680434|FG001|Off-study Phase|Death|174|||
106004637|NCT00883779|365680433|FG000|Off-study Phase|Refused treatment|1|||
106004638|NCT00883779|365680434|FG001|Off-study Phase|Refused treatment|1|||
106004639|NCT00883779|365680433|FG000|Off-study Phase|Failure to return|5|||
106004640|NCT00883779|365680434|FG001|Off-study Phase|Failure to return|6|||
106004641|NCT00883779|365680433|FG000|Off-study Phase|Other|18|||
106004642|NCT00883779|365680434|FG001|Off-study Phase|Other|21|||
106004643|NCT04913610|365680435|FG000|Randomized Participants|Did Not Receive Treatment|0|||
106132261|NCT01140347|366141953|FG001|Overall Study|Lost to Follow-up|6|||
106132262|NCT01140347|366141952|FG000|Overall Study|Withdrawal by Subject|13|||
106132263|NCT01140347|366141953|FG001|Overall Study|Withdrawal by Subject|8|||
106132264|NCT01449929|366141954|FG000|Randomization Phase 96 Week|Adverse Event|5|||
106132265|NCT01449929|366141955|FG001|Randomization Phase 96 Week|Adverse Event|13|||
106132266|NCT01449929|366141956|FG002|Randomization Phase 96 Week|Adverse Event|0|||
106132267|NCT01449929|366141954|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
106132268|NCT01449929|366141955|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
106132269|NCT01449929|366141956|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
106132270|NCT01449929|366141954|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
106132271|NCT01449929|366141955|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
106132272|NCT01449929|366141956|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
106132273|NCT01449929|366141954|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
106132274|NCT01449929|366141955|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
106132275|NCT01449929|366141956|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
106132276|NCT01449929|366141954|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
106132277|NCT01449929|366141955|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
106132278|NCT01449929|366141956|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
106004644|NCT04913610|365680436|FG001|Randomized Participants|Did Not Receive Treatment|0|||
106004645|NCT04913610|365680437|FG002|Randomized Participants|Did Not Receive Treatment|1|||
106004646|NCT04913610|365680438|FG003|Randomized Participants|Did Not Receive Treatment|1|||
106004647|NCT04913610|365680439|FG004|Randomized Participants|Did Not Receive Treatment|0|||
105694516|NCT03061175|364545133|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
105921308|NCT03573297|365371509|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
105921309|NCT03573297|365371510|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
105921310|NCT03573297|365371511|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
105921311|NCT03573297|365371512|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
105921312|NCT03573297|365371509|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
105921313|NCT03573297|365371510|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
105921314|NCT03573297|365371511|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
105921315|NCT03573297|365371512|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
105921316|NCT03573297|365371509|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
105921317|NCT03573297|365371510|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
105921318|NCT03573297|365371511|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
105921319|NCT03573297|365371512|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
105921320|NCT03573297|365371509|FG000|Open Label Treatment Period|Pregnancy|1|||
105694517|NCT03061175|364545134|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
105694518|NCT03061175|364545133|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
105694519|NCT03061175|364545134|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
105694520|NCT02243865|364545135|FG000|Overall Study|Protocol Violation|1|||
105694521|NCT02243865|364545136|FG001|Overall Study|Protocol Violation|3|||
105694522|NCT02243865|364545135|FG000|Overall Study|Lost to Follow-up|1|||
105694523|NCT02243865|364545136|FG001|Overall Study|Lost to Follow-up|1|||
105694524|NCT02243865|364545135|FG000|Overall Study|Withdrawal by Subject|1|||
105694525|NCT02243865|364545136|FG001|Overall Study|Withdrawal by Subject|0|||
105694526|NCT02243865|364545135|FG000|Overall Study|Adverse Event|1|||
105694527|NCT02243865|364545136|FG001|Overall Study|Adverse Event|1|||
105694528|NCT03044249|364545137|FG000|Overall Study|Adverse Event|4|||
105921321|NCT03573297|365371510|FG001|Open Label Treatment Period|Pregnancy|0|||
105921322|NCT03573297|365371511|FG002|Open Label Treatment Period|Pregnancy|0|||
105921323|NCT03573297|365371512|FG003|Open Label Treatment Period|Pregnancy|0|||
105921324|NCT03573297|365371509|FG000|Open Label Treatment Period|Protocol Violation|17|||
105921325|NCT03573297|365371510|FG001|Open Label Treatment Period|Protocol Violation|0|||
105921326|NCT03573297|365371511|FG002|Open Label Treatment Period|Protocol Violation|0|||
105921327|NCT03573297|365371512|FG003|Open Label Treatment Period|Protocol Violation|0|||
105921328|NCT03573297|365371509|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
105921329|NCT03573297|365371510|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
105921330|NCT03573297|365371511|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
105921331|NCT03573297|365371512|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
105921332|NCT03573297|365371509|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
105921333|NCT03573297|365371510|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
105921334|NCT03573297|365371511|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
105921335|NCT03573297|365371512|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
105921336|NCT03573297|365371509|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
105921337|NCT03573297|365371510|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
105921338|NCT03573297|365371511|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
105921339|NCT03573297|365371512|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
105921340|NCT03573297|365371509|FG000|Open Label Treatment Period|Other, Not Specified|7|||
105921341|NCT03573297|365371510|FG001|Open Label Treatment Period|Other, Not Specified|0|||
105921342|NCT03573297|365371511|FG002|Open Label Treatment Period|Other, Not Specified|0|||
105921343|NCT03573297|365371512|FG003|Open Label Treatment Period|Other, Not Specified|0|||
105921344|NCT03573297|365371509|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
105921345|NCT03573297|365371510|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
105921346|NCT03573297|365371511|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
105921347|NCT03573297|365371512|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
105921348|NCT03573297|365371509|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105921349|NCT03573297|365371510|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105921350|NCT03573297|365371511|FG002|Double-Blind Treatment Period|Adverse Event|5|||
105921351|NCT03573297|365371512|FG003|Double-Blind Treatment Period|Adverse Event|1|||
105921352|NCT03573297|365371509|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
105921353|NCT03573297|365371510|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
105921354|NCT03573297|365371511|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
105921355|NCT03573297|365371512|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
105921356|NCT03573297|365371509|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105921357|NCT03573297|365371510|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
105921358|NCT03573297|365371511|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
105921359|NCT03573297|365371512|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
106004648|NCT04913610|365680435|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
105694529|NCT03044249|364545138|FG001|Overall Study|Adverse Event|9|||
105694530|NCT03044249|364545137|FG000|Overall Study|Lost to Follow-up|1|||
105694531|NCT03044249|364545138|FG001|Overall Study|Lost to Follow-up|0|||
106004649|NCT04913610|365680436|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
106004650|NCT04913610|365680437|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
106004651|NCT04913610|365680438|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
106004652|NCT04913610|365680439|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
106004653|NCT02913482|365680440|FG000|Overall Study|Death|0|||
106004654|NCT02913482|365680441|FG001|Overall Study|Death|2|||
106004655|NCT02913482|365680442|FG002|Overall Study|Death|2|||
106004656|NCT02913482|365680440|FG000|Overall Study|Progressive Disease|1|||
106004657|NCT02913482|365680441|FG001|Overall Study|Progressive Disease|1|||
106004658|NCT02913482|365680442|FG002|Overall Study|Progressive Disease|1|||
106004659|NCT02913482|365680440|FG000|Overall Study|Reason not specified|0|||
106004660|NCT02913482|365680441|FG001|Overall Study|Reason not specified|0|||
106004661|NCT02913482|365680442|FG002|Overall Study|Reason not specified|1|||
106004662|NCT02913482|365680440|FG000|Overall Study|Withdrawal by Subject|0|||
106004663|NCT02913482|365680441|FG001|Overall Study|Withdrawal by Subject|1|||
106004664|NCT02913482|365680442|FG002|Overall Study|Withdrawal by Subject|1|||
106004665|NCT00549640|365680443|FG000|Overall Study|Withdrawal by Subject|6|||
106004666|NCT00549640|365680444|FG001|Overall Study|Withdrawal by Subject|12|||
106004667|NCT00549640|365680443|FG000|Overall Study|Adverse Event|5|||
106004668|NCT00549640|365680444|FG001|Overall Study|Adverse Event|0|||
106004669|NCT00549640|365680443|FG000|Overall Study|Lost to Follow-up|7|||
106004670|NCT00549640|365680444|FG001|Overall Study|Lost to Follow-up|4|||
106004671|NCT01046565|365680445|FG000|Overall Study|Adverse Event|2|||
106004672|NCT01046565|365680445|FG000|Overall Study|Withdrawal by Subject|7|||
106004673|NCT01476722|365680446|FG000|Overall Study|Adverse Event|1|||
106004674|NCT02978417|365680447|FG000|Overall Study|Lost to Follow-up|2|||
106004675|NCT02978417|365680448|FG001|Overall Study|Lost to Follow-up|2|||
106004676|NCT00317473|365680451|FG000|Overall Study|Withdrawal by Subject|2|||
106004677|NCT00317473|365680452|FG001|Overall Study|Withdrawal by Subject|1|||
106004678|NCT00317473|365680453|FG002|Overall Study|Withdrawal by Subject|2|||
106004679|NCT00317473|365680454|FG003|Overall Study|Withdrawal by Subject|1|||
106004680|NCT00317473|365680455|FG004|Overall Study|Withdrawal by Subject|3|||
106004681|NCT00317473|365680456|FG005|Overall Study|Withdrawal by Subject|1|||
106004682|NCT00317473|365680451|FG000|Overall Study|Relocation|1|||
106004683|NCT00317473|365680452|FG001|Overall Study|Relocation|0|||
106004684|NCT00317473|365680453|FG002|Overall Study|Relocation|1|||
106004685|NCT00317473|365680454|FG003|Overall Study|Relocation|1|||
106004686|NCT00317473|365680455|FG004|Overall Study|Relocation|5|||
106004687|NCT00317473|365680456|FG005|Overall Study|Relocation|2|||
106004688|NCT00317473|365680451|FG000|Overall Study|Death|1|||
106004689|NCT00317473|365680452|FG001|Overall Study|Death|0|||
106004690|NCT00317473|365680453|FG002|Overall Study|Death|0|||
106004691|NCT00317473|365680454|FG003|Overall Study|Death|0|||
106004692|NCT00317473|365680455|FG004|Overall Study|Death|0|||
106004693|NCT00317473|365680456|FG005|Overall Study|Death|0|||
106004694|NCT00317473|365680451|FG000|Overall Study|Other|0|||
106004695|NCT00317473|365680452|FG001|Overall Study|Other|2|||
106004696|NCT00317473|365680453|FG002|Overall Study|Other|0|||
106004697|NCT00317473|365680454|FG003|Overall Study|Other|0|||
106004698|NCT00317473|365680455|FG004|Overall Study|Other|0|||
106004699|NCT00317473|365680456|FG005|Overall Study|Other|0|||
106004700|NCT02051764|365680457|FG000|Overall Study|Study terminated by sponsor|0|||
106004701|NCT02051764|365680458|FG001|Overall Study|Study terminated by sponsor|7|||
106004702|NCT00685165|365680459|FG000|Washout Period of 14 Days|Adverse Event|1|||
106004703|NCT00685165|365680460|FG001|Washout Period of 14 Days|Adverse Event|0|||
106004704|NCT00795535|365680469|FG000|Overall Study|incomplete data and technical problems|20|||
106004705|NCT03353675|365680471|FG000|Overall Study|Adverse Event|4|||
106004706|NCT03309020|365680472|FG000|Overall Study|Death|1|||
106004707|NCT03309020|365680473|FG001|Overall Study|Death|0|||
106004708|NCT03309020|365680472|FG000|Overall Study|Did not undergo surgery|2|||
105694532|NCT03044249|364545137|FG000|Overall Study|Non-compliance with Study Drug|1|||
105694533|NCT03044249|364545138|FG001|Overall Study|Non-compliance with Study Drug|0|||
105694534|NCT03044249|364545137|FG000|Overall Study|Study Terminated by Sponsor|2|||
105694535|NCT03044249|364545138|FG001|Overall Study|Study Terminated by Sponsor|0|||
106004709|NCT03309020|365680473|FG001|Overall Study|Did not undergo surgery|1|||
106004710|NCT02741245|365680474|FG000|Overall Study|Adverse Event|0|||
106004711|NCT02741245|365680475|FG001|Overall Study|Adverse Event|0|||
106004712|NCT02741245|365680476|FG002|Overall Study|Adverse Event|0|||
106004713|NCT02741245|365680477|FG003|Overall Study|Adverse Event|2|||
106004714|NCT02741245|365680478|FG004|Overall Study|Adverse Event|2|||
106004715|NCT02741245|365680474|FG000|Overall Study|Protocol Violation|0|||
106004716|NCT02741245|365680475|FG001|Overall Study|Protocol Violation|1|||
106004717|NCT02741245|365680476|FG002|Overall Study|Protocol Violation|0|||
106004718|NCT02741245|365680477|FG003|Overall Study|Protocol Violation|1|||
106004719|NCT02741245|365680478|FG004|Overall Study|Protocol Violation|0|||
106004720|NCT02741245|365680474|FG000|Overall Study|Withdrawal by Subject|0|||
106004721|NCT02741245|365680475|FG001|Overall Study|Withdrawal by Subject|0|||
106004722|NCT02741245|365680476|FG002|Overall Study|Withdrawal by Subject|0|||
105921360|NCT03573297|365371509|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105921361|NCT03573297|365371510|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
105921362|NCT03573297|365371511|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
105921363|NCT03573297|365371512|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
105921364|NCT03573297|365371509|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105921365|NCT03573297|365371510|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
105921366|NCT03573297|365371511|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
105921367|NCT03573297|365371512|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
105921368|NCT03573297|365371509|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
105921369|NCT03573297|365371510|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
105921370|NCT03573297|365371511|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
105921371|NCT03573297|365371512|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
105921372|NCT03573297|365371509|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
105921373|NCT03573297|365371510|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
105921374|NCT03573297|365371511|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
105921375|NCT03573297|365371512|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
105921376|NCT03082729|365371515|FG000|Overall Study|Lost to Follow-up|7|||
105921377|NCT03082729|365371515|FG000|Overall Study|Physician Decision|2|||
105921378|NCT03082729|365371515|FG000|Overall Study|Withdrawal by Subject|1|||
105921379|NCT03082729|365371515|FG000|Overall Study|Lack of Efficacy|9|||
105921380|NCT03082729|365371515|FG000|Overall Study|Adverse Event|4|||
105921381|NCT03082729|365371515|FG000|Overall Study|Protocol Violation|6|||
105921382|NCT03082729|365371515|FG000|Overall Study|Fear of study procedure|1|||
105921383|NCT03082729|365371515|FG000|Overall Study|Scheduling conflict|1|||
105921384|NCT04239924|365371516|FG000|Overall Study|Lost to Follow-up|2|||
105921385|NCT03321721|365371519|FG000|Overall Study|Lost to Follow-up|4|||
105921386|NCT03321721|365371520|FG001|Overall Study|Lost to Follow-up|8|||
105921387|NCT03321721|365371521|FG002|Overall Study|Lost to Follow-up|11|||
105921388|NCT01416571|365371524|FG000|Overall Study|Lost to Follow-up|2|||
105921389|NCT03353220|365371525|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
105921390|NCT03353220|365371526|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
105921391|NCT01712516|365373492|FG000|Overall Study|Technical problems|0|||
105921392|NCT01712516|365373493|FG001|Overall Study|Technical problems|0|||
105921393|NCT01712516|365373494|FG002|Overall Study|Technical problems|0|||
105921394|NCT01712516|365373495|FG003|Overall Study|Technical problems|2|||
105921395|NCT01712516|365373492|FG000|Overall Study|Lost to Follow-up|0|||
105921396|NCT01712516|365373493|FG001|Overall Study|Lost to Follow-up|0|||
105921397|NCT01712516|365373494|FG002|Overall Study|Lost to Follow-up|2|||
105921398|NCT01712516|365373495|FG003|Overall Study|Lost to Follow-up|1|||
105921399|NCT01712516|365373492|FG000|Overall Study|Death|0|||
105921400|NCT01712516|365373493|FG001|Overall Study|Death|1|||
105921401|NCT01712516|365373494|FG002|Overall Study|Death|0|||
105921402|NCT01712516|365373495|FG003|Overall Study|Death|0|||
105921403|NCT01712516|365373492|FG000|Overall Study|Protocol deviation|1|||
105921404|NCT01712516|365373493|FG001|Overall Study|Protocol deviation|0|||
105921405|NCT01712516|365373494|FG002|Overall Study|Protocol deviation|1|||
105921406|NCT01712516|365373495|FG003|Overall Study|Protocol deviation|0|||
105921407|NCT01712516|365373492|FG000|Overall Study|Physician Decision|2|||
105921408|NCT01712516|365373493|FG001|Overall Study|Physician Decision|0|||
105921409|NCT01712516|365373494|FG002|Overall Study|Physician Decision|0|||
105921410|NCT01712516|365373495|FG003|Overall Study|Physician Decision|1|||
105921411|NCT01712516|365373492|FG000|Overall Study|Withdrawal by Subject|3|||
105921412|NCT01712516|365373493|FG001|Overall Study|Withdrawal by Subject|9|||
105921413|NCT01712516|365373494|FG002|Overall Study|Withdrawal by Subject|3|||
105921414|NCT01712516|365373495|FG003|Overall Study|Withdrawal by Subject|9|||
105921415|NCT01075048|365373496|FG000|Overall Study|Death|4|||
105921416|NCT01075048|365373497|FG001|Overall Study|Death|17|||
105921417|NCT01075048|365373498|FG002|Overall Study|Death|12|||
105921418|NCT01075048|365373496|FG000|Overall Study|Start of other or new therapy|4|||
105921419|NCT01075048|365373497|FG001|Overall Study|Start of other or new therapy|36|||
105921420|NCT01075048|365373498|FG002|Overall Study|Start of other or new therapy|46|||
105921421|NCT01075048|365373496|FG000|Overall Study|Withdrawal by Subject|1|||
105921422|NCT01075048|365373497|FG001|Overall Study|Withdrawal by Subject|6|||
105921423|NCT01075048|365373498|FG002|Overall Study|Withdrawal by Subject|3|||
105921424|NCT01075048|365373496|FG000|Overall Study|Lost to Follow-up|0|||
105921425|NCT01075048|365373497|FG001|Overall Study|Lost to Follow-up|1|||
105921426|NCT01075048|365373498|FG002|Overall Study|Lost to Follow-up|1|||
105921427|NCT01721798|365373499|FG000|Overall Study|Death|0|||
105921428|NCT01721798|365373500|FG001|Overall Study|Death|0|||
105787076|NCT03110107|364874908|FG019|Treatment Period|Disease Progression|14|||
105921429|NCT01721798|365373501|FG002|Overall Study|Death|1|||
105921430|NCT01721798|365373502|FG003|Overall Study|Death|1|||
105921431|NCT01721798|365373499|FG000|Overall Study|Lost to Follow-up|2|||
105921432|NCT01721798|365373500|FG001|Overall Study|Lost to Follow-up|2|||
105921433|NCT01721798|365373501|FG002|Overall Study|Lost to Follow-up|9|||
105921434|NCT01721798|365373502|FG003|Overall Study|Lost to Follow-up|9|||
105921435|NCT01721798|365373499|FG000|Overall Study|Pregnancy|0|||
105921436|NCT01721798|365373500|FG001|Overall Study|Pregnancy|0|||
105921437|NCT01721798|365373501|FG002|Overall Study|Pregnancy|1|||
105921438|NCT01721798|365373502|FG003|Overall Study|Pregnancy|1|||
105921439|NCT01721798|365373499|FG000|Overall Study|Withdrawal by Subject|1|||
105921440|NCT01721798|365373500|FG001|Overall Study|Withdrawal by Subject|0|||
105921441|NCT01721798|365373501|FG002|Overall Study|Withdrawal by Subject|2|||
105921442|NCT01721798|365373502|FG003|Overall Study|Withdrawal by Subject|1|||
105921443|NCT01721798|365373499|FG000|Overall Study|Not eligible for 24 month visit|1|||
105921444|NCT01721798|365373500|FG001|Overall Study|Not eligible for 24 month visit|0|||
105921445|NCT01721798|365373501|FG002|Overall Study|Not eligible for 24 month visit|8|||
105921446|NCT01721798|365373502|FG003|Overall Study|Not eligible for 24 month visit|7|||
105921447|NCT02791269|365373503|FG000|Overall Study|Lost to Follow-up|0|||
105921448|NCT02791269|365373504|FG001|Overall Study|Lost to Follow-up|1|||
105921449|NCT01649765|365373505|FG000|Overall Study|Adverse Event|5|||
105921450|NCT01649765|365373506|FG001|Overall Study|Adverse Event|3|||
105921451|NCT01649765|365373505|FG000|Overall Study|Lack of Efficacy|1|||
105921452|NCT01649765|365373506|FG001|Overall Study|Lack of Efficacy|1|||
105921453|NCT01649765|365373505|FG000|Overall Study|Physician Decision|0|||
105921454|NCT01649765|365373506|FG001|Overall Study|Physician Decision|3|||
105921455|NCT01649765|365373505|FG000|Overall Study|Protocol Violation|1|||
105921456|NCT01649765|365373506|FG001|Overall Study|Protocol Violation|0|||
105921457|NCT01649765|365373505|FG000|Overall Study|Withdrawal by Subject|2|||
105921458|NCT01649765|365373506|FG001|Overall Study|Withdrawal by Subject|1|||
105921459|NCT03427411|365373507|FG000|Overall Study|Screen failure - platelets too low|0|||
105921460|NCT03427411|365373508|FG001|Overall Study|Screen failure - platelets too low|1|||
105921461|NCT01125930|365373509|FG000|Overall Study|Adverse Event|0|||
105921462|NCT01125930|365373510|FG001|Overall Study|Adverse Event|1|||
105921463|NCT01125930|365373509|FG000|Overall Study|Withdrawal by Subject|1|||
105921464|NCT01125930|365373510|FG001|Overall Study|Withdrawal by Subject|6|||
105921465|NCT01125930|365373509|FG000|Overall Study|Protocol Violation|0|||
105921466|NCT01125930|365373510|FG001|Overall Study|Protocol Violation|1|||
105921467|NCT01125930|365373509|FG000|Overall Study|Lost to Follow-up|0|||
105921468|NCT01125930|365373510|FG001|Overall Study|Lost to Follow-up|2|||
105921469|NCT02472405|365373515|FG000|Overall Study|Lost to Follow-up|9|||
105921470|NCT02472405|365373515|FG000|Overall Study|Adverse Event|1|||
105921471|NCT00900562|365373516|FG000|Overall Study|Progressive disease|9|||
105921472|NCT00900562|365373517|FG001|Overall Study|Progressive disease|5|||
105921473|NCT00900562|365373516|FG000|Overall Study|Toxicity|1|||
105921474|NCT00900562|365373517|FG001|Overall Study|Toxicity|0|||
105921475|NCT00900562|365373516|FG000|Overall Study|Death|1|||
105921476|NCT00900562|365373517|FG001|Overall Study|Death|1|||
105921477|NCT00900562|365373516|FG000|Overall Study|Withdrawal by Subject|0|||
105921478|NCT00900562|365373517|FG001|Overall Study|Withdrawal by Subject|1|||
105921479|NCT00900562|365373516|FG000|Overall Study|Unrelated adverse event|1|||
105921480|NCT00900562|365373517|FG001|Overall Study|Unrelated adverse event|0|||
105921481|NCT02426684|365373518|FG000|Overall Study|Physician Decision|1|||
105921482|NCT03736967|365373519|FG000|Overall Study|Withdrawal by Subject|26|||
105921483|NCT03736967|365373520|FG001|Overall Study|Withdrawal by Subject|25|||
105921484|NCT03736967|365373521|FG002|Overall Study|Withdrawal by Subject|23|||
105921485|NCT03736967|365373522|FG003|Overall Study|Withdrawal by Subject|26|||
105921486|NCT03736967|365373519|FG000|Overall Study|Lost to Follow-up|3|||
105921487|NCT03736967|365373520|FG001|Overall Study|Lost to Follow-up|2|||
105921488|NCT03736967|365373521|FG002|Overall Study|Lost to Follow-up|1|||
105921489|NCT03736967|365373522|FG003|Overall Study|Lost to Follow-up|1|||
105921490|NCT03736967|365373519|FG000|Overall Study|Physician Decision|1|||
105921491|NCT03736967|365373520|FG001|Overall Study|Physician Decision|0|||
105921492|NCT03736967|365373521|FG002|Overall Study|Physician Decision|0|||
105921493|NCT03736967|365373522|FG003|Overall Study|Physician Decision|1|||
105921494|NCT03736967|365373519|FG000|Overall Study|Adverse Event|0|||
105921495|NCT03736967|365373520|FG001|Overall Study|Adverse Event|1|||
105921496|NCT03736967|365373521|FG002|Overall Study|Adverse Event|0|||
105921497|NCT03736967|365373522|FG003|Overall Study|Adverse Event|1|||
105921498|NCT03736967|365373519|FG000|Overall Study|Death|0|||
105921499|NCT03736967|365373520|FG001|Overall Study|Death|0|||
105921500|NCT03736967|365373521|FG002|Overall Study|Death|0|||
105921501|NCT03736967|365373522|FG003|Overall Study|Death|1|||
105921502|NCT03736967|365373519|FG000|Overall Study|Randomized but never treated|1|||
105921503|NCT03736967|365373520|FG001|Overall Study|Randomized but never treated|0|||
105921504|NCT03736967|365373521|FG002|Overall Study|Randomized but never treated|0|||
105921505|NCT03736967|365373522|FG003|Overall Study|Randomized but never treated|0|||
105921506|NCT02897349|365373523|FG000|Overall Study|Lost to Follow-up|2|||
105921507|NCT02897349|365373524|FG001|Overall Study|Lost to Follow-up|2|||
105921508|NCT02897349|365373523|FG000|Overall Study|Adverse Event|3|||
105921509|NCT02897349|365373524|FG001|Overall Study|Adverse Event|3|||
105921510|NCT02897349|365373523|FG000|Overall Study|Other than listed above|0|||
105921511|NCT02897349|365373524|FG001|Overall Study|Other than listed above|1|||
105921512|NCT03817528|365373525|FG000|Overall Study|Withdrawal by Subject|1|||
105921513|NCT03817528|365373525|FG000|Overall Study|Adverse Event|2|||
105921514|NCT02251275|365373528|FG000|Overall Study|Adverse Event|23|||
105921515|NCT02251275|365373529|FG001|Overall Study|Adverse Event|60|||
105921516|NCT02251275|365373530|FG002|Overall Study|Adverse Event|28|||
105921517|NCT02251275|365373531|FG003|Overall Study|Adverse Event|0|||
105921518|NCT02251275|365373532|FG004|Overall Study|Adverse Event|0|||
105921519|NCT02251275|365373528|FG000|Overall Study|Lost to Follow-up|5|||
105921520|NCT02251275|365373529|FG001|Overall Study|Lost to Follow-up|6|||
105921521|NCT02251275|365373530|FG002|Overall Study|Lost to Follow-up|4|||
105921522|NCT02251275|365373531|FG003|Overall Study|Lost to Follow-up|0|||
105921523|NCT02251275|365373532|FG004|Overall Study|Lost to Follow-up|0|||
105921524|NCT02251275|365373528|FG000|Overall Study|Physician Decision|19|||
105921525|NCT02251275|365373529|FG001|Overall Study|Physician Decision|30|||
105921526|NCT02251275|365373530|FG002|Overall Study|Physician Decision|26|||
105921527|NCT02251275|365373531|FG003|Overall Study|Physician Decision|0|||
105921528|NCT02251275|365373532|FG004|Overall Study|Physician Decision|1|||
105921529|NCT02251275|365373528|FG000|Overall Study|Protocol Deviation|0|||
105921530|NCT02251275|365373529|FG001|Overall Study|Protocol Deviation|0|||
105921531|NCT02251275|365373530|FG002|Overall Study|Protocol Deviation|1|||
105921532|NCT02251275|365373531|FG003|Overall Study|Protocol Deviation|0|||
105921533|NCT02251275|365373532|FG004|Overall Study|Protocol Deviation|0|||
105921534|NCT02251275|365373528|FG000|Overall Study|Withdrawal by Subject|25|||
105921535|NCT02251275|365373529|FG001|Overall Study|Withdrawal by Subject|51|||
105921536|NCT02251275|365373530|FG002|Overall Study|Withdrawal by Subject|35|||
105921537|NCT02251275|365373531|FG003|Overall Study|Withdrawal by Subject|1|||
105921538|NCT02251275|365373532|FG004|Overall Study|Withdrawal by Subject|0|||
105921539|NCT02349386|365373533|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
105921540|NCT02349386|365373534|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
105921541|NCT02349386|365373535|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
105921542|NCT02349386|365373536|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
105921543|NCT02349386|365373533|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
105921544|NCT02349386|365373534|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
105921545|NCT02349386|365373535|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
105921546|NCT02349386|365373536|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
105921547|NCT02349386|365373533|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
105921548|NCT02349386|365373534|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
105921549|NCT02349386|365373535|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
105921550|NCT02349386|365373536|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
105921551|NCT02349386|365373533|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
105921552|NCT02349386|365373534|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
105921553|NCT02349386|365373535|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
105921554|NCT02349386|365373536|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
105921555|NCT02349386|365373533|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
105921556|NCT02349386|365373534|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
105921557|NCT02349386|365373535|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
105921558|NCT02349386|365373536|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
105921559|NCT02349386|365373533|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
105921560|NCT02349386|365373534|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
105921561|NCT02349386|365373535|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
105921562|NCT02349386|365373536|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
105921563|NCT01712178|365373539|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
105921564|NCT01712178|365373540|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
105921565|NCT01712178|365373539|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
105921566|NCT01712178|365373540|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
105921567|NCT01712178|365373539|FG000|Overall Study|Lost to Follow-up|0|||
105921568|NCT01712178|365373540|FG001|Overall Study|Lost to Follow-up|1|||
105921569|NCT00091819|365373541|FG000|Overall Study|Adverse Event|1|||
105921570|NCT00091819|365373542|FG001|Overall Study|Adverse Event|1|||
105921571|NCT00091819|365373541|FG000|Overall Study|Death|4|||
105921572|NCT00091819|365373542|FG001|Overall Study|Death|5|||
105921573|NCT00091819|365373541|FG000|Overall Study|Lost to Follow-up|26|||
105921574|NCT00091819|365373542|FG001|Overall Study|Lost to Follow-up|23|||
105921575|NCT00091819|365373541|FG000|Overall Study|Withdrawal by Subject|5|||
105921576|NCT00091819|365373542|FG001|Overall Study|Withdrawal by Subject|8|||
105921577|NCT00091819|365373541|FG000|Overall Study|Protocol Violation|1|||
105921578|NCT00091819|365373542|FG001|Overall Study|Protocol Violation|2|||
105921579|NCT00091819|365373541|FG000|Overall Study|Other|2|||
105921580|NCT00091819|365373542|FG001|Overall Study|Other|3|||
105921581|NCT00091819|365373541|FG000|Overall Study|Never received study treatment|3|||
105921582|NCT00091819|365373542|FG001|Overall Study|Never received study treatment|4|||
105921583|NCT02471339|365373543|FG000|Overall Study|Did not provide follow-up data|2|||
105787077|NCT03110107|364874909|FG020|Treatment Period|Disease Progression|12|||
105787078|NCT03110107|364874910|FG021|Treatment Period|Disease Progression|16|||
105921584|NCT02471339|365373544|FG001|Overall Study|Did not provide follow-up data|0|||
105921585|NCT01259245|365373545|FG000|Overall Study|Withdrawal by Subject|27|||
105921586|NCT01259245|365373546|FG001|Overall Study|Withdrawal by Subject|24|||
105921587|NCT01259245|365373545|FG000|Overall Study|Death|1|||
105921588|NCT01259245|365373546|FG001|Overall Study|Death|2|||
105921589|NCT03451071|365373551|FG000|First Vaccine|Withdrawal by Subject|1|||
105921590|NCT03451071|365373551|FG000|Second Vaccine|Lost to Follow-up|19|||
105921591|NCT03451071|365373551|FG000|Third Vaccine|Lost to Follow-up|22|||
105921592|NCT03451071|365373551|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
105921593|NCT03363906|365373552|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
105921594|NCT03363906|365373553|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
105921595|NCT03363906|365373552|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
105921596|NCT03363906|365373553|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
105921597|NCT03363906|365373552|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
105921598|NCT03363906|365373553|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
105921599|NCT03363906|365373552|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
105921600|NCT03363906|365373553|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
105921601|NCT00676143|365373554|FG000|Overall Study|Adverse Event|34|||
105921602|NCT00676143|365373555|FG001|Overall Study|Adverse Event|60|||
105921603|NCT00676143|365373554|FG000|Overall Study|Death|4|||
105921604|NCT00676143|365373555|FG001|Overall Study|Death|4|||
105921605|NCT00676143|365373554|FG000|Overall Study|Lack of Efficacy|0|||
105921606|NCT00676143|365373555|FG001|Overall Study|Lack of Efficacy|6|||
105921607|NCT00676143|365373554|FG000|Overall Study|Lost to Follow-up|0|||
105921608|NCT00676143|365373555|FG001|Overall Study|Lost to Follow-up|13|||
105921609|NCT00676143|365373554|FG000|Overall Study|Physician Decision|5|||
105921610|NCT00676143|365373555|FG001|Overall Study|Physician Decision|8|||
105921611|NCT00676143|365373554|FG000|Overall Study|Protocol Violation|4|||
105921612|NCT00676143|365373555|FG001|Overall Study|Protocol Violation|8|||
105921613|NCT00676143|365373554|FG000|Overall Study|Withdrawal by Subject|24|||
105921614|NCT00676143|365373555|FG001|Overall Study|Withdrawal by Subject|42|||
105921615|NCT00676143|365373554|FG000|Overall Study|Discontinuation of study by sponsor|65|||
105921616|NCT00676143|365373555|FG001|Overall Study|Discontinuation of study by sponsor|88|||
105921617|NCT00676143|365373554|FG000|Overall Study|Failed to return|2|||
105921618|NCT00676143|365373555|FG001|Overall Study|Failed to return|1|||
105921619|NCT00676143|365373554|FG000|Overall Study|Loss of caregiver|5|||
105921620|NCT00676143|365373555|FG001|Overall Study|Loss of caregiver|3|||
105921621|NCT00676143|365373554|FG000|Overall Study|Other|11|||
105921622|NCT00676143|365373555|FG001|Overall Study|Other|20|||
105921623|NCT00676143|365373554|FG000|Overall Study|Participant participation unknown|1|||
105921624|NCT00676143|365373555|FG001|Overall Study|Participant participation unknown|4|||
105921625|NCT00676143|365373554|FG000|Overall Study|Vasogenic edema recurrence|1|||
105921626|NCT00676143|365373555|FG001|Overall Study|Vasogenic edema recurrence|3|||
105921627|NCT00819039|365373556|FG000|Overall Study|Physician Decision|1|||
105921628|NCT00819039|365373557|FG001|Overall Study|Physician Decision|0|||
105921629|NCT00819039|365373558|FG002|Overall Study|Physician Decision|1|||
105921630|NCT00819039|365373556|FG000|Overall Study|Protocol Violation|1|||
105921631|NCT00819039|365373557|FG001|Overall Study|Protocol Violation|0|||
105921632|NCT00819039|365373558|FG002|Overall Study|Protocol Violation|0|||
105921633|NCT00929669|365373559|FG000|Overall Study|elevated glucose levels|1|||
105921634|NCT01240694|365373560|FG000|Overall Study|Adverse Event|9|||
105921635|NCT01240694|365373560|FG000|Overall Study|Lack of Efficacy|6|||
105921636|NCT01240694|365373560|FG000|Overall Study|Withdrawal by Subject|6|||
105921637|NCT01240694|365373560|FG000|Overall Study|Protocol Violation|2|||
105921638|NCT01240694|365373560|FG000|Overall Study|Lost to Follow-up|2|||
105921639|NCT01240694|365373560|FG000|Overall Study|Other than specified|3|||
105921640|NCT01240694|365373560|FG000|Overall Study|Withdrawn due to early study termination|107|||
105921641|NCT01881425|365373561|FG000|Overall Study|Death|5|||
105921642|NCT01881425|365373562|FG001|Overall Study|Death|1|||
105921643|NCT01881425|365373561|FG000|Overall Study|Withdrawal by Subject|8|||
105921644|NCT01881425|365373562|FG001|Overall Study|Withdrawal by Subject|3|||
105921645|NCT01881425|365373561|FG000|Overall Study|Physician Decision|2|||
105921646|NCT01881425|365373562|FG001|Overall Study|Physician Decision|1|||
105921647|NCT01881425|365373561|FG000|Overall Study|Adverse Event|3|||
105921648|NCT01881425|365373562|FG001|Overall Study|Adverse Event|0|||
105921649|NCT01881425|365373561|FG000|Overall Study|General Anesthesia panic attack|0|||
105921650|NCT01881425|365373562|FG001|Overall Study|General Anesthesia panic attack|1|||
105921651|NCT01881425|365373561|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
105921652|NCT01881425|365373562|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
105921653|NCT01881425|365373561|FG000|Overall Study|Lost to Follow-up|7|||
105921654|NCT01881425|365373562|FG001|Overall Study|Lost to Follow-up|2|||
105921655|NCT03502798|365373565|FG000|Overall Study|equipment failure|0|||
105921656|NCT03502798|365373566|FG001|Overall Study|equipment failure|7|||
106132279|NCT01449929|366141954|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
105921657|NCT00485303|365373567|FG000|Overall Study|Adverse Event|5|||
105921658|NCT00485303|365373567|FG000|Overall Study|Progressive Disease|44|||
105921659|NCT00485303|365373567|FG000|Overall Study|Other|3|||
106132280|NCT01449929|366141955|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
106132281|NCT01449929|366141956|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
106132282|NCT01449929|366141954|FG000|Randomization Phase 96 Week|Physician Decision|2|||
106132283|NCT01449929|366141955|FG001|Randomization Phase 96 Week|Physician Decision|3|||
106132284|NCT01449929|366141956|FG002|Randomization Phase 96 Week|Physician Decision|0|||
106132285|NCT01449929|366141954|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
106132286|NCT01449929|366141955|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
106132287|NCT01449929|366141956|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
106132288|NCT01449929|366141954|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
106132289|NCT01449929|366141955|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
106132290|NCT01449929|366141956|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
106132291|NCT01449929|366141954|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
106132292|NCT01449929|366141955|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
106132293|NCT01449929|366141956|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
106132294|NCT01449929|366141954|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
106132295|NCT01449929|366141955|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
106132296|NCT01449929|366141956|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
106132297|NCT01871285|366141957|FG000|First Intervention (1 Day)|Adverse Event|1|||
106132298|NCT01871285|366141958|FG001|First Intervention (1 Day)|Adverse Event|0|||
106132299|NCT01871285|366141959|FG002|First Intervention (1 Day)|Adverse Event|0|||
106132300|NCT01871285|366141960|FG003|First Intervention (1 Day)|Adverse Event|0|||
106132301|NCT01871285|366141957|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
106132302|NCT01871285|366141958|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
106132303|NCT01871285|366141959|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
106132304|NCT01871285|366141960|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
106132305|NCT01959880|366141961|FG000|Overall Study|Withdrawal by Subject|11|||
106132306|NCT01959880|366141962|FG001|Overall Study|Withdrawal by Subject|13|||
106132307|NCT01959880|366141963|FG002|Overall Study|Withdrawal by Subject|8|||
106132308|NCT01959880|366141964|FG003|Overall Study|Withdrawal by Subject|7|||
106132309|NCT01959880|366141961|FG000|Overall Study|Death|1|||
106132310|NCT01959880|366141962|FG001|Overall Study|Death|10|||
106132311|NCT01959880|366141963|FG002|Overall Study|Death|1|||
106132312|NCT01959880|366141964|FG003|Overall Study|Death|2|||
105694536|NCT03044249|364545137|FG000|Overall Study|Withdrawal by Subject|2|||
106132313|NCT01959880|366141961|FG000|Overall Study|Lost to Follow-up|95|||
106132314|NCT01959880|366141962|FG001|Overall Study|Lost to Follow-up|18|||
106132315|NCT01959880|366141963|FG002|Overall Study|Lost to Follow-up|15|||
106132316|NCT01959880|366141964|FG003|Overall Study|Lost to Follow-up|8|||
106132317|NCT01959880|366141961|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
106132318|NCT01959880|366141962|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
106132319|NCT01959880|366141963|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
105694537|NCT03044249|364545138|FG001|Overall Study|Withdrawal by Subject|5|||
105694538|NCT02966223|364545145|FG000|Overall Study|Physician Decision|3|||
105694539|NCT02966223|364545145|FG000|Overall Study|Withdrawal by Subject|11|||
105694540|NCT02966223|364545145|FG000|Overall Study|Lost to Follow-up|1|||
105694541|NCT02003014|364545148|FG000|Overall Study|Case report forms uncollected|9|||
105694542|NCT02003014|364545148|FG000|Overall Study|Treatment started after contract period|1|||
105694543|NCT02003014|364545148|FG000|Overall Study|Patient did not visit the study site|5|||
105921660|NCT00485303|365373567|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
105921661|NCT00485303|365373567|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
105921662|NCT00297167|365373568|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
105921663|NCT00297167|365373569|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
105921664|NCT00297167|365373570|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
105921665|NCT00297167|365373568|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
105921666|NCT00297167|365373569|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
105921667|NCT00297167|365373570|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
105921668|NCT02410629|365373571|FG000|Overall Study|Family cannot commit to the study|2|||
105921669|NCT02410629|365373572|FG001|Overall Study|Family cannot commit to the study|1|||
105921670|NCT02410629|365373571|FG000|Overall Study|Subject returned to work|1|||
105921671|NCT02410629|365373572|FG001|Overall Study|Subject returned to work|0|||
105921672|NCT02410629|365373571|FG000|Overall Study|Subject moved back to home country|0|||
105921673|NCT02410629|365373572|FG001|Overall Study|Subject moved back to home country|1|||
105921674|NCT02410629|365373571|FG000|Overall Study|Subject underwent heart surgery|0|||
106132320|NCT01959880|366141964|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
106132321|NCT01959880|366141961|FG000|Overall Study|Study completed early-FDA approved|1003|||
106132322|NCT01959880|366141962|FG001|Overall Study|Study completed early-FDA approved|311|||
106132323|NCT01959880|366141963|FG002|Overall Study|Study completed early-FDA approved|179|||
106132324|NCT01959880|366141964|FG003|Overall Study|Study completed early-FDA approved|152|||
105694544|NCT02003014|364545148|FG000|Overall Study|Investigator's transfer|4|||
105694545|NCT01660451|364545149|FG000|Overall Study|Protocol Violation|0|||
106132325|NCT01919619|366141965|FG000|Overall Study|Physician Decision|1|||
106132326|NCT01919619|366141966|FG001|Overall Study|Physician Decision|1|||
106132327|NCT02501811|366141967|FG000|Overall Study|Death|1|||
106132328|NCT02501811|366141968|FG001|Overall Study|Death|3|||
106132329|NCT02501811|366141969|FG002|Overall Study|Death|2|||
106132330|NCT02501811|366141970|FG003|Overall Study|Death|3|||
106132331|NCT02501811|366141967|FG000|Overall Study|Withdrawal by Subject|3|||
106132332|NCT02501811|366141968|FG001|Overall Study|Withdrawal by Subject|3|||
106132333|NCT02501811|366141969|FG002|Overall Study|Withdrawal by Subject|2|||
106132334|NCT02501811|366141970|FG003|Overall Study|Withdrawal by Subject|3|||
106132335|NCT02501811|366141967|FG000|Overall Study|Lost to Follow-up|0|||
106132336|NCT02501811|366141968|FG001|Overall Study|Lost to Follow-up|0|||
106132337|NCT02501811|366141969|FG002|Overall Study|Lost to Follow-up|2|||
106132338|NCT02501811|366141970|FG003|Overall Study|Lost to Follow-up|1|||
106132339|NCT04610684|366143161|FG000|Study Treatment|Withdrawal by Subject|1|||
106132340|NCT04610684|366143161|FG000|Study Treatment|Disease Progression|2|||
106132341|NCT04610684|366143161|FG000|Follow up|Death|2|||
106132342|NCT04610684|366143161|FG000|Follow up|Withdrawal by Subject|1|||
106132343|NCT02206685|366143164|FG000|Overall Study|Surgery cancelled/changed|2|||
106132344|NCT02206685|366143165|FG001|Overall Study|Surgery cancelled/changed|3|||
106132345|NCT02206685|366143164|FG000|Overall Study|Withdrawal by Subject|1|||
106132346|NCT02206685|366143165|FG001|Overall Study|Withdrawal by Subject|2|||
106132347|NCT02206685|366143164|FG000|Overall Study|Protocol Violation|2|||
106132348|NCT02206685|366143165|FG001|Overall Study|Protocol Violation|2|||
106132349|NCT00093795|366143166|FG000|Overall Study|No follow up data|20|||
106132350|NCT00093795|366143167|FG001|Overall Study|No follow up data|16|||
106132351|NCT00093795|366143168|FG002|Overall Study|No follow up data|17|||
106132352|NCT03201757|366143171|FG000|Overall Study|Withdrawal by Subject|133|||
106132353|NCT03201757|366143171|FG000|Overall Study|Adverse Event|44|||
106132354|NCT03201757|366143171|FG000|Overall Study|Lost to Follow-up|37|||
106132355|NCT03201757|366143171|FG000|Overall Study|Pregnancy|2|||
106132356|NCT03201757|366143171|FG000|Overall Study|Lack of Efficacy|1|||
106132357|NCT03201757|366143171|FG000|Overall Study|Protocol Violation|20|||
106132358|NCT03201757|366143171|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
106132359|NCT03201757|366143171|FG000|Overall Study|Not Yet Determined|5|||
106132360|NCT03201757|366143171|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
106132361|NCT03201757|366143171|FG000|Overall Study|Other|20|||
106132362|NCT02256969|366143173|FG000|Overall Study|Screenfailed or withdrew|2|||
106132363|NCT02256969|366143174|FG001|Overall Study|Screenfailed or withdrew|1|||
106132364|NCT02256969|366143175|FG002|Overall Study|Screenfailed or withdrew|1|||
106132365|NCT02347943|366143176|FG000|Overall Study|Study was cancelled|140|||
106132366|NCT02347943|366143177|FG001|Overall Study|Study was cancelled|67|||
106132367|NCT02347943|366143178|FG002|Overall Study|Study was cancelled|45|||
106132368|NCT00303303|366143181|FG000|Overall Study|Withdrawal by Subject|0|||
106132369|NCT00303303|366143182|FG001|Overall Study|Withdrawal by Subject|0|||
106132370|NCT00303303|366143183|FG002|Overall Study|Withdrawal by Subject|1|||
106132371|NCT00691028|366143184|FG000|Open-label Period|Adverse Event|0|||
106132372|NCT00691028|366143185|FG001|Open-label Period|Adverse Event|0|||
106132373|NCT00691028|366143186|FG002|Open-label Period|Adverse Event|0|||
106132374|NCT00691028|366143187|FG003|Open-label Period|Adverse Event|16|||
105921675|NCT02410629|365373572|FG001|Overall Study|Subject underwent heart surgery|1|||
105921676|NCT01186770|365373575|FG000|Overall Study|Ineligibility|0|||
105921677|NCT01186770|365373576|FG001|Overall Study|Ineligibility|0|||
105921678|NCT01186770|365373577|FG002|Overall Study|Ineligibility|2|||
105921679|NCT01186770|365373578|FG003|Overall Study|Ineligibility|0|||
105921680|NCT01186770|365373575|FG000|Overall Study|Protocol Violation|7|||
105921681|NCT01186770|365373576|FG001|Overall Study|Protocol Violation|9|||
105921682|NCT01186770|365373577|FG002|Overall Study|Protocol Violation|12|||
105921683|NCT01186770|365373578|FG003|Overall Study|Protocol Violation|14|||
105921684|NCT01186770|365373575|FG000|Overall Study|Adverse Event|2|||
106132375|NCT00691028|366143184|FG000|Open-label Period|Withdrawal by Subject|0|||
106132376|NCT00691028|366143185|FG001|Open-label Period|Withdrawal by Subject|0|||
106132377|NCT00691028|366143186|FG002|Open-label Period|Withdrawal by Subject|0|||
106132378|NCT00691028|366143187|FG003|Open-label Period|Withdrawal by Subject|3|||
106132379|NCT00691028|366143184|FG000|Open-label Period|not come to a hospital|0|||
106132380|NCT00691028|366143185|FG001|Open-label Period|not come to a hospital|0|||
106132381|NCT00691028|366143186|FG002|Open-label Period|not come to a hospital|0|||
106132382|NCT00691028|366143187|FG003|Open-label Period|not come to a hospital|1|||
106132383|NCT00691028|366143184|FG000|Double-blind Period|Adverse Event|8|||
106132384|NCT00691028|366143185|FG001|Double-blind Period|Adverse Event|9|||
106132385|NCT00691028|366143186|FG002|Double-blind Period|Adverse Event|6|||
106132386|NCT00691028|366143187|FG003|Double-blind Period|Adverse Event|0|||
106132387|NCT00691028|366143184|FG000|Double-blind Period|Lack of Efficacy|4|||
106132388|NCT00691028|366143185|FG001|Double-blind Period|Lack of Efficacy|3|||
106132389|NCT00691028|366143186|FG002|Double-blind Period|Lack of Efficacy|2|||
105694546|NCT01660451|364545150|FG001|Overall Study|Protocol Violation|1|||
105694547|NCT01660451|364545151|FG002|Overall Study|Protocol Violation|1|||
105694548|NCT01660451|364545149|FG000|Overall Study|AE not associated with clinical disease progression|13|||
105694549|NCT01660451|364545150|FG001|Overall Study|AE not associated with clinical disease progression|10|||
105694550|NCT01660451|364545151|FG002|Overall Study|AE not associated with clinical disease progression|40|||
105694551|NCT01660451|364545149|FG000|Overall Study|AE associated with clinical disease progression|1|||
105694552|NCT01660451|364545150|FG001|Overall Study|AE associated with clinical disease progression|3|||
105694553|NCT01660451|364545151|FG002|Overall Study|AE associated with clinical disease progression|11|||
105694554|NCT01660451|364545149|FG000|Overall Study|Sponsor Decision|0|||
105694555|NCT01660451|364545150|FG001|Overall Study|Sponsor Decision|0|||
105694556|NCT01660451|364545151|FG002|Overall Study|Sponsor Decision|1|||
105694557|NCT01660451|364545149|FG000|Overall Study|Protocol Deviation|0|||
105694558|NCT01660451|364545150|FG001|Overall Study|Protocol Deviation|0|||
105694559|NCT01660451|364545151|FG002|Overall Study|Protocol Deviation|1|||
105694560|NCT01660451|364545149|FG000|Overall Study|Physician Decision|1|||
105694561|NCT01660451|364545150|FG001|Overall Study|Physician Decision|2|||
105694562|NCT01660451|364545151|FG002|Overall Study|Physician Decision|5|||
105694563|NCT01660451|364545149|FG000|Overall Study|Withdrawal by Subject|1|||
105694564|NCT01660451|364545150|FG001|Overall Study|Withdrawal by Subject|1|||
105694565|NCT01660451|364545151|FG002|Overall Study|Withdrawal by Subject|20|||
105694566|NCT01660451|364545149|FG000|Overall Study|Trial closure.|0|||
105694567|NCT01660451|364545150|FG001|Overall Study|Trial closure.|0|||
105694568|NCT01660451|364545151|FG002|Overall Study|Trial closure.|1|||
105694569|NCT01660451|364545149|FG000|Overall Study|Switching to other therapy|0|||
105694570|NCT01660451|364545150|FG001|Overall Study|Switching to other therapy|1|||
105694571|NCT01660451|364545151|FG002|Overall Study|Switching to other therapy|1|||
105694572|NCT01660451|364545149|FG000|Overall Study|Progressive disease - clinical progression|4|||
105694573|NCT01660451|364545150|FG001|Overall Study|Progressive disease - clinical progression|10|||
105694574|NCT01660451|364545151|FG002|Overall Study|Progressive disease - clinical progression|9|||
105694575|NCT01660451|364545149|FG000|Overall Study|Progressive disease - radiological progression|12|||
105694576|NCT01660451|364545150|FG001|Overall Study|Progressive disease - radiological progression|23|||
105694577|NCT01660451|364545151|FG002|Overall Study|Progressive disease - radiological progression|50|||
105694578|NCT01660451|364545149|FG000|Overall Study|Death|1|||
105694579|NCT01660451|364545150|FG001|Overall Study|Death|0|||
105694580|NCT01660451|364545151|FG002|Overall Study|Death|1|||
105694581|NCT01660451|364545149|FG000|Overall Study|Other|0|||
105694582|NCT01660451|364545150|FG001|Overall Study|Other|0|||
105694583|NCT01660451|364545151|FG002|Overall Study|Other|1|||
105694584|NCT03785678|364545152|FG000|Overall Study|Death|44|||
105694585|NCT03785678|364545153|FG001|Overall Study|Death|42|||
105694586|NCT03785678|364545152|FG000|Overall Study|Lost to Follow-up|4|||
105694587|NCT03785678|364545153|FG001|Overall Study|Lost to Follow-up|2|||
105694588|NCT03785678|364545152|FG000|Overall Study|Physician Decision|0|||
105694589|NCT03785678|364545153|FG001|Overall Study|Physician Decision|2|||
105694590|NCT03785678|364545152|FG000|Overall Study|Withdrawal by Subject|5|||
105694591|NCT03785678|364545153|FG001|Overall Study|Withdrawal by Subject|3|||
105694592|NCT01159912|364545154|FG000|Overall Study|Adverse Event|2|||
105694593|NCT01159912|364545155|FG001|Overall Study|Adverse Event|2|||
105694594|NCT01159912|364545156|FG002|Overall Study|Adverse Event|3|||
105921685|NCT01186770|365373576|FG001|Overall Study|Adverse Event|9|||
105921686|NCT01186770|365373577|FG002|Overall Study|Adverse Event|7|||
105921687|NCT01186770|365373578|FG003|Overall Study|Adverse Event|9|||
105921688|NCT01186770|365373575|FG000|Overall Study|Withdrawal by Subject|15|||
105921689|NCT01186770|365373576|FG001|Overall Study|Withdrawal by Subject|13|||
105921690|NCT01186770|365373577|FG002|Overall Study|Withdrawal by Subject|11|||
105921691|NCT01186770|365373578|FG003|Overall Study|Withdrawal by Subject|17|||
105921692|NCT01186770|365373575|FG000|Overall Study|Lost to Follow-up|10|||
105921693|NCT01186770|365373576|FG001|Overall Study|Lost to Follow-up|6|||
105921694|NCT01186770|365373577|FG002|Overall Study|Lost to Follow-up|14|||
105921695|NCT01186770|365373578|FG003|Overall Study|Lost to Follow-up|9|||
105921696|NCT01186770|365373575|FG000|Overall Study|Insufficient response to treatment|7|||
105921697|NCT01186770|365373576|FG001|Overall Study|Insufficient response to treatment|8|||
105921698|NCT01186770|365373577|FG002|Overall Study|Insufficient response to treatment|5|||
106004723|NCT02741245|365680477|FG003|Overall Study|Withdrawal by Subject|1|||
105694595|NCT01159912|364545154|FG000|Overall Study|Lack of Efficacy|23|||
105694596|NCT01159912|364545155|FG001|Overall Study|Lack of Efficacy|15|||
105694597|NCT01159912|364545156|FG002|Overall Study|Lack of Efficacy|14|||
105694598|NCT01159912|364545154|FG000|Overall Study|Protocol Violation|1|||
105694599|NCT01159912|364545155|FG001|Overall Study|Protocol Violation|2|||
105694600|NCT01159912|364545156|FG002|Overall Study|Protocol Violation|3|||
105694601|NCT01159912|364545154|FG000|Overall Study|Lost to Follow-up|4|||
105694602|NCT01159912|364545155|FG001|Overall Study|Lost to Follow-up|0|||
105694603|NCT01159912|364545156|FG002|Overall Study|Lost to Follow-up|0|||
105694604|NCT01159912|364545154|FG000|Overall Study|Physician Decision|0|||
105694605|NCT01159912|364545155|FG001|Overall Study|Physician Decision|0|||
105694606|NCT01159912|364545156|FG002|Overall Study|Physician Decision|3|||
106004724|NCT02741245|365680478|FG004|Overall Study|Withdrawal by Subject|0|||
106004725|NCT00601835|365680481|FG000|Overall Study|Withdrawal by Subject|9|||
106004726|NCT00601835|365680482|FG001|Overall Study|Withdrawal by Subject|6|||
106004727|NCT00601835|365680481|FG000|Overall Study|Physician Decision|1|||
106004728|NCT00601835|365680482|FG001|Overall Study|Physician Decision|0|||
105694607|NCT01159912|364545154|FG000|Overall Study|Withdrawal by Subject|10|||
105694608|NCT01159912|364545155|FG001|Overall Study|Withdrawal by Subject|3|||
105694609|NCT01159912|364545156|FG002|Overall Study|Withdrawal by Subject|3|||
105694610|NCT02456662|364545157|FG000|Overall Study|Lost to Follow-up|2|||
105694611|NCT02456662|364545158|FG001|Overall Study|Lost to Follow-up|1|||
105694612|NCT02322229|364545159|FG000|Overall Study|Physician Decision|2|||
105694613|NCT01667107|364545160|FG000|Overall Study|Adverse Event|4|||
105694614|NCT01667107|364545161|FG001|Overall Study|Adverse Event|3|||
105787079|NCT03110107|364874911|FG022|Treatment Period|Disease Progression|18|||
105787080|NCT03110107|364874912|FG023|Treatment Period|Disease Progression|13|||
105787081|NCT03110107|364874913|FG024|Treatment Period|Disease Progression|16|||
105787082|NCT03110107|364874914|FG025|Treatment Period|Disease Progression|31|||
105787083|NCT03110107|364874889|FG000|Treatment Period|Study drug toxicity|1|||
105787084|NCT03110107|364874890|FG001|Treatment Period|Study drug toxicity|0|||
105787085|NCT03110107|364874891|FG002|Treatment Period|Study drug toxicity|1|||
105787086|NCT03110107|364874892|FG003|Treatment Period|Study drug toxicity|2|||
105787087|NCT03110107|364874893|FG004|Treatment Period|Study drug toxicity|0|||
105787088|NCT03110107|364874894|FG005|Treatment Period|Study drug toxicity|3|||
105787089|NCT03110107|364874895|FG006|Treatment Period|Study drug toxicity|1|||
105787090|NCT03110107|364874896|FG007|Treatment Period|Study drug toxicity|1|||
105787091|NCT03110107|364874897|FG008|Treatment Period|Study drug toxicity|3|||
105787092|NCT03110107|364874898|FG009|Treatment Period|Study drug toxicity|2|||
105787093|NCT03110107|364874899|FG010|Treatment Period|Study drug toxicity|0|||
105787094|NCT03110107|364874900|FG011|Treatment Period|Study drug toxicity|2|||
105787095|NCT03110107|364874901|FG012|Treatment Period|Study drug toxicity|0|||
106004729|NCT00601835|365680481|FG000|Overall Study|Lost to Follow-up|37|||
106004730|NCT00601835|365680482|FG001|Overall Study|Lost to Follow-up|5|||
106004731|NCT00601835|365680481|FG000|Overall Study|Adverse Event|1|||
106004732|NCT00601835|365680482|FG001|Overall Study|Adverse Event|1|||
106004733|NCT00601835|365680481|FG000|Overall Study|Relocate|12|||
106004734|NCT00601835|365680482|FG001|Overall Study|Relocate|2|||
105694615|NCT01667107|364545160|FG000|Overall Study|Tolerability issues|0|||
105694616|NCT01667107|364545161|FG001|Overall Study|Tolerability issues|2|||
105787096|NCT03110107|364874902|FG013|Treatment Period|Study drug toxicity|0|||
105787097|NCT03110107|364874903|FG014|Treatment Period|Study drug toxicity|2|||
105921699|NCT01186770|365373578|FG003|Overall Study|Insufficient response to treatment|7|||
105921700|NCT01186770|365373575|FG000|Overall Study|Other than specified|0|||
105921701|NCT01186770|365373576|FG001|Overall Study|Other than specified|1|||
105921702|NCT01186770|365373577|FG002|Overall Study|Other than specified|1|||
105921703|NCT01186770|365373578|FG003|Overall Study|Other than specified|2|||
105921704|NCT01033136|365373593|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
105921705|NCT01033136|365373594|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
105921706|NCT00142415|365373598|FG000|Overall Study|Physician Decision|0|||
105921707|NCT00142415|365373599|FG001|Overall Study|Physician Decision|0|||
105921708|NCT00142415|365373600|FG002|Overall Study|Physician Decision|0|||
105921709|NCT00142415|365373601|FG003|Overall Study|Physician Decision|0|||
105921710|NCT00142415|365373602|FG004|Overall Study|Physician Decision|1|||
105921711|NCT00142415|365373603|FG005|Overall Study|Physician Decision|2|||
105921712|NCT00701363|365373609|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
105921713|NCT00701363|365373610|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
105921714|NCT00701363|365373611|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
105921715|NCT00701363|365373612|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
105921716|NCT00701363|365373609|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
105921717|NCT00701363|365373610|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
105921718|NCT00701363|365373611|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
105921719|NCT00701363|365373612|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
105921720|NCT00701363|365373609|FG000|Treatment Phase 1|Adverse Event|7|||
105921721|NCT00701363|365373610|FG001|Treatment Phase 1|Adverse Event|0|||
105921722|NCT00701363|365373611|FG002|Treatment Phase 1|Adverse Event|0|||
105787098|NCT03110107|364874904|FG015|Treatment Period|Study drug toxicity|3|||
105921723|NCT00701363|365373612|FG003|Treatment Phase 1|Adverse Event|0|||
105694617|NCT01667107|364545160|FG000|Overall Study|Protocol Violation|0|||
105921724|NCT00701363|365373609|FG000|Treatment Phase 1|Protocol Violation|1|||
105921725|NCT00701363|365373610|FG001|Treatment Phase 1|Protocol Violation|0|||
105921726|NCT00701363|365373611|FG002|Treatment Phase 1|Protocol Violation|0|||
105921727|NCT00701363|365373612|FG003|Treatment Phase 1|Protocol Violation|0|||
105921728|NCT00701363|365373609|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
106004735|NCT03361137|365680485|FG000|Overall Study|Reason not specified|1|||
106004736|NCT03361137|365680486|FG001|Overall Study|Reason not specified|0|||
106004737|NCT03361137|365680487|FG002|Overall Study|Reason not specified|0|||
105694618|NCT01667107|364545161|FG001|Overall Study|Protocol Violation|1|||
105787099|NCT03110107|364874905|FG016|Treatment Period|Study drug toxicity|3|||
105694619|NCT01667107|364545160|FG000|Overall Study|Lack of Efficacy|0|||
105694620|NCT01667107|364545161|FG001|Overall Study|Lack of Efficacy|1|||
105694621|NCT02281357|364545162|FG000|Overall Study|Adverse Event|2|||
105694622|NCT02281357|364545163|FG001|Overall Study|Adverse Event|1|||
105921729|NCT00701363|365373610|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
105921730|NCT00701363|365373611|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
105921731|NCT00701363|365373612|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
105921732|NCT00701363|365373609|FG000|Treatment Phase 1|Lack of Efficacy|1|||
105921733|NCT00701363|365373610|FG001|Treatment Phase 1|Lack of Efficacy|0|||
105921734|NCT00701363|365373611|FG002|Treatment Phase 1|Lack of Efficacy|0|||
105921735|NCT00701363|365373612|FG003|Treatment Phase 1|Lack of Efficacy|0|||
105921736|NCT00701363|365373609|FG000|Treatment Phase 2|Adverse Event|0|||
105921737|NCT00701363|365373610|FG001|Treatment Phase 2|Adverse Event|0|||
105921738|NCT00701363|365373611|FG002|Treatment Phase 2|Adverse Event|1|||
105921739|NCT00701363|365373612|FG003|Treatment Phase 2|Adverse Event|0|||
105921740|NCT00701363|365373609|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
105921741|NCT00701363|365373610|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
105921742|NCT00701363|365373611|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
105921743|NCT00701363|365373612|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
105921744|NCT03040726|365373613|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
105921745|NCT03040726|365373614|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
105921746|NCT03040726|365373613|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
105921747|NCT03040726|365373614|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
105921748|NCT03040726|365373613|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
105921749|NCT03040726|365373614|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
105921750|NCT03040726|365373613|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
105921751|NCT03040726|365373614|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
105694623|NCT02281357|364545162|FG000|Overall Study|Lost to Follow-up|1|||
105694624|NCT02281357|364545163|FG001|Overall Study|Lost to Follow-up|0|||
105694625|NCT02281357|364545162|FG000|Overall Study|Withdrawal by Subject|4|||
105694626|NCT02281357|364545163|FG001|Overall Study|Withdrawal by Subject|3|||
105694627|NCT00493220|364545164|FG000|Third Intervention|Withdrawal by Subject|1|||
105694628|NCT00493220|364545165|FG001|Third Intervention|Withdrawal by Subject|0|||
105694629|NCT00493220|364545166|FG002|Third Intervention|Withdrawal by Subject|0|||
105694630|NCT00493220|364545167|FG003|Third Intervention|Withdrawal by Subject|0|||
105694631|NCT00493220|364545168|FG004|Third Intervention|Withdrawal by Subject|0|||
105694632|NCT00493220|364545169|FG005|Third Intervention|Withdrawal by Subject|0|||
105694633|NCT04376827|364545171|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
105694634|NCT04376827|364545172|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
105694635|NCT04376827|364545171|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
105694636|NCT04376827|364545172|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
105694637|NCT04376827|364545171|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
105694638|NCT04376827|364545172|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
105921752|NCT03040726|365373613|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
105921753|NCT03040726|365373614|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
105921754|NCT04682301|365373619|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
105921755|NCT04682301|365373619|FG000|Overall Study|Death|2|||
105921756|NCT00315445|365373626|FG000|Overall Study|Adverse Event|7|||
105921757|NCT00315445|365373627|FG001|Overall Study|Adverse Event|12|||
105921758|NCT00315445|365373628|FG002|Overall Study|Adverse Event|15|||
105921759|NCT00315445|365373626|FG000|Overall Study|Lack of Efficacy|16|||
105921760|NCT00315445|365373627|FG001|Overall Study|Lack of Efficacy|1|||
105921761|NCT00315445|365373628|FG002|Overall Study|Lack of Efficacy|7|||
105921762|NCT00315445|365373626|FG000|Overall Study|Lost to Follow-up|1|||
105921763|NCT00315445|365373627|FG001|Overall Study|Lost to Follow-up|0|||
105921764|NCT00315445|365373628|FG002|Overall Study|Lost to Follow-up|1|||
105921765|NCT00315445|365373626|FG000|Overall Study|Protocol Violation|2|||
105921766|NCT00315445|365373627|FG001|Overall Study|Protocol Violation|0|||
105921767|NCT00315445|365373628|FG002|Overall Study|Protocol Violation|1|||
105921768|NCT00315445|365373626|FG000|Overall Study|Other|1|||
105921769|NCT00315445|365373627|FG001|Overall Study|Other|3|||
105694639|NCT04376827|364545171|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
105694640|NCT04376827|364545172|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
105694641|NCT04376827|364545171|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
105921770|NCT00315445|365373628|FG002|Overall Study|Other|0|||
105921771|NCT00671788|365373629|FG000|Overall Study|Adverse Event|8|||
105921772|NCT00671788|365373629|FG000|Overall Study|Refused further treatment|3|||
105921773|NCT00671788|365373629|FG000|Overall Study|Ineligible|1|||
105921774|NCT00671788|365373629|FG000|Overall Study|MD Decision|1|||
105921775|NCT00671788|365373629|FG000|Overall Study|Other|1|||
105694642|NCT04376827|364545172|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
105694643|NCT04042740|364546252|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
105694644|NCT04042740|364546252|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
105694645|NCT01809132|364546255|FG000|Overall Study|Withdrawal by Subject|0|||
105694646|NCT01809132|364546256|FG001|Overall Study|Withdrawal by Subject|0|||
105694647|NCT01809132|364546257|FG002|Overall Study|Withdrawal by Subject|1|||
105694648|NCT01480284|364546258|FG000|Overall Study|Withdrawal by Subject|2|||
105694649|NCT01480284|364546259|FG001|Overall Study|Withdrawal by Subject|0|||
105694650|NCT01480284|364546258|FG000|Overall Study|Adverse Event|1|||
105694651|NCT01480284|364546259|FG001|Overall Study|Adverse Event|0|||
105694652|NCT01480284|364546258|FG000|Overall Study|Study closed/terminated|3|||
105694653|NCT01480284|364546259|FG001|Overall Study|Study closed/terminated|0|||
105694654|NCT01480284|364546258|FG000|Overall Study|Lost to Follow-up|1|||
105694655|NCT01480284|364546259|FG001|Overall Study|Lost to Follow-up|0|||
105694656|NCT01480284|364546258|FG000|Overall Study|Physician Decision|1|||
105694657|NCT01480284|364546259|FG001|Overall Study|Physician Decision|0|||
105694658|NCT00832117|364546260|FG000|Overall Study|Death|1|||
105694659|NCT00832117|364546260|FG000|Overall Study|Disease Progression|11|||
105694660|NCT04439071|364546261|FG000|Overall Study|Lost to Follow-up|0|||
105694661|NCT04439071|364546262|FG001|Overall Study|Lost to Follow-up|3|||
105694662|NCT04439071|364546261|FG000|Overall Study|Withdrawal by Subject|3|||
105694663|NCT04439071|364546262|FG001|Overall Study|Withdrawal by Subject|8|||
105694664|NCT04439071|364546261|FG000|Overall Study|Death|6|||
105694665|NCT04439071|364546262|FG001|Overall Study|Death|4|||
105694666|NCT04439071|364546261|FG000|Overall Study|Other than specified|3|||
105694667|NCT04439071|364546262|FG001|Overall Study|Other than specified|3|||
105694668|NCT04439071|364546261|FG000|Overall Study|Randomized but not treated|2|||
105694669|NCT04439071|364546262|FG001|Overall Study|Randomized but not treated|0|||
105694670|NCT00529451|364546275|FG000|Overall Study|Subject withdrew consent|16|||
105694671|NCT00529451|364546276|FG001|Overall Study|Subject withdrew consent|21|||
105694672|NCT00529451|364546277|FG002|Overall Study|Subject withdrew consent|13|||
105694673|NCT00529451|364546278|FG003|Overall Study|Subject withdrew consent|12|||
105694674|NCT00529451|364546275|FG000|Overall Study|Adverse Event|9|||
105694675|NCT00529451|364546276|FG001|Overall Study|Adverse Event|16|||
105694676|NCT00529451|364546277|FG002|Overall Study|Adverse Event|14|||
105694677|NCT00529451|364546278|FG003|Overall Study|Adverse Event|8|||
105694678|NCT00529451|364546275|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
105694679|NCT00529451|364546276|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
105694680|NCT00529451|364546277|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
105694681|NCT00529451|364546278|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
105694682|NCT00529451|364546275|FG000|Overall Study|Lost to Follow-up|4|||
105921776|NCT01035138|365373630|FG000|Overall Study|Adverse Event|4|||
106004738|NCT03361137|365680488|FG003|Overall Study|Reason not specified|0|||
106004739|NCT03361137|365680489|FG004|Overall Study|Reason not specified|0|||
106004740|NCT01253291|365680490|FG000|Overall Study|Withdrawal by Subject|1|||
106004741|NCT01253291|365680491|FG001|Overall Study|Withdrawal by Subject|1|||
106004742|NCT01253291|365680492|FG002|Overall Study|Withdrawal by Subject|0|||
106004743|NCT01253291|365680493|FG003|Overall Study|Withdrawal by Subject|0|||
106004744|NCT01253291|365680494|FG004|Overall Study|Withdrawal by Subject|0|||
105921777|NCT01035138|365373631|FG001|Overall Study|Adverse Event|0|||
105921778|NCT01035138|365373632|FG002|Overall Study|Adverse Event|2|||
105921779|NCT01035138|365373630|FG000|Overall Study|Caregiver Decision|2|||
105921780|NCT01035138|365373631|FG001|Overall Study|Caregiver Decision|0|||
105921781|NCT01035138|365373632|FG002|Overall Study|Caregiver Decision|1|||
105921782|NCT01035138|365373630|FG000|Overall Study|Withdrawal by Subject|1|||
105921783|NCT01035138|365373631|FG001|Overall Study|Withdrawal by Subject|0|||
106004745|NCT01253291|365680490|FG000|Overall Study|Adverse Event|0|||
106004746|NCT01253291|365680491|FG001|Overall Study|Adverse Event|1|||
106004747|NCT01253291|365680492|FG002|Overall Study|Adverse Event|0|||
106004748|NCT01253291|365680493|FG003|Overall Study|Adverse Event|0|||
106004749|NCT01253291|365680494|FG004|Overall Study|Adverse Event|0|||
106004750|NCT01253291|365680490|FG000|Overall Study|Lack of Efficacy|1|||
105694683|NCT00529451|364546276|FG001|Overall Study|Lost to Follow-up|7|||
105694684|NCT00529451|364546277|FG002|Overall Study|Lost to Follow-up|4|||
105694685|NCT00529451|364546278|FG003|Overall Study|Lost to Follow-up|4|||
105921784|NCT01035138|365373632|FG002|Overall Study|Withdrawal by Subject|0|||
105921785|NCT01035138|365373630|FG000|Overall Study|Physician Decision|0|||
105921786|NCT01035138|365373631|FG001|Overall Study|Physician Decision|0|||
105921787|NCT01035138|365373632|FG002|Overall Study|Physician Decision|1|||
105921788|NCT01035138|365373630|FG000|Overall Study|Sponsor Decision|66|||
106004751|NCT01253291|365680491|FG001|Overall Study|Lack of Efficacy|0|||
106004752|NCT01253291|365680492|FG002|Overall Study|Lack of Efficacy|0|||
106004753|NCT01253291|365680493|FG003|Overall Study|Lack of Efficacy|0|||
106004754|NCT01253291|365680494|FG004|Overall Study|Lack of Efficacy|0|||
105694686|NCT00529451|364546275|FG000|Overall Study|Protocol deviation|1|||
105694687|NCT00529451|364546276|FG001|Overall Study|Protocol deviation|1|||
105694688|NCT00529451|364546277|FG002|Overall Study|Protocol deviation|4|||
105694689|NCT00529451|364546278|FG003|Overall Study|Protocol deviation|1|||
105921789|NCT01035138|365373631|FG001|Overall Study|Sponsor Decision|60|||
106004755|NCT01253291|365680490|FG000|Overall Study|Physician Decision|2|||
106004756|NCT01253291|365680491|FG001|Overall Study|Physician Decision|0|||
106004757|NCT01253291|365680492|FG002|Overall Study|Physician Decision|0|||
106004758|NCT01253291|365680493|FG003|Overall Study|Physician Decision|0|||
106004759|NCT01253291|365680494|FG004|Overall Study|Physician Decision|2|||
106004760|NCT01486966|365680495|FG000|Overall Study|Adverse Event|0|||
106004761|NCT01486966|365680496|FG001|Overall Study|Adverse Event|1|||
106004762|NCT01486966|365680495|FG000|Overall Study|Withdrawal by Subject|0|||
106004763|NCT01486966|365680496|FG001|Overall Study|Withdrawal by Subject|1|||
106004764|NCT00506350|365680504|FG000|Overall Study|Serious Adverse Event|1|||
106004765|NCT00506350|365680505|FG001|Overall Study|Serious Adverse Event|0|||
106004766|NCT00506350|365680506|FG002|Overall Study|Serious Adverse Event|0|||
106004767|NCT00506350|365680507|FG003|Overall Study|Serious Adverse Event|0|||
106004768|NCT00506350|365680508|FG004|Overall Study|Serious Adverse Event|0|||
106004769|NCT00506350|365680509|FG005|Overall Study|Serious Adverse Event|0|||
106004770|NCT00506350|365680510|FG006|Overall Study|Serious Adverse Event|0|||
106004771|NCT00506350|365680511|FG007|Overall Study|Serious Adverse Event|0|||
106004772|NCT00506350|365680512|FG008|Overall Study|Serious Adverse Event|0|||
105694690|NCT00529451|364546275|FG000|Overall Study|Administrative problems|1|||
105694691|NCT00529451|364546276|FG001|Overall Study|Administrative problems|1|||
105694692|NCT00529451|364546277|FG002|Overall Study|Administrative problems|0|||
106004773|NCT00506350|365680504|FG000|Overall Study|Adverse Event|0|||
106004774|NCT00506350|365680505|FG001|Overall Study|Adverse Event|0|||
106004775|NCT00506350|365680506|FG002|Overall Study|Adverse Event|0|||
106004776|NCT00506350|365680507|FG003|Overall Study|Adverse Event|0|||
106004777|NCT00506350|365680508|FG004|Overall Study|Adverse Event|0|||
106004778|NCT00506350|365680509|FG005|Overall Study|Adverse Event|0|||
106004779|NCT00506350|365680510|FG006|Overall Study|Adverse Event|0|||
106004780|NCT00506350|365680511|FG007|Overall Study|Adverse Event|1|||
106004781|NCT00506350|365680512|FG008|Overall Study|Adverse Event|1|||
106004782|NCT00506350|365680504|FG000|Overall Study|Protocol Violation|0|||
106004783|NCT00506350|365680505|FG001|Overall Study|Protocol Violation|0|||
106004784|NCT00506350|365680506|FG002|Overall Study|Protocol Violation|1|||
106004785|NCT00506350|365680507|FG003|Overall Study|Protocol Violation|0|||
105921790|NCT01035138|365373632|FG002|Overall Study|Sponsor Decision|42|||
105921791|NCT01035138|365373630|FG000|Overall Study|Lost to Follow-up|0|||
105921792|NCT01035138|365373631|FG001|Overall Study|Lost to Follow-up|0|||
105921793|NCT01035138|365373632|FG002|Overall Study|Lost to Follow-up|1|||
105921794|NCT02966834|365373633|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105921795|NCT02966834|365373634|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105921796|NCT02966834|365373635|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
106004786|NCT00506350|365680508|FG004|Overall Study|Protocol Violation|0|||
106004787|NCT00506350|365680509|FG005|Overall Study|Protocol Violation|0|||
106004788|NCT00506350|365680510|FG006|Overall Study|Protocol Violation|1|||
106004789|NCT00506350|365680511|FG007|Overall Study|Protocol Violation|0|||
106004790|NCT00506350|365680512|FG008|Overall Study|Protocol Violation|0|||
106004791|NCT00506350|365680504|FG000|Overall Study|Withdrawal by Subject|0|||
106004792|NCT00506350|365680505|FG001|Overall Study|Withdrawal by Subject|1|||
106004793|NCT00506350|365680506|FG002|Overall Study|Withdrawal by Subject|1|||
106004794|NCT00506350|365680507|FG003|Overall Study|Withdrawal by Subject|1|||
106004795|NCT00506350|365680508|FG004|Overall Study|Withdrawal by Subject|4|||
106004796|NCT00506350|365680509|FG005|Overall Study|Withdrawal by Subject|1|||
106004797|NCT00506350|365680510|FG006|Overall Study|Withdrawal by Subject|1|||
106004798|NCT00506350|365680511|FG007|Overall Study|Withdrawal by Subject|2|||
106004799|NCT00506350|365680512|FG008|Overall Study|Withdrawal by Subject|0|||
106004800|NCT00506350|365680504|FG000|Overall Study|Lost to Follow-up|1|||
106004801|NCT00506350|365680505|FG001|Overall Study|Lost to Follow-up|1|||
106004802|NCT00506350|365680506|FG002|Overall Study|Lost to Follow-up|1|||
106004803|NCT00506350|365680507|FG003|Overall Study|Lost to Follow-up|1|||
106004804|NCT00506350|365680508|FG004|Overall Study|Lost to Follow-up|2|||
106004805|NCT00506350|365680509|FG005|Overall Study|Lost to Follow-up|1|||
106004806|NCT00506350|365680510|FG006|Overall Study|Lost to Follow-up|0|||
106004807|NCT00506350|365680511|FG007|Overall Study|Lost to Follow-up|0|||
106004808|NCT00506350|365680512|FG008|Overall Study|Lost to Follow-up|2|||
106004809|NCT00506350|365680504|FG000|Overall Study|Medical Reason|0|||
105694693|NCT00529451|364546278|FG003|Overall Study|Administrative problems|2|||
105694694|NCT01245387|364546279|FG000|Overall Study|Lost to Follow-up|106|||
105694695|NCT01245387|364546279|FG000|Overall Study|Lack of Efficacy|195|||
105694696|NCT01245387|364546279|FG000|Overall Study|Adverse Event|9|||
105694697|NCT01245387|364546279|FG000|Overall Study|Death|3|||
105694698|NCT01245387|364546279|FG000|Overall Study|Other|131|||
105694699|NCT01245387|364546279|FG000|Overall Study|Missing discontinuation status|369|||
105694700|NCT04513665|364546280|FG000|Overall Study|Adverse Event|2|||
105694701|NCT04513665|364546281|FG001|Overall Study|Adverse Event|0|||
105694702|NCT04513665|364546280|FG000|Overall Study|Lack of Efficacy|14|||
105694703|NCT04513665|364546281|FG001|Overall Study|Lack of Efficacy|0|||
105694704|NCT02790138|364546282|FG000|Overall Study|Adverse Event|5|||
105694705|NCT02790138|364546283|FG001|Overall Study|Adverse Event|2|||
105694706|NCT02790138|364546282|FG000|Overall Study|Significant Protocol Deviation|0|||
105694707|NCT02790138|364546283|FG001|Overall Study|Significant Protocol Deviation|1|||
105694708|NCT02790138|364546282|FG000|Overall Study|Lost to Follow-up|1|||
105694709|NCT02790138|364546283|FG001|Overall Study|Lost to Follow-up|0|||
105694710|NCT02790138|364546282|FG000|Overall Study|Voluntary Withdrawal|8|||
105694711|NCT02790138|364546283|FG001|Overall Study|Voluntary Withdrawal|9|||
105694712|NCT02790138|364546282|FG000|Overall Study|Lack of Efficacy|6|||
105694713|NCT02790138|364546283|FG001|Overall Study|Lack of Efficacy|7|||
105694714|NCT02790138|364546282|FG000|Overall Study|Reason not Specified|1|||
105787100|NCT03110107|364874906|FG017|Treatment Period|Study drug toxicity|3|||
105921797|NCT02966834|365373636|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105921798|NCT02966834|365373637|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
106004810|NCT00506350|365680505|FG001|Overall Study|Medical Reason|0|||
106004811|NCT00506350|365680506|FG002|Overall Study|Medical Reason|0|||
106004812|NCT00506350|365680507|FG003|Overall Study|Medical Reason|0|||
106004813|NCT00506350|365680508|FG004|Overall Study|Medical Reason|1|||
106004814|NCT00506350|365680509|FG005|Overall Study|Medical Reason|0|||
106004815|NCT00506350|365680510|FG006|Overall Study|Medical Reason|0|||
106004816|NCT00506350|365680511|FG007|Overall Study|Medical Reason|0|||
106004817|NCT00506350|365680512|FG008|Overall Study|Medical Reason|0|||
105694715|NCT02790138|364546283|FG001|Overall Study|Reason not Specified|0|||
105694716|NCT02146599|364546286|FG000|Overall Study|Failed to meet inclusion criteria|5|||
105787101|NCT03110107|364874907|FG018|Treatment Period|Study drug toxicity|1|||
106004818|NCT00506350|365680504|FG000|Overall Study|Other|1|||
106004819|NCT00506350|365680505|FG001|Overall Study|Other|1|||
106004820|NCT00506350|365680506|FG002|Overall Study|Other|3|||
106132390|NCT00691028|366143187|FG003|Double-blind Period|Lack of Efficacy|0|||
106132391|NCT00691028|366143184|FG000|Double-blind Period|Withdrawal by Subject|1|||
106132392|NCT00691028|366143185|FG001|Double-blind Period|Withdrawal by Subject|0|||
106132393|NCT00691028|366143186|FG002|Double-blind Period|Withdrawal by Subject|1|||
106132394|NCT00691028|366143187|FG003|Double-blind Period|Withdrawal by Subject|0|||
106132395|NCT00691028|366143184|FG000|Double-blind Period|not come to a hospital.|0|||
106132396|NCT00691028|366143185|FG001|Double-blind Period|not come to a hospital.|1|||
106132397|NCT00691028|366143186|FG002|Double-blind Period|not come to a hospital.|0|||
106132398|NCT00691028|366143187|FG003|Double-blind Period|not come to a hospital.|0|||
106132399|NCT00582790|366143188|FG000|Overall Study|Rapid progression of disease|1|||
106132400|NCT00480441|366143190|FG000|Screening|Not Eligible|37|||
106132401|NCT00480441|366143191|FG001|Screening|Not Eligible|0|||
106132402|NCT00480441|366143192|FG002|Screening|Not Eligible|0|||
106132403|NCT00480441|366143190|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
106132404|NCT00480441|366143191|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
106132405|NCT00480441|366143192|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
106132406|NCT00480441|366143190|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
106132407|NCT00480441|366143191|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
106132408|NCT00480441|366143192|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
106132409|NCT00480441|366143190|FG000|Baseline Functional MRI|physical contraindication|4|||
106132410|NCT00480441|366143191|FG001|Baseline Functional MRI|physical contraindication|0|||
106132411|NCT00480441|366143192|FG002|Baseline Functional MRI|physical contraindication|0|||
106132412|NCT00480441|366143190|FG000|Randomization|Lost to Follow-up|0|||
106132413|NCT00480441|366143191|FG001|Randomization|Lost to Follow-up|7|||
106132414|NCT00480441|366143192|FG002|Randomization|Lost to Follow-up|2|||
106132415|NCT00748969|366143193|FG000|Overall Study|Withdrawal by Subject|1|||
106132416|NCT00748969|366143194|FG001|Overall Study|Withdrawal by Subject|0|||
106132417|NCT00748969|366143193|FG000|Overall Study|Withdrawal by Subject|0|||
106132418|NCT00748969|366143194|FG001|Overall Study|Withdrawal by Subject|1|||
106132419|NCT02334306|366143195|FG000|Double-blind Period|Adverse Event|0|||
106132420|NCT02334306|366143196|FG001|Double-blind Period|Adverse Event|1|||
106132421|NCT02334306|366143195|FG000|Double-blind Period|Withdrawal by Subject|1|||
106132422|NCT02334306|366143196|FG001|Double-blind Period|Withdrawal by Subject|1|||
106132423|NCT01687270|366143199|FG000|Overall Study|Lack of Efficacy|11|||
106132424|NCT01687270|366143199|FG000|Overall Study|Lost to Follow-up|1|||
106132425|NCT00465985|366143200|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
106132426|NCT00465985|366143201|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
106132427|NCT00465985|366143200|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
106132428|NCT00465985|366143201|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
106132429|NCT00465985|366143200|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
106132430|NCT00465985|366143201|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
106132431|NCT00465985|366143200|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
106132432|NCT00465985|366143201|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
106132433|NCT03302156|366143202|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
106132434|NCT03302156|366143203|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
106132435|NCT03302156|366143204|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
106132436|NCT00463151|366143205|FG000|Overall Study|Adverse Event|0|||
106132437|NCT00463151|366143206|FG001|Overall Study|Adverse Event|0|||
106132438|NCT00463151|366143207|FG002|Overall Study|Adverse Event|1|||
106132439|NCT00463151|366143208|FG003|Overall Study|Adverse Event|0|||
106132440|NCT00463151|366143205|FG000|Overall Study|Lack of Efficacy|2|||
106132441|NCT00463151|366143206|FG001|Overall Study|Lack of Efficacy|5|||
106132442|NCT00463151|366143207|FG002|Overall Study|Lack of Efficacy|2|||
106132443|NCT00463151|366143208|FG003|Overall Study|Lack of Efficacy|5|||
106132444|NCT00463151|366143205|FG000|Overall Study|Protocol Violation|0|||
106132445|NCT00463151|366143206|FG001|Overall Study|Protocol Violation|0|||
106132446|NCT00463151|366143207|FG002|Overall Study|Protocol Violation|0|||
106132447|NCT00463151|366143208|FG003|Overall Study|Protocol Violation|1|||
106132448|NCT00463151|366143205|FG000|Overall Study|Withdrawal by Subject|0|||
106132449|NCT00463151|366143206|FG001|Overall Study|Withdrawal by Subject|0|||
106132450|NCT00463151|366143207|FG002|Overall Study|Withdrawal by Subject|0|||
106132451|NCT00463151|366143208|FG003|Overall Study|Withdrawal by Subject|1|||
106132452|NCT01813422|366143209|FG000|Overall Study|Withdrawal by Subject|14|||
106132453|NCT01813422|366143210|FG001|Overall Study|Withdrawal by Subject|8|||
106132454|NCT01813422|366143209|FG000|Overall Study|Death|2|||
106132455|NCT01813422|366143210|FG001|Overall Study|Death|3|||
106132456|NCT01813422|366143209|FG000|Overall Study|Sponsor Decision|2|||
106132457|NCT01813422|366143210|FG001|Overall Study|Sponsor Decision|1|||
106132458|NCT01813422|366143209|FG000|Overall Study|Lost to Follow-up|2|||
106132459|NCT01813422|366143210|FG001|Overall Study|Lost to Follow-up|4|||
106132460|NCT04889118|366143212|FG000|Overall Study|Death|33|||
106132461|NCT04889118|366143213|FG001|Overall Study|Death|37|||
106132462|NCT04889118|366143212|FG000|Overall Study|Ongoing in Study|31|||
106132463|NCT04889118|366143213|FG001|Overall Study|Ongoing in Study|30|||
106132464|NCT00601640|366143216|FG000|Overall Study|Withdrawal by Subject|3|||
106004821|NCT00506350|365680507|FG003|Overall Study|Other|0|||
106132465|NCT00601640|366143217|FG001|Overall Study|Withdrawal by Subject|0|||
106132466|NCT00601640|366143218|FG002|Overall Study|Withdrawal by Subject|7|||
106132467|NCT00601640|366143216|FG000|Overall Study|Death|1|||
106132468|NCT00601640|366143217|FG001|Overall Study|Death|0|||
106132469|NCT00601640|366143218|FG002|Overall Study|Death|0|||
106132470|NCT00601640|366143216|FG000|Overall Study|Adverse Event|0|||
106132471|NCT00601640|366143217|FG001|Overall Study|Adverse Event|4|||
106132472|NCT00601640|366143218|FG002|Overall Study|Adverse Event|2|||
106132473|NCT00601640|366143216|FG000|Overall Study|intercurrent illness|1|||
106132474|NCT00601640|366143217|FG001|Overall Study|intercurrent illness|0|||
106132475|NCT00601640|366143218|FG002|Overall Study|intercurrent illness|0|||
106132476|NCT00601640|366143216|FG000|Overall Study|change in eligibility status|0|||
106132477|NCT00601640|366143217|FG001|Overall Study|change in eligibility status|1|||
106132478|NCT00601640|366143218|FG002|Overall Study|change in eligibility status|1|||
105921799|NCT02966834|365373638|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
105921800|NCT02966834|365373633|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
105921801|NCT02966834|365373634|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105921802|NCT02966834|365373635|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105921803|NCT02966834|365373636|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105921804|NCT02966834|365373637|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105921805|NCT02966834|365373638|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105921806|NCT02966834|365373633|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
105921807|NCT02966834|365373634|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
105921808|NCT02966834|365373635|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
105921809|NCT02966834|365373636|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
105921810|NCT02966834|365373637|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
105921811|NCT02966834|365373638|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
105921812|NCT02966834|365373633|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
105921813|NCT02966834|365373634|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
105921814|NCT02966834|365373635|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
105921815|NCT02966834|365373636|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
105921816|NCT02966834|365373637|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
105921817|NCT02966834|365373638|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
105921818|NCT02966834|365373633|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105921819|NCT02966834|365373634|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105921820|NCT02966834|365373635|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105921821|NCT02966834|365373636|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
105921822|NCT02966834|365373637|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
106004822|NCT00506350|365680508|FG004|Overall Study|Other|3|||
106132479|NCT00530777|366143219|FG000|Overall Study|Lost to Follow-up|0|||
106132480|NCT00530777|366143220|FG001|Overall Study|Lost to Follow-up|1|||
106132481|NCT00530777|366143219|FG000|Overall Study|Death|1|||
106132482|NCT00530777|366143220|FG001|Overall Study|Death|2|||
106132483|NCT00530777|366143219|FG000|Overall Study|Physician Decision|1|||
106132484|NCT00530777|366143220|FG001|Overall Study|Physician Decision|0|||
105694717|NCT00175877|364546287|FG000|Overall Study|Adverse Event|136|||
105694718|NCT00175877|364546287|FG000|Overall Study|Withdrawal by Subject|141|||
105694719|NCT00175877|364546287|FG000|Overall Study|Lost to Follow-up|9|||
105694720|NCT00175877|364546287|FG000|Overall Study|Lack of Efficacy|26|||
105694721|NCT00175877|364546287|FG000|Overall Study|Protocol Violation|15|||
105694722|NCT00175877|364546287|FG000|Overall Study|Other Reason|20|||
105694723|NCT00175877|364546287|FG000|Overall Study|AE & Other|1|||
105694724|NCT00175877|364546287|FG000|Overall Study|Withdrawal by subject & Other|1|||
105694725|NCT01368042|364546289|FG000|Overall Study|Death|14|||
105694726|NCT01368042|364546289|FG000|Overall Study|Protocol Violation|11|||
105694727|NCT01368042|364546289|FG000|Overall Study|Lost to Follow-up|4|||
105694728|NCT01368042|364546289|FG000|Overall Study|Transplanted|1|||
105694729|NCT00760669|364546290|FG000|Overall Study|Not assessed for overall improvement|18|||
105694730|NCT00760669|364546290|FG000|Overall Study|Participants missing efficacy assessment|6|||
105694731|NCT00760669|364546290|FG000|Overall Study|Participants with overlapping cases|1|||
105694732|NCT00760669|364546290|FG000|Overall Study|Took drug before entering in contract|5|||
105694733|NCT02632721|364546291|FG000|Overall Study|Adverse Event|0|||
105694734|NCT02632721|364546292|FG001|Overall Study|Adverse Event|0|||
105694735|NCT02632721|364546293|FG002|Overall Study|Adverse Event|2|||
105694736|NCT02632721|364546294|FG003|Overall Study|Adverse Event|5|||
105694737|NCT02632721|364546295|FG004|Overall Study|Adverse Event|3|||
105694738|NCT02632721|364546291|FG000|Overall Study|Dose limiting toxicity|0|||
105694739|NCT02632721|364546292|FG001|Overall Study|Dose limiting toxicity|0|||
105694740|NCT02632721|364546293|FG002|Overall Study|Dose limiting toxicity|0|||
105694741|NCT02632721|364546294|FG003|Overall Study|Dose limiting toxicity|1|||
105694742|NCT02632721|364546295|FG004|Overall Study|Dose limiting toxicity|0|||
105694743|NCT02632721|364546291|FG000|Overall Study|Progressive disease|3|||
105694744|NCT02632721|364546292|FG001|Overall Study|Progressive disease|0|||
105694745|NCT02632721|364546293|FG002|Overall Study|Progressive disease|4|||
105694746|NCT02632721|364546294|FG003|Overall Study|Progressive disease|6|||
105694747|NCT02632721|364546295|FG004|Overall Study|Progressive disease|5|||
105694748|NCT02632721|364546291|FG000|Overall Study|Refused to continue taking trial medication|0|||
105694749|NCT02632721|364546292|FG001|Overall Study|Refused to continue taking trial medication|1|||
105694750|NCT02632721|364546293|FG002|Overall Study|Refused to continue taking trial medication|1|||
105694751|NCT02632721|364546294|FG003|Overall Study|Refused to continue taking trial medication|1|||
105694752|NCT02632721|364546295|FG004|Overall Study|Refused to continue taking trial medication|2|||
105694753|NCT02632721|364546291|FG000|Overall Study|Inadequate clinical condition|0|||
105694754|NCT02632721|364546292|FG001|Overall Study|Inadequate clinical condition|0|||
105694755|NCT02632721|364546293|FG002|Overall Study|Inadequate clinical condition|0|||
105921823|NCT02966834|365373638|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
105921824|NCT02966834|365373633|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105921825|NCT02966834|365373634|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105921826|NCT02966834|365373635|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105921827|NCT02966834|365373636|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
105921828|NCT02966834|365373637|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105921829|NCT02966834|365373638|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
105921830|NCT03883386|365373641|FG000|First Assignment|Lost to Follow-up|1|||
105921831|NCT03883386|365373642|FG001|First Assignment|Lost to Follow-up|0|||
105921832|NCT03883386|365373641|FG000|First Assignment|Withdrawal by Subject|1|||
105921833|NCT03883386|365373642|FG001|First Assignment|Withdrawal by Subject|1|||
105921834|NCT02781324|365373648|FG000|Overall Study|Withdrawal by Subject|1|||
105921835|NCT02781324|365373649|FG001|Overall Study|Withdrawal by Subject|0|||
105921836|NCT02781324|365373648|FG000|Overall Study|Physician Decision|1|||
105921837|NCT02781324|365373649|FG001|Overall Study|Physician Decision|2|||
105921838|NCT02160626|365373650|FG000|Overall Study|Adverse Event|1|||
105921839|NCT02160626|365373651|FG001|Overall Study|Adverse Event|0|||
105921840|NCT02160626|365373652|FG002|Overall Study|Adverse Event|0|||
105921841|NCT02160626|365373650|FG000|Overall Study|Schedule not conducive to study visits|0|||
105921842|NCT02160626|365373651|FG001|Overall Study|Schedule not conducive to study visits|0|||
105921843|NCT02160626|365373652|FG002|Overall Study|Schedule not conducive to study visits|1|||
105921844|NCT02160626|365373650|FG000|Overall Study|Withdrawal by Subject|0|||
105921845|NCT02160626|365373651|FG001|Overall Study|Withdrawal by Subject|1|||
105921846|NCT02160626|365373652|FG002|Overall Study|Withdrawal by Subject|0|||
105694756|NCT02632721|364546294|FG003|Overall Study|Inadequate clinical condition|0|||
105694757|NCT02632721|364546295|FG004|Overall Study|Inadequate clinical condition|1|||
106132485|NCT00530777|366143219|FG000|Overall Study|Withdrawal by Subject|0|||
105694758|NCT02632721|364546291|FG000|Overall Study|No meet eligibility|0|||
105694759|NCT02632721|364546292|FG001|Overall Study|No meet eligibility|0|||
105921847|NCT03074500|365373653|FG000|Overall Study|Lost to Follow-up|1|||
105921848|NCT03074500|365373654|FG001|Overall Study|Lost to Follow-up|0|||
105921849|NCT03074500|365373655|FG002|Overall Study|Lost to Follow-up|0|||
105694760|NCT02632721|364546293|FG002|Overall Study|No meet eligibility|0|||
105694761|NCT02632721|364546294|FG003|Overall Study|No meet eligibility|0|||
105694762|NCT02632721|364546295|FG004|Overall Study|No meet eligibility|1|||
105694763|NCT02632721|364546291|FG000|Overall Study|Allergic reaction|0|||
105694764|NCT02632721|364546292|FG001|Overall Study|Allergic reaction|0|||
105694765|NCT02632721|364546293|FG002|Overall Study|Allergic reaction|0|||
105694766|NCT02632721|364546294|FG003|Overall Study|Allergic reaction|1|||
105694767|NCT02632721|364546295|FG004|Overall Study|Allergic reaction|0|||
105694768|NCT02632721|364546291|FG000|Overall Study|Receiving Decitabine locally|0|||
105694769|NCT02632721|364546292|FG001|Overall Study|Receiving Decitabine locally|0|||
105694770|NCT02632721|364546293|FG002|Overall Study|Receiving Decitabine locally|1|||
105694771|NCT02632721|364546294|FG003|Overall Study|Receiving Decitabine locally|0|||
105694772|NCT02632721|364546295|FG004|Overall Study|Receiving Decitabine locally|0|||
105694773|NCT02632721|364546291|FG000|Overall Study|No benefit from study treatment|1|||
105694774|NCT02632721|364546292|FG001|Overall Study|No benefit from study treatment|1|||
105694775|NCT02632721|364546293|FG002|Overall Study|No benefit from study treatment|0|||
105694776|NCT02632721|364546294|FG003|Overall Study|No benefit from study treatment|0|||
105694777|NCT02632721|364546295|FG004|Overall Study|No benefit from study treatment|1|||
105694778|NCT02632721|364546291|FG000|Overall Study|Patient wish for other treatment|0|||
105694779|NCT02632721|364546292|FG001|Overall Study|Patient wish for other treatment|1|||
105694780|NCT02632721|364546293|FG002|Overall Study|Patient wish for other treatment|0|||
105694781|NCT02632721|364546294|FG003|Overall Study|Patient wish for other treatment|0|||
105694782|NCT02632721|364546295|FG004|Overall Study|Patient wish for other treatment|0|||
105694783|NCT02632721|364546291|FG000|Overall Study|Relapsed Pneumonia|0|||
105694784|NCT02632721|364546292|FG001|Overall Study|Relapsed Pneumonia|0|||
105694785|NCT02632721|364546293|FG002|Overall Study|Relapsed Pneumonia|0|||
105694786|NCT02632721|364546294|FG003|Overall Study|Relapsed Pneumonia|0|||
105694787|NCT02632721|364546295|FG004|Overall Study|Relapsed Pneumonia|1|||
105694788|NCT02632721|364546291|FG000|Overall Study|Therapy refractory AML|0|||
106004823|NCT00506350|365680509|FG005|Overall Study|Other|0|||
106004824|NCT00506350|365680510|FG006|Overall Study|Other|0|||
106004825|NCT00506350|365680511|FG007|Overall Study|Other|2|||
106004826|NCT00506350|365680512|FG008|Overall Study|Other|2|||
106004827|NCT04972786|365680513|FG000|First Intervention (1 Day)|Adverse Event|1|||
106004828|NCT04972786|365680514|FG001|First Intervention (1 Day)|Adverse Event|0|||
106004829|NCT01419236|365682569|FG000|Overall Study|Adverse Event|1|||
106004830|NCT01419236|365682570|FG001|Overall Study|Adverse Event|0|||
105921850|NCT03074500|365373653|FG000|Overall Study|Lack of Efficacy|0|||
105921851|NCT03074500|365373654|FG001|Overall Study|Lack of Efficacy|1|||
105921852|NCT03074500|365373655|FG002|Overall Study|Lack of Efficacy|0|||
105921853|NCT03074500|365373653|FG000|Overall Study|Adverse Event|0|||
105921854|NCT03074500|365373654|FG001|Overall Study|Adverse Event|0|||
105921855|NCT03074500|365373655|FG002|Overall Study|Adverse Event|1|||
105921856|NCT02337764|365375209|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
105921857|NCT02337764|365375209|FG000|Overall Study|Voluntary Withdrawal|12|||
106004831|NCT01419236|365682569|FG000|Overall Study|Lack of Efficacy|0|||
106004832|NCT01419236|365682570|FG001|Overall Study|Lack of Efficacy|1|||
106004833|NCT01419236|365682569|FG000|Overall Study|Lost to Follow-up|1|||
106004834|NCT01419236|365682570|FG001|Overall Study|Lost to Follow-up|0|||
105694789|NCT02632721|364546292|FG001|Overall Study|Therapy refractory AML|0|||
105921858|NCT02337764|365375209|FG000|Overall Study|Lack of Efficacy|2|||
105921859|NCT01140906|365375215|FG000|Overall Study|Adverse Event|7|||
105921860|NCT01140906|365375216|FG001|Overall Study|Adverse Event|10|||
105921861|NCT01140906|365375217|FG002|Overall Study|Adverse Event|17|||
105921862|NCT01140906|365375218|FG003|Overall Study|Adverse Event|7|||
105921863|NCT01140906|365375215|FG000|Overall Study|Lack of Efficacy|6|||
105921864|NCT01140906|365375216|FG001|Overall Study|Lack of Efficacy|8|||
105921865|NCT01140906|365375217|FG002|Overall Study|Lack of Efficacy|2|||
105921866|NCT01140906|365375218|FG003|Overall Study|Lack of Efficacy|1|||
105921867|NCT01140906|365375215|FG000|Overall Study|Non-compliance|0|||
105921868|NCT01140906|365375216|FG001|Overall Study|Non-compliance|1|||
105921869|NCT01140906|365375217|FG002|Overall Study|Non-compliance|0|||
105921870|NCT01140906|365375218|FG003|Overall Study|Non-compliance|1|||
105921871|NCT01140906|365375215|FG000|Overall Study|Protocol Violation|5|||
105921872|NCT01140906|365375216|FG001|Overall Study|Protocol Violation|3|||
106004835|NCT01419236|365682569|FG000|Overall Study|Physician Decision|1|||
105694790|NCT02632721|364546293|FG002|Overall Study|Therapy refractory AML|0|||
105694791|NCT02632721|364546294|FG003|Overall Study|Therapy refractory AML|0|||
105694792|NCT02632721|364546295|FG004|Overall Study|Therapy refractory AML|1|||
105694793|NCT02632721|364546291|FG000|Overall Study|Increase of white blood cell count|0|||
105921873|NCT01140906|365375217|FG002|Overall Study|Protocol Violation|2|||
105921874|NCT01140906|365375218|FG003|Overall Study|Protocol Violation|1|||
106004836|NCT01419236|365682570|FG001|Overall Study|Physician Decision|0|||
106004837|NCT01419236|365682569|FG000|Overall Study|Withdrawal by Subject|1|||
105694794|NCT02632721|364546292|FG001|Overall Study|Increase of white blood cell count|0|||
105921875|NCT01140906|365375215|FG000|Overall Study|Withdrawal of consent|6|||
105921876|NCT01140906|365375216|FG001|Overall Study|Withdrawal of consent|6|||
105921877|NCT01140906|365375217|FG002|Overall Study|Withdrawal of consent|2|||
105921878|NCT01140906|365375218|FG003|Overall Study|Withdrawal of consent|2|||
106004838|NCT01419236|365682570|FG001|Overall Study|Withdrawal by Subject|4|||
106004839|NCT01419236|365682569|FG000|Overall Study|Entry Criteria Not Met|1|||
105694795|NCT02632721|364546293|FG002|Overall Study|Increase of white blood cell count|0|||
105694796|NCT02632721|364546294|FG003|Overall Study|Increase of white blood cell count|0|||
105921879|NCT01140906|365375215|FG000|Overall Study|Lost to Follow-up|1|||
105921880|NCT01140906|365375216|FG001|Overall Study|Lost to Follow-up|1|||
105921881|NCT01140906|365375217|FG002|Overall Study|Lost to Follow-up|0|||
105921882|NCT01140906|365375218|FG003|Overall Study|Lost to Follow-up|2|||
105921883|NCT01140906|365375215|FG000|Overall Study|Administrative or other reason|0|||
105921884|NCT01140906|365375216|FG001|Overall Study|Administrative or other reason|5|||
105921885|NCT01140906|365375217|FG002|Overall Study|Administrative or other reason|3|||
105921886|NCT01140906|365375218|FG003|Overall Study|Administrative or other reason|2|||
105921887|NCT00336544|365375219|FG000|Overall Study|Lack of Efficacy|8|||
105921888|NCT00336544|365375220|FG001|Overall Study|Lack of Efficacy|5|||
105921889|NCT00336544|365375219|FG000|Overall Study|Adverse Event|4|||
105921890|NCT00336544|365375220|FG001|Overall Study|Adverse Event|9|||
105921891|NCT00336544|365375219|FG000|Overall Study|Withdrawal by Subject|4|||
105921892|NCT00336544|365375220|FG001|Overall Study|Withdrawal by Subject|3|||
105921893|NCT00336544|365375219|FG000|Overall Study|Other|3|||
105921894|NCT00336544|365375220|FG001|Overall Study|Other|5|||
105921895|NCT00715208|365375221|FG000|Overall Study|Withdrawal by Subject|1|||
105921896|NCT00715208|365375222|FG001|Overall Study|Withdrawal by Subject|1|||
105921897|NCT00715208|365375221|FG000|Overall Study|Adverse Event|0|||
105921898|NCT00715208|365375222|FG001|Overall Study|Adverse Event|6|||
105921899|NCT00715208|365375221|FG000|Overall Study|Lack of Efficacy|0|||
105921900|NCT00715208|365375222|FG001|Overall Study|Lack of Efficacy|2|||
105921901|NCT01294046|365375225|FG000|Overall Study|Infection and surgical explant|1|||
105694797|NCT02632721|364546295|FG004|Overall Study|Increase of white blood cell count|1|||
105694798|NCT02632721|364546291|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
105694799|NCT02632721|364546292|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
105694800|NCT02632721|364546293|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
105694801|NCT02632721|364546294|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
105921902|NCT01294046|365375225|FG000|Overall Study|Eligibility criteria expanded|1|||
105921903|NCT01294046|365375225|FG000|Overall Study|Stimulation response inadqequate|1|||
105921904|NCT00607893|365375226|FG000|Overall Study|Lost to Follow-up|4|||
105921905|NCT00607893|365375227|FG001|Overall Study|Lost to Follow-up|0|||
105921906|NCT00607893|365375226|FG000|Overall Study|withdrew due to loss of interest|0|||
105921907|NCT00607893|365375227|FG001|Overall Study|withdrew due to loss of interest|1|||
105921908|NCT00607893|365375226|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
105921909|NCT00607893|365375227|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
105921910|NCT00607893|365375226|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
105921911|NCT00607893|365375227|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
105921912|NCT00607893|365375226|FG000|Overall Study|Declined to be treated|1|||
105921913|NCT00607893|365375227|FG001|Overall Study|Declined to be treated|0|||
105921914|NCT00607893|365375226|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
105921915|NCT00607893|365375227|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
105921916|NCT02566005|365375228|FG000|Overall Study|vaginal bleeding|0|||
105921917|NCT02566005|365375229|FG001|Overall Study|vaginal bleeding|1|||
105921918|NCT02566005|365375228|FG000|Overall Study|received foley|8|||
105921919|NCT02566005|365375229|FG001|Overall Study|received foley|0|||
105921920|NCT02566005|365375228|FG000|Overall Study|did not receive foley|0|||
105921921|NCT02566005|365375229|FG001|Overall Study|did not receive foley|1|||
105921922|NCT02566005|365375228|FG000|Overall Study|labor after randomization|0|||
105921923|NCT02566005|365375229|FG001|Overall Study|labor after randomization|4|||
105921924|NCT02058095|365375230|FG000|Overall Study|Adverse Event|1|||
105921925|NCT02058095|365375231|FG001|Overall Study|Adverse Event|0|||
105921926|NCT03157089|365375232|FG000|Overall Study|Treated only with pembrolizumab|1|||
105921927|NCT03157089|365375233|FG001|Overall Study|Treated only with pembrolizumab|0|||
105921928|NCT03157089|365375232|FG000|Overall Study|Adverse Event|5|||
105921929|NCT03157089|365375233|FG001|Overall Study|Adverse Event|4|||
105921930|NCT03157089|365375232|FG000|Overall Study|Progressive disease|6|||
105921931|NCT03157089|365375233|FG001|Overall Study|Progressive disease|8|||
105921932|NCT02932943|365375234|FG000|Overall Study|Lost to Follow-up|0|||
105921933|NCT02932943|365375235|FG001|Overall Study|Lost to Follow-up|2|||
105921934|NCT02932943|365375234|FG000|Overall Study|Adverse Event|2|||
105921935|NCT02932943|365375235|FG001|Overall Study|Adverse Event|2|||
105921936|NCT02932943|365375234|FG000|Overall Study|Withdrawal by Subject|3|||
105921937|NCT02932943|365375235|FG001|Overall Study|Withdrawal by Subject|3|||
105921938|NCT01454284|365375236|FG000|Overall Study|Adverse Event|20|||
105921939|NCT01454284|365375237|FG001|Overall Study|Adverse Event|7|||
105921940|NCT01454284|365375236|FG000|Overall Study|Death|0|||
105921941|NCT01454284|365375237|FG001|Overall Study|Death|3|||
105921942|NCT01454284|365375236|FG000|Overall Study|Lost to Follow-up|13|||
105921943|NCT01454284|365375237|FG001|Overall Study|Lost to Follow-up|8|||
105921944|NCT01454284|365375236|FG000|Overall Study|Protocol Violation|9|||
105921945|NCT01454284|365375237|FG001|Overall Study|Protocol Violation|6|||
105921946|NCT01454284|365375236|FG000|Overall Study|Withdrawal by Subject|58|||
105921947|NCT01454284|365375237|FG001|Overall Study|Withdrawal by Subject|36|||
105921948|NCT01454284|365375236|FG000|Overall Study|Physician Decision|16|||
105921949|NCT01454284|365375237|FG001|Overall Study|Physician Decision|11|||
105921950|NCT01454284|365375236|FG000|Overall Study|Sponsor Decision|0|||
105921951|NCT01454284|365375237|FG001|Overall Study|Sponsor Decision|2|||
105921952|NCT02665117|365375242|FG000|Overall Study|Physician Decision|1|||
105921953|NCT02665117|365375243|FG001|Overall Study|Physician Decision|0|||
105921954|NCT00977197|365375244|FG000|Overall Study|Withdrawal by Subject|3|||
105921955|NCT00977197|365375245|FG001|Overall Study|Withdrawal by Subject|4|||
105921956|NCT00977197|365375244|FG000|Overall Study|Adverse Event|3|||
105921957|NCT00977197|365375245|FG001|Overall Study|Adverse Event|1|||
105921958|NCT00977197|365375244|FG000|Overall Study|Lack of Efficacy|1|||
105921959|NCT00977197|365375245|FG001|Overall Study|Lack of Efficacy|0|||
105921960|NCT00977197|365375244|FG000|Overall Study|Lost to Follow-up|1|||
105921961|NCT00977197|365375245|FG001|Overall Study|Lost to Follow-up|3|||
105921962|NCT00977197|365375244|FG000|Overall Study|Nonadherence|1|||
105921963|NCT00977197|365375245|FG001|Overall Study|Nonadherence|1|||
105921964|NCT00784875|365375248|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
105921965|NCT00784875|365375249|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
105921966|NCT00784875|365375250|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
105921967|NCT00784875|365375251|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
105921968|NCT00784875|365375248|FG000|Period A - Baseline|Adverse Event|0|||
105921969|NCT00784875|365375249|FG001|Period A - Baseline|Adverse Event|0|||
105921970|NCT00784875|365375250|FG002|Period A - Baseline|Adverse Event|0|||
105694802|NCT02632721|364546295|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
105694803|NCT02663271|364546296|FG000|Overall Study|Withdrawal by Subject|5|||
105694804|NCT02663271|364546296|FG000|Overall Study|Lack of Efficacy|1|||
105694805|NCT01572675|364546297|FG000|Overall Study|End of prescribed treatment|140|||
105694806|NCT01572675|364546298|FG001|Overall Study|End of prescribed treatment|118|||
105694807|NCT01572675|364546297|FG000|Overall Study|Recovery|16|||
105694808|NCT01572675|364546298|FG001|Overall Study|Recovery|23|||
105694809|NCT01572675|364546297|FG000|Overall Study|Lack of Efficacy|31|||
105694810|NCT01572675|364546298|FG001|Overall Study|Lack of Efficacy|31|||
105694811|NCT01572675|364546297|FG000|Overall Study|Intolerance|6|||
105694812|NCT01572675|364546298|FG001|Overall Study|Intolerance|5|||
105694813|NCT01572675|364546297|FG000|Overall Study|Improved symptoms|8|||
105694814|NCT01572675|364546298|FG001|Overall Study|Improved symptoms|2|||
105694815|NCT01572675|364546297|FG000|Overall Study|Surgical intervention|3|||
105694816|NCT01572675|364546298|FG001|Overall Study|Surgical intervention|6|||
105694817|NCT01572675|364546297|FG000|Overall Study|Withdrawal by Subject|5|||
105694818|NCT01572675|364546298|FG001|Overall Study|Withdrawal by Subject|1|||
105694819|NCT01572675|364546297|FG000|Overall Study|Physician Decision|2|||
105694820|NCT01572675|364546298|FG001|Overall Study|Physician Decision|2|||
105694821|NCT01572675|364546297|FG000|Overall Study|Death unrelated to coxibs|1|||
105694822|NCT01572675|364546298|FG001|Overall Study|Death unrelated to coxibs|1|||
105694823|NCT01572675|364546297|FG000|Overall Study|Other disease detected|1|||
105694824|NCT01572675|364546298|FG001|Overall Study|Other disease detected|1|||
105694825|NCT01572675|364546297|FG000|Overall Study|Unknown reason|1|||
105694826|NCT01572675|364546298|FG001|Overall Study|Unknown reason|1|||
105694827|NCT01572675|364546297|FG000|Overall Study|Rheumatologist new evaluation|0|||
105694828|NCT01572675|364546298|FG001|Overall Study|Rheumatologist new evaluation|1|||
105694829|NCT01572675|364546297|FG000|Overall Study|Missing data|1|||
105694830|NCT01572675|364546298|FG001|Overall Study|Missing data|4|||
105694831|NCT01572675|364546297|FG000|Overall Study|Lost to Follow-up|22|||
105694832|NCT01572675|364546298|FG001|Overall Study|Lost to Follow-up|27|||
105694833|NCT03986866|364546307|FG000|Overall Study|Withdrawal by Subject|0|||
105694834|NCT03986866|364546308|FG001|Overall Study|Withdrawal by Subject|3|||
105694835|NCT03986866|364546307|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
105694836|NCT03986866|364546308|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
105694837|NCT04166383|364546309|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
105694838|NCT04166383|364546309|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
105694839|NCT04166383|364546309|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
105694840|NCT03346057|364546310|FG000|Overall Study|Death|1|||
105694841|NCT03346057|364546311|FG001|Overall Study|Death|2|||
105694842|NCT03346057|364546312|FG002|Overall Study|Death|0|||
105694843|NCT03346057|364546313|FG003|Overall Study|Death|0|||
105694844|NCT03346057|364546310|FG000|Overall Study|Lost to Follow-up|0|||
105694845|NCT03346057|364546311|FG001|Overall Study|Lost to Follow-up|2|||
105921971|NCT00784875|365375251|FG003|Period A - Baseline|Adverse Event|8|||
105921972|NCT00784875|365375248|FG000|Period A - Baseline|Protocol Violation|0|||
105694846|NCT03346057|364546312|FG002|Overall Study|Lost to Follow-up|1|||
105694847|NCT03346057|364546313|FG003|Overall Study|Lost to Follow-up|0|||
105694848|NCT03346057|364546310|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
105694849|NCT03346057|364546311|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
105921973|NCT00784875|365375249|FG001|Period A - Baseline|Protocol Violation|0|||
105921974|NCT00784875|365375250|FG002|Period A - Baseline|Protocol Violation|0|||
105921975|NCT00784875|365375251|FG003|Period A - Baseline|Protocol Violation|25|||
105921976|NCT00784875|365375248|FG000|Period A - Baseline|Withdrawal by Subject|0|||
105921977|NCT00784875|365375249|FG001|Period A - Baseline|Withdrawal by Subject|0|||
105921978|NCT00784875|365375250|FG002|Period A - Baseline|Withdrawal by Subject|0|||
105921979|NCT00784875|365375251|FG003|Period A - Baseline|Withdrawal by Subject|27|||
105921980|NCT00784875|365375248|FG000|Period A - Baseline|Physician Decision|0|||
105921981|NCT00784875|365375249|FG001|Period A - Baseline|Physician Decision|0|||
105921982|NCT00784875|365375250|FG002|Period A - Baseline|Physician Decision|0|||
105921983|NCT00784875|365375251|FG003|Period A - Baseline|Physician Decision|2|||
105921984|NCT00784875|365375248|FG000|Period A - Baseline|Sponsor Decision|0|||
105921985|NCT00784875|365375249|FG001|Period A - Baseline|Sponsor Decision|0|||
105921986|NCT00784875|365375250|FG002|Period A - Baseline|Sponsor Decision|0|||
105921987|NCT00784875|365375251|FG003|Period A - Baseline|Sponsor Decision|113|||
105921988|NCT00784875|365375248|FG000|Period A - Baseline|Lost to Follow-up|0|||
105921989|NCT00784875|365375249|FG001|Period A - Baseline|Lost to Follow-up|0|||
105921990|NCT00784875|365375250|FG002|Period A - Baseline|Lost to Follow-up|0|||
105921991|NCT00784875|365375251|FG003|Period A - Baseline|Lost to Follow-up|2|||
105921992|NCT00784875|365375248|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
105921993|NCT00784875|365375249|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
105921994|NCT00784875|365375250|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
105921995|NCT00784875|365375251|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
105921996|NCT00784875|365375248|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
105921997|NCT00784875|365375249|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
105921998|NCT00784875|365375250|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
105921999|NCT00784875|365375251|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
105922000|NCT00784875|365375248|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
105922001|NCT00784875|365375249|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
105922002|NCT00784875|365375250|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
105922003|NCT00784875|365375251|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
105922004|NCT00784875|365375248|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
105922005|NCT00784875|365375249|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
105922006|NCT00784875|365375250|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
105922007|NCT00784875|365375251|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
105922008|NCT00784875|365375248|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
105922009|NCT00784875|365375249|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
105694850|NCT03346057|364546312|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
105694851|NCT03346057|364546313|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
105694852|NCT03346057|364546310|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
105694853|NCT03346057|364546311|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
105694854|NCT03346057|364546312|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
105694855|NCT03346057|364546313|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
105694856|NCT03346057|364546310|FG000|Overall Study|Physician Decision|3|||
105694857|NCT03346057|364546311|FG001|Overall Study|Physician Decision|2|||
105922010|NCT00784875|365375250|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
105922011|NCT00784875|365375251|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
105922012|NCT00784875|365375248|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
105922013|NCT00784875|365375249|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
105922014|NCT00784875|365375250|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
105922015|NCT00784875|365375251|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
105922016|NCT00784875|365375248|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
105922017|NCT00784875|365375249|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
105922018|NCT00784875|365375250|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
105922019|NCT00784875|365375251|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
105922020|NCT00784875|365375248|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
105922021|NCT00784875|365375249|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
105922022|NCT00784875|365375250|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
105922023|NCT00784875|365375251|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
105922024|NCT00784875|365375248|FG000|Period C|Adverse Event|1|||
105922025|NCT00784875|365375249|FG001|Period C|Adverse Event|0|||
105922026|NCT00784875|365375250|FG002|Period C|Adverse Event|4|||
105922027|NCT00784875|365375251|FG003|Period C|Adverse Event|2|||
105922028|NCT00784875|365375248|FG000|Period C|Protocol Violation|0|||
105922029|NCT00784875|365375249|FG001|Period C|Protocol Violation|0|||
105922030|NCT00784875|365375250|FG002|Period C|Protocol Violation|1|||
105922031|NCT00784875|365375251|FG003|Period C|Protocol Violation|2|||
105922032|NCT00784875|365375248|FG000|Period C|Lack of Efficacy|0|||
105922033|NCT00784875|365375249|FG001|Period C|Lack of Efficacy|0|||
105922034|NCT00784875|365375250|FG002|Period C|Lack of Efficacy|1|||
105922035|NCT00784875|365375251|FG003|Period C|Lack of Efficacy|0|||
105922036|NCT00784875|365375248|FG000|Period C|Withdrawal by Subject|1|||
105922037|NCT00784875|365375249|FG001|Period C|Withdrawal by Subject|1|||
105922038|NCT00784875|365375250|FG002|Period C|Withdrawal by Subject|2|||
105694858|NCT03346057|364546312|FG002|Overall Study|Physician Decision|0|||
105694859|NCT03346057|364546313|FG003|Overall Study|Physician Decision|2|||
105694860|NCT03346057|364546310|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
105694861|NCT03346057|364546311|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
105694862|NCT03346057|364546312|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
105694863|NCT03346057|364546313|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
105694864|NCT03346057|364546310|FG000|Overall Study|Withdrawal by Subject|1|||
105694865|NCT03346057|364546311|FG001|Overall Study|Withdrawal by Subject|0|||
105694866|NCT03346057|364546312|FG002|Overall Study|Withdrawal by Subject|0|||
105694867|NCT03346057|364546313|FG003|Overall Study|Withdrawal by Subject|0|||
105694868|NCT03044886|364546314|FG000|Overall Study|Lost to Follow-up|15|||
105694869|NCT03044886|364546315|FG001|Overall Study|Lost to Follow-up|10|||
105694870|NCT03044886|364546316|FG002|Overall Study|Lost to Follow-up|12|||
105694871|NCT02921269|364546317|FG000|Overall Study|Did not complete DLT period|1|||
105694872|NCT02054325|364546320|FG000|Overall Study|Lost to Follow-up|8|||
105694873|NCT02054325|364546321|FG001|Overall Study|Lost to Follow-up|5|||
105694874|NCT00521053|364546324|FG000|Observation Phase|Disease Progression|55|||
105694875|NCT00521053|364546324|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
105694876|NCT00521053|364546324|FG000|Observation Phase|Death|2|||
105694877|NCT00521053|364546324|FG000|Observation Phase|Adverse Event|1|||
105694878|NCT00521053|364546324|FG000|Observation Phase|Other non-study melanoma treatment|1|||
105694879|NCT00521053|364546324|FG000|Observation Phase|Physician Decision|1|||
105694880|NCT01034540|364546325|FG000|Overall Study|Adverse Event|0|||
105694881|NCT01034540|364546326|FG001|Overall Study|Adverse Event|1|||
105694882|NCT05293743|364546330|FG000|Overall Study|Withdrawal by Subject|1|||
105694883|NCT05293743|364546331|FG001|Overall Study|Withdrawal by Subject|0|||
105694884|NCT00667823|364546337|FG000|Overall Study|Lost to Follow-up|5|||
105694885|NCT00667823|364546337|FG000|Overall Study|Adverse Event|7|||
105694886|NCT00667823|364546337|FG000|Overall Study|Death|182|||
105694887|NCT00667823|364546337|FG000|Overall Study|Withdrawal by Subject|12|||
105694888|NCT00667823|364546337|FG000|Overall Study|Other|8|||
105694889|NCT00667823|364546337|FG000|Overall Study|Missing (completion page missing)|2|||
105922039|NCT00784875|365375251|FG003|Period C|Withdrawal by Subject|0|||
105922040|NCT00784875|365375248|FG000|Period C|Physician Decision|0|||
105922041|NCT00784875|365375249|FG001|Period C|Physician Decision|0|||
105922042|NCT00784875|365375250|FG002|Period C|Physician Decision|1|||
105922043|NCT00784875|365375251|FG003|Period C|Physician Decision|1|||
105922044|NCT00784875|365375248|FG000|Period C|Sponsor Decision|5|||
105922045|NCT00784875|365375249|FG001|Period C|Sponsor Decision|5|||
105922046|NCT00784875|365375250|FG002|Period C|Sponsor Decision|4|||
105922047|NCT00784875|365375251|FG003|Period C|Sponsor Decision|2|||
105922048|NCT00784875|365375248|FG000|Period D|Adverse Event|0|||
105922049|NCT00784875|365375249|FG001|Period D|Adverse Event|2|||
105922050|NCT00784875|365375250|FG002|Period D|Adverse Event|2|||
105922051|NCT00784875|365375251|FG003|Period D|Adverse Event|0|||
105922052|NCT00784875|365375248|FG000|Period D|Protocol Violation|1|||
105922053|NCT00784875|365375249|FG001|Period D|Protocol Violation|0|||
105922054|NCT00784875|365375250|FG002|Period D|Protocol Violation|0|||
105922055|NCT00784875|365375251|FG003|Period D|Protocol Violation|0|||
105922056|NCT00784875|365375248|FG000|Period D|Withdrawal by Subject|2|||
105922057|NCT00784875|365375249|FG001|Period D|Withdrawal by Subject|0|||
105922058|NCT00784875|365375250|FG002|Period D|Withdrawal by Subject|2|||
105922059|NCT00784875|365375251|FG003|Period D|Withdrawal by Subject|0|||
105922060|NCT00784875|365375248|FG000|Period D|Physician Decision|0|||
105922061|NCT00784875|365375249|FG001|Period D|Physician Decision|1|||
105922062|NCT00784875|365375250|FG002|Period D|Physician Decision|0|||
105922063|NCT00784875|365375251|FG003|Period D|Physician Decision|0|||
105922064|NCT00784875|365375248|FG000|Period D|Sponsor Decision|1|||
105922065|NCT00784875|365375249|FG001|Period D|Sponsor Decision|1|||
105922066|NCT00784875|365375250|FG002|Period D|Sponsor Decision|1|||
105922067|NCT00784875|365375251|FG003|Period D|Sponsor Decision|0|||
105922068|NCT00784875|365375248|FG000|Period D|Lost to Follow-up|1|||
105922069|NCT00784875|365375249|FG001|Period D|Lost to Follow-up|0|||
105922070|NCT00784875|365375250|FG002|Period D|Lost to Follow-up|1|||
105922071|NCT00784875|365375251|FG003|Period D|Lost to Follow-up|1|||
105922072|NCT01432951|365375252|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
105922073|NCT02842866|365375255|FG000|Overall Study|Serious Adverse Event|0|||
105922074|NCT02842866|365375256|FG001|Overall Study|Serious Adverse Event|1|||
105922075|NCT02842866|365375255|FG000|Overall Study|Protocol Violation|4|||
105922076|NCT02842866|365375256|FG001|Overall Study|Protocol Violation|2|||
105922077|NCT02842866|365375255|FG000|Overall Study|Lost to Follow-up|2|||
105694890|NCT03734016|364546338|FG000|Overall Study|Sponsor Ended Study|225|||
105694891|NCT03734016|364546339|FG001|Overall Study|Sponsor Ended Study|200|||
105922078|NCT02842866|365375256|FG001|Overall Study|Lost to Follow-up|0|||
105694892|NCT03734016|364546338|FG000|Overall Study|Death|69|||
105694893|NCT03734016|364546339|FG001|Overall Study|Death|83|||
105694894|NCT03734016|364546338|FG000|Overall Study|Withdrawal by Subject|21|||
105922079|NCT02842866|365375255|FG000|Overall Study|Withdrawal by Subject|1|||
105922080|NCT02842866|365375256|FG001|Overall Study|Withdrawal by Subject|0|||
105694895|NCT03734016|364546339|FG001|Overall Study|Withdrawal by Subject|27|||
105922081|NCT00941928|365375257|FG000|Overall Study|Withdrawal by Subject|1|||
105922082|NCT00941928|365375257|FG000|Overall Study|Disease Progression|1|||
105694896|NCT03734016|364546338|FG000|Overall Study|Physician Decision|1|||
105694897|NCT03734016|364546339|FG001|Overall Study|Physician Decision|12|||
105694898|NCT03734016|364546338|FG000|Overall Study|Lost to Follow-up|6|||
105694899|NCT03734016|364546339|FG001|Overall Study|Lost to Follow-up|2|||
105694900|NCT03734016|364546338|FG000|Overall Study|Miscellaneous|5|||
105694901|NCT03734016|364546339|FG001|Overall Study|Miscellaneous|1|||
105694902|NCT01624259|364546342|FG000|Overall Study|Adverse Event|18|||
105694903|NCT01624259|364546343|FG001|Overall Study|Adverse Event|18|||
105694904|NCT01624259|364546342|FG000|Overall Study|Protocol Violation|1|||
105694905|NCT01624259|364546343|FG001|Overall Study|Protocol Violation|2|||
105694906|NCT01624259|364546342|FG000|Overall Study|Withdrawal by Subject|5|||
105694907|NCT01624259|364546343|FG001|Overall Study|Withdrawal by Subject|7|||
105694908|NCT01624259|364546342|FG000|Overall Study|Physician Decision|1|||
105694909|NCT01624259|364546343|FG001|Overall Study|Physician Decision|1|||
105694910|NCT01624259|364546342|FG000|Overall Study|Lost to Follow-up|2|||
105694911|NCT01624259|364546343|FG001|Overall Study|Lost to Follow-up|3|||
105694912|NCT01624259|364546342|FG000|Overall Study|Abnormal laboratory measure|3|||
105694913|NCT01624259|364546343|FG001|Overall Study|Abnormal laboratory measure|0|||
105694914|NCT01979835|364546346|FG000|Primary Outcome SA Measurment|failed insertion|18|||
105694915|NCT01979835|364546346|FG000|Follow-up|Lost to Follow-up|32|||
105694916|NCT01428661|364546352|FG000|Double-Masked Phase|Protocol Violation|9|||
105694917|NCT01428661|364546353|FG001|Double-Masked Phase|Protocol Violation|4|||
105694918|NCT01428661|364546354|FG002|Double-Masked Phase|Protocol Violation|0|||
105694919|NCT01428661|364546352|FG000|Double-Masked Phase|Adverse Event|13|||
105694920|NCT01428661|364546353|FG001|Double-Masked Phase|Adverse Event|4|||
105694921|NCT01428661|364546354|FG002|Double-Masked Phase|Adverse Event|0|||
105694922|NCT01428661|364546352|FG000|Double-Masked Phase|Lost to Follow-up|14|||
105694923|NCT01428661|364546353|FG001|Double-Masked Phase|Lost to Follow-up|14|||
105694924|NCT01428661|364546354|FG002|Double-Masked Phase|Lost to Follow-up|0|||
105694925|NCT01428661|364546352|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
105694926|NCT01428661|364546353|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
105694927|NCT01428661|364546354|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
105694928|NCT01428661|364546352|FG000|Double-Masked Phase|Lack of Efficacy|2|||
105694929|NCT01428661|364546353|FG001|Double-Masked Phase|Lack of Efficacy|1|||
105694930|NCT01428661|364546354|FG002|Double-Masked Phase|Lack of Efficacy|0|||
105694931|NCT01428661|364546352|FG000|Double-Masked Phase|*Various|1|||
105694932|NCT01428661|364546353|FG001|Double-Masked Phase|*Various|6|||
105694933|NCT01428661|364546354|FG002|Double-Masked Phase|*Various|0|||
105694934|NCT01428661|364546352|FG000|Open Label Extension|Protocol Violation|0|||
105694935|NCT01428661|364546353|FG001|Open Label Extension|Protocol Violation|0|||
105694936|NCT01428661|364546354|FG002|Open Label Extension|Protocol Violation|9|||
105694937|NCT01428661|364546352|FG000|Open Label Extension|Adverse Event|0|||
105694938|NCT01428661|364546353|FG001|Open Label Extension|Adverse Event|0|||
105694939|NCT01428661|364546354|FG002|Open Label Extension|Adverse Event|15|||
105694940|NCT01428661|364546352|FG000|Open Label Extension|Lost to Follow-up|0|||
105694941|NCT01428661|364546353|FG001|Open Label Extension|Lost to Follow-up|0|||
105694942|NCT01428661|364546354|FG002|Open Label Extension|Lost to Follow-up|38|||
105694943|NCT01428661|364546352|FG000|Open Label Extension|Withdrawal by Subject|0|||
105694944|NCT01428661|364546353|FG001|Open Label Extension|Withdrawal by Subject|0|||
105694945|NCT01428661|364546354|FG002|Open Label Extension|Withdrawal by Subject|49|||
105694946|NCT01428661|364546352|FG000|Open Label Extension|Lack of Efficacy|0|||
105694947|NCT01428661|364546353|FG001|Open Label Extension|Lack of Efficacy|0|||
105694948|NCT01428661|364546354|FG002|Open Label Extension|Lack of Efficacy|24|||
105694949|NCT01428661|364546352|FG000|Open Label Extension|**Various|0|||
105694950|NCT01428661|364546353|FG001|Open Label Extension|**Various|0|||
105922083|NCT02300610|365375262|FG000|Overall Study|Withdrawal by Subject|1|||
105922084|NCT02300610|365375263|FG001|Overall Study|Withdrawal by Subject|0|||
105922085|NCT02300610|365375264|FG002|Overall Study|Withdrawal by Subject|1|||
105922086|NCT00141921|365375265|FG000|Overall Study|Remain on Study|28|||
105922087|NCT00141921|365375265|FG000|Overall Study|Withdrawal by Subject|42|||
105922088|NCT00141921|365375265|FG000|Overall Study|Lost to Follow-up|19|||
105922089|NCT00141921|365375265|FG000|Overall Study|Noncompliance|17|||
105694951|NCT01428661|364546354|FG002|Open Label Extension|**Various|185|||
105694952|NCT01129921|364546357|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
105694953|NCT01129921|364546358|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
105694954|NCT01129921|364546357|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
105694955|NCT01129921|364546358|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
105694956|NCT01129921|364546357|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
105694957|NCT01129921|364546358|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
105694958|NCT01129921|364546357|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
105694959|NCT01129921|364546358|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
105694960|NCT01357577|364546359|FG000|Overall Study|Lost to Follow-up|20|||
105922090|NCT00141921|365375265|FG000|Overall Study|Disease Progression|7|||
105922091|NCT00141921|365375265|FG000|Overall Study|Protocol Deviation|7|||
105922092|NCT00141921|365375265|FG000|Overall Study|Adverse Event|5|||
106004840|NCT01419236|365682570|FG001|Overall Study|Entry Criteria Not Met|0|||
106004841|NCT01405768|365682571|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
106004842|NCT01405768|365682572|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
106004843|NCT01393158|365682573|FG000|Overall Study|Adverse Event|1|||
105922093|NCT00141921|365375265|FG000|Overall Study|Administrative Decision|2|||
105922094|NCT00141921|365375265|FG000|Overall Study|Pregnancy|4|||
105922095|NCT00141921|365375265|FG000|Overall Study|Ineligibility Determined|2|||
105922096|NCT00141921|365375265|FG000|Overall Study|Other|8|||
105922097|NCT03743194|365375267|FG000|Overall Study|Protocol Violation|7|||
105922098|NCT03743194|365375268|FG001|Overall Study|Protocol Violation|7|||
105922099|NCT03743194|365375267|FG000|Overall Study|Physician Decision|0|||
105922100|NCT03743194|365375268|FG001|Overall Study|Physician Decision|2|||
105922101|NCT01829347|365375269|FG000|VTI-210|Death|5|||
105922102|NCT01829347|365375270|FG001|VTI-210|Death|3|||
105922103|NCT01829347|365375269|FG000|VTI-210|Withdrawal by Subject|1|||
105922104|NCT01829347|365375270|FG001|VTI-210|Withdrawal by Subject|0|||
105922105|NCT01829347|365375269|FG000|VTI-210E|Death|2|||
105922106|NCT01829347|365375270|FG001|VTI-210E|Death|1|||
105922107|NCT01829347|365375269|FG000|VTI-210E|Study terminated prematurely|1|||
105922108|NCT01829347|365375270|FG001|VTI-210E|Study terminated prematurely|5|||
105922109|NCT02765035|365375283|FG000|First Intervention (90 Days)|Adverse Event|1|||
105922110|NCT02765035|365375284|FG001|First Intervention (90 Days)|Adverse Event|1|||
105922111|NCT02765035|365375283|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
105922112|NCT02765035|365375284|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
105922113|NCT04465422|365375295|FG000|Overall Study|Lost to Follow-up|0|||
105922114|NCT04465422|365375296|FG001|Overall Study|Lost to Follow-up|2|||
105922115|NCT00997893|365375297|FG000|Overall Study|Adverse Event|1|||
105922116|NCT00997893|365375298|FG001|Overall Study|Adverse Event|0|||
105922117|NCT00997893|365375299|FG002|Overall Study|Adverse Event|0|||
105922118|NCT00997893|365375297|FG000|Overall Study|Unable to meet study timelines|1|||
105922119|NCT00997893|365375298|FG001|Overall Study|Unable to meet study timelines|0|||
105922120|NCT00997893|365375299|FG002|Overall Study|Unable to meet study timelines|0|||
106004844|NCT01393158|365682574|FG001|Overall Study|Adverse Event|0|||
106004845|NCT01690052|365682577|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
106004846|NCT01690052|365682578|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
106004847|NCT01453049|365682579|FG000|Overall Study|Protocol Violation|2|||
106004848|NCT01453049|365682580|FG001|Overall Study|Protocol Violation|5|||
106004849|NCT01453049|365682579|FG000|Overall Study|Lost to Follow-up|2|||
106004850|NCT01453049|365682580|FG001|Overall Study|Lost to Follow-up|1|||
106004851|NCT01453049|365682579|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
106004852|NCT01453049|365682580|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
106004853|NCT01453049|365682579|FG000|Overall Study|Withdrawal by Subject|1|||
106004854|NCT01453049|365682580|FG001|Overall Study|Withdrawal by Subject|0|||
106004855|NCT01453049|365682579|FG000|Overall Study|Randomized in Error|1|||
106004856|NCT01453049|365682580|FG001|Overall Study|Randomized in Error|0|||
106004857|NCT03287791|365682586|FG000|Overall Study|Insufficient Therapeutic Response|0|||
106004858|NCT03287791|365682587|FG001|Overall Study|Insufficient Therapeutic Response|0|||
106004859|NCT03287791|365682588|FG002|Overall Study|Insufficient Therapeutic Response|1|||
106004860|NCT03287791|365682586|FG000|Overall Study|Adverse Event|0|||
106004861|NCT03287791|365682587|FG001|Overall Study|Adverse Event|4|||
106004862|NCT03287791|365682588|FG002|Overall Study|Adverse Event|3|||
106004863|NCT03287791|365682586|FG000|Overall Study|Withdrawal by Subject|12|||
106004864|NCT03287791|365682587|FG001|Overall Study|Withdrawal by Subject|12|||
106004865|NCT03287791|365682588|FG002|Overall Study|Withdrawal by Subject|17|||
105694961|NCT01357577|364546360|FG001|Overall Study|Lost to Follow-up|16|||
105922121|NCT00997893|365375297|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
105922122|NCT00997893|365375298|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
105922123|NCT00997893|365375299|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
105922124|NCT02147626|365375300|FG000|Overall Study|Lost to Follow-up|4|||
105922125|NCT02147626|365375301|FG001|Overall Study|Lost to Follow-up|4|||
105922126|NCT02147626|365375300|FG000|Overall Study|Pregnancy|1|||
105922127|NCT02147626|365375301|FG001|Overall Study|Pregnancy|2|||
106004866|NCT03287791|365682586|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
106132486|NCT00530777|366143220|FG001|Overall Study|Withdrawal by Subject|1|||
106132487|NCT00530777|366143219|FG000|Overall Study|Unable to adhere to visit schedule|5|||
106004867|NCT03287791|365682587|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
106004868|NCT03287791|365682588|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
106132488|NCT00530777|366143220|FG001|Overall Study|Unable to adhere to visit schedule|1|||
105922128|NCT02147626|365375300|FG000|Overall Study|Withdrawal by Subject|0|||
105922129|NCT02147626|365375301|FG001|Overall Study|Withdrawal by Subject|1|||
105922130|NCT00321763|365375302|FG000|Overall Study|Adverse Event|1|||
106004869|NCT03287791|365682586|FG000|Overall Study|Lost to Follow-up|8|||
106004870|NCT03287791|365682587|FG001|Overall Study|Lost to Follow-up|14|||
106004871|NCT03287791|365682588|FG002|Overall Study|Lost to Follow-up|11|||
106004872|NCT03287791|365682586|FG000|Overall Study|Protocol Violation|7|||
105922131|NCT00321763|365375303|FG001|Overall Study|Adverse Event|1|||
105922132|NCT00321763|365375304|FG002|Overall Study|Adverse Event|0|||
105694962|NCT01357577|364546359|FG000|Overall Study|Withdrawal by Subject|16|||
105694963|NCT01357577|364546360|FG001|Overall Study|Withdrawal by Subject|8|||
105694964|NCT01357577|364546359|FG000|Overall Study|look at data in database?|1|||
105694965|NCT01357577|364546360|FG001|Overall Study|look at data in database?|2|||
105694966|NCT04313153|364548159|FG000|Overall Study|Adverse Event (includes Death)|14|||
105694967|NCT04313153|364548160|FG001|Overall Study|Adverse Event (includes Death)|19|||
105694968|NCT04313153|364548161|FG002|Overall Study|Adverse Event (includes Death)|10|||
105694969|NCT04313153|364548159|FG000|Overall Study|Physician Decision|4|||
105694970|NCT04313153|364548160|FG001|Overall Study|Physician Decision|2|||
105694971|NCT04313153|364548161|FG002|Overall Study|Physician Decision|1|||
105694972|NCT04313153|364548159|FG000|Overall Study|Withdrawal by Subject|7|||
105694973|NCT04313153|364548160|FG001|Overall Study|Withdrawal by Subject|6|||
105694974|NCT04313153|364548161|FG002|Overall Study|Withdrawal by Subject|2|||
105694975|NCT04313153|364548159|FG000|Overall Study|Lack of Efficacy|3|||
105694976|NCT04313153|364548160|FG001|Overall Study|Lack of Efficacy|3|||
105694977|NCT04313153|364548161|FG002|Overall Study|Lack of Efficacy|0|||
105694978|NCT04313153|364548159|FG000|Overall Study|Lost to Follow-up|1|||
105694979|NCT04313153|364548160|FG001|Overall Study|Lost to Follow-up|0|||
105694980|NCT04313153|364548161|FG002|Overall Study|Lost to Follow-up|2|||
105694981|NCT04313153|364548159|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
105694982|NCT04313153|364548160|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
105694983|NCT04313153|364548161|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
105694984|NCT04313153|364548159|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
105694985|NCT04313153|364548160|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
105694986|NCT04313153|364548161|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
105694987|NCT04313153|364548159|FG000|Overall Study|Change in Dialysis Modality|0|||
105694988|NCT04313153|364548160|FG001|Overall Study|Change in Dialysis Modality|1|||
105694989|NCT04313153|364548161|FG002|Overall Study|Change in Dialysis Modality|2|||
105694990|NCT04313153|364548159|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
105694991|NCT04313153|364548160|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
105694992|NCT04313153|364548161|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
105694993|NCT04313153|364548159|FG000|Overall Study|Other|5|||
105694994|NCT04313153|364548160|FG001|Overall Study|Other|3|||
105694995|NCT04313153|364548161|FG002|Overall Study|Other|2|||
105694996|NCT05586269|364548164|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
105694997|NCT05586269|364548165|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
105694998|NCT05586269|364548166|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
105694999|NCT05586269|364548167|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
105695000|NCT05586269|364548164|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
105695001|NCT05586269|364548165|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
105695002|NCT05586269|364548166|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
105695003|NCT05586269|364548167|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
105695004|NCT04752475|364548168|FG000|Overall Study|Withdrawal by Subject|1|||
105695005|NCT04752475|364548169|FG001|Overall Study|Withdrawal by Subject|1|||
105695006|NCT00523718|364548175|FG000|Overall Study|Withdrawal by Subject|1|||
105695007|NCT00523718|364548176|FG001|Overall Study|Withdrawal by Subject|0|||
105695008|NCT00523718|364548175|FG000|Overall Study|Protocol Violation|2|||
105695009|NCT00523718|364548176|FG001|Overall Study|Protocol Violation|0|||
105695010|NCT02113579|364548179|FG000|Overall Study|Adverse Event|1|||
105922133|NCT00321763|365375305|FG003|Overall Study|Adverse Event|1|||
105922134|NCT00321763|365375302|FG000|Overall Study|Withdrawal by Subject|2|||
105922135|NCT00321763|365375303|FG001|Overall Study|Withdrawal by Subject|0|||
105922136|NCT00321763|365375304|FG002|Overall Study|Withdrawal by Subject|1|||
105922137|NCT00321763|365375305|FG003|Overall Study|Withdrawal by Subject|0|||
105922138|NCT00321763|365375302|FG000|Overall Study|Lost to Follow-up|3|||
105922139|NCT00321763|365375303|FG001|Overall Study|Lost to Follow-up|1|||
105922140|NCT00321763|365375304|FG002|Overall Study|Lost to Follow-up|5|||
105922141|NCT00321763|365375305|FG003|Overall Study|Lost to Follow-up|4|||
106132489|NCT01582243|366143225|FG000|Overall Study|Withdrawal by Subject|1|||
106132490|NCT01582243|366143225|FG000|Overall Study|Adverse Event|1|||
105695011|NCT02113579|364548180|FG001|Overall Study|Adverse Event|0|||
105695012|NCT02113579|364548179|FG000|Overall Study|Withdrawal by Subject|3|||
105695013|NCT02113579|364548180|FG001|Overall Study|Withdrawal by Subject|2|||
105695014|NCT02113579|364548179|FG000|Overall Study|Lost to Follow-up|6|||
105922142|NCT00284856|365375306|FG000|Overall Study|Adverse Event|3|||
105922143|NCT00284856|365375307|FG001|Overall Study|Adverse Event|3|||
105922144|NCT00284856|365375308|FG002|Overall Study|Adverse Event|3|||
105922145|NCT00284856|365375306|FG000|Overall Study|Lack of Efficacy|2|||
105922146|NCT00284856|365375307|FG001|Overall Study|Lack of Efficacy|1|||
105695015|NCT02113579|364548180|FG001|Overall Study|Lost to Follow-up|2|||
105695016|NCT02060383|364548181|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
105922147|NCT00284856|365375308|FG002|Overall Study|Lack of Efficacy|8|||
105922148|NCT00284856|365375306|FG000|Overall Study|Lost to Follow-up|25|||
105695017|NCT02060383|364548182|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
105695018|NCT02060383|364548183|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
105695019|NCT02060383|364548184|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
105695020|NCT02060383|364548185|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
105922149|NCT00284856|365375307|FG001|Overall Study|Lost to Follow-up|21|||
105922150|NCT00284856|365375308|FG002|Overall Study|Lost to Follow-up|22|||
105922151|NCT00284856|365375306|FG000|Overall Study|Protocol Violation|5|||
105922152|NCT00284856|365375307|FG001|Overall Study|Protocol Violation|4|||
105922153|NCT00284856|365375308|FG002|Overall Study|Protocol Violation|5|||
105922154|NCT00284856|365375306|FG000|Overall Study|Withdrawal by Subject|12|||
105922155|NCT00284856|365375307|FG001|Overall Study|Withdrawal by Subject|16|||
105922156|NCT00284856|365375308|FG002|Overall Study|Withdrawal by Subject|18|||
105922157|NCT00284856|365375306|FG000|Overall Study|Other|4|||
105922158|NCT00284856|365375307|FG001|Overall Study|Other|5|||
105922159|NCT00284856|365375308|FG002|Overall Study|Other|4|||
105922160|NCT01286129|365375309|FG000|Overall Study|Withdrawal by Subject|4|||
105922161|NCT01286129|365375310|FG001|Overall Study|Withdrawal by Subject|1|||
105922162|NCT01286129|365375309|FG000|Overall Study|Could not comply with study requirements|4|||
105922163|NCT01286129|365375310|FG001|Overall Study|Could not comply with study requirements|4|||
105922164|NCT02029417|365375311|FG000|Overall Study|Death|1|||
105922165|NCT02029417|365375311|FG000|Overall Study|Adverse Event|1|||
105922166|NCT03805841|365375312|FG000|Overall Study|Clinical Progression|2|||
105922167|NCT03805841|365375313|FG001|Overall Study|Clinical Progression|0|||
105922168|NCT03805841|365375314|FG002|Overall Study|Clinical Progression|0|||
105922169|NCT03805841|365375312|FG000|Overall Study|Death|0|||
105922170|NCT03805841|365375313|FG001|Overall Study|Death|3|||
105922171|NCT03805841|365375314|FG002|Overall Study|Death|1|||
105922172|NCT03805841|365375312|FG000|Overall Study|Lost to Follow-up|0|||
105922173|NCT03805841|365375313|FG001|Overall Study|Lost to Follow-up|0|||
105695021|NCT02060383|364548181|FG000|Core Phase|Adverse Event|2|||
105695022|NCT02060383|364548182|FG001|Core Phase|Adverse Event|0|||
105695023|NCT02060383|364548183|FG002|Core Phase|Adverse Event|0|||
105695024|NCT02060383|364548184|FG003|Core Phase|Adverse Event|2|||
105695025|NCT02060383|364548185|FG004|Core Phase|Adverse Event|6|||
105695026|NCT02060383|364548181|FG000|Core Phase|Administrative problems|0|||
105695027|NCT02060383|364548182|FG001|Core Phase|Administrative problems|1|||
105695028|NCT02060383|364548183|FG002|Core Phase|Administrative problems|0|||
105695029|NCT02060383|364548184|FG003|Core Phase|Administrative problems|0|||
105695030|NCT02060383|364548185|FG004|Core Phase|Administrative problems|0|||
105922174|NCT03805841|365375314|FG002|Overall Study|Lost to Follow-up|1|||
105922175|NCT03805841|365375312|FG000|Overall Study|Withdrawal by Subject|2|||
105922176|NCT03805841|365375313|FG001|Overall Study|Withdrawal by Subject|3|||
105922177|NCT03805841|365375314|FG002|Overall Study|Withdrawal by Subject|0|||
105922178|NCT03805841|365375312|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
105922179|NCT03805841|365375313|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
105922180|NCT03805841|365375314|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
105922181|NCT00465179|365375315|FG000|Overall Study|Adverse Event|4|||
105922182|NCT00465179|365375315|FG000|Overall Study|Withdrawal by Subject|2|||
105922183|NCT00465179|365375315|FG000|Overall Study|Progression of Disease|47|||
105922184|NCT01933594|365375316|FG000|Overall Study|Lost to Follow-up|1|||
106004873|NCT03287791|365682587|FG001|Overall Study|Protocol Violation|2|||
105695031|NCT02060383|364548181|FG000|Core Phase|Protocol Violation|0|||
105695032|NCT02060383|364548182|FG001|Core Phase|Protocol Violation|0|||
105695033|NCT02060383|364548183|FG002|Core Phase|Protocol Violation|0|||
105695034|NCT02060383|364548184|FG003|Core Phase|Protocol Violation|1|||
105695035|NCT02060383|364548185|FG004|Core Phase|Protocol Violation|0|||
105695036|NCT02060383|364548181|FG000|Core Phase|Withdrawal by Subject|0|||
105695037|NCT02060383|364548182|FG001|Core Phase|Withdrawal by Subject|0|||
105695038|NCT02060383|364548183|FG002|Core Phase|Withdrawal by Subject|0|||
105695039|NCT02060383|364548184|FG003|Core Phase|Withdrawal by Subject|4|||
105695040|NCT02060383|364548185|FG004|Core Phase|Withdrawal by Subject|2|||
105922185|NCT01933594|365375317|FG001|Overall Study|Lost to Follow-up|0|||
105922186|NCT01933594|365375318|FG002|Overall Study|Lost to Follow-up|0|||
105922187|NCT01933594|365375319|FG003|Overall Study|Lost to Follow-up|0|||
105922188|NCT01933594|365375320|FG004|Overall Study|Lost to Follow-up|1|||
105922189|NCT01933594|365375321|FG005|Overall Study|Lost to Follow-up|0|||
105922190|NCT01933594|365375316|FG000|Overall Study|Ineligible for subsequent study step|0|||
105695041|NCT02060383|364548181|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
105695042|NCT02060383|364548182|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
105695043|NCT02060383|364548183|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
105695044|NCT02060383|364548184|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
105695045|NCT02060383|364548185|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
105695046|NCT02060383|364548181|FG000|Extension Phase|Adverse Event|1|||
105695047|NCT02060383|364548182|FG001|Extension Phase|Adverse Event|1|||
105922191|NCT01933594|365375317|FG001|Overall Study|Ineligible for subsequent study step|0|||
106132491|NCT01582243|366143225|FG000|Overall Study|Lost to Follow-up|1|||
106132492|NCT02096003|366143228|FG000|Overall Study|Protocol Violation|0|||
105695048|NCT02060383|364548183|FG002|Extension Phase|Adverse Event|2|||
105695049|NCT02060383|364548184|FG003|Extension Phase|Adverse Event|0|||
105695050|NCT02060383|364548185|FG004|Extension Phase|Adverse Event|1|||
105695051|NCT02060383|364548181|FG000|Extension Phase|Withdrawal by Subject|0|||
105695052|NCT02060383|364548182|FG001|Extension Phase|Withdrawal by Subject|1|||
105695053|NCT02060383|364548183|FG002|Extension Phase|Withdrawal by Subject|0|||
105695054|NCT02060383|364548184|FG003|Extension Phase|Withdrawal by Subject|0|||
105695055|NCT02060383|364548185|FG004|Extension Phase|Withdrawal by Subject|2|||
105695056|NCT02060383|364548181|FG000|Extension Phase|Administrative problems|1|||
105695057|NCT02060383|364548182|FG001|Extension Phase|Administrative problems|0|||
105695058|NCT02060383|364548183|FG002|Extension Phase|Administrative problems|0|||
105695059|NCT02060383|364548184|FG003|Extension Phase|Administrative problems|0|||
105695060|NCT02060383|364548185|FG004|Extension Phase|Administrative problems|0|||
105695061|NCT02060383|364548181|FG000|Extension Phase|Death|0|||
105695062|NCT02060383|364548182|FG001|Extension Phase|Death|0|||
105695063|NCT02060383|364548183|FG002|Extension Phase|Death|1|||
105695064|NCT02060383|364548184|FG003|Extension Phase|Death|0|||
105695065|NCT02060383|364548185|FG004|Extension Phase|Death|1|||
105695066|NCT02060383|364548181|FG000|Extension Phase|Protocol Violation|0|||
105695067|NCT02060383|364548182|FG001|Extension Phase|Protocol Violation|0|||
105695068|NCT02060383|364548183|FG002|Extension Phase|Protocol Violation|0|||
105695069|NCT02060383|364548184|FG003|Extension Phase|Protocol Violation|0|||
105695070|NCT02060383|364548185|FG004|Extension Phase|Protocol Violation|1|||
105695071|NCT00332839|364548186|FG000|Core (Months 0 - 12)|Administrative problems|1|||
105695072|NCT00332839|364548187|FG001|Core (Months 0 - 12)|Administrative problems|1|||
105695073|NCT00332839|364548186|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
105922192|NCT01933594|365375318|FG002|Overall Study|Ineligible for subsequent study step|0|||
105922193|NCT01933594|365375319|FG003|Overall Study|Ineligible for subsequent study step|0|||
105922194|NCT01933594|365375320|FG004|Overall Study|Ineligible for subsequent study step|1|||
105922195|NCT01933594|365375321|FG005|Overall Study|Ineligible for subsequent study step|0|||
105695074|NCT00332839|364548187|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
105695075|NCT00332839|364548186|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
105695076|NCT00332839|364548187|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
105695077|NCT00332839|364548186|FG000|Core (Months 0 - 12)|Adverse Event|5|||
105695078|NCT00332839|364548187|FG001|Core (Months 0 - 12)|Adverse Event|15|||
105695079|NCT00332839|364548186|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
105695080|NCT00332839|364548187|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
105695081|NCT00332839|364548186|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
105695082|NCT00332839|364548187|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
105695083|NCT00332839|364548186|FG000|Follow-up (Months 12 - 60)|Death|1|||
105695084|NCT00332839|364548187|FG001|Follow-up (Months 12 - 60)|Death|1|||
105695085|NCT02217436|364548195|FG000|Overall Study|Protocol Violation|1|||
105695086|NCT02217436|364548196|FG001|Overall Study|Protocol Violation|1|||
105695087|NCT02217436|364548195|FG000|Overall Study|Incomplete data|0|||
105695088|NCT02217436|364548196|FG001|Overall Study|Incomplete data|1|||
105695089|NCT04641299|364548204|FG000|Overall Study|Adverse Event|0|||
105922196|NCT02121210|365375324|FG000|Overall Study|Adverse Event|5|||
105922197|NCT02121210|365375325|FG001|Overall Study|Adverse Event|7|||
105922198|NCT02121210|365375324|FG000|Overall Study|Lack of Efficacy|2|||
105922199|NCT02121210|365375325|FG001|Overall Study|Lack of Efficacy|0|||
105695090|NCT04641299|364548205|FG001|Overall Study|Adverse Event|0|||
105695091|NCT04641299|364548206|FG002|Overall Study|Adverse Event|2|||
105695092|NCT04641299|364548207|FG003|Overall Study|Adverse Event|0|||
105695093|NCT04641299|364548204|FG000|Overall Study|Lost to Follow-up|0|||
105695094|NCT04641299|364548205|FG001|Overall Study|Lost to Follow-up|1|||
105695095|NCT04641299|364548206|FG002|Overall Study|Lost to Follow-up|0|||
105695096|NCT04641299|364548207|FG003|Overall Study|Lost to Follow-up|0|||
105695097|NCT04641299|364548204|FG000|Overall Study|Withdrawal by Subject|1|||
105695098|NCT04641299|364548205|FG001|Overall Study|Withdrawal by Subject|0|||
105695099|NCT04641299|364548206|FG002|Overall Study|Withdrawal by Subject|0|||
105695100|NCT04641299|364548207|FG003|Overall Study|Withdrawal by Subject|0|||
105922200|NCT02121210|365375324|FG000|Overall Study|Other than specified above|0|||
106004874|NCT03287791|365682588|FG002|Overall Study|Protocol Violation|1|||
106004875|NCT03287791|365682586|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
106004876|NCT03287791|365682587|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
106132493|NCT02096003|366143229|FG001|Overall Study|Protocol Violation|2|||
105695101|NCT04641299|364548204|FG000|Overall Study|Reason not given|1|||
105695102|NCT04641299|364548205|FG001|Overall Study|Reason not given|0|||
105695103|NCT04641299|364548206|FG002|Overall Study|Reason not given|0|||
105922201|NCT02121210|365375325|FG001|Overall Study|Other than specified above|2|||
105695104|NCT04641299|364548207|FG003|Overall Study|Reason not given|0|||
105695105|NCT02020863|364548208|FG000|Overall Study|Discovery of Metastatic disease|4|||
105695106|NCT02020863|364548208|FG000|Overall Study|Team chose not to place an a line|1|||
105695107|NCT01920594|364548209|FG000|Overall Study|Adverse Event|4|||
105695108|NCT01920594|364548210|FG001|Overall Study|Adverse Event|2|||
105922202|NCT00830765|365375326|FG000|Overall Study|Protocol Violation|3|||
106132494|NCT02096003|366143228|FG000|Overall Study|additional surgery|2|||
105695109|NCT01920594|364548209|FG000|Overall Study|Lost to Follow-up|1|||
105695110|NCT01920594|364548210|FG001|Overall Study|Lost to Follow-up|0|||
105695111|NCT01920594|364548209|FG000|Overall Study|Recovery|2|||
105695112|NCT01920594|364548210|FG001|Overall Study|Recovery|0|||
105695113|NCT01920594|364548209|FG000|Overall Study|Investigator discretion|0|||
105695114|NCT01920594|364548210|FG001|Overall Study|Investigator discretion|1|||
105695115|NCT00880555|364548213|FG000|Overall Study|Physician Decision|0|||
105695116|NCT00880555|364548214|FG001|Overall Study|Physician Decision|8|||
105695117|NCT00880555|364548215|FG002|Overall Study|Physician Decision|0|||
105695118|NCT00880555|364548216|FG003|Overall Study|Physician Decision|2|||
105695119|NCT00880555|364548217|FG004|Overall Study|Physician Decision|1|||
105695120|NCT00880555|364548218|FG005|Overall Study|Physician Decision|0|||
105695121|NCT00880555|364548213|FG000|Overall Study|Withdrawal by Subject|1|||
105695122|NCT00880555|364548214|FG001|Overall Study|Withdrawal by Subject|1|||
105695123|NCT00880555|364548215|FG002|Overall Study|Withdrawal by Subject|0|||
105695124|NCT00880555|364548216|FG003|Overall Study|Withdrawal by Subject|0|||
105695125|NCT00880555|364548217|FG004|Overall Study|Withdrawal by Subject|0|||
105695126|NCT00880555|364548218|FG005|Overall Study|Withdrawal by Subject|0|||
105695127|NCT00880555|364548213|FG000|Overall Study|Lack of resources (hired rater)|9|||
105695128|NCT00880555|364548214|FG001|Overall Study|Lack of resources (hired rater)|7|||
105695129|NCT00880555|364548215|FG002|Overall Study|Lack of resources (hired rater)|5|||
105695130|NCT00880555|364548216|FG003|Overall Study|Lack of resources (hired rater)|0|||
105695131|NCT00880555|364548217|FG004|Overall Study|Lack of resources (hired rater)|0|||
105695132|NCT00880555|364548218|FG005|Overall Study|Lack of resources (hired rater)|0|||
105695133|NCT00880555|364548213|FG000|Overall Study|Death|0|||
105695134|NCT00880555|364548214|FG001|Overall Study|Death|0|||
105695135|NCT00880555|364548215|FG002|Overall Study|Death|0|||
105695136|NCT00880555|364548216|FG003|Overall Study|Death|0|||
105695137|NCT00880555|364548217|FG004|Overall Study|Death|0|||
105695138|NCT00880555|364548218|FG005|Overall Study|Death|1|||
105695139|NCT00880555|364548213|FG000|Overall Study|Lost to Follow-up|0|||
105695140|NCT00880555|364548214|FG001|Overall Study|Lost to Follow-up|1|||
105695141|NCT00880555|364548215|FG002|Overall Study|Lost to Follow-up|0|||
105695142|NCT00880555|364548216|FG003|Overall Study|Lost to Follow-up|0|||
105695143|NCT00880555|364548217|FG004|Overall Study|Lost to Follow-up|0|||
105695144|NCT00880555|364548218|FG005|Overall Study|Lost to Follow-up|0|||
105695145|NCT01628107|364548219|FG000|Overall Study|Withdrawal by Subject|17|||
105695146|NCT01628107|364548219|FG000|Overall Study|Lost to Follow-up|4|||
105695147|NCT01628107|364548219|FG000|Overall Study|Adverse Event|33|||
105695148|NCT01628107|364548219|FG000|Overall Study|Physician Decision|2|||
105695149|NCT01628107|364548219|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
105695150|NCT01628107|364548219|FG000|Overall Study|Non-compliant with Study Procedures|10|||
105695151|NCT01628107|364548219|FG000|Overall Study|Not Treated|8|||
105695152|NCT01628107|364548219|FG000|Overall Study|Sponsor Decision|11|||
105695153|NCT01628107|364548219|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
105695154|NCT01628107|364548219|FG000|Overall Study|Relocated|8|||
105695155|NCT01628107|364548219|FG000|Overall Study|Kidney Transplant|9|||
105695156|NCT01628107|364548219|FG000|Overall Study|Use of Standard of Care|9|||
105695157|NCT01205438|364548220|FG000|Overall Study|Adverse Event|19|||
105695158|NCT01205438|364548221|FG001|Overall Study|Adverse Event|17|||
105695159|NCT01205438|364548222|FG002|Overall Study|Adverse Event|24|||
105695160|NCT01205438|364548220|FG000|Overall Study|Death|1|||
105695161|NCT01205438|364548221|FG001|Overall Study|Death|1|||
105695162|NCT01205438|364548222|FG002|Overall Study|Death|3|||
105695163|NCT01205438|364548220|FG000|Overall Study|Entry Criteria Not Met|16|||
105695164|NCT01205438|364548221|FG001|Overall Study|Entry Criteria Not Met|15|||
105695165|NCT01205438|364548222|FG002|Overall Study|Entry Criteria Not Met|13|||
105695166|NCT01205438|364548220|FG000|Overall Study|Lack of Efficacy|14|||
105695167|NCT01205438|364548221|FG001|Overall Study|Lack of Efficacy|11|||
105695168|NCT01205438|364548222|FG002|Overall Study|Lack of Efficacy|14|||
105695169|NCT01205438|364548220|FG000|Overall Study|Lost to Follow-up|6|||
105695170|NCT01205438|364548221|FG001|Overall Study|Lost to Follow-up|7|||
105695171|NCT01205438|364548222|FG002|Overall Study|Lost to Follow-up|8|||
105695172|NCT01205438|364548220|FG000|Overall Study|Withdrawal by Subject|19|||
105695173|NCT01205438|364548221|FG001|Overall Study|Withdrawal by Subject|25|||
105695174|NCT01205438|364548222|FG002|Overall Study|Withdrawal by Subject|19|||
105695175|NCT01205438|364548220|FG000|Overall Study|Physician Decision|0|||
105695176|NCT01205438|364548221|FG001|Overall Study|Physician Decision|3|||
106132495|NCT02096003|366143229|FG001|Overall Study|additional surgery|1|||
105695177|NCT01205438|364548222|FG002|Overall Study|Physician Decision|2|||
105695178|NCT01205438|364548220|FG000|Overall Study|Protocol Violation|2|||
105695179|NCT01205438|364548221|FG001|Overall Study|Protocol Violation|7|||
105695180|NCT01205438|364548222|FG002|Overall Study|Protocol Violation|4|||
105695181|NCT01205438|364548220|FG000|Overall Study|Sponsor Decision|0|||
105695182|NCT01205438|364548221|FG001|Overall Study|Sponsor Decision|1|||
105695183|NCT01205438|364548222|FG002|Overall Study|Sponsor Decision|1|||
105695184|NCT00884325|364548223|FG000|Overall Study|Lost to Follow-up|1|||
105695185|NCT00884325|364548224|FG001|Overall Study|Lost to Follow-up|2|||
105922203|NCT00830765|365375327|FG001|Overall Study|Protocol Violation|2|||
105922204|NCT00402831|365375328|FG000|Overall Study|Lost to Follow-up|1|||
105922205|NCT00402831|365375329|FG001|Overall Study|Lost to Follow-up|2|||
105922206|NCT00402831|365375328|FG000|Overall Study|Non-compliance with protocol|0|||
105922207|NCT00402831|365375329|FG001|Overall Study|Non-compliance with protocol|1|||
105922208|NCT01299909|365375332|FG000|Overall Study|Lost to Follow-up|22|||
105922209|NCT01299909|365375333|FG001|Overall Study|Lost to Follow-up|18|||
105922210|NCT01299909|365375334|FG002|Overall Study|Lost to Follow-up|17|||
105922211|NCT02792504|365375337|FG000|Overall Study|Lost to Follow-up|24|||
105922212|NCT02792504|365375337|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
105922213|NCT01811238|365375344|FG000|Overall Study|Withdrawal by Subject|42|||
105922214|NCT01811238|365375344|FG000|Overall Study|Adverse Event|25|||
105922215|NCT01811238|365375344|FG000|Overall Study|Protocol Violation|4|||
105922216|NCT01811238|365375344|FG000|Overall Study|Lack of Efficacy|4|||
105922217|NCT01811238|365375344|FG000|Overall Study|subject refused study medication|6|||
105922218|NCT00848497|365375345|FG000|Overall Study|Screen failure|2|||
105922219|NCT00848497|365375346|FG001|Overall Study|Screen failure|0|||
105922220|NCT00848497|365375345|FG000|Overall Study|Withdrawal by Subject|0|||
105922221|NCT00848497|365375346|FG001|Overall Study|Withdrawal by Subject|1|||
105922222|NCT01832766|365375347|FG000|Washout|Lost to Follow-up|0|||
105922223|NCT01832766|365375348|FG001|Washout|Lost to Follow-up|1|||
105922224|NCT02340949|365375349|FG000|Overall Study|Adverse Event|4|||
105922225|NCT02340949|365375350|FG001|Overall Study|Adverse Event|2|||
105922226|NCT02340949|365375349|FG000|Overall Study|Withdrawal by Subject|2|||
105922227|NCT02340949|365375350|FG001|Overall Study|Withdrawal by Subject|0|||
105922228|NCT02340949|365375349|FG000|Overall Study|Progression disease|6|||
105922229|NCT02340949|365375350|FG001|Overall Study|Progression disease|2|||
105922230|NCT02340949|365375349|FG000|Overall Study|Death|3|||
105922231|NCT02340949|365375350|FG001|Overall Study|Death|0|||
105922232|NCT02340949|365375349|FG000|Overall Study|Physician Decision|1|||
105922233|NCT02340949|365375350|FG001|Overall Study|Physician Decision|0|||
105922234|NCT04711005|365375363|FG000|Overall Study|Withdrawal by Subject|0|||
105922235|NCT04711005|365375364|FG001|Overall Study|Withdrawal by Subject|0|||
105922236|NCT04711005|365375365|FG002|Overall Study|Withdrawal by Subject|0|||
105922237|NCT04711005|365375366|FG003|Overall Study|Withdrawal by Subject|0|||
105922238|NCT04711005|365375367|FG004|Overall Study|Withdrawal by Subject|0|||
105922239|NCT04711005|365375368|FG005|Overall Study|Withdrawal by Subject|0|||
105922240|NCT04711005|365375369|FG006|Overall Study|Withdrawal by Subject|0|||
105922241|NCT04711005|365375370|FG007|Overall Study|Withdrawal by Subject|1|||
105695186|NCT00884325|364548223|FG000|Overall Study|Lack of Efficacy|0|||
105695187|NCT00884325|364548224|FG001|Overall Study|Lack of Efficacy|1|||
105695188|NCT00884325|364548223|FG000|Overall Study|Withdrawal by Subject|1|||
105695189|NCT00884325|364548224|FG001|Overall Study|Withdrawal by Subject|1|||
105695190|NCT00884325|364548223|FG000|Overall Study|Not provided|1|||
105922242|NCT04711005|365375371|FG008|Overall Study|Withdrawal by Subject|0|||
105922243|NCT04711005|365375372|FG009|Overall Study|Withdrawal by Subject|0|||
105922244|NCT04711005|365375363|FG000|Overall Study|Physician Decision|0|||
105922245|NCT04711005|365375364|FG001|Overall Study|Physician Decision|0|||
105922246|NCT04711005|365375365|FG002|Overall Study|Physician Decision|0|||
105922247|NCT04711005|365375366|FG003|Overall Study|Physician Decision|0|||
105922248|NCT04711005|365375367|FG004|Overall Study|Physician Decision|0|||
105922249|NCT04711005|365375368|FG005|Overall Study|Physician Decision|0|||
105922250|NCT04711005|365375369|FG006|Overall Study|Physician Decision|0|||
105922251|NCT04711005|365375370|FG007|Overall Study|Physician Decision|2|||
105922252|NCT04711005|365375371|FG008|Overall Study|Physician Decision|1|||
105922253|NCT04711005|365375372|FG009|Overall Study|Physician Decision|0|||
105922254|NCT02034006|365376509|FG000|Overall Study|Withdrawal by Subject|7|||
105922255|NCT02034006|365376509|FG000|Overall Study|Lost to Follow-up|5|||
105922256|NCT02034006|365376509|FG000|Overall Study|Death|1|||
105922257|NCT02034006|365376509|FG000|Overall Study|Pregnancy|1|||
105922258|NCT01294514|365376524|FG000|Overall Study|Excluded due to Arrhythmia|1|||
105922259|NCT01715298|365376525|FG000|Overall Study|Lost to Follow-up|0|||
105922260|NCT01715298|365376526|FG001|Overall Study|Lost to Follow-up|2|||
105922261|NCT01715298|365376525|FG000|Overall Study|Patient/guardian decision|7|||
105922262|NCT01715298|365376526|FG001|Overall Study|Patient/guardian decision|9|||
105922263|NCT01118299|365376529|FG000|Overall Study|Death|7|||
105922264|NCT01118299|365376530|FG001|Overall Study|Death|5|||
105922265|NCT01118299|365376529|FG000|Overall Study|Withdrawal by Subject|8|||
105922266|NCT01118299|365376530|FG001|Overall Study|Withdrawal by Subject|8|||
105695191|NCT00884325|364548224|FG001|Overall Study|Not provided|0|||
105695192|NCT01186796|364548235|FG000|Overall Study|Adverse Event|3|||
105695193|NCT01186796|364548236|FG001|Overall Study|Adverse Event|0|||
105695194|NCT01186796|364548235|FG000|Overall Study|Withdrawal by Subject|1|||
105695195|NCT01186796|364548236|FG001|Overall Study|Withdrawal by Subject|1|||
105922267|NCT01118299|365376529|FG000|Overall Study|Lost to Follow-up|2|||
105922268|NCT01118299|365376530|FG001|Overall Study|Lost to Follow-up|1|||
105922269|NCT01118299|365376529|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
105922270|NCT01118299|365376530|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
105922271|NCT04459338|365376531|FG000|Overall Study|Loss of IV during study|1|||
105922272|NCT04459338|365376532|FG001|Overall Study|Loss of IV during study|0|||
105922273|NCT02690727|365376533|FG000|Overall Study|Adverse Event|2|||
105922274|NCT02690727|365376534|FG001|Overall Study|Adverse Event|2|||
105922275|NCT03286504|365376535|FG000|Overall Study|Lost to Follow-up|19|||
105922276|NCT03286504|365376536|FG001|Overall Study|Lost to Follow-up|16|||
105922277|NCT02110693|365376538|FG000|Overall Study|Withdrawal by Subject|6|||
105922278|NCT02110693|365376539|FG001|Overall Study|Withdrawal by Subject|7|||
105922279|NCT02110693|365376538|FG000|Overall Study|skipped assessment|15|||
105695196|NCT01186796|364548235|FG000|Overall Study|Protocol Violation|0|||
105695197|NCT01186796|364548236|FG001|Overall Study|Protocol Violation|1|||
105922280|NCT02110693|365376539|FG001|Overall Study|skipped assessment|18|||
105922281|NCT02110693|365376538|FG000|Overall Study|technical difficulties|6|||
105695198|NCT00433914|364548240|FG000|Overall Study|Withdrawal by Subject|0|||
105922282|NCT02110693|365376539|FG001|Overall Study|technical difficulties|4|||
105922283|NCT02110693|365376538|FG000|Overall Study|Other|1|||
105922284|NCT02110693|365376539|FG001|Overall Study|Other|0|||
105922285|NCT00147238|365376542|FG000|Overall Study|Inevaluable|8|||
105922286|NCT04424901|365376543|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
105922287|NCT04424901|365376544|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
105922288|NCT02765165|365376545|FG000|Treatment Period|Progressive disease|3|||
105922289|NCT02765165|365376546|FG001|Treatment Period|Progressive disease|2|||
105922290|NCT02765165|365376547|FG002|Treatment Period|Progressive disease|3|||
105922291|NCT02765165|365376548|FG003|Treatment Period|Progressive disease|3|||
105922292|NCT02765165|365376549|FG004|Treatment Period|Progressive disease|4|||
105922293|NCT02765165|365376550|FG005|Treatment Period|Progressive disease|2|||
105922294|NCT02765165|365376551|FG006|Treatment Period|Progressive disease|2|||
105922295|NCT02765165|365376545|FG000|Treatment Period|Physician Decision|0|||
105922296|NCT02765165|365376546|FG001|Treatment Period|Physician Decision|1|||
105922297|NCT02765165|365376547|FG002|Treatment Period|Physician Decision|0|||
105922298|NCT02765165|365376548|FG003|Treatment Period|Physician Decision|0|||
105922299|NCT02765165|365376549|FG004|Treatment Period|Physician Decision|0|||
105695199|NCT00433914|364548241|FG001|Overall Study|Withdrawal by Subject|2|||
105695200|NCT00433914|364548240|FG000|Overall Study|Lost to Follow-up|0|||
105695201|NCT00433914|364548241|FG001|Overall Study|Lost to Follow-up|1|||
105922300|NCT02765165|365376550|FG005|Treatment Period|Physician Decision|0|||
105922301|NCT02765165|365376551|FG006|Treatment Period|Physician Decision|0|||
105922302|NCT02765165|365376545|FG000|Treatment Period|Adverse Event|0|||
105922303|NCT02765165|365376546|FG001|Treatment Period|Adverse Event|1|||
105922304|NCT02765165|365376547|FG002|Treatment Period|Adverse Event|0|||
105922305|NCT02765165|365376548|FG003|Treatment Period|Adverse Event|0|||
105922306|NCT02765165|365376549|FG004|Treatment Period|Adverse Event|0|||
105922307|NCT02765165|365376550|FG005|Treatment Period|Adverse Event|0|||
105695202|NCT01490814|364548242|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
105922308|NCT02765165|365376551|FG006|Treatment Period|Adverse Event|0|||
105922309|NCT02765165|365376545|FG000|Treatment Period|Withdrawal by Subject|0|||
105922310|NCT02765165|365376546|FG001|Treatment Period|Withdrawal by Subject|0|||
105922311|NCT02765165|365376547|FG002|Treatment Period|Withdrawal by Subject|0|||
105922312|NCT02765165|365376548|FG003|Treatment Period|Withdrawal by Subject|0|||
105922313|NCT02765165|365376549|FG004|Treatment Period|Withdrawal by Subject|2|||
105922314|NCT02765165|365376550|FG005|Treatment Period|Withdrawal by Subject|0|||
105922315|NCT02765165|365376551|FG006|Treatment Period|Withdrawal by Subject|0|||
105922316|NCT02765165|365376545|FG000|Treatment Period|Study terminated|0|||
105922317|NCT02765165|365376546|FG001|Treatment Period|Study terminated|0|||
105922318|NCT02765165|365376547|FG002|Treatment Period|Study terminated|0|||
105922319|NCT02765165|365376548|FG003|Treatment Period|Study terminated|0|||
105922320|NCT02765165|365376549|FG004|Treatment Period|Study terminated|0|||
105922321|NCT02765165|365376550|FG005|Treatment Period|Study terminated|1|||
105922322|NCT02765165|365376551|FG006|Treatment Period|Study terminated|2|||
105922323|NCT02765165|365376545|FG000|Post-treatment Follow-up|Death|1|||
105922324|NCT02765165|365376546|FG001|Post-treatment Follow-up|Death|2|||
105922325|NCT02765165|365376547|FG002|Post-treatment Follow-up|Death|1|||
105922326|NCT02765165|365376548|FG003|Post-treatment Follow-up|Death|1|||
105922327|NCT02765165|365376549|FG004|Post-treatment Follow-up|Death|1|||
105922328|NCT02765165|365376550|FG005|Post-treatment Follow-up|Death|1|||
105922329|NCT02765165|365376551|FG006|Post-treatment Follow-up|Death|0|||
105922330|NCT02765165|365376545|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
105922331|NCT02765165|365376546|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
105922332|NCT02765165|365376547|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
105922333|NCT02765165|365376548|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
105922334|NCT02765165|365376549|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
105695203|NCT01490814|364548243|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
105695204|NCT01490814|364548242|FG000|Overall Study|Physician Decision|1|||
105695205|NCT01490814|364548243|FG001|Overall Study|Physician Decision|0|||
105695206|NCT01490814|364548242|FG000|Overall Study|Withdrawal by Subject|0|||
105695207|NCT01490814|364548243|FG001|Overall Study|Withdrawal by Subject|5|||
105695208|NCT00935272|364548257|FG000|Overall Study|Lost to Follow-up|10|||
105695209|NCT00935272|364548258|FG001|Overall Study|Lost to Follow-up|3|||
105922335|NCT02765165|365376550|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
105922336|NCT02765165|365376551|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
105922337|NCT02765165|365376545|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
105922338|NCT02765165|365376546|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
105695210|NCT00935272|364548257|FG000|Overall Study|Withdrawal by Subject|8|||
105695211|NCT00935272|364548258|FG001|Overall Study|Withdrawal by Subject|2|||
105922339|NCT02765165|365376547|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
105922340|NCT02765165|365376548|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
105922341|NCT02765165|365376549|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
105695212|NCT00935272|364548257|FG000|Overall Study|Physician Decision|1|||
105695213|NCT00935272|364548258|FG001|Overall Study|Physician Decision|0|||
105922342|NCT02765165|365376550|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
105695214|NCT00935272|364548257|FG000|Overall Study|Protocol Violation|0|||
105695215|NCT00935272|364548258|FG001|Overall Study|Protocol Violation|1|||
105695216|NCT01478360|364548261|FG000|Overall Study|Lost to Follow-up|1|||
105695217|NCT01478360|364548262|FG001|Overall Study|Lost to Follow-up|0|||
105695218|NCT01478360|364548261|FG000|Overall Study|Adverse Event|0|||
105695219|NCT01478360|364548262|FG001|Overall Study|Adverse Event|1|||
105695220|NCT01478360|364548261|FG000|Overall Study|Administrative problems|1|||
105695221|NCT01478360|364548262|FG001|Overall Study|Administrative problems|2|||
105695222|NCT01849497|364548264|FG000|Overall Study|Withdrawal by Subject|1|||
105695223|NCT01849497|364548265|FG001|Overall Study|Withdrawal by Subject|2|||
105695224|NCT01849497|364548264|FG000|Overall Study|Sponsor Decision|0|||
105695225|NCT01849497|364548265|FG001|Overall Study|Sponsor Decision|1|||
105695226|NCT01849497|364548264|FG000|Overall Study|Lost to Follow-up|0|||
105695227|NCT01849497|364548265|FG001|Overall Study|Lost to Follow-up|1|||
105695228|NCT00911625|364548289|FG000|Overall Study|Lost to Follow-up|7|||
105695229|NCT00911625|364548290|FG001|Overall Study|Lost to Follow-up|0|||
105695230|NCT00888381|364548296|FG000|Overall Study|Lost to Follow-up|0|||
105695231|NCT00888381|364548297|FG001|Overall Study|Lost to Follow-up|1|||
105695232|NCT00097773|364548298|FG000|Overall Study|Lost to Follow-up|2|||
105695233|NCT00097773|364548299|FG001|Overall Study|Lost to Follow-up|2|||
105695234|NCT00097773|364548300|FG002|Overall Study|Lost to Follow-up|0|||
105695235|NCT00097773|364548301|FG003|Overall Study|Lost to Follow-up|1|||
105695236|NCT00097773|364548298|FG000|Overall Study|Physician Decision|2|||
105695237|NCT00097773|364548299|FG001|Overall Study|Physician Decision|2|||
105695238|NCT00097773|364548300|FG002|Overall Study|Physician Decision|3|||
105695239|NCT00097773|364548301|FG003|Overall Study|Physician Decision|1|||
105695240|NCT00097773|364548298|FG000|Overall Study|Withdrawal by Subject|3|||
105695241|NCT00097773|364548299|FG001|Overall Study|Withdrawal by Subject|3|||
105695242|NCT00097773|364548300|FG002|Overall Study|Withdrawal by Subject|3|||
105695243|NCT00097773|364548301|FG003|Overall Study|Withdrawal by Subject|1|||
105695244|NCT00097773|364548298|FG000|Overall Study|Adverse Event|0|||
105695245|NCT00097773|364548299|FG001|Overall Study|Adverse Event|1|||
105695246|NCT00097773|364548300|FG002|Overall Study|Adverse Event|0|||
105695247|NCT00097773|364548301|FG003|Overall Study|Adverse Event|0|||
105695248|NCT00097773|364548298|FG000|Overall Study|Other|1|||
105695249|NCT00097773|364548299|FG001|Overall Study|Other|0|||
105695250|NCT00097773|364548300|FG002|Overall Study|Other|2|||
105695251|NCT00097773|364548301|FG003|Overall Study|Other|0|||
105695252|NCT00003702|364548302|FG000|Overall Study|Ineligible cell types|2|||
105695253|NCT00003702|364548303|FG001|Overall Study|Ineligible cell types|2|||
105695254|NCT00003702|364548302|FG000|Overall Study|Did not meet criteria for persistence|8|||
105695255|NCT00003702|364548303|FG001|Overall Study|Did not meet criteria for persistence|5|||
105695256|NCT00003702|364548302|FG000|Overall Study|WHO score > 6|2|||
105695257|NCT00003702|364548303|FG001|Overall Study|WHO score > 6|1|||
105695258|NCT00003702|364548302|FG000|Overall Study|Inadequate documentation of disease|1|||
105695259|NCT00003702|364548303|FG001|Overall Study|Inadequate documentation of disease|3|||
105695260|NCT00757003|364548304|FG000|Overall Study|Death|33|||
105695261|NCT00757003|364548304|FG000|Overall Study|Lost to Follow-up|9|||
105695262|NCT00757003|364548304|FG000|Overall Study|Withdrawal by Subject|4|||
105695263|NCT00757003|364548304|FG000|Overall Study|Surgically explanted|2|||
105695264|NCT00757003|364548304|FG000|Overall Study|Not implanted|1|||
105695265|NCT00544648|364548307|FG000|Overall Study|Withdrawal by Subject|1|||
105695266|NCT00544648|364548308|FG001|Overall Study|Withdrawal by Subject|0|||
105695267|NCT00544648|364548307|FG000|Overall Study|Adverse Event|1|||
105695268|NCT00544648|364548308|FG001|Overall Study|Adverse Event|1|||
105695269|NCT00544648|364548307|FG000|Overall Study|progression of disease|1|||
105695270|NCT00544648|364548308|FG001|Overall Study|progression of disease|0|||
105695271|NCT00504153|364548315|FG000|Overall Study|Withdrawal by Subject|1|||
105695272|NCT00504153|364548315|FG000|Overall Study|Adverse Event|4|||
105695273|NCT00504153|364548315|FG000|Overall Study|Death|1|||
105695274|NCT00074581|364548317|FG000|Overall Study|Death|15|||
105695275|NCT00074581|364548318|FG001|Overall Study|Death|16|||
105695276|NCT00074581|364548317|FG000|Overall Study|Withdrawal by Subject|50|||
105695277|NCT00074581|364548318|FG001|Overall Study|Withdrawal by Subject|49|||
105695278|NCT00074581|364548317|FG000|Overall Study|Unable to adhere to visit schedule|13|||
105695279|NCT00074581|364548318|FG001|Overall Study|Unable to adhere to visit schedule|14|||
105695280|NCT00074581|364548317|FG000|Overall Study|Relocated|14|||
105695281|NCT00074581|364548318|FG001|Overall Study|Relocated|9|||
105695282|NCT00074581|364548317|FG000|Overall Study|Were withdrawn by investigator|5|||
105695283|NCT00074581|364548318|FG001|Overall Study|Were withdrawn by investigator|2|||
105695284|NCT00074581|364548317|FG000|Overall Study|Lost to Follow-up|16|||
105695285|NCT00074581|364548318|FG001|Overall Study|Lost to Follow-up|11|||
105787102|NCT03110107|364874908|FG019|Treatment Period|Study drug toxicity|2|||
105787103|NCT03110107|364874909|FG020|Treatment Period|Study drug toxicity|2|||
105695286|NCT00074581|364548317|FG000|Overall Study|Ended relationship w. index participant|117|||
105695287|NCT00074581|364548318|FG001|Overall Study|Ended relationship w. index participant|106|||
105695288|NCT00074581|364548317|FG000|Overall Study|Other|14|||
105695289|NCT00074581|364548318|FG001|Overall Study|Other|19|||
106132496|NCT01008748|366143230|FG000|Overall Study|Lost to Follow-up|80|||
105695290|NCT00617604|364548322|FG000|Overall Study|Death|2|||
105695291|NCT00617604|364548323|FG001|Overall Study|Death|1|||
105695292|NCT00617604|364548322|FG000|Overall Study|Lost to Follow-up|1|||
105695293|NCT00617604|364548323|FG001|Overall Study|Lost to Follow-up|0|||
105695294|NCT00617604|364548322|FG000|Overall Study|Miscellaneous Reasons|8|||
105922343|NCT02765165|365376551|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
105922344|NCT02765165|365376545|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105922345|NCT02765165|365376546|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105922346|NCT02765165|365376547|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
105695295|NCT00617604|364548323|FG001|Overall Study|Miscellaneous Reasons|10|||
105695296|NCT00617604|364548322|FG000|Overall Study|Withdrawal by Subject|4|||
105695297|NCT00617604|364548323|FG001|Overall Study|Withdrawal by Subject|6|||
105695298|NCT00617604|364548322|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
105695299|NCT00617604|364548323|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
105695300|NCT01708291|364548324|FG000|Overall Study|fighting|2|||
105695301|NCT01708291|364548325|FG001|Overall Study|fighting|1|||
105695302|NCT04411628|364548328|FG000|Overall Study|Withdrawal by Subject|1|||
105695303|NCT04411628|364548329|FG001|Overall Study|Withdrawal by Subject|1|||
105695304|NCT04411628|364548330|FG002|Overall Study|Withdrawal by Subject|2|||
105922347|NCT02765165|365376548|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
105922348|NCT02765165|365376549|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105695305|NCT04411628|364548331|FG003|Overall Study|Withdrawal by Subject|0|||
105695306|NCT04411628|364548328|FG000|Overall Study|Lost to Follow-up|0|||
105695307|NCT04411628|364548329|FG001|Overall Study|Lost to Follow-up|1|||
105695308|NCT04411628|364548330|FG002|Overall Study|Lost to Follow-up|0|||
105695309|NCT04411628|364548331|FG003|Overall Study|Lost to Follow-up|0|||
105695310|NCT00732251|364548332|FG000|Overall Study|Lost to Follow-up|3|||
105695311|NCT00732251|364548332|FG000|Overall Study|Withdrawal by Subject|3|||
105695312|NCT00732251|364548332|FG000|Overall Study|Early Term due to Site Closure|1|||
105695313|NCT00932425|364548338|FG000|Overall Study|Lost to Follow-up|0|||
105695314|NCT00932425|364548339|FG001|Overall Study|Lost to Follow-up|1|||
105695315|NCT00932425|364548338|FG000|Overall Study|Withdrawal by Subject|0|||
105695316|NCT00932425|364548339|FG001|Overall Study|Withdrawal by Subject|1|||
105695317|NCT01854645|364548342|FG000|Overall Study|Protocol-Specified Criteria|13|||
105695318|NCT01854645|364548343|FG001|Overall Study|Protocol-Specified Criteria|10|||
105695319|NCT01854645|364548344|FG002|Overall Study|Protocol-Specified Criteria|8|||
105695320|NCT01854645|364548345|FG003|Overall Study|Protocol-Specified Criteria|5|||
105695321|NCT01854645|364548346|FG004|Overall Study|Protocol-Specified Criteria|7|||
105695322|NCT01854645|364548342|FG000|Overall Study|Administrative Reasons / Missing|0|||
105695323|NCT01854645|364548343|FG001|Overall Study|Administrative Reasons / Missing|0|||
105922349|NCT02765165|365376550|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105922350|NCT02765165|365376551|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
105922351|NCT02765165|365376545|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
105922352|NCT02765165|365376546|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
105922353|NCT02765165|365376547|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
105922354|NCT02765165|365376548|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
105922355|NCT02765165|365376549|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
105922356|NCT02765165|365376550|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
105922357|NCT02765165|365376551|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
105922358|NCT02765165|365376545|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
105922359|NCT02765165|365376546|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
105922360|NCT02765165|365376547|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
105922361|NCT02765165|365376548|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
105922362|NCT02765165|365376549|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
105922363|NCT02765165|365376550|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
105922364|NCT02765165|365376551|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
105922365|NCT00537277|365376552|FG000|Overall Study|Adverse Event|1|||
105922366|NCT00537277|365376552|FG000|Overall Study|Lack of Efficacy|2|||
105922367|NCT00537277|365376552|FG000|Overall Study|Lost to Follow-up|12|||
105922368|NCT00537277|365376552|FG000|Overall Study|Protocol Violation|11|||
105922369|NCT00537277|365376552|FG000|Overall Study|Unclassified|4|||
105695324|NCT01854645|364548344|FG002|Overall Study|Administrative Reasons / Missing|0|||
105695325|NCT01854645|364548345|FG003|Overall Study|Administrative Reasons / Missing|1|||
105695326|NCT01854645|364548346|FG004|Overall Study|Administrative Reasons / Missing|1|||
105695327|NCT01854645|364548342|FG000|Overall Study|Protocol Violation|3|||
105695328|NCT01854645|364548343|FG001|Overall Study|Protocol Violation|0|||
105922370|NCT00537277|365376552|FG000|Overall Study|Inability to tolerate trial medication|4|||
105695329|NCT01854645|364548344|FG002|Overall Study|Protocol Violation|5|||
105695330|NCT01854645|364548345|FG003|Overall Study|Protocol Violation|4|||
105695331|NCT01854645|364548346|FG004|Overall Study|Protocol Violation|1|||
105695332|NCT01854645|364548342|FG000|Overall Study|Lost to Follow-up|10|||
105695333|NCT01854645|364548343|FG001|Overall Study|Lost to Follow-up|7|||
105922371|NCT00537277|365376552|FG000|Overall Study|Non-compliance with trial procedures|15|||
105922372|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
105695334|NCT01854645|364548344|FG002|Overall Study|Lost to Follow-up|8|||
105695335|NCT01854645|364548345|FG003|Overall Study|Lost to Follow-up|5|||
105695336|NCT01854645|364548346|FG004|Overall Study|Lost to Follow-up|0|||
105695337|NCT01854645|364548342|FG000|Overall Study|Physician Decision|1|||
105695338|NCT01854645|364548343|FG001|Overall Study|Physician Decision|5|||
105695339|NCT01854645|364548344|FG002|Overall Study|Physician Decision|3|||
105695340|NCT01854645|364548345|FG003|Overall Study|Physician Decision|3|||
105695341|NCT01854645|364548346|FG004|Overall Study|Physician Decision|7|||
105695342|NCT01854645|364548342|FG000|Overall Study|Withdrawal by Subject|31|||
105695343|NCT01854645|364548343|FG001|Overall Study|Withdrawal by Subject|41|||
105695344|NCT01854645|364548344|FG002|Overall Study|Withdrawal by Subject|30|||
105695345|NCT01854645|364548345|FG003|Overall Study|Withdrawal by Subject|21|||
105695346|NCT01854645|364548346|FG004|Overall Study|Withdrawal by Subject|24|||
105695347|NCT01854645|364548342|FG000|Overall Study|Lack of Efficacy|7|||
105695348|NCT01854645|364548343|FG001|Overall Study|Lack of Efficacy|12|||
105695349|NCT01854645|364548344|FG002|Overall Study|Lack of Efficacy|9|||
105695350|NCT01854645|364548345|FG003|Overall Study|Lack of Efficacy|3|||
105922373|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
105695351|NCT01854645|364548346|FG004|Overall Study|Lack of Efficacy|9|||
105695352|NCT01854645|364548342|FG000|Overall Study|Adverse Event|33|||
105695353|NCT01854645|364548343|FG001|Overall Study|Adverse Event|31|||
105695354|NCT01854645|364548344|FG002|Overall Study|Adverse Event|19|||
105695355|NCT01854645|364548345|FG003|Overall Study|Adverse Event|20|||
105695356|NCT01854645|364548346|FG004|Overall Study|Adverse Event|11|||
105695357|NCT01721876|364548347|FG000|Overall Study|Not treated|1|||
105695358|NCT01721876|364548348|FG001|Overall Study|Not treated|4|||
105695359|NCT01721876|364548347|FG000|Overall Study|Disease progression / relapse|123|||
105695360|NCT01721876|364548348|FG001|Overall Study|Disease progression / relapse|156|||
105695361|NCT01721876|364548347|FG000|Overall Study|Death|6|||
105695362|NCT01721876|364548348|FG001|Overall Study|Death|13|||
105695363|NCT01721876|364548347|FG000|Overall Study|Adverse Event|41|||
105695364|NCT01721876|364548348|FG001|Overall Study|Adverse Event|165|||
105695365|NCT01721876|364548347|FG000|Overall Study|Protocol Violation|2|||
105695366|NCT01721876|364548348|FG001|Overall Study|Protocol Violation|1|||
105695367|NCT01721876|364548347|FG000|Overall Study|Withdrawal by Subject|15|||
105695368|NCT01721876|364548348|FG001|Overall Study|Withdrawal by Subject|38|||
105695369|NCT01721876|364548347|FG000|Overall Study|Reason not listed|34|||
105695370|NCT01721876|364548348|FG001|Overall Study|Reason not listed|63|||
105695371|NCT01721876|364548347|FG000|Overall Study|Sponsor terminated trial|0|||
105695372|NCT01721876|364548348|FG001|Overall Study|Sponsor terminated trial|4|||
105695373|NCT01202279|364548351|FG000|Overall Study|Adverse Event|8|||
105695374|NCT01202279|364548352|FG001|Overall Study|Adverse Event|6|||
105695375|NCT01202279|364548351|FG000|Overall Study|Withdrawal by Subject|13|||
105695376|NCT01202279|364548352|FG001|Overall Study|Withdrawal by Subject|10|||
105695377|NCT01202279|364548351|FG000|Overall Study|Physician Decision|0|||
105695378|NCT01202279|364548352|FG001|Overall Study|Physician Decision|1|||
105695379|NCT01202279|364548351|FG000|Overall Study|Lost to Follow-up|10|||
105695380|NCT01202279|364548352|FG001|Overall Study|Lost to Follow-up|7|||
105695381|NCT01202279|364548351|FG000|Overall Study|Protocol Violation|1|||
105695382|NCT01202279|364548352|FG001|Overall Study|Protocol Violation|1|||
105922374|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
105922375|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
105922376|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
105922377|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
105695383|NCT01202279|364548351|FG000|Overall Study|study compliance|5|||
105695384|NCT01202279|364548352|FG001|Overall Study|study compliance|2|||
105695385|NCT03805750|364548353|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
105695386|NCT03805750|364548354|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
105695387|NCT01984164|364548355|FG000|Overall Study|Withdrawal by Subject|4|||
105922378|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
105695388|NCT01984164|364548356|FG001|Overall Study|Withdrawal by Subject|3|||
105695389|NCT01984164|364548355|FG000|Overall Study|Adverse Event|5|||
105695390|NCT01984164|364548356|FG001|Overall Study|Adverse Event|19|||
105695391|NCT01984164|364548355|FG000|Overall Study|Lost to Follow-up|1|||
105695392|NCT01984164|364548356|FG001|Overall Study|Lost to Follow-up|3|||
105695393|NCT02546765|364548359|FG000|Overall Study|Withdrawal by Subject|0|||
105695394|NCT02546765|364548360|FG001|Overall Study|Withdrawal by Subject|1|||
105695395|NCT02546765|364548361|FG002|Overall Study|Withdrawal by Subject|0|||
105695396|NCT02546765|364548362|FG003|Overall Study|Withdrawal by Subject|0|||
105695397|NCT00475722|364548363|FG000|Overall Study|Withdrawal by Subject|12|||
105695398|NCT00475722|364548364|FG001|Overall Study|Withdrawal by Subject|12|||
105695399|NCT00475722|364548363|FG000|Overall Study|Protocol Violation|3|||
105695400|NCT00475722|364548364|FG001|Overall Study|Protocol Violation|0|||
105695401|NCT02568475|364548365|FG000|Overall Study|Lost to Follow-up|40|||
105695402|NCT02568475|364548366|FG001|Overall Study|Lost to Follow-up|39|||
105695403|NCT02568475|364548365|FG000|Overall Study|Withdrawal by Subject|2|||
105695404|NCT02568475|364548366|FG001|Overall Study|Withdrawal by Subject|0|||
105695405|NCT02568475|364548365|FG000|Overall Study|Discharged home|4|||
105695406|NCT02568475|364548366|FG001|Overall Study|Discharged home|4|||
105695407|NCT02568475|364548365|FG000|Overall Study|Short-term: Discharge location unknown|4|||
105695408|NCT02568475|364548366|FG001|Overall Study|Short-term: Discharge location unknown|0|||
105695409|NCT02568475|364548365|FG000|Overall Study|Transferred to another facility|1|||
105695410|NCT02568475|364548366|FG001|Overall Study|Transferred to another facility|0|||
105695411|NCT00290186|364548367|FG000|Overall Study|Adverse Event|1|||
105695412|NCT00290186|364548368|FG001|Overall Study|Adverse Event|1|||
105695413|NCT00290186|364548367|FG000|Overall Study|Lost to Follow-up|3|||
105695414|NCT00290186|364548368|FG001|Overall Study|Lost to Follow-up|2|||
105695415|NCT00290186|364548367|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
105695416|NCT00290186|364548368|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
105695417|NCT00290186|364548367|FG000|Overall Study|Withdrawal by Subject|0|||
105695418|NCT00290186|364548368|FG001|Overall Study|Withdrawal by Subject|1|||
105695419|NCT01200238|364548372|FG000|Overall Study|Adverse Event|2|||
105695420|NCT01200238|364548373|FG001|Overall Study|Adverse Event|1|||
105695421|NCT01200238|364548372|FG000|Overall Study|Progressive Disease|5|||
105695422|NCT01200238|364548373|FG001|Overall Study|Progressive Disease|8|||
105695423|NCT01200238|364548372|FG000|Overall Study|Withdrawal by Subject|0|||
105922379|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
105922380|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
105922381|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
105922382|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
105922383|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
105922384|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
105922385|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
105922386|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
105922387|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
105922388|NCT00410163|365376553|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
105922389|NCT00410163|365376554|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
105922390|NCT00410163|365376553|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
105922391|NCT00410163|365376554|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
105922392|NCT00410163|365376553|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
105922393|NCT00410163|365376554|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
105922394|NCT00410163|365376553|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
105922395|NCT00410163|365376554|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
105922396|NCT00410163|365376553|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
105922397|NCT00410163|365376554|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
105695424|NCT01200238|364548373|FG001|Overall Study|Withdrawal by Subject|1|||
105695425|NCT03441334|364549814|FG000|Overall Study|Withdrawal by Subject|1|||
105922398|NCT00410163|365376553|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
105695426|NCT03441334|364549815|FG001|Overall Study|Withdrawal by Subject|0|||
105695427|NCT00395863|364549818|FG000|Overall Study|Patients did not complete both exams|2|||
105695428|NCT00395863|364549819|FG001|Overall Study|Patients did not complete both exams|3|||
105695429|NCT03034460|364549823|FG000|Overall Study|Adverse Event|0|||
105695430|NCT03034460|364549824|FG001|Overall Study|Adverse Event|1|||
105695431|NCT03034460|364549823|FG000|Overall Study|Withdrawal by Subject|2|||
105695432|NCT03034460|364549824|FG001|Overall Study|Withdrawal by Subject|2|||
105695433|NCT03034460|364549823|FG000|Overall Study|Personal Reasons|1|||
105695434|NCT03034460|364549824|FG001|Overall Study|Personal Reasons|0|||
105695435|NCT00295633|364549825|FG000|Overall Study|Lack of Efficacy|19|||
105695436|NCT00295633|364549826|FG001|Overall Study|Lack of Efficacy|7|||
105922399|NCT00410163|365376554|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
105922400|NCT04009837|365376555|FG000|Overall Study|Withdrawal by Subject|5|||
105922401|NCT04009837|365376556|FG001|Overall Study|Withdrawal by Subject|4|||
106132497|NCT01008748|366143230|FG000|Overall Study|Other|1|||
105695437|NCT00295633|364549827|FG002|Overall Study|Lack of Efficacy|16|||
105695438|NCT00295633|364549825|FG000|Overall Study|Withdrawal of consent by subject|16|||
105695439|NCT00295633|364549826|FG001|Overall Study|Withdrawal of consent by subject|16|||
105695440|NCT00295633|364549827|FG002|Overall Study|Withdrawal of consent by subject|26|||
105695441|NCT00295633|364549825|FG000|Overall Study|Adverse Event|9|||
105695442|NCT00295633|364549826|FG001|Overall Study|Adverse Event|17|||
105695443|NCT00295633|364549827|FG002|Overall Study|Adverse Event|9|||
105695444|NCT00295633|364549825|FG000|Overall Study|Lost to Follow-up|6|||
105922402|NCT04009837|365376555|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
105922403|NCT04009837|365376556|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
105922404|NCT00112957|365376559|FG000|Overall Study|Progressive disease|18|||
105922405|NCT00112957|365376559|FG000|Overall Study|Physician Decision|1|||
105922406|NCT00797563|365376561|FG000|Overall Study|Adverse Event|1|||
105922407|NCT02309359|365376562|FG000|Overall Study|Adverse Event|4|||
105922408|NCT02309359|365376563|FG001|Overall Study|Adverse Event|5|||
105922409|NCT02309359|365376564|FG002|Overall Study|Adverse Event|5|||
105922410|NCT02309359|365376565|FG003|Overall Study|Adverse Event|4|||
105922411|NCT02309359|365376566|FG004|Overall Study|Adverse Event|4|||
105922412|NCT02309359|365376562|FG000|Overall Study|Death|1|||
105922413|NCT02309359|365376563|FG001|Overall Study|Death|0|||
105922414|NCT02309359|365376564|FG002|Overall Study|Death|0|||
105922415|NCT02309359|365376565|FG003|Overall Study|Death|0|||
105922416|NCT02309359|365376566|FG004|Overall Study|Death|0|||
105922417|NCT02309359|365376562|FG000|Overall Study|Withdrawal by Subject|2|||
105922418|NCT02309359|365376563|FG001|Overall Study|Withdrawal by Subject|2|||
105922419|NCT02309359|365376564|FG002|Overall Study|Withdrawal by Subject|4|||
105922420|NCT02309359|365376565|FG003|Overall Study|Withdrawal by Subject|4|||
105922421|NCT02309359|365376566|FG004|Overall Study|Withdrawal by Subject|0|||
105922422|NCT02309359|365376562|FG000|Overall Study|Lack of Efficacy|3|||
105922423|NCT02309359|365376563|FG001|Overall Study|Lack of Efficacy|1|||
105922424|NCT02309359|365376564|FG002|Overall Study|Lack of Efficacy|0|||
105922425|NCT02309359|365376565|FG003|Overall Study|Lack of Efficacy|0|||
105922426|NCT02309359|365376566|FG004|Overall Study|Lack of Efficacy|3|||
105922427|NCT02309359|365376562|FG000|Overall Study|Lost to Follow-up|0|||
105922428|NCT02309359|365376563|FG001|Overall Study|Lost to Follow-up|0|||
105922429|NCT02309359|365376564|FG002|Overall Study|Lost to Follow-up|0|||
105922430|NCT02309359|365376565|FG003|Overall Study|Lost to Follow-up|1|||
105922431|NCT02309359|365376566|FG004|Overall Study|Lost to Follow-up|0|||
105922432|NCT02309359|365376562|FG000|Overall Study|Other|2|||
105922433|NCT02309359|365376563|FG001|Overall Study|Other|0|||
105922434|NCT02309359|365376564|FG002|Overall Study|Other|2|||
105922435|NCT02309359|365376565|FG003|Overall Study|Other|3|||
105922436|NCT02309359|365376566|FG004|Overall Study|Other|2|||
105922437|NCT01192815|365376567|FG000|Overall Study|Withdrawal by Subject|1|||
105922438|NCT01192815|365376567|FG000|Overall Study|Lack of Efficacy|1|||
105922439|NCT02592824|365376568|FG000|Overall Study|Protocol Violation|5|||
105922440|NCT02592824|365376569|FG001|Overall Study|Protocol Violation|3|||
105922441|NCT02592824|365376568|FG000|Overall Study|Lost to Follow-up|2|||
105922442|NCT02592824|365376569|FG001|Overall Study|Lost to Follow-up|1|||
105922443|NCT01142336|365376570|FG000|Overall Study|Adverse Event|1|||
105922444|NCT01142336|365376571|FG001|Overall Study|Adverse Event|1|||
105922445|NCT01142336|365376570|FG000|Overall Study|Lost to Follow-up|0|||
105922446|NCT01142336|365376571|FG001|Overall Study|Lost to Follow-up|1|||
105922447|NCT01704261|365376572|FG000|Overall Study|Withdrawal by Subject|12|||
105922448|NCT01704261|365376573|FG001|Overall Study|Withdrawal by Subject|15|||
105922449|NCT01704261|365376572|FG000|Overall Study|Lost to Follow-up|1|||
105922450|NCT01704261|365376573|FG001|Overall Study|Lost to Follow-up|0|||
105922451|NCT00924898|365376574|FG000|Overall Study|Withdrawal by Subject|2|||
105922452|NCT01604785|365376575|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
105922453|NCT01604785|365376576|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
105922454|NCT00869960|365376577|FG000|Overall Study|Lost to Follow-up|2|||
105922455|NCT00314145|365376586|FG000|Overall Study|Withdrawal by Subject|8|||
105922456|NCT00314145|365376587|FG001|Overall Study|Withdrawal by Subject|10|||
105922457|NCT00314145|365376586|FG000|Overall Study|Lost to Follow-up|5|||
105922458|NCT00314145|365376587|FG001|Overall Study|Lost to Follow-up|12|||
105695445|NCT00295633|364549826|FG001|Overall Study|Lost to Follow-up|11|||
105695446|NCT00295633|364549827|FG002|Overall Study|Lost to Follow-up|7|||
105922459|NCT00314145|365376586|FG000|Overall Study|Physician Decision|3|||
105922460|NCT00314145|365376587|FG001|Overall Study|Physician Decision|4|||
105922461|NCT00314145|365376586|FG000|Overall Study|Adverse Event|0|||
105922462|NCT00314145|365376587|FG001|Overall Study|Adverse Event|3|||
105922463|NCT00314145|365376586|FG000|Overall Study|Protocol Violation|3|||
105922464|NCT00314145|365376587|FG001|Overall Study|Protocol Violation|0|||
105922465|NCT00314145|365376586|FG000|Overall Study|Sponsor Decision|2|||
105922466|NCT00314145|365376587|FG001|Overall Study|Sponsor Decision|0|||
105922467|NCT00639509|365376590|FG000|Overall Study|Death|1|||
105922468|NCT01143324|365376598|FG000|Overall Study|Lost to Follow-up|11|||
105922469|NCT01143324|365376598|FG000|Overall Study|Withdrawal by Subject|4|||
105922470|NCT01143324|365376598|FG000|Overall Study|Explant of the device|4|||
105922471|NCT02916927|365376599|FG000|Overall Study|Discharged prior to study drug receipt|0|||
105922472|NCT02916927|365376600|FG001|Overall Study|Discharged prior to study drug receipt|2|||
105922473|NCT02916927|365376599|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
105922474|NCT02916927|365376600|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
105922475|NCT02916927|365376599|FG000|Overall Study|Withdrawal before first time point|1|||
105922476|NCT02916927|365376600|FG001|Overall Study|Withdrawal before first time point|0|||
105922477|NCT01387269|365376601|FG000|Overall Study|Death|38|||
105922478|NCT01387269|365376602|FG001|Overall Study|Death|20|||
105922479|NCT01387269|365376601|FG000|Overall Study|Other|8|||
105922480|NCT01387269|365376602|FG001|Overall Study|Other|7|||
105922481|NCT01387269|365376601|FG000|Overall Study|Unrelated AE|12|||
105922482|NCT01387269|365376602|FG001|Overall Study|Unrelated AE|3|||
105922483|NCT01387269|365376601|FG000|Overall Study|Withdrawal by patient|32|||
105922484|NCT01387269|365376602|FG001|Overall Study|Withdrawal by patient|10|||
105922485|NCT01387269|365376601|FG000|Overall Study|Study drug-related AE|1|||
105922486|NCT01387269|365376602|FG001|Overall Study|Study drug-related AE|0|||
105922487|NCT01387269|365376601|FG000|Overall Study|Lost to Follow-up|1|||
105922488|NCT01387269|365376602|FG001|Overall Study|Lost to Follow-up|0|||
105922489|NCT00141817|365376604|FG000|Overall Study|Protocol Violation|0|||
105922490|NCT00141817|365376605|FG001|Overall Study|Protocol Violation|0|||
105922491|NCT00141817|365376606|FG002|Overall Study|Protocol Violation|1|||
105922492|NCT00141817|365376607|FG003|Overall Study|Protocol Violation|0|||
105922493|NCT00141817|365376604|FG000|Overall Study|Parent request|1|||
105922494|NCT00141817|365376605|FG001|Overall Study|Parent request|0|||
106004877|NCT03287791|365682588|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
106004878|NCT03287791|365682586|FG000|Overall Study|Too much time between 2 visits|0|||
106004879|NCT03287791|365682587|FG001|Overall Study|Too much time between 2 visits|1|||
106004880|NCT03287791|365682588|FG002|Overall Study|Too much time between 2 visits|0|||
106004881|NCT03287791|365682586|FG000|Overall Study|Non-compliance|0|||
106004882|NCT03287791|365682587|FG001|Overall Study|Non-compliance|1|||
106132498|NCT04824131|366143233|FG000|CAB LA Oral Phase|Adverse Event|1|||
105695447|NCT00295633|364549825|FG000|Overall Study|Physician Decision|9|||
105695448|NCT00295633|364549826|FG001|Overall Study|Physician Decision|10|||
105695449|NCT00295633|364549827|FG002|Overall Study|Physician Decision|8|||
105695450|NCT00295633|364549825|FG000|Overall Study|Poor/Noncompliance|2|||
105695451|NCT00295633|364549826|FG001|Overall Study|Poor/Noncompliance|2|||
105695452|NCT00295633|364549827|FG002|Overall Study|Poor/Noncompliance|6|||
105695453|NCT00295633|364549825|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
105695454|NCT00295633|364549826|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
105695455|NCT00295633|364549827|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
105695456|NCT00295633|364549825|FG000|Overall Study|Death|1|||
105695457|NCT00295633|364549826|FG001|Overall Study|Death|1|||
105695458|NCT00295633|364549827|FG002|Overall Study|Death|0|||
105695459|NCT00295633|364549825|FG000|Overall Study|Administrative reason by sponsor|0|||
105695460|NCT00295633|364549826|FG001|Overall Study|Administrative reason by sponsor|0|||
105695461|NCT00295633|364549827|FG002|Overall Study|Administrative reason by sponsor|1|||
105695462|NCT00419120|364549829|FG000|Long Term Follow up Period|study ongoing|10|||
105695463|NCT01069120|364549830|FG000|Overall Study|Study prematurely terminated|27|||
105695464|NCT00710879|364549832|FG000|Overall Study|Lost to Follow-up|2|||
105695465|NCT00710879|364549833|FG001|Overall Study|Lost to Follow-up|1|||
105695466|NCT00710879|364549832|FG000|Overall Study|Protocol Violation|0|||
105695467|NCT00710879|364549833|FG001|Overall Study|Protocol Violation|3|||
105695468|NCT01688466|364549834|FG000|Overall Study|Withdrawal by Subject|2|||
105695469|NCT01688466|364549835|FG001|Overall Study|Withdrawal by Subject|1|||
105695470|NCT01688466|364549834|FG000|Overall Study|Death|0|||
105695471|NCT01688466|364549835|FG001|Overall Study|Death|1|||
105695472|NCT01688466|364549834|FG000|Overall Study|Adverse Event|0|||
105695473|NCT01688466|364549835|FG001|Overall Study|Adverse Event|4|||
105695474|NCT01688466|364549834|FG000|Overall Study|Not evaluable|0|||
105695475|NCT01688466|364549835|FG001|Overall Study|Not evaluable|1|||
105695476|NCT01641237|364549837|FG000|Period II|Withdrawal by Subject|1|||
105695477|NCT01641237|364549838|FG001|Period II|Withdrawal by Subject|0|||
105695478|NCT01641237|364549839|FG002|Period II|Withdrawal by Subject|0|||
105695479|NCT01641237|364549840|FG003|Period II|Withdrawal by Subject|0|||
105922495|NCT00141817|365376606|FG002|Overall Study|Parent request|0|||
105922496|NCT00141817|365376607|FG003|Overall Study|Parent request|0|||
105922497|NCT00127803|365376614|FG000|Overall Study|Adverse Event|2|||
105922498|NCT00127803|365376615|FG001|Overall Study|Adverse Event|0|||
106132499|NCT04824131|366143233|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
106132500|NCT04824131|366143233|FG000|Step 3|Withdrawal by Subject|2|||
105695480|NCT01641237|364549837|FG000|Period III|Lost to Follow-up|1|||
105695481|NCT01641237|364549838|FG001|Period III|Lost to Follow-up|0|||
105695482|NCT01641237|364549839|FG002|Period III|Lost to Follow-up|0|||
105695483|NCT01641237|364549840|FG003|Period III|Lost to Follow-up|0|||
105695484|NCT00709111|364549841|FG000|Overall Study|Withdrawal by Subject|1|||
105695485|NCT00709111|364549841|FG000|Overall Study|Unable to attend clinic visits|1|||
105695486|NCT00915772|364549842|FG000|Overall Study|Adverse Event|12|||
105787104|NCT03110107|364874910|FG021|Treatment Period|Study drug toxicity|0|||
105922499|NCT00127803|365376616|FG002|Overall Study|Adverse Event|0|||
105922500|NCT00127803|365376617|FG003|Overall Study|Adverse Event|0|||
105922501|NCT00127803|365376614|FG000|Overall Study|Withdrawal by Subject|1|||
105922502|NCT00127803|365376615|FG001|Overall Study|Withdrawal by Subject|0|||
105922503|NCT00127803|365376616|FG002|Overall Study|Withdrawal by Subject|0|||
106004883|NCT03287791|365682588|FG002|Overall Study|Non-compliance|0|||
105922504|NCT00127803|365376617|FG003|Overall Study|Withdrawal by Subject|0|||
105695487|NCT00915772|364549843|FG001|Overall Study|Adverse Event|13|||
105695488|NCT00915772|364549844|FG002|Overall Study|Adverse Event|11|||
105695489|NCT00915772|364549842|FG000|Overall Study|Protocol Violation|4|||
105695490|NCT00915772|364549843|FG001|Overall Study|Protocol Violation|1|||
105695491|NCT00915772|364549844|FG002|Overall Study|Protocol Violation|2|||
105695492|NCT00915772|364549842|FG000|Overall Study|Lost to Follow-up|1|||
105695493|NCT00915772|364549843|FG001|Overall Study|Lost to Follow-up|2|||
105695494|NCT00915772|364549844|FG002|Overall Study|Lost to Follow-up|2|||
105695495|NCT00915772|364549842|FG000|Overall Study|Lack of Efficacy|9|||
105695496|NCT00915772|364549843|FG001|Overall Study|Lack of Efficacy|15|||
105695497|NCT00915772|364549844|FG002|Overall Study|Lack of Efficacy|3|||
105695498|NCT00915772|364549842|FG000|Overall Study|Refused to continue trial medication|6|||
105695499|NCT00915772|364549843|FG001|Overall Study|Refused to continue trial medication|8|||
105695500|NCT00915772|364549844|FG002|Overall Study|Refused to continue trial medication|4|||
105695501|NCT00915772|364549842|FG000|Overall Study|Any other reason|4|||
105695502|NCT00915772|364549843|FG001|Overall Study|Any other reason|7|||
105695503|NCT00915772|364549844|FG002|Overall Study|Any other reason|7|||
105695504|NCT00041080|364549853|FG000|Overall Study|Adverse Event|21|||
105695505|NCT00041080|364549854|FG001|Overall Study|Adverse Event|1|||
105695506|NCT00041080|364549853|FG000|Overall Study|Withdrawal by Subject|6|||
105695507|NCT00041080|364549854|FG001|Overall Study|Withdrawal by Subject|6|||
105695508|NCT00041080|364549853|FG000|Overall Study|Concommitant Illness/Other|1|||
105695509|NCT00041080|364549854|FG001|Overall Study|Concommitant Illness/Other|2|||
105695510|NCT00041080|364549853|FG000|Overall Study|Did not start therapy|1|||
105695511|NCT00041080|364549854|FG001|Overall Study|Did not start therapy|1|||
105695512|NCT00041080|364549853|FG000|Overall Study|Ineligible|1|||
105695513|NCT00041080|364549854|FG001|Overall Study|Ineligible|0|||
105695514|NCT01670539|364549855|FG000|Overall Study|Death|3|||
105695515|NCT01670539|364549856|FG001|Overall Study|Death|5|||
105695516|NCT01670539|364549855|FG000|Overall Study|Withdrawal by Subject|3|||
105695517|NCT01670539|364549856|FG001|Overall Study|Withdrawal by Subject|0|||
105695518|NCT00536809|364549859|FG000|Phase II|Adverse Event|1|||
105695519|NCT00536809|364549859|FG000|Phase II|Referred for surgical resection|1|||
105695520|NCT01526551|364549862|FG000|Overall Study|Lack of returned parental consent form|424|||
105695521|NCT05215262|364549863|FG000|Overall Study|Lost to Follow-up|12|||
105695522|NCT05215262|364549864|FG001|Overall Study|Lost to Follow-up|0|||
105695523|NCT00873366|364549866|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
105695524|NCT00873366|364549866|FG000|Overall Study|Off tamoxifen due to side effects|2|||
105695525|NCT00873366|364549866|FG000|Overall Study|Refused to continue DM-BT testing|3|||
105695526|NCT00646906|364549867|FG000|Crossover Period 1|Withdrawal by Subject|1|||
105695527|NCT00646906|364549868|FG001|Crossover Period 1|Withdrawal by Subject|0|||
105695528|NCT00646906|364549869|FG002|Crossover Period 1|Withdrawal by Subject|0|||
105695529|NCT00646906|364549870|FG003|Crossover Period 1|Withdrawal by Subject|0|||
105695530|NCT00646906|364549871|FG004|Crossover Period 1|Withdrawal by Subject|0|||
105695531|NCT00646906|364549872|FG005|Crossover Period 1|Withdrawal by Subject|1|||
105922505|NCT00127803|365376614|FG000|Overall Study|Lost to Follow-up|0|||
105922506|NCT00127803|365376615|FG001|Overall Study|Lost to Follow-up|0|||
105922507|NCT00127803|365376616|FG002|Overall Study|Lost to Follow-up|0|||
105922508|NCT00127803|365376617|FG003|Overall Study|Lost to Follow-up|1|||
105922509|NCT01047319|365376622|FG000|Overall Study|Teva requested participant withdrawal|3|||
105922510|NCT01047319|365376623|FG001|Overall Study|Teva requested participant withdrawal|0|||
105922511|NCT01047319|365376624|FG002|Overall Study|Teva requested participant withdrawal|1|||
105922512|NCT01047319|365376622|FG000|Overall Study|Protocol Violation|3|||
105922513|NCT01047319|365376623|FG001|Overall Study|Protocol Violation|2|||
105922514|NCT01047319|365376624|FG002|Overall Study|Protocol Violation|4|||
105922515|NCT01047319|365376622|FG000|Overall Study|Lack of Efficacy|4|||
105922516|NCT01047319|365376623|FG001|Overall Study|Lack of Efficacy|3|||
105922517|NCT01047319|365376624|FG002|Overall Study|Lack of Efficacy|3|||
105922518|NCT01047319|365376622|FG000|Overall Study|Death|5|||
105695532|NCT00646906|364549873|FG006|Crossover Period 1|Withdrawal by Subject|0|||
105695533|NCT00646906|364549867|FG000|Crossover Period 2|Withdrawal by Subject|0|||
105695534|NCT00646906|364549868|FG001|Crossover Period 2|Withdrawal by Subject|1|||
105695535|NCT00646906|364549869|FG002|Crossover Period 2|Withdrawal by Subject|2|||
105695536|NCT00646906|364549870|FG003|Crossover Period 2|Withdrawal by Subject|1|||
105695537|NCT00646906|364549871|FG004|Crossover Period 2|Withdrawal by Subject|0|||
105695538|NCT00646906|364549872|FG005|Crossover Period 2|Withdrawal by Subject|0|||
105695539|NCT00646906|364549873|FG006|Crossover Period 2|Withdrawal by Subject|0|||
105695540|NCT00646906|364549867|FG000|Crossover Period 2|Physician Decision|0|||
105922519|NCT01047319|365376623|FG001|Overall Study|Death|1|||
105922520|NCT01047319|365376624|FG002|Overall Study|Death|5|||
105922521|NCT01047319|365376622|FG000|Overall Study|Pregnancy|13|||
105922522|NCT01047319|365376623|FG001|Overall Study|Pregnancy|8|||
105922523|NCT01047319|365376624|FG002|Overall Study|Pregnancy|8|||
105695541|NCT00646906|364549868|FG001|Crossover Period 2|Physician Decision|0|||
105695542|NCT00646906|364549869|FG002|Crossover Period 2|Physician Decision|0|||
105695543|NCT00646906|364549870|FG003|Crossover Period 2|Physician Decision|0|||
105695544|NCT00646906|364549871|FG004|Crossover Period 2|Physician Decision|0|||
105695545|NCT00646906|364549872|FG005|Crossover Period 2|Physician Decision|0|||
105695546|NCT00646906|364549873|FG006|Crossover Period 2|Physician Decision|1|||
105695547|NCT02613884|364549882|FG000|Overall Study|Death|1|||
105695548|NCT02613884|364549882|FG000|Overall Study|Lost to Follow-up|1|||
105695549|NCT04422990|364549883|FG000|Overall Study|Withdrawal by Subject|0|||
105695550|NCT04422990|364549884|FG001|Overall Study|Withdrawal by Subject|1|||
105695551|NCT04422990|364549883|FG000|Overall Study|Travel|3|||
105695552|NCT04422990|364549884|FG001|Overall Study|Travel|0|||
105695553|NCT02486653|364549887|FG000|Overall Study|Withdrawal by Subject|1|||
105695554|NCT02486653|364549888|FG001|Overall Study|Withdrawal by Subject|3|||
105695555|NCT02486653|364549887|FG000|Overall Study|Protocol Violation|1|||
105695556|NCT02486653|364549888|FG001|Overall Study|Protocol Violation|0|||
105695557|NCT02486653|364549887|FG000|Overall Study|surgery cancelled|4|||
105695558|NCT02486653|364549888|FG001|Overall Study|surgery cancelled|1|||
105695559|NCT01092143|364549889|FG000|Overall Study|Adverse Event|10|||
105695560|NCT01092143|364549890|FG001|Overall Study|Adverse Event|5|||
105695561|NCT01092143|364549891|FG002|Overall Study|Adverse Event|1|||
105695562|NCT01092143|364549892|FG003|Overall Study|Adverse Event|4|||
105695563|NCT01092143|364549893|FG004|Overall Study|Adverse Event|3|||
105695564|NCT01092143|364549889|FG000|Overall Study|Lost to Follow-up|1|||
105695565|NCT01092143|364549890|FG001|Overall Study|Lost to Follow-up|0|||
105695566|NCT01092143|364549891|FG002|Overall Study|Lost to Follow-up|1|||
105695567|NCT01092143|364549892|FG003|Overall Study|Lost to Follow-up|0|||
105695568|NCT01092143|364549893|FG004|Overall Study|Lost to Follow-up|0|||
105695569|NCT01092143|364549889|FG000|Overall Study|Consent withdrawn|2|||
105695570|NCT01092143|364549890|FG001|Overall Study|Consent withdrawn|1|||
105695571|NCT01092143|364549891|FG002|Overall Study|Consent withdrawn|0|||
105695572|NCT01092143|364549892|FG003|Overall Study|Consent withdrawn|1|||
105695573|NCT01092143|364549893|FG004|Overall Study|Consent withdrawn|3|||
105695574|NCT01092143|364549889|FG000|Overall Study|Not treated|0|||
105695575|NCT01092143|364549890|FG001|Overall Study|Not treated|0|||
105695576|NCT01092143|364549891|FG002|Overall Study|Not treated|1|||
105695577|NCT01092143|364549892|FG003|Overall Study|Not treated|0|||
105695578|NCT01092143|364549893|FG004|Overall Study|Not treated|0|||
105695579|NCT01092143|364549889|FG000|Overall Study|did not reversibility criteria|0|||
105695580|NCT01092143|364549890|FG001|Overall Study|did not reversibility criteria|0|||
105695581|NCT01092143|364549891|FG002|Overall Study|did not reversibility criteria|1|||
105695582|NCT01092143|364549892|FG003|Overall Study|did not reversibility criteria|0|||
105695583|NCT01092143|364549893|FG004|Overall Study|did not reversibility criteria|0|||
105695584|NCT01092143|364549889|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
105695585|NCT01092143|364549890|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
105695586|NCT01092143|364549891|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
105695587|NCT01092143|364549892|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
105695588|NCT01092143|364549893|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
105695589|NCT01092143|364549889|FG000|Overall Study|Ineligible patient|1|||
105695590|NCT01092143|364549890|FG001|Overall Study|Ineligible patient|0|||
105695591|NCT01092143|364549891|FG002|Overall Study|Ineligible patient|0|||
105695592|NCT01092143|364549892|FG003|Overall Study|Ineligible patient|0|||
105695593|NCT01092143|364549893|FG004|Overall Study|Ineligible patient|0|||
105695594|NCT01092143|364549889|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
105695595|NCT01092143|364549890|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
105695596|NCT01092143|364549891|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
105922524|NCT01047319|365376622|FG000|Overall Study|Physician Decision|12|||
105922525|NCT01047319|365376623|FG001|Overall Study|Physician Decision|9|||
105922526|NCT01047319|365376624|FG002|Overall Study|Physician Decision|10|||
105695597|NCT01092143|364549892|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
105695598|NCT01092143|364549893|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
105695599|NCT01092143|364549889|FG000|Overall Study|Patient travel|0|||
105695600|NCT01092143|364549890|FG001|Overall Study|Patient travel|0|||
105695601|NCT01092143|364549891|FG002|Overall Study|Patient travel|0|||
105695602|NCT01092143|364549892|FG003|Overall Study|Patient travel|0|||
105695603|NCT01092143|364549893|FG004|Overall Study|Patient travel|1|||
105695604|NCT01092143|364549889|FG000|Overall Study|Non compliance with study medication|0|||
105695605|NCT01092143|364549890|FG001|Overall Study|Non compliance with study medication|0|||
105922527|NCT01047319|365376622|FG000|Overall Study|Lost to Follow-up|14|||
105695606|NCT01092143|364549891|FG002|Overall Study|Non compliance with study medication|0|||
105695607|NCT01092143|364549892|FG003|Overall Study|Non compliance with study medication|0|||
105695608|NCT01092143|364549893|FG004|Overall Study|Non compliance with study medication|1|||
105695609|NCT01092143|364549889|FG000|Overall Study|Randomized by mistake|0|||
105695610|NCT01092143|364549890|FG001|Overall Study|Randomized by mistake|0|||
105922528|NCT01047319|365376623|FG001|Overall Study|Lost to Follow-up|10|||
105922529|NCT01047319|365376624|FG002|Overall Study|Lost to Follow-up|10|||
105922530|NCT01047319|365376622|FG000|Overall Study|Adverse Event|16|||
105922531|NCT01047319|365376623|FG001|Overall Study|Adverse Event|27|||
105922532|NCT01047319|365376624|FG002|Overall Study|Adverse Event|21|||
105922533|NCT01047319|365376622|FG000|Overall Study|Withdrawal by Subject|77|||
106132501|NCT00121199|366143234|FG000|Overall Study|Adverse Event|11|||
106132502|NCT00121199|366143234|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
106132503|NCT00121199|366143234|FG000|Overall Study|Progression/Relapse|1|||
106132504|NCT00121199|366143234|FG000|Overall Study|Death|3|||
106132505|NCT00121199|366143234|FG000|Overall Study|Other - Not Protocol Specified|3|||
106132506|NCT00121199|366143234|FG000|Overall Study|Ineligible|9|||
106132507|NCT02820051|366143238|FG000|Overall Study|Lost to Follow-up|7|||
106132508|NCT02820051|366143239|FG001|Overall Study|Lost to Follow-up|4|||
106132509|NCT01723774|366143240|FG000|Neoadjuvant|Ki67 > 10%|4|||
106132510|NCT01723774|366143241|FG001|Neoadjuvant|Ki67 > 10%|0|||
106132511|NCT01723774|366143242|FG002|Neoadjuvant|Ki67 > 10%|10|||
106132512|NCT01723774|366143243|FG003|Neoadjuvant|Ki67 > 10%|0|||
106132513|NCT01723774|366143240|FG000|Neoadjuvant|Withdrawal by Subject|3|||
106132514|NCT01723774|366143241|FG001|Neoadjuvant|Withdrawal by Subject|1|||
106132515|NCT01723774|366143242|FG002|Neoadjuvant|Withdrawal by Subject|0|||
106132516|NCT01723774|366143243|FG003|Neoadjuvant|Withdrawal by Subject|0|||
106132517|NCT01723774|366143240|FG000|Neoadjuvant|Disease progression|0|||
106132518|NCT01723774|366143241|FG001|Neoadjuvant|Disease progression|1|||
106132519|NCT01723774|366143242|FG002|Neoadjuvant|Disease progression|1|||
106132520|NCT01723774|366143243|FG003|Neoadjuvant|Disease progression|0|||
106132521|NCT01723774|366143240|FG000|Neoadjuvant|Adverse Event|0|||
106132522|NCT01723774|366143241|FG001|Neoadjuvant|Adverse Event|1|||
106132523|NCT01723774|366143242|FG002|Neoadjuvant|Adverse Event|2|||
106132524|NCT01723774|366143243|FG003|Neoadjuvant|Adverse Event|0|||
106132525|NCT01723774|366143240|FG000|Neoadjuvant|High estradiol|0|||
106132526|NCT01723774|366143241|FG001|Neoadjuvant|High estradiol|1|||
106132527|NCT01723774|366143242|FG002|Neoadjuvant|High estradiol|0|||
106132528|NCT01723774|366143243|FG003|Neoadjuvant|High estradiol|0|||
106132529|NCT04956692|366143244|FG000|Overall Study|Death|115|||
106132530|NCT04956692|366143245|FG001|Overall Study|Death|47|||
106132531|NCT04956692|366143244|FG000|Overall Study|Lost to Follow-up|0|||
106132532|NCT04956692|366143245|FG001|Overall Study|Lost to Follow-up|1|||
106132533|NCT04956692|366143244|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
106132534|NCT04956692|366143245|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
106132535|NCT04956692|366143244|FG000|Overall Study|Withdrawal by Subject|5|||
106132536|NCT04956692|366143245|FG001|Overall Study|Withdrawal by Subject|2|||
106132537|NCT04956692|366143244|FG000|Overall Study|Ongoing in Study|236|||
106132538|NCT04956692|366143245|FG001|Overall Study|Ongoing in Study|123|||
106132539|NCT00614744|366143251|FG000|Overall Study|Lost to Follow-up|5|||
106132540|NCT00614744|366143252|FG001|Overall Study|Lost to Follow-up|4|||
106132541|NCT00614744|366143251|FG000|Overall Study|Incomplete for Behavior Issues|0|||
106132542|NCT00614744|366143252|FG001|Overall Study|Incomplete for Behavior Issues|2|||
106132543|NCT01822821|366143253|FG000|Overall Study|Eligible surgery cancelled|1|||
106132544|NCT01822821|366143254|FG001|Overall Study|Eligible surgery cancelled|1|||
106132545|NCT01822821|366143253|FG000|Overall Study|Other reasons|1|||
106132546|NCT01822821|366143254|FG001|Overall Study|Other reasons|0|||
106132547|NCT02042443|366143255|FG000|Overall Study|Adverse Event|2|||
106132548|NCT02042443|366143256|FG001|Overall Study|Adverse Event|1|||
106132549|NCT02042443|366143255|FG000|Overall Study|Withdrawal by Subject|0|||
106132550|NCT02042443|366143256|FG001|Overall Study|Withdrawal by Subject|1|||
106132551|NCT02042443|366143255|FG000|Overall Study|Progression|21|||
106132552|NCT02042443|366143256|FG001|Overall Study|Progression|17|||
106132553|NCT02042443|366143255|FG000|Overall Study|not protocol specified|1|||
106132554|NCT02042443|366143256|FG001|Overall Study|not protocol specified|1|||
106132555|NCT02042443|366143255|FG000|Overall Study|Not eligible/not analyzable|3|||
106132556|NCT02042443|366143256|FG001|Overall Study|Not eligible/not analyzable|6|||
106132557|NCT02320253|366143258|FG000|Overall Study|Withdrawal by Subject|3|||
106132558|NCT02320253|366143259|FG001|Overall Study|Withdrawal by Subject|0|||
106132559|NCT02320253|366143260|FG002|Overall Study|Withdrawal by Subject|0|||
106132560|NCT02320253|366143258|FG000|Overall Study|Lost to Follow-up|2|||
106132561|NCT02320253|366143259|FG001|Overall Study|Lost to Follow-up|2|||
106132562|NCT02320253|366143260|FG002|Overall Study|Lost to Follow-up|1|||
106132563|NCT02320253|366143258|FG000|Overall Study|Death|1|||
106132564|NCT02320253|366143259|FG001|Overall Study|Death|0|||
105787105|NCT03110107|364874911|FG022|Treatment Period|Study drug toxicity|2|||
106132565|NCT02320253|366143260|FG002|Overall Study|Death|1|||
106132566|NCT04794179|366143261|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
106132567|NCT04794179|366143262|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
106132568|NCT05780047|366143263|FG000|Overall Study|Did not submit baseline urine test kit|226|||
106132569|NCT05780047|366143263|FG000|Overall Study|Lost to Follow-up|34|||
105922534|NCT01047319|365376623|FG001|Overall Study|Withdrawal by Subject|75|||
106132570|NCT05780047|366143263|FG000|Overall Study|Did not submit second urine test kit|124|||
106132571|NCT03212365|366143266|FG000|Overall Study|Discharged prior to Xa level|12|||
105922535|NCT01047319|365376624|FG002|Overall Study|Withdrawal by Subject|87|||
105695611|NCT01092143|364549891|FG002|Overall Study|Randomized by mistake|0|||
105695612|NCT01092143|364549892|FG003|Overall Study|Randomized by mistake|1|||
105695613|NCT01092143|364549893|FG004|Overall Study|Randomized by mistake|0|||
105695614|NCT01092143|364549889|FG000|Overall Study|Pregnancy|0|||
105695615|NCT01092143|364549890|FG001|Overall Study|Pregnancy|0|||
105695616|NCT01092143|364549891|FG002|Overall Study|Pregnancy|0|||
105695617|NCT01092143|364549892|FG003|Overall Study|Pregnancy|1|||
105695618|NCT01092143|364549893|FG004|Overall Study|Pregnancy|0|||
105695619|NCT01621542|364549898|FG000|Overall Study|Adverse Event|0|||
105695620|NCT01621542|364549899|FG001|Overall Study|Adverse Event|0|||
105695621|NCT01621542|364549900|FG002|Overall Study|Adverse Event|1|||
105695622|NCT01621542|364549901|FG003|Overall Study|Adverse Event|3|||
105695623|NCT01621542|364549902|FG004|Overall Study|Adverse Event|0|||
105695624|NCT01621542|364549903|FG005|Overall Study|Adverse Event|0|||
105695625|NCT01621542|364549898|FG000|Overall Study|Death|0|||
105695626|NCT01621542|364549899|FG001|Overall Study|Death|1|||
105695627|NCT01621542|364549900|FG002|Overall Study|Death|0|||
105695628|NCT01621542|364549901|FG003|Overall Study|Death|0|||
105695629|NCT01621542|364549902|FG004|Overall Study|Death|0|||
105695630|NCT01621542|364549903|FG005|Overall Study|Death|0|||
105695631|NCT01621542|364549898|FG000|Overall Study|Physician Decision|1|||
105695632|NCT01621542|364549899|FG001|Overall Study|Physician Decision|0|||
105695633|NCT01621542|364549900|FG002|Overall Study|Physician Decision|1|||
105695634|NCT01621542|364549901|FG003|Overall Study|Physician Decision|13|||
105695635|NCT01621542|364549902|FG004|Overall Study|Physician Decision|3|||
105922536|NCT01047319|365376622|FG000|Overall Study|Study terminated by Sponsor|198|||
105922537|NCT01047319|365376623|FG001|Overall Study|Study terminated by Sponsor|215|||
105695636|NCT01621542|364549903|FG005|Overall Study|Physician Decision|1|||
105695637|NCT01621542|364549898|FG000|Overall Study|Withdrawal by Subject|2|||
105695638|NCT01621542|364549899|FG001|Overall Study|Withdrawal by Subject|0|||
105695639|NCT01621542|364549900|FG002|Overall Study|Withdrawal by Subject|1|||
105695640|NCT01621542|364549901|FG003|Overall Study|Withdrawal by Subject|3|||
105922538|NCT01047319|365376624|FG002|Overall Study|Study terminated by Sponsor|203|||
105922539|NCT02273167|365376630|FG000|Overall Study|Adverse Event|1|||
105922540|NCT02273167|365376631|FG001|Overall Study|Adverse Event|0|||
105922541|NCT02273167|365376632|FG002|Overall Study|Adverse Event|0|||
105922542|NCT02273167|365376630|FG000|Overall Study|Protocol Violation|3|||
105922543|NCT02273167|365376631|FG001|Overall Study|Protocol Violation|1|||
105922544|NCT02273167|365376632|FG002|Overall Study|Protocol Violation|1|||
105922545|NCT02273167|365376630|FG000|Overall Study|Lost to Follow-up|0|||
105922546|NCT02273167|365376631|FG001|Overall Study|Lost to Follow-up|1|||
105695641|NCT01621542|364549902|FG004|Overall Study|Withdrawal by Subject|3|||
105695642|NCT01621542|364549903|FG005|Overall Study|Withdrawal by Subject|3|||
105695643|NCT01621542|364549898|FG000|Overall Study|progression/treatment failure|2|||
105695644|NCT01621542|364549899|FG001|Overall Study|progression/treatment failure|4|||
105695645|NCT01621542|364549900|FG002|Overall Study|progression/treatment failure|3|||
105922547|NCT02273167|365376632|FG002|Overall Study|Lost to Follow-up|1|||
105922548|NCT02273167|365376630|FG000|Overall Study|Withdrawal by Subject|10|||
105922549|NCT02273167|365376631|FG001|Overall Study|Withdrawal by Subject|12|||
105922550|NCT02273167|365376632|FG002|Overall Study|Withdrawal by Subject|11|||
105922551|NCT02273167|365376630|FG000|Overall Study|Various|10|||
105922552|NCT02273167|365376631|FG001|Overall Study|Various|9|||
105922553|NCT02273167|365376632|FG002|Overall Study|Various|8|||
105922554|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
105922555|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
105695646|NCT01621542|364549901|FG003|Overall Study|progression/treatment failure|7|||
105695647|NCT01621542|364549902|FG004|Overall Study|progression/treatment failure|3|||
105695648|NCT01621542|364549903|FG005|Overall Study|progression/treatment failure|5|||
105695649|NCT01621542|364549898|FG000|Overall Study|Protocol Violation|0|||
105922556|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
105922557|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
105695650|NCT01621542|364549899|FG001|Overall Study|Protocol Violation|0|||
105695651|NCT01621542|364549900|FG002|Overall Study|Protocol Violation|0|||
105695652|NCT01621542|364549901|FG003|Overall Study|Protocol Violation|1|||
105695653|NCT01621542|364549902|FG004|Overall Study|Protocol Violation|0|||
105695654|NCT01621542|364549903|FG005|Overall Study|Protocol Violation|0|||
105695655|NCT01621542|364549898|FG000|Overall Study|study stopped by sponsor|0|||
105695656|NCT01621542|364549899|FG001|Overall Study|study stopped by sponsor|0|||
105695657|NCT01621542|364549900|FG002|Overall Study|study stopped by sponsor|0|||
105922558|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
105922559|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
105922560|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
105922561|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
105695658|NCT01621542|364549901|FG003|Overall Study|study stopped by sponsor|1|||
105922562|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
105922563|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
105695659|NCT01621542|364549902|FG004|Overall Study|study stopped by sponsor|0|||
105922564|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
105922565|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
105922566|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
105922567|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
105922568|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
106132572|NCT03212365|366143267|FG001|Overall Study|Discharged prior to Xa level|8|||
106132573|NCT03212365|366143266|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
106132574|NCT03212365|366143267|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
106132575|NCT03212365|366143266|FG000|Overall Study|Refused study medication|3|||
106132576|NCT03212365|366143267|FG001|Overall Study|Refused study medication|0|||
106132577|NCT03212365|366143266|FG000|Overall Study|Initiated heparin infusion on floor|1|||
106132578|NCT03212365|366143267|FG001|Overall Study|Initiated heparin infusion on floor|1|||
106132579|NCT03212365|366143266|FG000|Overall Study|Unexpected return to OR|1|||
106132580|NCT03212365|366143267|FG001|Overall Study|Unexpected return to OR|1|||
106132581|NCT03212365|366143266|FG000|Overall Study|Medication distribution error|1|||
106132582|NCT03212365|366143267|FG001|Overall Study|Medication distribution error|0|||
106132583|NCT03212365|366143266|FG000|Overall Study|Required epidural placement|1|||
105695660|NCT01621542|364549903|FG005|Overall Study|study stopped by sponsor|0|||
105695661|NCT00955279|364549904|FG000|Overall Study|Other|0|||
105695662|NCT00955279|364549905|FG001|Overall Study|Other|0|||
105695663|NCT00955279|364549906|FG002|Overall Study|Other|3|||
105695664|NCT00955279|364549904|FG000|Overall Study|Death|1|||
105695665|NCT00955279|364549905|FG001|Overall Study|Death|1|||
105695666|NCT00955279|364549906|FG002|Overall Study|Death|1|||
105695667|NCT00955279|364549904|FG000|Overall Study|Lost to Follow-up|0|||
105695668|NCT00955279|364549905|FG001|Overall Study|Lost to Follow-up|3|||
105695669|NCT00955279|364549906|FG002|Overall Study|Lost to Follow-up|1|||
105695670|NCT00955279|364549904|FG000|Overall Study|Withdrawal by Subject|2|||
105695671|NCT00955279|364549905|FG001|Overall Study|Withdrawal by Subject|0|||
105695672|NCT00955279|364549906|FG002|Overall Study|Withdrawal by Subject|3|||
105695673|NCT00430482|364549921|FG000|Completed Treatment|Insufficient Treatment|7|||
105695674|NCT00430482|364549922|FG001|Completed Treatment|Insufficient Treatment|11|||
105695675|NCT00397033|364549923|FG000|Overall Study|Adverse Event|7|||
105695676|NCT00397033|364549924|FG001|Overall Study|Adverse Event|10|||
105695677|NCT00397033|364549925|FG002|Overall Study|Adverse Event|4|||
105695678|NCT00397033|364549923|FG000|Overall Study|Lack of Efficacy|22|||
105695679|NCT00397033|364549924|FG001|Overall Study|Lack of Efficacy|12|||
105695680|NCT00397033|364549925|FG002|Overall Study|Lack of Efficacy|9|||
105695681|NCT00397033|364549923|FG000|Overall Study|Lost to Follow-up|3|||
105695682|NCT00397033|364549924|FG001|Overall Study|Lost to Follow-up|3|||
105922569|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
105922570|NCT00849056|365378501|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
105922571|NCT00849056|365378502|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
105922572|NCT00849056|365378501|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
105922573|NCT00849056|365378502|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
105922574|NCT00849056|365378501|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
105922575|NCT00849056|365378502|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
105922576|NCT00849056|365378501|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
105922577|NCT00849056|365378502|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
105922578|NCT00849056|365378501|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
105922579|NCT00849056|365378502|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
105922580|NCT00849056|365378501|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
105922581|NCT00849056|365378502|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
105922582|NCT00849056|365378501|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
105922583|NCT00849056|365378502|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
105922584|NCT00849056|365378501|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
105922585|NCT00849056|365378502|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
106132584|NCT03212365|366143267|FG001|Overall Study|Required epidural placement|0|||
106132585|NCT03212365|366143266|FG000|Overall Study|Withdrawal by Subject|0|||
106132586|NCT03212365|366143267|FG001|Overall Study|Withdrawal by Subject|1|||
106132587|NCT03212365|366143266|FG000|Overall Study|developed acute renal failure|0|||
106132588|NCT03212365|366143267|FG001|Overall Study|developed acute renal failure|1|||
106132589|NCT04438785|366143268|FG000|Overall Study|change of weight, give up intervention|2|||
106132590|NCT04438785|366143269|FG001|Overall Study|change of weight, give up intervention|10|||
106132591|NCT04011033|366143270|FG000|Overall Study|Physician Decision|2|||
106132592|NCT04011033|366143271|FG001|Overall Study|Physician Decision|3|||
106132593|NCT04011033|366143270|FG000|Overall Study|Withdrawal by Subject|1|||
105695683|NCT00397033|364549925|FG002|Overall Study|Lost to Follow-up|3|||
105922586|NCT01113749|365378503|FG000|Overall Study|Lost to Follow-up|1|||
105922587|NCT01113749|365378504|FG001|Overall Study|Lost to Follow-up|2|||
105695684|NCT00397033|364549923|FG000|Overall Study|Withdrawal by Subject|12|||
105695685|NCT00397033|364549924|FG001|Overall Study|Withdrawal by Subject|7|||
105695686|NCT00397033|364549925|FG002|Overall Study|Withdrawal by Subject|5|||
105922588|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
105922589|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
105922590|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Death|1|||
105922591|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Death|3|||
105922592|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
105922593|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
105922594|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
105922595|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
105922596|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
105922597|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
105922598|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
105922599|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
105922600|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
105922601|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
105922602|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
105922603|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
105922604|NCT00362232|365378505|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
105922605|NCT00362232|365378506|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
105922606|NCT00362232|365378505|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
105922607|NCT00362232|365378506|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
105922608|NCT00362232|365378505|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
105922609|NCT00362232|365378506|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
105922610|NCT00362232|365378505|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
105922611|NCT00362232|365378506|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
105922612|NCT00362232|365378505|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
105922613|NCT00362232|365378506|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
105922614|NCT03255187|365378509|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
105922615|NCT03255187|365378510|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
105922616|NCT03255187|365378509|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
105922617|NCT03255187|365378510|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
105922618|NCT00375752|365378511|FG000|Overall Study|Lack of Efficacy|4|||
105922619|NCT00375752|365378512|FG001|Overall Study|Lack of Efficacy|4|||
105922620|NCT00375752|365378511|FG000|Overall Study|Adverse Event|1|||
105922621|NCT00375752|365378512|FG001|Overall Study|Adverse Event|6|||
105922622|NCT00375752|365378511|FG000|Overall Study|Withdrawal by Subject|6|||
105922623|NCT00375752|365378512|FG001|Overall Study|Withdrawal by Subject|1|||
105922624|NCT00375752|365378511|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
105922625|NCT00375752|365378512|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
105922626|NCT00375752|365378511|FG000|Overall Study|Protocol Violation|0|||
105922627|NCT00375752|365378512|FG001|Overall Study|Protocol Violation|2|||
105922628|NCT00375752|365378511|FG000|Overall Study|Administrative Problems|0|||
105922629|NCT00375752|365378512|FG001|Overall Study|Administrative Problems|1|||
105922630|NCT00109343|365378513|FG000|Overall Study|Adverse Event|1|||
105922631|NCT00109343|365378514|FG001|Overall Study|Adverse Event|0|||
105922632|NCT00109343|365378515|FG002|Overall Study|Adverse Event|2|||
105922633|NCT00109343|365378513|FG000|Overall Study|Lack of Efficacy|1|||
105922634|NCT00109343|365378514|FG001|Overall Study|Lack of Efficacy|0|||
105922635|NCT00109343|365378515|FG002|Overall Study|Lack of Efficacy|0|||
105922636|NCT00109343|365378513|FG000|Overall Study|Lost to Follow-up|35|||
105922637|NCT00109343|365378514|FG001|Overall Study|Lost to Follow-up|20|||
105922638|NCT00109343|365378515|FG002|Overall Study|Lost to Follow-up|14|||
105922639|NCT00109343|365378513|FG000|Overall Study|Protocol Violation|1|||
105922640|NCT00109343|365378514|FG001|Overall Study|Protocol Violation|2|||
105922641|NCT00109343|365378515|FG002|Overall Study|Protocol Violation|2|||
105922642|NCT00109343|365378513|FG000|Overall Study|Withdrawal by Subject|15|||
106004884|NCT03287791|365682586|FG000|Overall Study|Did not meet inclusion criteria|1|||
105787106|NCT03110107|364874912|FG023|Treatment Period|Study drug toxicity|6|||
105922643|NCT00109343|365378514|FG001|Overall Study|Withdrawal by Subject|11|||
105922644|NCT00109343|365378515|FG002|Overall Study|Withdrawal by Subject|10|||
105922645|NCT00109343|365378513|FG000|Overall Study|Subject Moved|6|||
105922646|NCT00109343|365378514|FG001|Overall Study|Subject Moved|2|||
105922647|NCT00109343|365378515|FG002|Overall Study|Subject Moved|1|||
105922648|NCT00109343|365378513|FG000|Overall Study|Other|5|||
105922649|NCT00109343|365378514|FG001|Overall Study|Other|2|||
105922650|NCT00109343|365378515|FG002|Overall Study|Other|1|||
105922651|NCT01898078|365378516|FG000|Overall Study|Progressive Disease|1|||
105922652|NCT01898078|365378517|FG001|Overall Study|Progressive Disease|5|||
105922653|NCT01898078|365378516|FG000|Overall Study|Adverse Event|2|||
105922654|NCT01898078|365378517|FG001|Overall Study|Adverse Event|1|||
105922655|NCT01898078|365378516|FG000|Overall Study|Withdrawal by Subject|1|||
105922656|NCT01898078|365378517|FG001|Overall Study|Withdrawal by Subject|1|||
106132594|NCT04011033|366143271|FG001|Overall Study|Withdrawal by Subject|0|||
106132595|NCT05550337|366143272|FG000|Overall Study|Lack of Efficacy|0|||
106132596|NCT05550337|366143273|FG001|Overall Study|Lack of Efficacy|0|||
106132597|NCT05550337|366143274|FG002|Overall Study|Lack of Efficacy|1|||
106132598|NCT05550337|366143272|FG000|Overall Study|Adverse Event|1|||
105922657|NCT01898078|365378516|FG000|Overall Study|Symptomatic Deterioration|2|||
105922658|NCT01898078|365378517|FG001|Overall Study|Symptomatic Deterioration|0|||
105922659|NCT01898078|365378516|FG000|Overall Study|Reason not Specified|0|||
105922660|NCT01898078|365378517|FG001|Overall Study|Reason not Specified|1|||
105922661|NCT00703534|365378518|FG000|Overall Study|Adverse Event|14|||
105922662|NCT00703534|365378519|FG001|Overall Study|Adverse Event|3|||
105922663|NCT00703534|365378518|FG000|Overall Study|Withdrawal by Subject|8|||
105922664|NCT00703534|365378519|FG001|Overall Study|Withdrawal by Subject|7|||
105922665|NCT00703534|365378518|FG000|Overall Study|Incorrect Enrollment|6|||
105922666|NCT00703534|365378519|FG001|Overall Study|Incorrect Enrollment|6|||
105922667|NCT00703534|365378518|FG000|Overall Study|Lost to Follow-up|1|||
105922668|NCT00703534|365378519|FG001|Overall Study|Lost to Follow-up|4|||
105922669|NCT00703534|365378518|FG000|Overall Study|Severe Non Compliance|1|||
105922670|NCT00703534|365378519|FG001|Overall Study|Severe Non Compliance|5|||
105922671|NCT00089648|365378520|FG000|Overall Study|Adverse Event|7|||
105922672|NCT00089648|365378520|FG000|Overall Study|Withdrawal by Subject|1|||
105922673|NCT00089648|365378520|FG000|Overall Study|Lack of Efficacy|33|||
105922674|NCT00300053|365378522|FG000|Overall Study|Patient/Caregiver Preference|2|||
105922675|NCT00300053|365378523|FG001|Overall Study|Patient/Caregiver Preference|2|||
105922676|NCT00300053|365378524|FG002|Overall Study|Patient/Caregiver Preference|3|||
106132599|NCT05550337|366143273|FG001|Overall Study|Adverse Event|5|||
106132600|NCT05550337|366143274|FG002|Overall Study|Adverse Event|0|||
106132601|NCT05550337|366143272|FG000|Overall Study|Withdrawal by Subject|8|||
106132602|NCT05550337|366143273|FG001|Overall Study|Withdrawal by Subject|14|||
106132603|NCT05550337|366143274|FG002|Overall Study|Withdrawal by Subject|10|||
105787107|NCT03110107|364874913|FG024|Treatment Period|Study drug toxicity|7|||
105922677|NCT00300053|365378522|FG000|Overall Study|Death|0|||
105922678|NCT00300053|365378523|FG001|Overall Study|Death|0|||
105922679|NCT00300053|365378524|FG002|Overall Study|Death|3|||
105922680|NCT00300053|365378522|FG000|Overall Study|Lost to Follow-up|0|||
105922681|NCT00300053|365378523|FG001|Overall Study|Lost to Follow-up|1|||
105922682|NCT00300053|365378524|FG002|Overall Study|Lost to Follow-up|0|||
105922683|NCT03183908|365378527|FG000|Overall Study|Missing Symptom Diary Data|0|||
105922684|NCT03183908|365378528|FG001|Overall Study|Missing Symptom Diary Data|2|||
105922685|NCT00998946|365378532|FG000|Overall Study|Lost to Follow-up|1|||
105922686|NCT00998946|365378532|FG000|Overall Study|Withdrawal by Subject|1|||
105922687|NCT00998946|365378532|FG000|Overall Study|Death|2|||
105922688|NCT00998946|365378532|FG000|Overall Study|Reason Unspecified|3|||
105922689|NCT00998946|365378532|FG000|Overall Study|Enrolled but not Dosed|2|||
105922690|NCT01134042|365378537|FG000|Overall Study|Adverse Event|3|||
105922691|NCT01134042|365378538|FG001|Overall Study|Adverse Event|7|||
105922692|NCT01134042|365378539|FG002|Overall Study|Adverse Event|2|||
105922693|NCT01134042|365378537|FG000|Overall Study|Lack of Efficacy|21|||
105922694|NCT01134042|365378538|FG001|Overall Study|Lack of Efficacy|6|||
105922695|NCT01134042|365378539|FG002|Overall Study|Lack of Efficacy|18|||
105922696|NCT01134042|365378537|FG000|Overall Study|Protocol Violation|5|||
105922697|NCT01134042|365378538|FG001|Overall Study|Protocol Violation|3|||
105922698|NCT01134042|365378539|FG002|Overall Study|Protocol Violation|5|||
105922699|NCT01134042|365378537|FG000|Overall Study|Lost to Follow-up|2|||
105922700|NCT01134042|365378538|FG001|Overall Study|Lost to Follow-up|0|||
105922701|NCT01134042|365378539|FG002|Overall Study|Lost to Follow-up|1|||
105922702|NCT01134042|365378537|FG000|Overall Study|Physician Decision|4|||
105922703|NCT01134042|365378538|FG001|Overall Study|Physician Decision|8|||
105922704|NCT01134042|365378539|FG002|Overall Study|Physician Decision|1|||
106132604|NCT05550337|366143272|FG000|Overall Study|Pregnancy|0|||
106132605|NCT05550337|366143273|FG001|Overall Study|Pregnancy|0|||
106132606|NCT05550337|366143274|FG002|Overall Study|Pregnancy|1|||
106132607|NCT05550337|366143272|FG000|Overall Study|Protocol Violation|1|||
105922705|NCT01134042|365378537|FG000|Overall Study|Withdrawal by Subject|13|||
105922706|NCT01134042|365378538|FG001|Overall Study|Withdrawal by Subject|4|||
105922707|NCT01134042|365378539|FG002|Overall Study|Withdrawal by Subject|7|||
105922708|NCT01983930|365378540|FG000|Overall Study|Withdrawal by Subject|9|||
105922709|NCT01983930|365378541|FG001|Overall Study|Withdrawal by Subject|8|||
105922710|NCT01983930|365378540|FG000|Overall Study|Adverse Event|0|||
105922711|NCT01983930|365378541|FG001|Overall Study|Adverse Event|1|||
105922712|NCT00853385|365378542|FG000|Overall Study|Death|0|||
105922713|NCT00853385|365378543|FG001|Overall Study|Death|0|||
105922714|NCT00853385|365378544|FG002|Overall Study|Death|0|||
105922715|NCT00853385|365378545|FG003|Overall Study|Death|0|||
105922716|NCT00853385|365378546|FG004|Overall Study|Death|1|||
105922717|NCT00853385|365378542|FG000|Overall Study|Adverse Event|24|||
105922718|NCT00853385|365378543|FG001|Overall Study|Adverse Event|24|||
105922719|NCT00853385|365378544|FG002|Overall Study|Adverse Event|2|||
105922720|NCT00853385|365378545|FG003|Overall Study|Adverse Event|5|||
105922721|NCT00853385|365378546|FG004|Overall Study|Adverse Event|22|||
105922722|NCT00853385|365378542|FG000|Overall Study|Lack of Efficacy|6|||
105922723|NCT00853385|365378543|FG001|Overall Study|Lack of Efficacy|7|||
105922724|NCT00853385|365378544|FG002|Overall Study|Lack of Efficacy|3|||
105922725|NCT00853385|365378545|FG003|Overall Study|Lack of Efficacy|3|||
105922726|NCT00853385|365378546|FG004|Overall Study|Lack of Efficacy|6|||
105922727|NCT00853385|365378542|FG000|Overall Study|Lost to Follow-up|2|||
105922728|NCT00853385|365378543|FG001|Overall Study|Lost to Follow-up|1|||
105922729|NCT00853385|365378544|FG002|Overall Study|Lost to Follow-up|0|||
105922730|NCT00853385|365378545|FG003|Overall Study|Lost to Follow-up|0|||
105922731|NCT00853385|365378546|FG004|Overall Study|Lost to Follow-up|0|||
105922732|NCT00853385|365378542|FG000|Overall Study|Withdrawal by Subject|4|||
105922733|NCT00853385|365378543|FG001|Overall Study|Withdrawal by Subject|2|||
105922734|NCT00853385|365378544|FG002|Overall Study|Withdrawal by Subject|0|||
105922735|NCT00853385|365378545|FG003|Overall Study|Withdrawal by Subject|1|||
105922736|NCT00853385|365378546|FG004|Overall Study|Withdrawal by Subject|1|||
105922737|NCT00853385|365378542|FG000|Overall Study|Other|18|||
105922738|NCT00853385|365378543|FG001|Overall Study|Other|9|||
105922739|NCT00853385|365378544|FG002|Overall Study|Other|4|||
105922740|NCT00853385|365378545|FG003|Overall Study|Other|4|||
105922741|NCT00853385|365378546|FG004|Overall Study|Other|12|||
105922742|NCT00656617|365378549|FG000|Overall Study|Adverse Event|1|||
105922743|NCT00656617|365378549|FG000|Overall Study|Death|2|||
105922744|NCT00656617|365378549|FG000|Overall Study|Insurance Issues|2|||
105922745|NCT00656617|365378549|FG000|Overall Study|Move to different clinical trial|2|||
105922746|NCT00671749|365378550|FG000|Overall Study|Adverse Event|2|||
105922747|NCT00671749|365378550|FG000|Overall Study|Withdrawal by Subject|4|||
105922748|NCT00671749|365378550|FG000|Overall Study|Protocol Violation|1|||
105922749|NCT00671749|365378550|FG000|Overall Study|Lost to Follow-up|1|||
105922750|NCT02515227|365378551|FG000|Overall Study|Adverse Event|0|||
105922751|NCT02515227|365378552|FG001|Overall Study|Adverse Event|2|||
105922752|NCT02515227|365378551|FG000|Overall Study|Progressive disease|2|||
105922753|NCT02515227|365378552|FG001|Overall Study|Progressive disease|9|||
105922754|NCT01461551|365378553|FG000|Overall Study|Physician Decision|2|||
105922755|NCT01461551|365378554|FG001|Overall Study|Physician Decision|1|||
105922756|NCT01461551|365378555|FG002|Overall Study|Physician Decision|2|||
105922757|NCT01155141|365378556|FG000|Overall Study|Withdrawal by Subject|1|||
105922758|NCT01155141|365378556|FG000|Overall Study|Screen Failure|1|||
105922759|NCT03473197|365378557|FG000|Overall Study|Adverse Event|4|||
105922760|NCT03473197|365378557|FG000|Overall Study|Lost to Follow-up|1|||
105922761|NCT03473197|365378557|FG000|Overall Study|Withdrawal by Subject|5|||
105922762|NCT00785629|365378558|FG000|Overall Study|Adverse Event|2|||
105922763|NCT00785629|365378559|FG001|Overall Study|Adverse Event|1|||
105922764|NCT00785629|365378560|FG002|Overall Study|Adverse Event|1|||
105922765|NCT00785629|365378561|FG003|Overall Study|Adverse Event|5|||
105922766|NCT00785629|365378558|FG000|Overall Study|Protocol Violation|1|||
105922767|NCT00785629|365378559|FG001|Overall Study|Protocol Violation|2|||
105922768|NCT00785629|365378560|FG002|Overall Study|Protocol Violation|4|||
105922769|NCT00785629|365378561|FG003|Overall Study|Protocol Violation|5|||
105922770|NCT00785629|365378558|FG000|Overall Study|administrative decision|5|||
105922771|NCT00785629|365378559|FG001|Overall Study|administrative decision|1|||
105922772|NCT00785629|365378560|FG002|Overall Study|administrative decision|3|||
105922773|NCT00785629|365378561|FG003|Overall Study|administrative decision|4|||
105922774|NCT00785629|365378558|FG000|Overall Study|Withdrawal by Subject|0|||
105922775|NCT00785629|365378559|FG001|Overall Study|Withdrawal by Subject|1|||
105922776|NCT00785629|365378560|FG002|Overall Study|Withdrawal by Subject|2|||
105922777|NCT00785629|365378561|FG003|Overall Study|Withdrawal by Subject|2|||
105922778|NCT02020941|365378562|FG000|Overall Study|Adverse Event|1|||
105922779|NCT02020941|365378562|FG000|Overall Study|Physician Decision|2|||
105922780|NCT02020941|365378562|FG000|Overall Study|Withdrawal by Subject|1|||
105922781|NCT02020941|365378562|FG000|Overall Study|Disease Progression|4|||
105922782|NCT03482024|365378563|FG000|Overall Study|Physician Decision|1|||
105922783|NCT03482024|365378564|FG001|Overall Study|Physician Decision|0|||
105922784|NCT03482024|365378565|FG002|Overall Study|Physician Decision|0|||
105922785|NCT03482024|365378566|FG003|Overall Study|Physician Decision|0|||
105922786|NCT03482024|365378567|FG004|Overall Study|Physician Decision|0|||
105922787|NCT00634504|365378568|FG000|Overall Study|Protocol Violation|1|||
105922788|NCT00634504|365378569|FG001|Overall Study|Protocol Violation|0|||
105922789|NCT02736617|365378570|FG000|Treatment|Adverse Event|1|||
105922790|NCT02736617|365378570|FG000|Treatment|Lack of Efficacy|1|||
105922791|NCT02736617|365378570|FG000|Treatment|Withdrawal by Subject|1|||
105922792|NCT02736617|365378570|FG000|Maintenance|Lack of Efficacy|4|||
105922793|NCT02736617|365378570|FG000|Maintenance|Physician Decision|1|||
105922794|NCT02469857|365378573|FG000|Overall Study|Death|24|||
105922795|NCT02469857|365378574|FG001|Overall Study|Death|29|||
105922796|NCT02469857|365378573|FG000|Overall Study|Discontinuation|1|||
105922797|NCT02469857|365378574|FG001|Overall Study|Discontinuation|3|||
105922798|NCT01838876|365378579|FG000|Overall Study|Adverse Event|49|||
105922799|NCT01838876|365378579|FG000|Overall Study|Insufficient Therapeutic Response|10|||
105922800|NCT01838876|365378579|FG000|Overall Study|Protocol Violation|34|||
105922801|NCT01838876|365378579|FG000|Overall Study|Withdrawal of Consent|33|||
105922802|NCT01838876|365378579|FG000|Overall Study|Lost to Follow-up|21|||
105922803|NCT01838876|365378579|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
105922804|NCT01838876|365378579|FG000|Overall Study|Reason not Specified|7|||
105922805|NCT01838876|365378579|FG000|Overall Study|Did not meet eligibility criteria|78|||
105922806|NCT00961415|365378582|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
105922807|NCT00961415|365378583|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
105922808|NCT00961415|365378584|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
105922809|NCT00961415|365378582|FG000|Induction Treatment Phase|Death|77|||
105922810|NCT00961415|365378583|FG001|Induction Treatment Phase|Death|0|||
105922811|NCT00961415|365378584|FG002|Induction Treatment Phase|Death|0|||
105922812|NCT00961415|365378582|FG000|Induction Treatment Phase|Protocol Violation|1|||
105922813|NCT00961415|365378583|FG001|Induction Treatment Phase|Protocol Violation|0|||
105922814|NCT00961415|365378584|FG002|Induction Treatment Phase|Protocol Violation|0|||
105922815|NCT00961415|365378582|FG000|Induction Treatment Phase|Physician Decision|2|||
105922816|NCT00961415|365378583|FG001|Induction Treatment Phase|Physician Decision|0|||
105922817|NCT00961415|365378584|FG002|Induction Treatment Phase|Physician Decision|0|||
105922818|NCT00961415|365378582|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
105922819|NCT00961415|365378583|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
105922820|NCT00961415|365378584|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
105922821|NCT00961415|365378582|FG000|Induction Treatment Phase|Other Reason|5|||
105922822|NCT00961415|365378583|FG001|Induction Treatment Phase|Other Reason|0|||
105922823|NCT00961415|365378584|FG002|Induction Treatment Phase|Other Reason|0|||
105922824|NCT00961415|365378582|FG000|Maintenance Treatment Phase|Death|0|||
105922825|NCT00961415|365378583|FG001|Maintenance Treatment Phase|Death|42|||
105922826|NCT00961415|365378584|FG002|Maintenance Treatment Phase|Death|34|||
105922827|NCT00961415|365378582|FG000|Maintenance Treatment Phase|Investigators decision|0|||
105922828|NCT00961415|365378583|FG001|Maintenance Treatment Phase|Investigators decision|2|||
105922829|NCT00961415|365378584|FG002|Maintenance Treatment Phase|Investigators decision|0|||
105922830|NCT00961415|365378582|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
105922831|NCT00961415|365378583|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
105922832|NCT00961415|365378584|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
105922833|NCT00961415|365378582|FG000|Maintenance Treatment Phase|Other reason|0|||
105922834|NCT00961415|365378583|FG001|Maintenance Treatment Phase|Other reason|1|||
106132608|NCT05550337|366143273|FG001|Overall Study|Protocol Violation|3|||
106132609|NCT05550337|366143274|FG002|Overall Study|Protocol Violation|4|||
105695687|NCT00397033|364549923|FG000|Overall Study|Other|0|||
105695688|NCT00397033|364549924|FG001|Overall Study|Other|5|||
105695689|NCT00397033|364549925|FG002|Overall Study|Other|2|||
105695690|NCT03519867|364549926|FG000|Overall Study|Adverse Event|1|||
105695691|NCT03519867|364549927|FG001|Overall Study|Adverse Event|1|||
105695692|NCT03519867|364549928|FG002|Overall Study|Adverse Event|0|||
105695693|NCT03519867|364549929|FG003|Overall Study|Adverse Event|0|||
105695694|NCT03519867|364549930|FG004|Overall Study|Adverse Event|0|||
105695695|NCT03519867|364549931|FG005|Overall Study|Adverse Event|0|||
105695696|NCT03519867|364549932|FG006|Overall Study|Adverse Event|0|||
105695697|NCT03519867|364549933|FG007|Overall Study|Adverse Event|0|||
105695698|NCT03519867|364549934|FG008|Overall Study|Adverse Event|0|||
105695699|NCT03519867|364549935|FG009|Overall Study|Adverse Event|0|||
105695700|NCT03519867|364549926|FG000|Overall Study|Protocol Violation|0|||
105695701|NCT03519867|364549927|FG001|Overall Study|Protocol Violation|0|||
105695702|NCT03519867|364549928|FG002|Overall Study|Protocol Violation|0|||
105695703|NCT03519867|364549929|FG003|Overall Study|Protocol Violation|0|||
105695704|NCT03519867|364549930|FG004|Overall Study|Protocol Violation|0|||
105695705|NCT03519867|364549931|FG005|Overall Study|Protocol Violation|1|||
105695706|NCT03519867|364549932|FG006|Overall Study|Protocol Violation|0|||
105695707|NCT03519867|364549933|FG007|Overall Study|Protocol Violation|0|||
105695708|NCT03519867|364549934|FG008|Overall Study|Protocol Violation|0|||
105695709|NCT03519867|364549935|FG009|Overall Study|Protocol Violation|0|||
105695710|NCT03519867|364549926|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695711|NCT03519867|364549927|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695712|NCT03519867|364549928|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695713|NCT03519867|364549929|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695714|NCT03519867|364549930|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695715|NCT03519867|364549931|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695716|NCT03519867|364549932|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
105922835|NCT00961415|365378584|FG002|Maintenance Treatment Phase|Other reason|3|||
105922836|NCT00226655|365378585|FG000|Overall Study|Death|13|||
105922837|NCT00226655|365378585|FG000|Overall Study|Withdrawal by Subject|15|||
105922838|NCT00226655|365378585|FG000|Overall Study|Adverse Event|35|||
105922839|NCT00226655|365378585|FG000|Overall Study|Physician Decision|6|||
105695717|NCT03519867|364549933|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695718|NCT03519867|364549934|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695719|NCT03519867|364549935|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
105695720|NCT03519867|364549926|FG000|Overall Study|Admin. of other reversal agent|1|||
105922840|NCT00226655|365378585|FG000|Overall Study|Clinical deterioration|10|||
105922841|NCT00207740|365378594|FG000|Overall Study|Adverse Event|4|||
105922842|NCT00207740|365378595|FG001|Overall Study|Adverse Event|14|||
105922843|NCT00207740|365378596|FG002|Overall Study|Adverse Event|14|||
106004885|NCT03287791|365682587|FG001|Overall Study|Did not meet inclusion criteria|0|||
106004886|NCT03287791|365682588|FG002|Overall Study|Did not meet inclusion criteria|0|||
106004887|NCT01474317|365682591|FG000|Overall Study|Adverse Event|1|||
106004888|NCT01474317|365682591|FG000|Overall Study|Subject ineligible for study|1|||
106004889|NCT05482308|365682595|FG000|Overall Study|Withdrawal by Subject|1|||
106004890|NCT05482308|365682596|FG001|Overall Study|Withdrawal by Subject|0|||
106004891|NCT05482308|365682595|FG000|Overall Study|No longer meets eligibility criteria|0|||
106004892|NCT05482308|365682596|FG001|Overall Study|No longer meets eligibility criteria|1|||
106004893|NCT02891174|365682602|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
106004894|NCT02891174|365682603|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
106004895|NCT02891174|365682602|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
106004896|NCT02891174|365682603|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
106004897|NCT02891174|365682602|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
106004898|NCT02891174|365682603|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
106004899|NCT02891174|365682602|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
106004900|NCT02891174|365682603|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
106004901|NCT02891174|365682602|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
105922844|NCT00207740|365378597|FG003|Overall Study|Adverse Event|11|||
105922845|NCT00207740|365378594|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105922846|NCT00207740|365378595|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105922847|NCT00207740|365378596|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105922848|NCT00207740|365378597|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
105922849|NCT00207740|365378594|FG000|Overall Study|Lost to Follow-up|0|||
105922850|NCT00207740|365378595|FG001|Overall Study|Lost to Follow-up|2|||
105922851|NCT00207740|365378596|FG002|Overall Study|Lost to Follow-up|1|||
105922852|NCT00207740|365378597|FG003|Overall Study|Lost to Follow-up|1|||
105922853|NCT00207740|365378594|FG000|Overall Study|Death|0|||
105922854|NCT00207740|365378595|FG001|Overall Study|Death|0|||
105922855|NCT00207740|365378596|FG002|Overall Study|Death|0|||
105922856|NCT00207740|365378597|FG003|Overall Study|Death|1|||
105922857|NCT00207740|365378594|FG000|Overall Study|Sponsor Directive|22|||
105922858|NCT00207740|365378595|FG001|Overall Study|Sponsor Directive|15|||
105922859|NCT00207740|365378596|FG002|Overall Study|Sponsor Directive|16|||
105922860|NCT00207740|365378597|FG003|Overall Study|Sponsor Directive|21|||
105922861|NCT00207740|365378594|FG000|Overall Study|Other|2|||
105922862|NCT00207740|365378595|FG001|Overall Study|Other|10|||
105922863|NCT00207740|365378596|FG002|Overall Study|Other|7|||
105922864|NCT00207740|365378597|FG003|Overall Study|Other|5|||
105922865|NCT01285518|365378599|FG000|Overall Study|Lost to Follow-up|0|||
105922866|NCT01285518|365378600|FG001|Overall Study|Lost to Follow-up|0|||
105922867|NCT01285518|365378601|FG002|Overall Study|Lost to Follow-up|0|||
105922868|NCT01285518|365378602|FG003|Overall Study|Lost to Follow-up|0|||
105922869|NCT01285518|365378603|FG004|Overall Study|Lost to Follow-up|0|||
105922870|NCT01285518|365378604|FG005|Overall Study|Lost to Follow-up|1|||
105695721|NCT03519867|364549927|FG001|Overall Study|Admin. of other reversal agent|1|||
105695722|NCT03519867|364549928|FG002|Overall Study|Admin. of other reversal agent|0|||
105922871|NCT01285518|365378605|FG006|Overall Study|Lost to Follow-up|0|||
105922872|NCT01285518|365378606|FG007|Overall Study|Lost to Follow-up|0|||
105922873|NCT00879658|365378609|FG000|Overall Study|Abnormal laboratory value(s)|3|||
105922874|NCT00879658|365378610|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105922875|NCT00879658|365378611|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105922876|NCT00879658|365378612|FG003|Overall Study|Abnormal laboratory value(s)|1|||
105922877|NCT00879658|365378613|FG004|Overall Study|Abnormal laboratory value(s)|0|||
105922878|NCT00879658|365378614|FG005|Overall Study|Abnormal laboratory value(s)|0|||
105922879|NCT00879658|365378615|FG006|Overall Study|Abnormal laboratory value(s)|0|||
105922880|NCT00879658|365378609|FG000|Overall Study|Administrative problems|2|||
105922881|NCT00879658|365378610|FG001|Overall Study|Administrative problems|1|||
105922882|NCT00879658|365378611|FG002|Overall Study|Administrative problems|0|||
105922883|NCT00879658|365378612|FG003|Overall Study|Administrative problems|1|||
105922884|NCT00879658|365378613|FG004|Overall Study|Administrative problems|0|||
105922885|NCT00879658|365378614|FG005|Overall Study|Administrative problems|0|||
106004902|NCT02891174|365682603|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
106004903|NCT02891174|365682602|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
105922886|NCT00879658|365378615|FG006|Overall Study|Administrative problems|0|||
105922887|NCT00879658|365378609|FG000|Overall Study|Adverse Event|6|||
106132610|NCT05550337|366143272|FG000|Overall Study|Physician Decision|2|||
105695723|NCT03519867|364549929|FG003|Overall Study|Admin. of other reversal agent|0|||
105922888|NCT00879658|365378610|FG001|Overall Study|Adverse Event|4|||
105922889|NCT00879658|365378611|FG002|Overall Study|Adverse Event|3|||
105922890|NCT00879658|365378612|FG003|Overall Study|Adverse Event|1|||
106004904|NCT02891174|365682603|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
106004905|NCT02891174|365682602|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
106004906|NCT02891174|365682603|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
106004907|NCT02647281|365682604|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
106004908|NCT02647281|365682605|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
106004909|NCT02647281|365682606|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
106004910|NCT02647281|365682607|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
106004911|NCT02647281|365682608|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
106004912|NCT02647281|365682609|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
106004913|NCT02647281|365682610|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
106004914|NCT02647281|365682611|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
106004915|NCT02647281|365682612|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
105922891|NCT00879658|365378613|FG004|Overall Study|Adverse Event|2|||
105922892|NCT00879658|365378614|FG005|Overall Study|Adverse Event|0|||
105922893|NCT00879658|365378615|FG006|Overall Study|Adverse Event|0|||
105922894|NCT00879658|365378609|FG000|Overall Study|Protocol Violation|1|||
105922895|NCT00879658|365378610|FG001|Overall Study|Protocol Violation|0|||
105922896|NCT00879658|365378611|FG002|Overall Study|Protocol Violation|0|||
105922897|NCT00879658|365378612|FG003|Overall Study|Protocol Violation|0|||
105922898|NCT00879658|365378613|FG004|Overall Study|Protocol Violation|0|||
105922899|NCT00879658|365378614|FG005|Overall Study|Protocol Violation|0|||
105922900|NCT00879658|365378615|FG006|Overall Study|Protocol Violation|0|||
105922901|NCT00879658|365378609|FG000|Overall Study|Withdrawal by Subject|3|||
105922902|NCT00879658|365378610|FG001|Overall Study|Withdrawal by Subject|0|||
105922903|NCT00879658|365378611|FG002|Overall Study|Withdrawal by Subject|2|||
105922904|NCT00879658|365378612|FG003|Overall Study|Withdrawal by Subject|0|||
105922905|NCT00879658|365378613|FG004|Overall Study|Withdrawal by Subject|0|||
105922906|NCT00879658|365378614|FG005|Overall Study|Withdrawal by Subject|1|||
105922907|NCT00879658|365378615|FG006|Overall Study|Withdrawal by Subject|0|||
105922908|NCT00879658|365378609|FG000|Overall Study|Lack of Efficacy|0|||
105922909|NCT00879658|365378610|FG001|Overall Study|Lack of Efficacy|0|||
105922910|NCT00879658|365378611|FG002|Overall Study|Lack of Efficacy|2|||
105922911|NCT00879658|365378612|FG003|Overall Study|Lack of Efficacy|0|||
105922912|NCT00879658|365378613|FG004|Overall Study|Lack of Efficacy|0|||
105922913|NCT00879658|365378614|FG005|Overall Study|Lack of Efficacy|0|||
105922914|NCT00879658|365378615|FG006|Overall Study|Lack of Efficacy|0|||
105922915|NCT00879658|365378609|FG000|Overall Study|misrandomized (never received study med)|0|||
105922916|NCT00879658|365378610|FG001|Overall Study|misrandomized (never received study med)|0|||
105922917|NCT00879658|365378611|FG002|Overall Study|misrandomized (never received study med)|0|||
105922918|NCT00879658|365378612|FG003|Overall Study|misrandomized (never received study med)|1|||
105922919|NCT00879658|365378613|FG004|Overall Study|misrandomized (never received study med)|0|||
105922920|NCT00879658|365378614|FG005|Overall Study|misrandomized (never received study med)|0|||
105922921|NCT00879658|365378615|FG006|Overall Study|misrandomized (never received study med)|0|||
105922922|NCT02187783|365378616|FG000|Overall Study|Adverse Event|8|||
105922923|NCT02187783|365378616|FG000|Overall Study|Death|3|||
105922924|NCT02187783|365378616|FG000|Overall Study|Progressive disease|80|||
105922925|NCT02187783|365378616|FG000|Overall Study|Protocol Violation|3|||
105922926|NCT02187783|365378616|FG000|Overall Study|Physician Decision|2|||
105922927|NCT02187783|365378616|FG000|Overall Study|Withdrawal by Subject|9|||
105922928|NCT02187783|365378616|FG000|Overall Study|Study terminated by sponsor|1|||
105922929|NCT00471497|365378617|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
105922930|NCT00471497|365378618|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
105922931|NCT00471497|365378619|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
105922932|NCT00471497|365378617|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
105922933|NCT00471497|365378618|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
106004916|NCT01838694|365682613|FG000|Overall Study|Adverse Event|0|||
105922934|NCT00471497|365378619|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
105922935|NCT00471497|365378617|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
105922936|NCT00471497|365378618|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
105922937|NCT00471497|365378619|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
105922938|NCT00471497|365378617|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
105922939|NCT00471497|365378618|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
105922940|NCT00471497|365378619|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
105922941|NCT00471497|365378617|FG000|Core Treatment Phase|Lost to Follow-up|6|||
105922942|NCT00471497|365378618|FG001|Core Treatment Phase|Lost to Follow-up|6|||
105922943|NCT00471497|365378619|FG002|Core Treatment Phase|Lost to Follow-up|3|||
105922944|NCT00471497|365378617|FG000|Core Treatment Phase|Death|3|||
105922945|NCT00471497|365378618|FG001|Core Treatment Phase|Death|9|||
105922946|NCT00471497|365378619|FG002|Core Treatment Phase|Death|3|||
105922947|NCT00471497|365378617|FG000|Core Treatment Phase|Disease Progression|10|||
105922948|NCT00471497|365378618|FG001|Core Treatment Phase|Disease Progression|2|||
105922949|NCT00471497|365378619|FG002|Core Treatment Phase|Disease Progression|4|||
105922950|NCT00471497|365378617|FG000|Core Treatment Phase|Protocol Violation|6|||
105922951|NCT00471497|365378618|FG001|Core Treatment Phase|Protocol Violation|15|||
105922952|NCT00471497|365378619|FG002|Core Treatment Phase|Protocol Violation|11|||
105922953|NCT00471497|365378617|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
105922954|NCT00471497|365378618|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
105922955|NCT00471497|365378619|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
105922956|NCT00471497|365378617|FG000|Core Treatment Phase|Administrative problems|14|||
105922957|NCT00471497|365378618|FG001|Core Treatment Phase|Administrative problems|14|||
105922958|NCT00471497|365378619|FG002|Core Treatment Phase|Administrative problems|12|||
105922959|NCT00471497|365378617|FG000|Core Treatment Phase|Adverse Event|43|||
105922960|NCT00471497|365378618|FG001|Core Treatment Phase|Adverse Event|53|||
105922961|NCT00471497|365378619|FG002|Core Treatment Phase|Adverse Event|89|||
105922962|NCT00471497|365378617|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
105922963|NCT00471497|365378618|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
106004917|NCT01838694|365682614|FG001|Overall Study|Adverse Event|1|||
106004918|NCT00419393|365682615|FG000|Overall Study|Adverse Event|5|||
105922964|NCT00471497|365378619|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
105922965|NCT00471497|365378617|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
105922966|NCT00471497|365378618|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
105922967|NCT00471497|365378619|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
105922968|NCT00471497|365378617|FG000|Extension Phase|Adverse Event|9|||
105922969|NCT00471497|365378618|FG001|Extension Phase|Adverse Event|5|||
105922970|NCT00471497|365378619|FG002|Extension Phase|Adverse Event|1|||
105922971|NCT00471497|365378617|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
105922972|NCT00471497|365378618|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
105922973|NCT00471497|365378619|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
105922974|NCT00471497|365378617|FG000|Extension Phase|Withdrawal by Subject|3|||
105922975|NCT00471497|365378618|FG001|Extension Phase|Withdrawal by Subject|1|||
105922976|NCT00471497|365378619|FG002|Extension Phase|Withdrawal by Subject|0|||
105922977|NCT00471497|365378617|FG000|Extension Phase|Lost to Follow-up|2|||
105922978|NCT00471497|365378618|FG001|Extension Phase|Lost to Follow-up|0|||
105922979|NCT00471497|365378619|FG002|Extension Phase|Lost to Follow-up|0|||
105922980|NCT00471497|365378617|FG000|Extension Phase|Death|1|||
105922981|NCT00471497|365378618|FG001|Extension Phase|Death|0|||
105922982|NCT00471497|365378619|FG002|Extension Phase|Death|0|||
105922983|NCT00471497|365378617|FG000|Extension Phase|Disease progression|2|||
105922984|NCT00471497|365378618|FG001|Extension Phase|Disease progression|0|||
105922985|NCT00471497|365378619|FG002|Extension Phase|Disease progression|0|||
105922986|NCT00471497|365378617|FG000|Extension Phase|Protocol Violation|2|||
105922987|NCT00471497|365378618|FG001|Extension Phase|Protocol Violation|2|||
105922988|NCT00471497|365378619|FG002|Extension Phase|Protocol Violation|0|||
105922989|NCT02164916|365378622|FG000|Overall Study|Adverse Event|3|||
105922990|NCT02164916|365378623|FG001|Overall Study|Adverse Event|8|||
105922991|NCT02164916|365378622|FG000|Overall Study|Death|1|||
105922992|NCT02164916|365378623|FG001|Overall Study|Death|1|||
105922993|NCT02164916|365378622|FG000|Overall Study|Refusal unrelated to adverse event|3|||
105922994|NCT02164916|365378623|FG001|Overall Study|Refusal unrelated to adverse event|7|||
106004919|NCT00419393|365682615|FG000|Overall Study|Protocol Violation|5|||
106004920|NCT00419393|365682615|FG000|Overall Study|Withdrawal by Subject|7|||
106004921|NCT00419393|365682615|FG000|Overall Study|Other: Sponsor request|3|||
106004922|NCT00419393|365682615|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
106004923|NCT00419393|365682615|FG000|Overall Study|Other: Site closure|1|||
106004924|NCT00419393|365682615|FG000|Overall Study|Other: Other health problems|1|||
105922995|NCT02164916|365378622|FG000|Overall Study|Progression|37|||
105922996|NCT02164916|365378623|FG001|Overall Study|Progression|26|||
105922997|NCT02164916|365378622|FG000|Overall Study|Not protocol specified|5|||
105922998|NCT02164916|365378623|FG001|Overall Study|Not protocol specified|1|||
105922999|NCT02164916|365378622|FG000|Overall Study|Reason under review|1|||
105923000|NCT02164916|365378623|FG001|Overall Study|Reason under review|6|||
105923001|NCT02164916|365378622|FG000|Overall Study|Not eligible|2|||
105923002|NCT02164916|365378623|FG001|Overall Study|Not eligible|5|||
105923003|NCT00296517|365378624|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
105923004|NCT00296517|365378625|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
105923005|NCT00296517|365378624|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
105923006|NCT00296517|365378625|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
105923007|NCT00296517|365378624|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
105923008|NCT00296517|365378625|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
105923009|NCT00296517|365378624|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
105923010|NCT00296517|365378625|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
105923011|NCT00296517|365378624|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
105923012|NCT00296517|365378625|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
105923013|NCT00296517|365378624|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
105923014|NCT00296517|365378625|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
105923015|NCT00296517|365378624|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
105923016|NCT00296517|365378625|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
105923017|NCT00296517|365378624|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
105923018|NCT00296517|365378625|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
105923019|NCT00296517|365378624|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
105923020|NCT00296517|365378625|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
105923021|NCT00094445|365378635|FG000|Overall Study|Withdrawal by Subject|3|||
105923022|NCT00094445|365378635|FG000|Overall Study|Lost to Follow-up|1|||
105923023|NCT00094445|365378635|FG000|Overall Study|Progressive Disease|2|||
105923024|NCT03479905|365378638|FG000|Overall Study|Other airway method used|4|||
105923025|NCT03479905|365378639|FG001|Overall Study|Other airway method used|5|||
105923026|NCT03479905|365378640|FG002|Overall Study|Other airway method used|5|||
105923027|NCT02696798|365378645|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
105923028|NCT02696798|365378646|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
105923029|NCT02696798|365378647|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
105923030|NCT02696798|365378645|FG000|Blinded Treatment Dosing Period|Death|0|||
105923031|NCT02696798|365378646|FG001|Blinded Treatment Dosing Period|Death|0|||
105923032|NCT02696798|365378647|FG002|Blinded Treatment Dosing Period|Death|1|||
105923033|NCT02696798|365378645|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
105923034|NCT02696798|365378646|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
105923035|NCT02696798|365378647|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
105923036|NCT02696798|365378645|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
105923037|NCT02696798|365378646|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
105923038|NCT02696798|365378647|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
105923039|NCT02696798|365378645|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
105923040|NCT02696798|365378646|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
105923041|NCT02696798|365378647|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
105923042|NCT02696798|365378645|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
105923043|NCT02696798|365378646|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
105923044|NCT02696798|365378647|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
105923045|NCT02696798|365378645|FG000|Extended Treatment Period|Adverse Event|1|||
105923046|NCT02696798|365378646|FG001|Extended Treatment Period|Adverse Event|4|||
105923047|NCT02696798|365378647|FG002|Extended Treatment Period|Adverse Event|5|||
105923048|NCT02696798|365378645|FG000|Extended Treatment Period|Lack of Efficacy|7|||
105923049|NCT02696798|365378646|FG001|Extended Treatment Period|Lack of Efficacy|2|||
105923050|NCT02696798|365378647|FG002|Extended Treatment Period|Lack of Efficacy|2|||
105923051|NCT02696798|365378645|FG000|Extended Treatment Period|Lost to Follow-up|1|||
105923052|NCT02696798|365378646|FG001|Extended Treatment Period|Lost to Follow-up|0|||
105923053|NCT02696798|365378647|FG002|Extended Treatment Period|Lost to Follow-up|0|||
105923054|NCT02696798|365378645|FG000|Extended Treatment Period|Physician Decision|0|||
105923055|NCT02696798|365378646|FG001|Extended Treatment Period|Physician Decision|1|||
105923056|NCT02696798|365378647|FG002|Extended Treatment Period|Physician Decision|0|||
105923057|NCT02696798|365378645|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
105923058|NCT02696798|365378646|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
106132611|NCT05550337|366143273|FG001|Overall Study|Physician Decision|1|||
106132612|NCT05550337|366143274|FG002|Overall Study|Physician Decision|1|||
105695724|NCT03519867|364549930|FG004|Overall Study|Admin. of other reversal agent|0|||
105695725|NCT03519867|364549931|FG005|Overall Study|Admin. of other reversal agent|1|||
105695726|NCT03519867|364549932|FG006|Overall Study|Admin. of other reversal agent|0|||
105695727|NCT03519867|364549933|FG007|Overall Study|Admin. of other reversal agent|0|||
105695728|NCT03519867|364549934|FG008|Overall Study|Admin. of other reversal agent|0|||
105695729|NCT03519867|364549935|FG009|Overall Study|Admin. of other reversal agent|0|||
105695730|NCT03519867|364549926|FG000|Overall Study|Reason not provided|1|||
105695731|NCT03519867|364549927|FG001|Overall Study|Reason not provided|1|||
105695732|NCT03519867|364549928|FG002|Overall Study|Reason not provided|1|||
105923059|NCT02696798|365378647|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
105923060|NCT02696798|365378645|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
105923061|NCT02696798|365378646|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
105923062|NCT02696798|365378647|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
105923063|NCT02696798|365378645|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
105923064|NCT02696798|365378646|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
105923065|NCT02696798|365378647|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
106132613|NCT05550337|366143272|FG000|Overall Study|Lost to Follow-up|16|||
105695733|NCT03519867|364549929|FG003|Overall Study|Reason not provided|1|||
105695734|NCT03519867|364549930|FG004|Overall Study|Reason not provided|0|||
105695735|NCT03519867|364549931|FG005|Overall Study|Reason not provided|1|||
105695736|NCT03519867|364549932|FG006|Overall Study|Reason not provided|0|||
105695737|NCT03519867|364549933|FG007|Overall Study|Reason not provided|1|||
105695738|NCT03519867|364549934|FG008|Overall Study|Reason not provided|1|||
105695739|NCT03519867|364549935|FG009|Overall Study|Reason not provided|0|||
105695740|NCT02064920|364549939|FG000|Overall Study|Adverse Event|0|||
105695741|NCT02064920|364549940|FG001|Overall Study|Adverse Event|4|||
105695742|NCT02064920|364549939|FG000|Overall Study|Physician Decision|0|||
105695743|NCT02064920|364549940|FG001|Overall Study|Physician Decision|1|||
105695744|NCT02064920|364549939|FG000|Overall Study|Technical Problems|0|||
105695745|NCT02064920|364549940|FG001|Overall Study|Technical Problems|1|||
105695746|NCT02064920|364549939|FG000|Overall Study|Withdrawal by Subject|1|||
105695747|NCT02064920|364549940|FG001|Overall Study|Withdrawal by Subject|3|||
105695748|NCT00916279|364549941|FG000|Overall Study|Death|2|||
105695749|NCT00916279|364549941|FG000|Overall Study|Lost to Follow-up|2|||
105695750|NCT02109562|364549942|FG000|Overall Study|Insufficient clinical response|2|||
105695751|NCT02109562|364549943|FG001|Overall Study|Insufficient clinical response|0|||
105695752|NCT02109562|364549944|FG002|Overall Study|Insufficient clinical response|4|||
105695753|NCT02109562|364549942|FG000|Overall Study|Adverse Event|0|||
105695754|NCT02109562|364549943|FG001|Overall Study|Adverse Event|2|||
105695755|NCT02109562|364549944|FG002|Overall Study|Adverse Event|3|||
105695756|NCT02109562|364549942|FG000|Overall Study|Lost to Follow-up|1|||
105695757|NCT02109562|364549943|FG001|Overall Study|Lost to Follow-up|0|||
105695758|NCT02109562|364549944|FG002|Overall Study|Lost to Follow-up|1|||
105695759|NCT02109562|364549942|FG000|Overall Study|Protocol Violation|0|||
105695760|NCT02109562|364549943|FG001|Overall Study|Protocol Violation|3|||
105695761|NCT02109562|364549944|FG002|Overall Study|Protocol Violation|1|||
105695762|NCT02109562|364549942|FG000|Overall Study|Withdrawal by Subject|20|||
105695763|NCT02109562|364549943|FG001|Overall Study|Withdrawal by Subject|25|||
105695764|NCT02109562|364549944|FG002|Overall Study|Withdrawal by Subject|21|||
105695765|NCT02109562|364549942|FG000|Overall Study|Physician Decision|3|||
105695766|NCT02109562|364549943|FG001|Overall Study|Physician Decision|4|||
105695767|NCT02109562|364549944|FG002|Overall Study|Physician Decision|5|||
105695768|NCT00688155|364549945|FG000|Overall Study|Withdrawal by Subject|2|||
105695769|NCT00688155|364549946|FG001|Overall Study|Withdrawal by Subject|2|||
105695770|NCT00688155|364549947|FG002|Overall Study|Withdrawal by Subject|1|||
105695771|NCT00688155|364549948|FG003|Overall Study|Withdrawal by Subject|1|||
105695772|NCT03318978|364549949|FG000|Overall Study|Withdrawal by Subject|1|||
105695773|NCT02844816|364549950|FG000|Overall Study|No protocol treatment received|5|||
105695774|NCT02844816|364549951|FG001|Overall Study|No protocol treatment received|1|||
105695775|NCT02844816|364549950|FG000|Overall Study|Ineligible|22|||
105695776|NCT02844816|364549951|FG001|Overall Study|Ineligible|15|||
105695777|NCT02844816|364549950|FG000|Overall Study|Participant refusal|5|||
105695778|NCT02844816|364549951|FG001|Overall Study|Participant refusal|5|||
105695779|NCT02844816|364549950|FG000|Overall Study|Adverse Event|5|||
105695780|NCT02844816|364549951|FG001|Overall Study|Adverse Event|4|||
105695781|NCT02844816|364549950|FG000|Overall Study|Death|0|||
105695782|NCT02844816|364549951|FG001|Overall Study|Death|1|||
105695783|NCT02844816|364549950|FG000|Overall Study|Disease progression/recurrence|50|||
105695784|NCT02844816|364549951|FG001|Overall Study|Disease progression/recurrence|24|||
105695785|NCT02844816|364549950|FG000|Overall Study|Physician Decision|1|||
105695786|NCT02844816|364549951|FG001|Overall Study|Physician Decision|1|||
105695787|NCT04085523|364549952|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695788|NCT04085523|364549953|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695789|NCT04085523|364549954|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695790|NCT04085523|364549955|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695791|NCT04085523|364549956|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
105695792|NCT04085523|364549957|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
105695793|NCT01877915|364549961|FG000|Overall Study|Lost to Follow-up|10|||
105695794|NCT01877915|364549962|FG001|Overall Study|Lost to Follow-up|9|||
105695795|NCT01877915|364549961|FG000|Overall Study|Withdrawal by Subject|42|||
105695796|NCT01877915|364549962|FG001|Overall Study|Withdrawal by Subject|55|||
105695797|NCT01877915|364549961|FG000|Overall Study|Other|2|||
105695798|NCT01877915|364549962|FG001|Overall Study|Other|4|||
105695799|NCT03007979|364549963|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
105695800|NCT01005745|364549964|FG000|Overall Study|No TIL growth|1|||
105695801|NCT01005745|364549964|FG000|Overall Study|Disease progressed during TIL growth|3|||
105695802|NCT01005745|364549964|FG000|Overall Study|Death prior to treatment|1|||
105695803|NCT01005745|364549964|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
105695804|NCT03520959|364549965|FG000|Overall Study|Study terminated by Sponsor|0|||
105695805|NCT03520959|364549966|FG001|Overall Study|Study terminated by Sponsor|1|||
105695806|NCT01659151|364549969|FG000|Overall Study|Inadequate TIL growth|1|||
105695807|NCT00597753|364549970|FG000|Overall Study|Adverse Event|6|||
105695808|NCT00597753|364549971|FG001|Overall Study|Adverse Event|2|||
105695809|NCT00597753|364549970|FG000|Overall Study|Death|55|||
105695810|NCT00597753|364549971|FG001|Overall Study|Death|29|||
105695811|NCT00597753|364549970|FG000|Overall Study|Lack of Efficacy|2|||
105695812|NCT00597753|364549971|FG001|Overall Study|Lack of Efficacy|0|||
105695813|NCT00597753|364549970|FG000|Overall Study|Lost to Follow-up|10|||
105695814|NCT00597753|364549971|FG001|Overall Study|Lost to Follow-up|3|||
105695815|NCT00597753|364549970|FG000|Overall Study|Physician Decision|5|||
105695816|NCT00597753|364549971|FG001|Overall Study|Physician Decision|1|||
105695817|NCT00597753|364549970|FG000|Overall Study|Pregnancy|1|||
105695818|NCT00597753|364549971|FG001|Overall Study|Pregnancy|0|||
105695819|NCT00597753|364549970|FG000|Overall Study|Withdrawal by Subject|35|||
105695820|NCT00597753|364549971|FG001|Overall Study|Withdrawal by Subject|12|||
105695821|NCT00597753|364549970|FG000|Overall Study|Discontinued Dialysis|0|||
105695822|NCT00597753|364549971|FG001|Overall Study|Discontinued Dialysis|1|||
105695823|NCT00597753|364549970|FG000|Overall Study|Never dosed|2|||
105695824|NCT00597753|364549971|FG001|Overall Study|Never dosed|0|||
105695825|NCT00597753|364549970|FG000|Overall Study|Noncompliance|2|||
105695826|NCT00597753|364549971|FG001|Overall Study|Noncompliance|1|||
105695827|NCT00597753|364549970|FG000|Overall Study|Relocation|17|||
105695828|NCT00597753|364549971|FG001|Overall Study|Relocation|6|||
105695829|NCT00597753|364549970|FG000|Overall Study|Renal transplant|10|||
105695830|NCT00597753|364549971|FG001|Overall Study|Renal transplant|3|||
105695831|NCT00597753|364549970|FG000|Overall Study|Site closed by sponsor|19|||
105695832|NCT00597753|364549971|FG001|Overall Study|Site closed by sponsor|7|||
105695833|NCT00597753|364549970|FG000|Overall Study|Site elected to close|2|||
105695834|NCT00597753|364549971|FG001|Overall Study|Site elected to close|4|||
105695835|NCT03713034|364552401|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
105695836|NCT03713034|364552402|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
105695837|NCT02982590|364552408|FG000|Overall Study|Lost to Follow-up|0|||
105695838|NCT02982590|364552409|FG001|Overall Study|Lost to Follow-up|1|||
105695839|NCT02982590|364552408|FG000|Overall Study|Death|4|||
105695840|NCT02982590|364552409|FG001|Overall Study|Death|0|||
105695841|NCT01086410|364552410|FG000|Overall Study|Adverse Event|1|||
105695842|NCT01086410|364552411|FG001|Overall Study|Adverse Event|0|||
105695843|NCT01086410|364552412|FG002|Overall Study|Adverse Event|0|||
105695844|NCT01086410|364552413|FG003|Overall Study|Adverse Event|2|||
105695845|NCT01086410|364552410|FG000|Overall Study|Lack of Efficacy|1|||
105695846|NCT01086410|364552411|FG001|Overall Study|Lack of Efficacy|1|||
105695847|NCT01086410|364552412|FG002|Overall Study|Lack of Efficacy|0|||
105695848|NCT01086410|364552413|FG003|Overall Study|Lack of Efficacy|0|||
105695849|NCT01086410|364552410|FG000|Overall Study|Protocol Violation|1|||
105695850|NCT01086410|364552411|FG001|Overall Study|Protocol Violation|1|||
105695851|NCT01086410|364552412|FG002|Overall Study|Protocol Violation|0|||
105695852|NCT01086410|364552413|FG003|Overall Study|Protocol Violation|0|||
105695853|NCT01086410|364552410|FG000|Overall Study|Lost to Follow-up|0|||
105695854|NCT01086410|364552411|FG001|Overall Study|Lost to Follow-up|0|||
105695855|NCT01086410|364552412|FG002|Overall Study|Lost to Follow-up|1|||
105695856|NCT01086410|364552413|FG003|Overall Study|Lost to Follow-up|0|||
105695857|NCT02953639|364552414|FG000|Overall Study|Adverse Event|2|||
105695858|NCT02953639|364552415|FG001|Overall Study|Adverse Event|0|||
105695859|NCT02953639|364552416|FG002|Overall Study|Adverse Event|1|||
105695860|NCT02953639|364552414|FG000|Overall Study|Lost to Follow-up|8|||
105695861|NCT02953639|364552415|FG001|Overall Study|Lost to Follow-up|4|||
105695862|NCT02953639|364552416|FG002|Overall Study|Lost to Follow-up|3|||
105695863|NCT02953639|364552414|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105695864|NCT02953639|364552415|FG001|Overall Study|Non-Compliance With Study Drug|2|||
105695865|NCT02953639|364552416|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105695866|NCT02953639|364552414|FG000|Overall Study|Multiple Reasons|1|||
105695867|NCT02953639|364552415|FG001|Overall Study|Multiple Reasons|0|||
105695868|NCT02953639|364552416|FG002|Overall Study|Multiple Reasons|1|||
105695869|NCT02953639|364552414|FG000|Overall Study|Physician Decision|1|||
105695870|NCT02953639|364552415|FG001|Overall Study|Physician Decision|0|||
105695871|NCT02953639|364552416|FG002|Overall Study|Physician Decision|0|||
105695872|NCT02953639|364552414|FG000|Overall Study|Withdrawal by Subject|7|||
105695873|NCT02953639|364552415|FG001|Overall Study|Withdrawal by Subject|8|||
105695874|NCT02953639|364552416|FG002|Overall Study|Withdrawal by Subject|10|||
105695875|NCT02953639|364552414|FG000|Overall Study|Completed or Discontinued information is missing|1|||
105695876|NCT02953639|364552415|FG001|Overall Study|Completed or Discontinued information is missing|0|||
105695877|NCT02953639|364552416|FG002|Overall Study|Completed or Discontinued information is missing|0|||
105695878|NCT01022996|364552417|FG000|Overall Study|Adverse Event|14|||
105695879|NCT01022996|364552417|FG000|Overall Study|Withdrawal by Subject|3|||
105695880|NCT01022996|364552417|FG000|Overall Study|Lost to Follow-up|1|||
105695881|NCT01022996|364552417|FG000|Overall Study|Administrative problems|6|||
105695882|NCT01022996|364552417|FG000|Overall Study|Disease Progression|32|||
105695883|NCT01022996|364552417|FG000|Overall Study|Protocol Violation|1|||
105695884|NCT01830855|364552418|FG000|Overall Study|Other|7|||
105695885|NCT01830855|364552419|FG001|Overall Study|Other|1|||
105695886|NCT01830855|364552420|FG002|Overall Study|Other|4|||
105695887|NCT01830855|364552421|FG003|Overall Study|Other|4|||
105695888|NCT01830855|364552418|FG000|Overall Study|Medication error without associated AE|1|||
105695889|NCT01830855|364552419|FG001|Overall Study|Medication error without associated AE|0|||
105695890|NCT01830855|364552420|FG002|Overall Study|Medication error without associated AE|0|||
105695891|NCT01830855|364552421|FG003|Overall Study|Medication error without associated AE|1|||
105695892|NCT01830855|364552418|FG000|Overall Study|Pregnancy|3|||
105695893|NCT01830855|364552419|FG001|Overall Study|Pregnancy|1|||
105695894|NCT01830855|364552420|FG002|Overall Study|Pregnancy|2|||
106132614|NCT05550337|366143273|FG001|Overall Study|Lost to Follow-up|11|||
106132615|NCT05550337|366143274|FG002|Overall Study|Lost to Follow-up|11|||
106132616|NCT02027935|366143276|FG000|Overall Study|Death|1|||
106132617|NCT02027935|366143276|FG000|Overall Study|Lack of Efficacy|5|||
106132618|NCT02027935|366143276|FG000|Overall Study|Study Closure|1|||
106132619|NCT03115346|366143277|FG000|Overall Study|Did not have AAA surgery|28|||
106132620|NCT03115346|366143278|FG001|Overall Study|Did not have AAA surgery|15|||
106132621|NCT03115346|366143277|FG000|Overall Study|Death|3|||
106132622|NCT03115346|366143278|FG001|Overall Study|Death|1|||
106132623|NCT03115346|366143277|FG000|Overall Study|Withdrawal by Subject|0|||
106132624|NCT03115346|366143278|FG001|Overall Study|Withdrawal by Subject|3|||
106132625|NCT03115346|366143277|FG000|Overall Study|Lost to Follow-up|0|||
106132626|NCT03115346|366143278|FG001|Overall Study|Lost to Follow-up|3|||
106132627|NCT03697460|366143279|FG000|Overall Study|Withdrawal by Subject|3|||
106132628|NCT04949399|366143280|FG000|Overall Study|Lost to Follow-up|11|||
106132629|NCT04949399|366143281|FG001|Overall Study|Lost to Follow-up|6|||
106132630|NCT04949399|366143280|FG000|Overall Study|Withdrawal by Subject|2|||
106132631|NCT04949399|366143281|FG001|Overall Study|Withdrawal by Subject|3|||
106132632|NCT01515319|366143282|FG000|Overall Study|Withdrawal by Subject|0|||
106132633|NCT01515319|366143283|FG001|Overall Study|Withdrawal by Subject|0|||
106132634|NCT01515319|366143284|FG002|Overall Study|Withdrawal by Subject|0|||
106132635|NCT01515319|366143285|FG003|Overall Study|Withdrawal by Subject|0|||
106132636|NCT01515319|366143286|FG004|Overall Study|Withdrawal by Subject|0|||
106132637|NCT01515319|366143287|FG005|Overall Study|Withdrawal by Subject|0|||
106132638|NCT01515319|366143288|FG006|Overall Study|Withdrawal by Subject|1|||
106132639|NCT01515319|366143289|FG007|Overall Study|Withdrawal by Subject|0|||
106132640|NCT01515319|366143290|FG008|Overall Study|Withdrawal by Subject|0|||
106132641|NCT01515319|366143291|FG009|Overall Study|Withdrawal by Subject|0|||
106132642|NCT01515319|366143282|FG000|Overall Study|Adverse Event|0|||
106132643|NCT01515319|366143283|FG001|Overall Study|Adverse Event|0|||
106132644|NCT01515319|366143284|FG002|Overall Study|Adverse Event|0|||
106132645|NCT01515319|366143285|FG003|Overall Study|Adverse Event|0|||
106132646|NCT01515319|366143286|FG004|Overall Study|Adverse Event|0|||
106132647|NCT01515319|366143287|FG005|Overall Study|Adverse Event|0|||
106132648|NCT01515319|366143288|FG006|Overall Study|Adverse Event|0|||
106132649|NCT01515319|366143289|FG007|Overall Study|Adverse Event|0|||
106132650|NCT01515319|366143290|FG008|Overall Study|Adverse Event|3|||
106132651|NCT01515319|366143291|FG009|Overall Study|Adverse Event|0|||
106132652|NCT01515319|366143282|FG000|Overall Study|Protocol Violation|0|||
106132653|NCT01515319|366143283|FG001|Overall Study|Protocol Violation|0|||
106132654|NCT01515319|366143284|FG002|Overall Study|Protocol Violation|0|||
106132655|NCT01515319|366143285|FG003|Overall Study|Protocol Violation|0|||
106132656|NCT01515319|366143286|FG004|Overall Study|Protocol Violation|0|||
106132657|NCT01515319|366143287|FG005|Overall Study|Protocol Violation|0|||
106132658|NCT01515319|366143288|FG006|Overall Study|Protocol Violation|0|||
106132659|NCT01515319|366143289|FG007|Overall Study|Protocol Violation|0|||
106132660|NCT01515319|366143290|FG008|Overall Study|Protocol Violation|2|||
106132661|NCT01515319|366143291|FG009|Overall Study|Protocol Violation|0|||
106132662|NCT04159506|366143292|FG000|Overall Study|Lost to Follow-up|2|||
106132663|NCT04159506|366143293|FG001|Overall Study|Lost to Follow-up|5|||
106132664|NCT02449044|366143294|FG000|Overall Study|Lost to Follow-up|2|||
106132665|NCT02449044|366143294|FG000|Overall Study|Withdrawal by Subject|13|||
106132666|NCT02449044|366143294|FG000|Overall Study|Adverse Event|30|||
105695895|NCT01830855|364552421|FG003|Overall Study|Pregnancy|1|||
105695896|NCT01830855|364552418|FG000|Overall Study|No longer meets eligibility criteria|11|||
105695897|NCT01830855|364552419|FG001|Overall Study|No longer meets eligibility criteria|2|||
105695898|NCT01830855|364552420|FG002|Overall Study|No longer meets eligibility criteria|3|||
105695899|NCT01830855|364552421|FG003|Overall Study|No longer meets eligibility criteria|5|||
106132667|NCT02449044|366143294|FG000|Overall Study|Met Withdrawal Criteria|7|||
106132668|NCT02449044|366143294|FG000|Overall Study|Physician Decision|9|||
106132669|NCT02449044|366143294|FG000|Overall Study|Sponsor Discontinued Trial|3|||
106132670|NCT00662909|366143295|FG000|Overall Study|Adverse Event|17|||
105695900|NCT01830855|364552418|FG000|Overall Study|Adverse Event|11|||
105695901|NCT01830855|364552419|FG001|Overall Study|Adverse Event|5|||
105695902|NCT01830855|364552420|FG002|Overall Study|Adverse Event|6|||
105695903|NCT01830855|364552421|FG003|Overall Study|Adverse Event|3|||
105695904|NCT01830855|364552418|FG000|Overall Study|Protocol deviation|10|||
105695905|NCT01830855|364552419|FG001|Overall Study|Protocol deviation|5|||
105695906|NCT01830855|364552420|FG002|Overall Study|Protocol deviation|6|||
105695907|NCT01830855|364552421|FG003|Overall Study|Protocol deviation|6|||
105695908|NCT01830855|364552418|FG000|Overall Study|Withdrawal by Subject|33|||
105695909|NCT01830855|364552419|FG001|Overall Study|Withdrawal by Subject|14|||
105695910|NCT01830855|364552420|FG002|Overall Study|Withdrawal by Subject|10|||
105695911|NCT01830855|364552421|FG003|Overall Study|Withdrawal by Subject|12|||
105695912|NCT01830855|364552418|FG000|Overall Study|No longer willing to participate|32|||
105695913|NCT01830855|364552419|FG001|Overall Study|No longer willing to participate|13|||
105695914|NCT01830855|364552420|FG002|Overall Study|No longer willing to participate|12|||
105695915|NCT01830855|364552421|FG003|Overall Study|No longer willing to participate|17|||
105695916|NCT01830855|364552418|FG000|Overall Study|Lost to Follow-up|47|||
105695917|NCT01830855|364552419|FG001|Overall Study|Lost to Follow-up|20|||
105695918|NCT01830855|364552420|FG002|Overall Study|Lost to Follow-up|23|||
105695919|NCT01830855|364552421|FG003|Overall Study|Lost to Follow-up|33|||
105695920|NCT02767323|364552422|FG000|Overall Study|Withdrawal by Subject|17|||
105695921|NCT02767323|364552423|FG001|Overall Study|Withdrawal by Subject|5|||
105695922|NCT02767323|364552424|FG002|Overall Study|Withdrawal by Subject|13|||
105695923|NCT02767323|364552425|FG003|Overall Study|Withdrawal by Subject|0|||
105695924|NCT02767323|364552422|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
105695925|NCT02767323|364552423|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
105695926|NCT02767323|364552424|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
105695927|NCT02767323|364552425|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
105695928|NCT01667081|364552426|FG000|Overall Study|Death|43|||
105695929|NCT01667081|364552427|FG001|Overall Study|Death|3|||
105695930|NCT01667081|364552426|FG000|Overall Study|Lost to Follow-up|99|||
105695931|NCT01667081|364552427|FG001|Overall Study|Lost to Follow-up|48|||
105695932|NCT01667081|364552426|FG000|Overall Study|Physician Decision|16|||
105695933|NCT01667081|364552427|FG001|Overall Study|Physician Decision|2|||
105695934|NCT01667081|364552426|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
105695935|NCT01667081|364552427|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
105695936|NCT01667081|364552426|FG000|Overall Study|Withdrawal by Subject|90|||
105695937|NCT01667081|364552427|FG001|Overall Study|Withdrawal by Subject|35|||
105695938|NCT00930722|364552428|FG000|Overall Study|Lost to Follow-up|16|||
105695939|NCT00930722|364552428|FG000|Overall Study|No longer willing to participate|9|||
105695940|NCT00930722|364552428|FG000|Overall Study|Study terminated by sponsor|2|||
105695941|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Adverse Event|2|||
105695942|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Adverse Event|2|||
105695943|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Adverse Event|4|||
105695944|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Adverse Event|0|||
105695945|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Adverse Event|0|||
105695946|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Progressive disease|0|||
105695947|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Progressive disease|0|||
105695948|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Progressive disease|1|||
105695949|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Progressive disease|0|||
105695950|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Progressive disease|0|||
105695951|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
105695952|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
105695953|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
105695954|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
105695955|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
105695956|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
105695957|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
105695958|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
105695959|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
105695960|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
105695961|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
105695962|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
105695963|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
105787108|NCT03110107|364874914|FG025|Treatment Period|Study drug toxicity|6|||
105695964|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
105695965|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
105695966|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
105787109|NCT03110107|364874889|FG000|Treatment Period|Death|0|||
105787110|NCT03110107|364874890|FG001|Treatment Period|Death|0|||
105695967|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
105695968|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
105695969|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
105787111|NCT03110107|364874891|FG002|Treatment Period|Death|0|||
105695970|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
105695971|NCT03523728|364552429|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
105695972|NCT03523728|364552430|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
105695973|NCT03523728|364552431|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
105695974|NCT03523728|364552432|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
105695975|NCT03523728|364552433|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
105695976|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Adverse Event|0|||
105695977|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Adverse Event|0|||
105695978|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Adverse Event|0|||
105695979|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Adverse Event|1|||
105695980|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Adverse Event|2|||
105695981|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
105695982|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
105695983|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
105695984|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
105695985|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
105695986|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
105695987|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
105695988|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
105695989|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
105695990|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
105695991|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
105695992|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
105695993|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
105695994|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
105695995|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
105695996|NCT03523728|364552429|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
105695997|NCT03523728|364552430|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
105695998|NCT03523728|364552431|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
105695999|NCT03523728|364552432|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
105696000|NCT03523728|364552433|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
105696001|NCT00621751|364552437|FG000|Overall Study|Adverse Event|0|||
105696002|NCT00621751|364552438|FG001|Overall Study|Adverse Event|1|||
105696003|NCT01950247|364552439|FG000|Overall Study|Withdrawal by Subject|28|||
105696004|NCT01950247|364552440|FG001|Overall Study|Withdrawal by Subject|13|||
105696005|NCT01950247|364552439|FG000|Overall Study|Lost to Follow-up|18|||
105696006|NCT01950247|364552440|FG001|Overall Study|Lost to Follow-up|16|||
105696007|NCT01950247|364552439|FG000|Overall Study|Physician Decision|3|||
105696008|NCT01950247|364552440|FG001|Overall Study|Physician Decision|4|||
105696009|NCT01950247|364552439|FG000|Overall Study|Adverse Event|3|||
105696010|NCT01950247|364552440|FG001|Overall Study|Adverse Event|2|||
105696011|NCT01950247|364552439|FG000|Overall Study|Death|1|||
105696012|NCT01950247|364552440|FG001|Overall Study|Death|1|||
105696013|NCT01950247|364552439|FG000|Overall Study|Not Defined|4|||
105696014|NCT01950247|364552440|FG001|Overall Study|Not Defined|10|||
105696015|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
105696016|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
105696017|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
105696018|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
105696019|NCT00066742|364552447|FG000|Induction Chemoradiotherapy|Ineligible|3|||
105696020|NCT00066742|364552447|FG000|Consolidation Chemotherapy|not protocol specified|1|||
105696021|NCT00066742|364552447|FG000|Consolidation Chemotherapy|Ineligible|2|||
105696022|NCT02357134|364552448|FG000|Overall Study|Lost to Follow-up|1|||
105696023|NCT02357134|364552449|FG001|Overall Study|Lost to Follow-up|0|||
105696024|NCT02357134|364552450|FG002|Overall Study|Lost to Follow-up|0|||
105696025|NCT02357134|364552451|FG003|Overall Study|Lost to Follow-up|0|||
105696026|NCT03583450|364552463|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
105696027|NCT03583450|364552464|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
105696028|NCT03374995|364552465|FG000|Overall Study|Withdrawal by Subject|0|||
105696029|NCT03374995|364552466|FG001|Overall Study|Withdrawal by Subject|1|||
105696030|NCT03593850|364552468|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
105696031|NCT03593850|364552469|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
105696032|NCT05097716|364552470|FG000|Period 1|Adverse Event|1|||
105696033|NCT05097716|364552470|FG000|Period 1|Close contact with highly-transmissible infection|1|||
105696034|NCT00467779|364552475|FG000|Stage 1|Adverse Event|1|||
105696035|NCT00467779|364552476|FG001|Stage 1|Adverse Event|0|||
105696036|NCT00467779|364552477|FG002|Stage 1|Adverse Event|0|||
105696037|NCT00467779|364552478|FG003|Stage 1|Adverse Event|0|||
105696038|NCT00467779|364552479|FG004|Stage 1|Adverse Event|0|||
105696039|NCT00467779|364552480|FG005|Stage 1|Adverse Event|1|||
105696040|NCT00467779|364552481|FG006|Stage 1|Adverse Event|2|||
105696041|NCT00467779|364552482|FG007|Stage 1|Adverse Event|1|||
105696042|NCT00467779|364552483|FG008|Stage 1|Adverse Event|0|||
105696043|NCT00467779|364552484|FG009|Stage 1|Adverse Event|0|||
105787112|NCT03110107|364874892|FG003|Treatment Period|Death|0|||
105696044|NCT00467779|364552485|FG010|Stage 1|Adverse Event|0|||
105696045|NCT00467779|364552486|FG011|Stage 1|Adverse Event|0|||
105696046|NCT00467779|364552487|FG012|Stage 1|Adverse Event|0|||
105696047|NCT00467779|364552488|FG013|Stage 1|Adverse Event|0|||
105696048|NCT00467779|364552489|FG014|Stage 1|Adverse Event|0|||
105696049|NCT00467779|364552475|FG000|Stage 1|Disease Progression|2|||
105696050|NCT00467779|364552476|FG001|Stage 1|Disease Progression|2|||
105696051|NCT00467779|364552477|FG002|Stage 1|Disease Progression|2|||
105696052|NCT00467779|364552478|FG003|Stage 1|Disease Progression|3|||
105696053|NCT00467779|364552479|FG004|Stage 1|Disease Progression|2|||
105696054|NCT00467779|364552480|FG005|Stage 1|Disease Progression|2|||
105696055|NCT00467779|364552481|FG006|Stage 1|Disease Progression|4|||
105696056|NCT00467779|364552482|FG007|Stage 1|Disease Progression|5|||
105696057|NCT00467779|364552483|FG008|Stage 1|Disease Progression|0|||
105696058|NCT00467779|364552484|FG009|Stage 1|Disease Progression|0|||
105696059|NCT00467779|364552485|FG010|Stage 1|Disease Progression|0|||
105696060|NCT00467779|364552486|FG011|Stage 1|Disease Progression|0|||
105696061|NCT00467779|364552487|FG012|Stage 1|Disease Progression|0|||
105696062|NCT00467779|364552488|FG013|Stage 1|Disease Progression|0|||
105696063|NCT00467779|364552489|FG014|Stage 1|Disease Progression|0|||
105696064|NCT00467779|364552475|FG000|Stage 1|Unspecified Reason|1|||
105696065|NCT00467779|364552476|FG001|Stage 1|Unspecified Reason|0|||
105696066|NCT00467779|364552477|FG002|Stage 1|Unspecified Reason|1|||
105696067|NCT00467779|364552478|FG003|Stage 1|Unspecified Reason|0|||
105696068|NCT00467779|364552479|FG004|Stage 1|Unspecified Reason|1|||
105696069|NCT00467779|364552480|FG005|Stage 1|Unspecified Reason|2|||
105696070|NCT00467779|364552481|FG006|Stage 1|Unspecified Reason|0|||
105696071|NCT00467779|364552482|FG007|Stage 1|Unspecified Reason|0|||
105696072|NCT00467779|364552483|FG008|Stage 1|Unspecified Reason|0|||
105696073|NCT00467779|364552484|FG009|Stage 1|Unspecified Reason|0|||
105696074|NCT00467779|364552485|FG010|Stage 1|Unspecified Reason|0|||
105696075|NCT00467779|364552486|FG011|Stage 1|Unspecified Reason|0|||
105696076|NCT00467779|364552487|FG012|Stage 1|Unspecified Reason|0|||
105696077|NCT00467779|364552488|FG013|Stage 1|Unspecified Reason|0|||
105696078|NCT00467779|364552489|FG014|Stage 1|Unspecified Reason|0|||
105696079|NCT00467779|364552475|FG000|Stage 1|Physician Decision|0|||
105696080|NCT00467779|364552476|FG001|Stage 1|Physician Decision|1|||
105696081|NCT00467779|364552477|FG002|Stage 1|Physician Decision|0|||
105696082|NCT00467779|364552478|FG003|Stage 1|Physician Decision|0|||
105696083|NCT00467779|364552479|FG004|Stage 1|Physician Decision|0|||
105696084|NCT00467779|364552480|FG005|Stage 1|Physician Decision|0|||
105696085|NCT00467779|364552481|FG006|Stage 1|Physician Decision|0|||
105696086|NCT00467779|364552482|FG007|Stage 1|Physician Decision|0|||
105696087|NCT00467779|364552483|FG008|Stage 1|Physician Decision|0|||
105696088|NCT00467779|364552484|FG009|Stage 1|Physician Decision|0|||
105696089|NCT00467779|364552485|FG010|Stage 1|Physician Decision|0|||
105696090|NCT00467779|364552486|FG011|Stage 1|Physician Decision|0|||
105696091|NCT00467779|364552487|FG012|Stage 1|Physician Decision|0|||
105696092|NCT00467779|364552488|FG013|Stage 1|Physician Decision|0|||
105696093|NCT00467779|364552489|FG014|Stage 1|Physician Decision|0|||
105696094|NCT00467779|364552475|FG000|Stage 1|Withdrawal by Subject|0|||
105696095|NCT00467779|364552476|FG001|Stage 1|Withdrawal by Subject|0|||
105696096|NCT00467779|364552477|FG002|Stage 1|Withdrawal by Subject|0|||
105696097|NCT00467779|364552478|FG003|Stage 1|Withdrawal by Subject|0|||
105696098|NCT00467779|364552479|FG004|Stage 1|Withdrawal by Subject|0|||
105696099|NCT00467779|364552480|FG005|Stage 1|Withdrawal by Subject|0|||
105696100|NCT00467779|364552481|FG006|Stage 1|Withdrawal by Subject|1|||
105696101|NCT00467779|364552482|FG007|Stage 1|Withdrawal by Subject|1|||
105696102|NCT00467779|364552483|FG008|Stage 1|Withdrawal by Subject|0|||
105696103|NCT00467779|364552484|FG009|Stage 1|Withdrawal by Subject|0|||
105696104|NCT00467779|364552485|FG010|Stage 1|Withdrawal by Subject|0|||
105696105|NCT00467779|364552486|FG011|Stage 1|Withdrawal by Subject|0|||
105696106|NCT00467779|364552487|FG012|Stage 1|Withdrawal by Subject|0|||
105696107|NCT00467779|364552488|FG013|Stage 1|Withdrawal by Subject|0|||
105696108|NCT00467779|364552489|FG014|Stage 1|Withdrawal by Subject|0|||
105696109|NCT00467779|364552475|FG000|Stage 1A|Adverse Event|0|||
105696110|NCT00467779|364552476|FG001|Stage 1A|Adverse Event|0|||
105696111|NCT00467779|364552477|FG002|Stage 1A|Adverse Event|0|||
105696112|NCT00467779|364552478|FG003|Stage 1A|Adverse Event|0|||
105696113|NCT00467779|364552479|FG004|Stage 1A|Adverse Event|0|||
105696114|NCT00467779|364552480|FG005|Stage 1A|Adverse Event|0|||
105696115|NCT00467779|364552481|FG006|Stage 1A|Adverse Event|0|||
105923066|NCT02696798|365378645|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
105696116|NCT00467779|364552482|FG007|Stage 1A|Adverse Event|0|||
105696117|NCT00467779|364552483|FG008|Stage 1A|Adverse Event|0|||
105696118|NCT00467779|364552484|FG009|Stage 1A|Adverse Event|0|||
105696119|NCT00467779|364552485|FG010|Stage 1A|Adverse Event|0|||
105696120|NCT00467779|364552486|FG011|Stage 1A|Adverse Event|0|||
105696121|NCT00467779|364552487|FG012|Stage 1A|Adverse Event|1|||
105696122|NCT00467779|364552488|FG013|Stage 1A|Adverse Event|0|||
105696123|NCT00467779|364552489|FG014|Stage 1A|Adverse Event|0|||
105696124|NCT00467779|364552475|FG000|Stage 1A|Death|0|||
105696125|NCT00467779|364552476|FG001|Stage 1A|Death|0|||
105696126|NCT00467779|364552477|FG002|Stage 1A|Death|0|||
105696127|NCT00467779|364552478|FG003|Stage 1A|Death|0|||
105696128|NCT00467779|364552479|FG004|Stage 1A|Death|0|||
105696129|NCT00467779|364552480|FG005|Stage 1A|Death|0|||
105696130|NCT00467779|364552481|FG006|Stage 1A|Death|0|||
105696131|NCT00467779|364552482|FG007|Stage 1A|Death|0|||
105696132|NCT00467779|364552483|FG008|Stage 1A|Death|0|||
105696133|NCT00467779|364552484|FG009|Stage 1A|Death|0|||
105696134|NCT00467779|364552485|FG010|Stage 1A|Death|0|||
105696135|NCT00467779|364552486|FG011|Stage 1A|Death|1|||
105696136|NCT00467779|364552487|FG012|Stage 1A|Death|1|||
105696137|NCT00467779|364552488|FG013|Stage 1A|Death|0|||
105696138|NCT00467779|364552489|FG014|Stage 1A|Death|0|||
105696139|NCT00467779|364552475|FG000|Stage 1A|Disease Progression|0|||
105696140|NCT00467779|364552476|FG001|Stage 1A|Disease Progression|0|||
105696141|NCT00467779|364552477|FG002|Stage 1A|Disease Progression|0|||
105696142|NCT00467779|364552478|FG003|Stage 1A|Disease Progression|0|||
105696143|NCT00467779|364552479|FG004|Stage 1A|Disease Progression|0|||
105696144|NCT00467779|364552480|FG005|Stage 1A|Disease Progression|0|||
105696145|NCT00467779|364552481|FG006|Stage 1A|Disease Progression|0|||
105696146|NCT00467779|364552482|FG007|Stage 1A|Disease Progression|0|||
105696147|NCT00467779|364552483|FG008|Stage 1A|Disease Progression|0|||
105696148|NCT00467779|364552484|FG009|Stage 1A|Disease Progression|2|||
105696149|NCT00467779|364552485|FG010|Stage 1A|Disease Progression|2|||
105696150|NCT00467779|364552486|FG011|Stage 1A|Disease Progression|5|||
105696151|NCT00467779|364552487|FG012|Stage 1A|Disease Progression|2|||
105696152|NCT00467779|364552488|FG013|Stage 1A|Disease Progression|0|||
105696153|NCT00467779|364552489|FG014|Stage 1A|Disease Progression|0|||
105696154|NCT00467779|364552475|FG000|Stage 1A|Physician Decision|0|||
105696155|NCT00467779|364552476|FG001|Stage 1A|Physician Decision|0|||
105696156|NCT00467779|364552477|FG002|Stage 1A|Physician Decision|0|||
105696157|NCT00467779|364552478|FG003|Stage 1A|Physician Decision|0|||
105696158|NCT00467779|364552479|FG004|Stage 1A|Physician Decision|0|||
105696159|NCT00467779|364552480|FG005|Stage 1A|Physician Decision|0|||
105696160|NCT00467779|364552481|FG006|Stage 1A|Physician Decision|0|||
105696161|NCT00467779|364552482|FG007|Stage 1A|Physician Decision|0|||
105696162|NCT00467779|364552483|FG008|Stage 1A|Physician Decision|0|||
105696163|NCT00467779|364552484|FG009|Stage 1A|Physician Decision|1|||
105696164|NCT00467779|364552485|FG010|Stage 1A|Physician Decision|0|||
105696165|NCT00467779|364552486|FG011|Stage 1A|Physician Decision|0|||
105696166|NCT00467779|364552487|FG012|Stage 1A|Physician Decision|0|||
105696167|NCT00467779|364552488|FG013|Stage 1A|Physician Decision|0|||
105696168|NCT00467779|364552489|FG014|Stage 1A|Physician Decision|0|||
105696169|NCT00467779|364552475|FG000|Stage 1A|Withdrawal by Subject|0|||
105696170|NCT00467779|364552476|FG001|Stage 1A|Withdrawal by Subject|0|||
105696171|NCT00467779|364552477|FG002|Stage 1A|Withdrawal by Subject|0|||
105696172|NCT00467779|364552478|FG003|Stage 1A|Withdrawal by Subject|0|||
105696173|NCT00467779|364552479|FG004|Stage 1A|Withdrawal by Subject|0|||
105696174|NCT00467779|364552480|FG005|Stage 1A|Withdrawal by Subject|0|||
105696175|NCT00467779|364552481|FG006|Stage 1A|Withdrawal by Subject|0|||
105696176|NCT00467779|364552482|FG007|Stage 1A|Withdrawal by Subject|0|||
105696177|NCT00467779|364552483|FG008|Stage 1A|Withdrawal by Subject|0|||
105696178|NCT00467779|364552484|FG009|Stage 1A|Withdrawal by Subject|0|||
105696179|NCT00467779|364552485|FG010|Stage 1A|Withdrawal by Subject|1|||
105696180|NCT00467779|364552486|FG011|Stage 1A|Withdrawal by Subject|1|||
105696181|NCT00467779|364552487|FG012|Stage 1A|Withdrawal by Subject|1|||
105696182|NCT00467779|364552488|FG013|Stage 1A|Withdrawal by Subject|0|||
105696183|NCT00467779|364552489|FG014|Stage 1A|Withdrawal by Subject|0|||
105696184|NCT00467779|364552475|FG000|Stage 1A|Unspecified Reason|0|||
105696185|NCT00467779|364552476|FG001|Stage 1A|Unspecified Reason|0|||
105696186|NCT00467779|364552477|FG002|Stage 1A|Unspecified Reason|0|||
105696187|NCT00467779|364552478|FG003|Stage 1A|Unspecified Reason|0|||
105696188|NCT00467779|364552479|FG004|Stage 1A|Unspecified Reason|0|||
105696189|NCT00467779|364552480|FG005|Stage 1A|Unspecified Reason|0|||
105696190|NCT00467779|364552481|FG006|Stage 1A|Unspecified Reason|0|||
105696191|NCT00467779|364552482|FG007|Stage 1A|Unspecified Reason|0|||
105696192|NCT00467779|364552483|FG008|Stage 1A|Unspecified Reason|0|||
105696193|NCT00467779|364552484|FG009|Stage 1A|Unspecified Reason|0|||
105696194|NCT00467779|364552485|FG010|Stage 1A|Unspecified Reason|0|||
105696195|NCT00467779|364552486|FG011|Stage 1A|Unspecified Reason|1|||
105696196|NCT00467779|364552487|FG012|Stage 1A|Unspecified Reason|1|||
105696197|NCT00467779|364552488|FG013|Stage 1A|Unspecified Reason|0|||
105696198|NCT00467779|364552489|FG014|Stage 1A|Unspecified Reason|0|||
105696199|NCT00467779|364552475|FG000|Stage 2|Adverse Event|0|||
105696200|NCT00467779|364552476|FG001|Stage 2|Adverse Event|0|||
105696201|NCT00467779|364552477|FG002|Stage 2|Adverse Event|0|||
105696202|NCT00467779|364552478|FG003|Stage 2|Adverse Event|0|||
105696203|NCT00467779|364552479|FG004|Stage 2|Adverse Event|0|||
105696204|NCT00467779|364552480|FG005|Stage 2|Adverse Event|0|||
105696205|NCT00467779|364552481|FG006|Stage 2|Adverse Event|0|||
105696206|NCT00467779|364552482|FG007|Stage 2|Adverse Event|0|||
105696207|NCT00467779|364552483|FG008|Stage 2|Adverse Event|1|||
105696208|NCT00467779|364552484|FG009|Stage 2|Adverse Event|0|||
105696209|NCT00467779|364552485|FG010|Stage 2|Adverse Event|0|||
105696210|NCT00467779|364552486|FG011|Stage 2|Adverse Event|0|||
105696211|NCT00467779|364552487|FG012|Stage 2|Adverse Event|0|||
105696212|NCT00467779|364552488|FG013|Stage 2|Adverse Event|0|||
105696213|NCT00467779|364552489|FG014|Stage 2|Adverse Event|0|||
105696214|NCT00467779|364552475|FG000|Stage 2|Death|0|||
105696215|NCT00467779|364552476|FG001|Stage 2|Death|0|||
105696216|NCT00467779|364552477|FG002|Stage 2|Death|0|||
105696217|NCT00467779|364552478|FG003|Stage 2|Death|0|||
105696218|NCT00467779|364552479|FG004|Stage 2|Death|0|||
105696219|NCT00467779|364552480|FG005|Stage 2|Death|0|||
105696220|NCT00467779|364552481|FG006|Stage 2|Death|0|||
105696221|NCT00467779|364552482|FG007|Stage 2|Death|0|||
105696222|NCT00467779|364552483|FG008|Stage 2|Death|1|||
105696223|NCT00467779|364552484|FG009|Stage 2|Death|0|||
105696224|NCT00467779|364552485|FG010|Stage 2|Death|0|||
105696225|NCT00467779|364552486|FG011|Stage 2|Death|0|||
105696226|NCT00467779|364552487|FG012|Stage 2|Death|0|||
105696227|NCT00467779|364552488|FG013|Stage 2|Death|0|||
105696228|NCT00467779|364552489|FG014|Stage 2|Death|0|||
105696229|NCT00467779|364552475|FG000|Stage 2|Disease Progression|0|||
105696230|NCT00467779|364552476|FG001|Stage 2|Disease Progression|0|||
105696231|NCT00467779|364552477|FG002|Stage 2|Disease Progression|0|||
105696232|NCT00467779|364552478|FG003|Stage 2|Disease Progression|0|||
105696233|NCT00467779|364552479|FG004|Stage 2|Disease Progression|0|||
105696234|NCT00467779|364552480|FG005|Stage 2|Disease Progression|0|||
105696235|NCT00467779|364552481|FG006|Stage 2|Disease Progression|0|||
105696236|NCT00467779|364552482|FG007|Stage 2|Disease Progression|0|||
105696237|NCT00467779|364552483|FG008|Stage 2|Disease Progression|16|||
105696238|NCT00467779|364552484|FG009|Stage 2|Disease Progression|0|||
105696239|NCT00467779|364552485|FG010|Stage 2|Disease Progression|0|||
105696240|NCT00467779|364552486|FG011|Stage 2|Disease Progression|0|||
105696241|NCT00467779|364552487|FG012|Stage 2|Disease Progression|0|||
105696242|NCT00467779|364552488|FG013|Stage 2|Disease Progression|0|||
105696243|NCT00467779|364552489|FG014|Stage 2|Disease Progression|0|||
105696244|NCT00467779|364552475|FG000|Stage 2|Unspecified Reason|0|||
105696245|NCT00467779|364552476|FG001|Stage 2|Unspecified Reason|0|||
105696246|NCT00467779|364552477|FG002|Stage 2|Unspecified Reason|0|||
105696247|NCT00467779|364552478|FG003|Stage 2|Unspecified Reason|0|||
105696248|NCT00467779|364552479|FG004|Stage 2|Unspecified Reason|0|||
105696249|NCT00467779|364552480|FG005|Stage 2|Unspecified Reason|0|||
105696250|NCT00467779|364552481|FG006|Stage 2|Unspecified Reason|0|||
105696251|NCT00467779|364552482|FG007|Stage 2|Unspecified Reason|0|||
105696252|NCT00467779|364552483|FG008|Stage 2|Unspecified Reason|3|||
105696253|NCT00467779|364552484|FG009|Stage 2|Unspecified Reason|0|||
105696254|NCT00467779|364552485|FG010|Stage 2|Unspecified Reason|0|||
105696255|NCT00467779|364552486|FG011|Stage 2|Unspecified Reason|0|||
105696256|NCT00467779|364552487|FG012|Stage 2|Unspecified Reason|0|||
105696257|NCT00467779|364552488|FG013|Stage 2|Unspecified Reason|0|||
105696258|NCT00467779|364552489|FG014|Stage 2|Unspecified Reason|0|||
105696259|NCT00467779|364552475|FG000|Stage 2A|Adverse Event|0|||
105696260|NCT00467779|364552476|FG001|Stage 2A|Adverse Event|0|||
105696261|NCT00467779|364552477|FG002|Stage 2A|Adverse Event|0|||
105696262|NCT00467779|364552478|FG003|Stage 2A|Adverse Event|0|||
105696263|NCT00467779|364552479|FG004|Stage 2A|Adverse Event|0|||
105696264|NCT00467779|364552480|FG005|Stage 2A|Adverse Event|0|||
105696265|NCT00467779|364552481|FG006|Stage 2A|Adverse Event|0|||
105696266|NCT00467779|364552482|FG007|Stage 2A|Adverse Event|0|||
105696267|NCT00467779|364552483|FG008|Stage 2A|Adverse Event|0|||
105696268|NCT00467779|364552484|FG009|Stage 2A|Adverse Event|0|||
105696269|NCT00467779|364552485|FG010|Stage 2A|Adverse Event|0|||
105696270|NCT00467779|364552486|FG011|Stage 2A|Adverse Event|0|||
105696271|NCT00467779|364552487|FG012|Stage 2A|Adverse Event|0|||
105696272|NCT00467779|364552488|FG013|Stage 2A|Adverse Event|2|||
105696273|NCT00467779|364552489|FG014|Stage 2A|Adverse Event|0|||
105696274|NCT00467779|364552475|FG000|Stage 2A|Death|0|||
105696275|NCT00467779|364552476|FG001|Stage 2A|Death|0|||
105696276|NCT00467779|364552477|FG002|Stage 2A|Death|0|||
105696277|NCT00467779|364552478|FG003|Stage 2A|Death|0|||
105696278|NCT00467779|364552479|FG004|Stage 2A|Death|0|||
105696279|NCT00467779|364552480|FG005|Stage 2A|Death|0|||
105923067|NCT02696798|365378646|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
105696280|NCT00467779|364552481|FG006|Stage 2A|Death|0|||
105696281|NCT00467779|364552482|FG007|Stage 2A|Death|0|||
105696282|NCT00467779|364552483|FG008|Stage 2A|Death|0|||
105696283|NCT00467779|364552484|FG009|Stage 2A|Death|0|||
105696284|NCT00467779|364552485|FG010|Stage 2A|Death|0|||
105696285|NCT00467779|364552486|FG011|Stage 2A|Death|0|||
105696286|NCT00467779|364552487|FG012|Stage 2A|Death|0|||
105696287|NCT00467779|364552488|FG013|Stage 2A|Death|1|||
105696288|NCT00467779|364552489|FG014|Stage 2A|Death|0|||
105696289|NCT00467779|364552475|FG000|Stage 2A|Disease Progression|0|||
105696290|NCT00467779|364552476|FG001|Stage 2A|Disease Progression|0|||
105696291|NCT00467779|364552477|FG002|Stage 2A|Disease Progression|0|||
105696292|NCT00467779|364552478|FG003|Stage 2A|Disease Progression|0|||
105696293|NCT00467779|364552479|FG004|Stage 2A|Disease Progression|0|||
105696294|NCT00467779|364552480|FG005|Stage 2A|Disease Progression|0|||
105696295|NCT00467779|364552481|FG006|Stage 2A|Disease Progression|0|||
105696296|NCT00467779|364552482|FG007|Stage 2A|Disease Progression|0|||
105696297|NCT00467779|364552483|FG008|Stage 2A|Disease Progression|0|||
105696298|NCT00467779|364552484|FG009|Stage 2A|Disease Progression|0|||
105696299|NCT00467779|364552485|FG010|Stage 2A|Disease Progression|0|||
105696300|NCT00467779|364552486|FG011|Stage 2A|Disease Progression|0|||
105696301|NCT00467779|364552487|FG012|Stage 2A|Disease Progression|0|||
105696302|NCT00467779|364552488|FG013|Stage 2A|Disease Progression|10|||
105696303|NCT00467779|364552489|FG014|Stage 2A|Disease Progression|0|||
105696304|NCT00467779|364552475|FG000|Stage 2A|Unspecified Reason|0|||
105696305|NCT00467779|364552476|FG001|Stage 2A|Unspecified Reason|0|||
105696306|NCT00467779|364552477|FG002|Stage 2A|Unspecified Reason|0|||
105696307|NCT00467779|364552478|FG003|Stage 2A|Unspecified Reason|0|||
105696308|NCT00467779|364552479|FG004|Stage 2A|Unspecified Reason|0|||
105696309|NCT00467779|364552480|FG005|Stage 2A|Unspecified Reason|0|||
105696310|NCT00467779|364552481|FG006|Stage 2A|Unspecified Reason|0|||
105696311|NCT00467779|364552482|FG007|Stage 2A|Unspecified Reason|0|||
105696312|NCT00467779|364552483|FG008|Stage 2A|Unspecified Reason|0|||
105696313|NCT00467779|364552484|FG009|Stage 2A|Unspecified Reason|0|||
105696314|NCT00467779|364552485|FG010|Stage 2A|Unspecified Reason|0|||
105696315|NCT00467779|364552486|FG011|Stage 2A|Unspecified Reason|0|||
105696316|NCT00467779|364552487|FG012|Stage 2A|Unspecified Reason|0|||
105696317|NCT00467779|364552488|FG013|Stage 2A|Unspecified Reason|7|||
105696318|NCT00467779|364552489|FG014|Stage 2A|Unspecified Reason|0|||
105696319|NCT00467779|364552475|FG000|Stage 2A|Withdrawal by Subject|0|||
105696320|NCT00467779|364552476|FG001|Stage 2A|Withdrawal by Subject|0|||
105696321|NCT00467779|364552477|FG002|Stage 2A|Withdrawal by Subject|0|||
105696322|NCT00467779|364552478|FG003|Stage 2A|Withdrawal by Subject|0|||
105696323|NCT00467779|364552479|FG004|Stage 2A|Withdrawal by Subject|0|||
105696324|NCT00467779|364552480|FG005|Stage 2A|Withdrawal by Subject|0|||
105696325|NCT00467779|364552481|FG006|Stage 2A|Withdrawal by Subject|0|||
105696326|NCT00467779|364552482|FG007|Stage 2A|Withdrawal by Subject|0|||
105696327|NCT00467779|364552483|FG008|Stage 2A|Withdrawal by Subject|0|||
105696328|NCT00467779|364552484|FG009|Stage 2A|Withdrawal by Subject|0|||
105696329|NCT00467779|364552485|FG010|Stage 2A|Withdrawal by Subject|0|||
105696330|NCT00467779|364552486|FG011|Stage 2A|Withdrawal by Subject|0|||
105696331|NCT00467779|364552487|FG012|Stage 2A|Withdrawal by Subject|0|||
105696332|NCT00467779|364552488|FG013|Stage 2A|Withdrawal by Subject|1|||
105696333|NCT00467779|364552489|FG014|Stage 2A|Withdrawal by Subject|0|||
105696334|NCT00467779|364552475|FG000|Stage 3|Adverse Event|0|||
105696335|NCT00467779|364552476|FG001|Stage 3|Adverse Event|0|||
105696336|NCT00467779|364552477|FG002|Stage 3|Adverse Event|0|||
105696337|NCT00467779|364552478|FG003|Stage 3|Adverse Event|0|||
105696338|NCT00467779|364552479|FG004|Stage 3|Adverse Event|0|||
105696339|NCT00467779|364552480|FG005|Stage 3|Adverse Event|0|||
105696340|NCT00467779|364552481|FG006|Stage 3|Adverse Event|0|||
105696341|NCT00467779|364552482|FG007|Stage 3|Adverse Event|0|||
105696342|NCT00467779|364552483|FG008|Stage 3|Adverse Event|0|||
105696343|NCT00467779|364552484|FG009|Stage 3|Adverse Event|0|||
105696344|NCT00467779|364552485|FG010|Stage 3|Adverse Event|0|||
105696345|NCT00467779|364552486|FG011|Stage 3|Adverse Event|0|||
105696346|NCT00467779|364552487|FG012|Stage 3|Adverse Event|0|||
105696347|NCT00467779|364552488|FG013|Stage 3|Adverse Event|0|||
105696348|NCT00467779|364552489|FG014|Stage 3|Adverse Event|2|||
105696349|NCT00467779|364552475|FG000|Stage 3|Death|0|||
105696350|NCT00467779|364552476|FG001|Stage 3|Death|0|||
105696351|NCT00467779|364552477|FG002|Stage 3|Death|0|||
105696352|NCT00467779|364552478|FG003|Stage 3|Death|0|||
105696353|NCT00467779|364552479|FG004|Stage 3|Death|0|||
105696354|NCT00467779|364552480|FG005|Stage 3|Death|0|||
105696355|NCT00467779|364552481|FG006|Stage 3|Death|0|||
105696356|NCT00467779|364552482|FG007|Stage 3|Death|0|||
105696357|NCT00467779|364552483|FG008|Stage 3|Death|0|||
105696358|NCT00467779|364552484|FG009|Stage 3|Death|0|||
105696359|NCT00467779|364552485|FG010|Stage 3|Death|0|||
105696360|NCT00467779|364552486|FG011|Stage 3|Death|0|||
105696361|NCT00467779|364552487|FG012|Stage 3|Death|0|||
105696362|NCT00467779|364552488|FG013|Stage 3|Death|0|||
105696363|NCT00467779|364552489|FG014|Stage 3|Death|1|||
105696364|NCT00467779|364552475|FG000|Stage 3|Disease Progression|0|||
105923068|NCT02696798|365378647|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
105696365|NCT00467779|364552476|FG001|Stage 3|Disease Progression|0|||
105696366|NCT00467779|364552477|FG002|Stage 3|Disease Progression|0|||
105696367|NCT00467779|364552478|FG003|Stage 3|Disease Progression|0|||
105696368|NCT00467779|364552479|FG004|Stage 3|Disease Progression|0|||
105696369|NCT00467779|364552480|FG005|Stage 3|Disease Progression|0|||
105696370|NCT00467779|364552481|FG006|Stage 3|Disease Progression|0|||
106132671|NCT00662909|366143296|FG001|Overall Study|Adverse Event|18|||
105696371|NCT00467779|364552482|FG007|Stage 3|Disease Progression|0|||
105696372|NCT00467779|364552483|FG008|Stage 3|Disease Progression|0|||
105696373|NCT00467779|364552484|FG009|Stage 3|Disease Progression|0|||
105696374|NCT00467779|364552485|FG010|Stage 3|Disease Progression|0|||
105696375|NCT00467779|364552486|FG011|Stage 3|Disease Progression|0|||
105696376|NCT00467779|364552487|FG012|Stage 3|Disease Progression|0|||
105696377|NCT00467779|364552488|FG013|Stage 3|Disease Progression|0|||
105696378|NCT00467779|364552489|FG014|Stage 3|Disease Progression|9|||
105696379|NCT00467779|364552475|FG000|Stage 3|Unspecified Reason|0|||
105696380|NCT00467779|364552476|FG001|Stage 3|Unspecified Reason|0|||
105696381|NCT00467779|364552477|FG002|Stage 3|Unspecified Reason|0|||
105696382|NCT00467779|364552478|FG003|Stage 3|Unspecified Reason|0|||
105696383|NCT00467779|364552479|FG004|Stage 3|Unspecified Reason|0|||
105696384|NCT00467779|364552480|FG005|Stage 3|Unspecified Reason|0|||
105696385|NCT00467779|364552481|FG006|Stage 3|Unspecified Reason|0|||
105696386|NCT00467779|364552482|FG007|Stage 3|Unspecified Reason|0|||
105696387|NCT00467779|364552483|FG008|Stage 3|Unspecified Reason|0|||
105696388|NCT00467779|364552484|FG009|Stage 3|Unspecified Reason|0|||
105696389|NCT00467779|364552485|FG010|Stage 3|Unspecified Reason|0|||
105696390|NCT00467779|364552486|FG011|Stage 3|Unspecified Reason|0|||
105696391|NCT00467779|364552487|FG012|Stage 3|Unspecified Reason|0|||
105696392|NCT00467779|364552488|FG013|Stage 3|Unspecified Reason|0|||
105696393|NCT00467779|364552489|FG014|Stage 3|Unspecified Reason|5|||
105696394|NCT01195090|364552492|FG000|Overall Study|Adverse Event|1|||
105696395|NCT01195090|364552493|FG001|Overall Study|Adverse Event|2|||
105696396|NCT01195090|364552492|FG000|Overall Study|Lost to Follow-up|2|||
105696397|NCT01195090|364552493|FG001|Overall Study|Lost to Follow-up|2|||
105696398|NCT01195090|364552492|FG000|Overall Study|Protocol Violation|3|||
105696399|NCT01195090|364552493|FG001|Overall Study|Protocol Violation|4|||
105696400|NCT01701674|364552494|FG000|Overall Study|Unable to safely complete treatment|1|||
105696401|NCT00922480|364552499|FG000|Main Study|Protocol Violation|3|||
105696402|NCT00922480|364552500|FG001|Main Study|Protocol Violation|6|||
105696403|NCT00922480|364552499|FG000|Main Study|Adverse Event|6|||
105696404|NCT00922480|364552500|FG001|Main Study|Adverse Event|7|||
105696405|NCT00922480|364552499|FG000|Main Study|Lack of Efficacy|3|||
105696406|NCT00922480|364552500|FG001|Main Study|Lack of Efficacy|0|||
105696407|NCT00922480|364552499|FG000|Main Study|Withdrawal by Subject|20|||
105696408|NCT00922480|364552500|FG001|Main Study|Withdrawal by Subject|15|||
105696409|NCT00922480|364552499|FG000|Main Study|Lost to Follow-up|5|||
105696410|NCT00922480|364552500|FG001|Main Study|Lost to Follow-up|0|||
105696411|NCT00922480|364552499|FG000|Main Study|Physician Decision|0|||
105696412|NCT00922480|364552500|FG001|Main Study|Physician Decision|1|||
105696413|NCT00922480|364552499|FG000|Extension Study|Protocol Violation|3|||
105696414|NCT00922480|364552500|FG001|Extension Study|Protocol Violation|0|||
105696415|NCT00922480|364552499|FG000|Extension Study|Adverse Event|1|||
105696416|NCT00922480|364552500|FG001|Extension Study|Adverse Event|1|||
105696417|NCT00922480|364552499|FG000|Extension Study|Withdrawal by Subject|1|||
105696418|NCT00922480|364552500|FG001|Extension Study|Withdrawal by Subject|1|||
105696419|NCT00922480|364552499|FG000|Extension Study|Others|0|||
105696420|NCT00922480|364552500|FG001|Extension Study|Others|1|||
105696421|NCT04784897|364552501|FG000|Overall Study|Death|4|||
105696422|NCT04784897|364552502|FG001|Overall Study|Death|2|||
105696423|NCT04784897|364552503|FG002|Overall Study|Death|1|||
105696424|NCT04784897|364552501|FG000|Overall Study|Withdrawal by Subject|0|||
105696425|NCT04784897|364552502|FG001|Overall Study|Withdrawal by Subject|0|||
105696426|NCT04784897|364552503|FG002|Overall Study|Withdrawal by Subject|1|||
105696427|NCT03083847|364552504|FG000|Main|Physician Decision|0|||
105696428|NCT03083847|364552505|FG001|Main|Physician Decision|0|||
105696429|NCT03083847|364552506|FG002|Main|Physician Decision|0|||
105696430|NCT03083847|364552507|FG003|Main|Physician Decision|0|||
105696431|NCT03083847|364552508|FG004|Main|Physician Decision|0|||
105696432|NCT03083847|364552509|FG005|Main|Physician Decision|1|||
105696433|NCT03083847|364552510|FG006|Main|Physician Decision|0|||
105696434|NCT03083847|364552511|FG007|Main|Physician Decision|0|||
105696435|NCT03083847|364552512|FG008|Main|Physician Decision|0|||
105696436|NCT03083847|364552513|FG009|Main|Physician Decision|0|||
105696437|NCT03083847|364552504|FG000|Main|Pregnancy|0|||
105696438|NCT03083847|364552505|FG001|Main|Pregnancy|0|||
105696439|NCT03083847|364552506|FG002|Main|Pregnancy|0|||
105696440|NCT03083847|364552507|FG003|Main|Pregnancy|0|||
105696441|NCT03083847|364552508|FG004|Main|Pregnancy|0|||
105696442|NCT03083847|364552509|FG005|Main|Pregnancy|0|||
105696443|NCT03083847|364552510|FG006|Main|Pregnancy|0|||
105696444|NCT03083847|364552511|FG007|Main|Pregnancy|1|||
105696445|NCT03083847|364552512|FG008|Main|Pregnancy|0|||
105696446|NCT03083847|364552513|FG009|Main|Pregnancy|0|||
105696447|NCT03083847|364552504|FG000|Main|Adverse Event|0|||
105696448|NCT03083847|364552505|FG001|Main|Adverse Event|0|||
105696449|NCT03083847|364552506|FG002|Main|Adverse Event|0|||
105696450|NCT03083847|364552507|FG003|Main|Adverse Event|0|||
105696451|NCT03083847|364552508|FG004|Main|Adverse Event|0|||
105696452|NCT03083847|364552509|FG005|Main|Adverse Event|0|||
105696453|NCT03083847|364552510|FG006|Main|Adverse Event|0|||
105696454|NCT03083847|364552511|FG007|Main|Adverse Event|2|||
105696455|NCT03083847|364552512|FG008|Main|Adverse Event|0|||
105696456|NCT03083847|364552513|FG009|Main|Adverse Event|0|||
105696457|NCT03083847|364552504|FG000|Main|Withdrawal by Subject|0|||
105696458|NCT03083847|364552505|FG001|Main|Withdrawal by Subject|0|||
105696459|NCT03083847|364552506|FG002|Main|Withdrawal by Subject|0|||
105696460|NCT03083847|364552507|FG003|Main|Withdrawal by Subject|0|||
105696461|NCT03083847|364552508|FG004|Main|Withdrawal by Subject|0|||
105696462|NCT03083847|364552509|FG005|Main|Withdrawal by Subject|0|||
105696463|NCT03083847|364552510|FG006|Main|Withdrawal by Subject|1|||
105696464|NCT03083847|364552511|FG007|Main|Withdrawal by Subject|1|||
105696465|NCT03083847|364552512|FG008|Main|Withdrawal by Subject|0|||
105696466|NCT03083847|364552513|FG009|Main|Withdrawal by Subject|0|||
105696467|NCT00058552|364552514|FG000|Overall Study|Died prior to receiving treatment|4|||
105696468|NCT00058552|364552515|FG001|Overall Study|Died prior to receiving treatment|2|||
105696469|NCT00058552|364552514|FG000|Overall Study|Disease progression|52|||
105696470|NCT00058552|364552515|FG001|Overall Study|Disease progression|44|||
105696471|NCT00058552|364552514|FG000|Overall Study|Adverse Event|4|||
105696472|NCT00058552|364552515|FG001|Overall Study|Adverse Event|2|||
105696473|NCT00058552|364552514|FG000|Overall Study|Withdrawal by Subject|3|||
105696474|NCT00058552|364552515|FG001|Overall Study|Withdrawal by Subject|5|||
105696475|NCT00058552|364552514|FG000|Overall Study|Physician Decision|2|||
105696476|NCT00058552|364552515|FG001|Overall Study|Physician Decision|5|||
105696477|NCT00058552|364552514|FG000|Overall Study|Clinical disease progression|0|||
105696478|NCT00058552|364552515|FG001|Overall Study|Clinical disease progression|4|||
105696479|NCT02428855|364552516|FG000|Overall Study|Withdrawal by Subject|2|||
105696480|NCT02066311|364552517|FG000|Overall Study|Adverse Event|4|||
105696481|NCT02066311|364552517|FG000|Overall Study|Withdrawal by Subject|1|||
105696482|NCT02319668|364552520|FG000|Overall Study|Other (Not specified)|0|||
105696483|NCT02319668|364552521|FG001|Overall Study|Other (Not specified)|2|||
105696484|NCT01372150|364552524|FG000|Overall Study|Lack of Efficacy|3|||
105696485|NCT01372150|364552525|FG001|Overall Study|Lack of Efficacy|0|||
105696486|NCT01372150|364552526|FG002|Overall Study|Lack of Efficacy|1|||
105696487|NCT01372150|364552524|FG000|Overall Study|Lost to Follow-up|4|||
105696488|NCT01372150|364552525|FG001|Overall Study|Lost to Follow-up|5|||
105696489|NCT01372150|364552526|FG002|Overall Study|Lost to Follow-up|6|||
105696490|NCT01372150|364552524|FG000|Overall Study|Protocol Violation|1|||
105696491|NCT01372150|364552525|FG001|Overall Study|Protocol Violation|0|||
105696492|NCT01372150|364552526|FG002|Overall Study|Protocol Violation|3|||
105696493|NCT01372150|364552524|FG000|Overall Study|Withdrawal by Subject|2|||
105696494|NCT01372150|364552525|FG001|Overall Study|Withdrawal by Subject|7|||
105696495|NCT01372150|364552526|FG002|Overall Study|Withdrawal by Subject|2|||
105696496|NCT01372150|364552524|FG000|Overall Study|Other|1|||
105696497|NCT01372150|364552525|FG001|Overall Study|Other|0|||
105696498|NCT01372150|364552526|FG002|Overall Study|Other|2|||
105696499|NCT01372150|364552524|FG000|Overall Study|Adverse Event|2|||
105696500|NCT01372150|364552525|FG001|Overall Study|Adverse Event|1|||
105696501|NCT01372150|364552526|FG002|Overall Study|Adverse Event|2|||
105696502|NCT01372150|364552524|FG000|Overall Study|Randomized but not treated|0|||
105696503|NCT01372150|364552525|FG001|Overall Study|Randomized but not treated|1|||
105696504|NCT01372150|364552526|FG002|Overall Study|Randomized but not treated|0|||
105696505|NCT03198520|364552527|FG000|Overall Study|Physician Decision|2|||
105696506|NCT03198520|364552527|FG000|Overall Study|Protocol Violation|2|||
105696507|NCT03198520|364552527|FG000|Overall Study|Withdrawal by Subject|1|||
105696508|NCT03198520|364552527|FG000|Overall Study|Study Ended|1|||
105696509|NCT04353596|364552528|FG000|Overall Study|Protocol Violation|4|||
106004925|NCT00419393|365682615|FG000|Overall Study|Other: Investigator decision|1|||
106004926|NCT04516746|365682616|FG000|Overall Study|Randomized but not Treated|51|||
106004927|NCT04516746|365682617|FG001|Overall Study|Randomized but not Treated|19|||
106004928|NCT04516746|365682616|FG000|Overall Study|Adverse Event|0|||
106004929|NCT04516746|365682617|FG001|Overall Study|Adverse Event|1|||
106004930|NCT04516746|365682616|FG000|Overall Study|Death|62|||
105696510|NCT04353596|364552529|FG001|Overall Study|Protocol Violation|4|||
105696511|NCT04353596|364552528|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
105696512|NCT04353596|364552529|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
105696513|NCT02316340|364552532|FG000|First Progression|Clinical progression|2|||
105696514|NCT02316340|364552533|FG001|First Progression|Clinical progression|1|||
105696515|NCT02316340|364552532|FG000|First Progression|Withdrawal by Subject|1|||
105696516|NCT02316340|364552533|FG001|First Progression|Withdrawal by Subject|0|||
105696517|NCT02665052|364552534|FG000|Overall Study|Lost to Follow-up|1|||
105696518|NCT02665052|364552535|FG001|Overall Study|Lost to Follow-up|0|||
105696519|NCT02665052|364552536|FG002|Overall Study|Lost to Follow-up|0|||
105696520|NCT02665052|364552537|FG003|Overall Study|Lost to Follow-up|0|||
105696521|NCT02665052|364552534|FG000|Overall Study|Withdrawal by Subject|1|||
105696522|NCT02665052|364552535|FG001|Overall Study|Withdrawal by Subject|1|||
105696523|NCT02665052|364552536|FG002|Overall Study|Withdrawal by Subject|0|||
105696524|NCT02665052|364552537|FG003|Overall Study|Withdrawal by Subject|5|||
105696525|NCT02665052|364552534|FG000|Overall Study|Adverse Event|1|||
105696526|NCT02665052|364552535|FG001|Overall Study|Adverse Event|1|||
105696527|NCT02665052|364552536|FG002|Overall Study|Adverse Event|0|||
105696528|NCT02665052|364552537|FG003|Overall Study|Adverse Event|0|||
105696529|NCT00823823|364552538|FG000|Overall Study|Lost to Follow-up|3|||
105696530|NCT00823823|364552539|FG001|Overall Study|Lost to Follow-up|1|||
106004931|NCT04516746|365682617|FG001|Overall Study|Death|32|||
106004932|NCT04516746|365682616|FG000|Overall Study|Lost to Follow-up|3431|||
106004933|NCT04516746|365682617|FG001|Overall Study|Lost to Follow-up|1831|||
106004934|NCT04516746|365682616|FG000|Overall Study|Withdrawal by Subject|1946|||
105696531|NCT00823823|364552538|FG000|Overall Study|Protocol Violation|5|||
106004935|NCT04516746|365682617|FG001|Overall Study|Withdrawal by Subject|1696|||
105787113|NCT03110107|364874893|FG004|Treatment Period|Death|0|||
105787114|NCT03110107|364874894|FG005|Treatment Period|Death|0|||
105787115|NCT03110107|364874895|FG006|Treatment Period|Death|0|||
105787116|NCT03110107|364874896|FG007|Treatment Period|Death|0|||
105787117|NCT03110107|364874897|FG008|Treatment Period|Death|0|||
105787118|NCT03110107|364874898|FG009|Treatment Period|Death|0|||
105787119|NCT03110107|364874899|FG010|Treatment Period|Death|0|||
105787120|NCT03110107|364874900|FG011|Treatment Period|Death|0|||
105787121|NCT03110107|364874901|FG012|Treatment Period|Death|1|||
105787122|NCT03110107|364874902|FG013|Treatment Period|Death|0|||
105787123|NCT03110107|364874903|FG014|Treatment Period|Death|0|||
105787124|NCT03110107|364874904|FG015|Treatment Period|Death|0|||
105787125|NCT03110107|364874905|FG016|Treatment Period|Death|0|||
105787126|NCT03110107|364874906|FG017|Treatment Period|Death|0|||
105787127|NCT03110107|364874907|FG018|Treatment Period|Death|0|||
105787128|NCT03110107|364874908|FG019|Treatment Period|Death|0|||
105787129|NCT03110107|364874909|FG020|Treatment Period|Death|0|||
105787130|NCT03110107|364874910|FG021|Treatment Period|Death|0|||
105787131|NCT03110107|364874911|FG022|Treatment Period|Death|0|||
105787132|NCT03110107|364874912|FG023|Treatment Period|Death|0|||
105787133|NCT03110107|364874913|FG024|Treatment Period|Death|0|||
105787134|NCT03110107|364874914|FG025|Treatment Period|Death|0|||
105787135|NCT03110107|364874889|FG000|Treatment Period|Adverse Event|0|||
105696532|NCT00823823|364552539|FG001|Overall Study|Protocol Violation|5|||
105696533|NCT01986920|364552540|FG000|A- 101 25%|Withdrawal by Subject|1|||
105787136|NCT03110107|364874890|FG001|Treatment Period|Adverse Event|0|||
105787137|NCT03110107|364874891|FG002|Treatment Period|Adverse Event|1|||
105787138|NCT03110107|364874892|FG003|Treatment Period|Adverse Event|0|||
105787139|NCT03110107|364874893|FG004|Treatment Period|Adverse Event|0|||
105787140|NCT03110107|364874894|FG005|Treatment Period|Adverse Event|2|||
105787141|NCT03110107|364874895|FG006|Treatment Period|Adverse Event|0|||
105787142|NCT03110107|364874896|FG007|Treatment Period|Adverse Event|2|||
105787143|NCT03110107|364874897|FG008|Treatment Period|Adverse Event|0|||
105696534|NCT01986920|364552541|FG001|A- 101 25%|Withdrawal by Subject|0|||
105696535|NCT01986920|364552542|FG002|A- 101 25%|Withdrawal by Subject|0|||
105696536|NCT01986920|364552543|FG003|A- 101 25%|Withdrawal by Subject|0|||
105696537|NCT01986920|364552540|FG000|A-101 32.5%|Withdrawal by Subject|0|||
105696538|NCT01986920|364552541|FG001|A-101 32.5%|Withdrawal by Subject|1|||
105696539|NCT01986920|364552542|FG002|A-101 32.5%|Withdrawal by Subject|0|||
105696540|NCT01986920|364552543|FG003|A-101 32.5%|Withdrawal by Subject|0|||
105696541|NCT01986920|364552540|FG000|A-101 40%|Withdrawal by Subject|0|||
105696542|NCT01986920|364552541|FG001|A-101 40%|Withdrawal by Subject|0|||
105696543|NCT01986920|364552542|FG002|A-101 40%|Withdrawal by Subject|1|||
105696544|NCT01986920|364552543|FG003|A-101 40%|Withdrawal by Subject|0|||
105696545|NCT01986920|364552540|FG000|Placebo|Withdrawal by Subject|0|||
105696546|NCT01986920|364552541|FG001|Placebo|Withdrawal by Subject|0|||
105696547|NCT01986920|364552542|FG002|Placebo|Withdrawal by Subject|0|||
105696548|NCT01986920|364552543|FG003|Placebo|Withdrawal by Subject|1|||
105696549|NCT00233363|364552545|FG000|Overall Study|Adverse Event|1|||
105696550|NCT00233363|364552546|FG001|Overall Study|Adverse Event|2|||
105696551|NCT00233363|364552545|FG000|Overall Study|Lack of Efficacy|0|||
105696552|NCT00233363|364552546|FG001|Overall Study|Lack of Efficacy|2|||
105696553|NCT00233363|364552545|FG000|Overall Study|Withdrawal by Subject|1|||
105923069|NCT02696798|365378645|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
106132672|NCT00662909|366143297|FG002|Overall Study|Adverse Event|19|||
106132673|NCT00662909|366143295|FG000|Overall Study|Lack of Efficacy|9|||
106132674|NCT00662909|366143296|FG001|Overall Study|Lack of Efficacy|1|||
106132675|NCT00662909|366143297|FG002|Overall Study|Lack of Efficacy|5|||
106132676|NCT00662909|366143295|FG000|Overall Study|Withdrawal by Subject|29|||
106132677|NCT00662909|366143296|FG001|Overall Study|Withdrawal by Subject|22|||
106132678|NCT00662909|366143297|FG002|Overall Study|Withdrawal by Subject|16|||
106132679|NCT00662909|366143295|FG000|Overall Study|Lost to Follow-up|2|||
106132680|NCT00662909|366143296|FG001|Overall Study|Lost to Follow-up|9|||
106132681|NCT00662909|366143297|FG002|Overall Study|Lost to Follow-up|3|||
106132682|NCT00662909|366143295|FG000|Overall Study|Protocol Violation|7|||
106132683|NCT00662909|366143296|FG001|Overall Study|Protocol Violation|4|||
106132684|NCT00662909|366143297|FG002|Overall Study|Protocol Violation|5|||
105696554|NCT00233363|364552546|FG001|Overall Study|Withdrawal by Subject|1|||
105696555|NCT00233363|364552545|FG000|Overall Study|Aggravation of complication|1|||
105787144|NCT03110107|364874898|FG009|Treatment Period|Adverse Event|1|||
105787145|NCT03110107|364874899|FG010|Treatment Period|Adverse Event|0|||
105787146|NCT03110107|364874900|FG011|Treatment Period|Adverse Event|0|||
105787147|NCT03110107|364874901|FG012|Treatment Period|Adverse Event|0|||
105787148|NCT03110107|364874902|FG013|Treatment Period|Adverse Event|0|||
105696556|NCT00233363|364552546|FG001|Overall Study|Aggravation of complication|0|||
105696557|NCT00718549|364552547|FG000|Induction Phase|Disease Progression|1|||
105787149|NCT03110107|364874903|FG014|Treatment Period|Adverse Event|0|||
105787150|NCT03110107|364874904|FG015|Treatment Period|Adverse Event|2|||
105787151|NCT03110107|364874905|FG016|Treatment Period|Adverse Event|0|||
105787152|NCT03110107|364874906|FG017|Treatment Period|Adverse Event|1|||
105787153|NCT03110107|364874907|FG018|Treatment Period|Adverse Event|2|||
106132685|NCT00662909|366143295|FG000|Overall Study|Randomized- never received study drug|1|||
105696558|NCT00718549|364552548|FG001|Induction Phase|Disease Progression|0|||
105696559|NCT00718549|364552549|FG002|Induction Phase|Disease Progression|0|||
105696560|NCT00718549|364552547|FG000|Induction Phase|Eligibility Criteria Violation|2|||
105696561|NCT00718549|364552548|FG001|Induction Phase|Eligibility Criteria Violation|0|||
105696562|NCT00718549|364552549|FG002|Induction Phase|Eligibility Criteria Violation|0|||
105696563|NCT00718549|364552547|FG000|Induction Phase|Early Termination - No Additional Info|59|||
105696564|NCT00718549|364552548|FG001|Induction Phase|Early Termination - No Additional Info|0|||
105696565|NCT00718549|364552549|FG002|Induction Phase|Early Termination - No Additional Info|0|||
105696566|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
105696567|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
105696568|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
106004936|NCT04516746|365682616|FG000|Overall Study|Physician Decision|10|||
106004937|NCT04516746|365682617|FG001|Overall Study|Physician Decision|8|||
106004938|NCT04516746|365682616|FG000|Overall Study|Other|35|||
106004939|NCT04516746|365682617|FG001|Overall Study|Other|16|||
106004940|NCT00416624|365682618|FG000|Overall Study|Withdrawal by Subject|1|||
106004941|NCT00416624|365682619|FG001|Overall Study|Withdrawal by Subject|6|||
106004942|NCT00416624|365682620|FG002|Overall Study|Withdrawal by Subject|4|||
106004943|NCT00416624|365682621|FG003|Overall Study|Withdrawal by Subject|9|||
105696569|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Death|0|||
105696570|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Death|1|||
106004944|NCT00416624|365682618|FG000|Overall Study|Death|4|||
106132686|NCT00662909|366143296|FG001|Overall Study|Randomized- never received study drug|0|||
106132687|NCT00662909|366143297|FG002|Overall Study|Randomized- never received study drug|0|||
106132688|NCT00662909|366143295|FG000|Overall Study|Non-compliance with study procedures|3|||
106132689|NCT00662909|366143296|FG001|Overall Study|Non-compliance with study procedures|3|||
106132690|NCT00662909|366143297|FG002|Overall Study|Non-compliance with study procedures|2|||
106132691|NCT00662909|366143295|FG000|Overall Study|Physician Decision|1|||
106132692|NCT00662909|366143296|FG001|Overall Study|Physician Decision|1|||
106132693|NCT00662909|366143297|FG002|Overall Study|Physician Decision|2|||
106132694|NCT00662909|366143295|FG000|Overall Study|Eligibility criterion not met|0|||
106132695|NCT00662909|366143296|FG001|Overall Study|Eligibility criterion not met|1|||
106132696|NCT00662909|366143297|FG002|Overall Study|Eligibility criterion not met|1|||
106132697|NCT02401529|366144738|FG000|Overall Study|Lost to Follow-up|2|||
106132698|NCT02401529|366144739|FG001|Overall Study|Lost to Follow-up|1|||
106132699|NCT02401529|366144738|FG000|Overall Study|Physician Decision|2|||
106132700|NCT02401529|366144739|FG001|Overall Study|Physician Decision|6|||
106132701|NCT02401529|366144738|FG000|Overall Study|Protocol Violation|5|||
106132702|NCT02401529|366144739|FG001|Overall Study|Protocol Violation|0|||
106132703|NCT02491411|366144740|FG000|Overall Study|Physician Decision|4|||
106132704|NCT04034238|366144741|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
106132705|NCT04034238|366144742|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
106132706|NCT04034238|366144743|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
106132707|NCT04034238|366144744|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
106132708|NCT04034238|366144741|FG000|Dose Escalation Phase|Screen failures|0|||
106132709|NCT04034238|366144742|FG001|Dose Escalation Phase|Screen failures|0|||
106132710|NCT04034238|366144743|FG002|Dose Escalation Phase|Screen failures|0|||
106132711|NCT04034238|366144744|FG003|Dose Escalation Phase|Screen failures|2|||
106132712|NCT04034238|366144741|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
106132713|NCT04034238|366144742|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
106132714|NCT04034238|366144743|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
106132715|NCT04034238|366144744|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
106132716|NCT04034238|366144741|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
106132717|NCT04034238|366144742|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
106132718|NCT04034238|366144743|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
106132719|NCT04034238|366144744|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
106132720|NCT04672460|366144746|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
106132721|NCT04672460|366144747|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
106132722|NCT04672460|366144746|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
106132723|NCT04672460|366144747|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
106132724|NCT04672460|366144746|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
106132725|NCT04672460|366144747|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
106132726|NCT04672460|366144746|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
106132727|NCT04672460|366144747|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
106132728|NCT04672460|366144746|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
106132729|NCT04672460|366144747|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
106132730|NCT04672460|366144746|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
106132731|NCT04672460|366144747|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
106132732|NCT04672460|366144746|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
105696571|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Death|2|||
105696572|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
105696573|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
105696574|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
105696575|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Progression|0|||
105696576|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Progression|5|||
105696577|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Progression|14|||
105696578|NCT00718549|364552547|FG000|Maintenance/ Observation Phase|Relapse|0|||
105696579|NCT00718549|364552548|FG001|Maintenance/ Observation Phase|Relapse|3|||
105696580|NCT00718549|364552549|FG002|Maintenance/ Observation Phase|Relapse|2|||
105696581|NCT01353508|364552550|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
105696582|NCT01353508|364552551|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
105696583|NCT01353508|364552552|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
106004945|NCT00416624|365682619|FG001|Overall Study|Death|7|||
105696584|NCT01353508|364552553|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
105696585|NCT01353508|364552550|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
105696586|NCT01353508|364552551|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
105696587|NCT01353508|364552552|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
105696588|NCT01353508|364552553|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
105696589|NCT00701090|364552554|FG000|Overall Study|Adverse Event|11|||
105696590|NCT00701090|364552555|FG001|Overall Study|Adverse Event|2|||
105696591|NCT00701090|364552554|FG000|Overall Study|Death|0|||
105696592|NCT00701090|364552555|FG001|Overall Study|Death|1|||
105696593|NCT00701090|364552554|FG000|Overall Study|Lack of Efficacy|5|||
105696594|NCT00701090|364552555|FG001|Overall Study|Lack of Efficacy|4|||
105696595|NCT00701090|364552554|FG000|Overall Study|Lost to Follow-up|9|||
106004946|NCT00416624|365682620|FG002|Overall Study|Death|7|||
106004947|NCT00416624|365682621|FG003|Overall Study|Death|1|||
105696596|NCT00701090|364552555|FG001|Overall Study|Lost to Follow-up|9|||
105696597|NCT00701090|364552554|FG000|Overall Study|Physician Decision|3|||
105696598|NCT00701090|364552555|FG001|Overall Study|Physician Decision|4|||
105696599|NCT00701090|364552554|FG000|Overall Study|Protocol Violation|2|||
105696600|NCT00701090|364552555|FG001|Overall Study|Protocol Violation|3|||
105696601|NCT00701090|364552554|FG000|Overall Study|Withdrawal by Subject|11|||
105696602|NCT00701090|364552555|FG001|Overall Study|Withdrawal by Subject|16|||
105696603|NCT00701090|364552554|FG000|Overall Study|Other|7|||
105696604|NCT00701090|364552555|FG001|Overall Study|Other|12|||
105696605|NCT02844920|364552558|FG000|Overall Study|Lost to Follow-up|2|||
105696606|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Adverse Event|1|||
105696607|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Adverse Event|1|||
105696608|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Adverse Event|1|||
105696609|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Adverse Event|0|||
105696610|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Adverse Event|0|||
105696611|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Adverse Event|0|||
105696612|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Adverse Event|0|||
105696613|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Adverse Event|0|||
105696614|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
105696615|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
105696616|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696617|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
105696618|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696619|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696620|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696621|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
105696622|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105787154|NCT03110107|364874908|FG019|Treatment Period|Adverse Event|1|||
105787155|NCT03110107|364874909|FG020|Treatment Period|Adverse Event|4|||
105787156|NCT03110107|364874910|FG021|Treatment Period|Adverse Event|2|||
106004948|NCT00416624|365682618|FG000|Overall Study|Adverse Event|8|||
106004949|NCT00416624|365682619|FG001|Overall Study|Adverse Event|3|||
106004950|NCT00416624|365682620|FG002|Overall Study|Adverse Event|2|||
106004951|NCT00416624|365682621|FG003|Overall Study|Adverse Event|2|||
105696623|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696624|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
105696625|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696626|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696627|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696628|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105696629|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
105787157|NCT03110107|364874911|FG022|Treatment Period|Adverse Event|2|||
106004952|NCT00416624|365682618|FG000|Overall Study|Other|8|||
105696630|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696631|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696632|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
105696633|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696634|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696635|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696636|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696637|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
105696638|NCT02871778|364552565|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696639|NCT02871778|364552566|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
106132733|NCT04672460|366144747|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
106132734|NCT04672460|366144746|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
105696640|NCT02871778|364552567|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696641|NCT02871778|364552568|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696642|NCT02871778|364552569|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696643|NCT02871778|364552570|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696644|NCT02871778|364552571|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696645|NCT02871778|364552572|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
105696646|NCT02871778|364552565|FG000|Part A: Treatment Period 2|Adverse Event|2|||
105696647|NCT02871778|364552566|FG001|Part A: Treatment Period 2|Adverse Event|2|||
105696648|NCT02871778|364552567|FG002|Part A: Treatment Period 2|Adverse Event|0|||
105696649|NCT02871778|364552568|FG003|Part A: Treatment Period 2|Adverse Event|0|||
105696650|NCT02871778|364552569|FG004|Part A: Treatment Period 2|Adverse Event|0|||
105696651|NCT02871778|364552570|FG005|Part A: Treatment Period 2|Adverse Event|0|||
105696652|NCT02871778|364552571|FG006|Part A: Treatment Period 2|Adverse Event|0|||
105696653|NCT02871778|364552572|FG007|Part A: Treatment Period 2|Adverse Event|0|||
105696654|NCT02871778|364552565|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696655|NCT02871778|364552566|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696656|NCT02871778|364552567|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696657|NCT02871778|364552568|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
105696658|NCT02871778|364552569|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696659|NCT02871778|364552570|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696660|NCT02871778|364552571|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696661|NCT02871778|364552572|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
105696662|NCT02871778|364552565|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
105696663|NCT02871778|364552566|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696664|NCT02871778|364552567|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
105696665|NCT02871778|364552568|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696666|NCT02871778|364552569|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696667|NCT02871778|364552570|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696668|NCT02871778|364552571|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696669|NCT02871778|364552572|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
105696670|NCT02871778|364552565|FG000|Part B: Treatment Period 3|Adverse Event|0|||
105696671|NCT02871778|364552566|FG001|Part B: Treatment Period 3|Adverse Event|0|||
105696672|NCT02871778|364552567|FG002|Part B: Treatment Period 3|Adverse Event|0|||
105696673|NCT02871778|364552568|FG003|Part B: Treatment Period 3|Adverse Event|0|||
105696674|NCT02871778|364552569|FG004|Part B: Treatment Period 3|Adverse Event|1|||
105696675|NCT02871778|364552570|FG005|Part B: Treatment Period 3|Adverse Event|1|||
105696676|NCT02871778|364552571|FG006|Part B: Treatment Period 3|Adverse Event|1|||
105696677|NCT02871778|364552572|FG007|Part B: Treatment Period 3|Adverse Event|0|||
105696678|NCT02170779|364552581|FG000|Overall Study|Withdrawal by Subject|1|||
105696679|NCT02170779|364552582|FG001|Overall Study|Withdrawal by Subject|0|||
105696680|NCT02170779|364552581|FG000|Overall Study|Lost to Follow-up|0|||
106132735|NCT04672460|366144747|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
106132736|NCT04672460|366144746|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
106132737|NCT04672460|366144747|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
105696681|NCT02170779|364552582|FG001|Overall Study|Lost to Follow-up|1|||
105696682|NCT00369785|364552583|FG000|Overall Study|Physician Decision|3|||
105696683|NCT00369785|364552584|FG001|Overall Study|Physician Decision|2|||
105696684|NCT00369785|364552583|FG000|Overall Study|Death|1|||
105696685|NCT00369785|364552584|FG001|Overall Study|Death|2|||
105696686|NCT00369785|364552583|FG000|Overall Study|Withdrawal by Subject|7|||
105696687|NCT00369785|364552584|FG001|Overall Study|Withdrawal by Subject|6|||
105696688|NCT00369785|364552583|FG000|Overall Study|Toxicity|6|||
105696689|NCT00369785|364552584|FG001|Overall Study|Toxicity|4|||
105696690|NCT00369785|364552583|FG000|Overall Study|Never started|0|||
105696691|NCT00369785|364552584|FG001|Overall Study|Never started|2|||
105696692|NCT00369785|364552583|FG000|Overall Study|Progression|4|||
105696693|NCT00369785|364552584|FG001|Overall Study|Progression|4|||
105696694|NCT00369785|364552583|FG000|Overall Study|Multiple reasons|6|||
105696695|NCT00369785|364552584|FG001|Overall Study|Multiple reasons|5|||
105696696|NCT00800683|364552585|FG000|Overall Study|Adverse Event|11|||
105696697|NCT00800683|364552586|FG001|Overall Study|Adverse Event|8|||
105696698|NCT00800683|364552585|FG000|Overall Study|Lost to Follow-up|3|||
105696699|NCT00800683|364552586|FG001|Overall Study|Lost to Follow-up|1|||
105696700|NCT00800683|364552585|FG000|Overall Study|Withdrawal by Subject|1|||
105696701|NCT00800683|364552586|FG001|Overall Study|Withdrawal by Subject|7|||
105696702|NCT00800683|364552585|FG000|Overall Study|Lack of Efficacy|1|||
105696703|NCT00800683|364552586|FG001|Overall Study|Lack of Efficacy|1|||
105696704|NCT00800683|364552585|FG000|Overall Study|Other|1|||
105696705|NCT00800683|364552586|FG001|Overall Study|Other|2|||
105696706|NCT00545402|364552587|FG000|Overall Study|Discontinuation of treatment|17|||
105696707|NCT00545402|364552588|FG001|Overall Study|Discontinuation of treatment|9|||
105696708|NCT00545402|364552587|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
105696709|NCT00545402|364552588|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
105696710|NCT00545402|364552587|FG000|Overall Study|Death|5|||
105696711|NCT00545402|364552588|FG001|Overall Study|Death|7|||
105696712|NCT00545402|364552587|FG000|Overall Study|Graft loss|2|||
105696713|NCT00545402|364552588|FG001|Overall Study|Graft loss|4|||
105696714|NCT00545402|364552587|FG000|Overall Study|Withdrawal by Subject|0|||
105696715|NCT00545402|364552588|FG001|Overall Study|Withdrawal by Subject|1|||
105696716|NCT00545402|364552587|FG000|Overall Study|Protocol Violation|1|||
105696717|NCT00545402|364552588|FG001|Overall Study|Protocol Violation|0|||
105696718|NCT00545402|364552587|FG000|Overall Study|Reason not specified|1|||
105696719|NCT00545402|364552588|FG001|Overall Study|Reason not specified|1|||
105696720|NCT00310804|364552589|FG000|Overall Study|Lost to Follow-up|2|||
105696721|NCT00310804|364552590|FG001|Overall Study|Lost to Follow-up|0|||
105696722|NCT00310804|364552589|FG000|Overall Study|Withdrawal by Subject|3|||
105696723|NCT00310804|364552590|FG001|Overall Study|Withdrawal by Subject|0|||
105696724|NCT04136184|364552591|FG000|Overall Study|Lost to Follow-up|0|||
105696725|NCT04136184|364552592|FG001|Overall Study|Lost to Follow-up|3|||
105696726|NCT04136184|364552591|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
105696727|NCT04136184|364552592|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
105696728|NCT02783274|364552593|FG000|Overall Study|Withdrawal by Subject|16|||
105696729|NCT02783274|364552593|FG000|Overall Study|Physician Decision|6|||
105696730|NCT02783274|364552593|FG000|Overall Study|Death|9|||
105696731|NCT02783274|364552593|FG000|Overall Study|Lost to Follow-up|22|||
105696732|NCT02783274|364552593|FG000|Overall Study|Other|22|||
105696733|NCT03509467|364552594|FG000|Overall Study|Withdrawal by Subject|5|||
105696734|NCT03509467|364552595|FG001|Overall Study|Withdrawal by Subject|1|||
105696735|NCT03509467|364552596|FG002|Overall Study|Withdrawal by Subject|6|||
105696736|NCT03509467|364552597|FG003|Overall Study|Withdrawal by Subject|7|||
105696737|NCT03509467|364552598|FG004|Overall Study|Withdrawal by Subject|10|||
105696738|NCT03509467|364552599|FG005|Overall Study|Withdrawal by Subject|10|||
105696739|NCT03509467|364552600|FG006|Overall Study|Withdrawal by Subject|10|||
105696740|NCT03509467|364552601|FG007|Overall Study|Withdrawal by Subject|10|||
105696741|NCT03509467|364552594|FG000|Overall Study|Death|0|||
105696742|NCT03509467|364552595|FG001|Overall Study|Death|0|||
105696743|NCT03509467|364552596|FG002|Overall Study|Death|2|||
105696744|NCT03509467|364552597|FG003|Overall Study|Death|2|||
105696745|NCT03509467|364552598|FG004|Overall Study|Death|1|||
105696746|NCT03509467|364552599|FG005|Overall Study|Death|0|||
105696747|NCT03509467|364552600|FG006|Overall Study|Death|1|||
105696748|NCT03509467|364552601|FG007|Overall Study|Death|0|||
105696749|NCT03509467|364552594|FG000|Overall Study|Proxy Withdrawal|0|||
105696750|NCT03509467|364552595|FG001|Overall Study|Proxy Withdrawal|0|||
105696751|NCT03509467|364552596|FG002|Overall Study|Proxy Withdrawal|0|||
105696752|NCT03509467|364552597|FG003|Overall Study|Proxy Withdrawal|0|||
105696753|NCT03509467|364552598|FG004|Overall Study|Proxy Withdrawal|0|||
105787158|NCT03110107|364874912|FG023|Treatment Period|Adverse Event|2|||
105787159|NCT03110107|364874913|FG024|Treatment Period|Adverse Event|2|||
105787160|NCT03110107|364874914|FG025|Treatment Period|Adverse Event|4|||
105696754|NCT03509467|364552599|FG005|Overall Study|Proxy Withdrawal|0|||
105696755|NCT03509467|364552600|FG006|Overall Study|Proxy Withdrawal|0|||
105696756|NCT03509467|364552601|FG007|Overall Study|Proxy Withdrawal|1|||
105696757|NCT00482703|364552602|FG000|Overall Study|Poor compliance|1|||
105696758|NCT00482703|364552603|FG001|Overall Study|Poor compliance|0|||
105696759|NCT02982239|364554404|FG000|Overall Study|Lost to Follow-up|3|||
105696760|NCT02982239|364554405|FG001|Overall Study|Lost to Follow-up|2|||
105696761|NCT00388505|364554409|FG000|Overall Study|Adverse Event or Death|43|||
105696762|NCT00388505|364554410|FG001|Overall Study|Adverse Event or Death|17|||
105696763|NCT00388505|364554409|FG000|Overall Study|Withdrawal by Subject|24|||
105696764|NCT00388505|364554410|FG001|Overall Study|Withdrawal by Subject|9|||
105787161|NCT03110107|364874889|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
105696765|NCT00388505|364554409|FG000|Overall Study|Lost to Follow-up|5|||
105696766|NCT00388505|364554410|FG001|Overall Study|Lost to Follow-up|3|||
105696767|NCT00388505|364554409|FG000|Overall Study|Inappropriate Enrollment|0|||
105787162|NCT03110107|364874890|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
105696768|NCT00388505|364554410|FG001|Overall Study|Inappropriate Enrollment|1|||
105696769|NCT00388505|364554409|FG000|Overall Study|Administrative Reason|1|||
105696770|NCT00388505|364554410|FG001|Overall Study|Administrative Reason|0|||
105696771|NCT00388505|364554409|FG000|Overall Study|Protocol Violation|6|||
105696772|NCT00388505|364554410|FG001|Overall Study|Protocol Violation|5|||
105696773|NCT00388505|364554409|FG000|Overall Study|Unable to classify|4|||
105696774|NCT00388505|364554410|FG001|Overall Study|Unable to classify|3|||
105696775|NCT01942148|364554416|FG000|Overall Study|Adverse Event|4|||
105696776|NCT01942148|364554416|FG000|Overall Study|Lack of Efficacy|2|||
105696777|NCT01942148|364554416|FG000|Overall Study|Physician Decision|11|||
105696778|NCT01942148|364554416|FG000|Overall Study|Protocol Violation|1|||
105696779|NCT01942148|364554416|FG000|Overall Study|Withdrawal by Subject|8|||
105696780|NCT01942148|364554416|FG000|Overall Study|Use of the prohibition medicine|1|||
105696781|NCT02248259|364554417|FG000|Treatment Period 1|Adverse Event|0|||
105696782|NCT02248259|364554418|FG001|Treatment Period 1|Adverse Event|0|||
105696783|NCT02248259|364554419|FG002|Treatment Period 1|Adverse Event|1|||
105696784|NCT02248259|364554420|FG003|Treatment Period 1|Adverse Event|0|||
105696785|NCT02573870|364554421|FG000|Overall Study|Adverse Event|0|||
105696786|NCT02573870|364554422|FG001|Overall Study|Adverse Event|2|||
105696787|NCT02573870|364554421|FG000|Overall Study|Lack of Efficacy|0|||
105696788|NCT02573870|364554422|FG001|Overall Study|Lack of Efficacy|1|||
105696789|NCT02573870|364554421|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
105696790|NCT02573870|364554422|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
105696791|NCT02573870|364554421|FG000|Overall Study|Lost to Follow-up|0|||
105696792|NCT02573870|364554422|FG001|Overall Study|Lost to Follow-up|1|||
105696793|NCT02573870|364554421|FG000|Overall Study|Other: Fail to Meet Visit|0|||
105696794|NCT02573870|364554422|FG001|Overall Study|Other: Fail to Meet Visit|2|||
105923070|NCT02696798|365378646|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
105923071|NCT02696798|365378647|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
105923072|NCT02696798|365378645|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
105923073|NCT02696798|365378646|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
105923074|NCT02696798|365378647|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
105923075|NCT02696798|365378645|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
105923076|NCT02696798|365378646|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
105923077|NCT02696798|365378647|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
105923078|NCT00857389|365378648|FG000|Overall Study|Did not proceed to transplant|2|||
105923079|NCT01157845|365378649|FG000|Overall Study|Lost to Follow-up|5|||
105923080|NCT01157845|365378649|FG000|Overall Study|Withdrawal by Subject|12|||
105923081|NCT01157845|365378649|FG000|Overall Study|Physician Decision|3|||
105923082|NCT01157845|365378649|FG000|Overall Study|Protocol Violation|13|||
105923083|NCT01157845|365378649|FG000|Overall Study|Study was ended|1|||
105923084|NCT01157845|365378649|FG000|Overall Study|Device malfunction|1|||
105923085|NCT03311555|365378651|FG000|Overall Study|Adverse Event|1|||
105923086|NCT00834041|365378653|FG000|Overall Study|Withdrawal by Subject|1|||
105923087|NCT00834041|365378654|FG001|Overall Study|Withdrawal by Subject|0|||
105923088|NCT00834041|365378653|FG000|Overall Study|Lost to Follow-up|0|||
105923089|NCT00834041|365378654|FG001|Overall Study|Lost to Follow-up|1|||
105923090|NCT03069989|365378656|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
105923091|NCT03069989|365378657|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
105923092|NCT01171534|365380606|FG000|Overall Study|Lost to Follow-up|0|||
105923093|NCT01171534|365380607|FG001|Overall Study|Lost to Follow-up|2|||
105923094|NCT01171534|365380606|FG000|Overall Study|screen failure|0|||
105923095|NCT01171534|365380607|FG001|Overall Study|screen failure|1|||
105923096|NCT02711137|365380608|FG000|Overall Study|Death|1|||
105923097|NCT02711137|365380609|FG001|Overall Study|Death|4|||
105923098|NCT02711137|365380610|FG002|Overall Study|Death|5|||
105923099|NCT02711137|365380611|FG003|Overall Study|Death|5|||
105923100|NCT02711137|365380612|FG004|Overall Study|Death|3|||
105923101|NCT02711137|365380613|FG005|Overall Study|Death|1|||
105923102|NCT02711137|365380614|FG006|Overall Study|Death|61|||
105923103|NCT02711137|365380615|FG007|Overall Study|Death|3|||
105923104|NCT02711137|365380616|FG008|Overall Study|Death|0|||
105923105|NCT02711137|365380617|FG009|Overall Study|Death|1|||
105923106|NCT02711137|365380618|FG010|Overall Study|Death|1|||
105923107|NCT02711137|365380619|FG011|Overall Study|Death|1|||
105923108|NCT02711137|365380620|FG012|Overall Study|Death|0|||
105923109|NCT02711137|365380621|FG013|Overall Study|Death|0|||
105923110|NCT02711137|365380622|FG014|Overall Study|Death|0|||
105923111|NCT02711137|365380608|FG000|Overall Study|Study Terminated by Sponsor|0|||
105923112|NCT02711137|365380609|FG001|Overall Study|Study Terminated by Sponsor|0|||
105923113|NCT02711137|365380610|FG002|Overall Study|Study Terminated by Sponsor|1|||
105923114|NCT02711137|365380611|FG003|Overall Study|Study Terminated by Sponsor|0|||
105923115|NCT02711137|365380612|FG004|Overall Study|Study Terminated by Sponsor|0|||
105923116|NCT02711137|365380613|FG005|Overall Study|Study Terminated by Sponsor|0|||
105923117|NCT02711137|365380614|FG006|Overall Study|Study Terminated by Sponsor|1|||
105923118|NCT02711137|365380615|FG007|Overall Study|Study Terminated by Sponsor|0|||
105696795|NCT01858532|364554423|FG000|Overall Study|Adverse Event|58|||
105696796|NCT01858532|364554424|FG001|Overall Study|Adverse Event|50|||
105923119|NCT02711137|365380616|FG008|Overall Study|Study Terminated by Sponsor|0|||
105696797|NCT01858532|364554425|FG002|Overall Study|Adverse Event|23|||
105696798|NCT01858532|364554426|FG003|Overall Study|Adverse Event|28|||
105696799|NCT01858532|364554423|FG000|Overall Study|Withdrew consent|71|||
105696800|NCT01858532|364554424|FG001|Overall Study|Withdrew consent|93|||
105696801|NCT01858532|364554425|FG002|Overall Study|Withdrew consent|46|||
105696802|NCT01858532|364554426|FG003|Overall Study|Withdrew consent|27|||
105696803|NCT01858532|364554423|FG000|Overall Study|Lost to Follow-up|17|||
105696804|NCT01858532|364554424|FG001|Overall Study|Lost to Follow-up|26|||
105696805|NCT01858532|364554425|FG002|Overall Study|Lost to Follow-up|11|||
105696806|NCT01858532|364554426|FG003|Overall Study|Lost to Follow-up|14|||
105696807|NCT01858532|364554423|FG000|Overall Study|Deterioration of medical status|3|||
105696808|NCT01858532|364554424|FG001|Overall Study|Deterioration of medical status|4|||
105696809|NCT01858532|364554425|FG002|Overall Study|Deterioration of medical status|3|||
105696810|NCT01858532|364554426|FG003|Overall Study|Deterioration of medical status|7|||
105696811|NCT01858532|364554423|FG000|Overall Study|Investigator request|3|||
105696812|NCT01858532|364554424|FG001|Overall Study|Investigator request|4|||
105696813|NCT01858532|364554425|FG002|Overall Study|Investigator request|2|||
105696814|NCT01858532|364554426|FG003|Overall Study|Investigator request|6|||
105696815|NCT01858532|364554423|FG000|Overall Study|Other, not specified|29|||
105696816|NCT01858532|364554424|FG001|Overall Study|Other, not specified|15|||
105696817|NCT01858532|364554425|FG002|Overall Study|Other, not specified|13|||
105696818|NCT01858532|364554426|FG003|Overall Study|Other, not specified|11|||
105696819|NCT00434421|364554427|FG000|Overall Study|Withdrawal by Subject|1|||
105696820|NCT00434421|364554427|FG000|Overall Study|Non-compliance with study treatment|1|||
105696821|NCT02667275|364554430|FG000|Overall Study|Protocol Violation|11|||
105696822|NCT02667275|364554431|FG001|Overall Study|Protocol Violation|7|||
105696823|NCT02667275|364554430|FG000|Overall Study|Lost to Follow-up|0|||
105696824|NCT02667275|364554431|FG001|Overall Study|Lost to Follow-up|2|||
105696825|NCT02667275|364554430|FG000|Overall Study|Withdrawal by Subject|0|||
105696826|NCT02667275|364554431|FG001|Overall Study|Withdrawal by Subject|5|||
105696827|NCT02667275|364554430|FG000|Overall Study|Discontinued early without completing|0|||
105696828|NCT02667275|364554431|FG001|Overall Study|Discontinued early without completing|1|||
105696829|NCT01301456|364554432|FG000|Stage 1|Withdrawal by Subject|0|||
105696830|NCT01301456|364554433|FG001|Stage 1|Withdrawal by Subject|0|||
105696831|NCT01301456|364554434|FG002|Stage 1|Withdrawal by Subject|1|||
105696832|NCT01301456|364554435|FG003|Stage 1|Withdrawal by Subject|0|||
105696833|NCT01301456|364554436|FG004|Stage 1|Withdrawal by Subject|1|||
105696834|NCT01301456|364554437|FG005|Stage 1|Withdrawal by Subject|0|||
105696835|NCT01301456|364554438|FG006|Stage 1|Withdrawal by Subject|0|||
105696836|NCT01301456|364554439|FG007|Stage 1|Withdrawal by Subject|0|||
105696837|NCT01301456|364554440|FG008|Stage 1|Withdrawal by Subject|0|||
105696838|NCT01301456|364554441|FG009|Stage 1|Withdrawal by Subject|0|||
105696839|NCT01301456|364554442|FG010|Stage 1|Withdrawal by Subject|0|||
105696840|NCT01301456|364554443|FG011|Stage 1|Withdrawal by Subject|0|||
105696841|NCT01301456|364554432|FG000|Stage 1|Randomized but not treated|0|||
105696842|NCT01301456|364554433|FG001|Stage 1|Randomized but not treated|0|||
105696843|NCT01301456|364554434|FG002|Stage 1|Randomized but not treated|0|||
105696844|NCT01301456|364554435|FG003|Stage 1|Randomized but not treated|0|||
105696845|NCT01301456|364554436|FG004|Stage 1|Randomized but not treated|0|||
105696846|NCT01301456|364554437|FG005|Stage 1|Randomized but not treated|0|||
105696847|NCT01301456|364554438|FG006|Stage 1|Randomized but not treated|1|||
105696848|NCT01301456|364554439|FG007|Stage 1|Randomized but not treated|0|||
105696849|NCT01301456|364554440|FG008|Stage 1|Randomized but not treated|0|||
105696850|NCT01301456|364554441|FG009|Stage 1|Randomized but not treated|0|||
105696851|NCT01301456|364554442|FG010|Stage 1|Randomized but not treated|0|||
105696852|NCT01301456|364554443|FG011|Stage 1|Randomized but not treated|0|||
105696853|NCT01301456|364554432|FG000|Stage 2|Adverse Event|0|||
105696854|NCT01301456|364554433|FG001|Stage 2|Adverse Event|0|||
106004953|NCT00416624|365682619|FG001|Overall Study|Other|11|||
106004954|NCT00416624|365682620|FG002|Overall Study|Other|5|||
106004955|NCT00416624|365682621|FG003|Overall Study|Other|5|||
106004956|NCT00416624|365682618|FG000|Overall Study|Cancel|1|||
106004957|NCT00416624|365682619|FG001|Overall Study|Cancel|0|||
105696855|NCT01301456|364554434|FG002|Stage 2|Adverse Event|0|||
105696856|NCT01301456|364554435|FG003|Stage 2|Adverse Event|0|||
105696857|NCT01301456|364554436|FG004|Stage 2|Adverse Event|0|||
105696858|NCT01301456|364554437|FG005|Stage 2|Adverse Event|0|||
105696859|NCT01301456|364554438|FG006|Stage 2|Adverse Event|0|||
105696860|NCT01301456|364554439|FG007|Stage 2|Adverse Event|0|||
106004958|NCT00416624|365682620|FG002|Overall Study|Cancel|0|||
106004959|NCT00416624|365682621|FG003|Overall Study|Cancel|0|||
106004960|NCT00979901|365682622|FG000|Overall Study|Adverse Event|1|||
105696861|NCT01301456|364554440|FG008|Stage 2|Adverse Event|0|||
105696862|NCT01301456|364554441|FG009|Stage 2|Adverse Event|0|||
105696863|NCT01301456|364554442|FG010|Stage 2|Adverse Event|1|||
105696864|NCT01301456|364554443|FG011|Stage 2|Adverse Event|0|||
105696865|NCT03794583|364554444|FG000|Overall Study|Death|8|||
105696866|NCT03794583|364554444|FG000|Overall Study|Study Terminated by Sponsor|24|||
106004961|NCT00979901|365682623|FG001|Overall Study|Adverse Event|3|||
106004962|NCT00979901|365682624|FG002|Overall Study|Adverse Event|9|||
105696867|NCT03794583|364554444|FG000|Overall Study|Withdrawal by Subject|9|||
105696868|NCT01735279|364554447|FG000|Overall Study|Lost to Follow-up|11|||
105696869|NCT01735279|364554448|FG001|Overall Study|Lost to Follow-up|8|||
105696870|NCT01368536|364554449|FG000|Overall Study|Adverse Event|5|||
105696871|NCT01368536|364554450|FG001|Overall Study|Adverse Event|6|||
105696872|NCT01368536|364554451|FG002|Overall Study|Adverse Event|8|||
105696873|NCT01368536|364554449|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105696874|NCT01368536|364554450|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105696875|NCT01368536|364554451|FG002|Overall Study|Abnormal laboratory value(s)|2|||
105696876|NCT01368536|364554449|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105696877|NCT01368536|364554450|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105696878|NCT01368536|364554451|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105696879|NCT01368536|364554449|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
105696880|NCT01368536|364554450|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105696881|NCT01368536|364554451|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105696882|NCT01368536|364554449|FG000|Overall Study|No longer required study medication|0|||
105696883|NCT01368536|364554450|FG001|Overall Study|No longer required study medication|0|||
105696884|NCT01368536|364554451|FG002|Overall Study|No longer required study medication|1|||
105696885|NCT01368536|364554449|FG000|Overall Study|Withdrawal by Subject|2|||
105696886|NCT01368536|364554450|FG001|Overall Study|Withdrawal by Subject|5|||
105696887|NCT01368536|364554451|FG002|Overall Study|Withdrawal by Subject|4|||
105696888|NCT01368536|364554449|FG000|Overall Study|Lost to Follow-up|3|||
105696889|NCT01368536|364554450|FG001|Overall Study|Lost to Follow-up|3|||
105696890|NCT01368536|364554451|FG002|Overall Study|Lost to Follow-up|5|||
105696891|NCT01368536|364554449|FG000|Overall Study|Administrative problems|34|||
105696892|NCT01368536|364554450|FG001|Overall Study|Administrative problems|39|||
105696893|NCT01368536|364554451|FG002|Overall Study|Administrative problems|35|||
105696894|NCT01368536|364554449|FG000|Overall Study|Protocol deviation|0|||
105696895|NCT01368536|364554450|FG001|Overall Study|Protocol deviation|3|||
105696896|NCT01368536|364554451|FG002|Overall Study|Protocol deviation|1|||
105696897|NCT00496730|364554452|FG000|Overall Study|Lost to Follow-up|4|||
105696898|NCT00496730|364554453|FG001|Overall Study|Lost to Follow-up|3|||
105696899|NCT00496730|364554452|FG000|Overall Study|Withdrawal by Subject|2|||
105696900|NCT00496730|364554453|FG001|Overall Study|Withdrawal by Subject|2|||
105696901|NCT03962738|364554458|FG000|Overall Study|Protocol Deviation|3|||
105696902|NCT03962738|364554459|FG001|Overall Study|Protocol Deviation|0|||
105696903|NCT03962738|364554460|FG002|Overall Study|Protocol Deviation|1|||
105696904|NCT03962738|364554461|FG003|Overall Study|Protocol Deviation|1|||
105696905|NCT03962738|364554458|FG000|Overall Study|Withdrawal by Subject|4|||
105696906|NCT03962738|364554459|FG001|Overall Study|Withdrawal by Subject|0|||
105696907|NCT03962738|364554460|FG002|Overall Study|Withdrawal by Subject|0|||
105696908|NCT03962738|364554461|FG003|Overall Study|Withdrawal by Subject|0|||
105696909|NCT03962738|364554458|FG000|Overall Study|Lost to Follow-up|0|||
105696910|NCT03962738|364554459|FG001|Overall Study|Lost to Follow-up|0|||
105696911|NCT03962738|364554460|FG002|Overall Study|Lost to Follow-up|1|||
105696912|NCT03962738|364554461|FG003|Overall Study|Lost to Follow-up|0|||
105696913|NCT00509067|364554462|FG000|Overall Study|Lost to Follow-up|1|||
105696914|NCT00509067|364554463|FG001|Overall Study|Lost to Follow-up|1|||
105696915|NCT00509067|364554462|FG000|Overall Study|Adverse Event|3|||
105696916|NCT00509067|364554463|FG001|Overall Study|Adverse Event|1|||
105696917|NCT00509067|364554462|FG000|Overall Study|Protocol Violation|0|||
105696918|NCT00509067|364554463|FG001|Overall Study|Protocol Violation|3|||
105696919|NCT00131469|364554464|FG000|Overall Study|Withdrawal by Subject|3|||
105696920|NCT00131469|364554465|FG001|Overall Study|Withdrawal by Subject|4|||
105696921|NCT00131469|364554464|FG000|Overall Study|Protocol Violation|3|||
105696922|NCT00131469|364554465|FG001|Overall Study|Protocol Violation|1|||
105696923|NCT00131469|364554464|FG000|Overall Study|Death|0|||
105696924|NCT00131469|364554465|FG001|Overall Study|Death|1|||
105696925|NCT00131469|364554464|FG000|Overall Study|Lost to Follow-up|0|||
105696926|NCT00131469|364554465|FG001|Overall Study|Lost to Follow-up|1|||
105696927|NCT00131469|364554464|FG000|Overall Study|scan not analyzable|3|||
105696928|NCT00131469|364554465|FG001|Overall Study|scan not analyzable|6|||
105696929|NCT02247960|364554467|FG000|Patient Consent and Randomization|Physician Decision|2|||
105696930|NCT02247960|364554468|FG001|Patient Consent and Randomization|Physician Decision|2|||
105696931|NCT02247960|364554467|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
105696932|NCT02247960|364554468|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
105696933|NCT02247960|364554467|FG000|Catheter Removed|Lost to Follow-up|7|||
105696934|NCT02247960|364554468|FG001|Catheter Removed|Lost to Follow-up|10|||
105696935|NCT00702325|364554469|FG000|Overall Study|Adverse Event|1|||
105696936|NCT00702325|364554470|FG001|Overall Study|Adverse Event|0|||
105696937|NCT00702325|364554469|FG000|Overall Study|Withdrawal by Subject|7|||
105696938|NCT00702325|364554470|FG001|Overall Study|Withdrawal by Subject|7|||
105696939|NCT00702325|364554469|FG000|Overall Study|Lost to Follow-up|3|||
105696940|NCT00702325|364554470|FG001|Overall Study|Lost to Follow-up|4|||
105696941|NCT00702325|364554469|FG000|Overall Study|Incorrect enrollment|5|||
105696942|NCT00702325|364554470|FG001|Overall Study|Incorrect enrollment|7|||
105696943|NCT00702325|364554469|FG000|Overall Study|Developed study discontinuation criteria|18|||
105696944|NCT00702325|364554470|FG001|Overall Study|Developed study discontinuation criteria|28|||
105696945|NCT00702325|364554469|FG000|Overall Study|Severe noncompliance to protocol|3|||
105696946|NCT00702325|364554470|FG001|Overall Study|Severe noncompliance to protocol|3|||
105696947|NCT00702325|364554469|FG000|Overall Study|Termination due to lab results|1|||
105696948|NCT00702325|364554470|FG001|Overall Study|Termination due to lab results|0|||
105696949|NCT00702325|364554469|FG000|Overall Study|Didn't follow study medication dosage|0|||
105696950|NCT00702325|364554470|FG001|Overall Study|Didn't follow study medication dosage|2|||
105696951|NCT00702325|364554469|FG000|Overall Study|Withdrew consent|0|||
105696952|NCT00702325|364554470|FG001|Overall Study|Withdrew consent|1|||
105696953|NCT00702325|364554469|FG000|Overall Study|Incorrectly Discontinued|0|||
105696954|NCT00702325|364554470|FG001|Overall Study|Incorrectly Discontinued|1|||
105696955|NCT00736034|364554476|FG000|Overall Study|Adverse Event|2|||
105696956|NCT01022502|364554480|FG000|Overall Study|Adverse Event|1|||
105696957|NCT01022502|364554480|FG000|Overall Study|employment related reasons|1|||
105696958|NCT01022502|364554480|FG000|Overall Study|Withdrawal by Subject|1|||
105696959|NCT03716050|364554481|FG000|Overall Study|Lost to Follow-up|0|||
105696960|NCT03716050|364554482|FG001|Overall Study|Lost to Follow-up|0|||
105696961|NCT03716050|364554483|FG002|Overall Study|Lost to Follow-up|1|||
105696962|NCT03716050|364554484|FG003|Overall Study|Lost to Follow-up|0|||
105696963|NCT03716050|364554485|FG004|Overall Study|Lost to Follow-up|0|||
105696964|NCT03716050|364554486|FG005|Overall Study|Lost to Follow-up|0|||
105696965|NCT03716050|364554487|FG006|Overall Study|Lost to Follow-up|0|||
105696966|NCT03716050|364554488|FG007|Overall Study|Lost to Follow-up|0|||
105696967|NCT03716050|364554481|FG000|Overall Study|Physician Decision|0|||
105696968|NCT03716050|364554482|FG001|Overall Study|Physician Decision|0|||
105696969|NCT03716050|364554483|FG002|Overall Study|Physician Decision|0|||
105696970|NCT03716050|364554484|FG003|Overall Study|Physician Decision|1|||
105696971|NCT03716050|364554485|FG004|Overall Study|Physician Decision|0|||
105696972|NCT03716050|364554486|FG005|Overall Study|Physician Decision|0|||
105696973|NCT03716050|364554487|FG006|Overall Study|Physician Decision|0|||
105696974|NCT03716050|364554488|FG007|Overall Study|Physician Decision|0|||
105696975|NCT03716050|364554481|FG000|Overall Study|Protocol Violation|0|||
105696976|NCT03716050|364554482|FG001|Overall Study|Protocol Violation|0|||
105696977|NCT03716050|364554483|FG002|Overall Study|Protocol Violation|0|||
105696978|NCT03716050|364554484|FG003|Overall Study|Protocol Violation|1|||
105696979|NCT03716050|364554485|FG004|Overall Study|Protocol Violation|0|||
105696980|NCT03716050|364554486|FG005|Overall Study|Protocol Violation|0|||
105696981|NCT03716050|364554487|FG006|Overall Study|Protocol Violation|0|||
105696982|NCT03716050|364554488|FG007|Overall Study|Protocol Violation|2|||
105696983|NCT02361944|364554489|FG000|Overall Study|surgery cancellation|0|||
105696984|NCT02361944|364554490|FG001|Overall Study|surgery cancellation|1|||
105696985|NCT02463071|364554491|FG000|Overall Study|Adverse Event|3|||
105696986|NCT02463071|364554492|FG001|Overall Study|Adverse Event|5|||
105696987|NCT02463071|364554493|FG002|Overall Study|Adverse Event|1|||
105696988|NCT02463071|364554491|FG000|Overall Study|Death|1|||
105696989|NCT02463071|364554492|FG001|Overall Study|Death|0|||
105696990|NCT02463071|364554493|FG002|Overall Study|Death|0|||
105696991|NCT02463071|364554491|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
105696992|NCT02463071|364554492|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105696993|NCT02463071|364554493|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105696994|NCT02463071|364554491|FG000|Overall Study|Reason not specified|7|||
105696995|NCT02463071|364554492|FG001|Overall Study|Reason not specified|9|||
105696996|NCT02463071|364554493|FG002|Overall Study|Reason not specified|4|||
105696997|NCT02463071|364554491|FG000|Overall Study|Protocol Violation|0|||
105696998|NCT02463071|364554492|FG001|Overall Study|Protocol Violation|2|||
105696999|NCT02463071|364554493|FG002|Overall Study|Protocol Violation|0|||
105697000|NCT02463071|364554491|FG000|Overall Study|Lost to Follow-up|0|||
105697001|NCT02463071|364554492|FG001|Overall Study|Lost to Follow-up|0|||
105697002|NCT02463071|364554493|FG002|Overall Study|Lost to Follow-up|1|||
105697003|NCT00073528|364554494|FG000|Overall Study|Death|488|||
106004963|NCT00979901|365682625|FG003|Overall Study|Adverse Event|2|||
106004964|NCT00979901|365682622|FG000|Overall Study|Lack of Efficacy|8|||
105697004|NCT00073528|364554495|FG001|Overall Study|Death|473|||
105697005|NCT00073528|364554494|FG000|Overall Study|Lost to Follow-up|52|||
105697006|NCT00073528|364554495|FG001|Overall Study|Lost to Follow-up|45|||
105697007|NCT00073528|364554494|FG000|Overall Study|Withdrawal by Subject|50|||
105697008|NCT00073528|364554495|FG001|Overall Study|Withdrawal by Subject|45|||
105697009|NCT00073528|364554494|FG000|Overall Study|Study terminated by Sponsor|10|||
105697010|NCT00073528|364554495|FG001|Overall Study|Study terminated by Sponsor|29|||
105697011|NCT00073528|364554494|FG000|Overall Study|Other|18|||
105697012|NCT00073528|364554495|FG001|Overall Study|Other|19|||
105697013|NCT00073528|364554494|FG000|Overall Study|Other|9|||
105697014|NCT00073528|364554495|FG001|Overall Study|Other|12|||
105697015|NCT00073528|364554494|FG000|Overall Study|Protocol Violation|3|||
105697016|NCT00073528|364554495|FG001|Overall Study|Protocol Violation|5|||
105697017|NCT03086057|364554496|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
105697018|NCT03086057|364554497|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
105697019|NCT03086057|364554498|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
106004965|NCT00979901|365682623|FG001|Overall Study|Lack of Efficacy|4|||
105697020|NCT03086057|364554499|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
105697021|NCT03086057|364554496|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
105697022|NCT03086057|364554497|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
105697023|NCT03086057|364554498|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
105697024|NCT03086057|364554499|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
105697025|NCT03086057|364554496|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
105697026|NCT03086057|364554497|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
105697027|NCT03086057|364554498|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
105697028|NCT03086057|364554499|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
105697029|NCT03086057|364554496|FG000|Stage 1: PrEP Uptake|Death|1|||
105697030|NCT03086057|364554497|FG001|Stage 1: PrEP Uptake|Death|0|||
105697031|NCT03086057|364554498|FG002|Stage 1: PrEP Uptake|Death|0|||
105697032|NCT03086057|364554499|FG003|Stage 1: PrEP Uptake|Death|0|||
105697033|NCT03086057|364554496|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
105697034|NCT03086057|364554497|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
105697035|NCT03086057|364554498|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
105697036|NCT03086057|364554499|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
105697037|NCT03086057|364554496|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
105697038|NCT03086057|364554497|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
105697039|NCT03086057|364554498|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
105697040|NCT03086057|364554499|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
105697041|NCT03086057|364554496|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
105697042|NCT03086057|364554497|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
105697043|NCT03086057|364554498|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
105697044|NCT03086057|364554499|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
105697045|NCT00199836|364554504|FG000|Overall Study|Progressive Disease|5|||
105697046|NCT00199836|364554504|FG000|Overall Study|Death|1|||
105697047|NCT02101021|364554507|FG000|Overall Study|Death|4|||
105697048|NCT02101021|364554508|FG001|Overall Study|Death|3|||
105697049|NCT02101021|364554509|FG002|Overall Study|Death|6|||
105697050|NCT02101021|364554510|FG003|Overall Study|Death|0|||
105697051|NCT02101021|364554511|FG004|Overall Study|Death|3|||
105697052|NCT02101021|364554507|FG000|Overall Study|Withdrew Consent from study|1|||
105697053|NCT02101021|364554508|FG001|Overall Study|Withdrew Consent from study|1|||
105697054|NCT02101021|364554509|FG002|Overall Study|Withdrew Consent from study|0|||
105697055|NCT02101021|364554510|FG003|Overall Study|Withdrew Consent from study|2|||
105697056|NCT02101021|364554511|FG004|Overall Study|Withdrew Consent from study|0|||
105697057|NCT02101021|364554507|FG000|Overall Study|Lost to Follow-up|1|||
105697058|NCT02101021|364554508|FG001|Overall Study|Lost to Follow-up|0|||
105697059|NCT02101021|364554509|FG002|Overall Study|Lost to Follow-up|0|||
105697060|NCT02101021|364554510|FG003|Overall Study|Lost to Follow-up|0|||
105697061|NCT02101021|364554511|FG004|Overall Study|Lost to Follow-up|0|||
105697062|NCT02101021|364554507|FG000|Overall Study|Study Terminated by Sponsor|1|||
105697063|NCT02101021|364554508|FG001|Overall Study|Study Terminated by Sponsor|0|||
105697064|NCT02101021|364554509|FG002|Overall Study|Study Terminated by Sponsor|1|||
105697065|NCT02101021|364554510|FG003|Overall Study|Study Terminated by Sponsor|1|||
105697066|NCT02101021|364554511|FG004|Overall Study|Study Terminated by Sponsor|1|||
105697067|NCT01235793|364554512|FG000|Overall Study|Death|6|||
105697068|NCT01770912|364554513|FG000|Overall Study|Lost to Follow-up|2|||
105697069|NCT01770912|364554514|FG001|Overall Study|Lost to Follow-up|0|||
105697070|NCT04695392|364554515|FG000|Overall Study|Withdrawn by parent/guardian|0|||
105697071|NCT04695392|364554516|FG001|Overall Study|Withdrawn by parent/guardian|1|||
105697072|NCT04695392|364554515|FG000|Overall Study|Withdrawn by physician|0|||
105697073|NCT04695392|364554516|FG001|Overall Study|Withdrawn by physician|1|||
105697074|NCT01536951|364554517|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697075|NCT01536951|364554518|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697076|NCT01536951|364554519|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
105697077|NCT01536951|364554520|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697078|NCT01536951|364554521|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697079|NCT01536951|364554522|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697080|NCT01536951|364554523|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697081|NCT01536951|364554524|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697082|NCT01536951|364554525|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
105697083|NCT01536951|364554517|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
105697084|NCT01536951|364554518|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
105697085|NCT01536951|364554519|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
105697086|NCT01536951|364554520|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
105697087|NCT01536951|364554521|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
105697088|NCT01536951|364554522|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
105697089|NCT01536951|364554523|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
105697090|NCT01536951|364554524|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
105697091|NCT01536951|364554525|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
105697092|NCT01843972|364554526|FG000|Overall Study|Withdrawal by Subject|0|||
105697093|NCT01843972|364554527|FG001|Overall Study|Withdrawal by Subject|0|||
105697094|NCT01843972|364554528|FG002|Overall Study|Withdrawal by Subject|0|||
105697095|NCT01843972|364554529|FG003|Overall Study|Withdrawal by Subject|0|||
105697096|NCT01843972|364554530|FG004|Overall Study|Withdrawal by Subject|1|||
105697097|NCT01843972|364554531|FG005|Overall Study|Withdrawal by Subject|0|||
105697098|NCT01843972|364554532|FG006|Overall Study|Withdrawal by Subject|0|||
105697099|NCT01843972|364554533|FG007|Overall Study|Withdrawal by Subject|0|||
105697100|NCT01843972|364554534|FG008|Overall Study|Withdrawal by Subject|0|||
105697101|NCT01843972|364554535|FG009|Overall Study|Withdrawal by Subject|0|||
105697102|NCT00555477|364554538|FG000|Overall Study|Adverse Event|0|||
105697103|NCT00555477|364554539|FG001|Overall Study|Adverse Event|9|||
105697104|NCT00555477|364554538|FG000|Overall Study|Withdrawal by Subject|1|||
105697105|NCT00555477|364554539|FG001|Overall Study|Withdrawal by Subject|2|||
105697106|NCT00555477|364554538|FG000|Overall Study|Physician Decision|1|||
105697107|NCT00555477|364554539|FG001|Overall Study|Physician Decision|2|||
105697108|NCT01817751|364554540|FG000|Overall Study|Physician Decision|1|||
105697109|NCT00382018|364554541|FG000|Overall Study|Progression|0|||
105697110|NCT00382018|364554542|FG001|Overall Study|Progression|136|||
105697111|NCT00382018|364554543|FG002|Overall Study|Progression|51|||
105697112|NCT00382018|364554544|FG003|Overall Study|Progression|43|||
105697113|NCT00382018|364554541|FG000|Overall Study|Death|0|||
105697114|NCT00382018|364554542|FG001|Overall Study|Death|9|||
105697115|NCT00382018|364554543|FG002|Overall Study|Death|7|||
105697116|NCT00382018|364554544|FG003|Overall Study|Death|11|||
105697117|NCT00382018|364554541|FG000|Overall Study|Withdrawal by Subject|0|||
105697118|NCT00382018|364554542|FG001|Overall Study|Withdrawal by Subject|4|||
105697119|NCT00382018|364554543|FG002|Overall Study|Withdrawal by Subject|3|||
105697120|NCT00382018|364554544|FG003|Overall Study|Withdrawal by Subject|4|||
105697121|NCT00382018|364554541|FG000|Overall Study|Other, not protocol specified|0|||
105697122|NCT00382018|364554542|FG001|Overall Study|Other, not protocol specified|16|||
105697123|NCT00382018|364554543|FG002|Overall Study|Other, not protocol specified|3|||
105697124|NCT00382018|364554544|FG003|Overall Study|Other, not protocol specified|1|||
105697125|NCT01846624|364554545|FG000|Overall Study|Died during induction, no midostaurin|1|||
105697126|NCT01721057|364554548|FG000|Treatment Period|Withdrawal by Subject|11|||
105697127|NCT01721057|364554549|FG001|Treatment Period|Withdrawal by Subject|5|||
105697128|NCT01721057|364554550|FG002|Treatment Period|Withdrawal by Subject|8|||
105697129|NCT01721057|364554551|FG003|Treatment Period|Withdrawal by Subject|0|||
105697130|NCT01721057|364554552|FG004|Treatment Period|Withdrawal by Subject|0|||
105697131|NCT01721057|364554553|FG005|Treatment Period|Withdrawal by Subject|0|||
105697132|NCT01721057|364554554|FG006|Treatment Period|Withdrawal by Subject|0|||
105697133|NCT01721057|364554548|FG000|Treatment Period|Adverse Event|7|||
105697134|NCT01721057|364554549|FG001|Treatment Period|Adverse Event|10|||
105697135|NCT01721057|364554550|FG002|Treatment Period|Adverse Event|12|||
105697136|NCT01721057|364554551|FG003|Treatment Period|Adverse Event|0|||
105697137|NCT01721057|364554552|FG004|Treatment Period|Adverse Event|0|||
105697138|NCT01721057|364554553|FG005|Treatment Period|Adverse Event|0|||
105697139|NCT01721057|364554554|FG006|Treatment Period|Adverse Event|0|||
105697140|NCT01721057|364554548|FG000|Treatment Period|Lack of Efficacy|7|||
105697141|NCT01721057|364554549|FG001|Treatment Period|Lack of Efficacy|3|||
105697142|NCT01721057|364554550|FG002|Treatment Period|Lack of Efficacy|0|||
105697143|NCT01721057|364554551|FG003|Treatment Period|Lack of Efficacy|0|||
105697144|NCT01721057|364554552|FG004|Treatment Period|Lack of Efficacy|0|||
105697145|NCT01721057|364554553|FG005|Treatment Period|Lack of Efficacy|0|||
105697146|NCT01721057|364554554|FG006|Treatment Period|Lack of Efficacy|0|||
105697147|NCT01721057|364554548|FG000|Treatment Period|Lost to Follow-up|1|||
106132738|NCT04672460|366144746|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
105697148|NCT01721057|364554549|FG001|Treatment Period|Lost to Follow-up|0|||
105697149|NCT01721057|364554550|FG002|Treatment Period|Lost to Follow-up|0|||
105697150|NCT01721057|364554551|FG003|Treatment Period|Lost to Follow-up|0|||
105697151|NCT01721057|364554552|FG004|Treatment Period|Lost to Follow-up|0|||
105697152|NCT01721057|364554553|FG005|Treatment Period|Lost to Follow-up|0|||
105697153|NCT01721057|364554554|FG006|Treatment Period|Lost to Follow-up|0|||
106132739|NCT04672460|366144747|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
106132740|NCT04672460|366144746|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
106132741|NCT04672460|366144747|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
105697154|NCT01721057|364554548|FG000|Treatment Period|Physician Decision|0|||
105697155|NCT01721057|364554549|FG001|Treatment Period|Physician Decision|1|||
105697156|NCT01721057|364554550|FG002|Treatment Period|Physician Decision|3|||
105806510|NCT03038113|364949004|FG004|Overall Study|Withdrawal by Subject|0|||
105697157|NCT01721057|364554551|FG003|Treatment Period|Physician Decision|0|||
105697158|NCT01721057|364554552|FG004|Treatment Period|Physician Decision|0|||
105697159|NCT01721057|364554553|FG005|Treatment Period|Physician Decision|0|||
105697160|NCT01721057|364554554|FG006|Treatment Period|Physician Decision|0|||
105697161|NCT01721057|364554548|FG000|Treatment Period|Death|2|||
105697162|NCT01721057|364554549|FG001|Treatment Period|Death|0|||
105697163|NCT01721057|364554550|FG002|Treatment Period|Death|0|||
105697164|NCT01721057|364554551|FG003|Treatment Period|Death|0|||
105697165|NCT01721057|364554552|FG004|Treatment Period|Death|0|||
105697166|NCT01721057|364554553|FG005|Treatment Period|Death|0|||
105697167|NCT01721057|364554554|FG006|Treatment Period|Death|0|||
105697168|NCT01721057|364554548|FG000|Rescue Period|Adverse Event|0|||
105697169|NCT01721057|364554549|FG001|Rescue Period|Adverse Event|0|||
105697170|NCT01721057|364554550|FG002|Rescue Period|Adverse Event|0|||
105697171|NCT01721057|364554551|FG003|Rescue Period|Adverse Event|1|||
105697172|NCT01721057|364554552|FG004|Rescue Period|Adverse Event|0|||
105697173|NCT01721057|364554553|FG005|Rescue Period|Adverse Event|0|||
105697174|NCT01721057|364554554|FG006|Rescue Period|Adverse Event|0|||
105697175|NCT01721057|364554548|FG000|Rescue Period|Lack of Efficacy|0|||
105697176|NCT01721057|364554549|FG001|Rescue Period|Lack of Efficacy|0|||
105697177|NCT01721057|364554550|FG002|Rescue Period|Lack of Efficacy|0|||
105697178|NCT01721057|364554551|FG003|Rescue Period|Lack of Efficacy|2|||
105697179|NCT01721057|364554552|FG004|Rescue Period|Lack of Efficacy|0|||
105697180|NCT01721057|364554553|FG005|Rescue Period|Lack of Efficacy|0|||
105697181|NCT01721057|364554554|FG006|Rescue Period|Lack of Efficacy|0|||
105697182|NCT01889238|364554560|FG000|Overall Study|Death|1|||
105697183|NCT01889238|364554560|FG000|Overall Study|Withdrawal by Subject|1|||
105697184|NCT01889238|364554560|FG000|Overall Study|Adverse Event|6|||
105697185|NCT01889238|364554560|FG000|Overall Study|Disease Progression|104|||
105697186|NCT01889238|364554560|FG000|Overall Study|Other|6|||
105697187|NCT02717754|364554563|FG000|Overall Study|Incorrect Infusion Duration|0|||
105697188|NCT02717754|364554564|FG001|Overall Study|Incorrect Infusion Duration|0|||
105697189|NCT02717754|364554565|FG002|Overall Study|Incorrect Infusion Duration|0|||
105697190|NCT02717754|364554566|FG003|Overall Study|Incorrect Infusion Duration|10|||
105697191|NCT02717754|364554567|FG004|Overall Study|Incorrect Infusion Duration|20|||
105697192|NCT02717754|364554568|FG005|Overall Study|Incorrect Infusion Duration|20|||
105697193|NCT02592018|364554571|FG000|Overall Study|Adverse Event|1|||
105697194|NCT02592018|364554571|FG000|Overall Study|Lost to Follow-up|1|||
105697195|NCT02710136|364554572|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
105697196|NCT02710136|364554573|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
105697197|NCT00418665|364554574|FG000|Treatment Period|Ineligibility determined|1|||
105697198|NCT00418665|364554575|FG001|Treatment Period|Ineligibility determined|1|||
105697199|NCT00418665|364554576|FG002|Treatment Period|Ineligibility determined|0|||
105697200|NCT00418665|364554574|FG000|Treatment Period|Adverse Event|2|||
105697201|NCT00418665|364554575|FG001|Treatment Period|Adverse Event|2|||
105697202|NCT00418665|364554576|FG002|Treatment Period|Adverse Event|0|||
105697203|NCT00418665|364554574|FG000|Treatment Period|Withdrawal by Subject|0|||
106004966|NCT00979901|365682624|FG002|Overall Study|Lack of Efficacy|9|||
106004967|NCT00979901|365682625|FG003|Overall Study|Lack of Efficacy|0|||
106004968|NCT00979901|365682622|FG000|Overall Study|Lost to Follow-up|1|||
106004969|NCT00979901|365682623|FG001|Overall Study|Lost to Follow-up|1|||
106004970|NCT00979901|365682624|FG002|Overall Study|Lost to Follow-up|2|||
106004971|NCT00979901|365682625|FG003|Overall Study|Lost to Follow-up|0|||
106004972|NCT00979901|365682622|FG000|Overall Study|Protocol Violation|2|||
106004973|NCT00979901|365682623|FG001|Overall Study|Protocol Violation|2|||
106004974|NCT00979901|365682624|FG002|Overall Study|Protocol Violation|7|||
106004975|NCT00979901|365682625|FG003|Overall Study|Protocol Violation|1|||
106004976|NCT00979901|365682622|FG000|Overall Study|Withdrawal by Subject|2|||
106004977|NCT00979901|365682623|FG001|Overall Study|Withdrawal by Subject|1|||
106004978|NCT00979901|365682624|FG002|Overall Study|Withdrawal by Subject|1|||
106004979|NCT00979901|365682625|FG003|Overall Study|Withdrawal by Subject|1|||
106004980|NCT00979901|365682622|FG000|Overall Study|Noncompliance|1|||
106004981|NCT00979901|365682623|FG001|Overall Study|Noncompliance|0|||
106004982|NCT00979901|365682624|FG002|Overall Study|Noncompliance|0|||
106004983|NCT00979901|365682625|FG003|Overall Study|Noncompliance|0|||
106004984|NCT00979901|365682622|FG000|Overall Study|out-of-state|1|||
106004985|NCT00979901|365682623|FG001|Overall Study|out-of-state|0|||
106004986|NCT00979901|365682624|FG002|Overall Study|out-of-state|0|||
106004987|NCT00979901|365682625|FG003|Overall Study|out-of-state|0|||
106004988|NCT00979901|365682622|FG000|Overall Study|vacation|1|||
106004989|NCT00979901|365682623|FG001|Overall Study|vacation|0|||
106004990|NCT00979901|365682624|FG002|Overall Study|vacation|0|||
105697204|NCT00418665|364554575|FG001|Treatment Period|Withdrawal by Subject|3|||
105697205|NCT00418665|364554576|FG002|Treatment Period|Withdrawal by Subject|1|||
105697206|NCT00418665|364554574|FG000|Treatment Period|Requirement for alternative therapy|1|||
105697207|NCT00418665|364554575|FG001|Treatment Period|Requirement for alternative therapy|0|||
105697208|NCT00418665|364554576|FG002|Treatment Period|Requirement for alternative therapy|0|||
105697209|NCT00418665|364554574|FG000|Treatment Period|Physician Decision|1|||
105697210|NCT00418665|364554575|FG001|Treatment Period|Physician Decision|0|||
105697211|NCT00418665|364554576|FG002|Treatment Period|Physician Decision|3|||
105697212|NCT00418665|364554574|FG000|Treatment Extension|Adverse Event|1|||
106004991|NCT00979901|365682625|FG003|Overall Study|vacation|0|||
106004992|NCT00979901|365682622|FG000|Overall Study|elevated lab values pre-randomization|1|||
106004993|NCT00979901|365682623|FG001|Overall Study|elevated lab values pre-randomization|0|||
105697213|NCT00418665|364554575|FG001|Treatment Extension|Adverse Event|0|||
105697214|NCT00418665|364554576|FG002|Treatment Extension|Adverse Event|0|||
105697215|NCT00418665|364554574|FG000|Treatment Extension|Withdrawal by Subject|1|||
105697216|NCT00418665|364554575|FG001|Treatment Extension|Withdrawal by Subject|0|||
105697217|NCT00418665|364554576|FG002|Treatment Extension|Withdrawal by Subject|0|||
105697218|NCT00418665|364554574|FG000|Treatment Extension|Requirement for alternative therapy|2|||
105697219|NCT00418665|364554575|FG001|Treatment Extension|Requirement for alternative therapy|2|||
105697220|NCT00418665|364554576|FG002|Treatment Extension|Requirement for alternative therapy|0|||
105697221|NCT00418665|364554574|FG000|Treatment Extension|Physician Decision|2|||
105697222|NCT00418665|364554575|FG001|Treatment Extension|Physician Decision|2|||
105697223|NCT00418665|364554576|FG002|Treatment Extension|Physician Decision|1|||
105697224|NCT00418665|364554574|FG000|Treatment Extension|Death|0|||
105697225|NCT00418665|364554575|FG001|Treatment Extension|Death|0|||
105697226|NCT00418665|364554576|FG002|Treatment Extension|Death|1|||
105697227|NCT01133379|364554577|FG000|Overall Study|Withdrawal by Subject|0|||
105697228|NCT01133379|364554578|FG001|Overall Study|Withdrawal by Subject|1|||
105697229|NCT01133379|364554579|FG002|Overall Study|Withdrawal by Subject|1|||
105697230|NCT01133379|364554577|FG000|Overall Study|Lost to Follow-up|1|||
105697231|NCT01133379|364554578|FG001|Overall Study|Lost to Follow-up|1|||
105697232|NCT01133379|364554579|FG002|Overall Study|Lost to Follow-up|1|||
105697233|NCT00591214|364554580|FG000|Overall Study|Physician Decision|7|||
105697234|NCT00591214|364554580|FG000|Overall Study|Withdrawal by Subject|1|||
105697235|NCT00729378|364556082|FG000|Baseline|Did not complete study measurements|72|||
105697236|NCT00729378|364556083|FG001|Baseline|Did not complete study measurements|33|||
105697237|NCT00729378|364556082|FG000|Baseline|Withdrawal by Subject|66|||
105697238|NCT00729378|364556083|FG001|Baseline|Withdrawal by Subject|59|||
105697239|NCT00729378|364556082|FG000|12-months|Lost to Follow-up|100|||
105697240|NCT00729378|364556083|FG001|12-months|Lost to Follow-up|65|||
105697241|NCT00729378|364556082|FG000|24-months|Lost to Follow-up|72|||
105697242|NCT00729378|364556083|FG001|24-months|Lost to Follow-up|51|||
105697243|NCT00729378|364556082|FG000|36-months|Lost to Follow-up|15|||
105697244|NCT00729378|364556083|FG001|36-months|Lost to Follow-up|6|||
105697245|NCT02246582|364556086|FG000|Overall Study|Withdrawal by Subject|3|||
105697246|NCT02246582|364556087|FG001|Overall Study|Withdrawal by Subject|4|||
105697247|NCT00574145|364556088|FG000|Overall Study|Withdrawal by Subject|2|||
105697248|NCT00574145|364556089|FG001|Overall Study|Withdrawal by Subject|1|||
105697249|NCT00382720|364556091|FG000|Overall Study|Adverse Event|21|||
105697250|NCT00382720|364556092|FG001|Overall Study|Adverse Event|23|||
105697251|NCT00382720|364556093|FG002|Overall Study|Adverse Event|15|||
105697252|NCT00382720|364556091|FG000|Overall Study|Protocol Violation|2|||
105697253|NCT00382720|364556092|FG001|Overall Study|Protocol Violation|5|||
105697254|NCT00382720|364556093|FG002|Overall Study|Protocol Violation|1|||
105697255|NCT00382720|364556091|FG000|Overall Study|Death|0|||
105697256|NCT00382720|364556092|FG001|Overall Study|Death|1|||
105697257|NCT00382720|364556093|FG002|Overall Study|Death|2|||
105697258|NCT00382720|364556091|FG000|Overall Study|Progressive disease|37|||
105697259|NCT00382720|364556092|FG001|Overall Study|Progressive disease|28|||
105697260|NCT00382720|364556093|FG002|Overall Study|Progressive disease|38|||
105697261|NCT00382720|364556091|FG000|Overall Study|Withdrew consent|1|||
105697262|NCT00382720|364556092|FG001|Overall Study|Withdrew consent|1|||
105697263|NCT00382720|364556093|FG002|Overall Study|Withdrew consent|2|||
105697264|NCT00382720|364556091|FG000|Overall Study|Withdrawal by Subject|11|||
105697265|NCT00382720|364556092|FG001|Overall Study|Withdrawal by Subject|20|||
105697266|NCT00382720|364556093|FG002|Overall Study|Withdrawal by Subject|12|||
105697267|NCT00382720|364556091|FG000|Overall Study|Surgery|1|||
105697268|NCT00382720|364556092|FG001|Overall Study|Surgery|1|||
105923120|NCT02711137|365380617|FG009|Overall Study|Study Terminated by Sponsor|0|||
105923121|NCT02711137|365380618|FG010|Overall Study|Study Terminated by Sponsor|0|||
105923122|NCT02711137|365380619|FG011|Overall Study|Study Terminated by Sponsor|0|||
105923123|NCT02711137|365380620|FG012|Overall Study|Study Terminated by Sponsor|0|||
105923124|NCT02711137|365380621|FG013|Overall Study|Study Terminated by Sponsor|0|||
105923125|NCT02711137|365380622|FG014|Overall Study|Study Terminated by Sponsor|0|||
105923126|NCT02711137|365380608|FG000|Overall Study|Physician Decision|1|||
105923127|NCT02711137|365380609|FG001|Overall Study|Physician Decision|0|||
105923128|NCT02711137|365380610|FG002|Overall Study|Physician Decision|2|||
105923129|NCT02711137|365380611|FG003|Overall Study|Physician Decision|1|||
105923130|NCT02711137|365380612|FG004|Overall Study|Physician Decision|1|||
105697269|NCT00382720|364556093|FG002|Overall Study|Surgery|4|||
105697270|NCT00382720|364556091|FG000|Overall Study|Patient did not receive study medication|1|||
105697271|NCT00382720|364556092|FG001|Overall Study|Patient did not receive study medication|1|||
105697272|NCT00382720|364556093|FG002|Overall Study|Patient did not receive study medication|4|||
105697273|NCT00382720|364556091|FG000|Overall Study|Clinically progressive disease|0|||
105923131|NCT02711137|365380613|FG005|Overall Study|Physician Decision|0|||
105923132|NCT02711137|365380614|FG006|Overall Study|Physician Decision|12|||
105923133|NCT02711137|365380615|FG007|Overall Study|Physician Decision|2|||
105697274|NCT00382720|364556092|FG001|Overall Study|Clinically progressive disease|1|||
105697275|NCT00382720|364556093|FG002|Overall Study|Clinically progressive disease|0|||
105697276|NCT00382720|364556091|FG000|Overall Study|Good prognosis|0|||
105697277|NCT00382720|364556092|FG001|Overall Study|Good prognosis|1|||
105697278|NCT00382720|364556093|FG002|Overall Study|Good prognosis|0|||
105697279|NCT00382720|364556091|FG000|Overall Study|Investigator/Clinical decision|5|||
105697280|NCT00382720|364556092|FG001|Overall Study|Investigator/Clinical decision|6|||
105697281|NCT00382720|364556093|FG002|Overall Study|Investigator/Clinical decision|6|||
105697282|NCT00382720|364556091|FG000|Overall Study|Discontinued at end of study|0|||
105697283|NCT00382720|364556092|FG001|Overall Study|Discontinued at end of study|1|||
105697284|NCT00382720|364556093|FG002|Overall Study|Discontinued at end of study|2|||
105697285|NCT00682448|364556094|FG000|Overall Study|Adverse Event|1|||
105697286|NCT00682448|364556095|FG001|Overall Study|Adverse Event|2|||
105697287|NCT00682448|364556094|FG000|Overall Study|Lack of Efficacy|1|||
105697288|NCT00682448|364556095|FG001|Overall Study|Lack of Efficacy|0|||
105697289|NCT00682448|364556094|FG000|Overall Study|Lost to Follow-up|1|||
105697290|NCT00682448|364556095|FG001|Overall Study|Lost to Follow-up|3|||
105697291|NCT00682448|364556094|FG000|Overall Study|Pregnancy|0|||
105697292|NCT00682448|364556095|FG001|Overall Study|Pregnancy|1|||
105697293|NCT00682448|364556094|FG000|Overall Study|Withdrawal by Subject|2|||
105697294|NCT00682448|364556095|FG001|Overall Study|Withdrawal by Subject|0|||
105697295|NCT02737852|364556096|FG000|Overall Study|Withdrawal by Subject|2|||
105697296|NCT02592551|364556097|FG000|Overall Study|Not evaluable|1|||
105697297|NCT02592551|364556098|FG001|Overall Study|Not evaluable|3|||
105697298|NCT02592551|364556099|FG002|Overall Study|Not evaluable|0|||
105697299|NCT01876251|364556102|FG000|Overall Study|Clinical progression|1|||
105697300|NCT01876251|364556103|FG001|Overall Study|Clinical progression|0|||
105697301|NCT01876251|364556104|FG002|Overall Study|Clinical progression|0|||
105697302|NCT01876251|364556102|FG000|Overall Study|Death|2|||
105697303|NCT01876251|364556103|FG001|Overall Study|Death|0|||
105697304|NCT01876251|364556104|FG002|Overall Study|Death|1|||
105697305|NCT01876251|364556102|FG000|Overall Study|Participant started new treatment|1|||
105697306|NCT01876251|364556103|FG001|Overall Study|Participant started new treatment|0|||
105697307|NCT01876251|364556104|FG002|Overall Study|Participant started new treatment|1|||
105697308|NCT01876251|364556102|FG000|Overall Study|Participant refused further follow-up|0|||
105697309|NCT01876251|364556103|FG001|Overall Study|Participant refused further follow-up|0|||
105697310|NCT01876251|364556104|FG002|Overall Study|Participant refused further follow-up|1|||
105697311|NCT01876251|364556102|FG000|Overall Study|Study terminated|1|||
105697312|NCT01876251|364556103|FG001|Overall Study|Study terminated|0|||
106004994|NCT00979901|365682624|FG002|Overall Study|elevated lab values pre-randomization|0|||
106004995|NCT00979901|365682625|FG003|Overall Study|elevated lab values pre-randomization|0|||
106004996|NCT00979901|365682622|FG000|Overall Study|Discontinued in Error|0|||
106004997|NCT00979901|365682623|FG001|Overall Study|Discontinued in Error|1|||
106004998|NCT00979901|365682624|FG002|Overall Study|Discontinued in Error|0|||
106004999|NCT00979901|365682625|FG003|Overall Study|Discontinued in Error|0|||
105697313|NCT01876251|364556104|FG002|Overall Study|Study terminated|0|||
105697314|NCT01876251|364556102|FG000|Overall Study|Objective progression or relapse|10|||
105697315|NCT01876251|364556103|FG001|Overall Study|Objective progression or relapse|3|||
105697316|NCT01876251|364556104|FG002|Overall Study|Objective progression or relapse|8|||
105697317|NCT00761306|364556105|FG000|Overall Study|Adverse Event|5|||
105697318|NCT00761306|364556105|FG000|Overall Study|Lack of Efficacy|4|||
105697319|NCT00761306|364556105|FG000|Overall Study|Protocol Violation|2|||
105697320|NCT00761306|364556105|FG000|Overall Study|Withdrawal of Consent|3|||
105697321|NCT00761306|364556105|FG000|Overall Study|Lost to Follow-up|1|||
105697322|NCT00761306|364556105|FG000|Overall Study|Administrative or Other Reasons|5|||
105697323|NCT00268437|364556106|FG000|Overall Study|Ineligible|1|||
105697324|NCT05162027|364556109|FG000|Overall Study|Adverse Event|1|||
105697325|NCT05162027|364556110|FG001|Overall Study|Adverse Event|0|||
105697326|NCT03335163|364556111|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
105697327|NCT03335163|364556111|FG000|Overall Study|Withdrawal by Subject|18|||
105697328|NCT01704287|364556114|FG000|Initial Treatment Period|Death|139|||
105697329|NCT01704287|364556115|FG001|Initial Treatment Period|Death|129|||
105697330|NCT01704287|364556116|FG002|Initial Treatment Period|Death|71|||
105697331|NCT01704287|364556117|FG003|Initial Treatment Period|Death|0|||
105697332|NCT01704287|364556118|FG004|Initial Treatment Period|Death|0|||
106005000|NCT00979901|365682622|FG000|Overall Study|Left Country|0|||
106132742|NCT04672460|366144746|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
105697333|NCT01704287|364556114|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
105697334|NCT01704287|364556115|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
105697335|NCT01704287|364556116|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
105697336|NCT01704287|364556117|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
105697337|NCT01704287|364556118|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
105697338|NCT01704287|364556114|FG000|Initial Treatment Period|Lost to Follow-up|5|||
105697339|NCT01704287|364556115|FG001|Initial Treatment Period|Lost to Follow-up|3|||
105697340|NCT01704287|364556116|FG002|Initial Treatment Period|Lost to Follow-up|0|||
105697341|NCT01704287|364556117|FG003|Initial Treatment Period|Lost to Follow-up|0|||
105697342|NCT01704287|364556118|FG004|Initial Treatment Period|Lost to Follow-up|0|||
105697343|NCT01704287|364556114|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
106005001|NCT00979901|365682623|FG001|Overall Study|Left Country|0|||
105697344|NCT01704287|364556115|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
105697345|NCT01704287|364556116|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
105697346|NCT01704287|364556117|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
105697347|NCT01704287|364556118|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
105697348|NCT01704287|364556114|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
105697349|NCT01704287|364556115|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
105697350|NCT01704287|364556116|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
105697351|NCT01704287|364556117|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
105697352|NCT01704287|364556118|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
105697353|NCT01704287|364556114|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
105697354|NCT01704287|364556115|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
105697355|NCT01704287|364556116|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
105697356|NCT01704287|364556117|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
105697357|NCT01704287|364556118|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
105697358|NCT01704287|364556114|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
105697359|NCT01704287|364556115|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
105697360|NCT01704287|364556116|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
105697361|NCT01704287|364556117|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
105697362|NCT01704287|364556118|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
106005002|NCT00979901|365682624|FG002|Overall Study|Left Country|1|||
105697363|NCT04196803|364556119|FG000|Overall Study|Withdrawal by Subject|1|||
105697364|NCT04196803|364556120|FG001|Overall Study|Withdrawal by Subject|3|||
105697365|NCT04196803|364556119|FG000|Overall Study|Adverse Event|4|||
105697366|NCT04196803|364556120|FG001|Overall Study|Adverse Event|2|||
106005003|NCT00979901|365682625|FG003|Overall Study|Left Country|0|||
106005004|NCT00979901|365682622|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
106005005|NCT00979901|365682623|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
106005006|NCT00979901|365682624|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
106005007|NCT00979901|365682625|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
106005008|NCT01751061|365682626|FG000|Overall Study|Death|1|||
106005009|NCT01751061|365682627|FG001|Overall Study|Death|0|||
106005010|NCT01751061|365682626|FG000|Overall Study|patient death|5|||
106005011|NCT01751061|365682627|FG001|Overall Study|patient death|0|||
105697367|NCT04196803|364556119|FG000|Overall Study|Lost to Follow-up|0|||
105697368|NCT04196803|364556120|FG001|Overall Study|Lost to Follow-up|1|||
105697369|NCT04490395|364556121|FG000|Overall Study|Lost to Follow-up|0|||
105697370|NCT04490395|364556122|FG001|Overall Study|Lost to Follow-up|1|||
105697371|NCT01462435|364556126|FG000|Overall Study|Lack of Efficacy|1|||
105697372|NCT01462435|364556127|FG001|Overall Study|Lack of Efficacy|0|||
105697373|NCT01462435|364556128|FG002|Overall Study|Lack of Efficacy|0|||
105697374|NCT01462435|364556129|FG003|Overall Study|Lack of Efficacy|3|||
105697375|NCT01462435|364556126|FG000|Overall Study|Physician Decision|0|||
105697376|NCT01462435|364556127|FG001|Overall Study|Physician Decision|0|||
105697377|NCT01462435|364556128|FG002|Overall Study|Physician Decision|1|||
105697378|NCT01462435|364556129|FG003|Overall Study|Physician Decision|0|||
105697379|NCT01462435|364556126|FG000|Overall Study|Withdrawal by Subject|0|||
105697380|NCT01462435|364556127|FG001|Overall Study|Withdrawal by Subject|0|||
105697381|NCT01462435|364556128|FG002|Overall Study|Withdrawal by Subject|0|||
105697382|NCT01462435|364556129|FG003|Overall Study|Withdrawal by Subject|1|||
105697383|NCT01462435|364556126|FG000|Overall Study|Lost to Follow-up|0|||
105697384|NCT01462435|364556127|FG001|Overall Study|Lost to Follow-up|0|||
105697385|NCT01462435|364556128|FG002|Overall Study|Lost to Follow-up|0|||
105697386|NCT01462435|364556129|FG003|Overall Study|Lost to Follow-up|1|||
105697387|NCT03104075|364556131|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
105697388|NCT03104075|364556132|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
105697389|NCT03349775|364556133|FG000|Overall Study|Side Effects|1|||
105697390|NCT03349775|364556134|FG001|Overall Study|Side Effects|2|||
105697391|NCT03349775|364556133|FG000|Overall Study|Withdrawal by Subject|1|||
105697392|NCT03349775|364556134|FG001|Overall Study|Withdrawal by Subject|1|||
105697393|NCT03349775|364556133|FG000|Overall Study|No primary outcome measurements|0|||
105697394|NCT03349775|364556134|FG001|Overall Study|No primary outcome measurements|1|||
105697395|NCT01516970|364556135|FG000|Overall Study|Lost to Follow-up|7|||
105697396|NCT01516970|364556136|FG001|Overall Study|Lost to Follow-up|8|||
105697397|NCT01516970|364556135|FG000|Overall Study|Adverse Event|1|||
105697398|NCT01516970|364556136|FG001|Overall Study|Adverse Event|5|||
105697399|NCT01516970|364556135|FG000|Overall Study|Withdrawal by Subject|1|||
105697400|NCT01516970|364556136|FG001|Overall Study|Withdrawal by Subject|1|||
105697401|NCT01516970|364556135|FG000|Overall Study|Other|9|||
105697402|NCT01516970|364556136|FG001|Overall Study|Other|7|||
105697403|NCT02716675|364556138|FG000|Overall Study|Death|2|||
105697404|NCT02716675|364556139|FG001|Overall Study|Death|3|||
105697405|NCT02716675|364556140|FG002|Overall Study|Death|0|||
106005012|NCT01751061|365682626|FG000|Overall Study|Lost to Follow-up|40|||
106132743|NCT04672460|366144747|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
105697406|NCT02716675|364556138|FG000|Overall Study|Physician Decision|2|||
105697407|NCT02716675|364556139|FG001|Overall Study|Physician Decision|1|||
105697408|NCT02716675|364556140|FG002|Overall Study|Physician Decision|1|||
105697409|NCT02716675|364556138|FG000|Overall Study|Lost to Follow-up|100|||
105697410|NCT02716675|364556139|FG001|Overall Study|Lost to Follow-up|87|||
105697411|NCT02716675|364556140|FG002|Overall Study|Lost to Follow-up|99|||
105697412|NCT02716675|364556138|FG000|Overall Study|Withdrawal by Subject|22|||
105697413|NCT02716675|364556139|FG001|Overall Study|Withdrawal by Subject|25|||
105697414|NCT02716675|364556140|FG002|Overall Study|Withdrawal by Subject|20|||
105697415|NCT02716675|364556138|FG000|Overall Study|Protocol Violation|0|||
105697416|NCT02716675|364556139|FG001|Overall Study|Protocol Violation|3|||
105697417|NCT02716675|364556140|FG002|Overall Study|Protocol Violation|1|||
105697418|NCT02716675|364556138|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
105697419|NCT02716675|364556139|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
105697420|NCT02716675|364556140|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
105697421|NCT02716675|364556138|FG000|Overall Study|Other|38|||
105697422|NCT02716675|364556139|FG001|Overall Study|Other|47|||
105697423|NCT02716675|364556140|FG002|Overall Study|Other|48|||
105697424|NCT01211535|364556143|FG000|Overall Study|Adverse Event|0|||
105697425|NCT01211535|364556144|FG001|Overall Study|Adverse Event|1|||
105697426|NCT01380730|364556150|FG000|Overall Study|Death|0|||
105697427|NCT01380730|364556151|FG001|Overall Study|Death|0|||
105697428|NCT01380730|364556152|FG002|Overall Study|Death|0|||
105697429|NCT01380730|364556153|FG003|Overall Study|Death|0|||
105697430|NCT01380730|364556154|FG004|Overall Study|Death|1|||
105697431|NCT01380730|364556155|FG005|Overall Study|Death|0|||
105697432|NCT01380730|364556156|FG006|Overall Study|Death|0|||
105697433|NCT01380730|364556157|FG007|Overall Study|Death|0|||
105697434|NCT05111041|364556159|FG000|Overall Study|Lost to Follow-up|6|||
105697435|NCT05111041|364556160|FG001|Overall Study|Lost to Follow-up|7|||
105697436|NCT05111041|364556159|FG000|Overall Study|Withdrawal by Subject|1|||
105697437|NCT05111041|364556160|FG001|Overall Study|Withdrawal by Subject|0|||
105697438|NCT01205230|364556161|FG000|Overall Study|Adverse Event|4|||
105697439|NCT01205230|364556162|FG001|Overall Study|Adverse Event|0|||
105697440|NCT01205230|364556161|FG000|Overall Study|Physician Decision|1|||
105697441|NCT01205230|364556162|FG001|Overall Study|Physician Decision|0|||
105697442|NCT00359021|364556163|FG000|Overall Study|Adverse Event|26|||
105697443|NCT00359021|364556164|FG001|Overall Study|Adverse Event|8|||
105697444|NCT00359021|364556163|FG000|Overall Study|Subject Non-Compliant|1|||
105697445|NCT00359021|364556164|FG001|Overall Study|Subject Non-Compliant|2|||
105697446|NCT00359021|364556163|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
105697447|NCT00359021|364556164|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
105697448|NCT00359021|364556163|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
105697449|NCT00359021|364556164|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
105697450|NCT00359021|364556163|FG000|Overall Study|Withdrawal by Subject|2|||
105697451|NCT00359021|364556164|FG001|Overall Study|Withdrawal by Subject|9|||
105697452|NCT00359021|364556163|FG000|Overall Study|Lost to Follow-up|1|||
105697453|NCT00359021|364556164|FG001|Overall Study|Lost to Follow-up|0|||
105697454|NCT00359021|364556163|FG000|Overall Study|Other|4|||
105697455|NCT00359021|364556164|FG001|Overall Study|Other|1|||
105697456|NCT00359021|364556163|FG000|Overall Study|Pregnancy|1|||
105697457|NCT00359021|364556164|FG001|Overall Study|Pregnancy|0|||
105697458|NCT01537198|364556172|FG000|Overall Study|RSV infection|2|||
105697459|NCT01537198|364556172|FG000|Overall Study|Adverse Event|4|||
105697460|NCT01537198|364556172|FG000|Overall Study|No Further Visits to the Clinic|37|||
105697461|NCT01537198|364556172|FG000|Overall Study|Other|111|||
105697462|NCT00766090|364556173|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697463|NCT00766090|364556174|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697464|NCT00766090|364556175|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697465|NCT00766090|364556176|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697466|NCT00766090|364556177|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697467|NCT00766090|364556178|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697468|NCT00766090|364556179|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697469|NCT00766090|364556180|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697470|NCT00766090|364556181|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
105697471|NCT00766090|364556182|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697472|NCT00766090|364556183|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697473|NCT00766090|364556184|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105697474|NCT00766090|364556173|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
105697475|NCT00766090|364556174|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697476|NCT00766090|364556175|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105923134|NCT02711137|365380616|FG008|Overall Study|Physician Decision|1|||
105697477|NCT00766090|364556176|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697478|NCT00766090|364556177|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697479|NCT00766090|364556178|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697480|NCT00766090|364556179|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697481|NCT00766090|364556180|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697482|NCT00766090|364556181|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697483|NCT00766090|364556182|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697484|NCT00766090|364556183|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697485|NCT00766090|364556184|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
105697486|NCT00766090|364556173|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105697487|NCT00766090|364556174|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697488|NCT00766090|364556175|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697489|NCT00766090|364556176|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105697490|NCT00766090|364556177|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697491|NCT00766090|364556178|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697492|NCT00766090|364556179|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697493|NCT00766090|364556180|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697494|NCT00766090|364556181|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697495|NCT00766090|364556182|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697496|NCT00766090|364556183|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697497|NCT00766090|364556184|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105697498|NCT00766090|364556173|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697499|NCT00766090|364556174|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697500|NCT00766090|364556175|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
105697501|NCT00766090|364556176|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697502|NCT00766090|364556177|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697503|NCT00766090|364556178|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697504|NCT00766090|364556179|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697505|NCT00766090|364556180|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697506|NCT00766090|364556181|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697507|NCT00766090|364556182|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697508|NCT00766090|364556183|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697509|NCT00766090|364556184|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
105697510|NCT00766090|364556173|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697511|NCT00766090|364556174|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697512|NCT00766090|364556175|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697513|NCT00766090|364556176|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697514|NCT00766090|364556177|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
105697515|NCT00766090|364556178|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697516|NCT00766090|364556179|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697517|NCT00766090|364556180|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697518|NCT00766090|364556181|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697519|NCT00766090|364556182|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697520|NCT00766090|364556183|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697521|NCT00766090|364556184|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105697522|NCT00766090|364556173|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697523|NCT00766090|364556174|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697524|NCT00766090|364556175|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
105697525|NCT00766090|364556176|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697526|NCT00766090|364556177|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697527|NCT00766090|364556178|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697528|NCT00766090|364556179|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697529|NCT00766090|364556180|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697530|NCT00766090|364556181|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697531|NCT00766090|364556182|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697532|NCT00766090|364556183|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697533|NCT00766090|364556184|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
105697534|NCT00766090|364556173|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
105697535|NCT00766090|364556174|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
105697536|NCT00766090|364556175|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
105697537|NCT00766090|364556176|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
105697538|NCT00766090|364556177|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
105697539|NCT00766090|364556178|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
105697540|NCT00766090|364556179|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
105697541|NCT00766090|364556180|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
105697542|NCT00766090|364556181|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
105697543|NCT00766090|364556182|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
105697544|NCT00766090|364556183|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
105697545|NCT00766090|364556184|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
105697546|NCT00766090|364556173|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697547|NCT00766090|364556174|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697548|NCT00766090|364556175|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697549|NCT00766090|364556176|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697550|NCT00766090|364556177|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697551|NCT00766090|364556178|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
105697552|NCT00766090|364556179|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697553|NCT00766090|364556180|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697554|NCT00766090|364556181|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697555|NCT00766090|364556182|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697556|NCT00766090|364556183|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697557|NCT00766090|364556184|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
105697558|NCT00766090|364556173|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697559|NCT00766090|364556174|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
105697560|NCT00766090|364556175|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697561|NCT00766090|364556176|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
105697562|NCT00766090|364556177|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697563|NCT00766090|364556178|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697564|NCT00766090|364556179|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697565|NCT00766090|364556180|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697566|NCT00766090|364556181|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697567|NCT00766090|364556182|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697568|NCT00766090|364556183|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
105697569|NCT00766090|364556184|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
105697570|NCT00766090|364556173|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697571|NCT00766090|364556174|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697572|NCT00766090|364556175|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697573|NCT00766090|364556176|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697574|NCT00766090|364556177|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
105697575|NCT00766090|364556178|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697576|NCT00766090|364556179|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697577|NCT00766090|364556180|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697578|NCT00766090|364556181|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697579|NCT00766090|364556182|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697580|NCT00766090|364556183|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697581|NCT00766090|364556184|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
105697582|NCT01221727|364556185|FG000|Overall Study|Physician Decision|2|||
105697583|NCT01221727|364556186|FG001|Overall Study|Physician Decision|0|||
105697584|NCT01221727|364556185|FG000|Overall Study|Withdrawal by Subject|1|||
105697585|NCT01221727|364556186|FG001|Overall Study|Withdrawal by Subject|1|||
105923135|NCT02711137|365380617|FG009|Overall Study|Physician Decision|1|||
105923136|NCT02711137|365380618|FG010|Overall Study|Physician Decision|3|||
105923137|NCT02711137|365380619|FG011|Overall Study|Physician Decision|2|||
105923138|NCT02711137|365380620|FG012|Overall Study|Physician Decision|1|||
105923139|NCT02711137|365380621|FG013|Overall Study|Physician Decision|1|||
105923140|NCT02711137|365380622|FG014|Overall Study|Physician Decision|2|||
105923141|NCT02711137|365380608|FG000|Overall Study|Other|0|||
105923142|NCT02711137|365380609|FG001|Overall Study|Other|1|||
105923143|NCT02711137|365380610|FG002|Overall Study|Other|0|||
105923144|NCT02711137|365380611|FG003|Overall Study|Other|0|||
105923145|NCT02711137|365380612|FG004|Overall Study|Other|0|||
105923146|NCT02711137|365380613|FG005|Overall Study|Other|0|||
105923147|NCT02711137|365380614|FG006|Overall Study|Other|3|||
105923148|NCT02711137|365380615|FG007|Overall Study|Other|0|||
105923149|NCT02711137|365380616|FG008|Overall Study|Other|0|||
105923150|NCT02711137|365380617|FG009|Overall Study|Other|0|||
105923151|NCT02711137|365380618|FG010|Overall Study|Other|0|||
105923152|NCT02711137|365380619|FG011|Overall Study|Other|0|||
105923153|NCT02711137|365380620|FG012|Overall Study|Other|0|||
105923154|NCT02711137|365380621|FG013|Overall Study|Other|0|||
105923155|NCT02711137|365380622|FG014|Overall Study|Other|1|||
105923156|NCT02711137|365380608|FG000|Overall Study|Withdrawal by Subject|1|||
105923157|NCT02711137|365380609|FG001|Overall Study|Withdrawal by Subject|0|||
105697586|NCT02566577|364556188|FG000|Overall Study|Withdrawal by Subject|1|||
105697587|NCT02566577|364556189|FG001|Overall Study|Withdrawal by Subject|1|||
105697588|NCT02566577|364556188|FG000|Overall Study|Equipment failure|1|||
105923158|NCT02711137|365380610|FG002|Overall Study|Withdrawal by Subject|0|||
105923159|NCT02711137|365380611|FG003|Overall Study|Withdrawal by Subject|1|||
105923160|NCT02711137|365380612|FG004|Overall Study|Withdrawal by Subject|1|||
105923161|NCT02711137|365380613|FG005|Overall Study|Withdrawal by Subject|0|||
105923162|NCT02711137|365380614|FG006|Overall Study|Withdrawal by Subject|7|||
105923163|NCT02711137|365380615|FG007|Overall Study|Withdrawal by Subject|0|||
105697589|NCT02566577|364556189|FG001|Overall Study|Equipment failure|1|||
105697590|NCT02566577|364556188|FG000|Overall Study|Physical limitation|1|||
106005013|NCT01751061|365682627|FG001|Overall Study|Lost to Follow-up|25|||
106005014|NCT01751061|365682626|FG000|Overall Study|patient regained decisional capacity|4|||
106005015|NCT01751061|365682627|FG001|Overall Study|patient regained decisional capacity|8|||
105697591|NCT02566577|364556189|FG001|Overall Study|Physical limitation|0|||
105697592|NCT03654976|364556198|FG000|Overall Study|Withdrawal by Subject|12|||
105697593|NCT03654976|364556199|FG001|Overall Study|Withdrawal by Subject|11|||
105697594|NCT03654976|364556198|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
105697595|NCT03654976|364556199|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
106005016|NCT01751061|365682626|FG000|Overall Study|Withdrawal by Subject|4|||
105697596|NCT03654976|364556198|FG000|Overall Study|Adverse Event|5|||
105697597|NCT03654976|364556199|FG001|Overall Study|Adverse Event|0|||
105697598|NCT03654976|364556198|FG000|Overall Study|Lost to Follow-up|2|||
105697599|NCT03654976|364556199|FG001|Overall Study|Lost to Follow-up|0|||
105697600|NCT03654976|364556198|FG000|Overall Study|Lack of Efficacy|0|||
105697601|NCT03654976|364556199|FG001|Overall Study|Lack of Efficacy|1|||
105697602|NCT00898443|364556200|FG000|Overall Study|Withdrawal by Subject|1|||
105697603|NCT00898443|364556201|FG001|Overall Study|Withdrawal by Subject|0|||
105697604|NCT00078325|364556204|FG000|Overall Study|Adverse Event|15|||
105697605|NCT00078325|364556205|FG001|Overall Study|Adverse Event|10|||
105697606|NCT00078325|364556206|FG002|Overall Study|Adverse Event|5|||
105697607|NCT00078325|364556204|FG000|Overall Study|Protocol Violation|2|||
105697608|NCT00078325|364556205|FG001|Overall Study|Protocol Violation|2|||
106005017|NCT01751061|365682627|FG001|Overall Study|Withdrawal by Subject|1|||
106005018|NCT01751061|365682626|FG000|Overall Study|Physician Decision|2|||
106005019|NCT01751061|365682627|FG001|Overall Study|Physician Decision|0|||
106005020|NCT01194830|365682631|FG000|Overall Study|Adverse Event|3|||
106005021|NCT01194830|365682632|FG001|Overall Study|Adverse Event|2|||
106005022|NCT01194830|365682631|FG000|Overall Study|Protocol Violation|5|||
106005023|NCT01194830|365682632|FG001|Overall Study|Protocol Violation|4|||
106005024|NCT01194830|365682631|FG000|Overall Study|Lost to Follow-up|9|||
106005025|NCT01194830|365682632|FG001|Overall Study|Lost to Follow-up|7|||
106005026|NCT01194830|365682631|FG000|Overall Study|Withdrawal by Subject|2|||
106005027|NCT01194830|365682632|FG001|Overall Study|Withdrawal by Subject|1|||
106005028|NCT01194830|365682631|FG000|Overall Study|Lack of Efficacy|1|||
106005029|NCT01194830|365682632|FG001|Overall Study|Lack of Efficacy|1|||
106005030|NCT01194830|365682631|FG000|Overall Study|Non-compliance issues|4|||
106005031|NCT01194830|365682632|FG001|Overall Study|Non-compliance issues|4|||
106005032|NCT01194830|365682631|FG000|Overall Study|Other Reason|12|||
106005033|NCT01194830|365682632|FG001|Overall Study|Other Reason|8|||
106005034|NCT03115359|365682633|FG000|Overall Study|Withdrawal by Subject|29|||
106005035|NCT03115359|365682634|FG001|Overall Study|Withdrawal by Subject|39|||
106005036|NCT03115359|365682633|FG000|Overall Study|Scheduling conflict|25|||
106005037|NCT03115359|365682634|FG001|Overall Study|Scheduling conflict|23|||
106005038|NCT03115359|365682633|FG000|Overall Study|Personal reasons including health|12|||
105697609|NCT00078325|364556206|FG002|Overall Study|Protocol Violation|0|||
105697610|NCT00078325|364556204|FG000|Overall Study|Withdrawal by Subject|1|||
105697611|NCT00078325|364556205|FG001|Overall Study|Withdrawal by Subject|5|||
105697612|NCT00078325|364556206|FG002|Overall Study|Withdrawal by Subject|3|||
105697613|NCT00078325|364556204|FG000|Overall Study|Lost to Follow-up|0|||
105697614|NCT00078325|364556205|FG001|Overall Study|Lost to Follow-up|1|||
106005039|NCT03115359|365682634|FG001|Overall Study|Personal reasons including health|9|||
106005040|NCT03115359|365682633|FG000|Overall Study|Transportation barriers|3|||
106005041|NCT03115359|365682634|FG001|Overall Study|Transportation barriers|0|||
105697615|NCT00078325|364556206|FG002|Overall Study|Lost to Follow-up|1|||
105697616|NCT00078325|364556204|FG000|Overall Study|Physician Decision|2|||
105697617|NCT00078325|364556205|FG001|Overall Study|Physician Decision|0|||
105697618|NCT00078325|364556206|FG002|Overall Study|Physician Decision|1|||
106005042|NCT03115359|365682633|FG000|Overall Study|No longer interested|5|||
106005043|NCT03115359|365682634|FG001|Overall Study|No longer interested|4|||
106005044|NCT03115359|365682633|FG000|Overall Study|No reason provided|45|||
106132744|NCT04672460|366144746|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
105697619|NCT00078325|364556204|FG000|Overall Study|Miscellaneous|1|||
105697620|NCT00078325|364556205|FG001|Overall Study|Miscellaneous|1|||
105697621|NCT00078325|364556206|FG002|Overall Study|Miscellaneous|1|||
105697622|NCT02625233|364556207|FG000|Overall Study|Adverse Event|2|||
105697623|NCT02625233|364556208|FG001|Overall Study|Adverse Event|0|||
105697624|NCT01436084|364556209|FG000|Overall Study|Disease Progression|2|||
105697625|NCT01436084|364556209|FG000|Overall Study|Withdrawal by Subject|1|||
105697626|NCT01436084|364556209|FG000|Overall Study|Early Closure of Study|1|||
106005045|NCT03115359|365682634|FG001|Overall Study|No reason provided|47|||
106005046|NCT03284710|365682639|FG000|Overall Study|Withdrawal by Subject|1|||
106005047|NCT03284710|365682640|FG001|Overall Study|Withdrawal by Subject|0|||
106005048|NCT03284710|365682641|FG002|Overall Study|Withdrawal by Subject|1|||
106005049|NCT03284710|365682642|FG003|Overall Study|Withdrawal by Subject|6|||
106005050|NCT03284710|365682639|FG000|Overall Study|Lost to Follow-up|3|||
106005051|NCT03284710|365682640|FG001|Overall Study|Lost to Follow-up|3|||
105697627|NCT00445224|364556215|FG000|Specific Exercises|Withdrawal by Subject|3|||
105697628|NCT00445224|364556216|FG001|Specific Exercises|Withdrawal by Subject|3|||
105697629|NCT00445224|364556215|FG000|Specific Exercises|Withdrawal by Subject|1|||
105697630|NCT00445224|364556216|FG001|Specific Exercises|Withdrawal by Subject|0|||
105697631|NCT02046096|364556217|FG000|Overall Study|Death|28|||
105697632|NCT02046096|364556218|FG001|Overall Study|Death|45|||
105697633|NCT02046096|364556217|FG000|Overall Study|Lost to Follow-up|9|||
105697634|NCT02046096|364556218|FG001|Overall Study|Lost to Follow-up|20|||
105697635|NCT02046096|364556217|FG000|Overall Study|Withdrawal by Subject|5|||
105697636|NCT02046096|364556218|FG001|Overall Study|Withdrawal by Subject|17|||
105697637|NCT02046096|364556217|FG000|Overall Study|Other endpoint|2|||
105697638|NCT02046096|364556218|FG001|Overall Study|Other endpoint|19|||
105697639|NCT00943579|364556219|FG000|Overall Study|Adverse Event|4|||
105697640|NCT00943579|364556220|FG001|Overall Study|Adverse Event|3|||
105697641|NCT00943579|364556219|FG000|Overall Study|Lack of Efficacy|2|||
105697642|NCT00943579|364556220|FG001|Overall Study|Lack of Efficacy|2|||
105697643|NCT03337542|364556225|FG000|Overall Study|Withdrew Consent|17|||
105697644|NCT03337542|364556225|FG000|Overall Study|Allergic Adverse Event|1|||
105697645|NCT03337542|364556225|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
105697646|NCT03337542|364556225|FG000|Overall Study|Lost to Follow-up|1|||
105697647|NCT03337542|364556225|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
105697648|NCT00121108|364556226|FG000|Overall Study|Lost to Follow-up|10|||
105697649|NCT00121108|364556227|FG001|Overall Study|Lost to Follow-up|22|||
105697650|NCT00121108|364556226|FG000|Overall Study|Withdrawal by Subject|106|||
105697651|NCT00121108|364556227|FG001|Overall Study|Withdrawal by Subject|195|||
105697652|NCT00121108|364556226|FG000|Overall Study|Death|5|||
105697653|NCT00121108|364556227|FG001|Overall Study|Death|8|||
105697654|NCT01380379|364556228|FG000|Overall Study|Pregnancy|1|||
105697655|NCT02779855|364556235|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
105697656|NCT02779855|364556236|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
105697657|NCT02779855|364556237|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
105697658|NCT02229539|364557339|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
105697659|NCT02229539|364557340|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
105697660|NCT02229539|364557341|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
105697661|NCT02229539|364557339|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
105697662|NCT02229539|364557340|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
105697663|NCT02229539|364557341|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
105697664|NCT02229539|364557339|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
105697665|NCT02229539|364557340|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
105697666|NCT02229539|364557341|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
105697667|NCT02229539|364557339|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
105697668|NCT02229539|364557340|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
105697669|NCT02229539|364557341|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
105697670|NCT02229539|364557339|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
105697671|NCT02229539|364557340|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
105697672|NCT02229539|364557341|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
105697673|NCT02229539|364557339|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
105697674|NCT02229539|364557340|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
105697675|NCT02229539|364557341|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
105697676|NCT00938717|364557343|FG000|Overall Study|Adverse Event|10|||
105697677|NCT00938717|364557344|FG001|Overall Study|Adverse Event|41|||
105697678|NCT00938717|364557343|FG000|Overall Study|Protocol Violation|11|||
105697679|NCT00938717|364557344|FG001|Overall Study|Protocol Violation|8|||
105697680|NCT00938717|364557343|FG000|Overall Study|Withdrawal by Subject|26|||
105697681|NCT00938717|364557344|FG001|Overall Study|Withdrawal by Subject|24|||
105697682|NCT00938717|364557343|FG000|Overall Study|Lost to Follow-up|13|||
105697683|NCT00938717|364557344|FG001|Overall Study|Lost to Follow-up|18|||
105697684|NCT00938717|364557343|FG000|Overall Study|Lack of Efficacy|33|||
105697685|NCT00938717|364557344|FG001|Overall Study|Lack of Efficacy|15|||
105697686|NCT00938717|364557343|FG000|Overall Study|Other reason|5|||
105697687|NCT00938717|364557344|FG001|Overall Study|Other reason|2|||
105697688|NCT02230254|364557347|FG000|Overall Study|Lost to Follow-up|3|||
105697689|NCT02023242|364557349|FG000|Overall Study|Lost to Follow-up|3|||
105697690|NCT02023242|364557350|FG001|Overall Study|Lost to Follow-up|1|||
105697691|NCT02023242|364557349|FG000|Overall Study|Death|0|||
105697692|NCT02023242|364557350|FG001|Overall Study|Death|1|||
105923164|NCT02711137|365380616|FG008|Overall Study|Withdrawal by Subject|0|||
105923165|NCT02711137|365380617|FG009|Overall Study|Withdrawal by Subject|0|||
105923166|NCT02711137|365380618|FG010|Overall Study|Withdrawal by Subject|0|||
105923167|NCT02711137|365380619|FG011|Overall Study|Withdrawal by Subject|0|||
105923168|NCT02711137|365380620|FG012|Overall Study|Withdrawal by Subject|0|||
105923169|NCT02711137|365380621|FG013|Overall Study|Withdrawal by Subject|1|||
105923170|NCT02711137|365380622|FG014|Overall Study|Withdrawal by Subject|0|||
105923171|NCT02711137|365380608|FG000|Overall Study|Lost to Follow-up|1|||
105923172|NCT02711137|365380609|FG001|Overall Study|Lost to Follow-up|0|||
105923173|NCT02711137|365380610|FG002|Overall Study|Lost to Follow-up|0|||
105923174|NCT02711137|365380611|FG003|Overall Study|Lost to Follow-up|0|||
105923175|NCT02711137|365380612|FG004|Overall Study|Lost to Follow-up|0|||
105923176|NCT02711137|365380613|FG005|Overall Study|Lost to Follow-up|0|||
105923177|NCT02711137|365380614|FG006|Overall Study|Lost to Follow-up|2|||
105923178|NCT02711137|365380615|FG007|Overall Study|Lost to Follow-up|0|||
105923179|NCT02711137|365380616|FG008|Overall Study|Lost to Follow-up|0|||
105923180|NCT02711137|365380617|FG009|Overall Study|Lost to Follow-up|0|||
105923181|NCT02711137|365380618|FG010|Overall Study|Lost to Follow-up|0|||
105923182|NCT02711137|365380619|FG011|Overall Study|Lost to Follow-up|0|||
105923183|NCT02711137|365380620|FG012|Overall Study|Lost to Follow-up|0|||
105923184|NCT02711137|365380621|FG013|Overall Study|Lost to Follow-up|0|||
105923185|NCT02711137|365380622|FG014|Overall Study|Lost to Follow-up|0|||
105923186|NCT00548327|365380623|FG000|Overall Study|Adverse Event|0|||
105923187|NCT00548327|365380624|FG001|Overall Study|Adverse Event|1|||
105923188|NCT00274456|365380628|FG000|Overall Study|Still on treatment|2|||
105923189|NCT00274456|365380629|FG001|Overall Study|Still on treatment|3|||
105923190|NCT00274456|365380630|FG002|Overall Study|Still on treatment|5|||
105923191|NCT00274456|365380631|FG003|Overall Study|Still on treatment|1|||
105923192|NCT00274456|365380628|FG000|Overall Study|Unacceptable toxicity|10|||
105923193|NCT00274456|365380629|FG001|Overall Study|Unacceptable toxicity|5|||
105923194|NCT00274456|365380630|FG002|Overall Study|Unacceptable toxicity|12|||
105923195|NCT00274456|365380631|FG003|Overall Study|Unacceptable toxicity|16|||
105923196|NCT00274456|365380628|FG000|Overall Study|Adverse Event|0|||
105923197|NCT00274456|365380629|FG001|Overall Study|Adverse Event|1|||
105923198|NCT00274456|365380630|FG002|Overall Study|Adverse Event|2|||
105923199|NCT00274456|365380631|FG003|Overall Study|Adverse Event|2|||
105923200|NCT00274456|365380628|FG000|Overall Study|Physician Decision|7|||
105923201|NCT00274456|365380629|FG001|Overall Study|Physician Decision|5|||
105923202|NCT00274456|365380630|FG002|Overall Study|Physician Decision|6|||
105923203|NCT00274456|365380631|FG003|Overall Study|Physician Decision|13|||
105923204|NCT00274456|365380628|FG000|Overall Study|Lost to Follow-up|0|||
105923205|NCT00274456|365380629|FG001|Overall Study|Lost to Follow-up|0|||
105923206|NCT00274456|365380630|FG002|Overall Study|Lost to Follow-up|1|||
105923207|NCT00274456|365380631|FG003|Overall Study|Lost to Follow-up|0|||
105923208|NCT00274456|365380628|FG000|Overall Study|Withdrawal by Subject|18|||
105923209|NCT00274456|365380629|FG001|Overall Study|Withdrawal by Subject|13|||
105923210|NCT00274456|365380630|FG002|Overall Study|Withdrawal by Subject|9|||
105923211|NCT00274456|365380631|FG003|Overall Study|Withdrawal by Subject|13|||
105923212|NCT02194465|365380632|FG000|Overall Study|Adverse Event|6|||
105923213|NCT02194465|365380633|FG001|Overall Study|Adverse Event|1|||
105923214|NCT02194465|365380634|FG002|Overall Study|Adverse Event|4|||
105923215|NCT02194465|365380635|FG003|Overall Study|Adverse Event|4|||
105923216|NCT02194465|365380636|FG004|Overall Study|Adverse Event|4|||
105923217|NCT02194465|365380637|FG005|Overall Study|Adverse Event|2|||
105923218|NCT02194465|365380638|FG006|Overall Study|Adverse Event|0|||
105923219|NCT02194465|365380632|FG000|Overall Study|Lost to Follow-up|0|||
105923220|NCT02194465|365380633|FG001|Overall Study|Lost to Follow-up|0|||
105923221|NCT02194465|365380634|FG002|Overall Study|Lost to Follow-up|0|||
105923222|NCT02194465|365380635|FG003|Overall Study|Lost to Follow-up|1|||
105923223|NCT02194465|365380636|FG004|Overall Study|Lost to Follow-up|0|||
105923224|NCT02194465|365380637|FG005|Overall Study|Lost to Follow-up|1|||
105923225|NCT02194465|365380638|FG006|Overall Study|Lost to Follow-up|0|||
105923226|NCT02194465|365380632|FG000|Overall Study|Physician Decision|1|||
105923227|NCT02194465|365380633|FG001|Overall Study|Physician Decision|0|||
105923228|NCT02194465|365380634|FG002|Overall Study|Physician Decision|0|||
105923229|NCT02194465|365380635|FG003|Overall Study|Physician Decision|0|||
105923230|NCT02194465|365380636|FG004|Overall Study|Physician Decision|0|||
105923231|NCT02194465|365380637|FG005|Overall Study|Physician Decision|0|||
105923232|NCT02194465|365380638|FG006|Overall Study|Physician Decision|0|||
105923233|NCT02194465|365380632|FG000|Overall Study|Protocol Violation|1|||
105923234|NCT02194465|365380633|FG001|Overall Study|Protocol Violation|1|||
105923235|NCT02194465|365380634|FG002|Overall Study|Protocol Violation|2|||
105923236|NCT02194465|365380635|FG003|Overall Study|Protocol Violation|1|||
105923237|NCT02194465|365380636|FG004|Overall Study|Protocol Violation|1|||
105923238|NCT02194465|365380637|FG005|Overall Study|Protocol Violation|0|||
105923239|NCT02194465|365380638|FG006|Overall Study|Protocol Violation|0|||
105923240|NCT02194465|365380632|FG000|Overall Study|Withdrawal by Subject|1|||
105923241|NCT02194465|365380633|FG001|Overall Study|Withdrawal by Subject|3|||
105923242|NCT02194465|365380634|FG002|Overall Study|Withdrawal by Subject|1|||
105923243|NCT02194465|365380635|FG003|Overall Study|Withdrawal by Subject|2|||
105923244|NCT02194465|365380636|FG004|Overall Study|Withdrawal by Subject|2|||
105923245|NCT02194465|365380637|FG005|Overall Study|Withdrawal by Subject|1|||
105923246|NCT02194465|365380638|FG006|Overall Study|Withdrawal by Subject|2|||
105923247|NCT02194465|365380632|FG000|Overall Study|Discontinued follow-up period|0|||
105923248|NCT02194465|365380633|FG001|Overall Study|Discontinued follow-up period|2|||
105923249|NCT02194465|365380634|FG002|Overall Study|Discontinued follow-up period|1|||
105923250|NCT02194465|365380635|FG003|Overall Study|Discontinued follow-up period|0|||
105923251|NCT02194465|365380636|FG004|Overall Study|Discontinued follow-up period|2|||
105923252|NCT02194465|365380637|FG005|Overall Study|Discontinued follow-up period|0|||
105923253|NCT02194465|365380638|FG006|Overall Study|Discontinued follow-up period|0|||
105923254|NCT00961064|365380639|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
105923255|NCT00961064|365380639|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
105923256|NCT00961064|365380639|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
105923257|NCT00961064|365380639|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
105697777|NCT02713542|364557361|FG000|Overall Study|Use of prohibited medication|14|||
105697778|NCT02713542|364557362|FG001|Overall Study|Use of prohibited medication|5|||
105697779|NCT02713542|364557361|FG000|Overall Study|Withdrawal by Subject|4|||
105697780|NCT02713542|364557362|FG001|Overall Study|Withdrawal by Subject|1|||
105697781|NCT01555151|364557365|FG000|Overall Study|Withdrawal by Subject|6|||
105697782|NCT01555151|364557366|FG001|Overall Study|Withdrawal by Subject|2|||
105697783|NCT01555151|364557367|FG002|Overall Study|Withdrawal by Subject|0|||
105697784|NCT01555151|364557368|FG003|Overall Study|Withdrawal by Subject|2|||
105697785|NCT01555151|364557365|FG000|Overall Study|Administrative|3|||
105697786|NCT01555151|364557366|FG001|Overall Study|Administrative|1|||
105697787|NCT01555151|364557367|FG002|Overall Study|Administrative|2|||
105697788|NCT01555151|364557368|FG003|Overall Study|Administrative|0|||
105697789|NCT01555151|364557365|FG000|Overall Study|Protocol Violation|3|||
105697790|NCT01555151|364557366|FG001|Overall Study|Protocol Violation|3|||
105697791|NCT01555151|364557367|FG002|Overall Study|Protocol Violation|3|||
105697792|NCT01555151|364557368|FG003|Overall Study|Protocol Violation|5|||
105697793|NCT01555151|364557365|FG000|Overall Study|Adverse Event|1|||
105697794|NCT01555151|364557366|FG001|Overall Study|Adverse Event|2|||
105697795|NCT01555151|364557367|FG002|Overall Study|Adverse Event|1|||
105697796|NCT01555151|364557368|FG003|Overall Study|Adverse Event|2|||
105697797|NCT01555151|364557365|FG000|Overall Study|Lost to Follow-up|0|||
105697798|NCT01555151|364557366|FG001|Overall Study|Lost to Follow-up|0|||
105697799|NCT01555151|364557367|FG002|Overall Study|Lost to Follow-up|0|||
105697800|NCT01555151|364557368|FG003|Overall Study|Lost to Follow-up|1|||
105697801|NCT01576172|364557369|FG000|Overall Study|Ineligible|2|||
105697802|NCT01576172|364557370|FG001|Overall Study|Ineligible|1|||
105697803|NCT01576172|364557369|FG000|Overall Study|Withdrawal by Subject|2|||
105697804|NCT01576172|364557370|FG001|Overall Study|Withdrawal by Subject|0|||
105697805|NCT01576172|364557369|FG000|Overall Study|Insurance issue|1|||
105697806|NCT01576172|364557370|FG001|Overall Study|Insurance issue|0|||
105697807|NCT00800436|364557373|FG000|Overall Study|Withdrawal by Subject|0|||
105697808|NCT00800436|364557374|FG001|Overall Study|Withdrawal by Subject|0|||
105697809|NCT00800436|364557375|FG002|Overall Study|Withdrawal by Subject|1|||
105697810|NCT00800436|364557376|FG003|Overall Study|Withdrawal by Subject|1|||
105697811|NCT00800436|364557377|FG004|Overall Study|Withdrawal by Subject|0|||
105697812|NCT00800436|364557378|FG005|Overall Study|Withdrawal by Subject|0|||
105697813|NCT00800436|364557379|FG006|Overall Study|Withdrawal by Subject|0|||
105697814|NCT03680911|364557385|FG000|At Home Treatment|Study Termination|3|||
105697815|NCT03680911|364557386|FG001|At Home Treatment|Study Termination|0|||
105697816|NCT03680911|364557385|FG000|At Home Treatment|Lost to Follow-up|0|||
105697817|NCT03680911|364557386|FG001|At Home Treatment|Lost to Follow-up|1|||
105697818|NCT03680911|364557385|FG000|At Home Treatment|Withdrawal by Subject|0|||
105697819|NCT03680911|364557386|FG001|At Home Treatment|Withdrawal by Subject|2|||
105697820|NCT03680911|364557385|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
105697821|NCT03680911|364557386|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
105697822|NCT03024970|364557389|FG000|First Intervention|Adverse Event|1|||
105697823|NCT03024970|364557390|FG001|First Intervention|Adverse Event|0|||
105697824|NCT03024970|364557389|FG000|Second Intervention|Lost to Follow-up|1|||
105697825|NCT03024970|364557390|FG001|Second Intervention|Lost to Follow-up|0|||
105697826|NCT00356889|364557392|FG000|Overall Study|Protocol Violation|2|||
105697827|NCT00356889|364557392|FG000|Overall Study|Adverse Event|1|||
105697828|NCT03123250|364557393|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
105697829|NCT03199040|364557394|FG000|Overall Study|Lack of Efficacy|2|||
105697830|NCT03199040|364557395|FG001|Overall Study|Lack of Efficacy|0|||
105697831|NCT03199040|364557394|FG000|Overall Study|Withdrawal by Subject|2|||
105697832|NCT03199040|364557395|FG001|Overall Study|Withdrawal by Subject|0|||
105697833|NCT03199040|364557394|FG000|Overall Study|Adverse Event|0|||
105697834|NCT03199040|364557395|FG001|Overall Study|Adverse Event|1|||
105697835|NCT03199040|364557394|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
105697836|NCT03199040|364557395|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
105697837|NCT01226459|364557396|FG000|Overall Study|Adverse Event|2|||
105697838|NCT01226459|364557397|FG001|Overall Study|Adverse Event|8|||
105697839|NCT01226459|364557396|FG000|Overall Study|Protocol Violation|4|||
105697840|NCT01226459|364557397|FG001|Overall Study|Protocol Violation|3|||
105787163|NCT03110107|364874891|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
105697841|NCT01226459|364557396|FG000|Overall Study|Withdrawal by Subject|10|||
105697842|NCT01226459|364557397|FG001|Overall Study|Withdrawal by Subject|13|||
105697843|NCT01226459|364557396|FG000|Overall Study|Lost to Follow-up|4|||
105697844|NCT01226459|364557397|FG001|Overall Study|Lost to Follow-up|8|||
105697845|NCT01226459|364557396|FG000|Overall Study|Pregnancy|1|||
105697846|NCT01226459|364557397|FG001|Overall Study|Pregnancy|0|||
105697847|NCT03700320|364557401|FG000|Overall Study|Adverse Event|5|||
105697848|NCT03700320|364557402|FG001|Overall Study|Adverse Event|31|||
105697849|NCT03700320|364557401|FG000|Overall Study|Lack of Efficacy|2|||
105697850|NCT03700320|364557402|FG001|Overall Study|Lack of Efficacy|5|||
105697851|NCT03700320|364557401|FG000|Overall Study|Withdrawal by Subject|29|||
105697852|NCT03700320|364557402|FG001|Overall Study|Withdrawal by Subject|75|||
105697853|NCT03700320|364557401|FG000|Overall Study|Lost to Follow-up|16|||
105697854|NCT03700320|364557402|FG001|Overall Study|Lost to Follow-up|23|||
105697855|NCT03700320|364557401|FG000|Overall Study|Pregnancy|2|||
105697856|NCT03700320|364557402|FG001|Overall Study|Pregnancy|4|||
105697857|NCT03700320|364557401|FG000|Overall Study|Protocol Deviation|7|||
105697858|NCT03700320|364557402|FG001|Overall Study|Protocol Deviation|31|||
105697859|NCT03700320|364557401|FG000|Overall Study|Non-compliance with Study Drug|1|||
105697860|NCT03700320|364557402|FG001|Overall Study|Non-compliance with Study Drug|3|||
105697861|NCT03700320|364557401|FG000|Overall Study|Reason not Specified|0|||
105697862|NCT03700320|364557402|FG001|Overall Study|Reason not Specified|1|||
105697863|NCT04688775|364557405|FG000|Placebo-controlled Period|Randomized, not treated|1|||
105697864|NCT04688775|364557406|FG001|Placebo-controlled Period|Randomized, not treated|1|||
105697865|NCT04688775|364557407|FG002|Placebo-controlled Period|Randomized, not treated|0|||
105697866|NCT04688775|364557408|FG003|Placebo-controlled Period|Randomized, not treated|0|||
105697867|NCT04688775|364557405|FG000|Placebo-controlled Period|Adverse Event|2|||
105697868|NCT04688775|364557406|FG001|Placebo-controlled Period|Adverse Event|0|||
105697869|NCT04688775|364557407|FG002|Placebo-controlled Period|Adverse Event|0|||
105697870|NCT04688775|364557408|FG003|Placebo-controlled Period|Adverse Event|0|||
105697871|NCT04688775|364557405|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
105697872|NCT04688775|364557406|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
105697873|NCT04688775|364557407|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
105697874|NCT04688775|364557408|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
105697875|NCT04688775|364557405|FG000|Placebo-controlled Period|Protocol Violation|0|||
105697876|NCT04688775|364557406|FG001|Placebo-controlled Period|Protocol Violation|1|||
105697877|NCT04688775|364557407|FG002|Placebo-controlled Period|Protocol Violation|0|||
105697878|NCT04688775|364557408|FG003|Placebo-controlled Period|Protocol Violation|0|||
105697879|NCT04688775|364557405|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
106005052|NCT03284710|365682641|FG002|Overall Study|Lost to Follow-up|1|||
106005053|NCT03284710|365682642|FG003|Overall Study|Lost to Follow-up|0|||
106005054|NCT03284710|365682639|FG000|Overall Study|Physician Decision|1|||
106005055|NCT03284710|365682640|FG001|Overall Study|Physician Decision|0|||
106005056|NCT03284710|365682641|FG002|Overall Study|Physician Decision|0|||
106005057|NCT03284710|365682642|FG003|Overall Study|Physician Decision|0|||
106005058|NCT03284710|365682639|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
106005059|NCT03284710|365682640|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
106005060|NCT03284710|365682641|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
106005061|NCT03284710|365682642|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
106005062|NCT03284710|365682639|FG000|Overall Study|HIV Infection|0|||
106005063|NCT03284710|365682640|FG001|Overall Study|HIV Infection|2|||
106005064|NCT03284710|365682641|FG002|Overall Study|HIV Infection|2|||
106005065|NCT03284710|365682642|FG003|Overall Study|HIV Infection|1|||
106005066|NCT00141453|365682644|FG000|Overall Study|Protocol Violation|6|||
106005067|NCT00141453|365682645|FG001|Overall Study|Protocol Violation|5|||
106005068|NCT00443040|365682648|FG000|Overall Study|Withdrawal by Subject|1|||
106005069|NCT00443040|365682649|FG001|Overall Study|Withdrawal by Subject|0|||
106005070|NCT00443040|365682650|FG002|Overall Study|Withdrawal by Subject|0|||
106005071|NCT00443040|365682648|FG000|Overall Study|Converted to an open laparotomy|3|||
106005072|NCT00443040|365682649|FG001|Overall Study|Converted to an open laparotomy|0|||
106005073|NCT00443040|365682650|FG002|Overall Study|Converted to an open laparotomy|1|||
106005074|NCT02269124|365682654|FG000|Overall Study|Lost to Follow-up|1|||
105697880|NCT04688775|364557406|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
106005075|NCT02269124|365682655|FG001|Overall Study|Lost to Follow-up|0|||
106005076|NCT02269124|365682654|FG000|Overall Study|Withdrawal by Subject|0|||
105697881|NCT04688775|364557407|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
105697882|NCT04688775|364557408|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
105697883|NCT04688775|364557405|FG000|Placebo-controlled Period|Other reasons|0|||
106005077|NCT02269124|365682655|FG001|Overall Study|Withdrawal by Subject|2|||
105697884|NCT04688775|364557406|FG001|Placebo-controlled Period|Other reasons|1|||
105697885|NCT04688775|364557407|FG002|Placebo-controlled Period|Other reasons|0|||
105697886|NCT04688775|364557408|FG003|Placebo-controlled Period|Other reasons|0|||
105697887|NCT04688775|364557405|FG000|Delayed Start Period|Adverse Event|0|||
105697888|NCT04688775|364557406|FG001|Delayed Start Period|Adverse Event|0|||
105697889|NCT04688775|364557407|FG002|Delayed Start Period|Adverse Event|1|||
105697890|NCT04688775|364557408|FG003|Delayed Start Period|Adverse Event|0|||
106005078|NCT03452540|365682656|FG000|Overall Study|Adverse Event|1|||
106005079|NCT03452540|365682656|FG000|Overall Study|Withdrawal by Subject|1|||
106005080|NCT03452540|365682656|FG000|Overall Study|Other SAE and AE|2|||
106005081|NCT04529083|365682660|FG000|Overall Study|Withdrawal by Subject|3|||
106016889|NCT03847896|365725908|FG003|Overall Study|Withdrawal by parent/guardian|0|||
105697891|NCT04688775|364557405|FG000|Delayed Start Period|Lack of Efficacy|0|||
105697892|NCT04688775|364557406|FG001|Delayed Start Period|Lack of Efficacy|0|||
105697893|NCT04688775|364557407|FG002|Delayed Start Period|Lack of Efficacy|0|||
105697894|NCT04688775|364557408|FG003|Delayed Start Period|Lack of Efficacy|3|||
105697895|NCT04688775|364557405|FG000|Delayed Start Period|Withdrawal by Subject|0|||
105697896|NCT04688775|364557406|FG001|Delayed Start Period|Withdrawal by Subject|0|||
105697897|NCT04688775|364557407|FG002|Delayed Start Period|Withdrawal by Subject|2|||
105697898|NCT04688775|364557408|FG003|Delayed Start Period|Withdrawal by Subject|4|||
105697899|NCT04688775|364557405|FG000|Delayed Start Period|Lost to Follow-up|0|||
105697900|NCT04688775|364557406|FG001|Delayed Start Period|Lost to Follow-up|0|||
105697901|NCT04688775|364557407|FG002|Delayed Start Period|Lost to Follow-up|2|||
105697902|NCT04688775|364557408|FG003|Delayed Start Period|Lost to Follow-up|1|||
105697903|NCT04688775|364557405|FG000|Delayed Start Period|other reasons|0|||
105697904|NCT04688775|364557406|FG001|Delayed Start Period|other reasons|0|||
105697905|NCT04688775|364557407|FG002|Delayed Start Period|other reasons|1|||
105697906|NCT04688775|364557408|FG003|Delayed Start Period|other reasons|0|||
105697907|NCT05093322|364557409|FG000|Overall Study|Death|6|||
105697908|NCT05093322|364557410|FG001|Overall Study|Death|2|||
105697909|NCT05093322|364557409|FG000|Overall Study|Other|4|||
105697910|NCT05093322|364557410|FG001|Overall Study|Other|1|||
105697911|NCT03574753|364557413|FG000|Overall Study|Adverse Event|3|||
105697912|NCT03574753|364557413|FG000|Overall Study|Progression/relapse|19|||
105697913|NCT03574753|364557413|FG000|Overall Study|Death|1|||
105697914|NCT02811549|364557414|FG000|Overall Study|Lost to Follow-up|1|||
105697915|NCT02811549|364557414|FG000|Overall Study|Withdrawal by Subject|3|||
105697916|NCT02811549|364557414|FG000|Overall Study|Subject screen failed|4|||
105697917|NCT02811549|364557414|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
105697918|NCT00789880|364557416|FG000|Overall Study|Adverse Event|0|||
105697919|NCT00789880|364557417|FG001|Overall Study|Adverse Event|0|||
105697920|NCT00789880|364557418|FG002|Overall Study|Adverse Event|0|||
105697921|NCT00789880|364557419|FG003|Overall Study|Adverse Event|0|||
105697922|NCT00789880|364557420|FG004|Overall Study|Adverse Event|1|||
105697923|NCT00789880|364557421|FG005|Overall Study|Adverse Event|0|||
105697924|NCT00789880|364557416|FG000|Overall Study|Protocol Violation|0|||
105697925|NCT00789880|364557417|FG001|Overall Study|Protocol Violation|1|||
105697926|NCT00789880|364557418|FG002|Overall Study|Protocol Violation|0|||
105697927|NCT00789880|364557419|FG003|Overall Study|Protocol Violation|1|||
105697928|NCT00789880|364557420|FG004|Overall Study|Protocol Violation|0|||
105697929|NCT00789880|364557421|FG005|Overall Study|Protocol Violation|0|||
105697930|NCT00789880|364557416|FG000|Overall Study|Withdrawal by Subject|1|||
105697931|NCT00789880|364557417|FG001|Overall Study|Withdrawal by Subject|0|||
105697932|NCT00789880|364557418|FG002|Overall Study|Withdrawal by Subject|0|||
105697933|NCT00789880|364557419|FG003|Overall Study|Withdrawal by Subject|0|||
105697934|NCT00789880|364557420|FG004|Overall Study|Withdrawal by Subject|2|||
105697935|NCT00789880|364557421|FG005|Overall Study|Withdrawal by Subject|0|||
105697936|NCT01177683|364557422|FG000|Study Treatment|Disease Progressions during treatment|2|||
105697937|NCT01177683|364557423|FG001|Study Treatment|Disease Progressions during treatment|0|||
105697938|NCT01177683|364557424|FG002|Study Treatment|Disease Progressions during treatment|3|||
105697939|NCT01177683|364557422|FG000|Study Treatment|Adverse Event|0|||
105697940|NCT01177683|364557423|FG001|Study Treatment|Adverse Event|1|||
105697941|NCT01177683|364557424|FG002|Study Treatment|Adverse Event|12|||
105697942|NCT01177683|364557422|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
105697943|NCT01177683|364557423|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
105697944|NCT01177683|364557424|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
105697945|NCT01177683|364557422|FG000|Study Treatment|Alternative therapy|0|||
105697946|NCT01177683|364557423|FG001|Study Treatment|Alternative therapy|0|||
105697947|NCT01177683|364557424|FG002|Study Treatment|Alternative therapy|4|||
105697948|NCT01177683|364557422|FG000|Study Treatment|Physician Decision|1|||
105697949|NCT01177683|364557423|FG001|Study Treatment|Physician Decision|0|||
105697950|NCT01177683|364557424|FG002|Study Treatment|Physician Decision|1|||
105697951|NCT01177683|364557422|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
105697952|NCT01177683|364557423|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
105697953|NCT01177683|364557424|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
105697954|NCT01177683|364557422|FG000|Study Treatment|Symptomatic Deterioration|0|||
105697955|NCT01177683|364557423|FG001|Study Treatment|Symptomatic Deterioration|0|||
106016890|NCT03847896|365725909|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105697956|NCT01177683|364557424|FG002|Study Treatment|Symptomatic Deterioration|1|||
105697957|NCT01177683|364557422|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
105697958|NCT01177683|364557423|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
105697959|NCT01177683|364557424|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
106005082|NCT03305666|365682661|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
106005083|NCT03305666|365682662|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
106005084|NCT00914849|365682663|FG000|Overall Study|Withdrawal by Subject|1|||
106005085|NCT00914849|365682664|FG001|Overall Study|Withdrawal by Subject|0|||
106005086|NCT00914849|365682663|FG000|Overall Study|Not eligible|0|||
106005087|NCT00914849|365682664|FG001|Overall Study|Not eligible|1|||
106005088|NCT01001221|365682665|FG000|Overall Study|Adverse Event|1|||
106005089|NCT01001221|365682666|FG001|Overall Study|Adverse Event|2|||
106005090|NCT01001221|365682667|FG002|Overall Study|Adverse Event|0|||
106005091|NCT01001221|365682668|FG003|Overall Study|Adverse Event|2|||
106005092|NCT01001221|365682669|FG004|Overall Study|Adverse Event|0|||
106132745|NCT04672460|366144747|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
106132746|NCT04672460|366144746|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
106132747|NCT04672460|366144747|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
106132748|NCT04672460|366144746|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
105697960|NCT01177683|364557422|FG000|Follow up|Patient lost to follow up|0|||
105697961|NCT01177683|364557423|FG001|Follow up|Patient lost to follow up|0|||
105697962|NCT01177683|364557424|FG002|Follow up|Patient lost to follow up|2|||
105697963|NCT01177683|364557422|FG000|Follow up|Death|2|||
105697964|NCT01177683|364557423|FG001|Follow up|Death|1|||
105697965|NCT01177683|364557424|FG002|Follow up|Death|7|||
105697966|NCT01177683|364557422|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
105697967|NCT01177683|364557423|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
105697968|NCT01177683|364557424|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
105697969|NCT03472924|364557430|FG000|Overall Study|Adverse Event|1|||
105697970|NCT03472924|364557431|FG001|Overall Study|Adverse Event|0|||
105697971|NCT00427349|364557434|FG000|Overall Study|Lack of Efficacy|23|||
105697972|NCT00427349|364557434|FG000|Overall Study|Adverse Event|14|||
105697973|NCT00427349|364557434|FG000|Overall Study|Death|1|||
105697974|NCT00427349|364557434|FG000|Overall Study|Withdrawal by Subject|3|||
105697975|NCT00427349|364557434|FG000|Overall Study|Alternative therapy|1|||
105697976|NCT00427349|364557434|FG000|Overall Study|Other|2|||
105697977|NCT00427349|364557434|FG000|Overall Study|Ineligible|1|||
105697978|NCT00427349|364557434|FG000|Overall Study|Never started therapy|1|||
105697979|NCT01977820|364557435|FG000|Overall Study|Sponsor terminated the study|1|||
105697980|NCT01977820|364557436|FG001|Overall Study|Sponsor terminated the study|1|||
106132749|NCT04672460|366144747|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
106132750|NCT04672460|366144746|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
106132751|NCT04672460|366144747|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
106132752|NCT04672460|366144746|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
106132753|NCT04672460|366144747|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
106132754|NCT00079937|366144748|FG000|Overall Study|Adverse Event|2|||
106132755|NCT00079937|366144749|FG001|Overall Study|Adverse Event|1|||
106132756|NCT00079937|366144748|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
106132757|NCT00079937|366144749|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
106132758|NCT00079937|366144748|FG000|Overall Study|Subject no longer requires study drug|3|||
106132759|NCT00079937|366144749|FG001|Overall Study|Subject no longer requires study drug|0|||
106132760|NCT00079937|366144748|FG000|Overall Study|Protocol Violation|8|||
106132761|NCT00079937|366144749|FG001|Overall Study|Protocol Violation|6|||
106132762|NCT00079937|366144748|FG000|Overall Study|Withdrawal by Subject|21|||
106132763|NCT00079937|366144749|FG001|Overall Study|Withdrawal by Subject|7|||
106132764|NCT00079937|366144748|FG000|Overall Study|Lost to Follow-up|12|||
106132765|NCT00079937|366144749|FG001|Overall Study|Lost to Follow-up|5|||
105697981|NCT00698997|364557438|FG000|Overall Study|Lost to Follow-up|3|||
105697982|NCT00698997|364557439|FG001|Overall Study|Lost to Follow-up|0|||
105697983|NCT00698997|364557438|FG000|Overall Study|Withdrawal by Subject|7|||
105697984|NCT00698997|364557439|FG001|Overall Study|Withdrawal by Subject|27|||
105697985|NCT05082376|364557442|FG000|Overall Study|Lost to Follow-up|2|||
106005093|NCT01001221|365682665|FG000|Overall Study|Disease progression|3|||
106005094|NCT01001221|365682666|FG001|Overall Study|Disease progression|2|||
106005095|NCT01001221|365682667|FG002|Overall Study|Disease progression|2|||
106005096|NCT01001221|365682668|FG003|Overall Study|Disease progression|4|||
106132766|NCT00079937|366144748|FG000|Overall Study|Administrative problems|22|||
106132767|NCT00079937|366144749|FG001|Overall Study|Administrative problems|11|||
106132768|NCT01106287|366144750|FG000|Overall Study|Adverse Event|1|||
105697986|NCT01045798|364557450|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
105697987|NCT01045798|364557451|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
105697988|NCT01045798|364557450|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
105697989|NCT01045798|364557451|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
105697990|NCT01045798|364557450|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
105697991|NCT01045798|364557451|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
106005097|NCT01001221|365682669|FG004|Overall Study|Disease progression|0|||
106005098|NCT01001221|365682665|FG000|Overall Study|Other|1|||
106005099|NCT01001221|365682666|FG001|Overall Study|Other|1|||
106005100|NCT01001221|365682667|FG002|Overall Study|Other|0|||
106005101|NCT01001221|365682668|FG003|Overall Study|Other|0|||
106005102|NCT01001221|365682669|FG004|Overall Study|Other|0|||
106005103|NCT01001221|365682665|FG000|Overall Study|Not treated; protocol exclusion|0|||
106005104|NCT01001221|365682666|FG001|Overall Study|Not treated; protocol exclusion|0|||
106005105|NCT01001221|365682667|FG002|Overall Study|Not treated; protocol exclusion|1|||
106005106|NCT01001221|365682668|FG003|Overall Study|Not treated; protocol exclusion|0|||
106005107|NCT01001221|365682669|FG004|Overall Study|Not treated; protocol exclusion|0|||
106005108|NCT00265564|365682672|FG000|Overall Study|Lost to Follow-up|5|||
106005109|NCT00265564|365682673|FG001|Overall Study|Lost to Follow-up|7|||
106005110|NCT00265564|365682672|FG000|Overall Study|met exclusion criteria|5|||
106005111|NCT00265564|365682673|FG001|Overall Study|met exclusion criteria|2|||
106005112|NCT01176032|365682677|FG000|Overall Study|Adverse Event|1|||
105697992|NCT01045798|364557450|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
105697993|NCT01045798|364557451|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
105697994|NCT04669535|364557453|FG000|Overall Study|Death|1|||
105697995|NCT04669535|364557454|FG001|Overall Study|Death|1|||
105697996|NCT04669535|364557455|FG002|Overall Study|Death|0|||
105697997|NCT04669535|364557456|FG003|Overall Study|Death|0|||
105697998|NCT01401842|364557457|FG000|Overall Study|Withdrawal by Subject|3|||
105697999|NCT01401842|364557458|FG001|Overall Study|Withdrawal by Subject|2|||
105698000|NCT01401842|364557457|FG000|Overall Study|academic reason|4|||
105698001|NCT01401842|364557458|FG001|Overall Study|academic reason|1|||
105698002|NCT01401842|364557457|FG000|Overall Study|changed companies|20|||
105698003|NCT01401842|364557458|FG001|Overall Study|changed companies|34|||
105698004|NCT01401842|364557457|FG000|Overall Study|discharged from US Army|3|||
105698005|NCT01401842|364557458|FG001|Overall Study|discharged from US Army|4|||
105698006|NCT01401842|364557457|FG000|Overall Study|invalid follow-up strength data|1|||
105698007|NCT01401842|364557458|FG001|Overall Study|invalid follow-up strength data|4|||
105698008|NCT01401842|364557457|FG000|Overall Study|on profile|9|||
105698009|NCT01401842|364557458|FG001|Overall Study|on profile|5|||
105698010|NCT01401842|364557457|FG000|Overall Study|other/unknown|28|||
105698011|NCT01401842|364557458|FG001|Overall Study|other/unknown|17|||
105698012|NCT00282295|364557459|FG000|Overall Study|Adverse Event|0|||
105698013|NCT00282295|364557460|FG001|Overall Study|Adverse Event|1|||
106005113|NCT01176032|365682678|FG001|Overall Study|Adverse Event|0|||
106005114|NCT01176032|365682677|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
106005115|NCT01176032|365682678|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
106005116|NCT01176032|365682677|FG000|Overall Study|Protocol Violation|1|||
106005117|NCT01176032|365682678|FG001|Overall Study|Protocol Violation|0|||
106005118|NCT01176032|365682677|FG000|Overall Study|Informed consent withdrawn|3|||
106005119|NCT01176032|365682678|FG001|Overall Study|Informed consent withdrawn|0|||
106005120|NCT01176032|365682677|FG000|Overall Study|Other|1|||
106005121|NCT01176032|365682678|FG001|Overall Study|Other|0|||
106005122|NCT01469221|365682679|FG000|Double Blind Phase|Protocol Violation|1|||
106005123|NCT01469221|365682680|FG001|Double Blind Phase|Protocol Violation|0|||
106005124|NCT01469221|365682681|FG002|Double Blind Phase|Protocol Violation|0|||
106005125|NCT01469221|365682679|FG000|Double Blind Phase|Physician Decision|1|||
106005126|NCT01469221|365682680|FG001|Double Blind Phase|Physician Decision|1|||
106005127|NCT01469221|365682681|FG002|Double Blind Phase|Physician Decision|0|||
106005128|NCT01469221|365682679|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
106005129|NCT01469221|365682680|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
106005130|NCT01469221|365682681|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
106005131|NCT03582215|365682682|FG000|Overall Study|Adverse Event|1|||
106005132|NCT03582215|365682683|FG001|Overall Study|Adverse Event|0|||
106005133|NCT03582215|365682684|FG002|Overall Study|Adverse Event|0|||
106005134|NCT03582215|365682685|FG003|Overall Study|Adverse Event|0|||
106005135|NCT03582215|365682686|FG004|Overall Study|Adverse Event|0|||
106005136|NCT03582215|365682687|FG005|Overall Study|Adverse Event|0|||
106005137|NCT03582215|365682688|FG006|Overall Study|Adverse Event|2|||
106005138|NCT03582215|365682689|FG007|Overall Study|Adverse Event|2|||
106005139|NCT02163902|365682690|FG000|Overall Study|Subject's Request|3|||
106005140|NCT02163902|365682691|FG001|Overall Study|Subject's Request|4|||
105698014|NCT00282295|364557461|FG002|Overall Study|Adverse Event|0|||
105698015|NCT00282295|364557459|FG000|Overall Study|Serious Adverse Events|0|||
105698016|NCT00282295|364557460|FG001|Overall Study|Serious Adverse Events|0|||
105698017|NCT00282295|364557461|FG002|Overall Study|Serious Adverse Events|1|||
105698018|NCT00282295|364557459|FG000|Overall Study|Protocol Violation|0|||
106005141|NCT02163902|365682690|FG000|Overall Study|Lost to Follow-up|6|||
106005142|NCT02163902|365682691|FG001|Overall Study|Lost to Follow-up|7|||
106005143|NCT02163902|365682690|FG000|Overall Study|Administrative Decision|2|||
106005144|NCT02163902|365682691|FG001|Overall Study|Administrative Decision|2|||
106005145|NCT00499681|365682692|FG000|Overall Study|toxicity|0|||
106005146|NCT00499681|365682693|FG001|Overall Study|toxicity|1|||
106005147|NCT00499681|365682692|FG000|Overall Study|disease progression|0|||
105698019|NCT00282295|364557460|FG001|Overall Study|Protocol Violation|2|||
106005148|NCT00499681|365682693|FG001|Overall Study|disease progression|1|||
106005149|NCT00659061|365682694|FG000|Overall Study|Migration due to political unrest|21|||
105698020|NCT00282295|364557461|FG002|Overall Study|Protocol Violation|1|||
105698021|NCT00282295|364557459|FG000|Overall Study|Withdrawal by Subject|2|||
105698022|NCT00282295|364557460|FG001|Overall Study|Withdrawal by Subject|6|||
105698023|NCT00282295|364557461|FG002|Overall Study|Withdrawal by Subject|4|||
105698024|NCT00282295|364557459|FG000|Overall Study|Lost to Follow-up|1|||
105698025|NCT00282295|364557460|FG001|Overall Study|Lost to Follow-up|7|||
105698026|NCT00282295|364557461|FG002|Overall Study|Lost to Follow-up|2|||
105698027|NCT00282295|364557459|FG000|Overall Study|Other|0|||
105698028|NCT00282295|364557460|FG001|Overall Study|Other|1|||
105698029|NCT00282295|364557461|FG002|Overall Study|Other|0|||
105698030|NCT03416153|364557464|FG000|Overall Study|Physician Decision|1|||
105698031|NCT03416153|364557465|FG001|Overall Study|Physician Decision|1|||
105698032|NCT03416153|364557464|FG000|Overall Study|Withdrawal by Subject|1|||
105698033|NCT03416153|364557465|FG001|Overall Study|Withdrawal by Subject|0|||
105698034|NCT03227471|364559132|FG000|Overall Study|Withdrawal by Subject|0|||
105698035|NCT03227471|364559133|FG001|Overall Study|Withdrawal by Subject|0|||
105923258|NCT00961064|365380639|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
105923259|NCT00961064|365380639|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
105923260|NCT00961064|365380639|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
105923261|NCT00961064|365380639|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
105923262|NCT01648764|365380640|FG000|Overall Study|Progressive Disease|0|||
105923263|NCT01648764|365380641|FG001|Overall Study|Progressive Disease|1|||
105923264|NCT01648764|365380642|FG002|Overall Study|Progressive Disease|0|||
105923265|NCT01648764|365380643|FG003|Overall Study|Progressive Disease|0|||
105923266|NCT01648764|365380644|FG004|Overall Study|Progressive Disease|0|||
105923267|NCT01648764|365380645|FG005|Overall Study|Progressive Disease|1|||
105923268|NCT01648764|365380646|FG006|Overall Study|Progressive Disease|1|||
105923269|NCT01648764|365380647|FG007|Overall Study|Progressive Disease|0|||
105923270|NCT01648764|365380648|FG008|Overall Study|Progressive Disease|0|||
105923271|NCT01648764|365380649|FG009|Overall Study|Progressive Disease|2|||
105923272|NCT01648764|365380650|FG010|Overall Study|Progressive Disease|0|||
105923273|NCT01648764|365380651|FG011|Overall Study|Progressive Disease|1|||
105923274|NCT01648764|365380652|FG012|Overall Study|Progressive Disease|2|||
105923275|NCT01648764|365380653|FG013|Overall Study|Progressive Disease|1|||
105923276|NCT01648764|365380640|FG000|Overall Study|Adverse Event|0|||
105923277|NCT01648764|365380641|FG001|Overall Study|Adverse Event|0|||
105698036|NCT03227471|364559134|FG002|Overall Study|Withdrawal by Subject|0|||
105923278|NCT01648764|365380642|FG002|Overall Study|Adverse Event|0|||
105923279|NCT01648764|365380643|FG003|Overall Study|Adverse Event|0|||
105923280|NCT01648764|365380644|FG004|Overall Study|Adverse Event|0|||
105923281|NCT01648764|365380645|FG005|Overall Study|Adverse Event|1|||
105923282|NCT01648764|365380646|FG006|Overall Study|Adverse Event|0|||
105923283|NCT01648764|365380647|FG007|Overall Study|Adverse Event|0|||
105923284|NCT01648764|365380648|FG008|Overall Study|Adverse Event|0|||
105923285|NCT01648764|365380649|FG009|Overall Study|Adverse Event|1|||
105923286|NCT01648764|365380650|FG010|Overall Study|Adverse Event|0|||
105923287|NCT01648764|365380651|FG011|Overall Study|Adverse Event|3|||
105923288|NCT01648764|365380652|FG012|Overall Study|Adverse Event|1|||
105923289|NCT01648764|365380653|FG013|Overall Study|Adverse Event|1|||
105923290|NCT01648764|365380640|FG000|Overall Study|Death|0|||
105923291|NCT01648764|365380641|FG001|Overall Study|Death|0|||
105923292|NCT01648764|365380642|FG002|Overall Study|Death|0|||
105923293|NCT01648764|365380643|FG003|Overall Study|Death|0|||
105923294|NCT01648764|365380644|FG004|Overall Study|Death|0|||
105698037|NCT03227471|364559135|FG003|Overall Study|Withdrawal by Subject|0|||
105698038|NCT03227471|364559136|FG004|Overall Study|Withdrawal by Subject|1|||
105698039|NCT03227471|364559137|FG005|Overall Study|Withdrawal by Subject|0|||
105923295|NCT01648764|365380645|FG005|Overall Study|Death|0|||
105923296|NCT01648764|365380646|FG006|Overall Study|Death|1|||
105923297|NCT01648764|365380647|FG007|Overall Study|Death|0|||
105923298|NCT01648764|365380648|FG008|Overall Study|Death|0|||
105923299|NCT01648764|365380649|FG009|Overall Study|Death|0|||
105923300|NCT01648764|365380650|FG010|Overall Study|Death|0|||
105923301|NCT01648764|365380651|FG011|Overall Study|Death|0|||
105923302|NCT01648764|365380652|FG012|Overall Study|Death|0|||
105923303|NCT01648764|365380653|FG013|Overall Study|Death|1|||
105698040|NCT03227471|364559138|FG006|Overall Study|Withdrawal by Subject|0|||
105923304|NCT01648764|365380640|FG000|Overall Study|Withdrawal by Subject|0|||
105923305|NCT01648764|365380641|FG001|Overall Study|Withdrawal by Subject|0|||
105923306|NCT01648764|365380642|FG002|Overall Study|Withdrawal by Subject|0|||
105923307|NCT01648764|365380643|FG003|Overall Study|Withdrawal by Subject|0|||
105923308|NCT01648764|365380644|FG004|Overall Study|Withdrawal by Subject|0|||
105923309|NCT01648764|365380645|FG005|Overall Study|Withdrawal by Subject|0|||
105923310|NCT01648764|365380646|FG006|Overall Study|Withdrawal by Subject|2|||
105923311|NCT01648764|365380647|FG007|Overall Study|Withdrawal by Subject|0|||
105923312|NCT01648764|365380648|FG008|Overall Study|Withdrawal by Subject|0|||
105923313|NCT01648764|365380649|FG009|Overall Study|Withdrawal by Subject|0|||
105923314|NCT01648764|365380650|FG010|Overall Study|Withdrawal by Subject|0|||
105923315|NCT01648764|365380651|FG011|Overall Study|Withdrawal by Subject|0|||
105923316|NCT01648764|365380652|FG012|Overall Study|Withdrawal by Subject|1|||
105923317|NCT01648764|365380653|FG013|Overall Study|Withdrawal by Subject|0|||
105923318|NCT01648764|365380640|FG000|Overall Study|Investigator Decision|0|||
105923319|NCT01648764|365380641|FG001|Overall Study|Investigator Decision|0|||
105923320|NCT01648764|365380642|FG002|Overall Study|Investigator Decision|0|||
105923321|NCT01648764|365380643|FG003|Overall Study|Investigator Decision|0|||
105923322|NCT01648764|365380644|FG004|Overall Study|Investigator Decision|0|||
105923323|NCT01648764|365380645|FG005|Overall Study|Investigator Decision|0|||
105923324|NCT01648764|365380646|FG006|Overall Study|Investigator Decision|1|||
105923325|NCT01648764|365380647|FG007|Overall Study|Investigator Decision|0|||
105923326|NCT01648764|365380648|FG008|Overall Study|Investigator Decision|0|||
105923327|NCT01648764|365380649|FG009|Overall Study|Investigator Decision|0|||
105923328|NCT01648764|365380650|FG010|Overall Study|Investigator Decision|0|||
105923329|NCT01648764|365380651|FG011|Overall Study|Investigator Decision|1|||
105923330|NCT01648764|365380652|FG012|Overall Study|Investigator Decision|0|||
105923331|NCT01648764|365380653|FG013|Overall Study|Investigator Decision|0|||
105923332|NCT00947544|365380654|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
105923333|NCT00947544|365380655|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
105923334|NCT00761319|365380656|FG000|Overall Study|Protocol Violation|21|||
105923335|NCT00761319|365380657|FG001|Overall Study|Protocol Violation|14|||
105923336|NCT00761319|365380656|FG000|Overall Study|Adverse Event|11|||
105923337|NCT00761319|365380657|FG001|Overall Study|Adverse Event|7|||
105923338|NCT00761319|365380656|FG000|Overall Study|Withdrawal by Subject|8|||
105923339|NCT00761319|365380657|FG001|Overall Study|Withdrawal by Subject|7|||
105923340|NCT00761319|365380656|FG000|Overall Study|Noncompliance|4|||
105923341|NCT00761319|365380657|FG001|Overall Study|Noncompliance|3|||
105923342|NCT00761319|365380656|FG000|Overall Study|Lost to Follow-up|1|||
105923343|NCT00761319|365380657|FG001|Overall Study|Lost to Follow-up|1|||
105923344|NCT00761319|365380656|FG000|Overall Study|Nonspecified|2|||
105923345|NCT00761319|365380657|FG001|Overall Study|Nonspecified|2|||
105923346|NCT00761319|365380656|FG000|Overall Study|Missing|1|||
105923347|NCT00761319|365380657|FG001|Overall Study|Missing|0|||
105923348|NCT03617588|365380661|FG000|Overall Study|Withdrawal by Subject|1|||
105923349|NCT03617588|365380662|FG001|Overall Study|Withdrawal by Subject|0|||
105923350|NCT03261401|365380665|FG000|Overall Study|Withdrawal by Subject|0|||
105923351|NCT03261401|365380666|FG001|Overall Study|Withdrawal by Subject|0|||
105923352|NCT03261401|365380667|FG002|Overall Study|Withdrawal by Subject|0|||
105923353|NCT03261401|365380668|FG003|Overall Study|Withdrawal by Subject|0|||
105923354|NCT03261401|365380669|FG004|Overall Study|Withdrawal by Subject|0|||
105923355|NCT03261401|365380670|FG005|Overall Study|Withdrawal by Subject|1|||
105923356|NCT03261401|365380671|FG006|Overall Study|Withdrawal by Subject|0|||
105923357|NCT03261401|365380672|FG007|Overall Study|Withdrawal by Subject|0|||
105923358|NCT03261401|365380673|FG008|Overall Study|Withdrawal by Subject|0|||
105923359|NCT03261401|365380674|FG009|Overall Study|Withdrawal by Subject|0|||
105923360|NCT03261401|365380675|FG010|Overall Study|Withdrawal by Subject|0|||
105923361|NCT03261401|365380676|FG011|Overall Study|Withdrawal by Subject|0|||
105923362|NCT03261401|365380677|FG012|Overall Study|Withdrawal by Subject|0|||
105923363|NCT03261401|365380665|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
105923364|NCT03261401|365380666|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
105923365|NCT03261401|365380667|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
105923366|NCT03261401|365380668|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
106005150|NCT00659061|365682695|FG001|Overall Study|Migration due to political unrest|15|||
105923367|NCT03261401|365380669|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
105923368|NCT03261401|365380670|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
105923369|NCT03261401|365380671|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
105923370|NCT03261401|365380672|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
105923371|NCT03261401|365380673|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
105923372|NCT03261401|365380674|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
105923373|NCT03261401|365380675|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
105923374|NCT03261401|365380676|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
105923375|NCT03261401|365380677|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
105923376|NCT01126424|365380678|FG000|Overall Study|Adverse Event|0|||
105923377|NCT01126424|365380679|FG001|Overall Study|Adverse Event|0|||
105923378|NCT01126424|365380680|FG002|Overall Study|Adverse Event|0|||
105923379|NCT01126424|365380681|FG003|Overall Study|Adverse Event|0|||
105923380|NCT01126424|365380682|FG004|Overall Study|Adverse Event|1|||
105923381|NCT01126424|365380683|FG005|Overall Study|Adverse Event|0|||
105923382|NCT01126424|365380678|FG000|Overall Study|Withdrawal by Subject|0|||
105923383|NCT01126424|365380679|FG001|Overall Study|Withdrawal by Subject|0|||
105923384|NCT01126424|365380680|FG002|Overall Study|Withdrawal by Subject|1|||
105923385|NCT01126424|365380681|FG003|Overall Study|Withdrawal by Subject|3|||
105923386|NCT01126424|365380682|FG004|Overall Study|Withdrawal by Subject|1|||
105923387|NCT01126424|365380683|FG005|Overall Study|Withdrawal by Subject|0|||
105923388|NCT01006629|365380686|FG000|Overall Study|Adverse Event|1|||
105923389|NCT01006629|365380686|FG000|Overall Study|Parent refused to continue participation|1|||
105923390|NCT01006629|365380686|FG000|Overall Study|Parent unable to perform site visit|4|||
105923391|NCT01499511|365380687|FG000|Overall Study|Death|1|||
105923392|NCT01499511|365380688|FG001|Overall Study|Death|0|||
105923393|NCT00316004|365380689|FG000|Overall Study|Subject was not given study fluid.|14|||
105923394|NCT00316004|365380690|FG001|Overall Study|Subject was not given study fluid.|14|||
105923395|NCT00316004|365380691|FG002|Overall Study|Subject was not given study fluid.|21|||
105923396|NCT02701634|365380702|FG000|Overall Study|Adverse Event|2|||
105923397|NCT02701634|365380703|FG001|Overall Study|Adverse Event|3|||
105923398|NCT02701634|365380702|FG000|Overall Study|Death|1|||
105923399|NCT02701634|365380703|FG001|Overall Study|Death|0|||
105923400|NCT02701634|365380702|FG000|Overall Study|Investigator's Discretion|7|||
105923401|NCT02701634|365380703|FG001|Overall Study|Investigator's Discretion|4|||
105923402|NCT02701634|365380702|FG000|Overall Study|Study terminated by Sponsor|15|||
105923403|NCT02701634|365380703|FG001|Overall Study|Study terminated by Sponsor|17|||
105923404|NCT02701634|365380702|FG000|Overall Study|Withdrew Consent|6|||
105923405|NCT02701634|365380703|FG001|Overall Study|Withdrew Consent|7|||
105923406|NCT02701634|365380702|FG000|Overall Study|Randomized but not treated|1|||
105923407|NCT02701634|365380703|FG001|Overall Study|Randomized but not treated|0|||
105923408|NCT03530696|365380704|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
105923409|NCT03530696|365380705|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
105923410|NCT01056536|365380708|FG000|Overall Study|Lost to Follow-up|202|||
105923411|NCT01056536|365380709|FG001|Overall Study|Lost to Follow-up|116|||
105923412|NCT01056536|365380710|FG002|Overall Study|Lost to Follow-up|248|||
105923413|NCT03839641|365380711|FG000|Overall Study|Withdrawal by Subject|1|||
105923414|NCT03839641|365380712|FG001|Overall Study|Withdrawal by Subject|1|||
105923415|NCT03188822|365380717|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
105923416|NCT03188822|365380717|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
105923417|NCT02550795|365380725|FG000|Overall Study|Physician Decision|0|||
105923418|NCT02550795|365380726|FG001|Overall Study|Physician Decision|1|||
105923419|NCT02550795|365380727|FG002|Overall Study|Physician Decision|0|||
105923420|NCT00294658|365380728|FG000|Overall Study|Death|0|||
105923421|NCT00294658|365380729|FG001|Overall Study|Death|1|||
105923422|NCT00294658|365380728|FG000|Overall Study|Lost to Follow-up|4|||
105923423|NCT00294658|365380729|FG001|Overall Study|Lost to Follow-up|0|||
105923424|NCT00294658|365380728|FG000|Overall Study|Physician Decision|1|||
105923425|NCT00294658|365380729|FG001|Overall Study|Physician Decision|2|||
105923426|NCT00294658|365380728|FG000|Overall Study|Pregnancy|0|||
105923427|NCT00294658|365380729|FG001|Overall Study|Pregnancy|1|||
105923428|NCT00294658|365380728|FG000|Overall Study|Withdrawal by Subject|0|||
105923429|NCT00294658|365380729|FG001|Overall Study|Withdrawal by Subject|4|||
105923430|NCT00294658|365380728|FG000|Overall Study|Found to have invasive thymoma|1|||
105923431|NCT00294658|365380729|FG001|Overall Study|Found to have invasive thymoma|0|||
105923432|NCT00294658|365380728|FG000|Overall Study|Patient and family were not satisfied|0|||
105923433|NCT00294658|365380729|FG001|Overall Study|Patient and family were not satisfied|1|||
105923434|NCT00262925|365380730|FG000|Overall Study|Lack of Efficacy|3|||
105923435|NCT00262925|365380730|FG000|Overall Study|Adverse Event|4|||
105923436|NCT00262925|365380730|FG000|Overall Study|Death|2|||
105923437|NCT00262925|365380730|FG000|Overall Study|alternative therapy|1|||
105923438|NCT00262925|365380730|FG000|Overall Study|Other|1|||
105923439|NCT03462680|365380733|FG000|Overall Study|Withdrawal by Subject|3|||
105923440|NCT03462680|365380734|FG001|Overall Study|Withdrawal by Subject|5|||
105787164|NCT03110107|364874892|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
105787165|NCT03110107|364874893|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
105787166|NCT03110107|364874894|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
105787167|NCT03110107|364874895|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
105787168|NCT03110107|364874896|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
105787169|NCT03110107|364874897|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
105787170|NCT03110107|364874898|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
105787171|NCT03110107|364874899|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
105787172|NCT03110107|364874900|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
105787173|NCT03110107|364874901|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
105787174|NCT03110107|364874902|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
105787175|NCT03110107|364874903|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
105787176|NCT03110107|364874904|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
105787177|NCT03110107|364874905|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
105787178|NCT03110107|364874906|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
105787179|NCT03110107|364874907|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
105787180|NCT03110107|364874908|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
105787181|NCT03110107|364874909|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
105787182|NCT03110107|364874910|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
105787183|NCT03110107|364874911|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
105787184|NCT03110107|364874912|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
105787185|NCT03110107|364874913|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
105787186|NCT03110107|364874914|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
105787187|NCT03110107|364874889|FG000|Treatment Period|Participant withdrew consent|0|||
105787188|NCT03110107|364874890|FG001|Treatment Period|Participant withdrew consent|0|||
105787189|NCT03110107|364874891|FG002|Treatment Period|Participant withdrew consent|1|||
105787190|NCT03110107|364874892|FG003|Treatment Period|Participant withdrew consent|0|||
105787191|NCT03110107|364874893|FG004|Treatment Period|Participant withdrew consent|4|||
105787192|NCT03110107|364874894|FG005|Treatment Period|Participant withdrew consent|3|||
105923441|NCT00392223|365380735|FG000|Overall Study|Adverse Event|5|||
105923442|NCT00392223|365380736|FG001|Overall Study|Adverse Event|4|||
105923443|NCT00392223|365380735|FG000|Overall Study|Lost to Follow-up|1|||
105923444|NCT00392223|365380736|FG001|Overall Study|Lost to Follow-up|4|||
105923445|NCT00392223|365380735|FG000|Overall Study|Protocol Violation|0|||
105923446|NCT00392223|365380736|FG001|Overall Study|Protocol Violation|3|||
105923447|NCT00392223|365380735|FG000|Overall Study|Withdrawal by Subject|3|||
105923448|NCT00392223|365380736|FG001|Overall Study|Withdrawal by Subject|2|||
105923449|NCT02246777|365380738|FG000|Overall Study|Adverse Event|2|||
105923450|NCT02246777|365380738|FG000|Overall Study|Change of residence|1|||
105923451|NCT01991795|365380739|FG000|Overall Study|Lost to Follow-up|6|||
105923452|NCT01991795|365380740|FG001|Overall Study|Lost to Follow-up|4|||
105923453|NCT01991795|365380739|FG000|Overall Study|Withdrawal by Subject|117|||
105923454|NCT01991795|365380740|FG001|Overall Study|Withdrawal by Subject|94|||
105923455|NCT01991795|365380739|FG000|Overall Study|Site prematurely closed by sponsor|26|||
105923456|NCT01991795|365380740|FG001|Overall Study|Site prematurely closed by sponsor|25|||
105923457|NCT01316575|365380741|FG000|Overall Study|Withdrawal by Subject|2|||
105923458|NCT01316575|365380742|FG001|Overall Study|Withdrawal by Subject|0|||
105923459|NCT01316575|365380741|FG000|Overall Study|Required alternate treatment|0|||
105923460|NCT01316575|365380742|FG001|Overall Study|Required alternate treatment|1|||
105923461|NCT01232283|365380743|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
105923462|NCT01232283|365380744|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
105923463|NCT01232283|365380745|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105923464|NCT01232283|365380746|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105923465|NCT01232283|365380747|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105923466|NCT01232283|365380748|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105923467|NCT01232283|365380749|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105923468|NCT01232283|365380750|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105923469|NCT01232283|365380751|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105923470|NCT01232283|365380752|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
105923471|NCT01232283|365380743|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
105923472|NCT01232283|365380744|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
105923473|NCT01232283|365380745|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105923474|NCT01232283|365380746|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105923475|NCT01232283|365380747|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105923476|NCT01232283|365380748|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105923477|NCT01232283|365380749|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105923478|NCT01232283|365380750|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105923479|NCT01232283|365380751|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105923480|NCT01232283|365380752|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
105923481|NCT01232283|365380743|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
105923482|NCT01232283|365380744|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923483|NCT01232283|365380745|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923484|NCT01232283|365380746|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923485|NCT01232283|365380747|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923486|NCT01232283|365380748|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923487|NCT01232283|365380749|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923488|NCT01232283|365380750|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923489|NCT01232283|365380751|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923490|NCT01232283|365380752|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
105923491|NCT01232283|365380743|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
105923492|NCT01232283|365380744|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
105923493|NCT01232283|365380745|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105923494|NCT01232283|365380746|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105923495|NCT01232283|365380747|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105923496|NCT01232283|365380748|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105923497|NCT01232283|365380749|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105923498|NCT01232283|365380750|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105923499|NCT01232283|365380751|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105923500|NCT01232283|365380752|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
105923501|NCT01232283|365380743|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
105923502|NCT01232283|365380744|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
105923503|NCT01232283|365380745|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105923504|NCT01232283|365380746|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105923505|NCT01232283|365380747|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105923506|NCT01232283|365380748|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
106016891|NCT03847896|365725905|FG000|Overall Study|Adverse Event|2|||
105923507|NCT01232283|365380749|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105923508|NCT01232283|365380750|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105923509|NCT01232283|365380751|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105923510|NCT01232283|365380752|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
105923511|NCT01232283|365380743|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
105923512|NCT01232283|365380744|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
105923513|NCT01232283|365380745|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105923514|NCT01232283|365380746|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105923515|NCT01232283|365380747|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105923516|NCT01232283|365380748|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105923517|NCT01232283|365380749|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105923518|NCT01232283|365380750|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105923519|NCT01232283|365380751|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105923520|NCT01232283|365380752|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
105923521|NCT01232283|365380743|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
105923522|NCT01232283|365380744|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
105923523|NCT01232283|365380745|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105923524|NCT01232283|365380746|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105923525|NCT01232283|365380747|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105923526|NCT01232283|365380748|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105923527|NCT01232283|365380749|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105923528|NCT01232283|365380750|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105923529|NCT01232283|365380751|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105923530|NCT01232283|365380752|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
105923531|NCT01232283|365380743|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105923532|NCT01232283|365380744|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105923533|NCT01232283|365380745|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
105923534|NCT01232283|365380746|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
105923535|NCT01232283|365380747|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105923536|NCT01232283|365380748|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105923537|NCT01232283|365380749|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105923538|NCT01232283|365380750|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105923539|NCT01232283|365380751|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105923540|NCT01232283|365380752|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
105923541|NCT01232283|365380743|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105923542|NCT01232283|365380744|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105923543|NCT01232283|365380745|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
105923544|NCT01232283|365380746|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
105923545|NCT01232283|365380747|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105923546|NCT01232283|365380748|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105923547|NCT01232283|365380749|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105923548|NCT01232283|365380750|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105923549|NCT01232283|365380751|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105923550|NCT01232283|365380752|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
105923551|NCT01232283|365380743|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923552|NCT01232283|365380744|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923553|NCT01232283|365380745|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
105923554|NCT01232283|365380746|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923555|NCT01232283|365380747|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923556|NCT01232283|365380748|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923557|NCT01232283|365380749|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923558|NCT01232283|365380750|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923559|NCT01232283|365380751|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923560|NCT01232283|365380752|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
105923561|NCT01232283|365380743|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105923562|NCT01232283|365380744|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105923563|NCT01232283|365380745|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
105923564|NCT01232283|365380746|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
105923565|NCT01232283|365380747|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105923566|NCT01232283|365380748|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105923567|NCT01232283|365380749|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105923568|NCT01232283|365380750|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
106005151|NCT03119259|365682700|FG000|Overall Study|Withdrawn as no longer eligible|1|||
106005152|NCT03119259|365682701|FG001|Overall Study|Withdrawn as no longer eligible|0|||
106005153|NCT03119259|365682700|FG000|Overall Study|Withdrawal by Subject|4|||
106005154|NCT03119259|365682701|FG001|Overall Study|Withdrawal by Subject|2|||
106005155|NCT03119259|365682700|FG000|Overall Study|Lost to Follow-up|0|||
106005156|NCT03119259|365682701|FG001|Overall Study|Lost to Follow-up|1|||
106005157|NCT01277744|365682702|FG000|Overall Study|Physician Decision|2|||
106005158|NCT03740048|365682704|FG000|Overall Study|Withdrawal by Subject|1|||
106005159|NCT03740048|365682705|FG001|Overall Study|Withdrawal by Subject|1|||
106005160|NCT03740048|365682704|FG000|Overall Study|Death|1|||
106005161|NCT03740048|365682705|FG001|Overall Study|Death|6|||
106005162|NCT03740048|365682704|FG000|Overall Study|Switched to thrice-weekly HD|2|||
105923569|NCT01232283|365380751|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105923570|NCT01232283|365380752|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
105923571|NCT01232283|365380743|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
106005163|NCT03740048|365682705|FG001|Overall Study|Switched to thrice-weekly HD|0|||
106005164|NCT03740048|365682704|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
106005165|NCT03740048|365682705|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
106005166|NCT03740048|365682704|FG000|Overall Study|Lost to Follow-up|0|||
106132769|NCT01106287|366144751|FG001|Overall Study|Adverse Event|0|||
106132770|NCT01106287|366144752|FG002|Overall Study|Adverse Event|0|||
106132771|NCT01106287|366144753|FG003|Overall Study|Adverse Event|0|||
105923572|NCT01232283|365380744|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
106005167|NCT03740048|365682705|FG001|Overall Study|Lost to Follow-up|1|||
106005168|NCT03740048|365682704|FG000|Overall Study|Non-compliance with HD|0|||
106132772|NCT05074498|366144754|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
105923573|NCT01232283|365380745|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
105923574|NCT01232283|365380746|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
105923575|NCT01232283|365380747|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105923576|NCT01232283|365380748|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105923577|NCT01232283|365380749|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105923578|NCT01232283|365380750|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105923579|NCT01232283|365380751|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105923580|NCT01232283|365380752|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
105923581|NCT01232283|365380743|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
105923582|NCT01232283|365380744|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
105923583|NCT01232283|365380745|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
105923584|NCT01232283|365380746|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
105923585|NCT01232283|365380747|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
105923586|NCT01232283|365380748|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
105923587|NCT01232283|365380749|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
105923588|NCT01232283|365380750|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
105923589|NCT01232283|365380751|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
105923590|NCT01232283|365380752|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
105923591|NCT01232283|365380743|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105923592|NCT01232283|365380744|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105923593|NCT01232283|365380745|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105923594|NCT01232283|365380746|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105923595|NCT01232283|365380747|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
105923596|NCT01232283|365380748|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
105923597|NCT01232283|365380749|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105923598|NCT01232283|365380750|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
105923599|NCT01232283|365380751|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105923600|NCT01232283|365380752|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
105923601|NCT01232283|365380743|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105923602|NCT01232283|365380744|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105923603|NCT01232283|365380745|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105923604|NCT01232283|365380746|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105923605|NCT01232283|365380747|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
105923606|NCT01232283|365380748|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105923607|NCT01232283|365380749|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
105923608|NCT01232283|365380750|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
105923609|NCT01232283|365380751|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105923610|NCT01232283|365380752|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
105923611|NCT01232283|365380743|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105923612|NCT01232283|365380744|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105923613|NCT01232283|365380745|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105923614|NCT01232283|365380746|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105923615|NCT01232283|365380747|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
105923616|NCT01232283|365380748|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
105923617|NCT01232283|365380749|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
105923618|NCT01232283|365380750|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
105923619|NCT01232283|365380751|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105923620|NCT01232283|365380752|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
105923621|NCT01232283|365380743|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923622|NCT01232283|365380744|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923623|NCT01232283|365380745|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923624|NCT01232283|365380746|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923625|NCT01232283|365380747|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
105923626|NCT01232283|365380748|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923627|NCT01232283|365380749|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923628|NCT01232283|365380750|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923629|NCT01232283|365380751|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923630|NCT01232283|365380752|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
105923631|NCT01232283|365380743|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105923632|NCT01232283|365380744|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105923633|NCT01232283|365380745|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105923634|NCT01232283|365380746|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105923635|NCT01232283|365380747|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
105923636|NCT01232283|365380748|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105923637|NCT01232283|365380749|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
105923638|NCT01232283|365380750|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
105923639|NCT01232283|365380751|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105923640|NCT01232283|365380752|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
105923641|NCT01232283|365380743|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105923642|NCT01232283|365380744|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105923643|NCT01232283|365380745|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105923644|NCT01232283|365380746|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105923645|NCT01232283|365380747|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105923646|NCT01232283|365380748|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105923647|NCT01232283|365380749|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105698041|NCT03227471|364559139|FG007|Overall Study|Withdrawal by Subject|0|||
105698042|NCT03227471|364559140|FG008|Overall Study|Withdrawal by Subject|0|||
105923648|NCT01232283|365380750|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
105923649|NCT01232283|365380751|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105923650|NCT01232283|365380752|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
105923651|NCT01232283|365380743|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923652|NCT01232283|365380744|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923653|NCT01232283|365380745|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923654|NCT01232283|365380746|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923655|NCT01232283|365380747|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923656|NCT01232283|365380748|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
105923657|NCT01232283|365380749|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923658|NCT01232283|365380750|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923659|NCT01232283|365380751|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923660|NCT01232283|365380752|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
105923661|NCT01232283|365380743|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105923662|NCT01232283|365380744|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105923663|NCT01232283|365380745|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105923664|NCT01232283|365380746|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105923665|NCT01232283|365380747|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105923666|NCT01232283|365380748|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105923667|NCT01232283|365380749|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105923668|NCT01232283|365380750|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
105923669|NCT01232283|365380751|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
105923670|NCT01232283|365380752|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
105923671|NCT01232283|365380743|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105923672|NCT01232283|365380744|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105923673|NCT01232283|365380745|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105923674|NCT01232283|365380746|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105923675|NCT01232283|365380747|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105923676|NCT01232283|365380748|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105923677|NCT01232283|365380749|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105923678|NCT01232283|365380750|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
105923679|NCT01232283|365380751|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
105923680|NCT01232283|365380752|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
105923681|NCT01232283|365380743|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105923682|NCT01232283|365380744|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105923683|NCT01232283|365380745|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105923684|NCT01232283|365380746|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105923685|NCT01232283|365380747|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105923686|NCT01232283|365380748|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105923687|NCT01232283|365380749|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105923688|NCT01232283|365380750|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
105923689|NCT01232283|365380751|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
105923690|NCT01232283|365380752|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
105923691|NCT01232283|365380743|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105923692|NCT01232283|365380744|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105923693|NCT01232283|365380745|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105923694|NCT01232283|365380746|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105923695|NCT01232283|365380747|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105923696|NCT01232283|365380748|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105923697|NCT01232283|365380749|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105923698|NCT01232283|365380750|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
105923699|NCT01232283|365380751|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
105923700|NCT01232283|365380752|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
105698043|NCT03227471|364559141|FG009|Overall Study|Withdrawal by Subject|0|||
105698044|NCT03227471|364559142|FG010|Overall Study|Withdrawal by Subject|0|||
105923701|NCT01232283|365380743|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105923702|NCT01232283|365380744|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105923703|NCT01232283|365380745|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105923704|NCT01232283|365380746|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105923705|NCT01232283|365380747|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105923706|NCT01232283|365380748|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105923707|NCT01232283|365380749|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105923708|NCT01232283|365380750|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
105923709|NCT01232283|365380751|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
105923710|NCT01232283|365380752|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
105923711|NCT01232283|365380743|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923712|NCT01232283|365380744|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923713|NCT01232283|365380745|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923714|NCT01232283|365380746|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923715|NCT01232283|365380747|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923716|NCT01232283|365380748|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923717|NCT01232283|365380749|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923718|NCT01232283|365380750|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923719|NCT01232283|365380751|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
105923720|NCT01232283|365380752|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
105923721|NCT01232283|365380743|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923722|NCT01232283|365380744|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923723|NCT01232283|365380745|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923724|NCT01232283|365380746|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923725|NCT01232283|365380747|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923726|NCT01232283|365380748|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923727|NCT01232283|365380749|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923728|NCT01232283|365380750|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923729|NCT01232283|365380751|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
105923730|NCT01232283|365380752|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
105923731|NCT01232283|365380743|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105923732|NCT01232283|365380744|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105923733|NCT01232283|365380745|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105923734|NCT01232283|365380746|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105923735|NCT01232283|365380747|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105923736|NCT01232283|365380748|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105923737|NCT01232283|365380749|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105923738|NCT01232283|365380750|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
105923739|NCT01232283|365380751|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
105923740|NCT01232283|365380752|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
105923741|NCT01192178|365380753|FG000|Overall Study|Withdrawal by Subject|6|||
105923742|NCT01192178|365380754|FG001|Overall Study|Withdrawal by Subject|10|||
105923743|NCT01192178|365380753|FG000|Overall Study|Protocol Violation|10|||
105923744|NCT01192178|365380754|FG001|Overall Study|Protocol Violation|3|||
105923745|NCT01192178|365380753|FG000|Overall Study|Physician Decision|2|||
105923746|NCT01192178|365380754|FG001|Overall Study|Physician Decision|4|||
105923747|NCT01192178|365380753|FG000|Overall Study|Lost to Follow-up|3|||
105923748|NCT01192178|365380754|FG001|Overall Study|Lost to Follow-up|3|||
105923749|NCT01192178|365380753|FG000|Overall Study|Adverse Event|2|||
105923750|NCT01192178|365380754|FG001|Overall Study|Adverse Event|1|||
105923751|NCT01192178|365380753|FG000|Overall Study|Lack of Efficacy|1|||
105923752|NCT01192178|365380754|FG001|Overall Study|Lack of Efficacy|2|||
105923753|NCT01977846|365380755|FG000|Total Study - Prospective|Death|0|||
105923754|NCT01977846|365380756|FG001|Total Study - Prospective|Death|1|||
105923755|NCT01977846|365380755|FG000|Total Study - Prospective|Lost to Follow-up|0|||
105923756|NCT01977846|365380756|FG001|Total Study - Prospective|Lost to Follow-up|8|||
105923757|NCT01977846|365380755|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
105923758|NCT01977846|365380756|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
105923759|NCT01977846|365380755|FG000|Total Study - Prospective|Not available at time of visit|0|||
105923760|NCT01977846|365380756|FG001|Total Study - Prospective|Not available at time of visit|5|||
105923761|NCT01977846|365380755|FG000|Total Study - Prospective|No show|0|||
105923762|NCT01977846|365380756|FG001|Total Study - Prospective|No show|1|||
105923763|NCT01977846|365380755|FG000|Total Study - Prospective|Protocol Violation|0|||
105923764|NCT01977846|365380756|FG001|Total Study - Prospective|Protocol Violation|1|||
105923765|NCT02460289|365380757|FG000|Overall Study|Adverse Event|1|||
105923766|NCT02460289|365380757|FG000|Overall Study|Withdrawal by Subject|8|||
105923767|NCT02460289|365380757|FG000|Overall Study|Lost to Follow-up|1|||
105923768|NCT01922934|365380758|FG000|Eligible Patients|Death|0|||
105923769|NCT01922934|365380759|FG001|Eligible Patients|Death|7|||
105923770|NCT01922934|365380758|FG000|Eligible Patients|Physician Decision|17|||
105923771|NCT01922934|365380759|FG001|Eligible Patients|Physician Decision|0|||
105923772|NCT01922934|365380758|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
105923773|NCT01922934|365380759|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
105923774|NCT01922934|365380758|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
105923775|NCT01922934|365380759|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
105923776|NCT01922934|365380758|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
105923777|NCT01922934|365380759|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
105923778|NCT01922934|365380758|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
105923779|NCT01922934|365380759|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
105923780|NCT00964782|365380760|FG000|Overall Study|Lost to Follow-up|1|||
105923781|NCT00964782|365380761|FG001|Overall Study|Lost to Follow-up|0|||
105923782|NCT01850641|365380764|FG000|Overall Study|Physician Decision|1|||
105923783|NCT01850641|365380764|FG000|Overall Study|Decrease in serum phosphorus|1|||
105923784|NCT01850641|365380764|FG000|Overall Study|Decrease in serum calcium|2|||
105923785|NCT01850641|365380764|FG000|Overall Study|Increase in serum ferritin|1|||
105923786|NCT02774889|365380774|FG000|Overall Study|Lost to Follow-up|2|||
105923787|NCT02774889|365380775|FG001|Overall Study|Lost to Follow-up|1|||
105923788|NCT00858988|365380776|FG000|Analysis|Lactulose unable to be detected in urine|2|||
105923789|NCT00858988|365380777|FG001|Analysis|Lactulose unable to be detected in urine|1|||
105923790|NCT00846365|365380780|FG000|Overall Study|Adverse Event|20|||
105923791|NCT00846365|365380781|FG001|Overall Study|Adverse Event|30|||
105923792|NCT00846365|365380782|FG002|Overall Study|Adverse Event|11|||
105923793|NCT00846365|365380780|FG000|Overall Study|Protocol Violation|5|||
105923794|NCT00846365|365380781|FG001|Overall Study|Protocol Violation|4|||
105923795|NCT00846365|365380782|FG002|Overall Study|Protocol Violation|0|||
105923796|NCT00846365|365380780|FG000|Overall Study|Lost to Follow-up|8|||
105923797|NCT00846365|365380781|FG001|Overall Study|Lost to Follow-up|2|||
105923798|NCT00846365|365380782|FG002|Overall Study|Lost to Follow-up|5|||
105923799|NCT00846365|365380780|FG000|Overall Study|Withdrawal by Subject|11|||
105923800|NCT00846365|365380781|FG001|Overall Study|Withdrawal by Subject|11|||
105923801|NCT00846365|365380782|FG002|Overall Study|Withdrawal by Subject|9|||
105923802|NCT00846365|365380780|FG000|Overall Study|Pregnancy|1|||
105923803|NCT00846365|365380781|FG001|Overall Study|Pregnancy|0|||
105923804|NCT00846365|365380782|FG002|Overall Study|Pregnancy|0|||
105923805|NCT00846365|365380780|FG000|Overall Study|Lack of Efficacy|1|||
105923806|NCT00846365|365380781|FG001|Overall Study|Lack of Efficacy|1|||
105923807|NCT00846365|365380782|FG002|Overall Study|Lack of Efficacy|2|||
105923808|NCT00846365|365380780|FG000|Overall Study|Other|9|||
105923809|NCT00846365|365380781|FG001|Overall Study|Other|1|||
105923810|NCT00846365|365380782|FG002|Overall Study|Other|6|||
105923811|NCT01349595|365380783|FG000|Overall Study|Lack of funding|2|||
105923812|NCT01349595|365380784|FG001|Overall Study|Lack of funding|2|||
105923813|NCT00655889|365380785|FG000|Overall Study|Inadequate cell growth|1|||
105923814|NCT00655889|365380785|FG000|Overall Study|Protocol Violation|1|||
105923815|NCT01925417|365380786|FG000|Overall Study|Withdrawal by Subject|2|||
105923816|NCT01925417|365380786|FG000|Overall Study|Death|1|||
105923817|NCT00862992|365380787|FG000|Overall Study|Adverse Event|2|||
105923818|NCT00862992|365380788|FG001|Overall Study|Adverse Event|1|||
105923819|NCT00862992|365380789|FG002|Overall Study|Adverse Event|1|||
105923820|NCT00862992|365380787|FG000|Overall Study|Physician Decision|1|||
105923821|NCT00862992|365380788|FG001|Overall Study|Physician Decision|0|||
105923822|NCT00862992|365380789|FG002|Overall Study|Physician Decision|0|||
105923823|NCT00862992|365380787|FG000|Overall Study|Withdrawal by Subject|0|||
105923824|NCT00862992|365380788|FG001|Overall Study|Withdrawal by Subject|0|||
105923825|NCT00862992|365380789|FG002|Overall Study|Withdrawal by Subject|2|||
105923826|NCT00720759|365380790|FG000|Overall Study|Lost to Follow-up|0|||
105923827|NCT00720759|365380791|FG001|Overall Study|Lost to Follow-up|1|||
105923828|NCT00720759|365380792|FG002|Overall Study|Lost to Follow-up|1|||
105923829|NCT00720759|365380793|FG003|Overall Study|Lost to Follow-up|0|||
105923830|NCT00769561|365380794|FG000|Overall Study|Withdrawal by Subject|2|||
105923831|NCT00769561|365380795|FG001|Overall Study|Withdrawal by Subject|2|||
106132773|NCT05074498|366144755|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
106132774|NCT05074498|366144756|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
105923832|NCT00769561|365380794|FG000|Overall Study|Lost to Follow-up|1|||
105923833|NCT00769561|365380795|FG001|Overall Study|Lost to Follow-up|3|||
105923834|NCT02145390|365380809|FG000|Overall Study|Withdrawal by Subject|1|||
106132775|NCT05074498|366144757|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
105923835|NCT03846479|365381933|FG000|Overall Study|Death|8|||
105923836|NCT03846479|365381933|FG000|Overall Study|Lost to Follow-up|1|||
105923837|NCT02233413|365381934|FG000|Overall Study|Lost to Follow-up|7|||
105923838|NCT02233413|365381935|FG001|Overall Study|Lost to Follow-up|9|||
105923839|NCT02233413|365381934|FG000|Overall Study|Withdrawal by Subject|4|||
105923840|NCT02233413|365381935|FG001|Overall Study|Withdrawal by Subject|5|||
105923841|NCT03979313|365381940|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
105923842|NCT03979313|365381941|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
106132776|NCT05074498|366144758|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
105923843|NCT03979313|365381940|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
105923844|NCT03979313|365381941|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
105923845|NCT03979313|365381940|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
105923846|NCT03979313|365381941|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
105923847|NCT03979313|365381940|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
105923848|NCT03979313|365381941|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
105923849|NCT03979313|365381940|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
105923850|NCT03979313|365381941|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
105923851|NCT03979313|365381940|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
105923852|NCT03979313|365381941|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
105923853|NCT03979313|365381940|FG000|All Subjects|Any Other Reason|16|||
105923854|NCT03979313|365381941|FG001|All Subjects|Any Other Reason|23|||
105923855|NCT03979313|365381940|FG000|All Subjects|Covid-19|1|||
105923856|NCT03979313|365381941|FG001|All Subjects|Covid-19|3|||
105923857|NCT03979313|365381940|FG000|All Subjects|Withdrawal by Subject|35|||
105923858|NCT03979313|365381941|FG001|All Subjects|Withdrawal by Subject|44|||
105923859|NCT03979313|365381940|FG000|All Subjects|Death|0|||
105923860|NCT03979313|365381941|FG001|All Subjects|Death|5|||
105923861|NCT03979313|365381940|FG000|All Subjects|Lost to Follow-up|28|||
105923862|NCT03979313|365381941|FG001|All Subjects|Lost to Follow-up|61|||
105923863|NCT00423605|365381942|FG000|Overall Study|Adverse Event|129|||
105923864|NCT00423605|365381942|FG000|Overall Study|Withdrawal by Subject|36|||
105923865|NCT00423605|365381942|FG000|Overall Study|Lost to Follow-up|15|||
105923866|NCT00423605|365381942|FG000|Overall Study|Lack of Efficacy|38|||
105923867|NCT00423605|365381942|FG000|Overall Study|Sponsor Decision|3|||
105923868|NCT00423605|365381942|FG000|Overall Study|Physician Decision|8|||
105698045|NCT03227471|364559143|FG011|Overall Study|Withdrawal by Subject|0|||
105698046|NCT03227471|364559144|FG012|Overall Study|Withdrawal by Subject|1|||
105923869|NCT00423605|365381942|FG000|Overall Study|Protocol Violation|7|||
105923870|NCT00423605|365381942|FG000|Overall Study|Not one of the pre-specified options|5|||
105923871|NCT03738696|365381943|FG000|Overall Study|Withdrawal by Subject|0|||
105923872|NCT03738696|365381944|FG001|Overall Study|Withdrawal by Subject|1|||
105923873|NCT03738696|365381943|FG000|Overall Study|Lost to Follow-up|8|||
105923874|NCT03738696|365381944|FG001|Overall Study|Lost to Follow-up|14|||
105923875|NCT03095287|365381946|FG000|Overall Study|Treatment Failure|1|||
105923876|NCT03095287|365381946|FG000|Overall Study|Adverse Event|1|||
105923877|NCT00764517|365381952|FG000|Overall Study|Adverse Event|9|||
105923878|NCT00764517|365381953|FG001|Overall Study|Adverse Event|3|||
105923879|NCT00764517|365381952|FG000|Overall Study|Death|3|||
105923880|NCT00764517|365381953|FG001|Overall Study|Death|11|||
105923881|NCT00764517|365381952|FG000|Overall Study|Physician Decision|3|||
105923882|NCT00764517|365381953|FG001|Overall Study|Physician Decision|0|||
105923883|NCT05350423|365381955|FG000|Overall Study|Lost to Follow-up|3|||
105923884|NCT05350423|365381956|FG001|Overall Study|Lost to Follow-up|3|||
105923885|NCT05350423|365381955|FG000|Overall Study|screen failure|5|||
105923886|NCT05350423|365381956|FG001|Overall Study|screen failure|6|||
105923887|NCT01027949|365381964|FG000|Overall Study|Death|174|||
105923888|NCT01027949|365381964|FG000|Overall Study|Progressive Disease|163|||
105923889|NCT01027949|365381964|FG000|Overall Study|Adverse Event|172|||
105923890|NCT01027949|365381964|FG000|Overall Study|Withdrawal by Subject|113|||
105923891|NCT01027949|365381964|FG000|Overall Study|Lost to Follow-up|17|||
105923892|NCT01027949|365381964|FG000|Overall Study|Protocol Violation|13|||
105923893|NCT01027949|365381964|FG000|Overall Study|PI Decision|8|||
105923894|NCT01027949|365381964|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
105923895|NCT01027949|365381964|FG000|Overall Study|Non-compliance with Study Procedures|7|||
105923896|NCT01027949|365381964|FG000|Overall Study|Lung Transplant|5|||
105923897|NCT01027949|365381964|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
105923898|NCT01027949|365381964|FG000|Overall Study|Use of Excluded Medication|2|||
105923899|NCT01027949|365381964|FG000|Overall Study|Patient Self-discontinuation|1|||
105923900|NCT01027949|365381964|FG000|Overall Study|Pregnancy|1|||
105698047|NCT03227471|364559145|FG013|Overall Study|Withdrawal by Subject|0|||
105923901|NCT01027949|365381964|FG000|Overall Study|Surgery|1|||
105923902|NCT00984867|365381971|FG000|Overall Study|Adverse Event|3|||
105923903|NCT00984867|365381972|FG001|Overall Study|Adverse Event|7|||
105923904|NCT00984867|365381971|FG000|Overall Study|Death|1|||
105923905|NCT00984867|365381972|FG001|Overall Study|Death|0|||
105923906|NCT00984867|365381971|FG000|Overall Study|Withdrawal by Subject|13|||
105923907|NCT00984867|365381972|FG001|Overall Study|Withdrawal by Subject|4|||
105923908|NCT00984867|365381971|FG000|Overall Study|Lost to Follow-up|3|||
105923909|NCT00984867|365381972|FG001|Overall Study|Lost to Follow-up|4|||
105923910|NCT00984867|365381971|FG000|Overall Study|Poor/non-compliance|0|||
105923911|NCT00984867|365381972|FG001|Overall Study|Poor/non-compliance|1|||
105923912|NCT00984867|365381971|FG000|Overall Study|Subject no longer meets study criteria|1|||
105923913|NCT00984867|365381972|FG001|Overall Study|Subject no longer meets study criteria|1|||
105923914|NCT00984867|365381971|FG000|Overall Study|site closing|1|||
105923915|NCT00984867|365381972|FG001|Overall Study|site closing|0|||
105923916|NCT00984867|365381971|FG000|Overall Study|lack of efficacy and subject compliance|1|||
105923917|NCT00984867|365381972|FG001|Overall Study|lack of efficacy and subject compliance|0|||
105923918|NCT01541748|365381973|FG000|Overall Study|Lost to Follow-up|17|||
105923919|NCT01541748|365381973|FG000|Overall Study|Moved out of state|1|||
105923920|NCT01541748|365381973|FG000|Overall Study|Withdrawal by Subject|7|||
105923921|NCT01541748|365381973|FG000|Overall Study|Screen failure|5|||
105923922|NCT01541748|365381973|FG000|Overall Study|Did not receive study device|1|||
105923923|NCT00626639|365381981|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
105923924|NCT00626639|365381982|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
105923925|NCT00827567|365381983|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
105923926|NCT00303186|365381985|FG000|Overall Study|Other|52|||
105923927|NCT00851591|365381988|FG000|Overall Study|Withdrawal by Subject|2|||
105923928|NCT00851591|365381989|FG001|Overall Study|Withdrawal by Subject|0|||
105923929|NCT02326883|365381990|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
105923930|NCT02326883|365381991|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
105923931|NCT02326883|365381992|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
105923932|NCT05001620|365381995|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
105923933|NCT05001620|365381996|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
105923934|NCT00481676|365381997|FG000|Overall Study|Adverse Event|0|||
105923935|NCT00481676|365381998|FG001|Overall Study|Adverse Event|1|||
105923936|NCT00481676|365381997|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105923937|NCT00481676|365381998|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105923938|NCT00481676|365381997|FG000|Overall Study|Administrative problem|1|||
105923939|NCT00481676|365381998|FG001|Overall Study|Administrative problem|0|||
105923940|NCT03937778|365381999|FG000|Overall Study|Withdrawal by Subject|1|||
105923941|NCT03937778|365381999|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
105923942|NCT02911116|365382000|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105923943|NCT02911116|365382001|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105923944|NCT02911116|365382000|FG000|Overall Study|Lost to Follow-up|0|||
105923945|NCT02911116|365382001|FG001|Overall Study|Lost to Follow-up|1|||
105923946|NCT01513590|365382002|FG000|Overall Study|Adverse Event|2|||
105923947|NCT01513590|365382003|FG001|Overall Study|Adverse Event|3|||
105923948|NCT01513590|365382002|FG000|Overall Study|Withdrawal Criteria|3|||
105923949|NCT01513590|365382003|FG001|Overall Study|Withdrawal Criteria|0|||
105923950|NCT01513590|365382002|FG000|Overall Study|Unclassified|5|||
105923951|NCT01513590|365382003|FG001|Overall Study|Unclassified|10|||
105923952|NCT01056276|365382004|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
105923953|NCT01056276|365382005|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
105923954|NCT01056276|365382004|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
105923955|NCT01056276|365382005|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
105923956|NCT01056276|365382004|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
105923957|NCT01056276|365382005|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
105923958|NCT01056276|365382004|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
105923959|NCT01056276|365382005|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
105923960|NCT01056276|365382004|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
105923961|NCT01056276|365382005|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
105923962|NCT01056276|365382004|FG000|Treatment Period-Cycles 1-8|Death|3|||
105923963|NCT01056276|365382005|FG001|Treatment Period-Cycles 1-8|Death|1|||
105923964|NCT01056276|365382004|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
105923965|NCT01056276|365382005|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
105923966|NCT01056276|365382004|FG000|Maintenance Therapy|Toxicity|0|||
105923967|NCT01056276|365382005|FG001|Maintenance Therapy|Toxicity|2|||
105923968|NCT01056276|365382004|FG000|Maintenance Therapy|Progressive Disease|0|||
105923969|NCT01056276|365382005|FG001|Maintenance Therapy|Progressive Disease|9|||
105923970|NCT01056276|365382004|FG000|Maintenance Therapy|Physician Decision|0|||
105923971|NCT01056276|365382005|FG001|Maintenance Therapy|Physician Decision|1|||
105923972|NCT01056276|365382004|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
105923973|NCT01056276|365382005|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
105923974|NCT01056276|365382004|FG000|Maintenance Therapy|Intercurrent Illness|0|||
105923975|NCT01056276|365382005|FG001|Maintenance Therapy|Intercurrent Illness|1|||
105923976|NCT01056276|365382004|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
105923977|NCT01056276|365382005|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
105923978|NCT00937950|365382006|FG000|Overall Study|Withdrawal by Subject|23|||
105923979|NCT00937950|365382006|FG000|Overall Study|Migrated/moved from study area|27|||
105923980|NCT00937950|365382006|FG000|Overall Study|Lost to Follow-up|144|||
105923981|NCT00937950|365382006|FG000|Overall Study|Missing confirmed|4|||
105787193|NCT03110107|364874895|FG006|Treatment Period|Participant withdrew consent|0|||
106005169|NCT03740048|365682705|FG001|Overall Study|Non-compliance with HD|1|||
106005170|NCT00918281|365682706|FG000|Overall Study|Physician Decision|29|||
106005171|NCT00083889|365682709|FG000|Overall Study|Adverse Event|76|||
106005172|NCT00083889|365682710|FG001|Overall Study|Adverse Event|86|||
106005173|NCT00083889|365682709|FG000|Overall Study|Protocol Violation|2|||
106005174|NCT00083889|365682710|FG001|Overall Study|Protocol Violation|2|||
106005175|NCT00083889|365682709|FG000|Overall Study|Withdrawal by Subject|22|||
106005176|NCT00083889|365682710|FG001|Overall Study|Withdrawal by Subject|24|||
106005177|NCT00083889|365682709|FG000|Overall Study|Lack of Efficacy|240|||
106005178|NCT00083889|365682710|FG001|Overall Study|Lack of Efficacy|219|||
106005179|NCT00083889|365682709|FG000|Overall Study|Decision of sponsor|32|||
106005180|NCT00083889|365682710|FG001|Overall Study|Decision of sponsor|4|||
106005181|NCT00083889|365682709|FG000|Overall Study|Randomized: did not take study drug|0|||
106005182|NCT00083889|365682710|FG001|Overall Study|Randomized: did not take study drug|15|||
106005183|NCT00083889|365682709|FG000|Overall Study|Completed on marketed sunitinub|3|||
106005184|NCT00083889|365682710|FG001|Overall Study|Completed on marketed sunitinub|0|||
106005185|NCT00083889|365682709|FG000|Overall Study|Crossover to SU011248|0|||
106005186|NCT00083889|365682710|FG001|Overall Study|Crossover to SU011248|25|||
106005187|NCT00168844|365682711|FG000|Overall Study|Adverse Event|31|||
106005188|NCT00168844|365682712|FG001|Overall Study|Adverse Event|32|||
106005189|NCT00168844|365682713|FG002|Overall Study|Adverse Event|48|||
106005190|NCT00168844|365682711|FG000|Overall Study|Lost to Follow-up|4|||
106005191|NCT00168844|365682712|FG001|Overall Study|Lost to Follow-up|5|||
106005192|NCT00168844|365682713|FG002|Overall Study|Lost to Follow-up|11|||
106005193|NCT00168844|365682711|FG000|Overall Study|Withdrawal by Subject|12|||
106005194|NCT00168844|365682712|FG001|Overall Study|Withdrawal by Subject|9|||
106005195|NCT00168844|365682713|FG002|Overall Study|Withdrawal by Subject|19|||
106005196|NCT00168844|365682711|FG000|Overall Study|Protocol Violation|2|||
106005197|NCT00168844|365682712|FG001|Overall Study|Protocol Violation|2|||
106005198|NCT00168844|365682713|FG002|Overall Study|Protocol Violation|4|||
106005199|NCT00168844|365682711|FG000|Overall Study|Other|6|||
106005200|NCT00168844|365682712|FG001|Overall Study|Other|7|||
106005201|NCT00168844|365682713|FG002|Overall Study|Other|9|||
106005202|NCT01339832|365682718|FG000|Overall Study|Lost to Follow-up|3|||
106005203|NCT01339832|365682718|FG000|Overall Study|Death|11|||
106005204|NCT02025179|365682722|FG000|Overall Study|Lost to Follow-up|0|||
106005205|NCT02025179|365682723|FG001|Overall Study|Lost to Follow-up|0|||
106005206|NCT02025179|365682724|FG002|Overall Study|Lost to Follow-up|1|||
106005207|NCT02362724|365682725|FG000|Overall Study|Withdrawal by Subject|3|||
106005208|NCT02362724|365682726|FG001|Overall Study|Withdrawal by Subject|1|||
106005209|NCT02362724|365682725|FG000|Overall Study|Adverse Event|3|||
106005210|NCT02362724|365682726|FG001|Overall Study|Adverse Event|0|||
106005211|NCT01927497|365682727|FG000|Overall Study|Death|0|||
106005212|NCT01927497|365682728|FG001|Overall Study|Death|1|||
106005213|NCT01927497|365682727|FG000|Overall Study|Protocol Violation|2|||
106005214|NCT01927497|365682728|FG001|Overall Study|Protocol Violation|0|||
106005215|NCT03137992|365682729|FG000|Washout Period 1|Adverse Event|1|||
106005216|NCT03137992|365682730|FG001|Washout Period 1|Adverse Event|1|||
105787194|NCT03110107|364874896|FG007|Treatment Period|Participant withdrew consent|0|||
105923982|NCT00937950|365382006|FG000|Overall Study|Other|18|||
105923983|NCT01137786|365382008|FG000|Overall Study|Lost to Follow-up|0|||
105923984|NCT01137786|365382009|FG001|Overall Study|Lost to Follow-up|2|||
105923985|NCT01137786|365382008|FG000|Overall Study|Withdrawal by Subject|1|||
105923986|NCT01137786|365382009|FG001|Overall Study|Withdrawal by Subject|1|||
105923987|NCT01200355|365382012|FG000|Overall Study|Death|7|||
105923988|NCT01200355|365382013|FG001|Overall Study|Death|2|||
105923989|NCT03834350|365382014|FG000|Overall Study|Withdrawal by Subject|1|||
105923990|NCT01572792|365382017|FG000|Lead-in Study|Lost to Follow-up|5|||
105923991|NCT01572792|365382018|FG001|Lead-in Study|Lost to Follow-up|9|||
105923992|NCT01572792|365382019|FG002|Lead-in Study|Lost to Follow-up|4|||
105923993|NCT01572792|365382020|FG003|Lead-in Study|Lost to Follow-up|2|||
105923994|NCT01572792|365382021|FG004|Lead-in Study|Lost to Follow-up|4|||
105923995|NCT01572792|365382017|FG000|Lead-in Study|Withdrawal by Subject|22|||
105923996|NCT01572792|365382018|FG001|Lead-in Study|Withdrawal by Subject|11|||
105923997|NCT01572792|365382019|FG002|Lead-in Study|Withdrawal by Subject|12|||
105923998|NCT01572792|365382020|FG003|Lead-in Study|Withdrawal by Subject|24|||
106005217|NCT03137992|365682731|FG002|Washout Period 1|Adverse Event|0|||
106005218|NCT03137992|365682732|FG003|Washout Period 1|Adverse Event|0|||
106005219|NCT03137992|365682733|FG004|Washout Period 1|Adverse Event|0|||
105923999|NCT01572792|365382021|FG004|Lead-in Study|Withdrawal by Subject|11|||
106005220|NCT03137992|365682734|FG005|Washout Period 1|Adverse Event|1|||
106005221|NCT03137992|365682729|FG000|Washout Period 1|Withdrawal by Subject|0|||
106005222|NCT03137992|365682730|FG001|Washout Period 1|Withdrawal by Subject|1|||
106005223|NCT03137992|365682731|FG002|Washout Period 1|Withdrawal by Subject|1|||
106005224|NCT03137992|365682732|FG003|Washout Period 1|Withdrawal by Subject|0|||
105924000|NCT01572792|365382017|FG000|Lead-in Study|Protocol Violation|19|||
106005225|NCT03137992|365682733|FG004|Washout Period 1|Withdrawal by Subject|0|||
106005226|NCT03137992|365682734|FG005|Washout Period 1|Withdrawal by Subject|0|||
106005227|NCT03137992|365682729|FG000|Washout Period 1|Principal Investigator Discretion|0|||
105924001|NCT01572792|365382018|FG001|Lead-in Study|Protocol Violation|10|||
105924002|NCT01572792|365382019|FG002|Lead-in Study|Protocol Violation|12|||
105924003|NCT01572792|365382020|FG003|Lead-in Study|Protocol Violation|13|||
105924004|NCT01572792|365382021|FG004|Lead-in Study|Protocol Violation|21|||
105924005|NCT01572792|365382017|FG000|Lead-in Study|Lack of Efficacy|20|||
105924006|NCT01572792|365382018|FG001|Lead-in Study|Lack of Efficacy|5|||
105924007|NCT01572792|365382019|FG002|Lead-in Study|Lack of Efficacy|4|||
105924008|NCT01572792|365382020|FG003|Lead-in Study|Lack of Efficacy|8|||
105924009|NCT01572792|365382021|FG004|Lead-in Study|Lack of Efficacy|10|||
106132777|NCT05074498|366144759|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
106132778|NCT05074498|366144754|FG000|Part 1 (Upto Day 104)|Other|1|||
106132779|NCT05074498|366144755|FG001|Part 1 (Upto Day 104)|Other|0|||
106132780|NCT05074498|366144756|FG002|Part 1 (Upto Day 104)|Other|0|||
106132781|NCT05074498|366144757|FG003|Part 1 (Upto Day 104)|Other|0|||
105924010|NCT01572792|365382017|FG000|Lead-in Study|Adverse Event|21|||
105924011|NCT01572792|365382018|FG001|Lead-in Study|Adverse Event|21|||
105924012|NCT01572792|365382019|FG002|Lead-in Study|Adverse Event|22|||
105924013|NCT01572792|365382020|FG003|Lead-in Study|Adverse Event|16|||
105924014|NCT01572792|365382021|FG004|Lead-in Study|Adverse Event|14|||
105924015|NCT01572792|365382017|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
105924016|NCT01572792|365382018|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
105924017|NCT01572792|365382019|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
105924018|NCT01572792|365382020|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
105924019|NCT01572792|365382021|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
105924020|NCT01572792|365382017|FG000|Extension Study|Lost to Follow-up|6|||
105924021|NCT01572792|365382018|FG001|Extension Study|Lost to Follow-up|2|||
105924022|NCT01572792|365382019|FG002|Extension Study|Lost to Follow-up|0|||
105924023|NCT01572792|365382020|FG003|Extension Study|Lost to Follow-up|3|||
105924024|NCT01572792|365382021|FG004|Extension Study|Lost to Follow-up|3|||
105924025|NCT01572792|365382017|FG000|Extension Study|Withdrawal by Subject|7|||
105924026|NCT01572792|365382018|FG001|Extension Study|Withdrawal by Subject|6|||
105924027|NCT01572792|365382019|FG002|Extension Study|Withdrawal by Subject|11|||
105924028|NCT01572792|365382020|FG003|Extension Study|Withdrawal by Subject|8|||
105924029|NCT01572792|365382021|FG004|Extension Study|Withdrawal by Subject|14|||
105924030|NCT01572792|365382017|FG000|Extension Study|Protocol Violation|0|||
105924031|NCT01572792|365382018|FG001|Extension Study|Protocol Violation|4|||
105924032|NCT01572792|365382019|FG002|Extension Study|Protocol Violation|3|||
105924033|NCT01572792|365382020|FG003|Extension Study|Protocol Violation|4|||
105924034|NCT01572792|365382021|FG004|Extension Study|Protocol Violation|3|||
105924035|NCT01572792|365382017|FG000|Extension Study|Lack of Efficacy|2|||
105924036|NCT01572792|365382018|FG001|Extension Study|Lack of Efficacy|3|||
105924037|NCT01572792|365382019|FG002|Extension Study|Lack of Efficacy|3|||
105924038|NCT01572792|365382020|FG003|Extension Study|Lack of Efficacy|2|||
105924039|NCT01572792|365382021|FG004|Extension Study|Lack of Efficacy|2|||
105924040|NCT01572792|365382017|FG000|Extension Study|Adverse Event|7|||
105924041|NCT01572792|365382018|FG001|Extension Study|Adverse Event|6|||
105924042|NCT01572792|365382019|FG002|Extension Study|Adverse Event|5|||
105924043|NCT01572792|365382020|FG003|Extension Study|Adverse Event|6|||
105924044|NCT01572792|365382021|FG004|Extension Study|Adverse Event|4|||
105924045|NCT01572792|365382017|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
105924046|NCT01572792|365382018|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
105924047|NCT01572792|365382019|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
105924048|NCT01572792|365382020|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
105924049|NCT01572792|365382021|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
105924050|NCT02178956|365382022|FG000|Overall Study|Lost to Follow-up|4|||
105924051|NCT02178956|365382023|FG001|Overall Study|Lost to Follow-up|4|||
105924052|NCT02178956|365382022|FG000|Overall Study|Sponsor terminated study|49|||
105924053|NCT02178956|365382023|FG001|Overall Study|Sponsor terminated study|58|||
105924054|NCT02178956|365382022|FG000|Overall Study|Withdrawal by Subject|15|||
105924055|NCT02178956|365382023|FG001|Overall Study|Withdrawal by Subject|11|||
105924056|NCT02178956|365382022|FG000|Overall Study|Various Reasons|3|||
105924057|NCT02178956|365382023|FG001|Overall Study|Various Reasons|5|||
105924058|NCT01910441|365382025|FG000|Overall Study|Sponsor decision|0|||
105924059|NCT01910441|365382026|FG001|Overall Study|Sponsor decision|2|||
105924060|NCT01910441|365382025|FG000|Overall Study|Lost to Follow-up|6|||
105924061|NCT01910441|365382026|FG001|Overall Study|Lost to Follow-up|5|||
105924062|NCT01910441|365382025|FG000|Overall Study|Withdrawal by Subject|0|||
105924063|NCT01910441|365382026|FG001|Overall Study|Withdrawal by Subject|1|||
105924064|NCT01910441|365382025|FG000|Overall Study|Non-compliance|0|||
105924065|NCT01910441|365382026|FG001|Overall Study|Non-compliance|1|||
105924066|NCT01910441|365382025|FG000|Overall Study|Adverse Event|1|||
105924067|NCT01910441|365382026|FG001|Overall Study|Adverse Event|0|||
105924068|NCT01910441|365382025|FG000|Overall Study|Physician Decision|0|||
105924069|NCT01910441|365382026|FG001|Overall Study|Physician Decision|1|||
105924070|NCT02401230|365382033|FG000|Overall Study|Adverse Event|3|||
105924071|NCT02401230|365382034|FG001|Overall Study|Adverse Event|2|||
106132782|NCT05074498|366144758|FG004|Part 1 (Upto Day 104)|Other|0|||
105924072|NCT02401230|365382035|FG002|Overall Study|Adverse Event|0|||
105924073|NCT02401230|365382033|FG000|Overall Study|Withdrawal by Subject|2|||
105924074|NCT02401230|365382034|FG001|Overall Study|Withdrawal by Subject|1|||
105924075|NCT02401230|365382035|FG002|Overall Study|Withdrawal by Subject|1|||
105924076|NCT02401230|365382033|FG000|Overall Study|Lost to Follow-up|1|||
105924077|NCT02401230|365382034|FG001|Overall Study|Lost to Follow-up|3|||
105924078|NCT02401230|365382035|FG002|Overall Study|Lost to Follow-up|3|||
105924079|NCT03122106|365382038|FG000|Overall Study|Not enough tissue|1|||
105924080|NCT03122106|365382038|FG000|Overall Study|Disease progression during screening|2|||
105924081|NCT03122106|365382038|FG000|Overall Study|Poor RNA quality for vaccine|1|||
105924082|NCT00596635|365382039|FG000|Overall Study|Lost to Follow-up|0|||
105924083|NCT00596635|365382040|FG001|Overall Study|Lost to Follow-up|2|||
105924084|NCT00596635|365382041|FG002|Overall Study|Lost to Follow-up|0|||
105924085|NCT00596635|365382039|FG000|Overall Study|Treatment for symptomatic UTI|4|||
105924086|NCT00596635|365382040|FG001|Overall Study|Treatment for symptomatic UTI|6|||
105924087|NCT00596635|365382041|FG002|Overall Study|Treatment for symptomatic UTI|3|||
105924088|NCT00596635|365382039|FG000|Overall Study|Hip fracture|2|||
105924089|NCT00596635|365382040|FG001|Overall Study|Hip fracture|3|||
105924090|NCT00596635|365382041|FG002|Overall Study|Hip fracture|3|||
106005228|NCT03137992|365682730|FG001|Washout Period 1|Principal Investigator Discretion|1|||
106005229|NCT03137992|365682731|FG002|Washout Period 1|Principal Investigator Discretion|0|||
106005230|NCT03137992|365682732|FG003|Washout Period 1|Principal Investigator Discretion|0|||
106005231|NCT03137992|365682733|FG004|Washout Period 1|Principal Investigator Discretion|0|||
106005232|NCT03137992|365682734|FG005|Washout Period 1|Principal Investigator Discretion|0|||
106005233|NCT03137992|365682729|FG000|Washout Period 1|COPD Exacerbation|1|||
106005234|NCT03137992|365682730|FG001|Washout Period 1|COPD Exacerbation|1|||
106005235|NCT03137992|365682731|FG002|Washout Period 1|COPD Exacerbation|1|||
106005236|NCT03137992|365682732|FG003|Washout Period 1|COPD Exacerbation|0|||
106005237|NCT03137992|365682733|FG004|Washout Period 1|COPD Exacerbation|1|||
106005238|NCT03137992|365682734|FG005|Washout Period 1|COPD Exacerbation|1|||
106005239|NCT03137992|365682729|FG000|Washout Period 1|Subject Noncompliance|1|||
106005240|NCT03137992|365682730|FG001|Washout Period 1|Subject Noncompliance|0|||
106005241|NCT03137992|365682731|FG002|Washout Period 1|Subject Noncompliance|0|||
106132783|NCT05074498|366144759|FG005|Part 1 (Upto Day 104)|Other|0|||
105924091|NCT00596635|365382039|FG000|Overall Study|Could not provide urine specimen|1|||
105924092|NCT00596635|365382040|FG001|Overall Study|Could not provide urine specimen|2|||
105924093|NCT00596635|365382041|FG002|Overall Study|Could not provide urine specimen|2|||
105924094|NCT01101178|365382044|FG000|Period 1|Withdrawal by Subject|1|||
105924095|NCT01101178|365382045|FG001|Period 1|Withdrawal by Subject|2|||
105924096|NCT01101178|365382044|FG000|Period 1|Positive drug screen|1|||
105924097|NCT01101178|365382045|FG001|Period 1|Positive drug screen|1|||
105924098|NCT01101178|365382044|FG000|Period 1|Adverse Event|2|||
105924099|NCT01101178|365382045|FG001|Period 1|Adverse Event|1|||
105924100|NCT01101178|365382044|FG000|Period 2|Withdrawal by Subject|0|||
105924101|NCT01101178|365382045|FG001|Period 2|Withdrawal by Subject|1|||
105924102|NCT00724945|365382046|FG000|Period 1|non-compliance|1|||
105924103|NCT00724945|365382047|FG001|Period 1|non-compliance|0|||
105924104|NCT00724945|365382046|FG000|Period 1|Adverse Event|1|||
105924105|NCT00724945|365382047|FG001|Period 1|Adverse Event|1|||
105924106|NCT00724945|365382046|FG000|Period 1|Lost to Follow-up|1|||
105924107|NCT00724945|365382047|FG001|Period 1|Lost to Follow-up|0|||
105924108|NCT00724945|365382046|FG000|Period 2|lens comfort issue|3|||
106005242|NCT03137992|365682732|FG003|Washout Period 1|Subject Noncompliance|0|||
106005243|NCT03137992|365682733|FG004|Washout Period 1|Subject Noncompliance|1|||
106005244|NCT03137992|365682734|FG005|Washout Period 1|Subject Noncompliance|0|||
106132784|NCT05074498|366144754|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
106132785|NCT05074498|366144755|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
106132786|NCT05074498|366144756|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
105924109|NCT00724945|365382047|FG001|Period 2|lens comfort issue|0|||
105924110|NCT00724945|365382046|FG000|Period 2|lens physiology issue|1|||
105924111|NCT00724945|365382047|FG001|Period 2|lens physiology issue|0|||
105924112|NCT01163617|365382048|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105924113|NCT01163617|365382049|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
105924114|NCT01163617|365382050|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105924115|NCT01163617|365382051|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105924116|NCT01163617|365382052|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105924117|NCT01163617|365382053|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105924118|NCT01163617|365382054|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105924119|NCT01163617|365382055|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
105924120|NCT01163617|365382048|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105924121|NCT01163617|365382049|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
106005245|NCT03137992|365682729|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
106005246|NCT03137992|365682730|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
106132787|NCT05074498|366144757|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
105924122|NCT01163617|365382050|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105924123|NCT01163617|365382051|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105924124|NCT01163617|365382052|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105924125|NCT01163617|365382053|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105924126|NCT01163617|365382054|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105924127|NCT01163617|365382055|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
105924128|NCT01163617|365382048|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105924129|NCT01163617|365382049|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105924130|NCT01163617|365382050|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
105924131|NCT01163617|365382051|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105924132|NCT01163617|365382052|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105924133|NCT01163617|365382053|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105924134|NCT01163617|365382054|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105924135|NCT01163617|365382055|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
105924136|NCT02394756|365382056|FG000|Period 1|Lens Discomfort|0|||
105924137|NCT02394756|365382057|FG001|Period 1|Lens Discomfort|0|||
105924138|NCT02394756|365382058|FG002|Period 1|Lens Discomfort|0|||
105924139|NCT02394756|365382059|FG003|Period 1|Lens Discomfort|0|||
105924140|NCT02394756|365382060|FG004|Period 1|Lens Discomfort|0|||
105924141|NCT02394756|365382061|FG005|Period 1|Lens Discomfort|1|||
105924142|NCT02394756|365382056|FG000|Period 1|Withdrawal by Subject|0|||
105924143|NCT02394756|365382057|FG001|Period 1|Withdrawal by Subject|1|||
105924144|NCT02394756|365382058|FG002|Period 1|Withdrawal by Subject|1|||
105924145|NCT02394756|365382059|FG003|Period 1|Withdrawal by Subject|1|||
105924146|NCT02394756|365382060|FG004|Period 1|Withdrawal by Subject|0|||
105924147|NCT02394756|365382061|FG005|Period 1|Withdrawal by Subject|0|||
105924148|NCT02394756|365382056|FG000|Period 2|Unsatisfactory Visual Response|0|||
105924149|NCT02394756|365382057|FG001|Period 2|Unsatisfactory Visual Response|0|||
105924150|NCT02394756|365382058|FG002|Period 2|Unsatisfactory Visual Response|0|||
105924151|NCT02394756|365382059|FG003|Period 2|Unsatisfactory Visual Response|0|||
105924152|NCT02394756|365382060|FG004|Period 2|Unsatisfactory Visual Response|1|||
105924153|NCT02394756|365382061|FG005|Period 2|Unsatisfactory Visual Response|0|||
105924154|NCT01277861|365382063|FG000|Overall Study|Physician Decision|2|||
105924155|NCT01277861|365382064|FG001|Overall Study|Physician Decision|2|||
105924156|NCT01288430|365383960|FG000|Part 1|Progressive disease|2|||
105924157|NCT01288430|365383961|FG001|Part 1|Progressive disease|1|||
105924158|NCT01288430|365383962|FG002|Part 1|Progressive disease|1|||
105924159|NCT01288430|365383963|FG003|Part 1|Progressive disease|6|||
105924160|NCT01288430|365383964|FG004|Part 1|Progressive disease|2|||
105924161|NCT01288430|365383965|FG005|Part 1|Progressive disease|4|||
105924162|NCT01288430|365383966|FG006|Part 1|Progressive disease|2|||
105924163|NCT01288430|365383967|FG007|Part 1|Progressive disease|0|||
105924164|NCT01288430|365383968|FG008|Part 1|Progressive disease|0|||
105924165|NCT01288430|365383969|FG009|Part 1|Progressive disease|0|||
105924166|NCT01288430|365383960|FG000|Part 1|Clinical disease progression|0|||
105924167|NCT01288430|365383961|FG001|Part 1|Clinical disease progression|0|||
105924168|NCT01288430|365383962|FG002|Part 1|Clinical disease progression|1|||
105924169|NCT01288430|365383963|FG003|Part 1|Clinical disease progression|0|||
105924170|NCT01288430|365383964|FG004|Part 1|Clinical disease progression|0|||
105924171|NCT01288430|365383965|FG005|Part 1|Clinical disease progression|2|||
105924172|NCT01288430|365383966|FG006|Part 1|Clinical disease progression|2|||
105924173|NCT01288430|365383967|FG007|Part 1|Clinical disease progression|0|||
105924174|NCT01288430|365383968|FG008|Part 1|Clinical disease progression|0|||
105924175|NCT01288430|365383969|FG009|Part 1|Clinical disease progression|0|||
105924176|NCT01288430|365383960|FG000|Part 1|Death due to disease progression|0|||
105924177|NCT01288430|365383961|FG001|Part 1|Death due to disease progression|0|||
105924178|NCT01288430|365383962|FG002|Part 1|Death due to disease progression|0|||
105924179|NCT01288430|365383963|FG003|Part 1|Death due to disease progression|0|||
105924180|NCT01288430|365383964|FG004|Part 1|Death due to disease progression|1|||
105924181|NCT01288430|365383965|FG005|Part 1|Death due to disease progression|0|||
105924182|NCT01288430|365383966|FG006|Part 1|Death due to disease progression|0|||
105924183|NCT01288430|365383967|FG007|Part 1|Death due to disease progression|0|||
105924184|NCT01288430|365383968|FG008|Part 1|Death due to disease progression|0|||
105924185|NCT01288430|365383969|FG009|Part 1|Death due to disease progression|0|||
105924186|NCT01288430|365383960|FG000|Part 1|Adverse Event|0|||
105924187|NCT01288430|365383961|FG001|Part 1|Adverse Event|0|||
105924188|NCT01288430|365383962|FG002|Part 1|Adverse Event|3|||
105924189|NCT01288430|365383963|FG003|Part 1|Adverse Event|1|||
105924190|NCT01288430|365383964|FG004|Part 1|Adverse Event|0|||
105924191|NCT01288430|365383965|FG005|Part 1|Adverse Event|0|||
105924192|NCT01288430|365383966|FG006|Part 1|Adverse Event|2|||
105924193|NCT01288430|365383967|FG007|Part 1|Adverse Event|0|||
105924194|NCT01288430|365383968|FG008|Part 1|Adverse Event|0|||
105924195|NCT01288430|365383969|FG009|Part 1|Adverse Event|0|||
105924196|NCT01288430|365383960|FG000|Part 1|Other|0|||
105924197|NCT01288430|365383961|FG001|Part 1|Other|2|||
105924198|NCT01288430|365383962|FG002|Part 1|Other|0|||
105924199|NCT01288430|365383963|FG003|Part 1|Other|0|||
105924200|NCT01288430|365383964|FG004|Part 1|Other|0|||
105924201|NCT01288430|365383965|FG005|Part 1|Other|0|||
106005247|NCT03137992|365682731|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
105698048|NCT03227471|364559146|FG014|Overall Study|Withdrawal by Subject|0|||
105698049|NCT03227471|364559132|FG000|Overall Study|Randomized, Never Dosed|0|||
105698050|NCT03227471|364559133|FG001|Overall Study|Randomized, Never Dosed|0|||
105698051|NCT03227471|364559134|FG002|Overall Study|Randomized, Never Dosed|0|||
105698052|NCT03227471|364559135|FG003|Overall Study|Randomized, Never Dosed|0|||
105698053|NCT03227471|364559136|FG004|Overall Study|Randomized, Never Dosed|0|||
105698054|NCT03227471|364559137|FG005|Overall Study|Randomized, Never Dosed|0|||
105698055|NCT03227471|364559138|FG006|Overall Study|Randomized, Never Dosed|0|||
105698056|NCT03227471|364559139|FG007|Overall Study|Randomized, Never Dosed|0|||
105698057|NCT03227471|364559140|FG008|Overall Study|Randomized, Never Dosed|0|||
105698058|NCT03227471|364559141|FG009|Overall Study|Randomized, Never Dosed|0|||
105698059|NCT03227471|364559142|FG010|Overall Study|Randomized, Never Dosed|0|||
105698060|NCT03227471|364559143|FG011|Overall Study|Randomized, Never Dosed|0|||
105698061|NCT03227471|364559144|FG012|Overall Study|Randomized, Never Dosed|0|||
105698062|NCT03227471|364559145|FG013|Overall Study|Randomized, Never Dosed|0|||
105698063|NCT03227471|364559146|FG014|Overall Study|Randomized, Never Dosed|1|||
105698064|NCT00257166|364559150|FG000|Overall Study|Adverse Event|18|||
105698065|NCT00257166|364559151|FG001|Overall Study|Adverse Event|13|||
105698066|NCT00257166|364559150|FG000|Overall Study|Laboratory abnormality|1|||
105698067|NCT00257166|364559151|FG001|Overall Study|Laboratory abnormality|0|||
105698068|NCT00257166|364559150|FG000|Overall Study|Lost to Follow-up|8|||
105698069|NCT00257166|364559151|FG001|Overall Study|Lost to Follow-up|1|||
105698070|NCT00257166|364559150|FG000|Overall Study|Withdrawal by Subject|9|||
105698071|NCT00257166|364559151|FG001|Overall Study|Withdrawal by Subject|2|||
105698072|NCT00257166|364559150|FG000|Overall Study|Other|16|||
105698073|NCT00257166|364559151|FG001|Overall Study|Other|21|||
105698074|NCT00257166|364559150|FG000|Overall Study|Randomized, but not treated|1|||
105698075|NCT00257166|364559151|FG001|Overall Study|Randomized, but not treated|0|||
105698076|NCT00525044|364559158|FG000|Overall Study|Lost to Follow-up|0|||
105698077|NCT00525044|364559159|FG001|Overall Study|Lost to Follow-up|1|||
105698078|NCT02142738|364559165|FG000|Overall Study|Adverse Event|13|||
105698079|NCT02142738|364559166|FG001|Overall Study|Adverse Event|9|||
105698080|NCT02142738|364559165|FG000|Overall Study|Death|92|||
105698081|NCT02142738|364559166|FG001|Overall Study|Death|112|||
105698082|NCT02142738|364559165|FG000|Overall Study|Lost to Follow-up|0|||
105698083|NCT02142738|364559166|FG001|Overall Study|Lost to Follow-up|3|||
105698084|NCT02142738|364559165|FG000|Overall Study|Withdrawal by Subject|6|||
105698085|NCT02142738|364559166|FG001|Overall Study|Withdrawal by Subject|7|||
105698086|NCT02142738|364559165|FG000|Overall Study|Follow up ended by sponsor|43|||
105698087|NCT02142738|364559166|FG001|Overall Study|Follow up ended by sponsor|20|||
105698088|NCT03688880|364559167|FG000|Overall Study|Withdrawal by Subject|0|||
105698089|NCT03688880|364559168|FG001|Overall Study|Withdrawal by Subject|2|||
105698090|NCT03688880|364559167|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
105698091|NCT03688880|364559168|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
105698092|NCT03688880|364559167|FG000|Overall Study|Lost to Follow-up|4|||
105698093|NCT03688880|364559168|FG001|Overall Study|Lost to Follow-up|7|||
105698094|NCT03688880|364559167|FG000|Overall Study|Adverse Event|0|||
105698095|NCT03688880|364559168|FG001|Overall Study|Adverse Event|2|||
105698096|NCT03688880|364559167|FG000|Overall Study|Device deficiencies|0|||
105698097|NCT03688880|364559168|FG001|Overall Study|Device deficiencies|2|||
105698098|NCT03688880|364559167|FG000|Overall Study|Other|10|||
105698099|NCT03688880|364559168|FG001|Overall Study|Other|16|||
105698100|NCT02553265|364559169|FG000|Enrollment|Death|0|||
105698101|NCT02553265|364559170|FG001|Enrollment|Death|0|||
105698102|NCT02553265|364559171|FG002|Enrollment|Death|1|||
105698103|NCT02553265|364559169|FG000|First Intervention (28 Days)|Adverse Event|1|||
105698104|NCT02553265|364559170|FG001|First Intervention (28 Days)|Adverse Event|0|||
105698105|NCT02553265|364559171|FG002|First Intervention (28 Days)|Adverse Event|0|||
105698106|NCT02553265|364559169|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
105698107|NCT02553265|364559170|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
105698108|NCT02553265|364559171|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
105698109|NCT02553265|364559169|FG000|Second Intervention (28 Days)|Adverse Event|1|||
105698110|NCT02553265|364559170|FG001|Second Intervention (28 Days)|Adverse Event|0|||
105698111|NCT02553265|364559171|FG002|Second Intervention (28 Days)|Adverse Event|0|||
105698112|NCT02553265|364559169|FG000|Third Intervention (28 Days)|Adverse Event|1|||
105698113|NCT02553265|364559170|FG001|Third Intervention (28 Days)|Adverse Event|0|||
105698114|NCT02553265|364559171|FG002|Third Intervention (28 Days)|Adverse Event|0|||
105924202|NCT01288430|365383966|FG006|Part 1|Other|1|||
105924203|NCT01288430|365383967|FG007|Part 1|Other|0|||
105924204|NCT01288430|365383968|FG008|Part 1|Other|0|||
105924205|NCT01288430|365383969|FG009|Part 1|Other|0|||
105924206|NCT01288430|365383960|FG000|Part 2|Progressive disease|0|||
105924207|NCT01288430|365383961|FG001|Part 2|Progressive disease|0|||
105924208|NCT01288430|365383962|FG002|Part 2|Progressive disease|0|||
105924209|NCT01288430|365383963|FG003|Part 2|Progressive disease|0|||
105924210|NCT01288430|365383964|FG004|Part 2|Progressive disease|0|||
105924211|NCT01288430|365383965|FG005|Part 2|Progressive disease|0|||
105924212|NCT01288430|365383966|FG006|Part 2|Progressive disease|0|||
105924213|NCT01288430|365383967|FG007|Part 2|Progressive disease|8|||
105924214|NCT01288430|365383968|FG008|Part 2|Progressive disease|7|||
105698115|NCT02553265|364559169|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
105698116|NCT02553265|364559170|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
105698117|NCT02553265|364559171|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
105698118|NCT02163187|364559173|FG000|Overall Study|Device removed|1|||
105698119|NCT02163187|364559174|FG001|Overall Study|Device removed|0|||
105924215|NCT01288430|365383969|FG009|Part 2|Progressive disease|2|||
105924216|NCT01288430|365383960|FG000|Part 2|Clinical disease progression|0|||
105924217|NCT01288430|365383961|FG001|Part 2|Clinical disease progression|0|||
105924218|NCT01288430|365383962|FG002|Part 2|Clinical disease progression|0|||
105924219|NCT01288430|365383963|FG003|Part 2|Clinical disease progression|0|||
105924220|NCT01288430|365383964|FG004|Part 2|Clinical disease progression|0|||
105924221|NCT01288430|365383965|FG005|Part 2|Clinical disease progression|0|||
105924222|NCT01288430|365383966|FG006|Part 2|Clinical disease progression|0|||
105924223|NCT01288430|365383967|FG007|Part 2|Clinical disease progression|2|||
105924224|NCT01288430|365383968|FG008|Part 2|Clinical disease progression|0|||
105924225|NCT01288430|365383969|FG009|Part 2|Clinical disease progression|0|||
105698120|NCT02163187|364559173|FG000|Overall Study|Progressive disease|1|||
105698121|NCT02163187|364559174|FG001|Overall Study|Progressive disease|0|||
105698122|NCT04854434|364559175|FG000|Overall Study|Death|1|||
105698123|NCT04854434|364559176|FG001|Overall Study|Death|3|||
105698124|NCT04854434|364559177|FG002|Overall Study|Death|4|||
105698125|NCT04854434|364559175|FG000|Overall Study|Study Terminated by Sponsor|2|||
105698126|NCT04854434|364559176|FG001|Overall Study|Study Terminated by Sponsor|0|||
105698127|NCT04854434|364559177|FG002|Overall Study|Study Terminated by Sponsor|0|||
105698128|NCT04854434|364559175|FG000|Overall Study|Other|1|||
105698129|NCT04854434|364559176|FG001|Overall Study|Other|1|||
105698130|NCT04854434|364559177|FG002|Overall Study|Other|0|||
105698131|NCT01469182|364559179|FG000|Overall Study|Adverse Event|21|||
105698132|NCT01469182|364559180|FG001|Overall Study|Adverse Event|3|||
105698133|NCT01469182|364559179|FG000|Overall Study|Lost to Follow-up|3|||
105698134|NCT01469182|364559180|FG001|Overall Study|Lost to Follow-up|0|||
105698135|NCT01469182|364559179|FG000|Overall Study|Withdrawal by Subject|4|||
105698136|NCT01469182|364559180|FG001|Overall Study|Withdrawal by Subject|1|||
105698137|NCT01469182|364559179|FG000|Overall Study|Protocol Violation|4|||
105698138|NCT01469182|364559180|FG001|Overall Study|Protocol Violation|2|||
105698139|NCT01469182|364559179|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
105698140|NCT01469182|364559180|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
105698141|NCT00514514|364559181|FG000|Pre-phase|Death|10|||
105698142|NCT00514514|364559182|FG001|Pre-phase|Death|0|||
105698143|NCT00514514|364559183|FG002|Pre-phase|Death|0|||
105698144|NCT00514514|364559181|FG000|Pre-phase|administrative problems|2|||
105698145|NCT00514514|364559182|FG001|Pre-phase|administrative problems|0|||
105698146|NCT00514514|364559183|FG002|Pre-phase|administrative problems|0|||
105698147|NCT00514514|364559181|FG000|Pre-phase|Protocol Violation|6|||
105698148|NCT00514514|364559182|FG001|Pre-phase|Protocol Violation|0|||
105698149|NCT00514514|364559183|FG002|Pre-phase|Protocol Violation|0|||
105698150|NCT00514514|364559181|FG000|Pre-phase|condition no longer requires study drug|7|||
105698151|NCT00514514|364559182|FG001|Pre-phase|condition no longer requires study drug|0|||
105698152|NCT00514514|364559183|FG002|Pre-phase|condition no longer requires study drug|0|||
105698153|NCT00514514|364559181|FG000|Pre-phase|abnormal test procedure results|15|||
105698154|NCT00514514|364559182|FG001|Pre-phase|abnormal test procedure results|0|||
105698155|NCT00514514|364559183|FG002|Pre-phase|abnormal test procedure results|0|||
105698156|NCT00514514|364559181|FG000|Pre-phase|Lost to Follow-up|2|||
105787195|NCT03110107|364874897|FG008|Treatment Period|Participant withdrew consent|0|||
105787196|NCT03110107|364874898|FG009|Treatment Period|Participant withdrew consent|1|||
105787197|NCT03110107|364874899|FG010|Treatment Period|Participant withdrew consent|0|||
105698157|NCT00514514|364559182|FG001|Pre-phase|Lost to Follow-up|0|||
105698158|NCT00514514|364559183|FG002|Pre-phase|Lost to Follow-up|0|||
105698159|NCT00514514|364559181|FG000|Pre-phase|abnormal lab values|23|||
105698160|NCT00514514|364559182|FG001|Pre-phase|abnormal lab values|0|||
105698161|NCT00514514|364559183|FG002|Pre-phase|abnormal lab values|0|||
105698162|NCT00514514|364559181|FG000|Pre-phase|Lack of Efficacy|35|||
105924226|NCT01288430|365383960|FG000|Part 2|Withdrawal by Subject|0|||
105787198|NCT03110107|364874900|FG011|Treatment Period|Participant withdrew consent|0|||
105924227|NCT01288430|365383961|FG001|Part 2|Withdrawal by Subject|0|||
105924228|NCT01288430|365383962|FG002|Part 2|Withdrawal by Subject|0|||
105924229|NCT01288430|365383963|FG003|Part 2|Withdrawal by Subject|0|||
105924230|NCT01288430|365383964|FG004|Part 2|Withdrawal by Subject|0|||
105698163|NCT00514514|364559182|FG001|Pre-phase|Lack of Efficacy|0|||
105698164|NCT00514514|364559183|FG002|Pre-phase|Lack of Efficacy|0|||
105924231|NCT01288430|365383965|FG005|Part 2|Withdrawal by Subject|0|||
105698165|NCT00514514|364559181|FG000|Pre-phase|Adverse Event|137|||
105698166|NCT00514514|364559182|FG001|Pre-phase|Adverse Event|0|||
105698167|NCT00514514|364559183|FG002|Pre-phase|Adverse Event|0|||
105698168|NCT00514514|364559181|FG000|Pre-phase|Withdrawal by Subject|66|||
105698169|NCT00514514|364559182|FG001|Pre-phase|Withdrawal by Subject|0|||
105698170|NCT00514514|364559183|FG002|Pre-phase|Withdrawal by Subject|0|||
105698171|NCT00514514|364559181|FG000|Randomized - 9 Month|Death|3|||
105698172|NCT00514514|364559182|FG001|Randomized - 9 Month|Death|2|||
105698173|NCT00514514|364559183|FG002|Randomized - 9 Month|Death|2|||
105698174|NCT00514514|364559181|FG000|Randomized - 9 Month|Administrative problems|1|||
105698175|NCT00514514|364559182|FG001|Randomized - 9 Month|Administrative problems|1|||
105698176|NCT00514514|364559183|FG002|Randomized - 9 Month|Administrative problems|2|||
105698177|NCT00514514|364559181|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
105698178|NCT00514514|364559182|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
105698179|NCT00514514|364559183|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
105698180|NCT00514514|364559181|FG000|Randomized - 9 Month|Protocol Violation|1|||
105698181|NCT00514514|364559182|FG001|Randomized - 9 Month|Protocol Violation|1|||
105698182|NCT00514514|364559183|FG002|Randomized - 9 Month|Protocol Violation|0|||
105698183|NCT00514514|364559181|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
105698184|NCT00514514|364559182|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
105698185|NCT00514514|364559183|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
105924232|NCT01288430|365383966|FG006|Part 2|Withdrawal by Subject|0|||
105924233|NCT01288430|365383967|FG007|Part 2|Withdrawal by Subject|1|||
105924234|NCT01288430|365383968|FG008|Part 2|Withdrawal by Subject|4|||
105924235|NCT01288430|365383969|FG009|Part 2|Withdrawal by Subject|0|||
105924236|NCT01288430|365383960|FG000|Part 2|Adverse Event|0|||
105924237|NCT01288430|365383961|FG001|Part 2|Adverse Event|0|||
105924238|NCT01288430|365383962|FG002|Part 2|Adverse Event|0|||
105924239|NCT01288430|365383963|FG003|Part 2|Adverse Event|0|||
105924240|NCT01288430|365383964|FG004|Part 2|Adverse Event|0|||
105924241|NCT01288430|365383965|FG005|Part 2|Adverse Event|0|||
105924242|NCT01288430|365383966|FG006|Part 2|Adverse Event|0|||
105924243|NCT01288430|365383967|FG007|Part 2|Adverse Event|1|||
105924244|NCT01288430|365383968|FG008|Part 2|Adverse Event|1|||
105924245|NCT01288430|365383969|FG009|Part 2|Adverse Event|0|||
105924246|NCT01288430|365383960|FG000|Part 2|Other|0|||
105924247|NCT01288430|365383961|FG001|Part 2|Other|0|||
105924248|NCT01288430|365383962|FG002|Part 2|Other|0|||
105924249|NCT01288430|365383963|FG003|Part 2|Other|0|||
105924250|NCT01288430|365383964|FG004|Part 2|Other|0|||
105924251|NCT01288430|365383965|FG005|Part 2|Other|0|||
105924252|NCT01288430|365383966|FG006|Part 2|Other|0|||
105924253|NCT01288430|365383967|FG007|Part 2|Other|0|||
105924254|NCT01288430|365383968|FG008|Part 2|Other|0|||
105924255|NCT01288430|365383969|FG009|Part 2|Other|1|||
105924256|NCT02100631|365383970|FG000|Overall Study|Withdrawal by Subject|1|||
105924257|NCT02100631|365383971|FG001|Overall Study|Withdrawal by Subject|0|||
105924258|NCT02100631|365383972|FG002|Overall Study|Withdrawal by Subject|0|||
105924259|NCT02100631|365383970|FG000|Overall Study|Lost to Follow-up|3|||
105924260|NCT02100631|365383971|FG001|Overall Study|Lost to Follow-up|4|||
105924261|NCT02100631|365383972|FG002|Overall Study|Lost to Follow-up|0|||
105924262|NCT02100631|365383970|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
105924263|NCT02100631|365383971|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
105924264|NCT02100631|365383972|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
105924265|NCT01408641|365383975|FG000|Overall Study|Physician Decision|1|||
105924266|NCT01408641|365383976|FG001|Overall Study|Physician Decision|0|||
105924267|NCT00576758|365383977|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
105924268|NCT00576758|365383978|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
105924269|NCT00576758|365383977|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
105924270|NCT00576758|365383978|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
105924271|NCT00576758|365383977|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
105924272|NCT00576758|365383978|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
105924273|NCT00576758|365383977|FG000|Induction Treatment Period|Death|1|||
105924274|NCT00576758|365383978|FG001|Induction Treatment Period|Death|0|||
105924275|NCT00576758|365383977|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
105924276|NCT00576758|365383978|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
105924277|NCT00576758|365383977|FG000|Induction Treatment Period|Withdrew consent|1|||
105924278|NCT00576758|365383978|FG001|Induction Treatment Period|Withdrew consent|0|||
105924279|NCT00576758|365383977|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
105924280|NCT00576758|365383978|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
105924281|NCT00576758|365383977|FG000|Extension Treatment Period|Death|1|||
105924282|NCT00576758|365383978|FG001|Extension Treatment Period|Death|1|||
105698186|NCT00514514|364559181|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
105698187|NCT00514514|364559182|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
105698188|NCT00514514|364559183|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
105924283|NCT00576758|365383977|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
106005248|NCT03137992|365682732|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
106005249|NCT03137992|365682733|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
106005250|NCT03137992|365682734|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
106005251|NCT03137992|365682729|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
106005252|NCT03137992|365682730|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
106005253|NCT03137992|365682731|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
106005254|NCT03137992|365682732|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
106005255|NCT03137992|365682733|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
106005256|NCT03137992|365682734|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
106005257|NCT03137992|365682729|FG000|Period 2 (Visit 3)|Adverse Event|0|||
106005258|NCT03137992|365682730|FG001|Period 2 (Visit 3)|Adverse Event|1|||
106005259|NCT03137992|365682731|FG002|Period 2 (Visit 3)|Adverse Event|0|||
106005260|NCT03137992|365682732|FG003|Period 2 (Visit 3)|Adverse Event|0|||
106005261|NCT03137992|365682733|FG004|Period 2 (Visit 3)|Adverse Event|0|||
106005262|NCT03137992|365682734|FG005|Period 2 (Visit 3)|Adverse Event|0|||
106005263|NCT03137992|365682729|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
106005264|NCT03137992|365682730|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
106005265|NCT03137992|365682731|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
106005266|NCT03137992|365682732|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
106005267|NCT03137992|365682733|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
106005268|NCT03137992|365682734|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
106005269|NCT03137992|365682729|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
106005270|NCT03137992|365682730|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
106005271|NCT03137992|365682731|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
106005272|NCT03137992|365682732|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
106005273|NCT03137992|365682733|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
106005274|NCT03137992|365682734|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
106005275|NCT03137992|365682729|FG000|Washout Period 2|COPD Exacerbation|1|||
106005276|NCT03137992|365682730|FG001|Washout Period 2|COPD Exacerbation|1|||
106005277|NCT03137992|365682731|FG002|Washout Period 2|COPD Exacerbation|0|||
106005278|NCT03137992|365682732|FG003|Washout Period 2|COPD Exacerbation|0|||
106005279|NCT03137992|365682733|FG004|Washout Period 2|COPD Exacerbation|1|||
106005280|NCT03137992|365682734|FG005|Washout Period 2|COPD Exacerbation|0|||
106005281|NCT03137992|365682729|FG000|Washout Period 2|Subject Non-compliance|0|||
106005282|NCT03137992|365682730|FG001|Washout Period 2|Subject Non-compliance|1|||
106005283|NCT03137992|365682731|FG002|Washout Period 2|Subject Non-compliance|0|||
106005284|NCT03137992|365682732|FG003|Washout Period 2|Subject Non-compliance|0|||
106005285|NCT03137992|365682733|FG004|Washout Period 2|Subject Non-compliance|0|||
106005286|NCT03137992|365682734|FG005|Washout Period 2|Subject Non-compliance|0|||
105924284|NCT00576758|365383978|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
105924285|NCT00576758|365383977|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
105924286|NCT00576758|365383978|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
105924287|NCT00576758|365383977|FG000|Extension Treatment Period|Administrative/Other|3|||
105924288|NCT00576758|365383978|FG001|Extension Treatment Period|Administrative/Other|1|||
105924289|NCT00576758|365383977|FG000|Follow-up Period|Administrative/Other|6|||
105924290|NCT00576758|365383978|FG001|Follow-up Period|Administrative/Other|8|||
105924291|NCT00576758|365383977|FG000|Follow-up Period|Death|3|||
105924292|NCT00576758|365383978|FG001|Follow-up Period|Death|3|||
105924293|NCT00576758|365383977|FG000|Follow-up Period|Insufficient therapeutic response|16|||
105924294|NCT00576758|365383978|FG001|Follow-up Period|Insufficient therapeutic response|5|||
105698189|NCT00514514|364559181|FG000|Randomized - 9 Month|Adverse Event|25|||
105698190|NCT00514514|364559182|FG001|Randomized - 9 Month|Adverse Event|44|||
105698191|NCT00514514|364559183|FG002|Randomized - 9 Month|Adverse Event|27|||
105698192|NCT00514514|364559181|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
105698193|NCT00514514|364559182|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
105698194|NCT00514514|364559183|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
105698195|NCT00514514|364559181|FG000|Extension - 4 Years|Lost to Follow-up|12|||
105698196|NCT00514514|364559182|FG001|Extension - 4 Years|Lost to Follow-up|10|||
105698197|NCT00514514|364559183|FG002|Extension - 4 Years|Lost to Follow-up|9|||
105924295|NCT00576758|365383977|FG000|Follow-up Period|Withdrew consent|2|||
105924296|NCT00576758|365383978|FG001|Follow-up Period|Withdrew consent|1|||
106005287|NCT03137992|365682729|FG000|Washout Period 2|Adverse Event|0|||
106005288|NCT03137992|365682730|FG001|Washout Period 2|Adverse Event|0|||
106005289|NCT03137992|365682731|FG002|Washout Period 2|Adverse Event|0|||
106005290|NCT03137992|365682732|FG003|Washout Period 2|Adverse Event|1|||
106005291|NCT03137992|365682733|FG004|Washout Period 2|Adverse Event|1|||
106005292|NCT03137992|365682734|FG005|Washout Period 2|Adverse Event|0|||
106005293|NCT03137992|365682729|FG000|Washout Period 2|Withdrawal by Subject|1|||
106005294|NCT03137992|365682730|FG001|Washout Period 2|Withdrawal by Subject|0|||
106005295|NCT03137992|365682731|FG002|Washout Period 2|Withdrawal by Subject|0|||
106005296|NCT03137992|365682732|FG003|Washout Period 2|Withdrawal by Subject|0|||
106005297|NCT03137992|365682733|FG004|Washout Period 2|Withdrawal by Subject|1|||
106005298|NCT03137992|365682734|FG005|Washout Period 2|Withdrawal by Subject|0|||
106005299|NCT03137992|365682729|FG000|Washout Period 2|Sponsor Decision|0|||
106005300|NCT03137992|365682730|FG001|Washout Period 2|Sponsor Decision|0|||
105698198|NCT00514514|364559181|FG000|Extension - 4 Years|Administrative problems|3|||
105698199|NCT00514514|364559182|FG001|Extension - 4 Years|Administrative problems|1|||
105698200|NCT00514514|364559183|FG002|Extension - 4 Years|Administrative problems|1|||
105698201|NCT00514514|364559181|FG000|Extension - 4 Years|Death|8|||
105698202|NCT00514514|364559182|FG001|Extension - 4 Years|Death|3|||
105698203|NCT00514514|364559183|FG002|Extension - 4 Years|Death|6|||
105698204|NCT00514514|364559181|FG000|Extension - 4 Years|Adverse Event|9|||
105698205|NCT00514514|364559182|FG001|Extension - 4 Years|Adverse Event|6|||
105698206|NCT00514514|364559183|FG002|Extension - 4 Years|Adverse Event|3|||
105698207|NCT03785925|364559185|FG000|Overall Study|Withdrawal by Subject|15|||
105698208|NCT03785925|364559185|FG000|Overall Study|Lost to Follow-up|1|||
105698209|NCT01756040|364559186|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
105698210|NCT01756040|364559186|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
105698211|NCT01756040|364559186|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
105698212|NCT01274715|364559187|FG000|Overall Study|Lost to Follow-up|1|||
105698213|NCT01274715|364559187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
105698214|NCT01274715|364559187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
105698215|NCT01274715|364559187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
105698216|NCT04479436|364559189|FG000|Overall Study|Progressive disease|26|||
105698217|NCT04479436|364559190|FG001|Overall Study|Progressive disease|1|||
105698218|NCT04479436|364559189|FG000|Overall Study|Adverse Event|6|||
105698219|NCT04479436|364559190|FG001|Overall Study|Adverse Event|0|||
105698220|NCT04479436|364559189|FG000|Overall Study|Withdrawal by Subject|5|||
105698221|NCT04479436|364559190|FG001|Overall Study|Withdrawal by Subject|0|||
105698222|NCT04479436|364559189|FG000|Overall Study|Clinical progression|1|||
105698223|NCT04479436|364559190|FG001|Overall Study|Clinical progression|0|||
105698224|NCT04479436|364559189|FG000|Overall Study|Physician Decision|1|||
105698225|NCT04479436|364559190|FG001|Overall Study|Physician Decision|0|||
105698226|NCT01848288|364559191|FG000|Overall Study|Death|1|||
105698227|NCT01848288|364559191|FG000|Overall Study|Protocol Violation|1|||
105698228|NCT01848288|364559191|FG000|Overall Study|Withdrawal by Subject|1|||
105698229|NCT02865018|364559196|FG000|Overall Study|Withdrawal by Subject|1|||
105698230|NCT00290290|364559197|FG000|Overall Study|Death|3|||
105698231|NCT00290290|364559198|FG001|Overall Study|Death|4|||
105698232|NCT00290290|364559197|FG000|Overall Study|Withdrawal by Subject|2|||
105698233|NCT00290290|364559198|FG001|Overall Study|Withdrawal by Subject|2|||
105698234|NCT00290290|364559197|FG000|Overall Study|Underwent clean surgical procedure|13|||
105698235|NCT00290290|364559198|FG001|Overall Study|Underwent clean surgical procedure|12|||
105698236|NCT00549939|364559203|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
105698237|NCT00549939|364559204|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
105698238|NCT00549939|364559205|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
105698239|NCT00549939|364559203|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
105698240|NCT00549939|364559204|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
105698241|NCT00549939|364559205|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
105698242|NCT00549939|364559203|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
105698243|NCT00549939|364559204|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
105698244|NCT00549939|364559205|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
105698245|NCT00549939|364559203|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
105698246|NCT00549939|364559204|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
105698247|NCT00549939|364559205|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
105698248|NCT00549939|364559203|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
105698249|NCT00549939|364559204|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
105698250|NCT00549939|364559205|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
105698251|NCT00549939|364559203|FG000|40-week Open Label Treatment Period|Other|0|||
105698252|NCT00549939|364559204|FG001|40-week Open Label Treatment Period|Other|1|||
105698253|NCT00549939|364559205|FG002|40-week Open Label Treatment Period|Other|4|||
105698254|NCT01519934|364559208|FG000|Overall Study|Lost to Follow-up|3|||
105698255|NCT01994382|364559209|FG000|Overall Study|Informed consent withdrawn|0|||
105698256|NCT01994382|364559210|FG001|Overall Study|Informed consent withdrawn|0|||
105698257|NCT01994382|364559211|FG002|Overall Study|Informed consent withdrawn|0|||
105698258|NCT01994382|364559212|FG003|Overall Study|Informed consent withdrawn|0|||
105698259|NCT01994382|364559213|FG004|Overall Study|Informed consent withdrawn|0|||
105698260|NCT01994382|364559214|FG005|Overall Study|Informed consent withdrawn|0|||
105698261|NCT01994382|364559215|FG006|Overall Study|Informed consent withdrawn|1|||
105924297|NCT01136954|365383982|FG000|Overall Study|Adverse Event|3|||
105924298|NCT01136954|365383983|FG001|Overall Study|Adverse Event|2|||
105698262|NCT01994382|364559216|FG007|Overall Study|Informed consent withdrawn|0|||
105698263|NCT01994382|364559217|FG008|Overall Study|Informed consent withdrawn|0|||
105698264|NCT01994382|364559218|FG009|Overall Study|Informed consent withdrawn|0|||
105698265|NCT01994382|364559219|FG010|Overall Study|Informed consent withdrawn|0|||
105698266|NCT01994382|364559220|FG011|Overall Study|Informed consent withdrawn|0|||
105698267|NCT01994382|364559221|FG012|Overall Study|Informed consent withdrawn|0|||
105924299|NCT01136954|365383982|FG000|Overall Study|Withdrawal by Subject|6|||
105924300|NCT01136954|365383983|FG001|Overall Study|Withdrawal by Subject|2|||
105924301|NCT01136954|365383982|FG000|Overall Study|Lack of Efficacy|14|||
105924302|NCT01136954|365383983|FG001|Overall Study|Lack of Efficacy|13|||
105924303|NCT01136954|365383982|FG000|Overall Study|Physician Decision|0|||
105924304|NCT01136954|365383983|FG001|Overall Study|Physician Decision|1|||
105924305|NCT01136954|365383982|FG000|Overall Study|Other|1|||
105924306|NCT01136954|365383983|FG001|Overall Study|Other|3|||
105924307|NCT03801252|365383985|FG000|Overall Study|Protocol Violation|1|||
105924308|NCT03801252|365383986|FG001|Overall Study|Protocol Violation|2|||
105924309|NCT02471183|365383987|FG000|Main Treatment Period|Adverse Event|1|||
105924310|NCT02471183|365383987|FG000|Main Treatment Period|Withdrawal by Subject|1|||
105924311|NCT02471183|365383987|FG000|Extended Treatment Period|Lack of Efficacy|1|||
105924312|NCT03345004|365383989|FG000|Overall Study|Physician Decision|1|||
105924313|NCT03345004|365383990|FG001|Overall Study|Physician Decision|0|||
105924314|NCT03345004|365383989|FG000|Overall Study|Withdrawal by Subject|0|||
105924315|NCT03345004|365383990|FG001|Overall Study|Withdrawal by Subject|1|||
105924316|NCT01013753|365383991|FG000|Overall Study|Adverse Event|8|||
105924317|NCT01013753|365383991|FG000|Overall Study|Protocol Violation|3|||
105924318|NCT01013753|365383991|FG000|Overall Study|Lost to Follow-up|1|||
105924319|NCT01013753|365383991|FG000|Overall Study|Withdrawal by Subject|2|||
105924320|NCT01013753|365383991|FG000|Overall Study|Other|2|||
105924321|NCT00393367|365383992|FG000|Overall Study|Protocol Violation|2|||
105924322|NCT00393367|365383993|FG001|Overall Study|Protocol Violation|5|||
105924323|NCT00393367|365383992|FG000|Overall Study|Withdrawal by Subject|0|||
105924324|NCT00393367|365383993|FG001|Overall Study|Withdrawal by Subject|2|||
105924325|NCT00915525|365383996|FG000|Overall Study|Protocol Violation|9|||
105924326|NCT00915525|365383997|FG001|Overall Study|Protocol Violation|4|||
105924327|NCT00915525|365383996|FG000|Overall Study|Withdrawal by Subject|59|||
105924328|NCT00915525|365383997|FG001|Overall Study|Withdrawal by Subject|21|||
105924329|NCT00915525|365383996|FG000|Overall Study|Lost to Follow-up|27|||
105924330|NCT00915525|365383997|FG001|Overall Study|Lost to Follow-up|16|||
105924331|NCT00915525|365383996|FG000|Overall Study|Pregnancy|2|||
105924332|NCT00915525|365383997|FG001|Overall Study|Pregnancy|0|||
105924333|NCT00915525|365383996|FG000|Overall Study|Lack of Efficacy|15|||
105924334|NCT00915525|365383997|FG001|Overall Study|Lack of Efficacy|32|||
105924335|NCT00915525|365383996|FG000|Overall Study|Adverse Event|29|||
105924336|NCT00915525|365383997|FG001|Overall Study|Adverse Event|13|||
105924337|NCT00915525|365383996|FG000|Overall Study|Missing|12|||
105924338|NCT00915525|365383997|FG001|Overall Study|Missing|1|||
105924339|NCT00915525|365383996|FG000|Overall Study|Other Reason|35|||
105924340|NCT00915525|365383997|FG001|Overall Study|Other Reason|12|||
105924341|NCT00915525|365383996|FG000|Overall Study|Site Closed|27|||
105924342|NCT00915525|365383997|FG001|Overall Study|Site Closed|9|||
105924343|NCT00915525|365383996|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
105924344|NCT00915525|365383997|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
105924345|NCT00915525|365383996|FG000|Overall Study|Study Burden|28|||
105924346|NCT00915525|365383997|FG001|Overall Study|Study Burden|12|||
105924347|NCT00915525|365383996|FG000|Overall Study|Non-Compliance|3|||
105924348|NCT00915525|365383997|FG001|Overall Study|Non-Compliance|1|||
105924349|NCT00915525|365383996|FG000|Overall Study|Patient Moved|15|||
105924350|NCT00915525|365383997|FG001|Overall Study|Patient Moved|9|||
105924351|NCT01432327|365383998|FG000|Posttest 3 Months|depression|3|||
105924352|NCT01432327|365383999|FG001|Posttest 3 Months|depression|0|||
105924353|NCT01432327|365384000|FG002|Posttest 3 Months|depression|0|||
105924354|NCT01432327|365384001|FG003|Posttest 3 Months|depression|0|||
105924355|NCT01432327|365383998|FG000|Posttest 3 Months|Lost to Follow-up|1|||
105924356|NCT01432327|365383999|FG001|Posttest 3 Months|Lost to Follow-up|0|||
105924357|NCT01432327|365384000|FG002|Posttest 3 Months|Lost to Follow-up|2|||
105924358|NCT01432327|365384001|FG003|Posttest 3 Months|Lost to Follow-up|1|||
105924359|NCT01432327|365383998|FG000|Posttest 3 Months|Allergic reaction|0|||
105924360|NCT01432327|365383999|FG001|Posttest 3 Months|Allergic reaction|2|||
105924361|NCT01432327|365384000|FG002|Posttest 3 Months|Allergic reaction|0|||
106005301|NCT03137992|365682731|FG002|Washout Period 2|Sponsor Decision|0|||
105924362|NCT01432327|365384001|FG003|Posttest 3 Months|Allergic reaction|0|||
105924363|NCT01432327|365383998|FG000|Posttest 6 Months|Lost to Follow-up|0|||
105924364|NCT01432327|365383999|FG001|Posttest 6 Months|Lost to Follow-up|0|||
105924365|NCT01432327|365384000|FG002|Posttest 6 Months|Lost to Follow-up|3|||
105924366|NCT01432327|365384001|FG003|Posttest 6 Months|Lost to Follow-up|2|||
105924367|NCT01432327|365383998|FG000|Posttest 6 Months|Allergic reaction|0|||
105924368|NCT01432327|365383999|FG001|Posttest 6 Months|Allergic reaction|0|||
105924369|NCT01432327|365384000|FG002|Posttest 6 Months|Allergic reaction|1|||
105924370|NCT01432327|365384001|FG003|Posttest 6 Months|Allergic reaction|0|||
105924371|NCT01432327|365383998|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
106005302|NCT03137992|365682732|FG003|Washout Period 2|Sponsor Decision|0|||
105924372|NCT01432327|365383999|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
105924373|NCT01432327|365384000|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
105924374|NCT01432327|365384001|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
106005303|NCT03137992|365682733|FG004|Washout Period 2|Sponsor Decision|0|||
105698268|NCT01994382|364559222|FG013|Overall Study|Informed consent withdrawn|0|||
105698269|NCT01994382|364559223|FG014|Overall Study|Informed consent withdrawn|0|||
105698270|NCT01994382|364559224|FG015|Overall Study|Informed consent withdrawn|0|||
105698271|NCT01994382|364559225|FG016|Overall Study|Informed consent withdrawn|0|||
105698272|NCT01994382|364559209|FG000|Overall Study|Progressive disease|3|||
105698273|NCT01994382|364559210|FG001|Overall Study|Progressive disease|4|||
105698274|NCT01994382|364559211|FG002|Overall Study|Progressive disease|4|||
105698275|NCT01994382|364559212|FG003|Overall Study|Progressive disease|3|||
105698276|NCT01994382|364559213|FG004|Overall Study|Progressive disease|2|||
105698277|NCT01994382|364559214|FG005|Overall Study|Progressive disease|3|||
105698278|NCT01994382|364559215|FG006|Overall Study|Progressive disease|3|||
105698279|NCT01994382|364559216|FG007|Overall Study|Progressive disease|6|||
105698280|NCT01994382|364559217|FG008|Overall Study|Progressive disease|2|||
105698281|NCT01994382|364559218|FG009|Overall Study|Progressive disease|2|||
105698282|NCT01994382|364559219|FG010|Overall Study|Progressive disease|13|||
105698283|NCT01994382|364559220|FG011|Overall Study|Progressive disease|8|||
105698284|NCT01994382|364559221|FG012|Overall Study|Progressive disease|7|||
105698285|NCT01994382|364559222|FG013|Overall Study|Progressive disease|3|||
105698286|NCT01994382|364559223|FG014|Overall Study|Progressive disease|6|||
105698287|NCT01994382|364559224|FG015|Overall Study|Progressive disease|44|||
105698288|NCT01994382|364559225|FG016|Overall Study|Progressive disease|28|||
105698289|NCT01994382|364559209|FG000|Overall Study|Physician Decision|0|||
105698290|NCT01994382|364559210|FG001|Overall Study|Physician Decision|1|||
105698291|NCT01994382|364559211|FG002|Overall Study|Physician Decision|0|||
105698292|NCT01994382|364559212|FG003|Overall Study|Physician Decision|0|||
105698293|NCT01994382|364559213|FG004|Overall Study|Physician Decision|0|||
105924375|NCT01432327|365383998|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
105924376|NCT01432327|365383999|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
105924377|NCT01432327|365384000|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
105924378|NCT01432327|365384001|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
105924379|NCT01432327|365383998|FG000|Posttest 1 Year|Lost to Follow-up|0|||
105924380|NCT01432327|365383999|FG001|Posttest 1 Year|Lost to Follow-up|0|||
105924381|NCT01432327|365384000|FG002|Posttest 1 Year|Lost to Follow-up|4|||
105924382|NCT01432327|365384001|FG003|Posttest 1 Year|Lost to Follow-up|2|||
105924383|NCT01432327|365383998|FG000|Posttest 1 Year|Allergic reaction|0|||
105924384|NCT01432327|365383999|FG001|Posttest 1 Year|Allergic reaction|0|||
106005304|NCT03137992|365682734|FG005|Washout Period 2|Sponsor Decision|1|||
106005305|NCT03137992|365682729|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
106005306|NCT03137992|365682730|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
106005307|NCT03137992|365682731|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
106005308|NCT03137992|365682732|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
106005309|NCT03137992|365682733|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
106005310|NCT03137992|365682734|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
106005311|NCT03137992|365682729|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
106005312|NCT03137992|365682730|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
106005313|NCT03137992|365682731|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
106005314|NCT03137992|365682732|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
106005315|NCT03137992|365682733|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
106005316|NCT03137992|365682734|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
106005317|NCT03137992|365682729|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
106005318|NCT03137992|365682730|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
106005319|NCT03137992|365682731|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
106005320|NCT03137992|365682732|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
106005321|NCT03137992|365682733|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
106005322|NCT03137992|365682734|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
106005323|NCT03137992|365682729|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
106005324|NCT03137992|365682730|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
106005325|NCT03137992|365682731|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
106005326|NCT03137992|365682732|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
106005327|NCT03137992|365682733|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
106005328|NCT03137992|365682734|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
106005329|NCT03137992|365682729|FG000|Part 2 (Open-label Extension)|Per study team|1|||
105698294|NCT01994382|364559214|FG005|Overall Study|Physician Decision|0|||
105698295|NCT01994382|364559215|FG006|Overall Study|Physician Decision|0|||
105698296|NCT01994382|364559216|FG007|Overall Study|Physician Decision|0|||
105698297|NCT01994382|364559217|FG008|Overall Study|Physician Decision|0|||
105698298|NCT01994382|364559218|FG009|Overall Study|Physician Decision|0|||
105698299|NCT01994382|364559219|FG010|Overall Study|Physician Decision|3|||
105698300|NCT01994382|364559220|FG011|Overall Study|Physician Decision|1|||
105698301|NCT01994382|364559221|FG012|Overall Study|Physician Decision|1|||
105924385|NCT01432327|365384000|FG002|Posttest 1 Year|Allergic reaction|1|||
105924386|NCT01432327|365384001|FG003|Posttest 1 Year|Allergic reaction|1|||
105698302|NCT01994382|364559222|FG013|Overall Study|Physician Decision|0|||
105698303|NCT01994382|364559223|FG014|Overall Study|Physician Decision|1|||
105924387|NCT02097277|365384003|FG000|Overall Study|Subject no longer meets study criteria|0|||
105698304|NCT01994382|364559224|FG015|Overall Study|Physician Decision|4|||
105698305|NCT01994382|364559225|FG016|Overall Study|Physician Decision|2|||
105698306|NCT01994382|364559209|FG000|Overall Study|Death|0|||
105698307|NCT01994382|364559210|FG001|Overall Study|Death|0|||
105698308|NCT01994382|364559211|FG002|Overall Study|Death|0|||
105698309|NCT01994382|364559212|FG003|Overall Study|Death|0|||
105698310|NCT01994382|364559213|FG004|Overall Study|Death|1|||
105698311|NCT01994382|364559214|FG005|Overall Study|Death|0|||
105698312|NCT01994382|364559215|FG006|Overall Study|Death|0|||
105698313|NCT01994382|364559216|FG007|Overall Study|Death|0|||
105698314|NCT01994382|364559217|FG008|Overall Study|Death|1|||
105698315|NCT01994382|364559218|FG009|Overall Study|Death|1|||
105698316|NCT01994382|364559219|FG010|Overall Study|Death|0|||
105698317|NCT01994382|364559220|FG011|Overall Study|Death|0|||
105698318|NCT01994382|364559221|FG012|Overall Study|Death|0|||
105698319|NCT01994382|364559222|FG013|Overall Study|Death|0|||
105698320|NCT01994382|364559223|FG014|Overall Study|Death|0|||
105698321|NCT01994382|364559224|FG015|Overall Study|Death|1|||
105698322|NCT01994382|364559225|FG016|Overall Study|Death|0|||
105698323|NCT01994382|364559209|FG000|Overall Study|Adverse Event|0|||
105698324|NCT01994382|364559210|FG001|Overall Study|Adverse Event|1|||
105698325|NCT01994382|364559211|FG002|Overall Study|Adverse Event|2|||
105698326|NCT01994382|364559212|FG003|Overall Study|Adverse Event|0|||
105698327|NCT01994382|364559213|FG004|Overall Study|Adverse Event|0|||
105698328|NCT01994382|364559214|FG005|Overall Study|Adverse Event|0|||
105698329|NCT01994382|364559215|FG006|Overall Study|Adverse Event|0|||
105698330|NCT01994382|364559216|FG007|Overall Study|Adverse Event|0|||
105698331|NCT01994382|364559217|FG008|Overall Study|Adverse Event|0|||
105698332|NCT01994382|364559218|FG009|Overall Study|Adverse Event|0|||
105698333|NCT01994382|364559219|FG010|Overall Study|Adverse Event|15|||
105698334|NCT01994382|364559220|FG011|Overall Study|Adverse Event|2|||
105698335|NCT01994382|364559221|FG012|Overall Study|Adverse Event|7|||
105698336|NCT01994382|364559222|FG013|Overall Study|Adverse Event|3|||
105698337|NCT01994382|364559223|FG014|Overall Study|Adverse Event|17|||
105698338|NCT01994382|364559224|FG015|Overall Study|Adverse Event|6|||
105698339|NCT01994382|364559225|FG016|Overall Study|Adverse Event|3|||
105698340|NCT01994382|364559209|FG000|Overall Study|Other than specified|0|||
105698341|NCT01994382|364559210|FG001|Overall Study|Other than specified|0|||
105698342|NCT01994382|364559211|FG002|Overall Study|Other than specified|0|||
105698343|NCT01994382|364559212|FG003|Overall Study|Other than specified|0|||
105698344|NCT01994382|364559213|FG004|Overall Study|Other than specified|0|||
105698345|NCT01994382|364559214|FG005|Overall Study|Other than specified|0|||
105698346|NCT01994382|364559215|FG006|Overall Study|Other than specified|0|||
105698347|NCT01994382|364559216|FG007|Overall Study|Other than specified|0|||
105698348|NCT01994382|364559217|FG008|Overall Study|Other than specified|0|||
105698349|NCT01994382|364559218|FG009|Overall Study|Other than specified|0|||
105698350|NCT01994382|364559219|FG010|Overall Study|Other than specified|2|||
105698351|NCT01994382|364559220|FG011|Overall Study|Other than specified|0|||
105698352|NCT01994382|364559221|FG012|Overall Study|Other than specified|2|||
105698353|NCT01994382|364559222|FG013|Overall Study|Other than specified|0|||
105698354|NCT01994382|364559223|FG014|Overall Study|Other than specified|0|||
105698355|NCT01994382|364559224|FG015|Overall Study|Other than specified|4|||
105698356|NCT01994382|364559225|FG016|Overall Study|Other than specified|4|||
105698357|NCT01994382|364559209|FG000|Overall Study|Withdrawal by Subject|0|||
105698358|NCT01994382|364559210|FG001|Overall Study|Withdrawal by Subject|0|||
105698359|NCT01994382|364559211|FG002|Overall Study|Withdrawal by Subject|0|||
105698360|NCT01994382|364559212|FG003|Overall Study|Withdrawal by Subject|0|||
105698361|NCT01994382|364559213|FG004|Overall Study|Withdrawal by Subject|0|||
105698362|NCT01994382|364559214|FG005|Overall Study|Withdrawal by Subject|0|||
105698363|NCT01994382|364559215|FG006|Overall Study|Withdrawal by Subject|0|||
105698364|NCT01994382|364559216|FG007|Overall Study|Withdrawal by Subject|0|||
105698365|NCT01994382|364559217|FG008|Overall Study|Withdrawal by Subject|0|||
105698366|NCT01994382|364559218|FG009|Overall Study|Withdrawal by Subject|0|||
105698367|NCT01994382|364559219|FG010|Overall Study|Withdrawal by Subject|6|||
105698368|NCT01994382|364559220|FG011|Overall Study|Withdrawal by Subject|0|||
105698369|NCT01994382|364559221|FG012|Overall Study|Withdrawal by Subject|2|||
105698370|NCT01994382|364559222|FG013|Overall Study|Withdrawal by Subject|0|||
105698371|NCT01994382|364559223|FG014|Overall Study|Withdrawal by Subject|4|||
105698372|NCT01994382|364559224|FG015|Overall Study|Withdrawal by Subject|3|||
105698373|NCT01994382|364559225|FG016|Overall Study|Withdrawal by Subject|0|||
105698374|NCT01994382|364559209|FG000|Overall Study|Lost to Follow-up|0|||
105698375|NCT01994382|364559210|FG001|Overall Study|Lost to Follow-up|0|||
105698376|NCT01994382|364559211|FG002|Overall Study|Lost to Follow-up|0|||
105698377|NCT01994382|364559212|FG003|Overall Study|Lost to Follow-up|0|||
105698378|NCT01994382|364559213|FG004|Overall Study|Lost to Follow-up|0|||
105698379|NCT01994382|364559214|FG005|Overall Study|Lost to Follow-up|0|||
105698380|NCT01994382|364559215|FG006|Overall Study|Lost to Follow-up|0|||
105698381|NCT01994382|364559216|FG007|Overall Study|Lost to Follow-up|0|||
105698382|NCT01994382|364559217|FG008|Overall Study|Lost to Follow-up|0|||
105698383|NCT01994382|364559218|FG009|Overall Study|Lost to Follow-up|0|||
106005330|NCT03137992|365682730|FG001|Part 2 (Open-label Extension)|Per study team|0|||
106005331|NCT03137992|365682731|FG002|Part 2 (Open-label Extension)|Per study team|0|||
106005332|NCT03137992|365682732|FG003|Part 2 (Open-label Extension)|Per study team|0|||
106005333|NCT03137992|365682733|FG004|Part 2 (Open-label Extension)|Per study team|0|||
105698384|NCT01994382|364559219|FG010|Overall Study|Lost to Follow-up|1|||
105698385|NCT01994382|364559220|FG011|Overall Study|Lost to Follow-up|0|||
105698386|NCT01994382|364559221|FG012|Overall Study|Lost to Follow-up|0|||
105698387|NCT01994382|364559222|FG013|Overall Study|Lost to Follow-up|0|||
105698388|NCT01994382|364559223|FG014|Overall Study|Lost to Follow-up|0|||
105698389|NCT01994382|364559224|FG015|Overall Study|Lost to Follow-up|0|||
105698390|NCT01994382|364559225|FG016|Overall Study|Lost to Follow-up|0|||
105698391|NCT01994382|364559209|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698392|NCT01994382|364559210|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698393|NCT01994382|364559211|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698394|NCT01994382|364559212|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698395|NCT01994382|364559213|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698396|NCT01994382|364559214|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698397|NCT01994382|364559215|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698398|NCT01994382|364559216|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698399|NCT01994382|364559217|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698400|NCT01994382|364559218|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698401|NCT01994382|364559219|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
105698402|NCT01994382|364559220|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698403|NCT01994382|364559221|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
105698404|NCT01994382|364559222|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698405|NCT01994382|364559223|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
105698406|NCT01994382|364559224|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
105698407|NCT01994382|364559225|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
105698408|NCT01994382|364559209|FG000|Overall Study|Protocol violation/noncompliance|0|||
105698409|NCT01994382|364559210|FG001|Overall Study|Protocol violation/noncompliance|0|||
105698410|NCT01994382|364559211|FG002|Overall Study|Protocol violation/noncompliance|0|||
105698411|NCT01994382|364559212|FG003|Overall Study|Protocol violation/noncompliance|0|||
105698412|NCT01994382|364559213|FG004|Overall Study|Protocol violation/noncompliance|0|||
105698413|NCT01994382|364559214|FG005|Overall Study|Protocol violation/noncompliance|0|||
105698414|NCT01994382|364559215|FG006|Overall Study|Protocol violation/noncompliance|0|||
105698415|NCT01994382|364559216|FG007|Overall Study|Protocol violation/noncompliance|0|||
105698416|NCT01994382|364559217|FG008|Overall Study|Protocol violation/noncompliance|0|||
105698417|NCT01994382|364559218|FG009|Overall Study|Protocol violation/noncompliance|0|||
105698418|NCT01994382|364559219|FG010|Overall Study|Protocol violation/noncompliance|0|||
105698419|NCT01994382|364559220|FG011|Overall Study|Protocol violation/noncompliance|1|||
105698420|NCT01994382|364559221|FG012|Overall Study|Protocol violation/noncompliance|0|||
105698421|NCT01994382|364559222|FG013|Overall Study|Protocol violation/noncompliance|0|||
105698422|NCT01994382|364559223|FG014|Overall Study|Protocol violation/noncompliance|0|||
105698423|NCT01994382|364559224|FG015|Overall Study|Protocol violation/noncompliance|0|||
105698424|NCT01994382|364559225|FG016|Overall Study|Protocol violation/noncompliance|2|||
105698425|NCT01994382|364559209|FG000|Overall Study|Rolled over to Phase 2a|0|||
105698426|NCT01994382|364559210|FG001|Overall Study|Rolled over to Phase 2a|0|||
105698427|NCT01994382|364559211|FG002|Overall Study|Rolled over to Phase 2a|1|||
105698428|NCT01994382|364559212|FG003|Overall Study|Rolled over to Phase 2a|0|||
105698429|NCT01994382|364559213|FG004|Overall Study|Rolled over to Phase 2a|0|||
106005334|NCT03137992|365682734|FG005|Part 2 (Open-label Extension)|Per study team|0|||
106005335|NCT03137992|365682729|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
106005336|NCT03137992|365682730|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
106005337|NCT03137992|365682731|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
106005338|NCT03137992|365682732|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
106005339|NCT03137992|365682733|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
106005340|NCT03137992|365682734|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
106005341|NCT03905096|365682735|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
106005342|NCT03905096|365682736|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
106005343|NCT01350999|365682737|FG000|Overall Study|Adverse Event|4|||
105698430|NCT01994382|364559214|FG005|Overall Study|Rolled over to Phase 2a|0|||
105698431|NCT01994382|364559215|FG006|Overall Study|Rolled over to Phase 2a|0|||
105698432|NCT01994382|364559216|FG007|Overall Study|Rolled over to Phase 2a|0|||
105698433|NCT01994382|364559217|FG008|Overall Study|Rolled over to Phase 2a|0|||
105698434|NCT01994382|364559218|FG009|Overall Study|Rolled over to Phase 2a|2|||
106005344|NCT01350999|365682738|FG001|Overall Study|Adverse Event|9|||
106132788|NCT05074498|366144758|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
105698435|NCT01994382|364559219|FG010|Overall Study|Rolled over to Phase 2a|0|||
105698436|NCT01994382|364559220|FG011|Overall Study|Rolled over to Phase 2a|0|||
105698437|NCT01994382|364559221|FG012|Overall Study|Rolled over to Phase 2a|0|||
105698438|NCT01994382|364559222|FG013|Overall Study|Rolled over to Phase 2a|0|||
105698439|NCT01994382|364559223|FG014|Overall Study|Rolled over to Phase 2a|0|||
105698440|NCT01994382|364559224|FG015|Overall Study|Rolled over to Phase 2a|0|||
105698441|NCT01994382|364559225|FG016|Overall Study|Rolled over to Phase 2a|0|||
105698442|NCT01236573|364559228|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698443|NCT01236573|364559229|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698444|NCT01236573|364559230|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698445|NCT01236573|364559231|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698446|NCT01236573|364559232|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698447|NCT01236573|364559233|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698448|NCT01236573|364559234|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
105698449|NCT01236573|364559235|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698450|NCT01236573|364559236|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
105698451|NCT01236573|364559237|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
105698452|NCT01236573|364559238|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
105698453|NCT01236573|364559228|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698454|NCT01236573|364559229|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698455|NCT01236573|364559230|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698456|NCT01236573|364559231|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698457|NCT01236573|364559232|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698458|NCT01236573|364559233|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698459|NCT01236573|364559234|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698460|NCT01236573|364559235|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698461|NCT01236573|364559236|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
105698462|NCT01236573|364559237|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698463|NCT01236573|364559238|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
105698464|NCT01236573|364559228|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698465|NCT01236573|364559229|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698466|NCT01236573|364559230|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698467|NCT01236573|364559231|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698468|NCT01236573|364559232|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698469|NCT01236573|364559233|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698470|NCT01236573|364559234|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698471|NCT01236573|364559235|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105924388|NCT02097277|365384004|FG001|Overall Study|Subject no longer meets study criteria|1|||
105924389|NCT02097277|365384005|FG002|Overall Study|Subject no longer meets study criteria|0|||
105924390|NCT02097277|365384006|FG003|Overall Study|Subject no longer meets study criteria|1|||
105924391|NCT02097277|365384007|FG004|Overall Study|Subject no longer meets study criteria|0|||
105924392|NCT02097277|365384003|FG000|Overall Study|Subject request to discontinue treatment|0|||
105924393|NCT02097277|365384004|FG001|Overall Study|Subject request to discontinue treatment|0|||
105924394|NCT02097277|365384005|FG002|Overall Study|Subject request to discontinue treatment|0|||
105924395|NCT02097277|365384006|FG003|Overall Study|Subject request to discontinue treatment|0|||
105924396|NCT02097277|365384007|FG004|Overall Study|Subject request to discontinue treatment|1|||
105924397|NCT02097277|365384003|FG000|Overall Study|Lost to Follow-up|0|||
105924398|NCT02097277|365384004|FG001|Overall Study|Lost to Follow-up|1|||
105924399|NCT02097277|365384005|FG002|Overall Study|Lost to Follow-up|1|||
105924400|NCT02097277|365384006|FG003|Overall Study|Lost to Follow-up|0|||
106005345|NCT01350999|365682739|FG002|Overall Study|Adverse Event|10|||
106005346|NCT01350999|365682737|FG000|Overall Study|Voluntary withdrawal|3|||
106005347|NCT01350999|365682738|FG001|Overall Study|Voluntary withdrawal|4|||
105698472|NCT01236573|364559236|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698473|NCT01236573|364559237|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
105698474|NCT01236573|364559238|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
105698475|NCT00424749|364559240|FG000|Overall Study|Withdrawal by Subject|1|||
105698476|NCT04534491|364559241|FG000|Overall Study|Not completed end-of-study interview|24|||
105698477|NCT04534491|364559241|FG000|Overall Study|Non-users|70|||
105698478|NCT04534491|364559241|FG000|Overall Study|Non-verifiable users|58|||
105698479|NCT01231659|364559242|FG000|Overall Study|Adverse Event|9|||
105698480|NCT01231659|364559242|FG000|Overall Study|Disease Progression|48|||
105698481|NCT01231659|364559242|FG000|Overall Study|Death|2|||
105924401|NCT02097277|365384007|FG004|Overall Study|Lost to Follow-up|0|||
105924402|NCT02097277|365384003|FG000|Overall Study|Withdrawal by Subject|2|||
105924403|NCT02097277|365384004|FG001|Overall Study|Withdrawal by Subject|1|||
105924404|NCT02097277|365384005|FG002|Overall Study|Withdrawal by Subject|0|||
105924405|NCT02097277|365384006|FG003|Overall Study|Withdrawal by Subject|1|||
105924406|NCT02097277|365384007|FG004|Overall Study|Withdrawal by Subject|0|||
105698482|NCT01231659|364559242|FG000|Overall Study|Patient refused to complete study visit|1|||
105698483|NCT01231659|364559242|FG000|Overall Study|Other protocol defined criteria|12|||
105698484|NCT03000179|364559243|FG000|Overall Study|Lost to Follow-up|2|||
105698485|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
105698486|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
105698487|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
105698488|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
105698489|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
105698490|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
105698491|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
105698492|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
105698493|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
105698494|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
105698495|NCT01299376|364559249|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
105698496|NCT01299376|364559250|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
105698497|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
105698498|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
105698499|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
105698500|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
105698501|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
105698502|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
105698503|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
105698504|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
105698505|NCT01299376|364559249|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
105698506|NCT01299376|364559250|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
105787199|NCT03110107|364874901|FG012|Treatment Period|Participant withdrew consent|0|||
105787200|NCT03110107|364874902|FG013|Treatment Period|Participant withdrew consent|0|||
105787201|NCT03110107|364874903|FG014|Treatment Period|Participant withdrew consent|0|||
105787202|NCT03110107|364874904|FG015|Treatment Period|Participant withdrew consent|0|||
105787203|NCT03110107|364874905|FG016|Treatment Period|Participant withdrew consent|0|||
105787204|NCT03110107|364874906|FG017|Treatment Period|Participant withdrew consent|0|||
105787205|NCT03110107|364874907|FG018|Treatment Period|Participant withdrew consent|0|||
105924407|NCT02097277|365384003|FG000|Overall Study|Adverse Event|0|||
105924408|NCT02097277|365384004|FG001|Overall Study|Adverse Event|0|||
105924409|NCT02097277|365384005|FG002|Overall Study|Adverse Event|1|||
105924410|NCT02097277|365384006|FG003|Overall Study|Adverse Event|2|||
105924411|NCT02097277|365384007|FG004|Overall Study|Adverse Event|0|||
105924412|NCT00577408|365384013|FG000|Overall Study|Stopped attending study visits|9|||
105924413|NCT00577408|365384014|FG001|Overall Study|Stopped attending study visits|11|||
105924414|NCT00577408|365384013|FG000|Overall Study|Continued opioid use|3|||
105924415|NCT00577408|365384014|FG001|Overall Study|Continued opioid use|2|||
105924416|NCT00577408|365384013|FG000|Overall Study|Non-compliance with study meds|0|||
105924417|NCT00577408|365384014|FG001|Overall Study|Non-compliance with study meds|3|||
105924418|NCT00577408|365384013|FG000|Overall Study|Refused Oral Naltrexone|0|||
105924419|NCT00577408|365384014|FG001|Overall Study|Refused Oral Naltrexone|1|||
105924420|NCT00577408|365384013|FG000|Overall Study|Moved out of state|0|||
105924421|NCT00577408|365384014|FG001|Overall Study|Moved out of state|1|||
105924422|NCT00577408|365384013|FG000|Overall Study|Scheduling Issues|0|||
105924423|NCT00577408|365384014|FG001|Overall Study|Scheduling Issues|3|||
105924424|NCT00577408|365384013|FG000|Overall Study|Death|0|||
105924425|NCT00577408|365384014|FG001|Overall Study|Death|1|||
105924426|NCT00577408|365384013|FG000|Overall Study|Psychiatric hospitalization|0|||
105924427|NCT00577408|365384014|FG001|Overall Study|Psychiatric hospitalization|1|||
105924428|NCT01091259|365384015|FG000|Overall Study|Adverse Event|3|||
105924429|NCT01091259|365384015|FG000|Overall Study|Lack of Efficacy|2|||
106132789|NCT05074498|366144759|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
106132790|NCT05074498|366144754|FG000|Part 2 (Upto Day 104)|Death|0|||
106132791|NCT05074498|366144755|FG001|Part 2 (Upto Day 104)|Death|0|||
105698507|NCT00113074|364559252|FG000|Overall Study|Lost to Follow-up|10|||
105698508|NCT00113074|364559253|FG001|Overall Study|Lost to Follow-up|10|||
105698509|NCT00113074|364559254|FG002|Overall Study|Lost to Follow-up|14|||
105698510|NCT02375724|364559255|FG000|Overall Study|Lack of Efficacy|1|||
105698511|NCT02375724|364559256|FG001|Overall Study|Lack of Efficacy|1|||
105924430|NCT03320369|365384016|FG000|Overall Study|Adverse Event|1|||
105924431|NCT03320369|365384016|FG000|Overall Study|Withdrawal by Subject|2|||
105924432|NCT01970371|365384022|FG000|Overall Study|Death|8|||
105924433|NCT01970371|365384023|FG001|Overall Study|Death|13|||
105924434|NCT01970371|365384024|FG002|Overall Study|Death|12|||
105924435|NCT01970371|365384022|FG000|Overall Study|Lost to Follow-up|0|||
105924436|NCT01970371|365384023|FG001|Overall Study|Lost to Follow-up|0|||
105924437|NCT01970371|365384024|FG002|Overall Study|Lost to Follow-up|1|||
105924438|NCT02239328|365384025|FG000|Overall Study|Benign disease noted at time of surgery|6|||
106132792|NCT05074498|366144756|FG002|Part 2 (Upto Day 104)|Death|0|||
105698512|NCT02375724|364559255|FG000|Overall Study|Withdrawal by Subject|1|||
105698513|NCT02375724|364559256|FG001|Overall Study|Withdrawal by Subject|1|||
105698514|NCT02375724|364559255|FG000|Overall Study|Lost to Follow-up|1|||
105698515|NCT02375724|364559256|FG001|Overall Study|Lost to Follow-up|0|||
105698516|NCT02375724|364559255|FG000|Overall Study|Protocol Violation|1|||
105698517|NCT02375724|364559256|FG001|Overall Study|Protocol Violation|0|||
105698518|NCT02375724|364559255|FG000|Overall Study|Adverse Event|2|||
105698519|NCT02375724|364559256|FG001|Overall Study|Adverse Event|4|||
105698520|NCT02114268|364559257|FG000|Overall Study|Lost to Follow-up|4|||
105698521|NCT02114268|364559258|FG001|Overall Study|Lost to Follow-up|1|||
105698522|NCT02114268|364559259|FG002|Overall Study|Lost to Follow-up|1|||
105698523|NCT02114268|364559260|FG003|Overall Study|Lost to Follow-up|0|||
105698524|NCT02114268|364559261|FG004|Overall Study|Lost to Follow-up|0|||
105698525|NCT02114268|364559262|FG005|Overall Study|Lost to Follow-up|2|||
105698526|NCT02114268|364559257|FG000|Overall Study|Withdrawal by Subject|1|||
105698527|NCT02114268|364559258|FG001|Overall Study|Withdrawal by Subject|0|||
105698528|NCT02114268|364559259|FG002|Overall Study|Withdrawal by Subject|0|||
105698529|NCT02114268|364559260|FG003|Overall Study|Withdrawal by Subject|0|||
105698530|NCT02114268|364559261|FG004|Overall Study|Withdrawal by Subject|0|||
105698531|NCT02114268|364559262|FG005|Overall Study|Withdrawal by Subject|1|||
105698532|NCT02114268|364559257|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
105698533|NCT02114268|364559258|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
105698534|NCT02114268|364559259|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
105698535|NCT02114268|364559260|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
105698536|NCT02114268|364559261|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
105698537|NCT02114268|364559262|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
105698538|NCT02285777|364559263|FG000|Overall Study|Withdrawal by Subject|1|||
105698539|NCT02285777|364559264|FG001|Overall Study|Withdrawal by Subject|1|||
105698540|NCT02285777|364559263|FG000|Overall Study|Lost to Follow-up|4|||
105698541|NCT02285777|364559264|FG001|Overall Study|Lost to Follow-up|2|||
105698542|NCT00590044|364559265|FG000|Overall Study|Withdrawal by Subject|2|||
105698543|NCT00590044|364559266|FG001|Overall Study|Withdrawal by Subject|2|||
105698544|NCT00590044|364559265|FG000|Overall Study|wrong insulin arm assigned|1|||
105698545|NCT00590044|364559266|FG001|Overall Study|wrong insulin arm assigned|0|||
105698546|NCT00590044|364559265|FG000|Overall Study|Protocol Violation|1|||
105698547|NCT00590044|364559266|FG001|Overall Study|Protocol Violation|0|||
105698548|NCT01924182|364559267|FG000|Overall Study|Withdrawal by Subject|1|||
105698549|NCT01924182|364559268|FG001|Overall Study|Withdrawal by Subject|0|||
105698550|NCT04425720|364559272|FG000|Overall Study|Withdrawal by Subject|0|||
105698551|NCT04425720|364559273|FG001|Overall Study|Withdrawal by Subject|20|||
105698552|NCT00609986|364559274|FG000|Overall Study|Did not receive transplant or treatment|8|||
105698553|NCT00609986|364559275|FG001|Overall Study|Did not receive transplant or treatment|3|||
105698554|NCT02090413|364559280|FG000|Overall Study|Adverse Event|11|||
105698555|NCT02090413|364559281|FG001|Overall Study|Adverse Event|15|||
105698556|NCT02090413|364559282|FG002|Overall Study|Adverse Event|20|||
105698557|NCT02090413|364559280|FG000|Overall Study|Flushing event|2|||
105698558|NCT02090413|364559281|FG001|Overall Study|Flushing event|0|||
105698559|NCT02090413|364559282|FG002|Overall Study|Flushing event|1|||
105698560|NCT02090413|364559280|FG000|Overall Study|Withdrawal by Subject|2|||
105698561|NCT02090413|364559281|FG001|Overall Study|Withdrawal by Subject|2|||
105698562|NCT02090413|364559282|FG002|Overall Study|Withdrawal by Subject|2|||
105924439|NCT02239328|365384025|FG000|Overall Study|Equipment or website malfunction|2|||
105924440|NCT01348269|365384026|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
105924441|NCT01348269|365384027|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
105924442|NCT01348269|365384026|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
105924443|NCT01348269|365384027|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
105924444|NCT01348269|365384026|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
105924445|NCT01348269|365384027|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
105924446|NCT02412657|365384032|FG000|Overall Study|Lost to Follow-up|1|||
105924447|NCT02412657|365384033|FG001|Overall Study|Lost to Follow-up|0|||
105924448|NCT02412657|365384034|FG002|Overall Study|Lost to Follow-up|0|||
105698563|NCT02090413|364559280|FG000|Overall Study|Investigator Decision|1|||
105698564|NCT02090413|364559281|FG001|Overall Study|Investigator Decision|1|||
105698565|NCT02090413|364559282|FG002|Overall Study|Investigator Decision|0|||
105924449|NCT02412657|365384032|FG000|Overall Study|Protocol Violation|0|||
105698566|NCT02090413|364559280|FG000|Overall Study|Other|2|||
105698567|NCT02090413|364559281|FG001|Overall Study|Other|1|||
105698568|NCT02090413|364559282|FG002|Overall Study|Other|0|||
105698569|NCT02090413|364559280|FG000|Overall Study|Lost to Follow-up|1|||
105698570|NCT02090413|364559281|FG001|Overall Study|Lost to Follow-up|1|||
105698571|NCT02090413|364559282|FG002|Overall Study|Lost to Follow-up|0|||
105698572|NCT04998812|364559283|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
105924450|NCT02412657|365384033|FG001|Overall Study|Protocol Violation|2|||
106005348|NCT01350999|365682739|FG002|Overall Study|Voluntary withdrawal|6|||
105787206|NCT03110107|364874908|FG019|Treatment Period|Participant withdrew consent|1|||
105698573|NCT04998812|364559284|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
105698574|NCT04998812|364559283|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
105698575|NCT04998812|364559284|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
105698576|NCT04998812|364559283|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
105698577|NCT04998812|364559284|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
105698578|NCT04998812|364559283|FG000|Vaccination Period|Ongoing in study|23|||
105698579|NCT04998812|364559284|FG001|Vaccination Period|Ongoing in study|23|||
105698580|NCT03496012|364561271|FG000|Overall Study|Withdrawal by Subject|2|||
105698581|NCT03496012|364561272|FG001|Overall Study|Withdrawal by Subject|0|||
105698582|NCT03496012|364561273|FG002|Overall Study|Withdrawal by Subject|2|||
105698583|NCT03496012|364561271|FG000|Overall Study|Adverse Event|0|||
105698584|NCT03496012|364561272|FG001|Overall Study|Adverse Event|0|||
105698585|NCT03496012|364561273|FG002|Overall Study|Adverse Event|1|||
105698586|NCT03496012|364561271|FG000|Overall Study|Reason Not Specified|2|||
105698587|NCT03496012|364561272|FG001|Overall Study|Reason Not Specified|0|||
105698588|NCT03496012|364561273|FG002|Overall Study|Reason Not Specified|1|||
105698589|NCT04050670|364561276|FG000|Period 3|Physician Decision|0|||
105698590|NCT04050670|364561277|FG001|Period 3|Physician Decision|1|||
105698591|NCT04050670|364561278|FG002|Period 3|Physician Decision|0|||
105698592|NCT00449670|364561280|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
105698593|NCT00449670|364561281|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
105698594|NCT00449670|364561280|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
105698595|NCT00449670|364561281|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
105698596|NCT00449670|364561280|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
105698597|NCT00449670|364561281|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
105698598|NCT00449670|364561280|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
105698599|NCT00449670|364561281|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
105698600|NCT00449670|364561280|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
105698601|NCT00449670|364561281|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
105698602|NCT00449670|364561280|FG000|Booster Phase (Study no.109873)|Other|0|||
105698603|NCT00449670|364561281|FG001|Booster Phase (Study no.109873)|Other|2|||
105698604|NCT04183790|364561285|FG000|Overall Study|Participants did not rollover to Part B|12|||
105698605|NCT04183790|364561286|FG001|Overall Study|Participants did not rollover to Part B|0|||
105698606|NCT04183790|364561285|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
105698607|NCT04183790|364561286|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
105698608|NCT04183790|364561285|FG000|Overall Study|Commercial drug is available for participant|6|||
105698609|NCT04183790|364561286|FG001|Overall Study|Commercial drug is available for participant|0|||
105698610|NCT04183790|364561285|FG000|Overall Study|Adverse Event|1|||
105698611|NCT04183790|364561286|FG001|Overall Study|Adverse Event|0|||
105698612|NCT04183790|364561285|FG000|Overall Study|Not enrolled in 107 study|0|||
105698613|NCT04183790|364561286|FG001|Overall Study|Not enrolled in 107 study|2|||
105698614|NCT01251653|364561287|FG000|Overall Study|Progressive Disease|1|||
105698615|NCT01251653|364561288|FG001|Overall Study|Progressive Disease|7|||
105698616|NCT01251653|364561289|FG002|Overall Study|Progressive Disease|16|||
105698617|NCT01251653|364561290|FG003|Overall Study|Progressive Disease|4|||
105698618|NCT01251653|364561291|FG004|Overall Study|Progressive Disease|0|||
105698619|NCT01251653|364561292|FG005|Overall Study|Progressive Disease|17|||
105698620|NCT01251653|364561293|FG006|Overall Study|Progressive Disease|14|||
105698621|NCT01251653|364561294|FG007|Overall Study|Progressive Disease|7|||
105698622|NCT01251653|364561295|FG008|Overall Study|Progressive Disease|5|||
105924451|NCT02412657|365384034|FG002|Overall Study|Protocol Violation|3|||
105924452|NCT00460798|365384035|FG000|Overall Study|Death|59|||
105924453|NCT00460798|365384035|FG000|Overall Study|Adverse Event|27|||
105924454|NCT00460798|365384035|FG000|Overall Study|Lost to Follow-up|19|||
105924455|NCT00460798|365384035|FG000|Overall Study|Progressive Disease|99|||
105924456|NCT00460798|365384035|FG000|Overall Study|Other|27|||
105924457|NCT00460798|365384035|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
105924458|NCT00460798|365384035|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
106132793|NCT05074498|366144757|FG003|Part 2 (Upto Day 104)|Death|0|||
105698623|NCT01251653|364561287|FG000|Overall Study|Dose-limiting toxicity|0|||
105698624|NCT01251653|364561288|FG001|Overall Study|Dose-limiting toxicity|1|||
105698625|NCT01251653|364561289|FG002|Overall Study|Dose-limiting toxicity|1|||
105698626|NCT01251653|364561290|FG003|Overall Study|Dose-limiting toxicity|1|||
105698627|NCT01251653|364561291|FG004|Overall Study|Dose-limiting toxicity|0|||
105698628|NCT01251653|364561292|FG005|Overall Study|Dose-limiting toxicity|0|||
105698629|NCT01251653|364561293|FG006|Overall Study|Dose-limiting toxicity|2|||
105698630|NCT01251653|364561294|FG007|Overall Study|Dose-limiting toxicity|0|||
105698631|NCT01251653|364561295|FG008|Overall Study|Dose-limiting toxicity|0|||
105924459|NCT00920816|365384036|FG000|Overall Study|Death|116|||
105924460|NCT00920816|365384037|FG001|Overall Study|Death|63|||
105698632|NCT01251653|364561287|FG000|Overall Study|Adverse Event|1|||
105698633|NCT01251653|364561288|FG001|Overall Study|Adverse Event|0|||
105698634|NCT01251653|364561289|FG002|Overall Study|Adverse Event|2|||
105924461|NCT00920816|365384038|FG002|Overall Study|Death|8|||
105698635|NCT01251653|364561290|FG003|Overall Study|Adverse Event|1|||
105698636|NCT01251653|364561291|FG004|Overall Study|Adverse Event|1|||
105698637|NCT01251653|364561292|FG005|Overall Study|Adverse Event|0|||
105698638|NCT01251653|364561293|FG006|Overall Study|Adverse Event|2|||
105698639|NCT01251653|364561294|FG007|Overall Study|Adverse Event|2|||
105698640|NCT01251653|364561295|FG008|Overall Study|Adverse Event|1|||
105698641|NCT01251653|364561287|FG000|Overall Study|Withdrawal by Subject|1|||
105698642|NCT01251653|364561288|FG001|Overall Study|Withdrawal by Subject|0|||
105698643|NCT01251653|364561289|FG002|Overall Study|Withdrawal by Subject|1|||
105698644|NCT01251653|364561290|FG003|Overall Study|Withdrawal by Subject|0|||
105698645|NCT01251653|364561291|FG004|Overall Study|Withdrawal by Subject|1|||
105698646|NCT01251653|364561292|FG005|Overall Study|Withdrawal by Subject|1|||
105924462|NCT00920816|365384039|FG003|Overall Study|Death|3|||
105924463|NCT00920816|365384036|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
105924464|NCT00920816|365384037|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
105924465|NCT00920816|365384038|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
105924466|NCT00920816|365384039|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
105924467|NCT00920816|365384036|FG000|Overall Study|Global deterioration of health status|2|||
105924468|NCT00920816|365384037|FG001|Overall Study|Global deterioration of health status|0|||
105924469|NCT00920816|365384038|FG002|Overall Study|Global deterioration of health status|0|||
105924470|NCT00920816|365384039|FG003|Overall Study|Global deterioration of health status|0|||
105924471|NCT00920816|365384036|FG000|Overall Study|Objective progression or relapse|6|||
105924472|NCT00920816|365384037|FG001|Overall Study|Objective progression or relapse|2|||
105698647|NCT01251653|364561293|FG006|Overall Study|Withdrawal by Subject|0|||
105698648|NCT01251653|364561294|FG007|Overall Study|Withdrawal by Subject|1|||
105698649|NCT01251653|364561295|FG008|Overall Study|Withdrawal by Subject|0|||
105698650|NCT01251653|364561287|FG000|Overall Study|Other reason not mentioned above|0|||
105698651|NCT01251653|364561288|FG001|Overall Study|Other reason not mentioned above|0|||
105698652|NCT01251653|364561289|FG002|Overall Study|Other reason not mentioned above|0|||
105698653|NCT01251653|364561290|FG003|Overall Study|Other reason not mentioned above|0|||
105698654|NCT01251653|364561291|FG004|Overall Study|Other reason not mentioned above|0|||
105698655|NCT01251653|364561292|FG005|Overall Study|Other reason not mentioned above|0|||
105698656|NCT01251653|364561293|FG006|Overall Study|Other reason not mentioned above|0|||
105698657|NCT01251653|364561294|FG007|Overall Study|Other reason not mentioned above|2|||
105698658|NCT01251653|364561295|FG008|Overall Study|Other reason not mentioned above|0|||
105698659|NCT00847145|364561296|FG000|Overall Study|AE or Death|0|||
105698660|NCT00847145|364561297|FG001|Overall Study|AE or Death|1|||
105698661|NCT00847145|364561298|FG002|Overall Study|AE or Death|1|||
105698662|NCT00847145|364561299|FG003|Overall Study|AE or Death|0|||
105698663|NCT00847145|364561300|FG004|Overall Study|AE or Death|0|||
105698664|NCT00847145|364561301|FG005|Overall Study|AE or Death|0|||
105698665|NCT00847145|364561302|FG006|Overall Study|AE or Death|0|||
105698666|NCT00847145|364561303|FG007|Overall Study|AE or Death|0|||
105698667|NCT00847145|364561296|FG000|Overall Study|Withdrawal by Subject|3|||
105698668|NCT00847145|364561297|FG001|Overall Study|Withdrawal by Subject|4|||
105698669|NCT00847145|364561298|FG002|Overall Study|Withdrawal by Subject|6|||
105698670|NCT00847145|364561299|FG003|Overall Study|Withdrawal by Subject|1|||
105698671|NCT00847145|364561300|FG004|Overall Study|Withdrawal by Subject|0|||
105698672|NCT00847145|364561301|FG005|Overall Study|Withdrawal by Subject|0|||
105698673|NCT00847145|364561302|FG006|Overall Study|Withdrawal by Subject|1|||
105698674|NCT00847145|364561303|FG007|Overall Study|Withdrawal by Subject|1|||
105924473|NCT00920816|365384038|FG002|Overall Study|Objective progression or relapse|0|||
105698675|NCT00847145|364561296|FG000|Overall Study|Lost to Follow-up|3|||
105698676|NCT00847145|364561297|FG001|Overall Study|Lost to Follow-up|1|||
105698677|NCT00847145|364561298|FG002|Overall Study|Lost to Follow-up|1|||
105698678|NCT00847145|364561299|FG003|Overall Study|Lost to Follow-up|0|||
105698679|NCT00847145|364561300|FG004|Overall Study|Lost to Follow-up|4|||
105698680|NCT00847145|364561301|FG005|Overall Study|Lost to Follow-up|4|||
105698681|NCT00847145|364561302|FG006|Overall Study|Lost to Follow-up|8|||
105698682|NCT00847145|364561303|FG007|Overall Study|Lost to Follow-up|2|||
105698683|NCT00847145|364561296|FG000|Overall Study|Inappropriate enrollment|0|||
105698684|NCT00847145|364561297|FG001|Overall Study|Inappropriate enrollment|0|||
105698685|NCT00847145|364561298|FG002|Overall Study|Inappropriate enrollment|0|||
105698686|NCT00847145|364561299|FG003|Overall Study|Inappropriate enrollment|0|||
105698687|NCT00847145|364561300|FG004|Overall Study|Inappropriate enrollment|1|||
105698688|NCT00847145|364561301|FG005|Overall Study|Inappropriate enrollment|0|||
105698689|NCT00847145|364561302|FG006|Overall Study|Inappropriate enrollment|0|||
105698690|NCT00847145|364561303|FG007|Overall Study|Inappropriate enrollment|0|||
105698691|NCT00847145|364561296|FG000|Overall Study|Protocol Violation|0|||
105698692|NCT00847145|364561297|FG001|Overall Study|Protocol Violation|0|||
105698693|NCT00847145|364561298|FG002|Overall Study|Protocol Violation|3|||
105698694|NCT00847145|364561299|FG003|Overall Study|Protocol Violation|0|||
105698695|NCT00847145|364561300|FG004|Overall Study|Protocol Violation|1|||
105698696|NCT00847145|364561301|FG005|Overall Study|Protocol Violation|0|||
105924474|NCT00920816|365384039|FG003|Overall Study|Objective progression or relapse|0|||
105924475|NCT00920816|365384036|FG000|Overall Study|Other|26|||
105924476|NCT00920816|365384037|FG001|Overall Study|Other|15|||
105924477|NCT00920816|365384038|FG002|Overall Study|Other|1|||
105924478|NCT00920816|365384039|FG003|Overall Study|Other|2|||
105924479|NCT00920816|365384036|FG000|Overall Study|Lost to Follow-up|11|||
105924480|NCT00920816|365384037|FG001|Overall Study|Lost to Follow-up|2|||
105924481|NCT00920816|365384038|FG002|Overall Study|Lost to Follow-up|0|||
105924482|NCT00920816|365384039|FG003|Overall Study|Lost to Follow-up|0|||
105924483|NCT00920816|365384036|FG000|Overall Study|Adverse Event|1|||
105924484|NCT00920816|365384037|FG001|Overall Study|Adverse Event|1|||
105924485|NCT00920816|365384038|FG002|Overall Study|Adverse Event|1|||
105924486|NCT00920816|365384039|FG003|Overall Study|Adverse Event|0|||
105924487|NCT00920816|365384036|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
105924488|NCT00920816|365384037|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
105924489|NCT00920816|365384038|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
105924490|NCT00920816|365384039|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
105924491|NCT00920816|365384036|FG000|Overall Study|Randomized but not treated|3|||
105924492|NCT00920816|365384037|FG001|Overall Study|Randomized but not treated|0|||
105924493|NCT00920816|365384038|FG002|Overall Study|Randomized but not treated|0|||
105924494|NCT00920816|365384039|FG003|Overall Study|Randomized but not treated|0|||
105924495|NCT01180777|365384044|FG000|Overall Study|Protocol Violation|6|||
105924496|NCT01180777|365384044|FG000|Overall Study|Poor lens fit|4|||
105924497|NCT01180777|365384044|FG000|Overall Study|Lost to Follow-up|1|||
105924498|NCT01180777|365384044|FG000|Overall Study|Adverse Event|1|||
105924499|NCT01281306|365384045|FG000|Overall Study|Lack of Efficacy|0|||
105924500|NCT01281306|365384046|FG001|Overall Study|Lack of Efficacy|1|||
105924501|NCT01281306|365384047|FG002|Overall Study|Lack of Efficacy|3|||
105924502|NCT01281306|365384048|FG003|Overall Study|Lack of Efficacy|0|||
105924503|NCT01281306|365384049|FG004|Overall Study|Lack of Efficacy|2|||
105924504|NCT01281306|365384050|FG005|Overall Study|Lack of Efficacy|0|||
105924505|NCT01281306|365384051|FG006|Overall Study|Lack of Efficacy|1|||
105924506|NCT01281306|365384045|FG000|Overall Study|Withdrawal by Subject|1|||
105924507|NCT01281306|365384046|FG001|Overall Study|Withdrawal by Subject|0|||
105924508|NCT01281306|365384047|FG002|Overall Study|Withdrawal by Subject|2|||
105924509|NCT01281306|365384048|FG003|Overall Study|Withdrawal by Subject|4|||
105924510|NCT01281306|365384049|FG004|Overall Study|Withdrawal by Subject|1|||
105924511|NCT01281306|365384050|FG005|Overall Study|Withdrawal by Subject|3|||
105924512|NCT01281306|365384051|FG006|Overall Study|Withdrawal by Subject|1|||
105924513|NCT01281306|365384045|FG000|Overall Study|Protocol deviation|0|||
105924514|NCT01281306|365384046|FG001|Overall Study|Protocol deviation|1|||
105924515|NCT01281306|365384047|FG002|Overall Study|Protocol deviation|1|||
105924516|NCT01281306|365384048|FG003|Overall Study|Protocol deviation|1|||
105924517|NCT01281306|365384049|FG004|Overall Study|Protocol deviation|1|||
105924518|NCT01281306|365384050|FG005|Overall Study|Protocol deviation|0|||
105924519|NCT01281306|365384051|FG006|Overall Study|Protocol deviation|0|||
105924520|NCT01281306|365384045|FG000|Overall Study|Condition no longer requires study drug|1|||
106005349|NCT01350999|365682737|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
106005350|NCT01350999|365682738|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
105924521|NCT01281306|365384046|FG001|Overall Study|Condition no longer requires study drug|0|||
105924522|NCT01281306|365384047|FG002|Overall Study|Condition no longer requires study drug|0|||
105924523|NCT01281306|365384048|FG003|Overall Study|Condition no longer requires study drug|0|||
105924524|NCT01281306|365384049|FG004|Overall Study|Condition no longer requires study drug|0|||
105924525|NCT01281306|365384050|FG005|Overall Study|Condition no longer requires study drug|1|||
105924526|NCT01281306|365384051|FG006|Overall Study|Condition no longer requires study drug|1|||
105924527|NCT01281306|365384045|FG000|Overall Study|Lost to Follow-up|1|||
105924528|NCT01281306|365384046|FG001|Overall Study|Lost to Follow-up|0|||
105924529|NCT01281306|365384047|FG002|Overall Study|Lost to Follow-up|0|||
106005351|NCT01350999|365682739|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
105698697|NCT00847145|364561302|FG006|Overall Study|Protocol Violation|0|||
105698698|NCT00847145|364561303|FG007|Overall Study|Protocol Violation|1|||
105698699|NCT04419610|364561304|FG000|Overall Study|Withdrawal by Subject|3|||
105924530|NCT01281306|365384048|FG003|Overall Study|Lost to Follow-up|2|||
105924531|NCT01281306|365384049|FG004|Overall Study|Lost to Follow-up|0|||
105924532|NCT01281306|365384050|FG005|Overall Study|Lost to Follow-up|0|||
105924533|NCT01281306|365384051|FG006|Overall Study|Lost to Follow-up|1|||
105924534|NCT01281306|365384045|FG000|Overall Study|Death|1|||
105924535|NCT01281306|365384046|FG001|Overall Study|Death|0|||
105924536|NCT01281306|365384047|FG002|Overall Study|Death|0|||
105924537|NCT01281306|365384048|FG003|Overall Study|Death|0|||
105924538|NCT01281306|365384049|FG004|Overall Study|Death|0|||
105698700|NCT04419610|364561305|FG001|Overall Study|Withdrawal by Subject|1|||
105698701|NCT04419610|364561304|FG000|Overall Study|Adverse Event|1|||
105698702|NCT04419610|364561305|FG001|Overall Study|Adverse Event|0|||
105698703|NCT04419610|364561304|FG000|Overall Study|discharged early|1|||
105698704|NCT04419610|364561305|FG001|Overall Study|discharged early|1|||
105698705|NCT00885703|364561306|FG000|Overall Study|Death|9|||
105698706|NCT00885703|364561307|FG001|Overall Study|Death|7|||
105698707|NCT00885703|364561308|FG002|Overall Study|Death|8|||
105698708|NCT00885703|364561309|FG003|Overall Study|Death|7|||
105698709|NCT00885703|364561310|FG004|Overall Study|Death|7|||
105698710|NCT00885703|364561311|FG005|Overall Study|Death|8|||
105698711|NCT00885703|364561312|FG006|Overall Study|Death|4|||
105698712|NCT00885703|364561306|FG000|Overall Study|Lost to Follow-up|0|||
105698713|NCT00885703|364561307|FG001|Overall Study|Lost to Follow-up|0|||
105698714|NCT00885703|364561308|FG002|Overall Study|Lost to Follow-up|1|||
105698715|NCT00885703|364561309|FG003|Overall Study|Lost to Follow-up|0|||
105698716|NCT00885703|364561310|FG004|Overall Study|Lost to Follow-up|0|||
105698717|NCT00885703|364561311|FG005|Overall Study|Lost to Follow-up|1|||
105698718|NCT00885703|364561312|FG006|Overall Study|Lost to Follow-up|0|||
105698719|NCT00885703|364561306|FG000|Overall Study|Withdrawal by Subject|0|||
105698720|NCT00885703|364561307|FG001|Overall Study|Withdrawal by Subject|0|||
105698721|NCT00885703|364561308|FG002|Overall Study|Withdrawal by Subject|0|||
105698722|NCT00885703|364561309|FG003|Overall Study|Withdrawal by Subject|1|||
105698723|NCT00885703|364561310|FG004|Overall Study|Withdrawal by Subject|3|||
105698724|NCT00885703|364561311|FG005|Overall Study|Withdrawal by Subject|1|||
105698725|NCT00885703|364561312|FG006|Overall Study|Withdrawal by Subject|1|||
105698726|NCT00885703|364561306|FG000|Overall Study|Ineligible (no CM)|1|||
105698727|NCT00885703|364561307|FG001|Overall Study|Ineligible (no CM)|3|||
105698728|NCT00885703|364561308|FG002|Overall Study|Ineligible (no CM)|2|||
105698729|NCT00885703|364561309|FG003|Overall Study|Ineligible (no CM)|1|||
105698730|NCT00885703|364561310|FG004|Overall Study|Ineligible (no CM)|2|||
105698731|NCT00885703|364561311|FG005|Overall Study|Ineligible (no CM)|3|||
105698732|NCT00885703|364561312|FG006|Overall Study|Ineligible (no CM)|1|||
105698733|NCT01717287|364561316|FG000|Overall Study|Lost to Follow-up|0|||
105698734|NCT01717287|364561317|FG001|Overall Study|Lost to Follow-up|2|||
105698735|NCT01717287|364561316|FG000|Overall Study|Protocol Violation|0|||
105698736|NCT01717287|364561317|FG001|Overall Study|Protocol Violation|1|||
105698737|NCT00404820|364561318|FG000|Overall Study|Adverse Event|4|||
105698738|NCT00404820|364561319|FG001|Overall Study|Adverse Event|16|||
105698739|NCT00404820|364561318|FG000|Overall Study|Withdrawal by Subject|5|||
105698740|NCT00404820|364561319|FG001|Overall Study|Withdrawal by Subject|3|||
105698741|NCT00404820|364561318|FG000|Overall Study|Lost to Follow-up|7|||
105698742|NCT00404820|364561319|FG001|Overall Study|Lost to Follow-up|3|||
105698743|NCT00404820|364561318|FG000|Overall Study|Administrative problems|2|||
105698744|NCT00404820|364561319|FG001|Overall Study|Administrative problems|0|||
105924539|NCT01281306|365384050|FG005|Overall Study|Death|0|||
105924540|NCT01281306|365384051|FG006|Overall Study|Death|0|||
105924541|NCT01281306|365384045|FG000|Overall Study|Adverse Event|3|||
106005352|NCT03724942|365682740|FG000|Overall Study|Adverse Event|20|||
106005353|NCT03724942|365682741|FG001|Overall Study|Adverse Event|14|||
106005354|NCT03724942|365682740|FG000|Overall Study|Lack of Efficacy|0|||
106005355|NCT03724942|365682741|FG001|Overall Study|Lack of Efficacy|1|||
106005356|NCT03724942|365682740|FG000|Overall Study|Physician Decision|5|||
106005357|NCT03724942|365682741|FG001|Overall Study|Physician Decision|2|||
106005358|NCT03724942|365682740|FG000|Overall Study|Protocol Violation|1|||
106132794|NCT05074498|366144758|FG004|Part 2 (Upto Day 104)|Death|1|||
105698745|NCT00404820|364561318|FG000|Overall Study|Death|1|||
105698746|NCT00404820|364561319|FG001|Overall Study|Death|0|||
105698747|NCT00404820|364561318|FG000|Overall Study|Other|0|||
105698748|NCT00404820|364561319|FG001|Overall Study|Other|2|||
105698749|NCT01168973|364561320|FG000|Overall Study|Progressive Disease|341|||
105698750|NCT01168973|364561321|FG001|Overall Study|Progressive Disease|429|||
105698751|NCT01168973|364561320|FG000|Overall Study|Adverse Event|94|||
105698752|NCT01168973|364561321|FG001|Overall Study|Adverse Event|55|||
105698753|NCT01168973|364561320|FG000|Overall Study|Withdrawal by Subject|90|||
105698754|NCT01168973|364561321|FG001|Overall Study|Withdrawal by Subject|53|||
105924542|NCT01281306|365384046|FG001|Overall Study|Adverse Event|2|||
105698755|NCT01168973|364561320|FG000|Overall Study|Death|42|||
105698756|NCT01168973|364561321|FG001|Overall Study|Death|45|||
105698757|NCT01168973|364561320|FG000|Overall Study|Physician Decision|37|||
105698758|NCT01168973|364561321|FG001|Overall Study|Physician Decision|19|||
105924543|NCT01281306|365384047|FG002|Overall Study|Adverse Event|2|||
106005359|NCT03724942|365682741|FG001|Overall Study|Protocol Violation|0|||
105698759|NCT01168973|364561320|FG000|Overall Study|Sponsor Decision|2|||
105698760|NCT01168973|364561321|FG001|Overall Study|Sponsor Decision|1|||
105698761|NCT01168973|364561320|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
105698762|NCT01168973|364561321|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
105698763|NCT05092919|364561322|FG000|Overall Study|Lost to Follow-up|7|||
105698764|NCT05092919|364561322|FG000|Overall Study|Withdrawal by Subject|2|||
105924544|NCT01281306|365384048|FG003|Overall Study|Adverse Event|3|||
105924545|NCT01281306|365384049|FG004|Overall Study|Adverse Event|5|||
105924546|NCT01281306|365384050|FG005|Overall Study|Adverse Event|3|||
105924547|NCT01281306|365384051|FG006|Overall Study|Adverse Event|3|||
105924548|NCT01281306|365384045|FG000|Overall Study|Randomized in error|1|||
105924549|NCT01281306|365384046|FG001|Overall Study|Randomized in error|0|||
105924550|NCT01281306|365384047|FG002|Overall Study|Randomized in error|0|||
105924551|NCT01281306|365384048|FG003|Overall Study|Randomized in error|1|||
105924552|NCT01281306|365384049|FG004|Overall Study|Randomized in error|0|||
105924553|NCT01281306|365384050|FG005|Overall Study|Randomized in error|0|||
105924554|NCT01281306|365384051|FG006|Overall Study|Randomized in error|0|||
105924555|NCT04115059|365384052|FG000|Overall Study|Withdrawal by Subject|1|||
105924556|NCT04115059|365384052|FG000|Overall Study|Lack of Efficacy|2|||
105924557|NCT04167462|365384058|FG000|Overall Study|Other reasons|3|||
105924558|NCT04167462|365384059|FG001|Overall Study|Other reasons|2|||
105924559|NCT04167462|365384058|FG000|Overall Study|Withdrawal by Subject|6|||
105924560|NCT04167462|365384059|FG001|Overall Study|Withdrawal by Subject|7|||
105924561|NCT04167462|365384058|FG000|Overall Study|Adverse Event|4|||
105924562|NCT04167462|365384059|FG001|Overall Study|Adverse Event|0|||
105924563|NCT04167462|365384058|FG000|Overall Study|Pregnancy|1|||
105924564|NCT04167462|365384059|FG001|Overall Study|Pregnancy|0|||
105924565|NCT04167462|365384058|FG000|Overall Study|Lack of Efficacy|0|||
105924566|NCT04167462|365384059|FG001|Overall Study|Lack of Efficacy|1|||
105924567|NCT03331562|365384060|FG000|Overall Study|Adverse Event|2|||
105924568|NCT03331562|365384061|FG001|Overall Study|Adverse Event|0|||
105924569|NCT03331562|365384060|FG000|Overall Study|Death|1|||
105924570|NCT03331562|365384061|FG001|Overall Study|Death|0|||
105924571|NCT03718000|365384062|FG000|Overall Study|Relocation|2|||
105924572|NCT03718000|365384063|FG001|Overall Study|Relocation|4|||
105924573|NCT03718000|365384062|FG000|Overall Study|Pregnancy|0|||
105924574|NCT03718000|365384063|FG001|Overall Study|Pregnancy|1|||
105924575|NCT00630292|365384066|FG000|Overall Study|Withdrawal by Subject|1|||
105924576|NCT01582451|365384067|FG000|Overall Study|Adverse Event|1|||
105924577|NCT01582451|365384068|FG001|Overall Study|Adverse Event|3|||
105924578|NCT01582451|365384067|FG000|Overall Study|Death|3|||
105924579|NCT01582451|365384068|FG001|Overall Study|Death|3|||
105924580|NCT01582451|365384067|FG000|Overall Study|Lost to Follow-up|0|||
105924581|NCT01582451|365384068|FG001|Overall Study|Lost to Follow-up|2|||
105924582|NCT01582451|365384067|FG000|Overall Study|Protocol Violation|11|||
105924583|NCT01582451|365384068|FG001|Overall Study|Protocol Violation|3|||
105924584|NCT01582451|365384067|FG000|Overall Study|Withdrawal by Subject|13|||
105924585|NCT01582451|365384068|FG001|Overall Study|Withdrawal by Subject|9|||
105924586|NCT01582451|365384067|FG000|Overall Study|Physician Decision|3|||
105924587|NCT01582451|365384068|FG001|Overall Study|Physician Decision|0|||
105924588|NCT01582451|365384067|FG000|Overall Study|Sponsor Decision|1|||
105924589|NCT01582451|365384068|FG001|Overall Study|Sponsor Decision|0|||
105924590|NCT03620162|365384069|FG000|Overall Study|Physician Decision|4|||
105924591|NCT03620162|365384070|FG001|Overall Study|Physician Decision|0|||
105924592|NCT03620162|365384071|FG002|Overall Study|Physician Decision|1|||
105924593|NCT03620162|365384072|FG003|Overall Study|Physician Decision|0|||
105924594|NCT03620162|365384073|FG004|Overall Study|Physician Decision|2|||
105924595|NCT03620162|365384069|FG000|Overall Study|Lost to Follow-up|2|||
105924596|NCT03620162|365384070|FG001|Overall Study|Lost to Follow-up|6|||
106132795|NCT05074498|366144759|FG005|Part 2 (Upto Day 104)|Death|0|||
106132796|NCT05074498|366144754|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
105698765|NCT02807480|364561323|FG000|Overall Study|Withdrawal by Subject|14|||
105924597|NCT03620162|365384071|FG002|Overall Study|Lost to Follow-up|7|||
105924598|NCT03620162|365384072|FG003|Overall Study|Lost to Follow-up|3|||
105924599|NCT03620162|365384073|FG004|Overall Study|Lost to Follow-up|2|||
105924600|NCT03620162|365384069|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
105924601|NCT03620162|365384070|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
105924602|NCT03620162|365384071|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
105924603|NCT03620162|365384072|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
105924604|NCT03620162|365384073|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
105924605|NCT00487188|365384076|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
105924606|NCT00487188|365384077|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
105924607|NCT00487188|365384078|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
105924608|NCT00487188|365384076|FG000|Induction Phase|Adverse Event|5|||
105698766|NCT02807480|364561324|FG001|Overall Study|Withdrawal by Subject|10|||
105924609|NCT00487188|365384077|FG001|Induction Phase|Adverse Event|0|||
105924610|NCT00487188|365384078|FG002|Induction Phase|Adverse Event|0|||
105924611|NCT00487188|365384076|FG000|Induction Phase|Lack of Efficacy|0|||
105924612|NCT00487188|365384077|FG001|Induction Phase|Lack of Efficacy|1|||
105698767|NCT01007032|364561326|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
105698768|NCT01007032|364561327|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
105698769|NCT01007032|364561328|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
105698770|NCT01007032|364561329|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
105698771|NCT01007032|364561326|FG000|Overall Study|Withdrawal by Subject|0|||
105698772|NCT01007032|364561327|FG001|Overall Study|Withdrawal by Subject|0|||
105698773|NCT01007032|364561328|FG002|Overall Study|Withdrawal by Subject|0|||
106005360|NCT03724942|365682740|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
106005361|NCT03724942|365682741|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
106005362|NCT03724942|365682740|FG000|Overall Study|Withdrawal by Legal Representative|3|||
106005363|NCT03724942|365682741|FG001|Overall Study|Withdrawal by Legal Representative|0|||
106005364|NCT01602224|365684678|FG000|Overall Study|Adverse Event|0|||
106132797|NCT05074498|366144755|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
106132798|NCT05074498|366144756|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
106132799|NCT05074498|366144757|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
106132800|NCT05074498|366144758|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
106132801|NCT05074498|366144759|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
106132802|NCT05074498|366144754|FG000|Part 2 (Upto Day 104)|Other|0|||
106132803|NCT05074498|366144755|FG001|Part 2 (Upto Day 104)|Other|0|||
106132804|NCT05074498|366144756|FG002|Part 2 (Upto Day 104)|Other|0|||
106132805|NCT05074498|366144757|FG003|Part 2 (Upto Day 104)|Other|0|||
106132806|NCT05074498|366144758|FG004|Part 2 (Upto Day 104)|Other|1|||
106132807|NCT05074498|366144759|FG005|Part 2 (Upto Day 104)|Other|0|||
106132808|NCT00946114|366144762|FG000|Overall Study|Death|5|||
106132809|NCT00946114|366144763|FG001|Overall Study|Death|2|||
106132810|NCT00946114|366144762|FG000|Overall Study|Other|1|||
105698774|NCT01007032|364561329|FG003|Overall Study|Withdrawal by Subject|1|||
105698775|NCT02285920|364561331|FG000|Overall Study|Kidney transplantation|2|||
105698776|NCT02285920|364561332|FG001|Overall Study|Kidney transplantation|2|||
105698777|NCT02285920|364561333|FG002|Overall Study|Kidney transplantation|2|||
105698778|NCT02285920|364561334|FG003|Overall Study|Kidney transplantation|0|||
105924613|NCT00487188|365384078|FG002|Induction Phase|Lack of Efficacy|0|||
105924614|NCT00487188|365384076|FG000|Induction Phase|Protocol Violation|1|||
105924615|NCT00487188|365384077|FG001|Induction Phase|Protocol Violation|0|||
105924616|NCT00487188|365384078|FG002|Induction Phase|Protocol Violation|0|||
105924617|NCT00487188|365384076|FG000|Induction Phase|Refused Treatment|1|||
105924618|NCT00487188|365384077|FG001|Induction Phase|Refused Treatment|2|||
105924619|NCT00487188|365384078|FG002|Induction Phase|Refused Treatment|0|||
105924620|NCT00487188|365384076|FG000|Induction Phase|Lost to Follow-up|2|||
105924621|NCT00487188|365384077|FG001|Induction Phase|Lost to Follow-up|2|||
105924622|NCT00487188|365384078|FG002|Induction Phase|Lost to Follow-up|0|||
105924623|NCT00487188|365384076|FG000|Induction Phase|Administrative|0|||
105924624|NCT00487188|365384077|FG001|Induction Phase|Administrative|1|||
105924625|NCT00487188|365384078|FG002|Induction Phase|Administrative|0|||
105924626|NCT00487188|365384076|FG000|Maintenance Phase|Adverse Event|1|||
105924627|NCT00487188|365384077|FG001|Maintenance Phase|Adverse Event|0|||
105924628|NCT00487188|365384078|FG002|Maintenance Phase|Adverse Event|0|||
105924629|NCT00487188|365384076|FG000|Maintenance Phase|Death|1|||
105924630|NCT00487188|365384077|FG001|Maintenance Phase|Death|0|||
105924631|NCT00487188|365384078|FG002|Maintenance Phase|Death|0|||
105924632|NCT00487188|365384076|FG000|Maintenance Phase|Lost to Follow-up|1|||
105924633|NCT00487188|365384077|FG001|Maintenance Phase|Lost to Follow-up|0|||
105924634|NCT00487188|365384078|FG002|Maintenance Phase|Lost to Follow-up|0|||
105924635|NCT00487188|365384076|FG000|Maintenance Phase|Administrative|0|||
105924636|NCT00487188|365384077|FG001|Maintenance Phase|Administrative|0|||
105924637|NCT00487188|365384078|FG002|Maintenance Phase|Administrative|1|||
105924638|NCT02472353|365384080|FG000|Overall Study|Lost to Follow-up|1|||
105924639|NCT02472353|365384081|FG001|Overall Study|Lost to Follow-up|1|||
105924640|NCT02472353|365384080|FG000|Overall Study|Withdrawal by Subject|2|||
105924641|NCT02472353|365384081|FG001|Overall Study|Withdrawal by Subject|1|||
105924642|NCT02472353|365384080|FG000|Overall Study|Study Termination|1|||
105924643|NCT02472353|365384081|FG001|Overall Study|Study Termination|4|||
105924644|NCT02101294|365384082|FG000|Overall Study|Withdrawal by Subject|5|||
105924645|NCT02101294|365384082|FG000|Overall Study|Lost to Follow-up|6|||
105924646|NCT03416179|365384083|FG000|Overall Study|Death|90|||
105924647|NCT03416179|365384084|FG001|Overall Study|Death|87|||
105924648|NCT03416179|365384085|FG002|Overall Study|Death|117|||
105924649|NCT03416179|365384086|FG003|Overall Study|Death|113|||
105924650|NCT03416179|365384083|FG000|Overall Study|Withdrawal by Subject|15|||
105924651|NCT03416179|365384084|FG001|Overall Study|Withdrawal by Subject|20|||
105924652|NCT03416179|365384085|FG002|Overall Study|Withdrawal by Subject|6|||
105924653|NCT03416179|365384086|FG003|Overall Study|Withdrawal by Subject|9|||
105924654|NCT03416179|365384083|FG000|Overall Study|Lost to Follow-up|1|||
105924655|NCT03416179|365384084|FG001|Overall Study|Lost to Follow-up|1|||
105924656|NCT03416179|365384085|FG002|Overall Study|Lost to Follow-up|0|||
105924657|NCT03416179|365384086|FG003|Overall Study|Lost to Follow-up|3|||
106132811|NCT00946114|366144763|FG001|Overall Study|Other|0|||
106132812|NCT00946114|366144762|FG000|Overall Study|Withdrawal by Subject|2|||
106132813|NCT00946114|366144763|FG001|Overall Study|Withdrawal by Subject|0|||
106132814|NCT00051311|366144777|FG000|Overall Study|Starting new study|0|||
106132815|NCT00051311|366144778|FG001|Overall Study|Starting new study|1|||
106132816|NCT00051311|366144777|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
106132817|NCT00051311|366144778|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
106132818|NCT00051311|366144777|FG000|Overall Study|Death of recipient|8|||
106132819|NCT00051311|366144778|FG001|Overall Study|Death of recipient|8|||
106132820|NCT00051311|366144777|FG000|Overall Study|Recipient taken off study|4|||
106132821|NCT00051311|366144778|FG001|Overall Study|Recipient taken off study|4|||
106132822|NCT03532178|366144792|FG000|First Period|Withdrawal by Subject|1|||
106132823|NCT03532178|366144793|FG001|First Period|Withdrawal by Subject|3|||
105698779|NCT02285920|364561331|FG000|Overall Study|Change to peritoneal dialysis|0|||
105698780|NCT02285920|364561332|FG001|Overall Study|Change to peritoneal dialysis|0|||
105698781|NCT02285920|364561333|FG002|Overall Study|Change to peritoneal dialysis|1|||
105698782|NCT02285920|364561334|FG003|Overall Study|Change to peritoneal dialysis|0|||
105698783|NCT02285920|364561331|FG000|Overall Study|Transfer to non-participating unit|0|||
105698784|NCT02285920|364561332|FG001|Overall Study|Transfer to non-participating unit|1|||
105698785|NCT02285920|364561333|FG002|Overall Study|Transfer to non-participating unit|0|||
105698786|NCT02285920|364561334|FG003|Overall Study|Transfer to non-participating unit|0|||
105924658|NCT03416179|365384083|FG000|Overall Study|Study participation terminated by Sponsor|93|||
105924659|NCT03416179|365384084|FG001|Overall Study|Study participation terminated by Sponsor|91|||
105924660|NCT03416179|365384085|FG002|Overall Study|Study participation terminated by Sponsor|26|||
105924661|NCT03416179|365384086|FG003|Overall Study|Study participation terminated by Sponsor|31|||
105924662|NCT03416179|365384083|FG000|Overall Study|Other|2|||
105924663|NCT03416179|365384084|FG001|Overall Study|Other|3|||
105924664|NCT03416179|365384085|FG002|Overall Study|Other|1|||
105924665|NCT03416179|365384086|FG003|Overall Study|Other|0|||
105924666|NCT01682031|365384091|FG000|Overall Study|Withdrawal by Subject|0|||
105924667|NCT01682031|365384092|FG001|Overall Study|Withdrawal by Subject|1|||
105924668|NCT01682031|365384091|FG000|Overall Study|Adverse Event|0|||
105924669|NCT01682031|365384092|FG001|Overall Study|Adverse Event|2|||
105924670|NCT01682031|365384091|FG000|Overall Study|MRI results indicate increased nodul|0|||
105924671|NCT01682031|365384092|FG001|Overall Study|MRI results indicate increased nodul|1|||
105924672|NCT01682031|365384091|FG000|Overall Study|Patient could not swallow tablets|1|||
105924673|NCT01682031|365384092|FG001|Overall Study|Patient could not swallow tablets|0|||
106005365|NCT01602224|365684679|FG001|Overall Study|Adverse Event|1|||
106005366|NCT01602224|365684680|FG002|Overall Study|Adverse Event|0|||
106005367|NCT01602224|365684678|FG000|Overall Study|Investigator Decison|1|||
106005368|NCT01602224|365684679|FG001|Overall Study|Investigator Decison|0|||
106005369|NCT01602224|365684680|FG002|Overall Study|Investigator Decison|0|||
106005370|NCT01602224|365684678|FG000|Overall Study|Lost to Follow-up|0|||
106005371|NCT01602224|365684679|FG001|Overall Study|Lost to Follow-up|0|||
106005372|NCT01602224|365684680|FG002|Overall Study|Lost to Follow-up|1|||
106005373|NCT01602224|365684678|FG000|Overall Study|Protocol Violation|0|||
106005374|NCT01602224|365684679|FG001|Overall Study|Protocol Violation|1|||
106005375|NCT01602224|365684680|FG002|Overall Study|Protocol Violation|0|||
106005376|NCT01602224|365684678|FG000|Overall Study|Sponsor Decision|2|||
106005377|NCT01602224|365684679|FG001|Overall Study|Sponsor Decision|3|||
106005378|NCT01602224|365684680|FG002|Overall Study|Sponsor Decision|2|||
106005379|NCT01602224|365684678|FG000|Overall Study|Withdrawal by Subject|5|||
106005380|NCT01602224|365684679|FG001|Overall Study|Withdrawal by Subject|3|||
106005381|NCT01602224|365684680|FG002|Overall Study|Withdrawal by Subject|3|||
106005382|NCT00770653|365684681|FG000|Overall Study|Adverse Event|13|||
106005383|NCT00770653|365684682|FG001|Overall Study|Adverse Event|5|||
106005384|NCT00770653|365684681|FG000|Overall Study|Protocol Violation|8|||
106005385|NCT00770653|365684682|FG001|Overall Study|Protocol Violation|6|||
106005386|NCT00770653|365684681|FG000|Overall Study|Withdrawal by Subject|4|||
106005387|NCT00770653|365684682|FG001|Overall Study|Withdrawal by Subject|7|||
106005388|NCT00770653|365684681|FG000|Overall Study|Lack of Compliance|1|||
106005389|NCT00770653|365684682|FG001|Overall Study|Lack of Compliance|4|||
106005390|NCT00770653|365684681|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
106005391|NCT00770653|365684682|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
106005392|NCT00770653|365684681|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
106005393|NCT00770653|365684682|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
106132824|NCT03532178|366144792|FG000|First Period|technical issues in data collection Technical issues|0|||
106132825|NCT03532178|366144793|FG001|First Period|technical issues in data collection Technical issues|1|||
105698787|NCT02285920|364561331|FG000|Overall Study|Dialysis discontinuation|0|||
105924674|NCT01682031|365384091|FG000|Overall Study|Patient stopped selenium on his own|0|||
105924675|NCT01682031|365384092|FG001|Overall Study|Patient stopped selenium on his own|1|||
106005394|NCT00770653|365684681|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
106005395|NCT00770653|365684682|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
106005396|NCT00770653|365684681|FG000|Overall Study|Lost to Follow-up|1|||
105698788|NCT02285920|364561332|FG001|Overall Study|Dialysis discontinuation|1|||
105698789|NCT02285920|364561333|FG002|Overall Study|Dialysis discontinuation|0|||
105698790|NCT02285920|364561334|FG003|Overall Study|Dialysis discontinuation|0|||
105698791|NCT02285920|364561331|FG000|Overall Study|Death|2|||
105698792|NCT02285920|364561332|FG001|Overall Study|Death|0|||
105698793|NCT02285920|364561333|FG002|Overall Study|Death|2|||
105698794|NCT02285920|364561334|FG003|Overall Study|Death|1|||
105698795|NCT00677820|364561335|FG000|Overall Study|Lost to Follow-up|1|||
105698796|NCT00677820|364561336|FG001|Overall Study|Lost to Follow-up|0|||
105698797|NCT01101438|364561338|FG000|Overall Study|Withdrawal by Subject|8|||
105698798|NCT01101438|364561339|FG001|Overall Study|Withdrawal by Subject|9|||
105698799|NCT01444742|364561340|FG000|Overall Study|Death|1|||
105698800|NCT01365039|364561344|FG000|Overall Study|Study related symptoms and complaints|1|||
105698801|NCT01365039|364561345|FG001|Overall Study|Study related symptoms and complaints|0|||
105698802|NCT00909181|364561346|FG000|Overall Study|Lost to Follow-up|39|||
105698803|NCT00909181|364561347|FG001|Overall Study|Lost to Follow-up|18|||
105698804|NCT00909181|364561348|FG002|Overall Study|Lost to Follow-up|33|||
105698805|NCT03677596|364561349|FG000|Overall Study|Adverse Event|0|||
105698806|NCT03677596|364561350|FG001|Overall Study|Adverse Event|1|||
105698807|NCT03677596|364561349|FG000|Overall Study|Death|10|||
105698808|NCT03677596|364561350|FG001|Overall Study|Death|6|||
105698809|NCT03677596|364561349|FG000|Overall Study|Lost to Follow-up|0|||
105698810|NCT03677596|364561350|FG001|Overall Study|Lost to Follow-up|1|||
105698811|NCT03677596|364561349|FG000|Overall Study|Progressive Disease|8|||
105698812|NCT03677596|364561350|FG001|Overall Study|Progressive Disease|8|||
105698813|NCT03677596|364561349|FG000|Overall Study|Withdrawal by Subject|3|||
105698814|NCT03677596|364561350|FG001|Overall Study|Withdrawal by Subject|0|||
105698815|NCT03677596|364561349|FG000|Overall Study|Disease Relapse|2|||
105698816|NCT03677596|364561350|FG001|Overall Study|Disease Relapse|2|||
105698817|NCT03677596|364561349|FG000|Overall Study|Other|0|||
105698818|NCT03677596|364561350|FG001|Overall Study|Other|1|||
105698819|NCT00003895|364561351|FG000|Overall Study|Adverse Event|4|||
105698820|NCT00003895|364561352|FG001|Overall Study|Adverse Event|0|||
105698821|NCT00003895|364561351|FG000|Overall Study|Lack of Efficacy|1|||
105698822|NCT00003895|364561352|FG001|Overall Study|Lack of Efficacy|1|||
105698823|NCT00003895|364561351|FG000|Overall Study|Patient Vacation|2|||
105698824|NCT00003895|364561352|FG001|Overall Study|Patient Vacation|0|||
105698825|NCT00003895|364561351|FG000|Overall Study|Withdrawal by Subject|0|||
105698826|NCT00003895|364561352|FG001|Overall Study|Withdrawal by Subject|3|||
105698827|NCT00806195|364561353|FG000|Overall Study|Death|6|||
105698828|NCT00806195|364561354|FG001|Overall Study|Death|0|||
105698829|NCT00806195|364561355|FG002|Overall Study|Death|1|||
105698830|NCT00806195|364561356|FG003|Overall Study|Death|0|||
105698831|NCT00806195|364561353|FG000|Overall Study|Adverse Event|25|||
105698832|NCT00806195|364561354|FG001|Overall Study|Adverse Event|5|||
105698833|NCT00806195|364561355|FG002|Overall Study|Adverse Event|11|||
105698834|NCT00806195|364561356|FG003|Overall Study|Adverse Event|2|||
105698835|NCT00806195|364561353|FG000|Overall Study|Withdrawal by Subject|119|||
105698836|NCT00806195|364561354|FG001|Overall Study|Withdrawal by Subject|31|||
105698837|NCT00806195|364561355|FG002|Overall Study|Withdrawal by Subject|76|||
105698838|NCT00806195|364561356|FG003|Overall Study|Withdrawal by Subject|35|||
105698839|NCT00806195|364561353|FG000|Overall Study|Lost to Follow-up|217|||
105698840|NCT00806195|364561354|FG001|Overall Study|Lost to Follow-up|66|||
105698841|NCT00806195|364561355|FG002|Overall Study|Lost to Follow-up|90|||
105924676|NCT00844519|365384098|FG000|Overall Study|Withdrawal by Subject|1|||
105924677|NCT00844519|365384099|FG001|Overall Study|Withdrawal by Subject|1|||
105924678|NCT00844519|365384098|FG000|Overall Study|Adverse Event|1|||
105924679|NCT00844519|365384099|FG001|Overall Study|Adverse Event|0|||
105924680|NCT01564407|365384109|FG000|Overall Study|Lost to Follow-up|0|||
105924681|NCT01564407|365384110|FG001|Overall Study|Lost to Follow-up|1|||
105924682|NCT01564407|365384111|FG002|Overall Study|Lost to Follow-up|0|||
105924683|NCT01564407|365384112|FG003|Overall Study|Lost to Follow-up|0|||
105924684|NCT01564407|365384113|FG004|Overall Study|Lost to Follow-up|0|||
105924685|NCT01564407|365384109|FG000|Overall Study|Withdrawal by Subject|0|||
105698842|NCT00806195|364561356|FG003|Overall Study|Lost to Follow-up|34|||
105698843|NCT00806195|364561353|FG000|Overall Study|Inappropriate Enrollment|0|||
105698844|NCT00806195|364561354|FG001|Overall Study|Inappropriate Enrollment|1|||
105924686|NCT01564407|365384110|FG001|Overall Study|Withdrawal by Subject|1|||
105924687|NCT01564407|365384111|FG002|Overall Study|Withdrawal by Subject|0|||
105698845|NCT00806195|364561355|FG002|Overall Study|Inappropriate Enrollment|0|||
105698846|NCT00806195|364561356|FG003|Overall Study|Inappropriate Enrollment|0|||
105698847|NCT00806195|364561353|FG000|Overall Study|Administrative Reason|113|||
105698848|NCT00806195|364561354|FG001|Overall Study|Administrative Reason|35|||
105698849|NCT00806195|364561355|FG002|Overall Study|Administrative Reason|66|||
105924688|NCT01564407|365384112|FG003|Overall Study|Withdrawal by Subject|0|||
105698850|NCT00806195|364561356|FG003|Overall Study|Administrative Reason|26|||
105698851|NCT00806195|364561353|FG000|Overall Study|Protocol Violation|34|||
105698852|NCT00806195|364561354|FG001|Overall Study|Protocol Violation|24|||
105698853|NCT00806195|364561355|FG002|Overall Study|Protocol Violation|26|||
105698854|NCT00806195|364561356|FG003|Overall Study|Protocol Violation|9|||
105698855|NCT02490475|364561357|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
105698856|NCT02490475|364561358|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
105698857|NCT02490475|364561359|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
105698858|NCT02490475|364561360|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
105698859|NCT02490475|364561357|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
105698860|NCT02490475|364561358|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
105698861|NCT02490475|364561359|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
105698862|NCT02490475|364561360|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
105698863|NCT02490475|364561357|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
105698864|NCT02490475|364561358|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
105698865|NCT02490475|364561359|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
105698866|NCT02490475|364561360|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
105698867|NCT02490475|364561357|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
105698868|NCT02490475|364561358|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
105698869|NCT02490475|364561359|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
105698870|NCT02490475|364561360|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
105698871|NCT02490475|364561357|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
105698872|NCT02490475|364561358|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
105698873|NCT02490475|364561359|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
105698874|NCT02490475|364561360|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
105698875|NCT02490475|364561357|FG000|Period 2: Extension Phase|Refused Treatment|0|||
105698876|NCT02490475|364561358|FG001|Period 2: Extension Phase|Refused Treatment|0|||
105698877|NCT02490475|364561359|FG002|Period 2: Extension Phase|Refused Treatment|0|||
105698878|NCT02490475|364561360|FG003|Period 2: Extension Phase|Refused Treatment|1|||
105698879|NCT02490475|364561357|FG000|Period 2: Extension Phase|Adverse Event|0|||
105698880|NCT02490475|364561358|FG001|Period 2: Extension Phase|Adverse Event|0|||
105698881|NCT02490475|364561359|FG002|Period 2: Extension Phase|Adverse Event|1|||
105698882|NCT02490475|364561360|FG003|Period 2: Extension Phase|Adverse Event|0|||
105698883|NCT00139776|364561361|FG000|Period I|Did not enter Period II|575|||
106005397|NCT00770653|365684682|FG001|Overall Study|Lost to Follow-up|2|||
106005398|NCT00770653|365684681|FG000|Overall Study|Physician Decision|1|||
105698884|NCT00139776|364561362|FG001|Period I|Did not enter Period II|0|||
105698885|NCT00139776|364561363|FG002|Period I|Did not enter Period II|0|||
105698886|NCT00139776|364561364|FG003|Period I|Did not enter Period II|0|||
105698887|NCT00139776|364561361|FG000|Period II|Not Randomized into Period III|0|||
105698888|NCT00139776|364561362|FG001|Period II|Not Randomized into Period III|322|||
105698889|NCT00139776|364561363|FG002|Period II|Not Randomized into Period III|0|||
105698890|NCT00139776|364561364|FG003|Period II|Not Randomized into Period III|0|||
105698891|NCT00139776|364561361|FG000|Period III|Adverse Event|0|||
105698892|NCT00139776|364561362|FG001|Period III|Adverse Event|0|||
105698893|NCT00139776|364561363|FG002|Period III|Adverse Event|22|||
105698894|NCT00139776|364561364|FG003|Period III|Adverse Event|23|||
105698895|NCT00139776|364561361|FG000|Period III|Other|0|||
105698896|NCT00139776|364561362|FG001|Period III|Other|0|||
105698897|NCT00139776|364561363|FG002|Period III|Other|23|||
105698898|NCT00139776|364561364|FG003|Period III|Other|34|||
105698899|NCT00139776|364561361|FG000|Period III|Lack of Efficacy|0|||
105698900|NCT00139776|364561362|FG001|Period III|Lack of Efficacy|0|||
105698901|NCT00139776|364561363|FG002|Period III|Lack of Efficacy|10|||
106005399|NCT00770653|365684682|FG001|Overall Study|Physician Decision|0|||
106005400|NCT00644423|365684683|FG000|Overall Study|Lost to Follow-up|1|||
106005401|NCT00644423|365684684|FG001|Overall Study|Lost to Follow-up|1|||
106005402|NCT01908426|365684685|FG000|Overall Study|Adverse Event|98|||
106005403|NCT01908426|365684686|FG001|Overall Study|Adverse Event|11|||
106005404|NCT01908426|365684685|FG000|Overall Study|Clinical Deterioration|72|||
106005405|NCT01908426|365684686|FG001|Overall Study|Clinical Deterioration|38|||
106005406|NCT01908426|365684685|FG000|Overall Study|Lack of Efficacy|3|||
106005407|NCT01908426|365684686|FG001|Overall Study|Lack of Efficacy|0|||
106005408|NCT01908426|365684685|FG000|Overall Study|Lost to Follow-up|0|||
106005409|NCT01908426|365684686|FG001|Overall Study|Lost to Follow-up|1|||
106005410|NCT01908426|365684685|FG000|Overall Study|Physician Decision|3|||
105698902|NCT00139776|364561364|FG003|Period III|Lack of Efficacy|24|||
106005411|NCT01908426|365684686|FG001|Overall Study|Physician Decision|3|||
106005412|NCT01908426|365684685|FG000|Overall Study|Withdrawal by Subject|11|||
106005413|NCT01908426|365684686|FG001|Overall Study|Withdrawal by Subject|6|||
106132826|NCT03532178|366144792|FG000|Second Period|Withdrawal by Subject|1|||
106132827|NCT03532178|366144793|FG001|Second Period|Withdrawal by Subject|1|||
105698903|NCT00139776|364561361|FG000|Period III|Lost to Follow-up|0|||
105698904|NCT00139776|364561362|FG001|Period III|Lost to Follow-up|0|||
105698905|NCT00139776|364561363|FG002|Period III|Lost to Follow-up|5|||
105698906|NCT00139776|364561364|FG003|Period III|Lost to Follow-up|4|||
106005414|NCT01908426|365684685|FG000|Overall Study|Progressive Disease|206|||
105698907|NCT00139776|364561361|FG000|Period III|Withdrawal by Subject|0|||
106005415|NCT01908426|365684686|FG001|Overall Study|Progressive Disease|152|||
106005416|NCT01908426|365684685|FG000|Overall Study|Protocol Violation|1|||
106005417|NCT01908426|365684686|FG001|Overall Study|Protocol Violation|0|||
105698908|NCT00139776|364561362|FG001|Period III|Withdrawal by Subject|0|||
105698909|NCT00139776|364561363|FG002|Period III|Withdrawal by Subject|16|||
105698910|NCT00139776|364561364|FG003|Period III|Withdrawal by Subject|21|||
105698911|NCT01360554|364561365|FG000|Overall Study|Death|359|||
105698912|NCT01360554|364561366|FG001|Overall Study|Death|371|||
105698913|NCT01360554|364561365|FG000|Overall Study|Lost to Follow-up|4|||
105698914|NCT01360554|364561366|FG001|Overall Study|Lost to Follow-up|4|||
105698915|NCT01360554|364561365|FG000|Overall Study|Withdrawal by Subject|23|||
105698916|NCT01360554|364561366|FG001|Overall Study|Withdrawal by Subject|24|||
105698917|NCT01360554|364561365|FG000|Overall Study|Study terminated by sponsor|49|||
105698918|NCT01360554|364561366|FG001|Overall Study|Study terminated by sponsor|37|||
105698919|NCT01360554|364561365|FG000|Overall Study|Other, not specified|1|||
105698920|NCT01360554|364561366|FG001|Overall Study|Other, not specified|0|||
105698921|NCT01360554|364561365|FG000|Overall Study|Randomized but not treated.|3|||
105698922|NCT01360554|364561366|FG001|Overall Study|Randomized but not treated.|3|||
105698923|NCT00187096|364561367|FG000|Overall Study|unacceptable toxicity|0|||
105698924|NCT00187096|364561368|FG001|Overall Study|unacceptable toxicity|0|||
105698925|NCT00187096|364561369|FG002|Overall Study|unacceptable toxicity|1|||
105698926|NCT04912245|364561374|FG000|Overall Study|Withdrawal by Subject|21|||
105698927|NCT04912245|364561375|FG001|Overall Study|Withdrawal by Subject|4|||
105698928|NCT04912245|364561374|FG000|Overall Study|Lost to Follow-up|5|||
105698929|NCT04912245|364561375|FG001|Overall Study|Lost to Follow-up|11|||
105698930|NCT04667377|364561380|FG000|Dose Escalation Period|Other not specified below|3|||
105698931|NCT04667377|364561381|FG001|Dose Escalation Period|Other not specified below|3|||
105698932|NCT04667377|364561382|FG002|Dose Escalation Period|Other not specified below|2|||
105698933|NCT04667377|364561383|FG003|Dose Escalation Period|Other not specified below|1|||
105698934|NCT04667377|364561384|FG004|Dose Escalation Period|Other not specified below|3|||
105698935|NCT04667377|364561380|FG000|Dose Escalation Period|Protocol Violation|2|||
105698936|NCT04667377|364561381|FG001|Dose Escalation Period|Protocol Violation|2|||
105698937|NCT04667377|364561382|FG002|Dose Escalation Period|Protocol Violation|0|||
105698938|NCT04667377|364561383|FG003|Dose Escalation Period|Protocol Violation|2|||
105698939|NCT04667377|364561384|FG004|Dose Escalation Period|Protocol Violation|1|||
105698940|NCT04667377|364561380|FG000|Dose Escalation Period|Burden of study procedures|2|||
105698941|NCT04667377|364561381|FG001|Dose Escalation Period|Burden of study procedures|1|||
105698942|NCT04667377|364561382|FG002|Dose Escalation Period|Burden of study procedures|1|||
105698943|NCT04667377|364561383|FG003|Dose Escalation Period|Burden of study procedures|1|||
105698944|NCT04667377|364561384|FG004|Dose Escalation Period|Burden of study procedures|5|||
105698945|NCT04667377|364561380|FG000|Dose Escalation Period|Change of residence|0|||
105698946|NCT04667377|364561381|FG001|Dose Escalation Period|Change of residence|0|||
105698947|NCT04667377|364561382|FG002|Dose Escalation Period|Change of residence|1|||
105698948|NCT04667377|364561383|FG003|Dose Escalation Period|Change of residence|0|||
105698949|NCT04667377|364561384|FG004|Dose Escalation Period|Change of residence|0|||
105924689|NCT01564407|365384113|FG004|Overall Study|Withdrawal by Subject|0|||
105924690|NCT01564407|365384109|FG000|Overall Study|funding lost, study ended|0|||
105924691|NCT01564407|365384110|FG001|Overall Study|funding lost, study ended|0|||
105924692|NCT01564407|365384111|FG002|Overall Study|funding lost, study ended|0|||
105924693|NCT01564407|365384112|FG003|Overall Study|funding lost, study ended|1|||
105924694|NCT01564407|365384113|FG004|Overall Study|funding lost, study ended|0|||
105924695|NCT01787838|365385776|FG000|Overall Study|refused|1413|||
105924696|NCT01431976|365385777|FG000|Overall Study|Adverse Event|6|||
105924697|NCT01431976|365385777|FG000|Overall Study|Lack of Efficacy|2|||
105924698|NCT01431976|365385777|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
105924699|NCT01431976|365385777|FG000|Overall Study|Physician Decision|1|||
105924700|NCT01431976|365385777|FG000|Overall Study|Withdrawal by Subject|1|||
105924701|NCT01963611|365385778|FG000|Overall Study|Adverse Event|1|||
105924702|NCT01963611|365385779|FG001|Overall Study|Adverse Event|1|||
105924703|NCT01963611|365385780|FG002|Overall Study|Adverse Event|3|||
105924704|NCT01963611|365385781|FG003|Overall Study|Adverse Event|4|||
105924705|NCT01963611|365385782|FG004|Overall Study|Adverse Event|3|||
105924706|NCT01963611|365385778|FG000|Overall Study|Protocol Violation|0|||
105698950|NCT04667377|364561380|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
105698951|NCT04667377|364561381|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
105698952|NCT04667377|364561382|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
105698953|NCT04667377|364561383|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
105698954|NCT04667377|364561384|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
105924707|NCT01963611|365385779|FG001|Overall Study|Protocol Violation|0|||
105924708|NCT01963611|365385780|FG002|Overall Study|Protocol Violation|0|||
105924709|NCT01963611|365385781|FG003|Overall Study|Protocol Violation|1|||
105924710|NCT01963611|365385782|FG004|Overall Study|Protocol Violation|0|||
105924711|NCT01963611|365385778|FG000|Overall Study|Lack of Efficacy|0|||
105924712|NCT01963611|365385779|FG001|Overall Study|Lack of Efficacy|0|||
105924713|NCT01963611|365385780|FG002|Overall Study|Lack of Efficacy|0|||
105924714|NCT01963611|365385781|FG003|Overall Study|Lack of Efficacy|1|||
105924715|NCT01963611|365385782|FG004|Overall Study|Lack of Efficacy|0|||
105698955|NCT04667377|364561380|FG000|Dose Escalation Period|Adverse Event|9|||
105698956|NCT04667377|364561381|FG001|Dose Escalation Period|Adverse Event|10|||
105698957|NCT04667377|364561382|FG002|Dose Escalation Period|Adverse Event|12|||
105698958|NCT04667377|364561383|FG003|Dose Escalation Period|Adverse Event|17|||
105698959|NCT04667377|364561384|FG004|Dose Escalation Period|Adverse Event|3|||
105698960|NCT04667377|364561380|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
105698961|NCT04667377|364561381|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
105698962|NCT04667377|364561382|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
105698963|NCT04667377|364561383|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
105698964|NCT04667377|364561384|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
105698965|NCT04667377|364561380|FG000|Dose Escalation Period|Not treated|1|||
105698966|NCT04667377|364561381|FG001|Dose Escalation Period|Not treated|0|||
105698967|NCT04667377|364561382|FG002|Dose Escalation Period|Not treated|0|||
105698968|NCT04667377|364561383|FG003|Dose Escalation Period|Not treated|0|||
105698969|NCT04667377|364561384|FG004|Dose Escalation Period|Not treated|0|||
105924716|NCT01963611|365385778|FG000|Overall Study|Withdrawal by Subject|3|||
105924717|NCT01963611|365385779|FG001|Overall Study|Withdrawal by Subject|2|||
105924718|NCT01963611|365385780|FG002|Overall Study|Withdrawal by Subject|1|||
105924719|NCT01963611|365385781|FG003|Overall Study|Withdrawal by Subject|1|||
105924720|NCT01963611|365385782|FG004|Overall Study|Withdrawal by Subject|3|||
105924721|NCT01963611|365385778|FG000|Overall Study|Other|47|||
105924722|NCT01963611|365385779|FG001|Overall Study|Other|46|||
105924723|NCT01963611|365385780|FG002|Overall Study|Other|48|||
105924724|NCT01963611|365385781|FG003|Overall Study|Other|45|||
105924725|NCT01963611|365385782|FG004|Overall Study|Other|45|||
105924726|NCT02394275|365385788|FG000|Overall Study|Adverse Event|22|||
105924727|NCT02394275|365385788|FG000|Overall Study|Lost to Follow-up|7|||
105924728|NCT00782067|365385791|FG000|Overall Study|Adverse Event|35|||
105924729|NCT00782067|365385791|FG000|Overall Study|Subject withdrew consent|11|||
105924730|NCT00782067|365385791|FG000|Overall Study|Lost to Follow-up|2|||
105924731|NCT00782067|365385791|FG000|Overall Study|Administrative problems|14|||
105924732|NCT00782067|365385791|FG000|Overall Study|Death|9|||
105924733|NCT00782067|365385791|FG000|Overall Study|Disease progression|43|||
105924734|NCT00782067|365385791|FG000|Overall Study|Protocol deviation|2|||
105924735|NCT00614393|365385793|FG000|Overall Study|Adverse Event|20|||
105924736|NCT00614393|365385794|FG001|Overall Study|Adverse Event|2|||
105924737|NCT00614393|365385795|FG002|Overall Study|Adverse Event|3|||
105924738|NCT00614393|365385796|FG003|Overall Study|Adverse Event|13|||
105924739|NCT00614393|365385797|FG004|Overall Study|Adverse Event|21|||
105924740|NCT00614393|365385793|FG000|Overall Study|Lost to Follow-up|0|||
105924741|NCT00614393|365385794|FG001|Overall Study|Lost to Follow-up|0|||
105924742|NCT00614393|365385795|FG002|Overall Study|Lost to Follow-up|0|||
105924743|NCT00614393|365385796|FG003|Overall Study|Lost to Follow-up|1|||
105924744|NCT00614393|365385797|FG004|Overall Study|Lost to Follow-up|2|||
105924745|NCT00614393|365385793|FG000|Overall Study|Physician Decision|17|||
105924746|NCT00614393|365385794|FG001|Overall Study|Physician Decision|0|||
105924747|NCT00614393|365385795|FG002|Overall Study|Physician Decision|1|||
105924748|NCT00614393|365385796|FG003|Overall Study|Physician Decision|8|||
105924749|NCT00614393|365385797|FG004|Overall Study|Physician Decision|9|||
105924750|NCT00614393|365385793|FG000|Overall Study|Progressive Disease|118|||
105924751|NCT00614393|365385794|FG001|Overall Study|Progressive Disease|5|||
105924752|NCT00614393|365385795|FG002|Overall Study|Progressive Disease|5|||
105924753|NCT00614393|365385796|FG003|Overall Study|Progressive Disease|138|||
105924754|NCT00614393|365385797|FG004|Overall Study|Progressive Disease|130|||
105924755|NCT00614393|365385793|FG000|Overall Study|Protocol Violation|1|||
105924756|NCT00614393|365385794|FG001|Overall Study|Protocol Violation|0|||
105924757|NCT00614393|365385795|FG002|Overall Study|Protocol Violation|0|||
105924758|NCT00614393|365385796|FG003|Overall Study|Protocol Violation|0|||
105924759|NCT00614393|365385797|FG004|Overall Study|Protocol Violation|0|||
105924760|NCT00614393|365385793|FG000|Overall Study|Terminated by Sponsor|0|||
105924761|NCT00614393|365385794|FG001|Overall Study|Terminated by Sponsor|0|||
105924762|NCT00614393|365385795|FG002|Overall Study|Terminated by Sponsor|0|||
105924763|NCT00614393|365385796|FG003|Overall Study|Terminated by Sponsor|0|||
105924764|NCT00614393|365385797|FG004|Overall Study|Terminated by Sponsor|1|||
105924765|NCT00614393|365385793|FG000|Overall Study|Withdrawal by Subject|20|||
105924766|NCT00614393|365385794|FG001|Overall Study|Withdrawal by Subject|1|||
105698970|NCT04667377|364561380|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
105924767|NCT00614393|365385795|FG002|Overall Study|Withdrawal by Subject|1|||
105924768|NCT00614393|365385796|FG003|Overall Study|Withdrawal by Subject|16|||
105924769|NCT00614393|365385797|FG004|Overall Study|Withdrawal by Subject|13|||
105924770|NCT00614393|365385793|FG000|Overall Study|Other|4|||
105924771|NCT00614393|365385794|FG001|Overall Study|Other|0|||
105924772|NCT00614393|365385795|FG002|Overall Study|Other|0|||
105924773|NCT00614393|365385796|FG003|Overall Study|Other|4|||
105924774|NCT00614393|365385797|FG004|Overall Study|Other|2|||
105924775|NCT00614393|365385793|FG000|Overall Study|Not Treated|0|||
105924776|NCT00614393|365385794|FG001|Overall Study|Not Treated|0|||
105924777|NCT00614393|365385795|FG002|Overall Study|Not Treated|0|||
105924778|NCT00614393|365385796|FG003|Overall Study|Not Treated|0|||
105924779|NCT00614393|365385797|FG004|Overall Study|Not Treated|2|||
105924780|NCT02328105|365385798|FG000|Overall Study|Death|6|||
105698971|NCT04667377|364561381|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
105698972|NCT04667377|364561382|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
105698973|NCT04667377|364561383|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
105698974|NCT04667377|364561384|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
105698975|NCT04667377|364561380|FG000|Dose Escalation Period|Lost to Follow-up|0|||
106005418|NCT01908426|365684685|FG000|Overall Study|No Study Treatment Given|3|||
106005419|NCT01908426|365684686|FG001|Overall Study|No Study Treatment Given|0|||
106005420|NCT03346434|365684687|FG000|Overall Study|Randomized in Error|0|||
106005421|NCT03346434|365684688|FG001|Overall Study|Randomized in Error|0|||
105698976|NCT04667377|364561381|FG001|Dose Escalation Period|Lost to Follow-up|1|||
105698977|NCT04667377|364561382|FG002|Dose Escalation Period|Lost to Follow-up|0|||
105698978|NCT04667377|364561383|FG003|Dose Escalation Period|Lost to Follow-up|0|||
105698979|NCT04667377|364561384|FG004|Dose Escalation Period|Lost to Follow-up|0|||
106005422|NCT03346434|365684689|FG002|Overall Study|Randomized in Error|0|||
106005423|NCT03346434|365684690|FG003|Overall Study|Randomized in Error|0|||
106005424|NCT03346434|365684691|FG004|Overall Study|Randomized in Error|1|||
106005425|NCT03346434|365684692|FG005|Overall Study|Randomized in Error|0|||
106005426|NCT03346434|365684687|FG000|Overall Study|Withdrawal by Subject|0|||
106005427|NCT03346434|365684688|FG001|Overall Study|Withdrawal by Subject|0|||
106005428|NCT03346434|365684689|FG002|Overall Study|Withdrawal by Subject|1|||
106005429|NCT03346434|365684690|FG003|Overall Study|Withdrawal by Subject|0|||
106005430|NCT03346434|365684691|FG004|Overall Study|Withdrawal by Subject|1|||
106005431|NCT03346434|365684692|FG005|Overall Study|Withdrawal by Subject|0|||
106005432|NCT03346434|365684687|FG000|Overall Study|Lost to Follow-up|0|||
106005433|NCT03346434|365684688|FG001|Overall Study|Lost to Follow-up|0|||
106005434|NCT03346434|365684689|FG002|Overall Study|Lost to Follow-up|0|||
106005435|NCT03346434|365684690|FG003|Overall Study|Lost to Follow-up|0|||
106005436|NCT03346434|365684691|FG004|Overall Study|Lost to Follow-up|1|||
106005437|NCT03346434|365684692|FG005|Overall Study|Lost to Follow-up|1|||
106005438|NCT03346434|365684687|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
106005439|NCT03346434|365684688|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
106005440|NCT03346434|365684689|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
106005441|NCT03346434|365684690|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
106005442|NCT03346434|365684691|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
106005443|NCT03346434|365684692|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
106005444|NCT03525444|365684696|FG000|Overall Study|Adverse Event|0|||
106005445|NCT03525444|365684697|FG001|Overall Study|Adverse Event|1|||
106005446|NCT03525444|365684696|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
106005447|NCT03525444|365684697|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
106005448|NCT03525444|365684696|FG000|Overall Study|Other|0|||
106005449|NCT03525444|365684697|FG001|Overall Study|Other|1|||
106005450|NCT00262860|365684700|FG000|Overall Study|Adverse Event|2|||
106005451|NCT02973100|365684703|FG000|Overall Study|Adverse Event|1|||
106005452|NCT02973100|365684704|FG001|Overall Study|Adverse Event|2|||
106005453|NCT02973100|365684705|FG002|Overall Study|Adverse Event|1|||
106005454|NCT02973100|365684706|FG003|Overall Study|Adverse Event|2|||
106005455|NCT02973100|365684703|FG000|Overall Study|Lost to Follow-up|3|||
106005456|NCT02973100|365684704|FG001|Overall Study|Lost to Follow-up|1|||
106005457|NCT02973100|365684705|FG002|Overall Study|Lost to Follow-up|1|||
105698980|NCT04667377|364561380|FG000|Maintenance Period|Perceived lack of efficacy|0|||
106005458|NCT02973100|365684706|FG003|Overall Study|Lost to Follow-up|0|||
106005459|NCT02973100|365684703|FG000|Overall Study|Withdrawal by Subject|3|||
106005460|NCT02973100|365684704|FG001|Overall Study|Withdrawal by Subject|5|||
106005461|NCT02973100|365684705|FG002|Overall Study|Withdrawal by Subject|1|||
106005462|NCT02973100|365684706|FG003|Overall Study|Withdrawal by Subject|4|||
106005463|NCT02973100|365684703|FG000|Overall Study|Notification of change in address|0|||
106005464|NCT02973100|365684704|FG001|Overall Study|Notification of change in address|0|||
106005465|NCT02973100|365684705|FG002|Overall Study|Notification of change in address|0|||
106005466|NCT02973100|365684706|FG003|Overall Study|Notification of change in address|1|||
106005467|NCT02973100|365684703|FG000|Overall Study|Failed to attend Safety followup period|0|||
106005468|NCT02973100|365684704|FG001|Overall Study|Failed to attend Safety followup period|0|||
106005469|NCT02973100|365684705|FG002|Overall Study|Failed to attend Safety followup period|1|||
105698981|NCT04667377|364561381|FG001|Maintenance Period|Perceived lack of efficacy|2|||
105698982|NCT04667377|364561382|FG002|Maintenance Period|Perceived lack of efficacy|1|||
106005470|NCT02973100|365684706|FG003|Overall Study|Failed to attend Safety followup period|0|||
106005471|NCT02426580|365684707|FG000|Overall Study|Death|2|||
106005472|NCT02426580|365684708|FG001|Overall Study|Death|2|||
106005473|NCT02426580|365684707|FG000|Overall Study|Lost to Follow-up|0|||
106132828|NCT03532178|366144792|FG000|Second Period|Technical issues|0|||
106132829|NCT03532178|366144793|FG001|Second Period|Technical issues|1|||
105698983|NCT04667377|364561383|FG003|Maintenance Period|Perceived lack of efficacy|0|||
105698984|NCT04667377|364561384|FG004|Maintenance Period|Perceived lack of efficacy|1|||
106005474|NCT02426580|365684708|FG001|Overall Study|Lost to Follow-up|9|||
106132830|NCT02390557|366144794|FG000|Wave 2|Survey non-respondent|72|||
105698985|NCT04667377|364561380|FG000|Maintenance Period|Adverse Event|2|||
106005475|NCT02426580|365684707|FG000|Overall Study|transfer to hemodialysis|5|||
106005476|NCT02426580|365684708|FG001|Overall Study|transfer to hemodialysis|5|||
106005477|NCT02426580|365684707|FG000|Overall Study|Kidney transplant|3|||
106005478|NCT02426580|365684708|FG001|Overall Study|Kidney transplant|0|||
106005479|NCT02426580|365684707|FG000|Overall Study|Allergic to egg white|1|||
106005480|NCT02426580|365684708|FG001|Overall Study|Allergic to egg white|0|||
106005481|NCT01419769|365684709|FG000|Overall Study|Did not receive the AXIOS stent|3|||
106005482|NCT01419769|365684709|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
106005483|NCT01600326|365684713|FG000|Overall Study|Lost to Follow-up|1|||
106005484|NCT01600326|365684714|FG001|Overall Study|Lost to Follow-up|1|||
106005485|NCT04456504|365684715|FG000|Overall Study|Lost to Follow-up|2|||
106005486|NCT01131507|365684717|FG000|Overall Study|Adverse Event|1|||
106005487|NCT01131507|365684717|FG000|Overall Study|Lost to Follow-up|1|||
106005488|NCT01131507|365684717|FG000|Overall Study|Withdrawal by Subject|1|||
106005489|NCT03224130|365684724|FG000|Overall Study|consent issue|0|||
106005490|NCT03224130|365684725|FG001|Overall Study|consent issue|1|||
106005491|NCT04750824|365684731|FG000|Overall Study|Toxicity/intolerability|3|||
106005492|NCT04750824|365684732|FG001|Overall Study|Toxicity/intolerability|1|||
106005493|NCT04750824|365684731|FG000|Overall Study|Death|1|||
106005494|NCT04750824|365684732|FG001|Overall Study|Death|3|||
106005495|NCT04750824|365684731|FG000|Overall Study|Scheduled duration of therapy complete|1|||
106005496|NCT04750824|365684732|FG001|Overall Study|Scheduled duration of therapy complete|9|||
106005497|NCT04750824|365684731|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
105698986|NCT04667377|364561381|FG001|Maintenance Period|Adverse Event|8|||
105698987|NCT04667377|364561382|FG002|Maintenance Period|Adverse Event|5|||
105698988|NCT04667377|364561383|FG003|Maintenance Period|Adverse Event|4|||
105698989|NCT04667377|364561384|FG004|Maintenance Period|Adverse Event|1|||
105698990|NCT04667377|364561380|FG000|Maintenance Period|Adverse event: COVID infection|0|||
105698991|NCT04667377|364561381|FG001|Maintenance Period|Adverse event: COVID infection|1|||
105698992|NCT04667377|364561382|FG002|Maintenance Period|Adverse event: COVID infection|0|||
105698993|NCT04667377|364561383|FG003|Maintenance Period|Adverse event: COVID infection|0|||
105698994|NCT04667377|364561384|FG004|Maintenance Period|Adverse event: COVID infection|0|||
105698995|NCT04667377|364561380|FG000|Maintenance Period|COVID-related|0|||
105698996|NCT04667377|364561381|FG001|Maintenance Period|COVID-related|0|||
105698997|NCT04667377|364561382|FG002|Maintenance Period|COVID-related|1|||
105698998|NCT04667377|364561383|FG003|Maintenance Period|COVID-related|1|||
105924781|NCT02328105|365385798|FG000|Overall Study|Withdrawal by Subject|1|||
105924782|NCT02328105|365385798|FG000|Overall Study|Still On Study in Follow-Up|4|||
105924783|NCT02441283|365385799|FG000|Overall Study|Withdrew consent|15|||
105924784|NCT02441283|365385799|FG000|Overall Study|Lost to Follow-up|42|||
105924785|NCT02441283|365385799|FG000|Overall Study|Death|1|||
105924786|NCT02441283|365385799|FG000|Overall Study|Other, not specified|32|||
105924787|NCT01189266|365385800|FG000|Overall Study|Adverse Event|1|||
105924788|NCT01189266|365385801|FG001|Overall Study|Adverse Event|0|||
105924789|NCT01189266|365385802|FG002|Overall Study|Adverse Event|5|||
105924790|NCT01189266|365385800|FG000|Overall Study|Death|0|||
105924791|NCT01189266|365385801|FG001|Overall Study|Death|0|||
105924792|NCT01189266|365385802|FG002|Overall Study|Death|5|||
105924793|NCT01189266|365385800|FG000|Overall Study|Lack of Efficacy|4|||
105924794|NCT01189266|365385801|FG001|Overall Study|Lack of Efficacy|5|||
105924795|NCT01189266|365385802|FG002|Overall Study|Lack of Efficacy|44|||
105924796|NCT01189266|365385800|FG000|Overall Study|Physician Decision|0|||
105924797|NCT01189266|365385801|FG001|Overall Study|Physician Decision|0|||
105924798|NCT01189266|365385802|FG002|Overall Study|Physician Decision|1|||
106005498|NCT04750824|365684732|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
106005499|NCT03547518|365684733|FG000|Overall Study|Lost to Follow-up|2|||
106005500|NCT03547518|365684734|FG001|Overall Study|Lost to Follow-up|0|||
106005501|NCT00614575|365684737|FG000|Overall Study|Adverse Event|106|||
106005502|NCT00614575|365684737|FG000|Overall Study|Lost to Follow-up|55|||
106005503|NCT00614575|365684737|FG000|Overall Study|Lack of Efficacy|14|||
106005504|NCT00614575|365684737|FG000|Overall Study|Withdrawal by Subject|6|||
106005505|NCT00614575|365684737|FG000|Overall Study|Death|3|||
105698999|NCT04667377|364561384|FG004|Maintenance Period|COVID-related|0|||
105699000|NCT04667377|364561380|FG000|Maintenance Period|Protocol Violation|1|||
105699001|NCT04667377|364561381|FG001|Maintenance Period|Protocol Violation|0|||
105699002|NCT04667377|364561382|FG002|Maintenance Period|Protocol Violation|0|||
105699003|NCT04667377|364561383|FG003|Maintenance Period|Protocol Violation|0|||
105699004|NCT04667377|364561384|FG004|Maintenance Period|Protocol Violation|1|||
105924799|NCT01189266|365385800|FG000|Overall Study|Protocol Violation|0|||
105924800|NCT01189266|365385801|FG001|Overall Study|Protocol Violation|1|||
105924801|NCT01189266|365385802|FG002|Overall Study|Protocol Violation|1|||
105924802|NCT01189266|365385800|FG000|Overall Study|Withdrawal by Subject|0|||
105924803|NCT01189266|365385801|FG001|Overall Study|Withdrawal by Subject|0|||
106005506|NCT00614575|365684737|FG000|Overall Study|Physician Decision|2|||
106005507|NCT00614575|365684737|FG000|Overall Study|No data were collected.|18|||
106005508|NCT00614575|365684737|FG000|Overall Study|Irregularly enrolled patients|23|||
106005509|NCT00614575|365684737|FG000|Overall Study|No treatment|1|||
106005510|NCT01018030|365684738|FG000|Overall Study|Adverse Event|10|||
105699005|NCT04667377|364561380|FG000|Maintenance Period|Burden of study procedures|1|||
105699006|NCT04667377|364561381|FG001|Maintenance Period|Burden of study procedures|2|||
105699007|NCT04667377|364561382|FG002|Maintenance Period|Burden of study procedures|0|||
105699008|NCT04667377|364561383|FG003|Maintenance Period|Burden of study procedures|1|||
105699009|NCT04667377|364561384|FG004|Maintenance Period|Burden of study procedures|0|||
105699010|NCT04667377|364561380|FG000|Maintenance Period|Change of residence|0|||
105699011|NCT04667377|364561381|FG001|Maintenance Period|Change of residence|1|||
105699012|NCT04667377|364561382|FG002|Maintenance Period|Change of residence|0|||
105699013|NCT04667377|364561383|FG003|Maintenance Period|Change of residence|0|||
105699014|NCT04667377|364561384|FG004|Maintenance Period|Change of residence|1|||
105699015|NCT04667377|364561380|FG000|Maintenance Period|Missing|1|||
105699016|NCT04667377|364561381|FG001|Maintenance Period|Missing|0|||
105699017|NCT04667377|364561382|FG002|Maintenance Period|Missing|0|||
105699018|NCT04667377|364561383|FG003|Maintenance Period|Missing|0|||
105699019|NCT04667377|364561384|FG004|Maintenance Period|Missing|0|||
105699020|NCT04667377|364561380|FG000|Maintenance Period|Other than listed above|2|||
105699021|NCT04667377|364561381|FG001|Maintenance Period|Other than listed above|0|||
105699022|NCT04667377|364561382|FG002|Maintenance Period|Other than listed above|3|||
105699023|NCT04667377|364561383|FG003|Maintenance Period|Other than listed above|2|||
105699024|NCT04667377|364561384|FG004|Maintenance Period|Other than listed above|6|||
105699025|NCT04667377|364561380|FG000|Maintenance Period|Withdrawal by Subject|0|||
105699026|NCT04667377|364561381|FG001|Maintenance Period|Withdrawal by Subject|1|||
105699027|NCT04667377|364561382|FG002|Maintenance Period|Withdrawal by Subject|0|||
105699028|NCT04667377|364561383|FG003|Maintenance Period|Withdrawal by Subject|0|||
105699029|NCT04667377|364561384|FG004|Maintenance Period|Withdrawal by Subject|0|||
105699030|NCT04667377|364561380|FG000|Maintenance Period|Lost to Follow-up|1|||
105699031|NCT04667377|364561381|FG001|Maintenance Period|Lost to Follow-up|0|||
105699032|NCT04667377|364561382|FG002|Maintenance Period|Lost to Follow-up|1|||
105699033|NCT04667377|364561383|FG003|Maintenance Period|Lost to Follow-up|0|||
105699034|NCT04667377|364561384|FG004|Maintenance Period|Lost to Follow-up|1|||
105699035|NCT01011439|364561385|FG000|Overall Study|Death|37|||
105699036|NCT01011439|364561385|FG000|Overall Study|Lost to Follow-up|4|||
105699037|NCT01011439|364561385|FG000|Overall Study|Withdrawal by Subject|1|||
105699038|NCT01011439|364561385|FG000|Overall Study|Sponsor's decision|15|||
105699039|NCT03861936|364561386|FG000|Overall Study|Withdrawal by Subject|4|||
105699040|NCT03861936|364561387|FG001|Overall Study|Withdrawal by Subject|1|||
105699041|NCT03861936|364561388|FG002|Overall Study|Withdrawal by Subject|3|||
105699042|NCT03861936|364561386|FG000|Overall Study|Lost to Follow-up|5|||
105699043|NCT03861936|364561387|FG001|Overall Study|Lost to Follow-up|3|||
105699044|NCT03861936|364561388|FG002|Overall Study|Lost to Follow-up|3|||
105699045|NCT03861936|364561386|FG000|Overall Study|Physician Decision|0|||
105699046|NCT03861936|364561387|FG001|Overall Study|Physician Decision|1|||
105699047|NCT03861936|364561388|FG002|Overall Study|Physician Decision|0|||
105699048|NCT03861936|364561386|FG000|Overall Study|Protocol Deviation|0|||
105699049|NCT03861936|364561387|FG001|Overall Study|Protocol Deviation|0|||
105699050|NCT03861936|364561388|FG002|Overall Study|Protocol Deviation|1|||
105699051|NCT03861936|364561386|FG000|Overall Study|Reason not Specified|5|||
105699052|NCT03861936|364561387|FG001|Overall Study|Reason not Specified|5|||
105699053|NCT03861936|364561388|FG002|Overall Study|Reason not Specified|3|||
105699054|NCT01161043|364561389|FG000|Overall Study|Withdrawal by Subject|3|||
105699055|NCT00383084|364561396|FG000|Overall Study|Withdrawal by Subject|12|||
105699056|NCT00383084|364561397|FG001|Overall Study|Withdrawal by Subject|10|||
105699057|NCT05418673|364561398|FG000|Overall Study|Study Terminated by Sponsor|2|||
105699058|NCT05418673|364561399|FG001|Overall Study|Study Terminated by Sponsor|4|||
105699059|NCT05418673|364561398|FG000|Overall Study|Lost to Follow-up|1|||
105699060|NCT05418673|364561399|FG001|Overall Study|Lost to Follow-up|0|||
105699061|NCT02161575|364561402|FG000|Overall Study|Protocol Violation|8|||
105699062|NCT02161575|364561402|FG000|Overall Study|Lack of Efficacy|1|||
105699063|NCT02161575|364561402|FG000|Overall Study|Adverse Event|2|||
105699064|NCT01835015|364561403|FG000|Overall Study|Adverse Event|0|||
105699065|NCT01835015|364561404|FG001|Overall Study|Adverse Event|0|||
105699066|NCT01835015|364561405|FG002|Overall Study|Adverse Event|1|||
105699067|NCT01835015|364561406|FG003|Overall Study|Adverse Event|0|||
105699068|NCT01835015|364561407|FG004|Overall Study|Adverse Event|0|||
106132831|NCT02390557|366144795|FG001|Wave 2|Survey non-respondent|41|||
105699069|NCT02138617|364561412|FG000|Overall Study|Death|1|||
105699070|NCT02138617|364561413|FG001|Overall Study|Death|2|||
105699071|NCT02138617|364561414|FG002|Overall Study|Death|2|||
105699072|NCT02138617|364561412|FG000|Overall Study|Adverse Event|8|||
105699073|NCT02138617|364561413|FG001|Overall Study|Adverse Event|5|||
105699074|NCT02138617|364561414|FG002|Overall Study|Adverse Event|2|||
105699075|NCT02138617|364561412|FG000|Overall Study|Disease Progression|20|||
105699076|NCT02138617|364561413|FG001|Overall Study|Disease Progression|13|||
105699077|NCT02138617|364561414|FG002|Overall Study|Disease Progression|4|||
105699078|NCT02138617|364561412|FG000|Overall Study|Withdrawal by Subject|7|||
105699079|NCT02138617|364561413|FG001|Overall Study|Withdrawal by Subject|10|||
105699080|NCT02138617|364561414|FG002|Overall Study|Withdrawal by Subject|2|||
106132832|NCT02390557|366144796|FG002|Wave 2|Survey non-respondent|23|||
105699081|NCT02138617|364561412|FG000|Overall Study|other complicating disease|0|||
105699082|NCT02138617|364561413|FG001|Overall Study|other complicating disease|2|||
105699083|NCT02138617|364561414|FG002|Overall Study|other complicating disease|0|||
105699084|NCT02138617|364561412|FG000|Overall Study|Protocol Violation|1|||
105699085|NCT02138617|364561413|FG001|Overall Study|Protocol Violation|0|||
105699086|NCT02138617|364561414|FG002|Overall Study|Protocol Violation|0|||
105699087|NCT02138617|364561412|FG000|Overall Study|Physician Decision|7|||
105699088|NCT02138617|364561413|FG001|Overall Study|Physician Decision|6|||
105699089|NCT02138617|364561414|FG002|Overall Study|Physician Decision|0|||
105699090|NCT02138617|364561412|FG000|Overall Study|financial reason|0|||
105699091|NCT02138617|364561413|FG001|Overall Study|financial reason|1|||
105699092|NCT02138617|364561414|FG002|Overall Study|financial reason|0|||
105699093|NCT02138617|364561412|FG000|Overall Study|other therapy|3|||
105699094|NCT02138617|364561413|FG001|Overall Study|other therapy|4|||
105699095|NCT02138617|364561414|FG002|Overall Study|other therapy|0|||
105699096|NCT01961349|364561415|FG000|Overall Study|Withdrawal by Subject|1|||
105699097|NCT01961349|364561416|FG001|Overall Study|Withdrawal by Subject|4|||
105699098|NCT01961349|364561417|FG002|Overall Study|Withdrawal by Subject|0|||
105699099|NCT01961349|364561415|FG000|Overall Study|Adverse Event|0|||
105699100|NCT01961349|364561416|FG001|Overall Study|Adverse Event|0|||
105699101|NCT01961349|364561417|FG002|Overall Study|Adverse Event|1|||
105699102|NCT01961349|364561415|FG000|Overall Study|registration error, personal reason etc|2|||
105699103|NCT01961349|364561416|FG001|Overall Study|registration error, personal reason etc|2|||
105699104|NCT01961349|364561417|FG002|Overall Study|registration error, personal reason etc|1|||
105699105|NCT00574288|364561428|FG000|Overall Study|Adverse Event|2|||
105699106|NCT00574288|364561429|FG001|Overall Study|Adverse Event|0|||
105699107|NCT00574288|364561430|FG002|Overall Study|Adverse Event|0|||
105699108|NCT00574288|364561431|FG003|Overall Study|Adverse Event|0|||
105699109|NCT00574288|364561432|FG004|Overall Study|Adverse Event|1|||
105699110|NCT00574288|364561433|FG005|Overall Study|Adverse Event|0|||
105699111|NCT00574288|364561434|FG006|Overall Study|Adverse Event|0|||
105699112|NCT00574288|364561428|FG000|Overall Study|Death|0|||
105699113|NCT00574288|364561429|FG001|Overall Study|Death|0|||
105699114|NCT00574288|364561430|FG002|Overall Study|Death|0|||
105699115|NCT00574288|364561431|FG003|Overall Study|Death|0|||
105699116|NCT00574288|364561432|FG004|Overall Study|Death|0|||
105699117|NCT00574288|364561433|FG005|Overall Study|Death|25|||
105699118|NCT00574288|364561434|FG006|Overall Study|Death|21|||
105699119|NCT00574288|364561428|FG000|Overall Study|Lost to Follow-up|0|||
105699120|NCT00574288|364561429|FG001|Overall Study|Lost to Follow-up|0|||
105699121|NCT00574288|364561430|FG002|Overall Study|Lost to Follow-up|0|||
105699122|NCT00574288|364561431|FG003|Overall Study|Lost to Follow-up|0|||
105699123|NCT00574288|364561432|FG004|Overall Study|Lost to Follow-up|0|||
105699124|NCT00574288|364561433|FG005|Overall Study|Lost to Follow-up|1|||
105699125|NCT00574288|364561434|FG006|Overall Study|Lost to Follow-up|2|||
105699126|NCT00574288|364561428|FG000|Overall Study|Study Terminated By Sponsor|0|||
105699127|NCT00574288|364561429|FG001|Overall Study|Study Terminated By Sponsor|0|||
105699128|NCT00574288|364561430|FG002|Overall Study|Study Terminated By Sponsor|0|||
105699129|NCT00574288|364561431|FG003|Overall Study|Study Terminated By Sponsor|0|||
105699130|NCT00574288|364561432|FG004|Overall Study|Study Terminated By Sponsor|0|||
105699131|NCT00574288|364561433|FG005|Overall Study|Study Terminated By Sponsor|0|||
105699132|NCT00574288|364561434|FG006|Overall Study|Study Terminated By Sponsor|5|||
105699133|NCT00574288|364561428|FG000|Overall Study|Progressive Disease|17|||
105699134|NCT00574288|364561429|FG001|Overall Study|Progressive Disease|2|||
105699135|NCT00574288|364561430|FG002|Overall Study|Progressive Disease|3|||
105699136|NCT00574288|364561431|FG003|Overall Study|Progressive Disease|2|||
105699137|NCT00574288|364561432|FG004|Overall Study|Progressive Disease|1|||
105699138|NCT00574288|364561433|FG005|Overall Study|Progressive Disease|0|||
105699139|NCT00574288|364561434|FG006|Overall Study|Progressive Disease|0|||
105699140|NCT00574288|364561428|FG000|Overall Study|Other|1|||
105699141|NCT00574288|364561429|FG001|Overall Study|Other|1|||
105699142|NCT00574288|364561430|FG002|Overall Study|Other|0|||
105699143|NCT00574288|364561431|FG003|Overall Study|Other|0|||
105699144|NCT00574288|364561432|FG004|Overall Study|Other|0|||
105699145|NCT00574288|364561433|FG005|Overall Study|Other|0|||
105699146|NCT00574288|364561434|FG006|Overall Study|Other|0|||
105699147|NCT03625687|364561435|FG000|Overall Study|Death|1|||
105699148|NCT01431274|364561436|FG000|Overall Study|Adverse Event|51|||
105699149|NCT01431274|364561437|FG001|Overall Study|Adverse Event|37|||
105699150|NCT01431274|364561438|FG002|Overall Study|Adverse Event|43|||
105699151|NCT01431274|364561439|FG003|Overall Study|Adverse Event|30|||
105699152|NCT01431274|364561440|FG004|Overall Study|Adverse Event|37|||
105699153|NCT01431274|364561436|FG000|Overall Study|Consent withdrawn not due to AE|29|||
105699154|NCT01431274|364561437|FG001|Overall Study|Consent withdrawn not due to AE|20|||
105699155|NCT01431274|364561438|FG002|Overall Study|Consent withdrawn not due to AE|17|||
105699156|NCT01431274|364561439|FG003|Overall Study|Consent withdrawn not due to AE|20|||
105699157|NCT01431274|364561440|FG004|Overall Study|Consent withdrawn not due to AE|11|||
105699158|NCT01431274|364561436|FG000|Overall Study|Non compliant with protocol|5|||
105699159|NCT01431274|364561437|FG001|Overall Study|Non compliant with protocol|8|||
105699160|NCT01431274|364561438|FG002|Overall Study|Non compliant with protocol|4|||
105699161|NCT01431274|364561439|FG003|Overall Study|Non compliant with protocol|4|||
105699162|NCT01431274|364561440|FG004|Overall Study|Non compliant with protocol|4|||
105699163|NCT01431274|364561436|FG000|Overall Study|Lost to Follow-up|6|||
105699164|NCT01431274|364561437|FG001|Overall Study|Lost to Follow-up|7|||
105699165|NCT01431274|364561438|FG002|Overall Study|Lost to Follow-up|1|||
105699166|NCT01431274|364561439|FG003|Overall Study|Lost to Follow-up|4|||
105699167|NCT01431274|364561440|FG004|Overall Study|Lost to Follow-up|0|||
105699168|NCT01431274|364561436|FG000|Overall Study|Other reason not stated above|6|||
105699169|NCT01431274|364561437|FG001|Overall Study|Other reason not stated above|5|||
105699170|NCT01431274|364561438|FG002|Overall Study|Other reason not stated above|7|||
105699171|NCT01431274|364561439|FG003|Overall Study|Other reason not stated above|2|||
105699172|NCT01431274|364561440|FG004|Overall Study|Other reason not stated above|4|||
105699173|NCT01543828|364561441|FG000|Treatment 2|Lost to Follow-up|1|||
105699174|NCT01543828|364561442|FG001|Treatment 2|Lost to Follow-up|0|||
105699175|NCT00474708|364561443|FG000|Overall Study|Lack of Efficacy|11|||
105699176|NCT00474708|364561444|FG001|Overall Study|Lack of Efficacy|5|||
105699177|NCT00474708|364561443|FG000|Overall Study|Suicide ideation/behavior|0|||
105699178|NCT00474708|364561444|FG001|Overall Study|Suicide ideation/behavior|1|||
105699179|NCT00474708|364561443|FG000|Overall Study|Withdrawal by Subject|7|||
105699180|NCT00474708|364561444|FG001|Overall Study|Withdrawal by Subject|0|||
105699181|NCT00474708|364561443|FG000|Overall Study|Lack of compliance|12|||
105699182|NCT00474708|364561444|FG001|Overall Study|Lack of compliance|4|||
105699183|NCT00474708|364561443|FG000|Overall Study|Lost to Follow-up|18|||
105699184|NCT00474708|364561444|FG001|Overall Study|Lost to Follow-up|9|||
105699185|NCT00474708|364561443|FG000|Overall Study|Physician Decision|9|||
105699186|NCT00474708|364561444|FG001|Overall Study|Physician Decision|6|||
105699187|NCT04607148|364561449|FG000|Overall Study|Withdrawal by Subject|0|||
105699188|NCT04607148|364561450|FG001|Overall Study|Withdrawal by Subject|4|||
105699189|NCT04607148|364561451|FG002|Overall Study|Withdrawal by Subject|2|||
105699190|NCT04607148|364561452|FG003|Overall Study|Withdrawal by Subject|8|||
105699191|NCT04607148|364561449|FG000|Overall Study|Study Terminated by Sponsor|14|||
105699192|NCT04607148|364561450|FG001|Overall Study|Study Terminated by Sponsor|59|||
105699193|NCT04607148|364561451|FG002|Overall Study|Study Terminated by Sponsor|9|||
105699194|NCT04607148|364561452|FG003|Overall Study|Study Terminated by Sponsor|39|||
105699195|NCT04607148|364561449|FG000|Overall Study|Sponsor Decision|0|||
106005511|NCT01018030|365684739|FG001|Overall Study|Adverse Event|5|||
106005512|NCT01018030|365684740|FG002|Overall Study|Adverse Event|5|||
106005513|NCT01018030|365684738|FG000|Overall Study|Withdrawal by Subject|2|||
106005514|NCT01018030|365684739|FG001|Overall Study|Withdrawal by Subject|2|||
106005515|NCT01018030|365684740|FG002|Overall Study|Withdrawal by Subject|4|||
106005516|NCT01018030|365684738|FG000|Overall Study|Lost to Follow-up|2|||
105699196|NCT04607148|364561450|FG001|Overall Study|Sponsor Decision|0|||
105699197|NCT04607148|364561451|FG002|Overall Study|Sponsor Decision|1|||
105699198|NCT04607148|364561452|FG003|Overall Study|Sponsor Decision|0|||
105699199|NCT04607148|364561449|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105699200|NCT04607148|364561450|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105699201|NCT04607148|364561451|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105787207|NCT03110107|364874909|FG020|Treatment Period|Participant withdrew consent|0|||
105699202|NCT04607148|364561452|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105699203|NCT04607148|364561449|FG000|Overall Study|Lost to Follow-up|0|||
105699204|NCT04607148|364561450|FG001|Overall Study|Lost to Follow-up|2|||
105699205|NCT04607148|364561451|FG002|Overall Study|Lost to Follow-up|0|||
105787208|NCT03110107|364874910|FG021|Treatment Period|Participant withdrew consent|2|||
105787209|NCT03110107|364874911|FG022|Treatment Period|Participant withdrew consent|0|||
105787210|NCT03110107|364874912|FG023|Treatment Period|Participant withdrew consent|0|||
105787211|NCT03110107|364874913|FG024|Treatment Period|Participant withdrew consent|0|||
105787212|NCT03110107|364874914|FG025|Treatment Period|Participant withdrew consent|2|||
105787213|NCT03110107|364874889|FG000|Treatment Period|Participants no longer meets study criteria|0|||
105787214|NCT03110107|364874890|FG001|Treatment Period|Participants no longer meets study criteria|0|||
105787215|NCT03110107|364874891|FG002|Treatment Period|Participants no longer meets study criteria|0|||
105699206|NCT04607148|364561452|FG003|Overall Study|Lost to Follow-up|0|||
105699207|NCT04607148|364561449|FG000|Overall Study|Death|0|||
105699208|NCT04607148|364561450|FG001|Overall Study|Death|3|||
105699209|NCT04607148|364561451|FG002|Overall Study|Death|0|||
105787216|NCT03110107|364874892|FG003|Treatment Period|Participants no longer meets study criteria|0|||
105699210|NCT04607148|364561452|FG003|Overall Study|Death|1|||
105699211|NCT04607148|364561449|FG000|Overall Study|Adverse Event|0|||
105699212|NCT04607148|364561450|FG001|Overall Study|Adverse Event|1|||
105699213|NCT04607148|364561451|FG002|Overall Study|Adverse Event|0|||
106005517|NCT01018030|365684739|FG001|Overall Study|Lost to Follow-up|0|||
105699214|NCT04607148|364561452|FG003|Overall Study|Adverse Event|0|||
105699215|NCT00916149|364561453|FG000|Overall Study|Lost to Follow-up|3|||
106005518|NCT01018030|365684740|FG002|Overall Study|Lost to Follow-up|3|||
105699216|NCT00916149|364561454|FG001|Overall Study|Lost to Follow-up|2|||
105699217|NCT00916149|364561455|FG002|Overall Study|Lost to Follow-up|0|||
105699218|NCT00916149|364561453|FG000|Overall Study|Unable to place scalp EEG leads|1|||
105699219|NCT00916149|364561454|FG001|Overall Study|Unable to place scalp EEG leads|0|||
105699220|NCT00916149|364561455|FG002|Overall Study|Unable to place scalp EEG leads|0|||
105699221|NCT04305275|364561456|FG000|Overall Study|Adverse Event|4|||
105699222|NCT04305275|364561457|FG001|Overall Study|Adverse Event|0|||
105699223|NCT04305275|364561456|FG000|Overall Study|Lost to Follow-up|1|||
105699224|NCT04305275|364561457|FG001|Overall Study|Lost to Follow-up|1|||
105699225|NCT04305275|364561456|FG000|Overall Study|Withdrawal by Participant|8|||
105699226|NCT04305275|364561457|FG001|Overall Study|Withdrawal by Participant|1|||
105699227|NCT00589420|364561458|FG000|Overall Study|screen failure|1|||
105699228|NCT00243386|364561459|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
105699229|NCT00243386|364561460|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
105924804|NCT01189266|365385802|FG002|Overall Study|Withdrawal by Subject|1|||
105924805|NCT01189266|365385800|FG000|Overall Study|Patient refuses further therapy|1|||
105924806|NCT01189266|365385801|FG001|Overall Study|Patient refuses further therapy|0|||
105924807|NCT01189266|365385802|FG002|Overall Study|Patient refuses further therapy|7|||
105924808|NCT01189266|365385800|FG000|Overall Study|No treatment|0|||
105924809|NCT01189266|365385801|FG001|Overall Study|No treatment|0|||
105924810|NCT01189266|365385802|FG002|Overall Study|No treatment|1|||
105924811|NCT01129128|365385803|FG000|Overall Study|Lost to Follow-up|2|||
105924812|NCT01129128|365385804|FG001|Overall Study|Lost to Follow-up|2|||
105924813|NCT01129128|365385805|FG002|Overall Study|Lost to Follow-up|1|||
105924814|NCT01129128|365385803|FG000|Overall Study|Protocol Violation|0|||
105924815|NCT01129128|365385804|FG001|Overall Study|Protocol Violation|1|||
105924816|NCT01129128|365385805|FG002|Overall Study|Protocol Violation|0|||
105924817|NCT01129128|365385803|FG000|Overall Study|Withdrawal by Subject|0|||
105924818|NCT01129128|365385804|FG001|Overall Study|Withdrawal by Subject|1|||
105924819|NCT01129128|365385805|FG002|Overall Study|Withdrawal by Subject|3|||
105924820|NCT01129128|365385803|FG000|Overall Study|Physician Decision|1|||
105924821|NCT01129128|365385804|FG001|Overall Study|Physician Decision|0|||
105924822|NCT01129128|365385805|FG002|Overall Study|Physician Decision|0|||
105924823|NCT03881371|365385807|FG000|Overall Study|Adverse Event|8|||
105924824|NCT03881371|365385808|FG001|Overall Study|Adverse Event|9|||
105924825|NCT03881371|365385807|FG000|Overall Study|Death|1|||
105924826|NCT03881371|365385808|FG001|Overall Study|Death|0|||
105924827|NCT03881371|365385807|FG000|Overall Study|Lost to Follow-up|1|||
105924828|NCT03881371|365385808|FG001|Overall Study|Lost to Follow-up|0|||
105924829|NCT03881371|365385807|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105924830|NCT03881371|365385808|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105924831|NCT03881371|365385807|FG000|Overall Study|Physician Decision|3|||
105924832|NCT03881371|365385808|FG001|Overall Study|Physician Decision|3|||
105924833|NCT03881371|365385807|FG000|Overall Study|Withdrawal by Subject|2|||
105924834|NCT03881371|365385808|FG001|Overall Study|Withdrawal by Subject|10|||
105924835|NCT03881371|365385807|FG000|Overall Study|Discontinuation from Study|1|||
105924836|NCT03881371|365385808|FG001|Overall Study|Discontinuation from Study|0|||
105924837|NCT00933933|365385809|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
105924838|NCT00933933|365385810|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
105924839|NCT00933933|365385811|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
105924840|NCT00933933|365385809|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
105924841|NCT00933933|365385810|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
105924842|NCT00933933|365385811|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
105924843|NCT03822416|365385812|FG000|Overall Study|Lost to Follow-up|1|||
105924844|NCT03822416|365385813|FG001|Overall Study|Lost to Follow-up|0|||
105924845|NCT03822416|365385812|FG000|Overall Study|Withdrawal by Subject|0|||
105924846|NCT03822416|365385813|FG001|Overall Study|Withdrawal by Subject|1|||
105699230|NCT00243386|364561461|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
105924847|NCT04666298|365385814|FG000|Overall Study|Subject decision|1|||
105924848|NCT04666298|365385815|FG001|Overall Study|Subject decision|0|||
105699231|NCT00243386|364561459|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
105699232|NCT00243386|364561460|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
105699233|NCT00243386|364561461|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
105924849|NCT04666298|365385816|FG002|Overall Study|Subject decision|0|||
105699234|NCT00243386|364561459|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
105699235|NCT00243386|364561460|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
105699236|NCT00243386|364561461|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
105699237|NCT00243386|364561459|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
105699238|NCT00243386|364561460|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
105924850|NCT04666298|365385817|FG003|Overall Study|Subject decision|2|||
105924851|NCT04666298|365385814|FG000|Overall Study|Death|1|||
105924852|NCT04666298|365385815|FG001|Overall Study|Death|0|||
105924853|NCT04666298|365385816|FG002|Overall Study|Death|0|||
105924854|NCT04666298|365385817|FG003|Overall Study|Death|0|||
105924855|NCT04666298|365385814|FG000|Overall Study|Lost to Follow-up|0|||
105924856|NCT04666298|365385815|FG001|Overall Study|Lost to Follow-up|0|||
105924857|NCT04666298|365385816|FG002|Overall Study|Lost to Follow-up|0|||
105924858|NCT04666298|365385817|FG003|Overall Study|Lost to Follow-up|1|||
105699239|NCT00243386|364561461|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
105699240|NCT00243386|364561459|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
105699241|NCT00243386|364561460|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
105699242|NCT00243386|364561461|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
105699243|NCT00243386|364561459|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
105699244|NCT00243386|364561460|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
105699245|NCT00243386|364561461|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
105699246|NCT00243386|364561459|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
105699247|NCT00243386|364561460|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
105699248|NCT00243386|364561461|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
105699249|NCT00243386|364561459|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
105699250|NCT00243386|364561460|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
105699251|NCT00243386|364561461|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
105699252|NCT00912028|364561462|FG000|Overall Study|Lost to Follow-up|2|||
105699253|NCT00912028|364561463|FG001|Overall Study|Lost to Follow-up|3|||
105699254|NCT00912028|364561464|FG002|Overall Study|Lost to Follow-up|0|||
105699255|NCT00912028|364561465|FG003|Overall Study|Lost to Follow-up|1|||
105699256|NCT00912028|364561466|FG004|Overall Study|Lost to Follow-up|3|||
105699257|NCT00912028|364561462|FG000|Overall Study|Withdrawal by Subject|3|||
105699258|NCT00912028|364561463|FG001|Overall Study|Withdrawal by Subject|0|||
105699259|NCT00912028|364561464|FG002|Overall Study|Withdrawal by Subject|0|||
105699260|NCT00912028|364561465|FG003|Overall Study|Withdrawal by Subject|0|||
105699261|NCT00912028|364561466|FG004|Overall Study|Withdrawal by Subject|0|||
105699262|NCT00766038|364562941|FG000|Overall Study|Lost to Follow-up|15|||
105699263|NCT00766038|364562942|FG001|Overall Study|Lost to Follow-up|14|||
105699264|NCT01524198|364562943|FG000|Overall Study|Protocol Violation|8|||
105699265|NCT01524198|364562944|FG001|Overall Study|Protocol Violation|6|||
105699266|NCT01524198|364562943|FG000|Overall Study|Withdrawal by Subject|15|||
105699267|NCT01524198|364562944|FG001|Overall Study|Withdrawal by Subject|10|||
105699268|NCT01502709|364562945|FG000|Overall Study|Lost to Follow-up|4|||
105699269|NCT01502709|364562946|FG001|Overall Study|Lost to Follow-up|0|||
105699270|NCT00307151|364562947|FG000|Overall Study|Death|4|||
105699271|NCT00307151|364562948|FG001|Overall Study|Death|3|||
105699272|NCT00307151|364562949|FG002|Overall Study|Death|10|||
105699273|NCT00307151|364562950|FG003|Overall Study|Death|3|||
105699274|NCT00307151|364562947|FG000|Overall Study|Severe debilitation, unable to continue|1|||
105699275|NCT00307151|364562948|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105699276|NCT00307151|364562949|FG002|Overall Study|Severe debilitation, unable to continue|0|||
105699277|NCT00307151|364562950|FG003|Overall Study|Severe debilitation, unable to continue|0|||
105699278|NCT00307151|364562947|FG000|Overall Study|Subject unable to get to clinic|1|||
105699279|NCT00307151|364562948|FG001|Overall Study|Subject unable to get to clinic|0|||
105699280|NCT00307151|364562949|FG002|Overall Study|Subject unable to get to clinic|6|||
105699281|NCT00307151|364562950|FG003|Overall Study|Subject unable to get to clinic|2|||
105699282|NCT00307151|364562947|FG000|Overall Study|Withdrew consent|0|||
105699283|NCT00307151|364562948|FG001|Overall Study|Withdrew consent|1|||
105699284|NCT00307151|364562949|FG002|Overall Study|Withdrew consent|1|||
105699285|NCT00307151|364562950|FG003|Overall Study|Withdrew consent|3|||
105699286|NCT00307151|364562947|FG000|Overall Study|Not willing to adhere to study reqs|2|||
105699287|NCT00307151|364562948|FG001|Overall Study|Not willing to adhere to study reqs|0|||
105699288|NCT00307151|364562949|FG002|Overall Study|Not willing to adhere to study reqs|2|||
105699289|NCT00307151|364562950|FG003|Overall Study|Not willing to adhere to study reqs|2|||
105699290|NCT00307151|364562947|FG000|Overall Study|Clinic unable to contact subject|3|||
105699291|NCT00307151|364562948|FG001|Overall Study|Clinic unable to contact subject|3|||
105699292|NCT00307151|364562949|FG002|Overall Study|Clinic unable to contact subject|1|||
105699293|NCT00307151|364562950|FG003|Overall Study|Clinic unable to contact subject|1|||
105699294|NCT01490450|364562951|FG000|Period 1|Lack of Efficacy|2|||
105699295|NCT01490450|364562952|FG001|Period 1|Lack of Efficacy|0|||
105699296|NCT01490450|364562953|FG002|Period 1|Lack of Efficacy|3|||
106005519|NCT01018030|365684738|FG000|Overall Study|Protocol Violation|2|||
106005520|NCT01018030|365684739|FG001|Overall Study|Protocol Violation|1|||
106005521|NCT01018030|365684740|FG002|Overall Study|Protocol Violation|0|||
105699297|NCT01490450|364562954|FG003|Period 1|Lack of Efficacy|0|||
105699298|NCT01490450|364562951|FG000|Period 1|Adverse Event|0|||
105699299|NCT01490450|364562952|FG001|Period 1|Adverse Event|0|||
105699300|NCT01490450|364562953|FG002|Period 1|Adverse Event|0|||
105699301|NCT01490450|364562954|FG003|Period 1|Adverse Event|5|||
105699302|NCT01490450|364562951|FG000|Period 1|Request to discontinue treatment|1|||
105699303|NCT01490450|364562952|FG001|Period 1|Request to discontinue treatment|0|||
105699304|NCT01490450|364562953|FG002|Period 1|Request to discontinue treatment|0|||
105699305|NCT01490450|364562954|FG003|Period 1|Request to discontinue treatment|0|||
105699306|NCT01490450|364562951|FG000|Period 1|Withdrawal by Subject|0|||
105699307|NCT01490450|364562952|FG001|Period 1|Withdrawal by Subject|0|||
106005522|NCT01018030|365684738|FG000|Overall Study|Physician Decision|1|||
106005523|NCT01018030|365684739|FG001|Overall Study|Physician Decision|0|||
105699308|NCT01490450|364562953|FG002|Period 1|Withdrawal by Subject|0|||
105699309|NCT01490450|364562954|FG003|Period 1|Withdrawal by Subject|3|||
105699310|NCT01490450|364562951|FG000|Period 1|No longer met study criteria|0|||
105699311|NCT01490450|364562952|FG001|Period 1|No longer met study criteria|1|||
105699312|NCT01490450|364562953|FG002|Period 1|No longer met study criteria|1|||
105699313|NCT01490450|364562954|FG003|Period 1|No longer met study criteria|0|||
105699314|NCT01490450|364562951|FG000|Period 2|Lack of Efficacy|0|||
105699315|NCT01490450|364562952|FG001|Period 2|Lack of Efficacy|0|||
105699316|NCT01490450|364562953|FG002|Period 2|Lack of Efficacy|0|||
105699317|NCT01490450|364562954|FG003|Period 2|Lack of Efficacy|1|||
105699318|NCT01490450|364562951|FG000|Period 2|Adverse Event|1|||
105699319|NCT01490450|364562952|FG001|Period 2|Adverse Event|1|||
105699320|NCT01490450|364562953|FG002|Period 2|Adverse Event|0|||
105699321|NCT01490450|364562954|FG003|Period 2|Adverse Event|1|||
105699322|NCT01490450|364562951|FG000|Period 2|Withdrawal by Subject|1|||
105699323|NCT01490450|364562952|FG001|Period 2|Withdrawal by Subject|0|||
105699324|NCT01490450|364562953|FG002|Period 2|Withdrawal by Subject|0|||
105699325|NCT01490450|364562954|FG003|Period 2|Withdrawal by Subject|0|||
105699326|NCT01490450|364562951|FG000|Period 2|Lost to Follow-up|0|||
105699327|NCT01490450|364562952|FG001|Period 2|Lost to Follow-up|0|||
105699328|NCT01490450|364562953|FG002|Period 2|Lost to Follow-up|0|||
105699329|NCT01490450|364562954|FG003|Period 2|Lost to Follow-up|2|||
105699330|NCT00516048|364562957|FG000|Overall Study|Death|0|||
105699331|NCT00516048|364562958|FG001|Overall Study|Death|0|||
105699332|NCT00516048|364562959|FG002|Overall Study|Death|1|||
105699333|NCT00516048|364562957|FG000|Overall Study|Subject Decision|0|||
105699334|NCT00516048|364562958|FG001|Overall Study|Subject Decision|2|||
105699335|NCT00516048|364562959|FG002|Overall Study|Subject Decision|0|||
105699336|NCT00054704|364562964|FG000|Overall Study|Lack of Efficacy|2|||
105699337|NCT00054704|364562965|FG001|Overall Study|Lack of Efficacy|3|||
105699338|NCT00054704|364562964|FG000|Overall Study|Adverse Event|3|||
105699339|NCT00054704|364562965|FG001|Overall Study|Adverse Event|1|||
105699340|NCT00054704|364562964|FG000|Overall Study|Lost to Follow-up|0|||
105699341|NCT00054704|364562965|FG001|Overall Study|Lost to Follow-up|1|||
105699342|NCT02289742|364562968|FG000|First Wear Period|Adverse event prior to treatment|0|||
105699343|NCT02289742|364562969|FG001|First Wear Period|Adverse event prior to treatment|1|||
105699344|NCT02289742|364562970|FG002|First Wear Period|Adverse event prior to treatment|0|||
105699345|NCT02289742|364562971|FG003|First Wear Period|Adverse event prior to treatment|0|||
105699346|NCT02289742|364562968|FG000|First Wear Period|Adverse Event|0|||
105699347|NCT02289742|364562969|FG001|First Wear Period|Adverse Event|0|||
105699348|NCT02289742|364562970|FG002|First Wear Period|Adverse Event|1|||
105699349|NCT02289742|364562971|FG003|First Wear Period|Adverse Event|0|||
105699350|NCT02289742|364562968|FG000|First Wear Period|Other prior to treatment|0|||
105699351|NCT02289742|364562969|FG001|First Wear Period|Other prior to treatment|0|||
105924859|NCT04666298|365385814|FG000|Overall Study|Physician Decision|0|||
105924860|NCT04666298|365385815|FG001|Overall Study|Physician Decision|0|||
105924861|NCT04666298|365385816|FG002|Overall Study|Physician Decision|0|||
105924862|NCT04666298|365385817|FG003|Overall Study|Physician Decision|1|||
105924863|NCT04666298|365385814|FG000|Overall Study|Protocol deviation|0|||
105924864|NCT04666298|365385815|FG001|Overall Study|Protocol deviation|0|||
105924865|NCT04666298|365385816|FG002|Overall Study|Protocol deviation|1|||
105924866|NCT04666298|365385817|FG003|Overall Study|Protocol deviation|0|||
105924867|NCT01995201|365385818|FG000|From Baseline Until Week 24|Adverse Event|4|||
105924868|NCT01995201|365385819|FG001|From Baseline Until Week 24|Adverse Event|15|||
105699352|NCT02289742|364562970|FG002|First Wear Period|Other prior to treatment|0|||
105699353|NCT02289742|364562971|FG003|First Wear Period|Other prior to treatment|1|||
105924869|NCT01995201|365385820|FG002|From Baseline Until Week 24|Adverse Event|0|||
105924870|NCT01995201|365385821|FG003|From Baseline Until Week 24|Adverse Event|0|||
105924871|NCT01995201|365385822|FG004|From Baseline Until Week 24|Adverse Event|0|||
105924872|NCT01995201|365385823|FG005|From Baseline Until Week 24|Adverse Event|0|||
105924873|NCT01995201|365385824|FG006|From Baseline Until Week 24|Adverse Event|0|||
105924874|NCT01995201|365385818|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105699354|NCT02289742|364562968|FG000|Third Wear Period|Adverse Event|0|||
105699355|NCT02289742|364562969|FG001|Third Wear Period|Adverse Event|1|||
105699356|NCT02289742|364562970|FG002|Third Wear Period|Adverse Event|0|||
105699357|NCT02289742|364562971|FG003|Third Wear Period|Adverse Event|0|||
105924875|NCT01995201|365385819|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
106132833|NCT03278028|366144800|FG000|Overall Study|Lost to Follow-up|1|||
106132834|NCT03278028|366144801|FG001|Overall Study|Lost to Follow-up|0|||
105699358|NCT02289742|364562968|FG000|Third Wear Period|Reason not given|0|||
105699359|NCT02289742|364562969|FG001|Third Wear Period|Reason not given|0|||
105699360|NCT02289742|364562970|FG002|Third Wear Period|Reason not given|0|||
105699361|NCT02289742|364562971|FG003|Third Wear Period|Reason not given|1|||
105699362|NCT02535715|364562975|FG000|Overall Study|Withdrawal by Subject|0|||
105924876|NCT01995201|365385820|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105699363|NCT02535715|364562976|FG001|Overall Study|Withdrawal by Subject|0|||
105699364|NCT02535715|364562977|FG002|Overall Study|Withdrawal by Subject|1|||
106132835|NCT03278028|366144800|FG000|Overall Study|Withdrawal by Subject|3|||
105699365|NCT00971178|364562981|FG000|Overall Study|Lost to Follow-up|2|||
105699366|NCT00971178|364562982|FG001|Overall Study|Lost to Follow-up|2|||
105699367|NCT00971178|364562983|FG002|Overall Study|Lost to Follow-up|2|||
105699368|NCT01376778|364562987|FG000|Overall Study|Lost to Follow-up|3|||
105699369|NCT01376778|364562988|FG001|Overall Study|Lost to Follow-up|2|||
105699370|NCT00596947|364562990|FG000|Overall Study|study halted due to low enrollment|5|||
105699371|NCT00596947|364562991|FG001|Overall Study|study halted due to low enrollment|3|||
105699372|NCT00596947|364562990|FG000|Overall Study|Lost to Follow-up|1|||
105699373|NCT00596947|364562991|FG001|Overall Study|Lost to Follow-up|0|||
105699374|NCT01075412|364562992|FG000|Overall Study|Withdrawal by Subject|0|||
105699375|NCT01075412|364562993|FG001|Overall Study|Withdrawal by Subject|1|||
105699376|NCT01390272|364562994|FG000|Overall Study|Death|3|||
105699377|NCT01390272|364562995|FG001|Overall Study|Death|2|||
105699378|NCT01390272|364562994|FG000|Overall Study|Withdrawal by Subject|9|||
105699379|NCT01390272|364562995|FG001|Overall Study|Withdrawal by Subject|5|||
105699380|NCT01390272|364562994|FG000|Overall Study|Patient moved, no longer eligible|5|||
105699381|NCT01390272|364562995|FG001|Overall Study|Patient moved, no longer eligible|8|||
105699382|NCT01069172|364562998|FG000|Overall Study|Withdrawal by Subject|1|||
105699383|NCT01069172|364562999|FG001|Overall Study|Withdrawal by Subject|0|||
105699384|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
105699385|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
105699386|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Death|0|||
105699387|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Death|1|||
105699388|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
105699389|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
105699390|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
105699391|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
105924877|NCT01995201|365385821|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105924878|NCT01995201|365385822|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105699392|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
105699393|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
105699394|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
105699395|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
105699396|NCT00843518|364563002|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
105699397|NCT00843518|364563003|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
105699398|NCT01786603|364563004|FG000|Overall Study|Death|5|||
105699399|NCT01786603|364563005|FG001|Overall Study|Death|1|||
105699400|NCT01786603|364563004|FG000|Overall Study|Adverse Event|6|||
105699401|NCT01786603|364563005|FG001|Overall Study|Adverse Event|2|||
105699402|NCT01786603|364563004|FG000|Overall Study|Physician decision to withdraw|6|||
105699403|NCT01786603|364563005|FG001|Overall Study|Physician decision to withdraw|7|||
105699404|NCT01786603|364563004|FG000|Overall Study|Lost to Follow-up|1|||
105699405|NCT01786603|364563005|FG001|Overall Study|Lost to Follow-up|2|||
105699406|NCT01066585|364563010|FG000|Overall Study|Protocol Violation|1|||
105924879|NCT01995201|365385823|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105924880|NCT01995201|365385824|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
105924881|NCT01995201|365385818|FG000|From Baseline Until Week 24|Death|0|||
105924882|NCT01995201|365385819|FG001|From Baseline Until Week 24|Death|1|||
105924883|NCT01995201|365385820|FG002|From Baseline Until Week 24|Death|0|||
105924884|NCT01995201|365385821|FG003|From Baseline Until Week 24|Death|0|||
105924885|NCT01995201|365385822|FG004|From Baseline Until Week 24|Death|0|||
105924886|NCT01995201|365385823|FG005|From Baseline Until Week 24|Death|0|||
105924887|NCT01995201|365385824|FG006|From Baseline Until Week 24|Death|0|||
105924888|NCT01995201|365385818|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
105924889|NCT01995201|365385819|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
105924890|NCT01995201|365385820|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
105924891|NCT01995201|365385821|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
105699407|NCT01066585|364563011|FG001|Overall Study|Protocol Violation|0|||
105699408|NCT01066585|364563010|FG000|Overall Study|Withdrawal by Subject|0|||
105699409|NCT01066585|364563011|FG001|Overall Study|Withdrawal by Subject|3|||
105699410|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
105699411|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
105699412|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
105699413|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
105699414|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
105699415|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
105699416|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105924892|NCT01995201|365385822|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
105924893|NCT01995201|365385823|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
105699417|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105699418|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
105924894|NCT01995201|365385824|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
105924895|NCT01995201|365385818|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
105699419|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
105699420|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
105699421|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
105699422|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
105699423|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
105699424|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
105699425|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
105699426|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
105699427|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
106132836|NCT03278028|366144801|FG001|Overall Study|Withdrawal by Subject|1|||
106132837|NCT03278028|366144800|FG000|Overall Study|Pregnancy|0|||
106132838|NCT03278028|366144801|FG001|Overall Study|Pregnancy|1|||
106132839|NCT00293462|366144807|FG000|Overall Study|Withdrawal by Subject|4|||
105699428|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
105699429|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
105699430|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
105699431|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
105699432|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
105699433|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
105699434|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Death|2|||
105699435|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Death|1|||
105699436|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Death|0|||
105699437|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Death|0|||
105699438|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
105699439|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
105699440|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
105699441|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
105699442|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
105699443|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
105699444|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
105699445|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
105699446|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
105699447|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
105699448|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105699449|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105699450|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
105924896|NCT01995201|365385819|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
105924897|NCT01995201|365385820|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
105924898|NCT01995201|365385821|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
105924899|NCT01995201|365385822|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
105924900|NCT01995201|365385823|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
105924901|NCT01995201|365385824|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
105924902|NCT01995201|365385818|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
105924903|NCT01995201|365385819|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
105924904|NCT01995201|365385820|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
105924905|NCT01995201|365385821|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
105924906|NCT01995201|365385822|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
105924907|NCT01995201|365385823|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
105924908|NCT01995201|365385824|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
105924909|NCT01995201|365385818|FG000|From Baseline Until Week 24|Physician Decision|0|||
105924910|NCT01995201|365385819|FG001|From Baseline Until Week 24|Physician Decision|2|||
105924911|NCT01995201|365385820|FG002|From Baseline Until Week 24|Physician Decision|0|||
105924912|NCT01995201|365385821|FG003|From Baseline Until Week 24|Physician Decision|0|||
105924913|NCT01995201|365385822|FG004|From Baseline Until Week 24|Physician Decision|0|||
105924914|NCT01995201|365385823|FG005|From Baseline Until Week 24|Physician Decision|0|||
105924915|NCT01995201|365385824|FG006|From Baseline Until Week 24|Physician Decision|0|||
105924916|NCT01995201|365385818|FG000|From Baseline Until Week 24|Protocol Violation|0|||
105924917|NCT01995201|365385819|FG001|From Baseline Until Week 24|Protocol Violation|9|||
105924918|NCT01995201|365385820|FG002|From Baseline Until Week 24|Protocol Violation|0|||
105924919|NCT01995201|365385821|FG003|From Baseline Until Week 24|Protocol Violation|0|||
105924920|NCT01995201|365385822|FG004|From Baseline Until Week 24|Protocol Violation|0|||
105924921|NCT01995201|365385823|FG005|From Baseline Until Week 24|Protocol Violation|0|||
106132840|NCT00293462|366144808|FG001|Overall Study|Withdrawal by Subject|3|||
105924922|NCT01995201|365385824|FG006|From Baseline Until Week 24|Protocol Violation|0|||
105924923|NCT01995201|365385818|FG000|From Week 24 Until Week 48|Adverse Event|0|||
105924924|NCT01995201|365385819|FG001|From Week 24 Until Week 48|Adverse Event|0|||
105924925|NCT01995201|365385820|FG002|From Week 24 Until Week 48|Adverse Event|2|||
105924926|NCT01995201|365385821|FG003|From Week 24 Until Week 48|Adverse Event|1|||
106132841|NCT00293462|366144809|FG002|Overall Study|Withdrawal by Subject|8|||
106132842|NCT00293462|366144807|FG000|Overall Study|Death|1|||
105699451|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
105699452|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
105699453|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
105699454|NCT01940471|364563014|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
105699455|NCT01940471|364563015|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
105699456|NCT01940471|364563016|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
105699457|NCT01940471|364563017|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
105699458|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
105699459|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
105699460|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
105699461|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
105699462|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105699463|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105699464|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
105699465|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
105699466|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
105699467|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
105699468|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
105699469|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
105699470|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
105699471|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
105699472|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
105699473|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
105699474|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105699475|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105699476|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
105699477|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
105699478|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105699479|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105699480|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
105699481|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
105699482|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105699483|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105699484|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
105699485|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105699486|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
105699487|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
105699488|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
105699489|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
105699490|NCT01940471|364563014|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105699491|NCT01940471|364563015|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105699492|NCT01940471|364563016|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
105699493|NCT01940471|364563017|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105699494|NCT01136655|364563018|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
105699495|NCT01136655|364563018|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
105699496|NCT01136655|364563018|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
105699497|NCT01136655|364563018|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
105699498|NCT01358760|364563023|FG000|Overall Study|Adverse Event|3|||
105699499|NCT01358760|364563024|FG001|Overall Study|Adverse Event|4|||
105699500|NCT01358760|364563025|FG002|Overall Study|Adverse Event|3|||
105699501|NCT01358760|364563023|FG000|Overall Study|Lost to Follow-up|1|||
105699502|NCT01358760|364563024|FG001|Overall Study|Lost to Follow-up|1|||
105699503|NCT01358760|364563025|FG002|Overall Study|Lost to Follow-up|3|||
105699504|NCT01358760|364563023|FG000|Overall Study|Withdrawal by Subject|5|||
105699505|NCT01358760|364563024|FG001|Overall Study|Withdrawal by Subject|3|||
105699506|NCT01358760|364563025|FG002|Overall Study|Withdrawal by Subject|2|||
105699507|NCT01358760|364563023|FG000|Overall Study|Physician Decision|1|||
105699508|NCT01358760|364563024|FG001|Overall Study|Physician Decision|0|||
105699509|NCT01358760|364563025|FG002|Overall Study|Physician Decision|1|||
105699510|NCT01358760|364563023|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
105699511|NCT01358760|364563024|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
105699512|NCT01358760|364563025|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
105699513|NCT03710486|364563026|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
105699514|NCT03710486|364563027|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
105699515|NCT03710486|364563026|FG000|Overall Study|Missing|0|||
105699516|NCT03710486|364563027|FG001|Overall Study|Missing|2|||
105699517|NCT01987960|364563028|FG000|Period 1|Adverse Event|24|||
105699518|NCT01987960|364563029|FG001|Period 1|Adverse Event|0|||
105699519|NCT01987960|364563030|FG002|Period 1|Adverse Event|0|||
105699520|NCT01987960|364563031|FG003|Period 1|Adverse Event|0|||
105699521|NCT01987960|364563028|FG000|Period 1|Lack of Efficacy|4|||
105699522|NCT01987960|364563029|FG001|Period 1|Lack of Efficacy|0|||
105699523|NCT01987960|364563030|FG002|Period 1|Lack of Efficacy|0|||
105699524|NCT01987960|364563031|FG003|Period 1|Lack of Efficacy|0|||
105699525|NCT01987960|364563028|FG000|Period 1|Non-compliance with IMP|6|||
105699526|NCT01987960|364563029|FG001|Period 1|Non-compliance with IMP|0|||
105699527|NCT01987960|364563030|FG002|Period 1|Non-compliance with IMP|0|||
106005524|NCT01018030|365684740|FG002|Overall Study|Physician Decision|1|||
106005525|NCT01018030|365684738|FG000|Overall Study|Lack of Efficacy|1|||
106005526|NCT01018030|365684739|FG001|Overall Study|Lack of Efficacy|0|||
105699528|NCT01987960|364563031|FG003|Period 1|Non-compliance with IMP|0|||
105699529|NCT01987960|364563028|FG000|Period 1|Protocol Violation|12|||
105699530|NCT01987960|364563029|FG001|Period 1|Protocol Violation|0|||
105699531|NCT01987960|364563030|FG002|Period 1|Protocol Violation|0|||
105699532|NCT01987960|364563031|FG003|Period 1|Protocol Violation|0|||
105699533|NCT01987960|364563028|FG000|Period 1|Withdrawal by Subject|21|||
105699534|NCT01987960|364563029|FG001|Period 1|Withdrawal by Subject|0|||
105699535|NCT01987960|364563030|FG002|Period 1|Withdrawal by Subject|0|||
105699536|NCT01987960|364563031|FG003|Period 1|Withdrawal by Subject|0|||
105699537|NCT01987960|364563028|FG000|Period 1|Lost to Follow-up|40|||
105699538|NCT01987960|364563029|FG001|Period 1|Lost to Follow-up|0|||
105699539|NCT01987960|364563030|FG002|Period 1|Lost to Follow-up|0|||
105699540|NCT01987960|364563031|FG003|Period 1|Lost to Follow-up|0|||
105699541|NCT01987960|364563028|FG000|Period 1|administrative or other reason|75|||
105699542|NCT01987960|364563029|FG001|Period 1|administrative or other reason|0|||
105699543|NCT01987960|364563030|FG002|Period 1|administrative or other reason|0|||
105699544|NCT01987960|364563031|FG003|Period 1|administrative or other reason|0|||
105699545|NCT01987960|364563028|FG000|Period 1|Withdrawal of consent before treatment|4|||
105699546|NCT01987960|364563029|FG001|Period 1|Withdrawal of consent before treatment|0|||
105699547|NCT01987960|364563030|FG002|Period 1|Withdrawal of consent before treatment|0|||
105699548|NCT01987960|364563031|FG003|Period 1|Withdrawal of consent before treatment|0|||
105699549|NCT01987960|364563028|FG000|Period 2|Adverse Event|0|||
105699550|NCT01987960|364563029|FG001|Period 2|Adverse Event|0|||
105699551|NCT01987960|364563030|FG002|Period 2|Adverse Event|1|||
106005527|NCT01018030|365684740|FG002|Overall Study|Lack of Efficacy|0|||
106005528|NCT01018030|365684738|FG000|Overall Study|Did Not Receive Study Drug|1|||
105699552|NCT01987960|364563031|FG003|Period 2|Adverse Event|0|||
105699553|NCT01987960|364563028|FG000|Period 2|Withdrawal by Subject|0|||
105699554|NCT01987960|364563029|FG001|Period 2|Withdrawal by Subject|0|||
105699555|NCT01987960|364563030|FG002|Period 2|Withdrawal by Subject|1|||
105699556|NCT01987960|364563031|FG003|Period 2|Withdrawal by Subject|0|||
105699557|NCT01987960|364563028|FG000|Period 2|Administrative or other reason|0|||
105699558|NCT01987960|364563029|FG001|Period 2|Administrative or other reason|5|||
105699559|NCT01987960|364563030|FG002|Period 2|Administrative or other reason|7|||
105699560|NCT01987960|364563031|FG003|Period 2|Administrative or other reason|0|||
105699561|NCT01987960|364563028|FG000|Period 3|Adverse Event|0|||
105699562|NCT01987960|364563029|FG001|Period 3|Adverse Event|0|||
105699563|NCT01987960|364563030|FG002|Period 3|Adverse Event|0|||
105699564|NCT01987960|364563031|FG003|Period 3|Adverse Event|7|||
105699565|NCT01987960|364563028|FG000|Period 3|Non-compliance with IMP|0|||
106005529|NCT01018030|365684739|FG001|Overall Study|Did Not Receive Study Drug|3|||
106005530|NCT01018030|365684740|FG002|Overall Study|Did Not Receive Study Drug|0|||
106005531|NCT01600885|365684757|FG000|First Period|Adverse Event|1|||
105699566|NCT01987960|364563029|FG001|Period 3|Non-compliance with IMP|0|||
105699567|NCT01987960|364563030|FG002|Period 3|Non-compliance with IMP|0|||
105699568|NCT01987960|364563031|FG003|Period 3|Non-compliance with IMP|1|||
105699569|NCT01987960|364563028|FG000|Period 3|Protocol Violation|0|||
105699570|NCT01987960|364563029|FG001|Period 3|Protocol Violation|0|||
105699571|NCT01987960|364563030|FG002|Period 3|Protocol Violation|0|||
106005532|NCT01600885|365684758|FG001|First Period|Adverse Event|1|||
106005533|NCT01600885|365684757|FG000|First Period|moved out of area|1|||
105699572|NCT01987960|364563031|FG003|Period 3|Protocol Violation|6|||
105699573|NCT01987960|364563028|FG000|Period 3|Withdrawal by Subject|0|||
105699574|NCT01987960|364563029|FG001|Period 3|Withdrawal by Subject|0|||
105699575|NCT01987960|364563030|FG002|Period 3|Withdrawal by Subject|0|||
105699576|NCT01987960|364563031|FG003|Period 3|Withdrawal by Subject|9|||
105699577|NCT01987960|364563028|FG000|Period 3|Lost to Follow-up|0|||
106005534|NCT01600885|365684758|FG001|First Period|moved out of area|0|||
106005535|NCT01903356|365684764|FG000|Overall Study|Lost to Follow-up|7|||
106132843|NCT00293462|366144808|FG001|Overall Study|Death|0|||
105699578|NCT01987960|364563029|FG001|Period 3|Lost to Follow-up|0|||
105699579|NCT01987960|364563030|FG002|Period 3|Lost to Follow-up|0|||
105699580|NCT01987960|364563031|FG003|Period 3|Lost to Follow-up|5|||
105699581|NCT01987960|364563028|FG000|Period 3|Administrative or other reason|0|||
105699582|NCT01987960|364563029|FG001|Period 3|Administrative or other reason|0|||
105699583|NCT01987960|364563030|FG002|Period 3|Administrative or other reason|0|||
106132844|NCT00293462|366144809|FG002|Overall Study|Death|0|||
105699584|NCT01987960|364563031|FG003|Period 3|Administrative or other reason|43|||
105699585|NCT00932360|364563032|FG000|Washout (One Week)|Withdrawal by Subject|0|||
105699586|NCT00932360|364563033|FG001|Washout (One Week)|Withdrawal by Subject|0|||
105699587|NCT00932360|364563034|FG002|Washout (One Week)|Withdrawal by Subject|0|||
105699588|NCT00932360|364563035|FG003|Washout (One Week)|Withdrawal by Subject|0|||
105699589|NCT00932360|364563036|FG004|Washout (One Week)|Withdrawal by Subject|2|||
105699590|NCT00932360|364563037|FG005|Washout (One Week)|Withdrawal by Subject|0|||
105699591|NCT01147744|364563038|FG000|Overall Study|Protocol Violation|1|||
105699592|NCT01147744|364563039|FG001|Overall Study|Protocol Violation|0|||
105699593|NCT01147744|364563040|FG002|Overall Study|Protocol Violation|1|||
105699594|NCT01147744|364563041|FG003|Overall Study|Protocol Violation|0|||
105699595|NCT01147744|364563042|FG004|Overall Study|Protocol Violation|1|||
105699596|NCT01147744|364563043|FG005|Overall Study|Protocol Violation|3|||
105699597|NCT01147744|364563044|FG006|Overall Study|Protocol Violation|1|||
105699598|NCT01147744|364563038|FG000|Overall Study|Physician Decision|0|||
105699599|NCT01147744|364563039|FG001|Overall Study|Physician Decision|1|||
105699600|NCT01147744|364563040|FG002|Overall Study|Physician Decision|1|||
105699601|NCT01147744|364563041|FG003|Overall Study|Physician Decision|0|||
105699602|NCT01147744|364563042|FG004|Overall Study|Physician Decision|0|||
105699603|NCT01147744|364563043|FG005|Overall Study|Physician Decision|0|||
105699604|NCT01147744|364563044|FG006|Overall Study|Physician Decision|1|||
105699605|NCT01147744|364563038|FG000|Overall Study|Lack of Efficacy|11|||
105699606|NCT01147744|364563039|FG001|Overall Study|Lack of Efficacy|11|||
105699607|NCT01147744|364563040|FG002|Overall Study|Lack of Efficacy|9|||
105699608|NCT01147744|364563041|FG003|Overall Study|Lack of Efficacy|11|||
105699609|NCT01147744|364563042|FG004|Overall Study|Lack of Efficacy|13|||
105699610|NCT01147744|364563043|FG005|Overall Study|Lack of Efficacy|8|||
105699611|NCT01147744|364563044|FG006|Overall Study|Lack of Efficacy|7|||
105699612|NCT01147744|364563038|FG000|Overall Study|Adverse Event|1|||
105699613|NCT01147744|364563039|FG001|Overall Study|Adverse Event|2|||
105699614|NCT01147744|364563040|FG002|Overall Study|Adverse Event|3|||
105699615|NCT01147744|364563041|FG003|Overall Study|Adverse Event|0|||
105699616|NCT01147744|364563042|FG004|Overall Study|Adverse Event|2|||
105699617|NCT01147744|364563043|FG005|Overall Study|Adverse Event|1|||
105699618|NCT01147744|364563044|FG006|Overall Study|Adverse Event|2|||
105699619|NCT01147744|364563038|FG000|Overall Study|Withdrawal by Subject|8|||
105699620|NCT01147744|364563039|FG001|Overall Study|Withdrawal by Subject|4|||
105699621|NCT01147744|364563040|FG002|Overall Study|Withdrawal by Subject|2|||
105699622|NCT01147744|364563041|FG003|Overall Study|Withdrawal by Subject|2|||
105699623|NCT01147744|364563042|FG004|Overall Study|Withdrawal by Subject|2|||
105699624|NCT01147744|364563043|FG005|Overall Study|Withdrawal by Subject|5|||
105699625|NCT01147744|364563044|FG006|Overall Study|Withdrawal by Subject|2|||
105699626|NCT01147744|364563038|FG000|Overall Study|Lost to Follow-up|0|||
105699627|NCT01147744|364563039|FG001|Overall Study|Lost to Follow-up|1|||
105699628|NCT01147744|364563040|FG002|Overall Study|Lost to Follow-up|0|||
105699629|NCT01147744|364563041|FG003|Overall Study|Lost to Follow-up|0|||
105699630|NCT01147744|364563042|FG004|Overall Study|Lost to Follow-up|0|||
105699631|NCT01147744|364563043|FG005|Overall Study|Lost to Follow-up|0|||
105699632|NCT01147744|364563044|FG006|Overall Study|Lost to Follow-up|0|||
105699633|NCT01147744|364563038|FG000|Overall Study|Sponsor decision to amend protocol|7|||
105699634|NCT01147744|364563039|FG001|Overall Study|Sponsor decision to amend protocol|4|||
105699635|NCT01147744|364563040|FG002|Overall Study|Sponsor decision to amend protocol|2|||
105699636|NCT01147744|364563041|FG003|Overall Study|Sponsor decision to amend protocol|5|||
105699637|NCT01147744|364563042|FG004|Overall Study|Sponsor decision to amend protocol|7|||
105699638|NCT01147744|364563043|FG005|Overall Study|Sponsor decision to amend protocol|2|||
105699639|NCT01147744|364563044|FG006|Overall Study|Sponsor decision to amend protocol|6|||
105699640|NCT01147744|364563038|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105699641|NCT01147744|364563039|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105699642|NCT01147744|364563040|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105699643|NCT01147744|364563041|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105699644|NCT01147744|364563042|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105787217|NCT03110107|364874893|FG004|Treatment Period|Participants no longer meets study criteria|0|||
105787218|NCT03110107|364874894|FG005|Treatment Period|Participants no longer meets study criteria|0|||
105787219|NCT03110107|364874895|FG006|Treatment Period|Participants no longer meets study criteria|0|||
105787220|NCT03110107|364874896|FG007|Treatment Period|Participants no longer meets study criteria|0|||
105699645|NCT01147744|364563043|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105699646|NCT01147744|364563044|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105699647|NCT02437864|364563049|FG000|Overall Study|Protocol Violation|4|||
105699648|NCT02437864|364563050|FG001|Overall Study|Protocol Violation|0|||
105699649|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
105699650|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
105699651|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
105699652|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
105699653|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
105699654|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
106016892|NCT03847896|365725906|FG001|Overall Study|Adverse Event|1|||
105699655|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
105699656|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
105699657|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
105699658|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
105699659|NCT00219284|364563052|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
105699660|NCT00219284|364563053|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
105924927|NCT01995201|365385822|FG004|From Week 24 Until Week 48|Adverse Event|1|||
105924928|NCT01995201|365385823|FG005|From Week 24 Until Week 48|Adverse Event|3|||
105924929|NCT01995201|365385824|FG006|From Week 24 Until Week 48|Adverse Event|1|||
105924930|NCT01995201|365385818|FG000|From Week 24 Until Week 48|Death|0|||
105924931|NCT01995201|365385819|FG001|From Week 24 Until Week 48|Death|0|||
105924932|NCT01995201|365385820|FG002|From Week 24 Until Week 48|Death|0|||
105924933|NCT01995201|365385821|FG003|From Week 24 Until Week 48|Death|0|||
105924934|NCT01995201|365385822|FG004|From Week 24 Until Week 48|Death|0|||
105924935|NCT01995201|365385823|FG005|From Week 24 Until Week 48|Death|2|||
105924936|NCT01995201|365385824|FG006|From Week 24 Until Week 48|Death|0|||
105924937|NCT01995201|365385818|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
105924938|NCT01995201|365385819|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
105924939|NCT01995201|365385820|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
105924940|NCT01995201|365385821|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
105924941|NCT01995201|365385822|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
105924942|NCT01995201|365385823|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
105924943|NCT01995201|365385824|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
105924944|NCT01995201|365385818|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
105924945|NCT01995201|365385819|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
105924946|NCT01995201|365385820|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
105924947|NCT01995201|365385821|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
105924948|NCT01995201|365385822|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
105924949|NCT01995201|365385823|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
105924950|NCT01995201|365385824|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
105924951|NCT01995201|365385818|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105924952|NCT01995201|365385819|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105924953|NCT01995201|365385820|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
105924954|NCT01995201|365385821|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105924955|NCT01995201|365385822|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
105924956|NCT01995201|365385823|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
105924957|NCT01995201|365385824|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
106132845|NCT00293462|366144807|FG000|Overall Study|Lost to Follow-up|0|||
106132846|NCT00293462|366144808|FG001|Overall Study|Lost to Follow-up|1|||
106132847|NCT00293462|366144809|FG002|Overall Study|Lost to Follow-up|0|||
106132848|NCT00293462|366144807|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
106132849|NCT00293462|366144808|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
106132850|NCT00293462|366144809|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
106132851|NCT00293462|366144807|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
106132852|NCT00293462|366144808|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
106132853|NCT00293462|366144809|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
106132854|NCT00293462|366144807|FG000|Overall Study|Refuse Radiation Treatment|1|||
106132855|NCT00293462|366144808|FG001|Overall Study|Refuse Radiation Treatment|0|||
106132856|NCT00293462|366144809|FG002|Overall Study|Refuse Radiation Treatment|0|||
106132857|NCT00293462|366144807|FG000|Overall Study|No Show|0|||
106132858|NCT00293462|366144808|FG001|Overall Study|No Show|0|||
106132859|NCT00293462|366144809|FG002|Overall Study|No Show|1|||
106132860|NCT00293462|366144807|FG000|Overall Study|Went back to his home country|0|||
106132861|NCT00293462|366144808|FG001|Overall Study|Went back to his home country|0|||
106132862|NCT00293462|366144809|FG002|Overall Study|Went back to his home country|1|||
106132863|NCT00293462|366144807|FG000|Overall Study|Blood clot after chemotherapy|0|||
106132864|NCT00293462|366144808|FG001|Overall Study|Blood clot after chemotherapy|0|||
106132865|NCT00293462|366144809|FG002|Overall Study|Blood clot after chemotherapy|1|||
106132866|NCT00293462|366144807|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
106132867|NCT00293462|366144808|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
105699661|NCT00219284|364563052|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
105699662|NCT00219284|364563053|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
106132868|NCT00293462|366144809|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
105787221|NCT03110107|364874897|FG008|Treatment Period|Participants no longer meets study criteria|0|||
105924958|NCT01995201|365385818|FG000|From Week 24 Until Week 48|Physician Decision|0|||
105924959|NCT01995201|365385819|FG001|From Week 24 Until Week 48|Physician Decision|0|||
105924960|NCT01995201|365385820|FG002|From Week 24 Until Week 48|Physician Decision|0|||
105924961|NCT01995201|365385821|FG003|From Week 24 Until Week 48|Physician Decision|0|||
105924962|NCT01995201|365385822|FG004|From Week 24 Until Week 48|Physician Decision|1|||
105924963|NCT01995201|365385823|FG005|From Week 24 Until Week 48|Physician Decision|0|||
106132869|NCT00293462|366144807|FG000|Overall Study|Possible Tracheostomy leakage|0|||
106132870|NCT00293462|366144808|FG001|Overall Study|Possible Tracheostomy leakage|1|||
106132871|NCT00293462|366144809|FG002|Overall Study|Possible Tracheostomy leakage|0|||
106132872|NCT00293462|366144807|FG000|Overall Study|Low radiation dose in oral cavity|0|||
106132873|NCT00293462|366144808|FG001|Overall Study|Low radiation dose in oral cavity|1|||
106132874|NCT00293462|366144809|FG002|Overall Study|Low radiation dose in oral cavity|0|||
106132875|NCT00293462|366144807|FG000|Overall Study|Physician Decision|0|||
106132876|NCT00293462|366144808|FG001|Overall Study|Physician Decision|1|||
106132877|NCT00293462|366144809|FG002|Overall Study|Physician Decision|0|||
106132878|NCT02950545|366144812|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
106132879|NCT02950545|366144813|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
106132880|NCT02950545|366144814|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
106132881|NCT02950545|366144815|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
106132882|NCT02950545|366144816|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
106132883|NCT02950545|366144817|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
106132884|NCT02950545|366144812|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
105699663|NCT00219284|364563052|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
106132885|NCT02950545|366144813|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
105699664|NCT00219284|364563053|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
105924964|NCT01995201|365385824|FG006|From Week 24 Until Week 48|Physician Decision|0|||
105924965|NCT01995201|365385818|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
105924966|NCT01995201|365385819|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
105924967|NCT01995201|365385820|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
105924968|NCT01995201|365385821|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
105924969|NCT01995201|365385822|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
105924970|NCT01995201|365385823|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
105924971|NCT01995201|365385824|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
105924972|NCT03329001|365385825|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105924973|NCT03329001|365385826|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105924974|NCT03329001|365385827|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
105924975|NCT03329001|365385828|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
105924976|NCT03329001|365385829|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105924977|NCT03329001|365385830|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105924978|NCT03329001|365385831|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105924979|NCT03329001|365385832|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
105924980|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105924981|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105924982|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105924983|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
105924984|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105924985|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105924986|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105924987|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
105924988|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105924989|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105924990|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105924991|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
105924992|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105924993|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105924994|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105924995|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
105924996|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105924997|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105924998|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105924999|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
106132886|NCT02950545|366144814|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
106132887|NCT02950545|366144815|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
106132888|NCT02950545|366144816|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
106132889|NCT02950545|366144817|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
106132890|NCT02950545|366144812|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
106132891|NCT02950545|366144813|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
106132892|NCT02950545|366144814|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
106132893|NCT02950545|366144815|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
105699665|NCT00219284|364563052|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
105925000|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
106132894|NCT02950545|366144816|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
106132895|NCT02950545|366144817|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
105925001|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105925002|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105925003|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
105925004|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105925005|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105925006|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
105925007|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105925008|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105925009|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105925010|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105925011|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
105925012|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
106005536|NCT01903356|365684764|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
106005537|NCT01903356|365684764|FG000|Overall Study|Violated the dosage and administration|3|||
106005538|NCT01009060|365684765|FG000|Overall Study|Adverse Event|1|||
106005539|NCT01009060|365684766|FG001|Overall Study|Adverse Event|2|||
106005540|NCT01009060|365684765|FG000|Overall Study|Protocol Violation|0|||
106005541|NCT01009060|365684766|FG001|Overall Study|Protocol Violation|1|||
106005542|NCT01009060|365684765|FG000|Overall Study|Lost to Follow-up|1|||
106005543|NCT01009060|365684766|FG001|Overall Study|Lost to Follow-up|0|||
106005544|NCT01009060|365684765|FG000|Overall Study|Physician Decision|1|||
106005545|NCT01009060|365684766|FG001|Overall Study|Physician Decision|1|||
106005546|NCT01009060|365684765|FG000|Overall Study|Withdrawal by Subject|1|||
106016893|NCT03847896|365725907|FG002|Overall Study|Adverse Event|3|||
105699666|NCT00219284|364563053|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
105699667|NCT03184077|364563056|FG000|Overall Study|Lost to Follow-up|21|||
105699668|NCT03184077|364563057|FG001|Overall Study|Lost to Follow-up|21|||
105699669|NCT04013529|364563058|FG000|Overall Study|Withdrawal by Subject|1|||
105699670|NCT04013529|364563059|FG001|Overall Study|Withdrawal by Subject|1|||
105699671|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
105699672|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
105699673|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
105699674|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
105699675|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
105699676|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
105699677|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
105699678|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
105699679|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
105699680|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
105699681|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
105699682|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
105699683|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
105699684|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
105699685|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
105699686|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
105699687|NCT00262522|364563060|FG000|Study Start Through 8 Weeks|Death|1|||
105699688|NCT00262522|364563061|FG001|Study Start Through 8 Weeks|Death|0|||
105699689|NCT00262522|364563062|FG002|Study Start Through 8 Weeks|Death|0|||
105699690|NCT00262522|364563063|FG003|Study Start Through 8 Weeks|Death|0|||
105699691|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
105699692|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
105699693|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
105699694|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
105699695|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
105699696|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
105699697|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
105699698|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
105699699|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
105699700|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
105699701|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
105699702|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
105699703|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
105699704|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
105699705|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
105699706|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
105699707|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Death|2|||
105699708|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Death|0|||
105699709|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Death|1|||
106005547|NCT01009060|365684766|FG001|Overall Study|Withdrawal by Subject|1|||
106005548|NCT00005906|365684767|FG000|Overall Study|Lack of Efficacy|3|||
106005549|NCT04196686|365684769|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
106005550|NCT04196686|365684770|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
106005551|NCT02587221|365684775|FG000|Overall Study|Adverse Event|3|||
106005552|NCT02587221|365684776|FG001|Overall Study|Adverse Event|3|||
106005553|NCT02587221|365684775|FG000|Overall Study|Death|33|||
106005554|NCT02587221|365684776|FG001|Overall Study|Death|34|||
106005555|NCT02587221|365684775|FG000|Overall Study|Withdrawal by Subject|66|||
106005556|NCT02587221|365684776|FG001|Overall Study|Withdrawal by Subject|61|||
106005557|NCT02587221|365684775|FG000|Overall Study|Lost to Follow-up|21|||
106005558|NCT02587221|365684776|FG001|Overall Study|Lost to Follow-up|19|||
106005559|NCT02587221|365684775|FG000|Overall Study|Protocol Violation|6|||
106005560|NCT02587221|365684776|FG001|Overall Study|Protocol Violation|5|||
106005561|NCT02587221|365684775|FG000|Overall Study|Other Reason or Unspecified|2|||
106005562|NCT02587221|365684776|FG001|Overall Study|Other Reason or Unspecified|1|||
106132896|NCT02950545|366144812|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
106132897|NCT02950545|366144813|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
106132898|NCT02950545|366144814|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
106132899|NCT02950545|366144815|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
106132900|NCT02950545|366144816|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
106005563|NCT02546609|365684777|FG000|Overall Study|Withdrawal by Subject|0|||
106005564|NCT02546609|365684778|FG001|Overall Study|Withdrawal by Subject|1|||
106005565|NCT02546609|365684779|FG002|Overall Study|Withdrawal by Subject|2|||
106005566|NCT02546609|365684777|FG000|Overall Study|Adverse Event|0|||
106005567|NCT02546609|365684778|FG001|Overall Study|Adverse Event|6|||
106005568|NCT02546609|365684779|FG002|Overall Study|Adverse Event|1|||
106005569|NCT02546609|365684777|FG000|Overall Study|Protocol Violation|0|||
106005570|NCT02546609|365684778|FG001|Overall Study|Protocol Violation|1|||
106005571|NCT02546609|365684779|FG002|Overall Study|Protocol Violation|1|||
106005572|NCT02546609|365684777|FG000|Overall Study|Lost to Follow-up|2|||
106005573|NCT02546609|365684778|FG001|Overall Study|Lost to Follow-up|3|||
106005574|NCT02546609|365684779|FG002|Overall Study|Lost to Follow-up|1|||
106005575|NCT02546609|365684777|FG000|Overall Study|travel or work schedule restriction|0|||
106005576|NCT02546609|365684778|FG001|Overall Study|travel or work schedule restriction|0|||
106005577|NCT02546609|365684779|FG002|Overall Study|travel or work schedule restriction|2|||
106005578|NCT03796728|365684784|FG000|Overall Study|Lost to Follow-up|8|||
106005579|NCT03796728|365684784|FG000|Overall Study|Reason not Specified|16|||
106005580|NCT01149096|365684786|FG000|Overall Study|Lost to Follow-up|0|||
106005581|NCT01149096|365684787|FG001|Overall Study|Lost to Follow-up|1|||
106005582|NCT00325897|365684788|FG000|Overall Study|Lost to Follow-up|12|||
106005583|NCT00325897|365684789|FG001|Overall Study|Lost to Follow-up|13|||
106005584|NCT04079296|365684790|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
106005585|NCT04079296|365684791|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
106005586|NCT04079296|365684792|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
106005587|NCT04079296|365684793|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
106005588|NCT04079296|365684794|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
106005589|NCT04079296|365684790|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
106005590|NCT04079296|365684791|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
106005591|NCT04079296|365684792|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
106005592|NCT04079296|365684793|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
106005593|NCT04079296|365684794|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
106005594|NCT04079296|365684790|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
106005595|NCT04079296|365684791|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
106005596|NCT04079296|365684792|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
106005597|NCT04079296|365684793|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
106005598|NCT04079296|365684794|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
106005599|NCT04079296|365684790|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
106005600|NCT04079296|365684791|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
106005601|NCT04079296|365684792|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
106005602|NCT04079296|365684793|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
106005603|NCT04079296|365684794|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
106005604|NCT04079296|365684790|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
106005605|NCT04079296|365684791|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
106005606|NCT04079296|365684792|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
106005607|NCT04079296|365684793|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
106005608|NCT04079296|365684794|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
106005609|NCT04079296|365684790|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
106005610|NCT04079296|365684791|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
106005611|NCT04079296|365684792|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
106005612|NCT04079296|365684793|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
106132901|NCT02950545|366144817|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
106016894|NCT03847896|365725908|FG003|Overall Study|Adverse Event|2|||
105925013|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105925014|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
105925015|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105925016|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
106005613|NCT04079296|365684794|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
106005614|NCT04079296|365684790|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
106005615|NCT04079296|365684791|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
106005616|NCT04079296|365684792|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
106005617|NCT04079296|365684793|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
106005618|NCT04079296|365684794|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
106005619|NCT04079296|365684790|FG000|Dose Expansion Phase (168 Days)|Death|0|||
106005620|NCT04079296|365684791|FG001|Dose Expansion Phase (168 Days)|Death|0|||
106005621|NCT04079296|365684792|FG002|Dose Expansion Phase (168 Days)|Death|0|||
106005622|NCT04079296|365684793|FG003|Dose Expansion Phase (168 Days)|Death|1|||
106005623|NCT04079296|365684794|FG004|Dose Expansion Phase (168 Days)|Death|0|||
106005624|NCT03748823|365684795|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
106005625|NCT03748823|365684796|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
106005626|NCT03748823|365684795|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
106005627|NCT03748823|365684796|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
106005628|NCT03748823|365684795|FG000|Extension Period|Withdrawal by Subject|9|||
106005629|NCT03748823|365684796|FG001|Extension Period|Withdrawal by Subject|12|||
106005630|NCT03748823|365684795|FG000|Extension Period|Death|2|||
106005631|NCT03748823|365684796|FG001|Extension Period|Death|2|||
106005632|NCT03748823|365684795|FG000|Extension Period|Other than Specified|0|||
106005633|NCT03748823|365684796|FG001|Extension Period|Other than Specified|1|||
106005634|NCT03748823|365684795|FG000|Extension Period|Protocol Violation|1|||
106005635|NCT03748823|365684796|FG001|Extension Period|Protocol Violation|0|||
106005636|NCT03748823|365684795|FG000|Extension Period|Lost to Follow-up|0|||
106005637|NCT03748823|365684796|FG001|Extension Period|Lost to Follow-up|1|||
106005638|NCT03748823|365684795|FG000|Extension Period|Lack of Efficacy|0|||
105925017|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105925018|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
105925019|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
106005639|NCT03748823|365684796|FG001|Extension Period|Lack of Efficacy|1|||
106005640|NCT03748823|365684795|FG000|Extension Period|Physician Decision|1|||
106005641|NCT03748823|365684796|FG001|Extension Period|Physician Decision|2|||
106005642|NCT02240485|365684797|FG000|3 Months Post-admission|Lost to Follow-up|1|||
106005643|NCT02240485|365684798|FG001|3 Months Post-admission|Lost to Follow-up|5|||
106005644|NCT02240485|365684797|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
106005645|NCT02240485|365684798|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
106005646|NCT02240485|365684797|FG000|9 Months Post-admission|Lost to Follow-up|3|||
106005647|NCT02240485|365684798|FG001|9 Months Post-admission|Lost to Follow-up|1|||
106005648|NCT02240485|365684797|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
106005649|NCT02240485|365684798|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
106005650|NCT02240485|365684797|FG000|18 Months Post-admission|Lost to Follow-up|1|||
106005651|NCT02240485|365684798|FG001|18 Months Post-admission|Lost to Follow-up|1|||
106005652|NCT02240485|365684797|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
105699710|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Death|0|||
106005653|NCT02240485|365684798|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
106005654|NCT00703014|365684799|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
106005655|NCT00703014|365684800|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
106005656|NCT00703014|365684801|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
105699711|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
105699712|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
105699713|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
105699714|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
105699715|NCT00262522|364563060|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
105699716|NCT00262522|364563061|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
105699717|NCT00262522|364563062|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
105699718|NCT00262522|364563063|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
105699719|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
105699720|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
105699721|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
105699722|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
105699723|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
105699724|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
105699725|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
105699726|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
105699727|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
105699728|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
105699729|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
105699730|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
105699731|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
105699732|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
105699733|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
105699734|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
105699735|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Death|2|||
105699736|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Death|0|||
105699737|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Death|2|||
105699738|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Death|0|||
105699739|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
105699740|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
105699741|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
105699742|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
105699743|NCT00262522|364563060|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
105699744|NCT00262522|364563061|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
105699745|NCT00262522|364563062|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
105699746|NCT00262522|364563063|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
105699747|NCT05419128|364563065|FG000|Overall Study|Withdrawal by Subject|1|||
105699748|NCT05419128|364563066|FG001|Overall Study|Withdrawal by Subject|1|||
105699749|NCT05419128|364563067|FG002|Overall Study|Withdrawal by Subject|0|||
105699750|NCT05419128|364563068|FG003|Overall Study|Withdrawal by Subject|1|||
105699751|NCT05419128|364563069|FG004|Overall Study|Withdrawal by Subject|1|||
105699752|NCT05419128|364563070|FG005|Overall Study|Withdrawal by Subject|0|||
105699753|NCT05419128|364563065|FG000|Overall Study|Lost to Follow-up|0|||
105699754|NCT05419128|364563066|FG001|Overall Study|Lost to Follow-up|0|||
105699755|NCT05419128|364563067|FG002|Overall Study|Lost to Follow-up|1|||
105699756|NCT05419128|364563068|FG003|Overall Study|Lost to Follow-up|0|||
105699757|NCT05419128|364563069|FG004|Overall Study|Lost to Follow-up|0|||
105699758|NCT05419128|364563070|FG005|Overall Study|Lost to Follow-up|1|||
105699759|NCT00517751|364563071|FG000|Overall Study|Death|3|||
105699760|NCT00517751|364563071|FG000|Overall Study|Withdrawal by Subject|37|||
105699761|NCT00517751|364563071|FG000|Overall Study|Lost to Follow-up|4|||
105699762|NCT00517751|364563071|FG000|Overall Study|patient not over due|6|||
105699763|NCT00517751|364563071|FG000|Overall Study|Patient not due for visit|76|||
105699764|NCT00517751|364563071|FG000|Overall Study|Missing|3|||
105699765|NCT02321930|364563076|FG000|Overall Study|Lost to Follow-up|1|||
105699766|NCT01293968|364563077|FG000|Overall Study|non-cooperation|3|||
106132902|NCT02950545|366144812|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
106132903|NCT02950545|366144813|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
105925020|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105925021|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105925022|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
105925023|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105699767|NCT01293968|364563078|FG001|Overall Study|non-cooperation|3|||
105699768|NCT02228720|364563079|FG000|Open Label - Day 30|Lost to Follow-up|1|||
105699769|NCT01423851|364563080|FG000|Whole Study|Disease progression|2|||
105699770|NCT01423851|364563081|FG001|Whole Study|Disease progression|1|||
105699771|NCT01423851|364563082|FG002|Whole Study|Disease progression|1|||
105699772|NCT01423851|364563083|FG003|Whole Study|Disease progression|4|||
105699773|NCT01423851|364563084|FG004|Whole Study|Disease progression|1|||
105699774|NCT01423851|364563085|FG005|Whole Study|Disease progression|3|||
105699775|NCT01423851|364563086|FG006|Whole Study|Disease progression|1|||
105699776|NCT01423851|364563087|FG007|Whole Study|Disease progression|4|||
105699777|NCT01423851|364563088|FG008|Whole Study|Disease progression|0|||
105699778|NCT01423851|364563089|FG009|Whole Study|Disease progression|2|||
105699779|NCT01423851|364563090|FG010|Whole Study|Disease progression|10|||
105699780|NCT01423851|364563080|FG000|Whole Study|Physician Decision|0|||
105925024|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105952103|NCT03314935|365488184|FG000|Phase 1|"Captured as Other in Database"|0|||
106132904|NCT02950545|366144814|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
106132905|NCT02950545|366144815|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
106132906|NCT02950545|366144816|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
106132907|NCT02950545|366144817|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
106132908|NCT03255941|366144818|FG000|Overall Study|Not eligible or refused injection|37|||
106132909|NCT03255941|366144819|FG001|Overall Study|Not eligible or refused injection|44|||
106132910|NCT03255941|366144820|FG002|Overall Study|Not eligible or refused injection|5|||
106132911|NCT03255941|366144821|FG003|Overall Study|Not eligible or refused injection|6|||
106132912|NCT03255941|366144818|FG000|Overall Study|Did not complete exit interview|1|||
106132913|NCT03255941|366144819|FG001|Overall Study|Did not complete exit interview|2|||
106132914|NCT03255941|366144820|FG002|Overall Study|Did not complete exit interview|0|||
105699781|NCT01423851|364563081|FG001|Whole Study|Physician Decision|1|||
105699782|NCT01423851|364563082|FG002|Whole Study|Physician Decision|2|||
106132915|NCT03255941|366144821|FG003|Overall Study|Did not complete exit interview|0|||
106132916|NCT00372060|366144822|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
106005657|NCT00703014|365684802|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
106005658|NCT00703014|365684799|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
106005659|NCT00703014|365684800|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
106005660|NCT00703014|365684801|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
106005661|NCT00703014|365684802|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
106005662|NCT05121766|365684803|FG000|Overall Study|Covid reinfection|3|||
106005663|NCT05121766|365684804|FG001|Overall Study|Covid reinfection|0|||
106005664|NCT05121766|365684803|FG000|Overall Study|Withdrawal by Subject|3|||
106005665|NCT05121766|365684804|FG001|Overall Study|Withdrawal by Subject|1|||
106005666|NCT05121766|365684803|FG000|Overall Study|Adverse Event|2|||
106005667|NCT05121766|365684804|FG001|Overall Study|Adverse Event|4|||
106005668|NCT05121766|365684803|FG000|Overall Study|Lost to Follow-up|0|||
106005669|NCT05121766|365684804|FG001|Overall Study|Lost to Follow-up|1|||
106005670|NCT02960217|365684806|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
106005671|NCT02960217|365684807|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
106005672|NCT02960217|365684806|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
106005673|NCT02960217|365684807|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
106005674|NCT02960217|365684806|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
106005675|NCT02960217|365684807|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
106005676|NCT02960217|365684806|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
106005677|NCT02960217|365684807|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
106005678|NCT02960217|365684806|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
106005679|NCT02960217|365684807|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
106005680|NCT02960217|365684806|FG000|Open-Label Extension Phase|Adverse Event|1|||
106005681|NCT02960217|365684807|FG001|Open-Label Extension Phase|Adverse Event|0|||
106005682|NCT02960217|365684806|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
106005683|NCT02960217|365684807|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
106005684|NCT02960217|365684806|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
106005685|NCT02960217|365684807|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
106005686|NCT02960217|365684806|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
105699783|NCT01423851|364563083|FG003|Whole Study|Physician Decision|0|||
106005687|NCT02960217|365684807|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
106005688|NCT03624881|365684808|FG000|Overall Study|Screen Failure|14|||
106005689|NCT03624881|365684809|FG001|Overall Study|Screen Failure|0|||
106005690|NCT03624881|365684808|FG000|Overall Study|No Catheter Inserted|6|||
105699784|NCT01423851|364563084|FG004|Whole Study|Physician Decision|2|||
106005691|NCT03624881|365684809|FG001|Overall Study|No Catheter Inserted|1|||
106005692|NCT03624881|365684808|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
106005693|NCT03624881|365684809|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
106005694|NCT03624881|365684808|FG000|Overall Study|Death|2|||
106005695|NCT03624881|365684809|FG001|Overall Study|Death|0|||
106005696|NCT03624881|365684808|FG000|Overall Study|Lost to Follow-up|10|||
105699785|NCT01423851|364563085|FG005|Whole Study|Physician Decision|0|||
105699786|NCT01423851|364563086|FG006|Whole Study|Physician Decision|2|||
106005697|NCT03624881|365684809|FG001|Overall Study|Lost to Follow-up|4|||
106132917|NCT00372060|366144823|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
106132918|NCT00372060|366144822|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
106132919|NCT00372060|366144823|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
106132920|NCT00372060|366144822|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
106132921|NCT00372060|366144823|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
106132922|NCT00372060|366144822|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
106132923|NCT00372060|366144823|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
106132924|NCT00372060|366144822|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
106132925|NCT00372060|366144823|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
106132926|NCT00372060|366144822|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
106132927|NCT00372060|366144823|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
106132928|NCT03398356|366144827|FG000|Before Treatment|Lost to Follow-up|1|||
106132929|NCT03398356|366144828|FG001|Before Treatment|Lost to Follow-up|2|||
106132930|NCT03398356|366144829|FG002|Before Treatment|Lost to Follow-up|0|||
106132931|NCT03398356|366144827|FG000|Before Treatment|drug intolerance|2|||
106132932|NCT03398356|366144828|FG001|Before Treatment|drug intolerance|1|||
106132933|NCT03398356|366144829|FG002|Before Treatment|drug intolerance|0|||
106132934|NCT03398356|366144827|FG000|Before Treatment|Withdrawal by Subject|0|||
106132935|NCT03398356|366144828|FG001|Before Treatment|Withdrawal by Subject|5|||
106132936|NCT03398356|366144829|FG002|Before Treatment|Withdrawal by Subject|0|||
106132937|NCT03398356|366144827|FG000|Before Treatment|Physician Decision|0|||
106132938|NCT03398356|366144828|FG001|Before Treatment|Physician Decision|0|||
106132939|NCT03398356|366144829|FG002|Before Treatment|Physician Decision|11|||
106132940|NCT03398356|366144827|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
106132941|NCT03398356|366144828|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
106132942|NCT03398356|366144829|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
106132943|NCT02412761|366144831|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
106132944|NCT02412761|366144832|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
106132945|NCT02412761|366144833|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
106132946|NCT02412761|366144834|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
106132947|NCT02412761|366144835|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
106132948|NCT02412761|366144836|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
106132949|NCT02240680|366144837|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
106132950|NCT02240680|366144838|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
106132951|NCT02240680|366144839|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
106132952|NCT02240680|366144840|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
106132953|NCT02240680|366144837|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
106132954|NCT02240680|366144838|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
106132955|NCT02240680|366144839|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
106132956|NCT02240680|366144840|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
106132957|NCT02240680|366144837|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
106132958|NCT02240680|366144838|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
106132959|NCT02240680|366144839|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
106132960|NCT02240680|366144840|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
106132961|NCT02240680|366144837|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
106132962|NCT02240680|366144838|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
106132963|NCT02240680|366144839|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
106132964|NCT02240680|366144840|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
106132965|NCT02240680|366144837|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
106132966|NCT02240680|366144838|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
106132967|NCT02240680|366144839|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
106132968|NCT02240680|366144840|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
106132969|NCT02240680|366144837|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
106132970|NCT02240680|366144838|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
106132971|NCT02240680|366144839|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
106132972|NCT02240680|366144840|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
106132973|NCT02240680|366144837|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
106132974|NCT02240680|366144838|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
106132975|NCT02240680|366144839|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
106132976|NCT02240680|366144840|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
106132977|NCT02240680|366144837|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
106132978|NCT02240680|366144838|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
106132979|NCT02240680|366144839|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
106132980|NCT02240680|366144840|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
105787222|NCT03110107|364874898|FG009|Treatment Period|Participants no longer meets study criteria|0|||
106132981|NCT00647348|366144847|FG000|Overall Study|Lost to Follow-up|3|||
106132982|NCT00647348|366144848|FG001|Overall Study|Lost to Follow-up|6|||
106132983|NCT01417000|366144849|FG000|Overall Study|Death|59|||
106132984|NCT01417000|366144850|FG001|Overall Study|Death|28|||
105925025|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105925026|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105925027|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
105925028|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105925029|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105925030|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
105925031|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105925032|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105925033|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105925034|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105925035|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
105925036|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105925037|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105925038|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
105925039|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
105925040|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105925041|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105925042|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105925043|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
105925044|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105925045|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105925046|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
105925047|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105925048|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105925049|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105925050|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105925051|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
105925052|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105925053|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105925054|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
105925055|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
105925056|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105699787|NCT01423851|364563087|FG007|Whole Study|Physician Decision|1|||
105699788|NCT01423851|364563088|FG008|Whole Study|Physician Decision|3|||
105699789|NCT01423851|364563089|FG009|Whole Study|Physician Decision|4|||
105699790|NCT01423851|364563090|FG010|Whole Study|Physician Decision|12|||
106005698|NCT03624881|365684808|FG000|Overall Study|Withdrawal by Subject|12|||
106005699|NCT03624881|365684809|FG001|Overall Study|Withdrawal by Subject|1|||
106005700|NCT00388349|365684810|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
106005701|NCT00388349|365684811|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
106005702|NCT02657889|365684814|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
106005703|NCT02657889|365684815|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
106005704|NCT02657889|365684816|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
106005705|NCT02657889|365684817|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
106005706|NCT02657889|365684814|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
106005707|NCT02657889|365684815|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
106005708|NCT02657889|365684816|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
106005709|NCT02657889|365684817|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
106005710|NCT02657889|365684814|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
106005711|NCT02657889|365684815|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
106005712|NCT02657889|365684816|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
106005713|NCT02657889|365684817|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
106005714|NCT02657889|365684814|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
106005715|NCT02657889|365684815|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
106005716|NCT02657889|365684816|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
106005717|NCT02657889|365684817|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
106005718|NCT02657889|365684814|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
106005719|NCT02657889|365684815|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
106005720|NCT02657889|365684816|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
106005721|NCT02657889|365684817|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
106005722|NCT02657889|365684814|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
106132985|NCT01417000|366144849|FG000|Overall Study|Lost to Follow-up|1|||
106132986|NCT01417000|366144850|FG001|Overall Study|Lost to Follow-up|0|||
106132987|NCT01417000|366144849|FG000|Overall Study|Study Terminated by Sponsor|1|||
106132988|NCT01417000|366144850|FG001|Overall Study|Study Terminated by Sponsor|1|||
106132989|NCT01657682|366144851|FG000|Overall Study|Lost to Follow-up|1|||
106132990|NCT01657682|366144852|FG001|Overall Study|Lost to Follow-up|0|||
106132991|NCT01657682|366144853|FG002|Overall Study|Lost to Follow-up|0|||
106132992|NCT01657682|366144851|FG000|Overall Study|Withdrawal by Subject|0|||
106132993|NCT01657682|366144852|FG001|Overall Study|Withdrawal by Subject|1|||
106132994|NCT01657682|366144853|FG002|Overall Study|Withdrawal by Subject|1|||
106132995|NCT01657682|366144851|FG000|Overall Study|Adverse Event|0|||
106132996|NCT01657682|366144852|FG001|Overall Study|Adverse Event|1|||
106132997|NCT01657682|366144853|FG002|Overall Study|Adverse Event|0|||
106132998|NCT00958009|366144858|FG000|Overall Study|Adverse Event|1|||
106132999|NCT00958009|366144858|FG000|Overall Study|Subject found device difficult to use|1|||
106133000|NCT00282438|366144867|FG000|Overall Study|Lack of Efficacy|1|||
106133001|NCT00282438|366144868|FG001|Overall Study|Lack of Efficacy|0|||
106133002|NCT00282438|366144867|FG000|Overall Study|Death|0|||
106133003|NCT00282438|366144868|FG001|Overall Study|Death|1|||
106133004|NCT01872611|366144870|FG000|Overall Study|Adverse Event|3|||
106133005|NCT01872611|366144871|FG001|Overall Study|Adverse Event|1|||
106133006|NCT01872611|366144870|FG000|Overall Study|Adverse Event, prior to treatment|0|||
106133007|NCT01872611|366144871|FG001|Overall Study|Adverse Event, prior to treatment|1|||
106133008|NCT01872611|366144870|FG000|Overall Study|Death|0|||
106133009|NCT01872611|366144871|FG001|Overall Study|Death|1|||
106133010|NCT01872611|366144870|FG000|Overall Study|Death, prior to treatment|0|||
106133011|NCT01872611|366144871|FG001|Overall Study|Death, prior to treatment|1|||
106133012|NCT01872611|366144870|FG000|Overall Study|Lost to Follow-up|8|||
106133013|NCT01872611|366144871|FG001|Overall Study|Lost to Follow-up|1|||
106133014|NCT01872611|366144870|FG000|Overall Study|Physician Decision|1|||
106133015|NCT01872611|366144871|FG001|Overall Study|Physician Decision|0|||
106133016|NCT01872611|366144870|FG000|Overall Study|Withdrawal by Subject|6|||
106133017|NCT01872611|366144871|FG001|Overall Study|Withdrawal by Subject|1|||
105699791|NCT01423851|364563080|FG000|Whole Study|Withdrawal by Subject|1|||
105699792|NCT01423851|364563081|FG001|Whole Study|Withdrawal by Subject|1|||
105699793|NCT01423851|364563082|FG002|Whole Study|Withdrawal by Subject|0|||
106005723|NCT02657889|365684815|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
105699794|NCT01423851|364563083|FG003|Whole Study|Withdrawal by Subject|0|||
106133018|NCT01872611|366144870|FG000|Overall Study|Reason not provided|6|||
106133019|NCT01872611|366144871|FG001|Overall Study|Reason not provided|6|||
106133020|NCT04088188|366144879|FG000|Overall Study|Withdrawal by Subject|2|||
106133021|NCT04088188|366144880|FG001|Overall Study|Withdrawal by Subject|0|||
106133022|NCT04088188|366144879|FG000|Overall Study|Adverse Event|2|||
106133023|NCT04088188|366144880|FG001|Overall Study|Adverse Event|0|||
106133024|NCT03124108|366144881|FG000|Overall Study|Adverse Event|0|||
106133025|NCT03124108|366144882|FG001|Overall Study|Adverse Event|1|||
105699795|NCT01423851|364563084|FG004|Whole Study|Withdrawal by Subject|0|||
105787223|NCT03110107|364874899|FG010|Treatment Period|Participants no longer meets study criteria|0|||
105787224|NCT03110107|364874900|FG011|Treatment Period|Participants no longer meets study criteria|0|||
105925057|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105925058|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105925059|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
105925060|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105925061|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105925062|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
105925063|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
105925064|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105925065|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105925066|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105925067|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
105925068|NCT03329001|365385825|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105925069|NCT03329001|365385826|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105925070|NCT03329001|365385827|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
105925071|NCT03329001|365385828|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
105925072|NCT03329001|365385829|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105925073|NCT03329001|365385830|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105925074|NCT03329001|365385831|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105925075|NCT03329001|365385832|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
105925076|NCT03329001|365385825|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105925077|NCT03329001|365385826|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105925078|NCT03329001|365385827|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105925079|NCT03329001|365385828|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
105925080|NCT03329001|365385829|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105925081|NCT03329001|365385830|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105925082|NCT03329001|365385831|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105925083|NCT03329001|365385832|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
105925084|NCT03329001|365385825|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105925085|NCT03329001|365385826|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105925086|NCT03329001|365385827|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105925087|NCT03329001|365385828|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
105925088|NCT03329001|365385829|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105925089|NCT03329001|365385830|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105925090|NCT03329001|365385831|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105925091|NCT03329001|365385832|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
105925092|NCT03329001|365385825|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105925093|NCT03329001|365385826|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105925094|NCT03329001|365385827|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
105787225|NCT03110107|364874901|FG012|Treatment Period|Participants no longer meets study criteria|0|||
105699796|NCT01423851|364563085|FG005|Whole Study|Withdrawal by Subject|0|||
105699797|NCT01423851|364563086|FG006|Whole Study|Withdrawal by Subject|0|||
105699798|NCT01423851|364563087|FG007|Whole Study|Withdrawal by Subject|0|||
105699799|NCT01423851|364563088|FG008|Whole Study|Withdrawal by Subject|2|||
105699800|NCT01423851|364563089|FG009|Whole Study|Withdrawal by Subject|0|||
105699801|NCT01423851|364563090|FG010|Whole Study|Withdrawal by Subject|4|||
105699802|NCT01423851|364563080|FG000|Whole Study|Adverse Event|0|||
105699803|NCT01423851|364563081|FG001|Whole Study|Adverse Event|0|||
105699804|NCT01423851|364563082|FG002|Whole Study|Adverse Event|0|||
105699805|NCT01423851|364563083|FG003|Whole Study|Adverse Event|2|||
105699806|NCT01423851|364563084|FG004|Whole Study|Adverse Event|0|||
105699807|NCT01423851|364563085|FG005|Whole Study|Adverse Event|0|||
105699808|NCT01423851|364563086|FG006|Whole Study|Adverse Event|0|||
105699809|NCT01423851|364563087|FG007|Whole Study|Adverse Event|3|||
105699810|NCT01423851|364563088|FG008|Whole Study|Adverse Event|3|||
105699811|NCT01423851|364563089|FG009|Whole Study|Adverse Event|2|||
105699812|NCT01423851|364563090|FG010|Whole Study|Adverse Event|3|||
105699813|NCT00362414|364565016|FG000|Overall Study|Death|2|||
105699814|NCT00362414|364565016|FG000|Overall Study|Adverse Event|1|||
105699815|NCT02369848|364565017|FG000|Overall Study|Death|1|||
105699816|NCT02369848|364565017|FG000|Overall Study|Withdrawal by Subject|2|||
105699817|NCT02369848|364565017|FG000|Overall Study|Lost to Follow-up|1|||
105699818|NCT03281668|364565019|FG000|Overall Study|Physician Decision|1|||
105699819|NCT03281668|364565019|FG000|Overall Study|scheduling conflict, family circumstance|2|||
105699820|NCT03281668|364565019|FG000|Overall Study|Withdrawal by Subject|4|||
105699821|NCT03281668|364565019|FG000|Overall Study|Lost to Follow-up|1|||
105699822|NCT02053168|364565020|FG000|Overall Study|Withdrawal by Subject|1|||
105699823|NCT02053168|364565020|FG000|Overall Study|Physician Decision|1|||
105699824|NCT02053168|364565020|FG000|Overall Study|Lost to Follow-up|1|||
105699825|NCT02687542|364565021|FG000|Overall Study|Medication error without associated AEs|0|||
105699826|NCT02687542|364565022|FG001|Overall Study|Medication error without associated AEs|0|||
105699827|NCT02687542|364565023|FG002|Overall Study|Medication error without associated AEs|0|||
105925095|NCT03329001|365385828|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105925096|NCT03329001|365385829|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105925097|NCT03329001|365385830|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105925098|NCT03329001|365385831|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105925099|NCT03329001|365385832|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
105925100|NCT03329001|365385825|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105925101|NCT03329001|365385826|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105925102|NCT03329001|365385827|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
105925103|NCT03329001|365385828|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
105925104|NCT03329001|365385829|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105925105|NCT03329001|365385830|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105925106|NCT03329001|365385831|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105925107|NCT03329001|365385832|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
105925108|NCT03329001|365385825|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105925109|NCT03329001|365385826|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105925110|NCT03329001|365385827|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
105925111|NCT03329001|365385828|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105925112|NCT03329001|365385829|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105925113|NCT03329001|365385830|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105925114|NCT03329001|365385831|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105925115|NCT03329001|365385832|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
105925116|NCT03329001|365385825|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105925117|NCT03329001|365385826|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105925118|NCT03329001|365385827|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
105925119|NCT03329001|365385828|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105925120|NCT03329001|365385829|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105925121|NCT03329001|365385830|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105925122|NCT03329001|365385831|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105925123|NCT03329001|365385832|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
105925124|NCT03329001|365385825|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105925125|NCT03329001|365385826|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
106133026|NCT03124108|366144883|FG002|Overall Study|Adverse Event|0|||
106133027|NCT00631917|366144884|FG000|Overall Study|Adverse Event|34|||
106133028|NCT00631917|366144885|FG001|Overall Study|Adverse Event|45|||
105925126|NCT03329001|365385827|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105925127|NCT03329001|365385828|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
105925128|NCT03329001|365385829|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105925129|NCT03329001|365385830|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105925130|NCT03329001|365385831|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105925131|NCT03329001|365385832|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
105925132|NCT03329001|365385825|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105925133|NCT03329001|365385826|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105925134|NCT03329001|365385827|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105925135|NCT03329001|365385828|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105925136|NCT03329001|365385829|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105925137|NCT03329001|365385830|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
105925138|NCT03329001|365385831|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105925139|NCT03329001|365385832|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
105925140|NCT03329001|365385825|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105925141|NCT03329001|365385826|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105925142|NCT03329001|365385827|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105925143|NCT03329001|365385828|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105925144|NCT03329001|365385829|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
105925145|NCT03329001|365385830|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105925146|NCT03329001|365385831|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105925147|NCT03329001|365385832|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
105925148|NCT03329001|365385825|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
106133029|NCT00631917|366144884|FG000|Overall Study|Abnormal laboratory value(s)|2|||
106133030|NCT00631917|366144885|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105699828|NCT02687542|364565024|FG003|Overall Study|Medication error without associated AEs|0|||
105925149|NCT03329001|365385826|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105925150|NCT03329001|365385827|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105925151|NCT03329001|365385828|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105925152|NCT03329001|365385829|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
105925153|NCT03329001|365385830|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
105925154|NCT03329001|365385831|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105925155|NCT03329001|365385832|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
105925156|NCT03329001|365385825|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105925157|NCT03329001|365385826|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105925158|NCT03329001|365385827|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
106133031|NCT00631917|366144884|FG000|Overall Study|Abnormal test procedure result(s)|3|||
106133032|NCT00631917|366144885|FG001|Overall Study|Abnormal test procedure result(s)|2|||
106133033|NCT00631917|366144884|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
106133034|NCT00631917|366144885|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
106133035|NCT00631917|366144884|FG000|Overall Study|No longer required study drug|0|||
106133036|NCT00631917|366144885|FG001|Overall Study|No longer required study drug|1|||
106133037|NCT00631917|366144884|FG000|Overall Study|Protocol deviation|6|||
106133038|NCT00631917|366144885|FG001|Overall Study|Protocol deviation|5|||
106133039|NCT00631917|366144884|FG000|Overall Study|Subject withdrew consent|25|||
106133040|NCT00631917|366144885|FG001|Overall Study|Subject withdrew consent|33|||
106133041|NCT00631917|366144884|FG000|Overall Study|Lost to Follow-up|7|||
106133042|NCT00631917|366144885|FG001|Overall Study|Lost to Follow-up|7|||
106133043|NCT00631917|366144884|FG000|Overall Study|Administrative problems|2|||
106133044|NCT00631917|366144885|FG001|Overall Study|Administrative problems|0|||
106133045|NCT00631917|366144884|FG000|Overall Study|Death|1|||
106133046|NCT00631917|366144885|FG001|Overall Study|Death|0|||
106133047|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
106133048|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
106133049|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
106133050|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Death|3|||
106133051|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Death|0|||
106133052|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Death|0|||
106133053|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
106133054|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
106133055|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
106133056|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
106133057|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
106133058|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
106133059|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
106133060|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
106133061|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
106133062|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
106133063|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
106133064|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
106133065|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
106133066|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
106133067|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
106133068|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Other|1|||
106133069|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Other|0|||
106133070|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Other|0|||
106133071|NCT02403323|366144886|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
106133072|NCT02403323|366144887|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
106133073|NCT02403323|366144888|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
106133074|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
106133075|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
106133076|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
106133077|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
106133078|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
106133079|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
106133080|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
106133081|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
106133082|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
106133083|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
106133084|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
106133085|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
105925159|NCT03329001|365385828|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105925160|NCT03329001|365385829|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
105925161|NCT03329001|365385830|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105925162|NCT03329001|365385831|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
106133086|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
106133087|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
106133088|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
106133089|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
106133090|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
106133091|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
106133092|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
106133093|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
106133094|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
106133095|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
106133096|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
106133097|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
106133098|NCT02403323|366144886|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
106133099|NCT02403323|366144887|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
106133100|NCT02403323|366144888|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
106133101|NCT05750745|366144893|FG000|Overall Study|Adverse Event|1|||
106133102|NCT05750745|366144894|FG001|Overall Study|Adverse Event|0|||
106133103|NCT05750745|366144895|FG002|Overall Study|Adverse Event|0|||
106133104|NCT05750745|366144893|FG000|Overall Study|Protocol Violation|1|||
106133105|NCT05750745|366144894|FG001|Overall Study|Protocol Violation|0|||
106133106|NCT05750745|366144895|FG002|Overall Study|Protocol Violation|0|||
106133107|NCT05750745|366144893|FG000|Overall Study|Withdrawal by Subject|0|||
106133108|NCT05750745|366144894|FG001|Overall Study|Withdrawal by Subject|1|||
106133109|NCT05750745|366144895|FG002|Overall Study|Withdrawal by Subject|0|||
106133110|NCT02189863|366144896|FG000|First 2 Weeks|Motion Sickness|4|||
106133111|NCT02189863|366144897|FG001|First 2 Weeks|Motion Sickness|2|||
106133112|NCT01458275|366144898|FG000|Overall Study|Adverse Event|3|||
106133113|NCT01458275|366144899|FG001|Overall Study|Adverse Event|4|||
106133114|NCT01458275|366144900|FG002|Overall Study|Adverse Event|1|||
106133115|NCT01458275|366144898|FG000|Overall Study|Lost to Follow-up|3|||
106133116|NCT01458275|366144899|FG001|Overall Study|Lost to Follow-up|2|||
106133117|NCT01458275|366144900|FG002|Overall Study|Lost to Follow-up|5|||
106133118|NCT01458275|366144898|FG000|Overall Study|Protocol Violation|5|||
106133119|NCT01458275|366144899|FG001|Overall Study|Protocol Violation|5|||
106133120|NCT01458275|366144900|FG002|Overall Study|Protocol Violation|2|||
106133121|NCT01458275|366144898|FG000|Overall Study|Withdrawal by Subject|3|||
106133122|NCT01458275|366144899|FG001|Overall Study|Withdrawal by Subject|2|||
106133123|NCT01458275|366144900|FG002|Overall Study|Withdrawal by Subject|1|||
106133124|NCT01304706|366146174|FG000|Overall Study|Adverse Event|2|||
106133125|NCT01304706|366146174|FG000|Overall Study|Lack of Efficacy|1|||
106133126|NCT01304706|366146174|FG000|Overall Study|Death|3|||
106133127|NCT01304706|366146174|FG000|Overall Study|Withdrawal by Subject|3|||
106133128|NCT01304706|366146174|FG000|Overall Study|Lost to Follow-up|7|||
106133129|NCT01304706|366146174|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
106133130|NCT04978363|366146177|FG000|Overall Study|Other medical issues unrelated to the study|0|||
106133131|NCT04978363|366146178|FG001|Overall Study|Other medical issues unrelated to the study|0|||
106133132|NCT04978363|366146179|FG002|Overall Study|Other medical issues unrelated to the study|0|||
106133133|NCT04978363|366146180|FG003|Overall Study|Other medical issues unrelated to the study|0|||
106133134|NCT04978363|366146181|FG004|Overall Study|Other medical issues unrelated to the study|1|||
106133135|NCT04978363|366146182|FG005|Overall Study|Other medical issues unrelated to the study|0|||
106133136|NCT04978363|366146183|FG006|Overall Study|Other medical issues unrelated to the study|0|||
106133137|NCT04978363|366146184|FG007|Overall Study|Other medical issues unrelated to the study|0|||
106133138|NCT04978363|366146185|FG008|Overall Study|Other medical issues unrelated to the study|0|||
106133139|NCT04978363|366146186|FG009|Overall Study|Other medical issues unrelated to the study|0|||
106133140|NCT04978363|366146187|FG010|Overall Study|Other medical issues unrelated to the study|0|||
106133141|NCT04978363|366146177|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
106133142|NCT04978363|366146178|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
106133143|NCT04978363|366146179|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
106133144|NCT04978363|366146180|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
106133145|NCT04978363|366146181|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
106133146|NCT04978363|366146182|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
106133147|NCT04978363|366146183|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
106133148|NCT04978363|366146184|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
106133149|NCT04978363|366146185|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
106133150|NCT04978363|366146186|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
105925163|NCT03329001|365385832|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
105925164|NCT03329001|365385825|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105925165|NCT03329001|365385826|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
106133151|NCT04978363|366146187|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
106133152|NCT04978363|366146177|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133153|NCT04978363|366146178|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
106133154|NCT04978363|366146179|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133155|NCT04978363|366146180|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133156|NCT04978363|366146181|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133157|NCT04978363|366146182|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133158|NCT04978363|366146183|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133159|NCT04978363|366146184|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133160|NCT04978363|366146185|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133161|NCT04978363|366146186|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
106133162|NCT04978363|366146187|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
105699829|NCT02687542|364565025|FG004|Overall Study|Medication error without associated AEs|1|||
105699830|NCT02687542|364565021|FG000|Overall Study|Lost to Follow-up|0|||
105699831|NCT02687542|364565022|FG001|Overall Study|Lost to Follow-up|0|||
105699832|NCT02687542|364565023|FG002|Overall Study|Lost to Follow-up|0|||
105699833|NCT02687542|364565024|FG003|Overall Study|Lost to Follow-up|0|||
105699834|NCT02687542|364565025|FG004|Overall Study|Lost to Follow-up|1|||
105699835|NCT02687542|364565021|FG000|Overall Study|Protocol Violation|0|||
105699836|NCT02687542|364565022|FG001|Overall Study|Protocol Violation|1|||
105699837|NCT02687542|364565023|FG002|Overall Study|Protocol Violation|0|||
105699838|NCT02687542|364565024|FG003|Overall Study|Protocol Violation|0|||
105699839|NCT02687542|364565025|FG004|Overall Study|Protocol Violation|0|||
105699840|NCT02687542|364565021|FG000|Overall Study|Other|5|||
105699841|NCT02687542|364565022|FG001|Overall Study|Other|9|||
105699842|NCT02687542|364565023|FG002|Overall Study|Other|10|||
105699843|NCT02687542|364565024|FG003|Overall Study|Other|6|||
105699844|NCT02687542|364565025|FG004|Overall Study|Other|5|||
105699845|NCT02687542|364565021|FG000|Overall Study|Adverse Event|3|||
105699846|NCT02687542|364565022|FG001|Overall Study|Adverse Event|1|||
105699847|NCT02687542|364565023|FG002|Overall Study|Adverse Event|3|||
105699848|NCT02687542|364565024|FG003|Overall Study|Adverse Event|2|||
105699849|NCT02687542|364565025|FG004|Overall Study|Adverse Event|9|||
105699850|NCT02687542|364565021|FG000|Overall Study|Withdrawal by Subject|0|||
105699851|NCT02687542|364565022|FG001|Overall Study|Withdrawal by Subject|1|||
105699852|NCT02687542|364565023|FG002|Overall Study|Withdrawal by Subject|1|||
105699853|NCT02687542|364565024|FG003|Overall Study|Withdrawal by Subject|2|||
105699854|NCT02687542|364565025|FG004|Overall Study|Withdrawal by Subject|4|||
105699855|NCT01838616|364565026|FG000|Titration Period|Adverse Event|18|||
105699856|NCT01838616|364565027|FG001|Titration Period|Adverse Event|48|||
105699857|NCT01838616|364565026|FG000|Titration Period|Lack of Efficacy|5|||
105699858|NCT01838616|364565027|FG001|Titration Period|Lack of Efficacy|12|||
105699859|NCT01838616|364565026|FG000|Titration Period|Withdrawal by Subject|5|||
105699860|NCT01838616|364565027|FG001|Titration Period|Withdrawal by Subject|5|||
105699861|NCT01838616|364565026|FG000|Titration Period|Technical problems|1|||
105699862|NCT01838616|364565027|FG001|Titration Period|Technical problems|0|||
105699863|NCT01838616|364565026|FG000|Titration Period|Other|1|||
105699864|NCT01838616|364565027|FG001|Titration Period|Other|0|||
105699865|NCT01838616|364565026|FG000|Titration Period|Protocol Violation|0|||
105699866|NCT01838616|364565027|FG001|Titration Period|Protocol Violation|1|||
105699867|NCT01838616|364565026|FG000|Continuation Period|Lack of Efficacy|3|||
105699868|NCT01838616|364565027|FG001|Continuation Period|Lack of Efficacy|5|||
105699869|NCT01838616|364565026|FG000|Continuation Period|Adverse Event|8|||
105699870|NCT01838616|364565027|FG001|Continuation Period|Adverse Event|4|||
105699871|NCT01838616|364565026|FG000|Continuation Period|Protocol Violation|2|||
105699872|NCT01838616|364565027|FG001|Continuation Period|Protocol Violation|0|||
105699873|NCT01838616|364565026|FG000|Continuation Period|Lost to Follow-up|1|||
105699874|NCT01838616|364565027|FG001|Continuation Period|Lost to Follow-up|0|||
105699875|NCT01838616|364565026|FG000|Continuation Period|Withdrawal by Subject|0|||
105699876|NCT01838616|364565027|FG001|Continuation Period|Withdrawal by Subject|4|||
105699877|NCT01838616|364565026|FG000|Continuation Period|Technical problems|0|||
105699878|NCT01838616|364565027|FG001|Continuation Period|Technical problems|1|||
105699879|NCT01838616|364565026|FG000|Pick-up Arm|Lack of Efficacy|4|||
105699880|NCT01838616|364565027|FG001|Pick-up Arm|Lack of Efficacy|0|||
105699881|NCT01838616|364565026|FG000|Pick-up Arm|Adverse Event|9|||
105699882|NCT01838616|364565027|FG001|Pick-up Arm|Adverse Event|0|||
105699883|NCT01838616|364565026|FG000|Pick-up Arm|Withdrawal by Subject|1|||
105699884|NCT01838616|364565027|FG001|Pick-up Arm|Withdrawal by Subject|0|||
105699885|NCT01838616|364565026|FG000|Pick-up Arm|Technical problems|1|||
106133163|NCT01251614|366146188|FG000|Overall Study|Adverse Event|1|||
105699886|NCT01838616|364565027|FG001|Pick-up Arm|Technical problems|0|||
105699887|NCT00257725|364565028|FG000|Overall Study|Adverse Event|3|||
105699888|NCT00833053|364565035|FG000|Overall Study|Adverse Event|4|||
105699889|NCT00833053|364565036|FG001|Overall Study|Adverse Event|0|||
105699890|NCT00833053|364565035|FG000|Overall Study|Treatment Failure|3|||
105699891|NCT00833053|364565036|FG001|Overall Study|Treatment Failure|1|||
105699892|NCT00833053|364565035|FG000|Overall Study|Withdrawal by Subject|0|||
105699893|NCT00833053|364565036|FG001|Overall Study|Withdrawal by Subject|1|||
105699894|NCT00833053|364565035|FG000|Overall Study|Protocol Violation|2|||
105699895|NCT00833053|364565036|FG001|Overall Study|Protocol Violation|1|||
105699896|NCT02318667|364565043|FG000|Overall Study|Adverse Event|1|||
105699897|NCT02318667|364565043|FG000|Overall Study|Lack of Efficacy|6|||
105699898|NCT02318667|364565043|FG000|Overall Study|Protocol Violation|2|||
105699899|NCT00003535|364565044|FG000|Overall Study|Not evaluable|5|||
105699900|NCT04353284|364565049|FG000|Overall Study|Adverse Event|1|||
105699901|NCT04353284|364565050|FG001|Overall Study|Adverse Event|1|||
105699902|NCT04353284|364565049|FG000|Overall Study|Lost to Follow-up|1|||
105699903|NCT04353284|364565050|FG001|Overall Study|Lost to Follow-up|0|||
105699904|NCT03807349|364565051|FG000|Overall Study|Early Study Termination|9|||
105925166|NCT03329001|365385827|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105925167|NCT03329001|365385828|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
106133164|NCT01251614|366146189|FG001|Overall Study|Adverse Event|0|||
106133165|NCT01251614|366146190|FG002|Overall Study|Adverse Event|1|||
106133166|NCT01251614|366146188|FG000|Overall Study|Lack of Efficacy|1|||
106133167|NCT01251614|366146189|FG001|Overall Study|Lack of Efficacy|9|||
106133168|NCT01251614|366146190|FG002|Overall Study|Lack of Efficacy|4|||
106133169|NCT01251614|366146188|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
106133170|NCT01251614|366146189|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
106133171|NCT01251614|366146190|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
106133172|NCT01251614|366146188|FG000|Overall Study|Pregnancy|0|||
106133173|NCT01251614|366146189|FG001|Overall Study|Pregnancy|0|||
106133174|NCT01251614|366146190|FG002|Overall Study|Pregnancy|2|||
106133175|NCT01251614|366146188|FG000|Overall Study|Loss of Disease Control|0|||
106133176|NCT01251614|366146189|FG001|Overall Study|Loss of Disease Control|1|||
106133177|NCT01251614|366146190|FG002|Overall Study|Loss of Disease Control|0|||
106133178|NCT01251614|366146188|FG000|Overall Study|Withdrawal by Subject|0|||
106133179|NCT01251614|366146189|FG001|Overall Study|Withdrawal by Subject|2|||
106133180|NCT01251614|366146190|FG002|Overall Study|Withdrawal by Subject|1|||
106133181|NCT01251614|366146188|FG000|Overall Study|Lost to Follow-up|0|||
106133182|NCT01251614|366146189|FG001|Overall Study|Lost to Follow-up|1|||
106133183|NCT01251614|366146190|FG002|Overall Study|Lost to Follow-up|0|||
106133184|NCT00049517|366146191|FG000|Induction|Disease progression|0|||
106133185|NCT00049517|366146192|FG001|Induction|Disease progression|0|||
106133186|NCT00049517|366146193|FG002|Induction|Disease progression|0|||
106133187|NCT00049517|366146194|FG003|Induction|Disease progression|0|||
106133188|NCT00049517|366146195|FG004|Induction|Disease progression|18|||
106133189|NCT00049517|366146196|FG005|Induction|Disease progression|11|||
106133190|NCT00049517|366146191|FG000|Induction|Adverse Event|0|||
106133191|NCT00049517|366146192|FG001|Induction|Adverse Event|0|||
106133192|NCT00049517|366146193|FG002|Induction|Adverse Event|0|||
106133193|NCT00049517|366146194|FG003|Induction|Adverse Event|0|||
106133194|NCT00049517|366146195|FG004|Induction|Adverse Event|5|||
106133195|NCT00049517|366146196|FG005|Induction|Adverse Event|7|||
106133196|NCT00049517|366146191|FG000|Induction|Death|0|||
106133197|NCT00049517|366146192|FG001|Induction|Death|0|||
106133198|NCT00049517|366146193|FG002|Induction|Death|0|||
106133199|NCT00049517|366146194|FG003|Induction|Death|0|||
106133200|NCT00049517|366146195|FG004|Induction|Death|9|||
106133201|NCT00049517|366146196|FG005|Induction|Death|6|||
106133202|NCT00049517|366146191|FG000|Induction|Withdrawal by Subject|0|||
106133203|NCT00049517|366146192|FG001|Induction|Withdrawal by Subject|0|||
106133204|NCT00049517|366146193|FG002|Induction|Withdrawal by Subject|0|||
106133205|NCT00049517|366146194|FG003|Induction|Withdrawal by Subject|0|||
106133206|NCT00049517|366146195|FG004|Induction|Withdrawal by Subject|1|||
106133207|NCT00049517|366146196|FG005|Induction|Withdrawal by Subject|3|||
106133208|NCT00049517|366146191|FG000|Induction|Alternative therapy|0|||
106133209|NCT00049517|366146192|FG001|Induction|Alternative therapy|0|||
106133210|NCT00049517|366146193|FG002|Induction|Alternative therapy|0|||
106133211|NCT00049517|366146194|FG003|Induction|Alternative therapy|0|||
106133212|NCT00049517|366146195|FG004|Induction|Alternative therapy|2|||
106133213|NCT00049517|366146196|FG005|Induction|Alternative therapy|2|||
106133214|NCT00049517|366146191|FG000|Induction|Other complicating disease|0|||
106133215|NCT00049517|366146192|FG001|Induction|Other complicating disease|0|||
106133216|NCT00049517|366146193|FG002|Induction|Other complicating disease|0|||
106133217|NCT00049517|366146194|FG003|Induction|Other complicating disease|0|||
106133218|NCT00049517|366146195|FG004|Induction|Other complicating disease|3|||
106133219|NCT00049517|366146196|FG005|Induction|Other complicating disease|0|||
106133220|NCT00049517|366146191|FG000|Induction|Reasons not reported|0|||
106133221|NCT00049517|366146192|FG001|Induction|Reasons not reported|0|||
106133222|NCT00049517|366146193|FG002|Induction|Reasons not reported|0|||
106133223|NCT00049517|366146194|FG003|Induction|Reasons not reported|0|||
106133224|NCT00049517|366146195|FG004|Induction|Reasons not reported|22|||
106133225|NCT00049517|366146196|FG005|Induction|Reasons not reported|25|||
106133226|NCT00049517|366146191|FG000|Conditioning/Transplant|Disease progression|14|||
105925168|NCT03329001|365385829|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
105925169|NCT03329001|365385830|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
105925170|NCT03329001|365385831|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105925171|NCT03329001|365385832|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
105925172|NCT03329001|365385825|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105925173|NCT03329001|365385826|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105925174|NCT03329001|365385827|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105925175|NCT03329001|365385828|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105925176|NCT03329001|365385829|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105925177|NCT03329001|365385830|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
105925178|NCT03329001|365385831|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
105925179|NCT03329001|365385832|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
105925180|NCT03329001|365385825|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105925181|NCT03329001|365385826|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105925182|NCT03329001|365385827|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105925183|NCT03329001|365385828|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105925184|NCT03329001|365385829|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
106133227|NCT00049517|366146192|FG001|Conditioning/Transplant|Disease progression|6|||
106133228|NCT00049517|366146193|FG002|Conditioning/Transplant|Disease progression|10|||
106133229|NCT00049517|366146194|FG003|Conditioning/Transplant|Disease progression|6|||
106133230|NCT00049517|366146195|FG004|Conditioning/Transplant|Disease progression|0|||
105925185|NCT03329001|365385830|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105925186|NCT03329001|365385831|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
105925187|NCT03329001|365385832|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
105925188|NCT03329001|365385825|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105925189|NCT03329001|365385826|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
106133231|NCT00049517|366146196|FG005|Conditioning/Transplant|Disease progression|0|||
106133232|NCT00049517|366146191|FG000|Conditioning/Transplant|Adverse Event|2|||
106133233|NCT00049517|366146192|FG001|Conditioning/Transplant|Adverse Event|1|||
106133234|NCT00049517|366146193|FG002|Conditioning/Transplant|Adverse Event|4|||
106133235|NCT00049517|366146194|FG003|Conditioning/Transplant|Adverse Event|8|||
106133236|NCT00049517|366146195|FG004|Conditioning/Transplant|Adverse Event|0|||
106133237|NCT00049517|366146196|FG005|Conditioning/Transplant|Adverse Event|0|||
106133238|NCT00049517|366146191|FG000|Conditioning/Transplant|Death|1|||
106133239|NCT00049517|366146192|FG001|Conditioning/Transplant|Death|0|||
106133240|NCT00049517|366146193|FG002|Conditioning/Transplant|Death|0|||
106133241|NCT00049517|366146194|FG003|Conditioning/Transplant|Death|2|||
106133242|NCT00049517|366146195|FG004|Conditioning/Transplant|Death|0|||
106133243|NCT00049517|366146196|FG005|Conditioning/Transplant|Death|0|||
106133244|NCT00049517|366146191|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
106133245|NCT00049517|366146192|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
106133246|NCT00049517|366146193|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
106133247|NCT00049517|366146194|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
106133248|NCT00049517|366146195|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
106133249|NCT00049517|366146196|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
106133250|NCT00049517|366146191|FG000|Conditioning/Transplant|Alternative therapy|4|||
106133251|NCT00049517|366146192|FG001|Conditioning/Transplant|Alternative therapy|4|||
106133252|NCT00049517|366146193|FG002|Conditioning/Transplant|Alternative therapy|2|||
106133253|NCT00049517|366146194|FG003|Conditioning/Transplant|Alternative therapy|1|||
106133254|NCT00049517|366146195|FG004|Conditioning/Transplant|Alternative therapy|1|||
106133255|NCT00049517|366146196|FG005|Conditioning/Transplant|Alternative therapy|0|||
106133256|NCT00049517|366146191|FG000|Conditioning/Transplant|Other complicating disease|2|||
106133257|NCT00049517|366146192|FG001|Conditioning/Transplant|Other complicating disease|0|||
106133258|NCT00049517|366146193|FG002|Conditioning/Transplant|Other complicating disease|0|||
106133259|NCT00049517|366146194|FG003|Conditioning/Transplant|Other complicating disease|4|||
106133260|NCT00049517|366146195|FG004|Conditioning/Transplant|Other complicating disease|0|||
106133261|NCT00049517|366146196|FG005|Conditioning/Transplant|Other complicating disease|1|||
106133262|NCT00049517|366146191|FG000|Conditioning/Transplant|Reasons not reported|25|||
106133263|NCT00049517|366146192|FG001|Conditioning/Transplant|Reasons not reported|31|||
106133264|NCT00049517|366146193|FG002|Conditioning/Transplant|Reasons not reported|18|||
106133265|NCT00049517|366146194|FG003|Conditioning/Transplant|Reasons not reported|15|||
106133266|NCT00049517|366146195|FG004|Conditioning/Transplant|Reasons not reported|5|||
106133267|NCT00049517|366146196|FG005|Conditioning/Transplant|Reasons not reported|5|||
106133268|NCT04730947|366146197|FG000|Overall Study|Withdrawal by Subject|0|||
106133269|NCT04730947|366146198|FG001|Overall Study|Withdrawal by Subject|1|||
106133270|NCT01450943|366146199|FG000|Overall Study|Screen failure, loss to follow-up|2|||
106133271|NCT01450943|366146200|FG001|Overall Study|Screen failure, loss to follow-up|7|||
106005724|NCT02657889|365684816|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
106005725|NCT02657889|365684817|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
106005726|NCT02657889|365684814|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
106005727|NCT02657889|365684815|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
106005728|NCT02657889|365684816|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
106005729|NCT02657889|365684817|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
106005730|NCT02657889|365684814|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
106005731|NCT02657889|365684815|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
106005732|NCT02657889|365684816|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
106005733|NCT02657889|365684817|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
106005734|NCT02657889|365684814|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
106005735|NCT02657889|365684815|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
106005736|NCT02657889|365684816|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
106005737|NCT02657889|365684817|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
106005738|NCT02657889|365684814|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
106005739|NCT02657889|365684815|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
106005740|NCT02657889|365684816|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
106005741|NCT02657889|365684817|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
106005742|NCT02657889|365684814|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
106005743|NCT02657889|365684815|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
106005744|NCT02657889|365684816|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
106005745|NCT02657889|365684817|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
106005746|NCT02657889|365684814|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
106005747|NCT02657889|365684815|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
106005748|NCT02657889|365684816|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
106005749|NCT02657889|365684817|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
106005750|NCT00556075|365684820|FG000|Overall Study|Lost to Follow-up|3|||
106005751|NCT00556075|365684821|FG001|Overall Study|Lost to Follow-up|0|||
106005752|NCT00556075|365684822|FG002|Overall Study|Lost to Follow-up|3|||
106005753|NCT00556075|365684820|FG000|Overall Study|Withdrawal by Subject|3|||
106005754|NCT00556075|365684821|FG001|Overall Study|Withdrawal by Subject|3|||
106005755|NCT00556075|365684822|FG002|Overall Study|Withdrawal by Subject|0|||
106005756|NCT00556075|365684820|FG000|Overall Study|Protocol Violation|1|||
106005757|NCT00556075|365684821|FG001|Overall Study|Protocol Violation|1|||
106005758|NCT00556075|365684822|FG002|Overall Study|Protocol Violation|3|||
106005759|NCT00556075|365684820|FG000|Overall Study|Not eligible|1|||
106005760|NCT00556075|365684821|FG001|Overall Study|Not eligible|1|||
106005761|NCT00556075|365684822|FG002|Overall Study|Not eligible|2|||
106005762|NCT00556075|365684820|FG000|Overall Study|Adverse Event|1|||
106005763|NCT00556075|365684821|FG001|Overall Study|Adverse Event|2|||
105925190|NCT03329001|365385827|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105925191|NCT03329001|365385828|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105925192|NCT03329001|365385829|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105925193|NCT03329001|365385830|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
105925194|NCT03329001|365385831|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
105925195|NCT03329001|365385832|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
105925196|NCT03329001|365385825|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105925197|NCT03329001|365385826|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105925198|NCT03329001|365385827|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
106005764|NCT00556075|365684822|FG002|Overall Study|Adverse Event|0|||
106005765|NCT00556075|365684820|FG000|Overall Study|Personal issues|4|||
106005766|NCT00556075|365684821|FG001|Overall Study|Personal issues|1|||
106005767|NCT00556075|365684822|FG002|Overall Study|Personal issues|0|||
105787226|NCT03110107|364874902|FG013|Treatment Period|Participants no longer meets study criteria|0|||
105787227|NCT03110107|364874903|FG014|Treatment Period|Participants no longer meets study criteria|0|||
105787228|NCT03110107|364874904|FG015|Treatment Period|Participants no longer meets study criteria|0|||
105787229|NCT03110107|364874905|FG016|Treatment Period|Participants no longer meets study criteria|0|||
105787230|NCT03110107|364874906|FG017|Treatment Period|Participants no longer meets study criteria|0|||
105787231|NCT03110107|364874907|FG018|Treatment Period|Participants no longer meets study criteria|0|||
105787232|NCT03110107|364874908|FG019|Treatment Period|Participants no longer meets study criteria|0|||
105787233|NCT03110107|364874909|FG020|Treatment Period|Participants no longer meets study criteria|0|||
105925199|NCT03329001|365385828|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105925200|NCT03329001|365385829|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105925201|NCT03329001|365385830|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
105925202|NCT03329001|365385831|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
105925203|NCT03329001|365385832|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
105925204|NCT02709369|365385834|FG000|Overall Study|Lost to Follow-up|15|||
105925205|NCT02709369|365385834|FG000|Overall Study|Withdrawal by Subject|10|||
106133272|NCT01450943|366146201|FG002|Overall Study|Screen failure, loss to follow-up|6|||
106133273|NCT01460381|366146204|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
106133274|NCT01460381|366146205|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
106133275|NCT01684046|366146206|FG000|Period 1, First 30 Days|Adverse Event|0|||
106133276|NCT01684046|366146207|FG001|Period 1, First 30 Days|Adverse Event|2|||
106133277|NCT05458102|366146208|FG000|Overall Study|Withdrew consent|2|||
106133278|NCT05458102|366146209|FG001|Overall Study|Withdrew consent|0|||
106133279|NCT05458102|366146208|FG000|Overall Study|Adverse Event|1|||
106133280|NCT05458102|366146209|FG001|Overall Study|Adverse Event|0|||
106133281|NCT05458102|366146208|FG000|Overall Study|Enrolled but never treated|1|||
106133282|NCT05458102|366146209|FG001|Overall Study|Enrolled but never treated|0|||
106133283|NCT05458102|366146208|FG000|Overall Study|Protocol Violation|1|||
106133284|NCT05458102|366146209|FG001|Overall Study|Protocol Violation|0|||
106133285|NCT04454567|366146212|FG000|Overall Study|Study Terminated by Sponsor|1|||
106133286|NCT04454567|366146213|FG001|Overall Study|Study Terminated by Sponsor|1|||
106133287|NCT01323660|366146214|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
106133288|NCT01323660|366146215|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
106133289|NCT01323660|366146216|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
106133290|NCT01323660|366146217|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
106133291|NCT01323660|366146218|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
106133292|NCT01323660|366146219|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
106133293|NCT01323660|366146214|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
106133294|NCT01323660|366146215|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
106133295|NCT01323660|366146216|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
106133296|NCT01323660|366146217|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
106133297|NCT01323660|366146218|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
106133298|NCT01323660|366146219|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
106133299|NCT01323660|366146214|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
106133300|NCT01323660|366146215|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
106133301|NCT01323660|366146216|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
106133302|NCT01323660|366146217|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
106133303|NCT01323660|366146218|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
106133304|NCT01323660|366146219|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
106133305|NCT01323660|366146214|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
106133306|NCT01323660|366146215|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
106133307|NCT01323660|366146216|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
106133308|NCT01323660|366146217|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
106133309|NCT01323660|366146218|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
106133310|NCT01323660|366146219|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
106133311|NCT01323660|366146214|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106133312|NCT01323660|366146215|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106133313|NCT01323660|366146216|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106133314|NCT01323660|366146217|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106133315|NCT01323660|366146218|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
106133316|NCT01323660|366146219|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106133317|NCT01323660|366146214|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
106133318|NCT01323660|366146215|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
106133319|NCT01323660|366146216|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
106133320|NCT01323660|366146217|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
106133321|NCT01323660|366146218|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
106133322|NCT01323660|366146219|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
106133323|NCT01323660|366146214|FG000|Washout Period (14 Days)|Adverse Event|0|||
106133324|NCT01323660|366146215|FG001|Washout Period (14 Days)|Adverse Event|0|||
105925206|NCT02709369|365385834|FG000|Overall Study|Did not received intervention|2|||
105925207|NCT00963235|365385835|FG000|Overall Study|Withdrawal by Subject|22|||
105925208|NCT00963235|365385835|FG000|Overall Study|Lost to Follow-up|14|||
105925209|NCT00963235|365385835|FG000|Overall Study|Failed to return|9|||
105925210|NCT00963235|365385835|FG000|Overall Study|Protocol Violation|7|||
105925211|NCT00963235|365385835|FG000|Overall Study|Adverse Event|5|||
105925212|NCT00963235|365385835|FG000|Overall Study|Physician Decision|2|||
105925213|NCT00963235|365385835|FG000|Overall Study|Other|1|||
105925214|NCT01311661|365385836|FG000|Overall Study|Adverse Event|2|||
105925215|NCT01311661|365385836|FG000|Overall Study|Protocol Violation|3|||
105925216|NCT01311661|365385836|FG000|Overall Study|Withdrawal by Subject|2|||
105925217|NCT01900314|365385837|FG000|Overall Study|Lost to Follow-up|1|||
105925218|NCT01900314|365385838|FG001|Overall Study|Lost to Follow-up|0|||
105925219|NCT01900314|365385837|FG000|Overall Study|Protocol Violation|0|||
105925220|NCT01900314|365385838|FG001|Overall Study|Protocol Violation|1|||
105925221|NCT01900314|365385837|FG000|Overall Study|Withdrawal by Subject|3|||
105925222|NCT01900314|365385838|FG001|Overall Study|Withdrawal by Subject|3|||
105925223|NCT01104766|365385840|FG000|Overall Study|Did not meet inc/exc criteria|1|||
105787234|NCT03110107|364874910|FG021|Treatment Period|Participants no longer meets study criteria|0|||
105925224|NCT01104766|365385841|FG001|Overall Study|Did not meet inc/exc criteria|0|||
105925225|NCT01104766|365385842|FG002|Overall Study|Did not meet inc/exc criteria|0|||
105925226|NCT01104766|365385843|FG003|Overall Study|Did not meet inc/exc criteria|0|||
105925227|NCT01104766|365385840|FG000|Overall Study|Adverse Event|17|||
105925228|NCT01104766|365385841|FG001|Overall Study|Adverse Event|15|||
105925229|NCT01104766|365385842|FG002|Overall Study|Adverse Event|20|||
105925230|NCT01104766|365385843|FG003|Overall Study|Adverse Event|14|||
106005768|NCT00556075|365684820|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
106005769|NCT00556075|365684821|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
106005770|NCT00556075|365684822|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
106005771|NCT00395746|365684823|FG000|Overall Study|Adverse Event|5|||
106005772|NCT00395746|365684824|FG001|Overall Study|Adverse Event|2|||
106005773|NCT00395746|365684825|FG002|Overall Study|Adverse Event|2|||
106005774|NCT00395746|365684823|FG000|Overall Study|Protocol Violation|0|||
106005775|NCT00395746|365684824|FG001|Overall Study|Protocol Violation|1|||
106005776|NCT00395746|365684825|FG002|Overall Study|Protocol Violation|0|||
106005777|NCT00395746|365684823|FG000|Overall Study|Lack of Efficacy|2|||
106005778|NCT00395746|365684824|FG001|Overall Study|Lack of Efficacy|0|||
106005779|NCT00395746|365684825|FG002|Overall Study|Lack of Efficacy|17|||
106005780|NCT00395746|365684823|FG000|Overall Study|Hypoglycaemia|2|||
106005781|NCT00395746|365684824|FG001|Overall Study|Hypoglycaemia|1|||
106005782|NCT00395746|365684825|FG002|Overall Study|Hypoglycaemia|0|||
106005783|NCT00395746|365684823|FG000|Overall Study|Subject decision|0|||
106005784|NCT00395746|365684824|FG001|Overall Study|Subject decision|0|||
106005785|NCT00395746|365684825|FG002|Overall Study|Subject decision|1|||
106005786|NCT00395746|365684823|FG000|Overall Study|Withdrawal of consent|0|||
106005787|NCT00395746|365684824|FG001|Overall Study|Withdrawal of consent|0|||
106005788|NCT00395746|365684825|FG002|Overall Study|Withdrawal of consent|1|||
106005789|NCT00395746|365684823|FG000|Overall Study|Difficultulty in use of device|0|||
106005790|NCT00395746|365684824|FG001|Overall Study|Difficultulty in use of device|0|||
106005791|NCT00395746|365684825|FG002|Overall Study|Difficultulty in use of device|1|||
106005792|NCT00395746|365684823|FG000|Overall Study|Unable to visit site on schedule|1|||
106005793|NCT00395746|365684824|FG001|Overall Study|Unable to visit site on schedule|0|||
106005794|NCT00395746|365684825|FG002|Overall Study|Unable to visit site on schedule|0|||
105787235|NCT03110107|364874911|FG022|Treatment Period|Participants no longer meets study criteria|0|||
106005795|NCT03914417|365684826|FG000|Overall Study|Withdrawal by Subject|2|||
106005796|NCT01420861|365684833|FG000|Overall Study|Adverse Event|2|||
106005797|NCT01420861|365684833|FG000|Overall Study|Study terminated by Sponsor|7|||
106005798|NCT01420861|365684833|FG000|Overall Study|Screen failure|7|||
106005799|NCT01420861|365684833|FG000|Overall Study|Randomized not Treated|2|||
106005800|NCT01247324|365684837|FG000|Overall Study|Death|6|||
106005801|NCT01247324|365684838|FG001|Overall Study|Death|10|||
106133325|NCT01323660|366146216|FG002|Washout Period (14 Days)|Adverse Event|0|||
106133326|NCT01323660|366146217|FG003|Washout Period (14 Days)|Adverse Event|0|||
106133327|NCT01323660|366146218|FG004|Washout Period (14 Days)|Adverse Event|1|||
106133328|NCT01323660|366146219|FG005|Washout Period (14 Days)|Adverse Event|0|||
106133329|NCT01323660|366146214|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
106133330|NCT01323660|366146215|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
106133331|NCT01323660|366146216|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
106133332|NCT01323660|366146217|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
106133333|NCT01323660|366146218|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
106133334|NCT01323660|366146219|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
106133335|NCT01323660|366146214|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
106133336|NCT01323660|366146215|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
106133337|NCT01323660|366146216|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
106133338|NCT01323660|366146217|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
106133339|NCT01323660|366146218|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
106133340|NCT01323660|366146219|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
106133341|NCT01323660|366146214|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
106133342|NCT01323660|366146215|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
106133343|NCT01323660|366146216|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
106133344|NCT01323660|366146217|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
106133345|NCT01323660|366146218|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
106133346|NCT01323660|366146219|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
106133347|NCT01323660|366146214|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
106133348|NCT01323660|366146215|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
106133349|NCT01323660|366146216|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
106133350|NCT01323660|366146217|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
106133351|NCT01323660|366146218|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
106133352|NCT01323660|366146219|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
106133353|NCT01323660|366146214|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
106133354|NCT01323660|366146215|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
106133355|NCT01323660|366146216|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
106133356|NCT01323660|366146217|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
106133357|NCT01323660|366146218|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
106133358|NCT01323660|366146219|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
106133359|NCT01323660|366146214|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
106133360|NCT01323660|366146215|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
106133361|NCT01323660|366146216|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
106005802|NCT01247324|365684837|FG000|Overall Study|Physician Decision|2|||
106133362|NCT01323660|366146217|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
106133363|NCT01323660|366146218|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
106133364|NCT01323660|366146219|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
106133365|NCT01360840|366146220|FG000|Overall Study|Ongoing at data cut-off|10|||
106133366|NCT01360840|366146221|FG001|Overall Study|Ongoing at data cut-off|10|||
106133367|NCT01360840|366146222|FG002|Overall Study|Ongoing at data cut-off|9|||
106133368|NCT03101592|366146223|FG000|Overall Study|participant files could not be located|111|||
106133369|NCT03101592|366146224|FG001|Overall Study|participant files could not be located|170|||
106133370|NCT03101592|366146225|FG002|Overall Study|participant files could not be located|118|||
106133371|NCT01528709|366146226|FG000|Overall Study|Death|2|||
106133372|NCT01528709|366146227|FG001|Overall Study|Death|0|||
106133373|NCT01528709|366146226|FG000|Overall Study|Withdrawal by Subject|10|||
106133374|NCT01528709|366146227|FG001|Overall Study|Withdrawal by Subject|15|||
106133375|NCT01528709|366146226|FG000|Overall Study|allergy|1|||
106133376|NCT01528709|366146227|FG001|Overall Study|allergy|0|||
106133377|NCT05124899|366146230|FG000|Overall Study|Lost to Follow-up|3|||
106133378|NCT03432533|366146233|FG000|Overall Study|Lost to Follow-up|1|||
106133379|NCT03432533|366146234|FG001|Overall Study|Lost to Follow-up|2|||
106133380|NCT03432533|366146233|FG000|Overall Study|Withdrawal by Subject|14|||
106133381|NCT03432533|366146234|FG001|Overall Study|Withdrawal by Subject|9|||
106133382|NCT01648283|366146235|FG000|Overall Study|Withdrawal by Subject|14|||
106133383|NCT01653743|366146237|FG000|Overall Study|Withdrawal by Subject|1|||
106133384|NCT01653743|366146238|FG001|Overall Study|Withdrawal by Subject|0|||
106133385|NCT01653743|366146237|FG000|Overall Study|Investigator discretion|3|||
106133386|NCT01653743|366146238|FG001|Overall Study|Investigator discretion|0|||
106133387|NCT03382821|366146243|FG000|Overall Study|Did not receive allocated intervention.|0|||
106133388|NCT03382821|366146244|FG001|Overall Study|Did not receive allocated intervention.|3|||
106133389|NCT01674569|366146252|FG000|Overall Study|Adverse Event|0|||
106133390|NCT01674569|366146253|FG001|Overall Study|Adverse Event|2|||
106133391|NCT01674569|366146254|FG002|Overall Study|Adverse Event|0|||
106133392|NCT01674569|366146255|FG003|Overall Study|Adverse Event|1|||
106133393|NCT01674569|366146256|FG004|Overall Study|Adverse Event|2|||
106133394|NCT01674569|366146257|FG005|Overall Study|Adverse Event|2|||
106133395|NCT01674569|366146252|FG000|Overall Study|Protocol Violation|0|||
106133396|NCT01674569|366146253|FG001|Overall Study|Protocol Violation|1|||
106133397|NCT01674569|366146254|FG002|Overall Study|Protocol Violation|1|||
106133398|NCT01674569|366146255|FG003|Overall Study|Protocol Violation|0|||
106133399|NCT01674569|366146256|FG004|Overall Study|Protocol Violation|0|||
106133400|NCT01674569|366146257|FG005|Overall Study|Protocol Violation|0|||
106133401|NCT01674569|366146252|FG000|Overall Study|Withdrawal by Subject|0|||
106133402|NCT01674569|366146253|FG001|Overall Study|Withdrawal by Subject|0|||
106133403|NCT01674569|366146254|FG002|Overall Study|Withdrawal by Subject|1|||
106133404|NCT01674569|366146255|FG003|Overall Study|Withdrawal by Subject|0|||
106133405|NCT01674569|366146256|FG004|Overall Study|Withdrawal by Subject|0|||
106133406|NCT01674569|366146257|FG005|Overall Study|Withdrawal by Subject|0|||
106133407|NCT05650333|366146263|FG000|Treatment Period (7 Days)|Adverse Event|1|||
106133408|NCT01649427|366146264|FG000|Overall Study|Adverse Event|1|||
106133409|NCT01649427|366146265|FG001|Overall Study|Adverse Event|1|||
106133410|NCT01649427|366146264|FG000|Overall Study|Withdrawal by Subject|8|||
106133411|NCT01649427|366146265|FG001|Overall Study|Withdrawal by Subject|7|||
106133412|NCT01649427|366146264|FG000|Overall Study|Lost to Follow-up|0|||
106133413|NCT01649427|366146265|FG001|Overall Study|Lost to Follow-up|1|||
106133414|NCT01649427|366146264|FG000|Overall Study|Graft loss|0|||
106133415|NCT01649427|366146265|FG001|Overall Study|Graft loss|1|||
106133416|NCT01649427|366146264|FG000|Overall Study|Surgical problems during nephrectomy|2|||
106133417|NCT01649427|366146265|FG001|Overall Study|Surgical problems during nephrectomy|2|||
106133418|NCT02138916|366146266|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
106133419|NCT02138916|366146267|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
106133420|NCT02138916|366146268|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
106133421|NCT02138916|366146266|FG000|Overall Study|Death|14|||
106133422|NCT02138916|366146267|FG001|Overall Study|Death|11|||
106133423|NCT02138916|366146268|FG002|Overall Study|Death|12|||
106133424|NCT02138916|366146266|FG000|Overall Study|Withdrawal by Subject|27|||
106133425|NCT02138916|366146267|FG001|Overall Study|Withdrawal by Subject|31|||
106133426|NCT02138916|366146268|FG002|Overall Study|Withdrawal by Subject|32|||
106133427|NCT02138916|366146266|FG000|Overall Study|Study specific withdrawal criteria|0|||
106133428|NCT02138916|366146267|FG001|Overall Study|Study specific withdrawal criteria|0|||
106133429|NCT02138916|366146268|FG002|Overall Study|Study specific withdrawal criteria|1|||
106133430|NCT02138916|366146266|FG000|Overall Study|incorrect enrolment|1|||
106133431|NCT02138916|366146267|FG001|Overall Study|incorrect enrolment|1|||
106133432|NCT02138916|366146268|FG002|Overall Study|incorrect enrolment|0|||
106133433|NCT02138916|366146266|FG000|Overall Study|Severe non-compliance|1|||
106133434|NCT02138916|366146267|FG001|Overall Study|Severe non-compliance|2|||
106133435|NCT02138916|366146268|FG002|Overall Study|Severe non-compliance|1|||
105925231|NCT01104766|365385840|FG000|Overall Study|Lack of Efficacy|20|||
106133436|NCT02138916|366146266|FG000|Overall Study|Lost to Follow-up|4|||
106133437|NCT02138916|366146267|FG001|Overall Study|Lost to Follow-up|2|||
106133438|NCT02138916|366146268|FG002|Overall Study|Lost to Follow-up|3|||
106133439|NCT02138916|366146266|FG000|Overall Study|Adverse Event|4|||
106133440|NCT02138916|366146267|FG001|Overall Study|Adverse Event|4|||
106133441|NCT02138916|366146268|FG002|Overall Study|Adverse Event|3|||
106133442|NCT00764868|366146276|FG000|Overall Study|Adverse Event|18|||
106133443|NCT00764868|366146276|FG000|Overall Study|Withdrawal by Subject|31|||
106133444|NCT00764868|366146276|FG000|Overall Study|Non-compliance|16|||
106133445|NCT00764868|366146276|FG000|Overall Study|Lost to Follow-up|25|||
106133446|NCT00764868|366146276|FG000|Overall Study|Lack of Efficacy|5|||
106133447|NCT00764868|366146276|FG000|Overall Study|Subject moved|7|||
106133448|NCT00764868|366146276|FG000|Overall Study|Pregnancy|3|||
106133449|NCT00764868|366146276|FG000|Overall Study|Prohibited medication|1|||
106133450|NCT00764868|366146276|FG000|Overall Study|Out of town|1|||
106133451|NCT00764868|366146276|FG000|Overall Study|Misuse and compliance of study drug|1|||
106133452|NCT00764868|366146276|FG000|Overall Study|Subject sent to boarding school|1|||
106133453|NCT00764868|366146276|FG000|Overall Study|Met an exclusion criteria|1|||
106133454|NCT00764868|366146276|FG000|Overall Study|Positive drug screen|2|||
106133455|NCT00764868|366146276|FG000|Overall Study|Sponsor requested withdrawal|1|||
106133456|NCT03005288|366146281|FG000|Overall Study|Withdrawal by Subject|7|||
106133457|NCT03005288|366146282|FG001|Overall Study|Withdrawal by Subject|5|||
106133458|NCT03005288|366146281|FG000|Overall Study|Lost to Follow-up|0|||
106133459|NCT03005288|366146282|FG001|Overall Study|Lost to Follow-up|1|||
106133460|NCT03005288|366146281|FG000|Overall Study|Adverse Event|5|||
105925232|NCT01104766|365385841|FG001|Overall Study|Lack of Efficacy|15|||
105925233|NCT01104766|365385842|FG002|Overall Study|Lack of Efficacy|14|||
105925234|NCT01104766|365385843|FG003|Overall Study|Lack of Efficacy|8|||
105925235|NCT01104766|365385840|FG000|Overall Study|Protocol Violation|2|||
105925236|NCT01104766|365385841|FG001|Overall Study|Protocol Violation|0|||
105925237|NCT01104766|365385842|FG002|Overall Study|Protocol Violation|0|||
105925238|NCT01104766|365385843|FG003|Overall Study|Protocol Violation|0|||
105925239|NCT01104766|365385840|FG000|Overall Study|Withdrawal by Subject|17|||
105925240|NCT01104766|365385841|FG001|Overall Study|Withdrawal by Subject|19|||
105925241|NCT01104766|365385842|FG002|Overall Study|Withdrawal by Subject|25|||
105925242|NCT01104766|365385843|FG003|Overall Study|Withdrawal by Subject|15|||
105925243|NCT01104766|365385840|FG000|Overall Study|Lost to Follow-up|1|||
105925244|NCT01104766|365385841|FG001|Overall Study|Lost to Follow-up|2|||
105925245|NCT01104766|365385842|FG002|Overall Study|Lost to Follow-up|1|||
105925246|NCT01104766|365385843|FG003|Overall Study|Lost to Follow-up|1|||
105925247|NCT01341470|365385844|FG000|Overall Study|Sponsor decision|0|||
105925248|NCT01341470|365385845|FG001|Overall Study|Sponsor decision|0|||
105925249|NCT01341470|365385846|FG002|Overall Study|Sponsor decision|1|||
105925250|NCT01341470|365385847|FG003|Overall Study|Sponsor decision|1|||
105925251|NCT01341470|365385848|FG004|Overall Study|Sponsor decision|0|||
105925252|NCT01341470|365385849|FG005|Overall Study|Sponsor decision|1|||
105925253|NCT01136915|365385850|FG000|Overall Study|Lost to Follow-up|2|||
105925254|NCT01136915|365385851|FG001|Overall Study|Lost to Follow-up|0|||
105925255|NCT01136915|365385850|FG000|Overall Study|Exclusion criterion met|0|||
105925256|NCT01136915|365385851|FG001|Overall Study|Exclusion criterion met|1|||
105925257|NCT01756235|365385852|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
105925258|NCT01044498|365385853|FG000|Overall Study|Withdrew consent|1|||
105925259|NCT01044498|365385854|FG001|Overall Study|Withdrew consent|1|||
105925260|NCT01044498|365385853|FG000|Overall Study|Adverse Event|1|||
105925261|NCT01044498|365385854|FG001|Overall Study|Adverse Event|1|||
105925262|NCT01044498|365385853|FG000|Overall Study|Other|1|||
105925263|NCT01044498|365385854|FG001|Overall Study|Other|0|||
105925264|NCT00390013|365385855|FG000|Phase 1|tired|0|||
105925265|NCT00390013|365385856|FG001|Phase 1|tired|0|||
105925266|NCT00390013|365385857|FG002|Phase 1|tired|0|||
105925267|NCT00390013|365385858|FG003|Phase 1|tired|1|||
105925268|NCT00390013|365385855|FG000|Phase 2 First Treatment|tired|1|||
105925269|NCT00390013|365385856|FG001|Phase 2 First Treatment|tired|0|||
105925270|NCT00390013|365385857|FG002|Phase 2 First Treatment|tired|0|||
105925271|NCT00390013|365385858|FG003|Phase 2 First Treatment|tired|0|||
105925272|NCT00390013|365385855|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
105925273|NCT00390013|365385856|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
106133461|NCT03005288|366146282|FG001|Overall Study|Adverse Event|0|||
106133462|NCT03005288|366146281|FG000|Overall Study|Protocol deviation|0|||
106133463|NCT03005288|366146282|FG001|Overall Study|Protocol deviation|1|||
106133464|NCT03005288|366146281|FG000|Overall Study|Physician Decision|0|||
106133465|NCT03005288|366146282|FG001|Overall Study|Physician Decision|1|||
105925274|NCT00390013|365385857|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
105925275|NCT00390013|365385858|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
105925276|NCT03034967|365385861|FG000|Overall Study|Withdrawal by Subject|9|||
105925277|NCT03034967|365385862|FG001|Overall Study|Withdrawal by Subject|2|||
105925278|NCT03034967|365385863|FG002|Overall Study|Withdrawal by Subject|6|||
105925279|NCT03034967|365385864|FG003|Overall Study|Withdrawal by Subject|6|||
105925280|NCT03034967|365385865|FG004|Overall Study|Withdrawal by Subject|9|||
106133466|NCT01823341|366146283|FG000|Overall Study|Failed run-in|7|||
105925281|NCT03034967|365385866|FG005|Overall Study|Withdrawal by Subject|2|||
105699941|NCT04773106|364565056|FG000|Overall Study|Withdrawal by Subject|3|||
105699942|NCT04773106|364565056|FG000|Overall Study|Death|1|||
105699943|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
105699944|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
105699945|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
105699946|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
105699947|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
105699948|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
105925282|NCT03034967|365385861|FG000|Overall Study|Physician Decision|1|||
105925283|NCT03034967|365385862|FG001|Overall Study|Physician Decision|0|||
105925284|NCT03034967|365385863|FG002|Overall Study|Physician Decision|1|||
105925285|NCT03034967|365385864|FG003|Overall Study|Physician Decision|1|||
105925286|NCT03034967|365385865|FG004|Overall Study|Physician Decision|1|||
105925287|NCT03034967|365385866|FG005|Overall Study|Physician Decision|0|||
105925288|NCT03034967|365385861|FG000|Overall Study|Lost to Follow-up|0|||
105925289|NCT03034967|365385862|FG001|Overall Study|Lost to Follow-up|0|||
105925290|NCT03034967|365385863|FG002|Overall Study|Lost to Follow-up|0|||
105925291|NCT03034967|365385864|FG003|Overall Study|Lost to Follow-up|1|||
105925292|NCT03034967|365385865|FG004|Overall Study|Lost to Follow-up|0|||
105925293|NCT03034967|365385866|FG005|Overall Study|Lost to Follow-up|2|||
105925294|NCT03034967|365385861|FG000|Overall Study|Liver function test abnormality|0|||
105925295|NCT03034967|365385862|FG001|Overall Study|Liver function test abnormality|0|||
105925296|NCT03034967|365385863|FG002|Overall Study|Liver function test abnormality|1|||
105925297|NCT03034967|365385864|FG003|Overall Study|Liver function test abnormality|0|||
105925298|NCT03034967|365385865|FG004|Overall Study|Liver function test abnormality|0|||
105925299|NCT03034967|365385866|FG005|Overall Study|Liver function test abnormality|0|||
105925300|NCT03034967|365385861|FG000|Overall Study|Protocol Violation|1|||
105925301|NCT03034967|365385862|FG001|Overall Study|Protocol Violation|0|||
105925302|NCT03034967|365385863|FG002|Overall Study|Protocol Violation|0|||
105925303|NCT03034967|365385864|FG003|Overall Study|Protocol Violation|0|||
105925304|NCT03034967|365385865|FG004|Overall Study|Protocol Violation|0|||
105925305|NCT03034967|365385866|FG005|Overall Study|Protocol Violation|2|||
105925306|NCT03034967|365385861|FG000|Overall Study|Lack of Efficacy|0|||
105699949|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
105699950|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105925307|NCT03034967|365385862|FG001|Overall Study|Lack of Efficacy|1|||
105925308|NCT03034967|365385863|FG002|Overall Study|Lack of Efficacy|2|||
105925309|NCT03034967|365385864|FG003|Overall Study|Lack of Efficacy|1|||
105925310|NCT03034967|365385865|FG004|Overall Study|Lack of Efficacy|1|||
105925311|NCT03034967|365385866|FG005|Overall Study|Lack of Efficacy|0|||
105925312|NCT03034967|365385861|FG000|Overall Study|Adverse Event, non-fatal|3|||
105699951|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699952|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699953|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699954|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
105699955|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699956|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699957|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699958|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699959|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
105699960|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
105699961|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
105699962|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699963|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699964|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699965|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699966|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
105699967|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699968|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699969|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699970|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699971|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699972|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
105699973|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
105699974|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699975|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699976|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699977|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699978|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
105699979|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699980|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699981|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699982|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699983|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699984|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699985|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
105925313|NCT03034967|365385862|FG001|Overall Study|Adverse Event, non-fatal|1|||
105925314|NCT03034967|365385863|FG002|Overall Study|Adverse Event, non-fatal|2|||
105925315|NCT03034967|365385864|FG003|Overall Study|Adverse Event, non-fatal|0|||
105925316|NCT03034967|365385865|FG004|Overall Study|Adverse Event, non-fatal|2|||
105925317|NCT03034967|365385866|FG005|Overall Study|Adverse Event, non-fatal|8|||
105925318|NCT03034967|365385861|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
105925319|NCT03034967|365385862|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
105925320|NCT03034967|365385863|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
105925321|NCT03034967|365385864|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
105925322|NCT03034967|365385865|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
105925323|NCT03034967|365385866|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
105925324|NCT02225587|365385869|FG000|Overall Study|Adverse Event|5|||
105925325|NCT02225587|365385870|FG001|Overall Study|Adverse Event|5|||
105925326|NCT02225587|365385869|FG000|Overall Study|Lost to Follow-up|5|||
105925327|NCT02225587|365385870|FG001|Overall Study|Lost to Follow-up|5|||
105925328|NCT02225587|365385869|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105925329|NCT02225587|365385870|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105925330|NCT02225587|365385869|FG000|Overall Study|Physician Decision|2|||
105925331|NCT02225587|365385870|FG001|Overall Study|Physician Decision|0|||
105925332|NCT02225587|365385869|FG000|Overall Study|Protocol Violation|1|||
105925333|NCT02225587|365385870|FG001|Overall Study|Protocol Violation|0|||
105925334|NCT02225587|365385869|FG000|Overall Study|Participant Moved|1|||
105925335|NCT02225587|365385870|FG001|Overall Study|Participant Moved|0|||
105925336|NCT02225587|365385869|FG000|Overall Study|Withdrawal by Subject|13|||
105925337|NCT02225587|365385870|FG001|Overall Study|Withdrawal by Subject|28|||
105925338|NCT01551173|365385876|FG000|Overall Study|Withdrawal by Subject|11|||
105925339|NCT01551173|365385877|FG001|Overall Study|Withdrawal by Subject|16|||
105925340|NCT01551173|365385876|FG000|Overall Study|Adverse Event|7|||
105925341|NCT01551173|365385877|FG001|Overall Study|Adverse Event|6|||
105925342|NCT01551173|365385876|FG000|Overall Study|Lost to Follow-up|5|||
105925343|NCT01551173|365385877|FG001|Overall Study|Lost to Follow-up|7|||
105925344|NCT01551173|365385876|FG000|Overall Study|Other|5|||
105925345|NCT01551173|365385877|FG001|Overall Study|Other|3|||
106005803|NCT01247324|365684838|FG001|Overall Study|Physician Decision|3|||
106133467|NCT01823341|366146283|FG000|Overall Study|Withdrawal by Subject|7|||
106005804|NCT01247324|365684837|FG000|Overall Study|Non-compliance with study drug|3|||
106005805|NCT01247324|365684838|FG001|Overall Study|Non-compliance with study drug|0|||
106005806|NCT01247324|365684837|FG000|Overall Study|Lack of Efficacy|24|||
106005807|NCT01247324|365684838|FG001|Overall Study|Lack of Efficacy|14|||
106005808|NCT01247324|365684837|FG000|Overall Study|Non-compliance|3|||
106005809|NCT01247324|365684838|FG001|Overall Study|Non-compliance|2|||
106005810|NCT01247324|365684837|FG000|Overall Study|Pregnancy|5|||
106005811|NCT01247324|365684838|FG001|Overall Study|Pregnancy|10|||
106005812|NCT01247324|365684837|FG000|Overall Study|Protocol Violation|1|||
106005813|NCT01247324|365684838|FG001|Overall Study|Protocol Violation|1|||
106005814|NCT01247324|365684837|FG000|Overall Study|Reason not specified|42|||
106005815|NCT01247324|365684838|FG001|Overall Study|Reason not specified|32|||
105787236|NCT03110107|364874912|FG023|Treatment Period|Participants no longer meets study criteria|1|||
106005816|NCT01247324|365684837|FG000|Overall Study|Consent withdrawn by participant|41|||
106005817|NCT01247324|365684838|FG001|Overall Study|Consent withdrawn by participant|56|||
106005818|NCT01247324|365684837|FG000|Overall Study|Adverse Event|49|||
105699986|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699987|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699988|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699989|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699990|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
105699991|NCT02819635|364565057|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
105699992|NCT02819635|364565058|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
105699993|NCT02819635|364565059|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
105699994|NCT02819635|364565060|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
105699995|NCT02819635|364565061|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
105699996|NCT02819635|364565062|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
105699997|NCT02819635|364565063|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
105699998|NCT02819635|364565064|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105699999|NCT02819635|364565065|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105700000|NCT02819635|364565066|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105700001|NCT02819635|364565067|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105700002|NCT02819635|364565068|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
105700003|NCT02819635|364565057|FG000|Substudy 2, Part 2|Adverse Event|0|||
105700004|NCT02819635|364565058|FG001|Substudy 2, Part 2|Adverse Event|0|||
105700005|NCT02819635|364565059|FG002|Substudy 2, Part 2|Adverse Event|0|||
105700006|NCT02819635|364565060|FG003|Substudy 2, Part 2|Adverse Event|0|||
105700007|NCT02819635|364565061|FG004|Substudy 2, Part 2|Adverse Event|0|||
105700008|NCT02819635|364565062|FG005|Substudy 2, Part 2|Adverse Event|4|||
105700009|NCT02819635|364565063|FG006|Substudy 2, Part 2|Adverse Event|0|||
105700010|NCT02819635|364565064|FG007|Substudy 2, Part 2|Adverse Event|0|||
105700011|NCT02819635|364565065|FG008|Substudy 2, Part 2|Adverse Event|0|||
105700012|NCT02819635|364565066|FG009|Substudy 2, Part 2|Adverse Event|0|||
105700013|NCT02819635|364565067|FG010|Substudy 2, Part 2|Adverse Event|0|||
105700014|NCT02819635|364565068|FG011|Substudy 2, Part 2|Adverse Event|0|||
105700015|NCT02819635|364565057|FG000|Substudy 2, Part 2|Withdrew consent|0|||
105700016|NCT02819635|364565058|FG001|Substudy 2, Part 2|Withdrew consent|0|||
105700017|NCT02819635|364565059|FG002|Substudy 2, Part 2|Withdrew consent|0|||
105700018|NCT02819635|364565060|FG003|Substudy 2, Part 2|Withdrew consent|0|||
105700019|NCT02819635|364565061|FG004|Substudy 2, Part 2|Withdrew consent|0|||
105700020|NCT02819635|364565062|FG005|Substudy 2, Part 2|Withdrew consent|3|||
105700021|NCT02819635|364565063|FG006|Substudy 2, Part 2|Withdrew consent|1|||
105700022|NCT02819635|364565064|FG007|Substudy 2, Part 2|Withdrew consent|0|||
105700023|NCT02819635|364565065|FG008|Substudy 2, Part 2|Withdrew consent|0|||
105700024|NCT02819635|364565066|FG009|Substudy 2, Part 2|Withdrew consent|0|||
105700025|NCT02819635|364565067|FG010|Substudy 2, Part 2|Withdrew consent|0|||
105700026|NCT02819635|364565068|FG011|Substudy 2, Part 2|Withdrew consent|0|||
105700027|NCT02819635|364565057|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
105700028|NCT02819635|364565058|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
105700029|NCT02819635|364565059|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
105700030|NCT02819635|364565060|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
105700031|NCT02819635|364565061|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
105700032|NCT02819635|364565062|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
105700033|NCT02819635|364565063|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
105700034|NCT02819635|364565064|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
105700035|NCT02819635|364565065|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
105700036|NCT02819635|364565066|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
105700037|NCT02819635|364565067|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
105700038|NCT02819635|364565068|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
105700039|NCT02819635|364565057|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700040|NCT02819635|364565058|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700041|NCT02819635|364565059|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700042|NCT02819635|364565060|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700043|NCT02819635|364565061|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700044|NCT02819635|364565062|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700045|NCT02819635|364565063|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
105700046|NCT02819635|364565064|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700047|NCT02819635|364565065|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105925346|NCT00976027|365385878|FG000|Overall Study|Serious Adverse Event|36|||
105925347|NCT00976027|365385879|FG001|Overall Study|Serious Adverse Event|17|||
105925348|NCT00976027|365385878|FG000|Overall Study|Adverse Event|0|||
105925349|NCT00976027|365385879|FG001|Overall Study|Adverse Event|2|||
105700048|NCT02819635|364565066|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700049|NCT02819635|364565067|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700050|NCT02819635|364565068|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
105700051|NCT02819635|364565057|FG000|Substudy 2, Part 2|Other, not specified|0|||
105700052|NCT02819635|364565058|FG001|Substudy 2, Part 2|Other, not specified|0|||
105700053|NCT02819635|364565059|FG002|Substudy 2, Part 2|Other, not specified|0|||
105700054|NCT02819635|364565060|FG003|Substudy 2, Part 2|Other, not specified|0|||
105700055|NCT02819635|364565061|FG004|Substudy 2, Part 2|Other, not specified|0|||
105700056|NCT02819635|364565062|FG005|Substudy 2, Part 2|Other, not specified|4|||
105700057|NCT02819635|364565063|FG006|Substudy 2, Part 2|Other, not specified|8|||
105700058|NCT02819635|364565064|FG007|Substudy 2, Part 2|Other, not specified|0|||
105700059|NCT02819635|364565065|FG008|Substudy 2, Part 2|Other, not specified|0|||
105700060|NCT02819635|364565066|FG009|Substudy 2, Part 2|Other, not specified|0|||
105700061|NCT02819635|364565067|FG010|Substudy 2, Part 2|Other, not specified|0|||
105700062|NCT02819635|364565068|FG011|Substudy 2, Part 2|Other, not specified|0|||
105700063|NCT02819635|364565057|FG000|Substudy 3|Adverse Event|0|||
105700064|NCT02819635|364565058|FG001|Substudy 3|Adverse Event|0|||
105700065|NCT02819635|364565059|FG002|Substudy 3|Adverse Event|0|||
105700066|NCT02819635|364565060|FG003|Substudy 3|Adverse Event|0|||
105700067|NCT02819635|364565061|FG004|Substudy 3|Adverse Event|0|||
105700068|NCT02819635|364565062|FG005|Substudy 3|Adverse Event|0|||
105700069|NCT02819635|364565063|FG006|Substudy 3|Adverse Event|0|||
105700070|NCT02819635|364565064|FG007|Substudy 3|Adverse Event|0|||
105700071|NCT02819635|364565065|FG008|Substudy 3|Adverse Event|32|||
105700072|NCT02819635|364565066|FG009|Substudy 3|Adverse Event|3|||
105700073|NCT02819635|364565067|FG010|Substudy 3|Adverse Event|12|||
105700074|NCT02819635|364565068|FG011|Substudy 3|Adverse Event|18|||
105700075|NCT02819635|364565057|FG000|Substudy 3|Withdrew consent|0|||
105700076|NCT02819635|364565058|FG001|Substudy 3|Withdrew consent|0|||
105700077|NCT02819635|364565059|FG002|Substudy 3|Withdrew consent|0|||
105700078|NCT02819635|364565060|FG003|Substudy 3|Withdrew consent|0|||
105700079|NCT02819635|364565061|FG004|Substudy 3|Withdrew consent|0|||
105700080|NCT02819635|364565062|FG005|Substudy 3|Withdrew consent|0|||
105700081|NCT02819635|364565063|FG006|Substudy 3|Withdrew consent|0|||
105700082|NCT02819635|364565064|FG007|Substudy 3|Withdrew consent|0|||
105700083|NCT02819635|364565065|FG008|Substudy 3|Withdrew consent|11|||
105700084|NCT02819635|364565066|FG009|Substudy 3|Withdrew consent|1|||
105700085|NCT02819635|364565067|FG010|Substudy 3|Withdrew consent|4|||
105700086|NCT02819635|364565068|FG011|Substudy 3|Withdrew consent|9|||
105700087|NCT02819635|364565057|FG000|Substudy 3|Lost to Follow-up|0|||
105700088|NCT02819635|364565058|FG001|Substudy 3|Lost to Follow-up|0|||
105700089|NCT02819635|364565059|FG002|Substudy 3|Lost to Follow-up|0|||
105700090|NCT02819635|364565060|FG003|Substudy 3|Lost to Follow-up|0|||
105925350|NCT00976027|365385878|FG000|Overall Study|Protocol Violation|60|||
105925351|NCT00976027|365385879|FG001|Overall Study|Protocol Violation|27|||
105925352|NCT00976027|365385878|FG000|Overall Study|Lost to Follow-up|208|||
105925353|NCT00976027|365385879|FG001|Overall Study|Lost to Follow-up|103|||
105925354|NCT00976027|365385878|FG000|Overall Study|Withdrawal by Subject|107|||
105925355|NCT00976027|365385879|FG001|Overall Study|Withdrawal by Subject|66|||
105925356|NCT01402700|365385886|FG000|Overall Study|Death|3|||
105925357|NCT01402700|365385886|FG000|Overall Study|Withdrawal by Subject|3|||
105700091|NCT02819635|364565061|FG004|Substudy 3|Lost to Follow-up|0|||
105925358|NCT01402700|365385886|FG000|Overall Study|Missed Visit|1|||
105925359|NCT01160614|365385887|FG000|Overall Study|Withdrawal by Subject|0|||
105925360|NCT01160614|365385888|FG001|Overall Study|Withdrawal by Subject|2|||
105925361|NCT03506477|365385890|FG000|Overall Study|Withdrawal by Subject|1|||
105925362|NCT03506477|365385891|FG001|Overall Study|Withdrawal by Subject|0|||
105925363|NCT00927472|365385892|FG000|Overall Study|Withdrawal by Subject|10|||
105925364|NCT00927472|365385893|FG001|Overall Study|Withdrawal by Subject|11|||
105925365|NCT00927472|365385892|FG000|Overall Study|Lost to Follow-up|1|||
105925366|NCT00927472|365385893|FG001|Overall Study|Lost to Follow-up|6|||
105925367|NCT00927472|365385892|FG000|Overall Study|Protocol Violation|0|||
105925368|NCT00927472|365385893|FG001|Overall Study|Protocol Violation|1|||
105925369|NCT00927472|365385892|FG000|Overall Study|Post treatment Assessment out of window|0|||
106133468|NCT01823341|366146283|FG000|Overall Study|Adverse Event|1|||
105700092|NCT02819635|364565062|FG005|Substudy 3|Lost to Follow-up|0|||
105700093|NCT02819635|364565063|FG006|Substudy 3|Lost to Follow-up|0|||
105700094|NCT02819635|364565064|FG007|Substudy 3|Lost to Follow-up|0|||
105925370|NCT00927472|365385893|FG001|Overall Study|Post treatment Assessment out of window|4|||
105925371|NCT04584788|365385897|FG000|Overall Study|Physician Decision|8|||
106133469|NCT01737268|366146287|FG000|Overall Study|Adverse Event|6|||
105925372|NCT04584788|365385897|FG000|Overall Study|Withdrawal by Subject|1|||
105925373|NCT04584788|365385897|FG000|Overall Study|Adverse Event|3|||
105925374|NCT02207608|365385898|FG000|Overall Study|Adverse Event|1|||
105700095|NCT02819635|364565065|FG008|Substudy 3|Lost to Follow-up|1|||
105700096|NCT02819635|364565066|FG009|Substudy 3|Lost to Follow-up|0|||
105700097|NCT02819635|364565067|FG010|Substudy 3|Lost to Follow-up|1|||
105700098|NCT02819635|364565068|FG011|Substudy 3|Lost to Follow-up|1|||
105700099|NCT02819635|364565057|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700100|NCT02819635|364565058|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700101|NCT02819635|364565059|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700102|NCT02819635|364565060|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
105925375|NCT02207608|365385899|FG001|Overall Study|Adverse Event|0|||
106005819|NCT01247324|365684838|FG001|Overall Study|Adverse Event|35|||
106133470|NCT01737268|366146287|FG000|Overall Study|Worsening of Target Disease|2|||
106005820|NCT01247324|365684837|FG000|Overall Study|Lost to Follow-up|3|||
106005821|NCT01247324|365684838|FG001|Overall Study|Lost to Follow-up|6|||
106005822|NCT01247324|365684837|FG000|Overall Study|Study Terminated by Sponsor|4|||
106133471|NCT01737268|366146287|FG000|Overall Study|In consideration of the patient's safety|1|||
106133472|NCT01190176|366146290|FG000|Overall Study|Withdrawal by Subject|1|||
106133473|NCT01190176|366146290|FG000|Overall Study|Lost to Follow-up|1|||
106133474|NCT02081391|366146291|FG000|12-hour Treatment|Withdrawal by Subject|3|||
106133475|NCT02081391|366146292|FG001|12-hour Treatment|Withdrawal by Subject|2|||
106133476|NCT02081391|366146293|FG002|12-hour Treatment|Withdrawal by Subject|0|||
106133477|NCT02081391|366146294|FG003|12-hour Treatment|Withdrawal by Subject|0|||
106133478|NCT02081391|366146291|FG000|12-hour Treatment|Physician Decision|4|||
106133479|NCT02081391|366146292|FG001|12-hour Treatment|Physician Decision|1|||
106133480|NCT02081391|366146293|FG002|12-hour Treatment|Physician Decision|0|||
106133481|NCT02081391|366146294|FG003|12-hour Treatment|Physician Decision|0|||
106133482|NCT02081391|366146291|FG000|12-hour Treatment|Lack of Efficacy|3|||
106133483|NCT02081391|366146292|FG001|12-hour Treatment|Lack of Efficacy|0|||
106133484|NCT02081391|366146293|FG002|12-hour Treatment|Lack of Efficacy|0|||
106133485|NCT02081391|366146294|FG003|12-hour Treatment|Lack of Efficacy|0|||
106133486|NCT02081391|366146291|FG000|12-hour Treatment|Adverse Event|4|||
106133487|NCT02081391|366146292|FG001|12-hour Treatment|Adverse Event|2|||
106133488|NCT02081391|366146293|FG002|12-hour Treatment|Adverse Event|0|||
106133489|NCT02081391|366146294|FG003|12-hour Treatment|Adverse Event|0|||
106133490|NCT02081391|366146291|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
106133491|NCT02081391|366146292|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
106133492|NCT02081391|366146293|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
106133493|NCT02081391|366146294|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
106133494|NCT02081391|366146291|FG000|12-hour Treatment|Further reasons|2|||
106133495|NCT02081391|366146292|FG001|12-hour Treatment|Further reasons|1|||
106133496|NCT02081391|366146293|FG002|12-hour Treatment|Further reasons|0|||
106133497|NCT02081391|366146294|FG003|12-hour Treatment|Further reasons|0|||
106133498|NCT02081391|366146291|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
106133499|NCT02081391|366146292|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
106133500|NCT02081391|366146293|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
106133501|NCT02081391|366146294|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
106133502|NCT02081391|366146291|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
106133503|NCT02081391|366146292|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
106133504|NCT02081391|366146293|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
106133505|NCT02081391|366146294|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
106133506|NCT02081391|366146291|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
106133507|NCT02081391|366146292|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
106133508|NCT02081391|366146293|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
106133509|NCT02081391|366146294|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
106133510|NCT02081391|366146291|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
106133511|NCT02081391|366146292|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
106133512|NCT02081391|366146293|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
106133513|NCT02081391|366146294|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
106133514|NCT02081391|366146291|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
106133515|NCT02081391|366146292|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
106133516|NCT02081391|366146293|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
106133517|NCT02081391|366146294|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
106133518|NCT02081391|366146291|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
106133519|NCT02081391|366146292|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
106133520|NCT02081391|366146293|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
106133521|NCT02081391|366146294|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
106133522|NCT00665561|366146295|FG000|Overall Study|Death recorded on subject summary pages|75|||
106133523|NCT00665561|366146296|FG001|Overall Study|Death recorded on subject summary pages|75|||
106133524|NCT00665561|366146295|FG000|Overall Study|Does not meet entrance criteria|19|||
106133525|NCT00665561|366146296|FG001|Overall Study|Does not meet entrance criteria|21|||
106133526|NCT00665561|366146295|FG000|Overall Study|Lost to Follow-up|203|||
106133527|NCT00665561|366146296|FG001|Overall Study|Lost to Follow-up|264|||
106133528|NCT00665561|366146295|FG000|Overall Study|Withdrawal by Subject|74|||
106133529|NCT00665561|366146296|FG001|Overall Study|Withdrawal by Subject|65|||
106133530|NCT00665561|366146295|FG000|Overall Study|Other|123|||
106133531|NCT00665561|366146296|FG001|Overall Study|Other|108|||
106133532|NCT00665561|366146295|FG000|Overall Study|Site closed|8|||
106133533|NCT00665561|366146296|FG001|Overall Study|Site closed|0|||
106133534|NCT00665561|366146295|FG000|Overall Study|Withdrawn due to pregnancy|0|||
106133535|NCT00665561|366146296|FG001|Overall Study|Withdrawn due to pregnancy|1|||
106133536|NCT04155424|366146300|FG000|Overall Study|Other than specified|3|||
106005823|NCT01247324|365684838|FG001|Overall Study|Study Terminated by Sponsor|1|||
105700103|NCT02819635|364565061|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700104|NCT02819635|364565062|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700105|NCT02819635|364565063|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700106|NCT02819635|364565064|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700107|NCT02819635|364565065|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700108|NCT02819635|364565066|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700109|NCT02819635|364565067|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
105700110|NCT02819635|364565068|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
105700111|NCT02819635|364565057|FG000|Substudy 3|Other, not specified|0|||
105700112|NCT02819635|364565058|FG001|Substudy 3|Other, not specified|0|||
105700113|NCT02819635|364565059|FG002|Substudy 3|Other, not specified|0|||
105700114|NCT02819635|364565060|FG003|Substudy 3|Other, not specified|0|||
105700115|NCT02819635|364565061|FG004|Substudy 3|Other, not specified|0|||
105700116|NCT02819635|364565062|FG005|Substudy 3|Other, not specified|0|||
105700117|NCT02819635|364565063|FG006|Substudy 3|Other, not specified|0|||
105700118|NCT02819635|364565064|FG007|Substudy 3|Other, not specified|0|||
105700119|NCT02819635|364565065|FG008|Substudy 3|Other, not specified|202|||
105700120|NCT02819635|364565066|FG009|Substudy 3|Other, not specified|5|||
105700121|NCT02819635|364565067|FG010|Substudy 3|Other, not specified|89|||
105700122|NCT02819635|364565068|FG011|Substudy 3|Other, not specified|39|||
105700123|NCT02164929|364565073|FG000|Overall Study|Converted to open procedure|1|||
105700124|NCT02164929|364565074|FG001|Overall Study|Converted to open procedure|0|||
105700125|NCT02164929|364565075|FG002|Overall Study|Converted to open procedure|0|||
105700126|NCT02164929|364565076|FG003|Overall Study|Converted to open procedure|2|||
105700127|NCT02164929|364565073|FG000|Overall Study|Failed regional block|0|||
105700128|NCT02164929|364565074|FG001|Overall Study|Failed regional block|0|||
105700129|NCT02164929|364565075|FG002|Overall Study|Failed regional block|1|||
105700130|NCT02164929|364565076|FG003|Overall Study|Failed regional block|0|||
105700131|NCT02969187|364565077|FG000|Overall Study|Physician Decision|12|||
105700132|NCT02969187|364565078|FG001|Overall Study|Physician Decision|13|||
105700133|NCT01486927|364565079|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
105700134|NCT01486927|364565079|FG000|Overall Study|Physician Decision|1|||
105700135|NCT01486927|364565079|FG000|Overall Study|50 Exposure days not reached|2|||
105700136|NCT01486927|364565079|FG000|Overall Study|Withdrawal by Subject|8|||
105700137|NCT01486927|364565079|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
105700138|NCT00365456|364565080|FG000|Trial Period I (12 Months)|Adverse Event|84|||
105700139|NCT00365456|364565081|FG001|Trial Period I (12 Months)|Adverse Event|0|||
105700140|NCT00365456|364565080|FG000|Trial Period I (12 Months)|Non-compliance|3|||
105700141|NCT00365456|364565081|FG001|Trial Period I (12 Months)|Non-compliance|0|||
105700142|NCT00365456|364565080|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
105700143|NCT00365456|364565081|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
105700144|NCT00365456|364565080|FG000|Trial Period I (12 Months)|Other|11|||
105700145|NCT00365456|364565081|FG001|Trial Period I (12 Months)|Other|0|||
105700146|NCT00365456|364565080|FG000|Trial Period II (12 Months)|Adverse Event|0|||
105700147|NCT00365456|364565081|FG001|Trial Period II (12 Months)|Adverse Event|6|||
105700148|NCT00365456|364565080|FG000|Trial Period II (12 Months)|Non-compliance|0|||
105700149|NCT00365456|364565081|FG001|Trial Period II (12 Months)|Non-compliance|2|||
105700150|NCT00365456|364565080|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
105700151|NCT00365456|364565081|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
105700152|NCT00365456|364565080|FG000|Trial Period II (12 Months)|Other|0|||
105700153|NCT00365456|364565081|FG001|Trial Period II (12 Months)|Other|1|||
105700154|NCT00365456|364565080|FG000|Trial Period III (12 Months)|Adverse Event|13|||
105700155|NCT00365456|364565081|FG001|Trial Period III (12 Months)|Adverse Event|3|||
105700156|NCT00365456|364565080|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
105700157|NCT00365456|364565081|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
105700158|NCT00365456|364565080|FG000|Trial Period III (12 Months)|Other|1|||
105700159|NCT00365456|364565081|FG001|Trial Period III (12 Months)|Other|1|||
105700160|NCT03668600|364565082|FG000|Overall Study|Study Terminated by the Sponsor|157|||
105700161|NCT03668600|364565082|FG000|Overall Study|Protocol Violation|1|||
105700162|NCT03668600|364565082|FG000|Overall Study|Pregnancy|1|||
105700163|NCT03668600|364565082|FG000|Overall Study|Lost to Follow-up|7|||
105700164|NCT03668600|364565082|FG000|Overall Study|Withdrawal by Subject|56|||
105700165|NCT03668600|364565082|FG000|Overall Study|Lack of Efficacy|7|||
105700166|NCT03668600|364565082|FG000|Overall Study|Adverse Event|1|||
105700167|NCT02234284|364565084|FG000|Overall Study|Death|4|||
105700168|NCT02234284|364565085|FG001|Overall Study|Death|2|||
105700169|NCT02234284|364565084|FG000|Overall Study|Withdrawal by Subject|1|||
105700170|NCT02234284|364565085|FG001|Overall Study|Withdrawal by Subject|0|||
105700171|NCT02234284|364565084|FG000|Overall Study|Lost to Follow-up|20|||
105700172|NCT02234284|364565085|FG001|Overall Study|Lost to Follow-up|7|||
105700173|NCT01476475|364565086|FG000|Overall Study|Adverse Event|6|||
105700174|NCT01476475|364565087|FG001|Overall Study|Adverse Event|0|||
105700175|NCT01476475|364565086|FG000|Overall Study|Poor compliance to protocol|1|||
105700176|NCT01476475|364565087|FG001|Overall Study|Poor compliance to protocol|1|||
105700177|NCT01476475|364565086|FG000|Overall Study|Other reasons|4|||
105700178|NCT01476475|364565087|FG001|Overall Study|Other reasons|2|||
106133537|NCT04155424|366146300|FG000|Overall Study|Withdrawal by Subject|1|||
105700179|NCT02577406|364565088|FG000|Randomized Period|Death|1|||
105700180|NCT02577406|364565089|FG001|Randomized Period|Death|0|||
105700181|NCT02577406|364565088|FG000|Randomized Period|Other reasons|0|||
105700182|NCT02577406|364565089|FG001|Randomized Period|Other reasons|20|||
105700183|NCT02577406|364565088|FG000|Treatment Period|Death|38|||
105700184|NCT02577406|364565089|FG001|Treatment Period|Death|23|||
105700185|NCT02577406|364565088|FG000|Treatment Period|Adverse Event|17|||
105700186|NCT02577406|364565089|FG001|Treatment Period|Adverse Event|12|||
105700187|NCT02577406|364565088|FG000|Treatment Period|Progressive Disease|53|||
105700188|NCT02577406|364565089|FG001|Treatment Period|Progressive Disease|37|||
105700189|NCT02577406|364565088|FG000|Treatment Period|Withdrawal by Subject|10|||
105700190|NCT02577406|364565089|FG001|Treatment Period|Withdrawal by Subject|24|||
105700191|NCT02577406|364565088|FG000|Treatment Period|Lost to Follow-up|0|||
105700192|NCT02577406|364565089|FG001|Treatment Period|Lost to Follow-up|1|||
105700193|NCT02577406|364565088|FG000|Treatment Period|Transition to commercially available treatment|1|||
105700194|NCT02577406|364565089|FG001|Treatment Period|Transition to commercially available treatment|1|||
105700195|NCT02577406|364565088|FG000|Treatment Period|Physician Decision|1|||
105700196|NCT02577406|364565089|FG001|Treatment Period|Physician Decision|0|||
105700197|NCT02577406|364565088|FG000|Treatment Period|Disease Relapse|28|||
105700198|NCT02577406|364565089|FG001|Treatment Period|Disease Relapse|1|||
105700199|NCT02577406|364565088|FG000|Treatment Period|Protocol Violation|0|||
105700200|NCT02577406|364565089|FG001|Treatment Period|Protocol Violation|1|||
105700201|NCT02577406|364565088|FG000|Treatment Period|Other Reasons|3|||
105700202|NCT02577406|364565089|FG001|Treatment Period|Other Reasons|39|||
105700203|NCT02577406|364565088|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
105700204|NCT02577406|364565089|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
105700205|NCT05291689|364565092|FG000|Overall Study|Adverse Event|3|||
105700206|NCT05291689|364565092|FG000|Overall Study|Lack of Efficacy|10|||
105700207|NCT05291689|364565092|FG000|Overall Study|Withdrawal by Subject|4|||
105700208|NCT05500274|364565093|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
105700209|NCT05500274|364565094|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
105700210|NCT05500274|364565093|FG000|Overall Study|Lost to Follow-up|76|||
105700211|NCT05500274|364565094|FG001|Overall Study|Lost to Follow-up|51|||
105700212|NCT01816061|364565097|FG000|Overall Study|Lost to Follow-up|13|||
105700213|NCT01816061|364565098|FG001|Overall Study|Lost to Follow-up|24|||
105700214|NCT01265615|364565099|FG000|Overall Study|Protocol Violation|2|||
105700215|NCT01265615|364565100|FG001|Overall Study|Protocol Violation|2|||
105700216|NCT01265615|364565101|FG002|Overall Study|Protocol Violation|4|||
105700217|NCT01265615|364565102|FG003|Overall Study|Protocol Violation|3|||
105700218|NCT02576444|364565105|FG000|Overall Study|Death|1|||
105700219|NCT02576444|364565106|FG001|Overall Study|Death|1|||
105700220|NCT02576444|364565107|FG002|Overall Study|Death|0|||
105700221|NCT02576444|364565108|FG003|Overall Study|Death|0|||
105700222|NCT02576444|364565105|FG000|Overall Study|Withdrawal by Subject|0|||
105700223|NCT02576444|364565106|FG001|Overall Study|Withdrawal by Subject|0|||
105700224|NCT02576444|364565107|FG002|Overall Study|Withdrawal by Subject|2|||
105700225|NCT02576444|364565108|FG003|Overall Study|Withdrawal by Subject|0|||
105925376|NCT00632359|365385902|FG000|Overall Study|Withdrawal by Subject|2|||
105925377|NCT04167670|365387831|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
105925378|NCT04167670|365387832|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
105925379|NCT04167670|365387833|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
105925380|NCT04167670|365387831|FG000|Overall Study|Significant protocol deviation|3|||
105925381|NCT04167670|365387832|FG001|Overall Study|Significant protocol deviation|1|||
105925382|NCT04167670|365387833|FG002|Overall Study|Significant protocol deviation|0|||
105925383|NCT04167670|365387831|FG000|Overall Study|Lost to Follow-up|0|||
105925384|NCT04167670|365387832|FG001|Overall Study|Lost to Follow-up|3|||
105925385|NCT04167670|365387833|FG002|Overall Study|Lost to Follow-up|3|||
105925386|NCT04167670|365387831|FG000|Overall Study|Voluntary Withdrawal|0|||
105925387|NCT04167670|365387832|FG001|Overall Study|Voluntary Withdrawal|1|||
105925388|NCT04167670|365387833|FG002|Overall Study|Voluntary Withdrawal|1|||
105925389|NCT04167670|365387831|FG000|Overall Study|Withdrawal of Consent|4|||
105925390|NCT04167670|365387832|FG001|Overall Study|Withdrawal of Consent|1|||
105925391|NCT04167670|365387833|FG002|Overall Study|Withdrawal of Consent|3|||
105925392|NCT04167670|365387831|FG000|Overall Study|Miscellaneous|7|||
105925393|NCT04167670|365387832|FG001|Overall Study|Miscellaneous|5|||
105925394|NCT04167670|365387833|FG002|Overall Study|Miscellaneous|3|||
105925395|NCT01127061|365387834|FG000|Overall Study|Lost to Follow-up|7|||
105925396|NCT01127061|365387835|FG001|Overall Study|Lost to Follow-up|10|||
106133538|NCT04155424|366146300|FG000|Overall Study|Adverse Event|1|||
105700226|NCT02576444|364565105|FG000|Overall Study|Adverse Event|0|||
105700227|NCT02576444|364565106|FG001|Overall Study|Adverse Event|0|||
105700228|NCT02576444|364565107|FG002|Overall Study|Adverse Event|1|||
105925397|NCT01127061|365387834|FG000|Overall Study|Physician Decision|3|||
105925398|NCT01127061|365387835|FG001|Overall Study|Physician Decision|3|||
105925399|NCT03595748|365387836|FG000|Overall Study|Death|11|||
105925400|NCT03595748|365387837|FG001|Overall Study|Death|12|||
105700229|NCT02576444|364565108|FG003|Overall Study|Adverse Event|0|||
105700230|NCT02576444|364565105|FG000|Overall Study|Physician Decision|0|||
105700231|NCT02576444|364565106|FG001|Overall Study|Physician Decision|0|||
105700232|NCT02576444|364565107|FG002|Overall Study|Physician Decision|1|||
105700233|NCT02576444|364565108|FG003|Overall Study|Physician Decision|0|||
105700234|NCT02953340|364565109|FG000|Overall Study|Death|0|||
105700235|NCT02953340|364565110|FG001|Overall Study|Death|1|||
105700236|NCT02953340|364565109|FG000|Overall Study|Investigator Decision|3|||
105700237|NCT02953340|364565110|FG001|Overall Study|Investigator Decision|3|||
105700238|NCT02953340|364565109|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
105787237|NCT03110107|364874913|FG024|Treatment Period|Participants no longer meets study criteria|0|||
105787238|NCT03110107|364874914|FG025|Treatment Period|Participants no longer meets study criteria|0|||
105787239|NCT03110107|364874889|FG000|Treatment Period|Other Reasons|0|||
105787240|NCT03110107|364874890|FG001|Treatment Period|Other Reasons|0|||
105787241|NCT03110107|364874891|FG002|Treatment Period|Other Reasons|1|||
105925401|NCT03595748|365387836|FG000|Overall Study|Withdrawal by Subject|28|||
105925402|NCT03595748|365387837|FG001|Overall Study|Withdrawal by Subject|29|||
105925403|NCT03595748|365387836|FG000|Overall Study|Protocol Violation|0|||
105925404|NCT03595748|365387837|FG001|Overall Study|Protocol Violation|1|||
105925405|NCT00549055|365387840|FG000|Overall Study|Adverse Event|4|||
105925406|NCT00549055|365387840|FG000|Overall Study|Lack of Efficacy|18|||
105925407|NCT00549055|365387840|FG000|Overall Study|Stabilization|5|||
105925408|NCT00549055|365387840|FG000|Overall Study|Progression to fibrosis|2|||
105925409|NCT00549055|365387840|FG000|Overall Study|Decrease of size|1|||
105925410|NCT00549055|365387840|FG000|Overall Study|Active choroidal neovascula increased|1|||
105925411|NCT00549055|365387840|FG000|Overall Study|Vitreous hemorrhage|1|||
105925412|NCT00549055|365387840|FG000|Overall Study|Growth choroidal neovascularisation|1|||
105925413|NCT00549055|365387840|FG000|Overall Study|Choroidal neovascularization|1|||
105925414|NCT00549055|365387840|FG000|Overall Study|Very low visual acuity (VA)|1|||
105925415|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
105925416|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
105925417|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
105925418|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
105925419|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
105925420|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
105925421|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
105925422|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
105925423|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
105925424|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
105925425|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
105925426|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
105925427|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
105925428|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
105925429|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
105925430|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
105925431|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
105925432|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
105925433|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
105925434|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
105925435|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
105925436|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
105925437|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
105925438|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
105925439|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
105925440|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
105925441|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
105925442|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
105925443|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
105925444|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
105925445|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
106005824|NCT01247324|365684837|FG000|Overall Study|Missing|2|||
105787242|NCT03110107|364874892|FG003|Treatment Period|Other Reasons|1|||
105700239|NCT02953340|364565110|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
105700240|NCT02953340|364565109|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
105700241|NCT02953340|364565110|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
105787243|NCT03110107|364874893|FG004|Treatment Period|Other Reasons|0|||
105700242|NCT02953340|364565109|FG000|Overall Study|Withdrawal by Subject|9|||
105787244|NCT03110107|364874894|FG005|Treatment Period|Other Reasons|1|||
105700243|NCT02953340|364565110|FG001|Overall Study|Withdrawal by Subject|9|||
105700244|NCT02953340|364565109|FG000|Overall Study|Sponsor decision|0|||
105700245|NCT02953340|364565110|FG001|Overall Study|Sponsor decision|2|||
105700246|NCT02953340|364565109|FG000|Overall Study|Lost to Follow-up|3|||
105700247|NCT02953340|364565110|FG001|Overall Study|Lost to Follow-up|2|||
105700248|NCT02953340|364565109|FG000|Overall Study|Reason not specified|2|||
105700249|NCT02953340|364565110|FG001|Overall Study|Reason not specified|2|||
105700250|NCT03370120|364565111|FG000|Overall Study|Adverse event, non-fatal|24|||
105700251|NCT03370120|364565111|FG000|Overall Study|Withdrawal by Subject|6|||
105700252|NCT03370120|364565111|FG000|Overall Study|Lost to Follow-up|1|||
105700253|NCT03370120|364565111|FG000|Overall Study|Lack of Efficacy|37|||
105700254|NCT03370120|364565111|FG000|Overall Study|Per sponsor's instructions|1|||
105700255|NCT03370120|364565111|FG000|Overall Study|Study was terminated by parent company UCB|2|||
105700256|NCT03370120|364565111|FG000|Overall Study|The study was ended by the promoter|3|||
105700257|NCT03370120|364565111|FG000|Overall Study|Discontinuation of drug development|3|||
105700258|NCT03370120|364565111|FG000|Overall Study|End of project|2|||
105700259|NCT03370120|364565111|FG000|Overall Study|Premature study closure|2|||
105700260|NCT03370120|364565111|FG000|Overall Study|Premature program termination|1|||
105700261|NCT03370120|364565111|FG000|Overall Study|Premature study termination|7|||
105700262|NCT03370120|364565111|FG000|Overall Study|Trial terminated by sponsor|2|||
105700263|NCT03370120|364565111|FG000|Overall Study|Trial discontinued by sponsor|2|||
105700264|NCT03370120|364565111|FG000|Overall Study|Study ended|15|||
105700265|NCT03370120|364565111|FG000|Overall Study|Clinical trial has been cancelled|1|||
105700266|NCT03370120|364565111|FG000|Overall Study|End of study per sponsor decision|2|||
105700267|NCT03370120|364565111|FG000|Overall Study|Promoter's decision|2|||
105700268|NCT03370120|364565111|FG000|Overall Study|The trial has been suspended|3|||
105700269|NCT03370120|364565111|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
105700270|NCT03370120|364565111|FG000|Overall Study|Early termination by order of sponsor|2|||
105700271|NCT03370120|364565111|FG000|Overall Study|Discontinuation of the study|5|||
105700272|NCT03370120|364565111|FG000|Overall Study|End of clinical trial discontinuation|1|||
105700273|NCT03370120|364565111|FG000|Overall Study|Because the clinical trial ended halfway|4|||
105700274|NCT03370120|364565111|FG000|Overall Study|Development discontinued|5|||
105700275|NCT03370120|364565111|FG000|Overall Study|Padsenovil program closed|3|||
105700276|NCT03370120|364565111|FG000|Overall Study|End of project|2|||
105700277|NCT03370120|364565111|FG000|Overall Study|Termination of project|1|||
105700278|NCT03370120|364565111|FG000|Overall Study|The study was interrupted by sponsor|4|||
105700279|NCT03370120|364565111|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
105700280|NCT03370120|364565111|FG000|Overall Study|End of sponsor decision|1|||
105700281|NCT03370120|364565111|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
105700282|NCT03370120|364565111|FG000|Overall Study|Early termination of studies|5|||
105700283|NCT03370120|364565111|FG000|Overall Study|This study is ended early|1|||
105700284|NCT03370120|364565111|FG000|Overall Study|End of padsevonil program|2|||
105700285|NCT03370120|364565111|FG000|Overall Study|Decision of sponsor|6|||
105700286|NCT03370120|364565111|FG000|Overall Study|Asked by the sponsor|3|||
105700287|NCT03370120|364565111|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
105700288|NCT03370120|364565111|FG000|Overall Study|PI decision poor compliance from participant|1|||
105700289|NCT03370120|364565111|FG000|Overall Study|Promoter ended the study|3|||
105700290|NCT03370120|364565111|FG000|Overall Study|Premature study close by sponsor's decision|4|||
105925446|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
105925447|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
105925448|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
105925449|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
105925450|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
105925451|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
106133539|NCT05567952|366148087|FG000|Overall Study|Lost to Follow-up|3|||
106133540|NCT05567952|366148088|FG001|Overall Study|Lost to Follow-up|2|||
105925452|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
105925453|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
105925454|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
105925455|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
105925456|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
105925457|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
105925458|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
105925459|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
105925460|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
105925461|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
106133541|NCT05567952|366148087|FG000|Overall Study|Withdrawal by Subject|6|||
105700291|NCT03370120|364565111|FG000|Overall Study|Study terminated by sponsor|33|||
105700292|NCT03370120|364565111|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
105700293|NCT03370120|364565111|FG000|Overall Study|Sponsor decision to terminate study|63|||
105700294|NCT03370120|364565111|FG000|Overall Study|Program closure|3|||
105700295|NCT03370120|364565111|FG000|Overall Study|Study ended prematurely|1|||
105700296|NCT03370120|364565111|FG000|Overall Study|Study stopped by sponsor|2|||
105700297|NCT03370120|364565111|FG000|Overall Study|Program termination|55|||
105700298|NCT03370120|364565111|FG000|Overall Study|Sponsor decision|62|||
105700299|NCT03370120|364565111|FG000|Overall Study|Sponsor study closure|10|||
105700300|NCT00454857|364565112|FG000|Overall Study|Withdrawal by Subject|15|||
105700301|NCT00454857|364565112|FG000|Overall Study|Lost to Follow-up|16|||
105700302|NCT00454857|364565112|FG000|Overall Study|Noncompliance|6|||
105700303|NCT00454857|364565112|FG000|Overall Study|Death|5|||
105700304|NCT00454857|364565112|FG000|Overall Study|Other|11|||
105700305|NCT00454857|364565112|FG000|Overall Study|Reason unknown|1|||
105700306|NCT04206020|364565114|FG000|Overall Study|Adverse Event|1|||
105700307|NCT04206020|364565115|FG001|Overall Study|Adverse Event|4|||
105700308|NCT04206020|364565114|FG000|Overall Study|Protocol Violation|2|||
105700309|NCT04206020|364565115|FG001|Overall Study|Protocol Violation|0|||
105700310|NCT04206020|364565114|FG000|Overall Study|Withdrawal by Subject|2|||
105700311|NCT04206020|364565115|FG001|Overall Study|Withdrawal by Subject|0|||
105700312|NCT04206020|364565114|FG000|Overall Study|Lost to Follow-up|2|||
105700313|NCT04206020|364565115|FG001|Overall Study|Lost to Follow-up|0|||
105700314|NCT04206020|364565114|FG000|Overall Study|Pregnancy|0|||
105700315|NCT04206020|364565115|FG001|Overall Study|Pregnancy|1|||
105700316|NCT04206020|364565114|FG000|Overall Study|Unable to attend visits|1|||
105700317|NCT04206020|364565115|FG001|Overall Study|Unable to attend visits|2|||
105700318|NCT00829179|364565116|FG000|Overall Study|Withdrawal by Subject|1|||
105700319|NCT00928889|364565117|FG000|Overall Study|Lost to Follow-up|3|||
105700320|NCT00928889|364565118|FG001|Overall Study|Lost to Follow-up|1|||
105700321|NCT00928889|364565117|FG000|Overall Study|Protocol Violation|0|||
105700322|NCT00928889|364565118|FG001|Overall Study|Protocol Violation|1|||
105700323|NCT00928889|364565117|FG000|Overall Study|Adverse Event|1|||
105700324|NCT00928889|364565118|FG001|Overall Study|Adverse Event|0|||
105700325|NCT00928889|364565117|FG000|Overall Study|Other|1|||
105700326|NCT00928889|364565118|FG001|Overall Study|Other|0|||
105700327|NCT02700412|364565119|FG000|Overall Study|Adverse Event|6|||
105700328|NCT02700412|364565119|FG000|Overall Study|Death|1|||
105700329|NCT02700412|364565119|FG000|Overall Study|Lack of Efficacy|19|||
105700330|NCT02700412|364565119|FG000|Overall Study|Protocol Violation|5|||
105700331|NCT02700412|364565119|FG000|Overall Study|Withdrawal by Subject|2|||
105700332|NCT04416555|364565120|FG000|Overall Study|Withdrawal by Subject|0|||
105700333|NCT04416555|364565121|FG001|Overall Study|Withdrawal by Subject|3|||
105700334|NCT01517893|364565128|FG000|Overall Study|Withdrawal by Subject|3|||
105700335|NCT01517893|364565129|FG001|Overall Study|Withdrawal by Subject|0|||
105700336|NCT00865904|364565133|FG000|Overall Study|Randomized but not Treated|2|||
105700337|NCT00865904|364565134|FG001|Overall Study|Randomized but not Treated|0|||
105700338|NCT00865904|364565135|FG002|Overall Study|Randomized but not Treated|0|||
105700339|NCT00865904|364565136|FG003|Overall Study|Randomized but not Treated|1|||
105700340|NCT00865904|364565137|FG004|Overall Study|Randomized but not Treated|1|||
105700341|NCT04206605|364565138|FG000|Overall Study|Adverse Event|0|||
105700342|NCT04206605|364565139|FG001|Overall Study|Adverse Event|1|||
105700343|NCT04206605|364565138|FG000|Overall Study|Withdrawal by Subject|1|||
105700344|NCT04206605|364565139|FG001|Overall Study|Withdrawal by Subject|0|||
105700345|NCT00942175|364565141|FG000|Overall Study|Adverse Event|2|||
105700346|NCT00942175|364565142|FG001|Overall Study|Adverse Event|1|||
105700347|NCT00942175|364565143|FG002|Overall Study|Adverse Event|0|||
105700348|NCT00942175|364565144|FG003|Overall Study|Adverse Event|0|||
105700349|NCT00942175|364565141|FG000|Overall Study|Protocol Violation|0|||
105700350|NCT00942175|364565142|FG001|Overall Study|Protocol Violation|1|||
105700351|NCT00942175|364565143|FG002|Overall Study|Protocol Violation|2|||
105700352|NCT00942175|364565144|FG003|Overall Study|Protocol Violation|0|||
105700353|NCT00942175|364565141|FG000|Overall Study|Pregnancy|0|||
105700354|NCT00942175|364565142|FG001|Overall Study|Pregnancy|0|||
105700355|NCT00942175|364565143|FG002|Overall Study|Pregnancy|0|||
105700356|NCT00942175|364565144|FG003|Overall Study|Pregnancy|1|||
105925462|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
105925463|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
105925464|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
105925465|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
105925466|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
105700357|NCT00942175|364565141|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
105700358|NCT00942175|364565142|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
105925467|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
105700359|NCT00942175|364565143|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
105700360|NCT00942175|364565144|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
105700361|NCT00942175|364565141|FG000|Overall Study|Low Platelet Count|0|||
105700362|NCT00942175|364565142|FG001|Overall Study|Low Platelet Count|2|||
105700363|NCT00942175|364565143|FG002|Overall Study|Low Platelet Count|0|||
105700364|NCT00942175|364565144|FG003|Overall Study|Low Platelet Count|0|||
105925468|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
106005825|NCT01247324|365684838|FG001|Overall Study|Missing|1|||
106005826|NCT00948064|365686432|FG000|Phase I|No treatment received|1|||
105925469|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
105925470|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
106005827|NCT00948064|365686433|FG001|Phase I|No treatment received|0|||
106005828|NCT00948064|365686434|FG002|Phase I|No treatment received|0|||
106005829|NCT00948064|365686432|FG000|Phase II|Physician Decision|0|||
106005830|NCT00948064|365686433|FG001|Phase II|Physician Decision|0|||
106005831|NCT00948064|365686434|FG002|Phase II|Physician Decision|1|||
106005832|NCT00948064|365686432|FG000|Phase II|Withdrawal by Subject|0|||
105925471|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
105925472|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
105925473|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
105925474|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
105925475|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
105925476|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
105925477|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
106005833|NCT00948064|365686433|FG001|Phase II|Withdrawal by Subject|1|||
106005834|NCT00948064|365686434|FG002|Phase II|Withdrawal by Subject|0|||
106005835|NCT03409796|365686437|FG000|Overall Study|Adverse Event|2|||
106005836|NCT03409796|365686438|FG001|Overall Study|Adverse Event|0|||
106005837|NCT03409796|365686437|FG000|Overall Study|Other|0|||
106005838|NCT03409796|365686438|FG001|Overall Study|Other|1|||
106005839|NCT01352117|365686439|FG000|Overall Study|Death|15|||
106005840|NCT01352117|365686440|FG001|Overall Study|Death|16|||
106005841|NCT01352117|365686439|FG000|Overall Study|Withdrawal by Subject|1|||
106005842|NCT01352117|365686440|FG001|Overall Study|Withdrawal by Subject|0|||
106005843|NCT01352117|365686439|FG000|Overall Study|Lost to Follow-up|2|||
106005844|NCT01352117|365686440|FG001|Overall Study|Lost to Follow-up|7|||
106005845|NCT01352117|365686439|FG000|Overall Study|Non-adherent to study requirements|1|||
106005846|NCT01352117|365686440|FG001|Overall Study|Non-adherent to study requirements|1|||
106005847|NCT01352117|365686439|FG000|Overall Study|Did not initiate study treatment|1|||
106005848|NCT01352117|365686440|FG001|Overall Study|Did not initiate study treatment|0|||
106005849|NCT01352117|365686439|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
106005850|NCT01352117|365686440|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
106005851|NCT00633477|365686441|FG000|Overall Study|Death|1|||
106005852|NCT00633477|365686442|FG001|Overall Study|Death|0|||
106005853|NCT00633477|365686441|FG000|Overall Study|Randomized but not treated|1|||
106005854|NCT00633477|365686442|FG001|Overall Study|Randomized but not treated|0|||
106005855|NCT04906499|365686451|FG000|Overall Study|Lack of time|1|||
106005856|NCT01766050|365686452|FG000|Overall Study|Adverse Event|1|||
106005857|NCT01766050|365686452|FG000|Overall Study|Lost to Follow-up|1|||
106005858|NCT01766050|365686452|FG000|Overall Study|Withdrawal by Subject|2|||
106005859|NCT00179621|365686453|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
106005860|NCT00179621|365686454|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
106005861|NCT00179621|365686455|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
106005862|NCT00179621|365686456|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
106005863|NCT00179621|365686453|FG000|Double-Blind Period|Adverse Event|2|||
106005864|NCT00179621|365686454|FG001|Double-Blind Period|Adverse Event|7|||
106005865|NCT00179621|365686455|FG002|Double-Blind Period|Adverse Event|4|||
106005866|NCT00179621|365686456|FG003|Double-Blind Period|Adverse Event|0|||
106005867|NCT00179621|365686453|FG000|Double-Blind Period|Withdrawal by Subject|2|||
106005868|NCT00179621|365686454|FG001|Double-Blind Period|Withdrawal by Subject|1|||
106005869|NCT00179621|365686455|FG002|Double-Blind Period|Withdrawal by Subject|3|||
106005870|NCT00179621|365686456|FG003|Double-Blind Period|Withdrawal by Subject|0|||
106005871|NCT00179621|365686453|FG000|Double-Blind Period|Death|0|||
106005872|NCT00179621|365686454|FG001|Double-Blind Period|Death|1|||
106005873|NCT00179621|365686455|FG002|Double-Blind Period|Death|2|||
106005874|NCT00179621|365686456|FG003|Double-Blind Period|Death|0|||
106005875|NCT00179621|365686453|FG000|Double-Blind Period|Protocol Violation|1|||
106005876|NCT00179621|365686454|FG001|Double-Blind Period|Protocol Violation|0|||
105925478|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
106005877|NCT00179621|365686455|FG002|Double-Blind Period|Protocol Violation|0|||
106005878|NCT00179621|365686456|FG003|Double-Blind Period|Protocol Violation|0|||
106005879|NCT00179621|365686453|FG000|Double-Blind Period|Other|0|||
106005880|NCT00179621|365686454|FG001|Double-Blind Period|Other|2|||
106005881|NCT00179621|365686455|FG002|Double-Blind Period|Other|2|||
106005882|NCT00179621|365686456|FG003|Double-Blind Period|Other|0|||
106005883|NCT00179621|365686453|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
106005884|NCT00179621|365686454|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
106005885|NCT00179621|365686455|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
106133542|NCT05567952|366148088|FG001|Overall Study|Withdrawal by Subject|3|||
106133543|NCT05567952|366148087|FG000|Overall Study|Other|3|||
106005886|NCT00179621|365686456|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
106005887|NCT00179621|365686453|FG000|Open-Label Period|Adverse Event|0|||
105925479|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
105925480|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
105700365|NCT02973087|364565149|FG000|Overall Study|Withdrawal by Subject|2|||
105700366|NCT02973087|364565150|FG001|Overall Study|Withdrawal by Subject|1|||
105700367|NCT02973087|364565149|FG000|Overall Study|Adverse Event|1|||
105700368|NCT02973087|364565150|FG001|Overall Study|Adverse Event|0|||
105700369|NCT02973087|364565149|FG000|Overall Study|other|1|||
105700370|NCT02973087|364565150|FG001|Overall Study|other|1|||
105700371|NCT00450723|364565152|FG000|Overall Study|Physician Decision|5|||
105700372|NCT01473563|364565153|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
105700373|NCT02536313|364565154|FG000|Overall Study|Lack of Efficacy|0|||
105700374|NCT02536313|364565155|FG001|Overall Study|Lack of Efficacy|1|||
105700375|NCT04143009|364565159|FG000|Pilot Trial|Lost to Follow-up|0|||
105700376|NCT04143009|364565160|FG001|Pilot Trial|Lost to Follow-up|1|||
105700377|NCT04143009|364565161|FG002|Pilot Trial|Lost to Follow-up|1|||
105700378|NCT01357655|364565162|FG000|Overall Study|Administrative Reason by Sponsor|45|||
105700379|NCT01357655|364565163|FG001|Overall Study|Administrative Reason by Sponsor|0|||
105700380|NCT01357655|364565162|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105700381|NCT01357655|364565163|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105700382|NCT01357655|364565162|FG000|Overall Study|Disease Progression|1|||
105700383|NCT01357655|364565163|FG001|Overall Study|Disease Progression|0|||
105700384|NCT01357655|364565162|FG000|Overall Study|Lost to Follow-up|2|||
105700385|NCT01357655|364565163|FG001|Overall Study|Lost to Follow-up|0|||
105700386|NCT01357655|364565162|FG000|Overall Study|Maximum Clinical Benefit|2|||
105700387|NCT01357655|364565163|FG001|Overall Study|Maximum Clinical Benefit|0|||
105700388|NCT01357655|364565162|FG000|Overall Study|Reason Unspecified|1|||
105700389|NCT01357655|364565163|FG001|Overall Study|Reason Unspecified|0|||
105700390|NCT01357655|364565162|FG000|Overall Study|Study Drug Toxicity|11|||
105700391|NCT01357655|364565163|FG001|Overall Study|Study Drug Toxicity|0|||
105700392|NCT01357655|364565162|FG000|Overall Study|Subject Withdrew Consent|1|||
105700393|NCT01357655|364565163|FG001|Overall Study|Subject Withdrew Consent|0|||
105700394|NCT05003622|364565164|FG000|Overall Study|Progressive disease|2|||
105700395|NCT05003622|364565164|FG000|Overall Study|Withdrawal by Subject|1|||
105700396|NCT04722042|364565169|FG000|Overall Study|Withdrawal by Subject|2|||
105700397|NCT04722042|364565170|FG001|Overall Study|Withdrawal by Subject|1|||
105700398|NCT04722042|364565171|FG002|Overall Study|Withdrawal by Subject|0|||
105700399|NCT01449461|364565174|FG000|Overall Study|Adverse Event|0|||
105700400|NCT01449461|364565175|FG001|Overall Study|Adverse Event|3|||
105700401|NCT01449461|364565176|FG002|Overall Study|Adverse Event|2|||
105700402|NCT01449461|364565177|FG003|Overall Study|Adverse Event|3|||
105700403|NCT01449461|364565178|FG004|Overall Study|Adverse Event|4|||
105700404|NCT01449461|364565179|FG005|Overall Study|Adverse Event|4|||
105700405|NCT01449461|364565174|FG000|Overall Study|Death|0|||
105700406|NCT01449461|364565175|FG001|Overall Study|Death|2|||
105700407|NCT01449461|364565176|FG002|Overall Study|Death|0|||
105700408|NCT01449461|364565177|FG003|Overall Study|Death|0|||
105700409|NCT01449461|364565178|FG004|Overall Study|Death|7|||
105700410|NCT01449461|364565179|FG005|Overall Study|Death|1|||
105700411|NCT01449461|364565174|FG000|Overall Study|Physician Decision|0|||
105700412|NCT01449461|364565175|FG001|Overall Study|Physician Decision|1|||
105700413|NCT01449461|364565176|FG002|Overall Study|Physician Decision|0|||
105925481|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
105925482|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
105925483|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
105925484|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
105925485|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
105925486|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
105925487|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
105925488|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
105925489|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
105925490|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
105925491|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
105925492|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
105925493|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
105925494|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
105700414|NCT01449461|364565177|FG003|Overall Study|Physician Decision|4|||
105700415|NCT01449461|364565178|FG004|Overall Study|Physician Decision|1|||
105700416|NCT01449461|364565179|FG005|Overall Study|Physician Decision|0|||
105700417|NCT01449461|364565174|FG000|Overall Study|Documented Progressive Disease|4|||
105700418|NCT01449461|364565175|FG001|Overall Study|Documented Progressive Disease|7|||
105700419|NCT01449461|364565176|FG002|Overall Study|Documented Progressive Disease|14|||
105700420|NCT01449461|364565177|FG003|Overall Study|Documented Progressive Disease|15|||
105700421|NCT01449461|364565178|FG004|Overall Study|Documented Progressive Disease|24|||
105700422|NCT01449461|364565179|FG005|Overall Study|Documented Progressive Disease|5|||
105700423|NCT01449461|364565174|FG000|Overall Study|Clinical Progressive Disease|2|||
105700424|NCT01449461|364565175|FG001|Overall Study|Clinical Progressive Disease|2|||
105700425|NCT01449461|364565176|FG002|Overall Study|Clinical Progressive Disease|0|||
105700426|NCT01449461|364565177|FG003|Overall Study|Clinical Progressive Disease|3|||
105700427|NCT01449461|364565178|FG004|Overall Study|Clinical Progressive Disease|4|||
105700428|NCT01449461|364565179|FG005|Overall Study|Clinical Progressive Disease|2|||
105700429|NCT01449461|364565174|FG000|Overall Study|Protocol Violation|0|||
105700430|NCT01449461|364565175|FG001|Overall Study|Protocol Violation|0|||
105700431|NCT01449461|364565176|FG002|Overall Study|Protocol Violation|0|||
105700432|NCT01449461|364565177|FG003|Overall Study|Protocol Violation|1|||
105700433|NCT01449461|364565178|FG004|Overall Study|Protocol Violation|0|||
105700434|NCT01449461|364565179|FG005|Overall Study|Protocol Violation|0|||
105700435|NCT01449461|364565174|FG000|Overall Study|Site Terminated by Sponsor|0|||
105700436|NCT01449461|364565175|FG001|Overall Study|Site Terminated by Sponsor|1|||
105700437|NCT01449461|364565176|FG002|Overall Study|Site Terminated by Sponsor|2|||
105700438|NCT01449461|364565177|FG003|Overall Study|Site Terminated by Sponsor|3|||
105700439|NCT01449461|364565178|FG004|Overall Study|Site Terminated by Sponsor|4|||
105700440|NCT01449461|364565179|FG005|Overall Study|Site Terminated by Sponsor|1|||
105700441|NCT01449461|364565174|FG000|Overall Study|Withdrawal by Subject|0|||
105700442|NCT01449461|364565175|FG001|Overall Study|Withdrawal by Subject|1|||
105700443|NCT01449461|364565176|FG002|Overall Study|Withdrawal by Subject|0|||
105700444|NCT01449461|364565177|FG003|Overall Study|Withdrawal by Subject|0|||
105700445|NCT01449461|364565178|FG004|Overall Study|Withdrawal by Subject|2|||
105700446|NCT01449461|364565179|FG005|Overall Study|Withdrawal by Subject|1|||
105700447|NCT01449461|364565174|FG000|Overall Study|Reason not Specified|0|||
105700448|NCT01449461|364565175|FG001|Overall Study|Reason not Specified|1|||
105700449|NCT01449461|364565176|FG002|Overall Study|Reason not Specified|0|||
105700450|NCT01449461|364565177|FG003|Overall Study|Reason not Specified|3|||
105700451|NCT01449461|364565178|FG004|Overall Study|Reason not Specified|2|||
105700452|NCT01449461|364565179|FG005|Overall Study|Reason not Specified|1|||
105700453|NCT00853749|364565184|FG000|Overall Study|Lost to Follow-up|0|||
105700454|NCT00853749|364565185|FG001|Overall Study|Lost to Follow-up|1|||
105700455|NCT04857996|364565186|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
105700456|NCT04857996|364565187|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
105700457|NCT04857996|364565186|FG000|Overall Study|Lost to Follow-up|1|||
105700458|NCT04857996|364565187|FG001|Overall Study|Lost to Follow-up|3|||
105787245|NCT03110107|364874895|FG006|Treatment Period|Other Reasons|0|||
105787246|NCT03110107|364874896|FG007|Treatment Period|Other Reasons|0|||
105787247|NCT03110107|364874897|FG008|Treatment Period|Other Reasons|0|||
105787248|NCT03110107|364874898|FG009|Treatment Period|Other Reasons|0|||
105787249|NCT03110107|364874899|FG010|Treatment Period|Other Reasons|0|||
105787250|NCT03110107|364874900|FG011|Treatment Period|Other Reasons|0|||
105925495|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
105925496|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
105925497|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
105925498|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
105925499|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
105925500|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
105925501|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
105925502|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
105925503|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
105925504|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
105925505|NCT00090103|365387843|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
105925506|NCT00090103|365387844|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
105925507|NCT00090103|365387845|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
105925508|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
105925509|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
105925510|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
105925511|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
105925512|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
105925513|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
105925514|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
105925515|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
106005888|NCT00179621|365686454|FG001|Open-Label Period|Adverse Event|6|||
106133544|NCT05567952|366148088|FG001|Overall Study|Other|1|||
105700459|NCT04857996|364565186|FG000|Overall Study|Site Closure|1|||
105700460|NCT04857996|364565187|FG001|Overall Study|Site Closure|0|||
105700461|NCT04857996|364565186|FG000|Overall Study|Withdrawal by Subject|1|||
105700462|NCT04857996|364565187|FG001|Overall Study|Withdrawal by Subject|0|||
105787251|NCT03110107|364874901|FG012|Treatment Period|Other Reasons|0|||
105925516|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
105925517|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
105925518|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
105925519|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
105925520|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
105925521|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
105925522|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
105925523|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
105925524|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
105925525|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
105925526|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
105925527|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
105925528|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
105925529|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
105925530|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
105925531|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
105925532|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
105925533|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
105700463|NCT02269787|364565188|FG000|Overall Study|Lost to Follow-up|20|||
105700464|NCT02269787|364565189|FG001|Overall Study|Lost to Follow-up|6|||
105700465|NCT02269787|364565188|FG000|Overall Study|Death|2|||
105700466|NCT02269787|364565189|FG001|Overall Study|Death|3|||
105700467|NCT02269787|364565188|FG000|Overall Study|Incapacitated|0|||
105700468|NCT02269787|364565189|FG001|Overall Study|Incapacitated|1|||
105925534|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
105925535|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
105925536|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
105925537|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
105925538|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
105925539|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
105925540|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
105925541|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
105925542|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
105925543|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
105925544|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
106005889|NCT00179621|365686455|FG002|Open-Label Period|Adverse Event|5|||
105700469|NCT00470054|364565190|FG000|Overall Study|Ineligible|1|||
105700470|NCT00840086|364566664|FG000|Overall Study|Adverse Event|1|||
105700471|NCT00840086|364566664|FG000|Overall Study|Protocol Violation|2|||
105700472|NCT00840086|364566664|FG000|Overall Study|Lost to Follow-up|1|||
105700473|NCT02236520|364566666|FG000|Overall Study|Physician Decision|0|||
105700474|NCT02236520|364566667|FG001|Overall Study|Physician Decision|5|||
105700475|NCT02236520|364566668|FG002|Overall Study|Physician Decision|0|||
105700476|NCT02236520|364566669|FG003|Overall Study|Physician Decision|0|||
105700477|NCT02236520|364566666|FG000|Overall Study|Withdrawal by Subject|1|||
105700478|NCT02236520|364566667|FG001|Overall Study|Withdrawal by Subject|0|||
105700479|NCT02236520|364566668|FG002|Overall Study|Withdrawal by Subject|0|||
105700480|NCT02236520|364566669|FG003|Overall Study|Withdrawal by Subject|1|||
105700481|NCT02236520|364566666|FG000|Overall Study|Pregnancy|1|||
105700482|NCT02236520|364566667|FG001|Overall Study|Pregnancy|0|||
105700483|NCT02236520|364566668|FG002|Overall Study|Pregnancy|0|||
105700484|NCT02236520|364566669|FG003|Overall Study|Pregnancy|0|||
105700485|NCT01785160|364566670|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
105700486|NCT01785160|364566670|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
105700487|NCT02081534|364566671|FG000|Overall Study|Adverse Event|5|||
105700488|NCT02081534|364566672|FG001|Overall Study|Adverse Event|4|||
105700489|NCT02081534|364566673|FG002|Overall Study|Adverse Event|3|||
105700490|NCT02081534|364566674|FG003|Overall Study|Adverse Event|10|||
105700491|NCT02081534|364566675|FG004|Overall Study|Adverse Event|2|||
105700492|NCT02081534|364566676|FG005|Overall Study|Adverse Event|8|||
105700493|NCT02081534|364566677|FG006|Overall Study|Adverse Event|2|||
105700494|NCT02081534|364566671|FG000|Overall Study|Withdrawal by Subject|0|||
105700495|NCT02081534|364566672|FG001|Overall Study|Withdrawal by Subject|1|||
105700496|NCT02081534|364566673|FG002|Overall Study|Withdrawal by Subject|1|||
105700497|NCT02081534|364566674|FG003|Overall Study|Withdrawal by Subject|1|||
105700498|NCT02081534|364566675|FG004|Overall Study|Withdrawal by Subject|1|||
105700499|NCT02081534|364566676|FG005|Overall Study|Withdrawal by Subject|0|||
105700500|NCT02081534|364566677|FG006|Overall Study|Withdrawal by Subject|1|||
105700501|NCT02081534|364566671|FG000|Overall Study|Protocol Violation|0|||
105700502|NCT02081534|364566672|FG001|Overall Study|Protocol Violation|3|||
105700503|NCT02081534|364566673|FG002|Overall Study|Protocol Violation|0|||
105700504|NCT02081534|364566674|FG003|Overall Study|Protocol Violation|0|||
105700505|NCT02081534|364566675|FG004|Overall Study|Protocol Violation|0|||
105700506|NCT02081534|364566676|FG005|Overall Study|Protocol Violation|0|||
105700507|NCT02081534|364566677|FG006|Overall Study|Protocol Violation|1|||
105700508|NCT02081534|364566671|FG000|Overall Study|Lost to Follow-up|0|||
105700509|NCT02081534|364566672|FG001|Overall Study|Lost to Follow-up|0|||
105700510|NCT02081534|364566673|FG002|Overall Study|Lost to Follow-up|0|||
105700511|NCT02081534|364566674|FG003|Overall Study|Lost to Follow-up|2|||
105700512|NCT02081534|364566675|FG004|Overall Study|Lost to Follow-up|1|||
105700513|NCT02081534|364566676|FG005|Overall Study|Lost to Follow-up|1|||
106005890|NCT00179621|365686456|FG003|Open-Label Period|Adverse Event|6|||
106005891|NCT00179621|365686453|FG000|Open-Label Period|Withdrawal by Subject|0|||
106005892|NCT00179621|365686454|FG001|Open-Label Period|Withdrawal by Subject|2|||
106005893|NCT00179621|365686455|FG002|Open-Label Period|Withdrawal by Subject|2|||
106005894|NCT00179621|365686456|FG003|Open-Label Period|Withdrawal by Subject|2|||
106005895|NCT00179621|365686453|FG000|Open-Label Period|Death|0|||
106005896|NCT00179621|365686454|FG001|Open-Label Period|Death|0|||
106005897|NCT00179621|365686455|FG002|Open-Label Period|Death|1|||
106005898|NCT00179621|365686456|FG003|Open-Label Period|Death|2|||
106005899|NCT00179621|365686453|FG000|Open-Label Period|Other|0|||
106005900|NCT00179621|365686454|FG001|Open-Label Period|Other|1|||
106005901|NCT00179621|365686455|FG002|Open-Label Period|Other|1|||
106005902|NCT00179621|365686456|FG003|Open-Label Period|Other|2|||
106005903|NCT00878501|365686467|FG000|Overall Study|Adverse Event|11|||
106005904|NCT00878501|365686468|FG001|Overall Study|Adverse Event|3|||
106005905|NCT00878501|365686469|FG002|Overall Study|Adverse Event|3|||
106005906|NCT00878501|365686467|FG000|Overall Study|Lack of Efficacy|2|||
106005907|NCT00878501|365686468|FG001|Overall Study|Lack of Efficacy|1|||
106005908|NCT00878501|365686469|FG002|Overall Study|Lack of Efficacy|0|||
105700514|NCT02081534|364566677|FG006|Overall Study|Lost to Follow-up|0|||
106005909|NCT00878501|365686467|FG000|Overall Study|Withdrawal by Subject|2|||
106005910|NCT00878501|365686468|FG001|Overall Study|Withdrawal by Subject|1|||
106005911|NCT00878501|365686469|FG002|Overall Study|Withdrawal by Subject|2|||
106005912|NCT00878501|365686467|FG000|Overall Study|Protocol Violation|0|||
106005913|NCT00878501|365686468|FG001|Overall Study|Protocol Violation|0|||
106005914|NCT00878501|365686469|FG002|Overall Study|Protocol Violation|1|||
105700515|NCT00762892|364566678|FG000|Overall Study|Lost to Follow-up|2|||
105700516|NCT00762892|364566679|FG001|Overall Study|Lost to Follow-up|5|||
105700517|NCT00762892|364566678|FG000|Overall Study|Withdrawal by Subject|0|||
105700518|NCT00762892|364566679|FG001|Overall Study|Withdrawal by Subject|1|||
105700519|NCT00762892|364566678|FG000|Overall Study|Death|1|||
105700520|NCT00762892|364566679|FG001|Overall Study|Death|0|||
105700521|NCT00762892|364566678|FG000|Overall Study|Pregnancy|1|||
105700522|NCT00762892|364566679|FG001|Overall Study|Pregnancy|0|||
105700523|NCT00762892|364566678|FG000|Overall Study|Incarceration|1|||
105700524|NCT00762892|364566679|FG001|Overall Study|Incarceration|0|||
106005915|NCT00878501|365686467|FG000|Overall Study|Incorrect enrolment|1|||
105700525|NCT04640272|364566680|FG000|Overall Study|Subject moved out of area|1|||
105700526|NCT00880399|364566681|FG000|Overall Study|Adverse Event|4|||
105700527|NCT00880399|364566682|FG001|Overall Study|Adverse Event|6|||
105700528|NCT00880399|364566683|FG002|Overall Study|Adverse Event|5|||
105700529|NCT00880399|364566681|FG000|Overall Study|Lack of Efficacy|1|||
105700530|NCT00880399|364566682|FG001|Overall Study|Lack of Efficacy|4|||
105700531|NCT00880399|364566683|FG002|Overall Study|Lack of Efficacy|2|||
105700532|NCT00880399|364566681|FG000|Overall Study|Protocol Violation|4|||
105700533|NCT00880399|364566682|FG001|Overall Study|Protocol Violation|4|||
105700534|NCT00880399|364566683|FG002|Overall Study|Protocol Violation|6|||
105700535|NCT00880399|364566681|FG000|Overall Study|Study closed/terminated|3|||
105700536|NCT00880399|364566682|FG001|Overall Study|Study closed/terminated|7|||
105700537|NCT00880399|364566683|FG002|Overall Study|Study closed/terminated|4|||
105700538|NCT00880399|364566681|FG000|Overall Study|Lost to Follow-up|8|||
105700539|NCT00880399|364566682|FG001|Overall Study|Lost to Follow-up|5|||
105700540|NCT00880399|364566683|FG002|Overall Study|Lost to Follow-up|3|||
105700541|NCT00880399|364566681|FG000|Overall Study|Physician Decision|5|||
105700542|NCT00880399|364566682|FG001|Overall Study|Physician Decision|0|||
105700543|NCT00880399|364566683|FG002|Overall Study|Physician Decision|3|||
105700544|NCT00880399|364566681|FG000|Overall Study|Withdrawal by Subject|6|||
105700545|NCT00880399|364566682|FG001|Overall Study|Withdrawal by Subject|3|||
105700546|NCT00880399|364566683|FG002|Overall Study|Withdrawal by Subject|3|||
105700547|NCT02181816|364566684|FG000|Overall Study|Case Report Forms Uncollected|38|||
105700548|NCT02181816|364566684|FG000|Overall Study|Protocol Deviation|21|||
105700549|NCT00294060|364566687|FG000|Overall Study|Death|225|||
105700550|NCT00294060|364566687|FG000|Overall Study|Other|59|||
105700551|NCT00294060|364566687|FG000|Overall Study|Lost to Follow-up|55|||
105700552|NCT00294060|364566687|FG000|Overall Study|Withdrawal by Subject|11|||
105700553|NCT00294060|364566687|FG000|Overall Study|Physician Decision|797|||
105700554|NCT00294060|364566687|FG000|Overall Study|Medical condition|3|||
105700555|NCT00294060|364566687|FG000|Overall Study|Device explanted/not replaced|23|||
105700556|NCT02349048|364566689|FG000|Overall Study|Withdrawal by Subject|4|||
105700557|NCT02349048|364566690|FG001|Overall Study|Withdrawal by Subject|0|||
105700558|NCT02349048|364566689|FG000|Overall Study|Lost to Follow-up|1|||
105700559|NCT02349048|364566690|FG001|Overall Study|Lost to Follow-up|0|||
105700560|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
105700561|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
105700562|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
105700563|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
105700564|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
105700565|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
105700566|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
105700567|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
105700568|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
105700569|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
105700570|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
105700571|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
105700572|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
105700573|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
105700574|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
105700575|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
105700576|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
105700577|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
106005916|NCT00878501|365686468|FG001|Overall Study|Incorrect enrolment|2|||
106005917|NCT00878501|365686469|FG002|Overall Study|Incorrect enrolment|0|||
106005918|NCT00878501|365686467|FG000|Overall Study|Intake of prohibited concom. medication|0|||
106005919|NCT00878501|365686468|FG001|Overall Study|Intake of prohibited concom. medication|0|||
106133545|NCT04213846|366148090|FG000|Overall Study|Withdrawal by Subject|7|||
106133546|NCT04213846|366148091|FG001|Overall Study|Withdrawal by Subject|6|||
106133547|NCT04213846|366148090|FG000|Overall Study|Lost to Follow-up|15|||
105700578|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
105700579|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
105700580|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
105700581|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
105700582|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
105700583|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
105700584|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
105700585|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
105700586|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
105700587|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
105700588|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
105700589|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
105700590|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700591|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700592|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700593|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700594|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700595|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700596|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
105700597|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
105700598|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
105700599|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
105700600|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
105700601|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
105700602|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
105700603|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
105925545|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
105925546|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
105925547|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
105925548|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
105925549|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
105925550|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
105925551|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
105925552|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
105925553|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
105925554|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
105925555|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
105925556|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Death|1|||
105925557|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Death|0|||
105925558|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Death|1|||
105925559|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
105925560|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
105925561|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
105925562|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
105925563|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
105925564|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
105925565|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
105925566|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
105925567|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
105925568|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
105925569|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
105925570|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
105925571|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
105925572|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
105925573|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
105925574|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
105925575|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
105925576|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
105925577|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
105925578|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
105925579|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
105925580|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Depression|0|||
105925581|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Depression|1|||
105925582|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Depression|0|||
105925583|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
105925584|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
105925585|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
105925586|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Jailed|0|||
105925587|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Jailed|1|||
105925588|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Jailed|0|||
105925589|NCT00090103|365387843|FG000|16-Week Safety Follow-up Period|Other|0|||
105925590|NCT00090103|365387844|FG001|16-Week Safety Follow-up Period|Other|1|||
105925591|NCT00090103|365387845|FG002|16-Week Safety Follow-up Period|Other|0|||
105925592|NCT00855582|365387853|FG000|Overall Study|Adverse Event|2|||
105925593|NCT00855582|365387854|FG001|Overall Study|Adverse Event|6|||
105700604|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
105925594|NCT00855582|365387855|FG002|Overall Study|Adverse Event|3|||
105925595|NCT00855582|365387853|FG000|Overall Study|Death|1|||
105925596|NCT00855582|365387854|FG001|Overall Study|Death|0|||
105925597|NCT00855582|365387855|FG002|Overall Study|Death|0|||
105925598|NCT00855582|365387853|FG000|Overall Study|Lack of Efficacy|1|||
105925599|NCT00855582|365387854|FG001|Overall Study|Lack of Efficacy|3|||
105925600|NCT00855582|365387855|FG002|Overall Study|Lack of Efficacy|8|||
105925601|NCT00855582|365387853|FG000|Overall Study|Lost to Follow-up|1|||
105925602|NCT00855582|365387854|FG001|Overall Study|Lost to Follow-up|3|||
105925603|NCT00855582|365387855|FG002|Overall Study|Lost to Follow-up|1|||
105925604|NCT00855582|365387853|FG000|Overall Study|Physician Decision|0|||
105925605|NCT00855582|365387854|FG001|Overall Study|Physician Decision|0|||
105925606|NCT00855582|365387855|FG002|Overall Study|Physician Decision|1|||
105925607|NCT00855582|365387853|FG000|Overall Study|Protocol Violation|6|||
105925608|NCT00855582|365387854|FG001|Overall Study|Protocol Violation|2|||
105925609|NCT00855582|365387855|FG002|Overall Study|Protocol Violation|6|||
105925610|NCT00855582|365387853|FG000|Overall Study|Entry Criteria Not Met|8|||
105925611|NCT00855582|365387854|FG001|Overall Study|Entry Criteria Not Met|6|||
105925612|NCT00855582|365387855|FG002|Overall Study|Entry Criteria Not Met|3|||
105925613|NCT00855582|365387853|FG000|Overall Study|Withdrawal by Subject|7|||
105925614|NCT00855582|365387854|FG001|Overall Study|Withdrawal by Subject|4|||
105925615|NCT00855582|365387855|FG002|Overall Study|Withdrawal by Subject|8|||
105925616|NCT01588509|365387856|FG000|Overall Study|Lost to Follow-up|1|||
105925617|NCT01588509|365387857|FG001|Overall Study|Lost to Follow-up|0|||
105925618|NCT01732692|365387858|FG000|Overall Study|Adverse Event|0|||
105925619|NCT01732692|365387859|FG001|Overall Study|Adverse Event|1|||
105925620|NCT02030600|365387860|FG000|Treatment Period 1|Adverse Event|5|||
105925621|NCT02030600|365387861|FG001|Treatment Period 1|Adverse Event|7|||
105925622|NCT02030600|365387860|FG000|Treatment Period 1|Lack of Efficacy|0|||
105925623|NCT02030600|365387861|FG001|Treatment Period 1|Lack of Efficacy|1|||
105925624|NCT02030600|365387860|FG000|Treatment Period 1|Lost to Follow-up|11|||
105925625|NCT02030600|365387861|FG001|Treatment Period 1|Lost to Follow-up|3|||
105925626|NCT02030600|365387860|FG000|Treatment Period 1|Protocol Violation|22|||
105925627|NCT02030600|365387861|FG001|Treatment Period 1|Protocol Violation|17|||
105925628|NCT02030600|365387860|FG000|Treatment Period 1|Withdrawal by Subject|13|||
105925629|NCT02030600|365387861|FG001|Treatment Period 1|Withdrawal by Subject|17|||
105925630|NCT02030600|365387860|FG000|Treatment Period 1|Casebook Unsigned|1|||
105925631|NCT02030600|365387861|FG001|Treatment Period 1|Casebook Unsigned|0|||
105925632|NCT02030600|365387860|FG000|Treatment Period 1|Unclassified|1|||
105925633|NCT02030600|365387861|FG001|Treatment Period 1|Unclassified|0|||
105925634|NCT02030600|365387860|FG000|Treatment Period 2|Adverse Event|4|||
105925635|NCT02030600|365387861|FG001|Treatment Period 2|Adverse Event|4|||
105925636|NCT02030600|365387860|FG000|Treatment Period 2|Lack of Efficacy|2|||
105925637|NCT02030600|365387861|FG001|Treatment Period 2|Lack of Efficacy|1|||
105925638|NCT02030600|365387860|FG000|Treatment Period 2|Lost to Follow-up|4|||
105925639|NCT02030600|365387861|FG001|Treatment Period 2|Lost to Follow-up|2|||
105925640|NCT02030600|365387860|FG000|Treatment Period 2|Protocol Violation|1|||
105925641|NCT02030600|365387861|FG001|Treatment Period 2|Protocol Violation|2|||
105925642|NCT02030600|365387860|FG000|Treatment Period 2|Withdrawal by Subject|13|||
105925643|NCT02030600|365387861|FG001|Treatment Period 2|Withdrawal by Subject|9|||
105925644|NCT02030600|365387860|FG000|Treatment Period 2|Unclassified|1|||
105925645|NCT02030600|365387861|FG001|Treatment Period 2|Unclassified|0|||
105925646|NCT01155323|365387862|FG000|First Intervention|exclusion criteria|1|||
105925647|NCT01155323|365387863|FG001|First Intervention|exclusion criteria|1|||
105925648|NCT01155323|365387862|FG000|Second Intervention|Lost to Follow-up|1|||
105925649|NCT01155323|365387863|FG001|Second Intervention|Lost to Follow-up|1|||
105925650|NCT01208051|365387866|FG000|Total Enrollment|Withdrawal by Subject|0|||
105925651|NCT01208051|365387867|FG001|Total Enrollment|Withdrawal by Subject|1|||
105925652|NCT01208051|365387868|FG002|Total Enrollment|Withdrawal by Subject|0|||
105925653|NCT01208051|365387869|FG003|Total Enrollment|Withdrawal by Subject|0|||
105925654|NCT01208051|365387870|FG004|Total Enrollment|Withdrawal by Subject|2|||
105925655|NCT01208051|365387866|FG000|Total Enrollment|Brain metastases|0|||
105925656|NCT01208051|365387867|FG001|Total Enrollment|Brain metastases|0|||
105925657|NCT01208051|365387868|FG002|Total Enrollment|Brain metastases|1|||
105925658|NCT01208051|365387869|FG003|Total Enrollment|Brain metastases|0|||
105925659|NCT01208051|365387870|FG004|Total Enrollment|Brain metastases|0|||
105925660|NCT00973973|365387876|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
105925661|NCT00973973|365387877|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
105925662|NCT00973973|365387876|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
105925663|NCT00973973|365387877|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
105925664|NCT00973973|365387876|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
105925665|NCT00973973|365387877|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
105925666|NCT00973973|365387876|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
105925667|NCT00973973|365387877|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
105925668|NCT00973973|365387876|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
105925669|NCT00973973|365387877|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
105925670|NCT00973973|365387876|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
105925671|NCT00973973|365387877|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
105700605|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
105700606|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
105700607|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
105700608|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
105700609|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700610|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700611|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700612|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700613|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
105700614|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700615|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
105925672|NCT00973973|365387876|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
105925673|NCT00973973|365387877|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
105925674|NCT00973973|365387876|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
105925675|NCT00973973|365387877|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
105925676|NCT00973973|365387876|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
105925677|NCT00973973|365387877|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
105925678|NCT00973973|365387876|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
105925679|NCT00973973|365387877|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
105925680|NCT00973973|365387876|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
105925681|NCT00973973|365387877|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
105925682|NCT00973973|365387876|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
105925683|NCT00973973|365387877|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
105925684|NCT00671060|365387878|FG000|Overall Study|Protocol Violation|1|||
105925685|NCT00671060|365387879|FG001|Overall Study|Protocol Violation|0|||
105925686|NCT00671060|365387878|FG000|Overall Study|Physician Decision|0|||
105925687|NCT00671060|365387879|FG001|Overall Study|Physician Decision|1|||
105925688|NCT02832037|365387880|FG000|Overall Study|Administrative reasons|0|||
105925689|NCT02832037|365387881|FG001|Overall Study|Administrative reasons|0|||
105925690|NCT02832037|365387882|FG002|Overall Study|Administrative reasons|1|||
105925691|NCT02832037|365387883|FG003|Overall Study|Administrative reasons|0|||
105925692|NCT02832037|365387884|FG004|Overall Study|Administrative reasons|0|||
105925693|NCT02832037|365387880|FG000|Overall Study|Protocol Violation|3|||
105925694|NCT02832037|365387881|FG001|Overall Study|Protocol Violation|0|||
105925695|NCT02832037|365387882|FG002|Overall Study|Protocol Violation|4|||
105925696|NCT02832037|365387883|FG003|Overall Study|Protocol Violation|1|||
105925697|NCT02832037|365387884|FG004|Overall Study|Protocol Violation|2|||
105925698|NCT02832037|365387880|FG000|Overall Study|Lost to Follow-up|2|||
105925699|NCT02832037|365387881|FG001|Overall Study|Lost to Follow-up|0|||
105925700|NCT02832037|365387882|FG002|Overall Study|Lost to Follow-up|3|||
105925701|NCT02832037|365387883|FG003|Overall Study|Lost to Follow-up|0|||
105925702|NCT02832037|365387884|FG004|Overall Study|Lost to Follow-up|5|||
105925703|NCT02832037|365387880|FG000|Overall Study|Withdrawal by Subject|9|||
105925704|NCT02832037|365387881|FG001|Overall Study|Withdrawal by Subject|8|||
105925705|NCT02832037|365387882|FG002|Overall Study|Withdrawal by Subject|0|||
105925706|NCT02832037|365387883|FG003|Overall Study|Withdrawal by Subject|4|||
105925707|NCT02832037|365387884|FG004|Overall Study|Withdrawal by Subject|8|||
105925708|NCT02832037|365387880|FG000|Overall Study|Adverse Event|5|||
105925709|NCT02832037|365387881|FG001|Overall Study|Adverse Event|4|||
105925710|NCT02832037|365387882|FG002|Overall Study|Adverse Event|0|||
105925711|NCT02832037|365387883|FG003|Overall Study|Adverse Event|2|||
105925712|NCT02832037|365387884|FG004|Overall Study|Adverse Event|4|||
105925713|NCT02107898|365387887|FG000|Overall Study|Adverse Event|4|||
105925714|NCT02107898|365387888|FG001|Overall Study|Adverse Event|7|||
106005920|NCT00878501|365686469|FG002|Overall Study|Intake of prohibited concom. medication|1|||
106005921|NCT00878501|365686467|FG000|Overall Study|Mis-randomisation of patient|1|||
106005922|NCT00878501|365686468|FG001|Overall Study|Mis-randomisation of patient|0|||
106005923|NCT00878501|365686469|FG002|Overall Study|Mis-randomisation of patient|0|||
106005924|NCT00878501|365686467|FG000|Overall Study|Administrative|0|||
106005925|NCT00878501|365686468|FG001|Overall Study|Administrative|0|||
106005926|NCT00878501|365686469|FG002|Overall Study|Administrative|1|||
106005927|NCT02412306|365686478|FG000|Overall Study|Lost to Follow-up|0|||
106005928|NCT02412306|365686479|FG001|Overall Study|Lost to Follow-up|1|||
105925715|NCT02107898|365387887|FG000|Overall Study|Poor compliance to protocol|0|||
105925716|NCT02107898|365387888|FG001|Overall Study|Poor compliance to protocol|1|||
105925717|NCT02107898|365387887|FG000|Overall Study|Participant moved|0|||
105925718|NCT02107898|365387888|FG001|Overall Study|Participant moved|2|||
105925719|NCT02107898|365387887|FG000|Overall Study|Consent withdrawn by participant|2|||
105925720|NCT02107898|365387888|FG001|Overall Study|Consent withdrawn by participant|1|||
105925721|NCT02107898|365387887|FG000|Overall Study|Randomized but not treated|0|||
106005929|NCT02412306|365686480|FG002|Overall Study|Lost to Follow-up|0|||
106005930|NCT02412306|365686481|FG003|Overall Study|Lost to Follow-up|0|||
105925722|NCT02107898|365387888|FG001|Overall Study|Randomized but not treated|1|||
105700616|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700617|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700618|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700619|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
105700620|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700621|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
105700622|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700623|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700624|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700625|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
105700626|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105700627|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
105700628|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105700629|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105925723|NCT00620542|365387889|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
105925724|NCT00620542|365387890|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
105925725|NCT00620542|365387891|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
105925726|NCT00620542|365387892|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
105925727|NCT00620542|365387889|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
105925728|NCT00620542|365387890|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
105925729|NCT00620542|365387891|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105925730|NCT00620542|365387892|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105925731|NCT00620542|365387889|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
105925732|NCT00620542|365387890|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
105925733|NCT00620542|365387891|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
105925734|NCT00620542|365387892|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
105925735|NCT00620542|365387889|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
105925736|NCT00620542|365387890|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
105925737|NCT00620542|365387891|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
105925738|NCT00620542|365387892|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
105925739|NCT00620542|365387889|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105925740|NCT00620542|365387890|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
105925741|NCT00620542|365387891|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105700630|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105700631|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
105700632|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700633|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
105700634|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700635|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700636|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700637|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
105700638|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700639|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700640|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700641|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
105700642|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700643|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
105700644|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700645|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700646|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700647|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
105700648|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700649|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
105700650|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105700651|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105925742|NCT00620542|365387892|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
105925743|NCT00620542|365387889|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
105925744|NCT00620542|365387890|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
105925745|NCT00620542|365387891|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
105925746|NCT00620542|365387892|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
105925747|NCT00620542|365387889|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
105700652|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105700653|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105700654|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
106005931|NCT02412306|365686482|FG004|Overall Study|Lost to Follow-up|0|||
106005932|NCT02412306|365686478|FG000|Overall Study|Withdrawal by Subject|0|||
106005933|NCT02412306|365686479|FG001|Overall Study|Withdrawal by Subject|0|||
106005934|NCT02412306|365686480|FG002|Overall Study|Withdrawal by Subject|1|||
106005935|NCT02412306|365686481|FG003|Overall Study|Withdrawal by Subject|0|||
105700655|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
105700656|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700657|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700658|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700659|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700660|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
105700661|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
105700662|NCT00111800|364566691|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700663|NCT00111800|364566692|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700664|NCT00111800|364566693|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700665|NCT00111800|364566694|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700666|NCT00111800|364566695|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
105700667|NCT00111800|364566696|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
105700668|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
105700669|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
105700670|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
105700671|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
105700672|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
105700673|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
105700674|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
105700675|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
105700676|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
105700677|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
105700678|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
105700679|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
105700680|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
106005936|NCT02412306|365686482|FG004|Overall Study|Withdrawal by Subject|0|||
106005937|NCT02412306|365686478|FG000|Overall Study|Death|5|||
106005938|NCT02412306|365686479|FG001|Overall Study|Death|7|||
106005939|NCT02412306|365686480|FG002|Overall Study|Death|15|||
106005940|NCT02412306|365686481|FG003|Overall Study|Death|0|||
106005941|NCT02412306|365686482|FG004|Overall Study|Death|2|||
106005942|NCT02953652|365686490|FG000|Overall Study|Adverse Event|18|||
106005943|NCT02953652|365686490|FG000|Overall Study|Withdrawal by Subject|6|||
106005944|NCT02953652|365686490|FG000|Overall Study|Protocol Violation|1|||
106005945|NCT02953652|365686490|FG000|Overall Study|Disease Progression|27|||
106005946|NCT04742556|365686495|FG000|Overall Study|Withdrawal by Subject|0|||
106005947|NCT04742556|365686496|FG001|Overall Study|Withdrawal by Subject|1|||
105700681|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
105700682|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
105700683|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
105700684|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
105700685|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
105700686|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
105700687|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
105700688|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
105700689|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
105787252|NCT03110107|364874902|FG013|Treatment Period|Other Reasons|0|||
105787253|NCT03110107|364874903|FG014|Treatment Period|Other Reasons|0|||
106005948|NCT04742556|365686497|FG002|Overall Study|Withdrawal by Subject|0|||
106005949|NCT04742556|365686495|FG000|Overall Study|Adverse Event|0|||
106005950|NCT04742556|365686496|FG001|Overall Study|Adverse Event|0|||
106005951|NCT04742556|365686497|FG002|Overall Study|Adverse Event|2|||
106005952|NCT04742556|365686495|FG000|Overall Study|Clinical disease progression|0|||
106005953|NCT04742556|365686496|FG001|Overall Study|Clinical disease progression|1|||
106005954|NCT04742556|365686497|FG002|Overall Study|Clinical disease progression|2|||
106005955|NCT04742556|365686495|FG000|Overall Study|Objective disease progression|3|||
106005956|NCT04742556|365686496|FG001|Overall Study|Objective disease progression|2|||
106005957|NCT04742556|365686497|FG002|Overall Study|Objective disease progression|4|||
106016895|NCT03847896|365725909|FG004|Overall Study|Adverse Event|4|||
106133548|NCT04213846|366148091|FG001|Overall Study|Lost to Follow-up|21|||
105700690|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
105700691|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
105700692|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700693|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700694|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
105700695|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105787254|NCT03110107|364874904|FG015|Treatment Period|Other Reasons|0|||
105787255|NCT03110107|364874905|FG016|Treatment Period|Other Reasons|0|||
105787256|NCT03110107|364874906|FG017|Treatment Period|Other Reasons|0|||
105787257|NCT03110107|364874907|FG018|Treatment Period|Other Reasons|0|||
105787258|NCT03110107|364874908|FG019|Treatment Period|Other Reasons|0|||
105787259|NCT03110107|364874909|FG020|Treatment Period|Other Reasons|0|||
105787260|NCT03110107|364874910|FG021|Treatment Period|Other Reasons|0|||
105787261|NCT03110107|364874911|FG022|Treatment Period|Other Reasons|0|||
105787262|NCT03110107|364874912|FG023|Treatment Period|Other Reasons|0|||
105787263|NCT03110107|364874913|FG024|Treatment Period|Other Reasons|1|||
105787264|NCT03110107|364874914|FG025|Treatment Period|Other Reasons|0|||
105787265|NCT02652793|364874915|FG000|Overall Study|Adverse Event|1|||
105787266|NCT02652793|364874915|FG000|Overall Study|Lost to Follow-up|2|||
105925748|NCT00620542|365387890|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
105925749|NCT00620542|365387891|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
105925750|NCT00620542|365387892|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
105925751|NCT00620542|365387889|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
105925752|NCT00620542|365387890|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
105925753|NCT00620542|365387891|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
105925754|NCT00620542|365387892|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
105925755|NCT00620542|365387889|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
105925756|NCT00620542|365387890|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
105925757|NCT00620542|365387891|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
105925758|NCT00620542|365387892|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
105925759|NCT00620542|365387889|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
105925760|NCT00620542|365387890|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
105925761|NCT00620542|365387891|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
105925762|NCT00620542|365387892|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
105925763|NCT00620542|365387889|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
105925764|NCT00620542|365387890|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
105925765|NCT00620542|365387891|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
105925766|NCT00620542|365387892|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
105925767|NCT00620542|365387889|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
105925768|NCT00620542|365387890|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
105925769|NCT00620542|365387891|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
105925770|NCT00620542|365387892|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
105925771|NCT00620542|365387889|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
105925772|NCT00620542|365387890|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
105925773|NCT00620542|365387891|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
105925774|NCT00620542|365387892|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
105925775|NCT00620542|365387889|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
105925776|NCT00620542|365387890|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
105925777|NCT00620542|365387891|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
105925778|NCT00620542|365387892|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
105925779|NCT00620542|365387889|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
105925780|NCT00620542|365387890|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
105925781|NCT00620542|365387891|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
105925782|NCT00620542|365387892|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
105925783|NCT02453048|365387893|FG000|Overall Study|Only part of initial 6 mo. study|0|||
105925784|NCT02453048|365387894|FG001|Overall Study|Only part of initial 6 mo. study|0|||
105925785|NCT02453048|365387895|FG002|Overall Study|Only part of initial 6 mo. study|0|||
105925786|NCT02453048|365387896|FG003|Overall Study|Only part of initial 6 mo. study|0|||
105925787|NCT02453048|365387897|FG004|Overall Study|Only part of initial 6 mo. study|6|||
105925788|NCT02453048|365387893|FG000|Overall Study|Lost to Follow-up|0|||
105925789|NCT02453048|365387894|FG001|Overall Study|Lost to Follow-up|1|||
105925790|NCT02453048|365387895|FG002|Overall Study|Lost to Follow-up|2|||
105925791|NCT02453048|365387896|FG003|Overall Study|Lost to Follow-up|0|||
105925792|NCT02453048|365387897|FG004|Overall Study|Lost to Follow-up|0|||
105925793|NCT01283386|365387902|FG000|Overall Study|Death|2|||
105925794|NCT01283386|365387903|FG001|Overall Study|Death|0|||
105925795|NCT01283386|365387902|FG000|Overall Study|Withdrawal by Subject|2|||
105925796|NCT01283386|365387903|FG001|Overall Study|Withdrawal by Subject|1|||
105925797|NCT01283386|365387902|FG000|Overall Study|Relapse of underlying disease|1|||
105925798|NCT01283386|365387903|FG001|Overall Study|Relapse of underlying disease|3|||
105925799|NCT01283386|365387902|FG000|Overall Study|Progression of underlying disease|2|||
105925800|NCT01283386|365387903|FG001|Overall Study|Progression of underlying disease|7|||
105925801|NCT01283386|365387902|FG000|Overall Study|Reason not specified|1|||
105925802|NCT01283386|365387903|FG001|Overall Study|Reason not specified|0|||
105925803|NCT01283386|365387902|FG000|Overall Study|Protocol Violation|0|||
105925804|NCT01283386|365387903|FG001|Overall Study|Protocol Violation|1|||
105925805|NCT04796415|365387906|FG000|Overall Study|not interested|12|||
105925806|NCT04796415|365387906|FG000|Overall Study|health issue|8|||
105925807|NCT04796415|365387906|FG000|Overall Study|Other|4|||
105925808|NCT04796415|365387906|FG000|Overall Study|discharged from home health service|3|||
105925809|NCT04796415|365387906|FG000|Overall Study|re-hospitalization|2|||
105925810|NCT04796415|365387906|FG000|Overall Study|moving to nursing home|1|||
105925811|NCT04796415|365387906|FG000|Overall Study|lost contact|1|||
105925812|NCT03483103|365387907|FG000|Pre-Treatment Phase|Other reasons|1|||
105925813|NCT03483103|365387907|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
105925814|NCT03483103|365387907|FG000|Pre-Treatment Phase|Disease-related complications|1|||
105925815|NCT03483103|365387907|FG000|Pre-Treatment Phase|Death|5|||
105925816|NCT03483103|365387907|FG000|Treatment Phase|Withdrawal by Subject|7|||
105925817|NCT03483103|365387907|FG000|Treatment Phase|Other reasons|1|||
105925818|NCT03483103|365387907|FG000|Treatment Phase|Death|23|||
105925819|NCT03483103|365387907|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
105925820|NCT03483103|365387907|FG000|Treatment Phase|Received nonconforming product|1|||
105925821|NCT04810962|365387908|FG000|Overall Study|Adverse Event|0|||
105925822|NCT04810962|365387909|FG001|Overall Study|Adverse Event|1|||
105925823|NCT04810962|365387908|FG000|Overall Study|Lost to Follow-up|2|||
105925824|NCT04810962|365387909|FG001|Overall Study|Lost to Follow-up|1|||
105925825|NCT04810962|365387908|FG000|Overall Study|Physician Decision|1|||
105925826|NCT04810962|365387909|FG001|Overall Study|Physician Decision|0|||
105925827|NCT04810962|365387908|FG000|Overall Study|Withdrawal by Subject|1|||
105925828|NCT04810962|365387909|FG001|Overall Study|Withdrawal by Subject|3|||
105925829|NCT04810962|365387908|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
105925830|NCT04810962|365387909|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
105925831|NCT00435942|365387910|FG000|Overall Study|Death|17|||
105925832|NCT00435942|365387911|FG001|Overall Study|Death|10|||
105925833|NCT00435942|365387910|FG000|Overall Study|Withdrawal by Subject|2|||
105925834|NCT00435942|365387911|FG001|Overall Study|Withdrawal by Subject|0|||
105925835|NCT00435942|365387910|FG000|Overall Study|Lost to Follow-up|0|||
105925836|NCT00435942|365387911|FG001|Overall Study|Lost to Follow-up|16|||
105925837|NCT00435942|365387910|FG000|Overall Study|Conversion to Open Repair|1|||
105925838|NCT00435942|365387911|FG001|Overall Study|Conversion to Open Repair|0|||
105925839|NCT00435942|365387910|FG000|Overall Study|Technical Failure|3|||
105925840|NCT00435942|365387911|FG001|Overall Study|Technical Failure|0|||
105925841|NCT00435942|365387910|FG000|Overall Study|Other|0|||
105925842|NCT00435942|365387911|FG001|Overall Study|Other|1|||
105925843|NCT04727749|365387912|FG000|Overall Study|Lost to Follow-up|10|||
105925844|NCT04727749|365387913|FG001|Overall Study|Lost to Follow-up|3|||
105925845|NCT01481779|365387915|FG000|Overall Study|Adverse Event|23|||
105925846|NCT01481779|365387916|FG001|Overall Study|Adverse Event|5|||
105925847|NCT01481779|365387915|FG000|Overall Study|Lost to Follow-up|3|||
105925848|NCT01481779|365387916|FG001|Overall Study|Lost to Follow-up|2|||
105925849|NCT01481779|365387915|FG000|Overall Study|Protocol Violation|2|||
105925850|NCT01481779|365387916|FG001|Overall Study|Protocol Violation|3|||
105925851|NCT01481779|365387915|FG000|Overall Study|Withdrawal by Subject|26|||
105925852|NCT01481779|365387916|FG001|Overall Study|Withdrawal by Subject|13|||
105925853|NCT01481779|365387915|FG000|Overall Study|Physician Decision|13|||
106005958|NCT01488045|365686502|FG000|Overall Study|Withdrawal by Subject|6|||
105787267|NCT02652793|364874915|FG000|Overall Study|Withdrawal by Subject|1|||
105925854|NCT01481779|365387916|FG001|Overall Study|Physician Decision|4|||
105925855|NCT01481779|365387915|FG000|Overall Study|Sponsor Decision|3|||
105925856|NCT01481779|365387916|FG001|Overall Study|Sponsor Decision|1|||
105925857|NCT02378181|365387917|FG000|Overall Study|Lost to Follow-up|2|||
105925858|NCT02378181|365387918|FG001|Overall Study|Lost to Follow-up|5|||
105925859|NCT02378181|365387917|FG000|Overall Study|Withdrawal by Subject|1|||
105925860|NCT02378181|365387918|FG001|Overall Study|Withdrawal by Subject|1|||
105925861|NCT02378181|365387917|FG000|Overall Study|Incarcerated|0|||
105925862|NCT02378181|365387918|FG001|Overall Study|Incarcerated|1|||
105925863|NCT00805532|365387922|FG000|Overall Study|invalid data|0|||
105925864|NCT00805532|365387923|FG001|Overall Study|invalid data|1|||
105925865|NCT01859741|365387924|FG000|Overall Study|Death|3|||
105925866|NCT01859741|365387925|FG001|Overall Study|Death|2|||
105925867|NCT01859741|365387926|FG002|Overall Study|Death|4|||
105925868|NCT01859741|365387927|FG003|Overall Study|Death|3|||
105925869|NCT01859741|365387928|FG004|Overall Study|Death|5|||
105925870|NCT01859741|365387929|FG005|Overall Study|Death|4|||
105925871|NCT01859741|365387930|FG006|Overall Study|Death|51|||
105925872|NCT01859741|365387931|FG007|Overall Study|Death|51|||
105925873|NCT01859741|365387924|FG000|Overall Study|Lost to Follow-up|0|||
105925874|NCT01859741|365387925|FG001|Overall Study|Lost to Follow-up|0|||
105925875|NCT01859741|365387926|FG002|Overall Study|Lost to Follow-up|0|||
106005959|NCT01488045|365686503|FG001|Overall Study|Withdrawal by Subject|11|||
105925876|NCT01859741|365387927|FG003|Overall Study|Lost to Follow-up|0|||
105925877|NCT01859741|365387928|FG004|Overall Study|Lost to Follow-up|0|||
105925878|NCT01859741|365387929|FG005|Overall Study|Lost to Follow-up|1|||
105925879|NCT01859741|365387930|FG006|Overall Study|Lost to Follow-up|0|||
105925880|NCT01859741|365387931|FG007|Overall Study|Lost to Follow-up|4|||
105925881|NCT01859741|365387924|FG000|Overall Study|Withdrawal by Subject|0|||
105925882|NCT01859741|365387925|FG001|Overall Study|Withdrawal by Subject|1|||
105925883|NCT01859741|365387926|FG002|Overall Study|Withdrawal by Subject|2|||
105925884|NCT01859741|365387927|FG003|Overall Study|Withdrawal by Subject|0|||
105925885|NCT01859741|365387928|FG004|Overall Study|Withdrawal by Subject|0|||
105925886|NCT01859741|365387929|FG005|Overall Study|Withdrawal by Subject|1|||
105925887|NCT01859741|365387930|FG006|Overall Study|Withdrawal by Subject|1|||
105925888|NCT01859741|365387931|FG007|Overall Study|Withdrawal by Subject|1|||
105925889|NCT01859741|365387924|FG000|Overall Study|Study Terminated by Sponsor|0|||
105925890|NCT01859741|365387925|FG001|Overall Study|Study Terminated by Sponsor|0|||
105925891|NCT01859741|365387926|FG002|Overall Study|Study Terminated by Sponsor|0|||
105925892|NCT01859741|365387927|FG003|Overall Study|Study Terminated by Sponsor|0|||
105925893|NCT01859741|365387928|FG004|Overall Study|Study Terminated by Sponsor|1|||
105925894|NCT01859741|365387929|FG005|Overall Study|Study Terminated by Sponsor|0|||
105925895|NCT01859741|365387930|FG006|Overall Study|Study Terminated by Sponsor|16|||
105925896|NCT01859741|365387931|FG007|Overall Study|Study Terminated by Sponsor|14|||
105925897|NCT01859741|365387924|FG000|Overall Study|Other|0|||
105925898|NCT01859741|365387925|FG001|Overall Study|Other|0|||
105925899|NCT01859741|365387926|FG002|Overall Study|Other|0|||
105925900|NCT01859741|365387927|FG003|Overall Study|Other|0|||
105925901|NCT01859741|365387928|FG004|Overall Study|Other|0|||
105925902|NCT01859741|365387929|FG005|Overall Study|Other|0|||
105925903|NCT01859741|365387930|FG006|Overall Study|Other|2|||
105925904|NCT01859741|365387931|FG007|Overall Study|Other|0|||
105925905|NCT04491994|365387937|FG000|Overall Study|Withdrawal by Subject|10|||
105925906|NCT04491994|365387938|FG001|Overall Study|Withdrawal by Subject|5|||
105925907|NCT04491994|365387937|FG000|Overall Study|developed fever > 3 days|4|||
105925908|NCT04491994|365387938|FG001|Overall Study|developed fever > 3 days|1|||
105925909|NCT04491994|365387937|FG000|Overall Study|Protocol Violation|11|||
105925910|NCT04491994|365387938|FG001|Overall Study|Protocol Violation|2|||
105925911|NCT04491994|365387937|FG000|Overall Study|Lost to Follow-up|4|||
105925912|NCT04491994|365387938|FG001|Overall Study|Lost to Follow-up|3|||
105925913|NCT02320396|365387939|FG000|Overall Study|Adverse Event|2|||
105925914|NCT02320396|365387940|FG001|Overall Study|Adverse Event|2|||
105925915|NCT02320396|365387939|FG000|Overall Study|Pregnancy|0|||
105925916|NCT02320396|365387940|FG001|Overall Study|Pregnancy|1|||
105925917|NCT02320396|365387939|FG000|Overall Study|Protocol Violation|0|||
105925918|NCT02320396|365387940|FG001|Overall Study|Protocol Violation|1|||
105925919|NCT02320396|365387939|FG000|Overall Study|Withdrawal by Subject|2|||
105787268|NCT03985982|364874916|FG000|Double-Blind Phase|Lost to Follow-up|4|||
105787269|NCT03985982|364874917|FG001|Double-Blind Phase|Lost to Follow-up|3|||
105925920|NCT02320396|365387940|FG001|Overall Study|Withdrawal by Subject|0|||
105925921|NCT00505921|365387942|FG000|Overall Study|Ineligible|1|||
105925922|NCT00505921|365387942|FG000|Overall Study|Failed to Mobilize|8|||
105925923|NCT01369433|365387945|FG000|Overall Study|Adverse Event|31|||
105925924|NCT01369433|365387946|FG001|Overall Study|Adverse Event|1|||
105925925|NCT01369433|365387945|FG000|Overall Study|Required significant surgical procedure|1|||
105925926|NCT01369433|365387946|FG001|Overall Study|Required significant surgical procedure|0|||
105925927|NCT01369433|365387945|FG000|Overall Study|Non-compliance|1|||
105925928|NCT01369433|365387946|FG001|Overall Study|Non-compliance|0|||
105925929|NCT01369433|365387945|FG000|Overall Study|Withdrawal by Subject|5|||
105925930|NCT01369433|365387946|FG001|Overall Study|Withdrawal by Subject|2|||
105925931|NCT01369433|365387945|FG000|Overall Study|Study terminated by Sponsor|67|||
105925932|NCT01369433|365387946|FG001|Overall Study|Study terminated by Sponsor|0|||
105925933|NCT01369433|365387945|FG000|Overall Study|Lost to Follow-up|1|||
105925934|NCT01369433|365387946|FG001|Overall Study|Lost to Follow-up|0|||
105925935|NCT01369433|365387945|FG000|Overall Study|Death|5|||
105925936|NCT01369433|365387946|FG001|Overall Study|Death|0|||
105925937|NCT01369433|365387945|FG000|Overall Study|Investigator discretion|6|||
105925938|NCT01369433|365387946|FG001|Overall Study|Investigator discretion|1|||
105925939|NCT01369433|365387945|FG000|Overall Study|Progressive Disease|92|||
105925940|NCT01369433|365387946|FG001|Overall Study|Progressive Disease|12|||
105925941|NCT01553851|365387947|FG000|Overall Study|Adverse Event|2|||
105925942|NCT01553851|365387947|FG000|Overall Study|constipation|1|||
105925943|NCT00311168|365387953|FG000|First Intervention|Withdrawal by Subject|2|||
105925944|NCT00311168|365387954|FG001|First Intervention|Withdrawal by Subject|2|||
105925945|NCT00311168|365387953|FG000|First Intervention|Lost to Follow-up|1|||
105925946|NCT00311168|365387954|FG001|First Intervention|Lost to Follow-up|1|||
105925947|NCT00311168|365387953|FG000|First Intervention|Protocol Violation|1|||
105925948|NCT00311168|365387954|FG001|First Intervention|Protocol Violation|1|||
105925949|NCT00311168|365387953|FG000|First Intervention|Adverse Event|1|||
105925950|NCT00311168|365387954|FG001|First Intervention|Adverse Event|0|||
105925951|NCT00311168|365387953|FG000|First Intervention|Other|2|||
105925952|NCT00311168|365387954|FG001|First Intervention|Other|2|||
105925953|NCT00311168|365387953|FG000|Second Intervention|Lost to Follow-up|9|||
105925954|NCT00311168|365387954|FG001|Second Intervention|Lost to Follow-up|2|||
105925955|NCT00311168|365387953|FG000|Second Intervention|Withdrawal by Subject|0|||
105925956|NCT00311168|365387954|FG001|Second Intervention|Withdrawal by Subject|1|||
105925957|NCT00311168|365387953|FG000|Second Intervention|Other|1|||
105925958|NCT00311168|365387954|FG001|Second Intervention|Other|1|||
105925959|NCT01697579|365387955|FG000|Base Study-Cycle 1|Adverse Event|1|||
105925960|NCT01697579|365387956|FG001|Base Study-Cycle 1|Adverse Event|0|||
105925961|NCT01697579|365387957|FG002|Base Study-Cycle 1|Adverse Event|0|||
105925962|NCT01697579|365387958|FG003|Base Study-Cycle 1|Adverse Event|0|||
105925963|NCT01697579|365387959|FG004|Base Study-Cycle 1|Adverse Event|0|||
105925964|NCT01697579|365387960|FG005|Base Study-Cycle 1|Adverse Event|0|||
105925965|NCT01697579|365387961|FG006|Base Study-Cycle 1|Adverse Event|0|||
105925966|NCT01697579|365387955|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
105925967|NCT01697579|365387956|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105925968|NCT01697579|365387957|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105925969|NCT01697579|365387958|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105925970|NCT01697579|365387959|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105925971|NCT01697579|365387960|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105925972|NCT01697579|365387961|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
105925973|NCT01697579|365387955|FG000|Base Study-Cycle 1|Protocol Violation|0|||
105925974|NCT01697579|365387956|FG001|Base Study-Cycle 1|Protocol Violation|0|||
105925975|NCT01697579|365387957|FG002|Base Study-Cycle 1|Protocol Violation|0|||
105925976|NCT01697579|365387958|FG003|Base Study-Cycle 1|Protocol Violation|0|||
105925977|NCT01697579|365387959|FG004|Base Study-Cycle 1|Protocol Violation|3|||
105925978|NCT01697579|365387960|FG005|Base Study-Cycle 1|Protocol Violation|0|||
105925979|NCT01697579|365387961|FG006|Base Study-Cycle 1|Protocol Violation|0|||
105925980|NCT01697579|365387955|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105925981|NCT01697579|365387956|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
105925982|NCT01697579|365387957|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105925983|NCT01697579|365387958|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105925984|NCT01697579|365387959|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105925985|NCT01697579|365387960|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105925986|NCT01697579|365387961|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
105925987|NCT01697579|365387955|FG000|Base Study-Cycle 1|Technical Problems|0|||
105925988|NCT01697579|365387956|FG001|Base Study-Cycle 1|Technical Problems|0|||
105925989|NCT01697579|365387957|FG002|Base Study-Cycle 1|Technical Problems|1|||
105925990|NCT01697579|365387958|FG003|Base Study-Cycle 1|Technical Problems|1|||
105925991|NCT01697579|365387959|FG004|Base Study-Cycle 1|Technical Problems|0|||
105925992|NCT01697579|365387960|FG005|Base Study-Cycle 1|Technical Problems|0|||
105925993|NCT01697579|365387961|FG006|Base Study-Cycle 1|Technical Problems|0|||
105925994|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Death|0|||
105925995|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Death|0|||
105925996|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Death|0|||
105925997|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Death|0|||
105925998|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Death|0|||
105925999|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Death|0|||
105926000|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Death|2|||
105926001|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105926002|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105926003|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105926004|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105926005|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105926006|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
105926007|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
105926008|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
105926009|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
105926010|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
105926011|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
105926012|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
105926013|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
105926014|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
105926015|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105926016|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105926017|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105926018|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105926019|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105926020|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
105926021|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
105926022|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105926023|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105926024|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105926025|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105926026|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
105926027|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
105926028|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
105926029|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105926030|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105926031|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105926032|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105926033|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105926034|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
105926035|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
105926036|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105926037|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105926038|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105926039|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105926040|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
105926041|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
105926042|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
105926043|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105926044|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105926045|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105926046|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105926047|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
105926048|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
105926049|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
105926050|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105926051|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105926052|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105926053|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105926054|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105926055|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
105926056|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
105926057|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
105926058|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
105926059|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
105926060|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
105926061|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
105926062|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
105926063|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
105926064|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
105926065|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
105926066|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
105926067|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
105926068|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
105926069|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
105926070|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
105926071|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105926072|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105926073|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105926074|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105926075|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
105926076|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
105926077|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
105926078|NCT01697579|365387955|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105926079|NCT01697579|365387956|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105926080|NCT01697579|365387957|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105926081|NCT01697579|365387958|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105926082|NCT01697579|365387959|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
105926083|NCT01697579|365387960|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
106005960|NCT01488045|365686502|FG000|Overall Study|Failure to present for colonoscopy|3|||
106133549|NCT04423393|366148095|FG000|Overall Study|Withdrawal by Subject|0|||
106133550|NCT04423393|366148096|FG001|Overall Study|Withdrawal by Subject|0|||
106133551|NCT04423393|366148097|FG002|Overall Study|Withdrawal by Subject|0|||
105926084|NCT01697579|365387961|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
105926085|NCT00975923|365387969|FG000|Overall Study|Withdrawal by Subject|0|||
105926086|NCT00975923|365387970|FG001|Overall Study|Withdrawal by Subject|1|||
105926087|NCT00695019|365387972|FG000|Overall Study|Withdrawal by Subject|8|||
105926088|NCT00695019|365387973|FG001|Overall Study|Withdrawal by Subject|6|||
105926089|NCT00695019|365387974|FG002|Overall Study|Withdrawal by Subject|4|||
105926090|NCT00695019|365387972|FG000|Overall Study|Protocol Violation|1|||
105926091|NCT00695019|365387973|FG001|Overall Study|Protocol Violation|3|||
105926092|NCT00695019|365387974|FG002|Overall Study|Protocol Violation|1|||
105926093|NCT00695019|365387972|FG000|Overall Study|Lack of Efficacy|0|||
105926094|NCT00695019|365387973|FG001|Overall Study|Lack of Efficacy|0|||
105926095|NCT00695019|365387974|FG002|Overall Study|Lack of Efficacy|1|||
105926096|NCT00695019|365387972|FG000|Overall Study|Various|4|||
105926097|NCT00695019|365387973|FG001|Overall Study|Various|5|||
105926098|NCT00695019|365387974|FG002|Overall Study|Various|4|||
105926099|NCT02278354|365387980|FG000|Overall Study|Lost to Follow-up|2|||
105926100|NCT02278354|365387981|FG001|Overall Study|Lost to Follow-up|2|||
105926101|NCT02278354|365387980|FG000|Overall Study|Withdrawal by Subject|0|||
105926102|NCT02278354|365387981|FG001|Overall Study|Withdrawal by Subject|1|||
105926103|NCT02278354|365387980|FG000|Overall Study|<10 professional fights|2|||
105926104|NCT02278354|365387981|FG001|Overall Study|<10 professional fights|0|||
105926105|NCT01901562|365387983|FG000|Overall Study|Protocol Violation|5|||
105926106|NCT01901562|365387983|FG000|Overall Study|Excluded intraoperatively|4|||
105926107|NCT03197129|365387984|FG000|Overall Study|did not answer the VPT: shyness|4|||
105926108|NCT03197129|365387985|FG001|Overall Study|did not answer the VPT: shyness|5|||
105926109|NCT02572167|365387987|FG000|Overall Study|Withdrawal by Subject|0|||
105926110|NCT02572167|365387988|FG001|Overall Study|Withdrawal by Subject|3|||
105926111|NCT02572167|365387989|FG002|Overall Study|Withdrawal by Subject|0|||
105926112|NCT02572167|365387987|FG000|Overall Study|Lost to Follow-up|2|||
105926113|NCT02572167|365387988|FG001|Overall Study|Lost to Follow-up|5|||
105926114|NCT02572167|365387989|FG002|Overall Study|Lost to Follow-up|3|||
105926115|NCT02572167|365387987|FG000|Overall Study|Death|0|||
105926116|NCT02572167|365387988|FG001|Overall Study|Death|8|||
105926117|NCT02572167|365387989|FG002|Overall Study|Death|3|||
105926118|NCT02572167|365387987|FG000|Overall Study|Did not meet inclusion criteria|0|||
105926119|NCT02572167|365387988|FG001|Overall Study|Did not meet inclusion criteria|0|||
105926120|NCT02572167|365387989|FG002|Overall Study|Did not meet inclusion criteria|1|||
105926121|NCT02572167|365387987|FG000|Overall Study|Study closure by Sponsor|4|||
105926122|NCT02572167|365387988|FG001|Overall Study|Study closure by Sponsor|40|||
105926123|NCT02572167|365387989|FG002|Overall Study|Study closure by Sponsor|24|||
105926124|NCT00005047|365387990|FG000|Overall Study|Withdrawal by Subject|12|||
105926125|NCT00005047|365387991|FG001|Overall Study|Withdrawal by Subject|0|||
105926126|NCT00005047|365387992|FG002|Overall Study|Withdrawal by Subject|0|||
105926127|NCT00005047|365387993|FG003|Overall Study|Withdrawal by Subject|0|||
105926128|NCT00005047|365387990|FG000|Overall Study|Adverse Event|5|||
105926129|NCT00005047|365387991|FG001|Overall Study|Adverse Event|0|||
105926130|NCT00005047|365387992|FG002|Overall Study|Adverse Event|0|||
105926131|NCT00005047|365387993|FG003|Overall Study|Adverse Event|0|||
105926132|NCT00005047|365387990|FG000|Overall Study|Lost to Follow-up|1|||
105926133|NCT00005047|365387991|FG001|Overall Study|Lost to Follow-up|0|||
105926134|NCT00005047|365387992|FG002|Overall Study|Lost to Follow-up|0|||
105926135|NCT00005047|365387993|FG003|Overall Study|Lost to Follow-up|0|||
105926136|NCT00005047|365387990|FG000|Overall Study|Lack of Efficacy|1|||
105926137|NCT00005047|365387991|FG001|Overall Study|Lack of Efficacy|0|||
105926138|NCT00005047|365387992|FG002|Overall Study|Lack of Efficacy|0|||
105926139|NCT00005047|365387993|FG003|Overall Study|Lack of Efficacy|0|||
105926140|NCT00580840|365387994|FG000|Run-in|Adverse Event|17|||
105926141|NCT00580840|365387995|FG001|Run-in|Adverse Event|0|||
105926142|NCT00580840|365387996|FG002|Run-in|Adverse Event|0|||
105926143|NCT00580840|365387997|FG003|Run-in|Adverse Event|0|||
105926144|NCT00580840|365387994|FG000|Run-in|Lack of Efficacy|93|||
105926145|NCT00580840|365387995|FG001|Run-in|Lack of Efficacy|0|||
105926146|NCT00580840|365387996|FG002|Run-in|Lack of Efficacy|0|||
105926147|NCT00580840|365387997|FG003|Run-in|Lack of Efficacy|0|||
105926148|NCT00580840|365387994|FG000|Run-in|Loss of Efficacy|1|||
106005961|NCT01488045|365686503|FG001|Overall Study|Failure to present for colonoscopy|6|||
106005962|NCT01488045|365686502|FG000|Overall Study|Failure to report exclusion criteria|0|||
105926149|NCT00580840|365387995|FG001|Run-in|Loss of Efficacy|0|||
105926150|NCT00580840|365387996|FG002|Run-in|Loss of Efficacy|0|||
105926151|NCT00580840|365387997|FG003|Run-in|Loss of Efficacy|0|||
105926152|NCT00580840|365387994|FG000|Run-in|Lost to Follow-up|4|||
105926153|NCT00580840|365387995|FG001|Run-in|Lost to Follow-up|0|||
105926154|NCT00580840|365387996|FG002|Run-in|Lost to Follow-up|0|||
105926155|NCT00580840|365387997|FG003|Run-in|Lost to Follow-up|0|||
105926156|NCT00580840|365387994|FG000|Run-in|Withdrawal by Subject|5|||
105926157|NCT00580840|365387995|FG001|Run-in|Withdrawal by Subject|0|||
105926158|NCT00580840|365387996|FG002|Run-in|Withdrawal by Subject|0|||
105926159|NCT00580840|365387997|FG003|Run-in|Withdrawal by Subject|0|||
105926160|NCT00580840|365387994|FG000|Run-in|Other: Per Sponsor Request|2|||
105926161|NCT00580840|365387995|FG001|Run-in|Other: Per Sponsor Request|0|||
105926162|NCT00580840|365387996|FG002|Run-in|Other: Per Sponsor Request|0|||
105926163|NCT00580840|365387997|FG003|Run-in|Other: Per Sponsor Request|0|||
105926164|NCT00580840|365387994|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
105926165|NCT00580840|365387995|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
106005963|NCT01488045|365686503|FG001|Overall Study|Failure to report exclusion criteria|1|||
106005964|NCT00524485|365686510|FG000|Overall Study|Withdrawal by Subject|5|||
106005965|NCT02399215|365686511|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
106005966|NCT02399215|365686511|FG000|Overall Study|Withdrawal by Subject|1|||
106005967|NCT00436332|365686512|FG000|Overall Study|Adverse Event|9|||
106005968|NCT00436332|365686512|FG000|Overall Study|Withdrawal by Subject|2|||
105926166|NCT00580840|365387996|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
105926167|NCT00580840|365387997|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
106005969|NCT00436332|365686512|FG000|Overall Study|Progression|59|||
106005970|NCT00436332|365686512|FG000|Overall Study|Death|2|||
106005971|NCT00436332|365686512|FG000|Overall Study|Not Protocol Specified|6|||
106005972|NCT00436332|365686512|FG000|Overall Study|Ineligible|2|||
106005973|NCT00436332|365686512|FG000|Overall Study|Never Received Treatment|3|||
106005974|NCT03617172|365686513|FG000|Overall Study|Lost to Follow-up|1|||
106005975|NCT03617172|365686514|FG001|Overall Study|Lost to Follow-up|0|||
105926168|NCT00580840|365387994|FG000|Run-in|Other: Exclusionary Lab Value|1|||
105926169|NCT00580840|365387995|FG001|Run-in|Other: Exclusionary Lab Value|0|||
105926170|NCT00580840|365387996|FG002|Run-in|Other: Exclusionary Lab Value|0|||
105926171|NCT00580840|365387997|FG003|Run-in|Other: Exclusionary Lab Value|0|||
105926172|NCT00580840|365387994|FG000|Double-Blind|Adverse Event|0|||
105926173|NCT00580840|365387995|FG001|Double-Blind|Adverse Event|3|||
105926174|NCT00580840|365387996|FG002|Double-Blind|Adverse Event|4|||
105926175|NCT00580840|365387997|FG003|Double-Blind|Adverse Event|1|||
105926176|NCT00580840|365387994|FG000|Double-Blind|Loss of Efficacy|0|||
105926177|NCT00580840|365387995|FG001|Double-Blind|Loss of Efficacy|1|||
105926178|NCT00580840|365387996|FG002|Double-Blind|Loss of Efficacy|2|||
105926179|NCT00580840|365387997|FG003|Double-Blind|Loss of Efficacy|10|||
105926180|NCT00580840|365387994|FG000|Double-Blind|Lost to Follow-up|0|||
105926181|NCT00580840|365387995|FG001|Double-Blind|Lost to Follow-up|1|||
105926182|NCT00580840|365387996|FG002|Double-Blind|Lost to Follow-up|0|||
105926183|NCT00580840|365387997|FG003|Double-Blind|Lost to Follow-up|2|||
105926184|NCT00580840|365387994|FG000|Double-Blind|Withdrawal by Subject|0|||
106005976|NCT00189540|365686515|FG000|Overall Study|Withdrawal by Subject|3|||
106005977|NCT00189540|365686516|FG001|Overall Study|Withdrawal by Subject|0|||
106005978|NCT00189540|365686515|FG000|Overall Study|Death|4|||
106005979|NCT00189540|365686516|FG001|Overall Study|Death|1|||
106005980|NCT00472108|365686517|FG000|Overall Study|Lost to Follow-up|0|||
105700696|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700697|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
105700698|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700699|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
105700700|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700701|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700702|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700703|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
105700704|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700705|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700706|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
105700707|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700708|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700709|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
105700710|NCT00111800|364566691|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105700711|NCT00111800|364566692|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
106005981|NCT00472108|365686518|FG001|Overall Study|Lost to Follow-up|1|||
106005982|NCT00062439|365686519|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
106005983|NCT00062439|365686519|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
105700712|NCT00111800|364566693|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
105700713|NCT00111800|364566694|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105700714|NCT00111800|364566695|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105926185|NCT00580840|365387995|FG001|Double-Blind|Withdrawal by Subject|1|||
105926186|NCT00580840|365387996|FG002|Double-Blind|Withdrawal by Subject|2|||
105926187|NCT00580840|365387997|FG003|Double-Blind|Withdrawal by Subject|2|||
106005984|NCT00062439|365686519|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
106005985|NCT00062439|365686519|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
106005986|NCT00062439|365686519|FG000|Post Chemoradiation Assessment|Death|1|||
105926188|NCT00580840|365387994|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
105926189|NCT00580840|365387995|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
105700715|NCT00111800|364566696|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
105700716|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
105700717|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
105700718|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
105700719|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
105700720|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
105700721|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
105700722|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
105700723|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
105700724|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
105700725|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
105700726|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
105700727|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
105700728|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
105700729|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
105700730|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
105700731|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
105700732|NCT00094770|364566697|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
105700733|NCT00094770|364566698|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
105700734|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
105700735|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
105700736|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
105700737|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
105700738|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
105700739|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
105700740|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
105700741|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
105700742|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
105700743|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
105700744|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
105700745|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
105700746|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
105700747|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
105700748|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
105700749|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
105700750|NCT00094770|364566697|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
105700751|NCT00094770|364566698|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
105700752|NCT00253643|364566699|FG000|Overall Study|Withdrawal by Subject|0|||
105700753|NCT00253643|364566700|FG001|Overall Study|Withdrawal by Subject|0|||
105700754|NCT00253643|364566701|FG002|Overall Study|Withdrawal by Subject|1|||
105700755|NCT00253643|364566702|FG003|Overall Study|Withdrawal by Subject|1|||
105700756|NCT00253643|364566699|FG000|Overall Study|Non-Compliance|0|||
105700757|NCT00253643|364566700|FG001|Overall Study|Non-Compliance|0|||
105700758|NCT00253643|364566701|FG002|Overall Study|Non-Compliance|0|||
105700759|NCT00253643|364566702|FG003|Overall Study|Non-Compliance|2|||
105700760|NCT01549275|364566703|FG000|Overall Study|Lost to Follow-up|1|||
105700761|NCT01549275|364566704|FG001|Overall Study|Lost to Follow-up|0|||
105700762|NCT01843842|364566707|FG000|Overall Study|Do not meet inclusion criteria|1|||
105700763|NCT01843842|364566708|FG001|Overall Study|Do not meet inclusion criteria|1|||
105700764|NCT01671111|364566709|FG000|Overall Study|Adverse Event|2|||
105700765|NCT01671111|364566709|FG000|Overall Study|Lack of Efficacy|1|||
105700766|NCT01671111|364566709|FG000|Overall Study|Withdrawal by Subject|2|||
105700767|NCT01671111|364566709|FG000|Overall Study|Physician Decision|1|||
105700768|NCT01671111|364566709|FG000|Overall Study|Other|24|||
105700769|NCT02343159|364566712|FG000|Overall Study|Early Study Termination|16|||
105700770|NCT02343159|364566713|FG001|Overall Study|Early Study Termination|19|||
105700771|NCT02343159|364566714|FG002|Overall Study|Early Study Termination|23|||
105700772|NCT02343159|364566712|FG000|Overall Study|Physician Decision|2|||
105700773|NCT02343159|364566713|FG001|Overall Study|Physician Decision|0|||
105700774|NCT02343159|364566714|FG002|Overall Study|Physician Decision|1|||
105700775|NCT02343159|364566712|FG000|Overall Study|Withdrawal by Subject|3|||
105700776|NCT02343159|364566713|FG001|Overall Study|Withdrawal by Subject|0|||
105700777|NCT02343159|364566714|FG002|Overall Study|Withdrawal by Subject|2|||
105700778|NCT02343159|364566712|FG000|Overall Study|Lost to Follow-up|0|||
105700779|NCT02343159|364566713|FG001|Overall Study|Lost to Follow-up|2|||
105700780|NCT02343159|364566714|FG002|Overall Study|Lost to Follow-up|2|||
105700781|NCT02343159|364566712|FG000|Overall Study|Adverse Event|4|||
105700782|NCT02343159|364566713|FG001|Overall Study|Adverse Event|4|||
105700783|NCT02343159|364566714|FG002|Overall Study|Adverse Event|2|||
105700784|NCT02343159|364566712|FG000|Overall Study|Sponsor Decision|0|||
105700785|NCT02343159|364566713|FG001|Overall Study|Sponsor Decision|1|||
105700786|NCT02343159|364566714|FG002|Overall Study|Sponsor Decision|0|||
105700787|NCT02343159|364566712|FG000|Overall Study|Enrollment Error|1|||
105700788|NCT02343159|364566713|FG001|Overall Study|Enrollment Error|0|||
105787270|NCT03985982|364874918|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105787271|NCT03985982|364874916|FG000|Double-Blind Phase|Physician Decision|1|||
105787272|NCT03985982|364874917|FG001|Double-Blind Phase|Physician Decision|0|||
105787273|NCT03985982|364874918|FG002|Double-Blind Phase|Physician Decision|0|||
105787274|NCT03985982|364874916|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
105787275|NCT03985982|364874917|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
105787276|NCT03985982|364874918|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105787277|NCT03985982|364874916|FG000|Double-Blind Phase|COVID-19|1|||
105787278|NCT03985982|364874917|FG001|Double-Blind Phase|COVID-19|0|||
105787279|NCT03985982|364874918|FG002|Double-Blind Phase|COVID-19|0|||
105787280|NCT03985982|364874916|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
106133552|NCT04423393|366148098|FG003|Overall Study|Withdrawal by Subject|0|||
106133553|NCT04423393|366148099|FG004|Overall Study|Withdrawal by Subject|0|||
106133554|NCT04423393|366148100|FG005|Overall Study|Withdrawal by Subject|1|||
106133555|NCT04423393|366148101|FG006|Overall Study|Withdrawal by Subject|0|||
106133556|NCT04423393|366148102|FG007|Overall Study|Withdrawal by Subject|0|||
106133557|NCT04423393|366148103|FG008|Overall Study|Withdrawal by Subject|0|||
106133558|NCT04423393|366148104|FG009|Overall Study|Withdrawal by Subject|0|||
106133559|NCT04423393|366148105|FG010|Overall Study|Withdrawal by Subject|0|||
106133560|NCT04423393|366148106|FG011|Overall Study|Withdrawal by Subject|0|||
106133561|NCT04423393|366148107|FG012|Overall Study|Withdrawal by Subject|0|||
106133562|NCT04423393|366148108|FG013|Overall Study|Withdrawal by Subject|1|||
106133563|NCT04423393|366148109|FG014|Overall Study|Withdrawal by Subject|0|||
106133564|NCT04423393|366148110|FG015|Overall Study|Withdrawal by Subject|0|||
106133565|NCT04423393|366148111|FG016|Overall Study|Withdrawal by Subject|0|||
106133566|NCT04423393|366148112|FG017|Overall Study|Withdrawal by Subject|0|||
106133567|NCT04423393|366148095|FG000|Overall Study|Sponsor Decision|0|||
105700789|NCT02343159|364566714|FG002|Overall Study|Enrollment Error|0|||
105700790|NCT02004262|364566715|FG000|Overall Study|Death|67|||
105700791|NCT02004262|364566716|FG001|Overall Study|Death|64|||
105700792|NCT02004262|364566717|FG002|Overall Study|Death|66|||
105700793|NCT02004262|364566718|FG003|Overall Study|Death|28|||
105700794|NCT02004262|364566719|FG004|Overall Study|Death|29|||
106133568|NCT04423393|366148096|FG001|Overall Study|Sponsor Decision|0|||
106133569|NCT04423393|366148097|FG002|Overall Study|Sponsor Decision|0|||
105700795|NCT02004262|364566720|FG005|Overall Study|Death|22|||
105700796|NCT02004262|364566715|FG000|Overall Study|Withdrawal by Subject|1|||
106133570|NCT04423393|366148098|FG003|Overall Study|Sponsor Decision|0|||
105700797|NCT02004262|364566716|FG001|Overall Study|Withdrawal by Subject|0|||
105700798|NCT02004262|364566717|FG002|Overall Study|Withdrawal by Subject|4|||
105700799|NCT02004262|364566718|FG003|Overall Study|Withdrawal by Subject|0|||
105700800|NCT02004262|364566719|FG004|Overall Study|Withdrawal by Subject|1|||
105700801|NCT02004262|364566720|FG005|Overall Study|Withdrawal by Subject|3|||
105700802|NCT02004262|364566715|FG000|Overall Study|Lost to Follow-up|1|||
105700803|NCT02004262|364566716|FG001|Overall Study|Lost to Follow-up|1|||
105700804|NCT02004262|364566717|FG002|Overall Study|Lost to Follow-up|0|||
105700805|NCT02004262|364566718|FG003|Overall Study|Lost to Follow-up|0|||
105700806|NCT02004262|364566719|FG004|Overall Study|Lost to Follow-up|0|||
105700807|NCT02004262|364566720|FG005|Overall Study|Lost to Follow-up|0|||
105700808|NCT02004262|364566715|FG000|Overall Study|Study Terminated by Sponsor|4|||
105700809|NCT02004262|364566716|FG001|Overall Study|Study Terminated by Sponsor|3|||
105700810|NCT02004262|364566717|FG002|Overall Study|Study Terminated by Sponsor|2|||
105700811|NCT02004262|364566718|FG003|Overall Study|Study Terminated by Sponsor|1|||
105700812|NCT02004262|364566719|FG004|Overall Study|Study Terminated by Sponsor|1|||
105700813|NCT02004262|364566720|FG005|Overall Study|Study Terminated by Sponsor|5|||
105700814|NCT01923285|364566721|FG000|Overall Study|Withdrawal by Subject|7|||
105700815|NCT01923285|364566722|FG001|Overall Study|Withdrawal by Subject|6|||
105700816|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Death|0|||
105700817|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Death|2|||
105700818|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Death|0|||
105700819|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
105700820|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
105700821|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
105700822|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
105700823|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
105700824|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
105700825|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
105700826|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
105700827|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
105700828|NCT03200366|364566723|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
106133571|NCT04423393|366148099|FG004|Overall Study|Sponsor Decision|0|||
105700829|NCT03200366|364566724|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
105787281|NCT03985982|364874917|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
105700830|NCT03200366|364566725|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
105700831|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Death|1|||
105700832|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Death|1|||
105700833|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Death|1|||
105700834|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
105700835|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
105700836|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
105700837|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
105700838|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
105700839|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
105700840|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
105700841|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
105700842|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
105700843|NCT03200366|364566723|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
105700844|NCT03200366|364566724|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
105700845|NCT03200366|364566725|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
105700846|NCT03200366|364566723|FG000|9 Month Post-Baseline Interview|Death|1|||
105700847|NCT03200366|364566724|FG001|9 Month Post-Baseline Interview|Death|1|||
105700848|NCT03200366|364566725|FG002|9 Month Post-Baseline Interview|Death|1|||
105700849|NCT03200366|364566723|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
105700850|NCT03200366|364566724|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
105700851|NCT03200366|364566725|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
105700852|NCT03200366|364566723|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
105700853|NCT03200366|364566724|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
105700854|NCT03200366|364566725|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
105700855|NCT03200366|364566723|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
105700856|NCT03200366|364566724|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
105700857|NCT03200366|364566725|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
105700858|NCT04315181|364566728|FG000|Overall Study|Non-responsive to drug conditions.|1|||
105700859|NCT00711425|364566729|FG000|Overall Study|Protocol Violation|1|||
105700860|NCT00711425|364566729|FG000|Overall Study|Death|2|||
105700861|NCT00711425|364566729|FG000|Overall Study|Lost to Follow-up|1|||
105700862|NCT05879107|364566730|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
105700863|NCT05879107|364566731|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
105700864|NCT05879107|364566730|FG000|Overall Study|Migrated / moved from the study area|1|||
105700865|NCT05879107|364566731|FG001|Overall Study|Migrated / moved from the study area|1|||
105700866|NCT05879107|364566730|FG000|Overall Study|Lost to Follow-up|8|||
105700867|NCT05879107|364566731|FG001|Overall Study|Lost to Follow-up|13|||
105700868|NCT05879107|364566730|FG000|Overall Study|Death|0|||
105700869|NCT05879107|364566731|FG001|Overall Study|Death|2|||
105700870|NCT05879107|364566730|FG000|Overall Study|Other|0|||
105700871|NCT05879107|364566731|FG001|Overall Study|Other|3|||
105700872|NCT01056510|364566732|FG000|Overall Study|Dropout Before Start of Treatment|1|||
105700873|NCT01056510|364566733|FG001|Overall Study|Dropout Before Start of Treatment|1|||
105700874|NCT01056510|364566732|FG000|Overall Study|Withdrawal by Subject|4|||
105700875|NCT01056510|364566733|FG001|Overall Study|Withdrawal by Subject|2|||
105700876|NCT01056510|364566732|FG000|Overall Study|Death|29|||
105700877|NCT01056510|364566733|FG001|Overall Study|Death|34|||
105700878|NCT01056510|364566732|FG000|Overall Study|Noncompliance|1|||
105700879|NCT01056510|364566733|FG001|Overall Study|Noncompliance|3|||
105700880|NCT01056510|364566732|FG000|Overall Study|Physician Decision|4|||
105700881|NCT01056510|364566733|FG001|Overall Study|Physician Decision|5|||
105700882|NCT01056510|364566732|FG000|Overall Study|Lost to Follow-up|5|||
105700883|NCT01056510|364566733|FG001|Overall Study|Lost to Follow-up|6|||
105700884|NCT01056510|364566732|FG000|Overall Study|Other|10|||
105700885|NCT01056510|364566733|FG001|Overall Study|Other|12|||
105700886|NCT01056510|364566732|FG000|Overall Study|Missing|0|||
105700887|NCT01056510|364566733|FG001|Overall Study|Missing|1|||
105700888|NCT01793142|364566736|FG000|Overall Study|Randomized not treated|7|||
105700889|NCT01087775|364566737|FG000|Overall Study|failed inclusion criteria|2|||
105700890|NCT01553188|364566738|FG000|Overall Study|Patient choice|1|||
105700891|NCT01553188|364566739|FG001|Overall Study|Patient choice|0|||
105700892|NCT01553188|364566740|FG002|Overall Study|Patient choice|0|||
105700893|NCT01553188|364566741|FG003|Overall Study|Patient choice|0|||
105700894|NCT01553188|364566738|FG000|Overall Study|Intercurrent illness and adverse event|0|||
105700895|NCT01553188|364566739|FG001|Overall Study|Intercurrent illness and adverse event|1|||
105700896|NCT01553188|364566740|FG002|Overall Study|Intercurrent illness and adverse event|2|||
105700897|NCT01553188|364566741|FG003|Overall Study|Intercurrent illness and adverse event|0|||
105700898|NCT01617070|364566743|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
105700899|NCT00117598|364566744|FG000|Prior to Treatment Cross Over|Death|40|||
105700900|NCT00117598|364566745|FG001|Prior to Treatment Cross Over|Death|41|||
105700901|NCT00117598|364566746|FG002|Prior to Treatment Cross Over|Death|37|||
105700902|NCT00117598|364566747|FG003|Prior to Treatment Cross Over|Death|0|||
105700903|NCT00117598|364566748|FG004|Prior to Treatment Cross Over|Death|0|||
105700904|NCT00117598|364566744|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
105700905|NCT00117598|364566745|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
105700906|NCT00117598|364566746|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
105700907|NCT00117598|364566747|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
105700908|NCT00117598|364566748|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
105700909|NCT00117598|364566744|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
105700910|NCT00117598|364566745|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
105700911|NCT00117598|364566746|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
105700912|NCT00117598|364566747|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
105700913|NCT00117598|364566748|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
105700914|NCT00117598|364566744|FG000|Prior to Treatment Cross Over|Other|15|||
105700915|NCT00117598|364566745|FG001|Prior to Treatment Cross Over|Other|9|||
105700916|NCT00117598|364566746|FG002|Prior to Treatment Cross Over|Other|9|||
105700917|NCT00117598|364566747|FG003|Prior to Treatment Cross Over|Other|0|||
105700918|NCT00117598|364566748|FG004|Prior to Treatment Cross Over|Other|0|||
105700919|NCT00117598|364566744|FG000|After Treament Cross Over|Death|0|||
105700920|NCT00117598|364566745|FG001|After Treament Cross Over|Death|0|||
105700921|NCT00117598|364566746|FG002|After Treament Cross Over|Death|0|||
105700922|NCT00117598|364566747|FG003|After Treament Cross Over|Death|1|||
105700923|NCT00117598|364566748|FG004|After Treament Cross Over|Death|2|||
105926190|NCT00580840|365387996|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
105926191|NCT00580840|365387997|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
105926192|NCT00580840|365387994|FG000|Double-Blind|Other: Forbidden Medication|0|||
105926193|NCT00580840|365387995|FG001|Double-Blind|Other: Forbidden Medication|0|||
105926194|NCT00580840|365387996|FG002|Double-Blind|Other: Forbidden Medication|1|||
105926195|NCT00580840|365387997|FG003|Double-Blind|Other: Forbidden Medication|0|||
105926196|NCT00433537|365387998|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
105926197|NCT00433537|365387999|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
105926198|NCT00433537|365388000|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
105926199|NCT00433537|365387998|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
105926200|NCT00433537|365387999|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
105926201|NCT00433537|365388000|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
105926202|NCT00433537|365387998|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
105926203|NCT00433537|365387999|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
105926204|NCT00433537|365388000|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
105926205|NCT00433537|365387998|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
105926206|NCT00433537|365387999|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
105926207|NCT00433537|365388000|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
105926208|NCT00433537|365387998|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
105926209|NCT00433537|365387999|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
105926210|NCT00433537|365388000|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
105926211|NCT00433537|365387998|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
105926212|NCT00433537|365387999|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
105926213|NCT00433537|365388000|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
105926214|NCT00433537|365387998|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
105926215|NCT00433537|365387999|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
105926216|NCT00433537|365388000|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
105926217|NCT00433537|365387998|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
105926218|NCT00433537|365387999|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
105926219|NCT00433537|365388000|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
105926220|NCT00433537|365387998|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
105926221|NCT00433537|365387999|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
105926222|NCT00433537|365388000|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
105926223|NCT00831844|365388003|FG000|Overall Study|Adverse Event|2|||
105926224|NCT00831844|365388004|FG001|Overall Study|Adverse Event|0|||
105926225|NCT00831844|365388005|FG002|Overall Study|Adverse Event|0|||
105926226|NCT00831844|365388006|FG003|Overall Study|Adverse Event|0|||
105926227|NCT00831844|365388007|FG004|Overall Study|Adverse Event|1|||
105926228|NCT00831844|365388008|FG005|Overall Study|Adverse Event|1|||
105926229|NCT00831844|365388009|FG006|Overall Study|Adverse Event|2|||
105926230|NCT00831844|365388010|FG007|Overall Study|Adverse Event|0|||
105926231|NCT00831844|365388011|FG008|Overall Study|Adverse Event|0|||
105926232|NCT00831844|365388012|FG009|Overall Study|Adverse Event|0|||
105926233|NCT00831844|365388003|FG000|Overall Study|Death|0|||
105700924|NCT00117598|364566744|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
105926234|NCT00831844|365388004|FG001|Overall Study|Death|0|||
105926235|NCT00831844|365388005|FG002|Overall Study|Death|0|||
105926236|NCT00831844|365388006|FG003|Overall Study|Death|1|||
105926237|NCT00831844|365388007|FG004|Overall Study|Death|0|||
105926238|NCT00831844|365388008|FG005|Overall Study|Death|0|||
105700925|NCT00117598|364566745|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
105700926|NCT00117598|364566746|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
105700927|NCT00117598|364566747|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
105700928|NCT00117598|364566748|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
105700929|NCT00117598|364566744|FG000|After Treament Cross Over|Other|0|||
105700930|NCT00117598|364566745|FG001|After Treament Cross Over|Other|0|||
105700931|NCT00117598|364566746|FG002|After Treament Cross Over|Other|0|||
105700932|NCT00117598|364566747|FG003|After Treament Cross Over|Other|1|||
105700933|NCT00117598|364566748|FG004|After Treament Cross Over|Other|2|||
105700934|NCT04544475|364566749|FG000|Overall Study|Withdrawal by Subject|1|||
105700935|NCT04544475|364566750|FG001|Overall Study|Withdrawal by Subject|3|||
106005987|NCT00062439|365686519|FG000|Post Chemoradiation Assessment|Disease progression|2|||
106005988|NCT00062439|365686519|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
106005989|NCT00062439|365686519|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
106005990|NCT00062439|365686519|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
106005991|NCT00062439|365686519|FG000|Surgery|Physician Decision|4|||
105700936|NCT00808236|364566751|FG000|Overall Study|Was not resuscitated|50|||
105700937|NCT00808236|364566752|FG001|Overall Study|Was not resuscitated|56|||
105700938|NCT00808236|364566751|FG000|Overall Study|Pre-defined exclusion|13|||
105700939|NCT00808236|364566752|FG001|Overall Study|Pre-defined exclusion|3|||
105700940|NCT00808236|364566751|FG000|Overall Study|Lost to Follow-up|1|||
105700941|NCT00808236|364566752|FG001|Overall Study|Lost to Follow-up|1|||
105700942|NCT00808236|364566751|FG000|Overall Study|Physician Decision|0|||
105700943|NCT00808236|364566752|FG001|Overall Study|Physician Decision|1|||
105700944|NCT00808236|364566751|FG000|Overall Study|Death|18|||
105700945|NCT00808236|364566752|FG001|Overall Study|Death|30|||
105700946|NCT02230384|364566753|FG000|Phase 1|Lost to Follow-up|1|||
105700947|NCT02230384|364566754|FG001|Phase 1|Lost to Follow-up|0|||
105700948|NCT02230384|364566753|FG000|Phase 1|Physician Decision|0|||
105700949|NCT02230384|364566754|FG001|Phase 1|Physician Decision|1|||
105700950|NCT02230384|364566753|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
105700951|NCT02230384|364566754|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
105700952|NCT02230384|364566753|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
105700953|NCT02230384|364566754|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
105700954|NCT02230384|364566753|FG000|Phase 2 - Switch|Adverse Event|2|||
105700955|NCT02230384|364566754|FG001|Phase 2 - Switch|Adverse Event|0|||
105700956|NCT05376215|364566755|FG000|Overall Study|Withdrawal by Subject|2|||
105700957|NCT05376215|364566756|FG001|Overall Study|Withdrawal by Subject|1|||
105700958|NCT05376215|364566755|FG000|Overall Study|Lost to Follow-up|0|||
105700959|NCT05376215|364566756|FG001|Overall Study|Lost to Follow-up|1|||
105700960|NCT01301950|364566761|FG000|Overall Study|Surgery was cancelled by patient|0|||
106005992|NCT00062439|365686519|FG000|Surgery|Death|1|||
106005993|NCT00062439|365686519|FG000|Surgery|Adverse Event|2|||
106005994|NCT00062439|365686519|FG000|Consolidation Chemotherapy|Adverse Event|2|||
106005995|NCT01924845|365686520|FG000|Overall Study|Adverse Event|3|||
106005996|NCT01924845|365686520|FG000|Overall Study|Withdrawal by Subject|2|||
106005997|NCT01924845|365686520|FG000|Overall Study|Protocol Violation|1|||
106005998|NCT00713609|365686521|FG000|Overall Study|Adverse Event|2|||
106005999|NCT00713609|365686522|FG001|Overall Study|Adverse Event|0|||
106006000|NCT00713609|365686523|FG002|Overall Study|Adverse Event|2|||
106006001|NCT00713609|365686524|FG003|Overall Study|Adverse Event|2|||
106006002|NCT00713609|365686525|FG004|Overall Study|Adverse Event|3|||
106006003|NCT00713609|365686526|FG005|Overall Study|Adverse Event|1|||
106006004|NCT00713609|365686521|FG000|Overall Study|Lost to Follow-up|5|||
106006005|NCT00713609|365686522|FG001|Overall Study|Lost to Follow-up|7|||
105700961|NCT01301950|364566762|FG001|Overall Study|Surgery was cancelled by patient|1|||
105700962|NCT01378858|364566763|FG000|Overall Study|Withdrawal by Subject|4|||
105700963|NCT01378858|364566764|FG001|Overall Study|Withdrawal by Subject|4|||
105700964|NCT03715153|364566765|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
105700965|NCT03715153|364566766|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
105700966|NCT03715153|364566765|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
105700967|NCT03715153|364566766|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
105700968|NCT03715153|364566765|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
105700969|NCT03715153|364566766|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
105700970|NCT03715153|364566765|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
105700971|NCT03715153|364566766|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
105700972|NCT03715153|364566765|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
105700973|NCT03715153|364566766|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
105700974|NCT03715153|364566765|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
106006006|NCT00713609|365686523|FG002|Overall Study|Lost to Follow-up|5|||
106006007|NCT00713609|365686524|FG003|Overall Study|Lost to Follow-up|5|||
106006008|NCT00713609|365686525|FG004|Overall Study|Lost to Follow-up|7|||
105700975|NCT03715153|364566766|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
105700976|NCT01378104|364566767|FG000|Overall Study|Adverse Event|8|||
105700977|NCT01378104|364566768|FG001|Overall Study|Adverse Event|8|||
105700978|NCT01378104|364566767|FG000|Overall Study|Lack of Efficacy|7|||
105700979|NCT01378104|364566768|FG001|Overall Study|Lack of Efficacy|5|||
105700980|NCT01378104|364566767|FG000|Overall Study|Withdrawal by Subject|12|||
105700981|NCT01378104|364566768|FG001|Overall Study|Withdrawal by Subject|13|||
105700982|NCT01506960|364566773|FG000|Overall Study|Did not meet angiographic criteria|47|||
105700983|NCT03610724|364566774|FG000|Overall Study|Death|17|||
105700984|NCT03610724|364566774|FG000|Overall Study|Lost to Follow-up|1|||
105700985|NCT03610724|364566774|FG000|Overall Study|Physician Decision|1|||
105700986|NCT03610724|364566774|FG000|Overall Study|Died prior to infusion|1|||
105700987|NCT01519765|364566775|FG000|Overall Study|Adverse Event|0|||
105700988|NCT01519765|364566776|FG001|Overall Study|Adverse Event|1|||
105700989|NCT01519765|364566775|FG000|Overall Study|Lack of Efficacy|2|||
105700990|NCT01519765|364566776|FG001|Overall Study|Lack of Efficacy|0|||
105700991|NCT01519765|364566775|FG000|Overall Study|Protocol Violation|1|||
105700992|NCT01519765|364566776|FG001|Overall Study|Protocol Violation|0|||
105700993|NCT01519765|364566775|FG000|Overall Study|Withdrawal by Subject|0|||
105700994|NCT01519765|364566776|FG001|Overall Study|Withdrawal by Subject|1|||
105700995|NCT00786565|364566780|FG000|Enrollment Prior to Surgery|Site Closed|3|||
105700996|NCT00786565|364566780|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
105700997|NCT00786565|364566780|FG000|Post Surgery|Abnormal macular pucker|1|||
105700998|NCT00786565|364566780|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
105700999|NCT00578136|364566781|FG000|Overall Study|Not given intervention|1|||
105701000|NCT00578136|364566782|FG001|Overall Study|Not given intervention|1|||
105701001|NCT02047253|364566783|FG000|Overall Study|Lost to Follow-up|8|||
105701002|NCT01892163|364566788|FG000|Overall Study|Death|1|||
105701003|NCT01892163|364566789|FG001|Overall Study|Death|1|||
105701004|NCT01892163|364566788|FG000|Overall Study|Lost to Follow-up|1|||
105701005|NCT01892163|364566789|FG001|Overall Study|Lost to Follow-up|0|||
105701006|NCT03302975|364566790|FG000|Overall Study|Lost to Follow-up|4|||
105701007|NCT00432042|364566792|FG000|Overall Study|Protocol Violation|2|||
105701008|NCT00432042|364566793|FG001|Overall Study|Protocol Violation|0|||
105701009|NCT00432042|364566794|FG002|Overall Study|Protocol Violation|0|||
105701010|NCT00432042|364566792|FG000|Overall Study|Withdrawal by Subject|0|||
105701011|NCT00432042|364566793|FG001|Overall Study|Withdrawal by Subject|0|||
105701012|NCT00432042|364566794|FG002|Overall Study|Withdrawal by Subject|2|||
105701013|NCT00432042|364566792|FG000|Overall Study|Lost to Follow-up|5|||
105701014|NCT00432042|364566793|FG001|Overall Study|Lost to Follow-up|1|||
105701015|NCT00432042|364566794|FG002|Overall Study|Lost to Follow-up|0|||
105701016|NCT00993265|364566795|FG000|Overall Study|Adverse Event|1|||
105701017|NCT00993265|364566796|FG001|Overall Study|Adverse Event|0|||
105701018|NCT00993265|364566795|FG000|Overall Study|Changed dose of concomitant drug|2|||
105701019|NCT00993265|364566796|FG001|Overall Study|Changed dose of concomitant drug|0|||
105701020|NCT00993265|364566795|FG000|Overall Study|Non-compliant with study medication|1|||
105701021|NCT00993265|364566796|FG001|Overall Study|Non-compliant with study medication|0|||
105701022|NCT01484977|364566797|FG000|Overall Study|Adverse Event|8|||
105701023|NCT01484977|364566797|FG000|Overall Study|Lack of Efficacy|4|||
105701024|NCT01484977|364566797|FG000|Overall Study|Protocol Violation|6|||
105701025|NCT01484977|364566797|FG000|Overall Study|Lost to Follow-up|1|||
105701026|NCT01484977|364566797|FG000|Overall Study|Withdrawal by Subject|4|||
105701027|NCT01484977|364566797|FG000|Overall Study|Subject Protocol Non-compliant|1|||
105701028|NCT01484977|364566797|FG000|Overall Study|Moving Overseas|1|||
105701029|NCT01484977|364566797|FG000|Overall Study|Low White Blood Cell Count|1|||
105701030|NCT01484977|364566797|FG000|Overall Study|Lack of Compliance|1|||
105701031|NCT00798135|364566800|FG000|Overall Study|Disease progression, relapse|11|||
105701032|NCT00798135|364566800|FG000|Overall Study|Disease progression, refractory|1|||
105701033|NCT00798135|364566800|FG000|Overall Study|Physician Decision|1|||
105701034|NCT01392677|364566809|FG000|Overall Study|Adverse Event|3|||
105701035|NCT01392677|364566810|FG001|Overall Study|Adverse Event|1|||
105701036|NCT01392677|364566809|FG000|Overall Study|Withdrawal by Subject|0|||
105701037|NCT01392677|364566810|FG001|Overall Study|Withdrawal by Subject|2|||
105701038|NCT01392677|364566809|FG000|Overall Study|Incorrect enrollment|2|||
105701039|NCT01392677|364566810|FG001|Overall Study|Incorrect enrollment|3|||
105701040|NCT01392677|364566809|FG000|Overall Study|Other reason|3|||
105701041|NCT01392677|364566810|FG001|Overall Study|Other reason|2|||
105701042|NCT00528021|364566813|FG000|Overall Study|Lack of Efficacy|17|||
105701043|NCT00528021|364566814|FG001|Overall Study|Lack of Efficacy|13|||
105701044|NCT00528021|364566815|FG002|Overall Study|Lack of Efficacy|7|||
105701045|NCT00528021|364566816|FG003|Overall Study|Lack of Efficacy|9|||
105701046|NCT00388973|364568489|FG000|Overall Study|Adverse Event|16|||
105701047|NCT00388973|364568490|FG001|Overall Study|Adverse Event|6|||
105701048|NCT00388973|364568489|FG000|Overall Study|Lack of Efficacy|1|||
105701049|NCT00388973|364568490|FG001|Overall Study|Lack of Efficacy|12|||
105701050|NCT00388973|364568489|FG000|Overall Study|Protocol Violation|3|||
105701051|NCT00388973|364568490|FG001|Overall Study|Protocol Violation|0|||
105701052|NCT00388973|364568489|FG000|Overall Study|Withdrawal by Subject|14|||
105701053|NCT00388973|364568490|FG001|Overall Study|Withdrawal by Subject|17|||
105701054|NCT00388973|364568489|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
105701055|NCT00388973|364568490|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
105701056|NCT00388973|364568489|FG000|Overall Study|Did not complete 61 days of treatment|5|||
106133572|NCT04423393|366148100|FG005|Overall Study|Sponsor Decision|0|||
106133573|NCT04423393|366148101|FG006|Overall Study|Sponsor Decision|0|||
106133574|NCT04423393|366148102|FG007|Overall Study|Sponsor Decision|0|||
106006009|NCT00713609|365686526|FG005|Overall Study|Lost to Follow-up|0|||
106006010|NCT00713609|365686521|FG000|Overall Study|Lack of Efficacy|1|||
105701057|NCT00388973|364568490|FG001|Overall Study|Did not complete 61 days of treatment|4|||
105701058|NCT00388973|364568489|FG000|Overall Study|Left region|0|||
105701059|NCT00388973|364568490|FG001|Overall Study|Left region|1|||
105701060|NCT00388973|364568489|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
105701061|NCT00388973|364568490|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
105701062|NCT02833974|364568497|FG000|Overall Study|Lost to Follow-up|1|||
105701063|NCT02833974|364568498|FG001|Overall Study|Lost to Follow-up|0|||
105701064|NCT02833974|364568497|FG000|Overall Study|Adverse Event|0|||
105701065|NCT02833974|364568498|FG001|Overall Study|Adverse Event|3|||
105701066|NCT00636675|364568499|FG000|Overall Study|Lost to Follow-up|121|||
105701067|NCT00636675|364568500|FG001|Overall Study|Lost to Follow-up|31|||
105701068|NCT00636675|364568499|FG000|Overall Study|Withdrawal by Subject|19|||
105701069|NCT00636675|364568500|FG001|Overall Study|Withdrawal by Subject|10|||
105701070|NCT00096785|364568501|FG000|Overall Study|Lost to Follow-up|1|||
105701071|NCT00096785|364568502|FG001|Overall Study|Lost to Follow-up|0|||
105701072|NCT00096785|364568501|FG000|Overall Study|Withdrawal by Subject|0|||
105701073|NCT00096785|364568502|FG001|Overall Study|Withdrawal by Subject|1|||
105701074|NCT00096785|364568501|FG000|Overall Study|Relocated|1|||
105701075|NCT00096785|364568502|FG001|Overall Study|Relocated|0|||
105701076|NCT04053868|364568503|FG000|Overall Study|Withdrawal by Subject|1|||
105701077|NCT04053868|364568504|FG001|Overall Study|Withdrawal by Subject|0|||
105701078|NCT01761292|364568505|FG000|Part 1|Adverse Event|1|||
105701079|NCT01761292|364568505|FG000|Part 1|not receiving treatment in Part 1|1|||
105701080|NCT01761292|364568505|FG000|Extension 1|Withdrawal by Subject|1|||
105701081|NCT03332498|364568506|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
105701082|NCT03332498|364568507|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
105701083|NCT03332498|364568508|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
105701084|NCT01566773|364568509|FG000|Overall Study|Protocol specified criteria|4|||
105701085|NCT01566773|364568509|FG000|Overall Study|Protocol Violation|4|||
105701086|NCT01566773|364568509|FG000|Overall Study|Withdrawal by Subject|9|||
105701087|NCT01566773|364568509|FG000|Overall Study|Administrative reason|1|||
105701088|NCT01566773|364568509|FG000|Overall Study|Adverse Event|10|||
105701089|NCT01566773|364568509|FG000|Overall Study|Physician Decision|2|||
105701090|NCT02187471|364568511|FG000|Overall Study|Protocol Violation|4|||
105701091|NCT02187471|364568512|FG001|Overall Study|Protocol Violation|5|||
105701092|NCT02187471|364568513|FG002|Overall Study|Protocol Violation|4|||
105701093|NCT02187471|364568514|FG003|Overall Study|Protocol Violation|4|||
105701094|NCT02187471|364568511|FG000|Overall Study|Missing|0|||
105701095|NCT02187471|364568512|FG001|Overall Study|Missing|0|||
105701096|NCT02187471|364568513|FG002|Overall Study|Missing|0|||
105701097|NCT02187471|364568514|FG003|Overall Study|Missing|1|||
105701098|NCT02187471|364568511|FG000|Overall Study|Lack of Efficacy|18|||
105701099|NCT02187471|364568512|FG001|Overall Study|Lack of Efficacy|9|||
105701100|NCT02187471|364568513|FG002|Overall Study|Lack of Efficacy|13|||
105701101|NCT02187471|364568514|FG003|Overall Study|Lack of Efficacy|11|||
105701102|NCT02187471|364568511|FG000|Overall Study|Adverse Event|24|||
105701103|NCT02187471|364568512|FG001|Overall Study|Adverse Event|34|||
105701104|NCT02187471|364568513|FG002|Overall Study|Adverse Event|44|||
105701105|NCT02187471|364568514|FG003|Overall Study|Adverse Event|36|||
106006011|NCT00713609|365686522|FG001|Overall Study|Lack of Efficacy|3|||
106006012|NCT00713609|365686523|FG002|Overall Study|Lack of Efficacy|0|||
106006013|NCT00713609|365686524|FG003|Overall Study|Lack of Efficacy|0|||
106006014|NCT00713609|365686525|FG004|Overall Study|Lack of Efficacy|1|||
106006015|NCT00713609|365686526|FG005|Overall Study|Lack of Efficacy|0|||
106006016|NCT00713609|365686521|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
106006017|NCT00713609|365686522|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
106006018|NCT00713609|365686523|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
106006019|NCT00713609|365686524|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
106133575|NCT04423393|366148103|FG008|Overall Study|Sponsor Decision|0|||
106133576|NCT04423393|366148104|FG009|Overall Study|Sponsor Decision|0|||
106133577|NCT04423393|366148105|FG010|Overall Study|Sponsor Decision|0|||
106133578|NCT04423393|366148106|FG011|Overall Study|Sponsor Decision|0|||
106133579|NCT04423393|366148107|FG012|Overall Study|Sponsor Decision|0|||
106133580|NCT04423393|366148108|FG013|Overall Study|Sponsor Decision|1|||
106133581|NCT04423393|366148109|FG014|Overall Study|Sponsor Decision|0|||
105701106|NCT02187471|364568511|FG000|Overall Study|Withdrawal by Subject|23|||
106006020|NCT00713609|365686525|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
106133582|NCT04423393|366148110|FG015|Overall Study|Sponsor Decision|0|||
105701107|NCT02187471|364568512|FG001|Overall Study|Withdrawal by Subject|29|||
105701108|NCT02187471|364568513|FG002|Overall Study|Withdrawal by Subject|22|||
105701109|NCT02187471|364568514|FG003|Overall Study|Withdrawal by Subject|24|||
105701110|NCT02187471|364568511|FG000|Overall Study|Other|7|||
105701111|NCT02187471|364568512|FG001|Overall Study|Other|5|||
106133583|NCT04423393|366148111|FG016|Overall Study|Sponsor Decision|0|||
105701112|NCT02187471|364568513|FG002|Overall Study|Other|3|||
105701113|NCT02187471|364568514|FG003|Overall Study|Other|4|||
105701114|NCT00957528|364568516|FG000|Overall Study|Protocol Violation|0|||
105701115|NCT00957528|364568517|FG001|Overall Study|Protocol Violation|1|||
105701116|NCT00957528|364568518|FG002|Overall Study|Protocol Violation|0|||
105701117|NCT00957528|364568516|FG000|Overall Study|Withdrawal by Subject|0|||
105701118|NCT00957528|364568517|FG001|Overall Study|Withdrawal by Subject|0|||
105701119|NCT00957528|364568518|FG002|Overall Study|Withdrawal by Subject|1|||
105701120|NCT01033734|364568519|FG000|Overall Study|Withdrawal by Subject|1|||
105701121|NCT00914927|364568520|FG000|Overall Study|Adverse Event|0|||
105701122|NCT00914927|364568521|FG001|Overall Study|Adverse Event|0|||
105701123|NCT00914927|364568522|FG002|Overall Study|Adverse Event|0|||
105701124|NCT00914927|364568523|FG003|Overall Study|Adverse Event|0|||
105701125|NCT00914927|364568524|FG004|Overall Study|Adverse Event|1|||
105701126|NCT00914927|364568525|FG005|Overall Study|Adverse Event|0|||
105701127|NCT00914927|364568526|FG006|Overall Study|Adverse Event|0|||
105701128|NCT00914927|364568520|FG000|Overall Study|Withdrawal by Subject|0|||
105701129|NCT00914927|364568521|FG001|Overall Study|Withdrawal by Subject|1|||
105701130|NCT00914927|364568522|FG002|Overall Study|Withdrawal by Subject|0|||
105701131|NCT00914927|364568523|FG003|Overall Study|Withdrawal by Subject|1|||
105701132|NCT00914927|364568524|FG004|Overall Study|Withdrawal by Subject|0|||
105701133|NCT00914927|364568525|FG005|Overall Study|Withdrawal by Subject|0|||
105701134|NCT00914927|364568526|FG006|Overall Study|Withdrawal by Subject|0|||
105701135|NCT00914927|364568520|FG000|Overall Study|Lost to Follow-up|0|||
105701136|NCT00914927|364568521|FG001|Overall Study|Lost to Follow-up|0|||
105701137|NCT00914927|364568522|FG002|Overall Study|Lost to Follow-up|0|||
105701138|NCT00914927|364568523|FG003|Overall Study|Lost to Follow-up|1|||
105701139|NCT00914927|364568524|FG004|Overall Study|Lost to Follow-up|0|||
105701140|NCT00914927|364568525|FG005|Overall Study|Lost to Follow-up|0|||
105701141|NCT00914927|364568526|FG006|Overall Study|Lost to Follow-up|0|||
105701142|NCT00914927|364568520|FG000|Overall Study|Administrative/Other|2|||
105701143|NCT00914927|364568521|FG001|Overall Study|Administrative/Other|1|||
105701144|NCT00914927|364568522|FG002|Overall Study|Administrative/Other|0|||
105701145|NCT00914927|364568523|FG003|Overall Study|Administrative/Other|0|||
105701146|NCT00914927|364568524|FG004|Overall Study|Administrative/Other|1|||
105701147|NCT00914927|364568525|FG005|Overall Study|Administrative/Other|0|||
105701148|NCT00914927|364568526|FG006|Overall Study|Administrative/Other|0|||
105701149|NCT01040351|364568529|FG000|Overall Study|poor ovarian response|1|||
105701150|NCT01040351|364568530|FG001|Overall Study|poor ovarian response|2|||
105701151|NCT00122681|364568534|FG000|Overall Study|Adverse Event|20|||
105701152|NCT00122681|364568535|FG001|Overall Study|Adverse Event|16|||
105701153|NCT00122681|364568534|FG000|Overall Study|Lost to Follow-up|1080|||
105701154|NCT00122681|364568535|FG001|Overall Study|Lost to Follow-up|1097|||
105701155|NCT00122681|364568534|FG000|Overall Study|Protocol Violation|7|||
105701156|NCT00122681|364568535|FG001|Overall Study|Protocol Violation|10|||
105701157|NCT00122681|364568534|FG000|Overall Study|Withdrawal by Subject|257|||
105701158|NCT00122681|364568535|FG001|Overall Study|Withdrawal by Subject|251|||
105701159|NCT00122681|364568534|FG000|Overall Study|Personal reasons|150|||
105701160|NCT00122681|364568535|FG001|Overall Study|Personal reasons|147|||
105701161|NCT02016820|364568537|FG000|Overall Study|Lost to Follow-up|2|||
105701162|NCT02016820|364568538|FG001|Overall Study|Lost to Follow-up|4|||
105701163|NCT00258674|364568539|FG000|Overall Study|Death|32|||
105701164|NCT00258674|364568540|FG001|Overall Study|Death|53|||
105701165|NCT00258674|364568541|FG002|Overall Study|Death|34|||
105701166|NCT04247061|364568542|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
105701167|NCT04247061|364568542|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
106006021|NCT00713609|365686526|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
105701168|NCT04247061|364568542|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
106006022|NCT00713609|365686521|FG000|Overall Study|Withdrawal by Subject|6|||
106006023|NCT00713609|365686522|FG001|Overall Study|Withdrawal by Subject|1|||
106006024|NCT00713609|365686523|FG002|Overall Study|Withdrawal by Subject|5|||
106006025|NCT00713609|365686524|FG003|Overall Study|Withdrawal by Subject|1|||
106006026|NCT00713609|365686525|FG004|Overall Study|Withdrawal by Subject|5|||
106006027|NCT00713609|365686526|FG005|Overall Study|Withdrawal by Subject|7|||
106006028|NCT00713609|365686521|FG000|Overall Study|Protocol Violation|6|||
106006029|NCT00713609|365686522|FG001|Overall Study|Protocol Violation|3|||
106006030|NCT00713609|365686523|FG002|Overall Study|Protocol Violation|1|||
106006031|NCT00713609|365686524|FG003|Overall Study|Protocol Violation|1|||
106133584|NCT04423393|366148112|FG017|Overall Study|Sponsor Decision|0|||
105701169|NCT01744665|364568556|FG000|Monitoring Phase|Adverse Event|4|||
106133585|NCT04091672|366148113|FG000|Overall Study|Death|6|||
105701170|NCT01744665|364568556|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
105701171|NCT01744665|364568556|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
105701172|NCT01744665|364568556|FG000|Monitoring Phase|Withdrawal by Subject|5|||
106006032|NCT00713609|365686525|FG004|Overall Study|Protocol Violation|2|||
106006033|NCT00713609|365686526|FG005|Overall Study|Protocol Violation|0|||
106006034|NCT01546857|365686531|FG000|Overall Study|Withdrawal by Subject|2|||
105701173|NCT01744665|364568556|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
105701174|NCT01744665|364568556|FG000|Consolidation Phase|Adverse Event|2|||
105701175|NCT01744665|364568556|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
105701176|NCT01744665|364568556|FG000|Consolidation Phase|Withdrawal by Subject|4|||
105701177|NCT01744665|364568556|FG000|Consolidation Phase|Administrative problems|9|||
105701178|NCT01744665|364568556|FG000|Re-initiation Phase|Administrative problems|10|||
105701179|NCT01744665|364568556|FG000|Re-initiation Phase|Adverse Event|1|||
105701180|NCT01744665|364568556|FG000|Re-initiation Phase|No longer required treatment|1|||
105701181|NCT01744665|364568556|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
105701182|NCT00807742|364568557|FG000|Overall Study|Death|9|||
105701183|NCT00807742|364568558|FG001|Overall Study|Death|2|||
105701184|NCT00807742|364568557|FG000|Overall Study|Withdrawal by Subject|2|||
105701185|NCT00807742|364568558|FG001|Overall Study|Withdrawal by Subject|1|||
105701186|NCT00807742|364568557|FG000|Overall Study|Lost to Follow-up|35|||
105701187|NCT00807742|364568558|FG001|Overall Study|Lost to Follow-up|51|||
105701188|NCT00492752|364568559|FG000|Double Blind Treatment|Death|13|||
105701189|NCT00492752|364568560|FG001|Double Blind Treatment|Death|0|||
105701190|NCT00492752|364568561|FG002|Double Blind Treatment|Death|2|||
105701191|NCT00492752|364568562|FG003|Double Blind Treatment|Death|0|||
105701192|NCT00492752|364568559|FG000|Double Blind Treatment|Adverse Event|1|||
105701193|NCT00492752|364568560|FG001|Double Blind Treatment|Adverse Event|0|||
105701194|NCT00492752|364568561|FG002|Double Blind Treatment|Adverse Event|0|||
105701195|NCT00492752|364568562|FG003|Double Blind Treatment|Adverse Event|0|||
105701196|NCT00492752|364568559|FG000|Double Blind Treatment|Protocol Violation|0|||
105701197|NCT00492752|364568560|FG001|Double Blind Treatment|Protocol Violation|0|||
105701198|NCT00492752|364568561|FG002|Double Blind Treatment|Protocol Violation|1|||
105701199|NCT00492752|364568562|FG003|Double Blind Treatment|Protocol Violation|0|||
105701200|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
105701201|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
105701202|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
105701203|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
105701204|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
105701205|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
105701206|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
105701207|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
106006035|NCT01546857|365686532|FG001|Overall Study|Withdrawal by Subject|3|||
106006036|NCT00333775|365686535|FG000|Overall Study|Death|144|||
106006037|NCT00333775|365686536|FG001|Overall Study|Death|149|||
106006038|NCT00333775|365686537|FG002|Overall Study|Death|143|||
106006039|NCT00333775|365686535|FG000|Overall Study|In Follow-up When Study Stopped|87|||
106006040|NCT00333775|365686536|FG001|Overall Study|In Follow-up When Study Stopped|92|||
105701208|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
105701209|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
105701210|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
105701211|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
105701212|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
105701213|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
105701214|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
105701215|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
105701216|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
105701217|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
106006041|NCT00333775|365686537|FG002|Overall Study|In Follow-up When Study Stopped|96|||
106006042|NCT00333775|365686535|FG000|Overall Study|Lost to Follow-up|10|||
106006043|NCT00333775|365686536|FG001|Overall Study|Lost to Follow-up|7|||
106006044|NCT00333775|365686537|FG002|Overall Study|Lost to Follow-up|8|||
106006045|NCT01791244|365686538|FG000|Overall Study|Adverse Event|5|||
106006046|NCT01791244|365686539|FG001|Overall Study|Adverse Event|7|||
106006047|NCT01791244|365686538|FG000|Overall Study|Insufficient clinical response|10|||
106006048|NCT01791244|365686539|FG001|Overall Study|Insufficient clinical response|10|||
106006049|NCT01791244|365686538|FG000|Overall Study|Laboratory Abnormality|0|||
106006050|NCT01791244|365686539|FG001|Overall Study|Laboratory Abnormality|1|||
106006051|NCT01383928|365686542|FG000|Overall Study|Initiation of ASCT|2|||
106006052|NCT01383928|365686543|FG001|Overall Study|Initiation of ASCT|1|||
106006053|NCT01383928|365686544|FG002|Overall Study|Initiation of ASCT|18|||
106006054|NCT01383928|365686542|FG000|Overall Study|Adverse Event|1|||
105701218|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
105701219|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
106006055|NCT01383928|365686543|FG001|Overall Study|Adverse Event|2|||
106006056|NCT01383928|365686544|FG002|Overall Study|Adverse Event|8|||
106006057|NCT01383928|365686542|FG000|Overall Study|Other|1|||
106006058|NCT01383928|365686543|FG001|Overall Study|Other|3|||
106006059|NCT01383928|365686544|FG002|Overall Study|Other|4|||
106006060|NCT01383928|365686542|FG000|Overall Study|Progressive Disease|1|||
106006061|NCT01383928|365686543|FG001|Overall Study|Progressive Disease|1|||
105701220|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
105701221|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
105701222|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
105701223|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
105701224|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
105701225|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
105701226|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
105701227|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
105701228|NCT00492752|364568559|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
105701229|NCT00492752|364568560|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
105701230|NCT00492752|364568561|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
105701231|NCT00492752|364568562|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
105701232|NCT03803059|364568563|FG000|Overall Study|Protocol Violation|2|||
105701233|NCT03803059|364568563|FG000|Overall Study|Lost to Follow-up|1|||
105701234|NCT03159091|364568564|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
105701235|NCT03159091|364568565|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
105701236|NCT03159091|364568564|FG000|Overall Study|Patient has taken no dose of study drug|0|||
105701237|NCT03159091|364568565|FG001|Overall Study|Patient has taken no dose of study drug|1|||
105701238|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
105701239|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
105701240|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
105701241|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
105701242|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
105701243|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
105701244|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
105701245|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
105701246|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to death|4|||
105701247|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to death|3|||
105701248|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
105701249|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
105701250|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
105701251|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
105701252|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
105701253|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
105701254|NCT02258451|364568566|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
105701255|NCT02258451|364568567|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
105701256|NCT02258451|364568566|FG000|Overall Study|Other reason|1|||
105701257|NCT02258451|364568567|FG001|Overall Study|Other reason|1|||
105701258|NCT02258451|364568566|FG000|Overall Study|Never treated|2|||
105701259|NCT02258451|364568567|FG001|Overall Study|Never treated|3|||
105701260|NCT05248295|364568579|FG000|Overall Study|found ineligible|4|||
105701261|NCT05248295|364568580|FG001|Overall Study|found ineligible|1|||
105701262|NCT05248295|364568579|FG000|Overall Study|Withdrawal by Subject|0|||
105701263|NCT05248295|364568580|FG001|Overall Study|Withdrawal by Subject|1|||
105701264|NCT05248295|364568579|FG000|Overall Study|Data loss: audio recording error|1|||
105701265|NCT05248295|364568580|FG001|Overall Study|Data loss: audio recording error|1|||
105701266|NCT04066491|364568581|FG000|Overall Study|Randomized, not treated|0|||
105701267|NCT04066491|364568582|FG001|Overall Study|Randomized, not treated|0|||
105701268|NCT04066491|364568583|FG002|Overall Study|Randomized, not treated|2|||
105701269|NCT04506086|364568584|FG000|Overall Study|Withdrawal by Subject|2|||
105701270|NCT03021499|364568585|FG000|Overall Study|Adverse Event|1|||
105701271|NCT03021499|364568586|FG001|Overall Study|Adverse Event|0|||
105701272|NCT03021499|364568585|FG000|Overall Study|Death|1|||
105701273|NCT03021499|364568586|FG001|Overall Study|Death|5|||
105701274|NCT03021499|364568585|FG000|Overall Study|Lack of Efficacy|0|||
105701275|NCT03021499|364568586|FG001|Overall Study|Lack of Efficacy|1|||
105701276|NCT03021499|364568585|FG000|Overall Study|Lost to Follow-up|1|||
105701277|NCT03021499|364568586|FG001|Overall Study|Lost to Follow-up|3|||
105701278|NCT03021499|364568585|FG000|Overall Study|Physician Decision|2|||
105701279|NCT03021499|364568586|FG001|Overall Study|Physician Decision|3|||
105701280|NCT03021499|364568585|FG000|Overall Study|Pregnancy|1|||
105701281|NCT03021499|364568586|FG001|Overall Study|Pregnancy|0|||
105701282|NCT03021499|364568585|FG000|Overall Study|Withdrawal by Subject|7|||
105926239|NCT00831844|365388009|FG006|Overall Study|Death|0|||
105926240|NCT00831844|365388010|FG007|Overall Study|Death|0|||
105701283|NCT03021499|364568586|FG001|Overall Study|Withdrawal by Subject|14|||
105701284|NCT03021499|364568585|FG000|Overall Study|Prohibited medication required|1|||
105701285|NCT03021499|364568586|FG001|Overall Study|Prohibited medication required|0|||
105701286|NCT03021499|364568585|FG000|Overall Study|Protocol non-compliance|1|||
105701287|NCT03021499|364568586|FG001|Overall Study|Protocol non-compliance|1|||
105701288|NCT03021499|364568585|FG000|Overall Study|None of the above|0|||
105701289|NCT03021499|364568586|FG001|Overall Study|None of the above|4|||
105701290|NCT03021499|364568585|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
105701291|NCT03021499|364568586|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
105701292|NCT01210690|364568587|FG000|Overall Study|Adverse Event|7|||
105701293|NCT01210690|364568587|FG000|Overall Study|Lack of Efficacy|12|||
105701294|NCT01210690|364568587|FG000|Overall Study|Lost to Follow-up|3|||
105701295|NCT01210690|364568587|FG000|Overall Study|Disease Remission|1|||
105701296|NCT01210690|364568587|FG000|Overall Study|Withdrawal by Subject|1|||
105701297|NCT01210690|364568587|FG000|Overall Study|Patient refused to swallow|1|||
105701298|NCT01210690|364568587|FG000|Overall Study|Patient could not take glucose|1|||
105701299|NCT00495820|364568588|FG000|Overall Study|Adverse Event|1|||
105701300|NCT00495820|364568589|FG001|Overall Study|Adverse Event|1|||
105701301|NCT00820950|364568590|FG000|Overall Study|Scheduling Conflict|0|||
105701302|NCT00820950|364568591|FG001|Overall Study|Scheduling Conflict|0|||
105701303|NCT00820950|364568592|FG002|Overall Study|Scheduling Conflict|0|||
105701304|NCT00820950|364568593|FG003|Overall Study|Scheduling Conflict|0|||
105701305|NCT00820950|364568594|FG004|Overall Study|Scheduling Conflict|0|||
105701306|NCT00820950|364568595|FG005|Overall Study|Scheduling Conflict|0|||
105701307|NCT00820950|364568596|FG006|Overall Study|Scheduling Conflict|1|||
105701308|NCT00820950|364568597|FG007|Overall Study|Scheduling Conflict|1|||
105701309|NCT00820950|364568598|FG008|Overall Study|Scheduling Conflict|0|||
105701310|NCT00820950|364568599|FG009|Overall Study|Scheduling Conflict|0|||
105701311|NCT00820950|364568590|FG000|Overall Study|Protocol Violation|1|||
105701312|NCT00820950|364568591|FG001|Overall Study|Protocol Violation|1|||
105701313|NCT00820950|364568592|FG002|Overall Study|Protocol Violation|0|||
105701314|NCT00820950|364568593|FG003|Overall Study|Protocol Violation|0|||
105701315|NCT00820950|364568594|FG004|Overall Study|Protocol Violation|0|||
105701316|NCT00820950|364568595|FG005|Overall Study|Protocol Violation|0|||
105701317|NCT00820950|364568596|FG006|Overall Study|Protocol Violation|0|||
105701318|NCT00820950|364568597|FG007|Overall Study|Protocol Violation|0|||
105701319|NCT00820950|364568598|FG008|Overall Study|Protocol Violation|0|||
105701320|NCT00820950|364568599|FG009|Overall Study|Protocol Violation|0|||
105701321|NCT04202679|364568600|FG000|Overall Study|Adverse Event|2|||
105701322|NCT04202679|364568601|FG001|Overall Study|Adverse Event|0|||
105701323|NCT04202679|364568600|FG000|Overall Study|Poor compliance to protocol|1|||
105701324|NCT04202679|364568601|FG001|Overall Study|Poor compliance to protocol|0|||
105701325|NCT04202679|364568600|FG000|Overall Study|Withdrawal by Subject|23|||
105701326|NCT04202679|364568601|FG001|Overall Study|Withdrawal by Subject|6|||
105701327|NCT00687440|364568602|FG000|Overall Study|Adverse Event|3|||
105701328|NCT00687440|364568602|FG000|Overall Study|Lost to Follow-up|3|||
105701329|NCT00687440|364568602|FG000|Overall Study|Lack of Efficacy|2|||
105701330|NCT00687440|364568602|FG000|Overall Study|Death|2|||
105701331|NCT00687440|364568602|FG000|Overall Study|Other|1|||
105701332|NCT00687440|364568602|FG000|Overall Study|Missing|1|||
105701333|NCT04869345|364568606|FG000|Overall Study|Lost to Follow-up|8|||
105701334|NCT04869345|364568607|FG001|Overall Study|Lost to Follow-up|3|||
105701335|NCT03996876|364568610|FG000|Overall Study|Incomplete Data|2|||
105701336|NCT03996876|364568611|FG001|Overall Study|Incomplete Data|4|||
105701337|NCT05054114|364568614|FG000|Overall Study|Protocol Violation|13|||
105701338|NCT05054114|364568615|FG001|Overall Study|Protocol Violation|1|||
105701339|NCT05054114|364568614|FG000|Overall Study|Pregnancy|0|||
105701340|NCT05054114|364568615|FG001|Overall Study|Pregnancy|1|||
105701341|NCT02186847|364568618|FG000|Overall Study|Protocol Violation|3|||
105701342|NCT02186847|364568619|FG001|Overall Study|Protocol Violation|0|||
105701343|NCT05264740|364568620|FG000|Baseline|Withdrawal by Subject|0|||
105701344|NCT05264740|364568621|FG001|Baseline|Withdrawal by Subject|1|||
105701345|NCT05264740|364568620|FG000|Follow Up 1|Lost to Follow-up|1|||
105701346|NCT05264740|364568621|FG001|Follow Up 1|Lost to Follow-up|1|||
105701347|NCT05264740|364568620|FG000|Follow Up 1|Withdrawal by Subject|0|||
105701348|NCT05264740|364568621|FG001|Follow Up 1|Withdrawal by Subject|1|||
105701349|NCT05264740|364568620|FG000|Follow Up 2|Lost to Follow-up|1|||
105701350|NCT05264740|364568621|FG001|Follow Up 2|Lost to Follow-up|4|||
105701351|NCT05264740|364568620|FG000|Follow Up 3|Lost to Follow-up|7|||
105701352|NCT05264740|364568621|FG001|Follow Up 3|Lost to Follow-up|4|||
105701353|NCT03080883|364568623|FG000|Overall Study|Withdrawal by Subject|11|||
105701354|NCT03080883|364568624|FG001|Overall Study|Withdrawal by Subject|15|||
105701355|NCT03080883|364568623|FG000|Overall Study|Adverse Event|22|||
105701356|NCT03080883|364568624|FG001|Overall Study|Adverse Event|22|||
105701357|NCT03080883|364568623|FG000|Overall Study|Alternative Therapy|0|||
105701358|NCT03080883|364568624|FG001|Overall Study|Alternative Therapy|3|||
105701359|NCT03080883|364568623|FG000|Overall Study|Other Complicating Disease|9|||
105701360|NCT03080883|364568624|FG001|Overall Study|Other Complicating Disease|5|||
105701361|NCT03080883|364568623|FG000|Overall Study|Death|21|||
105701362|NCT03080883|364568624|FG001|Overall Study|Death|16|||
105701363|NCT03080883|364568623|FG000|Overall Study|Physician Decision|2|||
105701364|NCT03080883|364568624|FG001|Overall Study|Physician Decision|2|||
105701365|NCT03080883|364568623|FG000|Overall Study|Disease Progression|2|||
105701366|NCT03080883|364568624|FG001|Overall Study|Disease Progression|8|||
105701367|NCT03080883|364568623|FG000|Overall Study|Lost to Follow-up|1|||
105701368|NCT03080883|364568624|FG001|Overall Study|Lost to Follow-up|1|||
105701369|NCT02663453|364568628|FG000|Overall Study|Death|4|||
105701370|NCT02663453|364568629|FG001|Overall Study|Death|4|||
105701371|NCT02663453|364568628|FG000|Overall Study|Withdrawal by Subject|1|||
105701372|NCT02663453|364568629|FG001|Overall Study|Withdrawal by Subject|0|||
105701373|NCT03697720|364569894|FG000|Overall Study|Lost to Follow-up|7|||
105701374|NCT01439282|364569901|FG000|Overall Study|Adverse Event|5|||
105701375|NCT01439282|364569902|FG001|Overall Study|Adverse Event|0|||
105701376|NCT01439282|364569901|FG000|Overall Study|Withdrawal by Subject|2|||
105701377|NCT01439282|364569902|FG001|Overall Study|Withdrawal by Subject|0|||
105701378|NCT01439282|364569901|FG000|Overall Study|Other|1|||
105701379|NCT01439282|364569902|FG001|Overall Study|Other|1|||
105701380|NCT02966509|364569905|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
105701381|NCT02966509|364569906|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
105701382|NCT02966509|364569905|FG000|Baseline Satisfaction Survey|Death|0|||
105701383|NCT02966509|364569906|FG001|Baseline Satisfaction Survey|Death|1|||
105701384|NCT02966509|364569905|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
105701385|NCT02966509|364569906|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
105701386|NCT02966509|364569905|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
105701387|NCT02966509|364569906|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
105701388|NCT02966509|364569905|FG000|6 Month Satisfaction Decision Survey|Death|22|||
105701389|NCT02966509|364569906|FG001|6 Month Satisfaction Decision Survey|Death|25|||
105701390|NCT02966509|364569905|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
105701391|NCT02966509|364569906|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
105701392|NCT02966509|364569905|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
105701393|NCT02966509|364569906|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
105701394|NCT02966509|364569905|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
105701395|NCT02966509|364569906|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
105701396|NCT02966509|364569905|FG000|6 Month Satisfaction Survey|Death|36|||
105701397|NCT02966509|364569906|FG001|6 Month Satisfaction Survey|Death|33|||
105701398|NCT02966509|364569905|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
105701399|NCT02966509|364569906|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
105701400|NCT02966509|364569905|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
105701401|NCT02966509|364569906|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
105701402|NCT02966509|364569905|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
105701403|NCT02966509|364569906|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
105701404|NCT02966509|364569905|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
105701405|NCT02966509|364569906|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
105701406|NCT02966509|364569905|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
105701407|NCT02966509|364569906|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
105701408|NCT01543152|364569909|FG000|Overall Study|Withdrawal by Subject|0|||
105701409|NCT01543152|364569910|FG001|Overall Study|Withdrawal by Subject|2|||
106133586|NCT04091672|366148114|FG001|Overall Study|Death|6|||
105701410|NCT01543152|364569911|FG002|Overall Study|Withdrawal by Subject|0|||
105701411|NCT01543152|364569912|FG003|Overall Study|Withdrawal by Subject|0|||
106133587|NCT04091672|366148113|FG000|Overall Study|Lost to Follow-up|7|||
106133588|NCT04091672|366148114|FG001|Overall Study|Lost to Follow-up|7|||
106133589|NCT04091672|366148113|FG000|Overall Study|Withdrawal by Subject|3|||
106133590|NCT04091672|366148114|FG001|Overall Study|Withdrawal by Subject|3|||
106133591|NCT04091672|366148113|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
106133592|NCT04091672|366148114|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
106133593|NCT05296629|366148115|FG000|Overall Study|Withdrawal by Subject|3|||
105701412|NCT01543152|364569913|FG004|Overall Study|Withdrawal by Subject|0|||
105701413|NCT00916357|364569914|FG000|Period 1|Withdrawal by Subject|1|||
105701414|NCT00916357|364569915|FG001|Period 1|Withdrawal by Subject|0|||
105701415|NCT00916357|364569916|FG002|Period 1|Withdrawal by Subject|0|||
105701416|NCT00916357|364569917|FG003|Period 1|Withdrawal by Subject|0|||
105701417|NCT00916357|364569918|FG004|Period 1|Withdrawal by Subject|0|||
105701418|NCT00916357|364569919|FG005|Period 1|Withdrawal by Subject|0|||
105926241|NCT00831844|365388011|FG008|Overall Study|Death|0|||
105926242|NCT00831844|365388012|FG009|Overall Study|Death|0|||
106133594|NCT05296629|366148116|FG001|Overall Study|Withdrawal by Subject|10|||
106133595|NCT05296629|366148117|FG002|Overall Study|Withdrawal by Subject|4|||
105701419|NCT00916357|364569914|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701420|NCT00916357|364569915|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701421|NCT00916357|364569916|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701422|NCT00916357|364569917|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
105701423|NCT00916357|364569918|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701424|NCT00916357|364569919|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
105701425|NCT02234479|364569920|FG000|Overall Study|Withdrawal by Subject|1|||
105701426|NCT02234479|364569921|FG001|Overall Study|Withdrawal by Subject|3|||
105701427|NCT01911442|364569922|FG000|Overall Study|Adverse Event|2|||
105701428|NCT01911442|364569923|FG001|Overall Study|Adverse Event|2|||
105701429|NCT01911442|364569924|FG002|Overall Study|Adverse Event|4|||
105701430|NCT01911442|364569922|FG000|Overall Study|Lack of Efficacy|1|||
105701431|NCT01911442|364569923|FG001|Overall Study|Lack of Efficacy|1|||
105701432|NCT01911442|364569924|FG002|Overall Study|Lack of Efficacy|1|||
105701433|NCT01911442|364569922|FG000|Overall Study|Lost to Follow-up|2|||
105701434|NCT01911442|364569923|FG001|Overall Study|Lost to Follow-up|0|||
105701435|NCT01911442|364569924|FG002|Overall Study|Lost to Follow-up|1|||
105701436|NCT01911442|364569922|FG000|Overall Study|Withdrawal by Subject|1|||
105701437|NCT01911442|364569923|FG001|Overall Study|Withdrawal by Subject|0|||
105701438|NCT01911442|364569924|FG002|Overall Study|Withdrawal by Subject|6|||
105701439|NCT01911442|364569922|FG000|Overall Study|Mother's Work Schedule|0|||
105701440|NCT01911442|364569923|FG001|Overall Study|Mother's Work Schedule|1|||
105701441|NCT01911442|364569924|FG002|Overall Study|Mother's Work Schedule|0|||
105701442|NCT01648790|364569925|FG000|Treatment 3|Withdrawal by Subject|0|||
105701443|NCT01648790|364569926|FG001|Treatment 3|Withdrawal by Subject|0|||
105701444|NCT01648790|364569927|FG002|Treatment 3|Withdrawal by Subject|0|||
105701445|NCT01648790|364569928|FG003|Treatment 3|Withdrawal by Subject|1|||
105701446|NCT01648790|364569929|FG004|Treatment 3|Withdrawal by Subject|0|||
105701447|NCT02159729|364569931|FG000|Overall Study|Adverse Event|0|||
105701448|NCT02159729|364569932|FG001|Overall Study|Adverse Event|1|||
105701449|NCT02159729|364569931|FG000|Overall Study|Subject's Request|13|||
105701450|NCT02159729|364569932|FG001|Overall Study|Subject's Request|10|||
105701451|NCT02159729|364569931|FG000|Overall Study|Lost to Follow-up|24|||
105701452|NCT02159729|364569932|FG001|Overall Study|Lost to Follow-up|9|||
105701453|NCT02159729|364569931|FG000|Overall Study|Non compliance|2|||
105701454|NCT02159729|364569932|FG001|Overall Study|Non compliance|0|||
105701455|NCT02159729|364569931|FG000|Overall Study|Other Unspecified|3|||
105701456|NCT02159729|364569932|FG001|Overall Study|Other Unspecified|1|||
105701457|NCT02636582|364569933|FG000|Overall Study|Surgical Pathology|1|||
105701458|NCT02636582|364569934|FG001|Overall Study|Surgical Pathology|0|||
105701459|NCT01263483|364569935|FG000|Overall Study|Adverse Event|4|||
105701460|NCT01263483|364569936|FG001|Overall Study|Adverse Event|0|||
105701461|NCT01263483|364569937|FG002|Overall Study|Adverse Event|3|||
105701462|NCT01263483|364569935|FG000|Overall Study|Withdrawal by Subject|1|||
105701463|NCT01263483|364569936|FG001|Overall Study|Withdrawal by Subject|0|||
105701464|NCT01263483|364569937|FG002|Overall Study|Withdrawal by Subject|0|||
105701465|NCT01263483|364569935|FG000|Overall Study|Lack of Efficacy|2|||
105701466|NCT01263483|364569936|FG001|Overall Study|Lack of Efficacy|0|||
105701467|NCT01263483|364569937|FG002|Overall Study|Lack of Efficacy|0|||
105701468|NCT01263483|364569935|FG000|Overall Study|Protocol Violation|0|||
105701469|NCT01263483|364569936|FG001|Overall Study|Protocol Violation|1|||
105701470|NCT01263483|364569937|FG002|Overall Study|Protocol Violation|1|||
105701471|NCT01263483|364569935|FG000|Overall Study|Participant Unavailability|0|||
105701472|NCT01263483|364569936|FG001|Overall Study|Participant Unavailability|1|||
105701473|NCT01263483|364569937|FG002|Overall Study|Participant Unavailability|1|||
105701474|NCT00326209|364569938|FG000|Overall Study|Adverse Event|28|||
105701475|NCT00326209|364569938|FG000|Overall Study|Withdrawal by Subject|22|||
105701476|NCT00326209|364569938|FG000|Overall Study|Lack of Efficacy|31|||
105701477|NCT00326209|364569938|FG000|Overall Study|Lost to Follow-up|18|||
105701478|NCT00326209|364569938|FG000|Overall Study|Participant non-compliant|6|||
105701479|NCT00326209|364569938|FG000|Overall Study|Sponsor closed study|173|||
105701480|NCT00326209|364569938|FG000|Overall Study|Prohibited medication use|1|||
105701481|NCT00326209|364569938|FG000|Overall Study|Violation of entry criteria|1|||
106133596|NCT05296629|366148115|FG000|Overall Study|Lost to Follow-up|2|||
106133597|NCT05296629|366148116|FG001|Overall Study|Lost to Follow-up|7|||
105701482|NCT00326209|364569938|FG000|Overall Study|Withdrawn in error|1|||
105701483|NCT00326209|364569938|FG000|Overall Study|Pregnancy|1|||
105701484|NCT00714285|364569939|FG000|Overall Study|Lost to Follow-up|0|||
105701485|NCT00714285|364569940|FG001|Overall Study|Lost to Follow-up|2|||
105701486|NCT00714285|364569941|FG002|Overall Study|Lost to Follow-up|0|||
105701487|NCT00714285|364569942|FG003|Overall Study|Lost to Follow-up|1|||
105701488|NCT00714285|364569939|FG000|Overall Study|Migrated/moved from study area|0|||
105701489|NCT00714285|364569940|FG001|Overall Study|Migrated/moved from study area|1|||
105701490|NCT00714285|364569941|FG002|Overall Study|Migrated/moved from study area|0|||
105701491|NCT00714285|364569942|FG003|Overall Study|Migrated/moved from study area|0|||
105701492|NCT01372384|364569943|FG000|Overall Study|Progression of disease|3|||
105701493|NCT01131676|364569948|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
105701494|NCT01131676|364569949|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
105701495|NCT01131676|364569950|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
105701496|NCT01131676|364569948|FG000|Discontinuation From Treatment|Not treated|4|||
105701497|NCT01131676|364569949|FG001|Discontinuation From Treatment|Not treated|2|||
105701498|NCT01131676|364569950|FG002|Discontinuation From Treatment|Not treated|2|||
105701499|NCT01131676|364569948|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
105701500|NCT01131676|364569949|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
105701501|NCT01131676|364569950|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
105701502|NCT01131676|364569948|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
106133598|NCT05296629|366148117|FG002|Overall Study|Lost to Follow-up|1|||
106133599|NCT05296629|366148115|FG000|Overall Study|Adverse Event|0|||
106133600|NCT05296629|366148116|FG001|Overall Study|Adverse Event|4|||
106133601|NCT05296629|366148117|FG002|Overall Study|Adverse Event|2|||
106133602|NCT05296629|366148115|FG000|Overall Study|Protocol Violation|0|||
106133603|NCT05296629|366148116|FG001|Overall Study|Protocol Violation|2|||
105701503|NCT01131676|364569949|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
105701504|NCT01131676|364569950|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
105701505|NCT01131676|364569948|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
105701506|NCT01131676|364569949|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
105701507|NCT01131676|364569950|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
105701508|NCT01131676|364569948|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
105701509|NCT01131676|364569949|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
105701510|NCT01131676|364569950|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
105701511|NCT01131676|364569948|FG000|Discontinuation From Treatment|Other than those specified|162|||
105701512|NCT01131676|364569949|FG001|Discontinuation From Treatment|Other than those specified|142|||
105701513|NCT01131676|364569950|FG002|Discontinuation From Treatment|Other than those specified|125|||
105701514|NCT01131676|364569948|FG000|Discontinuation From Treatment|Adverse Event|303|||
105701515|NCT01131676|364569949|FG001|Discontinuation From Treatment|Adverse Event|267|||
105701516|NCT01131676|364569950|FG002|Discontinuation From Treatment|Adverse Event|273|||
105701517|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
105701518|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
105701519|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
105701520|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
105701521|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
105701522|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
105701523|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
105701524|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
105701525|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
105701526|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
105701527|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
106133604|NCT05296629|366148117|FG002|Overall Study|Protocol Violation|0|||
106133605|NCT01939158|366148123|FG000|Overall Study|Adverse Event|1|||
106133606|NCT01939158|366148124|FG001|Overall Study|Adverse Event|0|||
106133607|NCT01939158|366148125|FG002|Overall Study|Adverse Event|0|||
105787282|NCT03985982|364874918|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
105787283|NCT03985982|364874916|FG000|Open-Label Phase|Lost to Follow-up|0|||
105787284|NCT03985982|364874917|FG001|Open-Label Phase|Lost to Follow-up|0|||
105701528|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
105701529|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
105701530|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
105701531|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
105701532|NCT01131676|364569948|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
105701533|NCT01131676|364569949|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
105701534|NCT01131676|364569950|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
105787285|NCT03985982|364874918|FG002|Open-Label Phase|Lost to Follow-up|13|||
105787286|NCT03985982|364874916|FG000|Open-Label Phase|Physician Decision|0|||
106133608|NCT01939158|366148126|FG003|Overall Study|Adverse Event|0|||
105701535|NCT01278745|364569951|FG000|Overall Study|Death|2|||
105701536|NCT01278745|364569952|FG001|Overall Study|Death|5|||
105701537|NCT01278745|364569953|FG002|Overall Study|Death|7|||
105701538|NCT01278745|364569954|FG003|Overall Study|Death|0|||
105701539|NCT01278745|364569951|FG000|Overall Study|Physician Decision|1|||
105701540|NCT01278745|364569952|FG001|Overall Study|Physician Decision|0|||
105701541|NCT01278745|364569953|FG002|Overall Study|Physician Decision|0|||
105701542|NCT01278745|364569954|FG003|Overall Study|Physician Decision|9|||
105701543|NCT01278745|364569951|FG000|Overall Study|Withdrawal by Subject|1|||
105701544|NCT01278745|364569952|FG001|Overall Study|Withdrawal by Subject|1|||
105701545|NCT01278745|364569953|FG002|Overall Study|Withdrawal by Subject|5|||
105701546|NCT01278745|364569954|FG003|Overall Study|Withdrawal by Subject|1|||
105701547|NCT01278745|364569951|FG000|Overall Study|Sponsor Decision|1|||
105701548|NCT01278745|364569952|FG001|Overall Study|Sponsor Decision|0|||
105701549|NCT01278745|364569953|FG002|Overall Study|Sponsor Decision|62|||
105701550|NCT01278745|364569954|FG003|Overall Study|Sponsor Decision|6|||
105701551|NCT01278745|364569951|FG000|Overall Study|Ineligible|0|||
105701552|NCT01278745|364569952|FG001|Overall Study|Ineligible|0|||
105701553|NCT01278745|364569953|FG002|Overall Study|Ineligible|42|||
106133609|NCT01939158|366148123|FG000|Overall Study|Withdrawal by Subject|22|||
106133610|NCT01939158|366148124|FG001|Overall Study|Withdrawal by Subject|25|||
106133611|NCT01939158|366148125|FG002|Overall Study|Withdrawal by Subject|15|||
106006062|NCT01383928|365686544|FG002|Overall Study|Progressive Disease|5|||
105701554|NCT01278745|364569954|FG003|Overall Study|Ineligible|61|||
105701555|NCT01278745|364569951|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
105701556|NCT01278745|364569952|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
105701557|NCT01278745|364569953|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
105701558|NCT01278745|364569954|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
105701559|NCT00441974|364569955|FG000|Overall Study|Adverse Event|6|||
105701560|NCT00441974|364569955|FG000|Overall Study|Consent Withdrawn|35|||
105701561|NCT00441974|364569955|FG000|Overall Study|Lost to Follow-up|80|||
105701562|NCT00441974|364569955|FG000|Overall Study|Protocol Violation|7|||
105701563|NCT01111851|364569956|FG000|Overall Study|All planned PET scans were not obtained.|2|||
105701564|NCT01111851|364569957|FG001|Overall Study|All planned PET scans were not obtained.|0|||
105701565|NCT01471015|364569958|FG000|Overall Study|Death|0|||
105701566|NCT01471015|364569959|FG001|Overall Study|Death|1|||
106006063|NCT01383928|365686542|FG000|Overall Study|Withdrawal by Subject|0|||
106006064|NCT01383928|365686543|FG001|Overall Study|Withdrawal by Subject|0|||
106006065|NCT01383928|365686544|FG002|Overall Study|Withdrawal by Subject|4|||
106006066|NCT01383928|365686542|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
106006067|NCT01383928|365686543|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
106006068|NCT01383928|365686544|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
106006069|NCT04423718|365686545|FG000|Overall Study|Adverse Event|6|||
106006070|NCT04423718|365686546|FG001|Overall Study|Adverse Event|2|||
106006071|NCT04423718|365686547|FG002|Overall Study|Adverse Event|5|||
105701567|NCT01471015|364569960|FG002|Overall Study|Death|1|||
106006072|NCT04423718|365686545|FG000|Overall Study|Physician Decision|1|||
106006073|NCT04423718|365686546|FG001|Overall Study|Physician Decision|4|||
106006074|NCT04423718|365686547|FG002|Overall Study|Physician Decision|1|||
106006075|NCT04423718|365686545|FG000|Overall Study|Protocol Violation|0|||
106006076|NCT04423718|365686546|FG001|Overall Study|Protocol Violation|1|||
106006077|NCT04423718|365686547|FG002|Overall Study|Protocol Violation|1|||
106006078|NCT04423718|365686545|FG000|Overall Study|Lost to Follow-up|1|||
105701568|NCT03374189|364569965|FG000|Overall Study|Lost to Follow-up|1|||
105701569|NCT03374189|364569966|FG001|Overall Study|Lost to Follow-up|0|||
105701570|NCT04712110|364569967|FG000|Overall Study|Lost to Follow-up|0|||
105701571|NCT04712110|364569968|FG001|Overall Study|Lost to Follow-up|1|||
105701572|NCT04712110|364569967|FG000|Overall Study|Withdrawal by Subject|0|||
105701573|NCT04712110|364569968|FG001|Overall Study|Withdrawal by Subject|4|||
105701574|NCT04712110|364569967|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
106006079|NCT04423718|365686546|FG001|Overall Study|Lost to Follow-up|1|||
106006080|NCT04423718|365686547|FG002|Overall Study|Lost to Follow-up|2|||
106006081|NCT04423718|365686545|FG000|Overall Study|Lack of Efficacy|2|||
106006082|NCT04423718|365686546|FG001|Overall Study|Lack of Efficacy|0|||
106006083|NCT04423718|365686547|FG002|Overall Study|Lack of Efficacy|0|||
106006084|NCT04423718|365686545|FG000|Overall Study|Withdrawal by Subject|6|||
106006085|NCT04423718|365686546|FG001|Overall Study|Withdrawal by Subject|8|||
106006086|NCT04423718|365686547|FG002|Overall Study|Withdrawal by Subject|14|||
106006087|NCT04423718|365686545|FG000|Overall Study|Death|5|||
106006088|NCT04423718|365686546|FG001|Overall Study|Death|3|||
106006089|NCT04423718|365686547|FG002|Overall Study|Death|2|||
106006090|NCT04423718|365686545|FG000|Overall Study|COVID-19 pandemic|2|||
106006091|NCT04423718|365686546|FG001|Overall Study|COVID-19 pandemic|2|||
106006092|NCT04423718|365686547|FG002|Overall Study|COVID-19 pandemic|2|||
106133612|NCT01939158|366148126|FG003|Overall Study|Withdrawal by Subject|17|||
106133613|NCT01939158|366148123|FG000|Overall Study|Migrated/moved from study area|5|||
106133614|NCT01939158|366148124|FG001|Overall Study|Migrated/moved from study area|7|||
106133615|NCT01939158|366148125|FG002|Overall Study|Migrated/moved from study area|3|||
106133616|NCT01939158|366148126|FG003|Overall Study|Migrated/moved from study area|6|||
105701575|NCT04712110|364569968|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
105701576|NCT01309659|364569969|FG000|Overall Study|Protocol Violation|0|||
105701577|NCT01309659|364569970|FG001|Overall Study|Protocol Violation|1|||
105701578|NCT00804570|364569971|FG000|Overall Study|Adverse Event|14|||
106133617|NCT01939158|366148123|FG000|Overall Study|Lost to Follow-up|18|||
105701579|NCT00804570|364569972|FG001|Overall Study|Adverse Event|7|||
105701580|NCT00804570|364569971|FG000|Overall Study|Lack of Efficacy|0|||
105701581|NCT00804570|364569972|FG001|Overall Study|Lack of Efficacy|1|||
105701582|NCT00804570|364569971|FG000|Overall Study|Lost to Follow-up|18|||
105701583|NCT00804570|364569972|FG001|Overall Study|Lost to Follow-up|21|||
105701584|NCT00804570|364569971|FG000|Overall Study|Entry criteria not met|5|||
106006093|NCT04423718|365686545|FG000|Overall Study|Other|6|||
106006094|NCT04423718|365686546|FG001|Overall Study|Other|2|||
106006095|NCT04423718|365686547|FG002|Overall Study|Other|2|||
106006096|NCT04423718|365686545|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
105701585|NCT00804570|364569972|FG001|Overall Study|Entry criteria not met|5|||
105701586|NCT00804570|364569971|FG000|Overall Study|Protocol Violation|12|||
106006097|NCT04423718|365686546|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
106006098|NCT04423718|365686547|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
106133618|NCT01939158|366148124|FG001|Overall Study|Lost to Follow-up|17|||
106006099|NCT01346358|365686548|FG000|Overall Study|Withdrawal by Subject|1|||
106006100|NCT01346358|365686549|FG001|Overall Study|Withdrawal by Subject|0|||
106006101|NCT01346358|365686550|FG002|Overall Study|Withdrawal by Subject|1|||
106006102|NCT01346358|365686551|FG003|Overall Study|Withdrawal by Subject|1|||
106006103|NCT01346358|365686552|FG004|Overall Study|Withdrawal by Subject|0|||
106006104|NCT01346358|365686553|FG005|Overall Study|Withdrawal by Subject|2|||
106006105|NCT01346358|365686554|FG006|Overall Study|Withdrawal by Subject|1|||
106006106|NCT01346358|365686555|FG007|Overall Study|Withdrawal by Subject|1|||
106006107|NCT01346358|365686556|FG008|Overall Study|Withdrawal by Subject|1|||
106006108|NCT01346358|365686548|FG000|Overall Study|Adverse Event|1|||
106006109|NCT01346358|365686549|FG001|Overall Study|Adverse Event|0|||
106006110|NCT01346358|365686550|FG002|Overall Study|Adverse Event|0|||
106006111|NCT01346358|365686551|FG003|Overall Study|Adverse Event|0|||
106006112|NCT01346358|365686552|FG004|Overall Study|Adverse Event|1|||
106006113|NCT01346358|365686553|FG005|Overall Study|Adverse Event|0|||
105701587|NCT00804570|364569972|FG001|Overall Study|Protocol Violation|16|||
105701588|NCT00804570|364569971|FG000|Overall Study|Physician Decision|1|||
106006114|NCT01346358|365686554|FG006|Overall Study|Adverse Event|0|||
106006115|NCT01346358|365686555|FG007|Overall Study|Adverse Event|0|||
106006116|NCT01346358|365686556|FG008|Overall Study|Adverse Event|1|||
106006117|NCT01346358|365686548|FG000|Overall Study|Non-Compliance|0|||
106006118|NCT01346358|365686549|FG001|Overall Study|Non-Compliance|0|||
106006119|NCT01346358|365686550|FG002|Overall Study|Non-Compliance|0|||
106006120|NCT01346358|365686551|FG003|Overall Study|Non-Compliance|0|||
106006121|NCT01346358|365686552|FG004|Overall Study|Non-Compliance|0|||
106006122|NCT01346358|365686553|FG005|Overall Study|Non-Compliance|0|||
106006123|NCT01346358|365686554|FG006|Overall Study|Non-Compliance|0|||
106006124|NCT01346358|365686555|FG007|Overall Study|Non-Compliance|2|||
106006125|NCT01346358|365686556|FG008|Overall Study|Non-Compliance|0|||
106006126|NCT01346358|365686548|FG000|Overall Study|Physician Decision|0|||
106006127|NCT01346358|365686549|FG001|Overall Study|Physician Decision|1|||
106006128|NCT01346358|365686550|FG002|Overall Study|Physician Decision|0|||
106006129|NCT01346358|365686551|FG003|Overall Study|Physician Decision|0|||
106006130|NCT01346358|365686552|FG004|Overall Study|Physician Decision|0|||
106006131|NCT01346358|365686553|FG005|Overall Study|Physician Decision|0|||
106006132|NCT01346358|365686554|FG006|Overall Study|Physician Decision|0|||
106006133|NCT01346358|365686555|FG007|Overall Study|Physician Decision|1|||
106006134|NCT01346358|365686556|FG008|Overall Study|Physician Decision|1|||
106006135|NCT01643668|365686559|FG000|Overall Study|Death|1|||
105701589|NCT00804570|364569972|FG001|Overall Study|Physician Decision|2|||
105701590|NCT00804570|364569971|FG000|Overall Study|Sponsor decision|1|||
105701591|NCT00804570|364569972|FG001|Overall Study|Sponsor decision|4|||
105701592|NCT00804570|364569971|FG000|Overall Study|Withdrawal by Subject|21|||
105701593|NCT00804570|364569972|FG001|Overall Study|Withdrawal by Subject|38|||
105701594|NCT02285998|364569975|FG000|Overall Study|Adverse Event|9|||
105701595|NCT02285998|364569976|FG001|Overall Study|Adverse Event|8|||
105701596|NCT02285998|364569975|FG000|Overall Study|Physician Decision|1|||
105701597|NCT02285998|364569976|FG001|Overall Study|Physician Decision|2|||
105701598|NCT02285998|364569975|FG000|Overall Study|Lost to Follow-up|176|||
105701599|NCT02285998|364569976|FG001|Overall Study|Lost to Follow-up|172|||
105701600|NCT02285998|364569975|FG000|Overall Study|Withdrawal by Subject|53|||
105701601|NCT02285998|364569976|FG001|Overall Study|Withdrawal by Subject|61|||
105701602|NCT02285998|364569975|FG000|Overall Study|Other Reasons|7|||
105701603|NCT02285998|364569976|FG001|Overall Study|Other Reasons|10|||
105701604|NCT04037748|364569977|FG000|Treatment Period 1|Withdrawal by Subject|3|||
105701605|NCT04037748|364569978|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105701606|NCT04037748|364569977|FG000|Treatment Period 1|Adverse Event|1|||
105701607|NCT04037748|364569978|FG001|Treatment Period 1|Adverse Event|1|||
105701608|NCT04037748|364569977|FG000|Treatment Period 1|Protocol Violation|4|||
105701609|NCT04037748|364569978|FG001|Treatment Period 1|Protocol Violation|5|||
105701610|NCT04037748|364569977|FG000|Treatment Period 2|Adverse Event|0|||
105701611|NCT04037748|364569978|FG001|Treatment Period 2|Adverse Event|1|||
105701612|NCT04037748|364569977|FG000|Treatment Period 2|Protocol Violation|2|||
105701613|NCT04037748|364569978|FG001|Treatment Period 2|Protocol Violation|0|||
105701614|NCT00545298|364569979|FG000|Overall Study|Issues with Standard of Care|2|||
105701615|NCT00545298|364569980|FG001|Overall Study|Issues with Standard of Care|0|||
105701616|NCT00545298|364569981|FG002|Overall Study|Issues with Standard of Care|1|||
106133619|NCT01939158|366148125|FG002|Overall Study|Lost to Follow-up|17|||
106006136|NCT01650558|365686560|FG000|Overall Study|Migration out of study area|61|||
106133620|NCT01939158|366148126|FG003|Overall Study|Lost to Follow-up|17|||
105701617|NCT01820364|364569982|FG000|Part I: LGX818|Death|1|||
106006137|NCT01650558|365686561|FG001|Overall Study|Migration out of study area|71|||
106006138|NCT01650558|365686562|FG002|Overall Study|Migration out of study area|56|||
106006139|NCT01650558|365686560|FG000|Overall Study|Lost to Follow-up|10|||
106006140|NCT01650558|365686561|FG001|Overall Study|Lost to Follow-up|13|||
106006141|NCT01650558|365686562|FG002|Overall Study|Lost to Follow-up|6|||
106006142|NCT01650558|365686560|FG000|Overall Study|Death|10|||
106006143|NCT01650558|365686561|FG001|Overall Study|Death|6|||
106006144|NCT01650558|365686562|FG002|Overall Study|Death|8|||
106006145|NCT01650558|365686560|FG000|Overall Study|Withdrawal by Subject|1|||
106006146|NCT01650558|365686561|FG001|Overall Study|Withdrawal by Subject|1|||
106006147|NCT01650558|365686562|FG002|Overall Study|Withdrawal by Subject|3|||
106006148|NCT01650558|365686560|FG000|Overall Study|Non-compliant participant|1|||
106006149|NCT01650558|365686561|FG001|Overall Study|Non-compliant participant|0|||
106006150|NCT01650558|365686562|FG002|Overall Study|Non-compliant participant|2|||
106006151|NCT01650558|365686560|FG000|Overall Study|Physician Decision|0|||
106006152|NCT01650558|365686561|FG001|Overall Study|Physician Decision|1|||
106006153|NCT01650558|365686562|FG002|Overall Study|Physician Decision|0|||
106006154|NCT00918385|365686563|FG000|Monotherapy|Adverse Event|1|||
106006155|NCT00918385|365686564|FG001|Monotherapy|Adverse Event|6|||
106006156|NCT00918385|365686563|FG000|Monotherapy|Complicating illness|1|||
106006157|NCT00918385|365686564|FG001|Monotherapy|Complicating illness|0|||
106006158|NCT00918385|365686563|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
106006159|NCT00918385|365686564|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
106006160|NCT00918385|365686563|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
106006161|NCT00918385|365686564|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
106006162|NCT00918385|365686563|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
106006163|NCT00918385|365686564|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
106006164|NCT00918385|365686563|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
106006165|NCT00918385|365686564|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
106006166|NCT02734693|365686565|FG000|Overall Study|Adverse Event|1|||
106006167|NCT02734693|365686566|FG001|Overall Study|Adverse Event|3|||
106006168|NCT02734693|365686567|FG002|Overall Study|Adverse Event|3|||
106006169|NCT02734693|365686565|FG000|Overall Study|Lack of Efficacy|1|||
106006170|NCT02734693|365686566|FG001|Overall Study|Lack of Efficacy|0|||
106006171|NCT02734693|365686567|FG002|Overall Study|Lack of Efficacy|0|||
106006172|NCT02734693|365686565|FG000|Overall Study|Lost to Follow-up|2|||
106006173|NCT02734693|365686566|FG001|Overall Study|Lost to Follow-up|0|||
106006174|NCT02734693|365686567|FG002|Overall Study|Lost to Follow-up|0|||
106006175|NCT02734693|365686565|FG000|Overall Study|Protocol Violation|1|||
106006176|NCT02734693|365686566|FG001|Overall Study|Protocol Violation|0|||
106006177|NCT02734693|365686567|FG002|Overall Study|Protocol Violation|0|||
106006178|NCT02734693|365686565|FG000|Overall Study|Withdrawal by Subject|1|||
106006179|NCT02734693|365686566|FG001|Overall Study|Withdrawal by Subject|0|||
106006180|NCT02734693|365686567|FG002|Overall Study|Withdrawal by Subject|0|||
106006181|NCT03261336|365686569|FG000|Overall Study|Adverse Event|1|||
106006182|NCT00292942|365686571|FG000|Overall Study|Withdrawal by Subject|0|||
106006183|NCT00292942|365686572|FG001|Overall Study|Withdrawal by Subject|0|||
106006184|NCT00292942|365686573|FG002|Overall Study|Withdrawal by Subject|1|||
106006185|NCT00292942|365686574|FG003|Overall Study|Withdrawal by Subject|0|||
106006186|NCT00292942|365686571|FG000|Overall Study|Adverse Event|0|||
106006187|NCT00292942|365686572|FG001|Overall Study|Adverse Event|0|||
106006188|NCT00292942|365686573|FG002|Overall Study|Adverse Event|0|||
106006189|NCT00292942|365686574|FG003|Overall Study|Adverse Event|1|||
106006190|NCT00644358|365686575|FG000|Overall Study|Adverse Event|124|||
106006191|NCT00644358|365686575|FG000|Overall Study|Lost to Follow-up|105|||
106006192|NCT00644358|365686575|FG000|Overall Study|Consent Withdrawal|64|||
106006193|NCT00644358|365686575|FG000|Overall Study|Lack of Effectiveness|39|||
106006194|NCT00644358|365686575|FG000|Overall Study|Protocol Violation|5|||
106006195|NCT00644358|365686575|FG000|Overall Study|Noncompliance|14|||
106006196|NCT00644358|365686575|FG000|Overall Study|Other Unspecified|11|||
106006197|NCT00758771|365686578|FG000|Overall Study|Withdrawal by Subject|1|||
106006198|NCT00758771|365686579|FG001|Overall Study|Withdrawal by Subject|1|||
106006199|NCT00758771|365686578|FG000|Overall Study|Did not meet eligibility criteria|2|||
106006200|NCT00758771|365686579|FG001|Overall Study|Did not meet eligibility criteria|4|||
106133621|NCT01939158|366148123|FG000|Overall Study|Death|0|||
106133622|NCT01939158|366148124|FG001|Overall Study|Death|0|||
106133623|NCT01939158|366148125|FG002|Overall Study|Death|1|||
106006201|NCT01451606|365686587|FG000|Overall Study|Withdrawal by Subject|4|||
106006202|NCT01451606|365686588|FG001|Overall Study|Withdrawal by Subject|3|||
106006203|NCT04011540|365686590|FG000|Overall Study|Lost to Follow-up|9|||
106006204|NCT04011540|365686591|FG001|Overall Study|Lost to Follow-up|6|||
106006205|NCT02138890|365686592|FG000|Overall Study|Adverse Event|1|||
106006206|NCT02138890|365686593|FG001|Overall Study|Adverse Event|0|||
106006207|NCT00537394|365686594|FG000|First Year of Follow-up|Death|7|||
106006208|NCT00537394|365686595|FG001|First Year of Follow-up|Death|0|||
106006209|NCT00537394|365686596|FG002|First Year of Follow-up|Death|0|||
106006210|NCT00537394|365686594|FG000|First Year of Follow-up|Severe debilitation|1|||
106133624|NCT01939158|366148126|FG003|Overall Study|Death|1|||
106006211|NCT00537394|365686595|FG001|First Year of Follow-up|Severe debilitation|0|||
106006212|NCT00537394|365686596|FG002|First Year of Follow-up|Severe debilitation|1|||
106006213|NCT00537394|365686594|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
106006214|NCT00537394|365686595|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
106006215|NCT00537394|365686596|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
106133625|NCT01939158|366148123|FG000|Overall Study|No longer meets eligibility criteria|0|||
105701618|NCT01820364|364569983|FG001|Part I: LGX818|Death|0|||
105701619|NCT01820364|364569982|FG000|Part I: LGX818|Administrative Problems|3|||
105701620|NCT01820364|364569983|FG001|Part I: LGX818|Administrative Problems|0|||
105701621|NCT01820364|364569982|FG000|Part I: LGX818|Adverse Event|6|||
105701622|NCT01820364|364569983|FG001|Part I: LGX818|Adverse Event|0|||
105701623|NCT01820364|364569982|FG000|Part I: LGX818|Disease Progression|4|||
105701624|NCT01820364|364569983|FG001|Part I: LGX818|Disease Progression|0|||
105701625|NCT01820364|364569982|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
105701626|NCT01820364|364569983|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
105701627|NCT03451084|364569986|FG000|Overall Study|Withdrawal by Subject|2|||
105701628|NCT03451084|364569987|FG001|Overall Study|Withdrawal by Subject|1|||
105701629|NCT03451084|364569988|FG002|Overall Study|Withdrawal by Subject|2|||
105701630|NCT03451084|364569989|FG003|Overall Study|Withdrawal by Subject|1|||
105701631|NCT03451084|364569986|FG000|Overall Study|Disease recurrence|0|||
105701632|NCT03451084|364569987|FG001|Overall Study|Disease recurrence|2|||
105701633|NCT03451084|364569988|FG002|Overall Study|Disease recurrence|0|||
105701634|NCT03451084|364569989|FG003|Overall Study|Disease recurrence|0|||
105701635|NCT03451084|364569986|FG000|Overall Study|Lack of Efficacy|0|||
105701636|NCT03451084|364569987|FG001|Overall Study|Lack of Efficacy|3|||
105701637|NCT03451084|364569988|FG002|Overall Study|Lack of Efficacy|0|||
105701638|NCT03451084|364569989|FG003|Overall Study|Lack of Efficacy|1|||
105701639|NCT03451084|364569986|FG000|Overall Study|Death|1|||
105701640|NCT03451084|364569987|FG001|Overall Study|Death|0|||
105701641|NCT03451084|364569988|FG002|Overall Study|Death|2|||
105701642|NCT03451084|364569989|FG003|Overall Study|Death|0|||
105701643|NCT03451084|364569986|FG000|Overall Study|Physician Decision|0|||
105701644|NCT03451084|364569987|FG001|Overall Study|Physician Decision|0|||
105701645|NCT03451084|364569988|FG002|Overall Study|Physician Decision|2|||
105701646|NCT03451084|364569989|FG003|Overall Study|Physician Decision|2|||
106133626|NCT01939158|366148124|FG001|Overall Study|No longer meets eligibility criteria|0|||
106133627|NCT01939158|366148125|FG002|Overall Study|No longer meets eligibility criteria|1|||
106133628|NCT01939158|366148126|FG003|Overall Study|No longer meets eligibility criteria|0|||
106133629|NCT01939158|366148123|FG000|Overall Study|Other|1|||
106133630|NCT01939158|366148124|FG001|Overall Study|Other|3|||
106133631|NCT01939158|366148125|FG002|Overall Study|Other|4|||
106133632|NCT01939158|366148126|FG003|Overall Study|Other|3|||
106133633|NCT01097655|366148131|FG000|Overall Study|Withdrawal by Subject|1|||
105701647|NCT03451084|364569986|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
105701648|NCT03451084|364569987|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
105926243|NCT00831844|365388003|FG000|Overall Study|Lack of Efficacy|8|||
106133634|NCT01097655|366148131|FG000|Overall Study|Subject Documented Twice|1|||
105701649|NCT03451084|364569988|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
105701650|NCT03451084|364569989|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
105701651|NCT03418129|364569992|FG000|Overall Study|Lost to Follow-up|11|||
105701652|NCT03418129|364569993|FG001|Overall Study|Lost to Follow-up|20|||
105701653|NCT03418129|364569994|FG002|Overall Study|Lost to Follow-up|15|||
105701654|NCT03418129|364569992|FG000|Overall Study|Withdrawal by Subject|3|||
105701655|NCT03418129|364569993|FG001|Overall Study|Withdrawal by Subject|6|||
105701656|NCT03418129|364569994|FG002|Overall Study|Withdrawal by Subject|4|||
105701657|NCT05289570|364570008|FG000|Overall Study|Physician Decision|1|||
105701658|NCT02664272|364570013|FG000|Overall Study|Fluoroscopic images not made available|2|||
105701659|NCT00964743|364570018|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
105701660|NCT00781911|364570020|FG000|Overall Study|Adverse Event|4|||
105701661|NCT00781911|364570021|FG001|Overall Study|Adverse Event|4|||
105701662|NCT00781911|364570020|FG000|Overall Study|Withdrawal by Subject|1|||
105701663|NCT00781911|364570021|FG001|Overall Study|Withdrawal by Subject|2|||
105701664|NCT00781911|364570020|FG000|Overall Study|Physician Decision|0|||
105701665|NCT00781911|364570021|FG001|Overall Study|Physician Decision|2|||
105701666|NCT00781911|364570020|FG000|Overall Study|Sponsor Decision|1|||
105701667|NCT00781911|364570021|FG001|Overall Study|Sponsor Decision|0|||
105701668|NCT00501007|364570028|FG000|Overall Study|Inclusion criteria not met.|29|||
105701669|NCT00501007|364570029|FG001|Overall Study|Inclusion criteria not met.|25|||
105701670|NCT02255409|364570032|FG000|Overall Study|Administrative Reason|3|||
105701671|NCT02255409|364570033|FG001|Overall Study|Administrative Reason|7|||
105701672|NCT02255409|364570032|FG000|Overall Study|Withdrawal by Subject|1|||
105701673|NCT02255409|364570033|FG001|Overall Study|Withdrawal by Subject|5|||
105701674|NCT02255409|364570032|FG000|Overall Study|Lost to Follow-up|10|||
105701675|NCT02255409|364570033|FG001|Overall Study|Lost to Follow-up|19|||
105701676|NCT03765138|364570034|FG000|Overall Study|Lost to Follow-up|1|||
105701677|NCT04050982|364570035|FG000|Overall Study|Did not meet eligibility criteria|0|||
105701678|NCT04050982|364570036|FG001|Overall Study|Did not meet eligibility criteria|1|||
105701679|NCT04050982|364570037|FG002|Overall Study|Did not meet eligibility criteria|0|||
105701680|NCT04050982|364570035|FG000|Overall Study|Withdrawal by Subject|1|||
105701681|NCT04050982|364570036|FG001|Overall Study|Withdrawal by Subject|0|||
105701682|NCT04050982|364570037|FG002|Overall Study|Withdrawal by Subject|0|||
105701683|NCT04050982|364570035|FG000|Overall Study|Unable to enroll on platform|1|||
105701684|NCT04050982|364570036|FG001|Overall Study|Unable to enroll on platform|0|||
105701685|NCT04050982|364570037|FG002|Overall Study|Unable to enroll on platform|0|||
105701686|NCT01538628|364570041|FG000|Overall Study|Withdrawal by Subject|1|||
105701687|NCT01538628|364570042|FG001|Overall Study|Withdrawal by Subject|1|||
105701688|NCT01538628|364570041|FG000|Overall Study|Lost to Follow-up|0|||
105701689|NCT01538628|364570042|FG001|Overall Study|Lost to Follow-up|1|||
105701690|NCT00102960|364570044|FG000|Overall Study|Death|23|||
105701691|NCT00102960|364570045|FG001|Overall Study|Death|11|||
105701692|NCT00102960|364570046|FG002|Overall Study|Death|11|||
105701693|NCT00102960|364570044|FG000|Overall Study|Lost to Follow-up|6|||
105701694|NCT00102960|364570045|FG001|Overall Study|Lost to Follow-up|12|||
105701695|NCT00102960|364570046|FG002|Overall Study|Lost to Follow-up|16|||
105701696|NCT00102960|364570044|FG000|Overall Study|Withdrawal by Subject|1|||
105701697|NCT00102960|364570045|FG001|Overall Study|Withdrawal by Subject|0|||
105701698|NCT00102960|364570046|FG002|Overall Study|Withdrawal by Subject|1|||
105701699|NCT00736255|364571799|FG000|Overall Study|Adverse Event|1|||
105701700|NCT00736255|364571800|FG001|Overall Study|Adverse Event|0|||
105701701|NCT00736255|364571799|FG000|Overall Study|Physician Decision|1|||
105701702|NCT00736255|364571800|FG001|Overall Study|Physician Decision|0|||
105701703|NCT00736255|364571799|FG000|Overall Study|Non-compliance|1|||
105701704|NCT00736255|364571800|FG001|Overall Study|Non-compliance|1|||
105701705|NCT02232802|364571804|FG000|Period 1|Sponsor request|1|||
105701706|NCT02232802|364571805|FG001|Period 1|Sponsor request|0|||
105701707|NCT02232802|364571804|FG000|Period 1|Adverse Event|1|||
105701708|NCT02232802|364571805|FG001|Period 1|Adverse Event|1|||
105701709|NCT01183143|364571809|FG000|Overall Study|Protocol Violation|115|||
105701710|NCT01183143|364571809|FG000|Overall Study|Withdrawal by Subject|19|||
105701711|NCT01183143|364571809|FG000|Overall Study|Subject Questionnaires not returned|5|||
105701712|NCT01183143|364571809|FG000|Overall Study|Subjects enrolled, but not treated|11|||
105701713|NCT04096274|364571811|FG000|Phase I|Lost to Follow-up|5|||
105701714|NCT04096274|364571812|FG001|Phase I|Lost to Follow-up|5|||
105701715|NCT04096274|364571811|FG000|Phase II|Lost to Follow-up|11|||
105701716|NCT04096274|364571812|FG001|Phase II|Lost to Follow-up|11|||
105701717|NCT00346073|364571821|FG000|Overall Study|Serious Adverse Event|2|||
105701718|NCT00346073|364571822|FG001|Overall Study|Serious Adverse Event|0|||
105701719|NCT00346073|364571821|FG000|Overall Study|Lost to Follow-up|39|||
105701720|NCT00346073|364571822|FG001|Overall Study|Lost to Follow-up|24|||
105701721|NCT00457015|364571823|FG000|Overall Study|Left study site against medical advice|0|||
105701722|NCT00457015|364571824|FG001|Overall Study|Left study site against medical advice|1|||
105701723|NCT04342871|364571825|FG000|Overall Study|Death|4|||
105701724|NCT04342871|364571825|FG000|Overall Study|Clinical deterioration/illness progression|2|||
105701725|NCT04342871|364571825|FG000|Overall Study|Did not complete baseline assessments|5|||
105701726|NCT04342871|364571825|FG000|Overall Study|Lost to Follow-up|13|||
105701727|NCT00747643|364571827|FG000|Overall Study|Withdrawal by Subject|36|||
105701728|NCT00747643|364571828|FG001|Overall Study|Withdrawal by Subject|27|||
105701729|NCT02263079|364571831|FG000|Overall Study|Physician Decision|1|||
105701730|NCT02263079|364571832|FG001|Overall Study|Physician Decision|0|||
105701731|NCT02263079|364571833|FG002|Overall Study|Physician Decision|0|||
105701732|NCT02263079|364571831|FG000|Overall Study|Withdrawal by Subject|2|||
105701733|NCT02263079|364571832|FG001|Overall Study|Withdrawal by Subject|8|||
105701734|NCT02263079|364571833|FG002|Overall Study|Withdrawal by Subject|0|||
105701735|NCT01199042|364571834|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
105701736|NCT01199042|364571834|FG000|At Home (3 Months)|Lost to Follow-up|1|||
105701737|NCT01227187|364571839|FG000|Overall Study|Physician Decision|0|||
105701738|NCT01227187|364571840|FG001|Overall Study|Physician Decision|0|||
105701739|NCT01227187|364571841|FG002|Overall Study|Physician Decision|0|||
105701740|NCT01227187|364571842|FG003|Overall Study|Physician Decision|1|||
105701741|NCT02554019|364571843|FG000|Overall Study|Withdrawal by Subject|1|||
105701742|NCT02554019|364571844|FG001|Overall Study|Withdrawal by Subject|0|||
105701743|NCT02554019|364571845|FG002|Overall Study|Withdrawal by Subject|2|||
105701744|NCT02554019|364571843|FG000|Overall Study|Adverse Event|1|||
105701745|NCT02554019|364571844|FG001|Overall Study|Adverse Event|0|||
105701746|NCT02554019|364571845|FG002|Overall Study|Adverse Event|0|||
105701747|NCT03179891|364571849|FG000|First Intervention|Withdrawal by Subject|1|||
105701748|NCT03179891|364571850|FG001|First Intervention|Withdrawal by Subject|1|||
105701749|NCT03179891|364571849|FG000|First Intervention|Unspecified reason|1|||
105701750|NCT03179891|364571850|FG001|First Intervention|Unspecified reason|0|||
105701751|NCT03179891|364571849|FG000|First Intervention|Protocol Violation|0|||
105701752|NCT03179891|364571850|FG001|First Intervention|Protocol Violation|1|||
105701753|NCT02113436|364571851|FG000|Period 1: 8 Weeks|Adverse Event|1|||
105701754|NCT02113436|364571852|FG001|Period 1: 8 Weeks|Adverse Event|0|||
105701755|NCT02113436|364571853|FG002|Period 1: 8 Weeks|Adverse Event|0|||
105701756|NCT02113436|364571854|FG003|Period 1: 8 Weeks|Adverse Event|0|||
105701757|NCT02113436|364571851|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
105701758|NCT02113436|364571852|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
105701759|NCT02113436|364571853|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
105701760|NCT02113436|364571854|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
105701761|NCT02113436|364571851|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
105701762|NCT02113436|364571852|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
105701763|NCT02113436|364571853|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
105701764|NCT02113436|364571854|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
105701765|NCT02113436|364571851|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
105701766|NCT02113436|364571852|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
105701767|NCT02113436|364571853|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
105701768|NCT02113436|364571854|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
105701769|NCT02113436|364571851|FG000|Period 2: 16 Weeks|Adverse Event|0|||
105701770|NCT02113436|364571852|FG001|Period 2: 16 Weeks|Adverse Event|0|||
105701771|NCT02113436|364571853|FG002|Period 2: 16 Weeks|Adverse Event|4|||
105701772|NCT02113436|364571854|FG003|Period 2: 16 Weeks|Adverse Event|5|||
105701773|NCT02113436|364571851|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
105701774|NCT02113436|364571852|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
105701775|NCT02113436|364571853|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
105701776|NCT02113436|364571854|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
105701777|NCT02113436|364571851|FG000|Period 2: 16 Weeks|Physician Decision|0|||
105701778|NCT02113436|364571852|FG001|Period 2: 16 Weeks|Physician Decision|0|||
105701779|NCT02113436|364571853|FG002|Period 2: 16 Weeks|Physician Decision|2|||
105701780|NCT02113436|364571854|FG003|Period 2: 16 Weeks|Physician Decision|0|||
105701781|NCT02113436|364571851|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
105701782|NCT02113436|364571852|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
105701783|NCT02113436|364571853|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
105701784|NCT02113436|364571854|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
105701785|NCT01732796|364571855|FG000|Overall Study|Adverse Event|16|||
105701786|NCT01732796|364571856|FG001|Overall Study|Adverse Event|16|||
105701787|NCT01732796|364571857|FG002|Overall Study|Adverse Event|4|||
105701788|NCT01732796|364571855|FG000|Overall Study|Lack of Efficacy|21|||
105701789|NCT01732796|364571856|FG001|Overall Study|Lack of Efficacy|18|||
105701790|NCT01732796|364571857|FG002|Overall Study|Lack of Efficacy|5|||
105701791|NCT01732796|364571855|FG000|Overall Study|Lost to Follow-up|2|||
105701792|NCT01732796|364571856|FG001|Overall Study|Lost to Follow-up|0|||
105701793|NCT01732796|364571857|FG002|Overall Study|Lost to Follow-up|0|||
105701794|NCT01732796|364571855|FG000|Overall Study|Withdrawal by Subject|6|||
105701795|NCT01732796|364571856|FG001|Overall Study|Withdrawal by Subject|8|||
105701796|NCT01732796|364571857|FG002|Overall Study|Withdrawal by Subject|2|||
105701797|NCT01732796|364571855|FG000|Overall Study|Other reason not defined above|1|||
105701798|NCT01732796|364571856|FG001|Overall Study|Other reason not defined above|0|||
105701799|NCT01732796|364571857|FG002|Overall Study|Other reason not defined above|2|||
105701800|NCT01967628|364571861|FG000|Overall Study|Withdrawal by Subject|2|||
105701801|NCT01967628|364571862|FG001|Overall Study|Withdrawal by Subject|0|||
105701802|NCT01967628|364571861|FG000|Overall Study|Unable to complete bronchoscopy|4|||
105701803|NCT01967628|364571862|FG001|Overall Study|Unable to complete bronchoscopy|6|||
105701804|NCT01967628|364571861|FG000|Overall Study|Lost to Follow-up|1|||
105701805|NCT01967628|364571862|FG001|Overall Study|Lost to Follow-up|0|||
105701806|NCT01967628|364571861|FG000|Overall Study|Low protein concentration in sample|20|||
105701807|NCT01967628|364571862|FG001|Overall Study|Low protein concentration in sample|25|||
105701808|NCT01197521|364571863|FG000|Overall Study|Not reported|24|||
105701809|NCT01197521|364571864|FG001|Overall Study|Not reported|25|||
105701810|NCT01197521|364571865|FG002|Overall Study|Not reported|21|||
105701811|NCT01197521|364571863|FG000|Overall Study|Enrolment in long term extension|42|||
106006216|NCT00537394|365686594|FG000|First Year of Follow-up|Lost to Follow-up|1|||
106006217|NCT00537394|365686595|FG001|First Year of Follow-up|Lost to Follow-up|5|||
106006218|NCT00537394|365686596|FG002|First Year of Follow-up|Lost to Follow-up|1|||
105701812|NCT01197521|364571864|FG001|Overall Study|Enrolment in long term extension|36|||
105701813|NCT01197521|364571865|FG002|Overall Study|Enrolment in long term extension|87|||
105701814|NCT01197521|364571863|FG000|Overall Study|Severe non-compliance to protocol|1|||
105701815|NCT01197521|364571864|FG001|Overall Study|Severe non-compliance to protocol|3|||
105701816|NCT01197521|364571865|FG002|Overall Study|Severe non-compliance to protocol|3|||
105701817|NCT01197521|364571863|FG000|Overall Study|Lack of therapeutic response|2|||
105701818|NCT01197521|364571864|FG001|Overall Study|Lack of therapeutic response|3|||
105701819|NCT01197521|364571865|FG002|Overall Study|Lack of therapeutic response|4|||
105701820|NCT01197521|364571863|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
105701821|NCT01197521|364571864|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
105701822|NCT01197521|364571865|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
105701823|NCT01197521|364571863|FG000|Overall Study|Lost to Follow-up|3|||
105701824|NCT01197521|364571864|FG001|Overall Study|Lost to Follow-up|2|||
105701825|NCT01197521|364571865|FG002|Overall Study|Lost to Follow-up|2|||
106006219|NCT00537394|365686594|FG000|2nd Year of Follow-up|Death|4|||
106006220|NCT00537394|365686595|FG001|2nd Year of Follow-up|Death|1|||
106006221|NCT00537394|365686596|FG002|2nd Year of Follow-up|Death|2|||
106006222|NCT00537394|365686594|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
106006223|NCT00537394|365686595|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
106006224|NCT00537394|365686596|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
106006225|NCT00537394|365686594|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
106006226|NCT00537394|365686595|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
106006227|NCT00537394|365686596|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
106006228|NCT00537394|365686594|FG000|2nd Year of Follow-up|Clinic site closure|1|||
106006229|NCT00537394|365686595|FG001|2nd Year of Follow-up|Clinic site closure|0|||
106006230|NCT00537394|365686596|FG002|2nd Year of Follow-up|Clinic site closure|0|||
106006231|NCT03668873|365686597|FG000|Overall Study|Lost to Follow-up|6|||
106006232|NCT03668873|365686598|FG001|Overall Study|Lost to Follow-up|3|||
106006233|NCT02485691|365686605|FG000|Overall Study|Adverse Event|25|||
106006234|NCT02485691|365686606|FG001|Overall Study|Adverse Event|11|||
106006235|NCT02485691|365686605|FG000|Overall Study|Poor compliance to protocol|0|||
106006236|NCT02485691|365686606|FG001|Overall Study|Poor compliance to protocol|1|||
106006237|NCT02485691|365686605|FG000|Overall Study|Disease progression|57|||
106006238|NCT02485691|365686606|FG001|Overall Study|Disease progression|92|||
106006239|NCT02485691|365686605|FG000|Overall Study|Investigator's decision|23|||
106006240|NCT02485691|365686606|FG001|Overall Study|Investigator's decision|5|||
106006241|NCT02485691|365686605|FG000|Overall Study|Participant's request|13|||
106006242|NCT02485691|365686606|FG001|Overall Study|Participant's request|6|||
106006243|NCT02485691|365686605|FG000|Overall Study|Other reason|8|||
106006244|NCT02485691|365686606|FG001|Overall Study|Other reason|9|||
106006245|NCT02485691|365686605|FG000|Overall Study|Randomized and not treated|3|||
106006246|NCT02485691|365686606|FG001|Overall Study|Randomized and not treated|2|||
106006247|NCT03836625|365686609|FG000|Overall Study|Lost to Follow-up|9|||
106006248|NCT03836625|365686610|FG001|Overall Study|Lost to Follow-up|9|||
106006249|NCT03836625|365686609|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
106006250|NCT03836625|365686610|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
106006251|NCT03836625|365686609|FG000|Overall Study|Death|0|||
106006252|NCT03836625|365686610|FG001|Overall Study|Death|1|||
106006253|NCT03836625|365686609|FG000|Overall Study|Refused follow-up|0|||
105701826|NCT01197521|364571863|FG000|Overall Study|Adverse Event|25|||
106006254|NCT03836625|365686610|FG001|Overall Study|Refused follow-up|1|||
106006255|NCT04515771|365688143|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
106006256|NCT04515771|365688144|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
106006257|NCT04515771|365688143|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
106006258|NCT04515771|365688144|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
106006259|NCT04515771|365688143|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
106006260|NCT04515771|365688144|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
106006261|NCT00948246|365688147|FG000|Overall Study|Lost to Follow-up|11|||
106006262|NCT00948246|365688147|FG000|Overall Study|Adverse Event|11|||
105701827|NCT01197521|364571864|FG001|Overall Study|Adverse Event|28|||
105701828|NCT01197521|364571865|FG002|Overall Study|Adverse Event|24|||
105701829|NCT03259074|364571866|FG000|Overall Study|Adverse Event|9|||
105701830|NCT03259074|364571867|FG001|Overall Study|Adverse Event|12|||
105701831|NCT03259074|364571868|FG002|Overall Study|Adverse Event|8|||
105701832|NCT03259074|364571866|FG000|Overall Study|Death|1|||
105701833|NCT03259074|364571867|FG001|Overall Study|Death|1|||
105701834|NCT03259074|364571868|FG002|Overall Study|Death|3|||
105701835|NCT03259074|364571866|FG000|Overall Study|Lost to Follow-up|2|||
105701836|NCT03259074|364571867|FG001|Overall Study|Lost to Follow-up|4|||
105701837|NCT03259074|364571868|FG002|Overall Study|Lost to Follow-up|3|||
105701838|NCT03259074|364571866|FG000|Overall Study|New Therapy For Study Indication|1|||
105701839|NCT03259074|364571867|FG001|Overall Study|New Therapy For Study Indication|2|||
105701840|NCT03259074|364571868|FG002|Overall Study|New Therapy For Study Indication|2|||
105701841|NCT03259074|364571866|FG000|Overall Study|Physician Decision|4|||
105701842|NCT03259074|364571867|FG001|Overall Study|Physician Decision|12|||
105701843|NCT03259074|364571868|FG002|Overall Study|Physician Decision|10|||
105701844|NCT03259074|364571866|FG000|Overall Study|Pregnancy|1|||
105701845|NCT03259074|364571867|FG001|Overall Study|Pregnancy|1|||
105701846|NCT03259074|364571868|FG002|Overall Study|Pregnancy|0|||
105701847|NCT03259074|364571866|FG000|Overall Study|Progressive Disease|1|||
105701848|NCT03259074|364571867|FG001|Overall Study|Progressive Disease|0|||
105701849|NCT03259074|364571868|FG002|Overall Study|Progressive Disease|0|||
105701850|NCT03259074|364571866|FG000|Overall Study|Protocol Deviation|1|||
105701851|NCT03259074|364571867|FG001|Overall Study|Protocol Deviation|1|||
105701852|NCT03259074|364571868|FG002|Overall Study|Protocol Deviation|3|||
105701853|NCT03259074|364571866|FG000|Overall Study|Subject/Guardian Decision|13|||
105701854|NCT03259074|364571867|FG001|Overall Study|Subject/Guardian Decision|16|||
105701855|NCT03259074|364571868|FG002|Overall Study|Subject/Guardian Decision|14|||
105701856|NCT00618410|364571871|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
105701857|NCT00618410|364571872|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
105701858|NCT03901079|364571875|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
105701859|NCT03975920|364571876|FG000|Overall Study|Lost to Follow-up|1|||
105701860|NCT03975920|364571877|FG001|Overall Study|Lost to Follow-up|2|||
105701861|NCT03975920|364571876|FG000|Overall Study|Protocol Violation|1|||
105701862|NCT03975920|364571877|FG001|Overall Study|Protocol Violation|1|||
105701863|NCT03975920|364571876|FG000|Overall Study|Did not complete survey|2|||
105701864|NCT03975920|364571877|FG001|Overall Study|Did not complete survey|1|||
105701865|NCT00827606|364571878|FG000|Overall Study|Protocol Violation|4|||
105701866|NCT00827606|364571879|FG001|Overall Study|Protocol Violation|3|||
105701867|NCT00827606|364571878|FG000|Overall Study|Lost to Follow-up|3|||
105701868|NCT00827606|364571879|FG001|Overall Study|Lost to Follow-up|1|||
105701869|NCT00827606|364571878|FG000|Overall Study|Withdrawal by Subject|7|||
105701870|NCT00827606|364571879|FG001|Overall Study|Withdrawal by Subject|6|||
105701871|NCT00827606|364571878|FG000|Overall Study|Pregnancy|0|||
105701872|NCT00827606|364571879|FG001|Overall Study|Pregnancy|1|||
105701873|NCT00827606|364571878|FG000|Overall Study|Other|5|||
105701874|NCT00827606|364571879|FG001|Overall Study|Other|13|||
105701875|NCT00827606|364571878|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
105701876|NCT00827606|364571879|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
105701877|NCT00827606|364571878|FG000|Overall Study|Adverse Event|4|||
105701878|NCT00827606|364571879|FG001|Overall Study|Adverse Event|2|||
105701879|NCT00841568|364571880|FG000|Overall Study|Adverse Event|1|||
105701880|NCT00841568|364571880|FG000|Overall Study|Death|1|||
105701881|NCT00841568|364571880|FG000|Overall Study|Withdrawal by Subject|2|||
105701882|NCT00841568|364571880|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
105701883|NCT04995055|364571887|FG000|Period 1|COVID-19 Related|1|||
105701884|NCT04995055|364571888|FG001|Period 1|COVID-19 Related|0|||
105701885|NCT04995055|364571887|FG000|Period 1|Withdrawal by Subject|0|||
105701886|NCT04995055|364571888|FG001|Period 1|Withdrawal by Subject|1|||
105701887|NCT04995055|364571887|FG000|Period 1|Subject discontinued due to timing|4|||
105701888|NCT04995055|364571888|FG001|Period 1|Subject discontinued due to timing|4|||
105701889|NCT00825162|364571891|FG000|Overall Study|Withdrawal by Subject|11|||
105701890|NCT00825162|364571892|FG001|Overall Study|Withdrawal by Subject|13|||
105701891|NCT00825162|364571893|FG002|Overall Study|Withdrawal by Subject|3|||
105701892|NCT00825162|364571891|FG000|Overall Study|Lost to Follow-up|9|||
105701893|NCT00825162|364571892|FG001|Overall Study|Lost to Follow-up|6|||
105701894|NCT00825162|364571893|FG002|Overall Study|Lost to Follow-up|3|||
105701895|NCT00825162|364571891|FG000|Overall Study|Physician Decision|2|||
105701896|NCT00825162|364571892|FG001|Overall Study|Physician Decision|0|||
105701897|NCT00825162|364571893|FG002|Overall Study|Physician Decision|0|||
105701898|NCT00825162|364571891|FG000|Overall Study|Move away from the study area|1|||
105701899|NCT00825162|364571892|FG001|Overall Study|Move away from the study area|0|||
105701900|NCT00825162|364571893|FG002|Overall Study|Move away from the study area|0|||
105701901|NCT00825162|364571891|FG000|Overall Study|Unable to attend the study visit|5|||
105701902|NCT00825162|364571892|FG001|Overall Study|Unable to attend the study visit|2|||
105701903|NCT00825162|364571893|FG002|Overall Study|Unable to attend the study visit|0|||
105701904|NCT00939783|364571894|FG000|Overall Study|Death|6|||
105701905|NCT00939783|364571894|FG000|Overall Study|Adverse Event|39|||
105701906|NCT00939783|364571894|FG000|Overall Study|Study Terminated by Sponsor|498|||
105701907|NCT00939783|364571894|FG000|Overall Study|Withdrawal by Subject|78|||
105701908|NCT00939783|364571894|FG000|Overall Study|Other|16|||
105701909|NCT00939783|364571894|FG000|Overall Study|Lost to Follow-up|8|||
105701910|NCT00939783|364571894|FG000|Overall Study|Protocol Violation|3|||
105701911|NCT00939783|364571894|FG000|Overall Study|Enrolled but not treated|1|||
105701912|NCT03073980|364571895|FG000|Overall Study|Lost to Follow-up|10|||
105701913|NCT03073980|364571896|FG001|Overall Study|Lost to Follow-up|2|||
105701914|NCT03073980|364571897|FG002|Overall Study|Lost to Follow-up|9|||
105701915|NCT03073980|364571895|FG000|Overall Study|No post-procedure data|0|||
105701916|NCT03073980|364571896|FG001|Overall Study|No post-procedure data|0|||
105701917|NCT03073980|364571897|FG002|Overall Study|No post-procedure data|2|||
105701918|NCT00545064|364571900|FG000|Overall Study|Lost to Follow-up|3|||
105701919|NCT00545064|364571900|FG000|Overall Study|Withdrawal by Subject|2|||
105701920|NCT00545064|364571900|FG000|Overall Study|did not complete course of treatment|1|||
105701921|NCT00545064|364571900|FG000|Overall Study|cancel all appointments, no rebooking|1|||
105701922|NCT00545064|364571900|FG000|Overall Study|inclement weather|1|||
105701923|NCT00884273|364571903|FG000|Overall Study|Adverse Event|0|||
105701924|NCT00884273|364571904|FG001|Overall Study|Adverse Event|2|||
105701925|NCT00884273|364571903|FG000|Overall Study|Protocol Violation|1|||
105701926|NCT00884273|364571904|FG001|Overall Study|Protocol Violation|3|||
105701927|NCT00884273|364571903|FG000|Overall Study|Practical reasons|1|||
105701928|NCT00884273|364571904|FG001|Overall Study|Practical reasons|0|||
105701929|NCT00583362|364571905|FG000|Overall Study|Adverse Event|44|||
105701930|NCT00583362|364571905|FG000|Overall Study|Lack of Efficacy|22|||
105701931|NCT00583362|364571905|FG000|Overall Study|Lost to Follow-up|4|||
105701932|NCT00583362|364571905|FG000|Overall Study|Non-compliance with study drug|28|||
105701933|NCT00583362|364571905|FG000|Overall Study|Pregnancy|7|||
105701934|NCT00583362|364571905|FG000|Overall Study|Miscommunication of visit window|5|||
105701935|NCT00583362|364571905|FG000|Overall Study|Current site closed|7|||
105701936|NCT00583362|364571905|FG000|Overall Study|Subject not dosed in LBSL99|1|||
105701937|NCT00583362|364571905|FG000|Overall Study|Subject moved out of the country/state|2|||
105701938|NCT00583362|364571905|FG000|Overall Study|Missed visits due to staff changes|1|||
105701939|NCT00583362|364571905|FG000|Overall Study|Misunderstanding of protocol|1|||
105701940|NCT00583362|364571905|FG000|Overall Study|Behavioral problems and non-compliance|1|||
105701941|NCT00583362|364571905|FG000|Overall Study|Sponsor request due to missed doses|1|||
105701942|NCT00583362|364571905|FG000|Overall Study|Physician Decision|19|||
105701943|NCT00583362|364571905|FG000|Overall Study|Protocol Violation|2|||
105701944|NCT00583362|364571905|FG000|Overall Study|Withdrawal by Subject|57|||
105701945|NCT02937818|364571906|FG000|Overall Study|Participants decision|2|||
105701946|NCT02937818|364571907|FG001|Overall Study|Participants decision|1|||
105701947|NCT02937818|364571908|FG002|Overall Study|Participants decision|1|||
105701948|NCT02937818|364571909|FG003|Overall Study|Participants decision|1|||
105701949|NCT02937818|364571906|FG000|Overall Study|Adverse Event|2|||
105701950|NCT02937818|364571907|FG001|Overall Study|Adverse Event|4|||
105701951|NCT02937818|364571908|FG002|Overall Study|Adverse Event|1|||
105701952|NCT02937818|364571909|FG003|Overall Study|Adverse Event|1|||
105701953|NCT02937818|364571906|FG000|Overall Study|Disease progression|17|||
105701954|NCT02937818|364571907|FG001|Overall Study|Disease progression|15|||
105701955|NCT02937818|364571908|FG002|Overall Study|Disease progression|7|||
105701956|NCT02937818|364571909|FG003|Overall Study|Disease progression|19|||
105701957|NCT02937818|364571906|FG000|Overall Study|Condition under investigation worsened|0|||
105701958|NCT02937818|364571907|FG001|Overall Study|Condition under investigation worsened|0|||
105701959|NCT02937818|364571908|FG002|Overall Study|Condition under investigation worsened|1|||
105701960|NCT02937818|364571909|FG003|Overall Study|Condition under investigation worsened|0|||
105701961|NCT02700997|364571910|FG000|Overall Study|Did not undergo CT imaging|1|||
105701962|NCT02700997|364571910|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
105701963|NCT02739620|364571913|FG000|Overall Study|Lost to Follow-up|3|||
105701964|NCT02739620|364571914|FG001|Overall Study|Lost to Follow-up|1|||
105701965|NCT02739620|364571913|FG000|Overall Study|Adverse Event|0|||
105701966|NCT02739620|364571914|FG001|Overall Study|Adverse Event|1|||
105701967|NCT04126083|364571915|FG000|Overall Study|Withdrawal by Subject|1|||
105701968|NCT02873936|364571916|FG000|Overall Study|Withdrew Consent|4|||
106006263|NCT00948246|365688147|FG000|Overall Study|Death|1|||
105701969|NCT02873936|364571917|FG001|Overall Study|Withdrew Consent|11|||
105701970|NCT02873936|364571918|FG002|Overall Study|Withdrew Consent|20|||
105701971|NCT02873936|364571916|FG000|Overall Study|Investigator's Discretion|3|||
105701972|NCT02873936|364571917|FG001|Overall Study|Investigator's Discretion|5|||
105701973|NCT02873936|364571918|FG002|Overall Study|Investigator's Discretion|4|||
105701974|NCT02873936|364571916|FG000|Overall Study|Adverse Event|3|||
105701975|NCT02873936|364571917|FG001|Overall Study|Adverse Event|5|||
106006264|NCT00948246|365688147|FG000|Overall Study|Withdrawal by Subject|1|||
105701976|NCT02873936|364571918|FG002|Overall Study|Adverse Event|3|||
105701977|NCT02873936|364571916|FG000|Overall Study|Protocol Violation|0|||
106006265|NCT03598036|365688148|FG000|Overall Study|Withdrawal by Subject|1|||
105701978|NCT02873936|364571917|FG001|Overall Study|Protocol Violation|1|||
106006266|NCT03598036|365688149|FG001|Overall Study|Withdrawal by Subject|0|||
105701979|NCT02873936|364571918|FG002|Overall Study|Protocol Violation|3|||
105701980|NCT02873936|364571916|FG000|Overall Study|Lost to Follow-up|1|||
105701981|NCT02873936|364571917|FG001|Overall Study|Lost to Follow-up|1|||
105701982|NCT02873936|364571918|FG002|Overall Study|Lost to Follow-up|1|||
106006267|NCT04124939|365688150|FG000|Overall Study|Lost to Follow-up|1|||
106006268|NCT04124939|365688151|FG001|Overall Study|Lost to Follow-up|3|||
105701983|NCT02873936|364571916|FG000|Overall Study|Non-compliance With Study Drug|1|||
105701984|NCT02873936|364571917|FG001|Overall Study|Non-compliance With Study Drug|0|||
105701985|NCT02873936|364571918|FG002|Overall Study|Non-compliance With Study Drug|1|||
106006269|NCT02587520|365688152|FG000|Overall Study|Protocol Violation|2|||
106006270|NCT02587520|365688153|FG001|Overall Study|Protocol Violation|0|||
106006271|NCT02587520|365688154|FG002|Overall Study|Protocol Violation|0|||
106006272|NCT02587520|365688155|FG003|Overall Study|Protocol Violation|2|||
106006273|NCT02587520|365688156|FG004|Overall Study|Protocol Violation|0|||
106006274|NCT02587520|365688157|FG005|Overall Study|Protocol Violation|1|||
106006275|NCT02587520|365688158|FG006|Overall Study|Protocol Violation|1|||
106006276|NCT02587520|365688159|FG007|Overall Study|Protocol Violation|1|||
106006277|NCT02587520|365688160|FG008|Overall Study|Protocol Violation|3|||
106006278|NCT02587520|365688161|FG009|Overall Study|Protocol Violation|3|||
106006279|NCT02587520|365688162|FG010|Overall Study|Protocol Violation|1|||
106006280|NCT02587520|365688163|FG011|Overall Study|Protocol Violation|2|||
105701986|NCT02873936|364571916|FG000|Overall Study|Randomized but not Dosed|1|||
105701987|NCT02873936|364571917|FG001|Overall Study|Randomized but not Dosed|0|||
105701988|NCT02873936|364571918|FG002|Overall Study|Randomized but not Dosed|0|||
105701989|NCT05513625|364571919|FG000|Overall Study|Withdrawal by Subject|1|||
105701990|NCT01279850|364571920|FG000|Overall Study|Protocol Violation|50|||
105701991|NCT01279850|364571920|FG000|Overall Study|No Drug Administration Information|7|||
105701992|NCT01279850|364571920|FG000|Overall Study|No Visit After Treatment|34|||
105701993|NCT01131520|364571921|FG000|Overall Study|Computer problem|1|||
105701994|NCT01131520|364571922|FG001|Overall Study|Computer problem|0|||
105701995|NCT01131520|364571921|FG000|Overall Study|Counselor not available|0|||
105701996|NCT01131520|364571922|FG001|Overall Study|Counselor not available|3|||
105701997|NCT01131520|364571921|FG000|Overall Study|Subject changed history after enrollment|0|||
105701998|NCT01131520|364571922|FG001|Overall Study|Subject changed history after enrollment|1|||
105701999|NCT01073267|364571926|FG000|Overall Study|Disease Progression|3|||
105702000|NCT01225731|364571927|FG000|Part 1|Did not meet eligibility criteria|1|||
106006281|NCT02587520|365688164|FG012|Overall Study|Protocol Violation|0|||
106006282|NCT02587520|365688165|FG013|Overall Study|Protocol Violation|0|||
106006283|NCT02587520|365688166|FG014|Overall Study|Protocol Violation|0|||
106006284|NCT02587520|365688167|FG015|Overall Study|Protocol Violation|0|||
106006285|NCT02587520|365688168|FG016|Overall Study|Protocol Violation|0|||
106006286|NCT02587520|365688169|FG017|Overall Study|Protocol Violation|0|||
106006287|NCT02587520|365688152|FG000|Overall Study|Adverse Event|0|||
106006288|NCT02587520|365688153|FG001|Overall Study|Adverse Event|0|||
106006289|NCT02587520|365688154|FG002|Overall Study|Adverse Event|0|||
106006290|NCT02587520|365688155|FG003|Overall Study|Adverse Event|0|||
106006291|NCT02587520|365688156|FG004|Overall Study|Adverse Event|0|||
105702001|NCT01225731|364571928|FG001|Part 1|Did not meet eligibility criteria|0|||
105702002|NCT01225731|364571929|FG002|Part 1|Did not meet eligibility criteria|0|||
105702003|NCT01225731|364571930|FG003|Part 1|Did not meet eligibility criteria|0|||
105702004|NCT01225731|364571931|FG004|Part 1|Did not meet eligibility criteria|1|||
105702005|NCT01225731|364571932|FG005|Part 1|Did not meet eligibility criteria|0|||
105702006|NCT01225731|364571933|FG006|Part 1|Did not meet eligibility criteria|0|||
105702007|NCT01225731|364571934|FG007|Part 1|Did not meet eligibility criteria|0|||
105702008|NCT01225731|364571935|FG008|Part 1|Did not meet eligibility criteria|0|||
105702009|NCT01225731|364571936|FG009|Part 1|Did not meet eligibility criteria|0|||
105702010|NCT01225731|364571937|FG010|Part 1|Did not meet eligibility criteria|0|||
105702011|NCT01225731|364571938|FG011|Part 1|Did not meet eligibility criteria|0|||
105702012|NCT01225731|364571939|FG012|Part 1|Did not meet eligibility criteria|0|||
105702013|NCT01225731|364571927|FG000|Part 1|Adverse Event|1|||
105702014|NCT01225731|364571928|FG001|Part 1|Adverse Event|2|||
105702015|NCT01225731|364571929|FG002|Part 1|Adverse Event|1|||
105702016|NCT01225731|364571930|FG003|Part 1|Adverse Event|1|||
105702017|NCT01225731|364571931|FG004|Part 1|Adverse Event|1|||
105702018|NCT01225731|364571932|FG005|Part 1|Adverse Event|0|||
105702019|NCT01225731|364571933|FG006|Part 1|Adverse Event|0|||
105702020|NCT01225731|364571934|FG007|Part 1|Adverse Event|0|||
105702021|NCT01225731|364571935|FG008|Part 1|Adverse Event|0|||
105702022|NCT01225731|364571936|FG009|Part 1|Adverse Event|0|||
105702023|NCT01225731|364571937|FG010|Part 1|Adverse Event|0|||
105702024|NCT01225731|364571938|FG011|Part 1|Adverse Event|0|||
105702025|NCT01225731|364571939|FG012|Part 1|Adverse Event|0|||
105702026|NCT01225731|364571927|FG000|Part 1|Withdrawal by Subject|0|||
106006292|NCT02587520|365688157|FG005|Overall Study|Adverse Event|0|||
106006293|NCT02587520|365688158|FG006|Overall Study|Adverse Event|0|||
106006294|NCT02587520|365688159|FG007|Overall Study|Adverse Event|0|||
105702027|NCT01225731|364571928|FG001|Part 1|Withdrawal by Subject|3|||
106006295|NCT02587520|365688160|FG008|Overall Study|Adverse Event|0|||
106006296|NCT02587520|365688161|FG009|Overall Study|Adverse Event|0|||
106006297|NCT02587520|365688162|FG010|Overall Study|Adverse Event|0|||
106006298|NCT02587520|365688163|FG011|Overall Study|Adverse Event|1|||
106006299|NCT02587520|365688164|FG012|Overall Study|Adverse Event|0|||
105702028|NCT01225731|364571929|FG002|Part 1|Withdrawal by Subject|0|||
105702029|NCT01225731|364571930|FG003|Part 1|Withdrawal by Subject|0|||
105702030|NCT01225731|364571931|FG004|Part 1|Withdrawal by Subject|4|||
105702031|NCT01225731|364571932|FG005|Part 1|Withdrawal by Subject|0|||
105702032|NCT01225731|364571933|FG006|Part 1|Withdrawal by Subject|0|||
105702033|NCT01225731|364571934|FG007|Part 1|Withdrawal by Subject|0|||
105702034|NCT01225731|364571935|FG008|Part 1|Withdrawal by Subject|0|||
105702035|NCT01225731|364571936|FG009|Part 1|Withdrawal by Subject|0|||
105702036|NCT01225731|364571937|FG010|Part 1|Withdrawal by Subject|0|||
105702037|NCT01225731|364571938|FG011|Part 1|Withdrawal by Subject|0|||
105702038|NCT01225731|364571939|FG012|Part 1|Withdrawal by Subject|0|||
105702039|NCT01225731|364571927|FG000|Part 1|Protocol Violation|0|||
105702040|NCT01225731|364571928|FG001|Part 1|Protocol Violation|0|||
105702041|NCT01225731|364571929|FG002|Part 1|Protocol Violation|0|||
105702042|NCT01225731|364571930|FG003|Part 1|Protocol Violation|1|||
105702043|NCT01225731|364571931|FG004|Part 1|Protocol Violation|0|||
105702044|NCT01225731|364571932|FG005|Part 1|Protocol Violation|0|||
105702045|NCT01225731|364571933|FG006|Part 1|Protocol Violation|0|||
105702046|NCT01225731|364571934|FG007|Part 1|Protocol Violation|0|||
105702047|NCT01225731|364571935|FG008|Part 1|Protocol Violation|0|||
105702048|NCT01225731|364571936|FG009|Part 1|Protocol Violation|0|||
105702049|NCT01225731|364571937|FG010|Part 1|Protocol Violation|0|||
105702050|NCT01225731|364571938|FG011|Part 1|Protocol Violation|0|||
105702051|NCT01225731|364571939|FG012|Part 1|Protocol Violation|0|||
105702052|NCT01225731|364571927|FG000|Part 2|Protocol Violation|0|||
105702053|NCT01225731|364571928|FG001|Part 2|Protocol Violation|0|||
105702054|NCT01225731|364571929|FG002|Part 2|Protocol Violation|0|||
105702055|NCT01225731|364571930|FG003|Part 2|Protocol Violation|0|||
105702056|NCT01225731|364571931|FG004|Part 2|Protocol Violation|0|||
105702057|NCT01225731|364571932|FG005|Part 2|Protocol Violation|1|||
105702058|NCT01225731|364571933|FG006|Part 2|Protocol Violation|0|||
105702059|NCT01225731|364571934|FG007|Part 2|Protocol Violation|0|||
105702060|NCT01225731|364571935|FG008|Part 2|Protocol Violation|1|||
105702061|NCT01225731|364571936|FG009|Part 2|Protocol Violation|0|||
105702062|NCT01225731|364571937|FG010|Part 2|Protocol Violation|0|||
105702063|NCT01225731|364571938|FG011|Part 2|Protocol Violation|0|||
105702064|NCT01225731|364571939|FG012|Part 2|Protocol Violation|0|||
105702065|NCT01225731|364571927|FG000|Part 2|Adverse Event|0|||
105702066|NCT01225731|364571928|FG001|Part 2|Adverse Event|0|||
105702067|NCT01225731|364571929|FG002|Part 2|Adverse Event|0|||
105702068|NCT01225731|364571930|FG003|Part 2|Adverse Event|0|||
105702069|NCT01225731|364571931|FG004|Part 2|Adverse Event|0|||
105702070|NCT01225731|364571932|FG005|Part 2|Adverse Event|0|||
105702071|NCT01225731|364571933|FG006|Part 2|Adverse Event|4|||
105702072|NCT01225731|364571934|FG007|Part 2|Adverse Event|4|||
105702073|NCT01225731|364571935|FG008|Part 2|Adverse Event|2|||
105702074|NCT01225731|364571936|FG009|Part 2|Adverse Event|0|||
105702075|NCT01225731|364571937|FG010|Part 2|Adverse Event|0|||
105702076|NCT01225731|364571938|FG011|Part 2|Adverse Event|0|||
105702077|NCT01225731|364571939|FG012|Part 2|Adverse Event|0|||
105702078|NCT01225731|364571927|FG000|Part 2|Lack of Efficacy|0|||
105702079|NCT01225731|364571928|FG001|Part 2|Lack of Efficacy|0|||
105702080|NCT01225731|364571929|FG002|Part 2|Lack of Efficacy|0|||
105702081|NCT01225731|364571930|FG003|Part 2|Lack of Efficacy|0|||
105702082|NCT01225731|364571931|FG004|Part 2|Lack of Efficacy|0|||
105702083|NCT01225731|364571932|FG005|Part 2|Lack of Efficacy|1|||
105702084|NCT01225731|364571933|FG006|Part 2|Lack of Efficacy|0|||
105702085|NCT01225731|364571934|FG007|Part 2|Lack of Efficacy|12|||
105702086|NCT01225731|364571935|FG008|Part 2|Lack of Efficacy|3|||
105702087|NCT01225731|364571936|FG009|Part 2|Lack of Efficacy|0|||
105702088|NCT01225731|364571937|FG010|Part 2|Lack of Efficacy|0|||
105702089|NCT01225731|364571938|FG011|Part 2|Lack of Efficacy|0|||
105702090|NCT01225731|364571939|FG012|Part 2|Lack of Efficacy|0|||
105702091|NCT01225731|364571927|FG000|Part 2|Pregnancy|0|||
105702092|NCT01225731|364571928|FG001|Part 2|Pregnancy|0|||
105702093|NCT01225731|364571929|FG002|Part 2|Pregnancy|0|||
105787287|NCT03985982|364874917|FG001|Open-Label Phase|Physician Decision|0|||
105702094|NCT01225731|364571930|FG003|Part 2|Pregnancy|0|||
105787288|NCT03985982|364874918|FG002|Open-Label Phase|Physician Decision|2|||
105926244|NCT00831844|365388004|FG001|Overall Study|Lack of Efficacy|10|||
105702095|NCT01225731|364571931|FG004|Part 2|Pregnancy|0|||
105702096|NCT01225731|364571932|FG005|Part 2|Pregnancy|0|||
105702097|NCT01225731|364571933|FG006|Part 2|Pregnancy|1|||
105702098|NCT01225731|364571934|FG007|Part 2|Pregnancy|0|||
105702099|NCT01225731|364571935|FG008|Part 2|Pregnancy|1|||
105702100|NCT01225731|364571936|FG009|Part 2|Pregnancy|0|||
105702101|NCT01225731|364571937|FG010|Part 2|Pregnancy|0|||
105702102|NCT01225731|364571938|FG011|Part 2|Pregnancy|0|||
105702103|NCT01225731|364571939|FG012|Part 2|Pregnancy|0|||
105702104|NCT01225731|364571927|FG000|Part 2|Lost to Follow-up|0|||
105702105|NCT01225731|364571928|FG001|Part 2|Lost to Follow-up|0|||
105702106|NCT01225731|364571929|FG002|Part 2|Lost to Follow-up|0|||
105702107|NCT01225731|364571930|FG003|Part 2|Lost to Follow-up|0|||
105702108|NCT01225731|364571931|FG004|Part 2|Lost to Follow-up|0|||
105702109|NCT01225731|364571932|FG005|Part 2|Lost to Follow-up|0|||
105926245|NCT00831844|365388005|FG002|Overall Study|Lack of Efficacy|15|||
105926246|NCT00831844|365388006|FG003|Overall Study|Lack of Efficacy|8|||
105926247|NCT00831844|365388007|FG004|Overall Study|Lack of Efficacy|11|||
105702110|NCT01225731|364571933|FG006|Part 2|Lost to Follow-up|0|||
105702111|NCT01225731|364571934|FG007|Part 2|Lost to Follow-up|3|||
105702112|NCT01225731|364571935|FG008|Part 2|Lost to Follow-up|1|||
105702113|NCT01225731|364571936|FG009|Part 2|Lost to Follow-up|0|||
105702114|NCT01225731|364571937|FG010|Part 2|Lost to Follow-up|0|||
105702115|NCT01225731|364571938|FG011|Part 2|Lost to Follow-up|0|||
105702116|NCT01225731|364571939|FG012|Part 2|Lost to Follow-up|0|||
105702117|NCT01225731|364571927|FG000|Part 2|Physician Decision|0|||
105702118|NCT01225731|364571928|FG001|Part 2|Physician Decision|0|||
105702119|NCT01225731|364571929|FG002|Part 2|Physician Decision|0|||
105702120|NCT01225731|364571930|FG003|Part 2|Physician Decision|0|||
105702121|NCT01225731|364571931|FG004|Part 2|Physician Decision|0|||
105702122|NCT01225731|364571932|FG005|Part 2|Physician Decision|0|||
105702123|NCT01225731|364571933|FG006|Part 2|Physician Decision|0|||
105702124|NCT01225731|364571934|FG007|Part 2|Physician Decision|2|||
105702125|NCT01225731|364571935|FG008|Part 2|Physician Decision|2|||
105702126|NCT01225731|364571936|FG009|Part 2|Physician Decision|0|||
105702127|NCT01225731|364571937|FG010|Part 2|Physician Decision|0|||
105702128|NCT01225731|364571938|FG011|Part 2|Physician Decision|0|||
105702129|NCT01225731|364571939|FG012|Part 2|Physician Decision|0|||
105702130|NCT01225731|364571927|FG000|Part 2|Withdrawal by Subject|0|||
105702131|NCT01225731|364571928|FG001|Part 2|Withdrawal by Subject|0|||
105787289|NCT03985982|364874916|FG000|Open-Label Phase|Withdrawal by Subject|0|||
105787290|NCT03985982|364874917|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105787291|NCT03985982|364874918|FG002|Open-Label Phase|Withdrawal by Subject|11|||
105787292|NCT02356159|364874925|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787293|NCT02356159|364874926|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787294|NCT02356159|364874927|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787295|NCT02356159|364874928|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787296|NCT02356159|364874929|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
105787297|NCT02356159|364874930|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
105787298|NCT04963231|364874931|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
105702132|NCT01225731|364571929|FG002|Part 2|Withdrawal by Subject|0|||
105702133|NCT01225731|364571930|FG003|Part 2|Withdrawal by Subject|0|||
105702134|NCT01225731|364571931|FG004|Part 2|Withdrawal by Subject|0|||
105702135|NCT01225731|364571932|FG005|Part 2|Withdrawal by Subject|1|||
105702136|NCT01225731|364571933|FG006|Part 2|Withdrawal by Subject|3|||
105702137|NCT01225731|364571934|FG007|Part 2|Withdrawal by Subject|4|||
105702138|NCT01225731|364571935|FG008|Part 2|Withdrawal by Subject|1|||
105702139|NCT01225731|364571936|FG009|Part 2|Withdrawal by Subject|0|||
105702140|NCT01225731|364571937|FG010|Part 2|Withdrawal by Subject|0|||
105702141|NCT01225731|364571938|FG011|Part 2|Withdrawal by Subject|0|||
105702142|NCT01225731|364571939|FG012|Part 2|Withdrawal by Subject|0|||
105702143|NCT01225731|364571927|FG000|Part 3|Adverse Event|0|||
105702144|NCT01225731|364571928|FG001|Part 3|Adverse Event|0|||
105702145|NCT01225731|364571929|FG002|Part 3|Adverse Event|0|||
105787299|NCT04963231|364874932|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
105787300|NCT04963231|364874933|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
105787301|NCT04963231|364874931|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
105787302|NCT04963231|364874932|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
105702146|NCT01225731|364571930|FG003|Part 3|Adverse Event|0|||
105702147|NCT01225731|364571931|FG004|Part 3|Adverse Event|0|||
105702148|NCT01225731|364571932|FG005|Part 3|Adverse Event|0|||
105702149|NCT01225731|364571933|FG006|Part 3|Adverse Event|0|||
105702150|NCT01225731|364571934|FG007|Part 3|Adverse Event|0|||
105787303|NCT04963231|364874933|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
105787304|NCT04963231|364874931|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
105787305|NCT04963231|364874932|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
105702151|NCT01225731|364571935|FG008|Part 3|Adverse Event|0|||
105702152|NCT01225731|364571936|FG009|Part 3|Adverse Event|0|||
105702153|NCT01225731|364571937|FG010|Part 3|Adverse Event|1|||
105702154|NCT01225731|364571938|FG011|Part 3|Adverse Event|1|||
105702155|NCT01225731|364571939|FG012|Part 3|Adverse Event|0|||
105702156|NCT01225731|364571927|FG000|Part 3|Lost to Follow-up|0|||
105702157|NCT01225731|364571928|FG001|Part 3|Lost to Follow-up|0|||
105702158|NCT01225731|364571929|FG002|Part 3|Lost to Follow-up|0|||
105702159|NCT01225731|364571930|FG003|Part 3|Lost to Follow-up|0|||
105702160|NCT01225731|364571931|FG004|Part 3|Lost to Follow-up|0|||
105702161|NCT01225731|364571932|FG005|Part 3|Lost to Follow-up|0|||
105702162|NCT01225731|364571933|FG006|Part 3|Lost to Follow-up|0|||
105702163|NCT01225731|364571934|FG007|Part 3|Lost to Follow-up|0|||
105702164|NCT01225731|364571935|FG008|Part 3|Lost to Follow-up|0|||
105702165|NCT01225731|364571936|FG009|Part 3|Lost to Follow-up|0|||
105702166|NCT01225731|364571937|FG010|Part 3|Lost to Follow-up|1|||
105702167|NCT01225731|364571938|FG011|Part 3|Lost to Follow-up|2|||
105702168|NCT01225731|364571939|FG012|Part 3|Lost to Follow-up|1|||
105702169|NCT01225731|364571927|FG000|Part 3|Physician Decision|0|||
105702170|NCT01225731|364571928|FG001|Part 3|Physician Decision|0|||
105702171|NCT01225731|364571929|FG002|Part 3|Physician Decision|0|||
105702172|NCT01225731|364571930|FG003|Part 3|Physician Decision|0|||
105702173|NCT01225731|364571931|FG004|Part 3|Physician Decision|0|||
105702174|NCT01225731|364571932|FG005|Part 3|Physician Decision|0|||
105702175|NCT01225731|364571933|FG006|Part 3|Physician Decision|0|||
105702176|NCT01225731|364571934|FG007|Part 3|Physician Decision|0|||
105702177|NCT01225731|364571935|FG008|Part 3|Physician Decision|0|||
105702178|NCT01225731|364571936|FG009|Part 3|Physician Decision|0|||
105702179|NCT01225731|364571937|FG010|Part 3|Physician Decision|0|||
105702180|NCT01225731|364571938|FG011|Part 3|Physician Decision|1|||
105702181|NCT01225731|364571939|FG012|Part 3|Physician Decision|2|||
105702182|NCT01225731|364571927|FG000|Part 3|Withdrawal by Subject|0|||
105702183|NCT01225731|364571928|FG001|Part 3|Withdrawal by Subject|0|||
105702184|NCT01225731|364571929|FG002|Part 3|Withdrawal by Subject|0|||
105702185|NCT01225731|364571930|FG003|Part 3|Withdrawal by Subject|0|||
105702186|NCT01225731|364571931|FG004|Part 3|Withdrawal by Subject|0|||
105702187|NCT01225731|364571932|FG005|Part 3|Withdrawal by Subject|0|||
105702188|NCT01225731|364571933|FG006|Part 3|Withdrawal by Subject|0|||
105702189|NCT01225731|364571934|FG007|Part 3|Withdrawal by Subject|0|||
105702190|NCT01225731|364571935|FG008|Part 3|Withdrawal by Subject|0|||
105702191|NCT01225731|364571936|FG009|Part 3|Withdrawal by Subject|0|||
105702192|NCT01225731|364571937|FG010|Part 3|Withdrawal by Subject|4|||
105702193|NCT01225731|364571938|FG011|Part 3|Withdrawal by Subject|6|||
105702194|NCT01225731|364571939|FG012|Part 3|Withdrawal by Subject|4|||
105702195|NCT01342484|364571942|FG000|Overall Study|Other Reasons|1|||
105702196|NCT01342484|364571943|FG001|Overall Study|Other Reasons|0|||
105702197|NCT01342484|364571944|FG002|Overall Study|Other Reasons|0|||
105702198|NCT01342484|364571942|FG000|Overall Study|Protocol Violation|0|||
105702199|NCT01342484|364571943|FG001|Overall Study|Protocol Violation|0|||
105702200|NCT01342484|364571944|FG002|Overall Study|Protocol Violation|1|||
105702201|NCT01342484|364571942|FG000|Overall Study|Withdrawal by Subject|1|||
105702202|NCT01342484|364571943|FG001|Overall Study|Withdrawal by Subject|0|||
105702203|NCT01342484|364571944|FG002|Overall Study|Withdrawal by Subject|0|||
105702204|NCT01840579|364571947|FG000|Overall Study|Status not recorded|0|||
105702205|NCT01840579|364571948|FG001|Overall Study|Status not recorded|0|||
105702206|NCT01840579|364571949|FG002|Overall Study|Status not recorded|2|||
105702207|NCT01840579|364571950|FG003|Overall Study|Status not recorded|3|||
105702208|NCT01840579|364571951|FG004|Overall Study|Status not recorded|4|||
105702209|NCT01840579|364571952|FG005|Overall Study|Status not recorded|3|||
105702210|NCT01840579|364571953|FG006|Overall Study|Status not recorded|0|||
105702211|NCT01840579|364571954|FG007|Overall Study|Status not recorded|3|||
105702212|NCT01840579|364571955|FG008|Overall Study|Status not recorded|3|||
105702213|NCT01840579|364571956|FG009|Overall Study|Status not recorded|3|||
105702214|NCT01840579|364571947|FG000|Overall Study|Progressive disease|3|||
105702215|NCT01840579|364571948|FG001|Overall Study|Progressive disease|5|||
105702216|NCT01840579|364571949|FG002|Overall Study|Progressive disease|0|||
105702217|NCT01840579|364571950|FG003|Overall Study|Progressive disease|0|||
105702218|NCT01840579|364571951|FG004|Overall Study|Progressive disease|0|||
105702219|NCT01840579|364571952|FG005|Overall Study|Progressive disease|0|||
105702220|NCT01840579|364571953|FG006|Overall Study|Progressive disease|0|||
105702221|NCT01840579|364571954|FG007|Overall Study|Progressive disease|0|||
105702222|NCT01840579|364571955|FG008|Overall Study|Progressive disease|0|||
105702223|NCT01840579|364571956|FG009|Overall Study|Progressive disease|0|||
105702224|NCT01840579|364571947|FG000|Overall Study|Ongoing in study|0|||
105702225|NCT01840579|364571948|FG001|Overall Study|Ongoing in study|1|||
105702226|NCT01840579|364571949|FG002|Overall Study|Ongoing in study|0|||
105702227|NCT01840579|364571950|FG003|Overall Study|Ongoing in study|0|||
105702228|NCT01840579|364571951|FG004|Overall Study|Ongoing in study|0|||
105702229|NCT01840579|364571952|FG005|Overall Study|Ongoing in study|0|||
105702230|NCT01840579|364571953|FG006|Overall Study|Ongoing in study|0|||
105702231|NCT01840579|364571954|FG007|Overall Study|Ongoing in study|0|||
105702232|NCT01840579|364571955|FG008|Overall Study|Ongoing in study|0|||
105702233|NCT01840579|364571956|FG009|Overall Study|Ongoing in study|0|||
105702234|NCT01840579|364571947|FG000|Overall Study|Death|0|||
105702235|NCT01840579|364571948|FG001|Overall Study|Death|0|||
105702236|NCT01840579|364571949|FG002|Overall Study|Death|0|||
105702237|NCT01840579|364571950|FG003|Overall Study|Death|0|||
105702238|NCT01840579|364571951|FG004|Overall Study|Death|0|||
105702239|NCT01840579|364571952|FG005|Overall Study|Death|1|||
105702240|NCT01840579|364571953|FG006|Overall Study|Death|0|||
105702241|NCT01840579|364571954|FG007|Overall Study|Death|0|||
105702242|NCT01840579|364571955|FG008|Overall Study|Death|0|||
105702243|NCT01840579|364571956|FG009|Overall Study|Death|0|||
105702244|NCT01840579|364571947|FG000|Overall Study|Adverse Event|0|||
105702245|NCT01840579|364571948|FG001|Overall Study|Adverse Event|1|||
105702246|NCT01840579|364571949|FG002|Overall Study|Adverse Event|0|||
105702247|NCT01840579|364571950|FG003|Overall Study|Adverse Event|0|||
105702248|NCT01840579|364571951|FG004|Overall Study|Adverse Event|0|||
105702249|NCT01840579|364571952|FG005|Overall Study|Adverse Event|0|||
105702250|NCT01840579|364571953|FG006|Overall Study|Adverse Event|0|||
105702251|NCT01840579|364571954|FG007|Overall Study|Adverse Event|0|||
105702252|NCT01840579|364571955|FG008|Overall Study|Adverse Event|0|||
105702253|NCT01840579|364571956|FG009|Overall Study|Adverse Event|0|||
105702254|NCT01840579|364571947|FG000|Overall Study|Follow-up ended by Sponsor|0|||
105702255|NCT01840579|364571948|FG001|Overall Study|Follow-up ended by Sponsor|0|||
105702256|NCT01840579|364571949|FG002|Overall Study|Follow-up ended by Sponsor|0|||
105702257|NCT01840579|364571950|FG003|Overall Study|Follow-up ended by Sponsor|0|||
105702258|NCT01840579|364571951|FG004|Overall Study|Follow-up ended by Sponsor|0|||
105702259|NCT01840579|364571952|FG005|Overall Study|Follow-up ended by Sponsor|0|||
105702260|NCT01840579|364571953|FG006|Overall Study|Follow-up ended by Sponsor|2|||
105702261|NCT01840579|364571954|FG007|Overall Study|Follow-up ended by Sponsor|0|||
105702262|NCT01840579|364571955|FG008|Overall Study|Follow-up ended by Sponsor|0|||
105702263|NCT01840579|364571956|FG009|Overall Study|Follow-up ended by Sponsor|0|||
105702264|NCT02577146|364571958|FG000|Overall Study|Lost to Follow-up|8|||
105702265|NCT02577146|364571958|FG000|Overall Study|Physician Decision|3|||
105702266|NCT02577146|364571958|FG000|Overall Study|Screen Failure|17|||
105702267|NCT01624662|364571959|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
105702268|NCT01624662|364571960|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
105702269|NCT01624662|364571961|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
105702270|NCT01624662|364571962|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
105702271|NCT01624662|364571959|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
105702272|NCT01624662|364571960|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
105702273|NCT01624662|364571961|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
105702274|NCT01624662|364571962|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
105702275|NCT01624662|364571959|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105702276|NCT01624662|364571960|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
105702277|NCT01624662|364571961|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105702278|NCT01624662|364571962|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105702279|NCT01624662|364571959|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
105702280|NCT01624662|364571960|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
105702281|NCT01624662|364571961|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
105702282|NCT01624662|364571962|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
105702283|NCT01624662|364571959|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
105702284|NCT01624662|364571960|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
105702285|NCT01624662|364571961|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
105702286|NCT01624662|364571962|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
105702287|NCT01624662|364571959|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105702288|NCT01624662|364571960|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
105702289|NCT01624662|364571961|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105702290|NCT01624662|364571962|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105702291|NCT01624662|364571959|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
105702292|NCT01624662|364571960|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
105702293|NCT01624662|364571961|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
105702294|NCT01624662|364571962|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
105702295|NCT03116698|364571965|FG000|Overall Study|Adverse Event|1|||
105702296|NCT03116698|364571966|FG001|Overall Study|Adverse Event|1|||
105702297|NCT03116698|364571967|FG002|Overall Study|Adverse Event|1|||
105702298|NCT03116698|364571968|FG003|Overall Study|Adverse Event|0|||
105702299|NCT03116698|364571965|FG000|Overall Study|Withdrawal by Subject|1|||
105702300|NCT03116698|364571966|FG001|Overall Study|Withdrawal by Subject|4|||
106006300|NCT02587520|365688165|FG013|Overall Study|Adverse Event|0|||
105702301|NCT03116698|364571967|FG002|Overall Study|Withdrawal by Subject|5|||
105702302|NCT03116698|364571968|FG003|Overall Study|Withdrawal by Subject|2|||
105702303|NCT03116698|364571965|FG000|Overall Study|Lost to Follow-up|2|||
105702304|NCT03116698|364571966|FG001|Overall Study|Lost to Follow-up|0|||
105702305|NCT03116698|364571967|FG002|Overall Study|Lost to Follow-up|0|||
105702306|NCT03116698|364571968|FG003|Overall Study|Lost to Follow-up|0|||
105702307|NCT03116698|364571965|FG000|Overall Study|Physician Decision|1|||
105702308|NCT03116698|364571966|FG001|Overall Study|Physician Decision|1|||
105702309|NCT03116698|364571967|FG002|Overall Study|Physician Decision|0|||
105702310|NCT03116698|364571968|FG003|Overall Study|Physician Decision|0|||
105702311|NCT03116698|364571965|FG000|Overall Study|Protocol Violation|1|||
105702312|NCT03116698|364571966|FG001|Overall Study|Protocol Violation|0|||
105702313|NCT03116698|364571967|FG002|Overall Study|Protocol Violation|0|||
105702314|NCT03116698|364571968|FG003|Overall Study|Protocol Violation|0|||
105702315|NCT03116698|364571965|FG000|Overall Study|Death|0|||
105702316|NCT03116698|364571966|FG001|Overall Study|Death|0|||
105702317|NCT03116698|364571967|FG002|Overall Study|Death|2|||
105702318|NCT03116698|364571968|FG003|Overall Study|Death|0|||
105702319|NCT03834519|364571969|FG000|Overall Study|Lost to Follow-up|2|||
105702320|NCT03834519|364571970|FG001|Overall Study|Lost to Follow-up|1|||
105702321|NCT03834519|364571969|FG000|Overall Study|Withdrawal by Subject|5|||
105702322|NCT03834519|364571970|FG001|Overall Study|Withdrawal by Subject|8|||
105702323|NCT03834519|364571969|FG000|Overall Study|Death|368|||
105702324|NCT03834519|364571970|FG001|Overall Study|Death|174|||
105702325|NCT03834519|364571969|FG000|Overall Study|Physician Decision|5|||
105702326|NCT03834519|364571970|FG001|Overall Study|Physician Decision|1|||
105702327|NCT03834519|364571969|FG000|Overall Study|Sponsor decision|149|||
105702328|NCT03834519|364571970|FG001|Overall Study|Sponsor decision|80|||
105702329|NCT04294901|364571971|FG000|Overall Study|Death|86|||
105702330|NCT04294901|364571972|FG001|Overall Study|Death|110|||
105702331|NCT04294901|364571971|FG000|Overall Study|Provider did not have historical control patients|581|||
105702332|NCT04294901|364571972|FG001|Overall Study|Provider did not have historical control patients|0|||
105702333|NCT04294901|364571971|FG000|Overall Study|Provider did not have intervention patients|0|||
105702334|NCT04294901|364571972|FG001|Overall Study|Provider did not have intervention patients|98|||
105702335|NCT03581786|364572917|FG000|Overall Study|Death|17|||
105702336|NCT03581786|364572918|FG001|Overall Study|Death|12|||
105702337|NCT03581786|364572917|FG000|Overall Study|Withdrawal by Subject|2|||
105702338|NCT03581786|364572918|FG001|Overall Study|Withdrawal by Subject|4|||
105702339|NCT03581786|364572917|FG000|Overall Study|Lost to Follow-up|1|||
105702340|NCT03581786|364572918|FG001|Overall Study|Lost to Follow-up|0|||
105702341|NCT03581786|364572917|FG000|Overall Study|reason other than specified above|0|||
105702342|NCT03581786|364572918|FG001|Overall Study|reason other than specified above|1|||
105702343|NCT03581786|364572917|FG000|Overall Study|Ongoing in the study|123|||
105702344|NCT03581786|364572918|FG001|Overall Study|Ongoing in the study|129|||
105702345|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
105702346|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
105702347|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
105702348|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
105702349|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
105702350|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
105702351|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Death|2|||
105702352|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Death|0|||
105702353|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
105702354|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
105702355|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
105702356|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
105702357|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
105702358|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
106006301|NCT02587520|365688166|FG014|Overall Study|Adverse Event|0|||
105702359|NCT02603120|364572919|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
105702360|NCT02603120|364572920|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
105702361|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
105702362|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
105702363|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
105702364|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
105702365|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
105702366|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
105702367|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
105702368|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
106006302|NCT02587520|365688167|FG015|Overall Study|Adverse Event|0|||
106006303|NCT02587520|365688168|FG016|Overall Study|Adverse Event|0|||
105702369|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
105702370|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
105702371|NCT02603120|364572919|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
106006304|NCT02587520|365688169|FG017|Overall Study|Adverse Event|0|||
106006305|NCT02587520|365688152|FG000|Overall Study|Withdrawal by Subject|0|||
106006306|NCT02587520|365688153|FG001|Overall Study|Withdrawal by Subject|0|||
106006307|NCT02587520|365688154|FG002|Overall Study|Withdrawal by Subject|1|||
106006308|NCT02587520|365688155|FG003|Overall Study|Withdrawal by Subject|1|||
106006309|NCT02587520|365688156|FG004|Overall Study|Withdrawal by Subject|0|||
106006310|NCT02587520|365688157|FG005|Overall Study|Withdrawal by Subject|1|||
105702372|NCT02603120|364572920|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
105702373|NCT00176605|364572924|FG000|Overall Study|Withdrawal by Subject|2|||
105702374|NCT01321710|364572925|FG000|Overall Study|Lost to Follow-up|4|||
105702375|NCT01321710|364572926|FG001|Overall Study|Lost to Follow-up|5|||
105702376|NCT01321710|364572927|FG002|Overall Study|Lost to Follow-up|0|||
105702377|NCT02463409|364572928|FG000|Overall Study|Withdrawal by Subject|1|||
105702378|NCT02463409|364572928|FG000|Overall Study|Screen failure|1|||
105702379|NCT00772954|364572929|FG000|Overall Study|Adverse Event|0|||
105702380|NCT00772954|364572930|FG001|Overall Study|Adverse Event|0|||
105702381|NCT00772954|364572931|FG002|Overall Study|Adverse Event|1|||
105702382|NCT01349465|364572933|FG000|Overall Study|Adverse Event|1|||
105702383|NCT01349465|364572934|FG001|Overall Study|Adverse Event|0|||
105702384|NCT01349465|364572933|FG000|Overall Study|Death|3|||
105702385|NCT01349465|364572934|FG001|Overall Study|Death|0|||
105702386|NCT01349465|364572933|FG000|Overall Study|Lost to Follow-up|10|||
105702387|NCT01349465|364572934|FG001|Overall Study|Lost to Follow-up|1|||
105702388|NCT01349465|364572933|FG000|Overall Study|Withdrawal by Subject|4|||
105702389|NCT01349465|364572934|FG001|Overall Study|Withdrawal by Subject|2|||
105702390|NCT01349465|364572933|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
105702391|NCT01349465|364572934|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
105702392|NCT01438489|364572935|FG000|Overall Study|Lost to Follow-up|4|||
105702393|NCT01438489|364572936|FG001|Overall Study|Lost to Follow-up|2|||
105702394|NCT01438489|364572937|FG002|Overall Study|Lost to Follow-up|2|||
105702395|NCT01438489|364572935|FG000|Overall Study|Withdrawal by Subject|11|||
105702396|NCT01438489|364572936|FG001|Overall Study|Withdrawal by Subject|3|||
105702397|NCT01438489|364572937|FG002|Overall Study|Withdrawal by Subject|8|||
105702398|NCT01438489|364572935|FG000|Overall Study|Death|0|||
105702399|NCT01438489|364572936|FG001|Overall Study|Death|0|||
105702400|NCT01438489|364572937|FG002|Overall Study|Death|1|||
105702401|NCT01438489|364572935|FG000|Overall Study|Sponsor decision|4|||
105702402|NCT01438489|364572936|FG001|Overall Study|Sponsor decision|1|||
105702403|NCT01438489|364572937|FG002|Overall Study|Sponsor decision|4|||
105702404|NCT01438489|364572935|FG000|Overall Study|Subject choice/Subject moved|2|||
105702405|NCT01438489|364572936|FG001|Overall Study|Subject choice/Subject moved|1|||
105702406|NCT01438489|364572937|FG002|Overall Study|Subject choice/Subject moved|1|||
105702407|NCT01438489|364572935|FG000|Overall Study|Investigator decision|0|||
105702408|NCT01438489|364572936|FG001|Overall Study|Investigator decision|1|||
105702409|NCT01438489|364572937|FG002|Overall Study|Investigator decision|0|||
105702410|NCT01438489|364572935|FG000|Overall Study|AE/SAEs|2|||
105702411|NCT01438489|364572936|FG001|Overall Study|AE/SAEs|1|||
105702412|NCT01438489|364572937|FG002|Overall Study|AE/SAEs|1|||
105702413|NCT01438489|364572935|FG000|Overall Study|Received prohibited medication|1|||
105702414|NCT01438489|364572936|FG001|Overall Study|Received prohibited medication|0|||
105702415|NCT01438489|364572937|FG002|Overall Study|Received prohibited medication|0|||
105702416|NCT01438489|364572935|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
105702417|NCT01438489|364572936|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
105702418|NCT01438489|364572937|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
105702419|NCT01438489|364572935|FG000|Overall Study|Inadequate venous access|0|||
105702420|NCT01438489|364572936|FG001|Overall Study|Inadequate venous access|2|||
105702421|NCT01438489|364572937|FG002|Overall Study|Inadequate venous access|0|||
105702422|NCT02037295|364572938|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
105702423|NCT02037295|364572939|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
106133635|NCT01097655|366148131|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
106133636|NCT01345292|366148132|FG000|Overall Study|Withdrawal by Subject|2|||
106133637|NCT01345292|366148133|FG001|Overall Study|Withdrawal by Subject|0|||
105702424|NCT02037295|364572940|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
105702425|NCT02037295|364572941|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
105702426|NCT01140451|364572945|FG000|Overall Study|Withdrawal by Subject|26|||
105702427|NCT01140451|364572946|FG001|Overall Study|Withdrawal by Subject|33|||
105702428|NCT01140451|364572945|FG000|Overall Study|Adverse Event|2|||
105702429|NCT01140451|364572946|FG001|Overall Study|Adverse Event|6|||
105702430|NCT01140451|364572945|FG000|Overall Study|Physician Decision|5|||
105702431|NCT01140451|364572946|FG001|Overall Study|Physician Decision|3|||
105702432|NCT01140451|364572945|FG000|Overall Study|Lost to Follow-up|2|||
105702433|NCT01140451|364572946|FG001|Overall Study|Lost to Follow-up|0|||
106133638|NCT01345292|366148134|FG002|Overall Study|Withdrawal by Subject|1|||
106006311|NCT02587520|365688158|FG006|Overall Study|Withdrawal by Subject|1|||
106006312|NCT02587520|365688159|FG007|Overall Study|Withdrawal by Subject|0|||
105702434|NCT01140451|364572945|FG000|Overall Study|Participants Planning Pregnancy|3|||
105702435|NCT01140451|364572946|FG001|Overall Study|Participants Planning Pregnancy|0|||
105702436|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
105702437|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
105702438|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
105702439|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
105702440|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
105702441|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
105702442|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
105702443|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
105702444|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
105702445|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
105702446|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
105702447|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
105702448|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
105702449|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
105702450|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
105702451|NCT00960661|364572950|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
105702452|NCT00960661|364572951|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
105702453|NCT00960661|364572952|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
105702454|NCT00960661|364572950|FG000|Interventional Phase|Adverse Event|0|||
105702455|NCT00960661|364572951|FG001|Interventional Phase|Adverse Event|17|||
105702456|NCT00960661|364572952|FG002|Interventional Phase|Adverse Event|8|||
105702457|NCT00960661|364572950|FG000|Interventional Phase|Death|0|||
105702458|NCT00960661|364572951|FG001|Interventional Phase|Death|1|||
105702459|NCT00960661|364572952|FG002|Interventional Phase|Death|0|||
105702460|NCT00960661|364572950|FG000|Interventional Phase|Lost to Follow-up|0|||
105702461|NCT00960661|364572951|FG001|Interventional Phase|Lost to Follow-up|0|||
105702462|NCT00960661|364572952|FG002|Interventional Phase|Lost to Follow-up|2|||
105702463|NCT00960661|364572950|FG000|Interventional Phase|entry criteria not met|0|||
105702464|NCT00960661|364572951|FG001|Interventional Phase|entry criteria not met|3|||
105702465|NCT00960661|364572952|FG002|Interventional Phase|entry criteria not met|0|||
105702466|NCT00960661|364572950|FG000|Interventional Phase|Protocol Violation|0|||
105702467|NCT00960661|364572951|FG001|Interventional Phase|Protocol Violation|7|||
105702468|NCT00960661|364572952|FG002|Interventional Phase|Protocol Violation|2|||
105702469|NCT00960661|364572950|FG000|Interventional Phase|Withdrawal by Subject|0|||
105702470|NCT00960661|364572951|FG001|Interventional Phase|Withdrawal by Subject|18|||
105702471|NCT00960661|364572952|FG002|Interventional Phase|Withdrawal by Subject|29|||
105702472|NCT00960661|364572950|FG000|Interventional Phase|Physician Decision|0|||
105702473|NCT00960661|364572951|FG001|Interventional Phase|Physician Decision|3|||
105702474|NCT00960661|364572952|FG002|Interventional Phase|Physician Decision|5|||
105702475|NCT00960661|364572950|FG000|Interventional Phase|sponsor decision|0|||
105702476|NCT00960661|364572951|FG001|Interventional Phase|sponsor decision|1|||
105702477|NCT00960661|364572952|FG002|Interventional Phase|sponsor decision|0|||
105702478|NCT00960661|364572950|FG000|Interventional Phase|Lack of Efficacy|0|||
105702479|NCT00960661|364572951|FG001|Interventional Phase|Lack of Efficacy|2|||
105702480|NCT00960661|364572952|FG002|Interventional Phase|Lack of Efficacy|0|||
105702481|NCT02699892|364572953|FG000|Overall Study|Other|36|||
105702482|NCT01148537|364572959|FG000|Overall Study|Withdrawal by Subject|1|||
105702483|NCT01148537|364572960|FG001|Overall Study|Withdrawal by Subject|0|||
105702484|NCT01148537|364572961|FG002|Overall Study|Withdrawal by Subject|2|||
105702485|NCT01148537|364572959|FG000|Overall Study|Adverse Event|2|||
105702486|NCT01148537|364572960|FG001|Overall Study|Adverse Event|0|||
105702487|NCT01148537|364572961|FG002|Overall Study|Adverse Event|1|||
105702488|NCT02770547|364572962|FG000|Overall Study|Patient non-compliant|1|||
105702489|NCT02770547|364572963|FG001|Overall Study|Patient non-compliant|0|||
105702490|NCT02770547|364572962|FG000|Overall Study|Adverse Event|0|||
105702491|NCT02770547|364572963|FG001|Overall Study|Adverse Event|1|||
105702492|NCT03134599|364572965|FG000|Week 1|Lost to Follow-up|0|||
105702493|NCT03134599|364572966|FG001|Week 1|Lost to Follow-up|0|||
105702494|NCT03134599|364572967|FG002|Week 1|Lost to Follow-up|0|||
105702495|NCT03134599|364572968|FG003|Week 1|Lost to Follow-up|0|||
105702496|NCT03134599|364572969|FG004|Week 1|Lost to Follow-up|1|||
105702497|NCT03134599|364572970|FG005|Week 1|Lost to Follow-up|0|||
105702498|NCT03134599|364572965|FG000|Week 2|Lost to Follow-up|1|||
105702499|NCT03134599|364572966|FG001|Week 2|Lost to Follow-up|0|||
105702500|NCT03134599|364572967|FG002|Week 2|Lost to Follow-up|0|||
105702501|NCT03134599|364572968|FG003|Week 2|Lost to Follow-up|1|||
105702502|NCT03134599|364572969|FG004|Week 2|Lost to Follow-up|1|||
105702503|NCT03134599|364572970|FG005|Week 2|Lost to Follow-up|0|||
105702504|NCT03134599|364572965|FG000|Week 3|Lost to Follow-up|0|||
105702505|NCT03134599|364572966|FG001|Week 3|Lost to Follow-up|0|||
105702506|NCT03134599|364572967|FG002|Week 3|Lost to Follow-up|0|||
105702507|NCT03134599|364572968|FG003|Week 3|Lost to Follow-up|1|||
105702508|NCT03134599|364572969|FG004|Week 3|Lost to Follow-up|0|||
105702509|NCT03134599|364572970|FG005|Week 3|Lost to Follow-up|1|||
106006313|NCT02587520|365688160|FG008|Overall Study|Withdrawal by Subject|0|||
106006314|NCT02587520|365688161|FG009|Overall Study|Withdrawal by Subject|0|||
106006315|NCT02587520|365688162|FG010|Overall Study|Withdrawal by Subject|0|||
106006316|NCT02587520|365688163|FG011|Overall Study|Withdrawal by Subject|0|||
106006317|NCT02587520|365688164|FG012|Overall Study|Withdrawal by Subject|0|||
106006318|NCT02587520|365688165|FG013|Overall Study|Withdrawal by Subject|1|||
106006319|NCT02587520|365688166|FG014|Overall Study|Withdrawal by Subject|0|||
106006320|NCT02587520|365688167|FG015|Overall Study|Withdrawal by Subject|0|||
106006321|NCT02587520|365688168|FG016|Overall Study|Withdrawal by Subject|0|||
106006322|NCT02587520|365688169|FG017|Overall Study|Withdrawal by Subject|0|||
106006323|NCT02587520|365688152|FG000|Overall Study|Lost to Follow-up|0|||
106006324|NCT02587520|365688153|FG001|Overall Study|Lost to Follow-up|2|||
106006325|NCT02587520|365688154|FG002|Overall Study|Lost to Follow-up|0|||
106006326|NCT02587520|365688155|FG003|Overall Study|Lost to Follow-up|2|||
106006327|NCT02587520|365688156|FG004|Overall Study|Lost to Follow-up|0|||
106006328|NCT02587520|365688157|FG005|Overall Study|Lost to Follow-up|1|||
106006329|NCT02587520|365688158|FG006|Overall Study|Lost to Follow-up|1|||
106006330|NCT02587520|365688159|FG007|Overall Study|Lost to Follow-up|1|||
106006331|NCT02587520|365688160|FG008|Overall Study|Lost to Follow-up|0|||
106006332|NCT02587520|365688161|FG009|Overall Study|Lost to Follow-up|2|||
106006333|NCT02587520|365688162|FG010|Overall Study|Lost to Follow-up|2|||
106006334|NCT02587520|365688163|FG011|Overall Study|Lost to Follow-up|1|||
106006335|NCT02587520|365688164|FG012|Overall Study|Lost to Follow-up|0|||
106006336|NCT02587520|365688165|FG013|Overall Study|Lost to Follow-up|0|||
106006337|NCT02587520|365688166|FG014|Overall Study|Lost to Follow-up|0|||
106006338|NCT02587520|365688167|FG015|Overall Study|Lost to Follow-up|0|||
106006339|NCT02587520|365688168|FG016|Overall Study|Lost to Follow-up|0|||
106006340|NCT02587520|365688169|FG017|Overall Study|Lost to Follow-up|0|||
106006341|NCT03623243|365688170|FG000|Overall Study|Adverse Event|15|||
106006342|NCT03623243|365688170|FG000|Overall Study|Guardian Decision|1|||
106006343|NCT03623243|365688170|FG000|Overall Study|New Therapy for Study Indication|1|||
106006344|NCT03623243|365688170|FG000|Overall Study|Protocol Deviation|3|||
106006345|NCT03623243|365688170|FG000|Overall Study|Physician Decision|4|||
106006346|NCT03623243|365688170|FG000|Overall Study|Patient Decision|15|||
106006347|NCT03182374|365688173|FG000|Overall Study|Lost to Follow-up|3|||
106006348|NCT03182374|365688174|FG001|Overall Study|Lost to Follow-up|2|||
106006349|NCT03182374|365688173|FG000|Overall Study|Lack of Efficacy|8|||
106006350|NCT03182374|365688174|FG001|Overall Study|Lack of Efficacy|14|||
105702510|NCT00393887|364572971|FG000|Overall Study|Physician Decision|5|||
106006351|NCT03182374|365688173|FG000|Overall Study|Withdrawal by Subject|1|||
106006352|NCT03182374|365688174|FG001|Overall Study|Withdrawal by Subject|1|||
106006353|NCT03182374|365688173|FG000|Overall Study|exit for non-compliance|1|||
106006354|NCT03182374|365688174|FG001|Overall Study|exit for non-compliance|1|||
106006355|NCT03182374|365688173|FG000|Overall Study|one subject was randomized but not treated|1|||
106006356|NCT03182374|365688174|FG001|Overall Study|one subject was randomized but not treated|0|||
106006357|NCT03182374|365688173|FG000|Overall Study|Other reasons|0|||
106006358|NCT03182374|365688174|FG001|Overall Study|Other reasons|3|||
106006359|NCT05635461|365688175|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
106006360|NCT05635461|365688176|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
106006361|NCT05635461|365688177|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
106006362|NCT05635461|365688178|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
106006363|NCT05635461|365688179|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
106006364|NCT05635461|365688180|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
106006365|NCT05635461|365688175|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
106006366|NCT05635461|365688176|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
106006367|NCT05635461|365688177|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
106006368|NCT05635461|365688178|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
106006369|NCT05635461|365688179|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
106006370|NCT05635461|365688180|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
106133639|NCT03303105|366148137|FG000|Overall Study|Adverse Event|0|||
106133640|NCT03303105|366148138|FG001|Overall Study|Adverse Event|2|||
106133641|NCT03303105|366148137|FG000|Overall Study|Lack of Efficacy|1|||
106133642|NCT03303105|366148138|FG001|Overall Study|Lack of Efficacy|0|||
106133643|NCT03303105|366148137|FG000|Overall Study|Protocol Violation|1|||
106006371|NCT05635461|365688175|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
106006372|NCT05635461|365688176|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
106006373|NCT05635461|365688177|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
106006374|NCT05635461|365688178|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
106006375|NCT05635461|365688179|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
106006376|NCT05635461|365688180|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
106006377|NCT04890652|365688183|FG000|Overall Study|Withdrawal by Subject|2|||
106006378|NCT05543265|365688186|FG000|Overall Study|Lost to Follow-up|3|||
106006379|NCT05543265|365688187|FG001|Overall Study|Lost to Follow-up|3|||
106006380|NCT05543265|365688186|FG000|Overall Study|Withdrawal by Subject|0|||
106006381|NCT05543265|365688187|FG001|Overall Study|Withdrawal by Subject|1|||
106006382|NCT05316597|365688188|FG000|First Session|Withdrawal by Subject|0|||
105702511|NCT00393887|364572972|FG001|Overall Study|Physician Decision|0|||
105702512|NCT00393887|364572971|FG000|Overall Study|Lost to Follow-up|11|||
105702513|NCT00393887|364572972|FG001|Overall Study|Lost to Follow-up|9|||
105702514|NCT00632099|364572981|FG000|Overall Study|Lost to Follow-up|3|||
105702515|NCT00632099|364572982|FG001|Overall Study|Lost to Follow-up|3|||
105702516|NCT03462576|364572990|FG000|Overall Study|Protocol Violation|5|||
105702517|NCT03462576|364572991|FG001|Overall Study|Protocol Violation|11|||
105702518|NCT03462576|364572992|FG002|Overall Study|Protocol Violation|7|||
105702519|NCT03462576|364572990|FG000|Overall Study|Device Malfunction|0|||
105702520|NCT03462576|364572991|FG001|Overall Study|Device Malfunction|0|||
105702521|NCT03462576|364572992|FG002|Overall Study|Device Malfunction|1|||
105702522|NCT03201458|364572996|FG000|Overall Study|No longer eligible|2|||
105702523|NCT03201458|364572997|FG001|Overall Study|No longer eligible|5|||
105702524|NCT03201458|364572996|FG000|Overall Study|Health event before starting|1|||
105702525|NCT03201458|364572997|FG001|Overall Study|Health event before starting|0|||
105702526|NCT03201458|364572996|FG000|Overall Study|Physician Decision|1|||
105702527|NCT03201458|364572997|FG001|Overall Study|Physician Decision|0|||
105702528|NCT00715026|364573002|FG000|Overall Study|Withdrawal by Subject|5|||
105702529|NCT00715026|364573002|FG000|Overall Study|Lost to Follow-up|3|||
105702530|NCT00715026|364573002|FG000|Overall Study|Protocol Violation|1|||
105702531|NCT00715026|364573002|FG000|Overall Study|Surgery done on non-study consented hip|1|||
105702532|NCT03962101|364573004|FG000|Overall Study|Adverse Event|1|||
105702533|NCT03962101|364573004|FG000|Overall Study|Physician Decision|2|||
105702534|NCT03962101|364573004|FG000|Overall Study|Not related to medical events|1|||
105702535|NCT00750737|364573005|FG000|Overall Study|Withdrawal by Subject|3|||
105702536|NCT00750737|364573006|FG001|Overall Study|Withdrawal by Subject|3|||
105702537|NCT00271596|364573007|FG000|Overall Study|Protocol Violation|1|||
105702538|NCT00271596|364573008|FG001|Overall Study|Protocol Violation|0|||
105702539|NCT00271596|364573007|FG000|Overall Study|Withdrawal by Subject|0|||
105702540|NCT00271596|364573008|FG001|Overall Study|Withdrawal by Subject|1|||
105702541|NCT04707157|364573009|FG000|Overall Study|Adverse Event|12|||
105702542|NCT04707157|364573010|FG001|Overall Study|Adverse Event|3|||
105702543|NCT04707157|364573009|FG000|Overall Study|Lost to Follow-up|2|||
105702544|NCT04707157|364573010|FG001|Overall Study|Lost to Follow-up|0|||
105702545|NCT04707157|364573009|FG000|Overall Study|Sponsor's decision|1|||
105702546|NCT04707157|364573010|FG001|Overall Study|Sponsor's decision|0|||
105702547|NCT04707157|364573009|FG000|Overall Study|Physician Decision|8|||
105702548|NCT04707157|364573010|FG001|Overall Study|Physician Decision|5|||
105702549|NCT04707157|364573009|FG000|Overall Study|Protocol Deviation|1|||
105702550|NCT04707157|364573010|FG001|Overall Study|Protocol Deviation|0|||
105702551|NCT04707157|364573009|FG000|Overall Study|Withdrawal by Subject|1|||
105702552|NCT04707157|364573010|FG001|Overall Study|Withdrawal by Subject|1|||
105702553|NCT02409290|364573013|FG000|Overall Study|Protocol Violation|3|||
105702554|NCT02409290|364573014|FG001|Overall Study|Protocol Violation|6|||
105702555|NCT02409290|364573015|FG002|Overall Study|Protocol Violation|9|||
105702556|NCT02409290|364573016|FG003|Overall Study|Protocol Violation|4|||
105702557|NCT02409290|364573013|FG000|Overall Study|No positive culture/no baseline sample|3|||
105702558|NCT02409290|364573014|FG001|Overall Study|No positive culture/no baseline sample|9|||
105702559|NCT02409290|364573015|FG002|Overall Study|No positive culture/no baseline sample|6|||
105702560|NCT02409290|364573016|FG003|Overall Study|No positive culture/no baseline sample|5|||
105702561|NCT02409290|364573013|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
105702562|NCT02409290|364573014|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
105702563|NCT02409290|364573015|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
105702564|NCT02409290|364573016|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
105702565|NCT02025907|364573021|FG000|Overall Study|Lack of Efficacy|1|||
105702566|NCT02025907|364573022|FG001|Overall Study|Lack of Efficacy|0|||
105702567|NCT02025907|364573021|FG000|Overall Study|Withdrawal by Subject|15|||
105702568|NCT02025907|364573022|FG001|Overall Study|Withdrawal by Subject|8|||
105702569|NCT02025907|364573021|FG000|Overall Study|Protocol Violation|2|||
105702570|NCT02025907|364573022|FG001|Overall Study|Protocol Violation|0|||
105702571|NCT02025907|364573021|FG000|Overall Study|Physician Decision|2|||
105702572|NCT02025907|364573022|FG001|Overall Study|Physician Decision|0|||
105702573|NCT02025907|364573021|FG000|Overall Study|Lost to Follow-up|2|||
105702574|NCT02025907|364573022|FG001|Overall Study|Lost to Follow-up|2|||
106006383|NCT05316597|365688189|FG001|First Session|Withdrawal by Subject|1|||
106006384|NCT05316597|365688188|FG000|Washout Period|Lost to Follow-up|1|||
106006385|NCT05316597|365688189|FG001|Washout Period|Lost to Follow-up|2|||
105702575|NCT02025907|364573021|FG000|Overall Study|Adverse Event|3|||
105702576|NCT02025907|364573022|FG001|Overall Study|Adverse Event|1|||
105702577|NCT02025907|364573021|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
105702578|NCT02025907|364573022|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
105702579|NCT03317795|364573023|FG000|Overall Study|IUD Expulsion|1|||
105702580|NCT03317795|364573024|FG001|Overall Study|IUD Expulsion|0|||
105702581|NCT03317795|364573023|FG000|Overall Study|Lost to Follow-up|1|||
105702582|NCT03317795|364573024|FG001|Overall Study|Lost to Follow-up|3|||
106006386|NCT05316597|365688188|FG000|Washout Period|Physician Decision|1|||
105702583|NCT03317795|364573023|FG000|Overall Study|Treatment change|0|||
105702584|NCT03317795|364573024|FG001|Overall Study|Treatment change|3|||
105702585|NCT03317795|364573023|FG000|Overall Study|Intolerance of medication|0|||
105702586|NCT03317795|364573024|FG001|Overall Study|Intolerance of medication|1|||
105702587|NCT03077685|364573025|FG000|Overall Study|Lost to Follow-up|0|||
105702588|NCT03077685|364573026|FG001|Overall Study|Lost to Follow-up|0|||
105702589|NCT03077685|364573027|FG002|Overall Study|Lost to Follow-up|0|||
105702590|NCT03077685|364573028|FG003|Overall Study|Lost to Follow-up|0|||
105702591|NCT03077685|364573029|FG004|Overall Study|Lost to Follow-up|1|||
105702592|NCT03077685|364573025|FG000|Overall Study|Death|0|||
105702593|NCT03077685|364573026|FG001|Overall Study|Death|0|||
105702594|NCT03077685|364573027|FG002|Overall Study|Death|1|||
105702595|NCT03077685|364573028|FG003|Overall Study|Death|1|||
105702596|NCT03077685|364573029|FG004|Overall Study|Death|3|||
105702597|NCT03077685|364573025|FG000|Overall Study|Withdrawal by Subject|0|||
105702598|NCT03077685|364573026|FG001|Overall Study|Withdrawal by Subject|0|||
105702599|NCT03077685|364573027|FG002|Overall Study|Withdrawal by Subject|0|||
105702600|NCT03077685|364573028|FG003|Overall Study|Withdrawal by Subject|2|||
105702601|NCT03077685|364573029|FG004|Overall Study|Withdrawal by Subject|1|||
105702602|NCT03077685|364573025|FG000|Overall Study|Physician Decision|0|||
105702603|NCT03077685|364573026|FG001|Overall Study|Physician Decision|0|||
105702604|NCT03077685|364573027|FG002|Overall Study|Physician Decision|1|||
105702605|NCT03077685|364573028|FG003|Overall Study|Physician Decision|0|||
105702606|NCT03077685|364573029|FG004|Overall Study|Physician Decision|3|||
105702607|NCT03077685|364573025|FG000|Overall Study|Disease Progression|1|||
105702608|NCT03077685|364573026|FG001|Overall Study|Disease Progression|0|||
105702609|NCT03077685|364573027|FG002|Overall Study|Disease Progression|0|||
105702610|NCT03077685|364573028|FG003|Overall Study|Disease Progression|2|||
105702611|NCT03077685|364573029|FG004|Overall Study|Disease Progression|1|||
105702612|NCT03077685|364573025|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
105702613|NCT03077685|364573026|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
105702614|NCT03077685|364573027|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
105702615|NCT03077685|364573028|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
105702616|NCT03077685|364573029|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
105702617|NCT03077685|364573025|FG000|Overall Study|Subject entered hospice care|0|||
105702618|NCT03077685|364573026|FG001|Overall Study|Subject entered hospice care|0|||
105702619|NCT03077685|364573027|FG002|Overall Study|Subject entered hospice care|0|||
105702620|NCT03077685|364573028|FG003|Overall Study|Subject entered hospice care|0|||
105702621|NCT03077685|364573029|FG004|Overall Study|Subject entered hospice care|1|||
105702622|NCT02116777|364573040|FG000|Overall Study|Adverse Event|0|||
105702623|NCT02116777|364573041|FG001|Overall Study|Adverse Event|0|||
105702624|NCT02116777|364573042|FG002|Overall Study|Adverse Event|0|||
105702625|NCT02116777|364573043|FG003|Overall Study|Adverse Event|0|||
105702626|NCT02116777|364573044|FG004|Overall Study|Adverse Event|2|||
105702627|NCT02116777|364573045|FG005|Overall Study|Adverse Event|2|||
105702628|NCT02116777|364573046|FG006|Overall Study|Adverse Event|0|||
105702629|NCT02116777|364573040|FG000|Overall Study|Death|0|||
105702630|NCT02116777|364573041|FG001|Overall Study|Death|0|||
105702631|NCT02116777|364573042|FG002|Overall Study|Death|0|||
105702632|NCT02116777|364573043|FG003|Overall Study|Death|1|||
105702633|NCT02116777|364573044|FG004|Overall Study|Death|0|||
105702634|NCT02116777|364573045|FG005|Overall Study|Death|0|||
105702635|NCT02116777|364573046|FG006|Overall Study|Death|0|||
105702636|NCT02116777|364573040|FG000|Overall Study|Lack of Efficacy|3|||
105702637|NCT02116777|364573041|FG001|Overall Study|Lack of Efficacy|3|||
105702638|NCT02116777|364573042|FG002|Overall Study|Lack of Efficacy|3|||
105702639|NCT02116777|364573043|FG003|Overall Study|Lack of Efficacy|8|||
105702640|NCT02116777|364573044|FG004|Overall Study|Lack of Efficacy|4|||
105702641|NCT02116777|364573045|FG005|Overall Study|Lack of Efficacy|1|||
105702642|NCT02116777|364573046|FG006|Overall Study|Lack of Efficacy|9|||
106133644|NCT03303105|366148138|FG001|Overall Study|Protocol Violation|0|||
106133645|NCT03303105|366148137|FG000|Overall Study|Withdrawal by Subject|0|||
106133646|NCT03303105|366148138|FG001|Overall Study|Withdrawal by Subject|2|||
105702643|NCT02116777|364573040|FG000|Overall Study|Physician Decision|0|||
105702644|NCT02116777|364573041|FG001|Overall Study|Physician Decision|0|||
105702645|NCT02116777|364573042|FG002|Overall Study|Physician Decision|0|||
105702646|NCT02116777|364573043|FG003|Overall Study|Physician Decision|2|||
105702647|NCT02116777|364573044|FG004|Overall Study|Physician Decision|0|||
105702648|NCT02116777|364573045|FG005|Overall Study|Physician Decision|0|||
105702649|NCT02116777|364573046|FG006|Overall Study|Physician Decision|0|||
105702650|NCT02116777|364573040|FG000|Overall Study|Protocol Violation|0|||
105702651|NCT02116777|364573041|FG001|Overall Study|Protocol Violation|0|||
105702652|NCT02116777|364573042|FG002|Overall Study|Protocol Violation|0|||
105702653|NCT02116777|364573043|FG003|Overall Study|Protocol Violation|1|||
105702654|NCT02116777|364573044|FG004|Overall Study|Protocol Violation|0|||
105702655|NCT02116777|364573045|FG005|Overall Study|Protocol Violation|0|||
105702656|NCT02116777|364573046|FG006|Overall Study|Protocol Violation|0|||
105702657|NCT02116777|364573040|FG000|Overall Study|Withdrawal by Subject|0|||
105702658|NCT02116777|364573041|FG001|Overall Study|Withdrawal by Subject|0|||
105926248|NCT00831844|365388008|FG005|Overall Study|Lack of Efficacy|17|||
106006387|NCT05316597|365688189|FG001|Washout Period|Physician Decision|1|||
106006388|NCT05316597|365688188|FG000|Washout Period|Excluded before second session|1|||
106006389|NCT05316597|365688189|FG001|Washout Period|Excluded before second session|1|||
106006390|NCT05316597|365688188|FG000|Washout Period|Withdrawal by Subject|0|||
106006391|NCT05316597|365688189|FG001|Washout Period|Withdrawal by Subject|4|||
106006392|NCT05526716|365688190|FG000|Overall Study|Death|1|||
106006393|NCT05526716|365688191|FG001|Overall Study|Death|2|||
106006394|NCT05526716|365688190|FG000|Overall Study|Lost to Follow-up|17|||
106006395|NCT05526716|365688191|FG001|Overall Study|Lost to Follow-up|15|||
106006396|NCT05526716|365688190|FG000|Overall Study|Physician Decision|0|||
106006397|NCT05526716|365688191|FG001|Overall Study|Physician Decision|1|||
106006398|NCT05526716|365688190|FG000|Overall Study|Randomized by mistake without study treatment|0|||
106006399|NCT05526716|365688191|FG001|Overall Study|Randomized by mistake without study treatment|1|||
106006400|NCT05526716|365688190|FG000|Overall Study|Withdrawal by Subject|12|||
106006401|NCT05526716|365688191|FG001|Overall Study|Withdrawal by Subject|12|||
106006402|NCT05526716|365688190|FG000|Overall Study|Not reported|0|||
106006403|NCT05526716|365688191|FG001|Overall Study|Not reported|2|||
106006404|NCT02384551|365688199|FG000|Overall Study|Lost to Follow-up|13|||
106006405|NCT02384551|365688200|FG001|Overall Study|Lost to Follow-up|14|||
106006406|NCT02384551|365688201|FG002|Overall Study|Lost to Follow-up|14|||
106006407|NCT02384551|365688202|FG003|Overall Study|Lost to Follow-up|14|||
106006408|NCT03035032|365688205|FG000|Overall Study|Adverse Event|2|||
106006409|NCT03035032|365688205|FG000|Overall Study|Death|9|||
106006410|NCT03035032|365688205|FG000|Overall Study|Lost to Follow-up|1|||
106006411|NCT03035032|365688205|FG000|Overall Study|Progressive Disease|22|||
106006412|NCT03035032|365688205|FG000|Overall Study|Protocol Violation|2|||
106006413|NCT03035032|365688205|FG000|Overall Study|Withdrawal by Subject|2|||
106006414|NCT03035032|365688205|FG000|Overall Study|Physician Decision|5|||
106006415|NCT02201524|365688206|FG000|Overall Study|Adverse Event|0|||
106006416|NCT02201524|365688207|FG001|Overall Study|Adverse Event|2|||
106006417|NCT02201524|365688208|FG002|Overall Study|Adverse Event|1|||
106006418|NCT02201524|365688209|FG003|Overall Study|Adverse Event|0|||
106006419|NCT02201524|365688206|FG000|Overall Study|Insufficient clinical response|1|||
106006420|NCT02201524|365688207|FG001|Overall Study|Insufficient clinical response|0|||
106006421|NCT02201524|365688208|FG002|Overall Study|Insufficient clinical response|0|||
106006422|NCT02201524|365688209|FG003|Overall Study|Insufficient clinical response|0|||
106006423|NCT02201524|365688206|FG000|Overall Study|Lost to Follow-up|0|||
106006424|NCT02201524|365688207|FG001|Overall Study|Lost to Follow-up|0|||
106006425|NCT02201524|365688208|FG002|Overall Study|Lost to Follow-up|2|||
106006426|NCT02201524|365688209|FG003|Overall Study|Lost to Follow-up|0|||
106006427|NCT02201524|365688206|FG000|Overall Study|No longer meets eligibility criteria|0|||
106006428|NCT02201524|365688207|FG001|Overall Study|No longer meets eligibility criteria|0|||
106006429|NCT02201524|365688208|FG002|Overall Study|No longer meets eligibility criteria|0|||
106006430|NCT02201524|365688209|FG003|Overall Study|No longer meets eligibility criteria|2|||
105702659|NCT02116777|364573042|FG002|Overall Study|Withdrawal by Subject|0|||
105702660|NCT02116777|364573043|FG003|Overall Study|Withdrawal by Subject|1|||
105702661|NCT02116777|364573044|FG004|Overall Study|Withdrawal by Subject|0|||
105702662|NCT02116777|364573045|FG005|Overall Study|Withdrawal by Subject|0|||
105702663|NCT02116777|364573046|FG006|Overall Study|Withdrawal by Subject|0|||
105702664|NCT02322125|364574460|FG000|Overall Study|Withdrawal by Subject|2|||
105702665|NCT00750698|364574466|FG000|Overall Study|Withdrawal by Subject|1|||
105926249|NCT00831844|365388009|FG006|Overall Study|Lack of Efficacy|8|||
105926250|NCT00831844|365388010|FG007|Overall Study|Lack of Efficacy|9|||
105926251|NCT00831844|365388011|FG008|Overall Study|Lack of Efficacy|7|||
105926252|NCT00831844|365388012|FG009|Overall Study|Lack of Efficacy|0|||
105926253|NCT00831844|365388003|FG000|Overall Study|Physician Decision|0|||
105926254|NCT00831844|365388004|FG001|Overall Study|Physician Decision|1|||
105926255|NCT00831844|365388005|FG002|Overall Study|Physician Decision|3|||
105926256|NCT00831844|365388006|FG003|Overall Study|Physician Decision|1|||
106006431|NCT02201524|365688206|FG000|Overall Study|Protocol Violation|0|||
106006432|NCT02201524|365688207|FG001|Overall Study|Protocol Violation|0|||
105702666|NCT00750698|364574467|FG001|Overall Study|Withdrawal by Subject|0|||
105702667|NCT00750698|364574466|FG000|Overall Study|Progressive disease|5|||
105702668|NCT00750698|364574467|FG001|Overall Study|Progressive disease|2|||
105702669|NCT03557281|364574468|FG000|Overall Study|Investigator discretion|0|||
105702670|NCT03557281|364574469|FG001|Overall Study|Investigator discretion|0|||
105702671|NCT03557281|364574470|FG002|Overall Study|Investigator discretion|1|||
106006433|NCT02201524|365688208|FG002|Overall Study|Protocol Violation|0|||
105702672|NCT03557281|364574471|FG003|Overall Study|Investigator discretion|0|||
106006434|NCT02201524|365688209|FG003|Overall Study|Protocol Violation|1|||
106006435|NCT02201524|365688206|FG000|Overall Study|Withdrawal by Subject|0|||
105926257|NCT00831844|365388007|FG004|Overall Study|Physician Decision|1|||
105926258|NCT00831844|365388008|FG005|Overall Study|Physician Decision|1|||
105926259|NCT00831844|365388009|FG006|Overall Study|Physician Decision|0|||
105926260|NCT00831844|365388010|FG007|Overall Study|Physician Decision|0|||
105926261|NCT00831844|365388011|FG008|Overall Study|Physician Decision|1|||
105702673|NCT03557281|364574472|FG004|Overall Study|Investigator discretion|0|||
105702674|NCT03557281|364574468|FG000|Overall Study|Withdrawal by Subject|0|||
105702675|NCT03557281|364574469|FG001|Overall Study|Withdrawal by Subject|1|||
105702676|NCT03557281|364574470|FG002|Overall Study|Withdrawal by Subject|1|||
105702677|NCT03557281|364574471|FG003|Overall Study|Withdrawal by Subject|1|||
105702678|NCT03557281|364574472|FG004|Overall Study|Withdrawal by Subject|2|||
105787306|NCT04963231|364874933|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
105787307|NCT04963231|364874931|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
105787308|NCT04963231|364874932|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
105787309|NCT04963231|364874933|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
105787310|NCT04963231|364874931|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
105787311|NCT04963231|364874932|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
105787312|NCT04963231|364874933|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
105787313|NCT04963231|364874931|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
105787314|NCT04963231|364874932|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
105702679|NCT03557281|364574468|FG000|Overall Study|Randomized, but did not receive treatment|0|||
105702680|NCT03557281|364574469|FG001|Overall Study|Randomized, but did not receive treatment|0|||
105702681|NCT03557281|364574470|FG002|Overall Study|Randomized, but did not receive treatment|0|||
105702682|NCT03557281|364574471|FG003|Overall Study|Randomized, but did not receive treatment|0|||
105702683|NCT03557281|364574472|FG004|Overall Study|Randomized, but did not receive treatment|1|||
105702684|NCT02325219|364574473|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
105702685|NCT02325219|364574474|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
105702686|NCT02325219|364574475|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
105702687|NCT02325219|364574476|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
105702688|NCT02325219|364574477|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
105787315|NCT04963231|364874933|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
105702689|NCT02325219|364574473|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
105702690|NCT02325219|364574474|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
105702691|NCT02325219|364574475|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105702692|NCT02325219|364574476|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105702693|NCT02325219|364574477|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
105702694|NCT02325219|364574473|FG000|Controlled Period (Week 0 - 16)|Other|0|||
105702695|NCT02325219|364574474|FG001|Controlled Period (Week 0 - 16)|Other|0|||
105702696|NCT02325219|364574475|FG002|Controlled Period (Week 0 - 16)|Other|1|||
105787316|NCT04963231|364874931|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
105787317|NCT04963231|364874932|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
105787318|NCT04963231|364874933|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
105787319|NCT05450198|364874934|FG000|Overall Study|Withdrawal by Subject|1|||
105702697|NCT02325219|364574476|FG003|Controlled Period (Week 0 - 16)|Other|0|||
105702698|NCT02325219|364574477|FG004|Controlled Period (Week 0 - 16)|Other|0|||
105702699|NCT02325219|364574473|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105702700|NCT02325219|364574474|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105702701|NCT02325219|364574475|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105702702|NCT02325219|364574476|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
105702703|NCT02325219|364574477|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
105702704|NCT02325219|364574473|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
105702705|NCT02325219|364574474|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
105702706|NCT02325219|364574475|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
105702707|NCT02325219|364574476|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
105702708|NCT02325219|364574477|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
105787320|NCT05450198|364874935|FG001|Overall Study|Withdrawal by Subject|1|||
105787321|NCT05450198|364874936|FG002|Overall Study|Withdrawal by Subject|2|||
105787322|NCT05450198|364874937|FG003|Overall Study|Withdrawal by Subject|0|||
105787323|NCT05450198|364874934|FG000|Overall Study|Lost to Follow-up|1|||
105702709|NCT02325219|364574473|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105702710|NCT02325219|364574474|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
105702711|NCT02325219|364574475|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105702712|NCT02325219|364574476|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105702713|NCT02325219|364574477|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
105702714|NCT04036708|364574478|FG000|Overall Study|Lost to Follow-up|14|||
105787324|NCT05450198|364874935|FG001|Overall Study|Lost to Follow-up|0|||
105702715|NCT04036708|364574479|FG001|Overall Study|Lost to Follow-up|4|||
105702716|NCT04036708|364574480|FG002|Overall Study|Lost to Follow-up|14|||
105702717|NCT04036708|364574481|FG003|Overall Study|Lost to Follow-up|4|||
105702718|NCT02918864|364574482|FG000|Overall Study|Withdrawal by Subject|1|||
105702719|NCT02918864|364574483|FG001|Overall Study|Withdrawal by Subject|1|||
105702720|NCT02918864|364574482|FG000|Overall Study|Lost to Follow-up|3|||
105702721|NCT02918864|364574483|FG001|Overall Study|Lost to Follow-up|2|||
105702722|NCT02257372|364574486|FG000|Overall Study|Adverse Event|3|||
105702723|NCT02257372|364574487|FG001|Overall Study|Adverse Event|7|||
105702724|NCT02257372|364574486|FG000|Overall Study|Lack of Efficacy|2|||
105702725|NCT02257372|364574487|FG001|Overall Study|Lack of Efficacy|1|||
105702726|NCT02257372|364574486|FG000|Overall Study|Protocol Violation|1|||
105702727|NCT02257372|364574487|FG001|Overall Study|Protocol Violation|1|||
105702728|NCT02257372|364574486|FG000|Overall Study|Lost to Follow-up|0|||
105702729|NCT02257372|364574487|FG001|Overall Study|Lost to Follow-up|1|||
105702730|NCT02257372|364574486|FG000|Overall Study|Withdrew consent|1|||
105702731|NCT02257372|364574487|FG001|Overall Study|Withdrew consent|0|||
105702732|NCT00552175|364574498|FG000|Overall Study|Lack of Efficacy|2|||
105702733|NCT00552175|364574499|FG001|Overall Study|Lack of Efficacy|0|||
105702734|NCT00552175|364574500|FG002|Overall Study|Lack of Efficacy|1|||
105702735|NCT00552175|364574498|FG000|Overall Study|Adverse Event|9|||
105702736|NCT00552175|364574499|FG001|Overall Study|Adverse Event|9|||
105702737|NCT00552175|364574500|FG002|Overall Study|Adverse Event|10|||
105702738|NCT00552175|364574498|FG000|Overall Study|Withdrawal by Subject|2|||
105702739|NCT00552175|364574499|FG001|Overall Study|Withdrawal by Subject|2|||
105702740|NCT00552175|364574500|FG002|Overall Study|Withdrawal by Subject|1|||
105702741|NCT00552175|364574498|FG000|Overall Study|Lost to Follow-up|0|||
105702742|NCT00552175|364574499|FG001|Overall Study|Lost to Follow-up|0|||
105702743|NCT00552175|364574500|FG002|Overall Study|Lost to Follow-up|1|||
105702744|NCT00552175|364574498|FG000|Overall Study|Entry Criteria Not Met|1|||
105702745|NCT00552175|364574499|FG001|Overall Study|Entry Criteria Not Met|1|||
105702746|NCT00552175|364574500|FG002|Overall Study|Entry Criteria Not Met|0|||
105702747|NCT00552175|364574498|FG000|Overall Study|Reason Not Specified|3|||
105702748|NCT00552175|364574499|FG001|Overall Study|Reason Not Specified|1|||
105702749|NCT00552175|364574500|FG002|Overall Study|Reason Not Specified|1|||
105702750|NCT00631020|364574507|FG000|Overall Study|Lost to Follow-up|7|||
105702751|NCT00631020|364574507|FG000|Overall Study|Incarcerated|1|||
105702752|NCT02614859|364574512|FG000|Overall Study|Physician Decision|0|||
105702753|NCT02614859|364574513|FG001|Overall Study|Physician Decision|1|||
105702754|NCT03972969|364574515|FG000|3-month Follow-up|Death|1|||
105702755|NCT03972969|364574516|FG001|3-month Follow-up|Death|1|||
105702756|NCT03972969|364574517|FG002|3-month Follow-up|Death|0|||
105702757|NCT03972969|364574515|FG000|6-month Follow-up|Death|1|||
105702758|NCT03972969|364574516|FG001|6-month Follow-up|Death|1|||
105702759|NCT03972969|364574517|FG002|6-month Follow-up|Death|1|||
105702760|NCT03972969|364574515|FG000|6-month Follow-up|Lost to Follow-up|2|||
105702761|NCT03972969|364574516|FG001|6-month Follow-up|Lost to Follow-up|2|||
105702762|NCT03972969|364574517|FG002|6-month Follow-up|Lost to Follow-up|2|||
105702763|NCT00732303|364574518|FG000|Overall Study|Study Terminated|2|||
105702764|NCT02919436|364574519|FG000|Overall Study|Did not undergo surgery|16|||
105702765|NCT02919436|364574520|FG001|Overall Study|Did not undergo surgery|20|||
105702766|NCT02919436|364574519|FG000|Overall Study|Enrolled before trial registration|44|||
105702767|NCT02919436|364574520|FG001|Overall Study|Enrolled before trial registration|33|||
105702768|NCT04718974|364574522|FG000|Overall Study|Death|0|||
105702769|NCT04718974|364574523|FG001|Overall Study|Death|2|||
105702770|NCT04718974|364574522|FG000|Overall Study|Lost to Follow-up|10|||
105702771|NCT04718974|364574523|FG001|Overall Study|Lost to Follow-up|20|||
105702772|NCT04718974|364574522|FG000|Overall Study|Transferred out|2|||
105702773|NCT04718974|364574523|FG001|Overall Study|Transferred out|4|||
105702774|NCT01389752|364574524|FG000|Study Period 1|Sponsor decision|0|||
105702775|NCT01389752|364574525|FG001|Study Period 1|Sponsor decision|2|||
105702776|NCT01389752|364574524|FG000|Study Period 2|Sponsor decision|1|||
105702777|NCT01389752|364574525|FG001|Study Period 2|Sponsor decision|0|||
105702778|NCT01157364|364574530|FG000|Overall Study|Other Reasons|1|||
105702779|NCT01157364|364574531|FG001|Overall Study|Other Reasons|1|||
105702780|NCT01157364|364574532|FG002|Overall Study|Other Reasons|2|||
105702781|NCT01157364|364574533|FG003|Overall Study|Other Reasons|1|||
105702782|NCT01157364|364574534|FG004|Overall Study|Other Reasons|0|||
105702783|NCT01157364|364574535|FG005|Overall Study|Other Reasons|0|||
105702784|NCT01157364|364574530|FG000|Overall Study|Personal Reasons|0|||
105702785|NCT01157364|364574531|FG001|Overall Study|Personal Reasons|2|||
105702786|NCT01157364|364574532|FG002|Overall Study|Personal Reasons|0|||
105702787|NCT01157364|364574533|FG003|Overall Study|Personal Reasons|0|||
105702788|NCT01157364|364574534|FG004|Overall Study|Personal Reasons|1|||
105702789|NCT01157364|364574535|FG005|Overall Study|Personal Reasons|1|||
105702790|NCT01157364|364574530|FG000|Overall Study|Lost to Follow-up|1|||
105702791|NCT01157364|364574531|FG001|Overall Study|Lost to Follow-up|0|||
105702792|NCT01157364|364574532|FG002|Overall Study|Lost to Follow-up|1|||
105702793|NCT01157364|364574533|FG003|Overall Study|Lost to Follow-up|0|||
105702794|NCT01157364|364574534|FG004|Overall Study|Lost to Follow-up|0|||
105702795|NCT01157364|364574535|FG005|Overall Study|Lost to Follow-up|0|||
105702796|NCT01157364|364574530|FG000|Overall Study|Lack of Efficacy|0|||
105702797|NCT01157364|364574531|FG001|Overall Study|Lack of Efficacy|0|||
105702798|NCT01157364|364574532|FG002|Overall Study|Lack of Efficacy|0|||
105702799|NCT01157364|364574533|FG003|Overall Study|Lack of Efficacy|1|||
105702800|NCT01157364|364574534|FG004|Overall Study|Lack of Efficacy|0|||
105702801|NCT01157364|364574535|FG005|Overall Study|Lack of Efficacy|0|||
105702802|NCT01157364|364574530|FG000|Overall Study|Adverse Event|0|||
105702803|NCT01157364|364574531|FG001|Overall Study|Adverse Event|1|||
105702804|NCT01157364|364574532|FG002|Overall Study|Adverse Event|1|||
105702805|NCT01157364|364574533|FG003|Overall Study|Adverse Event|0|||
105702806|NCT01157364|364574534|FG004|Overall Study|Adverse Event|1|||
105702807|NCT01157364|364574535|FG005|Overall Study|Adverse Event|0|||
105702808|NCT01576549|364574546|FG000|Overall Study|Sponsor Decision|2|||
105702809|NCT04191382|364574547|FG000|Overall Study|Withdrawal by Subject|1|||
105702810|NCT04191382|364574548|FG001|Overall Study|Withdrawal by Subject|0|||
105702811|NCT04191382|364574549|FG002|Overall Study|Withdrawal by Subject|0|||
105702812|NCT03882970|364574556|FG000|Overall Study|Adverse Event|5|||
105702813|NCT03882970|364574557|FG001|Overall Study|Adverse Event|7|||
105702814|NCT03882970|364574558|FG002|Overall Study|Adverse Event|3|||
105702815|NCT03882970|364574559|FG003|Overall Study|Adverse Event|1|||
105702816|NCT03882970|364574556|FG000|Overall Study|Death|1|||
105702817|NCT03882970|364574557|FG001|Overall Study|Death|2|||
105702818|NCT03882970|364574558|FG002|Overall Study|Death|1|||
105702819|NCT03882970|364574559|FG003|Overall Study|Death|1|||
105702820|NCT03882970|364574556|FG000|Overall Study|Lost to Follow-up|8|||
105702821|NCT03882970|364574557|FG001|Overall Study|Lost to Follow-up|9|||
105702822|NCT03882970|364574558|FG002|Overall Study|Lost to Follow-up|5|||
105702823|NCT03882970|364574559|FG003|Overall Study|Lost to Follow-up|5|||
105702824|NCT03882970|364574556|FG000|Overall Study|Physician Decision|0|||
105702825|NCT03882970|364574557|FG001|Overall Study|Physician Decision|2|||
105702826|NCT03882970|364574558|FG002|Overall Study|Physician Decision|2|||
105702827|NCT03882970|364574559|FG003|Overall Study|Physician Decision|2|||
105702828|NCT03882970|364574556|FG000|Overall Study|Protocol Violation|2|||
105702829|NCT03882970|364574557|FG001|Overall Study|Protocol Violation|0|||
105702830|NCT03882970|364574558|FG002|Overall Study|Protocol Violation|0|||
105702831|NCT03882970|364574559|FG003|Overall Study|Protocol Violation|0|||
105702832|NCT03882970|364574556|FG000|Overall Study|Withdrawal by Subject|8|||
105702833|NCT03882970|364574557|FG001|Overall Study|Withdrawal by Subject|17|||
105702834|NCT03882970|364574558|FG002|Overall Study|Withdrawal by Subject|7|||
105702835|NCT03882970|364574559|FG003|Overall Study|Withdrawal by Subject|22|||
105702836|NCT03882970|364574556|FG000|Overall Study|Personal Reason|2|||
105702837|NCT03882970|364574557|FG001|Overall Study|Personal Reason|3|||
105702838|NCT03882970|364574558|FG002|Overall Study|Personal Reason|1|||
105702839|NCT03882970|364574559|FG003|Overall Study|Personal Reason|3|||
105702840|NCT04744207|364574560|FG000|Treatment|Withdrawal by Subject|2|||
105702841|NCT04744207|364574561|FG001|Treatment|Withdrawal by Subject|0|||
105702842|NCT04744207|364574560|FG000|Treatment|Adverse Event|1|||
105702843|NCT04744207|364574561|FG001|Treatment|Adverse Event|2|||
105702844|NCT00282334|364574564|FG000|Overall Study|Withdrawal by Subject|8|||
105702845|NCT00282334|364574565|FG001|Overall Study|Withdrawal by Subject|5|||
105702846|NCT03681119|364574568|FG000|Overall Study|No specific reason|4|||
105702847|NCT03681119|364574569|FG001|Overall Study|No specific reason|0|||
105702848|NCT03681119|364574568|FG000|Overall Study|Sickness|2|||
105702849|NCT03681119|364574569|FG001|Overall Study|Sickness|0|||
105702850|NCT02813694|364574573|FG000|Overall Study|Physician Decision|0|||
105702851|NCT02813694|364574574|FG001|Overall Study|Physician Decision|1|||
105702852|NCT02813694|364574573|FG000|Overall Study|Withdrawal by Subject|10|||
105702853|NCT02813694|364574574|FG001|Overall Study|Withdrawal by Subject|9|||
105702854|NCT02813694|364574573|FG000|Overall Study|Lost to Follow-up|1|||
105702855|NCT02813694|364574574|FG001|Overall Study|Lost to Follow-up|1|||
105702856|NCT02813694|364574573|FG000|Overall Study|Death|3|||
105702857|NCT02813694|364574574|FG001|Overall Study|Death|3|||
105702858|NCT02813694|364574573|FG000|Overall Study|Randomized- did not receive study drug|2|||
105702859|NCT02813694|364574574|FG001|Overall Study|Randomized- did not receive study drug|0|||
105702860|NCT02813694|364574573|FG000|Overall Study|Patient hospitalized|1|||
105702861|NCT02813694|364574574|FG001|Overall Study|Patient hospitalized|0|||
105702862|NCT00879645|364574581|FG000|Overall Study|Adverse Event|1|||
105702863|NCT00879645|364574582|FG001|Overall Study|Adverse Event|0|||
105702864|NCT00879645|364574583|FG002|Overall Study|Adverse Event|0|||
105702865|NCT00879645|364574584|FG003|Overall Study|Adverse Event|0|||
105702866|NCT01549002|364574587|FG000|Overall Study|Excessive pain|0|||
105702867|NCT01549002|364574588|FG001|Overall Study|Excessive pain|2|||
105702868|NCT01549002|364574587|FG000|Overall Study|Moderate sedation required|0|||
105702869|NCT01549002|364574588|FG001|Overall Study|Moderate sedation required|2|||
105702870|NCT03631732|364574591|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
105702871|NCT03631732|364574592|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
105702872|NCT03631732|364574591|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
105702873|NCT03631732|364574592|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
105702874|NCT03631732|364574591|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
105702875|NCT03631732|364574592|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
105702876|NCT03631732|364574591|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
105702877|NCT03631732|364574592|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
105702878|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
105702879|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
105702880|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
105702881|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
105702882|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
105702883|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
105702884|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
105702885|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
105702886|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
105702887|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
105702888|NCT03631732|364574591|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
105702889|NCT03631732|364574592|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
105702890|NCT02354222|364574597|FG000|Overall Study|Adverse Event|0|||
105702891|NCT02354222|364574598|FG001|Overall Study|Adverse Event|3|||
105702892|NCT02354222|364574597|FG000|Overall Study|Physician Decision|1|||
105702893|NCT02354222|364574598|FG001|Overall Study|Physician Decision|1|||
105702894|NCT02354222|364574597|FG000|Overall Study|Pregnancy|1|||
105702895|NCT02354222|364574598|FG001|Overall Study|Pregnancy|0|||
105702896|NCT02354222|364574597|FG000|Overall Study|Withdrawal by Subject|2|||
105702897|NCT02354222|364574598|FG001|Overall Study|Withdrawal by Subject|3|||
105702898|NCT02354222|364574597|FG000|Overall Study|Conflict with the stopping criteria|0|||
105702899|NCT02354222|364574598|FG001|Overall Study|Conflict with the stopping criteria|4|||
105702900|NCT01585272|364574599|FG000|Overall Study|Adverse Event|22|||
105702901|NCT01585272|364574599|FG000|Overall Study|Protocol Violation|7|||
105702902|NCT01585272|364574599|FG000|Overall Study|Withdrawal by Subject|10|||
105702903|NCT00645593|364574600|FG000|Overall Study|Later found to be ineligible|1|||
105702904|NCT00645593|364574601|FG001|Overall Study|Later found to be ineligible|0|||
105702905|NCT00788372|364574603|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
105702906|NCT00788372|364574603|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
105702907|NCT00788372|364574603|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
105702908|NCT00788372|364574603|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
105702909|NCT00788372|364574603|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
105702910|NCT00788372|364574603|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
105702911|NCT00788372|364574603|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
105702912|NCT01508702|364574604|FG000|Overall Study|Adverse Event|7|||
105702913|NCT01508702|364574605|FG001|Overall Study|Adverse Event|3|||
105702914|NCT01508702|364574604|FG000|Overall Study|Gout flare|2|||
105702915|NCT01508702|364574605|FG001|Overall Study|Gout flare|0|||
105702916|NCT01508702|364574604|FG000|Overall Study|Protocol Violation|2|||
105702917|NCT01508702|364574605|FG001|Overall Study|Protocol Violation|1|||
105702918|NCT01508702|364574604|FG000|Overall Study|Lost to Follow-up|1|||
105702919|NCT01508702|364574605|FG001|Overall Study|Lost to Follow-up|2|||
105702920|NCT01508702|364574604|FG000|Overall Study|Withdrawal by Subject|11|||
105702921|NCT01508702|364574605|FG001|Overall Study|Withdrawal by Subject|7|||
105702922|NCT01553136|364574606|FG000|Overall Study|Adverse Event|3|||
105702923|NCT01553136|364574607|FG001|Overall Study|Adverse Event|2|||
105702924|NCT01553136|364574606|FG000|Overall Study|Withdrawal by Subject|2|||
105702925|NCT01553136|364574607|FG001|Overall Study|Withdrawal by Subject|3|||
105702926|NCT01553136|364574606|FG000|Overall Study|Lost to Follow-up|4|||
105702927|NCT01553136|364574607|FG001|Overall Study|Lost to Follow-up|10|||
105702928|NCT01553136|364574606|FG000|Overall Study|Physician Decision|2|||
105702929|NCT01553136|364574607|FG001|Overall Study|Physician Decision|3|||
105702930|NCT01553136|364574606|FG000|Overall Study|Scheduling Difficulties|5|||
105702931|NCT01553136|364574607|FG001|Overall Study|Scheduling Difficulties|4|||
105702932|NCT01979536|364574608|FG000|Overall Study|Physician Decision|2|||
105702933|NCT01979536|364574609|FG001|Overall Study|Physician Decision|3|||
105702934|NCT01979536|364574608|FG000|Overall Study|Withdrawal by Subject|0|||
105702935|NCT01979536|364574609|FG001|Overall Study|Withdrawal by Subject|1|||
105702936|NCT01979536|364574608|FG000|Overall Study|Refusal|0|||
105702937|NCT01979536|364574609|FG001|Overall Study|Refusal|1|||
105702938|NCT01979536|364574608|FG000|Overall Study|Relapse|0|||
105702939|NCT01979536|364574609|FG001|Overall Study|Relapse|1|||
105702940|NCT01979536|364574608|FG000|Overall Study|Study terminated by Sponsor|0|||
105702941|NCT01979536|364574609|FG001|Overall Study|Study terminated by Sponsor|1|||
105702942|NCT01979536|364574608|FG000|Overall Study|Did not start treatment|0|||
105787325|NCT05450198|364874936|FG002|Overall Study|Lost to Follow-up|2|||
105787326|NCT05450198|364874937|FG003|Overall Study|Lost to Follow-up|1|||
105702943|NCT01979536|364574609|FG001|Overall Study|Did not start treatment|1|||
105787327|NCT01243762|364874938|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
105787328|NCT01243762|364874939|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
105787329|NCT01243762|364874940|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
105702944|NCT01014689|364574610|FG000|Overall Study|Lack of Efficacy|0|||
105702945|NCT01014689|364574611|FG001|Overall Study|Lack of Efficacy|1|||
105702946|NCT01014689|364574610|FG000|Overall Study|Adverse Event|3|||
105702947|NCT01014689|364574611|FG001|Overall Study|Adverse Event|0|||
105702948|NCT01014689|364574610|FG000|Overall Study|Withdrawal by Subject|5|||
105702949|NCT01014689|364574611|FG001|Overall Study|Withdrawal by Subject|4|||
105702950|NCT01014689|364574610|FG000|Overall Study|Protocol Violation|1|||
105702951|NCT01014689|364574611|FG001|Overall Study|Protocol Violation|1|||
105702952|NCT01014689|364574610|FG000|Overall Study|Lost to Follow-up|3|||
105702953|NCT01014689|364574611|FG001|Overall Study|Lost to Follow-up|7|||
105702954|NCT01014689|364574610|FG000|Overall Study|Pregnancy|1|||
105702955|NCT01014689|364574611|FG001|Overall Study|Pregnancy|0|||
105702956|NCT00733954|364574612|FG000|Overall Study|Lost to Follow-up|5|||
105702957|NCT00733954|364574613|FG001|Overall Study|Lost to Follow-up|2|||
105702958|NCT00733954|364574612|FG000|Overall Study|Protocol Violation|1|||
105702959|NCT00733954|364574613|FG001|Overall Study|Protocol Violation|0|||
105702960|NCT00733954|364574612|FG000|Overall Study|Withdrawal by Subject|2|||
105702961|NCT00733954|364574613|FG001|Overall Study|Withdrawal by Subject|0|||
105702962|NCT04360551|364576421|FG000|Overall Study|Withdrawal by Subject|1|||
105702963|NCT04360551|364576422|FG001|Overall Study|Withdrawal by Subject|0|||
105702964|NCT00075023|364576424|FG000|Pilot Study|Physician Decision|1|||
105702965|NCT00075023|364576425|FG001|Pilot Study|Physician Decision|2|||
105702966|NCT00075023|364576424|FG000|Pilot Study|Withdrawal by Subject|1|||
105702967|NCT00075023|364576425|FG001|Pilot Study|Withdrawal by Subject|0|||
105702968|NCT04179734|364576426|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
105702969|NCT04179734|364576427|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
105702970|NCT04179734|364576426|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
105702971|NCT04179734|364576427|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
105702972|NCT02982954|364576428|FG000|Overall Study|Death|55|||
105702973|NCT02982954|364576429|FG001|Overall Study|Death|29|||
105702974|NCT02982954|364576430|FG002|Overall Study|Death|15|||
105702975|NCT02982954|364576431|FG003|Overall Study|Death|20|||
105702976|NCT02982954|364576428|FG000|Overall Study|Lost to Follow-up|2|||
105702977|NCT02982954|364576429|FG001|Overall Study|Lost to Follow-up|1|||
105702978|NCT02982954|364576430|FG002|Overall Study|Lost to Follow-up|0|||
105702979|NCT02982954|364576431|FG003|Overall Study|Lost to Follow-up|0|||
105702980|NCT02982954|364576428|FG000|Overall Study|Participant withdrew consent|7|||
105702981|NCT02982954|364576429|FG001|Overall Study|Participant withdrew consent|5|||
105702982|NCT02982954|364576430|FG002|Overall Study|Participant withdrew consent|1|||
105702983|NCT02982954|364576431|FG003|Overall Study|Participant withdrew consent|1|||
105702984|NCT02982954|364576428|FG000|Overall Study|Other reasons|42|||
105702985|NCT02982954|364576429|FG001|Overall Study|Other reasons|17|||
105702986|NCT02982954|364576430|FG002|Overall Study|Other reasons|12|||
105702987|NCT02982954|364576431|FG003|Overall Study|Other reasons|3|||
105702988|NCT02982954|364576428|FG000|Overall Study|Premature site closure|0|||
105702989|NCT02982954|364576429|FG001|Overall Study|Premature site closure|0|||
105702990|NCT02982954|364576430|FG002|Overall Study|Premature site closure|0|||
105702991|NCT02982954|364576431|FG003|Overall Study|Premature site closure|1|||
105702992|NCT01429584|364576432|FG000|Overall Study|Withdrawal by Subject|1|||
105702993|NCT01429584|364576433|FG001|Overall Study|Withdrawal by Subject|0|||
105702994|NCT01429584|364576432|FG000|Overall Study|Protocol Violation|0|||
105702995|NCT01429584|364576433|FG001|Overall Study|Protocol Violation|1|||
105702996|NCT00402649|364576434|FG000|Overall Study|Lost to Follow-up|1|||
105702997|NCT00402649|364576434|FG000|Overall Study|Withdrawal by Subject|1|||
105702998|NCT01999465|364576435|FG000|Overall Study|Lost to Follow-up|0|||
105702999|NCT01999465|364576436|FG001|Overall Study|Lost to Follow-up|2|||
105703000|NCT01999465|364576435|FG000|Overall Study|Protocol Violation|0|||
105703001|NCT01999465|364576436|FG001|Overall Study|Protocol Violation|1|||
105703002|NCT01611974|364576440|FG000|Overall Study|Death|10|||
105703003|NCT01611974|364576441|FG001|Overall Study|Death|12|||
105703004|NCT01611974|364576442|FG002|Overall Study|Death|10|||
105703005|NCT01611974|364576440|FG000|Overall Study|Lost to Follow-up|0|||
105703006|NCT01611974|364576441|FG001|Overall Study|Lost to Follow-up|1|||
105703007|NCT01611974|364576442|FG002|Overall Study|Lost to Follow-up|0|||
105703008|NCT01611974|364576440|FG000|Overall Study|Physician Decision|5|||
105703009|NCT01611974|364576441|FG001|Overall Study|Physician Decision|1|||
105703010|NCT01611974|364576442|FG002|Overall Study|Physician Decision|2|||
106006436|NCT02201524|365688207|FG001|Overall Study|Withdrawal by Subject|0|||
106006437|NCT02201524|365688208|FG002|Overall Study|Withdrawal by Subject|1|||
105703011|NCT01611974|364576440|FG000|Overall Study|Withdrawal by Subject|0|||
106006438|NCT02201524|365688209|FG003|Overall Study|Withdrawal by Subject|1|||
105703012|NCT01611974|364576441|FG001|Overall Study|Withdrawal by Subject|1|||
105703013|NCT01611974|364576442|FG002|Overall Study|Withdrawal by Subject|4|||
106006439|NCT02201524|365688206|FG000|Overall Study|Other|1|||
105703014|NCT01308008|364576443|FG000|4 Weeks|Illness, disinterest, time|9|||
106006440|NCT02201524|365688207|FG001|Overall Study|Other|1|||
105703015|NCT01308008|364576444|FG001|4 Weeks|Illness, disinterest, time|2|||
105703016|NCT01417195|364576445|FG000|Overall Study|Stimulation failure|1|||
105703017|NCT01417195|364576446|FG001|Overall Study|Stimulation failure|0|||
105703018|NCT01417195|364576445|FG000|Overall Study|No embryos for transfer|0|||
105703019|NCT01417195|364576446|FG001|Overall Study|No embryos for transfer|1|||
105703020|NCT01417195|364576445|FG000|Overall Study|No transfer due to risk of OHSS|1|||
105703021|NCT01417195|364576446|FG001|Overall Study|No transfer due to risk of OHSS|0|||
105703022|NCT01417195|364576445|FG000|Overall Study|No transfer due to elevated progesterone|1|||
105703023|NCT01417195|364576446|FG001|Overall Study|No transfer due to elevated progesterone|0|||
105703024|NCT01773109|364576447|FG000|Overall Study|Symptomatic Progression|2|||
105703025|NCT01773109|364576447|FG000|Overall Study|Death|1|||
105703026|NCT01239342|364576448|FG000|Overall Study|Adverse Event|1|||
105703027|NCT01239342|364576449|FG001|Overall Study|Adverse Event|0|||
105703028|NCT01239342|364576448|FG000|Overall Study|Withdrawal by Subject|1|||
105703029|NCT01239342|364576449|FG001|Overall Study|Withdrawal by Subject|5|||
105703030|NCT01239342|364576448|FG000|Overall Study|Reason Unknown|1|||
105703031|NCT01239342|364576449|FG001|Overall Study|Reason Unknown|1|||
106133647|NCT01789203|366148143|FG000|Overall Study|Adverse Event|2|||
106133648|NCT01789203|366148144|FG001|Overall Study|Adverse Event|2|||
106133649|NCT01789203|366148143|FG000|Overall Study|Withdrawal by Subject|1|||
106133650|NCT01789203|366148144|FG001|Overall Study|Withdrawal by Subject|0|||
106133651|NCT01789203|366148143|FG000|Overall Study|Death|1|||
106133652|NCT01789203|366148144|FG001|Overall Study|Death|0|||
106133653|NCT01789203|366148143|FG000|Overall Study|Protocol Violation|2|||
106133654|NCT01789203|366148144|FG001|Overall Study|Protocol Violation|1|||
106133655|NCT01789203|366148143|FG000|Overall Study|Other|1|||
106133656|NCT01789203|366148144|FG001|Overall Study|Other|1|||
106133657|NCT01789203|366148143|FG000|Overall Study|patient non-adherent|2|||
106133658|NCT01789203|366148144|FG001|Overall Study|patient non-adherent|0|||
106133659|NCT05328973|366148145|FG000|Overall Study|Withdrawal by Subject|0|||
106133660|NCT05328973|366148146|FG001|Overall Study|Withdrawal by Subject|1|||
106133661|NCT00498186|366148149|FG000|Overall Study|Protocol Violation|10|||
106133662|NCT00498186|366148149|FG000|Overall Study|Lack of Efficacy|31|||
106133663|NCT00498186|366148149|FG000|Overall Study|Adverse Event|89|||
105703032|NCT02495844|364576450|FG000|Overall Study|Lack of Efficacy|1|||
105703033|NCT02495844|364576451|FG001|Overall Study|Lack of Efficacy|2|||
106133664|NCT00498186|366148149|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
106133665|NCT00498186|366148149|FG000|Overall Study|Withdrawal by Subject|18|||
105703034|NCT02495844|364576450|FG000|Overall Study|AE, non-fatal|0|||
105703035|NCT02495844|364576451|FG001|Overall Study|AE, non-fatal|1|||
105703036|NCT02495844|364576450|FG000|Overall Study|Hepatitis Positivity|0|||
105926262|NCT00831844|365388012|FG009|Overall Study|Physician Decision|0|||
105926263|NCT00831844|365388003|FG000|Overall Study|Withdrawal by Subject|0|||
105926264|NCT00831844|365388004|FG001|Overall Study|Withdrawal by Subject|0|||
105703037|NCT02495844|364576451|FG001|Overall Study|Hepatitis Positivity|1|||
105926265|NCT00831844|365388005|FG002|Overall Study|Withdrawal by Subject|1|||
105926266|NCT00831844|365388006|FG003|Overall Study|Withdrawal by Subject|0|||
105926267|NCT00831844|365388007|FG004|Overall Study|Withdrawal by Subject|0|||
105926268|NCT00831844|365388008|FG005|Overall Study|Withdrawal by Subject|0|||
105926269|NCT00831844|365388009|FG006|Overall Study|Withdrawal by Subject|0|||
106133666|NCT00498186|366148149|FG000|Overall Study|Lost to Follow-up|3|||
105703038|NCT04766021|364576454|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
105926270|NCT00831844|365388010|FG007|Overall Study|Withdrawal by Subject|1|||
105926271|NCT00831844|365388011|FG008|Overall Study|Withdrawal by Subject|1|||
105926272|NCT00831844|365388012|FG009|Overall Study|Withdrawal by Subject|0|||
105926273|NCT00831844|365388003|FG000|Overall Study|Ineligible|0|||
105787330|NCT01243762|364874941|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
105787331|NCT01243762|364874942|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
105787332|NCT01243762|364874943|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
105787333|NCT01243762|364874944|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
105787334|NCT01243762|364874938|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787335|NCT01243762|364874939|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
105787336|NCT01243762|364874940|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787337|NCT01243762|364874941|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
105787338|NCT01243762|364874942|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787339|NCT01243762|364874943|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787340|NCT01243762|364874944|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
105787341|NCT01243762|364874938|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
105787342|NCT01243762|364874939|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
105787343|NCT01243762|364874940|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
105787344|NCT01243762|364874941|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
105787345|NCT01243762|364874942|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
105787346|NCT01243762|364874943|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
105787347|NCT01243762|364874944|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
105787348|NCT01243762|364874938|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787349|NCT01243762|364874939|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
105787350|NCT01243762|364874940|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787351|NCT01243762|364874941|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787352|NCT01243762|364874942|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787353|NCT01243762|364874943|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105787354|NCT01243762|364874944|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
105703039|NCT04766021|364576454|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
105703040|NCT03577730|364576456|FG000|Overall Study|Physician Decision|3|||
105703041|NCT03577730|364576457|FG001|Overall Study|Physician Decision|1|||
105703042|NCT03577730|364576456|FG000|Overall Study|Did not receive allocated intervention|1|||
105703043|NCT03577730|364576457|FG001|Overall Study|Did not receive allocated intervention|0|||
105703044|NCT02187172|364576458|FG000|Overall Study|Lost to Follow-up|1|||
105703045|NCT02187172|364576459|FG001|Overall Study|Lost to Follow-up|2|||
105703046|NCT02187172|364576458|FG000|Overall Study|Lack of Efficacy|1|||
105703047|NCT02187172|364576459|FG001|Overall Study|Lack of Efficacy|2|||
105703048|NCT02187172|364576458|FG000|Overall Study|Adverse Event|0|||
105703049|NCT02187172|364576459|FG001|Overall Study|Adverse Event|1|||
105703050|NCT02187172|364576458|FG000|Overall Study|Physician Decision|1|||
105703051|NCT02187172|364576459|FG001|Overall Study|Physician Decision|1|||
105703052|NCT04091087|364576466|FG000|Overall Study|Not treated|1|||
105703053|NCT04091087|364576467|FG001|Overall Study|Not treated|0|||
105703054|NCT04091087|364576466|FG000|Overall Study|Adverse Event|4|||
105703055|NCT04091087|364576467|FG001|Overall Study|Adverse Event|4|||
105703056|NCT04091087|364576466|FG000|Overall Study|Protocol Violation|0|||
105703057|NCT04091087|364576467|FG001|Overall Study|Protocol Violation|1|||
105703058|NCT04091087|364576466|FG000|Overall Study|Withdrawal by Subject|5|||
105703059|NCT04091087|364576467|FG001|Overall Study|Withdrawal by Subject|2|||
105703060|NCT04962022|364576468|FG000|Period 1|Withdrawal by Subject|1|||
105703061|NCT04962022|364576469|FG001|Period 1|Withdrawal by Subject|0|||
105703062|NCT01356407|364576472|FG000|Overall Study|Lost to Follow-up|2|||
105703063|NCT01356407|364576473|FG001|Overall Study|Lost to Follow-up|0|||
105703064|NCT01356407|364576472|FG000|Overall Study|Patient Withdrew Consent|2|||
105703065|NCT01356407|364576473|FG001|Overall Study|Patient Withdrew Consent|1|||
105703066|NCT01356407|364576472|FG000|Overall Study|Could not afford IMP administration|0|||
105703067|NCT01356407|364576473|FG001|Overall Study|Could not afford IMP administration|1|||
105703068|NCT01356407|364576472|FG000|Overall Study|Not complete Endoscopy|2|||
105703069|NCT01356407|364576473|FG001|Overall Study|Not complete Endoscopy|2|||
105703070|NCT02055820|364576474|FG000|Phase I: Dose-Finding|Death|1|||
105703071|NCT02055820|364576475|FG001|Phase I: Dose-Finding|Death|0|||
105703072|NCT02055820|364576476|FG002|Phase I: Dose-Finding|Death|1|||
105703073|NCT02055820|364576477|FG003|Phase I: Dose-Finding|Death|2|||
105703074|NCT02055820|364576478|FG004|Phase I: Dose-Finding|Death|0|||
105703075|NCT02055820|364576479|FG005|Phase I: Dose-Finding|Death|1|||
105703076|NCT02055820|364576480|FG006|Phase I: Dose-Finding|Death|1|||
106133667|NCT00498186|366148149|FG000|Overall Study|Other|10|||
106133668|NCT00448864|366148150|FG000|Overall Study|Death|1|||
106133669|NCT00448864|366148151|FG001|Overall Study|Death|0|||
106133670|NCT00448864|366148152|FG002|Overall Study|Death|0|||
106133671|NCT00448864|366148150|FG000|Overall Study|Lost to Follow-up|3|||
106133672|NCT00448864|366148151|FG001|Overall Study|Lost to Follow-up|1|||
106133673|NCT00448864|366148152|FG002|Overall Study|Lost to Follow-up|0|||
105703077|NCT02055820|364576481|FG007|Phase I: Dose-Finding|Death|0|||
105703078|NCT02055820|364576482|FG008|Phase I: Dose-Finding|Death|0|||
105703079|NCT02055820|364576483|FG009|Phase I: Dose-Finding|Death|0|||
105703080|NCT02055820|364576474|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105787355|NCT01243762|364874938|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105703081|NCT02055820|364576475|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703082|NCT02055820|364576476|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703083|NCT02055820|364576477|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703084|NCT02055820|364576478|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703085|NCT02055820|364576479|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
105703086|NCT02055820|364576480|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703087|NCT02055820|364576481|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703088|NCT02055820|364576482|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703089|NCT02055820|364576483|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
105703090|NCT02055820|364576474|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703091|NCT02055820|364576475|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703092|NCT02055820|364576476|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703093|NCT02055820|364576477|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
105703094|NCT02055820|364576478|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703095|NCT02055820|364576479|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703096|NCT02055820|364576480|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
105703097|NCT02055820|364576481|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703098|NCT02055820|364576482|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703099|NCT02055820|364576483|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
105703100|NCT02055820|364576474|FG000|Phase II: Expansion|Death|0|||
105703101|NCT02055820|364576475|FG001|Phase II: Expansion|Death|0|||
105703102|NCT02055820|364576476|FG002|Phase II: Expansion|Death|0|||
105703103|NCT02055820|364576477|FG003|Phase II: Expansion|Death|0|||
105703104|NCT02055820|364576478|FG004|Phase II: Expansion|Death|33|||
105703105|NCT02055820|364576479|FG005|Phase II: Expansion|Death|0|||
105703106|NCT02055820|364576480|FG006|Phase II: Expansion|Death|0|||
105703107|NCT02055820|364576481|FG007|Phase II: Expansion|Death|0|||
105703108|NCT02055820|364576482|FG008|Phase II: Expansion|Death|0|||
105703109|NCT02055820|364576483|FG009|Phase II: Expansion|Death|0|||
105703110|NCT02055820|364576474|FG000|Phase II: Expansion|Lost to Follow-up|0|||
105703111|NCT02055820|364576475|FG001|Phase II: Expansion|Lost to Follow-up|0|||
105703112|NCT02055820|364576476|FG002|Phase II: Expansion|Lost to Follow-up|0|||
105703113|NCT02055820|364576477|FG003|Phase II: Expansion|Lost to Follow-up|0|||
105703114|NCT02055820|364576478|FG004|Phase II: Expansion|Lost to Follow-up|4|||
105703115|NCT02055820|364576479|FG005|Phase II: Expansion|Lost to Follow-up|0|||
106006441|NCT02201524|365688208|FG002|Overall Study|Other|0|||
105703116|NCT02055820|364576480|FG006|Phase II: Expansion|Lost to Follow-up|0|||
106006442|NCT02201524|365688209|FG003|Overall Study|Other|0|||
106006443|NCT02914639|365688210|FG000|Overall Study|Withdrawal by Subject|0|||
106006444|NCT02914639|365688211|FG001|Overall Study|Withdrawal by Subject|2|||
106006445|NCT04664153|365688216|FG000|Overall Study|Lack of Efficacy|0|||
106006446|NCT04664153|365688217|FG001|Overall Study|Lack of Efficacy|0|||
105703117|NCT02055820|364576481|FG007|Phase II: Expansion|Lost to Follow-up|0|||
105703118|NCT02055820|364576482|FG008|Phase II: Expansion|Lost to Follow-up|0|||
105703119|NCT02055820|364576483|FG009|Phase II: Expansion|Lost to Follow-up|0|||
105703120|NCT02055820|364576474|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
106006447|NCT04664153|365688218|FG002|Overall Study|Lack of Efficacy|1|||
105703121|NCT02055820|364576475|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
105703122|NCT02055820|364576476|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
106006448|NCT04664153|365688219|FG003|Overall Study|Lack of Efficacy|0|||
105703123|NCT02055820|364576477|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
105703124|NCT02055820|364576478|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
105703125|NCT02055820|364576479|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
105703126|NCT02055820|364576480|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
105703127|NCT02055820|364576481|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
105703128|NCT02055820|364576482|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
105703129|NCT02055820|364576483|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
105703130|NCT00133991|364576486|FG000|Overall Study|Death|4|||
105703131|NCT03002155|364576487|FG000|Overall Study|Lost to Follow-up|1|||
105703132|NCT03002155|364576488|FG001|Overall Study|Lost to Follow-up|2|||
105703133|NCT03002155|364576487|FG000|Overall Study|Withdrawal by Subject|1|||
105703134|NCT03002155|364576488|FG001|Overall Study|Withdrawal by Subject|0|||
105703135|NCT03002155|364576487|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
105703136|NCT03002155|364576488|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
106006449|NCT04664153|365688216|FG000|Overall Study|Physician Decision|0|||
106006450|NCT04664153|365688217|FG001|Overall Study|Physician Decision|0|||
106006451|NCT04664153|365688218|FG002|Overall Study|Physician Decision|1|||
106006452|NCT04664153|365688219|FG003|Overall Study|Physician Decision|0|||
106006453|NCT04664153|365688216|FG000|Overall Study|Withdrawal by Subject|3|||
105703137|NCT02830776|364576489|FG000|Overall Study|Lost to Follow-up|1|||
105703138|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
105703139|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
105703140|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
105703141|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
105703142|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
105703143|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
105703144|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
105703145|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
105703146|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
105703147|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
105703148|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
105703149|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
105703150|NCT03029143|364576490|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
105703151|NCT03029143|364576491|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
105703152|NCT03029143|364576492|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
105703153|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
105703154|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
105703155|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
105703156|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
105703157|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
105703158|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
105703159|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105703160|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105703161|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
105703162|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
105703163|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
105703164|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
105703165|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105703166|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
105703167|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
105703168|NCT03029143|364576490|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
105703169|NCT03029143|364576491|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
106006454|NCT04664153|365688217|FG001|Overall Study|Withdrawal by Subject|2|||
105703170|NCT03029143|364576492|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
105703171|NCT01765920|364576495|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
105703172|NCT01765920|364576496|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
105703173|NCT01765920|364576495|FG000|Overall Study|Patient code disclosure|0|||
105703174|NCT01765920|364576496|FG001|Overall Study|Patient code disclosure|1|||
105703175|NCT00961220|364576497|FG000|Overall Study|Adverse Event|3|||
106006455|NCT04664153|365688218|FG002|Overall Study|Withdrawal by Subject|1|||
106006456|NCT04664153|365688219|FG003|Overall Study|Withdrawal by Subject|2|||
106006457|NCT04664153|365688216|FG000|Overall Study|Other|0|||
106133674|NCT00448864|366148150|FG000|Overall Study|Physician Decision|1|||
106006458|NCT04664153|365688217|FG001|Overall Study|Other|1|||
106133675|NCT00448864|366148151|FG001|Overall Study|Physician Decision|0|||
106006459|NCT04664153|365688218|FG002|Overall Study|Other|0|||
106006460|NCT04664153|365688219|FG003|Overall Study|Other|0|||
106006461|NCT04664153|365688216|FG000|Overall Study|Adverse Event|4|||
106006462|NCT04664153|365688217|FG001|Overall Study|Adverse Event|0|||
106006463|NCT04664153|365688218|FG002|Overall Study|Adverse Event|1|||
105703176|NCT00961220|364576497|FG000|Overall Study|Lack of Efficacy|1|||
105703177|NCT00961220|364576497|FG000|Overall Study|No IV access for O6BG|1|||
105703178|NCT00961220|364576497|FG000|Overall Study|O6BG no longer supplied|1|||
105703179|NCT00961220|364576497|FG000|Overall Study|Complete Response prior to 12 courses|1|||
105703180|NCT01265797|364576498|FG000|Run-in Month|Withdrawal by Subject|0|||
105703181|NCT01265797|364576499|FG001|Run-in Month|Withdrawal by Subject|4|||
105703182|NCT01265797|364576498|FG000|Run-in Month|1st seizure during run-in month|0|||
105703183|NCT01265797|364576499|FG001|Run-in Month|1st seizure during run-in month|1|||
105703184|NCT01265797|364576498|FG000|Blinded Month|Lack of Efficacy|5|||
105703185|NCT01265797|364576499|FG001|Blinded Month|Lack of Efficacy|0|||
105703186|NCT01265797|364576498|FG000|Blinded Month|Lost to Follow-up|1|||
105703187|NCT01265797|364576499|FG001|Blinded Month|Lost to Follow-up|0|||
105703188|NCT01265797|364576498|FG000|Blinded Month|Protocol Violation|2|||
105703189|NCT01265797|364576499|FG001|Blinded Month|Protocol Violation|1|||
105703190|NCT01265797|364576498|FG000|Blinded Month|Adverse Event|2|||
105703191|NCT01265797|364576499|FG001|Blinded Month|Adverse Event|0|||
105703192|NCT01265797|364576498|FG000|Blinded Month|Diary data incomplete|0|||
105703193|NCT01265797|364576499|FG001|Blinded Month|Diary data incomplete|1|||
105703194|NCT01265797|364576498|FG000|Open Label Month|Lost to Follow-up|0|||
105703195|NCT01265797|364576499|FG001|Open Label Month|Lost to Follow-up|1|||
105703196|NCT01439204|364576500|FG000|Overall Study|Withdrawal by Subject|0|||
105703197|NCT01439204|364576501|FG001|Overall Study|Withdrawal by Subject|1|||
105703198|NCT01439204|364576500|FG000|Overall Study|Lost to Follow-up|0|||
105703199|NCT01439204|364576501|FG001|Overall Study|Lost to Follow-up|2|||
105703200|NCT01439204|364576500|FG000|Overall Study|No longer meets study criteria|1|||
105703201|NCT01439204|364576501|FG001|Overall Study|No longer meets study criteria|0|||
105703202|NCT01439204|364576500|FG000|Overall Study|poor/non-compliance|3|||
105703203|NCT01439204|364576501|FG001|Overall Study|poor/non-compliance|0|||
105703204|NCT03917823|364576503|FG000|Overall Study|Lost to Follow-up|1|||
105703205|NCT03917823|364576504|FG001|Overall Study|Lost to Follow-up|1|||
105703206|NCT03917823|364576503|FG000|Overall Study|Withdrawal by Subject|0|||
105703207|NCT03917823|364576504|FG001|Overall Study|Withdrawal by Subject|1|||
105703208|NCT02370615|364576505|FG000|Overall Study|Adverse Event|1|||
105703209|NCT02370615|364576506|FG001|Overall Study|Adverse Event|0|||
105703210|NCT00455013|364576507|FG000|Short Term Period|Adverse Event|2|||
105703211|NCT00455013|364576508|FG001|Short Term Period|Adverse Event|5|||
105703212|NCT00455013|364576509|FG002|Short Term Period|Adverse Event|0|||
105703213|NCT00455013|364576507|FG000|Short Term Period|Withdrawal by Subject|0|||
105703214|NCT00455013|364576508|FG001|Short Term Period|Withdrawal by Subject|0|||
105703215|NCT00455013|364576509|FG002|Short Term Period|Withdrawal by Subject|1|||
105703216|NCT00455013|364576507|FG000|Short Term Period|Lack of Efficacy|4|||
105703217|NCT00455013|364576508|FG001|Short Term Period|Lack of Efficacy|0|||
105703218|NCT00455013|364576509|FG002|Short Term Period|Lack of Efficacy|0|||
105703219|NCT00455013|364576507|FG000|Short Term Period|Other|0|||
105703220|NCT00455013|364576508|FG001|Short Term Period|Other|0|||
105703221|NCT00455013|364576509|FG002|Short Term Period|Other|1|||
105703222|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Adverse Event|0|||
105703223|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Adverse Event|1|||
105703224|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Adverse Event|1|||
105703225|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
105703226|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
106006464|NCT04664153|365688219|FG003|Overall Study|Adverse Event|0|||
106006465|NCT01045460|365688220|FG000|Overall Study|Physician Decision|3|||
105703227|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
105703228|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Death|1|||
105703229|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Death|1|||
105703230|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Death|0|||
105703231|NCT00455013|364576507|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
105703232|NCT00455013|364576508|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
105703233|NCT00455013|364576509|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
105703234|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
105703235|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
105703236|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
105703237|NCT00455013|364576507|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
105703238|NCT00455013|364576508|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
105703239|NCT00455013|364576509|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
105703240|NCT00455013|364576507|FG000|Long Term Extension (LTE)|non-specified|0|||
105703241|NCT00455013|364576508|FG001|Long Term Extension (LTE)|non-specified|0|||
105703242|NCT00455013|364576509|FG002|Long Term Extension (LTE)|non-specified|1|||
105703243|NCT01015768|364576511|FG000|Overall Study|Some subject data unuseable|4|||
105703244|NCT01015768|364576512|FG001|Overall Study|Some subject data unuseable|4|||
106006466|NCT01045460|365688221|FG001|Overall Study|Physician Decision|2|||
105703245|NCT00754793|364576513|FG000|Overall Study|voluntary withdrawn from study|0|||
105703246|NCT00754793|364576514|FG001|Overall Study|voluntary withdrawn from study|1|||
105703247|NCT00577642|364576515|FG000|Overall Study|Clinical Disease Progression|1|||
105703248|NCT00917150|364576520|FG000|Overall Study|Adverse Event|12|||
105703249|NCT00917150|364576521|FG001|Overall Study|Adverse Event|7|||
105703250|NCT00917150|364576522|FG002|Overall Study|Adverse Event|12|||
105703251|NCT00917150|364576523|FG003|Overall Study|Adverse Event|11|||
105703252|NCT00917150|364576520|FG000|Overall Study|Death|1|||
105703253|NCT00917150|364576521|FG001|Overall Study|Death|4|||
105703254|NCT00917150|364576522|FG002|Overall Study|Death|3|||
105703255|NCT00917150|364576523|FG003|Overall Study|Death|2|||
105703256|NCT00917150|364576520|FG000|Overall Study|Lost to Follow-up|1|||
105703257|NCT00917150|364576521|FG001|Overall Study|Lost to Follow-up|0|||
105703258|NCT00917150|364576522|FG002|Overall Study|Lost to Follow-up|4|||
105703259|NCT00917150|364576523|FG003|Overall Study|Lost to Follow-up|2|||
105703260|NCT00917150|364576520|FG000|Overall Study|Physician Decision|0|||
105926274|NCT00831844|365388004|FG001|Overall Study|Ineligible|1|||
105926275|NCT00831844|365388005|FG002|Overall Study|Ineligible|1|||
105703261|NCT00917150|364576521|FG001|Overall Study|Physician Decision|2|||
105703262|NCT00917150|364576522|FG002|Overall Study|Physician Decision|0|||
105703263|NCT00917150|364576523|FG003|Overall Study|Physician Decision|1|||
105926276|NCT00831844|365388006|FG003|Overall Study|Ineligible|0|||
105703264|NCT00917150|364576520|FG000|Overall Study|Protocol Violation|5|||
105703265|NCT00917150|364576521|FG001|Overall Study|Protocol Violation|5|||
105703266|NCT00917150|364576522|FG002|Overall Study|Protocol Violation|3|||
105703267|NCT00917150|364576523|FG003|Overall Study|Protocol Violation|5|||
105703268|NCT00917150|364576520|FG000|Overall Study|Withdrawal by Subject|15|||
105703269|NCT00917150|364576521|FG001|Overall Study|Withdrawal by Subject|16|||
105703270|NCT00917150|364576522|FG002|Overall Study|Withdrawal by Subject|18|||
105703271|NCT00917150|364576523|FG003|Overall Study|Withdrawal by Subject|11|||
105703272|NCT00917150|364576520|FG000|Overall Study|Other than specified|3|||
105703273|NCT00917150|364576521|FG001|Overall Study|Other than specified|3|||
105703274|NCT00917150|364576522|FG002|Overall Study|Other than specified|2|||
105703275|NCT00917150|364576523|FG003|Overall Study|Other than specified|2|||
105703276|NCT02054897|364576528|FG000|Overall Study|Withdrawal by Subject|2|||
105703277|NCT02054897|364576529|FG001|Overall Study|Withdrawal by Subject|0|||
105703278|NCT02054897|364576530|FG002|Overall Study|Withdrawal by Subject|2|||
105703279|NCT02054897|364576528|FG000|Overall Study|Missing follow-up information|3|||
105703280|NCT02054897|364576529|FG001|Overall Study|Missing follow-up information|5|||
105703281|NCT02054897|364576530|FG002|Overall Study|Missing follow-up information|3|||
105703282|NCT02054897|364576528|FG000|Overall Study|Lost to Follow-up|4|||
105703283|NCT02054897|364576529|FG001|Overall Study|Lost to Follow-up|2|||
105703284|NCT02054897|364576530|FG002|Overall Study|Lost to Follow-up|7|||
105703285|NCT02054897|364576528|FG000|Overall Study|Randomized but not exposed|1|||
105703286|NCT02054897|364576529|FG001|Overall Study|Randomized but not exposed|0|||
105703287|NCT02054897|364576530|FG002|Overall Study|Randomized but not exposed|0|||
105703288|NCT00950664|364576534|FG000|First Intervention|Lost to Follow-up|1|||
105703289|NCT00950664|364576535|FG001|First Intervention|Lost to Follow-up|3|||
105703290|NCT00950664|364576534|FG000|First Intervention|Withdrawal by Subject|2|||
105703291|NCT00950664|364576535|FG001|First Intervention|Withdrawal by Subject|2|||
105703292|NCT00640328|364576536|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703293|NCT00640328|364576537|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
105703294|NCT00640328|364576538|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703295|NCT00640328|364576539|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703296|NCT00640328|364576540|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703297|NCT00640328|364576541|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
105703298|NCT00640328|364576536|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703299|NCT00640328|364576537|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703300|NCT00640328|364576538|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703301|NCT00640328|364576539|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703302|NCT00640328|364576540|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
105703303|NCT00640328|364576541|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
105703304|NCT00640328|364576536|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703305|NCT00640328|364576537|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703306|NCT00640328|364576538|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
105703307|NCT00640328|364576539|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703308|NCT00640328|364576540|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703309|NCT00640328|364576541|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
105703310|NCT00640328|364576536|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
105703311|NCT00640328|364576537|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
105703312|NCT00640328|364576538|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
105703313|NCT00640328|364576539|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
105926277|NCT00831844|365388007|FG004|Overall Study|Ineligible|1|||
105926278|NCT00831844|365388008|FG005|Overall Study|Ineligible|0|||
105926279|NCT00831844|365388009|FG006|Overall Study|Ineligible|0|||
105926280|NCT00831844|365388010|FG007|Overall Study|Ineligible|0|||
105926281|NCT00831844|365388011|FG008|Overall Study|Ineligible|0|||
105926282|NCT00831844|365388012|FG009|Overall Study|Ineligible|0|||
105926283|NCT03980223|365388013|FG000|Overall Study|Lost to Follow-up|3|||
105926284|NCT03980223|365388014|FG001|Overall Study|Lost to Follow-up|7|||
105926285|NCT03980223|365388015|FG002|Overall Study|Lost to Follow-up|10|||
105703314|NCT00640328|364576540|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
105703315|NCT00640328|364576541|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
105703316|NCT02374099|364576542|FG000|Overall Study|Adverse Event|1|||
105703317|NCT02374099|364576543|FG001|Overall Study|Adverse Event|0|||
105703318|NCT02374099|364576542|FG000|Overall Study|Progressive Disease|35|||
105703319|NCT02374099|364576543|FG001|Overall Study|Progressive Disease|40|||
105703320|NCT02374099|364576542|FG000|Overall Study|Withdrawal by Subject|5|||
105926286|NCT03980223|365388016|FG003|Overall Study|Lost to Follow-up|8|||
105926287|NCT03980223|365388013|FG000|Overall Study|Withdrawal by Subject|0|||
105926288|NCT03980223|365388014|FG001|Overall Study|Withdrawal by Subject|0|||
105926289|NCT03980223|365388015|FG002|Overall Study|Withdrawal by Subject|1|||
105926290|NCT03980223|365388016|FG003|Overall Study|Withdrawal by Subject|2|||
105926291|NCT03980223|365388013|FG000|Overall Study|Physician Decision|0|||
105703321|NCT02374099|364576543|FG001|Overall Study|Withdrawal by Subject|1|||
105703322|NCT02374099|364576542|FG000|Overall Study|Miscellaneous|2|||
105703323|NCT02374099|364576543|FG001|Overall Study|Miscellaneous|3|||
105703324|NCT02374099|364576542|FG000|Overall Study|Randomized, but not treated|2|||
105703325|NCT02374099|364576543|FG001|Overall Study|Randomized, but not treated|1|||
105703326|NCT02374099|364576542|FG000|Overall Study|Study Terminated by Sponsor|3|||
105703327|NCT02374099|364576543|FG001|Overall Study|Study Terminated by Sponsor|4|||
105703328|NCT01033825|364576544|FG000|Overall Study|Withdrawal by Subject|2|||
105703329|NCT01033825|364576545|FG001|Overall Study|Withdrawal by Subject|3|||
105703330|NCT01033825|364576546|FG002|Overall Study|Withdrawal by Subject|2|||
105703331|NCT01033825|364576547|FG003|Overall Study|Withdrawal by Subject|1|||
105703332|NCT01033825|364576548|FG004|Overall Study|Withdrawal by Subject|1|||
105703333|NCT01033825|364576549|FG005|Overall Study|Withdrawal by Subject|0|||
105703334|NCT01033825|364576550|FG006|Overall Study|Withdrawal by Subject|0|||
105703335|NCT01033825|364576544|FG000|Overall Study|Adverse Event|0|||
105703336|NCT01033825|364576545|FG001|Overall Study|Adverse Event|0|||
105703337|NCT01033825|364576546|FG002|Overall Study|Adverse Event|0|||
105703338|NCT01033825|364576547|FG003|Overall Study|Adverse Event|1|||
105703339|NCT01033825|364576548|FG004|Overall Study|Adverse Event|0|||
105703340|NCT01033825|364576549|FG005|Overall Study|Adverse Event|0|||
105703341|NCT01033825|364576550|FG006|Overall Study|Adverse Event|0|||
105703342|NCT01033825|364576544|FG000|Overall Study|Protocol Violation|1|||
105703343|NCT01033825|364576545|FG001|Overall Study|Protocol Violation|0|||
105703344|NCT01033825|364576546|FG002|Overall Study|Protocol Violation|0|||
105703345|NCT01033825|364576547|FG003|Overall Study|Protocol Violation|0|||
105703346|NCT01033825|364576548|FG004|Overall Study|Protocol Violation|0|||
105703347|NCT01033825|364576549|FG005|Overall Study|Protocol Violation|0|||
105703348|NCT01033825|364576550|FG006|Overall Study|Protocol Violation|0|||
105703349|NCT01033825|364576544|FG000|Overall Study|Other|0|||
105703350|NCT01033825|364576545|FG001|Overall Study|Other|0|||
105703351|NCT01033825|364576546|FG002|Overall Study|Other|0|||
105703352|NCT01033825|364576547|FG003|Overall Study|Other|0|||
105703353|NCT01033825|364576548|FG004|Overall Study|Other|1|||
105703354|NCT01033825|364576549|FG005|Overall Study|Other|0|||
105703355|NCT01033825|364576550|FG006|Overall Study|Other|0|||
105703356|NCT00081159|364576551|FG000|Overall Study|Withdrawal by Subject|0|||
105703357|NCT00081159|364576552|FG001|Overall Study|Withdrawal by Subject|3|||
105703358|NCT00081159|364576551|FG000|Overall Study|Myelosuppression prior to treatment|0|||
105703359|NCT00081159|364576552|FG001|Overall Study|Myelosuppression prior to treatment|1|||
105703360|NCT00081159|364576551|FG000|Overall Study|Lost to Follow-up|2|||
105703361|NCT00081159|364576552|FG001|Overall Study|Lost to Follow-up|1|||
105703362|NCT01714687|364576555|FG000|Overall Study|Withdrawal by Subject|1|||
105703363|NCT01714687|364576556|FG001|Overall Study|Withdrawal by Subject|0|||
105703364|NCT01714687|364576555|FG000|Overall Study|Lost to Follow-up|2|||
105703365|NCT01714687|364576556|FG001|Overall Study|Lost to Follow-up|4|||
105703366|NCT01439555|364576558|FG000|Overall Study|Protocol Violation|1|||
105926292|NCT03980223|365388014|FG001|Overall Study|Physician Decision|0|||
105926293|NCT03980223|365388015|FG002|Overall Study|Physician Decision|1|||
106133676|NCT00448864|366148152|FG002|Overall Study|Physician Decision|1|||
106133677|NCT00448864|366148150|FG000|Overall Study|Withdrawal by Subject|0|||
106133678|NCT00448864|366148151|FG001|Overall Study|Withdrawal by Subject|2|||
106133679|NCT00448864|366148152|FG002|Overall Study|Withdrawal by Subject|0|||
106133680|NCT00448864|366148150|FG000|Overall Study|Protocol Violation|0|||
106133681|NCT00448864|366148151|FG001|Overall Study|Protocol Violation|2|||
106133682|NCT00448864|366148152|FG002|Overall Study|Protocol Violation|0|||
105703367|NCT02581202|364576563|FG000|Overall Study|Lack of Efficacy|2|||
105703368|NCT02581202|364576563|FG000|Overall Study|Withdrawal by Subject|4|||
105703369|NCT02581202|364576563|FG000|Overall Study|Lost to Follow-up|5|||
105703370|NCT02581202|364576563|FG000|Overall Study|Pregnancy|3|||
105703371|NCT05038020|364576567|FG000|Overall Study|Early Termination|3|||
105703372|NCT05038020|364576568|FG001|Overall Study|Early Termination|0|||
105703373|NCT03703882|364578375|FG000|Overall Study|Adverse Event|1|||
105703374|NCT03703882|364578376|FG001|Overall Study|Adverse Event|0|||
105703375|NCT03703882|364578375|FG000|Overall Study|Lost to Follow-up|0|||
105703376|NCT03703882|364578376|FG001|Overall Study|Lost to Follow-up|2|||
105703377|NCT03703882|364578375|FG000|Overall Study|Non-compliance with study drug|0|||
105703378|NCT03703882|364578376|FG001|Overall Study|Non-compliance with study drug|1|||
105703379|NCT03703882|364578375|FG000|Overall Study|Physician Decision|0|||
105703380|NCT03703882|364578376|FG001|Overall Study|Physician Decision|1|||
105703381|NCT03703882|364578375|FG000|Overall Study|Progressive disease|1|||
105703382|NCT03703882|364578376|FG001|Overall Study|Progressive disease|0|||
105703383|NCT03703882|364578375|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105703384|NCT03703882|364578376|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105703385|NCT03703882|364578375|FG000|Overall Study|Starting another treatment|0|||
105703386|NCT03703882|364578376|FG001|Overall Study|Starting another treatment|1|||
105703387|NCT03703882|364578375|FG000|Overall Study|noncompliance with study procedures|0|||
105703388|NCT03703882|364578376|FG001|Overall Study|noncompliance with study procedures|1|||
105703389|NCT03357731|364578377|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
105926294|NCT03980223|365388016|FG003|Overall Study|Physician Decision|0|||
106006467|NCT01045460|365688220|FG000|Overall Study|Lost to Follow-up|0|||
106006468|NCT01045460|365688221|FG001|Overall Study|Lost to Follow-up|1|||
106006469|NCT01045460|365688220|FG000|Overall Study|Lack of Efficacy|3|||
106006470|NCT01045460|365688221|FG001|Overall Study|Lack of Efficacy|0|||
106006471|NCT00001832|365688222|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
106006472|NCT00001832|365688223|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
106006473|NCT00001832|365688224|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
106006474|NCT00001832|365688225|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
106006475|NCT00001832|365688226|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
106006476|NCT00001832|365688227|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
106006477|NCT00001832|365688228|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
106006478|NCT00001832|365688229|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
106006479|NCT00001832|365688230|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
106006480|NCT00001832|365688231|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
106006481|NCT00001832|365688232|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
106006482|NCT00001832|365688233|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
106006483|NCT00001832|365688234|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
106006484|NCT00001832|365688235|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
106006485|NCT00001832|365688236|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
106006486|NCT00001832|365688222|FG000|Treatment Period|Death during treatment|0|||
106006487|NCT00001832|365688223|FG001|Treatment Period|Death during treatment|0|||
106006488|NCT00001832|365688224|FG002|Treatment Period|Death during treatment|0|||
106006489|NCT00001832|365688225|FG003|Treatment Period|Death during treatment|0|||
106006490|NCT00001832|365688226|FG004|Treatment Period|Death during treatment|0|||
106006491|NCT00001832|365688227|FG005|Treatment Period|Death during treatment|1|||
106006492|NCT00001832|365688228|FG006|Treatment Period|Death during treatment|0|||
106006493|NCT00001832|365688229|FG007|Treatment Period|Death during treatment|0|||
106006494|NCT00001832|365688230|FG008|Treatment Period|Death during treatment|0|||
106006495|NCT00001832|365688231|FG009|Treatment Period|Death during treatment|0|||
106006496|NCT00001832|365688232|FG010|Treatment Period|Death during treatment|0|||
106006497|NCT00001832|365688233|FG011|Treatment Period|Death during treatment|0|||
106006498|NCT00001832|365688234|FG012|Treatment Period|Death during treatment|0|||
106006499|NCT00001832|365688235|FG013|Treatment Period|Death during treatment|0|||
106006500|NCT00001832|365688236|FG014|Treatment Period|Death during treatment|0|||
106006501|NCT00001832|365688222|FG000|Treatment Period|Not treated|0|||
106006502|NCT00001832|365688223|FG001|Treatment Period|Not treated|0|||
106006503|NCT00001832|365688224|FG002|Treatment Period|Not treated|0|||
106006504|NCT00001832|365688225|FG003|Treatment Period|Not treated|0|||
106006505|NCT00001832|365688226|FG004|Treatment Period|Not treated|0|||
106006506|NCT00001832|365688227|FG005|Treatment Period|Not treated|0|||
106006507|NCT00001832|365688228|FG006|Treatment Period|Not treated|0|||
106006508|NCT00001832|365688229|FG007|Treatment Period|Not treated|1|||
106006509|NCT00001832|365688230|FG008|Treatment Period|Not treated|0|||
106006510|NCT00001832|365688231|FG009|Treatment Period|Not treated|0|||
106006511|NCT00001832|365688232|FG010|Treatment Period|Not treated|0|||
106006512|NCT00001832|365688233|FG011|Treatment Period|Not treated|0|||
106006513|NCT00001832|365688234|FG012|Treatment Period|Not treated|0|||
106006514|NCT00001832|365688235|FG013|Treatment Period|Not treated|0|||
106006515|NCT00001832|365688236|FG014|Treatment Period|Not treated|0|||
106006516|NCT02358473|365688240|FG000|Overall Study|Disease Progession|6|||
106006517|NCT02358473|365688240|FG000|Overall Study|Adverse Event|3|||
106006518|NCT02358473|365688240|FG000|Overall Study|Withdrawal by Subject|2|||
106006519|NCT02358473|365688240|FG000|Overall Study|Physician Decision|2|||
106006520|NCT04038359|365688253|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
106006521|NCT04038359|365688254|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
106006522|NCT04038359|365688253|FG000|Overall Study|Death|8|||
106006523|NCT04038359|365688254|FG001|Overall Study|Death|7|||
106006524|NCT04038359|365688253|FG000|Overall Study|Lost to Follow-up|3|||
106006525|NCT04038359|365688254|FG001|Overall Study|Lost to Follow-up|0|||
106006526|NCT04038359|365688253|FG000|Overall Study|Participant Moved|1|||
106006527|NCT04038359|365688254|FG001|Overall Study|Participant Moved|0|||
106006528|NCT04038359|365688253|FG000|Overall Study|Withdrawal by Subject|4|||
106006529|NCT04038359|365688254|FG001|Overall Study|Withdrawal by Subject|3|||
106006530|NCT04038359|365688253|FG000|Overall Study|Physician Decision|3|||
106133683|NCT01175707|366148154|FG000|Overall Study|Adverse Event|4|||
105703390|NCT03357731|364578378|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
106006531|NCT04038359|365688254|FG001|Overall Study|Physician Decision|2|||
106006532|NCT04038359|365688253|FG000|Overall Study|Adverse Event|0|||
106006533|NCT04038359|365688254|FG001|Overall Study|Adverse Event|2|||
106006534|NCT04038359|365688253|FG000|Overall Study|Progressive Disease|0|||
106006535|NCT04038359|365688254|FG001|Overall Study|Progressive Disease|1|||
106006536|NCT04949191|365688255|FG000|Overall Study|Non-compliance with Study Drug|1|||
106006537|NCT04949191|365688256|FG001|Overall Study|Non-compliance with Study Drug|0|||
106006538|NCT04949191|365688257|FG002|Overall Study|Non-compliance with Study Drug|0|||
106006539|NCT04949191|365688258|FG003|Overall Study|Non-compliance with Study Drug|0|||
106006540|NCT04949191|365688255|FG000|Overall Study|Progressive Disease|0|||
106006541|NCT04949191|365688256|FG001|Overall Study|Progressive Disease|1|||
106006542|NCT04949191|365688257|FG002|Overall Study|Progressive Disease|0|||
106006543|NCT04949191|365688258|FG003|Overall Study|Progressive Disease|0|||
106006544|NCT04949191|365688255|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
106006545|NCT04949191|365688256|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
106006546|NCT04949191|365688257|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
106006547|NCT04949191|365688258|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
106006548|NCT04949191|365688255|FG000|Overall Study|Sponsor Terminated Study|0|||
106006549|NCT04949191|365688256|FG001|Overall Study|Sponsor Terminated Study|0|||
106006550|NCT04949191|365688257|FG002|Overall Study|Sponsor Terminated Study|1|||
106006551|NCT04949191|365688258|FG003|Overall Study|Sponsor Terminated Study|1|||
106006552|NCT03259230|365688261|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
106006553|NCT03259230|365688262|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
106006554|NCT01033240|365688263|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
106006555|NCT01033240|365688264|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
106006556|NCT01033240|365688265|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
106006557|NCT01033240|365688263|FG000|Overall Study|Death|2|||
106006558|NCT01033240|365688264|FG001|Overall Study|Death|0|||
106006559|NCT01033240|365688265|FG002|Overall Study|Death|0|||
106006560|NCT01033240|365688263|FG000|Overall Study|Withdrew Consent|2|||
106006561|NCT01033240|365688264|FG001|Overall Study|Withdrew Consent|9|||
106006562|NCT01033240|365688265|FG002|Overall Study|Withdrew Consent|2|||
106006563|NCT01033240|365688263|FG000|Overall Study|Disease Progression|35|||
106006564|NCT01033240|365688264|FG001|Overall Study|Disease Progression|32|||
106006565|NCT01033240|365688265|FG002|Overall Study|Disease Progression|41|||
106006566|NCT01033240|365688263|FG000|Overall Study|Investigator Discretion|0|||
106006567|NCT01033240|365688264|FG001|Overall Study|Investigator Discretion|0|||
106006568|NCT01033240|365688265|FG002|Overall Study|Investigator Discretion|2|||
105703391|NCT03357731|364578379|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
105703392|NCT03357731|364578380|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
105703393|NCT03357731|364578381|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
105703394|NCT03357731|364578382|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
105703395|NCT03357731|364578377|FG000|Overall Study|Acute bradycardia and hypotension|0|||
105703396|NCT03357731|364578378|FG001|Overall Study|Acute bradycardia and hypotension|0|||
105703397|NCT03357731|364578379|FG002|Overall Study|Acute bradycardia and hypotension|0|||
105703398|NCT03357731|364578380|FG003|Overall Study|Acute bradycardia and hypotension|1|||
105703399|NCT03357731|364578381|FG004|Overall Study|Acute bradycardia and hypotension|0|||
105703400|NCT03357731|364578382|FG005|Overall Study|Acute bradycardia and hypotension|0|||
105703401|NCT03357731|364578377|FG000|Overall Study|Adverse Event|0|||
105703402|NCT03357731|364578378|FG001|Overall Study|Adverse Event|0|||
105703403|NCT03357731|364578379|FG002|Overall Study|Adverse Event|0|||
105703404|NCT03357731|364578380|FG003|Overall Study|Adverse Event|0|||
105703405|NCT03357731|364578381|FG004|Overall Study|Adverse Event|0|||
105703406|NCT03357731|364578382|FG005|Overall Study|Adverse Event|1|||
105703407|NCT03357731|364578377|FG000|Overall Study|Hypotension|0|||
105703408|NCT03357731|364578378|FG001|Overall Study|Hypotension|0|||
105703409|NCT03357731|364578379|FG002|Overall Study|Hypotension|1|||
105703410|NCT03357731|364578380|FG003|Overall Study|Hypotension|1|||
105703411|NCT03357731|364578381|FG004|Overall Study|Hypotension|0|||
105703412|NCT03357731|364578382|FG005|Overall Study|Hypotension|0|||
105703413|NCT03357731|364578377|FG000|Overall Study|Lost to Follow-up|0|||
105703414|NCT03357731|364578378|FG001|Overall Study|Lost to Follow-up|0|||
105703415|NCT03357731|364578379|FG002|Overall Study|Lost to Follow-up|0|||
105703416|NCT03357731|364578380|FG003|Overall Study|Lost to Follow-up|1|||
105703417|NCT03357731|364578381|FG004|Overall Study|Lost to Follow-up|0|||
105703418|NCT03357731|364578382|FG005|Overall Study|Lost to Follow-up|0|||
105703419|NCT02104583|364578383|FG000|Overall Study|New ICD or CRT-D implanted|2|||
105703420|NCT02104583|364578384|FG001|Overall Study|New ICD or CRT-D implanted|0|||
105703421|NCT02104583|364578385|FG002|Overall Study|New ICD or CRT-D implanted|1|||
105703422|NCT02104583|364578386|FG003|Overall Study|New ICD or CRT-D implanted|0|||
106006569|NCT01033240|365688263|FG000|Overall Study|Other|0|||
106006570|NCT01033240|365688264|FG001|Overall Study|Other|1|||
106006571|NCT01033240|365688265|FG002|Overall Study|Other|2|||
106006572|NCT05468814|365688266|FG000|Overall Study|Lost to Follow-up|5|||
106006573|NCT05468814|365688267|FG001|Overall Study|Lost to Follow-up|6|||
105703423|NCT02104583|364578387|FG004|Overall Study|New ICD or CRT-D implanted|0|||
105703424|NCT02104583|364578383|FG000|Overall Study|Death|2|||
105703425|NCT02104583|364578384|FG001|Overall Study|Death|1|||
105703426|NCT02104583|364578385|FG002|Overall Study|Death|3|||
105703427|NCT02104583|364578386|FG003|Overall Study|Death|3|||
105703428|NCT02104583|364578387|FG004|Overall Study|Death|5|||
106006574|NCT04716426|365688269|FG000|Overall Study|Vaccination|1|||
106006575|NCT04716426|365688270|FG001|Overall Study|Vaccination|1|||
106006576|NCT04716426|365688269|FG000|Overall Study|Contamination|1|||
106006577|NCT04716426|365688270|FG001|Overall Study|Contamination|0|||
106006578|NCT00551759|365688271|FG000|Overall Study|Adverse Event|7|||
106006579|NCT00551759|365688271|FG000|Overall Study|Death|5|||
105703429|NCT02104583|364578383|FG000|Overall Study|Subject required cardiac ablation|6|||
105703430|NCT02104583|364578384|FG001|Overall Study|Subject required cardiac ablation|4|||
105703431|NCT02104583|364578385|FG002|Overall Study|Subject required cardiac ablation|4|||
105703432|NCT02104583|364578386|FG003|Overall Study|Subject required cardiac ablation|5|||
105703433|NCT02104583|364578387|FG004|Overall Study|Subject required cardiac ablation|4|||
105703434|NCT02104583|364578383|FG000|Overall Study|Subject required prohibited medication|0|||
105703435|NCT02104583|364578384|FG001|Overall Study|Subject required prohibited medication|1|||
105703436|NCT02104583|364578385|FG002|Overall Study|Subject required prohibited medication|1|||
105703437|NCT02104583|364578386|FG003|Overall Study|Subject required prohibited medication|0|||
105703438|NCT02104583|364578387|FG004|Overall Study|Subject required prohibited medication|1|||
105703439|NCT02104583|364578383|FG000|Overall Study|Withdrew Consent|3|||
105703440|NCT02104583|364578384|FG001|Overall Study|Withdrew Consent|2|||
105703441|NCT02104583|364578385|FG002|Overall Study|Withdrew Consent|0|||
105703442|NCT02104583|364578386|FG003|Overall Study|Withdrew Consent|2|||
105703443|NCT02104583|364578387|FG004|Overall Study|Withdrew Consent|1|||
105703444|NCT02104583|364578383|FG000|Overall Study|Investigator's Discretion|1|||
105703445|NCT02104583|364578384|FG001|Overall Study|Investigator's Discretion|0|||
105703446|NCT02104583|364578385|FG002|Overall Study|Investigator's Discretion|0|||
105703447|NCT02104583|364578386|FG003|Overall Study|Investigator's Discretion|0|||
105703448|NCT02104583|364578387|FG004|Overall Study|Investigator's Discretion|0|||
105703449|NCT02104583|364578383|FG000|Overall Study|Protocol Violation|0|||
105703450|NCT02104583|364578384|FG001|Overall Study|Protocol Violation|0|||
105703451|NCT02104583|364578385|FG002|Overall Study|Protocol Violation|1|||
105703452|NCT02104583|364578386|FG003|Overall Study|Protocol Violation|0|||
105703453|NCT02104583|364578387|FG004|Overall Study|Protocol Violation|0|||
105703454|NCT02104583|364578383|FG000|Overall Study|Adverse Event|3|||
105703455|NCT02104583|364578384|FG001|Overall Study|Adverse Event|3|||
105703456|NCT02104583|364578385|FG002|Overall Study|Adverse Event|6|||
105703457|NCT02104583|364578386|FG003|Overall Study|Adverse Event|6|||
105703458|NCT02104583|364578387|FG004|Overall Study|Adverse Event|1|||
105703459|NCT02104583|364578383|FG000|Overall Study|Lost to Follow-up|1|||
105703460|NCT02104583|364578384|FG001|Overall Study|Lost to Follow-up|0|||
105703461|NCT02104583|364578385|FG002|Overall Study|Lost to Follow-up|0|||
105703462|NCT02104583|364578386|FG003|Overall Study|Lost to Follow-up|0|||
105703463|NCT02104583|364578387|FG004|Overall Study|Lost to Follow-up|0|||
105703464|NCT02104583|364578383|FG000|Overall Study|Randomized but Never Treated|0|||
105703465|NCT02104583|364578384|FG001|Overall Study|Randomized but Never Treated|0|||
105703466|NCT02104583|364578385|FG002|Overall Study|Randomized but Never Treated|0|||
105703467|NCT02104583|364578386|FG003|Overall Study|Randomized but Never Treated|1|||
105703468|NCT02104583|364578387|FG004|Overall Study|Randomized but Never Treated|0|||
105703469|NCT02347098|364578388|FG000|Overall Study|Death|1|||
105703470|NCT02347098|364578389|FG001|Overall Study|Death|0|||
105703471|NCT02347098|364578388|FG000|Overall Study|Withdrawal by Subject|1|||
105703472|NCT02347098|364578389|FG001|Overall Study|Withdrawal by Subject|0|||
105703473|NCT02347098|364578388|FG000|Overall Study|Lost to Follow-up|2|||
105703474|NCT02347098|364578389|FG001|Overall Study|Lost to Follow-up|2|||
105703475|NCT02347098|364578388|FG000|Overall Study|Refuse Follow-up Visit|1|||
105703476|NCT02347098|364578389|FG001|Overall Study|Refuse Follow-up Visit|5|||
105703477|NCT02347098|364578388|FG000|Overall Study|no visit due to illness|2|||
105703478|NCT02347098|364578389|FG001|Overall Study|no visit due to illness|1|||
105703479|NCT03923426|364578391|FG000|Overall Study|Other|19|||
105703480|NCT03923426|364578391|FG000|Overall Study|Lost to Follow-up|16|||
105703481|NCT03923426|364578391|FG000|Overall Study|Death|107|||
105703482|NCT03923426|364578391|FG000|Overall Study|Incomplete response to question|13|||
106006580|NCT00551759|365688271|FG000|Overall Study|Ineligible|1|||
106006581|NCT00625131|365688275|FG000|Overall Study|Lost to Follow-up|3|||
106006582|NCT00625131|365688276|FG001|Overall Study|Lost to Follow-up|2|||
105703483|NCT00751400|364578394|FG000|Overall Study|Lost to Follow-up|10|||
105703484|NCT00847912|364578396|FG000|Overall Study|Protocol Violation|6|||
105703485|NCT00847912|364578397|FG001|Overall Study|Protocol Violation|7|||
105703486|NCT00847912|364578396|FG000|Overall Study|Withdrawal by Subject|3|||
105703487|NCT00847912|364578397|FG001|Overall Study|Withdrawal by Subject|6|||
105703488|NCT01324232|364578398|FG000|Overall Study|Protocol Violation|0|||
105703489|NCT01324232|364578399|FG001|Overall Study|Protocol Violation|0|||
105703490|NCT01324232|364578400|FG002|Overall Study|Protocol Violation|0|||
105703491|NCT01324232|364578401|FG003|Overall Study|Protocol Violation|2|||
105703492|NCT01324232|364578398|FG000|Overall Study|Missing|0|||
105703493|NCT01324232|364578399|FG001|Overall Study|Missing|0|||
105703494|NCT01324232|364578400|FG002|Overall Study|Missing|1|||
105703495|NCT01324232|364578401|FG003|Overall Study|Missing|0|||
105703496|NCT01324232|364578398|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
105703497|NCT01324232|364578399|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
105703498|NCT01324232|364578400|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
105703499|NCT01324232|364578401|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
106006583|NCT00625131|365688277|FG002|Overall Study|Lost to Follow-up|0|||
106006584|NCT00625131|365688275|FG000|Overall Study|Withdrawal by Subject|1|||
105703500|NCT01324232|364578398|FG000|Overall Study|Lack of Efficacy|2|||
105703501|NCT01324232|364578399|FG001|Overall Study|Lack of Efficacy|1|||
105703502|NCT01324232|364578400|FG002|Overall Study|Lack of Efficacy|2|||
105703503|NCT01324232|364578401|FG003|Overall Study|Lack of Efficacy|2|||
105703504|NCT01324232|364578398|FG000|Overall Study|Participant Refused Medication|0|||
105703505|NCT01324232|364578399|FG001|Overall Study|Participant Refused Medication|1|||
105703506|NCT01324232|364578400|FG002|Overall Study|Participant Refused Medication|0|||
105703507|NCT01324232|364578401|FG003|Overall Study|Participant Refused Medication|0|||
105703508|NCT01324232|364578398|FG000|Overall Study|Intercurrent illness|0|||
105703509|NCT01324232|364578399|FG001|Overall Study|Intercurrent illness|0|||
105703510|NCT01324232|364578400|FG002|Overall Study|Intercurrent illness|0|||
105703511|NCT01324232|364578401|FG003|Overall Study|Intercurrent illness|1|||
105703512|NCT01324232|364578398|FG000|Overall Study|Adverse Event|2|||
105703513|NCT01324232|364578399|FG001|Overall Study|Adverse Event|5|||
105703514|NCT01324232|364578400|FG002|Overall Study|Adverse Event|6|||
105703515|NCT01324232|364578401|FG003|Overall Study|Adverse Event|6|||
105703516|NCT01324232|364578398|FG000|Overall Study|Withdrawal by Subject|0|||
105703517|NCT01324232|364578399|FG001|Overall Study|Withdrawal by Subject|3|||
105703518|NCT01324232|364578400|FG002|Overall Study|Withdrawal by Subject|4|||
105703519|NCT01324232|364578401|FG003|Overall Study|Withdrawal by Subject|0|||
105703520|NCT01324232|364578398|FG000|Overall Study|Lost to Follow-up|1|||
105703521|NCT01324232|364578399|FG001|Overall Study|Lost to Follow-up|0|||
105703522|NCT01324232|364578400|FG002|Overall Study|Lost to Follow-up|0|||
105703523|NCT01324232|364578401|FG003|Overall Study|Lost to Follow-up|0|||
105703524|NCT00661531|364578402|FG000|Overall Study|Withdrawal by Subject|3|||
105703525|NCT00530270|364578405|FG000|Overall Study|Protocol Violation|1|||
105703526|NCT00530270|364578406|FG001|Overall Study|Protocol Violation|0|||
105703527|NCT03703102|364578414|FG000|Overall Study|Adverse Event|4|||
105703528|NCT03703102|364578415|FG001|Overall Study|Adverse Event|3|||
105703529|NCT03703102|364578416|FG002|Overall Study|Adverse Event|7|||
105703530|NCT03703102|364578417|FG003|Overall Study|Adverse Event|3|||
105703531|NCT03703102|364578418|FG004|Overall Study|Adverse Event|13|||
105703532|NCT03703102|364578414|FG000|Overall Study|Lack of Efficacy|4|||
105703533|NCT03703102|364578415|FG001|Overall Study|Lack of Efficacy|0|||
105703534|NCT03703102|364578416|FG002|Overall Study|Lack of Efficacy|1|||
105703535|NCT03703102|364578417|FG003|Overall Study|Lack of Efficacy|4|||
105703536|NCT03703102|364578418|FG004|Overall Study|Lack of Efficacy|1|||
105703537|NCT03703102|364578414|FG000|Overall Study|Lost to Follow-up|0|||
105703538|NCT03703102|364578415|FG001|Overall Study|Lost to Follow-up|0|||
105703539|NCT03703102|364578416|FG002|Overall Study|Lost to Follow-up|1|||
105703540|NCT03703102|364578417|FG003|Overall Study|Lost to Follow-up|2|||
105703541|NCT03703102|364578418|FG004|Overall Study|Lost to Follow-up|2|||
105703542|NCT03703102|364578414|FG000|Overall Study|Physician Decision|2|||
105703543|NCT03703102|364578415|FG001|Overall Study|Physician Decision|2|||
105703544|NCT03703102|364578416|FG002|Overall Study|Physician Decision|2|||
105703545|NCT03703102|364578417|FG003|Overall Study|Physician Decision|2|||
105703546|NCT03703102|364578418|FG004|Overall Study|Physician Decision|4|||
105703547|NCT03703102|364578414|FG000|Overall Study|Withdrawal by Subject|7|||
105703548|NCT03703102|364578415|FG001|Overall Study|Withdrawal by Subject|5|||
105703549|NCT03703102|364578416|FG002|Overall Study|Withdrawal by Subject|5|||
105703550|NCT03703102|364578417|FG003|Overall Study|Withdrawal by Subject|5|||
105703551|NCT03703102|364578418|FG004|Overall Study|Withdrawal by Subject|9|||
105703552|NCT03703102|364578414|FG000|Overall Study|Ineligibility|0|||
105703553|NCT03703102|364578415|FG001|Overall Study|Ineligibility|0|||
105703554|NCT03703102|364578416|FG002|Overall Study|Ineligibility|1|||
105703555|NCT03703102|364578417|FG003|Overall Study|Ineligibility|0|||
105703556|NCT03703102|364578418|FG004|Overall Study|Ineligibility|0|||
105703557|NCT03703102|364578414|FG000|Overall Study|Protocol Deviation|4|||
105703558|NCT03703102|364578415|FG001|Overall Study|Protocol Deviation|4|||
105703559|NCT03703102|364578416|FG002|Overall Study|Protocol Deviation|3|||
105703560|NCT03703102|364578417|FG003|Overall Study|Protocol Deviation|0|||
105703561|NCT03703102|364578418|FG004|Overall Study|Protocol Deviation|0|||
105703562|NCT03703102|364578414|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105703563|NCT03703102|364578415|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105703564|NCT03703102|364578416|FG002|Overall Study|Non-Compliance with Study Drug|2|||
105703565|NCT03703102|364578417|FG003|Overall Study|Non-Compliance with Study Drug|1|||
105703566|NCT03703102|364578418|FG004|Overall Study|Non-Compliance with Study Drug|4|||
105703567|NCT02311153|364578419|FG000|Overall Study|Lost to Follow-up|5|||
105703568|NCT02311153|364578420|FG001|Overall Study|Lost to Follow-up|7|||
105703569|NCT00838331|364578421|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
105703570|NCT00405067|364578426|FG000|Overall Study|Adverse Event|4|||
105703571|NCT00405067|364578427|FG001|Overall Study|Adverse Event|9|||
105703572|NCT00405067|364578428|FG002|Overall Study|Adverse Event|4|||
105703573|NCT00405067|364578426|FG000|Overall Study|Lost to Follow-up|0|||
105703574|NCT00405067|364578427|FG001|Overall Study|Lost to Follow-up|0|||
105703575|NCT00405067|364578428|FG002|Overall Study|Lost to Follow-up|1|||
106006585|NCT00625131|365688276|FG001|Overall Study|Withdrawal by Subject|0|||
106006586|NCT00625131|365688277|FG002|Overall Study|Withdrawal by Subject|5|||
106006587|NCT00771914|365688278|FG000|Overall Study|Physician Decision|0|||
106006588|NCT00771914|365688279|FG001|Overall Study|Physician Decision|0|||
106006589|NCT00771914|365688280|FG002|Overall Study|Physician Decision|0|||
106006590|NCT00771914|365688281|FG003|Overall Study|Physician Decision|1|||
106006591|NCT00771914|365688278|FG000|Overall Study|Lost to Follow-up|0|||
106006592|NCT00771914|365688279|FG001|Overall Study|Lost to Follow-up|0|||
106006593|NCT00771914|365688280|FG002|Overall Study|Lost to Follow-up|0|||
106006594|NCT00771914|365688281|FG003|Overall Study|Lost to Follow-up|1|||
106006595|NCT01743469|365688284|FG000|Active Treatment Phase|Adverse Event|10|||
106006596|NCT01743469|365688285|FG001|Active Treatment Phase|Adverse Event|5|||
106006597|NCT01743469|365688286|FG002|Active Treatment Phase|Adverse Event|8|||
106006598|NCT01743469|365688287|FG003|Active Treatment Phase|Adverse Event|1|||
106006599|NCT01743469|365688284|FG000|Active Treatment Phase|Disease Progression|40|||
106006600|NCT01743469|365688285|FG001|Active Treatment Phase|Disease Progression|47|||
106006601|NCT01743469|365688286|FG002|Active Treatment Phase|Disease Progression|30|||
106006602|NCT01743469|365688287|FG003|Active Treatment Phase|Disease Progression|20|||
106006603|NCT01743469|365688284|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
106006604|NCT01743469|365688285|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
106006605|NCT01743469|365688286|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
106006606|NCT01743469|365688287|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
106006607|NCT01743469|365688284|FG000|Active Treatment Phase|Missing|1|||
106006608|NCT01743469|365688285|FG001|Active Treatment Phase|Missing|0|||
106006609|NCT01743469|365688286|FG002|Active Treatment Phase|Missing|0|||
106006610|NCT01743469|365688287|FG003|Active Treatment Phase|Missing|0|||
106133684|NCT01175707|366148155|FG001|Overall Study|Adverse Event|6|||
106133685|NCT00763282|366148161|FG000|Overall Study|Withdrawal by Subject|6|||
106133686|NCT00763282|366148162|FG001|Overall Study|Withdrawal by Subject|5|||
106133687|NCT00763282|366148161|FG000|Overall Study|Death|4|||
106133688|NCT00763282|366148162|FG001|Overall Study|Death|3|||
106133689|NCT00763282|366148161|FG000|Overall Study|Lost to Follow-up|22|||
105926295|NCT03980223|365388013|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
105926296|NCT03980223|365388014|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
105926297|NCT03980223|365388015|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
105926298|NCT03980223|365388016|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
105926299|NCT01937299|365388020|FG000|Overall Study|Adverse Event|13|||
105926300|NCT01937299|365388021|FG001|Overall Study|Adverse Event|0|||
105926301|NCT01937299|365388020|FG000|Overall Study|Lack of Efficacy|0|||
105926302|NCT01937299|365388021|FG001|Overall Study|Lack of Efficacy|4|||
105926303|NCT01937299|365388020|FG000|Overall Study|Withdrawal by Subject|1|||
105926304|NCT01937299|365388021|FG001|Overall Study|Withdrawal by Subject|0|||
105926305|NCT00385840|365388022|FG000|Overall Study|Adverse Event|1|||
105926306|NCT00385840|365388023|FG001|Overall Study|Adverse Event|1|||
105926307|NCT00385840|365388022|FG000|Overall Study|Lost to Follow-up|3|||
105926308|NCT00385840|365388023|FG001|Overall Study|Lost to Follow-up|13|||
105926309|NCT05172570|365388025|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
105926310|NCT05172570|365388026|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
105926311|NCT05172570|365388027|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
105926312|NCT05172570|365388025|FG000|Overall Study|PI Decision due to equipment shortages|0|||
105926313|NCT05172570|365388026|FG001|Overall Study|PI Decision due to equipment shortages|0|||
105926314|NCT05172570|365388027|FG002|Overall Study|PI Decision due to equipment shortages|1|||
105926315|NCT01260948|365388038|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
105926316|NCT01260948|365388039|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
105926317|NCT01260948|365388038|FG000|Second Intervention|Emesis|0|||
105926318|NCT01260948|365388039|FG001|Second Intervention|Emesis|1|||
105926319|NCT00640289|365388040|FG000|Overall Study|Death|3|||
105926320|NCT00640289|365388040|FG000|Overall Study|Withdrawal by Subject|1|||
105926321|NCT00640289|365388040|FG000|Overall Study|Lost to Follow-up|1|||
105926322|NCT00640289|365388040|FG000|Overall Study|Data collected under different amendment|2|||
105926323|NCT00640289|365388040|FG000|Overall Study|Transferred to another center|1|||
105926324|NCT00640289|365388040|FG000|Overall Study|Missing status|5|||
105926325|NCT00462462|365388041|FG000|Overall Study|Physician Decision|0|||
106006611|NCT01743469|365688284|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
106006612|NCT01743469|365688285|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
106006613|NCT01743469|365688286|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
106006614|NCT01743469|365688287|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
106133690|NCT00763282|366148162|FG001|Overall Study|Lost to Follow-up|26|||
106133691|NCT00742274|366148163|FG000|Overall Study|Death|1|||
106133692|NCT00742274|366148164|FG001|Overall Study|Death|0|||
106133693|NCT00742274|366148163|FG000|Overall Study|Withdrawal by Subject|1|||
105926326|NCT00462462|365388042|FG001|Overall Study|Physician Decision|1|||
105926327|NCT00765076|365388043|FG000|Overall Study|Adverse Event|1|||
105703576|NCT01650636|364578429|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
105703577|NCT01650636|364578430|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
105703578|NCT01650636|364578429|FG000|Washout up to 5 Months|Physician Decision|2|||
106006615|NCT01743469|365688284|FG000|Follow-up Period - Post-Treatment|Death|43|||
106006616|NCT01743469|365688285|FG001|Follow-up Period - Post-Treatment|Death|47|||
105703579|NCT01650636|364578430|FG001|Washout up to 5 Months|Physician Decision|2|||
106006617|NCT01743469|365688286|FG002|Follow-up Period - Post-Treatment|Death|22|||
106006618|NCT01743469|365688287|FG003|Follow-up Period - Post-Treatment|Death|16|||
106006619|NCT01743469|365688284|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
106006620|NCT01743469|365688285|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
106006621|NCT01743469|365688286|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
106006622|NCT01743469|365688287|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
106006623|NCT02559622|365688290|FG000|Overall Study|Progressive disease|0|||
106006624|NCT02559622|365688291|FG001|Overall Study|Progressive disease|1|||
106006625|NCT02559622|365688292|FG002|Overall Study|Progressive disease|0|||
106006626|NCT02559622|365688293|FG003|Overall Study|Progressive disease|0|||
106133694|NCT00742274|366148164|FG001|Overall Study|Withdrawal by Subject|2|||
105703580|NCT01650636|364578429|FG000|Washout up to 5 Months|Death|1|||
105703581|NCT01650636|364578430|FG001|Washout up to 5 Months|Death|0|||
105703582|NCT01650636|364578429|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
105703583|NCT01650636|364578430|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
105703584|NCT01650636|364578429|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
105703585|NCT01650636|364578430|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
105703586|NCT01650636|364578429|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
105703587|NCT01650636|364578430|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
105703588|NCT02018822|364578431|FG000|Overall Study|filling replaced by crown|0|||
105926328|NCT00765076|365388044|FG001|Overall Study|Adverse Event|0|||
105926329|NCT00765076|365388045|FG002|Overall Study|Adverse Event|0|||
105926330|NCT00765076|365388043|FG000|Overall Study|Withdrawal by Subject|0|||
105926331|NCT00765076|365388044|FG001|Overall Study|Withdrawal by Subject|0|||
105926332|NCT00765076|365388045|FG002|Overall Study|Withdrawal by Subject|1|||
105926333|NCT01685437|365388046|FG000|Overall Study|Withdrawal by Subject|22|||
105926334|NCT01685437|365388046|FG000|Overall Study|Lost to Follow-up|3|||
105926335|NCT01685437|365388046|FG000|Overall Study|Adverse Event|1|||
105926336|NCT01685437|365388046|FG000|Overall Study|Protocol Violation|4|||
105926337|NCT01685437|365388046|FG000|Overall Study|Unable to make visits due to work|1|||
105926338|NCT00768053|365388047|FG000|Overall Study|Adverse Event|10|||
105926339|NCT00768053|365388047|FG000|Overall Study|Lost to Follow-up|1|||
105926340|NCT04307394|365389801|FG000|Overall Study|Lost to Follow-up|3|||
105926341|NCT04307394|365389801|FG000|Overall Study|Withdrawal by Subject|2|||
105926342|NCT01121926|365389802|FG000|First Intervention Period|Adverse Event|1|||
105926343|NCT01121926|365389803|FG001|First Intervention Period|Adverse Event|0|||
105926344|NCT01121926|365389802|FG000|Washout Period|Adverse Event|0|||
105926345|NCT01121926|365389803|FG001|Washout Period|Adverse Event|1|||
105926346|NCT01121926|365389802|FG000|Washout Period|Positive pregnancy test|0|||
105926347|NCT01121926|365389803|FG001|Washout Period|Positive pregnancy test|1|||
105926348|NCT02536794|365389804|FG000|Reached 1st Response Assessment|Adverse Event|2|||
105926349|NCT02536794|365389804|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
105926350|NCT02536794|365389804|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
105926351|NCT02536794|365389804|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
105926352|NCT02536794|365389804|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
105926353|NCT02536794|365389804|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
105926354|NCT00416949|365389807|FG000|Overall Study|Patients refused to participate|5|||
105926355|NCT01531153|365389811|FG000|Overall Study|Withdrawal by Subject|10|||
105926356|NCT01531153|365389812|FG001|Overall Study|Withdrawal by Subject|9|||
105926357|NCT01531153|365389813|FG002|Overall Study|Withdrawal by Subject|15|||
105926358|NCT00770367|365389814|FG000|First Intervention|Withdrawal by Subject|0|||
105926359|NCT00770367|365389815|FG001|First Intervention|Withdrawal by Subject|2|||
105926360|NCT00770367|365389814|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
105926361|NCT00770367|365389815|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
105926362|NCT00770367|365389814|FG000|Second Intervention|Lost to Follow-up|2|||
105926363|NCT00770367|365389815|FG001|Second Intervention|Lost to Follow-up|0|||
105926364|NCT01898130|365389816|FG000|Treatment|Withdrawal by Subject|2|||
105926365|NCT01898130|365389816|FG000|Treatment|Progressive Disease|4|||
105926366|NCT01898130|365389816|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
105926367|NCT02382939|365389822|FG000|Overall Study|Adverse Event|1|||
105926368|NCT02382939|365389823|FG001|Overall Study|Adverse Event|1|||
105926369|NCT02382939|365389822|FG000|Overall Study|Withdrawal by Subject|2|||
105926370|NCT02382939|365389823|FG001|Overall Study|Withdrawal by Subject|2|||
105926371|NCT00717886|365389824|FG000|Overall Study|Withdrawal by Subject|3|||
105926372|NCT00717886|365389824|FG000|Overall Study|Treatment Failure|1|||
106006627|NCT02559622|365688290|FG000|Overall Study|Adverse Event|0|||
106133695|NCT00742274|366148163|FG000|Overall Study|Removed for medical reasons|1|||
105926373|NCT02313155|365389825|FG000|Overall Study|Lost to Follow-up|0|||
105926374|NCT02313155|365389826|FG001|Overall Study|Lost to Follow-up|1|||
106133696|NCT00742274|366148164|FG001|Overall Study|Removed for medical reasons|1|||
106133697|NCT01928940|366148165|FG000|Overall Study|Adverse Event|0|||
106133698|NCT01928940|366148166|FG001|Overall Study|Adverse Event|1|||
106133699|NCT01352507|366148169|FG000|Treatment Period 1|Adverse Event|3|||
106133700|NCT01352507|366148170|FG001|Treatment Period 1|Adverse Event|0|||
106133701|NCT01352507|366148169|FG000|Treatment Period 1|Lost to Follow-up|3|||
106133702|NCT01352507|366148170|FG001|Treatment Period 1|Lost to Follow-up|4|||
106133703|NCT01352507|366148169|FG000|Treatment Period 1|Withdrawal by Subject|7|||
106133704|NCT01352507|366148170|FG001|Treatment Period 1|Withdrawal by Subject|5|||
106133705|NCT01352507|366148169|FG000|Treatment Period 1|Physician Decision|1|||
106133706|NCT01352507|366148170|FG001|Treatment Period 1|Physician Decision|0|||
106133707|NCT01352507|366148169|FG000|Washout Period|Withdrawal by Subject|0|||
106133708|NCT01352507|366148170|FG001|Washout Period|Withdrawal by Subject|1|||
106133709|NCT01352507|366148169|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
106133710|NCT01352507|366148170|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
106133711|NCT01352507|366148169|FG000|Treatment Period 2|Withdrawal by Subject|4|||
106133712|NCT01352507|366148170|FG001|Treatment Period 2|Withdrawal by Subject|3|||
106133713|NCT01352507|366148169|FG000|Treatment Period 2|Lack of Efficacy|1|||
106133714|NCT01352507|366148170|FG001|Treatment Period 2|Lack of Efficacy|0|||
106133715|NCT02365298|366148171|FG000|Period 2|incorrect Rx dispensed|1|||
106133716|NCT02365298|366148172|FG001|Period 2|incorrect Rx dispensed|0|||
106133717|NCT02365298|366148171|FG000|Period 2|Discontinued at request of Sponsor|1|||
106133718|NCT02365298|366148172|FG001|Period 2|Discontinued at request of Sponsor|0|||
106133719|NCT02365298|366148171|FG000|Period 2|Test Article longer available|0|||
106133720|NCT02365298|366148172|FG001|Period 2|Test Article longer available|1|||
105703589|NCT02018822|364578432|FG001|Overall Study|filling replaced by crown|1|||
105703590|NCT02018822|364578433|FG002|Overall Study|filling replaced by crown|0|||
105703591|NCT02018822|364578431|FG000|Overall Study|Physician Decision|0|||
105703592|NCT02018822|364578432|FG001|Overall Study|Physician Decision|1|||
105703593|NCT02018822|364578433|FG002|Overall Study|Physician Decision|1|||
105703594|NCT02018822|364578431|FG000|Overall Study|Lost to Follow-up|6|||
105703595|NCT02018822|364578432|FG001|Overall Study|Lost to Follow-up|6|||
105703596|NCT02018822|364578433|FG002|Overall Study|Lost to Follow-up|5|||
105703597|NCT03699007|364578444|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
105703598|NCT03699007|364578445|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
105703599|NCT03699007|364578444|FG000|6-month Follow Up|Lost to Follow-up|2|||
105703600|NCT03699007|364578445|FG001|6-month Follow Up|Lost to Follow-up|3|||
105703601|NCT04081363|364578446|FG000|Overall Study|Withdrawal by Subject|1|||
105703602|NCT04081363|364578447|FG001|Overall Study|Withdrawal by Subject|0|||
105703603|NCT04251910|364578449|FG000|Overall Study|Covid 19 lockdown|0|||
105703604|NCT04251910|364578450|FG001|Overall Study|Covid 19 lockdown|5|||
105703605|NCT04251910|364578451|FG002|Overall Study|Covid 19 lockdown|0|||
105703606|NCT04251910|364578452|FG003|Overall Study|Covid 19 lockdown|4|||
105703607|NCT04251910|364578453|FG004|Overall Study|Covid 19 lockdown|0|||
105703608|NCT04251910|364578454|FG005|Overall Study|Covid 19 lockdown|0|||
105703609|NCT04251910|364578449|FG000|Overall Study|Assisted living facility was closed|0|||
105703610|NCT04251910|364578450|FG001|Overall Study|Assisted living facility was closed|0|||
105703611|NCT04251910|364578451|FG002|Overall Study|Assisted living facility was closed|0|||
106006628|NCT02559622|365688291|FG001|Overall Study|Adverse Event|2|||
106006629|NCT02559622|365688292|FG002|Overall Study|Adverse Event|2|||
106006630|NCT02559622|365688293|FG003|Overall Study|Adverse Event|2|||
106006631|NCT02559622|365688290|FG000|Overall Study|Patient/guardian decision|1|||
106006632|NCT02559622|365688291|FG001|Overall Study|Patient/guardian decision|2|||
106006633|NCT02559622|365688292|FG002|Overall Study|Patient/guardian decision|0|||
106006634|NCT02559622|365688293|FG003|Overall Study|Patient/guardian decision|1|||
106006635|NCT00231816|365688296|FG000|Overall Study|Adverse Event|1|||
106006636|NCT00231816|365688297|FG001|Overall Study|Adverse Event|0|||
106006637|NCT00231816|365688296|FG000|Overall Study|Lost to Follow-up|8|||
106006638|NCT00231816|365688297|FG001|Overall Study|Lost to Follow-up|5|||
106006639|NCT00231816|365688296|FG000|Overall Study|Protocol Violation|2|||
106006640|NCT00231816|365688297|FG001|Overall Study|Protocol Violation|3|||
106006641|NCT00231816|365688296|FG000|Overall Study|Withdrawal by Subject|3|||
106006642|NCT00231816|365688297|FG001|Overall Study|Withdrawal by Subject|3|||
106006643|NCT00231816|365688296|FG000|Overall Study|Other|2|||
106006644|NCT00231816|365688297|FG001|Overall Study|Other|1|||
106006645|NCT03341299|365688299|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
105703612|NCT04251910|364578452|FG003|Overall Study|Assisted living facility was closed|0|||
105703613|NCT04251910|364578453|FG004|Overall Study|Assisted living facility was closed|1|||
105703614|NCT04251910|364578454|FG005|Overall Study|Assisted living facility was closed|0|||
105703615|NCT02184195|364578457|FG000|Overall Study|Patient decision|5|||
105703616|NCT02184195|364578458|FG001|Overall Study|Patient decision|2|||
106006646|NCT03341299|365688300|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
106006647|NCT03341299|365688301|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
106006648|NCT03341299|365688302|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
106133721|NCT02365298|366148171|FG000|Period 2|Protocol Violation|0|||
106133722|NCT02365298|366148172|FG001|Period 2|Protocol Violation|1|||
106006649|NCT03009058|365688305|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
106006650|NCT02234843|365688311|FG000|Overall Study|Death|1|||
106006651|NCT02234843|365688312|FG001|Overall Study|Death|0|||
106006652|NCT02234843|365688313|FG002|Overall Study|Death|0|||
106006653|NCT02234843|365688314|FG003|Overall Study|Death|0|||
106006654|NCT02234843|365688315|FG004|Overall Study|Death|0|||
106006655|NCT02234843|365688316|FG005|Overall Study|Death|0|||
106006656|NCT02234843|365688317|FG006|Overall Study|Death|0|||
106006657|NCT02234843|365688318|FG007|Overall Study|Death|0|||
106006658|NCT02234843|365688319|FG008|Overall Study|Death|0|||
106006659|NCT02234843|365688320|FG009|Overall Study|Death|0|||
106006660|NCT02234843|365688311|FG000|Overall Study|Protocol Violation|1|||
106006661|NCT02234843|365688312|FG001|Overall Study|Protocol Violation|0|||
106006662|NCT02234843|365688313|FG002|Overall Study|Protocol Violation|1|||
106006663|NCT02234843|365688314|FG003|Overall Study|Protocol Violation|0|||
106006664|NCT02234843|365688315|FG004|Overall Study|Protocol Violation|0|||
106006665|NCT02234843|365688316|FG005|Overall Study|Protocol Violation|0|||
106006666|NCT02234843|365688317|FG006|Overall Study|Protocol Violation|0|||
106006667|NCT02234843|365688318|FG007|Overall Study|Protocol Violation|0|||
106006668|NCT02234843|365688319|FG008|Overall Study|Protocol Violation|0|||
106006669|NCT02234843|365688320|FG009|Overall Study|Protocol Violation|0|||
106006670|NCT02234843|365688311|FG000|Overall Study|Efficacy outcome reached|2|||
106006671|NCT02234843|365688312|FG001|Overall Study|Efficacy outcome reached|0|||
106006672|NCT02234843|365688313|FG002|Overall Study|Efficacy outcome reached|0|||
106006673|NCT02234843|365688314|FG003|Overall Study|Efficacy outcome reached|0|||
106006674|NCT02234843|365688315|FG004|Overall Study|Efficacy outcome reached|0|||
106006675|NCT02234843|365688316|FG005|Overall Study|Efficacy outcome reached|2|||
106006676|NCT02234843|365688317|FG006|Overall Study|Efficacy outcome reached|0|||
106006677|NCT02234843|365688318|FG007|Overall Study|Efficacy outcome reached|0|||
106006678|NCT02234843|365688319|FG008|Overall Study|Efficacy outcome reached|0|||
106006679|NCT02234843|365688320|FG009|Overall Study|Efficacy outcome reached|0|||
106006680|NCT02234843|365688311|FG000|Overall Study|Patient convenience|2|||
106006681|NCT02234843|365688312|FG001|Overall Study|Patient convenience|0|||
106006682|NCT02234843|365688313|FG002|Overall Study|Patient convenience|0|||
106006683|NCT02234843|365688314|FG003|Overall Study|Patient convenience|0|||
106006684|NCT02234843|365688315|FG004|Overall Study|Patient convenience|0|||
106006685|NCT02234843|365688316|FG005|Overall Study|Patient convenience|1|||
106006686|NCT02234843|365688317|FG006|Overall Study|Patient convenience|0|||
106006687|NCT02234843|365688318|FG007|Overall Study|Patient convenience|0|||
106006688|NCT02234843|365688319|FG008|Overall Study|Patient convenience|0|||
106006689|NCT02234843|365688320|FG009|Overall Study|Patient convenience|0|||
106006690|NCT02234843|365688311|FG000|Overall Study|Withdrawal by Subject|5|||
106006691|NCT02234843|365688312|FG001|Overall Study|Withdrawal by Subject|1|||
106006692|NCT02234843|365688313|FG002|Overall Study|Withdrawal by Subject|1|||
106006693|NCT02234843|365688314|FG003|Overall Study|Withdrawal by Subject|0|||
106006694|NCT02234843|365688315|FG004|Overall Study|Withdrawal by Subject|0|||
106006695|NCT02234843|365688316|FG005|Overall Study|Withdrawal by Subject|7|||
106006696|NCT02234843|365688317|FG006|Overall Study|Withdrawal by Subject|0|||
106006697|NCT02234843|365688318|FG007|Overall Study|Withdrawal by Subject|0|||
106006698|NCT02234843|365688319|FG008|Overall Study|Withdrawal by Subject|0|||
106006699|NCT02234843|365688320|FG009|Overall Study|Withdrawal by Subject|0|||
106006700|NCT02234843|365688311|FG000|Overall Study|Recovery|1|||
106006701|NCT02234843|365688312|FG001|Overall Study|Recovery|0|||
106006702|NCT02234843|365688313|FG002|Overall Study|Recovery|0|||
106006703|NCT02234843|365688314|FG003|Overall Study|Recovery|0|||
106006704|NCT02234843|365688315|FG004|Overall Study|Recovery|0|||
106006705|NCT02234843|365688316|FG005|Overall Study|Recovery|0|||
106006706|NCT02234843|365688317|FG006|Overall Study|Recovery|0|||
106006707|NCT02234843|365688318|FG007|Overall Study|Recovery|0|||
106133723|NCT01763047|366148175|FG000|Period 1|Test Article Not Available|4|||
106133724|NCT01763047|366148176|FG001|Period 1|Test Article Not Available|1|||
106133725|NCT01763047|366148175|FG000|Period 1|Protocol Violation|4|||
105926375|NCT01303419|365389830|FG000|Overall Study|Discontinuation of study|60|||
105926376|NCT01303419|365389830|FG000|Overall Study|Did not complete both imaging methods|5|||
105926377|NCT01303419|365389830|FG000|Overall Study|Did not meet all I/E after screening|31|||
105926378|NCT00303628|365389832|FG000|Overall Study|Disease progression|0|||
105926379|NCT00303628|365389833|FG001|Overall Study|Disease progression|1|||
105926380|NCT00303628|365389832|FG000|Overall Study|Adverse Event|26|||
105926381|NCT00303628|365389833|FG001|Overall Study|Adverse Event|36|||
105926382|NCT00303628|365389832|FG000|Overall Study|Death|0|||
105926383|NCT00303628|365389833|FG001|Overall Study|Death|1|||
105926384|NCT00303628|365389832|FG000|Overall Study|Withdrawal by Subject|11|||
105926385|NCT00303628|365389833|FG001|Overall Study|Withdrawal by Subject|20|||
105926386|NCT00303628|365389832|FG000|Overall Study|Alternative therapy|2|||
105926387|NCT00303628|365389833|FG001|Overall Study|Alternative therapy|0|||
106006708|NCT02234843|365688319|FG008|Overall Study|Recovery|0|||
106006709|NCT02234843|365688320|FG009|Overall Study|Recovery|0|||
106006710|NCT02234843|365688311|FG000|Overall Study|Other|0|||
106006711|NCT02234843|365688312|FG001|Overall Study|Other|2|||
106006712|NCT02234843|365688313|FG002|Overall Study|Other|0|||
105703617|NCT02184195|364578457|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105703618|NCT02184195|364578458|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105703619|NCT02184195|364578457|FG000|Overall Study|Death|67|||
105703620|NCT02184195|364578458|FG001|Overall Study|Death|44|||
105703621|NCT02184195|364578457|FG000|Overall Study|Lost to Follow-up|1|||
105703622|NCT02184195|364578458|FG001|Overall Study|Lost to Follow-up|5|||
105703623|NCT02184195|364578457|FG000|Overall Study|Other|0|||
105703624|NCT02184195|364578458|FG001|Overall Study|Other|3|||
105703625|NCT00290342|364578459|FG000|Overall Study|Other|0|||
105703626|NCT00290342|364578460|FG001|Overall Study|Other|1|||
105703627|NCT00290342|364578459|FG000|Overall Study|Withdrawal by Subject|6|||
105703628|NCT00290342|364578460|FG001|Overall Study|Withdrawal by Subject|4|||
105703629|NCT00290342|364578459|FG000|Overall Study|Lost to Follow-up|1|||
105703630|NCT00290342|364578460|FG001|Overall Study|Lost to Follow-up|0|||
105703631|NCT00978029|364578466|FG000|Overall Study|Adverse Event|1|||
105703632|NCT00978029|364578467|FG001|Overall Study|Adverse Event|2|||
105703633|NCT00978029|364578468|FG002|Overall Study|Adverse Event|5|||
105703634|NCT00978029|364578466|FG000|Overall Study|Withdrawal by Subject|0|||
105703635|NCT00978029|364578467|FG001|Overall Study|Withdrawal by Subject|0|||
105703636|NCT00978029|364578468|FG002|Overall Study|Withdrawal by Subject|1|||
105703637|NCT00978029|364578466|FG000|Overall Study|Protocol Violation|0|||
105703638|NCT00978029|364578467|FG001|Overall Study|Protocol Violation|1|||
105703639|NCT00978029|364578468|FG002|Overall Study|Protocol Violation|0|||
105703640|NCT02121262|364578469|FG000|Overall Study|Adverse Event|6|||
105703641|NCT02121262|364578470|FG001|Overall Study|Adverse Event|3|||
105703642|NCT02121262|364578469|FG000|Overall Study|Lack of Efficacy|3|||
105703643|NCT02121262|364578470|FG001|Overall Study|Lack of Efficacy|0|||
105703644|NCT02121262|364578469|FG000|Overall Study|Personal Reasons|19|||
105703645|NCT02121262|364578470|FG001|Overall Study|Personal Reasons|5|||
105703646|NCT02121262|364578469|FG000|Overall Study|Protocol Violation|1|||
105703647|NCT02121262|364578470|FG001|Overall Study|Protocol Violation|1|||
105703648|NCT02121262|364578469|FG000|Overall Study|Participant Dropped-out|0|||
105703649|NCT02121262|364578470|FG001|Overall Study|Participant Dropped-out|1|||
105703650|NCT02121262|364578469|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
105703651|NCT02121262|364578470|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
105703652|NCT02121262|364578469|FG000|Overall Study|Consent Withdrawn|1|||
105703653|NCT02121262|364578470|FG001|Overall Study|Consent Withdrawn|0|||
105703654|NCT02829138|364578471|FG000|Overall Study|Withdrawal by Subject|1|||
105703655|NCT02829138|364578472|FG001|Overall Study|Withdrawal by Subject|0|||
105703656|NCT01394627|364578473|FG000|First Intervention (1 Day)|poor intravenous access|0|||
105703657|NCT01394627|364578474|FG001|First Intervention (1 Day)|poor intravenous access|1|||
105703658|NCT01394627|364578473|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
105703659|NCT01394627|364578474|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
105787356|NCT01243762|364874939|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
105787357|NCT01243762|364874940|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105703660|NCT00777101|364578478|FG000|Overall Study|Death|48|||
105703661|NCT00777101|364578479|FG001|Overall Study|Death|43|||
105703662|NCT00777101|364578478|FG000|Overall Study|Withdrawal by Subject|11|||
105703663|NCT00777101|364578479|FG001|Overall Study|Withdrawal by Subject|6|||
105703664|NCT00777101|364578478|FG000|Overall Study|Lost to Follow-up|2|||
105703665|NCT00777101|364578479|FG001|Overall Study|Lost to Follow-up|1|||
105703666|NCT00777101|364578478|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
105703667|NCT00777101|364578479|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105703668|NCT00777101|364578478|FG000|Overall Study|Failed to Return|0|||
105703669|NCT00777101|364578479|FG001|Overall Study|Failed to Return|1|||
105703670|NCT02411539|364578482|FG000|Overall Study|Lost to Follow-up|2|||
105703671|NCT02411539|364578483|FG001|Overall Study|Lost to Follow-up|0|||
105703672|NCT02411539|364578482|FG000|Overall Study|Confounding medical condition|0|||
105703673|NCT02411539|364578483|FG001|Overall Study|Confounding medical condition|1|||
105703674|NCT01347554|364578484|FG000|Overall Study|Lack of Efficacy|7|||
105703675|NCT01347554|364578485|FG001|Overall Study|Lack of Efficacy|11|||
105703676|NCT00886600|364578486|FG000|Double-blind Monotherapy|Adverse Event|1|||
105703677|NCT00886600|364578487|FG001|Double-blind Monotherapy|Adverse Event|1|||
105703678|NCT00886600|364578488|FG002|Double-blind Monotherapy|Adverse Event|1|||
105703679|NCT00886600|364578489|FG003|Double-blind Monotherapy|Adverse Event|1|||
105703680|NCT00886600|364578486|FG000|Double-blind Monotherapy|Protocol Violation|0|||
105703681|NCT00886600|364578487|FG001|Double-blind Monotherapy|Protocol Violation|0|||
105703682|NCT00886600|364578488|FG002|Double-blind Monotherapy|Protocol Violation|0|||
105703683|NCT00886600|364578489|FG003|Double-blind Monotherapy|Protocol Violation|1|||
105703684|NCT00886600|364578486|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
105703685|NCT00886600|364578487|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
105703686|NCT00886600|364578488|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
105703687|NCT00886600|364578489|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
105703688|NCT00886600|364578486|FG000|Combination Therapy Period|Adverse Event|0|||
105703689|NCT00886600|364578487|FG001|Combination Therapy Period|Adverse Event|0|||
105703690|NCT00886600|364578488|FG002|Combination Therapy Period|Adverse Event|1|||
106006713|NCT02234843|365688314|FG003|Overall Study|Other|1|||
106006714|NCT02234843|365688315|FG004|Overall Study|Other|0|||
106006715|NCT02234843|365688316|FG005|Overall Study|Other|1|||
106006716|NCT02234843|365688317|FG006|Overall Study|Other|0|||
106006717|NCT02234843|365688318|FG007|Overall Study|Other|1|||
105703691|NCT00886600|364578489|FG003|Combination Therapy Period|Adverse Event|0|||
105703692|NCT00886600|364578486|FG000|Combination Therapy Period|Protocol Violation|0|||
105703693|NCT00886600|364578487|FG001|Combination Therapy Period|Protocol Violation|0|||
105703694|NCT00886600|364578488|FG002|Combination Therapy Period|Protocol Violation|1|||
105703695|NCT00886600|364578489|FG003|Combination Therapy Period|Protocol Violation|0|||
105703696|NCT04288154|364578490|FG000|Overall Study|Withdrawal by Subject|9|||
105703697|NCT04288154|364578491|FG001|Overall Study|Withdrawal by Subject|9|||
105703698|NCT01251367|364578492|FG000|Overall Study|Protocol Violation|1|||
105703699|NCT01251367|364578492|FG000|Overall Study|Lack of Efficacy|2|||
105703700|NCT01251367|364578492|FG000|Overall Study|Adverse Event|19|||
105703701|NCT01251367|364578492|FG000|Overall Study|Withdrawal by Subject|36|||
105926388|NCT00303628|365389832|FG000|Overall Study|Other complicating disease|0|||
105926389|NCT00303628|365389833|FG001|Overall Study|Other complicating disease|1|||
105926390|NCT00303628|365389832|FG000|Overall Study|Not start protocol therapy|3|||
105926391|NCT00303628|365389833|FG001|Overall Study|Not start protocol therapy|5|||
105926392|NCT00303628|365389832|FG000|Overall Study|Other|8|||
105926393|NCT00303628|365389833|FG001|Overall Study|Other|9|||
105926394|NCT00376506|365389834|FG000|Overall Study|Death|0|||
105926395|NCT00376506|365389835|FG001|Overall Study|Death|2|||
105926396|NCT02452190|365389839|FG000|Overall Study|Withdrawal by Sponsor|1|||
105926397|NCT02452190|365389840|FG001|Overall Study|Withdrawal by Sponsor|3|||
105926398|NCT02452190|365389839|FG000|Overall Study|Pregnancy|1|||
105926399|NCT02452190|365389840|FG001|Overall Study|Pregnancy|0|||
105926400|NCT02452190|365389839|FG000|Overall Study|Investigator's Decision|2|||
105926401|NCT02452190|365389840|FG001|Overall Study|Investigator's Decision|0|||
105926402|NCT02452190|365389839|FG000|Overall Study|Lack of Efficacy|3|||
105926403|NCT02452190|365389840|FG001|Overall Study|Lack of Efficacy|1|||
105926404|NCT02452190|365389839|FG000|Overall Study|Lost to Follow-up|4|||
105926405|NCT02452190|365389840|FG001|Overall Study|Lost to Follow-up|3|||
105926406|NCT02452190|365389839|FG000|Overall Study|Adverse Event|2|||
105926407|NCT02452190|365389840|FG001|Overall Study|Adverse Event|5|||
105926408|NCT02452190|365389839|FG000|Overall Study|Withdrawal by Subject|20|||
105926409|NCT02452190|365389840|FG001|Overall Study|Withdrawal by Subject|11|||
105926410|NCT02452190|365389839|FG000|Overall Study|Noncompliance with study drug|1|||
105926411|NCT02452190|365389840|FG001|Overall Study|Noncompliance with study drug|0|||
105926412|NCT02452190|365389839|FG000|Overall Study|Participant traveled abroad|1|||
105926413|NCT02452190|365389840|FG001|Overall Study|Participant traveled abroad|0|||
105926414|NCT02452190|365389839|FG000|Overall Study|Death|0|||
105926415|NCT02452190|365389840|FG001|Overall Study|Death|1|||
105926416|NCT02948400|365389841|FG000|Overall Study|Withdrawal by Subject|17|||
105926417|NCT02948400|365389842|FG001|Overall Study|Withdrawal by Subject|10|||
105926418|NCT02948400|365389841|FG000|Overall Study|failed to attend appointments|47|||
105926419|NCT02948400|365389842|FG001|Overall Study|failed to attend appointments|34|||
105926420|NCT02948400|365389841|FG000|Overall Study|COVID-related closure|6|||
105926421|NCT02948400|365389842|FG001|Overall Study|COVID-related closure|2|||
105926422|NCT02948400|365389841|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
105926423|NCT02948400|365389842|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
105926424|NCT02948400|365389841|FG000|Overall Study|motion sickness in virtual reality|2|||
105926425|NCT02948400|365389842|FG001|Overall Study|motion sickness in virtual reality|0|||
105926426|NCT02403271|365389843|FG000|Period 1|Other varied reasons|1|||
105926427|NCT02403271|365389844|FG001|Period 1|Other varied reasons|0|||
105926428|NCT02403271|365389843|FG000|Period 2|Withdrawal by Subject|0|||
105926429|NCT02403271|365389844|FG001|Period 2|Withdrawal by Subject|14|||
105926430|NCT02403271|365389843|FG000|Period 2|Death|0|||
105926431|NCT02403271|365389844|FG001|Period 2|Death|84|||
105926432|NCT02403271|365389843|FG000|Period 2|Lost to Follow-up|0|||
105926433|NCT02403271|365389844|FG001|Period 2|Lost to Follow-up|2|||
105926434|NCT02403271|365389843|FG000|Period 2|Study Terminated by Sponsor|0|||
105926435|NCT02403271|365389844|FG001|Period 2|Study Terminated by Sponsor|14|||
105926436|NCT02403271|365389843|FG000|Period 2|Other varied reasons|0|||
106006718|NCT02234843|365688319|FG008|Overall Study|Other|0|||
105703702|NCT01251367|364578492|FG000|Overall Study|Lost to Follow-up|5|||
105926437|NCT02403271|365389844|FG001|Period 2|Other varied reasons|10|||
105926438|NCT00876343|365389847|FG000|Overall Study|Adverse Event|7|||
105926439|NCT00876343|365389848|FG001|Overall Study|Adverse Event|8|||
105926440|NCT00876343|365389849|FG002|Overall Study|Adverse Event|2|||
105926441|NCT00876343|365389847|FG000|Overall Study|Withdrawal by Subject|4|||
105926442|NCT00876343|365389848|FG001|Overall Study|Withdrawal by Subject|4|||
105926443|NCT00876343|365389849|FG002|Overall Study|Withdrawal by Subject|3|||
105926444|NCT00876343|365389847|FG000|Overall Study|Lack of Efficacy|0|||
105926445|NCT00876343|365389848|FG001|Overall Study|Lack of Efficacy|0|||
105926446|NCT00876343|365389849|FG002|Overall Study|Lack of Efficacy|1|||
106006719|NCT02234843|365688320|FG009|Overall Study|Other|0|||
105703703|NCT01251367|364578492|FG000|Overall Study|Subject Required Alternative Treatment|7|||
105703704|NCT01251367|364578492|FG000|Overall Study|No Study Drug Available|1|||
105703705|NCT01251367|364578492|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
105703706|NCT01251367|364578492|FG000|Overall Study|End of Study Visit Performed in Error|1|||
105703707|NCT00004259|364578494|FG000|Overall Study|Protocol Violation|1|||
105703708|NCT00004259|364578495|FG001|Overall Study|Protocol Violation|2|||
105703709|NCT00004259|364578496|FG002|Overall Study|Protocol Violation|0|||
105703710|NCT00004259|364578497|FG003|Overall Study|Protocol Violation|0|||
105703711|NCT00004259|364578494|FG000|Overall Study|Withdrawal by Subject|0|||
105703712|NCT00004259|364578495|FG001|Overall Study|Withdrawal by Subject|2|||
105703713|NCT00004259|364578496|FG002|Overall Study|Withdrawal by Subject|0|||
105703714|NCT00004259|364578497|FG003|Overall Study|Withdrawal by Subject|0|||
105703715|NCT00135668|364578498|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
105703716|NCT00135668|364578499|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
105703717|NCT00135668|364578500|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
105703718|NCT00135668|364578501|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
105703719|NCT01227044|364578504|FG000|Overall Study|Lost to Follow-up|5|||
105703720|NCT01227044|364578505|FG001|Overall Study|Lost to Follow-up|7|||
105703721|NCT01227044|364578504|FG000|Overall Study|Discontinued Intervention|1|||
105703722|NCT01227044|364578505|FG001|Overall Study|Discontinued Intervention|2|||
105703723|NCT01277549|364578508|FG000|Overall Study|Failed to meet eligibility criteria|13|||
105703724|NCT01277549|364578509|FG001|Overall Study|Failed to meet eligibility criteria|9|||
105703725|NCT01277549|364578508|FG000|Overall Study|Withdrawal by Subject|1|||
105703726|NCT01277549|364578509|FG001|Overall Study|Withdrawal by Subject|3|||
105703727|NCT01277549|364578508|FG000|Overall Study|Protocol Violation|10|||
105703728|NCT01277549|364578509|FG001|Overall Study|Protocol Violation|1|||
105703729|NCT01277549|364578508|FG000|Overall Study|Physician Decision|2|||
105703730|NCT01277549|364578509|FG001|Overall Study|Physician Decision|1|||
105703731|NCT02424253|364578510|FG000|Overall Study|Other, unspecified|1|||
105703732|NCT02424253|364578511|FG001|Overall Study|Other, unspecified|0|||
105703733|NCT02424253|364578510|FG000|Overall Study|Compliance problems|1|||
105703734|NCT02424253|364578511|FG001|Overall Study|Compliance problems|0|||
105703735|NCT02424253|364578510|FG000|Overall Study|Physician Decision|2|||
105703736|NCT02424253|364578511|FG001|Overall Study|Physician Decision|0|||
105703737|NCT02424253|364578510|FG000|Overall Study|Lack of Efficacy|0|||
105703738|NCT02424253|364578511|FG001|Overall Study|Lack of Efficacy|7|||
105703739|NCT02424253|364578510|FG000|Overall Study|Adverse Event|2|||
105703740|NCT02424253|364578511|FG001|Overall Study|Adverse Event|0|||
105703741|NCT02424253|364578510|FG000|Overall Study|Consent withdrawn by subject|4|||
105703742|NCT02424253|364578511|FG001|Overall Study|Consent withdrawn by subject|1|||
105703743|NCT02424253|364578510|FG000|Overall Study|Lost to Follow-up|1|||
105703744|NCT02424253|364578511|FG001|Overall Study|Lost to Follow-up|1|||
105703745|NCT00473343|364578512|FG000|Overall Study|Adverse Event|9|||
105703746|NCT00473343|364578512|FG000|Overall Study|Lost to Follow-up|8|||
105703747|NCT00473343|364578512|FG000|Overall Study|Treatment failure|27|||
105703748|NCT00473343|364578512|FG000|Overall Study|Withdrew consent|3|||
105703749|NCT00473343|364578512|FG000|Overall Study|Other un-specified reason|3|||
105703750|NCT02290873|364578523|FG000|Overall Study|Withdrawal by Subject|0|||
105703751|NCT02290873|364578524|FG001|Overall Study|Withdrawal by Subject|1|||
105703752|NCT02290873|364578525|FG002|Overall Study|Withdrawal by Subject|1|||
105703753|NCT02290873|364578523|FG000|Overall Study|Nellcor device error|1|||
105703754|NCT02290873|364578524|FG001|Overall Study|Nellcor device error|0|||
105703755|NCT02290873|364578525|FG002|Overall Study|Nellcor device error|0|||
105703756|NCT02290873|364578523|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
105703757|NCT02290873|364578524|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
105703758|NCT02290873|364578525|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
105703759|NCT02290873|364578523|FG000|Overall Study|Protocol Violation|0|||
105703760|NCT02290873|364578524|FG001|Overall Study|Protocol Violation|0|||
105703761|NCT02290873|364578525|FG002|Overall Study|Protocol Violation|1|||
105703762|NCT02287623|364578529|FG000|Overall Study|Protocol Violation|0|||
105703763|NCT02287623|364578530|FG001|Overall Study|Protocol Violation|1|||
105703764|NCT03891264|364578531|FG000|Overall Study|Adverse Event|1|||
105703765|NCT03891264|364578531|FG000|Overall Study|Withdrawal by Subject|2|||
105703766|NCT03891264|364578531|FG000|Overall Study|Physician Decision|2|||
105703767|NCT01970501|364578532|FG000|Overall Study|Discontinuation of study by sponsor|16|||
105703768|NCT01970501|364578533|FG001|Overall Study|Discontinuation of study by sponsor|14|||
105703769|NCT01970501|364578532|FG000|Overall Study|Withdrawal by Subject|6|||
105703770|NCT01970501|364578533|FG001|Overall Study|Withdrawal by Subject|7|||
105703771|NCT01970501|364578532|FG000|Overall Study|Adverse Event|2|||
105703772|NCT01970501|364578533|FG001|Overall Study|Adverse Event|4|||
105703773|NCT01970501|364578532|FG000|Overall Study|Death|1|||
105703774|NCT01970501|364578533|FG001|Overall Study|Death|3|||
105703775|NCT01970501|364578532|FG000|Overall Study|Physician Decision|2|||
105703776|NCT01970501|364578533|FG001|Overall Study|Physician Decision|0|||
105703777|NCT00794157|364578534|FG000|Overall Study|Adverse Event|4|||
105703778|NCT00794157|364578535|FG001|Overall Study|Adverse Event|1|||
106006720|NCT02234843|365688311|FG000|Overall Study|Physician Decision|4|||
106006721|NCT02234843|365688312|FG001|Overall Study|Physician Decision|1|||
106006722|NCT02234843|365688313|FG002|Overall Study|Physician Decision|0|||
106006723|NCT02234843|365688314|FG003|Overall Study|Physician Decision|1|||
106006724|NCT02234843|365688315|FG004|Overall Study|Physician Decision|0|||
106006725|NCT02234843|365688316|FG005|Overall Study|Physician Decision|0|||
106006726|NCT02234843|365688317|FG006|Overall Study|Physician Decision|0|||
106006727|NCT02234843|365688318|FG007|Overall Study|Physician Decision|1|||
106006728|NCT02234843|365688319|FG008|Overall Study|Physician Decision|0|||
106006729|NCT02234843|365688320|FG009|Overall Study|Physician Decision|0|||
106006730|NCT02234843|365688311|FG000|Overall Study|Adverse Event|5|||
106006731|NCT02234843|365688312|FG001|Overall Study|Adverse Event|1|||
106006732|NCT02234843|365688313|FG002|Overall Study|Adverse Event|1|||
106006733|NCT02234843|365688314|FG003|Overall Study|Adverse Event|3|||
106006734|NCT02234843|365688315|FG004|Overall Study|Adverse Event|2|||
106006735|NCT02234843|365688316|FG005|Overall Study|Adverse Event|1|||
106006736|NCT02234843|365688317|FG006|Overall Study|Adverse Event|0|||
106006737|NCT02234843|365688318|FG007|Overall Study|Adverse Event|0|||
106006738|NCT02234843|365688319|FG008|Overall Study|Adverse Event|1|||
106006739|NCT02234843|365688320|FG009|Overall Study|Adverse Event|0|||
106006740|NCT02234843|365688311|FG000|Overall Study|Non-compliance with study drug|1|||
106006741|NCT02234843|365688312|FG001|Overall Study|Non-compliance with study drug|0|||
106006742|NCT02234843|365688313|FG002|Overall Study|Non-compliance with study drug|0|||
106006743|NCT02234843|365688314|FG003|Overall Study|Non-compliance with study drug|0|||
106006744|NCT02234843|365688315|FG004|Overall Study|Non-compliance with study drug|0|||
106006745|NCT02234843|365688316|FG005|Overall Study|Non-compliance with study drug|1|||
106006746|NCT02234843|365688317|FG006|Overall Study|Non-compliance with study drug|1|||
106006747|NCT02234843|365688318|FG007|Overall Study|Non-compliance with study drug|0|||
106006748|NCT02234843|365688319|FG008|Overall Study|Non-compliance with study drug|0|||
106006749|NCT02234843|365688320|FG009|Overall Study|Non-compliance with study drug|0|||
106006750|NCT02234843|365688311|FG000|Overall Study|Lost to Follow-up|0|||
106006751|NCT02234843|365688312|FG001|Overall Study|Lost to Follow-up|1|||
106006752|NCT02234843|365688313|FG002|Overall Study|Lost to Follow-up|0|||
106006753|NCT02234843|365688314|FG003|Overall Study|Lost to Follow-up|0|||
106006754|NCT02234843|365688315|FG004|Overall Study|Lost to Follow-up|0|||
106006755|NCT02234843|365688316|FG005|Overall Study|Lost to Follow-up|0|||
106006756|NCT02234843|365688317|FG006|Overall Study|Lost to Follow-up|1|||
105703779|NCT00794157|364578536|FG002|Overall Study|Adverse Event|8|||
105703780|NCT00794157|364578534|FG000|Overall Study|Subject withdrew consent|2|||
105703781|NCT00794157|364578535|FG001|Overall Study|Subject withdrew consent|0|||
105703782|NCT00794157|364578536|FG002|Overall Study|Subject withdrew consent|3|||
105703783|NCT00794157|364578534|FG000|Overall Study|Lost to Follow-up|2|||
105703784|NCT00794157|364578535|FG001|Overall Study|Lost to Follow-up|0|||
105703785|NCT00794157|364578536|FG002|Overall Study|Lost to Follow-up|1|||
105703786|NCT00794157|364578534|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105703787|NCT00794157|364578535|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105703788|NCT00794157|364578536|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105703789|NCT00794157|364578534|FG000|Overall Study|Administrative problems|1|||
105703790|NCT00794157|364578535|FG001|Overall Study|Administrative problems|7|||
105703791|NCT00794157|364578536|FG002|Overall Study|Administrative problems|4|||
105703792|NCT00794157|364578534|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105703793|NCT00794157|364578535|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105703794|NCT00794157|364578536|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105703795|NCT00794157|364578534|FG000|Overall Study|Protocol deviation|0|||
105703796|NCT00794157|364578535|FG001|Overall Study|Protocol deviation|1|||
105703797|NCT00794157|364578536|FG002|Overall Study|Protocol deviation|1|||
105703798|NCT01692275|364578537|FG000|Overall Study|Lost to Follow-up|57|||
105703799|NCT01692275|364578538|FG001|Overall Study|Lost to Follow-up|48|||
105703800|NCT01692275|364578537|FG000|Overall Study|Withdrawal by Subject|9|||
105703801|NCT01692275|364578538|FG001|Overall Study|Withdrawal by Subject|11|||
105703802|NCT00708123|364578540|FG000|Period 1|Protocol Violation|0|||
105703803|NCT00708123|364578541|FG001|Period 1|Protocol Violation|1|||
106006757|NCT02234843|365688318|FG007|Overall Study|Lost to Follow-up|0|||
106006758|NCT02234843|365688319|FG008|Overall Study|Lost to Follow-up|0|||
106006759|NCT02234843|365688320|FG009|Overall Study|Lost to Follow-up|0|||
106006760|NCT01691794|365688321|FG000|Overall Study|Poor/Non-Compliance|1|||
106006761|NCT01691794|365688322|FG001|Overall Study|Poor/Non-Compliance|4|||
106006762|NCT01691794|365688323|FG002|Overall Study|Poor/Non-Compliance|1|||
105703804|NCT00708123|364578542|FG002|Period 1|Protocol Violation|0|||
105703805|NCT00708123|364578543|FG003|Period 1|Protocol Violation|1|||
105703806|NCT00708123|364578544|FG004|Period 1|Protocol Violation|0|||
105703807|NCT00708123|364578540|FG000|Period 1|Adverse Event|0|||
105703808|NCT00708123|364578541|FG001|Period 1|Adverse Event|0|||
106006763|NCT01691794|365688321|FG000|Overall Study|Death|0|||
106006764|NCT01691794|365688322|FG001|Overall Study|Death|0|||
106006765|NCT01691794|365688323|FG002|Overall Study|Death|1|||
106006766|NCT01691794|365688321|FG000|Overall Study|Lack of Efficacy|0|||
106006767|NCT01691794|365688322|FG001|Overall Study|Lack of Efficacy|7|||
106133726|NCT01763047|366148176|FG001|Period 1|Protocol Violation|4|||
106133727|NCT01763047|366148175|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
106133728|NCT01763047|366148176|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
106133729|NCT01763047|366148175|FG000|Period 1|Adverse Event|0|||
106133730|NCT01763047|366148176|FG001|Period 1|Adverse Event|1|||
105703809|NCT00708123|364578542|FG002|Period 1|Adverse Event|1|||
105703810|NCT00708123|364578543|FG003|Period 1|Adverse Event|0|||
105703811|NCT00708123|364578544|FG004|Period 1|Adverse Event|0|||
105703812|NCT00708123|364578540|FG000|Period 2|Protocol Violation|0|||
105703813|NCT00708123|364578541|FG001|Period 2|Protocol Violation|0|||
105703814|NCT00708123|364578542|FG002|Period 2|Protocol Violation|0|||
105703815|NCT00708123|364578543|FG003|Period 2|Protocol Violation|1|||
105703816|NCT00708123|364578544|FG004|Period 2|Protocol Violation|0|||
105703817|NCT00708123|364578540|FG000|Period 2|Other Reason|1|||
105703818|NCT00708123|364578541|FG001|Period 2|Other Reason|0|||
105703819|NCT00708123|364578542|FG002|Period 2|Other Reason|0|||
105703820|NCT00708123|364578543|FG003|Period 2|Other Reason|0|||
105703821|NCT00708123|364578544|FG004|Period 2|Other Reason|0|||
105703822|NCT00708123|364578540|FG000|Period 3|Lost to Follow-up|0|||
105703823|NCT00708123|364578541|FG001|Period 3|Lost to Follow-up|0|||
105703824|NCT00708123|364578542|FG002|Period 3|Lost to Follow-up|1|||
105703825|NCT00708123|364578543|FG003|Period 3|Lost to Follow-up|1|||
105703826|NCT00708123|364578544|FG004|Period 3|Lost to Follow-up|0|||
105703827|NCT00708123|364578540|FG000|Period 4|Protocol Violation|0|||
105703828|NCT00708123|364578541|FG001|Period 4|Protocol Violation|1|||
105703829|NCT00708123|364578542|FG002|Period 4|Protocol Violation|0|||
105703830|NCT00708123|364578543|FG003|Period 4|Protocol Violation|0|||
105703831|NCT00708123|364578544|FG004|Period 4|Protocol Violation|0|||
105703832|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Adverse Event|2|||
105703833|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Adverse Event|0|||
105703834|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Adverse Event|1|||
105703835|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Adverse Event|1|||
105703836|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Other|1|||
105703837|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Other|4|||
105703838|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Other|4|||
105703839|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Other|0|||
105703840|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
105703841|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
105703842|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
105703843|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
105703844|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
105703845|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
105703846|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
105703847|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
105703848|NCT00531752|364578545|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
105703849|NCT00531752|364578546|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
105703850|NCT00531752|364578547|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
105703851|NCT00531752|364578548|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
105703852|NCT00531752|364578545|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
105703853|NCT00531752|364578546|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
105703854|NCT00531752|364578547|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
105703855|NCT00531752|364578548|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
105703856|NCT00531752|364578545|FG000|Second Double-blind Intervention Period|Other|1|||
105703857|NCT00531752|364578546|FG001|Second Double-blind Intervention Period|Other|1|||
105703858|NCT00531752|364578547|FG002|Second Double-blind Intervention Period|Other|0|||
105703859|NCT00531752|364578548|FG003|Second Double-blind Intervention Period|Other|0|||
105703860|NCT00531752|364578545|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
105703861|NCT00531752|364578546|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
105703862|NCT00531752|364578547|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
105703863|NCT00531752|364578548|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
105703864|NCT00531752|364578545|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
106133731|NCT01763047|366148175|FG000|Period 1|Unsatisfactory Visual Response|0|||
106133732|NCT01763047|366148176|FG001|Period 1|Unsatisfactory Visual Response|3|||
105703865|NCT00531752|364578546|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
105703866|NCT00531752|364578547|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
105703867|NCT00531752|364578548|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
105703868|NCT03099187|364578551|FG000|Double-blind Treatment|Adverse Event|19|||
105703869|NCT03099187|364578552|FG001|Double-blind Treatment|Adverse Event|1|||
105703870|NCT03099187|364578553|FG002|Double-blind Treatment|Adverse Event|0|||
105703871|NCT03099187|364578554|FG003|Double-blind Treatment|Adverse Event|0|||
105703872|NCT03099187|364578551|FG000|Double-blind Treatment|Death|1|||
106133733|NCT01763047|366148175|FG000|Period 1|Lens Power Not Available|0|||
105703873|NCT03099187|364578552|FG001|Double-blind Treatment|Death|3|||
105703874|NCT03099187|364578553|FG002|Double-blind Treatment|Death|0|||
105703875|NCT03099187|364578554|FG003|Double-blind Treatment|Death|0|||
105703876|NCT03099187|364578551|FG000|Double-blind Treatment|Lack of Efficacy|1|||
105703877|NCT03099187|364578552|FG001|Double-blind Treatment|Lack of Efficacy|0|||
105703878|NCT03099187|364578553|FG002|Double-blind Treatment|Lack of Efficacy|0|||
105703879|NCT03099187|364578554|FG003|Double-blind Treatment|Lack of Efficacy|0|||
105703880|NCT03099187|364578551|FG000|Double-blind Treatment|Physician Decision|2|||
105703881|NCT03099187|364578552|FG001|Double-blind Treatment|Physician Decision|1|||
105703882|NCT03099187|364578553|FG002|Double-blind Treatment|Physician Decision|0|||
105703883|NCT03099187|364578554|FG003|Double-blind Treatment|Physician Decision|0|||
105703884|NCT03099187|364578551|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
105703885|NCT03099187|364578552|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
105703886|NCT03099187|364578553|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
105926447|NCT00876343|365389847|FG000|Overall Study|Protocol Violation|4|||
105926448|NCT00876343|365389848|FG001|Overall Study|Protocol Violation|1|||
105926449|NCT00876343|365389849|FG002|Overall Study|Protocol Violation|1|||
105926450|NCT00876343|365389847|FG000|Overall Study|Physician Decision|0|||
105926451|NCT00876343|365389848|FG001|Overall Study|Physician Decision|1|||
105926452|NCT00876343|365389849|FG002|Overall Study|Physician Decision|1|||
105926453|NCT00876343|365389847|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
105926454|NCT00876343|365389848|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
105926455|NCT00876343|365389849|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
105926456|NCT00876343|365389847|FG000|Overall Study|Change of residence or other commitments|2|||
105926457|NCT00876343|365389848|FG001|Overall Study|Change of residence or other commitments|2|||
105926458|NCT00876343|365389849|FG002|Overall Study|Change of residence or other commitments|3|||
105926459|NCT02989389|365389850|FG000|Period 1|Lost to Follow-up|0|||
105926460|NCT02989389|365389851|FG001|Period 1|Lost to Follow-up|1|||
105926461|NCT02989389|365389852|FG002|Period 1|Lost to Follow-up|0|||
105926462|NCT02989389|365389853|FG003|Period 1|Lost to Follow-up|0|||
105926463|NCT02989389|365389854|FG004|Period 1|Lost to Follow-up|0|||
105926464|NCT02989389|365389855|FG005|Period 1|Lost to Follow-up|0|||
105926465|NCT02989389|365389856|FG006|Period 1|Lost to Follow-up|0|||
105926466|NCT02989389|365389857|FG007|Period 1|Lost to Follow-up|0|||
105926467|NCT02989389|365389858|FG008|Period 1|Lost to Follow-up|0|||
105926468|NCT02989389|365389859|FG009|Period 1|Lost to Follow-up|0|||
105926469|NCT02989389|365389850|FG000|Period 1|Physician Decision|0|||
105926470|NCT02989389|365389851|FG001|Period 1|Physician Decision|0|||
105926471|NCT02989389|365389852|FG002|Period 1|Physician Decision|0|||
105926472|NCT02989389|365389853|FG003|Period 1|Physician Decision|0|||
105926473|NCT02989389|365389854|FG004|Period 1|Physician Decision|0|||
105926474|NCT02989389|365389855|FG005|Period 1|Physician Decision|0|||
105926475|NCT02989389|365389856|FG006|Period 1|Physician Decision|0|||
105926476|NCT02989389|365389857|FG007|Period 1|Physician Decision|0|||
105926477|NCT02989389|365389858|FG008|Period 1|Physician Decision|1|||
105926478|NCT02989389|365389859|FG009|Period 1|Physician Decision|0|||
105926479|NCT00374868|365389860|FG000|Overall Study|Adverse Event|12|||
105926480|NCT00374868|365389860|FG000|Overall Study|Progressive Disease|7|||
105926481|NCT00374868|365389860|FG000|Overall Study|Physician Decision|13|||
105926482|NCT00374868|365389860|FG000|Overall Study|Lost to Follow-up|1|||
105926483|NCT00374868|365389860|FG000|Overall Study|Death|2|||
105926484|NCT00374868|365389860|FG000|Overall Study|Other - Not Specified|1|||
105926485|NCT04470427|365389861|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
105926486|NCT04470427|365389862|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
105926487|NCT04470427|365389863|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
105926488|NCT04470427|365389864|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
105926489|NCT04470427|365389865|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
105926490|NCT04470427|365389866|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
105926491|NCT04470427|365389861|FG000|Part B :Open-label|Other than specified|0|||
105926492|NCT04470427|365389862|FG001|Part B :Open-label|Other than specified|0|||
105926493|NCT04470427|365389863|FG002|Part B :Open-label|Other than specified|788|||
105926494|NCT04470427|365389864|FG003|Part B :Open-label|Other than specified|0|||
105926495|NCT04470427|365389865|FG004|Part B :Open-label|Other than specified|523|||
105926496|NCT04470427|365389866|FG005|Part B :Open-label|Other than specified|0|||
105926497|NCT04470427|365389861|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
105926498|NCT04470427|365389862|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
105926499|NCT04470427|365389863|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
105703887|NCT03099187|364578554|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
105703888|NCT03099187|364578551|FG000|Double-blind Treatment|Lung transplantation|0|||
105926500|NCT04470427|365389864|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
105926501|NCT04470427|365389865|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
105926502|NCT04470427|365389866|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
105926503|NCT04470427|365389861|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
105926504|NCT04470427|365389862|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
105926505|NCT04470427|365389863|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
106006768|NCT01691794|365688323|FG002|Overall Study|Lack of Efficacy|1|||
106006769|NCT01691794|365688321|FG000|Overall Study|Participant request to discontinue|0|||
105703889|NCT03099187|364578552|FG001|Double-blind Treatment|Lung transplantation|1|||
105703890|NCT03099187|364578553|FG002|Double-blind Treatment|Lung transplantation|0|||
105703891|NCT03099187|364578554|FG003|Double-blind Treatment|Lung transplantation|0|||
105703892|NCT03099187|364578551|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
105703893|NCT03099187|364578552|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
105703894|NCT03099187|364578553|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
105703895|NCT03099187|364578554|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
105703896|NCT03099187|364578551|FG000|Double-blind Treatment|Disease progression|0|||
105703897|NCT03099187|364578552|FG001|Double-blind Treatment|Disease progression|1|||
105703898|NCT03099187|364578553|FG002|Double-blind Treatment|Disease progression|0|||
105703899|NCT03099187|364578554|FG003|Double-blind Treatment|Disease progression|0|||
105703900|NCT03099187|364578551|FG000|Double-blind Treatment|Randomization error|0|||
105703901|NCT03099187|364578552|FG001|Double-blind Treatment|Randomization error|2|||
105703902|NCT03099187|364578553|FG002|Double-blind Treatment|Randomization error|0|||
105703903|NCT03099187|364578554|FG003|Double-blind Treatment|Randomization error|0|||
105703904|NCT03099187|364578551|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
105703905|NCT03099187|364578552|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
105703906|NCT03099187|364578553|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
105703907|NCT03099187|364578554|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
105703908|NCT03099187|364578551|FG000|12-month Safety Follow-up|Adverse Event|0|||
105703909|NCT03099187|364578552|FG001|12-month Safety Follow-up|Adverse Event|0|||
105703910|NCT03099187|364578553|FG002|12-month Safety Follow-up|Adverse Event|5|||
105703911|NCT03099187|364578554|FG003|12-month Safety Follow-up|Adverse Event|12|||
105703912|NCT03099187|364578551|FG000|12-month Safety Follow-up|Death|0|||
105703913|NCT03099187|364578552|FG001|12-month Safety Follow-up|Death|0|||
105703914|NCT03099187|364578553|FG002|12-month Safety Follow-up|Death|7|||
105703915|NCT03099187|364578554|FG003|12-month Safety Follow-up|Death|9|||
105703916|NCT03099187|364578551|FG000|12-month Safety Follow-up|Lung transplantation|0|||
105703917|NCT03099187|364578552|FG001|12-month Safety Follow-up|Lung transplantation|0|||
105703918|NCT03099187|364578553|FG002|12-month Safety Follow-up|Lung transplantation|2|||
105703919|NCT03099187|364578554|FG003|12-month Safety Follow-up|Lung transplantation|1|||
105703920|NCT03099187|364578551|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
105703921|NCT03099187|364578552|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
105703922|NCT03099187|364578553|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
105703923|NCT03099187|364578554|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
105703924|NCT03099187|364578551|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
105703925|NCT03099187|364578552|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
105703926|NCT03099187|364578553|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
105703927|NCT03099187|364578554|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
105703928|NCT03099187|364578551|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
105703929|NCT03099187|364578552|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
105703930|NCT03099187|364578553|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
105703931|NCT03099187|364578554|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
105703932|NCT03099187|364578551|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
105703933|NCT03099187|364578552|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
105703934|NCT03099187|364578553|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
105703935|NCT03099187|364578554|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
105703936|NCT01100437|364578555|FG000|Titration/Stabilization|Adverse Event|0|||
105703937|NCT01100437|364578556|FG001|Titration/Stabilization|Adverse Event|0|||
105703938|NCT01100437|364578557|FG002|Titration/Stabilization|Adverse Event|4|||
105703939|NCT01100437|364578555|FG000|Titration/Stabilization|Non-compliance|0|||
105703940|NCT01100437|364578556|FG001|Titration/Stabilization|Non-compliance|0|||
105703941|NCT01100437|364578557|FG002|Titration/Stabilization|Non-compliance|1|||
105703942|NCT01100437|364578555|FG000|Titration/Stabilization|Sponsor canceled study|0|||
105703943|NCT01100437|364578556|FG001|Titration/Stabilization|Sponsor canceled study|0|||
105703944|NCT01100437|364578557|FG002|Titration/Stabilization|Sponsor canceled study|1|||
105703945|NCT01100437|364578555|FG000|Maintenance|Withdrawal by Subject|0|||
105703946|NCT01100437|364578556|FG001|Maintenance|Withdrawal by Subject|0|||
105703947|NCT01100437|364578557|FG002|Maintenance|Withdrawal by Subject|1|||
106006770|NCT01691794|365688322|FG001|Overall Study|Participant request to discontinue|1|||
106006771|NCT01691794|365688323|FG002|Overall Study|Participant request to discontinue|0|||
106006772|NCT01691794|365688321|FG000|Overall Study|Adverse Event|0|||
105703948|NCT01100437|364578555|FG000|Maintenance|Sponsor termination of study|0|||
105703949|NCT01100437|364578556|FG001|Maintenance|Sponsor termination of study|0|||
105703950|NCT01100437|364578557|FG002|Maintenance|Sponsor termination of study|1|||
105703951|NCT00894556|364578563|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
105703952|NCT00894556|364578564|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
105703953|NCT00894556|364578565|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
106006773|NCT01691794|365688322|FG001|Overall Study|Adverse Event|1|||
105703954|NCT00894556|364578566|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
106133734|NCT01763047|366148176|FG001|Period 1|Lens Power Not Available|1|||
106133735|NCT01763047|366148175|FG000|Period 1|Study Site office Closed|0|||
106133736|NCT01763047|366148176|FG001|Period 1|Study Site office Closed|1|||
105703955|NCT00894556|364578563|FG000|Treatment Phase|Lost to Follow-up|2|||
105703956|NCT00894556|364578564|FG001|Treatment Phase|Lost to Follow-up|3|||
105703957|NCT00894556|364578565|FG002|Treatment Phase|Lost to Follow-up|1|||
105703958|NCT00894556|364578566|FG003|Treatment Phase|Lost to Follow-up|0|||
105703959|NCT00894556|364578563|FG000|Treatment Phase|Lack of Qualifying Event|2|||
105703960|NCT00894556|364578564|FG001|Treatment Phase|Lack of Qualifying Event|1|||
105703961|NCT00894556|364578565|FG002|Treatment Phase|Lack of Qualifying Event|0|||
105703962|NCT00894556|364578566|FG003|Treatment Phase|Lack of Qualifying Event|0|||
105703963|NCT01430455|364578569|FG000|Overall Study|Withdrawal by Subject|1|||
105703964|NCT01430455|364578569|FG000|Overall Study|Switched to follow-up phase|1|||
105703965|NCT01617460|364580148|FG000|Overall Study|Adverse Event|10|||
105703966|NCT01617460|364580148|FG000|Overall Study|Physician Decision|16|||
105703967|NCT01617460|364580148|FG000|Overall Study|Protocol Violation|5|||
105703968|NCT01617460|364580148|FG000|Overall Study|Withdrawal by Subject|9|||
105703969|NCT02634151|364580149|FG000|Overall Study|Withdrawal by Subject|1|||
105703970|NCT02634151|364580150|FG001|Overall Study|Withdrawal by Subject|0|||
105703971|NCT02634151|364580149|FG000|Overall Study|Non-Compliance|0|||
105703972|NCT02634151|364580150|FG001|Overall Study|Non-Compliance|1|||
105703973|NCT02634151|364580149|FG000|Overall Study|Other|0|||
105703974|NCT02634151|364580150|FG001|Overall Study|Other|1|||
105703975|NCT01146873|364580157|FG000|Overall Study|Transfer out|0|||
105703976|NCT01146873|364580158|FG001|Overall Study|Transfer out|6|||
105703977|NCT01379274|364580159|FG000|Overall Study|funding withdrawn|1|||
105703978|NCT01560780|364580160|FG000|Overall Study|Death|2|||
105703979|NCT01560780|364580161|FG001|Overall Study|Death|1|||
105703980|NCT01560780|364580160|FG000|Overall Study|Patient Preference|11|||
105703981|NCT01560780|364580161|FG001|Overall Study|Patient Preference|11|||
105703982|NCT01032915|364580162|FG000|Overall Study|Adverse Event|2|||
105703983|NCT01032915|364580163|FG001|Overall Study|Adverse Event|2|||
105703984|NCT01032915|364580164|FG002|Overall Study|Adverse Event|1|||
105703985|NCT01032915|364580165|FG003|Overall Study|Adverse Event|1|||
105703986|NCT01032915|364580162|FG000|Overall Study|Abnormal test procedure result|0|||
105703987|NCT01032915|364580163|FG001|Overall Study|Abnormal test procedure result|0|||
105703988|NCT01032915|364580164|FG002|Overall Study|Abnormal test procedure result|1|||
105703989|NCT01032915|364580165|FG003|Overall Study|Abnormal test procedure result|0|||
105703990|NCT01032915|364580162|FG000|Overall Study|Withdrawal by Subject|0|||
105703991|NCT01032915|364580163|FG001|Overall Study|Withdrawal by Subject|3|||
105703992|NCT01032915|364580164|FG002|Overall Study|Withdrawal by Subject|1|||
105703993|NCT01032915|364580165|FG003|Overall Study|Withdrawal by Subject|1|||
105703994|NCT01032915|364580162|FG000|Overall Study|Administrative reasons|5|||
105703995|NCT01032915|364580163|FG001|Overall Study|Administrative reasons|6|||
105703996|NCT01032915|364580164|FG002|Overall Study|Administrative reasons|4|||
105703997|NCT01032915|364580165|FG003|Overall Study|Administrative reasons|4|||
105703998|NCT01032915|364580162|FG000|Overall Study|Protocol Violation|1|||
105703999|NCT01032915|364580163|FG001|Overall Study|Protocol Violation|0|||
105704000|NCT01032915|364580164|FG002|Overall Study|Protocol Violation|0|||
105704001|NCT01032915|364580165|FG003|Overall Study|Protocol Violation|1|||
105704002|NCT02915523|364580166|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
105704003|NCT02915523|364580167|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
105704004|NCT02915523|364580168|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
105704005|NCT02915523|364580169|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
105704006|NCT02915523|364580166|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
105704007|NCT02915523|364580167|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
105704008|NCT02915523|364580168|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
105704009|NCT02915523|364580169|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
105704010|NCT02915523|364580166|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
105704011|NCT02915523|364580167|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
105704012|NCT02915523|364580168|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
105704013|NCT02915523|364580169|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
105704014|NCT02915523|364580166|FG000|Expansion Phase (Phase 2)|Death|0|||
105704015|NCT02915523|364580167|FG001|Expansion Phase (Phase 2)|Death|0|||
105704016|NCT02915523|364580168|FG002|Expansion Phase (Phase 2)|Death|26|||
105704017|NCT02915523|364580169|FG003|Expansion Phase (Phase 2)|Death|53|||
105926506|NCT04470427|365389864|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
106133737|NCT01763047|366148175|FG000|Period 2|Lens Discomfort|1|||
105704018|NCT02915523|364580166|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
105704019|NCT02915523|364580167|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
105704020|NCT02915523|364580168|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
105704021|NCT02915523|364580169|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
105704022|NCT02915523|364580166|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
106133738|NCT01763047|366148176|FG001|Period 2|Lens Discomfort|0|||
105704023|NCT02915523|364580167|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
105704024|NCT02915523|364580168|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
105704025|NCT02915523|364580169|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
105704026|NCT02915523|364580166|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
105704027|NCT02915523|364580167|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
105704028|NCT02915523|364580168|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
105704029|NCT02915523|364580169|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
105704030|NCT03548935|364580170|FG000|Overall Study|Withdrawal by Subject|26|||
105704031|NCT03548935|364580171|FG001|Overall Study|Withdrawal by Subject|17|||
105704032|NCT03548935|364580170|FG000|Overall Study|Lost to Follow-up|39|||
105704033|NCT03548935|364580171|FG001|Overall Study|Lost to Follow-up|28|||
105704034|NCT03548935|364580170|FG000|Overall Study|Death|1|||
105704035|NCT03548935|364580171|FG001|Overall Study|Death|1|||
105704036|NCT01074190|364580173|FG000|Overall Study|Emergency Cesarean Delivery|1|||
105704037|NCT01074190|364580174|FG001|Overall Study|Emergency Cesarean Delivery|2|||
105704038|NCT01074190|364580175|FG002|Overall Study|Emergency Cesarean Delivery|1|||
105704039|NCT01074190|364580173|FG000|Overall Study|Protocol Violation|2|||
105704040|NCT01074190|364580174|FG001|Overall Study|Protocol Violation|1|||
105704041|NCT01074190|364580175|FG002|Overall Study|Protocol Violation|0|||
105704042|NCT01074190|364580173|FG000|Overall Study|Delivered in under 90 minutes|0|||
105704043|NCT01074190|364580174|FG001|Overall Study|Delivered in under 90 minutes|2|||
105704044|NCT01074190|364580175|FG002|Overall Study|Delivered in under 90 minutes|1|||
105704045|NCT01074190|364580173|FG000|Overall Study|Subject withdrew consent|1|||
105704046|NCT01074190|364580174|FG001|Overall Study|Subject withdrew consent|1|||
105704047|NCT01074190|364580175|FG002|Overall Study|Subject withdrew consent|1|||
105704048|NCT01399788|364580178|FG000|First Intervention Period|Adverse Event|1|||
105704049|NCT01399788|364580179|FG001|First Intervention Period|Adverse Event|0|||
105704050|NCT01709435|364580183|FG000|Overall Study|Adverse Event|1|||
105704051|NCT01709435|364580184|FG001|Overall Study|Adverse Event|1|||
105704052|NCT01709435|364580185|FG002|Overall Study|Adverse Event|1|||
105704053|NCT01709435|364580186|FG003|Overall Study|Adverse Event|0|||
105704054|NCT01709435|364580187|FG004|Overall Study|Adverse Event|0|||
105704055|NCT01709435|364580188|FG005|Overall Study|Adverse Event|1|||
105704056|NCT01709435|364580183|FG000|Overall Study|Lack of Efficacy|5|||
105704057|NCT01709435|364580184|FG001|Overall Study|Lack of Efficacy|7|||
105704058|NCT01709435|364580185|FG002|Overall Study|Lack of Efficacy|2|||
105704059|NCT01709435|364580186|FG003|Overall Study|Lack of Efficacy|2|||
105704060|NCT01709435|364580187|FG004|Overall Study|Lack of Efficacy|6|||
105704061|NCT01709435|364580188|FG005|Overall Study|Lack of Efficacy|3|||
105704062|NCT01709435|364580183|FG000|Overall Study|Physician Decision|0|||
105704063|NCT01709435|364580184|FG001|Overall Study|Physician Decision|1|||
105704064|NCT01709435|364580185|FG002|Overall Study|Physician Decision|0|||
105704065|NCT01709435|364580186|FG003|Overall Study|Physician Decision|1|||
105704066|NCT01709435|364580187|FG004|Overall Study|Physician Decision|2|||
105704067|NCT01709435|364580188|FG005|Overall Study|Physician Decision|0|||
105704068|NCT01709435|364580183|FG000|Overall Study|Withdrawal by Subject|0|||
105704069|NCT01709435|364580184|FG001|Overall Study|Withdrawal by Subject|0|||
105704070|NCT01709435|364580185|FG002|Overall Study|Withdrawal by Subject|3|||
105704071|NCT01709435|364580186|FG003|Overall Study|Withdrawal by Subject|0|||
105704072|NCT01709435|364580187|FG004|Overall Study|Withdrawal by Subject|2|||
105704073|NCT01709435|364580188|FG005|Overall Study|Withdrawal by Subject|2|||
105704074|NCT01780662|364580189|FG000|Overall Study|Adverse Event|1|||
105704075|NCT01780662|364580190|FG001|Overall Study|Adverse Event|0|||
105704076|NCT01780662|364580191|FG002|Overall Study|Adverse Event|2|||
105704077|NCT01780662|364580189|FG000|Overall Study|Physician Decision|0|||
105704078|NCT01780662|364580190|FG001|Overall Study|Physician Decision|5|||
105704079|NCT01780662|364580191|FG002|Overall Study|Physician Decision|7|||
105704080|NCT01780662|364580189|FG000|Overall Study|Protocol Violation|0|||
105704081|NCT01780662|364580190|FG001|Overall Study|Protocol Violation|1|||
105704082|NCT01780662|364580191|FG002|Overall Study|Protocol Violation|0|||
105704083|NCT01780662|364580189|FG000|Overall Study|Ineligible|0|||
105704084|NCT01780662|364580190|FG001|Overall Study|Ineligible|0|||
105704085|NCT01780662|364580191|FG002|Overall Study|Ineligible|1|||
105704086|NCT01604265|364580192|FG000|Overall Study|Adverse Event|1|||
105704087|NCT01604265|364580193|FG001|Overall Study|Adverse Event|0|||
105704088|NCT01604265|364580192|FG000|Overall Study|Withdrawal by Subject|1|||
105926507|NCT04470427|365389865|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
105926508|NCT04470427|365389866|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
105926509|NCT02802228|365389867|FG000|Overall Study|Withdrawal by Subject|2|||
105926510|NCT02802228|365389868|FG001|Overall Study|Withdrawal by Subject|0|||
105926511|NCT02802228|365389867|FG000|Overall Study|Lost to Follow-up|1|||
105926512|NCT02802228|365389868|FG001|Overall Study|Lost to Follow-up|0|||
105704089|NCT01604265|364580193|FG001|Overall Study|Withdrawal by Subject|0|||
105704090|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
105704091|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
105704092|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
105926513|NCT02802228|365389867|FG000|Overall Study|Adverse Event|1|||
105926514|NCT02802228|365389868|FG001|Overall Study|Adverse Event|0|||
105926515|NCT02802228|365389867|FG000|Overall Study|Physician Decision|1|||
105704093|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
105704094|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
105704095|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
105704096|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
105704097|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
105704098|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
105704099|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
105704100|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
105704101|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
105704102|NCT00708500|364580194|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
105704103|NCT00708500|364580195|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
105704104|NCT00708500|364580196|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
105704105|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
105704106|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
105704107|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
105704108|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
105704109|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
105704110|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
105704111|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
105704112|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
105704113|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
105704114|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
105704115|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
105704116|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
105704117|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
105704118|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
105704119|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
105704120|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
105704121|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
105704122|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
105704123|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
105704124|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
105704125|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
105704126|NCT00708500|364580194|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
105704127|NCT00708500|364580195|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
105704128|NCT00708500|364580196|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
105704129|NCT00708500|364580194|FG000|FOLLOWUP|Adverse Event|0|||
105704130|NCT00708500|364580195|FG001|FOLLOWUP|Adverse Event|1|||
105704131|NCT00708500|364580196|FG002|FOLLOWUP|Adverse Event|0|||
105704132|NCT00708500|364580194|FG000|FOLLOWUP|Lost to Follow-up|1|||
105704133|NCT00708500|364580195|FG001|FOLLOWUP|Lost to Follow-up|6|||
105704134|NCT00708500|364580196|FG002|FOLLOWUP|Lost to Follow-up|4|||
105704135|NCT00708500|364580194|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
105704136|NCT00708500|364580195|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
105704137|NCT00708500|364580196|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
105704138|NCT00708500|364580194|FG000|FOLLOWUP|Subject withdrew consent|31|||
105704139|NCT00708500|364580195|FG001|FOLLOWUP|Subject withdrew consent|4|||
105704140|NCT00708500|364580196|FG002|FOLLOWUP|Subject withdrew consent|5|||
105704141|NCT00708500|364580194|FG000|FOLLOWUP|Non-compliance with protocol|5|||
105704142|NCT00708500|364580195|FG001|FOLLOWUP|Non-compliance with protocol|0|||
105704143|NCT00708500|364580196|FG002|FOLLOWUP|Non-compliance with protocol|1|||
105704144|NCT00705783|364580201|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
105704145|NCT00705783|364580202|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
105704146|NCT00705783|364580203|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
105704147|NCT00705783|364580201|FG000|Conversion Phase|Lost to Follow-up|13|||
105704148|NCT00705783|364580202|FG001|Conversion Phase|Lost to Follow-up|0|||
105704149|NCT00705783|364580203|FG002|Conversion Phase|Lost to Follow-up|0|||
105704150|NCT00705783|364580201|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
105704151|NCT00705783|364580202|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
105704152|NCT00705783|364580203|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
105704153|NCT00705783|364580201|FG000|Conversion Phase|Withdrawn by Investigator|4|||
105704154|NCT00705783|364580202|FG001|Conversion Phase|Withdrawn by Investigator|0|||
105704155|NCT00705783|364580203|FG002|Conversion Phase|Withdrawn by Investigator|0|||
105704156|NCT00705783|364580201|FG000|Conversion Phase|Withdrew Consent|24|||
105704157|NCT00705783|364580202|FG001|Conversion Phase|Withdrew Consent|0|||
105704158|NCT00705783|364580203|FG002|Conversion Phase|Withdrew Consent|0|||
105926516|NCT02802228|365389868|FG001|Overall Study|Physician Decision|0|||
105704159|NCT00705783|364580201|FG000|Conversion Phase|Protocol Deviation|2|||
105704160|NCT00705783|364580202|FG001|Conversion Phase|Protocol Deviation|0|||
105704161|NCT00705783|364580203|FG002|Conversion Phase|Protocol Deviation|0|||
105704162|NCT00705783|364580201|FG000|Conversion Phase|Adverse Event|11|||
105704163|NCT00705783|364580202|FG001|Conversion Phase|Adverse Event|0|||
105704164|NCT00705783|364580203|FG002|Conversion Phase|Adverse Event|0|||
105704165|NCT00705783|364580201|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
105704166|NCT00705783|364580202|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105704167|NCT00705783|364580203|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
105704168|NCT00705783|364580201|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
105704169|NCT00705783|364580202|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105704170|NCT00705783|364580203|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
105704171|NCT00705783|364580201|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
105704172|NCT00705783|364580202|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
105704173|NCT00705783|364580203|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
105704174|NCT00705783|364580201|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
105704175|NCT00705783|364580202|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
105704176|NCT00705783|364580203|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
105704177|NCT00705783|364580201|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
105704178|NCT00705783|364580202|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105704179|NCT00705783|364580203|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
105704180|NCT00705783|364580201|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
105704181|NCT00705783|364580202|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105704182|NCT00705783|364580203|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
105704183|NCT00705783|364580201|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
105704184|NCT00705783|364580202|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
105704185|NCT00705783|364580203|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
105704186|NCT00705783|364580201|FG000|Oral Stabilization Phase|Adverse Event|14|||
105704187|NCT00705783|364580202|FG001|Oral Stabilization Phase|Adverse Event|0|||
105704188|NCT00705783|364580203|FG002|Oral Stabilization Phase|Adverse Event|0|||
105704189|NCT00705783|364580201|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
105704190|NCT00705783|364580202|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105704191|NCT00705783|364580203|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105704192|NCT00705783|364580201|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
105704193|NCT00705783|364580202|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105704194|NCT00705783|364580203|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105704195|NCT00705783|364580201|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
105704196|NCT00705783|364580202|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
105704197|NCT00705783|364580203|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
105704198|NCT00705783|364580201|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
105704199|NCT00705783|364580202|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
105704200|NCT00705783|364580203|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
105704201|NCT00705783|364580201|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
105704202|NCT00705783|364580202|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
105704203|NCT00705783|364580203|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
105704204|NCT00705783|364580201|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
105704205|NCT00705783|364580202|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
105704206|NCT00705783|364580203|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
105704207|NCT00705783|364580201|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
105704208|NCT00705783|364580202|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
105704209|NCT00705783|364580203|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
105704210|NCT00705783|364580201|FG000|Depot Stabilization Phase|Adverse Event|17|||
105704211|NCT00705783|364580202|FG001|Depot Stabilization Phase|Adverse Event|0|||
105704212|NCT00705783|364580203|FG002|Depot Stabilization Phase|Adverse Event|0|||
105704213|NCT00705783|364580201|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
105704214|NCT00705783|364580202|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105704215|NCT00705783|364580203|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
105704216|NCT00705783|364580201|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
105704217|NCT00705783|364580202|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105704218|NCT00705783|364580203|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
105704219|NCT00705783|364580201|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
105704220|NCT00705783|364580202|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
105704221|NCT00705783|364580203|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
105704222|NCT00705783|364580201|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
105704223|NCT00705783|364580202|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
105704224|NCT00705783|364580203|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
105704225|NCT00705783|364580201|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
105704226|NCT00705783|364580202|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
105704227|NCT00705783|364580203|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
105704228|NCT00705783|364580201|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
105704229|NCT00705783|364580202|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
105704230|NCT00705783|364580203|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
105704231|NCT00705783|364580201|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
105704232|NCT00705783|364580202|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
105704233|NCT00705783|364580203|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
105704234|NCT00705783|364580201|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
105704235|NCT00705783|364580202|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
105704236|NCT00705783|364580203|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
105704237|NCT00705783|364580201|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
105704238|NCT00705783|364580202|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
105704239|NCT00705783|364580203|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
105704240|NCT00705783|364580201|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
105704241|NCT00705783|364580202|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
105704242|NCT00705783|364580203|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
105704243|NCT00705783|364580201|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
105704244|NCT00705783|364580202|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
105704245|NCT00705783|364580203|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
105704246|NCT01029366|364580216|FG000|Overall Study|Withdrawal by Subject|1|||
105704247|NCT01029366|364580217|FG001|Overall Study|Withdrawal by Subject|0|||
105704248|NCT01029366|364580216|FG000|Overall Study|Death|1|||
105704249|NCT01029366|364580217|FG001|Overall Study|Death|1|||
105704250|NCT01029366|364580216|FG000|Overall Study|disease progression|2|||
105704251|NCT01029366|364580217|FG001|Overall Study|disease progression|0|||
105704252|NCT01029366|364580216|FG000|Overall Study|manufacturing failure|0|||
105704253|NCT01029366|364580217|FG001|Overall Study|manufacturing failure|1|||
105704254|NCT00607386|364580223|FG000|Overall Study|Physician Decision|1|||
105704255|NCT01422915|364580229|FG000|Overall Study|Adverse Event|1|||
105704256|NCT01152021|364580231|FG000|Overall Study|Adverse Event|4|||
105704257|NCT01152021|364580232|FG001|Overall Study|Adverse Event|4|||
105704258|NCT01152021|364580231|FG000|Overall Study|Study drug had expired|1|||
105704259|NCT01152021|364580232|FG001|Overall Study|Study drug had expired|0|||
105704260|NCT01152021|364580231|FG000|Overall Study|Physician Decision|1|||
105704261|NCT01152021|364580232|FG001|Overall Study|Physician Decision|1|||
105704262|NCT01152021|364580231|FG000|Overall Study|No access to study drug in Pharmacy|0|||
105704263|NCT01152021|364580232|FG001|Overall Study|No access to study drug in Pharmacy|1|||
105704264|NCT03775421|364580234|FG000|Overall Study|Lost to Follow-up|2|||
105704265|NCT03775421|364580234|FG000|Overall Study|Withdrawal by Subject|10|||
105704266|NCT03775421|364580234|FG000|Overall Study|Physician Decision|3|||
105704267|NCT03775421|364580234|FG000|Overall Study|Death|1|||
105704268|NCT03775421|364580234|FG000|Overall Study|Study Terminated by Sponsor|94|||
105704269|NCT00623428|364580235|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
105704270|NCT00623428|364580236|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
105704271|NCT00623428|364580235|FG000|Treatment Period|Death|0|||
105704272|NCT00623428|364580236|FG001|Treatment Period|Death|1|||
105704273|NCT00623428|364580235|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
105704274|NCT00623428|364580236|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
105704275|NCT00623428|364580235|FG000|Treatment Period|Insufficient therapeutic response|0|||
105704276|NCT00623428|364580236|FG001|Treatment Period|Insufficient therapeutic response|2|||
105704277|NCT00623428|364580235|FG000|Treatment Period|Other|0|||
105704278|NCT00623428|364580236|FG001|Treatment Period|Other|1|||
105704279|NCT00623428|364580235|FG000|Treatment Period|Withdrawal by Subject|0|||
105704280|NCT00623428|364580236|FG001|Treatment Period|Withdrawal by Subject|1|||
105704281|NCT00623428|364580235|FG000|Follow-up Period|Relapse post-treatment|11|||
105704282|NCT00623428|364580236|FG001|Follow-up Period|Relapse post-treatment|3|||
105704283|NCT00623428|364580235|FG000|Follow-up Period|Failure to return|10|||
105704284|NCT00623428|364580236|FG001|Follow-up Period|Failure to return|2|||
105704285|NCT00623428|364580235|FG000|Follow-up Period|Patient withdrew consent|5|||
105704286|NCT00623428|364580236|FG001|Follow-up Period|Patient withdrew consent|4|||
105704287|NCT00623428|364580235|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
105704288|NCT00623428|364580236|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
105704289|NCT00623428|364580235|FG000|Follow-up Period|Did not cooperate|0|||
105704290|NCT00623428|364580236|FG001|Follow-up Period|Did not cooperate|3|||
106133739|NCT01763047|366148175|FG000|Period 2|No longer meets Eligibility Criteria|1|||
105704291|NCT00623428|364580235|FG000|Follow-up Period|Reason not specified|1|||
105704292|NCT00623428|364580236|FG001|Follow-up Period|Reason not specified|1|||
105704293|NCT00623428|364580235|FG000|Follow-up Period|Death|0|||
106133740|NCT01763047|366148176|FG001|Period 2|No longer meets Eligibility Criteria|0|||
105704294|NCT00623428|364580236|FG001|Follow-up Period|Death|1|||
105704295|NCT00205855|364580245|FG000|Overall Study|Only received temporary implants|16|||
105704296|NCT00205855|364580245|FG000|Overall Study|Withdrawal by Subject|5|||
105704297|NCT01445951|364580247|FG000|Overall Study|Adverse Event|16|||
105704298|NCT01445951|364580248|FG001|Overall Study|Adverse Event|9|||
105704299|NCT01445951|364580249|FG002|Overall Study|Adverse Event|0|||
105704300|NCT01445951|364580247|FG000|Overall Study|Protocol Violation|2|||
105704301|NCT01445951|364580248|FG001|Overall Study|Protocol Violation|2|||
105704302|NCT01445951|364580249|FG002|Overall Study|Protocol Violation|2|||
105704303|NCT01445951|364580247|FG000|Overall Study|Withdrawal by Subject|21|||
105704304|NCT01445951|364580248|FG001|Overall Study|Withdrawal by Subject|16|||
105704305|NCT01445951|364580249|FG002|Overall Study|Withdrawal by Subject|8|||
105704306|NCT01445951|364580247|FG000|Overall Study|Physician Decision|3|||
105704307|NCT01445951|364580248|FG001|Overall Study|Physician Decision|1|||
105704308|NCT01445951|364580249|FG002|Overall Study|Physician Decision|0|||
105704309|NCT01445951|364580247|FG000|Overall Study|Lost to Follow-up|1|||
105704310|NCT01445951|364580248|FG001|Overall Study|Lost to Follow-up|2|||
105704311|NCT01445951|364580249|FG002|Overall Study|Lost to Follow-up|4|||
105704312|NCT01445951|364580247|FG000|Overall Study|Pregnancy|0|||
105704313|NCT01445951|364580248|FG001|Overall Study|Pregnancy|1|||
105704314|NCT01445951|364580249|FG002|Overall Study|Pregnancy|4|||
105704315|NCT01445951|364580247|FG000|Overall Study|Death|0|||
105704316|NCT01445951|364580248|FG001|Overall Study|Death|0|||
105704317|NCT01445951|364580249|FG002|Overall Study|Death|1|||
105704318|NCT01445951|364580247|FG000|Overall Study|Non-compliance with study drug|1|||
105704319|NCT01445951|364580248|FG001|Overall Study|Non-compliance with study drug|2|||
105704320|NCT01445951|364580249|FG002|Overall Study|Non-compliance with study drug|0|||
105704321|NCT01445951|364580247|FG000|Overall Study|Non-compliance with protocol|0|||
105704322|NCT01445951|364580248|FG001|Overall Study|Non-compliance with protocol|1|||
105704323|NCT01445951|364580249|FG002|Overall Study|Non-compliance with protocol|0|||
105704324|NCT01445951|364580247|FG000|Overall Study|Sponsor decision - subject travel|0|||
105704325|NCT01445951|364580248|FG001|Overall Study|Sponsor decision - subject travel|1|||
105704326|NCT01445951|364580249|FG002|Overall Study|Sponsor decision - subject travel|0|||
105704327|NCT01445951|364580247|FG000|Overall Study|Cough|0|||
105704328|NCT01445951|364580248|FG001|Overall Study|Cough|1|||
105704329|NCT01445951|364580249|FG002|Overall Study|Cough|0|||
105704330|NCT02943564|364580250|FG000|Overall Study|Miscellaneous Reasons|0|||
105704331|NCT02943564|364580251|FG001|Overall Study|Miscellaneous Reasons|0|||
105704332|NCT02943564|364580252|FG002|Overall Study|Miscellaneous Reasons|3|||
105704333|NCT02943564|364580250|FG000|Overall Study|Site terminated by sponsor|0|||
105704334|NCT02943564|364580251|FG001|Overall Study|Site terminated by sponsor|1|||
105704335|NCT02943564|364580252|FG002|Overall Study|Site terminated by sponsor|0|||
105704336|NCT02943564|364580250|FG000|Overall Study|Non-compliance with study drug|0|||
105704337|NCT02943564|364580251|FG001|Overall Study|Non-compliance with study drug|1|||
105704338|NCT02943564|364580252|FG002|Overall Study|Non-compliance with study drug|0|||
105704339|NCT02943564|364580250|FG000|Overall Study|Pregnancy|0|||
105704340|NCT02943564|364580251|FG001|Overall Study|Pregnancy|1|||
105704341|NCT02943564|364580252|FG002|Overall Study|Pregnancy|1|||
105704342|NCT02943564|364580250|FG000|Overall Study|Protocol Violation|2|||
105704343|NCT02943564|364580251|FG001|Overall Study|Protocol Violation|2|||
105704344|NCT02943564|364580252|FG002|Overall Study|Protocol Violation|2|||
105704345|NCT02943564|364580250|FG000|Overall Study|Lost to Follow-up|1|||
105704346|NCT02943564|364580251|FG001|Overall Study|Lost to Follow-up|0|||
105704347|NCT02943564|364580252|FG002|Overall Study|Lost to Follow-up|0|||
105704348|NCT02943564|364580250|FG000|Overall Study|Withdrawal by Subject|6|||
105704349|NCT02943564|364580251|FG001|Overall Study|Withdrawal by Subject|5|||
105704350|NCT02943564|364580252|FG002|Overall Study|Withdrawal by Subject|2|||
105704351|NCT02943564|364580250|FG000|Overall Study|Adverse Event|1|||
105704352|NCT02943564|364580251|FG001|Overall Study|Adverse Event|2|||
105704353|NCT02943564|364580252|FG002|Overall Study|Adverse Event|1|||
105704354|NCT02943564|364580250|FG000|Overall Study|Lack of Efficacy|0|||
105704355|NCT02943564|364580251|FG001|Overall Study|Lack of Efficacy|1|||
105704356|NCT02943564|364580252|FG002|Overall Study|Lack of Efficacy|0|||
105704357|NCT03028870|364580253|FG000|Overall Study|Adverse Event|7|||
105704358|NCT03028870|364580254|FG001|Overall Study|Adverse Event|4|||
105704359|NCT03028870|364580255|FG002|Overall Study|Adverse Event|3|||
105704360|NCT03028870|364580256|FG003|Overall Study|Adverse Event|3|||
105704361|NCT03028870|364580253|FG000|Overall Study|Withdrawal by Subject|1|||
105704362|NCT03028870|364580254|FG001|Overall Study|Withdrawal by Subject|1|||
105926517|NCT01018979|365389869|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
106006774|NCT01691794|365688323|FG002|Overall Study|Adverse Event|1|||
105704363|NCT03028870|364580255|FG002|Overall Study|Withdrawal by Subject|1|||
105704364|NCT03028870|364580256|FG003|Overall Study|Withdrawal by Subject|2|||
105704365|NCT03028870|364580253|FG000|Overall Study|Lost to Follow-up|1|||
105704366|NCT03028870|364580254|FG001|Overall Study|Lost to Follow-up|0|||
105704367|NCT03028870|364580255|FG002|Overall Study|Lost to Follow-up|0|||
105704368|NCT03028870|364580256|FG003|Overall Study|Lost to Follow-up|0|||
105704369|NCT03028870|364580253|FG000|Overall Study|Lack of Efficacy|3|||
105704370|NCT03028870|364580254|FG001|Overall Study|Lack of Efficacy|0|||
105704371|NCT03028870|364580255|FG002|Overall Study|Lack of Efficacy|0|||
105704372|NCT03028870|364580256|FG003|Overall Study|Lack of Efficacy|0|||
105704373|NCT03028870|364580253|FG000|Overall Study|Administrative|5|||
105704374|NCT03028870|364580254|FG001|Overall Study|Administrative|5|||
105704375|NCT03028870|364580255|FG002|Overall Study|Administrative|12|||
105704376|NCT03028870|364580256|FG003|Overall Study|Administrative|4|||
105704377|NCT00490451|364580259|FG000|Overall Study|Adverse Event|3|||
106133741|NCT01763047|366148175|FG000|Period 2|Study Site office Closed|1|||
106133742|NCT01763047|366148176|FG001|Period 2|Study Site office Closed|1|||
105704378|NCT00490451|364580260|FG001|Overall Study|Adverse Event|3|||
105704379|NCT00490451|364580259|FG000|Overall Study|Death|3|||
105704380|NCT00490451|364580260|FG001|Overall Study|Death|1|||
105704381|NCT00490451|364580259|FG000|Overall Study|Withdrawal by Subject|2|||
105704382|NCT00490451|364580260|FG001|Overall Study|Withdrawal by Subject|0|||
105704383|NCT00490451|364580259|FG000|Overall Study|Investigator Decision|1|||
105704384|NCT00490451|364580260|FG001|Overall Study|Investigator Decision|0|||
105704385|NCT00490451|364580259|FG000|Overall Study|Protocol Violation|1|||
105704386|NCT00490451|364580260|FG001|Overall Study|Protocol Violation|0|||
105704387|NCT00490451|364580259|FG000|Overall Study|Progressive Disease|53|||
105704388|NCT00490451|364580260|FG001|Overall Study|Progressive Disease|34|||
105704389|NCT04486950|364580261|FG000|Overall Study|Lost to Follow-up|0|||
105704390|NCT04486950|364580262|FG001|Overall Study|Lost to Follow-up|0|||
105704391|NCT04486950|364580263|FG002|Overall Study|Lost to Follow-up|0|||
105704392|NCT04486950|364580264|FG003|Overall Study|Lost to Follow-up|0|||
105704393|NCT04486950|364580265|FG004|Overall Study|Lost to Follow-up|0|||
105704394|NCT04486950|364580266|FG005|Overall Study|Lost to Follow-up|1|||
105704395|NCT04486950|364580267|FG006|Overall Study|Lost to Follow-up|0|||
105704396|NCT01181011|364580268|FG000|Overall Study|Adverse Event|2|||
105704397|NCT01181011|364580268|FG000|Overall Study|Lost to Follow-up|1|||
105704398|NCT00550680|364580269|FG000|Overall Study|Administrative Reasons|1|||
106133743|NCT01763047|366148175|FG000|Period 2|Unsatisfactory Visual Response|1|||
106133744|NCT01763047|366148176|FG001|Period 2|Unsatisfactory Visual Response|1|||
105704399|NCT00550680|364580269|FG000|Overall Study|Adverse Event|5|||
105704400|NCT00550680|364580269|FG000|Overall Study|Death|3|||
105704401|NCT00550680|364580269|FG000|Overall Study|Early Improvement|1|||
105704402|NCT00550680|364580269|FG000|Overall Study|Lost to Follow-up|3|||
105704403|NCT00550680|364580269|FG000|Overall Study|Lack of Efficacy|1|||
105704404|NCT00550680|364580269|FG000|Overall Study|Other|10|||
105704405|NCT00550680|364580269|FG000|Overall Study|Protocol Violation|7|||
105704406|NCT00550680|364580269|FG000|Overall Study|Refused Treatment|19|||
105704407|NCT00550680|364580269|FG000|Overall Study|Screen Failure|6|||
105704408|NCT00923130|364580270|FG000|Overall Study|Stopped treatment due to progression|17|||
105704409|NCT00923130|364580270|FG000|Overall Study|Death|1|||
106133745|NCT01763047|366148175|FG000|Period 2|Protocol Violation|0|||
106133746|NCT01763047|366148176|FG001|Period 2|Protocol Violation|2|||
105704410|NCT00923130|364580270|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
105704411|NCT00923130|364580270|FG000|Overall Study|Switched to alternative treatment|2|||
105704412|NCT00923130|364580270|FG000|Overall Study|Refused further treatment|2|||
105704413|NCT00562354|364580271|FG000|Overall Study|Physician Decision|0|||
105704414|NCT00562354|364580272|FG001|Overall Study|Physician Decision|1|||
105704415|NCT00562354|364580271|FG000|Overall Study|Lost to Follow-up|0|||
105704416|NCT00562354|364580272|FG001|Overall Study|Lost to Follow-up|1|||
105704417|NCT03693625|364580273|FG000|Overall Study|Adverse Event|2|||
105704418|NCT03693625|364580274|FG001|Overall Study|Adverse Event|0|||
105704419|NCT03693625|364580273|FG000|Overall Study|Study Terminated By Sponsor|20|||
105704420|NCT03693625|364580274|FG001|Overall Study|Study Terminated By Sponsor|7|||
105704421|NCT03693625|364580273|FG000|Overall Study|Withdrawal by Subject|1|||
105704422|NCT03693625|364580274|FG001|Overall Study|Withdrawal by Subject|1|||
105704423|NCT00250835|364580276|FG000|Overall Study|Withdrawal by Subject|1|||
106133747|NCT01763047|366148175|FG000|Period 2|Unsatisfactory lens Fitting|0|||
105704424|NCT01187953|364580277|FG000|Overall Study|Death|11|||
105704425|NCT01187953|364580278|FG001|Overall Study|Death|13|||
105704426|NCT01187953|364580277|FG000|Overall Study|Adverse Event|1|||
105704427|NCT01187953|364580278|FG001|Overall Study|Adverse Event|2|||
105704428|NCT01187953|364580277|FG000|Overall Study|Lost to Follow-up|0|||
105704429|NCT01187953|364580278|FG001|Overall Study|Lost to Follow-up|3|||
105704430|NCT01187953|364580277|FG000|Overall Study|Withdrawal by Subject|3|||
105704431|NCT01187953|364580278|FG001|Overall Study|Withdrawal by Subject|3|||
105704432|NCT03921424|364580279|FG000|Overall Study|Lost to Follow-up|0|||
105704433|NCT03921424|364580280|FG001|Overall Study|Lost to Follow-up|1|||
105704434|NCT03921424|364580279|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105704435|NCT03921424|364580280|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
105704436|NCT01246583|364580287|FG000|Overall Study|Lost to Follow-up|0|||
105704437|NCT01246583|364580288|FG001|Overall Study|Lost to Follow-up|0|||
106133748|NCT01763047|366148176|FG001|Period 2|Unsatisfactory lens Fitting|1|||
105704438|NCT01246583|364580289|FG002|Overall Study|Lost to Follow-up|0|||
105704439|NCT01246583|364580290|FG003|Overall Study|Lost to Follow-up|1|||
105704440|NCT01246583|364580287|FG000|Overall Study|Protocol Violation|0|||
105704441|NCT01246583|364580288|FG001|Overall Study|Protocol Violation|0|||
105704442|NCT01246583|364580289|FG002|Overall Study|Protocol Violation|1|||
105704443|NCT01246583|364580290|FG003|Overall Study|Protocol Violation|0|||
105704444|NCT01246583|364580287|FG000|Overall Study|Withdrawal by Subject|1|||
105704445|NCT01246583|364580288|FG001|Overall Study|Withdrawal by Subject|0|||
105704446|NCT01246583|364580289|FG002|Overall Study|Withdrawal by Subject|0|||
105704447|NCT01246583|364580290|FG003|Overall Study|Withdrawal by Subject|0|||
105704448|NCT01806779|364580291|FG000|Overall Study|Physician Decision|2|||
105704449|NCT01806779|364580292|FG001|Overall Study|Physician Decision|0|||
105704450|NCT01806779|364580293|FG002|Overall Study|Physician Decision|1|||
105704451|NCT01806779|364580291|FG000|Overall Study|Lack of Efficacy|1|||
105704452|NCT01806779|364580292|FG001|Overall Study|Lack of Efficacy|1|||
105704453|NCT01806779|364580293|FG002|Overall Study|Lack of Efficacy|0|||
105704454|NCT01806779|364580291|FG000|Overall Study|Lost to Follow-up|19|||
105704455|NCT01806779|364580292|FG001|Overall Study|Lost to Follow-up|20|||
105704456|NCT01806779|364580293|FG002|Overall Study|Lost to Follow-up|0|||
105704457|NCT01806779|364580291|FG000|Overall Study|Withdrawal by Subject|20|||
105704458|NCT01806779|364580292|FG001|Overall Study|Withdrawal by Subject|23|||
105704459|NCT01806779|364580293|FG002|Overall Study|Withdrawal by Subject|22|||
105704460|NCT02595450|364580296|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
105704461|NCT02595450|364580296|FG000|Overall Study|Enrolled, but not treated|8|||
105704462|NCT01934556|364580297|FG000|Overall Study|Withdrawal by Subject|0|||
105704463|NCT01934556|364580298|FG001|Overall Study|Withdrawal by Subject|1|||
105704464|NCT01934556|364580299|FG002|Overall Study|Withdrawal by Subject|1|||
105704465|NCT01934556|364580297|FG000|Overall Study|Lost to Follow-up|4|||
105704466|NCT01934556|364580298|FG001|Overall Study|Lost to Follow-up|10|||
105704467|NCT01934556|364580299|FG002|Overall Study|Lost to Follow-up|7|||
105704468|NCT01934556|364580297|FG000|Overall Study|Death|1|||
105704469|NCT01934556|364580298|FG001|Overall Study|Death|5|||
105704470|NCT01934556|364580299|FG002|Overall Study|Death|2|||
105704471|NCT03723707|364582298|FG000|Overall Study|Death|32|||
105704472|NCT03723707|364582299|FG001|Overall Study|Death|32|||
105704473|NCT03723707|364582298|FG000|Overall Study|Admitted to long term care|12|||
105704474|NCT03723707|364582299|FG001|Overall Study|Admitted to long term care|12|||
105704475|NCT03723707|364582298|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
105704476|NCT03723707|364582299|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
105704477|NCT03723707|364582298|FG000|Overall Study|Lost to Follow-up|40|||
105704478|NCT03723707|364582299|FG001|Overall Study|Lost to Follow-up|22|||
105704479|NCT03723707|364582298|FG000|Overall Study|Discontinued after study closure|24|||
105704480|NCT03723707|364582299|FG001|Overall Study|Discontinued after study closure|12|||
105704481|NCT05121480|364582300|FG000|Overall Study|Lack of Efficacy|2|||
105704482|NCT05121480|364582301|FG001|Overall Study|Lack of Efficacy|2|||
105704483|NCT05121480|364582302|FG002|Overall Study|Lack of Efficacy|1|||
105704484|NCT05121480|364582303|FG003|Overall Study|Lack of Efficacy|4|||
105704485|NCT05121480|364582304|FG004|Overall Study|Lack of Efficacy|0|||
105704486|NCT05121480|364582305|FG005|Overall Study|Lack of Efficacy|1|||
105704487|NCT05121480|364582306|FG006|Overall Study|Lack of Efficacy|0|||
105704488|NCT05121480|364582307|FG007|Overall Study|Lack of Efficacy|2|||
105704489|NCT05121480|364582300|FG000|Overall Study|Treatment Failure|0|||
105704490|NCT05121480|364582301|FG001|Overall Study|Treatment Failure|2|||
105704491|NCT05121480|364582302|FG002|Overall Study|Treatment Failure|0|||
105704492|NCT05121480|364582303|FG003|Overall Study|Treatment Failure|1|||
105704493|NCT05121480|364582304|FG004|Overall Study|Treatment Failure|0|||
105704494|NCT05121480|364582305|FG005|Overall Study|Treatment Failure|0|||
105704495|NCT05121480|364582306|FG006|Overall Study|Treatment Failure|0|||
105704496|NCT05121480|364582307|FG007|Overall Study|Treatment Failure|0|||
105704497|NCT05121480|364582300|FG000|Overall Study|Adverse Event|0|||
105704498|NCT05121480|364582301|FG001|Overall Study|Adverse Event|1|||
105704499|NCT05121480|364582302|FG002|Overall Study|Adverse Event|0|||
105704500|NCT05121480|364582303|FG003|Overall Study|Adverse Event|5|||
105704501|NCT05121480|364582304|FG004|Overall Study|Adverse Event|3|||
105704502|NCT05121480|364582305|FG005|Overall Study|Adverse Event|2|||
105704503|NCT05121480|364582306|FG006|Overall Study|Adverse Event|0|||
105704504|NCT05121480|364582307|FG007|Overall Study|Adverse Event|4|||
105704505|NCT05121480|364582300|FG000|Overall Study|Withdrawal by Subject|4|||
105704506|NCT05121480|364582301|FG001|Overall Study|Withdrawal by Subject|9|||
105704507|NCT05121480|364582302|FG002|Overall Study|Withdrawal by Subject|1|||
105704508|NCT05121480|364582303|FG003|Overall Study|Withdrawal by Subject|8|||
105704509|NCT05121480|364582304|FG004|Overall Study|Withdrawal by Subject|0|||
105704510|NCT05121480|364582305|FG005|Overall Study|Withdrawal by Subject|9|||
105704511|NCT05121480|364582306|FG006|Overall Study|Withdrawal by Subject|0|||
105704512|NCT05121480|364582307|FG007|Overall Study|Withdrawal by Subject|4|||
105704513|NCT05121480|364582300|FG000|Overall Study|Non-compliance with the protocol|0|||
105704514|NCT05121480|364582301|FG001|Overall Study|Non-compliance with the protocol|0|||
105704515|NCT05121480|364582302|FG002|Overall Study|Non-compliance with the protocol|0|||
105704516|NCT05121480|364582303|FG003|Overall Study|Non-compliance with the protocol|0|||
105704517|NCT05121480|364582304|FG004|Overall Study|Non-compliance with the protocol|1|||
105704518|NCT05121480|364582305|FG005|Overall Study|Non-compliance with the protocol|6|||
105926518|NCT01018979|365389870|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
105926519|NCT01018979|365389869|FG000|Overall Study|Not received at least one dose|0|||
105926520|NCT01018979|365389870|FG001|Overall Study|Not received at least one dose|1|||
105926521|NCT01925794|365389871|FG000|180 Days|Death|2|||
105926522|NCT01925794|365389871|FG000|180 Days|Withdrawal by Subject|2|||
105926523|NCT01925794|365389871|FG000|270 Days|Death|2|||
105926524|NCT01925794|365389871|FG000|270 Days|Protocol Violation|3|||
105926525|NCT03301714|365389872|FG000|Overall Study|Lost to Follow-up|10|||
105926526|NCT03301714|365389873|FG001|Overall Study|Lost to Follow-up|4|||
105926527|NCT03301714|365389874|FG002|Overall Study|Lost to Follow-up|4|||
105926528|NCT03301714|365389872|FG000|Overall Study|Did not receive allocated intervention|0|||
105926529|NCT03301714|365389873|FG001|Overall Study|Did not receive allocated intervention|2|||
105926530|NCT03301714|365389874|FG002|Overall Study|Did not receive allocated intervention|3|||
105926531|NCT00088153|365389875|FG000|Overall Study|Physician Decision|3|||
106006775|NCT01691794|365688321|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
105704519|NCT05121480|364582306|FG006|Overall Study|Non-compliance with the protocol|0|||
105704520|NCT05121480|364582307|FG007|Overall Study|Non-compliance with the protocol|1|||
105704521|NCT05121480|364582300|FG000|Overall Study|Lost to Follow-up|0|||
105704522|NCT05121480|364582301|FG001|Overall Study|Lost to Follow-up|4|||
105704523|NCT05121480|364582302|FG002|Overall Study|Lost to Follow-up|1|||
105704524|NCT05121480|364582303|FG003|Overall Study|Lost to Follow-up|3|||
105704525|NCT05121480|364582304|FG004|Overall Study|Lost to Follow-up|1|||
105704526|NCT05121480|364582305|FG005|Overall Study|Lost to Follow-up|1|||
105704527|NCT05121480|364582306|FG006|Overall Study|Lost to Follow-up|1|||
105704528|NCT05121480|364582307|FG007|Overall Study|Lost to Follow-up|4|||
105704529|NCT05121480|364582300|FG000|Overall Study|Physician Decision|0|||
105704530|NCT05121480|364582301|FG001|Overall Study|Physician Decision|0|||
105704531|NCT05121480|364582302|FG002|Overall Study|Physician Decision|0|||
105704532|NCT05121480|364582303|FG003|Overall Study|Physician Decision|0|||
105704533|NCT05121480|364582304|FG004|Overall Study|Physician Decision|0|||
105704534|NCT05121480|364582305|FG005|Overall Study|Physician Decision|1|||
105704535|NCT05121480|364582306|FG006|Overall Study|Physician Decision|0|||
105704536|NCT05121480|364582307|FG007|Overall Study|Physician Decision|1|||
105704537|NCT05121480|364582300|FG000|Overall Study|Other Reason|0|||
105704538|NCT05121480|364582301|FG001|Overall Study|Other Reason|0|||
105704539|NCT05121480|364582302|FG002|Overall Study|Other Reason|0|||
105704540|NCT05121480|364582303|FG003|Overall Study|Other Reason|0|||
105704541|NCT05121480|364582304|FG004|Overall Study|Other Reason|0|||
105704542|NCT05121480|364582305|FG005|Overall Study|Other Reason|1|||
105926532|NCT00088153|365389876|FG001|Overall Study|Physician Decision|3|||
105926533|NCT00088153|365389875|FG000|Overall Study|Withdrawal by Subject|10|||
105926534|NCT00088153|365389876|FG001|Overall Study|Withdrawal by Subject|10|||
105926535|NCT00088153|365389875|FG000|Overall Study|Lost to Follow-up|11|||
105926536|NCT00088153|365389876|FG001|Overall Study|Lost to Follow-up|12|||
105926537|NCT00157755|365389878|FG000|Overall Study|Death|2|||
105926538|NCT00157755|365389879|FG001|Overall Study|Death|3|||
105926539|NCT00157755|365389880|FG002|Overall Study|Death|3|||
105926540|NCT00157755|365389881|FG003|Overall Study|Death|2|||
105926541|NCT00157755|365389882|FG004|Overall Study|Death|0|||
105926542|NCT00157755|365389883|FG005|Overall Study|Death|0|||
105926543|NCT00157755|365389878|FG000|Overall Study|Lost to Follow-up|0|||
105926544|NCT00157755|365389879|FG001|Overall Study|Lost to Follow-up|0|||
105926545|NCT00157755|365389880|FG002|Overall Study|Lost to Follow-up|1|||
105926546|NCT00157755|365389881|FG003|Overall Study|Lost to Follow-up|0|||
105926547|NCT00157755|365389882|FG004|Overall Study|Lost to Follow-up|0|||
105926548|NCT00157755|365389883|FG005|Overall Study|Lost to Follow-up|0|||
105926549|NCT00157755|365389878|FG000|Overall Study|Withdrawal by Subject|0|||
105926550|NCT00157755|365389879|FG001|Overall Study|Withdrawal by Subject|0|||
105926551|NCT00157755|365389880|FG002|Overall Study|Withdrawal by Subject|1|||
105926552|NCT00157755|365389881|FG003|Overall Study|Withdrawal by Subject|1|||
105926553|NCT00157755|365389882|FG004|Overall Study|Withdrawal by Subject|1|||
105926554|NCT00157755|365389883|FG005|Overall Study|Withdrawal by Subject|2|||
105926555|NCT00157755|365389878|FG000|Overall Study|Explant due to infection|0|||
105926556|NCT00157755|365389879|FG001|Overall Study|Explant due to infection|0|||
105926557|NCT00157755|365389880|FG002|Overall Study|Explant due to infection|1|||
105926558|NCT00157755|365389881|FG003|Overall Study|Explant due to infection|0|||
105926559|NCT00157755|365389882|FG004|Overall Study|Explant due to infection|0|||
105926560|NCT00157755|365389883|FG005|Overall Study|Explant due to infection|0|||
105926561|NCT00157755|365389878|FG000|Overall Study|Medical reason|0|||
105926562|NCT00157755|365389879|FG001|Overall Study|Medical reason|0|||
105926563|NCT00157755|365389880|FG002|Overall Study|Medical reason|1|||
105926564|NCT00157755|365389881|FG003|Overall Study|Medical reason|1|||
105926565|NCT00157755|365389882|FG004|Overall Study|Medical reason|0|||
105926566|NCT00157755|365389883|FG005|Overall Study|Medical reason|0|||
105926567|NCT00157755|365389878|FG000|Overall Study|Study site closure|0|||
105926568|NCT00157755|365389879|FG001|Overall Study|Study site closure|1|||
105926569|NCT00157755|365389880|FG002|Overall Study|Study site closure|0|||
105926570|NCT00157755|365389881|FG003|Overall Study|Study site closure|0|||
105926571|NCT00157755|365389882|FG004|Overall Study|Study site closure|0|||
105926572|NCT00157755|365389883|FG005|Overall Study|Study site closure|0|||
105704543|NCT05121480|364582306|FG006|Overall Study|Other Reason|1|||
105926573|NCT00157755|365389878|FG000|Overall Study|Subject non-compliance|0|||
105926574|NCT00157755|365389879|FG001|Overall Study|Subject non-compliance|0|||
105704544|NCT05121480|364582307|FG007|Overall Study|Other Reason|1|||
105704545|NCT00666458|364582308|FG000|Overall Study|Adverse Event|8|||
105926575|NCT00157755|365389880|FG002|Overall Study|Subject non-compliance|0|||
105926576|NCT00157755|365389881|FG003|Overall Study|Subject non-compliance|0|||
105926577|NCT00157755|365389882|FG004|Overall Study|Subject non-compliance|0|||
105926578|NCT00157755|365389883|FG005|Overall Study|Subject non-compliance|1|||
105926579|NCT00157755|365389878|FG000|Overall Study|Study completion|0|||
105704546|NCT00666458|364582309|FG001|Overall Study|Adverse Event|7|||
105704547|NCT00666458|364582308|FG000|Overall Study|Withdrawal by Subject|5|||
105704548|NCT00666458|364582309|FG001|Overall Study|Withdrawal by Subject|4|||
105704549|NCT00666458|364582308|FG000|Overall Study|Lost to Follow-up|0|||
105704550|NCT00666458|364582309|FG001|Overall Study|Lost to Follow-up|3|||
105926580|NCT00157755|365389879|FG001|Overall Study|Study completion|0|||
105926581|NCT00157755|365389880|FG002|Overall Study|Study completion|0|||
105926582|NCT00157755|365389881|FG003|Overall Study|Study completion|0|||
105926583|NCT00157755|365389882|FG004|Overall Study|Study completion|1|||
105704551|NCT00666458|364582308|FG000|Overall Study|Administrative reason by sponsor|1|||
105926584|NCT00157755|365389883|FG005|Overall Study|Study completion|2|||
106006776|NCT01691794|365688322|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
106006777|NCT01691794|365688323|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
106006778|NCT01691794|365688321|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
106006779|NCT01691794|365688322|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
106006780|NCT01691794|365688323|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
106006781|NCT00844844|365688324|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
106006782|NCT00844844|365688324|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
106006783|NCT00844844|365688324|FG000|Extension Treatment Period|Adverse Event|2|||
106006784|NCT00844844|365688324|FG000|Post Treatment Period|Withdrawal by Subject|1|||
106006785|NCT02016781|365688328|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
106006786|NCT02016781|365688329|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
106006787|NCT02016781|365688328|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
106006788|NCT02016781|365688329|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
106006789|NCT02016781|365688328|FG000|Final Database Lock|Withdrawal by Subject|2|||
106006790|NCT02016781|365688329|FG001|Final Database Lock|Withdrawal by Subject|1|||
106006791|NCT02016781|365688328|FG000|Final Database Lock|Lost to Follow-up|11|||
106006792|NCT02016781|365688329|FG001|Final Database Lock|Lost to Follow-up|4|||
106006793|NCT02016781|365688328|FG000|Final Database Lock|Missing data|0|||
106006794|NCT02016781|365688329|FG001|Final Database Lock|Missing data|3|||
106006795|NCT01400698|365688340|FG000|Overall Study|Lost to Follow-up|2|||
106006796|NCT01400698|365688341|FG001|Overall Study|Lost to Follow-up|5|||
105704552|NCT00666458|364582309|FG001|Overall Study|Administrative reason by sponsor|1|||
105704553|NCT00666458|364582308|FG000|Overall Study|Incorrect enrollment|7|||
105704554|NCT00666458|364582309|FG001|Overall Study|Incorrect enrollment|1|||
105704555|NCT00666458|364582308|FG000|Overall Study|Study specific discontinuation criteria|14|||
105704556|NCT00666458|364582309|FG001|Overall Study|Study specific discontinuation criteria|7|||
105704557|NCT00666458|364582308|FG000|Overall Study|Severe non-compliance to the protocol|1|||
105704558|NCT00666458|364582309|FG001|Overall Study|Severe non-compliance to the protocol|1|||
105704559|NCT00666458|364582308|FG000|Overall Study|Safety reasons|1|||
105704560|NCT00666458|364582309|FG001|Overall Study|Safety reasons|0|||
105704561|NCT00666458|364582308|FG000|Overall Study|Medical history of anemia|1|||
105704562|NCT00666458|364582309|FG001|Overall Study|Medical history of anemia|0|||
105704563|NCT02222207|364582310|FG000|Overall Study|Death|1|||
105704564|NCT02222207|364582310|FG000|Overall Study|Other reasons|2|||
105704565|NCT02222207|364582310|FG000|Overall Study|Adverse Event|1|||
105704566|NCT01230307|364582316|FG000|Overall Study|LVAD Placement|0|||
105704567|NCT01230307|364582317|FG001|Overall Study|LVAD Placement|2|||
105704568|NCT00530894|364582322|FG000|Overall Study|Death|84|||
105704569|NCT00530894|364582323|FG001|Overall Study|Death|89|||
105704570|NCT00530894|364582324|FG002|Overall Study|Death|55|||
105704571|NCT00530894|364582325|FG003|Overall Study|Death|89|||
105704572|NCT00530894|364582322|FG000|Overall Study|Lost to Follow-up|1|||
105704573|NCT00530894|364582323|FG001|Overall Study|Lost to Follow-up|3|||
105704574|NCT00530894|364582324|FG002|Overall Study|Lost to Follow-up|0|||
105704575|NCT00530894|364582325|FG003|Overall Study|Lost to Follow-up|0|||
105704576|NCT00530894|364582322|FG000|Overall Study|Withdrawal by Subject|1|||
105704577|NCT00530894|364582323|FG001|Overall Study|Withdrawal by Subject|23|||
105704578|NCT00530894|364582324|FG002|Overall Study|Withdrawal by Subject|0|||
105704579|NCT00530894|364582325|FG003|Overall Study|Withdrawal by Subject|5|||
105704580|NCT00530894|364582322|FG000|Overall Study|Alive and censored prior to 1 year|2|||
105704581|NCT00530894|364582323|FG001|Overall Study|Alive and censored prior to 1 year|0|||
105704582|NCT00530894|364582324|FG002|Overall Study|Alive and censored prior to 1 year|0|||
105704583|NCT00530894|364582325|FG003|Overall Study|Alive and censored prior to 1 year|0|||
105704584|NCT02256540|364582326|FG000|Overall Study|Withdrawal by Subject|0|||
105704585|NCT02256540|364582327|FG001|Overall Study|Withdrawal by Subject|1|||
105704586|NCT02256540|364582328|FG002|Overall Study|Withdrawal by Subject|1|||
105704587|NCT02256540|364582326|FG000|Overall Study|Back pain preventing exercise|0|||
105704588|NCT02256540|364582327|FG001|Overall Study|Back pain preventing exercise|0|||
105704589|NCT02256540|364582328|FG002|Overall Study|Back pain preventing exercise|1|||
105704590|NCT01230242|364582329|FG000|Overall Study|Physician Decision|2|||
105704591|NCT01230242|364582329|FG000|Overall Study|Withdrawal by Subject|1|||
106006797|NCT01400698|365688342|FG002|Overall Study|Lost to Follow-up|2|||
106006798|NCT01400698|365688343|FG003|Overall Study|Lost to Follow-up|1|||
106006799|NCT01400698|365688344|FG004|Overall Study|Lost to Follow-up|4|||
106006800|NCT01400698|365688345|FG005|Overall Study|Lost to Follow-up|3|||
106006801|NCT01400698|365688340|FG000|Overall Study|Withdrawal by Subject|8|||
106006802|NCT01400698|365688341|FG001|Overall Study|Withdrawal by Subject|2|||
106006803|NCT01400698|365688342|FG002|Overall Study|Withdrawal by Subject|0|||
106006804|NCT01400698|365688343|FG003|Overall Study|Withdrawal by Subject|4|||
106006805|NCT01400698|365688344|FG004|Overall Study|Withdrawal by Subject|1|||
106006806|NCT01400698|365688345|FG005|Overall Study|Withdrawal by Subject|3|||
105704592|NCT04329702|364582336|FG000|Overall Study|illness|3|||
105704593|NCT04329702|364582337|FG001|Overall Study|illness|4|||
106133749|NCT00916006|366148179|FG000|Overall Study|Adverse Event|1|||
105704594|NCT04329702|364582338|FG002|Overall Study|illness|0|||
106006807|NCT01400698|365688340|FG000|Overall Study|Protocol Violation|0|||
106006808|NCT01400698|365688341|FG001|Overall Study|Protocol Violation|1|||
106006809|NCT01400698|365688342|FG002|Overall Study|Protocol Violation|0|||
106006810|NCT01400698|365688343|FG003|Overall Study|Protocol Violation|0|||
106006811|NCT01400698|365688344|FG004|Overall Study|Protocol Violation|1|||
106006812|NCT01400698|365688345|FG005|Overall Study|Protocol Violation|0|||
106006813|NCT01400698|365688340|FG000|Overall Study|Non-compliance|0|||
106006814|NCT01400698|365688341|FG001|Overall Study|Non-compliance|1|||
106006815|NCT01400698|365688342|FG002|Overall Study|Non-compliance|0|||
106006816|NCT01400698|365688343|FG003|Overall Study|Non-compliance|1|||
106006817|NCT01400698|365688344|FG004|Overall Study|Non-compliance|0|||
106006818|NCT01400698|365688345|FG005|Overall Study|Non-compliance|0|||
106006819|NCT01400698|365688340|FG000|Overall Study|Adverse Event|1|||
106006820|NCT01400698|365688341|FG001|Overall Study|Adverse Event|0|||
106006821|NCT01400698|365688342|FG002|Overall Study|Adverse Event|0|||
106006822|NCT01400698|365688343|FG003|Overall Study|Adverse Event|0|||
106006823|NCT01400698|365688344|FG004|Overall Study|Adverse Event|0|||
106006824|NCT01400698|365688345|FG005|Overall Study|Adverse Event|0|||
106006825|NCT01400698|365688340|FG000|Overall Study|Other|4|||
105704595|NCT04329702|364582336|FG000|Overall Study|Lost to Follow-up|0|||
105704596|NCT04329702|364582337|FG001|Overall Study|Lost to Follow-up|0|||
105704597|NCT04329702|364582338|FG002|Overall Study|Lost to Follow-up|2|||
105704598|NCT04329702|364582336|FG000|Overall Study|Death|0|||
105704599|NCT04329702|364582337|FG001|Overall Study|Death|2|||
105704600|NCT04329702|364582338|FG002|Overall Study|Death|0|||
105704601|NCT00766532|364582339|FG000|Overall Study|Protocol Violation|2|||
105704602|NCT03719690|364582342|FG000|Overall Study|Withdrawal by Subject|5|||
105704603|NCT03719690|364582343|FG001|Overall Study|Withdrawal by Subject|10|||
105704604|NCT03719690|364582342|FG000|Overall Study|Death|40|||
105704605|NCT03719690|364582343|FG001|Overall Study|Death|149|||
105704606|NCT03719690|364582342|FG000|Overall Study|Miscellaneous|12|||
105704607|NCT03719690|364582343|FG001|Overall Study|Miscellaneous|56|||
105704608|NCT03719690|364582342|FG000|Overall Study|Lost to Follow-up|2|||
105704609|NCT03719690|364582343|FG001|Overall Study|Lost to Follow-up|18|||
105704610|NCT03719690|364582342|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
105704611|NCT03719690|364582343|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
105704612|NCT00573430|364582346|FG000|Overall Study|Incorrect enrollment of randomization|0|||
106006826|NCT01400698|365688341|FG001|Overall Study|Other|2|||
105704613|NCT00573430|364582347|FG001|Overall Study|Incorrect enrollment of randomization|4|||
105704614|NCT00573430|364582348|FG002|Overall Study|Incorrect enrollment of randomization|3|||
105704615|NCT00573430|364582346|FG000|Overall Study|Adverse Event|0|||
106006827|NCT01400698|365688342|FG002|Overall Study|Other|0|||
106006828|NCT01400698|365688343|FG003|Overall Study|Other|2|||
106006829|NCT01400698|365688344|FG004|Overall Study|Other|1|||
106006830|NCT01400698|365688345|FG005|Overall Study|Other|0|||
106006831|NCT05472090|365688346|FG000|Overall Study|Adverse Event|2|||
106006832|NCT05472090|365688347|FG001|Overall Study|Adverse Event|3|||
106006833|NCT05472090|365688346|FG000|Overall Study|Lack of Efficacy|1|||
106006834|NCT05472090|365688347|FG001|Overall Study|Lack of Efficacy|0|||
105704616|NCT00573430|364582347|FG001|Overall Study|Adverse Event|0|||
105704617|NCT00573430|364582348|FG002|Overall Study|Adverse Event|2|||
105704618|NCT00573430|364582346|FG000|Overall Study|Withdrawal by Subject|1|||
105704619|NCT00573430|364582347|FG001|Overall Study|Withdrawal by Subject|0|||
105704620|NCT00573430|364582348|FG002|Overall Study|Withdrawal by Subject|1|||
105704621|NCT00573430|364582346|FG000|Overall Study|Protocol Violation|0|||
106006835|NCT05472090|365688346|FG000|Overall Study|Physician Decision|1|||
106006836|NCT05472090|365688347|FG001|Overall Study|Physician Decision|0|||
106133750|NCT00916006|366148180|FG001|Overall Study|Adverse Event|1|||
106133751|NCT00916006|366148179|FG000|Overall Study|Withdrawal by Subject|2|||
106133752|NCT00916006|366148180|FG001|Overall Study|Withdrawal by Subject|5|||
106133753|NCT00916006|366148179|FG000|Overall Study|Protocol Violation|0|||
106133754|NCT00916006|366148180|FG001|Overall Study|Protocol Violation|1|||
106133755|NCT00783692|366148191|FG000|Induction Phase|Adverse Event|7|||
106133756|NCT00783692|366148192|FG001|Induction Phase|Adverse Event|9|||
105704622|NCT00573430|364582347|FG001|Overall Study|Protocol Violation|1|||
105704623|NCT00573430|364582348|FG002|Overall Study|Protocol Violation|1|||
105704624|NCT00573430|364582346|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105704625|NCT00573430|364582347|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105704626|NCT00573430|364582348|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
105704627|NCT00769002|364582350|FG000|Overall Study|Study was not completed, no data|9|||
105704628|NCT00769002|364582351|FG001|Overall Study|Study was not completed, no data|9|||
105704629|NCT01918007|364582352|FG000|Overall Study|Baseline oximetry not acceptable|11|||
105704630|NCT01918007|364582353|FG001|Overall Study|Baseline oximetry not acceptable|7|||
105704631|NCT01918007|364582352|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
105704632|NCT01918007|364582353|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
105704633|NCT01918007|364582352|FG000|Overall Study|Lost to Follow-up|4|||
105704634|NCT01918007|364582353|FG001|Overall Study|Lost to Follow-up|7|||
105704635|NCT03363321|364582354|FG000|Overall Study|Withdrawal by Subject|0|||
105704636|NCT03363321|364582355|FG001|Overall Study|Withdrawal by Subject|1|||
105704637|NCT03363321|364582356|FG002|Overall Study|Withdrawal by Subject|0|||
105704638|NCT03363321|364582357|FG003|Overall Study|Withdrawal by Subject|1|||
105704639|NCT03363321|364582358|FG004|Overall Study|Withdrawal by Subject|0|||
105704640|NCT00930761|364582360|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
105926585|NCT01757847|365389889|FG000|Overall Study|Withdrawal by Subject|3|||
105926586|NCT01757847|365389890|FG001|Overall Study|Withdrawal by Subject|4|||
105926587|NCT00325416|365389891|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
105926588|NCT00325416|365389892|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
105926589|NCT00325416|365389891|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
105926590|NCT00325416|365389892|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
105926591|NCT00325416|365389891|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
105926592|NCT00325416|365389892|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
105926593|NCT00325416|365389891|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
105926594|NCT00325416|365389892|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
105926595|NCT00325416|365389891|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
105926596|NCT00325416|365389892|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
105926597|NCT00325416|365389891|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
105926598|NCT00325416|365389892|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
105926599|NCT02324153|365389898|FG000|Overall Study|Withdrawal by Subject|4|||
105926600|NCT02324153|365389899|FG001|Overall Study|Withdrawal by Subject|1|||
105926601|NCT02324153|365389898|FG000|Overall Study|Surgery postponed after randomization|3|||
105926602|NCT02324153|365389899|FG001|Overall Study|Surgery postponed after randomization|0|||
105926603|NCT02324153|365389898|FG000|Overall Study|Developed delirium preoperatively|1|||
105926604|NCT02324153|365389899|FG001|Overall Study|Developed delirium preoperatively|0|||
105926605|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
105926606|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
105926607|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
105926608|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
105926609|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
105926610|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
105926611|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
105926612|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
105926613|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
105926614|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
105926615|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
105926616|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
105926617|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
105926618|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
105926619|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
106133757|NCT00783692|366148193|FG002|Induction Phase|Adverse Event|24|||
106133758|NCT00783692|366148194|FG003|Induction Phase|Adverse Event|0|||
105926620|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
105926621|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
106133759|NCT00783692|366148195|FG004|Induction Phase|Adverse Event|0|||
105704641|NCT00930761|364582361|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
105704642|NCT00930761|364582360|FG000|Overall Study|less than 3 music therapy sessions|0|||
106006837|NCT05472090|365688346|FG000|Overall Study|Withdrawal by Subject|2|||
106006838|NCT05472090|365688347|FG001|Overall Study|Withdrawal by Subject|0|||
106006839|NCT05472090|365688346|FG000|Overall Study|Lost to Follow-up|0|||
106006840|NCT05472090|365688347|FG001|Overall Study|Lost to Follow-up|3|||
106006841|NCT00740220|365690212|FG000|Overall Study|screen failures (non-COPD patients)|9|||
106006842|NCT00812708|365690217|FG000|Overall Study|Device could not be implanted|2|||
106006843|NCT00812708|365690217|FG000|Overall Study|Lack of medical insurance|1|||
106006844|NCT00812708|365690217|FG000|Overall Study|Switched to another study|1|||
105704643|NCT00930761|364582361|FG001|Overall Study|less than 3 music therapy sessions|3|||
105704644|NCT01118351|364582362|FG000|Overall Study|Adverse Event|3|||
106006845|NCT00812708|365690217|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
106006846|NCT00812708|365690217|FG000|Overall Study|Signed consent but later withdrew|3|||
106006847|NCT01959503|365690218|FG000|Overall Study|Death|2|||
106006848|NCT01959503|365690219|FG001|Overall Study|Death|1|||
106006849|NCT01959503|365690218|FG000|Overall Study|Randomized but not treated|1|||
106006850|NCT01959503|365690219|FG001|Overall Study|Randomized but not treated|1|||
106006851|NCT04235140|365690228|FG000|Overall Study|Adverse Event|2|||
106006852|NCT04235140|365690228|FG000|Overall Study|Lost to Follow-up|1|||
106006853|NCT04235140|365690228|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
106006854|NCT04235140|365690228|FG000|Overall Study|Commercial drug is available for participants|7|||
106133760|NCT00783692|366148196|FG005|Induction Phase|Adverse Event|0|||
106133761|NCT00783692|366148197|FG006|Induction Phase|Adverse Event|0|||
106133762|NCT00783692|366148191|FG000|Induction Phase|Protocol Violation|0|||
106133763|NCT00783692|366148192|FG001|Induction Phase|Protocol Violation|0|||
106133764|NCT00783692|366148193|FG002|Induction Phase|Protocol Violation|1|||
105704645|NCT01118351|364582362|FG000|Overall Study|Withdrawal by Subject|1|||
105704646|NCT03221751|364582363|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
105704647|NCT03221751|364582364|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
105704648|NCT01263639|364582365|FG000|Overall Study|Lost to Follow-up|66|||
105704649|NCT01263639|364582366|FG001|Overall Study|Lost to Follow-up|70|||
105704650|NCT01263639|364582365|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
105704651|NCT01263639|364582366|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
105704652|NCT00053417|364582367|FG000|Overall Study|Adverse Event|1|||
105704653|NCT00053417|364582368|FG001|Overall Study|Adverse Event|0|||
105704654|NCT00053417|364582369|FG002|Overall Study|Adverse Event|1|||
105704655|NCT00053417|364582370|FG003|Overall Study|Adverse Event|5|||
105704656|NCT00053417|364582367|FG000|Overall Study|Non-Compliance|0|||
105704657|NCT00053417|364582368|FG001|Overall Study|Non-Compliance|0|||
105704658|NCT00053417|364582369|FG002|Overall Study|Non-Compliance|0|||
105704659|NCT00053417|364582370|FG003|Overall Study|Non-Compliance|1|||
105704660|NCT00053417|364582367|FG000|Overall Study|Withdrawal by Subject|0|||
105704661|NCT00053417|364582368|FG001|Overall Study|Withdrawal by Subject|1|||
105704662|NCT00053417|364582369|FG002|Overall Study|Withdrawal by Subject|0|||
105704663|NCT00053417|364582370|FG003|Overall Study|Withdrawal by Subject|0|||
105704664|NCT00053417|364582367|FG000|Overall Study|Lost to Follow-up|1|||
105704665|NCT00053417|364582368|FG001|Overall Study|Lost to Follow-up|1|||
105704666|NCT00053417|364582369|FG002|Overall Study|Lost to Follow-up|0|||
105704667|NCT00053417|364582370|FG003|Overall Study|Lost to Follow-up|0|||
105704668|NCT04951037|364582371|FG000|Overall Study|Lost to Follow-up|16|||
105704669|NCT04951037|364582371|FG000|Overall Study|Withdrawal by Subject|5|||
105704670|NCT04951037|364582371|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
105704671|NCT00183274|364582372|FG000|Phase 1: Open-Label|Adverse Event|31|||
105704672|NCT00183274|364582373|FG001|Phase 1: Open-Label|Adverse Event|0|||
105704673|NCT00183274|364582374|FG002|Phase 1: Open-Label|Adverse Event|0|||
105704674|NCT00183274|364582375|FG003|Phase 1: Open-Label|Adverse Event|0|||
105704675|NCT00183274|364582376|FG004|Phase 1: Open-Label|Adverse Event|0|||
105704676|NCT00183274|364582377|FG005|Phase 1: Open-Label|Adverse Event|0|||
105704677|NCT00183274|364582372|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
105704678|NCT00183274|364582373|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
105704679|NCT00183274|364582374|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
105704680|NCT00183274|364582375|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
105704681|NCT00183274|364582376|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
105926622|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
105926623|NCT01069939|365389907|FG000|Randomised and Included in the Analyses|Removal|1|||
105926624|NCT01069939|365389908|FG001|Randomised and Included in the Analyses|Removal|0|||
105926625|NCT05166876|365389909|FG000|Overall Study|Withdrawal by Subject|1|||
105926626|NCT05166876|365389910|FG001|Overall Study|Withdrawal by Subject|0|||
105926627|NCT05166876|365389911|FG002|Overall Study|Withdrawal by Subject|0|||
105926628|NCT00658528|365389912|FG000|Overall Study|Adverse Event|5|||
105926629|NCT00658528|365389913|FG001|Overall Study|Adverse Event|7|||
105926630|NCT00658528|365389912|FG000|Overall Study|Lost to Follow-up|14|||
105926631|NCT00658528|365389913|FG001|Overall Study|Lost to Follow-up|22|||
105926632|NCT00658528|365389912|FG000|Overall Study|Withdrawal by Subject|8|||
106006855|NCT00672555|365690229|FG000|Overall Study|Lost to Follow-up|4|||
106133765|NCT00783692|366148194|FG003|Induction Phase|Protocol Violation|0|||
106133766|NCT00783692|366148195|FG004|Induction Phase|Protocol Violation|0|||
106006856|NCT00672555|365690229|FG000|Overall Study|Did not want to answer questionnaire|2|||
106006857|NCT00474487|365690230|FG000|Overall Study|Withdrawal by Subject|6|||
106006858|NCT00474487|365690231|FG001|Overall Study|Withdrawal by Subject|0|||
106006859|NCT00474487|365690232|FG002|Overall Study|Withdrawal by Subject|0|||
106006860|NCT00474487|365690233|FG003|Overall Study|Withdrawal by Subject|0|||
106006861|NCT00474487|365690230|FG000|Overall Study|Lost to Follow-up|20|||
106006862|NCT00474487|365690231|FG001|Overall Study|Lost to Follow-up|1|||
106006863|NCT00474487|365690232|FG002|Overall Study|Lost to Follow-up|7|||
106006864|NCT00474487|365690233|FG003|Overall Study|Lost to Follow-up|0|||
105704682|NCT00183274|364582377|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
105704683|NCT00183274|364582372|FG000|Phase 1: Open-Label|Protocol Violation|11|||
105704684|NCT00183274|364582373|FG001|Phase 1: Open-Label|Protocol Violation|0|||
105704685|NCT00183274|364582374|FG002|Phase 1: Open-Label|Protocol Violation|0|||
105704686|NCT00183274|364582375|FG003|Phase 1: Open-Label|Protocol Violation|0|||
105704687|NCT00183274|364582376|FG004|Phase 1: Open-Label|Protocol Violation|0|||
105704688|NCT00183274|364582377|FG005|Phase 1: Open-Label|Protocol Violation|0|||
105704689|NCT00183274|364582372|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
105704690|NCT00183274|364582373|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704691|NCT00183274|364582374|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704692|NCT00183274|364582375|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704693|NCT00183274|364582376|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704694|NCT00183274|364582377|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
105704695|NCT00183274|364582372|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
105704696|NCT00183274|364582373|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
105704697|NCT00183274|364582374|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
105704698|NCT00183274|364582375|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
105704699|NCT00183274|364582376|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
105704700|NCT00183274|364582377|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
105704701|NCT00183274|364582372|FG000|Phase 1: Open-Label|Other|9|||
105704702|NCT00183274|364582373|FG001|Phase 1: Open-Label|Other|0|||
105704703|NCT00183274|364582374|FG002|Phase 1: Open-Label|Other|0|||
105704704|NCT00183274|364582375|FG003|Phase 1: Open-Label|Other|0|||
105704705|NCT00183274|364582376|FG004|Phase 1: Open-Label|Other|0|||
105704706|NCT00183274|364582377|FG005|Phase 1: Open-Label|Other|0|||
105704707|NCT00183274|364582372|FG000|Phase 2: Double-Blind|Relapsed|0|||
105704708|NCT00183274|364582373|FG001|Phase 2: Double-Blind|Relapsed|8|||
105704709|NCT00183274|364582374|FG002|Phase 2: Double-Blind|Relapsed|29|||
105926633|NCT00658528|365389913|FG001|Overall Study|Withdrawal by Subject|6|||
105926634|NCT00658528|365389912|FG000|Overall Study|Withdrawal of consent|5|||
105926635|NCT00658528|365389913|FG001|Overall Study|Withdrawal of consent|6|||
105926636|NCT00658528|365389912|FG000|Overall Study|Other|8|||
105926637|NCT00658528|365389913|FG001|Overall Study|Other|4|||
105926638|NCT01913353|365389914|FG000|Overall Study|Adverse Event|2|||
105926639|NCT01913353|365389915|FG001|Overall Study|Adverse Event|0|||
105926640|NCT01913353|365389914|FG000|Overall Study|Physician Decision|0|||
105926641|NCT01913353|365389915|FG001|Overall Study|Physician Decision|2|||
105926642|NCT01913353|365389914|FG000|Overall Study|Withdrawal by Subject|20|||
105926643|NCT01913353|365389915|FG001|Overall Study|Withdrawal by Subject|6|||
105926644|NCT01913353|365389914|FG000|Overall Study|multiple reasons|10|||
105926645|NCT01913353|365389915|FG001|Overall Study|multiple reasons|7|||
105926646|NCT01147458|365389916|FG000|First Intervention|Study terminated by sponsor|8|||
105926647|NCT01147458|365389917|FG001|First Intervention|Study terminated by sponsor|8|||
105926648|NCT01147458|365389918|FG002|First Intervention|Study terminated by sponsor|7|||
105926649|NCT01147458|365389919|FG003|First Intervention|Study terminated by sponsor|8|||
105926650|NCT01147458|365389916|FG000|First Intervention|Protocol Violation|2|||
105926651|NCT01147458|365389917|FG001|First Intervention|Protocol Violation|3|||
105926652|NCT01147458|365389918|FG002|First Intervention|Protocol Violation|2|||
105926653|NCT01147458|365389919|FG003|First Intervention|Protocol Violation|3|||
105926654|NCT01147458|365389916|FG000|First Intervention|Withdrawal by Subject|3|||
105926655|NCT01147458|365389917|FG001|First Intervention|Withdrawal by Subject|0|||
105926656|NCT01147458|365389918|FG002|First Intervention|Withdrawal by Subject|1|||
105926657|NCT01147458|365389919|FG003|First Intervention|Withdrawal by Subject|0|||
105926658|NCT01147458|365389916|FG000|First Intervention|Adverse Event|0|||
106006865|NCT00474487|365690230|FG000|Overall Study|Inappropriate enrollment|4|||
106006866|NCT00474487|365690231|FG001|Overall Study|Inappropriate enrollment|0|||
106006867|NCT00474487|365690232|FG002|Overall Study|Inappropriate enrollment|7|||
105704710|NCT00183274|364582375|FG003|Phase 2: Double-Blind|Relapsed|0|||
105704711|NCT00183274|364582376|FG004|Phase 2: Double-Blind|Relapsed|0|||
105926659|NCT01147458|365389917|FG001|First Intervention|Adverse Event|3|||
105926660|NCT01147458|365389918|FG002|First Intervention|Adverse Event|2|||
105926661|NCT01147458|365389919|FG003|First Intervention|Adverse Event|3|||
105926662|NCT01147458|365389916|FG000|First Intervention|Other|1|||
105926663|NCT01147458|365389917|FG001|First Intervention|Other|2|||
105926664|NCT01147458|365389918|FG002|First Intervention|Other|0|||
105704712|NCT00183274|364582377|FG005|Phase 2: Double-Blind|Relapsed|0|||
105704713|NCT00183274|364582372|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
105926665|NCT01147458|365389919|FG003|First Intervention|Other|0|||
106006868|NCT00474487|365690233|FG003|Overall Study|Inappropriate enrollment|0|||
105704714|NCT00183274|364582373|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
105704715|NCT00183274|364582374|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
105704716|NCT00183274|364582375|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
105704717|NCT00183274|364582376|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
105704718|NCT00183274|364582377|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
105704719|NCT00183274|364582372|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
105704720|NCT00183274|364582373|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
105704721|NCT00183274|364582374|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
105704722|NCT00183274|364582375|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
105704723|NCT00183274|364582376|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
105704724|NCT00183274|364582377|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
105704725|NCT00183274|364582372|FG000|Phase 3: Double-Blind|Relapsed|0|||
105704726|NCT00183274|364582373|FG001|Phase 3: Double-Blind|Relapsed|0|||
105704727|NCT00183274|364582374|FG002|Phase 3: Double-Blind|Relapsed|0|||
105704728|NCT00183274|364582375|FG003|Phase 3: Double-Blind|Relapsed|1|||
105704729|NCT00183274|364582376|FG004|Phase 3: Double-Blind|Relapsed|11|||
105704730|NCT00183274|364582377|FG005|Phase 3: Double-Blind|Relapsed|2|||
105704731|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
105704732|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
105704733|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
105704734|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
105704735|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
105704736|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
105704737|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
105704738|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
105704739|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
105704740|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
105704741|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
105926666|NCT01147458|365389916|FG000|Second Intervention|Study terminated by sponsor|7|||
105926667|NCT01147458|365389917|FG001|Second Intervention|Study terminated by sponsor|5|||
105926668|NCT01147458|365389918|FG002|Second Intervention|Study terminated by sponsor|5|||
105926669|NCT01147458|365389919|FG003|Second Intervention|Study terminated by sponsor|3|||
105926670|NCT01147458|365389916|FG000|Second Intervention|Protocol Violation|0|||
105926671|NCT01147458|365389917|FG001|Second Intervention|Protocol Violation|1|||
105926672|NCT01147458|365389918|FG002|Second Intervention|Protocol Violation|1|||
105926673|NCT01147458|365389919|FG003|Second Intervention|Protocol Violation|0|||
105926674|NCT01147458|365389916|FG000|Second Intervention|Withdrawal by Subject|0|||
105926675|NCT01147458|365389917|FG001|Second Intervention|Withdrawal by Subject|1|||
105926676|NCT01147458|365389918|FG002|Second Intervention|Withdrawal by Subject|0|||
105926677|NCT01147458|365389919|FG003|Second Intervention|Withdrawal by Subject|0|||
105926678|NCT01147458|365389916|FG000|Second Intervention|Adverse Event|2|||
105926679|NCT01147458|365389917|FG001|Second Intervention|Adverse Event|0|||
105926680|NCT01147458|365389918|FG002|Second Intervention|Adverse Event|1|||
105926681|NCT01147458|365389919|FG003|Second Intervention|Adverse Event|1|||
105926682|NCT01147458|365389916|FG000|Second Intervention|Other|0|||
105926683|NCT01147458|365389917|FG001|Second Intervention|Other|0|||
105926684|NCT01147458|365389918|FG002|Second Intervention|Other|1|||
105926685|NCT01147458|365389919|FG003|Second Intervention|Other|0|||
105926686|NCT03010501|365389920|FG000|Study Week 1|Withdrawal by Subject|2|||
105926687|NCT03010501|365389921|FG001|Study Week 1|Withdrawal by Subject|1|||
105926688|NCT03010501|365389922|FG002|Study Week 1|Withdrawal by Subject|0|||
105926689|NCT03010501|365389923|FG003|Study Week 1|Withdrawal by Subject|2|||
105926690|NCT03010501|365389924|FG004|Study Week 1|Withdrawal by Subject|0|||
105926691|NCT03010501|365389925|FG005|Study Week 1|Withdrawal by Subject|0|||
105926692|NCT03010501|365389920|FG000|Study Week 3|Withdrawal by Subject|0|||
105926693|NCT03010501|365389921|FG001|Study Week 3|Withdrawal by Subject|0|||
105926694|NCT03010501|365389922|FG002|Study Week 3|Withdrawal by Subject|0|||
105926695|NCT03010501|365389923|FG003|Study Week 3|Withdrawal by Subject|1|||
105926696|NCT03010501|365389924|FG004|Study Week 3|Withdrawal by Subject|0|||
105926697|NCT03010501|365389925|FG005|Study Week 3|Withdrawal by Subject|0|||
105926698|NCT03550209|365389927|FG000|Overall Study|Lost to Follow-up|1|||
105926699|NCT03550209|365389928|FG001|Overall Study|Lost to Follow-up|0|||
105926700|NCT03550209|365389929|FG002|Overall Study|Lost to Follow-up|1|||
105704742|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
105704743|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
105926701|NCT03550209|365389930|FG003|Overall Study|Lost to Follow-up|0|||
105926702|NCT03550209|365389927|FG000|Overall Study|Withdrawal by Subject|0|||
105926703|NCT03550209|365389928|FG001|Overall Study|Withdrawal by Subject|3|||
105704744|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
105704745|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
105704746|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
105704747|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
105926704|NCT03550209|365389929|FG002|Overall Study|Withdrawal by Subject|1|||
105926705|NCT03550209|365389930|FG003|Overall Study|Withdrawal by Subject|2|||
106006869|NCT00474487|365690230|FG000|Overall Study|Death|0|||
106006870|NCT00474487|365690231|FG001|Overall Study|Death|1|||
106006871|NCT00474487|365690232|FG002|Overall Study|Death|0|||
106006872|NCT00474487|365690233|FG003|Overall Study|Death|0|||
106006873|NCT02153086|365690237|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
106006874|NCT02153086|365690237|FG000|Overall Study|Other|2|||
106006875|NCT00248625|365690238|FG000|Overall Study|Withdrawal by Subject|0|||
106006876|NCT00248625|365690239|FG001|Overall Study|Withdrawal by Subject|2|||
106006877|NCT02182895|365690243|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
105704748|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
105704749|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
105704750|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
105704751|NCT02706873|364582380|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
105704752|NCT02706873|364582381|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
105704753|NCT02706873|364582382|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
105704754|NCT02706873|364582383|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
105704755|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
105704756|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
105704757|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
105704758|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
105704759|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
105704760|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
105704761|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
105704762|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
105704763|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
105704764|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
105704765|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
105704766|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
105704767|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
105704768|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
105704769|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
105704770|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
105704771|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
105704772|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
105704773|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
105704774|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
105704775|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
105704776|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
105704777|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
105704778|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
105704779|NCT02706873|364582380|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
105704780|NCT02706873|364582381|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
105704781|NCT02706873|364582382|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
105704782|NCT02706873|364582383|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
105704783|NCT00143312|364582398|FG000|Overall Study|Death|11|||
105704784|NCT00143312|364582398|FG000|Overall Study|Adverse Event|2|||
105704785|NCT00143312|364582398|FG000|Overall Study|Lost to Follow-up|1|||
105704786|NCT00143312|364582398|FG000|Overall Study|Other|1|||
105704787|NCT00143312|364582398|FG000|Overall Study|Withdrawal by Subject|1|||
105704788|NCT02863809|364582399|FG000|Overall Study|Adverse Event|8|||
105704789|NCT02863809|364582400|FG001|Overall Study|Adverse Event|8|||
105704790|NCT02863809|364582399|FG000|Overall Study|Withdrawal by Subject|0|||
105704791|NCT02863809|364582400|FG001|Overall Study|Withdrawal by Subject|1|||
105704792|NCT02863809|364582399|FG000|Overall Study|Lost to Follow-up|1|||
105704793|NCT02863809|364582400|FG001|Overall Study|Lost to Follow-up|1|||
105704794|NCT02863809|364582399|FG000|Overall Study|Death|1|||
105704795|NCT02863809|364582400|FG001|Overall Study|Death|0|||
106006878|NCT02182895|365690244|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
106006879|NCT00836589|365690250|FG000|Overall Study|Lost to Follow-up|246|||
106006880|NCT00836589|365690250|FG000|Overall Study|Death|429|||
106006881|NCT00836589|365690250|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
106006882|NCT00074711|365690252|FG000|Overall Study|Withdrawal by Subject|1|||
106006883|NCT00074711|365690253|FG001|Overall Study|Withdrawal by Subject|1|||
105787358|NCT01243762|364874941|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
106006884|NCT00074711|365690252|FG000|Overall Study|Lost to Follow-up|10|||
106133767|NCT00783692|366148196|FG005|Induction Phase|Protocol Violation|0|||
106133768|NCT00783692|366148197|FG006|Induction Phase|Protocol Violation|0|||
105704796|NCT00440947|364582401|FG000|36-Week Induction Phase|Adverse Event|16|||
105704797|NCT00440947|364582402|FG001|36-Week Induction Phase|Adverse Event|0|||
106006885|NCT00074711|365690253|FG001|Overall Study|Lost to Follow-up|8|||
106133769|NCT00783692|366148191|FG000|Induction Phase|Lack of Efficacy|1|||
105704798|NCT00440947|364582403|FG002|36-Week Induction Phase|Adverse Event|0|||
106006886|NCT00074711|365690252|FG000|Overall Study|Participant stopped study drug|4|||
106006887|NCT00074711|365690253|FG001|Overall Study|Participant stopped study drug|6|||
106006888|NCT04201431|365690256|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
106006889|NCT04201431|365690257|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
106006890|NCT04201431|365690258|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
106006891|NCT04629508|365690259|FG000|Overall Study|Adverse Event|1|||
106006892|NCT04629508|365690259|FG000|Overall Study|Death|2|||
106006893|NCT04629508|365690259|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
106006894|NCT03253796|365690264|FG000|Period 1: Run-In|Adverse Event|4|||
106006895|NCT03253796|365690265|FG001|Period 1: Run-In|Adverse Event|0|||
106006896|NCT03253796|365690266|FG002|Period 1: Run-In|Adverse Event|0|||
106006897|NCT03253796|365690267|FG003|Period 1: Run-In|Adverse Event|0|||
106006898|NCT03253796|365690268|FG004|Period 1: Run-In|Adverse Event|0|||
106006899|NCT03253796|365690264|FG000|Period 1: Run-In|Lack of Efficacy|1|||
106006900|NCT03253796|365690265|FG001|Period 1: Run-In|Lack of Efficacy|0|||
106006901|NCT03253796|365690266|FG002|Period 1: Run-In|Lack of Efficacy|0|||
106006902|NCT03253796|365690267|FG003|Period 1: Run-In|Lack of Efficacy|0|||
106006903|NCT03253796|365690268|FG004|Period 1: Run-In|Lack of Efficacy|0|||
106006904|NCT03253796|365690264|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
106006905|NCT03253796|365690265|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
106006906|NCT03253796|365690266|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
106006907|NCT03253796|365690267|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
106006908|NCT03253796|365690268|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
106006909|NCT03253796|365690264|FG000|Period 1: Run-In|Protocol Violation|5|||
106006910|NCT03253796|365690265|FG001|Period 1: Run-In|Protocol Violation|0|||
106006911|NCT03253796|365690266|FG002|Period 1: Run-In|Protocol Violation|0|||
106006912|NCT03253796|365690267|FG003|Period 1: Run-In|Protocol Violation|0|||
106006913|NCT03253796|365690268|FG004|Period 1: Run-In|Protocol Violation|0|||
106006914|NCT03253796|365690264|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
106006915|NCT03253796|365690265|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
106006916|NCT03253796|365690266|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
106006917|NCT03253796|365690267|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
106006918|NCT03253796|365690268|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
106006919|NCT03253796|365690264|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
106006920|NCT03253796|365690265|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
106006921|NCT03253796|365690266|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
106006922|NCT03253796|365690267|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
106006923|NCT03253796|365690268|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
106006924|NCT03253796|365690264|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
106006925|NCT03253796|365690265|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
106006926|NCT03253796|365690266|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
106006927|NCT03253796|365690267|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
106006928|NCT03253796|365690268|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
106006929|NCT03253796|365690264|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
106006930|NCT03253796|365690265|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
106006931|NCT03253796|365690266|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
106006932|NCT03253796|365690267|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
106006933|NCT03253796|365690268|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
106006934|NCT03253796|365690264|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
106006935|NCT03253796|365690265|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
106006936|NCT03253796|365690266|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
106006937|NCT03253796|365690267|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
106006938|NCT03253796|365690268|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
106006939|NCT03253796|365690264|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
106006940|NCT03253796|365690265|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
106006941|NCT03253796|365690266|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
106006942|NCT03253796|365690267|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
106006943|NCT03253796|365690268|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
106006944|NCT03253796|365690264|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
106006945|NCT03253796|365690265|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
106006946|NCT03253796|365690266|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
106006947|NCT03253796|365690267|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
106006948|NCT03253796|365690268|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
106006949|NCT02163538|365690271|FG000|Overall Study|Protocol Violation|1|||
106006950|NCT02163538|365690272|FG001|Overall Study|Protocol Violation|0|||
106006951|NCT02163538|365690271|FG000|Overall Study|Physician Decision|0|||
106006952|NCT02163538|365690272|FG001|Overall Study|Physician Decision|1|||
106006953|NCT01056822|365690282|FG000|Overall Study|Adverse Event|0|||
106006954|NCT01056822|365690283|FG001|Overall Study|Adverse Event|1|||
106006955|NCT01056822|365690282|FG000|Overall Study|Protocol Violation|6|||
106006956|NCT01056822|365690283|FG001|Overall Study|Protocol Violation|5|||
106006957|NCT01056822|365690282|FG000|Overall Study|Withdrawal by Subject|1|||
106006958|NCT01056822|365690283|FG001|Overall Study|Withdrawal by Subject|1|||
106006959|NCT01056822|365690282|FG000|Overall Study|Lost to Follow-up|1|||
106006960|NCT01056822|365690283|FG001|Overall Study|Lost to Follow-up|0|||
106006961|NCT02761330|365690289|FG000|Treatment Week 1|Withdrawal by Subject|0|||
106006962|NCT02761330|365690290|FG001|Treatment Week 1|Withdrawal by Subject|0|||
106006963|NCT02761330|365690291|FG002|Treatment Week 1|Withdrawal by Subject|0|||
106006964|NCT02761330|365690292|FG003|Treatment Week 1|Withdrawal by Subject|1|||
106006965|NCT02761330|365690293|FG004|Treatment Week 1|Withdrawal by Subject|0|||
106006966|NCT02761330|365690294|FG005|Treatment Week 1|Withdrawal by Subject|1|||
106006967|NCT03043313|365690297|FG000|Overall Study|Withdrawal by Subject|5|||
106006968|NCT03043313|365690298|FG001|Overall Study|Withdrawal by Subject|1|||
106006969|NCT03043313|365690299|FG002|Overall Study|Withdrawal by Subject|1|||
106006970|NCT03043313|365690297|FG000|Overall Study|Lost to Follow-up|1|||
106006971|NCT03043313|365690298|FG001|Overall Study|Lost to Follow-up|1|||
106006972|NCT03043313|365690299|FG002|Overall Study|Lost to Follow-up|0|||
106006973|NCT03043313|365690297|FG000|Overall Study|Death|28|||
106006974|NCT03043313|365690298|FG001|Overall Study|Death|26|||
106006975|NCT03043313|365690299|FG002|Overall Study|Death|17|||
106006976|NCT03043313|365690297|FG000|Overall Study|Participation terminated by sponsor|11|||
106006977|NCT03043313|365690298|FG001|Overall Study|Participation terminated by sponsor|13|||
106006978|NCT03043313|365690299|FG002|Overall Study|Participation terminated by sponsor|13|||
106006979|NCT00980954|365690300|FG000|Overall Study|Protocol Violation|9|||
106006980|NCT00980954|365690301|FG001|Overall Study|Protocol Violation|15|||
106006981|NCT00849940|365690302|FG000|Overall Study|Physician Decision|4|||
106006982|NCT04292535|365690307|FG000|Overall Study|Withdrawal by Subject|0|||
106006983|NCT04292535|365690308|FG001|Overall Study|Withdrawal by Subject|0|||
106006984|NCT04292535|365690309|FG002|Overall Study|Withdrawal by Subject|0|||
106006985|NCT04292535|365690310|FG003|Overall Study|Withdrawal by Subject|0|||
106006986|NCT04292535|365690311|FG004|Overall Study|Withdrawal by Subject|0|||
105704799|NCT00440947|364582404|FG003|36-Week Induction Phase|Adverse Event|0|||
105704800|NCT00440947|364582405|FG004|36-Week Induction Phase|Adverse Event|0|||
105704801|NCT00440947|364582401|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
105704802|NCT00440947|364582402|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
105704803|NCT00440947|364582403|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
105704804|NCT00440947|364582404|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
105704805|NCT00440947|364582405|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
105926706|NCT03550209|365389927|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
105926707|NCT03550209|365389928|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
105926708|NCT03550209|365389929|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
105926709|NCT03550209|365389930|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
105926710|NCT02555878|365389931|FG000|Overall Study|Lost to Follow-up|2|||
105926711|NCT02555878|365389932|FG001|Overall Study|Lost to Follow-up|3|||
105926712|NCT02555878|365389931|FG000|Overall Study|Withdrawal by Subject|48|||
105926713|NCT02555878|365389932|FG001|Overall Study|Withdrawal by Subject|48|||
105926714|NCT02555878|365389931|FG000|Overall Study|Adverse Event|12|||
105926715|NCT02555878|365389932|FG001|Overall Study|Adverse Event|8|||
105704806|NCT00440947|364582401|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
105704807|NCT00440947|364582402|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
105704808|NCT00440947|364582403|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
105704809|NCT00440947|364582404|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
105704810|NCT00440947|364582405|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
105704811|NCT00440947|364582401|FG000|36-Week Induction Phase|Non-compliance|10|||
105704812|NCT00440947|364582402|FG001|36-Week Induction Phase|Non-compliance|0|||
105704813|NCT00440947|364582403|FG002|36-Week Induction Phase|Non-compliance|0|||
105704814|NCT00440947|364582404|FG003|36-Week Induction Phase|Non-compliance|0|||
105704815|NCT00440947|364582405|FG004|36-Week Induction Phase|Non-compliance|0|||
105704816|NCT00440947|364582401|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
105704817|NCT00440947|364582402|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
105704818|NCT00440947|364582403|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
105704819|NCT00440947|364582404|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
105704820|NCT00440947|364582405|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
105704821|NCT00440947|364582401|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
105926716|NCT02555878|365389931|FG000|Overall Study|Death|74|||
105926717|NCT02555878|365389932|FG001|Overall Study|Death|59|||
105926718|NCT02555878|365389931|FG000|Overall Study|Protocol Violation|1|||
105926719|NCT02555878|365389932|FG001|Overall Study|Protocol Violation|2|||
105926720|NCT02555878|365389931|FG000|Overall Study|Physician Decision|12|||
106006987|NCT04292535|365690312|FG005|Overall Study|Withdrawal by Subject|0|||
106006988|NCT04292535|365690313|FG006|Overall Study|Withdrawal by Subject|0|||
106006989|NCT04292535|365690314|FG007|Overall Study|Withdrawal by Subject|1|||
106006990|NCT04292535|365690315|FG008|Overall Study|Withdrawal by Subject|0|||
106006991|NCT04292535|365690316|FG009|Overall Study|Withdrawal by Subject|0|||
105787359|NCT01243762|364874942|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105787360|NCT01243762|364874943|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
105787361|NCT01243762|364874944|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
105787362|NCT01243762|364874938|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
105787363|NCT01243762|364874939|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
105787364|NCT01243762|364874940|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
105787365|NCT01243762|364874941|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
105787366|NCT01243762|364874942|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
105787367|NCT01243762|364874943|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
105787368|NCT01243762|364874944|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
105787369|NCT01243762|364874938|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787370|NCT01243762|364874939|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
105787371|NCT01243762|364874940|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787372|NCT01243762|364874941|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787373|NCT01243762|364874942|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
105787374|NCT01243762|364874943|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787375|NCT01243762|364874944|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
105787376|NCT01243762|364874938|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105787377|NCT01243762|364874939|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105926721|NCT02555878|365389932|FG001|Overall Study|Physician Decision|13|||
105926722|NCT02555878|365389931|FG000|Overall Study|Other|17|||
105926723|NCT02555878|365389932|FG001|Overall Study|Other|17|||
105926724|NCT02875080|365389933|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
105926725|NCT02875080|365389934|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
105926726|NCT02875080|365389935|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
105926727|NCT01164475|365389936|FG000|Overall Study|Lack of Efficacy|1|||
105926728|NCT01164475|365389937|FG001|Overall Study|Lack of Efficacy|0|||
105926729|NCT01164475|365389936|FG000|Overall Study|Other|0|||
105926730|NCT01164475|365389937|FG001|Overall Study|Other|1|||
105926731|NCT01164475|365389936|FG000|Overall Study|Progressive disease|0|||
105926732|NCT01164475|365389937|FG001|Overall Study|Progressive disease|1|||
105926733|NCT01164475|365389936|FG000|Overall Study|Protocol Violation|1|||
105926734|NCT01164475|365389937|FG001|Overall Study|Protocol Violation|0|||
105926735|NCT02335944|365389938|FG000|Treatment Phase|Progressive Disease|2|||
105926736|NCT02335944|365389939|FG001|Treatment Phase|Progressive Disease|5|||
105926737|NCT02335944|365389940|FG002|Treatment Phase|Progressive Disease|2|||
105926738|NCT02335944|365389941|FG003|Treatment Phase|Progressive Disease|11|||
105926739|NCT02335944|365389942|FG004|Treatment Phase|Progressive Disease|4|||
105926740|NCT02335944|365389943|FG005|Treatment Phase|Progressive Disease|25|||
105926741|NCT02335944|365389944|FG006|Treatment Phase|Progressive Disease|2|||
105926742|NCT02335944|365389945|FG007|Treatment Phase|Progressive Disease|30|||
105926743|NCT02335944|365389946|FG008|Treatment Phase|Progressive Disease|27|||
105926744|NCT02335944|365389947|FG009|Treatment Phase|Progressive Disease|0|||
105926745|NCT02335944|365389938|FG000|Treatment Phase|Adverse Event|2|||
105926746|NCT02335944|365389939|FG001|Treatment Phase|Adverse Event|0|||
105926747|NCT02335944|365389940|FG002|Treatment Phase|Adverse Event|0|||
105926748|NCT02335944|365389941|FG003|Treatment Phase|Adverse Event|2|||
105926749|NCT02335944|365389942|FG004|Treatment Phase|Adverse Event|1|||
105926750|NCT02335944|365389943|FG005|Treatment Phase|Adverse Event|15|||
105926751|NCT02335944|365389944|FG006|Treatment Phase|Adverse Event|0|||
105926752|NCT02335944|365389945|FG007|Treatment Phase|Adverse Event|5|||
105926753|NCT02335944|365389946|FG008|Treatment Phase|Adverse Event|7|||
105926754|NCT02335944|365389947|FG009|Treatment Phase|Adverse Event|0|||
105926755|NCT02335944|365389938|FG000|Treatment Phase|Physician Decision|0|||
105926756|NCT02335944|365389939|FG001|Treatment Phase|Physician Decision|0|||
106133770|NCT00783692|366148192|FG001|Induction Phase|Lack of Efficacy|3|||
105787378|NCT01243762|364874940|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105926757|NCT02335944|365389940|FG002|Treatment Phase|Physician Decision|0|||
105926758|NCT02335944|365389941|FG003|Treatment Phase|Physician Decision|1|||
105926759|NCT02335944|365389942|FG004|Treatment Phase|Physician Decision|0|||
105926760|NCT02335944|365389943|FG005|Treatment Phase|Physician Decision|6|||
105926761|NCT02335944|365389944|FG006|Treatment Phase|Physician Decision|1|||
105926762|NCT02335944|365389945|FG007|Treatment Phase|Physician Decision|2|||
105926763|NCT02335944|365389946|FG008|Treatment Phase|Physician Decision|1|||
105926764|NCT02335944|365389947|FG009|Treatment Phase|Physician Decision|0|||
105926765|NCT02335944|365389938|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
105926766|NCT02335944|365389939|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
105926767|NCT02335944|365389940|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
105926768|NCT02335944|365389941|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
105926769|NCT02335944|365389942|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
105926770|NCT02335944|365389943|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
105926771|NCT02335944|365389944|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
105926772|NCT02335944|365389945|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
105704822|NCT00440947|364582402|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
105704823|NCT00440947|364582403|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
105704824|NCT00440947|364582404|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
105704825|NCT00440947|364582405|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
105704826|NCT00440947|364582401|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
105704827|NCT00440947|364582402|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
105704828|NCT00440947|364582403|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
105704829|NCT00440947|364582404|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
105704830|NCT00440947|364582405|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
105704831|NCT00440947|364582401|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
105704832|NCT00440947|364582402|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
105704833|NCT00440947|364582403|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
105704834|NCT00440947|364582404|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
105704835|NCT00440947|364582405|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
105704836|NCT00440947|364582401|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
105704837|NCT00440947|364582402|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
105704838|NCT00440947|364582403|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
105704839|NCT00440947|364582404|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
105704840|NCT00440947|364582405|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
105704841|NCT00440947|364582401|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
106006992|NCT04292535|365690317|FG010|Overall Study|Withdrawal by Subject|0|||
106006993|NCT04292535|365690318|FG011|Overall Study|Withdrawal by Subject|0|||
106006994|NCT04292535|365690319|FG012|Overall Study|Withdrawal by Subject|0|||
106006995|NCT04292535|365690320|FG013|Overall Study|Withdrawal by Subject|0|||
105704842|NCT00440947|364582402|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
106006996|NCT04292535|365690307|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
106006997|NCT04292535|365690308|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105704843|NCT00440947|364582403|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
105704844|NCT00440947|364582404|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
105704845|NCT00440947|364582405|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
105704846|NCT00440947|364582401|FG000|36-Week Induction Phase|Incarceration|3|||
105704847|NCT00440947|364582402|FG001|36-Week Induction Phase|Incarceration|0|||
105704848|NCT00440947|364582403|FG002|36-Week Induction Phase|Incarceration|0|||
105704849|NCT00440947|364582404|FG003|36-Week Induction Phase|Incarceration|0|||
105704850|NCT00440947|364582405|FG004|36-Week Induction Phase|Incarceration|0|||
105704851|NCT00440947|364582401|FG000|36-Week Induction Phase|Pregnancy|1|||
105704852|NCT00440947|364582402|FG001|36-Week Induction Phase|Pregnancy|0|||
105704853|NCT00440947|364582403|FG002|36-Week Induction Phase|Pregnancy|0|||
105704854|NCT00440947|364582404|FG003|36-Week Induction Phase|Pregnancy|0|||
105704855|NCT00440947|364582405|FG004|36-Week Induction Phase|Pregnancy|0|||
105704856|NCT00440947|364582401|FG000|48-Week Randomization Phase|Adverse Event|0|||
105704857|NCT00440947|364582402|FG001|48-Week Randomization Phase|Adverse Event|2|||
105704858|NCT00440947|364582403|FG002|48-Week Randomization Phase|Adverse Event|5|||
105704859|NCT00440947|364582404|FG003|48-Week Randomization Phase|Adverse Event|0|||
105704860|NCT00440947|364582405|FG004|48-Week Randomization Phase|Adverse Event|0|||
105704861|NCT00440947|364582401|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
105704862|NCT00440947|364582402|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
105704863|NCT00440947|364582403|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
105704864|NCT00440947|364582404|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
105704865|NCT00440947|364582405|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
105704866|NCT00440947|364582401|FG000|48-Week Randomization Phase|Non-compliance|0|||
105704867|NCT00440947|364582402|FG001|48-Week Randomization Phase|Non-compliance|3|||
105704868|NCT00440947|364582403|FG002|48-Week Randomization Phase|Non-compliance|4|||
105704869|NCT00440947|364582404|FG003|48-Week Randomization Phase|Non-compliance|0|||
105704870|NCT00440947|364582405|FG004|48-Week Randomization Phase|Non-compliance|0|||
105704871|NCT00440947|364582401|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
105704872|NCT00440947|364582402|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
106133771|NCT00783692|366148193|FG002|Induction Phase|Lack of Efficacy|28|||
105704873|NCT00440947|364582403|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
105704874|NCT00440947|364582404|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
105704875|NCT00440947|364582405|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
105704876|NCT00440947|364582401|FG000|48-Week Randomization Phase|Protocol Violation|0|||
105704877|NCT00440947|364582402|FG001|48-Week Randomization Phase|Protocol Violation|0|||
105704878|NCT00440947|364582403|FG002|48-Week Randomization Phase|Protocol Violation|1|||
106006998|NCT04292535|365690309|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
106006999|NCT04292535|365690310|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105704879|NCT00440947|364582404|FG003|48-Week Randomization Phase|Protocol Violation|0|||
106007000|NCT04292535|365690311|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105704880|NCT00440947|364582405|FG004|48-Week Randomization Phase|Protocol Violation|0|||
105704881|NCT00440947|364582401|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
105704882|NCT00440947|364582402|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
105704883|NCT00440947|364582403|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
105704884|NCT00440947|364582404|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
105704885|NCT00440947|364582405|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
105704886|NCT00440947|364582401|FG000|48-Week Randomization Phase|Pregnancy|0|||
105704887|NCT00440947|364582402|FG001|48-Week Randomization Phase|Pregnancy|0|||
105704888|NCT00440947|364582403|FG002|48-Week Randomization Phase|Pregnancy|1|||
105704889|NCT00440947|364582404|FG003|48-Week Randomization Phase|Pregnancy|0|||
105704890|NCT00440947|364582405|FG004|48-Week Randomization Phase|Pregnancy|0|||
105704891|NCT00440947|364582401|FG000|48-Week Randomization Phase|Incarceration|0|||
105704892|NCT00440947|364582402|FG001|48-Week Randomization Phase|Incarceration|3|||
105704893|NCT00440947|364582403|FG002|48-Week Randomization Phase|Incarceration|0|||
105704894|NCT00440947|364582404|FG003|48-Week Randomization Phase|Incarceration|0|||
105704895|NCT00440947|364582405|FG004|48-Week Randomization Phase|Incarceration|0|||
105704896|NCT00440947|364582401|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
105704897|NCT00440947|364582402|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
105704898|NCT00440947|364582403|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
105704899|NCT00440947|364582404|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
105704900|NCT00440947|364582405|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
105704901|NCT00440947|364582401|FG000|48-Week Randomization Phase|Physician Decision|0|||
105704902|NCT00440947|364582402|FG001|48-Week Randomization Phase|Physician Decision|2|||
105704903|NCT00440947|364582403|FG002|48-Week Randomization Phase|Physician Decision|0|||
105704904|NCT00440947|364582404|FG003|48-Week Randomization Phase|Physician Decision|0|||
105704905|NCT00440947|364582405|FG004|48-Week Randomization Phase|Physician Decision|0|||
105704906|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
105704907|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
105704908|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
105704909|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
105704910|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
105704911|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
105704912|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
105704913|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
105704914|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
105704915|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
105704916|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
105704917|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
105704918|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
105704919|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
105704920|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
105704921|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
105704922|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
105704923|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
105704924|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
105704925|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
105704926|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
105704927|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
105704928|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
105704929|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
105704930|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
105926773|NCT02335944|365389946|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
105926774|NCT02335944|365389947|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
105926775|NCT02335944|365389938|FG000|Treatment Phase|Subject/Guardian Decision|0|||
105926776|NCT02335944|365389939|FG001|Treatment Phase|Subject/Guardian Decision|0|||
105926777|NCT02335944|365389940|FG002|Treatment Phase|Subject/Guardian Decision|1|||
105926778|NCT02335944|365389941|FG003|Treatment Phase|Subject/Guardian Decision|0|||
105926779|NCT02335944|365389942|FG004|Treatment Phase|Subject/Guardian Decision|0|||
105926780|NCT02335944|365389943|FG005|Treatment Phase|Subject/Guardian Decision|1|||
105926781|NCT02335944|365389944|FG006|Treatment Phase|Subject/Guardian Decision|0|||
105926782|NCT02335944|365389945|FG007|Treatment Phase|Subject/Guardian Decision|4|||
105926783|NCT02335944|365389946|FG008|Treatment Phase|Subject/Guardian Decision|0|||
105926784|NCT02335944|365389947|FG009|Treatment Phase|Subject/Guardian Decision|0|||
105926785|NCT02335944|365389938|FG000|Post-treatment Follow-up|Progressive Disease|0|||
105926786|NCT02335944|365389939|FG001|Post-treatment Follow-up|Progressive Disease|0|||
105704931|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
105704932|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
105926787|NCT02335944|365389940|FG002|Post-treatment Follow-up|Progressive Disease|0|||
105926788|NCT02335944|365389941|FG003|Post-treatment Follow-up|Progressive Disease|1|||
105704933|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
105704934|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
105704935|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
105704936|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
105704937|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
105704938|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
105704939|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
105704940|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
105704941|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
105926789|NCT02335944|365389942|FG004|Post-treatment Follow-up|Progressive Disease|0|||
105926790|NCT02335944|365389943|FG005|Post-treatment Follow-up|Progressive Disease|9|||
105926791|NCT02335944|365389944|FG006|Post-treatment Follow-up|Progressive Disease|0|||
105704942|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
105704943|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
105704944|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
105704945|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
105704946|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
105704947|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
105704948|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
105704949|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
105926792|NCT02335944|365389945|FG007|Post-treatment Follow-up|Progressive Disease|2|||
105926793|NCT02335944|365389946|FG008|Post-treatment Follow-up|Progressive Disease|3|||
105926794|NCT02335944|365389947|FG009|Post-treatment Follow-up|Progressive Disease|0|||
105926795|NCT02335944|365389938|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926796|NCT02335944|365389939|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926797|NCT02335944|365389940|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926798|NCT02335944|365389941|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926799|NCT02335944|365389942|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926800|NCT02335944|365389943|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
105926801|NCT02335944|365389944|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926802|NCT02335944|365389945|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926803|NCT02335944|365389946|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926804|NCT02335944|365389947|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
105926805|NCT02335944|365389938|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926806|NCT02335944|365389939|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926807|NCT02335944|365389940|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926808|NCT02335944|365389941|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926809|NCT02335944|365389942|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926810|NCT02335944|365389943|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926811|NCT02335944|365389944|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926812|NCT02335944|365389945|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
105926813|NCT02335944|365389946|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926814|NCT02335944|365389947|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
105926815|NCT02335944|365389938|FG000|Post-treatment Follow-up|Adverse Event|0|||
105926816|NCT02335944|365389939|FG001|Post-treatment Follow-up|Adverse Event|0|||
105926817|NCT02335944|365389940|FG002|Post-treatment Follow-up|Adverse Event|0|||
105926818|NCT02335944|365389941|FG003|Post-treatment Follow-up|Adverse Event|0|||
105926819|NCT02335944|365389942|FG004|Post-treatment Follow-up|Adverse Event|0|||
105926820|NCT02335944|365389943|FG005|Post-treatment Follow-up|Adverse Event|1|||
105926821|NCT02335944|365389944|FG006|Post-treatment Follow-up|Adverse Event|0|||
105926822|NCT02335944|365389945|FG007|Post-treatment Follow-up|Adverse Event|0|||
105926823|NCT02335944|365389946|FG008|Post-treatment Follow-up|Adverse Event|0|||
105926824|NCT02335944|365389947|FG009|Post-treatment Follow-up|Adverse Event|0|||
105926825|NCT02335944|365389938|FG000|Post-treatment Follow-up|Death|0|||
105926826|NCT02335944|365389939|FG001|Post-treatment Follow-up|Death|0|||
105926827|NCT02335944|365389940|FG002|Post-treatment Follow-up|Death|0|||
105926828|NCT02335944|365389941|FG003|Post-treatment Follow-up|Death|1|||
105926829|NCT02335944|365389942|FG004|Post-treatment Follow-up|Death|0|||
105926830|NCT02335944|365389943|FG005|Post-treatment Follow-up|Death|1|||
105926831|NCT02335944|365389944|FG006|Post-treatment Follow-up|Death|0|||
105926832|NCT02335944|365389945|FG007|Post-treatment Follow-up|Death|0|||
105704950|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
105704951|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
105704952|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
105926833|NCT02335944|365389946|FG008|Post-treatment Follow-up|Death|0|||
106133772|NCT00783692|366148194|FG003|Induction Phase|Lack of Efficacy|0|||
106133773|NCT00783692|366148195|FG004|Induction Phase|Lack of Efficacy|0|||
106133774|NCT00783692|366148196|FG005|Induction Phase|Lack of Efficacy|0|||
105926834|NCT02335944|365389947|FG009|Post-treatment Follow-up|Death|0|||
105926835|NCT02335944|365389938|FG000|Post-treatment Follow-up|Physician Decision|1|||
105704953|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
105704954|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
105704955|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
105704956|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
105704957|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
105704958|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
105704959|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
105704960|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
105704961|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Other|0|||
105704962|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Other|0|||
105704963|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Other|0|||
105704964|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Other|1|||
105704965|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Other|0|||
105704966|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
105704967|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
105704968|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
105704969|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
105704970|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
105704971|NCT00440947|364582401|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
105704972|NCT00440947|364582402|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
105704973|NCT00440947|364582403|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
105704974|NCT00440947|364582404|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
105704975|NCT00440947|364582405|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
105704976|NCT00974675|364582406|FG000|Overall Study|Adverse Event|2|||
105704977|NCT00974675|364582407|FG001|Overall Study|Adverse Event|1|||
105704978|NCT00974675|364582408|FG002|Overall Study|Adverse Event|1|||
105704979|NCT00974675|364582409|FG003|Overall Study|Adverse Event|1|||
105704980|NCT00974675|364582406|FG000|Overall Study|Physician Decision|0|||
105704981|NCT00974675|364582407|FG001|Overall Study|Physician Decision|0|||
105704982|NCT00974675|364582408|FG002|Overall Study|Physician Decision|1|||
105704983|NCT00974675|364582409|FG003|Overall Study|Physician Decision|0|||
105704984|NCT00974675|364582406|FG000|Overall Study|Participant on holiday; unable to attend|0|||
105926836|NCT02335944|365389939|FG001|Post-treatment Follow-up|Physician Decision|0|||
105926837|NCT02335944|365389940|FG002|Post-treatment Follow-up|Physician Decision|0|||
105926838|NCT02335944|365389941|FG003|Post-treatment Follow-up|Physician Decision|0|||
105926839|NCT02335944|365389942|FG004|Post-treatment Follow-up|Physician Decision|0|||
105926840|NCT02335944|365389943|FG005|Post-treatment Follow-up|Physician Decision|0|||
105926841|NCT02335944|365389944|FG006|Post-treatment Follow-up|Physician Decision|0|||
105926842|NCT02335944|365389945|FG007|Post-treatment Follow-up|Physician Decision|1|||
105926843|NCT02335944|365389946|FG008|Post-treatment Follow-up|Physician Decision|0|||
105926844|NCT02335944|365389947|FG009|Post-treatment Follow-up|Physician Decision|0|||
105926845|NCT00832975|365389948|FG000|Overall Study|Lost to Follow-up|7|||
105926846|NCT00832975|365389948|FG000|Overall Study|Protocol Violation|6|||
105926847|NCT00832975|365389948|FG000|Overall Study|Death|5|||
105926848|NCT00832975|365389948|FG000|Overall Study|Physician Decision|4|||
105926849|NCT00832975|365389948|FG000|Overall Study|Withdrawal by Subject|3|||
105926850|NCT00832975|365389948|FG000|Overall Study|Other reasons|14|||
105926851|NCT01706328|365389954|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
105926852|NCT01706328|365389955|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105926853|NCT01706328|365389956|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
105926854|NCT01706328|365389954|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
105926855|NCT01706328|365389955|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105926856|NCT01706328|365389956|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105926857|NCT01706328|365389954|FG000|2-week Run-in Period|Physician Decision|4|||
106007001|NCT04292535|365690312|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105704985|NCT00974675|364582407|FG001|Overall Study|Participant on holiday; unable to attend|0|||
105704986|NCT00974675|364582408|FG002|Overall Study|Participant on holiday; unable to attend|0|||
105704987|NCT00974675|364582409|FG003|Overall Study|Participant on holiday; unable to attend|1|||
105704988|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
105704989|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
105704990|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
105704991|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
105704992|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
105926858|NCT01706328|365389955|FG001|2-week Run-in Period|Physician Decision|0|||
105926859|NCT01706328|365389956|FG002|2-week Run-in Period|Physician Decision|0|||
105926860|NCT01706328|365389954|FG000|2-week Run-in Period|Adverse Event|4|||
105926861|NCT01706328|365389955|FG001|2-week Run-in Period|Adverse Event|0|||
105926862|NCT01706328|365389956|FG002|2-week Run-in Period|Adverse Event|0|||
105926863|NCT01706328|365389954|FG000|2-week Run-in Period|Lost to Follow-up|2|||
105926864|NCT01706328|365389955|FG001|2-week Run-in Period|Lost to Follow-up|0|||
105926865|NCT01706328|365389956|FG002|2-week Run-in Period|Lost to Follow-up|0|||
106007002|NCT04292535|365690313|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105704993|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
105704994|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
105704995|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
105704996|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
105704997|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
105704998|NCT04041284|364582413|FG000|DB Phase (12 Weeks)|Other than specified|1|||
105704999|NCT04041284|364582414|FG001|DB Phase (12 Weeks)|Other than specified|0|||
105705000|NCT04041284|364582413|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
105705001|NCT04041284|364582414|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
105705002|NCT04041284|364582413|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
105705003|NCT04041284|364582414|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
105705004|NCT04041284|364582413|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
105705005|NCT04041284|364582414|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
105705006|NCT04041284|364582413|FG000|OL Phase (12 Weeks)|Other than specified|6|||
105705007|NCT04041284|364582414|FG001|OL Phase (12 Weeks)|Other than specified|2|||
105705008|NCT00606320|364582415|FG000|Overall Study|Adverse Event|3|||
105705009|NCT00606320|364582415|FG000|Overall Study|Lack of Efficacy|5|||
105705010|NCT00606320|364582415|FG000|Overall Study|Physician Decision|7|||
105705011|NCT00606320|364582415|FG000|Overall Study|Protocol Violation|8|||
105705012|NCT00606320|364582415|FG000|Overall Study|Withdrawal by Subject|10|||
105705013|NCT00606320|364582415|FG000|Overall Study|Progression to depressive phase|4|||
105705014|NCT00563186|364582416|FG000|Overall Study|LOS<48 hours|97|||
105705015|NCT00563186|364582417|FG001|Overall Study|LOS<48 hours|74|||
105705016|NCT00563186|364582416|FG000|Overall Study|Incomplete data|1|||
105705017|NCT00563186|364582417|FG001|Overall Study|Incomplete data|1|||
105705018|NCT04839380|364582418|FG000|Overall Study|Withdrawal by Subject|2|||
105705019|NCT04839380|364582418|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
105705020|NCT00513500|364582419|FG000|Overall Study|Lost to Follow-up|35|||
105705021|NCT00513500|364582420|FG001|Overall Study|Lost to Follow-up|39|||
105705022|NCT00513500|364582419|FG000|Overall Study|Death|2|||
105705023|NCT00513500|364582420|FG001|Overall Study|Death|1|||
105705024|NCT00513500|364582419|FG000|Overall Study|Hospitalized|4|||
105705025|NCT00513500|364582420|FG001|Overall Study|Hospitalized|14|||
105705026|NCT00996944|364582422|FG000|Double-blind Treatment Period|Adverse Event|2|||
105705027|NCT00996944|364582423|FG001|Double-blind Treatment Period|Adverse Event|1|||
105705028|NCT00996944|364582422|FG000|Double-blind Treatment Period|Protocol Violation|1|||
105705029|NCT00996944|364582423|FG001|Double-blind Treatment Period|Protocol Violation|0|||
105705030|NCT00996944|364582422|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
105705031|NCT00996944|364582423|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
105705032|NCT00996944|364582422|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105705033|NCT00996944|364582423|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
105705034|NCT00996944|364582422|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
105705035|NCT00996944|364582423|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
105705036|NCT00769184|364582424|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
105705037|NCT00769184|364582425|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
105705038|NCT00769184|364582424|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
105705039|NCT00769184|364582425|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
105705040|NCT00769184|364582424|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
105705041|NCT00769184|364582425|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
105705042|NCT00889265|364582433|FG000|Overall Study|Adverse Event|1|||
105705043|NCT00889265|364582433|FG000|Overall Study|Lost to Follow-up|5|||
105705044|NCT00889265|364582433|FG000|Overall Study|Protocol Violation|1|||
105705045|NCT00401375|364582437|FG000|Overall Study|Protocol Violation|2|||
105705046|NCT00401375|364582438|FG001|Overall Study|Protocol Violation|2|||
105705047|NCT00401375|364582439|FG002|Overall Study|Protocol Violation|1|||
105705048|NCT00401375|364582437|FG000|Overall Study|Adverse Event|6|||
105705049|NCT00401375|364582438|FG001|Overall Study|Adverse Event|11|||
106007003|NCT04292535|365690314|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
106007004|NCT04292535|365690315|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105705050|NCT00401375|364582439|FG002|Overall Study|Adverse Event|10|||
105705051|NCT00401375|364582437|FG000|Overall Study|Withdrawal by Subject|9|||
105705052|NCT00401375|364582438|FG001|Overall Study|Withdrawal by Subject|7|||
105705053|NCT00401375|364582439|FG002|Overall Study|Withdrawal by Subject|7|||
105705054|NCT00401375|364582437|FG000|Overall Study|Lost to Follow-up|0|||
106007005|NCT04292535|365690316|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105705055|NCT00401375|364582438|FG001|Overall Study|Lost to Follow-up|1|||
105705056|NCT00401375|364582439|FG002|Overall Study|Lost to Follow-up|1|||
106007006|NCT04292535|365690317|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105705057|NCT00401375|364582437|FG000|Overall Study|Other than specified|2|||
105705058|NCT00401375|364582438|FG001|Overall Study|Other than specified|1|||
105705059|NCT00401375|364582439|FG002|Overall Study|Other than specified|3|||
105705060|NCT00401375|364582437|FG000|Overall Study|Randomized but not treated|3|||
105705061|NCT00401375|364582438|FG001|Overall Study|Randomized but not treated|3|||
105705062|NCT00401375|364582439|FG002|Overall Study|Randomized but not treated|3|||
105705063|NCT00361270|364582440|FG000|Overall Study|Death|0|||
105705064|NCT00361270|364582441|FG001|Overall Study|Death|0|||
105705065|NCT00361270|364582442|FG002|Overall Study|Death|0|||
105705066|NCT00361270|364582443|FG003|Overall Study|Death|2|||
105705067|NCT00361270|364582440|FG000|Overall Study|Lost to Follow-up|4|||
105705068|NCT00361270|364582441|FG001|Overall Study|Lost to Follow-up|1|||
105705069|NCT00361270|364582442|FG002|Overall Study|Lost to Follow-up|0|||
105705070|NCT00361270|364582443|FG003|Overall Study|Lost to Follow-up|0|||
105705071|NCT00361270|364582440|FG000|Overall Study|Physician Decision|0|||
105705072|NCT00361270|364582441|FG001|Overall Study|Physician Decision|0|||
105705073|NCT00361270|364582442|FG002|Overall Study|Physician Decision|1|||
105705074|NCT00361270|364582443|FG003|Overall Study|Physician Decision|0|||
105705075|NCT00361270|364582440|FG000|Overall Study|Protocol Violation|9|||
105705076|NCT00361270|364582441|FG001|Overall Study|Protocol Violation|4|||
105705077|NCT00361270|364582442|FG002|Overall Study|Protocol Violation|5|||
105705078|NCT00361270|364582443|FG003|Overall Study|Protocol Violation|4|||
105705079|NCT00361270|364582440|FG000|Overall Study|Withdrawal by Subject|6|||
105705080|NCT00361270|364582441|FG001|Overall Study|Withdrawal by Subject|6|||
105705081|NCT00361270|364582442|FG002|Overall Study|Withdrawal by Subject|3|||
105705082|NCT00361270|364582443|FG003|Overall Study|Withdrawal by Subject|7|||
105705083|NCT00361270|364582440|FG000|Overall Study|Afraid of Hypnosis|1|||
105705084|NCT00361270|364582441|FG001|Overall Study|Afraid of Hypnosis|2|||
105705085|NCT00361270|364582442|FG002|Overall Study|Afraid of Hypnosis|0|||
105705086|NCT00361270|364582443|FG003|Overall Study|Afraid of Hypnosis|0|||
105705087|NCT00361270|364582440|FG000|Overall Study|Problems with Transportation|4|||
105705088|NCT00361270|364582441|FG001|Overall Study|Problems with Transportation|0|||
105705089|NCT00361270|364582442|FG002|Overall Study|Problems with Transportation|0|||
105705090|NCT00361270|364582443|FG003|Overall Study|Problems with Transportation|0|||
105705091|NCT00361270|364582440|FG000|Overall Study|Adverse Event|0|||
105705092|NCT00361270|364582441|FG001|Overall Study|Adverse Event|1|||
105705093|NCT00361270|364582442|FG002|Overall Study|Adverse Event|1|||
105705094|NCT00361270|364582443|FG003|Overall Study|Adverse Event|0|||
105705095|NCT02821715|364582445|FG000|Overall Study|Protocol Violation|1|||
105705096|NCT02821715|364582446|FG001|Overall Study|Protocol Violation|0|||
105705097|NCT02821715|364582447|FG002|Overall Study|Protocol Violation|0|||
105705098|NCT02821715|364582448|FG003|Overall Study|Protocol Violation|0|||
105705099|NCT02821715|364582449|FG004|Overall Study|Protocol Violation|0|||
105705100|NCT02821715|364582450|FG005|Overall Study|Protocol Violation|0|||
105705101|NCT00677014|364582451|FG000|Overall Study|Lost to Follow-up|20|||
105705102|NCT00677014|364582452|FG001|Overall Study|Lost to Follow-up|12|||
105705103|NCT00677014|364582453|FG002|Overall Study|Lost to Follow-up|24|||
105705104|NCT00677014|364582451|FG000|Overall Study|Death|6|||
105705105|NCT00677014|364582452|FG001|Overall Study|Death|15|||
105705106|NCT00677014|364582453|FG002|Overall Study|Death|7|||
105705107|NCT00677014|364582451|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
105705108|NCT00677014|364582452|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
105705109|NCT00677014|364582453|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
105705110|NCT01326546|364582454|FG000|Overall Study|Lost to Follow-up|8|||
105705111|NCT01326546|364582455|FG001|Overall Study|Lost to Follow-up|7|||
105705112|NCT01326546|364582454|FG000|Overall Study|Protocol Violation|3|||
105705113|NCT01326546|364582455|FG001|Overall Study|Protocol Violation|4|||
105705114|NCT01326546|364582454|FG000|Overall Study|Pregnancy|0|||
105705115|NCT01326546|364582455|FG001|Overall Study|Pregnancy|1|||
105705116|NCT01326546|364582454|FG000|Overall Study|Adverse Event|1|||
105705117|NCT01326546|364582455|FG001|Overall Study|Adverse Event|0|||
105705118|NCT01326546|364582454|FG000|Overall Study|Withdrawal by Subject|5|||
105705119|NCT01326546|364582455|FG001|Overall Study|Withdrawal by Subject|1|||
105705120|NCT03152019|364582456|FG000|Overall Study|Adverse Event|0|||
105705121|NCT03152019|364582457|FG001|Overall Study|Adverse Event|1|||
105926866|NCT01706328|365389954|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
105926867|NCT01706328|365389955|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
105926868|NCT01706328|365389956|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
105926869|NCT01706328|365389954|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
105926870|NCT01706328|365389955|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
105926871|NCT01706328|365389956|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
105705122|NCT04294719|364582458|FG000|Overall Study|Withdrawal by Subject|1|||
105705123|NCT00254501|364582462|FG000|Overall Study|Lost to Follow-up|1|||
105705124|NCT00254501|364582463|FG001|Overall Study|Lost to Follow-up|1|||
105705125|NCT04194528|364582471|FG000|Overall Study|Adverse Event|1|||
105926872|NCT01706328|365389954|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
106133775|NCT00783692|366148197|FG006|Induction Phase|Lack of Efficacy|0|||
105705126|NCT03770260|364583693|FG000|Overall Study|Disease progression|0|||
105705127|NCT03770260|364583694|FG001|Overall Study|Disease progression|1|||
105705128|NCT03770260|364583695|FG002|Overall Study|Disease progression|0|||
105705129|NCT03770260|364583696|FG003|Overall Study|Disease progression|0|||
105705130|NCT00609791|364583697|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
105705131|NCT00075400|364583698|FG000|Overall Study|Ineligible: wrong primary|1|||
105705132|NCT00075400|364583698|FG000|Overall Study|Never treated|2|||
105705133|NCT00980200|364583702|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
105705134|NCT00980200|364583703|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
105705135|NCT00980200|364583704|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
105705136|NCT00980200|364583705|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
105705137|NCT00980200|364583706|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
105705138|NCT00980200|364583702|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
105705139|NCT00980200|364583703|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
105705140|NCT00980200|364583704|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
105705141|NCT00980200|364583705|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
105705142|NCT00980200|364583706|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
105705143|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
105705144|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
105705145|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
105705146|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
105705147|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
105705148|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
105705149|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
105705150|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
105705151|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
105705152|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
105705153|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
105705154|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
105705155|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
105705156|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
105705157|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
105705158|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
105705159|NCT03670953|364583712|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
105705160|NCT03670953|364583713|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
105705161|NCT03670953|364583714|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
105705162|NCT03670953|364583715|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
105705163|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
105705164|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
105705165|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
105705166|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
105926873|NCT01706328|365389955|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
105926874|NCT01706328|365389956|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
105926875|NCT01706328|365389954|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
105926876|NCT01706328|365389955|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
105926877|NCT01706328|365389956|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
105926878|NCT01706328|365389954|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
105926879|NCT01706328|365389955|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
105926880|NCT01706328|365389956|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
105926881|NCT01706328|365389954|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
105926882|NCT01706328|365389955|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
105926883|NCT01706328|365389956|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
105926884|NCT01706328|365389954|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105926885|NCT01706328|365389955|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
105926886|NCT01706328|365389956|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
105926887|NCT01202591|365389957|FG000|Overall Study|Adverse Event|2|||
105926888|NCT01202591|365389958|FG001|Overall Study|Adverse Event|1|||
105926889|NCT01202591|365389959|FG002|Overall Study|Adverse Event|4|||
105926890|NCT01202591|365389960|FG003|Overall Study|Adverse Event|4|||
105926891|NCT01202591|365389961|FG004|Overall Study|Adverse Event|0|||
105926892|NCT01202591|365389962|FG005|Overall Study|Adverse Event|0|||
105926893|NCT01202591|365389957|FG000|Overall Study|Other reason as per investigator|3|||
105926894|NCT01202591|365389958|FG001|Overall Study|Other reason as per investigator|4|||
105926895|NCT01202591|365389959|FG002|Overall Study|Other reason as per investigator|7|||
105926896|NCT01202591|365389960|FG003|Overall Study|Other reason as per investigator|3|||
105926897|NCT01202591|365389961|FG004|Overall Study|Other reason as per investigator|1|||
105926898|NCT01202591|365389962|FG005|Overall Study|Other reason as per investigator|3|||
105926899|NCT01202591|365389957|FG000|Overall Study|Withdrawal by Subject|0|||
105926900|NCT01202591|365389958|FG001|Overall Study|Withdrawal by Subject|0|||
105926901|NCT01202591|365389959|FG002|Overall Study|Withdrawal by Subject|0|||
105926902|NCT01202591|365389960|FG003|Overall Study|Withdrawal by Subject|0|||
105926903|NCT01202591|365389961|FG004|Overall Study|Withdrawal by Subject|2|||
105926904|NCT01202591|365389962|FG005|Overall Study|Withdrawal by Subject|1|||
105705167|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
105705168|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
105705169|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
105705170|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
105705171|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
105705172|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
105705173|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
105705174|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
105705175|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
105705176|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
105926905|NCT01202591|365389957|FG000|Overall Study|Objective Disease Progression|0|||
105926906|NCT01202591|365389958|FG001|Overall Study|Objective Disease Progression|0|||
105926907|NCT01202591|365389959|FG002|Overall Study|Objective Disease Progression|0|||
105926908|NCT01202591|365389960|FG003|Overall Study|Objective Disease Progression|0|||
105926909|NCT01202591|365389961|FG004|Overall Study|Objective Disease Progression|2|||
105926910|NCT01202591|365389962|FG005|Overall Study|Objective Disease Progression|0|||
105926911|NCT03018938|365389963|FG000|Overall Study|Death|0|||
105926912|NCT03018938|365389964|FG001|Overall Study|Death|1|||
105926913|NCT03018938|365389963|FG000|Overall Study|Lost to Follow-up|21|||
105926914|NCT03018938|365389964|FG001|Overall Study|Lost to Follow-up|32|||
105926915|NCT03018938|365389963|FG000|Overall Study|Withdrawal by Subject|38|||
105926916|NCT03018938|365389964|FG001|Overall Study|Withdrawal by Subject|45|||
105926917|NCT03018938|365389963|FG000|Overall Study|Physician Decision|3|||
105926918|NCT03018938|365389964|FG001|Overall Study|Physician Decision|2|||
105926919|NCT03018938|365389963|FG000|Overall Study|Sponsor Decision|0|||
105926920|NCT03018938|365389964|FG001|Overall Study|Sponsor Decision|1|||
105926921|NCT03018938|365389963|FG000|Overall Study|Screen failure-After randomization|4|||
105926922|NCT03018938|365389964|FG001|Overall Study|Screen failure-After randomization|2|||
105926923|NCT03018938|365389963|FG000|Overall Study|Not recorded|0|||
105926924|NCT03018938|365389964|FG001|Overall Study|Not recorded|2|||
105926925|NCT02811159|365389965|FG000|Treatment Course 1|Lost to Follow-up|1|||
105926926|NCT00191100|365389966|FG000|Overall Study|Adverse Event|18|||
105926927|NCT00191100|365389967|FG001|Overall Study|Adverse Event|1|||
105926928|NCT00191100|365389966|FG000|Overall Study|Lost to Follow-up|2|||
105926929|NCT00191100|365389967|FG001|Overall Study|Lost to Follow-up|0|||
105926930|NCT00191100|365389966|FG000|Overall Study|Patient Moved|0|||
105926931|NCT00191100|365389967|FG001|Overall Study|Patient Moved|1|||
105926932|NCT00191100|365389966|FG000|Overall Study|Withdrawal by Subject|9|||
105926933|NCT00191100|365389967|FG001|Overall Study|Withdrawal by Subject|3|||
105926934|NCT00191100|365389966|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
105926935|NCT00191100|365389967|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
105926936|NCT00191100|365389966|FG000|Overall Study|Clinical Relapse|2|||
105926937|NCT00191100|365389967|FG001|Overall Study|Clinical Relapse|1|||
105926938|NCT00191100|365389966|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
105926939|NCT00191100|365389967|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
105926940|NCT00191100|365389966|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
105926941|NCT00191100|365389967|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
105926942|NCT00191100|365389966|FG000|Overall Study|Physician Decision|3|||
105926943|NCT00191100|365389967|FG001|Overall Study|Physician Decision|1|||
105926944|NCT00191100|365389966|FG000|Overall Study|Death from Study Drug Toxicity|2|||
105926945|NCT00191100|365389967|FG001|Overall Study|Death from Study Drug Toxicity|0|||
105926946|NCT00191100|365389966|FG000|Overall Study|Protocol Violation|1|||
105926947|NCT00191100|365389967|FG001|Overall Study|Protocol Violation|1|||
105926948|NCT00191100|365389966|FG000|Overall Study|Death from Other Cause|1|||
105926949|NCT00191100|365389967|FG001|Overall Study|Death from Other Cause|0|||
105926950|NCT00191100|365389966|FG000|Overall Study|Reason Not Specified|0|||
105926951|NCT00191100|365389967|FG001|Overall Study|Reason Not Specified|1|||
105926952|NCT02406612|365389970|FG000|Overall Study|Screening Failure|3|||
105926953|NCT02406612|365389971|FG001|Overall Study|Screening Failure|0|||
105926954|NCT02406612|365389970|FG000|Overall Study|Intra-procedural Exclusion|1|||
105926955|NCT02406612|365389971|FG001|Overall Study|Intra-procedural Exclusion|3|||
105926956|NCT02406612|365389970|FG000|Overall Study|Guidewire Failure|0|||
105926957|NCT02406612|365389971|FG001|Overall Study|Guidewire Failure|1|||
105926958|NCT02830087|365389976|FG000|Overall Study|No study staff to follow-up patients|4|||
105926959|NCT02830087|365389977|FG001|Overall Study|No study staff to follow-up patients|4|||
105926960|NCT02830087|365389978|FG002|Overall Study|No study staff to follow-up patients|4|||
105926961|NCT02830087|365389979|FG003|Overall Study|No study staff to follow-up patients|3|||
105926962|NCT02830087|365389980|FG004|Overall Study|No study staff to follow-up patients|3|||
105926963|NCT02830087|365389981|FG005|Overall Study|No study staff to follow-up patients|3|||
105926964|NCT01525589|365389982|FG000|Overall Study|Non-treatment-related AE|1|||
106133776|NCT00783692|366148191|FG000|Induction Phase|Withdrawal by Subject|3|||
105926965|NCT01525589|365389983|FG001|Overall Study|Non-treatment-related AE|0|||
105926966|NCT01525589|365389984|FG002|Overall Study|Non-treatment-related AE|0|||
105926967|NCT01525589|365389982|FG000|Overall Study|Progressive disease|48|||
105926968|NCT01525589|365389983|FG001|Overall Study|Progressive disease|15|||
105926969|NCT01525589|365389984|FG002|Overall Study|Progressive disease|29|||
105926970|NCT01525589|365389982|FG000|Overall Study|Never treated|2|||
105926971|NCT01525589|365389983|FG001|Overall Study|Never treated|0|||
105926972|NCT01525589|365389984|FG002|Overall Study|Never treated|0|||
105926973|NCT01525589|365389982|FG000|Overall Study|Physician Decision|4|||
105926974|NCT01525589|365389983|FG001|Overall Study|Physician Decision|2|||
105926975|NCT01525589|365389984|FG002|Overall Study|Physician Decision|2|||
105926976|NCT01525589|365389982|FG000|Overall Study|Death|0|||
105926977|NCT01525589|365389983|FG001|Overall Study|Death|0|||
105926978|NCT01525589|365389984|FG002|Overall Study|Death|2|||
105926979|NCT01525589|365389982|FG000|Overall Study|Treatment-related AE|1|||
105926980|NCT01525589|365389983|FG001|Overall Study|Treatment-related AE|1|||
105926981|NCT01525589|365389984|FG002|Overall Study|Treatment-related AE|2|||
105926982|NCT01525589|365389982|FG000|Overall Study|Other reasons|0|||
105926983|NCT01525589|365389983|FG001|Overall Study|Other reasons|1|||
105926984|NCT01525589|365389984|FG002|Overall Study|Other reasons|0|||
105926985|NCT01525589|365389982|FG000|Overall Study|Withdrawal by Subject|0|||
105926986|NCT01525589|365389983|FG001|Overall Study|Withdrawal by Subject|1|||
105926987|NCT01525589|365389984|FG002|Overall Study|Withdrawal by Subject|0|||
105926988|NCT00003456|365391841|FG000|Overall Study|Not evaluable|8|||
105926989|NCT00479232|365391842|FG000|Overall Study|Adverse Event|0|||
105926990|NCT00479232|365391843|FG001|Overall Study|Adverse Event|0|||
105926991|NCT00479232|365391844|FG002|Overall Study|Adverse Event|5|||
105926992|NCT00479232|365391845|FG003|Overall Study|Adverse Event|0|||
105926993|NCT00479232|365391846|FG004|Overall Study|Adverse Event|0|||
105926994|NCT00479232|365391847|FG005|Overall Study|Adverse Event|10|||
105926995|NCT00479232|365391842|FG000|Overall Study|Deviation from Protocol|0|||
105926996|NCT00479232|365391843|FG001|Overall Study|Deviation from Protocol|0|||
105926997|NCT00479232|365391844|FG002|Overall Study|Deviation from Protocol|1|||
105926998|NCT00479232|365391845|FG003|Overall Study|Deviation from Protocol|0|||
105926999|NCT00479232|365391846|FG004|Overall Study|Deviation from Protocol|0|||
105927000|NCT00479232|365391847|FG005|Overall Study|Deviation from Protocol|0|||
105927001|NCT00479232|365391842|FG000|Overall Study|Lack of Efficacy|0|||
105927002|NCT00479232|365391843|FG001|Overall Study|Lack of Efficacy|0|||
105927003|NCT00479232|365391844|FG002|Overall Study|Lack of Efficacy|2|||
105927004|NCT00479232|365391845|FG003|Overall Study|Lack of Efficacy|0|||
105927005|NCT00479232|365391846|FG004|Overall Study|Lack of Efficacy|0|||
105927006|NCT00479232|365391847|FG005|Overall Study|Lack of Efficacy|4|||
105927007|NCT00479232|365391842|FG000|Overall Study|Physician Decision|0|||
105927008|NCT00479232|365391843|FG001|Overall Study|Physician Decision|0|||
105927009|NCT00479232|365391844|FG002|Overall Study|Physician Decision|2|||
105927010|NCT00479232|365391845|FG003|Overall Study|Physician Decision|0|||
105927011|NCT00479232|365391846|FG004|Overall Study|Physician Decision|0|||
105927012|NCT00479232|365391847|FG005|Overall Study|Physician Decision|1|||
105927013|NCT00479232|365391842|FG000|Overall Study|Progressive Disease|3|||
105927014|NCT00479232|365391843|FG001|Overall Study|Progressive Disease|1|||
105927015|NCT00479232|365391844|FG002|Overall Study|Progressive Disease|12|||
105927016|NCT00479232|365391845|FG003|Overall Study|Progressive Disease|3|||
105927017|NCT00479232|365391846|FG004|Overall Study|Progressive Disease|3|||
105927018|NCT00479232|365391847|FG005|Overall Study|Progressive Disease|12|||
105927019|NCT00479232|365391842|FG000|Overall Study|Withdrew Consent|0|||
105927020|NCT00479232|365391843|FG001|Overall Study|Withdrew Consent|2|||
105927021|NCT00479232|365391844|FG002|Overall Study|Withdrew Consent|6|||
105927022|NCT00479232|365391845|FG003|Overall Study|Withdrew Consent|0|||
105927023|NCT00479232|365391846|FG004|Overall Study|Withdrew Consent|1|||
105927024|NCT00479232|365391847|FG005|Overall Study|Withdrew Consent|3|||
105927025|NCT01373229|365391848|FG000|Overall Study|Death|3|||
105927026|NCT01373229|365391848|FG000|Overall Study|Physician Decision|3|||
105927027|NCT02293499|365391849|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
105927028|NCT02293499|365391850|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
105927029|NCT02293499|365391851|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
105927030|NCT02293499|365391849|FG000|Intervention - Camp|Withdrawal by Subject|3|||
105927031|NCT02293499|365391850|FG001|Intervention - Camp|Withdrawal by Subject|6|||
105927032|NCT02293499|365391851|FG002|Intervention - Camp|Withdrawal by Subject|2|||
106007007|NCT04292535|365690318|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
105927033|NCT02293499|365391849|FG000|Intervention - Camp|these are those not showing up at camp|24|||
105927034|NCT02293499|365391850|FG001|Intervention - Camp|these are those not showing up at camp|28|||
105927035|NCT02293499|365391851|FG002|Intervention - Camp|these are those not showing up at camp|4|||
105927036|NCT02293499|365391849|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
105927037|NCT02293499|365391850|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
105927038|NCT02293499|365391851|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
105927039|NCT02293499|365391849|FG000|3 Month Follow Up|Lost to Follow-up|14|||
105927040|NCT02293499|365391850|FG001|3 Month Follow Up|Lost to Follow-up|15|||
105927041|NCT02293499|365391851|FG002|3 Month Follow Up|Lost to Follow-up|6|||
105927042|NCT02293499|365391849|FG000|6 Month Follow Up|Lost to Follow-up|17|||
105927043|NCT02293499|365391850|FG001|6 Month Follow Up|Lost to Follow-up|27|||
105927044|NCT02293499|365391851|FG002|6 Month Follow Up|Lost to Follow-up|6|||
105927045|NCT02293499|365391849|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
106007008|NCT04292535|365690319|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
106007009|NCT04292535|365690320|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
106007010|NCT04292535|365690307|FG000|Overall Study|Report of Dizziness|0|||
106007011|NCT04292535|365690308|FG001|Overall Study|Report of Dizziness|0|||
106007012|NCT04292535|365690309|FG002|Overall Study|Report of Dizziness|0|||
106007013|NCT04292535|365690310|FG003|Overall Study|Report of Dizziness|0|||
106007014|NCT04292535|365690311|FG004|Overall Study|Report of Dizziness|0|||
106007015|NCT04292535|365690312|FG005|Overall Study|Report of Dizziness|0|||
106007016|NCT04292535|365690313|FG006|Overall Study|Report of Dizziness|0|||
106007017|NCT04292535|365690314|FG007|Overall Study|Report of Dizziness|0|||
106007018|NCT04292535|365690315|FG008|Overall Study|Report of Dizziness|0|||
106007019|NCT04292535|365690316|FG009|Overall Study|Report of Dizziness|0|||
106007020|NCT04292535|365690317|FG010|Overall Study|Report of Dizziness|0|||
106007021|NCT04292535|365690318|FG011|Overall Study|Report of Dizziness|0|||
106007022|NCT04292535|365690319|FG012|Overall Study|Report of Dizziness|0|||
106007023|NCT04292535|365690320|FG013|Overall Study|Report of Dizziness|1|||
106007024|NCT04292535|365690307|FG000|Overall Study|Equipment Failure|0|||
106007025|NCT04292535|365690308|FG001|Overall Study|Equipment Failure|0|||
106007026|NCT04292535|365690309|FG002|Overall Study|Equipment Failure|0|||
106007027|NCT04292535|365690310|FG003|Overall Study|Equipment Failure|0|||
106007028|NCT04292535|365690311|FG004|Overall Study|Equipment Failure|0|||
106007029|NCT04292535|365690312|FG005|Overall Study|Equipment Failure|0|||
106007030|NCT04292535|365690313|FG006|Overall Study|Equipment Failure|0|||
106007031|NCT04292535|365690314|FG007|Overall Study|Equipment Failure|0|||
106007032|NCT04292535|365690315|FG008|Overall Study|Equipment Failure|0|||
106007033|NCT04292535|365690316|FG009|Overall Study|Equipment Failure|0|||
106007034|NCT04292535|365690317|FG010|Overall Study|Equipment Failure|0|||
106007035|NCT04292535|365690318|FG011|Overall Study|Equipment Failure|1|||
106007036|NCT04292535|365690319|FG012|Overall Study|Equipment Failure|0|||
106007037|NCT04292535|365690320|FG013|Overall Study|Equipment Failure|0|||
106007038|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
106007039|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
106007040|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
106007041|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
106007042|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
106007043|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
106007044|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
106007045|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
106007046|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
106007047|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
106007048|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
106007049|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
106007050|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
106007051|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
106007052|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
106007053|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
106007054|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
106007055|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
106007056|NCT03605667|365690321|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
106007057|NCT03605667|365690322|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
106007058|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
105705177|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
105705178|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
105705179|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
105705180|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
105705181|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
105705182|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
105705183|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
106007059|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
106007060|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Other|6|||
106007061|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Other|8|||
106007062|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
106007063|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
106007064|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
106007065|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
106007066|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
106007067|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
106007068|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
106007069|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
106007070|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
106007071|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
106007072|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
105705184|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
105705185|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
105705186|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
105705187|NCT03670953|364583712|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
105705188|NCT03670953|364583713|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
105705189|NCT03670953|364583714|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
105927046|NCT02293499|365391850|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
105927047|NCT02293499|365391851|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
105927048|NCT02293499|365391849|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
105927049|NCT02293499|365391850|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
105927050|NCT02293499|365391851|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
105927051|NCT02293499|365391849|FG000|9 Month Follow Up|Lost to Follow-up|24|||
105927052|NCT02293499|365391850|FG001|9 Month Follow Up|Lost to Follow-up|28|||
105927053|NCT02293499|365391851|FG002|9 Month Follow Up|Lost to Follow-up|4|||
105927054|NCT02293499|365391849|FG000|12 Month Follow Up|Lost to Follow-up|26|||
105927055|NCT02293499|365391850|FG001|12 Month Follow Up|Lost to Follow-up|25|||
105927056|NCT02293499|365391851|FG002|12 Month Follow Up|Lost to Follow-up|6|||
105927057|NCT02293499|365391849|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
105927058|NCT02293499|365391850|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
105927059|NCT02293499|365391851|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
105927060|NCT02293499|365391849|FG000|15 Month Follow Up|Lost to Follow-up|22|||
105927061|NCT02293499|365391850|FG001|15 Month Follow Up|Lost to Follow-up|22|||
105927062|NCT02293499|365391851|FG002|15 Month Follow Up|Lost to Follow-up|7|||
105927063|NCT01991314|365391857|FG000|Overall Study|Adverse Event|5|||
105927064|NCT01991314|365391858|FG001|Overall Study|Adverse Event|1|||
105927065|NCT01991314|365391857|FG000|Overall Study|Lost to Follow-up|6|||
105927066|NCT01991314|365391858|FG001|Overall Study|Lost to Follow-up|10|||
105927067|NCT00970944|365391859|FG000|Overall Study|Death|1|||
105927068|NCT00970944|365391860|FG001|Overall Study|Death|0|||
105927069|NCT00970944|365391859|FG000|Overall Study|Physician Decision|0|||
105927070|NCT00970944|365391860|FG001|Overall Study|Physician Decision|2|||
105927071|NCT05177094|365391861|FG000|Overall Study|Adverse Event|5|||
105927072|NCT05177094|365391862|FG001|Overall Study|Adverse Event|5|||
105927073|NCT05177094|365391861|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
105927074|NCT05177094|365391862|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
105927075|NCT05177094|365391861|FG000|Overall Study|Protocol Deviation|3|||
105927076|NCT05177094|365391862|FG001|Overall Study|Protocol Deviation|0|||
105927077|NCT05177094|365391861|FG000|Overall Study|Withdrawal by Subject|6|||
105927078|NCT05177094|365391862|FG001|Overall Study|Withdrawal by Subject|3|||
105927079|NCT05177094|365391861|FG000|Overall Study|Participant could not tolerate long study visits|1|||
105927080|NCT05177094|365391862|FG001|Overall Study|Participant could not tolerate long study visits|0|||
105927081|NCT01033942|365391863|FG000|Overall Study|Withdrawal by Subject|1|||
105927082|NCT01033942|365391864|FG001|Overall Study|Withdrawal by Subject|1|||
105927083|NCT01033942|365391865|FG002|Overall Study|Withdrawal by Subject|1|||
105927084|NCT01033942|365391863|FG000|Overall Study|Lost to Follow-up|1|||
105927085|NCT01033942|365391864|FG001|Overall Study|Lost to Follow-up|0|||
105927086|NCT01033942|365391865|FG002|Overall Study|Lost to Follow-up|0|||
105927087|NCT01033942|365391863|FG000|Overall Study|Enrolled in Extension Study|0|||
105927088|NCT01033942|365391864|FG001|Overall Study|Enrolled in Extension Study|3|||
105927089|NCT01033942|365391865|FG002|Overall Study|Enrolled in Extension Study|0|||
105927090|NCT02737618|365391866|FG000|Overall Study|Withdrawal by Subject|9|||
105927091|NCT02397837|365391870|FG000|Overall Study|Withdrawal by Subject|6|||
105927092|NCT02397837|365391871|FG001|Overall Study|Withdrawal by Subject|5|||
105927093|NCT02397837|365391870|FG000|Overall Study|Physician Decision|1|||
105927094|NCT02397837|365391871|FG001|Overall Study|Physician Decision|1|||
105927095|NCT01771913|365391872|FG000|Overall Study|Withdrawal by Subject|1|||
105927096|NCT01771913|365391873|FG001|Overall Study|Withdrawal by Subject|0|||
105927097|NCT02782468|365391874|FG000|Overall Study|Progressive Disease|2|||
106007073|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
105705190|NCT03670953|364583715|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
105705191|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
105705192|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
105705193|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
105705194|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
105705195|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
105705196|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
105705197|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
105927098|NCT02782468|365391875|FG001|Overall Study|Progressive Disease|5|||
105927099|NCT02782468|365391876|FG002|Overall Study|Progressive Disease|0|||
105927100|NCT02782468|365391877|FG003|Overall Study|Progressive Disease|4|||
105927101|NCT02782468|365391874|FG000|Overall Study|Adverse Event|0|||
105927102|NCT02782468|365391875|FG001|Overall Study|Adverse Event|2|||
105927103|NCT02782468|365391876|FG002|Overall Study|Adverse Event|2|||
105927104|NCT02782468|365391877|FG003|Overall Study|Adverse Event|3|||
105705198|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
105705199|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
105705200|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
105705201|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
105705202|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
105705203|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
105705204|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
105705205|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
105705206|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
105705207|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
105705208|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
105705209|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
105705210|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
105705211|NCT03670953|364583712|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
105705212|NCT03670953|364583713|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
105705213|NCT03670953|364583714|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
105705214|NCT03670953|364583715|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
105705215|NCT00412750|364583716|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105705216|NCT00412750|364583717|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105705217|NCT00412750|364583718|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105705218|NCT00412750|364583716|FG000|Overall Study|Administrative problems|21|||
105705219|NCT00412750|364583717|FG001|Overall Study|Administrative problems|17|||
105705220|NCT00412750|364583718|FG002|Overall Study|Administrative problems|14|||
105705221|NCT00412750|364583716|FG000|Overall Study|Adverse Event|8|||
105705222|NCT00412750|364583717|FG001|Overall Study|Adverse Event|3|||
105705223|NCT00412750|364583718|FG002|Overall Study|Adverse Event|3|||
105705224|NCT00412750|364583716|FG000|Overall Study|Lost to Follow-up|1|||
105787379|NCT01243762|364874941|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
105927105|NCT02782468|365391874|FG000|Overall Study|Other|0|||
105927106|NCT02782468|365391875|FG001|Overall Study|Other|0|||
105927107|NCT02782468|365391876|FG002|Overall Study|Other|1|||
105927108|NCT02782468|365391877|FG003|Overall Study|Other|1|||
105927109|NCT02782468|365391874|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
105927110|NCT02782468|365391875|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
105927111|NCT02782468|365391876|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
105927112|NCT02782468|365391877|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
105927113|NCT02782468|365391874|FG000|Overall Study|Symptomatic Deterioration|0|||
105927114|NCT02782468|365391875|FG001|Overall Study|Symptomatic Deterioration|0|||
105927115|NCT02782468|365391876|FG002|Overall Study|Symptomatic Deterioration|0|||
105927116|NCT02782468|365391877|FG003|Overall Study|Symptomatic Deterioration|1|||
105927117|NCT02782468|365391874|FG000|Overall Study|Withdrawal by Subject|1|||
105927118|NCT02782468|365391875|FG001|Overall Study|Withdrawal by Subject|0|||
105927119|NCT02782468|365391876|FG002|Overall Study|Withdrawal by Subject|0|||
105927120|NCT02782468|365391877|FG003|Overall Study|Withdrawal by Subject|0|||
105927121|NCT01410604|365391878|FG000|Overall Study|Adverse Event|2|||
105927122|NCT01410604|365391879|FG001|Overall Study|Adverse Event|1|||
105927123|NCT01410604|365391878|FG000|Overall Study|Lost to Follow-up|1|||
105927124|NCT01410604|365391879|FG001|Overall Study|Lost to Follow-up|0|||
105927125|NCT01410604|365391878|FG000|Overall Study|Physician Decision|0|||
105927126|NCT01410604|365391879|FG001|Overall Study|Physician Decision|1|||
105927127|NCT00356590|365391880|FG000|Overall Study|Adverse Event|54|||
105927128|NCT00356590|365391880|FG000|Overall Study|Death|10|||
105927129|NCT00356590|365391880|FG000|Overall Study|Lost to Follow-up|35|||
105927130|NCT00356590|365391880|FG000|Overall Study|Physician Decision|46|||
105927131|NCT00356590|365391880|FG000|Overall Study|Withdrawal by Subject|41|||
105927132|NCT00356590|365391880|FG000|Overall Study|Completed month 12 only|2|||
105927133|NCT00356590|365391880|FG000|Overall Study|Protocol issues|6|||
105927134|NCT00356590|365391880|FG000|Overall Study|Response status|28|||
105927135|NCT00356590|365391880|FG000|Overall Study|Other|52|||
105927136|NCT00817063|365391887|FG000|Overall Study|Adverse Event|32|||
105927137|NCT00817063|365391888|FG001|Overall Study|Adverse Event|13|||
105927138|NCT00817063|365391887|FG000|Overall Study|Death|1|||
105927139|NCT00817063|365391888|FG001|Overall Study|Death|1|||
105927140|NCT00817063|365391887|FG000|Overall Study|Lack of Efficacy|33|||
105927141|NCT00817063|365391888|FG001|Overall Study|Lack of Efficacy|86|||
106007074|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Death|0|||
105927142|NCT00817063|365391887|FG000|Overall Study|Failure to Return|13|||
105927143|NCT00817063|365391888|FG001|Overall Study|Failure to Return|12|||
105927144|NCT00817063|365391887|FG000|Overall Study|Violation of Selection at Entry|7|||
105927145|NCT00817063|365391888|FG001|Overall Study|Violation of Selection at Entry|4|||
105927146|NCT00817063|365391887|FG000|Overall Study|Protocol Violation|3|||
105927147|NCT00817063|365391888|FG001|Overall Study|Protocol Violation|8|||
105927148|NCT00817063|365391887|FG000|Overall Study|Withdrawal by Subject|17|||
106007075|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Death|2|||
105705225|NCT00412750|364583717|FG001|Overall Study|Lost to Follow-up|0|||
105705226|NCT00412750|364583718|FG002|Overall Study|Lost to Follow-up|1|||
105705227|NCT00412750|364583716|FG000|Overall Study|Withdrawal by Subject|0|||
105705228|NCT00412750|364583717|FG001|Overall Study|Withdrawal by Subject|1|||
105705229|NCT00412750|364583718|FG002|Overall Study|Withdrawal by Subject|2|||
105705230|NCT00412750|364583716|FG000|Overall Study|Lack of Efficacy|0|||
105705231|NCT00412750|364583717|FG001|Overall Study|Lack of Efficacy|0|||
105705232|NCT00412750|364583718|FG002|Overall Study|Lack of Efficacy|3|||
105705233|NCT01097746|364583724|FG000|Overall Study|Adverse Event|4|||
105705234|NCT01097746|364583724|FG000|Overall Study|taken off study before any treatment given|1|||
105705235|NCT00390546|364583725|FG000|Overall Study|Renal impairment|1|||
105705236|NCT00390546|364583726|FG001|Overall Study|Renal impairment|0|||
105705237|NCT00390546|364583725|FG000|Overall Study|Physician Decision|5|||
105705238|NCT00390546|364583726|FG001|Overall Study|Physician Decision|5|||
105705239|NCT00631371|364583727|FG000|Overall Study|Lost to Follow-up|24|||
105705240|NCT00631371|364583728|FG001|Overall Study|Lost to Follow-up|19|||
105705241|NCT00631371|364583727|FG000|Overall Study|Other reason|5|||
105927149|NCT00817063|365391888|FG001|Overall Study|Withdrawal by Subject|37|||
105927150|NCT00817063|365391887|FG000|Overall Study|Early Improvement|19|||
105927151|NCT00817063|365391888|FG001|Overall Study|Early Improvement|4|||
105927152|NCT00817063|365391887|FG000|Overall Study|Administrative|10|||
105927153|NCT00817063|365391888|FG001|Overall Study|Administrative|4|||
105927154|NCT00817063|365391887|FG000|Overall Study|Abnormality of Laboratory Test|2|||
105927155|NCT00817063|365391888|FG001|Overall Study|Abnormality of Laboratory Test|1|||
105927156|NCT01496456|365391889|FG000|Overall Study|Protocol Violation|1|||
105927157|NCT01496456|365391889|FG000|Overall Study|Lost to Follow-up|7|||
105927158|NCT00407511|365391890|FG000|Overall Study|Adverse Event|9|||
105927159|NCT00407511|365391890|FG000|Overall Study|Lost to Follow-up|4|||
105927160|NCT00407511|365391890|FG000|Overall Study|Other|5|||
105927161|NCT00407511|365391890|FG000|Overall Study|Withdrawal by Subject|4|||
105927162|NCT00529035|365391891|FG000|Overall Study|Withdrawal by Subject|1|||
105927163|NCT03439514|365391892|FG000|Double-Blind Treatment Period|Other|4|||
105927164|NCT03439514|365391893|FG001|Double-Blind Treatment Period|Other|1|||
105927165|NCT03439514|365391892|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
105927166|NCT03439514|365391893|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105927167|NCT03439514|365391892|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
105927168|NCT03439514|365391893|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
105927169|NCT03439514|365391892|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
105927170|NCT03439514|365391893|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
105927171|NCT03439514|365391892|FG000|Double-Blind Treatment Period|Death|1|||
105927172|NCT03439514|365391893|FG001|Double-Blind Treatment Period|Death|2|||
105927173|NCT01521364|365391894|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
105927174|NCT01521364|365391894|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
105927175|NCT00712920|365391895|FG000|Overall Study|Adverse Event|3|||
105927176|NCT00712920|365391896|FG001|Overall Study|Adverse Event|4|||
105927177|NCT00712920|365391897|FG002|Overall Study|Adverse Event|7|||
105927178|NCT00712920|365391895|FG000|Overall Study|Withdrawal by Subject|4|||
105927179|NCT00712920|365391896|FG001|Overall Study|Withdrawal by Subject|2|||
105927180|NCT00712920|365391897|FG002|Overall Study|Withdrawal by Subject|1|||
105927181|NCT00712920|365391895|FG000|Overall Study|Lost to Follow-up|1|||
105927182|NCT00712920|365391896|FG001|Overall Study|Lost to Follow-up|4|||
105927183|NCT00712920|365391897|FG002|Overall Study|Lost to Follow-up|0|||
105927184|NCT00712920|365391895|FG000|Overall Study|Lack of Efficacy|1|||
105927185|NCT00712920|365391896|FG001|Overall Study|Lack of Efficacy|0|||
105927186|NCT00712920|365391897|FG002|Overall Study|Lack of Efficacy|1|||
105927187|NCT00712920|365391895|FG000|Overall Study|Other|5|||
105927188|NCT00712920|365391896|FG001|Overall Study|Other|7|||
105927189|NCT00712920|365391897|FG002|Overall Study|Other|3|||
105927190|NCT00712920|365391895|FG000|Overall Study|Non-compliance|3|||
105927191|NCT00712920|365391896|FG001|Overall Study|Non-compliance|0|||
105927192|NCT00712920|365391897|FG002|Overall Study|Non-compliance|0|||
105927193|NCT03329989|365391901|FG000|Overall Study|Withdrawal by Subject|9|||
105927194|NCT03329989|365391901|FG000|Overall Study|Lost to Follow-up|8|||
105927195|NCT03329989|365391901|FG000|Overall Study|Adverse Event|5|||
105927196|NCT03329989|365391901|FG000|Overall Study|Protocol Violation|1|||
105705242|NCT00631371|364583728|FG001|Overall Study|Other reason|12|||
105705243|NCT00631371|364583727|FG000|Overall Study|subject request|38|||
105705244|NCT00631371|364583728|FG001|Overall Study|subject request|45|||
105927197|NCT02696616|365391903|FG000|Overall Study|Adverse Event|0|||
105927198|NCT02696616|365391904|FG001|Overall Study|Adverse Event|1|||
105927199|NCT02696616|365391905|FG002|Overall Study|Adverse Event|0|||
105927200|NCT02696616|365391906|FG003|Overall Study|Adverse Event|0|||
105927201|NCT02696616|365391907|FG004|Overall Study|Adverse Event|0|||
105927202|NCT02696616|365391908|FG005|Overall Study|Adverse Event|0|||
105705245|NCT00631371|364583727|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
105927203|NCT02696616|365391909|FG006|Overall Study|Adverse Event|0|||
105927204|NCT01732783|365391910|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
106007076|NCT03605667|365690321|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
106007077|NCT03605667|365690322|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
106007078|NCT04528641|365690323|FG000|Overall Study|Withdrawal by Subject|0|||
106007079|NCT04528641|365690324|FG001|Overall Study|Withdrawal by Subject|0|||
105705246|NCT00631371|364583728|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
105705247|NCT00631371|364583727|FG000|Overall Study|Death|263|||
105705248|NCT00631371|364583728|FG001|Overall Study|Death|239|||
105705249|NCT01135498|364583736|FG000|Overall Study|Adverse Event|20|||
105705250|NCT01135498|364583736|FG000|Overall Study|Progressive disease|38|||
105705251|NCT01135498|364583736|FG000|Overall Study|Investigator judgement|25|||
106007080|NCT04528641|365690325|FG002|Overall Study|Withdrawal by Subject|0|||
106007081|NCT04528641|365690326|FG003|Overall Study|Withdrawal by Subject|1|||
106007082|NCT04528641|365690327|FG004|Overall Study|Withdrawal by Subject|0|||
106007083|NCT04528641|365690328|FG005|Overall Study|Withdrawal by Subject|1|||
106007084|NCT04607005|365690329|FG000|Overall Study|Adverse Event|0|||
106007085|NCT04607005|365690330|FG001|Overall Study|Adverse Event|1|||
106007086|NCT04607005|365690329|FG000|Overall Study|Lack of Efficacy|1|||
106007087|NCT04607005|365690330|FG001|Overall Study|Lack of Efficacy|6|||
106007088|NCT04607005|365690329|FG000|Overall Study|Withdrawal by Subject|4|||
106007089|NCT04607005|365690330|FG001|Overall Study|Withdrawal by Subject|9|||
106007090|NCT04607005|365690329|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
106007091|NCT04607005|365690330|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
106007092|NCT04886154|365690331|FG000|Overall Study|Adverse Event|0|||
106007093|NCT04886154|365690332|FG001|Overall Study|Adverse Event|0|||
106007094|NCT04886154|365690333|FG002|Overall Study|Adverse Event|0|||
106007095|NCT04886154|365690334|FG003|Overall Study|Adverse Event|0|||
106007096|NCT04886154|365690335|FG004|Overall Study|Adverse Event|1|||
106007097|NCT04886154|365690336|FG005|Overall Study|Adverse Event|0|||
106007098|NCT04886154|365690337|FG006|Overall Study|Adverse Event|0|||
106007099|NCT04886154|365690338|FG007|Overall Study|Adverse Event|1|||
106007100|NCT04886154|365690339|FG008|Overall Study|Adverse Event|1|||
106007101|NCT04886154|365690340|FG009|Overall Study|Adverse Event|0|||
106007102|NCT04886154|365690341|FG010|Overall Study|Adverse Event|0|||
106007103|NCT04886154|365690342|FG011|Overall Study|Adverse Event|1|||
106007104|NCT04886154|365690343|FG012|Overall Study|Adverse Event|0|||
106007105|NCT04886154|365690344|FG013|Overall Study|Adverse Event|0|||
106007106|NCT04886154|365690345|FG014|Overall Study|Adverse Event|3|||
106007107|NCT04886154|365690331|FG000|Overall Study|Lost to Follow-up|1|||
106007108|NCT04886154|365690332|FG001|Overall Study|Lost to Follow-up|0|||
106007109|NCT04886154|365690333|FG002|Overall Study|Lost to Follow-up|2|||
106007110|NCT04886154|365690334|FG003|Overall Study|Lost to Follow-up|0|||
106007111|NCT04886154|365690335|FG004|Overall Study|Lost to Follow-up|17|||
106007112|NCT04886154|365690336|FG005|Overall Study|Lost to Follow-up|7|||
106007113|NCT04886154|365690337|FG006|Overall Study|Lost to Follow-up|8|||
106007114|NCT04886154|365690338|FG007|Overall Study|Lost to Follow-up|7|||
106007115|NCT04886154|365690339|FG008|Overall Study|Lost to Follow-up|8|||
106007116|NCT04886154|365690340|FG009|Overall Study|Lost to Follow-up|0|||
106007117|NCT04886154|365690341|FG010|Overall Study|Lost to Follow-up|2|||
106007118|NCT04886154|365690342|FG011|Overall Study|Lost to Follow-up|0|||
106007119|NCT04886154|365690343|FG012|Overall Study|Lost to Follow-up|0|||
105705252|NCT01135498|364583736|FG000|Overall Study|Withdrawal by Subject|4|||
105705253|NCT01135498|364583736|FG000|Overall Study|Death|1|||
105705254|NCT01135498|364583736|FG000|Overall Study|Ongoing at time of analysis|2|||
105705255|NCT00129766|364583741|FG000|Overall Study|Death|3|||
105705256|NCT00129766|364583742|FG001|Overall Study|Death|8|||
105705257|NCT00129766|364583741|FG000|Overall Study|Withdrawal of consent|31|||
106007120|NCT04886154|365690344|FG013|Overall Study|Lost to Follow-up|0|||
106007121|NCT04886154|365690345|FG014|Overall Study|Lost to Follow-up|0|||
106007122|NCT04886154|365690331|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007123|NCT04886154|365690332|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007124|NCT04886154|365690333|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105705258|NCT00129766|364583742|FG001|Overall Study|Withdrawal of consent|30|||
105705259|NCT00129766|364583741|FG000|Overall Study|Lost to Follow-up|26|||
105705260|NCT00129766|364583742|FG001|Overall Study|Lost to Follow-up|21|||
106007125|NCT04886154|365690334|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007126|NCT04886154|365690335|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007127|NCT04886154|365690336|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105705261|NCT05440539|364583744|FG000|Overall Study|Lost to Follow-up|4|||
106007128|NCT04886154|365690337|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
106007129|NCT04886154|365690338|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007130|NCT04886154|365690339|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007131|NCT04886154|365690340|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007132|NCT04886154|365690341|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007133|NCT04886154|365690342|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007134|NCT04886154|365690343|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106007135|NCT04886154|365690344|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
105705262|NCT05440539|364583745|FG001|Overall Study|Lost to Follow-up|4|||
105705263|NCT05440539|364583744|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
105705264|NCT05440539|364583745|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
105705265|NCT01577186|364583746|FG000|Overall Study|Adverse Event|23|||
105705266|NCT01577186|364583746|FG000|Overall Study|Death|1|||
105705267|NCT01577186|364583746|FG000|Overall Study|Lost to Follow-up|28|||
105705268|NCT01577186|364583746|FG000|Overall Study|Withdrawal by Subject|35|||
105705269|NCT01577186|364583746|FG000|Overall Study|Insufficient Response|18|||
105705270|NCT01577186|364583746|FG000|Overall Study|Ineligible to Continue|15|||
105705271|NCT01577186|364583746|FG000|Overall Study|Non-Compliant|8|||
105705272|NCT01577186|364583746|FG000|Overall Study|Other|2|||
105705273|NCT03287219|364583747|FG000|Overall Study|Protocol Violation|0|||
105705274|NCT03287219|364583748|FG001|Overall Study|Protocol Violation|2|||
105705275|NCT02797808|364583753|FG000|Overall Study|Withdrawal by Subject|1|||
105705276|NCT02797808|364583754|FG001|Overall Study|Withdrawal by Subject|1|||
105705277|NCT02797808|364583753|FG000|Overall Study|Physician Decision|6|||
105705278|NCT02797808|364583754|FG001|Overall Study|Physician Decision|2|||
105705279|NCT03571646|364583756|FG000|Overall Study|Adverse Event|1|||
105705280|NCT03571646|364583757|FG001|Overall Study|Adverse Event|0|||
105705281|NCT03571646|364583756|FG000|Overall Study|Withdrawal by Subject|1|||
105705282|NCT03571646|364583757|FG001|Overall Study|Withdrawal by Subject|1|||
105705283|NCT04677959|364583758|FG000|Overall Study|Adverse Event|1|||
105705284|NCT04677959|364583759|FG001|Overall Study|Adverse Event|9|||
105705285|NCT04677959|364583758|FG000|Overall Study|Withdrawal by Subject|2|||
105705286|NCT04677959|364583759|FG001|Overall Study|Withdrawal by Subject|15|||
105705287|NCT04677959|364583758|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105705288|NCT04677959|364583759|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105705289|NCT04677959|364583758|FG000|Overall Study|Non-compliance with study drug|0|||
105705290|NCT04677959|364583759|FG001|Overall Study|Non-compliance with study drug|2|||
105705291|NCT04677959|364583758|FG000|Overall Study|Protocol deviation|0|||
105705292|NCT04677959|364583759|FG001|Overall Study|Protocol deviation|11|||
105705293|NCT04677959|364583758|FG000|Overall Study|Lost to Follow-up|9|||
105705294|NCT04677959|364583759|FG001|Overall Study|Lost to Follow-up|13|||
105705295|NCT04677959|364583758|FG000|Overall Study|Other than specified|0|||
105705296|NCT04677959|364583759|FG001|Overall Study|Other than specified|8|||
105705297|NCT00535132|364583760|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
105705298|NCT00535132|364583761|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
105705299|NCT00535132|364583760|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
105705300|NCT00535132|364583761|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
105705301|NCT00264875|364583762|FG000|Overall Study|Adverse Event|6|||
105705302|NCT00264875|364583762|FG000|Overall Study|Lost to Follow-up|6|||
105705303|NCT00264875|364583762|FG000|Overall Study|Protocol Violation|11|||
105705304|NCT00264875|364583762|FG000|Overall Study|Withdrawal by Subject|7|||
105705305|NCT02590588|364583763|FG000|Overall Study|Adverse Event|1|||
105705306|NCT05630937|364583765|FG000|Overall Study|Study terminated by sponsor|1|||
105705307|NCT05630937|364583766|FG001|Overall Study|Study terminated by sponsor|1|||
105705308|NCT05630937|364583767|FG002|Overall Study|Study terminated by sponsor|8|||
105705309|NCT05630937|364583768|FG003|Overall Study|Study terminated by sponsor|0|||
105705310|NCT05630937|364583765|FG000|Overall Study|Lost to Follow-up|0|||
105705311|NCT05630937|364583766|FG001|Overall Study|Lost to Follow-up|0|||
105705312|NCT05630937|364583767|FG002|Overall Study|Lost to Follow-up|1|||
105705313|NCT05630937|364583768|FG003|Overall Study|Lost to Follow-up|0|||
105705314|NCT05630937|364583765|FG000|Overall Study|Enrolled but not treated|0|||
105705315|NCT05630937|364583766|FG001|Overall Study|Enrolled but not treated|0|||
105705316|NCT05630937|364583767|FG002|Overall Study|Enrolled but not treated|0|||
105705317|NCT05630937|364583768|FG003|Overall Study|Enrolled but not treated|1|||
105705318|NCT03031301|364583769|FG000|Overall Study|Protocol Violation|4|||
105705319|NCT03031301|364583770|FG001|Overall Study|Protocol Violation|8|||
105705320|NCT03031301|364583769|FG000|Overall Study|Withdrawal by Subject|7|||
105705321|NCT03031301|364583770|FG001|Overall Study|Withdrawal by Subject|4|||
105705322|NCT03031301|364583769|FG000|Overall Study|Lost to Follow-up|4|||
105705323|NCT03031301|364583770|FG001|Overall Study|Lost to Follow-up|12|||
105705324|NCT03031301|364583769|FG000|Overall Study|Noncompliance|1|||
105705325|NCT03031301|364583770|FG001|Overall Study|Noncompliance|3|||
105705326|NCT03031301|364583769|FG000|Overall Study|Technical issue|1|||
105705327|NCT03031301|364583770|FG001|Overall Study|Technical issue|1|||
105705328|NCT03031301|364583769|FG000|Overall Study|Adverse Event|1|||
105705329|NCT03031301|364583770|FG001|Overall Study|Adverse Event|0|||
105705330|NCT02182687|364583782|FG000|Overall Study|Withdrawal by Subject|4|||
105705331|NCT02182687|364583783|FG001|Overall Study|Withdrawal by Subject|0|||
105705332|NCT02182687|364583782|FG000|Overall Study|Adverse Event|1|||
105705333|NCT02182687|364583783|FG001|Overall Study|Adverse Event|0|||
105927205|NCT01732783|365391911|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
105705334|NCT02182687|364583782|FG000|Overall Study|Lost to Follow-up|0|||
105705335|NCT02182687|364583783|FG001|Overall Study|Lost to Follow-up|1|||
105927206|NCT01732783|365391912|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
105705336|NCT01297270|364583784|FG000|Overall Study|Adverse Event|19|||
105705337|NCT01297270|364583785|FG001|Overall Study|Adverse Event|32|||
105705338|NCT01297270|364583786|FG002|Overall Study|Adverse Event|5|||
105705339|NCT01297270|364583784|FG000|Overall Study|Lack of Efficacy|15|||
105705340|NCT01297270|364583785|FG001|Overall Study|Lack of Efficacy|17|||
105705341|NCT01297270|364583786|FG002|Overall Study|Lack of Efficacy|15|||
105705342|NCT01297270|364583784|FG000|Overall Study|Lost to Follow-up|1|||
105705343|NCT01297270|364583785|FG001|Overall Study|Lost to Follow-up|2|||
105705344|NCT01297270|364583786|FG002|Overall Study|Lost to Follow-up|1|||
105705345|NCT01297270|364583784|FG000|Overall Study|Protocol Violation|0|||
105705346|NCT01297270|364583785|FG001|Overall Study|Protocol Violation|2|||
105705347|NCT01297270|364583786|FG002|Overall Study|Protocol Violation|0|||
105705348|NCT01297270|364583784|FG000|Overall Study|Withdrawal by Subject|7|||
105705349|NCT01297270|364583785|FG001|Overall Study|Withdrawal by Subject|15|||
105705350|NCT01297270|364583786|FG002|Overall Study|Withdrawal by Subject|7|||
105705351|NCT01297270|364583784|FG000|Overall Study|Other reason not defined above|3|||
105705352|NCT01297270|364583785|FG001|Overall Study|Other reason not defined above|3|||
105705353|NCT01297270|364583786|FG002|Overall Study|Other reason not defined above|1|||
105705354|NCT01297270|364583784|FG000|Overall Study|Not treated|0|||
105705355|NCT01297270|364583785|FG001|Overall Study|Not treated|1|||
105705356|NCT01297270|364583786|FG002|Overall Study|Not treated|0|||
105705357|NCT03965689|364583787|FG000|Overall Study|Too sick to get study intervention|2|||
105705358|NCT00794677|364583793|FG000|First Intervention|Withdrawal by Subject|2|||
105705359|NCT00794677|364583794|FG001|First Intervention|Withdrawal by Subject|0|||
105705360|NCT02716987|364583795|FG000|Overall Study|Ligand synthesis failure|0|||
105705361|NCT02716987|364583796|FG001|Overall Study|Ligand synthesis failure|0|||
105705362|NCT02716987|364583797|FG002|Overall Study|Ligand synthesis failure|1|||
105705363|NCT02716987|364583798|FG003|Overall Study|Ligand synthesis failure|0|||
105705364|NCT02716987|364583799|FG004|Overall Study|Ligand synthesis failure|0|||
105705365|NCT02716987|364583800|FG005|Overall Study|Ligand synthesis failure|0|||
105705366|NCT02716987|364583795|FG000|Overall Study|Withdrawal by Subject|0|||
105705367|NCT02716987|364583796|FG001|Overall Study|Withdrawal by Subject|0|||
105705368|NCT02716987|364583797|FG002|Overall Study|Withdrawal by Subject|0|||
105705369|NCT02716987|364583798|FG003|Overall Study|Withdrawal by Subject|0|||
105705370|NCT02716987|364583799|FG004|Overall Study|Withdrawal by Subject|1|||
105705371|NCT02716987|364583800|FG005|Overall Study|Withdrawal by Subject|1|||
105705372|NCT03223428|364583802|FG000|Overall Study|No longer taking Xermelo|27|||
105705373|NCT03223428|364583802|FG000|Overall Study|Declined Consent|1|||
105705374|NCT03223428|364583802|FG000|Overall Study|Non-responders|56|||
105705375|NCT03223428|364583802|FG000|Overall Study|Withdrawal by Subject|14|||
105705376|NCT01834274|364583803|FG000|Overall Study|Study Termination|41|||
105927207|NCT01732783|365391910|FG000|Overall Study|Death|13|||
105927208|NCT01732783|365391911|FG001|Overall Study|Death|4|||
105927209|NCT01732783|365391912|FG002|Overall Study|Death|1|||
105927210|NCT01732783|365391910|FG000|Overall Study|Lost to Follow-up|7|||
105927211|NCT01732783|365391911|FG001|Overall Study|Lost to Follow-up|1|||
105927212|NCT01732783|365391912|FG002|Overall Study|Lost to Follow-up|1|||
105927213|NCT01732783|365391910|FG000|Overall Study|Administrative Decision|8|||
105927214|NCT01732783|365391911|FG001|Overall Study|Administrative Decision|2|||
105927215|NCT01732783|365391912|FG002|Overall Study|Administrative Decision|1|||
105927216|NCT01732783|365391910|FG000|Overall Study|Withdrawal by Subject|1|||
105927217|NCT01732783|365391911|FG001|Overall Study|Withdrawal by Subject|0|||
105927218|NCT01732783|365391912|FG002|Overall Study|Withdrawal by Subject|0|||
105927219|NCT01500083|365391913|FG000|Overall Study|Adverse Event|4|||
105927220|NCT01500083|365391914|FG001|Overall Study|Adverse Event|17|||
105927221|NCT01500083|365391913|FG000|Overall Study|Death|0|||
105927222|NCT01500083|365391914|FG001|Overall Study|Death|2|||
105927223|NCT01500083|365391913|FG000|Overall Study|Lost to Follow-up|1|||
105927224|NCT01500083|365391914|FG001|Overall Study|Lost to Follow-up|0|||
105927225|NCT01500083|365391913|FG000|Overall Study|Withdrawal of Consent|0|||
105927226|NCT01500083|365391914|FG001|Overall Study|Withdrawal of Consent|1|||
105927227|NCT01500083|365391913|FG000|Overall Study|Disease Progression|2|||
105705377|NCT01834274|364583804|FG001|Overall Study|Study Termination|38|||
105705378|NCT01834274|364583803|FG000|Overall Study|Withdrawal by Subject|1|||
105705379|NCT01834274|364583804|FG001|Overall Study|Withdrawal by Subject|1|||
105705380|NCT01834274|364583803|FG000|Overall Study|Lost to Follow-up|3|||
105705381|NCT01834274|364583804|FG001|Overall Study|Lost to Follow-up|1|||
105705382|NCT01834274|364583803|FG000|Overall Study|Other|2|||
105705383|NCT01834274|364583804|FG001|Overall Study|Other|1|||
105787380|NCT01243762|364874942|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
105705384|NCT02728830|364583805|FG000|Overall Study|Exclusionary Surgery|9|||
105705385|NCT02728830|364583805|FG000|Overall Study|Exclusionary Pathology|6|||
105927228|NCT01500083|365391914|FG001|Overall Study|Disease Progression|10|||
105927229|NCT01500083|365391913|FG000|Overall Study|Investigator Discretion|3|||
105705386|NCT02728830|364583805|FG000|Overall Study|Physician Decision|3|||
105927230|NCT01500083|365391914|FG001|Overall Study|Investigator Discretion|8|||
105927231|NCT01500083|365391913|FG000|Overall Study|Other Reasons|2|||
105705387|NCT02728830|364583805|FG000|Overall Study|Withdrawal by Subject|2|||
105705388|NCT02728830|364583805|FG000|Overall Study|Lost to Follow-up|1|||
105705389|NCT02728830|364583805|FG000|Overall Study|Exclusionary Lab Values|1|||
105705390|NCT02728830|364583805|FG000|Overall Study|Contraindicated Illness|1|||
105705391|NCT02728830|364583805|FG000|Overall Study|Language Barrier|1|||
105705392|NCT02039375|364583810|FG000|Overall Study|Lost to Follow-up|2|||
105705393|NCT04770389|364583811|FG000|Overall Study|Adverse Event|1|||
105705394|NCT04770389|364583812|FG001|Overall Study|Adverse Event|2|||
105705395|NCT04770389|364583813|FG002|Overall Study|Adverse Event|0|||
105705396|NCT04770389|364583814|FG003|Overall Study|Adverse Event|1|||
105705397|NCT04770389|364583811|FG000|Overall Study|Withdrawal by Subject|0|||
105705398|NCT04770389|364583812|FG001|Overall Study|Withdrawal by Subject|2|||
105705399|NCT04770389|364583813|FG002|Overall Study|Withdrawal by Subject|1|||
105705400|NCT04770389|364583814|FG003|Overall Study|Withdrawal by Subject|0|||
105705401|NCT04770389|364583811|FG000|Overall Study|Failed attempt to draw blood|1|||
105705402|NCT04770389|364583812|FG001|Overall Study|Failed attempt to draw blood|0|||
105705403|NCT04770389|364583813|FG002|Overall Study|Failed attempt to draw blood|0|||
105705404|NCT04770389|364583814|FG003|Overall Study|Failed attempt to draw blood|0|||
105705405|NCT04770389|364583811|FG000|Overall Study|Left the country|0|||
105705406|NCT04770389|364583812|FG001|Overall Study|Left the country|0|||
105705407|NCT04770389|364583813|FG002|Overall Study|Left the country|1|||
105705408|NCT04770389|364583814|FG003|Overall Study|Left the country|2|||
105705409|NCT04770389|364583811|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
105705410|NCT04770389|364583812|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
105705411|NCT04770389|364583813|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
105705412|NCT04770389|364583814|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
105705413|NCT04770389|364583811|FG000|Overall Study|Lost to Follow-up|0|||
105705414|NCT04770389|364583812|FG001|Overall Study|Lost to Follow-up|0|||
105705415|NCT04770389|364583813|FG002|Overall Study|Lost to Follow-up|0|||
105705416|NCT04770389|364583814|FG003|Overall Study|Lost to Follow-up|1|||
105705417|NCT04770389|364583811|FG000|Overall Study|Moved away from study site|0|||
105705418|NCT04770389|364583812|FG001|Overall Study|Moved away from study site|1|||
105705419|NCT04770389|364583813|FG002|Overall Study|Moved away from study site|0|||
105705420|NCT04770389|364583814|FG003|Overall Study|Moved away from study site|0|||
105705421|NCT00137111|364583818|FG000|Total Therapy|Death|35|||
105705422|NCT00137111|364583819|FG001|Total Therapy|Death|0|||
105705423|NCT00137111|364583820|FG002|Total Therapy|Death|0|||
105705424|NCT00137111|364583821|FG003|Total Therapy|Death|0|||
105705425|NCT00137111|364583818|FG000|Total Therapy|Non Compliance|5|||
105705426|NCT00137111|364583819|FG001|Total Therapy|Non Compliance|0|||
105705427|NCT00137111|364583820|FG002|Total Therapy|Non Compliance|0|||
105705428|NCT00137111|364583821|FG003|Total Therapy|Non Compliance|0|||
105705429|NCT00317109|364583826|FG000|Overall Study|Withdrawal by Subject|2|||
105705430|NCT00317109|364583827|FG001|Overall Study|Withdrawal by Subject|0|||
105705431|NCT00317109|364583826|FG000|Overall Study|Migated/moved from study area|1|||
105705432|NCT00317109|364583827|FG001|Overall Study|Migated/moved from study area|0|||
105705433|NCT01026831|364583828|FG000|Overall Study|Adverse Event|4|||
105705434|NCT01026831|364583829|FG001|Overall Study|Adverse Event|3|||
105705435|NCT01026831|364583828|FG000|Overall Study|Lost to Follow-up|2|||
105705436|NCT01026831|364583829|FG001|Overall Study|Lost to Follow-up|0|||
105705437|NCT01026831|364583828|FG000|Overall Study|Physician Decision|1|||
105705438|NCT01026831|364583829|FG001|Overall Study|Physician Decision|1|||
105705439|NCT01026831|364583828|FG000|Overall Study|Protocol Violation|0|||
105705440|NCT01026831|364583829|FG001|Overall Study|Protocol Violation|2|||
105705441|NCT01026831|364583828|FG000|Overall Study|Withdrawal by Subject|7|||
105705442|NCT01026831|364583829|FG001|Overall Study|Withdrawal by Subject|5|||
105705443|NCT00761514|364583832|FG000|Overall Study|Adverse Event|1|||
105705444|NCT00761514|364583832|FG000|Overall Study|Withdrawal by Subject|2|||
105705445|NCT00761514|364583832|FG000|Overall Study|Lost to Follow-up|1|||
105927232|NCT01500083|365391914|FG001|Overall Study|Other Reasons|5|||
105927233|NCT01555931|365391915|FG000|Overall Study|Lost to Follow-up|2|||
105927234|NCT01555931|365391916|FG001|Overall Study|Lost to Follow-up|5|||
105927235|NCT04871113|365391917|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927236|NCT04871113|365391918|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927237|NCT04871113|365391919|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927238|NCT04871113|365391920|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927239|NCT04871113|365391921|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927240|NCT04871113|365391922|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
105927241|NCT04871113|365391923|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927242|NCT04871113|365391924|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927243|NCT04871113|365391925|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927244|NCT04871113|365391926|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
105927245|NCT04871113|365391917|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105927246|NCT04871113|365391918|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105927247|NCT04871113|365391919|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105927248|NCT04871113|365391920|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105927249|NCT04871113|365391921|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105927250|NCT04871113|365391922|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105927251|NCT04871113|365391923|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
105927252|NCT04871113|365391924|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
105927253|NCT04871113|365391925|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
105927254|NCT04871113|365391926|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
106007136|NCT04886154|365690345|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
106133777|NCT00783692|366148192|FG001|Induction Phase|Withdrawal by Subject|9|||
106133778|NCT00783692|366148193|FG002|Induction Phase|Withdrawal by Subject|16|||
105705446|NCT00761514|364583832|FG000|Overall Study|Health insurance didn't cover study drug|1|||
105705447|NCT00761514|364583832|FG000|Overall Study|Problem complying with study visit|1|||
105705448|NCT00761514|364583832|FG000|Overall Study|Unable to pay for medications|1|||
105705449|NCT00852995|364583835|FG000|Overall Study|Adverse Event|1|||
105705450|NCT00852995|364583836|FG001|Overall Study|Adverse Event|0|||
105705451|NCT00852995|364583837|FG002|Overall Study|Adverse Event|4|||
105705452|NCT00852995|364583838|FG003|Overall Study|Adverse Event|0|||
105705453|NCT00852995|364583839|FG004|Overall Study|Adverse Event|0|||
105705454|NCT00852995|364583835|FG000|Overall Study|Lost to Follow-up|0|||
105705455|NCT00852995|364583836|FG001|Overall Study|Lost to Follow-up|1|||
105705456|NCT00852995|364583837|FG002|Overall Study|Lost to Follow-up|1|||
105705457|NCT00852995|364583838|FG003|Overall Study|Lost to Follow-up|0|||
105705458|NCT00852995|364583839|FG004|Overall Study|Lost to Follow-up|0|||
105705459|NCT00852995|364583835|FG000|Overall Study|Withdrawal by Subject|4|||
105705460|NCT00852995|364583836|FG001|Overall Study|Withdrawal by Subject|0|||
105705461|NCT00852995|364583837|FG002|Overall Study|Withdrawal by Subject|0|||
105705462|NCT00852995|364583838|FG003|Overall Study|Withdrawal by Subject|1|||
105705463|NCT00852995|364583839|FG004|Overall Study|Withdrawal by Subject|2|||
105705464|NCT00852995|364583835|FG000|Overall Study|Non-Compliance|0|||
105705465|NCT00852995|364583836|FG001|Overall Study|Non-Compliance|0|||
105705466|NCT00852995|364583837|FG002|Overall Study|Non-Compliance|0|||
105705467|NCT00852995|364583838|FG003|Overall Study|Non-Compliance|2|||
105705468|NCT00852995|364583839|FG004|Overall Study|Non-Compliance|0|||
105705469|NCT00852995|364583835|FG000|Overall Study|Progressive Disease|1|||
105705470|NCT00852995|364583836|FG001|Overall Study|Progressive Disease|0|||
105705471|NCT00852995|364583837|FG002|Overall Study|Progressive Disease|0|||
105705472|NCT00852995|364583838|FG003|Overall Study|Progressive Disease|2|||
105705473|NCT00852995|364583839|FG004|Overall Study|Progressive Disease|1|||
105705474|NCT00852995|364583835|FG000|Overall Study|Physician Decision|1|||
105705475|NCT00852995|364583836|FG001|Overall Study|Physician Decision|0|||
105705476|NCT00852995|364583837|FG002|Overall Study|Physician Decision|0|||
105705477|NCT00852995|364583838|FG003|Overall Study|Physician Decision|0|||
105705478|NCT00852995|364583839|FG004|Overall Study|Physician Decision|0|||
105705479|NCT00852995|364583835|FG000|Overall Study|Protocol Violation|0|||
105705480|NCT00852995|364583836|FG001|Overall Study|Protocol Violation|0|||
105705481|NCT00852995|364583837|FG002|Overall Study|Protocol Violation|0|||
105705482|NCT00852995|364583838|FG003|Overall Study|Protocol Violation|0|||
105705483|NCT00852995|364583839|FG004|Overall Study|Protocol Violation|1|||
105705484|NCT00852995|364583835|FG000|Overall Study|Moved Out of Area|1|||
105705485|NCT00852995|364583836|FG001|Overall Study|Moved Out of Area|0|||
105705486|NCT00852995|364583837|FG002|Overall Study|Moved Out of Area|0|||
105705487|NCT00852995|364583838|FG003|Overall Study|Moved Out of Area|0|||
105705488|NCT00852995|364583839|FG004|Overall Study|Moved Out of Area|0|||
105705489|NCT02457637|364583840|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
105705490|NCT01836783|364583841|FG000|Overall Study|Withdrawal by Subject|0|||
105705491|NCT01836783|364583842|FG001|Overall Study|Withdrawal by Subject|2|||
105705492|NCT04942925|364583844|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
105705493|NCT04942925|364583845|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
105705494|NCT04942925|364583844|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
105705495|NCT04942925|364583845|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
105705496|NCT01273883|364583846|FG000|First Intervention|Adverse Event|2|||
105705497|NCT01273883|364583847|FG001|First Intervention|Adverse Event|1|||
105927255|NCT02299167|365391927|FG000|Overall Study|patients were excluded from the study|11|||
105927256|NCT02606253|365391930|FG000|Overall Study|Adverse Event|2|||
105927257|NCT02606253|365391931|FG001|Overall Study|Adverse Event|0|||
106133779|NCT00783692|366148194|FG003|Induction Phase|Withdrawal by Subject|0|||
106133780|NCT00783692|366148195|FG004|Induction Phase|Withdrawal by Subject|0|||
105705498|NCT01273883|364583846|FG000|Second Intervention|Lost to Follow-up|1|||
105705499|NCT01273883|364583847|FG001|Second Intervention|Lost to Follow-up|1|||
105705500|NCT01273883|364583846|FG000|Second Intervention|Lack of Efficacy|1|||
105705501|NCT01273883|364583847|FG001|Second Intervention|Lack of Efficacy|0|||
105705502|NCT00371865|364583849|FG000|Overall Study|Lack of Efficacy|0|||
105705503|NCT00371865|364583850|FG001|Overall Study|Lack of Efficacy|2|||
105705504|NCT00371865|364583849|FG000|Overall Study|Protocol Violation|3|||
105705505|NCT00371865|364583850|FG001|Overall Study|Protocol Violation|2|||
105705506|NCT00371865|364583849|FG000|Overall Study|Withdrawal by Subject|12|||
105705507|NCT00371865|364583850|FG001|Overall Study|Withdrawal by Subject|10|||
105705508|NCT03217266|364585136|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
105705509|NCT03217266|364585137|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
105705510|NCT03217266|364585138|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
105705511|NCT03217266|364585139|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
105705512|NCT03217266|364585136|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
105705513|NCT03217266|364585137|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
105705514|NCT03217266|364585138|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
105705515|NCT03217266|364585139|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
105705516|NCT03217266|364585136|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
105705517|NCT03217266|364585137|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
105705518|NCT03217266|364585138|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
105705519|NCT03217266|364585139|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
105705520|NCT04218201|364585140|FG000|Overall Study|Death|0|||
105705521|NCT04218201|364585141|FG001|Overall Study|Death|0|||
105705522|NCT04218201|364585142|FG002|Overall Study|Death|2|||
105705523|NCT04218201|364585143|FG003|Overall Study|Death|0|||
105705524|NCT04218201|364585140|FG000|Overall Study|Unable to contact participant|4|||
105705525|NCT04218201|364585141|FG001|Overall Study|Unable to contact participant|0|||
105705526|NCT04218201|364585142|FG002|Overall Study|Unable to contact participant|3|||
105705527|NCT04218201|364585143|FG003|Overall Study|Unable to contact participant|0|||
105705528|NCT04218201|364585140|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
105705529|NCT04218201|364585141|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
105705530|NCT04218201|364585142|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
105705531|NCT04218201|364585143|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
105705532|NCT04218201|364585140|FG000|Overall Study|Withdrawal by Subject|2|||
105705533|NCT04218201|364585141|FG001|Overall Study|Withdrawal by Subject|0|||
105705534|NCT04218201|364585142|FG002|Overall Study|Withdrawal by Subject|0|||
105705535|NCT04218201|364585143|FG003|Overall Study|Withdrawal by Subject|0|||
105705536|NCT04218201|364585140|FG000|Overall Study|PCP plans to leave practice|0|||
105705537|NCT04218201|364585141|FG001|Overall Study|PCP plans to leave practice|8|||
105705538|NCT04218201|364585142|FG002|Overall Study|PCP plans to leave practice|0|||
105705539|NCT04218201|364585143|FG003|Overall Study|PCP plans to leave practice|5|||
105705540|NCT04218201|364585140|FG000|Overall Study|Reduced panel|0|||
105705541|NCT04218201|364585141|FG001|Overall Study|Reduced panel|0|||
105705542|NCT04218201|364585142|FG002|Overall Study|Reduced panel|0|||
105705543|NCT04218201|364585143|FG003|Overall Study|Reduced panel|1|||
105705544|NCT04218201|364585140|FG000|Overall Study|No longer interested in participating|0|||
105705545|NCT04218201|364585141|FG001|Overall Study|No longer interested in participating|1|||
105705546|NCT04218201|364585142|FG002|Overall Study|No longer interested in participating|0|||
105705547|NCT04218201|364585143|FG003|Overall Study|No longer interested in participating|0|||
105705548|NCT04649255|364585146|FG000|Overall Study|Death|9|||
105705549|NCT04649255|364585146|FG000|Overall Study|Withdrawal by Subject|1|||
105705550|NCT01395394|364585159|FG000|Baseline Study Visit|Protocol Violation|1|||
105705551|NCT01395394|364585160|FG001|Baseline Study Visit|Protocol Violation|0|||
105705552|NCT01395394|364585161|FG002|Baseline Study Visit|Protocol Violation|0|||
105927258|NCT02606253|365391932|FG002|Overall Study|Adverse Event|0|||
105927259|NCT02606253|365391930|FG000|Overall Study|Protocol Violation|2|||
105927260|NCT02606253|365391931|FG001|Overall Study|Protocol Violation|1|||
105927261|NCT02606253|365391932|FG002|Overall Study|Protocol Violation|0|||
105705553|NCT01157078|364585164|FG000|Overall Study|Withdrawal by Subject|12|||
105705554|NCT01157078|364585165|FG001|Overall Study|Withdrawal by Subject|14|||
105705555|NCT01157078|364585164|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105705556|NCT01157078|364585165|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105705557|NCT01157078|364585164|FG000|Overall Study|Adverse Event|6|||
105705558|NCT01157078|364585165|FG001|Overall Study|Adverse Event|6|||
105705559|NCT01157078|364585164|FG000|Overall Study|Severe non-compliance to protocol|2|||
105705560|NCT01157078|364585165|FG001|Overall Study|Severe non-compliance to protocol|4|||
105705561|NCT01157078|364585164|FG000|Overall Study|Condition under investigation worsened|0|||
105705562|NCT01157078|364585165|FG001|Overall Study|Condition under investigation worsened|1|||
105705563|NCT01157078|364585164|FG000|Overall Study|Lack of Efficacy|2|||
105927262|NCT02606253|365391930|FG000|Overall Study|Physician Decision|1|||
105705564|NCT01157078|364585165|FG001|Overall Study|Lack of Efficacy|0|||
105705565|NCT01157078|364585164|FG000|Overall Study|Study-specific withdrawal criteria|2|||
105705566|NCT01157078|364585165|FG001|Overall Study|Study-specific withdrawal criteria|2|||
105705567|NCT01157078|364585164|FG000|Overall Study|Lost to Follow-up|7|||
105705568|NCT01157078|364585165|FG001|Overall Study|Lost to Follow-up|5|||
105705569|NCT01157078|364585164|FG000|Overall Study|Other|2|||
105927263|NCT02606253|365391931|FG001|Overall Study|Physician Decision|1|||
105705570|NCT01157078|364585165|FG001|Overall Study|Other|4|||
105705571|NCT04329806|364585168|FG000|Overall Study|Physician Decision|3|||
105705572|NCT04329806|364585169|FG001|Overall Study|Physician Decision|4|||
105705573|NCT00513409|364585170|FG000|Overall Study|Adverse Event|0|||
105705574|NCT00513409|364585171|FG001|Overall Study|Adverse Event|1|||
105787381|NCT01243762|364874943|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105787382|NCT01243762|364874944|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
105787383|NCT00003526|364874945|FG000|Overall Study|Not evaluable|6|||
105787384|NCT00489411|364874946|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
105787385|NCT00489411|364874947|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
105787386|NCT00489411|364874946|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
105787387|NCT00489411|364874947|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
105787388|NCT00489411|364874946|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
105787389|NCT00489411|364874947|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
105787390|NCT00489411|364874946|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
105787391|NCT00489411|364874947|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
105787392|NCT00489411|364874946|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
105787393|NCT00489411|364874947|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
105787394|NCT00308555|364874948|FG000|Overall Study|Withdrawal by Subject|1|||
105787395|NCT00308555|364874949|FG001|Overall Study|Withdrawal by Subject|0|||
105787396|NCT00308555|364874948|FG000|Overall Study|Physician Decision|2|||
105787397|NCT00308555|364874949|FG001|Overall Study|Physician Decision|0|||
105787398|NCT00276458|364874950|FG000|Overall Study|Adverse Event|0|||
105787399|NCT00276458|364874951|FG001|Overall Study|Adverse Event|2|||
105787400|NCT00276458|364874950|FG000|Overall Study|Lost to Follow-up|2|||
105787401|NCT00276458|364874951|FG001|Overall Study|Lost to Follow-up|2|||
105705575|NCT00513409|364585170|FG000|Overall Study|Withdrawal by Subject|0|||
105705576|NCT00513409|364585171|FG001|Overall Study|Withdrawal by Subject|2|||
105787402|NCT00276458|364874950|FG000|Overall Study|Protocol Violation|4|||
105927264|NCT02606253|365391932|FG002|Overall Study|Physician Decision|0|||
105927265|NCT00689936|365391938|FG000|Active Treatment Phase|Adverse Event|68|||
105705577|NCT00513409|364585170|FG000|Overall Study|Lost to Follow-up|0|||
105927266|NCT00689936|365391939|FG001|Active Treatment Phase|Adverse Event|71|||
105927267|NCT00689936|365391940|FG002|Active Treatment Phase|Adverse Event|76|||
105927268|NCT00689936|365391938|FG000|Active Treatment Phase|Disease Progression|273|||
105705578|NCT00513409|364585171|FG001|Overall Study|Lost to Follow-up|1|||
105705579|NCT00513409|364585170|FG000|Overall Study|Physician Decision|1|||
105705580|NCT00513409|364585171|FG001|Overall Study|Physician Decision|0|||
105705581|NCT00513409|364585170|FG000|Overall Study|Visit 3 not done|1|||
105705582|NCT00513409|364585171|FG001|Overall Study|Visit 3 not done|2|||
105705583|NCT02145741|364585172|FG000|Overall Study|Progressive disease|3|||
105705584|NCT02145741|364585173|FG001|Overall Study|Progressive disease|6|||
105705585|NCT02145741|364585174|FG002|Overall Study|Progressive disease|6|||
105705586|NCT02145741|364585172|FG000|Overall Study|quality issue with the administered drug|3|||
105705587|NCT02145741|364585173|FG001|Overall Study|quality issue with the administered drug|0|||
105705588|NCT02145741|364585174|FG002|Overall Study|quality issue with the administered drug|0|||
105705589|NCT01192022|364585175|FG000|Overall Study|Withdrawal of Consent|3|||
105705590|NCT01192022|364585176|FG001|Overall Study|Withdrawal of Consent|1|||
105705591|NCT01192022|364585177|FG002|Overall Study|Withdrawal of Consent|0|||
105705592|NCT01192022|364585178|FG003|Overall Study|Withdrawal of Consent|0|||
105705593|NCT01192022|364585179|FG004|Overall Study|Withdrawal of Consent|0|||
105705594|NCT01192022|364585175|FG000|Overall Study|Lost to Follow-up|4|||
105705595|NCT01192022|364585176|FG001|Overall Study|Lost to Follow-up|2|||
105705596|NCT01192022|364585177|FG002|Overall Study|Lost to Follow-up|1|||
105705597|NCT01192022|364585178|FG003|Overall Study|Lost to Follow-up|1|||
105787403|NCT00276458|364874951|FG001|Overall Study|Protocol Violation|3|||
105787404|NCT04668066|364874954|FG000|Part 1: Treatment Phase|Adverse Event|0|||
105927269|NCT00689936|365391939|FG001|Active Treatment Phase|Disease Progression|362|||
105927270|NCT00689936|365391940|FG002|Active Treatment Phase|Disease Progression|339|||
105927271|NCT00689936|365391938|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
105927272|NCT00689936|365391939|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
105927273|NCT00689936|365391940|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
105927274|NCT00689936|365391938|FG000|Active Treatment Phase|Death|60|||
105787405|NCT04668066|364874955|FG001|Part 1: Treatment Phase|Adverse Event|0|||
105787406|NCT04668066|364874956|FG002|Part 1: Treatment Phase|Adverse Event|0|||
105787407|NCT04668066|364874957|FG003|Part 1: Treatment Phase|Adverse Event|0|||
105927275|NCT00689936|365391939|FG001|Active Treatment Phase|Death|28|||
105927276|NCT00689936|365391940|FG002|Active Treatment Phase|Death|37|||
105705598|NCT01192022|364585179|FG004|Overall Study|Lost to Follow-up|0|||
105787408|NCT04668066|364874958|FG004|Part 1: Treatment Phase|Adverse Event|0|||
105787409|NCT04668066|364874959|FG005|Part 1: Treatment Phase|Adverse Event|0|||
105787410|NCT04668066|364874960|FG006|Part 1: Treatment Phase|Adverse Event|0|||
105927277|NCT00689936|365391938|FG000|Active Treatment Phase|Lost to Follow-up|0|||
105705599|NCT01192022|364585175|FG000|Overall Study|Adverse Event|1|||
105705600|NCT01192022|364585176|FG001|Overall Study|Adverse Event|0|||
105705601|NCT01192022|364585177|FG002|Overall Study|Adverse Event|0|||
105705602|NCT01192022|364585178|FG003|Overall Study|Adverse Event|0|||
105705603|NCT01192022|364585179|FG004|Overall Study|Adverse Event|0|||
105787411|NCT04668066|364874961|FG007|Part 1: Treatment Phase|Adverse Event|0|||
105787412|NCT04668066|364874962|FG008|Part 1: Treatment Phase|Adverse Event|0|||
105787413|NCT04668066|364874963|FG009|Part 1: Treatment Phase|Adverse Event|0|||
105787414|NCT04668066|364874964|FG010|Part 1: Treatment Phase|Adverse Event|0|||
105787415|NCT04668066|364874965|FG011|Part 1: Treatment Phase|Adverse Event|1|||
105787416|NCT04668066|364874966|FG012|Part 1: Treatment Phase|Adverse Event|1|||
105787417|NCT04668066|364874967|FG013|Part 1: Treatment Phase|Adverse Event|0|||
105787418|NCT04668066|364874968|FG014|Part 1: Treatment Phase|Adverse Event|0|||
105787419|NCT04668066|364874969|FG015|Part 1: Treatment Phase|Adverse Event|0|||
105787420|NCT04668066|364874970|FG016|Part 1: Treatment Phase|Adverse Event|0|||
105787421|NCT04668066|364874971|FG017|Part 1: Treatment Phase|Adverse Event|0|||
105787422|NCT04668066|364874972|FG018|Part 1: Treatment Phase|Adverse Event|0|||
105787423|NCT04668066|364874954|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787424|NCT04668066|364874955|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787425|NCT04668066|364874956|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
105787426|NCT04668066|364874957|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787427|NCT04668066|364874958|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787428|NCT04668066|364874959|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787429|NCT04668066|364874960|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787430|NCT04668066|364874961|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787431|NCT04668066|364874962|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787432|NCT04668066|364874963|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787433|NCT04668066|364874964|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787434|NCT04668066|364874965|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787435|NCT04668066|364874966|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787436|NCT04668066|364874967|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787437|NCT04668066|364874968|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787438|NCT04668066|364874969|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787439|NCT04668066|364874970|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787440|NCT04668066|364874971|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787441|NCT04668066|364874972|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
105787442|NCT04668066|364874954|FG000|Part 1: Treatment Phase|Other|0|||
105787443|NCT04668066|364874955|FG001|Part 1: Treatment Phase|Other|0|||
105787444|NCT04668066|364874956|FG002|Part 1: Treatment Phase|Other|0|||
105787445|NCT04668066|364874957|FG003|Part 1: Treatment Phase|Other|0|||
105787446|NCT04668066|364874958|FG004|Part 1: Treatment Phase|Other|0|||
105787447|NCT04668066|364874959|FG005|Part 1: Treatment Phase|Other|0|||
105787448|NCT04668066|364874960|FG006|Part 1: Treatment Phase|Other|0|||
105787449|NCT04668066|364874961|FG007|Part 1: Treatment Phase|Other|0|||
105787450|NCT04668066|364874962|FG008|Part 1: Treatment Phase|Other|0|||
105787451|NCT04668066|364874963|FG009|Part 1: Treatment Phase|Other|0|||
105787452|NCT04668066|364874964|FG010|Part 1: Treatment Phase|Other|0|||
105787453|NCT04668066|364874965|FG011|Part 1: Treatment Phase|Other|1|||
105787454|NCT04668066|364874966|FG012|Part 1: Treatment Phase|Other|0|||
105787455|NCT04668066|364874967|FG013|Part 1: Treatment Phase|Other|0|||
105787456|NCT04668066|364874968|FG014|Part 1: Treatment Phase|Other|0|||
105787457|NCT04668066|364874969|FG015|Part 1: Treatment Phase|Other|0|||
105787458|NCT04668066|364874970|FG016|Part 1: Treatment Phase|Other|0|||
105787459|NCT04668066|364874971|FG017|Part 1: Treatment Phase|Other|0|||
105927278|NCT00689936|365391939|FG001|Active Treatment Phase|Lost to Follow-up|2|||
105927279|NCT00689936|365391940|FG002|Active Treatment Phase|Lost to Follow-up|2|||
105927280|NCT00689936|365391938|FG000|Active Treatment Phase|Protocol Violation|2|||
105927281|NCT00689936|365391939|FG001|Active Treatment Phase|Protocol Violation|2|||
105927282|NCT00689936|365391940|FG002|Active Treatment Phase|Protocol Violation|4|||
105927283|NCT00689936|365391938|FG000|Active Treatment Phase|Study Close Out|64|||
105927284|NCT00689936|365391939|FG001|Active Treatment Phase|Study Close Out|26|||
105927285|NCT00689936|365391940|FG002|Active Treatment Phase|Study Close Out|21|||
105787460|NCT04668066|364874972|FG018|Part 1: Treatment Phase|Other|0|||
105787461|NCT04668066|364874954|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787462|NCT04668066|364874955|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105927286|NCT00689936|365391938|FG000|Active Treatment Phase|Miscellaneous|52|||
105927287|NCT00689936|365391939|FG001|Active Treatment Phase|Miscellaneous|34|||
105927288|NCT00689936|365391940|FG002|Active Treatment Phase|Miscellaneous|47|||
105927289|NCT00689936|365391938|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
105927290|NCT00689936|365391939|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
106007137|NCT04886154|365690331|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105787463|NCT04668066|364874956|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787464|NCT04668066|364874957|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787465|NCT04668066|364874958|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787466|NCT04668066|364874959|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787467|NCT04668066|364874960|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787468|NCT04668066|364874961|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787469|NCT04668066|364874962|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787470|NCT04668066|364874963|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787471|NCT04668066|364874964|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787472|NCT04668066|364874965|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105705604|NCT01192022|364585175|FG000|Overall Study|Fatal Adverse Event|4|||
105705605|NCT01192022|364585176|FG001|Overall Study|Fatal Adverse Event|6|||
105705606|NCT01192022|364585177|FG002|Overall Study|Fatal Adverse Event|0|||
105705607|NCT01192022|364585178|FG003|Overall Study|Fatal Adverse Event|0|||
105705608|NCT01192022|364585179|FG004|Overall Study|Fatal Adverse Event|1|||
105705609|NCT01192022|364585175|FG000|Overall Study|Physician withdrew-patient hardship|1|||
105705610|NCT01192022|364585176|FG001|Overall Study|Physician withdrew-patient hardship|0|||
105705611|NCT01192022|364585177|FG002|Overall Study|Physician withdrew-patient hardship|0|||
105705612|NCT01192022|364585178|FG003|Overall Study|Physician withdrew-patient hardship|0|||
105705613|NCT01192022|364585179|FG004|Overall Study|Physician withdrew-patient hardship|0|||
105705614|NCT01192022|364585175|FG000|Overall Study|Patient too sick from chemotherapy|0|||
105705615|NCT01192022|364585176|FG001|Overall Study|Patient too sick from chemotherapy|1|||
105705616|NCT01192022|364585177|FG002|Overall Study|Patient too sick from chemotherapy|0|||
105705617|NCT01192022|364585178|FG003|Overall Study|Patient too sick from chemotherapy|0|||
105705618|NCT01192022|364585179|FG004|Overall Study|Patient too sick from chemotherapy|0|||
105705619|NCT01192022|364585175|FG000|Overall Study|Patient needed surgery|0|||
105705620|NCT01192022|364585176|FG001|Overall Study|Patient needed surgery|1|||
105705621|NCT01192022|364585177|FG002|Overall Study|Patient needed surgery|0|||
105705622|NCT01192022|364585178|FG003|Overall Study|Patient needed surgery|0|||
105705623|NCT01192022|364585179|FG004|Overall Study|Patient needed surgery|0|||
105705624|NCT01192022|364585175|FG000|Overall Study|Parents did not allow all follow up|0|||
105705625|NCT01192022|364585176|FG001|Overall Study|Parents did not allow all follow up|0|||
105705626|NCT01192022|364585177|FG002|Overall Study|Parents did not allow all follow up|0|||
105705627|NCT01192022|364585178|FG003|Overall Study|Parents did not allow all follow up|1|||
105705628|NCT01192022|364585179|FG004|Overall Study|Parents did not allow all follow up|0|||
105705629|NCT02646982|364585180|FG000|Overall Study|Adverse Event|1|||
105705630|NCT02646982|364585181|FG001|Overall Study|Adverse Event|1|||
105705631|NCT02646982|364585180|FG000|Overall Study|Withdrawal by Subject|2|||
105705632|NCT02646982|364585181|FG001|Overall Study|Withdrawal by Subject|1|||
105705633|NCT01594853|364585182|FG000|Overall Study|Withdrawal by Subject|1|||
105705634|NCT01594853|364585183|FG001|Overall Study|Withdrawal by Subject|1|||
105705635|NCT01594853|364585182|FG000|Overall Study|Lost to Follow-up|1|||
105705636|NCT01594853|364585183|FG001|Overall Study|Lost to Follow-up|1|||
105705637|NCT01594853|364585182|FG000|Overall Study|noncompliance with exercise|0|||
105705638|NCT01594853|364585183|FG001|Overall Study|noncompliance with exercise|1|||
105705639|NCT01902966|364585184|FG000|Overall Study|Death|1|||
105705640|NCT01902966|364585184|FG000|Overall Study|Physician Decision|1|||
105705641|NCT01902966|364585184|FG000|Overall Study|Withdrawal by Subject|1|||
105705642|NCT01081912|364585190|FG000|Conversion/Titration|Adverse Event|47|||
105705643|NCT01081912|364585191|FG001|Conversion/Titration|Adverse Event|0|||
105705644|NCT01081912|364585192|FG002|Conversion/Titration|Adverse Event|0|||
105705645|NCT01081912|364585190|FG000|Conversion/Titration|Lack of Efficacy|17|||
105705646|NCT01081912|364585191|FG001|Conversion/Titration|Lack of Efficacy|0|||
105705647|NCT01081912|364585192|FG002|Conversion/Titration|Lack of Efficacy|0|||
105705648|NCT01081912|364585190|FG000|Conversion/Titration|Lost to Follow-up|5|||
105705649|NCT01081912|364585191|FG001|Conversion/Titration|Lost to Follow-up|0|||
105705650|NCT01081912|364585192|FG002|Conversion/Titration|Lost to Follow-up|0|||
105705651|NCT01081912|364585190|FG000|Conversion/Titration|Physician Decision|2|||
105705652|NCT01081912|364585191|FG001|Conversion/Titration|Physician Decision|0|||
105705653|NCT01081912|364585192|FG002|Conversion/Titration|Physician Decision|0|||
105705654|NCT01081912|364585190|FG000|Conversion/Titration|Protocol Violation|67|||
105705655|NCT01081912|364585191|FG001|Conversion/Titration|Protocol Violation|0|||
105705656|NCT01081912|364585192|FG002|Conversion/Titration|Protocol Violation|0|||
105705657|NCT01081912|364585190|FG000|Conversion/Titration|Withdrawal by Subject|23|||
105705658|NCT01081912|364585191|FG001|Conversion/Titration|Withdrawal by Subject|0|||
105705659|NCT01081912|364585192|FG002|Conversion/Titration|Withdrawal by Subject|0|||
105705660|NCT01081912|364585190|FG000|Conversion/Titration|Non-Compliance|47|||
105705661|NCT01081912|364585191|FG001|Conversion/Titration|Non-Compliance|0|||
105705662|NCT01081912|364585192|FG002|Conversion/Titration|Non-Compliance|0|||
105705663|NCT01081912|364585190|FG000|Maintenance Treatment|Adverse Event|0|||
105705664|NCT01081912|364585191|FG001|Maintenance Treatment|Adverse Event|2|||
105705665|NCT01081912|364585192|FG002|Maintenance Treatment|Adverse Event|12|||
105927291|NCT00689936|365391940|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
105927292|NCT01138046|365391941|FG000|Overall Study|Withdrawal due to death|6|||
105927293|NCT02836769|365391942|FG000|Overall Study|Lost to Follow-up|10|||
105927294|NCT02836769|365391942|FG000|Overall Study|Medical withdrawal|2|||
105927295|NCT02836769|365391942|FG000|Overall Study|Withdrawal by Subject|3|||
105705666|NCT01081912|364585190|FG000|Maintenance Treatment|Lack of Efficacy|0|||
105705667|NCT01081912|364585191|FG001|Maintenance Treatment|Lack of Efficacy|14|||
105705668|NCT01081912|364585192|FG002|Maintenance Treatment|Lack of Efficacy|64|||
105705669|NCT01081912|364585190|FG000|Maintenance Treatment|Lost to Follow-up|0|||
105705670|NCT01081912|364585191|FG001|Maintenance Treatment|Lost to Follow-up|1|||
105705671|NCT01081912|364585192|FG002|Maintenance Treatment|Lost to Follow-up|0|||
105705672|NCT01081912|364585190|FG000|Maintenance Treatment|Physician Decision|0|||
105705673|NCT01081912|364585191|FG001|Maintenance Treatment|Physician Decision|0|||
105787473|NCT04668066|364874966|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
105787474|NCT04668066|364874967|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787475|NCT04668066|364874968|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787476|NCT04668066|364874969|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
105787477|NCT04668066|364874970|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787478|NCT04668066|364874971|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787479|NCT04668066|364874972|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
105787480|NCT04668066|364874954|FG000|Part 1: Follow-Up|Adverse Event|0|||
105787481|NCT04668066|364874955|FG001|Part 1: Follow-Up|Adverse Event|0|||
105787482|NCT04668066|364874956|FG002|Part 1: Follow-Up|Adverse Event|0|||
105787483|NCT04668066|364874957|FG003|Part 1: Follow-Up|Adverse Event|0|||
105787484|NCT04668066|364874958|FG004|Part 1: Follow-Up|Adverse Event|0|||
105787485|NCT04668066|364874959|FG005|Part 1: Follow-Up|Adverse Event|0|||
105787486|NCT04668066|364874960|FG006|Part 1: Follow-Up|Adverse Event|0|||
105787487|NCT04668066|364874961|FG007|Part 1: Follow-Up|Adverse Event|0|||
105787488|NCT04668066|364874962|FG008|Part 1: Follow-Up|Adverse Event|0|||
105787489|NCT04668066|364874963|FG009|Part 1: Follow-Up|Adverse Event|0|||
105787490|NCT04668066|364874964|FG010|Part 1: Follow-Up|Adverse Event|0|||
105787491|NCT04668066|364874965|FG011|Part 1: Follow-Up|Adverse Event|1|||
105787492|NCT04668066|364874966|FG012|Part 1: Follow-Up|Adverse Event|0|||
105787493|NCT04668066|364874967|FG013|Part 1: Follow-Up|Adverse Event|0|||
105787494|NCT04668066|364874968|FG014|Part 1: Follow-Up|Adverse Event|0|||
105787495|NCT04668066|364874969|FG015|Part 1: Follow-Up|Adverse Event|0|||
105787496|NCT04668066|364874970|FG016|Part 1: Follow-Up|Adverse Event|0|||
105787497|NCT04668066|364874971|FG017|Part 1: Follow-Up|Adverse Event|0|||
105787498|NCT04668066|364874972|FG018|Part 1: Follow-Up|Adverse Event|0|||
105787499|NCT04668066|364874954|FG000|Part 1: Follow-Up|Other|0|||
105787500|NCT04668066|364874955|FG001|Part 1: Follow-Up|Other|0|||
105787501|NCT04668066|364874956|FG002|Part 1: Follow-Up|Other|0|||
105787502|NCT04668066|364874957|FG003|Part 1: Follow-Up|Other|0|||
105787503|NCT04668066|364874958|FG004|Part 1: Follow-Up|Other|0|||
105787504|NCT04668066|364874959|FG005|Part 1: Follow-Up|Other|0|||
105787505|NCT04668066|364874960|FG006|Part 1: Follow-Up|Other|0|||
105787506|NCT04668066|364874961|FG007|Part 1: Follow-Up|Other|0|||
105787507|NCT04668066|364874962|FG008|Part 1: Follow-Up|Other|0|||
105787508|NCT04668066|364874963|FG009|Part 1: Follow-Up|Other|0|||
105787509|NCT04668066|364874964|FG010|Part 1: Follow-Up|Other|0|||
105787510|NCT04668066|364874965|FG011|Part 1: Follow-Up|Other|1|||
105787511|NCT04668066|364874966|FG012|Part 1: Follow-Up|Other|1|||
105787512|NCT04668066|364874967|FG013|Part 1: Follow-Up|Other|0|||
105787513|NCT04668066|364874968|FG014|Part 1: Follow-Up|Other|0|||
105787514|NCT04668066|364874969|FG015|Part 1: Follow-Up|Other|0|||
105787515|NCT04668066|364874970|FG016|Part 1: Follow-Up|Other|0|||
105787516|NCT04668066|364874971|FG017|Part 1: Follow-Up|Other|0|||
105787517|NCT04668066|364874972|FG018|Part 1: Follow-Up|Other|0|||
105787518|NCT04668066|364874954|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787519|NCT04668066|364874955|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787520|NCT04668066|364874956|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787521|NCT04668066|364874957|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787522|NCT04668066|364874958|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787523|NCT04668066|364874959|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787524|NCT04668066|364874960|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787525|NCT04668066|364874961|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787526|NCT04668066|364874962|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787527|NCT04668066|364874963|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787528|NCT04668066|364874964|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787529|NCT04668066|364874965|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787530|NCT04668066|364874966|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
105787531|NCT04668066|364874967|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
105927296|NCT02755090|365391947|FG000|Overall Study|equipment malfunction|1|||
105927297|NCT02755090|365391948|FG001|Overall Study|equipment malfunction|0|||
106133781|NCT00783692|366148196|FG005|Induction Phase|Withdrawal by Subject|0|||
106133782|NCT00783692|366148197|FG006|Induction Phase|Withdrawal by Subject|0|||
105787532|NCT04668066|364874968|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787533|NCT04668066|364874969|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
105787534|NCT04668066|364874970|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787535|NCT04668066|364874971|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787536|NCT04668066|364874972|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
105787537|NCT04668066|364874954|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787538|NCT04668066|364874955|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787539|NCT04668066|364874956|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787540|NCT04668066|364874957|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787541|NCT04668066|364874958|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787542|NCT04668066|364874959|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787543|NCT04668066|364874960|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787544|NCT04668066|364874961|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787545|NCT04668066|364874962|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105927298|NCT03188185|365391949|FG000|Stage 1|Adverse Event|4|||
105705674|NCT01081912|364585192|FG002|Maintenance Treatment|Physician Decision|1|||
105705675|NCT01081912|364585190|FG000|Maintenance Treatment|Protocol Violation|0|||
105705676|NCT01081912|364585191|FG001|Maintenance Treatment|Protocol Violation|1|||
105705677|NCT01081912|364585192|FG002|Maintenance Treatment|Protocol Violation|2|||
105705678|NCT01081912|364585190|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
105705679|NCT01081912|364585191|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
105705680|NCT01081912|364585192|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
105705681|NCT01081912|364585190|FG000|Maintenance Treatment|Non-Compliance|0|||
106133783|NCT00783692|366148191|FG000|Induction Phase|Lost to Follow-up|0|||
106133784|NCT00783692|366148192|FG001|Induction Phase|Lost to Follow-up|0|||
106133785|NCT00783692|366148193|FG002|Induction Phase|Lost to Follow-up|3|||
105705682|NCT01081912|364585191|FG001|Maintenance Treatment|Non-Compliance|4|||
105705683|NCT01081912|364585192|FG002|Maintenance Treatment|Non-Compliance|7|||
105705684|NCT01081912|364585190|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
105705685|NCT01081912|364585191|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
105705686|NCT01081912|364585192|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
105705687|NCT00001379|364585193|FG000|Initial Treatment|Disease progression|21|||
105705688|NCT00001379|364585194|FG001|Initial Treatment|Disease progression|3|||
105705689|NCT00001379|364585195|FG002|Initial Treatment|Disease progression|0|||
105705690|NCT00001379|364585196|FG003|Initial Treatment|Disease progression|0|||
105705691|NCT00001379|364585193|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
105705692|NCT00001379|364585194|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
105705693|NCT00001379|364585195|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
105705694|NCT00001379|364585196|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
105705695|NCT00001379|364585193|FG000|Initial Treatment|Received alternative treatment|2|||
105705696|NCT00001379|364585194|FG001|Initial Treatment|Received alternative treatment|1|||
105705697|NCT00001379|364585195|FG002|Initial Treatment|Received alternative treatment|0|||
106133786|NCT00783692|366148194|FG003|Induction Phase|Lost to Follow-up|0|||
105705698|NCT00001379|364585196|FG003|Initial Treatment|Received alternative treatment|0|||
105705699|NCT00001379|364585193|FG000|Initial Treatment|Refused further treatment|2|||
106133787|NCT00783692|366148195|FG004|Induction Phase|Lost to Follow-up|0|||
106133788|NCT00783692|366148196|FG005|Induction Phase|Lost to Follow-up|0|||
106133789|NCT00783692|366148197|FG006|Induction Phase|Lost to Follow-up|0|||
106133790|NCT00783692|366148191|FG000|Induction Phase|Other|0|||
106133791|NCT00783692|366148192|FG001|Induction Phase|Other|0|||
106133792|NCT00783692|366148193|FG002|Induction Phase|Other|2|||
106133793|NCT00783692|366148194|FG003|Induction Phase|Other|0|||
106133794|NCT00783692|366148195|FG004|Induction Phase|Other|0|||
106133795|NCT00783692|366148196|FG005|Induction Phase|Other|0|||
106133796|NCT00783692|366148197|FG006|Induction Phase|Other|0|||
105705700|NCT00001379|364585194|FG001|Initial Treatment|Refused further treatment|0|||
105705701|NCT00001379|364585195|FG002|Initial Treatment|Refused further treatment|0|||
105705702|NCT00001379|364585196|FG003|Initial Treatment|Refused further treatment|0|||
105705703|NCT00001379|364585193|FG000|Initial Treatment|Did not receive protocol treatment|0|||
105705704|NCT00001379|364585194|FG001|Initial Treatment|Did not receive protocol treatment|0|||
105705705|NCT00001379|364585195|FG002|Initial Treatment|Did not receive protocol treatment|5|||
105705706|NCT00001379|364585196|FG003|Initial Treatment|Did not receive protocol treatment|0|||
105705707|NCT00001379|364585193|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
105705708|NCT00001379|364585194|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
105705709|NCT00001379|364585195|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
105705710|NCT00001379|364585196|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
105705711|NCT00001379|364585193|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
105705712|NCT00001379|364585194|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
105705713|NCT00001379|364585195|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
105705714|NCT00001379|364585196|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
105705715|NCT00001379|364585193|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
105705716|NCT00001379|364585194|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
106133797|NCT00783692|366148191|FG000|Maintenance Phase|Adverse Event|7|||
106133798|NCT00783692|366148192|FG001|Maintenance Phase|Adverse Event|0|||
106133799|NCT00783692|366148193|FG002|Maintenance Phase|Adverse Event|0|||
106133800|NCT00783692|366148194|FG003|Maintenance Phase|Adverse Event|15|||
106133801|NCT00783692|366148195|FG004|Maintenance Phase|Adverse Event|12|||
106133802|NCT00783692|366148196|FG005|Maintenance Phase|Adverse Event|9|||
106133803|NCT00783692|366148197|FG006|Maintenance Phase|Adverse Event|38|||
105705717|NCT00001379|364585195|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
105705718|NCT00001379|364585196|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
105705719|NCT00001379|364585193|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
105705720|NCT00001379|364585194|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
106133804|NCT00783692|366148191|FG000|Maintenance Phase|Protocol Violation|0|||
106133805|NCT00783692|366148192|FG001|Maintenance Phase|Protocol Violation|0|||
105705721|NCT00001379|364585195|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
105705722|NCT00001379|364585196|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
105705723|NCT00001379|364585193|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
105705724|NCT00001379|364585194|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
105705725|NCT00001379|364585195|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
105705726|NCT00001379|364585196|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
105705727|NCT04458922|364585197|FG000|Overall Study|Withdrawal by Subject|1|||
105705728|NCT04458922|364585198|FG001|Overall Study|Withdrawal by Subject|0|||
105705729|NCT04458922|364585199|FG002|Overall Study|Withdrawal by Subject|2|||
105705730|NCT04458922|364585197|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
105705731|NCT04458922|364585198|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
105705732|NCT04458922|364585199|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
105705733|NCT04458922|364585197|FG000|Overall Study|Adverse Event|1|||
105705734|NCT04458922|364585198|FG001|Overall Study|Adverse Event|0|||
105705735|NCT04458922|364585199|FG002|Overall Study|Adverse Event|0|||
105705736|NCT04458922|364585197|FG000|Overall Study|Started new study|0|||
105705737|NCT04458922|364585198|FG001|Overall Study|Started new study|0|||
105705738|NCT04458922|364585199|FG002|Overall Study|Started new study|1|||
105705739|NCT04458922|364585197|FG000|Overall Study|Progressive disease|6|||
105705740|NCT04458922|364585198|FG001|Overall Study|Progressive disease|8|||
105705741|NCT04458922|364585199|FG002|Overall Study|Progressive disease|2|||
105705742|NCT04458922|364585197|FG000|Overall Study|Death|1|||
105705743|NCT04458922|364585198|FG001|Overall Study|Death|0|||
105705744|NCT04458922|364585199|FG002|Overall Study|Death|2|||
105705745|NCT04458922|364585197|FG000|Overall Study|Participant started chemotherapy|0|||
105705746|NCT04458922|364585198|FG001|Overall Study|Participant started chemotherapy|1|||
105705747|NCT04458922|364585199|FG002|Overall Study|Participant started chemotherapy|0|||
105705748|NCT00960843|364585200|FG000|Overall Study|Lost to Follow-up|2|||
105705749|NCT00960843|364585201|FG001|Overall Study|Lost to Follow-up|0|||
105705750|NCT00960843|364585200|FG000|Overall Study|Protocol Violation|0|||
105705751|NCT00960843|364585201|FG001|Overall Study|Protocol Violation|4|||
105705752|NCT00960843|364585200|FG000|Overall Study|Repeated needle dislodgment|0|||
105705753|NCT00960843|364585201|FG001|Overall Study|Repeated needle dislodgment|1|||
105705754|NCT00542269|364585202|FG000|Overall Study|Adverse Event|10|||
105705755|NCT00542269|364585203|FG001|Overall Study|Adverse Event|4|||
105705756|NCT00542269|364585204|FG002|Overall Study|Adverse Event|5|||
105705757|NCT00542269|364585202|FG000|Overall Study|Protocol Violation|1|||
105705758|NCT00542269|364585203|FG001|Overall Study|Protocol Violation|1|||
105705759|NCT00542269|364585204|FG002|Overall Study|Protocol Violation|0|||
105705760|NCT00542269|364585202|FG000|Overall Study|Withdrawal by Subject|1|||
105705761|NCT00542269|364585203|FG001|Overall Study|Withdrawal by Subject|0|||
105705762|NCT00542269|364585204|FG002|Overall Study|Withdrawal by Subject|0|||
105705763|NCT00542269|364585202|FG000|Overall Study|Administrative problems|1|||
105705764|NCT00542269|364585203|FG001|Overall Study|Administrative problems|1|||
105705765|NCT00542269|364585204|FG002|Overall Study|Administrative problems|1|||
105705766|NCT00652366|364585205|FG000|Overall Study|Adverse Event|8|||
105705767|NCT00652366|364585206|FG001|Overall Study|Adverse Event|4|||
105705768|NCT00652366|364585207|FG002|Overall Study|Adverse Event|7|||
105705769|NCT00652366|364585208|FG003|Overall Study|Adverse Event|17|||
105705770|NCT00652366|364585209|FG004|Overall Study|Adverse Event|13|||
105927299|NCT03188185|365391950|FG001|Stage 1|Adverse Event|12|||
105705771|NCT00652366|364585205|FG000|Overall Study|Death|5|||
105927300|NCT03188185|365391951|FG002|Stage 1|Adverse Event|0|||
105927301|NCT03188185|365391952|FG003|Stage 1|Adverse Event|0|||
105927302|NCT03188185|365391949|FG000|Stage 1|Lack of Efficacy|0|||
105927303|NCT03188185|365391950|FG001|Stage 1|Lack of Efficacy|2|||
105927304|NCT03188185|365391951|FG002|Stage 1|Lack of Efficacy|0|||
105927305|NCT03188185|365391952|FG003|Stage 1|Lack of Efficacy|0|||
105927306|NCT03188185|365391949|FG000|Stage 1|Lost to Follow-up|6|||
105927307|NCT03188185|365391950|FG001|Stage 1|Lost to Follow-up|1|||
105927308|NCT03188185|365391951|FG002|Stage 1|Lost to Follow-up|0|||
105927309|NCT03188185|365391952|FG003|Stage 1|Lost to Follow-up|0|||
105927310|NCT03188185|365391949|FG000|Stage 1|Withdrawal by Subject|9|||
105927311|NCT03188185|365391950|FG001|Stage 1|Withdrawal by Subject|0|||
105927312|NCT03188185|365391951|FG002|Stage 1|Withdrawal by Subject|0|||
105705772|NCT00652366|364585206|FG001|Overall Study|Death|4|||
105705773|NCT00652366|364585207|FG002|Overall Study|Death|1|||
105705774|NCT00652366|364585208|FG003|Overall Study|Death|8|||
105705775|NCT00652366|364585209|FG004|Overall Study|Death|5|||
105927313|NCT03188185|365391952|FG003|Stage 1|Withdrawal by Subject|0|||
105927314|NCT03188185|365391949|FG000|Stage 1|Identified as a professional patient|0|||
105927315|NCT03188185|365391950|FG001|Stage 1|Identified as a professional patient|1|||
105927316|NCT03188185|365391951|FG002|Stage 1|Identified as a professional patient|0|||
105705776|NCT00652366|364585205|FG000|Overall Study|Lack of Efficacy|84|||
105705777|NCT00652366|364585206|FG001|Overall Study|Lack of Efficacy|58|||
105705778|NCT00652366|364585207|FG002|Overall Study|Lack of Efficacy|53|||
105927317|NCT03188185|365391952|FG003|Stage 1|Identified as a professional patient|0|||
105927318|NCT03188185|365391949|FG000|Stage 2|Adverse Event|0|||
105787546|NCT04668066|364874963|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787547|NCT04668066|364874964|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787548|NCT04668066|364874965|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787549|NCT04668066|364874966|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787550|NCT04668066|364874967|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787551|NCT04668066|364874968|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787552|NCT04668066|364874969|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787553|NCT04668066|364874970|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787554|NCT04668066|364874971|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
105787555|NCT04668066|364874972|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
105787556|NCT04668066|364874954|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787557|NCT04668066|364874955|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787558|NCT04668066|364874956|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787559|NCT04668066|364874957|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787560|NCT04668066|364874958|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787561|NCT04668066|364874959|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787562|NCT04668066|364874960|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787563|NCT04668066|364874961|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787564|NCT04668066|364874962|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787565|NCT04668066|364874963|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787566|NCT04668066|364874964|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787567|NCT04668066|364874965|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787568|NCT04668066|364874966|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787569|NCT04668066|364874967|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787570|NCT04668066|364874968|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787571|NCT04668066|364874969|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787572|NCT04668066|364874970|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787573|NCT04668066|364874971|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
105787574|NCT04668066|364874972|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
105787575|NCT04668066|364874954|FG000|Part 2: Treatment Phase|Other|0|||
105787576|NCT04668066|364874955|FG001|Part 2: Treatment Phase|Other|0|||
105787577|NCT04668066|364874956|FG002|Part 2: Treatment Phase|Other|0|||
105787578|NCT04668066|364874957|FG003|Part 2: Treatment Phase|Other|0|||
105787579|NCT04668066|364874958|FG004|Part 2: Treatment Phase|Other|0|||
105787580|NCT04668066|364874959|FG005|Part 2: Treatment Phase|Other|0|||
105705779|NCT00652366|364585208|FG003|Overall Study|Lack of Efficacy|133|||
105705780|NCT00652366|364585209|FG004|Overall Study|Lack of Efficacy|13|||
105705781|NCT00652366|364585205|FG000|Overall Study|Violation of Selection Criteria|0|||
105705782|NCT00652366|364585206|FG001|Overall Study|Violation of Selection Criteria|0|||
105705783|NCT00652366|364585207|FG002|Overall Study|Violation of Selection Criteria|1|||
105705784|NCT00652366|364585208|FG003|Overall Study|Violation of Selection Criteria|0|||
105705785|NCT00652366|364585209|FG004|Overall Study|Violation of Selection Criteria|0|||
105705786|NCT00652366|364585205|FG000|Overall Study|Protocol Violation|1|||
105705787|NCT00652366|364585206|FG001|Overall Study|Protocol Violation|0|||
105705788|NCT00652366|364585207|FG002|Overall Study|Protocol Violation|0|||
105705789|NCT00652366|364585208|FG003|Overall Study|Protocol Violation|0|||
105705790|NCT00652366|364585209|FG004|Overall Study|Protocol Violation|0|||
105705791|NCT00652366|364585205|FG000|Overall Study|Refused treatment|3|||
105705792|NCT00652366|364585206|FG001|Overall Study|Refused treatment|7|||
105705793|NCT00652366|364585207|FG002|Overall Study|Refused treatment|6|||
105705794|NCT00652366|364585208|FG003|Overall Study|Refused treatment|17|||
105705795|NCT00652366|364585209|FG004|Overall Study|Refused treatment|5|||
105705796|NCT00652366|364585205|FG000|Overall Study|Other|5|||
105705797|NCT00652366|364585206|FG001|Overall Study|Other|2|||
105705798|NCT00652366|364585207|FG002|Overall Study|Other|3|||
105705799|NCT00652366|364585208|FG003|Overall Study|Other|4|||
105705800|NCT00652366|364585209|FG004|Overall Study|Other|0|||
105705801|NCT00845650|364585214|FG000|Overall Study|Withdrawal by Subject|0|||
105705802|NCT00845650|364585215|FG001|Overall Study|Withdrawal by Subject|0|||
105705803|NCT00845650|364585216|FG002|Overall Study|Withdrawal by Subject|0|||
105705804|NCT00845650|364585217|FG003|Overall Study|Withdrawal by Subject|0|||
105705805|NCT00845650|364585218|FG004|Overall Study|Withdrawal by Subject|2|||
105705806|NCT00845650|364585219|FG005|Overall Study|Withdrawal by Subject|0|||
105705807|NCT00845650|364585214|FG000|Overall Study|Lost to Follow-up|0|||
105705808|NCT00845650|364585215|FG001|Overall Study|Lost to Follow-up|0|||
105787581|NCT04668066|364874960|FG006|Part 2: Treatment Phase|Other|0|||
105787582|NCT04668066|364874961|FG007|Part 2: Treatment Phase|Other|0|||
105787583|NCT04668066|364874962|FG008|Part 2: Treatment Phase|Other|0|||
105787584|NCT04668066|364874963|FG009|Part 2: Treatment Phase|Other|0|||
105787585|NCT04668066|364874964|FG010|Part 2: Treatment Phase|Other|0|||
105787586|NCT04668066|364874965|FG011|Part 2: Treatment Phase|Other|0|||
105787587|NCT04668066|364874966|FG012|Part 2: Treatment Phase|Other|0|||
105787588|NCT04668066|364874967|FG013|Part 2: Treatment Phase|Other|0|||
105787589|NCT04668066|364874968|FG014|Part 2: Treatment Phase|Other|0|||
105705809|NCT00845650|364585216|FG002|Overall Study|Lost to Follow-up|3|||
105705810|NCT00845650|364585217|FG003|Overall Study|Lost to Follow-up|1|||
105705811|NCT00845650|364585218|FG004|Overall Study|Lost to Follow-up|0|||
105787590|NCT04668066|364874969|FG015|Part 2: Treatment Phase|Other|0|||
105787591|NCT04668066|364874970|FG016|Part 2: Treatment Phase|Other|0|||
105787592|NCT04668066|364874971|FG017|Part 2: Treatment Phase|Other|0|||
105787593|NCT04668066|364874972|FG018|Part 2: Treatment Phase|Other|1|||
105787594|NCT04668066|364874954|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787595|NCT04668066|364874955|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787596|NCT04668066|364874956|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787597|NCT04668066|364874957|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787598|NCT04668066|364874958|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787599|NCT04668066|364874959|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787600|NCT04668066|364874960|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787601|NCT04668066|364874961|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787602|NCT04668066|364874962|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787603|NCT04668066|364874963|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787604|NCT04668066|364874964|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787605|NCT04668066|364874965|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787606|NCT04668066|364874966|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787607|NCT04668066|364874967|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787608|NCT04668066|364874968|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787609|NCT04668066|364874969|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787610|NCT04668066|364874970|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787611|NCT04668066|364874971|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
105787612|NCT04668066|364874972|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
105787613|NCT01015118|364874974|FG000|Overall Study|Protocol Violation|5|||
105787614|NCT01015118|364874975|FG001|Overall Study|Protocol Violation|6|||
105787615|NCT01015118|364874974|FG000|Overall Study|Withdrawal by Subject|103|||
105787616|NCT01015118|364874975|FG001|Overall Study|Withdrawal by Subject|27|||
105787617|NCT01015118|364874974|FG000|Overall Study|Other Adverse Event (AE)|141|||
105787618|NCT01015118|364874975|FG001|Overall Study|Other Adverse Event (AE)|33|||
105787619|NCT01015118|364874974|FG000|Overall Study|Worsening or AE of underlying disease|5|||
105787620|NCT01015118|364874975|FG001|Overall Study|Worsening or AE of underlying disease|4|||
105787621|NCT01015118|364874974|FG000|Overall Study|Progressive disease|364|||
105787622|NCT01015118|364874975|FG001|Overall Study|Progressive disease|229|||
105787623|NCT01015118|364874974|FG000|Overall Study|Not treated|9|||
105787624|NCT01015118|364874975|FG001|Overall Study|Not treated|5|||
105787625|NCT01015118|364874974|FG000|Overall Study|Other than stated above|42|||
105787626|NCT01015118|364874975|FG001|Overall Study|Other than stated above|23|||
105787627|NCT02388906|364874976|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
105787628|NCT02388906|364874977|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
105787629|NCT02388906|364874976|FG000|Treatment Period|Disease progression|121|||
105787630|NCT02388906|364874977|FG001|Treatment Period|Disease progression|100|||
105787631|NCT02388906|364874976|FG000|Treatment Period|Study drug toxicity|41|||
105787632|NCT02388906|364874977|FG001|Treatment Period|Study drug toxicity|208|||
105787633|NCT02388906|364874976|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
105787634|NCT02388906|364874977|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
105787635|NCT02388906|364874976|FG000|Treatment Period|Participant request to stop treatment|5|||
105787636|NCT02388906|364874977|FG001|Treatment Period|Participant request to stop treatment|9|||
105787637|NCT02388906|364874976|FG000|Treatment Period|Participant withdrew consent|2|||
105787638|NCT02388906|364874977|FG001|Treatment Period|Participant withdrew consent|3|||
105787639|NCT02388906|364874976|FG000|Treatment Period|Poor/non-compliance|0|||
105787640|NCT02388906|364874977|FG001|Treatment Period|Poor/non-compliance|1|||
105787641|NCT02388906|364874976|FG000|Treatment Period|Participant no longer meets study criteria|0|||
105787642|NCT02388906|364874977|FG001|Treatment Period|Participant no longer meets study criteria|1|||
105787643|NCT02388906|364874976|FG000|Treatment Period|Other reasons|3|||
105787644|NCT02388906|364874977|FG001|Treatment Period|Other reasons|3|||
105787645|NCT00480077|364874978|FG000|Overall Study|Death|19|||
105787646|NCT00480077|364874979|FG001|Overall Study|Death|15|||
105787647|NCT00480077|364874978|FG000|Overall Study|early exit|12|||
105787648|NCT00480077|364874979|FG001|Overall Study|early exit|11|||
105787649|NCT02255422|364874980|FG000|Overall Study|Withdrawal by Subject|0|||
105787650|NCT02255422|364874981|FG001|Overall Study|Withdrawal by Subject|0|||
105787651|NCT02255422|364874982|FG002|Overall Study|Withdrawal by Subject|0|||
105787652|NCT02255422|364874983|FG003|Overall Study|Withdrawal by Subject|0|||
105787653|NCT02255422|364874984|FG004|Overall Study|Withdrawal by Subject|0|||
105787654|NCT02255422|364874985|FG005|Overall Study|Withdrawal by Subject|0|||
105787655|NCT02255422|364874986|FG006|Overall Study|Withdrawal by Subject|2|||
105787656|NCT02255422|364874980|FG000|Overall Study|Lost to Follow-up|0|||
105787657|NCT02255422|364874981|FG001|Overall Study|Lost to Follow-up|0|||
105787658|NCT02255422|364874982|FG002|Overall Study|Lost to Follow-up|1|||
105787659|NCT02255422|364874983|FG003|Overall Study|Lost to Follow-up|0|||
105787660|NCT02255422|364874984|FG004|Overall Study|Lost to Follow-up|0|||
105787661|NCT02255422|364874985|FG005|Overall Study|Lost to Follow-up|0|||
105787662|NCT02255422|364874986|FG006|Overall Study|Lost to Follow-up|0|||
105787663|NCT03282123|364874987|FG000|Overall Study|Withdrawal by Subject|5|||
105787664|NCT05153629|364874989|FG000|Overall Study|Withdrawal by Subject|0|||
105787665|NCT05153629|364874990|FG001|Overall Study|Withdrawal by Subject|2|||
105705812|NCT00845650|364585219|FG005|Overall Study|Lost to Follow-up|1|||
105705813|NCT00845650|364585214|FG000|Overall Study|Sponsor hold on dosing|0|||
105705814|NCT00845650|364585215|FG001|Overall Study|Sponsor hold on dosing|0|||
105705815|NCT00845650|364585216|FG002|Overall Study|Sponsor hold on dosing|0|||
105705816|NCT00845650|364585217|FG003|Overall Study|Sponsor hold on dosing|0|||
105705817|NCT00845650|364585218|FG004|Overall Study|Sponsor hold on dosing|1|||
105705818|NCT00845650|364585219|FG005|Overall Study|Sponsor hold on dosing|1|||
105705819|NCT00845650|364585214|FG000|Overall Study|Unable to access IV line|1|||
105705820|NCT00845650|364585215|FG001|Overall Study|Unable to access IV line|0|||
105705821|NCT00845650|364585216|FG002|Overall Study|Unable to access IV line|0|||
105705822|NCT00845650|364585217|FG003|Overall Study|Unable to access IV line|0|||
105705823|NCT00845650|364585218|FG004|Overall Study|Unable to access IV line|0|||
105705824|NCT00845650|364585219|FG005|Overall Study|Unable to access IV line|0|||
105705825|NCT00814892|364585220|FG000|Overall Study|Disease Progression|1|||
105705826|NCT00814892|364585220|FG000|Overall Study|Study Termination|1|||
105705827|NCT03861559|364585223|FG000|Overall Study|Adverse Event|0|||
105705828|NCT03861559|364585224|FG001|Overall Study|Adverse Event|2|||
105705829|NCT03861559|364585223|FG000|Overall Study|Treatment failure|0|||
105705830|NCT03861559|364585224|FG001|Overall Study|Treatment failure|2|||
105705831|NCT03861559|364585223|FG000|Overall Study|Noncompliance|1|||
105705832|NCT03861559|364585224|FG001|Overall Study|Noncompliance|1|||
105705833|NCT03861559|364585223|FG000|Overall Study|Did not meet eligibility requirements|1|||
105705834|NCT03861559|364585224|FG001|Overall Study|Did not meet eligibility requirements|0|||
105705835|NCT03440814|364585229|FG000|Overall Study|Adverse Event|2|||
105705836|NCT03440814|364585230|FG001|Overall Study|Adverse Event|1|||
105705837|NCT03440814|364585229|FG000|Overall Study|Lost to Follow-up|2|||
105705838|NCT03440814|364585230|FG001|Overall Study|Lost to Follow-up|0|||
105705839|NCT03440814|364585229|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
105705840|NCT03440814|364585230|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
105705841|NCT02500121|364585231|FG000|Overall Study|Lost to Follow-up|0|||
105705842|NCT02500121|364585232|FG001|Overall Study|Lost to Follow-up|1|||
105705843|NCT02500121|364585231|FG000|Overall Study|Withdrawal by Subject|1|||
105705844|NCT02500121|364585232|FG001|Overall Study|Withdrawal by Subject|1|||
105705845|NCT02500121|364585231|FG000|Overall Study|Death|26|||
105705846|NCT02500121|364585232|FG001|Overall Study|Death|24|||
105705847|NCT00088374|364585233|FG000|Overall Study|patient did not receive any 17AAG|1|||
105705848|NCT00088374|364585233|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
105705849|NCT01437397|364585234|FG000|Overall Study|Lost to Follow-up|9|||
105705850|NCT01437397|364585235|FG001|Overall Study|Lost to Follow-up|4|||
105705851|NCT01437397|364585236|FG002|Overall Study|Lost to Follow-up|2|||
105705852|NCT01437397|364585237|FG003|Overall Study|Lost to Follow-up|4|||
105705853|NCT01437397|364585238|FG004|Overall Study|Lost to Follow-up|5|||
105705854|NCT01437397|364585234|FG000|Overall Study|Withdrawal by Subject|11|||
105705855|NCT01437397|364585235|FG001|Overall Study|Withdrawal by Subject|12|||
105705856|NCT01437397|364585236|FG002|Overall Study|Withdrawal by Subject|24|||
105705857|NCT01437397|364585237|FG003|Overall Study|Withdrawal by Subject|11|||
105705858|NCT01437397|364585238|FG004|Overall Study|Withdrawal by Subject|22|||
105705859|NCT01437397|364585234|FG000|Overall Study|Protocol Violation|10|||
105705860|NCT01437397|364585235|FG001|Overall Study|Protocol Violation|12|||
105705861|NCT01437397|364585236|FG002|Overall Study|Protocol Violation|13|||
105705862|NCT01437397|364585237|FG003|Overall Study|Protocol Violation|21|||
105705863|NCT01437397|364585238|FG004|Overall Study|Protocol Violation|19|||
105705864|NCT01437397|364585234|FG000|Overall Study|Lack of Efficacy|5|||
105705865|NCT01437397|364585235|FG001|Overall Study|Lack of Efficacy|4|||
105705866|NCT01437397|364585236|FG002|Overall Study|Lack of Efficacy|8|||
106007138|NCT04886154|365690332|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106007139|NCT04886154|365690333|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106007140|NCT04886154|365690334|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106007141|NCT04886154|365690335|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
106007142|NCT04886154|365690336|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106007143|NCT04886154|365690337|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
106007144|NCT04886154|365690338|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105705867|NCT01437397|364585237|FG003|Overall Study|Lack of Efficacy|10|||
105705868|NCT01437397|364585238|FG004|Overall Study|Lack of Efficacy|20|||
105705869|NCT01437397|364585234|FG000|Overall Study|Adverse Event|21|||
105705870|NCT01437397|364585235|FG001|Overall Study|Adverse Event|22|||
105705871|NCT01437397|364585236|FG002|Overall Study|Adverse Event|16|||
105705872|NCT01437397|364585237|FG003|Overall Study|Adverse Event|14|||
105705873|NCT01437397|364585238|FG004|Overall Study|Adverse Event|21|||
105705874|NCT01437397|364585234|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
105705875|NCT01437397|364585235|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
105705876|NCT01437397|364585236|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
105705877|NCT01437397|364585237|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
105705878|NCT01437397|364585238|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
105705879|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Death|3|||
105705880|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Death|0|||
105705881|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Adverse Event|12|||
105705882|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Adverse Event|6|||
105705883|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
105705884|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
105705885|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
105705886|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
105705887|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
105705888|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
105705889|NCT00159861|364585239|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
105705890|NCT00159861|364585240|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
105705891|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Death|24|||
105705892|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Death|28|||
105705893|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
105705894|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
105705895|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
105705896|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
105705897|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
105705898|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
105705899|NCT00159861|364585239|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
105705900|NCT00159861|364585240|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
105705901|NCT01632566|364585241|FG000|Overall Study|Withdrawal by Subject|0|||
105705902|NCT01632566|364585242|FG001|Overall Study|Withdrawal by Subject|1|||
105705903|NCT01632566|364585243|FG002|Overall Study|Withdrawal by Subject|0|||
105705904|NCT01632566|364585244|FG003|Overall Study|Withdrawal by Subject|0|||
105705905|NCT01632566|364585245|FG004|Overall Study|Withdrawal by Subject|0|||
105705906|NCT01632566|364585241|FG000|Overall Study|Sponsor Decision|0|||
105705907|NCT01632566|364585242|FG001|Overall Study|Sponsor Decision|2|||
105705908|NCT01632566|364585243|FG002|Overall Study|Sponsor Decision|9|||
105705909|NCT01632566|364585244|FG003|Overall Study|Sponsor Decision|2|||
105705910|NCT01632566|364585245|FG004|Overall Study|Sponsor Decision|2|||
105705911|NCT01318109|364585246|FG000|Overall Study|Adverse Event|0|||
105705912|NCT01318109|364585247|FG001|Overall Study|Adverse Event|2|||
105705913|NCT01318109|364585248|FG002|Overall Study|Adverse Event|0|||
105705914|NCT01318109|364585246|FG000|Overall Study|Withdrawal by Subject|1|||
105705915|NCT01318109|364585247|FG001|Overall Study|Withdrawal by Subject|0|||
105705916|NCT01318109|364585248|FG002|Overall Study|Withdrawal by Subject|0|||
105705917|NCT01318109|364585246|FG000|Overall Study|Schedule Conflict|0|||
105705918|NCT01318109|364585247|FG001|Overall Study|Schedule Conflict|1|||
105705919|NCT01318109|364585248|FG002|Overall Study|Schedule Conflict|0|||
105705920|NCT02124564|364585251|FG000|Treatment Period|Adverse Event|2|||
105705921|NCT02124564|364585251|FG000|Treatment Period|Lack of Efficacy|3|||
105705922|NCT02124564|364585251|FG000|Treatment Period|Withdrawal by Subject|2|||
105705923|NCT03885089|364585253|FG000|Overall Study|No informed consent for publication of study results|2|||
105705924|NCT03349099|364585256|FG000|Overall Study|Physician Decision|3|||
105705925|NCT03349099|364585257|FG001|Overall Study|Physician Decision|4|||
105705926|NCT03349099|364585256|FG000|Overall Study|Stone migrated from the kidney|1|||
105705927|NCT03349099|364585257|FG001|Overall Study|Stone migrated from the kidney|0|||
105705928|NCT00278993|364585260|FG000|Overall Study|Adverse Event|24|||
105705929|NCT00278993|364585260|FG000|Overall Study|Withdrawal by Subject|5|||
105705930|NCT00278993|364585260|FG000|Overall Study|Progressive Disease|65|||
105705931|NCT00278993|364585260|FG000|Overall Study|Physician Decision|9|||
105705932|NCT00278993|364585260|FG000|Overall Study|Not Otherwise Specified|4|||
105705933|NCT02043548|364585263|FG000|Overall Study|Lack of Efficacy|1|||
105705934|NCT02043548|364585264|FG001|Overall Study|Lack of Efficacy|0|||
105705935|NCT02043548|364585263|FG000|Overall Study|Adverse Event|0|||
105705936|NCT02043548|364585264|FG001|Overall Study|Adverse Event|1|||
105705937|NCT04518462|364585266|FG000|Overall Study|Withdrawal by Subject|0|||
105705938|NCT04518462|364585267|FG001|Overall Study|Withdrawal by Subject|0|||
105705939|NCT04518462|364585268|FG002|Overall Study|Withdrawal by Subject|1|||
105705940|NCT04518462|364585266|FG000|Overall Study|Physician Decision|1|||
105705941|NCT04518462|364585267|FG001|Overall Study|Physician Decision|1|||
105705942|NCT04518462|364585268|FG002|Overall Study|Physician Decision|0|||
105705943|NCT01003210|364585269|FG000|Overall Study|Lost to Follow-up|1|||
106133806|NCT00783692|366148193|FG002|Maintenance Phase|Protocol Violation|0|||
105705944|NCT01003210|364585270|FG001|Overall Study|Lost to Follow-up|3|||
105705945|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
105705946|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
105705947|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
105705948|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
105705949|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
105705950|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
105705951|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
105705952|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
105705953|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
105705954|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
105705955|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
105705956|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
105705957|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
105705958|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
105705959|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
105705960|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
105705961|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
105705962|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
105705963|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
105705964|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
105705965|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
105705966|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
105705967|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
105705968|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
105705969|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
105705970|NCT03829657|364585273|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
105705971|NCT03829657|364585274|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
105705972|NCT03829657|364585275|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
105705973|NCT03829657|364585276|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
105705974|NCT03829657|364585277|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
105705975|NCT03829657|364585273|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
105705976|NCT03829657|364585274|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
105705977|NCT03829657|364585275|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
105705978|NCT03829657|364585276|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
105705979|NCT03829657|364585277|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
105705980|NCT03829657|364585273|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
105705981|NCT03829657|364585274|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
105705982|NCT03829657|364585275|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
105705983|NCT03829657|364585276|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
105705984|NCT03829657|364585277|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
105705985|NCT03829657|364585273|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
105705986|NCT03829657|364585274|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
105705987|NCT03829657|364585275|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
105705988|NCT03829657|364585276|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
105705989|NCT03829657|364585277|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
105705990|NCT03829657|364585273|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
105705991|NCT03829657|364585274|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
105705992|NCT03829657|364585275|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
105705993|NCT03829657|364585276|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
105705994|NCT03829657|364585277|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
105705995|NCT00333359|364585280|FG000|Overall Study|Adverse Event|29|||
105705996|NCT00333359|364585281|FG001|Overall Study|Adverse Event|35|||
105705997|NCT00333359|364585280|FG000|Overall Study|Withdrawal by Subject|19|||
105705998|NCT00333359|364585281|FG001|Overall Study|Withdrawal by Subject|37|||
105705999|NCT00333359|364585280|FG000|Overall Study|Physician Decision|2|||
105706000|NCT00333359|364585281|FG001|Overall Study|Physician Decision|2|||
105706001|NCT00333359|364585280|FG000|Overall Study|Protocol Non-compliance|2|||
105706002|NCT00333359|364585281|FG001|Overall Study|Protocol Non-compliance|8|||
105706003|NCT00333359|364585280|FG000|Overall Study|Lost to Follow-up|15|||
105706004|NCT00333359|364585281|FG001|Overall Study|Lost to Follow-up|25|||
105706005|NCT00333359|364585280|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
105706006|NCT00333359|364585281|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
105706007|NCT00333359|364585280|FG000|Overall Study|Treatment Failure|3|||
105706008|NCT00333359|364585281|FG001|Overall Study|Treatment Failure|8|||
105706009|NCT00333359|364585280|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
105706010|NCT00333359|364585281|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
105706011|NCT01452152|364585282|FG000|Overall Study|Study termination by sponsor|5|||
105706012|NCT01452152|364585283|FG001|Overall Study|Study termination by sponsor|0|||
105706013|NCT01452152|364585284|FG002|Overall Study|Study termination by sponsor|4|||
106007145|NCT04886154|365690339|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106007146|NCT04886154|365690340|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106007147|NCT04886154|365690341|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105787666|NCT03743571|364874991|FG000|Overall Study|Withdrawal by Subject|1|||
105787667|NCT03743571|364874992|FG001|Overall Study|Withdrawal by Subject|1|||
105787668|NCT03743571|364874991|FG000|Overall Study|Lost to Follow-up|1|||
105787669|NCT03743571|364874992|FG001|Overall Study|Lost to Follow-up|2|||
105787670|NCT04115488|364874993|FG000|Overall Study|Adverse Event|8|||
105787671|NCT04115488|364874994|FG001|Overall Study|Adverse Event|4|||
105787672|NCT04115488|364874993|FG000|Overall Study|Withdrawal by Subject|3|||
105787673|NCT04115488|364874994|FG001|Overall Study|Withdrawal by Subject|6|||
105787674|NCT04115488|364874993|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
105706014|NCT02867995|364585285|FG000|Overall Study|Withdrawal by Subject|0|||
105706015|NCT02867995|364585286|FG001|Overall Study|Withdrawal by Subject|1|||
105706016|NCT02867995|364585285|FG000|Overall Study|Lost to Follow-up|0|||
105706017|NCT02867995|364585286|FG001|Overall Study|Lost to Follow-up|2|||
105706018|NCT03315871|364585289|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
105706019|NCT03315871|364585290|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
105706020|NCT03315871|364585291|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
105706021|NCT03315871|364585289|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
105706022|NCT03315871|364585290|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
105706023|NCT03315871|364585291|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
105706024|NCT03315871|364585289|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
105706025|NCT03315871|364585290|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
105706026|NCT03315871|364585291|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
105787675|NCT04115488|364874994|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
105787676|NCT04115488|364874993|FG000|Overall Study|Patient 's location change|1|||
105706027|NCT03315871|364585289|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
105706028|NCT03315871|364585290|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
105706029|NCT03315871|364585291|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
105706030|NCT03315871|364585289|FG000|PROSTVAC + CV301|Progressive disease|0|||
105706031|NCT03315871|364585290|FG001|PROSTVAC + CV301|Progressive disease|0|||
105706032|NCT03315871|364585291|FG002|PROSTVAC + CV301|Progressive disease|1|||
105787677|NCT04115488|364874994|FG001|Overall Study|Patient 's location change|0|||
105787678|NCT04115488|364874993|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
105787679|NCT04115488|364874994|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
105706033|NCT03315871|364585289|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
105787680|NCT02756182|364875005|FG000|Overall Study|StudyTechnical Difficulties|4|||
105787681|NCT01458535|364876749|FG000|Overall Study|Other|0|||
105787682|NCT01458535|364876750|FG001|Overall Study|Other|0|||
105787683|NCT01458535|364876751|FG002|Overall Study|Other|0|||
105706034|NCT03315871|364585290|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
105706035|NCT03315871|364585291|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
105706036|NCT03578367|364585292|FG000|Overall Study|Adverse Event|0|||
105706037|NCT03578367|364585293|FG001|Overall Study|Adverse Event|3|||
105706038|NCT03578367|364585294|FG002|Overall Study|Adverse Event|0|||
105706039|NCT03578367|364585295|FG003|Overall Study|Adverse Event|5|||
105706040|NCT03578367|364585292|FG000|Overall Study|Withdrawal by Subject|2|||
105706041|NCT03578367|364585293|FG001|Overall Study|Withdrawal by Subject|2|||
105706042|NCT03578367|364585294|FG002|Overall Study|Withdrawal by Subject|1|||
105787684|NCT01458535|364876752|FG003|Overall Study|Other|0|||
105787685|NCT01458535|364876753|FG004|Overall Study|Other|1|||
105787686|NCT01458535|364876754|FG005|Overall Study|Other|1|||
105787687|NCT01458535|364876749|FG000|Overall Study|Withdrawal by Subject|0|||
105787688|NCT01458535|364876750|FG001|Overall Study|Withdrawal by Subject|0|||
105787689|NCT01458535|364876751|FG002|Overall Study|Withdrawal by Subject|2|||
105787690|NCT01458535|364876752|FG003|Overall Study|Withdrawal by Subject|0|||
105787691|NCT01458535|364876753|FG004|Overall Study|Withdrawal by Subject|1|||
105787692|NCT01458535|364876754|FG005|Overall Study|Withdrawal by Subject|1|||
105787693|NCT01458535|364876749|FG000|Overall Study|Lost to Follow-up|0|||
105787694|NCT01458535|364876750|FG001|Overall Study|Lost to Follow-up|2|||
105787695|NCT01458535|364876751|FG002|Overall Study|Lost to Follow-up|0|||
105927319|NCT03188185|365391950|FG001|Stage 2|Adverse Event|0|||
105787696|NCT01458535|364876752|FG003|Overall Study|Lost to Follow-up|3|||
105787697|NCT01458535|364876753|FG004|Overall Study|Lost to Follow-up|2|||
105787698|NCT01458535|364876754|FG005|Overall Study|Lost to Follow-up|2|||
105787699|NCT01458535|364876749|FG000|Overall Study|Adverse Event|0|||
105787700|NCT01458535|364876750|FG001|Overall Study|Adverse Event|0|||
105706043|NCT03578367|364585295|FG003|Overall Study|Withdrawal by Subject|3|||
105706044|NCT03578367|364585292|FG000|Overall Study|Physician Decision|0|||
105706045|NCT03578367|364585293|FG001|Overall Study|Physician Decision|0|||
105787701|NCT01458535|364876751|FG002|Overall Study|Adverse Event|0|||
105787702|NCT01458535|364876752|FG003|Overall Study|Adverse Event|1|||
105787703|NCT01458535|364876753|FG004|Overall Study|Adverse Event|0|||
105706046|NCT03578367|364585294|FG002|Overall Study|Physician Decision|14|||
105706047|NCT03578367|364585295|FG003|Overall Study|Physician Decision|0|||
105706048|NCT03578367|364585292|FG000|Overall Study|Death|1|||
105706049|NCT03578367|364585293|FG001|Overall Study|Death|0|||
105706050|NCT03578367|364585294|FG002|Overall Study|Death|0|||
105706051|NCT03578367|364585295|FG003|Overall Study|Death|0|||
105706052|NCT03578367|364585292|FG000|Overall Study|Not treated|0|||
105927320|NCT03188185|365391951|FG002|Stage 2|Adverse Event|2|||
105706053|NCT03578367|364585293|FG001|Overall Study|Not treated|0|||
105927321|NCT03188185|365391952|FG003|Stage 2|Adverse Event|4|||
105927322|NCT03188185|365391949|FG000|Stage 2|Lack of Efficacy|0|||
105927323|NCT03188185|365391950|FG001|Stage 2|Lack of Efficacy|0|||
105927324|NCT03188185|365391951|FG002|Stage 2|Lack of Efficacy|3|||
105927325|NCT03188185|365391952|FG003|Stage 2|Lack of Efficacy|0|||
105927326|NCT03188185|365391949|FG000|Stage 2|Lost to Follow-up|0|||
105927327|NCT03188185|365391950|FG001|Stage 2|Lost to Follow-up|0|||
105927328|NCT03188185|365391951|FG002|Stage 2|Lost to Follow-up|1|||
105927329|NCT03188185|365391952|FG003|Stage 2|Lost to Follow-up|0|||
105706054|NCT03578367|364585294|FG002|Overall Study|Not treated|1|||
105927330|NCT03188185|365391949|FG000|Stage 2|Physician Decision|0|||
105927331|NCT03188185|365391950|FG001|Stage 2|Physician Decision|0|||
106007148|NCT04886154|365690342|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106007149|NCT04886154|365690343|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105706055|NCT03578367|364585295|FG003|Overall Study|Not treated|0|||
105706056|NCT02484911|364587202|FG000|Overall Study|Withdrawal by Subject|2|||
105706057|NCT02484911|364587203|FG001|Overall Study|Withdrawal by Subject|1|||
105706058|NCT02484911|364587202|FG000|Overall Study|Protocol Violation|2|||
105706059|NCT02484911|364587203|FG001|Overall Study|Protocol Violation|1|||
105706060|NCT01652885|364587204|FG000|Overall Study|Adverse Event|1|||
105706061|NCT00490568|364587205|FG000|Overall Study|Adverse Event|116|||
105706062|NCT00490568|364587205|FG000|Overall Study|Lost to Follow-up|13|||
105706063|NCT00490568|364587205|FG000|Overall Study|Protocol Violation|45|||
105706064|NCT00490568|364587205|FG000|Overall Study|Withdrawal by Subject|135|||
105706065|NCT00490568|364587205|FG000|Overall Study|Still in the study at termination|974|||
105706066|NCT00490568|364587205|FG000|Overall Study|Other|1|||
105706067|NCT00490568|364587205|FG000|Overall Study|Exclusion criteria met|1|||
105706068|NCT00490568|364587205|FG000|Overall Study|Caregiver related|20|||
105706069|NCT00490568|364587205|FG000|Overall Study|Abnormal ECG|25|||
105706070|NCT00490568|364587205|FG000|Overall Study|Participant refused follow-up|9|||
105706071|NCT00490568|364587205|FG000|Overall Study|Legal representative withdrew consent|1|||
105706072|NCT00490568|364587205|FG000|Overall Study|Disease progression|4|||
105706073|NCT00490568|364587205|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
105706074|NCT00490568|364587205|FG000|Overall Study|Investigator decision|3|||
105706075|NCT00490568|364587205|FG000|Overall Study|Non-Compliance|7|||
105706076|NCT00490568|364587205|FG000|Overall Study|Efficacy related|3|||
105706077|NCT00490568|364587205|FG000|Overall Study|Participant died|1|||
105927332|NCT03188185|365391951|FG002|Stage 2|Physician Decision|0|||
105927333|NCT03188185|365391952|FG003|Stage 2|Physician Decision|1|||
105706078|NCT00490568|364587205|FG000|Overall Study|Participant withdrawal due to surgery|1|||
106007150|NCT04886154|365690344|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106007151|NCT04886154|365690345|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
106007152|NCT04886154|365690331|FG000|Overall Study|Other, Not Specified|0|||
106007153|NCT04886154|365690332|FG001|Overall Study|Other, Not Specified|0|||
106007154|NCT04886154|365690333|FG002|Overall Study|Other, Not Specified|0|||
106007155|NCT04886154|365690334|FG003|Overall Study|Other, Not Specified|0|||
106007156|NCT04886154|365690335|FG004|Overall Study|Other, Not Specified|11|||
106007157|NCT04886154|365690336|FG005|Overall Study|Other, Not Specified|8|||
106007158|NCT04886154|365690337|FG006|Overall Study|Other, Not Specified|9|||
106007159|NCT04886154|365690338|FG007|Overall Study|Other, Not Specified|10|||
106007160|NCT04886154|365690339|FG008|Overall Study|Other, Not Specified|6|||
106007161|NCT04886154|365690340|FG009|Overall Study|Other, Not Specified|1|||
106007162|NCT04886154|365690341|FG010|Overall Study|Other, Not Specified|1|||
106007163|NCT04886154|365690342|FG011|Overall Study|Other, Not Specified|2|||
105706079|NCT03468855|364587206|FG000|Overall Study|Adverse Event|2|||
105706080|NCT03468855|364587206|FG000|Overall Study|Lost to Follow-up|5|||
105706081|NCT03468855|364587206|FG000|Overall Study|Withdrawal by Subject|3|||
105706082|NCT03468855|364587206|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
106007164|NCT04886154|365690343|FG012|Overall Study|Other, Not Specified|1|||
105706083|NCT02135692|364587207|FG000|Overall Study|Adverse Event|3|||
105706084|NCT02135692|364587207|FG000|Overall Study|Lack of Efficacy|2|||
106007165|NCT04886154|365690344|FG013|Overall Study|Other, Not Specified|2|||
105706085|NCT02135692|364587207|FG000|Overall Study|Protocol Violation|2|||
105706086|NCT02135692|364587207|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
105706087|NCT02135692|364587207|FG000|Overall Study|Product commercially available|159|||
105706088|NCT02135692|364587207|FG000|Overall Study|Study closed/terminated|153|||
105927334|NCT03188185|365391949|FG000|Stage 2|Withdrawal by Subject|0|||
105927335|NCT03188185|365391950|FG001|Stage 2|Withdrawal by Subject|0|||
105927336|NCT03188185|365391951|FG002|Stage 2|Withdrawal by Subject|3|||
105927337|NCT03188185|365391952|FG003|Stage 2|Withdrawal by Subject|1|||
105927338|NCT00790036|365391953|FG000|Overall Study|Abnormal lab values|3|||
105927339|NCT00790036|365391954|FG001|Overall Study|Abnormal lab values|2|||
105927340|NCT00790036|365391953|FG000|Overall Study|Administrative problems|5|||
105927341|NCT00790036|365391954|FG001|Overall Study|Administrative problems|9|||
105927342|NCT00790036|365391953|FG000|Overall Study|Adverse Event|113|||
105927343|NCT00790036|365391954|FG001|Overall Study|Adverse Event|44|||
105927344|NCT00790036|365391953|FG000|Overall Study|Death|1|||
105927345|NCT00790036|365391954|FG001|Overall Study|Death|0|||
105927346|NCT00790036|365391953|FG000|Overall Study|Disease progression|24|||
105927347|NCT00790036|365391954|FG001|Overall Study|Disease progression|48|||
105927348|NCT00790036|365391953|FG000|Overall Study|Lost to Follow-up|1|||
105706089|NCT02135692|364587207|FG000|Overall Study|Lost to Follow-up|4|||
105706090|NCT02135692|364587207|FG000|Overall Study|Withdrawal by Subject|15|||
105706091|NCT01042600|364587208|FG000|Overall Study|Ineligible|1|||
105706092|NCT01042600|364587209|FG001|Overall Study|Ineligible|0|||
105706093|NCT01137773|364587213|FG000|Overall Study|Death|3|||
105706094|NCT01137773|364587214|FG001|Overall Study|Death|3|||
105706095|NCT01137773|364587213|FG000|Overall Study|Lost to Follow-up|6|||
105706096|NCT01137773|364587214|FG001|Overall Study|Lost to Follow-up|0|||
105706097|NCT00812214|364587215|FG000|Overall Study|Lost to Follow-up|3|||
105706098|NCT00812214|364587216|FG001|Overall Study|Lost to Follow-up|1|||
105706099|NCT00789529|364587220|FG000|Overall Study|Withdrawal by Subject|0|||
105706100|NCT00789529|364587221|FG001|Overall Study|Withdrawal by Subject|1|||
105706101|NCT00789529|364587220|FG000|Overall Study|Other Reason|1|||
105706102|NCT00789529|364587221|FG001|Overall Study|Other Reason|0|||
105706103|NCT01849874|364587223|FG000|Overall Study|Death|89|||
105706104|NCT01849874|364587224|FG001|Overall Study|Death|42|||
105706105|NCT01849874|364587223|FG000|Overall Study|Withdrawal by Subject|17|||
105706106|NCT01849874|364587224|FG001|Overall Study|Withdrawal by Subject|16|||
105706107|NCT01849874|364587223|FG000|Overall Study|Lost to Follow-up|3|||
105706108|NCT01849874|364587224|FG001|Overall Study|Lost to Follow-up|2|||
105706109|NCT01849874|364587223|FG000|Overall Study|Study Termination By Sponsor|93|||
105706110|NCT01849874|364587224|FG001|Overall Study|Study Termination By Sponsor|48|||
105706111|NCT01849874|364587223|FG000|Overall Study|Completed as per protocol amendment 6|3|||
105706112|NCT01849874|364587224|FG001|Overall Study|Completed as per protocol amendment 6|0|||
105706113|NCT01849874|364587223|FG000|Overall Study|Physician Decision|7|||
105706114|NCT01849874|364587224|FG001|Overall Study|Physician Decision|1|||
105706115|NCT01849874|364587223|FG000|Overall Study|Other|16|||
105706116|NCT01849874|364587224|FG001|Overall Study|Other|4|||
105706117|NCT03189446|364587225|FG000|Overall Study|Adverse Event|2|||
105706118|NCT03189446|364587225|FG000|Overall Study|Withdrawal by Subject|2|||
105706119|NCT03189446|364587225|FG000|Overall Study|Physician Decision|1|||
105706120|NCT05634577|364587226|FG000|Overall Study|Lost to Follow-up|1|||
105706121|NCT05634577|364587226|FG000|Overall Study|Withdrawal by Subject|1|||
105706122|NCT01351389|364587227|FG000|Overall Study|Withdrawal by Subject|7|||
105706123|NCT01351389|364587228|FG001|Overall Study|Withdrawal by Subject|0|||
105706124|NCT01351389|364587227|FG000|Overall Study|did not complete intervention|23|||
105706125|NCT01351389|364587228|FG001|Overall Study|did not complete intervention|15|||
105706126|NCT02830880|364587229|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
105706127|NCT02830880|364587229|FG000|Overall Study|Death|1|||
105706128|NCT02830880|364587229|FG000|Overall Study|Physician Decision|1|||
105706129|NCT00713700|364587230|FG000|Overall Study|Lost to Follow-up|3|||
105706130|NCT00713700|364587230|FG000|Overall Study|Withdrawal by Subject|1|||
105706131|NCT03551509|364587235|FG000|Overall Study|Lost to Follow-up|0|||
105706132|NCT03551509|364587236|FG001|Overall Study|Lost to Follow-up|1|||
105706133|NCT03551509|364587237|FG002|Overall Study|Lost to Follow-up|0|||
105706134|NCT03709654|364587238|FG000|Overall Study|Lost to Follow-up|1|||
105706135|NCT03709654|364587239|FG001|Overall Study|Lost to Follow-up|1|||
105706136|NCT03709654|364587238|FG000|Overall Study|Withdrawal by Subject|1|||
105706137|NCT03709654|364587239|FG001|Overall Study|Withdrawal by Subject|1|||
105706138|NCT03709654|364587238|FG000|Overall Study|Adverse Event|1|||
105706139|NCT03709654|364587239|FG001|Overall Study|Adverse Event|0|||
105706140|NCT02631200|364587242|FG000|First Period|Death|1|||
105706141|NCT02631200|364587243|FG001|First Period|Death|2|||
105706142|NCT02631200|364587242|FG000|First Period|Patient ill-health|2|||
105706143|NCT02631200|364587243|FG001|First Period|Patient ill-health|4|||
105706144|NCT02631200|364587242|FG000|First Period|Withdrawal by Subject|4|||
105706145|NCT02631200|364587243|FG001|First Period|Withdrawal by Subject|1|||
105787704|NCT01458535|364876754|FG005|Overall Study|Adverse Event|0|||
105927349|NCT00790036|365391954|FG001|Overall Study|Lost to Follow-up|2|||
105927350|NCT00790036|365391953|FG000|Overall Study|Protocol Violation|10|||
105706146|NCT02631200|364587242|FG000|Deferred Period|Death|0|||
105706147|NCT02631200|364587243|FG001|Deferred Period|Death|1|||
105706148|NCT02631200|364587242|FG000|Deferred Period|Received kidney transplant|0|||
105706149|NCT02631200|364587243|FG001|Deferred Period|Received kidney transplant|1|||
105706150|NCT02631200|364587242|FG000|Deferred Period|Withdrawal by Subject|0|||
105706151|NCT02631200|364587243|FG001|Deferred Period|Withdrawal by Subject|2|||
105706152|NCT02631200|364587242|FG000|Deferred Period|Lost to Follow-up|0|||
105706153|NCT02631200|364587243|FG001|Deferred Period|Lost to Follow-up|1|||
105706154|NCT00711100|364587246|FG000|Overall Study|Lack of Efficacy|5|||
105706155|NCT00711100|364587246|FG000|Overall Study|Withdrawal by Subject|8|||
105706156|NCT03548558|364587247|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
105706157|NCT03548558|364587248|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
105706158|NCT03548558|364587249|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
105706159|NCT03548558|364587250|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
105706160|NCT03548558|364587251|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
105706161|NCT03548558|364587252|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
105706162|NCT03548558|364587253|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
105706163|NCT03548558|364587247|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
105706164|NCT03548558|364587248|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
105706165|NCT03548558|364587249|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
105706166|NCT03548558|364587250|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
105706167|NCT03548558|364587251|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
105706168|NCT03548558|364587252|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
105706169|NCT03548558|364587253|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
105706170|NCT03548558|364587247|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
105706171|NCT03548558|364587248|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
105706172|NCT03548558|364587249|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
105706173|NCT03548558|364587250|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
105706174|NCT03548558|364587251|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
105706175|NCT03548558|364587252|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
105706176|NCT03548558|364587253|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
105706177|NCT03548558|364587247|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
105706178|NCT03548558|364587248|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
105706179|NCT03548558|364587249|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
105706180|NCT03548558|364587250|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
105706181|NCT03548558|364587251|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
105706182|NCT03548558|364587252|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
105706183|NCT03548558|364587253|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
105706184|NCT03548558|364587247|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
105706185|NCT03548558|364587248|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
105706186|NCT03548558|364587249|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
105706187|NCT03548558|364587250|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
105706188|NCT03548558|364587251|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
105706189|NCT03548558|364587252|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
105706190|NCT03548558|364587253|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
105706191|NCT03548558|364587247|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
105706192|NCT03548558|364587248|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
105706193|NCT03548558|364587249|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
105706194|NCT03548558|364587250|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
105706195|NCT03548558|364587251|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
105706196|NCT03548558|364587252|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
105706197|NCT03548558|364587253|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
105706198|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
105706199|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
105706200|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
105706201|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
105706202|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
105706203|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
105706204|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
105706205|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
105706206|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
105706207|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
105706208|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
105706209|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
105706210|NCT00783094|364587254|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
105706211|NCT00783094|364587255|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
105927351|NCT00790036|365391954|FG001|Overall Study|Protocol Violation|2|||
105927352|NCT00790036|365391953|FG000|Overall Study|Withdrawal by Subject|18|||
105927353|NCT00790036|365391954|FG001|Overall Study|Withdrawal by Subject|7|||
105927354|NCT00790036|365391953|FG000|Overall Study|Subject/guardian decision|20|||
105927355|NCT00790036|365391954|FG001|Overall Study|Subject/guardian decision|7|||
105927356|NCT01179516|365391955|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
105927357|NCT01179516|365391956|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
105927358|NCT01179516|365391957|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
105787705|NCT02546986|364876755|FG000|Treatment Period|Progressive Disease|20|||
105787706|NCT02546986|364876756|FG001|Treatment Period|Progressive Disease|22|||
105787707|NCT02546986|364876755|FG000|Treatment Period|Adverse Event|14|||
105787708|NCT02546986|364876756|FG001|Treatment Period|Adverse Event|6|||
105787709|NCT02546986|364876755|FG000|Treatment Period|Symptomatic Deterioration|4|||
105787710|NCT02546986|364876756|FG001|Treatment Period|Symptomatic Deterioration|3|||
105787711|NCT02546986|364876755|FG000|Treatment Period|Death|3|||
105787712|NCT02546986|364876756|FG001|Treatment Period|Death|4|||
105787713|NCT02546986|364876755|FG000|Treatment Period|Physician Decision|1|||
105787714|NCT02546986|364876756|FG001|Treatment Period|Physician Decision|2|||
105787715|NCT02546986|364876755|FG000|Treatment Period|Protocol Violation|1|||
105787716|NCT02546986|364876756|FG001|Treatment Period|Protocol Violation|0|||
105787717|NCT02546986|364876755|FG000|Treatment Period|Withdrawal by Subject|1|||
105787718|NCT02546986|364876756|FG001|Treatment Period|Withdrawal by Subject|1|||
105787719|NCT02546986|364876755|FG000|Treatment Period|Non-compliance with Study Drug|0|||
105787720|NCT02546986|364876756|FG001|Treatment Period|Non-compliance with Study Drug|1|||
105787721|NCT02546986|364876755|FG000|Treatment Period|Study Terminated by Sponsor|0|||
105787722|NCT02546986|364876756|FG001|Treatment Period|Study Terminated by Sponsor|1|||
105787723|NCT02546986|364876755|FG000|Treatment Period|Miscellaneous|7|||
105787724|NCT02546986|364876756|FG001|Treatment Period|Miscellaneous|9|||
105787725|NCT02546986|364876755|FG000|Survival Follow-Up Phase|Missing Status|3|||
105787726|NCT02546986|364876756|FG001|Survival Follow-Up Phase|Missing Status|5|||
105787727|NCT02546986|364876755|FG000|Survival Follow-Up Phase|Death|18|||
105787728|NCT02546986|364876756|FG001|Survival Follow-Up Phase|Death|12|||
105787729|NCT02546986|364876755|FG000|Survival Follow-Up Phase|Alive|13|||
105787730|NCT02546986|364876756|FG001|Survival Follow-Up Phase|Alive|16|||
105706212|NCT00783094|364587256|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
105706213|NCT00783094|364587254|FG000|Open-Label Extension Period|Adverse Event|12|||
105706214|NCT00783094|364587255|FG001|Open-Label Extension Period|Adverse Event|7|||
105706215|NCT00783094|364587256|FG002|Open-Label Extension Period|Adverse Event|16|||
105706216|NCT00783094|364587254|FG000|Open-Label Extension Period|Death|0|||
105706217|NCT00783094|364587255|FG001|Open-Label Extension Period|Death|0|||
105706218|NCT00783094|364587256|FG002|Open-Label Extension Period|Death|1|||
105706219|NCT00783094|364587254|FG000|Open-Label Extension Period|Protocol Violation|4|||
105706220|NCT00783094|364587255|FG001|Open-Label Extension Period|Protocol Violation|5|||
105706221|NCT00783094|364587256|FG002|Open-Label Extension Period|Protocol Violation|7|||
105706222|NCT00783094|364587254|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
105706223|NCT00783094|364587255|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
105706224|NCT00783094|364587256|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
105706225|NCT00783094|364587254|FG000|Open-Label Extension Period|Physician Decision|4|||
105706226|NCT00783094|364587255|FG001|Open-Label Extension Period|Physician Decision|2|||
105706227|NCT00783094|364587256|FG002|Open-Label Extension Period|Physician Decision|3|||
105706228|NCT00783094|364587254|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
105706229|NCT00783094|364587255|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
105706230|NCT00783094|364587256|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
105706231|NCT02513329|364587262|FG000|Overall Study|Lost to Follow-up|5|||
105706232|NCT02513329|364587263|FG001|Overall Study|Lost to Follow-up|2|||
105706233|NCT01496885|364587264|FG000|Overall Study|Lost to Follow-up|13|||
105706234|NCT01496885|364587264|FG000|Overall Study|Withdrawal by Subject|7|||
105706235|NCT01496885|364587264|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
105787731|NCT02546986|364876755|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
105706236|NCT01496885|364587264|FG000|Overall Study|Death|1|||
105706237|NCT03273166|364587265|FG000|Overall Study|Withdrawn prior to Completion|31|||
105706238|NCT01294670|364587266|FG000|Overall Study|Not treated|1|||
105706239|NCT01294670|364587267|FG001|Overall Study|Not treated|0|||
105706240|NCT01294670|364587268|FG002|Overall Study|Not treated|0|||
105706241|NCT01294670|364587269|FG003|Overall Study|Not treated|0|||
105706242|NCT01294670|364587270|FG004|Overall Study|Not treated|0|||
105787732|NCT02546986|364876756|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
105927359|NCT01179516|365391955|FG000|Overall Study|Lack of Efficacy|4|||
105927360|NCT01179516|365391956|FG001|Overall Study|Lack of Efficacy|2|||
105927361|NCT01179516|365391957|FG002|Overall Study|Lack of Efficacy|0|||
105927362|NCT01179516|365391955|FG000|Overall Study|Noncompliance with Study Drug|2|||
105927363|NCT01179516|365391956|FG001|Overall Study|Noncompliance with Study Drug|0|||
105927364|NCT01179516|365391957|FG002|Overall Study|Noncompliance with Study Drug|1|||
105927365|NCT01179516|365391955|FG000|Overall Study|Protocol Deviations|4|||
105927366|NCT01179516|365391956|FG001|Overall Study|Protocol Deviations|3|||
105927367|NCT01179516|365391957|FG002|Overall Study|Protocol Deviations|3|||
105927368|NCT01179516|365391955|FG000|Overall Study|Withdrawal of Consent|2|||
105927369|NCT01179516|365391956|FG001|Overall Study|Withdrawal of Consent|6|||
105927370|NCT01179516|365391957|FG002|Overall Study|Withdrawal of Consent|10|||
105927371|NCT01179516|365391955|FG000|Overall Study|Lost to Follow-up|7|||
105927372|NCT01179516|365391956|FG001|Overall Study|Lost to Follow-up|7|||
105927373|NCT01179516|365391957|FG002|Overall Study|Lost to Follow-up|3|||
105927374|NCT01179516|365391955|FG000|Overall Study|Other|2|||
105927375|NCT01179516|365391956|FG001|Overall Study|Other|0|||
106133807|NCT00783692|366148194|FG003|Maintenance Phase|Protocol Violation|1|||
106133808|NCT00783692|366148195|FG004|Maintenance Phase|Protocol Violation|2|||
106133809|NCT00783692|366148196|FG005|Maintenance Phase|Protocol Violation|3|||
106133810|NCT00783692|366148197|FG006|Maintenance Phase|Protocol Violation|4|||
106133811|NCT00783692|366148191|FG000|Maintenance Phase|Lack of Efficacy|79|||
105706243|NCT02083380|364587272|FG000|Overall Study|Lack of Efficacy|68|||
105706244|NCT02083380|364587273|FG001|Overall Study|Lack of Efficacy|79|||
105706245|NCT02083380|364587274|FG002|Overall Study|Lack of Efficacy|64|||
105706246|NCT02083380|364587272|FG000|Overall Study|Withdrawal by Subject|9|||
105706247|NCT02083380|364587273|FG001|Overall Study|Withdrawal by Subject|3|||
105706248|NCT02083380|364587274|FG002|Overall Study|Withdrawal by Subject|7|||
105706249|NCT02083380|364587272|FG000|Overall Study|Physician Decision|1|||
105706250|NCT02083380|364587273|FG001|Overall Study|Physician Decision|6|||
105706251|NCT02083380|364587274|FG002|Overall Study|Physician Decision|3|||
105706252|NCT02083380|364587272|FG000|Overall Study|Adverse Event|0|||
105706253|NCT02083380|364587273|FG001|Overall Study|Adverse Event|0|||
105706254|NCT02083380|364587274|FG002|Overall Study|Adverse Event|1|||
105706255|NCT02083380|364587272|FG000|Overall Study|Lost to Follow-up|5|||
105706256|NCT02083380|364587273|FG001|Overall Study|Lost to Follow-up|3|||
105706257|NCT02083380|364587274|FG002|Overall Study|Lost to Follow-up|3|||
105706258|NCT02083380|364587272|FG000|Overall Study|Other|8|||
105706259|NCT02083380|364587273|FG001|Overall Study|Other|4|||
105706260|NCT02083380|364587274|FG002|Overall Study|Other|6|||
105706261|NCT02669017|364587275|FG000|Overall Study|Death|1|||
105706262|NCT02669017|364587276|FG001|Overall Study|Death|2|||
105706263|NCT02669017|364587277|FG002|Overall Study|Death|2|||
105706264|NCT02669017|364587278|FG003|Overall Study|Death|3|||
105706265|NCT02669017|364587279|FG004|Overall Study|Death|8|||
105706266|NCT02669017|364587280|FG005|Overall Study|Death|18|||
105706267|NCT02669017|364587281|FG006|Overall Study|Death|10|||
105706268|NCT02669017|364587282|FG007|Overall Study|Death|47|||
105706269|NCT02669017|364587283|FG008|Overall Study|Death|20|||
105706270|NCT02669017|364587275|FG000|Overall Study|Withdrawal by Subject|0|||
105706271|NCT02669017|364587276|FG001|Overall Study|Withdrawal by Subject|0|||
105706272|NCT02669017|364587277|FG002|Overall Study|Withdrawal by Subject|0|||
105706273|NCT02669017|364587278|FG003|Overall Study|Withdrawal by Subject|1|||
105927376|NCT01179516|365391957|FG002|Overall Study|Other|2|||
105927377|NCT02612155|365391958|FG000|Overall Study|Death|1|||
105927378|NCT02612155|365391959|FG001|Overall Study|Death|1|||
105927379|NCT02612155|365391958|FG000|Overall Study|Lost to Follow-up|2|||
105927380|NCT02612155|365391959|FG001|Overall Study|Lost to Follow-up|2|||
105927381|NCT03349515|365391962|FG000|Overall Study|Lack of Efficacy|2|||
105927382|NCT03349515|365391963|FG001|Overall Study|Lack of Efficacy|0|||
105927383|NCT03349515|365391962|FG000|Overall Study|Physician Decision|3|||
105927384|NCT03349515|365391963|FG001|Overall Study|Physician Decision|1|||
105927385|NCT05073315|365391970|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
105927386|NCT05073315|365391971|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
105927387|NCT05073315|365391972|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
105927388|NCT05073315|365391970|FG000|Period 1 (Lead-in Period)|Death|1|||
105927389|NCT05073315|365391971|FG001|Period 1 (Lead-in Period)|Death|0|||
105927390|NCT05073315|365391972|FG002|Period 1 (Lead-in Period)|Death|0|||
105927391|NCT05073315|365391970|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
105927392|NCT05073315|365391971|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
105927393|NCT05073315|365391972|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
105927394|NCT05073315|365391970|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
105927395|NCT05073315|365391971|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
105927396|NCT05073315|365391972|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
105927397|NCT05073315|365391970|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
105927398|NCT05073315|365391971|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
105927399|NCT05073315|365391972|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
105927400|NCT05073315|365391970|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
105927401|NCT05073315|365391971|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
105927402|NCT05073315|365391972|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
105927403|NCT05073315|365391970|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
105927404|NCT05073315|365391971|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
105927405|NCT05073315|365391972|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
105927406|NCT05073315|365391970|FG000|Period 2|Adverse Event|0|||
105927407|NCT05073315|365391971|FG001|Period 2|Adverse Event|3|||
105927408|NCT05073315|365391972|FG002|Period 2|Adverse Event|6|||
105927409|NCT05073315|365391970|FG000|Period 2|Lost to Follow-up|0|||
105927410|NCT05073315|365391971|FG001|Period 2|Lost to Follow-up|5|||
105927411|NCT05073315|365391972|FG002|Period 2|Lost to Follow-up|5|||
105927412|NCT05073315|365391970|FG000|Period 2|Withdrawal by Subject|0|||
105927413|NCT05073315|365391971|FG001|Period 2|Withdrawal by Subject|4|||
105927414|NCT05073315|365391972|FG002|Period 2|Withdrawal by Subject|9|||
105927415|NCT05073315|365391970|FG000|Period 2|Protocol Violation|0|||
105706274|NCT02669017|364587279|FG004|Overall Study|Withdrawal by Subject|2|||
105706275|NCT02669017|364587280|FG005|Overall Study|Withdrawal by Subject|0|||
105927416|NCT05073315|365391971|FG001|Period 2|Protocol Violation|0|||
105927417|NCT05073315|365391972|FG002|Period 2|Protocol Violation|1|||
105927418|NCT01695746|365391973|FG000|Overall Study|Adverse Event|1|||
105927419|NCT01695746|365391973|FG000|Overall Study|Non-compliance by the participant|3|||
105927420|NCT01695746|365391973|FG000|Overall Study|Protocol Violation|5|||
105706276|NCT02669017|364587281|FG006|Overall Study|Withdrawal by Subject|0|||
105706277|NCT02669017|364587282|FG007|Overall Study|Withdrawal by Subject|2|||
105706278|NCT02669017|364587283|FG008|Overall Study|Withdrawal by Subject|2|||
105706279|NCT02669017|364587275|FG000|Overall Study|Lost to Follow-up|0|||
105706280|NCT02669017|364587276|FG001|Overall Study|Lost to Follow-up|0|||
105706281|NCT02669017|364587277|FG002|Overall Study|Lost to Follow-up|0|||
105706282|NCT02669017|364587278|FG003|Overall Study|Lost to Follow-up|0|||
105706283|NCT02669017|364587279|FG004|Overall Study|Lost to Follow-up|0|||
105706284|NCT02669017|364587280|FG005|Overall Study|Lost to Follow-up|0|||
105706285|NCT02669017|364587281|FG006|Overall Study|Lost to Follow-up|0|||
105706286|NCT02669017|364587282|FG007|Overall Study|Lost to Follow-up|0|||
105706287|NCT02669017|364587283|FG008|Overall Study|Lost to Follow-up|1|||
105706288|NCT02669017|364587275|FG000|Overall Study|Miscellaneous|0|||
105706289|NCT02669017|364587276|FG001|Overall Study|Miscellaneous|0|||
105706290|NCT02669017|364587277|FG002|Overall Study|Miscellaneous|0|||
105706291|NCT02669017|364587278|FG003|Overall Study|Miscellaneous|0|||
105706292|NCT02669017|364587279|FG004|Overall Study|Miscellaneous|2|||
105706293|NCT02669017|364587280|FG005|Overall Study|Miscellaneous|1|||
105706294|NCT02669017|364587281|FG006|Overall Study|Miscellaneous|1|||
105706295|NCT02669017|364587282|FG007|Overall Study|Miscellaneous|13|||
105706296|NCT02669017|364587283|FG008|Overall Study|Miscellaneous|2|||
105706297|NCT03808077|364587284|FG000|Overall Study|Physician Decision|2|||
105706298|NCT03808077|364587285|FG001|Overall Study|Physician Decision|3|||
105706299|NCT03808077|364587284|FG000|Overall Study|Withdrawal by Subject|1|||
105706300|NCT03808077|364587285|FG001|Overall Study|Withdrawal by Subject|0|||
105706301|NCT03808077|364587284|FG000|Overall Study|Equipment Issues|2|||
105706302|NCT03808077|364587285|FG001|Overall Study|Equipment Issues|1|||
105706303|NCT04152161|364587286|FG000|Overall Study|Death|0|||
105706304|NCT04152161|364587287|FG001|Overall Study|Death|1|||
105706305|NCT04152161|364587286|FG000|Overall Study|Physician Decision|0|||
105706306|NCT04152161|364587287|FG001|Overall Study|Physician Decision|1|||
105706307|NCT04152161|364587286|FG000|Overall Study|Lost to Follow-up|9|||
105706308|NCT04152161|364587287|FG001|Overall Study|Lost to Follow-up|3|||
105706309|NCT04152161|364587286|FG000|Overall Study|Protocol Violation|1|||
105706310|NCT04152161|364587287|FG001|Overall Study|Protocol Violation|0|||
105706311|NCT04152161|364587286|FG000|Overall Study|Withdrawal by Subject|29|||
105706312|NCT04152161|364587287|FG001|Overall Study|Withdrawal by Subject|28|||
105706313|NCT04152161|364587286|FG000|Overall Study|Sponsor termination of study|750|||
105706314|NCT04152161|364587287|FG001|Overall Study|Sponsor termination of study|755|||
105706315|NCT04152161|364587286|FG000|Overall Study|Other|20|||
105706316|NCT04152161|364587287|FG001|Overall Study|Other|18|||
105927421|NCT01695746|365391973|FG000|Overall Study|Participant not willing to participate|3|||
105706318|NCT03246958|364587289|FG000|Overall Study|Withdrawal by Subject|0|||
105706319|NCT03246958|364587290|FG001|Overall Study|Withdrawal by Subject|1|||
105706320|NCT03246958|364587291|FG002|Overall Study|Withdrawal by Subject|0|||
105706321|NCT03246958|364587292|FG003|Overall Study|Withdrawal by Subject|0|||
105706322|NCT03246958|364587293|FG004|Overall Study|Withdrawal by Subject|0|||
105706323|NCT03246958|364587294|FG005|Overall Study|Withdrawal by Subject|1|||
105706324|NCT03246958|364587295|FG006|Overall Study|Withdrawal by Subject|0|||
105706325|NCT03246958|364587289|FG000|Overall Study|Progression|13|||
105706326|NCT03246958|364587290|FG001|Overall Study|Progression|9|||
105706327|NCT03246958|364587291|FG002|Overall Study|Progression|3|||
105706328|NCT03246958|364587292|FG003|Overall Study|Progression|2|||
105706329|NCT03246958|364587293|FG004|Overall Study|Progression|1|||
105706330|NCT03246958|364587294|FG005|Overall Study|Progression|2|||
105706331|NCT03246958|364587295|FG006|Overall Study|Progression|1|||
105706332|NCT03246958|364587289|FG000|Overall Study|Adverse Event|2|||
105706333|NCT03246958|364587290|FG001|Overall Study|Adverse Event|2|||
105706334|NCT03246958|364587291|FG002|Overall Study|Adverse Event|0|||
105706335|NCT03246958|364587292|FG003|Overall Study|Adverse Event|1|||
105706336|NCT03246958|364587293|FG004|Overall Study|Adverse Event|1|||
105706337|NCT03246958|364587294|FG005|Overall Study|Adverse Event|0|||
105706338|NCT03246958|364587295|FG006|Overall Study|Adverse Event|2|||
105927422|NCT02232698|365391974|FG000|Overall Study|Pregnancy|1|||
105706339|NCT03246958|364587289|FG000|Overall Study|Death|0|||
105706340|NCT03246958|364587290|FG001|Overall Study|Death|1|||
105706341|NCT03246958|364587291|FG002|Overall Study|Death|0|||
105706342|NCT03246958|364587292|FG003|Overall Study|Death|0|||
105706343|NCT03246958|364587293|FG004|Overall Study|Death|0|||
105706344|NCT03246958|364587294|FG005|Overall Study|Death|0|||
105706345|NCT03246958|364587295|FG006|Overall Study|Death|0|||
105706346|NCT03246958|364587289|FG000|Overall Study|Physician Decision|0|||
105927423|NCT02232698|365391975|FG001|Overall Study|Pregnancy|1|||
105706347|NCT03246958|364587290|FG001|Overall Study|Physician Decision|0|||
105706348|NCT03246958|364587291|FG002|Overall Study|Physician Decision|0|||
105706349|NCT03246958|364587292|FG003|Overall Study|Physician Decision|1|||
105706350|NCT03246958|364587293|FG004|Overall Study|Physician Decision|0|||
105706351|NCT03246958|364587294|FG005|Overall Study|Physician Decision|0|||
105706352|NCT03246958|364587295|FG006|Overall Study|Physician Decision|0|||
105706353|NCT03246958|364587289|FG000|Overall Study|Never start treatment|1|||
105706354|NCT03246958|364587290|FG001|Overall Study|Never start treatment|0|||
105706355|NCT03246958|364587291|FG002|Overall Study|Never start treatment|0|||
105706356|NCT03246958|364587292|FG003|Overall Study|Never start treatment|0|||
105706357|NCT03246958|364587293|FG004|Overall Study|Never start treatment|0|||
105706358|NCT03246958|364587294|FG005|Overall Study|Never start treatment|0|||
105706359|NCT03246958|364587295|FG006|Overall Study|Never start treatment|0|||
105706360|NCT03246958|364587289|FG000|Overall Study|Over enrollment|0|||
105706361|NCT03246958|364587290|FG001|Overall Study|Over enrollment|2|||
105706362|NCT03246958|364587291|FG002|Overall Study|Over enrollment|0|||
105706363|NCT03246958|364587292|FG003|Overall Study|Over enrollment|0|||
105706364|NCT03246958|364587293|FG004|Overall Study|Over enrollment|0|||
105706365|NCT03246958|364587294|FG005|Overall Study|Over enrollment|0|||
105706366|NCT03246958|364587295|FG006|Overall Study|Over enrollment|0|||
105706367|NCT00876187|364587302|FG000|Overall Study|Adverse Event|14|||
105706368|NCT00876187|364587303|FG001|Overall Study|Adverse Event|12|||
105706369|NCT00876187|364587304|FG002|Overall Study|Adverse Event|19|||
105706370|NCT00876187|364587305|FG003|Overall Study|Adverse Event|29|||
105706371|NCT00876187|364587306|FG004|Overall Study|Adverse Event|10|||
105706372|NCT00876187|364587302|FG000|Overall Study|Lack of Efficacy|59|||
105706373|NCT00876187|364587303|FG001|Overall Study|Lack of Efficacy|34|||
105706374|NCT00876187|364587304|FG002|Overall Study|Lack of Efficacy|45|||
105706375|NCT00876187|364587305|FG003|Overall Study|Lack of Efficacy|34|||
105706376|NCT00876187|364587306|FG004|Overall Study|Lack of Efficacy|59|||
105706377|NCT00876187|364587302|FG000|Overall Study|Lost to Follow-up|9|||
105706378|NCT00876187|364587303|FG001|Overall Study|Lost to Follow-up|10|||
105706379|NCT00876187|364587304|FG002|Overall Study|Lost to Follow-up|8|||
105706380|NCT00876187|364587305|FG003|Overall Study|Lost to Follow-up|8|||
105706381|NCT00876187|364587306|FG004|Overall Study|Lost to Follow-up|11|||
105706382|NCT00876187|364587302|FG000|Overall Study|Protocol Violation|6|||
105706383|NCT00876187|364587303|FG001|Overall Study|Protocol Violation|7|||
105706384|NCT00876187|364587304|FG002|Overall Study|Protocol Violation|7|||
105706385|NCT00876187|364587305|FG003|Overall Study|Protocol Violation|6|||
105706386|NCT00876187|364587306|FG004|Overall Study|Protocol Violation|3|||
105706387|NCT00876187|364587302|FG000|Overall Study|Withdrawal by Subject|16|||
105706388|NCT00876187|364587303|FG001|Overall Study|Withdrawal by Subject|26|||
105706389|NCT00876187|364587304|FG002|Overall Study|Withdrawal by Subject|32|||
105706390|NCT00876187|364587305|FG003|Overall Study|Withdrawal by Subject|38|||
105706391|NCT00876187|364587306|FG004|Overall Study|Withdrawal by Subject|37|||
105706392|NCT00876187|364587302|FG000|Overall Study|Entered extension study|101|||
105706393|NCT00876187|364587303|FG001|Overall Study|Entered extension study|120|||
105706394|NCT00876187|364587304|FG002|Overall Study|Entered extension study|156|||
105706395|NCT00876187|364587305|FG003|Overall Study|Entered extension study|151|||
105706396|NCT00876187|364587306|FG004|Overall Study|Entered extension study|144|||
105706397|NCT00876187|364587302|FG000|Overall Study|Randomized but not treated|3|||
105706398|NCT00876187|364587303|FG001|Overall Study|Randomized but not treated|1|||
105706399|NCT00876187|364587304|FG002|Overall Study|Randomized but not treated|3|||
105706400|NCT00876187|364587305|FG003|Overall Study|Randomized but not treated|2|||
105706401|NCT00876187|364587306|FG004|Overall Study|Randomized but not treated|3|||
105706402|NCT00876187|364587302|FG000|Overall Study|Other|2|||
105706403|NCT00876187|364587303|FG001|Overall Study|Other|5|||
105706404|NCT00876187|364587304|FG002|Overall Study|Other|9|||
105706405|NCT00876187|364587305|FG003|Overall Study|Other|7|||
105706406|NCT00876187|364587306|FG004|Overall Study|Other|4|||
105706407|NCT01500278|364587307|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
105706408|NCT01500278|364587308|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
105706409|NCT01500278|364587307|FG000|Week 0 - Week 12|Protocol Violation|10|||
105706410|NCT01500278|364587308|FG001|Week 0 - Week 12|Protocol Violation|16|||
105706411|NCT01500278|364587307|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
105706412|NCT01500278|364587308|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
105706413|NCT01500278|364587307|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
105706414|NCT01500278|364587308|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
105706415|NCT01500278|364587307|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
105706416|NCT01500278|364587308|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
105706417|NCT01500278|364587307|FG000|Week 0 - Week 12|Patient decision|1|||
105706418|NCT01500278|364587308|FG001|Week 0 - Week 12|Patient decision|0|||
105706419|NCT01500278|364587307|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
105706420|NCT01500278|364587308|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
105706421|NCT01500278|364587307|FG000|Week 0 - Week 12|Investigator decision|1|||
105706422|NCT01500278|364587308|FG001|Week 0 - Week 12|Investigator decision|0|||
105706423|NCT01500278|364587307|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
105787733|NCT05993299|364876757|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
105706424|NCT01500278|364587308|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
105706425|NCT01500278|364587307|FG000|Week 0 - Week 12|Sponsor decision|1|||
105927424|NCT02232698|365391974|FG000|Overall Study|Met exclusion criteria|1|||
105927425|NCT02232698|365391975|FG001|Overall Study|Met exclusion criteria|1|||
105927426|NCT02232698|365391974|FG000|Overall Study|Had device-associated symptoms|7|||
105927427|NCT02232698|365391975|FG001|Overall Study|Had device-associated symptoms|0|||
105927428|NCT02232698|365391974|FG000|Overall Study|Non-compliance with study device|1|||
105927429|NCT02232698|365391975|FG001|Overall Study|Non-compliance with study device|4|||
105927430|NCT02232698|365391974|FG000|Overall Study|Allocated to control group|0|||
105927431|NCT02232698|365391975|FG001|Overall Study|Allocated to control group|3|||
105927432|NCT02232698|365391974|FG000|Overall Study|Withdrawal by Subject|0|||
105927433|NCT02232698|365391975|FG001|Overall Study|Withdrawal by Subject|11|||
105927434|NCT00433290|365391977|FG000|Overall Study|Adverse Event|24|||
105927435|NCT00433290|365391978|FG001|Overall Study|Adverse Event|7|||
105927436|NCT00433290|365391977|FG000|Overall Study|Lack of Efficacy|1|||
105706426|NCT01500278|364587308|FG001|Week 0 - Week 12|Sponsor decision|0|||
105706427|NCT01500278|364587307|FG000|Week 0 - Week 12|Personal reason|0|||
105706428|NCT01500278|364587308|FG001|Week 0 - Week 12|Personal reason|1|||
105706429|NCT01500278|364587307|FG000|Week 0 - Week 12|Other serious disease|0|||
105706430|NCT01500278|364587308|FG001|Week 0 - Week 12|Other serious disease|1|||
105706431|NCT01500278|364587307|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
105706432|NCT01500278|364587308|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
105706433|NCT01500278|364587307|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
105706434|NCT01500278|364587308|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
105706435|NCT01500278|364587307|FG000|Week 13 - Week 104|Protocol Violation|6|||
105706436|NCT01500278|364587308|FG001|Week 13 - Week 104|Protocol Violation|6|||
105706437|NCT01500278|364587307|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
105706438|NCT01500278|364587308|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
105706439|NCT01500278|364587307|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
105706440|NCT01500278|364587308|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
105706441|NCT01500278|364587307|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
105706442|NCT01500278|364587308|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
105706443|NCT01500278|364587307|FG000|Week 13 - Week 104|Non/bad compliance|7|||
105706444|NCT01500278|364587308|FG001|Week 13 - Week 104|Non/bad compliance|5|||
105706445|NCT01500278|364587307|FG000|Week 13 - Week 104|Recurrent infections|1|||
105706446|NCT01500278|364587308|FG001|Week 13 - Week 104|Recurrent infections|0|||
105706447|NCT01500278|364587307|FG000|Week 13 - Week 104|False positive test|1|||
105706448|NCT01500278|364587308|FG001|Week 13 - Week 104|False positive test|2|||
105706449|NCT01500278|364587307|FG000|Week 13 - Week 104|Sponsor request|4|||
105706450|NCT01500278|364587308|FG001|Week 13 - Week 104|Sponsor request|0|||
105706451|NCT01500278|364587307|FG000|Week 13 - Week 104|Withdrawn in error|1|||
105706452|NCT01500278|364587308|FG001|Week 13 - Week 104|Withdrawn in error|0|||
105706453|NCT01500278|364587307|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
105706454|NCT01500278|364587308|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
105706455|NCT01500278|364587307|FG000|Week 13 - Week 104|Protocol deviation|1|||
105706456|NCT01500278|364587308|FG001|Week 13 - Week 104|Protocol deviation|0|||
105706457|NCT01500278|364587307|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
105706458|NCT01500278|364587308|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
105706459|NCT01500278|364587307|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
105706460|NCT01500278|364587308|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
105706461|NCT01500278|364587307|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
105706462|NCT01500278|364587308|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
105706463|NCT01500278|364587307|FG000|Week 13 - Week 104|Relocation|0|||
105706464|NCT01500278|364587308|FG001|Week 13 - Week 104|Relocation|1|||
105706465|NCT01500278|364587307|FG000|Week 13 - Week 104|Sponsor decision|0|||
105706466|NCT01500278|364587308|FG001|Week 13 - Week 104|Sponsor decision|2|||
105706467|NCT01500278|364587307|FG000|Week 13 - Week 104|Medical monitor decision|0|||
105706468|NCT01500278|364587308|FG001|Week 13 - Week 104|Medical monitor decision|2|||
105706469|NCT01500278|364587307|FG000|Week 13 - Week 104|Personal reason|0|||
105706470|NCT01500278|364587308|FG001|Week 13 - Week 104|Personal reason|1|||
105706471|NCT01500278|364587307|FG000|Week 13 - Week 104|Not completed|0|||
105706472|NCT01500278|364587308|FG001|Week 13 - Week 104|Not completed|1|||
105706473|NCT01500278|364587307|FG000|Week 13 - Week 104|Death|2|||
105706474|NCT01500278|364587308|FG001|Week 13 - Week 104|Death|4|||
105706475|NCT01500278|364587307|FG000|Week 13 - Week 104|Adverse Event|54|||
105706476|NCT01500278|364587308|FG001|Week 13 - Week 104|Adverse Event|54|||
105706477|NCT00763815|364587309|FG000|Overall Study|Adverse Event|14|||
105706478|NCT00763815|364587310|FG001|Overall Study|Adverse Event|29|||
105706479|NCT00763815|364587309|FG000|Overall Study|Lack of Efficacy|10|||
105706480|NCT00763815|364587310|FG001|Overall Study|Lack of Efficacy|11|||
105706481|NCT00763815|364587309|FG000|Overall Study|Poor Compliance to Protocol|6|||
105706482|NCT00763815|364587310|FG001|Overall Study|Poor Compliance to Protocol|6|||
105706483|NCT00763815|364587309|FG000|Overall Study|Lost to Follow-up|2|||
105706484|NCT00763815|364587310|FG001|Overall Study|Lost to Follow-up|4|||
105706485|NCT00763815|364587309|FG000|Overall Study|Early Termination|1|||
105706486|NCT00763815|364587310|FG001|Overall Study|Early Termination|0|||
105927437|NCT00433290|365391978|FG001|Overall Study|Lack of Efficacy|5|||
105787734|NCT05993299|364876757|FG000|Overall Study|Ongoing|4|||
105787735|NCT05644756|364876758|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
105787736|NCT05644756|364876758|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
105787737|NCT02968810|364876759|FG000|Overall Study|Lost to Follow-up|1|||
105787738|NCT02968810|364876760|FG001|Overall Study|Lost to Follow-up|0|||
105787739|NCT02968810|364876759|FG000|Overall Study|Physician Decision|1|||
105787740|NCT02968810|364876760|FG001|Overall Study|Physician Decision|0|||
105787741|NCT02968810|364876759|FG000|Overall Study|Withdrawal by Subject|1|||
105787742|NCT02968810|364876760|FG001|Overall Study|Withdrawal by Subject|3|||
105787743|NCT02968810|364876759|FG000|Overall Study|Disease Progression|0|||
105787744|NCT02968810|364876760|FG001|Overall Study|Disease Progression|1|||
105787745|NCT03113760|364876761|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
105787746|NCT03113760|364876762|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
105787747|NCT03113760|364876763|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
105787748|NCT03113760|364876764|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
105787749|NCT03113760|364876761|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
105787750|NCT03113760|364876762|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
105787751|NCT03113760|364876763|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
105787752|NCT03113760|364876764|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
105787753|NCT03113760|364876761|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
105787754|NCT03113760|364876762|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
105787755|NCT03113760|364876763|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
105706487|NCT00763815|364587309|FG000|Overall Study|Familial and Personal Reasons|9|||
105706488|NCT00763815|364587310|FG001|Overall Study|Familial and Personal Reasons|16|||
105706489|NCT00763815|364587309|FG000|Overall Study|Physician Decision|1|||
105706490|NCT00763815|364587310|FG001|Overall Study|Physician Decision|0|||
105706491|NCT00763815|364587309|FG000|Overall Study|Withdrawal by Subject|7|||
105706492|NCT00763815|364587310|FG001|Overall Study|Withdrawal by Subject|12|||
105706493|NCT00763815|364587309|FG000|Overall Study|Protocol Violation|2|||
105706494|NCT00763815|364587310|FG001|Overall Study|Protocol Violation|5|||
105706495|NCT00763815|364587309|FG000|Overall Study|Sponsor's Decision|0|||
105706496|NCT00763815|364587310|FG001|Overall Study|Sponsor's Decision|1|||
105706497|NCT00283595|364587311|FG000|Overall Study|Withdrawal by Subject|1|||
105787756|NCT03113760|364876764|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
105787757|NCT01059175|364876766|FG000|Overall Study|Death|17|||
105787758|NCT01059175|364876767|FG001|Overall Study|Death|17|||
105787759|NCT01059175|364876766|FG000|Overall Study|Adverse Event|4|||
105787760|NCT01059175|364876767|FG001|Overall Study|Adverse Event|2|||
105787761|NCT01059175|364876766|FG000|Overall Study|Lost to Follow-up|0|||
105787762|NCT01059175|364876767|FG001|Overall Study|Lost to Follow-up|1|||
105787763|NCT01283009|364876768|FG000|Overall Study|Death|83|||
105787764|NCT01283009|364876769|FG001|Overall Study|Death|78|||
105787765|NCT01283009|364876768|FG000|Overall Study|Study ended early|23|||
105787766|NCT01283009|364876769|FG001|Overall Study|Study ended early|26|||
105787767|NCT01283009|364876768|FG000|Overall Study|Withdrawal by Subject|10|||
105787768|NCT01283009|364876769|FG001|Overall Study|Withdrawal by Subject|8|||
105787769|NCT01283009|364876768|FG000|Overall Study|Physician Decision|1|||
105787770|NCT01283009|364876769|FG001|Overall Study|Physician Decision|1|||
105787771|NCT01283009|364876768|FG000|Overall Study|Lost to Follow-up|1|||
105787772|NCT01283009|364876769|FG001|Overall Study|Lost to Follow-up|0|||
105787773|NCT01283009|364876768|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
105787774|NCT01283009|364876769|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
105787775|NCT03557775|364876770|FG000|Overall Study|Withdrawal by Subject|1|||
105787776|NCT03557775|364876771|FG001|Overall Study|Withdrawal by Subject|2|||
105787777|NCT03557775|364876772|FG002|Overall Study|Withdrawal by Subject|4|||
105787778|NCT03557775|364876770|FG000|Overall Study|Physician Decision|0|||
105787779|NCT03557775|364876771|FG001|Overall Study|Physician Decision|1|||
105787780|NCT03557775|364876772|FG002|Overall Study|Physician Decision|0|||
105787781|NCT01725217|364876775|FG000|Overall Study|Withdrawal by Subject|1|||
105787782|NCT01725217|364876776|FG001|Overall Study|Withdrawal by Subject|0|||
105787783|NCT01725217|364876777|FG002|Overall Study|Withdrawal by Subject|0|||
105787784|NCT01353586|364876778|FG000|Overall Study|Procedure terminated prior to ablation|3|||
105787785|NCT01353586|364876779|FG001|Overall Study|Procedure terminated prior to ablation|0|||
105927438|NCT00433290|365391977|FG000|Overall Study|Withdrawal by Subject|4|||
105706498|NCT00283595|364587312|FG001|Overall Study|Withdrawal by Subject|2|||
105706499|NCT00906087|364587315|FG000|Initial Washout|Withdrawal by Subject|1|||
105706500|NCT00906087|364587315|FG000|Initial Washout|Physician Decision|1|||
105787786|NCT01353586|364876778|FG000|Overall Study|Never had insertion of study catheter|4|||
105787787|NCT01353586|364876779|FG001|Overall Study|Never had insertion of study catheter|1|||
105787788|NCT01353586|364876778|FG000|Overall Study|Neurological exam not done|0|||
105787789|NCT01353586|364876779|FG001|Overall Study|Neurological exam not done|1|||
105787790|NCT01023815|364876780|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
105787791|NCT01023815|364876781|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
105787792|NCT01023815|364876782|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
105706501|NCT01081249|364587320|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
105706502|NCT01081249|364587321|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
105706503|NCT03016325|364587324|FG000|Treatment Period|Participant withdrew consent|0|||
105706504|NCT03016325|364587325|FG001|Treatment Period|Participant withdrew consent|1|||
105706505|NCT03016325|364587326|FG002|Treatment Period|Participant withdrew consent|0|||
105706506|NCT03016325|364587327|FG003|Treatment Period|Participant withdrew consent|0|||
105706507|NCT03016325|364587328|FG004|Treatment Period|Participant withdrew consent|0|||
105706508|NCT03016325|364587329|FG005|Treatment Period|Participant withdrew consent|0|||
105706509|NCT03016325|364587330|FG006|Treatment Period|Participant withdrew consent|0|||
105706510|NCT03016325|364587331|FG007|Treatment Period|Participant withdrew consent|0|||
105706511|NCT03016325|364587324|FG000|Treatment Period|Death|0|||
105706512|NCT03016325|364587325|FG001|Treatment Period|Death|0|||
105706513|NCT03016325|364587326|FG002|Treatment Period|Death|0|||
105706514|NCT03016325|364587327|FG003|Treatment Period|Death|0|||
105706515|NCT03016325|364587328|FG004|Treatment Period|Death|2|||
105706516|NCT03016325|364587329|FG005|Treatment Period|Death|0|||
105706517|NCT03016325|364587330|FG006|Treatment Period|Death|0|||
105706518|NCT03016325|364587331|FG007|Treatment Period|Death|0|||
105706519|NCT03016325|364587324|FG000|Treatment Period|Participant refuses assessments|0|||
105706520|NCT03016325|364587325|FG001|Treatment Period|Participant refuses assessments|0|||
105706521|NCT03016325|364587326|FG002|Treatment Period|Participant refuses assessments|1|||
105706522|NCT03016325|364587327|FG003|Treatment Period|Participant refuses assessments|0|||
105706523|NCT03016325|364587328|FG004|Treatment Period|Participant refuses assessments|0|||
105706524|NCT03016325|364587329|FG005|Treatment Period|Participant refuses assessments|0|||
105706525|NCT03016325|364587330|FG006|Treatment Period|Participant refuses assessments|0|||
105706526|NCT03016325|364587331|FG007|Treatment Period|Participant refuses assessments|0|||
105706527|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Death|2|||
105706528|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Death|0|||
105706529|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Death|5|||
105706530|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Death|6|||
105706531|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Death|3|||
105706532|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Death|0|||
105706533|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Death|0|||
105706534|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Death|0|||
105706535|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
105706536|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706537|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
105706538|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
105706539|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706540|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706541|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706542|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
105706543|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
105706544|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706545|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706546|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
105706547|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
105706548|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706549|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706550|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
105706551|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
105706552|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
105706553|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
105706554|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
105706555|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
105706556|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
105706557|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
105706558|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
105706559|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706560|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706561|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706562|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706563|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
105706564|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706565|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
105706566|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
105706567|NCT03016325|364587324|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706568|NCT03016325|364587325|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
106133812|NCT00783692|366148192|FG001|Maintenance Phase|Lack of Efficacy|0|||
106133813|NCT00783692|366148193|FG002|Maintenance Phase|Lack of Efficacy|0|||
105706569|NCT03016325|364587326|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
105706570|NCT03016325|364587327|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105927439|NCT00433290|365391978|FG001|Overall Study|Withdrawal by Subject|2|||
105927440|NCT00433290|365391977|FG000|Overall Study|Protocol Violation|3|||
105927441|NCT00433290|365391978|FG001|Overall Study|Protocol Violation|2|||
105927442|NCT00433290|365391977|FG000|Overall Study|Physician Decision|2|||
106133814|NCT00783692|366148194|FG003|Maintenance Phase|Lack of Efficacy|64|||
105706571|NCT03016325|364587328|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706572|NCT03016325|364587329|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706573|NCT03016325|364587330|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706574|NCT03016325|364587331|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
105706575|NCT03016325|364587324|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706576|NCT03016325|364587325|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
105706577|NCT03016325|364587326|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706578|NCT03016325|364587327|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706579|NCT03016325|364587328|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706580|NCT03016325|364587329|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706581|NCT03016325|364587330|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706582|NCT03016325|364587331|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
105706583|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Death|3|||
105706584|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Death|3|||
105706585|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Death|11|||
105706586|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Death|12|||
105706587|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Death|9|||
105706588|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Death|0|||
105706589|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Death|0|||
105706590|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Death|1|||
105706591|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
105706592|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706593|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706594|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706595|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706596|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706597|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706598|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
105706599|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706600|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706601|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706602|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706603|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
105706604|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706605|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
105706606|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
105706607|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706608|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706609|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706610|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706611|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
105706612|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706613|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706614|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
105706615|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706616|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706617|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706618|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706619|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
105706620|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706621|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706622|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
105706623|NCT03016325|364587324|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105787793|NCT01023815|364876783|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
105927443|NCT00433290|365391978|FG001|Overall Study|Physician Decision|0|||
106133815|NCT00783692|366148195|FG004|Maintenance Phase|Lack of Efficacy|58|||
106133816|NCT00783692|366148196|FG005|Maintenance Phase|Lack of Efficacy|48|||
106133817|NCT00783692|366148197|FG006|Maintenance Phase|Lack of Efficacy|177|||
106133818|NCT00783692|366148191|FG000|Maintenance Phase|Withdrawal by Subject|7|||
105787794|NCT01023815|364876780|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
105927444|NCT00433290|365391977|FG000|Overall Study|Entry Criteria Not Met|0|||
105927445|NCT00433290|365391978|FG001|Overall Study|Entry Criteria Not Met|1|||
106133819|NCT00783692|366148192|FG001|Maintenance Phase|Withdrawal by Subject|0|||
106133820|NCT00783692|366148193|FG002|Maintenance Phase|Withdrawal by Subject|0|||
105706624|NCT03016325|364587325|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706625|NCT03016325|364587326|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706626|NCT03016325|364587327|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
105706627|NCT03016325|364587328|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706628|NCT03016325|364587329|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706629|NCT03016325|364587330|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706630|NCT03016325|364587331|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
105706631|NCT03016325|364587324|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706632|NCT03016325|364587325|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
105706633|NCT03016325|364587326|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706634|NCT03016325|364587327|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706635|NCT03016325|364587328|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706636|NCT03016325|364587329|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706637|NCT03016325|364587330|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706638|NCT03016325|364587331|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
105706639|NCT03016325|364587324|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706640|NCT03016325|364587325|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706641|NCT03016325|364587326|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706642|NCT03016325|364587327|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706643|NCT03016325|364587328|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
105706644|NCT03016325|364587329|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
105706645|NCT03016325|364587330|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
105706646|NCT03016325|364587331|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
105706647|NCT02595723|364587332|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
105706648|NCT02595723|364587333|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
105706649|NCT02595723|364587334|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
105706650|NCT02595723|364587332|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
105706651|NCT02595723|364587333|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
105706652|NCT02595723|364587334|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
105706653|NCT01087905|364587335|FG000|Overall Study|Lost to Follow-up|24|||
105706654|NCT01087905|364587336|FG001|Overall Study|Lost to Follow-up|28|||
105706655|NCT01087905|364587337|FG002|Overall Study|Lost to Follow-up|18|||
105706656|NCT01087905|364587338|FG003|Overall Study|Lost to Follow-up|31|||
105706657|NCT01087905|364587339|FG004|Overall Study|Lost to Follow-up|27|||
105706658|NCT01087905|364587340|FG005|Overall Study|Lost to Follow-up|25|||
105706659|NCT01087905|364587341|FG006|Overall Study|Lost to Follow-up|20|||
105706660|NCT01087905|364587342|FG007|Overall Study|Lost to Follow-up|24|||
105706661|NCT01087905|364587335|FG000|Overall Study|Withdrawal by Subject|5|||
105706662|NCT01087905|364587336|FG001|Overall Study|Withdrawal by Subject|4|||
105706663|NCT01087905|364587337|FG002|Overall Study|Withdrawal by Subject|4|||
105706664|NCT01087905|364587338|FG003|Overall Study|Withdrawal by Subject|5|||
105706665|NCT01087905|364587339|FG004|Overall Study|Withdrawal by Subject|4|||
105706666|NCT01087905|364587340|FG005|Overall Study|Withdrawal by Subject|3|||
105706667|NCT01087905|364587341|FG006|Overall Study|Withdrawal by Subject|3|||
105706668|NCT01087905|364587342|FG007|Overall Study|Withdrawal by Subject|5|||
105706669|NCT00749996|364587344|FG000|Overall Study|Lost to Follow-up|7|||
105706670|NCT00749996|364587345|FG001|Overall Study|Lost to Follow-up|4|||
105706671|NCT00749996|364587344|FG000|Overall Study|Withdrawal by Subject|5|||
105706672|NCT00749996|364587345|FG001|Overall Study|Withdrawal by Subject|4|||
105706673|NCT00749996|364587344|FG000|Overall Study|Protocol Violation|2|||
105706674|NCT00749996|364587345|FG001|Overall Study|Protocol Violation|3|||
105706675|NCT00749996|364587344|FG000|Overall Study|Physician Decision|2|||
105706676|NCT00749996|364587345|FG001|Overall Study|Physician Decision|0|||
105706677|NCT00749996|364587344|FG000|Overall Study|Pregnancy|0|||
105706678|NCT00749996|364587345|FG001|Overall Study|Pregnancy|2|||
105706679|NCT00749996|364587344|FG000|Overall Study|Adverse Event|1|||
105706680|NCT00749996|364587345|FG001|Overall Study|Adverse Event|0|||
105706681|NCT00749996|364587344|FG000|Overall Study|Death|1|||
105706682|NCT00749996|364587345|FG001|Overall Study|Death|0|||
105706683|NCT01902290|364587346|FG000|Overall Study|Withdrawal by Subject|19|||
105706684|NCT01902290|364587347|FG001|Overall Study|Withdrawal by Subject|27|||
105706685|NCT01902290|364587346|FG000|Overall Study|Lost to Follow-up|2|||
106133821|NCT00783692|366148194|FG003|Maintenance Phase|Withdrawal by Subject|7|||
106133822|NCT00783692|366148195|FG004|Maintenance Phase|Withdrawal by Subject|6|||
105706686|NCT01902290|364587347|FG001|Overall Study|Lost to Follow-up|2|||
105706687|NCT01902290|364587346|FG000|Overall Study|Death|1|||
105706688|NCT01902290|364587347|FG001|Overall Study|Death|0|||
105706689|NCT01902290|364587346|FG000|Overall Study|Sponsor Decision|26|||
105706690|NCT01902290|364587347|FG001|Overall Study|Sponsor Decision|24|||
105706691|NCT00517829|364587348|FG000|Overall Study|Adverse Event|22|||
105706692|NCT00517829|364587349|FG001|Overall Study|Adverse Event|34|||
105706693|NCT00517829|364587348|FG000|Overall Study|Disease Progression|39|||
105706694|NCT00517829|364587349|FG001|Overall Study|Disease Progression|32|||
105706695|NCT00517829|364587348|FG000|Overall Study|Patient Request|6|||
105706696|NCT00517829|364587349|FG001|Overall Study|Patient Request|5|||
105706697|NCT00517829|364587348|FG000|Overall Study|Investigator Request|5|||
105706698|NCT00517829|364587349|FG001|Overall Study|Investigator Request|3|||
105706699|NCT00517829|364587348|FG000|Overall Study|Other|3|||
105706700|NCT00517829|364587349|FG001|Overall Study|Other|1|||
105706701|NCT01568593|364587352|FG000|Overall Study|Lack of Efficacy|4|||
105706702|NCT01568593|364587353|FG001|Overall Study|Lack of Efficacy|1|||
105706703|NCT01568593|364587352|FG000|Overall Study|Adverse Event|3|||
105706704|NCT01568593|364587353|FG001|Overall Study|Adverse Event|2|||
105706705|NCT00419380|364587358|FG000|Overall Study|Lack of Efficacy|1|||
105706706|NCT00419380|364587359|FG001|Overall Study|Lack of Efficacy|7|||
105706707|NCT00419380|364587358|FG000|Overall Study|Physician Decision|0|||
105706708|NCT00419380|364587359|FG001|Overall Study|Physician Decision|1|||
105706709|NCT00419380|364587358|FG000|Overall Study|Lost to Follow-up|0|||
105706710|NCT00419380|364587359|FG001|Overall Study|Lost to Follow-up|1|||
105706711|NCT00419380|364587358|FG000|Overall Study|Withdrawal by Subject|0|||
105706712|NCT00419380|364587359|FG001|Overall Study|Withdrawal by Subject|1|||
105706713|NCT03127384|364587362|FG000|Overall Study|Lost to Follow-up|4|||
105706714|NCT03127384|364587362|FG000|Overall Study|Subject request|2|||
105706715|NCT01505634|364587364|FG000|Overall Study|Withdrawal by Subject|2|||
105706716|NCT01505634|364587365|FG001|Overall Study|Withdrawal by Subject|5|||
105706717|NCT01505634|364587366|FG002|Overall Study|Withdrawal by Subject|1|||
105706718|NCT01505634|364587364|FG000|Overall Study|Physician Decision|1|||
105706719|NCT01505634|364587365|FG001|Overall Study|Physician Decision|1|||
105706720|NCT01505634|364587366|FG002|Overall Study|Physician Decision|0|||
105706721|NCT01505634|364587364|FG000|Overall Study|Adverse Event|1|||
105706722|NCT01505634|364587365|FG001|Overall Study|Adverse Event|0|||
105706723|NCT01505634|364587366|FG002|Overall Study|Adverse Event|0|||
105706724|NCT01505634|364587364|FG000|Overall Study|Insufficient supply of drug at site|1|||
105706725|NCT01505634|364587365|FG001|Overall Study|Insufficient supply of drug at site|0|||
105706726|NCT01505634|364587366|FG002|Overall Study|Insufficient supply of drug at site|0|||
105706727|NCT01505634|364587364|FG000|Overall Study|Protocol Violation|2|||
105706728|NCT01505634|364587365|FG001|Overall Study|Protocol Violation|0|||
105706729|NCT01505634|364587366|FG002|Overall Study|Protocol Violation|0|||
105706730|NCT01505634|364587364|FG000|Overall Study|Lost to Follow-up|1|||
105706731|NCT01505634|364587365|FG001|Overall Study|Lost to Follow-up|4|||
105706732|NCT01505634|364587366|FG002|Overall Study|Lost to Follow-up|4|||
105706733|NCT01505634|364587364|FG000|Overall Study|Death|1|||
105706734|NCT01505634|364587365|FG001|Overall Study|Death|0|||
105706735|NCT01505634|364587366|FG002|Overall Study|Death|0|||
105706736|NCT01505634|364587364|FG000|Overall Study|In a conflict zone|0|||
105706737|NCT01505634|364587365|FG001|Overall Study|In a conflict zone|0|||
105706738|NCT01505634|364587366|FG002|Overall Study|In a conflict zone|1|||
105706739|NCT03873714|364587367|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
105706740|NCT01883635|364587368|FG000|Overall Study|Withdrawal by Subject|4|||
105706741|NCT01883635|364587369|FG001|Overall Study|Withdrawal by Subject|0|||
105706742|NCT00844753|364587370|FG000|Overall Study|Lack of Efficacy|1|||
105706743|NCT00844753|364587371|FG001|Overall Study|Lack of Efficacy|0|||
105706744|NCT00844753|364587372|FG002|Overall Study|Lack of Efficacy|2|||
105706745|NCT00844753|364587373|FG003|Overall Study|Lack of Efficacy|2|||
105706746|NCT00844753|364587370|FG000|Overall Study|Adverse Event|3|||
105706747|NCT00844753|364587371|FG001|Overall Study|Adverse Event|2|||
105706748|NCT00844753|364587372|FG002|Overall Study|Adverse Event|5|||
105706749|NCT00844753|364587373|FG003|Overall Study|Adverse Event|5|||
105706750|NCT00844753|364587370|FG000|Overall Study|Lost to Follow-up|1|||
105706751|NCT00844753|364587371|FG001|Overall Study|Lost to Follow-up|1|||
105706752|NCT00844753|364587372|FG002|Overall Study|Lost to Follow-up|0|||
105706753|NCT00844753|364587373|FG003|Overall Study|Lost to Follow-up|1|||
105706754|NCT00844753|364587370|FG000|Overall Study|could not swallow medication|2|||
105927446|NCT00433290|365391977|FG000|Overall Study|Lost to Follow-up|1|||
105927447|NCT00433290|365391978|FG001|Overall Study|Lost to Follow-up|0|||
105927448|NCT01397747|365391981|FG000|Overall Study|Multitarget DNA test excluded|689|||
105706755|NCT00844753|364587371|FG001|Overall Study|could not swallow medication|0|||
105706756|NCT00844753|364587372|FG002|Overall Study|could not swallow medication|0|||
105706757|NCT00844753|364587373|FG003|Overall Study|could not swallow medication|0|||
105706758|NCT00844753|364587370|FG000|Overall Study|Withdrawal by Subject|1|||
105706759|NCT00844753|364587371|FG001|Overall Study|Withdrawal by Subject|0|||
105706760|NCT00844753|364587372|FG002|Overall Study|Withdrawal by Subject|0|||
105706761|NCT00844753|364587373|FG003|Overall Study|Withdrawal by Subject|3|||
105706762|NCT03499028|364587379|FG000|Overall Study|Lost to Follow-up|12|||
105706763|NCT03499028|364587380|FG001|Overall Study|Lost to Follow-up|9|||
105927449|NCT01397747|365391981|FG000|Overall Study|Colonoscopy excluded|304|||
105706764|NCT03499028|364587379|FG000|Overall Study|Withdrawal by Subject|5|||
105706765|NCT03499028|364587380|FG001|Overall Study|Withdrawal by Subject|8|||
105706766|NCT03499028|364587379|FG000|Overall Study|Unplanned SNF discharge|5|||
105706767|NCT03499028|364587380|FG001|Overall Study|Unplanned SNF discharge|8|||
105706768|NCT03451773|364589091|FG000|Overall Study|Death on study|1|||
105706769|NCT03451773|364589092|FG001|Overall Study|Death on study|5|||
105706770|NCT03451773|364589091|FG000|Overall Study|Death during follow-up period|0|||
105787795|NCT01023815|364876781|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
105787796|NCT01023815|364876782|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
105787797|NCT01023815|364876783|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
105787798|NCT01023815|364876780|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
105706771|NCT03451773|364589092|FG001|Overall Study|Death during follow-up period|1|||
105706772|NCT01908101|364589097|FG000|Overall Study|Physician Decision|1|||
105706773|NCT01908101|364589097|FG000|Overall Study|Withdrawal by Subject|1|||
105706774|NCT01908101|364589097|FG000|Overall Study|Incorrect Diagnosis|2|||
105706775|NCT01908101|364589097|FG000|Overall Study|Incorrect Starting Dose|1|||
105706776|NCT01908101|364589097|FG000|Overall Study|Did not complete the first cycle|4|||
105706777|NCT02356562|364589098|FG000|Overall Study|Withdrawal by Subject|0|||
105787799|NCT01023815|364876781|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
105787800|NCT01023815|364876782|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
105787801|NCT01023815|364876783|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
105787802|NCT01023815|364876780|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
105787803|NCT01023815|364876781|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
105787804|NCT01023815|364876782|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
105787805|NCT01023815|364876783|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
105787806|NCT01023815|364876780|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
105787807|NCT01023815|364876781|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
105706778|NCT02356562|364589099|FG001|Overall Study|Withdrawal by Subject|1|||
105706779|NCT02356562|364589098|FG000|Overall Study|Re-entered treatment in a previous study|1|||
105787808|NCT01023815|364876782|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
105787809|NCT01023815|364876783|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
105787810|NCT01901393|364876784|FG000|Overall Study|Adverse Event|1|||
105787811|NCT01901393|364876785|FG001|Overall Study|Adverse Event|0|||
105787812|NCT00910000|364876786|FG000|Overall Study|Adverse Event|0|||
105787813|NCT00910000|364876787|FG001|Overall Study|Adverse Event|3|||
105787814|NCT00910000|364876788|FG002|Overall Study|Adverse Event|2|||
105787815|NCT00910000|364876789|FG003|Overall Study|Adverse Event|2|||
105787816|NCT00910000|364876790|FG004|Overall Study|Adverse Event|0|||
105787817|NCT00910000|364876791|FG005|Overall Study|Adverse Event|1|||
105787818|NCT00910000|364876786|FG000|Overall Study|Withdrawal by Subject|0|||
105787819|NCT00910000|364876787|FG001|Overall Study|Withdrawal by Subject|0|||
105787820|NCT00910000|364876788|FG002|Overall Study|Withdrawal by Subject|1|||
105787821|NCT00910000|364876789|FG003|Overall Study|Withdrawal by Subject|0|||
105787822|NCT00910000|364876790|FG004|Overall Study|Withdrawal by Subject|1|||
105787823|NCT00910000|364876791|FG005|Overall Study|Withdrawal by Subject|0|||
105787824|NCT03125382|364876794|FG000|Randomization|screening failure|1|||
105787825|NCT03125382|364876795|FG001|Randomization|screening failure|4|||
105787826|NCT03125382|364876796|FG002|Randomization|screening failure|2|||
105787827|NCT03125382|364876797|FG003|Randomization|screening failure|0|||
105787828|NCT03125382|364876794|FG000|Follow-up|Death|1|||
105787829|NCT03125382|364876795|FG001|Follow-up|Death|2|||
105787830|NCT03125382|364876796|FG002|Follow-up|Death|1|||
105787831|NCT03125382|364876797|FG003|Follow-up|Death|2|||
105787832|NCT03125382|364876794|FG000|Follow-up|Lost to Follow-up|1|||
105787833|NCT03125382|364876795|FG001|Follow-up|Lost to Follow-up|4|||
105787834|NCT03125382|364876796|FG002|Follow-up|Lost to Follow-up|3|||
105787835|NCT03125382|364876797|FG003|Follow-up|Lost to Follow-up|1|||
105787836|NCT00483119|364876798|FG000|Overall Study|Adverse Event|0|||
105787837|NCT00483119|364876799|FG001|Overall Study|Adverse Event|1|||
105787838|NCT00483119|364876798|FG000|Overall Study|Physician Decision|1|||
105787839|NCT00483119|364876799|FG001|Overall Study|Physician Decision|0|||
105787840|NCT03522506|364876801|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105787841|NCT03522506|364876802|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105787842|NCT03522506|364876803|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105787843|NCT03522506|364876804|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105787844|NCT03522506|364876801|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
106007166|NCT04886154|365690345|FG014|Overall Study|Other, Not Specified|3|||
105706780|NCT02356562|364589099|FG001|Overall Study|Re-entered treatment in a previous study|0|||
105706781|NCT02356562|364589098|FG000|Overall Study|site closure|1|||
106007167|NCT00668148|365690350|FG000|Overall Study|Adverse Event|5|||
105787845|NCT03522506|364876802|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105787846|NCT03522506|364876803|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105706782|NCT02356562|364589099|FG001|Overall Study|site closure|0|||
105706783|NCT03311711|364589102|FG000|Overall Study|Death|1|||
105787847|NCT03522506|364876804|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
105787848|NCT03480243|364876805|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
105787849|NCT03480243|364876805|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
106007168|NCT00668148|365690350|FG000|Overall Study|Subject Non-compliance|1|||
105787850|NCT04035499|364876810|FG000|Overall Study|Death|2|||
105706784|NCT03311711|364589103|FG001|Overall Study|Death|0|||
105706785|NCT03311711|364589104|FG002|Overall Study|Death|0|||
105706786|NCT03311711|364589105|FG003|Overall Study|Death|0|||
105706787|NCT03311711|364589106|FG004|Overall Study|Death|0|||
105706788|NCT03311711|364589107|FG005|Overall Study|Death|0|||
105706789|NCT03311711|364589108|FG006|Overall Study|Death|1|||
105706790|NCT03311711|364589109|FG007|Overall Study|Death|0|||
105706791|NCT03311711|364589110|FG008|Overall Study|Death|1|||
105706792|NCT03311711|364589111|FG009|Overall Study|Death|0|||
105706793|NCT03311711|364589102|FG000|Overall Study|Death of dyad partner|0|||
105706794|NCT03311711|364589103|FG001|Overall Study|Death of dyad partner|1|||
105706795|NCT03311711|364589104|FG002|Overall Study|Death of dyad partner|0|||
105706796|NCT03311711|364589105|FG003|Overall Study|Death of dyad partner|0|||
105706797|NCT03311711|364589106|FG004|Overall Study|Death of dyad partner|0|||
105706798|NCT03311711|364589107|FG005|Overall Study|Death of dyad partner|0|||
105706799|NCT03311711|364589108|FG006|Overall Study|Death of dyad partner|0|||
105706800|NCT03311711|364589109|FG007|Overall Study|Death of dyad partner|1|||
105706801|NCT03311711|364589110|FG008|Overall Study|Death of dyad partner|0|||
105706802|NCT03311711|364589111|FG009|Overall Study|Death of dyad partner|1|||
105706803|NCT03311711|364589102|FG000|Overall Study|Lost to Follow-up|2|||
105706804|NCT03311711|364589103|FG001|Overall Study|Lost to Follow-up|2|||
105706805|NCT03311711|364589104|FG002|Overall Study|Lost to Follow-up|0|||
105706806|NCT03311711|364589105|FG003|Overall Study|Lost to Follow-up|0|||
105706807|NCT03311711|364589106|FG004|Overall Study|Lost to Follow-up|0|||
105706808|NCT03311711|364589107|FG005|Overall Study|Lost to Follow-up|0|||
105706809|NCT03311711|364589108|FG006|Overall Study|Lost to Follow-up|1|||
105706810|NCT03311711|364589109|FG007|Overall Study|Lost to Follow-up|1|||
105706811|NCT03311711|364589110|FG008|Overall Study|Lost to Follow-up|0|||
105706812|NCT03311711|364589111|FG009|Overall Study|Lost to Follow-up|0|||
105706813|NCT03311711|364589102|FG000|Overall Study|Withdrawal by Subject|1|||
105706814|NCT03311711|364589103|FG001|Overall Study|Withdrawal by Subject|1|||
105706815|NCT03311711|364589104|FG002|Overall Study|Withdrawal by Subject|0|||
105706816|NCT03311711|364589105|FG003|Overall Study|Withdrawal by Subject|0|||
105706817|NCT03311711|364589106|FG004|Overall Study|Withdrawal by Subject|0|||
105706818|NCT03311711|364589107|FG005|Overall Study|Withdrawal by Subject|0|||
105706819|NCT03311711|364589108|FG006|Overall Study|Withdrawal by Subject|3|||
105706820|NCT03311711|364589109|FG007|Overall Study|Withdrawal by Subject|3|||
105706821|NCT03311711|364589110|FG008|Overall Study|Withdrawal by Subject|0|||
105706822|NCT03311711|364589111|FG009|Overall Study|Withdrawal by Subject|0|||
105706823|NCT01982292|364589112|FG000|Overall Study|Adverse Event|2|||
105706824|NCT01982292|364589113|FG001|Overall Study|Adverse Event|0|||
105706825|NCT01982292|364589112|FG000|Overall Study|Death|1|||
105706826|NCT01982292|364589113|FG001|Overall Study|Death|0|||
105706827|NCT01982292|364589112|FG000|Overall Study|Lost to Follow-up|2|||
105706828|NCT01982292|364589113|FG001|Overall Study|Lost to Follow-up|0|||
105706829|NCT01982292|364589112|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
105706830|NCT01982292|364589113|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
105706831|NCT01982292|364589112|FG000|Overall Study|Protocol Deviation|1|||
105706832|NCT01982292|364589113|FG001|Overall Study|Protocol Deviation|0|||
105706833|NCT01982292|364589112|FG000|Overall Study|Patient/Guardian Decision|3|||
105706834|NCT01982292|364589113|FG001|Overall Study|Patient/Guardian Decision|1|||
105706835|NCT01982292|364589112|FG000|Overall Study|Technical Problems|2|||
105706836|NCT01982292|364589113|FG001|Overall Study|Technical Problems|0|||
105706837|NCT04839978|364589114|FG000|Overall Study|Lost to Follow-up|135|||
105706838|NCT04839978|364589115|FG001|Overall Study|Lost to Follow-up|147|||
105706839|NCT03865706|364589117|FG000|Overall Study|Death|0|||
105706840|NCT03865706|364589118|FG001|Overall Study|Death|3|||
105706841|NCT03865706|364589119|FG002|Overall Study|Death|1|||
105706842|NCT02095535|364589120|FG000|Recruitment|Protocol Violation|2|||
105706843|NCT01877187|364589121|FG000|Overall Study|Death|2|||
105706844|NCT01877187|364589121|FG000|Overall Study|Withdrawal by Subject|4|||
105706845|NCT01877187|364589121|FG000|Overall Study|Lost to Follow-up|3|||
105706846|NCT01877187|364589121|FG000|Overall Study|Declining clinical status|11|||
105706847|NCT01877187|364589121|FG000|Overall Study|Liver transplant|2|||
105706848|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Adverse Event|0|||
105706849|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Adverse Event|1|||
105706850|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Adverse Event|1|||
105706851|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Adverse Event|0|||
105706852|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
105706853|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
105706854|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
105706855|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
105706856|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
105706857|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
105706858|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
105706859|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
105706860|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
105706861|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
105706862|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
105706863|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
105706864|NCT03776175|364589122|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
105706865|NCT03776175|364589123|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
105706866|NCT03776175|364589124|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
105706867|NCT03776175|364589125|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
105706868|NCT03776175|364589122|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
105706869|NCT03776175|364589123|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
105706870|NCT03776175|364589124|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
105706871|NCT03776175|364589125|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
105706872|NCT00811135|364589128|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
105706873|NCT00811135|364589128|FG000|Overall Study|Death|3|||
105706874|NCT00811135|364589128|FG000|Overall Study|Protocol Violation|2|||
105706875|NCT00811135|364589128|FG000|Overall Study|Violation of Selection Criteria|1|||
105706876|NCT00811135|364589128|FG000|Overall Study|Refused Treatment|1|||
105706877|NCT00811135|364589128|FG000|Overall Study|Withdrawal by Subject|3|||
105706878|NCT00811135|364589128|FG000|Overall Study|Administrative/Other Unspecified|11|||
105706879|NCT00811135|364589128|FG000|Overall Study|Ongoing|59|||
105706880|NCT05098041|364589134|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
105706881|NCT02599961|364589135|FG000|Overall Study|Withdrawal by Subject|1|||
105706882|NCT02599961|364589135|FG000|Overall Study|Subject Non-Compliance|2|||
105706883|NCT02599961|364589135|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
105706884|NCT02599961|364589135|FG000|Overall Study|Other, Not Specified|3|||
105706885|NCT00464334|364589138|FG000|Overall Study|Adverse Event|0|||
105706886|NCT00464334|364589139|FG001|Overall Study|Adverse Event|0|||
105706887|NCT00464334|364589140|FG002|Overall Study|Adverse Event|0|||
105706888|NCT00464334|364589141|FG003|Overall Study|Adverse Event|1|||
105706889|NCT00464334|364589142|FG004|Overall Study|Adverse Event|1|||
105706890|NCT00464334|364589143|FG005|Overall Study|Adverse Event|1|||
105706891|NCT00464334|364589144|FG006|Overall Study|Adverse Event|0|||
105706892|NCT00464334|364589145|FG007|Overall Study|Adverse Event|0|||
105706893|NCT00464334|364589146|FG008|Overall Study|Adverse Event|2|||
105706894|NCT00464334|364589147|FG009|Overall Study|Adverse Event|1|||
105706895|NCT00464334|364589148|FG010|Overall Study|Adverse Event|2|||
105706896|NCT00464334|364589138|FG000|Overall Study|Lack of Efficacy|0|||
105706897|NCT00464334|364589139|FG001|Overall Study|Lack of Efficacy|1|||
105706898|NCT00464334|364589140|FG002|Overall Study|Lack of Efficacy|0|||
105706899|NCT00464334|364589141|FG003|Overall Study|Lack of Efficacy|0|||
105706900|NCT00464334|364589142|FG004|Overall Study|Lack of Efficacy|0|||
105706901|NCT00464334|364589143|FG005|Overall Study|Lack of Efficacy|0|||
105706902|NCT00464334|364589144|FG006|Overall Study|Lack of Efficacy|0|||
105706903|NCT00464334|364589145|FG007|Overall Study|Lack of Efficacy|0|||
105706904|NCT00464334|364589146|FG008|Overall Study|Lack of Efficacy|0|||
105706905|NCT00464334|364589147|FG009|Overall Study|Lack of Efficacy|0|||
105706906|NCT00464334|364589148|FG010|Overall Study|Lack of Efficacy|0|||
105706907|NCT00464334|364589138|FG000|Overall Study|Lost to Follow-up|0|||
105706908|NCT00464334|364589139|FG001|Overall Study|Lost to Follow-up|0|||
105706909|NCT00464334|364589140|FG002|Overall Study|Lost to Follow-up|1|||
105706910|NCT00464334|364589141|FG003|Overall Study|Lost to Follow-up|0|||
105706911|NCT00464334|364589142|FG004|Overall Study|Lost to Follow-up|1|||
105706912|NCT00464334|364589143|FG005|Overall Study|Lost to Follow-up|0|||
105706913|NCT00464334|364589144|FG006|Overall Study|Lost to Follow-up|1|||
105706914|NCT00464334|364589145|FG007|Overall Study|Lost to Follow-up|0|||
105706915|NCT00464334|364589146|FG008|Overall Study|Lost to Follow-up|0|||
105706916|NCT00464334|364589147|FG009|Overall Study|Lost to Follow-up|0|||
105927450|NCT01397747|365391981|FG000|Overall Study|FIT excluded|34|||
105927451|NCT02583269|365391982|FG000|Overall Study|Patient hospitalized prior to start|1|||
105927452|NCT02583269|365391983|FG001|Overall Study|Patient hospitalized prior to start|0|||
105927453|NCT02583269|365391984|FG002|Overall Study|Patient hospitalized prior to start|0|||
105927454|NCT02583269|365391985|FG003|Overall Study|Patient hospitalized prior to start|0|||
105927455|NCT02583269|365391986|FG004|Overall Study|Patient hospitalized prior to start|0|||
105927456|NCT00770809|365393332|FG000|Overall Study|Adverse Event|9|||
105927457|NCT00770809|365393333|FG001|Overall Study|Adverse Event|1|||
105927458|NCT00770809|365393334|FG002|Overall Study|Adverse Event|12|||
105706917|NCT00464334|364589148|FG010|Overall Study|Lost to Follow-up|2|||
105706918|NCT00464334|364589138|FG000|Overall Study|Progressive Disease|0|||
105706919|NCT00464334|364589139|FG001|Overall Study|Progressive Disease|0|||
105706920|NCT00464334|364589140|FG002|Overall Study|Progressive Disease|0|||
105706921|NCT00464334|364589141|FG003|Overall Study|Progressive Disease|0|||
105706922|NCT00464334|364589142|FG004|Overall Study|Progressive Disease|0|||
105706923|NCT00464334|364589143|FG005|Overall Study|Progressive Disease|1|||
105706924|NCT00464334|364589144|FG006|Overall Study|Progressive Disease|0|||
105706925|NCT00464334|364589145|FG007|Overall Study|Progressive Disease|0|||
105706926|NCT00464334|364589146|FG008|Overall Study|Progressive Disease|1|||
105706927|NCT00464334|364589147|FG009|Overall Study|Progressive Disease|0|||
105706928|NCT00464334|364589148|FG010|Overall Study|Progressive Disease|0|||
105706929|NCT00464334|364589138|FG000|Overall Study|Study Terminated by Sponsor|0|||
105706930|NCT00464334|364589139|FG001|Overall Study|Study Terminated by Sponsor|0|||
105706931|NCT00464334|364589140|FG002|Overall Study|Study Terminated by Sponsor|0|||
105706932|NCT00464334|364589141|FG003|Overall Study|Study Terminated by Sponsor|1|||
105706933|NCT00464334|364589142|FG004|Overall Study|Study Terminated by Sponsor|0|||
105706934|NCT00464334|364589143|FG005|Overall Study|Study Terminated by Sponsor|0|||
105706935|NCT00464334|364589144|FG006|Overall Study|Study Terminated by Sponsor|0|||
105706936|NCT00464334|364589145|FG007|Overall Study|Study Terminated by Sponsor|0|||
105706937|NCT00464334|364589146|FG008|Overall Study|Study Terminated by Sponsor|0|||
105706938|NCT00464334|364589147|FG009|Overall Study|Study Terminated by Sponsor|0|||
105706939|NCT00464334|364589148|FG010|Overall Study|Study Terminated by Sponsor|0|||
105706940|NCT00464334|364589138|FG000|Overall Study|Withdrawal by Subject|1|||
105706941|NCT00464334|364589139|FG001|Overall Study|Withdrawal by Subject|7|||
105706942|NCT00464334|364589140|FG002|Overall Study|Withdrawal by Subject|4|||
105706943|NCT00464334|364589141|FG003|Overall Study|Withdrawal by Subject|2|||
105706944|NCT00464334|364589142|FG004|Overall Study|Withdrawal by Subject|2|||
105706945|NCT00464334|364589143|FG005|Overall Study|Withdrawal by Subject|2|||
105706946|NCT00464334|364589144|FG006|Overall Study|Withdrawal by Subject|2|||
105706947|NCT00464334|364589145|FG007|Overall Study|Withdrawal by Subject|1|||
105706948|NCT00464334|364589146|FG008|Overall Study|Withdrawal by Subject|3|||
105706949|NCT00464334|364589147|FG009|Overall Study|Withdrawal by Subject|0|||
105706950|NCT00464334|364589148|FG010|Overall Study|Withdrawal by Subject|0|||
105706951|NCT00586495|364589151|FG000|Treatment Period|Adverse Event|11|||
105706952|NCT00586495|364589151|FG000|Treatment Period|Death|1|||
105706953|NCT00586495|364589151|FG000|Treatment Period|Protocol Violation|1|||
105706954|NCT00586495|364589151|FG000|Treatment Period|Withdrawal by Subject|1|||
105706955|NCT00586495|364589151|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
105706956|NCT00586495|364589151|FG000|Treatment Period|Switch to commercial drug|10|||
105706957|NCT00586495|364589151|FG000|Follow-up|Death|40|||
105706958|NCT00586495|364589151|FG000|Follow-up|Lost to Follow-up|1|||
105706959|NCT00586495|364589151|FG000|Follow-up|Withdrawal by Subject|4|||
105706960|NCT00586495|364589151|FG000|Follow-up|Protocol driven decision point|37|||
105706961|NCT00586495|364589151|FG000|Follow-up|Switch to commercial drug|10|||
105706962|NCT00401752|364589152|FG000|Overall Study|Adverse Event|2|||
105706963|NCT00401752|364589153|FG001|Overall Study|Adverse Event|5|||
105706964|NCT00401752|364589152|FG000|Overall Study|Withdrawal by Subject|2|||
105706965|NCT00401752|364589153|FG001|Overall Study|Withdrawal by Subject|6|||
105706966|NCT00401752|364589152|FG000|Overall Study|Lost to Follow-up|1|||
105706967|NCT00401752|364589153|FG001|Overall Study|Lost to Follow-up|4|||
105706968|NCT00401752|364589152|FG000|Overall Study|Development of any exclusion criteria|4|||
105927459|NCT00770809|365393332|FG000|Overall Study|Death|1|||
105927460|NCT00770809|365393333|FG001|Overall Study|Death|0|||
105927461|NCT00770809|365393334|FG002|Overall Study|Death|0|||
105927462|NCT00770809|365393332|FG000|Overall Study|Withdrawal by Subject|3|||
105927463|NCT00770809|365393333|FG001|Overall Study|Withdrawal by Subject|3|||
105927464|NCT00770809|365393334|FG002|Overall Study|Withdrawal by Subject|7|||
105927465|NCT00770809|365393332|FG000|Overall Study|Progression|2|||
105927466|NCT00770809|365393333|FG001|Overall Study|Progression|2|||
105927467|NCT00770809|365393334|FG002|Overall Study|Progression|0|||
105927468|NCT00770809|365393332|FG000|Overall Study|Complicating illness|0|||
105927469|NCT00770809|365393333|FG001|Overall Study|Complicating illness|0|||
105927470|NCT00770809|365393334|FG002|Overall Study|Complicating illness|1|||
105927471|NCT00770809|365393332|FG000|Overall Study|Other Medical Reasons|2|||
105927472|NCT00770809|365393333|FG001|Overall Study|Other Medical Reasons|4|||
105927473|NCT00770809|365393334|FG002|Overall Study|Other Medical Reasons|3|||
105927474|NCT02332707|365393336|FG000|Overall Study|Adverse Event|0|||
105927475|NCT02332707|365393337|FG001|Overall Study|Adverse Event|0|||
105927476|NCT02332707|365393338|FG002|Overall Study|Adverse Event|0|||
105927477|NCT02332707|365393339|FG003|Overall Study|Adverse Event|0|||
105927478|NCT02332707|365393340|FG004|Overall Study|Adverse Event|0|||
105927479|NCT02332707|365393341|FG005|Overall Study|Adverse Event|0|||
105706969|NCT00401752|364589153|FG001|Overall Study|Development of any exclusion criteria|2|||
105706970|NCT00401752|364589152|FG000|Overall Study|Physician Decision|1|||
105706971|NCT00401752|364589153|FG001|Overall Study|Physician Decision|1|||
105706972|NCT02432235|364589154|FG000|Overall Study|Death|1|||
105706973|NCT02432235|364589155|FG001|Overall Study|Death|1|||
105706974|NCT02432235|364589156|FG002|Overall Study|Death|2|||
105927480|NCT02332707|365393342|FG006|Overall Study|Adverse Event|0|||
105927481|NCT02332707|365393343|FG007|Overall Study|Adverse Event|0|||
105706975|NCT02432235|364589157|FG003|Overall Study|Death|2|||
105706976|NCT02432235|364589158|FG004|Overall Study|Death|1|||
105927482|NCT02332707|365393344|FG008|Overall Study|Adverse Event|0|||
105706977|NCT02432235|364589159|FG005|Overall Study|Death|3|||
105927483|NCT02332707|365393345|FG009|Overall Study|Adverse Event|0|||
105706978|NCT02432235|364589160|FG006|Overall Study|Death|11|||
105927484|NCT02332707|365393346|FG010|Overall Study|Adverse Event|0|||
105927485|NCT02332707|365393347|FG011|Overall Study|Adverse Event|0|||
105927486|NCT02332707|365393348|FG012|Overall Study|Adverse Event|1|||
105706979|NCT02432235|364589161|FG007|Overall Study|Death|15|||
105706980|NCT02432235|364589162|FG008|Overall Study|Death|15|||
105706981|NCT02432235|364589163|FG009|Overall Study|Death|3|||
105706982|NCT02432235|364589164|FG010|Overall Study|Death|1|||
105706983|NCT02432235|364589165|FG011|Overall Study|Death|0|||
105706984|NCT02432235|364589154|FG000|Overall Study|Withdrawal by Subject|0|||
105706985|NCT02432235|364589155|FG001|Overall Study|Withdrawal by Subject|1|||
105706986|NCT02432235|364589156|FG002|Overall Study|Withdrawal by Subject|0|||
105706987|NCT02432235|364589157|FG003|Overall Study|Withdrawal by Subject|0|||
105706988|NCT02432235|364589158|FG004|Overall Study|Withdrawal by Subject|0|||
105706989|NCT02432235|364589159|FG005|Overall Study|Withdrawal by Subject|2|||
105706990|NCT02432235|364589160|FG006|Overall Study|Withdrawal by Subject|5|||
105706991|NCT02432235|364589161|FG007|Overall Study|Withdrawal by Subject|3|||
105706992|NCT02432235|364589162|FG008|Overall Study|Withdrawal by Subject|1|||
105706993|NCT02432235|364589163|FG009|Overall Study|Withdrawal by Subject|0|||
105706994|NCT02432235|364589164|FG010|Overall Study|Withdrawal by Subject|0|||
105706995|NCT02432235|364589165|FG011|Overall Study|Withdrawal by Subject|0|||
105706996|NCT02432235|364589154|FG000|Overall Study|Lost to Follow-up|0|||
105706997|NCT02432235|364589155|FG001|Overall Study|Lost to Follow-up|0|||
105706998|NCT02432235|364589156|FG002|Overall Study|Lost to Follow-up|0|||
105706999|NCT02432235|364589157|FG003|Overall Study|Lost to Follow-up|0|||
105707000|NCT02432235|364589158|FG004|Overall Study|Lost to Follow-up|0|||
105707001|NCT02432235|364589159|FG005|Overall Study|Lost to Follow-up|1|||
105707002|NCT02432235|364589160|FG006|Overall Study|Lost to Follow-up|0|||
105707003|NCT02432235|364589161|FG007|Overall Study|Lost to Follow-up|0|||
105707004|NCT02432235|364589162|FG008|Overall Study|Lost to Follow-up|1|||
105707005|NCT02432235|364589163|FG009|Overall Study|Lost to Follow-up|0|||
105707006|NCT02432235|364589164|FG010|Overall Study|Lost to Follow-up|0|||
105707007|NCT02432235|364589165|FG011|Overall Study|Lost to Follow-up|0|||
105707008|NCT02432235|364589154|FG000|Overall Study|Miscellaneous|0|||
105707009|NCT02432235|364589155|FG001|Overall Study|Miscellaneous|0|||
105707010|NCT02432235|364589156|FG002|Overall Study|Miscellaneous|0|||
105707011|NCT02432235|364589157|FG003|Overall Study|Miscellaneous|0|||
105707012|NCT02432235|364589158|FG004|Overall Study|Miscellaneous|1|||
105707013|NCT02432235|364589159|FG005|Overall Study|Miscellaneous|6|||
105707014|NCT02432235|364589160|FG006|Overall Study|Miscellaneous|2|||
105707015|NCT02432235|364589161|FG007|Overall Study|Miscellaneous|2|||
105707016|NCT02432235|364589162|FG008|Overall Study|Miscellaneous|4|||
105707017|NCT02432235|364589163|FG009|Overall Study|Miscellaneous|0|||
105707018|NCT02432235|364589164|FG010|Overall Study|Miscellaneous|0|||
105707019|NCT02432235|364589165|FG011|Overall Study|Miscellaneous|1|||
105707020|NCT01965262|364589168|FG000|Second Intervention (7 Days)|Discontinued|0|||
105707021|NCT01965262|364589169|FG001|Second Intervention (7 Days)|Discontinued|1|||
105707022|NCT01965262|364589168|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
105707023|NCT01965262|364589169|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
105707024|NCT01965262|364589168|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
105707025|NCT01965262|364589169|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
105707026|NCT02898259|364589170|FG000|Overall Study|Adverse Event|0|||
105707027|NCT02898259|364589171|FG001|Overall Study|Adverse Event|0|||
105707028|NCT02898259|364589172|FG002|Overall Study|Adverse Event|1|||
105707029|NCT02898259|364589173|FG003|Overall Study|Adverse Event|0|||
105707030|NCT02898259|364589174|FG004|Overall Study|Adverse Event|0|||
105707031|NCT02898259|364589170|FG000|Overall Study|Lack of Efficacy|1|||
105707032|NCT02898259|364589171|FG001|Overall Study|Lack of Efficacy|1|||
105707033|NCT02898259|364589172|FG002|Overall Study|Lack of Efficacy|3|||
105707034|NCT02898259|364589173|FG003|Overall Study|Lack of Efficacy|0|||
105707035|NCT02898259|364589174|FG004|Overall Study|Lack of Efficacy|0|||
105707036|NCT02898259|364589170|FG000|Overall Study|Lost to Follow-up|0|||
105707037|NCT02898259|364589171|FG001|Overall Study|Lost to Follow-up|0|||
105707038|NCT02898259|364589172|FG002|Overall Study|Lost to Follow-up|1|||
105707039|NCT02898259|364589173|FG003|Overall Study|Lost to Follow-up|0|||
105707040|NCT02898259|364589174|FG004|Overall Study|Lost to Follow-up|0|||
105707041|NCT02898259|364589170|FG000|Overall Study|Transformation before study began|0|||
105707042|NCT02898259|364589171|FG001|Overall Study|Transformation before study began|0|||
105707043|NCT02898259|364589172|FG002|Overall Study|Transformation before study began|0|||
105707044|NCT02898259|364589173|FG003|Overall Study|Transformation before study began|1|||
105707045|NCT02898259|364589174|FG004|Overall Study|Transformation before study began|0|||
105707046|NCT01046877|364589175|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
105707047|NCT01046877|364589175|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
105707048|NCT01888640|364589179|FG000|Overall Study|Lost to Follow-up|1|||
105707049|NCT01888640|364589180|FG001|Overall Study|Lost to Follow-up|2|||
105707050|NCT01888640|364589181|FG002|Overall Study|Lost to Follow-up|0|||
105707051|NCT01888640|364589179|FG000|Overall Study|Withdrawal by Subject|15|||
105707052|NCT01888640|364589180|FG001|Overall Study|Withdrawal by Subject|11|||
105707053|NCT01888640|364589181|FG002|Overall Study|Withdrawal by Subject|4|||
105707054|NCT01888640|364589179|FG000|Overall Study|Minimum dose not met|10|||
105707055|NCT01888640|364589180|FG001|Overall Study|Minimum dose not met|16|||
105707056|NCT01888640|364589181|FG002|Overall Study|Minimum dose not met|0|||
105787851|NCT04035499|364876810|FG000|Overall Study|Withdrawal by Subject|1|||
105787852|NCT00262119|364876814|FG000|Overall Study|Lost to Follow-up|38|||
105787853|NCT00262119|364876815|FG001|Overall Study|Lost to Follow-up|51|||
105787854|NCT00262119|364876816|FG002|Overall Study|Lost to Follow-up|42|||
105787855|NCT00262119|364876814|FG000|Overall Study|Death|20|||
105707057|NCT01888640|364589179|FG000|Overall Study|Given wrong unit (placebo)|1|||
105787856|NCT00262119|364876815|FG001|Overall Study|Death|19|||
105787857|NCT00262119|364876816|FG002|Overall Study|Death|16|||
105707058|NCT01888640|364589180|FG001|Overall Study|Given wrong unit (placebo)|0|||
105707059|NCT01888640|364589181|FG002|Overall Study|Given wrong unit (placebo)|0|||
105787858|NCT00400985|364876817|FG000|Overall Study|Withdrawal by Subject|5|||
105787859|NCT00400985|364876817|FG000|Overall Study|system modification|8|||
105787860|NCT00400985|364876817|FG000|Overall Study|Death|30|||
105787861|NCT00400985|364876817|FG000|Overall Study|Lost to Follow-up|9|||
105787862|NCT00965562|364876818|FG000|Overall Study|Lost to Follow-up|1|||
105787863|NCT00965562|364876819|FG001|Overall Study|Lost to Follow-up|2|||
105787864|NCT00965562|364876820|FG002|Overall Study|Lost to Follow-up|3|||
105787865|NCT00965562|364876818|FG000|Overall Study|Withdrawal by Subject|2|||
105787866|NCT00965562|364876819|FG001|Overall Study|Withdrawal by Subject|2|||
105787867|NCT00965562|364876820|FG002|Overall Study|Withdrawal by Subject|0|||
105787868|NCT04411641|364876829|FG000|DB Period|Other|7|||
105787869|NCT04411641|364876830|FG001|DB Period|Other|27|||
105787870|NCT04411641|364876831|FG002|DB Period|Other|0|||
105787871|NCT04411641|364876832|FG003|DB Period|Other|0|||
105787872|NCT04411641|364876829|FG000|DB Period|Withdrawal by Subject|67|||
105787873|NCT04411641|364876830|FG001|DB Period|Withdrawal by Subject|122|||
105787874|NCT04411641|364876831|FG002|DB Period|Withdrawal by Subject|0|||
105787875|NCT04411641|364876832|FG003|DB Period|Withdrawal by Subject|0|||
105787876|NCT04411641|364876829|FG000|DB Period|Progressive disease|76|||
105787877|NCT04411641|364876830|FG001|DB Period|Progressive disease|116|||
105787878|NCT04411641|364876831|FG002|DB Period|Progressive disease|0|||
105787879|NCT04411641|364876832|FG003|DB Period|Progressive disease|0|||
105787880|NCT04411641|364876829|FG000|DB Period|Poor compliance to protocol|1|||
105787881|NCT04411641|364876830|FG001|DB Period|Poor compliance to protocol|5|||
105787882|NCT04411641|364876831|FG002|DB Period|Poor compliance to protocol|0|||
105787883|NCT04411641|364876832|FG003|DB Period|Poor compliance to protocol|0|||
105787884|NCT04411641|364876829|FG000|DB Period|Lack of Efficacy|19|||
105787885|NCT04411641|364876830|FG001|DB Period|Lack of Efficacy|19|||
105787886|NCT04411641|364876831|FG002|DB Period|Lack of Efficacy|0|||
105787887|NCT04411641|364876832|FG003|DB Period|Lack of Efficacy|0|||
105787888|NCT04411641|364876829|FG000|DB Period|Adverse Event|13|||
105787889|NCT04411641|364876830|FG001|DB Period|Adverse Event|29|||
105787890|NCT04411641|364876831|FG002|DB Period|Adverse Event|0|||
105787891|NCT04411641|364876832|FG003|DB Period|Adverse Event|0|||
105787892|NCT04411641|364876829|FG000|DB Period|Randomized and not treated|2|||
105787893|NCT04411641|364876830|FG001|DB Period|Randomized and not treated|2|||
105707060|NCT01888640|364589179|FG000|Overall Study|Excluded for prior TENS|0|||
105707061|NCT01888640|364589180|FG001|Overall Study|Excluded for prior TENS|1|||
105707062|NCT01888640|364589181|FG002|Overall Study|Excluded for prior TENS|0|||
105707063|NCT01888640|364589179|FG000|Overall Study|Researcher Termination of Participant|0|||
105707064|NCT01888640|364589180|FG001|Overall Study|Researcher Termination of Participant|1|||
105707065|NCT01888640|364589181|FG002|Overall Study|Researcher Termination of Participant|1|||
105707066|NCT00385255|364589190|FG000|Overall Study|Serious Adverse Event|1|||
105787894|NCT04411641|364876831|FG002|DB Period|Randomized and not treated|0|||
105787895|NCT04411641|364876832|FG003|DB Period|Randomized and not treated|0|||
105787896|NCT04411641|364876829|FG000|OL|Withdrawal by Subject|0|||
105787897|NCT04411641|364876830|FG001|OL|Withdrawal by Subject|0|||
105787898|NCT04411641|364876831|FG002|OL|Withdrawal by Subject|6|||
105787899|NCT04411641|364876832|FG003|OL|Withdrawal by Subject|17|||
106007169|NCT00668148|365690350|FG000|Overall Study|Progressive Disease Before Treatment|2|||
106007170|NCT00668148|365690350|FG000|Overall Study|Withdrawal of Consent|2|||
106133823|NCT00783692|366148196|FG005|Maintenance Phase|Withdrawal by Subject|9|||
106133824|NCT00783692|366148197|FG006|Maintenance Phase|Withdrawal by Subject|24|||
105707067|NCT00385255|364589191|FG001|Overall Study|Serious Adverse Event|2|||
105707068|NCT00385255|364589190|FG000|Overall Study|Protocol Violation|0|||
105787900|NCT04411641|364876829|FG000|OL|Progressive disease|0|||
105787901|NCT04411641|364876830|FG001|OL|Progressive disease|0|||
105787902|NCT04411641|364876831|FG002|OL|Progressive disease|1|||
105787903|NCT04411641|364876832|FG003|OL|Progressive disease|2|||
105787904|NCT04411641|364876829|FG000|OL|Poor compliance to protocol|0|||
105787905|NCT04411641|364876830|FG001|OL|Poor compliance to protocol|0|||
105787906|NCT04411641|364876831|FG002|OL|Poor compliance to protocol|1|||
105787907|NCT04411641|364876832|FG003|OL|Poor compliance to protocol|0|||
105787908|NCT04411641|364876829|FG000|OL|Adverse Event|0|||
105787909|NCT04411641|364876830|FG001|OL|Adverse Event|0|||
105787910|NCT04411641|364876831|FG002|OL|Adverse Event|1|||
105787911|NCT04411641|364876832|FG003|OL|Adverse Event|0|||
105787912|NCT04411641|364876829|FG000|OL|Other|0|||
105787913|NCT04411641|364876830|FG001|OL|Other|0|||
105787914|NCT04411641|364876831|FG002|OL|Other|0|||
105787915|NCT04411641|364876832|FG003|OL|Other|6|||
105787916|NCT00602667|364876833|FG000|Overall Study|Still on Therapy|0|||
105707069|NCT00385255|364589191|FG001|Overall Study|Protocol Violation|4|||
105707070|NCT00385255|364589190|FG000|Overall Study|Withdrawal by Subject|0|||
105707071|NCT00385255|364589191|FG001|Overall Study|Withdrawal by Subject|8|||
105707072|NCT00385255|364589190|FG000|Overall Study|Migrated/moved from study area|0|||
105707073|NCT00385255|364589191|FG001|Overall Study|Migrated/moved from study area|1|||
105707074|NCT00385255|364589190|FG000|Overall Study|Lost to Follow-up|20|||
105707075|NCT00385255|364589191|FG001|Overall Study|Lost to Follow-up|58|||
105707076|NCT02199080|364589192|FG000|Overall Study|Protocol Violation|12|||
105707077|NCT01929408|364589195|FG000|Overall Study|received HCT as initial treatment|8|||
105707078|NCT02228590|364589197|FG000|Overall Study|Withdrawal by Subject|1|||
105707079|NCT00506883|364589200|FG000|Overall Study|Lost to Follow-up|1|||
105707080|NCT00506883|364589201|FG001|Overall Study|Lost to Follow-up|1|||
105707081|NCT00506883|364589202|FG002|Overall Study|Lost to Follow-up|1|||
105707082|NCT00506883|364589200|FG000|Overall Study|Withdrawal by Subject|1|||
105707083|NCT00506883|364589201|FG001|Overall Study|Withdrawal by Subject|0|||
105707084|NCT00506883|364589202|FG002|Overall Study|Withdrawal by Subject|1|||
105707085|NCT00506883|364589200|FG000|Overall Study|Lack of Efficacy|0|||
105707086|NCT00506883|364589201|FG001|Overall Study|Lack of Efficacy|1|||
105707087|NCT00506883|364589202|FG002|Overall Study|Lack of Efficacy|1|||
105707088|NCT00506883|364589200|FG000|Overall Study|Other|5|||
105707089|NCT00506883|364589201|FG001|Overall Study|Other|1|||
105707090|NCT00506883|364589202|FG002|Overall Study|Other|1|||
105707091|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
105707092|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
105707093|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
105707094|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
105707095|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
105707096|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
105707097|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
105707098|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
105707099|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
105707100|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
105707101|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
105707102|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
105707103|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
105707104|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
105707105|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
105707106|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
105707107|NCT00391222|364589203|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
105707108|NCT00391222|364589204|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
105707109|NCT00391222|364589205|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
105707110|NCT00391222|364589206|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
105707111|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
105707112|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
105707113|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
105707114|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
105707115|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
105707116|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
105707117|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
105707118|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
105707119|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
105707120|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
105707121|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
105707122|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
105927487|NCT02332707|365393349|FG013|Overall Study|Adverse Event|0|||
105927488|NCT02332707|365393350|FG014|Overall Study|Adverse Event|0|||
105927489|NCT02332707|365393351|FG015|Overall Study|Adverse Event|0|||
105927490|NCT02332707|365393352|FG016|Overall Study|Adverse Event|0|||
105927491|NCT02332707|365393353|FG017|Overall Study|Adverse Event|0|||
105927492|NCT02332707|365393336|FG000|Overall Study|Lost to Follow-up|0|||
105927493|NCT02332707|365393337|FG001|Overall Study|Lost to Follow-up|0|||
105927494|NCT02332707|365393338|FG002|Overall Study|Lost to Follow-up|0|||
105927495|NCT02332707|365393339|FG003|Overall Study|Lost to Follow-up|0|||
105927496|NCT02332707|365393340|FG004|Overall Study|Lost to Follow-up|0|||
105927497|NCT02332707|365393341|FG005|Overall Study|Lost to Follow-up|1|||
105707123|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
105707124|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
105707125|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
105707126|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
105927498|NCT02332707|365393342|FG006|Overall Study|Lost to Follow-up|0|||
105927499|NCT02332707|365393343|FG007|Overall Study|Lost to Follow-up|0|||
105927500|NCT02332707|365393344|FG008|Overall Study|Lost to Follow-up|0|||
105707127|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
105707128|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
105707129|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
105707130|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
105707131|NCT00391222|364589203|FG000|Period III (Double-Blind Treatment)|Other|6|||
105707132|NCT00391222|364589204|FG001|Period III (Double-Blind Treatment)|Other|1|||
105707133|NCT00391222|364589205|FG002|Period III (Double-Blind Treatment)|Other|6|||
105707134|NCT00391222|364589206|FG003|Period III (Double-Blind Treatment)|Other|0|||
105707135|NCT02109484|364589207|FG000|Overall Study|Lost to Follow-up|0|||
105707136|NCT02109484|364589208|FG001|Overall Study|Lost to Follow-up|0|||
105707137|NCT02109484|364589209|FG002|Overall Study|Lost to Follow-up|0|||
105707138|NCT02109484|364589210|FG003|Overall Study|Lost to Follow-up|1|||
105707139|NCT02109484|364589211|FG004|Overall Study|Lost to Follow-up|1|||
105707140|NCT02109484|364589212|FG005|Overall Study|Lost to Follow-up|0|||
105707141|NCT02109484|364589213|FG006|Overall Study|Lost to Follow-up|1|||
105707142|NCT02109484|364589214|FG007|Overall Study|Lost to Follow-up|0|||
105707143|NCT02109484|364589207|FG000|Overall Study|Withdrawal by Subject|0|||
105707144|NCT02109484|364589208|FG001|Overall Study|Withdrawal by Subject|0|||
105707145|NCT02109484|364589209|FG002|Overall Study|Withdrawal by Subject|0|||
105707146|NCT02109484|364589210|FG003|Overall Study|Withdrawal by Subject|0|||
105707147|NCT02109484|364589211|FG004|Overall Study|Withdrawal by Subject|1|||
105707148|NCT02109484|364589212|FG005|Overall Study|Withdrawal by Subject|1|||
105707149|NCT02109484|364589213|FG006|Overall Study|Withdrawal by Subject|1|||
105707150|NCT02109484|364589214|FG007|Overall Study|Withdrawal by Subject|0|||
105707151|NCT02109484|364589207|FG000|Overall Study|Physician Decision|0|||
105707152|NCT02109484|364589208|FG001|Overall Study|Physician Decision|0|||
105707153|NCT02109484|364589209|FG002|Overall Study|Physician Decision|0|||
105707154|NCT02109484|364589210|FG003|Overall Study|Physician Decision|0|||
105707155|NCT02109484|364589211|FG004|Overall Study|Physician Decision|2|||
105707156|NCT02109484|364589212|FG005|Overall Study|Physician Decision|0|||
105707157|NCT02109484|364589213|FG006|Overall Study|Physician Decision|0|||
105707158|NCT02109484|364589214|FG007|Overall Study|Physician Decision|0|||
105707159|NCT02109484|364589207|FG000|Overall Study|Death|0|||
105707160|NCT02109484|364589208|FG001|Overall Study|Death|0|||
105707161|NCT02109484|364589209|FG002|Overall Study|Death|0|||
105707162|NCT02109484|364589210|FG003|Overall Study|Death|0|||
105707163|NCT02109484|364589211|FG004|Overall Study|Death|0|||
105707164|NCT02109484|364589212|FG005|Overall Study|Death|0|||
105707165|NCT02109484|364589213|FG006|Overall Study|Death|0|||
105707166|NCT02109484|364589214|FG007|Overall Study|Death|2|||
105707167|NCT02109484|364589207|FG000|Overall Study|Moved away from study area|0|||
105707168|NCT02109484|364589208|FG001|Overall Study|Moved away from study area|0|||
105707169|NCT02109484|364589209|FG002|Overall Study|Moved away from study area|0|||
105707170|NCT02109484|364589210|FG003|Overall Study|Moved away from study area|0|||
105707171|NCT02109484|364589211|FG004|Overall Study|Moved away from study area|0|||
105707172|NCT02109484|364589212|FG005|Overall Study|Moved away from study area|0|||
105707173|NCT02109484|364589213|FG006|Overall Study|Moved away from study area|1|||
105707174|NCT02109484|364589214|FG007|Overall Study|Moved away from study area|1|||
105707175|NCT00143455|364589215|FG000|Cohort 1|Adverse Event|8|||
105707176|NCT00143455|364589216|FG001|Cohort 1|Adverse Event|4|||
105707177|NCT00143455|364589217|FG002|Cohort 1|Adverse Event|0|||
105707178|NCT00143455|364589218|FG003|Cohort 1|Adverse Event|0|||
105707179|NCT00143455|364589215|FG000|Cohort 1|Death|5|||
105707180|NCT00143455|364589216|FG001|Cohort 1|Death|2|||
105707181|NCT00143455|364589217|FG002|Cohort 1|Death|0|||
105707182|NCT00143455|364589218|FG003|Cohort 1|Death|0|||
105707183|NCT00143455|364589215|FG000|Cohort 1|Progressive Disease|0|||
105707184|NCT00143455|364589216|FG001|Cohort 1|Progressive Disease|6|||
105707185|NCT00143455|364589217|FG002|Cohort 1|Progressive Disease|0|||
105707186|NCT00143455|364589218|FG003|Cohort 1|Progressive Disease|0|||
105707187|NCT00143455|364589215|FG000|Cohort 1|Withdrawal by Subject|1|||
105707188|NCT00143455|364589216|FG001|Cohort 1|Withdrawal by Subject|4|||
105707189|NCT00143455|364589217|FG002|Cohort 1|Withdrawal by Subject|0|||
105707190|NCT00143455|364589218|FG003|Cohort 1|Withdrawal by Subject|0|||
105707191|NCT00143455|364589215|FG000|Cohort 1|Randomized But Not Treated|0|||
105707192|NCT00143455|364589216|FG001|Cohort 1|Randomized But Not Treated|1|||
106133825|NCT00783692|366148191|FG000|Maintenance Phase|Lost to Follow-up|2|||
106133826|NCT00783692|366148192|FG001|Maintenance Phase|Lost to Follow-up|0|||
105707193|NCT00143455|364589217|FG002|Cohort 1|Randomized But Not Treated|0|||
105707194|NCT00143455|364589218|FG003|Cohort 1|Randomized But Not Treated|0|||
105707195|NCT00143455|364589215|FG000|Cohort 2|Adverse Event|0|||
105707196|NCT00143455|364589216|FG001|Cohort 2|Adverse Event|0|||
105707197|NCT00143455|364589217|FG002|Cohort 2|Adverse Event|42|||
106133827|NCT00783692|366148193|FG002|Maintenance Phase|Lost to Follow-up|0|||
106133828|NCT00783692|366148194|FG003|Maintenance Phase|Lost to Follow-up|1|||
105707198|NCT00143455|364589218|FG003|Cohort 2|Adverse Event|30|||
105707199|NCT00143455|364589215|FG000|Cohort 2|No Longer Required Study Treatment|0|||
105707200|NCT00143455|364589216|FG001|Cohort 2|No Longer Required Study Treatment|0|||
105707201|NCT00143455|364589217|FG002|Cohort 2|No Longer Required Study Treatment|1|||
106007171|NCT03253393|365690351|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
106007172|NCT03253393|365690352|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
106007173|NCT03253393|365690353|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
105707202|NCT00143455|364589218|FG003|Cohort 2|No Longer Required Study Treatment|0|||
105707203|NCT00143455|364589215|FG000|Cohort 2|Protocol Violation|0|||
105707204|NCT00143455|364589216|FG001|Cohort 2|Protocol Violation|0|||
105707205|NCT00143455|364589217|FG002|Cohort 2|Protocol Violation|1|||
105707206|NCT00143455|364589218|FG003|Cohort 2|Protocol Violation|1|||
105707207|NCT00143455|364589215|FG000|Cohort 2|Lost to Follow-up|0|||
105707208|NCT00143455|364589216|FG001|Cohort 2|Lost to Follow-up|0|||
105707209|NCT00143455|364589217|FG002|Cohort 2|Lost to Follow-up|1|||
105707210|NCT00143455|364589218|FG003|Cohort 2|Lost to Follow-up|4|||
105707211|NCT00143455|364589215|FG000|Cohort 2|Death|0|||
105707212|NCT00143455|364589216|FG001|Cohort 2|Death|0|||
105707213|NCT00143455|364589217|FG002|Cohort 2|Death|20|||
105707214|NCT00143455|364589218|FG003|Cohort 2|Death|12|||
105707215|NCT00143455|364589215|FG000|Cohort 2|Progressive Disease|0|||
105707216|NCT00143455|364589216|FG001|Cohort 2|Progressive Disease|0|||
105707217|NCT00143455|364589217|FG002|Cohort 2|Progressive Disease|20|||
105707218|NCT00143455|364589218|FG003|Cohort 2|Progressive Disease|27|||
105707219|NCT00143455|364589215|FG000|Cohort 2|Withdrawal by Subject|0|||
105707220|NCT00143455|364589216|FG001|Cohort 2|Withdrawal by Subject|0|||
105707221|NCT00143455|364589217|FG002|Cohort 2|Withdrawal by Subject|13|||
105707222|NCT00143455|364589218|FG003|Cohort 2|Withdrawal by Subject|12|||
105707223|NCT00143455|364589215|FG000|Cohort 2|Other|0|||
105707224|NCT00143455|364589216|FG001|Cohort 2|Other|0|||
105707225|NCT00143455|364589217|FG002|Cohort 2|Other|7|||
105707226|NCT00143455|364589218|FG003|Cohort 2|Other|6|||
105707227|NCT00143455|364589215|FG000|Cohort 2|Randomized But Not Treated|0|||
105707228|NCT00143455|364589216|FG001|Cohort 2|Randomized But Not Treated|0|||
105707229|NCT00143455|364589217|FG002|Cohort 2|Randomized But Not Treated|1|||
105707230|NCT00143455|364589218|FG003|Cohort 2|Randomized But Not Treated|1|||
105707231|NCT01325428|364589219|FG000|Part A|Progressive disease according to RECIST|9|||
105707232|NCT01325428|364589219|FG000|Part A|Clinical signs, symptoms of progression|2|||
105707233|NCT01325428|364589219|FG000|Part A|Other adverse event|1|||
105707234|NCT01325428|364589219|FG000|Part A|Refused continue taking trial medication|2|||
105707235|NCT01325428|364589219|FG000|Part A|Other reason not defined above|2|||
105707236|NCT01325428|364589219|FG000|Part B|Refused continue taking trial medication|2|||
105707237|NCT01325428|364589219|FG000|Part B|Other reason not defined above|1|||
105707238|NCT03215771|364589224|FG000|Overall Study|Withdrawal by Subject|2|||
105707239|NCT03215771|364589224|FG000|Overall Study|Physician Decision|1|||
105707240|NCT00574275|364589225|FG000|Overall Study|Randomized but not treated|2|||
105707241|NCT00574275|364589226|FG001|Overall Study|Randomized but not treated|3|||
105707242|NCT00574275|364589225|FG000|Overall Study|Adverse Event|32|||
105707243|NCT00574275|364589226|FG001|Overall Study|Adverse Event|76|||
105707244|NCT00574275|364589225|FG000|Overall Study|Disease progression|160|||
105707245|NCT00574275|364589226|FG001|Overall Study|Disease progression|146|||
105707246|NCT00574275|364589225|FG000|Overall Study|Lost to Follow-up|2|||
105707247|NCT00574275|364589226|FG001|Overall Study|Lost to Follow-up|1|||
105707248|NCT00574275|364589225|FG000|Overall Study|Study stopped based on DMC decision|62|||
105707249|NCT00574275|364589226|FG001|Overall Study|Study stopped based on DMC decision|23|||
105707250|NCT00574275|364589225|FG000|Overall Study|Withdrawal by Subject|15|||
105707251|NCT00574275|364589226|FG001|Overall Study|Withdrawal by Subject|17|||
105707252|NCT00574275|364589225|FG000|Overall Study|Error calculating tumor measurement|1|||
105707253|NCT00574275|364589226|FG001|Overall Study|Error calculating tumor measurement|0|||
105707254|NCT00574275|364589225|FG000|Overall Study|Physician Decision|1|||
105707255|NCT00574275|364589226|FG001|Overall Study|Physician Decision|1|||
105707256|NCT00574275|364589225|FG000|Overall Study|Protocol Violation|0|||
106007174|NCT00446849|365692180|FG000|Acute Phase|Lack of Efficacy|64|||
106007175|NCT00446849|365692180|FG000|Acute Phase|Protocol Violation|10|||
106007176|NCT00446849|365692180|FG000|Acute Phase|Consent withdrawn|4|||
106133829|NCT00783692|366148195|FG004|Maintenance Phase|Lost to Follow-up|3|||
105707257|NCT00574275|364589226|FG001|Overall Study|Protocol Violation|1|||
105707258|NCT00574275|364589225|FG000|Overall Study|Patient and Investigator decision|0|||
105707259|NCT00574275|364589226|FG001|Overall Study|Patient and Investigator decision|1|||
105707260|NCT00574275|364589225|FG000|Overall Study|Insurance change|0|||
105707261|NCT00574275|364589226|FG001|Overall Study|Insurance change|1|||
105707262|NCT00574275|364589225|FG000|Overall Study|Operation for curative intent|0|||
105707263|NCT00574275|364589226|FG001|Overall Study|Operation for curative intent|1|||
105707264|NCT00689871|364589227|FG000|Overall Study|Lost to Follow-up|123|||
105707265|NCT00689871|364589228|FG001|Overall Study|Lost to Follow-up|13|||
105707266|NCT00689871|364589229|FG002|Overall Study|Lost to Follow-up|37|||
105707267|NCT00689871|364589230|FG003|Overall Study|Lost to Follow-up|1|||
106133830|NCT00783692|366148196|FG005|Maintenance Phase|Lost to Follow-up|2|||
105707268|NCT00689871|364589227|FG000|Overall Study|Explanted of All Study Devices|36|||
105707269|NCT00689871|364589228|FG001|Overall Study|Explanted of All Study Devices|25|||
105787917|NCT00602667|364876834|FG001|Overall Study|Still on Therapy|2|||
105787918|NCT00602667|364876835|FG002|Overall Study|Still on Therapy|2|||
105787919|NCT00602667|364876833|FG000|Overall Study|Death|0|||
105787920|NCT00602667|364876834|FG001|Overall Study|Death|1|||
105787921|NCT00602667|364876835|FG002|Overall Study|Death|1|||
105787922|NCT00602667|364876833|FG000|Overall Study|Family request|3|||
105787923|NCT00602667|364876834|FG001|Overall Study|Family request|25|||
105787924|NCT00602667|364876835|FG002|Overall Study|Family request|6|||
105927501|NCT02332707|365393345|FG009|Overall Study|Lost to Follow-up|0|||
105927502|NCT02332707|365393346|FG010|Overall Study|Lost to Follow-up|2|||
105927503|NCT02332707|365393347|FG011|Overall Study|Lost to Follow-up|0|||
105927504|NCT02332707|365393348|FG012|Overall Study|Lost to Follow-up|3|||
105927505|NCT02332707|365393349|FG013|Overall Study|Lost to Follow-up|0|||
105927506|NCT02332707|365393350|FG014|Overall Study|Lost to Follow-up|0|||
105927507|NCT02332707|365393351|FG015|Overall Study|Lost to Follow-up|0|||
105927508|NCT02332707|365393352|FG016|Overall Study|Lost to Follow-up|0|||
105927509|NCT02332707|365393353|FG017|Overall Study|Lost to Follow-up|0|||
105927510|NCT02332707|365393336|FG000|Overall Study|Physician Decision|0|||
105927511|NCT02332707|365393337|FG001|Overall Study|Physician Decision|0|||
105927512|NCT02332707|365393338|FG002|Overall Study|Physician Decision|0|||
105927513|NCT02332707|365393339|FG003|Overall Study|Physician Decision|1|||
105927514|NCT02332707|365393340|FG004|Overall Study|Physician Decision|0|||
105927515|NCT02332707|365393341|FG005|Overall Study|Physician Decision|0|||
105927516|NCT02332707|365393342|FG006|Overall Study|Physician Decision|0|||
105927517|NCT02332707|365393343|FG007|Overall Study|Physician Decision|0|||
105927518|NCT02332707|365393344|FG008|Overall Study|Physician Decision|0|||
105927519|NCT02332707|365393345|FG009|Overall Study|Physician Decision|0|||
105927520|NCT02332707|365393346|FG010|Overall Study|Physician Decision|0|||
105927521|NCT02332707|365393347|FG011|Overall Study|Physician Decision|0|||
105927522|NCT02332707|365393348|FG012|Overall Study|Physician Decision|1|||
105927523|NCT02332707|365393349|FG013|Overall Study|Physician Decision|0|||
105927524|NCT02332707|365393350|FG014|Overall Study|Physician Decision|0|||
105927525|NCT02332707|365393351|FG015|Overall Study|Physician Decision|0|||
105927526|NCT02332707|365393352|FG016|Overall Study|Physician Decision|0|||
105927527|NCT02332707|365393353|FG017|Overall Study|Physician Decision|0|||
105927528|NCT02332707|365393336|FG000|Overall Study|Withdrawal by Subject|0|||
105927529|NCT02332707|365393337|FG001|Overall Study|Withdrawal by Subject|0|||
105927530|NCT02332707|365393338|FG002|Overall Study|Withdrawal by Subject|1|||
105927531|NCT02332707|365393339|FG003|Overall Study|Withdrawal by Subject|0|||
105927532|NCT02332707|365393340|FG004|Overall Study|Withdrawal by Subject|0|||
105927533|NCT02332707|365393341|FG005|Overall Study|Withdrawal by Subject|0|||
105927534|NCT02332707|365393342|FG006|Overall Study|Withdrawal by Subject|0|||
105927535|NCT02332707|365393343|FG007|Overall Study|Withdrawal by Subject|0|||
105927536|NCT02332707|365393344|FG008|Overall Study|Withdrawal by Subject|0|||
105927537|NCT02332707|365393345|FG009|Overall Study|Withdrawal by Subject|3|||
105927538|NCT02332707|365393346|FG010|Overall Study|Withdrawal by Subject|0|||
105927539|NCT02332707|365393347|FG011|Overall Study|Withdrawal by Subject|0|||
105927540|NCT02332707|365393348|FG012|Overall Study|Withdrawal by Subject|0|||
105927541|NCT02332707|365393349|FG013|Overall Study|Withdrawal by Subject|0|||
105927542|NCT02332707|365393350|FG014|Overall Study|Withdrawal by Subject|0|||
105927543|NCT02332707|365393351|FG015|Overall Study|Withdrawal by Subject|0|||
105927544|NCT02332707|365393352|FG016|Overall Study|Withdrawal by Subject|0|||
105927545|NCT02332707|365393353|FG017|Overall Study|Withdrawal by Subject|0|||
105927546|NCT05399771|365393354|FG000|Overall Study|Physician Decision|3|||
105927547|NCT05399771|365393354|FG000|Overall Study|Adverse Event|1|||
105927548|NCT00143507|365393365|FG000|Overall Study|Death|572|||
105927549|NCT00143507|365393366|FG001|Overall Study|Death|547|||
105927550|NCT00143507|365393365|FG000|Overall Study|Withdrawal by Subject|114|||
105927551|NCT00143507|365393366|FG001|Overall Study|Withdrawal by Subject|102|||
105927552|NCT00143507|365393365|FG000|Overall Study|Lost to Follow-up|1|||
105927553|NCT00143507|365393366|FG001|Overall Study|Lost to Follow-up|0|||
105787925|NCT00602667|364876833|FG000|Overall Study|Excessive toxicity|1|||
105787926|NCT00602667|364876834|FG001|Overall Study|Excessive toxicity|1|||
105787927|NCT00602667|364876835|FG002|Overall Study|Excessive toxicity|0|||
105927554|NCT00143507|365393365|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
105927555|NCT00143507|365393366|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
105927556|NCT00587457|365393367|FG000|Overall Study|Adverse Event|1|||
105927557|NCT00587457|365393368|FG001|Overall Study|Adverse Event|2|||
105927558|NCT00587457|365393369|FG002|Overall Study|Adverse Event|1|||
105927559|NCT00587457|365393367|FG000|Overall Study|Disease progression|2|||
105927560|NCT00587457|365393368|FG001|Overall Study|Disease progression|0|||
105927561|NCT00587457|365393369|FG002|Overall Study|Disease progression|2|||
105927562|NCT00587457|365393367|FG000|Overall Study|Initiation of alternative therapy|0|||
106007177|NCT00446849|365692180|FG000|Acute Phase|Lost to Follow-up|2|||
105787928|NCT00602667|364876833|FG000|Overall Study|Second malignancy|0|||
105787929|NCT00602667|364876834|FG001|Overall Study|Second malignancy|1|||
105787930|NCT00602667|364876835|FG002|Overall Study|Second malignancy|0|||
105927563|NCT00587457|365393368|FG001|Overall Study|Initiation of alternative therapy|1|||
105927564|NCT00587457|365393369|FG002|Overall Study|Initiation of alternative therapy|0|||
105787931|NCT00602667|364876833|FG000|Overall Study|Physician Decision|2|||
105707270|NCT00689871|364589229|FG002|Overall Study|Explanted of All Study Devices|29|||
105707271|NCT00689871|364589230|FG003|Overall Study|Explanted of All Study Devices|3|||
105707272|NCT00689871|364589227|FG000|Overall Study|Withdrawal by Subject|13|||
105707273|NCT00689871|364589228|FG001|Overall Study|Withdrawal by Subject|3|||
105707274|NCT00689871|364589229|FG002|Overall Study|Withdrawal by Subject|4|||
105787932|NCT00602667|364876834|FG001|Overall Study|Physician Decision|3|||
105787933|NCT00602667|364876835|FG002|Overall Study|Physician Decision|8|||
105787934|NCT00602667|364876833|FG000|Overall Study|Progressive disease|13|||
105787935|NCT00602667|364876834|FG001|Overall Study|Progressive disease|48|||
105787936|NCT00602667|364876835|FG002|Overall Study|Progressive disease|45|||
105787937|NCT00602667|364876833|FG000|Overall Study|Progressive disease prior to therapy|0|||
105787938|NCT00602667|364876834|FG001|Overall Study|Progressive disease prior to therapy|0|||
105787939|NCT00602667|364876835|FG002|Overall Study|Progressive disease prior to therapy|1|||
105787940|NCT04410991|364876836|FG000|Overall Study|Poor compliance to protocol|5|||
105787941|NCT04410991|364876837|FG001|Overall Study|Poor compliance to protocol|4|||
105787942|NCT04410991|364876836|FG000|Overall Study|Withdrawal by Subject|59|||
105787943|NCT04410991|364876837|FG001|Overall Study|Withdrawal by Subject|55|||
105787944|NCT04410991|364876836|FG000|Overall Study|Other|10|||
105787945|NCT04410991|364876837|FG001|Overall Study|Other|4|||
105787946|NCT02003209|364876838|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
105787947|NCT02003209|364876839|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
105787948|NCT01195662|364876840|FG000|Double Blind Treatment Period|Adverse Event|4|||
105707275|NCT00689871|364589230|FG003|Overall Study|Withdrawal by Subject|1|||
105707276|NCT00689871|364589227|FG000|Overall Study|Death|1|||
105707277|NCT00689871|364589228|FG001|Overall Study|Death|10|||
105707278|NCT00689871|364589229|FG002|Overall Study|Death|2|||
105707279|NCT00689871|364589230|FG003|Overall Study|Death|2|||
105707280|NCT00689871|364589227|FG000|Overall Study|Physician Decision|2|||
105707281|NCT00689871|364589228|FG001|Overall Study|Physician Decision|1|||
105707282|NCT00689871|364589229|FG002|Overall Study|Physician Decision|1|||
105787949|NCT01195662|364876841|FG001|Double Blind Treatment Period|Adverse Event|1|||
105787950|NCT01195662|364876842|FG002|Double Blind Treatment Period|Adverse Event|2|||
105787951|NCT01195662|364876840|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
105787952|NCT01195662|364876841|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
105787953|NCT01195662|364876842|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
105787954|NCT01195662|364876840|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
105787955|NCT01195662|364876841|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
105927565|NCT00587457|365393367|FG000|Overall Study|Undefined|0|||
105927566|NCT00587457|365393368|FG001|Overall Study|Undefined|0|||
105927567|NCT00587457|365393369|FG002|Overall Study|Undefined|1|||
105927568|NCT00587457|365393367|FG000|Overall Study|Development of neutralizing Abs|0|||
105927569|NCT00587457|365393368|FG001|Overall Study|Development of neutralizing Abs|0|||
105927570|NCT00587457|365393369|FG002|Overall Study|Development of neutralizing Abs|1|||
105927571|NCT00484159|365393370|FG000|Overall Study|Lost to Follow-up|1|||
105927572|NCT00484159|365393371|FG001|Overall Study|Lost to Follow-up|1|||
105927573|NCT00484159|365393372|FG002|Overall Study|Lost to Follow-up|0|||
105927574|NCT00177671|365393373|FG000|Overall Study|Withdrawal by Subject|5|||
105927575|NCT00177671|365393374|FG001|Overall Study|Withdrawal by Subject|6|||
105927576|NCT00177671|365393373|FG000|Overall Study|medical complications|2|||
105927577|NCT00177671|365393374|FG001|Overall Study|medical complications|0|||
105927578|NCT00177671|365393373|FG000|Overall Study|Adverse Event|6|||
105927579|NCT00177671|365393374|FG001|Overall Study|Adverse Event|0|||
105927580|NCT00177671|365393373|FG000|Overall Study|Physician Decision|12|||
105927581|NCT00177671|365393374|FG001|Overall Study|Physician Decision|8|||
105927582|NCT03807843|365393375|FG000|Overall Study|Lost to Follow-up|1|||
105927583|NCT03807843|365393376|FG001|Overall Study|Lost to Follow-up|0|||
105927584|NCT01312129|365393377|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
105927585|NCT01312129|365393378|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
105927586|NCT01847209|365393379|FG000|Overall Study|Withdrawal by Subject|1|||
106133831|NCT00783692|366148197|FG006|Maintenance Phase|Lost to Follow-up|5|||
105707283|NCT00689871|364589230|FG003|Overall Study|Physician Decision|0|||
105707284|NCT02703311|364589231|FG000|Overall Study|Death|5|||
105707285|NCT02703311|364589231|FG000|Overall Study|Withdrawal by Subject|3|||
105707286|NCT04703075|364589235|FG000|Overall Study|Adverse Event|11|||
105787956|NCT01195662|364876842|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
105787957|NCT01195662|364876840|FG000|Double Blind Treatment Period|Administrative reason|2|||
105787958|NCT01195662|364876841|FG001|Double Blind Treatment Period|Administrative reason|1|||
105787959|NCT01195662|364876842|FG002|Double Blind Treatment Period|Administrative reason|1|||
105787960|NCT01195662|364876840|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
105787961|NCT01195662|364876841|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
105787962|NCT01195662|364876842|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
105927587|NCT01847209|365393379|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
105927588|NCT00729586|365393380|FG000|Overall Study|Ineligible|0|||
105707287|NCT04703075|364589236|FG001|Overall Study|Adverse Event|7|||
105927589|NCT00729586|365393381|FG001|Overall Study|Ineligible|1|||
105707288|NCT04703075|364589235|FG000|Overall Study|Lost to Follow-up|6|||
105707289|NCT04703075|364589236|FG001|Overall Study|Lost to Follow-up|12|||
105707290|NCT04703075|364589235|FG000|Overall Study|Physician Decision|3|||
105707291|NCT04703075|364589236|FG001|Overall Study|Physician Decision|0|||
105707292|NCT04703075|364589235|FG000|Overall Study|Moved|0|||
105707293|NCT04703075|364589236|FG001|Overall Study|Moved|2|||
105707294|NCT04703075|364589235|FG000|Overall Study|Index INH Resistant|0|||
105707295|NCT04703075|364589236|FG001|Overall Study|Index INH Resistant|1|||
105707296|NCT04703075|364589235|FG000|Overall Study|Lack of Efficacy|6|||
105707297|NCT04703075|364589236|FG001|Overall Study|Lack of Efficacy|18|||
105707298|NCT02788747|364589237|FG000|Overall Study|Adverse Event|1|||
105707299|NCT02788747|364589238|FG001|Overall Study|Adverse Event|0|||
105707300|NCT02788747|364589239|FG002|Overall Study|Adverse Event|0|||
105707301|NCT01119248|364589240|FG000|Overall Study|Physician Decision|5|||
105707302|NCT01967550|364589241|FG000|Overall Study|Withdrawal by Subject|1|||
105707303|NCT01967550|364589242|FG001|Overall Study|Withdrawal by Subject|0|||
105927590|NCT00729586|365393380|FG000|Overall Study|never treated|1|||
105927591|NCT00729586|365393381|FG001|Overall Study|never treated|0|||
105927592|NCT02008370|365393402|FG000|Overall Study|Lost to Follow-up|7|||
105927593|NCT00662259|365393403|FG000|Overall Study|Adverse Event|2|||
105927594|NCT00662259|365393404|FG001|Overall Study|Adverse Event|0|||
105927595|NCT00972738|365393405|FG000|Overall Study|Adverse Event|7|||
105927596|NCT00972738|365393406|FG001|Overall Study|Adverse Event|1|||
105927597|NCT00972738|365393407|FG002|Overall Study|Adverse Event|8|||
105927598|NCT00972738|365393405|FG000|Overall Study|Protocol Violation|2|||
105927599|NCT00972738|365393406|FG001|Overall Study|Protocol Violation|1|||
105927600|NCT00972738|365393407|FG002|Overall Study|Protocol Violation|3|||
105927601|NCT00972738|365393405|FG000|Overall Study|Lost to Follow-up|1|||
105927602|NCT00972738|365393406|FG001|Overall Study|Lost to Follow-up|0|||
105927603|NCT00972738|365393407|FG002|Overall Study|Lost to Follow-up|1|||
105927604|NCT00972738|365393405|FG000|Overall Study|Lack of Efficacy|5|||
105927605|NCT00972738|365393406|FG001|Overall Study|Lack of Efficacy|1|||
105927606|NCT00972738|365393407|FG002|Overall Study|Lack of Efficacy|11|||
105927607|NCT00972738|365393405|FG000|Overall Study|Withdrawal by Subject|5|||
105927608|NCT00972738|365393406|FG001|Overall Study|Withdrawal by Subject|1|||
105927609|NCT00972738|365393407|FG002|Overall Study|Withdrawal by Subject|4|||
105927610|NCT00972738|365393405|FG000|Overall Study|Moved|0|||
105927611|NCT00972738|365393406|FG001|Overall Study|Moved|0|||
105707304|NCT01967550|364589241|FG000|Overall Study|Adverse Event|2|||
105707305|NCT01967550|364589242|FG001|Overall Study|Adverse Event|0|||
105707306|NCT01967550|364589241|FG000|Overall Study|Protocol Violation|2|||
105707307|NCT01967550|364589242|FG001|Overall Study|Protocol Violation|1|||
105707308|NCT01967550|364589241|FG000|Overall Study|Non Compliance|0|||
105707309|NCT01967550|364589242|FG001|Overall Study|Non Compliance|1|||
105707310|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
105707311|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
105707312|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
105707313|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
105707314|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
105707315|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
105927612|NCT00972738|365393407|FG002|Overall Study|Moved|1|||
105927613|NCT00972738|365393405|FG000|Overall Study|Other|1|||
105707316|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
105707317|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
105707318|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
105707319|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
105707320|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
105707321|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
105707322|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
105707323|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
105707324|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
105707325|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
105927614|NCT00972738|365393406|FG001|Overall Study|Other|2|||
105707326|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
105707327|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
105927615|NCT00972738|365393407|FG002|Overall Study|Other|1|||
105707328|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
105707329|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
105707330|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
105707331|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
105927616|NCT02693418|365393410|FG000|Overall Study|Lost to Follow-up|1|||
105927617|NCT02693418|365393411|FG001|Overall Study|Lost to Follow-up|2|||
105927618|NCT02693418|365393412|FG002|Overall Study|Lost to Follow-up|0|||
105927619|NCT02693418|365393413|FG003|Overall Study|Lost to Follow-up|0|||
105927620|NCT02693418|365393414|FG004|Overall Study|Lost to Follow-up|0|||
105927621|NCT02693418|365393410|FG000|Overall Study|Menses during study period|0|||
105787963|NCT01195662|364876840|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
105787964|NCT01195662|364876841|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
105787965|NCT01195662|364876842|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
105787966|NCT01195662|364876840|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
105707332|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
105707333|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
105707334|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
105787967|NCT01195662|364876841|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
105787968|NCT01195662|364876842|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
105707335|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
105707336|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
105707337|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
105707338|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
105707339|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
105707340|NCT00784654|364589243|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
105707341|NCT00784654|364589244|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
105707342|NCT00784654|364589245|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
105707343|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
105707344|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
105707345|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
105707346|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
105707347|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
105707348|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
105707349|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
105707350|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
105707351|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
105787969|NCT01195662|364876840|FG000|Double Blind Treatment Period|Non-specified|3|||
105787970|NCT01195662|364876841|FG001|Double Blind Treatment Period|Non-specified|0|||
105787971|NCT01195662|364876842|FG002|Double Blind Treatment Period|Non-specified|0|||
105787972|NCT01195662|364876840|FG000|Double Blind Treatment Period|Missing disposition information|0|||
105787973|NCT01195662|364876841|FG001|Double Blind Treatment Period|Missing disposition information|1|||
105787974|NCT01195662|364876842|FG002|Double Blind Treatment Period|Missing disposition information|1|||
105787975|NCT01195662|364876840|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
105707352|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
105707353|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
105707354|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
105707355|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Adverse Event|0|||
105707356|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Adverse Event|1|||
105707357|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Adverse Event|1|||
105707358|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
105707359|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
105707360|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
105707361|NCT00784654|364589243|FG000|Randomized Withdrawal Period|Family reasons|0|||
105707362|NCT00784654|364589244|FG001|Randomized Withdrawal Period|Family reasons|0|||
105707363|NCT00784654|364589245|FG002|Randomized Withdrawal Period|Family reasons|1|||
105707364|NCT01180660|364589246|FG000|Overall Study|Changed to open surgery|1|||
105707365|NCT01180660|364589247|FG001|Overall Study|Changed to open surgery|0|||
105707366|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
105707367|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
105707368|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
105787976|NCT01195662|364876841|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
105787977|NCT01195662|364876842|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
105787978|NCT01195662|364876840|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
105787979|NCT01195662|364876841|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
105787980|NCT01195662|364876842|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
105927622|NCT02693418|365393411|FG001|Overall Study|Menses during study period|0|||
105927623|NCT02693418|365393412|FG002|Overall Study|Menses during study period|2|||
105927624|NCT02693418|365393413|FG003|Overall Study|Menses during study period|0|||
105927625|NCT02693418|365393414|FG004|Overall Study|Menses during study period|0|||
105787981|NCT01215968|364876843|FG000|Overall Study|Adverse Event|0|||
106133832|NCT00783692|366148191|FG000|Maintenance Phase|Other|0|||
106133833|NCT00783692|366148192|FG001|Maintenance Phase|Other|0|||
105787982|NCT01215968|364876844|FG001|Overall Study|Adverse Event|2|||
105787983|NCT01215968|364876843|FG000|Overall Study|Protocol Violation|2|||
105927626|NCT02513199|365393415|FG000|Treatment|Death|1|||
106133834|NCT00783692|366148193|FG002|Maintenance Phase|Other|0|||
106133835|NCT00783692|366148194|FG003|Maintenance Phase|Other|1|||
105707369|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
105707370|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
105707371|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
105707372|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
105707373|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
105707374|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
105707375|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
105707376|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
105707377|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
105707378|NCT02425826|364589251|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
105707379|NCT02425826|364589252|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
105707380|NCT02425826|364589253|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
105707381|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
105707382|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
105707383|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
105707384|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
105707385|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
105707386|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
105707387|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
105707388|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
105707389|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
105707390|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
105707391|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
105707392|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
105707393|NCT02425826|364589251|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
105707394|NCT02425826|364589252|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
105707395|NCT02425826|364589253|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
105927627|NCT02513199|365393415|FG000|Treatment|Lost to Follow-up|1|||
105927628|NCT02513199|365393415|FG000|Follow-Up|Death|11|||
105707396|NCT01328951|364589262|FG000|Overall Study|Disease Progression|17|||
105707397|NCT01328951|364589263|FG001|Overall Study|Disease Progression|14|||
105707398|NCT01328951|364589262|FG000|Overall Study|Adverse Event|2|||
105707399|NCT01328951|364589263|FG001|Overall Study|Adverse Event|0|||
105707400|NCT01328951|364589262|FG000|Overall Study|Death|243|||
105707401|NCT01328951|364589263|FG001|Overall Study|Death|258|||
105707402|NCT01328951|364589262|FG000|Overall Study|Lost to Follow-up|6|||
105707403|NCT01328951|364589263|FG001|Overall Study|Lost to Follow-up|7|||
105707404|NCT01328951|364589262|FG000|Overall Study|Withdrawal by Subject|6|||
105707405|NCT01328951|364589263|FG001|Overall Study|Withdrawal by Subject|6|||
105707406|NCT01328951|364589262|FG000|Overall Study|Study Closed by the Sponsor|36|||
105707407|NCT01328951|364589263|FG001|Overall Study|Study Closed by the Sponsor|31|||
105707408|NCT01328951|364589262|FG000|Overall Study|Other|11|||
105707409|NCT01328951|364589263|FG001|Overall Study|Other|6|||
105707410|NCT04489888|364589264|FG000|Overall Study|Death|75|||
105707411|NCT04489888|364589264|FG000|Overall Study|Sponsor Decision|26|||
105707412|NCT04042103|364589265|FG000|Overall Study|Lost to Follow-up|1|||
105707413|NCT04042103|364589265|FG000|Overall Study|Withdrawal by Subject|1|||
105707414|NCT04153188|364589266|FG000|Overall Study|Lost to Follow-up|1|||
105707415|NCT04153188|364589267|FG001|Overall Study|Lost to Follow-up|1|||
105707416|NCT04153188|364589266|FG000|Overall Study|Withdrawal by Subject|2|||
105707417|NCT04153188|364589267|FG001|Overall Study|Withdrawal by Subject|0|||
105707418|NCT04153188|364589266|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
105707419|NCT04153188|364589267|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
105707420|NCT04418076|364589268|FG000|Overall Study|Death|1|||
105707421|NCT04418076|364589269|FG001|Overall Study|Death|0|||
105707422|NCT04418076|364589270|FG002|Overall Study|Death|0|||
105707423|NCT04418076|364589271|FG003|Overall Study|Death|0|||
105707424|NCT04418076|364589268|FG000|Overall Study|Lost to Follow-up|2|||
105707425|NCT04418076|364589269|FG001|Overall Study|Lost to Follow-up|5|||
105707426|NCT04418076|364589270|FG002|Overall Study|Lost to Follow-up|1|||
105707427|NCT04418076|364589271|FG003|Overall Study|Lost to Follow-up|2|||
105787984|NCT01215968|364876844|FG001|Overall Study|Protocol Violation|4|||
105787985|NCT01215968|364876843|FG000|Overall Study|Not received study drug|0|||
105707428|NCT04418076|364589268|FG000|Overall Study|Withdrawal by Subject|1|||
105707429|NCT04418076|364589269|FG001|Overall Study|Withdrawal by Subject|0|||
105707430|NCT04418076|364589270|FG002|Overall Study|Withdrawal by Subject|1|||
105707431|NCT04418076|364589271|FG003|Overall Study|Withdrawal by Subject|1|||
105707432|NCT04418076|364589268|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
105707433|NCT04418076|364589269|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
105707434|NCT04418076|364589270|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
105707435|NCT04418076|364589271|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
105927629|NCT04137887|365393428|FG000|Overall Study|Death|102|||
105707436|NCT00805480|364589272|FG000|Overall Study|Withdrawal by Subject|13|||
105707437|NCT00805480|364589273|FG001|Overall Study|Withdrawal by Subject|5|||
105707438|NCT00805480|364589274|FG002|Overall Study|Withdrawal by Subject|11|||
105707439|NCT00805480|364589275|FG003|Overall Study|Withdrawal by Subject|5|||
105707440|NCT00805480|364589272|FG000|Overall Study|Lost to Follow-up|1|||
105707441|NCT00805480|364589273|FG001|Overall Study|Lost to Follow-up|2|||
105787986|NCT01215968|364876844|FG001|Overall Study|Not received study drug|1|||
105707442|NCT00805480|364589274|FG002|Overall Study|Lost to Follow-up|0|||
105707443|NCT00805480|364589275|FG003|Overall Study|Lost to Follow-up|0|||
105707444|NCT00805480|364589272|FG000|Overall Study|Adverse Event|0|||
105707445|NCT00805480|364589273|FG001|Overall Study|Adverse Event|0|||
105707446|NCT00805480|364589274|FG002|Overall Study|Adverse Event|1|||
105707447|NCT00805480|364589275|FG003|Overall Study|Adverse Event|0|||
105707448|NCT04129528|364590813|FG000|Overall Study|Adverse Event|1|||
105707449|NCT04129528|364590814|FG001|Overall Study|Adverse Event|0|||
105707450|NCT04129528|364590813|FG000|Overall Study|Physician Decision|1|||
105707451|NCT04129528|364590814|FG001|Overall Study|Physician Decision|1|||
105707452|NCT04129528|364590813|FG000|Overall Study|Withdrawal by Subject|1|||
105707453|NCT04129528|364590814|FG001|Overall Study|Withdrawal by Subject|1|||
105787987|NCT01250418|364876848|FG000|Overall Study|monitor data failure|1|||
105787988|NCT01250418|364876849|FG001|Overall Study|monitor data failure|1|||
105707454|NCT01964352|364590815|FG000|Overall Study|Adverse Event|13|||
105787989|NCT01761565|364876850|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
105787990|NCT00816166|364876851|FG000|Overall Study|Lost to Follow-up|6|||
105787991|NCT00816166|364876852|FG001|Overall Study|Lost to Follow-up|10|||
105787992|NCT00816166|364876851|FG000|Overall Study|Death|4|||
105787993|NCT00816166|364876852|FG001|Overall Study|Death|2|||
105787994|NCT02851069|364876854|FG000|Overall Study|Failure to Return|3|||
105787995|NCT02851069|364876854|FG000|Overall Study|Other|3|||
105787996|NCT04745676|364876857|FG000|Overall Study|Death|1|||
105787997|NCT04745676|364876858|FG001|Overall Study|Death|0|||
105787998|NCT04745676|364876859|FG002|Overall Study|Death|0|||
105787999|NCT00885677|364876860|FG000|Overall Study|Death|40|||
105788000|NCT00885677|364876861|FG001|Overall Study|Death|34|||
105788001|NCT00885677|364876860|FG000|Overall Study|Lost to Follow-up|15|||
105788002|NCT00885677|364876861|FG001|Overall Study|Lost to Follow-up|13|||
105788003|NCT00885677|364876860|FG000|Overall Study|Protocol Violation|54|||
105788004|NCT00885677|364876861|FG001|Overall Study|Protocol Violation|54|||
105788005|NCT00885677|364876860|FG000|Overall Study|premature study closure|41|||
105788006|NCT00885677|364876861|FG001|Overall Study|premature study closure|44|||
105788007|NCT00885677|364876860|FG000|Overall Study|device/lead revision or replacement|7|||
105788008|NCT00885677|364876861|FG001|Overall Study|device/lead revision or replacement|6|||
105788009|NCT00885677|364876860|FG000|Overall Study|Heart transplantation|1|||
105788010|NCT00885677|364876861|FG001|Overall Study|Heart transplantation|0|||
105788011|NCT00885677|364876860|FG000|Overall Study|Inclusion/exclusion not met|25|||
105788012|NCT00885677|364876861|FG001|Overall Study|Inclusion/exclusion not met|27|||
105788013|NCT01821391|364876862|FG000|Overall Study|Adverse Event|1|||
105788014|NCT01821391|364876863|FG001|Overall Study|Adverse Event|0|||
105788015|NCT00975000|364876865|FG000|Overall Study|Other|1|||
105788016|NCT00975000|364876866|FG001|Overall Study|Other|0|||
105788017|NCT00975000|364876865|FG000|Overall Study|Adverse Event|1|||
105788018|NCT00975000|364876866|FG001|Overall Study|Adverse Event|1|||
105788019|NCT00975000|364876865|FG000|Overall Study|Withdrawal by Subject|2|||
105788020|NCT00975000|364876866|FG001|Overall Study|Withdrawal by Subject|2|||
105788021|NCT00975000|364876865|FG000|Overall Study|Lost to Follow-up|0|||
105788022|NCT00975000|364876866|FG001|Overall Study|Lost to Follow-up|1|||
105788023|NCT00975000|364876865|FG000|Overall Study|Protocol-specified Criteria|1|||
105788024|NCT00975000|364876866|FG001|Overall Study|Protocol-specified Criteria|0|||
105788025|NCT00975000|364876865|FG000|Overall Study|Non-compliance|0|||
105788026|NCT00975000|364876866|FG001|Overall Study|Non-compliance|1|||
105788027|NCT04880850|364876872|FG000|Overall Study|Death|2|||
105788028|NCT04880850|364876873|FG001|Overall Study|Death|1|||
105788029|NCT04880850|364876872|FG000|Overall Study|Lost to Follow-up|3|||
105788030|NCT04880850|364876873|FG001|Overall Study|Lost to Follow-up|6|||
105788031|NCT04880850|364876872|FG000|Overall Study|Physician Decision|2|||
105788032|NCT04880850|364876873|FG001|Overall Study|Physician Decision|1|||
105788033|NCT04880850|364876872|FG000|Overall Study|Withdrawal by Subject|9|||
105788034|NCT04880850|364876873|FG001|Overall Study|Withdrawal by Subject|10|||
105788035|NCT00437294|364878169|FG000|Overall Study|Adverse Event|5|||
105788036|NCT00437294|364878170|FG001|Overall Study|Adverse Event|4|||
105788037|NCT00437294|364878169|FG000|Overall Study|Death|5|||
105927630|NCT04137887|365393429|FG001|Overall Study|Death|92|||
105707455|NCT01964352|364590816|FG001|Overall Study|Adverse Event|3|||
105707456|NCT01964352|364590817|FG002|Overall Study|Adverse Event|4|||
105707457|NCT01964352|364590818|FG003|Overall Study|Adverse Event|3|||
105707458|NCT01964352|364590815|FG000|Overall Study|Lack of Efficacy|6|||
105707459|NCT01964352|364590816|FG001|Overall Study|Lack of Efficacy|0|||
105707460|NCT01964352|364590817|FG002|Overall Study|Lack of Efficacy|0|||
105788038|NCT00437294|364878170|FG001|Overall Study|Death|2|||
105788039|NCT00437294|364878169|FG000|Overall Study|Physician Decision|0|||
105707461|NCT01964352|364590818|FG003|Overall Study|Lack of Efficacy|0|||
105707462|NCT01964352|364590815|FG000|Overall Study|Protocol Violation|2|||
105707463|NCT01964352|364590816|FG001|Overall Study|Protocol Violation|4|||
105707464|NCT01964352|364590817|FG002|Overall Study|Protocol Violation|0|||
105707465|NCT01964352|364590818|FG003|Overall Study|Protocol Violation|2|||
105707466|NCT01964352|364590815|FG000|Overall Study|Lost to Follow-up|1|||
105707467|NCT01964352|364590816|FG001|Overall Study|Lost to Follow-up|0|||
105707468|NCT01964352|364590817|FG002|Overall Study|Lost to Follow-up|0|||
105707469|NCT01964352|364590818|FG003|Overall Study|Lost to Follow-up|1|||
105707470|NCT01964352|364590815|FG000|Overall Study|Withdrawal by Subject|4|||
105707471|NCT01964352|364590816|FG001|Overall Study|Withdrawal by Subject|2|||
105707472|NCT01964352|364590817|FG002|Overall Study|Withdrawal by Subject|1|||
105707473|NCT01964352|364590818|FG003|Overall Study|Withdrawal by Subject|0|||
105707474|NCT01964352|364590815|FG000|Overall Study|Other than stated above|0|||
105707475|NCT01964352|364590816|FG001|Overall Study|Other than stated above|2|||
105707476|NCT01964352|364590817|FG002|Overall Study|Other than stated above|1|||
105707477|NCT01964352|364590818|FG003|Overall Study|Other than stated above|2|||
105707478|NCT00105443|364590830|FG000|Double-Blind Treatment|Adverse Event|1|||
105707479|NCT00105443|364590831|FG001|Double-Blind Treatment|Adverse Event|0|||
105707480|NCT00105443|364590832|FG002|Double-Blind Treatment|Adverse Event|0|||
105707481|NCT00105443|364590833|FG003|Double-Blind Treatment|Adverse Event|0|||
105707482|NCT00105443|364590830|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
105707483|NCT00105443|364590831|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
105707484|NCT00105443|364590832|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
105707485|NCT00105443|364590833|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
105707486|NCT00105443|364590830|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
105707487|NCT00105443|364590831|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
105707488|NCT00105443|364590832|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
105707489|NCT00105443|364590833|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
105707490|NCT00105443|364590830|FG000|Double-Blind Treatment|Physician Decision|1|||
105707491|NCT00105443|364590831|FG001|Double-Blind Treatment|Physician Decision|0|||
105707492|NCT00105443|364590832|FG002|Double-Blind Treatment|Physician Decision|2|||
105707493|NCT00105443|364590833|FG003|Double-Blind Treatment|Physician Decision|0|||
105707494|NCT00105443|364590830|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
105707495|NCT00105443|364590831|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
105707496|NCT00105443|364590832|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
105707497|NCT00105443|364590833|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
105707498|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
105707499|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
105707500|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
105707501|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
105707502|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
105707503|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
105707504|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
105707505|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
105707506|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
105707507|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
105707508|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
105707509|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
105707510|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
105707511|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
105707512|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
105707513|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
105707514|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
105707515|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
105707516|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
105707517|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
105707518|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
105707519|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
105707520|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
105707521|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
105707522|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
105707523|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
105707524|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
105707525|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
105788040|NCT00437294|364878170|FG001|Overall Study|Physician Decision|3|||
105788041|NCT00437294|364878169|FG000|Overall Study|Withdrawal by Subject|5|||
105788042|NCT00437294|364878170|FG001|Overall Study|Withdrawal by Subject|0|||
105788043|NCT00437294|364878169|FG000|Overall Study|Progressive Disease|19|||
105788044|NCT00437294|364878170|FG001|Overall Study|Progressive Disease|23|||
106007178|NCT00446849|365692180|FG000|Acute Phase|Physician Decision|1|||
105707526|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
105707527|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
105707528|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
105707529|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
105707530|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
105707531|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
105707532|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
105707533|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
105707534|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
105707535|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
105707536|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
105707537|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
105707538|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
105707539|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
105707540|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
105707541|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
105707542|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
105707543|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
105707544|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
105707545|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
105707546|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
105707547|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
105707548|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
105707549|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
105707550|NCT00105443|364590830|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
105707551|NCT00105443|364590831|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
105707552|NCT00105443|364590832|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
105707553|NCT00105443|364590833|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
105707554|NCT02164981|364590834|FG000|Started|Withdrawal by Subject|2|||
105707555|NCT02164981|364590835|FG001|Started|Withdrawal by Subject|1|||
105707556|NCT02164981|364590836|FG002|Started|Withdrawal by Subject|0|||
105707557|NCT02164981|364590834|FG000|Started|Protocol Violation|2|||
105707558|NCT02164981|364590835|FG001|Started|Protocol Violation|0|||
105707559|NCT02164981|364590836|FG002|Started|Protocol Violation|0|||
105707560|NCT02164981|364590834|FG000|Started|Adverse Event|1|||
105707561|NCT02164981|364590835|FG001|Started|Adverse Event|2|||
105707562|NCT02164981|364590836|FG002|Started|Adverse Event|0|||
105707563|NCT02164981|364590834|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
105707564|NCT02164981|364590835|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
105707565|NCT02164981|364590836|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
105707566|NCT02164981|364590834|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
105707567|NCT02164981|364590835|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
105707568|NCT02164981|364590836|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
105707569|NCT02164981|364590834|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
105707570|NCT02164981|364590835|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
105707571|NCT02164981|364590836|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
105707572|NCT01736579|364590837|FG000|Overall Study|Termination of Study by Sponsor|2|||
105707573|NCT01736579|364590838|FG001|Overall Study|Termination of Study by Sponsor|2|||
105707574|NCT01995071|364590839|FG000|Overall Study|Adverse Event|0|||
105707575|NCT01995071|364590840|FG001|Overall Study|Adverse Event|0|||
105707576|NCT01995071|364590841|FG002|Overall Study|Adverse Event|0|||
105707577|NCT01995071|364590842|FG003|Overall Study|Adverse Event|0|||
105707578|NCT01995071|364590843|FG004|Overall Study|Adverse Event|0|||
105707579|NCT01995071|364590844|FG005|Overall Study|Adverse Event|0|||
105707580|NCT01995071|364590845|FG006|Overall Study|Adverse Event|1|||
105707581|NCT01995071|364590846|FG007|Overall Study|Adverse Event|0|||
105707582|NCT01995071|364590847|FG008|Overall Study|Adverse Event|0|||
105707583|NCT01995071|364590848|FG009|Overall Study|Adverse Event|0|||
105707584|NCT01995071|364590849|FG010|Overall Study|Adverse Event|0|||
105707585|NCT01995071|364590850|FG011|Overall Study|Adverse Event|0|||
105707586|NCT01995071|364590839|FG000|Overall Study|Moved|0|||
105707587|NCT01995071|364590840|FG001|Overall Study|Moved|0|||
105707588|NCT01995071|364590841|FG002|Overall Study|Moved|1|||
105707589|NCT01995071|364590842|FG003|Overall Study|Moved|0|||
105707590|NCT01995071|364590843|FG004|Overall Study|Moved|1|||
105707591|NCT01995071|364590844|FG005|Overall Study|Moved|0|||
105707592|NCT01995071|364590845|FG006|Overall Study|Moved|0|||
105707593|NCT01995071|364590846|FG007|Overall Study|Moved|0|||
105707594|NCT01995071|364590847|FG008|Overall Study|Moved|0|||
106007179|NCT00446849|365692180|FG000|Acute Phase|noncompliance|1|||
105927631|NCT04137887|365393428|FG000|Overall Study|Withdrawal by Subject|2|||
105927632|NCT04137887|365393429|FG001|Overall Study|Withdrawal by Subject|3|||
105707595|NCT01995071|364590848|FG009|Overall Study|Moved|0|||
105707596|NCT01995071|364590849|FG010|Overall Study|Moved|1|||
105707597|NCT01995071|364590850|FG011|Overall Study|Moved|0|||
105707598|NCT01995071|364590839|FG000|Overall Study|Lost to Follow-up|1|||
105707599|NCT01995071|364590840|FG001|Overall Study|Lost to Follow-up|0|||
105707600|NCT01995071|364590841|FG002|Overall Study|Lost to Follow-up|0|||
105707601|NCT01995071|364590842|FG003|Overall Study|Lost to Follow-up|0|||
105707602|NCT01995071|364590843|FG004|Overall Study|Lost to Follow-up|0|||
105707603|NCT01995071|364590844|FG005|Overall Study|Lost to Follow-up|0|||
105707604|NCT01995071|364590845|FG006|Overall Study|Lost to Follow-up|0|||
105707605|NCT01995071|364590846|FG007|Overall Study|Lost to Follow-up|1|||
105707606|NCT01995071|364590847|FG008|Overall Study|Lost to Follow-up|1|||
105707607|NCT01995071|364590848|FG009|Overall Study|Lost to Follow-up|0|||
105707608|NCT01995071|364590849|FG010|Overall Study|Lost to Follow-up|0|||
105707609|NCT01995071|364590850|FG011|Overall Study|Lost to Follow-up|0|||
105707610|NCT01995071|364590839|FG000|Overall Study|Incarcerated|0|||
105707611|NCT01995071|364590840|FG001|Overall Study|Incarcerated|0|||
105707612|NCT01995071|364590841|FG002|Overall Study|Incarcerated|0|||
105707613|NCT01995071|364590842|FG003|Overall Study|Incarcerated|0|||
105707614|NCT01995071|364590843|FG004|Overall Study|Incarcerated|0|||
105707615|NCT01995071|364590844|FG005|Overall Study|Incarcerated|0|||
105707616|NCT01995071|364590845|FG006|Overall Study|Incarcerated|0|||
105707617|NCT01995071|364590846|FG007|Overall Study|Incarcerated|1|||
105707618|NCT01995071|364590847|FG008|Overall Study|Incarcerated|0|||
105707619|NCT01995071|364590848|FG009|Overall Study|Incarcerated|0|||
105707620|NCT01995071|364590849|FG010|Overall Study|Incarcerated|0|||
105707621|NCT01995071|364590850|FG011|Overall Study|Incarcerated|0|||
105707622|NCT04541004|364590856|FG000|Overall Study|Adverse Event|2|||
105707623|NCT00621504|364590858|FG000|Overall Study|Adverse Event|1|||
105707624|NCT00621504|364590859|FG001|Overall Study|Adverse Event|3|||
105707625|NCT00621504|364590858|FG000|Overall Study|At the request of sponsor/investigator|1|||
105707626|NCT00621504|364590859|FG001|Overall Study|At the request of sponsor/investigator|0|||
105707627|NCT00621504|364590858|FG000|Overall Study|Withdrew consent|9|||
105707628|NCT00621504|364590859|FG001|Overall Study|Withdrew consent|6|||
105707629|NCT00621504|364590858|FG000|Overall Study|Lost to Follow-up|8|||
105707630|NCT00621504|364590859|FG001|Overall Study|Lost to Follow-up|10|||
105707631|NCT00621504|364590858|FG000|Overall Study|Other|1|||
105707632|NCT00621504|364590859|FG001|Overall Study|Other|0|||
105707633|NCT00621504|364590858|FG000|Overall Study|Death|6|||
105707634|NCT00621504|364590859|FG001|Overall Study|Death|6|||
105707635|NCT04429061|364590861|FG000|Overall Study|Lost to Follow-up|62|||
105707636|NCT04429061|364590862|FG001|Overall Study|Lost to Follow-up|87|||
105707637|NCT04429061|364590861|FG000|Overall Study|Withdrawal by Subject|3|||
105707638|NCT04429061|364590862|FG001|Overall Study|Withdrawal by Subject|4|||
105707639|NCT01870401|364590871|FG000|Overall Study|Death|48|||
105707640|NCT01870401|364590872|FG001|Overall Study|Death|24|||
105707641|NCT01870401|364590871|FG000|Overall Study|Withdrawal by Subject|39|||
105707642|NCT01870401|364590872|FG001|Overall Study|Withdrawal by Subject|26|||
105707643|NCT01870401|364590871|FG000|Overall Study|Lost to Follow-up|19|||
105707644|NCT01870401|364590872|FG001|Overall Study|Lost to Follow-up|14|||
105707645|NCT01870401|364590871|FG000|Overall Study|Other|9|||
105707646|NCT01870401|364590872|FG001|Overall Study|Other|7|||
105707647|NCT01870401|364590871|FG000|Overall Study|On-going in the Study|35|||
105707648|NCT01870401|364590872|FG001|Overall Study|On-going in the Study|25|||
105707649|NCT02363686|364590875|FG000|Overall Study|Withdrawal by Subject|22|||
105707650|NCT02363686|364590875|FG000|Overall Study|incomplete FEES examinations|13|||
105707651|NCT00957008|364590879|FG000|Overall Study|Withdrawal by Subject|13|||
105707652|NCT00957008|364590880|FG001|Overall Study|Withdrawal by Subject|10|||
105707653|NCT00957008|364590881|FG002|Overall Study|Withdrawal by Subject|12|||
105707654|NCT00957008|364590882|FG003|Overall Study|Withdrawal by Subject|16|||
105707655|NCT00957008|364590879|FG000|Overall Study|Lost to Follow-up|3|||
105707656|NCT00957008|364590880|FG001|Overall Study|Lost to Follow-up|1|||
105707657|NCT00957008|364590881|FG002|Overall Study|Lost to Follow-up|3|||
105707658|NCT00957008|364590882|FG003|Overall Study|Lost to Follow-up|4|||
105707659|NCT00957008|364590879|FG000|Overall Study|Physician Decision|1|||
105707660|NCT00957008|364590880|FG001|Overall Study|Physician Decision|0|||
105707661|NCT00957008|364590881|FG002|Overall Study|Physician Decision|1|||
105707662|NCT00957008|364590882|FG003|Overall Study|Physician Decision|1|||
105707663|NCT00957008|364590879|FG000|Overall Study|Relocated; Family conflict|4|||
105707664|NCT00957008|364590880|FG001|Overall Study|Relocated; Family conflict|1|||
105707665|NCT00957008|364590881|FG002|Overall Study|Relocated; Family conflict|1|||
105707666|NCT00957008|364590882|FG003|Overall Study|Relocated; Family conflict|3|||
105707667|NCT03509350|364590889|FG000|Overall Study|Withdrawal by Subject|0|||
105707668|NCT03509350|364590890|FG001|Overall Study|Withdrawal by Subject|2|||
105707669|NCT01425203|364590891|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
105707670|NCT01425203|364590892|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
105707671|NCT01425203|364590893|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
105707672|NCT01425203|364590891|FG000|Treatment Phase|Failure at futility timepoint|8|||
105707673|NCT01425203|364590892|FG001|Treatment Phase|Failure at futility timepoint|27|||
105707674|NCT01425203|364590893|FG002|Treatment Phase|Failure at futility timepoint|0|||
105707675|NCT01425203|364590891|FG000|Treatment Phase|Other virologic failure criteria|5|||
105707676|NCT01425203|364590892|FG001|Treatment Phase|Other virologic failure criteria|3|||
105707677|NCT01425203|364590893|FG002|Treatment Phase|Other virologic failure criteria|0|||
105707678|NCT01425203|364590891|FG000|Treatment Phase|Unidentified reasons|11|||
105707679|NCT01425203|364590892|FG001|Treatment Phase|Unidentified reasons|5|||
105707680|NCT01425203|364590893|FG002|Treatment Phase|Unidentified reasons|0|||
105707681|NCT01425203|364590891|FG000|Treatment Phase|Did not receive treatment|0|||
105707682|NCT01425203|364590892|FG001|Treatment Phase|Did not receive treatment|1|||
105707683|NCT01425203|364590893|FG002|Treatment Phase|Did not receive treatment|0|||
105707684|NCT01425203|364590891|FG000|Crossover Phase|Failure at futility timepoint|0|||
105707685|NCT01425203|364590892|FG001|Crossover Phase|Failure at futility timepoint|0|||
105707686|NCT01425203|364590893|FG002|Crossover Phase|Failure at futility timepoint|3|||
105707687|NCT01425203|364590891|FG000|Crossover Phase|Other virologic failure criteria|0|||
105707688|NCT01425203|364590892|FG001|Crossover Phase|Other virologic failure criteria|0|||
105707689|NCT01425203|364590893|FG002|Crossover Phase|Other virologic failure criteria|3|||
105707690|NCT01784861|364590900|FG000|Overall Study|Adverse Event|0|||
105707691|NCT01784861|364590901|FG001|Overall Study|Adverse Event|0|||
105707692|NCT01784861|364590902|FG002|Overall Study|Adverse Event|1|||
105707693|NCT01784861|364590903|FG003|Overall Study|Adverse Event|2|||
105707694|NCT01784861|364590904|FG004|Overall Study|Adverse Event|1|||
105707695|NCT01784861|364590905|FG005|Overall Study|Adverse Event|0|||
105707696|NCT01784861|364590900|FG000|Overall Study|Withdrawal by Subject|0|||
105707697|NCT01784861|364590901|FG001|Overall Study|Withdrawal by Subject|0|||
105707698|NCT01784861|364590902|FG002|Overall Study|Withdrawal by Subject|0|||
105707699|NCT01784861|364590903|FG003|Overall Study|Withdrawal by Subject|1|||
105707700|NCT01784861|364590904|FG004|Overall Study|Withdrawal by Subject|0|||
105707701|NCT01784861|364590905|FG005|Overall Study|Withdrawal by Subject|0|||
105707702|NCT01784861|364590900|FG000|Overall Study|Physician Decision|0|||
105707703|NCT01784861|364590901|FG001|Overall Study|Physician Decision|0|||
105707704|NCT01784861|364590902|FG002|Overall Study|Physician Decision|0|||
105707705|NCT01784861|364590903|FG003|Overall Study|Physician Decision|2|||
105707706|NCT01784861|364590904|FG004|Overall Study|Physician Decision|0|||
105707707|NCT01784861|364590905|FG005|Overall Study|Physician Decision|1|||
105707708|NCT00797732|364590909|FG000|Overall Study|Withdrawal by Subject|3|||
105707709|NCT00797732|364590910|FG001|Overall Study|Withdrawal by Subject|3|||
105707710|NCT00797732|364590911|FG002|Overall Study|Withdrawal by Subject|0|||
105707711|NCT00797732|364590909|FG000|Overall Study|Lost to Follow-up|1|||
105707712|NCT00797732|364590910|FG001|Overall Study|Lost to Follow-up|0|||
105707713|NCT00797732|364590911|FG002|Overall Study|Lost to Follow-up|0|||
105707714|NCT00797732|364590909|FG000|Overall Study|Death|1|||
105707715|NCT00797732|364590910|FG001|Overall Study|Death|0|||
105707716|NCT00797732|364590911|FG002|Overall Study|Death|0|||
105707717|NCT00797732|364590909|FG000|Overall Study|Not meet inclusion criteria|0|||
105707718|NCT00797732|364590910|FG001|Overall Study|Not meet inclusion criteria|0|||
105707719|NCT00797732|364590911|FG002|Overall Study|Not meet inclusion criteria|7|||
105707720|NCT00797732|364590909|FG000|Overall Study|Excluded due to time constraints|0|||
105707721|NCT00797732|364590910|FG001|Overall Study|Excluded due to time constraints|0|||
105707722|NCT00797732|364590911|FG002|Overall Study|Excluded due to time constraints|24|||
105707723|NCT00797732|364590909|FG000|Overall Study|Refused to Participate|0|||
105707724|NCT00797732|364590910|FG001|Overall Study|Refused to Participate|0|||
105707725|NCT00797732|364590911|FG002|Overall Study|Refused to Participate|123|||
105707726|NCT02250274|364590925|FG000|Overall Study|Insufficient blood draw amount|7|||
105707727|NCT02250274|364590926|FG001|Overall Study|Insufficient blood draw amount|6|||
105707728|NCT01627899|364590931|FG000|Overall Study|Study terminated early by sponsor.|5|||
105707729|NCT00271817|364590937|FG000|Part 1|Adverse Event|68|||
105707730|NCT00271817|364590938|FG001|Part 1|Adverse Event|25|||
105707731|NCT00271817|364590939|FG002|Part 1|Adverse Event|156|||
105707732|NCT00271817|364590937|FG000|Part 1|Lost to Follow-up|6|||
105707733|NCT00271817|364590938|FG001|Part 1|Lost to Follow-up|8|||
105707734|NCT00271817|364590939|FG002|Part 1|Lost to Follow-up|24|||
105707735|NCT00271817|364590937|FG000|Part 1|Protocol Violation|5|||
105707736|NCT00271817|364590938|FG001|Part 1|Protocol Violation|4|||
105707737|NCT00271817|364590939|FG002|Part 1|Protocol Violation|7|||
105707738|NCT00271817|364590937|FG000|Part 1|Patient Moved|3|||
105707739|NCT00271817|364590938|FG001|Part 1|Patient Moved|1|||
105707740|NCT00271817|364590939|FG002|Part 1|Patient Moved|5|||
105707741|NCT00271817|364590937|FG000|Part 1|Withdrawal by Subject|23|||
105707742|NCT00271817|364590938|FG001|Part 1|Withdrawal by Subject|17|||
105707743|NCT00271817|364590939|FG002|Part 1|Withdrawal by Subject|45|||
105707744|NCT00271817|364590937|FG000|Part 1|LDL < 50 mg/dL|1|||
105707745|NCT00271817|364590938|FG001|Part 1|LDL < 50 mg/dL|4|||
105707746|NCT00271817|364590939|FG002|Part 1|LDL < 50 mg/dL|48|||
105707747|NCT00271817|364590937|FG000|Part 2|Adverse Event|0|||
105707748|NCT00271817|364590938|FG001|Part 2|Adverse Event|17|||
105707749|NCT00271817|364590939|FG002|Part 2|Adverse Event|33|||
105707750|NCT00271817|364590937|FG000|Part 2|Lack of Efficacy|0|||
105707751|NCT00271817|364590938|FG001|Part 2|Lack of Efficacy|1|||
105707752|NCT00271817|364590939|FG002|Part 2|Lack of Efficacy|6|||
105707753|NCT00271817|364590937|FG000|Part 2|Lost to Follow-up|0|||
105707754|NCT00271817|364590938|FG001|Part 2|Lost to Follow-up|6|||
105707755|NCT00271817|364590939|FG002|Part 2|Lost to Follow-up|18|||
105707756|NCT00271817|364590937|FG000|Part 2|Protocol Violation|0|||
105707757|NCT00271817|364590938|FG001|Part 2|Protocol Violation|3|||
105707758|NCT00271817|364590939|FG002|Part 2|Protocol Violation|5|||
105707759|NCT00271817|364590937|FG000|Part 2|Patient Moved|0|||
105707760|NCT00271817|364590938|FG001|Part 2|Patient Moved|0|||
105707761|NCT00271817|364590939|FG002|Part 2|Patient Moved|5|||
105707762|NCT00271817|364590937|FG000|Part 2|Withdrawal by Subject|0|||
105707763|NCT00271817|364590938|FG001|Part 2|Withdrawal by Subject|2|||
105707764|NCT00271817|364590939|FG002|Part 2|Withdrawal by Subject|13|||
105707765|NCT00271817|364590937|FG000|Part 2|LDL < 50 mg/dL|0|||
105707766|NCT00271817|364590938|FG001|Part 2|LDL < 50 mg/dL|3|||
105707767|NCT00271817|364590939|FG002|Part 2|LDL < 50 mg/dL|4|||
105707768|NCT01471782|364590942|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
105707769|NCT01471782|364590943|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
105707770|NCT01471782|364590944|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
105707771|NCT01471782|364590945|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
105707772|NCT01471782|364590946|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
105707773|NCT01471782|364590947|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
105707774|NCT01471782|364590942|FG000|Overall Study|Lack of Efficacy|1|||
105707775|NCT01471782|364590943|FG001|Overall Study|Lack of Efficacy|2|||
105707776|NCT01471782|364590944|FG002|Overall Study|Lack of Efficacy|1|||
105707777|NCT01471782|364590945|FG003|Overall Study|Lack of Efficacy|1|||
105707778|NCT01471782|364590946|FG004|Overall Study|Lack of Efficacy|5|||
105707779|NCT01471782|364590947|FG005|Overall Study|Lack of Efficacy|18|||
105707780|NCT01471782|364590942|FG000|Overall Study|Adverse Event|1|||
105707781|NCT01471782|364590943|FG001|Overall Study|Adverse Event|1|||
105707782|NCT01471782|364590944|FG002|Overall Study|Adverse Event|2|||
105707783|NCT01471782|364590945|FG003|Overall Study|Adverse Event|2|||
105707784|NCT01471782|364590946|FG004|Overall Study|Adverse Event|3|||
105707785|NCT01471782|364590947|FG005|Overall Study|Adverse Event|1|||
105707786|NCT01471782|364590942|FG000|Overall Study|Other|0|||
105707787|NCT01471782|364590943|FG001|Overall Study|Other|0|||
105707788|NCT01471782|364590944|FG002|Overall Study|Other|1|||
105707789|NCT01471782|364590945|FG003|Overall Study|Other|1|||
105707790|NCT01471782|364590946|FG004|Overall Study|Other|6|||
105707791|NCT01471782|364590947|FG005|Overall Study|Other|5|||
105707792|NCT01471782|364590942|FG000|Overall Study|Change of Chemotherapy|1|||
105707793|NCT01471782|364590943|FG001|Overall Study|Change of Chemotherapy|1|||
105707794|NCT01471782|364590944|FG002|Overall Study|Change of Chemotherapy|0|||
105707795|NCT01471782|364590945|FG003|Overall Study|Change of Chemotherapy|0|||
105707796|NCT01471782|364590946|FG004|Overall Study|Change of Chemotherapy|1|||
105927633|NCT04137887|365393428|FG000|Overall Study|Randomized but not treated|0|||
105927634|NCT04137887|365393429|FG001|Overall Study|Randomized but not treated|1|||
105927635|NCT00313170|365393431|FG000|Overall Study|Death|2|||
105927636|NCT00313170|365393432|FG001|Overall Study|Death|4|||
105927637|NCT00313170|365393433|FG002|Overall Study|Death|2|||
105707797|NCT01471782|364590947|FG005|Overall Study|Change of Chemotherapy|4|||
105707798|NCT01471782|364590942|FG000|Overall Study|Disease Relapse|0|||
105707799|NCT01471782|364590943|FG001|Overall Study|Disease Relapse|0|||
105707800|NCT01471782|364590944|FG002|Overall Study|Disease Relapse|0|||
105707801|NCT01471782|364590945|FG003|Overall Study|Disease Relapse|1|||
105707802|NCT01471782|364590946|FG004|Overall Study|Disease Relapse|2|||
105707803|NCT01471782|364590947|FG005|Overall Study|Disease Relapse|1|||
105707804|NCT01471782|364590942|FG000|Overall Study|Physician Decision|0|||
105707805|NCT01471782|364590943|FG001|Overall Study|Physician Decision|0|||
105707806|NCT01471782|364590944|FG002|Overall Study|Physician Decision|0|||
105707807|NCT01471782|364590945|FG003|Overall Study|Physician Decision|0|||
105707808|NCT01471782|364590946|FG004|Overall Study|Physician Decision|3|||
105707809|NCT01471782|364590947|FG005|Overall Study|Physician Decision|8|||
105707810|NCT01471782|364590942|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105707811|NCT01471782|364590943|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105707812|NCT01471782|364590944|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105927638|NCT00313170|365393431|FG000|Overall Study|Adverse Event|1|||
105927639|NCT00313170|365393432|FG001|Overall Study|Adverse Event|2|||
105927640|NCT00313170|365393433|FG002|Overall Study|Adverse Event|0|||
105927641|NCT00313170|365393431|FG000|Overall Study|Disease progression|31|||
105927642|NCT00313170|365393432|FG001|Overall Study|Disease progression|26|||
105927643|NCT00313170|365393433|FG002|Overall Study|Disease progression|27|||
105927644|NCT00313170|365393431|FG000|Overall Study|Withdrawal by Subject|1|||
105707813|NCT01471782|364590945|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105707814|NCT01471782|364590946|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
105707815|NCT01471782|364590947|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
105707816|NCT01471782|364590942|FG000|Overall Study|Death|0|||
105707817|NCT01471782|364590943|FG001|Overall Study|Death|0|||
105707818|NCT01471782|364590944|FG002|Overall Study|Death|0|||
105707819|NCT01471782|364590945|FG003|Overall Study|Death|0|||
105707820|NCT01471782|364590946|FG004|Overall Study|Death|0|||
105707821|NCT01471782|364590947|FG005|Overall Study|Death|1|||
105707822|NCT01425008|364590948|FG000|Dose Escalation Phase|Progressive Disease|2|||
105707823|NCT01425008|364590949|FG001|Dose Escalation Phase|Progressive Disease|3|||
105707824|NCT01425008|364590950|FG002|Dose Escalation Phase|Progressive Disease|2|||
105707825|NCT01425008|364590951|FG003|Dose Escalation Phase|Progressive Disease|3|||
105707826|NCT01425008|364590952|FG004|Dose Escalation Phase|Progressive Disease|5|||
105707827|NCT01425008|364590953|FG005|Dose Escalation Phase|Progressive Disease|4|||
105707828|NCT01425008|364590954|FG006|Dose Escalation Phase|Progressive Disease|0|||
105707829|NCT01425008|364590955|FG007|Dose Escalation Phase|Progressive Disease|2|||
105707830|NCT01425008|364590956|FG008|Dose Escalation Phase|Progressive Disease|6|||
105707831|NCT01425008|364590957|FG009|Dose Escalation Phase|Progressive Disease|2|||
105707832|NCT01425008|364590958|FG010|Dose Escalation Phase|Progressive Disease|0|||
105707833|NCT01425008|364590959|FG011|Dose Escalation Phase|Progressive Disease|0|||
105707834|NCT01425008|364590960|FG012|Dose Escalation Phase|Progressive Disease|0|||
105707835|NCT01425008|364590961|FG013|Dose Escalation Phase|Progressive Disease|0|||
105707836|NCT01425008|364590962|FG014|Dose Escalation Phase|Progressive Disease|0|||
105707837|NCT01425008|364590963|FG015|Dose Escalation Phase|Progressive Disease|0|||
105707838|NCT01425008|364590964|FG016|Dose Escalation Phase|Progressive Disease|0|||
105707839|NCT01425008|364590965|FG017|Dose Escalation Phase|Progressive Disease|0|||
105707840|NCT01425008|364590966|FG018|Dose Escalation Phase|Progressive Disease|0|||
105707841|NCT01425008|364590948|FG000|Dose Escalation Phase|Adverse Event|2|||
105707842|NCT01425008|364590949|FG001|Dose Escalation Phase|Adverse Event|0|||
105707843|NCT01425008|364590950|FG002|Dose Escalation Phase|Adverse Event|0|||
105707844|NCT01425008|364590951|FG003|Dose Escalation Phase|Adverse Event|0|||
105707845|NCT01425008|364590952|FG004|Dose Escalation Phase|Adverse Event|0|||
105707846|NCT01425008|364590953|FG005|Dose Escalation Phase|Adverse Event|2|||
105707847|NCT01425008|364590954|FG006|Dose Escalation Phase|Adverse Event|0|||
105707848|NCT01425008|364590955|FG007|Dose Escalation Phase|Adverse Event|0|||
105707849|NCT01425008|364590956|FG008|Dose Escalation Phase|Adverse Event|2|||
105707850|NCT01425008|364590957|FG009|Dose Escalation Phase|Adverse Event|0|||
105707851|NCT01425008|364590958|FG010|Dose Escalation Phase|Adverse Event|0|||
105707852|NCT01425008|364590959|FG011|Dose Escalation Phase|Adverse Event|0|||
105707853|NCT01425008|364590960|FG012|Dose Escalation Phase|Adverse Event|0|||
105707854|NCT01425008|364590961|FG013|Dose Escalation Phase|Adverse Event|0|||
105707855|NCT01425008|364590962|FG014|Dose Escalation Phase|Adverse Event|0|||
105707856|NCT01425008|364590963|FG015|Dose Escalation Phase|Adverse Event|0|||
105707857|NCT01425008|364590964|FG016|Dose Escalation Phase|Adverse Event|0|||
105707858|NCT01425008|364590965|FG017|Dose Escalation Phase|Adverse Event|0|||
105707859|NCT01425008|364590966|FG018|Dose Escalation Phase|Adverse Event|0|||
105707860|NCT01425008|364590948|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707861|NCT01425008|364590949|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707862|NCT01425008|364590950|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707863|NCT01425008|364590951|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707864|NCT01425008|364590952|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
105707865|NCT01425008|364590953|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707866|NCT01425008|364590954|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
105707867|NCT01425008|364590955|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
105707868|NCT01425008|364590956|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
105707869|NCT01425008|364590957|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707870|NCT01425008|364590958|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707871|NCT01425008|364590959|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707872|NCT01425008|364590960|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105927645|NCT00313170|365393432|FG001|Overall Study|Withdrawal by Subject|0|||
105927646|NCT00313170|365393433|FG002|Overall Study|Withdrawal by Subject|1|||
105927647|NCT00313170|365393431|FG000|Overall Study|Incorrect enrollment|0|||
105927648|NCT00313170|365393432|FG001|Overall Study|Incorrect enrollment|2|||
105927649|NCT00313170|365393433|FG002|Overall Study|Incorrect enrollment|1|||
105927650|NCT00313170|365393431|FG000|Overall Study|Lost to Follow-up|0|||
105707873|NCT01425008|364590961|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105927651|NCT00313170|365393432|FG001|Overall Study|Lost to Follow-up|0|||
106133836|NCT00783692|366148195|FG004|Maintenance Phase|Other|0|||
105707874|NCT01425008|364590962|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707875|NCT01425008|364590963|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707876|NCT01425008|364590964|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707877|NCT01425008|364590965|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707878|NCT01425008|364590966|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
105707879|NCT01425008|364590948|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
105707880|NCT01425008|364590949|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
105927652|NCT00313170|365393433|FG002|Overall Study|Lost to Follow-up|1|||
105927653|NCT00313170|365393431|FG000|Overall Study|Progression (investigators opinion)|1|||
105927654|NCT00313170|365393432|FG001|Overall Study|Progression (investigators opinion)|0|||
105927655|NCT00313170|365393433|FG002|Overall Study|Progression (investigators opinion)|0|||
105927656|NCT00898807|365393443|FG000|Overall Study|Withdrawal by Subject|5|||
105927657|NCT00898807|365393444|FG001|Overall Study|Withdrawal by Subject|3|||
105927658|NCT00898807|365393443|FG000|Overall Study|Family pressure to discontinue|2|||
105707881|NCT01425008|364590950|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
105707882|NCT01425008|364590951|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105707883|NCT01425008|364590952|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
105707884|NCT01425008|364590953|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
105707885|NCT01425008|364590954|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
105707886|NCT01425008|364590955|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
105707887|NCT01425008|364590956|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
105707888|NCT01425008|364590957|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
105707889|NCT01425008|364590958|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
105707890|NCT01425008|364590959|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
105707891|NCT01425008|364590960|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
105707892|NCT01425008|364590961|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
105707893|NCT01425008|364590962|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
105707894|NCT01425008|364590963|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
105707895|NCT01425008|364590964|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
105707896|NCT01425008|364590965|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
105707897|NCT01425008|364590966|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
105707898|NCT01425008|364590948|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707899|NCT01425008|364590949|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707900|NCT01425008|364590950|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
105707901|NCT01425008|364590951|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707902|NCT01425008|364590952|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707903|NCT01425008|364590953|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707904|NCT01425008|364590954|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707905|NCT01425008|364590955|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707906|NCT01425008|364590956|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
105707907|NCT01425008|364590957|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
105707908|NCT01425008|364590958|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707909|NCT01425008|364590959|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707910|NCT01425008|364590960|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707911|NCT01425008|364590961|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707912|NCT01425008|364590962|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707913|NCT01425008|364590963|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707914|NCT01425008|364590964|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707915|NCT01425008|364590965|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707916|NCT01425008|364590966|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
105707917|NCT01425008|364590948|FG000|Dose Escalation Phase|Other|0|||
105707918|NCT01425008|364590949|FG001|Dose Escalation Phase|Other|0|||
105707919|NCT01425008|364590950|FG002|Dose Escalation Phase|Other|0|||
105707920|NCT01425008|364590951|FG003|Dose Escalation Phase|Other|0|||
105707921|NCT01425008|364590952|FG004|Dose Escalation Phase|Other|0|||
105707922|NCT01425008|364590953|FG005|Dose Escalation Phase|Other|0|||
105707923|NCT01425008|364590954|FG006|Dose Escalation Phase|Other|0|||
105707924|NCT01425008|364590955|FG007|Dose Escalation Phase|Other|0|||
105707925|NCT01425008|364590956|FG008|Dose Escalation Phase|Other|1|||
105707926|NCT01425008|364590957|FG009|Dose Escalation Phase|Other|0|||
105707927|NCT01425008|364590958|FG010|Dose Escalation Phase|Other|0|||
105707928|NCT01425008|364590959|FG011|Dose Escalation Phase|Other|0|||
105707929|NCT01425008|364590960|FG012|Dose Escalation Phase|Other|0|||
105707930|NCT01425008|364590961|FG013|Dose Escalation Phase|Other|0|||
105707931|NCT01425008|364590962|FG014|Dose Escalation Phase|Other|0|||
105707932|NCT01425008|364590963|FG015|Dose Escalation Phase|Other|0|||
105707933|NCT01425008|364590964|FG016|Dose Escalation Phase|Other|0|||
105707934|NCT01425008|364590965|FG017|Dose Escalation Phase|Other|0|||
105707935|NCT01425008|364590966|FG018|Dose Escalation Phase|Other|0|||
105707936|NCT01425008|364590948|FG000|Dose Expansion Phase|Progressive Disease|0|||
105707937|NCT01425008|364590949|FG001|Dose Expansion Phase|Progressive Disease|0|||
105707938|NCT01425008|364590950|FG002|Dose Expansion Phase|Progressive Disease|0|||
105707939|NCT01425008|364590951|FG003|Dose Expansion Phase|Progressive Disease|0|||
105707940|NCT01425008|364590952|FG004|Dose Expansion Phase|Progressive Disease|0|||
105707941|NCT01425008|364590953|FG005|Dose Expansion Phase|Progressive Disease|0|||
105707942|NCT01425008|364590954|FG006|Dose Expansion Phase|Progressive Disease|0|||
105707943|NCT01425008|364590955|FG007|Dose Expansion Phase|Progressive Disease|0|||
105707944|NCT01425008|364590956|FG008|Dose Expansion Phase|Progressive Disease|0|||
105707945|NCT01425008|364590957|FG009|Dose Expansion Phase|Progressive Disease|0|||
105707946|NCT01425008|364590958|FG010|Dose Expansion Phase|Progressive Disease|10|||
105927659|NCT00898807|365393444|FG001|Overall Study|Family pressure to discontinue|2|||
105927660|NCT00898807|365393443|FG000|Overall Study|Lost to Follow-up|1|||
105927661|NCT00898807|365393444|FG001|Overall Study|Lost to Follow-up|3|||
105707947|NCT01425008|364590959|FG011|Dose Expansion Phase|Progressive Disease|4|||
105707948|NCT01425008|364590960|FG012|Dose Expansion Phase|Progressive Disease|12|||
105707949|NCT01425008|364590961|FG013|Dose Expansion Phase|Progressive Disease|1|||
105707950|NCT01425008|364590962|FG014|Dose Expansion Phase|Progressive Disease|5|||
105707951|NCT01425008|364590963|FG015|Dose Expansion Phase|Progressive Disease|8|||
105707952|NCT01425008|364590964|FG016|Dose Expansion Phase|Progressive Disease|9|||
105707953|NCT01425008|364590965|FG017|Dose Expansion Phase|Progressive Disease|2|||
105707954|NCT01425008|364590966|FG018|Dose Expansion Phase|Progressive Disease|10|||
105707955|NCT01425008|364590948|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
105707956|NCT01425008|364590949|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
105707957|NCT01425008|364590950|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
105707958|NCT01425008|364590951|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
105707959|NCT01425008|364590952|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
105707960|NCT01425008|364590953|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
105707961|NCT01425008|364590954|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
105707962|NCT01425008|364590955|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
105707963|NCT01425008|364590956|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
105707964|NCT01425008|364590957|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
105707965|NCT01425008|364590958|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
105707966|NCT01425008|364590959|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
105707967|NCT01425008|364590960|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
105707968|NCT01425008|364590961|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
105707969|NCT01425008|364590962|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
105707970|NCT01425008|364590963|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
105707971|NCT01425008|364590964|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
105707972|NCT01425008|364590965|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
105707973|NCT01425008|364590966|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
105707974|NCT01425008|364590948|FG000|Dose Expansion Phase|Other|0|||
105707975|NCT01425008|364590949|FG001|Dose Expansion Phase|Other|0|||
105707976|NCT01425008|364590950|FG002|Dose Expansion Phase|Other|0|||
105707977|NCT01425008|364590951|FG003|Dose Expansion Phase|Other|0|||
105707978|NCT01425008|364590952|FG004|Dose Expansion Phase|Other|0|||
105707979|NCT01425008|364590953|FG005|Dose Expansion Phase|Other|0|||
105707980|NCT01425008|364590954|FG006|Dose Expansion Phase|Other|0|||
105707981|NCT01425008|364590955|FG007|Dose Expansion Phase|Other|0|||
105707982|NCT01425008|364590956|FG008|Dose Expansion Phase|Other|0|||
105707983|NCT01425008|364590957|FG009|Dose Expansion Phase|Other|0|||
105707984|NCT01425008|364590958|FG010|Dose Expansion Phase|Other|0|||
105707985|NCT01425008|364590959|FG011|Dose Expansion Phase|Other|0|||
105707986|NCT01425008|364590960|FG012|Dose Expansion Phase|Other|1|||
105707987|NCT01425008|364590961|FG013|Dose Expansion Phase|Other|0|||
105707988|NCT01425008|364590962|FG014|Dose Expansion Phase|Other|0|||
105707989|NCT01425008|364590963|FG015|Dose Expansion Phase|Other|0|||
105707990|NCT01425008|364590964|FG016|Dose Expansion Phase|Other|2|||
105927662|NCT00898807|365393443|FG000|Overall Study|Death|0|||
105927663|NCT00898807|365393444|FG001|Overall Study|Death|1|||
105927664|NCT04398134|365393445|FG000|Overall Study|Adverse Event|0|||
105927665|NCT04398134|365393446|FG001|Overall Study|Adverse Event|0|||
105927666|NCT04398134|365393447|FG002|Overall Study|Adverse Event|1|||
105927667|NCT04398134|365393448|FG003|Overall Study|Adverse Event|0|||
105707991|NCT01425008|364590965|FG017|Dose Expansion Phase|Other|0|||
105707992|NCT01425008|364590966|FG018|Dose Expansion Phase|Other|4|||
105927668|NCT04398134|365393445|FG000|Overall Study|Withdrawal by Subject|2|||
105707993|NCT01425008|364590948|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707994|NCT01425008|364590949|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
105927669|NCT04398134|365393446|FG001|Overall Study|Withdrawal by Subject|0|||
105927670|NCT04398134|365393447|FG002|Overall Study|Withdrawal by Subject|0|||
105927671|NCT04398134|365393448|FG003|Overall Study|Withdrawal by Subject|1|||
105927672|NCT04398134|365393445|FG000|Overall Study|Study Terminated by Sponsor|30|||
105927673|NCT04398134|365393446|FG001|Overall Study|Study Terminated by Sponsor|11|||
105927674|NCT04398134|365393447|FG002|Overall Study|Study Terminated by Sponsor|32|||
105927675|NCT04398134|365393448|FG003|Overall Study|Study Terminated by Sponsor|11|||
105927676|NCT01334515|365393449|FG000|Overall Study|Adverse Event|1|||
105927677|NCT01334515|365393450|FG001|Overall Study|Adverse Event|6|||
105927678|NCT01334515|365393449|FG000|Overall Study|Death|1|||
105927679|NCT01334515|365393450|FG001|Overall Study|Death|0|||
105927680|NCT01334515|365393449|FG000|Overall Study|Lack of Efficacy|8|||
105927681|NCT01334515|365393450|FG001|Overall Study|Lack of Efficacy|21|||
105927682|NCT01334515|365393449|FG000|Overall Study|Physician Decision|1|||
105927683|NCT01334515|365393450|FG001|Overall Study|Physician Decision|1|||
105927684|NCT01334515|365393449|FG000|Overall Study|Withdrawal by Subject|1|||
105927685|NCT01334515|365393450|FG001|Overall Study|Withdrawal by Subject|1|||
105707995|NCT01425008|364590950|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707996|NCT01425008|364590951|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707997|NCT01425008|364590952|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707998|NCT01425008|364590953|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
105707999|NCT01425008|364590954|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708000|NCT01425008|364590955|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708001|NCT01425008|364590956|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708002|NCT01425008|364590957|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708003|NCT01425008|364590958|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
105708004|NCT01425008|364590959|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
105708005|NCT01425008|364590960|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708006|NCT01425008|364590961|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708007|NCT01425008|364590962|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708008|NCT01425008|364590963|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
105708009|NCT01425008|364590964|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
105708010|NCT01425008|364590965|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
105708011|NCT01425008|364590966|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
105708012|NCT01425008|364590948|FG000|Dose Expansion Phase|Adverse Event|0|||
105708013|NCT01425008|364590949|FG001|Dose Expansion Phase|Adverse Event|0|||
105708014|NCT01425008|364590950|FG002|Dose Expansion Phase|Adverse Event|0|||
105708015|NCT01425008|364590951|FG003|Dose Expansion Phase|Adverse Event|0|||
105708016|NCT01425008|364590952|FG004|Dose Expansion Phase|Adverse Event|0|||
105708017|NCT01425008|364590953|FG005|Dose Expansion Phase|Adverse Event|0|||
105708018|NCT01425008|364590954|FG006|Dose Expansion Phase|Adverse Event|0|||
105927686|NCT00221104|365393452|FG000|Overall Study|Adverse Event|1|||
105927687|NCT00221104|365393453|FG001|Overall Study|Adverse Event|0|||
105927688|NCT00221104|365393452|FG000|Overall Study|Physician Decision|1|||
105927689|NCT00221104|365393453|FG001|Overall Study|Physician Decision|0|||
105927690|NCT00221104|365393452|FG000|Overall Study|Protocol Violation|2|||
105927691|NCT00221104|365393453|FG001|Overall Study|Protocol Violation|0|||
105927692|NCT00221104|365393452|FG000|Overall Study|Withdrawal by Subject|42|||
105927693|NCT00221104|365393453|FG001|Overall Study|Withdrawal by Subject|29|||
105927694|NCT00221104|365393452|FG000|Overall Study|Others|37|||
105927695|NCT00221104|365393453|FG001|Overall Study|Others|47|||
105927696|NCT02691572|365393463|FG000|Overall Study|Withdrawal by Subject|1|||
105927697|NCT02691572|365393464|FG001|Overall Study|Withdrawal by Subject|0|||
105927698|NCT02691572|365393463|FG000|Overall Study|Protocol Violation|0|||
105927699|NCT02691572|365393464|FG001|Overall Study|Protocol Violation|1|||
105927700|NCT01860989|365393465|FG000|Overall Study|Unsatisfactory therapeutic|5|||
105927701|NCT00700635|365393468|FG000|Overall Study|Adverse Event|1|||
105927702|NCT00700635|365393469|FG001|Overall Study|Adverse Event|0|||
105927703|NCT00700635|365393470|FG002|Overall Study|Adverse Event|0|||
105927704|NCT00700635|365393468|FG000|Overall Study|Lost to Follow-up|1|||
105927705|NCT00700635|365393469|FG001|Overall Study|Lost to Follow-up|3|||
105927706|NCT00700635|365393470|FG002|Overall Study|Lost to Follow-up|0|||
105927707|NCT00700635|365393468|FG000|Overall Study|Protocol Violation|2|||
105927708|NCT00700635|365393469|FG001|Overall Study|Protocol Violation|2|||
105927709|NCT00700635|365393470|FG002|Overall Study|Protocol Violation|0|||
105927710|NCT00700635|365393468|FG000|Overall Study|Withdrawal by Subject|7|||
105927711|NCT00700635|365393469|FG001|Overall Study|Withdrawal by Subject|3|||
105927712|NCT00700635|365393470|FG002|Overall Study|Withdrawal by Subject|1|||
105927713|NCT01214720|365393473|FG000|Overall Study|Alive and still on treatment|34|||
105927714|NCT01214720|365393474|FG001|Overall Study|Alive and still on treatment|18|||
105927715|NCT01214720|365393473|FG000|Overall Study|Alive and in follow-up|45|||
105927716|NCT01214720|365393474|FG001|Overall Study|Alive and in follow-up|48|||
105927717|NCT01214720|365393473|FG000|Overall Study|Lost to Follow-up|6|||
105927718|NCT01214720|365393474|FG001|Overall Study|Lost to Follow-up|2|||
105927719|NCT02347787|365393475|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
105927720|NCT02347787|365393476|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
105927721|NCT02347787|365393475|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
105708019|NCT01425008|364590955|FG007|Dose Expansion Phase|Adverse Event|0|||
105708020|NCT01425008|364590956|FG008|Dose Expansion Phase|Adverse Event|0|||
105708021|NCT01425008|364590957|FG009|Dose Expansion Phase|Adverse Event|0|||
105708022|NCT01425008|364590958|FG010|Dose Expansion Phase|Adverse Event|2|||
105708023|NCT01425008|364590959|FG011|Dose Expansion Phase|Adverse Event|3|||
105708024|NCT01425008|364590960|FG012|Dose Expansion Phase|Adverse Event|3|||
105708025|NCT01425008|364590961|FG013|Dose Expansion Phase|Adverse Event|0|||
105708026|NCT01425008|364590962|FG014|Dose Expansion Phase|Adverse Event|1|||
105708027|NCT01425008|364590963|FG015|Dose Expansion Phase|Adverse Event|1|||
105708028|NCT01425008|364590964|FG016|Dose Expansion Phase|Adverse Event|5|||
105708029|NCT01425008|364590965|FG017|Dose Expansion Phase|Adverse Event|0|||
105708030|NCT01425008|364590966|FG018|Dose Expansion Phase|Adverse Event|3|||
105708031|NCT01425008|364590948|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
105708032|NCT01425008|364590949|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
105708033|NCT01425008|364590950|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
105708034|NCT01425008|364590951|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
105708035|NCT01425008|364590952|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
105708036|NCT01425008|364590953|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
105708037|NCT01425008|364590954|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
105708038|NCT01425008|364590955|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
105708039|NCT01425008|364590956|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
105708040|NCT01425008|364590957|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
105708041|NCT01425008|364590958|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
105708042|NCT01425008|364590959|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
105708043|NCT01425008|364590960|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
105708044|NCT01425008|364590961|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
105708045|NCT01425008|364590962|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
105708046|NCT01425008|364590963|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
105708047|NCT01425008|364590964|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
105708048|NCT01425008|364590965|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
105708049|NCT01425008|364590966|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
105708050|NCT01425008|364590948|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708051|NCT01425008|364590949|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708052|NCT01425008|364590950|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708053|NCT01425008|364590951|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708054|NCT01425008|364590952|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708055|NCT01425008|364590953|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708056|NCT01425008|364590954|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708057|NCT01425008|364590955|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708058|NCT01425008|364590956|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708059|NCT01425008|364590957|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708060|NCT01425008|364590958|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708061|NCT01425008|364590959|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708062|NCT01425008|364590960|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708063|NCT01425008|364590961|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105788045|NCT00437294|364878169|FG000|Overall Study|Sponsor Decision|8|||
105788046|NCT00437294|364878170|FG001|Overall Study|Sponsor Decision|9|||
106007180|NCT00446849|365692180|FG000|Maintenance Phase|Lack of Efficacy|40|||
106007181|NCT00446849|365692180|FG000|Maintenance Phase|Protocol Violation|7|||
106007182|NCT00446849|365692180|FG000|Maintenance Phase|Adverse Event|6|||
106007183|NCT00446849|365692180|FG000|Maintenance Phase|Consent withdrawn|5|||
106007184|NCT00446849|365692180|FG000|Maintenance Phase|Lost to Follow-up|3|||
106007185|NCT00446849|365692180|FG000|Maintenance Phase|Pregnancy|1|||
106007186|NCT00446849|365692180|FG000|Maintenance Phase|noncompliance|2|||
106007187|NCT00446849|365692180|FG000|Maintenance Phase|prohibited medication use|2|||
106007188|NCT00446849|365692180|FG000|Maintenance Phase|antibiotic use|1|||
106007189|NCT00446849|365692180|FG000|Maintenance Phase|study closure|1|||
106007190|NCT00446849|365692180|FG000|Maintenance Phase|hydrocodone use|1|||
106007191|NCT00446849|365692180|FG000|Maintenance Phase|concomitant medication use|1|||
106007192|NCT02443688|365692181|FG000|Overall Study|Adverse Event|2|||
106007193|NCT02443688|365692182|FG001|Overall Study|Adverse Event|3|||
106007194|NCT02443688|365692183|FG002|Overall Study|Adverse Event|2|||
106007195|NCT02443688|365692181|FG000|Overall Study|Lost to Follow-up|1|||
106007196|NCT02443688|365692182|FG001|Overall Study|Lost to Follow-up|0|||
105708064|NCT01425008|364590962|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708065|NCT01425008|364590963|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708066|NCT01425008|364590964|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708067|NCT01425008|364590965|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
105708068|NCT01425008|364590966|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
105708069|NCT00264238|364590968|FG000|Overall Study|Protocol Violation|1|||
105708070|NCT01314716|364590969|FG000|Double-Blind Phase|Randomized but not treated|1|||
106007197|NCT02443688|365692183|FG002|Overall Study|Lost to Follow-up|0|||
106007198|NCT02443688|365692181|FG000|Overall Study|Physician Decision|3|||
105708071|NCT01314716|364590970|FG001|Double-Blind Phase|Randomized but not treated|1|||
105708072|NCT01314716|364590969|FG000|Double-Blind Phase|Adverse Event|10|||
105708073|NCT01314716|364590970|FG001|Double-Blind Phase|Adverse Event|4|||
105708074|NCT01314716|364590969|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
105708075|NCT01314716|364590970|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
105708076|NCT01314716|364590969|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105708077|NCT01314716|364590970|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105708078|NCT01314716|364590969|FG000|Double-Blind Phase|Sponsor request|1|||
105708079|NCT01314716|364590970|FG001|Double-Blind Phase|Sponsor request|2|||
105708080|NCT01314716|364590969|FG000|Double-Blind Phase|Physician Decision|0|||
105708081|NCT01314716|364590970|FG001|Double-Blind Phase|Physician Decision|1|||
105708082|NCT01314716|364590969|FG000|Open-Label Phase|Adverse Event|4|||
105708083|NCT01314716|364590970|FG001|Open-Label Phase|Adverse Event|6|||
105708084|NCT01314716|364590969|FG000|Open-Label Phase|Withdrawal by Subject|1|||
105927722|NCT02347787|365393476|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
105708085|NCT01314716|364590970|FG001|Open-Label Phase|Withdrawal by Subject|2|||
105708086|NCT01314716|364590969|FG000|Open-Label Phase|Physician Decision|5|||
105708087|NCT01314716|364590970|FG001|Open-Label Phase|Physician Decision|4|||
105708088|NCT01411085|364590973|FG000|Overall Study|Physician Decision|1|||
105708089|NCT01411085|364590973|FG000|Overall Study|Protocol Violation|1|||
105708090|NCT01411085|364590973|FG000|Overall Study|Adverse Event|1|||
105708091|NCT00562588|364590974|FG000|Overall Study|Adverse Event|40|||
105708092|NCT00562588|364590975|FG001|Overall Study|Adverse Event|58|||
105708093|NCT00562588|364590974|FG000|Overall Study|Protocol Violation|30|||
105708094|NCT00562588|364590975|FG001|Overall Study|Protocol Violation|26|||
105708095|NCT00562588|364590974|FG000|Overall Study|Lost to Follow-up|12|||
105708096|NCT00562588|364590975|FG001|Overall Study|Lost to Follow-up|4|||
105708097|NCT00562588|364590974|FG000|Overall Study|Withdrawal by Subject|10|||
105708098|NCT00562588|364590975|FG001|Overall Study|Withdrawal by Subject|9|||
105708099|NCT00562588|364590974|FG000|Overall Study|Other|0|||
105708100|NCT00562588|364590975|FG001|Overall Study|Other|2|||
105708101|NCT03164616|364590976|FG000|Overall Study|Death|250|||
105708102|NCT03164616|364590977|FG001|Overall Study|Death|264|||
105708103|NCT03164616|364590978|FG002|Overall Study|Death|279|||
105708104|NCT03164616|364590976|FG000|Overall Study|Lost to Follow-up|2|||
105708105|NCT03164616|364590977|FG001|Overall Study|Lost to Follow-up|2|||
105708106|NCT03164616|364590978|FG002|Overall Study|Lost to Follow-up|2|||
105708107|NCT03164616|364590976|FG000|Overall Study|Withdrawal by Subject|6|||
105708108|NCT03164616|364590977|FG001|Overall Study|Withdrawal by Subject|7|||
105708109|NCT03164616|364590978|FG002|Overall Study|Withdrawal by Subject|16|||
105708110|NCT02193074|364590979|FG000|Overall Study|Withdrawal by Subject|1|||
105708111|NCT02193074|364590980|FG001|Overall Study|Withdrawal by Subject|2|||
105708112|NCT02193074|364590979|FG000|Overall Study|Adverse Event|16|||
105708113|NCT02193074|364590980|FG001|Overall Study|Adverse Event|13|||
105708114|NCT02926950|364590981|FG000|Overall Study|Adverse Event|4|||
105708115|NCT02926950|364590982|FG001|Overall Study|Adverse Event|6|||
105708116|NCT02926950|364590981|FG000|Overall Study|At the participant's own request|21|||
105708117|NCT02926950|364590982|FG001|Overall Study|At the participant's own request|25|||
105708118|NCT02926950|364590981|FG000|Overall Study|Reason not Specified|17|||
105708119|NCT02926950|364590982|FG001|Overall Study|Reason not Specified|9|||
105708120|NCT02926950|364590981|FG000|Overall Study|Lost to Follow-up|7|||
105708121|NCT02926950|364590982|FG001|Overall Study|Lost to Follow-up|8|||
105708122|NCT03124563|364590983|FG000|Overall Study|Lost to Follow-up|1|||
105708123|NCT03124563|364590984|FG001|Overall Study|Lost to Follow-up|1|||
105708124|NCT03124563|364590983|FG000|Overall Study|Withdrawal by Subject|1|||
105708125|NCT03124563|364590984|FG001|Overall Study|Withdrawal by Subject|1|||
105708126|NCT01823679|364592831|FG000|Overall Study|Death|1|||
105708127|NCT00477165|364592832|FG000|Overall Study|Adverse Event|7|||
105927723|NCT02347787|365393475|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
105927724|NCT02347787|365393476|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
105927725|NCT02347787|365393475|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
106007199|NCT02443688|365692182|FG001|Overall Study|Physician Decision|0|||
105708128|NCT00477165|364592833|FG001|Overall Study|Adverse Event|2|||
105708129|NCT04682405|364592835|FG000|Overall Study|Adverse Event|0|||
105708130|NCT04682405|364592836|FG001|Overall Study|Adverse Event|1|||
105708131|NCT05048719|364592839|FG000|Overall Study|Withdrawal by Subject|2|||
105708132|NCT05048719|364592840|FG001|Overall Study|Withdrawal by Subject|1|||
105708133|NCT05048719|364592841|FG002|Overall Study|Withdrawal by Subject|3|||
105708134|NCT05048719|364592842|FG003|Overall Study|Withdrawal by Subject|1|||
105708135|NCT05048719|364592843|FG004|Overall Study|Withdrawal by Subject|0|||
105708136|NCT05048719|364592844|FG005|Overall Study|Withdrawal by Subject|2|||
105708137|NCT05048719|364592845|FG006|Overall Study|Withdrawal by Subject|1|||
105708138|NCT05048719|364592846|FG007|Overall Study|Withdrawal by Subject|1|||
105708139|NCT05048719|364592847|FG008|Overall Study|Withdrawal by Subject|0|||
105708140|NCT05048719|364592839|FG000|Overall Study|Death|1|||
105708141|NCT05048719|364592840|FG001|Overall Study|Death|0|||
105708142|NCT05048719|364592841|FG002|Overall Study|Death|0|||
105708143|NCT05048719|364592842|FG003|Overall Study|Death|0|||
105927726|NCT02347787|365393476|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
105708144|NCT05048719|364592843|FG004|Overall Study|Death|0|||
105708145|NCT05048719|364592844|FG005|Overall Study|Death|0|||
105708146|NCT05048719|364592845|FG006|Overall Study|Death|0|||
105708147|NCT05048719|364592846|FG007|Overall Study|Death|0|||
105708148|NCT05048719|364592847|FG008|Overall Study|Death|0|||
105708149|NCT05048719|364592839|FG000|Overall Study|Adverse Event|0|||
105708150|NCT05048719|364592840|FG001|Overall Study|Adverse Event|1|||
105708151|NCT05048719|364592841|FG002|Overall Study|Adverse Event|2|||
105708152|NCT05048719|364592842|FG003|Overall Study|Adverse Event|0|||
105708153|NCT05048719|364592843|FG004|Overall Study|Adverse Event|1|||
105708154|NCT05048719|364592844|FG005|Overall Study|Adverse Event|0|||
105708155|NCT05048719|364592845|FG006|Overall Study|Adverse Event|0|||
105708156|NCT05048719|364592846|FG007|Overall Study|Adverse Event|0|||
105708157|NCT05048719|364592847|FG008|Overall Study|Adverse Event|0|||
105708158|NCT05048719|364592839|FG000|Overall Study|Lost to Follow-up|0|||
105927727|NCT00544882|365393489|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
105927728|NCT00544882|365393490|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
105927729|NCT00544882|365393491|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
105927730|NCT00544882|365393489|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
105927731|NCT00544882|365393490|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
105927732|NCT00544882|365393491|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
105927733|NCT00544882|365393489|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
105927734|NCT00544882|365393490|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
105927735|NCT00544882|365393491|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
105927736|NCT00544882|365393489|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
105927737|NCT00544882|365393490|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
105927738|NCT00544882|365393491|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
105927739|NCT00544882|365393489|FG000|Cycle 3: Follow-up|Noncompliance|0|||
105927740|NCT00544882|365393490|FG001|Cycle 3: Follow-up|Noncompliance|1|||
105927741|NCT00544882|365393491|FG002|Cycle 3: Follow-up|Noncompliance|0|||
105927742|NCT00544882|365393489|FG000|Cycle 3: Follow-up|Pregnancy|0|||
105927743|NCT00544882|365393490|FG001|Cycle 3: Follow-up|Pregnancy|1|||
105927744|NCT00544882|365393491|FG002|Cycle 3: Follow-up|Pregnancy|0|||
105927745|NCT01179399|365393494|FG000|Overall Study|Adverse Event|1|||
105927746|NCT01179399|365393494|FG000|Overall Study|Lack of Efficacy|30|||
105927747|NCT01179399|365393494|FG000|Overall Study|Withdrawal by Subject|1|||
105927748|NCT00690898|365395280|FG000|SCREENING|Screen failure|18|||
105927749|NCT00690898|365395280|FG000|TREATMENT|Adverse Event|3|||
105927750|NCT00690898|365395280|FG000|TREATMENT|Lack of Efficacy|18|||
105927751|NCT00690898|365395280|FG000|TREATMENT|Withdrawal by Subject|4|||
105927752|NCT00690898|365395280|FG000|TREATMENT|Other (not otherwise specified)|1|||
105927753|NCT00541229|365395281|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
105927754|NCT00541229|365395282|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
105927755|NCT00541229|365395283|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
105927756|NCT00541229|365395284|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
105927757|NCT00541229|365395285|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
105927758|NCT00541229|365395286|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
105927759|NCT00541229|365395281|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105927760|NCT00541229|365395282|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105927761|NCT00541229|365395283|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105927762|NCT00541229|365395284|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105927763|NCT00541229|365395285|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
105927764|NCT00541229|365395286|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
105927765|NCT00541229|365395281|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105927766|NCT00541229|365395282|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105927767|NCT00541229|365395283|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105927768|NCT00541229|365395284|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105927769|NCT00541229|365395285|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
105927770|NCT00541229|365395286|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
105927771|NCT00541229|365395281|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
105927772|NCT00541229|365395282|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
105927773|NCT00541229|365395283|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
105927774|NCT00541229|365395284|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
106133837|NCT00783692|366148196|FG005|Maintenance Phase|Other|1|||
105708159|NCT05048719|364592840|FG001|Overall Study|Lost to Follow-up|0|||
105708160|NCT05048719|364592841|FG002|Overall Study|Lost to Follow-up|1|||
105708161|NCT05048719|364592842|FG003|Overall Study|Lost to Follow-up|3|||
105708162|NCT05048719|364592843|FG004|Overall Study|Lost to Follow-up|1|||
105708163|NCT05048719|364592844|FG005|Overall Study|Lost to Follow-up|1|||
105708164|NCT05048719|364592845|FG006|Overall Study|Lost to Follow-up|1|||
105927775|NCT00541229|365395285|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
105927776|NCT00541229|365395286|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
105927777|NCT00541229|365395281|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
105927778|NCT00541229|365395282|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
105927779|NCT00541229|365395283|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
106133838|NCT00783692|366148197|FG006|Maintenance Phase|Other|1|||
106133839|NCT01096056|366148200|FG000|Overall Study|Lost to Follow-up|0|||
106133840|NCT01096056|366148201|FG001|Overall Study|Lost to Follow-up|1|||
106133841|NCT03717194|366148203|FG000|Overall Study|Withdrawal by Subject|2|||
106133842|NCT03717194|366148204|FG001|Overall Study|Withdrawal by Subject|4|||
106133843|NCT03717194|366148203|FG000|Overall Study|Adverse Event|1|||
106133844|NCT03717194|366148204|FG001|Overall Study|Adverse Event|1|||
106133845|NCT03563053|366148205|FG000|Overall Study|Withdrawal by Subject|17|||
106133846|NCT03563053|366148205|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
106133847|NCT03563053|366148205|FG000|Overall Study|Adverse Event|3|||
106133848|NCT03563053|366148205|FG000|Overall Study|Physician Decision|1|||
106133849|NCT03563053|366148205|FG000|Overall Study|study terminated by sponsor|71|||
106133850|NCT03677375|366148207|FG000|Overall Study|Incomplete procedure|8|||
106133851|NCT03677375|366148207|FG000|Overall Study|Adverse Event|3|||
106133852|NCT03677375|366148207|FG000|Overall Study|Physician Decision|1|||
106133853|NCT03824236|366148211|FG000|Overall Study|Lost to Follow-up|0|||
106133854|NCT03824236|366148212|FG001|Overall Study|Lost to Follow-up|0|||
106133855|NCT03824236|366148213|FG002|Overall Study|Lost to Follow-up|1|||
106133856|NCT01143077|366148216|FG000|Overall Study|Lack of Efficacy|0|||
106133857|NCT01143077|366148217|FG001|Overall Study|Lack of Efficacy|2|||
106133858|NCT01143077|366148218|FG002|Overall Study|Lack of Efficacy|1|||
106133859|NCT01143077|366148216|FG000|Overall Study|Adverse Event|5|||
106133860|NCT01143077|366148217|FG001|Overall Study|Adverse Event|6|||
106133861|NCT01143077|366148218|FG002|Overall Study|Adverse Event|5|||
106133862|NCT01143077|366148216|FG000|Overall Study|Lost to Follow-up|2|||
106133863|NCT01143077|366148217|FG001|Overall Study|Lost to Follow-up|3|||
106133864|NCT01143077|366148218|FG002|Overall Study|Lost to Follow-up|4|||
106133865|NCT01143077|366148216|FG000|Overall Study|Protocol Violation|2|||
106133866|NCT01143077|366148217|FG001|Overall Study|Protocol Violation|0|||
106133867|NCT01143077|366148218|FG002|Overall Study|Protocol Violation|0|||
106133868|NCT01143077|366148216|FG000|Overall Study|Withdrawal by Subject|4|||
106133869|NCT01143077|366148217|FG001|Overall Study|Withdrawal by Subject|3|||
106133870|NCT01143077|366148218|FG002|Overall Study|Withdrawal by Subject|3|||
106133871|NCT01143077|366148216|FG000|Overall Study|Non-compliance with study drug|0|||
106133872|NCT01143077|366148217|FG001|Overall Study|Non-compliance with study drug|1|||
106133873|NCT01143077|366148218|FG002|Overall Study|Non-compliance with study drug|1|||
106133874|NCT01143077|366148216|FG000|Overall Study|Administrative|1|||
106133875|NCT01143077|366148217|FG001|Overall Study|Administrative|0|||
106133876|NCT01143077|366148218|FG002|Overall Study|Administrative|0|||
106133877|NCT01143077|366148216|FG000|Overall Study|Principal Investigator Decision|2|||
106133878|NCT01143077|366148217|FG001|Overall Study|Principal Investigator Decision|0|||
106133879|NCT01143077|366148218|FG002|Overall Study|Principal Investigator Decision|1|||
106133880|NCT01333514|366148219|FG000|Overall Study|Withdrawal by Subject|1|||
106133881|NCT01333514|366148220|FG001|Overall Study|Withdrawal by Subject|0|||
106133882|NCT00836810|366148221|FG000|Overall Study|New diagnosis|1|||
106133883|NCT00836810|366148222|FG001|Overall Study|New diagnosis|0|||
106133884|NCT00389519|366148225|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
106133885|NCT00389519|366148226|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
106133886|NCT00389519|366148227|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
106133887|NCT00389519|366148228|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
106133888|NCT00389519|366148225|FG000|Placebo Run-In|Withdrawal by Subject|19|||
106133889|NCT00389519|366148226|FG001|Placebo Run-In|Withdrawal by Subject|0|||
106133890|NCT00389519|366148227|FG002|Placebo Run-In|Withdrawal by Subject|0|||
106133891|NCT00389519|366148228|FG003|Placebo Run-In|Withdrawal by Subject|0|||
106133892|NCT00389519|366148225|FG000|Placebo Run-In|Reason not specified|40|||
106133893|NCT00389519|366148226|FG001|Placebo Run-In|Reason not specified|0|||
106133894|NCT00389519|366148227|FG002|Placebo Run-In|Reason not specified|0|||
105708165|NCT05048719|364592846|FG007|Overall Study|Lost to Follow-up|1|||
105708166|NCT05048719|364592847|FG008|Overall Study|Lost to Follow-up|0|||
105708167|NCT05048719|364592839|FG000|Overall Study|Physician Decision|0|||
105708168|NCT05048719|364592840|FG001|Overall Study|Physician Decision|0|||
105708169|NCT05048719|364592841|FG002|Overall Study|Physician Decision|0|||
106133895|NCT00389519|366148228|FG003|Placebo Run-In|Reason not specified|0|||
106133896|NCT00389519|366148225|FG000|Randomized|Did not receive study drug|2|||
106133897|NCT00389519|366148226|FG001|Randomized|Did not receive study drug|0|||
106133898|NCT00389519|366148227|FG002|Randomized|Did not receive study drug|0|||
106133899|NCT00389519|366148228|FG003|Randomized|Did not receive study drug|0|||
106133900|NCT00389519|366148225|FG000|Treated|Adverse Event|1|||
106133901|NCT00389519|366148226|FG001|Treated|Adverse Event|0|||
106133902|NCT00389519|366148227|FG002|Treated|Adverse Event|0|||
105708170|NCT05048719|364592842|FG003|Overall Study|Physician Decision|0|||
106133903|NCT00389519|366148228|FG003|Treated|Adverse Event|2|||
106133904|NCT00389519|366148225|FG000|Treated|Reason not specified|1|||
106133905|NCT00389519|366148226|FG001|Treated|Reason not specified|1|||
106133906|NCT00389519|366148227|FG002|Treated|Reason not specified|0|||
106133907|NCT00389519|366148228|FG003|Treated|Reason not specified|2|||
106133908|NCT02040844|366148229|FG000|Overall Study|Adverse Event|0|||
105708171|NCT05048719|364592843|FG004|Overall Study|Physician Decision|0|||
105708172|NCT05048719|364592844|FG005|Overall Study|Physician Decision|0|||
105708173|NCT05048719|364592845|FG006|Overall Study|Physician Decision|0|||
105708174|NCT05048719|364592846|FG007|Overall Study|Physician Decision|1|||
105708175|NCT05048719|364592847|FG008|Overall Study|Physician Decision|1|||
105708176|NCT05048719|364592839|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
105708177|NCT05048719|364592840|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708178|NCT05048719|364592841|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708179|NCT05048719|364592842|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708180|NCT05048719|364592843|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708181|NCT05048719|364592844|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708182|NCT05048719|364592845|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708183|NCT05048719|364592846|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708184|NCT05048719|364592847|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
105708185|NCT05048719|364592839|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708186|NCT05048719|364592840|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
105708187|NCT05048719|364592841|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708188|NCT05048719|364592842|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708189|NCT05048719|364592843|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708190|NCT05048719|364592844|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708191|NCT05048719|364592845|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708192|NCT05048719|364592846|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708193|NCT05048719|364592847|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
105708194|NCT05048719|364592839|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708195|NCT05048719|364592840|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
105708196|NCT05048719|364592841|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708197|NCT05048719|364592842|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708198|NCT05048719|364592843|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708199|NCT05048719|364592844|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708200|NCT05048719|364592845|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708201|NCT05048719|364592846|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708202|NCT05048719|364592847|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
105708203|NCT05048719|364592839|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708204|NCT05048719|364592840|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708205|NCT05048719|364592841|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708206|NCT05048719|364592842|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
105708207|NCT05048719|364592843|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708208|NCT05048719|364592844|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708209|NCT05048719|364592845|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708210|NCT05048719|364592846|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708211|NCT05048719|364592847|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
105708212|NCT05048719|364592839|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708213|NCT05048719|364592840|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708214|NCT05048719|364592841|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708215|NCT05048719|364592842|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708216|NCT05048719|364592843|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708217|NCT05048719|364592844|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
105708218|NCT05048719|364592845|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708219|NCT05048719|364592846|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708220|NCT05048719|364592847|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
105708221|NCT01623271|364592848|FG000|Overall Study|Withdrawal by Subject|2|||
105708222|NCT00879229|364592849|FG000|Overall Study|Study terminated by Sponsor|13|||
105708223|NCT00879229|364592850|FG001|Overall Study|Study terminated by Sponsor|12|||
105927780|NCT00541229|365395284|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
105927781|NCT00541229|365395285|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
105927782|NCT00541229|365395286|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
105927783|NCT00541229|365395281|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
105927784|NCT00541229|365395282|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
105708224|NCT00879229|364592849|FG000|Overall Study|Death|4|||
105927785|NCT00541229|365395283|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
105927786|NCT00541229|365395284|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
106007200|NCT02443688|365692183|FG002|Overall Study|Physician Decision|1|||
106007201|NCT02443688|365692181|FG000|Overall Study|Pregnancy|0|||
106007202|NCT02443688|365692182|FG001|Overall Study|Pregnancy|0|||
106007203|NCT02443688|365692183|FG002|Overall Study|Pregnancy|1|||
106007204|NCT02443688|365692181|FG000|Overall Study|Withdrawal by Subject|3|||
106007205|NCT02443688|365692182|FG001|Overall Study|Withdrawal by Subject|3|||
106007206|NCT02443688|365692183|FG002|Overall Study|Withdrawal by Subject|4|||
106007207|NCT02443688|365692181|FG000|Overall Study|Non-compliance with study drug|1|||
106007208|NCT02443688|365692182|FG001|Overall Study|Non-compliance with study drug|2|||
106007209|NCT02443688|365692183|FG002|Overall Study|Non-compliance with study drug|4|||
106007210|NCT02443688|365692181|FG000|Overall Study|Sponsor Request|2|||
106007211|NCT02443688|365692182|FG001|Overall Study|Sponsor Request|1|||
106007212|NCT02443688|365692183|FG002|Overall Study|Sponsor Request|0|||
106007213|NCT01317472|365692186|FG000|Overall Study|Withdrawal by Subject|1|||
106007214|NCT01317472|365692187|FG001|Overall Study|Withdrawal by Subject|0|||
106007215|NCT01317472|365692186|FG000|Overall Study|Unrelated hospitalization|1|||
106007216|NCT01317472|365692187|FG001|Overall Study|Unrelated hospitalization|0|||
106007217|NCT01815918|365692188|FG000|Overall Study|Patient samples not analyzable|3|||
106007218|NCT01815918|365692189|FG001|Overall Study|Patient samples not analyzable|4|||
106007219|NCT01815918|365692188|FG000|Overall Study|Lack of Efficacy|15|||
106007220|NCT01815918|365692189|FG001|Overall Study|Lack of Efficacy|15|||
106007221|NCT05546476|365692191|FG000|Period 1: Part A|Adverse Event|2|||
106007222|NCT05546476|365692192|FG001|Period 1: Part A|Adverse Event|0|||
106007223|NCT05546476|365692193|FG002|Period 1: Part A|Adverse Event|0|||
106007224|NCT05546476|365692194|FG003|Period 1: Part A|Adverse Event|1|||
106007225|NCT05546476|365692191|FG000|Period 1: Part A|Death|4|||
106007226|NCT05546476|365692192|FG001|Period 1: Part A|Death|4|||
106007227|NCT05546476|365692193|FG002|Period 1: Part A|Death|5|||
106007228|NCT05546476|365692194|FG003|Period 1: Part A|Death|6|||
106007229|NCT05546476|365692191|FG000|Period 1: Part A|Lack of Efficacy|0|||
106007230|NCT05546476|365692192|FG001|Period 1: Part A|Lack of Efficacy|0|||
106007231|NCT05546476|365692193|FG002|Period 1: Part A|Lack of Efficacy|0|||
106007232|NCT05546476|365692194|FG003|Period 1: Part A|Lack of Efficacy|1|||
106007233|NCT05546476|365692191|FG000|Period 1: Part A|Lost to Follow-up|0|||
106007234|NCT05546476|365692192|FG001|Period 1: Part A|Lost to Follow-up|0|||
106007235|NCT05546476|365692193|FG002|Period 1: Part A|Lost to Follow-up|0|||
106007236|NCT05546476|365692194|FG003|Period 1: Part A|Lost to Follow-up|1|||
106007237|NCT05546476|365692191|FG000|Period 1: Part A|Physician Decision|1|||
106007238|NCT05546476|365692192|FG001|Period 1: Part A|Physician Decision|0|||
106007239|NCT05546476|365692193|FG002|Period 1: Part A|Physician Decision|0|||
106007240|NCT05546476|365692194|FG003|Period 1: Part A|Physician Decision|0|||
106007241|NCT05546476|365692191|FG000|Period 1: Part A|Progressive disease|3|||
106007242|NCT05546476|365692192|FG001|Period 1: Part A|Progressive disease|5|||
106007243|NCT05546476|365692193|FG002|Period 1: Part A|Progressive disease|0|||
106007244|NCT05546476|365692194|FG003|Period 1: Part A|Progressive disease|1|||
106007245|NCT05546476|365692191|FG000|Period 1: Part A|Withdrawal by Subject|1|||
106007246|NCT05546476|365692192|FG001|Period 1: Part A|Withdrawal by Subject|1|||
106007247|NCT05546476|365692193|FG002|Period 1: Part A|Withdrawal by Subject|1|||
106007248|NCT05546476|365692194|FG003|Period 1: Part A|Withdrawal by Subject|2|||
106007249|NCT05546476|365692191|FG000|Period 1: Part A|Global deterioration of health status|2|||
106007250|NCT05546476|365692192|FG001|Period 1: Part A|Global deterioration of health status|2|||
106007251|NCT05546476|365692193|FG002|Period 1: Part A|Global deterioration of health status|1|||
106007252|NCT05546476|365692194|FG003|Period 1: Part A|Global deterioration of health status|4|||
106007253|NCT05546476|365692191|FG000|Period 1: Part A|Other: Unspecified|0|||
106007254|NCT05546476|365692192|FG001|Period 1: Part A|Other: Unspecified|2|||
106007255|NCT05546476|365692193|FG002|Period 1: Part A|Other: Unspecified|0|||
106007256|NCT05546476|365692194|FG003|Period 1: Part A|Other: Unspecified|0|||
106007257|NCT05546476|365692191|FG000|Period 2: Part B|Ongoing|26|||
106007258|NCT05546476|365692192|FG001|Period 2: Part B|Ongoing|27|||
106007259|NCT05546476|365692193|FG002|Period 2: Part B|Ongoing|35|||
106007260|NCT05546476|365692194|FG003|Period 2: Part B|Ongoing|29|||
105708225|NCT00879229|364592850|FG001|Overall Study|Death|2|||
105708226|NCT00879229|364592849|FG000|Overall Study|Adverse Event|2|||
106007261|NCT02814916|365692197|FG000|Overall Study|Withdrawal of consent|0|||
106007262|NCT02814916|365692198|FG001|Overall Study|Withdrawal of consent|2|||
106007263|NCT02814916|365692199|FG002|Overall Study|Withdrawal of consent|0|||
106007264|NCT02814916|365692197|FG000|Overall Study|Lost to Follow-up|0|||
106007265|NCT02814916|365692198|FG001|Overall Study|Lost to Follow-up|1|||
106007266|NCT02814916|365692199|FG002|Overall Study|Lost to Follow-up|0|||
106007267|NCT02814916|365692197|FG000|Overall Study|Other, not specified|0|||
106007268|NCT02814916|365692198|FG001|Overall Study|Other, not specified|1|||
106007269|NCT02814916|365692199|FG002|Overall Study|Other, not specified|0|||
106007270|NCT04205812|365692202|FG000|Randomized Treatment Period|Ongoing|28|||
106007271|NCT04205812|365692203|FG001|Randomized Treatment Period|Ongoing|138|||
106007272|NCT04205812|365692202|FG000|Randomized Treatment Period|Death|94|||
106007273|NCT04205812|365692203|FG001|Randomized Treatment Period|Death|226|||
106007274|NCT04205812|365692202|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
106133909|NCT02040844|366148230|FG001|Overall Study|Adverse Event|0|||
106133910|NCT02040844|366148231|FG002|Overall Study|Adverse Event|1|||
105708227|NCT00879229|364592850|FG001|Overall Study|Adverse Event|0|||
105708228|NCT00879229|364592849|FG000|Overall Study|Withdrawal by Subject|1|||
105708229|NCT00879229|364592850|FG001|Overall Study|Withdrawal by Subject|0|||
105708230|NCT00879229|364592849|FG000|Overall Study|Clinical status did not improve|1|||
105708231|NCT00879229|364592850|FG001|Overall Study|Clinical status did not improve|0|||
105708232|NCT00879229|364592849|FG000|Overall Study|Other|1|||
106007275|NCT04205812|365692203|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
106007276|NCT04205812|365692202|FG000|Randomized Treatment Period|Physician Decision|1|||
106007277|NCT04205812|365692203|FG001|Randomized Treatment Period|Physician Decision|4|||
106007278|NCT04205812|365692202|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
106007279|NCT04205812|365692203|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
106007280|NCT04205812|365692202|FG000|Randomized Treatment Period|Progressive Disease|0|||
106007281|NCT04205812|365692203|FG001|Randomized Treatment Period|Progressive Disease|1|||
106007282|NCT04205812|365692202|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
106007283|NCT04205812|365692203|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
106007284|NCT04205812|365692202|FG000|Monotherapy Treatment Period|Ongoing|17|||
106007285|NCT04205812|365692203|FG001|Monotherapy Treatment Period|Ongoing|0|||
106007286|NCT04205812|365692202|FG000|Monotherapy Treatment Period|Death|39|||
106007287|NCT04205812|365692203|FG001|Monotherapy Treatment Period|Death|0|||
106007288|NCT04205812|365692202|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
106007289|NCT04205812|365692203|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
106007290|NCT04205812|365692202|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
106007291|NCT04205812|365692203|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
106007292|NCT04613362|365692206|FG000|3 Month Follow-up|Lost to Follow-up|1|||
106007293|NCT04613362|365692207|FG001|3 Month Follow-up|Lost to Follow-up|2|||
106007294|NCT04613362|365692206|FG000|6 Month Follow-up|Lost to Follow-up|0|||
106007295|NCT04613362|365692207|FG001|6 Month Follow-up|Lost to Follow-up|1|||
106007296|NCT05365217|365692209|FG000|Treatment Period 1|Withdrawal by Subject|1|||
106007297|NCT05365217|365692210|FG001|Treatment Period 1|Withdrawal by Subject|0|||
106007298|NCT03882021|365692212|FG000|Enrollment|Procedure aborted/cancelled|2|||
106007299|NCT03882021|365692212|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
106007300|NCT03882021|365692212|FG000|Enrollment to 3-Month|Death|1|||
106007301|NCT03882021|365692212|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
106007302|NCT03882021|365692212|FG000|Enrollment to 3-Month|Missed Visit|4|||
106007303|NCT03882021|365692212|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
106007304|NCT03882021|365692212|FG000|6-Month to 12-Month Visit|Death|1|||
106007305|NCT03882021|365692212|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
106007306|NCT03186209|365692213|FG000|Overall Study|Withdrawal by Subject|11|||
106007307|NCT03186209|365692214|FG001|Overall Study|Withdrawal by Subject|22|||
106007308|NCT03186209|365692213|FG000|Overall Study|Pregnancy|1|||
106007309|NCT03186209|365692214|FG001|Overall Study|Pregnancy|0|||
106007310|NCT03186209|365692213|FG000|Overall Study|Adverse Event|4|||
106007311|NCT03186209|365692214|FG001|Overall Study|Adverse Event|0|||
106007312|NCT03186209|365692213|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
106007313|NCT03186209|365692214|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
106007314|NCT03186209|365692213|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
106007315|NCT03186209|365692214|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
106007316|NCT03186209|365692213|FG000|Overall Study|Fail to meet randomization criteria|0|||
106007317|NCT03186209|365692214|FG001|Overall Study|Fail to meet randomization criteria|1|||
106007318|NCT03186209|365692213|FG000|Overall Study|Lost to Follow-up|0|||
106007319|NCT03186209|365692214|FG001|Overall Study|Lost to Follow-up|1|||
106007320|NCT05236270|365692218|FG000|Overall Study|Lost to Follow-up|3|||
106007321|NCT05236270|365692219|FG001|Overall Study|Lost to Follow-up|2|||
106133911|NCT02040844|366148229|FG000|Overall Study|Withdrawal by Subject|16|||
106133912|NCT02040844|366148230|FG001|Overall Study|Withdrawal by Subject|22|||
106133913|NCT02040844|366148231|FG002|Overall Study|Withdrawal by Subject|25|||
106133914|NCT02040844|366148229|FG000|Overall Study|Lost to Follow-up|12|||
106133915|NCT02040844|366148230|FG001|Overall Study|Lost to Follow-up|9|||
106133916|NCT02040844|366148231|FG002|Overall Study|Lost to Follow-up|13|||
106133917|NCT02040844|366148229|FG000|Overall Study|Missing|13|||
105708233|NCT00879229|364592850|FG001|Overall Study|Other|0|||
105708234|NCT00522431|364592851|FG000|Overall Study|Adverse Event|5|||
106007322|NCT05236270|365692220|FG002|Overall Study|Lost to Follow-up|0|||
106007323|NCT05236270|365692221|FG003|Overall Study|Lost to Follow-up|0|||
106007324|NCT05236270|365692222|FG004|Overall Study|Lost to Follow-up|2|||
106007325|NCT05236270|365692223|FG005|Overall Study|Lost to Follow-up|0|||
106007326|NCT05236270|365692224|FG006|Overall Study|Lost to Follow-up|1|||
106007327|NCT05236270|365692225|FG007|Overall Study|Lost to Follow-up|3|||
106007328|NCT00322881|365692226|FG000|Overall Study|Death|2|||
106133918|NCT02040844|366148230|FG001|Overall Study|Missing|3|||
106133919|NCT02040844|366148231|FG002|Overall Study|Missing|2|||
105708235|NCT00522431|364592851|FG000|Overall Study|Protocol Violation|2|||
105708236|NCT00522431|364592851|FG000|Overall Study|Withdrawal by Subject|2|||
105708237|NCT00522431|364592851|FG000|Overall Study|Subject non-compliance|1|||
105708238|NCT00522431|364592851|FG000|Overall Study|Other/unknown|1|||
105708239|NCT01339559|364592852|FG000|Overall Study|Adverse Event|92|||
105708240|NCT01339559|364592852|FG000|Overall Study|Death|5|||
105708241|NCT01339559|364592852|FG000|Overall Study|Lack of Efficacy|164|||
105708242|NCT01339559|364592852|FG000|Overall Study|Lost to Follow-up|22|||
105708243|NCT01339559|364592852|FG000|Overall Study|Subject choice|89|||
105708244|NCT01339559|364592852|FG000|Overall Study|Protocol Violation|15|||
105708245|NCT01339559|364592852|FG000|Overall Study|Study closure at site|1|||
105708246|NCT01339559|364592852|FG000|Overall Study|Incarcerated|2|||
105708247|NCT01339559|364592852|FG000|Overall Study|Epilepsy surgery|1|||
105708248|NCT01339559|364592852|FG000|Overall Study|Pregnancy planned|2|||
105708249|NCT01339559|364592852|FG000|Overall Study|Left the country|1|||
105708250|NCT01339559|364592852|FG000|Overall Study|Investigator decision|2|||
105708251|NCT01339559|364592852|FG000|Overall Study|Patient didn't wish to continue|1|||
105708252|NCT01339559|364592852|FG000|Overall Study|PI decision|1|||
105708253|NCT03548051|364592854|FG000|Overall Study|Death|1|||
105708254|NCT03548051|364592855|FG001|Overall Study|Death|1|||
105708255|NCT03548051|364592854|FG000|Overall Study|Withdrawal by Subject|1|||
105708256|NCT03548051|364592855|FG001|Overall Study|Withdrawal by Subject|0|||
105708257|NCT00049673|364592856|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
105708258|NCT00049673|364592857|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
105708259|NCT04623242|364592861|FG000|Overall Study|Withdrawal by Subject|7|||
105708260|NCT04623242|364592862|FG001|Overall Study|Withdrawal by Subject|12|||
106007329|NCT00322881|365692226|FG000|Overall Study|Adverse Event|1|||
106133920|NCT02040844|366148229|FG000|Overall Study|Non-specified|8|||
106133921|NCT02040844|366148230|FG001|Overall Study|Non-specified|2|||
106133922|NCT02040844|366148231|FG002|Overall Study|Non-specified|5|||
106133923|NCT02040844|366148229|FG000|Overall Study|Concomitant medication|1|||
106133924|NCT02040844|366148230|FG001|Overall Study|Concomitant medication|3|||
106133925|NCT02040844|366148231|FG002|Overall Study|Concomitant medication|1|||
106133926|NCT00946192|366148232|FG000|Overall Study|Lost to Follow-up|6|||
106133927|NCT00946192|366148233|FG001|Overall Study|Lost to Follow-up|11|||
106133928|NCT00946192|366148234|FG002|Overall Study|Lost to Follow-up|9|||
105708261|NCT04623242|364592863|FG002|Overall Study|Withdrawal by Subject|5|||
105708262|NCT04623242|364592864|FG003|Overall Study|Withdrawal by Subject|7|||
105708263|NCT04623242|364592865|FG004|Overall Study|Withdrawal by Subject|0|||
105708264|NCT04623242|364592861|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
105708265|NCT04623242|364592862|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
105760703|NCT05567393|364776148|FG017|Overall Study|Voluntary Withdrawal|0|||
105760704|NCT04199793|364776151|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
105760705|NCT04199793|364776152|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
105760706|NCT04199793|364776151|FG000|Overall Study|Withdrawal by Subject|1|||
105760707|NCT04199793|364776152|FG001|Overall Study|Withdrawal by Subject|1|||
105760708|NCT01406652|364776157|FG000|Overall Study|Lost-to-follow-up|3|||
105760709|NCT01406652|364776158|FG001|Overall Study|Lost-to-follow-up|4|||
105760710|NCT01406652|364776157|FG000|Overall Study|Withdrawal by Subject|2|||
105760711|NCT01406652|364776158|FG001|Overall Study|Withdrawal by Subject|2|||
105760712|NCT01406652|364776157|FG000|Overall Study|Insufficient follow-up|5|||
105760713|NCT01406652|364776158|FG001|Overall Study|Insufficient follow-up|4|||
105760714|NCT01406652|364776157|FG000|Overall Study|Infection not sure|10|||
105760715|NCT01406652|364776158|FG001|Overall Study|Infection not sure|10|||
105760716|NCT00141037|364776159|FG000|Overall Study|Physician Decision|1|||
105760717|NCT00141037|364776160|FG001|Overall Study|Physician Decision|2|||
105760718|NCT00141037|364776159|FG000|Overall Study|Lost to Follow-up|3|||
105760719|NCT00141037|364776160|FG001|Overall Study|Lost to Follow-up|1|||
105760720|NCT00141037|364776159|FG000|Overall Study|Protocol Violation|0|||
105760721|NCT00141037|364776160|FG001|Overall Study|Protocol Violation|2|||
105760722|NCT00141037|364776159|FG000|Overall Study|Withdrawal by Subject|2|||
105760723|NCT00141037|364776160|FG001|Overall Study|Withdrawal by Subject|1|||
105760724|NCT00141037|364776159|FG000|Overall Study|Other|0|||
105760725|NCT00141037|364776160|FG001|Overall Study|Other|1|||
105760726|NCT00141037|364776159|FG000|Overall Study|Moved from area|1|||
105760727|NCT00141037|364776160|FG001|Overall Study|Moved from area|7|||
105760728|NCT00141037|364776159|FG000|Overall Study|Graft Failure|3|||
105760729|NCT00141037|364776160|FG001|Overall Study|Graft Failure|4|||
105760730|NCT03310580|364776163|FG000|Overall Study|Adverse Event|0|||
105760731|NCT03310580|364776164|FG001|Overall Study|Adverse Event|1|||
105760732|NCT03310580|364776165|FG002|Overall Study|Adverse Event|0|||
105760733|NCT00795509|364776171|FG000|Overall Study|Protocol Violation|31|||
105760734|NCT01079195|364776172|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
105760735|NCT01079195|364776172|FG000|Overall Study|No Documentation Available|437|||
105760736|NCT01079195|364776172|FG000|Overall Study|Adverse Event|157|||
105760737|NCT01079195|364776172|FG000|Overall Study|Reason Unknown|39|||
105760738|NCT01079195|364776172|FG000|Overall Study|Withdrawal by Subject|18|||
105760739|NCT01079195|364776172|FG000|Overall Study|Financial Reasons|15|||
105788047|NCT00437294|364878169|FG000|Overall Study|Protocol Violation|0|||
105788048|NCT00437294|364878170|FG001|Overall Study|Protocol Violation|1|||
105788049|NCT00437294|364878169|FG000|Overall Study|Entry criteria not met|1|||
106133929|NCT00946192|366148232|FG000|Overall Study|Withdrawal by Subject|10|||
105708266|NCT04623242|364592863|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
105708267|NCT04623242|364592864|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
105708268|NCT04623242|364592865|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
105708269|NCT04623242|364592861|FG000|Overall Study|Subject unblinded to mutation status|0|||
105708270|NCT04623242|364592862|FG001|Overall Study|Subject unblinded to mutation status|0|||
105708271|NCT04623242|364592863|FG002|Overall Study|Subject unblinded to mutation status|0|||
105708272|NCT04623242|364592864|FG003|Overall Study|Subject unblinded to mutation status|13|||
105708273|NCT04623242|364592865|FG004|Overall Study|Subject unblinded to mutation status|0|||
105708274|NCT00452699|364592866|FG000|Overall Study|Adverse Event|10|||
105708275|NCT00452699|364592867|FG001|Overall Study|Adverse Event|3|||
105708276|NCT00452699|364592866|FG000|Overall Study|Lack of Efficacy|6|||
105708277|NCT00452699|364592867|FG001|Overall Study|Lack of Efficacy|4|||
105708278|NCT00452699|364592866|FG000|Overall Study|Lost to Follow-up|6|||
105708279|NCT00452699|364592867|FG001|Overall Study|Lost to Follow-up|9|||
105708280|NCT00452699|364592866|FG000|Overall Study|Protocol Violation|21|||
105708281|NCT00452699|364592867|FG001|Overall Study|Protocol Violation|25|||
105708282|NCT00452699|364592866|FG000|Overall Study|Withdrawal by Subject|26|||
105708283|NCT00452699|364592867|FG001|Overall Study|Withdrawal by Subject|25|||
105708284|NCT00452699|364592866|FG000|Overall Study|Other|12|||
105708285|NCT00452699|364592867|FG001|Overall Study|Other|7|||
105708286|NCT00493870|364592868|FG000|Overall Study|Lost to Follow-up|12|||
105708287|NCT00493870|364592869|FG001|Overall Study|Lost to Follow-up|15|||
105708288|NCT03733392|364592870|FG000|Overall Study|Withdrawal by Subject|11|||
105708289|NCT03733392|364592871|FG001|Overall Study|Withdrawal by Subject|1|||
105708290|NCT03733392|364592870|FG000|Overall Study|Death|1|||
105708291|NCT03733392|364592871|FG001|Overall Study|Death|0|||
105708292|NCT03733392|364592870|FG000|Overall Study|Lost to Follow-up|5|||
105708293|NCT03733392|364592871|FG001|Overall Study|Lost to Follow-up|0|||
105708294|NCT03733392|364592870|FG000|Overall Study|Protocol Violation|0|||
105708295|NCT03733392|364592871|FG001|Overall Study|Protocol Violation|1|||
105708296|NCT03733392|364592870|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
105708297|NCT03733392|364592871|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
105708298|NCT03733392|364592870|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
105708299|NCT03733392|364592871|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
105708300|NCT03733392|364592870|FG000|Overall Study|Patient Non-Compliance|2|||
105708301|NCT03733392|364592871|FG001|Overall Study|Patient Non-Compliance|1|||
105708302|NCT03733392|364592870|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
105708303|NCT03733392|364592871|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
105708304|NCT03733392|364592870|FG000|Overall Study|Withdrawal prior to procedure|5|||
105708305|NCT03733392|364592871|FG001|Overall Study|Withdrawal prior to procedure|2|||
105708306|NCT00356278|364592872|FG000|Overall Study|Withdrawal by Subject|25|||
105708307|NCT00356278|364592873|FG001|Overall Study|Withdrawal by Subject|15|||
105708308|NCT00356278|364592874|FG002|Overall Study|Withdrawal by Subject|19|||
105708309|NCT05594173|364592877|FG000|Overall Study|Adverse Event|1|||
105708310|NCT05594173|364592877|FG000|Overall Study|COVID-19 Pandemic|2|||
105708311|NCT00647556|364592878|FG000|Overall Study|Adverse Event|0|||
105708312|NCT00647556|364592879|FG001|Overall Study|Adverse Event|1|||
105708313|NCT00647556|364592878|FG000|Overall Study|Lost to Follow-up|1|||
105708314|NCT00647556|364592879|FG001|Overall Study|Lost to Follow-up|0|||
105708315|NCT00647556|364592878|FG000|Overall Study|Protocol Violation|0|||
105708316|NCT00647556|364592879|FG001|Overall Study|Protocol Violation|1|||
105708317|NCT00647556|364592878|FG000|Overall Study|Withdrawal by Subject|1|||
105708318|NCT00647556|364592879|FG001|Overall Study|Withdrawal by Subject|0|||
105708319|NCT00647556|364592878|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
105708320|NCT00647556|364592879|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
105708321|NCT00883337|364592880|FG000|Core Treatment Period|Adverse Event|9|||
105708322|NCT00883337|364592881|FG001|Core Treatment Period|Adverse Event|12|||
105708323|NCT00883337|364592882|FG002|Core Treatment Period|Adverse Event|22|||
105708324|NCT00883337|364592880|FG000|Core Treatment Period|Lack of Efficacy|7|||
105708325|NCT00883337|364592881|FG001|Core Treatment Period|Lack of Efficacy|4|||
105708326|NCT00883337|364592882|FG002|Core Treatment Period|Lack of Efficacy|2|||
105708327|NCT00883337|364592880|FG000|Core Treatment Period|Lost to Follow-up|1|||
105708328|NCT00883337|364592881|FG001|Core Treatment Period|Lost to Follow-up|1|||
105708329|NCT00883337|364592882|FG002|Core Treatment Period|Lost to Follow-up|0|||
105708330|NCT00883337|364592880|FG000|Core Treatment Period|Withdrawal by Subject|2|||
105708331|NCT00883337|364592881|FG001|Core Treatment Period|Withdrawal by Subject|2|||
105708332|NCT00883337|364592882|FG002|Core Treatment Period|Withdrawal by Subject|6|||
105708333|NCT00883337|364592880|FG000|Core Treatment Period|Wish to be pregnant|1|||
105708334|NCT00883337|364592881|FG001|Core Treatment Period|Wish to be pregnant|2|||
106007330|NCT00322881|365692226|FG000|Overall Study|Disease Progression|2|||
106007331|NCT00528112|365692227|FG000|Treatment up to 3 Years|Adverse Event|313|||
106007332|NCT00528112|365692228|FG001|Treatment up to 3 Years|Adverse Event|278|||
106007333|NCT00528112|365692227|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
106007334|NCT00528112|365692228|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
106007335|NCT00528112|365692227|FG000|Treatment up to 3 Years|Protocol Violation|16|||
106007336|NCT00528112|365692228|FG001|Treatment up to 3 Years|Protocol Violation|16|||
106007337|NCT00528112|365692227|FG000|Treatment up to 3 Years|Death|0|||
106007338|NCT00528112|365692228|FG001|Treatment up to 3 Years|Death|1|||
106007339|NCT00528112|365692227|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
106007340|NCT00528112|365692228|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
106007341|NCT00528112|365692227|FG000|Treatment up to 3 Years|Pregnancy|9|||
106007342|NCT00528112|365692228|FG001|Treatment up to 3 Years|Pregnancy|10|||
106007343|NCT00528112|365692227|FG000|Treatment up to 3 Years|Other reasons|186|||
106007344|NCT00528112|365692228|FG001|Treatment up to 3 Years|Other reasons|186|||
106007345|NCT00528112|365692227|FG000|Extension Phase|Withdrawal by Subject|0|||
106007346|NCT00528112|365692228|FG001|Extension Phase|Withdrawal by Subject|3|||
106007347|NCT00528112|365692227|FG000|Extension Phase|Other reasons|0|||
106007348|NCT00528112|365692228|FG001|Extension Phase|Other reasons|100|||
106007349|NCT00528112|365692227|FG000|Extension Phase|Pregnancy|0|||
106007350|NCT00528112|365692228|FG001|Extension Phase|Pregnancy|3|||
106007351|NCT00528112|365692227|FG000|Extension Phase|Lost to Follow-up|0|||
106007352|NCT00528112|365692228|FG001|Extension Phase|Lost to Follow-up|12|||
106007353|NCT00528112|365692227|FG000|Extension Phase|Death|0|||
106007354|NCT00528112|365692228|FG001|Extension Phase|Death|1|||
106007355|NCT00528112|365692227|FG000|Extension Phase|Adverse Event|0|||
106007356|NCT00528112|365692228|FG001|Extension Phase|Adverse Event|36|||
106007357|NCT00528112|365692227|FG000|Extension Phase|Protocol Violation|0|||
106007358|NCT00528112|365692228|FG001|Extension Phase|Protocol Violation|2|||
106007359|NCT01075243|365692229|FG000|Overall Study|Lost to Follow-up|5|||
105708335|NCT00883337|364592882|FG002|Core Treatment Period|Wish to be pregnant|1|||
105708336|NCT00883337|364592880|FG000|Core Treatment Period|Poor compliance to protocol|0|||
105708337|NCT00883337|364592881|FG001|Core Treatment Period|Poor compliance to protocol|0|||
105708338|NCT00883337|364592882|FG002|Core Treatment Period|Poor compliance to protocol|1|||
105708339|NCT00883337|364592880|FG000|Core Treatment Period|Other than above|0|||
105708340|NCT00883337|364592881|FG001|Core Treatment Period|Other than above|1|||
105708341|NCT00883337|364592882|FG002|Core Treatment Period|Other than above|1|||
105708342|NCT00883337|364592880|FG000|Extension Treatment Period|Adverse Event|8|||
105708343|NCT00883337|364592881|FG001|Extension Treatment Period|Adverse Event|5|||
105708344|NCT00883337|364592882|FG002|Extension Treatment Period|Adverse Event|5|||
105708345|NCT00883337|364592880|FG000|Extension Treatment Period|Lack of Efficacy|8|||
105708346|NCT00883337|364592881|FG001|Extension Treatment Period|Lack of Efficacy|8|||
105708347|NCT00883337|364592882|FG002|Extension Treatment Period|Lack of Efficacy|8|||
105708348|NCT00883337|364592880|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
105708349|NCT00883337|364592881|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
105708350|NCT00883337|364592882|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
105708351|NCT00883337|364592880|FG000|Extension Treatment Period|Lost to Follow-up|1|||
105708352|NCT00883337|364592881|FG001|Extension Treatment Period|Lost to Follow-up|0|||
105708353|NCT00883337|364592882|FG002|Extension Treatment Period|Lost to Follow-up|0|||
105708354|NCT00883337|364592880|FG000|Extension Treatment Period|Other than above|10|||
105708355|NCT00883337|364592881|FG001|Extension Treatment Period|Other than above|9|||
105708356|NCT00883337|364592882|FG002|Extension Treatment Period|Other than above|5|||
105708357|NCT00687362|364592884|FG000|Overall Study|Protocol Violation|2|||
105708358|NCT00687362|364592884|FG000|Overall Study|Withdrawal by Subject|1|||
105708359|NCT00925015|364592888|FG000|Overall Study|Adverse Event|1|||
105708360|NCT00925015|364592889|FG001|Overall Study|Adverse Event|2|||
105708361|NCT00925015|364592890|FG002|Overall Study|Adverse Event|1|||
105708362|NCT00925015|364592888|FG000|Overall Study|Physician Decision|0|||
105708363|NCT00925015|364592889|FG001|Overall Study|Physician Decision|1|||
105708364|NCT00925015|364592890|FG002|Overall Study|Physician Decision|0|||
105708365|NCT00925015|364592888|FG000|Overall Study|Progressive Disease|7|||
105708366|NCT00925015|364592889|FG001|Overall Study|Progressive Disease|3|||
106007360|NCT01075243|365692230|FG001|Overall Study|Lost to Follow-up|2|||
106007361|NCT01075243|365692231|FG002|Overall Study|Lost to Follow-up|0|||
106133930|NCT00946192|366148233|FG001|Overall Study|Withdrawal by Subject|7|||
105708367|NCT00925015|364592890|FG002|Overall Study|Progressive Disease|4|||
105708368|NCT00925015|364592888|FG000|Overall Study|Withdrawal by Subject|0|||
106007362|NCT01075243|365692229|FG000|Overall Study|Withdrawal by Subject|1|||
106007363|NCT01075243|365692230|FG001|Overall Study|Withdrawal by Subject|1|||
106007364|NCT01075243|365692231|FG002|Overall Study|Withdrawal by Subject|0|||
106007365|NCT00627393|365692234|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
105708369|NCT00925015|364592889|FG001|Overall Study|Withdrawal by Subject|0|||
105708370|NCT00925015|364592890|FG002|Overall Study|Withdrawal by Subject|1|||
105708371|NCT00179309|364592891|FG000|Treatment|Toxicity|2|||
105708372|NCT00179309|364592892|FG001|Treatment|Toxicity|3|||
106007366|NCT00627393|365692235|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
106007367|NCT00627393|365692234|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
106007368|NCT00627393|365692235|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
106007369|NCT00627393|365692234|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
106007370|NCT00627393|365692235|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
106007371|NCT00627393|365692234|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
106007372|NCT00627393|365692235|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
106007373|NCT01521117|365692236|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
106007374|NCT01521117|365692237|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
106007375|NCT01521117|365692236|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
106007376|NCT01521117|365692237|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
106007377|NCT01521117|365692236|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
106007378|NCT01521117|365692237|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
106007379|NCT03337308|365692238|FG000|Overall Study|Adverse Event|2|||
106007380|NCT03337308|365692239|FG001|Overall Study|Adverse Event|3|||
106007381|NCT03337308|365692240|FG002|Overall Study|Adverse Event|3|||
106007382|NCT03337308|365692241|FG003|Overall Study|Adverse Event|1|||
106007383|NCT03337308|365692238|FG000|Overall Study|Lost to Follow-up|1|||
106007384|NCT03337308|365692239|FG001|Overall Study|Lost to Follow-up|2|||
106007385|NCT03337308|365692240|FG002|Overall Study|Lost to Follow-up|0|||
106007386|NCT03337308|365692241|FG003|Overall Study|Lost to Follow-up|0|||
106007387|NCT03337308|365692238|FG000|Overall Study|Withdrawal by Subject|2|||
106007388|NCT03337308|365692239|FG001|Overall Study|Withdrawal by Subject|1|||
106007389|NCT03337308|365692240|FG002|Overall Study|Withdrawal by Subject|2|||
106007390|NCT03337308|365692241|FG003|Overall Study|Withdrawal by Subject|1|||
106007391|NCT03337308|365692238|FG000|Overall Study|Protocol Violation|0|||
106007392|NCT03337308|365692239|FG001|Overall Study|Protocol Violation|1|||
105708373|NCT00179309|364592891|FG000|Treatment|Withdrawal by Subject|1|||
105708374|NCT00179309|364592892|FG001|Treatment|Withdrawal by Subject|2|||
105708375|NCT00179309|364592891|FG000|Treatment|Allergy|1|||
105708376|NCT00179309|364592892|FG001|Treatment|Allergy|0|||
105708377|NCT00623480|364592893|FG000|Overall Study|Lost to Follow-up|0|||
105708378|NCT00623480|364592894|FG001|Overall Study|Lost to Follow-up|1|||
105708379|NCT00623480|364592893|FG000|Overall Study|Withdrawal by Subject|2|||
105708380|NCT00623480|364592894|FG001|Overall Study|Withdrawal by Subject|4|||
105708381|NCT00623480|364592893|FG000|Overall Study|Lack of Efficacy|1|||
105708382|NCT00623480|364592894|FG001|Overall Study|Lack of Efficacy|0|||
105708383|NCT00623480|364592893|FG000|Overall Study|Non-compliant with study medication|4|||
105708384|NCT00623480|364592894|FG001|Overall Study|Non-compliant with study medication|0|||
105708385|NCT00623480|364592893|FG000|Overall Study|Protocol Violation|0|||
105708386|NCT00623480|364592894|FG001|Overall Study|Protocol Violation|1|||
105708387|NCT00623480|364592893|FG000|Overall Study|Site closed by sponsor|0|||
105708388|NCT00623480|364592894|FG001|Overall Study|Site closed by sponsor|1|||
105708389|NCT00781456|364592895|FG000|Overall Study|Adverse Event|3|||
105708390|NCT00781456|364592896|FG001|Overall Study|Adverse Event|3|||
105708391|NCT00781456|364592895|FG000|Overall Study|Withdrawal by Subject|3|||
105708392|NCT00781456|364592896|FG001|Overall Study|Withdrawal by Subject|5|||
105708393|NCT00781456|364592895|FG000|Overall Study|Protocol Violation|4|||
105708394|NCT00781456|364592896|FG001|Overall Study|Protocol Violation|1|||
105708395|NCT00781456|364592895|FG000|Overall Study|Noncompliance With Protocol|1|||
105708396|NCT00781456|364592896|FG001|Overall Study|Noncompliance With Protocol|1|||
105708397|NCT00781456|364592895|FG000|Overall Study|Lost to Follow-up|10|||
105708398|NCT00781456|364592896|FG001|Overall Study|Lost to Follow-up|5|||
105708399|NCT00781456|364592895|FG000|Overall Study|Other Reason, Unknown|0|||
105708400|NCT00781456|364592896|FG001|Overall Study|Other Reason, Unknown|1|||
105708401|NCT04677712|364592897|FG000|Overall Study|Lost to Follow-up|0|||
105708402|NCT04677712|364592898|FG001|Overall Study|Lost to Follow-up|1|||
105927787|NCT00541229|365395285|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
105927788|NCT00541229|365395286|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
105927789|NCT00541229|365395281|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
105927790|NCT00541229|365395282|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
105927791|NCT00541229|365395283|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
105927792|NCT00541229|365395284|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
105927793|NCT00541229|365395285|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
105927794|NCT00541229|365395286|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
105927795|NCT00541229|365395281|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
105927796|NCT00541229|365395282|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
106007393|NCT03337308|365692240|FG002|Overall Study|Protocol Violation|0|||
106007394|NCT03337308|365692241|FG003|Overall Study|Protocol Violation|0|||
106007395|NCT05498649|365692243|FG000|Overall Study|Lost to Follow-up|1|||
106007396|NCT01668784|365692244|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
106007397|NCT01668784|365692245|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
105708403|NCT04677712|364592899|FG002|Overall Study|Lost to Follow-up|0|||
105708404|NCT04677712|364592900|FG003|Overall Study|Lost to Follow-up|0|||
105708405|NCT04677712|364592901|FG004|Overall Study|Lost to Follow-up|0|||
105927797|NCT00541229|365395283|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
105708406|NCT04677712|364592902|FG005|Overall Study|Lost to Follow-up|0|||
105708407|NCT01289015|364592903|FG000|Overall Study|Protocol Violation|12|||
105708408|NCT01289015|364592904|FG001|Overall Study|Protocol Violation|9|||
105708409|NCT01289015|364592903|FG000|Overall Study|Adverse Event|3|||
105708410|NCT01289015|364592904|FG001|Overall Study|Adverse Event|0|||
105708411|NCT01289015|364592903|FG000|Overall Study|Lost to Follow-up|33|||
105708412|NCT01289015|364592904|FG001|Overall Study|Lost to Follow-up|17|||
105708413|NCT01289015|364592903|FG000|Overall Study|Withdrawal by Subject|17|||
105708414|NCT01289015|364592904|FG001|Overall Study|Withdrawal by Subject|8|||
105708415|NCT01289015|364592903|FG000|Overall Study|Disease progression|1|||
105708416|NCT01289015|364592904|FG001|Overall Study|Disease progression|0|||
105708417|NCT01289015|364592903|FG000|Overall Study|Negative baseline culture and others|33|||
105708418|NCT01289015|364592904|FG001|Overall Study|Negative baseline culture and others|20|||
105708419|NCT02412787|364592905|FG000|Overall Study|Withdrawal by Subject|9|||
105708420|NCT02412787|364592905|FG000|Overall Study|Participation Terminated by Investigator|1|||
105708421|NCT02412787|364592905|FG000|Overall Study|Site Terminated by Sponsor|21|||
105708422|NCT02412787|364592905|FG000|Overall Study|Technical Problems|1|||
105708423|NCT02412787|364592905|FG000|Overall Study|Reason Not Specified|1|||
105708424|NCT00915681|364592906|FG000|Overall Study|Screening failures|46|||
105708425|NCT01970995|364592907|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
105708426|NCT01970995|364592908|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
105708427|NCT01970995|364592909|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
105708428|NCT01970995|364592907|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
105708429|NCT01970995|364592908|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
105708430|NCT01970995|364592909|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
105708431|NCT00845728|364592915|FG000|Overall Study|Abnormal laboratory value (s)|2|||
105708432|NCT00845728|364592916|FG001|Overall Study|Abnormal laboratory value (s)|2|||
105708433|NCT00845728|364592915|FG000|Overall Study|Patient's inability to use the device|4|||
105708434|NCT00845728|364592916|FG001|Overall Study|Patient's inability to use the device|6|||
105708435|NCT00845728|364592915|FG000|Overall Study|Abnormal test procedure result (s)|7|||
105708436|NCT00845728|364592916|FG001|Overall Study|Abnormal test procedure result (s)|2|||
105708437|NCT00845728|364592915|FG000|Overall Study|Lost to Follow-up|22|||
105708438|NCT00845728|364592916|FG001|Overall Study|Lost to Follow-up|13|||
105708439|NCT00845728|364592915|FG000|Overall Study|Death|24|||
105708440|NCT00845728|364592916|FG001|Overall Study|Death|26|||
105708441|NCT00845728|364592915|FG000|Overall Study|Administrative Problems|34|||
105708442|NCT00845728|364592916|FG001|Overall Study|Administrative Problems|26|||
105708443|NCT00845728|364592915|FG000|Overall Study|Protocol Violation|36|||
105708444|NCT00845728|364592916|FG001|Overall Study|Protocol Violation|24|||
105708445|NCT00845728|364592915|FG000|Overall Study|Lack of Efficacy|51|||
105708446|NCT00845728|364592916|FG001|Overall Study|Lack of Efficacy|39|||
105708447|NCT00845728|364592915|FG000|Overall Study|Adverse Event|101|||
105708448|NCT00845728|364592916|FG001|Overall Study|Adverse Event|96|||
105708449|NCT00845728|364592915|FG000|Overall Study|Withdrawal by Subject|105|||
105708450|NCT00845728|364592916|FG001|Overall Study|Withdrawal by Subject|108|||
105708451|NCT01780831|364592917|FG000|Overall Study|Withdrawal by Subject|0|||
105708452|NCT01780831|364592918|FG001|Overall Study|Withdrawal by Subject|0|||
105708453|NCT01780831|364592919|FG002|Overall Study|Withdrawal by Subject|4|||
105708454|NCT01780831|364592920|FG003|Overall Study|Withdrawal by Subject|0|||
105708455|NCT01780831|364592917|FG000|Overall Study|Lost to Follow-up|0|||
105708456|NCT01780831|364592918|FG001|Overall Study|Lost to Follow-up|0|||
105708457|NCT01780831|364592919|FG002|Overall Study|Lost to Follow-up|0|||
105927798|NCT00541229|365395284|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
105927799|NCT00541229|365395285|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
105927800|NCT00541229|365395286|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
105927801|NCT00541229|365395281|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
105927802|NCT00541229|365395282|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
105927803|NCT00541229|365395283|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
105927804|NCT00541229|365395284|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
105708458|NCT01780831|364592920|FG003|Overall Study|Lost to Follow-up|1|||
105708459|NCT02970292|364592931|FG000|Overall Study|Physician Decision|1|||
105708460|NCT02970292|364592932|FG001|Overall Study|Physician Decision|1|||
105708461|NCT02970292|364592931|FG000|Overall Study|Withdrawal by Subject|11|||
105708462|NCT02970292|364592932|FG001|Overall Study|Withdrawal by Subject|5|||
105708463|NCT02970292|364592931|FG000|Overall Study|Noncompliance with study drug|2|||
105708464|NCT02970292|364592932|FG001|Overall Study|Noncompliance with study drug|2|||
105708465|NCT02970292|364592931|FG000|Overall Study|Adverse Event|5|||
105708466|NCT02970292|364592932|FG001|Overall Study|Adverse Event|0|||
105708467|NCT02970292|364592931|FG000|Overall Study|Lack of Efficacy|1|||
105708468|NCT02970292|364592932|FG001|Overall Study|Lack of Efficacy|0|||
105708469|NCT02970292|364592931|FG000|Overall Study|Lost to Follow-up|1|||
105927805|NCT00541229|365395285|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
105927806|NCT00541229|365395286|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
106007398|NCT01668784|365692244|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
105927807|NCT00541229|365395281|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
105708470|NCT02970292|364592932|FG001|Overall Study|Lost to Follow-up|0|||
105708471|NCT02970292|364592931|FG000|Overall Study|Protocol Violation|2|||
105708472|NCT02970292|364592932|FG001|Overall Study|Protocol Violation|0|||
105708473|NCT02970292|364592931|FG000|Overall Study|Other|1|||
105708474|NCT02970292|364592932|FG001|Overall Study|Other|0|||
105708475|NCT02980224|364592937|FG000|Overall Study|Adverse Event|4|||
105708476|NCT02980224|364592938|FG001|Overall Study|Adverse Event|1|||
105708477|NCT02980224|364592937|FG000|Overall Study|Withdrawal by Subject|0|||
105708478|NCT02980224|364592938|FG001|Overall Study|Withdrawal by Subject|2|||
105708479|NCT03594227|364592943|FG000|Overall Study|Adverse Event|2|||
105708480|NCT03594227|364592944|FG001|Overall Study|Adverse Event|1|||
105708481|NCT03594227|364592945|FG002|Overall Study|Adverse Event|0|||
105708482|NCT03594227|364592946|FG003|Overall Study|Adverse Event|2|||
105708483|NCT03594227|364592943|FG000|Overall Study|Lost to Follow-up|1|||
105708484|NCT03594227|364592944|FG001|Overall Study|Lost to Follow-up|1|||
105708485|NCT03594227|364592945|FG002|Overall Study|Lost to Follow-up|1|||
105708486|NCT03594227|364592946|FG003|Overall Study|Lost to Follow-up|0|||
105708487|NCT03594227|364592943|FG000|Overall Study|Withdrawal by Subject|1|||
105708488|NCT03594227|364592944|FG001|Overall Study|Withdrawal by Subject|1|||
105708489|NCT03594227|364592945|FG002|Overall Study|Withdrawal by Subject|1|||
105708490|NCT03594227|364592946|FG003|Overall Study|Withdrawal by Subject|1|||
105708491|NCT03594227|364592943|FG000|Overall Study|Pregnancy|0|||
105708492|NCT03594227|364592944|FG001|Overall Study|Pregnancy|1|||
105708493|NCT03594227|364592945|FG002|Overall Study|Pregnancy|0|||
105708494|NCT03594227|364592946|FG003|Overall Study|Pregnancy|0|||
105708495|NCT03594227|364592943|FG000|Overall Study|Sponsor Decision|0|||
105708496|NCT03594227|364592944|FG001|Overall Study|Sponsor Decision|0|||
105708497|NCT03594227|364592945|FG002|Overall Study|Sponsor Decision|0|||
105708498|NCT03594227|364592946|FG003|Overall Study|Sponsor Decision|1|||
105708499|NCT03594227|364592943|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
105708500|NCT03594227|364592944|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
105708501|NCT03594227|364592945|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
105708502|NCT03594227|364592946|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
105708503|NCT00109707|364592947|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
105708504|NCT00109707|364592948|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
105708505|NCT00109707|364592949|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
105708506|NCT00109707|364592947|FG000|Overall Study|Abnormal laboratory values|1|||
105708507|NCT00109707|364592948|FG001|Overall Study|Abnormal laboratory values|0|||
105708508|NCT00109707|364592949|FG002|Overall Study|Abnormal laboratory values|0|||
105708509|NCT00109707|364592947|FG000|Overall Study|Administrative problems|2|||
105708510|NCT00109707|364592948|FG001|Overall Study|Administrative problems|0|||
105708511|NCT00109707|364592949|FG002|Overall Study|Administrative problems|1|||
105708512|NCT00109707|364592947|FG000|Overall Study|Adverse Event|10|||
105708513|NCT00109707|364592948|FG001|Overall Study|Adverse Event|2|||
105708514|NCT00109707|364592949|FG002|Overall Study|Adverse Event|3|||
105708515|NCT00109707|364592947|FG000|Overall Study|Death|4|||
105708516|NCT00109707|364592948|FG001|Overall Study|Death|0|||
105927808|NCT00541229|365395282|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
105927809|NCT00541229|365395283|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
105927810|NCT00541229|365395284|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
105927811|NCT00541229|365395285|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
105927812|NCT00541229|365395286|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
105927813|NCT00541229|365395281|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
105927814|NCT00541229|365395282|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
105927815|NCT00541229|365395283|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
106007399|NCT01668784|365692245|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
106007400|NCT01668784|365692244|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
106133931|NCT00946192|366148234|FG002|Overall Study|Withdrawal by Subject|3|||
105708517|NCT00109707|364592949|FG002|Overall Study|Death|0|||
105708518|NCT00109707|364592947|FG000|Overall Study|Disease progression|12|||
105708519|NCT00109707|364592948|FG001|Overall Study|Disease progression|4|||
105708520|NCT00109707|364592949|FG002|Overall Study|Disease progression|3|||
105708521|NCT00109707|364592947|FG000|Overall Study|Lost to Follow-up|3|||
105708522|NCT00109707|364592948|FG001|Overall Study|Lost to Follow-up|0|||
105708523|NCT00109707|364592949|FG002|Overall Study|Lost to Follow-up|0|||
105708524|NCT00109707|364592947|FG000|Overall Study|Protocol Violation|1|||
105708525|NCT00109707|364592948|FG001|Overall Study|Protocol Violation|0|||
105708526|NCT00109707|364592949|FG002|Overall Study|Protocol Violation|0|||
105708527|NCT00109707|364592947|FG000|Overall Study|Patient withdrew consent|6|||
105708528|NCT00109707|364592948|FG001|Overall Study|Patient withdrew consent|1|||
105708529|NCT00109707|364592949|FG002|Overall Study|Patient withdrew consent|0|||
105708530|NCT02443883|364592950|FG000|Overall Study|Adverse Event|0|||
105708531|NCT02443883|364592951|FG001|Overall Study|Adverse Event|1|||
105708532|NCT02443883|364592952|FG002|Overall Study|Adverse Event|0|||
105708533|NCT02443883|364592953|FG003|Overall Study|Adverse Event|0|||
105927816|NCT00541229|365395284|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
105927817|NCT00541229|365395285|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
105927818|NCT00541229|365395286|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
105927819|NCT00541229|365395281|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105927820|NCT00541229|365395282|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105927821|NCT00541229|365395283|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105927822|NCT00541229|365395284|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105927823|NCT00541229|365395285|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
105927824|NCT00541229|365395286|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
105927825|NCT00541229|365395281|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
105927826|NCT00541229|365395282|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
105927827|NCT00541229|365395283|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
105927828|NCT00541229|365395284|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
105927829|NCT00541229|365395285|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
105927830|NCT00541229|365395286|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
105927831|NCT00541229|365395281|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
105927832|NCT00541229|365395282|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
106133932|NCT00946192|366148232|FG000|Overall Study|Did not start medication|2|||
106133933|NCT00946192|366148233|FG001|Overall Study|Did not start medication|0|||
106133934|NCT00946192|366148234|FG002|Overall Study|Did not start medication|0|||
106133935|NCT02014558|366148235|FG000|Overall Study|Never Received Study Drug|0|||
106133936|NCT02014558|366148236|FG001|Overall Study|Never Received Study Drug|0|||
106133937|NCT02014558|366148237|FG002|Overall Study|Never Received Study Drug|0|||
106133938|NCT02014558|366148238|FG003|Overall Study|Never Received Study Drug|0|||
106133939|NCT02014558|366148239|FG004|Overall Study|Never Received Study Drug|1|||
106133940|NCT02014558|366148240|FG005|Overall Study|Never Received Study Drug|0|||
106133941|NCT02014558|366148241|FG006|Overall Study|Never Received Study Drug|1|||
106133942|NCT02014558|366148242|FG007|Overall Study|Never Received Study Drug|0|||
106133943|NCT02014558|366148243|FG008|Overall Study|Never Received Study Drug|2|||
106133944|NCT02014558|366148244|FG009|Overall Study|Never Received Study Drug|0|||
106133945|NCT02014558|366148245|FG010|Overall Study|Never Received Study Drug|2|||
106133946|NCT02014558|366148246|FG011|Overall Study|Never Received Study Drug|2|||
106133947|NCT02014558|366148247|FG012|Overall Study|Never Received Study Drug|0|||
106133948|NCT02014558|366148235|FG000|Overall Study|Adverse Event|0|||
106133949|NCT02014558|366148236|FG001|Overall Study|Adverse Event|0|||
106133950|NCT02014558|366148237|FG002|Overall Study|Adverse Event|0|||
106133951|NCT02014558|366148238|FG003|Overall Study|Adverse Event|0|||
106133952|NCT02014558|366148239|FG004|Overall Study|Adverse Event|1|||
106133953|NCT02014558|366148240|FG005|Overall Study|Adverse Event|0|||
106133954|NCT02014558|366148241|FG006|Overall Study|Adverse Event|0|||
106133955|NCT02014558|366148242|FG007|Overall Study|Adverse Event|0|||
106133956|NCT02014558|366148243|FG008|Overall Study|Adverse Event|2|||
106133957|NCT02014558|366148244|FG009|Overall Study|Adverse Event|2|||
106133958|NCT02014558|366148245|FG010|Overall Study|Adverse Event|5|||
106133959|NCT02014558|366148246|FG011|Overall Study|Adverse Event|21|||
106133960|NCT02014558|366148247|FG012|Overall Study|Adverse Event|3|||
106133961|NCT02014558|366148235|FG000|Overall Study|Death|1|||
106133962|NCT02014558|366148236|FG001|Overall Study|Death|0|||
106133963|NCT02014558|366148237|FG002|Overall Study|Death|0|||
106133964|NCT02014558|366148238|FG003|Overall Study|Death|0|||
106133965|NCT02014558|366148239|FG004|Overall Study|Death|0|||
106133966|NCT02014558|366148240|FG005|Overall Study|Death|0|||
106133967|NCT02014558|366148241|FG006|Overall Study|Death|1|||
106133968|NCT02014558|366148242|FG007|Overall Study|Death|1|||
106133969|NCT02014558|366148243|FG008|Overall Study|Death|2|||
106133970|NCT02014558|366148244|FG009|Overall Study|Death|5|||
106133971|NCT02014558|366148245|FG010|Overall Study|Death|5|||
106133972|NCT02014558|366148246|FG011|Overall Study|Death|19|||
106133973|NCT02014558|366148247|FG012|Overall Study|Death|2|||
106133974|NCT02014558|366148235|FG000|Overall Study|Lack of Efficacy|1|||
106133975|NCT02014558|366148236|FG001|Overall Study|Lack of Efficacy|2|||
106133976|NCT02014558|366148237|FG002|Overall Study|Lack of Efficacy|1|||
106133977|NCT02014558|366148238|FG003|Overall Study|Lack of Efficacy|1|||
106133978|NCT02014558|366148239|FG004|Overall Study|Lack of Efficacy|0|||
106133979|NCT02014558|366148240|FG005|Overall Study|Lack of Efficacy|0|||
106133980|NCT02014558|366148241|FG006|Overall Study|Lack of Efficacy|1|||
106133981|NCT02014558|366148242|FG007|Overall Study|Lack of Efficacy|3|||
106133982|NCT02014558|366148243|FG008|Overall Study|Lack of Efficacy|3|||
106133983|NCT02014558|366148244|FG009|Overall Study|Lack of Efficacy|3|||
106133984|NCT02014558|366148245|FG010|Overall Study|Lack of Efficacy|16|||
106133985|NCT02014558|366148246|FG011|Overall Study|Lack of Efficacy|8|||
105708534|NCT02443883|364592950|FG000|Overall Study|Lost to Follow-up|3|||
106133986|NCT02014558|366148247|FG012|Overall Study|Lack of Efficacy|5|||
106133987|NCT02014558|366148235|FG000|Overall Study|Lost to Follow-up|0|||
106133988|NCT02014558|366148236|FG001|Overall Study|Lost to Follow-up|0|||
106133989|NCT02014558|366148237|FG002|Overall Study|Lost to Follow-up|0|||
105708535|NCT02443883|364592951|FG001|Overall Study|Lost to Follow-up|2|||
105708536|NCT02443883|364592952|FG002|Overall Study|Lost to Follow-up|1|||
105708537|NCT02443883|364592953|FG003|Overall Study|Lost to Follow-up|0|||
105708538|NCT02443883|364592950|FG000|Overall Study|Physician Decision|1|||
105708539|NCT02443883|364592951|FG001|Overall Study|Physician Decision|1|||
105708540|NCT02443883|364592952|FG002|Overall Study|Physician Decision|0|||
105708541|NCT02443883|364592953|FG003|Overall Study|Physician Decision|3|||
105708542|NCT02443883|364592950|FG000|Overall Study|Withdrawal by Subject|1|||
105708543|NCT02443883|364592951|FG001|Overall Study|Withdrawal by Subject|0|||
105708544|NCT02443883|364592952|FG002|Overall Study|Withdrawal by Subject|0|||
105708545|NCT02443883|364592953|FG003|Overall Study|Withdrawal by Subject|2|||
105708546|NCT02443883|364592950|FG000|Overall Study|Randomized, but never treated|1|||
105708547|NCT02443883|364592951|FG001|Overall Study|Randomized, but never treated|0|||
105708548|NCT02443883|364592952|FG002|Overall Study|Randomized, but never treated|0|||
105708549|NCT02443883|364592953|FG003|Overall Study|Randomized, but never treated|0|||
105708550|NCT00446511|364592954|FG000|Overall Study|Adverse Event|7|||
105708551|NCT00446511|364592955|FG001|Overall Study|Adverse Event|2|||
105708552|NCT00446511|364592956|FG002|Overall Study|Adverse Event|3|||
105708553|NCT00446511|364592957|FG003|Overall Study|Adverse Event|1|||
105708554|NCT00446511|364592954|FG000|Overall Study|Protocol Violation|0|||
105708555|NCT00446511|364592955|FG001|Overall Study|Protocol Violation|0|||
105708556|NCT00446511|364592956|FG002|Overall Study|Protocol Violation|0|||
105708557|NCT00446511|364592957|FG003|Overall Study|Protocol Violation|1|||
106007401|NCT01668784|365692245|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
106007402|NCT01668784|365692244|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
106007403|NCT01668784|365692245|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
106007404|NCT01668784|365692244|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
106007405|NCT01668784|365692245|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
106007406|NCT01668784|365692244|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
106007407|NCT01668784|365692245|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
106007408|NCT01668784|365692244|FG000|Treatment Period|Disease Progression|316|||
105708558|NCT00446511|364592954|FG000|Overall Study|Withdrawal by Subject|0|||
106007409|NCT01668784|365692245|FG001|Treatment Period|Disease Progression|293|||
106007410|NCT01668784|365692244|FG000|Treatment Period|Study Drug Toxicity|46|||
106007411|NCT01668784|365692245|FG001|Treatment Period|Study Drug Toxicity|53|||
106007412|NCT01668784|365692244|FG000|Treatment Period|Death|1|||
106007413|NCT01668784|365692245|FG001|Treatment Period|Death|1|||
106007414|NCT01668784|365692244|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
106007415|NCT01668784|365692245|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
106007416|NCT01668784|365692244|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
106007417|NCT01668784|365692245|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
106007418|NCT01668784|365692244|FG000|Treatment Period|Withdrawal by Subject|5|||
106007419|NCT01668784|365692245|FG001|Treatment Period|Withdrawal by Subject|3|||
106007420|NCT01668784|365692244|FG000|Treatment Period|Maximal Clinical Benefit|3|||
106007421|NCT01668784|365692245|FG001|Treatment Period|Maximal Clinical Benefit|3|||
105708559|NCT00446511|364592955|FG001|Overall Study|Withdrawal by Subject|0|||
106007422|NCT01668784|365692244|FG000|Treatment Period|Other|2|||
106007423|NCT01668784|365692245|FG001|Treatment Period|Other|8|||
106007424|NCT01668784|365692244|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
106007425|NCT01668784|365692245|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
106007426|NCT00617734|365692247|FG000|Overall Study|Withdrew Consent|2|||
106007427|NCT00617734|365692248|FG001|Overall Study|Withdrew Consent|0|||
106007428|NCT00617734|365692247|FG000|Overall Study|Adverse Event|4|||
106007429|NCT00617734|365692248|FG001|Overall Study|Adverse Event|1|||
106007430|NCT00617734|365692247|FG000|Overall Study|Protocol Violation|1|||
106007431|NCT00617734|365692248|FG001|Overall Study|Protocol Violation|0|||
106007432|NCT00617734|365692247|FG000|Overall Study|Found Ineligible After Randomization|1|||
106007433|NCT00617734|365692248|FG001|Overall Study|Found Ineligible After Randomization|4|||
106133990|NCT02014558|366148238|FG003|Overall Study|Lost to Follow-up|0|||
105708560|NCT00446511|364592956|FG002|Overall Study|Withdrawal by Subject|0|||
105708561|NCT00446511|364592957|FG003|Overall Study|Withdrawal by Subject|3|||
106007434|NCT00617734|365692247|FG000|Overall Study|Lost to Follow-up|0|||
106007435|NCT00617734|365692248|FG001|Overall Study|Lost to Follow-up|1|||
106007436|NCT00604565|365692250|FG000|Overall Study|Study terminated|0|||
106007437|NCT00604565|365692251|FG001|Overall Study|Study terminated|3|||
106007438|NCT02260934|365692252|FG000|Overall Study|Lost to Follow-up|2|||
106133991|NCT02014558|366148239|FG004|Overall Study|Lost to Follow-up|0|||
105708562|NCT00446511|364592954|FG000|Overall Study|Administrative Problems|3|||
105708563|NCT00446511|364592955|FG001|Overall Study|Administrative Problems|0|||
105708564|NCT00446511|364592956|FG002|Overall Study|Administrative Problems|4|||
105708565|NCT00446511|364592957|FG003|Overall Study|Administrative Problems|1|||
105708566|NCT01265550|364592958|FG000|Pre Randomization|Withdrawal by Subject|0|||
105708567|NCT01265550|364592959|FG001|Pre Randomization|Withdrawal by Subject|0|||
105708568|NCT01265550|364592960|FG002|Pre Randomization|Withdrawal by Subject|0|||
105708569|NCT01265550|364592961|FG003|Pre Randomization|Withdrawal by Subject|70|||
105708570|NCT01265550|364592958|FG000|Pre Randomization|Technical Exclusions|0|||
105708571|NCT01265550|364592959|FG001|Pre Randomization|Technical Exclusions|0|||
105708572|NCT01265550|364592960|FG002|Pre Randomization|Technical Exclusions|0|||
105708573|NCT01265550|364592961|FG003|Pre Randomization|Technical Exclusions|54|||
105708574|NCT01265550|364592958|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
105708575|NCT01265550|364592959|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
105708576|NCT01265550|364592960|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
105708577|NCT01265550|364592961|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
105708578|NCT01265550|364592958|FG000|Pre Randomization|Non-GERD organic disorders|0|||
105708579|NCT01265550|364592959|FG001|Pre Randomization|Non-GERD organic disorders|0|||
105708580|NCT01265550|364592960|FG002|Pre Randomization|Non-GERD organic disorders|0|||
105708581|NCT01265550|364592961|FG003|Pre Randomization|Non-GERD organic disorders|23|||
105708582|NCT01265550|364592958|FG000|Pre Randomization|Functional heartburn|0|||
105708583|NCT01265550|364592959|FG001|Pre Randomization|Functional heartburn|0|||
105708584|NCT01265550|364592960|FG002|Pre Randomization|Functional heartburn|0|||
105708585|NCT01265550|364592961|FG003|Pre Randomization|Functional heartburn|99|||
105708586|NCT00075504|364592964|FG000|Overall Study|Withdrawal by Subject|9|||
105708587|NCT00075504|364592965|FG001|Overall Study|Withdrawal by Subject|7|||
105708588|NCT03436862|364592966|FG000|Overall Study|Adverse Event|4|||
105708589|NCT03436862|364592966|FG000|Overall Study|Progressive Disease|2|||
105708590|NCT00606086|364592967|FG000|Overall Study|Adverse Event|1|||
105708591|NCT00606086|364592968|FG001|Overall Study|Adverse Event|1|||
106133992|NCT02014558|366148240|FG005|Overall Study|Lost to Follow-up|0|||
106133993|NCT02014558|366148241|FG006|Overall Study|Lost to Follow-up|0|||
105708592|NCT00606086|364592967|FG000|Overall Study|Lost to Follow-up|4|||
105708593|NCT00606086|364592968|FG001|Overall Study|Lost to Follow-up|8|||
105927833|NCT00541229|365395283|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
105927834|NCT00541229|365395284|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
105927835|NCT00541229|365395285|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
105927836|NCT00541229|365395286|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
105927837|NCT00541229|365395281|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105927838|NCT00541229|365395282|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105927839|NCT00541229|365395283|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105927840|NCT00541229|365395284|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105927841|NCT00541229|365395285|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
105927842|NCT00541229|365395286|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
105927843|NCT00541229|365395281|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105927844|NCT00541229|365395282|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105927845|NCT00541229|365395283|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
105927846|NCT00541229|365395284|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105927847|NCT00541229|365395285|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105927848|NCT00541229|365395286|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
105927849|NCT00876395|365395287|FG000|Overall Study|Untreated|8|||
105927850|NCT00876395|365395288|FG001|Overall Study|Untreated|1|||
105927851|NCT00876395|365395287|FG000|Overall Study|Adverse Event|63|||
105927852|NCT00876395|365395288|FG001|Overall Study|Adverse Event|11|||
105927853|NCT00876395|365395287|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105927854|NCT00876395|365395288|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105927855|NCT00876395|365395287|FG000|Overall Study|Disease progression|259|||
105927856|NCT00876395|365395288|FG001|Overall Study|Disease progression|162|||
105927857|NCT00876395|365395287|FG000|Overall Study|New cancer therapy|25|||
105927858|NCT00876395|365395288|FG001|Overall Study|New cancer therapy|7|||
105927859|NCT00876395|365395287|FG000|Overall Study|Protocol Violation|5|||
105927860|NCT00876395|365395288|FG001|Overall Study|Protocol Violation|2|||
105927861|NCT00876395|365395287|FG000|Overall Study|Withdrawal by Subject|66|||
105927862|NCT00876395|365395288|FG001|Overall Study|Withdrawal by Subject|33|||
105927863|NCT00876395|365395287|FG000|Overall Study|Lost to Follow-up|2|||
105927864|NCT00876395|365395288|FG001|Overall Study|Lost to Follow-up|0|||
106133994|NCT02014558|366148242|FG007|Overall Study|Lost to Follow-up|0|||
106133995|NCT02014558|366148243|FG008|Overall Study|Lost to Follow-up|0|||
105708594|NCT00606086|364592967|FG000|Overall Study|Protocol Violation|1|||
105708595|NCT00606086|364592968|FG001|Overall Study|Protocol Violation|0|||
105708596|NCT00606086|364592967|FG000|Overall Study|Withdrawal by Subject|5|||
105788050|NCT00437294|364878170|FG001|Overall Study|Entry criteria not met|1|||
105927865|NCT00876395|365395287|FG000|Overall Study|Administrative problems|39|||
105927866|NCT00876395|365395288|FG001|Overall Study|Administrative problems|23|||
105927867|NCT00876395|365395287|FG000|Overall Study|Death|12|||
105927868|NCT00876395|365395288|FG001|Overall Study|Death|0|||
105708597|NCT00606086|364592968|FG001|Overall Study|Withdrawal by Subject|3|||
105708598|NCT00606086|364592967|FG000|Overall Study|Non-compliance|0|||
105708599|NCT00606086|364592968|FG001|Overall Study|Non-compliance|1|||
105708600|NCT00606086|364592967|FG000|Overall Study|Randomized, not treated|1|||
105788051|NCT02660489|364878174|FG000|Overall Study|Lost to Follow-up|1|||
105927869|NCT03439839|365395289|FG000|Overall Study|Death|3|||
105708601|NCT00606086|364592968|FG001|Overall Study|Randomized, not treated|2|||
105708602|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
105708603|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
105708604|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
105708605|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
105708606|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105708607|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105708608|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
105708609|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105708610|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
105708611|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105708612|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105708613|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105708614|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
105708615|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
105708616|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
105708617|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
105708618|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
105708619|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
105708620|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
105708621|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
105708622|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
105708623|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
105708624|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
105708625|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
105708626|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
105708627|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708628|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708629|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708630|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708631|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
105708632|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708633|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
105708634|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708635|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708636|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708637|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
105708638|NCT03403205|364592973|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
105708639|NCT03403205|364592974|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
105708640|NCT03403205|364592975|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
105708641|NCT03403205|364592976|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
105708642|NCT03403205|364592977|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
105708643|NCT03403205|364592978|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
105708644|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
105708645|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
105708646|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
105708647|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
105708648|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
105708649|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
105708650|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
105708651|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
105708652|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
105708653|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
105708654|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
105708655|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
105708656|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Death|1|||
105708657|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Death|0|||
105708658|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Death|0|||
105708659|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Death|0|||
105708660|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Death|0|||
105708661|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Death|0|||
105708662|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
105708663|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105708664|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
106007439|NCT02260934|365692253|FG001|Overall Study|Lost to Follow-up|1|||
106007440|NCT02260934|365692252|FG000|Overall Study|Withdrawal by Subject|0|||
106007441|NCT02260934|365692253|FG001|Overall Study|Withdrawal by Subject|2|||
105708665|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105708666|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105708667|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
105708668|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
105708669|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
105708670|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
105708671|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
105708672|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
105708673|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
105708674|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
105708675|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708676|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708677|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708678|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708679|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
105708680|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
105708681|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
105708682|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
105708683|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
105708684|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
105708685|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
105708686|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
105708687|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
105708688|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
105708689|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
105708690|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
105708691|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
105708692|NCT03403205|364592973|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
105708693|NCT03403205|364592974|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
105708694|NCT03403205|364592975|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
105708695|NCT03403205|364592976|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
105708696|NCT03403205|364592977|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
105708697|NCT03403205|364592978|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
105708698|NCT00498173|364592982|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
105708699|NCT00498173|364592983|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
105708700|NCT00498173|364592984|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
105708701|NCT02289950|364592988|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
105708702|NCT02289950|364592989|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
105708703|NCT02289950|364592988|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
105708704|NCT02289950|364592989|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
105708705|NCT02289950|364592988|FG000|Overall Study|Lost to Follow-up|1|||
105708706|NCT02289950|364592989|FG001|Overall Study|Lost to Follow-up|0|||
105708707|NCT02289950|364592988|FG000|Overall Study|Physician Decision|9|||
105708708|NCT02289950|364592989|FG001|Overall Study|Physician Decision|3|||
105708709|NCT02289950|364592988|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
105708710|NCT02289950|364592989|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
105708711|NCT02289950|364592988|FG000|Overall Study|Withdrawal by Subject|1|||
105708712|NCT02289950|364592989|FG001|Overall Study|Withdrawal by Subject|3|||
105708713|NCT02289950|364592988|FG000|Overall Study|Test article held for greater than 28 days|0|||
105708714|NCT02289950|364592989|FG001|Overall Study|Test article held for greater than 28 days|1|||
105927870|NCT03439839|365395290|FG001|Overall Study|Death|0|||
105708715|NCT02289950|364592988|FG000|Overall Study|Adverse Event|11|||
105927871|NCT03720847|365395291|FG000|Washout|Physician Decision|1|||
105927872|NCT03720847|365395292|FG001|Washout|Physician Decision|2|||
105927873|NCT01239680|365395297|FG000|Overall Study|Withdrawal by Subject|2|||
105927874|NCT01239680|365395298|FG001|Overall Study|Withdrawal by Subject|0|||
105927875|NCT03033901|365395299|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
105927876|NCT03033901|365395299|FG000|Overall Study|Refused PSG|23|||
105927877|NCT03033901|365395299|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
105927878|NCT03033901|365395299|FG000|Overall Study|Missing Oximetry Data|3|||
105708716|NCT02289950|364592989|FG001|Overall Study|Adverse Event|3|||
105708717|NCT02289950|364592988|FG000|Overall Study|Death|1|||
105708718|NCT02289950|364592989|FG001|Overall Study|Death|1|||
105708719|NCT02289950|364592988|FG000|Overall Study|Other|5|||
105927879|NCT00924651|365395302|FG000|Overall Study|Chemo started too soon|2|||
105927880|NCT00924651|365395303|FG001|Overall Study|Chemo started too soon|3|||
105927881|NCT00924651|365395302|FG000|Overall Study|No Reason|3|||
105927882|NCT00924651|365395303|FG001|Overall Study|No Reason|7|||
105927883|NCT00924651|365395302|FG000|Overall Study|Overwhelmed|6|||
105927884|NCT00924651|365395303|FG001|Overall Study|Overwhelmed|6|||
106007442|NCT02260934|365692252|FG000|Overall Study|Participant Relocated|1|||
106007443|NCT02260934|365692253|FG001|Overall Study|Participant Relocated|0|||
106007444|NCT02260934|365692252|FG000|Overall Study|Site error|0|||
106007445|NCT02260934|365692253|FG001|Overall Study|Site error|1|||
105708720|NCT02289950|364592989|FG001|Overall Study|Other|2|||
105708721|NCT02289950|364592988|FG000|Overall Study|Not Treated|2|||
105708722|NCT02289950|364592989|FG001|Overall Study|Not Treated|1|||
105708723|NCT01394939|364594454|FG000|Overall Study|Adverse Event|1|||
105708724|NCT01394939|364594455|FG001|Overall Study|Adverse Event|3|||
105708725|NCT01394939|364594456|FG002|Overall Study|Adverse Event|0|||
105708726|NCT01394939|364594457|FG003|Overall Study|Adverse Event|2|||
105708727|NCT01394939|364594454|FG000|Overall Study|Death|0|||
105708728|NCT01394939|364594455|FG001|Overall Study|Death|2|||
105708729|NCT01394939|364594456|FG002|Overall Study|Death|0|||
105708730|NCT01394939|364594457|FG003|Overall Study|Death|0|||
105708731|NCT01394939|364594454|FG000|Overall Study|Physician Decision|0|||
105708732|NCT01394939|364594455|FG001|Overall Study|Physician Decision|1|||
105708733|NCT01394939|364594456|FG002|Overall Study|Physician Decision|0|||
105708734|NCT01394939|364594457|FG003|Overall Study|Physician Decision|0|||
105708735|NCT01394939|364594454|FG000|Overall Study|Withdrawal by Subject|0|||
105708736|NCT01394939|364594455|FG001|Overall Study|Withdrawal by Subject|2|||
105708737|NCT01394939|364594456|FG002|Overall Study|Withdrawal by Subject|0|||
105708738|NCT01394939|364594457|FG003|Overall Study|Withdrawal by Subject|2|||
105708739|NCT01394939|364594454|FG000|Overall Study|Others|0|||
105708740|NCT01394939|364594455|FG001|Overall Study|Others|2|||
105708741|NCT01394939|364594456|FG002|Overall Study|Others|0|||
105708742|NCT01394939|364594457|FG003|Overall Study|Others|3|||
105708743|NCT03368170|364594458|FG000|Overall Study|Adverse Event|2|||
105708744|NCT03368170|364594459|FG001|Overall Study|Adverse Event|1|||
105708745|NCT02068547|364594461|FG000|Overall Study|Lost to Follow-up|3|||
105708746|NCT02068547|364594462|FG001|Overall Study|Lost to Follow-up|3|||
105708747|NCT02068547|364594461|FG000|Overall Study|Physician Decision|1|||
105708748|NCT02068547|364594462|FG001|Overall Study|Physician Decision|0|||
105708749|NCT03657043|364594463|FG000|Overall Study|Withdrawal by Subject|1|||
105708750|NCT03657043|364594464|FG001|Overall Study|Withdrawal by Subject|1|||
105708751|NCT03657043|364594465|FG002|Overall Study|Withdrawal by Subject|0|||
105708752|NCT03657043|364594466|FG003|Overall Study|Withdrawal by Subject|0|||
105708753|NCT03657043|364594467|FG004|Overall Study|Withdrawal by Subject|4|||
105708754|NCT03657043|364594463|FG000|Overall Study|Study closure by Sponsor|0|||
105708755|NCT03657043|364594464|FG001|Overall Study|Study closure by Sponsor|2|||
105708756|NCT03657043|364594465|FG002|Overall Study|Study closure by Sponsor|0|||
105708757|NCT03657043|364594466|FG003|Overall Study|Study closure by Sponsor|0|||
105708758|NCT03657043|364594467|FG004|Overall Study|Study closure by Sponsor|17|||
105708759|NCT03657043|364594463|FG000|Overall Study|Lost to Follow-up|0|||
105708760|NCT03657043|364594464|FG001|Overall Study|Lost to Follow-up|0|||
105708761|NCT03657043|364594465|FG002|Overall Study|Lost to Follow-up|0|||
105708762|NCT03657043|364594466|FG003|Overall Study|Lost to Follow-up|0|||
105708763|NCT03657043|364594467|FG004|Overall Study|Lost to Follow-up|4|||
105708764|NCT03657043|364594463|FG000|Overall Study|Death|6|||
105708765|NCT03657043|364594464|FG001|Overall Study|Death|5|||
105708766|NCT03657043|364594465|FG002|Overall Study|Death|0|||
105708767|NCT03657043|364594466|FG003|Overall Study|Death|0|||
105708768|NCT03657043|364594467|FG004|Overall Study|Death|53|||
105708769|NCT03657043|364594463|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
105708770|NCT03657043|364594464|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
105708771|NCT03657043|364594465|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
105708772|NCT03657043|364594466|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
105708773|NCT03657043|364594467|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
105708774|NCT03657043|364594463|FG000|Overall Study|Adverse Event|0|||
105708775|NCT03657043|364594464|FG001|Overall Study|Adverse Event|0|||
105708776|NCT03657043|364594465|FG002|Overall Study|Adverse Event|0|||
105708777|NCT03657043|364594466|FG003|Overall Study|Adverse Event|0|||
105708778|NCT03657043|364594467|FG004|Overall Study|Adverse Event|2|||
105708779|NCT03657043|364594463|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
105708780|NCT03657043|364594464|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
105708781|NCT03657043|364594465|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
105927885|NCT00924651|365395302|FG000|Overall Study|Noncompliant|1|||
105927886|NCT00924651|365395303|FG001|Overall Study|Noncompliant|4|||
105927887|NCT00924651|365395302|FG000|Overall Study|Medical|1|||
106133996|NCT02014558|366148244|FG009|Overall Study|Lost to Follow-up|0|||
105708782|NCT03657043|364594466|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
105708783|NCT03657043|364594467|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
105708784|NCT03657043|364594463|FG000|Overall Study|Withdrawal - declined follow-up|0|||
105708785|NCT03657043|364594464|FG001|Overall Study|Withdrawal - declined follow-up|0|||
105708786|NCT03657043|364594465|FG002|Overall Study|Withdrawal - declined follow-up|0|||
105708787|NCT03657043|364594466|FG003|Overall Study|Withdrawal - declined follow-up|0|||
105708788|NCT03657043|364594467|FG004|Overall Study|Withdrawal - declined follow-up|1|||
105708789|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
105708790|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
105708791|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
105708792|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
105788052|NCT02660489|364878175|FG001|Overall Study|Lost to Follow-up|1|||
106133997|NCT02014558|366148245|FG010|Overall Study|Lost to Follow-up|1|||
106133998|NCT02014558|366148246|FG011|Overall Study|Lost to Follow-up|0|||
106133999|NCT02014558|366148247|FG012|Overall Study|Lost to Follow-up|0|||
106134000|NCT02014558|366148235|FG000|Overall Study|Progressive Disease|1|||
106134001|NCT02014558|366148236|FG001|Overall Study|Progressive Disease|0|||
106134002|NCT02014558|366148237|FG002|Overall Study|Progressive Disease|1|||
105708793|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
105708794|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
105708795|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
105708796|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
106134003|NCT02014558|366148238|FG003|Overall Study|Progressive Disease|1|||
106134004|NCT02014558|366148239|FG004|Overall Study|Progressive Disease|1|||
105708797|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
105708798|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
105708799|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
105708800|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
105708801|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
105708802|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
105708803|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
105708804|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
105708805|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
105708806|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
105708807|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
105708808|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
105708809|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
105788053|NCT02660489|364878174|FG000|Overall Study|Adverse Event|1|||
105788054|NCT02660489|364878175|FG001|Overall Study|Adverse Event|3|||
105788055|NCT02660489|364878174|FG000|Overall Study|no rhinovirus infection|4|||
105927888|NCT00924651|365395303|FG001|Overall Study|Medical|3|||
105927889|NCT00924651|365395302|FG000|Overall Study|Changed Mind|10|||
105927890|NCT00924651|365395303|FG001|Overall Study|Changed Mind|1|||
105927891|NCT00924651|365395302|FG000|Overall Study|Incomplete Form|2|||
105927892|NCT00924651|365395303|FG001|Overall Study|Incomplete Form|1|||
105927893|NCT03915067|365395306|FG000|Overall Study|Adverse Event|0|||
105927894|NCT03915067|365395307|FG001|Overall Study|Adverse Event|0|||
105927895|NCT03915067|365395308|FG002|Overall Study|Adverse Event|1|||
105927896|NCT03915067|365395306|FG000|Overall Study|Withdrawal by Subject|4|||
105927897|NCT03915067|365395307|FG001|Overall Study|Withdrawal by Subject|3|||
105927898|NCT03915067|365395308|FG002|Overall Study|Withdrawal by Subject|0|||
105927899|NCT03915067|365395306|FG000|Overall Study|Lost to Follow-up|3|||
105927900|NCT03915067|365395307|FG001|Overall Study|Lost to Follow-up|2|||
105927901|NCT03915067|365395308|FG002|Overall Study|Lost to Follow-up|0|||
105927902|NCT03915067|365395306|FG000|Overall Study|Protocol Deviation|0|||
105927903|NCT03915067|365395307|FG001|Overall Study|Protocol Deviation|0|||
105927904|NCT03915067|365395308|FG002|Overall Study|Protocol Deviation|1|||
105927905|NCT03915067|365395306|FG000|Overall Study|Covid-19 Related Issues|2|||
105927906|NCT03915067|365395307|FG001|Overall Study|Covid-19 Related Issues|4|||
105927907|NCT03915067|365395308|FG002|Overall Study|Covid-19 Related Issues|4|||
105927908|NCT03915067|365395306|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
105927909|NCT03915067|365395307|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
105927910|NCT03915067|365395308|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
105927911|NCT03317496|365395309|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
105927912|NCT03317496|365395310|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
105927913|NCT03317496|365395311|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
105927914|NCT03317496|365395312|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
105927915|NCT03317496|365395313|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
105927916|NCT03317496|365395309|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
105927917|NCT03317496|365395310|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
105927918|NCT03317496|365395311|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
105927919|NCT03317496|365395312|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
105927920|NCT03317496|365395313|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
105927921|NCT03317496|365395309|FG000|Phase 1b Lead-in: Treatment|Death|0|||
105927922|NCT03317496|365395310|FG001|Phase 1b Lead-in: Treatment|Death|0|||
105927923|NCT03317496|365395311|FG002|Phase 1b Lead-in: Treatment|Death|1|||
105927924|NCT03317496|365395312|FG003|Phase 1b Lead-in: Treatment|Death|0|||
105927925|NCT03317496|365395313|FG004|Phase 1b Lead-in: Treatment|Death|0|||
105927926|NCT03317496|365395309|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
106134005|NCT02014558|366148240|FG005|Overall Study|Progressive Disease|2|||
105927927|NCT03317496|365395310|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
105927928|NCT03317496|365395311|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
105927929|NCT03317496|365395312|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
105927930|NCT03317496|365395313|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
105927931|NCT03317496|365395309|FG000|Phase 1b Lead-in: Treatment|Other|2|||
105927932|NCT03317496|365395310|FG001|Phase 1b Lead-in: Treatment|Other|1|||
105708810|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
105708811|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
105708812|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
105708813|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
105708814|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
105708815|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
105708816|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
105708817|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
105708818|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
105708819|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
105708820|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
105708821|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
105708822|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
105708823|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
105708824|NCT02831673|364594468|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
105708825|NCT02831673|364594469|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
105708826|NCT02831673|364594470|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
105708827|NCT02831673|364594471|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
105708828|NCT02831673|364594472|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
105708829|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105708830|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105708831|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
105708832|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
105708833|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
105708834|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105708835|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105708836|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
105708837|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
105708838|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
105708839|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105708840|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105708841|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105708842|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
105927933|NCT03317496|365395311|FG002|Phase 1b Lead-in: Treatment|Other|0|||
105927934|NCT03317496|365395312|FG003|Phase 1b Lead-in: Treatment|Other|0|||
105927935|NCT03317496|365395313|FG004|Phase 1b Lead-in: Treatment|Other|0|||
105927936|NCT03317496|365395309|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
105927937|NCT03317496|365395310|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
105927938|NCT03317496|365395311|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
105927939|NCT03317496|365395312|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
105927940|NCT03317496|365395313|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
105927941|NCT03317496|365395309|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
105927942|NCT03317496|365395310|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
105927943|NCT03317496|365395311|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
105927944|NCT03317496|365395312|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
105927945|NCT03317496|365395313|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
105927946|NCT03317496|365395309|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
105927947|NCT03317496|365395310|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
105927948|NCT03317496|365395311|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
105927949|NCT03317496|365395312|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
105927950|NCT03317496|365395313|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
105927951|NCT03317496|365395309|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
105927952|NCT03317496|365395310|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
105927953|NCT03317496|365395311|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
105927954|NCT03317496|365395312|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
105927955|NCT03317496|365395313|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
105927956|NCT03317496|365395309|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
105927957|NCT03317496|365395310|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
105927958|NCT03317496|365395311|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
105927959|NCT03317496|365395312|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
105927960|NCT03317496|365395313|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
105927961|NCT03317496|365395309|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
105927962|NCT03317496|365395310|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
105927963|NCT03317496|365395311|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
105927964|NCT03317496|365395312|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
105927965|NCT03317496|365395313|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
105927966|NCT03317496|365395309|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
106134006|NCT02014558|366148241|FG006|Overall Study|Progressive Disease|1|||
106134007|NCT02014558|366148242|FG007|Overall Study|Progressive Disease|6|||
105708843|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
105708844|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
105708845|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
105708846|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
105708847|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
105708848|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
105708849|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105708850|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105708851|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
105708852|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
105708853|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
105708854|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105708855|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105708856|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
105708857|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
105708858|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
105708859|NCT02831673|364594468|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105708860|NCT02831673|364594469|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105708861|NCT02831673|364594470|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
105708862|NCT02831673|364594471|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
105708863|NCT02831673|364594472|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
105708864|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
105708865|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
105708866|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
105708867|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
105708868|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
105708869|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105708870|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105708871|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105708872|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
105708873|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
105708874|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105708875|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105708876|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105708877|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
105708878|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
105708879|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105708880|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105708881|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105708882|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
105708883|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
105708884|NCT02831673|364594468|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105708885|NCT02831673|364594469|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105708886|NCT02831673|364594470|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105708887|NCT02831673|364594471|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
105708888|NCT02831673|364594472|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
105708889|NCT03047980|364594473|FG000|Overall Study|Adverse Event|1|||
105708890|NCT01408147|364594474|FG000|Overall Study|Withdrawal by Subject|0|||
105708891|NCT01408147|364594475|FG001|Overall Study|Withdrawal by Subject|1|||
105708892|NCT02229552|364594476|FG000|Baseline|Withdrawal by Subject|6|||
105708893|NCT02229552|364594476|FG000|1-year Follow up|Withdrawal by Subject|7|||
105708894|NCT02229552|364594476|FG000|1-year Follow up|Lost to Follow-up|18|||
105708895|NCT02229552|364594476|FG000|2-Year Follow up|Withdrawal by Subject|9|||
105708896|NCT02229552|364594476|FG000|2-Year Follow up|Lost to Follow-up|17|||
105708897|NCT00746252|364594477|FG000|Overall Study|weight gain >7.5 %|1|||
105708898|NCT00746252|364594478|FG001|Overall Study|weight gain >7.5 %|2|||
105708899|NCT01049035|364594479|FG000|Overall Study|Serious adverse event|0|||
105708900|NCT01049035|364594480|FG001|Overall Study|Serious adverse event|1|||
105708901|NCT01049035|364594481|FG002|Overall Study|Serious adverse event|1|||
105708902|NCT01049035|364594482|FG003|Overall Study|Serious adverse event|2|||
105708903|NCT01049035|364594483|FG004|Overall Study|Serious adverse event|0|||
105708904|NCT01049035|364594484|FG005|Overall Study|Serious adverse event|0|||
105708905|NCT01049035|364594485|FG006|Overall Study|Serious adverse event|0|||
105708906|NCT01049035|364594479|FG000|Overall Study|Other adverse event (AE)|0|||
105708907|NCT01049035|364594480|FG001|Overall Study|Other adverse event (AE)|0|||
105708908|NCT01049035|364594481|FG002|Overall Study|Other adverse event (AE)|0|||
105708909|NCT01049035|364594482|FG003|Overall Study|Other adverse event (AE)|1|||
105708910|NCT01049035|364594483|FG004|Overall Study|Other adverse event (AE)|0|||
105708911|NCT01049035|364594484|FG005|Overall Study|Other adverse event (AE)|0|||
105708912|NCT01049035|364594485|FG006|Overall Study|Other adverse event (AE)|0|||
105708913|NCT01049035|364594479|FG000|Overall Study|Non-compliance with the protocol|12|||
105708914|NCT01049035|364594480|FG001|Overall Study|Non-compliance with the protocol|6|||
105708915|NCT01049035|364594481|FG002|Overall Study|Non-compliance with the protocol|14|||
105708916|NCT01049035|364594482|FG003|Overall Study|Non-compliance with the protocol|5|||
105708917|NCT01049035|364594483|FG004|Overall Study|Non-compliance with the protocol|3|||
105708918|NCT01049035|364594484|FG005|Overall Study|Non-compliance with the protocol|4|||
105708919|NCT01049035|364594485|FG006|Overall Study|Non-compliance with the protocol|10|||
105708920|NCT01049035|364594479|FG000|Overall Study|Lost to Follow-up|5|||
105708921|NCT01049035|364594480|FG001|Overall Study|Lost to Follow-up|4|||
105708922|NCT01049035|364594481|FG002|Overall Study|Lost to Follow-up|4|||
105708923|NCT01049035|364594482|FG003|Overall Study|Lost to Follow-up|1|||
105708924|NCT01049035|364594483|FG004|Overall Study|Lost to Follow-up|0|||
105708925|NCT01049035|364594484|FG005|Overall Study|Lost to Follow-up|3|||
105708926|NCT01049035|364594485|FG006|Overall Study|Lost to Follow-up|3|||
105708927|NCT01049035|364594479|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
105708928|NCT01049035|364594480|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
105708929|NCT01049035|364594481|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
105708930|NCT01049035|364594482|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
105708931|NCT01049035|364594483|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
105708932|NCT01049035|364594484|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
105708933|NCT01049035|364594485|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
105708934|NCT03927105|364594486|FG000|Overall Study|Death|1|||
105708935|NCT03927105|364594486|FG000|Overall Study|In observation for potential re-treatment|2|||
105708936|NCT03927105|364594486|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
105708937|NCT00082888|364594489|FG000|Overall Study|Ineligible|1|||
105708938|NCT00082888|364594490|FG001|Overall Study|Ineligible|0|||
105708939|NCT00082888|364594491|FG002|Overall Study|Ineligible|0|||
105708940|NCT02239939|364594492|FG000|Overall Study|Adverse Event|1|||
105708941|NCT02239939|364594493|FG001|Overall Study|Adverse Event|0|||
105708942|NCT02239939|364594492|FG000|Overall Study|Withdrawal by Subject|1|||
105708943|NCT02239939|364594493|FG001|Overall Study|Withdrawal by Subject|1|||
105708944|NCT02239939|364594492|FG000|Overall Study|Lost to Follow-up|0|||
105708945|NCT02239939|364594493|FG001|Overall Study|Lost to Follow-up|1|||
105708946|NCT01659320|364594494|FG000|Overall Study|Withdrawal by Subject|2|||
105708947|NCT01659320|364594494|FG000|Overall Study|Physician Decision|1|||
105708948|NCT01514682|364594495|FG000|Overall Study|Withdrawal by Subject|2|||
105708949|NCT01514682|364594496|FG001|Overall Study|Withdrawal by Subject|3|||
105708950|NCT01514682|364594495|FG000|Overall Study|Physician Decision|4|||
105708951|NCT01514682|364594496|FG001|Overall Study|Physician Decision|3|||
105708952|NCT00820898|364594499|FG000|Overall Study|Inelgible - wrong primary site|1|||
105708953|NCT02721355|364594502|FG000|Overall Study|Lost to Follow-up|6|||
105708954|NCT02721355|364594503|FG001|Overall Study|Lost to Follow-up|1|||
105708955|NCT04312009|364594504|FG000|Overall Study|Withdrawal by Subject|2|||
105708956|NCT04312009|364594505|FG001|Overall Study|Withdrawal by Subject|1|||
105708957|NCT02192827|364594506|FG000|Overall Study|Lost to Follow-up|25|||
105708958|NCT02192827|364594507|FG001|Overall Study|Lost to Follow-up|27|||
105708959|NCT02192827|364594506|FG000|Overall Study|Given additional steroids with admission|13|||
105708960|NCT02192827|364594507|FG001|Overall Study|Given additional steroids with admission|11|||
105708961|NCT00414453|364594514|FG000|Overall Study|Abnormal lab work|16|||
105708962|NCT00290433|364594517|FG000|Overall Study|Disease Progression|13|||
105708963|NCT00290433|364594517|FG000|Overall Study|Adverse Event|14|||
105708964|NCT00290433|364594517|FG000|Overall Study|Withdrawal by Subject|1|||
105708965|NCT00290433|364594517|FG000|Overall Study|Non-Compliance|1|||
105708966|NCT00290433|364594517|FG000|Overall Study|Congestive Heart Failure|1|||
105708967|NCT00290433|364594517|FG000|Overall Study|Transplant in CR|5|||
106134008|NCT02014558|366148243|FG008|Overall Study|Progressive Disease|5|||
106134009|NCT02014558|366148244|FG009|Overall Study|Progressive Disease|6|||
106134010|NCT02014558|366148245|FG010|Overall Study|Progressive Disease|22|||
106134011|NCT02014558|366148246|FG011|Overall Study|Progressive Disease|31|||
106134012|NCT02014558|366148247|FG012|Overall Study|Progressive Disease|6|||
105708968|NCT00290433|364594517|FG000|Overall Study|Unrelated Infection/Death|1|||
105708969|NCT02559687|364594518|FG000|Overall Study|Death|112|||
105708970|NCT02559687|364594518|FG000|Overall Study|Sponsor Decision|5|||
105708971|NCT02559687|364594518|FG000|Overall Study|Withdrawal by Subject|4|||
105708972|NCT02264990|364594523|FG000|Overall Study|Death|255|||
105708973|NCT02264990|364594524|FG001|Overall Study|Death|250|||
105708974|NCT02264990|364594523|FG000|Overall Study|Withdrawal by Subject|4|||
105708975|NCT02264990|364594524|FG001|Overall Study|Withdrawal by Subject|5|||
105708976|NCT02264990|364594523|FG000|Overall Study|Lost to Follow-up|1|||
105708977|NCT02264990|364594524|FG001|Overall Study|Lost to Follow-up|3|||
105708978|NCT02264990|364594523|FG000|Overall Study|Other|0|||
105708979|NCT02264990|364594524|FG001|Overall Study|Other|1|||
105708980|NCT00790907|364594528|FG000|Overall Study|Adverse Event|9|||
105708981|NCT00790907|364594529|FG001|Overall Study|Adverse Event|7|||
105708982|NCT00790907|364594530|FG002|Overall Study|Adverse Event|6|||
105708983|NCT00790907|364594528|FG000|Overall Study|Physician Decision|304|||
105708984|NCT00790907|364594529|FG001|Overall Study|Physician Decision|271|||
105708985|NCT00790907|364594530|FG002|Overall Study|Physician Decision|255|||
105708986|NCT00790907|364594528|FG000|Overall Study|Withdrawal by Subject|1|||
105708987|NCT00790907|364594529|FG001|Overall Study|Withdrawal by Subject|7|||
105708988|NCT00790907|364594530|FG002|Overall Study|Withdrawal by Subject|5|||
105708989|NCT00790907|364594528|FG000|Overall Study|Bleeding Event|11|||
105708990|NCT00790907|364594529|FG001|Overall Study|Bleeding Event|16|||
105708991|NCT00790907|364594530|FG002|Overall Study|Bleeding Event|21|||
105708992|NCT00790907|364594528|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
105708993|NCT00790907|364594529|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
105708994|NCT00790907|364594530|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
105708995|NCT00790907|364594528|FG000|Overall Study|Qualifying Condition Not Present|29|||
105708996|NCT00790907|364594529|FG001|Overall Study|Qualifying Condition Not Present|14|||
105708997|NCT00790907|364594530|FG002|Overall Study|Qualifying Condition Not Present|16|||
105708998|NCT00790907|364594528|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
106007446|NCT00517296|365692254|FG000|Overall Study|Withdrawal by Subject|1|||
106007447|NCT00517296|365692255|FG001|Overall Study|Withdrawal by Subject|0|||
106007448|NCT04366349|365692256|FG000|Overall Study|Withdrawal by Subject|1|||
106007449|NCT04366349|365692257|FG001|Overall Study|Withdrawal by Subject|0|||
106007450|NCT04366349|365692258|FG002|Overall Study|Withdrawal by Subject|0|||
106007451|NCT04366349|365692259|FG003|Overall Study|Withdrawal by Subject|0|||
106007452|NCT04366349|365692260|FG004|Overall Study|Withdrawal by Subject|0|||
106007453|NCT04366349|365692261|FG005|Overall Study|Withdrawal by Subject|0|||
106007454|NCT03413891|365692265|FG000|Overall Study|Lost to Follow-up|2|||
106007455|NCT03413891|365692266|FG001|Overall Study|Lost to Follow-up|1|||
106007456|NCT03413891|365692265|FG000|Overall Study|Protocol Violation|0|||
106007457|NCT03413891|365692266|FG001|Overall Study|Protocol Violation|1|||
106007458|NCT03474588|365692270|FG000|Overall Study|Withdrawal by Subject|4|||
106007459|NCT03474588|365692271|FG001|Overall Study|Withdrawal by Subject|3|||
106007460|NCT03474588|365692270|FG000|Overall Study|Death|0|||
106007461|NCT03474588|365692271|FG001|Overall Study|Death|1|||
106134013|NCT02014558|366148235|FG000|Overall Study|Withdrawal by Subject|0|||
106134014|NCT02014558|366148236|FG001|Overall Study|Withdrawal by Subject|0|||
106134015|NCT02014558|366148237|FG002|Overall Study|Withdrawal by Subject|0|||
106134016|NCT02014558|366148238|FG003|Overall Study|Withdrawal by Subject|0|||
106134017|NCT02014558|366148239|FG004|Overall Study|Withdrawal by Subject|1|||
106134018|NCT02014558|366148240|FG005|Overall Study|Withdrawal by Subject|0|||
106134019|NCT02014558|366148241|FG006|Overall Study|Withdrawal by Subject|0|||
106134020|NCT02014558|366148242|FG007|Overall Study|Withdrawal by Subject|0|||
106134021|NCT02014558|366148243|FG008|Overall Study|Withdrawal by Subject|0|||
106134022|NCT02014558|366148244|FG009|Overall Study|Withdrawal by Subject|2|||
106134023|NCT02014558|366148245|FG010|Overall Study|Withdrawal by Subject|6|||
106134024|NCT02014558|366148246|FG011|Overall Study|Withdrawal by Subject|10|||
106134025|NCT02014558|366148247|FG012|Overall Study|Withdrawal by Subject|0|||
106134026|NCT02014558|366148235|FG000|Overall Study|Miscellaneous|2|||
106134027|NCT02014558|366148236|FG001|Overall Study|Miscellaneous|1|||
106134028|NCT02014558|366148237|FG002|Overall Study|Miscellaneous|1|||
106134029|NCT02014558|366148238|FG003|Overall Study|Miscellaneous|1|||
106134030|NCT02014558|366148239|FG004|Overall Study|Miscellaneous|0|||
106134031|NCT02014558|366148240|FG005|Overall Study|Miscellaneous|1|||
106134032|NCT02014558|366148241|FG006|Overall Study|Miscellaneous|0|||
106134033|NCT02014558|366148242|FG007|Overall Study|Miscellaneous|1|||
106134034|NCT02014558|366148243|FG008|Overall Study|Miscellaneous|1|||
106134035|NCT02014558|366148244|FG009|Overall Study|Miscellaneous|3|||
106134036|NCT02014558|366148245|FG010|Overall Study|Miscellaneous|12|||
105708999|NCT00790907|364594529|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
105709000|NCT00790907|364594530|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
105709001|NCT00790907|364594528|FG000|Overall Study|Did Not Receive Study Drug|10|||
105709002|NCT00790907|364594529|FG001|Overall Study|Did Not Receive Study Drug|0|||
106007462|NCT01607957|365692273|FG000|Overall Study|Not treated|1|||
106134037|NCT02014558|366148246|FG011|Overall Study|Miscellaneous|11|||
106134038|NCT02014558|366148247|FG012|Overall Study|Miscellaneous|1|||
105709003|NCT00790907|364594530|FG002|Overall Study|Did Not Receive Study Drug|0|||
105709004|NCT01618214|364594531|FG000|Overall Study|Adverse Event|3|||
105709005|NCT01618214|364594532|FG001|Overall Study|Adverse Event|1|||
106007463|NCT01607957|365692274|FG001|Overall Study|Not treated|1|||
106007464|NCT01607957|365692273|FG000|Overall Study|Death|367|||
106134039|NCT04580407|366148248|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
106134040|NCT05567159|366148258|FG000|Overall Study|Adverse Event|4|||
105709006|NCT01618214|364594531|FG000|Overall Study|Lack of Efficacy|1|||
105709007|NCT01618214|364594532|FG001|Overall Study|Lack of Efficacy|1|||
106134041|NCT05567159|366148258|FG000|Overall Study|Physician Decision|3|||
106134042|NCT05567159|366148258|FG000|Overall Study|Protocol deviation|1|||
106134043|NCT03158948|366150315|FG000|Overall Study|Death|1|||
106134044|NCT03158948|366150316|FG001|Overall Study|Death|1|||
106134045|NCT03158948|366150317|FG002|Overall Study|Death|3|||
106134046|NCT03158948|366150318|FG003|Overall Study|Death|2|||
106134047|NCT03158948|366150315|FG000|Overall Study|Physician Decision|0|||
106134048|NCT03158948|366150316|FG001|Overall Study|Physician Decision|0|||
106134049|NCT03158948|366150317|FG002|Overall Study|Physician Decision|0|||
106134050|NCT03158948|366150318|FG003|Overall Study|Physician Decision|1|||
106134051|NCT02153788|366150319|FG000|Overall Study|Physician Decision|2|||
106134052|NCT02153788|366150320|FG001|Overall Study|Physician Decision|1|||
106134053|NCT00256308|366150323|FG000|Overall Study|Death|2|||
106134054|NCT01195675|366150327|FG000|Overall Study|Adverse Event|1|||
106134055|NCT01195675|366150327|FG000|Overall Study|Withdrawal by Subject|2|||
106134056|NCT00072475|366150328|FG000|Overall Study|Adverse Event|44|||
106134057|NCT00072475|366150328|FG000|Overall Study|Death|3|||
105927967|NCT03317496|365395310|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
105927968|NCT03317496|365395311|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
105927969|NCT03317496|365395312|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
105927970|NCT03317496|365395313|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
105927971|NCT03317496|365395309|FG000|Phase 2: Treatment|Adverse Event|0|||
105927972|NCT03317496|365395310|FG001|Phase 2: Treatment|Adverse Event|0|||
105927973|NCT03317496|365395311|FG002|Phase 2: Treatment|Adverse Event|0|||
105927974|NCT03317496|365395312|FG003|Phase 2: Treatment|Adverse Event|0|||
105927975|NCT03317496|365395313|FG004|Phase 2: Treatment|Adverse Event|6|||
105927976|NCT03317496|365395309|FG000|Phase 2: Treatment|Progressive disease|0|||
105927977|NCT03317496|365395310|FG001|Phase 2: Treatment|Progressive disease|0|||
105927978|NCT03317496|365395311|FG002|Phase 2: Treatment|Progressive disease|0|||
105927979|NCT03317496|365395312|FG003|Phase 2: Treatment|Progressive disease|0|||
105927980|NCT03317496|365395313|FG004|Phase 2: Treatment|Progressive disease|22|||
105927981|NCT03317496|365395309|FG000|Phase 2: Treatment|Other|0|||
105927982|NCT03317496|365395310|FG001|Phase 2: Treatment|Other|0|||
105927983|NCT03317496|365395311|FG002|Phase 2: Treatment|Other|0|||
105927984|NCT03317496|365395312|FG003|Phase 2: Treatment|Other|0|||
105927985|NCT03317496|365395313|FG004|Phase 2: Treatment|Other|4|||
105927986|NCT03317496|365395309|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
105927987|NCT03317496|365395310|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
105927988|NCT03317496|365395311|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
105927989|NCT03317496|365395312|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
105927990|NCT03317496|365395313|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
105927991|NCT03317496|365395309|FG000|Phase 2: Treatment|Physician Decision|0|||
105927992|NCT03317496|365395310|FG001|Phase 2: Treatment|Physician Decision|0|||
105927993|NCT03317496|365395311|FG002|Phase 2: Treatment|Physician Decision|0|||
105927994|NCT03317496|365395312|FG003|Phase 2: Treatment|Physician Decision|0|||
105927995|NCT03317496|365395313|FG004|Phase 2: Treatment|Physician Decision|1|||
105927996|NCT03317496|365395309|FG000|Phase 2: Treatment|Death|0|||
105927997|NCT03317496|365395310|FG001|Phase 2: Treatment|Death|0|||
105927998|NCT03317496|365395311|FG002|Phase 2: Treatment|Death|0|||
105927999|NCT03317496|365395312|FG003|Phase 2: Treatment|Death|0|||
105928000|NCT03317496|365395313|FG004|Phase 2: Treatment|Death|1|||
105928001|NCT03317496|365395309|FG000|Phase 2: Follow-up|Death|0|||
105928002|NCT03317496|365395310|FG001|Phase 2: Follow-up|Death|0|||
105928003|NCT03317496|365395311|FG002|Phase 2: Follow-up|Death|0|||
105928004|NCT03317496|365395312|FG003|Phase 2: Follow-up|Death|0|||
105928005|NCT03317496|365395313|FG004|Phase 2: Follow-up|Death|24|||
105928006|NCT03317496|365395309|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
105928007|NCT03317496|365395310|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
105928008|NCT03317496|365395311|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
105928009|NCT03317496|365395312|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
105928010|NCT03317496|365395313|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
105928011|NCT03317496|365395309|FG000|Phase 2: Follow-up|Other|0|||
105928012|NCT03317496|365395310|FG001|Phase 2: Follow-up|Other|0|||
105928013|NCT03317496|365395311|FG002|Phase 2: Follow-up|Other|0|||
105928014|NCT03317496|365395312|FG003|Phase 2: Follow-up|Other|0|||
105928015|NCT03317496|365395313|FG004|Phase 2: Follow-up|Other|1|||
105928016|NCT03317496|365395309|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
105928017|NCT03317496|365395310|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
105928018|NCT03317496|365395311|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
105928019|NCT03317496|365395312|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
105928020|NCT03317496|365395313|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
105928021|NCT01750346|365395314|FG000|Overall Study|Adverse Event|1|||
105928022|NCT01750346|365395315|FG001|Overall Study|Adverse Event|0|||
105928023|NCT01750346|365395316|FG002|Overall Study|Adverse Event|0|||
105928024|NCT02260986|365395317|FG000|Overall Study|Adverse Event|24|||
105928025|NCT02260986|365395318|FG001|Overall Study|Adverse Event|0|||
106007465|NCT01607957|365692274|FG001|Overall Study|Death|211|||
105928026|NCT02260986|365395319|FG002|Overall Study|Adverse Event|11|||
105928027|NCT02260986|365395317|FG000|Overall Study|Lack of Efficacy|27|||
105928028|NCT02260986|365395318|FG001|Overall Study|Lack of Efficacy|3|||
106134058|NCT00072475|366150328|FG000|Overall Study|Withdrawal by Subject|46|||
105709008|NCT01618214|364594531|FG000|Overall Study|Protocol Violation|1|||
105709009|NCT01618214|364594532|FG001|Overall Study|Protocol Violation|4|||
105709010|NCT01618214|364594531|FG000|Overall Study|Withdrawal Criteria|1|||
105709011|NCT01618214|364594532|FG001|Overall Study|Withdrawal Criteria|2|||
105709012|NCT01618214|364594531|FG000|Overall Study|Unclassified|4|||
105709013|NCT01618214|364594532|FG001|Overall Study|Unclassified|5|||
105709014|NCT01097863|364594533|FG000|Overall Study|Discomfort|1|||
105709015|NCT01097863|364594534|FG001|Overall Study|Discomfort|0|||
105709016|NCT01097863|364594535|FG002|Overall Study|Discomfort|1|||
105709017|NCT01097863|364594533|FG000|Overall Study|Did not return for final visit|0|||
105709018|NCT01097863|364594534|FG001|Overall Study|Did not return for final visit|0|||
105709019|NCT01097863|364594535|FG002|Overall Study|Did not return for final visit|1|||
105709020|NCT00796315|364594536|FG000|Overall Study|Protocol Violation|0|||
105709021|NCT00796315|364594537|FG001|Overall Study|Protocol Violation|1|||
105709022|NCT00796315|364594538|FG002|Overall Study|Protocol Violation|0|||
105709023|NCT03847610|364594539|FG000|Overall Study|Withdrawal by Subject|1|||
105709024|NCT01627860|364594540|FG000|Overall Study|Adverse Event|9|||
105709025|NCT01627860|364594541|FG001|Overall Study|Adverse Event|4|||
105709026|NCT01627860|364594540|FG000|Overall Study|Withdrawal by Subject|2|||
105709027|NCT01627860|364594541|FG001|Overall Study|Withdrawal by Subject|1|||
105709028|NCT01627860|364594540|FG000|Overall Study|Seizure frequency doubled|0|||
105709029|NCT01627860|364594541|FG001|Overall Study|Seizure frequency doubled|1|||
105709030|NCT01627860|364594540|FG000|Overall Study|Protocol Violation|1|||
105709031|NCT01627860|364594541|FG001|Overall Study|Protocol Violation|0|||
105928029|NCT02260986|365395319|FG002|Overall Study|Lack of Efficacy|0|||
105928030|NCT02260986|365395317|FG000|Overall Study|Protocol Violation|14|||
105928031|NCT02260986|365395318|FG001|Overall Study|Protocol Violation|5|||
105928032|NCT02260986|365395319|FG002|Overall Study|Protocol Violation|16|||
105928033|NCT02260986|365395317|FG000|Overall Study|Car accident|0|||
105928034|NCT02260986|365395318|FG001|Overall Study|Car accident|0|||
105928035|NCT02260986|365395319|FG002|Overall Study|Car accident|1|||
105928036|NCT02260986|365395317|FG000|Overall Study|Withdrawal by Subject|17|||
105928037|NCT02260986|365395318|FG001|Overall Study|Withdrawal by Subject|4|||
105928038|NCT02260986|365395319|FG002|Overall Study|Withdrawal by Subject|9|||
105928039|NCT02260986|365395317|FG000|Overall Study|Incorrect randomization|0|||
105928040|NCT02260986|365395318|FG001|Overall Study|Incorrect randomization|1|||
105928041|NCT02260986|365395319|FG002|Overall Study|Incorrect randomization|0|||
105928042|NCT02260986|365395317|FG000|Overall Study|Lack of investigation product supply|2|||
105928043|NCT02260986|365395318|FG001|Overall Study|Lack of investigation product supply|0|||
105928044|NCT02260986|365395319|FG002|Overall Study|Lack of investigation product supply|1|||
105928045|NCT02260986|365395317|FG000|Overall Study|Lost to Follow-up|4|||
105928046|NCT02260986|365395318|FG001|Overall Study|Lost to Follow-up|0|||
105928047|NCT02260986|365395319|FG002|Overall Study|Lost to Follow-up|3|||
105928048|NCT02260986|365395317|FG000|Overall Study|Pregnancy|2|||
105928049|NCT02260986|365395318|FG001|Overall Study|Pregnancy|0|||
105928050|NCT02260986|365395319|FG002|Overall Study|Pregnancy|0|||
105928051|NCT01001104|365395320|FG000|Overall Study|Adverse Event|2|||
105928052|NCT01001104|365395321|FG001|Overall Study|Adverse Event|1|||
105709032|NCT02069899|364594564|FG000|Overall Study|Adverse Event|6|||
105709033|NCT02069899|364594565|FG001|Overall Study|Adverse Event|0|||
105709034|NCT02069899|364594566|FG002|Overall Study|Adverse Event|1|||
105709035|NCT02069899|364594564|FG000|Overall Study|Withdrawal by Participant|2|||
105709036|NCT02069899|364594565|FG001|Overall Study|Withdrawal by Participant|0|||
105709037|NCT02069899|364594566|FG002|Overall Study|Withdrawal by Participant|0|||
105928053|NCT01001104|365395322|FG002|Overall Study|Adverse Event|0|||
105928054|NCT01001104|365395323|FG003|Overall Study|Adverse Event|0|||
105928055|NCT01001104|365395320|FG000|Overall Study|Lost to Follow-up|0|||
105928056|NCT01001104|365395321|FG001|Overall Study|Lost to Follow-up|0|||
105928057|NCT01001104|365395322|FG002|Overall Study|Lost to Follow-up|1|||
105928058|NCT01001104|365395323|FG003|Overall Study|Lost to Follow-up|0|||
105928059|NCT01001104|365395320|FG000|Overall Study|Entry Criteria Not Met|0|||
105928060|NCT01001104|365395321|FG001|Overall Study|Entry Criteria Not Met|0|||
105928061|NCT01001104|365395322|FG002|Overall Study|Entry Criteria Not Met|0|||
105928062|NCT01001104|365395323|FG003|Overall Study|Entry Criteria Not Met|1|||
105928063|NCT01001104|365395320|FG000|Overall Study|Withdrawal by Subject|0|||
105928064|NCT01001104|365395321|FG001|Overall Study|Withdrawal by Subject|0|||
105928065|NCT01001104|365395322|FG002|Overall Study|Withdrawal by Subject|0|||
105709038|NCT02069899|364594564|FG000|Overall Study|Lost to Follow-up|1|||
105709039|NCT02069899|364594565|FG001|Overall Study|Lost to Follow-up|0|||
105709040|NCT02069899|364594566|FG002|Overall Study|Lost to Follow-up|1|||
105709041|NCT02069899|364594564|FG000|Overall Study|Other|4|||
105709042|NCT02069899|364594565|FG001|Overall Study|Other|0|||
105709043|NCT02069899|364594566|FG002|Overall Study|Other|0|||
105709044|NCT02069899|364594564|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
105928066|NCT01001104|365395323|FG003|Overall Study|Withdrawal by Subject|2|||
105928067|NCT02034591|365395325|FG000|Overall Study|Withdrawal by Subject|0|||
105928068|NCT02034591|365395326|FG001|Overall Study|Withdrawal by Subject|0|||
105928069|NCT02034591|365395327|FG002|Overall Study|Withdrawal by Subject|0|||
105709045|NCT02069899|364594565|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
105709046|NCT02069899|364594566|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
105709047|NCT02069899|364594564|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
105709048|NCT02069899|364594565|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
105709049|NCT02069899|364594566|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
105709050|NCT01079182|364594567|FG000|Overall Study|Lost to Follow-up|1634|||
105709051|NCT01079182|364594567|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
105709052|NCT01079182|364594567|FG000|Overall Study|Lack of Efficacy|514|||
105709053|NCT01079182|364594567|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
105709054|NCT01079182|364594567|FG000|Overall Study|Reasons not Evaluated|271|||
105709055|NCT02751502|364594568|FG000|Overall Study|Lack of funding|4|||
105709056|NCT02678390|364594569|FG000|AE (1 Day)|Withdrawal by Subject|0|||
105709057|NCT02678390|364594570|FG001|AE (1 Day)|Withdrawal by Subject|1|||
105709058|NCT02508194|364594571|FG000|Overall Study|Death|5|||
105928070|NCT02034591|365395328|FG003|Overall Study|Withdrawal by Subject|0|||
105928071|NCT02034591|365395329|FG004|Overall Study|Withdrawal by Subject|1|||
105928072|NCT02034591|365395330|FG005|Overall Study|Withdrawal by Subject|0|||
105928073|NCT00599313|365395331|FG000|Overall Study|Adverse Event|19|||
105928074|NCT00599313|365395331|FG000|Overall Study|Disease Progression|12|||
105928075|NCT00599313|365395331|FG000|Overall Study|Patient Request|4|||
105928076|NCT00599313|365395331|FG000|Overall Study|Ineligible|1|||
105928077|NCT01793935|365395334|FG000|Overall Study|Pregnancy|1|||
105928078|NCT01793935|365395335|FG001|Overall Study|Pregnancy|0|||
105928079|NCT01793935|365395334|FG000|Overall Study|Protocol Violation|2|||
105928080|NCT01793935|365395335|FG001|Overall Study|Protocol Violation|1|||
105928081|NCT01793935|365395334|FG000|Overall Study|Adverse Event|2|||
105928082|NCT01793935|365395335|FG001|Overall Study|Adverse Event|0|||
105928083|NCT01793935|365395334|FG000|Overall Study|Patient did not take study medication|1|||
105928084|NCT01793935|365395335|FG001|Overall Study|Patient did not take study medication|1|||
105928085|NCT01793935|365395334|FG000|Overall Study|Lost to Follow-up|0|||
105928086|NCT01793935|365395335|FG001|Overall Study|Lost to Follow-up|1|||
105928087|NCT04919161|365395338|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
105928088|NCT04919161|365395339|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
105928089|NCT04919161|365395338|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
105928090|NCT04919161|365395339|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
105928091|NCT04919161|365395338|FG000|Overall Study|Acute ankle sprain after session 1|0|||
105928092|NCT04919161|365395339|FG001|Overall Study|Acute ankle sprain after session 1|1|||
105928093|NCT02175758|365395340|FG000|Treatment Phase|Lost to Follow-up|0|||
105928094|NCT02175758|365395341|FG001|Treatment Phase|Lost to Follow-up|1|||
105928095|NCT02175758|365395342|FG002|Treatment Phase|Lost to Follow-up|0|||
105928096|NCT02175758|365395343|FG003|Treatment Phase|Lost to Follow-up|0|||
105928097|NCT02175758|365395344|FG004|Treatment Phase|Lost to Follow-up|0|||
105928098|NCT02175758|365395345|FG005|Treatment Phase|Lost to Follow-up|0|||
105928099|NCT02175758|365395340|FG000|Treatment Phase|Adverse Event|0|||
105928100|NCT02175758|365395341|FG001|Treatment Phase|Adverse Event|0|||
105928101|NCT02175758|365395342|FG002|Treatment Phase|Adverse Event|0|||
105928102|NCT02175758|365395343|FG003|Treatment Phase|Adverse Event|0|||
106134059|NCT00072475|366150328|FG000|Overall Study|Patient/Investigator Decision|4|||
106134060|NCT00940017|366150329|FG000|Overall Study|did not meet entrance criteria|3|||
105709059|NCT02508194|364594572|FG001|Overall Study|Death|3|||
105709060|NCT02508194|364594571|FG000|Overall Study|Lost to Follow-up|25|||
105709061|NCT02508194|364594572|FG001|Overall Study|Lost to Follow-up|18|||
105709062|NCT02508194|364594571|FG000|Overall Study|Withdrawal by Subject|20|||
105709063|NCT02508194|364594572|FG001|Overall Study|Withdrawal by Subject|18|||
105709064|NCT02508194|364594571|FG000|Overall Study|Error in Randomization|1|||
105709065|NCT02508194|364594572|FG001|Overall Study|Error in Randomization|3|||
105928103|NCT02175758|365395344|FG004|Treatment Phase|Adverse Event|1|||
105928104|NCT02175758|365395345|FG005|Treatment Phase|Adverse Event|0|||
105928105|NCT02489773|365395346|FG000|Overall Study|Lost to Follow-up|4|||
105928106|NCT02489773|365395347|FG001|Overall Study|Lost to Follow-up|1|||
105928107|NCT02489773|365395346|FG000|Overall Study|Physician Decision|1|||
105928108|NCT02489773|365395347|FG001|Overall Study|Physician Decision|0|||
105928109|NCT02489773|365395346|FG000|Overall Study|Withdrawal by Subject|1|||
105928110|NCT02489773|365395347|FG001|Overall Study|Withdrawal by Subject|0|||
105928111|NCT02489773|365395346|FG000|Overall Study|Leave the country or the state|1|||
105928112|NCT02489773|365395347|FG001|Overall Study|Leave the country or the state|1|||
105928113|NCT02362451|365395348|FG000|Overall Study|Withdrawal by Subject|0|||
105928114|NCT02362451|365395349|FG001|Overall Study|Withdrawal by Subject|1|||
105928115|NCT02362451|365395348|FG000|Overall Study|Lack of Efficacy|2|||
105928116|NCT02362451|365395349|FG001|Overall Study|Lack of Efficacy|0|||
105928117|NCT02362451|365395348|FG000|Overall Study|Progression|1|||
105709066|NCT02508194|364594571|FG000|Overall Study|Principal Investigator Decision|1|||
105928118|NCT02362451|365395349|FG001|Overall Study|Progression|0|||
105928119|NCT02362451|365395348|FG000|Overall Study|Participant chose other therapy.|1|||
105709067|NCT02508194|364594572|FG001|Overall Study|Principal Investigator Decision|2|||
105709068|NCT00511355|364594573|FG000|Overall Study|Adverse Event|4|||
105709069|NCT00511355|364594574|FG001|Overall Study|Adverse Event|4|||
105709070|NCT00511355|364594573|FG000|Overall Study|Pregnancy Wish|1|||
105709071|NCT00511355|364594574|FG001|Overall Study|Pregnancy Wish|0|||
105709072|NCT00511355|364594573|FG000|Overall Study|Lost to Follow-up|2|||
105709073|NCT00511355|364594574|FG001|Overall Study|Lost to Follow-up|1|||
105709074|NCT00511355|364594573|FG000|Overall Study|Other Reason|0|||
105709075|NCT00511355|364594574|FG001|Overall Study|Other Reason|1|||
105709076|NCT00511355|364594573|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
105709077|NCT00511355|364594574|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
105709078|NCT00511355|364594573|FG000|Overall Study|Withdrawal of informed consent|0|||
105709079|NCT00511355|364594574|FG001|Overall Study|Withdrawal of informed consent|1|||
105709080|NCT00511355|364594573|FG000|Overall Study|Other reason pre-treatment|0|||
105709081|NCT00511355|364594574|FG001|Overall Study|Other reason pre-treatment|1|||
105709082|NCT05574062|364594575|FG000|Pre Run-In|Screening failure|3|||
105709083|NCT05574062|364594576|FG001|Pre Run-In|Screening failure|0|||
105709084|NCT05574062|364594577|FG002|Pre Run-In|Screening failure|0|||
105709085|NCT05574062|364594578|FG003|Pre Run-In|Screening failure|0|||
105709086|NCT05574062|364594579|FG004|Pre Run-In|Screening failure|0|||
105709087|NCT05574062|364594575|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
105709088|NCT05574062|364594576|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
105709089|NCT05574062|364594577|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
105709090|NCT05574062|364594578|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
105709091|NCT05574062|364594579|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
105709092|NCT05574062|364594575|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
105709093|NCT05574062|364594576|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
105709094|NCT05574062|364594577|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
105709095|NCT05574062|364594578|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
105709096|NCT05574062|364594579|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
105709097|NCT05574062|364594575|FG000|Continuation Phase Period 1|Physician Decision|1|||
105709098|NCT05574062|364594576|FG001|Continuation Phase Period 1|Physician Decision|0|||
105709099|NCT05574062|364594577|FG002|Continuation Phase Period 1|Physician Decision|0|||
105709100|NCT05574062|364594578|FG003|Continuation Phase Period 1|Physician Decision|0|||
105709101|NCT05574062|364594579|FG004|Continuation Phase Period 1|Physician Decision|0|||
105709102|NCT05574062|364594575|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
105709103|NCT05574062|364594576|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
105709104|NCT05574062|364594577|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
105709105|NCT05574062|364594578|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
105709106|NCT05574062|364594579|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
105709107|NCT05574062|364594575|FG000|Continuation Phase Period 1|Adverse Event|1|||
105709108|NCT05574062|364594576|FG001|Continuation Phase Period 1|Adverse Event|0|||
105709109|NCT05574062|364594577|FG002|Continuation Phase Period 1|Adverse Event|0|||
105709110|NCT05574062|364594578|FG003|Continuation Phase Period 1|Adverse Event|0|||
105709111|NCT05574062|364594579|FG004|Continuation Phase Period 1|Adverse Event|0|||
105709112|NCT05574062|364594575|FG000|Continuation Phase Period 1|Death|1|||
105709113|NCT05574062|364594576|FG001|Continuation Phase Period 1|Death|0|||
105709114|NCT05574062|364594577|FG002|Continuation Phase Period 1|Death|0|||
105709115|NCT05574062|364594578|FG003|Continuation Phase Period 1|Death|0|||
105709116|NCT05574062|364594579|FG004|Continuation Phase Period 1|Death|0|||
105709117|NCT05574062|364594575|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
105709118|NCT05574062|364594576|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
105709119|NCT05574062|364594577|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
105928120|NCT02362451|365395349|FG001|Overall Study|Participant chose other therapy.|0|||
105928121|NCT01879852|365395352|FG000|Overall Study|Withdrawal by Subject|2|||
105928122|NCT01879852|365395353|FG001|Overall Study|Withdrawal by Subject|0|||
105928123|NCT02115386|365395354|FG000|Overall Study|Protocol Violation|1|||
105928124|NCT02115386|365395354|FG000|Overall Study|Administrative - trial was terminated|6|||
105709120|NCT05574062|364594578|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
105709121|NCT05574062|364594579|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
105709122|NCT01358864|364594580|FG000|Overall Study|Adverse Event|0|||
105928125|NCT02493855|365395355|FG000|Overall Study|Non-compliance|1|||
105928126|NCT02493855|365395356|FG001|Overall Study|Non-compliance|0|||
105928127|NCT02493855|365395357|FG002|Overall Study|Non-compliance|0|||
105928128|NCT02493855|365395355|FG000|Overall Study|Adverse Event|0|||
105709123|NCT01358864|364594581|FG001|Overall Study|Adverse Event|6|||
105709124|NCT01358864|364594582|FG002|Overall Study|Adverse Event|9|||
106007466|NCT01607957|365692273|FG000|Overall Study|Lost to Follow-up|3|||
105709125|NCT01358864|364594583|FG003|Overall Study|Adverse Event|0|||
105709126|NCT01358864|364594584|FG004|Overall Study|Adverse Event|4|||
105709127|NCT01358864|364594585|FG005|Overall Study|Adverse Event|8|||
105709128|NCT01358864|364594586|FG006|Overall Study|Adverse Event|12|||
105709129|NCT01358864|364594587|FG007|Overall Study|Adverse Event|7|||
105928129|NCT02493855|365395356|FG001|Overall Study|Adverse Event|1|||
105709130|NCT01358864|364594580|FG000|Overall Study|Lack of Efficacy|26|||
105709131|NCT01358864|364594581|FG001|Overall Study|Lack of Efficacy|3|||
105709132|NCT01358864|364594582|FG002|Overall Study|Lack of Efficacy|4|||
105709133|NCT01358864|364594583|FG003|Overall Study|Lack of Efficacy|19|||
105709134|NCT01358864|364594584|FG004|Overall Study|Lack of Efficacy|7|||
105709135|NCT01358864|364594585|FG005|Overall Study|Lack of Efficacy|4|||
105709136|NCT01358864|364594586|FG006|Overall Study|Lack of Efficacy|49|||
105709137|NCT01358864|364594587|FG007|Overall Study|Lack of Efficacy|44|||
105709138|NCT01358864|364594580|FG000|Overall Study|Lost to Follow-up|0|||
105709139|NCT01358864|364594581|FG001|Overall Study|Lost to Follow-up|0|||
105709140|NCT01358864|364594582|FG002|Overall Study|Lost to Follow-up|1|||
105709141|NCT01358864|364594583|FG003|Overall Study|Lost to Follow-up|0|||
105709142|NCT01358864|364594584|FG004|Overall Study|Lost to Follow-up|0|||
105709143|NCT01358864|364594585|FG005|Overall Study|Lost to Follow-up|0|||
105709144|NCT01358864|364594586|FG006|Overall Study|Lost to Follow-up|0|||
105709145|NCT01358864|364594587|FG007|Overall Study|Lost to Follow-up|1|||
105709146|NCT01358864|364594580|FG000|Overall Study|Withdrawal by Subject|3|||
105709147|NCT01358864|364594581|FG001|Overall Study|Withdrawal by Subject|4|||
105709148|NCT01358864|364594582|FG002|Overall Study|Withdrawal by Subject|2|||
105709149|NCT01358864|364594583|FG003|Overall Study|Withdrawal by Subject|0|||
105709150|NCT01358864|364594584|FG004|Overall Study|Withdrawal by Subject|0|||
105709151|NCT01358864|364594585|FG005|Overall Study|Withdrawal by Subject|1|||
105709152|NCT01358864|364594586|FG006|Overall Study|Withdrawal by Subject|1|||
105709153|NCT01358864|364594587|FG007|Overall Study|Withdrawal by Subject|3|||
105709154|NCT01358864|364594580|FG000|Overall Study|Other reason not defined above|2|||
105709155|NCT01358864|364594581|FG001|Overall Study|Other reason not defined above|0|||
105709156|NCT01358864|364594582|FG002|Overall Study|Other reason not defined above|0|||
105709157|NCT01358864|364594583|FG003|Overall Study|Other reason not defined above|0|||
105709158|NCT01358864|364594584|FG004|Overall Study|Other reason not defined above|0|||
105709159|NCT01358864|364594585|FG005|Overall Study|Other reason not defined above|0|||
105709160|NCT01358864|364594586|FG006|Overall Study|Other reason not defined above|2|||
105709161|NCT01358864|364594587|FG007|Overall Study|Other reason not defined above|0|||
105709162|NCT01358864|364594580|FG000|Overall Study|Not treated|0|||
105709163|NCT01358864|364594581|FG001|Overall Study|Not treated|0|||
105709164|NCT01358864|364594582|FG002|Overall Study|Not treated|0|||
105709165|NCT01358864|364594583|FG003|Overall Study|Not treated|0|||
105709166|NCT01358864|364594584|FG004|Overall Study|Not treated|0|||
105709167|NCT01358864|364594585|FG005|Overall Study|Not treated|0|||
105709168|NCT01358864|364594586|FG006|Overall Study|Not treated|1|||
105709169|NCT01358864|364594587|FG007|Overall Study|Not treated|0|||
105709170|NCT01250379|364594589|FG000|Overall Study|Death|141|||
105709171|NCT01250379|364594590|FG001|Overall Study|Death|148|||
105709172|NCT01250379|364594589|FG000|Overall Study|Withdrawal by Subject|32|||
105709173|NCT01250379|364594590|FG001|Overall Study|Withdrawal by Subject|20|||
105709174|NCT01250379|364594589|FG000|Overall Study|Physician Decision|11|||
105709175|NCT01250379|364594590|FG001|Overall Study|Physician Decision|3|||
105709176|NCT01250379|364594589|FG000|Overall Study|Protocol Violation|2|||
105709177|NCT01250379|364594590|FG001|Overall Study|Protocol Violation|8|||
105709178|NCT01250379|364594589|FG000|Overall Study|Lost to Follow-up|9|||
105709179|NCT01250379|364594590|FG001|Overall Study|Lost to Follow-up|6|||
105709180|NCT01250379|364594589|FG000|Overall Study|Adverse Event|5|||
105709181|NCT01250379|364594590|FG001|Overall Study|Adverse Event|4|||
105709182|NCT01250379|364594589|FG000|Overall Study|Other|0|||
105709183|NCT01250379|364594590|FG001|Overall Study|Other|4|||
105709184|NCT01250379|364594589|FG000|Overall Study|Participant noncompliance|2|||
105928130|NCT02493855|365395357|FG002|Overall Study|Adverse Event|0|||
105928131|NCT02493855|365395355|FG000|Overall Study|Withdrawal by Subject|1|||
105928132|NCT02493855|365395356|FG001|Overall Study|Withdrawal by Subject|0|||
105928133|NCT02493855|365395357|FG002|Overall Study|Withdrawal by Subject|0|||
105928134|NCT00429299|365395364|FG000|Overall Study|Disease Progression|1|||
106134061|NCT00940017|366150329|FG000|Overall Study|Adverse Event|1|||
106134062|NCT02949271|366150332|FG000|Overall Study|Lack of Efficacy|5|||
105928135|NCT00429299|365395365|FG001|Overall Study|Disease Progression|1|||
105928136|NCT00429299|365395366|FG002|Overall Study|Disease Progression|0|||
106134063|NCT02949271|366150333|FG001|Overall Study|Lack of Efficacy|4|||
105709185|NCT01250379|364594590|FG001|Overall Study|Participant noncompliance|0|||
105709186|NCT01534533|364594591|FG000|Overall Study|Lost to Follow-up|3|||
105709187|NCT01534533|364594592|FG001|Overall Study|Lost to Follow-up|0|||
105709188|NCT01534533|364594593|FG002|Overall Study|Lost to Follow-up|4|||
105788056|NCT02660489|364878175|FG001|Overall Study|no rhinovirus infection|4|||
106134064|NCT02949271|366150332|FG000|Overall Study|Lost to Follow-up|3|||
106134065|NCT02949271|366150333|FG001|Overall Study|Lost to Follow-up|6|||
105709189|NCT01534533|364594594|FG003|Overall Study|Lost to Follow-up|3|||
105709190|NCT01534533|364594591|FG000|Overall Study|Withdrawal by Subject|5|||
105709191|NCT01534533|364594592|FG001|Overall Study|Withdrawal by Subject|3|||
105709192|NCT01534533|364594593|FG002|Overall Study|Withdrawal by Subject|4|||
105709193|NCT01534533|364594594|FG003|Overall Study|Withdrawal by Subject|1|||
105709194|NCT03505021|364594595|FG000|Overall Study|Protocol Violation|1|||
105709195|NCT03505021|364594596|FG001|Overall Study|Protocol Violation|0|||
105709196|NCT03505021|364594595|FG000|Overall Study|Death|9|||
105709197|NCT03505021|364594596|FG001|Overall Study|Death|8|||
105709198|NCT03505021|364594595|FG000|Overall Study|Consent withdrawn by subject|6|||
105709199|NCT03505021|364594596|FG001|Overall Study|Consent withdrawn by subject|1|||
105709200|NCT03505021|364594595|FG000|Overall Study|Lost to Follow-up|5|||
105709201|NCT03505021|364594596|FG001|Overall Study|Lost to Follow-up|3|||
105709202|NCT03505021|364594595|FG000|Overall Study|Adverse Event|26|||
105709203|NCT03505021|364594596|FG001|Overall Study|Adverse Event|9|||
105709204|NCT03505021|364594595|FG000|Overall Study|Disease progression|33|||
105709205|NCT03505021|364594596|FG001|Overall Study|Disease progression|17|||
105709206|NCT03505021|364594595|FG000|Overall Study|Other|11|||
105709207|NCT03505021|364594596|FG001|Overall Study|Other|5|||
105709208|NCT03505021|364594595|FG000|Overall Study|Personal reason|21|||
105709209|NCT03505021|364594596|FG001|Overall Study|Personal reason|12|||
105709210|NCT00150592|364596071|FG000|Overall Study|Adverse Event|4|||
105709211|NCT00150592|364596072|FG001|Overall Study|Adverse Event|1|||
105709212|NCT00150592|364596071|FG000|Overall Study|Protocol Violation|1|||
105709213|NCT00150592|364596072|FG001|Overall Study|Protocol Violation|0|||
105709214|NCT00150592|364596071|FG000|Overall Study|Withdrawal by Subject|1|||
105709215|NCT00150592|364596072|FG001|Overall Study|Withdrawal by Subject|2|||
105709216|NCT00150592|364596071|FG000|Overall Study|Non-compliance|1|||
105709217|NCT00150592|364596072|FG001|Overall Study|Non-compliance|0|||
105709218|NCT01783678|364596073|FG000|Overall Study|Randomized but Not Treated|0|||
105709219|NCT01783678|364596074|FG001|Overall Study|Randomized but Not Treated|0|||
105709220|NCT01783678|364596075|FG002|Overall Study|Randomized but Not Treated|0|||
105709221|NCT01783678|364596076|FG003|Overall Study|Randomized but Not Treated|1|||
105709222|NCT01783678|364596077|FG004|Overall Study|Randomized but Not Treated|0|||
105709223|NCT01783678|364596078|FG005|Overall Study|Randomized but Not Treated|0|||
105709224|NCT01783678|364596073|FG000|Overall Study|Lack of Efficacy|1|||
105709225|NCT01783678|364596074|FG001|Overall Study|Lack of Efficacy|13|||
105709226|NCT01783678|364596075|FG002|Overall Study|Lack of Efficacy|1|||
105709227|NCT01783678|364596076|FG003|Overall Study|Lack of Efficacy|3|||
105709228|NCT01783678|364596077|FG004|Overall Study|Lack of Efficacy|6|||
105709229|NCT01783678|364596078|FG005|Overall Study|Lack of Efficacy|5|||
105709230|NCT01783678|364596073|FG000|Overall Study|Lost to Follow-up|0|||
105709231|NCT01783678|364596074|FG001|Overall Study|Lost to Follow-up|4|||
105709232|NCT01783678|364596075|FG002|Overall Study|Lost to Follow-up|0|||
105709233|NCT01783678|364596076|FG003|Overall Study|Lost to Follow-up|2|||
105709234|NCT01783678|364596077|FG004|Overall Study|Lost to Follow-up|1|||
105709235|NCT01783678|364596078|FG005|Overall Study|Lost to Follow-up|0|||
105709236|NCT01783678|364596073|FG000|Overall Study|Withdrew Consent|1|||
105709237|NCT01783678|364596074|FG001|Overall Study|Withdrew Consent|1|||
105709238|NCT01783678|364596075|FG002|Overall Study|Withdrew Consent|0|||
105709239|NCT01783678|364596076|FG003|Overall Study|Withdrew Consent|2|||
105709240|NCT01783678|364596077|FG004|Overall Study|Withdrew Consent|0|||
105709241|NCT01783678|364596078|FG005|Overall Study|Withdrew Consent|0|||
105709242|NCT02049944|364596079|FG000|Overall Study|Protocol Violation|2|||
105709243|NCT00706134|364596080|FG000|Overall Study|Adverse Event|8|||
105709244|NCT00706134|364596081|FG001|Overall Study|Adverse Event|7|||
105709245|NCT00706134|364596082|FG002|Overall Study|Adverse Event|2|||
105709246|NCT00706134|364596083|FG003|Overall Study|Adverse Event|3|||
105709247|NCT00706134|364596080|FG000|Overall Study|Lost to Follow-up|0|||
105709248|NCT00706134|364596081|FG001|Overall Study|Lost to Follow-up|1|||
105709249|NCT00706134|364596082|FG002|Overall Study|Lost to Follow-up|0|||
105709250|NCT00706134|364596083|FG003|Overall Study|Lost to Follow-up|0|||
105709251|NCT00706134|364596080|FG000|Overall Study|Protocol Violation|0|||
105709252|NCT00706134|364596081|FG001|Overall Study|Protocol Violation|6|||
105709253|NCT00706134|364596082|FG002|Overall Study|Protocol Violation|0|||
105709254|NCT00706134|364596083|FG003|Overall Study|Protocol Violation|3|||
105709255|NCT00706134|364596080|FG000|Overall Study|Withdrawal by Subject|1|||
105709256|NCT00706134|364596081|FG001|Overall Study|Withdrawal by Subject|2|||
105709257|NCT00706134|364596082|FG002|Overall Study|Withdrawal by Subject|1|||
105709258|NCT00706134|364596083|FG003|Overall Study|Withdrawal by Subject|0|||
105709259|NCT00706134|364596080|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
105709260|NCT00706134|364596081|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105709261|NCT00706134|364596082|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
105709262|NCT00706134|364596083|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
105709263|NCT00706134|364596080|FG000|Overall Study|Did not meet study criteria|2|||
105928137|NCT00429299|365395364|FG000|Overall Study|Adverse Event|2|||
105709264|NCT00706134|364596081|FG001|Overall Study|Did not meet study criteria|0|||
105709265|NCT00706134|364596082|FG002|Overall Study|Did not meet study criteria|0|||
105709266|NCT00706134|364596083|FG003|Overall Study|Did not meet study criteria|0|||
105709267|NCT03691974|364596086|FG000|Overall Study|Physician Decision|1|||
105709268|NCT03691974|364596087|FG001|Overall Study|Physician Decision|0|||
105709269|NCT03691974|364596086|FG000|Overall Study|Adverse Event|1|||
105709270|NCT03691974|364596087|FG001|Overall Study|Adverse Event|0|||
105709271|NCT03691974|364596086|FG000|Overall Study|Withdrawal by Subject|11|||
105709272|NCT03691974|364596087|FG001|Overall Study|Withdrawal by Subject|9|||
105709273|NCT03691974|364596086|FG000|Overall Study|Protocol Violation|1|||
105928138|NCT00429299|365395365|FG001|Overall Study|Adverse Event|5|||
105709274|NCT03691974|364596087|FG001|Overall Study|Protocol Violation|0|||
105709275|NCT03691974|364596086|FG000|Overall Study|Lost to Follow-up|8|||
105709276|NCT03691974|364596087|FG001|Overall Study|Lost to Follow-up|7|||
105709277|NCT03468309|364596090|FG000|Overall Study|Lost to Follow-up|4|||
105709278|NCT03468309|364596090|FG000|Overall Study|Withdrawal by Subject|2|||
105709279|NCT00488982|364596091|FG000|Course 1|Physician Decision|0|||
105709280|NCT00488982|364596092|FG001|Course 1|Physician Decision|2|||
105709281|NCT00488982|364596093|FG002|Course 1|Physician Decision|4|||
105709282|NCT00488982|364596091|FG000|Course 1|Withdrawal by Subject|0|||
105709283|NCT00488982|364596092|FG001|Course 1|Withdrawal by Subject|8|||
105709284|NCT00488982|364596093|FG002|Course 1|Withdrawal by Subject|2|||
105709285|NCT00488982|364596091|FG000|Course 1|nonprotocol therapy|0|||
105709286|NCT00488982|364596092|FG001|Course 1|nonprotocol therapy|2|||
105709287|NCT00488982|364596093|FG002|Course 1|nonprotocol therapy|2|||
105709288|NCT00488982|364596091|FG000|Course 1|Adverse Event|0|||
105709289|NCT00488982|364596092|FG001|Course 1|Adverse Event|0|||
105709290|NCT00488982|364596093|FG002|Course 1|Adverse Event|6|||
105709291|NCT01485627|364596094|FG000|Overall Study|Patient withdrew|6|||
105709292|NCT01485627|364596095|FG001|Overall Study|Patient withdrew|5|||
105709293|NCT01485627|364596094|FG000|Overall Study|Patient died|3|||
105709294|NCT01485627|364596095|FG001|Overall Study|Patient died|1|||
105709295|NCT01485627|364596094|FG000|Overall Study|Patient lost to followup|0|||
105709296|NCT01485627|364596095|FG001|Overall Study|Patient lost to followup|1|||
105709297|NCT01485627|364596094|FG000|Overall Study|Caregiver withdrew|3|||
105709298|NCT01485627|364596095|FG001|Overall Study|Caregiver withdrew|3|||
105709299|NCT01485627|364596094|FG000|Overall Study|Caregiver lost to follow up|11|||
105709300|NCT01485627|364596095|FG001|Overall Study|Caregiver lost to follow up|12|||
105709301|NCT01485627|364596094|FG000|Overall Study|Caregiver died|1|||
105709302|NCT01485627|364596095|FG001|Overall Study|Caregiver died|0|||
105709303|NCT01485627|364596094|FG000|Overall Study|caregiver was not bereaved|42|||
105709304|NCT01485627|364596095|FG001|Overall Study|caregiver was not bereaved|35|||
105709305|NCT01709149|364596096|FG000|Open-label Lead-in Phase|Adverse Event|109|||
105709306|NCT01709149|364596097|FG001|Open-label Lead-in Phase|Adverse Event|0|||
105709307|NCT01709149|364596098|FG002|Open-label Lead-in Phase|Adverse Event|0|||
105709308|NCT01709149|364596096|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
105709309|NCT01709149|364596097|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
106007467|NCT01607957|365692274|FG001|Overall Study|Lost to Follow-up|3|||
106007468|NCT01607957|365692273|FG000|Overall Study|Participant refusal|1|||
106007469|NCT01607957|365692274|FG001|Overall Study|Participant refusal|0|||
106007470|NCT00945009|365692283|FG000|Overall Study|Lack of Efficacy|10|||
106007471|NCT00945009|365692284|FG001|Overall Study|Lack of Efficacy|0|||
106007472|NCT00945009|365692285|FG002|Overall Study|Lack of Efficacy|0|||
106007473|NCT00945009|365692283|FG000|Overall Study|Physician Decision|21|||
106007474|NCT00945009|365692284|FG001|Overall Study|Physician Decision|4|||
106007475|NCT00945009|365692285|FG002|Overall Study|Physician Decision|3|||
106007476|NCT00945009|365692283|FG000|Overall Study|Protocol Violation|6|||
106007477|NCT00945009|365692284|FG001|Overall Study|Protocol Violation|1|||
106007478|NCT00945009|365692285|FG002|Overall Study|Protocol Violation|0|||
106007479|NCT00945009|365692283|FG000|Overall Study|Withdrawal by Subject|1|||
106007480|NCT00945009|365692284|FG001|Overall Study|Withdrawal by Subject|0|||
106007481|NCT00945009|365692285|FG002|Overall Study|Withdrawal by Subject|0|||
106007482|NCT00945009|365692283|FG000|Overall Study|Ineligible|6|||
106007483|NCT00945009|365692284|FG001|Overall Study|Ineligible|1|||
106007484|NCT00945009|365692285|FG002|Overall Study|Ineligible|0|||
106007485|NCT00945009|365692283|FG000|Overall Study|Inevaluable|0|||
106007486|NCT00945009|365692284|FG001|Overall Study|Inevaluable|1|||
105709310|NCT01709149|364596098|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
105709311|NCT01709149|364596096|FG000|Open-label Lead-in Phase|Death|1|||
105709312|NCT01709149|364596097|FG001|Open-label Lead-in Phase|Death|0|||
105709313|NCT01709149|364596098|FG002|Open-label Lead-in Phase|Death|0|||
105709314|NCT01709149|364596096|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
105709315|NCT01709149|364596097|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
105709316|NCT01709149|364596098|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
105709317|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
105709318|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
105709319|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
105709320|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105709321|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
105709322|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
106007487|NCT00945009|365692285|FG002|Overall Study|Inevaluable|0|||
106007488|NCT00945009|365692283|FG000|Overall Study|Refusal of further protocol|1|||
106007489|NCT00945009|365692284|FG001|Overall Study|Refusal of further protocol|0|||
106007490|NCT00945009|365692285|FG002|Overall Study|Refusal of further protocol|0|||
106007491|NCT03919773|365692286|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
106007492|NCT03919773|365692287|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
105709323|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
105709324|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
106134066|NCT02949271|366150332|FG000|Overall Study|Physician Decision|5|||
106134067|NCT02949271|366150333|FG001|Overall Study|Physician Decision|5|||
106134068|NCT02949271|366150332|FG000|Overall Study|Protocol Violation|6|||
106134069|NCT02949271|366150333|FG001|Overall Study|Protocol Violation|3|||
106134070|NCT02949271|366150332|FG000|Overall Study|Withdrawal by Subject|1|||
106134071|NCT02949271|366150333|FG001|Overall Study|Withdrawal by Subject|0|||
106134072|NCT02949271|366150332|FG000|Overall Study|Delivered prior to intervention|7|||
106134073|NCT02949271|366150333|FG001|Overall Study|Delivered prior to intervention|9|||
106134074|NCT02949271|366150332|FG000|Overall Study|Outside the window for cervical dilation|2|||
106134075|NCT02949271|366150333|FG001|Overall Study|Outside the window for cervical dilation|3|||
106134076|NCT02790606|366150339|FG000|Overall Study|Death|27|||
106134077|NCT02790606|366150339|FG000|Overall Study|Lost to Follow-up|4|||
106134078|NCT02790606|366150339|FG000|Overall Study|Physician Decision|3|||
106134079|NCT02790606|366150339|FG000|Overall Study|Withdrawal by Subject|1|||
106134080|NCT02735915|366150340|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
106134081|NCT02735915|366150340|FG000|Overall Study|Withdrawal following SAE|2|||
106134082|NCT02735915|366150340|FG000|Overall Study|Withdrawal by Subject|1|||
106134083|NCT01211665|366150344|FG000|Overall Study|Withdrawal by Subject|1|||
106134084|NCT01211665|366150345|FG001|Overall Study|Withdrawal by Subject|0|||
106134085|NCT01211665|366150344|FG000|Overall Study|Death|1|||
105709325|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
105709326|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
105709327|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
105709328|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
105709329|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
105709330|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
105709331|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
105709332|NCT01709149|364596096|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105709333|NCT01709149|364596097|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
105709334|NCT01709149|364596098|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105709335|NCT03245450|364596101|FG000|Overall Study|Radiological disease progression|3|||
105709336|NCT03245450|364596102|FG001|Overall Study|Radiological disease progression|3|||
105709337|NCT03245450|364596103|FG002|Overall Study|Radiological disease progression|2|||
105709338|NCT03245450|364596104|FG003|Overall Study|Radiological disease progression|2|||
105709339|NCT03245450|364596105|FG004|Overall Study|Radiological disease progression|7|||
105709340|NCT03245450|364596106|FG005|Overall Study|Radiological disease progression|6|||
105709341|NCT03245450|364596107|FG006|Overall Study|Radiological disease progression|6|||
105709342|NCT03245450|364596101|FG000|Overall Study|Clinical disease progression|0|||
105709343|NCT03245450|364596102|FG001|Overall Study|Clinical disease progression|0|||
105709344|NCT03245450|364596103|FG002|Overall Study|Clinical disease progression|1|||
105709345|NCT03245450|364596104|FG003|Overall Study|Clinical disease progression|0|||
105709346|NCT03245450|364596105|FG004|Overall Study|Clinical disease progression|0|||
105709347|NCT03245450|364596106|FG005|Overall Study|Clinical disease progression|2|||
105709348|NCT03245450|364596107|FG006|Overall Study|Clinical disease progression|0|||
105709349|NCT03245450|364596101|FG000|Overall Study|Other|0|||
105709350|NCT03245450|364596102|FG001|Overall Study|Other|0|||
105709351|NCT03245450|364596103|FG002|Overall Study|Other|0|||
105709352|NCT03245450|364596104|FG003|Overall Study|Other|1|||
105709353|NCT03245450|364596105|FG004|Overall Study|Other|1|||
105709354|NCT03245450|364596106|FG005|Overall Study|Other|1|||
105709355|NCT03245450|364596107|FG006|Overall Study|Other|1|||
105709356|NCT03245450|364596101|FG000|Overall Study|Withdrawal by Subject|0|||
105709357|NCT03245450|364596102|FG001|Overall Study|Withdrawal by Subject|1|||
105709358|NCT03245450|364596103|FG002|Overall Study|Withdrawal by Subject|0|||
105709359|NCT03245450|364596104|FG003|Overall Study|Withdrawal by Subject|0|||
105709360|NCT03245450|364596105|FG004|Overall Study|Withdrawal by Subject|0|||
105709361|NCT03245450|364596106|FG005|Overall Study|Withdrawal by Subject|0|||
105709362|NCT03245450|364596107|FG006|Overall Study|Withdrawal by Subject|0|||
105709363|NCT03245450|364596101|FG000|Overall Study|Adverse Event|0|||
105709364|NCT03245450|364596102|FG001|Overall Study|Adverse Event|0|||
105709365|NCT03245450|364596103|FG002|Overall Study|Adverse Event|0|||
105709366|NCT03245450|364596104|FG003|Overall Study|Adverse Event|0|||
105709367|NCT03245450|364596105|FG004|Overall Study|Adverse Event|1|||
106134086|NCT01211665|366150345|FG001|Overall Study|Death|0|||
105709368|NCT03245450|364596106|FG005|Overall Study|Adverse Event|0|||
105709369|NCT03245450|364596107|FG006|Overall Study|Adverse Event|2|||
105709370|NCT02429414|364596108|FG000|Overall Study|Physician Decision|0|||
105709371|NCT02429414|364596109|FG001|Overall Study|Physician Decision|1|||
106134087|NCT00495469|366150348|FG000|Overall Study|Adverse Event|0|||
106134088|NCT00495469|366150349|FG001|Overall Study|Adverse Event|1|||
105709372|NCT00267748|364596110|FG000|Non-randomized Period|Progressive disease|10|||
105709373|NCT00267748|364596111|FG001|Non-randomized Period|Progressive disease|0|||
106134089|NCT00495469|366150350|FG002|Overall Study|Adverse Event|3|||
106134090|NCT00495469|366150351|FG003|Overall Study|Adverse Event|0|||
105709374|NCT00267748|364596112|FG002|Non-randomized Period|Progressive disease|0|||
105709375|NCT00267748|364596110|FG000|Non-randomized Period|Adverse Event|8|||
105709376|NCT00267748|364596111|FG001|Non-randomized Period|Adverse Event|0|||
105709377|NCT00267748|364596112|FG002|Non-randomized Period|Adverse Event|0|||
105709378|NCT00267748|364596110|FG000|Non-randomized Period|Death|1|||
105709379|NCT00267748|364596111|FG001|Non-randomized Period|Death|0|||
105709380|NCT00267748|364596112|FG002|Non-randomized Period|Death|0|||
105709381|NCT00267748|364596110|FG000|Non-randomized Period|Participant not willing to participate|1|||
105709382|NCT00267748|364596111|FG001|Non-randomized Period|Participant not willing to participate|0|||
105709383|NCT00267748|364596112|FG002|Non-randomized Period|Participant not willing to participate|0|||
105709384|NCT00267748|364596110|FG000|Non-randomized Period|Other|3|||
105709385|NCT00267748|364596111|FG001|Non-randomized Period|Other|0|||
105709386|NCT00267748|364596112|FG002|Non-randomized Period|Other|0|||
105709387|NCT00267748|364596110|FG000|Randomized Period|Death|0|||
105709388|NCT00267748|364596111|FG001|Randomized Period|Death|2|||
105709389|NCT00267748|364596112|FG002|Randomized Period|Death|3|||
105709390|NCT00267748|364596110|FG000|Randomized Period|Adverse Event|0|||
105709391|NCT00267748|364596111|FG001|Randomized Period|Adverse Event|23|||
105709392|NCT00267748|364596112|FG002|Randomized Period|Adverse Event|25|||
105709393|NCT00267748|364596110|FG000|Randomized Period|Global deterioration of health status|0|||
105709394|NCT00267748|364596111|FG001|Randomized Period|Global deterioration of health status|6|||
105709395|NCT00267748|364596112|FG002|Randomized Period|Global deterioration of health status|7|||
105709396|NCT00267748|364596110|FG000|Randomized Period|Lost to Follow-up|0|||
105709397|NCT00267748|364596111|FG001|Randomized Period|Lost to Follow-up|1|||
105709398|NCT00267748|364596112|FG002|Randomized Period|Lost to Follow-up|0|||
105709399|NCT00267748|364596110|FG000|Randomized Period|Objective progression or relapse|0|||
105709400|NCT00267748|364596111|FG001|Randomized Period|Objective progression or relapse|77|||
105709401|NCT00267748|364596112|FG002|Randomized Period|Objective progression or relapse|86|||
105709402|NCT00267748|364596110|FG000|Randomized Period|Withdrawal by Subject|0|||
105709403|NCT00267748|364596111|FG001|Randomized Period|Withdrawal by Subject|9|||
105709404|NCT00267748|364596112|FG002|Randomized Period|Withdrawal by Subject|2|||
105709405|NCT00267748|364596110|FG000|Randomized Period|Other|0|||
105709406|NCT00267748|364596111|FG001|Randomized Period|Other|9|||
105709407|NCT00267748|364596112|FG002|Randomized Period|Other|6|||
105709408|NCT00267748|364596110|FG000|Randomized Period|randomized but not treated|0|||
105709409|NCT00267748|364596111|FG001|Randomized Period|randomized but not treated|0|||
105709410|NCT00267748|364596112|FG002|Randomized Period|randomized but not treated|3|||
105709411|NCT01294800|364596113|FG000|Overall Study|Adverse Event|7|||
105709412|NCT01294800|364596114|FG001|Overall Study|Adverse Event|6|||
105709413|NCT01294800|364596115|FG002|Overall Study|Adverse Event|12|||
105709414|NCT01294800|364596116|FG003|Overall Study|Adverse Event|5|||
105709415|NCT01294800|364596113|FG000|Overall Study|Subject Withdrew Consent|2|||
105709416|NCT01294800|364596114|FG001|Overall Study|Subject Withdrew Consent|2|||
105709417|NCT01294800|364596115|FG002|Overall Study|Subject Withdrew Consent|2|||
105709418|NCT01294800|364596116|FG003|Overall Study|Subject Withdrew Consent|11|||
105709419|NCT01294800|364596113|FG000|Overall Study|Lost to Follow-up|0|||
105709420|NCT01294800|364596114|FG001|Overall Study|Lost to Follow-up|0|||
105709421|NCT01294800|364596115|FG002|Overall Study|Lost to Follow-up|1|||
105709422|NCT01294800|364596116|FG003|Overall Study|Lost to Follow-up|0|||
105709423|NCT01294800|364596113|FG000|Overall Study|Non-compliance With Protocol|0|||
105709424|NCT01294800|364596114|FG001|Overall Study|Non-compliance With Protocol|1|||
105709425|NCT01294800|364596115|FG002|Overall Study|Non-compliance With Protocol|1|||
105709426|NCT01294800|364596116|FG003|Overall Study|Non-compliance With Protocol|0|||
105709427|NCT01294800|364596113|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
105709428|NCT01294800|364596114|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
105709429|NCT01294800|364596115|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
105928139|NCT00429299|365395366|FG002|Overall Study|Adverse Event|1|||
105928140|NCT00429299|365395364|FG000|Overall Study|Protocol Violation|1|||
105928141|NCT00429299|365395365|FG001|Overall Study|Protocol Violation|0|||
105928142|NCT00429299|365395366|FG002|Overall Study|Protocol Violation|0|||
105928143|NCT00429299|365395364|FG000|Overall Study|Withdrawal by Subject|0|||
105709430|NCT01294800|364596116|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
105928144|NCT00429299|365395365|FG001|Overall Study|Withdrawal by Subject|1|||
105928145|NCT00429299|365395366|FG002|Overall Study|Withdrawal by Subject|3|||
105928146|NCT01510756|365395367|FG000|Overall Study|Death|1|||
105709431|NCT01662895|364596126|FG000|Overall Study|Lost to Follow-up|0|||
105709432|NCT01662895|364596127|FG001|Overall Study|Lost to Follow-up|1|||
105709433|NCT01827670|364596128|FG000|Overall Study|Withdrawal of Consent|3|||
105709434|NCT01827670|364596129|FG001|Overall Study|Withdrawal of Consent|2|||
105709435|NCT01827670|364596128|FG000|Overall Study|Lost to Follow-up|0|||
105709436|NCT01827670|364596129|FG001|Overall Study|Lost to Follow-up|1|||
105928147|NCT01510756|365395367|FG000|Overall Study|Lack of Efficacy|2|||
105709437|NCT00835237|364596131|FG000|Overall Study|Lost to Follow-up|4|||
105709438|NCT00835237|364596132|FG001|Overall Study|Lost to Follow-up|0|||
105709439|NCT00835237|364596131|FG000|Overall Study|Withdrawal by Subject|2|||
105928148|NCT01510756|365395367|FG000|Overall Study|Physician Decision|1|||
105928149|NCT01922011|365395368|FG000|Overall Study|Protocol Violation|0|||
105928150|NCT01922011|365395369|FG001|Overall Study|Protocol Violation|1|||
105928151|NCT01922011|365395368|FG000|Overall Study|Physician Decision|0|||
105928152|NCT01922011|365395369|FG001|Overall Study|Physician Decision|1|||
105928153|NCT01922011|365395368|FG000|Overall Study|Parent/Guardian Decision|3|||
105928154|NCT01922011|365395369|FG001|Overall Study|Parent/Guardian Decision|0|||
105928155|NCT01922011|365395368|FG000|Overall Study|Lost to Follow-up|0|||
105928156|NCT01922011|365395369|FG001|Overall Study|Lost to Follow-up|1|||
105928157|NCT01922011|365395368|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
105928158|NCT01922011|365395369|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
105928159|NCT01922011|365395368|FG000|Overall Study|Not Treated|1|||
105928160|NCT01922011|365395369|FG001|Overall Study|Not Treated|0|||
105928161|NCT01922011|365395368|FG000|Overall Study|Lack of willing home health agency|1|||
105928162|NCT01922011|365395369|FG001|Overall Study|Lack of willing home health agency|0|||
105928163|NCT01922011|365395368|FG000|Overall Study|Randomized in error|1|||
105928164|NCT01922011|365395369|FG001|Overall Study|Randomized in error|0|||
105928165|NCT02447029|365395373|FG000|Overall Study|Withdrawal by Subject|3|||
105928166|NCT02447029|365395374|FG001|Overall Study|Withdrawal by Subject|2|||
105928167|NCT00726557|365395375|FG000|Overall Study|Screening failure|4|||
105928168|NCT00726557|365395375|FG000|Overall Study|No end of treatment documentation|37|||
105928169|NCT00726557|365395375|FG000|Overall Study|No follow-up documentation available|55|||
105928170|NCT00726557|365395375|FG000|Overall Study|Treatment less than 3 months|17|||
105928171|NCT00726557|365395375|FG000|Overall Study|Inclusion criteria not met|15|||
105928172|NCT01257542|365395376|FG000|Overall Study|Protocol Violation|3|||
105928173|NCT01257542|365395377|FG001|Overall Study|Protocol Violation|5|||
105928174|NCT01257542|365395376|FG000|Overall Study|Withdrawal by Subject|0|||
105928175|NCT01257542|365395377|FG001|Overall Study|Withdrawal by Subject|2|||
105928176|NCT00081458|365395378|FG000|Overall Study|Adverse Event|1|||
105928177|NCT00081458|365395379|FG001|Overall Study|Adverse Event|5|||
105928178|NCT00081458|365395380|FG002|Overall Study|Adverse Event|2|||
105928179|NCT00081458|365395378|FG000|Overall Study|Withdrawal by Subject|0|||
105928180|NCT00081458|365395379|FG001|Overall Study|Withdrawal by Subject|3|||
105928181|NCT00081458|365395380|FG002|Overall Study|Withdrawal by Subject|1|||
105928182|NCT00081458|365395378|FG000|Overall Study|Randomized but not dosed|0|||
105928183|NCT00081458|365395379|FG001|Overall Study|Randomized but not dosed|0|||
105928184|NCT00081458|365395380|FG002|Overall Study|Randomized but not dosed|1|||
105928185|NCT01946802|365395390|FG000|Overall Study|Death|1|||
105928186|NCT01946802|365395390|FG000|Overall Study|Withdrawal by Subject|2|||
105928187|NCT01946802|365395390|FG000|Overall Study|Combined septic shock|1|||
105928188|NCT01946802|365395390|FG000|Overall Study|Protocol Violation|1|||
105928189|NCT03097315|365395391|FG000|Overall Study|Withdrawal by Subject|1|||
105928190|NCT04327271|365395392|FG000|Overall Study|Death|1|||
105928191|NCT04327271|365395393|FG001|Overall Study|Death|0|||
105928192|NCT04327271|365395392|FG000|Overall Study|Withdrawal by Subject|1|||
105928193|NCT04327271|365395393|FG001|Overall Study|Withdrawal by Subject|0|||
105928194|NCT04327271|365395392|FG000|Overall Study|randomization error (data capture)|4|||
105928195|NCT04327271|365395393|FG001|Overall Study|randomization error (data capture)|3|||
105928196|NCT03637374|365395394|FG000|Overall Study|Death|2|||
105928197|NCT03637374|365395395|FG001|Overall Study|Death|0|||
105709440|NCT00835237|364596132|FG001|Overall Study|Withdrawal by Subject|0|||
105709441|NCT01692301|364596133|FG000|Overall Study|Adverse Event|15|||
105709442|NCT01692301|364596134|FG001|Overall Study|Adverse Event|12|||
105709443|NCT01692301|364596133|FG000|Overall Study|Death|1|||
105709444|NCT01692301|364596134|FG001|Overall Study|Death|2|||
105709445|NCT01692301|364596133|FG000|Overall Study|Lack of Efficacy|0|||
105709446|NCT01692301|364596134|FG001|Overall Study|Lack of Efficacy|5|||
105709447|NCT01692301|364596133|FG000|Overall Study|Non-compliance with study treatment|1|||
105709448|NCT01692301|364596134|FG001|Overall Study|Non-compliance with study treatment|2|||
105709449|NCT01692301|364596133|FG000|Overall Study|Protocol deviation|9|||
105709450|NCT01692301|364596134|FG001|Overall Study|Protocol deviation|2|||
105709451|NCT01692301|364596133|FG000|Overall Study|Patient/guardian decision|16|||
105928198|NCT02691663|365395397|FG000|Overall Study|Screen failure after baseline|2|||
105928199|NCT02691663|365395398|FG001|Overall Study|Screen failure after baseline|2|||
105928200|NCT02691663|365395397|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
105928201|NCT02691663|365395398|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
105709452|NCT01692301|364596134|FG001|Overall Study|Patient/guardian decision|15|||
105709453|NCT01692301|364596133|FG000|Overall Study|Technical problems|0|||
105928202|NCT02691663|365395397|FG000|Overall Study|Withdrawn after Follow up 2|1|||
105928203|NCT02691663|365395398|FG001|Overall Study|Withdrawn after Follow up 2|1|||
105928204|NCT02691663|365395397|FG000|Overall Study|Lost to Follow-up|3|||
105928205|NCT02691663|365395398|FG001|Overall Study|Lost to Follow-up|2|||
105928206|NCT03142750|365395399|FG000|Overall Study|Lost to Follow-up|4|||
105928207|NCT03142750|365395400|FG001|Overall Study|Lost to Follow-up|1|||
105928208|NCT05561140|365395401|FG000|Randomized Treatment Period|Adverse Event|1|||
105709454|NCT01692301|364596134|FG001|Overall Study|Technical problems|1|||
105928209|NCT05561140|365395402|FG001|Randomized Treatment Period|Adverse Event|0|||
105928210|NCT05561140|365395401|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
106134091|NCT00495469|366150352|FG004|Overall Study|Adverse Event|1|||
105709455|NCT01692301|364596133|FG000|Overall Study|Physician Decision|2|||
105709456|NCT01692301|364596134|FG001|Overall Study|Physician Decision|2|||
105709457|NCT01692301|364596133|FG000|Overall Study|Lost to Follow-up|1|||
105709458|NCT01692301|364596134|FG001|Overall Study|Lost to Follow-up|1|||
105709459|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
105709460|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
105709461|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
105709462|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
105709463|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
105709464|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
105709465|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
105709466|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
105709467|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
105709468|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
105709469|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
105709470|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
105709471|NCT01142726|364596135|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
105709472|NCT01142726|364596136|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
105709473|NCT01142726|364596137|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
105709474|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
105709475|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
105709476|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
105709477|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
105709478|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
105709479|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
105709480|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
105709481|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
105709482|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
105709483|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
105709484|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
105709485|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
105709486|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
105709487|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
105709488|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
105709489|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
105709490|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
105709491|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
105709492|NCT01142726|364596135|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
105709493|NCT01142726|364596136|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
105709494|NCT01142726|364596137|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
105709495|NCT01142726|364596135|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
105709496|NCT01142726|364596136|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
105709497|NCT01142726|364596137|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
105709498|NCT01142726|364596135|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
105709499|NCT01142726|364596136|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
105709500|NCT01142726|364596137|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
105709501|NCT01142726|364596135|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
105709502|NCT01142726|364596136|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
105709503|NCT01142726|364596137|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
105709504|NCT01142726|364596135|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
105709505|NCT01142726|364596136|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
105709506|NCT01142726|364596137|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
105709507|NCT03713944|364596138|FG000|Study Treatment|Patient non-compliance|1|||
105709508|NCT03713944|364596138|FG000|Study Treatment|Alternative Cancer Therapy|3|||
105709509|NCT03713944|364596138|FG000|Study Treatment|Disease Progression|18|||
105709510|NCT03713944|364596138|FG000|Study Treatment|AE/Side Effects/Complications|2|||
105709511|NCT03713944|364596138|FG000|Study Treatment|Death|2|||
105709512|NCT03713944|364596138|FG000|Study Treatment|Withdrawal by Subject|1|||
105709513|NCT03713944|364596138|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
105928211|NCT05561140|365395402|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
106134092|NCT00495469|366150353|FG005|Overall Study|Adverse Event|1|||
105709514|NCT03713944|364596138|FG000|Study Treatment|Symptomatic Deterioration|2|||
105709515|NCT03713944|364596138|FG000|Follow up|Withdrawal by Subject|2|||
105709516|NCT03713944|364596138|FG000|Follow up|Death|11|||
105928212|NCT05561140|365395401|FG000|Open Label Treatment Period|Adverse Event|6|||
106134093|NCT00495469|366150354|FG006|Overall Study|Adverse Event|1|||
106134094|NCT00495469|366150348|FG000|Overall Study|Lost to Follow-up|1|||
105709517|NCT03713944|364596138|FG000|Follow up|Study Terminated|3|||
105709518|NCT02111993|364596139|FG000|Overall Study|Physician Decision|5|||
105709519|NCT02111993|364596140|FG001|Overall Study|Physician Decision|4|||
105709520|NCT00293579|364596141|FG000|Overall Study|Withdrawal by Subject|1|||
105709521|NCT03694925|364596144|FG000|Overall Study|Inadequate laboratory testing|0|||
105709522|NCT03694925|364596145|FG001|Overall Study|Inadequate laboratory testing|3|||
105709523|NCT03694925|364596146|FG002|Overall Study|Inadequate laboratory testing|0|||
105709524|NCT00343889|364596160|FG000|Overall Study|Lost to Follow-up|2|||
105709525|NCT00343889|364596161|FG001|Overall Study|Lost to Follow-up|0|||
105709526|NCT00343889|364596160|FG000|Overall Study|Withdrawal by Subject|0|||
105709527|NCT00343889|364596161|FG001|Overall Study|Withdrawal by Subject|1|||
105709528|NCT00343889|364596160|FG000|Overall Study|Protocol Violation|1|||
105709529|NCT00343889|364596161|FG001|Overall Study|Protocol Violation|0|||
105709530|NCT01294579|364596162|FG000|Overall Study|Disease progression|12|||
105709531|NCT01294579|364596162|FG000|Overall Study|Adverse Event|11|||
105709532|NCT01294579|364596162|FG000|Overall Study|Study closed/terminated|3|||
105709533|NCT01294579|364596162|FG000|Overall Study|Lost to Follow-up|1|||
105709534|NCT01294579|364596162|FG000|Overall Study|Physician Decision|3|||
105709535|NCT01294579|364596162|FG000|Overall Study|Withdrawal by Subject|5|||
105709536|NCT01967537|364596165|FG000|Overall Study|Withdrawal by Subject|52|||
105709537|NCT01967537|364596165|FG000|Overall Study|Refuse treatment|2|||
105709538|NCT01967537|364596165|FG000|Overall Study|Lost to Follow-up|6|||
105709539|NCT04417894|364596168|FG000|Overall Study|Lost to Follow-up|3|||
105709540|NCT04417894|364596169|FG001|Overall Study|Lost to Follow-up|0|||
105709541|NCT04417894|364596168|FG000|Overall Study|Withdrawal by Subject|7|||
105709542|NCT04417894|364596169|FG001|Overall Study|Withdrawal by Subject|6|||
105709543|NCT04417894|364596168|FG000|Overall Study|Lack of Efficacy|3|||
105709544|NCT04417894|364596169|FG001|Overall Study|Lack of Efficacy|1|||
105709545|NCT01464307|364596170|FG000|Main Period|Death|0|||
105709546|NCT01464307|364596171|FG001|Main Period|Death|1|||
105709547|NCT01464307|364596170|FG000|Main Period|Adverse Event|6|||
105709548|NCT01464307|364596171|FG001|Main Period|Adverse Event|1|||
105709549|NCT01464307|364596170|FG000|Main Period|Lack of Efficacy|2|||
105709550|NCT01464307|364596171|FG001|Main Period|Lack of Efficacy|0|||
105709551|NCT01464307|364596170|FG000|Main Period|Withdrawal by Subject|5|||
105709552|NCT01464307|364596171|FG001|Main Period|Withdrawal by Subject|2|||
105709553|NCT01464307|364596170|FG000|Main Period|Predefined discontinuation criteria|2|||
105709554|NCT01464307|364596171|FG001|Main Period|Predefined discontinuation criteria|1|||
105709555|NCT01464307|364596170|FG000|Open-Label Extension Period|Adverse Event|15|||
105709556|NCT01464307|364596171|FG001|Open-Label Extension Period|Adverse Event|0|||
105709557|NCT01464307|364596170|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
105709558|NCT01464307|364596171|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
105709559|NCT01464307|364596170|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
105709560|NCT01464307|364596171|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
105709561|NCT01464307|364596170|FG000|Open-Label Extension Period|Death|1|||
105709562|NCT01464307|364596171|FG001|Open-Label Extension Period|Death|0|||
105709563|NCT01464307|364596170|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
105709564|NCT01464307|364596171|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
105709565|NCT01464307|364596170|FG000|Open-Label Extension Period|Non-compliance|9|||
105709566|NCT01464307|364596171|FG001|Open-Label Extension Period|Non-compliance|0|||
105709567|NCT01464307|364596170|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
105709568|NCT01464307|364596171|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
105709569|NCT03652662|364596172|FG000|Overall Study|Withdrawal by Subject|2|||
105709570|NCT03652662|364596173|FG001|Overall Study|Withdrawal by Subject|1|||
105709571|NCT03652662|364596172|FG000|Overall Study|Lost to Follow-up|1|||
105928213|NCT05561140|365395402|FG001|Open Label Treatment Period|Adverse Event|4|||
105928214|NCT05561140|365395401|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
105928215|NCT05561140|365395402|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
105928216|NCT05561140|365395401|FG000|Open Label Treatment Period|Physician Decision|0|||
105928217|NCT05561140|365395402|FG001|Open Label Treatment Period|Physician Decision|1|||
105928218|NCT05561140|365395401|FG000|Open Label Treatment Period|Pregnancy|1|||
105928219|NCT05561140|365395402|FG001|Open Label Treatment Period|Pregnancy|0|||
105928220|NCT05561140|365395401|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
105928221|NCT05561140|365395402|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
105709572|NCT03652662|364596173|FG001|Overall Study|Lost to Follow-up|0|||
105709573|NCT04327388|364596174|FG000|Overall Study|Adverse Event|17|||
105709574|NCT04327388|364596175|FG001|Overall Study|Adverse Event|18|||
105709575|NCT04327388|364596176|FG002|Overall Study|Adverse Event|9|||
105709576|NCT04327388|364596174|FG000|Overall Study|Other|1|||
105709577|NCT04327388|364596175|FG001|Overall Study|Other|2|||
105709578|NCT04327388|364596176|FG002|Overall Study|Other|0|||
105709579|NCT04327388|364596174|FG000|Overall Study|Randomized and not treated|2|||
105709580|NCT04327388|364596175|FG001|Overall Study|Randomized and not treated|0|||
105928222|NCT05561140|365395401|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
105709581|NCT04327388|364596176|FG002|Overall Study|Randomized and not treated|2|||
105709582|NCT00720109|364596177|FG000|Induction Period|Did not meet eligibility criteria|3|||
105709583|NCT00720109|364596178|FG001|Induction Period|Did not meet eligibility criteria|0|||
105709584|NCT00720109|364596179|FG002|Induction Period|Did not meet eligibility criteria|0|||
105709585|NCT00720109|364596177|FG000|Induction Period|Bone Marrow Transplant|2|||
105709586|NCT00720109|364596178|FG001|Induction Period|Bone Marrow Transplant|0|||
105709587|NCT00720109|364596179|FG002|Induction Period|Bone Marrow Transplant|0|||
105709588|NCT00720109|364596177|FG000|Induction Period|Physician Decision|1|||
105709589|NCT00720109|364596178|FG001|Induction Period|Physician Decision|0|||
105709590|NCT00720109|364596179|FG002|Induction Period|Physician Decision|0|||
105709591|NCT00720109|364596177|FG000|Risk Stratification Period|Adverse Event|0|||
105709592|NCT00720109|364596178|FG001|Risk Stratification Period|Adverse Event|1|||
105709593|NCT00720109|364596179|FG002|Risk Stratification Period|Adverse Event|0|||
105709594|NCT00720109|364596177|FG000|Risk Stratification Period|Physician Decision|0|||
105709595|NCT00720109|364596178|FG001|Risk Stratification Period|Physician Decision|2|||
105709596|NCT00720109|364596179|FG002|Risk Stratification Period|Physician Decision|1|||
105709597|NCT00720109|364596177|FG000|Risk Stratification Period|Bone marrow transplant|0|||
105709598|NCT00720109|364596178|FG001|Risk Stratification Period|Bone marrow transplant|9|||
105709599|NCT00720109|364596179|FG002|Risk Stratification Period|Bone marrow transplant|7|||
105709600|NCT00720109|364596177|FG000|Risk Stratification Period|Disease progression or relapse|0|||
105709601|NCT00720109|364596178|FG001|Risk Stratification Period|Disease progression or relapse|2|||
105709602|NCT00720109|364596179|FG002|Risk Stratification Period|Disease progression or relapse|0|||
105709603|NCT00720109|364596177|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
105709604|NCT00720109|364596178|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
105709605|NCT00720109|364596179|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
105709606|NCT01110200|364596180|FG000|Overall Study|Adverse Event|28|||
105709607|NCT01110200|364596181|FG001|Overall Study|Adverse Event|28|||
105709608|NCT01110200|364596180|FG000|Overall Study|Withdrawal by Subject|25|||
105709609|NCT01110200|364596181|FG001|Overall Study|Withdrawal by Subject|32|||
105709610|NCT01110200|364596180|FG000|Overall Study|Lack of Efficacy|16|||
105709611|NCT01110200|364596181|FG001|Overall Study|Lack of Efficacy|25|||
105709612|NCT01110200|364596180|FG000|Overall Study|Protocol Violation|14|||
105709613|NCT01110200|364596181|FG001|Overall Study|Protocol Violation|12|||
105709614|NCT01110200|364596180|FG000|Overall Study|Physician Decision|13|||
105709615|NCT01110200|364596181|FG001|Overall Study|Physician Decision|17|||
105709616|NCT01110200|364596180|FG000|Overall Study|Lost to Follow-up|10|||
105709617|NCT01110200|364596181|FG001|Overall Study|Lost to Follow-up|7|||
105709618|NCT03595553|364596182|FG000|Overall Study|Withdrawal by Subject|20|||
105709619|NCT03595553|364596183|FG001|Overall Study|Withdrawal by Subject|8|||
105709620|NCT03595553|364596182|FG000|Overall Study|Physician Decision|3|||
105709621|NCT03595553|364596183|FG001|Overall Study|Physician Decision|2|||
105709622|NCT03595553|364596182|FG000|Overall Study|Adverse Event|2|||
105709623|NCT03595553|364596183|FG001|Overall Study|Adverse Event|5|||
105709624|NCT03595553|364596182|FG000|Overall Study|Death|24|||
105709625|NCT03595553|364596183|FG001|Overall Study|Death|22|||
105709626|NCT03595553|364596182|FG000|Overall Study|Lost to Follow-up|6|||
105709627|NCT03595553|364596183|FG001|Overall Study|Lost to Follow-up|7|||
105709628|NCT03595553|364596182|FG000|Overall Study|Other as indicated in CSR|3|||
105709629|NCT03595553|364596183|FG001|Overall Study|Other as indicated in CSR|3|||
105709630|NCT03595553|364596182|FG000|Overall Study|Sponsor Decision|0|||
105709631|NCT03595553|364596183|FG001|Overall Study|Sponsor Decision|1|||
105709632|NCT03074474|364596186|FG000|Overall Study|Lost to Follow-up|10|||
105709633|NCT03074474|364596186|FG000|Overall Study|Withdrawal by Subject|10|||
106007493|NCT03919773|365692286|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
106007494|NCT03919773|365692287|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
106007495|NCT04659044|365692288|FG000|Induction|Physician Decision|1|||
106134095|NCT00495469|366150349|FG001|Overall Study|Lost to Follow-up|1|||
105709634|NCT03074474|364596186|FG000|Overall Study|Death|4|||
105709635|NCT03074474|364596186|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
105709636|NCT00512798|364596193|FG000|Overall Study|Death|0|||
105709637|NCT00512798|364596194|FG001|Overall Study|Death|3|||
105709638|NCT00512798|364596193|FG000|Overall Study|Adverse Event|2|||
105709639|NCT00512798|364596194|FG001|Overall Study|Adverse Event|4|||
105709640|NCT00512798|364596193|FG000|Overall Study|Progression of disease|14|||
105709641|NCT00512798|364596194|FG001|Overall Study|Progression of disease|20|||
105709642|NCT00512798|364596193|FG000|Overall Study|Withdrawal by Subject|3|||
105709643|NCT00512798|364596194|FG001|Overall Study|Withdrawal by Subject|0|||
105709644|NCT03434977|364596195|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
105709645|NCT03434977|364596196|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
105709646|NCT04899232|364596198|FG000|Screening Period|Physician Decision|1|||
105709647|NCT04899232|364596199|FG001|Screening Period|Physician Decision|0|||
106007496|NCT04659044|365692288|FG000|Induction|Adverse Event|2|||
105709648|NCT04899232|364596200|FG002|Screening Period|Physician Decision|0|||
106007497|NCT05177354|365692289|FG000|Implant to 30-day Visit|Physician Decision|1|||
105709649|NCT04899232|364596198|FG000|Screening Period|Withdrawal by Subject|1|||
105709650|NCT04899232|364596199|FG001|Screening Period|Withdrawal by Subject|0|||
105709651|NCT04899232|364596200|FG002|Screening Period|Withdrawal by Subject|0|||
105709652|NCT04899232|364596198|FG000|Screening Period|Participant discharged before receiving intervention|3|||
105709653|NCT04899232|364596199|FG001|Screening Period|Participant discharged before receiving intervention|0|||
105709654|NCT04899232|364596200|FG002|Screening Period|Participant discharged before receiving intervention|0|||
105709655|NCT00936208|364596202|FG000|Overall Study|Protocol Violation|37|||
105709656|NCT00936208|364596203|FG001|Overall Study|Protocol Violation|22|||
105709657|NCT00700271|364596204|FG000|Overall Study|Adverse Event|4|||
105709658|NCT00700271|364596205|FG001|Overall Study|Adverse Event|6|||
105709659|NCT00700271|364596204|FG000|Overall Study|Protocol Violation|1|||
105709660|NCT00700271|364596205|FG001|Overall Study|Protocol Violation|0|||
105709661|NCT00700271|364596204|FG000|Overall Study|Administrative Reasons|1|||
105709662|NCT00700271|364596205|FG001|Overall Study|Administrative Reasons|0|||
105709663|NCT00700271|364596204|FG000|Overall Study|Withdrawal by Subject|6|||
105709664|NCT00700271|364596205|FG001|Overall Study|Withdrawal by Subject|4|||
105709665|NCT00700271|364596204|FG000|Overall Study|Lost to Follow-up|2|||
105709666|NCT00700271|364596205|FG001|Overall Study|Lost to Follow-up|2|||
105709667|NCT00861744|364596206|FG000|Overall Study|Adverse Event|0|||
105709668|NCT00861744|364596207|FG001|Overall Study|Adverse Event|0|||
105709669|NCT00861744|364596208|FG002|Overall Study|Adverse Event|0|||
105709670|NCT00861744|364596209|FG003|Overall Study|Adverse Event|1|||
105709671|NCT00861744|364596206|FG000|Overall Study|Lost to Follow-up|7|||
105709672|NCT00861744|364596207|FG001|Overall Study|Lost to Follow-up|19|||
105709673|NCT00861744|364596208|FG002|Overall Study|Lost to Follow-up|17|||
105709674|NCT00861744|364596209|FG003|Overall Study|Lost to Follow-up|12|||
105709675|NCT00861744|364596206|FG000|Overall Study|Withdrawal by Subject|10|||
105709676|NCT00861744|364596207|FG001|Overall Study|Withdrawal by Subject|6|||
105709677|NCT00861744|364596208|FG002|Overall Study|Withdrawal by Subject|6|||
105709678|NCT00861744|364596209|FG003|Overall Study|Withdrawal by Subject|19|||
105709679|NCT00861744|364596206|FG000|Overall Study|Protocol Violation|0|||
105709680|NCT00861744|364596207|FG001|Overall Study|Protocol Violation|1|||
105709681|NCT00861744|364596208|FG002|Overall Study|Protocol Violation|0|||
105709682|NCT00861744|364596209|FG003|Overall Study|Protocol Violation|0|||
105709683|NCT00861744|364596206|FG000|Overall Study|Migration from study area|0|||
105709684|NCT00861744|364596207|FG001|Overall Study|Migration from study area|3|||
105709685|NCT00861744|364596208|FG002|Overall Study|Migration from study area|1|||
105709686|NCT00861744|364596209|FG003|Overall Study|Migration from study area|0|||
105709687|NCT00861744|364596206|FG000|Overall Study|Blood draws|0|||
105709688|NCT00861744|364596207|FG001|Overall Study|Blood draws|0|||
105709689|NCT00861744|364596208|FG002|Overall Study|Blood draws|0|||
105709690|NCT00861744|364596209|FG003|Overall Study|Blood draws|1|||
105709691|NCT01344876|364596210|FG000|Overall Study|Adverse Event|0|||
105709692|NCT01344876|364596211|FG001|Overall Study|Adverse Event|0|||
105709693|NCT01344876|364596212|FG002|Overall Study|Adverse Event|0|||
105709694|NCT01344876|364596213|FG003|Overall Study|Adverse Event|0|||
105709695|NCT01344876|364596214|FG004|Overall Study|Adverse Event|1|||
105709696|NCT01344876|364596210|FG000|Overall Study|Withdrawal by Subject|0|||
105709697|NCT01344876|364596211|FG001|Overall Study|Withdrawal by Subject|0|||
105709698|NCT01344876|364596212|FG002|Overall Study|Withdrawal by Subject|1|||
105709699|NCT01344876|364596213|FG003|Overall Study|Withdrawal by Subject|0|||
105709700|NCT01344876|364596214|FG004|Overall Study|Withdrawal by Subject|0|||
105709701|NCT01344876|364596210|FG000|Overall Study|Definite progression of primary disease|1|||
105709702|NCT01344876|364596211|FG001|Overall Study|Definite progression of primary disease|0|||
105709703|NCT01344876|364596212|FG002|Overall Study|Definite progression of primary disease|0|||
105709704|NCT01344876|364596213|FG003|Overall Study|Definite progression of primary disease|3|||
105709705|NCT01344876|364596214|FG004|Overall Study|Definite progression of primary disease|0|||
105709706|NCT04428424|364596215|FG000|Overall Study|Does not meet entrance criteria|132|||
105709707|NCT04428424|364596215|FG000|Overall Study|Lost to Follow-up|115|||
105709708|NCT01928381|364596216|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
105709709|NCT01928381|364596217|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709710|NCT01928381|364596218|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709711|NCT01928381|364596219|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709712|NCT01928381|364596220|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105928223|NCT05561140|365395402|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
105928224|NCT05561140|365395401|FG000|Open Label Treatment Period|Other|1|||
105928225|NCT05561140|365395402|FG001|Open Label Treatment Period|Other|0|||
105788057|NCT00054639|364878176|FG000|Overall Study|Lack of Efficacy|1|||
105788058|NCT00054639|364878176|FG000|Overall Study|Physician Decision|1|||
105928226|NCT03487445|365395403|FG000|Randomization|Not treated for administrative reasons|1|||
105928227|NCT03487445|365395404|FG001|Randomization|Not treated for administrative reasons|0|||
105709713|NCT01928381|364596221|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709714|NCT01928381|364596222|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
105709715|NCT01928381|364596216|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
105709716|NCT01928381|364596217|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
105788059|NCT01600755|364878177|FG000|Overall Study|Withdrawal by Subject|6|||
105788060|NCT04780776|364878178|FG000|Titration Week 1-5|Lost to Follow-up|2|||
105709717|NCT01928381|364596218|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
105709718|NCT01928381|364596219|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
105709719|NCT01928381|364596220|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
105709720|NCT01928381|364596221|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
105709721|NCT01928381|364596222|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
105709722|NCT01928381|364596216|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
105709723|NCT01928381|364596217|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709724|NCT01928381|364596218|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709725|NCT01928381|364596219|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709726|NCT01928381|364596220|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709727|NCT01928381|364596221|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709728|NCT01928381|364596222|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
105709729|NCT01928381|364596216|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
105709730|NCT01928381|364596217|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
105709731|NCT01928381|364596218|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
105709732|NCT01928381|364596219|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
105709733|NCT01928381|364596220|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
105709734|NCT01928381|364596221|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
105709735|NCT01928381|364596222|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
105709736|NCT01928381|364596216|FG000|Part 1 - Pain Training|Protocol Violation|1|||
105709737|NCT01928381|364596217|FG001|Part 1 - Pain Training|Protocol Violation|0|||
105709738|NCT01928381|364596218|FG002|Part 1 - Pain Training|Protocol Violation|0|||
105709739|NCT01928381|364596219|FG003|Part 1 - Pain Training|Protocol Violation|0|||
105709740|NCT01928381|364596220|FG004|Part 1 - Pain Training|Protocol Violation|0|||
105709741|NCT01928381|364596221|FG005|Part 1 - Pain Training|Protocol Violation|0|||
105709742|NCT01928381|364596222|FG006|Part 1 - Pain Training|Protocol Violation|0|||
105709743|NCT01928381|364596216|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
105709744|NCT01928381|364596217|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709745|NCT01928381|364596218|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709746|NCT01928381|364596219|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709747|NCT01928381|364596220|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709748|NCT01928381|364596221|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709749|NCT01928381|364596222|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
105709750|NCT01928381|364596216|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
105709751|NCT01928381|364596217|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709752|NCT01928381|364596218|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709753|NCT01928381|364596219|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709754|NCT01928381|364596220|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709755|NCT01928381|364596221|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709756|NCT01928381|364596222|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
105709757|NCT01928381|364596216|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
105709758|NCT01928381|364596217|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709759|NCT01928381|364596218|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105928228|NCT01666652|365395409|FG000|Overall Study|Serious Adverse Event|0|||
105928229|NCT01666652|365395410|FG001|Overall Study|Serious Adverse Event|0|||
105928230|NCT01666652|365395411|FG002|Overall Study|Serious Adverse Event|0|||
105928231|NCT01666652|365395412|FG003|Overall Study|Serious Adverse Event|1|||
105928232|NCT01666652|365395413|FG004|Overall Study|Serious Adverse Event|0|||
105928233|NCT01666652|365395409|FG000|Overall Study|Withdrawal by Subject|0|||
105928234|NCT01666652|365395410|FG001|Overall Study|Withdrawal by Subject|0|||
105928235|NCT01666652|365395411|FG002|Overall Study|Withdrawal by Subject|0|||
105928236|NCT01666652|365395412|FG003|Overall Study|Withdrawal by Subject|0|||
105928237|NCT01666652|365395413|FG004|Overall Study|Withdrawal by Subject|1|||
105928238|NCT01666652|365395409|FG000|Overall Study|Moved from study area|1|||
105928239|NCT01666652|365395410|FG001|Overall Study|Moved from study area|0|||
105928240|NCT01666652|365395411|FG002|Overall Study|Moved from study area|0|||
105928241|NCT01666652|365395412|FG003|Overall Study|Moved from study area|2|||
105928242|NCT01666652|365395413|FG004|Overall Study|Moved from study area|0|||
105928243|NCT01666652|365395409|FG000|Overall Study|Lost to Follow-up|1|||
105928244|NCT01666652|365395410|FG001|Overall Study|Lost to Follow-up|1|||
105928245|NCT01666652|365395411|FG002|Overall Study|Lost to Follow-up|1|||
105928246|NCT01666652|365395412|FG003|Overall Study|Lost to Follow-up|1|||
105928247|NCT01666652|365395413|FG004|Overall Study|Lost to Follow-up|0|||
105928248|NCT03325439|365395414|FG000|Overall Study|Ineligibility|3|||
105928249|NCT00866320|365395415|FG000|Overall Study|Withdrawal by Subject|4|||
105928250|NCT00866320|365395415|FG000|Overall Study|Death|2|||
105928251|NCT03412890|365395419|FG000|Overall Study|Adverse Event|5|||
105928252|NCT03412890|365395420|FG001|Overall Study|Adverse Event|5|||
105928253|NCT03412890|365395421|FG002|Overall Study|Adverse Event|9|||
105928254|NCT03412890|365395419|FG000|Overall Study|Protocol deviation|2|||
105709760|NCT01928381|364596219|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709761|NCT01928381|364596220|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709762|NCT01928381|364596221|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709763|NCT01928381|364596222|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
105709764|NCT01928381|364596216|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
105709765|NCT01928381|364596217|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709766|NCT01928381|364596218|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709767|NCT01928381|364596219|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709768|NCT01928381|364596220|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709769|NCT01928381|364596221|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105928255|NCT03412890|365395420|FG001|Overall Study|Protocol deviation|1|||
105928256|NCT03412890|365395421|FG002|Overall Study|Protocol deviation|2|||
105928257|NCT03412890|365395419|FG000|Overall Study|Lost to Follow-up|7|||
105928258|NCT03412890|365395420|FG001|Overall Study|Lost to Follow-up|10|||
105709770|NCT01928381|364596222|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
105709771|NCT01928381|364596216|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709772|NCT01928381|364596217|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709773|NCT01928381|364596218|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
105709774|NCT01928381|364596219|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709775|NCT01928381|364596220|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709776|NCT01928381|364596221|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709777|NCT01928381|364596222|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
105709778|NCT01928381|364596216|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709779|NCT01928381|364596217|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709780|NCT01928381|364596218|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
105709781|NCT01928381|364596219|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709782|NCT01928381|364596220|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709783|NCT01928381|364596221|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709784|NCT01928381|364596222|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
105709785|NCT01928381|364596216|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709786|NCT01928381|364596217|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709787|NCT01928381|364596218|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709788|NCT01928381|364596219|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709789|NCT01928381|364596220|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
105709790|NCT01928381|364596221|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
105709791|NCT01928381|364596222|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
105709792|NCT01928381|364596216|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
105709793|NCT01928381|364596217|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
105709794|NCT01928381|364596218|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
105709795|NCT01928381|364596219|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
105709796|NCT01928381|364596220|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
105709797|NCT01928381|364596221|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
105709798|NCT01928381|364596222|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
105709799|NCT01928381|364596216|FG000|Washout First Intervention|Protocol Violation|0|||
105709800|NCT01928381|364596217|FG001|Washout First Intervention|Protocol Violation|0|||
105709801|NCT01928381|364596218|FG002|Washout First Intervention|Protocol Violation|0|||
105709802|NCT01928381|364596219|FG003|Washout First Intervention|Protocol Violation|0|||
105709803|NCT01928381|364596220|FG004|Washout First Intervention|Protocol Violation|1|||
105709804|NCT01928381|364596221|FG005|Washout First Intervention|Protocol Violation|0|||
105709805|NCT01928381|364596222|FG006|Washout First Intervention|Protocol Violation|0|||
105709806|NCT01928381|364596216|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709807|NCT01928381|364596217|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
105709808|NCT01928381|364596218|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709809|NCT01928381|364596219|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
105709810|NCT01928381|364596220|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709811|NCT01928381|364596221|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709812|NCT01928381|364596222|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
105709813|NCT01928381|364596216|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709814|NCT01928381|364596217|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709815|NCT01928381|364596218|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
105709816|NCT01928381|364596219|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
105788061|NCT04780776|364878179|FG001|Titration Week 1-5|Lost to Follow-up|8|||
105788062|NCT04780776|364878178|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
105788063|NCT04780776|364878179|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
105788064|NCT04780776|364878178|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
105788065|NCT04780776|364878179|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
105928259|NCT03412890|365395421|FG002|Overall Study|Lost to Follow-up|10|||
105928260|NCT03412890|365395419|FG000|Overall Study|Withdrawal by Subject|9|||
105928261|NCT03412890|365395420|FG001|Overall Study|Withdrawal by Subject|12|||
105928262|NCT03412890|365395421|FG002|Overall Study|Withdrawal by Subject|11|||
106134096|NCT00495469|366150350|FG002|Overall Study|Lost to Follow-up|3|||
106134097|NCT00495469|366150351|FG003|Overall Study|Lost to Follow-up|1|||
106134098|NCT00495469|366150352|FG004|Overall Study|Lost to Follow-up|0|||
106134099|NCT00495469|366150353|FG005|Overall Study|Lost to Follow-up|0|||
106134100|NCT00495469|366150354|FG006|Overall Study|Lost to Follow-up|0|||
106134101|NCT00495469|366150348|FG000|Overall Study|Protocol Violation|0|||
106134102|NCT00495469|366150349|FG001|Overall Study|Protocol Violation|0|||
106134103|NCT00495469|366150350|FG002|Overall Study|Protocol Violation|0|||
106134104|NCT00495469|366150351|FG003|Overall Study|Protocol Violation|0|||
106134105|NCT00495469|366150352|FG004|Overall Study|Protocol Violation|1|||
106134106|NCT00495469|366150353|FG005|Overall Study|Protocol Violation|2|||
106134107|NCT00495469|366150354|FG006|Overall Study|Protocol Violation|0|||
106134108|NCT00495469|366150348|FG000|Overall Study|Withdrawal by Subject|5|||
106134109|NCT00495469|366150349|FG001|Overall Study|Withdrawal by Subject|3|||
106134110|NCT00495469|366150350|FG002|Overall Study|Withdrawal by Subject|1|||
106134111|NCT00495469|366150351|FG003|Overall Study|Withdrawal by Subject|3|||
106134112|NCT00495469|366150352|FG004|Overall Study|Withdrawal by Subject|3|||
106134113|NCT00495469|366150353|FG005|Overall Study|Withdrawal by Subject|2|||
106134114|NCT00495469|366150354|FG006|Overall Study|Withdrawal by Subject|3|||
106134115|NCT00495469|366150348|FG000|Overall Study|Lack of Efficacy|0|||
106134116|NCT00495469|366150349|FG001|Overall Study|Lack of Efficacy|0|||
106134117|NCT00495469|366150350|FG002|Overall Study|Lack of Efficacy|0|||
106134118|NCT00495469|366150351|FG003|Overall Study|Lack of Efficacy|0|||
106134119|NCT00495469|366150352|FG004|Overall Study|Lack of Efficacy|0|||
106134120|NCT00495469|366150353|FG005|Overall Study|Lack of Efficacy|0|||
106134121|NCT00495469|366150354|FG006|Overall Study|Lack of Efficacy|1|||
106134122|NCT00495469|366150348|FG000|Overall Study|Liver function test abnormality|0|||
106134123|NCT00495469|366150349|FG001|Overall Study|Liver function test abnormality|1|||
106134124|NCT00495469|366150350|FG002|Overall Study|Liver function test abnormality|0|||
106134125|NCT00495469|366150351|FG003|Overall Study|Liver function test abnormality|0|||
106134126|NCT00495469|366150352|FG004|Overall Study|Liver function test abnormality|0|||
106134127|NCT00495469|366150353|FG005|Overall Study|Liver function test abnormality|0|||
106134128|NCT00495469|366150354|FG006|Overall Study|Liver function test abnormality|0|||
106134129|NCT00495469|366150348|FG000|Overall Study|ST depression at randomisation in ECG|0|||
106134130|NCT00495469|366150349|FG001|Overall Study|ST depression at randomisation in ECG|1|||
106134131|NCT00495469|366150350|FG002|Overall Study|ST depression at randomisation in ECG|0|||
106134132|NCT00495469|366150351|FG003|Overall Study|ST depression at randomisation in ECG|0|||
106134133|NCT00495469|366150352|FG004|Overall Study|ST depression at randomisation in ECG|0|||
106134134|NCT00495469|366150353|FG005|Overall Study|ST depression at randomisation in ECG|0|||
106134135|NCT00495469|366150354|FG006|Overall Study|ST depression at randomisation in ECG|0|||
106134136|NCT01390857|366150355|FG000|Overall Study|Protocol Violation|2|||
106134137|NCT01390857|366150355|FG000|Overall Study|Lost to Follow-up|1|||
106134138|NCT01390857|366150355|FG000|Overall Study|No Visit after the First Visit|7|||
106134139|NCT01123161|366150356|FG000|Overall Study|Lost to Follow-up|1|||
106134140|NCT01123161|366150357|FG001|Overall Study|Lost to Follow-up|0|||
106134141|NCT01123161|366150356|FG000|Overall Study|Withdrawal by Subject|1|||
106134142|NCT01123161|366150357|FG001|Overall Study|Withdrawal by Subject|0|||
106134143|NCT02757885|366150358|FG000|Overall Study|Screen Failures|4|||
106134144|NCT02501629|366150362|FG000|Overall Study|Death|0|||
106134145|NCT02501629|366150363|FG001|Overall Study|Death|1|||
106134146|NCT02501629|366150362|FG000|Overall Study|Withdrawn from study by sponsor|1|||
106134147|NCT02501629|366150363|FG001|Overall Study|Withdrawn from study by sponsor|0|||
106134148|NCT02501629|366150362|FG000|Overall Study|Early termination by sponsor|1|||
106134149|NCT02501629|366150363|FG001|Overall Study|Early termination by sponsor|0|||
106134150|NCT02501629|366150362|FG000|Overall Study|Withdrawal by Subject|3|||
106134151|NCT02501629|366150363|FG001|Overall Study|Withdrawal by Subject|5|||
106134152|NCT02501629|366150362|FG000|Overall Study|Subject did not return to site|0|||
106134153|NCT02501629|366150363|FG001|Overall Study|Subject did not return to site|1|||
106134154|NCT00886613|366150366|FG000|Overall Study|Protocol deviation (Part B)|1|||
106134155|NCT00886613|366150367|FG001|Overall Study|Protocol deviation (Part B)|0|||
106134156|NCT00886613|366150368|FG002|Overall Study|Protocol deviation (Part B)|0|||
106134157|NCT00886613|366150366|FG000|Overall Study|Lost to follow-up (Part B)|1|||
106134158|NCT00886613|366150367|FG001|Overall Study|Lost to follow-up (Part B)|0|||
106134159|NCT00886613|366150368|FG002|Overall Study|Lost to follow-up (Part B)|1|||
106134160|NCT00886613|366150366|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
106134161|NCT00886613|366150367|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
106134162|NCT00886613|366150368|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
106134163|NCT05349864|366150373|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
106134164|NCT05349864|366150374|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
106134165|NCT03710564|366150375|FG000|Overall Study|Study Terminated by Sponsor|104|||
106134166|NCT03710564|366150376|FG001|Overall Study|Study Terminated by Sponsor|55|||
106134167|NCT03710564|366150375|FG000|Overall Study|Withdrawal by Subject|57|||
106134168|NCT03710564|366150376|FG001|Overall Study|Withdrawal by Subject|25|||
106134169|NCT03710564|366150375|FG000|Overall Study|Death|10|||
106134170|NCT03710564|366150376|FG001|Overall Study|Death|4|||
105709817|NCT01928381|364596220|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709818|NCT01928381|364596221|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709819|NCT01928381|364596222|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
105709820|NCT04818593|364596225|FG000|Overall Study|Low Oocyte Yield|8|||
105709821|NCT04818593|364596226|FG001|Overall Study|Low Oocyte Yield|8|||
105709822|NCT04818593|364596225|FG000|Overall Study|Not ICSI Insemination|7|||
105709823|NCT04818593|364596226|FG001|Overall Study|Not ICSI Insemination|7|||
105709824|NCT04818593|364596225|FG000|Overall Study|Poor Sperm Quality|2|||
106007498|NCT05177354|365692289|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
106007499|NCT05177354|365692289|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
105709825|NCT04818593|364596226|FG001|Overall Study|Poor Sperm Quality|2|||
105709826|NCT04818593|364596225|FG000|Overall Study|Withdrawal by Subject|2|||
105709827|NCT04818593|364596226|FG001|Overall Study|Withdrawal by Subject|2|||
105709828|NCT04818593|364596225|FG000|Overall Study|Conversion to IUI due to low response|1|||
105709829|NCT04818593|364596226|FG001|Overall Study|Conversion to IUI due to low response|1|||
105709830|NCT01564862|364596227|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
105709831|NCT01564862|364596228|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
105709832|NCT01564862|364596229|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
105709833|NCT01564862|364596227|FG000|Overall Study|Major Protocol Deviation|3|||
105709834|NCT01564862|364596228|FG001|Overall Study|Major Protocol Deviation|3|||
105709835|NCT01564862|364596229|FG002|Overall Study|Major Protocol Deviation|4|||
105709836|NCT01564862|364596227|FG000|Overall Study|Lost to Follow-up|10|||
105709837|NCT01564862|364596228|FG001|Overall Study|Lost to Follow-up|8|||
105709838|NCT01564862|364596229|FG002|Overall Study|Lost to Follow-up|6|||
105709839|NCT01564862|364596227|FG000|Overall Study|Voluntary Withdrawal|9|||
105709840|NCT01564862|364596228|FG001|Overall Study|Voluntary Withdrawal|6|||
105709841|NCT01564862|364596229|FG002|Overall Study|Voluntary Withdrawal|8|||
105709842|NCT01564862|364596227|FG000|Overall Study|Lack of Efficacy|1|||
105709843|NCT01564862|364596228|FG001|Overall Study|Lack of Efficacy|5|||
105709844|NCT01564862|364596229|FG002|Overall Study|Lack of Efficacy|6|||
105709845|NCT01564862|364596227|FG000|Overall Study|Other reason(s)|1|||
105709846|NCT01564862|364596228|FG001|Overall Study|Other reason(s)|0|||
105709847|NCT01564862|364596229|FG002|Overall Study|Other reason(s)|0|||
105709848|NCT03809611|364596230|FG000|Overall Study|Withdrawal by Subject|1|||
105709849|NCT03809611|364596231|FG001|Overall Study|Withdrawal by Subject|1|||
105709850|NCT05032157|364598139|FG000|Overall Study|Adverse Event|12|||
105709851|NCT05032157|364598140|FG001|Overall Study|Adverse Event|7|||
105709852|NCT05032157|364598139|FG000|Overall Study|Pregnancy|0|||
105709853|NCT05032157|364598140|FG001|Overall Study|Pregnancy|2|||
105709854|NCT05032157|364598139|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105709855|NCT05032157|364598140|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
105709856|NCT05032157|364598139|FG000|Overall Study|Protocol Deviation|8|||
105709857|NCT05032157|364598140|FG001|Overall Study|Protocol Deviation|4|||
105709858|NCT05032157|364598139|FG000|Overall Study|Lost to Follow-up|1|||
105709859|NCT05032157|364598140|FG001|Overall Study|Lost to Follow-up|3|||
105709860|NCT05032157|364598139|FG000|Overall Study|Physician Decision|7|||
105709861|NCT05032157|364598140|FG001|Overall Study|Physician Decision|2|||
106007500|NCT05177354|365692289|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
106007501|NCT02331134|365692290|FG000|Overall Study|Withdrawal by Subject|1|||
106007502|NCT04825574|365692294|FG000|Overall Study|Commercial treatment became available|1|||
106007503|NCT04825574|365692294|FG000|Overall Study|Disease progression|1|||
106007504|NCT05417438|365692295|FG000|Overall Study|Withdrawal by Subject|3|||
105709862|NCT05032157|364598139|FG000|Overall Study|Patient Decision|38|||
105709863|NCT05032157|364598140|FG001|Overall Study|Patient Decision|19|||
105709864|NCT02627495|364598143|FG000|Overall Study|Withdrawal by Subject|4|||
106007505|NCT02702492|365692298|FG000|Overall Study|Disease progression|3|||
106134171|NCT03710564|366150375|FG000|Overall Study|Lost to Follow-up|5|||
106134172|NCT03710564|366150376|FG001|Overall Study|Lost to Follow-up|4|||
106134173|NCT03710564|366150375|FG000|Overall Study|Protocol Violation|3|||
105709865|NCT00880893|364598144|FG000|Overall Study|Protocol Violation|13|||
105709866|NCT00880893|364598145|FG001|Overall Study|Protocol Violation|1|||
105709867|NCT00880893|364598144|FG000|Overall Study|Withdrawal by Subject|15|||
105709868|NCT00880893|364598145|FG001|Overall Study|Withdrawal by Subject|11|||
105709869|NCT00880893|364598144|FG000|Overall Study|Lost to Follow-up|76|||
105709870|NCT00880893|364598145|FG001|Overall Study|Lost to Follow-up|33|||
105709871|NCT00880893|364598144|FG000|Overall Study|Serious adverse event|3|||
105709872|NCT00880893|364598145|FG001|Overall Study|Serious adverse event|0|||
105709873|NCT00112905|364598150|FG000|Overall Study|Adverse Event|4|||
105709874|NCT00112905|364598150|FG000|Overall Study|Death|1|||
105709875|NCT00112905|364598150|FG000|Overall Study|Ineligibility|5|||
105709876|NCT00112905|364598150|FG000|Overall Study|Alternative treatment|1|||
105709877|NCT00112905|364598150|FG000|Overall Study|performance status was deteiorating|1|||
105709878|NCT03354663|364598152|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
105709879|NCT03354663|364598152|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
105709880|NCT03354663|364598152|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
105788066|NCT00593385|364878188|FG000|Overall Study|Death|14|||
106007506|NCT02702492|365692299|FG001|Overall Study|Disease progression|3|||
106007507|NCT02702492|365692300|FG002|Overall Study|Disease progression|2|||
106007508|NCT02702492|365692301|FG003|Overall Study|Disease progression|4|||
106007509|NCT02702492|365692302|FG004|Overall Study|Disease progression|4|||
106007510|NCT02702492|365692303|FG005|Overall Study|Disease progression|1|||
106007511|NCT02702492|365692304|FG006|Overall Study|Disease progression|2|||
106007512|NCT02702492|365692305|FG007|Overall Study|Disease progression|8|||
106007513|NCT02702492|365692306|FG008|Overall Study|Disease progression|5|||
106007514|NCT02702492|365692307|FG009|Overall Study|Disease progression|1|||
106007515|NCT02702492|365692308|FG010|Overall Study|Disease progression|0|||
106007516|NCT02702492|365692309|FG011|Overall Study|Disease progression|3|||
106007517|NCT02702492|365692310|FG012|Overall Study|Disease progression|2|||
106007518|NCT02702492|365692298|FG000|Overall Study|Clinical progression|0|||
106007519|NCT02702492|365692299|FG001|Overall Study|Clinical progression|0|||
106007520|NCT02702492|365692300|FG002|Overall Study|Clinical progression|2|||
106007521|NCT02702492|365692301|FG003|Overall Study|Clinical progression|1|||
106007522|NCT02702492|365692302|FG004|Overall Study|Clinical progression|0|||
106007523|NCT02702492|365692303|FG005|Overall Study|Clinical progression|2|||
106007524|NCT02702492|365692304|FG006|Overall Study|Clinical progression|1|||
106007525|NCT02702492|365692305|FG007|Overall Study|Clinical progression|4|||
106007526|NCT02702492|365692306|FG008|Overall Study|Clinical progression|0|||
106007527|NCT02702492|365692307|FG009|Overall Study|Clinical progression|0|||
106007528|NCT02702492|365692308|FG010|Overall Study|Clinical progression|1|||
106007529|NCT02702492|365692309|FG011|Overall Study|Clinical progression|2|||
106007530|NCT02702492|365692310|FG012|Overall Study|Clinical progression|0|||
106007531|NCT02702492|365692298|FG000|Overall Study|Adverse Event|0|||
106007532|NCT02702492|365692299|FG001|Overall Study|Adverse Event|0|||
106007533|NCT02702492|365692300|FG002|Overall Study|Adverse Event|1|||
106007534|NCT02702492|365692301|FG003|Overall Study|Adverse Event|2|||
106007535|NCT02702492|365692302|FG004|Overall Study|Adverse Event|1|||
106007536|NCT02702492|365692303|FG005|Overall Study|Adverse Event|0|||
106007537|NCT02702492|365692304|FG006|Overall Study|Adverse Event|1|||
106007538|NCT02702492|365692305|FG007|Overall Study|Adverse Event|0|||
106007539|NCT02702492|365692306|FG008|Overall Study|Adverse Event|2|||
106007540|NCT02702492|365692307|FG009|Overall Study|Adverse Event|0|||
106007541|NCT02702492|365692308|FG010|Overall Study|Adverse Event|0|||
106134174|NCT03710564|366150376|FG001|Overall Study|Protocol Violation|2|||
106134175|NCT03710564|366150375|FG000|Overall Study|Adverse Event|3|||
106134176|NCT03710564|366150376|FG001|Overall Study|Adverse Event|0|||
106134177|NCT03710564|366150375|FG000|Overall Study|Physician Decision|2|||
106134178|NCT03710564|366150376|FG001|Overall Study|Physician Decision|3|||
106134179|NCT00797225|366150380|FG000|Weeks 1 to 12|Adverse Event|0|||
106134180|NCT00797225|366150381|FG001|Weeks 1 to 12|Adverse Event|0|||
106134181|NCT00797225|366150382|FG002|Weeks 1 to 12|Adverse Event|1|||
106134182|NCT00797225|366150383|FG003|Weeks 1 to 12|Adverse Event|0|||
106134183|NCT00797225|366150384|FG004|Weeks 1 to 12|Adverse Event|0|||
106134184|NCT00797225|366150385|FG005|Weeks 1 to 12|Adverse Event|0|||
106134185|NCT00797225|366150386|FG006|Weeks 1 to 12|Adverse Event|0|||
106134186|NCT00797225|366150387|FG007|Weeks 1 to 12|Adverse Event|0|||
106134187|NCT00797225|366150380|FG000|Weeks 1 to 12|Non-compliance|0|||
106134188|NCT00797225|366150381|FG001|Weeks 1 to 12|Non-compliance|1|||
106134189|NCT00797225|366150382|FG002|Weeks 1 to 12|Non-compliance|0|||
106134190|NCT00797225|366150383|FG003|Weeks 1 to 12|Non-compliance|0|||
106134191|NCT00797225|366150384|FG004|Weeks 1 to 12|Non-compliance|0|||
106134192|NCT00797225|366150385|FG005|Weeks 1 to 12|Non-compliance|0|||
106134193|NCT00797225|366150386|FG006|Weeks 1 to 12|Non-compliance|0|||
106134194|NCT00797225|366150387|FG007|Weeks 1 to 12|Non-compliance|0|||
106134195|NCT00797225|366150380|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
106134196|NCT00797225|366150381|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
106134197|NCT00797225|366150382|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
106134198|NCT00797225|366150383|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
106134199|NCT00797225|366150384|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
106134200|NCT00797225|366150385|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
106134201|NCT00797225|366150386|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
106134202|NCT00797225|366150387|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
106134203|NCT00797225|366150380|FG000|Weeks 1 to 12|Sponsor Decision|1|||
106134204|NCT00797225|366150381|FG001|Weeks 1 to 12|Sponsor Decision|0|||
106134205|NCT00797225|366150382|FG002|Weeks 1 to 12|Sponsor Decision|0|||
106134206|NCT00797225|366150383|FG003|Weeks 1 to 12|Sponsor Decision|0|||
106134207|NCT00797225|366150384|FG004|Weeks 1 to 12|Sponsor Decision|0|||
106134208|NCT00797225|366150385|FG005|Weeks 1 to 12|Sponsor Decision|0|||
106134209|NCT00797225|366150386|FG006|Weeks 1 to 12|Sponsor Decision|0|||
106134210|NCT00797225|366150387|FG007|Weeks 1 to 12|Sponsor Decision|0|||
106134211|NCT00797225|366150380|FG000|Weeks 13 to 24|Non-compliance|0|||
106134212|NCT00797225|366150381|FG001|Weeks 13 to 24|Non-compliance|2|||
106134213|NCT00797225|366150382|FG002|Weeks 13 to 24|Non-compliance|0|||
106134214|NCT00797225|366150383|FG003|Weeks 13 to 24|Non-compliance|0|||
106134215|NCT00797225|366150384|FG004|Weeks 13 to 24|Non-compliance|0|||
106134216|NCT00797225|366150385|FG005|Weeks 13 to 24|Non-compliance|0|||
106134217|NCT00797225|366150386|FG006|Weeks 13 to 24|Non-compliance|0|||
106134218|NCT00797225|366150387|FG007|Weeks 13 to 24|Non-compliance|0|||
106134219|NCT00797225|366150380|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
106134220|NCT00797225|366150381|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
106134221|NCT00797225|366150382|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
106134222|NCT00797225|366150383|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
106134223|NCT00797225|366150384|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
106134224|NCT00797225|366150385|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
106134225|NCT00797225|366150386|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
106134226|NCT00797225|366150387|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
106134227|NCT00797225|366150380|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
106134228|NCT00797225|366150381|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
106134229|NCT00797225|366150382|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
106134230|NCT00797225|366150383|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
106134231|NCT00797225|366150384|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
106134232|NCT00797225|366150385|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
106134233|NCT00797225|366150386|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
106134234|NCT00797225|366150387|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
106134235|NCT00797225|366150380|FG000|Weeks 13 to 24|Adverse Event|0|||
105709881|NCT03354663|364598152|FG000|Completed 30-day Visit|Missed Visit|1|||
105709882|NCT01661140|364598153|FG000|Open-Label Period|Adverse Event|44|||
106134236|NCT00797225|366150381|FG001|Weeks 13 to 24|Adverse Event|1|||
106134237|NCT00797225|366150382|FG002|Weeks 13 to 24|Adverse Event|0|||
106134238|NCT00797225|366150383|FG003|Weeks 13 to 24|Adverse Event|0|||
106134239|NCT00797225|366150384|FG004|Weeks 13 to 24|Adverse Event|0|||
106134240|NCT00797225|366150385|FG005|Weeks 13 to 24|Adverse Event|0|||
106134241|NCT00797225|366150386|FG006|Weeks 13 to 24|Adverse Event|1|||
106134242|NCT00797225|366150387|FG007|Weeks 13 to 24|Adverse Event|0|||
106134243|NCT00797225|366150380|FG000|Weeks 13 to 24|Sponsor Decision|0|||
106134244|NCT00797225|366150381|FG001|Weeks 13 to 24|Sponsor Decision|0|||
106134245|NCT00797225|366150382|FG002|Weeks 13 to 24|Sponsor Decision|0|||
105709883|NCT01661140|364598154|FG001|Open-Label Period|Adverse Event|0|||
106134246|NCT00797225|366150383|FG003|Weeks 13 to 24|Sponsor Decision|0|||
106134247|NCT00797225|366150384|FG004|Weeks 13 to 24|Sponsor Decision|0|||
106134248|NCT00797225|366150385|FG005|Weeks 13 to 24|Sponsor Decision|0|||
106134249|NCT00797225|366150386|FG006|Weeks 13 to 24|Sponsor Decision|1|||
106134250|NCT00797225|366150387|FG007|Weeks 13 to 24|Sponsor Decision|0|||
105709884|NCT01661140|364598155|FG002|Open-Label Period|Adverse Event|0|||
105709885|NCT01661140|364598153|FG000|Open-Label Period|Protocol Violation|3|||
105928263|NCT03412890|365395419|FG000|Overall Study|Lack of Efficacy|2|||
105928264|NCT03412890|365395420|FG001|Overall Study|Lack of Efficacy|7|||
105928265|NCT03412890|365395421|FG002|Overall Study|Lack of Efficacy|5|||
105928266|NCT03412890|365395419|FG000|Overall Study|Other|5|||
105928267|NCT03412890|365395420|FG001|Overall Study|Other|6|||
105928268|NCT03412890|365395421|FG002|Overall Study|Other|5|||
105928269|NCT03412890|365395419|FG000|Overall Study|Participants who did not receive any study drug|0|||
105928270|NCT03412890|365395420|FG001|Overall Study|Participants who did not receive any study drug|1|||
105928271|NCT03412890|365395421|FG002|Overall Study|Participants who did not receive any study drug|0|||
105928272|NCT01132755|365395422|FG000|Overall Study|Procedure not done due to medical reason|23|||
105928273|NCT01132755|365395422|FG000|Overall Study|Protocol Violation|15|||
105928274|NCT01132755|365395422|FG000|Overall Study|Withdrawal by Subject|4|||
105928275|NCT04069520|365395424|FG000|Overall Study|Lost to Follow-up|0|||
105928276|NCT04069520|365395425|FG001|Overall Study|Lost to Follow-up|2|||
106007542|NCT02702492|365692309|FG011|Overall Study|Adverse Event|0|||
106007543|NCT02702492|365692310|FG012|Overall Study|Adverse Event|1|||
106007544|NCT02702492|365692298|FG000|Overall Study|Other|0|||
106007545|NCT02702492|365692299|FG001|Overall Study|Other|0|||
106007546|NCT02702492|365692300|FG002|Overall Study|Other|0|||
106007547|NCT02702492|365692301|FG003|Overall Study|Other|0|||
106007548|NCT02702492|365692302|FG004|Overall Study|Other|0|||
106007549|NCT02702492|365692303|FG005|Overall Study|Other|0|||
106007550|NCT02702492|365692304|FG006|Overall Study|Other|0|||
106007551|NCT02702492|365692305|FG007|Overall Study|Other|0|||
106007552|NCT02702492|365692306|FG008|Overall Study|Other|0|||
106007553|NCT02702492|365692307|FG009|Overall Study|Other|0|||
106007554|NCT02702492|365692308|FG010|Overall Study|Other|0|||
106007555|NCT02702492|365692309|FG011|Overall Study|Other|0|||
106007556|NCT02702492|365692310|FG012|Overall Study|Other|1|||
106007557|NCT00089297|365693462|FG000|Overall Study|Adverse Event|9|||
106007558|NCT00089297|365693462|FG000|Overall Study|Death|1|||
106007559|NCT00089297|365693462|FG000|Overall Study|Withdrawal by Subject|12|||
106007560|NCT00089297|365693462|FG000|Overall Study|Disease progression|2|||
106007561|NCT00089297|365693462|FG000|Overall Study|Ineligible|11|||
106007562|NCT00089297|365693462|FG000|Overall Study|Secondary malignancy|1|||
106007563|NCT00089297|365693462|FG000|Overall Study|IRB approval not ready|1|||
106007564|NCT00089297|365693462|FG000|Overall Study|Non-compliance|1|||
106007565|NCT01775501|365693466|FG000|Overall Study|Discontinued prior to treatment|1|||
106007566|NCT04607668|365693476|FG000|Overall Study|Death|49|||
106007567|NCT04607668|365693477|FG001|Overall Study|Death|26|||
106007568|NCT04607668|365693476|FG000|Overall Study|Lost to Follow-up|3|||
106007569|NCT04607668|365693477|FG001|Overall Study|Lost to Follow-up|4|||
106007570|NCT04607668|365693476|FG000|Overall Study|Study terminated by Sponsor|92|||
106007571|NCT04607668|365693477|FG001|Overall Study|Study terminated by Sponsor|114|||
106007572|NCT04607668|365693476|FG000|Overall Study|Withdrawal by Subject|12|||
106007573|NCT04607668|365693477|FG001|Overall Study|Withdrawal by Subject|11|||
106007574|NCT04607668|365693476|FG000|Overall Study|Other, unspecified|8|||
106007575|NCT04607668|365693477|FG001|Overall Study|Other, unspecified|7|||
106007576|NCT04199351|365693478|FG000|Overall Study|Decision by sponsor|0|||
106007577|NCT04199351|365693479|FG001|Overall Study|Decision by sponsor|0|||
106007578|NCT04199351|365693480|FG002|Overall Study|Decision by sponsor|0|||
106007579|NCT04199351|365693481|FG003|Overall Study|Decision by sponsor|2|||
106007580|NCT04199351|365693482|FG004|Overall Study|Decision by sponsor|0|||
106007581|NCT04199351|365693483|FG005|Overall Study|Decision by sponsor|0|||
106007582|NCT04199351|365693484|FG006|Overall Study|Decision by sponsor|0|||
106007583|NCT04199351|365693485|FG007|Overall Study|Decision by sponsor|0|||
106007584|NCT04199351|365693486|FG008|Overall Study|Decision by sponsor|0|||
106007585|NCT04199351|365693487|FG009|Overall Study|Decision by sponsor|6|||
105709886|NCT01661140|364598154|FG001|Open-Label Period|Protocol Violation|0|||
105709887|NCT01661140|364598155|FG002|Open-Label Period|Protocol Violation|0|||
105928277|NCT04069520|365395424|FG000|Overall Study|Withdrawal by Subject|0|||
105928278|NCT04069520|365395425|FG001|Overall Study|Withdrawal by Subject|1|||
105928279|NCT04069520|365395424|FG000|Overall Study|Prior Injury|1|||
105928280|NCT04069520|365395425|FG001|Overall Study|Prior Injury|0|||
105928281|NCT04069520|365395424|FG000|Overall Study|Orthodontia|1|||
105928282|NCT04069520|365395425|FG001|Overall Study|Orthodontia|0|||
105928283|NCT04069520|365395424|FG000|Overall Study|Cut from team|0|||
106007586|NCT04199351|365693478|FG000|Overall Study|Lost to Follow-up|0|||
106007587|NCT04199351|365693479|FG001|Overall Study|Lost to Follow-up|0|||
106007588|NCT04199351|365693480|FG002|Overall Study|Lost to Follow-up|1|||
106007589|NCT04199351|365693481|FG003|Overall Study|Lost to Follow-up|0|||
106007590|NCT04199351|365693482|FG004|Overall Study|Lost to Follow-up|0|||
106007591|NCT04199351|365693483|FG005|Overall Study|Lost to Follow-up|1|||
106007592|NCT04199351|365693484|FG006|Overall Study|Lost to Follow-up|0|||
106007593|NCT04199351|365693485|FG007|Overall Study|Lost to Follow-up|0|||
106007594|NCT04199351|365693486|FG008|Overall Study|Lost to Follow-up|0|||
106007595|NCT04199351|365693487|FG009|Overall Study|Lost to Follow-up|0|||
106007596|NCT04199351|365693478|FG000|Overall Study|Withdrawal by Subject|0|||
105928284|NCT04069520|365395425|FG001|Overall Study|Cut from team|2|||
105928285|NCT00849472|365395426|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
105928286|NCT00849472|365395426|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
105928287|NCT00849472|365395426|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
105928288|NCT00849472|365395426|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
105928289|NCT00849472|365395426|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
105928290|NCT00849472|365395426|FG000|Weekly Paclitaxel|Disease Progression|1|||
105928291|NCT00849472|365395426|FG000|Weekly Paclitaxel|Adverse Event|11|||
105928292|NCT00849472|365395426|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
105928293|NCT00849472|365395426|FG000|Weekly Paclitaxel|Physician Decision|3|||
105928294|NCT00849472|365395426|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
105928295|NCT00849472|365395426|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
105928296|NCT00849472|365395426|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
105928297|NCT00849472|365395426|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
105928298|NCT00849472|365395426|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
105928299|NCT00849472|365395426|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
105928300|NCT00849472|365395426|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
105928301|NCT00849472|365395426|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
105928302|NCT04615507|365395427|FG000|Period 1|Covid-19 exposure|2|||
105928303|NCT04615507|365395428|FG001|Period 1|Covid-19 exposure|1|||
105928304|NCT04615507|365395427|FG000|Period 2|Covid-19 exposure|0|||
105928305|NCT04615507|365395428|FG001|Period 2|Covid-19 exposure|1|||
105928306|NCT04615507|365395427|FG000|Period 2|Protocol Violation|1|||
105928307|NCT04615507|365395428|FG001|Period 2|Protocol Violation|0|||
105928308|NCT04615507|365395427|FG000|Period 2|Withdrawal by Subject|1|||
105928309|NCT04615507|365395428|FG001|Period 2|Withdrawal by Subject|0|||
105928310|NCT04615507|365395427|FG000|Period 2|Adverse Event|0|||
105928311|NCT04615507|365395428|FG001|Period 2|Adverse Event|1|||
105928312|NCT04615507|365395427|FG000|Period 3|Covid-19 exposure|0|||
105928313|NCT04615507|365395428|FG001|Period 3|Covid-19 exposure|1|||
105928314|NCT00699751|365395429|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
105928315|NCT00699751|365395430|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
105928316|NCT00699751|365395429|FG000|Period 1: Without/Before Drug Switch|Death|28|||
105928317|NCT00699751|365395430|FG001|Period 1: Without/Before Drug Switch|Death|29|||
105928318|NCT00699751|365395429|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
105928319|NCT00699751|365395430|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
105928320|NCT00699751|365395429|FG000|Period 1: Without/Before Drug Switch|Other|30|||
105928321|NCT00699751|365395430|FG001|Period 1: Without/Before Drug Switch|Other|20|||
105928322|NCT00699751|365395429|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
105928323|NCT00699751|365395430|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
105928324|NCT00699751|365395429|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
105928325|NCT00699751|365395430|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
105928326|NCT00699751|365395429|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
105928327|NCT00699751|365395430|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
105928328|NCT00699751|365395429|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
105928329|NCT00699751|365395430|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
105928330|NCT02965833|365395433|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
105928331|NCT02965833|365395434|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
105928332|NCT02965833|365395433|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
105928333|NCT02965833|365395434|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
105928334|NCT02965833|365395433|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
105928335|NCT02965833|365395434|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
105928336|NCT02965833|365395433|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
105928337|NCT02965833|365395434|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
105928338|NCT02965833|365395433|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
105928339|NCT02965833|365395434|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
105928340|NCT03370302|365395435|FG000|Dose Escalation Phase|Other|0|||
105928341|NCT03370302|365395436|FG001|Dose Escalation Phase|Other|1|||
105928342|NCT03370302|365395437|FG002|Dose Escalation Phase|Other|1|||
105928343|NCT03370302|365395438|FG003|Dose Escalation Phase|Other|0|||
105928344|NCT03370302|365395439|FG004|Dose Escalation Phase|Other|0|||
105928345|NCT03370302|365395440|FG005|Dose Escalation Phase|Other|0|||
105928346|NCT03370302|365395435|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
105928347|NCT03370302|365395436|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
105928348|NCT03370302|365395437|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
105928349|NCT03370302|365395438|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105928350|NCT03370302|365395439|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
105928351|NCT03370302|365395440|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
105928352|NCT03370302|365395435|FG000|Dose Escalation Phase|Adverse Event|1|||
105928353|NCT03370302|365395436|FG001|Dose Escalation Phase|Adverse Event|0|||
105928354|NCT03370302|365395437|FG002|Dose Escalation Phase|Adverse Event|2|||
105928355|NCT03370302|365395438|FG003|Dose Escalation Phase|Adverse Event|0|||
105928356|NCT03370302|365395439|FG004|Dose Escalation Phase|Adverse Event|0|||
105928357|NCT03370302|365395440|FG005|Dose Escalation Phase|Adverse Event|0|||
105928358|NCT03370302|365395435|FG000|Dose Escalation Phase|Progressive Disease|2|||
105928359|NCT03370302|365395436|FG001|Dose Escalation Phase|Progressive Disease|4|||
105928360|NCT03370302|365395437|FG002|Dose Escalation Phase|Progressive Disease|2|||
105788067|NCT00593385|364878188|FG000|Overall Study|Lost to Follow-up|17|||
105709888|NCT01661140|364598153|FG000|Open-Label Period|Withdrawal by Subject|5|||
105709889|NCT01661140|364598154|FG001|Open-Label Period|Withdrawal by Subject|0|||
105709890|NCT01661140|364598155|FG002|Open-Label Period|Withdrawal by Subject|0|||
105709891|NCT01661140|364598153|FG000|Open-Label Period|Investigator Decision|3|||
105709892|NCT01661140|364598154|FG001|Open-Label Period|Investigator Decision|0|||
105709893|NCT01661140|364598155|FG002|Open-Label Period|Investigator Decision|0|||
105709894|NCT01661140|364598153|FG000|Open-Label Period|Death|1|||
105709895|NCT01661140|364598154|FG001|Open-Label Period|Death|0|||
105709896|NCT01661140|364598155|FG002|Open-Label Period|Death|0|||
105709897|NCT01661140|364598153|FG000|Open-Label Period|Administrative/Other|1|||
105709898|NCT01661140|364598154|FG001|Open-Label Period|Administrative/Other|0|||
105709899|NCT01661140|364598155|FG002|Open-Label Period|Administrative/Other|0|||
105709900|NCT01661140|364598153|FG000|Open-Label Period|Sponsor termination|16|||
105709901|NCT01661140|364598154|FG001|Open-Label Period|Sponsor termination|0|||
105709902|NCT01661140|364598155|FG002|Open-Label Period|Sponsor termination|0|||
105709903|NCT01661140|364598153|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
105709904|NCT01661140|364598154|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
105709905|NCT01661140|364598155|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
105709906|NCT01661140|364598153|FG000|Open-Label Period|Lost to Follow-up|2|||
105709907|NCT01661140|364598154|FG001|Open-Label Period|Lost to Follow-up|0|||
105709908|NCT01661140|364598155|FG002|Open-Label Period|Lost to Follow-up|0|||
105709909|NCT01661140|364598153|FG000|Double-Blind Period|Refused Treatment|0|||
105709910|NCT01661140|364598154|FG001|Double-Blind Period|Refused Treatment|0|||
105709911|NCT01661140|364598155|FG002|Double-Blind Period|Refused Treatment|1|||
105709912|NCT01661140|364598153|FG000|Double-Blind Period|Adverse Event|0|||
105709913|NCT01661140|364598154|FG001|Double-Blind Period|Adverse Event|16|||
105709914|NCT01661140|364598155|FG002|Double-Blind Period|Adverse Event|18|||
105709915|NCT01661140|364598153|FG000|Double-Blind Period|Protocol Violation|0|||
105709916|NCT01661140|364598154|FG001|Double-Blind Period|Protocol Violation|2|||
105709917|NCT01661140|364598155|FG002|Double-Blind Period|Protocol Violation|3|||
105709918|NCT01661140|364598153|FG000|Double-Blind Period|Withdrawal by Subject|0|||
105709919|NCT01661140|364598154|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105709920|NCT01661140|364598155|FG002|Double-Blind Period|Withdrawal by Subject|3|||
105709921|NCT01661140|364598153|FG000|Double-Blind Period|Investigator's Decision|0|||
105709922|NCT01661140|364598154|FG001|Double-Blind Period|Investigator's Decision|1|||
105709923|NCT01661140|364598155|FG002|Double-Blind Period|Investigator's Decision|2|||
105709924|NCT01661140|364598153|FG000|Double-Blind Period|Sponsor Termination|0|||
105709925|NCT01661140|364598154|FG001|Double-Blind Period|Sponsor Termination|14|||
105709926|NCT01661140|364598155|FG002|Double-Blind Period|Sponsor Termination|17|||
105928361|NCT03370302|365395438|FG003|Dose Escalation Phase|Progressive Disease|0|||
105928362|NCT03370302|365395439|FG004|Dose Escalation Phase|Progressive Disease|3|||
105709927|NCT01661140|364598153|FG000|Double-Blind Period|Administrative/Other|0|||
105709928|NCT01661140|364598154|FG001|Double-Blind Period|Administrative/Other|7|||
105709929|NCT01661140|364598155|FG002|Double-Blind Period|Administrative/Other|6|||
105709930|NCT00691483|364598156|FG000|Overall Study|Adverse Event|14|||
105709931|NCT00691483|364598157|FG001|Overall Study|Adverse Event|6|||
105709932|NCT00691483|364598156|FG000|Overall Study|Lost to Follow-up|17|||
105709933|NCT00691483|364598157|FG001|Overall Study|Lost to Follow-up|10|||
105709934|NCT00691483|364598156|FG000|Overall Study|Withdrawal by Subject|24|||
105709935|NCT00691483|364598157|FG001|Overall Study|Withdrawal by Subject|7|||
105709936|NCT00691483|364598156|FG000|Overall Study|Other known cause|6|||
105709937|NCT00691483|364598157|FG001|Overall Study|Other known cause|1|||
105709938|NCT00691483|364598156|FG000|Overall Study|Randomized by not treated|7|||
105928363|NCT03370302|365395440|FG005|Dose Escalation Phase|Progressive Disease|1|||
105709939|NCT00691483|364598157|FG001|Overall Study|Randomized by not treated|1|||
105709940|NCT01391000|364598158|FG000|Overall Study|Lost to Follow-up|2|||
105709941|NCT01391000|364598159|FG001|Overall Study|Lost to Follow-up|0|||
105709942|NCT00590590|364598169|FG000|Overall Study|Lack of Efficacy|1|||
105709943|NCT00590590|364598170|FG001|Overall Study|Lack of Efficacy|2|||
105709944|NCT00590590|364598171|FG002|Overall Study|Lack of Efficacy|0|||
105709945|NCT00590590|364598169|FG000|Overall Study|Adverse Event|1|||
105709946|NCT00590590|364598170|FG001|Overall Study|Adverse Event|0|||
105709947|NCT00590590|364598171|FG002|Overall Study|Adverse Event|0|||
105709948|NCT00590590|364598169|FG000|Overall Study|Protocol Violation|0|||
105709949|NCT00590590|364598170|FG001|Overall Study|Protocol Violation|0|||
105788068|NCT00593385|364878188|FG000|Overall Study|Withdrawal by Subject|9|||
105788069|NCT00848965|364878189|FG000|Overall Study|Adverse Event|1|||
105709950|NCT00590590|364598171|FG002|Overall Study|Protocol Violation|2|||
105709951|NCT00590590|364598169|FG000|Overall Study|Lost to Follow-up|4|||
105709952|NCT00590590|364598170|FG001|Overall Study|Lost to Follow-up|1|||
105709953|NCT00590590|364598171|FG002|Overall Study|Lost to Follow-up|2|||
105788070|NCT00848965|364878189|FG000|Overall Study|Withdrawal by Subject|1|||
105788071|NCT01471197|364878194|FG000|Overall Study|Disease Progression|4|||
105709954|NCT00590590|364598169|FG000|Overall Study|Withdrawal by Subject|0|||
105709955|NCT00590590|364598170|FG001|Overall Study|Withdrawal by Subject|1|||
105709956|NCT00590590|364598171|FG002|Overall Study|Withdrawal by Subject|1|||
105928364|NCT03370302|365395435|FG000|Dose Expansion Phase|Progressive Disease|0|||
105709957|NCT00590590|364598169|FG000|Overall Study|Did not complete due to study closure|1|||
105709958|NCT00590590|364598170|FG001|Overall Study|Did not complete due to study closure|1|||
105709959|NCT00590590|364598171|FG002|Overall Study|Did not complete due to study closure|1|||
105709960|NCT00590590|364598169|FG000|Overall Study|Did not complete study|0|||
105709961|NCT00590590|364598170|FG001|Overall Study|Did not complete study|1|||
105709962|NCT00590590|364598171|FG002|Overall Study|Did not complete study|0|||
105709963|NCT02684981|364598173|FG000|Overall Study|Permanently discontinued the treatment|157|||
105709964|NCT02684981|364598174|FG001|Overall Study|Permanently discontinued the treatment|161|||
105709965|NCT02684981|364598175|FG002|Overall Study|Permanently discontinued the treatment|110|||
105709966|NCT02684981|364598173|FG000|Overall Study|Other|83|||
105709967|NCT02684981|364598174|FG001|Overall Study|Other|49|||
105709968|NCT02684981|364598175|FG002|Overall Study|Other|17|||
105709969|NCT01745146|364598176|FG000|Overall Study|Withdrawal by Subject|1|||
105709970|NCT01745146|364598177|FG001|Overall Study|Withdrawal by Subject|3|||
105709971|NCT01745146|364598176|FG000|Overall Study|Lost to Follow-up|2|||
105709972|NCT01745146|364598177|FG001|Overall Study|Lost to Follow-up|0|||
105709973|NCT01262365|364598178|FG000|Overall Study|Lack of Efficacy|35|||
105709974|NCT01262365|364598179|FG001|Overall Study|Lack of Efficacy|30|||
105709975|NCT01262365|364598180|FG002|Overall Study|Lack of Efficacy|47|||
105709976|NCT01262365|364598178|FG000|Overall Study|Protocol Violation|3|||
105709977|NCT01262365|364598179|FG001|Overall Study|Protocol Violation|1|||
105709978|NCT01262365|364598180|FG002|Overall Study|Protocol Violation|1|||
105709979|NCT01262365|364598178|FG000|Overall Study|Lost to Follow-up|3|||
105709980|NCT01262365|364598179|FG001|Overall Study|Lost to Follow-up|7|||
105709981|NCT01262365|364598180|FG002|Overall Study|Lost to Follow-up|6|||
105709982|NCT01262365|364598178|FG000|Overall Study|Withdrawal by Subject|17|||
105709983|NCT01262365|364598179|FG001|Overall Study|Withdrawal by Subject|22|||
105709984|NCT01262365|364598180|FG002|Overall Study|Withdrawal by Subject|22|||
105709985|NCT01262365|364598178|FG000|Overall Study|Death|1|||
105709986|NCT01262365|364598179|FG001|Overall Study|Death|2|||
105709987|NCT01262365|364598180|FG002|Overall Study|Death|1|||
105709988|NCT01262365|364598178|FG000|Overall Study|Adverse Event|26|||
105709989|NCT01262365|364598179|FG001|Overall Study|Adverse Event|16|||
105709990|NCT01262365|364598180|FG002|Overall Study|Adverse Event|11|||
105709991|NCT01262365|364598178|FG000|Overall Study|sponsor decision|1|||
105709992|NCT01262365|364598179|FG001|Overall Study|sponsor decision|1|||
105928365|NCT03370302|365395436|FG001|Dose Expansion Phase|Progressive Disease|0|||
105928366|NCT03370302|365395437|FG002|Dose Expansion Phase|Progressive Disease|0|||
105928367|NCT03370302|365395438|FG003|Dose Expansion Phase|Progressive Disease|6|||
105928368|NCT03370302|365395439|FG004|Dose Expansion Phase|Progressive Disease|0|||
105928369|NCT03370302|365395440|FG005|Dose Expansion Phase|Progressive Disease|0|||
105928370|NCT01039675|365395450|FG000|Overall Study|Adverse Event|0|||
105928371|NCT01039675|365395451|FG001|Overall Study|Adverse Event|2|||
105928372|NCT01039675|365395450|FG000|Overall Study|Lack of Efficacy|0|||
106007597|NCT04199351|365693479|FG001|Overall Study|Withdrawal by Subject|1|||
106007598|NCT04199351|365693480|FG002|Overall Study|Withdrawal by Subject|0|||
106007599|NCT04199351|365693481|FG003|Overall Study|Withdrawal by Subject|0|||
106007600|NCT04199351|365693482|FG004|Overall Study|Withdrawal by Subject|1|||
106007601|NCT04199351|365693483|FG005|Overall Study|Withdrawal by Subject|4|||
106007602|NCT04199351|365693484|FG006|Overall Study|Withdrawal by Subject|2|||
106007603|NCT04199351|365693485|FG007|Overall Study|Withdrawal by Subject|0|||
106007604|NCT04199351|365693486|FG008|Overall Study|Withdrawal by Subject|3|||
106007605|NCT04199351|365693487|FG009|Overall Study|Withdrawal by Subject|0|||
106134251|NCT02954055|366150388|FG000|Overall Study|Did not initiate therapy|6|||
106134252|NCT02954055|366150389|FG001|Overall Study|Did not initiate therapy|1|||
106134253|NCT01599325|366150390|FG000|Primary Parent Phase|Adverse Event|5|||
106134254|NCT01599325|366150390|FG000|Primary Parent Phase|Disease Progression|7|||
106134255|NCT01599325|366150390|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
106134256|NCT01599325|366150390|FG000|Primary Parent Phase|Death|13|||
105928373|NCT01039675|365395451|FG001|Overall Study|Lack of Efficacy|2|||
105928374|NCT01039675|365395450|FG000|Overall Study|Withdrawal by Subject|0|||
106134257|NCT01599325|366150390|FG000|Primary Parent Phase|Protocol Violation|1|||
105928375|NCT01039675|365395451|FG001|Overall Study|Withdrawal by Subject|1|||
105928376|NCT01039675|365395450|FG000|Overall Study|Lost to Follow-up|0|||
106134258|NCT01599325|366150390|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
106134259|NCT01599325|366150390|FG000|Primary Parent Phase|Other|2|||
105709993|NCT01262365|364598180|FG002|Overall Study|sponsor decision|0|||
105928377|NCT01039675|365395451|FG001|Overall Study|Lost to Follow-up|1|||
105709994|NCT01262365|364598178|FG000|Overall Study|Randomization error|1|||
105709995|NCT01262365|364598179|FG001|Overall Study|Randomization error|0|||
105709996|NCT01262365|364598180|FG002|Overall Study|Randomization error|2|||
106007606|NCT03007966|365693489|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
105709997|NCT01262365|364598178|FG000|Overall Study|Non-compliance|1|||
105709998|NCT01262365|364598179|FG001|Overall Study|Non-compliance|0|||
106007607|NCT03007966|365693490|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
105709999|NCT01262365|364598180|FG002|Overall Study|Non-compliance|2|||
105710000|NCT01262365|364598178|FG000|Overall Study|Suspected pregnancy|1|||
105710001|NCT01262365|364598179|FG001|Overall Study|Suspected pregnancy|0|||
105710002|NCT01262365|364598180|FG002|Overall Study|Suspected pregnancy|0|||
105710003|NCT01262365|364598178|FG000|Overall Study|Patient pregnant|1|||
105710004|NCT01262365|364598179|FG001|Overall Study|Patient pregnant|0|||
105710005|NCT01262365|364598180|FG002|Overall Study|Patient pregnant|1|||
105710006|NCT01262365|364598178|FG000|Overall Study|Toxicity related to study drug|0|||
105710007|NCT01262365|364598179|FG001|Overall Study|Toxicity related to study drug|1|||
105710008|NCT01262365|364598180|FG002|Overall Study|Toxicity related to study drug|0|||
105710009|NCT01262365|364598178|FG000|Overall Study|Cannot tolerate the protocol|0|||
105710010|NCT01262365|364598179|FG001|Overall Study|Cannot tolerate the protocol|1|||
105710011|NCT01262365|364598180|FG002|Overall Study|Cannot tolerate the protocol|0|||
105710012|NCT01262365|364598178|FG000|Overall Study|Patient unavailable|0|||
105710013|NCT01262365|364598179|FG001|Overall Study|Patient unavailable|0|||
105710014|NCT01262365|364598180|FG002|Overall Study|Patient unavailable|1|||
105710015|NCT00494091|364598181|FG000|Overall Study|Death|5|||
105710016|NCT00494091|364598182|FG001|Overall Study|Death|54|||
105710017|NCT00494091|364598181|FG000|Overall Study|Lost to Follow-up|0|||
105710018|NCT00494091|364598182|FG001|Overall Study|Lost to Follow-up|4|||
105710019|NCT00494091|364598181|FG000|Overall Study|Other|1|||
105710020|NCT00494091|364598182|FG001|Overall Study|Other|11|||
105710021|NCT00494091|364598181|FG000|Overall Study|Withdrawal by Subject|0|||
105710022|NCT00494091|364598182|FG001|Overall Study|Withdrawal by Subject|7|||
105710023|NCT00326898|364598186|FG000|Overall Study|Disease progression|52|||
105710024|NCT00326898|364598187|FG001|Overall Study|Disease progression|54|||
105710025|NCT00326898|364598188|FG002|Overall Study|Disease progression|102|||
105928378|NCT01039675|365395450|FG000|Overall Study|Physician Decision|0|||
105928379|NCT01039675|365395451|FG001|Overall Study|Physician Decision|1|||
105928380|NCT04827446|365396570|FG000|Overall Study|Lost to Follow-up|1|||
106134260|NCT01599325|366150390|FG000|Extension Phase|Study Closure|1|||
106134261|NCT01599325|366150390|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
106134262|NCT01599325|366150390|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
105928381|NCT04827446|365396571|FG001|Overall Study|Lost to Follow-up|1|||
105928382|NCT04827446|365396570|FG000|Overall Study|Death|2|||
105928383|NCT04827446|365396571|FG001|Overall Study|Death|0|||
105928384|NCT04827446|365396570|FG000|Overall Study|Withdrawal by Subject|2|||
105928385|NCT04827446|365396571|FG001|Overall Study|Withdrawal by Subject|2|||
105928386|NCT05638737|365396574|FG000|Overall Study|Withdrawal by Subject|4|||
105928387|NCT05638737|365396575|FG001|Overall Study|Withdrawal by Subject|7|||
105928388|NCT03234881|365396576|FG000|Overall Study|Lost to Follow-up|9|||
105928389|NCT03234881|365396577|FG001|Overall Study|Lost to Follow-up|3|||
105928390|NCT01482221|365396578|FG000|Overall Study|Lack of Efficacy|1|||
105928391|NCT01482221|365396579|FG001|Overall Study|Lack of Efficacy|0|||
105928392|NCT01482221|365396580|FG002|Overall Study|Lack of Efficacy|1|||
105928393|NCT01482221|365396578|FG000|Overall Study|Lost to Follow-up|3|||
105928394|NCT01482221|365396579|FG001|Overall Study|Lost to Follow-up|2|||
105928395|NCT01482221|365396580|FG002|Overall Study|Lost to Follow-up|1|||
105928396|NCT01482221|365396578|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
105928397|NCT01482221|365396579|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
105928398|NCT01482221|365396580|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
105928399|NCT01482221|365396578|FG000|Overall Study|Condition under Investigation Worsened|3|||
105928400|NCT01482221|365396579|FG001|Overall Study|Condition under Investigation Worsened|2|||
105928401|NCT01482221|365396580|FG002|Overall Study|Condition under Investigation Worsened|4|||
105928402|NCT01482221|365396578|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
105928403|NCT01482221|365396579|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
105928404|NCT01482221|365396580|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
105928405|NCT01482221|365396578|FG000|Overall Study|Adverse Event|1|||
105928406|NCT01482221|365396579|FG001|Overall Study|Adverse Event|7|||
105928407|NCT01482221|365396580|FG002|Overall Study|Adverse Event|3|||
105928408|NCT01482221|365396578|FG000|Overall Study|Withdrawal by Subject|10|||
105928409|NCT01482221|365396579|FG001|Overall Study|Withdrawal by Subject|7|||
105928410|NCT01482221|365396580|FG002|Overall Study|Withdrawal by Subject|12|||
105928411|NCT01482221|365396578|FG000|Overall Study|Incorrect randomization|0|||
105928412|NCT01482221|365396579|FG001|Overall Study|Incorrect randomization|1|||
105928413|NCT01482221|365396580|FG002|Overall Study|Incorrect randomization|0|||
105928414|NCT01482221|365396578|FG000|Overall Study|Physician Decision|0|||
106134263|NCT01599325|366150390|FG000|Extension Phase|Disease Progression|1|||
105928415|NCT01482221|365396579|FG001|Overall Study|Physician Decision|1|||
105710026|NCT00326898|364598186|FG000|Overall Study|Adverse Event|124|||
105710027|NCT00326898|364598187|FG001|Overall Study|Adverse Event|128|||
105710028|NCT00326898|364598188|FG002|Overall Study|Adverse Event|33|||
105710029|NCT00326898|364598186|FG000|Overall Study|Death|2|||
105710030|NCT00326898|364598187|FG001|Overall Study|Death|0|||
105710031|NCT00326898|364598188|FG002|Overall Study|Death|0|||
105928416|NCT01482221|365396580|FG002|Overall Study|Physician Decision|0|||
105928417|NCT03086343|365396581|FG000|Period 1|Adverse Event|7|||
105710032|NCT00326898|364598186|FG000|Overall Study|Withdrawal by Subject|134|||
105928418|NCT03086343|365396582|FG001|Period 1|Adverse Event|7|||
105928419|NCT03086343|365396583|FG002|Period 1|Adverse Event|0|||
105710033|NCT00326898|364598187|FG001|Overall Study|Withdrawal by Subject|128|||
105710034|NCT00326898|364598188|FG002|Overall Study|Withdrawal by Subject|32|||
105710035|NCT00326898|364598186|FG000|Overall Study|Alternative therapy|1|||
105710036|NCT00326898|364598187|FG001|Overall Study|Alternative therapy|0|||
105710037|NCT00326898|364598188|FG002|Overall Study|Alternative therapy|0|||
105710038|NCT00326898|364598186|FG000|Overall Study|Other complicating disease|5|||
105710039|NCT00326898|364598187|FG001|Overall Study|Other complicating disease|5|||
105710040|NCT00326898|364598188|FG002|Overall Study|Other complicating disease|4|||
105710041|NCT00326898|364598186|FG000|Overall Study|Other/Missing/Unknown|33|||
105710042|NCT00326898|364598187|FG001|Overall Study|Other/Missing/Unknown|28|||
105710043|NCT00326898|364598188|FG002|Overall Study|Other/Missing/Unknown|32|||
105710044|NCT00272038|364598189|FG000|Overall Study|withdrew before they received 2 cycles|7|||
105710045|NCT03847987|364598190|FG000|Overall Study|Lost to Follow-up|1|||
105710046|NCT03847987|364598191|FG001|Overall Study|Lost to Follow-up|0|||
105710047|NCT03847987|364598190|FG000|Overall Study|Adverse Event|2|||
105710048|NCT03847987|364598191|FG001|Overall Study|Adverse Event|0|||
105710049|NCT04161131|364598192|FG000|Overall Study|Ineligible|2|||
105710050|NCT04161131|364598192|FG000|Overall Study|Lost to Follow-up|4|||
105710051|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
105710052|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
105710053|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
105710054|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
105710055|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
106134264|NCT01599325|366150390|FG000|Extension Phase|Withdrawal by Subject|8|||
105710056|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
105710057|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
105710058|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
105710059|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
105710060|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
105710061|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
105928420|NCT03086343|365396584|FG003|Period 1|Adverse Event|1|||
105928421|NCT03086343|365396581|FG000|Period 1|Withdrawal by Subject|6|||
105928422|NCT03086343|365396582|FG001|Period 1|Withdrawal by Subject|10|||
105928423|NCT03086343|365396583|FG002|Period 1|Withdrawal by Subject|0|||
105928424|NCT03086343|365396584|FG003|Period 1|Withdrawal by Subject|0|||
105928425|NCT03086343|365396581|FG000|Period 1|Lost to Follow-up|1|||
105928426|NCT03086343|365396582|FG001|Period 1|Lost to Follow-up|3|||
105928427|NCT03086343|365396583|FG002|Period 1|Lost to Follow-up|1|||
105928428|NCT03086343|365396584|FG003|Period 1|Lost to Follow-up|0|||
105928429|NCT03086343|365396581|FG000|Period 1|Other, Not Specified|10|||
105928430|NCT03086343|365396582|FG001|Period 1|Other, Not Specified|12|||
105928431|NCT03086343|365396583|FG002|Period 1|Other, Not Specified|2|||
105928432|NCT03086343|365396584|FG003|Period 1|Other, Not Specified|1|||
105928433|NCT03086343|365396581|FG000|Period 1|Missing|1|||
105928434|NCT03086343|365396582|FG001|Period 1|Missing|0|||
105928435|NCT03086343|365396583|FG002|Period 1|Missing|0|||
105928436|NCT03086343|365396584|FG003|Period 1|Missing|0|||
105928437|NCT03086343|365396581|FG000|Period 2|Adverse Event|20|||
105928438|NCT03086343|365396582|FG001|Period 2|Adverse Event|11|||
105928439|NCT03086343|365396583|FG002|Period 2|Adverse Event|1|||
105928440|NCT03086343|365396584|FG003|Period 2|Adverse Event|2|||
105928441|NCT03086343|365396581|FG000|Period 2|Withdrawal by Subject|15|||
105928442|NCT03086343|365396582|FG001|Period 2|Withdrawal by Subject|25|||
105928443|NCT03086343|365396583|FG002|Period 2|Withdrawal by Subject|2|||
105928444|NCT03086343|365396584|FG003|Period 2|Withdrawal by Subject|2|||
105928445|NCT03086343|365396581|FG000|Period 2|Lost to Follow-up|6|||
105928446|NCT03086343|365396582|FG001|Period 2|Lost to Follow-up|11|||
105928447|NCT03086343|365396583|FG002|Period 2|Lost to Follow-up|1|||
105928448|NCT03086343|365396584|FG003|Period 2|Lost to Follow-up|0|||
105928449|NCT03086343|365396581|FG000|Period 2|COVID-19 Infection|5|||
105928450|NCT03086343|365396582|FG001|Period 2|COVID-19 Infection|0|||
105928451|NCT03086343|365396583|FG002|Period 2|COVID-19 Infection|0|||
105928452|NCT03086343|365396584|FG003|Period 2|COVID-19 Infection|0|||
105928453|NCT03086343|365396581|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
105928454|NCT03086343|365396582|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
105928455|NCT03086343|365396583|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
105928456|NCT03086343|365396584|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
105928457|NCT03086343|365396581|FG000|Period 2|Other, Not Specified|23|||
105928458|NCT03086343|365396582|FG001|Period 2|Other, Not Specified|22|||
106134265|NCT01119703|366150391|FG000|Overall Study|Adverse Event|0|||
105710062|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
105928459|NCT03086343|365396583|FG002|Period 2|Other, Not Specified|2|||
105928460|NCT03086343|365396584|FG003|Period 2|Other, Not Specified|4|||
105928461|NCT04900272|365396585|FG000|Overall Study|Lost to Follow-up|2|||
105928462|NCT04900272|365396585|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
105928463|NCT04900272|365396585|FG000|Overall Study|Withdrawal by Subject|1|||
105928464|NCT01047501|365396586|FG000|Overall Study|Adverse Event|7|||
105928465|NCT01047501|365396587|FG001|Overall Study|Adverse Event|8|||
106007608|NCT01428258|365693491|FG000|Intervention 1|Withdrawal by Subject|2|||
106007609|NCT01428258|365693492|FG001|Intervention 1|Withdrawal by Subject|0|||
106007610|NCT02177695|365693493|FG000|ITT Analysis|Ineligible|5|||
106007611|NCT02177695|365693494|FG001|ITT Analysis|Ineligible|5|||
106007612|NCT02177695|365693493|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
106007613|NCT02177695|365693494|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
106007614|NCT02177695|365693493|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
106007615|NCT02177695|365693494|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
106007616|NCT02177695|365693493|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
106007617|NCT02177695|365693494|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
106007618|NCT03466658|365693503|FG000|Overall Study|Withdrawal by Subject|3|||
106007619|NCT00772538|365693504|FG000|Overall Study|Adverse Event|6|||
106007620|NCT00772538|365693505|FG001|Overall Study|Adverse Event|6|||
106007621|NCT00772538|365693504|FG000|Overall Study|Protocol Violation|3|||
106007622|NCT00772538|365693505|FG001|Overall Study|Protocol Violation|3|||
106007623|NCT00772538|365693504|FG000|Overall Study|Lost to Follow-up|1|||
106007624|NCT00772538|365693505|FG001|Overall Study|Lost to Follow-up|1|||
106007625|NCT00772538|365693504|FG000|Overall Study|Withdrawal by Subject|3|||
106007626|NCT00772538|365693505|FG001|Overall Study|Withdrawal by Subject|8|||
106007627|NCT00772538|365693504|FG000|Overall Study|Lack of Efficacy|0|||
106007628|NCT00772538|365693505|FG001|Overall Study|Lack of Efficacy|1|||
106007629|NCT00772538|365693504|FG000|Overall Study|Other|7|||
106007630|NCT00772538|365693505|FG001|Overall Study|Other|7|||
106007631|NCT01089504|365693506|FG000|Overall Study|Lost to Follow-up|1|||
106007632|NCT01089504|365693507|FG001|Overall Study|Lost to Follow-up|1|||
106007633|NCT01089504|365693506|FG000|Overall Study|Withdrawal by Subject|2|||
106007634|NCT01089504|365693507|FG001|Overall Study|Withdrawal by Subject|0|||
106007635|NCT01680341|365693512|FG000|Overall Study|Adverse Event|3|||
106007636|NCT01680341|365693513|FG001|Overall Study|Adverse Event|2|||
106007637|NCT01680341|365693512|FG000|Overall Study|Unclassified|18|||
106007638|NCT01680341|365693513|FG001|Overall Study|Unclassified|15|||
106007639|NCT02230410|365693514|FG000|Overall Study|Screen Failure|3|||
106007640|NCT00499486|365693515|FG000|Overall Study|Withdrawal by Subject|16|||
106007641|NCT00656513|365693516|FG000|Overall Study|Protocol Violation|1|||
106007642|NCT00656513|365693517|FG001|Overall Study|Protocol Violation|0|||
106007643|NCT00656513|365693518|FG002|Overall Study|Protocol Violation|2|||
106007644|NCT00656513|365693516|FG000|Overall Study|Withdrawal by Subject|0|||
106007645|NCT00656513|365693517|FG001|Overall Study|Withdrawal by Subject|11|||
106007646|NCT00656513|365693518|FG002|Overall Study|Withdrawal by Subject|4|||
106007647|NCT00656513|365693516|FG000|Overall Study|Death|0|||
106007648|NCT00656513|365693517|FG001|Overall Study|Death|0|||
106007649|NCT00656513|365693518|FG002|Overall Study|Death|1|||
106007650|NCT00656513|365693516|FG000|Overall Study|Missing data|0|||
106007651|NCT00656513|365693517|FG001|Overall Study|Missing data|11|||
106007652|NCT00656513|365693518|FG002|Overall Study|Missing data|9|||
106007653|NCT00656513|365693516|FG000|Overall Study|Incomplete treatment|3|||
106007654|NCT00656513|365693517|FG001|Overall Study|Incomplete treatment|0|||
106007655|NCT00656513|365693518|FG002|Overall Study|Incomplete treatment|0|||
106007656|NCT00656513|365693516|FG000|Overall Study|Treatment completed outside of timeframe|0|||
106007657|NCT00656513|365693517|FG001|Overall Study|Treatment completed outside of timeframe|3|||
106007658|NCT00656513|365693518|FG002|Overall Study|Treatment completed outside of timeframe|1|||
106007659|NCT00656513|365693516|FG000|Overall Study|Missing baseline form|0|||
106007660|NCT00656513|365693517|FG001|Overall Study|Missing baseline form|5|||
106007661|NCT00656513|365693518|FG002|Overall Study|Missing baseline form|5|||
106007662|NCT03780452|365693519|FG000|Overall Study|Screening failure|2|||
106007663|NCT00087152|365693520|FG000|Overall Study|Ineligible|6|||
106007664|NCT03379818|365693523|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
105710063|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
105710064|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
105710065|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
105710066|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
105710067|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
106007665|NCT03379818|365693524|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
106007666|NCT03379818|365693523|FG000|Overall Study|Withdrawal by Subject|2|||
106007667|NCT03379818|365693524|FG001|Overall Study|Withdrawal by Subject|3|||
106007668|NCT03379818|365693523|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
106007669|NCT03379818|365693524|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
106007670|NCT03199976|365693526|FG000|Overall Study|Lack of Efficacy|3|||
106007671|NCT03199976|365693527|FG001|Overall Study|Lack of Efficacy|6|||
106007672|NCT03199976|365693528|FG002|Overall Study|Lack of Efficacy|13|||
106007673|NCT03199976|365693526|FG000|Overall Study|Withdrawal by Subject|1|||
106007674|NCT03199976|365693527|FG001|Overall Study|Withdrawal by Subject|0|||
106007675|NCT03199976|365693528|FG002|Overall Study|Withdrawal by Subject|0|||
106007676|NCT03199976|365693526|FG000|Overall Study|Lost to Follow-up|0|||
106007677|NCT03199976|365693527|FG001|Overall Study|Lost to Follow-up|1|||
105710068|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
105710069|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
105710070|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
105710071|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
105710072|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
105710073|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
105710074|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
105710075|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
105710076|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
105710077|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
105710078|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
105710079|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
105710080|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
105710081|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
105710082|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
105710083|NCT03605680|364598193|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
105710084|NCT03605680|364598194|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
105710085|NCT03605680|364598195|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
105710086|NCT03605680|364598196|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
105710087|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
105710088|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
105710089|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
105710090|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
105710091|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
105710092|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
105710093|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
105710094|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
105710095|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105710096|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105710097|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105710098|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
105710099|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
105710100|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
105710101|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
105710102|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
105710103|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
105710104|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
105710105|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
105710106|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
105710107|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
105710108|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
105710109|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
105710110|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
105710111|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
105710112|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
105710113|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
105710114|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
105710115|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
105710116|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
105710117|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
105710118|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
105928466|NCT01047501|365396588|FG002|Overall Study|Adverse Event|5|||
105710119|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
105710120|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
105710121|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
105710122|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
105710123|NCT03605680|364598193|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
105710124|NCT03605680|364598194|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
105710125|NCT03605680|364598195|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
105928467|NCT01047501|365396586|FG000|Overall Study|Withdrew Consent|6|||
105928468|NCT01047501|365396587|FG001|Overall Study|Withdrew Consent|2|||
105710126|NCT03605680|364598196|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
105710127|NCT01652287|364598199|FG000|Overall Study|Withdrawal by Subject|2|||
105710128|NCT01652287|364598200|FG001|Overall Study|Withdrawal by Subject|0|||
105710129|NCT00527605|364598201|FG000|Overall Study|Adverse Event|3|||
105710130|NCT00527605|364598202|FG001|Overall Study|Adverse Event|0|||
105710131|NCT00527605|364598201|FG000|Overall Study|Withdrawal by Subject|3|||
105710132|NCT00527605|364598202|FG001|Overall Study|Withdrawal by Subject|7|||
105710133|NCT00527605|364598201|FG000|Overall Study|Lost to Follow-up|6|||
105710134|NCT00527605|364598202|FG001|Overall Study|Lost to Follow-up|2|||
105710135|NCT00527605|364598201|FG000|Overall Study|Protocol Violation|1|||
105710136|NCT00527605|364598202|FG001|Overall Study|Protocol Violation|2|||
105710137|NCT02615990|364598207|FG000|Overall Study|study terminated|1|||
105710138|NCT02615990|364598208|FG001|Overall Study|study terminated|1|||
105710139|NCT00763139|364598209|FG000|Overall Study|Adverse Event|4|||
105710140|NCT00763139|364598210|FG001|Overall Study|Adverse Event|2|||
105710141|NCT00763139|364598209|FG000|Overall Study|Withdrawal by Subject|0|||
105710142|NCT00763139|364598210|FG001|Overall Study|Withdrawal by Subject|1|||
105710143|NCT00763139|364598209|FG000|Overall Study|med change not allowed by protocol|1|||
105710144|NCT00763139|364598210|FG001|Overall Study|med change not allowed by protocol|0|||
105710145|NCT02354703|364598211|FG000|Overall Study|Withdrawal by Subject|1|||
105710146|NCT02354703|364598212|FG001|Overall Study|Withdrawal by Subject|1|||
105710147|NCT02354703|364598213|FG002|Overall Study|Withdrawal by Subject|1|||
105710148|NCT02354703|364598214|FG003|Overall Study|Withdrawal by Subject|1|||
105710149|NCT02354703|364598211|FG000|Overall Study|Lost to Follow-up|2|||
105710150|NCT02354703|364598212|FG001|Overall Study|Lost to Follow-up|7|||
105710151|NCT02354703|364598213|FG002|Overall Study|Lost to Follow-up|9|||
105710152|NCT02354703|364598214|FG003|Overall Study|Lost to Follow-up|2|||
105710153|NCT02354703|364598211|FG000|Overall Study|Adverse Event|0|||
105710154|NCT02354703|364598212|FG001|Overall Study|Adverse Event|0|||
105710155|NCT02354703|364598213|FG002|Overall Study|Adverse Event|1|||
105710156|NCT02354703|364598214|FG003|Overall Study|Adverse Event|0|||
105710157|NCT00559507|364598222|FG000|Overall Study|Not treated, patient ineligible|3|||
105710158|NCT02889796|364598225|FG000|Overall Study|Withdrew Consent|18|||
105710159|NCT02889796|364598226|FG001|Overall Study|Withdrew Consent|29|||
105710160|NCT02889796|364598227|FG002|Overall Study|Withdrew Consent|20|||
105710161|NCT02889796|364598228|FG003|Overall Study|Withdrew Consent|1|||
105710162|NCT02889796|364598229|FG004|Overall Study|Withdrew Consent|2|||
105710163|NCT02889796|364598230|FG005|Overall Study|Withdrew Consent|35|||
105710164|NCT02889796|364598225|FG000|Overall Study|Investigator's Discretion|10|||
105710165|NCT02889796|364598226|FG001|Overall Study|Investigator's Discretion|9|||
105710166|NCT02889796|364598227|FG002|Overall Study|Investigator's Discretion|10|||
105710167|NCT02889796|364598228|FG003|Overall Study|Investigator's Discretion|3|||
105710168|NCT02889796|364598229|FG004|Overall Study|Investigator's Discretion|0|||
105710169|NCT02889796|364598230|FG005|Overall Study|Investigator's Discretion|15|||
105710170|NCT02889796|364598225|FG000|Overall Study|Adverse Event|17|||
105710171|NCT02889796|364598226|FG001|Overall Study|Adverse Event|8|||
105710172|NCT02889796|364598227|FG002|Overall Study|Adverse Event|8|||
105710173|NCT02889796|364598228|FG003|Overall Study|Adverse Event|4|||
105710174|NCT02889796|364598229|FG004|Overall Study|Adverse Event|1|||
105710175|NCT02889796|364598230|FG005|Overall Study|Adverse Event|7|||
105710176|NCT02889796|364598225|FG000|Overall Study|Lost to Follow-up|5|||
105710177|NCT02889796|364598226|FG001|Overall Study|Lost to Follow-up|7|||
105710178|NCT02889796|364598227|FG002|Overall Study|Lost to Follow-up|2|||
105710179|NCT02889796|364598228|FG003|Overall Study|Lost to Follow-up|0|||
105710180|NCT02889796|364598229|FG004|Overall Study|Lost to Follow-up|2|||
105710181|NCT02889796|364598230|FG005|Overall Study|Lost to Follow-up|6|||
105710182|NCT02889796|364598225|FG000|Overall Study|Protocol Violation|0|||
105710183|NCT02889796|364598226|FG001|Overall Study|Protocol Violation|1|||
105710184|NCT02889796|364598227|FG002|Overall Study|Protocol Violation|3|||
105710185|NCT02889796|364598228|FG003|Overall Study|Protocol Violation|0|||
105710186|NCT02889796|364598229|FG004|Overall Study|Protocol Violation|0|||
106007678|NCT03199976|365693528|FG002|Overall Study|Lost to Follow-up|1|||
105710187|NCT02889796|364598230|FG005|Overall Study|Protocol Violation|4|||
106007679|NCT04602390|365693529|FG000|Overall Study|Withdrawal by Subject|0|||
106007680|NCT04602390|365693530|FG001|Overall Study|Withdrawal by Subject|0|||
106134266|NCT01119703|366150392|FG001|Overall Study|Adverse Event|1|||
105710188|NCT02889796|364598225|FG000|Overall Study|Non-compliance With Study Drug|0|||
105710189|NCT02889796|364598226|FG001|Overall Study|Non-compliance With Study Drug|2|||
105710190|NCT02889796|364598227|FG002|Overall Study|Non-compliance With Study Drug|0|||
105710191|NCT02889796|364598228|FG003|Overall Study|Non-compliance With Study Drug|0|||
105710192|NCT02889796|364598229|FG004|Overall Study|Non-compliance With Study Drug|1|||
105710193|NCT02889796|364598230|FG005|Overall Study|Non-compliance With Study Drug|2|||
105710194|NCT02889796|364598225|FG000|Overall Study|Death|1|||
105710195|NCT02889796|364598226|FG001|Overall Study|Death|1|||
105710196|NCT02889796|364598227|FG002|Overall Study|Death|0|||
105710197|NCT02889796|364598228|FG003|Overall Study|Death|1|||
105710198|NCT02889796|364598229|FG004|Overall Study|Death|0|||
105710199|NCT02889796|364598230|FG005|Overall Study|Death|1|||
106007681|NCT04602390|365693531|FG002|Overall Study|Withdrawal by Subject|0|||
106007682|NCT04602390|365693532|FG003|Overall Study|Withdrawal by Subject|0|||
106007683|NCT04602390|365693533|FG004|Overall Study|Withdrawal by Subject|1|||
106007684|NCT04602390|365693534|FG005|Overall Study|Withdrawal by Subject|0|||
105710200|NCT02889796|364598225|FG000|Overall Study|Pregnancy|0|||
106007685|NCT04602390|365693529|FG000|Overall Study|Adverse Event|0|||
105710201|NCT02889796|364598226|FG001|Overall Study|Pregnancy|1|||
105710202|NCT02889796|364598227|FG002|Overall Study|Pregnancy|1|||
105710203|NCT02889796|364598228|FG003|Overall Study|Pregnancy|0|||
105710204|NCT02889796|364598229|FG004|Overall Study|Pregnancy|0|||
105710205|NCT02889796|364598230|FG005|Overall Study|Pregnancy|0|||
105710206|NCT02889796|364598225|FG000|Overall Study|Randomized but not Dosed|2|||
105710207|NCT02889796|364598226|FG001|Overall Study|Randomized but not Dosed|0|||
105710208|NCT02889796|364598227|FG002|Overall Study|Randomized but not Dosed|0|||
105710209|NCT02889796|364598228|FG003|Overall Study|Randomized but not Dosed|0|||
105710210|NCT02889796|364598229|FG004|Overall Study|Randomized but not Dosed|0|||
106007686|NCT04602390|365693530|FG001|Overall Study|Adverse Event|0|||
106007687|NCT04602390|365693531|FG002|Overall Study|Adverse Event|0|||
106007688|NCT04602390|365693532|FG003|Overall Study|Adverse Event|0|||
106007689|NCT04602390|365693533|FG004|Overall Study|Adverse Event|0|||
106007690|NCT04602390|365693534|FG005|Overall Study|Adverse Event|1|||
106007691|NCT03988400|365693536|FG000|Overall Study|Adverse Event|1|||
106007692|NCT03988400|365693537|FG001|Overall Study|Adverse Event|0|||
106007693|NCT03988400|365693536|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
106007694|NCT03988400|365693537|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
106007695|NCT03988400|365693536|FG000|Overall Study|Lost to Follow-up|0|||
106007696|NCT03988400|365693537|FG001|Overall Study|Lost to Follow-up|1|||
106007697|NCT03486912|365693542|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
106007698|NCT03486912|365693543|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
106007699|NCT03486912|365693544|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
106007700|NCT03486912|365693545|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
106007701|NCT03486912|365693542|FG000|Treatment Period|Withdrawal by Subject|3|||
106007702|NCT03486912|365693543|FG001|Treatment Period|Withdrawal by Subject|3|||
106007703|NCT03486912|365693544|FG002|Treatment Period|Withdrawal by Subject|3|||
106007704|NCT03486912|365693545|FG003|Treatment Period|Withdrawal by Subject|2|||
106007705|NCT03486912|365693542|FG000|Treatment Period|Other Reasons|0|||
106007706|NCT03486912|365693543|FG001|Treatment Period|Other Reasons|2|||
106007707|NCT03486912|365693544|FG002|Treatment Period|Other Reasons|1|||
106007708|NCT03486912|365693545|FG003|Treatment Period|Other Reasons|1|||
106134267|NCT01511250|366150393|FG000|Overall Study|Withdrawal of Consent|1|||
105710211|NCT02889796|364598230|FG005|Overall Study|Randomized but not Dosed|2|||
105710212|NCT02787863|364598233|FG000|Overall Study|Death|1|||
105710213|NCT02787863|364598234|FG001|Overall Study|Death|0|||
105710214|NCT02787863|364598235|FG002|Overall Study|Death|1|||
105710215|NCT02787863|364598236|FG003|Overall Study|Death|0|||
105710216|NCT02787863|364598237|FG004|Overall Study|Death|0|||
105710217|NCT02787863|364598238|FG005|Overall Study|Death|0|||
105710218|NCT02787863|364598239|FG006|Overall Study|Death|0|||
105710219|NCT02787863|364598240|FG007|Overall Study|Death|0|||
105710220|NCT02787863|364598233|FG000|Overall Study|Withdrawal by Subject|0|||
105710221|NCT02787863|364598234|FG001|Overall Study|Withdrawal by Subject|1|||
105710222|NCT02787863|364598235|FG002|Overall Study|Withdrawal by Subject|1|||
105788072|NCT01471197|364878195|FG001|Overall Study|Disease Progression|2|||
106134268|NCT01511250|366150394|FG001|Overall Study|Withdrawal of Consent|0|||
106134269|NCT01511250|366150395|FG002|Overall Study|Withdrawal of Consent|0|||
106134270|NCT01511250|366150396|FG003|Overall Study|Withdrawal of Consent|0|||
106134271|NCT01511250|366150397|FG004|Overall Study|Withdrawal of Consent|0|||
106134272|NCT01511250|366150398|FG005|Overall Study|Withdrawal of Consent|0|||
106134273|NCT01511250|366150399|FG006|Overall Study|Withdrawal of Consent|0|||
106134274|NCT01511250|366150400|FG007|Overall Study|Withdrawal of Consent|1|||
106134275|NCT01511250|366150401|FG008|Overall Study|Withdrawal of Consent|1|||
106134276|NCT01511250|366150402|FG009|Overall Study|Withdrawal of Consent|0|||
106134277|NCT01511250|366150393|FG000|Overall Study|Sponsor/Investigator Decision|1|||
106134278|NCT01511250|366150394|FG001|Overall Study|Sponsor/Investigator Decision|0|||
106134279|NCT01511250|366150395|FG002|Overall Study|Sponsor/Investigator Decision|0|||
105710223|NCT02787863|364598236|FG003|Overall Study|Withdrawal by Subject|0|||
105710224|NCT02787863|364598237|FG004|Overall Study|Withdrawal by Subject|0|||
105710225|NCT02787863|364598238|FG005|Overall Study|Withdrawal by Subject|0|||
105710226|NCT02787863|364598239|FG006|Overall Study|Withdrawal by Subject|0|||
105710227|NCT02787863|364598240|FG007|Overall Study|Withdrawal by Subject|0|||
106007709|NCT03486912|365693542|FG000|Treatment Period|Adverse Event|0|||
106007710|NCT03486912|365693543|FG001|Treatment Period|Adverse Event|1|||
106007711|NCT03486912|365693544|FG002|Treatment Period|Adverse Event|1|||
106007712|NCT03486912|365693545|FG003|Treatment Period|Adverse Event|0|||
106007713|NCT03486912|365693542|FG000|Treatment Period|Lost to Follow-up|1|||
105710228|NCT01414257|364598241|FG000|Overall Study|No Visit After First Day of Treatment|12|||
105710229|NCT01414257|364598241|FG000|Overall Study|Protocol Violation|10|||
105710230|NCT01978093|364598243|FG000|Overall Study|Death|1|||
105710231|NCT01978093|364598244|FG001|Overall Study|Death|0|||
105710232|NCT01978093|364598243|FG000|Overall Study|Adverse Event|0|||
105710233|NCT01978093|364598244|FG001|Overall Study|Adverse Event|5|||
105710234|NCT01978093|364598243|FG000|Overall Study|Protocol Violation|8|||
105710235|NCT01978093|364598244|FG001|Overall Study|Protocol Violation|2|||
105710236|NCT01978093|364598243|FG000|Overall Study|Withdrawal by Subject|29|||
105710237|NCT01978093|364598244|FG001|Overall Study|Withdrawal by Subject|25|||
105710238|NCT01978093|364598243|FG000|Overall Study|Lost to Follow-up|11|||
105710239|NCT01978093|364598244|FG001|Overall Study|Lost to Follow-up|15|||
105710240|NCT01978093|364598243|FG000|Overall Study|Migrated/moved from study area|11|||
105710241|NCT01978093|364598244|FG001|Overall Study|Migrated/moved from study area|13|||
105710242|NCT01978093|364598243|FG000|Overall Study|Loss of kaiser coverage|4|||
105710243|NCT01978093|364598244|FG001|Overall Study|Loss of kaiser coverage|10|||
105710244|NCT01978093|364598243|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
105710245|NCT01978093|364598244|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
105710246|NCT01978093|364598243|FG000|Overall Study|Mother lost custody of child|0|||
105710247|NCT01978093|364598244|FG001|Overall Study|Mother lost custody of child|1|||
105710248|NCT01978093|364598243|FG000|Overall Study|Child was in care of grandmother|0|||
105710249|NCT01978093|364598244|FG001|Overall Study|Child was in care of grandmother|1|||
105710250|NCT01978093|364598243|FG000|Overall Study|N/A for vaccine administration|0|||
105710251|NCT01978093|364598244|FG001|Overall Study|N/A for vaccine administration|1|||
105710252|NCT01784965|364598249|FG000|Overall Study|Withdrawal by Subject|6|||
105710253|NCT01784965|364598250|FG001|Overall Study|Withdrawal by Subject|3|||
105710254|NCT01784965|364598249|FG000|Overall Study|Adverse Event|0|||
105710255|NCT01784965|364598250|FG001|Overall Study|Adverse Event|8|||
105710256|NCT02469090|364598251|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
105710257|NCT02469090|364598252|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
105710258|NCT02469090|364598253|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
105710259|NCT02469090|364598251|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
105710260|NCT02469090|364598252|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
105710261|NCT02469090|364598253|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
105710262|NCT02469090|364598251|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
105710263|NCT02469090|364598252|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
105710264|NCT02469090|364598253|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
105710265|NCT02469090|364598251|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
105710266|NCT02469090|364598252|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
105710267|NCT02469090|364598253|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
105710268|NCT02469090|364598251|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
105710269|NCT02469090|364598252|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
105710270|NCT02469090|364598253|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
105710271|NCT02469090|364598251|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
105710272|NCT02469090|364598252|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
105710273|NCT02469090|364598253|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
105710274|NCT02469090|364598251|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
105710275|NCT02469090|364598252|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
105710276|NCT02469090|364598253|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
105710277|NCT02469090|364598251|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
105710278|NCT02469090|364598252|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
105710279|NCT02469090|364598253|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
105710280|NCT03286842|364598254|FG000|Overall Study|Patients rolled over to another study|80|||
105710281|NCT01098071|364598258|FG000|Overall Study|Surgery (adenoidectomy)|2|||
105710282|NCT01098071|364598258|FG000|Overall Study|Lost to Follow-up|13|||
105710283|NCT01895322|364598262|FG000|Overall Study|Adverse Event|1|||
105710284|NCT01895322|364598262|FG000|Overall Study|Withdrawal by Subject|2|||
105710285|NCT01895322|364598262|FG000|Overall Study|Protocol Violation|10|||
105710286|NCT01926782|364598263|FG000|Overall Study|Participant moved|2|||
105710287|NCT01926782|364598264|FG001|Overall Study|Participant moved|0|||
105710288|NCT01926782|364598265|FG002|Overall Study|Participant moved|1|||
105710289|NCT01926782|364598266|FG003|Overall Study|Participant moved|1|||
105710290|NCT01926782|364598267|FG004|Overall Study|Participant moved|0|||
105710291|NCT01926782|364598268|FG005|Overall Study|Participant moved|3|||
105788073|NCT01471197|364878194|FG000|Overall Study|Death|1|||
105710292|NCT01926782|364598263|FG000|Overall Study|Physician Decision|0|||
105710293|NCT01926782|364598264|FG001|Overall Study|Physician Decision|2|||
105710294|NCT01926782|364598265|FG002|Overall Study|Physician Decision|1|||
105788074|NCT01471197|364878195|FG001|Overall Study|Death|0|||
105710295|NCT01926782|364598266|FG003|Overall Study|Physician Decision|1|||
105788075|NCT01471197|364878194|FG000|Overall Study|Study Drug Toxicity|1|||
105710296|NCT01926782|364598267|FG004|Overall Study|Physician Decision|0|||
105788076|NCT01471197|364878195|FG001|Overall Study|Study Drug Toxicity|0|||
105710297|NCT01926782|364598268|FG005|Overall Study|Physician Decision|0|||
105710298|NCT01926782|364598263|FG000|Overall Study|Other than specified|2|||
105710299|NCT01926782|364598264|FG001|Overall Study|Other than specified|3|||
105710300|NCT01926782|364598265|FG002|Overall Study|Other than specified|5|||
105710301|NCT01926782|364598266|FG003|Overall Study|Other than specified|12|||
105710302|NCT01926782|364598267|FG004|Overall Study|Other than specified|4|||
105710303|NCT01926782|364598268|FG005|Overall Study|Other than specified|11|||
105710304|NCT01926782|364598263|FG000|Overall Study|Adverse Event|13|||
105710305|NCT01926782|364598264|FG001|Overall Study|Adverse Event|4|||
105710306|NCT01926782|364598265|FG002|Overall Study|Adverse Event|17|||
105710307|NCT01926782|364598266|FG003|Overall Study|Adverse Event|4|||
105710308|NCT01926782|364598267|FG004|Overall Study|Adverse Event|3|||
105710309|NCT01926782|364598268|FG005|Overall Study|Adverse Event|14|||
105710310|NCT01926782|364598263|FG000|Overall Study|Poor compliance to protocol|5|||
105710311|NCT01926782|364598264|FG001|Overall Study|Poor compliance to protocol|3|||
105710312|NCT01926782|364598265|FG002|Overall Study|Poor compliance to protocol|8|||
105710313|NCT01926782|364598266|FG003|Overall Study|Poor compliance to protocol|0|||
105710314|NCT01926782|364598267|FG004|Overall Study|Poor compliance to protocol|1|||
105710315|NCT01926782|364598268|FG005|Overall Study|Poor compliance to protocol|6|||
105710316|NCT01926782|364598263|FG000|Overall Study|Randomized and not treated|0|||
105710317|NCT01926782|364598264|FG001|Overall Study|Randomized and not treated|0|||
105710318|NCT01926782|364598265|FG002|Overall Study|Randomized and not treated|0|||
105710319|NCT01926782|364598266|FG003|Overall Study|Randomized and not treated|1|||
105710320|NCT01926782|364598267|FG004|Overall Study|Randomized and not treated|0|||
105710321|NCT01926782|364598268|FG005|Overall Study|Randomized and not treated|0|||
105710322|NCT01926782|364598263|FG000|Overall Study|Withdrawal by Subject|6|||
105710323|NCT01926782|364598264|FG001|Overall Study|Withdrawal by Subject|1|||
105928469|NCT01047501|365396588|FG002|Overall Study|Withdrew Consent|4|||
105710324|NCT01926782|364598265|FG002|Overall Study|Withdrawal by Subject|8|||
105710325|NCT01926782|364598266|FG003|Overall Study|Withdrawal by Subject|1|||
105710326|NCT01926782|364598267|FG004|Overall Study|Withdrawal by Subject|0|||
105710327|NCT01926782|364598268|FG005|Overall Study|Withdrawal by Subject|5|||
105710328|NCT01926782|364598263|FG000|Overall Study|Related to study drug administration|0|||
105710329|NCT01926782|364598264|FG001|Overall Study|Related to study drug administration|0|||
105710330|NCT01926782|364598265|FG002|Overall Study|Related to study drug administration|0|||
105710331|NCT01926782|364598266|FG003|Overall Study|Related to study drug administration|0|||
105710332|NCT01926782|364598267|FG004|Overall Study|Related to study drug administration|0|||
105710333|NCT01926782|364598268|FG005|Overall Study|Related to study drug administration|2|||
105710334|NCT02275338|364598271|FG000|Overall Study|Adverse Event|15|||
105710335|NCT02275338|364598271|FG000|Overall Study|Lack of Efficacy|3|||
105710336|NCT02275338|364598271|FG000|Overall Study|Withdrawal by Subject|4|||
105710337|NCT02275338|364598271|FG000|Overall Study|Disease progression (death)|1|||
105710338|NCT02275338|364598271|FG000|Overall Study|Ineligible to start Phase 2|4|||
105710339|NCT02275338|364598271|FG000|Overall Study|Reason not specified|5|||
105710340|NCT02275338|364598271|FG000|Overall Study|Does not meet entry criteria|1|||
105710341|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
105710342|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
105710343|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
105710344|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
105710345|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
105710346|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
105710347|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
105710348|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
105710349|NCT00382993|364598272|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
105710350|NCT00382993|364598273|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
105928470|NCT01047501|365396586|FG000|Overall Study|Lost to Follow-up|0|||
105928471|NCT01047501|365396587|FG001|Overall Study|Lost to Follow-up|1|||
105710351|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
105710352|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
105710353|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
105710354|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
105710355|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
105710356|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
105928472|NCT01047501|365396588|FG002|Overall Study|Lost to Follow-up|1|||
105710357|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
105710358|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
105710359|NCT00382993|364598272|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
105710360|NCT00382993|364598273|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
105710361|NCT01857869|364598276|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
105928473|NCT01047501|365396586|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
105928474|NCT01047501|365396587|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
105710362|NCT01857869|364598277|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
105710363|NCT01857869|364598278|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
105710364|NCT01857869|364598279|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
105710365|NCT01857869|364598280|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
105710366|NCT01857869|364598281|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
105710367|NCT01857869|364598282|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
105710368|NCT01857869|364598283|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
105710369|NCT01857869|364598284|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
105710370|NCT01857869|364598285|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
105710371|NCT01857869|364598276|FG000|Primary/Challenge Phase|Pregnancy|1|||
105710372|NCT01857869|364598277|FG001|Primary/Challenge Phase|Pregnancy|0|||
105710373|NCT01857869|364598278|FG002|Primary/Challenge Phase|Pregnancy|0|||
105710374|NCT01857869|364598279|FG003|Primary/Challenge Phase|Pregnancy|0|||
105710375|NCT01857869|364598280|FG004|Primary/Challenge Phase|Pregnancy|0|||
105710376|NCT01857869|364598281|FG005|Primary/Challenge Phase|Pregnancy|0|||
105710377|NCT01857869|364598282|FG006|Primary/Challenge Phase|Pregnancy|0|||
105710378|NCT01857869|364598283|FG007|Primary/Challenge Phase|Pregnancy|0|||
105710379|NCT01857869|364598284|FG008|Primary/Challenge Phase|Pregnancy|0|||
105710380|NCT01857869|364598285|FG009|Primary/Challenge Phase|Pregnancy|0|||
105710381|NCT01857869|364598276|FG000|Primary/Challenge Phase|Protocol Violation|1|||
105710382|NCT01857869|364598277|FG001|Primary/Challenge Phase|Protocol Violation|0|||
105710383|NCT01857869|364598278|FG002|Primary/Challenge Phase|Protocol Violation|0|||
105710384|NCT01857869|364598279|FG003|Primary/Challenge Phase|Protocol Violation|0|||
105710385|NCT01857869|364598280|FG004|Primary/Challenge Phase|Protocol Violation|0|||
105710386|NCT01857869|364598281|FG005|Primary/Challenge Phase|Protocol Violation|0|||
105710387|NCT01857869|364598282|FG006|Primary/Challenge Phase|Protocol Violation|0|||
105710388|NCT01857869|364598283|FG007|Primary/Challenge Phase|Protocol Violation|0|||
105710389|NCT01857869|364598284|FG008|Primary/Challenge Phase|Protocol Violation|0|||
105710390|NCT01857869|364598285|FG009|Primary/Challenge Phase|Protocol Violation|0|||
105710391|NCT01857869|364598276|FG000|Primary/Challenge Phase|Other|1|||
105710392|NCT01857869|364598277|FG001|Primary/Challenge Phase|Other|1|||
105710393|NCT01857869|364598278|FG002|Primary/Challenge Phase|Other|0|||
105710394|NCT01857869|364598279|FG003|Primary/Challenge Phase|Other|0|||
105710395|NCT01857869|364598280|FG004|Primary/Challenge Phase|Other|0|||
105710396|NCT01857869|364598281|FG005|Primary/Challenge Phase|Other|0|||
105710397|NCT01857869|364598282|FG006|Primary/Challenge Phase|Other|0|||
105710398|NCT01857869|364598283|FG007|Primary/Challenge Phase|Other|0|||
105710399|NCT01857869|364598284|FG008|Primary/Challenge Phase|Other|0|||
105710400|NCT01857869|364598285|FG009|Primary/Challenge Phase|Other|0|||
105710401|NCT01857869|364598276|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710402|NCT01857869|364598277|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710403|NCT01857869|364598278|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710404|NCT01857869|364598279|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
105710405|NCT01857869|364598280|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710406|NCT01857869|364598281|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710407|NCT01857869|364598282|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710408|NCT01857869|364598283|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710409|NCT01857869|364598284|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710410|NCT01857869|364598285|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
105710411|NCT01857869|364598276|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710412|NCT01857869|364598277|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710413|NCT01857869|364598278|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710414|NCT01857869|364598279|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
105710415|NCT01857869|364598280|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710416|NCT01857869|364598281|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710417|NCT01857869|364598282|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710418|NCT01857869|364598283|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710419|NCT01857869|364598284|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710420|NCT01857869|364598285|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
105710421|NCT03298022|364598286|FG000|Overall Study|Lack of Efficacy|4|||
105710422|NCT03298022|364598286|FG000|Overall Study|Withdrawal by Subject|7|||
105928475|NCT01047501|365396588|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
105928476|NCT01047501|365396586|FG000|Overall Study|Death|1|||
105928477|NCT01047501|365396587|FG001|Overall Study|Death|0|||
105928478|NCT01047501|365396588|FG002|Overall Study|Death|0|||
105928479|NCT01047501|365396586|FG000|Overall Study|Other discontinuation|1|||
105710423|NCT03298022|364598286|FG000|Overall Study|Adverse Event|1|||
105928480|NCT01047501|365396587|FG001|Overall Study|Other discontinuation|0|||
105710424|NCT03298022|364598286|FG000|Overall Study|disease relapse|1|||
105710425|NCT01445769|364598287|FG000|Overall Study|Consent Withdrawn|2|||
105710426|NCT01445769|364598287|FG000|Overall Study|Disease Progression|1|||
105710427|NCT01445769|364598287|FG000|Overall Study|Lost to Follow-up|5|||
105928481|NCT01047501|365396588|FG002|Overall Study|Other discontinuation|1|||
105928482|NCT01047501|365396586|FG000|Overall Study|Investigator judgement|0|||
105710428|NCT03099707|364598288|FG000|Overall Study|Withdrawal by Subject|0|||
105710429|NCT03099707|364598289|FG001|Overall Study|Withdrawal by Subject|3|||
105710430|NCT03099707|364598288|FG000|Overall Study|Lost to Follow-up|0|||
105710431|NCT03099707|364598289|FG001|Overall Study|Lost to Follow-up|1|||
105710432|NCT00262873|364598292|FG000|Overall Study|Adverse Event|3|||
105710433|NCT00262873|364598292|FG000|Overall Study|Withdrawal by Subject|5|||
105710434|NCT00487539|364598293|FG000|Overall Study|Adverse Event|3|||
105710435|NCT00487539|364598294|FG001|Overall Study|Adverse Event|2|||
105710436|NCT00487539|364598295|FG002|Overall Study|Adverse Event|1|||
105710437|NCT00487539|364598296|FG003|Overall Study|Adverse Event|1|||
105710438|NCT00487539|364598293|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105710439|NCT00487539|364598294|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105710440|NCT00487539|364598295|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105710441|NCT00487539|364598296|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
105710442|NCT00487539|364598293|FG000|Overall Study|Other|3|||
105710443|NCT00487539|364598294|FG001|Overall Study|Other|1|||
105710444|NCT00487539|364598295|FG002|Overall Study|Other|2|||
105710445|NCT00487539|364598296|FG003|Overall Study|Other|2|||
105710446|NCT00903175|364598297|FG000|Period 1 - First Line|Adverse Event|36|||
105710447|NCT00903175|364598298|FG001|Period 1 - First Line|Adverse Event|50|||
105710448|NCT00903175|364598297|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
105710449|NCT00903175|364598298|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
105710450|NCT00903175|364598297|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
105710451|NCT00903175|364598298|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
105710452|NCT00903175|364598297|FG000|Period 1 - First Line|Protocol Violation|3|||
105710453|NCT00903175|364598298|FG001|Period 1 - First Line|Protocol Violation|3|||
105710454|NCT00903175|364598297|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
105710455|NCT00903175|364598298|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
105710456|NCT00903175|364598297|FG000|Period 1 - First Line|Administrative problems|12|||
105710457|NCT00903175|364598298|FG001|Period 1 - First Line|Administrative problems|13|||
105710458|NCT00903175|364598297|FG000|Period 1 - First Line|Death|17|||
105710459|NCT00903175|364598298|FG001|Period 1 - First Line|Death|10|||
105710460|NCT00903175|364598297|FG000|Period 2 - Second Line|Missing|1|||
105710461|NCT00903175|364598298|FG001|Period 2 - Second Line|Missing|0|||
105710462|NCT00903175|364598297|FG000|Period 2 - Second Line|Adverse Event|16|||
105928483|NCT01047501|365396587|FG001|Overall Study|Investigator judgement|0|||
105928484|NCT01047501|365396588|FG002|Overall Study|Investigator judgement|1|||
105928485|NCT05607043|365396589|FG000|Overall Study|Lost to Follow-up|2|||
105928486|NCT00741611|365396590|FG000|Overall Study|Death|0|||
105928487|NCT00741611|365396591|FG001|Overall Study|Death|0|||
105928488|NCT00741611|365396592|FG002|Overall Study|Death|1|||
105928489|NCT00741611|365396590|FG000|Overall Study|Withdrawal by Subject|0|||
105928490|NCT00741611|365396591|FG001|Overall Study|Withdrawal by Subject|2|||
105928491|NCT00741611|365396592|FG002|Overall Study|Withdrawal by Subject|2|||
105928492|NCT00800540|365396600|FG000|Period One: 6 Weeks|Noncompliance|1|||
105928493|NCT00800540|365396601|FG001|Period One: 6 Weeks|Noncompliance|0|||
105928494|NCT00800540|365396600|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
105928495|NCT00800540|365396601|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
105928496|NCT00800540|365396600|FG000|Period 2: 6 Weeks|Adverse Event|0|||
105928497|NCT00800540|365396601|FG001|Period 2: 6 Weeks|Adverse Event|1|||
105928498|NCT01239745|365396602|FG000|Overall Study|Study terminated by sponsor|45|||
105928499|NCT01239745|365396602|FG000|Overall Study|Adverse Event|1|||
105928500|NCT03600428|365396604|FG000|Overall Study|Not eligible|0|||
105928501|NCT03600428|365396605|FG001|Overall Study|Not eligible|1|||
105928502|NCT03600428|365396604|FG000|Overall Study|Lost to Follow-up|5|||
105928503|NCT03600428|365396605|FG001|Overall Study|Lost to Follow-up|4|||
105928504|NCT00770484|365396606|FG000|Overall Study|Withdrawal by Subject|1|||
105928505|NCT00770484|365396607|FG001|Overall Study|Withdrawal by Subject|0|||
105928506|NCT00894647|365396608|FG000|Overall Study|Adverse Event|5|||
105710463|NCT00903175|364598298|FG001|Period 2 - Second Line|Adverse Event|20|||
105710464|NCT00903175|364598297|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
105710465|NCT00903175|364598298|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
105710466|NCT00903175|364598297|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
105710467|NCT00903175|364598298|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
105710468|NCT00903175|364598297|FG000|Period 2 - Second Line|Administrative problems|19|||
105928507|NCT00894647|365396609|FG001|Overall Study|Adverse Event|4|||
105928508|NCT00894647|365396608|FG000|Overall Study|Withdrawal by Subject|4|||
105928509|NCT00894647|365396609|FG001|Overall Study|Withdrawal by Subject|4|||
105928510|NCT00894647|365396608|FG000|Overall Study|Lost to Follow-up|0|||
105928511|NCT00894647|365396609|FG001|Overall Study|Lost to Follow-up|2|||
106007714|NCT03486912|365693543|FG001|Treatment Period|Lost to Follow-up|0|||
105710469|NCT00903175|364598298|FG001|Period 2 - Second Line|Administrative problems|9|||
105710470|NCT00903175|364598297|FG000|Period 2 - Second Line|Death|5|||
105710471|NCT00903175|364598298|FG001|Period 2 - Second Line|Death|2|||
105710472|NCT00516737|364598301|FG000|Overall Study|Lost to Follow-up|2|||
105928512|NCT00894647|365396608|FG000|Overall Study|Non-compliance with study procedures|0|||
105710473|NCT00516737|364598302|FG001|Overall Study|Lost to Follow-up|0|||
105710474|NCT00516737|364598301|FG000|Overall Study|Physician Decision|0|||
105710475|NCT00516737|364598302|FG001|Overall Study|Physician Decision|1|||
105710476|NCT00516737|364598301|FG000|Overall Study|Withdrawal by Subject|0|||
105710477|NCT00516737|364598302|FG001|Overall Study|Withdrawal by Subject|1|||
105710478|NCT00516737|364598301|FG000|Overall Study|Lack of Qualifying Event|9|||
105710479|NCT00516737|364598302|FG001|Overall Study|Lack of Qualifying Event|6|||
105710480|NCT01035905|364598303|FG000|Overall Study|Lack of Efficacy|1|||
105710481|NCT01035905|364598304|FG001|Overall Study|Lack of Efficacy|1|||
105710482|NCT01844895|364598305|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
105710483|NCT01844895|364598305|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
105710484|NCT01844895|364598305|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
105710485|NCT01844895|364598305|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
105710486|NCT01844895|364598305|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
105710487|NCT01844895|364598305|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
105710488|NCT01844895|364598305|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
105710489|NCT00874120|364601298|FG000|First Intervention|Adverse Event|0|||
105710490|NCT00874120|364601299|FG001|First Intervention|Adverse Event|1|||
105710491|NCT00874120|364601298|FG000|First Intervention|Withdrawal by Subject|2|||
105710492|NCT00874120|364601299|FG001|First Intervention|Withdrawal by Subject|0|||
105710493|NCT00874120|364601298|FG000|First Intervention|Lost to Follow-up|0|||
105710494|NCT00874120|364601299|FG001|First Intervention|Lost to Follow-up|1|||
105710495|NCT00874120|364601298|FG000|First Intervention|Protocol Violation|3|||
105710496|NCT00874120|364601299|FG001|First Intervention|Protocol Violation|0|||
105710497|NCT00874120|364601298|FG000|First Intervention|positive drug test|1|||
105710498|NCT00874120|364601299|FG001|First Intervention|positive drug test|0|||
105710499|NCT00874120|364601298|FG000|Second Intervention|Withdrawal by Subject|1|||
105710500|NCT00874120|364601299|FG001|Second Intervention|Withdrawal by Subject|0|||
105710501|NCT00874120|364601298|FG000|Second Intervention|Protocol Violation|1|||
105710502|NCT00874120|364601299|FG001|Second Intervention|Protocol Violation|0|||
105710503|NCT02404103|364601305|FG000|Overall Study|Adverse Event|1|||
105710504|NCT02404103|364601306|FG001|Overall Study|Adverse Event|0|||
105710505|NCT02404103|364601305|FG000|Overall Study|Lost to Follow-up|3|||
105710506|NCT02404103|364601306|FG001|Overall Study|Lost to Follow-up|3|||
105710507|NCT02543528|364601307|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
105928513|NCT00894647|365396609|FG001|Overall Study|Non-compliance with study procedures|2|||
105928514|NCT00894647|365396608|FG000|Overall Study|Other, not due to AE|1|||
105928515|NCT00894647|365396609|FG001|Overall Study|Other, not due to AE|2|||
105928516|NCT02153827|365396615|FG000|Overall Study|Lost to Follow-up|3|||
105928517|NCT02153827|365396616|FG001|Overall Study|Lost to Follow-up|9|||
105928518|NCT00153920|365396617|FG000|Overall Study|Adverse Event|9|||
105928519|NCT00153920|365396617|FG000|Overall Study|Progressive Disease|9|||
105928520|NCT00153920|365396617|FG000|Overall Study|Physician Decision|3|||
105928521|NCT00153920|365396617|FG000|Overall Study|Lack of Response|3|||
105928522|NCT00153920|365396617|FG000|Overall Study|Death|2|||
105928523|NCT00153920|365396617|FG000|Overall Study|Withdrawal by Subject|1|||
105928524|NCT00153920|365396617|FG000|Overall Study|Non-Protocol Therapy|1|||
105928525|NCT00153920|365396617|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
105928526|NCT00153920|365396617|FG000|Overall Study|Progressive Disease before Trt|1|||
105928527|NCT02541903|365396620|FG000|Overall Study|Death|1|||
105928528|NCT04795323|365396626|FG000|Overall Study|Did not interact with TARA|1|||
105928529|NCT04795323|365396627|FG001|Overall Study|Did not interact with TARA|0|||
105928530|NCT01479530|365396628|FG000|Overall Study|Adverse Event|5|||
105928531|NCT01479530|365396629|FG001|Overall Study|Adverse Event|6|||
105928532|NCT01479530|365396628|FG000|Overall Study|Lack of Efficacy|0|||
105928533|NCT01479530|365396629|FG001|Overall Study|Lack of Efficacy|1|||
105928534|NCT01479530|365396628|FG000|Overall Study|Protocol Violation|2|||
105928535|NCT01479530|365396629|FG001|Overall Study|Protocol Violation|3|||
105928536|NCT01479530|365396628|FG000|Overall Study|Withdrawal of Consent|3|||
105928537|NCT01479530|365396629|FG001|Overall Study|Withdrawal of Consent|2|||
105928538|NCT00776997|365396630|FG000|Overall Study|Adverse Event|2|||
105928539|NCT06377488|365396631|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
105928540|NCT06377488|365396631|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
105928541|NCT06377488|365396631|FG000|Overall Study|Protocol Violation|1|||
105928542|NCT06377488|365396631|FG000|Overall Study|Lost to Follow-up|1|||
105928543|NCT06377488|365396631|FG000|Overall Study|Incorrect Lens Dispensed|2|||
105928544|NCT02315625|365396636|FG000|First Intervention|Disease Progression|1|||
105710508|NCT02543528|364601308|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
105710509|NCT02543528|364601309|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
105710510|NCT02543528|364601310|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
105928545|NCT02315625|365396637|FG001|First Intervention|Disease Progression|0|||
105928546|NCT02315625|365396636|FG000|Second Intervention|Physician Decision|2|||
105928547|NCT02315625|365396637|FG001|Second Intervention|Physician Decision|1|||
105928548|NCT02315625|365396636|FG000|Second Intervention|Study closure|1|||
105928549|NCT02315625|365396637|FG001|Second Intervention|Study closure|0|||
105928550|NCT02315625|365396636|FG000|Second Intervention|Disease Progression|1|||
105710511|NCT02543528|364601311|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
105710512|NCT02543528|364601307|FG000|Adaptation Period|Lens Handling Difficultes|0|||
105710513|NCT02543528|364601308|FG001|Adaptation Period|Lens Handling Difficultes|0|||
105710514|NCT02543528|364601309|FG002|Adaptation Period|Lens Handling Difficultes|0|||
105710515|NCT02543528|364601310|FG003|Adaptation Period|Lens Handling Difficultes|0|||
105710516|NCT02543528|364601311|FG004|Adaptation Period|Lens Handling Difficultes|8|||
105710517|NCT02543528|364601307|FG000|Adaptation Period|Lost to Follow-up|0|||
105710518|NCT02543528|364601308|FG001|Adaptation Period|Lost to Follow-up|0|||
105710519|NCT02543528|364601309|FG002|Adaptation Period|Lost to Follow-up|0|||
105710520|NCT02543528|364601310|FG003|Adaptation Period|Lost to Follow-up|0|||
105710521|NCT02543528|364601311|FG004|Adaptation Period|Lost to Follow-up|14|||
105710522|NCT02543528|364601307|FG000|Adaptation Period|Adverse Event|0|||
105710523|NCT02543528|364601308|FG001|Adaptation Period|Adverse Event|0|||
105710524|NCT02543528|364601309|FG002|Adaptation Period|Adverse Event|0|||
105710525|NCT02543528|364601310|FG003|Adaptation Period|Adverse Event|0|||
105710526|NCT02543528|364601311|FG004|Adaptation Period|Adverse Event|2|||
105710527|NCT02543528|364601307|FG000|Extended Wear Period|Adverse Event|17|||
105710528|NCT02543528|364601308|FG001|Extended Wear Period|Adverse Event|11|||
105710529|NCT02543528|364601309|FG002|Extended Wear Period|Adverse Event|16|||
105710530|NCT02543528|364601310|FG003|Extended Wear Period|Adverse Event|3|||
105710531|NCT02543528|364601311|FG004|Extended Wear Period|Adverse Event|0|||
105710532|NCT02543528|364601307|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
105710533|NCT02543528|364601308|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
105710534|NCT02543528|364601309|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
105710535|NCT02543528|364601310|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
105710536|NCT02543528|364601311|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
105710537|NCT02543528|364601307|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
105710538|NCT02543528|364601308|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
105710539|NCT02543528|364601309|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
105710540|NCT02543528|364601310|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
105710541|NCT02543528|364601311|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
105710542|NCT02543528|364601307|FG000|Extended Wear Period|Lost to Follow-up|0|||
105710543|NCT02543528|364601308|FG001|Extended Wear Period|Lost to Follow-up|1|||
105710544|NCT02543528|364601309|FG002|Extended Wear Period|Lost to Follow-up|2|||
106134280|NCT01511250|366150396|FG003|Overall Study|Sponsor/Investigator Decision|0|||
105710545|NCT02543528|364601310|FG003|Extended Wear Period|Lost to Follow-up|1|||
105710546|NCT02543528|364601311|FG004|Extended Wear Period|Lost to Follow-up|0|||
105710547|NCT02543528|364601307|FG000|Extended Wear Period|Withdrawal by Subject|10|||
105710548|NCT02543528|364601308|FG001|Extended Wear Period|Withdrawal by Subject|9|||
105710549|NCT02543528|364601309|FG002|Extended Wear Period|Withdrawal by Subject|4|||
105710550|NCT02543528|364601310|FG003|Extended Wear Period|Withdrawal by Subject|5|||
105710551|NCT02543528|364601311|FG004|Extended Wear Period|Withdrawal by Subject|0|||
105710552|NCT00328627|364601312|FG000|Overall Study|Hyperglycemic Rescue|41|||
105710553|NCT00328627|364601313|FG001|Overall Study|Hyperglycemic Rescue|18|||
105710554|NCT00328627|364601314|FG002|Overall Study|Hyperglycemic Rescue|16|||
105710555|NCT00328627|364601315|FG003|Overall Study|Hyperglycemic Rescue|13|||
105710556|NCT00328627|364601316|FG004|Overall Study|Hyperglycemic Rescue|6|||
105710557|NCT00328627|364601317|FG005|Overall Study|Hyperglycemic Rescue|5|||
105710558|NCT00328627|364601318|FG006|Overall Study|Hyperglycemic Rescue|19|||
105710559|NCT00328627|364601319|FG007|Overall Study|Hyperglycemic Rescue|6|||
105710560|NCT00328627|364601320|FG008|Overall Study|Hyperglycemic Rescue|6|||
105928551|NCT02315625|365396637|FG001|Second Intervention|Disease Progression|0|||
105928552|NCT00021255|365396640|FG000|Overall Study|Death|1|||
105928553|NCT00021255|365396641|FG001|Overall Study|Death|0|||
105928554|NCT00021255|365396642|FG002|Overall Study|Death|2|||
105710561|NCT00328627|364601321|FG009|Overall Study|Hyperglycemic Rescue|11|||
105928555|NCT00021255|365396640|FG000|Overall Study|Breast cancer relapse|5|||
105928556|NCT00021255|365396641|FG001|Overall Study|Breast cancer relapse|18|||
105928557|NCT00021255|365396642|FG002|Overall Study|Breast cancer relapse|11|||
105928558|NCT00021255|365396640|FG000|Overall Study|Second primary malignancy|0|||
105928559|NCT00021255|365396641|FG001|Overall Study|Second primary malignancy|4|||
105928560|NCT00021255|365396642|FG002|Overall Study|Second primary malignancy|1|||
105710562|NCT00328627|364601322|FG010|Overall Study|Hyperglycemic Rescue|3|||
105710563|NCT00328627|364601323|FG011|Overall Study|Hyperglycemic Rescue|2|||
105710564|NCT00328627|364601312|FG000|Overall Study|Adverse Event|3|||
105710565|NCT00328627|364601313|FG001|Overall Study|Adverse Event|1|||
105710566|NCT00328627|364601314|FG002|Overall Study|Adverse Event|2|||
105710567|NCT00328627|364601315|FG003|Overall Study|Adverse Event|3|||
105710568|NCT00328627|364601316|FG004|Overall Study|Adverse Event|1|||
105710569|NCT00328627|364601317|FG005|Overall Study|Adverse Event|2|||
105710570|NCT00328627|364601318|FG006|Overall Study|Adverse Event|1|||
105928561|NCT00021255|365396640|FG000|Overall Study|Withdrawal by Subject|41|||
105928562|NCT00021255|365396641|FG001|Overall Study|Withdrawal by Subject|64|||
105928563|NCT00021255|365396642|FG002|Overall Study|Withdrawal by Subject|26|||
105710571|NCT00328627|364601319|FG007|Overall Study|Adverse Event|2|||
105710572|NCT00328627|364601320|FG008|Overall Study|Adverse Event|0|||
105710573|NCT00328627|364601321|FG009|Overall Study|Adverse Event|7|||
105710574|NCT00328627|364601322|FG010|Overall Study|Adverse Event|5|||
105710575|NCT00328627|364601323|FG011|Overall Study|Adverse Event|4|||
105710576|NCT00328627|364601312|FG000|Overall Study|Protocol Violation|2|||
105710577|NCT00328627|364601313|FG001|Overall Study|Protocol Violation|2|||
105710578|NCT00328627|364601314|FG002|Overall Study|Protocol Violation|2|||
105710579|NCT00328627|364601315|FG003|Overall Study|Protocol Violation|8|||
105710580|NCT00328627|364601316|FG004|Overall Study|Protocol Violation|5|||
105710581|NCT00328627|364601317|FG005|Overall Study|Protocol Violation|5|||
105710582|NCT00328627|364601318|FG006|Overall Study|Protocol Violation|6|||
105710583|NCT00328627|364601319|FG007|Overall Study|Protocol Violation|2|||
105710584|NCT00328627|364601320|FG008|Overall Study|Protocol Violation|1|||
105710585|NCT00328627|364601321|FG009|Overall Study|Protocol Violation|4|||
105710586|NCT00328627|364601322|FG010|Overall Study|Protocol Violation|6|||
105710587|NCT00328627|364601323|FG011|Overall Study|Protocol Violation|2|||
105710588|NCT00328627|364601312|FG000|Overall Study|Lost to Follow-up|4|||
105710589|NCT00328627|364601313|FG001|Overall Study|Lost to Follow-up|2|||
105710590|NCT00328627|364601314|FG002|Overall Study|Lost to Follow-up|2|||
105710591|NCT00328627|364601315|FG003|Overall Study|Lost to Follow-up|4|||
105710592|NCT00328627|364601316|FG004|Overall Study|Lost to Follow-up|0|||
105710593|NCT00328627|364601317|FG005|Overall Study|Lost to Follow-up|2|||
105710594|NCT00328627|364601318|FG006|Overall Study|Lost to Follow-up|3|||
105710595|NCT00328627|364601319|FG007|Overall Study|Lost to Follow-up|0|||
105710596|NCT00328627|364601320|FG008|Overall Study|Lost to Follow-up|3|||
105710597|NCT00328627|364601321|FG009|Overall Study|Lost to Follow-up|2|||
105710598|NCT00328627|364601322|FG010|Overall Study|Lost to Follow-up|0|||
105710599|NCT00328627|364601323|FG011|Overall Study|Lost to Follow-up|1|||
105710600|NCT00328627|364601312|FG000|Overall Study|Withdrawal by Subject|5|||
105710601|NCT00328627|364601313|FG001|Overall Study|Withdrawal by Subject|4|||
105710602|NCT00328627|364601314|FG002|Overall Study|Withdrawal by Subject|5|||
105710603|NCT00328627|364601315|FG003|Overall Study|Withdrawal by Subject|6|||
105710604|NCT00328627|364601316|FG004|Overall Study|Withdrawal by Subject|2|||
105710605|NCT00328627|364601317|FG005|Overall Study|Withdrawal by Subject|5|||
105710606|NCT00328627|364601318|FG006|Overall Study|Withdrawal by Subject|4|||
105710607|NCT00328627|364601319|FG007|Overall Study|Withdrawal by Subject|4|||
105710608|NCT00328627|364601320|FG008|Overall Study|Withdrawal by Subject|4|||
105710609|NCT00328627|364601321|FG009|Overall Study|Withdrawal by Subject|5|||
105710610|NCT00328627|364601322|FG010|Overall Study|Withdrawal by Subject|2|||
105710611|NCT00328627|364601323|FG011|Overall Study|Withdrawal by Subject|7|||
105710612|NCT00328627|364601312|FG000|Overall Study|Pregnancy|0|||
105710613|NCT00328627|364601313|FG001|Overall Study|Pregnancy|1|||
105710614|NCT00328627|364601314|FG002|Overall Study|Pregnancy|0|||
105710615|NCT00328627|364601315|FG003|Overall Study|Pregnancy|0|||
105710616|NCT00328627|364601316|FG004|Overall Study|Pregnancy|0|||
105710617|NCT00328627|364601317|FG005|Overall Study|Pregnancy|0|||
105710618|NCT00328627|364601318|FG006|Overall Study|Pregnancy|0|||
105710619|NCT00328627|364601319|FG007|Overall Study|Pregnancy|0|||
105710620|NCT00328627|364601320|FG008|Overall Study|Pregnancy|0|||
105710621|NCT00328627|364601321|FG009|Overall Study|Pregnancy|0|||
105710622|NCT00328627|364601322|FG010|Overall Study|Pregnancy|0|||
105710623|NCT00328627|364601323|FG011|Overall Study|Pregnancy|0|||
105710624|NCT00328627|364601312|FG000|Overall Study|Physician Decision|4|||
105710625|NCT00328627|364601313|FG001|Overall Study|Physician Decision|3|||
105710626|NCT00328627|364601314|FG002|Overall Study|Physician Decision|1|||
106007715|NCT03486912|365693544|FG002|Treatment Period|Lost to Follow-up|0|||
105928564|NCT00021255|365396640|FG000|Overall Study|Lost to Follow-up|0|||
105928565|NCT00021255|365396641|FG001|Overall Study|Lost to Follow-up|2|||
105928566|NCT00021255|365396642|FG002|Overall Study|Lost to Follow-up|3|||
105928567|NCT00021255|365396640|FG000|Overall Study|Cardiac toxicity|0|||
105928568|NCT00021255|365396641|FG001|Overall Study|Cardiac toxicity|61|||
105928569|NCT00021255|365396642|FG002|Overall Study|Cardiac toxicity|32|||
105928570|NCT00021255|365396640|FG000|Overall Study|Herceptin toxicity|0|||
105928571|NCT00021255|365396641|FG001|Overall Study|Herceptin toxicity|22|||
105710627|NCT00328627|364601315|FG003|Overall Study|Physician Decision|2|||
105710628|NCT00328627|364601316|FG004|Overall Study|Physician Decision|1|||
105710629|NCT00328627|364601317|FG005|Overall Study|Physician Decision|1|||
105710630|NCT00328627|364601318|FG006|Overall Study|Physician Decision|1|||
105710631|NCT00328627|364601319|FG007|Overall Study|Physician Decision|0|||
105710632|NCT00328627|364601320|FG008|Overall Study|Physician Decision|3|||
105710633|NCT00328627|364601321|FG009|Overall Study|Physician Decision|2|||
105710634|NCT00328627|364601322|FG010|Overall Study|Physician Decision|1|||
105710635|NCT00328627|364601323|FG011|Overall Study|Physician Decision|0|||
105710636|NCT00328627|364601312|FG000|Overall Study|Other|0|||
105710637|NCT00328627|364601313|FG001|Overall Study|Other|0|||
105710638|NCT00328627|364601314|FG002|Overall Study|Other|0|||
105710639|NCT00328627|364601315|FG003|Overall Study|Other|1|||
105710640|NCT00328627|364601316|FG004|Overall Study|Other|0|||
105928572|NCT00021255|365396642|FG002|Overall Study|Herceptin toxicity|6|||
105928573|NCT00021255|365396640|FG000|Overall Study|Adverse Event|46|||
105710641|NCT00328627|364601317|FG005|Overall Study|Other|0|||
105710642|NCT00328627|364601318|FG006|Overall Study|Other|1|||
105710643|NCT00328627|364601319|FG007|Overall Study|Other|0|||
105710644|NCT00328627|364601320|FG008|Overall Study|Other|0|||
105710645|NCT00328627|364601321|FG009|Overall Study|Other|1|||
105710646|NCT00328627|364601322|FG010|Overall Study|Other|1|||
105710647|NCT00328627|364601323|FG011|Overall Study|Other|0|||
105710648|NCT01662440|364601324|FG000|Overall Study|Adverse Event|1|||
105710649|NCT01662440|364601325|FG001|Overall Study|Adverse Event|0|||
106134281|NCT01511250|366150397|FG004|Overall Study|Sponsor/Investigator Decision|0|||
106134282|NCT01511250|366150398|FG005|Overall Study|Sponsor/Investigator Decision|0|||
106134283|NCT01511250|366150399|FG006|Overall Study|Sponsor/Investigator Decision|0|||
106134284|NCT01511250|366150400|FG007|Overall Study|Sponsor/Investigator Decision|0|||
106134285|NCT01511250|366150401|FG008|Overall Study|Sponsor/Investigator Decision|0|||
106134286|NCT01511250|366150402|FG009|Overall Study|Sponsor/Investigator Decision|0|||
106134287|NCT01511250|366150393|FG000|Overall Study|Lost to Follow-up|7|||
106134288|NCT01511250|366150394|FG001|Overall Study|Lost to Follow-up|3|||
105710650|NCT01662440|364601326|FG002|Overall Study|Adverse Event|0|||
105710651|NCT01662440|364601327|FG003|Overall Study|Adverse Event|1|||
105710652|NCT01662440|364601324|FG000|Overall Study|Death|0|||
105710653|NCT01662440|364601325|FG001|Overall Study|Death|1|||
105710654|NCT01662440|364601326|FG002|Overall Study|Death|0|||
105710655|NCT01662440|364601327|FG003|Overall Study|Death|0|||
105710656|NCT01662440|364601324|FG000|Overall Study|Lost to Follow-up|2|||
105710657|NCT01662440|364601325|FG001|Overall Study|Lost to Follow-up|2|||
105710658|NCT01662440|364601326|FG002|Overall Study|Lost to Follow-up|4|||
105710659|NCT01662440|364601327|FG003|Overall Study|Lost to Follow-up|1|||
105710660|NCT01662440|364601324|FG000|Overall Study|Subject moved to another country.|0|||
105710661|NCT01662440|364601325|FG001|Overall Study|Subject moved to another country.|1|||
105710662|NCT01662440|364601326|FG002|Overall Study|Subject moved to another country.|0|||
105710663|NCT01662440|364601327|FG003|Overall Study|Subject moved to another country.|0|||
105710664|NCT01662440|364601324|FG000|Overall Study|Protocol Violation|1|||
105710665|NCT01662440|364601325|FG001|Overall Study|Protocol Violation|0|||
105710666|NCT01662440|364601326|FG002|Overall Study|Protocol Violation|0|||
105710667|NCT01662440|364601327|FG003|Overall Study|Protocol Violation|0|||
105710668|NCT01662440|364601324|FG000|Overall Study|Withdrawal by Subject|5|||
105710669|NCT01662440|364601325|FG001|Overall Study|Withdrawal by Subject|2|||
105710670|NCT01662440|364601326|FG002|Overall Study|Withdrawal by Subject|2|||
105710671|NCT01662440|364601327|FG003|Overall Study|Withdrawal by Subject|2|||
105710672|NCT01765673|364601328|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
105710673|NCT00971945|364601333|FG000|Overall Study|Progressive Disease|3|||
105710674|NCT00971945|364601333|FG000|Overall Study|Change in treatment policy|1|||
105710675|NCT00971945|364601333|FG000|Overall Study|Other reasons|2|||
105710676|NCT01535729|364601338|FG000|Overall Study|Withdrawal by Subject|2|||
105710677|NCT01535729|364601338|FG000|Overall Study|Disease progression|230|||
105710678|NCT01535729|364601338|FG000|Overall Study|Discontinued treatment|25|||
105710679|NCT01535729|364601338|FG000|Overall Study|Lost to Follow-up|8|||
105710680|NCT01535729|364601338|FG000|Overall Study|Death|52|||
105710681|NCT01535729|364601338|FG000|Overall Study|Other|19|||
105710682|NCT01535729|364601338|FG000|Overall Study|Did not sign informed consent|1|||
105710683|NCT01535729|364601338|FG000|Overall Study|No previous chemotherapy|33|||
105710684|NCT01535729|364601338|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
105710685|NCT01535729|364601338|FG000|Overall Study|Protocol Violation|11|||
105710686|NCT01535729|364601338|FG000|Overall Study|Screening failure|1|||
105710687|NCT01535729|364601338|FG000|Overall Study|Not treated|9|||
105710688|NCT01535729|364601338|FG000|Overall Study|No participant record available|5|||
105710689|NCT01592760|364601341|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
105710690|NCT01592760|364601342|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
105710691|NCT01592760|364601343|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
105710692|NCT01363986|364601344|FG000|Overall Study|Disease progression|1|||
105710693|NCT01637142|364601345|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
105710694|NCT00130832|364601346|FG000|Overall Study|Adverse Event|1|||
105928574|NCT00021255|365396641|FG001|Overall Study|Adverse Event|30|||
105710695|NCT00130832|364601347|FG001|Overall Study|Adverse Event|1|||
105710696|NCT00130832|364601346|FG000|Overall Study|Lost to Follow-up|1|||
105710697|NCT00130832|364601347|FG001|Overall Study|Lost to Follow-up|2|||
105710698|NCT00130832|364601346|FG000|Overall Study|Protocol Violation|6|||
105710699|NCT00130832|364601347|FG001|Overall Study|Protocol Violation|8|||
105710700|NCT00130832|364601346|FG000|Overall Study|Withdrawal by Subject|6|||
105710701|NCT00130832|364601347|FG001|Overall Study|Withdrawal by Subject|1|||
105710702|NCT00130832|364601346|FG000|Overall Study|Moved|2|||
105710703|NCT00130832|364601347|FG001|Overall Study|Moved|2|||
105710704|NCT00130832|364601346|FG000|Overall Study|Other|0|||
105710705|NCT00130832|364601347|FG001|Overall Study|Other|3|||
105710706|NCT03905863|364601348|FG000|Overall Study|Adverse Event|2|||
105710707|NCT03905863|364601349|FG001|Overall Study|Adverse Event|4|||
105710708|NCT03905863|364601348|FG000|Overall Study|Withdrawal by Subject|2|||
105788077|NCT00779857|364878202|FG000|Overall Study|Death|1|||
105710709|NCT03905863|364601349|FG001|Overall Study|Withdrawal by Subject|2|||
105710710|NCT03905863|364601348|FG000|Overall Study|Physician Decision|0|||
105710711|NCT03905863|364601349|FG001|Overall Study|Physician Decision|3|||
105710712|NCT03905863|364601348|FG000|Overall Study|Lost to Follow-up|1|||
105710713|NCT03905863|364601349|FG001|Overall Study|Lost to Follow-up|0|||
105710714|NCT03905863|364601348|FG000|Overall Study|Protocol Violation|0|||
105710715|NCT03905863|364601349|FG001|Overall Study|Protocol Violation|2|||
105710716|NCT03905863|364601348|FG000|Overall Study|Death|0|||
105710717|NCT03905863|364601349|FG001|Overall Study|Death|1|||
105710718|NCT02111564|364601351|FG000|Overall Study|Death|109|||
105710719|NCT02111564|364601352|FG001|Overall Study|Death|120|||
105710720|NCT02111564|364601351|FG000|Overall Study|Lost to Follow-up|2|||
105710721|NCT02111564|364601352|FG001|Overall Study|Lost to Follow-up|3|||
105710722|NCT02111564|364601351|FG000|Overall Study|Withdrawal by Subject|20|||
105710723|NCT02111564|364601352|FG001|Overall Study|Withdrawal by Subject|20|||
105710724|NCT02944448|364601353|FG000|Overall Study|Adverse Event|37|||
105710725|NCT02944448|364601354|FG001|Overall Study|Adverse Event|6|||
105710726|NCT02944448|364601353|FG000|Overall Study|Lack of Efficacy|8|||
105710727|NCT02944448|364601354|FG001|Overall Study|Lack of Efficacy|5|||
105710728|NCT02944448|364601353|FG000|Overall Study|Lost to Follow-up|3|||
105710729|NCT02944448|364601354|FG001|Overall Study|Lost to Follow-up|1|||
105710730|NCT02944448|364601353|FG000|Overall Study|Protocol Violation|25|||
105710731|NCT02944448|364601354|FG001|Overall Study|Protocol Violation|7|||
105710732|NCT02944448|364601353|FG000|Overall Study|Withdrawal by Subject|14|||
105710733|NCT02944448|364601354|FG001|Overall Study|Withdrawal by Subject|4|||
105710734|NCT02944448|364601353|FG000|Overall Study|Sponsor did not supply drug in time|0|||
105710735|NCT02944448|364601354|FG001|Overall Study|Sponsor did not supply drug in time|1|||
105710736|NCT02944448|364601353|FG000|Overall Study|Noncompliant with dosing|1|||
105710737|NCT02944448|364601354|FG001|Overall Study|Noncompliant with dosing|0|||
105710738|NCT02944448|364601353|FG000|Overall Study|Abnormal laboratory values|1|||
105710739|NCT02944448|364601354|FG001|Overall Study|Abnormal laboratory values|0|||
105710740|NCT02468648|364601355|FG000|Overall Study|Death|1|||
105710741|NCT01368835|364601356|FG000|Overall Study|Inclusion criteria/photography quality|22|||
105710742|NCT01368835|364601356|FG000|Overall Study|Lost to Follow-up|11|||
105710743|NCT01678144|364601359|FG000|Stage 1: MAR Classic|Adverse Event|1|||
105710744|NCT03118297|364601360|FG000|Overall Study|Lost to Follow-up|0|||
105710745|NCT03118297|364601361|FG001|Overall Study|Lost to Follow-up|2|||
105710746|NCT01882907|364601362|FG000|Overall Study|Adverse Event|3|||
105710747|NCT01882907|364601363|FG001|Overall Study|Adverse Event|1|||
105710748|NCT01882907|364601362|FG000|Overall Study|Lack of Efficacy|0|||
105710749|NCT01882907|364601363|FG001|Overall Study|Lack of Efficacy|3|||
105710750|NCT01882907|364601362|FG000|Overall Study|Lost to Follow-up|1|||
105710751|NCT01882907|364601363|FG001|Overall Study|Lost to Follow-up|4|||
105710752|NCT01882907|364601362|FG000|Overall Study|Protocol Violation|10|||
105710753|NCT01882907|364601363|FG001|Overall Study|Protocol Violation|14|||
105710754|NCT01882907|364601362|FG000|Overall Study|Withdrawal by Subject|0|||
105710755|NCT01882907|364601363|FG001|Overall Study|Withdrawal by Subject|6|||
105710756|NCT01777152|364601365|FG000|Overall Study|Withdrawal by Subject|22|||
105710757|NCT01777152|364601366|FG001|Overall Study|Withdrawal by Subject|16|||
105710758|NCT01777152|364601365|FG000|Overall Study|Lost to Follow-up|3|||
105710759|NCT01777152|364601366|FG001|Overall Study|Lost to Follow-up|5|||
105710760|NCT01777152|364601365|FG000|Overall Study|Death|68|||
105710761|NCT01777152|364601366|FG001|Overall Study|Death|89|||
105710762|NCT01777152|364601365|FG000|Overall Study|Not eligible, no study drug received|1|||
105710763|NCT01777152|364601366|FG001|Overall Study|Not eligible, no study drug received|0|||
105710764|NCT01777152|364601365|FG000|Overall Study|Change of diagnosis|1|||
105710765|NCT01777152|364601366|FG001|Overall Study|Change of diagnosis|0|||
105710766|NCT00424827|364601371|FG000|Overall Study|Adverse Event|1|||
105788078|NCT00779857|364878202|FG000|Overall Study|Withdrawal by Subject|3|||
105788079|NCT00779857|364878202|FG000|Overall Study|Missed Visit|2|||
105788080|NCT00620776|364878207|FG000|Overall Study|Did not receive treatment|3|||
105788081|NCT00620776|364878208|FG001|Overall Study|Did not receive treatment|5|||
105788082|NCT00620776|364878207|FG000|Overall Study|Adverse Event|2|||
105788083|NCT00620776|364878208|FG001|Overall Study|Adverse Event|3|||
105928575|NCT00021255|365396642|FG002|Overall Study|Adverse Event|18|||
105928576|NCT00021255|365396640|FG000|Overall Study|Protocol Violation|0|||
105710767|NCT03446885|364601376|FG000|Overall Study|Lost to Follow-up|1|||
105710768|NCT03446885|364601377|FG001|Overall Study|Lost to Follow-up|0|||
105710769|NCT03446885|364601376|FG000|Overall Study|Did not complete entire visit|1|||
105710770|NCT03446885|364601377|FG001|Overall Study|Did not complete entire visit|0|||
105710771|NCT03132636|364601381|FG000|Overall Study|Adverse Event|1|||
105710772|NCT03132636|364601382|FG001|Overall Study|Adverse Event|2|||
105710773|NCT03132636|364601381|FG000|Overall Study|Death|4|||
105710774|NCT03132636|364601382|FG001|Overall Study|Death|7|||
105710775|NCT03132636|364601381|FG000|Overall Study|Lost to Follow-up|3|||
105710776|NCT03132636|364601382|FG001|Overall Study|Lost to Follow-up|2|||
105710777|NCT03132636|364601381|FG000|Overall Study|Non compliance with protocol by participant|1|||
105710778|NCT03132636|364601382|FG001|Overall Study|Non compliance with protocol by participant|1|||
105710779|NCT03132636|364601381|FG000|Overall Study|Subject decision|1|||
105710780|NCT03132636|364601382|FG001|Overall Study|Subject decision|9|||
105710781|NCT03132636|364601381|FG000|Overall Study|Sponsor decision|0|||
105710782|NCT03132636|364601382|FG001|Overall Study|Sponsor decision|1|||
105710783|NCT03132636|364601381|FG000|Overall Study|Physician Decision|1|||
105710784|NCT03132636|364601382|FG001|Overall Study|Physician Decision|0|||
105710785|NCT03132636|364601381|FG000|Overall Study|Progressive disease|33|||
105710786|NCT03132636|364601382|FG001|Overall Study|Progressive disease|36|||
105710787|NCT03132636|364601381|FG000|Overall Study|Withdrawal of consent|2|||
105710788|NCT03132636|364601382|FG001|Overall Study|Withdrawal of consent|5|||
105710789|NCT03132636|364601381|FG000|Overall Study|Did not re-consent|1|||
105710790|NCT03132636|364601382|FG001|Overall Study|Did not re-consent|0|||
105710791|NCT03132636|364601381|FG000|Overall Study|Lost insurance coverage|1|||
105710792|NCT03132636|364601382|FG001|Overall Study|Lost insurance coverage|0|||
105710793|NCT03132636|364601381|FG000|Overall Study|Related to radiological outcomes|0|||
105710794|NCT03132636|364601382|FG001|Overall Study|Related to radiological outcomes|1|||
105710795|NCT03132636|364601381|FG000|Overall Study|Unable to come to site for continued visits|0|||
105710796|NCT03132636|364601382|FG001|Overall Study|Unable to come to site for continued visits|1|||
105710797|NCT03178487|364601388|FG000|Period 1|Adverse Event|1|||
105710798|NCT03178487|364601389|FG001|Period 1|Adverse Event|2|||
105710799|NCT03178487|364601388|FG000|Period 1|Withdrawal by Subject|2|||
105710800|NCT03178487|364601389|FG001|Period 1|Withdrawal by Subject|1|||
105710801|NCT03178487|364601388|FG000|Period 1|Lost to Follow-up|1|||
105710802|NCT03178487|364601389|FG001|Period 1|Lost to Follow-up|0|||
105710803|NCT03178487|364601388|FG000|Period 1|Other|0|||
105710804|NCT03178487|364601389|FG001|Period 1|Other|1|||
105710805|NCT03178487|364601388|FG000|Period 2|Adverse Event|4|||
105710806|NCT03178487|364601389|FG001|Period 2|Adverse Event|4|||
105710807|NCT03178487|364601388|FG000|Period 2|Withdrawal by Subject|6|||
105710808|NCT03178487|364601389|FG001|Period 2|Withdrawal by Subject|6|||
105710809|NCT03178487|364601388|FG000|Period 2|Lost to Follow-up|2|||
105710810|NCT03178487|364601389|FG001|Period 2|Lost to Follow-up|2|||
105710811|NCT03178487|364601388|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
105710812|NCT03178487|364601389|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
105710813|NCT03178487|364601388|FG000|Period 2|Other|8|||
105710814|NCT03178487|364601389|FG001|Period 2|Other|7|||
105710815|NCT01453855|364601390|FG000|Overall Study|Adverse Event|3|||
105710816|NCT01453855|364601391|FG001|Overall Study|Adverse Event|4|||
105710817|NCT01453855|364601390|FG000|Overall Study|Lost to Follow-up|2|||
105710818|NCT01453855|364601391|FG001|Overall Study|Lost to Follow-up|1|||
105710819|NCT01453855|364601390|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
105710820|NCT01453855|364601391|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
105710821|NCT01453855|364601390|FG000|Overall Study|Noncompliance|1|||
105710822|NCT01453855|364601391|FG001|Overall Study|Noncompliance|0|||
105710823|NCT01453855|364601390|FG000|Overall Study|Inadequate Control of IOP|1|||
105710824|NCT01453855|364601391|FG001|Overall Study|Inadequate Control of IOP|5|||
105710825|NCT01453855|364601390|FG000|Overall Study|Other|0|||
105710826|NCT01453855|364601391|FG001|Overall Study|Other|1|||
105710827|NCT03655756|364601398|FG000|Overall Study|Death|1|||
105710828|NCT00252057|364601399|FG000|Overall Study|Withdrawal by Subject|2|||
105710829|NCT00252057|364601400|FG001|Overall Study|Withdrawal by Subject|5|||
105928577|NCT00021255|365396641|FG001|Overall Study|Protocol Violation|2|||
105928578|NCT00021255|365396642|FG002|Overall Study|Protocol Violation|0|||
105928579|NCT00021255|365396640|FG000|Overall Study|Other than specified above|0|||
105928580|NCT00021255|365396641|FG001|Overall Study|Other than specified above|38|||
105928581|NCT00021255|365396642|FG002|Overall Study|Other than specified above|19|||
105928582|NCT00021255|365396640|FG000|Overall Study|Missing|0|||
105928583|NCT00021255|365396641|FG001|Overall Study|Missing|27|||
105928584|NCT00021255|365396642|FG002|Overall Study|Missing|13|||
105928585|NCT00021255|365396640|FG000|Overall Study|Randomized but not treated|28|||
105710830|NCT00252057|364601399|FG000|Overall Study|Death|1|||
105710831|NCT00252057|364601400|FG001|Overall Study|Death|2|||
105710832|NCT00252057|364601399|FG000|Overall Study|Participant previously enrolled|0|||
105710833|NCT00252057|364601400|FG001|Overall Study|Participant previously enrolled|1|||
105710834|NCT03948178|364601404|FG000|Overall Study|Protocol Violation|1|||
105710835|NCT03948178|364601404|FG000|Overall Study|Lost to Follow-up|2|||
105710836|NCT03948178|364601404|FG000|Overall Study|Withdrawal by Subject|2|||
105710837|NCT03948178|364601404|FG000|Overall Study|Reason not known|2|||
105710838|NCT03948178|364601404|FG000|Overall Study|Personal reason|14|||
105710839|NCT03948178|364601404|FG000|Overall Study|Disease progression|30|||
105710840|NCT03948178|364601404|FG000|Overall Study|Adverse Event|12|||
105710841|NCT03948178|364601404|FG000|Overall Study|Sponsor terminated study|164|||
105710842|NCT04607733|364601410|FG000|Overall Study|Lost to Follow-up|1|||
105710843|NCT04607733|364601411|FG001|Overall Study|Lost to Follow-up|0|||
105710844|NCT04607733|364601412|FG002|Overall Study|Lost to Follow-up|0|||
105710845|NCT04607733|364601413|FG003|Overall Study|Lost to Follow-up|1|||
105928586|NCT00021255|365396641|FG001|Overall Study|Randomized but not treated|2|||
105710846|NCT04607733|364601414|FG004|Overall Study|Lost to Follow-up|1|||
105710847|NCT04607733|364601415|FG005|Overall Study|Lost to Follow-up|0|||
105710848|NCT04607733|364601410|FG000|Overall Study|Withdrawal by Subject|0|||
105710849|NCT04607733|364601411|FG001|Overall Study|Withdrawal by Subject|0|||
105928587|NCT00021255|365396642|FG002|Overall Study|Randomized but not treated|18|||
105928588|NCT00387127|365396645|FG000|Overall Study|Lost to Follow-up|0|||
105928589|NCT00387127|365396646|FG001|Overall Study|Lost to Follow-up|4|||
105928590|NCT00387127|365396645|FG000|Overall Study|Death|16|||
105928591|NCT00387127|365396646|FG001|Overall Study|Death|16|||
105928592|NCT00387127|365396645|FG000|Overall Study|Physician Decision|0|||
105928593|NCT00387127|365396646|FG001|Overall Study|Physician Decision|1|||
105928594|NCT00387127|365396645|FG000|Overall Study|Withdrawal by Subject|3|||
105928595|NCT00387127|365396646|FG001|Overall Study|Withdrawal by Subject|2|||
105928596|NCT00387127|365396645|FG000|Overall Study|Required by Protocol Amendment #4|12|||
106007716|NCT03486912|365693545|FG003|Treatment Period|Lost to Follow-up|2|||
106134289|NCT01511250|366150395|FG002|Overall Study|Lost to Follow-up|3|||
106134290|NCT01511250|366150396|FG003|Overall Study|Lost to Follow-up|3|||
106134291|NCT01511250|366150397|FG004|Overall Study|Lost to Follow-up|0|||
105710850|NCT04607733|364601412|FG002|Overall Study|Withdrawal by Subject|0|||
105710851|NCT04607733|364601413|FG003|Overall Study|Withdrawal by Subject|0|||
105710852|NCT04607733|364601414|FG004|Overall Study|Withdrawal by Subject|1|||
105710853|NCT04607733|364601415|FG005|Overall Study|Withdrawal by Subject|0|||
105928597|NCT00387127|365396646|FG001|Overall Study|Required by Protocol Amendment #4|10|||
105928598|NCT00387127|365396645|FG000|Overall Study|Serious Adverse Event|1|||
105928599|NCT00387127|365396646|FG001|Overall Study|Serious Adverse Event|1|||
105928600|NCT00387127|365396645|FG000|Overall Study|Sponsor Unblinded|1|||
105928601|NCT00387127|365396646|FG001|Overall Study|Sponsor Unblinded|0|||
105928602|NCT02393755|365396647|FG000|Overall Study|Withdrawal by Subject|0|||
105928603|NCT02393755|365396648|FG001|Overall Study|Withdrawal by Subject|3|||
105928604|NCT02393755|365396647|FG000|Overall Study|Adverse Event|0|||
105928605|NCT02393755|365396648|FG001|Overall Study|Adverse Event|2|||
105928606|NCT02393755|365396647|FG000|Overall Study|Physician Decision|0|||
105928607|NCT02393755|365396648|FG001|Overall Study|Physician Decision|2|||
105928608|NCT01786109|365396651|FG000|Overall Study|fail manometry barostat tube placement|1|||
105928609|NCT01786109|365396652|FG001|Overall Study|fail manometry barostat tube placement|0|||
105928610|NCT01786109|365396653|FG002|Overall Study|fail manometry barostat tube placement|0|||
105928611|NCT01786109|365396651|FG000|Overall Study|unrelated illness|0|||
105928612|NCT01786109|365396652|FG001|Overall Study|unrelated illness|0|||
105928613|NCT01786109|365396653|FG002|Overall Study|unrelated illness|1|||
105928614|NCT01786109|365396651|FG000|Overall Study|adverse effects colon preparation|0|||
105928615|NCT01786109|365396652|FG001|Overall Study|adverse effects colon preparation|0|||
105928616|NCT01786109|365396653|FG002|Overall Study|adverse effects colon preparation|1|||
105928617|NCT02949934|365396656|FG000|Natural Drinking Period|Adverse Event|1|||
105928618|NCT02949934|365396657|FG001|Natural Drinking Period|Adverse Event|0|||
105928619|NCT02949934|365396658|FG002|Natural Drinking Period|Adverse Event|0|||
105928620|NCT02949934|365396659|FG003|Natural Drinking Period|Adverse Event|1|||
105928621|NCT02949934|365396660|FG004|Natural Drinking Period|Adverse Event|0|||
105928622|NCT02949934|365396661|FG005|Natural Drinking Period|Adverse Event|0|||
105928623|NCT02949934|365396656|FG000|Natural Drinking Period|Lost to Follow-up|0|||
105928624|NCT02949934|365396657|FG001|Natural Drinking Period|Lost to Follow-up|0|||
105928625|NCT02949934|365396658|FG002|Natural Drinking Period|Lost to Follow-up|0|||
105928626|NCT02949934|365396659|FG003|Natural Drinking Period|Lost to Follow-up|0|||
105928627|NCT02949934|365396660|FG004|Natural Drinking Period|Lost to Follow-up|1|||
105928628|NCT02949934|365396661|FG005|Natural Drinking Period|Lost to Follow-up|0|||
105928629|NCT02949934|365396656|FG000|Neuroimaging|Protocol Violation|2|||
105928630|NCT02949934|365396657|FG001|Neuroimaging|Protocol Violation|0|||
105928631|NCT02949934|365396658|FG002|Neuroimaging|Protocol Violation|0|||
105928632|NCT02949934|365396659|FG003|Neuroimaging|Protocol Violation|0|||
105928633|NCT02949934|365396660|FG004|Neuroimaging|Protocol Violation|1|||
105928634|NCT02949934|365396661|FG005|Neuroimaging|Protocol Violation|0|||
105928635|NCT02949934|365396656|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
105928636|NCT02949934|365396657|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
105928637|NCT02949934|365396658|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
105928638|NCT02949934|365396659|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
105928639|NCT02949934|365396660|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
105928640|NCT02949934|365396661|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
105928641|NCT02949934|365396656|FG000|Neuroimaging|Not scanned|0|||
105928642|NCT02949934|365396657|FG001|Neuroimaging|Not scanned|0|||
106007717|NCT02242942|365693548|FG000|Overall Study|Death|17|||
105788084|NCT00620776|364878207|FG000|Overall Study|Lack of Efficacy|2|||
105928643|NCT02949934|365396658|FG002|Neuroimaging|Not scanned|1|||
105928644|NCT02949934|365396659|FG003|Neuroimaging|Not scanned|0|||
105928645|NCT02949934|365396660|FG004|Neuroimaging|Not scanned|0|||
105928646|NCT02949934|365396661|FG005|Neuroimaging|Not scanned|2|||
106007718|NCT02242942|365693549|FG001|Overall Study|Death|20|||
106134292|NCT01511250|366150398|FG005|Overall Study|Lost to Follow-up|0|||
105710854|NCT01847885|364601439|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
105710855|NCT01847885|364601440|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
105710856|NCT01847885|364601441|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
105710857|NCT01847885|364601439|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
105710858|NCT01847885|364601440|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
105710859|NCT01847885|364601441|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
105710860|NCT01847885|364601439|FG000|Initial Enrollment (Consented)|Screen failure|39|||
105710861|NCT01847885|364601440|FG001|Initial Enrollment (Consented)|Screen failure|0|||
105710862|NCT01847885|364601441|FG002|Initial Enrollment (Consented)|Screen failure|0|||
105710863|NCT01847885|364601439|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
105710864|NCT01847885|364601440|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
105710865|NCT01847885|364601441|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
105710866|NCT01847885|364601439|FG000|Randomization|Protocol Violation|0|||
105710867|NCT01847885|364601440|FG001|Randomization|Protocol Violation|1|||
105710868|NCT01847885|364601441|FG002|Randomization|Protocol Violation|0|||
105710869|NCT01847885|364601439|FG000|Randomization|Withdrawal by Subject|0|||
105710870|NCT01847885|364601440|FG001|Randomization|Withdrawal by Subject|0|||
105710871|NCT01847885|364601441|FG002|Randomization|Withdrawal by Subject|2|||
105710872|NCT01847885|364601439|FG000|Randomization|Screen Failure|0|||
106134293|NCT01511250|366150399|FG006|Overall Study|Lost to Follow-up|2|||
106134294|NCT01511250|366150400|FG007|Overall Study|Lost to Follow-up|3|||
106134295|NCT01511250|366150401|FG008|Overall Study|Lost to Follow-up|13|||
106134296|NCT01511250|366150402|FG009|Overall Study|Lost to Follow-up|5|||
106134297|NCT01511250|366150393|FG000|Overall Study|Protocol Violation|0|||
105710873|NCT01847885|364601440|FG001|Randomization|Screen Failure|3|||
105710874|NCT01847885|364601441|FG002|Randomization|Screen Failure|0|||
105710875|NCT02941627|364601444|FG000|Overall Study|Death|1|||
105710876|NCT02941627|364601444|FG000|Overall Study|Surgical failure|1|||
106007719|NCT02242942|365693550|FG002|Overall Study|Death|2|||
106134298|NCT01511250|366150394|FG001|Overall Study|Protocol Violation|2|||
106134299|NCT01511250|366150395|FG002|Overall Study|Protocol Violation|1|||
106134300|NCT01511250|366150396|FG003|Overall Study|Protocol Violation|0|||
105710877|NCT02941627|364601444|FG000|Overall Study|cholesteatoma prevented implantation|1|||
105710878|NCT00411554|364601445|FG000|Overall Study|Adverse Event|2|||
105710879|NCT00411554|364601446|FG001|Overall Study|Adverse Event|4|||
106134301|NCT01511250|366150397|FG004|Overall Study|Protocol Violation|0|||
106007720|NCT02242942|365693548|FG000|Overall Study|Physician Decision|1|||
106007721|NCT02242942|365693549|FG001|Overall Study|Physician Decision|0|||
106007722|NCT02242942|365693550|FG002|Overall Study|Physician Decision|0|||
106007723|NCT02242942|365693548|FG000|Overall Study|Withdrawal by Subject|8|||
106007724|NCT02242942|365693549|FG001|Overall Study|Withdrawal by Subject|10|||
106007725|NCT02242942|365693550|FG002|Overall Study|Withdrawal by Subject|0|||
106007726|NCT02242942|365693548|FG000|Overall Study|On-going in Study|190|||
106007727|NCT02242942|365693549|FG001|Overall Study|On-going in Study|186|||
106007728|NCT02242942|365693550|FG002|Overall Study|On-going in Study|11|||
106007729|NCT04842747|365693551|FG000|Overall Study|Withdrawal by Subject|6|||
106007730|NCT04842747|365693552|FG001|Overall Study|Withdrawal by Subject|2|||
106007731|NCT04842747|365693551|FG000|Overall Study|Lost to Follow-up|1|||
106007732|NCT04842747|365693552|FG001|Overall Study|Lost to Follow-up|2|||
106007733|NCT04842747|365693551|FG000|Overall Study|Physician Decision|1|||
106007734|NCT04842747|365693552|FG001|Overall Study|Physician Decision|0|||
106007735|NCT04842747|365693551|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
106007736|NCT04842747|365693552|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
106007737|NCT02285855|365693553|FG000|Overall Study|Withdrawal by Subject|2|||
106007738|NCT02285855|365693554|FG001|Overall Study|Withdrawal by Subject|1|||
106007739|NCT01446159|365693556|FG000|Overall Study|Withdrawal by Subject|1|||
106007740|NCT01446159|365693557|FG001|Overall Study|Withdrawal by Subject|0|||
106007741|NCT01446159|365693558|FG002|Overall Study|Withdrawal by Subject|14|||
106007742|NCT01446159|365693559|FG003|Overall Study|Withdrawal by Subject|11|||
106007743|NCT01446159|365693556|FG000|Overall Study|Lost to Follow-up|0|||
106007744|NCT01446159|365693557|FG001|Overall Study|Lost to Follow-up|0|||
106007745|NCT01446159|365693558|FG002|Overall Study|Lost to Follow-up|1|||
106007746|NCT01446159|365693559|FG003|Overall Study|Lost to Follow-up|2|||
106007747|NCT01446159|365693556|FG000|Overall Study|Death|2|||
105710880|NCT00411554|364601445|FG000|Overall Study|Lack of Efficacy|2|||
105710881|NCT00411554|364601446|FG001|Overall Study|Lack of Efficacy|5|||
105710882|NCT00411554|364601445|FG000|Overall Study|Withdrawal by Subject|3|||
105710883|NCT00411554|364601446|FG001|Overall Study|Withdrawal by Subject|0|||
105710884|NCT00411554|364601445|FG000|Overall Study|Patient Moved|1|||
105710885|NCT00411554|364601446|FG001|Overall Study|Patient Moved|0|||
105710886|NCT00774345|364601447|FG000|Pre-treatment|Other reasons|2|||
105710887|NCT00774345|364601448|FG001|Pre-treatment|Other reasons|0|||
105710888|NCT00774345|364601447|FG000|Treatment|Adverse Event|61|||
105710889|NCT00774345|364601448|FG001|Treatment|Adverse Event|15|||
105710890|NCT00774345|364601447|FG000|Treatment|Progressive Disease without histologic transformation|51|||
105710891|NCT00774345|364601448|FG001|Treatment|Progressive Disease without histologic transformation|111|||
105710892|NCT00774345|364601447|FG000|Treatment|Progressive Disease with histologic transformation|4|||
105710893|NCT00774345|364601448|FG001|Treatment|Progressive Disease with histologic transformation|2|||
105710894|NCT00774345|364601447|FG000|Treatment|Withdrawal by Subject|5|||
105710895|NCT00774345|364601448|FG001|Treatment|Withdrawal by Subject|2|||
105710896|NCT00774345|364601447|FG000|Treatment|Lost to Follow-up|1|||
105710897|NCT00774345|364601448|FG001|Treatment|Lost to Follow-up|1|||
105710898|NCT00774345|364601447|FG000|Treatment|Death|4|||
105710899|NCT00774345|364601448|FG001|Treatment|Death|0|||
105710900|NCT00774345|364601447|FG000|Treatment|Other Reasons|32|||
105710901|NCT00774345|364601448|FG001|Treatment|Other Reasons|26|||
105710902|NCT02161211|364601449|FG000|Overall Study|Lost to Follow-up|21|||
105710903|NCT02161211|364601450|FG001|Overall Study|Lost to Follow-up|27|||
105710904|NCT02161211|364601451|FG002|Overall Study|Lost to Follow-up|21|||
105710905|NCT02161211|364601449|FG000|Overall Study|Dropped|12|||
106007748|NCT01446159|365693557|FG001|Overall Study|Death|3|||
106007749|NCT01446159|365693558|FG002|Overall Study|Death|43|||
106007750|NCT01446159|365693559|FG003|Overall Study|Death|36|||
106007751|NCT01446159|365693556|FG000|Overall Study|Other|0|||
106007752|NCT01446159|365693557|FG001|Overall Study|Other|0|||
106007753|NCT01446159|365693558|FG002|Overall Study|Other|13|||
106007754|NCT01446159|365693559|FG003|Overall Study|Other|13|||
106007755|NCT02183675|365693560|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
106007756|NCT02183675|365693561|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
106007757|NCT02183675|365693562|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
106007758|NCT02183675|365693563|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
105710906|NCT02161211|364601450|FG001|Overall Study|Dropped|5|||
105710907|NCT02161211|364601451|FG002|Overall Study|Dropped|9|||
105710908|NCT01422239|364601452|FG000|Overall Study|Lost to Follow-up|4|||
105710909|NCT01422239|364601453|FG001|Overall Study|Lost to Follow-up|3|||
105710910|NCT03167073|364601457|FG000|Overall Study|Stillbirth|1|||
105710911|NCT03167073|364601458|FG001|Overall Study|Stillbirth|0|||
105710912|NCT01276236|364601459|FG000|Overall Study|Lack of Efficacy|2|||
105710913|NCT01276236|364601459|FG000|Overall Study|Withdrawal by Subject|4|||
105710914|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
105710915|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
105710916|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
105710917|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
105788085|NCT00620776|364878208|FG001|Overall Study|Lack of Efficacy|1|||
105788086|NCT00620776|364878207|FG000|Overall Study|Lost to Follow-up|2|||
105788087|NCT00620776|364878208|FG001|Overall Study|Lost to Follow-up|5|||
105788088|NCT00620776|364878207|FG000|Overall Study|Withdrawal by Subject|3|||
105788089|NCT00620776|364878208|FG001|Overall Study|Withdrawal by Subject|2|||
105788090|NCT03253809|364878209|FG000|Overall Study|Unable to obtain study related data|14|||
105788091|NCT00455923|364878213|FG000|Overall Study|Pregnancy|0|||
106007759|NCT02183675|365693564|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
106007760|NCT02183675|365693565|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
106007761|NCT01614249|365693566|FG000|Overall Study|Lost to Follow-up|11|||
106007762|NCT01614249|365693567|FG001|Overall Study|Lost to Follow-up|23|||
106007763|NCT02954536|365693568|FG000|Overall Study|Adverse Event|2|||
106007764|NCT02954536|365693568|FG000|Overall Study|Death|12|||
106007765|NCT00374140|365693572|FG000|Overall Study|Lost to Follow-up|1|||
106007766|NCT00374140|365693572|FG000|Overall Study|Protocol Violation|1|||
106007767|NCT01576341|365693573|FG000|Overall Study|Withdrawal by Subject|24|||
106007768|NCT01576341|365693573|FG000|Overall Study|Adverse Event|10|||
105710918|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
105710919|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
105710920|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
105710921|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
105710922|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
105710923|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
105788092|NCT00455923|364878214|FG001|Overall Study|Pregnancy|2|||
106007769|NCT01576341|365693573|FG000|Overall Study|Death|21|||
106007770|NCT01576341|365693573|FG000|Overall Study|Physician Decision|2|||
106007771|NCT01576341|365693573|FG000|Overall Study|Lost to Follow-up|2|||
106007772|NCT01576341|365693573|FG000|Overall Study|Kidney transplantation|10|||
106007773|NCT01576341|365693573|FG000|Overall Study|Protocol Violation|12|||
106007774|NCT01576341|365693573|FG000|Overall Study|Other|12|||
106007775|NCT01844765|365693574|FG000|Overall Study|Adverse Event|6|||
106007776|NCT01844765|365693575|FG001|Overall Study|Adverse Event|8|||
106007777|NCT01844765|365693574|FG000|Overall Study|Withdrawal by Subject|2|||
106007778|NCT01844765|365693575|FG001|Overall Study|Withdrawal by Subject|3|||
106007779|NCT01844765|365693574|FG000|Overall Study|Disease progression|1|||
106007780|NCT01844765|365693575|FG001|Overall Study|Disease progression|0|||
106007781|NCT01844765|365693574|FG000|Overall Study|Administrative problems|3|||
106007782|NCT01844765|365693575|FG001|Overall Study|Administrative problems|4|||
106007783|NCT01844765|365693574|FG000|Overall Study|Protocol deviation|2|||
106007784|NCT01844765|365693575|FG001|Overall Study|Protocol deviation|0|||
106007785|NCT01844765|365693574|FG000|Overall Study|Untreated|1|||
106007786|NCT01844765|365693575|FG001|Overall Study|Untreated|0|||
106007787|NCT04764162|365693581|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
106007788|NCT04764162|365693582|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
106007789|NCT02783690|365693583|FG000|Overall Study|Withdrawal by Subject|3|||
106007790|NCT02783690|365693584|FG001|Overall Study|Withdrawal by Subject|3|||
106007791|NCT03589859|365693585|FG000|Overall Study|Withdrawal by Subject|0|||
106007792|NCT03589859|365693586|FG001|Overall Study|Withdrawal by Subject|6|||
106007793|NCT04966013|365693587|FG000|Overall Study|Withdrawal by Subject|0|||
106007794|NCT04966013|365693588|FG001|Overall Study|Withdrawal by Subject|2|||
106007795|NCT04966013|365693589|FG002|Overall Study|Withdrawal by Subject|1|||
106007796|NCT04966013|365693587|FG000|Overall Study|Adverse Event|2|||
106007797|NCT04966013|365693588|FG001|Overall Study|Adverse Event|1|||
106007798|NCT04966013|365693589|FG002|Overall Study|Adverse Event|1|||
106007799|NCT03518086|365693590|FG000|Overall Study|Adverse Event|23|||
106007800|NCT03518086|365693591|FG001|Overall Study|Adverse Event|15|||
106007801|NCT03518086|365693592|FG002|Overall Study|Adverse Event|3|||
106007802|NCT03518086|365693593|FG003|Overall Study|Adverse Event|2|||
106007803|NCT03518086|365693590|FG000|Overall Study|Withdrawal by Subject|8|||
106007804|NCT03518086|365693591|FG001|Overall Study|Withdrawal by Subject|5|||
106007805|NCT03518086|365693592|FG002|Overall Study|Withdrawal by Subject|1|||
105710924|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
105788093|NCT00455923|364878213|FG000|Overall Study|Other|3|||
105710925|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
105710926|NCT01400451|364601460|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
105710927|NCT01400451|364601461|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
105710928|NCT01400451|364601462|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
105710929|NCT02799069|364601465|FG000|Overall Study|Adverse Event|0|||
105710930|NCT02799069|364601466|FG001|Overall Study|Adverse Event|2|||
105710931|NCT02799069|364601467|FG002|Overall Study|Adverse Event|2|||
105710932|NCT02799069|364601465|FG000|Overall Study|Lack of Efficacy|2|||
105710933|NCT02799069|364601466|FG001|Overall Study|Lack of Efficacy|0|||
105710934|NCT02799069|364601467|FG002|Overall Study|Lack of Efficacy|0|||
105788094|NCT00455923|364878214|FG001|Overall Study|Other|1|||
105788095|NCT04964960|364878215|FG000|Overall Study|Withdrawal by Subject|1|||
105788096|NCT02319642|364878216|FG000|Overall Study|Adverse Event|2|||
105788097|NCT02319642|364878217|FG001|Overall Study|Adverse Event|4|||
105788098|NCT02319642|364878216|FG000|Overall Study|Lack of Efficacy|1|||
105788099|NCT02319642|364878217|FG001|Overall Study|Lack of Efficacy|1|||
105788100|NCT02319642|364878216|FG000|Overall Study|Withdrawal by Subject|1|||
105788101|NCT02319642|364878217|FG001|Overall Study|Withdrawal by Subject|1|||
105788102|NCT05275673|364878218|FG000|Overall Study|Study Termination by Sponsor|2|||
105788103|NCT05275673|364878219|FG001|Overall Study|Study Termination by Sponsor|3|||
105788104|NCT05275673|364878218|FG000|Overall Study|Death|1|||
105788105|NCT05275673|364878219|FG001|Overall Study|Death|0|||
105788106|NCT05275673|364878218|FG000|Overall Study|Withdrawal by Subject|1|||
106007806|NCT03518086|365693593|FG003|Overall Study|Withdrawal by Subject|0|||
106007807|NCT03518086|365693590|FG000|Overall Study|Lack of Efficacy|5|||
105788107|NCT05275673|364878219|FG001|Overall Study|Withdrawal by Subject|0|||
105788108|NCT03426995|364878220|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788109|NCT03426995|364878221|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788110|NCT03426995|364878222|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
105788111|NCT03426995|364878223|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105928647|NCT02949934|365396656|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
105928648|NCT02949934|365396657|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
105928649|NCT02949934|365396658|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
105928650|NCT02949934|365396659|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
105928651|NCT02949934|365396660|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
105928652|NCT02949934|365396661|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
106007808|NCT03518086|365693591|FG001|Overall Study|Lack of Efficacy|5|||
106007809|NCT03518086|365693592|FG002|Overall Study|Lack of Efficacy|0|||
106007810|NCT03518086|365693593|FG003|Overall Study|Lack of Efficacy|2|||
106007811|NCT03518086|365693590|FG000|Overall Study|Protocol Violation|1|||
106007812|NCT03518086|365693591|FG001|Overall Study|Protocol Violation|5|||
106007813|NCT03518086|365693592|FG002|Overall Study|Protocol Violation|1|||
106007814|NCT03518086|365693593|FG003|Overall Study|Protocol Violation|3|||
106007815|NCT03518086|365693590|FG000|Overall Study|Lost to Follow-up|0|||
106007816|NCT03518086|365693591|FG001|Overall Study|Lost to Follow-up|3|||
106007817|NCT03518086|365693592|FG002|Overall Study|Lost to Follow-up|0|||
106007818|NCT03518086|365693593|FG003|Overall Study|Lost to Follow-up|0|||
106007819|NCT03518086|365693590|FG000|Overall Study|Insufficient Diary Data|0|||
106134302|NCT01511250|366150398|FG005|Overall Study|Protocol Violation|0|||
106134303|NCT01511250|366150399|FG006|Overall Study|Protocol Violation|0|||
106134304|NCT01511250|366150400|FG007|Overall Study|Protocol Violation|0|||
106134305|NCT01511250|366150401|FG008|Overall Study|Protocol Violation|0|||
105928653|NCT02949934|365396656|FG000|Bar Laboratory|Adverse Event|1|||
105928654|NCT02949934|365396657|FG001|Bar Laboratory|Adverse Event|0|||
105928655|NCT02949934|365396658|FG002|Bar Laboratory|Adverse Event|2|||
106007820|NCT03518086|365693591|FG001|Overall Study|Insufficient Diary Data|2|||
106007821|NCT03518086|365693592|FG002|Overall Study|Insufficient Diary Data|0|||
106007822|NCT03518086|365693593|FG003|Overall Study|Insufficient Diary Data|0|||
106007823|NCT03518086|365693590|FG000|Overall Study|Non- compliance to Protocol|0|||
106007824|NCT03518086|365693591|FG001|Overall Study|Non- compliance to Protocol|1|||
106007825|NCT03518086|365693592|FG002|Overall Study|Non- compliance to Protocol|0|||
106007826|NCT03518086|365693593|FG003|Overall Study|Non- compliance to Protocol|0|||
106007827|NCT03518086|365693590|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
106134306|NCT01511250|366150402|FG009|Overall Study|Protocol Violation|0|||
106134307|NCT03404843|366150406|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
106134308|NCT03404843|366150407|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
105710935|NCT02799069|364601465|FG000|Overall Study|Lost to Follow-up|1|||
106007828|NCT03518086|365693591|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
106134309|NCT02974010|366150409|FG000|Overall Study|Lost to Follow-up|3|||
106134310|NCT02974010|366150410|FG001|Overall Study|Lost to Follow-up|1|||
106134311|NCT02974010|366150411|FG002|Overall Study|Lost to Follow-up|0|||
105710936|NCT02799069|364601466|FG001|Overall Study|Lost to Follow-up|1|||
105710937|NCT02799069|364601467|FG002|Overall Study|Lost to Follow-up|0|||
105710938|NCT02799069|364601465|FG000|Overall Study|Withdrawal by Subject|4|||
105710939|NCT02799069|364601466|FG001|Overall Study|Withdrawal by Subject|4|||
105710940|NCT02799069|364601467|FG002|Overall Study|Withdrawal by Subject|3|||
105710941|NCT02799069|364601465|FG000|Overall Study|Protocol Violation|1|||
105928656|NCT02949934|365396659|FG003|Bar Laboratory|Adverse Event|0|||
105928657|NCT02949934|365396660|FG004|Bar Laboratory|Adverse Event|1|||
105928658|NCT02949934|365396661|FG005|Bar Laboratory|Adverse Event|0|||
105928659|NCT02949934|365396656|FG000|Bar Laboratory|Protocol Violation|0|||
105928660|NCT02949934|365396657|FG001|Bar Laboratory|Protocol Violation|0|||
105928661|NCT02949934|365396658|FG002|Bar Laboratory|Protocol Violation|0|||
105928662|NCT02949934|365396659|FG003|Bar Laboratory|Protocol Violation|1|||
105928663|NCT02949934|365396660|FG004|Bar Laboratory|Protocol Violation|0|||
105928664|NCT02949934|365396661|FG005|Bar Laboratory|Protocol Violation|0|||
105928665|NCT01068912|365396662|FG000|Overall Study|Adverse Event|2|||
105928666|NCT01068912|365396663|FG001|Overall Study|Adverse Event|3|||
105928667|NCT01068912|365396664|FG002|Overall Study|Adverse Event|2|||
105928668|NCT01068912|365396662|FG000|Overall Study|Withdrawal by Subject|5|||
105928669|NCT01068912|365396663|FG001|Overall Study|Withdrawal by Subject|6|||
105710942|NCT02799069|364601466|FG001|Overall Study|Protocol Violation|0|||
105710943|NCT02799069|364601467|FG002|Overall Study|Protocol Violation|2|||
105928670|NCT01068912|365396664|FG002|Overall Study|Withdrawal by Subject|6|||
105710944|NCT00848354|364601468|FG000|Phase 1|Adverse Event|5|||
105710945|NCT00848354|364601469|FG001|Phase 1|Adverse Event|4|||
105928671|NCT01068912|365396662|FG000|Overall Study|Lost to Follow-up|3|||
105928672|NCT01068912|365396663|FG001|Overall Study|Lost to Follow-up|7|||
105928673|NCT01068912|365396664|FG002|Overall Study|Lost to Follow-up|3|||
105928674|NCT01068912|365396662|FG000|Overall Study|Protocol Violation|0|||
105928675|NCT01068912|365396663|FG001|Overall Study|Protocol Violation|2|||
105928676|NCT01068912|365396664|FG002|Overall Study|Protocol Violation|0|||
105928677|NCT01068912|365396662|FG000|Overall Study|aggravation influenza|1|||
105928678|NCT01068912|365396663|FG001|Overall Study|aggravation influenza|1|||
105928679|NCT01068912|365396664|FG002|Overall Study|aggravation influenza|1|||
105928680|NCT01068912|365396662|FG000|Overall Study|other underlying illness|0|||
105928681|NCT01068912|365396663|FG001|Overall Study|other underlying illness|3|||
105928682|NCT01068912|365396664|FG002|Overall Study|other underlying illness|3|||
106134312|NCT02974010|366150412|FG003|Overall Study|Lost to Follow-up|0|||
106134313|NCT02974010|366150409|FG000|Overall Study|Withdrawal by Subject|2|||
106134314|NCT02974010|366150410|FG001|Overall Study|Withdrawal by Subject|1|||
106134315|NCT02974010|366150411|FG002|Overall Study|Withdrawal by Subject|0|||
106134316|NCT02974010|366150412|FG003|Overall Study|Withdrawal by Subject|0|||
106134317|NCT02974010|366150409|FG000|Overall Study|Adverse Event|0|||
106134318|NCT02974010|366150410|FG001|Overall Study|Adverse Event|1|||
106134319|NCT02974010|366150411|FG002|Overall Study|Adverse Event|0|||
106134320|NCT02974010|366150412|FG003|Overall Study|Adverse Event|0|||
106134321|NCT02974010|366150409|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
106134322|NCT02974010|366150410|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
106134323|NCT02974010|366150411|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
106134324|NCT02974010|366150412|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
106134325|NCT02974010|366150409|FG000|Overall Study|Lack of Efficacy|0|||
106134326|NCT02974010|366150410|FG001|Overall Study|Lack of Efficacy|0|||
106134327|NCT02974010|366150411|FG002|Overall Study|Lack of Efficacy|1|||
106134328|NCT02974010|366150412|FG003|Overall Study|Lack of Efficacy|0|||
106134329|NCT02095158|366150413|FG000|Overall Study|Adverse Event|14|||
106134330|NCT02095158|366150413|FG000|Overall Study|Lack of Efficacy|3|||
106134331|NCT02095158|366150413|FG000|Overall Study|Pregnancy|1|||
106134332|NCT02095158|366150413|FG000|Overall Study|Lost to Follow-up|20|||
106134333|NCT02095158|366150413|FG000|Overall Study|Personal Reasons|35|||
106134334|NCT02095158|366150413|FG000|Overall Study|Protocol Violation|1|||
106134335|NCT02095158|366150413|FG000|Overall Study|Other Miscellaneous Reasons|1|||
106134336|NCT01941316|366150414|FG000|Overall Study|Adverse Event|0|||
106134337|NCT01941316|366150415|FG001|Overall Study|Adverse Event|1|||
106134338|NCT01941316|366150416|FG002|Overall Study|Adverse Event|0|||
106134339|NCT01941316|366150417|FG003|Overall Study|Adverse Event|7|||
106134340|NCT01941316|366150414|FG000|Overall Study|Progressive Disease|3|||
106134341|NCT01941316|366150415|FG001|Overall Study|Progressive Disease|6|||
106134342|NCT01941316|366150416|FG002|Overall Study|Progressive Disease|2|||
106134343|NCT01941316|366150417|FG003|Overall Study|Progressive Disease|29|||
106134344|NCT01941316|366150414|FG000|Overall Study|Withdrawal by Subject|0|||
106134345|NCT01941316|366150415|FG001|Overall Study|Withdrawal by Subject|2|||
106134346|NCT01941316|366150416|FG002|Overall Study|Withdrawal by Subject|1|||
106134347|NCT01941316|366150417|FG003|Overall Study|Withdrawal by Subject|8|||
106134348|NCT01941316|366150414|FG000|Overall Study|Death|0|||
106134349|NCT01941316|366150415|FG001|Overall Study|Death|0|||
106134350|NCT01941316|366150416|FG002|Overall Study|Death|0|||
106134351|NCT01941316|366150417|FG003|Overall Study|Death|3|||
106134352|NCT01941316|366150414|FG000|Overall Study|Physician Decision|0|||
106134353|NCT01941316|366150415|FG001|Overall Study|Physician Decision|0|||
106134354|NCT01941316|366150416|FG002|Overall Study|Physician Decision|0|||
106134355|NCT01941316|366150417|FG003|Overall Study|Physician Decision|3|||
106134356|NCT01941316|366150414|FG000|Overall Study|Protocol Violation|0|||
106134357|NCT01941316|366150415|FG001|Overall Study|Protocol Violation|0|||
106134358|NCT01941316|366150416|FG002|Overall Study|Protocol Violation|0|||
106134359|NCT01941316|366150417|FG003|Overall Study|Protocol Violation|3|||
106134360|NCT01941316|366150414|FG000|Overall Study|Intercurrent illness|0|||
106134361|NCT01941316|366150415|FG001|Overall Study|Intercurrent illness|0|||
106134362|NCT01941316|366150416|FG002|Overall Study|Intercurrent illness|0|||
106134363|NCT01941316|366150417|FG003|Overall Study|Intercurrent illness|1|||
106134364|NCT01941316|366150414|FG000|Overall Study|Other, not specified|0|||
105928683|NCT01947933|365396670|FG000|Overall Study|Withdrawal by Subject|0|||
105928684|NCT01947933|365396671|FG001|Overall Study|Withdrawal by Subject|0|||
106007829|NCT03518086|365693592|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
106134365|NCT01941316|366150415|FG001|Overall Study|Other, not specified|0|||
106134366|NCT01941316|366150416|FG002|Overall Study|Other, not specified|0|||
106134367|NCT01941316|366150417|FG003|Overall Study|Other, not specified|1|||
106134368|NCT02775435|366150418|FG000|Overall Study|Adverse Event|32|||
106134369|NCT02775435|366150419|FG001|Overall Study|Adverse Event|27|||
106134370|NCT02775435|366150418|FG000|Overall Study|Lost to Follow-up|2|||
106134371|NCT02775435|366150419|FG001|Overall Study|Lost to Follow-up|2|||
106134372|NCT02775435|366150418|FG000|Overall Study|Sponsor decision|44|||
106134373|NCT02775435|366150419|FG001|Overall Study|Sponsor decision|19|||
106134374|NCT02775435|366150418|FG000|Overall Study|Withdrawal by Subject|4|||
105928685|NCT01947933|365396672|FG002|Overall Study|Withdrawal by Subject|1|||
105928686|NCT01947933|365396673|FG003|Overall Study|Withdrawal by Subject|0|||
105710946|NCT00848354|364601468|FG000|Phase 1|Discontinuation of study by sponsor|2|||
105710947|NCT00848354|364601469|FG001|Phase 1|Discontinuation of study by sponsor|1|||
105710948|NCT00848354|364601468|FG000|Phase 1|Failed to return|0|||
105710949|NCT00848354|364601469|FG001|Phase 1|Failed to return|1|||
105710950|NCT00848354|364601468|FG000|Phase 1|Lost to Follow-up|1|||
105710951|NCT00848354|364601469|FG001|Phase 1|Lost to Follow-up|1|||
105710952|NCT00848354|364601468|FG000|Phase 1|Unspecified Reason|1|||
105710953|NCT00848354|364601469|FG001|Phase 1|Unspecified Reason|1|||
105710954|NCT00848354|364601468|FG000|Phase 1|Protocol Violation|1|||
105710955|NCT00848354|364601469|FG001|Phase 1|Protocol Violation|1|||
105710956|NCT00848354|364601468|FG000|Phase 1|Withdrawal by Subject|2|||
106134375|NCT02775435|366150419|FG001|Overall Study|Withdrawal by Subject|9|||
106134376|NCT02775435|366150418|FG000|Overall Study|Death|196|||
106134377|NCT02775435|366150419|FG001|Overall Study|Death|224|||
106134378|NCT02107014|366150420|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
106134379|NCT03396913|366150421|FG000|Overall Study|Lost to Follow-up|0|||
106134380|NCT03396913|366150422|FG001|Overall Study|Lost to Follow-up|6|||
106134381|NCT00768066|366150427|FG000|Overall Study|Did not receive study product injection.|3|||
106134382|NCT00768066|366150428|FG001|Overall Study|Did not receive study product injection.|3|||
106134383|NCT00768066|366150429|FG002|Overall Study|Did not receive study product injection.|0|||
105710957|NCT00848354|364601469|FG001|Phase 1|Withdrawal by Subject|4|||
105710958|NCT00848354|364601468|FG000|Phase 1|Lack of Efficacy|0|||
105710959|NCT00848354|364601469|FG001|Phase 1|Lack of Efficacy|1|||
105928687|NCT01947933|365396674|FG004|Overall Study|Withdrawal by Subject|0|||
105928688|NCT01947933|365396675|FG005|Overall Study|Withdrawal by Subject|0|||
105928689|NCT01947933|365396676|FG006|Overall Study|Withdrawal by Subject|0|||
105928690|NCT01947933|365396677|FG007|Overall Study|Withdrawal by Subject|0|||
105928691|NCT01947933|365396678|FG008|Overall Study|Withdrawal by Subject|0|||
105928692|NCT01947933|365396670|FG000|Overall Study|Lost to Follow-up|0|||
105928693|NCT01947933|365396671|FG001|Overall Study|Lost to Follow-up|0|||
105928694|NCT01947933|365396672|FG002|Overall Study|Lost to Follow-up|0|||
105928695|NCT01947933|365396673|FG003|Overall Study|Lost to Follow-up|0|||
105928696|NCT01947933|365396674|FG004|Overall Study|Lost to Follow-up|0|||
105928697|NCT01947933|365396675|FG005|Overall Study|Lost to Follow-up|0|||
105928698|NCT01947933|365396676|FG006|Overall Study|Lost to Follow-up|0|||
105928699|NCT01947933|365396677|FG007|Overall Study|Lost to Follow-up|0|||
105928700|NCT01947933|365396678|FG008|Overall Study|Lost to Follow-up|1|||
105928701|NCT00294398|365396679|FG000|Overall Study|Lost to Follow-up|21|||
105928702|NCT00294398|365396680|FG001|Overall Study|Lost to Follow-up|26|||
105928703|NCT01428128|365396685|FG000|Overall Study|Withdrawal by Subject|4|||
105928704|NCT01428128|365396685|FG000|Overall Study|Screen failure by p53|10|||
105928705|NCT01428128|365396685|FG000|Overall Study|Received Neulasta in one cycle|2|||
105928706|NCT01428128|365396685|FG000|Overall Study|Adverse Event|1|||
105928707|NCT00985790|365396686|FG000|Overall Study|Withdrawal by Subject|1|||
105928708|NCT00985790|365396687|FG001|Overall Study|Withdrawal by Subject|1|||
105928709|NCT00985790|365396686|FG000|Overall Study|Lost to Follow-up|6|||
105928710|NCT00985790|365396687|FG001|Overall Study|Lost to Follow-up|7|||
105928711|NCT03407482|365396688|FG000|Overall Study|Adverse Event|12|||
105928712|NCT03407482|365396688|FG000|Overall Study|Disease Relapse|1|||
105928713|NCT03407482|365396688|FG000|Overall Study|Lost to Follow-up|1|||
105928714|NCT03407482|365396688|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105928715|NCT03407482|365396688|FG000|Overall Study|Pregnancy|2|||
105928716|NCT03407482|365396688|FG000|Overall Study|Protocol Violation|1|||
105928717|NCT03407482|365396688|FG000|Overall Study|Study Terminated By Sponsor|106|||
105928718|NCT03407482|365396688|FG000|Overall Study|Withdrawal by Subject|6|||
105928719|NCT03407482|365396688|FG000|Overall Study|Data Entry Error|1|||
105928720|NCT03442569|365396689|FG000|Overall Study|Subject was ineligible after enrollment|1|||
105928721|NCT00424008|365396690|FG000|Overall Study|Adverse Event|8|||
105928722|NCT00424008|365396691|FG001|Overall Study|Adverse Event|6|||
106134384|NCT04831775|366150430|FG000|Overall Study|Lost to Follow-up|11|||
106134385|NCT04831775|366150431|FG001|Overall Study|Lost to Follow-up|13|||
106134386|NCT03369951|366150433|FG000|Overall Study|Withdrawal by Subject|3|||
106134387|NCT03369951|366150433|FG000|Overall Study|Death|1|||
106134388|NCT03369951|366150433|FG000|Overall Study|Lost to Follow-up|1|||
106134389|NCT03369951|366150433|FG000|Overall Study|Protocol Violation|1|||
106144116|NCT01317420|366186961|FG012|Overall Study|Refused to cont. taking trial medication|1|||
105710960|NCT00848354|364601468|FG000|Phase 2 Year 1|Adverse Event|7|||
105710961|NCT00848354|364601469|FG001|Phase 2 Year 1|Adverse Event|2|||
105710962|NCT00848354|364601468|FG000|Phase 2 Year 1|Death|1|||
105710963|NCT00848354|364601469|FG001|Phase 2 Year 1|Death|0|||
105710964|NCT00848354|364601468|FG000|Phase 2 Year 1|Failed to Return|1|||
105928723|NCT00424008|365396690|FG000|Overall Study|Lack of Efficacy|40|||
105928724|NCT00424008|365396691|FG001|Overall Study|Lack of Efficacy|34|||
105928725|NCT00424008|365396690|FG000|Overall Study|Lost to Follow-up|1|||
105928726|NCT00424008|365396691|FG001|Overall Study|Lost to Follow-up|2|||
105928727|NCT00424008|365396690|FG000|Overall Study|Withdrawal by Subject|5|||
105928728|NCT00424008|365396691|FG001|Overall Study|Withdrawal by Subject|8|||
105928729|NCT00424008|365396690|FG000|Overall Study|Noncompliance with protocol|13|||
105928730|NCT00424008|365396691|FG001|Overall Study|Noncompliance with protocol|7|||
105710965|NCT00848354|364601469|FG001|Phase 2 Year 1|Failed to Return|1|||
105710966|NCT00848354|364601468|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
105710967|NCT00848354|364601469|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
105710968|NCT00848354|364601468|FG000|Phase 2 Year 1|Unspecified Reason|3|||
105710969|NCT00848354|364601469|FG001|Phase 2 Year 1|Unspecified Reason|0|||
105710970|NCT00848354|364601468|FG000|Phase 2 Year 1|Protocol Violation|4|||
105710971|NCT00848354|364601469|FG001|Phase 2 Year 1|Protocol Violation|1|||
105710972|NCT00848354|364601468|FG000|Phase 2 Year 1|Subject Request|1|||
105710973|NCT00848354|364601469|FG001|Phase 2 Year 1|Subject Request|2|||
106007830|NCT03518086|365693593|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
105710974|NCT00848354|364601468|FG000|Phase 2 Year 2|Adverse Event|12|||
106007831|NCT03518086|365693590|FG000|Overall Study|Site Terminated by Sponsor|0|||
106007832|NCT03518086|365693591|FG001|Overall Study|Site Terminated by Sponsor|1|||
106007833|NCT03518086|365693592|FG002|Overall Study|Site Terminated by Sponsor|0|||
106007834|NCT03518086|365693593|FG003|Overall Study|Site Terminated by Sponsor|0|||
106007835|NCT03518086|365693590|FG000|Overall Study|Pregnancy|0|||
106007836|NCT03518086|365693591|FG001|Overall Study|Pregnancy|0|||
106007837|NCT03518086|365693592|FG002|Overall Study|Pregnancy|0|||
106007838|NCT03518086|365693593|FG003|Overall Study|Pregnancy|2|||
106007839|NCT05967260|365693594|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
106007840|NCT05967260|365693595|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
106007841|NCT02336282|365693596|FG000|Overall Study|Unrelated illness|1|||
106007842|NCT02336282|365693596|FG000|Overall Study|Uncomfortable with technology|1|||
106007843|NCT02336282|365693596|FG000|Overall Study|Lost to Follow-up|1|||
106007844|NCT02336282|365693596|FG000|Overall Study|Not enough time to complete sessions|2|||
106007845|NCT04875975|365693597|FG000|Overall Study|Adverse Event|1|||
106007846|NCT04875975|365693598|FG001|Overall Study|Adverse Event|2|||
106007847|NCT04875975|365693597|FG000|Overall Study|Lack of Efficacy|2|||
106007848|NCT04875975|365693598|FG001|Overall Study|Lack of Efficacy|2|||
106007849|NCT04875975|365693597|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
106007850|NCT04875975|365693598|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
106007851|NCT04875975|365693597|FG000|Overall Study|Relapse With Insults|0|||
106007852|NCT04875975|365693598|FG001|Overall Study|Relapse With Insults|1|||
106007853|NCT04875975|365693597|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
106007854|NCT04875975|365693598|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
106007855|NCT00781768|365695128|FG000|Overall Study|Not transplanted.|0|||
106007856|NCT00781768|365695129|FG001|Overall Study|Not transplanted.|2|||
106007857|NCT02458313|365695130|FG000|Overall Study|Withdrawal by Subject|6|||
106007858|NCT02458313|365695131|FG001|Overall Study|Withdrawal by Subject|8|||
106007859|NCT02458313|365695130|FG000|Overall Study|Excluded for motion during MRI|1|||
106007860|NCT02458313|365695131|FG001|Overall Study|Excluded for motion during MRI|2|||
106007861|NCT00904969|365695132|FG000|Overall Study|Lost to Follow-up|4|||
106007862|NCT00904969|365695132|FG000|Overall Study|Withdrawal by Subject|3|||
106007863|NCT00904969|365695132|FG000|Overall Study|Additional Treatments|11|||
106007864|NCT00904969|365695132|FG000|Overall Study|Case Aborted; Subject Exited|1|||
106007865|NCT01097668|365695133|FG000|Overall Study|Withdrawal by Subject|1|||
106007866|NCT01097668|365695134|FG001|Overall Study|Withdrawal by Subject|2|||
106007867|NCT01097668|365695133|FG000|Overall Study|Lost to Follow-up|1|||
106007868|NCT01097668|365695134|FG001|Overall Study|Lost to Follow-up|0|||
106007869|NCT03037385|365695135|FG000|Overall Study|Adverse Event|0|||
106007870|NCT03037385|365695136|FG001|Overall Study|Adverse Event|0|||
106007871|NCT03037385|365695137|FG002|Overall Study|Adverse Event|1|||
106007872|NCT03037385|365695138|FG003|Overall Study|Adverse Event|0|||
106007873|NCT03037385|365695139|FG004|Overall Study|Adverse Event|0|||
106007874|NCT03037385|365695140|FG005|Overall Study|Adverse Event|0|||
106007875|NCT03037385|365695141|FG006|Overall Study|Adverse Event|0|||
106007876|NCT03037385|365695142|FG007|Overall Study|Adverse Event|0|||
106007877|NCT03037385|365695143|FG008|Overall Study|Adverse Event|0|||
106007878|NCT03037385|365695144|FG009|Overall Study|Adverse Event|6|||
106007879|NCT03037385|365695135|FG000|Overall Study|Death|1|||
106007880|NCT03037385|365695136|FG001|Overall Study|Death|4|||
106007881|NCT03037385|365695137|FG002|Overall Study|Death|2|||
106007882|NCT03037385|365695138|FG003|Overall Study|Death|2|||
106007883|NCT03037385|365695139|FG004|Overall Study|Death|5|||
106007884|NCT03037385|365695140|FG005|Overall Study|Death|2|||
105710975|NCT00848354|364601469|FG001|Phase 2 Year 2|Adverse Event|2|||
106007885|NCT03037385|365695141|FG006|Overall Study|Death|1|||
106007886|NCT03037385|365695142|FG007|Overall Study|Death|4|||
106007887|NCT03037385|365695143|FG008|Overall Study|Death|3|||
105788112|NCT03426995|364878224|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
106007888|NCT03037385|365695144|FG009|Overall Study|Death|240|||
106007889|NCT03037385|365695135|FG000|Overall Study|Initiation of Another Therapy|1|||
106007890|NCT03037385|365695136|FG001|Overall Study|Initiation of Another Therapy|0|||
106007891|NCT03037385|365695137|FG002|Overall Study|Initiation of Another Therapy|0|||
105710976|NCT00848354|364601468|FG000|Phase 2 Year 2|Death|2|||
105710977|NCT00848354|364601469|FG001|Phase 2 Year 2|Death|0|||
105928731|NCT00424008|365396690|FG000|Overall Study|Did not meet protocol eligibility|16|||
105928732|NCT00424008|365396691|FG001|Overall Study|Did not meet protocol eligibility|21|||
105928733|NCT00424008|365396690|FG000|Overall Study|Administrative|266|||
105928734|NCT00424008|365396691|FG001|Overall Study|Administrative|257|||
105928735|NCT01928771|365396693|FG000|Overall Study|Adverse Event|6|||
105928736|NCT01928771|365396694|FG001|Overall Study|Adverse Event|5|||
105928737|NCT01928771|365396695|FG002|Overall Study|Adverse Event|1|||
105928738|NCT01928771|365396693|FG000|Overall Study|Death|2|||
105710978|NCT00848354|364601468|FG000|Phase 2 Year 2|Failed to return|3|||
105710979|NCT00848354|364601469|FG001|Phase 2 Year 2|Failed to return|0|||
105710980|NCT00848354|364601468|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
105710981|NCT00848354|364601469|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
105710982|NCT00848354|364601468|FG000|Phase 2 Year 2|Unspecified Reason|1|||
105710983|NCT00848354|364601469|FG001|Phase 2 Year 2|Unspecified Reason|0|||
105710984|NCT00848354|364601468|FG000|Phase 2 Year 2|Protocol Violation|1|||
105710985|NCT00848354|364601469|FG001|Phase 2 Year 2|Protocol Violation|1|||
105710986|NCT00848354|364601468|FG000|Phase 2 Year 2|Subject Request|1|||
105710987|NCT00848354|364601469|FG001|Phase 2 Year 2|Subject Request|1|||
105710988|NCT00848354|364601468|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
105710989|NCT00848354|364601469|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
105710990|NCT01972074|364601470|FG000|Overall Study|Adverse Event|4|||
105710991|NCT01972074|364601471|FG001|Overall Study|Adverse Event|1|||
105710992|NCT01972074|364601472|FG002|Overall Study|Adverse Event|0|||
105710993|NCT01972074|364601470|FG000|Overall Study|Lack of Efficacy|1|||
105710994|NCT01972074|364601471|FG001|Overall Study|Lack of Efficacy|1|||
105710995|NCT01972074|364601472|FG002|Overall Study|Lack of Efficacy|0|||
105928739|NCT01928771|365396694|FG001|Overall Study|Death|2|||
105928740|NCT01928771|365396695|FG002|Overall Study|Death|2|||
105928741|NCT01928771|365396693|FG000|Overall Study|Lost to Follow-up|5|||
105928742|NCT01928771|365396694|FG001|Overall Study|Lost to Follow-up|6|||
105928743|NCT01928771|365396695|FG002|Overall Study|Lost to Follow-up|3|||
105928744|NCT01928771|365396693|FG000|Overall Study|Withdrawal by Subject|20|||
105928745|NCT01928771|365396694|FG001|Overall Study|Withdrawal by Subject|15|||
105928746|NCT01928771|365396695|FG002|Overall Study|Withdrawal by Subject|17|||
105928747|NCT01928771|365396693|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
105928748|NCT01928771|365396694|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
105928749|NCT01928771|365396695|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
105928750|NCT01928771|365396693|FG000|Overall Study|Other Reasons|9|||
105928751|NCT01928771|365396694|FG001|Overall Study|Other Reasons|9|||
105928752|NCT01928771|365396695|FG002|Overall Study|Other Reasons|14|||
105928753|NCT01928771|365396693|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
105928754|NCT01928771|365396694|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
105928755|NCT01928771|365396695|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
105928756|NCT00134719|365397958|FG000|Primary Vaccination Phase|Adverse Event|4|||
105928757|NCT00134719|365397959|FG001|Primary Vaccination Phase|Adverse Event|0|||
105928758|NCT00134719|365397960|FG002|Primary Vaccination Phase|Adverse Event|0|||
105928759|NCT00134719|365397958|FG000|Primary Vaccination Phase|Protocol Violation|1|||
105928760|NCT00134719|365397959|FG001|Primary Vaccination Phase|Protocol Violation|0|||
105928761|NCT00134719|365397960|FG002|Primary Vaccination Phase|Protocol Violation|0|||
105928762|NCT00134719|365397958|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
105928763|NCT00134719|365397959|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
105928764|NCT00134719|365397960|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
105928765|NCT00134719|365397958|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
105928766|NCT00134719|365397959|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
105928767|NCT00134719|365397960|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
105928768|NCT00134719|365397958|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
105928769|NCT00134719|365397959|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
105928770|NCT00134719|365397960|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
105928771|NCT00134719|365397958|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
105928772|NCT00134719|365397959|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
105928773|NCT00134719|365397960|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
105928774|NCT00639379|365397963|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
105928775|NCT00639379|365397964|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
105928776|NCT00639379|365397963|FG000|Period 1 - 2 Weeks|lens issue|3|||
105928777|NCT00639379|365397964|FG001|Period 1 - 2 Weeks|lens issue|0|||
105928778|NCT00845182|365397965|FG000|Overall Study|Lost to Follow-up|3|||
105928779|NCT00845182|365397966|FG001|Overall Study|Lost to Follow-up|3|||
105928780|NCT00845182|365397967|FG002|Overall Study|Lost to Follow-up|4|||
105928781|NCT00845182|365397965|FG000|Overall Study|Adverse Event|0|||
105928782|NCT00845182|365397966|FG001|Overall Study|Adverse Event|1|||
105928783|NCT00845182|365397967|FG002|Overall Study|Adverse Event|1|||
105928784|NCT00845182|365397965|FG000|Overall Study|Physician Decision|0|||
105806511|NCT03038113|364949005|FG005|Overall Study|Withdrawal by Subject|0|||
105928785|NCT00845182|365397966|FG001|Overall Study|Physician Decision|0|||
105928786|NCT00845182|365397967|FG002|Overall Study|Physician Decision|1|||
105710996|NCT01972074|364601470|FG000|Overall Study|Lost to Follow-up|0|||
105710997|NCT01972074|364601471|FG001|Overall Study|Lost to Follow-up|1|||
105710998|NCT01972074|364601472|FG002|Overall Study|Lost to Follow-up|1|||
105710999|NCT01972074|364601470|FG000|Overall Study|Withdrawal by Subject|1|||
105928787|NCT01297244|365397968|FG000|Overall Study|Progressive disease|22|||
105928788|NCT01297244|365397969|FG001|Overall Study|Progressive disease|3|||
105928789|NCT01297244|365397968|FG000|Overall Study|Adverse Event|9|||
105928790|NCT01297244|365397969|FG001|Overall Study|Adverse Event|1|||
105928791|NCT01297244|365397968|FG000|Overall Study|Death|1|||
105928792|NCT01297244|365397969|FG001|Overall Study|Death|1|||
105928793|NCT01297244|365397968|FG000|Overall Study|Clinical progression|1|||
105928794|NCT01297244|365397969|FG001|Overall Study|Clinical progression|1|||
105928795|NCT01297244|365397968|FG000|Overall Study|Withdrawal by Subject|2|||
105928796|NCT01297244|365397969|FG001|Overall Study|Withdrawal by Subject|0|||
105928797|NCT00549328|365397970|FG000|Overall Study|Adverse Event|2|||
105928798|NCT00549328|365397970|FG000|Overall Study|Disease Progression|10|||
105928799|NCT00549328|365397970|FG000|Overall Study|Death|1|||
105928800|NCT00549328|365397970|FG000|Overall Study|Use of Prohibited Medication|1|||
105928801|NCT05161936|365397971|FG000|Overall Study|Study terminated by Sponsor|1|||
105928802|NCT05161936|365397972|FG001|Overall Study|Study terminated by Sponsor|0|||
105928803|NCT05161936|365397973|FG002|Overall Study|Study terminated by Sponsor|0|||
106007892|NCT03037385|365695138|FG003|Overall Study|Initiation of Another Therapy|0|||
106007893|NCT03037385|365695139|FG004|Overall Study|Initiation of Another Therapy|0|||
106007894|NCT03037385|365695140|FG005|Overall Study|Initiation of Another Therapy|0|||
106007895|NCT03037385|365695141|FG006|Overall Study|Initiation of Another Therapy|0|||
106007896|NCT03037385|365695142|FG007|Overall Study|Initiation of Another Therapy|1|||
106007897|NCT03037385|365695143|FG008|Overall Study|Initiation of Another Therapy|0|||
106007898|NCT03037385|365695144|FG009|Overall Study|Initiation of Another Therapy|2|||
106007899|NCT03037385|365695135|FG000|Overall Study|Lost to Follow-up|0|||
106007900|NCT03037385|365695136|FG001|Overall Study|Lost to Follow-up|0|||
106007901|NCT03037385|365695137|FG002|Overall Study|Lost to Follow-up|0|||
106007902|NCT03037385|365695138|FG003|Overall Study|Lost to Follow-up|0|||
106007903|NCT03037385|365695139|FG004|Overall Study|Lost to Follow-up|0|||
106007904|NCT03037385|365695140|FG005|Overall Study|Lost to Follow-up|1|||
106007905|NCT03037385|365695141|FG006|Overall Study|Lost to Follow-up|0|||
106007906|NCT03037385|365695142|FG007|Overall Study|Lost to Follow-up|0|||
106007907|NCT03037385|365695143|FG008|Overall Study|Lost to Follow-up|0|||
106007908|NCT03037385|365695144|FG009|Overall Study|Lost to Follow-up|16|||
106134390|NCT03499600|366150435|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
106134391|NCT03499600|366150436|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
106134392|NCT01729871|366150437|FG000|Overall Study|Adverse Event|7|||
106134393|NCT01729871|366150438|FG001|Overall Study|Adverse Event|7|||
106134394|NCT01729871|366150437|FG000|Overall Study|Death|0|||
106134395|NCT01729871|366150438|FG001|Overall Study|Death|1|||
106134396|NCT01729871|366150437|FG000|Overall Study|Lack of Efficacy|0|||
106134397|NCT01729871|366150438|FG001|Overall Study|Lack of Efficacy|1|||
106134398|NCT01729871|366150437|FG000|Overall Study|Physician Decision|0|||
106134399|NCT01729871|366150438|FG001|Overall Study|Physician Decision|2|||
106134400|NCT01729871|366150437|FG000|Overall Study|Protocol Violation|1|||
106134401|NCT01729871|366150438|FG001|Overall Study|Protocol Violation|0|||
106134402|NCT01729871|366150437|FG000|Overall Study|Withdrawal by Subject|0|||
106134403|NCT01729871|366150438|FG001|Overall Study|Withdrawal by Subject|3|||
106134404|NCT01729871|366150437|FG000|Overall Study|Other|4|||
106134405|NCT01729871|366150438|FG001|Overall Study|Other|9|||
106134406|NCT00630864|366150441|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
106134407|NCT00630864|366150441|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
106134408|NCT00430677|366150444|FG000|Short-term Period|Death|1|||
106134409|NCT00430677|366150445|FG001|Short-term Period|Death|1|||
106134410|NCT00430677|366150446|FG002|Short-term Period|Death|5|||
106134411|NCT00430677|366150444|FG000|Short-term Period|Adverse Event|15|||
106134412|NCT00430677|366150445|FG001|Short-term Period|Adverse Event|13|||
106134413|NCT00430677|366150446|FG002|Short-term Period|Adverse Event|9|||
106134414|NCT00430677|366150444|FG000|Short-term Period|Lack of Efficacy|5|||
106134415|NCT00430677|366150445|FG001|Short-term Period|Lack of Efficacy|6|||
106134416|NCT00430677|366150446|FG002|Short-term Period|Lack of Efficacy|4|||
106134417|NCT00430677|366150444|FG000|Short-term Period|Withdrawal by Subject|1|||
106134418|NCT00430677|366150445|FG001|Short-term Period|Withdrawal by Subject|1|||
106134419|NCT00430677|366150446|FG002|Short-term Period|Withdrawal by Subject|2|||
106134420|NCT00430677|366150444|FG000|Short-term Period|Participant no longer met study criteria|1|||
106134421|NCT00430677|366150445|FG001|Short-term Period|Participant no longer met study criteria|1|||
106134422|NCT00430677|366150446|FG002|Short-term Period|Participant no longer met study criteria|2|||
106134423|NCT00430677|366150444|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
106134424|NCT00430677|366150445|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
106134425|NCT00430677|366150446|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
106134426|NCT00430677|366150444|FG000|Short-term Period|Pregnancy|0|||
106134427|NCT00430677|366150445|FG001|Short-term Period|Pregnancy|2|||
106134428|NCT00430677|366150446|FG002|Short-term Period|Pregnancy|0|||
106134429|NCT00430677|366150444|FG000|Long-term Extension Period|Death|1|||
106134430|NCT00430677|366150445|FG001|Long-term Extension Period|Death|0|||
106134431|NCT00430677|366150446|FG002|Long-term Extension Period|Death|0|||
106134432|NCT00430677|366150444|FG000|Long-term Extension Period|Adverse Event|3|||
106134433|NCT00430677|366150445|FG001|Long-term Extension Period|Adverse Event|2|||
106134434|NCT00430677|366150446|FG002|Long-term Extension Period|Adverse Event|5|||
106134435|NCT00430677|366150444|FG000|Long-term Extension Period|Lack of Efficacy|5|||
106134436|NCT00430677|366150445|FG001|Long-term Extension Period|Lack of Efficacy|3|||
106134437|NCT00430677|366150446|FG002|Long-term Extension Period|Lack of Efficacy|8|||
106134438|NCT00430677|366150444|FG000|Long-term Extension Period|Lost to Follow-up|1|||
106134439|NCT00430677|366150445|FG001|Long-term Extension Period|Lost to Follow-up|1|||
106134440|NCT00430677|366150446|FG002|Long-term Extension Period|Lost to Follow-up|1|||
106134441|NCT00430677|366150444|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
106134442|NCT00430677|366150445|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
106134443|NCT00430677|366150446|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
106134444|NCT00430677|366150444|FG000|Long-term Extension Period|Pregnancy|1|||
106134445|NCT00430677|366150445|FG001|Long-term Extension Period|Pregnancy|1|||
106134446|NCT00430677|366150446|FG002|Long-term Extension Period|Pregnancy|0|||
106007909|NCT03037385|365695135|FG000|Overall Study|Physician Decision|0|||
106007910|NCT03037385|365695136|FG001|Overall Study|Physician Decision|0|||
106007911|NCT03037385|365695137|FG002|Overall Study|Physician Decision|0|||
106007912|NCT03037385|365695138|FG003|Overall Study|Physician Decision|0|||
106007913|NCT03037385|365695139|FG004|Overall Study|Physician Decision|0|||
106007914|NCT03037385|365695140|FG005|Overall Study|Physician Decision|0|||
106007915|NCT03037385|365695141|FG006|Overall Study|Physician Decision|0|||
106007916|NCT03037385|365695142|FG007|Overall Study|Physician Decision|0|||
106007917|NCT03037385|365695143|FG008|Overall Study|Physician Decision|0|||
106007918|NCT03037385|365695144|FG009|Overall Study|Physician Decision|1|||
106007919|NCT03037385|365695135|FG000|Overall Study|Progressive Disease|0|||
106007920|NCT03037385|365695136|FG001|Overall Study|Progressive Disease|1|||
106007921|NCT03037385|365695137|FG002|Overall Study|Progressive Disease|1|||
106007922|NCT03037385|365695138|FG003|Overall Study|Progressive Disease|5|||
106007923|NCT03037385|365695139|FG004|Overall Study|Progressive Disease|2|||
106007924|NCT03037385|365695140|FG005|Overall Study|Progressive Disease|0|||
106007925|NCT03037385|365695141|FG006|Overall Study|Progressive Disease|1|||
106007926|NCT03037385|365695142|FG007|Overall Study|Progressive Disease|0|||
106007927|NCT03037385|365695143|FG008|Overall Study|Progressive Disease|0|||
106007928|NCT03037385|365695144|FG009|Overall Study|Progressive Disease|30|||
106007929|NCT03037385|365695135|FG000|Overall Study|Withdrawal by Subject|0|||
106007930|NCT03037385|365695136|FG001|Overall Study|Withdrawal by Subject|0|||
106007931|NCT03037385|365695137|FG002|Overall Study|Withdrawal by Subject|1|||
106007932|NCT03037385|365695138|FG003|Overall Study|Withdrawal by Subject|2|||
106007933|NCT03037385|365695139|FG004|Overall Study|Withdrawal by Subject|1|||
106007934|NCT03037385|365695140|FG005|Overall Study|Withdrawal by Subject|3|||
106007935|NCT03037385|365695141|FG006|Overall Study|Withdrawal by Subject|0|||
106007936|NCT03037385|365695142|FG007|Overall Study|Withdrawal by Subject|0|||
106007937|NCT03037385|365695143|FG008|Overall Study|Withdrawal by Subject|0|||
106007938|NCT03037385|365695144|FG009|Overall Study|Withdrawal by Subject|52|||
106007939|NCT03037385|365695135|FG000|Overall Study|Reason Not Specified|0|||
106007940|NCT03037385|365695136|FG001|Overall Study|Reason Not Specified|1|||
106007941|NCT03037385|365695137|FG002|Overall Study|Reason Not Specified|0|||
106007942|NCT03037385|365695138|FG003|Overall Study|Reason Not Specified|4|||
106007943|NCT03037385|365695139|FG004|Overall Study|Reason Not Specified|3|||
106007944|NCT03037385|365695140|FG005|Overall Study|Reason Not Specified|6|||
106007945|NCT03037385|365695141|FG006|Overall Study|Reason Not Specified|2|||
106007946|NCT03037385|365695142|FG007|Overall Study|Reason Not Specified|0|||
106007947|NCT03037385|365695143|FG008|Overall Study|Reason Not Specified|1|||
106007948|NCT03037385|365695144|FG009|Overall Study|Reason Not Specified|181|||
106007949|NCT01702311|365695145|FG000|Overall Study|Withdrawal by Subject|3|||
106007950|NCT01702311|365695146|FG001|Overall Study|Withdrawal by Subject|2|||
106007951|NCT01702311|365695145|FG000|Overall Study|Discharge less than 24 hours|10|||
106007952|NCT01702311|365695146|FG001|Overall Study|Discharge less than 24 hours|7|||
106007953|NCT01702311|365695145|FG000|Overall Study|Physician Decision|3|||
106007954|NCT01702311|365695146|FG001|Overall Study|Physician Decision|4|||
106007955|NCT01473134|365695157|FG000|Overall Study|Lost to Follow-up|21|||
106007956|NCT01473134|365695158|FG001|Overall Study|Lost to Follow-up|13|||
106007957|NCT01473134|365695157|FG000|Overall Study|Protocol Violation|32|||
106007958|NCT01473134|365695158|FG001|Overall Study|Protocol Violation|19|||
106007959|NCT01473134|365695157|FG000|Overall Study|Withdrawal by Subject|1|||
106007960|NCT01473134|365695158|FG001|Overall Study|Withdrawal by Subject|2|||
106007961|NCT01473134|365695157|FG000|Overall Study|Death|0|||
106007962|NCT01473134|365695158|FG001|Overall Study|Death|1|||
106007963|NCT01473134|365695157|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
106007964|NCT01473134|365695158|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
106007965|NCT05176314|365695160|FG000|Overall Study|Lost to Follow-up|2|||
106007966|NCT05176314|365695160|FG000|Overall Study|Physician Decision|1|||
106007967|NCT05176314|365695160|FG000|Overall Study|Adverse Event|1|||
106007968|NCT00807911|365695161|FG000|Overall Study|Withdrawal by Subject|12|||
106007969|NCT00807911|365695162|FG001|Overall Study|Withdrawal by Subject|10|||
106007970|NCT00807911|365695161|FG000|Overall Study|Ineligible|0|||
106007971|NCT00807911|365695162|FG001|Overall Study|Ineligible|4|||
106007972|NCT03041038|365695163|FG000|Overall Study|Withdrawal by Subject|4|||
106007973|NCT03041038|365695164|FG001|Overall Study|Withdrawal by Subject|0|||
106007974|NCT03041038|365695163|FG000|Overall Study|Lost to Follow-up|1|||
106007975|NCT03041038|365695164|FG001|Overall Study|Lost to Follow-up|1|||
106007976|NCT03041038|365695163|FG000|Overall Study|Protocol Violation|1|||
106007977|NCT03041038|365695164|FG001|Overall Study|Protocol Violation|1|||
105788113|NCT03426995|364878225|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
106007978|NCT02388269|365695165|FG000|Overall Study|Adverse Event|2|||
106007979|NCT02388269|365695166|FG001|Overall Study|Adverse Event|0|||
106007980|NCT02388269|365695167|FG002|Overall Study|Adverse Event|0|||
106007981|NCT02388269|365695165|FG000|Overall Study|Withdrawal by Subject|1|||
106007982|NCT02388269|365695166|FG001|Overall Study|Withdrawal by Subject|2|||
106007983|NCT02388269|365695167|FG002|Overall Study|Withdrawal by Subject|0|||
106007984|NCT02388269|365695165|FG000|Overall Study|less than 50% stimulations|1|||
106134447|NCT00430677|366150444|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
106134448|NCT00430677|366150445|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
106134449|NCT00430677|366150446|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
106134450|NCT00430677|366150444|FG000|Long-term Extension Period|Other|2|||
106134451|NCT00430677|366150445|FG001|Long-term Extension Period|Other|1|||
106134452|NCT00430677|366150446|FG002|Long-term Extension Period|Other|1|||
106134453|NCT00430677|366150444|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
106134454|NCT00430677|366150445|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
106134455|NCT00430677|366150446|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
106134456|NCT03722446|366150447|FG000|Overall Study|Protocol Violation|15|||
106134457|NCT03722446|366150448|FG001|Overall Study|Protocol Violation|2|||
106134458|NCT01555762|366150449|FG000|Overall Study|No information on Bevacizumab intake|11|||
106134459|NCT01555762|366150449|FG000|Overall Study|Missing start date of infusion|8|||
106134460|NCT01555762|366150449|FG000|Overall Study|75 years old or more ticked No|1|||
106134461|NCT01555762|366150449|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
106134462|NCT01555762|366150449|FG000|Overall Study|Death linked to progression of disease|165|||
106134463|NCT01555762|366150449|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
106134464|NCT01555762|366150449|FG000|Overall Study|Investigator's decision|10|||
106134465|NCT01555762|366150449|FG000|Overall Study|Participant not wishing to continue|5|||
106134466|NCT01555762|366150449|FG000|Overall Study|Missing data|1|||
105928804|NCT05161936|365397971|FG000|Overall Study|Withdrawal by Subject|0|||
105928805|NCT05161936|365397972|FG001|Overall Study|Withdrawal by Subject|0|||
105928806|NCT05161936|365397973|FG002|Overall Study|Withdrawal by Subject|1|||
105928807|NCT05762679|365397978|FG000|Overall Study|Withdrawal by Subject|1|||
105928808|NCT05762679|365397978|FG000|Overall Study|No analyzable imaging data|1|||
105928809|NCT01716156|365397982|FG000|Overall Study|Protocol Violation|1|||
105928810|NCT01716156|365397983|FG001|Overall Study|Protocol Violation|0|||
105928811|NCT01716156|365397984|FG002|Overall Study|Protocol Violation|0|||
105928812|NCT01716156|365397982|FG000|Overall Study|Withdrawal by Subject|0|||
105928813|NCT01716156|365397983|FG001|Overall Study|Withdrawal by Subject|1|||
105928814|NCT01716156|365397984|FG002|Overall Study|Withdrawal by Subject|2|||
105928815|NCT01716156|365397982|FG000|Overall Study|Lost to Follow-up|1|||
105928816|NCT01716156|365397983|FG001|Overall Study|Lost to Follow-up|0|||
105928817|NCT01716156|365397984|FG002|Overall Study|Lost to Follow-up|0|||
105928818|NCT03925220|365397987|FG000|Overall Study|Withdrawal by Subject|4|||
105928819|NCT03925220|365397988|FG001|Overall Study|Withdrawal by Subject|4|||
105928820|NCT03925220|365397989|FG002|Overall Study|Withdrawal by Subject|4|||
105928821|NCT03925220|365397990|FG003|Overall Study|Withdrawal by Subject|4|||
105928822|NCT03925220|365397987|FG000|Overall Study|Lost to Follow-up|40|||
105928823|NCT03925220|365397988|FG001|Overall Study|Lost to Follow-up|46|||
105928824|NCT03925220|365397989|FG002|Overall Study|Lost to Follow-up|37|||
105928825|NCT03925220|365397990|FG003|Overall Study|Lost to Follow-up|38|||
105928826|NCT01944774|365397991|FG000|Overall Study|Withdrawal by Subject|2|||
105928827|NCT01944774|365397992|FG001|Overall Study|Withdrawal by Subject|3|||
105928828|NCT01944774|365397993|FG002|Overall Study|Withdrawal by Subject|3|||
105928829|NCT01944774|365397991|FG000|Overall Study|Adverse Event|3|||
105928830|NCT01944774|365397992|FG001|Overall Study|Adverse Event|2|||
105928831|NCT01944774|365397993|FG002|Overall Study|Adverse Event|3|||
105928832|NCT01944774|365397991|FG000|Overall Study|Lack of Efficacy|1|||
105928833|NCT01944774|365397992|FG001|Overall Study|Lack of Efficacy|2|||
105928834|NCT01944774|365397993|FG002|Overall Study|Lack of Efficacy|2|||
105928835|NCT01944774|365397991|FG000|Overall Study|Lost to Follow-up|0|||
105928836|NCT01944774|365397992|FG001|Overall Study|Lost to Follow-up|1|||
105928837|NCT01944774|365397993|FG002|Overall Study|Lost to Follow-up|0|||
105928838|NCT02112552|365397994|FG000|Overall Study|Withdrawal by Subject|1|||
105928839|NCT02112552|365397994|FG000|Overall Study|Adverse Event|1|||
105928840|NCT00774748|365397995|FG000|Overall Study|Lost to Follow-up|3|||
105928841|NCT02503865|365397996|FG000|Overall Study|Moved out of area|1|||
105928842|NCT02503865|365397997|FG001|Overall Study|Moved out of area|8|||
105928843|NCT02503865|365397998|FG002|Overall Study|Moved out of area|0|||
105928844|NCT02503865|365397996|FG000|Overall Study|Refused treatment|4|||
105928845|NCT02503865|365397997|FG001|Overall Study|Refused treatment|39|||
105928846|NCT02503865|365397998|FG002|Overall Study|Refused treatment|2|||
105928847|NCT01529268|365397999|FG000|Overall Study|Lost to Follow-up|9|||
105928848|NCT01529268|365398000|FG001|Overall Study|Lost to Follow-up|3|||
105928849|NCT01529268|365397999|FG000|Overall Study|Moved|3|||
105928850|NCT01529268|365398000|FG001|Overall Study|Moved|0|||
105928851|NCT00303953|365398001|FG000|Overall Study|Ineligible|1|||
105928852|NCT00303953|365398001|FG000|Overall Study|Death|1|||
106134467|NCT01555762|366150449|FG000|Overall Study|Death linked to an adverse event|14|||
106134468|NCT02068885|366150450|FG000|Overall Study|Withdrew|3|||
105928853|NCT00303953|365398001|FG000|Overall Study|Adverse Event|4|||
105928854|NCT00303953|365398001|FG000|Overall Study|Lack of Efficacy|12|||
105928855|NCT00303953|365398001|FG000|Overall Study|Physician Decision|1|||
105928856|NCT02337946|365398002|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
105928857|NCT02337946|365398003|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
105928858|NCT02337946|365398004|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
106007985|NCT02388269|365695166|FG001|Overall Study|less than 50% stimulations|0|||
106007986|NCT02388269|365695167|FG002|Overall Study|less than 50% stimulations|0|||
106007987|NCT02388269|365695165|FG000|Overall Study|no diary data|3|||
106007988|NCT02388269|365695166|FG001|Overall Study|no diary data|0|||
106007989|NCT02388269|365695167|FG002|Overall Study|no diary data|0|||
106007990|NCT02388269|365695165|FG000|Overall Study|Protocol Violation|2|||
106007991|NCT02388269|365695166|FG001|Overall Study|Protocol Violation|0|||
106007992|NCT02388269|365695167|FG002|Overall Study|Protocol Violation|0|||
106007993|NCT02388269|365695165|FG000|Overall Study|Screen Failure|0|||
106007994|NCT02388269|365695166|FG001|Overall Study|Screen Failure|0|||
106007995|NCT02388269|365695167|FG002|Overall Study|Screen Failure|10|||
106007996|NCT01553084|365695169|FG000|Overall Study|Withdrawal by Subject|15|||
106007997|NCT01553084|365695170|FG001|Overall Study|Withdrawal by Subject|13|||
106007998|NCT01553084|365695171|FG002|Overall Study|Withdrawal by Subject|35|||
106007999|NCT03962491|365695172|FG000|Overall Study|Lost to Follow-up|4|||
106008000|NCT03962491|365695173|FG001|Overall Study|Lost to Follow-up|5|||
106008001|NCT03651765|365695181|FG000|Overall Study|Adverse Event|6|||
106008002|NCT03651765|365695181|FG000|Overall Study|Lack of Efficacy|18|||
106134469|NCT02068885|366150451|FG001|Overall Study|Withdrew|5|||
106134470|NCT02068885|366150452|FG002|Overall Study|Withdrew|8|||
106134471|NCT00828919|366150453|FG000|Overall Study|Death|0|||
106134472|NCT00828919|366150454|FG001|Overall Study|Death|1|||
106134473|NCT00828919|366150455|FG002|Overall Study|Death|2|||
106134474|NCT00828919|366150456|FG003|Overall Study|Death|0|||
106134475|NCT00828919|366150457|FG004|Overall Study|Death|0|||
106134476|NCT00828919|366150453|FG000|Overall Study|Adverse Event|2|||
106134477|NCT00828919|366150454|FG001|Overall Study|Adverse Event|2|||
106134478|NCT00828919|366150455|FG002|Overall Study|Adverse Event|2|||
106134479|NCT00828919|366150456|FG003|Overall Study|Adverse Event|1|||
106134480|NCT00828919|366150457|FG004|Overall Study|Adverse Event|3|||
106134481|NCT00828919|366150453|FG000|Overall Study|Objective progression or relapse|4|||
106134482|NCT00828919|366150454|FG001|Overall Study|Objective progression or relapse|4|||
106134483|NCT00828919|366150455|FG002|Overall Study|Objective progression or relapse|11|||
106134484|NCT00828919|366150456|FG003|Overall Study|Objective progression or relapse|0|||
106134485|NCT00828919|366150457|FG004|Overall Study|Objective progression or relapse|5|||
106134486|NCT00828919|366150453|FG000|Overall Study|No longer willing to participate in study|0|||
106134487|NCT00828919|366150454|FG001|Overall Study|No longer willing to participate in study|0|||
106134488|NCT00828919|366150455|FG002|Overall Study|No longer willing to participate in study|2|||
106134489|NCT00828919|366150456|FG003|Overall Study|No longer willing to participate in study|0|||
106134490|NCT00828919|366150457|FG004|Overall Study|No longer willing to participate in study|0|||
106134491|NCT00828919|366150453|FG000|Overall Study|Insufficient Clinical Response|0|||
106134492|NCT00828919|366150454|FG001|Overall Study|Insufficient Clinical Response|1|||
106134493|NCT00828919|366150455|FG002|Overall Study|Insufficient Clinical Response|2|||
106134494|NCT00828919|366150456|FG003|Overall Study|Insufficient Clinical Response|0|||
106134495|NCT00828919|366150457|FG004|Overall Study|Insufficient Clinical Response|0|||
106134496|NCT00828919|366150453|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
106134497|NCT00828919|366150454|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
106134498|NCT00828919|366150455|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
106134499|NCT00828919|366150456|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
106134500|NCT00828919|366150457|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
106134501|NCT00828919|366150453|FG000|Overall Study|Other|1|||
106134502|NCT00828919|366150454|FG001|Overall Study|Other|0|||
106134503|NCT00828919|366150455|FG002|Overall Study|Other|1|||
106134504|NCT00828919|366150456|FG003|Overall Study|Other|1|||
106134505|NCT00828919|366150457|FG004|Overall Study|Other|0|||
106134506|NCT00828919|366150453|FG000|Overall Study|Lost to Follow-up|0|||
106134507|NCT00828919|366150454|FG001|Overall Study|Lost to Follow-up|1|||
106134508|NCT00828919|366150455|FG002|Overall Study|Lost to Follow-up|0|||
106134509|NCT00828919|366150456|FG003|Overall Study|Lost to Follow-up|0|||
106134510|NCT00828919|366150457|FG004|Overall Study|Lost to Follow-up|0|||
106134511|NCT01562743|366150460|FG000|Overall Study|Adverse Event|29|||
106134512|NCT01562743|366150460|FG000|Overall Study|Lack of Efficacy|3|||
106134513|NCT01562743|366150460|FG000|Overall Study|Withdrawal by Subject|13|||
106134514|NCT01562743|366150460|FG000|Overall Study|Protocol Violation|1|||
106134515|NCT01562743|366150460|FG000|Overall Study|Discontinuation criteria|2|||
106134516|NCT01562743|366150460|FG000|Overall Study|Lost to Follow-up|2|||
106134517|NCT01562743|366150460|FG000|Overall Study|Physician Decision|2|||
106134518|NCT03015740|366150461|FG000|Overall Study|Adverse Event|1|||
106134519|NCT03015740|366150462|FG001|Overall Study|Adverse Event|0|||
106134520|NCT03015740|366150463|FG002|Overall Study|Adverse Event|0|||
106134521|NCT03015740|366150461|FG000|Overall Study|Death|3|||
106134522|NCT03015740|366150462|FG001|Overall Study|Death|5|||
106008003|NCT03651765|365695181|FG000|Overall Study|Lost to Follow-up|5|||
106134523|NCT03015740|366150463|FG002|Overall Study|Death|0|||
106134524|NCT03015740|366150461|FG000|Overall Study|Withdrawal by Subject|2|||
106008004|NCT03651765|365695181|FG000|Overall Study|Non-Compliance with Study Drug|4|||
106008005|NCT03651765|365695181|FG000|Overall Study|Physician Decision|6|||
106008006|NCT03651765|365695181|FG000|Overall Study|Pregnancy|1|||
106008007|NCT03651765|365695181|FG000|Overall Study|Discontinued by Sponsor|40|||
106008008|NCT03651765|365695181|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
106008009|NCT03651765|365695181|FG000|Overall Study|Withdrawal by Subject|24|||
106008010|NCT03651765|365695181|FG000|Overall Study|Miscellaneous|6|||
106008011|NCT04852302|365695197|FG000|Overall Study|Withdrawal by Subject|2|||
106008012|NCT04852302|365695197|FG000|Overall Study|Did not complete CALM therapy.|2|||
106008013|NCT01263769|365695198|FG000|Overall Study|Non-Compliant with treatment|1|||
106008014|NCT03267277|365695199|FG000|Overall Study|Withdrawal by Subject|1|||
106008015|NCT05058365|365695200|FG000|Overall Study|Migration|1|||
106134525|NCT03015740|366150462|FG001|Overall Study|Withdrawal by Subject|0|||
106134526|NCT03015740|366150463|FG002|Overall Study|Withdrawal by Subject|0|||
106134527|NCT01518257|366152419|FG000|Overall Study|Lost to Follow-up|1|||
106134528|NCT01518257|366152420|FG001|Overall Study|Lost to Follow-up|0|||
106134529|NCT01518257|366152419|FG000|Overall Study|Other Miscellaneous Reason|1|||
106134530|NCT01518257|366152420|FG001|Overall Study|Other Miscellaneous Reason|0|||
106134531|NCT02333630|366152426|FG000|Overall Study|Lost to Follow-up|5|||
106134532|NCT02333630|366152427|FG001|Overall Study|Lost to Follow-up|2|||
106134533|NCT01289119|366152428|FG000|Overall Study|Adverse Event|2|||
106134534|NCT01289119|366152429|FG001|Overall Study|Adverse Event|1|||
106134535|NCT01289119|366152430|FG002|Overall Study|Adverse Event|0|||
106134536|NCT01289119|366152431|FG003|Overall Study|Adverse Event|2|||
106134537|NCT01289119|366152432|FG004|Overall Study|Adverse Event|1|||
106134538|NCT01289119|366152433|FG005|Overall Study|Adverse Event|0|||
106134539|NCT01289119|366152428|FG000|Overall Study|Major Protocol Deviation|2|||
106134540|NCT01289119|366152429|FG001|Overall Study|Major Protocol Deviation|1|||
106134541|NCT01289119|366152430|FG002|Overall Study|Major Protocol Deviation|3|||
106134542|NCT01289119|366152431|FG003|Overall Study|Major Protocol Deviation|0|||
106134543|NCT01289119|366152432|FG004|Overall Study|Major Protocol Deviation|2|||
106134544|NCT01289119|366152433|FG005|Overall Study|Major Protocol Deviation|1|||
106134545|NCT01289119|366152428|FG000|Overall Study|Lost to Follow-up|0|||
106134546|NCT01289119|366152429|FG001|Overall Study|Lost to Follow-up|3|||
106134547|NCT01289119|366152430|FG002|Overall Study|Lost to Follow-up|0|||
106134548|NCT01289119|366152431|FG003|Overall Study|Lost to Follow-up|0|||
106134549|NCT01289119|366152432|FG004|Overall Study|Lost to Follow-up|0|||
106134550|NCT01289119|366152433|FG005|Overall Study|Lost to Follow-up|1|||
106134551|NCT01289119|366152428|FG000|Overall Study|Withdrawal by Subject|4|||
106134552|NCT01289119|366152429|FG001|Overall Study|Withdrawal by Subject|2|||
106134553|NCT01289119|366152430|FG002|Overall Study|Withdrawal by Subject|4|||
106134554|NCT01289119|366152431|FG003|Overall Study|Withdrawal by Subject|3|||
106134555|NCT01289119|366152432|FG004|Overall Study|Withdrawal by Subject|1|||
106134556|NCT01289119|366152433|FG005|Overall Study|Withdrawal by Subject|1|||
106134557|NCT01289119|366152428|FG000|Overall Study|Pregnancy|0|||
106134558|NCT01289119|366152429|FG001|Overall Study|Pregnancy|1|||
106134559|NCT01289119|366152430|FG002|Overall Study|Pregnancy|0|||
106134560|NCT01289119|366152431|FG003|Overall Study|Pregnancy|0|||
106134561|NCT01289119|366152432|FG004|Overall Study|Pregnancy|0|||
106134562|NCT01289119|366152433|FG005|Overall Study|Pregnancy|0|||
106134563|NCT01289119|366152428|FG000|Overall Study|Lack of Efficacy|0|||
106134564|NCT01289119|366152429|FG001|Overall Study|Lack of Efficacy|1|||
106134565|NCT01289119|366152430|FG002|Overall Study|Lack of Efficacy|1|||
106134566|NCT01289119|366152431|FG003|Overall Study|Lack of Efficacy|1|||
106134567|NCT01289119|366152432|FG004|Overall Study|Lack of Efficacy|1|||
106134568|NCT01289119|366152433|FG005|Overall Study|Lack of Efficacy|1|||
106134569|NCT01289119|366152428|FG000|Overall Study|Other|1|||
106134570|NCT01289119|366152429|FG001|Overall Study|Other|0|||
106134571|NCT01289119|366152430|FG002|Overall Study|Other|1|||
106134572|NCT01289119|366152431|FG003|Overall Study|Other|0|||
106134573|NCT01289119|366152432|FG004|Overall Study|Other|0|||
106134574|NCT01289119|366152433|FG005|Overall Study|Other|0|||
106134575|NCT03646669|366152434|FG000|Overall Study|Withdrawal by Subject|5|||
106134576|NCT03646669|366152435|FG001|Overall Study|Withdrawal by Subject|0|||
106008016|NCT05058365|365695201|FG001|Overall Study|Migration|1|||
106008017|NCT04849364|365695202|FG000|Overall Study|Eligibility criteria not meet|0|||
106008018|NCT04849364|365695203|FG001|Overall Study|Eligibility criteria not meet|1|||
106008019|NCT04849364|365695204|FG002|Overall Study|Eligibility criteria not meet|0|||
106008020|NCT04298697|365695207|FG000|Overall Study|Lost to Follow-up|5|||
106008021|NCT04298697|365695208|FG001|Overall Study|Lost to Follow-up|5|||
106008022|NCT04298697|365695209|FG002|Overall Study|Lost to Follow-up|1|||
106008023|NCT04298697|365695210|FG003|Overall Study|Lost to Follow-up|0|||
106008024|NCT04298697|365695207|FG000|Overall Study|Withdrawal by Subject|0|||
106008025|NCT04298697|365695208|FG001|Overall Study|Withdrawal by Subject|3|||
106008026|NCT04298697|365695209|FG002|Overall Study|Withdrawal by Subject|2|||
106008027|NCT04298697|365695210|FG003|Overall Study|Withdrawal by Subject|3|||
106008028|NCT00449696|365695211|FG000|Overall Study|Other Treatment Required|6|||
106008029|NCT00449696|365695212|FG001|Overall Study|Other Treatment Required|1|||
106008030|NCT00449696|365695211|FG000|Overall Study|Withdrawal by Subject|5|||
106008031|NCT00449696|365695212|FG001|Overall Study|Withdrawal by Subject|5|||
106008032|NCT00449696|365695211|FG000|Overall Study|Lost to Follow-up|2|||
106008033|NCT00449696|365695212|FG001|Overall Study|Lost to Follow-up|3|||
106008034|NCT00449696|365695211|FG000|Overall Study|Others|7|||
106008035|NCT00449696|365695212|FG001|Overall Study|Others|0|||
106008036|NCT00468169|365695216|FG000|Overall Study|Withdrawal by Subject|1|||
106134577|NCT00672256|366152436|FG000|Overall Study|PI dropped, bad data|44|||
106134578|NCT00058058|366152437|FG000|Overall Study|Withdrawal by Subject|4|||
106134579|NCT00058058|366152437|FG000|Overall Study|Ineligible|20|||
106134580|NCT00058058|366152437|FG000|Overall Study|Claustrophobic|5|||
106134581|NCT00058058|366152437|FG000|Overall Study|technical issues|6|||
106134582|NCT00058058|366152437|FG000|Overall Study|Poor positioning, illness,pain|3|||
106134583|NCT04759131|366152440|FG000|Overall Study|Investigator's discretion|1|||
106134584|NCT04759131|366152441|FG001|Overall Study|Investigator's discretion|0|||
106134585|NCT04759131|366152440|FG000|Overall Study|Subject withdrawal|1|||
106134586|NCT04759131|366152441|FG001|Overall Study|Subject withdrawal|0|||
106134587|NCT01149681|366152442|FG000|Overall Study|Withdrawal by Subject|7|||
106134588|NCT01149681|366152442|FG000|Overall Study|Progressive disease|1|||
106134589|NCT01149681|366152442|FG000|Overall Study|Physician Decision|2|||
106134590|NCT01149681|366152442|FG000|Overall Study|adverse events nonrelated study drug|2|||
106134591|NCT03999554|366152447|FG000|Overall Study|Lost to Follow-up|4|||
106134592|NCT03999554|366152448|FG001|Overall Study|Lost to Follow-up|5|||
106134593|NCT03999554|366152449|FG002|Overall Study|Lost to Follow-up|4|||
106134594|NCT03999554|366152450|FG003|Overall Study|Lost to Follow-up|5|||
106134595|NCT03999554|366152451|FG004|Overall Study|Lost to Follow-up|8|||
106134596|NCT03999554|366152447|FG000|Overall Study|Protocol Violation|0|||
106134597|NCT03999554|366152448|FG001|Overall Study|Protocol Violation|0|||
106134598|NCT03999554|366152449|FG002|Overall Study|Protocol Violation|5|||
106134599|NCT03999554|366152450|FG003|Overall Study|Protocol Violation|0|||
106134600|NCT03999554|366152451|FG004|Overall Study|Protocol Violation|0|||
106134601|NCT03999554|366152447|FG000|Overall Study|Pregnancy|0|||
106134602|NCT03999554|366152448|FG001|Overall Study|Pregnancy|0|||
106134603|NCT03999554|366152449|FG002|Overall Study|Pregnancy|1|||
106134604|NCT03999554|366152450|FG003|Overall Study|Pregnancy|0|||
106134605|NCT03999554|366152451|FG004|Overall Study|Pregnancy|0|||
106134606|NCT03999554|366152447|FG000|Overall Study|Withdrawal by Subject|2|||
106134607|NCT03999554|366152448|FG001|Overall Study|Withdrawal by Subject|2|||
106134608|NCT03999554|366152449|FG002|Overall Study|Withdrawal by Subject|2|||
106134609|NCT03999554|366152450|FG003|Overall Study|Withdrawal by Subject|1|||
106134610|NCT03999554|366152451|FG004|Overall Study|Withdrawal by Subject|1|||
106134611|NCT03999554|366152447|FG000|Overall Study|failure to comply with protocol requirements|0|||
106134612|NCT03999554|366152448|FG001|Overall Study|failure to comply with protocol requirements|0|||
106134613|NCT03999554|366152449|FG002|Overall Study|failure to comply with protocol requirements|0|||
106134614|NCT03999554|366152450|FG003|Overall Study|failure to comply with protocol requirements|1|||
106134615|NCT03999554|366152451|FG004|Overall Study|failure to comply with protocol requirements|0|||
106134616|NCT03006341|366152452|FG000|Overall Study|Not linked in the EMR|25069|||
106134617|NCT03006341|366152453|FG001|Overall Study|Not linked in the EMR|67505|||
106134618|NCT03006341|366152454|FG002|Overall Study|Not linked in the EMR|30993|||
106134619|NCT03006341|366152455|FG003|Overall Study|Not linked in the EMR|10685|||
106134620|NCT00003656|366152456|FG000|Overall Study|Adverse Event|0|||
106134621|NCT00003656|366152457|FG001|Overall Study|Adverse Event|1|||
106134622|NCT03055767|366152458|FG000|Open-Label Period|Lost to Follow-up|0|||
106134623|NCT03055767|366152459|FG001|Open-Label Period|Lost to Follow-up|0|||
106134624|NCT03055767|366152460|FG002|Open-Label Period|Lost to Follow-up|2|||
106134625|NCT03055767|366152461|FG003|Open-Label Period|Lost to Follow-up|0|||
106134626|NCT03055767|366152458|FG000|Open-Label Period|Withdrawal by Subject|0|||
106134627|NCT03055767|366152459|FG001|Open-Label Period|Withdrawal by Subject|0|||
106008037|NCT00468169|365695217|FG001|Overall Study|Withdrawal by Subject|0|||
106008038|NCT01126749|365695222|FG000|Phase 1b|Other|0|||
106008039|NCT01126749|365695223|FG001|Phase 1b|Other|1|||
106008040|NCT01126749|365695224|FG002|Phase 1b|Other|0|||
106134628|NCT03055767|366152460|FG002|Open-Label Period|Withdrawal by Subject|0|||
106008041|NCT01126749|365695225|FG003|Phase 1b|Other|0|||
105928859|NCT02337946|365398002|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
105928860|NCT02337946|365398003|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
105928861|NCT02337946|365398004|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
105928862|NCT02337946|365398002|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
105928863|NCT02337946|365398003|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
105928864|NCT02337946|365398004|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
105928865|NCT02337946|365398002|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
105928866|NCT02337946|365398003|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
105928867|NCT02337946|365398004|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
105928868|NCT02337946|365398002|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
105928869|NCT02337946|365398003|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
105928870|NCT02337946|365398004|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
105928871|NCT02337946|365398002|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
105928872|NCT02337946|365398003|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
105928873|NCT02337946|365398004|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
105928874|NCT02337946|365398002|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
105928875|NCT02337946|365398003|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
105928876|NCT02337946|365398004|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
105928877|NCT02337946|365398002|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
105928878|NCT02337946|365398003|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
105928879|NCT02337946|365398004|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
105928880|NCT02337946|365398002|FG000|In-between Period|Without Informed Consent|1|||
105928881|NCT02337946|365398003|FG001|In-between Period|Without Informed Consent|0|||
105928882|NCT02337946|365398004|FG002|In-between Period|Without Informed Consent|0|||
105928883|NCT02337946|365398002|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
105928884|NCT02337946|365398003|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
105928885|NCT02337946|365398004|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
105928886|NCT02337946|365398002|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
105928887|NCT02337946|365398003|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
105928888|NCT02337946|365398004|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
105928889|NCT02337946|365398002|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
105928890|NCT02337946|365398003|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
105928891|NCT02337946|365398004|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
105928892|NCT02337946|365398002|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
105928893|NCT02337946|365398003|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
105928894|NCT02337946|365398004|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
105928895|NCT02337946|365398002|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
105928896|NCT02337946|365398003|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
105928897|NCT02337946|365398004|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
105928898|NCT02337946|365398002|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
105928899|NCT02337946|365398003|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
105928900|NCT02337946|365398004|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
105928901|NCT01327703|365398005|FG000|Second Treatment Period|Adverse Event|1|||
105928902|NCT01327703|365398006|FG001|Second Treatment Period|Adverse Event|1|||
105928903|NCT01327703|365398005|FG000|Second Treatment Period|Protocol Violation|0|||
105928904|NCT01327703|365398006|FG001|Second Treatment Period|Protocol Violation|1|||
105928905|NCT02068599|365398007|FG000|Overall Study|Adverse Event|4|||
105928906|NCT02068599|365398008|FG001|Overall Study|Adverse Event|1|||
105928907|NCT02068599|365398009|FG002|Overall Study|Adverse Event|1|||
105928908|NCT02068599|365398007|FG000|Overall Study|Withdrawal by Subject|2|||
105928909|NCT02068599|365398008|FG001|Overall Study|Withdrawal by Subject|7|||
105928910|NCT02068599|365398009|FG002|Overall Study|Withdrawal by Subject|5|||
105928911|NCT02068599|365398007|FG000|Overall Study|Protocol Violation|4|||
105928912|NCT02068599|365398008|FG001|Overall Study|Protocol Violation|2|||
105928913|NCT02068599|365398009|FG002|Overall Study|Protocol Violation|3|||
105928914|NCT02068599|365398007|FG000|Overall Study|Lost to Follow-up|1|||
105928915|NCT02068599|365398008|FG001|Overall Study|Lost to Follow-up|0|||
105928916|NCT02068599|365398009|FG002|Overall Study|Lost to Follow-up|0|||
105928917|NCT02068599|365398007|FG000|Overall Study|Lack of Efficacy|0|||
105928918|NCT02068599|365398008|FG001|Overall Study|Lack of Efficacy|0|||
105928919|NCT02068599|365398009|FG002|Overall Study|Lack of Efficacy|3|||
105928920|NCT02068599|365398007|FG000|Overall Study|Noncompliance|0|||
105928921|NCT02068599|365398008|FG001|Overall Study|Noncompliance|0|||
105928922|NCT02068599|365398009|FG002|Overall Study|Noncompliance|1|||
105928923|NCT04822194|365398011|FG000|Overall Study|Withdrawal by Subject|5|||
105928924|NCT04822194|365398012|FG001|Overall Study|Withdrawal by Subject|4|||
105928925|NCT04822194|365398011|FG000|Overall Study|Technical issues with MR scanner|1|||
105928926|NCT04822194|365398012|FG001|Overall Study|Technical issues with MR scanner|0|||
105928927|NCT04822194|365398011|FG000|Overall Study|Lost to Follow-up|5|||
105928928|NCT04822194|365398012|FG001|Overall Study|Lost to Follow-up|7|||
105928929|NCT00118287|365398015|FG000|Overall Study|Intracranial haemorrhage|1|||
106008042|NCT01126749|365695222|FG000|Phase 1b|Withdrawal by Subject|0|||
106008043|NCT01126749|365695223|FG001|Phase 1b|Withdrawal by Subject|1|||
106008044|NCT01126749|365695224|FG002|Phase 1b|Withdrawal by Subject|0|||
106008045|NCT01126749|365695225|FG003|Phase 1b|Withdrawal by Subject|0|||
106008046|NCT01126749|365695222|FG000|Phase 1b|Death|3|||
106008047|NCT01126749|365695223|FG001|Phase 1b|Death|4|||
106008048|NCT01126749|365695224|FG002|Phase 1b|Death|0|||
106008049|NCT01126749|365695225|FG003|Phase 1b|Death|0|||
106008050|NCT01126749|365695222|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
106008051|NCT01126749|365695223|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
106008052|NCT01126749|365695224|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
106008053|NCT01126749|365695225|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
106008054|NCT01126749|365695222|FG000|Phase 2|Study Termination by Sponsor|0|||
106008055|NCT01126749|365695223|FG001|Phase 2|Study Termination by Sponsor|0|||
106008056|NCT01126749|365695224|FG002|Phase 2|Study Termination by Sponsor|12|||
106008057|NCT01126749|365695225|FG003|Phase 2|Study Termination by Sponsor|6|||
106008058|NCT01126749|365695222|FG000|Phase 2|Other|0|||
106008059|NCT01126749|365695223|FG001|Phase 2|Other|0|||
106008060|NCT01126749|365695224|FG002|Phase 2|Other|4|||
106008061|NCT01126749|365695225|FG003|Phase 2|Other|2|||
105711000|NCT01972074|364601471|FG001|Overall Study|Withdrawal by Subject|1|||
105711001|NCT01972074|364601472|FG002|Overall Study|Withdrawal by Subject|1|||
105711002|NCT01972074|364601470|FG000|Overall Study|Scanner Unavailable|0|||
105711003|NCT01972074|364601471|FG001|Overall Study|Scanner Unavailable|0|||
105711004|NCT01972074|364601472|FG002|Overall Study|Scanner Unavailable|1|||
105711005|NCT01496066|364604384|FG000|Overall Study|Lost to Follow-up|8|||
105711006|NCT01496066|364604385|FG001|Overall Study|Lost to Follow-up|5|||
105711007|NCT01496066|364604384|FG000|Overall Study|Explant|3|||
105711008|NCT01496066|364604385|FG001|Overall Study|Explant|0|||
105711009|NCT01496066|364604384|FG000|Overall Study|Death|1|||
105711010|NCT01496066|364604385|FG001|Overall Study|Death|4|||
105711011|NCT02926209|364604386|FG000|Study Cohort|Poor Bowel Preparation|1|||
105711012|NCT02926209|364604387|FG001|Study Cohort|Poor Bowel Preparation|0|||
105711013|NCT00253630|364604388|FG000|Overall Study|ineligible|2|||
105711014|NCT03237065|364604389|FG000|Overall Study|Adverse Event|0|||
105711015|NCT03237065|364604390|FG001|Overall Study|Adverse Event|2|||
105711016|NCT03237065|364604389|FG000|Overall Study|Protocol Violation|0|||
105711017|NCT03237065|364604390|FG001|Overall Study|Protocol Violation|1|||
105711018|NCT03237065|364604389|FG000|Overall Study|Withdrawal by Subject|3|||
105711019|NCT03237065|364604390|FG001|Overall Study|Withdrawal by Subject|0|||
105711020|NCT03237065|364604389|FG000|Overall Study|Lost to Follow-up|1|||
105711021|NCT03237065|364604390|FG001|Overall Study|Lost to Follow-up|0|||
105711022|NCT03237065|364604389|FG000|Overall Study|Unable to obtain venous access|0|||
105711023|NCT03237065|364604390|FG001|Overall Study|Unable to obtain venous access|1|||
105711024|NCT00429858|364604391|FG000|Overall Study|Withdrawal by Subject|1|||
105711025|NCT00429858|364604391|FG000|Overall Study|Study Termination|1|||
105711026|NCT01587079|364604392|FG000|Overall Study|Protocol-specified criteria|9|||
105711027|NCT01587079|364604392|FG000|Overall Study|Protocol Violation|5|||
105711028|NCT01587079|364604392|FG000|Overall Study|Lost to Follow-up|2|||
105711029|NCT01587079|364604392|FG000|Overall Study|Physician Decision|2|||
105711030|NCT01587079|364604392|FG000|Overall Study|Withdrawal by Subject|7|||
105711031|NCT01587079|364604392|FG000|Overall Study|Adverse Event|14|||
105711032|NCT00705939|364604393|FG000|Overall Study|Protocol Violation|0|||
105711033|NCT00705939|364604394|FG001|Overall Study|Protocol Violation|0|||
105711034|NCT00705939|364604395|FG002|Overall Study|Protocol Violation|1|||
105711035|NCT00705939|364604393|FG000|Overall Study|Withdrawal by Subject|0|||
105711036|NCT00705939|364604394|FG001|Overall Study|Withdrawal by Subject|1|||
105711037|NCT00705939|364604395|FG002|Overall Study|Withdrawal by Subject|3|||
105711038|NCT00705939|364604393|FG000|Overall Study|Physician Decision|0|||
105711039|NCT00705939|364604394|FG001|Overall Study|Physician Decision|1|||
105711040|NCT00705939|364604395|FG002|Overall Study|Physician Decision|0|||
105711041|NCT01537211|364604400|FG000|Overall Study|Lost to Follow-up|0|||
105711042|NCT01537211|364604401|FG001|Overall Study|Lost to Follow-up|1|||
106008062|NCT01126749|365695222|FG000|Phase 2|Withdrawal by Subject|0|||
105711043|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
106008063|NCT01126749|365695223|FG001|Phase 2|Withdrawal by Subject|0|||
106008064|NCT01126749|365695224|FG002|Phase 2|Withdrawal by Subject|0|||
106008065|NCT01126749|365695225|FG003|Phase 2|Withdrawal by Subject|2|||
106008066|NCT01126749|365695222|FG000|Phase 2|Lost to Follow-up|0|||
106008067|NCT01126749|365695223|FG001|Phase 2|Lost to Follow-up|0|||
106134629|NCT03055767|366152461|FG003|Open-Label Period|Withdrawal by Subject|1|||
105711044|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
105711045|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
105711046|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
105711047|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
105711048|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
105711049|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
106008068|NCT01126749|365695224|FG002|Phase 2|Lost to Follow-up|0|||
106008069|NCT01126749|365695225|FG003|Phase 2|Lost to Follow-up|1|||
106008070|NCT01126749|365695222|FG000|Phase 2|Death|0|||
106008071|NCT01126749|365695223|FG001|Phase 2|Death|0|||
106008072|NCT01126749|365695224|FG002|Phase 2|Death|22|||
106008073|NCT01126749|365695225|FG003|Phase 2|Death|22|||
106008074|NCT01126749|365695222|FG000|Phase 2|Adverse Event|0|||
106008075|NCT01126749|365695223|FG001|Phase 2|Adverse Event|0|||
106008076|NCT01126749|365695224|FG002|Phase 2|Adverse Event|0|||
106008077|NCT01126749|365695225|FG003|Phase 2|Adverse Event|1|||
106008078|NCT01283139|365695226|FG000|Overall Study|Lost to Follow-up|5|||
106008079|NCT01283139|365695227|FG001|Overall Study|Lost to Follow-up|2|||
106008080|NCT01283139|365695228|FG002|Overall Study|Lost to Follow-up|3|||
106008081|NCT01283139|365695229|FG003|Overall Study|Lost to Follow-up|1|||
106008082|NCT01283139|365695226|FG000|Overall Study|Withdrawal by Subject|8|||
106008083|NCT01283139|365695227|FG001|Overall Study|Withdrawal by Subject|8|||
106008084|NCT01283139|365695228|FG002|Overall Study|Withdrawal by Subject|6|||
106008085|NCT01283139|365695229|FG003|Overall Study|Withdrawal by Subject|8|||
106008086|NCT01283139|365695226|FG000|Overall Study|Death|2|||
106008087|NCT01283139|365695227|FG001|Overall Study|Death|0|||
106008088|NCT01283139|365695228|FG002|Overall Study|Death|2|||
106008089|NCT01283139|365695229|FG003|Overall Study|Death|2|||
106008090|NCT01283139|365695226|FG000|Overall Study|Lack of Efficacy|1|||
106008091|NCT01283139|365695227|FG001|Overall Study|Lack of Efficacy|2|||
106008092|NCT01283139|365695228|FG002|Overall Study|Lack of Efficacy|2|||
106008093|NCT01283139|365695229|FG003|Overall Study|Lack of Efficacy|1|||
106008094|NCT01283139|365695226|FG000|Overall Study|Early termination due to AE/SAE|1|||
106008095|NCT01283139|365695227|FG001|Overall Study|Early termination due to AE/SAE|1|||
106008096|NCT01283139|365695228|FG002|Overall Study|Early termination due to AE/SAE|0|||
106008097|NCT01283139|365695229|FG003|Overall Study|Early termination due to AE/SAE|0|||
106008098|NCT01283139|365695226|FG000|Overall Study|Participant's refusal to continue|0|||
106008099|NCT01283139|365695227|FG001|Overall Study|Participant's refusal to continue|3|||
106008100|NCT01283139|365695228|FG002|Overall Study|Participant's refusal to continue|1|||
106008101|NCT01283139|365695229|FG003|Overall Study|Participant's refusal to continue|1|||
106008102|NCT01283139|365695226|FG000|Overall Study|Pregnancy|0|||
106008103|NCT01283139|365695227|FG001|Overall Study|Pregnancy|1|||
106008104|NCT01283139|365695228|FG002|Overall Study|Pregnancy|1|||
106008105|NCT01283139|365695229|FG003|Overall Study|Pregnancy|0|||
106008106|NCT01283139|365695226|FG000|Overall Study|Missed follow-up visit|0|||
106008107|NCT01283139|365695227|FG001|Overall Study|Missed follow-up visit|1|||
106008108|NCT01283139|365695228|FG002|Overall Study|Missed follow-up visit|2|||
106008109|NCT01283139|365695229|FG003|Overall Study|Missed follow-up visit|2|||
106008110|NCT01283139|365695226|FG000|Overall Study|Participant randomized in error|0|||
106008111|NCT01283139|365695227|FG001|Overall Study|Participant randomized in error|0|||
106008112|NCT01283139|365695228|FG002|Overall Study|Participant randomized in error|1|||
106008113|NCT01283139|365695229|FG003|Overall Study|Participant randomized in error|0|||
106008114|NCT00976274|365695230|FG000|Overall Study|Lost to Follow-up|5|||
106008115|NCT00976274|365695231|FG001|Overall Study|Lost to Follow-up|5|||
106008116|NCT00976274|365695230|FG000|Overall Study|Withdrawal by Subject|1|||
106008117|NCT00976274|365695231|FG001|Overall Study|Withdrawal by Subject|1|||
106008118|NCT00976274|365695230|FG000|Overall Study|Physician Decision|1|||
106008119|NCT00976274|365695231|FG001|Overall Study|Physician Decision|2|||
106008120|NCT00004563|365695232|FG000|Overall Study|Withdrawal by Subject|20|||
106008121|NCT00004563|365695233|FG001|Overall Study|Withdrawal by Subject|16|||
106008122|NCT00004563|365695232|FG000|Overall Study|Lack of Efficacy|3|||
106008123|NCT00004563|365695233|FG001|Overall Study|Lack of Efficacy|5|||
106008124|NCT00004563|365695232|FG000|Overall Study|Death|2|||
106008125|NCT00004563|365695233|FG001|Overall Study|Death|3|||
106008126|NCT00784563|365695234|FG000|Years 1 & 2|Withdrawal by Subject|3|||
106008127|NCT00784563|365695235|FG001|Years 1 & 2|Withdrawal by Subject|2|||
106008128|NCT00784563|365695236|FG002|Years 1 & 2|Withdrawal by Subject|0|||
106008129|NCT00784563|365695234|FG000|Years 1 & 2|Adverse Event|0|||
106008130|NCT00784563|365695235|FG001|Years 1 & 2|Adverse Event|3|||
106008131|NCT00784563|365695236|FG002|Years 1 & 2|Adverse Event|0|||
106008132|NCT00784563|365695234|FG000|Year 3|Withdrawal by Subject|0|||
106134630|NCT03686683|366152464|FG000|Overall Study|Withdrawal by Subject|52|||
106008133|NCT00784563|365695235|FG001|Year 3|Withdrawal by Subject|0|||
106008134|NCT00784563|365695236|FG002|Year 3|Withdrawal by Subject|2|||
106134631|NCT03686683|366152465|FG001|Overall Study|Withdrawal by Subject|32|||
106134632|NCT03686683|366152464|FG000|Overall Study|Lost to Follow-up|23|||
106008135|NCT00784563|365695234|FG000|Year 3|Adverse Event|0|||
106008136|NCT00784563|365695235|FG001|Year 3|Adverse Event|0|||
106008137|NCT00784563|365695236|FG002|Year 3|Adverse Event|1|||
106008138|NCT03050801|365695241|FG000|Experiment 1|Lost to Follow-up|0|||
106134633|NCT03686683|366152465|FG001|Overall Study|Lost to Follow-up|19|||
106134634|NCT03686683|366152464|FG000|Overall Study|Adverse Event|1|||
106008139|NCT03050801|365695242|FG001|Experiment 1|Lost to Follow-up|1|||
106008140|NCT03050801|365695243|FG002|Experiment 1|Lost to Follow-up|0|||
106008141|NCT03050801|365695244|FG003|Experiment 1|Lost to Follow-up|0|||
106008142|NCT03050801|365695245|FG004|Experiment 1|Lost to Follow-up|0|||
106008143|NCT03050801|365695246|FG005|Experiment 1|Lost to Follow-up|0|||
106008144|NCT03050801|365695241|FG000|Experiment 1|Physician Decision|0|||
106008145|NCT03050801|365695242|FG001|Experiment 1|Physician Decision|3|||
106134635|NCT03686683|366152465|FG001|Overall Study|Adverse Event|0|||
106134636|NCT03686683|366152464|FG000|Overall Study|Death|10|||
106134637|NCT03686683|366152465|FG001|Overall Study|Death|5|||
106134638|NCT03686683|366152464|FG000|Overall Study|Progressive Disease|1|||
106134639|NCT03686683|366152465|FG001|Overall Study|Progressive Disease|1|||
106134640|NCT03686683|366152464|FG000|Overall Study|Noncompliance|1|||
106134641|NCT03686683|366152465|FG001|Overall Study|Noncompliance|0|||
106134642|NCT03686683|366152464|FG000|Overall Study|Physician Decision|1|||
106134643|NCT03686683|366152465|FG001|Overall Study|Physician Decision|1|||
106134644|NCT03686683|366152464|FG000|Overall Study|Screen fail post-randomization|1|||
106134645|NCT03686683|366152465|FG001|Overall Study|Screen fail post-randomization|0|||
106134646|NCT03686683|366152464|FG000|Overall Study|Protocol Violation|3|||
106134647|NCT03686683|366152465|FG001|Overall Study|Protocol Violation|0|||
106134648|NCT03686683|366152464|FG000|Overall Study|No data available|1|||
106134649|NCT03686683|366152465|FG001|Overall Study|No data available|0|||
106134650|NCT01770860|366152466|FG000|Overall Study|Withdrawal by Subject|4|||
106134651|NCT01770860|366152466|FG000|Overall Study|Lost to Follow-up|1|||
106134652|NCT01770860|366152466|FG000|Overall Study|Administrative decision made by the PI|1|||
105928930|NCT00118287|365398015|FG000|Overall Study|Muscle pain|1|||
105928931|NCT05089357|365398019|FG000|Overall Study|Withdrawal by Subject|23|||
105928932|NCT05089357|365398019|FG000|Overall Study|Lost to Follow-up|6|||
105928933|NCT05089357|365398019|FG000|Overall Study|Medical reason|1|||
105928934|NCT05089357|365398019|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
105928935|NCT05089357|365398019|FG000|Overall Study|Pregnancy|2|||
105928936|NCT05591755|365398020|FG000|Overall Study|Screen Failure|1|||
105928937|NCT05591755|365398021|FG001|Overall Study|Screen Failure|0|||
105928938|NCT05591755|365398022|FG002|Overall Study|Screen Failure|0|||
105928939|NCT05591755|365398023|FG003|Overall Study|Screen Failure|0|||
105928940|NCT05591755|365398020|FG000|Overall Study|Protocol Violation|0|||
105928941|NCT05591755|365398021|FG001|Overall Study|Protocol Violation|0|||
105928942|NCT05591755|365398022|FG002|Overall Study|Protocol Violation|2|||
105928943|NCT05591755|365398023|FG003|Overall Study|Protocol Violation|0|||
105928944|NCT05591755|365398020|FG000|Overall Study|Withdrawal by Subject|0|||
105928945|NCT05591755|365398021|FG001|Overall Study|Withdrawal by Subject|1|||
105928946|NCT05591755|365398022|FG002|Overall Study|Withdrawal by Subject|0|||
105928947|NCT05591755|365398023|FG003|Overall Study|Withdrawal by Subject|0|||
105928948|NCT03828383|365398029|FG000|Overall Study|Lost to Follow-up|3|||
105928949|NCT03828383|365398030|FG001|Overall Study|Lost to Follow-up|2|||
105928950|NCT03828383|365398029|FG000|Overall Study|Withdrawal by Subject|4|||
105928951|NCT03828383|365398030|FG001|Overall Study|Withdrawal by Subject|5|||
105928952|NCT00504309|365398031|FG000|Overall Study|Death|0|||
105928953|NCT00504309|365398032|FG001|Overall Study|Death|0|||
105928954|NCT00504309|365398033|FG002|Overall Study|Death|0|||
105928955|NCT00504309|365398034|FG003|Overall Study|Death|0|||
105928956|NCT00504309|365398035|FG004|Overall Study|Death|1|||
105928957|NCT00504309|365398036|FG005|Overall Study|Death|0|||
105928958|NCT00504309|365398031|FG000|Overall Study|Withdrawal by Subject|0|||
105928959|NCT00504309|365398032|FG001|Overall Study|Withdrawal by Subject|0|||
105928960|NCT00504309|365398033|FG002|Overall Study|Withdrawal by Subject|1|||
105928961|NCT00504309|365398034|FG003|Overall Study|Withdrawal by Subject|0|||
105928962|NCT00504309|365398035|FG004|Overall Study|Withdrawal by Subject|0|||
105928963|NCT00504309|365398036|FG005|Overall Study|Withdrawal by Subject|0|||
105928964|NCT00308685|365398037|FG000|Overall Study|Lost to Follow-up|1|||
105928965|NCT00308685|365398038|FG001|Overall Study|Lost to Follow-up|0|||
105928966|NCT00308685|365398037|FG000|Overall Study|Need to administer prohibited medication|1|||
105928967|NCT00308685|365398038|FG001|Overall Study|Need to administer prohibited medication|2|||
105928968|NCT00308685|365398037|FG000|Overall Study|Other than specified|1|||
105928969|NCT00308685|365398038|FG001|Overall Study|Other than specified|3|||
105928970|NCT03770455|365398039|FG000|Overall Study|Screen failures|3|||
105928971|NCT03345095|365398040|FG000|Overall Study|Lack of Efficacy|184|||
105928972|NCT03345095|365398041|FG001|Overall Study|Lack of Efficacy|156|||
105928973|NCT03345095|365398040|FG000|Overall Study|Adverse Event|36|||
105928974|NCT03345095|365398041|FG001|Overall Study|Adverse Event|118|||
105928975|NCT03345095|365398040|FG000|Overall Study|Withdrawal by Subject|22|||
105928976|NCT03345095|365398041|FG001|Overall Study|Withdrawal by Subject|59|||
105928977|NCT03345095|365398040|FG000|Overall Study|Physician Decision|3|||
105928978|NCT03345095|365398041|FG001|Overall Study|Physician Decision|18|||
105928979|NCT03345095|365398040|FG000|Overall Study|Death|2|||
105928980|NCT03345095|365398041|FG001|Overall Study|Death|4|||
105928981|NCT03345095|365398040|FG000|Overall Study|Other reasons|2|||
105928982|NCT03345095|365398041|FG001|Overall Study|Other reasons|11|||
105928983|NCT03345095|365398040|FG000|Overall Study|Protocol Violation|0|||
105928984|NCT03345095|365398041|FG001|Overall Study|Protocol Violation|1|||
105928985|NCT01121575|365398042|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
105928986|NCT01121575|365398043|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
105711050|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
105711051|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
105711052|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
105711053|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
105711054|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
105928987|NCT01121575|365398044|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
105928988|NCT01121575|365398045|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
105928989|NCT01121575|365398046|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
105928990|NCT01121575|365398047|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
105928991|NCT01121575|365398042|FG000|Overall Study|Unspecified Reasons|8|||
105928992|NCT01121575|365398043|FG001|Overall Study|Unspecified Reasons|6|||
105928993|NCT01121575|365398044|FG002|Overall Study|Unspecified Reasons|7|||
105928994|NCT01121575|365398045|FG003|Overall Study|Unspecified Reasons|5|||
105928995|NCT01121575|365398046|FG004|Overall Study|Unspecified Reasons|13|||
105928996|NCT01121575|365398047|FG005|Overall Study|Unspecified Reasons|10|||
105928997|NCT01121575|365398042|FG000|Overall Study|Death|6|||
105928998|NCT01121575|365398043|FG001|Overall Study|Death|0|||
105928999|NCT01121575|365398044|FG002|Overall Study|Death|0|||
105929000|NCT01121575|365398045|FG003|Overall Study|Death|1|||
105929001|NCT01121575|365398046|FG004|Overall Study|Death|7|||
105929002|NCT01121575|365398047|FG005|Overall Study|Death|1|||
105929003|NCT02665455|365398048|FG000|Overall Study|Withdrawal by Subject|6|||
105929004|NCT02665455|365398048|FG000|Overall Study|Lost to Follow-up|1|||
105929005|NCT02665455|365398048|FG000|Overall Study|Adverse Event|1|||
105929006|NCT02665455|365398048|FG000|Overall Study|Protocol Violation|1|||
105929007|NCT02916771|365398049|FG000|Overall Study|Withdrawal by Subject|9|||
105929008|NCT02916771|365398049|FG000|Overall Study|Physician Decision|1|||
105929009|NCT02916771|365398049|FG000|Overall Study|Began treatment for another active malignancy|1|||
105929010|NCT00724503|365398050|FG000|Overall Study|Lost to Follow-up|4|||
105929011|NCT00724503|365398051|FG001|Overall Study|Lost to Follow-up|8|||
105929012|NCT00724503|365398050|FG000|Overall Study|Withdrawal by Subject|11|||
105929013|NCT00724503|365398051|FG001|Overall Study|Withdrawal by Subject|23|||
105929014|NCT00724503|365398050|FG000|Overall Study|Death|190|||
105929015|NCT00724503|365398051|FG001|Overall Study|Death|182|||
105929016|NCT00724503|365398050|FG000|Overall Study|Adverse Event|1|||
105929017|NCT00724503|365398051|FG001|Overall Study|Adverse Event|0|||
105929018|NCT00724503|365398050|FG000|Overall Study|Not otherwise specified|4|||
105929019|NCT00724503|365398051|FG001|Overall Study|Not otherwise specified|7|||
105929020|NCT03932331|365398066|FG000|Overall Study|Death|0|||
105929021|NCT03932331|365398067|FG001|Overall Study|Death|7|||
105929022|NCT03932331|365398068|FG002|Overall Study|Death|2|||
105929023|NCT03932331|365398066|FG000|Overall Study|Withdrawal by Subject|0|||
105929024|NCT03932331|365398067|FG001|Overall Study|Withdrawal by Subject|3|||
105929025|NCT03932331|365398068|FG002|Overall Study|Withdrawal by Subject|0|||
105929026|NCT03932331|365398066|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
105929027|NCT03932331|365398067|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
105929028|NCT03932331|365398068|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
105929029|NCT03932331|365398066|FG000|Overall Study|Progressive disease|3|||
105929030|NCT03932331|365398067|FG001|Overall Study|Progressive disease|0|||
106008146|NCT03050801|365695243|FG002|Experiment 1|Physician Decision|0|||
106008147|NCT03050801|365695244|FG003|Experiment 1|Physician Decision|0|||
106008148|NCT03050801|365695245|FG004|Experiment 1|Physician Decision|0|||
106008149|NCT03050801|365695246|FG005|Experiment 1|Physician Decision|0|||
106008150|NCT03050801|365695241|FG000|Experiment 1|Change of experimental design|0|||
106008151|NCT03050801|365695242|FG001|Experiment 1|Change of experimental design|3|||
106008152|NCT03050801|365695243|FG002|Experiment 1|Change of experimental design|0|||
106008153|NCT03050801|365695244|FG003|Experiment 1|Change of experimental design|0|||
106008154|NCT03050801|365695245|FG004|Experiment 1|Change of experimental design|0|||
106008155|NCT03050801|365695246|FG005|Experiment 1|Change of experimental design|0|||
106008156|NCT03050801|365695241|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
106008157|NCT03050801|365695242|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
106008158|NCT03050801|365695243|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
106008159|NCT03050801|365695244|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
106008160|NCT03050801|365695245|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
106134653|NCT02397889|366152472|FG000|Overall Study|Physician Decision|1|||
106134654|NCT02397889|366152473|FG001|Overall Study|Physician Decision|0|||
105711055|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
105929031|NCT03932331|365398068|FG002|Overall Study|Progressive disease|0|||
105929032|NCT03932331|365398066|FG000|Overall Study|Lung infection|1|||
105929033|NCT03932331|365398067|FG001|Overall Study|Lung infection|0|||
105929034|NCT03932331|365398068|FG002|Overall Study|Lung infection|0|||
105929035|NCT03932331|365398066|FG000|Overall Study|Other|0|||
105929036|NCT03932331|365398067|FG001|Overall Study|Other|0|||
105929037|NCT03932331|365398068|FG002|Overall Study|Other|58|||
105929038|NCT01407367|365398071|FG000|Overall Study|Death|24|||
105929039|NCT01407367|365398072|FG001|Overall Study|Death|32|||
106134655|NCT00320489|366152481|FG000|Overall Study|Adverse Event|26|||
106134656|NCT00320489|366152482|FG001|Overall Study|Adverse Event|25|||
106134657|NCT00320489|366152481|FG000|Overall Study|Clinical Relapse|26|||
106134658|NCT00320489|366152482|FG001|Overall Study|Clinical Relapse|20|||
106134659|NCT00320489|366152481|FG000|Overall Study|Death|0|||
106134660|NCT00320489|366152482|FG001|Overall Study|Death|2|||
106134661|NCT00320489|366152481|FG000|Overall Study|Entry Criteria Exclusion|2|||
106134662|NCT00320489|366152482|FG001|Overall Study|Entry Criteria Exclusion|4|||
106134663|NCT00320489|366152481|FG000|Overall Study|Lack of Efficacy|16|||
106134664|NCT00320489|366152482|FG001|Overall Study|Lack of Efficacy|7|||
106134665|NCT00320489|366152481|FG000|Overall Study|Lost to Follow-up|21|||
106134666|NCT00320489|366152482|FG001|Overall Study|Lost to Follow-up|22|||
106134667|NCT00320489|366152481|FG000|Overall Study|Physician Decision|8|||
106134668|NCT00320489|366152482|FG001|Overall Study|Physician Decision|8|||
106134669|NCT00320489|366152481|FG000|Overall Study|Protocol Violation|4|||
106134670|NCT00320489|366152482|FG001|Overall Study|Protocol Violation|4|||
106134671|NCT00320489|366152481|FG000|Overall Study|Sponsor Decision|3|||
106134672|NCT00320489|366152482|FG001|Overall Study|Sponsor Decision|3|||
106134673|NCT00320489|366152481|FG000|Overall Study|Withdrawal by Subject|39|||
106134674|NCT00320489|366152482|FG001|Overall Study|Withdrawal by Subject|41|||
106134675|NCT02282527|366152483|FG000|Overall Study|Lost to Follow-up|0|||
106134676|NCT02282527|366152484|FG001|Overall Study|Lost to Follow-up|1|||
106134677|NCT02282527|366152483|FG000|Overall Study|Lack of home health aid|1|||
106134678|NCT02282527|366152484|FG001|Overall Study|Lack of home health aid|0|||
106134679|NCT00941031|366152485|FG000|Induction Period|Lack of Efficacy|2|||
106134680|NCT00941031|366152486|FG001|Induction Period|Lack of Efficacy|1|||
106134681|NCT00941031|366152487|FG002|Induction Period|Lack of Efficacy|0|||
106134682|NCT00941031|366152488|FG003|Induction Period|Lack of Efficacy|5|||
106134683|NCT00941031|366152489|FG004|Induction Period|Lack of Efficacy|0|||
106134684|NCT00941031|366152490|FG005|Induction Period|Lack of Efficacy|0|||
105711056|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
105711057|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
105711058|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
105711059|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
105711060|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
105711061|NCT04418765|364604402|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
105711062|NCT04418765|364604403|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
105711063|NCT04418765|364604404|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
105711064|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
105711065|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
105711066|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
105711067|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
105711068|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
105711069|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
105711070|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
105711071|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
105711072|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
105711073|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
105711074|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
106134685|NCT00941031|366152491|FG006|Induction Period|Lack of Efficacy|0|||
106134686|NCT00941031|366152485|FG000|Induction Period|Withdrawal by Subject|1|||
106134687|NCT00941031|366152486|FG001|Induction Period|Withdrawal by Subject|2|||
106134688|NCT00941031|366152487|FG002|Induction Period|Withdrawal by Subject|2|||
106134689|NCT00941031|366152488|FG003|Induction Period|Withdrawal by Subject|2|||
106134690|NCT00941031|366152489|FG004|Induction Period|Withdrawal by Subject|0|||
106134691|NCT00941031|366152490|FG005|Induction Period|Withdrawal by Subject|0|||
106134692|NCT00941031|366152491|FG006|Induction Period|Withdrawal by Subject|0|||
106134693|NCT00941031|366152485|FG000|Induction Period|Adminstative Problems|1|||
106134694|NCT00941031|366152486|FG001|Induction Period|Adminstative Problems|1|||
106134695|NCT00941031|366152487|FG002|Induction Period|Adminstative Problems|1|||
106134696|NCT00941031|366152488|FG003|Induction Period|Adminstative Problems|0|||
105711075|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
105929040|NCT01407367|365398071|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
105711076|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
106134697|NCT00941031|366152489|FG004|Induction Period|Adminstative Problems|0|||
106134698|NCT00941031|366152490|FG005|Induction Period|Adminstative Problems|0|||
105711077|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
105929041|NCT01407367|365398072|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
106134699|NCT00941031|366152491|FG006|Induction Period|Adminstative Problems|0|||
106134700|NCT00941031|366152485|FG000|Induction Period|Adverse Event|1|||
106134701|NCT00941031|366152486|FG001|Induction Period|Adverse Event|0|||
106134702|NCT00941031|366152487|FG002|Induction Period|Adverse Event|3|||
106134703|NCT00941031|366152488|FG003|Induction Period|Adverse Event|2|||
106134704|NCT00941031|366152489|FG004|Induction Period|Adverse Event|0|||
106134705|NCT00941031|366152490|FG005|Induction Period|Adverse Event|0|||
105711078|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
105711079|NCT04418765|364604402|FG000|Extension Period (48 Weeks)|Other than specified|0|||
105711080|NCT04418765|364604403|FG001|Extension Period (48 Weeks)|Other than specified|5|||
105711081|NCT04418765|364604404|FG002|Extension Period (48 Weeks)|Other than specified|2|||
105711082|NCT02062658|364604405|FG000|Overall Study|Withdrawal by Subject|1|||
105711083|NCT02062658|364604405|FG000|Overall Study|Lack of Efficacy|1|||
105711084|NCT01789970|364604406|FG000|Open-label Titration Period|Adverse Event|68|||
105711085|NCT01789970|364604407|FG001|Open-label Titration Period|Adverse Event|0|||
105711086|NCT01789970|364604408|FG002|Open-label Titration Period|Adverse Event|0|||
105711087|NCT01789970|364604406|FG000|Open-label Titration Period|Lack of Efficacy|31|||
105711088|NCT01789970|364604407|FG001|Open-label Titration Period|Lack of Efficacy|0|||
106008161|NCT03050801|365695246|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
106008162|NCT03050801|365695241|FG000|Experiment 2|Lost to Follow-up|0|||
106008163|NCT03050801|365695242|FG001|Experiment 2|Lost to Follow-up|0|||
106008164|NCT03050801|365695243|FG002|Experiment 2|Lost to Follow-up|0|||
106008165|NCT03050801|365695244|FG003|Experiment 2|Lost to Follow-up|1|||
106008166|NCT03050801|365695245|FG004|Experiment 2|Lost to Follow-up|1|||
106008167|NCT03050801|365695246|FG005|Experiment 2|Lost to Follow-up|0|||
106008168|NCT03050801|365695241|FG000|Experiment 2|Physician Decision|0|||
106008169|NCT03050801|365695242|FG001|Experiment 2|Physician Decision|0|||
106008170|NCT03050801|365695243|FG002|Experiment 2|Physician Decision|0|||
106008171|NCT03050801|365695244|FG003|Experiment 2|Physician Decision|0|||
106008172|NCT03050801|365695245|FG004|Experiment 2|Physician Decision|1|||
106008173|NCT03050801|365695246|FG005|Experiment 2|Physician Decision|0|||
106008174|NCT03050801|365695241|FG000|Experiment 2|Pregnancy|0|||
106008175|NCT03050801|365695242|FG001|Experiment 2|Pregnancy|0|||
106008176|NCT03050801|365695243|FG002|Experiment 2|Pregnancy|0|||
106008177|NCT03050801|365695244|FG003|Experiment 2|Pregnancy|0|||
106008178|NCT03050801|365695245|FG004|Experiment 2|Pregnancy|1|||
106008179|NCT03050801|365695246|FG005|Experiment 2|Pregnancy|0|||
106008180|NCT03050801|365695241|FG000|Experiment 2|Withdrawal by Subject|0|||
106008181|NCT03050801|365695242|FG001|Experiment 2|Withdrawal by Subject|0|||
106008182|NCT03050801|365695243|FG002|Experiment 2|Withdrawal by Subject|0|||
106008183|NCT03050801|365695244|FG003|Experiment 2|Withdrawal by Subject|1|||
106008184|NCT03050801|365695245|FG004|Experiment 2|Withdrawal by Subject|0|||
106008185|NCT03050801|365695246|FG005|Experiment 2|Withdrawal by Subject|0|||
106008186|NCT03050801|365695241|FG000|Experiment 2|Poor data quality|0|||
106008187|NCT03050801|365695242|FG001|Experiment 2|Poor data quality|0|||
106008188|NCT03050801|365695243|FG002|Experiment 2|Poor data quality|0|||
106008189|NCT03050801|365695244|FG003|Experiment 2|Poor data quality|4|||
106008190|NCT03050801|365695245|FG004|Experiment 2|Poor data quality|1|||
106008191|NCT03050801|365695246|FG005|Experiment 2|Poor data quality|0|||
106008192|NCT03050801|365695241|FG000|Experiment 2|Discomfort during stimulation|0|||
106008193|NCT03050801|365695242|FG001|Experiment 2|Discomfort during stimulation|0|||
106008194|NCT03050801|365695243|FG002|Experiment 2|Discomfort during stimulation|0|||
106008195|NCT03050801|365695244|FG003|Experiment 2|Discomfort during stimulation|0|||
106008196|NCT03050801|365695245|FG004|Experiment 2|Discomfort during stimulation|0|||
106008197|NCT03050801|365695246|FG005|Experiment 2|Discomfort during stimulation|2|||
106008198|NCT00005780|365695247|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
106008199|NCT03600909|365695249|FG000|Overall Study|Not treated|0|||
106008200|NCT03600909|365695250|FG001|Overall Study|Not treated|3|||
105711089|NCT01789970|364604408|FG002|Open-label Titration Period|Lack of Efficacy|0|||
106008201|NCT03600909|365695251|FG002|Overall Study|Not treated|0|||
106008202|NCT00521079|365695252|FG000|Overall Study|Adverse Event|7|||
106008203|NCT00521079|365695253|FG001|Overall Study|Adverse Event|1|||
106008204|NCT00521079|365695252|FG000|Overall Study|Lost to Follow-up|2|||
106008205|NCT00521079|365695253|FG001|Overall Study|Lost to Follow-up|1|||
106008206|NCT00521079|365695252|FG000|Overall Study|Withdrawal by Subject|5|||
106008207|NCT00521079|365695253|FG001|Overall Study|Withdrawal by Subject|3|||
106008208|NCT04576988|365695254|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
106008209|NCT04576988|365695255|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
105788114|NCT03426995|364878226|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788115|NCT03426995|364878227|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
106008210|NCT04576988|365695254|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
106008211|NCT04576988|365695255|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
106008212|NCT04576988|365695254|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
106008213|NCT04576988|365695255|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
106008214|NCT04576988|365695254|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
106008215|NCT04576988|365695255|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
106134706|NCT00941031|366152491|FG006|Induction Period|Adverse Event|0|||
106134707|NCT00941031|366152485|FG000|Maintenance Period|Withdrawal by Subject|0|||
106008216|NCT04576988|365695254|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
106008217|NCT04576988|365695255|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
106008218|NCT04576988|365695254|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
105711090|NCT01789970|364604406|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
105711091|NCT01789970|364604407|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
105711092|NCT01789970|364604408|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
105711093|NCT01789970|364604406|FG000|Open-label Titration Period|Protocol Violation|18|||
105711094|NCT01789970|364604407|FG001|Open-label Titration Period|Protocol Violation|0|||
105711095|NCT01789970|364604408|FG002|Open-label Titration Period|Protocol Violation|0|||
105711096|NCT01789970|364604406|FG000|Open-label Titration Period|Lost to Follow-up|5|||
105711097|NCT01789970|364604407|FG001|Open-label Titration Period|Lost to Follow-up|0|||
105711098|NCT01789970|364604408|FG002|Open-label Titration Period|Lost to Follow-up|0|||
105929042|NCT01407367|365398071|FG000|Overall Study|Withdrawal by Subject|4|||
105929043|NCT01407367|365398072|FG001|Overall Study|Withdrawal by Subject|15|||
105929044|NCT01407367|365398071|FG000|Overall Study|Lost to Follow-up|0|||
105929045|NCT01407367|365398072|FG001|Overall Study|Lost to Follow-up|2|||
105929046|NCT01452347|365398073|FG000|Overall Study|Adverse Event|2|||
105929047|NCT01452347|365398074|FG001|Overall Study|Adverse Event|1|||
105929048|NCT01452347|365398073|FG000|Overall Study|Non compliance protocol|2|||
106008219|NCT04576988|365695255|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
106008220|NCT04576988|365695254|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
106008221|NCT04576988|365695255|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
105711099|NCT01789970|364604406|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
105711100|NCT01789970|364604407|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
105711101|NCT01789970|364604408|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
105711102|NCT01789970|364604406|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
105711103|NCT01789970|364604407|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
105711104|NCT01789970|364604408|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
105711105|NCT01789970|364604406|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
105711106|NCT01789970|364604407|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
105711107|NCT01789970|364604408|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
105711108|NCT01789970|364604406|FG000|Open-label Titration Period|Pregnancy|2|||
105711109|NCT01789970|364604407|FG001|Open-label Titration Period|Pregnancy|0|||
105711110|NCT01789970|364604408|FG002|Open-label Titration Period|Pregnancy|0|||
105711111|NCT01789970|364604406|FG000|Open-label Titration Period|Other|76|||
105711112|NCT01789970|364604407|FG001|Open-label Titration Period|Other|0|||
105711113|NCT01789970|364604408|FG002|Open-label Titration Period|Other|0|||
105711114|NCT01789970|364604406|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
105711115|NCT01789970|364604407|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
105711116|NCT01789970|364604408|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
105711117|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
105711118|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
105711119|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
105711120|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105711121|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
105711122|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
105711123|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105711124|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
105711125|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
105711126|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
105711127|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
105711128|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
105711129|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
105711130|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
105711131|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
105711132|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
105711133|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
105711134|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
105711135|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
105929049|NCT01452347|365398074|FG001|Overall Study|Non compliance protocol|0|||
105929050|NCT01452347|365398073|FG000|Overall Study|Lost to Follow-up|2|||
106008222|NCT04576988|365695254|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
106008223|NCT04576988|365695255|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
106134708|NCT00941031|366152486|FG001|Maintenance Period|Withdrawal by Subject|0|||
105711136|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
105711137|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
106008224|NCT04576988|365695254|FG000|Long Term Double Blind (LTDB)|Death|2|||
105711138|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
105929051|NCT01452347|365398074|FG001|Overall Study|Lost to Follow-up|0|||
105929052|NCT01452347|365398073|FG000|Overall Study|Withdrawal by Subject|3|||
105711139|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
105711140|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
105711141|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
105711142|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
105711143|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
105711144|NCT01789970|364604406|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
105929053|NCT01452347|365398074|FG001|Overall Study|Withdrawal by Subject|3|||
105929054|NCT01452347|365398073|FG000|Overall Study|Not treated|6|||
105929055|NCT01452347|365398074|FG001|Overall Study|Not treated|3|||
105929056|NCT01452347|365398073|FG000|Overall Study|Other reason not defined above|2|||
105929057|NCT01452347|365398074|FG001|Overall Study|Other reason not defined above|0|||
105929058|NCT01671059|365398075|FG000|Overall Study|Adverse Event|4|||
105929059|NCT01671059|365398075|FG000|Overall Study|Lack of Efficacy|1|||
105929060|NCT01350973|365398082|FG000|Overall Study|Adverse Event|4|||
105929061|NCT01350973|365398083|FG001|Overall Study|Adverse Event|7|||
105929062|NCT01350973|365398084|FG002|Overall Study|Adverse Event|7|||
105929063|NCT01350973|365398082|FG000|Overall Study|Voluntary Withdrawal|2|||
105929064|NCT01350973|365398083|FG001|Overall Study|Voluntary Withdrawal|1|||
105929065|NCT01350973|365398084|FG002|Overall Study|Voluntary Withdrawal|1|||
105929066|NCT01695772|365398085|FG000|Overall Study|Withdrawal by Subject|18|||
105929067|NCT01695772|365398085|FG000|Overall Study|Progressive Disease|8|||
105929068|NCT01695772|365398085|FG000|Overall Study|Investigator Decision|5|||
105929069|NCT01695772|365398085|FG000|Overall Study|Lost to Follow-up|4|||
105929070|NCT01695772|365398085|FG000|Overall Study|Protocol Violation|2|||
105929071|NCT01695772|365398085|FG000|Overall Study|Unspecified Reason|1|||
105929072|NCT02927145|365399589|FG000|Initial Recruitment|Withdrawal by Subject|0|||
105929073|NCT02927145|365399590|FG001|Initial Recruitment|Withdrawal by Subject|1|||
105929074|NCT02927145|365399591|FG002|Initial Recruitment|Withdrawal by Subject|1|||
105929075|NCT02927145|365399592|FG003|Initial Recruitment|Withdrawal by Subject|4|||
105929076|NCT02927145|365399593|FG004|Initial Recruitment|Withdrawal by Subject|1|||
105929077|NCT02927145|365399594|FG005|Initial Recruitment|Withdrawal by Subject|1|||
105929078|NCT02927145|365399595|FG006|Initial Recruitment|Withdrawal by Subject|0|||
105929079|NCT02927145|365399596|FG007|Initial Recruitment|Withdrawal by Subject|0|||
105929080|NCT02927145|365399597|FG008|Initial Recruitment|Withdrawal by Subject|2|||
105929081|NCT02927145|365399589|FG000|Initial Recruitment|Adverse Event|0|||
105929082|NCT02927145|365399590|FG001|Initial Recruitment|Adverse Event|0|||
105929083|NCT02927145|365399591|FG002|Initial Recruitment|Adverse Event|0|||
105929084|NCT02927145|365399592|FG003|Initial Recruitment|Adverse Event|0|||
105929085|NCT02927145|365399593|FG004|Initial Recruitment|Adverse Event|2|||
105929086|NCT02927145|365399594|FG005|Initial Recruitment|Adverse Event|0|||
105929087|NCT02927145|365399595|FG006|Initial Recruitment|Adverse Event|0|||
105929088|NCT02927145|365399596|FG007|Initial Recruitment|Adverse Event|0|||
105929089|NCT02927145|365399597|FG008|Initial Recruitment|Adverse Event|0|||
105929090|NCT02927145|365399589|FG000|Invitation for Additional Challenge|Pregnancy|0|||
105929091|NCT02927145|365399590|FG001|Invitation for Additional Challenge|Pregnancy|0|||
105929092|NCT02927145|365399591|FG002|Invitation for Additional Challenge|Pregnancy|0|||
105929093|NCT02927145|365399592|FG003|Invitation for Additional Challenge|Pregnancy|0|||
105929094|NCT02927145|365399593|FG004|Invitation for Additional Challenge|Pregnancy|0|||
105929095|NCT02927145|365399594|FG005|Invitation for Additional Challenge|Pregnancy|0|||
105929096|NCT02927145|365399595|FG006|Invitation for Additional Challenge|Pregnancy|1|||
105929097|NCT02927145|365399596|FG007|Invitation for Additional Challenge|Pregnancy|0|||
105929098|NCT02927145|365399597|FG008|Invitation for Additional Challenge|Pregnancy|0|||
105929099|NCT05059080|365399599|FG000|Overall Study|Withdrawal by Subject|3|||
105929100|NCT05059080|365399599|FG000|Overall Study|Study Terminated by Sponsor|64|||
105929101|NCT00263562|365399600|FG000|Overall Study|Protocol Violation|3|||
105929102|NCT00263562|365399601|FG001|Overall Study|Protocol Violation|0|||
105929103|NCT03927157|365399602|FG000|Overall Study|Adverse Event|1|||
105929104|NCT03927157|365399603|FG001|Overall Study|Adverse Event|3|||
105929105|NCT03927157|365399602|FG000|Overall Study|Protocol Violation|1|||
105929106|NCT03927157|365399603|FG001|Overall Study|Protocol Violation|2|||
105929107|NCT03927157|365399602|FG000|Overall Study|Withdrawal by Subject|8|||
105929108|NCT03927157|365399603|FG001|Overall Study|Withdrawal by Subject|21|||
105929109|NCT03927157|365399602|FG000|Overall Study|Due to COVID-19 pandemic|5|||
105929110|NCT03927157|365399603|FG001|Overall Study|Due to COVID-19 pandemic|2|||
105929111|NCT03927157|365399602|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
105929112|NCT03927157|365399603|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
105929113|NCT03927157|365399602|FG000|Overall Study|Other than above|0|||
105929114|NCT03927157|365399603|FG001|Overall Study|Other than above|1|||
105929115|NCT00875667|365399607|FG000|Overall Study|Adverse Event|29|||
105929116|NCT00875667|365399608|FG001|Overall Study|Adverse Event|10|||
105711145|NCT01789970|364604407|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
105711146|NCT01789970|364604408|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
105806512|NCT03038113|364949006|FG006|Overall Study|Withdrawal by Subject|0|||
105929117|NCT00875667|365399607|FG000|Overall Study|Withdrawal by Subject|17|||
105929118|NCT00875667|365399608|FG001|Overall Study|Withdrawal by Subject|5|||
105711147|NCT03345472|364604410|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
105711148|NCT03345472|364604410|FG000|Implant to 3 Months|Physician Decision|1|||
105711149|NCT03345472|364604410|FG000|Implant to 3 Months|Adverse Event|1|||
105711150|NCT03345472|364604410|FG000|3 Months to 12 Months|Physician Decision|3|||
106134709|NCT00941031|366152487|FG002|Maintenance Period|Withdrawal by Subject|0|||
106134710|NCT00941031|366152488|FG003|Maintenance Period|Withdrawal by Subject|0|||
106134711|NCT00941031|366152489|FG004|Maintenance Period|Withdrawal by Subject|6|||
106134712|NCT00941031|366152490|FG005|Maintenance Period|Withdrawal by Subject|2|||
106134713|NCT00941031|366152491|FG006|Maintenance Period|Withdrawal by Subject|13|||
106134714|NCT00941031|366152485|FG000|Maintenance Period|Administrative Problems|0|||
106134715|NCT00941031|366152486|FG001|Maintenance Period|Administrative Problems|0|||
106134716|NCT00941031|366152487|FG002|Maintenance Period|Administrative Problems|0|||
106134717|NCT00941031|366152488|FG003|Maintenance Period|Administrative Problems|0|||
106134718|NCT00941031|366152489|FG004|Maintenance Period|Administrative Problems|1|||
106134719|NCT00941031|366152490|FG005|Maintenance Period|Administrative Problems|0|||
106134720|NCT00941031|366152491|FG006|Maintenance Period|Administrative Problems|1|||
106134721|NCT00941031|366152485|FG000|Maintenance Period|Protocol Violation|0|||
106134722|NCT00941031|366152486|FG001|Maintenance Period|Protocol Violation|0|||
106134723|NCT00941031|366152487|FG002|Maintenance Period|Protocol Violation|0|||
106134724|NCT00941031|366152488|FG003|Maintenance Period|Protocol Violation|0|||
106134725|NCT00941031|366152489|FG004|Maintenance Period|Protocol Violation|0|||
106134726|NCT00941031|366152490|FG005|Maintenance Period|Protocol Violation|0|||
106134727|NCT00941031|366152491|FG006|Maintenance Period|Protocol Violation|1|||
106134728|NCT00941031|366152485|FG000|Maintenance Period|Adverse Event|0|||
106134729|NCT00941031|366152486|FG001|Maintenance Period|Adverse Event|0|||
106134730|NCT00941031|366152487|FG002|Maintenance Period|Adverse Event|0|||
106134731|NCT00941031|366152488|FG003|Maintenance Period|Adverse Event|0|||
106134732|NCT00941031|366152489|FG004|Maintenance Period|Adverse Event|0|||
106134733|NCT00941031|366152490|FG005|Maintenance Period|Adverse Event|2|||
106134734|NCT00941031|366152491|FG006|Maintenance Period|Adverse Event|8|||
106134735|NCT00941031|366152485|FG000|Maintenance Period|Lost to Follow-up|0|||
106134736|NCT00941031|366152486|FG001|Maintenance Period|Lost to Follow-up|0|||
106134737|NCT00941031|366152487|FG002|Maintenance Period|Lost to Follow-up|0|||
106134738|NCT00941031|366152488|FG003|Maintenance Period|Lost to Follow-up|0|||
106134739|NCT00941031|366152489|FG004|Maintenance Period|Lost to Follow-up|2|||
106134740|NCT00941031|366152490|FG005|Maintenance Period|Lost to Follow-up|2|||
106134741|NCT00941031|366152491|FG006|Maintenance Period|Lost to Follow-up|7|||
106134742|NCT00941031|366152485|FG000|Maintenance Period|Lack of Efficacy|0|||
106134743|NCT00941031|366152486|FG001|Maintenance Period|Lack of Efficacy|0|||
105711151|NCT03345472|364604410|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
105711152|NCT03345472|364604410|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
105711153|NCT03345472|364604410|FG000|3 Months to 12 Months|Adverse Event|1|||
105711154|NCT03345472|364604410|FG000|3 Months to 12 Months|Death|1|||
106134744|NCT00941031|366152487|FG002|Maintenance Period|Lack of Efficacy|0|||
106134745|NCT00941031|366152488|FG003|Maintenance Period|Lack of Efficacy|0|||
106134746|NCT00941031|366152489|FG004|Maintenance Period|Lack of Efficacy|0|||
106134747|NCT00941031|366152490|FG005|Maintenance Period|Lack of Efficacy|0|||
106134748|NCT00941031|366152491|FG006|Maintenance Period|Lack of Efficacy|13|||
106134749|NCT04555044|366152492|FG000|Overall Study|Adverse Event|0|||
106134750|NCT04555044|366152493|FG001|Overall Study|Adverse Event|1|||
106134751|NCT03761784|366152497|FG000|Overall Study|Adverse Event|4|||
105711155|NCT01121393|364604411|FG000|Overall Study|Progressive disease|201|||
105711156|NCT01121393|364604412|FG001|Overall Study|Progressive disease|20|||
105788116|NCT03426995|364878228|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788117|NCT03426995|364878229|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
106134752|NCT03761784|366152498|FG001|Overall Study|Adverse Event|0|||
105711157|NCT01121393|364604411|FG000|Overall Study|Other Adverse events|24|||
105711158|NCT01121393|364604412|FG001|Overall Study|Other Adverse events|45|||
106134753|NCT03761784|366152497|FG000|Overall Study|Lost to Follow-up|10|||
106134754|NCT03761784|366152498|FG001|Overall Study|Lost to Follow-up|7|||
105929119|NCT00875667|365399607|FG000|Overall Study|Death|7|||
105929120|NCT00875667|365399608|FG001|Overall Study|Death|2|||
105929121|NCT00875667|365399607|FG000|Overall Study|Protocol Violation|2|||
105929122|NCT00875667|365399608|FG001|Overall Study|Protocol Violation|0|||
105929123|NCT00875667|365399607|FG000|Overall Study|Disease Progression|100|||
105929124|NCT00875667|365399608|FG001|Overall Study|Disease Progression|49|||
105929125|NCT00875667|365399607|FG000|Overall Study|Miscellaneous|12|||
105929126|NCT00875667|365399608|FG001|Overall Study|Miscellaneous|6|||
105929127|NCT00875667|365399607|FG000|Overall Study|Randomized but no Study Drug Given|3|||
105929128|NCT00875667|365399608|FG001|Overall Study|Randomized but no Study Drug Given|1|||
105929129|NCT00923702|365399609|FG000|Overall Study|Ongoing enrollment|0|||
105929130|NCT00923702|365399610|FG001|Overall Study|Ongoing enrollment|0|||
105929131|NCT00923702|365399611|FG002|Overall Study|Ongoing enrollment|0|||
105929132|NCT00923702|365399612|FG003|Overall Study|Ongoing enrollment|0|||
105929133|NCT00923702|365399613|FG004|Overall Study|Ongoing enrollment|354|||
105929134|NCT01158404|365399616|FG000|Overall Study|Withdrawal by Subject|0|||
105929135|NCT01158404|365399617|FG001|Overall Study|Withdrawal by Subject|1|||
105929136|NCT01158404|365399618|FG002|Overall Study|Withdrawal by Subject|0|||
105929137|NCT01158404|365399619|FG003|Overall Study|Withdrawal by Subject|0|||
105929138|NCT01158404|365399620|FG004|Overall Study|Withdrawal by Subject|3|||
105929139|NCT01158404|365399621|FG005|Overall Study|Withdrawal by Subject|1|||
105929140|NCT01158404|365399622|FG006|Overall Study|Withdrawal by Subject|0|||
105929141|NCT01158404|365399623|FG007|Overall Study|Withdrawal by Subject|1|||
105929142|NCT01158404|365399616|FG000|Overall Study|Physician Decision|0|||
105929143|NCT01158404|365399617|FG001|Overall Study|Physician Decision|0|||
105929144|NCT01158404|365399618|FG002|Overall Study|Physician Decision|0|||
105929145|NCT01158404|365399619|FG003|Overall Study|Physician Decision|0|||
105929146|NCT01158404|365399620|FG004|Overall Study|Physician Decision|0|||
105929147|NCT01158404|365399621|FG005|Overall Study|Physician Decision|0|||
105929148|NCT01158404|365399622|FG006|Overall Study|Physician Decision|0|||
105929149|NCT01158404|365399623|FG007|Overall Study|Physician Decision|1|||
105929150|NCT01158404|365399616|FG000|Overall Study|Progressive Disease|0|||
105929151|NCT01158404|365399617|FG001|Overall Study|Progressive Disease|0|||
105929152|NCT01158404|365399618|FG002|Overall Study|Progressive Disease|0|||
105929153|NCT01158404|365399619|FG003|Overall Study|Progressive Disease|0|||
105929154|NCT01158404|365399620|FG004|Overall Study|Progressive Disease|0|||
105929155|NCT01158404|365399621|FG005|Overall Study|Progressive Disease|0|||
105929156|NCT01158404|365399622|FG006|Overall Study|Progressive Disease|1|||
105929157|NCT01158404|365399623|FG007|Overall Study|Progressive Disease|0|||
105929158|NCT00195429|365399625|FG000|Overall Study|Adverse Event|2|||
105929159|NCT00195429|365399626|FG001|Overall Study|Adverse Event|4|||
105929160|NCT00195429|365399625|FG000|Overall Study|Lack of Efficacy|2|||
105929161|NCT00195429|365399626|FG001|Overall Study|Lack of Efficacy|1|||
105929162|NCT00195429|365399625|FG000|Overall Study|Lost to Follow-up|1|||
105929163|NCT00195429|365399626|FG001|Overall Study|Lost to Follow-up|0|||
105929164|NCT00625378|365399628|FG000|Overall Study|Adverse Event|22|||
105929165|NCT00625378|365399629|FG001|Overall Study|Adverse Event|0|||
105929166|NCT00625378|365399628|FG000|Overall Study|Withdrawal by Subject|16|||
105929167|NCT00625378|365399629|FG001|Overall Study|Withdrawal by Subject|0|||
105929168|NCT00625378|365399628|FG000|Overall Study|Death|38|||
105929169|NCT00625378|365399629|FG001|Overall Study|Death|0|||
105929170|NCT00625378|365399628|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
105929171|NCT00625378|365399629|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
105929172|NCT00625378|365399628|FG000|Overall Study|Lost to Follow-up|17|||
105929173|NCT00625378|365399629|FG001|Overall Study|Lost to Follow-up|0|||
105929174|NCT00625378|365399628|FG000|Overall Study|Non-compliant with study medication|3|||
105929175|NCT00625378|365399629|FG001|Overall Study|Non-compliant with study medication|0|||
105929176|NCT00625378|365399628|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
105929177|NCT00625378|365399629|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
105929178|NCT00625378|365399628|FG000|Overall Study|Medical decision|1|||
105929179|NCT00625378|365399629|FG001|Overall Study|Medical decision|0|||
105929180|NCT00625378|365399628|FG000|Overall Study|Multiple toxicities|1|||
105929181|NCT00625378|365399629|FG001|Overall Study|Multiple toxicities|0|||
105929182|NCT00625378|365399628|FG000|Overall Study|New cancer|1|||
106008225|NCT04576988|365695255|FG001|Long Term Double Blind (LTDB)|Death|1|||
106008226|NCT04576988|365695254|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
106008227|NCT04576988|365695255|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
106008228|NCT04905134|365695261|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
106008229|NCT04905134|365695261|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
105711159|NCT01121393|364604411|FG000|Overall Study|Non-compliant with protocol|0|||
105711160|NCT01121393|364604412|FG001|Overall Study|Non-compliant with protocol|3|||
105711161|NCT01121393|364604411|FG000|Overall Study|Lost to Follow-up|1|||
105711162|NCT01121393|364604412|FG001|Overall Study|Lost to Follow-up|0|||
105711163|NCT01121393|364604411|FG000|Overall Study|Refused cont. medication|7|||
105711164|NCT01121393|364604412|FG001|Overall Study|Refused cont. medication|7|||
105711165|NCT01121393|364604411|FG000|Overall Study|Not treated|3|||
105711166|NCT01121393|364604412|FG001|Overall Study|Not treated|9|||
105711167|NCT01121393|364604411|FG000|Overall Study|Other than listed|6|||
105711168|NCT01121393|364604412|FG001|Overall Study|Other than listed|0|||
105711169|NCT02161562|364604413|FG000|Overall Study|Withdrawal by Subject|5|||
105711170|NCT02161562|364604414|FG001|Overall Study|Withdrawal by Subject|8|||
105711171|NCT02161562|364604413|FG000|Overall Study|Protocol Violation|9|||
105711172|NCT02161562|364604414|FG001|Overall Study|Protocol Violation|4|||
105711173|NCT02161562|364604413|FG000|Overall Study|Pregnancy|1|||
105711174|NCT02161562|364604414|FG001|Overall Study|Pregnancy|2|||
105711175|NCT02161562|364604413|FG000|Overall Study|Lost to Follow-up|3|||
105711176|NCT02161562|364604414|FG001|Overall Study|Lost to Follow-up|1|||
105711177|NCT02161562|364604413|FG000|Overall Study|Lack of Efficacy|4|||
105711178|NCT02161562|364604414|FG001|Overall Study|Lack of Efficacy|1|||
105711179|NCT02161562|364604413|FG000|Overall Study|Adverse Event|1|||
105711180|NCT02161562|364604414|FG001|Overall Study|Adverse Event|1|||
105711181|NCT02161562|364604413|FG000|Overall Study|Participant moved back to home country|1|||
105711182|NCT02161562|364604414|FG001|Overall Study|Participant moved back to home country|0|||
105711183|NCT02161562|364604413|FG000|Overall Study|Withdrew due to being out of the country|1|||
105711184|NCT02161562|364604414|FG001|Overall Study|Withdrew due to being out of the country|0|||
105711185|NCT02161562|364604413|FG000|Overall Study|Participant moved out of province|1|||
105711186|NCT02161562|364604414|FG001|Overall Study|Participant moved out of province|0|||
105929183|NCT00625378|365399629|FG001|Overall Study|New cancer|0|||
105929184|NCT00625378|365399628|FG000|Overall Study|PTA program|2|||
105711187|NCT01100944|364604415|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
105711188|NCT01100944|364604416|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
105711189|NCT01100944|364604417|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
105711190|NCT01100944|364604415|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
105711191|NCT01100944|364604416|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
105711192|NCT01100944|364604417|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
105711193|NCT01100944|364604415|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
105711194|NCT01100944|364604416|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
105711195|NCT01100944|364604417|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
105711196|NCT01100944|364604415|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
105711197|NCT01100944|364604416|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
106134755|NCT03761784|366152497|FG000|Overall Study|Pregnancy|1|||
106134756|NCT03761784|366152498|FG001|Overall Study|Pregnancy|0|||
106134757|NCT03761784|366152497|FG000|Overall Study|Protocol Violation|2|||
106134758|NCT03761784|366152498|FG001|Overall Study|Protocol Violation|0|||
106134759|NCT03761784|366152497|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
106134760|NCT03761784|366152498|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
106134761|NCT03761784|366152497|FG000|Overall Study|Withdrawal by Subject|9|||
106134762|NCT03761784|366152498|FG001|Overall Study|Withdrawal by Subject|4|||
106134763|NCT03761784|366152497|FG000|Overall Study|Physician Decision|1|||
106134764|NCT03761784|366152498|FG001|Overall Study|Physician Decision|0|||
106134765|NCT03761784|366152497|FG000|Overall Study|Other Than Specified|1|||
106134766|NCT03761784|366152498|FG001|Overall Study|Other Than Specified|0|||
106134767|NCT05487703|366152502|FG000|Overall Study|Other|19|||
106134768|NCT05487703|366152502|FG000|Overall Study|Participant not well|5|||
106134769|NCT05487703|366152502|FG000|Overall Study|Insurance Reasons|6|||
106134770|NCT05487703|366152502|FG000|Overall Study|Physician Decision|19|||
106134771|NCT05487703|366152502|FG000|Overall Study|Lack of Efficacy|60|||
106134772|NCT03852433|366152503|FG000|Overall Study|Withdrawal of consent|5|||
106134773|NCT03852433|366152504|FG001|Overall Study|Withdrawal of consent|8|||
106134774|NCT03852433|366152505|FG002|Overall Study|Withdrawal of consent|1|||
106134775|NCT03852433|366152506|FG003|Overall Study|Withdrawal of consent|1|||
106134776|NCT03852433|366152503|FG000|Overall Study|Adverse Event|1|||
106134777|NCT03852433|366152504|FG001|Overall Study|Adverse Event|1|||
106134778|NCT03852433|366152505|FG002|Overall Study|Adverse Event|1|||
106134779|NCT03852433|366152506|FG003|Overall Study|Adverse Event|1|||
106134780|NCT03852433|366152503|FG000|Overall Study|Lost to Follow-up|0|||
106134781|NCT03852433|366152504|FG001|Overall Study|Lost to Follow-up|1|||
106134782|NCT03852433|366152505|FG002|Overall Study|Lost to Follow-up|0|||
106134783|NCT03852433|366152506|FG003|Overall Study|Lost to Follow-up|1|||
106134784|NCT03852433|366152503|FG000|Overall Study|Pregnancy|0|||
106134785|NCT03852433|366152504|FG001|Overall Study|Pregnancy|1|||
106134786|NCT03852433|366152505|FG002|Overall Study|Pregnancy|1|||
106134787|NCT03852433|366152506|FG003|Overall Study|Pregnancy|0|||
106134788|NCT03852433|366152503|FG000|Overall Study|Protocol Violation|0|||
106134789|NCT03852433|366152504|FG001|Overall Study|Protocol Violation|0|||
106134790|NCT03852433|366152505|FG002|Overall Study|Protocol Violation|1|||
106134791|NCT03852433|366152506|FG003|Overall Study|Protocol Violation|1|||
106134792|NCT03852433|366152503|FG000|Overall Study|Death|0|||
106134793|NCT03852433|366152504|FG001|Overall Study|Death|0|||
106134794|NCT03852433|366152505|FG002|Overall Study|Death|1|||
105711198|NCT01100944|364604417|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
105929185|NCT00625378|365399629|FG001|Overall Study|PTA program|0|||
105929186|NCT00625378|365399628|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
105929187|NCT00625378|365399629|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
105929188|NCT00625378|365399628|FG000|Overall Study|Sponsor decision|1|||
105929189|NCT00625378|365399629|FG001|Overall Study|Sponsor decision|0|||
105929190|NCT00625378|365399628|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
105929191|NCT00625378|365399629|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
105929192|NCT00625378|365399628|FG000|Overall Study|Switch to commercial drug|6|||
105929193|NCT00625378|365399629|FG001|Overall Study|Switch to commercial drug|1|||
105929194|NCT00625378|365399628|FG000|Overall Study|Missing|2|||
105929195|NCT00625378|365399629|FG001|Overall Study|Missing|0|||
105929196|NCT00625378|365399628|FG000|Overall Study|End of treatment not available|2|||
105929197|NCT00625378|365399629|FG001|Overall Study|End of treatment not available|0|||
105929198|NCT00625378|365399628|FG000|Overall Study|Never treated|2|||
105929199|NCT00625378|365399629|FG001|Overall Study|Never treated|0|||
105929200|NCT03384966|365399631|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
105929201|NCT03384966|365399632|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
105929202|NCT03384966|365399633|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
105929203|NCT03384966|365399631|FG000|Follow-up Period|Adverse Event|1|||
106134795|NCT03852433|366152506|FG003|Overall Study|Death|0|||
106134796|NCT03852433|366152503|FG000|Overall Study|Lack of Efficacy|0|||
106134797|NCT03852433|366152504|FG001|Overall Study|Lack of Efficacy|1|||
106134798|NCT03852433|366152505|FG002|Overall Study|Lack of Efficacy|0|||
106134799|NCT03852433|366152506|FG003|Overall Study|Lack of Efficacy|0|||
106134800|NCT03852433|366152503|FG000|Overall Study|Non-compliance with study drug|0|||
106134801|NCT03852433|366152504|FG001|Overall Study|Non-compliance with study drug|0|||
106134802|NCT03852433|366152505|FG002|Overall Study|Non-compliance with study drug|0|||
105711199|NCT04372927|364604418|FG000|Overall Study|Death|1|||
105929204|NCT03384966|365399632|FG001|Follow-up Period|Adverse Event|0|||
105929205|NCT03384966|365399633|FG002|Follow-up Period|Adverse Event|0|||
105929206|NCT00997126|365399636|FG000|Overall Study|Physician Decision|7|||
105929207|NCT00997126|365399637|FG001|Overall Study|Physician Decision|11|||
105929208|NCT04925934|365399640|FG000|Overall Study|Adverse Event|1|||
105929209|NCT04925934|365399641|FG001|Overall Study|Adverse Event|0|||
105929210|NCT04925934|365399642|FG002|Overall Study|Adverse Event|0|||
105929211|NCT04925934|365399640|FG000|Overall Study|Lost to Follow-up|2|||
105929212|NCT04925934|365399641|FG001|Overall Study|Lost to Follow-up|0|||
105929213|NCT04925934|365399642|FG002|Overall Study|Lost to Follow-up|1|||
105929214|NCT04925934|365399640|FG000|Overall Study|Death|0|||
105929215|NCT04925934|365399641|FG001|Overall Study|Death|1|||
105929216|NCT04925934|365399642|FG002|Overall Study|Death|0|||
105929217|NCT04925934|365399640|FG000|Overall Study|Withdrawal by Subject|8|||
105929218|NCT04925934|365399641|FG001|Overall Study|Withdrawal by Subject|5|||
105929219|NCT04925934|365399642|FG002|Overall Study|Withdrawal by Subject|9|||
105929220|NCT04925934|365399640|FG000|Overall Study|Other|2|||
105929221|NCT04925934|365399641|FG001|Overall Study|Other|2|||
105711200|NCT01665807|364604421|FG000|Overall Study|Withdrawal by Subject|2|||
105711201|NCT01665807|364604422|FG001|Overall Study|Withdrawal by Subject|0|||
105711202|NCT01665807|364604423|FG002|Overall Study|Withdrawal by Subject|1|||
105711203|NCT01639833|364604427|FG000|Overall Study|Death|4|||
105711204|NCT01639833|364604428|FG001|Overall Study|Death|2|||
105711205|NCT01639833|364604427|FG000|Overall Study|Withdrawal by Subject|2|||
105711206|NCT01639833|364604428|FG001|Overall Study|Withdrawal by Subject|2|||
105929222|NCT04925934|365399642|FG002|Overall Study|Other|2|||
105711207|NCT02450578|364604431|FG000|Overall Study|ECG abnormality so not treated|1|||
105711208|NCT02450578|364604432|FG001|Overall Study|ECG abnormality so not treated|0|||
105711209|NCT02450578|364604433|FG002|Overall Study|ECG abnormality so not treated|0|||
105929223|NCT04925934|365399640|FG000|Overall Study|Eastern European Conflict|7|||
105929224|NCT04925934|365399641|FG001|Overall Study|Eastern European Conflict|3|||
105929225|NCT04925934|365399642|FG002|Overall Study|Eastern European Conflict|2|||
105929226|NCT04433975|365399643|FG000|1-month Follow Up|Withdrawal by Subject|1|||
105929227|NCT04433975|365399644|FG001|1-month Follow Up|Withdrawal by Subject|1|||
105929228|NCT04433975|365399643|FG000|1-month Follow Up|Lost to Follow-up|21|||
105929229|NCT04433975|365399644|FG001|1-month Follow Up|Lost to Follow-up|25|||
105929230|NCT04433975|365399643|FG000|3-month Follow Up|Lost to Follow-up|20|||
105929231|NCT04433975|365399644|FG001|3-month Follow Up|Lost to Follow-up|24|||
105929232|NCT04433975|365399643|FG000|3-month Follow Up|Death|1|||
105929233|NCT04433975|365399644|FG001|3-month Follow Up|Death|0|||
105929234|NCT04433975|365399643|FG000|3-month Follow Up|Withdrawal by Subject|2|||
106008230|NCT04583618|365695262|FG000|Overall Study|Adverse Event|0|||
106008231|NCT04583618|365695263|FG001|Overall Study|Adverse Event|0|||
106008232|NCT04583618|365695264|FG002|Overall Study|Adverse Event|1|||
106008233|NCT04583618|365695265|FG003|Overall Study|Adverse Event|0|||
106008234|NCT04583618|365695266|FG004|Overall Study|Adverse Event|0|||
106008235|NCT04583618|365695262|FG000|Overall Study|Protocol deviation|1|||
106008236|NCT04583618|365695263|FG001|Overall Study|Protocol deviation|1|||
106008237|NCT04583618|365695264|FG002|Overall Study|Protocol deviation|1|||
106008238|NCT04583618|365695265|FG003|Overall Study|Protocol deviation|0|||
106008239|NCT04583618|365695266|FG004|Overall Study|Protocol deviation|0|||
106008240|NCT04583618|365695262|FG000|Overall Study|Withdrawal by Subject|2|||
106008241|NCT04583618|365695263|FG001|Overall Study|Withdrawal by Subject|1|||
106008242|NCT04583618|365695264|FG002|Overall Study|Withdrawal by Subject|3|||
106008243|NCT04583618|365695265|FG003|Overall Study|Withdrawal by Subject|1|||
106008244|NCT04583618|365695266|FG004|Overall Study|Withdrawal by Subject|1|||
106008245|NCT04583618|365695262|FG000|Overall Study|Lost to Follow-up|0|||
106008246|NCT04583618|365695263|FG001|Overall Study|Lost to Follow-up|1|||
106008247|NCT04583618|365695264|FG002|Overall Study|Lost to Follow-up|3|||
106008248|NCT04583618|365695265|FG003|Overall Study|Lost to Follow-up|1|||
106008249|NCT04583618|365695266|FG004|Overall Study|Lost to Follow-up|1|||
106008250|NCT03642873|365695267|FG000|Third Intervention (1 Day)|Screen failure|0|||
106008251|NCT03642873|365695268|FG001|Third Intervention (1 Day)|Screen failure|0|||
106008252|NCT03642873|365695269|FG002|Third Intervention (1 Day)|Screen failure|0|||
106008253|NCT03642873|365695270|FG003|Third Intervention (1 Day)|Screen failure|0|||
106008254|NCT03642873|365695271|FG004|Third Intervention (1 Day)|Screen failure|1|||
106008255|NCT03642873|365695272|FG005|Third Intervention (1 Day)|Screen failure|0|||
106008256|NCT05556265|365695273|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
106008257|NCT05556265|365695274|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
106008258|NCT05556265|365695275|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
106008259|NCT05556265|365695276|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
106008260|NCT05556265|365695277|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
106008261|NCT05556265|365695273|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
106008262|NCT05556265|365695274|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
106008263|NCT05556265|365695275|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
105711210|NCT02450578|364604434|FG003|Overall Study|ECG abnormality so not treated|0|||
105929235|NCT04433975|365399644|FG001|3-month Follow Up|Withdrawal by Subject|0|||
105929236|NCT04433975|365399643|FG000|6-month Follow Up|Lost to Follow-up|23|||
105711211|NCT02574637|364604435|FG000|Double-blind Period|Adverse Event|1|||
105711212|NCT02574637|364604436|FG001|Double-blind Period|Adverse Event|0|||
105711213|NCT02574637|364604437|FG002|Double-blind Period|Adverse Event|0|||
105929237|NCT04433975|365399644|FG001|6-month Follow Up|Lost to Follow-up|28|||
105929238|NCT04433975|365399643|FG000|6-month Follow Up|Withdrawal by Subject|1|||
105929239|NCT04433975|365399644|FG001|6-month Follow Up|Withdrawal by Subject|1|||
105929240|NCT04433975|365399643|FG000|9-month Follow Up|Lost to Follow-up|27|||
105929241|NCT04433975|365399644|FG001|9-month Follow Up|Lost to Follow-up|36|||
105929242|NCT04433975|365399643|FG000|9-month Follow Up|Death|0|||
105929243|NCT04433975|365399644|FG001|9-month Follow Up|Death|1|||
105929244|NCT04433975|365399643|FG000|12-month Follow Up|Lost to Follow-up|27|||
105929245|NCT04433975|365399644|FG001|12-month Follow Up|Lost to Follow-up|31|||
105929246|NCT04606771|365399645|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
105929247|NCT04606771|365399646|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
105929248|NCT04606771|365399645|FG000|Overall Study|Death|5|||
105929249|NCT04606771|365399646|FG001|Overall Study|Death|6|||
105929250|NCT04606771|365399645|FG000|Overall Study|Wrong randomisation|0|||
105929251|NCT04606771|365399646|FG001|Overall Study|Wrong randomisation|1|||
105929252|NCT05221866|365399647|FG000|Overall Study|Withdrawal by Subject|5|||
105929253|NCT05221866|365399648|FG001|Overall Study|Withdrawal by Subject|7|||
105929254|NCT05221866|365399649|FG002|Overall Study|Withdrawal by Subject|6|||
105929255|NCT05221866|365399650|FG003|Overall Study|Withdrawal by Subject|4|||
105929256|NCT05221866|365399647|FG000|Overall Study|Physician Decision|3|||
105929257|NCT05221866|365399648|FG001|Overall Study|Physician Decision|2|||
105929258|NCT05221866|365399649|FG002|Overall Study|Physician Decision|1|||
105929259|NCT05221866|365399650|FG003|Overall Study|Physician Decision|4|||
105929260|NCT05221866|365399647|FG000|Overall Study|Lost to Follow-up|12|||
105929261|NCT05221866|365399648|FG001|Overall Study|Lost to Follow-up|17|||
105929262|NCT05221866|365399649|FG002|Overall Study|Lost to Follow-up|14|||
105929263|NCT05221866|365399650|FG003|Overall Study|Lost to Follow-up|14|||
105929264|NCT05221866|365399647|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
105929265|NCT05221866|365399648|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
105929266|NCT05221866|365399649|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
105929267|NCT05221866|365399650|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
105929268|NCT05324371|365399655|FG000|Overall Study|Withdrawal by Subject|1|||
105929269|NCT05324371|365399655|FG000|Overall Study|Death|1|||
105929270|NCT00927082|365399656|FG000|Overall Study|Lost to Follow-up|9|||
105929271|NCT00927082|365399657|FG001|Overall Study|Lost to Follow-up|8|||
105929272|NCT00927082|365399658|FG002|Overall Study|Lost to Follow-up|12|||
105929273|NCT00927082|365399659|FG003|Overall Study|Lost to Follow-up|16|||
105929274|NCT00927082|365399656|FG000|Overall Study|Withdrawal by Subject|3|||
105929275|NCT00927082|365399657|FG001|Overall Study|Withdrawal by Subject|2|||
105929276|NCT00927082|365399658|FG002|Overall Study|Withdrawal by Subject|7|||
105929277|NCT00927082|365399659|FG003|Overall Study|Withdrawal by Subject|2|||
106134803|NCT03852433|366152506|FG003|Overall Study|Non-compliance with study drug|1|||
106134804|NCT03852433|366152503|FG000|Overall Study|Physician Decision|1|||
106134805|NCT03852433|366152504|FG001|Overall Study|Physician Decision|0|||
106134806|NCT03852433|366152505|FG002|Overall Study|Physician Decision|0|||
106134807|NCT03852433|366152506|FG003|Overall Study|Physician Decision|0|||
106134808|NCT03852433|366152503|FG000|Overall Study|Randomized but never treated|1|||
106134809|NCT03852433|366152504|FG001|Overall Study|Randomized but never treated|0|||
106134810|NCT03852433|366152505|FG002|Overall Study|Randomized but never treated|0|||
106134811|NCT03852433|366152506|FG003|Overall Study|Randomized but never treated|0|||
106134812|NCT02616263|366152507|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
106134813|NCT02616263|366152508|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
106134814|NCT02616263|366152507|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
106134815|NCT02616263|366152508|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
105711214|NCT02574637|364604438|FG003|Double-blind Period|Adverse Event|0|||
105711215|NCT02574637|364604439|FG004|Double-blind Period|Adverse Event|0|||
105711216|NCT02574637|364604440|FG005|Double-blind Period|Adverse Event|0|||
105711217|NCT02574637|364604441|FG006|Double-blind Period|Adverse Event|0|||
105711218|NCT02574637|364604442|FG007|Double-blind Period|Adverse Event|0|||
105711219|NCT02574637|364604443|FG008|Double-blind Period|Adverse Event|0|||
105711220|NCT02574637|364604444|FG009|Double-blind Period|Adverse Event|0|||
105711221|NCT02574637|364604435|FG000|Double-blind Period|Lack of Efficacy|0|||
105929278|NCT00927082|365399656|FG000|Overall Study|Death|0|||
105929279|NCT00927082|365399657|FG001|Overall Study|Death|0|||
105929280|NCT00927082|365399658|FG002|Overall Study|Death|1|||
105929281|NCT00927082|365399659|FG003|Overall Study|Death|0|||
105929282|NCT00927082|365399656|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
105929283|NCT00927082|365399657|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
105929284|NCT00927082|365399658|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
105711222|NCT02574637|364604436|FG001|Double-blind Period|Lack of Efficacy|0|||
105711223|NCT02574637|364604437|FG002|Double-blind Period|Lack of Efficacy|2|||
105711224|NCT02574637|364604438|FG003|Double-blind Period|Lack of Efficacy|0|||
105711225|NCT02574637|364604439|FG004|Double-blind Period|Lack of Efficacy|0|||
105711226|NCT02574637|364604440|FG005|Double-blind Period|Lack of Efficacy|0|||
105711227|NCT02574637|364604441|FG006|Double-blind Period|Lack of Efficacy|0|||
105711228|NCT02574637|364604442|FG007|Double-blind Period|Lack of Efficacy|0|||
105711229|NCT02574637|364604443|FG008|Double-blind Period|Lack of Efficacy|0|||
105711230|NCT02574637|364604444|FG009|Double-blind Period|Lack of Efficacy|0|||
105711231|NCT02574637|364604435|FG000|Double-blind Period|Protocol Deviation|1|||
105711232|NCT02574637|364604436|FG001|Double-blind Period|Protocol Deviation|0|||
105711233|NCT02574637|364604437|FG002|Double-blind Period|Protocol Deviation|0|||
105711234|NCT02574637|364604438|FG003|Double-blind Period|Protocol Deviation|0|||
105711235|NCT02574637|364604439|FG004|Double-blind Period|Protocol Deviation|0|||
106134816|NCT02616263|366152507|FG000|6 Month to 1.5 Year|Death|1|||
106134817|NCT02616263|366152508|FG001|6 Month to 1.5 Year|Death|0|||
105711236|NCT02574637|364604440|FG005|Double-blind Period|Protocol Deviation|0|||
105711237|NCT02574637|364604441|FG006|Double-blind Period|Protocol Deviation|0|||
105711238|NCT02574637|364604442|FG007|Double-blind Period|Protocol Deviation|0|||
105711239|NCT02574637|364604443|FG008|Double-blind Period|Protocol Deviation|0|||
105711240|NCT02574637|364604444|FG009|Double-blind Period|Protocol Deviation|0|||
105711241|NCT02574637|364604435|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
105711242|NCT02574637|364604436|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
105788118|NCT03426995|364878230|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788119|NCT03426995|364878231|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105929285|NCT00927082|365399659|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
105929286|NCT00812097|365399660|FG000|Overall Study|Death|3|||
105929287|NCT00812097|365399661|FG001|Overall Study|Death|10|||
105929288|NCT00812097|365399662|FG002|Overall Study|Death|3|||
105929289|NCT00812097|365399663|FG003|Overall Study|Death|3|||
105929290|NCT00812097|365399660|FG000|Overall Study|Withdrawal by Subject|14|||
105929291|NCT00812097|365399661|FG001|Overall Study|Withdrawal by Subject|12|||
105929292|NCT00812097|365399662|FG002|Overall Study|Withdrawal by Subject|8|||
105929293|NCT00812097|365399663|FG003|Overall Study|Withdrawal by Subject|2|||
105929294|NCT00812097|365399660|FG000|Overall Study|Lost to Follow-up|90|||
105929295|NCT00812097|365399661|FG001|Overall Study|Lost to Follow-up|14|||
105929296|NCT00812097|365399662|FG002|Overall Study|Lost to Follow-up|17|||
105929297|NCT00812097|365399663|FG003|Overall Study|Lost to Follow-up|5|||
105929298|NCT00812097|365399660|FG000|Overall Study|Explantation of study device(s)|27|||
105929299|NCT00812097|365399661|FG001|Overall Study|Explantation of study device(s)|29|||
105929300|NCT00812097|365399662|FG002|Overall Study|Explantation of study device(s)|14|||
105929301|NCT00812097|365399663|FG003|Overall Study|Explantation of study device(s)|20|||
105929302|NCT00812097|365399660|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
105929303|NCT00812097|365399661|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
105929304|NCT00812097|365399662|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
105929305|NCT00812097|365399663|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
105929306|NCT03983109|365399665|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
105929307|NCT03983109|365399666|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
105929308|NCT00317369|365399670|FG000|Overall Study|Adverse Event|2|||
105929309|NCT00317369|365399671|FG001|Overall Study|Adverse Event|1|||
105929310|NCT00317369|365399672|FG002|Overall Study|Adverse Event|0|||
106134818|NCT02616263|366152507|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
106134819|NCT02616263|366152508|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
106134820|NCT02616263|366152507|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
106134821|NCT02616263|366152508|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
106134822|NCT02616263|366152507|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
106134823|NCT02616263|366152508|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
106134824|NCT03168438|366152511|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
106134825|NCT03168438|366152512|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
106134826|NCT02939183|366152515|FG000|Overall Study|Death|0|||
105929311|NCT00317369|365399670|FG000|Overall Study|Lack of Efficacy|0|||
105929312|NCT00317369|365399671|FG001|Overall Study|Lack of Efficacy|1|||
105929313|NCT00317369|365399672|FG002|Overall Study|Lack of Efficacy|1|||
106134827|NCT02939183|366152516|FG001|Overall Study|Death|0|||
106134828|NCT02939183|366152517|FG002|Overall Study|Death|1|||
105711243|NCT02574637|364604437|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
105711244|NCT02574637|364604438|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
105711245|NCT02574637|364604439|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
105711246|NCT02574637|364604440|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
105711247|NCT02574637|364604441|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
105711248|NCT02574637|364604442|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
105711249|NCT02574637|364604443|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
105711250|NCT02574637|364604444|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
105711251|NCT02574637|364604435|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
105711252|NCT02574637|364604436|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
105711253|NCT02574637|364604437|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
105711254|NCT02574637|364604438|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
105711255|NCT02574637|364604439|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
105711256|NCT02574637|364604440|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
105711257|NCT02574637|364604441|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
105711258|NCT02574637|364604442|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
106008264|NCT05556265|365695276|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
106008265|NCT05556265|365695277|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
106008266|NCT05556265|365695273|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
105711259|NCT02574637|364604443|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
105711260|NCT02574637|364604444|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
106008267|NCT05556265|365695274|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
106008268|NCT05556265|365695275|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
106008269|NCT05556265|365695276|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
106008270|NCT05556265|365695277|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
106008271|NCT05556265|365695273|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
106008272|NCT05556265|365695274|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
106008273|NCT05556265|365695275|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
106008274|NCT05556265|365695276|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
106008275|NCT05556265|365695277|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
106008276|NCT05556265|365695273|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
106008277|NCT05556265|365695274|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
106008278|NCT05556265|365695275|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
106008279|NCT05556265|365695276|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
105711261|NCT02574637|364604435|FG000|Double-blind Period|Reason Not Specified|0|||
105711262|NCT02574637|364604436|FG001|Double-blind Period|Reason Not Specified|0|||
105711263|NCT02574637|364604437|FG002|Double-blind Period|Reason Not Specified|0|||
105711264|NCT02574637|364604438|FG003|Double-blind Period|Reason Not Specified|1|||
105711265|NCT02574637|364604439|FG004|Double-blind Period|Reason Not Specified|0|||
105711266|NCT02574637|364604440|FG005|Double-blind Period|Reason Not Specified|0|||
105711267|NCT02574637|364604441|FG006|Double-blind Period|Reason Not Specified|0|||
105711268|NCT02574637|364604442|FG007|Double-blind Period|Reason Not Specified|0|||
105711269|NCT02574637|364604443|FG008|Double-blind Period|Reason Not Specified|0|||
105711270|NCT02574637|364604444|FG009|Double-blind Period|Reason Not Specified|0|||
105711271|NCT02574637|364604435|FG000|Open-label (OL) Period|Adverse Event|0|||
105711272|NCT02574637|364604436|FG001|Open-label (OL) Period|Adverse Event|0|||
105711273|NCT02574637|364604437|FG002|Open-label (OL) Period|Adverse Event|0|||
105711274|NCT02574637|364604438|FG003|Open-label (OL) Period|Adverse Event|0|||
105711275|NCT02574637|364604439|FG004|Open-label (OL) Period|Adverse Event|0|||
105711276|NCT02574637|364604440|FG005|Open-label (OL) Period|Adverse Event|0|||
105711277|NCT02574637|364604441|FG006|Open-label (OL) Period|Adverse Event|0|||
105788120|NCT03426995|364878232|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
106008280|NCT05556265|365695277|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
106008281|NCT05556265|365695273|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
106008282|NCT05556265|365695274|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
106008283|NCT05556265|365695275|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
106008284|NCT05556265|365695276|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
106008285|NCT05556265|365695277|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
106008286|NCT05556265|365695273|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
106008287|NCT05556265|365695274|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
106008288|NCT05556265|365695275|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
106008289|NCT05556265|365695276|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
106008290|NCT05556265|365695277|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
106008291|NCT05556265|365695273|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
105788121|NCT03426995|364878233|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105711278|NCT02574637|364604442|FG007|Open-label (OL) Period|Adverse Event|0|||
105711279|NCT02574637|364604443|FG008|Open-label (OL) Period|Adverse Event|1|||
105711280|NCT02574637|364604444|FG009|Open-label (OL) Period|Adverse Event|0|||
105711281|NCT02574637|364604435|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
105711282|NCT02574637|364604436|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
105711283|NCT02574637|364604437|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
105711284|NCT02574637|364604438|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
105711285|NCT02574637|364604439|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
105711286|NCT02574637|364604440|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
105711287|NCT02574637|364604441|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
105711288|NCT02574637|364604442|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
105711289|NCT02574637|364604443|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
105711290|NCT02574637|364604444|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
105711291|NCT02574637|364604435|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711292|NCT02574637|364604436|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711293|NCT02574637|364604437|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711294|NCT02574637|364604438|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711295|NCT02574637|364604439|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711296|NCT02574637|364604440|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
105711297|NCT02574637|364604441|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
105711298|NCT02574637|364604442|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
105711299|NCT02574637|364604443|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
105711300|NCT02574637|364604444|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
105711301|NCT00662792|364604446|FG000|Period 1|Personal Reasons|0|||
105711302|NCT00662792|364604447|FG001|Period 1|Personal Reasons|0|||
105711303|NCT00662792|364604448|FG002|Period 1|Personal Reasons|1|||
105711304|NCT00662792|364604449|FG003|Period 1|Personal Reasons|0|||
105711305|NCT00662792|364604446|FG000|Period 1|Refused continuing medication|0|||
105711306|NCT00662792|364604447|FG001|Period 1|Refused continuing medication|1|||
105711307|NCT00662792|364604448|FG002|Period 1|Refused continuing medication|1|||
105711308|NCT00662792|364604449|FG003|Period 1|Refused continuing medication|0|||
105711309|NCT00662792|364604446|FG000|Period 1|Lost to Follow-up|1|||
105711310|NCT00662792|364604447|FG001|Period 1|Lost to Follow-up|0|||
105711311|NCT00662792|364604448|FG002|Period 1|Lost to Follow-up|0|||
105711312|NCT00662792|364604449|FG003|Period 1|Lost to Follow-up|0|||
105711313|NCT00662792|364604446|FG000|Period 1|Other adverse event (AE)|0|||
105711314|NCT00662792|364604447|FG001|Period 1|Other adverse event (AE)|2|||
105929314|NCT00317369|365399670|FG000|Overall Study|Withdrawal by Subject|0|||
105929315|NCT00317369|365399671|FG001|Overall Study|Withdrawal by Subject|0|||
105929316|NCT00317369|365399672|FG002|Overall Study|Withdrawal by Subject|1|||
105929317|NCT01860404|365399673|FG000|Overall Study|Lost to Follow-up|3|||
105929318|NCT01860404|365399674|FG001|Overall Study|Lost to Follow-up|4|||
105929319|NCT01860404|365399675|FG002|Overall Study|Lost to Follow-up|1|||
105929320|NCT01860404|365399676|FG003|Overall Study|Lost to Follow-up|6|||
105929321|NCT01860404|365399677|FG004|Overall Study|Lost to Follow-up|4|||
105929322|NCT01860404|365399673|FG000|Overall Study|Withdrawal by Subject|0|||
105929323|NCT01860404|365399674|FG001|Overall Study|Withdrawal by Subject|0|||
105929324|NCT01860404|365399675|FG002|Overall Study|Withdrawal by Subject|4|||
105711315|NCT00662792|364604448|FG002|Period 1|Other adverse event (AE)|0|||
105929325|NCT01860404|365399676|FG003|Overall Study|Withdrawal by Subject|0|||
105929326|NCT01860404|365399677|FG004|Overall Study|Withdrawal by Subject|0|||
105929327|NCT05259033|365399682|FG000|Overall Study|Withdrawal by Subject|10|||
105929328|NCT05259033|365399683|FG001|Overall Study|Withdrawal by Subject|5|||
105929329|NCT05259033|365399682|FG000|Overall Study|Lost to Follow-up|1|||
105929330|NCT05259033|365399683|FG001|Overall Study|Lost to Follow-up|0|||
105711316|NCT00662792|364604449|FG003|Period 1|Other adverse event (AE)|0|||
105711317|NCT00662792|364604446|FG000|Period 1|Worsening of disease under study (AE)|1|||
105711318|NCT00662792|364604447|FG001|Period 1|Worsening of disease under study (AE)|3|||
105711319|NCT00662792|364604448|FG002|Period 1|Worsening of disease under study (AE)|2|||
105788122|NCT03426995|364878234|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105929331|NCT05259033|365399682|FG000|Overall Study|Death|2|||
105929332|NCT05259033|365399683|FG001|Overall Study|Death|0|||
106134829|NCT02939183|366152518|FG003|Overall Study|Death|0|||
106134830|NCT02939183|366152519|FG004|Overall Study|Death|0|||
106134831|NCT02939183|366152520|FG005|Overall Study|Death|2|||
106134832|NCT02939183|366152521|FG006|Overall Study|Death|1|||
106134833|NCT02939183|366152522|FG007|Overall Study|Death|0|||
106134834|NCT02939183|366152523|FG008|Overall Study|Death|0|||
106134835|NCT02939183|366152515|FG000|Overall Study|Sponsor decision|0|||
106134836|NCT02939183|366152516|FG001|Overall Study|Sponsor decision|1|||
106134837|NCT02939183|366152517|FG002|Overall Study|Sponsor decision|0|||
106134838|NCT02939183|366152518|FG003|Overall Study|Sponsor decision|1|||
106134839|NCT02939183|366152519|FG004|Overall Study|Sponsor decision|2|||
106134840|NCT02939183|366152520|FG005|Overall Study|Sponsor decision|0|||
106134841|NCT02939183|366152521|FG006|Overall Study|Sponsor decision|3|||
106134842|NCT02939183|366152522|FG007|Overall Study|Sponsor decision|1|||
106134843|NCT02939183|366152523|FG008|Overall Study|Sponsor decision|4|||
106134844|NCT02939183|366152515|FG000|Overall Study|Withdrawal by Subject|0|||
106008292|NCT05556265|365695274|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
106008293|NCT05556265|365695275|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
106008294|NCT05556265|365695276|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
106008295|NCT05556265|365695277|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
105711320|NCT00662792|364604449|FG003|Period 1|Worsening of disease under study (AE)|0|||
105711321|NCT00662792|364604446|FG000|Period 1|Not treated|0|||
105711322|NCT00662792|364604447|FG001|Period 1|Not treated|1|||
106008296|NCT05556265|365695273|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
106008297|NCT05556265|365695274|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
106008298|NCT05556265|365695275|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
106008299|NCT05556265|365695276|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
106008300|NCT05556265|365695277|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
106008301|NCT04609319|365695278|FG000|Overall Study|Death|64|||
106008302|NCT04609319|365695279|FG001|Overall Study|Death|49|||
106008303|NCT04609319|365695280|FG002|Overall Study|Death|1|||
106008304|NCT04609319|365695278|FG000|Overall Study|Withdrawal of consent|15|||
106008305|NCT04609319|365695279|FG001|Overall Study|Withdrawal of consent|3|||
106008306|NCT04609319|365695280|FG002|Overall Study|Withdrawal of consent|0|||
106008307|NCT04609319|365695278|FG000|Overall Study|Lost to Follow-up|20|||
106008308|NCT04609319|365695279|FG001|Overall Study|Lost to Follow-up|33|||
106008309|NCT04609319|365695280|FG002|Overall Study|Lost to Follow-up|0|||
106008310|NCT04609319|365695278|FG000|Overall Study|Alive until end of follow-up|60|||
106008311|NCT04609319|365695279|FG001|Overall Study|Alive until end of follow-up|53|||
106008312|NCT04609319|365695280|FG002|Overall Study|Alive until end of follow-up|1|||
106008313|NCT03221556|365695281|FG000|Allocation|post-randomization exclusion|0|||
106008314|NCT03221556|365695282|FG001|Allocation|post-randomization exclusion|1|||
106008315|NCT03221556|365695281|FG000|Follow-Up|Withdrawal by Subject|0|||
106008316|NCT03221556|365695282|FG001|Follow-Up|Withdrawal by Subject|1|||
106008317|NCT00626106|365695287|FG000|Overall Study|Withdrawal by Subject|2|||
106008318|NCT00626106|365695288|FG001|Overall Study|Withdrawal by Subject|1|||
106134845|NCT02939183|366152516|FG001|Overall Study|Withdrawal by Subject|2|||
106134846|NCT02939183|366152517|FG002|Overall Study|Withdrawal by Subject|0|||
106134847|NCT02939183|366152518|FG003|Overall Study|Withdrawal by Subject|1|||
106134848|NCT02939183|366152519|FG004|Overall Study|Withdrawal by Subject|0|||
106134849|NCT02939183|366152520|FG005|Overall Study|Withdrawal by Subject|0|||
106134850|NCT02939183|366152521|FG006|Overall Study|Withdrawal by Subject|2|||
106134851|NCT02939183|366152522|FG007|Overall Study|Withdrawal by Subject|2|||
106134852|NCT02939183|366152523|FG008|Overall Study|Withdrawal by Subject|2|||
106134853|NCT02939183|366152515|FG000|Overall Study|Not treated due to adverse event|0|||
106134854|NCT02939183|366152516|FG001|Overall Study|Not treated due to adverse event|0|||
106134855|NCT02939183|366152517|FG002|Overall Study|Not treated due to adverse event|0|||
106134856|NCT02939183|366152518|FG003|Overall Study|Not treated due to adverse event|1|||
106134857|NCT02939183|366152519|FG004|Overall Study|Not treated due to adverse event|0|||
106134858|NCT02939183|366152520|FG005|Overall Study|Not treated due to adverse event|0|||
106134859|NCT02939183|366152521|FG006|Overall Study|Not treated due to adverse event|1|||
106134860|NCT02939183|366152522|FG007|Overall Study|Not treated due to adverse event|0|||
106134861|NCT02939183|366152523|FG008|Overall Study|Not treated due to adverse event|0|||
106134862|NCT01446003|366152527|FG000|Period 1|Protocol Violation|2|||
106134863|NCT01446003|366152528|FG001|Period 1|Protocol Violation|0|||
106134864|NCT01446003|366152527|FG000|Period 2|Adverse Event|1|||
106134865|NCT01446003|366152528|FG001|Period 2|Adverse Event|0|||
106134866|NCT00318656|366152529|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
106134867|NCT00318656|366152530|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
106134868|NCT00318656|366152529|FG000|Overall Study|Did not receive any treatment|0|||
106134869|NCT00318656|366152530|FG001|Overall Study|Did not receive any treatment|1|||
106134870|NCT03905135|366152531|FG000|Dose Escalation|Adverse Event|1|||
106134871|NCT03905135|366152532|FG001|Dose Escalation|Adverse Event|1|||
106134872|NCT03905135|366152531|FG000|Dose Escalation|Progressive disease|3|||
106134873|NCT03905135|366152532|FG001|Dose Escalation|Progressive disease|1|||
106134874|NCT03905135|366152531|FG000|Dose Escalation|Intercurrent illness|1|||
106134875|NCT03905135|366152532|FG001|Dose Escalation|Intercurrent illness|0|||
106134876|NCT00490555|366152535|FG000|Overall Study|noncompliant with drug administration|0|||
106134877|NCT00490555|366152536|FG001|Overall Study|noncompliant with drug administration|0|||
106134878|NCT00490555|366152537|FG002|Overall Study|noncompliant with drug administration|2|||
106134879|NCT00490555|366152538|FG003|Overall Study|noncompliant with drug administration|0|||
106134880|NCT04550039|366152539|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
106134881|NCT04550039|366152540|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
105711323|NCT00662792|364604448|FG002|Period 1|Not treated|0|||
106008319|NCT00626106|365695287|FG000|Overall Study|Lost to Follow-up|1|||
106134882|NCT04550039|366152539|FG000|Overall Study|patient self-withdrew from study|0|||
106134883|NCT04550039|366152540|FG001|Overall Study|patient self-withdrew from study|1|||
106134884|NCT01656304|366152541|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
105711324|NCT00662792|364604449|FG003|Period 1|Not treated|0|||
105711325|NCT00662792|364604446|FG000|Period 2|Worsening of disease under study|1|||
105711326|NCT00662792|364604447|FG001|Period 2|Worsening of disease under study|0|||
105711327|NCT00662792|364604448|FG002|Period 2|Worsening of disease under study|0|||
105711328|NCT00662792|364604449|FG003|Period 2|Worsening of disease under study|3|||
105711329|NCT00662792|364604446|FG000|Period 3|Refused continuing medication|1|||
105711330|NCT00662792|364604447|FG001|Period 3|Refused continuing medication|0|||
106008320|NCT00626106|365695288|FG001|Overall Study|Lost to Follow-up|4|||
105711331|NCT00662792|364604448|FG002|Period 3|Refused continuing medication|1|||
105711332|NCT00662792|364604449|FG003|Period 3|Refused continuing medication|0|||
105711333|NCT00662792|364604446|FG000|Period 3|Other adverse event (AE)|0|||
105711334|NCT00662792|364604447|FG001|Period 3|Other adverse event (AE)|0|||
105711335|NCT00662792|364604448|FG002|Period 3|Other adverse event (AE)|1|||
105711336|NCT00662792|364604449|FG003|Period 3|Other adverse event (AE)|1|||
105711337|NCT00662792|364604446|FG000|Period 4|Refused continuing medication|0|||
105711338|NCT00662792|364604447|FG001|Period 4|Refused continuing medication|1|||
105711339|NCT00662792|364604448|FG002|Period 4|Refused continuing medication|0|||
105711340|NCT00662792|364604449|FG003|Period 4|Refused continuing medication|0|||
105711341|NCT00662792|364604446|FG000|Period 4|Other adverse event (AE)|1|||
105711342|NCT00662792|364604447|FG001|Period 4|Other adverse event (AE)|0|||
105711343|NCT00662792|364604448|FG002|Period 4|Other adverse event (AE)|0|||
105711344|NCT00662792|364604449|FG003|Period 4|Other adverse event (AE)|0|||
105711345|NCT00662792|364604446|FG000|Period 4|Worsening of disease under study (AE)|0|||
105711346|NCT00662792|364604447|FG001|Period 4|Worsening of disease under study (AE)|0|||
105711347|NCT00662792|364604448|FG002|Period 4|Worsening of disease under study (AE)|0|||
105929333|NCT03091439|365399684|FG000|Overall Study|Study Terminated by the Sponsor|1|||
105929334|NCT03091439|365399685|FG001|Overall Study|Study Terminated by the Sponsor|0|||
105929335|NCT04739709|365399686|FG000|Overall Study|Physician Decision|1|||
105929336|NCT04739709|365399687|FG001|Overall Study|Physician Decision|0|||
106008321|NCT00626106|365695287|FG000|Overall Study|Death|64|||
106008322|NCT00626106|365695288|FG001|Overall Study|Death|19|||
106008323|NCT04272242|365695289|FG000|Overall Study|Withdrawal by Subject|3|||
106008324|NCT04272242|365695289|FG000|Overall Study|Lost to Follow-up|1|||
105711348|NCT00662792|364604449|FG003|Period 4|Worsening of disease under study (AE)|1|||
105711349|NCT02706730|364604450|FG000|Overall Study|Adverse Event|3|||
105711350|NCT02706730|364604450|FG000|Overall Study|Lack of Efficacy|5|||
105711351|NCT02706730|364604450|FG000|Overall Study|Withdrawal by Subject|11|||
105711352|NCT02706730|364604450|FG000|Overall Study|Study Terminated by Sponsor|11|||
105711353|NCT02706730|364604450|FG000|Overall Study|Subject chose not to receive injection|3|||
105711354|NCT00094055|364604451|FG000|Overall Study|Adverse Event|11|||
105711355|NCT00094055|364604451|FG000|Overall Study|Death|4|||
105711356|NCT00094055|364604451|FG000|Overall Study|Lack of Efficacy|17|||
105711357|NCT00094055|364604451|FG000|Overall Study|Lost to Follow-up|2|||
105711358|NCT00094055|364604451|FG000|Overall Study|progressive disease|2|||
105711359|NCT00094055|364604451|FG000|Overall Study|clinical progression|1|||
105711360|NCT00094055|364604451|FG000|Overall Study|roll-over to another study|14|||
105711361|NCT00094055|364604451|FG000|Overall Study|Withdrawal by Subject|9|||
105711362|NCT01999582|364604452|FG000|Overall Study|Withdrawal by Subject|0|||
106008325|NCT04272242|365695289|FG000|Overall Study|Adverse Event|1|||
106008326|NCT00199381|365696920|FG000|Overall Study|Withdrawal by Subject|38|||
106008327|NCT00199381|365696920|FG000|Overall Study|Adverse Event|73|||
106134885|NCT01348087|366152548|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
106134886|NCT01348087|366152548|FG000|Overall Study|Administrative problems|79|||
105711363|NCT01999582|364604453|FG001|Overall Study|Withdrawal by Subject|0|||
105711364|NCT01999582|364604454|FG002|Overall Study|Withdrawal by Subject|0|||
105711365|NCT01999582|364604455|FG003|Overall Study|Withdrawal by Subject|1|||
105711366|NCT01999582|364604456|FG004|Overall Study|Withdrawal by Subject|0|||
105711367|NCT01999582|364604457|FG005|Overall Study|Withdrawal by Subject|0|||
105929337|NCT02184156|365399688|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
105929338|NCT02184156|365399689|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
105929339|NCT02184156|365399688|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
105929340|NCT02184156|365399689|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
105929341|NCT00283959|365399695|FG000|Extension Period|Low Compliance|1|||
105929342|NCT01483651|365399701|FG000|Overall Study|Withdrawal by Subject|0|||
105929343|NCT01483651|365399702|FG001|Overall Study|Withdrawal by Subject|1|||
105929344|NCT01483651|365399703|FG002|Overall Study|Withdrawal by Subject|1|||
105929345|NCT01483651|365399704|FG003|Overall Study|Withdrawal by Subject|0|||
105929346|NCT01483651|365399705|FG004|Overall Study|Withdrawal by Subject|0|||
105929347|NCT01483651|365399706|FG005|Overall Study|Withdrawal by Subject|1|||
105929348|NCT01018953|365399711|FG000|Overall Study|Adverse Event|2|||
105929349|NCT01018953|365399711|FG000|Overall Study|Withdrawal by Subject|1|||
105929350|NCT01018953|365399711|FG000|Overall Study|Study termination by sponsor|5|||
105929351|NCT01186419|365399712|FG000|Overall Study|Withdrawal by Subject|5|||
105929352|NCT01186419|365399713|FG001|Overall Study|Withdrawal by Subject|3|||
105929353|NCT01186419|365399712|FG000|Overall Study|Adverse Event|1|||
105929354|NCT01186419|365399713|FG001|Overall Study|Adverse Event|2|||
105929355|NCT01186419|365399712|FG000|Overall Study|Physician Decision|0|||
105929356|NCT01186419|365399713|FG001|Overall Study|Physician Decision|3|||
106134887|NCT01348087|366152548|FG000|Overall Study|protocol deviation|1|||
105711368|NCT01999582|364604452|FG000|Overall Study|Adverse Event|0|||
105929357|NCT01186419|365399712|FG000|Overall Study|Other|1|||
105929358|NCT01186419|365399713|FG001|Overall Study|Other|1|||
105929359|NCT01560416|365399721|FG000|Randomized Phase|Crossover Participants|7|||
105929360|NCT01560416|365399722|FG001|Randomized Phase|Crossover Participants|0|||
106008328|NCT00199381|365696920|FG000|Overall Study|Protocol Violation|6|||
105711369|NCT01999582|364604453|FG001|Overall Study|Adverse Event|0|||
105711370|NCT01999582|364604454|FG002|Overall Study|Adverse Event|3|||
105711371|NCT01999582|364604455|FG003|Overall Study|Adverse Event|0|||
105711372|NCT01999582|364604456|FG004|Overall Study|Adverse Event|1|||
106134888|NCT01348087|366152548|FG000|Overall Study|Lost to Follow-up|1|||
106134889|NCT01348087|366152548|FG000|Overall Study|Subject withdrew consent|7|||
106134890|NCT01348087|366152548|FG000|Overall Study|Adverse Event|25|||
106134891|NCT01007149|366152549|FG000|Overall Study|Administrative problems|0|||
106134892|NCT01007149|366152550|FG001|Overall Study|Administrative problems|1|||
106134893|NCT00828945|366152551|FG000|Overall Study|Death|4|||
106134894|NCT00828945|366152551|FG000|Overall Study|Participant was missing|1|||
106134895|NCT00828945|366152551|FG000|Overall Study|Other|36|||
106134896|NCT04888585|366152556|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
106134897|NCT04888585|366152557|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
106134898|NCT04888585|366152558|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
106134899|NCT04888585|366152559|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
106134900|NCT04888585|366152560|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
106134901|NCT04888585|366152561|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
106134902|NCT04888585|366152562|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
106134903|NCT04888585|366152563|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
106134904|NCT04888585|366152564|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
106134905|NCT04888585|366152565|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
106134906|NCT04888585|366152566|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
106134907|NCT04888585|366152556|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
106134908|NCT04888585|366152557|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
106134909|NCT04888585|366152558|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
106134910|NCT04888585|366152559|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
106134911|NCT04888585|366152560|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
106134912|NCT04888585|366152561|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
106134913|NCT04888585|366152562|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
106134914|NCT04888585|366152563|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
106134915|NCT04888585|366152564|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
106134916|NCT04888585|366152565|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
106134917|NCT04888585|366152566|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
106134918|NCT04888585|366152556|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134919|NCT04888585|366152557|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134920|NCT04888585|366152558|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
106134921|NCT04888585|366152559|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134922|NCT04888585|366152560|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
106134923|NCT04888585|366152561|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134924|NCT04888585|366152562|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134925|NCT04888585|366152563|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134926|NCT04888585|366152564|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134927|NCT04888585|366152565|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134928|NCT04888585|366152566|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
106134929|NCT04888585|366152556|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134930|NCT04888585|366152557|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134931|NCT04888585|366152558|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134932|NCT04888585|366152559|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134933|NCT04888585|366152560|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134934|NCT04888585|366152561|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134935|NCT04888585|366152562|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134936|NCT04888585|366152563|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
106134937|NCT04888585|366152564|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134938|NCT04888585|366152565|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
106134939|NCT04888585|366152566|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
106134940|NCT04888585|366152556|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
106134941|NCT04888585|366152557|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
106134942|NCT04888585|366152558|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
106134943|NCT04888585|366152559|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
106134944|NCT04888585|366152560|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
106134945|NCT04888585|366152561|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
106134946|NCT04888585|366152562|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
106134947|NCT04888585|366152563|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
106134948|NCT04888585|366152564|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
106134949|NCT04888585|366152565|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
105711373|NCT01999582|364604457|FG005|Overall Study|Adverse Event|0|||
105711374|NCT01999582|364604452|FG000|Overall Study|Other Reasons|1|||
105711375|NCT01999582|364604453|FG001|Overall Study|Other Reasons|0|||
105711376|NCT01999582|364604454|FG002|Overall Study|Other Reasons|3|||
105711377|NCT01999582|364604455|FG003|Overall Study|Other Reasons|1|||
105711378|NCT01999582|364604456|FG004|Overall Study|Other Reasons|1|||
105711379|NCT01999582|364604457|FG005|Overall Study|Other Reasons|2|||
105711380|NCT01999582|364604452|FG000|Overall Study|Protocol Violation|1|||
105711381|NCT01999582|364604453|FG001|Overall Study|Protocol Violation|0|||
105711382|NCT01999582|364604454|FG002|Overall Study|Protocol Violation|0|||
105711383|NCT01999582|364604455|FG003|Overall Study|Protocol Violation|0|||
105711384|NCT01999582|364604456|FG004|Overall Study|Protocol Violation|0|||
105711385|NCT01999582|364604457|FG005|Overall Study|Protocol Violation|1|||
105711386|NCT01999582|364604452|FG000|Overall Study|Lack of Efficacy|1|||
105711387|NCT01999582|364604453|FG001|Overall Study|Lack of Efficacy|3|||
105711388|NCT01999582|364604454|FG002|Overall Study|Lack of Efficacy|0|||
105711389|NCT01999582|364604455|FG003|Overall Study|Lack of Efficacy|1|||
105929361|NCT01030900|365399723|FG000|Overall Study|Not treated due to congestive heart failure|1|||
105929362|NCT01030900|365399723|FG000|Overall Study|Not treated due to rapid disease|1|||
105929363|NCT01301092|365399726|FG000|Overall Study|Lost to Follow-up|0|||
105711390|NCT01999582|364604456|FG004|Overall Study|Lack of Efficacy|0|||
105711391|NCT01999582|364604457|FG005|Overall Study|Lack of Efficacy|0|||
105929364|NCT01301092|365399727|FG001|Overall Study|Lost to Follow-up|0|||
105929365|NCT01301092|365399728|FG002|Overall Study|Lost to Follow-up|1|||
105929366|NCT03334175|365399729|FG000|Overall Study|Lost to Follow-up|0|||
105929367|NCT03334175|365399730|FG001|Overall Study|Lost to Follow-up|1|||
105929368|NCT02638493|365399731|FG000|Overall Study|Inability to provide semen samples|2|||
105929369|NCT02638493|365399732|FG001|Overall Study|Inability to provide semen samples|0|||
105929370|NCT02638493|365399733|FG002|Overall Study|Inability to provide semen samples|0|||
105929371|NCT01033071|365399734|FG000|Overall Study|Adverse Event|28|||
105929372|NCT01033071|365399735|FG001|Overall Study|Adverse Event|51|||
105929373|NCT01033071|365399736|FG002|Overall Study|Adverse Event|26|||
105929374|NCT01033071|365399734|FG000|Overall Study|Protocol Violation|0|||
105929375|NCT01033071|365399735|FG001|Overall Study|Protocol Violation|2|||
105929376|NCT01033071|365399736|FG002|Overall Study|Protocol Violation|1|||
105929377|NCT01033071|365399734|FG000|Overall Study|Lost to Follow-up|4|||
105929378|NCT01033071|365399735|FG001|Overall Study|Lost to Follow-up|5|||
105929379|NCT01033071|365399736|FG002|Overall Study|Lost to Follow-up|5|||
105929380|NCT01033071|365399734|FG000|Overall Study|Withdrawal by Subject|17|||
105929381|NCT01033071|365399735|FG001|Overall Study|Withdrawal by Subject|14|||
105711392|NCT02347176|364604458|FG000|Overall Study|Lost to Follow-up|2|||
105711393|NCT02347176|364604459|FG001|Overall Study|Lost to Follow-up|3|||
105711394|NCT02347176|364604460|FG002|Overall Study|Lost to Follow-up|1|||
105711395|NCT02347176|364604461|FG003|Overall Study|Lost to Follow-up|1|||
105929382|NCT01033071|365399736|FG002|Overall Study|Withdrawal by Subject|11|||
105929383|NCT01033071|365399734|FG000|Overall Study|Lack of Efficacy|0|||
105929384|NCT01033071|365399735|FG001|Overall Study|Lack of Efficacy|1|||
105929385|NCT01033071|365399736|FG002|Overall Study|Lack of Efficacy|1|||
105929386|NCT01033071|365399734|FG000|Overall Study|Other|6|||
105711396|NCT02347176|364604458|FG000|Overall Study|Withdrawal by Subject|9|||
105711397|NCT02347176|364604459|FG001|Overall Study|Withdrawal by Subject|5|||
105711398|NCT02347176|364604460|FG002|Overall Study|Withdrawal by Subject|5|||
105711399|NCT02347176|364604461|FG003|Overall Study|Withdrawal by Subject|3|||
105711400|NCT02347176|364604458|FG000|Overall Study|Other|1|||
105711401|NCT02347176|364604459|FG001|Overall Study|Other|2|||
105711402|NCT02347176|364604460|FG002|Overall Study|Other|2|||
105711403|NCT02347176|364604461|FG003|Overall Study|Other|0|||
105711404|NCT03603496|364604463|FG000|Overall Study|Death|19|||
105711405|NCT03603496|364604464|FG001|Overall Study|Death|24|||
105711406|NCT03603496|364604463|FG000|Overall Study|Lost to Follow-up|141|||
105711407|NCT03603496|364604464|FG001|Overall Study|Lost to Follow-up|141|||
105711408|NCT03603496|364604463|FG000|Overall Study|Withdrawal by Subject|26|||
105711409|NCT03603496|364604464|FG001|Overall Study|Withdrawal by Subject|20|||
105711410|NCT00699907|364604467|FG000|Overall Study|Withdrawal by Subject|2|||
105711411|NCT00699907|364604468|FG001|Overall Study|Withdrawal by Subject|1|||
105711412|NCT00699907|364604469|FG002|Overall Study|Withdrawal by Subject|0|||
105711413|NCT00699907|364604467|FG000|Overall Study|No usable sample|0|||
105711414|NCT00699907|364604468|FG001|Overall Study|No usable sample|9|||
105711415|NCT00699907|364604469|FG002|Overall Study|No usable sample|8|||
105711416|NCT01081795|364604470|FG000|Overall Study|Adverse Event|18|||
105711417|NCT01081795|364604471|FG001|Overall Study|Adverse Event|23|||
105711418|NCT01081795|364604472|FG002|Overall Study|Adverse Event|6|||
105711419|NCT01081795|364604470|FG000|Overall Study|Lack of Efficacy|7|||
105711420|NCT01081795|364604471|FG001|Overall Study|Lack of Efficacy|5|||
105711421|NCT01081795|364604472|FG002|Overall Study|Lack of Efficacy|19|||
105711422|NCT01081795|364604470|FG000|Overall Study|Subject's schedule|1|||
105711423|NCT01081795|364604471|FG001|Overall Study|Subject's schedule|1|||
105711424|NCT01081795|364604472|FG002|Overall Study|Subject's schedule|2|||
105711425|NCT01081795|364604470|FG000|Overall Study|Revocation of informed consent|2|||
105711426|NCT01081795|364604471|FG001|Overall Study|Revocation of informed consent|0|||
105711427|NCT01081795|364604472|FG002|Overall Study|Revocation of informed consent|0|||
105711428|NCT01081795|364604470|FG000|Overall Study|Ineligible for participation|1|||
105711429|NCT01081795|364604471|FG001|Overall Study|Ineligible for participation|0|||
105711430|NCT01081795|364604472|FG002|Overall Study|Ineligible for participation|0|||
105711431|NCT01081795|364604470|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
105711432|NCT01081795|364604471|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
105711433|NCT01081795|364604472|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
105711434|NCT01081795|364604470|FG000|Overall Study|Using drug with restricted days of use|2|||
105711435|NCT01081795|364604471|FG001|Overall Study|Using drug with restricted days of use|3|||
105711436|NCT01081795|364604472|FG002|Overall Study|Using drug with restricted days of use|2|||
105711437|NCT01081795|364604470|FG000|Overall Study|Other|1|||
105711438|NCT01081795|364604471|FG001|Overall Study|Other|2|||
105711439|NCT01081795|364604472|FG002|Overall Study|Other|0|||
105711440|NCT02462473|364604473|FG000|Overall Study|Death|1|||
105711441|NCT02462473|364604473|FG000|Overall Study|Other|3|||
105711442|NCT00661271|364604474|FG000|Overall Study|Lost to Follow-up|28|||
105711443|NCT00661271|364604475|FG001|Overall Study|Lost to Follow-up|25|||
105711444|NCT03728309|364604480|FG000|Overall Study|Randomized but not Treated|0|||
105711445|NCT03728309|364604481|FG001|Overall Study|Randomized but not Treated|1|||
105711446|NCT03728309|364604480|FG000|Overall Study|Adverse Event|0|||
105929387|NCT01033071|365399735|FG001|Overall Study|Other|4|||
105929388|NCT01033071|365399736|FG002|Overall Study|Other|3|||
105929389|NCT04073407|365399743|FG000|Part 1|Withdrawal by Subject|1|||
105929390|NCT04073407|365399744|FG001|Part 1|Withdrawal by Subject|0|||
105929391|NCT04073407|365399743|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
105929392|NCT04073407|365399744|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
105929393|NCT04073407|365399743|FG000|Part 2|Withdrawal by Subject|0|||
105929394|NCT04073407|365399744|FG001|Part 2|Withdrawal by Subject|1|||
105929395|NCT00992836|365401067|FG000|Overall Study|Lost to Follow-up|1|||
105929396|NCT00992836|365401067|FG000|Overall Study|Withdrawal by Subject|2|||
105929397|NCT00992836|365401067|FG000|Overall Study|Protocol Violation|2|||
105929398|NCT02323334|365401070|FG000|Period 3|Lost to Follow-up|0|||
105929399|NCT02323334|365401071|FG001|Period 3|Lost to Follow-up|0|||
105929400|NCT02323334|365401072|FG002|Period 3|Lost to Follow-up|1|||
105929401|NCT02323334|365401073|FG003|Period 3|Lost to Follow-up|0|||
105929402|NCT02323334|365401074|FG004|Period 3|Lost to Follow-up|0|||
105929403|NCT02323334|365401075|FG005|Period 3|Lost to Follow-up|0|||
105929404|NCT02323334|365401076|FG006|Period 3|Lost to Follow-up|0|||
105711447|NCT03728309|364604481|FG001|Overall Study|Adverse Event|1|||
105711448|NCT03728309|364604480|FG000|Overall Study|Withdrawal by Subject|2|||
105711449|NCT03728309|364604481|FG001|Overall Study|Withdrawal by Subject|8|||
105711450|NCT03728309|364604480|FG000|Overall Study|Lost to Follow-up|9|||
105711451|NCT03728309|364604481|FG001|Overall Study|Lost to Follow-up|10|||
105711452|NCT03728309|364604480|FG000|Overall Study|Protocol Deviation|0|||
105711453|NCT03728309|364604481|FG001|Overall Study|Protocol Deviation|1|||
105711454|NCT03728309|364604480|FG000|Overall Study|Due to COVID|1|||
105929405|NCT02323334|365401077|FG007|Period 3|Lost to Follow-up|0|||
105929406|NCT02323334|365401078|FG008|Period 3|Lost to Follow-up|0|||
105929407|NCT02323334|365401079|FG009|Period 3|Lost to Follow-up|0|||
105711455|NCT03728309|364604481|FG001|Overall Study|Due to COVID|3|||
105711456|NCT02436876|364604484|FG000|Overall Study|Lost to Follow-up|0|||
105929408|NCT02323334|365401080|FG010|Period 3|Lost to Follow-up|0|||
105711457|NCT02436876|364604485|FG001|Overall Study|Lost to Follow-up|1|||
105711458|NCT02436876|364604486|FG002|Overall Study|Lost to Follow-up|1|||
105711459|NCT02436876|364604487|FG003|Overall Study|Lost to Follow-up|1|||
105711460|NCT02436876|364604484|FG000|Overall Study|Withdrawal by Subject|1|||
106134950|NCT04888585|366152566|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
106134951|NCT04888585|366152556|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
106134952|NCT04888585|366152557|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
106134953|NCT04888585|366152558|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
106134954|NCT04888585|366152559|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
106134955|NCT04888585|366152560|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
106134956|NCT04888585|366152561|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
106134957|NCT04888585|366152562|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
106134958|NCT04888585|366152563|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
106134959|NCT04888585|366152564|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
106134960|NCT04888585|366152565|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
106134961|NCT04888585|366152566|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
106134962|NCT04888585|366152556|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
106134963|NCT04888585|366152557|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
106134964|NCT04888585|366152558|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
106134965|NCT04888585|366152559|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
106134966|NCT04888585|366152560|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
106134967|NCT04888585|366152561|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
106134968|NCT04888585|366152562|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
106134969|NCT04888585|366152563|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
106134970|NCT04888585|366152564|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
106134971|NCT04888585|366152565|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
106134972|NCT04888585|366152566|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
106134973|NCT04888585|366152556|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
106134974|NCT04888585|366152557|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
106134975|NCT04888585|366152558|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
106134976|NCT04888585|366152559|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
106134977|NCT04888585|366152560|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
106134978|NCT04888585|366152561|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
105711461|NCT02436876|364604485|FG001|Overall Study|Withdrawal by Subject|0|||
105711462|NCT02436876|364604486|FG002|Overall Study|Withdrawal by Subject|0|||
105711463|NCT02436876|364604487|FG003|Overall Study|Withdrawal by Subject|1|||
105711464|NCT02436876|364604484|FG000|Overall Study|Physician Decision|0|||
105711465|NCT02436876|364604485|FG001|Overall Study|Physician Decision|2|||
105711466|NCT02436876|364604486|FG002|Overall Study|Physician Decision|1|||
105711467|NCT02436876|364604487|FG003|Overall Study|Physician Decision|0|||
105711468|NCT02436876|364604484|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
105711469|NCT02436876|364604485|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
105711470|NCT02436876|364604486|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
105711471|NCT02436876|364604487|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
105711472|NCT00953758|364604488|FG000|Overall Study|Death|2|||
105711473|NCT00953758|364604489|FG001|Overall Study|Death|0|||
106008329|NCT00199381|365696920|FG000|Overall Study|Lack of Efficacy|27|||
106008330|NCT00199381|365696920|FG000|Overall Study|Not including due to early termination|37|||
106008331|NCT00199381|365696920|FG000|Overall Study|Study termination by Sponsor|323|||
106008332|NCT01910298|365696921|FG000|Overall Study|Adverse Event|1|||
106008333|NCT01910298|365696922|FG001|Overall Study|Adverse Event|0|||
106008334|NCT01910298|365696921|FG000|Overall Study|Withdrawal by Subject|2|||
106008335|NCT01910298|365696922|FG001|Overall Study|Withdrawal by Subject|7|||
106008336|NCT01910298|365696921|FG000|Overall Study|Protocol Deviation|0|||
106008337|NCT01910298|365696922|FG001|Overall Study|Protocol Deviation|5|||
106008338|NCT01910298|365696921|FG000|Overall Study|Lost to Follow-up|1|||
106008339|NCT01910298|365696922|FG001|Overall Study|Lost to Follow-up|1|||
106008340|NCT01910298|365696921|FG000|Overall Study|Study Terminated by Sponsor|1|||
106008341|NCT01910298|365696922|FG001|Overall Study|Study Terminated by Sponsor|17|||
106008342|NCT01910298|365696921|FG000|Overall Study|Other Miscellaneous Reasons|0|||
106008343|NCT01910298|365696922|FG001|Overall Study|Other Miscellaneous Reasons|2|||
106008344|NCT03175367|365696928|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
106008345|NCT03175367|365696929|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
106008346|NCT03175367|365696930|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
106008347|NCT03175367|365696931|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
106008348|NCT03175367|365696932|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
106008349|NCT03175367|365696933|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
106008350|NCT03175367|365696934|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
106008351|NCT03175367|365696928|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
106008352|NCT03175367|365696929|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
106008353|NCT03175367|365696930|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
106008354|NCT03175367|365696931|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
106008355|NCT03175367|365696932|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
106134979|NCT04888585|366152562|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
106134980|NCT04888585|366152563|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
106134981|NCT04888585|366152564|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
106134982|NCT04888585|366152565|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
106134983|NCT04888585|366152566|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
106134984|NCT03822351|366152567|FG000|Overall Study|Death|27|||
106134985|NCT03822351|366152568|FG001|Overall Study|Death|23|||
106134986|NCT03822351|366152569|FG002|Overall Study|Death|24|||
106134987|NCT03822351|366152567|FG000|Overall Study|Lost to Follow-up|6|||
106134988|NCT03822351|366152568|FG001|Overall Study|Lost to Follow-up|2|||
106134989|NCT03822351|366152569|FG002|Overall Study|Lost to Follow-up|1|||
106134990|NCT03822351|366152567|FG000|Overall Study|Withdrawal by Subject|10|||
106134991|NCT03822351|366152568|FG001|Overall Study|Withdrawal by Subject|4|||
106134992|NCT03822351|366152569|FG002|Overall Study|Withdrawal by Subject|6|||
106134993|NCT03822351|366152567|FG000|Overall Study|Progressive Disease|2|||
106134994|NCT03822351|366152568|FG001|Overall Study|Progressive Disease|1|||
106134995|NCT03822351|366152569|FG002|Overall Study|Progressive Disease|0|||
106134996|NCT03822351|366152567|FG000|Overall Study|Not Treated|1|||
106134997|NCT03822351|366152568|FG001|Overall Study|Not Treated|1|||
106134998|NCT03822351|366152569|FG002|Overall Study|Not Treated|1|||
106134999|NCT00462943|366152570|FG000|Overall Study|Failure to achieve a response|5|||
106135000|NCT00462943|366152571|FG001|Overall Study|Failure to achieve a response|5|||
106135001|NCT00462943|366152572|FG002|Overall Study|Failure to achieve a response|1|||
106135002|NCT00462943|366152570|FG000|Overall Study|Adverse Event|6|||
105711474|NCT00953758|364604490|FG002|Overall Study|Death|1|||
105711475|NCT00953758|364604491|FG003|Overall Study|Death|1|||
105711476|NCT00953758|364604492|FG004|Overall Study|Death|1|||
105711477|NCT00953758|364604493|FG005|Overall Study|Death|1|||
105711478|NCT00953758|364604494|FG006|Overall Study|Death|1|||
106135003|NCT00462943|366152571|FG001|Overall Study|Adverse Event|4|||
105711479|NCT00953758|364604495|FG007|Overall Study|Death|3|||
105711480|NCT00953758|364604496|FG008|Overall Study|Death|1|||
106008356|NCT03175367|365696933|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
106008357|NCT03175367|365696934|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
106135004|NCT00462943|366152572|FG002|Overall Study|Adverse Event|1|||
106135005|NCT00462943|366152570|FG000|Overall Study|Protocol Violation|1|||
105711481|NCT00953758|364604497|FG009|Overall Study|Death|0|||
105711482|NCT00953758|364604488|FG000|Overall Study|Participant refused further follow-up|0|||
105711483|NCT00953758|364604489|FG001|Overall Study|Participant refused further follow-up|0|||
105711484|NCT00953758|364604490|FG002|Overall Study|Participant refused further follow-up|1|||
105711485|NCT00953758|364604491|FG003|Overall Study|Participant refused further follow-up|0|||
105711486|NCT00953758|364604492|FG004|Overall Study|Participant refused further follow-up|3|||
105711487|NCT00953758|364604493|FG005|Overall Study|Participant refused further follow-up|0|||
105711488|NCT00953758|364604494|FG006|Overall Study|Participant refused further follow-up|0|||
105711489|NCT00953758|364604495|FG007|Overall Study|Participant refused further follow-up|0|||
105711490|NCT00953758|364604496|FG008|Overall Study|Participant refused further follow-up|1|||
105711491|NCT00953758|364604497|FG009|Overall Study|Participant refused further follow-up|0|||
105711492|NCT00953758|364604488|FG000|Overall Study|Lost to Follow-up|0|||
105711493|NCT00953758|364604489|FG001|Overall Study|Lost to Follow-up|0|||
105711494|NCT00953758|364604490|FG002|Overall Study|Lost to Follow-up|0|||
105711495|NCT00953758|364604491|FG003|Overall Study|Lost to Follow-up|1|||
105711496|NCT00953758|364604492|FG004|Overall Study|Lost to Follow-up|0|||
105711497|NCT00953758|364604493|FG005|Overall Study|Lost to Follow-up|0|||
105711498|NCT00953758|364604494|FG006|Overall Study|Lost to Follow-up|0|||
105711499|NCT00953758|364604495|FG007|Overall Study|Lost to Follow-up|1|||
105711500|NCT00953758|364604496|FG008|Overall Study|Lost to Follow-up|0|||
105711501|NCT00953758|364604497|FG009|Overall Study|Lost to Follow-up|1|||
105711502|NCT00953758|364604488|FG000|Overall Study|Physician Decision|0|||
105711503|NCT00953758|364604489|FG001|Overall Study|Physician Decision|0|||
106008358|NCT03175367|365696928|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
106008359|NCT03175367|365696929|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
106008360|NCT03175367|365696930|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
106008361|NCT03175367|365696931|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
106008362|NCT03175367|365696932|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
106008363|NCT03175367|365696933|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
106008364|NCT03175367|365696934|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
106008365|NCT03175367|365696928|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
106008366|NCT03175367|365696929|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
106008367|NCT03175367|365696930|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
106008368|NCT03175367|365696931|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
106008369|NCT03175367|365696932|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
106008370|NCT03175367|365696933|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
106008371|NCT03175367|365696934|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
106008372|NCT03175367|365696928|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
106008373|NCT03175367|365696929|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
106008374|NCT03175367|365696930|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
106008375|NCT03175367|365696931|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
106008376|NCT03175367|365696932|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
106008377|NCT03175367|365696933|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
106008378|NCT03175367|365696934|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
106008379|NCT03175367|365696928|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
106008380|NCT03175367|365696929|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
106008381|NCT03175367|365696930|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
106008382|NCT03175367|365696931|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
106008383|NCT03175367|365696932|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
106008384|NCT03175367|365696933|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
106008385|NCT03175367|365696934|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
106008386|NCT03175367|365696928|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008387|NCT03175367|365696929|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008388|NCT03175367|365696930|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008389|NCT03175367|365696931|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008390|NCT03175367|365696932|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008391|NCT03175367|365696933|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
106008392|NCT03175367|365696934|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
106008393|NCT03085095|365696940|FG000|Overall Study|Adverse Event|23|||
106008394|NCT03085095|365696941|FG001|Overall Study|Adverse Event|8|||
106008395|NCT03085095|365696940|FG000|Overall Study|Protocol Violation|0|||
106008396|NCT03085095|365696941|FG001|Overall Study|Protocol Violation|1|||
106008397|NCT03085095|365696940|FG000|Overall Study|Lost to Follow-up|2|||
106008398|NCT03085095|365696941|FG001|Overall Study|Lost to Follow-up|1|||
106008399|NCT03085095|365696940|FG000|Overall Study|Withdrawal by Subject|17|||
105711504|NCT00953758|364604490|FG002|Overall Study|Physician Decision|0|||
105711505|NCT00953758|364604491|FG003|Overall Study|Physician Decision|0|||
105711506|NCT00953758|364604492|FG004|Overall Study|Physician Decision|1|||
105711507|NCT00953758|364604493|FG005|Overall Study|Physician Decision|0|||
106135006|NCT00462943|366152571|FG001|Overall Study|Protocol Violation|0|||
106135007|NCT00462943|366152572|FG002|Overall Study|Protocol Violation|0|||
106135008|NCT00462943|366152570|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
106135009|NCT00462943|366152571|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
106135010|NCT00462943|366152572|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
106135011|NCT00462943|366152570|FG000|Overall Study|Disease Progression|15|||
106135012|NCT00462943|366152571|FG001|Overall Study|Disease Progression|15|||
106135013|NCT00462943|366152572|FG002|Overall Study|Disease Progression|9|||
106135014|NCT00462943|366152570|FG000|Overall Study|Death|5|||
106135015|NCT00462943|366152571|FG001|Overall Study|Death|2|||
106135016|NCT00462943|366152572|FG002|Overall Study|Death|7|||
106135017|NCT00462943|366152570|FG000|Overall Study|Stem Cell Transplant|1|||
106135018|NCT00462943|366152571|FG001|Overall Study|Stem Cell Transplant|1|||
106135019|NCT00462943|366152572|FG002|Overall Study|Stem Cell Transplant|0|||
106135020|NCT00462943|366152570|FG000|Overall Study|Bone Marrow Transplant|1|||
106135021|NCT00462943|366152571|FG001|Overall Study|Bone Marrow Transplant|0|||
106135022|NCT00462943|366152572|FG002|Overall Study|Bone Marrow Transplant|0|||
106135023|NCT00462943|366152570|FG000|Overall Study|Required Lymphocyte Infusion|1|||
106135024|NCT00462943|366152571|FG001|Overall Study|Required Lymphocyte Infusion|0|||
106135025|NCT00462943|366152572|FG002|Overall Study|Required Lymphocyte Infusion|0|||
106135026|NCT00462943|366152570|FG000|Overall Study|Transplant - not specified|1|||
106135027|NCT00462943|366152571|FG001|Overall Study|Transplant - not specified|0|||
106135028|NCT00462943|366152572|FG002|Overall Study|Transplant - not specified|1|||
106135029|NCT00462943|366152570|FG000|Overall Study|Physician Decision|1|||
106135030|NCT00462943|366152571|FG001|Overall Study|Physician Decision|0|||
106008400|NCT03085095|365696941|FG001|Overall Study|Withdrawal by Subject|6|||
106008401|NCT03085095|365696940|FG000|Overall Study|Physician Decision|9|||
106008402|NCT03085095|365696941|FG001|Overall Study|Physician Decision|3|||
106008403|NCT03085095|365696940|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
106008404|NCT03085095|365696941|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
106008405|NCT03085095|365696940|FG000|Overall Study|Did not Receive Study Drug|2|||
106008406|NCT03085095|365696941|FG001|Overall Study|Did not Receive Study Drug|2|||
106008407|NCT03085095|365696940|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
106135031|NCT00462943|366152572|FG002|Overall Study|Physician Decision|0|||
106135032|NCT00462943|366152570|FG000|Overall Study|Withdrawal by Subject|0|||
106135033|NCT00462943|366152571|FG001|Overall Study|Withdrawal by Subject|1|||
106135034|NCT00462943|366152572|FG002|Overall Study|Withdrawal by Subject|0|||
105711508|NCT00953758|364604494|FG006|Overall Study|Physician Decision|0|||
105711509|NCT00953758|364604495|FG007|Overall Study|Physician Decision|0|||
105711510|NCT00953758|364604496|FG008|Overall Study|Physician Decision|0|||
105711511|NCT00953758|364604497|FG009|Overall Study|Physician Decision|0|||
105711512|NCT00953758|364604488|FG000|Overall Study|Disease progression|0|||
105711513|NCT00953758|364604489|FG001|Overall Study|Disease progression|0|||
105711514|NCT00953758|364604490|FG002|Overall Study|Disease progression|0|||
105711515|NCT00953758|364604491|FG003|Overall Study|Disease progression|0|||
105711516|NCT00953758|364604492|FG004|Overall Study|Disease progression|1|||
105711517|NCT00953758|364604493|FG005|Overall Study|Disease progression|0|||
105711518|NCT00953758|364604494|FG006|Overall Study|Disease progression|0|||
105711519|NCT00953758|364604495|FG007|Overall Study|Disease progression|0|||
105711520|NCT00953758|364604496|FG008|Overall Study|Disease progression|0|||
105711521|NCT00953758|364604497|FG009|Overall Study|Disease progression|0|||
105711522|NCT00953758|364604488|FG000|Overall Study|Participant went for transplant|0|||
105711523|NCT00953758|364604489|FG001|Overall Study|Participant went for transplant|0|||
105711524|NCT00953758|364604490|FG002|Overall Study|Participant went for transplant|0|||
105711525|NCT00953758|364604491|FG003|Overall Study|Participant went for transplant|0|||
105711526|NCT00953758|364604492|FG004|Overall Study|Participant went for transplant|0|||
105711527|NCT00953758|364604493|FG005|Overall Study|Participant went for transplant|0|||
105711528|NCT00953758|364604494|FG006|Overall Study|Participant went for transplant|0|||
106008408|NCT03085095|365696941|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
106008409|NCT03459079|365696942|FG000|Overall Study|Adverse Event|4|||
106135035|NCT03568162|366152575|FG000|Overall Study|Adverse Event|0|||
106135036|NCT03568162|366152576|FG001|Overall Study|Adverse Event|1|||
106135037|NCT03568162|366152577|FG002|Overall Study|Adverse Event|2|||
106135038|NCT03568162|366152578|FG003|Overall Study|Adverse Event|0|||
106135039|NCT03568162|366152579|FG004|Overall Study|Adverse Event|0|||
105711529|NCT00953758|364604495|FG007|Overall Study|Participant went for transplant|0|||
105711530|NCT00953758|364604496|FG008|Overall Study|Participant went for transplant|1|||
105711531|NCT00953758|364604497|FG009|Overall Study|Participant went for transplant|0|||
105711532|NCT01536860|364604498|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
105711533|NCT01536860|364604499|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
106008410|NCT03459079|365696943|FG001|Overall Study|Adverse Event|2|||
106135040|NCT03568162|366152580|FG005|Overall Study|Adverse Event|1|||
106135041|NCT03568162|366152575|FG000|Overall Study|Death|0|||
106135042|NCT03568162|366152576|FG001|Overall Study|Death|0|||
105711534|NCT01536860|364604500|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
105929409|NCT02323334|365401081|FG011|Period 3|Lost to Follow-up|0|||
105929410|NCT02323334|365401082|FG012|Period 3|Lost to Follow-up|0|||
105929411|NCT02323334|365401083|FG013|Period 3|Lost to Follow-up|0|||
105929412|NCT02323334|365401084|FG014|Period 3|Lost to Follow-up|0|||
105929413|NCT02323334|365401085|FG015|Period 3|Lost to Follow-up|0|||
105929414|NCT02323334|365401086|FG016|Period 3|Lost to Follow-up|0|||
105929415|NCT02323334|365401070|FG000|Period 3|Withdrawal by Subject|1|||
105929416|NCT02323334|365401071|FG001|Period 3|Withdrawal by Subject|0|||
106135043|NCT03568162|366152577|FG002|Overall Study|Death|0|||
106135044|NCT03568162|366152578|FG003|Overall Study|Death|0|||
105711535|NCT01707693|364604501|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
105711536|NCT01707693|364604502|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
105711537|NCT01707693|364604501|FG000|Overall Study Allocation|Protocol Violation|4|||
105711538|NCT01707693|364604502|FG001|Overall Study Allocation|Protocol Violation|3|||
105711539|NCT01707693|364604501|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
105711540|NCT01707693|364604502|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
105711541|NCT01707693|364604501|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
105711542|NCT01707693|364604502|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
105711543|NCT01703858|364604503|FG000|Overall Study|Withdrawal by Subject|0|||
105788123|NCT03426995|364878235|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788124|NCT03426995|364878236|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788125|NCT03426995|364878237|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105929417|NCT02323334|365401072|FG002|Period 3|Withdrawal by Subject|0|||
105929418|NCT02323334|365401073|FG003|Period 3|Withdrawal by Subject|0|||
105929419|NCT02323334|365401074|FG004|Period 3|Withdrawal by Subject|0|||
105929420|NCT02323334|365401075|FG005|Period 3|Withdrawal by Subject|0|||
105929421|NCT02323334|365401076|FG006|Period 3|Withdrawal by Subject|0|||
105929422|NCT02323334|365401077|FG007|Period 3|Withdrawal by Subject|0|||
105929423|NCT02323334|365401078|FG008|Period 3|Withdrawal by Subject|0|||
105929424|NCT02323334|365401079|FG009|Period 3|Withdrawal by Subject|0|||
105929425|NCT02323334|365401080|FG010|Period 3|Withdrawal by Subject|0|||
105929426|NCT02323334|365401081|FG011|Period 3|Withdrawal by Subject|0|||
105929427|NCT02323334|365401082|FG012|Period 3|Withdrawal by Subject|0|||
105929428|NCT02323334|365401083|FG013|Period 3|Withdrawal by Subject|0|||
105929429|NCT02323334|365401084|FG014|Period 3|Withdrawal by Subject|0|||
105929430|NCT02323334|365401085|FG015|Period 3|Withdrawal by Subject|0|||
105929431|NCT02323334|365401086|FG016|Period 3|Withdrawal by Subject|0|||
105929432|NCT02506036|365401087|FG000|First Intervention (4-6 Weeks)|Death|1|||
105929433|NCT02506036|365401088|FG001|First Intervention (4-6 Weeks)|Death|0|||
105929434|NCT02506036|365401087|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
105929435|NCT02506036|365401088|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
105929436|NCT02506036|365401087|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
105929437|NCT02506036|365401088|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
105929438|NCT02316613|365401090|FG000|Overall Study|Death|63|||
105929439|NCT02316613|365401090|FG000|Overall Study|Lost to Follow-up|9|||
105929440|NCT02316613|365401090|FG000|Overall Study|Lymphoma transformation|2|||
105929441|NCT02316613|365401090|FG000|Overall Study|Participant moved/changed medical team|11|||
105929442|NCT02316613|365401090|FG000|Overall Study|No data and duplicate cases|5|||
105929443|NCT02316613|365401090|FG000|Overall Study|Did not met selection criteria|14|||
105929444|NCT02827708|365401095|FG000|Overall Study|Lost to Follow-up|3|||
105929445|NCT02827708|365401096|FG001|Overall Study|Lost to Follow-up|1|||
105929446|NCT02827708|365401095|FG000|Overall Study|Withdrawal by Subject|1|||
105929447|NCT02827708|365401096|FG001|Overall Study|Withdrawal by Subject|2|||
105929448|NCT02827708|365401095|FG000|Overall Study|Death|1|||
105929449|NCT02827708|365401096|FG001|Overall Study|Death|2|||
105929450|NCT02383173|365401102|FG000|Overall Study|Palliative Care Team withdrew|0|||
105929451|NCT02383173|365401103|FG001|Overall Study|Palliative Care Team withdrew|2|||
105929452|NCT04621760|365401104|FG000|Overall Study|Lost to Follow-up|2|||
105929453|NCT04621760|365401105|FG001|Overall Study|Lost to Follow-up|4|||
105929454|NCT04621760|365401104|FG000|Overall Study|Withdrawal by Subject|1|||
105929455|NCT04621760|365401105|FG001|Overall Study|Withdrawal by Subject|0|||
105929456|NCT03677401|365401108|FG000|Overall Study|Adverse Event|4|||
105929457|NCT03677401|365401109|FG001|Overall Study|Adverse Event|14|||
105929458|NCT03677401|365401108|FG000|Overall Study|Lack of Efficacy|3|||
105929459|NCT03677401|365401109|FG001|Overall Study|Lack of Efficacy|1|||
105929460|NCT03677401|365401108|FG000|Overall Study|Withdrawal by Subject|2|||
105929461|NCT03677401|365401109|FG001|Overall Study|Withdrawal by Subject|2|||
105929462|NCT03677401|365401108|FG000|Overall Study|Sponsor decision|0|||
105929463|NCT03677401|365401109|FG001|Overall Study|Sponsor decision|1|||
105929464|NCT03677401|365401108|FG000|Overall Study|Reason Unspecified|1|||
105929465|NCT03677401|365401109|FG001|Overall Study|Reason Unspecified|0|||
105929466|NCT01177410|365401112|FG000|Overall Study|Adverse Event|0|||
105929467|NCT01177410|365401113|FG001|Overall Study|Adverse Event|2|||
105929468|NCT01177410|365401114|FG002|Overall Study|Adverse Event|2|||
105929469|NCT01177410|365401112|FG000|Overall Study|Withdrawal by Subject|1|||
105929470|NCT01177410|365401113|FG001|Overall Study|Withdrawal by Subject|4|||
106135045|NCT03568162|366152579|FG004|Overall Study|Death|1|||
106135046|NCT03568162|366152580|FG005|Overall Study|Death|0|||
106135047|NCT03568162|366152575|FG000|Overall Study|Lost to Follow-up|3|||
106135048|NCT03568162|366152576|FG001|Overall Study|Lost to Follow-up|2|||
106135049|NCT03568162|366152577|FG002|Overall Study|Lost to Follow-up|4|||
106135050|NCT03568162|366152578|FG003|Overall Study|Lost to Follow-up|2|||
106135051|NCT03568162|366152579|FG004|Overall Study|Lost to Follow-up|3|||
106135052|NCT03568162|366152580|FG005|Overall Study|Lost to Follow-up|2|||
106135053|NCT03568162|366152575|FG000|Overall Study|Physician Decision|0|||
106135054|NCT03568162|366152576|FG001|Overall Study|Physician Decision|1|||
106135055|NCT03568162|366152577|FG002|Overall Study|Physician Decision|1|||
105711544|NCT01703858|364604504|FG001|Overall Study|Withdrawal by Subject|1|||
105711545|NCT01703858|364604505|FG002|Overall Study|Withdrawal by Subject|0|||
105711546|NCT01290692|364604510|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
105711547|NCT00993031|364604514|FG000|Overall Study|Death|0|||
105711548|NCT00993031|364604515|FG001|Overall Study|Death|1|||
105711549|NCT00993031|364604514|FG000|Overall Study|Physician Decision|0|||
105711550|NCT00993031|364604515|FG001|Overall Study|Physician Decision|2|||
105711551|NCT00993031|364604514|FG000|Overall Study|Withdrawal by Subject|3|||
105711552|NCT00993031|364604515|FG001|Overall Study|Withdrawal by Subject|3|||
105711553|NCT00993031|364604514|FG000|Overall Study|Lost to Follow-up|19|||
105711554|NCT00993031|364604515|FG001|Overall Study|Lost to Follow-up|13|||
105711555|NCT03115151|364604516|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
105711556|NCT03115151|364604517|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
105711557|NCT03115151|364604516|FG000|Overall Study|Epidural catheter removal|1|||
105711558|NCT03115151|364604517|FG001|Overall Study|Epidural catheter removal|0|||
105711559|NCT03115151|364604516|FG000|Overall Study|Withdrawal by Subject|0|||
105711560|NCT03115151|364604517|FG001|Overall Study|Withdrawal by Subject|1|||
105711561|NCT03115151|364604516|FG000|Overall Study|Intervention not received according to the protocol.|1|||
105711562|NCT03115151|364604517|FG001|Overall Study|Intervention not received according to the protocol.|1|||
105711563|NCT03115151|364604516|FG000|Overall Study|Physician Decision|1|||
105711564|NCT03115151|364604517|FG001|Overall Study|Physician Decision|0|||
105711565|NCT03115151|364604516|FG000|Overall Study|Randomization not applied|1|||
105711566|NCT03115151|364604517|FG001|Overall Study|Randomization not applied|1|||
105711567|NCT02971670|364604523|FG000|Overall Study|Withdrawal by Subject|4|||
105711568|NCT02971670|364604524|FG001|Overall Study|Withdrawal by Subject|1|||
105711569|NCT02971670|364604525|FG002|Overall Study|Withdrawal by Subject|1|||
105711570|NCT02971670|364604526|FG003|Overall Study|Withdrawal by Subject|2|||
105711571|NCT00288080|364604527|FG000|Overall Study|Withdrawal by Subject|1|||
105711572|NCT00288080|364604528|FG001|Overall Study|Withdrawal by Subject|3|||
105711573|NCT00288080|364604527|FG000|Overall Study|Protocol Violation|25|||
105711574|NCT00288080|364604528|FG001|Overall Study|Protocol Violation|20|||
105711575|NCT01543087|364604529|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
105711576|NCT01543087|364604530|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
105711577|NCT01543087|364604531|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
105711578|NCT01543087|364604532|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
106135056|NCT03568162|366152578|FG003|Overall Study|Physician Decision|0|||
106135057|NCT03568162|366152579|FG004|Overall Study|Physician Decision|1|||
106135058|NCT03568162|366152580|FG005|Overall Study|Physician Decision|0|||
106135059|NCT03568162|366152575|FG000|Overall Study|Pregnancy|0|||
106135060|NCT03568162|366152576|FG001|Overall Study|Pregnancy|0|||
106135061|NCT03568162|366152577|FG002|Overall Study|Pregnancy|0|||
105711579|NCT01543087|364604533|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
105711580|NCT01543087|364604534|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
105711581|NCT01543087|364604529|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
105711582|NCT01543087|364604530|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
105711583|NCT01543087|364604531|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
105711584|NCT01543087|364604532|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
105711585|NCT01543087|364604533|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
105711586|NCT01543087|364604534|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
105711587|NCT01543087|364604529|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
105711588|NCT01543087|364604530|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
105711589|NCT01543087|364604531|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
105711590|NCT01543087|364604532|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
105711591|NCT01543087|364604533|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
105711592|NCT01543087|364604534|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
105806513|NCT03038113|364949007|FG007|Overall Study|Withdrawal by Subject|0|||
106135062|NCT03568162|366152578|FG003|Overall Study|Pregnancy|1|||
106135063|NCT03568162|366152579|FG004|Overall Study|Pregnancy|0|||
105711593|NCT01543087|364604529|FG000|Stage 1 (48 Months)|Other than specified|5|||
105711594|NCT01543087|364604530|FG001|Stage 1 (48 Months)|Other than specified|0|||
105711595|NCT01543087|364604531|FG002|Stage 1 (48 Months)|Other than specified|9|||
105711596|NCT01543087|364604532|FG003|Stage 1 (48 Months)|Other than specified|0|||
105711597|NCT01543087|364604533|FG004|Stage 1 (48 Months)|Other than specified|0|||
106135064|NCT03568162|366152580|FG005|Overall Study|Pregnancy|0|||
106135065|NCT03568162|366152575|FG000|Overall Study|Protocol Violation|1|||
106135066|NCT03568162|366152576|FG001|Overall Study|Protocol Violation|0|||
106135067|NCT03568162|366152577|FG002|Overall Study|Protocol Violation|1|||
105711598|NCT01543087|364604534|FG005|Stage 1 (48 Months)|Other than specified|0|||
105711599|NCT01543087|364604529|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
105711600|NCT01543087|364604530|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
105711601|NCT01543087|364604531|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
105711602|NCT01543087|364604532|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
105711603|NCT01543087|364604533|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
105711604|NCT01543087|364604534|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
105711605|NCT01543087|364604529|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
105711606|NCT01543087|364604530|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
105711607|NCT01543087|364604531|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
105711608|NCT01543087|364604532|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
105711609|NCT01543087|364604533|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
105711610|NCT01543087|364604534|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
105711611|NCT01543087|364604529|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711612|NCT01543087|364604530|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711613|NCT01543087|364604531|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
105711614|NCT01543087|364604532|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711615|NCT01543087|364604533|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711616|NCT01543087|364604534|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
105711617|NCT00706030|364604537|FG000|Overall Study|Disease Progression|4|||
105929471|NCT01177410|365401114|FG002|Overall Study|Withdrawal by Subject|3|||
105929472|NCT01177410|365401112|FG000|Overall Study|Lost to Follow-up|0|||
105929473|NCT01177410|365401113|FG001|Overall Study|Lost to Follow-up|1|||
105929474|NCT01177410|365401114|FG002|Overall Study|Lost to Follow-up|0|||
105929475|NCT00421733|365401121|FG000|Overall Study|Adverse Event|4|||
105929476|NCT00421733|365401122|FG001|Overall Study|Adverse Event|9|||
105929477|NCT00421733|365401123|FG002|Overall Study|Adverse Event|2|||
105929478|NCT00421733|365401121|FG000|Overall Study|Lost to Follow-up|1|||
105929479|NCT00421733|365401122|FG001|Overall Study|Lost to Follow-up|2|||
105929480|NCT00421733|365401123|FG002|Overall Study|Lost to Follow-up|4|||
105929481|NCT00421733|365401121|FG000|Overall Study|Withdrawal by Subject|1|||
105929482|NCT00421733|365401122|FG001|Overall Study|Withdrawal by Subject|2|||
105929483|NCT00421733|365401123|FG002|Overall Study|Withdrawal by Subject|7|||
105929484|NCT00421733|365401121|FG000|Overall Study|Death|0|||
105929485|NCT00421733|365401122|FG001|Overall Study|Death|3|||
105929486|NCT00421733|365401123|FG002|Overall Study|Death|0|||
105929487|NCT00421733|365401121|FG000|Overall Study|Required dialysis|1|||
105929488|NCT00421733|365401122|FG001|Overall Study|Required dialysis|0|||
105929489|NCT00421733|365401123|FG002|Overall Study|Required dialysis|0|||
105929490|NCT00421733|365401121|FG000|Overall Study|Administrative|2|||
105929491|NCT00421733|365401122|FG001|Overall Study|Administrative|0|||
105929492|NCT00421733|365401123|FG002|Overall Study|Administrative|0|||
105929493|NCT00421733|365401121|FG000|Overall Study|Did not satisfy entry criteria|1|||
105929494|NCT00421733|365401122|FG001|Overall Study|Did not satisfy entry criteria|3|||
105929495|NCT00421733|365401123|FG002|Overall Study|Did not satisfy entry criteria|2|||
105929496|NCT00421733|365401121|FG000|Overall Study|Sponsor request|1|||
105929497|NCT00421733|365401122|FG001|Overall Study|Sponsor request|0|||
105929498|NCT00421733|365401123|FG002|Overall Study|Sponsor request|3|||
105929499|NCT00421733|365401121|FG000|Overall Study|Protocol deviation|4|||
105929500|NCT00421733|365401122|FG001|Overall Study|Protocol deviation|7|||
105929501|NCT00421733|365401123|FG002|Overall Study|Protocol deviation|2|||
105929502|NCT01913470|365401125|FG000|Overall Study|Lost to Follow-up|0|||
105929503|NCT01913470|365401126|FG001|Overall Study|Lost to Follow-up|1|||
105929504|NCT01913470|365401125|FG000|Overall Study|Physician Decision|0|||
105929505|NCT01913470|365401126|FG001|Overall Study|Physician Decision|1|||
105929506|NCT01913470|365401125|FG000|Overall Study|Withdrawal by Subject|0|||
106135068|NCT03568162|366152578|FG003|Overall Study|Protocol Violation|1|||
106135069|NCT03568162|366152579|FG004|Overall Study|Protocol Violation|1|||
105711618|NCT00706030|364604538|FG001|Overall Study|Disease Progression|6|||
105711619|NCT00706030|364604539|FG002|Overall Study|Disease Progression|46|||
105711620|NCT00706030|364604540|FG003|Overall Study|Disease Progression|12|||
105711621|NCT00706030|364604537|FG000|Overall Study|Adverse Event|1|||
105711622|NCT00706030|364604538|FG001|Overall Study|Adverse Event|0|||
105711623|NCT00706030|364604539|FG002|Overall Study|Adverse Event|4|||
105711624|NCT00706030|364604540|FG003|Overall Study|Adverse Event|2|||
105711625|NCT00706030|364604537|FG000|Overall Study|Withdrawal by Subject|1|||
105711626|NCT00706030|364604538|FG001|Overall Study|Withdrawal by Subject|0|||
105929507|NCT01913470|365401126|FG001|Overall Study|Withdrawal by Subject|1|||
105711627|NCT00706030|364604539|FG002|Overall Study|Withdrawal by Subject|2|||
105711628|NCT00706030|364604540|FG003|Overall Study|Withdrawal by Subject|0|||
105711629|NCT00706030|364604537|FG000|Overall Study|Physician Decision|0|||
105929508|NCT02070991|365401127|FG000|Overall Study|Death|2|||
105929509|NCT02070991|365401128|FG001|Overall Study|Death|0|||
106135070|NCT03568162|366152580|FG005|Overall Study|Protocol Violation|1|||
106135071|NCT03568162|366152575|FG000|Overall Study|Withdrawal by Subject|15|||
106135072|NCT03568162|366152576|FG001|Overall Study|Withdrawal by Subject|15|||
106135073|NCT03568162|366152577|FG002|Overall Study|Withdrawal by Subject|26|||
106135074|NCT03568162|366152578|FG003|Overall Study|Withdrawal by Subject|22|||
106135075|NCT03568162|366152579|FG004|Overall Study|Withdrawal by Subject|6|||
106135076|NCT03568162|366152580|FG005|Overall Study|Withdrawal by Subject|9|||
106135077|NCT03568162|366152575|FG000|Overall Study|Others|3|||
106135078|NCT03568162|366152576|FG001|Overall Study|Others|4|||
106135079|NCT03568162|366152577|FG002|Overall Study|Others|1|||
106135080|NCT03568162|366152578|FG003|Overall Study|Others|4|||
106135081|NCT03568162|366152579|FG004|Overall Study|Others|2|||
106135082|NCT03568162|366152580|FG005|Overall Study|Others|1|||
106135083|NCT02908464|366152581|FG000|Overall Study|Withdrawal by Subject|2|||
106135084|NCT02908464|366152582|FG001|Overall Study|Withdrawal by Subject|1|||
106135085|NCT02908464|366152581|FG000|Overall Study|Found ineligible after randomization|0|||
106135086|NCT02908464|366152582|FG001|Overall Study|Found ineligible after randomization|2|||
106135087|NCT03102242|366152583|FG000|Overall Study|Adverse Event|2|||
106135088|NCT01137292|366152584|FG000|Overall Study|Death|30|||
106135089|NCT01137292|366152584|FG000|Overall Study|Adverse Event|3|||
106135090|NCT01137292|366152584|FG000|Overall Study|Lack of Efficacy|13|||
106135091|NCT01137292|366152584|FG000|Overall Study|Lost to Follow-up|1|||
106135092|NCT01137292|366152584|FG000|Overall Study|Other|7|||
106135093|NCT00477412|366152589|FG000|Overall Study|Death|0|||
105711630|NCT00706030|364604538|FG001|Overall Study|Physician Decision|0|||
105711631|NCT00706030|364604539|FG002|Overall Study|Physician Decision|2|||
105711632|NCT00706030|364604540|FG003|Overall Study|Physician Decision|0|||
105711633|NCT00706030|364604537|FG000|Overall Study|Not recorded|0|||
105711634|NCT00706030|364604538|FG001|Overall Study|Not recorded|0|||
105711635|NCT00706030|364604539|FG002|Overall Study|Not recorded|2|||
105711636|NCT00706030|364604540|FG003|Overall Study|Not recorded|0|||
105711637|NCT00706030|364604537|FG000|Overall Study|Protocol Violation|0|||
105711638|NCT00706030|364604538|FG001|Overall Study|Protocol Violation|0|||
105711639|NCT00706030|364604539|FG002|Overall Study|Protocol Violation|1|||
105711640|NCT00706030|364604540|FG003|Overall Study|Protocol Violation|1|||
105711641|NCT00706030|364604537|FG000|Overall Study|Failed to return|0|||
105711642|NCT00706030|364604538|FG001|Overall Study|Failed to return|0|||
105711643|NCT00706030|364604539|FG002|Overall Study|Failed to return|1|||
105711644|NCT00706030|364604540|FG003|Overall Study|Failed to return|0|||
105711645|NCT00706030|364604537|FG000|Overall Study|Symptomatic Deterioration|0|||
105711646|NCT00706030|364604538|FG001|Overall Study|Symptomatic Deterioration|0|||
105711647|NCT00706030|364604539|FG002|Overall Study|Symptomatic Deterioration|1|||
105711648|NCT00706030|364604540|FG003|Overall Study|Symptomatic Deterioration|0|||
105711649|NCT00706030|364604537|FG000|Overall Study|No treatment received|0|||
105711650|NCT00706030|364604538|FG001|Overall Study|No treatment received|0|||
105711651|NCT00706030|364604539|FG002|Overall Study|No treatment received|0|||
105711652|NCT00706030|364604540|FG003|Overall Study|No treatment received|1|||
105711653|NCT00706030|364604537|FG000|Overall Study|Death|0|||
105711654|NCT00706030|364604538|FG001|Overall Study|Death|0|||
105711655|NCT00706030|364604539|FG002|Overall Study|Death|1|||
105711656|NCT00706030|364604540|FG003|Overall Study|Death|0|||
105711657|NCT05779072|364604542|FG000|Overall Study|Lost to Follow-up|0|||
105711658|NCT05779072|364604543|FG001|Overall Study|Lost to Follow-up|1|||
105711659|NCT05779072|364604542|FG000|Overall Study|Withdrawal by Subject|1|||
105711660|NCT05779072|364604543|FG001|Overall Study|Withdrawal by Subject|5|||
105711661|NCT02435849|364604544|FG000|Overall Study|Death|23|||
105711662|NCT02435849|364604545|FG001|Overall Study|Death|0|||
105711663|NCT02435849|364604544|FG000|Overall Study|Lack of Efficacy|10|||
105711664|NCT02435849|364604545|FG001|Overall Study|Lack of Efficacy|0|||
105711665|NCT02435849|364604544|FG000|Overall Study|New therapy for study indication|8|||
105711666|NCT02435849|364604545|FG001|Overall Study|New therapy for study indication|0|||
105711667|NCT02435849|364604544|FG000|Overall Study|Subject/guardian decision|5|||
105929510|NCT02070991|365401127|FG000|Overall Study|Withdrawal by Subject|1|||
105929511|NCT02070991|365401128|FG001|Overall Study|Withdrawal by Subject|0|||
106135094|NCT00477412|366152590|FG001|Overall Study|Death|0|||
105711668|NCT02435849|364604545|FG001|Overall Study|Subject/guardian decision|1|||
105711669|NCT02435849|364604544|FG000|Overall Study|Lost to Follow-up|1|||
106135095|NCT00477412|366152591|FG002|Overall Study|Death|0|||
106135096|NCT00477412|366152592|FG003|Overall Study|Death|4|||
106135097|NCT00477412|366152589|FG000|Overall Study|Lost to Follow-up|0|||
105929512|NCT03880565|365401129|FG000|Overall Study|Withdrawal by Subject|1|||
106135098|NCT00477412|366152590|FG001|Overall Study|Lost to Follow-up|0|||
106135099|NCT00477412|366152591|FG002|Overall Study|Lost to Follow-up|0|||
105711670|NCT02435849|364604545|FG001|Overall Study|Lost to Follow-up|0|||
105711671|NCT02435849|364604544|FG000|Overall Study|Physician Decision|1|||
105711672|NCT02435849|364604545|FG001|Overall Study|Physician Decision|0|||
105711673|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
105711674|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105711675|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105711676|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105788126|NCT03426995|364878238|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
105788127|NCT03426995|364878220|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788128|NCT03426995|364878221|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788129|NCT03426995|364878222|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788130|NCT03426995|364878223|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788131|NCT03426995|364878224|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788132|NCT03426995|364878225|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
105788133|NCT03426995|364878226|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788134|NCT03426995|364878227|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788135|NCT03426995|364878228|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788136|NCT03426995|364878229|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788137|NCT03426995|364878230|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788138|NCT03426995|364878231|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788139|NCT03426995|364878232|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788140|NCT03426995|364878233|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788141|NCT03426995|364878234|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788142|NCT03426995|364878235|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788143|NCT03426995|364878236|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788144|NCT03426995|364878237|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788145|NCT03426995|364878238|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
105788146|NCT03426995|364878220|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788147|NCT03426995|364878221|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788148|NCT03426995|364878222|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788149|NCT03426995|364878223|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788150|NCT03426995|364878224|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
105788151|NCT03426995|364878225|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
105929513|NCT03880565|365401130|FG001|Overall Study|Withdrawal by Subject|0|||
105929514|NCT04999020|365401131|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
105929515|NCT04999020|365401132|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
105929516|NCT04999020|365401133|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
105929517|NCT04999020|365401134|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
105929518|NCT04999020|365401131|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
105929519|NCT04999020|365401132|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
105929520|NCT04999020|365401133|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
105929521|NCT04999020|365401134|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
105929522|NCT04999020|365401131|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
105929523|NCT04999020|365401132|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
105929524|NCT04999020|365401133|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
105929525|NCT04999020|365401134|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
105929526|NCT04999020|365401131|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105929527|NCT04999020|365401132|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105929528|NCT04999020|365401133|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
105929529|NCT04999020|365401134|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
105929530|NCT04999020|365401131|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
105929531|NCT04999020|365401132|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
105929532|NCT04999020|365401133|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
105929533|NCT04999020|365401134|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
105929534|NCT04999020|365401131|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
105929535|NCT04999020|365401132|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
105929536|NCT04999020|365401133|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
105929537|NCT04999020|365401134|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
105929538|NCT04999020|365401131|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
105929539|NCT04999020|365401132|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
105929540|NCT04999020|365401133|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
105929541|NCT04999020|365401134|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
105929542|NCT04999020|365401131|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
105929543|NCT04999020|365401132|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
105929544|NCT04999020|365401133|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
105929545|NCT04999020|365401134|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
105929546|NCT00367458|365401135|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
105929547|NCT00367458|365401136|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
105929548|NCT02448043|365401139|FG000|Overall Study|Withdrawal by Subject|2|||
105929549|NCT02448043|365401140|FG001|Overall Study|Withdrawal by Subject|2|||
105929550|NCT02448043|365401139|FG000|Overall Study|Protocol Violation|1|||
105929551|NCT02448043|365401140|FG001|Overall Study|Protocol Violation|2|||
105929552|NCT00471107|365401144|FG000|Overall Study|Technical problems/data loss|3|||
105929553|NCT00471107|365401145|FG001|Overall Study|Technical problems/data loss|1|||
105711677|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105711678|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
105711679|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
105711680|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
105711681|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
105711682|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
105711683|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
105711684|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
105711685|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
105711686|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
105711687|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
105711688|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
105711689|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105711690|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105711691|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105711692|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105711693|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
105711694|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
105711695|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
105711696|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
105711697|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
105711698|NCT01017952|364604546|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
105711699|NCT01017952|364604547|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105711700|NCT01017952|364604548|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105711701|NCT01017952|364604549|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105711702|NCT01017952|364604550|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105711703|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
105711704|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
105711705|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
105711706|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
105929554|NCT00471107|365401146|FG002|Overall Study|Technical problems/data loss|3|||
105929555|NCT02942407|365401148|FG000|Overall Study|Lost to Follow-up|3|||
105929556|NCT02942407|365401149|FG001|Overall Study|Lost to Follow-up|2|||
105929557|NCT02942407|365401148|FG000|Overall Study|Withdrawal by Subject|7|||
105929558|NCT02942407|365401149|FG001|Overall Study|Withdrawal by Subject|9|||
105929559|NCT02942407|365401148|FG000|Overall Study|Death|16|||
105929560|NCT02942407|365401149|FG001|Overall Study|Death|13|||
105929561|NCT01769443|365401150|FG000|Overall Study|Study closure|1|||
105929562|NCT01769443|365401151|FG001|Overall Study|Study closure|0|||
105929563|NCT00933166|365401152|FG000|Overall Study|Lost to Follow-up|4|||
105929564|NCT00933166|365401152|FG000|Overall Study|Lack of Efficacy|9|||
105929565|NCT00933166|365401152|FG000|Overall Study|Unavailable|4|||
105929566|NCT00933166|365401152|FG000|Overall Study|Withdrawal by Subject|1|||
105929567|NCT04996264|365401153|FG000|Overall Study|Lost to Follow-up|0|||
105929568|NCT04996264|365401154|FG001|Overall Study|Lost to Follow-up|1|||
105929569|NCT04996264|365401153|FG000|Overall Study|Withdrawal by Subject|4|||
105929570|NCT04996264|365401154|FG001|Overall Study|Withdrawal by Subject|3|||
106008411|NCT03459079|365696944|FG002|Overall Study|Adverse Event|0|||
106008412|NCT03459079|365696942|FG000|Overall Study|Withdrawal by Subject|2|||
106008413|NCT03459079|365696943|FG001|Overall Study|Withdrawal by Subject|2|||
106008414|NCT03459079|365696944|FG002|Overall Study|Withdrawal by Subject|0|||
106008415|NCT02220920|365696945|FG000|Overall Study|Adverse Event|1|||
106008416|NCT02220920|365696946|FG001|Overall Study|Adverse Event|0|||
106008417|NCT02220920|365696945|FG000|Overall Study|Lack of Efficacy|0|||
106008418|NCT02220920|365696946|FG001|Overall Study|Lack of Efficacy|1|||
106008419|NCT02220920|365696945|FG000|Overall Study|Withdrawal by Subject|1|||
106008420|NCT02220920|365696946|FG001|Overall Study|Withdrawal by Subject|0|||
106008421|NCT02220920|365696945|FG000|Overall Study|Conflict with the stopping criteria|1|||
106008422|NCT02220920|365696946|FG001|Overall Study|Conflict with the stopping criteria|2|||
106008423|NCT03198715|365696947|FG000|Overall Study|Death|0|||
106008424|NCT03198715|365696948|FG001|Overall Study|Death|0|||
106008425|NCT03198715|365696949|FG002|Overall Study|Death|1|||
106135100|NCT00477412|366152592|FG003|Overall Study|Lost to Follow-up|1|||
106135101|NCT00477412|366152589|FG000|Overall Study|Withdrawal by Subject|0|||
106135102|NCT00477412|366152590|FG001|Overall Study|Withdrawal by Subject|0|||
106135103|NCT00477412|366152591|FG002|Overall Study|Withdrawal by Subject|0|||
106135104|NCT00477412|366152592|FG003|Overall Study|Withdrawal by Subject|2|||
105929571|NCT04996264|365401153|FG000|Overall Study|1 left AMA|0|||
105929572|NCT04996264|365401154|FG001|Overall Study|1 left AMA|1|||
105929573|NCT04996264|365401153|FG000|Overall Study|Subject changed hospitals|0|||
105929574|NCT04996264|365401154|FG001|Overall Study|Subject changed hospitals|1|||
106008426|NCT03198715|365696950|FG003|Overall Study|Death|0|||
106008427|NCT03198715|365696951|FG004|Overall Study|Death|2|||
105711707|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
105711708|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105711709|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
105711710|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
105711711|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
105711712|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
105711713|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
105711714|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
105711715|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
105711716|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
105711717|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
105711718|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
105711719|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
105711720|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
105711721|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
105711722|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
105711723|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105711724|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
105711725|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
105711726|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
105711727|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
105711728|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105929575|NCT04996264|365401153|FG000|Overall Study|unable to complete due to work|0|||
105929576|NCT04996264|365401154|FG001|Overall Study|unable to complete due to work|1|||
105929577|NCT00896233|365401155|FG000|Overall Study|Claustrophobia during MRI|1|||
105929578|NCT03753542|365401156|FG000|Overall Study|Lost to Follow-up|9|||
105929579|NCT03753542|365401157|FG001|Overall Study|Lost to Follow-up|14|||
105929580|NCT05103332|365401158|FG000|Overall Study|Lost to Follow-up|0|||
105929581|NCT05103332|365401159|FG001|Overall Study|Lost to Follow-up|2|||
105929582|NCT05103332|365401160|FG002|Overall Study|Lost to Follow-up|1|||
105929583|NCT05103332|365401161|FG003|Overall Study|Lost to Follow-up|0|||
105929584|NCT05103332|365401162|FG004|Overall Study|Lost to Follow-up|0|||
105929585|NCT05103332|365401163|FG005|Overall Study|Lost to Follow-up|2|||
105929586|NCT05103332|365401158|FG000|Overall Study|Physician Decision|0|||
105929587|NCT05103332|365401159|FG001|Overall Study|Physician Decision|1|||
105929588|NCT05103332|365401160|FG002|Overall Study|Physician Decision|0|||
105929589|NCT05103332|365401161|FG003|Overall Study|Physician Decision|1|||
105929590|NCT05103332|365401162|FG004|Overall Study|Physician Decision|0|||
105929591|NCT05103332|365401163|FG005|Overall Study|Physician Decision|0|||
105929592|NCT05103332|365401158|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
105929593|NCT05103332|365401159|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
105929594|NCT05103332|365401160|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
105929595|NCT05103332|365401161|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
105929596|NCT05103332|365401162|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
105929597|NCT05103332|365401163|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
105929598|NCT05103332|365401158|FG000|Overall Study|Unspeccified|0|||
105929599|NCT05103332|365401159|FG001|Overall Study|Unspeccified|0|||
105929600|NCT05103332|365401160|FG002|Overall Study|Unspeccified|0|||
105929601|NCT05103332|365401161|FG003|Overall Study|Unspeccified|1|||
105929602|NCT05103332|365401162|FG004|Overall Study|Unspeccified|0|||
105929603|NCT05103332|365401163|FG005|Overall Study|Unspeccified|0|||
105929604|NCT05104567|365401164|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105929605|NCT05104567|365401165|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
105929606|NCT05104567|365401166|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105711729|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
105711730|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
105711731|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105711732|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105711733|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105711734|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
105711735|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
105929607|NCT05104567|365401167|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105929608|NCT05104567|365401168|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105929609|NCT05104567|365401169|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
106135105|NCT00477412|366152589|FG000|Overall Study|Second Malignancy|0|||
106135106|NCT00477412|366152590|FG001|Overall Study|Second Malignancy|0|||
106135107|NCT00477412|366152591|FG002|Overall Study|Second Malignancy|0|||
106135108|NCT00477412|366152592|FG003|Overall Study|Second Malignancy|1|||
106135109|NCT00477412|366152589|FG000|Overall Study|Adverse Event|1|||
106135110|NCT00477412|366152590|FG001|Overall Study|Adverse Event|0|||
106135111|NCT00477412|366152591|FG002|Overall Study|Adverse Event|1|||
106135112|NCT00477412|366152592|FG003|Overall Study|Adverse Event|0|||
106135113|NCT00868231|366153983|FG000|Treatment Period 1|Adverse Event|0|||
106135114|NCT00868231|366153984|FG001|Treatment Period 1|Adverse Event|0|||
106135115|NCT00868231|366153985|FG002|Treatment Period 1|Adverse Event|0|||
106135116|NCT00868231|366153986|FG003|Treatment Period 1|Adverse Event|0|||
106135117|NCT00868231|366153987|FG004|Treatment Period 1|Adverse Event|1|||
106135118|NCT00868231|366153988|FG005|Treatment Period 1|Adverse Event|0|||
106135119|NCT00868231|366153983|FG000|Treatment Period 2|Adverse Event|1|||
106135120|NCT00868231|366153984|FG001|Treatment Period 2|Adverse Event|0|||
106008428|NCT03198715|365696947|FG000|Overall Study|Other|0|||
106008429|NCT03198715|365696948|FG001|Overall Study|Other|1|||
106008430|NCT03198715|365696949|FG002|Overall Study|Other|1|||
106008431|NCT03198715|365696950|FG003|Overall Study|Other|0|||
106008432|NCT03198715|365696951|FG004|Overall Study|Other|0|||
106008433|NCT06271993|365696952|FG000|Overall Study|Not reactive to histamine|5|||
106008434|NCT06271993|365696953|FG001|Overall Study|Not reactive to histamine|5|||
106008435|NCT06271993|365696954|FG002|Overall Study|Not reactive to histamine|5|||
106008436|NCT00286468|365696955|FG000|Overall Study|Hyperglycemic Rescue|28|||
106008437|NCT00286468|365696956|FG001|Overall Study|Hyperglycemic Rescue|30|||
106135121|NCT00868231|366153985|FG002|Treatment Period 2|Adverse Event|0|||
106135122|NCT00868231|366153986|FG003|Treatment Period 2|Adverse Event|0|||
106135123|NCT00868231|366153987|FG004|Treatment Period 2|Adverse Event|0|||
106135124|NCT00868231|366153988|FG005|Treatment Period 2|Adverse Event|0|||
106135125|NCT00868231|366153983|FG000|Treatment Period 3|Adverse Event|0|||
106135126|NCT00868231|366153984|FG001|Treatment Period 3|Adverse Event|0|||
106135127|NCT00868231|366153985|FG002|Treatment Period 3|Adverse Event|1|||
106135128|NCT00868231|366153986|FG003|Treatment Period 3|Adverse Event|0|||
106135129|NCT00868231|366153987|FG004|Treatment Period 3|Adverse Event|0|||
106135130|NCT00868231|366153988|FG005|Treatment Period 3|Adverse Event|0|||
106135131|NCT02321540|366153989|FG000|Overall Study|Death|0|||
106135132|NCT02321540|366153990|FG001|Overall Study|Death|1|||
106135133|NCT02321540|366153989|FG000|Overall Study|Progression|3|||
105711736|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
105711737|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
105711738|NCT01017952|364604546|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
105711739|NCT01017952|364604547|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
105711740|NCT01017952|364604548|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
105711741|NCT01017952|364604549|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
105711742|NCT01017952|364604550|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
105711743|NCT02387580|364604553|FG000|Overall Study|Withdrawal by Subject|0|||
105711744|NCT02387580|364604554|FG001|Overall Study|Withdrawal by Subject|0|||
105711745|NCT02387580|364604555|FG002|Overall Study|Withdrawal by Subject|0|||
105711746|NCT02387580|364604556|FG003|Overall Study|Withdrawal by Subject|1|||
105711747|NCT02387580|364604557|FG004|Overall Study|Withdrawal by Subject|0|||
105711748|NCT02387580|364604558|FG005|Overall Study|Withdrawal by Subject|0|||
105711749|NCT03461757|364604561|FG000|Overall Study|Adverse Event|1|||
105711750|NCT03461757|364604562|FG001|Overall Study|Adverse Event|0|||
105711751|NCT03461757|364604561|FG000|Overall Study|Lost to Follow-up|13|||
105711752|NCT03461757|364604562|FG001|Overall Study|Lost to Follow-up|7|||
105711753|NCT03461757|364604561|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
105711754|NCT03461757|364604562|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
105711755|NCT03461757|364604561|FG000|Overall Study|Non-compliance with study treatment|0|||
105711756|NCT03461757|364604562|FG001|Overall Study|Non-compliance with study treatment|1|||
105788152|NCT03426995|364878226|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
106008438|NCT00286468|365696957|FG002|Overall Study|Hyperglycemic Rescue|31|||
106135134|NCT02321540|366153990|FG001|Overall Study|Progression|9|||
106135135|NCT03255018|366153991|FG000|Overall Study|Death on study|0|||
106135136|NCT03255018|366153992|FG001|Overall Study|Death on study|5|||
105711757|NCT03461757|364604561|FG000|Overall Study|Pregnancy|2|||
105711758|NCT03461757|364604562|FG001|Overall Study|Pregnancy|0|||
105711759|NCT03461757|364604561|FG000|Overall Study|Protocol Violation|1|||
106008439|NCT00286468|365696955|FG000|Overall Study|Adverse Event|2|||
106135137|NCT03255018|366153991|FG000|Overall Study|Withdrawal by Subject|0|||
106008440|NCT00286468|365696956|FG001|Overall Study|Adverse Event|6|||
106008441|NCT00286468|365696957|FG002|Overall Study|Adverse Event|4|||
106135138|NCT03255018|366153992|FG001|Overall Study|Withdrawal by Subject|2|||
106135139|NCT00938340|366153993|FG000|Overall Study|Withdrawal by Subject|3|||
106135140|NCT00938340|366153993|FG000|Overall Study|Protocol Violation|1|||
106135141|NCT00938340|366153993|FG000|Overall Study|Adverse Event|1|||
106135142|NCT04353037|366153994|FG000|Overall Study|Lost to Follow-up|0|||
106135143|NCT04353037|366153995|FG001|Overall Study|Lost to Follow-up|1|||
106008442|NCT00286468|365696955|FG000|Overall Study|Protocol Violation|0|||
106008443|NCT00286468|365696956|FG001|Overall Study|Protocol Violation|3|||
106008444|NCT00286468|365696957|FG002|Overall Study|Protocol Violation|1|||
106008445|NCT00286468|365696955|FG000|Overall Study|Lost to Follow-up|1|||
106008446|NCT00286468|365696956|FG001|Overall Study|Lost to Follow-up|1|||
106008447|NCT00286468|365696957|FG002|Overall Study|Lost to Follow-up|2|||
106008448|NCT00286468|365696955|FG000|Overall Study|Withdrawal by Subject|3|||
106008449|NCT00286468|365696956|FG001|Overall Study|Withdrawal by Subject|8|||
106008450|NCT00286468|365696957|FG002|Overall Study|Withdrawal by Subject|11|||
106008451|NCT00286468|365696955|FG000|Overall Study|Physician Decision|3|||
106008452|NCT00286468|365696956|FG001|Overall Study|Physician Decision|2|||
106008453|NCT00286468|365696957|FG002|Overall Study|Physician Decision|1|||
106008454|NCT03103542|365696958|FG000|Overall Study|Physician Decision|2|||
106008455|NCT03103542|365696958|FG000|Overall Study|Adverse Event|2|||
106008456|NCT03103542|365696958|FG000|Overall Study|Other|2|||
106008457|NCT03103542|365696958|FG000|Overall Study|Withdrawal by Subject|1|||
106008458|NCT05137041|365696959|FG000|Overall Study|Lost to Follow-up|1|||
106008459|NCT05137041|365696960|FG001|Overall Study|Lost to Follow-up|1|||
106008460|NCT05137041|365696959|FG000|Overall Study|Withdrawal by Subject|0|||
106008461|NCT05137041|365696960|FG001|Overall Study|Withdrawal by Subject|2|||
106008462|NCT05137041|365696959|FG000|Overall Study|Reason not Specified|0|||
106008463|NCT05137041|365696960|FG001|Overall Study|Reason not Specified|1|||
106008464|NCT00981656|365696962|FG000|Overall Study|Protocol Violation|1|||
106008465|NCT00981656|365696962|FG000|Overall Study|Did not start protocol treatment|2|||
106008466|NCT00687596|365696963|FG000|Overall Study|Adverse Event (AE)|10|||
106008467|NCT00687596|365696964|FG001|Overall Study|Adverse Event (AE)|3|||
106008468|NCT00687596|365696963|FG000|Overall Study|Radiological Disease Progression|6|||
106008469|NCT00687596|365696964|FG001|Overall Study|Radiological Disease Progression|2|||
106008470|NCT00687596|365696963|FG000|Overall Study|Clinical Disease Progression|1|||
106008471|NCT00687596|365696964|FG001|Overall Study|Clinical Disease Progression|3|||
106008472|NCT00687596|365696963|FG000|Overall Study|Investigator Discretion|3|||
106008473|NCT00687596|365696964|FG001|Overall Study|Investigator Discretion|1|||
106008474|NCT00687596|365696963|FG000|Overall Study|Sponsor Terminated Study|6|||
106008475|NCT00687596|365696964|FG001|Overall Study|Sponsor Terminated Study|17|||
106008476|NCT02218372|365696966|FG000|Overall Study|Adverse Event|1|||
106008477|NCT02218372|365696967|FG001|Overall Study|Adverse Event|1|||
106008478|NCT02218372|365696966|FG000|Overall Study|Miscellaneous|2|||
106008479|NCT02218372|365696967|FG001|Overall Study|Miscellaneous|1|||
106008480|NCT02218372|365696966|FG000|Overall Study|Randomized but did not receive treatment|2|||
106008481|NCT02218372|365696967|FG001|Overall Study|Randomized but did not receive treatment|3|||
106008482|NCT02218372|365696966|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
106008483|NCT02218372|365696967|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
106008484|NCT03405792|365696988|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
106008485|NCT03405792|365696989|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
106008486|NCT03405792|365696988|FG000|Overall Study|o Did not receive pembrolizumab|1|||
106008487|NCT03405792|365696989|FG001|Overall Study|o Did not receive pembrolizumab|0|||
106008488|NCT02476617|365696990|FG000|Overall Study|Adverse Event|1|||
106008489|NCT02476617|365696990|FG000|Overall Study|Lost to Follow-up|1|||
106008490|NCT00561652|365696997|FG000|Overall Study|Withdrawal by Subject|0|||
106008491|NCT00561652|365696998|FG001|Overall Study|Withdrawal by Subject|1|||
106008492|NCT02718898|365697003|FG000|Blinded Treatment Period|Adverse Event|5|||
106008493|NCT02718898|365697004|FG001|Blinded Treatment Period|Adverse Event|1|||
106008494|NCT02718898|365697005|FG002|Blinded Treatment Period|Adverse Event|0|||
106008495|NCT02718898|365697006|FG003|Blinded Treatment Period|Adverse Event|0|||
106008496|NCT02718898|365697007|FG004|Blinded Treatment Period|Adverse Event|0|||
106008497|NCT02718898|365697008|FG005|Blinded Treatment Period|Adverse Event|0|||
106008498|NCT02718898|365697009|FG006|Blinded Treatment Period|Adverse Event|0|||
106008499|NCT02718898|365697003|FG000|Blinded Treatment Period|Physician Decision|1|||
106008500|NCT02718898|365697004|FG001|Blinded Treatment Period|Physician Decision|0|||
106008501|NCT02718898|365697005|FG002|Blinded Treatment Period|Physician Decision|0|||
106008502|NCT02718898|365697006|FG003|Blinded Treatment Period|Physician Decision|0|||
106008503|NCT02718898|365697007|FG004|Blinded Treatment Period|Physician Decision|0|||
106008504|NCT02718898|365697008|FG005|Blinded Treatment Period|Physician Decision|0|||
106008505|NCT02718898|365697009|FG006|Blinded Treatment Period|Physician Decision|0|||
106008506|NCT02718898|365697003|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
106008507|NCT02718898|365697004|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
106008508|NCT02718898|365697005|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
106008509|NCT02718898|365697006|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
106008510|NCT02718898|365697007|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
106008511|NCT02718898|365697008|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
106008512|NCT02718898|365697009|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
106008513|NCT02718898|365697003|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
106008514|NCT02718898|365697004|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
105929610|NCT05104567|365401170|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
105929611|NCT05104567|365401164|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
105929612|NCT05104567|365401165|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
105929613|NCT05104567|365401166|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
105929614|NCT05104567|365401167|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
105929615|NCT05104567|365401168|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
105929616|NCT05104567|365401169|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
105929617|NCT05104567|365401170|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
105929618|NCT05104567|365401164|FG000|Overall Study|Progressive disease|3|||
105929619|NCT05104567|365401165|FG001|Overall Study|Progressive disease|13|||
105929620|NCT05104567|365401166|FG002|Overall Study|Progressive disease|13|||
105711760|NCT03461757|364604562|FG001|Overall Study|Protocol Violation|1|||
105711761|NCT03461757|364604561|FG000|Overall Study|Withdrawal by Subject|7|||
105711762|NCT03461757|364604562|FG001|Overall Study|Withdrawal by Subject|7|||
105711763|NCT03461757|364604561|FG000|Overall Study|Other Reasons|1|||
105711764|NCT03461757|364604562|FG001|Overall Study|Other Reasons|4|||
105711765|NCT00879697|364604563|FG000|Overall Study|Physician Decision|2|||
105711766|NCT00879697|364604564|FG001|Overall Study|Physician Decision|2|||
105711767|NCT00993928|364604565|FG000|Overall Study|Withdrawal by Subject|4|||
105711768|NCT00993928|364604566|FG001|Overall Study|Withdrawal by Subject|7|||
105788153|NCT03426995|364878227|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105929621|NCT05104567|365401167|FG003|Overall Study|Progressive disease|17|||
105929622|NCT05104567|365401168|FG004|Overall Study|Progressive disease|17|||
105929623|NCT05104567|365401169|FG005|Overall Study|Progressive disease|28|||
105929624|NCT05104567|365401170|FG006|Overall Study|Progressive disease|24|||
105929625|NCT05104567|365401164|FG000|Overall Study|Withdrawal by Subject|1|||
105929626|NCT05104567|365401165|FG001|Overall Study|Withdrawal by Subject|1|||
105929627|NCT05104567|365401166|FG002|Overall Study|Withdrawal by Subject|2|||
105929628|NCT05104567|365401167|FG003|Overall Study|Withdrawal by Subject|0|||
105929629|NCT05104567|365401168|FG004|Overall Study|Withdrawal by Subject|0|||
105929630|NCT05104567|365401169|FG005|Overall Study|Withdrawal by Subject|0|||
105929631|NCT05104567|365401170|FG006|Overall Study|Withdrawal by Subject|0|||
105929632|NCT05104567|365401164|FG000|Overall Study|Other|1|||
105929633|NCT05104567|365401165|FG001|Overall Study|Other|1|||
105929634|NCT05104567|365401166|FG002|Overall Study|Other|1|||
105929635|NCT05104567|365401167|FG003|Overall Study|Other|0|||
105929636|NCT05104567|365401168|FG004|Overall Study|Other|0|||
105929637|NCT05104567|365401169|FG005|Overall Study|Other|0|||
105929638|NCT05104567|365401170|FG006|Overall Study|Other|0|||
105929639|NCT04180696|365401171|FG000|Overall Study|Death|5|||
105929640|NCT04180696|365401172|FG001|Overall Study|Death|6|||
105929641|NCT04180696|365401171|FG000|Overall Study|Lost to Follow-up|1|||
105929642|NCT04180696|365401172|FG001|Overall Study|Lost to Follow-up|0|||
105929643|NCT04180696|365401171|FG000|Overall Study|Withdrawal by Subject|0|||
105929644|NCT04180696|365401172|FG001|Overall Study|Withdrawal by Subject|1|||
105929645|NCT05537571|365401173|FG000|Overall Study|Withdrawal by Subject|1|||
105929646|NCT05537571|365401174|FG001|Overall Study|Withdrawal by Subject|1|||
105929647|NCT05537571|365401175|FG002|Overall Study|Withdrawal by Subject|0|||
105929648|NCT05537571|365401176|FG003|Overall Study|Withdrawal by Subject|0|||
105929649|NCT05537571|365401177|FG004|Overall Study|Withdrawal by Subject|0|||
105929650|NCT05537571|365401173|FG000|Overall Study|Adverse Event|2|||
105929651|NCT05537571|365401174|FG001|Overall Study|Adverse Event|0|||
105929652|NCT05537571|365401175|FG002|Overall Study|Adverse Event|0|||
105788154|NCT03426995|364878228|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788155|NCT03426995|364878229|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105929653|NCT05537571|365401176|FG003|Overall Study|Adverse Event|0|||
105929654|NCT05537571|365401177|FG004|Overall Study|Adverse Event|0|||
105929655|NCT05537571|365401173|FG000|Overall Study|Hepatitis A screening result|2|||
105929656|NCT05537571|365401174|FG001|Overall Study|Hepatitis A screening result|0|||
105929657|NCT05537571|365401175|FG002|Overall Study|Hepatitis A screening result|0|||
105929658|NCT05537571|365401176|FG003|Overall Study|Hepatitis A screening result|0|||
105929659|NCT05537571|365401177|FG004|Overall Study|Hepatitis A screening result|0|||
105929660|NCT05537571|365401173|FG000|Overall Study|Lost to Follow-up|0|||
105929661|NCT05537571|365401174|FG001|Overall Study|Lost to Follow-up|0|||
105929662|NCT05537571|365401175|FG002|Overall Study|Lost to Follow-up|1|||
105929663|NCT05537571|365401176|FG003|Overall Study|Lost to Follow-up|0|||
105929664|NCT05537571|365401177|FG004|Overall Study|Lost to Follow-up|1|||
105929665|NCT05752487|365401182|FG000|Overall Study|Enrolled, not treated|9|||
105929666|NCT05752487|365401182|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
105929667|NCT05752487|365401182|FG000|Overall Study|Withdrawal by Subject|2|||
105929668|NCT02593864|365401186|FG000|Overall Study|Withdrawal by Subject|3|||
105711769|NCT00993928|364604565|FG000|Overall Study|ineligible|1|||
105711770|NCT00993928|364604566|FG001|Overall Study|ineligible|0|||
105929669|NCT02593864|365401186|FG000|Overall Study|Lost to Follow-up|3|||
105929670|NCT04124965|365401190|FG000|Overall Study|Adverse event, non-fatal|3|||
105929671|NCT04124965|365401191|FG001|Overall Study|Adverse event, non-fatal|1|||
106135144|NCT04353037|366153996|FG002|Overall Study|Lost to Follow-up|2|||
106135145|NCT04353037|366153997|FG003|Overall Study|Lost to Follow-up|3|||
106135146|NCT04353037|366153994|FG000|Overall Study|Withdrawal by Subject|0|||
106135147|NCT04353037|366153995|FG001|Overall Study|Withdrawal by Subject|2|||
106135148|NCT04353037|366153996|FG002|Overall Study|Withdrawal by Subject|3|||
106135149|NCT04353037|366153997|FG003|Overall Study|Withdrawal by Subject|5|||
106135150|NCT04353037|366153994|FG000|Overall Study|Adverse Event|0|||
106135151|NCT04353037|366153995|FG001|Overall Study|Adverse Event|0|||
106135152|NCT04353037|366153996|FG002|Overall Study|Adverse Event|2|||
106135153|NCT04353037|366153997|FG003|Overall Study|Adverse Event|0|||
105711771|NCT00866307|364604569|FG000|Induction|Adverse Event|5|||
106135154|NCT04353037|366153994|FG000|Overall Study|Exposure Change|0|||
106135155|NCT04353037|366153995|FG001|Overall Study|Exposure Change|0|||
106135156|NCT04353037|366153996|FG002|Overall Study|Exposure Change|0|||
105711772|NCT00866307|364604570|FG001|Induction|Adverse Event|0|||
105711773|NCT00866307|364604571|FG002|Induction|Adverse Event|0|||
105711774|NCT00866307|364604569|FG000|Induction|Death|2|||
105711775|NCT00866307|364604570|FG001|Induction|Death|0|||
105711776|NCT00866307|364604571|FG002|Induction|Death|0|||
105711777|NCT00866307|364604569|FG000|Induction|Physician Decision|5|||
105711778|NCT00866307|364604570|FG001|Induction|Physician Decision|0|||
105711779|NCT00866307|364604571|FG002|Induction|Physician Decision|0|||
105711780|NCT00866307|364604569|FG000|Induction|Progressive Disease|1|||
105711781|NCT00866307|364604570|FG001|Induction|Progressive Disease|0|||
105711782|NCT00866307|364604571|FG002|Induction|Progressive Disease|0|||
105711783|NCT00866307|364604569|FG000|Induction|Identification of Patients with Day 29 M|3|||
105711784|NCT00866307|364604570|FG001|Induction|Identification of Patients with Day 29 M|0|||
105711785|NCT00866307|364604571|FG002|Induction|Identification of Patients with Day 29 M|0|||
105711786|NCT00866307|364604569|FG000|Induction|Inadequate cytognetic samples th|1|||
105711787|NCT00866307|364604570|FG001|Induction|Inadequate cytognetic samples th|0|||
105711788|NCT00866307|364604571|FG002|Induction|Inadequate cytognetic samples th|0|||
105711789|NCT00866307|364604569|FG000|Induction|Improper post-induction consent|2|||
105711790|NCT00866307|364604570|FG001|Induction|Improper post-induction consent|0|||
105711791|NCT00866307|364604571|FG002|Induction|Improper post-induction consent|0|||
105711792|NCT00866307|364604569|FG000|Induction|Study was closed at the time|1|||
105711793|NCT00866307|364604570|FG001|Induction|Study was closed at the time|0|||
105711794|NCT00866307|364604571|FG002|Induction|Study was closed at the time|0|||
105711795|NCT00866307|364604569|FG000|Consolidation/Maintenance|Adverse Event|0|||
105711796|NCT00866307|364604570|FG001|Consolidation/Maintenance|Adverse Event|0|||
105711797|NCT00866307|364604571|FG002|Consolidation/Maintenance|Adverse Event|8|||
105711798|NCT00866307|364604569|FG000|Consolidation/Maintenance|Death|0|||
105711799|NCT00866307|364604570|FG001|Consolidation/Maintenance|Death|0|||
105711800|NCT00866307|364604571|FG002|Consolidation/Maintenance|Death|1|||
105711801|NCT00866307|364604569|FG000|Consolidation/Maintenance|Physician Decision|0|||
105711802|NCT00866307|364604570|FG001|Consolidation/Maintenance|Physician Decision|3|||
105711803|NCT00866307|364604571|FG002|Consolidation/Maintenance|Physician Decision|2|||
105711804|NCT00866307|364604569|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
105711805|NCT00866307|364604570|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
105711806|NCT00866307|364604571|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
105711807|NCT00866307|364604569|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
105711808|NCT00866307|364604570|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
105711809|NCT00866307|364604571|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
105711810|NCT00866307|364604569|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
105711811|NCT00866307|364604570|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
105711812|NCT00866307|364604571|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
105711813|NCT00866307|364604569|FG000|Consolidation/Maintenance|Therapy error|0|||
105711814|NCT00866307|364604570|FG001|Consolidation/Maintenance|Therapy error|1|||
105711815|NCT00866307|364604571|FG002|Consolidation/Maintenance|Therapy error|0|||
105711816|NCT00866307|364604569|FG000|Consolidation/Maintenance|Non-compliance|0|||
105711817|NCT00866307|364604570|FG001|Consolidation/Maintenance|Non-compliance|0|||
105711818|NCT00866307|364604571|FG002|Consolidation/Maintenance|Non-compliance|1|||
105711819|NCT00866307|364604569|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
105711820|NCT00866307|364604570|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
105711821|NCT00866307|364604571|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
105711822|NCT02286947|364604572|FG000|Overall Study|Withdrawal by Subject|2|||
105711823|NCT01687712|364604573|FG000|Cycle 1|Not Biochemically Pregnant|386|||
105711824|NCT01687712|364604574|FG001|Cycle 1|Not Biochemically Pregnant|348|||
105711825|NCT01687712|364604573|FG000|Cycle 1|Early Pregnancy Loss|43|||
106008515|NCT02718898|365697005|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
106135157|NCT04353037|366153997|FG003|Overall Study|Exposure Change|2|||
106135158|NCT03635112|366153998|FG000|Overall Study|Adverse Event|5|||
106135159|NCT03635112|366153999|FG001|Overall Study|Adverse Event|9|||
105929672|NCT04124965|365401190|FG000|Overall Study|Withdrawal by Subject|1|||
105929673|NCT04124965|365401191|FG001|Overall Study|Withdrawal by Subject|1|||
105929674|NCT04124965|365401190|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
105929675|NCT04124965|365401191|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
105929676|NCT04124965|365401190|FG000|Overall Study|Pregnancy|1|||
105929677|NCT04124965|365401191|FG001|Overall Study|Pregnancy|0|||
105929678|NCT04124965|365401190|FG000|Overall Study|Sponsor and participant decision|0|||
105929679|NCT04124965|365401191|FG001|Overall Study|Sponsor and participant decision|1|||
105929680|NCT04124965|365401190|FG000|Overall Study|Personal surgery|0|||
105929681|NCT04124965|365401191|FG001|Overall Study|Personal surgery|1|||
105929682|NCT04124965|365401190|FG000|Overall Study|Physician Decision|0|||
105929683|NCT04124965|365401191|FG001|Overall Study|Physician Decision|1|||
105929684|NCT03003468|365401192|FG000|Overall Study|Withdrawal by Subject|0|||
105929685|NCT03003468|365401193|FG001|Overall Study|Withdrawal by Subject|0|||
105929686|NCT03003468|365401194|FG002|Overall Study|Withdrawal by Subject|1|||
105929687|NCT03003468|365401192|FG000|Overall Study|No measurable lesions|0|||
105929688|NCT03003468|365401193|FG001|Overall Study|No measurable lesions|0|||
105929689|NCT03003468|365401194|FG002|Overall Study|No measurable lesions|1|||
105929690|NCT00002874|365401195|FG000|Overall Study|Withdrawal by Subject|1|||
105929691|NCT00002874|365401196|FG001|Overall Study|Withdrawal by Subject|1|||
105929692|NCT00002874|365401195|FG000|Overall Study|Protocol Violation|44|||
105929693|NCT00002874|365401196|FG001|Overall Study|Protocol Violation|34|||
105929694|NCT00421993|365401197|FG000|Overall Study|Withdrawal by Subject|22|||
105929695|NCT00421993|365401198|FG001|Overall Study|Withdrawal by Subject|23|||
105929696|NCT00421993|365401199|FG002|Overall Study|Withdrawal by Subject|23|||
105929697|NCT00421993|365401200|FG003|Overall Study|Withdrawal by Subject|24|||
105929698|NCT00421993|365401197|FG000|Overall Study|Lost to Follow-up|18|||
105929699|NCT00421993|365401198|FG001|Overall Study|Lost to Follow-up|19|||
105929700|NCT00421993|365401199|FG002|Overall Study|Lost to Follow-up|22|||
105929701|NCT00421993|365401200|FG003|Overall Study|Lost to Follow-up|20|||
105929702|NCT00421993|365401197|FG000|Overall Study|Adverse Event|11|||
105929703|NCT00421993|365401198|FG001|Overall Study|Adverse Event|1|||
105929704|NCT00421993|365401199|FG002|Overall Study|Adverse Event|6|||
105929705|NCT00421993|365401200|FG003|Overall Study|Adverse Event|4|||
105929706|NCT00421993|365401197|FG000|Overall Study|Protocol Violation|2|||
105929707|NCT00421993|365401198|FG001|Overall Study|Protocol Violation|2|||
105929708|NCT00421993|365401199|FG002|Overall Study|Protocol Violation|0|||
105929709|NCT00421993|365401200|FG003|Overall Study|Protocol Violation|1|||
105929710|NCT00421993|365401197|FG000|Overall Study|Lack of Efficacy|0|||
105929711|NCT00421993|365401198|FG001|Overall Study|Lack of Efficacy|3|||
105929712|NCT00421993|365401199|FG002|Overall Study|Lack of Efficacy|0|||
105929713|NCT00421993|365401200|FG003|Overall Study|Lack of Efficacy|5|||
105929714|NCT00421993|365401197|FG000|Overall Study|Pregnancy|0|||
105929715|NCT00421993|365401198|FG001|Overall Study|Pregnancy|1|||
105929716|NCT00421993|365401199|FG002|Overall Study|Pregnancy|1|||
105929717|NCT00421993|365401200|FG003|Overall Study|Pregnancy|2|||
105929718|NCT00421993|365401197|FG000|Overall Study|Subject transportation issues|0|||
105929719|NCT00421993|365401198|FG001|Overall Study|Subject transportation issues|0|||
105929720|NCT00421993|365401199|FG002|Overall Study|Subject transportation issues|0|||
105929721|NCT00421993|365401200|FG003|Overall Study|Subject transportation issues|1|||
105929722|NCT02530242|365401203|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
105929723|NCT02530242|365401204|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
105929724|NCT01980888|365401205|FG000|Overall Study|Study Terminated by Sponsor|116|||
105929725|NCT01980888|365401206|FG001|Overall Study|Study Terminated by Sponsor|122|||
105929726|NCT01980888|365401205|FG000|Overall Study|Withdrew Consent|17|||
105929727|NCT01980888|365401206|FG001|Overall Study|Withdrew Consent|6|||
105929728|NCT01980888|365401205|FG000|Overall Study|Investigator's Discretion|8|||
105929729|NCT01980888|365401206|FG001|Overall Study|Investigator's Discretion|3|||
105929730|NCT01980888|365401205|FG000|Overall Study|Non-Compliance with Study Drug|3|||
105929731|NCT01980888|365401206|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105929732|NCT03158311|365401207|FG000|Overall Study|Subject/Guardian Decision|10|||
105929733|NCT03158311|365401208|FG001|Overall Study|Subject/Guardian Decision|6|||
105929734|NCT03158311|365401209|FG002|Overall Study|Subject/Guardian Decision|11|||
105929735|NCT03158311|365401207|FG000|Overall Study|Adverse Event|5|||
105929736|NCT03158311|365401208|FG001|Overall Study|Adverse Event|3|||
105929737|NCT03158311|365401209|FG002|Overall Study|Adverse Event|3|||
105929738|NCT03158311|365401207|FG000|Overall Study|Techinical Problems|3|||
105929739|NCT03158311|365401208|FG001|Overall Study|Techinical Problems|1|||
105929740|NCT03158311|365401209|FG002|Overall Study|Techinical Problems|5|||
105929741|NCT03158311|365401207|FG000|Overall Study|Physician Decision|2|||
105929742|NCT03158311|365401208|FG001|Overall Study|Physician Decision|3|||
105929743|NCT03158311|365401209|FG002|Overall Study|Physician Decision|7|||
105929744|NCT03158311|365401207|FG000|Overall Study|Lost to Follow-up|1|||
105929745|NCT03158311|365401208|FG001|Overall Study|Lost to Follow-up|1|||
105929746|NCT03158311|365401209|FG002|Overall Study|Lost to Follow-up|1|||
105929747|NCT03158311|365401207|FG000|Overall Study|Sponsor decision|1|||
105929748|NCT03158311|365401208|FG001|Overall Study|Sponsor decision|0|||
105929749|NCT03158311|365401209|FG002|Overall Study|Sponsor decision|0|||
106135160|NCT03635112|366154000|FG002|Overall Study|Adverse Event|14|||
106135161|NCT03635112|366153998|FG000|Overall Study|Lost to Follow-up|1|||
106135162|NCT03635112|366153999|FG001|Overall Study|Lost to Follow-up|0|||
106135163|NCT03635112|366154000|FG002|Overall Study|Lost to Follow-up|1|||
106135164|NCT03635112|366153998|FG000|Overall Study|Physician Decision|5|||
106135165|NCT03635112|366153999|FG001|Overall Study|Physician Decision|7|||
106135166|NCT03635112|366154000|FG002|Overall Study|Physician Decision|5|||
106135167|NCT03635112|366153998|FG000|Overall Study|Protocol Violation|0|||
106135168|NCT03635112|366153999|FG001|Overall Study|Protocol Violation|0|||
106135169|NCT03635112|366154000|FG002|Overall Study|Protocol Violation|1|||
105929750|NCT03158311|365401207|FG000|Overall Study|Pregnancy|0|||
105929751|NCT03158311|365401208|FG001|Overall Study|Pregnancy|2|||
105929752|NCT03158311|365401209|FG002|Overall Study|Pregnancy|0|||
105929753|NCT03158311|365401207|FG000|Overall Study|Randomized in error|0|||
105929754|NCT03158311|365401208|FG001|Overall Study|Randomized in error|0|||
105929755|NCT03158311|365401209|FG002|Overall Study|Randomized in error|1|||
105929756|NCT05643794|365402639|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
105929757|NCT05643794|365402640|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
105929758|NCT05643794|365402641|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
105929759|NCT05643794|365402639|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
105929760|NCT05643794|365402640|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105929761|NCT05643794|365402641|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
105929762|NCT05643794|365402639|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
105929763|NCT05643794|365402640|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
105929764|NCT05643794|365402641|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
105929765|NCT05643794|365402639|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105929766|NCT05643794|365402640|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
105929767|NCT05643794|365402641|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
105929768|NCT05643794|365402639|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
105929769|NCT05643794|365402640|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
105929770|NCT05643794|365402641|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
105929771|NCT05643794|365402639|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
105929772|NCT05643794|365402640|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
105929773|NCT05643794|365402641|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
105929774|NCT04706403|365402646|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
105929775|NCT04706403|365402647|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
105929776|NCT04706403|365402648|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
105929777|NCT04706403|365402649|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
105929778|NCT04706403|365402650|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
105929779|NCT01653262|365402651|FG000|Overall Study|Lack of Efficacy|1|||
105929780|NCT01653262|365402651|FG000|Overall Study|SAE, non-fatal|1|||
105929781|NCT01653262|365402651|FG000|Overall Study|AE, non-serious non-fatal|1|||
105929782|NCT04633447|365402654|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
105929783|NCT04633447|365402655|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
105929784|NCT04633447|365402654|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
105929785|NCT04633447|365402655|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
105929786|NCT04633447|365402654|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
105929787|NCT04633447|365402655|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
105929788|NCT04633447|365402654|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
105929789|NCT04633447|365402655|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
105929790|NCT04633447|365402654|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
105929791|NCT04633447|365402655|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
105929792|NCT04633447|365402654|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
105929793|NCT04633447|365402655|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
105929794|NCT01807520|365402656|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105929795|NCT01807520|365402657|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
105929796|NCT01807520|365402658|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
105929797|NCT01807520|365402659|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105929798|NCT01807520|365402660|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105929799|NCT01807520|365402661|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105929800|NCT01807520|365402662|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
105929801|NCT01807520|365402656|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
105929802|NCT01807520|365402657|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105929803|NCT01807520|365402658|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
106008516|NCT02718898|365697006|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
106008517|NCT02718898|365697007|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
106008518|NCT02718898|365697008|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
106008519|NCT02718898|365697009|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
106008520|NCT02718898|365697003|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
106008521|NCT02718898|365697004|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
106008522|NCT02718898|365697005|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
106008523|NCT02718898|365697006|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
106008524|NCT02718898|365697007|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
106008525|NCT02718898|365697008|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
106008526|NCT02718898|365697009|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
106008527|NCT02718898|365697003|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
106008528|NCT02718898|365697004|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
106008529|NCT02718898|365697005|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
106008530|NCT02718898|365697006|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
106008531|NCT02718898|365697007|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
106008532|NCT02718898|365697008|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
106008533|NCT02718898|365697009|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
106008534|NCT02718898|365697003|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008535|NCT02718898|365697004|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008536|NCT02718898|365697005|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
106008537|NCT02718898|365697006|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
106008538|NCT02718898|365697007|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008539|NCT02718898|365697008|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008540|NCT02718898|365697009|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
106008541|NCT02718898|365697003|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
106008542|NCT02718898|365697004|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
106008543|NCT02718898|365697005|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
106008544|NCT02718898|365697006|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
106008545|NCT02718898|365697007|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
106008546|NCT02718898|365697008|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
106008547|NCT02718898|365697009|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
106008548|NCT02718898|365697003|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
106008549|NCT02718898|365697004|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
106008550|NCT02718898|365697005|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
106008551|NCT02718898|365697006|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
106008552|NCT02718898|365697007|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
106008553|NCT02718898|365697008|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
106008554|NCT02718898|365697009|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
106008555|NCT02718898|365697003|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
106008556|NCT02718898|365697004|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
106008557|NCT02718898|365697005|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
106008558|NCT02718898|365697006|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
106008559|NCT02718898|365697007|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
106008560|NCT02718898|365697008|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
106008561|NCT02718898|365697009|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
106008562|NCT02718898|365697003|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
106008563|NCT02718898|365697004|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
106008564|NCT02718898|365697005|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
106008565|NCT02718898|365697006|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
106008566|NCT02718898|365697007|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
106008567|NCT02718898|365697008|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
106008568|NCT02718898|365697009|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
106008569|NCT02718898|365697003|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
106008570|NCT02718898|365697004|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
106008571|NCT02718898|365697005|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
106008572|NCT02718898|365697006|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
106008573|NCT02718898|365697007|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
106008574|NCT02718898|365697008|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
106008575|NCT02718898|365697009|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
106008576|NCT02718898|365697003|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106008577|NCT02718898|365697004|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106008578|NCT02718898|365697005|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106008579|NCT02718898|365697006|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106135170|NCT03635112|366153998|FG000|Overall Study|Study Terminated by Sponsor|11|||
105711826|NCT01687712|364604574|FG001|Cycle 1|Early Pregnancy Loss|60|||
105711827|NCT01687712|364604573|FG000|Cycle 1|Ectopic Pregnancy|5|||
106008580|NCT02718898|365697007|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
106008581|NCT02718898|365697008|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
106008582|NCT02718898|365697009|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
106008583|NCT00894803|365697012|FG000|Overall Study|Death|20|||
106008584|NCT00894803|365697013|FG001|Overall Study|Death|4|||
106008585|NCT00894803|365697012|FG000|Overall Study|Lost to Follow-up|0|||
106008586|NCT00894803|365697013|FG001|Overall Study|Lost to Follow-up|1|||
106008587|NCT04484961|365697014|FG000|Overall Study|Lost to Follow-up|9|||
106008588|NCT04484961|365697015|FG001|Overall Study|Lost to Follow-up|9|||
106008589|NCT01710345|365697016|FG000|Overall Study|Adverse Event|0|||
106008590|NCT01710345|365697017|FG001|Overall Study|Adverse Event|2|||
106008591|NCT01710345|365697018|FG002|Overall Study|Adverse Event|0|||
106008592|NCT01710345|365697016|FG000|Overall Study|Lack of Efficacy|2|||
106008593|NCT01710345|365697017|FG001|Overall Study|Lack of Efficacy|3|||
106008594|NCT01710345|365697018|FG002|Overall Study|Lack of Efficacy|1|||
106008595|NCT01710345|365697016|FG000|Overall Study|Drug Dosing Error|1|||
105711828|NCT01687712|364604574|FG001|Cycle 1|Ectopic Pregnancy|5|||
105711829|NCT01687712|364604573|FG000|Cycle 1|Heterotropic Pregnancy|1|||
105711830|NCT01687712|364604574|FG001|Cycle 1|Heterotropic Pregnancy|0|||
105711831|NCT01687712|364604573|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
105711832|NCT01687712|364604574|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
105711833|NCT01687712|364604573|FG000|Cycle 1|Abortion|3|||
105711834|NCT01687712|364604574|FG001|Cycle 1|Abortion|0|||
105711835|NCT01687712|364604573|FG000|Cycle 1|Intrauterine Fetal Death|0|||
105711836|NCT01687712|364604574|FG001|Cycle 1|Intrauterine Fetal Death|1|||
105711837|NCT01687712|364604573|FG000|Cycle 1|Lost to Follow-up|1|||
105711838|NCT01687712|364604574|FG001|Cycle 1|Lost to Follow-up|1|||
105711839|NCT01687712|364604573|FG000|Cycle 2|Not Biochemically Pregnant|74|||
105711840|NCT01687712|364604574|FG001|Cycle 2|Not Biochemically Pregnant|77|||
105711841|NCT01687712|364604573|FG000|Cycle 2|Early Pregnancy Loss|18|||
105711842|NCT01687712|364604574|FG001|Cycle 2|Early Pregnancy Loss|16|||
105711843|NCT01687712|364604573|FG000|Cycle 2|Ectopic Pregnancy|0|||
105711844|NCT01687712|364604574|FG001|Cycle 2|Ectopic Pregnancy|1|||
105711845|NCT01687712|364604573|FG000|Cycle 2|Still Birth|1|||
105711846|NCT01687712|364604574|FG001|Cycle 2|Still Birth|0|||
105711847|NCT01687712|364604573|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
105711848|NCT01687712|364604574|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
105711849|NCT01687712|364604573|FG000|Cycle 3|Not Biochemically Pregnant|21|||
105711850|NCT01687712|364604574|FG001|Cycle 3|Not Biochemically Pregnant|22|||
105711851|NCT01687712|364604573|FG000|Cycle 3|Early Pregnancy Loss|1|||
105711852|NCT01687712|364604574|FG001|Cycle 3|Early Pregnancy Loss|2|||
105711853|NCT01687712|364604573|FG000|Cycle 3|Ectopic Pregnancy|1|||
105711854|NCT01687712|364604574|FG001|Cycle 3|Ectopic Pregnancy|0|||
105711855|NCT01687712|364604573|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
105711856|NCT01687712|364604574|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
105711857|NCT03979274|364604577|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105711858|NCT03979274|364604578|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105711859|NCT02573155|364604579|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
105711860|NCT02573155|364604580|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
105711861|NCT02573155|364604579|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
105711862|NCT02573155|364604580|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
105711863|NCT02573155|364604579|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
105711864|NCT02573155|364604580|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
105711865|NCT02573155|364604579|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
105711866|NCT02573155|364604580|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
105711867|NCT02573155|364604579|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
105711868|NCT02573155|364604580|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
106008596|NCT01710345|365697017|FG001|Overall Study|Drug Dosing Error|0|||
106008597|NCT01710345|365697018|FG002|Overall Study|Drug Dosing Error|0|||
106008598|NCT01667900|365697021|FG000|Part B|Death|0|||
106008599|NCT01667900|365697022|FG001|Part B|Death|0|||
106008600|NCT01667900|365697023|FG002|Part B|Death|0|||
106008601|NCT01667900|365697024|FG003|Part B|Death|0|||
106135171|NCT03635112|366153999|FG001|Overall Study|Study Terminated by Sponsor|17|||
106135172|NCT03635112|366154000|FG002|Overall Study|Study Terminated by Sponsor|21|||
106135173|NCT03635112|366153998|FG000|Overall Study|Withdrawal by Subject|4|||
106135174|NCT03635112|366153999|FG001|Overall Study|Withdrawal by Subject|9|||
106135175|NCT03635112|366154000|FG002|Overall Study|Withdrawal by Subject|7|||
106135176|NCT03635112|366153998|FG000|Overall Study|Miscellaneous|0|||
106135177|NCT03635112|366153999|FG001|Overall Study|Miscellaneous|0|||
106135178|NCT03635112|366154000|FG002|Overall Study|Miscellaneous|1|||
106135179|NCT02993471|366154003|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
106135180|NCT02993471|366154003|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
106135181|NCT04582877|366154004|FG000|Overall Study|Did not use device measurement|5|||
106135182|NCT04582877|366154004|FG000|Overall Study|No fractional flow reserve test results|2|||
106135183|NCT04582877|366154004|FG000|Overall Study|Protocol Violation|1|||
106135184|NCT00335556|366154005|FG000|Overall Study|Death|0|||
106135185|NCT00335556|366154006|FG001|Overall Study|Death|5|||
106135186|NCT00335556|366154007|FG002|Overall Study|Death|0|||
106135187|NCT00335556|366154008|FG003|Overall Study|Death|0|||
106135188|NCT00335556|366154009|FG004|Overall Study|Death|1|||
106135189|NCT00335556|366154010|FG005|Overall Study|Death|0|||
106135190|NCT00335556|366154005|FG000|Overall Study|Lack of Efficacy|0|||
106135191|NCT00335556|366154006|FG001|Overall Study|Lack of Efficacy|19|||
106135192|NCT00335556|366154007|FG002|Overall Study|Lack of Efficacy|3|||
106135193|NCT00335556|366154008|FG003|Overall Study|Lack of Efficacy|3|||
106135194|NCT00335556|366154009|FG004|Overall Study|Lack of Efficacy|0|||
106135195|NCT00335556|366154010|FG005|Overall Study|Lack of Efficacy|1|||
106135196|NCT00335556|366154005|FG000|Overall Study|Physician Decision|0|||
106135197|NCT00335556|366154006|FG001|Overall Study|Physician Decision|6|||
106135198|NCT00335556|366154007|FG002|Overall Study|Physician Decision|2|||
106135199|NCT00335556|366154008|FG003|Overall Study|Physician Decision|1|||
106135200|NCT00335556|366154009|FG004|Overall Study|Physician Decision|0|||
106135201|NCT00335556|366154010|FG005|Overall Study|Physician Decision|0|||
106135202|NCT00335556|366154005|FG000|Overall Study|Ineligible|2|||
106135203|NCT00335556|366154006|FG001|Overall Study|Ineligible|0|||
106135204|NCT00335556|366154007|FG002|Overall Study|Ineligible|0|||
106135205|NCT00335556|366154008|FG003|Overall Study|Ineligible|0|||
106135206|NCT00335556|366154009|FG004|Overall Study|Ineligible|0|||
106135207|NCT00335556|366154010|FG005|Overall Study|Ineligible|0|||
106135208|NCT00335556|366154005|FG000|Overall Study|Refusal of further protocol therapy|0|||
106135209|NCT00335556|366154006|FG001|Overall Study|Refusal of further protocol therapy|4|||
106135210|NCT00335556|366154007|FG002|Overall Study|Refusal of further protocol therapy|0|||
106135211|NCT00335556|366154008|FG003|Overall Study|Refusal of further protocol therapy|1|||
106135212|NCT00335556|366154009|FG004|Overall Study|Refusal of further protocol therapy|0|||
106135213|NCT00335556|366154010|FG005|Overall Study|Refusal of further protocol therapy|0|||
106135214|NCT01878890|366154011|FG000|Overall Study|Protocol Violation|0|||
106135215|NCT01878890|366154012|FG001|Overall Study|Protocol Violation|1|||
106135216|NCT01878890|366154013|FG002|Overall Study|Protocol Violation|0|||
105711869|NCT02573155|364604579|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
105929804|NCT01807520|365402659|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105929805|NCT01807520|365402660|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105929806|NCT01807520|365402661|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105929807|NCT01807520|365402662|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
105929808|NCT01807520|365402656|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105929809|NCT01807520|365402657|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105929810|NCT01807520|365402658|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
105929811|NCT01807520|365402659|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105929812|NCT01807520|365402660|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105929813|NCT01807520|365402661|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105929814|NCT01807520|365402662|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
105929815|NCT01807520|365402656|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
105929816|NCT01807520|365402657|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105929817|NCT01807520|365402658|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105929818|NCT01807520|365402659|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105929819|NCT01807520|365402660|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105929820|NCT01807520|365402661|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105929821|NCT01807520|365402662|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
105929822|NCT01807520|365402656|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105929823|NCT01807520|365402657|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105929824|NCT01807520|365402658|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
106135217|NCT01878890|366154014|FG003|Overall Study|Protocol Violation|0|||
106135218|NCT03178201|366154016|FG000|Overall Study|Off study|5|||
106135219|NCT00567164|366154017|FG000|Overall Study|Withdrawal by Subject|171|||
106135220|NCT00567164|366154018|FG001|Overall Study|Withdrawal by Subject|21|||
106135221|NCT00567164|366154019|FG002|Overall Study|Withdrawal by Subject|17|||
106135222|NCT00567164|366154017|FG000|Overall Study|Protocol Violation|23|||
106135223|NCT00567164|366154018|FG001|Overall Study|Protocol Violation|4|||
106135224|NCT00567164|366154019|FG002|Overall Study|Protocol Violation|2|||
106135225|NCT00567164|366154017|FG000|Overall Study|Adverse Event|92|||
106135226|NCT00567164|366154018|FG001|Overall Study|Adverse Event|13|||
106135227|NCT00567164|366154019|FG002|Overall Study|Adverse Event|9|||
106135228|NCT00567164|366154017|FG000|Overall Study|Death|0|||
106135229|NCT00567164|366154018|FG001|Overall Study|Death|0|||
105711870|NCT02573155|364604580|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
105711871|NCT02573155|364604579|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
105711872|NCT02573155|364604580|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
105711873|NCT02573155|364604579|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
105711874|NCT02573155|364604580|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
105711875|NCT01681433|364604581|FG000|Overall Study|Lack of Efficacy|23|||
105711876|NCT01681433|364604582|FG001|Overall Study|Lack of Efficacy|23|||
105711877|NCT01681433|364604581|FG000|Overall Study|Withdrawal by Subject|5|||
105711878|NCT01681433|364604582|FG001|Overall Study|Withdrawal by Subject|5|||
105711879|NCT01681433|364604581|FG000|Overall Study|Protocol Violation|2|||
105711880|NCT01681433|364604582|FG001|Overall Study|Protocol Violation|0|||
105711881|NCT01681433|364604581|FG000|Overall Study|Adverse Event|2|||
105711882|NCT01681433|364604582|FG001|Overall Study|Adverse Event|4|||
105711883|NCT01681433|364604581|FG000|Overall Study|Lost to Follow-up|0|||
105711884|NCT01681433|364604582|FG001|Overall Study|Lost to Follow-up|1|||
105711885|NCT00730639|364604583|FG000|Overall Study|Adverse Event|3|||
105711886|NCT00730639|364604584|FG001|Overall Study|Adverse Event|0|||
105711887|NCT00730639|364604585|FG002|Overall Study|Adverse Event|9|||
105711888|NCT00730639|364604586|FG003|Overall Study|Adverse Event|8|||
105711889|NCT00730639|364604587|FG004|Overall Study|Adverse Event|23|||
105711890|NCT00730639|364604583|FG000|Overall Study|Complete Response|0|||
105711891|NCT00730639|364604584|FG001|Overall Study|Complete Response|0|||
105711892|NCT00730639|364604585|FG002|Overall Study|Complete Response|2|||
105711893|NCT00730639|364604586|FG003|Overall Study|Complete Response|2|||
105711894|NCT00730639|364604587|FG004|Overall Study|Complete Response|1|||
105929825|NCT01807520|365402659|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105929826|NCT01807520|365402660|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105929827|NCT01807520|365402661|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105929828|NCT01807520|365402662|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
105929829|NCT01807520|365402656|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
105929830|NCT01807520|365402657|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105929831|NCT01807520|365402658|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105929832|NCT01807520|365402659|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105929833|NCT01807520|365402660|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105929834|NCT01807520|365402661|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105929835|NCT01807520|365402662|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
105929836|NCT01807520|365402656|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
105929837|NCT01807520|365402657|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
105929838|NCT01807520|365402658|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
105929839|NCT01807520|365402659|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
105929840|NCT01807520|365402660|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
105929841|NCT01807520|365402661|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
105929842|NCT01807520|365402662|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
105929843|NCT01807520|365402656|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105929844|NCT01807520|365402657|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105929845|NCT01807520|365402658|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105929846|NCT01807520|365402659|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
105929847|NCT01807520|365402660|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105929848|NCT01807520|365402661|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105929849|NCT01807520|365402662|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
105929850|NCT01807520|365402656|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
105929851|NCT01807520|365402657|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105929852|NCT01807520|365402658|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105929853|NCT01807520|365402659|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105929854|NCT01807520|365402660|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105929855|NCT01807520|365402661|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105929856|NCT01807520|365402662|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
105929857|NCT01807520|365402656|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105929858|NCT01807520|365402657|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
105929859|NCT01807520|365402658|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
106008602|NCT01667900|365697025|FG004|Part B|Death|0|||
106135230|NCT00567164|366154019|FG002|Overall Study|Death|1|||
105711895|NCT00730639|364604583|FG000|Overall Study|Completed Maximum Cycles|0|||
105711896|NCT00730639|364604584|FG001|Overall Study|Completed Maximum Cycles|0|||
105711897|NCT00730639|364604585|FG002|Overall Study|Completed Maximum Cycles|11|||
105711898|NCT00730639|364604586|FG003|Overall Study|Completed Maximum Cycles|3|||
105788156|NCT03426995|364878230|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788157|NCT03426995|364878231|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788158|NCT03426995|364878232|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788159|NCT03426995|364878233|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788160|NCT03426995|364878234|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788161|NCT03426995|364878235|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788162|NCT03426995|364878236|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788163|NCT03426995|364878237|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788164|NCT03426995|364878238|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
105788165|NCT03426995|364878220|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788166|NCT03426995|364878221|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788167|NCT03426995|364878222|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788168|NCT03426995|364878223|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788169|NCT03426995|364878224|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788170|NCT03426995|364878225|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788171|NCT03426995|364878226|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788172|NCT03426995|364878227|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788173|NCT03426995|364878228|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788174|NCT03426995|364878229|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788175|NCT03426995|364878230|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
105788176|NCT03426995|364878231|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788177|NCT03426995|364878232|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788178|NCT03426995|364878233|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788179|NCT03426995|364878234|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788180|NCT03426995|364878235|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105929860|NCT01807520|365402659|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105929861|NCT01807520|365402660|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105929862|NCT01807520|365402661|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105929863|NCT01807520|365402662|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
105929864|NCT01807520|365402656|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
105929865|NCT01807520|365402657|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105929866|NCT01807520|365402658|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105929867|NCT01807520|365402659|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
105929868|NCT01807520|365402660|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105929869|NCT01807520|365402661|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105929870|NCT01807520|365402662|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
105929871|NCT01807520|365402656|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
105929872|NCT01807520|365402657|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
105929873|NCT01807520|365402658|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
105929874|NCT01807520|365402659|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
105929875|NCT01807520|365402660|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
105929876|NCT01807520|365402661|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
105929877|NCT01807520|365402662|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
105929878|NCT01807520|365402656|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
105929879|NCT01807520|365402657|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
105929880|NCT01807520|365402658|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
105929881|NCT01807520|365402659|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
105929882|NCT01807520|365402660|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
105929883|NCT01807520|365402661|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
105929884|NCT01807520|365402662|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
105929885|NCT01807520|365402656|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
105929886|NCT01807520|365402657|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
105929887|NCT01807520|365402658|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
105929888|NCT01807520|365402659|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
105929889|NCT01807520|365402660|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
105929890|NCT01807520|365402661|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
105929891|NCT01807520|365402662|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
105929892|NCT01807520|365402656|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105929893|NCT01807520|365402657|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105929894|NCT01807520|365402658|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105929895|NCT01807520|365402659|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105929896|NCT01807520|365402660|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105788181|NCT03426995|364878236|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788182|NCT03426995|364878237|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788183|NCT03426995|364878238|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
105788184|NCT03426995|364878220|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105711899|NCT00730639|364604587|FG004|Overall Study|Completed Maximum Cycles|6|||
105929897|NCT01807520|365402661|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
105929898|NCT01807520|365402662|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
105929899|NCT01807520|365402656|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105929900|NCT01807520|365402657|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105929901|NCT01807520|365402658|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105929902|NCT01807520|365402659|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105929903|NCT01807520|365402660|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105929904|NCT01807520|365402661|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
105929905|NCT01807520|365402662|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
105929906|NCT01807520|365402656|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105929907|NCT01807520|365402657|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105929908|NCT01807520|365402658|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105929909|NCT01807520|365402659|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105929910|NCT01807520|365402660|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
105929911|NCT01807520|365402661|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
105929912|NCT01807520|365402662|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
105929913|NCT02400736|365402663|FG000|Overall Study|Lost to Follow-up|6|||
105929914|NCT02400736|365402664|FG001|Overall Study|Lost to Follow-up|6|||
105929915|NCT02400736|365402663|FG000|Overall Study|Withdrawal by Subject|2|||
105929916|NCT02400736|365402664|FG001|Overall Study|Withdrawal by Subject|1|||
105929917|NCT02400736|365402663|FG000|Overall Study|Moved from the area|3|||
105929918|NCT02400736|365402664|FG001|Overall Study|Moved from the area|1|||
105929919|NCT03684057|365402665|FG000|Overall Study|Withdrawal by Subject|4|||
105929920|NCT03684057|365402666|FG001|Overall Study|Withdrawal by Subject|5|||
105929921|NCT01105130|365402667|FG000|Overall Study|Withdrawal by Subject|4|||
105929922|NCT01105130|365402668|FG001|Overall Study|Withdrawal by Subject|6|||
105929923|NCT01105130|365402669|FG002|Overall Study|Withdrawal by Subject|2|||
105929924|NCT01105130|365402667|FG000|Overall Study|Never Started|2|||
105929925|NCT01105130|365402668|FG001|Overall Study|Never Started|2|||
105929926|NCT01105130|365402669|FG002|Overall Study|Never Started|4|||
105929927|NCT01105130|365402667|FG000|Overall Study|Toxicity|1|||
105929928|NCT01105130|365402668|FG001|Overall Study|Toxicity|3|||
105929929|NCT01105130|365402669|FG002|Overall Study|Toxicity|2|||
105929930|NCT01105130|365402667|FG000|Overall Study|Multiple Reasons|3|||
105929931|NCT01105130|365402668|FG001|Overall Study|Multiple Reasons|0|||
105929932|NCT01105130|365402669|FG002|Overall Study|Multiple Reasons|2|||
105929933|NCT03298061|365402673|FG000|Overall Study|Adverse Event|3|||
105929934|NCT03298061|365402673|FG000|Overall Study|Lack of Efficacy|6|||
105929935|NCT03298061|365402673|FG000|Overall Study|Protocol Violation|1|||
105929936|NCT03298061|365402673|FG000|Overall Study|Physician Decision|7|||
105929937|NCT03298061|365402673|FG000|Overall Study|Withdrawal by Subject|10|||
105929938|NCT01617967|365402674|FG000|Overall Study|Protocol Violation|0|||
105929939|NCT01617967|365402675|FG001|Overall Study|Protocol Violation|0|||
105929940|NCT01617967|365402676|FG002|Overall Study|Protocol Violation|0|||
105929941|NCT01617967|365402677|FG003|Overall Study|Protocol Violation|1|||
105929942|NCT01617967|365402678|FG004|Overall Study|Protocol Violation|0|||
105929943|NCT01617967|365402679|FG005|Overall Study|Protocol Violation|0|||
105929944|NCT01617967|365402674|FG000|Overall Study|Withdrawal by Subject|0|||
105929945|NCT01617967|365402675|FG001|Overall Study|Withdrawal by Subject|0|||
105929946|NCT01617967|365402676|FG002|Overall Study|Withdrawal by Subject|0|||
105929947|NCT01617967|365402677|FG003|Overall Study|Withdrawal by Subject|0|||
105929948|NCT01617967|365402678|FG004|Overall Study|Withdrawal by Subject|0|||
105929949|NCT01617967|365402679|FG005|Overall Study|Withdrawal by Subject|1|||
105929950|NCT01617967|365402674|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
105929951|NCT01617967|365402675|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
105929952|NCT01617967|365402676|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
105711900|NCT00730639|364604583|FG000|Overall Study|Death|0|||
105711901|NCT00730639|364604584|FG001|Overall Study|Death|0|||
105711902|NCT00730639|364604585|FG002|Overall Study|Death|0|||
105711903|NCT00730639|364604586|FG003|Overall Study|Death|0|||
105711904|NCT00730639|364604587|FG004|Overall Study|Death|2|||
105711905|NCT00730639|364604583|FG000|Overall Study|Disease Progression|12|||
105711906|NCT00730639|364604584|FG001|Overall Study|Disease Progression|13|||
105711907|NCT00730639|364604585|FG002|Overall Study|Disease Progression|48|||
105711908|NCT00730639|364604586|FG003|Overall Study|Disease Progression|32|||
105711909|NCT00730639|364604587|FG004|Overall Study|Disease Progression|88|||
105929953|NCT01617967|365402677|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
105929954|NCT01617967|365402678|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
105929955|NCT01617967|365402679|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
105929956|NCT05276804|365402684|FG000|Overall Study|screen failure|23|||
105929957|NCT05276804|365402685|FG001|Overall Study|screen failure|0|||
105929958|NCT01137812|365402690|FG000|Overall Study|Adverse Event|21|||
105929959|NCT01137812|365402691|FG001|Overall Study|Adverse Event|14|||
105929960|NCT01137812|365402690|FG000|Overall Study|Lost to Follow-up|6|||
105929961|NCT01137812|365402691|FG001|Overall Study|Lost to Follow-up|8|||
105711910|NCT00730639|364604583|FG000|Overall Study|non-specified|0|||
105711911|NCT00730639|364604584|FG001|Overall Study|non-specified|0|||
105711912|NCT00730639|364604585|FG002|Overall Study|non-specified|4|||
105711913|NCT00730639|364604586|FG003|Overall Study|non-specified|2|||
105711914|NCT00730639|364604587|FG004|Overall Study|non-specified|3|||
105788185|NCT03426995|364878221|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788186|NCT03426995|364878222|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788187|NCT03426995|364878223|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788188|NCT03426995|364878224|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788189|NCT03426995|364878225|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788190|NCT03426995|364878226|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788191|NCT03426995|364878227|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
105788192|NCT03426995|364878228|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788193|NCT03426995|364878229|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788194|NCT03426995|364878230|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788195|NCT03426995|364878231|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788196|NCT03426995|364878232|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788197|NCT03426995|364878233|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788198|NCT03426995|364878234|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788199|NCT03426995|364878235|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788200|NCT03426995|364878236|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788201|NCT03426995|364878237|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788202|NCT03426995|364878238|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
105788203|NCT03426995|364878220|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788204|NCT03426995|364878221|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788205|NCT03426995|364878222|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788206|NCT03426995|364878223|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105711915|NCT00730639|364604583|FG000|Overall Study|Protocol Violation|0|||
105711916|NCT00730639|364604584|FG001|Overall Study|Protocol Violation|0|||
105711917|NCT00730639|364604585|FG002|Overall Study|Protocol Violation|1|||
105711918|NCT00730639|364604586|FG003|Overall Study|Protocol Violation|0|||
105788207|NCT03426995|364878224|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105929962|NCT01137812|365402690|FG000|Overall Study|Physician Decision|25|||
105711919|NCT00730639|364604587|FG004|Overall Study|Protocol Violation|0|||
105929963|NCT01137812|365402691|FG001|Overall Study|Physician Decision|17|||
105929964|NCT01137812|365402690|FG000|Overall Study|Protocol Violation|5|||
105929965|NCT01137812|365402691|FG001|Overall Study|Protocol Violation|4|||
105929966|NCT01137812|365402690|FG000|Overall Study|Withdrawal by Subject|5|||
105929967|NCT01137812|365402691|FG001|Overall Study|Withdrawal by Subject|13|||
105929968|NCT01137812|365402690|FG000|Overall Study|Death|2|||
105929969|NCT01137812|365402691|FG001|Overall Study|Death|0|||
105929970|NCT01137812|365402690|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
105929971|NCT01137812|365402691|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
105929972|NCT01137812|365402690|FG000|Overall Study|Other|19|||
105929973|NCT01137812|365402691|FG001|Overall Study|Other|27|||
105929974|NCT01348698|365402696|FG000|Overall Study|Does not meet lesion size criteria|1|||
105929975|NCT01348698|365402696|FG000|Overall Study|Death|3|||
105929976|NCT01348698|365402696|FG000|Overall Study|PI decision to close study|68|||
105929977|NCT02573467|365402698|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
106008603|NCT01667900|365697026|FG005|Part B|Death|0|||
106135231|NCT00567164|366154017|FG000|Overall Study|Lost to Follow-up|202|||
105788208|NCT03426995|364878225|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788209|NCT03426995|364878226|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788210|NCT03426995|364878227|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788211|NCT03426995|364878228|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788212|NCT03426995|364878229|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788213|NCT03426995|364878230|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788214|NCT03426995|364878231|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788215|NCT03426995|364878232|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788216|NCT03426995|364878233|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788217|NCT03426995|364878234|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
105788218|NCT03426995|364878235|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
105788219|NCT03426995|364878236|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788220|NCT03426995|364878237|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788221|NCT03426995|364878238|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
105788222|NCT03426995|364878220|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788223|NCT03426995|364878221|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788224|NCT03426995|364878222|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788225|NCT03426995|364878223|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788226|NCT03426995|364878224|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788227|NCT03426995|364878225|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788228|NCT03426995|364878226|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788229|NCT03426995|364878227|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105711920|NCT00730639|364604583|FG000|Overall Study|Withdrawal by Subject|0|||
105711921|NCT00730639|364604584|FG001|Overall Study|Withdrawal by Subject|0|||
105711922|NCT00730639|364604585|FG002|Overall Study|Withdrawal by Subject|6|||
105711923|NCT00730639|364604586|FG003|Overall Study|Withdrawal by Subject|3|||
105711924|NCT00730639|364604587|FG004|Overall Study|Withdrawal by Subject|4|||
105711925|NCT00730639|364604583|FG000|Overall Study|Treatment on-going|2|||
105711926|NCT00730639|364604584|FG001|Overall Study|Treatment on-going|5|||
105711927|NCT00730639|364604585|FG002|Overall Study|Treatment on-going|5|||
105711928|NCT00730639|364604586|FG003|Overall Study|Treatment on-going|4|||
105711929|NCT00730639|364604587|FG004|Overall Study|Treatment on-going|4|||
105711930|NCT01060059|364604588|FG000|Overall Study|Adverse Event|1|||
105711931|NCT01060059|364604589|FG001|Overall Study|Adverse Event|1|||
105711932|NCT01060059|364604588|FG000|Overall Study|Death|2|||
105711933|NCT01060059|364604589|FG001|Overall Study|Death|3|||
105711934|NCT01060059|364604588|FG000|Overall Study|Lost to Follow-up|18|||
105711935|NCT01060059|364604589|FG001|Overall Study|Lost to Follow-up|34|||
105711936|NCT01060059|364604588|FG000|Overall Study|entry criteria not met|4|||
105711937|NCT01060059|364604589|FG001|Overall Study|entry criteria not met|3|||
105711938|NCT01060059|364604588|FG000|Overall Study|Withdrawal by Subject|35|||
105711939|NCT01060059|364604589|FG001|Overall Study|Withdrawal by Subject|23|||
105711940|NCT01060059|364604588|FG000|Overall Study|lack of glycemic control|2|||
105711941|NCT01060059|364604589|FG001|Overall Study|lack of glycemic control|1|||
105788230|NCT03426995|364878228|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788231|NCT03426995|364878229|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105711942|NCT01060059|364604588|FG000|Overall Study|lack of compliance|5|||
105711943|NCT01060059|364604589|FG001|Overall Study|lack of compliance|2|||
105711944|NCT02665286|364604590|FG000|Overall Study|Lost to Follow-up|3|||
105711945|NCT02665286|364604591|FG001|Overall Study|Lost to Follow-up|2|||
105711946|NCT02665286|364604592|FG002|Overall Study|Lost to Follow-up|1|||
105711947|NCT02270242|364604601|FG000|Overall Study|Withdrawal by Subject|18|||
105788232|NCT03426995|364878230|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105929978|NCT02573467|365402699|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
105929979|NCT02573467|365402700|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
106008604|NCT01667900|365697027|FG006|Part B|Death|0|||
106135232|NCT00567164|366154018|FG001|Overall Study|Lost to Follow-up|23|||
106135233|NCT00567164|366154019|FG002|Overall Study|Lost to Follow-up|21|||
106135234|NCT00567164|366154017|FG000|Overall Study|Pregnancy|20|||
106135235|NCT00567164|366154018|FG001|Overall Study|Pregnancy|4|||
105929980|NCT02573467|365402701|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
105929981|NCT02573467|365402698|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
105929982|NCT02573467|365402699|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
105929983|NCT02573467|365402700|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
105929984|NCT02573467|365402701|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
105929985|NCT02573467|365402698|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
105929986|NCT02573467|365402699|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
105929987|NCT02573467|365402700|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
105929988|NCT02573467|365402701|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
105929989|NCT02573467|365402698|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
105929990|NCT02573467|365402699|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
105929991|NCT02573467|365402700|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
106135236|NCT00567164|366154019|FG002|Overall Study|Pregnancy|6|||
106135237|NCT00567164|366154017|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
106135238|NCT00567164|366154018|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
106135239|NCT00567164|366154019|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
106135240|NCT00567164|366154017|FG000|Overall Study|Missing|1|||
105711948|NCT02270242|364604602|FG001|Overall Study|Withdrawal by Subject|25|||
105711949|NCT02270242|364604601|FG000|Overall Study|Lost to Follow-up|41|||
105711950|NCT02270242|364604602|FG001|Overall Study|Lost to Follow-up|27|||
105711951|NCT02270242|364604601|FG000|Overall Study|Physician Decision|0|||
105711952|NCT02270242|364604602|FG001|Overall Study|Physician Decision|1|||
105711953|NCT00644787|364604607|FG000|Period 1: Titration Phase|Adverse Event|11|||
105711954|NCT00644787|364604608|FG001|Period 1: Titration Phase|Adverse Event|0|||
105711955|NCT00644787|364604609|FG002|Period 1: Titration Phase|Adverse Event|0|||
105711956|NCT00644787|364604607|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
105711957|NCT00644787|364604608|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
105711958|NCT00644787|364604609|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
105929992|NCT02573467|365402701|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
105929993|NCT02573467|365402698|FG000|Post-treatment Follow up Epoch|Death|1|||
105929994|NCT02573467|365402699|FG001|Post-treatment Follow up Epoch|Death|1|||
105929995|NCT02573467|365402700|FG002|Post-treatment Follow up Epoch|Death|0|||
106135241|NCT00567164|366154018|FG001|Overall Study|Missing|0|||
106135242|NCT00567164|366154019|FG002|Overall Study|Missing|0|||
106135243|NCT01190150|366154024|FG000|First Treatment|Withdrawal by Subject|1|||
105711959|NCT00644787|364604607|FG000|Period 1: Titration Phase|Physician Decision|1|||
105711960|NCT00644787|364604608|FG001|Period 1: Titration Phase|Physician Decision|0|||
105711961|NCT00644787|364604609|FG002|Period 1: Titration Phase|Physician Decision|0|||
105711962|NCT00644787|364604607|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
105788233|NCT03426995|364878231|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105929996|NCT02573467|365402701|FG003|Post-treatment Follow up Epoch|Death|1|||
105929997|NCT02573467|365402698|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
105929998|NCT02573467|365402699|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
105929999|NCT02573467|365402700|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
105930000|NCT02573467|365402701|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
105930001|NCT02573467|365402698|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
105930002|NCT02573467|365402699|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
105930003|NCT02573467|365402700|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
105930004|NCT02573467|365402701|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
105930005|NCT01160744|365402703|FG000|Overall Study|Withdrawal by Subject|11|||
105930006|NCT01160744|365402704|FG001|Overall Study|Withdrawal by Subject|5|||
105930007|NCT01160744|365402705|FG002|Overall Study|Withdrawal by Subject|6|||
105930008|NCT01160744|365402706|FG003|Overall Study|Withdrawal by Subject|4|||
106135244|NCT01190150|366154025|FG001|First Treatment|Withdrawal by Subject|0|||
106135245|NCT01190150|366154024|FG000|Washout|Withdrawal by Subject|0|||
106135246|NCT01190150|366154025|FG001|Washout|Withdrawal by Subject|1|||
106135247|NCT01190150|366154024|FG000|Washout|Difficulty in adherence|0|||
106135248|NCT01190150|366154025|FG001|Washout|Difficulty in adherence|1|||
106135249|NCT01664104|366154032|FG000|Overall Study|Adverse Event|6|||
106135250|NCT01664104|366154032|FG000|Overall Study|Lack of Efficacy|2|||
105711963|NCT00644787|364604608|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
106135251|NCT01664104|366154032|FG000|Overall Study|Withdrawal by Subject|1|||
106135252|NCT01664104|366154032|FG000|Overall Study|Lost to Follow-up|4|||
105711964|NCT00644787|364604609|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
105711965|NCT00644787|364604607|FG000|Period 1: Titration Phase|Worsening of complications|1|||
105930009|NCT01160744|365402703|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
105930010|NCT01160744|365402704|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
105930011|NCT01160744|365402705|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
106135253|NCT01664104|366154032|FG000|Overall Study|Other|1|||
105788234|NCT03426995|364878232|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788235|NCT03426995|364878233|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788236|NCT03426995|364878234|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
105788237|NCT03426995|364878235|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
105788238|NCT03426995|364878236|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788239|NCT03426995|364878237|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788240|NCT03426995|364878238|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
105788241|NCT04505592|364878239|FG000|Overall Study|Death|2|||
105788242|NCT04505592|364878240|FG001|Overall Study|Death|1|||
105788243|NCT00145119|364878257|FG000|Overall Study|Death|45|||
105788246|NCT03179462|364878262|FG000|Overall Study|screening failure|1|||
105788247|NCT03179462|364878263|FG001|Overall Study|screening failure|2|||
105788248|NCT03179462|364878264|FG002|Overall Study|screening failure|0|||
105788249|NCT04636437|364878265|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
105788250|NCT04636437|364878266|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
105788251|NCT04636437|364878267|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
105788252|NCT04636437|364878265|FG000|Overall Study|Started weight loss drug/program|2|||
105788253|NCT04636437|364878266|FG001|Overall Study|Started weight loss drug/program|1|||
105788254|NCT04636437|364878267|FG002|Overall Study|Started weight loss drug/program|1|||
105788255|NCT04636437|364878265|FG000|Overall Study|Lost to Follow-up|3|||
105788256|NCT04636437|364878266|FG001|Overall Study|Lost to Follow-up|1|||
105788257|NCT04636437|364878267|FG002|Overall Study|Lost to Follow-up|4|||
105788258|NCT04636437|364878265|FG000|Overall Study|Participant or physician decision|3|||
105788259|NCT04636437|364878266|FG001|Overall Study|Participant or physician decision|1|||
105788260|NCT04636437|364878267|FG002|Overall Study|Participant or physician decision|1|||
105788261|NCT00352664|364878271|FG000|Overall Study|Withdrawal by Subject|7|||
105788262|NCT00352664|364878272|FG001|Overall Study|Withdrawal by Subject|0|||
105788263|NCT04410978|364878281|FG000|Overall Study|Poor compliance to protocol|2|||
105788264|NCT04410978|364878282|FG001|Overall Study|Poor compliance to protocol|4|||
105788265|NCT04410978|364878281|FG000|Overall Study|Withdrawal by Subject|64|||
105788266|NCT04410978|364878282|FG001|Overall Study|Withdrawal by Subject|66|||
105788267|NCT04410978|364878281|FG000|Overall Study|Other|6|||
105788268|NCT04410978|364878282|FG001|Overall Study|Other|7|||
105788269|NCT04410978|364878281|FG000|Overall Study|Missing study status|1|||
105788270|NCT04410978|364878282|FG001|Overall Study|Missing study status|0|||
105930012|NCT01160744|365402706|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
105930013|NCT02056288|365402707|FG000|In-Hospital Data|Surgery cancelled|1|||
105930014|NCT02056288|365402708|FG001|In-Hospital Data|Surgery cancelled|0|||
105930015|NCT02056288|365402707|FG000|In-Hospital Data|Protocol Violation|3|||
105930016|NCT02056288|365402708|FG001|In-Hospital Data|Protocol Violation|0|||
105930017|NCT02056288|365402707|FG000|In-Hospital Data|Physician Decision|1|||
105930018|NCT02056288|365402708|FG001|In-Hospital Data|Physician Decision|0|||
105930019|NCT02056288|365402707|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
105930020|NCT02056288|365402708|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
105930021|NCT02384460|365402709|FG000|Overall Study|Protocol Violation|0|||
105930022|NCT02384460|365402710|FG001|Overall Study|Protocol Violation|1|||
105930023|NCT02384460|365402709|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
105930024|NCT02384460|365402710|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
105930025|NCT02384460|365402709|FG000|Overall Study|Adverse Event|5|||
105930026|NCT02384460|365402710|FG001|Overall Study|Adverse Event|2|||
105930027|NCT02384460|365402709|FG000|Overall Study|Withdrawal by Subject|0|||
105930028|NCT02384460|365402710|FG001|Overall Study|Withdrawal by Subject|3|||
105930029|NCT02384460|365402709|FG000|Overall Study|Elective medical treatment|1|||
105930030|NCT02384460|365402710|FG001|Overall Study|Elective medical treatment|0|||
105930031|NCT02384460|365402709|FG000|Overall Study|Non-compliance|1|||
105930032|NCT02384460|365402710|FG001|Overall Study|Non-compliance|0|||
105930033|NCT00500110|365402711|FG000|Overall Study|Withdrawal by Subject|3|||
105930034|NCT02441114|365402712|FG000|Washout2|Withdrawal by Subject|4|||
105930035|NCT03446573|365402714|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
105930036|NCT03446573|365402715|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
105930037|NCT03446573|365402714|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
105930038|NCT03446573|365402715|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
105930039|NCT03446573|365402714|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
105930040|NCT03446573|365402715|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
105930041|NCT03446573|365402714|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
105930042|NCT03446573|365402715|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
105930043|NCT03446573|365402714|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
105788307|NCT00526227|364878299|FG000|Overall Study|Device not implanted|1|||
105788308|NCT00526227|364878299|FG000|Overall Study|Death|1|||
105788309|NCT03222856|364878300|FG000|Overall Study|Adverse Event|6|||
105788310|NCT03222856|364878300|FG000|Overall Study|Death|1|||
105711966|NCT00644787|364604608|FG001|Period 1: Titration Phase|Worsening of complications|0|||
105711967|NCT00644787|364604609|FG002|Period 1: Titration Phase|Worsening of complications|0|||
105711968|NCT00644787|364604607|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
105711969|NCT00644787|364604608|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
105711970|NCT00644787|364604609|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
105711971|NCT00644787|364604607|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
105711972|NCT00644787|364604608|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
105711973|NCT00644787|364604609|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
105711974|NCT00644787|364604607|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
105930044|NCT03446573|365402715|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
105930045|NCT03446573|365402714|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
105930046|NCT03446573|365402715|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
105930047|NCT03446573|365402714|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
105930048|NCT03446573|365402715|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
105930049|NCT03446573|365402714|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
105711975|NCT00644787|364604608|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
105711976|NCT00644787|364604609|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
105711977|NCT00644787|364604607|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
105711978|NCT00644787|364604608|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
105711979|NCT00644787|364604609|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
105711980|NCT00644787|364604607|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
105711981|NCT00644787|364604608|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
105711982|NCT00644787|364604609|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
105711983|NCT00644787|364604607|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
105711984|NCT00644787|364604608|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
105711985|NCT00644787|364604609|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
105711986|NCT00644787|364604607|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
105711987|NCT00644787|364604608|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
105930050|NCT03446573|365402715|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
105930051|NCT03446573|365402714|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
105930052|NCT03446573|365402715|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
105930053|NCT03446573|365402714|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
105930054|NCT03446573|365402715|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
105930055|NCT03446573|365402714|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
105930056|NCT03446573|365402715|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
105930057|NCT03446573|365402714|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
105930058|NCT03446573|365402715|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
105930059|NCT03446573|365402714|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
105930060|NCT03446573|365402715|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
105930061|NCT02143778|365402719|FG000|Overall Study|Withdrawal by Subject|2|||
105930062|NCT02143778|365402719|FG000|Overall Study|Device malfunction|1|||
105930063|NCT04676646|365402720|FG000|Open-label Run-in Phase|Adverse Event|3|||
105930064|NCT04676646|365402721|FG001|Open-label Run-in Phase|Adverse Event|0|||
105930065|NCT04676646|365402722|FG002|Open-label Run-in Phase|Adverse Event|0|||
105930066|NCT04676646|365402720|FG000|Open-label Run-in Phase|Death|3|||
105930067|NCT04676646|365402721|FG001|Open-label Run-in Phase|Death|0|||
105930068|NCT04676646|365402722|FG002|Open-label Run-in Phase|Death|0|||
105930069|NCT04676646|365402720|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
105930070|NCT04676646|365402721|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
105930071|NCT04676646|365402722|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
105930072|NCT04676646|365402720|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
105930073|NCT04676646|365402721|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
105930074|NCT04676646|365402722|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
105930075|NCT04676646|365402720|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
105930076|NCT04676646|365402721|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
105711988|NCT00644787|364604609|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
105711989|NCT03355300|364604610|FG000|Overall Study|Physician Decision|0|||
105711990|NCT03355300|364604611|FG001|Overall Study|Physician Decision|1|||
105711991|NCT03355300|364604610|FG000|Overall Study|Lack of Efficacy|2|||
105711992|NCT03355300|364604611|FG001|Overall Study|Lack of Efficacy|1|||
105930077|NCT04676646|365402722|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
105788311|NCT00157820|364878301|FG000|Randomized|Physician Decision|4|||
106135254|NCT01664104|366154032|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
106135255|NCT03686384|366154036|FG000|Overall Study|Lack of Efficacy|4|||
106135256|NCT03686384|366154037|FG001|Overall Study|Lack of Efficacy|13|||
105711993|NCT03355300|364604610|FG000|Overall Study|Other reason|1|||
105788312|NCT00157820|364878302|FG001|Randomized|Physician Decision|2|||
105711994|NCT03355300|364604611|FG001|Overall Study|Other reason|0|||
105711995|NCT01489527|364604613|FG000|Overall Study|Pregnancy|9|||
105711996|NCT01489527|364604614|FG001|Overall Study|Pregnancy|14|||
105711997|NCT01489527|364604613|FG000|Overall Study|Participant moved|6|||
105711998|NCT01489527|364604614|FG001|Overall Study|Participant moved|7|||
105711999|NCT01489527|364604613|FG000|Overall Study|Withdrawal by Subject|0|||
105712000|NCT01489527|364604614|FG001|Overall Study|Withdrawal by Subject|4|||
105712001|NCT01489527|364604613|FG000|Overall Study|Lost to Follow-up|5|||
105712002|NCT01489527|364604614|FG001|Overall Study|Lost to Follow-up|1|||
105712003|NCT01489527|364604613|FG000|Overall Study|Procedures|1|||
105712004|NCT01489527|364604614|FG001|Overall Study|Procedures|0|||
105712005|NCT01489527|364604613|FG000|Overall Study|Not compliant|1|||
105712006|NCT01489527|364604614|FG001|Overall Study|Not compliant|0|||
105712007|NCT03048422|364604615|FG000|Overall Study|Death|1|||
105712008|NCT03048422|364604616|FG001|Overall Study|Death|0|||
105712009|NCT03048422|364604617|FG002|Overall Study|Death|0|||
105712010|NCT03048422|364604615|FG000|Overall Study|Lost to Follow-up|5|||
105712011|NCT03048422|364604616|FG001|Overall Study|Lost to Follow-up|0|||
105712012|NCT03048422|364604617|FG002|Overall Study|Lost to Follow-up|1|||
105712013|NCT03048422|364604615|FG000|Overall Study|Withdrawal by Subject|5|||
105712014|NCT03048422|364604616|FG001|Overall Study|Withdrawal by Subject|7|||
105712015|NCT03048422|364604617|FG002|Overall Study|Withdrawal by Subject|4|||
105712016|NCT03048422|364604615|FG000|Overall Study|Moved|3|||
105712017|NCT03048422|364604616|FG001|Overall Study|Moved|2|||
105712018|NCT03048422|364604617|FG002|Overall Study|Moved|2|||
105712019|NCT03048422|364604615|FG000|Overall Study|Noncompliant with Study Requirements|2|||
105712020|NCT03048422|364604616|FG001|Overall Study|Noncompliant with Study Requirements|1|||
105712021|NCT03048422|364604617|FG002|Overall Study|Noncompliant with Study Requirements|2|||
105712022|NCT03048422|364604615|FG000|Overall Study|Not Able to Get to Clinic|1|||
105712023|NCT03048422|364604616|FG001|Overall Study|Not Able to Get to Clinic|0|||
105712024|NCT03048422|364604617|FG002|Overall Study|Not Able to Get to Clinic|0|||
105712025|NCT01984268|364604618|FG000|Overall Study|Study Terminated|15|||
105712026|NCT01761266|364605936|FG000|Overall Study|Death|415|||
105712027|NCT01761266|364605937|FG001|Overall Study|Death|402|||
105712028|NCT01761266|364605936|FG000|Overall Study|Lost to Follow-up|8|||
105712029|NCT01761266|364605937|FG001|Overall Study|Lost to Follow-up|12|||
105712030|NCT01761266|364605936|FG000|Overall Study|Withdrawal by Subject|14|||
105712031|NCT01761266|364605937|FG001|Overall Study|Withdrawal by Subject|10|||
105712032|NCT01761266|364605936|FG000|Overall Study|Sponsor Decision|41|||
105712033|NCT01761266|364605937|FG001|Overall Study|Sponsor Decision|52|||
105712034|NCT02600507|364605938|FG000|Overall Study|Adverse Event|3|||
105712035|NCT02600507|364605939|FG001|Overall Study|Adverse Event|15|||
105712036|NCT02600507|364605940|FG002|Overall Study|Adverse Event|5|||
105712037|NCT02600507|364605938|FG000|Overall Study|Lack of Efficacy|3|||
105712038|NCT02600507|364605939|FG001|Overall Study|Lack of Efficacy|8|||
105712039|NCT02600507|364605940|FG002|Overall Study|Lack of Efficacy|5|||
105712040|NCT02600507|364605938|FG000|Overall Study|Lost to Follow-up|3|||
105712041|NCT02600507|364605939|FG001|Overall Study|Lost to Follow-up|5|||
105712042|NCT02600507|364605940|FG002|Overall Study|Lost to Follow-up|2|||
105712043|NCT02600507|364605938|FG000|Overall Study|Protocol Violation|12|||
105712044|NCT02600507|364605939|FG001|Overall Study|Protocol Violation|4|||
105712045|NCT02600507|364605940|FG002|Overall Study|Protocol Violation|4|||
105712046|NCT02600507|364605938|FG000|Overall Study|Physician Decision|1|||
105930078|NCT04676646|365402720|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
105930079|NCT04676646|365402721|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
105930080|NCT04676646|365402722|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
105930081|NCT04676646|365402720|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
105930082|NCT04676646|365402721|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
105712047|NCT02600507|364605939|FG001|Overall Study|Physician Decision|0|||
105712048|NCT02600507|364605940|FG002|Overall Study|Physician Decision|1|||
105712049|NCT02600507|364605938|FG000|Overall Study|Withdrawal by Subject|7|||
105712050|NCT02600507|364605939|FG001|Overall Study|Withdrawal by Subject|11|||
105712051|NCT02600507|364605940|FG002|Overall Study|Withdrawal by Subject|7|||
105712052|NCT02600507|364605938|FG000|Overall Study|Other|0|||
105712053|NCT02600507|364605939|FG001|Overall Study|Other|1|||
105712054|NCT02600507|364605940|FG002|Overall Study|Other|1|||
105712055|NCT00605085|364605943|FG000|Overall Study|Withdrawal by Subject|8|||
105712056|NCT00605085|364605944|FG001|Overall Study|Withdrawal by Subject|5|||
105712057|NCT00605085|364605943|FG000|Overall Study|Adverse Event|9|||
105712058|NCT00605085|364605944|FG001|Overall Study|Adverse Event|5|||
105712059|NCT00605085|364605943|FG000|Overall Study|Pregnancy|2|||
105712060|NCT00605085|364605944|FG001|Overall Study|Pregnancy|0|||
105712061|NCT00605085|364605943|FG000|Overall Study|Protocol Violation|3|||
105712062|NCT00605085|364605944|FG001|Overall Study|Protocol Violation|2|||
105712063|NCT00605085|364605943|FG000|Overall Study|Lost to Follow-up|10|||
105712064|NCT00605085|364605944|FG001|Overall Study|Lost to Follow-up|5|||
105712065|NCT00605085|364605943|FG000|Overall Study|administrative reasons|18|||
105712066|NCT00605085|364605944|FG001|Overall Study|administrative reasons|8|||
105930083|NCT04676646|365402722|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
105930084|NCT04676646|365402720|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
105930085|NCT04676646|365402721|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
105930086|NCT04676646|365402722|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
105930087|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
105930088|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
105930089|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
105930090|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Death|0|||
105930091|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Death|1|||
105930092|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Death|2|||
105930093|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
105930094|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
105930095|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
105712067|NCT03257267|364605945|FG000|Overall Study|Adverse Event|17|||
105712068|NCT03257267|364605946|FG001|Overall Study|Adverse Event|7|||
105712069|NCT03257267|364605945|FG000|Overall Study|Death|96|||
105712070|NCT03257267|364605946|FG001|Overall Study|Death|98|||
105712071|NCT03257267|364605945|FG000|Overall Study|Lost to Follow-up|2|||
105712072|NCT03257267|364605946|FG001|Overall Study|Lost to Follow-up|2|||
105712073|NCT03257267|364605945|FG000|Overall Study|Non-compliance with Study Drug|0|||
105712074|NCT03257267|364605946|FG001|Overall Study|Non-compliance with Study Drug|2|||
105712075|NCT03257267|364605945|FG000|Overall Study|Participant Decision|35|||
105712076|NCT03257267|364605946|FG001|Overall Study|Participant Decision|43|||
105712077|NCT03257267|364605945|FG000|Overall Study|Sponsor Decision|1|||
105712078|NCT03257267|364605946|FG001|Overall Study|Sponsor Decision|0|||
105712079|NCT03257267|364605945|FG000|Overall Study|Physician Decision|1|||
105712080|NCT03257267|364605946|FG001|Overall Study|Physician Decision|3|||
105712081|NCT03257267|364605945|FG000|Overall Study|Disease Progression|109|||
105712082|NCT03257267|364605946|FG001|Overall Study|Disease Progression|121|||
105712083|NCT03257267|364605945|FG000|Overall Study|Withdrawal by Subject|8|||
105712084|NCT03257267|364605946|FG001|Overall Study|Withdrawal by Subject|26|||
105712085|NCT03257267|364605945|FG000|Overall Study|Other|0|||
105712086|NCT03257267|364605946|FG001|Overall Study|Other|2|||
105712087|NCT04872101|364605947|FG000|Overall Study|Withdrawal by Subject|10|||
105712088|NCT04872101|364605948|FG001|Overall Study|Withdrawal by Subject|16|||
105712089|NCT04872101|364605947|FG000|Overall Study|Lack of Efficacy|6|||
105712090|NCT04872101|364605948|FG001|Overall Study|Lack of Efficacy|14|||
105712091|NCT04872101|364605947|FG000|Overall Study|Adverse Event|1|||
105712092|NCT04872101|364605948|FG001|Overall Study|Adverse Event|6|||
105712093|NCT04872101|364605947|FG000|Overall Study|Lost to Follow-up|2|||
105712094|NCT04872101|364605948|FG001|Overall Study|Lost to Follow-up|1|||
105712095|NCT04872101|364605947|FG000|Overall Study|Pregnancy|2|||
105930096|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
105930097|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
105930098|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
105930099|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
105930100|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
105930101|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
105930102|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
105930103|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
105952104|NCT03314935|365488185|FG001|Phase 1|"Captured as Other in Database"|2|||
106135257|NCT03686384|366154036|FG000|Overall Study|Lost to Follow-up|3|||
105712096|NCT04872101|364605948|FG001|Overall Study|Pregnancy|0|||
105712097|NCT04872101|364605947|FG000|Overall Study|Prohibited Medication|1|||
105712098|NCT04872101|364605948|FG001|Overall Study|Prohibited Medication|0|||
105712099|NCT04872101|364605947|FG000|Overall Study|Not dosed|1|||
105712100|NCT04872101|364605948|FG001|Overall Study|Not dosed|0|||
105712101|NCT00132132|364605949|FG000|Overall Study|Lost to Follow-up|7|||
105712102|NCT00132132|364605950|FG001|Overall Study|Lost to Follow-up|2|||
105712103|NCT02118792|364605955|FG000|Overall Study|Withdrawal by Subject|6|||
105712104|NCT02118792|364605956|FG001|Overall Study|Withdrawal by Subject|3|||
105788313|NCT00157820|364878303|FG002|Randomized|Physician Decision|3|||
105788314|NCT00157820|364878301|FG000|Randomized|Withdrawal by Subject|1|||
105712105|NCT02118792|364605955|FG000|Overall Study|Lost to Follow-up|4|||
105712106|NCT02118792|364605956|FG001|Overall Study|Lost to Follow-up|4|||
105712107|NCT02118792|364605955|FG000|Overall Study|Adverse Event|5|||
105712108|NCT02118792|364605956|FG001|Overall Study|Adverse Event|4|||
105712109|NCT02118792|364605955|FG000|Overall Study|Withdrawal by parent/guardian|14|||
105712110|NCT02118792|364605956|FG001|Overall Study|Withdrawal by parent/guardian|20|||
105788315|NCT00157820|364878302|FG001|Randomized|Withdrawal by Subject|2|||
105712111|NCT02118792|364605955|FG000|Overall Study|Other|1|||
105712112|NCT02118792|364605956|FG001|Overall Study|Other|6|||
105712113|NCT02118792|364605955|FG000|Overall Study|Randomised but not treated|1|||
105788316|NCT00157820|364878303|FG002|Randomized|Withdrawal by Subject|3|||
105712114|NCT02118792|364605956|FG001|Overall Study|Randomised but not treated|0|||
105712115|NCT02450487|364605969|FG000|Overall Study|Lost to Follow-up|3|||
105712116|NCT01562548|364605972|FG000|Overall Study|Lost to Follow-up|0|||
105712117|NCT01562548|364605973|FG001|Overall Study|Lost to Follow-up|0|||
105712118|NCT01562548|364605974|FG002|Overall Study|Lost to Follow-up|1|||
105712119|NCT01562548|364605975|FG003|Overall Study|Lost to Follow-up|0|||
105712120|NCT02296242|364605976|FG000|Overall Study|Death|1|||
105712121|NCT02296242|364605977|FG001|Overall Study|Death|1|||
105712122|NCT02296242|364605978|FG002|Overall Study|Death|1|||
105712123|NCT02296242|364605979|FG003|Overall Study|Death|1|||
105712124|NCT02296242|364605980|FG004|Overall Study|Death|1|||
105712125|NCT02296242|364605976|FG000|Overall Study|Withdrawal by Subject|0|||
105712126|NCT02296242|364605977|FG001|Overall Study|Withdrawal by Subject|0|||
105712127|NCT02296242|364605978|FG002|Overall Study|Withdrawal by Subject|1|||
105712128|NCT02296242|364605979|FG003|Overall Study|Withdrawal by Subject|1|||
105712129|NCT02296242|364605980|FG004|Overall Study|Withdrawal by Subject|3|||
105712130|NCT02296242|364605976|FG000|Overall Study|Disease Progression|1|||
105712131|NCT02296242|364605977|FG001|Overall Study|Disease Progression|3|||
105712132|NCT02296242|364605978|FG002|Overall Study|Disease Progression|2|||
105712133|NCT02296242|364605979|FG003|Overall Study|Disease Progression|8|||
105712134|NCT02296242|364605980|FG004|Overall Study|Disease Progression|11|||
105712135|NCT02296242|364605976|FG000|Overall Study|Unacceptable Toxicity|0|||
105712136|NCT02296242|364605977|FG001|Overall Study|Unacceptable Toxicity|0|||
105712137|NCT02296242|364605978|FG002|Overall Study|Unacceptable Toxicity|0|||
105712138|NCT02296242|364605979|FG003|Overall Study|Unacceptable Toxicity|0|||
105712139|NCT02296242|364605980|FG004|Overall Study|Unacceptable Toxicity|1|||
105712140|NCT02296242|364605976|FG000|Overall Study|Patient Condition Changed|0|||
105712141|NCT02296242|364605977|FG001|Overall Study|Patient Condition Changed|0|||
105712142|NCT02296242|364605978|FG002|Overall Study|Patient Condition Changed|2|||
105712143|NCT02296242|364605979|FG003|Overall Study|Patient Condition Changed|0|||
105712144|NCT02296242|364605980|FG004|Overall Study|Patient Condition Changed|1|||
105712145|NCT02296242|364605976|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
105712146|NCT02296242|364605977|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
105712147|NCT02296242|364605978|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
105712148|NCT02296242|364605979|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
105712149|NCT02296242|364605980|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
105712150|NCT02296242|364605976|FG000|Overall Study|Lost to Follow-up|1|||
105712151|NCT02296242|364605977|FG001|Overall Study|Lost to Follow-up|0|||
105712152|NCT02296242|364605978|FG002|Overall Study|Lost to Follow-up|0|||
105712153|NCT02296242|364605979|FG003|Overall Study|Lost to Follow-up|0|||
105712154|NCT02296242|364605980|FG004|Overall Study|Lost to Follow-up|0|||
105712155|NCT02296242|364605976|FG000|Overall Study|Need for Hydroxyurea|2|||
105712156|NCT02296242|364605977|FG001|Overall Study|Need for Hydroxyurea|0|||
105712157|NCT02296242|364605978|FG002|Overall Study|Need for Hydroxyurea|0|||
105712158|NCT02296242|364605979|FG003|Overall Study|Need for Hydroxyurea|0|||
105712159|NCT02296242|364605980|FG004|Overall Study|Need for Hydroxyurea|0|||
105712160|NCT02296242|364605976|FG000|Overall Study|Screened for Other Protocol|0|||
105712161|NCT02296242|364605977|FG001|Overall Study|Screened for Other Protocol|1|||
105712162|NCT02296242|364605978|FG002|Overall Study|Screened for Other Protocol|0|||
105712163|NCT02296242|364605979|FG003|Overall Study|Screened for Other Protocol|0|||
105712164|NCT02296242|364605980|FG004|Overall Study|Screened for Other Protocol|0|||
105712165|NCT02296242|364605976|FG000|Overall Study|Physician Decision|0|||
105712166|NCT02296242|364605977|FG001|Overall Study|Physician Decision|1|||
105712167|NCT02296242|364605978|FG002|Overall Study|Physician Decision|0|||
105712168|NCT02296242|364605979|FG003|Overall Study|Physician Decision|1|||
105712169|NCT02296242|364605980|FG004|Overall Study|Physician Decision|0|||
105712170|NCT02296242|364605976|FG000|Overall Study|Alternative Treatment|0|||
105712171|NCT02296242|364605977|FG001|Overall Study|Alternative Treatment|0|||
105712172|NCT02296242|364605978|FG002|Overall Study|Alternative Treatment|0|||
105712173|NCT02296242|364605979|FG003|Overall Study|Alternative Treatment|1|||
105712174|NCT02296242|364605980|FG004|Overall Study|Alternative Treatment|0|||
105712175|NCT02296242|364605976|FG000|Overall Study|Adverse Event|0|||
105712176|NCT02296242|364605977|FG001|Overall Study|Adverse Event|0|||
105930104|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
105712177|NCT02296242|364605978|FG002|Overall Study|Adverse Event|0|||
105712178|NCT02296242|364605979|FG003|Overall Study|Adverse Event|1|||
105712179|NCT02296242|364605980|FG004|Overall Study|Adverse Event|0|||
105712180|NCT02296242|364605976|FG000|Overall Study|Lack of Efficacy|0|||
105712181|NCT02296242|364605977|FG001|Overall Study|Lack of Efficacy|0|||
105712182|NCT02296242|364605978|FG002|Overall Study|Lack of Efficacy|0|||
105712183|NCT02296242|364605979|FG003|Overall Study|Lack of Efficacy|0|||
105712184|NCT02296242|364605980|FG004|Overall Study|Lack of Efficacy|3|||
105712185|NCT03021642|364605983|FG000|Washout Period (21 Days)|Adverse Event|1|||
105712186|NCT03021642|364605984|FG001|Washout Period (21 Days)|Adverse Event|1|||
105712187|NCT02499029|364605985|FG000|Overall Study|Lost to Follow-up|2|||
105712188|NCT02499029|364605986|FG001|Overall Study|Lost to Follow-up|2|||
105712189|NCT02499029|364605985|FG000|Overall Study|Physician Decision|2|||
105712190|NCT02499029|364605986|FG001|Overall Study|Physician Decision|1|||
105712191|NCT02499029|364605985|FG000|Overall Study|Death|1|||
105712192|NCT02499029|364605986|FG001|Overall Study|Death|0|||
105712193|NCT04317274|364605987|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
105712194|NCT04317274|364605988|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
105712195|NCT04317274|364605989|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
105712196|NCT04317274|364605990|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
105712197|NCT01164722|364605991|FG000|Overall Study|Adverse Event|0|||
105712198|NCT01164722|364605992|FG001|Overall Study|Adverse Event|1|||
105712199|NCT01164722|364605991|FG000|Overall Study|Withdrawal by Subject|3|||
105712200|NCT01164722|364605992|FG001|Overall Study|Withdrawal by Subject|4|||
105712201|NCT01164722|364605991|FG000|Overall Study|Lost to Follow-up|3|||
105712202|NCT01164722|364605992|FG001|Overall Study|Lost to Follow-up|6|||
105712203|NCT01164722|364605991|FG000|Overall Study|met protocol criteria for non-treatment|11|||
105712204|NCT01164722|364605992|FG001|Overall Study|met protocol criteria for non-treatment|1|||
105712205|NCT01164722|364605991|FG000|Overall Study|enrolled on other study, concomitant med|1|||
105712206|NCT01164722|364605992|FG001|Overall Study|enrolled on other study, concomitant med|3|||
105712207|NCT00193063|364605993|FG000|Overall Study|Lack of Efficacy|3|||
105712208|NCT00193063|364605993|FG000|Overall Study|Adverse Event|1|||
105712209|NCT01064167|364605995|FG000|Overall Study|Protocol Violation|14|||
105712210|NCT01064167|364605996|FG001|Overall Study|Protocol Violation|15|||
105712211|NCT04849780|364605997|FG000|Period 1|Covid-19 Related|1|||
105712212|NCT04849780|364605998|FG001|Period 1|Covid-19 Related|0|||
105712213|NCT04849780|364605997|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
105712214|NCT04849780|364605998|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
105712215|NCT04849780|364605997|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
105712216|NCT04849780|364605998|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
105712217|NCT02682901|364605999|FG000|Overall Study|Adverse Event|10|||
105712218|NCT02682901|364606000|FG001|Overall Study|Adverse Event|3|||
105712219|NCT02682901|364605999|FG000|Overall Study|Lack of Efficacy|0|||
105712220|NCT02682901|364606000|FG001|Overall Study|Lack of Efficacy|1|||
105712221|NCT01298492|364606001|FG000|Overall Study|Death|2|||
105712222|NCT01298492|364606001|FG000|Overall Study|Insufficient Clinical Response|22|||
105712223|NCT01298492|364606001|FG000|Overall Study|Lost to Follow-up|12|||
105712224|NCT01298492|364606001|FG000|Overall Study|Withdrawal by Subject|47|||
105712225|NCT01298492|364606001|FG000|Overall Study|Other (Unspecified)|7|||
105712226|NCT01298492|364606001|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
105712227|NCT01298492|364606001|FG000|Overall Study|Protocol Violation|2|||
105712228|NCT01298492|364606001|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
105712229|NCT01298492|364606001|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
105712230|NCT03870555|364606002|FG000|Period 3 (2 Days)|Adverse Event|1|||
105712231|NCT03870555|364606003|FG001|Period 3 (2 Days)|Adverse Event|0|||
105712232|NCT03870555|364606004|FG002|Period 3 (2 Days)|Adverse Event|0|||
105788317|NCT00157820|364878301|FG000|Randomized|Protocol Violation|2|||
105930105|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
105930106|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
105930107|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
105930108|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
105930109|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
105930110|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
105930111|NCT04676646|365402720|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
105930112|NCT04676646|365402721|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
105930113|NCT04676646|365402722|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
105930114|NCT02969018|365402723|FG000|Overall Study|Adverse Event|2|||
105930115|NCT02969018|365402724|FG001|Overall Study|Adverse Event|4|||
105930116|NCT02969018|365402725|FG002|Overall Study|Adverse Event|1|||
106008605|NCT01667900|365697028|FG007|Part B|Death|0|||
106008606|NCT01667900|365697029|FG008|Part B|Death|0|||
105712233|NCT03984305|364606006|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
105712234|NCT03984305|364606007|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
105712235|NCT03984305|364606006|FG000|Overall Study|Withdrawal by Subject|3|||
105712236|NCT03984305|364606007|FG001|Overall Study|Withdrawal by Subject|3|||
105712237|NCT03984305|364606006|FG000|Overall Study|Lost to Follow-up|1|||
105712238|NCT03984305|364606007|FG001|Overall Study|Lost to Follow-up|0|||
105712239|NCT01656434|364606008|FG000|Overall Study|Adverse Event|199|||
105712240|NCT01656434|364606009|FG001|Overall Study|Adverse Event|63|||
105712241|NCT01656434|364606008|FG000|Overall Study|Enrollment terminated at trial site|2|||
105712242|NCT01656434|364606009|FG001|Overall Study|Enrollment terminated at trial site|0|||
105712243|NCT01656434|364606008|FG000|Overall Study|Lost to Follow-up|309|||
106135258|NCT03686384|366154037|FG001|Overall Study|Lost to Follow-up|0|||
106135259|NCT03686384|366154036|FG000|Overall Study|Physician Decision|0|||
106135260|NCT03686384|366154037|FG001|Overall Study|Physician Decision|1|||
106135261|NCT03686384|366154036|FG000|Overall Study|Took prohibited medication|0|||
106135262|NCT03686384|366154037|FG001|Overall Study|Took prohibited medication|1|||
106135263|NCT05015478|366154040|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
106135264|NCT05015478|366154041|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
106135265|NCT05015478|366154042|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
106135266|NCT05015478|366154043|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
106135267|NCT01018511|366154045|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
106135268|NCT01018511|366154046|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
106135269|NCT01018511|366154047|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
106135270|NCT01018511|366154048|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
106135271|NCT01018511|366154045|FG000|Overall Study|Adverse Event|5|||
106135272|NCT01018511|366154046|FG001|Overall Study|Adverse Event|9|||
106135273|NCT01018511|366154047|FG002|Overall Study|Adverse Event|13|||
106135274|NCT01018511|366154048|FG003|Overall Study|Adverse Event|10|||
106135275|NCT01018511|366154045|FG000|Overall Study|Lack of Efficacy|4|||
106135276|NCT01018511|366154046|FG001|Overall Study|Lack of Efficacy|1|||
106135277|NCT01018511|366154047|FG002|Overall Study|Lack of Efficacy|1|||
106135278|NCT01018511|366154048|FG003|Overall Study|Lack of Efficacy|2|||
105788318|NCT00157820|364878302|FG001|Randomized|Protocol Violation|1|||
105788319|NCT00157820|364878303|FG002|Randomized|Protocol Violation|2|||
106135279|NCT01018511|366154045|FG000|Overall Study|Withdrawal by Subject|6|||
106135280|NCT01018511|366154046|FG001|Overall Study|Withdrawal by Subject|5|||
106135281|NCT01018511|366154047|FG002|Overall Study|Withdrawal by Subject|11|||
106135282|NCT01018511|366154048|FG003|Overall Study|Withdrawal by Subject|9|||
106135283|NCT01018511|366154045|FG000|Overall Study|Lost to Follow-up|0|||
106135284|NCT01018511|366154046|FG001|Overall Study|Lost to Follow-up|0|||
106135285|NCT01018511|366154047|FG002|Overall Study|Lost to Follow-up|1|||
106135286|NCT01018511|366154048|FG003|Overall Study|Lost to Follow-up|0|||
105788320|NCT00157820|364878301|FG000|1st 8 Month|Death|7|||
105788321|NCT00157820|364878302|FG001|1st 8 Month|Death|8|||
105788322|NCT00157820|364878303|FG002|1st 8 Month|Death|3|||
105788323|NCT00157820|364878301|FG000|1st 8 Month|Lost to Follow-up|1|||
105788324|NCT00157820|364878302|FG001|1st 8 Month|Lost to Follow-up|2|||
105788325|NCT00157820|364878303|FG002|1st 8 Month|Lost to Follow-up|1|||
105788326|NCT00157820|364878301|FG000|1st 8 Month|Premature cross-over|0|||
105788327|NCT00157820|364878302|FG001|1st 8 Month|Premature cross-over|2|||
105788328|NCT00157820|364878303|FG002|1st 8 Month|Premature cross-over|2|||
105788329|NCT00157820|364878301|FG000|2nd 8 Months|Death|3|||
105788330|NCT00157820|364878302|FG001|2nd 8 Months|Death|1|||
105788331|NCT00157820|364878303|FG002|2nd 8 Months|Death|3|||
105788332|NCT00157820|364878301|FG000|2nd 8 Months|Lost to Follow-up|1|||
105788333|NCT00157820|364878302|FG001|2nd 8 Months|Lost to Follow-up|5|||
106135287|NCT01018511|366154045|FG000|Overall Study|Protocol Violation|5|||
106135288|NCT01018511|366154046|FG001|Overall Study|Protocol Violation|8|||
106135289|NCT01018511|366154047|FG002|Overall Study|Protocol Violation|7|||
105788334|NCT00157820|364878303|FG002|2nd 8 Months|Lost to Follow-up|2|||
105788335|NCT00157820|364878301|FG000|2nd 8 Months|Premature cross-over|1|||
105788336|NCT00157820|364878302|FG001|2nd 8 Months|Premature cross-over|7|||
106008607|NCT01667900|365697030|FG009|Part B|Death|0|||
106135290|NCT01018511|366154048|FG003|Overall Study|Protocol Violation|9|||
106135291|NCT01018511|366154045|FG000|Overall Study|Miscellaneous|0|||
105788337|NCT00157820|364878303|FG002|2nd 8 Months|Premature cross-over|9|||
106008608|NCT01667900|365697031|FG010|Part B|Death|0|||
106135292|NCT01018511|366154046|FG001|Overall Study|Miscellaneous|2|||
106135293|NCT01018511|366154047|FG002|Overall Study|Miscellaneous|0|||
106135294|NCT01018511|366154048|FG003|Overall Study|Miscellaneous|0|||
105712244|NCT01656434|364606009|FG001|Overall Study|Lost to Follow-up|76|||
105712245|NCT01656434|364606008|FG000|Overall Study|Site discontinued study participation|24|||
105712246|NCT01656434|364606009|FG001|Overall Study|Site discontinued study participation|9|||
105712247|NCT01656434|364606008|FG000|Overall Study|Screen failure|2|||
105712248|NCT01656434|364606009|FG001|Overall Study|Screen failure|0|||
105712249|NCT01656434|364606008|FG000|Overall Study|Protocol Violation|7|||
105930117|NCT02969018|365402726|FG003|Overall Study|Adverse Event|2|||
105930118|NCT02969018|365402727|FG004|Overall Study|Adverse Event|0|||
105930119|NCT02969018|365402728|FG005|Overall Study|Adverse Event|1|||
105930120|NCT02969018|365402729|FG006|Overall Study|Adverse Event|2|||
105930121|NCT02969018|365402730|FG007|Overall Study|Adverse Event|0|||
105930122|NCT02969018|365402723|FG000|Overall Study|Lack of Efficacy|0|||
105930123|NCT02969018|365402724|FG001|Overall Study|Lack of Efficacy|1|||
105930124|NCT02969018|365402725|FG002|Overall Study|Lack of Efficacy|0|||
105930125|NCT02969018|365402726|FG003|Overall Study|Lack of Efficacy|0|||
105930126|NCT02969018|365402727|FG004|Overall Study|Lack of Efficacy|1|||
105930127|NCT02969018|365402728|FG005|Overall Study|Lack of Efficacy|1|||
105930128|NCT02969018|365402729|FG006|Overall Study|Lack of Efficacy|1|||
105930129|NCT02969018|365402730|FG007|Overall Study|Lack of Efficacy|1|||
105930130|NCT02969018|365402723|FG000|Overall Study|Lost to Follow-up|1|||
105930131|NCT02969018|365402724|FG001|Overall Study|Lost to Follow-up|2|||
105930132|NCT02969018|365402725|FG002|Overall Study|Lost to Follow-up|2|||
105930133|NCT02969018|365402726|FG003|Overall Study|Lost to Follow-up|0|||
105930134|NCT02969018|365402727|FG004|Overall Study|Lost to Follow-up|1|||
105930135|NCT02969018|365402728|FG005|Overall Study|Lost to Follow-up|1|||
105930136|NCT02969018|365402729|FG006|Overall Study|Lost to Follow-up|0|||
105930137|NCT02969018|365402730|FG007|Overall Study|Lost to Follow-up|1|||
105930138|NCT02969018|365402723|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105930139|NCT02969018|365402724|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105930140|NCT02969018|365402725|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
105930141|NCT02969018|365402726|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
105930142|NCT02969018|365402727|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
105930143|NCT02969018|365402728|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
105930144|NCT02969018|365402729|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
105930145|NCT02969018|365402730|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
105930146|NCT02969018|365402723|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105930147|NCT02969018|365402724|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105930148|NCT02969018|365402725|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105930149|NCT02969018|365402726|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105930150|NCT02969018|365402727|FG004|Overall Study|Non-Compliance With Study Drug|0|||
105930151|NCT02969018|365402728|FG005|Overall Study|Non-Compliance With Study Drug|0|||
105930152|NCT02969018|365402729|FG006|Overall Study|Non-Compliance With Study Drug|0|||
105930153|NCT02969018|365402730|FG007|Overall Study|Non-Compliance With Study Drug|0|||
105930154|NCT02969018|365402723|FG000|Overall Study|Other|0|||
105930155|NCT02969018|365402724|FG001|Overall Study|Other|0|||
105930156|NCT02969018|365402725|FG002|Overall Study|Other|0|||
105930157|NCT02969018|365402726|FG003|Overall Study|Other|1|||
105930158|NCT02969018|365402727|FG004|Overall Study|Other|0|||
105930159|NCT02969018|365402728|FG005|Overall Study|Other|0|||
105930160|NCT02969018|365402729|FG006|Overall Study|Other|0|||
105930161|NCT02969018|365402730|FG007|Overall Study|Other|2|||
105930162|NCT02969018|365402723|FG000|Overall Study|Pregnancy|0|||
105930163|NCT02969018|365402724|FG001|Overall Study|Pregnancy|0|||
105930164|NCT02969018|365402725|FG002|Overall Study|Pregnancy|0|||
105930165|NCT02969018|365402726|FG003|Overall Study|Pregnancy|0|||
105930166|NCT02969018|365402727|FG004|Overall Study|Pregnancy|0|||
105930167|NCT02969018|365402728|FG005|Overall Study|Pregnancy|1|||
105930168|NCT02969018|365402729|FG006|Overall Study|Pregnancy|0|||
105930169|NCT02969018|365402730|FG007|Overall Study|Pregnancy|0|||
105930170|NCT02969018|365402723|FG000|Overall Study|Protocol Violation|0|||
105930171|NCT02969018|365402724|FG001|Overall Study|Protocol Violation|0|||
105930172|NCT02969018|365402725|FG002|Overall Study|Protocol Violation|1|||
105712250|NCT01656434|364606009|FG001|Overall Study|Protocol Violation|0|||
105712251|NCT01656434|364606008|FG000|Overall Study|Pregnancy wish|18|||
105930173|NCT02969018|365402726|FG003|Overall Study|Protocol Violation|1|||
105930174|NCT02969018|365402727|FG004|Overall Study|Protocol Violation|0|||
105930175|NCT02969018|365402728|FG005|Overall Study|Protocol Violation|0|||
105930176|NCT02969018|365402729|FG006|Overall Study|Protocol Violation|0|||
105930177|NCT02969018|365402730|FG007|Overall Study|Protocol Violation|0|||
105930178|NCT02969018|365402723|FG000|Overall Study|Withdrawal by Subject|0|||
105930179|NCT02969018|365402724|FG001|Overall Study|Withdrawal by Subject|1|||
105930180|NCT02969018|365402725|FG002|Overall Study|Withdrawal by Subject|2|||
105930181|NCT02969018|365402726|FG003|Overall Study|Withdrawal by Subject|1|||
105930182|NCT02969018|365402727|FG004|Overall Study|Withdrawal by Subject|0|||
105930183|NCT02969018|365402728|FG005|Overall Study|Withdrawal by Subject|4|||
105930184|NCT02969018|365402729|FG006|Overall Study|Withdrawal by Subject|4|||
105930185|NCT02969018|365402730|FG007|Overall Study|Withdrawal by Subject|3|||
105930186|NCT04392635|365402733|FG000|Overall Study|Lost to Follow-up|0|||
105930187|NCT04392635|365402734|FG001|Overall Study|Lost to Follow-up|1|||
105930188|NCT02030418|365402735|FG000|Overall Study|Death|78|||
105930189|NCT02030418|365402735|FG000|Overall Study|Missed 12-Month Visit|9|||
105930190|NCT02030418|365402735|FG000|Overall Study|Withdrawn|57|||
105930191|NCT04477486|365402742|FG000|Overall Study|Death|2|||
105930192|NCT04477486|365402742|FG000|Overall Study|Ongoing at Time of Analysis|11|||
105930193|NCT04280562|365402743|FG000|Study|Adverse Event|2|||
105930194|NCT04280562|365402744|FG001|Study|Adverse Event|0|||
105930195|NCT04280562|365402743|FG000|Study|Lost to Follow-up|3|||
105930196|NCT04280562|365402744|FG001|Study|Lost to Follow-up|3|||
105930197|NCT02675452|365402745|FG000|Overall Study|Sponsor decision|0|||
105930198|NCT02675452|365402746|FG001|Overall Study|Sponsor decision|0|||
105930199|NCT02675452|365402747|FG002|Overall Study|Sponsor decision|0|||
105930200|NCT02675452|365402748|FG003|Overall Study|Sponsor decision|0|||
105930201|NCT02675452|365402749|FG004|Overall Study|Sponsor decision|0|||
105930202|NCT02675452|365402750|FG005|Overall Study|Sponsor decision|0|||
105930203|NCT02675452|365402751|FG006|Overall Study|Sponsor decision|0|||
105930204|NCT02675452|365402752|FG007|Overall Study|Sponsor decision|0|||
105930205|NCT02675452|365402753|FG008|Overall Study|Sponsor decision|0|||
105930206|NCT02675452|365402754|FG009|Overall Study|Sponsor decision|1|||
105930207|NCT02675452|365402755|FG010|Overall Study|Sponsor decision|0|||
105930208|NCT02675452|365402756|FG011|Overall Study|Sponsor decision|0|||
105930209|NCT02675452|365402757|FG012|Overall Study|Sponsor decision|0|||
105930210|NCT02675452|365402758|FG013|Overall Study|Sponsor decision|2|||
105930211|NCT02675452|365402759|FG014|Overall Study|Sponsor decision|1|||
105930212|NCT02675452|365402760|FG015|Overall Study|Sponsor decision|0|||
105930213|NCT02675452|365402761|FG016|Overall Study|Sponsor decision|1|||
105930214|NCT02675452|365402762|FG017|Overall Study|Sponsor decision|0|||
105930215|NCT02675452|365402763|FG018|Overall Study|Sponsor decision|0|||
105930216|NCT02675452|365402764|FG019|Overall Study|Sponsor decision|0|||
105930217|NCT02675452|365402765|FG020|Overall Study|Sponsor decision|0|||
105930218|NCT02675452|365402766|FG021|Overall Study|Sponsor decision|0|||
105930219|NCT02675452|365402767|FG022|Overall Study|Sponsor decision|0|||
105930220|NCT02675452|365402768|FG023|Overall Study|Sponsor decision|0|||
105930221|NCT02675452|365402769|FG024|Overall Study|Sponsor decision|0|||
105930222|NCT02675452|365402770|FG025|Overall Study|Sponsor decision|0|||
105930223|NCT02675452|365402771|FG026|Overall Study|Sponsor decision|2|||
105930224|NCT02675452|365402772|FG027|Overall Study|Sponsor decision|0|||
105930225|NCT02675452|365402773|FG028|Overall Study|Sponsor decision|0|||
105930226|NCT02675452|365402745|FG000|Overall Study|Withdrawal by Subject|0|||
105930227|NCT02675452|365402746|FG001|Overall Study|Withdrawal by Subject|0|||
105930228|NCT02675452|365402747|FG002|Overall Study|Withdrawal by Subject|0|||
105930229|NCT02675452|365402748|FG003|Overall Study|Withdrawal by Subject|0|||
105930230|NCT02675452|365402749|FG004|Overall Study|Withdrawal by Subject|0|||
105930231|NCT02675452|365402750|FG005|Overall Study|Withdrawal by Subject|0|||
105930232|NCT02675452|365402751|FG006|Overall Study|Withdrawal by Subject|0|||
105930233|NCT02675452|365402752|FG007|Overall Study|Withdrawal by Subject|0|||
105930234|NCT02675452|365402753|FG008|Overall Study|Withdrawal by Subject|0|||
105930235|NCT02675452|365402754|FG009|Overall Study|Withdrawal by Subject|1|||
105930236|NCT02675452|365402755|FG010|Overall Study|Withdrawal by Subject|0|||
105930237|NCT02675452|365402756|FG011|Overall Study|Withdrawal by Subject|1|||
105930238|NCT02675452|365402757|FG012|Overall Study|Withdrawal by Subject|0|||
105930239|NCT02675452|365402758|FG013|Overall Study|Withdrawal by Subject|1|||
105930240|NCT02675452|365402759|FG014|Overall Study|Withdrawal by Subject|1|||
105930241|NCT02675452|365402760|FG015|Overall Study|Withdrawal by Subject|0|||
105930242|NCT02675452|365402761|FG016|Overall Study|Withdrawal by Subject|2|||
105930243|NCT02675452|365402762|FG017|Overall Study|Withdrawal by Subject|0|||
105930244|NCT02675452|365402763|FG018|Overall Study|Withdrawal by Subject|0|||
105930245|NCT02675452|365402764|FG019|Overall Study|Withdrawal by Subject|0|||
105930246|NCT02675452|365402765|FG020|Overall Study|Withdrawal by Subject|0|||
105930247|NCT02675452|365402766|FG021|Overall Study|Withdrawal by Subject|0|||
105930248|NCT02675452|365402767|FG022|Overall Study|Withdrawal by Subject|3|||
105930249|NCT02675452|365402768|FG023|Overall Study|Withdrawal by Subject|0|||
105930250|NCT02675452|365402769|FG024|Overall Study|Withdrawal by Subject|1|||
105930251|NCT02675452|365402770|FG025|Overall Study|Withdrawal by Subject|0|||
105930252|NCT02675452|365402771|FG026|Overall Study|Withdrawal by Subject|1|||
105930253|NCT02675452|365402772|FG027|Overall Study|Withdrawal by Subject|3|||
105930254|NCT02675452|365402773|FG028|Overall Study|Withdrawal by Subject|4|||
105930255|NCT02675452|365402745|FG000|Overall Study|Death|0|||
105930256|NCT02675452|365402746|FG001|Overall Study|Death|0|||
105930257|NCT02675452|365402747|FG002|Overall Study|Death|1|||
105930258|NCT02675452|365402748|FG003|Overall Study|Death|0|||
105930259|NCT02675452|365402749|FG004|Overall Study|Death|0|||
105930260|NCT02675452|365402750|FG005|Overall Study|Death|1|||
105930261|NCT02675452|365402751|FG006|Overall Study|Death|0|||
105930262|NCT02675452|365402752|FG007|Overall Study|Death|0|||
105930263|NCT02675452|365402753|FG008|Overall Study|Death|1|||
105930264|NCT02675452|365402754|FG009|Overall Study|Death|0|||
105930265|NCT02675452|365402755|FG010|Overall Study|Death|0|||
105930266|NCT02675452|365402756|FG011|Overall Study|Death|0|||
106135295|NCT01740557|366154049|FG000|Overall Study|Ineligible|1|||
106135296|NCT01740557|366154049|FG000|Overall Study|Screen failure|1|||
106135297|NCT01268566|366154050|FG000|Overall Study|Lost to Follow-up|1|||
106135298|NCT01268566|366154050|FG000|Overall Study|Withdrawal by Subject|12|||
106135299|NCT01268566|366154050|FG000|Overall Study|Death|30|||
106135300|NCT00881335|366154052|FG000|Overall Study|Lost to Follow-up|3|||
106135301|NCT00881335|366154053|FG001|Overall Study|Lost to Follow-up|2|||
106135302|NCT02784704|366154056|FG000|Overall Study|Adverse Event|4|||
106135303|NCT02784704|366154057|FG001|Overall Study|Adverse Event|2|||
106135304|NCT02784704|366154056|FG000|Overall Study|Lost to Follow-up|6|||
106135305|NCT02784704|366154057|FG001|Overall Study|Lost to Follow-up|4|||
106135306|NCT02784704|366154056|FG000|Overall Study|Withdrawal by Subject|1|||
106135307|NCT02784704|366154057|FG001|Overall Study|Withdrawal by Subject|3|||
106135308|NCT02784704|366154056|FG000|Overall Study|Subject Non Compliance|2|||
106135309|NCT02784704|366154057|FG001|Overall Study|Subject Non Compliance|0|||
106135310|NCT01913340|366154058|FG000|Overall Study|Death|2|||
106135311|NCT01913340|366154059|FG001|Overall Study|Death|5|||
106135312|NCT01913340|366154058|FG000|Overall Study|Lost to Follow-up|1|||
106135313|NCT01913340|366154059|FG001|Overall Study|Lost to Follow-up|1|||
106135314|NCT00603538|366154060|FG000|Overall Study|Adverse Event|0|||
106135315|NCT00603538|366154061|FG001|Overall Study|Adverse Event|4|||
106135316|NCT00603538|366154062|FG002|Overall Study|Adverse Event|2|||
106135317|NCT00603538|366154060|FG000|Overall Study|Objective progression or relapse|3|||
106135318|NCT00603538|366154061|FG001|Overall Study|Objective progression or relapse|0|||
106135319|NCT00603538|366154062|FG002|Overall Study|Objective progression or relapse|0|||
106135320|NCT00117988|366154064|FG000|Overall Study|Death|3|||
106135321|NCT00117988|366154064|FG000|Overall Study|Adverse Event|1|||
106135322|NCT05196737|366154066|FG000|Non-intervention Week|Lost to Follow-up|2|||
106135323|NCT05196737|366154066|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
106135324|NCT00813488|366154067|FG000|Titration Period 1|Adverse Event|6|||
106135325|NCT00813488|366154068|FG001|Titration Period 1|Adverse Event|1|||
106135326|NCT00813488|366154067|FG000|Titration Period 1|Lack of Efficacy|9|||
106135327|NCT00813488|366154068|FG001|Titration Period 1|Lack of Efficacy|7|||
106135328|NCT00813488|366154067|FG000|Titration Period 1|Withdrawal by Subject|2|||
106135329|NCT00813488|366154068|FG001|Titration Period 1|Withdrawal by Subject|2|||
106135330|NCT00813488|366154067|FG000|Titration Period 1|Protocol Violation|4|||
106135331|NCT00813488|366154068|FG001|Titration Period 1|Protocol Violation|3|||
106135332|NCT00813488|366154067|FG000|Titration Period 1|Non-compliance to study medication|4|||
106135333|NCT00813488|366154068|FG001|Titration Period 1|Non-compliance to study medication|1|||
106135334|NCT00813488|366154067|FG000|Titration Period 1|Non-compliance to study procedures|2|||
106135335|NCT00813488|366154068|FG001|Titration Period 1|Non-compliance to study procedures|2|||
106135336|NCT00813488|366154067|FG000|Titration Period 1|Technical Difficulties|0|||
106135337|NCT00813488|366154068|FG001|Titration Period 1|Technical Difficulties|1|||
106135338|NCT00813488|366154067|FG000|Titration Period 2|Adverse Event|2|||
106135339|NCT00813488|366154068|FG001|Titration Period 2|Adverse Event|3|||
106135340|NCT00813488|366154067|FG000|Titration Period 2|Lack of Efficacy|8|||
106135341|NCT00813488|366154068|FG001|Titration Period 2|Lack of Efficacy|4|||
106135342|NCT00813488|366154067|FG000|Titration Period 2|Protocol Violation|3|||
106135343|NCT00813488|366154068|FG001|Titration Period 2|Protocol Violation|2|||
106135344|NCT00813488|366154067|FG000|Titration Period 2|Lost to Follow-up|1|||
106135345|NCT00813488|366154068|FG001|Titration Period 2|Lost to Follow-up|0|||
106135346|NCT00813488|366154067|FG000|Titration Period 2|Non-compliance with study procedures|2|||
106135347|NCT00813488|366154068|FG001|Titration Period 2|Non-compliance with study procedures|1|||
106135348|NCT00813488|366154067|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
106135349|NCT00813488|366154068|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
106135350|NCT00813488|366154067|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
106135351|NCT00813488|366154068|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
106135352|NCT00813488|366154067|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
106135353|NCT00813488|366154068|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
106135354|NCT00813488|366154067|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
106135355|NCT00813488|366154068|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
106135356|NCT00813488|366154067|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
106008609|NCT01667900|365697032|FG011|Part B|Death|0|||
106135357|NCT00813488|366154068|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
106008610|NCT01667900|365697033|FG012|Part B|Death|0|||
105930267|NCT02675452|365402757|FG012|Overall Study|Death|1|||
105930268|NCT02675452|365402758|FG013|Overall Study|Death|0|||
105930269|NCT02675452|365402759|FG014|Overall Study|Death|0|||
105930270|NCT02675452|365402760|FG015|Overall Study|Death|2|||
105930271|NCT02675452|365402761|FG016|Overall Study|Death|0|||
105930272|NCT02675452|365402762|FG017|Overall Study|Death|0|||
105930273|NCT02675452|365402763|FG018|Overall Study|Death|4|||
105930274|NCT02675452|365402764|FG019|Overall Study|Death|3|||
105930275|NCT02675452|365402765|FG020|Overall Study|Death|3|||
105930276|NCT02675452|365402766|FG021|Overall Study|Death|3|||
105930277|NCT02675452|365402767|FG022|Overall Study|Death|7|||
105930278|NCT02675452|365402768|FG023|Overall Study|Death|5|||
105930279|NCT02675452|365402769|FG024|Overall Study|Death|3|||
105930280|NCT02675452|365402770|FG025|Overall Study|Death|4|||
105930281|NCT02675452|365402771|FG026|Overall Study|Death|7|||
105930282|NCT02675452|365402772|FG027|Overall Study|Death|6|||
105930283|NCT02675452|365402773|FG028|Overall Study|Death|9|||
105930284|NCT02675452|365402745|FG000|Overall Study|Lost to Follow-up|0|||
105930285|NCT02675452|365402746|FG001|Overall Study|Lost to Follow-up|1|||
105930286|NCT02675452|365402747|FG002|Overall Study|Lost to Follow-up|0|||
105930287|NCT02675452|365402748|FG003|Overall Study|Lost to Follow-up|0|||
105930288|NCT02675452|365402749|FG004|Overall Study|Lost to Follow-up|0|||
105930289|NCT02675452|365402750|FG005|Overall Study|Lost to Follow-up|0|||
105930290|NCT02675452|365402751|FG006|Overall Study|Lost to Follow-up|0|||
106135358|NCT00813488|366154067|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
106135359|NCT00813488|366154068|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
106135360|NCT00813488|366154067|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
106135361|NCT00813488|366154068|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
105712252|NCT01656434|364606009|FG001|Overall Study|Pregnancy wish|6|||
105712253|NCT01656434|364606008|FG000|Overall Study|Pregnancy|45|||
105712254|NCT01656434|364606009|FG001|Overall Study|Pregnancy|10|||
105712255|NCT01656434|364606008|FG000|Overall Study|Physician Decision|7|||
105712256|NCT01656434|364606009|FG001|Overall Study|Physician Decision|2|||
105712257|NCT01656434|364606008|FG000|Overall Study|Non-compliance with study drug|48|||
105712258|NCT01656434|364606009|FG001|Overall Study|Non-compliance with study drug|9|||
105712259|NCT01656434|364606008|FG000|Overall Study|Study terminated by sponsor|1501|||
105712260|NCT01656434|364606009|FG001|Overall Study|Study terminated by sponsor|348|||
105712261|NCT01656434|364606008|FG000|Overall Study|Participant discontinued; drug related|13|||
105712262|NCT01656434|364606009|FG001|Overall Study|Participant discontinued; drug related|4|||
105712263|NCT01656434|364606008|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
105712264|NCT01656434|364606009|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
105712265|NCT01656434|364606008|FG000|Overall Study|Non-compliance with protocol|39|||
105712266|NCT01656434|364606009|FG001|Overall Study|Non-compliance with protocol|15|||
105712267|NCT01656434|364606008|FG000|Overall Study|Participant moved|40|||
105712268|NCT01656434|364606009|FG001|Overall Study|Participant moved|12|||
105712269|NCT01656434|364606008|FG000|Overall Study|Participant withdrew consent|28|||
105712270|NCT01656434|364606009|FG001|Overall Study|Participant withdrew consent|9|||
105712271|NCT01656434|364606008|FG000|Overall Study|Withdrawal by Subject|64|||
105712272|NCT01656434|364606009|FG001|Overall Study|Withdrawal by Subject|7|||
105712273|NCT01235962|364606010|FG000|Overall Study|Withdrawal by Subject|20|||
105712274|NCT01235962|364606011|FG001|Overall Study|Withdrawal by Subject|19|||
105712275|NCT01235962|364606012|FG002|Overall Study|Withdrawal by Subject|62|||
105712276|NCT01235962|364606013|FG003|Overall Study|Withdrawal by Subject|49|||
105712277|NCT01235962|364606010|FG000|Overall Study|Lost to Follow-up|21|||
105712278|NCT01235962|364606011|FG001|Overall Study|Lost to Follow-up|16|||
105712279|NCT01235962|364606012|FG002|Overall Study|Lost to Follow-up|47|||
105712280|NCT01235962|364606013|FG003|Overall Study|Lost to Follow-up|32|||
105712281|NCT01235962|364606010|FG000|Overall Study|Physician Decision|5|||
105712282|NCT01235962|364606011|FG001|Overall Study|Physician Decision|0|||
105712283|NCT01235962|364606012|FG002|Overall Study|Physician Decision|9|||
105712284|NCT01235962|364606013|FG003|Overall Study|Physician Decision|5|||
105712285|NCT01580397|364606014|FG000|Overall Study|Lack of Efficacy|14|||
105712286|NCT00357500|364606017|FG000|Overall Study|Adverse Event|3|||
105712287|NCT00357500|364606017|FG000|Overall Study|Withdrawal by Subject|5|||
105712288|NCT00357500|364606017|FG000|Overall Study|Progressive Disease|65|||
105712289|NCT00357500|364606017|FG000|Overall Study|Not Started Protocol Therapy|4|||
105712290|NCT03033875|364606018|FG000|Overall Study|Withdrawal by Subject|5|||
105712291|NCT03033875|364606019|FG001|Overall Study|Withdrawal by Subject|9|||
105712292|NCT03033875|364606020|FG002|Overall Study|Withdrawal by Subject|4|||
105712293|NCT03033875|364606018|FG000|Overall Study|Other|14|||
105930291|NCT02675452|365402752|FG007|Overall Study|Lost to Follow-up|0|||
105930292|NCT02675452|365402753|FG008|Overall Study|Lost to Follow-up|0|||
105930293|NCT02675452|365402754|FG009|Overall Study|Lost to Follow-up|0|||
105930294|NCT02675452|365402755|FG010|Overall Study|Lost to Follow-up|0|||
105930295|NCT02675452|365402756|FG011|Overall Study|Lost to Follow-up|0|||
105930296|NCT02675452|365402757|FG012|Overall Study|Lost to Follow-up|1|||
105930297|NCT02675452|365402758|FG013|Overall Study|Lost to Follow-up|0|||
105930298|NCT02675452|365402759|FG014|Overall Study|Lost to Follow-up|0|||
105930299|NCT02675452|365402760|FG015|Overall Study|Lost to Follow-up|0|||
105930300|NCT02675452|365402761|FG016|Overall Study|Lost to Follow-up|0|||
105930301|NCT02675452|365402762|FG017|Overall Study|Lost to Follow-up|0|||
105930302|NCT02675452|365402763|FG018|Overall Study|Lost to Follow-up|0|||
105930303|NCT02675452|365402764|FG019|Overall Study|Lost to Follow-up|0|||
105930304|NCT02675452|365402765|FG020|Overall Study|Lost to Follow-up|0|||
105930305|NCT02675452|365402766|FG021|Overall Study|Lost to Follow-up|0|||
105930306|NCT02675452|365402767|FG022|Overall Study|Lost to Follow-up|0|||
105930307|NCT02675452|365402768|FG023|Overall Study|Lost to Follow-up|0|||
105930308|NCT02675452|365402769|FG024|Overall Study|Lost to Follow-up|0|||
105930309|NCT02675452|365402770|FG025|Overall Study|Lost to Follow-up|0|||
105930310|NCT02675452|365402771|FG026|Overall Study|Lost to Follow-up|1|||
105930311|NCT02675452|365402772|FG027|Overall Study|Lost to Follow-up|0|||
105930312|NCT02675452|365402773|FG028|Overall Study|Lost to Follow-up|0|||
105930313|NCT02675452|365402745|FG000|Overall Study|Other|0|||
105930314|NCT02675452|365402746|FG001|Overall Study|Other|0|||
105930315|NCT02675452|365402747|FG002|Overall Study|Other|0|||
105930316|NCT02675452|365402748|FG003|Overall Study|Other|0|||
105930317|NCT02675452|365402749|FG004|Overall Study|Other|0|||
105930318|NCT02675452|365402750|FG005|Overall Study|Other|0|||
105930319|NCT02675452|365402751|FG006|Overall Study|Other|0|||
105930320|NCT02675452|365402752|FG007|Overall Study|Other|0|||
105930321|NCT02675452|365402753|FG008|Overall Study|Other|0|||
105930322|NCT02675452|365402754|FG009|Overall Study|Other|0|||
105930323|NCT02675452|365402755|FG010|Overall Study|Other|0|||
105930324|NCT02675452|365402756|FG011|Overall Study|Other|0|||
105930325|NCT02675452|365402757|FG012|Overall Study|Other|0|||
105930326|NCT02675452|365402758|FG013|Overall Study|Other|0|||
105930327|NCT02675452|365402759|FG014|Overall Study|Other|0|||
105930328|NCT02675452|365402760|FG015|Overall Study|Other|0|||
105930329|NCT02675452|365402761|FG016|Overall Study|Other|0|||
105930330|NCT02675452|365402762|FG017|Overall Study|Other|0|||
105930331|NCT02675452|365402763|FG018|Overall Study|Other|0|||
105930332|NCT02675452|365402764|FG019|Overall Study|Other|0|||
105930333|NCT02675452|365402765|FG020|Overall Study|Other|0|||
105930334|NCT02675452|365402766|FG021|Overall Study|Other|0|||
105930335|NCT02675452|365402767|FG022|Overall Study|Other|0|||
105930336|NCT02675452|365402768|FG023|Overall Study|Other|0|||
105930337|NCT02675452|365402769|FG024|Overall Study|Other|0|||
105930338|NCT02675452|365402770|FG025|Overall Study|Other|0|||
105930339|NCT02675452|365402771|FG026|Overall Study|Other|1|||
105930340|NCT02675452|365402772|FG027|Overall Study|Other|0|||
105930341|NCT02675452|365402773|FG028|Overall Study|Other|0|||
105930342|NCT04210375|365402780|FG000|Overall Study|Death|0|||
105930343|NCT04210375|365402781|FG001|Overall Study|Death|1|||
105930344|NCT04210375|365402782|FG002|Overall Study|Death|0|||
105930345|NCT04210375|365402783|FG003|Overall Study|Death|0|||
105930346|NCT01405911|365402784|FG000|Overall Study|Pre-treatment lab AE|0|||
105930347|NCT01405911|365402785|FG001|Overall Study|Pre-treatment lab AE|1|||
105930348|NCT01405911|365402786|FG002|Overall Study|Pre-treatment lab AE|0|||
105930349|NCT01405911|365402784|FG000|Overall Study|Lost to Follow-up|0|||
105930350|NCT01405911|365402785|FG001|Overall Study|Lost to Follow-up|1|||
105930351|NCT01405911|365402786|FG002|Overall Study|Lost to Follow-up|0|||
105930352|NCT01405911|365402784|FG000|Overall Study|Protocol Violation|1|||
105930353|NCT01405911|365402785|FG001|Overall Study|Protocol Violation|0|||
105930354|NCT01405911|365402786|FG002|Overall Study|Protocol Violation|0|||
105930355|NCT01405911|365402784|FG000|Overall Study|Withdrawal by Subject|3|||
105930356|NCT01405911|365402785|FG001|Overall Study|Withdrawal by Subject|1|||
105930357|NCT01405911|365402786|FG002|Overall Study|Withdrawal by Subject|1|||
105930358|NCT02114684|365402789|FG000|Overall Study|Death|6|||
105930359|NCT02114684|365402790|FG001|Overall Study|Death|4|||
105930360|NCT02114684|365402789|FG000|Overall Study|Lost to Follow-up|1|||
105930361|NCT02114684|365402790|FG001|Overall Study|Lost to Follow-up|2|||
105930362|NCT02114684|365402789|FG000|Overall Study|Withdrawal by Subject|1|||
105930363|NCT02114684|365402790|FG001|Overall Study|Withdrawal by Subject|2|||
105712294|NCT03033875|364606019|FG001|Overall Study|Other|15|||
105930364|NCT02114684|365402789|FG000|Overall Study|Relocation|3|||
105930365|NCT02114684|365402790|FG001|Overall Study|Relocation|1|||
105930366|NCT02114684|365402789|FG000|Overall Study|Rifampicin resistant on culture|0|||
105930367|NCT02114684|365402790|FG001|Overall Study|Rifampicin resistant on culture|1|||
105930368|NCT02114684|365402789|FG000|Overall Study|Patient Incarcerated|1|||
105930369|NCT02114684|365402790|FG001|Overall Study|Patient Incarcerated|0|||
105930370|NCT01363076|365404319|FG000|Overall Study|Withdrawal by Subject|0|||
105930371|NCT01363076|365404320|FG001|Overall Study|Withdrawal by Subject|1|||
105930372|NCT04333498|365404322|FG000|Overall Study|Lost to Follow-up|1|||
105930373|NCT04333498|365404323|FG001|Overall Study|Lost to Follow-up|0|||
105930374|NCT04333498|365404322|FG000|Overall Study|Lost to Follow-up|0|||
105930375|NCT04333498|365404323|FG001|Overall Study|Lost to Follow-up|1|||
105930376|NCT01631188|365404324|FG000|Overall Study|Physician Decision|75|||
105930377|NCT02582632|365404328|FG000|Overall Study|Other|1|||
105930378|NCT01002105|365404329|FG000|Overall Study|Lost to Follow-up|10|||
105930379|NCT01002105|365404330|FG001|Overall Study|Lost to Follow-up|16|||
105930380|NCT01002105|365404329|FG000|Overall Study|non compliance|5|||
105930381|NCT01002105|365404330|FG001|Overall Study|non compliance|3|||
105788338|NCT02087865|364880004|FG000|Overall Study|Withdrawal by Subject|6|||
105788339|NCT02087865|364880005|FG001|Overall Study|Withdrawal by Subject|0|||
105788340|NCT02087865|364880006|FG002|Overall Study|Withdrawal by Subject|1|||
105788341|NCT02087865|364880004|FG000|Overall Study|Lost to Follow-up|0|||
105788342|NCT02087865|364880005|FG001|Overall Study|Lost to Follow-up|0|||
105788343|NCT02087865|364880006|FG002|Overall Study|Lost to Follow-up|1|||
105788344|NCT02087865|364880004|FG000|Overall Study|Drug Non-compliance|0|||
105788345|NCT02087865|364880005|FG001|Overall Study|Drug Non-compliance|2|||
105788346|NCT02087865|364880006|FG002|Overall Study|Drug Non-compliance|0|||
105788347|NCT02087865|364880004|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
105788348|NCT02087865|364880005|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
105788349|NCT02087865|364880006|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
105788350|NCT03839693|364880007|FG000|Overall Study|Lost to Follow-up|0|||
105788351|NCT03839693|364880008|FG001|Overall Study|Lost to Follow-up|2|||
105788352|NCT03839693|364880009|FG002|Overall Study|Lost to Follow-up|2|||
105788353|NCT03839693|364880007|FG000|Overall Study|Withdrawal by Subject|1|||
105788354|NCT03839693|364880008|FG001|Overall Study|Withdrawal by Subject|0|||
105788355|NCT03839693|364880009|FG002|Overall Study|Withdrawal by Subject|2|||
105788356|NCT03839693|364880007|FG000|Overall Study|subject moved out of the area|1|||
105788357|NCT03839693|364880008|FG001|Overall Study|subject moved out of the area|0|||
105788358|NCT03839693|364880009|FG002|Overall Study|subject moved out of the area|0|||
105788359|NCT00700115|364880018|FG000|Overall Study|Withdrawal by Subject|1|||
105788360|NCT00700115|364880019|FG001|Overall Study|Withdrawal by Subject|0|||
105788361|NCT00700115|364880018|FG000|Overall Study|Lost to Follow-up|0|||
105788362|NCT00700115|364880019|FG001|Overall Study|Lost to Follow-up|1|||
105788363|NCT02983305|364880024|FG000|Overall Study|incomplete data|2|||
105788364|NCT02983305|364880025|FG001|Overall Study|incomplete data|0|||
105788365|NCT00822237|364880028|FG000|Dose 1 Vaccination|Not vaccinated|3|||
105788366|NCT00822237|364880029|FG001|Dose 1 Vaccination|Not vaccinated|0|||
105788367|NCT00822237|364880028|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
105788368|NCT00822237|364880029|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
105788369|NCT00822237|364880028|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
105788370|NCT00822237|364880029|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
105788371|NCT00822237|364880028|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
105788372|NCT00822237|364880029|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
105788373|NCT00822237|364880028|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
105788374|NCT00822237|364880029|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
105788375|NCT03433482|364880030|FG000|Overall Study|Lost to Follow-up|1|||
105788376|NCT03433482|364880031|FG001|Overall Study|Lost to Follow-up|0|||
105788377|NCT03433482|364880032|FG002|Overall Study|Lost to Follow-up|1|||
105788378|NCT03433482|364880033|FG003|Overall Study|Lost to Follow-up|1|||
105788379|NCT03433482|364880030|FG000|Overall Study|Withdrawal by Subject|0|||
105788380|NCT03433482|364880031|FG001|Overall Study|Withdrawal by Subject|0|||
105788381|NCT03433482|364880032|FG002|Overall Study|Withdrawal by Subject|1|||
105788382|NCT03433482|364880033|FG003|Overall Study|Withdrawal by Subject|0|||
105788383|NCT03433482|364880030|FG000|Overall Study|Unknown reason|0|||
105788384|NCT03433482|364880031|FG001|Overall Study|Unknown reason|0|||
105788385|NCT03433482|364880032|FG002|Overall Study|Unknown reason|2|||
105788386|NCT03433482|364880033|FG003|Overall Study|Unknown reason|0|||
105788387|NCT00953017|364880037|FG000|Overall Study|DId not show up for colonoscopy|4|||
105788388|NCT00953017|364880038|FG001|Overall Study|DId not show up for colonoscopy|4|||
105788389|NCT00953017|364880039|FG002|Overall Study|DId not show up for colonoscopy|5|||
105788390|NCT00953017|364880040|FG003|Overall Study|DId not show up for colonoscopy|4|||
105788391|NCT00953017|364880037|FG000|Overall Study|Incomplete data|1|||
105788392|NCT00953017|364880038|FG001|Overall Study|Incomplete data|1|||
105788393|NCT00953017|364880039|FG002|Overall Study|Incomplete data|0|||
105788394|NCT00953017|364880040|FG003|Overall Study|Incomplete data|0|||
105788395|NCT00953017|364880037|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
105788396|NCT00953017|364880038|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
105788397|NCT00953017|364880039|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
105788398|NCT00953017|364880040|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
106135362|NCT00813488|366154067|FG000|Double-blind Treatment Period 2|Other|1|||
106135363|NCT00813488|366154068|FG001|Double-blind Treatment Period 2|Other|0|||
106135364|NCT00813488|366154067|FG000|Open-label Extension|Adverse Event|1|||
105788399|NCT00953017|364880037|FG000|Overall Study|Brown stool prior to procedure|0|||
105788400|NCT00953017|364880038|FG001|Overall Study|Brown stool prior to procedure|0|||
105788401|NCT00953017|364880039|FG002|Overall Study|Brown stool prior to procedure|1|||
105788402|NCT00953017|364880040|FG003|Overall Study|Brown stool prior to procedure|0|||
105788403|NCT01473602|364880042|FG000|Overall Study|Adverse Event|1|||
105788404|NCT01473602|364880043|FG001|Overall Study|Adverse Event|2|||
105788405|NCT01473602|364880042|FG000|Overall Study|Death|0|||
105788406|NCT01473602|364880043|FG001|Overall Study|Death|1|||
105788407|NCT01473602|364880042|FG000|Overall Study|Lost to Follow-up|1|||
106135365|NCT00813488|366154068|FG001|Open-label Extension|Adverse Event|2|||
106135366|NCT00813488|366154067|FG000|Open-label Extension|Lack of Efficacy|3|||
105788408|NCT01473602|364880043|FG001|Overall Study|Lost to Follow-up|1|||
105712295|NCT03033875|364606020|FG002|Overall Study|Other|8|||
105712296|NCT02695628|364606022|FG000|Overall Study|Withdrawal by Subject|1|||
105712297|NCT02301403|364606023|FG000|Overall Study|Withdrawal by Subject|28|||
105712298|NCT02301403|364606024|FG001|Overall Study|Withdrawal by Subject|41|||
105712299|NCT00903929|364606025|FG000|Overall Study|Withdrawal by Subject|0|||
105712300|NCT00903929|364606026|FG001|Overall Study|Withdrawal by Subject|0|||
105712301|NCT00903929|364606027|FG002|Overall Study|Withdrawal by Subject|1|||
105930382|NCT01002105|365404329|FG000|Overall Study|condition worsened|4|||
105930383|NCT01002105|365404330|FG001|Overall Study|condition worsened|2|||
105930384|NCT00552058|365404333|FG000|Overall Study|Adverse Event|8|||
105930385|NCT00552058|365404334|FG001|Overall Study|Adverse Event|7|||
105930386|NCT00552058|365404333|FG000|Overall Study|Lack of Efficacy|1|||
105930387|NCT00552058|365404334|FG001|Overall Study|Lack of Efficacy|5|||
105930388|NCT00552058|365404333|FG000|Overall Study|Lost to Follow-up|1|||
105930389|NCT00552058|365404334|FG001|Overall Study|Lost to Follow-up|0|||
105930390|NCT00552058|365404333|FG000|Overall Study|Withdrawal by Subject|4|||
105930391|NCT00552058|365404334|FG001|Overall Study|Withdrawal by Subject|4|||
105930392|NCT00552058|365404333|FG000|Overall Study|Other: Protocol Violation|0|||
105930393|NCT00552058|365404334|FG001|Overall Study|Other: Protocol Violation|1|||
105930394|NCT00552058|365404333|FG000|Overall Study|Other: Non Compliance|1|||
105930395|NCT00552058|365404334|FG001|Overall Study|Other: Non Compliance|2|||
105930396|NCT00552058|365404333|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
105930397|NCT00552058|365404334|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
105930398|NCT00552058|365404333|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
105930399|NCT00552058|365404334|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
105930400|NCT00552058|365404333|FG000|Overall Study|Other: Positive Stool Result|0|||
105930401|NCT00552058|365404334|FG001|Overall Study|Other: Positive Stool Result|1|||
105930402|NCT00552058|365404333|FG000|Overall Study|Other: Randomized in error|0|||
105712302|NCT00903929|364606028|FG003|Overall Study|Withdrawal by Subject|2|||
105712303|NCT00903929|364606025|FG000|Overall Study|Adverse Event|0|||
105712304|NCT00903929|364606026|FG001|Overall Study|Adverse Event|0|||
105712305|NCT00903929|364606027|FG002|Overall Study|Adverse Event|0|||
105930403|NCT00552058|365404334|FG001|Overall Study|Other: Randomized in error|1|||
105930404|NCT00552058|365404333|FG000|Overall Study|Other: Sponsors Decision|0|||
105930405|NCT00552058|365404334|FG001|Overall Study|Other: Sponsors Decision|1|||
105930406|NCT00552058|365404333|FG000|Overall Study|Other: Early Roll Over|1|||
105930407|NCT00552058|365404334|FG001|Overall Study|Other: Early Roll Over|0|||
105930408|NCT03418675|365404335|FG000|Overall Study|Lost to Follow-up|13|||
105930409|NCT03418675|365404336|FG001|Overall Study|Lost to Follow-up|10|||
105930410|NCT03418675|365404335|FG000|Overall Study|Adverse Event|2|||
105930411|NCT03418675|365404336|FG001|Overall Study|Adverse Event|0|||
105930412|NCT00447278|365404337|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
105930413|NCT00447278|365404338|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
105930414|NCT00447278|365404337|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
105712306|NCT00903929|364606028|FG003|Overall Study|Adverse Event|1|||
105712307|NCT01913483|364606031|FG000|Overall Study|Withdrawal by Subject|1|||
105712308|NCT01913483|364606032|FG001|Overall Study|Withdrawal by Subject|2|||
105712309|NCT01913483|364606031|FG000|Overall Study|Lost to Follow-up|6|||
105712310|NCT01913483|364606032|FG001|Overall Study|Lost to Follow-up|3|||
105712311|NCT01913483|364606031|FG000|Overall Study|Death|14|||
105712312|NCT01913483|364606032|FG001|Overall Study|Death|17|||
105712313|NCT03434379|364606037|FG000|Global Period|Lost to Follow-up|3|||
105712314|NCT03434379|364606038|FG001|Global Period|Lost to Follow-up|6|||
105712315|NCT03434379|364606039|FG002|Global Period|Lost to Follow-up|0|||
105712316|NCT03434379|364606040|FG003|Global Period|Lost to Follow-up|0|||
105712317|NCT03434379|364606037|FG000|Global Period|Death|115|||
105712318|NCT03434379|364606038|FG001|Global Period|Death|228|||
105712319|NCT03434379|364606039|FG002|Global Period|Death|0|||
105712320|NCT03434379|364606040|FG003|Global Period|Death|0|||
105712321|NCT03434379|364606037|FG000|Global Period|Withdrawal by Subject|20|||
105712322|NCT03434379|364606038|FG001|Global Period|Withdrawal by Subject|21|||
105712323|NCT03434379|364606039|FG002|Global Period|Withdrawal by Subject|0|||
105712324|NCT03434379|364606040|FG003|Global Period|Withdrawal by Subject|0|||
105712325|NCT03434379|364606037|FG000|Global Period|Reason Unspecified|0|||
105712326|NCT03434379|364606038|FG001|Global Period|Reason Unspecified|1|||
105712327|NCT03434379|364606039|FG002|Global Period|Reason Unspecified|0|||
105712328|NCT03434379|364606040|FG003|Global Period|Reason Unspecified|0|||
105712329|NCT03434379|364606037|FG000|Global Period|Study Ended by Sponsor|26|||
105712330|NCT03434379|364606038|FG001|Global Period|Study Ended by Sponsor|80|||
105712331|NCT03434379|364606039|FG002|Global Period|Study Ended by Sponsor|0|||
105712332|NCT03434379|364606040|FG003|Global Period|Study Ended by Sponsor|0|||
105930415|NCT00447278|365404338|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
105930416|NCT00447278|365404337|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
105930417|NCT00447278|365404338|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
105930418|NCT00447278|365404337|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
105930419|NCT00447278|365404338|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
105930420|NCT00447278|365404337|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
106135367|NCT00813488|366154068|FG001|Open-label Extension|Lack of Efficacy|0|||
106135368|NCT00813488|366154067|FG000|Open-label Extension|Withdrawal by Subject|0|||
106135369|NCT00813488|366154068|FG001|Open-label Extension|Withdrawal by Subject|2|||
106135370|NCT00813488|366154067|FG000|Open-label Extension|Protocol Violation|1|||
105712333|NCT03434379|364606037|FG000|Global Period|Physician Decision|1|||
105712334|NCT03434379|364606038|FG001|Global Period|Physician Decision|0|||
105712335|NCT03434379|364606039|FG002|Global Period|Physician Decision|0|||
105712336|NCT03434379|364606040|FG003|Global Period|Physician Decision|0|||
105712337|NCT03434379|364606037|FG000|China Extension Period|Lost to Follow-up|0|||
105712338|NCT03434379|364606038|FG001|China Extension Period|Lost to Follow-up|0|||
105712339|NCT03434379|364606039|FG002|China Extension Period|Lost to Follow-up|2|||
105712340|NCT03434379|364606040|FG003|China Extension Period|Lost to Follow-up|3|||
105712341|NCT03434379|364606037|FG000|China Extension Period|Death|0|||
106008611|NCT01667900|365697034|FG013|Part B|Death|0|||
106008612|NCT01667900|365697035|FG014|Part B|Death|0|||
106135371|NCT00813488|366154068|FG001|Open-label Extension|Protocol Violation|2|||
106135372|NCT00813488|366154067|FG000|Open-label Extension|Non-compliance study medication|4|||
106135373|NCT00813488|366154068|FG001|Open-label Extension|Non-compliance study medication|0|||
106135374|NCT00813488|366154067|FG000|Open-label Extension|Non-compliance study procedures|2|||
106135375|NCT00813488|366154068|FG001|Open-label Extension|Non-compliance study procedures|1|||
105712342|NCT03434379|364606038|FG001|China Extension Period|Death|0|||
105712343|NCT03434379|364606039|FG002|China Extension Period|Death|46|||
105712344|NCT03434379|364606040|FG003|China Extension Period|Death|88|||
105712345|NCT03434379|364606037|FG000|China Extension Period|Withdrawal by Subject|0|||
105712346|NCT03434379|364606038|FG001|China Extension Period|Withdrawal by Subject|0|||
105712347|NCT03434379|364606039|FG002|China Extension Period|Withdrawal by Subject|8|||
105712348|NCT03434379|364606040|FG003|China Extension Period|Withdrawal by Subject|6|||
105712349|NCT03434379|364606037|FG000|China Extension Period|Study Ended by Sponsor|0|||
105712350|NCT03434379|364606038|FG001|China Extension Period|Study Ended by Sponsor|0|||
105712351|NCT03434379|364606039|FG002|China Extension Period|Study Ended by Sponsor|5|||
105712352|NCT03434379|364606040|FG003|China Extension Period|Study Ended by Sponsor|36|||
105712353|NCT03064841|364606041|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
105712354|NCT03064841|364606041|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
105712355|NCT03064841|364606041|FG000|Overall Study|Screen failure|2|||
105712356|NCT00454805|364606044|FG000|Overall Study|Withdrawal by Subject|9|||
105712357|NCT00454805|364606045|FG001|Overall Study|Withdrawal by Subject|2|||
105712358|NCT00454805|364606044|FG000|Overall Study|Death|0|||
105712359|NCT00454805|364606045|FG001|Overall Study|Death|2|||
105712360|NCT00454805|364606044|FG000|Overall Study|Disease progression|16|||
105712361|NCT00454805|364606045|FG001|Overall Study|Disease progression|19|||
105712362|NCT00454805|364606044|FG000|Overall Study|In order to begin radiotherapy|1|||
105712363|NCT00454805|364606045|FG001|Overall Study|In order to begin radiotherapy|0|||
105712364|NCT03920670|364606046|FG000|Overall Study|Protocol Violation|2|||
105712365|NCT03920670|364606047|FG001|Overall Study|Protocol Violation|2|||
105712366|NCT03920670|364606046|FG000|Overall Study|Adverse Event|1|||
105712367|NCT03920670|364606047|FG001|Overall Study|Adverse Event|0|||
105712368|NCT03208231|364606058|FG000|Overall Study|Death|1|||
105712369|NCT03208231|364606059|FG001|Overall Study|Death|2|||
105712370|NCT03208231|364606058|FG000|Overall Study|Moved and unable to get to clinic|1|||
105712371|NCT03208231|364606059|FG001|Overall Study|Moved and unable to get to clinic|0|||
105712372|NCT03208231|364606058|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
105712373|NCT03208231|364606059|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
105712374|NCT01777581|364606062|FG000|Overall Study|Lost to Follow-up|1|||
105712375|NCT01777581|364606063|FG001|Overall Study|Lost to Follow-up|1|||
105712376|NCT01777581|364606062|FG000|Overall Study|Adverse Event|2|||
105712377|NCT01777581|364606063|FG001|Overall Study|Adverse Event|0|||
105712378|NCT01777581|364606062|FG000|Overall Study|Lack of Efficacy|0|||
105712379|NCT01777581|364606063|FG001|Overall Study|Lack of Efficacy|1|||
105712380|NCT03864653|364606077|FG000|Overall Study|Withdrawal by Subject|1|||
105712381|NCT02321436|364606078|FG000|Overall Study|Withdrawal by Subject|1|||
105712382|NCT02321436|364606079|FG001|Overall Study|Withdrawal by Subject|0|||
105712383|NCT02321436|364606078|FG000|Overall Study|Lost to Follow-up|0|||
105712384|NCT02321436|364606079|FG001|Overall Study|Lost to Follow-up|1|||
105712385|NCT00817531|364607662|FG000|Overall Study|Adverse Event|1|||
105712386|NCT00817531|364607662|FG000|Overall Study|Lack of Efficacy|1|||
105712387|NCT03325673|364607663|FG000|Overall Study|Adverse Event|4|||
105712388|NCT03325673|364607664|FG001|Overall Study|Adverse Event|0|||
105712389|NCT00618748|364607672|FG000|Overall Study|Adverse Event|4|||
105712390|NCT00618748|364607673|FG001|Overall Study|Adverse Event|3|||
105712391|NCT00618748|364607674|FG002|Overall Study|Adverse Event|8|||
105712392|NCT00618748|364607672|FG000|Overall Study|Physician Decision|3|||
105712393|NCT00618748|364607673|FG001|Overall Study|Physician Decision|1|||
105712394|NCT00618748|364607674|FG002|Overall Study|Physician Decision|1|||
105712395|NCT00618748|364607672|FG000|Overall Study|Withdrawal by Subject|4|||
105712396|NCT00618748|364607673|FG001|Overall Study|Withdrawal by Subject|1|||
105712397|NCT00618748|364607674|FG002|Overall Study|Withdrawal by Subject|5|||
105788409|NCT01473602|364880042|FG000|Overall Study|Withdrawal by Subject|5|||
105788410|NCT01473602|364880043|FG001|Overall Study|Withdrawal by Subject|4|||
105788411|NCT01473602|364880042|FG000|Overall Study|Physician Decision|1|||
105712398|NCT02814565|364607675|FG000|Overall Study|Lack of Efficacy|0|||
105712399|NCT02814565|364607676|FG001|Overall Study|Lack of Efficacy|1|||
105712400|NCT02814565|364607675|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
105712401|NCT02814565|364607676|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
105712402|NCT03472560|364607677|FG000|Overall Study|Subject transfer to continuation protocol|0|||
105712403|NCT03472560|364607678|FG001|Overall Study|Subject transfer to continuation protocol|1|||
105712404|NCT03472560|364607677|FG000|Overall Study|Withdrawal by Subject|4|||
105712405|NCT03472560|364607678|FG001|Overall Study|Withdrawal by Subject|0|||
105712406|NCT03472560|364607677|FG000|Overall Study|Progressive disease|24|||
105712407|NCT03472560|364607678|FG001|Overall Study|Progressive disease|8|||
105712408|NCT03472560|364607677|FG000|Overall Study|Physician Decision|1|||
105712409|NCT03472560|364607678|FG001|Overall Study|Physician Decision|0|||
105712410|NCT03472560|364607677|FG000|Overall Study|Death|7|||
105712411|NCT03472560|364607678|FG001|Overall Study|Death|4|||
105712412|NCT03472560|364607677|FG000|Overall Study|Adverse Event|5|||
105712413|NCT03472560|364607678|FG001|Overall Study|Adverse Event|3|||
105712414|NCT03472560|364607677|FG000|Overall Study|Global deterioration of health status|0|||
105712415|NCT03472560|364607678|FG001|Overall Study|Global deterioration of health status|4|||
105712416|NCT02479802|364607679|FG000|Overall Study|Lost to Follow-up|1|||
105712417|NCT02479802|364607679|FG000|Overall Study|Adverse Event|1|||
105712418|NCT03124784|364607682|FG000|Overall Study|Adverse Event|1|||
105712419|NCT03124784|364607682|FG000|Overall Study|Computer/Equip Malfunction|1|||
105712420|NCT02792842|364607684|FG000|Overall Study|Adverse Event|4|||
105712421|NCT02792842|364607685|FG001|Overall Study|Adverse Event|2|||
105712422|NCT02792842|364607686|FG002|Overall Study|Adverse Event|3|||
105712423|NCT02792842|364607684|FG000|Overall Study|Withdrawal by Subject|0|||
105712424|NCT02792842|364607685|FG001|Overall Study|Withdrawal by Subject|1|||
105712425|NCT02792842|364607686|FG002|Overall Study|Withdrawal by Subject|2|||
105712426|NCT02792842|364607684|FG000|Overall Study|Lost to Follow-up|0|||
105712427|NCT02792842|364607685|FG001|Overall Study|Lost to Follow-up|0|||
105712428|NCT02792842|364607686|FG002|Overall Study|Lost to Follow-up|1|||
105712429|NCT02792842|364607684|FG000|Overall Study|Schedule delay|0|||
105712430|NCT02792842|364607685|FG001|Overall Study|Schedule delay|1|||
105712431|NCT02792842|364607686|FG002|Overall Study|Schedule delay|1|||
105712432|NCT01790048|364607688|FG000|Overall Study|Incorrect Age|9|||
105712433|NCT01790048|364607689|FG001|Overall Study|Incorrect Age|14|||
105712434|NCT01790048|364607688|FG000|Overall Study|data entry error|0|||
105788412|NCT01473602|364880043|FG001|Overall Study|Physician Decision|0|||
105788413|NCT03735680|364880046|FG000|Overall Study|Withdrawal by Subject|0|||
105788414|NCT03735680|364880047|FG001|Overall Study|Withdrawal by Subject|1|||
105788415|NCT03735680|364880048|FG002|Overall Study|Withdrawal by Subject|0|||
105788416|NCT03735680|364880049|FG003|Overall Study|Withdrawal by Subject|0|||
105788417|NCT03735680|364880050|FG004|Overall Study|Withdrawal by Subject|0|||
105788418|NCT03735680|364880051|FG005|Overall Study|Withdrawal by Subject|1|||
105788419|NCT03735680|364880046|FG000|Overall Study|Patient unable or unwilling to continue|0|||
105788420|NCT03735680|364880047|FG001|Overall Study|Patient unable or unwilling to continue|0|||
105788421|NCT03735680|364880048|FG002|Overall Study|Patient unable or unwilling to continue|1|||
105788422|NCT03735680|364880049|FG003|Overall Study|Patient unable or unwilling to continue|0|||
105788423|NCT03735680|364880050|FG004|Overall Study|Patient unable or unwilling to continue|0|||
105788424|NCT03735680|364880051|FG005|Overall Study|Patient unable or unwilling to continue|0|||
105788425|NCT01100073|364880052|FG000|Overall Study|Lack of Efficacy|4|||
106135376|NCT00813488|366154067|FG000|Open-label Extension|Other|1|||
106135377|NCT00813488|366154068|FG001|Open-label Extension|Other|0|||
106135378|NCT03971357|366154069|FG000|Overall Study|Lack of Efficacy|0|||
106135379|NCT03971357|366154070|FG001|Overall Study|Lack of Efficacy|1|||
106135380|NCT00819910|366154071|FG000|Overall Study|Adverse Event|0|||
105712435|NCT01790048|364607689|FG001|Overall Study|data entry error|1|||
105712436|NCT01790048|364607688|FG000|Overall Study|Other|0|||
105712437|NCT01790048|364607689|FG001|Overall Study|Other|2|||
105712438|NCT01790048|364607688|FG000|Overall Study|SAM at Enrollment|2|||
105712439|NCT01790048|364607689|FG001|Overall Study|SAM at Enrollment|0|||
105712440|NCT01790048|364607688|FG000|Overall Study|Measurement error|1|||
105788426|NCT01100073|364880052|FG000|Overall Study|Insufficient Tolerability|21|||
105788427|NCT01100073|364880052|FG000|Overall Study|Withdrawal by Subject|13|||
105788428|NCT01100073|364880052|FG000|Overall Study|Lost to Follow-up|39|||
105788429|NCT01100073|364880052|FG000|Overall Study|Lack of effect + patient's wish|2|||
105788430|NCT01100073|364880052|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
106135381|NCT00819910|366154072|FG001|Overall Study|Adverse Event|0|||
105712441|NCT01790048|364607689|FG001|Overall Study|Measurement error|0|||
105712442|NCT00159432|364607690|FG000|Overall Study|Adverse Event|1|||
105712443|NCT00159432|364607690|FG000|Overall Study|Death|1|||
105712444|NCT00159432|364607690|FG000|Overall Study|Lack of Efficacy|8|||
105712445|NCT01415752|364607694|FG000|Induction (Step 1)|Ineligible|4|||
105788431|NCT01100073|364880052|FG000|Overall Study|Other|8|||
105712446|NCT01415752|364607695|FG001|Induction (Step 1)|Ineligible|3|||
105712447|NCT01415752|364607696|FG002|Induction (Step 1)|Ineligible|4|||
105712448|NCT01415752|364607697|FG003|Induction (Step 1)|Ineligible|4|||
105712449|NCT01415752|364607694|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
105712450|NCT01415752|364607695|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
105712451|NCT01415752|364607696|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
105712452|NCT01415752|364607697|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
105712453|NCT01415752|364607694|FG000|Maintenance (Step 2)|Adverse Event|3|||
105712454|NCT01415752|364607695|FG001|Maintenance (Step 2)|Adverse Event|4|||
105712455|NCT01415752|364607696|FG002|Maintenance (Step 2)|Adverse Event|9|||
105712456|NCT01415752|364607697|FG003|Maintenance (Step 2)|Adverse Event|6|||
105712457|NCT01415752|364607694|FG000|Maintenance (Step 2)|Death|1|||
105712458|NCT01415752|364607695|FG001|Maintenance (Step 2)|Death|1|||
105712459|NCT01415752|364607696|FG002|Maintenance (Step 2)|Death|2|||
105712460|NCT01415752|364607697|FG003|Maintenance (Step 2)|Death|0|||
105712461|NCT01415752|364607694|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
105712462|NCT01415752|364607695|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
105712463|NCT01415752|364607696|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
105712464|NCT01415752|364607697|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
105712465|NCT01415752|364607694|FG000|Maintenance (Step 2)|Alternative therapy|0|||
105712466|NCT01415752|364607695|FG001|Maintenance (Step 2)|Alternative therapy|1|||
105712467|NCT01415752|364607696|FG002|Maintenance (Step 2)|Alternative therapy|0|||
105712468|NCT01415752|364607697|FG003|Maintenance (Step 2)|Alternative therapy|0|||
105712469|NCT01415752|364607694|FG000|Maintenance (Step 2)|Other reasons|3|||
105712470|NCT01415752|364607695|FG001|Maintenance (Step 2)|Other reasons|6|||
105712471|NCT01415752|364607696|FG002|Maintenance (Step 2)|Other reasons|4|||
105712472|NCT01415752|364607697|FG003|Maintenance (Step 2)|Other reasons|6|||
105712473|NCT01415752|364607694|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
105712474|NCT01415752|364607695|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
105712475|NCT01415752|364607696|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
105712476|NCT01415752|364607697|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
105712477|NCT01415752|364607694|FG000|Maintenance (Step 2)|ineligible|1|||
105712478|NCT01415752|364607695|FG001|Maintenance (Step 2)|ineligible|1|||
105712479|NCT01415752|364607696|FG002|Maintenance (Step 2)|ineligible|1|||
105712480|NCT01415752|364607697|FG003|Maintenance (Step 2)|ineligible|0|||
105712481|NCT01415752|364607694|FG000|Maintenance (Step 2)|Missing|4|||
105712482|NCT01415752|364607695|FG001|Maintenance (Step 2)|Missing|1|||
105712483|NCT01415752|364607696|FG002|Maintenance (Step 2)|Missing|4|||
105712484|NCT01415752|364607697|FG003|Maintenance (Step 2)|Missing|3|||
105712485|NCT00584194|364607698|FG000|Overall Study|Other|135|||
105712486|NCT01391507|364607699|FG000|Overall Study|Death|0|||
105712487|NCT01391507|364607700|FG001|Overall Study|Death|0|||
105712488|NCT01391507|364607701|FG002|Overall Study|Death|0|||
105712489|NCT01391507|364607702|FG003|Overall Study|Death|1|||
105712490|NCT01391507|364607699|FG000|Overall Study|Adverse Event|1|||
105712491|NCT01391507|364607700|FG001|Overall Study|Adverse Event|1|||
105712492|NCT01391507|364607701|FG002|Overall Study|Adverse Event|2|||
105712493|NCT01391507|364607702|FG003|Overall Study|Adverse Event|2|||
105712494|NCT01391507|364607699|FG000|Overall Study|Withdrawal by Subject|1|||
105712495|NCT01391507|364607700|FG001|Overall Study|Withdrawal by Subject|2|||
105712496|NCT01391507|364607701|FG002|Overall Study|Withdrawal by Subject|1|||
105712497|NCT01391507|364607702|FG003|Overall Study|Withdrawal by Subject|1|||
105712498|NCT01391507|364607699|FG000|Overall Study|Lack of Efficacy|0|||
105712499|NCT01391507|364607700|FG001|Overall Study|Lack of Efficacy|0|||
105930421|NCT00447278|365404338|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
105930422|NCT00447278|365404337|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
105930423|NCT00447278|365404338|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
105930424|NCT00447278|365404337|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
105930425|NCT00447278|365404338|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
105930426|NCT00447278|365404337|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
105930427|NCT00447278|365404338|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
105930428|NCT00447278|365404337|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
105930429|NCT00447278|365404338|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
105930430|NCT00447278|365404337|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
105930431|NCT00447278|365404338|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
105930432|NCT00447278|365404337|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
105712500|NCT01391507|364607701|FG002|Overall Study|Lack of Efficacy|0|||
105712501|NCT01391507|364607702|FG003|Overall Study|Lack of Efficacy|1|||
105712502|NCT01391507|364607699|FG000|Overall Study|Protocol Violation|2|||
105712503|NCT01391507|364607700|FG001|Overall Study|Protocol Violation|1|||
105712504|NCT01391507|364607701|FG002|Overall Study|Protocol Violation|1|||
105712505|NCT01391507|364607702|FG003|Overall Study|Protocol Violation|2|||
105712506|NCT03529773|364607705|FG000|Overall Study|Adverse Event|0|||
105712507|NCT03529773|364607706|FG001|Overall Study|Adverse Event|0|||
105712508|NCT03529773|364607707|FG002|Overall Study|Adverse Event|0|||
105712509|NCT03529773|364607708|FG003|Overall Study|Adverse Event|0|||
105712510|NCT03529773|364607709|FG004|Overall Study|Adverse Event|0|||
105712511|NCT03529773|364607710|FG005|Overall Study|Adverse Event|0|||
105712512|NCT03529773|364607711|FG006|Overall Study|Adverse Event|0|||
105712513|NCT03529773|364607712|FG007|Overall Study|Adverse Event|0|||
105712514|NCT03529773|364607713|FG008|Overall Study|Adverse Event|0|||
105712515|NCT03529773|364607714|FG009|Overall Study|Adverse Event|0|||
105712516|NCT03529773|364607715|FG010|Overall Study|Adverse Event|0|||
105712517|NCT03529773|364607716|FG011|Overall Study|Adverse Event|0|||
105712518|NCT03529773|364607717|FG012|Overall Study|Adverse Event|0|||
105712519|NCT03529773|364607718|FG013|Overall Study|Adverse Event|0|||
105712520|NCT03529773|364607719|FG014|Overall Study|Adverse Event|0|||
105712521|NCT03529773|364607720|FG015|Overall Study|Adverse Event|0|||
105712522|NCT03529773|364607721|FG016|Overall Study|Adverse Event|0|||
105712523|NCT03529773|364607722|FG017|Overall Study|Adverse Event|0|||
105712524|NCT03529773|364607723|FG018|Overall Study|Adverse Event|0|||
105712525|NCT03529773|364607724|FG019|Overall Study|Adverse Event|0|||
105712526|NCT03529773|364607725|FG020|Overall Study|Adverse Event|0|||
105712527|NCT03529773|364607726|FG021|Overall Study|Adverse Event|0|||
105712528|NCT03529773|364607727|FG022|Overall Study|Adverse Event|0|||
105712529|NCT03529773|364607728|FG023|Overall Study|Adverse Event|0|||
105712530|NCT03529773|364607729|FG024|Overall Study|Adverse Event|0|||
105712531|NCT03529773|364607730|FG025|Overall Study|Adverse Event|0|||
105712532|NCT03529773|364607731|FG026|Overall Study|Adverse Event|0|||
105712533|NCT03529773|364607732|FG027|Overall Study|Adverse Event|0|||
105712534|NCT03529773|364607733|FG028|Overall Study|Adverse Event|0|||
105712535|NCT03529773|364607734|FG029|Overall Study|Adverse Event|0|||
105712536|NCT03529773|364607735|FG030|Overall Study|Adverse Event|1|||
105712537|NCT03529773|364607736|FG031|Overall Study|Adverse Event|0|||
105712538|NCT03529773|364607737|FG032|Overall Study|Adverse Event|0|||
105712539|NCT03529773|364607738|FG033|Overall Study|Adverse Event|0|||
105712540|NCT03529773|364607739|FG034|Overall Study|Adverse Event|0|||
105712541|NCT03529773|364607740|FG035|Overall Study|Adverse Event|1|||
105712542|NCT03529773|364607741|FG036|Overall Study|Adverse Event|0|||
105712543|NCT03529773|364607742|FG037|Overall Study|Adverse Event|0|||
105712544|NCT03529773|364607743|FG038|Overall Study|Adverse Event|1|||
105712545|NCT03529773|364607744|FG039|Overall Study|Adverse Event|1|||
105712546|NCT03529773|364607705|FG000|Overall Study|Death|0|||
105712547|NCT03529773|364607706|FG001|Overall Study|Death|0|||
105712548|NCT03529773|364607707|FG002|Overall Study|Death|0|||
105788432|NCT01100073|364880052|FG000|Overall Study|Missing|5|||
105788433|NCT02526017|364880053|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788434|NCT02526017|364880054|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788435|NCT02526017|364880055|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105930433|NCT00447278|365404338|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
105930434|NCT00447278|365404337|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
105930435|NCT00447278|365404338|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
105930436|NCT00447278|365404337|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
105930437|NCT00447278|365404338|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
105930438|NCT00447278|365404337|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
105930439|NCT00447278|365404338|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
105930440|NCT02595749|365404339|FG000|Overall Study|Withdrawal by Subject|12|||
105930441|NCT02595749|365404340|FG001|Overall Study|Withdrawal by Subject|7|||
105930442|NCT05427916|365404341|FG000|Overall Study|Adverse Event|3|||
105930443|NCT05427916|365404342|FG001|Overall Study|Adverse Event|0|||
105930444|NCT05427916|365404341|FG000|Overall Study|Lack of Efficacy|6|||
105930445|NCT05427916|365404342|FG001|Overall Study|Lack of Efficacy|0|||
105930446|NCT05427916|365404341|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
105930447|NCT05427916|365404342|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
105930448|NCT01875237|365404343|FG000|Overall Study|GVDH before DLI|1|||
105930449|NCT01875237|365404344|FG001|Overall Study|GVDH before DLI|0|||
105930450|NCT01875237|365404343|FG000|Overall Study|DLI cells could not be produced|1|||
105712549|NCT03529773|364607708|FG003|Overall Study|Death|0|||
105712550|NCT03529773|364607709|FG004|Overall Study|Death|0|||
105712551|NCT03529773|364607710|FG005|Overall Study|Death|0|||
105712552|NCT03529773|364607711|FG006|Overall Study|Death|0|||
105712553|NCT03529773|364607712|FG007|Overall Study|Death|0|||
105712554|NCT03529773|364607713|FG008|Overall Study|Death|0|||
105712555|NCT03529773|364607714|FG009|Overall Study|Death|0|||
105712556|NCT03529773|364607715|FG010|Overall Study|Death|0|||
105712557|NCT03529773|364607716|FG011|Overall Study|Death|0|||
105712558|NCT03529773|364607717|FG012|Overall Study|Death|1|||
105712559|NCT03529773|364607718|FG013|Overall Study|Death|0|||
105712560|NCT03529773|364607719|FG014|Overall Study|Death|0|||
105712561|NCT03529773|364607720|FG015|Overall Study|Death|0|||
105712562|NCT03529773|364607721|FG016|Overall Study|Death|0|||
105712563|NCT03529773|364607722|FG017|Overall Study|Death|0|||
105712564|NCT03529773|364607723|FG018|Overall Study|Death|0|||
105712565|NCT03529773|364607724|FG019|Overall Study|Death|1|||
105930451|NCT01875237|365404344|FG001|Overall Study|DLI cells could not be produced|0|||
105712566|NCT03529773|364607725|FG020|Overall Study|Death|0|||
105712567|NCT03529773|364607726|FG021|Overall Study|Death|0|||
105712568|NCT03529773|364607727|FG022|Overall Study|Death|1|||
105712569|NCT03529773|364607728|FG023|Overall Study|Death|0|||
105712570|NCT03529773|364607729|FG024|Overall Study|Death|0|||
105712571|NCT03529773|364607730|FG025|Overall Study|Death|0|||
105712572|NCT03529773|364607731|FG026|Overall Study|Death|0|||
105712573|NCT03529773|364607732|FG027|Overall Study|Death|0|||
105712574|NCT03529773|364607733|FG028|Overall Study|Death|0|||
105712575|NCT03529773|364607734|FG029|Overall Study|Death|0|||
105712576|NCT03529773|364607735|FG030|Overall Study|Death|0|||
105712577|NCT03529773|364607736|FG031|Overall Study|Death|0|||
105712578|NCT03529773|364607737|FG032|Overall Study|Death|0|||
105788436|NCT02526017|364880056|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105712579|NCT03529773|364607738|FG033|Overall Study|Death|1|||
105712580|NCT03529773|364607739|FG034|Overall Study|Death|1|||
105712581|NCT03529773|364607740|FG035|Overall Study|Death|0|||
105712582|NCT03529773|364607741|FG036|Overall Study|Death|1|||
105712583|NCT03529773|364607742|FG037|Overall Study|Death|0|||
105712584|NCT03529773|364607743|FG038|Overall Study|Death|0|||
105712585|NCT03529773|364607744|FG039|Overall Study|Death|0|||
105712586|NCT03529773|364607705|FG000|Overall Study|Lost to Follow-up|0|||
105712587|NCT03529773|364607706|FG001|Overall Study|Lost to Follow-up|0|||
105712588|NCT03529773|364607707|FG002|Overall Study|Lost to Follow-up|1|||
105712589|NCT03529773|364607708|FG003|Overall Study|Lost to Follow-up|0|||
105712590|NCT03529773|364607709|FG004|Overall Study|Lost to Follow-up|1|||
105712591|NCT03529773|364607710|FG005|Overall Study|Lost to Follow-up|1|||
105712592|NCT03529773|364607711|FG006|Overall Study|Lost to Follow-up|0|||
105712593|NCT03529773|364607712|FG007|Overall Study|Lost to Follow-up|0|||
105712594|NCT03529773|364607713|FG008|Overall Study|Lost to Follow-up|0|||
105712595|NCT03529773|364607714|FG009|Overall Study|Lost to Follow-up|0|||
105712596|NCT03529773|364607715|FG010|Overall Study|Lost to Follow-up|0|||
105712597|NCT03529773|364607716|FG011|Overall Study|Lost to Follow-up|0|||
105712598|NCT03529773|364607717|FG012|Overall Study|Lost to Follow-up|0|||
105712599|NCT03529773|364607718|FG013|Overall Study|Lost to Follow-up|1|||
105712600|NCT03529773|364607719|FG014|Overall Study|Lost to Follow-up|4|||
105712601|NCT03529773|364607720|FG015|Overall Study|Lost to Follow-up|1|||
105712602|NCT03529773|364607721|FG016|Overall Study|Lost to Follow-up|1|||
105712603|NCT03529773|364607722|FG017|Overall Study|Lost to Follow-up|0|||
105712604|NCT03529773|364607723|FG018|Overall Study|Lost to Follow-up|1|||
105712605|NCT03529773|364607724|FG019|Overall Study|Lost to Follow-up|1|||
105712606|NCT03529773|364607725|FG020|Overall Study|Lost to Follow-up|2|||
105712607|NCT03529773|364607726|FG021|Overall Study|Lost to Follow-up|4|||
105712608|NCT03529773|364607727|FG022|Overall Study|Lost to Follow-up|3|||
105712609|NCT03529773|364607728|FG023|Overall Study|Lost to Follow-up|4|||
105712610|NCT03529773|364607729|FG024|Overall Study|Lost to Follow-up|3|||
105712611|NCT03529773|364607730|FG025|Overall Study|Lost to Follow-up|5|||
105712612|NCT03529773|364607731|FG026|Overall Study|Lost to Follow-up|5|||
105712613|NCT03529773|364607732|FG027|Overall Study|Lost to Follow-up|0|||
105712614|NCT03529773|364607733|FG028|Overall Study|Lost to Follow-up|0|||
105712615|NCT03529773|364607734|FG029|Overall Study|Lost to Follow-up|0|||
105712616|NCT03529773|364607735|FG030|Overall Study|Lost to Follow-up|1|||
105712617|NCT03529773|364607736|FG031|Overall Study|Lost to Follow-up|0|||
105712618|NCT03529773|364607737|FG032|Overall Study|Lost to Follow-up|0|||
105712619|NCT03529773|364607738|FG033|Overall Study|Lost to Follow-up|1|||
105712620|NCT03529773|364607739|FG034|Overall Study|Lost to Follow-up|1|||
105712621|NCT03529773|364607740|FG035|Overall Study|Lost to Follow-up|0|||
105712622|NCT03529773|364607741|FG036|Overall Study|Lost to Follow-up|0|||
105712623|NCT03529773|364607742|FG037|Overall Study|Lost to Follow-up|3|||
105712624|NCT03529773|364607743|FG038|Overall Study|Lost to Follow-up|1|||
105712625|NCT03529773|364607744|FG039|Overall Study|Lost to Follow-up|1|||
105712626|NCT03529773|364607705|FG000|Overall Study|No longer meets eligibility criteria|0|||
105712627|NCT03529773|364607706|FG001|Overall Study|No longer meets eligibility criteria|0|||
105712628|NCT03529773|364607707|FG002|Overall Study|No longer meets eligibility criteria|0|||
105712629|NCT03529773|364607708|FG003|Overall Study|No longer meets eligibility criteria|0|||
105712630|NCT03529773|364607709|FG004|Overall Study|No longer meets eligibility criteria|0|||
105712631|NCT03529773|364607710|FG005|Overall Study|No longer meets eligibility criteria|0|||
105712632|NCT03529773|364607711|FG006|Overall Study|No longer meets eligibility criteria|0|||
105712633|NCT03529773|364607712|FG007|Overall Study|No longer meets eligibility criteria|0|||
105712634|NCT03529773|364607713|FG008|Overall Study|No longer meets eligibility criteria|0|||
105712635|NCT03529773|364607714|FG009|Overall Study|No longer meets eligibility criteria|0|||
105712636|NCT03529773|364607715|FG010|Overall Study|No longer meets eligibility criteria|0|||
105712637|NCT03529773|364607716|FG011|Overall Study|No longer meets eligibility criteria|0|||
105712638|NCT03529773|364607717|FG012|Overall Study|No longer meets eligibility criteria|0|||
105712639|NCT03529773|364607718|FG013|Overall Study|No longer meets eligibility criteria|0|||
105712640|NCT03529773|364607719|FG014|Overall Study|No longer meets eligibility criteria|0|||
105712641|NCT03529773|364607720|FG015|Overall Study|No longer meets eligibility criteria|0|||
105712642|NCT03529773|364607721|FG016|Overall Study|No longer meets eligibility criteria|0|||
105712643|NCT03529773|364607722|FG017|Overall Study|No longer meets eligibility criteria|0|||
105930452|NCT04076579|365404345|FG000|Overall Study|Adverse Event|2|||
105930453|NCT04076579|365404346|FG001|Overall Study|Adverse Event|0|||
105930454|NCT04076579|365404345|FG000|Overall Study|discontinued due to toxicity|1|||
105930455|NCT04076579|365404346|FG001|Overall Study|discontinued due to toxicity|0|||
105930456|NCT04076579|365404345|FG000|Overall Study|Physician Decision|1|||
105930457|NCT04076579|365404346|FG001|Overall Study|Physician Decision|0|||
105930458|NCT04076579|365404345|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
105712644|NCT03529773|364607723|FG018|Overall Study|No longer meets eligibility criteria|0|||
105712645|NCT03529773|364607724|FG019|Overall Study|No longer meets eligibility criteria|0|||
105712646|NCT03529773|364607725|FG020|Overall Study|No longer meets eligibility criteria|0|||
105712647|NCT03529773|364607726|FG021|Overall Study|No longer meets eligibility criteria|0|||
105712648|NCT03529773|364607727|FG022|Overall Study|No longer meets eligibility criteria|1|||
105712649|NCT03529773|364607728|FG023|Overall Study|No longer meets eligibility criteria|0|||
105712650|NCT03529773|364607729|FG024|Overall Study|No longer meets eligibility criteria|0|||
105712651|NCT03529773|364607730|FG025|Overall Study|No longer meets eligibility criteria|0|||
105712652|NCT03529773|364607731|FG026|Overall Study|No longer meets eligibility criteria|0|||
105712653|NCT03529773|364607732|FG027|Overall Study|No longer meets eligibility criteria|0|||
105712654|NCT03529773|364607733|FG028|Overall Study|No longer meets eligibility criteria|0|||
105712655|NCT03529773|364607734|FG029|Overall Study|No longer meets eligibility criteria|0|||
105712656|NCT03529773|364607735|FG030|Overall Study|No longer meets eligibility criteria|0|||
105712657|NCT03529773|364607736|FG031|Overall Study|No longer meets eligibility criteria|0|||
105712658|NCT03529773|364607737|FG032|Overall Study|No longer meets eligibility criteria|0|||
105712659|NCT03529773|364607738|FG033|Overall Study|No longer meets eligibility criteria|0|||
105712660|NCT03529773|364607739|FG034|Overall Study|No longer meets eligibility criteria|0|||
105712661|NCT03529773|364607740|FG035|Overall Study|No longer meets eligibility criteria|0|||
105712662|NCT03529773|364607741|FG036|Overall Study|No longer meets eligibility criteria|0|||
105712663|NCT03529773|364607742|FG037|Overall Study|No longer meets eligibility criteria|0|||
105712664|NCT03529773|364607743|FG038|Overall Study|No longer meets eligibility criteria|1|||
105712665|NCT03529773|364607744|FG039|Overall Study|No longer meets eligibility criteria|0|||
105712666|NCT03529773|364607705|FG000|Overall Study|Other|0|||
105712667|NCT03529773|364607706|FG001|Overall Study|Other|0|||
105712668|NCT03529773|364607707|FG002|Overall Study|Other|0|||
105712669|NCT03529773|364607708|FG003|Overall Study|Other|0|||
105712670|NCT03529773|364607709|FG004|Overall Study|Other|0|||
105712671|NCT03529773|364607710|FG005|Overall Study|Other|0|||
105712672|NCT03529773|364607711|FG006|Overall Study|Other|0|||
105712673|NCT03529773|364607712|FG007|Overall Study|Other|0|||
105712674|NCT03529773|364607713|FG008|Overall Study|Other|0|||
105712675|NCT03529773|364607714|FG009|Overall Study|Other|0|||
105712676|NCT03529773|364607715|FG010|Overall Study|Other|0|||
105712677|NCT03529773|364607716|FG011|Overall Study|Other|0|||
105712678|NCT03529773|364607717|FG012|Overall Study|Other|1|||
105712679|NCT03529773|364607718|FG013|Overall Study|Other|0|||
105712680|NCT03529773|364607719|FG014|Overall Study|Other|2|||
105712681|NCT03529773|364607720|FG015|Overall Study|Other|0|||
105712682|NCT03529773|364607721|FG016|Overall Study|Other|0|||
105712683|NCT03529773|364607722|FG017|Overall Study|Other|3|||
105712684|NCT03529773|364607723|FG018|Overall Study|Other|0|||
105712685|NCT03529773|364607724|FG019|Overall Study|Other|0|||
105712686|NCT03529773|364607725|FG020|Overall Study|Other|1|||
105712687|NCT03529773|364607726|FG021|Overall Study|Other|0|||
105712688|NCT03529773|364607727|FG022|Overall Study|Other|1|||
105712689|NCT03529773|364607728|FG023|Overall Study|Other|0|||
105712690|NCT03529773|364607729|FG024|Overall Study|Other|3|||
105788437|NCT02526017|364880057|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
105930459|NCT04076579|365404346|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
105930460|NCT04076579|365404345|FG000|Overall Study|Noncompliance|0|||
105930461|NCT04076579|365404346|FG001|Overall Study|Noncompliance|1|||
105930462|NCT04076579|365404345|FG000|Overall Study|Withdrawal by Subject|0|||
105930463|NCT04076579|365404346|FG001|Overall Study|Withdrawal by Subject|2|||
105930464|NCT05558410|365404347|FG000|Overall Study|Adverse Event|1|||
105930465|NCT05558410|365404348|FG001|Overall Study|Adverse Event|2|||
105930466|NCT05558410|365404349|FG002|Overall Study|Adverse Event|0|||
105930467|NCT05558410|365404347|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
105930468|NCT05558410|365404348|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
105712691|NCT03529773|364607730|FG025|Overall Study|Other|2|||
105930469|NCT05558410|365404349|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
105712692|NCT03529773|364607731|FG026|Overall Study|Other|2|||
105712693|NCT03529773|364607732|FG027|Overall Study|Other|0|||
105712694|NCT03529773|364607733|FG028|Overall Study|Other|0|||
105712695|NCT03529773|364607734|FG029|Overall Study|Other|0|||
105930470|NCT05558410|365404347|FG000|Overall Study|Lost to Follow-up|10|||
105930471|NCT05558410|365404348|FG001|Overall Study|Lost to Follow-up|17|||
105930472|NCT05558410|365404349|FG002|Overall Study|Lost to Follow-up|19|||
105930473|NCT05558410|365404347|FG000|Overall Study|Death|1|||
105712696|NCT03529773|364607735|FG030|Overall Study|Other|0|||
105712697|NCT03529773|364607736|FG031|Overall Study|Other|0|||
105712698|NCT03529773|364607737|FG032|Overall Study|Other|0|||
105712699|NCT03529773|364607738|FG033|Overall Study|Other|0|||
105712700|NCT03529773|364607739|FG034|Overall Study|Other|1|||
105712701|NCT03529773|364607740|FG035|Overall Study|Other|1|||
105712702|NCT03529773|364607741|FG036|Overall Study|Other|0|||
105712703|NCT03529773|364607742|FG037|Overall Study|Other|0|||
105712704|NCT03529773|364607743|FG038|Overall Study|Other|0|||
105712705|NCT03529773|364607744|FG039|Overall Study|Other|0|||
105712706|NCT03529773|364607705|FG000|Overall Study|Physician Decision|0|||
105712707|NCT03529773|364607706|FG001|Overall Study|Physician Decision|0|||
105712708|NCT03529773|364607707|FG002|Overall Study|Physician Decision|0|||
105712709|NCT03529773|364607708|FG003|Overall Study|Physician Decision|0|||
105712710|NCT03529773|364607709|FG004|Overall Study|Physician Decision|0|||
105712711|NCT03529773|364607710|FG005|Overall Study|Physician Decision|0|||
105712712|NCT03529773|364607711|FG006|Overall Study|Physician Decision|0|||
105712713|NCT03529773|364607712|FG007|Overall Study|Physician Decision|0|||
105712714|NCT03529773|364607713|FG008|Overall Study|Physician Decision|0|||
105712715|NCT03529773|364607714|FG009|Overall Study|Physician Decision|0|||
105712716|NCT03529773|364607715|FG010|Overall Study|Physician Decision|0|||
105712717|NCT03529773|364607716|FG011|Overall Study|Physician Decision|0|||
105788438|NCT02526017|364880058|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788439|NCT02526017|364880059|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788440|NCT02526017|364880060|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788441|NCT02526017|364880061|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
105788442|NCT04621227|364880075|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
105788443|NCT04621227|364880075|FG000|Period 3 (29 Days)|Adverse Event|1|||
105788444|NCT04621227|364880075|FG000|Period 8 (2 Days)|Adverse Event|1|||
105788445|NCT00938392|364880076|FG000|Overall Study|Adverse Event|0|||
105788446|NCT00938392|364880077|FG001|Overall Study|Adverse Event|1|||
105788447|NCT00938392|364880076|FG000|Overall Study|Withdrawal by Subject|0|||
105788448|NCT00938392|364880077|FG001|Overall Study|Withdrawal by Subject|1|||
105788449|NCT00938392|364880076|FG000|Overall Study|Lost to Follow-up|2|||
105788450|NCT00938392|364880077|FG001|Overall Study|Lost to Follow-up|2|||
105788451|NCT00124709|364880081|FG000|Overall Study|Randomized but did not take medication|3|||
105788452|NCT00124709|364880082|FG001|Overall Study|Randomized but did not take medication|1|||
105788453|NCT00124709|364880081|FG000|Overall Study|Adverse Event|3|||
105788454|NCT00124709|364880082|FG001|Overall Study|Adverse Event|0|||
105788455|NCT00124709|364880081|FG000|Overall Study|Lack of Efficacy|5|||
105788456|NCT00124709|364880082|FG001|Overall Study|Lack of Efficacy|10|||
105788457|NCT00124709|364880081|FG000|Overall Study|Protocol Violation|3|||
105788458|NCT00124709|364880082|FG001|Overall Study|Protocol Violation|5|||
105788459|NCT00124709|364880081|FG000|Overall Study|Withdrawal by Subject|127|||
105788460|NCT00124709|364880082|FG001|Overall Study|Withdrawal by Subject|136|||
105788461|NCT00124709|364880081|FG000|Overall Study|Lost to Follow-up|114|||
105788462|NCT00124709|364880082|FG001|Overall Study|Lost to Follow-up|120|||
105788463|NCT00122954|364880083|FG000|Overall Study|Withdrawal by Subject|2|||
105788464|NCT00122954|364880084|FG001|Overall Study|Withdrawal by Subject|2|||
105788465|NCT00122954|364880083|FG000|Overall Study|Protocol Violation|0|||
105788466|NCT00122954|364880084|FG001|Overall Study|Protocol Violation|1|||
105788467|NCT00558831|364880087|FG000|Overall Study|Lost to Follow-up|1|||
106135382|NCT00819910|366154073|FG002|Overall Study|Adverse Event|2|||
106135383|NCT00819910|366154074|FG003|Overall Study|Adverse Event|1|||
105712718|NCT03529773|364607717|FG012|Overall Study|Physician Decision|0|||
105712719|NCT03529773|364607718|FG013|Overall Study|Physician Decision|0|||
105712720|NCT03529773|364607719|FG014|Overall Study|Physician Decision|0|||
105712721|NCT03529773|364607720|FG015|Overall Study|Physician Decision|0|||
105712722|NCT03529773|364607721|FG016|Overall Study|Physician Decision|0|||
105712723|NCT03529773|364607722|FG017|Overall Study|Physician Decision|0|||
105712724|NCT03529773|364607723|FG018|Overall Study|Physician Decision|0|||
105788468|NCT04633434|364880090|FG000|Overall Study|Lost to Follow-up|32|||
105788469|NCT04633434|364880091|FG001|Overall Study|Lost to Follow-up|32|||
105788470|NCT04888377|364880092|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
105788471|NCT04888377|364880093|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
105788472|NCT04888377|364880092|FG000|Overall Study|Physician Decision|6|||
105712725|NCT03529773|364607724|FG019|Overall Study|Physician Decision|1|||
105712726|NCT03529773|364607725|FG020|Overall Study|Physician Decision|1|||
105712727|NCT03529773|364607726|FG021|Overall Study|Physician Decision|0|||
105712728|NCT03529773|364607727|FG022|Overall Study|Physician Decision|0|||
105712729|NCT03529773|364607728|FG023|Overall Study|Physician Decision|0|||
105788473|NCT04888377|364880093|FG001|Overall Study|Physician Decision|6|||
105788474|NCT04888377|364880092|FG000|Overall Study|Withdrawal by Subject|7|||
105788475|NCT04888377|364880093|FG001|Overall Study|Withdrawal by Subject|3|||
105788476|NCT00526162|364880094|FG000|Overall Study|Device not implanted|3|||
105788477|NCT05279807|364880095|FG000|Overall Study|Withdrawal by Subject|1|||
105788478|NCT05279807|364880096|FG001|Overall Study|Withdrawal by Subject|0|||
105788479|NCT05279807|364880095|FG000|Overall Study|Adverse Event|0|||
105712730|NCT03529773|364607729|FG024|Overall Study|Physician Decision|0|||
105712731|NCT03529773|364607730|FG025|Overall Study|Physician Decision|0|||
105712732|NCT03529773|364607731|FG026|Overall Study|Physician Decision|0|||
105712733|NCT03529773|364607732|FG027|Overall Study|Physician Decision|0|||
105712734|NCT03529773|364607733|FG028|Overall Study|Physician Decision|0|||
105712735|NCT03529773|364607734|FG029|Overall Study|Physician Decision|0|||
105712736|NCT03529773|364607735|FG030|Overall Study|Physician Decision|0|||
105712737|NCT03529773|364607736|FG031|Overall Study|Physician Decision|0|||
105712738|NCT03529773|364607737|FG032|Overall Study|Physician Decision|0|||
105712739|NCT03529773|364607738|FG033|Overall Study|Physician Decision|0|||
105712740|NCT03529773|364607739|FG034|Overall Study|Physician Decision|0|||
105712741|NCT03529773|364607740|FG035|Overall Study|Physician Decision|0|||
105712742|NCT03529773|364607741|FG036|Overall Study|Physician Decision|0|||
105712743|NCT03529773|364607742|FG037|Overall Study|Physician Decision|0|||
105712744|NCT03529773|364607743|FG038|Overall Study|Physician Decision|0|||
105712745|NCT03529773|364607744|FG039|Overall Study|Physician Decision|0|||
105712746|NCT03529773|364607705|FG000|Overall Study|Protocol Violation|0|||
105712747|NCT03529773|364607706|FG001|Overall Study|Protocol Violation|0|||
105712748|NCT03529773|364607707|FG002|Overall Study|Protocol Violation|0|||
105712749|NCT03529773|364607708|FG003|Overall Study|Protocol Violation|0|||
105712750|NCT03529773|364607709|FG004|Overall Study|Protocol Violation|0|||
105712751|NCT03529773|364607710|FG005|Overall Study|Protocol Violation|0|||
105712752|NCT03529773|364607711|FG006|Overall Study|Protocol Violation|0|||
105712753|NCT03529773|364607712|FG007|Overall Study|Protocol Violation|0|||
105712754|NCT03529773|364607713|FG008|Overall Study|Protocol Violation|0|||
105712755|NCT03529773|364607714|FG009|Overall Study|Protocol Violation|0|||
105712756|NCT03529773|364607715|FG010|Overall Study|Protocol Violation|0|||
105712757|NCT03529773|364607716|FG011|Overall Study|Protocol Violation|0|||
105712758|NCT03529773|364607717|FG012|Overall Study|Protocol Violation|0|||
105712759|NCT03529773|364607718|FG013|Overall Study|Protocol Violation|0|||
105712760|NCT03529773|364607719|FG014|Overall Study|Protocol Violation|0|||
105712761|NCT03529773|364607720|FG015|Overall Study|Protocol Violation|0|||
105712762|NCT03529773|364607721|FG016|Overall Study|Protocol Violation|0|||
105712763|NCT03529773|364607722|FG017|Overall Study|Protocol Violation|0|||
105712764|NCT03529773|364607723|FG018|Overall Study|Protocol Violation|0|||
105712765|NCT03529773|364607724|FG019|Overall Study|Protocol Violation|0|||
105712766|NCT03529773|364607725|FG020|Overall Study|Protocol Violation|0|||
105712767|NCT03529773|364607726|FG021|Overall Study|Protocol Violation|0|||
105712768|NCT03529773|364607727|FG022|Overall Study|Protocol Violation|0|||
105712769|NCT03529773|364607728|FG023|Overall Study|Protocol Violation|0|||
105712770|NCT03529773|364607729|FG024|Overall Study|Protocol Violation|0|||
105712771|NCT03529773|364607730|FG025|Overall Study|Protocol Violation|0|||
105712772|NCT03529773|364607731|FG026|Overall Study|Protocol Violation|0|||
105712773|NCT03529773|364607732|FG027|Overall Study|Protocol Violation|0|||
105712774|NCT03529773|364607733|FG028|Overall Study|Protocol Violation|0|||
105712775|NCT03529773|364607734|FG029|Overall Study|Protocol Violation|0|||
105712776|NCT03529773|364607735|FG030|Overall Study|Protocol Violation|1|||
105712777|NCT03529773|364607736|FG031|Overall Study|Protocol Violation|0|||
105712778|NCT03529773|364607737|FG032|Overall Study|Protocol Violation|0|||
105712779|NCT03529773|364607738|FG033|Overall Study|Protocol Violation|0|||
105712780|NCT03529773|364607739|FG034|Overall Study|Protocol Violation|0|||
105712781|NCT03529773|364607740|FG035|Overall Study|Protocol Violation|0|||
105712782|NCT03529773|364607741|FG036|Overall Study|Protocol Violation|0|||
105712783|NCT03529773|364607742|FG037|Overall Study|Protocol Violation|0|||
105712784|NCT03529773|364607743|FG038|Overall Study|Protocol Violation|0|||
105712785|NCT03529773|364607744|FG039|Overall Study|Protocol Violation|0|||
105712786|NCT03529773|364607705|FG000|Overall Study|Withdrawal by Subject|0|||
105712787|NCT03529773|364607706|FG001|Overall Study|Withdrawal by Subject|0|||
105712788|NCT03529773|364607707|FG002|Overall Study|Withdrawal by Subject|0|||
105712789|NCT03529773|364607708|FG003|Overall Study|Withdrawal by Subject|0|||
105712790|NCT03529773|364607709|FG004|Overall Study|Withdrawal by Subject|0|||
105712791|NCT03529773|364607710|FG005|Overall Study|Withdrawal by Subject|0|||
105712792|NCT03529773|364607711|FG006|Overall Study|Withdrawal by Subject|0|||
105712793|NCT03529773|364607712|FG007|Overall Study|Withdrawal by Subject|1|||
105712794|NCT03529773|364607713|FG008|Overall Study|Withdrawal by Subject|0|||
105712795|NCT03529773|364607714|FG009|Overall Study|Withdrawal by Subject|1|||
105712796|NCT03529773|364607715|FG010|Overall Study|Withdrawal by Subject|1|||
105712797|NCT03529773|364607716|FG011|Overall Study|Withdrawal by Subject|0|||
105712798|NCT03529773|364607717|FG012|Overall Study|Withdrawal by Subject|0|||
105712799|NCT03529773|364607718|FG013|Overall Study|Withdrawal by Subject|0|||
105712800|NCT03529773|364607719|FG014|Overall Study|Withdrawal by Subject|0|||
105712801|NCT03529773|364607720|FG015|Overall Study|Withdrawal by Subject|3|||
105712802|NCT03529773|364607721|FG016|Overall Study|Withdrawal by Subject|0|||
105712803|NCT03529773|364607722|FG017|Overall Study|Withdrawal by Subject|2|||
105712804|NCT03529773|364607723|FG018|Overall Study|Withdrawal by Subject|3|||
105712805|NCT03529773|364607724|FG019|Overall Study|Withdrawal by Subject|1|||
105712806|NCT03529773|364607725|FG020|Overall Study|Withdrawal by Subject|3|||
105712807|NCT03529773|364607726|FG021|Overall Study|Withdrawal by Subject|1|||
105712808|NCT03529773|364607727|FG022|Overall Study|Withdrawal by Subject|1|||
105712809|NCT03529773|364607728|FG023|Overall Study|Withdrawal by Subject|2|||
105930474|NCT05558410|365404348|FG001|Overall Study|Death|0|||
105930475|NCT05558410|365404349|FG002|Overall Study|Death|0|||
105930476|NCT05558410|365404347|FG000|Overall Study|Other non-compliance|0|||
105930477|NCT05558410|365404348|FG001|Overall Study|Other non-compliance|1|||
105712810|NCT03529773|364607729|FG024|Overall Study|Withdrawal by Subject|2|||
105712811|NCT03529773|364607730|FG025|Overall Study|Withdrawal by Subject|4|||
105712812|NCT03529773|364607731|FG026|Overall Study|Withdrawal by Subject|2|||
105712813|NCT03529773|364607732|FG027|Overall Study|Withdrawal by Subject|1|||
105712814|NCT03529773|364607733|FG028|Overall Study|Withdrawal by Subject|1|||
105712815|NCT03529773|364607734|FG029|Overall Study|Withdrawal by Subject|0|||
105930478|NCT05558410|365404349|FG002|Overall Study|Other non-compliance|2|||
105930479|NCT05558410|365404347|FG000|Overall Study|Sponsor Decision|1|||
105930480|NCT05558410|365404348|FG001|Overall Study|Sponsor Decision|0|||
105930481|NCT05558410|365404349|FG002|Overall Study|Sponsor Decision|0|||
105930482|NCT05558410|365404347|FG000|Overall Study|Other|1|||
105930483|NCT05558410|365404348|FG001|Overall Study|Other|0|||
105930484|NCT05558410|365404349|FG002|Overall Study|Other|1|||
105930485|NCT02265744|365404350|FG000|Overall Study|Poor/Non-compliance|1|||
105930486|NCT02265744|365404351|FG001|Overall Study|Poor/Non-compliance|1|||
105930487|NCT02265744|365404352|FG002|Overall Study|Poor/Non-compliance|0|||
105930488|NCT02265744|365404353|FG003|Overall Study|Poor/Non-compliance|0|||
105930489|NCT02265744|365404354|FG004|Overall Study|Poor/Non-compliance|2|||
105930490|NCT02265744|365404350|FG000|Overall Study|Lost to Follow-up|0|||
105930491|NCT02265744|365404351|FG001|Overall Study|Lost to Follow-up|0|||
105930492|NCT02265744|365404352|FG002|Overall Study|Lost to Follow-up|0|||
105930493|NCT02265744|365404353|FG003|Overall Study|Lost to Follow-up|1|||
105930494|NCT02265744|365404354|FG004|Overall Study|Lost to Follow-up|0|||
105930495|NCT02265744|365404350|FG000|Overall Study|Death|0|||
105930496|NCT02265744|365404351|FG001|Overall Study|Death|0|||
105930497|NCT02265744|365404352|FG002|Overall Study|Death|0|||
105930498|NCT02265744|365404353|FG003|Overall Study|Death|2|||
105930499|NCT02265744|365404354|FG004|Overall Study|Death|0|||
105930500|NCT02265744|365404350|FG000|Overall Study|Withdrawal by Subject|2|||
105930501|NCT02265744|365404351|FG001|Overall Study|Withdrawal by Subject|0|||
105930502|NCT02265744|365404352|FG002|Overall Study|Withdrawal by Subject|0|||
105930503|NCT02265744|365404353|FG003|Overall Study|Withdrawal by Subject|2|||
105930504|NCT02265744|365404354|FG004|Overall Study|Withdrawal by Subject|0|||
105930505|NCT02265744|365404350|FG000|Overall Study|Participant request to discontinue|2|||
105930506|NCT02265744|365404351|FG001|Overall Study|Participant request to discontinue|2|||
105930507|NCT02265744|365404352|FG002|Overall Study|Participant request to discontinue|2|||
105930508|NCT02265744|365404353|FG003|Overall Study|Participant request to discontinue|0|||
105930509|NCT02265744|365404354|FG004|Overall Study|Participant request to discontinue|0|||
105930510|NCT02265744|365404350|FG000|Overall Study|Adverse Event|8|||
105930511|NCT02265744|365404351|FG001|Overall Study|Adverse Event|4|||
105930512|NCT02265744|365404352|FG002|Overall Study|Adverse Event|9|||
105930513|NCT02265744|365404353|FG003|Overall Study|Adverse Event|8|||
105930514|NCT02265744|365404354|FG004|Overall Study|Adverse Event|2|||
105930515|NCT02265744|365404350|FG000|Overall Study|Lack of Efficacy|2|||
105930516|NCT02265744|365404351|FG001|Overall Study|Lack of Efficacy|4|||
105930517|NCT02265744|365404352|FG002|Overall Study|Lack of Efficacy|3|||
105712816|NCT03529773|364607735|FG030|Overall Study|Withdrawal by Subject|0|||
105712817|NCT03529773|364607736|FG031|Overall Study|Withdrawal by Subject|0|||
105712818|NCT03529773|364607737|FG032|Overall Study|Withdrawal by Subject|0|||
105712819|NCT03529773|364607738|FG033|Overall Study|Withdrawal by Subject|0|||
105712820|NCT03529773|364607739|FG034|Overall Study|Withdrawal by Subject|1|||
105712821|NCT03529773|364607740|FG035|Overall Study|Withdrawal by Subject|2|||
105712822|NCT03529773|364607741|FG036|Overall Study|Withdrawal by Subject|0|||
105712823|NCT03529773|364607742|FG037|Overall Study|Withdrawal by Subject|2|||
105712824|NCT03529773|364607743|FG038|Overall Study|Withdrawal by Subject|1|||
105712825|NCT03529773|364607744|FG039|Overall Study|Withdrawal by Subject|1|||
105712826|NCT03529773|364607705|FG000|Overall Study|Screen Failure|0|||
105712827|NCT03529773|364607706|FG001|Overall Study|Screen Failure|0|||
105930518|NCT02265744|365404353|FG003|Overall Study|Lack of Efficacy|4|||
105930519|NCT02265744|365404354|FG004|Overall Study|Lack of Efficacy|5|||
105930520|NCT02265744|365404350|FG000|Overall Study|Reason not provided by Investigator|1|||
105930521|NCT02265744|365404351|FG001|Overall Study|Reason not provided by Investigator|0|||
105930522|NCT02265744|365404352|FG002|Overall Study|Reason not provided by Investigator|0|||
105930523|NCT02265744|365404353|FG003|Overall Study|Reason not provided by Investigator|2|||
105930524|NCT02265744|365404354|FG004|Overall Study|Reason not provided by Investigator|0|||
105930525|NCT02265744|365404350|FG000|Overall Study|Administrative reason by sponsor|3|||
105930526|NCT02265744|365404351|FG001|Overall Study|Administrative reason by sponsor|2|||
105930527|NCT02265744|365404352|FG002|Overall Study|Administrative reason by sponsor|2|||
105930528|NCT02265744|365404353|FG003|Overall Study|Administrative reason by sponsor|3|||
105930529|NCT02265744|365404354|FG004|Overall Study|Administrative reason by sponsor|3|||
105930530|NCT02265744|365404350|FG000|Overall Study|Subject no longer meets study criteria|0|||
105930531|NCT02265744|365404351|FG001|Overall Study|Subject no longer meets study criteria|0|||
105712828|NCT03529773|364607707|FG002|Overall Study|Screen Failure|0|||
105712829|NCT03529773|364607708|FG003|Overall Study|Screen Failure|0|||
105712830|NCT03529773|364607709|FG004|Overall Study|Screen Failure|0|||
105712831|NCT03529773|364607710|FG005|Overall Study|Screen Failure|0|||
105712832|NCT03529773|364607711|FG006|Overall Study|Screen Failure|0|||
105712833|NCT03529773|364607712|FG007|Overall Study|Screen Failure|0|||
105712834|NCT03529773|364607713|FG008|Overall Study|Screen Failure|0|||
105712835|NCT03529773|364607714|FG009|Overall Study|Screen Failure|0|||
105712836|NCT03529773|364607715|FG010|Overall Study|Screen Failure|0|||
105712837|NCT03529773|364607716|FG011|Overall Study|Screen Failure|0|||
105712838|NCT03529773|364607717|FG012|Overall Study|Screen Failure|0|||
105712839|NCT03529773|364607718|FG013|Overall Study|Screen Failure|0|||
105712840|NCT03529773|364607719|FG014|Overall Study|Screen Failure|0|||
105712841|NCT03529773|364607720|FG015|Overall Study|Screen Failure|0|||
105712842|NCT03529773|364607721|FG016|Overall Study|Screen Failure|0|||
105712843|NCT03529773|364607722|FG017|Overall Study|Screen Failure|0|||
105712844|NCT03529773|364607723|FG018|Overall Study|Screen Failure|0|||
105712845|NCT03529773|364607724|FG019|Overall Study|Screen Failure|0|||
105712846|NCT03529773|364607725|FG020|Overall Study|Screen Failure|0|||
105712847|NCT03529773|364607726|FG021|Overall Study|Screen Failure|0|||
105712848|NCT03529773|364607727|FG022|Overall Study|Screen Failure|0|||
105712849|NCT03529773|364607728|FG023|Overall Study|Screen Failure|0|||
105712850|NCT03529773|364607729|FG024|Overall Study|Screen Failure|0|||
105712851|NCT03529773|364607730|FG025|Overall Study|Screen Failure|0|||
105712852|NCT03529773|364607731|FG026|Overall Study|Screen Failure|0|||
105712853|NCT03529773|364607732|FG027|Overall Study|Screen Failure|0|||
105712854|NCT03529773|364607733|FG028|Overall Study|Screen Failure|0|||
105712855|NCT03529773|364607734|FG029|Overall Study|Screen Failure|0|||
105712856|NCT03529773|364607735|FG030|Overall Study|Screen Failure|0|||
105712857|NCT03529773|364607736|FG031|Overall Study|Screen Failure|0|||
105788480|NCT05279807|364880096|FG001|Overall Study|Adverse Event|1|||
105930532|NCT02265744|365404352|FG002|Overall Study|Subject no longer meets study criteria|0|||
105930533|NCT02265744|365404353|FG003|Overall Study|Subject no longer meets study criteria|0|||
105930534|NCT02265744|365404354|FG004|Overall Study|Subject no longer meets study criteria|1|||
105930535|NCT02265744|365404350|FG000|Overall Study|Pregnancy|1|||
105930536|NCT02265744|365404351|FG001|Overall Study|Pregnancy|2|||
105930537|NCT02265744|365404352|FG002|Overall Study|Pregnancy|1|||
105930538|NCT02265744|365404353|FG003|Overall Study|Pregnancy|1|||
105930539|NCT02265744|365404354|FG004|Overall Study|Pregnancy|0|||
105930540|NCT02639559|365404358|FG000|Overall Study|Mobilization failure|0|||
105930541|NCT02639559|365404359|FG001|Overall Study|Mobilization failure|3|||
105930542|NCT02639559|365404358|FG000|Overall Study|Issues with vascular acess|1|||
105930543|NCT02639559|365404359|FG001|Overall Study|Issues with vascular acess|0|||
105930544|NCT02202616|365404364|FG000|Overall Study|Screen failed|24|||
105930545|NCT02202616|365404364|FG000|Overall Study|Adverse Event|32|||
105930546|NCT02202616|365404364|FG000|Overall Study|Protocol deviation|18|||
105930547|NCT02202616|365404364|FG000|Overall Study|Patient withdrew consent|12|||
105930548|NCT02202616|365404364|FG000|Overall Study|Lost to Follow-up|6|||
105930549|NCT02202616|365404364|FG000|Overall Study|Administrative problems|6|||
105930550|NCT02202616|365404364|FG000|Overall Study|Abnormal test procedure result|1|||
105930551|NCT02202616|365404364|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105930552|NCT04790201|365404367|FG000|Overall Study|Lost to Follow-up|0|||
105930553|NCT04790201|365404368|FG001|Overall Study|Lost to Follow-up|0|||
105930554|NCT04790201|365404369|FG002|Overall Study|Lost to Follow-up|2|||
105930555|NCT04790201|365404367|FG000|Overall Study|Death|0|||
105930556|NCT04790201|365404368|FG001|Overall Study|Death|1|||
105930557|NCT04790201|365404369|FG002|Overall Study|Death|0|||
105930558|NCT04790201|365404367|FG000|Overall Study|Protocol Violation|1|||
105930559|NCT04790201|365404368|FG001|Overall Study|Protocol Violation|0|||
106008613|NCT01667900|365697036|FG015|Part B|Death|0|||
106008614|NCT01667900|365697037|FG016|Part B|Death|1|||
106135384|NCT00819910|366154071|FG000|Overall Study|Withdrawal by Subject|1|||
106135385|NCT00819910|366154072|FG001|Overall Study|Withdrawal by Subject|1|||
106135386|NCT00819910|366154073|FG002|Overall Study|Withdrawal by Subject|1|||
105712858|NCT03529773|364607737|FG032|Overall Study|Screen Failure|0|||
105930560|NCT04790201|365404369|FG002|Overall Study|Protocol Violation|1|||
105930561|NCT03670628|365404370|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
105712859|NCT03529773|364607738|FG033|Overall Study|Screen Failure|0|||
105712860|NCT03529773|364607739|FG034|Overall Study|Screen Failure|0|||
105712861|NCT03529773|364607740|FG035|Overall Study|Screen Failure|0|||
105712862|NCT03529773|364607741|FG036|Overall Study|Screen Failure|1|||
105712863|NCT03529773|364607742|FG037|Overall Study|Screen Failure|1|||
105930562|NCT03670628|365404371|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
105930563|NCT03670628|365404370|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
105930564|NCT03670628|365404371|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
105930565|NCT04339972|365404375|FG000|Overall Study|Scheduling Issues|3|||
106008615|NCT01667900|365697038|FG017|Part B|Death|0|||
106135387|NCT00819910|366154074|FG003|Overall Study|Withdrawal by Subject|0|||
106135388|NCT00819910|366154071|FG000|Overall Study|Lost to Follow-up|1|||
106135389|NCT00819910|366154072|FG001|Overall Study|Lost to Follow-up|0|||
106135390|NCT00819910|366154073|FG002|Overall Study|Lost to Follow-up|0|||
106135391|NCT00819910|366154074|FG003|Overall Study|Lost to Follow-up|0|||
106135392|NCT00871429|366154075|FG000|Overall Study|Lost to Follow-up|6|||
106135393|NCT00871429|366154075|FG000|Overall Study|Withdrawal by Subject|17|||
106135394|NCT00871429|366154075|FG000|Overall Study|Questionnaire not completed|1|||
106135395|NCT01772719|366154076|FG000|Overall Study|Withdrawal by Subject|3|||
106135396|NCT01772719|366154076|FG000|Overall Study|Adverse Event|2|||
106135397|NCT01772719|366154076|FG000|Overall Study|Protocol Violation|1|||
106135398|NCT01772719|366154076|FG000|Overall Study|Lost to Follow-up|1|||
106135399|NCT01311713|366154077|FG000|Overall Study|Death|0|||
106135400|NCT01311713|366154078|FG001|Overall Study|Death|0|||
106135401|NCT01311713|366154079|FG002|Overall Study|Death|1|||
106135402|NCT01311713|366154080|FG003|Overall Study|Death|1|||
106135403|NCT01311713|366154081|FG004|Overall Study|Death|0|||
106135404|NCT01311713|366154082|FG005|Overall Study|Death|1|||
106135405|NCT01311713|366154083|FG006|Overall Study|Death|0|||
106135406|NCT01311713|366154077|FG000|Overall Study|Adverse Event|0|||
106135407|NCT01311713|366154078|FG001|Overall Study|Adverse Event|1|||
106135408|NCT01311713|366154079|FG002|Overall Study|Adverse Event|0|||
106135409|NCT01311713|366154080|FG003|Overall Study|Adverse Event|2|||
106135410|NCT01311713|366154081|FG004|Overall Study|Adverse Event|0|||
106135411|NCT01311713|366154082|FG005|Overall Study|Adverse Event|0|||
106135412|NCT01311713|366154083|FG006|Overall Study|Adverse Event|2|||
106135413|NCT01311713|366154077|FG000|Overall Study|Withdrawal by Subject|0|||
106135414|NCT01311713|366154078|FG001|Overall Study|Withdrawal by Subject|1|||
106135415|NCT01311713|366154079|FG002|Overall Study|Withdrawal by Subject|1|||
106135416|NCT01311713|366154080|FG003|Overall Study|Withdrawal by Subject|0|||
106135417|NCT01311713|366154081|FG004|Overall Study|Withdrawal by Subject|0|||
106135418|NCT01311713|366154082|FG005|Overall Study|Withdrawal by Subject|1|||
106135419|NCT01311713|366154083|FG006|Overall Study|Withdrawal by Subject|2|||
106135420|NCT01311713|366154077|FG000|Overall Study|Disease progression|3|||
106135421|NCT01311713|366154078|FG001|Overall Study|Disease progression|4|||
106135422|NCT01311713|366154079|FG002|Overall Study|Disease progression|3|||
106135423|NCT01311713|366154080|FG003|Overall Study|Disease progression|2|||
106135424|NCT01311713|366154081|FG004|Overall Study|Disease progression|4|||
106135425|NCT01311713|366154082|FG005|Overall Study|Disease progression|4|||
106135426|NCT01311713|366154083|FG006|Overall Study|Disease progression|5|||
106135427|NCT01311713|366154077|FG000|Overall Study|Lost to Follow-up|0|||
106135428|NCT01311713|366154078|FG001|Overall Study|Lost to Follow-up|0|||
106135429|NCT01311713|366154079|FG002|Overall Study|Lost to Follow-up|1|||
106135430|NCT01311713|366154080|FG003|Overall Study|Lost to Follow-up|0|||
106135431|NCT01311713|366154081|FG004|Overall Study|Lost to Follow-up|0|||
106135432|NCT01311713|366154082|FG005|Overall Study|Lost to Follow-up|0|||
106135433|NCT01311713|366154083|FG006|Overall Study|Lost to Follow-up|0|||
106135434|NCT01311713|366154077|FG000|Overall Study|Stopped taking study medication|0|||
106135435|NCT01311713|366154078|FG001|Overall Study|Stopped taking study medication|0|||
106135436|NCT01311713|366154079|FG002|Overall Study|Stopped taking study medication|0|||
106135437|NCT01311713|366154080|FG003|Overall Study|Stopped taking study medication|1|||
106135438|NCT01311713|366154081|FG004|Overall Study|Stopped taking study medication|1|||
106135439|NCT01311713|366154082|FG005|Overall Study|Stopped taking study medication|0|||
105712864|NCT03529773|364607743|FG038|Overall Study|Screen Failure|0|||
105712865|NCT03529773|364607744|FG039|Overall Study|Screen Failure|1|||
105712866|NCT03529773|364607705|FG000|Overall Study|Randomized but not vaccinated|0|||
106135440|NCT01311713|366154083|FG006|Overall Study|Stopped taking study medication|0|||
105712867|NCT03529773|364607706|FG001|Overall Study|Randomized but not vaccinated|0|||
105712868|NCT03529773|364607707|FG002|Overall Study|Randomized but not vaccinated|0|||
105712869|NCT03529773|364607708|FG003|Overall Study|Randomized but not vaccinated|0|||
105712870|NCT03529773|364607709|FG004|Overall Study|Randomized but not vaccinated|0|||
105712871|NCT03529773|364607710|FG005|Overall Study|Randomized but not vaccinated|0|||
105712872|NCT03529773|364607711|FG006|Overall Study|Randomized but not vaccinated|0|||
105712873|NCT03529773|364607712|FG007|Overall Study|Randomized but not vaccinated|0|||
106135441|NCT01311713|366154077|FG000|Overall Study|Enrolled but not treated|0|||
106135442|NCT01311713|366154078|FG001|Overall Study|Enrolled but not treated|0|||
106135443|NCT01311713|366154079|FG002|Overall Study|Enrolled but not treated|1|||
106135444|NCT01311713|366154080|FG003|Overall Study|Enrolled but not treated|0|||
106135445|NCT01311713|366154081|FG004|Overall Study|Enrolled but not treated|0|||
106135446|NCT01311713|366154082|FG005|Overall Study|Enrolled but not treated|0|||
106135447|NCT01311713|366154083|FG006|Overall Study|Enrolled but not treated|0|||
105712874|NCT03529773|364607713|FG008|Overall Study|Randomized but not vaccinated|0|||
105712875|NCT03529773|364607714|FG009|Overall Study|Randomized but not vaccinated|0|||
105712876|NCT03529773|364607715|FG010|Overall Study|Randomized but not vaccinated|0|||
106135448|NCT01311713|366154077|FG000|Overall Study|Other than specified|0|||
106135449|NCT01311713|366154078|FG001|Overall Study|Other than specified|1|||
106135450|NCT01311713|366154079|FG002|Overall Study|Other than specified|2|||
105788481|NCT05279807|364880095|FG000|Overall Study|Laboratory Abnormal Results|1|||
105788482|NCT05279807|364880096|FG001|Overall Study|Laboratory Abnormal Results|0|||
105788483|NCT03526549|364880098|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
105788484|NCT03526549|364880099|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
105788485|NCT03526549|364880098|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
105788486|NCT03526549|364880099|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
105788487|NCT03526549|364880098|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
105788488|NCT03526549|364880099|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
105788489|NCT03526549|364880098|FG000|Open-label Phase|Adverse Event|4|||
105788490|NCT03526549|364880099|FG001|Open-label Phase|Adverse Event|0|||
105788491|NCT03526549|364880098|FG000|Open-label Phase|Withdrawal by Subject|54|||
105788492|NCT03526549|364880099|FG001|Open-label Phase|Withdrawal by Subject|0|||
105788493|NCT03526549|364880098|FG000|Open-label Phase|Lost to Follow-up|35|||
105788494|NCT03526549|364880099|FG001|Open-label Phase|Lost to Follow-up|0|||
105788495|NCT03526549|364880098|FG000|Open-label Phase|Other than Specified|5|||
105788496|NCT03526549|364880099|FG001|Open-label Phase|Other than Specified|0|||
105788497|NCT00478933|364880102|FG000|Overall Study|Protocol Violation|22|||
105788498|NCT00478933|364880102|FG000|Overall Study|Informed consent not verified|3|||
105788499|NCT00478933|364880102|FG000|Overall Study|Inadequate data available|53|||
105788500|NCT03586427|364880103|FG000|Overall Study|Lost to Follow-up|0|||
105788501|NCT03586427|364880104|FG001|Overall Study|Lost to Follow-up|3|||
105788502|NCT03586427|364880105|FG002|Overall Study|Lost to Follow-up|1|||
105788503|NCT03586427|364880106|FG003|Overall Study|Lost to Follow-up|3|||
105788504|NCT03586427|364880107|FG004|Overall Study|Lost to Follow-up|3|||
105788505|NCT03586427|364880103|FG000|Overall Study|Withdrawal by Subject|0|||
105930566|NCT04339972|365404376|FG001|Overall Study|Scheduling Issues|3|||
105930567|NCT04339972|365404375|FG000|Overall Study|dropout|1|||
106135451|NCT01311713|366154080|FG003|Overall Study|Other than specified|0|||
106135452|NCT01311713|366154081|FG004|Overall Study|Other than specified|0|||
106135453|NCT01311713|366154082|FG005|Overall Study|Other than specified|0|||
105712877|NCT03529773|364607716|FG011|Overall Study|Randomized but not vaccinated|0|||
105712878|NCT03529773|364607717|FG012|Overall Study|Randomized but not vaccinated|0|||
105712879|NCT03529773|364607718|FG013|Overall Study|Randomized but not vaccinated|0|||
105712880|NCT03529773|364607719|FG014|Overall Study|Randomized but not vaccinated|0|||
105712881|NCT03529773|364607720|FG015|Overall Study|Randomized but not vaccinated|0|||
105712882|NCT03529773|364607721|FG016|Overall Study|Randomized but not vaccinated|0|||
105712883|NCT03529773|364607722|FG017|Overall Study|Randomized but not vaccinated|1|||
105712884|NCT03529773|364607723|FG018|Overall Study|Randomized but not vaccinated|0|||
105712885|NCT03529773|364607724|FG019|Overall Study|Randomized but not vaccinated|0|||
105712886|NCT03529773|364607725|FG020|Overall Study|Randomized but not vaccinated|0|||
105712887|NCT03529773|364607726|FG021|Overall Study|Randomized but not vaccinated|0|||
105712888|NCT03529773|364607727|FG022|Overall Study|Randomized but not vaccinated|0|||
105712889|NCT03529773|364607728|FG023|Overall Study|Randomized but not vaccinated|0|||
105712890|NCT03529773|364607729|FG024|Overall Study|Randomized but not vaccinated|0|||
105712891|NCT03529773|364607730|FG025|Overall Study|Randomized but not vaccinated|0|||
105712892|NCT03529773|364607731|FG026|Overall Study|Randomized but not vaccinated|0|||
105712893|NCT03529773|364607732|FG027|Overall Study|Randomized but not vaccinated|1|||
105930568|NCT04339972|365404376|FG001|Overall Study|dropout|1|||
105930569|NCT04339972|365404375|FG000|Overall Study|Technical issues|1|||
105930570|NCT04339972|365404376|FG001|Overall Study|Technical issues|0|||
105930571|NCT04339972|365404375|FG000|Overall Study|Claustraphobia|0|||
105930572|NCT04339972|365404376|FG001|Overall Study|Claustraphobia|1|||
105930573|NCT03158688|365404377|FG000|Overall Study|Withdrawal by Subject|14|||
105930574|NCT03158688|365404378|FG001|Overall Study|Withdrawal by Subject|28|||
105930575|NCT03158688|365404377|FG000|Overall Study|Decision by sponsor|13|||
105930576|NCT03158688|365404378|FG001|Overall Study|Decision by sponsor|37|||
105930577|NCT03158688|365404377|FG000|Overall Study|Lost to Follow-up|4|||
105930578|NCT03158688|365404378|FG001|Overall Study|Lost to Follow-up|3|||
105930579|NCT03158688|365404377|FG000|Overall Study|Death|74|||
106008616|NCT01667900|365697039|FG018|Part B|Death|0|||
105712894|NCT03529773|364607733|FG028|Overall Study|Randomized but not vaccinated|0|||
105712895|NCT03529773|364607734|FG029|Overall Study|Randomized but not vaccinated|0|||
105788506|NCT03586427|364880104|FG001|Overall Study|Withdrawal by Subject|1|||
105788507|NCT03586427|364880105|FG002|Overall Study|Withdrawal by Subject|2|||
105788508|NCT03586427|364880106|FG003|Overall Study|Withdrawal by Subject|1|||
105788509|NCT03586427|364880107|FG004|Overall Study|Withdrawal by Subject|1|||
105788510|NCT03586427|364880103|FG000|Overall Study|Adverse Event|0|||
105788511|NCT03586427|364880104|FG001|Overall Study|Adverse Event|0|||
105788512|NCT03586427|364880105|FG002|Overall Study|Adverse Event|1|||
105788513|NCT03586427|364880106|FG003|Overall Study|Adverse Event|0|||
105930580|NCT03158688|365404378|FG001|Overall Study|Death|142|||
105930581|NCT04465955|365404385|FG000|Overall Study|Withdrew consent|6|||
105930582|NCT04465955|365404386|FG001|Overall Study|Withdrew consent|10|||
105930583|NCT04465955|365404387|FG002|Overall Study|Withdrew consent|7|||
106008617|NCT01667900|365697040|FG019|Part B|Death|0|||
106135454|NCT01311713|366154083|FG006|Overall Study|Other than specified|0|||
106135455|NCT01981356|366154086|FG000|Overall Study|Lost to Follow-up|4|||
106135456|NCT01981356|366154087|FG001|Overall Study|Lost to Follow-up|1|||
106135457|NCT01981356|366154086|FG000|Overall Study|Withdrawal by Subject|1|||
106135458|NCT01981356|366154087|FG001|Overall Study|Withdrawal by Subject|1|||
106135459|NCT01981356|366154086|FG000|Overall Study|Protocol Violation|2|||
106135460|NCT01981356|366154087|FG001|Overall Study|Protocol Violation|0|||
106135461|NCT04476043|366155954|FG000|Overall Study|Withdrawal by Subject|1|||
106135462|NCT04476043|366155955|FG001|Overall Study|Withdrawal by Subject|3|||
106135463|NCT04476043|366155956|FG002|Overall Study|Withdrawal by Subject|4|||
106135464|NCT04476043|366155957|FG003|Overall Study|Withdrawal by Subject|1|||
106135465|NCT04476043|366155954|FG000|Overall Study|Lost to Follow-up|1|||
105930584|NCT04465955|365404385|FG000|Overall Study|Adverse Event|6|||
105930585|NCT04465955|365404386|FG001|Overall Study|Adverse Event|5|||
105930586|NCT04465955|365404387|FG002|Overall Study|Adverse Event|1|||
106135466|NCT04476043|366155955|FG001|Overall Study|Lost to Follow-up|1|||
106135467|NCT04476043|366155956|FG002|Overall Study|Lost to Follow-up|2|||
106135468|NCT04476043|366155957|FG003|Overall Study|Lost to Follow-up|1|||
106135469|NCT04476043|366155954|FG000|Overall Study|Adverse Event|2|||
106135470|NCT04476043|366155955|FG001|Overall Study|Adverse Event|0|||
106135471|NCT04476043|366155956|FG002|Overall Study|Adverse Event|1|||
106135472|NCT04476043|366155957|FG003|Overall Study|Adverse Event|0|||
106135473|NCT04476043|366155954|FG000|Overall Study|Protocol Violation|0|||
106135474|NCT04476043|366155955|FG001|Overall Study|Protocol Violation|1|||
106135475|NCT04476043|366155956|FG002|Overall Study|Protocol Violation|0|||
106135476|NCT04476043|366155957|FG003|Overall Study|Protocol Violation|0|||
105712896|NCT03529773|364607735|FG030|Overall Study|Randomized but not vaccinated|0|||
105712897|NCT03529773|364607736|FG031|Overall Study|Randomized but not vaccinated|0|||
105712898|NCT03529773|364607737|FG032|Overall Study|Randomized but not vaccinated|0|||
105712899|NCT03529773|364607738|FG033|Overall Study|Randomized but not vaccinated|0|||
105712900|NCT03529773|364607739|FG034|Overall Study|Randomized but not vaccinated|0|||
105712901|NCT03529773|364607740|FG035|Overall Study|Randomized but not vaccinated|0|||
105712902|NCT03529773|364607741|FG036|Overall Study|Randomized but not vaccinated|0|||
105712903|NCT03529773|364607742|FG037|Overall Study|Randomized but not vaccinated|0|||
105712904|NCT03529773|364607743|FG038|Overall Study|Randomized but not vaccinated|0|||
105712905|NCT03529773|364607744|FG039|Overall Study|Randomized but not vaccinated|0|||
105712906|NCT01340209|364607745|FG000|Overall Study|Adverse Event|1|||
105712907|NCT01340209|364607746|FG001|Overall Study|Adverse Event|1|||
105712908|NCT01340209|364607747|FG002|Overall Study|Adverse Event|2|||
105712909|NCT01340209|364607745|FG000|Overall Study|Protocol Violation|1|||
105712910|NCT01340209|364607746|FG001|Overall Study|Protocol Violation|2|||
105712911|NCT01340209|364607747|FG002|Overall Study|Protocol Violation|1|||
105712912|NCT01340209|364607745|FG000|Overall Study|Withdrawal by Subject|0|||
105712913|NCT01340209|364607746|FG001|Overall Study|Withdrawal by Subject|0|||
105712914|NCT01340209|364607747|FG002|Overall Study|Withdrawal by Subject|1|||
105712915|NCT01340209|364607745|FG000|Overall Study|Other reason not defined above|3|||
105712916|NCT01340209|364607746|FG001|Overall Study|Other reason not defined above|5|||
105712917|NCT01340209|364607747|FG002|Overall Study|Other reason not defined above|4|||
105712918|NCT00209339|364607750|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
105712919|NCT00209339|364607750|FG000|At 12 Months Follow-up|Death|1|||
105712920|NCT00209339|364607750|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
105712921|NCT00209339|364607750|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
105712922|NCT00209339|364607750|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
105712923|NCT00209339|364607750|FG000|At 24 Months Follow-up|Death|1|||
105712924|NCT00209339|364607750|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
105712925|NCT00209339|364607750|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
105930587|NCT04465955|365404385|FG000|Overall Study|Lost to Follow-up|2|||
105930588|NCT04465955|365404386|FG001|Overall Study|Lost to Follow-up|0|||
105930589|NCT04465955|365404387|FG002|Overall Study|Lost to Follow-up|3|||
105930590|NCT04465955|365404385|FG000|Overall Study|Other|1|||
105930591|NCT04465955|365404386|FG001|Overall Study|Other|1|||
105930592|NCT04465955|365404387|FG002|Overall Study|Other|3|||
105930593|NCT02497755|365404388|FG000|Overall Study|Protocol Violation|1|||
105930594|NCT02497755|365404389|FG001|Overall Study|Protocol Violation|0|||
105712926|NCT00209339|364607750|FG000|At 4 Years Follow-up|Death|1|||
105712927|NCT00209339|364607750|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
105712928|NCT00209339|364607750|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
105712929|NCT00209339|364607750|FG000|At 5 Years Follow-up|Death|1|||
105930595|NCT03501277|365404392|FG000|Intervention Period 1 (4 Days)|Other|0|||
105930596|NCT03501277|365404393|FG001|Intervention Period 1 (4 Days)|Other|0|||
105930597|NCT03501277|365404394|FG002|Intervention Period 1 (4 Days)|Other|1|||
105930598|NCT03501277|365404395|FG003|Intervention Period 1 (4 Days)|Other|0|||
106135477|NCT01240356|366155961|FG000|Overall Study|Withdrawal by Subject|2|||
106135478|NCT01240356|366155962|FG001|Overall Study|Withdrawal by Subject|0|||
106135479|NCT01240356|366155961|FG000|Overall Study|MRI contraindication|1|||
106135480|NCT01240356|366155962|FG001|Overall Study|MRI contraindication|0|||
106135481|NCT01306331|366155963|FG000|Overall Study|Adverse Event|28|||
106135482|NCT01306331|366155964|FG001|Overall Study|Adverse Event|25|||
106135483|NCT01306331|366155963|FG000|Overall Study|Lost to Follow-up|321|||
106135484|NCT01306331|366155964|FG001|Overall Study|Lost to Follow-up|323|||
106135485|NCT01306331|366155963|FG000|Overall Study|Physician Decision|26|||
106135486|NCT01306331|366155964|FG001|Overall Study|Physician Decision|22|||
106135487|NCT01306331|366155963|FG000|Overall Study|Pregnancy|136|||
106135488|NCT01306331|366155964|FG001|Overall Study|Pregnancy|151|||
106135489|NCT01306331|366155963|FG000|Overall Study|Protocol Violation|154|||
106135490|NCT01306331|366155964|FG001|Overall Study|Protocol Violation|124|||
106135491|NCT01306331|366155963|FG000|Overall Study|Withdrawal by Subject|163|||
106135492|NCT01306331|366155964|FG001|Overall Study|Withdrawal by Subject|152|||
106135493|NCT01306331|366155963|FG000|Overall Study|Not sexually active|29|||
106135494|NCT01306331|366155964|FG001|Overall Study|Not sexually active|28|||
106135495|NCT01306331|366155963|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
106135496|NCT01306331|366155964|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
106135497|NCT01306331|366155963|FG000|Overall Study|Other|34|||
106135498|NCT01306331|366155964|FG001|Overall Study|Other|32|||
106135499|NCT00409708|366155968|FG000|Treatment|Abnormal test procedure result(s)|1|||
106135500|NCT00409708|366155969|FG001|Treatment|Abnormal test procedure result(s)|0|||
106135501|NCT00409708|366155968|FG000|Treatment|Lack of Efficacy|0|||
106135502|NCT00409708|366155969|FG001|Treatment|Lack of Efficacy|1|||
106135503|NCT00409708|366155968|FG000|Treatment|Protocol Violation|6|||
106135504|NCT00409708|366155969|FG001|Treatment|Protocol Violation|2|||
106135505|NCT00409708|366155968|FG000|Treatment|Withdrawal by Subject|3|||
106135506|NCT00409708|366155969|FG001|Treatment|Withdrawal by Subject|8|||
106135507|NCT00409708|366155968|FG000|Treatment|Lost to Follow-up|0|||
106135508|NCT00409708|366155969|FG001|Treatment|Lost to Follow-up|6|||
106135509|NCT00409708|366155968|FG000|Treatment|Administrative problems|5|||
106135510|NCT00409708|366155969|FG001|Treatment|Administrative problems|0|||
106135511|NCT00409708|366155968|FG000|Washout|Lack of Efficacy|9|||
106135512|NCT00409708|366155969|FG001|Washout|Lack of Efficacy|1|||
106135513|NCT00409708|366155968|FG000|Washout|Protocol Violation|0|||
106135514|NCT00409708|366155969|FG001|Washout|Protocol Violation|1|||
106135515|NCT00409708|366155968|FG000|Washout|Withdrawal by Subject|11|||
106135516|NCT00409708|366155969|FG001|Washout|Withdrawal by Subject|5|||
106135517|NCT00409708|366155968|FG000|Washout|Lost to Follow-up|1|||
106135518|NCT00409708|366155969|FG001|Washout|Lost to Follow-up|3|||
106135519|NCT01456780|366155971|FG000|Overall Study|Lost to Follow-up|3|||
105712930|NCT02268058|364607752|FG000|Overall Study|Protocol Violation|1|||
105712931|NCT02268058|364607753|FG001|Overall Study|Protocol Violation|0|||
105930599|NCT03501277|365404392|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
105930600|NCT03501277|365404393|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
105930601|NCT03501277|365404394|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
105930602|NCT03501277|365404395|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
105930603|NCT03501277|365404392|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
105930604|NCT03501277|365404393|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
105930605|NCT03501277|365404394|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
105930606|NCT03501277|365404395|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
105930607|NCT03501277|365404392|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
105930608|NCT03501277|365404393|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
105930609|NCT03501277|365404394|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
105930610|NCT03501277|365404395|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
105930611|NCT01131585|365404396|FG000|Overall Study|Adverse Event|0|||
105930612|NCT01131585|365404397|FG001|Overall Study|Adverse Event|2|||
105930613|NCT01131585|365404396|FG000|Overall Study|Abnormal laboratory value|1|||
105930614|NCT01131585|365404397|FG001|Overall Study|Abnormal laboratory value|0|||
105930615|NCT01131585|365404396|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105930616|NCT01131585|365404397|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105930617|NCT01131585|365404396|FG000|Overall Study|Protocol Violation|2|||
105930618|NCT01131585|365404397|FG001|Overall Study|Protocol Violation|1|||
105930619|NCT01131585|365404396|FG000|Overall Study|Withdrawal by Subject|3|||
105930620|NCT01131585|365404397|FG001|Overall Study|Withdrawal by Subject|3|||
106135520|NCT01456780|366155972|FG001|Overall Study|Lost to Follow-up|3|||
106135521|NCT01456780|366155973|FG002|Overall Study|Lost to Follow-up|0|||
106135522|NCT00926393|366155976|FG000|Overall Study|Withdrawal by Subject|1|||
105930621|NCT01131585|365404396|FG000|Overall Study|Lost to Follow-up|0|||
105930622|NCT01131585|365404397|FG001|Overall Study|Lost to Follow-up|1|||
105930623|NCT01131585|365404396|FG000|Overall Study|Administrative problems|1|||
105930624|NCT01131585|365404397|FG001|Overall Study|Administrative problems|1|||
105930625|NCT01131585|365404396|FG000|Overall Study|Study termination|78|||
106135523|NCT00926393|366155977|FG001|Overall Study|Withdrawal by Subject|2|||
106135524|NCT00926393|366155976|FG000|Overall Study|Adverse Event|1|||
106135525|NCT00926393|366155977|FG001|Overall Study|Adverse Event|1|||
106135526|NCT00984282|366155978|FG000|Double Blind Treatment|Adverse Event|40|||
106135527|NCT00984282|366155979|FG001|Double Blind Treatment|Adverse Event|6|||
106135528|NCT00984282|366155978|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
105930626|NCT01131585|365404397|FG001|Overall Study|Study termination|32|||
105930627|NCT01968785|365404398|FG000|Overall Study|Withdrawal by Subject|1|||
105930628|NCT01968785|365404399|FG001|Overall Study|Withdrawal by Subject|0|||
105930629|NCT06038643|365404402|FG000|Overall Study|Withdrawal by Subject|9|||
105930630|NCT06038643|365404403|FG001|Overall Study|Withdrawal by Subject|4|||
105930631|NCT06038643|365404402|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
105930632|NCT06038643|365404403|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
105930633|NCT02939781|365404408|FG000|Overall Study|Protocol Violation|8|||
105930634|NCT02939781|365404408|FG000|Overall Study|Withdrawal by Subject|1|||
105930635|NCT01666314|365404409|FG000|Overall Study|Adverse Event|3|||
105930636|NCT01666314|365404410|FG001|Overall Study|Adverse Event|13|||
105930637|NCT01666314|365404411|FG002|Overall Study|Adverse Event|7|||
105930638|NCT01666314|365404412|FG003|Overall Study|Adverse Event|7|||
105930639|NCT01666314|365404409|FG000|Overall Study|Progressive Disease|11|||
105930640|NCT01666314|365404410|FG001|Overall Study|Progressive Disease|9|||
105930641|NCT01666314|365404411|FG002|Overall Study|Progressive Disease|19|||
105930642|NCT01666314|365404412|FG003|Overall Study|Progressive Disease|20|||
105930643|NCT01666314|365404409|FG000|Overall Study|Symptomatic Deterioration|1|||
105930644|NCT01666314|365404410|FG001|Overall Study|Symptomatic Deterioration|0|||
105930645|NCT01666314|365404411|FG002|Overall Study|Symptomatic Deterioration|2|||
105930646|NCT01666314|365404412|FG003|Overall Study|Symptomatic Deterioration|0|||
105930647|NCT01666314|365404409|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
105930648|NCT01666314|365404410|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
105930649|NCT01666314|365404411|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
105930650|NCT01666314|365404412|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
105930651|NCT01666314|365404409|FG000|Overall Study|Withdrawal by Subject|1|||
105930652|NCT01666314|365404410|FG001|Overall Study|Withdrawal by Subject|1|||
105930653|NCT01666314|365404411|FG002|Overall Study|Withdrawal by Subject|2|||
105930654|NCT01666314|365404412|FG003|Overall Study|Withdrawal by Subject|3|||
105930655|NCT01666314|365404409|FG000|Overall Study|Reason not Specified|10|||
105930656|NCT01666314|365404410|FG001|Overall Study|Reason not Specified|7|||
105930657|NCT01666314|365404411|FG002|Overall Study|Reason not Specified|5|||
105930658|NCT01666314|365404412|FG003|Overall Study|Reason not Specified|5|||
105930659|NCT00032487|365404413|FG000|Overall Study|Withdrawal by Subject|67|||
105930660|NCT00032487|365404414|FG001|Overall Study|Withdrawal by Subject|43|||
105930661|NCT00032487|365404413|FG000|Overall Study|Adverse Event|3|||
105930662|NCT00032487|365404414|FG001|Overall Study|Adverse Event|7|||
105930663|NCT00032487|365404413|FG000|Overall Study|Lost to Follow-up|57|||
105930664|NCT00032487|365404414|FG001|Overall Study|Lost to Follow-up|58|||
105930665|NCT00032487|365404413|FG000|Overall Study|Had other reason|12|||
105930666|NCT00032487|365404414|FG001|Overall Study|Had other reason|12|||
105930667|NCT01727154|365404416|FG000|Overall Study|Death|17|||
105930668|NCT01727154|365404416|FG000|Overall Study|Withdrawal by Subject|14|||
105930669|NCT01727154|365404416|FG000|Overall Study|Subject Withdrew Consent|18|||
105930670|NCT01727154|365404416|FG000|Overall Study|Study Terminated|6|||
105930671|NCT01727154|365404416|FG000|Overall Study|No Discontinuation Documentation|4|||
105930672|NCT02015104|365404417|FG000|Overall Study|Withdrew consent after first dose drug|1|||
105930673|NCT02015104|365404418|FG001|Overall Study|Withdrew consent after first dose drug|0|||
105930674|NCT02015104|365404417|FG000|Overall Study|Withdrew consent prior to treatment|0|||
105930675|NCT02015104|365404418|FG001|Overall Study|Withdrew consent prior to treatment|1|||
105930676|NCT03834883|365404419|FG000|Second Treatment|Withdrawal by Subject|1|||
105930677|NCT03834883|365404420|FG001|Second Treatment|Withdrawal by Subject|0|||
105930678|NCT03834883|365404421|FG002|Second Treatment|Withdrawal by Subject|0|||
105930679|NCT03834883|365404422|FG003|Second Treatment|Withdrawal by Subject|0|||
105930680|NCT03834883|365404419|FG000|Second Treatment|COVID-19 pandemic|1|||
105930681|NCT03834883|365404420|FG001|Second Treatment|COVID-19 pandemic|0|||
105930682|NCT03834883|365404421|FG002|Second Treatment|COVID-19 pandemic|1|||
105930683|NCT03834883|365404422|FG003|Second Treatment|COVID-19 pandemic|1|||
105930684|NCT05762744|365404423|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
105930685|NCT05762744|365404424|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
105930686|NCT05762744|365404423|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
106135529|NCT00984282|366155979|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
106135530|NCT00984282|366155978|FG000|Double Blind Treatment|Physician Decision|1|||
106135531|NCT00984282|366155979|FG001|Double Blind Treatment|Physician Decision|2|||
105930687|NCT05762744|365404424|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
105930688|NCT00441896|365404425|FG000|Overall Study|Withdrawal by Subject|0|||
105930689|NCT00441896|365404426|FG001|Overall Study|Withdrawal by Subject|0|||
105930690|NCT00441896|365404427|FG002|Overall Study|Withdrawal by Subject|0|||
105930691|NCT00441896|365404428|FG003|Overall Study|Withdrawal by Subject|1|||
105930692|NCT00441896|365404429|FG004|Overall Study|Withdrawal by Subject|0|||
105930693|NCT00441896|365404430|FG005|Overall Study|Withdrawal by Subject|0|||
105930694|NCT00441896|365404431|FG006|Overall Study|Withdrawal by Subject|0|||
105930695|NCT00441896|365404432|FG007|Overall Study|Withdrawal by Subject|0|||
105930696|NCT00441896|365404433|FG008|Overall Study|Withdrawal by Subject|0|||
105712932|NCT02268058|364607754|FG002|Overall Study|Protocol Violation|0|||
105712933|NCT02268058|364607755|FG003|Overall Study|Protocol Violation|0|||
105712934|NCT01903837|364607757|FG000|Part A|Withdrawal by Subject|4|||
105712935|NCT01903837|364607758|FG001|Part A|Withdrawal by Subject|9|||
105712936|NCT01903837|364607759|FG002|Part A|Withdrawal by Subject|8|||
105712937|NCT01903837|364607760|FG003|Part A|Withdrawal by Subject|5|||
105712938|NCT01903837|364607757|FG000|Part A|Adverse Event|3|||
105712939|NCT01903837|364607758|FG001|Part A|Adverse Event|6|||
105712940|NCT01903837|364607759|FG002|Part A|Adverse Event|9|||
105712941|NCT01903837|364607760|FG003|Part A|Adverse Event|6|||
105712942|NCT01903837|364607757|FG000|Part A|Lost to Follow-up|9|||
105712943|NCT01903837|364607758|FG001|Part A|Lost to Follow-up|7|||
105712944|NCT01903837|364607759|FG002|Part A|Lost to Follow-up|7|||
105712945|NCT01903837|364607760|FG003|Part A|Lost to Follow-up|2|||
105712946|NCT01903837|364607757|FG000|Part A|Non-compliance with study drug|1|||
105712947|NCT01903837|364607758|FG001|Part A|Non-compliance with study drug|4|||
105712948|NCT01903837|364607759|FG002|Part A|Non-compliance with study drug|4|||
105712949|NCT01903837|364607760|FG003|Part A|Non-compliance with study drug|0|||
105712950|NCT01903837|364607757|FG000|Part A|Physician Decision|1|||
105712951|NCT01903837|364607758|FG001|Part A|Physician Decision|1|||
105712952|NCT01903837|364607759|FG002|Part A|Physician Decision|0|||
105712953|NCT01903837|364607760|FG003|Part A|Physician Decision|0|||
105712954|NCT01903837|364607757|FG000|Part A|Protocol Violation|1|||
105712955|NCT01903837|364607758|FG001|Part A|Protocol Violation|1|||
105712956|NCT01903837|364607759|FG002|Part A|Protocol Violation|0|||
105712957|NCT01903837|364607760|FG003|Part A|Protocol Violation|0|||
105712958|NCT01903837|364607757|FG000|Part B|Lost to Follow-up|0|||
105712959|NCT01903837|364607758|FG001|Part B|Lost to Follow-up|3|||
105712960|NCT01903837|364607759|FG002|Part B|Lost to Follow-up|3|||
105712961|NCT01903837|364607760|FG003|Part B|Lost to Follow-up|4|||
105712962|NCT01903837|364607757|FG000|Part B|Withdrawal by Subject|1|||
105712963|NCT01903837|364607758|FG001|Part B|Withdrawal by Subject|2|||
105712964|NCT01903837|364607759|FG002|Part B|Withdrawal by Subject|0|||
105712965|NCT01903837|364607760|FG003|Part B|Withdrawal by Subject|3|||
105712966|NCT01903837|364607757|FG000|Part B|Adverse Event|3|||
105712967|NCT01903837|364607758|FG001|Part B|Adverse Event|0|||
105712968|NCT01903837|364607759|FG002|Part B|Adverse Event|2|||
105712969|NCT01903837|364607760|FG003|Part B|Adverse Event|0|||
105712970|NCT01903837|364607757|FG000|Part B|Non-compliance with study drug|2|||
105712971|NCT01903837|364607758|FG001|Part B|Non-compliance with study drug|0|||
105712972|NCT01903837|364607759|FG002|Part B|Non-compliance with study drug|0|||
105712973|NCT01903837|364607760|FG003|Part B|Non-compliance with study drug|1|||
105712974|NCT01903837|364607757|FG000|Part B|Incarceration|2|||
105712975|NCT01903837|364607758|FG001|Part B|Incarceration|0|||
105712976|NCT01903837|364607759|FG002|Part B|Incarceration|0|||
105712977|NCT01903837|364607760|FG003|Part B|Incarceration|1|||
105712978|NCT01903837|364607757|FG000|Part B|Physician Decision|1|||
105712979|NCT01903837|364607758|FG001|Part B|Physician Decision|0|||
105712980|NCT01903837|364607759|FG002|Part B|Physician Decision|0|||
105712981|NCT01903837|364607760|FG003|Part B|Physician Decision|2|||
105712982|NCT01903837|364607757|FG000|Part B|Lack of Efficacy|0|||
105712983|NCT01903837|364607758|FG001|Part B|Lack of Efficacy|1|||
105712984|NCT01903837|364607759|FG002|Part B|Lack of Efficacy|0|||
105712985|NCT01903837|364607760|FG003|Part B|Lack of Efficacy|0|||
105712986|NCT05048342|364607761|FG000|Overall Study|Adverse Event|1|||
105712987|NCT05048342|364607761|FG000|Overall Study|Subject decision|2|||
105712988|NCT01441063|364607762|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
105712989|NCT01441063|364607762|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
105712990|NCT02623335|364607764|FG000|Overall Study|Death|8|||
105712991|NCT02623335|364607765|FG001|Overall Study|Death|7|||
105712992|NCT02623335|364607764|FG000|Overall Study|Lost to Follow-up|15|||
105712993|NCT02623335|364607765|FG001|Overall Study|Lost to Follow-up|23|||
105712994|NCT02623335|364607764|FG000|Overall Study|Withdrawal by Subject|2|||
105712995|NCT02623335|364607765|FG001|Overall Study|Withdrawal by Subject|5|||
105712996|NCT02623335|364607764|FG000|Overall Study|Protocol Violation|2|||
105712997|NCT02623335|364607765|FG001|Overall Study|Protocol Violation|1|||
105712998|NCT00430508|364607774|FG000|Overall Study|Adverse Event|2|||
105712999|NCT00430508|364607775|FG001|Overall Study|Adverse Event|3|||
105713000|NCT00430508|364607776|FG002|Overall Study|Adverse Event|5|||
105713001|NCT00430508|364607777|FG003|Overall Study|Adverse Event|3|||
105713002|NCT00430508|364607774|FG000|Overall Study|Withdrawal by Subject|0|||
105713003|NCT00430508|364607775|FG001|Overall Study|Withdrawal by Subject|1|||
105713004|NCT00430508|364607776|FG002|Overall Study|Withdrawal by Subject|1|||
105713005|NCT00430508|364607777|FG003|Overall Study|Withdrawal by Subject|1|||
105713006|NCT00430508|364607774|FG000|Overall Study|responder at visit 4|0|||
105713007|NCT00430508|364607775|FG001|Overall Study|responder at visit 4|0|||
105713008|NCT00430508|364607776|FG002|Overall Study|responder at visit 4|2|||
105713009|NCT00430508|364607777|FG003|Overall Study|responder at visit 4|0|||
105713010|NCT00430508|364607774|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
105713011|NCT00430508|364607775|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
105713012|NCT00430508|364607776|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
105713013|NCT00430508|364607777|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
105713014|NCT00430508|364607774|FG000|Overall Study|Other|1|||
105713015|NCT00430508|364607775|FG001|Overall Study|Other|1|||
105713016|NCT00430508|364607776|FG002|Overall Study|Other|3|||
105713017|NCT00430508|364607777|FG003|Overall Study|Other|0|||
105713018|NCT00999908|364607778|FG000|Treatment Period 1|Subject withdrew consent|2|||
105713019|NCT00999908|364607779|FG001|Treatment Period 1|Subject withdrew consent|0|||
105713020|NCT00999908|364607780|FG002|Treatment Period 1|Subject withdrew consent|0|||
105713021|NCT00999908|364607778|FG000|Treatment Period 2|Protocol Violation|1|||
105713022|NCT00999908|364607779|FG001|Treatment Period 2|Protocol Violation|0|||
105713023|NCT00999908|364607780|FG002|Treatment Period 2|Protocol Violation|0|||
105713024|NCT02809833|364607784|FG000|Overall Study|Death|3|||
105713025|NCT02809833|364607784|FG000|Overall Study|Intolerance|54|||
105713026|NCT02809833|364607784|FG000|Overall Study|Lack of Efficacy|89|||
105713027|NCT02809833|364607784|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
105713028|NCT02809833|364607784|FG000|Overall Study|Noncompliance|1|||
105713029|NCT02809833|364607784|FG000|Overall Study|Withdrawal by Subject|34|||
105713030|NCT02809833|364607784|FG000|Overall Study|Lost to Follow-up|35|||
105713031|NCT02809833|364607784|FG000|Overall Study|Adverse Event (AE)|24|||
105713032|NCT02809833|364607784|FG000|Overall Study|Other|5|||
105713033|NCT02809833|364607784|FG000|Overall Study|Missing Information|52|||
105713034|NCT03261531|364607785|FG000|Overall Study|Withdrawal by Subject|4|||
105713035|NCT00927095|364607786|FG000|Overall Study|Adverse Event|3|||
105713036|NCT00927095|364607787|FG001|Overall Study|Adverse Event|1|||
105713037|NCT00927095|364607788|FG002|Overall Study|Adverse Event|0|||
105713038|NCT00927095|364607786|FG000|Overall Study|Withdrawal by Subject|2|||
105930697|NCT00441896|365404434|FG009|Overall Study|Withdrawal by Subject|0|||
105930698|NCT00441896|365404425|FG000|Overall Study|Other|0|||
105930699|NCT00441896|365404426|FG001|Overall Study|Other|0|||
105930700|NCT00441896|365404427|FG002|Overall Study|Other|0|||
105930701|NCT00441896|365404428|FG003|Overall Study|Other|0|||
105930702|NCT00441896|365404429|FG004|Overall Study|Other|1|||
105930703|NCT00441896|365404430|FG005|Overall Study|Other|0|||
105930704|NCT00441896|365404431|FG006|Overall Study|Other|0|||
105930705|NCT00441896|365404432|FG007|Overall Study|Other|0|||
105930706|NCT00441896|365404433|FG008|Overall Study|Other|0|||
105930707|NCT00441896|365404434|FG009|Overall Study|Other|0|||
105930708|NCT02487199|365404435|FG000|Overall Study|Withdrew Consent|0|||
105930709|NCT02487199|365404436|FG001|Overall Study|Withdrew Consent|1|||
105930710|NCT00182637|365405767|FG000|Overall Study|Adverse Event|2|||
105930711|NCT00182637|365405767|FG000|Overall Study|Disease Progression|1|||
105930712|NCT01565694|365405768|FG000|Dose-Titration Period|Adverse Event|4|||
105930713|NCT01565694|365405768|FG000|Dose-Titration Period|Protocol Violation|10|||
105930714|NCT01565694|365405768|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
105930715|NCT05417113|365405770|FG000|Overall Study|Lost to Follow-up|2|||
105930716|NCT05417113|365405771|FG001|Overall Study|Lost to Follow-up|2|||
105930717|NCT01022580|365405772|FG000|Overall Study|Death|18|||
105930718|NCT01022580|365405773|FG001|Overall Study|Death|22|||
105930719|NCT00884949|365405774|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
105930720|NCT00884949|365405774|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
105930721|NCT00327171|365405777|FG000|Overall Study|Did not receive study medication|3|||
105930722|NCT00327171|365405778|FG001|Overall Study|Did not receive study medication|0|||
105930723|NCT00327171|365405777|FG000|Overall Study|Adverse Event|23|||
105930724|NCT00327171|365405778|FG001|Overall Study|Adverse Event|23|||
105930725|NCT00327171|365405777|FG000|Overall Study|Disease progression/lack of efficacy|68|||
105930726|NCT00327171|365405778|FG001|Overall Study|Disease progression/lack of efficacy|69|||
105930727|NCT00327171|365405777|FG000|Overall Study|Investigator/participant request|1|||
105930728|NCT00327171|365405778|FG001|Overall Study|Investigator/participant request|8|||
105930729|NCT00327171|365405777|FG000|Overall Study|Clinical progression|12|||
105930730|NCT00327171|365405778|FG001|Overall Study|Clinical progression|8|||
105930731|NCT00327171|365405777|FG000|Overall Study|Undisclosed history of ischemia|0|||
105930732|NCT00327171|365405778|FG001|Overall Study|Undisclosed history of ischemia|1|||
105930733|NCT00327171|365405777|FG000|Overall Study|Other|1|||
105930734|NCT00327171|365405778|FG001|Overall Study|Other|0|||
105713039|NCT00927095|364607787|FG001|Overall Study|Withdrawal by Subject|1|||
105713040|NCT00927095|364607788|FG002|Overall Study|Withdrawal by Subject|1|||
105713041|NCT00927095|364607786|FG000|Overall Study|Physician Decision|1|||
105713042|NCT00927095|364607787|FG001|Overall Study|Physician Decision|2|||
105713043|NCT00927095|364607788|FG002|Overall Study|Physician Decision|1|||
105930735|NCT01363440|365405781|FG000|Overall Study|Adverse Event|5|||
105930736|NCT01363440|365405782|FG001|Overall Study|Adverse Event|4|||
105930737|NCT01363440|365405783|FG002|Overall Study|Adverse Event|4|||
105930738|NCT01363440|365405781|FG000|Overall Study|Death|3|||
105930739|NCT01363440|365405782|FG001|Overall Study|Death|7|||
106135532|NCT00984282|366155978|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
105713044|NCT02556255|364607789|FG000|Overall Study|Lost to Follow-up|4|||
105713045|NCT00744874|364607790|FG000|Overall Study|Lost to Follow-up|1|||
105713046|NCT00744874|364607790|FG000|Overall Study|Withdrawal by Subject|1|||
105713047|NCT00744874|364607790|FG000|Overall Study|Study Device not available at procedure|1|||
105713048|NCT00744874|364607790|FG000|Overall Study|Unable to accomodate schedule|1|||
105713049|NCT01834729|364607798|FG000|Overall Study|Did not return bowel diaries|0|||
105713050|NCT01834729|364607799|FG001|Overall Study|Did not return bowel diaries|0|||
105713051|NCT01834729|364607800|FG002|Overall Study|Did not return bowel diaries|3|||
105713052|NCT01834729|364607801|FG003|Overall Study|Did not return bowel diaries|0|||
105713053|NCT01834729|364607798|FG000|Overall Study|Withdrawal by Subject|1|||
105713054|NCT01834729|364607799|FG001|Overall Study|Withdrawal by Subject|1|||
105713055|NCT01834729|364607800|FG002|Overall Study|Withdrawal by Subject|0|||
105713056|NCT01834729|364607801|FG003|Overall Study|Withdrawal by Subject|0|||
105713057|NCT01834729|364607798|FG000|Overall Study|Adverse Event|0|||
105713058|NCT01834729|364607799|FG001|Overall Study|Adverse Event|0|||
105713059|NCT01834729|364607800|FG002|Overall Study|Adverse Event|0|||
105713060|NCT01834729|364607801|FG003|Overall Study|Adverse Event|2|||
105713061|NCT01127165|364607802|FG000|Overall Study|Adverse Event|2|||
105713062|NCT01127165|364607803|FG001|Overall Study|Adverse Event|2|||
105713063|NCT01127165|364607802|FG000|Overall Study|Lack of Efficacy|10|||
105713064|NCT01127165|364607803|FG001|Overall Study|Lack of Efficacy|8|||
105713065|NCT01127165|364607802|FG000|Overall Study|Lost to Follow-up|3|||
105713066|NCT01127165|364607803|FG001|Overall Study|Lost to Follow-up|5|||
105713067|NCT01127165|364607802|FG000|Overall Study|Withdrawal by Subject|1|||
105713068|NCT01127165|364607803|FG001|Overall Study|Withdrawal by Subject|3|||
105713069|NCT01127165|364607802|FG000|Overall Study|Protocol Violation|0|||
105713070|NCT01127165|364607803|FG001|Overall Study|Protocol Violation|1|||
105713071|NCT00379795|364607804|FG000|Overall Study|Death|31|||
105713072|NCT00379795|364607805|FG001|Overall Study|Death|8|||
105713073|NCT00379795|364607806|FG002|Overall Study|Death|6|||
105713074|NCT00379795|364607807|FG003|Overall Study|Death|4|||
105713075|NCT00379795|364607808|FG004|Overall Study|Death|7|||
105713076|NCT00379795|364607804|FG000|Overall Study|Adverse Event|17|||
105713077|NCT00379795|364607805|FG001|Overall Study|Adverse Event|3|||
105713078|NCT00379795|364607806|FG002|Overall Study|Adverse Event|3|||
105713079|NCT00379795|364607807|FG003|Overall Study|Adverse Event|1|||
105713080|NCT00379795|364607808|FG004|Overall Study|Adverse Event|4|||
105713081|NCT00379795|364607804|FG000|Overall Study|Lost to Follow-up|8|||
105713082|NCT00379795|364607805|FG001|Overall Study|Lost to Follow-up|1|||
105713083|NCT00379795|364607806|FG002|Overall Study|Lost to Follow-up|2|||
105713084|NCT00379795|364607807|FG003|Overall Study|Lost to Follow-up|1|||
105713085|NCT00379795|364607808|FG004|Overall Study|Lost to Follow-up|4|||
105713086|NCT00379795|364607804|FG000|Overall Study|Physician Decision|25|||
105713087|NCT00379795|364607805|FG001|Overall Study|Physician Decision|0|||
105713088|NCT00379795|364607806|FG002|Overall Study|Physician Decision|2|||
105713089|NCT00379795|364607807|FG003|Overall Study|Physician Decision|2|||
105713090|NCT00379795|364607808|FG004|Overall Study|Physician Decision|2|||
105713091|NCT00379795|364607804|FG000|Overall Study|Withdrawal by Subject|94|||
105713092|NCT00379795|364607805|FG001|Overall Study|Withdrawal by Subject|11|||
105713093|NCT00379795|364607806|FG002|Overall Study|Withdrawal by Subject|19|||
105713094|NCT00379795|364607807|FG003|Overall Study|Withdrawal by Subject|7|||
105713095|NCT00379795|364607808|FG004|Overall Study|Withdrawal by Subject|14|||
105713096|NCT00379795|364607804|FG000|Overall Study|Subject non-compliance|7|||
105713097|NCT00379795|364607805|FG001|Overall Study|Subject non-compliance|2|||
105713098|NCT00379795|364607806|FG002|Overall Study|Subject non-compliance|0|||
105713099|NCT00379795|364607807|FG003|Overall Study|Subject non-compliance|0|||
105713100|NCT00379795|364607808|FG004|Overall Study|Subject non-compliance|1|||
105713101|NCT00379795|364607804|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
105713102|NCT00379795|364607805|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
105713103|NCT00379795|364607806|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
105713104|NCT00379795|364607807|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
105713105|NCT00379795|364607808|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
105713106|NCT00379795|364607804|FG000|Overall Study|Subjects condition mandated intervention|34|||
105713107|NCT00379795|364607805|FG001|Overall Study|Subjects condition mandated intervention|9|||
105713108|NCT00379795|364607806|FG002|Overall Study|Subjects condition mandated intervention|7|||
105713109|NCT00379795|364607807|FG003|Overall Study|Subjects condition mandated intervention|5|||
105713110|NCT00379795|364607808|FG004|Overall Study|Subjects condition mandated intervention|7|||
105713111|NCT00379795|364607804|FG000|Overall Study|Sponsor's decision|257|||
105713112|NCT00379795|364607805|FG001|Overall Study|Sponsor's decision|17|||
105713113|NCT00379795|364607806|FG002|Overall Study|Sponsor's decision|54|||
105713114|NCT00379795|364607807|FG003|Overall Study|Sponsor's decision|47|||
105713115|NCT00379795|364607808|FG004|Overall Study|Sponsor's decision|10|||
105713116|NCT00725075|364607809|FG000|Overall Study|Use of Excluded Medication|0|||
105713117|NCT00725075|364607810|FG001|Overall Study|Use of Excluded Medication|1|||
105713118|NCT00725075|364607811|FG002|Overall Study|Use of Excluded Medication|0|||
106135533|NCT00984282|366155979|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
106135534|NCT00984282|366155978|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
106135535|NCT00984282|366155979|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
106135536|NCT00984282|366155978|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
106135537|NCT00984282|366155979|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
106135538|NCT00984282|366155978|FG000|Double Blind Treatment|Lost to Follow-up|3|||
106135539|NCT00984282|366155979|FG001|Double Blind Treatment|Lost to Follow-up|0|||
106135540|NCT00984282|366155978|FG000|Double Blind Treatment|Death|8|||
106135541|NCT00984282|366155979|FG001|Double Blind Treatment|Death|4|||
106135542|NCT00984282|366155978|FG000|Double Blind Treatment|Not treated|0|||
106135543|NCT00984282|366155979|FG001|Double Blind Treatment|Not treated|1|||
106135544|NCT00984282|366155978|FG000|Double Blind Treatment|Switched to commercial drug|6|||
106135545|NCT00984282|366155979|FG001|Double Blind Treatment|Switched to commercial drug|1|||
106135546|NCT00984282|366155978|FG000|Double Blind Treatment|protocol driven decision point|1|||
106135547|NCT00984282|366155979|FG001|Double Blind Treatment|protocol driven decision point|1|||
106135548|NCT00984282|366155978|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
106135549|NCT00984282|366155979|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
106135550|NCT00984282|366155978|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
106135551|NCT00984282|366155979|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
106135552|NCT00984282|366155978|FG000|Open-label Treatment|Adverse Event|20|||
106135553|NCT00984282|366155979|FG001|Open-label Treatment|Adverse Event|30|||
106135554|NCT00984282|366155978|FG000|Open-label Treatment|Withdrawal by Subject|6|||
106135555|NCT00984282|366155979|FG001|Open-label Treatment|Withdrawal by Subject|21|||
106135556|NCT00984282|366155978|FG000|Open-label Treatment|Death|7|||
106135557|NCT00984282|366155979|FG001|Open-label Treatment|Death|15|||
106135558|NCT00984282|366155978|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
106135559|NCT00984282|366155979|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
106135560|NCT00984282|366155978|FG000|Open-label Treatment|Lost to Follow-up|1|||
106135561|NCT00984282|366155979|FG001|Open-label Treatment|Lost to Follow-up|1|||
106135562|NCT00984282|366155978|FG000|Open-label Treatment|Patient convenience|1|||
106135563|NCT00984282|366155979|FG001|Open-label Treatment|Patient convenience|0|||
106135564|NCT00984282|366155978|FG000|Open-label Treatment|Non-compliant with study medication|1|||
106135565|NCT00984282|366155979|FG001|Open-label Treatment|Non-compliant with study medication|0|||
106135566|NCT00984282|366155978|FG000|Open-label Treatment|Target lesion removed|0|||
106135567|NCT00984282|366155979|FG001|Open-label Treatment|Target lesion removed|1|||
106135568|NCT00984282|366155978|FG000|Open-label Treatment|Protocol driven decision point|1|||
106135569|NCT00984282|366155979|FG001|Open-label Treatment|Protocol driven decision point|1|||
106135570|NCT00984282|366155978|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
106135571|NCT00984282|366155979|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
106135572|NCT00984282|366155978|FG000|Open-label Treatment|Switched to commercial drug|6|||
106135573|NCT00984282|366155979|FG001|Open-label Treatment|Switched to commercial drug|7|||
106135574|NCT00984282|366155978|FG000|Open-label Treatment|Physician Decision|1|||
106135575|NCT00984282|366155979|FG001|Open-label Treatment|Physician Decision|0|||
106135576|NCT00984282|366155978|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
106135577|NCT00984282|366155979|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
106135578|NCT00984282|366155978|FG000|Long Term Follow-up|Death|27|||
106135579|NCT00984282|366155979|FG001|Long Term Follow-up|Death|68|||
106135580|NCT00984282|366155978|FG000|Long Term Follow-up|Lost to Follow-up|3|||
106135581|NCT00984282|366155979|FG001|Long Term Follow-up|Lost to Follow-up|6|||
106135582|NCT00984282|366155978|FG000|Long Term Follow-up|Protocol driven decision point|25|||
106135583|NCT00984282|366155979|FG001|Long Term Follow-up|Protocol driven decision point|26|||
106135584|NCT00984282|366155978|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
106135585|NCT00984282|366155979|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
106135586|NCT00984282|366155978|FG000|Long Term Follow-up|Switched to commercial drug|4|||
106135587|NCT00984282|366155979|FG001|Long Term Follow-up|Switched to commercial drug|2|||
106135588|NCT00984282|366155978|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
106135589|NCT00984282|366155979|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
106135590|NCT02223793|366155980|FG000|Overall Study|Lost to Follow-up|10|||
106135591|NCT02223793|366155981|FG001|Overall Study|Lost to Follow-up|1|||
106135592|NCT02223793|366155982|FG002|Overall Study|Lost to Follow-up|2|||
106135593|NCT02223793|366155980|FG000|Overall Study|Withdrawal by Subject|3|||
106135594|NCT02223793|366155981|FG001|Overall Study|Withdrawal by Subject|2|||
106135595|NCT02223793|366155982|FG002|Overall Study|Withdrawal by Subject|3|||
106135596|NCT02223793|366155980|FG000|Overall Study|Moved/studycenter unable to participate|4|||
106135597|NCT02223793|366155981|FG001|Overall Study|Moved/studycenter unable to participate|6|||
106135598|NCT02223793|366155982|FG002|Overall Study|Moved/studycenter unable to participate|8|||
106135599|NCT00151996|366155983|FG000|Overall Study|Adverse Event|3|||
106135600|NCT00151996|366155984|FG001|Overall Study|Adverse Event|2|||
106135601|NCT00151996|366155983|FG000|Overall Study|Withdrawal by Subject|1|||
106135602|NCT00151996|366155984|FG001|Overall Study|Withdrawal by Subject|1|||
106135603|NCT00151996|366155983|FG000|Overall Study|Protocol Violation|1|||
106135604|NCT00151996|366155984|FG001|Overall Study|Protocol Violation|2|||
106135605|NCT00151996|366155983|FG000|Overall Study|Sponsor's decision|0|||
106135606|NCT00151996|366155984|FG001|Overall Study|Sponsor's decision|2|||
106135607|NCT00315055|366155986|FG000|Overall Study|Protocol Violation|2|||
106135608|NCT00315055|366155987|FG001|Overall Study|Protocol Violation|4|||
106135609|NCT00315055|366155986|FG000|Overall Study|Lost to Follow-up|1|||
106135610|NCT00315055|366155987|FG001|Overall Study|Lost to Follow-up|1|||
106135611|NCT02359435|366155988|FG000|Overall Study|Lost to Follow-up|4|||
106135612|NCT02359435|366155989|FG001|Overall Study|Lost to Follow-up|4|||
106135613|NCT01704846|366155993|FG000|Treatment Period 2|Withdrawal by Subject|0|||
106135614|NCT01704846|366155994|FG001|Treatment Period 2|Withdrawal by Subject|1|||
106135615|NCT00530335|366155995|FG000|Overall Study|Adverse Event|3|||
106135616|NCT00530335|366155995|FG000|Overall Study|Protocol Violation|1|||
106135617|NCT00530335|366155995|FG000|Overall Study|Withdrawal by Subject|1|||
106135618|NCT00530335|366155995|FG000|Overall Study|Physician Decision|1|||
106135619|NCT01649791|366155996|FG000|Overall Study|Disease Progression|2|||
106135620|NCT01649791|366155996|FG000|Overall Study|Adverse Event|1|||
106135621|NCT04577183|366155997|FG000|Overall Study|Death|1|||
106135622|NCT04577183|366155997|FG000|Overall Study|Withdrawal by Subject|3|||
106135623|NCT04577183|366155997|FG000|Overall Study|Early termination|2|||
106135624|NCT01168401|366155998|FG000|Overall Study|Lost to Follow-up|1|||
106135625|NCT01168401|366155999|FG001|Overall Study|Lost to Follow-up|1|||
106135626|NCT01168401|366156000|FG002|Overall Study|Lost to Follow-up|2|||
106135627|NCT01168401|366156001|FG003|Overall Study|Lost to Follow-up|1|||
106135628|NCT01168401|366156002|FG004|Overall Study|Lost to Follow-up|0|||
106135629|NCT01168401|366156003|FG005|Overall Study|Lost to Follow-up|0|||
106135630|NCT01168401|366156004|FG006|Overall Study|Lost to Follow-up|0|||
106135631|NCT01168401|366156005|FG007|Overall Study|Lost to Follow-up|0|||
105713119|NCT00725075|364607809|FG000|Overall Study|Protocol Violation|0|||
105713120|NCT00725075|364607810|FG001|Overall Study|Protocol Violation|0|||
105713121|NCT00725075|364607811|FG002|Overall Study|Protocol Violation|1|||
105713122|NCT00725075|364607809|FG000|Overall Study|Lost to Follow-up|1|||
105713123|NCT00725075|364607810|FG001|Overall Study|Lost to Follow-up|0|||
105713124|NCT00725075|364607811|FG002|Overall Study|Lost to Follow-up|0|||
105713125|NCT00725075|364607809|FG000|Overall Study|Withdrawal by Subject|4|||
105713126|NCT00725075|364607810|FG001|Overall Study|Withdrawal by Subject|5|||
105713127|NCT00725075|364607811|FG002|Overall Study|Withdrawal by Subject|4|||
105713128|NCT00725075|364607809|FG000|Overall Study|Adverse Event|2|||
105713129|NCT00725075|364607810|FG001|Overall Study|Adverse Event|1|||
105713130|NCT00725075|364607811|FG002|Overall Study|Adverse Event|1|||
105713131|NCT00725075|364607809|FG000|Overall Study|Worsening of Disease|2|||
105713132|NCT00725075|364607810|FG001|Overall Study|Worsening of Disease|1|||
105713133|NCT00725075|364607811|FG002|Overall Study|Worsening of Disease|2|||
105713134|NCT00725075|364607809|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
105713135|NCT00725075|364607810|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
105713136|NCT00725075|364607811|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
105713137|NCT00725075|364607809|FG000|Overall Study|Other|1|||
105713138|NCT00725075|364607810|FG001|Overall Study|Other|0|||
105713139|NCT00725075|364607811|FG002|Overall Study|Other|0|||
105713140|NCT02340663|364607812|FG000|Overall Study|Lost to Follow-up|1|||
105713141|NCT02340663|364607813|FG001|Overall Study|Lost to Follow-up|0|||
105713142|NCT02340663|364607812|FG000|Overall Study|Protocol Violation|1|||
105713143|NCT02340663|364607813|FG001|Overall Study|Protocol Violation|0|||
105713144|NCT02340663|364607812|FG000|Overall Study|Withdrawal by Subject|3|||
105713145|NCT02340663|364607813|FG001|Overall Study|Withdrawal by Subject|1|||
105713146|NCT00352105|364607814|FG000|Overall Study|Death|5|||
105713147|NCT00352105|364607814|FG000|Overall Study|Withdrawal by Subject|5|||
105713148|NCT00352105|364607814|FG000|Overall Study|Lack of Efficacy|9|||
105713149|NCT00352105|364607814|FG000|Overall Study|Adverse Event|19|||
106135632|NCT01168401|366156006|FG008|Overall Study|Lost to Follow-up|0|||
106135633|NCT01168401|366156007|FG009|Overall Study|Lost to Follow-up|0|||
105713150|NCT00352105|364607814|FG000|Overall Study|Protocol Violation|2|||
105713151|NCT02004873|364607817|FG000|Overall Study|Implant unsuccessful|6|||
105713152|NCT02004873|364607817|FG000|Overall Study|Awaiting 6-month visit|390|||
105713153|NCT02004873|364607817|FG000|Overall Study|Missed 6-month visit|4|||
105713154|NCT02004873|364607817|FG000|Overall Study|Death|23|||
105713155|NCT02004873|364607817|FG000|Overall Study|Withdrawal by Subject|1|||
105713156|NCT00044512|364607818|FG000|Follow Up|Lost to Follow-up|2|||
106135634|NCT01168401|366156008|FG010|Overall Study|Lost to Follow-up|0|||
106135635|NCT01168401|366155998|FG000|Overall Study|Withdrawal by Subject|0|||
106135636|NCT01168401|366155999|FG001|Overall Study|Withdrawal by Subject|0|||
106135637|NCT01168401|366156000|FG002|Overall Study|Withdrawal by Subject|0|||
106135638|NCT01168401|366156001|FG003|Overall Study|Withdrawal by Subject|1|||
105713157|NCT01614093|364607826|FG000|Overall Study|Withdrawal by Subject|1|||
106135639|NCT01168401|366156002|FG004|Overall Study|Withdrawal by Subject|0|||
106135640|NCT01168401|366156003|FG005|Overall Study|Withdrawal by Subject|0|||
105930740|NCT01363440|365405783|FG002|Overall Study|Death|5|||
105930741|NCT01363440|365405781|FG000|Overall Study|Withdrawal by Subject|9|||
105930742|NCT01363440|365405782|FG001|Overall Study|Withdrawal by Subject|11|||
105930743|NCT01363440|365405783|FG002|Overall Study|Withdrawal by Subject|11|||
105930744|NCT01363440|365405781|FG000|Overall Study|Lost to Follow-up|2|||
105930745|NCT01363440|365405782|FG001|Overall Study|Lost to Follow-up|4|||
105930746|NCT01363440|365405783|FG002|Overall Study|Lost to Follow-up|5|||
105930747|NCT01363440|365405781|FG000|Overall Study|Other|4|||
105930748|NCT01363440|365405782|FG001|Overall Study|Other|5|||
105930749|NCT01363440|365405783|FG002|Overall Study|Other|2|||
105930750|NCT00266812|365405784|FG000|Overall Study|Disease Progression|9|||
105713158|NCT01816243|364607827|FG000|Overall Study|Adverse Event|6|||
105930751|NCT00266812|365405785|FG001|Overall Study|Disease Progression|3|||
105930752|NCT00266812|365405784|FG000|Overall Study|Death|5|||
105930753|NCT00266812|365405785|FG001|Overall Study|Death|4|||
105930754|NCT00266812|365405784|FG000|Overall Study|Adverse Event|3|||
105930755|NCT00266812|365405785|FG001|Overall Study|Adverse Event|1|||
105930756|NCT00266812|365405784|FG000|Overall Study|Protocol Violation|0|||
105930757|NCT00266812|365405785|FG001|Overall Study|Protocol Violation|1|||
105930758|NCT00266812|365405784|FG000|Overall Study|Withdrawal by Subject|0|||
105930759|NCT00266812|365405785|FG001|Overall Study|Withdrawal by Subject|2|||
105930760|NCT00266812|365405784|FG000|Overall Study|Discontinued before starting study drug|4|||
105930761|NCT00266812|365405785|FG001|Overall Study|Discontinued before starting study drug|0|||
105930762|NCT01166945|365405786|FG000|Randomized|diagnosed with Group A strep|4|||
105930763|NCT01166945|365405787|FG001|Randomized|diagnosed with Group A strep|4|||
105930764|NCT01166945|365405786|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
105930765|NCT01166945|365405787|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
105930766|NCT01166945|365405786|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
105930767|NCT01166945|365405787|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
105930768|NCT01166945|365405786|FG000|Day 30|Lost to Follow-up|4|||
105930769|NCT01166945|365405787|FG001|Day 30|Lost to Follow-up|3|||
105930770|NCT02636283|365405788|FG000|Overall Study|Adverse Event|2|||
105930771|NCT02636283|365405789|FG001|Overall Study|Adverse Event|0|||
105930772|NCT02636283|365405788|FG000|Overall Study|Trial Terminated Prematurely|0|||
105930773|NCT02636283|365405789|FG001|Overall Study|Trial Terminated Prematurely|3|||
105930774|NCT03422718|365405790|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
105930775|NCT03422718|365405791|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
105930776|NCT03422718|365405792|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
105930777|NCT03422718|365405793|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
105930778|NCT03422718|365405794|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
105930779|NCT03422718|365405795|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
105930780|NCT03422718|365405796|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
105930781|NCT03422718|365405797|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
105930782|NCT03422718|365405790|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
105930783|NCT03422718|365405791|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
105930784|NCT03422718|365405792|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
105930785|NCT03422718|365405793|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
105930786|NCT03422718|365405794|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
105930787|NCT03422718|365405795|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
105930788|NCT03422718|365405796|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
105930789|NCT03422718|365405797|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
105930790|NCT03422718|365405790|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
105713159|NCT01816243|364607827|FG000|Overall Study|Lost to Follow-up|1|||
105713160|NCT01816243|364607827|FG000|Overall Study|Lack of Efficacy|1|||
105713161|NCT01816243|364607827|FG000|Overall Study|Not eligible for the study|1|||
105713162|NCT01816243|364607827|FG000|Overall Study|Amputation|3|||
105713163|NCT03891901|364607828|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
105713164|NCT03891901|364607829|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713165|NCT03891901|364607830|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713166|NCT03891901|364607831|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713167|NCT03891901|364607832|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713168|NCT03891901|364607833|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713169|NCT03891901|364607834|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713170|NCT03891901|364607835|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713171|NCT03891901|364607836|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
105713172|NCT03891901|364607828|FG000|Overall Study|Adverse Event|2|||
105713173|NCT03891901|364607829|FG001|Overall Study|Adverse Event|2|||
105930791|NCT03422718|365405791|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
106135641|NCT01168401|366156004|FG006|Overall Study|Withdrawal by Subject|0|||
105713174|NCT03891901|364607830|FG002|Overall Study|Adverse Event|0|||
105713175|NCT03891901|364607831|FG003|Overall Study|Adverse Event|0|||
105952105|NCT03314935|365488186|FG002|Phase 1|"Captured as Other in Database"|0|||
105713176|NCT03891901|364607832|FG004|Overall Study|Adverse Event|0|||
105713177|NCT03891901|364607833|FG005|Overall Study|Adverse Event|0|||
105713178|NCT03891901|364607834|FG006|Overall Study|Adverse Event|0|||
105713179|NCT03891901|364607835|FG007|Overall Study|Adverse Event|0|||
105713180|NCT03891901|364607836|FG008|Overall Study|Adverse Event|0|||
105713181|NCT03891901|364607828|FG000|Overall Study|Poor venous access|1|||
105713182|NCT03891901|364607829|FG001|Overall Study|Poor venous access|0|||
105713183|NCT03891901|364607830|FG002|Overall Study|Poor venous access|0|||
105713184|NCT03891901|364607831|FG003|Overall Study|Poor venous access|0|||
105713185|NCT03891901|364607832|FG004|Overall Study|Poor venous access|0|||
105713186|NCT03891901|364607833|FG005|Overall Study|Poor venous access|0|||
105713187|NCT03891901|364607834|FG006|Overall Study|Poor venous access|0|||
105713188|NCT03891901|364607835|FG007|Overall Study|Poor venous access|0|||
105930792|NCT03422718|365405792|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
105930793|NCT03422718|365405793|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
105930794|NCT03422718|365405794|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
105930795|NCT03422718|365405795|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
105930796|NCT03422718|365405796|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
105930797|NCT03422718|365405797|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
105930798|NCT03422718|365405790|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105930799|NCT03422718|365405791|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
105930800|NCT03422718|365405792|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105930801|NCT03422718|365405793|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105930802|NCT03422718|365405794|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
105930803|NCT03422718|365405795|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
105930804|NCT03422718|365405796|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105930805|NCT03422718|365405797|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
105930806|NCT03422718|365405790|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
105930807|NCT03422718|365405791|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
105930808|NCT03422718|365405792|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
105930809|NCT03422718|365405793|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
105930810|NCT03422718|365405794|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
105930811|NCT03422718|365405795|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
105930812|NCT03422718|365405796|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
105930813|NCT03422718|365405797|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
105930814|NCT03422718|365405790|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
105930815|NCT03422718|365405791|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
105930816|NCT03422718|365405792|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
105930817|NCT03422718|365405793|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
105930818|NCT03422718|365405794|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
105930819|NCT03422718|365405795|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
105930820|NCT03422718|365405796|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
105930821|NCT03422718|365405797|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
105930822|NCT03309605|365405798|FG000|Overall Study|Adverse Event|0|||
105930823|NCT03309605|365405799|FG001|Overall Study|Adverse Event|0|||
105930824|NCT03309605|365405800|FG002|Overall Study|Adverse Event|0|||
105930825|NCT03309605|365405801|FG003|Overall Study|Adverse Event|1|||
105930826|NCT03309605|365405802|FG004|Overall Study|Adverse Event|0|||
105930827|NCT03309605|365405803|FG005|Overall Study|Adverse Event|0|||
105930828|NCT03309605|365405804|FG006|Overall Study|Adverse Event|2|||
105930829|NCT03309605|365405805|FG007|Overall Study|Adverse Event|1|||
105930830|NCT03309605|365405798|FG000|Overall Study|Withdrawal by Subject|0|||
105930831|NCT03309605|365405799|FG001|Overall Study|Withdrawal by Subject|0|||
105930832|NCT03309605|365405800|FG002|Overall Study|Withdrawal by Subject|0|||
105930833|NCT03309605|365405801|FG003|Overall Study|Withdrawal by Subject|0|||
105930834|NCT03309605|365405802|FG004|Overall Study|Withdrawal by Subject|1|||
105930835|NCT03309605|365405803|FG005|Overall Study|Withdrawal by Subject|0|||
105930836|NCT03309605|365405804|FG006|Overall Study|Withdrawal by Subject|1|||
105930837|NCT03309605|365405805|FG007|Overall Study|Withdrawal by Subject|1|||
105930838|NCT01625182|365405807|FG000|Overall Study|Administrative problems|1|||
105930839|NCT01625182|365405808|FG001|Overall Study|Administrative problems|0|||
105930840|NCT01625182|365405807|FG000|Overall Study|Protocol deviation|0|||
105930841|NCT01625182|365405808|FG001|Overall Study|Protocol deviation|2|||
106135642|NCT01168401|366156005|FG007|Overall Study|Withdrawal by Subject|0|||
106135643|NCT01168401|366156006|FG008|Overall Study|Withdrawal by Subject|0|||
106135644|NCT01168401|366156007|FG009|Overall Study|Withdrawal by Subject|0|||
106135645|NCT01168401|366156008|FG010|Overall Study|Withdrawal by Subject|0|||
106135646|NCT03085017|366156011|FG000|Overall Study|Death|0|||
105713189|NCT03891901|364607836|FG008|Overall Study|Poor venous access|0|||
105713190|NCT03891901|364607828|FG000|Overall Study|Withdrawal by Subject|0|||
105713191|NCT03891901|364607829|FG001|Overall Study|Withdrawal by Subject|2|||
105713192|NCT03891901|364607830|FG002|Overall Study|Withdrawal by Subject|0|||
105713193|NCT03891901|364607831|FG003|Overall Study|Withdrawal by Subject|0|||
105713194|NCT03891901|364607832|FG004|Overall Study|Withdrawal by Subject|0|||
105713195|NCT03891901|364607833|FG005|Overall Study|Withdrawal by Subject|0|||
105713196|NCT03891901|364607834|FG006|Overall Study|Withdrawal by Subject|0|||
105713197|NCT03891901|364607835|FG007|Overall Study|Withdrawal by Subject|0|||
105713198|NCT03891901|364607836|FG008|Overall Study|Withdrawal by Subject|0|||
105713199|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713200|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
105713201|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713202|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713203|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713204|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713205|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
105713206|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
105713207|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
105713208|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
105713209|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
105713210|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
105713211|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
105713212|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
105713213|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
105713214|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
105713215|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
105713216|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
105713217|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
105713218|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
105713219|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
105713220|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713221|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
105713222|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713223|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713224|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713225|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
105713226|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
105713227|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
105713228|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
105713229|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
105713230|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
105713231|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
105713232|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
105713233|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
105713234|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713235|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713236|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713237|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713238|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713239|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
105713240|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
105713241|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
105713242|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
105713243|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
105713244|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
105713245|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
105713246|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
105713247|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
105713248|NCT03742037|364607837|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713249|NCT03742037|364607838|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713250|NCT03742037|364607839|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713251|NCT03742037|364607840|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105788514|NCT03586427|364880107|FG004|Overall Study|Adverse Event|0|||
105788515|NCT03586427|364880103|FG000|Overall Study|Protocol Violation|0|||
105788516|NCT03586427|364880104|FG001|Overall Study|Protocol Violation|0|||
105788517|NCT03586427|364880105|FG002|Overall Study|Protocol Violation|1|||
105788518|NCT03586427|364880106|FG003|Overall Study|Protocol Violation|0|||
105788519|NCT03586427|364880107|FG004|Overall Study|Protocol Violation|1|||
105930842|NCT01625182|365405807|FG000|Overall Study|Adverse Event|2|||
106008618|NCT01345240|365697041|FG000|Overall Study|Adverse Event|3|||
106135647|NCT03085017|366156012|FG001|Overall Study|Death|3|||
106135648|NCT00991276|366156021|FG000|First Intervention Period|Adverse Event|0|||
106135649|NCT00991276|366156022|FG001|First Intervention Period|Adverse Event|1|||
106135650|NCT00991276|366156023|FG002|First Intervention Period|Adverse Event|0|||
106135651|NCT00991276|366156024|FG003|First Intervention Period|Adverse Event|1|||
106135652|NCT00991276|366156025|FG004|First Intervention Period|Adverse Event|0|||
106135653|NCT00991276|366156026|FG005|First Intervention Period|Adverse Event|0|||
106135654|NCT00991276|366156021|FG000|First Intervention Period|Protocol Violation|0|||
106135655|NCT00991276|366156022|FG001|First Intervention Period|Protocol Violation|0|||
106135656|NCT00991276|366156023|FG002|First Intervention Period|Protocol Violation|0|||
106135657|NCT00991276|366156024|FG003|First Intervention Period|Protocol Violation|0|||
106135658|NCT00991276|366156025|FG004|First Intervention Period|Protocol Violation|2|||
106135659|NCT00991276|366156026|FG005|First Intervention Period|Protocol Violation|0|||
106135660|NCT00991276|366156021|FG000|First Intervention Period|Insufficient clinical response|0|||
106135661|NCT00991276|366156022|FG001|First Intervention Period|Insufficient clinical response|0|||
106135662|NCT00991276|366156023|FG002|First Intervention Period|Insufficient clinical response|0|||
106135663|NCT00991276|366156024|FG003|First Intervention Period|Insufficient clinical response|0|||
106135664|NCT00991276|366156025|FG004|First Intervention Period|Insufficient clinical response|1|||
106135665|NCT00991276|366156026|FG005|First Intervention Period|Insufficient clinical response|0|||
106135666|NCT00991276|366156021|FG000|First Intervention Period|Other|0|||
106135667|NCT00991276|366156022|FG001|First Intervention Period|Other|0|||
106135668|NCT00991276|366156023|FG002|First Intervention Period|Other|0|||
106135669|NCT00991276|366156024|FG003|First Intervention Period|Other|1|||
106135670|NCT00991276|366156025|FG004|First Intervention Period|Other|1|||
106135671|NCT00991276|366156026|FG005|First Intervention Period|Other|0|||
106135672|NCT00991276|366156021|FG000|First Intervention Period|Withdrawal by Subject|0|||
106135673|NCT00991276|366156022|FG001|First Intervention Period|Withdrawal by Subject|1|||
106135674|NCT00991276|366156023|FG002|First Intervention Period|Withdrawal by Subject|0|||
106135675|NCT00991276|366156024|FG003|First Intervention Period|Withdrawal by Subject|1|||
106135676|NCT00991276|366156025|FG004|First Intervention Period|Withdrawal by Subject|0|||
106135677|NCT00991276|366156026|FG005|First Intervention Period|Withdrawal by Subject|1|||
106135678|NCT00991276|366156021|FG000|First Intervention Period|Lost to Follow-up|0|||
106135679|NCT00991276|366156022|FG001|First Intervention Period|Lost to Follow-up|1|||
105713252|NCT03742037|364607841|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713253|NCT03742037|364607842|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
105713254|NCT03742037|364607843|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
105713255|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
105713256|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
105713257|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
105713258|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
105713259|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
105713260|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
105713261|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
105713262|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
105713263|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
105713264|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
105713265|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
105713266|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
105713267|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
105713268|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
105713269|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713270|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
105713271|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
105713272|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713273|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713274|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713275|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
105713276|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
105713277|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105713278|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105713279|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105713280|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
105713281|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
106008619|NCT01345240|365697042|FG001|Overall Study|Adverse Event|5|||
106008620|NCT01345240|365697043|FG002|Overall Study|Adverse Event|4|||
105713282|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
105713283|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
105713284|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
105713285|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
105713286|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
105713287|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
105713288|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
105713289|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
105713290|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
105713291|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
105930843|NCT01625182|365405808|FG001|Overall Study|Adverse Event|0|||
105930844|NCT01625182|365405807|FG000|Overall Study|Withdrawal by Subject|5|||
105930845|NCT01625182|365405808|FG001|Overall Study|Withdrawal by Subject|1|||
105930846|NCT01625182|365405807|FG000|Overall Study|Lack of Efficacy|12|||
105930847|NCT01625182|365405808|FG001|Overall Study|Lack of Efficacy|8|||
105930848|NCT00986232|365405812|FG000|Overall Study|Adverse Event|1|||
105930849|NCT00986232|365405813|FG001|Overall Study|Adverse Event|2|||
105930850|NCT00986232|365405814|FG002|Overall Study|Adverse Event|3|||
105930851|NCT00986232|365405815|FG003|Overall Study|Adverse Event|0|||
105930852|NCT00986232|365405812|FG000|Overall Study|Lost to Follow-up|19|||
105930853|NCT00986232|365405813|FG001|Overall Study|Lost to Follow-up|12|||
105713292|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
105930854|NCT00986232|365405814|FG002|Overall Study|Lost to Follow-up|12|||
105713293|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
105713294|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
105713295|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
105713296|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
105713297|NCT03742037|364607837|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713298|NCT03742037|364607838|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713299|NCT03742037|364607839|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
105713300|NCT03742037|364607840|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713301|NCT03742037|364607841|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713302|NCT03742037|364607842|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105930855|NCT00986232|365405815|FG003|Overall Study|Lost to Follow-up|7|||
105930856|NCT00986232|365405812|FG000|Overall Study|Protocol Violation|2|||
105713303|NCT03742037|364607843|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
105713304|NCT00482014|364609598|FG000|Overall Study|Withdrawal by Subject|1|||
105713305|NCT00482014|364609599|FG001|Overall Study|Withdrawal by Subject|2|||
105713306|NCT00482014|364609600|FG002|Overall Study|Withdrawal by Subject|3|||
105713307|NCT00482014|364609601|FG003|Overall Study|Withdrawal by Subject|4|||
105713308|NCT00482014|364609598|FG000|Overall Study|Adverse Event|3|||
105713309|NCT00482014|364609599|FG001|Overall Study|Adverse Event|0|||
105713310|NCT00482014|364609600|FG002|Overall Study|Adverse Event|2|||
105713311|NCT00482014|364609601|FG003|Overall Study|Adverse Event|8|||
105713312|NCT00482014|364609598|FG000|Overall Study|Death|1|||
105713313|NCT00482014|364609599|FG001|Overall Study|Death|2|||
105713314|NCT00482014|364609600|FG002|Overall Study|Death|1|||
105713315|NCT00482014|364609601|FG003|Overall Study|Death|4|||
105713316|NCT00482014|364609598|FG000|Overall Study|Lack of Efficacy|1|||
105713317|NCT00482014|364609599|FG001|Overall Study|Lack of Efficacy|0|||
105713318|NCT00482014|364609600|FG002|Overall Study|Lack of Efficacy|4|||
105713319|NCT00482014|364609601|FG003|Overall Study|Lack of Efficacy|6|||
105713320|NCT00482014|364609598|FG000|Overall Study|Sponsor Decision|1|||
105713321|NCT00482014|364609599|FG001|Overall Study|Sponsor Decision|2|||
105713322|NCT00482014|364609600|FG002|Overall Study|Sponsor Decision|1|||
105713323|NCT00482014|364609601|FG003|Overall Study|Sponsor Decision|1|||
105713324|NCT01284114|364609602|FG000|Overall Study|viral infection|1|||
105713325|NCT01284114|364609602|FG000|Overall Study|From the results of ALLTITUDE study|1|||
105713326|NCT01284114|364609602|FG000|Overall Study|Symptomatic hypotension|1|||
105713327|NCT01284114|364609602|FG000|Overall Study|dizziness|1|||
105713328|NCT00598975|364609603|FG000|Overall Study|Adverse Event|1|||
105713329|NCT00598975|364609604|FG001|Overall Study|Adverse Event|1|||
105713330|NCT00598975|364609603|FG000|Overall Study|Brain metastases|1|||
105713331|NCT00598975|364609604|FG001|Overall Study|Brain metastases|0|||
105713332|NCT00598975|364609603|FG000|Overall Study|Withdrawal by Subject|1|||
105713333|NCT00598975|364609604|FG001|Overall Study|Withdrawal by Subject|1|||
105713334|NCT00598975|364609603|FG000|Overall Study|Withdrawal of consent|0|||
105713335|NCT00598975|364609604|FG001|Overall Study|Withdrawal of consent|1|||
105788520|NCT03586427|364880103|FG000|Overall Study|Noncompliance with study drug|0|||
105930857|NCT00986232|365405813|FG001|Overall Study|Protocol Violation|3|||
105713336|NCT00598975|364609603|FG000|Overall Study|Disease progression|8|||
105713337|NCT00598975|364609604|FG001|Overall Study|Disease progression|3|||
105713338|NCT00598975|364609603|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
105713339|NCT00598975|364609604|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
105713340|NCT03445000|364609605|FG000|Overall Study|Disease progression|8|||
105713341|NCT03445000|364609605|FG000|Overall Study|Adverse Event|3|||
105713342|NCT03445000|364609605|FG000|Overall Study|Death|2|||
105713343|NCT03445000|364609605|FG000|Overall Study|Physician Decision|1|||
105713344|NCT03409744|364609606|FG000|Overall Study|Death|2|||
105713345|NCT03409744|364609606|FG000|Overall Study|Physician Decision|5|||
105713346|NCT03409744|364609606|FG000|Overall Study|Pregnancy|1|||
105713347|NCT03409744|364609606|FG000|Overall Study|Lost to Follow-up|1|||
106135680|NCT00991276|366156023|FG002|First Intervention Period|Lost to Follow-up|0|||
106135681|NCT00991276|366156024|FG003|First Intervention Period|Lost to Follow-up|1|||
106135682|NCT00991276|366156025|FG004|First Intervention Period|Lost to Follow-up|0|||
106135683|NCT00991276|366156026|FG005|First Intervention Period|Lost to Follow-up|0|||
106135684|NCT00991276|366156021|FG000|Second Intervention Period|Adverse Event|0|||
106135685|NCT00991276|366156022|FG001|Second Intervention Period|Adverse Event|2|||
106135686|NCT00991276|366156023|FG002|Second Intervention Period|Adverse Event|0|||
106135687|NCT00991276|366156024|FG003|Second Intervention Period|Adverse Event|1|||
106135688|NCT00991276|366156025|FG004|Second Intervention Period|Adverse Event|1|||
106135689|NCT00991276|366156026|FG005|Second Intervention Period|Adverse Event|0|||
106135690|NCT00991276|366156021|FG000|Second Intervention Period|Protocol Violation|1|||
106135691|NCT00991276|366156022|FG001|Second Intervention Period|Protocol Violation|0|||
106135692|NCT00991276|366156023|FG002|Second Intervention Period|Protocol Violation|0|||
106135693|NCT00991276|366156024|FG003|Second Intervention Period|Protocol Violation|0|||
106135694|NCT00991276|366156025|FG004|Second Intervention Period|Protocol Violation|0|||
106135695|NCT00991276|366156026|FG005|Second Intervention Period|Protocol Violation|0|||
106135696|NCT00991276|366156021|FG000|Second Intervention Period|Other|0|||
106135697|NCT00991276|366156022|FG001|Second Intervention Period|Other|0|||
106135698|NCT00991276|366156023|FG002|Second Intervention Period|Other|0|||
106135699|NCT00991276|366156024|FG003|Second Intervention Period|Other|1|||
105713348|NCT03409744|364609606|FG000|Overall Study|Protocol Violation|1|||
105713349|NCT00264004|364609608|FG000|Overall Study|Adverse Event|2|||
105713350|NCT00264004|364609609|FG001|Overall Study|Adverse Event|3|||
105713351|NCT00264004|364609610|FG002|Overall Study|Adverse Event|6|||
105713352|NCT00264004|364609611|FG003|Overall Study|Adverse Event|4|||
105713353|NCT00264004|364609608|FG000|Overall Study|Withdrawal by Subject|0|||
105713354|NCT00264004|364609609|FG001|Overall Study|Withdrawal by Subject|1|||
105713355|NCT00264004|364609610|FG002|Overall Study|Withdrawal by Subject|2|||
105713356|NCT00264004|364609611|FG003|Overall Study|Withdrawal by Subject|2|||
105713357|NCT00264004|364609608|FG000|Overall Study|Other|2|||
105713358|NCT00264004|364609609|FG001|Overall Study|Other|2|||
105713359|NCT00264004|364609610|FG002|Overall Study|Other|0|||
105713360|NCT00264004|364609611|FG003|Overall Study|Other|3|||
105713361|NCT00264004|364609608|FG000|Overall Study|Development study specific disc. crit.|1|||
105713362|NCT00264004|364609609|FG001|Overall Study|Development study specific disc. crit.|0|||
105713363|NCT00264004|364609610|FG002|Overall Study|Development study specific disc. crit.|1|||
105713364|NCT00264004|364609611|FG003|Overall Study|Development study specific disc. crit.|0|||
105713365|NCT00264004|364609608|FG000|Overall Study|Cond. under inv. worsened|9|||
105713366|NCT00264004|364609609|FG001|Overall Study|Cond. under inv. worsened|5|||
105713367|NCT00264004|364609610|FG002|Overall Study|Cond. under inv. worsened|3|||
105713368|NCT00264004|364609611|FG003|Overall Study|Cond. under inv. worsened|4|||
105713369|NCT00264004|364609608|FG000|Overall Study|Not treated|3|||
105713370|NCT00264004|364609609|FG001|Overall Study|Not treated|0|||
105713371|NCT00264004|364609610|FG002|Overall Study|Not treated|2|||
105713372|NCT00264004|364609611|FG003|Overall Study|Not treated|2|||
105713373|NCT02787850|364609612|FG000|Overall Study|Withdrawal by Subject|0|||
105713374|NCT02787850|364609613|FG001|Overall Study|Withdrawal by Subject|1|||
105713375|NCT03718143|364609614|FG000|Overall Study|Death|1|||
105713376|NCT03718143|364609615|FG001|Overall Study|Death|0|||
105713377|NCT03718143|364609616|FG002|Overall Study|Death|0|||
105713378|NCT03718143|364609614|FG000|Overall Study|Progression of Disease|1|||
105713379|NCT03718143|364609615|FG001|Overall Study|Progression of Disease|0|||
105713380|NCT03718143|364609616|FG002|Overall Study|Progression of Disease|0|||
105713381|NCT03718143|364609614|FG000|Overall Study|Withdrawal of Informed Consent|1|||
105713382|NCT03718143|364609615|FG001|Overall Study|Withdrawal of Informed Consent|2|||
105713383|NCT03718143|364609616|FG002|Overall Study|Withdrawal of Informed Consent|1|||
105713384|NCT02921971|364609620|FG000|Overall Study|Adverse Event|1|||
105713385|NCT02921971|364609621|FG001|Overall Study|Adverse Event|2|||
105713386|NCT02921971|364609620|FG000|Overall Study|Lack of Efficacy|3|||
105713387|NCT02921971|364609621|FG001|Overall Study|Lack of Efficacy|1|||
105713388|NCT02921971|364609620|FG000|Overall Study|Other than specified above|2|||
105713389|NCT02921971|364609621|FG001|Overall Study|Other than specified above|1|||
105713390|NCT02105454|364609624|FG000|Overall Study|Withdrawal by Subject|1|||
105713391|NCT02322710|364609625|FG000|Overall Study|No efficacy assessment post-baseline|0|||
105788521|NCT03586427|364880104|FG001|Overall Study|Noncompliance with study drug|0|||
105788522|NCT03586427|364880105|FG002|Overall Study|Noncompliance with study drug|1|||
105713392|NCT02322710|364609626|FG001|Overall Study|No efficacy assessment post-baseline|1|||
105788523|NCT03586427|364880106|FG003|Overall Study|Noncompliance with study drug|0|||
105930858|NCT00986232|365405814|FG002|Overall Study|Protocol Violation|0|||
105930859|NCT00986232|365405815|FG003|Overall Study|Protocol Violation|1|||
105930860|NCT00986232|365405812|FG000|Overall Study|Withdrawal by Subject|13|||
105930861|NCT00986232|365405813|FG001|Overall Study|Withdrawal by Subject|16|||
105930862|NCT00986232|365405814|FG002|Overall Study|Withdrawal by Subject|12|||
105930863|NCT00986232|365405815|FG003|Overall Study|Withdrawal by Subject|3|||
105930864|NCT00986232|365405812|FG000|Overall Study|Missed one or more bleeds|13|||
105930865|NCT00986232|365405813|FG001|Overall Study|Missed one or more bleeds|10|||
105930866|NCT00986232|365405814|FG002|Overall Study|Missed one or more bleeds|6|||
105930867|NCT00986232|365405815|FG003|Overall Study|Missed one or more bleeds|7|||
105930868|NCT00986232|365405812|FG000|Overall Study|Incomplete safety follow-up|3|||
105930869|NCT00986232|365405813|FG001|Overall Study|Incomplete safety follow-up|7|||
105930870|NCT00986232|365405814|FG002|Overall Study|Incomplete safety follow-up|2|||
105930871|NCT00986232|365405815|FG003|Overall Study|Incomplete safety follow-up|2|||
105930872|NCT02930941|365405817|FG000|Overall Study|Lost to Follow-up|1|||
105788524|NCT03586427|364880107|FG004|Overall Study|Noncompliance with study drug|0|||
105788525|NCT03193996|364880110|FG000|Overall Study|Withdrawal by Subject|4|||
105788526|NCT03193996|364880110|FG000|Overall Study|Lost to Follow-up|4|||
105788527|NCT03193996|364880110|FG000|Overall Study|Physician Decision|2|||
105788528|NCT03193996|364880110|FG000|Overall Study|Pregnancy|1|||
105788529|NCT03193996|364880110|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
105788530|NCT03193996|364880110|FG000|Overall Study|Complicating disease|1|||
105788531|NCT00423137|364880111|FG000|Overall Study|Lost to Follow-up|0|||
105788532|NCT00423137|364880112|FG001|Overall Study|Lost to Follow-up|0|||
105788533|NCT00423137|364880113|FG002|Overall Study|Lost to Follow-up|1|||
105788534|NCT00423137|364880114|FG003|Overall Study|Lost to Follow-up|0|||
106135700|NCT00991276|366156025|FG004|Second Intervention Period|Other|0|||
106135701|NCT00991276|366156026|FG005|Second Intervention Period|Other|1|||
106135702|NCT00991276|366156021|FG000|Third Intervention Period|Protocol Violation|1|||
106135703|NCT00991276|366156022|FG001|Third Intervention Period|Protocol Violation|0|||
106135704|NCT00991276|366156023|FG002|Third Intervention Period|Protocol Violation|0|||
106135705|NCT00991276|366156024|FG003|Third Intervention Period|Protocol Violation|0|||
106135706|NCT00991276|366156025|FG004|Third Intervention Period|Protocol Violation|0|||
106135707|NCT00991276|366156026|FG005|Third Intervention Period|Protocol Violation|0|||
106135708|NCT00991276|366156021|FG000|Third Intervention Period|Other|0|||
106135709|NCT00991276|366156022|FG001|Third Intervention Period|Other|0|||
106135710|NCT00991276|366156023|FG002|Third Intervention Period|Other|0|||
106135711|NCT00991276|366156024|FG003|Third Intervention Period|Other|0|||
106135712|NCT00991276|366156025|FG004|Third Intervention Period|Other|0|||
106135713|NCT00991276|366156026|FG005|Third Intervention Period|Other|1|||
106135714|NCT00991276|366156021|FG000|Third Intervention Period|Adverse Event|0|||
105788535|NCT00423137|364880111|FG000|Overall Study|Protocol Violation|0|||
105930873|NCT02930941|365405818|FG001|Overall Study|Lost to Follow-up|2|||
105930874|NCT01967277|365405821|FG000|Overall Study|Lost to Follow-up|1|||
105930875|NCT01967277|365405822|FG001|Overall Study|Lost to Follow-up|2|||
105930876|NCT01967277|365405821|FG000|Overall Study|Unrelated illness|0|||
105930877|NCT01967277|365405822|FG001|Overall Study|Unrelated illness|1|||
105930878|NCT01243424|365405827|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
105930879|NCT01243424|365405828|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
105930880|NCT01243424|365405827|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
105930881|NCT01243424|365405828|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
105930882|NCT01243424|365405827|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
105788536|NCT00423137|364880112|FG001|Overall Study|Protocol Violation|0|||
105788537|NCT00423137|364880113|FG002|Overall Study|Protocol Violation|0|||
105930883|NCT01243424|365405828|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
105930884|NCT01243424|365405827|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
106008621|NCT01345240|365697044|FG003|Overall Study|Adverse Event|2|||
106135715|NCT00991276|366156022|FG001|Third Intervention Period|Adverse Event|0|||
105713393|NCT02322710|364609625|FG000|Overall Study|Protocol Violation|20|||
105713394|NCT02322710|364609626|FG001|Overall Study|Protocol Violation|25|||
105713395|NCT02740478|364609627|FG000|Overall Study|Withdrawal by Subject|1|||
105713396|NCT04316585|364609629|FG000|Overall Study|Adverse Event|2|||
105788538|NCT00423137|364880114|FG003|Overall Study|Protocol Violation|1|||
105788539|NCT00423137|364880111|FG000|Overall Study|Adverse Event Study disease worse|1|||
105713397|NCT04316585|364609630|FG001|Overall Study|Adverse Event|1|||
105713398|NCT04316585|364609629|FG000|Overall Study|Lost to Follow-up|1|||
105713399|NCT04316585|364609630|FG001|Overall Study|Lost to Follow-up|0|||
105713400|NCT04316585|364609629|FG000|Overall Study|Withdrawal by Subject|2|||
105713401|NCT04316585|364609630|FG001|Overall Study|Withdrawal by Subject|3|||
105713402|NCT04316585|364609629|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
105713403|NCT04316585|364609630|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
105713404|NCT04316585|364609629|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
105713405|NCT04316585|364609630|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
105713406|NCT02605642|364609634|FG000|Overall Study|Other|11|||
105713407|NCT02605642|364609635|FG001|Overall Study|Other|1|||
105713408|NCT02605642|364609634|FG000|Overall Study|Participant non-compliance|2|||
105713409|NCT02605642|364609635|FG001|Overall Study|Participant non-compliance|4|||
105713410|NCT02605642|364609634|FG000|Overall Study|Physician Decision|10|||
105930885|NCT01243424|365405828|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
105930886|NCT01243424|365405827|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
105930887|NCT01243424|365405828|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
105930888|NCT01243424|365405827|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
105930889|NCT01243424|365405828|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
105930890|NCT01243424|365405827|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
105930891|NCT01243424|365405828|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
105930892|NCT01243424|365405827|FG000|Discontinuation From Treatment|Not treated|5|||
105930893|NCT01243424|365405828|FG001|Discontinuation From Treatment|Not treated|4|||
105930894|NCT01243424|365405827|FG000|Discontinuation From Treatment|Adverse Event|457|||
105930895|NCT01243424|365405828|FG001|Discontinuation From Treatment|Adverse Event|523|||
105930896|NCT01243424|365405827|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
105930897|NCT01243424|365405828|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
105930898|NCT01243424|365405827|FG000|Discontinuation From Treatment|Protocol Violation|46|||
105930899|NCT01243424|365405828|FG001|Discontinuation From Treatment|Protocol Violation|47|||
105930900|NCT01243424|365405827|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
105930901|NCT01243424|365405828|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
105930902|NCT01243424|365405827|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
105930903|NCT01243424|365405828|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
105930904|NCT01243424|365405827|FG000|Discontinuation From Treatment|Other than listed above|230|||
105930905|NCT01243424|365405828|FG001|Discontinuation From Treatment|Other than listed above|211|||
105930906|NCT00397930|365405831|FG000|Overall Study|Personal reasons|14|||
105930907|NCT00397930|365405832|FG001|Overall Study|Personal reasons|8|||
105930908|NCT00397930|365405831|FG000|Overall Study|Other medical|9|||
105930909|NCT00397930|365405832|FG001|Overall Study|Other medical|4|||
105930910|NCT00397930|365405831|FG000|Overall Study|Unknown reasons|9|||
105930911|NCT00397930|365405832|FG001|Overall Study|Unknown reasons|14|||
105930912|NCT00397930|365405831|FG000|Overall Study|Noncompliant|3|||
105930913|NCT00397930|365405832|FG001|Overall Study|Noncompliant|2|||
105930914|NCT00397930|365405831|FG000|Overall Study|Too time-consuming|2|||
105930915|NCT00397930|365405832|FG001|Overall Study|Too time-consuming|9|||
105930916|NCT00397930|365405831|FG000|Overall Study|Started own yoga program|1|||
105930917|NCT00397930|365405832|FG001|Overall Study|Started own yoga program|1|||
105930918|NCT00397930|365405831|FG000|Overall Study|Did not want to be in control group|0|||
105930919|NCT00397930|365405832|FG001|Overall Study|Did not want to be in control group|1|||
105930920|NCT00397930|365405831|FG000|Overall Study|Withdrawal by Subject|0|||
105930921|NCT00397930|365405832|FG001|Overall Study|Withdrawal by Subject|8|||
105930922|NCT00397930|365405831|FG000|Overall Study|Missing data|0|||
105930923|NCT00397930|365405832|FG001|Overall Study|Missing data|4|||
105930924|NCT02400580|365405852|FG000|Overall Study|Withdrawal by Subject|1|||
105930925|NCT02400580|365405853|FG001|Overall Study|Withdrawal by Subject|1|||
105930926|NCT02400580|365405852|FG000|Overall Study|Adverse Event|1|||
105930927|NCT02400580|365405853|FG001|Overall Study|Adverse Event|0|||
105930928|NCT01060111|365405854|FG000|Overall Study|Adverse Event|9|||
105930929|NCT01060111|365405855|FG001|Overall Study|Adverse Event|5|||
105930930|NCT01060111|365405856|FG002|Overall Study|Adverse Event|18|||
105930931|NCT01060111|365405854|FG000|Overall Study|Lack of Efficacy|2|||
105930932|NCT01060111|365405855|FG001|Overall Study|Lack of Efficacy|1|||
105930933|NCT01060111|365405856|FG002|Overall Study|Lack of Efficacy|0|||
105930934|NCT01060111|365405854|FG000|Overall Study|Inappropriate participant|5|||
105930935|NCT01060111|365405855|FG001|Overall Study|Inappropriate participant|4|||
105930936|NCT01060111|365405856|FG002|Overall Study|Inappropriate participant|5|||
105930937|NCT01060111|365405854|FG000|Overall Study|Participants' evasion for hospital visit|0|||
105930938|NCT01060111|365405855|FG001|Overall Study|Participants' evasion for hospital visit|3|||
105930939|NCT01060111|365405856|FG002|Overall Study|Participants' evasion for hospital visit|2|||
105713411|NCT02605642|364609635|FG001|Overall Study|Physician Decision|0|||
105713412|NCT02605642|364609634|FG000|Overall Study|Lost to Follow-up|12|||
105713413|NCT02605642|364609635|FG001|Overall Study|Lost to Follow-up|1|||
105713414|NCT02605642|364609634|FG000|Overall Study|Adverse Event|14|||
105713415|NCT02605642|364609635|FG001|Overall Study|Adverse Event|2|||
105713416|NCT02605642|364609634|FG000|Overall Study|Withdrawal by Subject|23|||
105713417|NCT02605642|364609635|FG001|Overall Study|Withdrawal by Subject|2|||
105713418|NCT02605642|364609634|FG000|Overall Study|Lack of response|24|||
105713419|NCT02605642|364609635|FG001|Overall Study|Lack of response|11|||
105713420|NCT00984204|364609643|FG000|Overall Study|Death|1|||
105713421|NCT00984204|364609643|FG000|Overall Study|Lost to Follow-up|4|||
105713422|NCT00984204|364609643|FG000|Overall Study|Lack of Efficacy|10|||
105713423|NCT01449708|364609646|FG000|Overall Study|Protocol Violation|0|||
105713424|NCT01449708|364609647|FG001|Overall Study|Protocol Violation|1|||
105713425|NCT01449708|364609646|FG000|Overall Study|surgical complication|1|||
105713426|NCT01449708|364609647|FG001|Overall Study|surgical complication|2|||
105713427|NCT01449708|364609646|FG000|Overall Study|respiratory failure|1|||
105713428|NCT01449708|364609647|FG001|Overall Study|respiratory failure|0|||
105713429|NCT00975156|364609648|FG000|Overall Study|Protocol Violation|0|||
105713430|NCT00975156|364609649|FG001|Overall Study|Protocol Violation|1|||
105713431|NCT00223496|364609650|FG000|Overall Study|screen failure|9|||
105713432|NCT00223496|364609650|FG000|Overall Study|Lost to Follow-up|4|||
105713433|NCT00223496|364609650|FG000|Overall Study|Lack of Efficacy|6|||
105713434|NCT00223496|364609650|FG000|Overall Study|Withdrawal by Subject|1|||
105713435|NCT00223496|364609650|FG000|Overall Study|Physician Decision|2|||
105713436|NCT01407926|364609652|FG000|Overall Study|Lost to Follow-up|55|||
106135716|NCT00991276|366156023|FG002|Third Intervention Period|Adverse Event|1|||
106135717|NCT00991276|366156024|FG003|Third Intervention Period|Adverse Event|0|||
106135718|NCT00991276|366156025|FG004|Third Intervention Period|Adverse Event|0|||
106135719|NCT00991276|366156026|FG005|Third Intervention Period|Adverse Event|0|||
106135720|NCT00991276|366156021|FG000|Third Intervention Period|Withdrawal by Subject|0|||
106135721|NCT00991276|366156022|FG001|Third Intervention Period|Withdrawal by Subject|0|||
106135722|NCT00991276|366156023|FG002|Third Intervention Period|Withdrawal by Subject|0|||
106135723|NCT00991276|366156024|FG003|Third Intervention Period|Withdrawal by Subject|1|||
106135724|NCT00991276|366156025|FG004|Third Intervention Period|Withdrawal by Subject|0|||
106135725|NCT00991276|366156026|FG005|Third Intervention Period|Withdrawal by Subject|0|||
106135726|NCT01720043|366156027|FG000|Overall Study|Withdrawal by Subject|1|||
106135727|NCT01688973|366156028|FG000|Overall Study|Ineligible|2|||
106135728|NCT01688973|366156029|FG001|Overall Study|Ineligible|3|||
106135729|NCT03681691|366156035|FG000|Overall Study|COVID|1|||
106135730|NCT03681691|366156036|FG001|Overall Study|COVID|0|||
106135731|NCT03681691|366156035|FG000|Overall Study|prolonged bleeding|1|||
106135732|NCT03681691|366156036|FG001|Overall Study|prolonged bleeding|0|||
106135733|NCT03681691|366156035|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
106135734|NCT03681691|366156036|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
106135735|NCT01516892|366156037|FG000|Overall Study|Adverse Event|25|||
106135736|NCT01516892|366156037|FG000|Overall Study|Lack of Efficacy|35|||
106135737|NCT01516892|366156037|FG000|Overall Study|Pregnancy|5|||
106135738|NCT01516892|366156037|FG000|Overall Study|Lost to Follow-up|82|||
106135739|NCT01516892|366156037|FG000|Overall Study|Subject Withdrew Consent|92|||
106135740|NCT01516892|366156037|FG000|Overall Study|Protocol Violation|60|||
106135741|NCT01516892|366156037|FG000|Overall Study|Other Miscellaneous Reasons|43|||
106135742|NCT01516892|366156037|FG000|Overall Study|Missing|1|||
106135743|NCT03613129|366156039|FG000|Pre-treatment Assessment|Protocol Violation|2|||
106135744|NCT03613129|366156040|FG001|Pre-treatment Assessment|Protocol Violation|0|||
106135745|NCT03613129|366156041|FG002|Pre-treatment Assessment|Protocol Violation|0|||
106135746|NCT03613129|366156042|FG003|Pre-treatment Assessment|Protocol Violation|0|||
106135747|NCT03613129|366156043|FG004|Pre-treatment Assessment|Protocol Violation|0|||
106135748|NCT03613129|366156039|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
106135749|NCT03613129|366156040|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
106135750|NCT03613129|366156041|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
106135751|NCT03613129|366156042|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
106135752|NCT03613129|366156043|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
106135753|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
106135754|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
106135755|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
106135756|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
106135757|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Adverse Event|198|||
106135758|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Adverse Event|0|||
105713437|NCT05131204|364609653|FG000|Overall Study|Sponsor request|2|||
105713438|NCT05131204|364609654|FG001|Overall Study|Sponsor request|1|||
105713439|NCT01534676|364609655|FG000|Overall Study|Study closed due to poor enrollment|2|||
105713440|NCT01534676|364609656|FG001|Overall Study|Study closed due to poor enrollment|1|||
105713441|NCT01885000|364609658|FG000|Overall Study|Adverse Event|1|||
105713442|NCT01885000|364609659|FG001|Overall Study|Adverse Event|0|||
105713443|NCT01885000|364609658|FG000|Overall Study|Withdrawal by Subject|1|||
105713444|NCT01885000|364609659|FG001|Overall Study|Withdrawal by Subject|1|||
105713445|NCT01885000|364609658|FG000|Overall Study|Protocol Violation|0|||
105713446|NCT01885000|364609659|FG001|Overall Study|Protocol Violation|1|||
105713447|NCT05702515|364609660|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
105713448|NCT01396005|364609661|FG000|Overall Study|Withdrawal by Subject|0|||
105713449|NCT01396005|364609662|FG001|Overall Study|Withdrawal by Subject|1|||
105713450|NCT01396005|364609661|FG000|Overall Study|Non-compliance with protocol|0|||
105713451|NCT01396005|364609662|FG001|Overall Study|Non-compliance with protocol|1|||
105713452|NCT03757988|364609663|FG000|Overall Study|Withdrawal by Subject|1|||
105713453|NCT03946670|364609664|FG000|Overall Study|Progressive Disease|26|||
105713454|NCT03946670|364609665|FG001|Overall Study|Progressive Disease|23|||
105713455|NCT03946670|364609664|FG000|Overall Study|Adverse Event|7|||
105713456|NCT03946670|364609665|FG001|Overall Study|Adverse Event|9|||
105713457|NCT03946670|364609664|FG000|Overall Study|Death|5|||
105713458|NCT03946670|364609665|FG001|Overall Study|Death|6|||
105713459|NCT03946670|364609664|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
105713460|NCT03946670|364609665|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
105713461|NCT03946670|364609664|FG000|Overall Study|Subject Decision|4|||
106008622|NCT01345240|365697045|FG004|Overall Study|Adverse Event|1|||
105713462|NCT03946670|364609665|FG001|Overall Study|Subject Decision|4|||
105713463|NCT03946670|364609664|FG000|Overall Study|Physician Decision|3|||
105713464|NCT03946670|364609665|FG001|Overall Study|Physician Decision|3|||
105788540|NCT00423137|364880112|FG001|Overall Study|Adverse Event Study disease worse|0|||
105713465|NCT03946670|364609664|FG000|Overall Study|New Therapy for Study Indication|1|||
105713466|NCT03946670|364609665|FG001|Overall Study|New Therapy for Study Indication|0|||
105713467|NCT03946670|364609664|FG000|Overall Study|Not treated|1|||
105713468|NCT03946670|364609665|FG001|Overall Study|Not treated|1|||
105713469|NCT01239160|364609666|FG000|Overall Study|Lost to Follow-up|3|||
105713470|NCT01239160|364609667|FG001|Overall Study|Lost to Follow-up|5|||
105713471|NCT01239160|364609668|FG002|Overall Study|Lost to Follow-up|0|||
105713472|NCT01239160|364609666|FG000|Overall Study|Withdrawal by Subject|17|||
105713473|NCT01239160|364609667|FG001|Overall Study|Withdrawal by Subject|6|||
105930940|NCT01060111|365405854|FG000|Overall Study|Participants' non-cooperation|8|||
106135759|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Adverse Event|0|||
106135760|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Adverse Event|0|||
106135761|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Death|62|||
106135762|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Death|0|||
106135763|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Death|0|||
106135764|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Death|0|||
106135765|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
106135766|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
106135767|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
106135768|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
106135769|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Complicating disease|13|||
106135770|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Complicating disease|0|||
106135771|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Complicating disease|0|||
106135772|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Complicating disease|0|||
106135773|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
106135774|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
106135775|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
106135776|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
106135777|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
106135778|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
106135779|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
106135780|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
105930941|NCT01060111|365405855|FG001|Overall Study|Participants' non-cooperation|6|||
105930942|NCT01060111|365405856|FG002|Overall Study|Participants' non-cooperation|6|||
105930943|NCT01060111|365405854|FG000|Overall Study|Adverse event and insufficient effect|0|||
105930944|NCT01060111|365405855|FG001|Overall Study|Adverse event and insufficient effect|1|||
105930945|NCT01060111|365405856|FG002|Overall Study|Adverse event and insufficient effect|0|||
105930946|NCT01060111|365405854|FG000|Overall Study|Participants' non-cooperation|1|||
105930947|NCT01060111|365405855|FG001|Overall Study|Participants' non-cooperation|0|||
106135781|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Non-compliance|4|||
106135782|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Non-compliance|0|||
106135783|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Non-compliance|0|||
106135784|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Non-compliance|0|||
106135785|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Pain|4|||
106135786|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Pain|0|||
106135787|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Pain|0|||
105930948|NCT01060111|365405856|FG002|Overall Study|Participants' non-cooperation|0|||
105930949|NCT01060111|365405854|FG000|Overall Study|Other|2|||
105930950|NCT01060111|365405855|FG001|Overall Study|Other|3|||
105930951|NCT01060111|365405856|FG002|Overall Study|Other|4|||
105930952|NCT01336972|365405861|FG000|Overall Study|Adverse Event|1|||
105930953|NCT01336972|365405862|FG001|Overall Study|Adverse Event|1|||
105930954|NCT01336972|365405863|FG002|Overall Study|Adverse Event|0|||
105930955|NCT03954938|365405866|FG000|Overall Study|Withdrawal by Subject|2|||
105930956|NCT03954938|365405866|FG000|Overall Study|Adverse Event|1|||
105930957|NCT00685698|365405869|FG000|Overall Study|Withdrawal by Subject|1|||
105930958|NCT00685698|365405869|FG000|Overall Study|Protocol Violation|6|||
105930959|NCT00685698|365405869|FG000|Overall Study|Adverse Event|3|||
105930960|NCT00685698|365405869|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
105930961|NCT00685698|365405869|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
105930962|NCT00685698|365405869|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
106135788|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Pain|0|||
106135789|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
106135790|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
106135791|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
106135792|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
106135793|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Hospice care|1|||
105713474|NCT01239160|364609668|FG002|Overall Study|Withdrawal by Subject|2|||
105713475|NCT01239160|364609666|FG000|Overall Study|Physician Decision|5|||
105713476|NCT01239160|364609667|FG001|Overall Study|Physician Decision|7|||
105713477|NCT01239160|364609668|FG002|Overall Study|Physician Decision|2|||
105713478|NCT01239160|364609666|FG000|Overall Study|Early Termination Due to Study Closure|0|||
105713479|NCT01239160|364609667|FG001|Overall Study|Early Termination Due to Study Closure|1|||
105713480|NCT01239160|364609668|FG002|Overall Study|Early Termination Due to Study Closure|6|||
105713481|NCT02475655|364609669|FG000|Overall Study|Lost to Follow-up|0|||
105713482|NCT02475655|364609670|FG001|Overall Study|Lost to Follow-up|1|||
105713483|NCT00577993|364609690|FG000|Overall Study|Adverse Event|1|||
105713484|NCT00577993|364609691|FG001|Overall Study|Adverse Event|0|||
105713485|NCT00577993|364609692|FG002|Overall Study|Adverse Event|0|||
105713486|NCT00577993|364609690|FG000|Overall Study|Death|0|||
105713487|NCT00577993|364609691|FG001|Overall Study|Death|1|||
105713488|NCT00577993|364609692|FG002|Overall Study|Death|1|||
105713489|NCT00577993|364609690|FG000|Overall Study|Lack of Efficacy|0|||
105713490|NCT00577993|364609691|FG001|Overall Study|Lack of Efficacy|1|||
105713491|NCT00577993|364609692|FG002|Overall Study|Lack of Efficacy|0|||
105713492|NCT00577993|364609690|FG000|Overall Study|Protocol Violation|2|||
105713493|NCT00577993|364609691|FG001|Overall Study|Protocol Violation|3|||
105713494|NCT00577993|364609692|FG002|Overall Study|Protocol Violation|0|||
105713495|NCT00577993|364609690|FG000|Overall Study|Withdrawal by Subject|1|||
105713496|NCT00577993|364609691|FG001|Overall Study|Withdrawal by Subject|0|||
105713497|NCT00577993|364609692|FG002|Overall Study|Withdrawal by Subject|2|||
105713498|NCT00577993|364609690|FG000|Overall Study|Conversion|2|||
105713499|NCT00577993|364609691|FG001|Overall Study|Conversion|5|||
105713500|NCT00577993|364609692|FG002|Overall Study|Conversion|0|||
105713501|NCT00577993|364609690|FG000|Overall Study|Uninsured|1|||
105788541|NCT00423137|364880113|FG002|Overall Study|Adverse Event Study disease worse|3|||
105788542|NCT00423137|364880114|FG003|Overall Study|Adverse Event Study disease worse|1|||
105788543|NCT00423137|364880111|FG000|Overall Study|Adverse Event Other|0|||
105788544|NCT00423137|364880112|FG001|Overall Study|Adverse Event Other|0|||
105788545|NCT00423137|364880113|FG002|Overall Study|Adverse Event Other|2|||
105788546|NCT00423137|364880114|FG003|Overall Study|Adverse Event Other|0|||
105788547|NCT00348348|364880115|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
105788548|NCT00348348|364880116|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
105788549|NCT00348348|364880115|FG000|Overall Study|Lack of Efficacy|1|||
105788550|NCT00348348|364880116|FG001|Overall Study|Lack of Efficacy|1|||
105788551|NCT00348348|364880115|FG000|Overall Study|Lost to Follow-up|8|||
105788552|NCT00348348|364880116|FG001|Overall Study|Lost to Follow-up|10|||
105788553|NCT00348348|364880115|FG000|Overall Study|Withdrawal by Subject|4|||
105788554|NCT00348348|364880116|FG001|Overall Study|Withdrawal by Subject|1|||
105788555|NCT00348348|364880115|FG000|Overall Study|Other|7|||
105788556|NCT00348348|364880116|FG001|Overall Study|Other|4|||
105788557|NCT00348348|364880115|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
105788558|NCT00348348|364880116|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
105788559|NCT00348348|364880115|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
105788560|NCT00348348|364880116|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
105788561|NCT00348348|364880115|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
105788562|NCT00348348|364880116|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
105788563|NCT00348348|364880115|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
105788564|NCT00348348|364880116|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
105788565|NCT00348348|364880115|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
105788566|NCT00348348|364880116|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
105788567|NCT00348348|364880115|FG000|Overall Study|Adverse event probably related to study|1|||
105788568|NCT00348348|364880116|FG001|Overall Study|Adverse event probably related to study|0|||
105788569|NCT03710824|364880117|FG000|Overall Study|Withdrawal by Subject|1|||
105788570|NCT03710824|364880117|FG000|Overall Study|Lost to Follow-up|3|||
105788571|NCT03710824|364880117|FG000|Overall Study|Adverse Event|25|||
105788572|NCT03710824|364880117|FG000|Overall Study|Treatment discontinuation|2|||
105788573|NCT03358407|364880118|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788574|NCT03358407|364880119|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788575|NCT03358407|364880120|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
105788576|NCT03358407|364880121|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788577|NCT03358407|364880122|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788578|NCT03358407|364880123|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788579|NCT03358407|364880124|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105788580|NCT03358407|364880125|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105713502|NCT00577993|364609691|FG001|Overall Study|Uninsured|0|||
105713503|NCT00577993|364609692|FG002|Overall Study|Uninsured|0|||
105713504|NCT03033745|364609697|FG000|Overall Study|Protocol Violation|0|||
105713505|NCT03033745|364609698|FG001|Overall Study|Protocol Violation|0|||
105713506|NCT03033745|364609699|FG002|Overall Study|Protocol Violation|1|||
105788581|NCT03358407|364880126|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105713507|NCT03033745|364609697|FG000|Overall Study|Adverse Event|1|||
105713508|NCT03033745|364609698|FG001|Overall Study|Adverse Event|0|||
105713509|NCT03033745|364609699|FG002|Overall Study|Adverse Event|1|||
105713510|NCT03033745|364609697|FG000|Overall Study|Withdrawal by Subject|0|||
105713511|NCT03033745|364609698|FG001|Overall Study|Withdrawal by Subject|1|||
105713512|NCT03033745|364609699|FG002|Overall Study|Withdrawal by Subject|0|||
106135794|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Hospice care|0|||
106135795|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Hospice care|0|||
106135796|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Hospice care|0|||
106135797|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Physician Decision|1|||
105713513|NCT00684515|364609703|FG000|Overall Study|Adverse Event|3|||
105713514|NCT00684515|364609704|FG001|Overall Study|Adverse Event|3|||
105713515|NCT00684515|364609705|FG002|Overall Study|Adverse Event|1|||
105713516|NCT00684515|364609703|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
105713517|NCT00684515|364609704|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
105713518|NCT00684515|364609705|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
105930963|NCT01149538|365405870|FG000|Overall Study|Lost to Follow-up|0|||
105930964|NCT01149538|365405871|FG001|Overall Study|Lost to Follow-up|1|||
105930965|NCT01149538|365405870|FG000|Overall Study|Withdrawal by Subject|5|||
105930966|NCT01149538|365405871|FG001|Overall Study|Withdrawal by Subject|3|||
105930967|NCT01541254|365405881|FG000|Overall Study|Withdrawal by Subject|1|||
105930968|NCT01541254|365405881|FG000|Overall Study|excluded - metal allergy|1|||
105930969|NCT01541254|365405881|FG000|Overall Study|enrolled after study closed|1|||
105930970|NCT01541254|365405881|FG000|Overall Study|GI bleed prior to procedure|1|||
105930971|NCT01541254|365405881|FG000|Overall Study|stent not required|1|||
105930972|NCT01541254|365405881|FG000|Overall Study|alternate stent used|1|||
105930973|NCT06100250|365405882|FG000|Overall Study|Lost to Follow-up|5|||
105930974|NCT02021318|365405883|FG000|Overall Study|Adverse Event|2|||
105930975|NCT02021318|365405884|FG001|Overall Study|Adverse Event|1|||
105930976|NCT02021318|365405883|FG000|Overall Study|Death|33|||
105930977|NCT02021318|365405884|FG001|Overall Study|Death|34|||
105930978|NCT02021318|365405883|FG000|Overall Study|Lost to Follow-up|3|||
105930979|NCT02021318|365405884|FG001|Overall Study|Lost to Follow-up|3|||
105930980|NCT02021318|365405883|FG000|Overall Study|Progressive Disease|0|||
106135798|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Physician Decision|0|||
106135799|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Physician Decision|0|||
105930981|NCT02021318|365405884|FG001|Overall Study|Progressive Disease|1|||
105930982|NCT02021318|365405883|FG000|Overall Study|Withdrawal by Subject|30|||
106135800|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Physician Decision|0|||
106135801|NCT01107626|366156046|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
106135802|NCT01107626|366156047|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
106135803|NCT01107626|366156048|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
106135804|NCT01107626|366156049|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
106135805|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
106135806|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
106135807|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
106135808|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
106135809|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
106135810|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
106135811|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
106135812|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
106135813|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Death|0|||
106135814|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Death|8|||
105930983|NCT02021318|365405884|FG001|Overall Study|Withdrawal by Subject|18|||
105930984|NCT02021318|365405883|FG000|Overall Study|Physician Decision|3|||
105930985|NCT02021318|365405884|FG001|Overall Study|Physician Decision|3|||
105930986|NCT02021318|365405883|FG000|Overall Study|Miscellaneous|2|||
105930987|NCT02021318|365405884|FG001|Overall Study|Miscellaneous|3|||
105930988|NCT02569242|365405885|FG000|Overall Study|Death|1|||
105930989|NCT02569242|365405886|FG001|Overall Study|Death|0|||
105930990|NCT02569242|365405885|FG000|Overall Study|Withdrawal by Subject|0|||
105930991|NCT02569242|365405886|FG001|Overall Study|Withdrawal by Subject|1|||
105930992|NCT00689052|365405887|FG000|Overall Study|Adverse Event|4|||
105930993|NCT00689052|365405888|FG001|Overall Study|Adverse Event|6|||
105930994|NCT00689052|365405887|FG000|Overall Study|Protocol Violation|1|||
105930995|NCT00689052|365405888|FG001|Overall Study|Protocol Violation|0|||
105930996|NCT00689052|365405887|FG000|Overall Study|Lost to Follow-up|2|||
105930997|NCT00689052|365405888|FG001|Overall Study|Lost to Follow-up|0|||
105930998|NCT00689052|365405887|FG000|Overall Study|Withdrawal by Subject|2|||
105930999|NCT00689052|365405888|FG001|Overall Study|Withdrawal by Subject|0|||
105931000|NCT00689052|365405887|FG000|Overall Study|Early termination of the trial|22|||
105931001|NCT00689052|365405888|FG001|Overall Study|Early termination of the trial|24|||
105931002|NCT05661734|365405889|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
105931003|NCT05661734|365405889|FG000|Overall Study|Lost to Follow-up|13|||
106135815|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Death|2|||
106135816|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Death|13|||
105713519|NCT04016311|364609708|FG000|Overall Study|Withdrawal by Subject|1|||
105931004|NCT05661734|365405889|FG000|Overall Study|Enrolled but not dosed|2|||
105931005|NCT00003474|365405890|FG000|Overall Study|Not Evaluable|14|||
105713520|NCT04016311|364609709|FG001|Overall Study|Withdrawal by Subject|0|||
105931006|NCT01937117|365405895|FG000|Overall Study|Disease Progression|7|||
105931007|NCT01937117|365405895|FG000|Overall Study|Physician Decision|4|||
105713521|NCT04029519|364609711|FG000|Overall Study|Protocol Violation|1|||
105713522|NCT04029519|364609711|FG000|Overall Study|Withdrawal by Subject|3|||
105713523|NCT04029519|364609711|FG000|Overall Study|Lost to Follow-up|1|||
105713524|NCT03222349|364609712|FG000|Overall Study|Treatment B not done|5|||
105713525|NCT03222349|364609713|FG001|Overall Study|Treatment B not done|0|||
105713526|NCT03222349|364609712|FG000|Overall Study|Lost to Follow-up|1|||
105713527|NCT03222349|364609713|FG001|Overall Study|Lost to Follow-up|2|||
105931008|NCT01937117|365405895|FG000|Overall Study|Adverse Event|2|||
105931009|NCT03738215|365405896|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
105931010|NCT03738215|365405897|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
105931011|NCT03738215|365405898|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
105931012|NCT03738215|365405896|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
105931013|NCT03738215|365405897|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
105931014|NCT03738215|365405898|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105931015|NCT03738215|365405896|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
105931016|NCT03738215|365405897|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
105931017|NCT03738215|365405898|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
105931018|NCT03738215|365405896|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
105931019|NCT03738215|365405897|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
105931020|NCT03738215|365405898|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
105931021|NCT03738215|365405896|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
105931022|NCT03738215|365405897|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
105931023|NCT03738215|365405898|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
105931024|NCT03738215|365405896|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
105931025|NCT03738215|365405897|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
105931026|NCT03738215|365405898|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
105931027|NCT03738215|365405896|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
105931028|NCT03738215|365405897|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
105931029|NCT03738215|365405898|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
105931030|NCT03738215|365405896|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
105931031|NCT03738215|365405897|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
105931032|NCT03738215|365405898|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
105931033|NCT03738215|365405896|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
105931034|NCT03738215|365405897|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
105931035|NCT03738215|365405898|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
105931036|NCT03738215|365405896|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
105931037|NCT03738215|365405897|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
105931038|NCT03738215|365405898|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
105931039|NCT00853047|365405899|FG000|Core Phase|Participant Request|0|||
105931040|NCT00853047|365405900|FG001|Core Phase|Participant Request|0|||
105931041|NCT00853047|365405901|FG002|Core Phase|Participant Request|0|||
105931042|NCT00853047|365405902|FG003|Core Phase|Participant Request|1|||
105931043|NCT00853047|365405903|FG004|Core Phase|Participant Request|0|||
105931044|NCT00853047|365405904|FG005|Core Phase|Participant Request|0|||
105931045|NCT00853047|365405899|FG000|Open-Label Extension Phase|Participant Request|0|||
105931046|NCT00853047|365405900|FG001|Open-Label Extension Phase|Participant Request|0|||
105931047|NCT00853047|365405901|FG002|Open-Label Extension Phase|Participant Request|0|||
105931048|NCT00853047|365405902|FG003|Open-Label Extension Phase|Participant Request|0|||
105931049|NCT00853047|365405903|FG004|Open-Label Extension Phase|Participant Request|0|||
105931050|NCT00853047|365405904|FG005|Open-Label Extension Phase|Participant Request|7|||
105931051|NCT00853047|365405899|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
105931052|NCT00853047|365405900|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105931053|NCT00853047|365405901|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
105931054|NCT00853047|365405902|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
105931055|NCT00853047|365405903|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
105931056|NCT00853047|365405904|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
105931057|NCT00853047|365405899|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105931058|NCT00853047|365405900|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105931059|NCT00853047|365405901|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105931060|NCT00853047|365405902|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105713528|NCT03222349|364609712|FG000|Overall Study|Withdrawal by Subject|1|||
105713529|NCT03222349|364609713|FG001|Overall Study|Withdrawal by Subject|0|||
105931061|NCT00853047|365405903|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
105931062|NCT00853047|365405904|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
105931063|NCT00853047|365405899|FG000|Open-Label Extension Phase|Investigator Decision|0|||
105931064|NCT00853047|365405900|FG001|Open-Label Extension Phase|Investigator Decision|0|||
105713530|NCT03222349|364609712|FG000|Overall Study|Treatment A not done|0|||
105713531|NCT03222349|364609713|FG001|Overall Study|Treatment A not done|5|||
105713532|NCT03222349|364609712|FG000|Overall Study|Study terminated by sponsor|1|||
105713533|NCT03222349|364609713|FG001|Overall Study|Study terminated by sponsor|0|||
105931065|NCT00853047|365405901|FG002|Open-Label Extension Phase|Investigator Decision|0|||
105931066|NCT00853047|365405902|FG003|Open-Label Extension Phase|Investigator Decision|0|||
105931067|NCT00853047|365405903|FG004|Open-Label Extension Phase|Investigator Decision|0|||
105931068|NCT00853047|365405904|FG005|Open-Label Extension Phase|Investigator Decision|1|||
105931069|NCT00853047|365405899|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
105931070|NCT00853047|365405900|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
105931071|NCT00853047|365405901|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
105931072|NCT00853047|365405902|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
105931073|NCT00853047|365405903|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
105931074|NCT00853047|365405904|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
105931075|NCT00004859|365405909|FG000|Overall Study|Lack of Efficacy|43|||
105931076|NCT00004859|365405910|FG001|Overall Study|Lack of Efficacy|113|||
105931077|NCT00004859|365405909|FG000|Overall Study|Adverse Event|31|||
105931078|NCT00004859|365405910|FG001|Overall Study|Adverse Event|93|||
105931079|NCT00004859|365405909|FG000|Overall Study|Death|5|||
105931080|NCT00004859|365405910|FG001|Overall Study|Death|5|||
105931081|NCT00004859|365405909|FG000|Overall Study|Withdrawal by Subject|7|||
105931082|NCT00004859|365405910|FG001|Overall Study|Withdrawal by Subject|33|||
105931083|NCT00004859|365405909|FG000|Overall Study|Protocol Violation|2|||
105931084|NCT00004859|365405910|FG001|Overall Study|Protocol Violation|2|||
105931085|NCT00004859|365405909|FG000|Overall Study|other disease|0|||
105931086|NCT00004859|365405910|FG001|Overall Study|other disease|3|||
105931087|NCT00004859|365405909|FG000|Overall Study|error|3|||
105931088|NCT00004859|365405910|FG001|Overall Study|error|1|||
105931089|NCT00004859|365405909|FG000|Overall Study|missing data|14|||
105931090|NCT00004859|365405910|FG001|Overall Study|missing data|11|||
105931091|NCT00004859|365405909|FG000|Overall Study|Other|13|||
105931092|NCT00004859|365405910|FG001|Overall Study|Other|21|||
105931093|NCT02724644|365407642|FG000|Overall Study|Adverse Event|7|||
105931094|NCT02724644|365407643|FG001|Overall Study|Adverse Event|1|||
105931095|NCT02724644|365407642|FG000|Overall Study|Lost to Follow-up|6|||
105931096|NCT02724644|365407643|FG001|Overall Study|Lost to Follow-up|2|||
106135817|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
106135818|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
106135819|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
106135820|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
106135821|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
106135822|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
106135823|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
106135824|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
106135825|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
106135826|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
106135827|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
106135828|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
106135829|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
106135830|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
106135831|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
105713534|NCT01699087|364609716|FG000|Overall Study|Lost to Follow-up|7|||
105713535|NCT01699087|364609716|FG000|Overall Study|Screen failure (prior to treatment)|15|||
105713536|NCT01699087|364609716|FG000|Overall Study|Unable to make future visits|2|||
105713537|NCT00070941|364609717|FG000|Overall Study|Adverse Event|10|||
105713538|NCT00070941|364609718|FG001|Overall Study|Adverse Event|8|||
105713539|NCT00070941|364609719|FG002|Overall Study|Adverse Event|4|||
105713540|NCT02064387|364609720|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713541|NCT02064387|364609721|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713542|NCT02064387|364609722|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713543|NCT02064387|364609723|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713544|NCT02064387|364609724|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713545|NCT02064387|364609725|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713546|NCT02064387|364609726|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713547|NCT02064387|364609727|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
105713548|NCT02064387|364609728|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713549|NCT02064387|364609729|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
105713550|NCT02064387|364609730|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713551|NCT02064387|364609731|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
105713552|NCT02064387|364609720|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713553|NCT02064387|364609721|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713554|NCT02064387|364609722|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713555|NCT02064387|364609723|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713556|NCT02064387|364609724|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713557|NCT02064387|364609725|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713558|NCT02064387|364609726|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713559|NCT02064387|364609727|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
105713560|NCT02064387|364609728|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713561|NCT02064387|364609729|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713562|NCT02064387|364609730|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713563|NCT02064387|364609731|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
105713564|NCT02064387|364609720|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713565|NCT02064387|364609721|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713566|NCT02064387|364609722|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713567|NCT02064387|364609723|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713568|NCT02064387|364609724|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713569|NCT02064387|364609725|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713570|NCT02064387|364609726|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713571|NCT02064387|364609727|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713572|NCT02064387|364609728|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
105713573|NCT02064387|364609729|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713574|NCT02064387|364609730|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713575|NCT02064387|364609731|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
105713576|NCT02064387|364609720|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
105713577|NCT02064387|364609721|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
105713578|NCT02064387|364609722|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
105713579|NCT02064387|364609723|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
106008623|NCT01345240|365697041|FG000|Overall Study|Lost to Follow-up|8|||
105713580|NCT02064387|364609724|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
105713581|NCT02064387|364609725|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
105713582|NCT02064387|364609726|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
105713583|NCT02064387|364609727|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
105713584|NCT02064387|364609728|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
105788582|NCT03358407|364880127|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
105713585|NCT02064387|364609729|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
105713586|NCT02064387|364609730|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
105713587|NCT02064387|364609731|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
105713588|NCT02064387|364609720|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713589|NCT02064387|364609721|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713590|NCT02064387|364609722|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713591|NCT02064387|364609723|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713592|NCT02064387|364609724|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713593|NCT02064387|364609725|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713594|NCT02064387|364609726|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713595|NCT02064387|364609727|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713596|NCT02064387|364609728|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713597|NCT02064387|364609729|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713598|NCT02064387|364609730|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
105713599|NCT02064387|364609731|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
105713600|NCT00756938|364609736|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
105713601|NCT00756938|364609737|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
105713602|NCT00756938|364609738|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
105713603|NCT00756938|364609739|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
105713604|NCT00756938|364609736|FG000|12-week Base Study|Protocol Violation|0|||
105713605|NCT00756938|364609737|FG001|12-week Base Study|Protocol Violation|0|||
105931097|NCT02724644|365407642|FG000|Overall Study|Withdrawal by Subject|7|||
105931098|NCT02724644|365407643|FG001|Overall Study|Withdrawal by Subject|1|||
105931099|NCT02724644|365407642|FG000|Overall Study|Administrative|1|||
105931100|NCT02724644|365407643|FG001|Overall Study|Administrative|0|||
105931101|NCT04766333|365407644|FG000|Overall Study|Lost to Follow-up|40|||
105931102|NCT04766333|365407645|FG001|Overall Study|Lost to Follow-up|826|||
105931103|NCT03695094|365407648|FG000|Overall Study|Adverse Event|1|||
105931104|NCT03695094|365407649|FG001|Overall Study|Adverse Event|1|||
105931105|NCT03695094|365407648|FG000|Overall Study|Withdrawal by Subject|1|||
106008624|NCT01345240|365697042|FG001|Overall Study|Lost to Follow-up|9|||
105713606|NCT00756938|364609738|FG002|12-week Base Study|Protocol Violation|1|||
105713607|NCT00756938|364609739|FG003|12-week Base Study|Protocol Violation|0|||
105713608|NCT00756938|364609736|FG000|12-week Base Study|Lost to Follow-up|1|||
105713609|NCT00756938|364609737|FG001|12-week Base Study|Lost to Follow-up|0|||
105713610|NCT00756938|364609738|FG002|12-week Base Study|Lost to Follow-up|0|||
105713611|NCT00756938|364609739|FG003|12-week Base Study|Lost to Follow-up|0|||
105713612|NCT00756938|364609736|FG000|Optional Extension|Lack of Efficacy|0|||
105713613|NCT00756938|364609737|FG001|Optional Extension|Lack of Efficacy|0|||
105713614|NCT00756938|364609738|FG002|Optional Extension|Lack of Efficacy|0|||
105713615|NCT00756938|364609739|FG003|Optional Extension|Lack of Efficacy|1|||
105713616|NCT00756938|364609736|FG000|Optional Extension|End of Study|0|||
105713617|NCT00756938|364609737|FG001|Optional Extension|End of Study|0|||
105713618|NCT00756938|364609738|FG002|Optional Extension|End of Study|0|||
105713619|NCT00756938|364609739|FG003|Optional Extension|End of Study|11|||
105713620|NCT00756938|364609736|FG000|Optional Extension|Protocol-specific criteria met|0|||
105713621|NCT00756938|364609737|FG001|Optional Extension|Protocol-specific criteria met|0|||
105713622|NCT00756938|364609738|FG002|Optional Extension|Protocol-specific criteria met|0|||
105713623|NCT00756938|364609739|FG003|Optional Extension|Protocol-specific criteria met|9|||
105713624|NCT00756938|364609736|FG000|Optional Extension|Physician Decision|0|||
105713625|NCT00756938|364609737|FG001|Optional Extension|Physician Decision|0|||
105713626|NCT00756938|364609738|FG002|Optional Extension|Physician Decision|0|||
105713627|NCT00756938|364609739|FG003|Optional Extension|Physician Decision|3|||
105713628|NCT00756938|364609736|FG000|Optional Extension|Lost to Follow-up|0|||
105713629|NCT00756938|364609737|FG001|Optional Extension|Lost to Follow-up|0|||
105713630|NCT00756938|364609738|FG002|Optional Extension|Lost to Follow-up|0|||
105713631|NCT00756938|364609739|FG003|Optional Extension|Lost to Follow-up|1|||
105713632|NCT00756938|364609736|FG000|Optional Extension|Protocol Violation|0|||
105713633|NCT00756938|364609737|FG001|Optional Extension|Protocol Violation|0|||
105713634|NCT00756938|364609738|FG002|Optional Extension|Protocol Violation|0|||
105713635|NCT00756938|364609739|FG003|Optional Extension|Protocol Violation|1|||
105713636|NCT00756938|364609736|FG000|Optional Extension|Withdrawal by Subject|0|||
105713637|NCT00756938|364609737|FG001|Optional Extension|Withdrawal by Subject|0|||
105931106|NCT03695094|365407649|FG001|Overall Study|Withdrawal by Subject|0|||
105931107|NCT00530075|365407650|FG000|Overall Study|Adverse Event|1|||
106135832|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
106135833|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
106135834|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
106135835|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
106135836|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
106135837|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
106135838|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
106135839|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
106135840|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
106135841|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
106135842|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
106135843|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
106135844|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
106135845|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
106135846|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
106135847|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
106135848|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
106135849|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
106135850|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
106135851|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
106135852|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
106135853|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
106135854|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
106135855|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
106135856|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
106135857|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Pain|0|||
106135858|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Pain|0|||
105713638|NCT00756938|364609738|FG002|Optional Extension|Withdrawal by Subject|0|||
105713639|NCT00756938|364609739|FG003|Optional Extension|Withdrawal by Subject|10|||
105713640|NCT00756938|364609736|FG000|Optional Extension|Adverse Event|0|||
105713641|NCT00756938|364609737|FG001|Optional Extension|Adverse Event|0|||
105713642|NCT00756938|364609738|FG002|Optional Extension|Adverse Event|0|||
105713643|NCT00756938|364609739|FG003|Optional Extension|Adverse Event|1|||
105713644|NCT02302963|364609740|FG000|Overall Study|Withdrawal by Subject|2|||
105713645|NCT02302963|364609741|FG001|Overall Study|Withdrawal by Subject|1|||
105713646|NCT02302963|364609740|FG000|Overall Study|Steroid injection|0|||
105713647|NCT02302963|364609741|FG001|Overall Study|Steroid injection|1|||
105713648|NCT02302963|364609740|FG000|Overall Study|Physician Decision|1|||
105713649|NCT02302963|364609741|FG001|Overall Study|Physician Decision|0|||
105713650|NCT02319044|364609747|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
105931108|NCT00530075|365407650|FG000|Overall Study|Death|1|||
105713651|NCT02319044|364609748|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
105713652|NCT02319044|364609749|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
105713653|NCT02319044|364609747|FG000|Overall Study|Withdrawal by Subject|3|||
105713654|NCT02319044|364609748|FG001|Overall Study|Withdrawal by Subject|3|||
105713655|NCT02319044|364609749|FG002|Overall Study|Withdrawal by Subject|6|||
105713656|NCT02319044|364609747|FG000|Overall Study|Condition under investigation worsened|100|||
105713657|NCT02319044|364609748|FG001|Overall Study|Condition under investigation worsened|50|||
105713658|NCT02319044|364609749|FG002|Overall Study|Condition under investigation worsened|46|||
105713659|NCT02319044|364609747|FG000|Overall Study|Adverse Event|17|||
105713660|NCT02319044|364609748|FG001|Overall Study|Adverse Event|2|||
105713661|NCT02319044|364609749|FG002|Overall Study|Adverse Event|8|||
105713662|NCT02319044|364609747|FG000|Overall Study|Study specific discontinuation criteria|2|||
105713663|NCT02319044|364609748|FG001|Overall Study|Study specific discontinuation criteria|2|||
105713664|NCT02319044|364609749|FG002|Overall Study|Study specific discontinuation criteria|1|||
105713665|NCT02319044|364609747|FG000|Overall Study|Not treated|0|||
105713666|NCT02319044|364609748|FG001|Overall Study|Not treated|2|||
105713667|NCT02319044|364609749|FG002|Overall Study|Not treated|2|||
105713668|NCT03551743|364609750|FG000|Overall Study|Adverse Event|1|||
105713669|NCT03551743|364609751|FG001|Overall Study|Adverse Event|0|||
105713670|NCT03551743|364609752|FG002|Overall Study|Adverse Event|0|||
105713671|NCT03551743|364609753|FG003|Overall Study|Adverse Event|0|||
105713672|NCT03551743|364609750|FG000|Overall Study|Withdrawal by Subject|1|||
105713673|NCT03551743|364609751|FG001|Overall Study|Withdrawal by Subject|0|||
105713674|NCT03551743|364609752|FG002|Overall Study|Withdrawal by Subject|0|||
105788583|NCT03358407|364880118|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105713675|NCT03551743|364609753|FG003|Overall Study|Withdrawal by Subject|0|||
105713676|NCT01145066|364609754|FG000|Overall Study|To resume NSAIDs|2|||
105713677|NCT01145066|364609755|FG001|Overall Study|To resume NSAIDs|2|||
105713678|NCT01145066|364609756|FG002|Overall Study|To resume NSAIDs|1|||
105713679|NCT01145066|364609754|FG000|Overall Study|Non-related surgery|0|||
105713680|NCT01145066|364609755|FG001|Overall Study|Non-related surgery|0|||
105713681|NCT01145066|364609756|FG002|Overall Study|Non-related surgery|1|||
105713682|NCT01145066|364609754|FG000|Overall Study|Withdrawal by Subject|0|||
105713683|NCT01145066|364609755|FG001|Overall Study|Withdrawal by Subject|0|||
105713684|NCT01145066|364609756|FG002|Overall Study|Withdrawal by Subject|2|||
105713685|NCT01145066|364609754|FG000|Overall Study|To start new med|1|||
105713686|NCT01145066|364609755|FG001|Overall Study|To start new med|0|||
105713687|NCT01145066|364609756|FG002|Overall Study|To start new med|0|||
105713688|NCT01145066|364609754|FG000|Overall Study|problems swallowing capsule|1|||
105713689|NCT01145066|364609755|FG001|Overall Study|problems swallowing capsule|0|||
105713690|NCT01145066|364609756|FG002|Overall Study|problems swallowing capsule|0|||
105713691|NCT01145066|364609754|FG000|Overall Study|Abdominal discomfort|0|||
105713692|NCT01145066|364609755|FG001|Overall Study|Abdominal discomfort|1|||
105713693|NCT01145066|364609756|FG002|Overall Study|Abdominal discomfort|0|||
105713694|NCT01145066|364609754|FG000|Overall Study|Low platelet count|0|||
105713695|NCT01145066|364609755|FG001|Overall Study|Low platelet count|1|||
105713696|NCT01145066|364609756|FG002|Overall Study|Low platelet count|0|||
105713697|NCT00217087|364609757|FG000|Overall Study|decided to have esophagectomy|1|||
105713698|NCT00217087|364609758|FG001|Overall Study|decided to have esophagectomy|2|||
105713699|NCT00217087|364609757|FG000|Overall Study|completed less than 12 months return|10|||
105713700|NCT00217087|364609758|FG001|Overall Study|completed less than 12 months return|18|||
105713701|NCT01634555|364609767|FG000|Overall Study|Adverse Event|3|||
105713702|NCT01634555|364609767|FG000|Overall Study|Physician Decision|1|||
105713703|NCT01031446|364609774|FG000|Overall Study|Disease Progression|38|||
105713704|NCT01031446|364609774|FG000|Overall Study|Adverse Event|9|||
105713705|NCT01031446|364609774|FG000|Overall Study|Physician Decision|4|||
105713706|NCT01031446|364609774|FG000|Overall Study|Withdrawal by Subject|3|||
105713707|NCT01031446|364609774|FG000|Overall Study|Still on treatment|1|||
105713708|NCT00772668|364609777|FG000|Overall Study|Physician Decision|3|||
105713709|NCT01227902|364611898|FG000|Overall Study|Adverse Event|12|||
105713710|NCT01227902|364611899|FG001|Overall Study|Adverse Event|8|||
105713711|NCT01227902|364611900|FG002|Overall Study|Adverse Event|11|||
105713712|NCT01227902|364611901|FG003|Overall Study|Adverse Event|4|||
105713713|NCT01227902|364611898|FG000|Overall Study|Lack of Efficacy|1|||
105713714|NCT01227902|364611899|FG001|Overall Study|Lack of Efficacy|2|||
105713715|NCT01227902|364611900|FG002|Overall Study|Lack of Efficacy|2|||
105713716|NCT01227902|364611901|FG003|Overall Study|Lack of Efficacy|1|||
105713717|NCT01227902|364611898|FG000|Overall Study|Protocol Violation|1|||
105713718|NCT01227902|364611899|FG001|Overall Study|Protocol Violation|0|||
105713719|NCT01227902|364611900|FG002|Overall Study|Protocol Violation|0|||
105713720|NCT01227902|364611901|FG003|Overall Study|Protocol Violation|0|||
105713721|NCT01227902|364611898|FG000|Overall Study|Lost to Follow-up|0|||
105713722|NCT01227902|364611899|FG001|Overall Study|Lost to Follow-up|0|||
105713723|NCT01227902|364611900|FG002|Overall Study|Lost to Follow-up|1|||
105713724|NCT01227902|364611901|FG003|Overall Study|Lost to Follow-up|2|||
105713725|NCT01227902|364611898|FG000|Overall Study|Physician Decision|0|||
105713726|NCT01227902|364611899|FG001|Overall Study|Physician Decision|1|||
105713727|NCT01227902|364611900|FG002|Overall Study|Physician Decision|1|||
105713728|NCT01227902|364611901|FG003|Overall Study|Physician Decision|0|||
105713729|NCT01227902|364611898|FG000|Overall Study|Withdrawal by Subject|4|||
105713730|NCT01227902|364611899|FG001|Overall Study|Withdrawal by Subject|2|||
105713731|NCT01227902|364611900|FG002|Overall Study|Withdrawal by Subject|4|||
105713732|NCT01227902|364611901|FG003|Overall Study|Withdrawal by Subject|3|||
105713733|NCT01178138|364611904|FG000|Overall Study|Lost to Follow-up|8|||
105713734|NCT01178138|364611904|FG000|Overall Study|Withdrawal by Subject|7|||
105713735|NCT01178138|364611904|FG000|Overall Study|Physician Decision|8|||
105713736|NCT02634580|364611915|FG000|Double-blind Treatment Period|Subject Request|1|||
105713737|NCT02634580|364611916|FG001|Double-blind Treatment Period|Subject Request|0|||
105713738|NCT02634580|364611917|FG002|Double-blind Treatment Period|Subject Request|1|||
105713739|NCT02634580|364611918|FG003|Double-blind Treatment Period|Subject Request|1|||
105713740|NCT02634580|364611915|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
105931109|NCT00530075|365407650|FG000|Overall Study|Lack of Efficacy|3|||
105931110|NCT00530075|365407650|FG000|Overall Study|Protocol Violation|1|||
105931111|NCT00530075|365407650|FG000|Overall Study|Withdrawal by Subject|1|||
105931112|NCT00422461|365407657|FG000|Overall Study|Adverse Event|1|||
105931113|NCT00422461|365407658|FG001|Overall Study|Adverse Event|2|||
105931114|NCT00422461|365407659|FG002|Overall Study|Adverse Event|1|||
105931115|NCT00422461|365407660|FG003|Overall Study|Adverse Event|1|||
105931116|NCT00422461|365407657|FG000|Overall Study|Other|0|||
105931117|NCT00422461|365407658|FG001|Overall Study|Other|0|||
105931118|NCT00422461|365407659|FG002|Overall Study|Other|0|||
105931119|NCT00422461|365407660|FG003|Overall Study|Other|2|||
105931120|NCT00422461|365407657|FG000|Overall Study|Participants no longer willing to participate in study|1|||
106135859|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Pain|0|||
106135860|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Pain|1|||
106135861|NCT01107626|366156046|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
106135862|NCT01107626|366156047|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
106135863|NCT01107626|366156048|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
106135864|NCT01107626|366156049|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
106135865|NCT00711646|366156050|FG000|Overall Study|Adverse Event|6|||
106135866|NCT00711646|366156051|FG001|Overall Study|Adverse Event|1|||
106135867|NCT00711646|366156050|FG000|Overall Study|Withdrawal by Subject|4|||
106135868|NCT00711646|366156051|FG001|Overall Study|Withdrawal by Subject|0|||
106135869|NCT00711646|366156050|FG000|Overall Study|Protocol Violation|0|||
106135870|NCT00711646|366156051|FG001|Overall Study|Protocol Violation|1|||
106135871|NCT00711646|366156050|FG000|Overall Study|Lost to Follow-up|1|||
106135872|NCT00711646|366156051|FG001|Overall Study|Lost to Follow-up|0|||
106135873|NCT00711646|366156050|FG000|Overall Study|administrative decision|0|||
106135874|NCT00711646|366156051|FG001|Overall Study|administrative decision|1|||
106135875|NCT00711646|366156050|FG000|Overall Study|patient non-compliance|1|||
106135876|NCT00711646|366156051|FG001|Overall Study|patient non-compliance|0|||
106135877|NCT03107611|366156052|FG000|Overall Study|Adverse Event|1|||
106135878|NCT03107611|366156053|FG001|Overall Study|Adverse Event|0|||
106135879|NCT03107611|366156054|FG002|Overall Study|Adverse Event|2|||
105713741|NCT02634580|364611916|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
105713742|NCT02634580|364611917|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
105713743|NCT02634580|364611918|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
105713744|NCT00197054|364611922|FG000|Overall Study|Withdrawal by Subject|9|||
105788584|NCT03358407|364880119|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105931121|NCT00422461|365407658|FG001|Overall Study|Participants no longer willing to participate in study|0|||
105931122|NCT00422461|365407659|FG002|Overall Study|Participants no longer willing to participate in study|0|||
105931123|NCT00422461|365407660|FG003|Overall Study|Participants no longer willing to participate in study|0|||
105931124|NCT00422461|365407657|FG000|Overall Study|Randomized but not treated|1|||
105931125|NCT00422461|365407658|FG001|Overall Study|Randomized but not treated|1|||
105931126|NCT00422461|365407659|FG002|Overall Study|Randomized but not treated|0|||
105931127|NCT00422461|365407660|FG003|Overall Study|Randomized but not treated|0|||
105931128|NCT00145327|365407663|FG000|Overall Study|Withdrawal by Subject|77|||
106135880|NCT03107611|366156052|FG000|Overall Study|Lost to Follow-up|3|||
106135881|NCT03107611|366156053|FG001|Overall Study|Lost to Follow-up|3|||
106135882|NCT03107611|366156054|FG002|Overall Study|Lost to Follow-up|3|||
106135883|NCT03107611|366156052|FG000|Overall Study|Protocol Violation|0|||
106135884|NCT03107611|366156053|FG001|Overall Study|Protocol Violation|0|||
105713745|NCT00197054|364611923|FG001|Overall Study|Withdrawal by Subject|3|||
105713746|NCT00197054|364611924|FG002|Overall Study|Withdrawal by Subject|3|||
105713747|NCT00197054|364611922|FG000|Overall Study|Moved from area|7|||
105713748|NCT00197054|364611923|FG001|Overall Study|Moved from area|14|||
105713749|NCT00197054|364611924|FG002|Overall Study|Moved from area|9|||
105713750|NCT00197054|364611922|FG000|Overall Study|Lost to Follow-up|1|||
105713751|NCT00197054|364611923|FG001|Overall Study|Lost to Follow-up|4|||
105713752|NCT00197054|364611924|FG002|Overall Study|Lost to Follow-up|0|||
105713753|NCT00323557|364611925|FG000|Overall Study|Physician Decision|1|||
105713754|NCT00323557|364611926|FG001|Overall Study|Physician Decision|0|||
105713755|NCT00272987|364611927|FG000|Overall Study|Adverse Event|1|||
105713756|NCT00272987|364611928|FG001|Overall Study|Adverse Event|0|||
105713757|NCT00272987|364611929|FG002|Overall Study|Adverse Event|0|||
105713758|NCT00272987|364611927|FG000|Overall Study|Lost to Follow-up|3|||
105931129|NCT00145327|365407664|FG001|Overall Study|Withdrawal by Subject|72|||
105931130|NCT00145327|365407665|FG002|Overall Study|Withdrawal by Subject|164|||
105931131|NCT00145327|365407663|FG000|Overall Study|Death|26|||
105931132|NCT00145327|365407664|FG001|Overall Study|Death|18|||
106135885|NCT03107611|366156054|FG002|Overall Study|Protocol Violation|1|||
106135886|NCT03107611|366156052|FG000|Overall Study|Withdrawal by Subject|1|||
106135887|NCT03107611|366156053|FG001|Overall Study|Withdrawal by Subject|0|||
106135888|NCT03107611|366156054|FG002|Overall Study|Withdrawal by Subject|1|||
106135889|NCT03107611|366156052|FG000|Overall Study|Worsening signs/symptoms|2|||
106135890|NCT03107611|366156053|FG001|Overall Study|Worsening signs/symptoms|1|||
106135891|NCT03107611|366156054|FG002|Overall Study|Worsening signs/symptoms|2|||
106135892|NCT01720446|366156055|FG000|Overall Study|Lost to Follow-up|12|||
106135893|NCT01720446|366156056|FG001|Overall Study|Lost to Follow-up|6|||
106135894|NCT01720446|366156057|FG002|Overall Study|Lost to Follow-up|16|||
106135895|NCT01720446|366156058|FG003|Overall Study|Lost to Follow-up|16|||
106135896|NCT01720446|366156055|FG000|Overall Study|Withdrawal by Subject|2|||
106135897|NCT01720446|366156056|FG001|Overall Study|Withdrawal by Subject|5|||
106135898|NCT01720446|366156057|FG002|Overall Study|Withdrawal by Subject|4|||
106135899|NCT01720446|366156058|FG003|Overall Study|Withdrawal by Subject|4|||
106135900|NCT01020838|366156059|FG000|Overall Study|Death|90|||
106135901|NCT01020838|366156059|FG000|Overall Study|Adverse Event|1|||
106135902|NCT01020838|366156059|FG000|Overall Study|Withdrawal by Subject|9|||
106135903|NCT01020838|366156059|FG000|Overall Study|Lost to Follow-up|6|||
106135904|NCT01020838|366156059|FG000|Overall Study|Most common: Study ended by sponsor|77|||
106135905|NCT00930813|366156060|FG000|Overall Study|Death|4|||
106135906|NCT00930813|366156061|FG001|Overall Study|Death|5|||
106135907|NCT00930813|366156060|FG000|Overall Study|Withdrawal by Subject|2|||
106135908|NCT00930813|366156061|FG001|Overall Study|Withdrawal by Subject|5|||
106135909|NCT00930813|366156060|FG000|Overall Study|Lost to Follow-up|2|||
106135910|NCT00930813|366156061|FG001|Overall Study|Lost to Follow-up|4|||
106135911|NCT03441984|366156063|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
106135912|NCT03441984|366156064|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105931133|NCT00145327|365407665|FG002|Overall Study|Death|30|||
105931134|NCT00145327|365407663|FG000|Overall Study|Adverse Event|14|||
105931135|NCT00145327|365407664|FG001|Overall Study|Adverse Event|11|||
105931136|NCT00145327|365407665|FG002|Overall Study|Adverse Event|22|||
105931137|NCT00145327|365407663|FG000|Overall Study|Lost to Follow-up|9|||
105931138|NCT00145327|365407664|FG001|Overall Study|Lost to Follow-up|14|||
105931139|NCT00145327|365407665|FG002|Overall Study|Lost to Follow-up|14|||
105931140|NCT00145327|365407663|FG000|Overall Study|Administrative problems|12|||
105931141|NCT00145327|365407664|FG001|Overall Study|Administrative problems|9|||
105931142|NCT00145327|365407665|FG002|Overall Study|Administrative problems|13|||
105931143|NCT00145327|365407663|FG000|Overall Study|Protocol Violation|2|||
105931144|NCT00145327|365407664|FG001|Overall Study|Protocol Violation|0|||
105931145|NCT00145327|365407665|FG002|Overall Study|Protocol Violation|2|||
105931146|NCT00145327|365407663|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105931147|NCT00145327|365407664|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105931148|NCT00145327|365407665|FG002|Overall Study|Abnormal laboratory value(s)|2|||
105931149|NCT00145327|365407663|FG000|Overall Study|Missing - not stated|1|||
105931150|NCT00145327|365407664|FG001|Overall Study|Missing - not stated|0|||
106135913|NCT03441984|366156065|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
106135914|NCT03441984|366156066|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
106135915|NCT03441984|366156067|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
106135916|NCT03441984|366156068|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
106135917|NCT03441984|366156069|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
106135918|NCT03441984|366156070|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105931151|NCT00145327|365407665|FG002|Overall Study|Missing - not stated|1|||
106135919|NCT03441984|366156071|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
106135920|NCT03441984|366156072|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105713759|NCT00272987|364611928|FG001|Overall Study|Lost to Follow-up|1|||
105931152|NCT01795937|365407666|FG000|Overall Study|Withdrawal by Subject|1|||
105713760|NCT00272987|364611929|FG002|Overall Study|Lost to Follow-up|1|||
105713761|NCT00272987|364611927|FG000|Overall Study|Withdrawal by Subject|1|||
105931153|NCT01795937|365407667|FG001|Overall Study|Withdrawal by Subject|0|||
105931154|NCT01795937|365407668|FG002|Overall Study|Withdrawal by Subject|0|||
105931155|NCT01795937|365407666|FG000|Overall Study|Physician Decision|0|||
105788585|NCT03358407|364880120|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788586|NCT03358407|364880121|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788587|NCT03358407|364880122|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
105788588|NCT03358407|364880123|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788589|NCT03358407|364880124|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788590|NCT03358407|364880125|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788591|NCT03358407|364880126|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788592|NCT03358407|364880127|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788593|NCT03358407|364880118|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788594|NCT03358407|364880119|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788595|NCT03358407|364880120|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788596|NCT03358407|364880121|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788597|NCT03358407|364880122|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788598|NCT03358407|364880123|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
105788599|NCT03358407|364880124|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788600|NCT03358407|364880125|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
105788601|NCT03358407|364880126|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788602|NCT03358407|364880127|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
105788603|NCT03358407|364880118|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788604|NCT03358407|364880119|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788605|NCT03358407|364880120|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788606|NCT03358407|364880121|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788607|NCT03358407|364880122|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788608|NCT03358407|364880123|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
105788609|NCT03358407|364880124|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788610|NCT03358407|364880125|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
105788611|NCT03358407|364880126|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788612|NCT03358407|364880127|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
105788613|NCT03358407|364880118|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788614|NCT03358407|364880119|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788615|NCT03358407|364880120|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788616|NCT03358407|364880121|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788617|NCT03358407|364880122|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788618|NCT03358407|364880123|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
105788619|NCT03358407|364880124|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
105788620|NCT03358407|364880125|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788621|NCT03358407|364880126|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788622|NCT03358407|364880127|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
105788623|NCT03358407|364880118|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788624|NCT03358407|364880119|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788625|NCT03358407|364880120|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788626|NCT03358407|364880121|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788627|NCT03358407|364880122|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788628|NCT03358407|364880123|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
105788629|NCT03358407|364880124|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
105788630|NCT03358407|364880125|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
105788631|NCT03358407|364880126|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788632|NCT03358407|364880127|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
105788633|NCT04640168|364880128|FG000|Overall Study|Withdrawal by Subject|8|||
105788634|NCT04640168|364880129|FG001|Overall Study|Withdrawal by Subject|7|||
105788635|NCT04640168|364880128|FG000|Overall Study|Lost to Follow-up|1|||
105788636|NCT04640168|364880129|FG001|Overall Study|Lost to Follow-up|0|||
105788637|NCT04640168|364880128|FG000|Overall Study|Enrolled but not treated|12|||
105788638|NCT04640168|364880129|FG001|Overall Study|Enrolled but not treated|12|||
105788639|NCT02940392|364880130|FG000|Overall Study|Lost to Follow-up|3|||
105788640|NCT02940392|364880130|FG000|Overall Study|Retreatment|3|||
105788641|NCT02940392|364880130|FG000|Overall Study|Death|2|||
105788642|NCT03205046|364880131|FG000|Overall Study|Death|10|||
105788643|NCT03205046|364880132|FG001|Overall Study|Death|6|||
105788644|NCT03205046|364880131|FG000|Overall Study|Withdrawal by Subject|1|||
105788645|NCT03205046|364880132|FG001|Overall Study|Withdrawal by Subject|2|||
105788646|NCT03205046|364880131|FG000|Overall Study|Lost to Follow-up|0|||
105788647|NCT03205046|364880132|FG001|Overall Study|Lost to Follow-up|1|||
105788648|NCT03205046|364880131|FG000|Overall Study|Study terminated by sponsor|2|||
105788649|NCT03205046|364880132|FG001|Overall Study|Study terminated by sponsor|1|||
105788650|NCT03992456|364880135|FG000|Overall Study|Withdrawal by Subject|1|||
105788651|NCT03992456|364880136|FG001|Overall Study|Withdrawal by Subject|0|||
105788652|NCT03992456|364880135|FG000|Overall Study|Disease progression|4|||
105788653|NCT03992456|364880136|FG001|Overall Study|Disease progression|5|||
105788654|NCT03992456|364880135|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
105788655|NCT03992456|364880136|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
105788656|NCT04882085|364880153|FG000|Overall Study|Death|6|||
105788657|NCT04882085|364880154|FG001|Overall Study|Death|9|||
105788658|NCT04882085|364880153|FG000|Overall Study|Withdrawal by Subject|0|||
105788659|NCT04882085|364880154|FG001|Overall Study|Withdrawal by Subject|3|||
105788660|NCT04882085|364880153|FG000|Overall Study|Randomized not treated|1|||
105788661|NCT04882085|364880154|FG001|Overall Study|Randomized not treated|0|||
105788662|NCT03593525|364880155|FG000|Overall Study|Withdrawal by Subject|1|||
105788663|NCT03593525|364880156|FG001|Overall Study|Withdrawal by Subject|0|||
105788664|NCT03593525|364880155|FG000|Overall Study|Lost to Follow-up|7|||
105788665|NCT03593525|364880156|FG001|Overall Study|Lost to Follow-up|5|||
105788666|NCT05939388|364880157|FG000|Overall Study|Lost to Follow-up|1|||
105788667|NCT01602380|364880162|FG000|Overall Study|Death|147|||
105788668|NCT01602380|364880163|FG001|Overall Study|Death|145|||
105788669|NCT01602380|364880162|FG000|Overall Study|Withdrawal by Subject|39|||
105788670|NCT01602380|364880163|FG001|Overall Study|Withdrawal by Subject|41|||
105788671|NCT01602380|364880162|FG000|Overall Study|Lost to Follow-up|15|||
105788672|NCT01602380|364880163|FG001|Overall Study|Lost to Follow-up|12|||
105788673|NCT01602380|364880162|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105788674|NCT01602380|364880163|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
105788675|NCT01602380|364880162|FG000|Overall Study|Other|2|||
105788676|NCT01602380|364880163|FG001|Overall Study|Other|0|||
105788677|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
105788678|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
105788679|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
105788680|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
105788681|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
105788682|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
105788683|NCT00828009|364880164|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
105788684|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
105788685|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
105788686|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Death|1|||
105788687|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
105788688|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
105788689|NCT00828009|364880164|FG000|Step 2 - Maintenance Therapy|Other|1|||
105788690|NCT02062385|364880165|FG000|Overall Study|Adverse Event|19|||
105788691|NCT02062385|364880166|FG001|Overall Study|Adverse Event|13|||
105788692|NCT02062385|364880167|FG002|Overall Study|Adverse Event|1|||
105788693|NCT02062385|364880168|FG003|Overall Study|Adverse Event|0|||
105788694|NCT02062385|364880165|FG000|Overall Study|Protocol Violation|1|||
105788695|NCT02062385|364880166|FG001|Overall Study|Protocol Violation|0|||
105788696|NCT02062385|364880167|FG002|Overall Study|Protocol Violation|0|||
105788697|NCT02062385|364880168|FG003|Overall Study|Protocol Violation|0|||
105788698|NCT02062385|364880165|FG000|Overall Study|Incomplete EPI by database lock|2|||
105788699|NCT02062385|364880166|FG001|Overall Study|Incomplete EPI by database lock|0|||
105788700|NCT02062385|364880167|FG002|Overall Study|Incomplete EPI by database lock|0|||
105788701|NCT02062385|364880168|FG003|Overall Study|Incomplete EPI by database lock|0|||
105788702|NCT02062385|364880165|FG000|Overall Study|Moved|10|||
105788703|NCT02062385|364880166|FG001|Overall Study|Moved|11|||
105788704|NCT02062385|364880167|FG002|Overall Study|Moved|1|||
105788705|NCT02062385|364880168|FG003|Overall Study|Moved|0|||
105788706|NCT02062385|364880165|FG000|Overall Study|Withdrawn by parent/guardian|46|||
105788707|NCT02062385|364880166|FG001|Overall Study|Withdrawn by parent/guardian|41|||
105788708|NCT02062385|364880167|FG002|Overall Study|Withdrawn by parent/guardian|9|||
105788709|NCT02062385|364880168|FG003|Overall Study|Withdrawn by parent/guardian|8|||
105788710|NCT02062385|364880165|FG000|Overall Study|Death|0|||
105788711|NCT02062385|364880166|FG001|Overall Study|Death|0|||
105788712|NCT02062385|364880167|FG002|Overall Study|Death|0|||
106135921|NCT03441984|366156073|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
106135922|NCT03441984|366156074|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
105788713|NCT02062385|364880168|FG003|Overall Study|Death|1|||
105788714|NCT02062385|364880165|FG000|Overall Study|Lost to Follow-up|0|||
105788715|NCT02062385|364880166|FG001|Overall Study|Lost to Follow-up|0|||
105788716|NCT02062385|364880167|FG002|Overall Study|Lost to Follow-up|1|||
105788717|NCT02062385|364880168|FG003|Overall Study|Lost to Follow-up|0|||
105788718|NCT03188991|364880169|FG000|Overall Study|Withdrawal by Subject|0|||
105788719|NCT03188991|364880170|FG001|Overall Study|Withdrawal by Subject|0|||
106135923|NCT02430532|366156075|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
106135924|NCT02430532|366156076|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
106135925|NCT02430532|366156075|FG000|Overall Study|Consent Withdrawn|0|||
106135926|NCT02430532|366156076|FG001|Overall Study|Consent Withdrawn|2|||
106135927|NCT02430532|366156075|FG000|Overall Study|Adverse Event|0|||
105788720|NCT03188991|364880171|FG002|Overall Study|Withdrawal by Subject|0|||
105788721|NCT03188991|364880172|FG003|Overall Study|Withdrawal by Subject|1|||
105788722|NCT01721369|364880175|FG000|Overall Study|Not initial etiological diagnosis|12|||
105788723|NCT01300741|364881954|FG000|Overall Study|Lens deposits|1|||
105788724|NCT01300741|364881954|FG000|Overall Study|Lost to Follow-up|1|||
105788725|NCT01300741|364881954|FG000|Overall Study|Discomfort|1|||
105788726|NCT02325414|364881955|FG000|Overall Study|Withdrawal by Subject|3|||
105788727|NCT02325414|364881956|FG001|Overall Study|Withdrawal by Subject|1|||
105788728|NCT02325414|364881955|FG000|Overall Study|Lost to Follow-up|5|||
105788729|NCT02325414|364881956|FG001|Overall Study|Lost to Follow-up|5|||
105788730|NCT00726882|364881958|FG000|Overall Study|Withdrawal by Subject|5|||
105788731|NCT00726882|364881958|FG000|Overall Study|Lost to Follow-up|7|||
105788732|NCT00726882|364881958|FG000|Overall Study|Other|10|||
105788733|NCT00560573|364881959|FG000|Overall Study|Death|4|||
105788734|NCT00560573|364881960|FG001|Overall Study|Death|1|||
105788735|NCT00560573|364881961|FG002|Overall Study|Death|4|||
105788736|NCT00560573|364881962|FG003|Overall Study|Death|5|||
105788737|NCT00560573|364881963|FG004|Overall Study|Death|1|||
105788738|NCT00560573|364881964|FG005|Overall Study|Death|10|||
105788739|NCT00560573|364881959|FG000|Overall Study|Lost to Follow-up|0|||
105788740|NCT00560573|364881960|FG001|Overall Study|Lost to Follow-up|0|||
105788741|NCT00560573|364881961|FG002|Overall Study|Lost to Follow-up|0|||
105788742|NCT00560573|364881962|FG003|Overall Study|Lost to Follow-up|1|||
105788743|NCT00560573|364881963|FG004|Overall Study|Lost to Follow-up|1|||
105788744|NCT00560573|364881964|FG005|Overall Study|Lost to Follow-up|0|||
105788745|NCT00560573|364881959|FG000|Overall Study|Withdrawal by Subject|0|||
105788746|NCT00560573|364881960|FG001|Overall Study|Withdrawal by Subject|0|||
105788747|NCT00560573|364881961|FG002|Overall Study|Withdrawal by Subject|0|||
105788748|NCT00560573|364881962|FG003|Overall Study|Withdrawal by Subject|1|||
106135928|NCT02430532|366156076|FG001|Overall Study|Adverse Event|1|||
106135929|NCT01670019|366156079|FG000|Overall Study|Adverse Event|3|||
106135930|NCT01670019|366156080|FG001|Overall Study|Adverse Event|0|||
106135931|NCT01670019|366156079|FG000|Overall Study|Withdrawal by Subject|6|||
106135932|NCT01670019|366156080|FG001|Overall Study|Withdrawal by Subject|0|||
106135933|NCT03537651|366156081|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
106135934|NCT03537651|366156081|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
106135935|NCT03537651|366156081|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
106135936|NCT03537651|366156081|FG000|Part A (Up to 96 Weeks)|Other|1|||
106135937|NCT03537651|366156081|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
106135938|NCT03537651|366156081|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
106135939|NCT03537651|366156081|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
106135940|NCT03537651|366156081|FG000|Part B (Up to 192 Weeks)|Other|1|||
106135941|NCT02524288|366156082|FG000|Overall Study|Adverse Event|115|||
106135942|NCT02524288|366156082|FG000|Overall Study|Lost to Follow-up|216|||
106135943|NCT02524288|366156082|FG000|Overall Study|Non-Compliance With Protocol|32|||
106135944|NCT02524288|366156082|FG000|Overall Study|Non-Compliance With Study Drug|14|||
106135945|NCT02524288|366156082|FG000|Overall Study|Pregnancy Wish|6|||
106135946|NCT02524288|366156082|FG000|Overall Study|Protocol Violation|6|||
106135947|NCT02524288|366156082|FG000|Overall Study|Screen Failure|2|||
106135948|NCT02524288|366156082|FG000|Overall Study|Site Discontinued Study Participation|1|||
106135949|NCT02524288|366156082|FG000|Overall Study|Study Terminated By Sponsor|1417|||
106135950|NCT02524288|366156082|FG000|Overall Study|Subject Moved|32|||
106135951|NCT02524288|366156082|FG000|Overall Study|Withdrawal by Subject|76|||
106135952|NCT02524288|366156082|FG000|Overall Study|Pregnancy|22|||
106135953|NCT02524288|366156082|FG000|Overall Study|Physician Decision|2|||
106135954|NCT00517933|366156083|FG000|Period 1|Death|2|||
106135955|NCT00517933|366156084|FG001|Period 1|Death|1|||
106135956|NCT00517933|366156083|FG000|Period 1|Adverse Event|4|||
106135957|NCT00517933|366156084|FG001|Period 1|Adverse Event|4|||
106135958|NCT00517933|366156083|FG000|Period 1|Lost to Follow-up|2|||
106135959|NCT00517933|366156084|FG001|Period 1|Lost to Follow-up|0|||
105788749|NCT00560573|364881963|FG004|Overall Study|Withdrawal by Subject|1|||
106135960|NCT00517933|366156083|FG000|Period 1|Underwent lung transplant|0|||
106135961|NCT00517933|366156084|FG001|Period 1|Underwent lung transplant|1|||
106135962|NCT00517933|366156083|FG000|Period 2|Death|2|||
106135963|NCT00517933|366156084|FG001|Period 2|Death|4|||
105788750|NCT00560573|364881964|FG005|Overall Study|Withdrawal by Subject|0|||
106135964|NCT00517933|366156083|FG000|Period 2|Adverse Event|2|||
105788751|NCT00560573|364881959|FG000|Overall Study|Other|2|||
105788752|NCT00560573|364881960|FG001|Overall Study|Other|2|||
105788753|NCT00560573|364881961|FG002|Overall Study|Other|2|||
105788754|NCT00560573|364881962|FG003|Overall Study|Other|3|||
105788755|NCT00560573|364881963|FG004|Overall Study|Other|3|||
105788756|NCT00560573|364881964|FG005|Overall Study|Other|3|||
105713762|NCT00272987|364611928|FG001|Overall Study|Withdrawal by Subject|0|||
105713763|NCT00272987|364611929|FG002|Overall Study|Withdrawal by Subject|3|||
105713764|NCT00272987|364611927|FG000|Overall Study|Sponsor Terminated study|0|||
105713765|NCT00272987|364611928|FG001|Overall Study|Sponsor Terminated study|1|||
105713766|NCT00272987|364611929|FG002|Overall Study|Sponsor Terminated study|1|||
105713767|NCT00272987|364611927|FG000|Overall Study|Disease progression|1|||
105713768|NCT00272987|364611928|FG001|Overall Study|Disease progression|1|||
105713769|NCT00272987|364611929|FG002|Overall Study|Disease progression|2|||
105713770|NCT00272987|364611927|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
105713771|NCT00272987|364611928|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
105713772|NCT00272987|364611929|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
105713773|NCT00272987|364611927|FG000|Overall Study|Death|1|||
105713774|NCT00272987|364611928|FG001|Overall Study|Death|0|||
105713775|NCT00272987|364611929|FG002|Overall Study|Death|0|||
105713776|NCT02918019|364611930|FG000|Overall Study|Death|0|||
105713777|NCT02918019|364611931|FG001|Overall Study|Death|0|||
105713778|NCT02918019|364611932|FG002|Overall Study|Death|1|||
105713779|NCT02918019|364611933|FG003|Overall Study|Death|0|||
105713780|NCT02918019|364611930|FG000|Overall Study|Lost to Follow-up|1|||
105713781|NCT02918019|364611931|FG001|Overall Study|Lost to Follow-up|1|||
105713782|NCT02918019|364611932|FG002|Overall Study|Lost to Follow-up|0|||
105713783|NCT02918019|364611933|FG003|Overall Study|Lost to Follow-up|1|||
105713784|NCT02918019|364611930|FG000|Overall Study|Principal investigator request|0|||
105713785|NCT02918019|364611931|FG001|Overall Study|Principal investigator request|0|||
105713786|NCT02918019|364611932|FG002|Overall Study|Principal investigator request|0|||
105713787|NCT02918019|364611933|FG003|Overall Study|Principal investigator request|1|||
105713788|NCT02918019|364611930|FG000|Overall Study|Physician Decision|1|||
105713789|NCT02918019|364611931|FG001|Overall Study|Physician Decision|3|||
105713790|NCT02918019|364611932|FG002|Overall Study|Physician Decision|2|||
105713791|NCT02918019|364611933|FG003|Overall Study|Physician Decision|0|||
105713792|NCT02918019|364611930|FG000|Overall Study|Protocol deviation|1|||
105713793|NCT02918019|364611931|FG001|Overall Study|Protocol deviation|1|||
105713794|NCT02918019|364611932|FG002|Overall Study|Protocol deviation|0|||
105713795|NCT02918019|364611933|FG003|Overall Study|Protocol deviation|2|||
105931156|NCT01795937|365407667|FG001|Overall Study|Physician Decision|1|||
105931157|NCT01795937|365407668|FG002|Overall Study|Physician Decision|0|||
105931158|NCT01028053|365407669|FG000|Overall Study|Screen Failure|113|||
105931159|NCT01028053|365407669|FG000|Overall Study|Patient Request|11|||
105931160|NCT01028053|365407669|FG000|Overall Study|Protocol Violation|1|||
105931161|NCT01028053|365407669|FG000|Overall Study|Physician Decision|2|||
105931162|NCT01028053|365407669|FG000|Overall Study|Technical Problem|1|||
105931163|NCT01028053|365407669|FG000|Overall Study|Terminated by Sponsor|1|||
105931164|NCT01028053|365407669|FG000|Overall Study|Various reasons|4|||
105931165|NCT03315689|365407670|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
105931166|NCT03315689|365407671|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
105931167|NCT03315689|365407670|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
105931168|NCT03315689|365407671|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
105931169|NCT03315689|365407670|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
105931170|NCT03315689|365407671|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
105931171|NCT00864513|365407672|FG000|Overall Study|Withdrawal by Subject|3|||
105931172|NCT00762788|365407673|FG000|Overall Study|Lost to Follow-up|26|||
105931173|NCT00762788|365407674|FG001|Overall Study|Lost to Follow-up|37|||
105931174|NCT00762788|365407675|FG002|Overall Study|Lost to Follow-up|21|||
105931175|NCT00762788|365407676|FG003|Overall Study|Lost to Follow-up|26|||
105931176|NCT00762788|365407677|FG004|Overall Study|Lost to Follow-up|13|||
105931177|NCT00762788|365407678|FG005|Overall Study|Lost to Follow-up|21|||
105713796|NCT02918019|364611930|FG000|Overall Study|Withdrawal by Subject|3|||
105713797|NCT02918019|364611931|FG001|Overall Study|Withdrawal by Subject|4|||
105713798|NCT02918019|364611932|FG002|Overall Study|Withdrawal by Subject|6|||
105713799|NCT02918019|364611933|FG003|Overall Study|Withdrawal by Subject|4|||
105713800|NCT02918019|364611930|FG000|Overall Study|Adverse Event|0|||
105713801|NCT02918019|364611931|FG001|Overall Study|Adverse Event|1|||
105713802|NCT02918019|364611932|FG002|Overall Study|Adverse Event|0|||
105713803|NCT02918019|364611933|FG003|Overall Study|Adverse Event|1|||
105713804|NCT04823949|364611934|FG000|Overall Study|Withdrawal by Subject|0|||
105713805|NCT04823949|364611935|FG001|Overall Study|Withdrawal by Subject|4|||
105713806|NCT04823949|364611934|FG000|Overall Study|Physician Decision|0|||
105713807|NCT04823949|364611935|FG001|Overall Study|Physician Decision|1|||
105713808|NCT02474082|364611938|FG000|Overall Study|Adverse Event|2|||
105713809|NCT02474082|364611939|FG001|Overall Study|Adverse Event|32|||
105713810|NCT02474082|364611938|FG000|Overall Study|Withdrawal of informed consent|1|||
105713811|NCT02474082|364611939|FG001|Overall Study|Withdrawal of informed consent|11|||
105713812|NCT02474082|364611938|FG000|Overall Study|Lost to Follow-up|2|||
105713813|NCT02474082|364611939|FG001|Overall Study|Lost to Follow-up|2|||
105713814|NCT02474082|364611938|FG000|Overall Study|Dose tapering not achieved|0|||
105713815|NCT02474082|364611939|FG001|Overall Study|Dose tapering not achieved|4|||
105713816|NCT02474082|364611938|FG000|Overall Study|Participant/guardian decision|1|||
105713817|NCT02474082|364611939|FG001|Overall Study|Participant/guardian decision|2|||
105713818|NCT02474082|364611938|FG000|Overall Study|Non-compliance with study treatment|0|||
105713819|NCT02474082|364611939|FG001|Overall Study|Non-compliance with study treatment|2|||
105713820|NCT02474082|364611938|FG000|Overall Study|Protocol deviation|0|||
105713821|NCT02474082|364611939|FG001|Overall Study|Protocol deviation|1|||
105713822|NCT00797823|364611943|FG000|First Period (Initial Randomization)|Physician Decision|1|||
105713823|NCT00797823|364611944|FG001|First Period (Initial Randomization)|Physician Decision|0|||
105713824|NCT00797823|364611945|FG002|First Period (Initial Randomization)|Physician Decision|0|||
105713825|NCT02568046|364611946|FG000|Overall Study|Adverse Event|0|||
105713826|NCT02568046|364611947|FG001|Overall Study|Adverse Event|1|||
105713827|NCT02568046|364611946|FG000|Overall Study|Death|2|||
105713828|NCT02568046|364611947|FG001|Overall Study|Death|0|||
105713829|NCT02568046|364611946|FG000|Overall Study|Progressive Disease|1|||
105713830|NCT02568046|364611947|FG001|Overall Study|Progressive Disease|0|||
105713831|NCT02568046|364611946|FG000|Overall Study|Withdrawal by Subject|2|||
105713832|NCT02568046|364611947|FG001|Overall Study|Withdrawal by Subject|1|||
105713833|NCT02568046|364611946|FG000|Overall Study|Other Events|0|||
105713834|NCT02568046|364611947|FG001|Overall Study|Other Events|1|||
105713835|NCT00408694|364611948|FG000|Overall Study|Ineligible|1|||
105713836|NCT00408694|364611948|FG000|Overall Study|No protocol treatment|1|||
105713837|NCT00523991|364611949|FG000|Overall Study|Adverse Event|6|||
105713838|NCT00523991|364611950|FG001|Overall Study|Adverse Event|5|||
105713839|NCT00523991|364611949|FG000|Overall Study|Protocol Violation|1|||
105713840|NCT00523991|364611950|FG001|Overall Study|Protocol Violation|4|||
105713841|NCT00523991|364611949|FG000|Overall Study|Lost to Follow-up|4|||
105713842|NCT00523991|364611950|FG001|Overall Study|Lost to Follow-up|1|||
105931178|NCT03073109|365407679|FG000|Overall Study|Adverse Event|0|||
105931179|NCT03073109|365407680|FG001|Overall Study|Adverse Event|1|||
105931180|NCT03073109|365407679|FG000|Overall Study|Other|2|||
105931181|NCT03073109|365407680|FG001|Overall Study|Other|0|||
105931182|NCT03073109|365407679|FG000|Overall Study|Lost to Follow-up|8|||
105931183|NCT03073109|365407680|FG001|Overall Study|Lost to Follow-up|1|||
105931184|NCT00669331|365407681|FG000|Randomisation to First Dose|Adverse Event|1|||
105931185|NCT00669331|365407682|FG001|Randomisation to First Dose|Adverse Event|0|||
105931186|NCT00669331|365407681|FG000|Randomisation to First Dose|Protocol Violation|1|||
105931187|NCT00669331|365407682|FG001|Randomisation to First Dose|Protocol Violation|0|||
105931188|NCT00669331|365407681|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
105931189|NCT00669331|365407682|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
105931190|NCT00669331|365407681|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
105931191|NCT00669331|365407682|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
105931192|NCT00669331|365407681|FG000|Randomisation to First Dose|Death|1|||
105931193|NCT00669331|365407682|FG001|Randomisation to First Dose|Death|0|||
105931194|NCT00669331|365407681|FG000|Randomisation to First Dose|Sponsor decision|0|||
105931195|NCT00669331|365407682|FG001|Randomisation to First Dose|Sponsor decision|1|||
105931196|NCT00669331|365407681|FG000|Randomisation to First Dose|Randomised in error|3|||
105931197|NCT00669331|365407682|FG001|Randomisation to First Dose|Randomised in error|10|||
105931198|NCT00669331|365407681|FG000|Blinded Treatment Period|Adverse Event|16|||
105931199|NCT00669331|365407682|FG001|Blinded Treatment Period|Adverse Event|10|||
105931200|NCT00669331|365407681|FG000|Blinded Treatment Period|Protocol Violation|1|||
105931201|NCT00669331|365407682|FG001|Blinded Treatment Period|Protocol Violation|1|||
105931202|NCT00669331|365407681|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
105931203|NCT00669331|365407682|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
105931204|NCT00669331|365407681|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
105931205|NCT00669331|365407682|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
105931206|NCT00669331|365407681|FG000|Blinded Treatment Period|Death|0|||
105931207|NCT00669331|365407682|FG001|Blinded Treatment Period|Death|2|||
105931208|NCT00669331|365407681|FG000|Blinded Treatment Period|Physician Decision|3|||
105931209|NCT00669331|365407682|FG001|Blinded Treatment Period|Physician Decision|3|||
105931210|NCT00669331|365407681|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
105931211|NCT00669331|365407682|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
105931212|NCT00471354|365407685|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
105931213|NCT00471354|365407685|FG000|Overall Study|Adverse Event|13|||
105931214|NCT00471354|365407685|FG000|Overall Study|Protocol Violation|12|||
105931215|NCT00471354|365407685|FG000|Overall Study|Withdrawal by Subject|1|||
105713843|NCT00523991|364611949|FG000|Overall Study|Withdrawal by Subject|7|||
105713844|NCT00523991|364611950|FG001|Overall Study|Withdrawal by Subject|17|||
105713845|NCT00523991|364611949|FG000|Overall Study|Other reason (not specified)|3|||
105713846|NCT00523991|364611950|FG001|Overall Study|Other reason (not specified)|0|||
105713847|NCT01700192|364611951|FG000|Overall Study|Adverse Event|73|||
105713848|NCT01700192|364611952|FG001|Overall Study|Adverse Event|18|||
105713849|NCT01700192|364611951|FG000|Overall Study|Lack of Efficacy|1|||
105713850|NCT01700192|364611952|FG001|Overall Study|Lack of Efficacy|0|||
105931216|NCT00471354|365407685|FG000|Overall Study|Physician Decision|4|||
105931217|NCT00471354|365407685|FG000|Overall Study|Sponsor Decision|1|||
105931218|NCT00471354|365407685|FG000|Overall Study|Lost to Follow-up|3|||
105931219|NCT00471354|365407685|FG000|Overall Study|Lack of Efficacy|5|||
105788757|NCT00560573|364881959|FG000|Overall Study|Enrolled, not treated|0|||
105788758|NCT00560573|364881960|FG001|Overall Study|Enrolled, not treated|0|||
105788759|NCT00560573|364881961|FG002|Overall Study|Enrolled, not treated|0|||
105788760|NCT00560573|364881962|FG003|Overall Study|Enrolled, not treated|0|||
105788761|NCT00560573|364881963|FG004|Overall Study|Enrolled, not treated|1|||
105788762|NCT00560573|364881964|FG005|Overall Study|Enrolled, not treated|0|||
105788763|NCT01339273|364881965|FG000|Overall Study|Lost to Follow-up|8|||
105788764|NCT01339273|364881966|FG001|Overall Study|Lost to Follow-up|8|||
105788765|NCT00344968|364881967|FG000|Overall Study|Adverse Event|5|||
105788766|NCT00344968|364881968|FG001|Overall Study|Adverse Event|4|||
105788767|NCT00344968|364881969|FG002|Overall Study|Adverse Event|15|||
105788768|NCT00344968|364881967|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105788769|NCT00344968|364881968|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
106135965|NCT00517933|366156084|FG001|Period 2|Adverse Event|4|||
106135966|NCT00517933|366156083|FG000|Period 2|Physician Decision|1|||
106135967|NCT00517933|366156084|FG001|Period 2|Physician Decision|0|||
106135968|NCT00517933|366156083|FG000|Period 2|Withdrawal by Subject|1|||
105788770|NCT00344968|364881969|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105788771|NCT00344968|364881967|FG000|Overall Study|Protocol Violation|2|||
105788772|NCT00344968|364881968|FG001|Overall Study|Protocol Violation|2|||
105788773|NCT00344968|364881969|FG002|Overall Study|Protocol Violation|5|||
105788774|NCT00344968|364881967|FG000|Overall Study|Withdrawal by Subject|14|||
105788775|NCT00344968|364881968|FG001|Overall Study|Withdrawal by Subject|31|||
105788776|NCT00344968|364881969|FG002|Overall Study|Withdrawal by Subject|27|||
105788777|NCT00344968|364881967|FG000|Overall Study|Lost to Follow-up|24|||
105788778|NCT00344968|364881968|FG001|Overall Study|Lost to Follow-up|37|||
105788779|NCT00344968|364881969|FG002|Overall Study|Lost to Follow-up|37|||
106135969|NCT00517933|366156084|FG001|Period 2|Withdrawal by Subject|3|||
106135970|NCT00517933|366156083|FG000|Period 2|Underwent lung transplant|0|||
106135971|NCT00517933|366156084|FG001|Period 2|Underwent lung transplant|2|||
106135972|NCT01467700|366156086|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
106135973|NCT01467700|366156087|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
106135974|NCT01467700|366156088|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
105788780|NCT00344968|364881967|FG000|Overall Study|Death|11|||
105788781|NCT00344968|364881968|FG001|Overall Study|Death|27|||
106135975|NCT01467700|366156089|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
106135976|NCT01467700|366156086|FG000|Overall Study|Major Protocol Deviation|3|||
106135977|NCT01467700|366156087|FG001|Overall Study|Major Protocol Deviation|3|||
106135978|NCT01467700|366156088|FG002|Overall Study|Major Protocol Deviation|2|||
106135979|NCT01467700|366156089|FG003|Overall Study|Major Protocol Deviation|3|||
106135980|NCT01467700|366156086|FG000|Overall Study|Lost to Follow-up|6|||
106135981|NCT01467700|366156087|FG001|Overall Study|Lost to Follow-up|5|||
106135982|NCT01467700|366156088|FG002|Overall Study|Lost to Follow-up|2|||
106135983|NCT01467700|366156089|FG003|Overall Study|Lost to Follow-up|3|||
106135984|NCT01467700|366156086|FG000|Overall Study|Voluntary Withdrawal|5|||
106135985|NCT01467700|366156087|FG001|Overall Study|Voluntary Withdrawal|7|||
106135986|NCT01467700|366156088|FG002|Overall Study|Voluntary Withdrawal|6|||
106135987|NCT01467700|366156089|FG003|Overall Study|Voluntary Withdrawal|2|||
106135988|NCT01467700|366156086|FG000|Overall Study|Study Termination|6|||
106135989|NCT01467700|366156087|FG001|Overall Study|Study Termination|5|||
106135990|NCT01467700|366156088|FG002|Overall Study|Study Termination|10|||
106135991|NCT01467700|366156089|FG003|Overall Study|Study Termination|7|||
106135992|NCT01467700|366156086|FG000|Overall Study|Pregnancy|0|||
106135993|NCT01467700|366156087|FG001|Overall Study|Pregnancy|1|||
106135994|NCT01467700|366156088|FG002|Overall Study|Pregnancy|1|||
106135995|NCT01467700|366156089|FG003|Overall Study|Pregnancy|0|||
106135996|NCT01467700|366156086|FG000|Overall Study|Lack of Efficacy|2|||
105788782|NCT00344968|364881969|FG002|Overall Study|Death|31|||
105788783|NCT00344968|364881967|FG000|Overall Study|Other|0|||
105788784|NCT00344968|364881968|FG001|Overall Study|Other|1|||
105788785|NCT00344968|364881969|FG002|Overall Study|Other|0|||
105788786|NCT00518531|364881974|FG000|Treatment Period 1|Adverse Event|5|||
105788787|NCT00518531|364881975|FG001|Treatment Period 1|Adverse Event|0|||
105788788|NCT00518531|364881974|FG000|Treatment Period 1|Lost to Follow-up|5|||
105788789|NCT00518531|364881975|FG001|Treatment Period 1|Lost to Follow-up|3|||
105788790|NCT00518531|364881974|FG000|Treatment Period 1|Physician Decision|1|||
105788791|NCT00518531|364881975|FG001|Treatment Period 1|Physician Decision|0|||
106135997|NCT01467700|366156087|FG001|Overall Study|Lack of Efficacy|0|||
106135998|NCT01467700|366156088|FG002|Overall Study|Lack of Efficacy|2|||
106135999|NCT01467700|366156089|FG003|Overall Study|Lack of Efficacy|1|||
106136000|NCT01467700|366156086|FG000|Overall Study|Reason not Specified|1|||
106136001|NCT01467700|366156087|FG001|Overall Study|Reason not Specified|3|||
106136002|NCT01467700|366156088|FG002|Overall Study|Reason not Specified|2|||
106136003|NCT01467700|366156089|FG003|Overall Study|Reason not Specified|8|||
106136004|NCT00751036|366156090|FG000|Overall Study|Disease Progression|28|||
106136005|NCT00751036|366156091|FG001|Overall Study|Disease Progression|29|||
105788792|NCT00518531|364881974|FG000|Treatment Period 1|Protocol Violation|2|||
106008625|NCT01345240|365697043|FG002|Overall Study|Lost to Follow-up|14|||
105713851|NCT01700192|364611951|FG000|Overall Study|Lost to Follow-up|42|||
105713852|NCT01700192|364611952|FG001|Overall Study|Lost to Follow-up|29|||
105713853|NCT01700192|364611951|FG000|Overall Study|Noncompliance with study drug|0|||
105713854|NCT01700192|364611952|FG001|Overall Study|Noncompliance with study drug|5|||
105713855|NCT01700192|364611951|FG000|Overall Study|Physician Decision|2|||
105713856|NCT01700192|364611952|FG001|Overall Study|Physician Decision|3|||
105713857|NCT01700192|364611951|FG000|Overall Study|Pregnancy|1|||
105713858|NCT01700192|364611952|FG001|Overall Study|Pregnancy|4|||
105713859|NCT01700192|364611951|FG000|Overall Study|Progressive disease|1|||
105713860|NCT01700192|364611952|FG001|Overall Study|Progressive disease|0|||
105713861|NCT01700192|364611951|FG000|Overall Study|Protocol Violation|3|||
105713862|NCT01700192|364611952|FG001|Overall Study|Protocol Violation|4|||
105713863|NCT01700192|364611951|FG000|Overall Study|Technical problems|0|||
105713864|NCT01700192|364611952|FG001|Overall Study|Technical problems|1|||
105713865|NCT01700192|364611951|FG000|Overall Study|Withdrawal by Subject|56|||
105713866|NCT01700192|364611952|FG001|Overall Study|Withdrawal by Subject|64|||
105713867|NCT01700192|364611951|FG000|Overall Study|Never received study drug|1|||
105713868|NCT01700192|364611952|FG001|Overall Study|Never received study drug|0|||
105713869|NCT03403192|364611955|FG000|Overall Study|Lost to Follow-up|1|||
105713870|NCT03403192|364611956|FG001|Overall Study|Lost to Follow-up|2|||
105713871|NCT03403192|364611957|FG002|Overall Study|Lost to Follow-up|0|||
105713872|NCT03403192|364611958|FG003|Overall Study|Lost to Follow-up|0|||
105713873|NCT03403192|364611955|FG000|Overall Study|Unable to respond|0|||
105713874|NCT03403192|364611956|FG001|Overall Study|Unable to respond|1|||
105713875|NCT03403192|364611957|FG002|Overall Study|Unable to respond|0|||
105713876|NCT03403192|364611958|FG003|Overall Study|Unable to respond|0|||
105713877|NCT03403192|364611955|FG000|Overall Study|Incomplete|3|||
105713878|NCT03403192|364611956|FG001|Overall Study|Incomplete|1|||
105713879|NCT03403192|364611957|FG002|Overall Study|Incomplete|3|||
105713880|NCT03403192|364611958|FG003|Overall Study|Incomplete|6|||
105713881|NCT02486757|364611959|FG000|Overall Study|Lost to Follow-up|1|||
105713882|NCT02793232|364611960|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713883|NCT02793232|364611961|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713884|NCT02793232|364611962|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713885|NCT02793232|364611963|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713886|NCT02793232|364611964|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
105713887|NCT02793232|364611965|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713888|NCT02793232|364611966|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
105713889|NCT02793232|364611967|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713890|NCT02793232|364611968|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
105713891|NCT04673786|364611969|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
105713892|NCT04673786|364611970|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
105713893|NCT04673786|364611971|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
105713894|NCT04673786|364611969|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
105713895|NCT04673786|364611970|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
105713896|NCT04673786|364611971|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
105713897|NCT04673786|364611969|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
105713898|NCT04673786|364611970|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
105713899|NCT04673786|364611971|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
105713900|NCT04673786|364611969|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
105713901|NCT04673786|364611970|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
105713902|NCT04673786|364611971|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
105713903|NCT04673786|364611969|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
105713904|NCT04673786|364611970|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
105713905|NCT04673786|364611971|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
105713906|NCT04673786|364611969|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
105713907|NCT04673786|364611970|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
105713908|NCT04673786|364611971|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
105713909|NCT02979431|364611972|FG000|Overall Study|Parent/guardian withdrew consent|2|||
105713910|NCT02979431|364611973|FG001|Overall Study|Parent/guardian withdrew consent|1|||
105713911|NCT02979431|364611974|FG002|Overall Study|Parent/guardian withdrew consent|1|||
105713912|NCT02979431|364611975|FG003|Overall Study|Parent/guardian withdrew consent|1|||
105713913|NCT02979431|364611972|FG000|Overall Study|Randomized but received no study drug|1|||
105713914|NCT02979431|364611973|FG001|Overall Study|Randomized but received no study drug|1|||
105713915|NCT02979431|364611974|FG002|Overall Study|Randomized but received no study drug|0|||
105713916|NCT02979431|364611975|FG003|Overall Study|Randomized but received no study drug|0|||
105713917|NCT02979431|364611972|FG000|Overall Study|Adverse Event|0|||
105713918|NCT02979431|364611973|FG001|Overall Study|Adverse Event|0|||
105713919|NCT02979431|364611974|FG002|Overall Study|Adverse Event|1|||
105713920|NCT02979431|364611975|FG003|Overall Study|Adverse Event|0|||
105713921|NCT02979431|364611972|FG000|Overall Study|Subject left country after Day14|1|||
105713922|NCT02979431|364611973|FG001|Overall Study|Subject left country after Day14|0|||
106008626|NCT01345240|365697044|FG003|Overall Study|Lost to Follow-up|7|||
105931220|NCT00471354|365407685|FG000|Overall Study|Patient/Caregiver Decision|12|||
105713923|NCT02979431|364611974|FG002|Overall Study|Subject left country after Day14|0|||
105713924|NCT02979431|364611975|FG003|Overall Study|Subject left country after Day14|0|||
105713925|NCT03543410|364611976|FG000|Overall Study|Adverse Event|10|||
105713926|NCT03543410|364611977|FG001|Overall Study|Adverse Event|8|||
105713927|NCT03543410|364611978|FG002|Overall Study|Adverse Event|2|||
105713928|NCT03543410|364611976|FG000|Overall Study|Lack of Efficacy|0|||
105713929|NCT03543410|364611977|FG001|Overall Study|Lack of Efficacy|1|||
105713930|NCT03543410|364611978|FG002|Overall Study|Lack of Efficacy|0|||
105713931|NCT03543410|364611976|FG000|Overall Study|Lost to Follow-up|0|||
105713932|NCT03543410|364611977|FG001|Overall Study|Lost to Follow-up|1|||
105713933|NCT03543410|364611978|FG002|Overall Study|Lost to Follow-up|0|||
105713934|NCT03543410|364611976|FG000|Overall Study|Withdrawal by Subject|5|||
105713935|NCT03543410|364611977|FG001|Overall Study|Withdrawal by Subject|2|||
105713936|NCT03543410|364611978|FG002|Overall Study|Withdrawal by Subject|8|||
105713937|NCT03543410|364611976|FG000|Overall Study|Protocol Violation|0|||
105713938|NCT03543410|364611977|FG001|Overall Study|Protocol Violation|1|||
105713939|NCT03543410|364611978|FG002|Overall Study|Protocol Violation|0|||
105713940|NCT03543410|364611976|FG000|Overall Study|Due to COVID-19|4|||
105713941|NCT03543410|364611977|FG001|Overall Study|Due to COVID-19|0|||
105713942|NCT03543410|364611978|FG002|Overall Study|Due to COVID-19|2|||
105713943|NCT03543410|364611976|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
105713944|NCT03543410|364611977|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
105713945|NCT03543410|364611978|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
105713946|NCT03543410|364611976|FG000|Overall Study|Not Due to COVID-19|2|||
105713947|NCT03543410|364611977|FG001|Overall Study|Not Due to COVID-19|0|||
105713948|NCT03543410|364611978|FG002|Overall Study|Not Due to COVID-19|1|||
105713949|NCT02883244|364611979|FG000|Overall Study|Lost to Follow-up|0|||
105713950|NCT02883244|364611980|FG001|Overall Study|Lost to Follow-up|1|||
105713951|NCT02435914|364611981|FG000|Overall Study|Ocular Adverse Event|1|||
105713952|NCT02435914|364611982|FG001|Overall Study|Ocular Adverse Event|0|||
105713953|NCT02435914|364611983|FG002|Overall Study|Ocular Adverse Event|0|||
105713954|NCT02435914|364611984|FG003|Overall Study|Ocular Adverse Event|0|||
105713955|NCT02435914|364611981|FG000|Overall Study|Withdrawal by Subject|0|||
105713956|NCT02435914|364611982|FG001|Overall Study|Withdrawal by Subject|1|||
105713957|NCT02435914|364611983|FG002|Overall Study|Withdrawal by Subject|0|||
105713958|NCT02435914|364611984|FG003|Overall Study|Withdrawal by Subject|0|||
105713959|NCT02435914|364611981|FG000|Overall Study|Other Miscellaneous Reason|0|||
105713960|NCT02435914|364611982|FG001|Overall Study|Other Miscellaneous Reason|0|||
105713961|NCT02435914|364611983|FG002|Overall Study|Other Miscellaneous Reason|1|||
105713962|NCT02435914|364611984|FG003|Overall Study|Other Miscellaneous Reason|0|||
105713963|NCT01353703|364611985|FG000|Overall Study|Migrated/moved from study area|1|||
105713964|NCT01353703|364611986|FG001|Overall Study|Migrated/moved from study area|0|||
105713965|NCT01405053|364611998|FG000|Overall Study|Adverse Event|3|||
105713966|NCT01405053|364611999|FG001|Overall Study|Adverse Event|0|||
105713967|NCT01405053|364611998|FG000|Overall Study|Lost to Follow-up|0|||
105713968|NCT01405053|364611999|FG001|Overall Study|Lost to Follow-up|1|||
105713969|NCT01405053|364611998|FG000|Overall Study|Participant choice|2|||
105713970|NCT01405053|364611999|FG001|Overall Study|Participant choice|1|||
105713971|NCT01405053|364611998|FG000|Overall Study|Inadequate therapeutic effect|2|||
105713972|NCT01405053|364611999|FG001|Overall Study|Inadequate therapeutic effect|1|||
105713973|NCT01405053|364611998|FG000|Overall Study|Withdrawal by Subject|3|||
105713974|NCT01405053|364611999|FG001|Overall Study|Withdrawal by Subject|4|||
105713975|NCT01405053|364611998|FG000|Overall Study|Other|0|||
105713976|NCT01405053|364611999|FG001|Overall Study|Other|1|||
105713977|NCT04871711|364612000|FG000|Overall Study|Withdrawal by Subject|11|||
105713978|NCT04871711|364612001|FG001|Overall Study|Withdrawal by Subject|5|||
105713979|NCT04871711|364612000|FG000|Overall Study|Lack of Efficacy|5|||
105713980|NCT04871711|364612001|FG001|Overall Study|Lack of Efficacy|7|||
105713981|NCT04871711|364612000|FG000|Overall Study|Adverse Event|2|||
105713982|NCT04871711|364612001|FG001|Overall Study|Adverse Event|6|||
105713983|NCT04871711|364612000|FG000|Overall Study|Various reasons|2|||
105713984|NCT04871711|364612001|FG001|Overall Study|Various reasons|1|||
105713985|NCT04871711|364612000|FG000|Overall Study|Lost to Follow-up|0|||
105713986|NCT04871711|364612001|FG001|Overall Study|Lost to Follow-up|2|||
105713987|NCT01665144|364612002|FG000|Core Part|Withdrawal by Subject|96|||
105713988|NCT01665144|364612003|FG001|Core Part|Withdrawal by Subject|77|||
105713989|NCT01665144|364612004|FG002|Core Part|Withdrawal by Subject|0|||
105713990|NCT01665144|364612002|FG000|Core Part|Adverse Event|45|||
105713991|NCT01665144|364612003|FG001|Core Part|Adverse Event|18|||
105713992|NCT01665144|364612004|FG002|Core Part|Adverse Event|0|||
105713993|NCT01665144|364612002|FG000|Core Part|Lack of Efficacy|16|||
105713994|NCT01665144|364612003|FG001|Core Part|Lack of Efficacy|11|||
105713995|NCT01665144|364612004|FG002|Core Part|Lack of Efficacy|0|||
105713996|NCT01665144|364612002|FG000|Core Part|Lost to Follow-up|9|||
105713997|NCT01665144|364612003|FG001|Core Part|Lost to Follow-up|8|||
105713998|NCT01665144|364612004|FG002|Core Part|Lost to Follow-up|0|||
105713999|NCT01665144|364612002|FG000|Core Part|Physician Decision|13|||
106008627|NCT01345240|365697045|FG004|Overall Study|Lost to Follow-up|9|||
105714000|NCT01665144|364612003|FG001|Core Part|Physician Decision|1|||
105714001|NCT01665144|364612004|FG002|Core Part|Physician Decision|0|||
105788793|NCT00518531|364881975|FG001|Treatment Period 1|Protocol Violation|0|||
105788794|NCT00518531|364881974|FG000|Treatment Period 1|Withdrawal by Subject|4|||
105788795|NCT00518531|364881975|FG001|Treatment Period 1|Withdrawal by Subject|6|||
105788796|NCT00518531|364881974|FG000|Treatment Period 1|Early crossover|1|||
105788797|NCT00518531|364881975|FG001|Treatment Period 1|Early crossover|3|||
105788798|NCT00518531|364881974|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105788799|NCT00518531|364881975|FG001|Treatment Period 2|Withdrawal by Subject|8|||
105788800|NCT00518531|364881974|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
105788801|NCT00518531|364881975|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
105788802|NCT00518531|364881974|FG000|Treatment Period 2|Adverse Event|1|||
105788803|NCT00518531|364881975|FG001|Treatment Period 2|Adverse Event|7|||
105788804|NCT00518531|364881974|FG000|Treatment Period 2|Protocol-specified criteria|0|||
105788805|NCT00518531|364881975|FG001|Treatment Period 2|Protocol-specified criteria|1|||
105788806|NCT00518531|364881974|FG000|Treatment Period 2|Non-compliance|1|||
105788807|NCT00518531|364881975|FG001|Treatment Period 2|Non-compliance|2|||
105788808|NCT00968539|364881976|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
105788809|NCT00968539|364881977|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
105788810|NCT01976663|364881980|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
105788811|NCT01976663|364881980|FG000|Overall Study|Personal Reasons|6|||
105788812|NCT01976663|364881980|FG000|Overall Study|Withdrawal by Subject|4|||
105788813|NCT01976663|364881980|FG000|Overall Study|Screen Failure|3|||
105788814|NCT01976663|364881980|FG000|Overall Study|Adverse Event|2|||
105788815|NCT01976663|364881980|FG000|Overall Study|Lost to Follow-up|3|||
105788816|NCT05981365|364881981|FG000|Period 1|Adverse Event|1|||
105788817|NCT05981365|364881982|FG001|Period 1|Adverse Event|0|||
105788818|NCT03772574|364881983|FG000|Overall Study|Protocol Violation|2|||
105788819|NCT03772574|364881984|FG001|Overall Study|Protocol Violation|0|||
105788820|NCT03772574|364881985|FG002|Overall Study|Protocol Violation|0|||
105788821|NCT03772574|364881983|FG000|Overall Study|Discomfort|0|||
105788822|NCT03772574|364881984|FG001|Overall Study|Discomfort|5|||
105788823|NCT03772574|364881985|FG002|Overall Study|Discomfort|4|||
105788824|NCT02116309|364881991|FG000|Overall Study|Lost to Follow-up|0|||
105788825|NCT02116309|364881992|FG001|Overall Study|Lost to Follow-up|1|||
105788826|NCT00471237|364881993|FG000|Overall Study|Adverse Event|6|||
105788827|NCT00471237|364881994|FG001|Overall Study|Adverse Event|5|||
105788828|NCT00471237|364881995|FG002|Overall Study|Adverse Event|4|||
105714002|NCT01665144|364612002|FG000|Core Part|Progressive disease|8|||
105714003|NCT01665144|364612003|FG001|Core Part|Progressive disease|4|||
105714004|NCT01665144|364612004|FG002|Core Part|Progressive disease|0|||
105714005|NCT01665144|364612002|FG000|Core Part|Non-compliance with study treatment|5|||
105714006|NCT01665144|364612003|FG001|Core Part|Non-compliance with study treatment|0|||
105714007|NCT01665144|364612004|FG002|Core Part|Non-compliance with study treatment|0|||
105714008|NCT01665144|364612002|FG000|Core Part|Death|3|||
105714009|NCT01665144|364612003|FG001|Core Part|Death|1|||
105714010|NCT01665144|364612004|FG002|Core Part|Death|0|||
105714011|NCT01665144|364612002|FG000|Core Part|Protocol deviation|3|||
105714012|NCT01665144|364612003|FG001|Core Part|Protocol deviation|1|||
105714013|NCT01665144|364612004|FG002|Core Part|Protocol deviation|0|||
105714014|NCT01665144|364612002|FG000|Core Part|New therapy for study indication|2|||
105714015|NCT01665144|364612003|FG001|Core Part|New therapy for study indication|1|||
105714016|NCT01665144|364612004|FG002|Core Part|New therapy for study indication|0|||
105714017|NCT01665144|364612002|FG000|Core Part|Technical problems|2|||
105714018|NCT01665144|364612003|FG001|Core Part|Technical problems|0|||
105714019|NCT01665144|364612004|FG002|Core Part|Technical problems|0|||
105714020|NCT01665144|364612002|FG000|Extension Part|Patient/guardian decision|180|||
105714021|NCT01665144|364612003|FG001|Extension Part|Patient/guardian decision|0|||
105714022|NCT01665144|364612004|FG002|Extension Part|Patient/guardian decision|98|||
105714023|NCT01665144|364612002|FG000|Extension Part|Adverse Event|104|||
105714024|NCT01665144|364612003|FG001|Extension Part|Adverse Event|0|||
105714025|NCT01665144|364612004|FG002|Extension Part|Adverse Event|59|||
105714026|NCT01665144|364612002|FG000|Extension Part|Study closed early|42|||
105714027|NCT01665144|364612003|FG001|Extension Part|Study closed early|0|||
105714028|NCT01665144|364612004|FG002|Extension Part|Study closed early|19|||
105714029|NCT01665144|364612002|FG000|Extension Part|Progressive disease|36|||
105714030|NCT01665144|364612003|FG001|Extension Part|Progressive disease|0|||
105714031|NCT01665144|364612004|FG002|Extension Part|Progressive disease|14|||
105714032|NCT01665144|364612002|FG000|Extension Part|Lack of Efficacy|37|||
105714033|NCT01665144|364612003|FG001|Extension Part|Lack of Efficacy|0|||
105714034|NCT01665144|364612004|FG002|Extension Part|Lack of Efficacy|12|||
105788829|NCT00471237|364881996|FG003|Overall Study|Adverse Event|8|||
105788830|NCT00471237|364881997|FG004|Overall Study|Adverse Event|7|||
105788831|NCT00471237|364881998|FG005|Overall Study|Adverse Event|5|||
105788832|NCT00471237|364881999|FG006|Overall Study|Adverse Event|0|||
105788833|NCT00471237|364881993|FG000|Overall Study|Lost to Follow-up|1|||
105788834|NCT00471237|364881994|FG001|Overall Study|Lost to Follow-up|1|||
105788835|NCT00471237|364881995|FG002|Overall Study|Lost to Follow-up|0|||
105788836|NCT00471237|364881996|FG003|Overall Study|Lost to Follow-up|2|||
105788837|NCT00471237|364881997|FG004|Overall Study|Lost to Follow-up|3|||
105788838|NCT00471237|364881998|FG005|Overall Study|Lost to Follow-up|0|||
105788839|NCT00471237|364881999|FG006|Overall Study|Lost to Follow-up|0|||
105788840|NCT00471237|364881993|FG000|Overall Study|Protocol Violation|3|||
105788841|NCT00471237|364881994|FG001|Overall Study|Protocol Violation|6|||
105788842|NCT00471237|364881995|FG002|Overall Study|Protocol Violation|3|||
105788843|NCT00471237|364881996|FG003|Overall Study|Protocol Violation|2|||
105788844|NCT00471237|364881997|FG004|Overall Study|Protocol Violation|2|||
105788845|NCT00471237|364881998|FG005|Overall Study|Protocol Violation|4|||
105788846|NCT00471237|364881999|FG006|Overall Study|Protocol Violation|1|||
105788847|NCT00471237|364881993|FG000|Overall Study|Withdrawal by Subject|8|||
105788848|NCT00471237|364881994|FG001|Overall Study|Withdrawal by Subject|6|||
105788849|NCT00471237|364881995|FG002|Overall Study|Withdrawal by Subject|5|||
105788850|NCT00471237|364881996|FG003|Overall Study|Withdrawal by Subject|8|||
105788851|NCT00471237|364881997|FG004|Overall Study|Withdrawal by Subject|7|||
105788852|NCT00471237|364881998|FG005|Overall Study|Withdrawal by Subject|4|||
105788853|NCT00471237|364881999|FG006|Overall Study|Withdrawal by Subject|2|||
105788854|NCT00471237|364881993|FG000|Overall Study|Sponsor terminated study|20|||
105788855|NCT00471237|364881994|FG001|Overall Study|Sponsor terminated study|23|||
105788856|NCT00471237|364881995|FG002|Overall Study|Sponsor terminated study|19|||
105788857|NCT00471237|364881996|FG003|Overall Study|Sponsor terminated study|22|||
105788858|NCT00471237|364881997|FG004|Overall Study|Sponsor terminated study|18|||
105788859|NCT00471237|364881998|FG005|Overall Study|Sponsor terminated study|24|||
105788860|NCT00471237|364881999|FG006|Overall Study|Sponsor terminated study|0|||
105788861|NCT00471237|364881993|FG000|Overall Study|Non-compliance|0|||
105788862|NCT00471237|364881994|FG001|Overall Study|Non-compliance|1|||
105788863|NCT00471237|364881995|FG002|Overall Study|Non-compliance|0|||
105788864|NCT00471237|364881996|FG003|Overall Study|Non-compliance|1|||
105788865|NCT00471237|364881997|FG004|Overall Study|Non-compliance|0|||
105788866|NCT00471237|364881998|FG005|Overall Study|Non-compliance|0|||
105788867|NCT00471237|364881999|FG006|Overall Study|Non-compliance|0|||
105788868|NCT00471237|364881993|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
105788869|NCT00471237|364881994|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
105788870|NCT00471237|364881995|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
105788871|NCT00471237|364881996|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
105788872|NCT00471237|364881997|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
105788873|NCT00471237|364881998|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
105788874|NCT00471237|364881999|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
105788875|NCT00471237|364881993|FG000|Overall Study|Early stopping due to non-efficacy|1|||
105788876|NCT00471237|364881994|FG001|Overall Study|Early stopping due to non-efficacy|0|||
105788877|NCT00471237|364881995|FG002|Overall Study|Early stopping due to non-efficacy|0|||
105788878|NCT00471237|364881996|FG003|Overall Study|Early stopping due to non-efficacy|0|||
105788879|NCT00471237|364881997|FG004|Overall Study|Early stopping due to non-efficacy|1|||
105788880|NCT00471237|364881998|FG005|Overall Study|Early stopping due to non-efficacy|0|||
105788881|NCT00471237|364881999|FG006|Overall Study|Early stopping due to non-efficacy|0|||
105788882|NCT00471237|364881993|FG000|Overall Study|Participant planned to travel to abraod|1|||
105788883|NCT00471237|364881994|FG001|Overall Study|Participant planned to travel to abraod|0|||
105788884|NCT00471237|364881995|FG002|Overall Study|Participant planned to travel to abraod|0|||
105788885|NCT00471237|364881996|FG003|Overall Study|Participant planned to travel to abraod|0|||
105788886|NCT00471237|364881997|FG004|Overall Study|Participant planned to travel to abraod|0|||
105788887|NCT00471237|364881998|FG005|Overall Study|Participant planned to travel to abraod|1|||
105788888|NCT00471237|364881999|FG006|Overall Study|Participant planned to travel to abraod|0|||
105788889|NCT00471237|364881993|FG000|Overall Study|High parathyroid hormone|0|||
105788890|NCT00471237|364881994|FG001|Overall Study|High parathyroid hormone|0|||
105788891|NCT00471237|364881995|FG002|Overall Study|High parathyroid hormone|1|||
105788892|NCT00471237|364881996|FG003|Overall Study|High parathyroid hormone|0|||
105788893|NCT00471237|364881997|FG004|Overall Study|High parathyroid hormone|0|||
105788894|NCT00471237|364881998|FG005|Overall Study|High parathyroid hormone|0|||
105788895|NCT00471237|364881999|FG006|Overall Study|High parathyroid hormone|0|||
105788896|NCT00471237|364881993|FG000|Overall Study|Participant lost medication|0|||
105788897|NCT00471237|364881994|FG001|Overall Study|Participant lost medication|0|||
105788898|NCT00471237|364881995|FG002|Overall Study|Participant lost medication|0|||
105788899|NCT00471237|364881996|FG003|Overall Study|Participant lost medication|0|||
105788900|NCT00471237|364881997|FG004|Overall Study|Participant lost medication|1|||
105788901|NCT00471237|364881998|FG005|Overall Study|Participant lost medication|0|||
105788902|NCT00471237|364881999|FG006|Overall Study|Participant lost medication|0|||
105931221|NCT01829165|365407686|FG000|Overall Study|Did not complete intervention|2|||
105788903|NCT00471237|364881993|FG000|Overall Study|Administration of prohibited medicine|0|||
105788904|NCT00471237|364881994|FG001|Overall Study|Administration of prohibited medicine|0|||
105788905|NCT00471237|364881995|FG002|Overall Study|Administration of prohibited medicine|0|||
105788906|NCT00471237|364881996|FG003|Overall Study|Administration of prohibited medicine|0|||
105788907|NCT00471237|364881997|FG004|Overall Study|Administration of prohibited medicine|1|||
105788908|NCT00471237|364881998|FG005|Overall Study|Administration of prohibited medicine|0|||
105788909|NCT00471237|364881999|FG006|Overall Study|Administration of prohibited medicine|0|||
105788910|NCT00471237|364881993|FG000|Overall Study|Participant shifted residence|0|||
105788911|NCT00471237|364881994|FG001|Overall Study|Participant shifted residence|0|||
105788912|NCT00471237|364881995|FG002|Overall Study|Participant shifted residence|0|||
105788913|NCT00471237|364881996|FG003|Overall Study|Participant shifted residence|0|||
105788914|NCT00471237|364881997|FG004|Overall Study|Participant shifted residence|1|||
105788915|NCT00471237|364881998|FG005|Overall Study|Participant shifted residence|0|||
105788916|NCT00471237|364881999|FG006|Overall Study|Participant shifted residence|0|||
105788917|NCT00471237|364881993|FG000|Overall Study|Participant's decision|0|||
105788918|NCT00471237|364881994|FG001|Overall Study|Participant's decision|0|||
105788919|NCT00471237|364881995|FG002|Overall Study|Participant's decision|0|||
105788920|NCT00471237|364881996|FG003|Overall Study|Participant's decision|0|||
105788921|NCT00471237|364881997|FG004|Overall Study|Participant's decision|0|||
105788922|NCT00471237|364881998|FG005|Overall Study|Participant's decision|1|||
105788923|NCT00471237|364881999|FG006|Overall Study|Participant's decision|0|||
105788924|NCT02329834|364882002|FG000|Overall Study|Physician Decision|1|||
105788925|NCT02329834|364882003|FG001|Overall Study|Physician Decision|0|||
105788926|NCT00924313|364882004|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
105788927|NCT01317199|364882009|FG000|Dose-escalation Phase 1|Physician Decision|5|||
105788928|NCT01317199|364882010|FG001|Dose-escalation Phase 1|Physician Decision|0|||
105788929|NCT01317199|364882011|FG002|Dose-escalation Phase 1|Physician Decision|0|||
105788930|NCT01317199|364882012|FG003|Dose-escalation Phase 1|Physician Decision|0|||
105788931|NCT01317199|364882009|FG000|Dose-escalation Phase 1|Disease progression|1|||
105788932|NCT01317199|364882010|FG001|Dose-escalation Phase 1|Disease progression|0|||
105788933|NCT01317199|364882011|FG002|Dose-escalation Phase 1|Disease progression|0|||
105788934|NCT01317199|364882012|FG003|Dose-escalation Phase 1|Disease progression|0|||
105788935|NCT01317199|364882009|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
105788936|NCT01317199|364882010|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
105788937|NCT01317199|364882011|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
105788938|NCT01317199|364882012|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
105788939|NCT01317199|364882009|FG000|Randomized Phase 2|Disease progression|0|||
105788940|NCT01317199|364882010|FG001|Randomized Phase 2|Disease progression|3|||
106136006|NCT00751036|366156090|FG000|Overall Study|Adverse Event|6|||
106136007|NCT00751036|366156091|FG001|Overall Study|Adverse Event|4|||
106136008|NCT00751036|366156090|FG000|Overall Study|Administrative Problems|3|||
106136009|NCT00751036|366156091|FG001|Overall Study|Administrative Problems|4|||
106136010|NCT00751036|366156090|FG000|Overall Study|Withdrawal by Subject|5|||
106136011|NCT00751036|366156091|FG001|Overall Study|Withdrawal by Subject|2|||
106136012|NCT00751036|366156090|FG000|Overall Study|Death|3|||
106136013|NCT00751036|366156091|FG001|Overall Study|Death|3|||
106136014|NCT00751036|366156090|FG000|Overall Study|Lost to Follow-up|0|||
106136015|NCT00751036|366156091|FG001|Overall Study|Lost to Follow-up|1|||
106136016|NCT00751036|366156090|FG000|Overall Study|Protocol Violation|1|||
106136017|NCT00751036|366156091|FG001|Overall Study|Protocol Violation|0|||
106136018|NCT00751036|366156090|FG000|Overall Study|Missing end of Treatment Page|2|||
106136019|NCT00751036|366156091|FG001|Overall Study|Missing end of Treatment Page|3|||
106136020|NCT05460663|366156094|FG000|Overall Study|Withdrawal by Subject|2|||
106136021|NCT05460663|366156095|FG001|Overall Study|Withdrawal by Subject|5|||
106136022|NCT05273801|366156096|FG000|Overall Study|Physician Decision|1|||
106136023|NCT03820986|366156097|FG000|Overall Study|Death|177|||
106136024|NCT03820986|366156098|FG001|Overall Study|Death|156|||
106136025|NCT03820986|366156097|FG000|Overall Study|Lost to Follow-up|0|||
106136026|NCT03820986|366156098|FG001|Overall Study|Lost to Follow-up|1|||
106136027|NCT03820986|366156097|FG000|Overall Study|Withdrawal by Subject|8|||
106136028|NCT03820986|366156098|FG001|Overall Study|Withdrawal by Subject|3|||
106136029|NCT03820986|366156097|FG000|Overall Study|Ongoing|149|||
106136030|NCT03820986|366156098|FG001|Overall Study|Ongoing|180|||
106136031|NCT02013037|366156100|FG000|Overall Study|Death|6|||
106136032|NCT02013037|366156100|FG000|Overall Study|Withdrawal by Subject|1|||
106136033|NCT02013037|366156100|FG000|Overall Study|Awaiting Transplantation|7|||
106136034|NCT02013037|366156100|FG000|Overall Study|Transplanted without DSA|2|||
106136035|NCT02465359|366156101|FG000|Overall Study|Lack of Efficacy|1|||
105788941|NCT01317199|364882011|FG002|Randomized Phase 2|Disease progression|7|||
105788942|NCT01317199|364882012|FG003|Randomized Phase 2|Disease progression|5|||
106136036|NCT02465359|366156101|FG000|Overall Study|Withdrawal by Subject|1|||
106136037|NCT02465359|366156101|FG000|Overall Study|Adverse Event|1|||
106136038|NCT01244828|366156102|FG000|Overall Study|Adverse Event|37|||
106136039|NCT01244828|366156102|FG000|Overall Study|Withdrawal by Subject|31|||
106136040|NCT01244828|366156102|FG000|Overall Study|Lack of Efficacy|7|||
106136041|NCT01244828|366156102|FG000|Overall Study|Lost to Follow-up|2|||
106136042|NCT01244828|366156102|FG000|Overall Study|Other reason (not specified)|1|||
105788943|NCT01317199|364882009|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
105788944|NCT01317199|364882010|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
105788945|NCT01317199|364882011|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
105788946|NCT01317199|364882012|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
105788947|NCT01317199|364882009|FG000|Randomized Phase 2|Adverse Event|0|||
105788948|NCT01317199|364882010|FG001|Randomized Phase 2|Adverse Event|0|||
105788949|NCT01317199|364882011|FG002|Randomized Phase 2|Adverse Event|0|||
105788950|NCT01317199|364882012|FG003|Randomized Phase 2|Adverse Event|1|||
105788951|NCT01317199|364882009|FG000|Randomized Phase 2|Comorbidities|0|||
105788952|NCT01317199|364882010|FG001|Randomized Phase 2|Comorbidities|2|||
105788953|NCT01317199|364882011|FG002|Randomized Phase 2|Comorbidities|2|||
105788954|NCT01317199|364882012|FG003|Randomized Phase 2|Comorbidities|2|||
105788955|NCT01317199|364882009|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
105788956|NCT01317199|364882010|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
105788957|NCT01317199|364882011|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
105788958|NCT01317199|364882012|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
105788959|NCT01317199|364882009|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
105788960|NCT01317199|364882010|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
105788961|NCT01317199|364882011|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
105788962|NCT01317199|364882012|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
105788963|NCT01317199|364882009|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
105788964|NCT01317199|364882010|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
105788965|NCT01317199|364882011|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
105788966|NCT01317199|364882012|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
105788967|NCT01317199|364882009|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
105788968|NCT01317199|364882010|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
105788969|NCT01317199|364882011|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
105788970|NCT01317199|364882012|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
105788971|NCT01353209|364882013|FG000|Overall Study|Adverse Event|1|||
105788972|NCT01353209|364882014|FG001|Overall Study|Adverse Event|1|||
105788973|NCT01301625|364882017|FG000|Overall Study|Death|5|||
105788974|NCT01301625|364882017|FG000|Overall Study|Not Due|21|||
105788975|NCT01301625|364882017|FG000|Overall Study|Expected|8|||
105788976|NCT01301625|364882017|FG000|Overall Study|Lost to Follow-up|1|||
105788977|NCT00627094|364882021|FG000|Overall Study|Adverse Event|8|||
105788978|NCT00627094|364882022|FG001|Overall Study|Adverse Event|7|||
105788979|NCT00627094|364882021|FG000|Overall Study|Lost to Follow-up|1|||
105788980|NCT00627094|364882022|FG001|Overall Study|Lost to Follow-up|0|||
105788981|NCT00627094|364882021|FG000|Overall Study|Withdrawal by Subject|1|||
105788982|NCT00627094|364882022|FG001|Overall Study|Withdrawal by Subject|1|||
105788983|NCT00627094|364882021|FG000|Overall Study|ulcer healed|1|||
105788984|NCT00627094|364882022|FG001|Overall Study|ulcer healed|7|||
105788985|NCT00627094|364882021|FG000|Overall Study|Other reason|1|||
105788986|NCT00627094|364882022|FG001|Overall Study|Other reason|0|||
105788987|NCT04366258|364882023|FG000|Baseline Assessments|Screen Failure|21|||
105788988|NCT04366258|364882023|FG000|Baseline Assessments|Early Termination|3|||
105788989|NCT00183170|364882026|FG000|First Intervention|Did not complete study|1|||
105788990|NCT00183170|364882027|FG001|First Intervention|Did not complete study|0|||
105788991|NCT00183170|364882026|FG000|First Intervention|Did not meet targeted BrAC|1|||
105788992|NCT00183170|364882027|FG001|First Intervention|Did not meet targeted BrAC|0|||
105788993|NCT00183170|364882026|FG000|Washout 1 Week|Did not complete study|6|||
105788994|NCT00183170|364882027|FG001|Washout 1 Week|Did not complete study|8|||
105788995|NCT00183170|364882026|FG000|Second Intervention|Did not complete study|1|||
105788996|NCT00183170|364882027|FG001|Second Intervention|Did not complete study|0|||
105788997|NCT00183170|364882026|FG000|Second Intervention|Did not meet targeted BrAC|0|||
105788998|NCT00183170|364882027|FG001|Second Intervention|Did not meet targeted BrAC|2|||
105788999|NCT04983589|364882028|FG000|Overall Study|Withdrawal by Subject|0|||
105789000|NCT04983589|364882029|FG001|Overall Study|Withdrawal by Subject|3|||
105789001|NCT04983589|364882028|FG000|Overall Study|COVID-19 Infection|1|||
105789002|NCT04983589|364882029|FG001|Overall Study|COVID-19 Infection|0|||
105789003|NCT04983589|364882028|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
105789004|NCT04983589|364882029|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
105789005|NCT04764669|364882032|FG000|Overall Study|Adverse Event|1|||
105789006|NCT04764669|364882033|FG001|Overall Study|Adverse Event|0|||
105789007|NCT04764669|364882034|FG002|Overall Study|Adverse Event|1|||
105789008|NCT04764669|364882035|FG003|Overall Study|Adverse Event|0|||
105789009|NCT04764669|364882032|FG000|Overall Study|Subject Choice|0|||
105789010|NCT04764669|364882033|FG001|Overall Study|Subject Choice|0|||
105789011|NCT04764669|364882034|FG002|Overall Study|Subject Choice|1|||
105789012|NCT04764669|364882035|FG003|Overall Study|Subject Choice|0|||
105789013|NCT04764669|364882032|FG000|Overall Study|Withdrawal by Subject|2|||
105789014|NCT04764669|364882033|FG001|Overall Study|Withdrawal by Subject|0|||
105789015|NCT04764669|364882034|FG002|Overall Study|Withdrawal by Subject|0|||
106136043|NCT02952261|366156104|FG000|Overall Study|Withdrawal by Subject|4|||
105789016|NCT04764669|364882035|FG003|Overall Study|Withdrawal by Subject|0|||
105789017|NCT03919669|364882036|FG000|Overall Study|Withdrawal by Subject|1|||
105789018|NCT03919669|364882037|FG001|Overall Study|Withdrawal by Subject|0|||
105714035|NCT01665144|364612002|FG000|Extension Part|Physician Decision|29|||
105714036|NCT01665144|364612003|FG001|Extension Part|Physician Decision|0|||
105714037|NCT01665144|364612004|FG002|Extension Part|Physician Decision|13|||
105714038|NCT01665144|364612002|FG000|Extension Part|Technical problems|20|||
105714039|NCT01665144|364612003|FG001|Extension Part|Technical problems|0|||
105714040|NCT01665144|364612004|FG002|Extension Part|Technical problems|8|||
105714041|NCT01665144|364612002|FG000|Extension Part|Death|20|||
105714042|NCT01665144|364612003|FG001|Extension Part|Death|0|||
105714043|NCT01665144|364612004|FG002|Extension Part|Death|4|||
105714044|NCT01665144|364612002|FG000|Extension Part|Missing|12|||
105714045|NCT01665144|364612003|FG001|Extension Part|Missing|0|||
105789019|NCT03919669|364882038|FG002|Overall Study|Withdrawal by Subject|0|||
105789020|NCT00877799|364882042|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
105789021|NCT00877799|364882043|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
105789022|NCT00877799|364882044|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
105789023|NCT00877799|364882045|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
105789024|NCT00877799|364882046|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
105789025|NCT00877799|364882042|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
105789026|NCT00877799|364882043|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
105789027|NCT00877799|364882044|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
105789028|NCT00877799|364882045|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
105789029|NCT00877799|364882046|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
105789030|NCT00877799|364882042|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
105789031|NCT00877799|364882043|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
105789032|NCT00877799|364882044|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
105789033|NCT00877799|364882045|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
105789034|NCT00877799|364882046|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
105789035|NCT00877799|364882042|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
105789036|NCT00877799|364882043|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
105789037|NCT00877799|364882044|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
105789038|NCT00877799|364882045|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
105789039|NCT00877799|364882046|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
105789040|NCT00877799|364882042|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
105789041|NCT00877799|364882043|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
105789042|NCT00877799|364882044|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
105789043|NCT00877799|364882045|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
105789044|NCT00877799|364882046|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
105789045|NCT02331680|364882050|FG000|Overall Study|Adverse Event|3|||
105789046|NCT02331680|364882051|FG001|Overall Study|Adverse Event|0|||
105789047|NCT02331680|364882052|FG002|Overall Study|Adverse Event|2|||
105789048|NCT02331680|364882050|FG000|Overall Study|Physician Decision|1|||
105789049|NCT02331680|364882051|FG001|Overall Study|Physician Decision|1|||
105789050|NCT02331680|364882052|FG002|Overall Study|Physician Decision|2|||
105789051|NCT02331680|364882050|FG000|Overall Study|Withdrawal by Subject|0|||
105789052|NCT02331680|364882051|FG001|Overall Study|Withdrawal by Subject|1|||
105789053|NCT02331680|364882052|FG002|Overall Study|Withdrawal by Subject|2|||
105789054|NCT02331680|364882050|FG000|Overall Study|Met withdrawal criteria|2|||
105789055|NCT02331680|364882051|FG001|Overall Study|Met withdrawal criteria|2|||
105789056|NCT02331680|364882052|FG002|Overall Study|Met withdrawal criteria|5|||
105789057|NCT02331680|364882050|FG000|Overall Study|Non-compliance with study drug|0|||
105789058|NCT02331680|364882051|FG001|Overall Study|Non-compliance with study drug|0|||
105789059|NCT02331680|364882052|FG002|Overall Study|Non-compliance with study drug|1|||
105789060|NCT02331680|364882050|FG000|Overall Study|Protocol Violation|0|||
105789061|NCT02331680|364882051|FG001|Overall Study|Protocol Violation|0|||
105789062|NCT02331680|364882052|FG002|Overall Study|Protocol Violation|3|||
105789063|NCT00650806|364882053|FG000|Overall Study|Adverse Event|0|||
105789064|NCT00650806|364882054|FG001|Overall Study|Adverse Event|5|||
105789065|NCT00650806|364882055|FG002|Overall Study|Adverse Event|3|||
105714046|NCT01665144|364612004|FG002|Extension Part|Missing|6|||
105714047|NCT01665144|364612002|FG000|Extension Part|Lost to Follow-up|9|||
105714048|NCT01665144|364612003|FG001|Extension Part|Lost to Follow-up|0|||
105714049|NCT01665144|364612004|FG002|Extension Part|Lost to Follow-up|5|||
105714050|NCT01665144|364612002|FG000|Extension Part|New therapy for study indication|3|||
105714051|NCT01665144|364612003|FG001|Extension Part|New therapy for study indication|0|||
105714052|NCT01665144|364612004|FG002|Extension Part|New therapy for study indication|2|||
105714053|NCT01665144|364612002|FG000|Extension Part|Protocol deviation|3|||
105714054|NCT01665144|364612003|FG001|Extension Part|Protocol deviation|0|||
105714055|NCT01665144|364612004|FG002|Extension Part|Protocol deviation|0|||
105714056|NCT00654498|364612009|FG000|Overall Study|Not Treated|1|||
105714057|NCT00654498|364612010|FG001|Overall Study|Not Treated|0|||
105714058|NCT00654498|364612009|FG000|Overall Study|Adverse Event|6|||
105714059|NCT00654498|364612010|FG001|Overall Study|Adverse Event|1|||
105714060|NCT00654498|364612009|FG000|Overall Study|Protocol Violation|1|||
105714061|NCT00654498|364612010|FG001|Overall Study|Protocol Violation|1|||
105714062|NCT00654498|364612009|FG000|Overall Study|Lost to Follow-up|1|||
105714063|NCT00654498|364612010|FG001|Overall Study|Lost to Follow-up|5|||
105714064|NCT00654498|364612009|FG000|Overall Study|Withdrawal by Subject|1|||
105714065|NCT00654498|364612010|FG001|Overall Study|Withdrawal by Subject|0|||
105714066|NCT00654498|364612009|FG000|Overall Study|Other reason not defined above|4|||
105714067|NCT00654498|364612010|FG001|Overall Study|Other reason not defined above|5|||
105714068|NCT03179436|364612013|FG000|Overall Study|Withdrawal by Subject|1|||
105714069|NCT03179436|364612014|FG001|Overall Study|Withdrawal by Subject|0|||
105789066|NCT00650806|364882056|FG003|Overall Study|Adverse Event|4|||
105789067|NCT00650806|364882053|FG000|Overall Study|Lost to Follow-up|7|||
105789068|NCT00650806|364882054|FG001|Overall Study|Lost to Follow-up|6|||
105789069|NCT00650806|364882055|FG002|Overall Study|Lost to Follow-up|11|||
105789070|NCT00650806|364882056|FG003|Overall Study|Lost to Follow-up|10|||
105789071|NCT00650806|364882053|FG000|Overall Study|Protocol Violation|0|||
105789072|NCT00650806|364882054|FG001|Overall Study|Protocol Violation|0|||
105789073|NCT00650806|364882055|FG002|Overall Study|Protocol Violation|0|||
105789074|NCT00650806|364882056|FG003|Overall Study|Protocol Violation|1|||
105789075|NCT00650806|364882053|FG000|Overall Study|Pregnancy|0|||
105789076|NCT00650806|364882054|FG001|Overall Study|Pregnancy|0|||
105789077|NCT00650806|364882055|FG002|Overall Study|Pregnancy|0|||
105789078|NCT00650806|364882056|FG003|Overall Study|Pregnancy|1|||
105789079|NCT00650806|364882053|FG000|Overall Study|Withdrawal by Subject|7|||
105789080|NCT00650806|364882054|FG001|Overall Study|Withdrawal by Subject|5|||
105789081|NCT00650806|364882055|FG002|Overall Study|Withdrawal by Subject|8|||
105789082|NCT00650806|364882056|FG003|Overall Study|Withdrawal by Subject|6|||
105789083|NCT00650806|364882053|FG000|Overall Study|Noncompliance with study drug regimen|1|||
105789084|NCT00650806|364882054|FG001|Overall Study|Noncompliance with study drug regimen|1|||
105789085|NCT00650806|364882055|FG002|Overall Study|Noncompliance with study drug regimen|0|||
105789086|NCT00650806|364882056|FG003|Overall Study|Noncompliance with study drug regimen|0|||
105789087|NCT00650806|364882053|FG000|Overall Study|Study terminated by sponsor|2|||
105789088|NCT00650806|364882054|FG001|Overall Study|Study terminated by sponsor|3|||
105789089|NCT00650806|364882055|FG002|Overall Study|Study terminated by sponsor|5|||
105789090|NCT00650806|364882056|FG003|Overall Study|Study terminated by sponsor|4|||
105789091|NCT00650806|364882053|FG000|Overall Study|Other|1|||
105789092|NCT00650806|364882054|FG001|Overall Study|Other|1|||
105789093|NCT00650806|364882055|FG002|Overall Study|Other|2|||
105789094|NCT00650806|364882056|FG003|Overall Study|Other|0|||
105789095|NCT01329562|364882059|FG000|Overall Study|Protocol Violation|5|||
105789096|NCT01329562|364882060|FG001|Overall Study|Protocol Violation|3|||
105789097|NCT01329562|364882059|FG000|Overall Study|Lost to Follow-up|1|||
105789098|NCT01329562|364882060|FG001|Overall Study|Lost to Follow-up|1|||
105789099|NCT01329562|364882059|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
105789100|NCT01329562|364882060|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
105789101|NCT01329562|364882059|FG000|Overall Study|Physician Decision|0|||
105789102|NCT01329562|364882060|FG001|Overall Study|Physician Decision|1|||
105789103|NCT01381068|364882063|FG000|Overall Study|Death|1|||
105789104|NCT01381068|364882064|FG001|Overall Study|Death|0|||
105789105|NCT03539952|364882072|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
105789106|NCT03539952|364882073|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
105789107|NCT03539952|364882072|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
105789108|NCT03539952|364882073|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
105789109|NCT03539952|364882072|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
105789110|NCT03539952|364882073|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
105789111|NCT03539952|364882072|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
105789112|NCT03539952|364882073|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
105789113|NCT03539952|364882072|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
105789114|NCT03539952|364882073|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
105789115|NCT03539952|364882072|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
105789116|NCT03539952|364882073|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
105789117|NCT03539952|364882072|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
105789118|NCT03539952|364882073|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
105789119|NCT04066894|364882074|FG000|Overall Study|Lack of Efficacy|1|||
105714070|NCT03179436|364612015|FG002|Overall Study|Withdrawal by Subject|0|||
105714071|NCT03179436|364612016|FG003|Overall Study|Withdrawal by Subject|4|||
105714072|NCT03179436|364612017|FG004|Overall Study|Withdrawal by Subject|2|||
105789120|NCT04066894|364882074|FG000|Overall Study|Screen Failure|1|||
105789121|NCT00690573|364882081|FG000|Overall Study|Lack of Efficacy|8|||
106136044|NCT02952261|366156105|FG001|Overall Study|Withdrawal by Subject|5|||
106136045|NCT02952261|366156104|FG000|Overall Study|Protocol Violation|1|||
106136046|NCT02952261|366156105|FG001|Overall Study|Protocol Violation|0|||
106136047|NCT05233085|366156106|FG000|Overall Study|Adverse Event|1|||
106136048|NCT05233085|366156107|FG001|Overall Study|Adverse Event|0|||
106136049|NCT05233085|366156108|FG002|Overall Study|Adverse Event|0|||
106136050|NCT05233085|366156109|FG003|Overall Study|Adverse Event|0|||
106136051|NCT02624778|366157844|FG000|Overall Study|Lost to Follow-up|0|||
106136052|NCT02624778|366157845|FG001|Overall Study|Lost to Follow-up|0|||
106136053|NCT02624778|366157846|FG002|Overall Study|Lost to Follow-up|1|||
106136054|NCT02624778|366157847|FG003|Overall Study|Lost to Follow-up|0|||
106136055|NCT02624778|366157848|FG004|Overall Study|Lost to Follow-up|0|||
106136056|NCT02624778|366157849|FG005|Overall Study|Lost to Follow-up|0|||
106136057|NCT02624778|366157850|FG006|Overall Study|Lost to Follow-up|0|||
106136058|NCT02624778|366157851|FG007|Overall Study|Lost to Follow-up|0|||
106136059|NCT02624778|366157852|FG008|Overall Study|Lost to Follow-up|0|||
106136060|NCT02624778|366157844|FG000|Overall Study|Withdrawal by Subject|0|||
106136061|NCT02624778|366157845|FG001|Overall Study|Withdrawal by Subject|1|||
106136062|NCT02624778|366157846|FG002|Overall Study|Withdrawal by Subject|0|||
106136063|NCT02624778|366157847|FG003|Overall Study|Withdrawal by Subject|0|||
106136064|NCT02624778|366157848|FG004|Overall Study|Withdrawal by Subject|0|||
106136065|NCT02624778|366157849|FG005|Overall Study|Withdrawal by Subject|1|||
106136066|NCT02624778|366157850|FG006|Overall Study|Withdrawal by Subject|1|||
105931222|NCT01829165|365407687|FG001|Overall Study|Did not complete intervention|0|||
105931223|NCT01441414|365407688|FG000|Overall Study|Participant died|9|||
106136067|NCT02624778|366157851|FG007|Overall Study|Withdrawal by Subject|1|||
106136068|NCT02624778|366157852|FG008|Overall Study|Withdrawal by Subject|1|||
106136069|NCT02624778|366157844|FG000|Overall Study|Adverse Event|0|||
106136070|NCT02624778|366157845|FG001|Overall Study|Adverse Event|0|||
106136071|NCT02624778|366157846|FG002|Overall Study|Adverse Event|0|||
106136072|NCT02624778|366157847|FG003|Overall Study|Adverse Event|0|||
106136073|NCT02624778|366157848|FG004|Overall Study|Adverse Event|0|||
106136074|NCT02624778|366157849|FG005|Overall Study|Adverse Event|0|||
106136075|NCT02624778|366157850|FG006|Overall Study|Adverse Event|0|||
106136076|NCT02624778|366157851|FG007|Overall Study|Adverse Event|0|||
106136077|NCT02624778|366157852|FG008|Overall Study|Adverse Event|2|||
106136078|NCT02624778|366157844|FG000|Overall Study|Death|0|||
105931224|NCT01441414|365407688|FG000|Overall Study|Other reasons|3|||
105931225|NCT01441414|365407688|FG000|Overall Study|Study terminated by sponsor|2|||
105931226|NCT01441414|365407688|FG000|Overall Study|Subject refused further follow-up|1|||
105931227|NCT00617903|365407689|FG000|Overall Study|Withdrawal by Subject|2|||
105931228|NCT00617903|365407690|FG001|Overall Study|Withdrawal by Subject|3|||
105931229|NCT00617903|365407689|FG000|Overall Study|Lost to Follow-up|1|||
105931230|NCT00617903|365407690|FG001|Overall Study|Lost to Follow-up|1|||
105931231|NCT00617903|365407689|FG000|Overall Study|Lack of Efficacy|0|||
105931232|NCT00617903|365407690|FG001|Overall Study|Lack of Efficacy|1|||
105931233|NCT00617903|365407689|FG000|Overall Study|Adverse Event|0|||
105931234|NCT00617903|365407690|FG001|Overall Study|Adverse Event|1|||
105931235|NCT00617903|365407689|FG000|Overall Study|noncompliance|0|||
105931236|NCT00617903|365407690|FG001|Overall Study|noncompliance|1|||
105931237|NCT02217982|365407691|FG000|Overall Study|Trial discontinued|1|||
105931238|NCT02217982|365407692|FG001|Overall Study|Trial discontinued|0|||
105931239|NCT02217982|365407691|FG000|Overall Study|Adverse Event|0|||
105931240|NCT02217982|365407692|FG001|Overall Study|Adverse Event|1|||
105931241|NCT02421510|365407693|FG000|Overall Study|Other|4|||
105931242|NCT02421510|365407694|FG001|Overall Study|Other|2|||
105931243|NCT02421510|365407695|FG002|Overall Study|Other|3|||
105931244|NCT02421510|365407693|FG000|Overall Study|Protocol Violation|1|||
105931245|NCT02421510|365407694|FG001|Overall Study|Protocol Violation|2|||
105931246|NCT02421510|365407695|FG002|Overall Study|Protocol Violation|0|||
106136079|NCT02624778|366157845|FG001|Overall Study|Death|0|||
106136080|NCT02624778|366157846|FG002|Overall Study|Death|0|||
106136081|NCT02624778|366157847|FG003|Overall Study|Death|0|||
106136082|NCT02624778|366157848|FG004|Overall Study|Death|0|||
106136083|NCT02624778|366157849|FG005|Overall Study|Death|0|||
106136084|NCT02624778|366157850|FG006|Overall Study|Death|1|||
106136085|NCT02624778|366157851|FG007|Overall Study|Death|0|||
106136086|NCT02624778|366157852|FG008|Overall Study|Death|0|||
106136087|NCT02624778|366157844|FG000|Overall Study|Physician Decision|0|||
106136088|NCT02624778|366157845|FG001|Overall Study|Physician Decision|0|||
105931247|NCT02421510|365407693|FG000|Overall Study|Death|1|||
105931248|NCT02421510|365407694|FG001|Overall Study|Death|0|||
105931249|NCT02421510|365407695|FG002|Overall Study|Death|0|||
105931250|NCT02421510|365407693|FG000|Overall Study|Noncompliance with study drug|1|||
105931251|NCT02421510|365407694|FG001|Overall Study|Noncompliance with study drug|0|||
105931252|NCT02421510|365407695|FG002|Overall Study|Noncompliance with study drug|0|||
106136089|NCT02624778|366157846|FG002|Overall Study|Physician Decision|0|||
106136090|NCT02624778|366157847|FG003|Overall Study|Physician Decision|0|||
106136091|NCT02624778|366157848|FG004|Overall Study|Physician Decision|0|||
105931253|NCT02421510|365407693|FG000|Overall Study|Physician Decision|1|||
105789122|NCT00690573|364882081|FG000|Overall Study|Withdrawal by Subject|1|||
105789123|NCT01977482|364882082|FG000|Overall Study|Adverse Event|0|||
105789124|NCT01977482|364882083|FG001|Overall Study|Adverse Event|1|||
105789125|NCT01977482|364882084|FG002|Overall Study|Adverse Event|1|||
105789126|NCT01977482|364882085|FG003|Overall Study|Adverse Event|0|||
105789127|NCT01977482|364882086|FG004|Overall Study|Adverse Event|2|||
105789128|NCT01977482|364882087|FG005|Overall Study|Adverse Event|0|||
105789129|NCT01977482|364882082|FG000|Overall Study|Lost to Follow-up|1|||
105789130|NCT01977482|364882083|FG001|Overall Study|Lost to Follow-up|0|||
105789131|NCT01977482|364882084|FG002|Overall Study|Lost to Follow-up|0|||
105789132|NCT01977482|364882085|FG003|Overall Study|Lost to Follow-up|0|||
105789133|NCT01977482|364882086|FG004|Overall Study|Lost to Follow-up|0|||
105789134|NCT01977482|364882087|FG005|Overall Study|Lost to Follow-up|0|||
105931254|NCT02421510|365407694|FG001|Overall Study|Physician Decision|1|||
105931255|NCT02421510|365407695|FG002|Overall Study|Physician Decision|3|||
105931256|NCT02421510|365407693|FG000|Overall Study|Adverse Event|9|||
105931257|NCT02421510|365407694|FG001|Overall Study|Adverse Event|10|||
105931258|NCT02421510|365407695|FG002|Overall Study|Adverse Event|18|||
105789135|NCT01977482|364882082|FG000|Overall Study|Physician Decision|0|||
105789136|NCT01977482|364882083|FG001|Overall Study|Physician Decision|1|||
105789137|NCT01977482|364882084|FG002|Overall Study|Physician Decision|0|||
105789138|NCT01977482|364882085|FG003|Overall Study|Physician Decision|0|||
105789139|NCT01977482|364882086|FG004|Overall Study|Physician Decision|0|||
105931259|NCT02421510|365407693|FG000|Overall Study|Pregnancy|1|||
105931260|NCT02421510|365407694|FG001|Overall Study|Pregnancy|1|||
105931261|NCT02421510|365407695|FG002|Overall Study|Pregnancy|0|||
105931262|NCT02421510|365407693|FG000|Overall Study|Withdrawal by Subject|14|||
105931263|NCT02421510|365407694|FG001|Overall Study|Withdrawal by Subject|18|||
105931264|NCT02421510|365407695|FG002|Overall Study|Withdrawal by Subject|12|||
105931265|NCT02421510|365407693|FG000|Overall Study|Lost to Follow-up|1|||
105931266|NCT02421510|365407694|FG001|Overall Study|Lost to Follow-up|1|||
105931267|NCT02421510|365407695|FG002|Overall Study|Lost to Follow-up|0|||
105931268|NCT00827242|365407696|FG000|Overall Study|Withdrawal by Subject|2|||
105931269|NCT00827242|365407697|FG001|Overall Study|Withdrawal by Subject|4|||
105931270|NCT00827242|365407696|FG000|Overall Study|Protocol Violation|1|||
105931271|NCT00827242|365407697|FG001|Overall Study|Protocol Violation|3|||
105931272|NCT00827242|365407696|FG000|Overall Study|Lost to Follow-up|0|||
105931273|NCT00827242|365407697|FG001|Overall Study|Lost to Follow-up|3|||
105931274|NCT00827242|365407696|FG000|Overall Study|Adverse Event Excluding Death|2|||
105931275|NCT00827242|365407697|FG001|Overall Study|Adverse Event Excluding Death|1|||
105931276|NCT00827242|365407696|FG000|Overall Study|Entry Criteria Not Met|4|||
105931277|NCT00827242|365407697|FG001|Overall Study|Entry Criteria Not Met|1|||
105931278|NCT00827242|365407696|FG000|Overall Study|Physician Decision|2|||
105931279|NCT00827242|365407697|FG001|Overall Study|Physician Decision|0|||
105931280|NCT00827242|365407696|FG000|Overall Study|Death|1|||
105931281|NCT00827242|365407697|FG001|Overall Study|Death|0|||
105931282|NCT00827242|365407696|FG000|Overall Study|Lack of Efficacy|1|||
105931283|NCT00827242|365407697|FG001|Overall Study|Lack of Efficacy|0|||
105931284|NCT03123588|365407704|FG000|Overall Study|Study Terminated by Sponsor|2|||
105931285|NCT03123588|365407705|FG001|Overall Study|Study Terminated by Sponsor|5|||
105931286|NCT03123588|365407704|FG000|Overall Study|Withdrawal by Subject|1|||
105931287|NCT03123588|365407705|FG001|Overall Study|Withdrawal by Subject|0|||
105931288|NCT03123588|365407704|FG000|Overall Study|Adverse Event|1|||
105931289|NCT03123588|365407705|FG001|Overall Study|Adverse Event|0|||
105931290|NCT03123588|365407704|FG000|Overall Study|Physician Decision|2|||
105931291|NCT03123588|365407705|FG001|Overall Study|Physician Decision|1|||
105931292|NCT01814332|365407706|FG000|Overall Study|Adverse Event|8|||
105789140|NCT01977482|364882087|FG005|Overall Study|Physician Decision|0|||
105789141|NCT01977482|364882082|FG000|Overall Study|Protocol Violation|0|||
105931293|NCT01814332|365407707|FG001|Overall Study|Adverse Event|3|||
105931294|NCT01814332|365407706|FG000|Overall Study|Withdrawal by Subject|3|||
105931295|NCT01814332|365407707|FG001|Overall Study|Withdrawal by Subject|8|||
105789142|NCT01977482|364882083|FG001|Overall Study|Protocol Violation|0|||
105789143|NCT01977482|364882084|FG002|Overall Study|Protocol Violation|1|||
105789144|NCT01977482|364882085|FG003|Overall Study|Protocol Violation|0|||
105931296|NCT01814332|365407706|FG000|Overall Study|Protocol Violation|0|||
105789145|NCT01977482|364882086|FG004|Overall Study|Protocol Violation|0|||
105789146|NCT01977482|364882087|FG005|Overall Study|Protocol Violation|0|||
105789147|NCT01977482|364882082|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
105931297|NCT01814332|365407707|FG001|Overall Study|Protocol Violation|4|||
105789148|NCT01977482|364882083|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
105789149|NCT01977482|364882084|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
105789150|NCT01977482|364882085|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
105931298|NCT01814332|365407706|FG000|Overall Study|Lost to Follow-up|5|||
105931299|NCT01814332|365407707|FG001|Overall Study|Lost to Follow-up|1|||
105931300|NCT01755637|365407708|FG000|Period 1|Adverse Event|0|||
105931301|NCT01755637|365407709|FG001|Period 1|Adverse Event|1|||
105931302|NCT05987540|365407710|FG000|Overall Study|Withdrawal by Subject|2|||
105931303|NCT05987540|365407710|FG000|Overall Study|Death|1|||
105789151|NCT01977482|364882086|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
105789152|NCT01977482|364882087|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
105789153|NCT01977482|364882082|FG000|Overall Study|Withdrawal by Subject|2|||
105789154|NCT01977482|364882083|FG001|Overall Study|Withdrawal by Subject|4|||
105789155|NCT01977482|364882084|FG002|Overall Study|Withdrawal by Subject|1|||
105789156|NCT01977482|364882085|FG003|Overall Study|Withdrawal by Subject|3|||
105789157|NCT01977482|364882086|FG004|Overall Study|Withdrawal by Subject|1|||
105789158|NCT01977482|364882087|FG005|Overall Study|Withdrawal by Subject|5|||
105789159|NCT01361308|364883288|FG000|Overall Study|Withdrawal by Subject|9|||
105789160|NCT01361308|364883289|FG001|Overall Study|Withdrawal by Subject|13|||
105789161|NCT01361308|364883288|FG000|Overall Study|Physician Decision|3|||
105789162|NCT01361308|364883289|FG001|Overall Study|Physician Decision|3|||
105789163|NCT01361308|364883288|FG000|Overall Study|Lack of Efficacy|2|||
105789164|NCT01361308|364883289|FG001|Overall Study|Lack of Efficacy|0|||
105789165|NCT01361308|364883288|FG000|Overall Study|Protocol Violation|1|||
105789166|NCT01361308|364883289|FG001|Overall Study|Protocol Violation|0|||
105789167|NCT01361308|364883288|FG000|Overall Study|Lost to Follow-up|5|||
105789168|NCT01361308|364883289|FG001|Overall Study|Lost to Follow-up|4|||
105789169|NCT01361308|364883288|FG000|Overall Study|Adverse Event|8|||
105789170|NCT01361308|364883289|FG001|Overall Study|Adverse Event|4|||
105789171|NCT01361308|364883288|FG000|Overall Study|Eligibility Criteria Not Met|2|||
105789172|NCT01361308|364883289|FG001|Overall Study|Eligibility Criteria Not Met|3|||
105789173|NCT01361308|364883288|FG000|Overall Study|Failed C-SSRS|5|||
105789174|NCT01361308|364883289|FG001|Overall Study|Failed C-SSRS|2|||
105789175|NCT01361308|364883288|FG000|Overall Study|Other|0|||
105789176|NCT01361308|364883289|FG001|Overall Study|Other|1|||
105789177|NCT02503215|364883294|FG000|Overall Study|Unable to wear compression stockings|1|||
105789178|NCT02503215|364883294|FG000|Overall Study|Unable to use positive airway pressure|2|||
105789179|NCT01319994|364883295|FG000|Overall Study|Protocol Violation|7|||
105789180|NCT01319994|364883296|FG001|Overall Study|Protocol Violation|6|||
105789181|NCT01605370|364883297|FG000|Overall Study|Adverse Event|1|||
105789182|NCT01605370|364883298|FG001|Overall Study|Adverse Event|0|||
105789183|NCT01165424|364883300|FG000|Overall Study|Clinical adverse experiences|1|||
105789184|NCT01165424|364883300|FG000|Overall Study|Laboratory adverse experiences|1|||
105789185|NCT01165424|364883300|FG000|Overall Study|Did not meet entry criteria|1|||
105789186|NCT01165424|364883300|FG000|Overall Study|Participant moved (relocated)|1|||
105789187|NCT00978120|364883301|FG000|Overall Study|Death|0|||
105789188|NCT00978120|364883302|FG001|Overall Study|Death|0|||
105789189|NCT00978120|364883303|FG002|Overall Study|Death|0|||
105789190|NCT00978120|364883304|FG003|Overall Study|Death|1|||
105789191|NCT00978120|364883301|FG000|Overall Study|Lost to Follow-up|0|||
105789192|NCT00978120|364883302|FG001|Overall Study|Lost to Follow-up|0|||
105789193|NCT00978120|364883303|FG002|Overall Study|Lost to Follow-up|3|||
105789194|NCT00978120|364883304|FG003|Overall Study|Lost to Follow-up|0|||
105789195|NCT00978120|364883301|FG000|Overall Study|Withdrawal by Subject|2|||
105789196|NCT00978120|364883302|FG001|Overall Study|Withdrawal by Subject|0|||
105789197|NCT00978120|364883303|FG002|Overall Study|Withdrawal by Subject|0|||
105789198|NCT00978120|364883304|FG003|Overall Study|Withdrawal by Subject|0|||
105789199|NCT00978120|364883301|FG000|Overall Study|Moved out of state|0|||
105789200|NCT00978120|364883302|FG001|Overall Study|Moved out of state|0|||
105789201|NCT00978120|364883303|FG002|Overall Study|Moved out of state|0|||
105789202|NCT00978120|364883304|FG003|Overall Study|Moved out of state|1|||
105789203|NCT02871921|364883305|FG000|Overall Study|Withdrawal by Subject|34|||
105789204|NCT02871921|364883306|FG001|Overall Study|Withdrawal by Subject|27|||
105789205|NCT02871921|364883307|FG002|Overall Study|Withdrawal by Subject|27|||
106136092|NCT02624778|366157849|FG005|Overall Study|Physician Decision|0|||
105789206|NCT02871921|364883308|FG003|Overall Study|Withdrawal by Subject|30|||
105789207|NCT00320801|364883312|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
105789208|NCT00320801|364883313|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
105789209|NCT00320801|364883314|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
105789210|NCT00320801|364883315|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
105789211|NCT00320801|364883312|FG000|Open-label Run-in Period|Adverse Event|33|||
105789212|NCT00320801|364883313|FG001|Open-label Run-in Period|Adverse Event|0|||
105789213|NCT00320801|364883314|FG002|Open-label Run-in Period|Adverse Event|0|||
105789214|NCT00320801|364883315|FG003|Open-label Run-in Period|Adverse Event|0|||
105789215|NCT00320801|364883312|FG000|Open-label Run-in Period|Administrative|10|||
105789216|NCT00320801|364883313|FG001|Open-label Run-in Period|Administrative|0|||
105789217|NCT00320801|364883314|FG002|Open-label Run-in Period|Administrative|0|||
105789218|NCT00320801|364883315|FG003|Open-label Run-in Period|Administrative|0|||
105789219|NCT00320801|364883312|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
105789220|NCT00320801|364883313|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
105789221|NCT00320801|364883314|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
105789222|NCT00320801|364883315|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
105789223|NCT00320801|364883312|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
105789224|NCT00320801|364883313|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
105789225|NCT00320801|364883314|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
105789226|NCT00320801|364883315|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
105789227|NCT00320801|364883312|FG000|Open-label Run-in Period|Did not qualify|1|||
105789228|NCT00320801|364883313|FG001|Open-label Run-in Period|Did not qualify|0|||
105789229|NCT00320801|364883314|FG002|Open-label Run-in Period|Did not qualify|0|||
105789230|NCT00320801|364883315|FG003|Open-label Run-in Period|Did not qualify|0|||
105789231|NCT00320801|364883312|FG000|Double-blind Phase|Withdrawal by Subject|0|||
106136093|NCT02624778|366157850|FG006|Overall Study|Physician Decision|0|||
106136094|NCT02624778|366157851|FG007|Overall Study|Physician Decision|3|||
106136095|NCT02624778|366157852|FG008|Overall Study|Physician Decision|3|||
106136096|NCT00587288|366157853|FG000|Overall Study|Adverse Event|0|||
106136097|NCT00587288|366157854|FG001|Overall Study|Adverse Event|1|||
106136098|NCT00587288|366157853|FG000|Overall Study|Lack of Efficacy|2|||
106136099|NCT00587288|366157854|FG001|Overall Study|Lack of Efficacy|8|||
106136100|NCT00587288|366157853|FG000|Overall Study|Protocol Violation|1|||
106136101|NCT00587288|366157854|FG001|Overall Study|Protocol Violation|0|||
106136102|NCT00797862|366157855|FG000|Overall Study|Adverse Event|86|||
105789232|NCT00320801|364883313|FG001|Double-blind Phase|Withdrawal by Subject|0|||
106136103|NCT00797862|366157856|FG001|Overall Study|Adverse Event|44|||
106136104|NCT00797862|366157857|FG002|Overall Study|Adverse Event|58|||
105789233|NCT00320801|364883314|FG002|Double-blind Phase|Withdrawal by Subject|1|||
105789234|NCT00320801|364883315|FG003|Double-blind Phase|Withdrawal by Subject|0|||
105789235|NCT00320801|364883312|FG000|Double-blind Phase|Adverse Event|0|||
105789236|NCT00320801|364883313|FG001|Double-blind Phase|Adverse Event|2|||
105789237|NCT00320801|364883314|FG002|Double-blind Phase|Adverse Event|8|||
105789238|NCT00320801|364883315|FG003|Double-blind Phase|Adverse Event|0|||
105789239|NCT00320801|364883312|FG000|Double-blind Phase|Administrative|0|||
105789240|NCT00320801|364883313|FG001|Double-blind Phase|Administrative|0|||
106136105|NCT00797862|366157855|FG000|Overall Study|Abnormal Test Procedure Result|0|||
105789241|NCT00320801|364883314|FG002|Double-blind Phase|Administrative|4|||
105789242|NCT00320801|364883315|FG003|Double-blind Phase|Administrative|0|||
105789243|NCT00320801|364883312|FG000|Double-blind Phase|Lack of Efficacy|0|||
105789244|NCT00320801|364883313|FG001|Double-blind Phase|Lack of Efficacy|9|||
105789245|NCT00320801|364883314|FG002|Double-blind Phase|Lack of Efficacy|1|||
105789246|NCT00320801|364883315|FG003|Double-blind Phase|Lack of Efficacy|0|||
105789247|NCT00320801|364883312|FG000|Extension Phase|Withdrawal by Subject|0|||
105789248|NCT00320801|364883313|FG001|Extension Phase|Withdrawal by Subject|0|||
105789249|NCT00320801|364883314|FG002|Extension Phase|Withdrawal by Subject|0|||
105789250|NCT00320801|364883315|FG003|Extension Phase|Withdrawal by Subject|6|||
105789251|NCT00320801|364883312|FG000|Extension Phase|Adverse Event|0|||
105789252|NCT00320801|364883313|FG001|Extension Phase|Adverse Event|0|||
105789253|NCT00320801|364883314|FG002|Extension Phase|Adverse Event|0|||
105789254|NCT00320801|364883315|FG003|Extension Phase|Adverse Event|8|||
105789255|NCT00320801|364883312|FG000|Extension Phase|Administrative|0|||
105789256|NCT00320801|364883313|FG001|Extension Phase|Administrative|0|||
105789257|NCT00320801|364883314|FG002|Extension Phase|Administrative|0|||
105789258|NCT00320801|364883315|FG003|Extension Phase|Administrative|29|||
105789259|NCT00320801|364883312|FG000|Extension Phase|Lack of Efficacy|0|||
105789260|NCT00320801|364883313|FG001|Extension Phase|Lack of Efficacy|0|||
105789261|NCT00320801|364883314|FG002|Extension Phase|Lack of Efficacy|0|||
105789262|NCT00320801|364883315|FG003|Extension Phase|Lack of Efficacy|2|||
105789263|NCT00320801|364883312|FG000|Extension Phase|Lost to Follow-up|0|||
105789264|NCT00320801|364883313|FG001|Extension Phase|Lost to Follow-up|0|||
105789265|NCT00320801|364883314|FG002|Extension Phase|Lost to Follow-up|0|||
105789266|NCT00320801|364883315|FG003|Extension Phase|Lost to Follow-up|3|||
105789267|NCT00337727|364883316|FG000|Overall Study|Adverse Event|5|||
105789268|NCT00337727|364883317|FG001|Overall Study|Adverse Event|3|||
105789269|NCT00337727|364883316|FG000|Overall Study|Lost to Follow-up|5|||
105789270|NCT00337727|364883317|FG001|Overall Study|Lost to Follow-up|4|||
105789271|NCT00337727|364883316|FG000|Overall Study|Physician Decision|1|||
105789272|NCT00337727|364883317|FG001|Overall Study|Physician Decision|0|||
105789273|NCT00337727|364883316|FG000|Overall Study|Protocol Violation|4|||
105789274|NCT00337727|364883317|FG001|Overall Study|Protocol Violation|0|||
105789275|NCT00337727|364883316|FG000|Overall Study|Withdrawal by Subject|3|||
105789276|NCT00337727|364883317|FG001|Overall Study|Withdrawal by Subject|5|||
105789277|NCT00577031|364883319|FG000|Overall Study|Adverse Event|52|||
105789278|NCT00577031|364883319|FG000|Overall Study|Progression of disease|93|||
105789279|NCT00577031|364883319|FG000|Overall Study|Protocol Violation|5|||
105789280|NCT00577031|364883319|FG000|Overall Study|Participant withdrew consent|13|||
105789281|NCT00577031|364883319|FG000|Overall Study|Participant non-compliance|5|||
105789282|NCT00577031|364883319|FG000|Overall Study|Need for surgery|17|||
105789283|NCT00577031|364883319|FG000|Overall Study|Medical decision|14|||
105789284|NCT00577031|364883319|FG000|Overall Study|Death|6|||
105789285|NCT00943826|364883320|FG000|Concurrent Phase|Adverse Event|50|||
105789286|NCT00943826|364883321|FG001|Concurrent Phase|Adverse Event|27|||
105789287|NCT00943826|364883320|FG000|Concurrent Phase|Withdrew consent|3|||
105789288|NCT00943826|364883321|FG001|Concurrent Phase|Withdrew consent|7|||
105789289|NCT00943826|364883320|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
105789290|NCT00943826|364883321|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
105789291|NCT00943826|364883320|FG000|Concurrent Phase|Administrative reasons|2|||
105789292|NCT00943826|364883321|FG001|Concurrent Phase|Administrative reasons|1|||
105789293|NCT00943826|364883320|FG000|Concurrent Phase|Protocol Violation|1|||
105789294|NCT00943826|364883321|FG001|Concurrent Phase|Protocol Violation|0|||
105789295|NCT00943826|364883320|FG000|Maintenance Phase|Adverse Event|31|||
105789296|NCT00943826|364883321|FG001|Maintenance Phase|Adverse Event|30|||
105789297|NCT00943826|364883320|FG000|Maintenance Phase|Withdrew consent|2|||
105931304|NCT05987540|365407710|FG000|Overall Study|Study Termination|1|||
105931305|NCT05987540|365407710|FG000|Overall Study|Adverse Event|2|||
105931306|NCT02061592|365407711|FG000|Period 1|Withdrawal by Subject|1|||
105931307|NCT02061592|365407712|FG001|Period 1|Withdrawal by Subject|0|||
105931308|NCT02061592|365407711|FG000|Period 1|Protocol Violation|1|||
105931309|NCT02061592|365407712|FG001|Period 1|Protocol Violation|0|||
105931310|NCT02061592|365407711|FG000|Period 2|Lost to Follow-up|0|||
105789298|NCT00943826|364883321|FG001|Maintenance Phase|Withdrew consent|4|||
105789299|NCT00943826|364883320|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
105789300|NCT00943826|364883321|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
105789301|NCT00943826|364883320|FG000|Maintenance Phase|Administrative reasons|4|||
105789302|NCT00943826|364883321|FG001|Maintenance Phase|Administrative reasons|1|||
105789303|NCT00943826|364883320|FG000|Maintenance Phase|Failure to return|0|||
105789304|NCT00943826|364883321|FG001|Maintenance Phase|Failure to return|1|||
105789305|NCT00943826|364883320|FG000|Monotherapy Phase|Adverse Event|42|||
105789306|NCT00943826|364883321|FG001|Monotherapy Phase|Adverse Event|5|||
105789307|NCT00943826|364883320|FG000|Monotherapy Phase|Administrative reasons|11|||
105789308|NCT00943826|364883321|FG001|Monotherapy Phase|Administrative reasons|5|||
105789309|NCT00943826|364883320|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
105789310|NCT00943826|364883321|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
105931311|NCT02061592|365407712|FG001|Period 2|Lost to Follow-up|1|||
105789311|NCT00943826|364883320|FG000|Monotherapy Phase|Withdrew Consent|2|||
105789312|NCT00943826|364883321|FG001|Monotherapy Phase|Withdrew Consent|3|||
105789313|NCT00943826|364883320|FG000|Monotherapy Phase|Failure to return|2|||
105789314|NCT00943826|364883321|FG001|Monotherapy Phase|Failure to return|1|||
105789315|NCT00943826|364883320|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
105789316|NCT00943826|364883321|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
105789317|NCT00943826|364883320|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
105789318|NCT00943826|364883321|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
105789319|NCT00943826|364883320|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
105789320|NCT00943826|364883321|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
105789321|NCT00943826|364883320|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
105789322|NCT00943826|364883321|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
105789323|NCT04113746|364883322|FG000|Overall Study|Lost to Follow-up|4|||
105789324|NCT04113746|364883323|FG001|Overall Study|Lost to Follow-up|4|||
105789325|NCT01977625|364883324|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
105789326|NCT01977625|364883325|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105789327|NCT01977625|364883324|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105789328|NCT01977625|364883325|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
105789329|NCT00326625|364883326|FG000|Overall Study|Adverse Event|20|||
105789330|NCT00326625|364883327|FG001|Overall Study|Adverse Event|9|||
105789331|NCT00326625|364883326|FG000|Overall Study|Withdrawal by Subject|15|||
105789332|NCT00326625|364883327|FG001|Overall Study|Withdrawal by Subject|12|||
105931312|NCT03338023|365407713|FG000|Overall Study|Withdrawal by Subject|3|||
105931313|NCT03338023|365407714|FG001|Overall Study|Withdrawal by Subject|4|||
105931314|NCT03338023|365407713|FG000|Overall Study|Protocol Violation|3|||
105931315|NCT03338023|365407714|FG001|Overall Study|Protocol Violation|3|||
105931316|NCT03338023|365407713|FG000|Overall Study|Lost to Follow-up|2|||
105931317|NCT03338023|365407714|FG001|Overall Study|Lost to Follow-up|1|||
105931318|NCT03338023|365407713|FG000|Overall Study|Physician Decision|1|||
105931319|NCT03338023|365407714|FG001|Overall Study|Physician Decision|2|||
105931320|NCT05064800|365407715|FG000|Period 3|Withdrawal by Subject|0|||
105931321|NCT05064800|365407716|FG001|Period 3|Withdrawal by Subject|0|||
105931322|NCT05064800|365407717|FG002|Period 3|Withdrawal by Subject|0|||
105931323|NCT05064800|365407718|FG003|Period 3|Withdrawal by Subject|0|||
105931324|NCT05064800|365407719|FG004|Period 3|Withdrawal by Subject|1|||
105931325|NCT05064800|365407720|FG005|Period 3|Withdrawal by Subject|0|||
105931326|NCT01774370|365407724|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
105931327|NCT01774370|365407724|FG000|Overall Study|Administered prior to the contract date|4|||
105931328|NCT01774370|365407724|FG000|Overall Study|Subjects of contraindications|34|||
105931329|NCT01774370|365407724|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
105931330|NCT01774370|365407724|FG000|Overall Study|Follow-up failure|34|||
105931331|NCT00514917|365407728|FG000|Overall Study|Death|4|||
105931332|NCT00514917|365407729|FG001|Overall Study|Death|10|||
105931333|NCT00514917|365407728|FG000|Overall Study|Protocol Violation|1|||
105931334|NCT00514917|365407729|FG001|Overall Study|Protocol Violation|0|||
105931335|NCT00514917|365407728|FG000|Overall Study|Lost to Follow-up|4|||
105931336|NCT00514917|365407729|FG001|Overall Study|Lost to Follow-up|3|||
105931337|NCT00514917|365407728|FG000|Overall Study|Withdrawal by Subject|18|||
105931338|NCT00514917|365407729|FG001|Overall Study|Withdrawal by Subject|16|||
105931339|NCT00514917|365407728|FG000|Overall Study|Discontinued due to study closure|88|||
105931340|NCT00514917|365407729|FG001|Overall Study|Discontinued due to study closure|81|||
105931341|NCT00514917|365407728|FG000|Overall Study|Undefined|11|||
105931342|NCT00514917|365407729|FG001|Overall Study|Undefined|5|||
105931343|NCT02697422|365407730|FG000|Overall Study|Declined exit survey|9|||
105931344|NCT02697422|365407731|FG001|Overall Study|Declined exit survey|2|||
105931345|NCT02697422|365407730|FG000|Overall Study|Lost to Follow-up|13|||
105931346|NCT02697422|365407731|FG001|Overall Study|Lost to Follow-up|8|||
105931347|NCT02697422|365407730|FG000|Overall Study|Death|2|||
105931348|NCT02697422|365407731|FG001|Overall Study|Death|1|||
105789333|NCT00326625|364883326|FG000|Overall Study|Death|18|||
105789334|NCT00326625|364883327|FG001|Overall Study|Death|16|||
105789335|NCT00326625|364883326|FG000|Overall Study|Lost to Follow-up|1|||
105789336|NCT00326625|364883327|FG001|Overall Study|Lost to Follow-up|0|||
105789337|NCT00326625|364883326|FG000|Overall Study|prescheduled medical intervention|0|||
105789338|NCT00326625|364883327|FG001|Overall Study|prescheduled medical intervention|1|||
105789339|NCT02594384|364883328|FG000|Overall Study|Disease Progression|3|||
105789340|NCT02594384|364883329|FG001|Overall Study|Disease Progression|7|||
105789341|NCT02594384|364883330|FG002|Overall Study|Disease Progression|0|||
105789342|NCT02594384|364883331|FG003|Overall Study|Disease Progression|2|||
105789343|NCT02594384|364883332|FG004|Overall Study|Disease Progression|2|||
105789344|NCT02594384|364883333|FG005|Overall Study|Disease Progression|12|||
105931349|NCT02697422|365407730|FG000|Overall Study|Withdrawal by Subject|0|||
105931350|NCT02697422|365407731|FG001|Overall Study|Withdrawal by Subject|1|||
105931351|NCT02697422|365407730|FG000|Overall Study|Physician Decision|1|||
105931352|NCT02697422|365407731|FG001|Overall Study|Physician Decision|1|||
105931353|NCT02697422|365407730|FG000|Overall Study|Exit survey data lost|1|||
105789345|NCT02594384|364883334|FG006|Overall Study|Disease Progression|5|||
105789346|NCT02594384|364883335|FG007|Overall Study|Disease Progression|5|||
105789347|NCT02594384|364883328|FG000|Overall Study|Adverse Event|0|||
105789348|NCT02594384|364883329|FG001|Overall Study|Adverse Event|1|||
105789349|NCT02594384|364883330|FG002|Overall Study|Adverse Event|4|||
105789350|NCT02594384|364883331|FG003|Overall Study|Adverse Event|1|||
105789351|NCT02594384|364883332|FG004|Overall Study|Adverse Event|0|||
105789352|NCT02594384|364883333|FG005|Overall Study|Adverse Event|6|||
105789353|NCT02594384|364883334|FG006|Overall Study|Adverse Event|1|||
105789354|NCT02594384|364883335|FG007|Overall Study|Adverse Event|1|||
105789355|NCT02594384|364883328|FG000|Overall Study|Withdrawal by Subject|0|||
105789356|NCT02594384|364883329|FG001|Overall Study|Withdrawal by Subject|0|||
105789357|NCT02594384|364883330|FG002|Overall Study|Withdrawal by Subject|0|||
105789358|NCT02594384|364883331|FG003|Overall Study|Withdrawal by Subject|1|||
105789359|NCT02594384|364883332|FG004|Overall Study|Withdrawal by Subject|0|||
105789360|NCT02594384|364883333|FG005|Overall Study|Withdrawal by Subject|0|||
105789361|NCT02594384|364883334|FG006|Overall Study|Withdrawal by Subject|0|||
105789362|NCT02594384|364883335|FG007|Overall Study|Withdrawal by Subject|1|||
105789363|NCT02594384|364883328|FG000|Overall Study|Physician Decision|0|||
105789364|NCT02594384|364883329|FG001|Overall Study|Physician Decision|0|||
105789365|NCT02594384|364883330|FG002|Overall Study|Physician Decision|0|||
105789366|NCT02594384|364883331|FG003|Overall Study|Physician Decision|0|||
105789367|NCT02594384|364883332|FG004|Overall Study|Physician Decision|0|||
105789368|NCT02594384|364883333|FG005|Overall Study|Physician Decision|1|||
105789369|NCT02594384|364883334|FG006|Overall Study|Physician Decision|2|||
105789370|NCT02594384|364883335|FG007|Overall Study|Physician Decision|0|||
105789371|NCT02594384|364883328|FG000|Overall Study|Progressive Leukocytosis|0|||
105789372|NCT02594384|364883329|FG001|Overall Study|Progressive Leukocytosis|0|||
105789373|NCT02594384|364883330|FG002|Overall Study|Progressive Leukocytosis|1|||
105789374|NCT02594384|364883331|FG003|Overall Study|Progressive Leukocytosis|0|||
105789375|NCT02594384|364883332|FG004|Overall Study|Progressive Leukocytosis|0|||
105789376|NCT02594384|364883333|FG005|Overall Study|Progressive Leukocytosis|0|||
105789377|NCT02594384|364883334|FG006|Overall Study|Progressive Leukocytosis|0|||
105789378|NCT02594384|364883335|FG007|Overall Study|Progressive Leukocytosis|0|||
105789379|NCT02594384|364883328|FG000|Overall Study|Lack of Efficacy|0|||
105789380|NCT02594384|364883329|FG001|Overall Study|Lack of Efficacy|0|||
105789381|NCT02594384|364883330|FG002|Overall Study|Lack of Efficacy|0|||
105789382|NCT02594384|364883331|FG003|Overall Study|Lack of Efficacy|0|||
105789383|NCT02594384|364883332|FG004|Overall Study|Lack of Efficacy|1|||
105789384|NCT02594384|364883333|FG005|Overall Study|Lack of Efficacy|0|||
105789385|NCT02594384|364883334|FG006|Overall Study|Lack of Efficacy|0|||
105789386|NCT02594384|364883335|FG007|Overall Study|Lack of Efficacy|0|||
105789387|NCT02594384|364883328|FG000|Overall Study|Substantial noncompliance|0|||
105789388|NCT02594384|364883329|FG001|Overall Study|Substantial noncompliance|0|||
105789389|NCT02594384|364883330|FG002|Overall Study|Substantial noncompliance|0|||
105789390|NCT02594384|364883331|FG003|Overall Study|Substantial noncompliance|0|||
105789391|NCT02594384|364883332|FG004|Overall Study|Substantial noncompliance|0|||
105789392|NCT02594384|364883333|FG005|Overall Study|Substantial noncompliance|0|||
105789393|NCT02594384|364883334|FG006|Overall Study|Substantial noncompliance|1|||
105789394|NCT02594384|364883335|FG007|Overall Study|Substantial noncompliance|0|||
105789395|NCT00491322|364883336|FG000|Overall Study|Protocol Violation|1|||
105789396|NCT00491322|364883337|FG001|Overall Study|Protocol Violation|0|||
105789397|NCT00491322|364883336|FG000|Overall Study|Pregnancy|0|||
105789398|NCT00491322|364883337|FG001|Overall Study|Pregnancy|1|||
105789399|NCT00538473|364883338|FG000|Overall Study|Adverse Event|1|||
105789400|NCT00538473|364883339|FG001|Overall Study|Adverse Event|0|||
105789401|NCT02279888|364883340|FG000|Overall Study|Death|326|||
105789402|NCT02279888|364883340|FG000|Overall Study|Withdrawal by Subject|38|||
105789403|NCT02279888|364883340|FG000|Overall Study|Lost to Follow-up|21|||
105789404|NCT02279888|364883340|FG000|Overall Study|Physician Decision|62|||
105789405|NCT02279888|364883340|FG000|Overall Study|Subject Non-compliance|43|||
105789406|NCT02279888|364883340|FG000|Overall Study|Not implanted|14|||
105789407|NCT02279888|364883340|FG000|Overall Study|Visit not performed|26|||
105789408|NCT01891669|364883341|FG000|Overall Study|Death|0|||
105789409|NCT01891669|364883342|FG001|Overall Study|Death|0|||
105789410|NCT01891669|364883343|FG002|Overall Study|Death|0|||
105789411|NCT01891669|364883344|FG003|Overall Study|Death|0|||
105789412|NCT01891669|364883345|FG004|Overall Study|Death|0|||
105789413|NCT01891669|364883346|FG005|Overall Study|Death|0|||
105789414|NCT01891669|364883347|FG006|Overall Study|Death|0|||
105789415|NCT01891669|364883348|FG007|Overall Study|Death|1|||
105789416|NCT01891669|364883349|FG008|Overall Study|Death|0|||
105789417|NCT01891669|364883350|FG009|Overall Study|Death|1|||
105789418|NCT01891669|364883341|FG000|Overall Study|Withdrawal by Subject|1|||
105789419|NCT01891669|364883342|FG001|Overall Study|Withdrawal by Subject|1|||
105789420|NCT01891669|364883343|FG002|Overall Study|Withdrawal by Subject|0|||
105789421|NCT01891669|364883344|FG003|Overall Study|Withdrawal by Subject|0|||
105789422|NCT01891669|364883345|FG004|Overall Study|Withdrawal by Subject|0|||
105789423|NCT01891669|364883346|FG005|Overall Study|Withdrawal by Subject|0|||
105789424|NCT01891669|364883347|FG006|Overall Study|Withdrawal by Subject|1|||
106136106|NCT00797862|366157856|FG001|Overall Study|Abnormal Test Procedure Result|1|||
106136107|NCT00797862|366157857|FG002|Overall Study|Abnormal Test Procedure Result|1|||
106136108|NCT00797862|366157855|FG000|Overall Study|Lack of Efficacy|1|||
106136109|NCT00797862|366157856|FG001|Overall Study|Lack of Efficacy|7|||
106136110|NCT00797862|366157857|FG002|Overall Study|Lack of Efficacy|6|||
106136111|NCT00797862|366157855|FG000|Overall Study|No longer required study medication|1|||
105789425|NCT01891669|364883348|FG007|Overall Study|Withdrawal by Subject|2|||
106136112|NCT00797862|366157856|FG001|Overall Study|No longer required study medication|0|||
106136113|NCT00797862|366157857|FG002|Overall Study|No longer required study medication|0|||
106136114|NCT00797862|366157855|FG000|Overall Study|Withdrawal by Subject|14|||
106136115|NCT00797862|366157856|FG001|Overall Study|Withdrawal by Subject|7|||
106136116|NCT00797862|366157857|FG002|Overall Study|Withdrawal by Subject|7|||
106136117|NCT00797862|366157855|FG000|Overall Study|Lost to Follow-up|11|||
106136118|NCT00797862|366157856|FG001|Overall Study|Lost to Follow-up|0|||
106136119|NCT00797862|366157857|FG002|Overall Study|Lost to Follow-up|5|||
106136120|NCT00797862|366157855|FG000|Overall Study|Administrative Problem|4|||
106136121|NCT00797862|366157856|FG001|Overall Study|Administrative Problem|0|||
106136122|NCT00797862|366157857|FG002|Overall Study|Administrative Problem|0|||
106136123|NCT00797862|366157855|FG000|Overall Study|Protocol Violation|4|||
106136124|NCT00797862|366157856|FG001|Overall Study|Protocol Violation|6|||
106136125|NCT00797862|366157857|FG002|Overall Study|Protocol Violation|8|||
106136126|NCT00797862|366157855|FG000|Overall Study|Mis-randomized|3|||
106136127|NCT00797862|366157856|FG001|Overall Study|Mis-randomized|3|||
106136128|NCT00797862|366157857|FG002|Overall Study|Mis-randomized|1|||
106136129|NCT00531479|366157858|FG000|Overall Study|Death|68|||
106136130|NCT00531479|366157859|FG001|Overall Study|Death|71|||
106136131|NCT00531479|366157858|FG000|Overall Study|Lost to Follow-up|0|||
106136132|NCT00531479|366157859|FG001|Overall Study|Lost to Follow-up|2|||
106136133|NCT00531479|366157858|FG000|Overall Study|Other|0|||
106136134|NCT00531479|366157859|FG001|Overall Study|Other|1|||
106136135|NCT00531479|366157858|FG000|Overall Study|Withdrawal by Subject|6|||
106136136|NCT00531479|366157859|FG001|Overall Study|Withdrawal by Subject|6|||
106136137|NCT00531479|366157858|FG000|Overall Study|Did not receive treatment|2|||
106136138|NCT00531479|366157859|FG001|Overall Study|Did not receive treatment|3|||
106136139|NCT04565249|366157865|FG000|Overall Study|Death|0|||
106136140|NCT04565249|366157866|FG001|Overall Study|Death|0|||
106136141|NCT04565249|366157867|FG002|Overall Study|Death|0|||
106136142|NCT04565249|366157868|FG003|Overall Study|Death|1|||
105789426|NCT01891669|364883349|FG008|Overall Study|Withdrawal by Subject|1|||
106136143|NCT03120676|366157869|FG000|Overall Study|Not treated|1|||
106136144|NCT01729819|366157873|FG000|Overall Study|Adverse Event|2|||
106136145|NCT01729819|366157874|FG001|Overall Study|Adverse Event|4|||
106136146|NCT01729819|366157873|FG000|Overall Study|Lack of Efficacy|1|||
106136147|NCT01729819|366157874|FG001|Overall Study|Lack of Efficacy|0|||
106136148|NCT01729819|366157873|FG000|Overall Study|Lost to Follow-up|2|||
106136149|NCT01729819|366157874|FG001|Overall Study|Lost to Follow-up|0|||
106136150|NCT01729819|366157873|FG000|Overall Study|Other reason|1|||
106136151|NCT01729819|366157874|FG001|Overall Study|Other reason|0|||
106136152|NCT01729819|366157873|FG000|Overall Study|Protocol Violation|0|||
106136153|NCT01729819|366157874|FG001|Overall Study|Protocol Violation|1|||
105789427|NCT01891669|364883350|FG009|Overall Study|Withdrawal by Subject|1|||
105789428|NCT01891669|364883341|FG000|Overall Study|Other|1|||
105789429|NCT01891669|364883342|FG001|Overall Study|Other|0|||
105789430|NCT01891669|364883343|FG002|Overall Study|Other|0|||
105789431|NCT01891669|364883344|FG003|Overall Study|Other|0|||
105789432|NCT01891669|364883345|FG004|Overall Study|Other|0|||
105789433|NCT01891669|364883346|FG005|Overall Study|Other|0|||
105789434|NCT01891669|364883347|FG006|Overall Study|Other|0|||
105789435|NCT01891669|364883348|FG007|Overall Study|Other|1|||
105789436|NCT01891669|364883349|FG008|Overall Study|Other|0|||
105789437|NCT01891669|364883350|FG009|Overall Study|Other|0|||
105789438|NCT03843775|364883351|FG000|Overall Study|Adverse Event|1|||
105789439|NCT03843775|364883352|FG001|Overall Study|Adverse Event|1|||
105789440|NCT03843775|364883351|FG000|Overall Study|Lack of Efficacy|2|||
105789441|NCT03843775|364883352|FG001|Overall Study|Lack of Efficacy|6|||
105789442|NCT03843775|364883351|FG000|Overall Study|Withdrawal by Subject|0|||
105789443|NCT03843775|364883352|FG001|Overall Study|Withdrawal by Subject|1|||
105789444|NCT04150107|364883353|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
105789445|NCT04150107|364883354|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
105789446|NCT04150107|364883353|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
105789447|NCT04150107|364883354|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
105789448|NCT03930615|364883358|FG000|Overall Study|Death|9|||
105789449|NCT03930615|364883359|FG001|Overall Study|Death|3|||
105789450|NCT03930615|364883358|FG000|Overall Study|Lost to Follow-up|1|||
105789451|NCT03930615|364883359|FG001|Overall Study|Lost to Follow-up|2|||
105789452|NCT03930615|364883358|FG000|Overall Study|Physician Decision|3|||
105789453|NCT03930615|364883359|FG001|Overall Study|Physician Decision|4|||
105789454|NCT03930615|364883358|FG000|Overall Study|Withdrawal by Subject|13|||
105789455|NCT03930615|364883359|FG001|Overall Study|Withdrawal by Subject|2|||
105789456|NCT03930615|364883358|FG000|Overall Study|Not treated|1|||
105789457|NCT03930615|364883359|FG001|Overall Study|Not treated|1|||
105789458|NCT04611152|364883362|FG000|Overall Study|Adverse Event|9|||
105789459|NCT04611152|364883363|FG001|Overall Study|Adverse Event|8|||
105789460|NCT04611152|364883362|FG000|Overall Study|Non-compliance with study schedule|1|||
105789461|NCT04611152|364883363|FG001|Overall Study|Non-compliance with study schedule|3|||
105931354|NCT02697422|365407731|FG001|Overall Study|Exit survey data lost|0|||
105931355|NCT04243837|365407732|FG000|Overall Study|Adverse Event|2|||
105931356|NCT04243837|365407733|FG001|Overall Study|Adverse Event|1|||
105931357|NCT04243837|365407732|FG000|Overall Study|Withdrawal by Subject|4|||
105931358|NCT04243837|365407733|FG001|Overall Study|Withdrawal by Subject|2|||
105931359|NCT04243837|365407732|FG000|Overall Study|Covid-19 lock down|1|||
105931360|NCT04243837|365407733|FG001|Overall Study|Covid-19 lock down|0|||
105931361|NCT04243837|365407732|FG000|Overall Study|Study Terminated by Sponsor|11|||
105931362|NCT04243837|365407733|FG001|Overall Study|Study Terminated by Sponsor|12|||
105931363|NCT01436500|365407736|FG000|Overall Study|Death|1|||
105931364|NCT01436500|365407737|FG001|Overall Study|Death|0|||
105931365|NCT01436500|365407738|FG002|Overall Study|Death|0|||
105931366|NCT01436500|365407739|FG003|Overall Study|Death|0|||
105931367|NCT01436500|365407740|FG004|Overall Study|Death|0|||
105931368|NCT01436500|365407736|FG000|Overall Study|Adverse Event|0|||
105931369|NCT01436500|365407737|FG001|Overall Study|Adverse Event|2|||
105931370|NCT01436500|365407738|FG002|Overall Study|Adverse Event|2|||
105931371|NCT01436500|365407739|FG003|Overall Study|Adverse Event|0|||
105931372|NCT01436500|365407740|FG004|Overall Study|Adverse Event|1|||
105931373|NCT01436500|365407736|FG000|Overall Study|Withdrawal by Subject|0|||
105931374|NCT01436500|365407737|FG001|Overall Study|Withdrawal by Subject|0|||
105931375|NCT01436500|365407738|FG002|Overall Study|Withdrawal by Subject|2|||
105931376|NCT01436500|365407739|FG003|Overall Study|Withdrawal by Subject|0|||
105931377|NCT01436500|365407740|FG004|Overall Study|Withdrawal by Subject|2|||
105931378|NCT01436500|365407736|FG000|Overall Study|Physician Decision|0|||
105931379|NCT01436500|365407737|FG001|Overall Study|Physician Decision|0|||
105931380|NCT01436500|365407738|FG002|Overall Study|Physician Decision|1|||
105789462|NCT04611152|364883362|FG000|Overall Study|Withdrawal by Subject|5|||
105931381|NCT01436500|365407739|FG003|Overall Study|Physician Decision|0|||
105789463|NCT04611152|364883363|FG001|Overall Study|Withdrawal by Subject|6|||
105789464|NCT04611152|364883362|FG000|Overall Study|Lost to Follow-up|11|||
105931382|NCT01436500|365407740|FG004|Overall Study|Physician Decision|0|||
105931383|NCT01436500|365407736|FG000|Overall Study|liver transplant|1|||
105931384|NCT01436500|365407737|FG001|Overall Study|liver transplant|0|||
105931385|NCT01436500|365407738|FG002|Overall Study|liver transplant|0|||
105931386|NCT01436500|365407739|FG003|Overall Study|liver transplant|0|||
105789465|NCT04611152|364883363|FG001|Overall Study|Lost to Follow-up|2|||
105789466|NCT04456998|364883364|FG000|Overall Study|Adverse Event|0|||
105789467|NCT04456998|364883365|FG001|Overall Study|Adverse Event|4|||
105931387|NCT01436500|365407740|FG004|Overall Study|liver transplant|0|||
105931388|NCT01436500|365407736|FG000|Overall Study|initiation of dialysis|0|||
105931389|NCT01436500|365407737|FG001|Overall Study|initiation of dialysis|0|||
105789468|NCT04456998|364883364|FG000|Overall Study|Protocol Deviation|0|||
105789469|NCT04456998|364883365|FG001|Overall Study|Protocol Deviation|1|||
105789470|NCT04456998|364883364|FG000|Overall Study|Withdrawal by Subject|0|||
105789471|NCT04456998|364883365|FG001|Overall Study|Withdrawal by Subject|1|||
105789472|NCT00956813|364883369|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
105789473|NCT00956813|364883370|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
105789474|NCT00956813|364883369|FG000|Flaxseed and Placebo|Ineligible|3|||
105789475|NCT00956813|364883370|FG001|Flaxseed and Placebo|Ineligible|1|||
105789476|NCT03707145|364883373|FG000|Overall Study|Lost to Follow-up|0|||
105789477|NCT03707145|364883374|FG001|Overall Study|Lost to Follow-up|1|||
105789478|NCT03707145|364883375|FG002|Overall Study|Lost to Follow-up|1|||
105789479|NCT03707145|364883376|FG003|Overall Study|Lost to Follow-up|0|||
105714073|NCT03179436|364612018|FG005|Overall Study|Withdrawal by Subject|2|||
105714074|NCT03179436|364612019|FG006|Overall Study|Withdrawal by Subject|5|||
105714075|NCT03179436|364612020|FG007|Overall Study|Withdrawal by Subject|0|||
105714076|NCT03179436|364612021|FG008|Overall Study|Withdrawal by Subject|3|||
105714077|NCT03179436|364612022|FG009|Overall Study|Withdrawal by Subject|0|||
105714078|NCT03179436|364612023|FG010|Overall Study|Withdrawal by Subject|0|||
105789480|NCT04455620|364883377|FG000|Overall Study|Withdrawal by Subject|0|||
105789481|NCT04455620|364883378|FG001|Overall Study|Withdrawal by Subject|0|||
105789482|NCT04455620|364883379|FG002|Overall Study|Withdrawal by Subject|2|||
105714079|NCT03179436|364612024|FG011|Overall Study|Withdrawal by Subject|0|||
105714080|NCT03179436|364612013|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105714081|NCT03179436|364612014|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105714082|NCT03179436|364612015|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105714083|NCT03179436|364612016|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105714084|NCT03179436|364612017|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105714085|NCT03179436|364612018|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
105714086|NCT03179436|364612019|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
105714087|NCT03179436|364612020|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
105714088|NCT03179436|364612021|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
105714089|NCT03179436|364612022|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
105714090|NCT03179436|364612023|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
105714091|NCT03179436|364612024|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
105714092|NCT03179436|364612013|FG000|Overall Study|Sponsor Decision|0|||
105714093|NCT03179436|364612014|FG001|Overall Study|Sponsor Decision|0|||
105714094|NCT03179436|364612015|FG002|Overall Study|Sponsor Decision|1|||
105714095|NCT03179436|364612016|FG003|Overall Study|Sponsor Decision|3|||
105714096|NCT03179436|364612017|FG004|Overall Study|Sponsor Decision|9|||
105714097|NCT03179436|364612018|FG005|Overall Study|Sponsor Decision|7|||
105714098|NCT03179436|364612019|FG006|Overall Study|Sponsor Decision|2|||
105714099|NCT03179436|364612020|FG007|Overall Study|Sponsor Decision|4|||
105714100|NCT03179436|364612021|FG008|Overall Study|Sponsor Decision|23|||
105714101|NCT03179436|364612022|FG009|Overall Study|Sponsor Decision|6|||
105714102|NCT03179436|364612023|FG010|Overall Study|Sponsor Decision|7|||
105714103|NCT03179436|364612024|FG011|Overall Study|Sponsor Decision|5|||
105714104|NCT03179436|364612013|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714105|NCT03179436|364612014|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
105714106|NCT03179436|364612015|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714107|NCT03179436|364612016|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714108|NCT03179436|364612017|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714109|NCT03179436|364612018|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
105714110|NCT03179436|364612019|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714111|NCT03179436|364612020|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
105789483|NCT04455620|364883380|FG003|Overall Study|Withdrawal by Subject|0|||
105789484|NCT04455620|364883381|FG004|Overall Study|Withdrawal by Subject|1|||
105789485|NCT04455620|364883377|FG000|Overall Study|Lost to Follow-up|0|||
105789486|NCT04455620|364883378|FG001|Overall Study|Lost to Follow-up|0|||
105789487|NCT04455620|364883379|FG002|Overall Study|Lost to Follow-up|1|||
105714112|NCT03179436|364612021|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
105789488|NCT04455620|364883380|FG003|Overall Study|Lost to Follow-up|1|||
105789489|NCT04455620|364883381|FG004|Overall Study|Lost to Follow-up|0|||
105789490|NCT04455620|364883377|FG000|Overall Study|Death|1|||
105789491|NCT04455620|364883378|FG001|Overall Study|Death|6|||
105714113|NCT03179436|364612022|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714114|NCT03179436|364612023|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714115|NCT03179436|364612024|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
105714116|NCT03179436|364612013|FG000|Overall Study|Lost to Follow-up|1|||
105714117|NCT03179436|364612014|FG001|Overall Study|Lost to Follow-up|0|||
105714118|NCT03179436|364612015|FG002|Overall Study|Lost to Follow-up|0|||
105714119|NCT03179436|364612016|FG003|Overall Study|Lost to Follow-up|1|||
105931390|NCT01436500|365407738|FG002|Overall Study|initiation of dialysis|0|||
105931391|NCT01436500|365407739|FG003|Overall Study|initiation of dialysis|0|||
106136154|NCT01729819|366157873|FG000|Overall Study|Withdrawal by Subject|0|||
105789492|NCT04455620|364883379|FG002|Overall Study|Death|20|||
105789493|NCT04455620|364883380|FG003|Overall Study|Death|1|||
105789494|NCT04455620|364883381|FG004|Overall Study|Death|7|||
106136155|NCT01729819|366157874|FG001|Overall Study|Withdrawal by Subject|2|||
106136156|NCT01244984|366157875|FG000|Overall Study|Adverse Event|2|||
106136157|NCT01244984|366157876|FG001|Overall Study|Adverse Event|11|||
106136158|NCT01244984|366157877|FG002|Overall Study|Adverse Event|2|||
106136159|NCT01244984|366157875|FG000|Overall Study|Protocol Violation|1|||
106136160|NCT01244984|366157876|FG001|Overall Study|Protocol Violation|0|||
106136161|NCT01244984|366157877|FG002|Overall Study|Protocol Violation|0|||
106136162|NCT01244984|366157875|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
106136163|NCT01244984|366157876|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
106136164|NCT01244984|366157877|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
106136165|NCT01244984|366157875|FG000|Overall Study|Withdrawal by Subject|1|||
105714120|NCT03179436|364612017|FG004|Overall Study|Lost to Follow-up|0|||
105714121|NCT03179436|364612018|FG005|Overall Study|Lost to Follow-up|1|||
105714122|NCT03179436|364612019|FG006|Overall Study|Lost to Follow-up|0|||
105714123|NCT03179436|364612020|FG007|Overall Study|Lost to Follow-up|0|||
105714124|NCT03179436|364612021|FG008|Overall Study|Lost to Follow-up|1|||
105714125|NCT03179436|364612022|FG009|Overall Study|Lost to Follow-up|1|||
105714126|NCT03179436|364612023|FG010|Overall Study|Lost to Follow-up|0|||
105714127|NCT03179436|364612024|FG011|Overall Study|Lost to Follow-up|0|||
105714128|NCT03179436|364612013|FG000|Overall Study|Death|12|||
105714129|NCT03179436|364612014|FG001|Overall Study|Death|17|||
105714130|NCT03179436|364612015|FG002|Overall Study|Death|7|||
105714131|NCT03179436|364612016|FG003|Overall Study|Death|32|||
105714132|NCT03179436|364612017|FG004|Overall Study|Death|29|||
106136166|NCT01244984|366157876|FG001|Overall Study|Withdrawal by Subject|2|||
106136167|NCT01244984|366157877|FG002|Overall Study|Withdrawal by Subject|2|||
106136168|NCT01268891|366157879|FG000|Overall Study|Adverse Event|3|||
106136169|NCT01268891|366157880|FG001|Overall Study|Adverse Event|7|||
106136170|NCT01268891|366157879|FG000|Overall Study|Lack of Efficacy|1|||
106136171|NCT01268891|366157880|FG001|Overall Study|Lack of Efficacy|0|||
106136172|NCT01268891|366157879|FG000|Overall Study|Withdrawal of Consent|3|||
105714133|NCT03179436|364612018|FG005|Overall Study|Death|30|||
105714134|NCT03179436|364612019|FG006|Overall Study|Death|33|||
105714135|NCT03179436|364612020|FG007|Overall Study|Death|9|||
105714136|NCT03179436|364612021|FG008|Overall Study|Death|84|||
105714137|NCT03179436|364612022|FG009|Overall Study|Death|33|||
105714138|NCT03179436|364612023|FG010|Overall Study|Death|22|||
105714139|NCT03179436|364612024|FG011|Overall Study|Death|15|||
105714140|NCT01462266|364612025|FG000|Overall Study|Adverse Event|7|||
105714141|NCT01462266|364612026|FG001|Overall Study|Adverse Event|6|||
105714142|NCT01462266|364612025|FG000|Overall Study|Death|2|||
105714143|NCT01462266|364612026|FG001|Overall Study|Death|1|||
105714144|NCT01462266|364612025|FG000|Overall Study|Lack of Efficacy|0|||
105714145|NCT01462266|364612026|FG001|Overall Study|Lack of Efficacy|2|||
105714146|NCT01462266|364612025|FG000|Overall Study|Lost to Follow-up|4|||
105714147|NCT01462266|364612026|FG001|Overall Study|Lost to Follow-up|3|||
105714148|NCT01462266|364612025|FG000|Overall Study|Non-compliance with study drug|3|||
105714149|NCT01462266|364612026|FG001|Overall Study|Non-compliance with study drug|0|||
105931392|NCT01436500|365407740|FG004|Overall Study|initiation of dialysis|1|||
105931393|NCT01436500|365407736|FG000|Overall Study|discontinued study drug|1|||
105931394|NCT01436500|365407737|FG001|Overall Study|discontinued study drug|0|||
105931395|NCT01436500|365407738|FG002|Overall Study|discontinued study drug|0|||
105931396|NCT01436500|365407739|FG003|Overall Study|discontinued study drug|0|||
105931397|NCT01436500|365407740|FG004|Overall Study|discontinued study drug|0|||
105931398|NCT01436500|365407736|FG000|Overall Study|Other|0|||
105931399|NCT01436500|365407737|FG001|Overall Study|Other|1|||
105931400|NCT01436500|365407738|FG002|Overall Study|Other|0|||
105931401|NCT01436500|365407739|FG003|Overall Study|Other|1|||
105931402|NCT01436500|365407740|FG004|Overall Study|Other|0|||
105931403|NCT00977561|365407741|FG000|Overall Study|Death|3|||
105931404|NCT00977561|365407742|FG001|Overall Study|Death|2|||
105931405|NCT00977561|365407741|FG000|Overall Study|Study terminated|0|||
106136173|NCT01268891|366157880|FG001|Overall Study|Withdrawal of Consent|1|||
106136174|NCT01268891|366157879|FG000|Overall Study|Administrative or other reason(s)|1|||
105931406|NCT00977561|365407742|FG001|Overall Study|Study terminated|2|||
105931407|NCT00977561|365407741|FG000|Overall Study|Other|2|||
106136175|NCT01268891|366157880|FG001|Overall Study|Administrative or other reason(s)|0|||
106136176|NCT01124162|366157884|FG000|First Intervention|Adverse Event|2|||
106136177|NCT01124162|366157885|FG001|First Intervention|Adverse Event|0|||
106136178|NCT01124162|366157884|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105714150|NCT01462266|364612025|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
105714151|NCT01462266|364612026|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
105714152|NCT01462266|364612025|FG000|Overall Study|Physician Decision|2|||
105714153|NCT01462266|364612026|FG001|Overall Study|Physician Decision|5|||
105714154|NCT01462266|364612025|FG000|Overall Study|Protocol Violation|1|||
105714155|NCT01462266|364612026|FG001|Overall Study|Protocol Violation|3|||
105714156|NCT01462266|364612025|FG000|Overall Study|Withdrawal by Subject|7|||
105714157|NCT01462266|364612026|FG001|Overall Study|Withdrawal by Subject|2|||
105714158|NCT01462266|364612025|FG000|Overall Study|Screen failure|1|||
105714159|NCT01462266|364612026|FG001|Overall Study|Screen failure|1|||
105714160|NCT01106846|364612027|FG000|Overall Study|Change in surgical procedure|0|||
105714161|NCT01106846|364612028|FG001|Overall Study|Change in surgical procedure|1|||
105714162|NCT00803179|364612031|FG000|Overall Study|Lost to Follow-up|3|||
105714163|NCT00546052|364612033|FG000|Overall Study|Adverse Event|47|||
105714164|NCT00546052|364612033|FG000|Overall Study|Lost to Follow-up|144|||
105714165|NCT00546052|364612033|FG000|Overall Study|Protocol Violation|9|||
105714166|NCT00546052|364612033|FG000|Overall Study|Withdrawal by Subject|20|||
105714167|NCT00546052|364612033|FG000|Overall Study|Non Compliance|7|||
105714168|NCT01445678|364612037|FG000|Overall Study|Adverse Event|12|||
105714169|NCT01445678|364612038|FG001|Overall Study|Adverse Event|8|||
105714170|NCT01445678|364612037|FG000|Overall Study|Lack of Efficacy|0|||
105714171|NCT01445678|364612038|FG001|Overall Study|Lack of Efficacy|2|||
105714172|NCT01445678|364612037|FG000|Overall Study|Lost to Follow-up|8|||
105714173|NCT01445678|364612038|FG001|Overall Study|Lost to Follow-up|5|||
105714174|NCT01445678|364612037|FG000|Overall Study|Protocol Violation|1|||
105931408|NCT00977561|365407742|FG001|Overall Study|Other|0|||
105931409|NCT01873833|365407744|FG000|Overall Study|Withdrawal by Subject|1|||
105714175|NCT01445678|364612038|FG001|Overall Study|Protocol Violation|1|||
105714176|NCT01445678|364612037|FG000|Overall Study|Withdrawal by Subject|9|||
105714177|NCT01445678|364612038|FG001|Overall Study|Withdrawal by Subject|5|||
105714178|NCT02482129|364612039|FG000|Overall Study|Adverse Event-prior to treatment|0|||
105714179|NCT02482129|364612040|FG001|Overall Study|Adverse Event-prior to treatment|1|||
105714180|NCT02482129|364612039|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
105714181|NCT02482129|364612040|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
105714182|NCT02482129|364612039|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
105714183|NCT02482129|364612040|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
105714184|NCT02482129|364612039|FG000|Overall Study|Criteria not met-prior to treatment|1|||
105714185|NCT02482129|364612040|FG001|Overall Study|Criteria not met-prior to treatment|0|||
105714186|NCT02482129|364612039|FG000|Overall Study|Adverse Event|1|||
105714187|NCT02482129|364612040|FG001|Overall Study|Adverse Event|0|||
105714188|NCT02482129|364612039|FG000|Overall Study|Withdrawal by Subject|2|||
105714189|NCT02482129|364612040|FG001|Overall Study|Withdrawal by Subject|0|||
105714190|NCT02482129|364612039|FG000|Overall Study|Criteria not met|1|||
105714191|NCT02482129|364612040|FG001|Overall Study|Criteria not met|0|||
105714192|NCT01738971|364612041|FG000|Overall Study|Lost to Follow-up|19|||
105714193|NCT01738971|364612042|FG001|Overall Study|Lost to Follow-up|30|||
105714194|NCT01738971|364612043|FG002|Overall Study|Lost to Follow-up|17|||
105714195|NCT02447848|364612048|FG000|Overall Study|Patient discharged|3|||
105714196|NCT02447848|364612048|FG000|Overall Study|Lack of Efficacy|4|||
105714197|NCT02447848|364612048|FG000|Overall Study|Withdrawal by Subject|4|||
105714198|NCT01877083|364612049|FG000|Treatment Phase|Disease Progression|10|||
105714199|NCT01877083|364612049|FG000|Treatment Phase|Clinical Progression|1|||
105714200|NCT01877083|364612049|FG000|Treatment Phase|Adverse Event|6|||
105714201|NCT01877083|364612049|FG000|Treatment Phase|Withdrawal by Subject|2|||
105714202|NCT01877083|364612049|FG000|Treatment Phase|Lost to Follow-up|1|||
105714203|NCT01877083|364612049|FG000|Extension Phase|Disease Progression|3|||
105714204|NCT01877083|364612049|FG000|Extension Phase|Adverse Event|2|||
105714205|NCT00429585|364612050|FG000|Overall Study|Death|1|||
105714206|NCT00429585|364612051|FG001|Overall Study|Death|0|||
105714207|NCT00429585|364612050|FG000|Overall Study|Lost to Follow-up|27|||
105714208|NCT00429585|364612051|FG001|Overall Study|Lost to Follow-up|20|||
105714209|NCT00429585|364612050|FG000|Overall Study|Physician Decision|2|||
105714210|NCT00429585|364612051|FG001|Overall Study|Physician Decision|0|||
105714211|NCT01582308|364612052|FG000|Period 1|Withdrawal by Subject|0|||
105714212|NCT01582308|364612053|FG001|Period 1|Withdrawal by Subject|0|||
105714213|NCT01582308|364612054|FG002|Period 1|Withdrawal by Subject|0|||
105714214|NCT01582308|364612055|FG003|Period 1|Withdrawal by Subject|0|||
105714215|NCT01582308|364612056|FG004|Period 1|Withdrawal by Subject|0|||
105714216|NCT01582308|364612057|FG005|Period 1|Withdrawal by Subject|0|||
105714217|NCT01582308|364612058|FG006|Period 1|Withdrawal by Subject|1|||
105714218|NCT01582308|364612059|FG007|Period 1|Withdrawal by Subject|0|||
105714219|NCT01582308|364612060|FG008|Period 1|Withdrawal by Subject|0|||
105714220|NCT01582308|364612061|FG009|Period 1|Withdrawal by Subject|0|||
105931410|NCT04149353|365407748|FG000|Overall Study|Study terminated|1|||
105931411|NCT00356421|365407749|FG000|Overall Study|Lack of Efficacy|3|||
105714221|NCT01582308|364612052|FG000|10-day Washout Following Period 1|Physician Decision|0|||
105714222|NCT01582308|364612053|FG001|10-day Washout Following Period 1|Physician Decision|0|||
105714223|NCT01582308|364612054|FG002|10-day Washout Following Period 1|Physician Decision|0|||
105714224|NCT01582308|364612055|FG003|10-day Washout Following Period 1|Physician Decision|0|||
105714225|NCT01582308|364612056|FG004|10-day Washout Following Period 1|Physician Decision|1|||
105714226|NCT01582308|364612057|FG005|10-day Washout Following Period 1|Physician Decision|0|||
105714227|NCT01582308|364612058|FG006|10-day Washout Following Period 1|Physician Decision|0|||
105714228|NCT01582308|364612059|FG007|10-day Washout Following Period 1|Physician Decision|0|||
105714229|NCT01582308|364612060|FG008|10-day Washout Following Period 1|Physician Decision|0|||
105714230|NCT01582308|364612061|FG009|10-day Washout Following Period 1|Physician Decision|0|||
106136179|NCT01124162|366157885|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
106136180|NCT02680756|366157886|FG000|Overall Study|Adverse Event|10|||
106136181|NCT02680756|366157887|FG001|Overall Study|Adverse Event|2|||
106136182|NCT02680756|366157886|FG000|Overall Study|Lost to Follow-up|7|||
106136183|NCT02680756|366157887|FG001|Overall Study|Lost to Follow-up|6|||
106136184|NCT02680756|366157886|FG000|Overall Study|Withdrawal by Subject|5|||
106136185|NCT02680756|366157887|FG001|Overall Study|Withdrawal by Subject|5|||
106136186|NCT02680756|366157886|FG000|Overall Study|Physician Decision|4|||
106136187|NCT02680756|366157887|FG001|Overall Study|Physician Decision|1|||
106136188|NCT02680756|366157886|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
106136189|NCT02680756|366157887|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
106136190|NCT02680756|366157886|FG000|Overall Study|Blood transfusion for any reason|0|||
106136191|NCT02680756|366157887|FG001|Overall Study|Blood transfusion for any reason|1|||
106136192|NCT02680756|366157886|FG000|Overall Study|Death|1|||
106136193|NCT02680756|366157887|FG001|Overall Study|Death|0|||
106136194|NCT02680756|366157886|FG000|Overall Study|Protocol Violation|1|||
106136195|NCT02680756|366157887|FG001|Overall Study|Protocol Violation|0|||
106136196|NCT02680756|366157886|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
106136197|NCT02680756|366157887|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
106136198|NCT02680756|366157886|FG000|Overall Study|None of above or not recorded|3|||
106136199|NCT02680756|366157887|FG001|Overall Study|None of above or not recorded|2|||
106136200|NCT01838200|366157890|FG000|Overall Study|Adverse Event|0|||
106136201|NCT01838200|366157891|FG001|Overall Study|Adverse Event|2|||
106136202|NCT01838200|366157890|FG000|Overall Study|Progressive disease|3|||
106136203|NCT01838200|366157891|FG001|Overall Study|Progressive disease|0|||
106136204|NCT00269399|366157894|FG000|Overall Study|Lack of Efficacy|27|||
106136205|NCT00269399|366157895|FG001|Overall Study|Lack of Efficacy|10|||
106136206|NCT00269399|366157894|FG000|Overall Study|Adverse Event|10|||
106136207|NCT00269399|366157895|FG001|Overall Study|Adverse Event|4|||
106136208|NCT00269399|366157894|FG000|Overall Study|Withdrawal by Subject|2|||
106136209|NCT00269399|366157895|FG001|Overall Study|Withdrawal by Subject|5|||
106136210|NCT00269399|366157894|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
106136211|NCT00269399|366157895|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
106136212|NCT00269399|366157894|FG000|Overall Study|Other|0|||
106136213|NCT00269399|366157895|FG001|Overall Study|Other|4|||
106136214|NCT00269399|366157894|FG000|Overall Study|Development of exclusion criteria|0|||
106136215|NCT00269399|366157895|FG001|Overall Study|Development of exclusion criteria|1|||
106136216|NCT02049866|366157897|FG000|Overall Study|Withdrawal by Subject|1|||
106136217|NCT03721016|366157899|FG000|Overall Study|Adverse Event|0|||
106136218|NCT03721016|366157900|FG001|Overall Study|Adverse Event|1|||
106136219|NCT03721016|366157901|FG002|Overall Study|Adverse Event|1|||
106136220|NCT03721016|366157899|FG000|Overall Study|Withdrawal by Subject|8|||
106136221|NCT03721016|366157900|FG001|Overall Study|Withdrawal by Subject|16|||
106136222|NCT03721016|366157901|FG002|Overall Study|Withdrawal by Subject|13|||
106136223|NCT03721016|366157899|FG000|Overall Study|Lost to Follow-up|4|||
106136224|NCT03721016|366157900|FG001|Overall Study|Lost to Follow-up|6|||
106136225|NCT03721016|366157901|FG002|Overall Study|Lost to Follow-up|5|||
106136226|NCT03721016|366157899|FG000|Overall Study|Physician Decision|0|||
106136227|NCT03721016|366157900|FG001|Overall Study|Physician Decision|1|||
106136228|NCT03721016|366157901|FG002|Overall Study|Physician Decision|2|||
105714231|NCT01582308|364612052|FG000|Period 4|Physician Decision|1|||
105714232|NCT01582308|364612053|FG001|Period 4|Physician Decision|0|||
105714233|NCT01582308|364612054|FG002|Period 4|Physician Decision|0|||
105714234|NCT01582308|364612055|FG003|Period 4|Physician Decision|0|||
105714235|NCT01582308|364612056|FG004|Period 4|Physician Decision|0|||
105714236|NCT01582308|364612057|FG005|Period 4|Physician Decision|1|||
105714237|NCT01582308|364612058|FG006|Period 4|Physician Decision|0|||
105714238|NCT01582308|364612059|FG007|Period 4|Physician Decision|0|||
105714239|NCT01582308|364612060|FG008|Period 4|Physician Decision|0|||
105714240|NCT01582308|364612061|FG009|Period 4|Physician Decision|1|||
105714241|NCT01790503|364613858|FG000|Overall Study|Adverse Event|1|||
105714242|NCT01790503|364613859|FG001|Overall Study|Adverse Event|0|||
105714243|NCT01790503|364613860|FG002|Overall Study|Adverse Event|0|||
105714244|NCT01790503|364613861|FG003|Overall Study|Adverse Event|0|||
105714245|NCT01790503|364613862|FG004|Overall Study|Adverse Event|0|||
106136229|NCT03721016|366157899|FG000|Overall Study|Protocol Violation|0|||
106136230|NCT03721016|366157900|FG001|Overall Study|Protocol Violation|1|||
106136231|NCT03721016|366157901|FG002|Overall Study|Protocol Violation|0|||
106136232|NCT03721016|366157899|FG000|Overall Study|Site terminated by sponsor|3|||
106136233|NCT03721016|366157900|FG001|Overall Study|Site terminated by sponsor|7|||
106136234|NCT03721016|366157901|FG002|Overall Study|Site terminated by sponsor|6|||
105714246|NCT01790503|364613863|FG005|Overall Study|Adverse Event|2|||
106136235|NCT03721016|366157899|FG000|Overall Study|Subject exited early due to COVID-19|1|||
106136236|NCT03721016|366157900|FG001|Overall Study|Subject exited early due to COVID-19|0|||
105714247|NCT01790503|364613864|FG006|Overall Study|Adverse Event|0|||
105714248|NCT01790503|364613865|FG007|Overall Study|Adverse Event|0|||
105714249|NCT01790503|364613866|FG008|Overall Study|Adverse Event|2|||
105714250|NCT01790503|364613867|FG009|Overall Study|Adverse Event|4|||
105714251|NCT01790503|364613868|FG010|Overall Study|Adverse Event|7|||
105714252|NCT01790503|364613858|FG000|Overall Study|Withdrawal by Subject|0|||
105714253|NCT01790503|364613859|FG001|Overall Study|Withdrawal by Subject|0|||
105714254|NCT01790503|364613860|FG002|Overall Study|Withdrawal by Subject|1|||
105714255|NCT01790503|364613861|FG003|Overall Study|Withdrawal by Subject|1|||
105714256|NCT01790503|364613862|FG004|Overall Study|Withdrawal by Subject|1|||
105714257|NCT01790503|364613863|FG005|Overall Study|Withdrawal by Subject|2|||
105714258|NCT01790503|364613864|FG006|Overall Study|Withdrawal by Subject|1|||
105714259|NCT01790503|364613865|FG007|Overall Study|Withdrawal by Subject|0|||
105714260|NCT01790503|364613866|FG008|Overall Study|Withdrawal by Subject|0|||
105714261|NCT01790503|364613867|FG009|Overall Study|Withdrawal by Subject|0|||
105714262|NCT01790503|364613868|FG010|Overall Study|Withdrawal by Subject|1|||
105714263|NCT01790503|364613858|FG000|Overall Study|Disease progression|2|||
105714264|NCT01790503|364613859|FG001|Overall Study|Disease progression|1|||
105714265|NCT01790503|364613860|FG002|Overall Study|Disease progression|0|||
105714266|NCT01790503|364613861|FG003|Overall Study|Disease progression|1|||
105714267|NCT01790503|364613862|FG004|Overall Study|Disease progression|2|||
105714268|NCT01790503|364613863|FG005|Overall Study|Disease progression|1|||
105714269|NCT01790503|364613864|FG006|Overall Study|Disease progression|0|||
105714270|NCT01790503|364613865|FG007|Overall Study|Disease progression|1|||
105714271|NCT01790503|364613866|FG008|Overall Study|Disease progression|0|||
105714272|NCT01790503|364613867|FG009|Overall Study|Disease progression|17|||
105714273|NCT01790503|364613868|FG010|Overall Study|Disease progression|7|||
105714274|NCT01790503|364613858|FG000|Overall Study|Protocol Violation|0|||
105714275|NCT01790503|364613859|FG001|Overall Study|Protocol Violation|0|||
105714276|NCT01790503|364613860|FG002|Overall Study|Protocol Violation|0|||
105714277|NCT01790503|364613861|FG003|Overall Study|Protocol Violation|0|||
105714278|NCT01790503|364613862|FG004|Overall Study|Protocol Violation|0|||
105714279|NCT01790503|364613863|FG005|Overall Study|Protocol Violation|0|||
105714280|NCT01790503|364613864|FG006|Overall Study|Protocol Violation|0|||
105714281|NCT01790503|364613865|FG007|Overall Study|Protocol Violation|0|||
105714282|NCT01790503|364613866|FG008|Overall Study|Protocol Violation|0|||
105714283|NCT01790503|364613867|FG009|Overall Study|Protocol Violation|1|||
105714284|NCT01790503|364613868|FG010|Overall Study|Protocol Violation|0|||
105714285|NCT01790503|364613858|FG000|Overall Study|Physician Decision|0|||
105714286|NCT01790503|364613859|FG001|Overall Study|Physician Decision|0|||
105714287|NCT01790503|364613860|FG002|Overall Study|Physician Decision|0|||
105714288|NCT01790503|364613861|FG003|Overall Study|Physician Decision|0|||
105714289|NCT01790503|364613862|FG004|Overall Study|Physician Decision|0|||
105714290|NCT01790503|364613863|FG005|Overall Study|Physician Decision|0|||
105714291|NCT01790503|364613864|FG006|Overall Study|Physician Decision|0|||
105714292|NCT01790503|364613865|FG007|Overall Study|Physician Decision|0|||
105714293|NCT01790503|364613866|FG008|Overall Study|Physician Decision|0|||
105714294|NCT01790503|364613867|FG009|Overall Study|Physician Decision|1|||
105714295|NCT01790503|364613868|FG010|Overall Study|Physician Decision|1|||
105714296|NCT01790503|364613858|FG000|Overall Study|Death|0|||
105714297|NCT01790503|364613859|FG001|Overall Study|Death|0|||
105714298|NCT01790503|364613860|FG002|Overall Study|Death|0|||
105714299|NCT01790503|364613861|FG003|Overall Study|Death|0|||
105714300|NCT01790503|364613862|FG004|Overall Study|Death|0|||
105714301|NCT01790503|364613863|FG005|Overall Study|Death|0|||
105714302|NCT01790503|364613864|FG006|Overall Study|Death|0|||
105714303|NCT01790503|364613865|FG007|Overall Study|Death|0|||
105714304|NCT01790503|364613866|FG008|Overall Study|Death|0|||
105714305|NCT01790503|364613867|FG009|Overall Study|Death|1|||
105714306|NCT01790503|364613868|FG010|Overall Study|Death|0|||
105714307|NCT01790503|364613858|FG000|Overall Study|Non Compliance|0|||
105714308|NCT01790503|364613859|FG001|Overall Study|Non Compliance|0|||
105714309|NCT01790503|364613860|FG002|Overall Study|Non Compliance|0|||
105714310|NCT01790503|364613861|FG003|Overall Study|Non Compliance|0|||
105714311|NCT01790503|364613862|FG004|Overall Study|Non Compliance|1|||
105931412|NCT00356421|365407750|FG001|Overall Study|Lack of Efficacy|0|||
105931413|NCT00356421|365407749|FG000|Overall Study|Withdrawal by Subject|9|||
105714312|NCT01790503|364613863|FG005|Overall Study|Non Compliance|0|||
105714313|NCT01790503|364613864|FG006|Overall Study|Non Compliance|0|||
105714314|NCT01790503|364613865|FG007|Overall Study|Non Compliance|0|||
105714315|NCT01790503|364613866|FG008|Overall Study|Non Compliance|0|||
105714316|NCT01790503|364613867|FG009|Overall Study|Non Compliance|0|||
105714317|NCT01790503|364613868|FG010|Overall Study|Non Compliance|0|||
105714318|NCT01790503|364613858|FG000|Overall Study|Other|0|||
105714319|NCT01790503|364613859|FG001|Overall Study|Other|0|||
105931414|NCT00356421|365407750|FG001|Overall Study|Withdrawal by Subject|2|||
105714320|NCT01790503|364613860|FG002|Overall Study|Other|0|||
105714321|NCT01790503|364613861|FG003|Overall Study|Other|0|||
105714322|NCT01790503|364613862|FG004|Overall Study|Other|1|||
105714323|NCT01790503|364613863|FG005|Overall Study|Other|0|||
105714324|NCT01790503|364613864|FG006|Overall Study|Other|0|||
105714325|NCT01790503|364613865|FG007|Overall Study|Other|0|||
105714326|NCT01790503|364613866|FG008|Overall Study|Other|1|||
105714327|NCT01790503|364613867|FG009|Overall Study|Other|2|||
105714328|NCT01790503|364613868|FG010|Overall Study|Other|0|||
105714329|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Other|24|||
105714330|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Other|6|||
105714331|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
105714332|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
105714333|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
105714334|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
105714335|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
105714336|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
105714337|NCT01934140|364613869|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
105714338|NCT01934140|364613870|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
105714339|NCT01934140|364613869|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
105714340|NCT01934140|364613870|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
105714341|NCT01934140|364613869|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
105714342|NCT01934140|364613870|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
105714343|NCT01934140|364613869|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
105714344|NCT01934140|364613870|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
105714345|NCT01268293|364613871|FG000|Overall Study|Disease progression|7|||
105714346|NCT01268293|364613871|FG000|Overall Study|Adverse Event|1|||
105714347|NCT01268293|364613871|FG000|Overall Study|Subject choice|1|||
105714348|NCT03269344|364613872|FG000|Overall Study|Protocol Violation|4|||
105714349|NCT03269344|364613873|FG001|Overall Study|Protocol Violation|3|||
105714350|NCT02597855|364613874|FG000|Overall Study|Lost to Follow-up|2|||
105714351|NCT02597855|364613875|FG001|Overall Study|Lost to Follow-up|1|||
105714352|NCT00200850|364613876|FG000|Overall Study|relocation|1|||
105714353|NCT00200850|364613877|FG001|Overall Study|relocation|0|||
105714354|NCT00200850|364613878|FG002|Overall Study|relocation|1|||
105714355|NCT00200850|364613876|FG000|Overall Study|too busy|1|||
105714356|NCT00200850|364613877|FG001|Overall Study|too busy|0|||
105714357|NCT00200850|364613878|FG002|Overall Study|too busy|0|||
105714358|NCT00200850|364613876|FG000|Overall Study|Pregnancy|0|||
105714359|NCT00200850|364613877|FG001|Overall Study|Pregnancy|0|||
105714360|NCT00200850|364613878|FG002|Overall Study|Pregnancy|1|||
105714361|NCT00200850|364613876|FG000|Overall Study|Poor adherence|0|||
105714362|NCT00200850|364613877|FG001|Overall Study|Poor adherence|0|||
105714363|NCT00200850|364613878|FG002|Overall Study|Poor adherence|1|||
105714364|NCT00200850|364613876|FG000|Overall Study|optic neuritis|0|||
105714365|NCT00200850|364613877|FG001|Overall Study|optic neuritis|0|||
105714366|NCT00200850|364613878|FG002|Overall Study|optic neuritis|1|||
105714367|NCT00200850|364613876|FG000|Overall Study|Adverse Event|1|||
105714368|NCT00200850|364613877|FG001|Overall Study|Adverse Event|1|||
105714369|NCT00200850|364613878|FG002|Overall Study|Adverse Event|2|||
105714370|NCT00805740|364613879|FG000|Overall Study|Death|7|||
105714371|NCT00805740|364613880|FG001|Overall Study|Death|4|||
105714372|NCT00805740|364613879|FG000|Overall Study|Withdrawal by Subject|1|||
105714373|NCT00805740|364613880|FG001|Overall Study|Withdrawal by Subject|0|||
105714374|NCT00805740|364613879|FG000|Overall Study|Lost to Follow-up|1|||
105714375|NCT00805740|364613880|FG001|Overall Study|Lost to Follow-up|0|||
106008628|NCT03597347|365697048|FG000|Overall Study|Withdrawal by Subject|1|||
106136237|NCT03721016|366157901|FG002|Overall Study|Subject exited early due to COVID-19|0|||
105714376|NCT00805740|364613879|FG000|Overall Study|Randomized, but not treated|2|||
105714377|NCT00805740|364613880|FG001|Overall Study|Randomized, but not treated|0|||
105714378|NCT01946178|364613884|FG000|Overall Study|Pregnancy|1|||
105714379|NCT01946178|364613884|FG000|Overall Study|Lost to Follow-up|1|||
105714380|NCT01285908|364613887|FG000|Baseline Measurement|unable to insert catheter|1|||
105714381|NCT01285908|364613888|FG001|Baseline Measurement|unable to insert catheter|0|||
105714382|NCT01285908|364613889|FG002|Baseline Measurement|unable to insert catheter|0|||
105714383|NCT01285908|364613887|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
105714384|NCT01285908|364613888|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
105714385|NCT01285908|364613889|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
105714386|NCT01285908|364613887|FG000|Baseline Measurement|unable to tolerate procedure|1|||
105714387|NCT01285908|364613888|FG001|Baseline Measurement|unable to tolerate procedure|0|||
105714388|NCT01285908|364613889|FG002|Baseline Measurement|unable to tolerate procedure|0|||
105714389|NCT00493038|364613890|FG000|Treatment|Adverse Event|8|||
106136238|NCT04148937|366157902|FG000|Overall Study|Withdrawal by Subject|0|||
106136239|NCT04148937|366157903|FG001|Overall Study|Withdrawal by Subject|0|||
105714390|NCT00493038|364613891|FG001|Treatment|Adverse Event|4|||
105714391|NCT00493038|364613890|FG000|Treatment|Lost to Follow-up|5|||
105714392|NCT00493038|364613891|FG001|Treatment|Lost to Follow-up|3|||
105714393|NCT00493038|364613890|FG000|Treatment|Withdrawal by Subject|11|||
105714394|NCT00493038|364613891|FG001|Treatment|Withdrawal by Subject|12|||
105714395|NCT00493038|364613890|FG000|Treatment|Other|0|||
105714396|NCT00493038|364613891|FG001|Treatment|Other|1|||
105714397|NCT00493038|364613890|FG000|Follow-up|Lost to Follow-up|1|||
105714398|NCT00493038|364613891|FG001|Follow-up|Lost to Follow-up|0|||
106008629|NCT03597347|365697049|FG001|Overall Study|Withdrawal by Subject|1|||
105714399|NCT00608985|364613896|FG000|Overall Study|Adverse Event|2|||
105714400|NCT00608985|364613897|FG001|Overall Study|Adverse Event|7|||
105714401|NCT00608985|364613898|FG002|Overall Study|Adverse Event|4|||
105714402|NCT00608985|364613899|FG003|Overall Study|Adverse Event|6|||
105714403|NCT00608985|364613896|FG000|Overall Study|Administrative/Other|7|||
105714404|NCT00608985|364613897|FG001|Overall Study|Administrative/Other|4|||
105714405|NCT00608985|364613898|FG002|Overall Study|Administrative/Other|1|||
105714406|NCT00608985|364613899|FG003|Overall Study|Administrative/Other|2|||
105714407|NCT00608985|364613896|FG000|Overall Study|Withdrawal of Consent|5|||
105714408|NCT00608985|364613897|FG001|Overall Study|Withdrawal of Consent|1|||
105714409|NCT00608985|364613898|FG002|Overall Study|Withdrawal of Consent|1|||
105714410|NCT00608985|364613899|FG003|Overall Study|Withdrawal of Consent|1|||
105714411|NCT00608985|364613896|FG000|Overall Study|Lost to Follow-up|2|||
105714412|NCT00608985|364613897|FG001|Overall Study|Lost to Follow-up|1|||
105714413|NCT00608985|364613898|FG002|Overall Study|Lost to Follow-up|0|||
105714414|NCT00608985|364613899|FG003|Overall Study|Lost to Follow-up|0|||
105714415|NCT00094757|364613904|FG000|Overall Study|Adverse Event|11|||
105714416|NCT00094757|364613905|FG001|Overall Study|Adverse Event|9|||
105714417|NCT00094757|364613906|FG002|Overall Study|Adverse Event|6|||
105714418|NCT00094757|364613904|FG000|Overall Study|Lack of Efficacy|11|||
105714419|NCT00094757|364613905|FG001|Overall Study|Lack of Efficacy|15|||
105714420|NCT00094757|364613906|FG002|Overall Study|Lack of Efficacy|8|||
105714421|NCT00094757|364613904|FG000|Overall Study|Lost to Follow-up|3|||
105714422|NCT00094757|364613905|FG001|Overall Study|Lost to Follow-up|5|||
105714423|NCT00094757|364613906|FG002|Overall Study|Lost to Follow-up|6|||
105714424|NCT00094757|364613904|FG000|Overall Study|Patient Moved|2|||
105714425|NCT00094757|364613905|FG001|Overall Study|Patient Moved|1|||
105714426|NCT00094757|364613906|FG002|Overall Study|Patient Moved|1|||
105714427|NCT00094757|364613904|FG000|Overall Study|Protocol Violation|8|||
105714428|NCT00094757|364613905|FG001|Overall Study|Protocol Violation|5|||
105714429|NCT00094757|364613906|FG002|Overall Study|Protocol Violation|3|||
105714430|NCT00094757|364613904|FG000|Overall Study|Withdrawal by Subject|14|||
105714431|NCT00094757|364613905|FG001|Overall Study|Withdrawal by Subject|21|||
105714432|NCT00094757|364613906|FG002|Overall Study|Withdrawal by Subject|5|||
105714433|NCT00094757|364613904|FG000|Overall Study|Other|3|||
105714434|NCT00094757|364613905|FG001|Overall Study|Other|3|||
105714435|NCT00094757|364613906|FG002|Overall Study|Other|1|||
105714436|NCT00094757|364613904|FG000|Overall Study|Protocol specified discontinuation|1|||
105714437|NCT00094757|364613905|FG001|Overall Study|Protocol specified discontinuation|3|||
105714438|NCT00094757|364613906|FG002|Overall Study|Protocol specified discontinuation|0|||
105714439|NCT02239263|364613907|FG000|Overall Study|Protocol Violation|6|||
105714440|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Adverse Event|11|||
105714441|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Adverse Event|15|||
105714442|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
105714443|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
105714444|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
105931415|NCT00356421|365407749|FG000|Overall Study|Related to study drug|15|||
105931416|NCT00356421|365407750|FG001|Overall Study|Related to study drug|12|||
105931417|NCT00356421|365407749|FG000|Overall Study|Not related to study drug|5|||
105931418|NCT00356421|365407750|FG001|Overall Study|Not related to study drug|3|||
105931419|NCT00825175|365407751|FG000|Overall Study|Withdrawal by Subject|0|||
105931420|NCT00825175|365407752|FG001|Overall Study|Withdrawal by Subject|5|||
105931421|NCT00501085|365407753|FG000|Overall Study|Lost to Follow-up|195|||
105931422|NCT00501085|365407753|FG000|Overall Study|Withdrawal by Subject|34|||
105931423|NCT00501085|365407753|FG000|Overall Study|Subject Decision|1|||
105931424|NCT00501085|365407753|FG000|Overall Study|Revision Surgery|7|||
105931425|NCT00501085|365407753|FG000|Overall Study|Explantation Surgery|26|||
105931426|NCT00501085|365407753|FG000|Overall Study|Adverse Event|4|||
105931427|NCT00501085|365407753|FG000|Overall Study|Non-Compliance|24|||
105931428|NCT00501085|365407753|FG000|Overall Study|Study closed by sponsor|109|||
105931429|NCT00501085|365407753|FG000|Overall Study|Other loss to follow-up|32|||
105931430|NCT00887588|365407754|FG000|Core Period|Death|1|||
105931431|NCT00887588|365407755|FG001|Core Period|Death|1|||
105789495|NCT04455620|364883377|FG000|Overall Study|Study Termination|0|||
105789496|NCT04455620|364883378|FG001|Overall Study|Study Termination|2|||
105931432|NCT00887588|365407754|FG000|Core Period|Lost to Follow-up|3|||
105931433|NCT00887588|365407755|FG001|Core Period|Lost to Follow-up|1|||
105714445|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
105714446|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
105931434|NCT00887588|365407754|FG000|Core Period|Withdrawal by Subject|6|||
105931435|NCT00887588|365407755|FG001|Core Period|Withdrawal by Subject|8|||
105931436|NCT00887588|365407754|FG000|Core Period|Adverse Event|9|||
105714447|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
105714448|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
105714449|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
105714450|NCT01058096|364613908|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
105789497|NCT04455620|364883379|FG002|Overall Study|Study Termination|1|||
105931437|NCT00887588|365407755|FG001|Core Period|Adverse Event|11|||
105714451|NCT01058096|364613909|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
105714452|NCT00087646|364613914|FG000|Overall Study|Adverse Event|37|||
105714453|NCT00087646|364613915|FG001|Overall Study|Adverse Event|6|||
105714454|NCT00087646|364613916|FG002|Overall Study|Adverse Event|18|||
105714455|NCT00087646|364613917|FG003|Overall Study|Adverse Event|20|||
105714456|NCT00087646|364613914|FG000|Overall Study|Death|0|||
105714457|NCT00087646|364613915|FG001|Overall Study|Death|1|||
105714458|NCT00087646|364613916|FG002|Overall Study|Death|0|||
105714459|NCT00087646|364613917|FG003|Overall Study|Death|0|||
105714460|NCT00087646|364613914|FG000|Overall Study|Withdrawal by Subject|6|||
105714461|NCT00087646|364613915|FG001|Overall Study|Withdrawal by Subject|1|||
105714462|NCT00087646|364613916|FG002|Overall Study|Withdrawal by Subject|2|||
105714463|NCT00087646|364613917|FG003|Overall Study|Withdrawal by Subject|2|||
105714464|NCT00087646|364613914|FG000|Overall Study|Insufficient therapeutic response|64|||
105714465|NCT00087646|364613915|FG001|Overall Study|Insufficient therapeutic response|24|||
105714466|NCT00087646|364613916|FG002|Overall Study|Insufficient therapeutic response|38|||
105714467|NCT00087646|364613917|FG003|Overall Study|Insufficient therapeutic response|51|||
105714468|NCT00087646|364613914|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
105714469|NCT00087646|364613915|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
105714470|NCT00087646|364613916|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
105714471|NCT00087646|364613917|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
105714472|NCT00087646|364613914|FG000|Overall Study|Failure to Return|5|||
105714473|NCT00087646|364613915|FG001|Overall Study|Failure to Return|2|||
105714474|NCT00087646|364613916|FG002|Overall Study|Failure to Return|2|||
105714475|NCT00087646|364613917|FG003|Overall Study|Failure to Return|3|||
105714476|NCT00087646|364613914|FG000|Overall Study|Administrative/Other|6|||
105714477|NCT00087646|364613915|FG001|Overall Study|Administrative/Other|1|||
105714478|NCT00087646|364613916|FG002|Overall Study|Administrative/Other|1|||
105714479|NCT00087646|364613917|FG003|Overall Study|Administrative/Other|2|||
105714480|NCT00087646|364613914|FG000|Overall Study|Other Protocol Violation|3|||
105714481|NCT00087646|364613915|FG001|Overall Study|Other Protocol Violation|1|||
105714482|NCT00087646|364613916|FG002|Overall Study|Other Protocol Violation|0|||
105714483|NCT00087646|364613917|FG003|Overall Study|Other Protocol Violation|0|||
105714484|NCT00087646|364613914|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
105714485|NCT00087646|364613915|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
105714486|NCT00087646|364613916|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
105714487|NCT00087646|364613917|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
105714488|NCT02532855|364613918|FG000|Overall Study|Lost to Follow-up|4|||
105714489|NCT02532855|364613919|FG001|Overall Study|Lost to Follow-up|3|||
105714490|NCT02532855|364613918|FG000|Overall Study|Withdrawal by Subject|4|||
105714491|NCT02532855|364613919|FG001|Overall Study|Withdrawal by Subject|8|||
105714492|NCT02902120|364613920|FG000|Overall Study|Lack of Efficacy|1|||
105714493|NCT02551159|364613928|FG000|Overall Study|Death|352|||
105714494|NCT02551159|364613929|FG001|Overall Study|Death|174|||
105714495|NCT02551159|364613930|FG002|Overall Study|Death|161|||
105714496|NCT02551159|364613928|FG000|Overall Study|Withdrawal by Subject|8|||
105714497|NCT02551159|364613929|FG001|Overall Study|Withdrawal by Subject|5|||
105714498|NCT02551159|364613930|FG002|Overall Study|Withdrawal by Subject|16|||
105714499|NCT02551159|364613928|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
105714500|NCT02551159|364613929|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
105714501|NCT02551159|364613930|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
105714502|NCT00268242|364613931|FG000|Overall Study|Death|1|||
105714503|NCT02175680|364613937|FG000|Overall Study|non-compliance|1|||
105931438|NCT00887588|365407754|FG000|Extension Period|Adverse Event|4|||
105714504|NCT02175680|364613937|FG000|Overall Study|other non-medical reason|1|||
105714505|NCT02526550|364613942|FG000|Overall Study|Lost to Follow-up|1|||
105714506|NCT00091832|364613943|FG000|Overall Study|Physician Decision|1|||
105714507|NCT00091832|364613944|FG001|Overall Study|Physician Decision|0|||
105714508|NCT00091832|364613945|FG002|Overall Study|Physician Decision|0|||
105714509|NCT00091832|364613946|FG003|Overall Study|Physician Decision|0|||
105714510|NCT00091832|364613947|FG004|Overall Study|Physician Decision|0|||
105714511|NCT00091832|364613948|FG005|Overall Study|Physician Decision|0|||
105714512|NCT00091832|364613943|FG000|Overall Study|Adverse Event|0|||
105714513|NCT00091832|364613944|FG001|Overall Study|Adverse Event|0|||
105714514|NCT00091832|364613945|FG002|Overall Study|Adverse Event|0|||
105714515|NCT00091832|364613946|FG003|Overall Study|Adverse Event|1|||
105714516|NCT00091832|364613947|FG004|Overall Study|Adverse Event|3|||
105714517|NCT00091832|364613948|FG005|Overall Study|Adverse Event|0|||
105931439|NCT00887588|365407755|FG001|Extension Period|Adverse Event|4|||
105714518|NCT00091832|364613943|FG000|Overall Study|Withdrawal by Subject|4|||
105714519|NCT00091832|364613944|FG001|Overall Study|Withdrawal by Subject|5|||
105714520|NCT00091832|364613945|FG002|Overall Study|Withdrawal by Subject|0|||
105714521|NCT00091832|364613946|FG003|Overall Study|Withdrawal by Subject|1|||
105714522|NCT00091832|364613947|FG004|Overall Study|Withdrawal by Subject|3|||
105789498|NCT04455620|364883380|FG003|Overall Study|Study Termination|0|||
105789499|NCT04455620|364883381|FG004|Overall Study|Study Termination|6|||
105789500|NCT01023022|364883384|FG000|Overall Study|Death|5|||
105789501|NCT01023022|364883384|FG000|Overall Study|Lost to Follow-up|7|||
105789502|NCT01023022|364883384|FG000|Overall Study|due to technical issues|2|||
105789503|NCT03917654|364883385|FG000|Year 1|Withdrawal by Subject|1|||
106136240|NCT04148937|366157904|FG002|Overall Study|Withdrawal by Subject|0|||
106136241|NCT04148937|366157905|FG003|Overall Study|Withdrawal by Subject|1|||
105714523|NCT00091832|364613948|FG005|Overall Study|Withdrawal by Subject|1|||
105714524|NCT00091832|364613943|FG000|Overall Study|Death|6|||
105714525|NCT00091832|364613944|FG001|Overall Study|Death|4|||
105714526|NCT00091832|364613945|FG002|Overall Study|Death|5|||
105714527|NCT00091832|364613946|FG003|Overall Study|Death|8|||
105714528|NCT00091832|364613947|FG004|Overall Study|Death|5|||
105714529|NCT00091832|364613948|FG005|Overall Study|Death|6|||
105714530|NCT00091832|364613943|FG000|Overall Study|Disease Progression|2|||
105714531|NCT00091832|364613944|FG001|Overall Study|Disease Progression|0|||
105714532|NCT00091832|364613945|FG002|Overall Study|Disease Progression|0|||
105714533|NCT00091832|364613946|FG003|Overall Study|Disease Progression|1|||
105714534|NCT00091832|364613947|FG004|Overall Study|Disease Progression|1|||
105714535|NCT00091832|364613948|FG005|Overall Study|Disease Progression|2|||
105714536|NCT00091832|364613943|FG000|Overall Study|Ineligibility Determined|0|||
105714537|NCT00091832|364613944|FG001|Overall Study|Ineligibility Determined|0|||
105714538|NCT00091832|364613945|FG002|Overall Study|Ineligibility Determined|1|||
105714539|NCT00091832|364613946|FG003|Overall Study|Ineligibility Determined|0|||
105714540|NCT00091832|364613947|FG004|Overall Study|Ineligibility Determined|1|||
105714541|NCT00091832|364613948|FG005|Overall Study|Ineligibility Determined|0|||
105714542|NCT00091832|364613943|FG000|Overall Study|Lost to Follow-up|1|||
105714543|NCT00091832|364613944|FG001|Overall Study|Lost to Follow-up|0|||
105714544|NCT00091832|364613945|FG002|Overall Study|Lost to Follow-up|3|||
105714545|NCT00091832|364613946|FG003|Overall Study|Lost to Follow-up|3|||
105714546|NCT00091832|364613947|FG004|Overall Study|Lost to Follow-up|2|||
105714547|NCT00091832|364613948|FG005|Overall Study|Lost to Follow-up|1|||
105714548|NCT00091832|364613943|FG000|Overall Study|Noncompliance|0|||
105714549|NCT00091832|364613944|FG001|Overall Study|Noncompliance|1|||
105714550|NCT00091832|364613945|FG002|Overall Study|Noncompliance|0|||
105714551|NCT00091832|364613946|FG003|Overall Study|Noncompliance|0|||
105714552|NCT00091832|364613947|FG004|Overall Study|Noncompliance|0|||
105714553|NCT00091832|364613948|FG005|Overall Study|Noncompliance|0|||
105714554|NCT00091832|364613943|FG000|Overall Study|Other|0|||
105714555|NCT00091832|364613944|FG001|Overall Study|Other|1|||
105714556|NCT00091832|364613945|FG002|Overall Study|Other|2|||
105714557|NCT00091832|364613946|FG003|Overall Study|Other|0|||
105714558|NCT00091832|364613947|FG004|Overall Study|Other|0|||
105714559|NCT00091832|364613948|FG005|Overall Study|Other|0|||
105714560|NCT00091832|364613943|FG000|Overall Study|Protocol Violation|0|||
105714561|NCT00091832|364613944|FG001|Overall Study|Protocol Violation|0|||
106136242|NCT04148937|366157906|FG004|Overall Study|Withdrawal by Subject|0|||
106136243|NCT04148937|366157907|FG005|Overall Study|Withdrawal by Subject|1|||
106136244|NCT04148937|366157908|FG006|Overall Study|Withdrawal by Subject|1|||
106136245|NCT04148937|366157909|FG007|Overall Study|Withdrawal by Subject|0|||
106136246|NCT04148937|366157902|FG000|Overall Study|Lost to Follow-up|0|||
106136247|NCT04148937|366157903|FG001|Overall Study|Lost to Follow-up|0|||
105714562|NCT00091832|364613945|FG002|Overall Study|Protocol Violation|1|||
105714563|NCT00091832|364613946|FG003|Overall Study|Protocol Violation|0|||
105714564|NCT00091832|364613947|FG004|Overall Study|Protocol Violation|0|||
105714565|NCT00091832|364613948|FG005|Overall Study|Protocol Violation|1|||
105714566|NCT00915343|364613949|FG000|Part B - Open Label Period|Treatment switch|0|||
105714567|NCT00915343|364613950|FG001|Part B - Open Label Period|Treatment switch|0|||
105714568|NCT00915343|364613951|FG002|Part B - Open Label Period|Treatment switch|1|||
105714569|NCT00915343|364613949|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
105714570|NCT00915343|364613950|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
106136248|NCT04148937|366157904|FG002|Overall Study|Lost to Follow-up|1|||
106136249|NCT04148937|366157905|FG003|Overall Study|Lost to Follow-up|0|||
105714571|NCT00915343|364613951|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
105714572|NCT01920711|364613952|FG000|Overall Study|Death|347|||
105714573|NCT01920711|364613953|FG001|Overall Study|Death|356|||
105714574|NCT01920711|364613952|FG000|Overall Study|Lost to Follow-up|13|||
105714575|NCT01920711|364613953|FG001|Overall Study|Lost to Follow-up|14|||
105714576|NCT01920711|364613952|FG000|Overall Study|Withdrawal by Subject|4|||
105714577|NCT01920711|364613953|FG001|Overall Study|Withdrawal by Subject|3|||
105714578|NCT00626093|364613955|FG000|Overall Study|Lost to Follow-up|5|||
105714579|NCT00626093|364613955|FG000|Overall Study|Death|1|||
105714580|NCT00626093|364613955|FG000|Overall Study|Physician Decision|4|||
105714581|NCT00626093|364613955|FG000|Overall Study|Withdrawal by Subject|6|||
105714582|NCT00626093|364613955|FG000|Overall Study|Protocol Violation|1|||
105789504|NCT03917654|364883386|FG001|Year 1|Withdrawal by Subject|0|||
105789505|NCT03917654|364883387|FG002|Year 1|Withdrawal by Subject|0|||
105789506|NCT03917654|364883388|FG003|Year 1|Withdrawal by Subject|0|||
105714583|NCT00626093|364613955|FG000|Overall Study|One of the required devices not implante|6|||
105714584|NCT01282229|364613956|FG000|Overall Study|Protocol Violation|2|||
105714585|NCT00573794|364613963|FG000|Overall Study|Adverse Event|81|||
105714586|NCT00573794|364613963|FG000|Overall Study|Withdrew Consent|90|||
105714587|NCT00573794|364613963|FG000|Overall Study|Lost to Follow-up|13|||
105714588|NCT00573794|364613963|FG000|Overall Study|Protocol Violation|6|||
105714589|NCT00573794|364613963|FG000|Overall Study|Lack of Efficacy|94|||
105714590|NCT00573794|364613963|FG000|Overall Study|Other|46|||
105714591|NCT02026063|364613964|FG000|Overall Study|Physician Decision|0|||
105714592|NCT02026063|364613965|FG001|Overall Study|Physician Decision|10|||
105714593|NCT02026063|364613964|FG000|Overall Study|Noncompliance with Study Drug|1|||
105714594|NCT02026063|364613965|FG001|Overall Study|Noncompliance with Study Drug|1|||
105714595|NCT02026063|364613964|FG000|Overall Study|Withdrawal of Consent|1|||
105714596|NCT02026063|364613965|FG001|Overall Study|Withdrawal of Consent|6|||
105714597|NCT02026063|364613964|FG000|Overall Study|Adverse Event|5|||
105714598|NCT02026063|364613965|FG001|Overall Study|Adverse Event|20|||
105714599|NCT02026063|364613964|FG000|Overall Study|Lack of Efficacy|0|||
105714600|NCT02026063|364613965|FG001|Overall Study|Lack of Efficacy|4|||
105714601|NCT02026063|364613964|FG000|Overall Study|Lost to Follow-up|0|||
105714602|NCT02026063|364613965|FG001|Overall Study|Lost to Follow-up|1|||
105714603|NCT02026063|364613964|FG000|Overall Study|Reason not Specified|2|||
105714604|NCT02026063|364613965|FG001|Overall Study|Reason not Specified|7|||
105714605|NCT02154087|364613966|FG000|Overall Study|Study Termination|1|||
105714606|NCT03687502|364613969|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
105714607|NCT03687502|364613969|FG000|Overall Study|Lumason not available|1|||
105714608|NCT01116544|364613974|FG000|Overall Study|Protocol Violation|1|||
105714609|NCT01116544|364613975|FG001|Overall Study|Protocol Violation|0|||
105714610|NCT01116544|364613974|FG000|Overall Study|Withdrawal by Subject|1|||
105714611|NCT01116544|364613975|FG001|Overall Study|Withdrawal by Subject|1|||
105714612|NCT00486278|364613976|FG000|Overall Study|Adverse Event|5|||
105714613|NCT00486278|364613976|FG000|Overall Study|Withdrawal by Subject|2|||
105714614|NCT00486278|364613976|FG000|Overall Study|Physician Decision|2|||
105714615|NCT01724528|364613977|FG000|Overall Study|Death|3|||
105714616|NCT01724528|364613978|FG001|Overall Study|Death|0|||
105714617|NCT01724528|364613977|FG000|Overall Study|Withdrawal by Subject|0|||
105714618|NCT01724528|364613978|FG001|Overall Study|Withdrawal by Subject|2|||
105714619|NCT01724528|364613977|FG000|Overall Study|Protocol Violation|0|||
105714620|NCT01724528|364613978|FG001|Overall Study|Protocol Violation|1|||
105714621|NCT01724528|364613977|FG000|Overall Study|Patient refused to attend last visit|1|||
105714622|NCT01724528|364613978|FG001|Overall Study|Patient refused to attend last visit|0|||
105714623|NCT05501119|364613987|FG000|Overall Study|Withdrawal by Subject|2|||
105714624|NCT05501119|364613987|FG000|Overall Study|Lost to Follow-up|5|||
105714625|NCT02183519|364613988|FG000|Overall Study|computer error|3|||
105714626|NCT02183519|364613989|FG001|Overall Study|computer error|0|||
105714627|NCT02183519|364613988|FG000|Overall Study|Did not respond to cough inducter|0|||
105714628|NCT02183519|364613989|FG001|Overall Study|Did not respond to cough inducter|3|||
105714629|NCT01725750|364613990|FG000|Overall Study|Adverse Event|1|||
105714630|NCT01725750|364613991|FG001|Overall Study|Adverse Event|0|||
105714631|NCT01725750|364613990|FG000|Overall Study|Lost to Follow-up|1|||
105714632|NCT01725750|364613991|FG001|Overall Study|Lost to Follow-up|1|||
105714633|NCT01725750|364613990|FG000|Overall Study|Withdrawal by Subject|0|||
105714634|NCT01725750|364613991|FG001|Overall Study|Withdrawal by Subject|9|||
105714635|NCT02542072|364613992|FG000|First Intervention (1 Month)|Adverse Event|1|||
105714636|NCT02542072|364613993|FG001|First Intervention (1 Month)|Adverse Event|1|||
105714637|NCT02542072|364613992|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
105714638|NCT02542072|364613993|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
105714639|NCT02542072|364613992|FG000|First Intervention (1 Month)|Lens discomfort|1|||
106136250|NCT04148937|366157906|FG004|Overall Study|Lost to Follow-up|0|||
105714640|NCT02542072|364613993|FG001|First Intervention (1 Month)|Lens discomfort|2|||
105714641|NCT02542072|364613992|FG000|First Intervention (1 Month)|Protocol Violation|1|||
105714642|NCT02542072|364613993|FG001|First Intervention (1 Month)|Protocol Violation|0|||
105714643|NCT02542072|364613992|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
105714644|NCT02542072|364613993|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
105714645|NCT02542072|364613992|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
105714646|NCT02542072|364613993|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
105714647|NCT04556617|364613999|FG000|Overall Study|progressive disease|0|||
105714648|NCT04556617|364614000|FG001|Overall Study|progressive disease|2|||
105714649|NCT04556617|364614001|FG002|Overall Study|progressive disease|2|||
105714650|NCT04556617|364614002|FG003|Overall Study|progressive disease|1|||
105714651|NCT04556617|364614003|FG004|Overall Study|progressive disease|1|||
105714652|NCT04556617|364613999|FG000|Overall Study|Physician Decision|0|||
105714653|NCT04556617|364614000|FG001|Overall Study|Physician Decision|0|||
105714654|NCT04556617|364614001|FG002|Overall Study|Physician Decision|2|||
106136251|NCT04148937|366157907|FG005|Overall Study|Lost to Follow-up|2|||
106136252|NCT04148937|366157908|FG006|Overall Study|Lost to Follow-up|0|||
105714655|NCT04556617|364614002|FG003|Overall Study|Physician Decision|0|||
105714656|NCT04556617|364614003|FG004|Overall Study|Physician Decision|0|||
105714657|NCT04556617|364613999|FG000|Overall Study|Adverse Event|0|||
105714658|NCT04556617|364614000|FG001|Overall Study|Adverse Event|0|||
105714659|NCT04556617|364614001|FG002|Overall Study|Adverse Event|2|||
105714660|NCT04556617|364614002|FG003|Overall Study|Adverse Event|3|||
105714661|NCT04556617|364614003|FG004|Overall Study|Adverse Event|0|||
105714662|NCT04556617|364613999|FG000|Overall Study|Withdrawal by Subject|0|||
105714663|NCT04556617|364614000|FG001|Overall Study|Withdrawal by Subject|2|||
105714664|NCT04556617|364614001|FG002|Overall Study|Withdrawal by Subject|1|||
105714665|NCT04556617|364614002|FG003|Overall Study|Withdrawal by Subject|1|||
105714666|NCT04556617|364614003|FG004|Overall Study|Withdrawal by Subject|0|||
105714667|NCT04556617|364613999|FG000|Overall Study|PSA increase|0|||
105714668|NCT04556617|364614000|FG001|Overall Study|PSA increase|1|||
105714669|NCT04556617|364614001|FG002|Overall Study|PSA increase|0|||
105714670|NCT04556617|364614002|FG003|Overall Study|PSA increase|0|||
105714671|NCT04556617|364614003|FG004|Overall Study|PSA increase|0|||
105714672|NCT04556617|364613999|FG000|Overall Study|Sponsor study termination|1|||
105714673|NCT04556617|364614000|FG001|Overall Study|Sponsor study termination|0|||
105714674|NCT04556617|364614001|FG002|Overall Study|Sponsor study termination|0|||
105714675|NCT04556617|364614002|FG003|Overall Study|Sponsor study termination|0|||
105714676|NCT04556617|364614003|FG004|Overall Study|Sponsor study termination|0|||
105714677|NCT04949841|364614004|FG000|Overall Study|Adverse Event|7|||
105714678|NCT04949841|364614004|FG000|Overall Study|Death|1|||
105714679|NCT04949841|364614004|FG000|Overall Study|Withdrawal by Subject|52|||
105714680|NCT04949841|364614004|FG000|Overall Study|Pregnancy|4|||
105714681|NCT04949841|364614004|FG000|Overall Study|Lost to Follow-up|9|||
105714682|NCT04949841|364614004|FG000|Overall Study|Lack of Efficacy|55|||
105714683|NCT04949841|364614004|FG000|Overall Study|Various reasons|9|||
105714684|NCT02937350|364614011|FG000|Overall Study|Withdrawal by Subject|0|||
105714685|NCT02937350|364614012|FG001|Overall Study|Withdrawal by Subject|1|||
105714686|NCT02937350|364614013|FG002|Overall Study|Withdrawal by Subject|0|||
105714687|NCT02419508|364614014|FG000|Overall Study|Adverse Event|9|||
105714688|NCT02419508|364614015|FG001|Overall Study|Adverse Event|3|||
105714689|NCT02419508|364614014|FG000|Overall Study|Withdrawal by Subject|1|||
105714690|NCT02419508|364614015|FG001|Overall Study|Withdrawal by Subject|0|||
105714691|NCT02419508|364614014|FG000|Overall Study|Other - Reason not specified|0|||
105714692|NCT02419508|364614015|FG001|Overall Study|Other - Reason not specified|1|||
105714693|NCT04811716|364614016|FG000|Overall Study|Withdrawal by Subject|2|||
105714694|NCT04811716|364614017|FG001|Overall Study|Withdrawal by Subject|0|||
105714695|NCT02531646|364614022|FG000|Overall Study|equip. image processing issue|5|||
105714696|NCT02531646|364614023|FG001|Overall Study|equip. image processing issue|1|||
105714697|NCT02531646|364614024|FG002|Overall Study|equip. image processing issue|0|||
105714698|NCT00768898|364615545|FG000|Overall Study|Unrelated injury|1|||
105714699|NCT00768898|364615545|FG000|Overall Study|Headache|1|||
105714700|NCT02527707|364615546|FG000|Overall Study|Adverse Event|1|||
105714701|NCT02527707|364615546|FG000|Overall Study|Adverse Event|1|||
105714702|NCT03686397|364615547|FG000|Overall Study|Lack of Efficacy|3|||
105714703|NCT03686397|364615548|FG001|Overall Study|Lack of Efficacy|5|||
105714704|NCT03686397|364615547|FG000|Overall Study|Adverse Event|0|||
105714705|NCT03686397|364615548|FG001|Overall Study|Adverse Event|1|||
105714706|NCT03686397|364615547|FG000|Overall Study|Protocol Violation|0|||
105714707|NCT03686397|364615548|FG001|Overall Study|Protocol Violation|1|||
105714708|NCT03686397|364615547|FG000|Overall Study|Withdrawal by Subject|0|||
105714709|NCT03686397|364615548|FG001|Overall Study|Withdrawal by Subject|1|||
105714710|NCT03686397|364615547|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
105714711|NCT03686397|364615548|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
105714712|NCT00930059|364615549|FG000|Overall Study|Death|1|||
105714713|NCT00930059|364615550|FG001|Overall Study|Death|0|||
105714714|NCT00930059|364615549|FG000|Overall Study|Did not meet entrance criteria|1|||
105714715|NCT00930059|364615550|FG001|Overall Study|Did not meet entrance criteria|1|||
105714716|NCT00930059|364615549|FG000|Overall Study|Withdrawal by Subject|3|||
105714717|NCT00930059|364615550|FG001|Overall Study|Withdrawal by Subject|4|||
105714718|NCT00930059|364615549|FG000|Overall Study|Other|1|||
105714719|NCT00930059|364615550|FG001|Overall Study|Other|0|||
105714720|NCT00930059|364615549|FG000|Overall Study|1 site terminated by sponsor|1|||
105714721|NCT00930059|364615550|FG001|Overall Study|1 site terminated by sponsor|1|||
105714722|NCT00930059|364615549|FG000|Overall Study|Adverse Event|1|||
105714723|NCT00930059|364615550|FG001|Overall Study|Adverse Event|6|||
105714724|NCT01299766|364615554|FG000|Overall Study|Death|5|||
105714725|NCT01299766|364615555|FG001|Overall Study|Death|4|||
105714726|NCT01299766|364615554|FG000|Overall Study|Withdrawal by Subject|29|||
105714727|NCT01299766|364615555|FG001|Overall Study|Withdrawal by Subject|19|||
105714728|NCT03988907|364615558|FG000|Overall Study|Unable to complete visit|0|||
105714729|NCT03988907|364615559|FG001|Overall Study|Unable to complete visit|1|||
105714730|NCT01430442|364615563|FG000|Overall Study|Subject Withdrew Consent|3|||
105714731|NCT01430442|364615564|FG001|Overall Study|Subject Withdrew Consent|0|||
105714732|NCT01430442|364615565|FG002|Overall Study|Subject Withdrew Consent|1|||
105714733|NCT01430442|364615566|FG003|Overall Study|Subject Withdrew Consent|0|||
105714734|NCT01430442|364615567|FG004|Overall Study|Subject Withdrew Consent|2|||
105714735|NCT01430442|364615568|FG005|Overall Study|Subject Withdrew Consent|1|||
105714736|NCT01430442|364615569|FG006|Overall Study|Subject Withdrew Consent|5|||
105714737|NCT01430442|364615570|FG007|Overall Study|Subject Withdrew Consent|2|||
105714738|NCT01430442|364615563|FG000|Overall Study|Lost to Follow-up|2|||
105714739|NCT01430442|364615564|FG001|Overall Study|Lost to Follow-up|0|||
105714740|NCT01430442|364615565|FG002|Overall Study|Lost to Follow-up|1|||
105714741|NCT01430442|364615566|FG003|Overall Study|Lost to Follow-up|2|||
105714742|NCT01430442|364615567|FG004|Overall Study|Lost to Follow-up|2|||
105714743|NCT01430442|364615568|FG005|Overall Study|Lost to Follow-up|1|||
105714744|NCT01430442|364615569|FG006|Overall Study|Lost to Follow-up|5|||
105714745|NCT01430442|364615570|FG007|Overall Study|Lost to Follow-up|1|||
105714746|NCT01430442|364615563|FG000|Overall Study|Pregnancy|1|||
105714747|NCT01430442|364615564|FG001|Overall Study|Pregnancy|0|||
105714748|NCT01430442|364615565|FG002|Overall Study|Pregnancy|0|||
105714749|NCT01430442|364615566|FG003|Overall Study|Pregnancy|0|||
105714750|NCT01430442|364615567|FG004|Overall Study|Pregnancy|0|||
105714751|NCT01430442|364615568|FG005|Overall Study|Pregnancy|1|||
105714752|NCT01430442|364615569|FG006|Overall Study|Pregnancy|0|||
105714753|NCT01430442|364615570|FG007|Overall Study|Pregnancy|0|||
105714754|NCT01430442|364615563|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
105714755|NCT01430442|364615564|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
105714756|NCT01430442|364615565|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
105714757|NCT01430442|364615566|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
105714758|NCT01430442|364615567|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
105714759|NCT01430442|364615568|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
105714760|NCT01430442|364615569|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
105714761|NCT01430442|364615570|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
105714762|NCT01641939|364615571|FG000|Overall Study|Death|90|||
105714763|NCT01641939|364615572|FG001|Overall Study|Death|187|||
105714764|NCT01641939|364615573|FG002|Overall Study|Death|61|||
105714765|NCT01641939|364615571|FG000|Overall Study|Lost to Follow-up|3|||
105714766|NCT01641939|364615572|FG001|Overall Study|Lost to Follow-up|2|||
105714767|NCT01641939|364615573|FG002|Overall Study|Lost to Follow-up|1|||
105714768|NCT01641939|364615571|FG000|Overall Study|Withdrawal by Subject|14|||
105714769|NCT01641939|364615572|FG001|Overall Study|Withdrawal by Subject|11|||
105714770|NCT01641939|364615573|FG002|Overall Study|Withdrawal by Subject|5|||
105714771|NCT01641939|364615571|FG000|Overall Study|Study Terminated by Sponsor|10|||
105714772|NCT01641939|364615572|FG001|Overall Study|Study Terminated by Sponsor|28|||
105714773|NCT01641939|364615573|FG002|Overall Study|Study Terminated by Sponsor|3|||
105931440|NCT00887588|365407754|FG000|Extension Period|Death|0|||
105931441|NCT00887588|365407755|FG001|Extension Period|Death|1|||
105931442|NCT00887588|365407754|FG000|Extension Period|Protocol deviation|1|||
105931443|NCT00887588|365407755|FG001|Extension Period|Protocol deviation|0|||
105931444|NCT00887588|365407754|FG000|Extension Period|Lost to Follow-up|1|||
105931445|NCT00887588|365407755|FG001|Extension Period|Lost to Follow-up|0|||
105931446|NCT04595370|365407758|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
105931447|NCT04595370|365407759|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105931448|NCT04595370|365407760|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105931449|NCT04595370|365407761|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105931450|NCT04595370|365407762|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105931451|NCT04595370|365407763|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
105931452|NCT04595370|365407758|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105931453|NCT04595370|365407759|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105931454|NCT04595370|365407760|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
105931455|NCT04595370|365407761|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105931456|NCT04595370|365407762|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105931457|NCT04595370|365407763|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
105931458|NCT04595370|365407758|FG000|Overall Study|Adverse Event|0|||
105931459|NCT04595370|365407759|FG001|Overall Study|Adverse Event|4|||
105789507|NCT03917654|364883389|FG004|Year 1|Withdrawal by Subject|0|||
105789508|NCT03917654|364883390|FG005|Year 1|Withdrawal by Subject|1|||
105789509|NCT03917654|364883391|FG006|Year 1|Withdrawal by Subject|6|||
105789510|NCT03917654|364883392|FG007|Year 1|Withdrawal by Subject|2|||
105714774|NCT00568555|364615575|FG000|Overall Study|Withdrawal by Subject|1|||
105714775|NCT00568555|364615576|FG001|Overall Study|Withdrawal by Subject|1|||
105714776|NCT00699348|364615579|FG000|Overall Study|Death|6|||
105714777|NCT00699348|364615579|FG000|Overall Study|Adverse Event|15|||
105714778|NCT00699348|364615579|FG000|Overall Study|Withdrawal by Subject|11|||
105789511|NCT03917654|364883393|FG008|Year 1|Withdrawal by Subject|5|||
105714779|NCT00699348|364615579|FG000|Overall Study|Protocol Violation|10|||
105714780|NCT00699348|364615579|FG000|Overall Study|Lack of Efficacy|8|||
105714781|NCT00699348|364615579|FG000|Overall Study|Failure to return|1|||
105714782|NCT00699348|364615579|FG000|Overall Study|Blood transfusion|24|||
105789512|NCT03917654|364883394|FG009|Year 1|Withdrawal by Subject|3|||
105714783|NCT00699348|364615579|FG000|Overall Study|Renal transplantation|10|||
105714784|NCT00699348|364615579|FG000|Overall Study|Other|5|||
105714785|NCT00716976|364615580|FG000|Overall Study|Adverse Event|2|||
105714786|NCT00716976|364615581|FG001|Overall Study|Adverse Event|0|||
105714787|NCT00716976|364615580|FG000|Overall Study|Death|1|||
105714788|NCT00716976|364615581|FG001|Overall Study|Death|0|||
105714789|NCT00716976|364615580|FG000|Overall Study|Physician Decision|2|||
105714790|NCT00716976|364615581|FG001|Overall Study|Physician Decision|2|||
106136253|NCT04148937|366157909|FG007|Overall Study|Lost to Follow-up|0|||
105714791|NCT00716976|364615580|FG000|Overall Study|Withdrawal by Subject|5|||
105714792|NCT00716976|364615581|FG001|Overall Study|Withdrawal by Subject|1|||
105931460|NCT04595370|365407760|FG002|Overall Study|Adverse Event|3|||
105931461|NCT04595370|365407761|FG003|Overall Study|Adverse Event|1|||
105931462|NCT04595370|365407762|FG004|Overall Study|Adverse Event|1|||
106136254|NCT01876511|366157912|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
106136255|NCT01876511|366157913|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
106136256|NCT01876511|366157914|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
106136257|NCT01876511|366157912|FG000|Overall Study|Death (unrelated)|3|||
106136258|NCT01876511|366157913|FG001|Overall Study|Death (unrelated)|0|||
106136259|NCT01876511|366157914|FG002|Overall Study|Death (unrelated)|2|||
106136260|NCT01876511|366157912|FG000|Overall Study|Drug-related Toxicity|5|||
106136261|NCT01876511|366157913|FG001|Overall Study|Drug-related Toxicity|1|||
106136262|NCT01876511|366157914|FG002|Overall Study|Drug-related Toxicity|6|||
106136263|NCT01876511|366157912|FG000|Overall Study|Patient Decision|3|||
106136264|NCT01876511|366157913|FG001|Overall Study|Patient Decision|0|||
106136265|NCT01876511|366157914|FG002|Overall Study|Patient Decision|6|||
106136266|NCT01876511|366157912|FG000|Overall Study|Physician Decision|1|||
106136267|NCT01876511|366157913|FG001|Overall Study|Physician Decision|0|||
106136268|NCT01876511|366157914|FG002|Overall Study|Physician Decision|1|||
106136269|NCT02145182|366157915|FG000|Overall Study|Adverse Event|4|||
106136270|NCT02145182|366157916|FG001|Overall Study|Adverse Event|1|||
106136271|NCT02145182|366157915|FG000|Overall Study|Death|7|||
106136272|NCT02145182|366157916|FG001|Overall Study|Death|7|||
106136273|NCT02145182|366157915|FG000|Overall Study|Lost to Follow-up|2|||
106136274|NCT02145182|366157916|FG001|Overall Study|Lost to Follow-up|2|||
106136275|NCT02145182|366157915|FG000|Overall Study|Pre-transplant Withdrawal|0|||
106136276|NCT02145182|366157916|FG001|Overall Study|Pre-transplant Withdrawal|2|||
106136277|NCT02145182|366157915|FG000|Overall Study|Withdrawal by Subject|5|||
106136278|NCT02145182|366157916|FG001|Overall Study|Withdrawal by Subject|4|||
105714793|NCT00716976|364615580|FG000|Overall Study|Premature discontinuation cisplatin|5|||
105714794|NCT00716976|364615581|FG001|Overall Study|Premature discontinuation cisplatin|4|||
105931463|NCT04595370|365407763|FG005|Overall Study|Adverse Event|1|||
105931464|NCT04595370|365407758|FG000|Overall Study|Withdrawal of Consent|1|||
105931465|NCT04595370|365407759|FG001|Overall Study|Withdrawal of Consent|1|||
105931466|NCT04595370|365407760|FG002|Overall Study|Withdrawal of Consent|1|||
105931467|NCT04595370|365407761|FG003|Overall Study|Withdrawal of Consent|0|||
105931468|NCT04595370|365407762|FG004|Overall Study|Withdrawal of Consent|0|||
105931469|NCT04595370|365407763|FG005|Overall Study|Withdrawal of Consent|0|||
105931470|NCT04595370|365407758|FG000|Overall Study|Death|0|||
105931471|NCT04595370|365407759|FG001|Overall Study|Death|1|||
105931472|NCT04595370|365407760|FG002|Overall Study|Death|0|||
105931473|NCT04595370|365407761|FG003|Overall Study|Death|0|||
105931474|NCT04595370|365407762|FG004|Overall Study|Death|1|||
105931475|NCT04595370|365407763|FG005|Overall Study|Death|0|||
105931476|NCT04595370|365407758|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105931477|NCT04595370|365407759|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105931478|NCT04595370|365407760|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
105931479|NCT04595370|365407761|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105931480|NCT04595370|365407762|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105931481|NCT04595370|365407763|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105931482|NCT04595370|365407758|FG000|Overall Study|Withdrawal by Subject|0|||
105931483|NCT04595370|365407759|FG001|Overall Study|Withdrawal by Subject|0|||
105931484|NCT04595370|365407760|FG002|Overall Study|Withdrawal by Subject|1|||
105931485|NCT04595370|365407761|FG003|Overall Study|Withdrawal by Subject|0|||
105931486|NCT04595370|365407762|FG004|Overall Study|Withdrawal by Subject|2|||
106136279|NCT00588666|366157917|FG000|Overall Study|Adverse Event|4|||
106136280|NCT02274493|366157920|FG000|Overall Study|Withdrawal by Subject|1|||
105931487|NCT04595370|365407763|FG005|Overall Study|Withdrawal by Subject|0|||
105931488|NCT04595370|365407758|FG000|Overall Study|Lost to Follow-up|0|||
105931489|NCT04595370|365407759|FG001|Overall Study|Lost to Follow-up|0|||
105931490|NCT04595370|365407760|FG002|Overall Study|Lost to Follow-up|0|||
106136281|NCT04012853|366157921|FG000|Overall Study|Withdrawal by Subject|1|||
106136282|NCT04012853|366157922|FG001|Overall Study|Withdrawal by Subject|1|||
106136283|NCT04012853|366157921|FG000|Overall Study|Protocol Violation|1|||
106136284|NCT04012853|366157922|FG001|Overall Study|Protocol Violation|0|||
105714795|NCT00716976|364615580|FG000|Overall Study|Radiation during protocol|1|||
105714796|NCT00716976|364615581|FG001|Overall Study|Radiation during protocol|0|||
105789513|NCT03917654|364883395|FG010|Year 1|Withdrawal by Subject|1|||
105789514|NCT03917654|364883396|FG011|Year 1|Withdrawal by Subject|0|||
105789515|NCT03917654|364883385|FG000|Year 1|Travel|0|||
105789516|NCT03917654|364883386|FG001|Year 1|Travel|1|||
105789517|NCT03917654|364883387|FG002|Year 1|Travel|1|||
105789518|NCT03917654|364883388|FG003|Year 1|Travel|0|||
105789519|NCT03917654|364883389|FG004|Year 1|Travel|4|||
105789520|NCT03917654|364883390|FG005|Year 1|Travel|4|||
105789521|NCT03917654|364883391|FG006|Year 1|Travel|10|||
105789522|NCT03917654|364883392|FG007|Year 1|Travel|8|||
105789523|NCT03917654|364883393|FG008|Year 1|Travel|2|||
105789524|NCT03917654|364883394|FG009|Year 1|Travel|5|||
105789525|NCT03917654|364883395|FG010|Year 1|Travel|3|||
105789526|NCT03917654|364883396|FG011|Year 1|Travel|3|||
105789527|NCT03917654|364883385|FG000|Year 1|Subject moved away from site|0|||
105789528|NCT03917654|364883386|FG001|Year 1|Subject moved away from site|1|||
105789529|NCT03917654|364883387|FG002|Year 1|Subject moved away from site|0|||
105789530|NCT03917654|364883388|FG003|Year 1|Subject moved away from site|0|||
105789531|NCT03917654|364883389|FG004|Year 1|Subject moved away from site|0|||
105789532|NCT03917654|364883390|FG005|Year 1|Subject moved away from site|0|||
105789533|NCT03917654|364883391|FG006|Year 1|Subject moved away from site|1|||
106136285|NCT04012853|366157921|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
106136286|NCT04012853|366157922|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
106136287|NCT00580801|366157923|FG000|Overall Study|Physician Decision|1|||
106136288|NCT00580801|366157924|FG001|Overall Study|Physician Decision|0|||
106136289|NCT00580801|366157925|FG002|Overall Study|Physician Decision|0|||
106136290|NCT00580801|366157923|FG000|Overall Study|Adverse Event|2|||
106136291|NCT00580801|366157924|FG001|Overall Study|Adverse Event|0|||
106136292|NCT00580801|366157925|FG002|Overall Study|Adverse Event|0|||
106136293|NCT00580801|366157923|FG000|Overall Study|Lost to Follow-up|2|||
106136294|NCT00580801|366157924|FG001|Overall Study|Lost to Follow-up|0|||
106136295|NCT00580801|366157925|FG002|Overall Study|Lost to Follow-up|0|||
106136296|NCT00580801|366157923|FG000|Overall Study|Reached a virologic endpoint|0|||
106136297|NCT00580801|366157924|FG001|Overall Study|Reached a virologic endpoint|1|||
106136298|NCT00580801|366157925|FG002|Overall Study|Reached a virologic endpoint|2|||
106136299|NCT00580801|366157923|FG000|Overall Study|Participant non-compliant|0|||
106136300|NCT00580801|366157924|FG001|Overall Study|Participant non-compliant|0|||
106136301|NCT00580801|366157925|FG002|Overall Study|Participant non-compliant|1|||
106136302|NCT00580801|366157923|FG000|Overall Study|Travel|1|||
106136303|NCT00580801|366157924|FG001|Overall Study|Travel|0|||
106136304|NCT00580801|366157925|FG002|Overall Study|Travel|0|||
106136305|NCT00843193|366157926|FG000|Overall Study|Adverse Event|2|||
106136306|NCT00843193|366157927|FG001|Overall Study|Adverse Event|4|||
106136307|NCT00843193|366157926|FG000|Overall Study|Lack of Efficacy|1|||
106136308|NCT00843193|366157927|FG001|Overall Study|Lack of Efficacy|1|||
106136309|NCT00843193|366157926|FG000|Overall Study|Protocol Violation|1|||
106136310|NCT00843193|366157927|FG001|Overall Study|Protocol Violation|2|||
106136311|NCT00843193|366157926|FG000|Overall Study|Lost to Follow-up|1|||
106136312|NCT00843193|366157927|FG001|Overall Study|Lost to Follow-up|0|||
106136313|NCT00843193|366157926|FG000|Overall Study|Physician Decision|0|||
106136314|NCT00843193|366157927|FG001|Overall Study|Physician Decision|1|||
106136315|NCT00843193|366157926|FG000|Overall Study|Withdrawal by Subject|3|||
106136316|NCT00843193|366157927|FG001|Overall Study|Withdrawal by Subject|3|||
106136317|NCT04511650|366157928|FG000|Overall Study|Lost to Follow-up|1|||
106136318|NCT04511650|366157929|FG001|Overall Study|Lost to Follow-up|0|||
106136319|NCT04511650|366157930|FG002|Overall Study|Lost to Follow-up|0|||
106136320|NCT04511650|366157928|FG000|Overall Study|Withdrawal by Subject|1|||
106136321|NCT04511650|366157929|FG001|Overall Study|Withdrawal by Subject|0|||
106136322|NCT04511650|366157930|FG002|Overall Study|Withdrawal by Subject|0|||
106136323|NCT04511650|366157928|FG000|Overall Study|reason not provided|0|||
106136324|NCT04511650|366157929|FG001|Overall Study|reason not provided|0|||
106136325|NCT04511650|366157930|FG002|Overall Study|reason not provided|1|||
106136326|NCT04511650|366157928|FG000|Overall Study|Death|1|||
106136327|NCT04511650|366157929|FG001|Overall Study|Death|1|||
106136328|NCT04511650|366157930|FG002|Overall Study|Death|1|||
105789534|NCT03917654|364883392|FG007|Year 1|Subject moved away from site|2|||
105789535|NCT03917654|364883393|FG008|Year 1|Subject moved away from site|1|||
105789536|NCT03917654|364883394|FG009|Year 1|Subject moved away from site|0|||
105789537|NCT03917654|364883395|FG010|Year 1|Subject moved away from site|0|||
105789538|NCT03917654|364883396|FG011|Year 1|Subject moved away from site|3|||
105789539|NCT03917654|364883385|FG000|Year 1|Spouse/Family member request|0|||
106136329|NCT03601507|366157931|FG000|Overall Study|Adverse Event|1|||
106136330|NCT00197236|366157934|FG000|Overall Study|Adverse Event|1|||
106136331|NCT00197236|366157935|FG001|Overall Study|Adverse Event|0|||
106136332|NCT00197236|366157936|FG002|Overall Study|Adverse Event|1|||
105931491|NCT04595370|365407761|FG003|Overall Study|Lost to Follow-up|0|||
105931492|NCT04595370|365407762|FG004|Overall Study|Lost to Follow-up|1|||
105931493|NCT04595370|365407763|FG005|Overall Study|Lost to Follow-up|0|||
105931494|NCT04595370|365407758|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
105931495|NCT04595370|365407759|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
105931496|NCT04595370|365407760|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
105931497|NCT04595370|365407761|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
105931498|NCT04595370|365407762|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
105931499|NCT04595370|365407763|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
105931500|NCT05660538|365407765|FG000|Overall Study|Adverse Event|0|||
105931501|NCT05660538|365407766|FG001|Overall Study|Adverse Event|0|||
105931502|NCT05660538|365407767|FG002|Overall Study|Adverse Event|1|||
105931503|NCT05660538|365407768|FG003|Overall Study|Adverse Event|0|||
105931504|NCT05660538|365407765|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
105931505|NCT05660538|365407766|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
105931506|NCT05660538|365407767|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
105931507|NCT05660538|365407768|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
105931508|NCT05660538|365407765|FG000|Overall Study|Lost to Follow-up|0|||
105931509|NCT05660538|365407766|FG001|Overall Study|Lost to Follow-up|0|||
105931510|NCT05660538|365407767|FG002|Overall Study|Lost to Follow-up|1|||
105931511|NCT05660538|365407768|FG003|Overall Study|Lost to Follow-up|1|||
106136333|NCT00197236|366157934|FG000|Overall Study|Lost to Follow-up|5|||
106136334|NCT00197236|366157935|FG001|Overall Study|Lost to Follow-up|14|||
106136335|NCT00197236|366157936|FG002|Overall Study|Lost to Follow-up|6|||
106136336|NCT00197236|366157934|FG000|Overall Study|Protocol Violation|0|||
105714797|NCT00716976|364615580|FG000|Overall Study|Ineligibles|4|||
105931512|NCT05660538|365407765|FG000|Overall Study|Death|0|||
106136337|NCT00197236|366157935|FG001|Overall Study|Protocol Violation|0|||
106136338|NCT00197236|366157936|FG002|Overall Study|Protocol Violation|1|||
106136339|NCT00197236|366157934|FG000|Overall Study|Withdrawal by Subject|7|||
106136340|NCT00197236|366157935|FG001|Overall Study|Withdrawal by Subject|3|||
106136341|NCT00197236|366157936|FG002|Overall Study|Withdrawal by Subject|11|||
106136342|NCT00197236|366157934|FG000|Overall Study|Study drug/medication expiration|1|||
106136343|NCT00197236|366157935|FG001|Overall Study|Study drug/medication expiration|0|||
106136344|NCT00197236|366157936|FG002|Overall Study|Study drug/medication expiration|3|||
106136345|NCT00197236|366157934|FG000|Overall Study|Returned out of specified time window|0|||
106136346|NCT00197236|366157935|FG001|Overall Study|Returned out of specified time window|0|||
106136347|NCT00197236|366157936|FG002|Overall Study|Returned out of specified time window|1|||
106136348|NCT03885596|366157937|FG000|Overall Study|Withdrawal by Subject|2|||
106136349|NCT03885596|366157938|FG001|Overall Study|Withdrawal by Subject|1|||
106136350|NCT03885596|366157939|FG002|Overall Study|Withdrawal by Subject|0|||
106136351|NCT03885596|366157940|FG003|Overall Study|Withdrawal by Subject|0|||
106136352|NCT01076335|366157941|FG000|Overall Study|Withdrawal by Subject|3|||
106136353|NCT01076335|366157941|FG000|Overall Study|Withdrawal without treatment|1|||
106136354|NCT01981850|366157942|FG000|Main Phase Stage 1|Death|2|||
106136355|NCT01981850|366157943|FG001|Main Phase Stage 1|Death|0|||
106136356|NCT01981850|366157944|FG002|Main Phase Stage 1|Death|0|||
106136357|NCT01981850|366157945|FG003|Main Phase Stage 1|Death|0|||
106136358|NCT01981850|366157946|FG004|Main Phase Stage 1|Death|0|||
106136359|NCT01981850|366157947|FG005|Main Phase Stage 1|Death|0|||
106136360|NCT01981850|366157948|FG006|Main Phase Stage 1|Death|0|||
106136361|NCT01981850|366157949|FG007|Main Phase Stage 1|Death|0|||
106136362|NCT01981850|366157950|FG008|Main Phase Stage 1|Death|0|||
106136363|NCT01981850|366157951|FG009|Main Phase Stage 1|Death|0|||
106136364|NCT01981850|366157942|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
106136365|NCT01981850|366157943|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
106136366|NCT01981850|366157944|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
106136367|NCT01981850|366157945|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
106136368|NCT01981850|366157946|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
106136369|NCT01981850|366157947|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
106136370|NCT01981850|366157948|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
106136371|NCT01981850|366157949|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
105931513|NCT05660538|365407766|FG001|Overall Study|Death|0|||
105931514|NCT05660538|365407767|FG002|Overall Study|Death|1|||
106136372|NCT01981850|366157950|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
106136373|NCT01981850|366157951|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
106136374|NCT01981850|366157942|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
106136375|NCT01981850|366157943|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
106136376|NCT01981850|366157944|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
106136377|NCT01981850|366157945|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
106136378|NCT01981850|366157946|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
106136379|NCT01981850|366157947|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
106136380|NCT01981850|366157948|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
105714798|NCT00716976|364615581|FG001|Overall Study|Ineligibles|2|||
106136381|NCT01981850|366157949|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
106136382|NCT01981850|366157950|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
105931515|NCT05660538|365407768|FG003|Overall Study|Death|0|||
105931516|NCT05660538|365407765|FG000|Overall Study|Physician Decision|0|||
105931517|NCT05660538|365407766|FG001|Overall Study|Physician Decision|0|||
105931518|NCT05660538|365407767|FG002|Overall Study|Physician Decision|0|||
105931519|NCT05660538|365407768|FG003|Overall Study|Physician Decision|1|||
105931520|NCT05660538|365407765|FG000|Overall Study|Sponsor Decision|1|||
105931521|NCT05660538|365407766|FG001|Overall Study|Sponsor Decision|0|||
105931522|NCT05660538|365407767|FG002|Overall Study|Sponsor Decision|0|||
105931523|NCT05660538|365407768|FG003|Overall Study|Sponsor Decision|0|||
105931524|NCT05660538|365407765|FG000|Overall Study|Other|1|||
105931525|NCT05660538|365407766|FG001|Overall Study|Other|0|||
105931526|NCT05660538|365407767|FG002|Overall Study|Other|0|||
105931527|NCT05660538|365407768|FG003|Overall Study|Other|1|||
105931528|NCT05660538|365407765|FG000|Overall Study|Randomized but did not receive study drug|1|||
105931529|NCT05660538|365407766|FG001|Overall Study|Randomized but did not receive study drug|0|||
105931530|NCT05660538|365407767|FG002|Overall Study|Randomized but did not receive study drug|0|||
105931531|NCT05660538|365407768|FG003|Overall Study|Randomized but did not receive study drug|1|||
105931532|NCT05660538|365407765|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
105931533|NCT05660538|365407766|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
105931534|NCT05660538|365407767|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
105931535|NCT05660538|365407768|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
105931536|NCT04625972|365407769|FG000|Overall Study|Death|3|||
105931537|NCT04625972|365407770|FG001|Overall Study|Death|2|||
105931538|NCT04625972|365407769|FG000|Overall Study|Lost to Follow-up|82|||
105931539|NCT04625972|365407770|FG001|Overall Study|Lost to Follow-up|38|||
105931540|NCT04625972|365407769|FG000|Overall Study|Physician Decision|2|||
105931541|NCT04625972|365407770|FG001|Overall Study|Physician Decision|0|||
105931542|NCT04625972|365407769|FG000|Overall Study|Protocol Violation|0|||
105931543|NCT04625972|365407770|FG001|Overall Study|Protocol Violation|1|||
105931544|NCT04625972|365407769|FG000|Overall Study|Withdrawal by Subject|37|||
105931545|NCT04625972|365407770|FG001|Overall Study|Withdrawal by Subject|24|||
105931546|NCT04625972|365407769|FG000|Overall Study|Not specified elsewhere|8|||
105931547|NCT04625972|365407770|FG001|Overall Study|Not specified elsewhere|6|||
105931548|NCT00165698|365407771|FG000|Overall Study|Adverse Event|2|||
105931549|NCT00165698|365407772|FG001|Overall Study|Adverse Event|10|||
105931550|NCT00165698|365407771|FG000|Overall Study|Lost to Follow-up|2|||
105931551|NCT00165698|365407772|FG001|Overall Study|Lost to Follow-up|2|||
105931552|NCT00165698|365407771|FG000|Overall Study|Withdrawal by Subject|2|||
105931553|NCT00165698|365407772|FG001|Overall Study|Withdrawal by Subject|1|||
105931554|NCT00165698|365407771|FG000|Overall Study|Protocol Violation|1|||
105931555|NCT00165698|365407772|FG001|Overall Study|Protocol Violation|0|||
105931556|NCT00165698|365407771|FG000|Overall Study|Not Taken/Lost the medicine|1|||
105931557|NCT00165698|365407772|FG001|Overall Study|Not Taken/Lost the medicine|2|||
105931558|NCT01107457|365407773|FG000|Part A|Adverse Event|1|||
105931559|NCT01107457|365407774|FG001|Part A|Adverse Event|2|||
105931560|NCT01107457|365407775|FG002|Part A|Adverse Event|1|||
105931561|NCT01107457|365407776|FG003|Part A|Adverse Event|0|||
105931562|NCT01107457|365407777|FG004|Part A|Adverse Event|0|||
105931563|NCT01107457|365407778|FG005|Part A|Adverse Event|0|||
105931564|NCT01107457|365407773|FG000|Part A|Withdrawal by Subject|3|||
105931565|NCT01107457|365407774|FG001|Part A|Withdrawal by Subject|3|||
105931566|NCT01107457|365407775|FG002|Part A|Withdrawal by Subject|0|||
105931567|NCT01107457|365407776|FG003|Part A|Withdrawal by Subject|3|||
105931568|NCT01107457|365407777|FG004|Part A|Withdrawal by Subject|1|||
105931569|NCT01107457|365407778|FG005|Part A|Withdrawal by Subject|0|||
105931570|NCT01107457|365407773|FG000|Part A|Lost to Follow-up|0|||
105931571|NCT01107457|365407774|FG001|Part A|Lost to Follow-up|1|||
105931572|NCT01107457|365407775|FG002|Part A|Lost to Follow-up|0|||
105931573|NCT01107457|365407776|FG003|Part A|Lost to Follow-up|0|||
105931574|NCT01107457|365407777|FG004|Part A|Lost to Follow-up|0|||
105931575|NCT01107457|365407778|FG005|Part A|Lost to Follow-up|0|||
105931576|NCT01107457|365407773|FG000|Part A|Lack of Efficacy|1|||
105931577|NCT01107457|365407774|FG001|Part A|Lack of Efficacy|0|||
105931578|NCT01107457|365407775|FG002|Part A|Lack of Efficacy|0|||
105931579|NCT01107457|365407776|FG003|Part A|Lack of Efficacy|0|||
105931580|NCT01107457|365407777|FG004|Part A|Lack of Efficacy|0|||
105931581|NCT01107457|365407778|FG005|Part A|Lack of Efficacy|0|||
105931582|NCT01107457|365407773|FG000|Part A|Protocol Violation|0|||
105931583|NCT01107457|365407774|FG001|Part A|Protocol Violation|1|||
106136383|NCT01981850|366157951|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
106136384|NCT01981850|366157942|FG000|Main Phase Stage 1|Various reasons|0|||
105931584|NCT01107457|365407775|FG002|Part A|Protocol Violation|0|||
105931585|NCT01107457|365407776|FG003|Part A|Protocol Violation|0|||
105931586|NCT01107457|365407777|FG004|Part A|Protocol Violation|0|||
105931587|NCT01107457|365407778|FG005|Part A|Protocol Violation|0|||
105931588|NCT01107457|365407773|FG000|Part B and C|Adverse Event|0|||
105714799|NCT00122135|364615587|FG000|Overall Study|Withdrawal by Subject|3|||
105789540|NCT03917654|364883386|FG001|Year 1|Spouse/Family member request|0|||
105789541|NCT03917654|364883387|FG002|Year 1|Spouse/Family member request|1|||
105789542|NCT03917654|364883388|FG003|Year 1|Spouse/Family member request|0|||
105789543|NCT03917654|364883389|FG004|Year 1|Spouse/Family member request|1|||
105789544|NCT03917654|364883390|FG005|Year 1|Spouse/Family member request|0|||
105789545|NCT03917654|364883391|FG006|Year 1|Spouse/Family member request|0|||
105789546|NCT03917654|364883392|FG007|Year 1|Spouse/Family member request|2|||
105789547|NCT03917654|364883393|FG008|Year 1|Spouse/Family member request|0|||
105789548|NCT03917654|364883394|FG009|Year 1|Spouse/Family member request|0|||
105789549|NCT03917654|364883395|FG010|Year 1|Spouse/Family member request|0|||
105789550|NCT03917654|364883396|FG011|Year 1|Spouse/Family member request|1|||
105789551|NCT03917654|364883385|FG000|Year 1|Death|0|||
105931589|NCT01107457|365407774|FG001|Part B and C|Adverse Event|0|||
105931590|NCT01107457|365407775|FG002|Part B and C|Adverse Event|0|||
105931591|NCT01107457|365407776|FG003|Part B and C|Adverse Event|0|||
105714800|NCT00122135|364615588|FG001|Overall Study|Withdrawal by Subject|0|||
105714801|NCT00860158|364615591|FG000|Overall Study|Study Terminated|1|||
105714802|NCT05499520|364615597|FG000|Overall Study|Lost to Follow-up|0|||
105714803|NCT05499520|364615598|FG001|Overall Study|Lost to Follow-up|0|||
105714804|NCT05499520|364615599|FG002|Overall Study|Lost to Follow-up|38|||
105714805|NCT05499520|364615600|FG003|Overall Study|Lost to Follow-up|41|||
105714806|NCT05499520|364615601|FG004|Overall Study|Lost to Follow-up|46|||
105714807|NCT05499520|364615602|FG005|Overall Study|Lost to Follow-up|0|||
105714808|NCT05499520|364615603|FG006|Overall Study|Lost to Follow-up|31|||
105714809|NCT05499520|364615604|FG007|Overall Study|Lost to Follow-up|45|||
105714810|NCT05499520|364615605|FG008|Overall Study|Lost to Follow-up|42|||
105714811|NCT05499520|364615606|FG009|Overall Study|Lost to Follow-up|0|||
105714812|NCT05499520|364615607|FG010|Overall Study|Lost to Follow-up|0|||
105714813|NCT05499520|364615608|FG011|Overall Study|Lost to Follow-up|37|||
105714814|NCT05499520|364615609|FG012|Overall Study|Lost to Follow-up|53|||
105714815|NCT05499520|364615610|FG013|Overall Study|Lost to Follow-up|49|||
105714816|NCT05499520|364615611|FG014|Overall Study|Lost to Follow-up|0|||
105714817|NCT05499520|364615612|FG015|Overall Study|Lost to Follow-up|36|||
105714818|NCT05499520|364615613|FG016|Overall Study|Lost to Follow-up|58|||
105714819|NCT05499520|364615614|FG017|Overall Study|Lost to Follow-up|53|||
105714820|NCT02770326|364615621|FG000|Overall Study|Death|3|||
105714821|NCT02770326|364615621|FG000|Overall Study|Lost to Follow-up|1|||
105714822|NCT01613326|364615622|FG000|Overall Study|Adverse Event|7|||
105714823|NCT01613326|364615623|FG001|Overall Study|Adverse Event|5|||
105714824|NCT01613326|364615622|FG000|Overall Study|Withdrawal by Subject|3|||
105714825|NCT01613326|364615623|FG001|Overall Study|Withdrawal by Subject|4|||
105714826|NCT01613326|364615622|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105714827|NCT01613326|364615623|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105714828|NCT01613326|364615622|FG000|Overall Study|inability to use device|1|||
105714829|NCT01613326|364615623|FG001|Overall Study|inability to use device|0|||
105714830|NCT01613326|364615622|FG000|Overall Study|Lack of Efficacy|0|||
105931592|NCT01107457|365407777|FG004|Part B and C|Adverse Event|0|||
105931593|NCT01107457|365407778|FG005|Part B and C|Adverse Event|12|||
105931594|NCT01107457|365407773|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105931595|NCT01107457|365407774|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105714831|NCT01613326|364615623|FG001|Overall Study|Lack of Efficacy|1|||
105931596|NCT01107457|365407775|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105931597|NCT01107457|365407776|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105931598|NCT01107457|365407777|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
105931599|NCT01107457|365407778|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
105931600|NCT01107457|365407773|FG000|Part B and C|Physician Decision|0|||
105931601|NCT01107457|365407774|FG001|Part B and C|Physician Decision|0|||
105931602|NCT01107457|365407775|FG002|Part B and C|Physician Decision|0|||
105931603|NCT01107457|365407776|FG003|Part B and C|Physician Decision|0|||
105931604|NCT01107457|365407777|FG004|Part B and C|Physician Decision|0|||
105931605|NCT01107457|365407778|FG005|Part B and C|Physician Decision|3|||
105931606|NCT01107457|365407773|FG000|Part B and C|Lack of Efficacy|0|||
105931607|NCT01107457|365407774|FG001|Part B and C|Lack of Efficacy|0|||
105714832|NCT01613326|364615622|FG000|Overall Study|Lost to Follow-up|0|||
105714833|NCT01613326|364615623|FG001|Overall Study|Lost to Follow-up|1|||
105714834|NCT01613326|364615622|FG000|Overall Study|Administrative|0|||
105714835|NCT01613326|364615623|FG001|Overall Study|Administrative|2|||
105714836|NCT01613326|364615622|FG000|Overall Study|Protocol Violation|0|||
105714837|NCT01613326|364615623|FG001|Overall Study|Protocol Violation|1|||
105714838|NCT02971202|364615626|FG000|Overall Study|Pregnancy|1|||
105714839|NCT02971202|364615627|FG001|Overall Study|Pregnancy|0|||
105714840|NCT02971202|364615628|FG002|Overall Study|Pregnancy|0|||
105714841|NCT02971202|364615626|FG000|Overall Study|screen fail after consent|1|||
105789552|NCT03917654|364883386|FG001|Year 1|Death|0|||
105789553|NCT03917654|364883387|FG002|Year 1|Death|0|||
105789554|NCT03917654|364883388|FG003|Year 1|Death|0|||
105789555|NCT03917654|364883389|FG004|Year 1|Death|0|||
105931608|NCT01107457|365407775|FG002|Part B and C|Lack of Efficacy|0|||
105931609|NCT01107457|365407776|FG003|Part B and C|Lack of Efficacy|0|||
105714842|NCT02971202|364615627|FG001|Overall Study|screen fail after consent|0|||
105714843|NCT02971202|364615628|FG002|Overall Study|screen fail after consent|1|||
105714844|NCT03980938|364615631|FG000|Treatment Period 1|Study Terminated|1|||
105714845|NCT03980938|364615632|FG001|Treatment Period 1|Study Terminated|1|||
105714846|NCT03980938|364615631|FG000|Treatment Period 2|Study Terminated|2|||
105714847|NCT03980938|364615632|FG001|Treatment Period 2|Study Terminated|2|||
105714848|NCT02723201|364615633|FG000|Second Intervention Period|Protocol Violation|1|||
105714849|NCT02723201|364615634|FG001|Second Intervention Period|Protocol Violation|0|||
105714850|NCT02723201|364615635|FG002|Second Intervention Period|Protocol Violation|0|||
105714851|NCT02723201|364615633|FG000|Second Intervention Period|Adverse Event|1|||
105714852|NCT02723201|364615634|FG001|Second Intervention Period|Adverse Event|0|||
105714853|NCT02723201|364615635|FG002|Second Intervention Period|Adverse Event|0|||
105714854|NCT01445535|364615636|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
105714855|NCT01445535|364615637|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
105714856|NCT01445535|364615638|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
105714857|NCT01445535|364615639|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
105714858|NCT01445535|364615636|FG000|Overall Study|Disease progression|1|||
105714859|NCT01445535|364615637|FG001|Overall Study|Disease progression|0|||
105714860|NCT01445535|364615638|FG002|Overall Study|Disease progression|1|||
105714861|NCT01445535|364615639|FG003|Overall Study|Disease progression|0|||
105714862|NCT01445535|364615636|FG000|Overall Study|PI discretion|0|||
105714863|NCT01445535|364615637|FG001|Overall Study|PI discretion|0|||
105714864|NCT01445535|364615638|FG002|Overall Study|PI discretion|0|||
105714865|NCT01445535|364615639|FG003|Overall Study|PI discretion|1|||
105714866|NCT02908880|364615642|FG000|Overall Study|Lost to Follow-up|4|||
105714867|NCT02908880|364615642|FG000|Overall Study|Explantation of the device|1|||
105714868|NCT02908880|364615642|FG000|Overall Study|Withdrawal by Subject|17|||
105714869|NCT02908880|364615642|FG000|Overall Study|Death|5|||
105714870|NCT02421887|364615643|FG000|Overall Study|Lost to Follow-up|5|||
105714871|NCT02421887|364615644|FG001|Overall Study|Lost to Follow-up|0|||
105714872|NCT02421887|364615643|FG000|Overall Study|Withdrawal by Subject|8|||
105714873|NCT02421887|364615644|FG001|Overall Study|Withdrawal by Subject|5|||
105931610|NCT01107457|365407777|FG004|Part B and C|Lack of Efficacy|0|||
105931611|NCT01107457|365407778|FG005|Part B and C|Lack of Efficacy|7|||
105931612|NCT01107457|365407773|FG000|Part B and C|Lost to Follow-up|0|||
105931613|NCT01107457|365407774|FG001|Part B and C|Lost to Follow-up|0|||
105931614|NCT01107457|365407775|FG002|Part B and C|Lost to Follow-up|0|||
105931615|NCT01107457|365407776|FG003|Part B and C|Lost to Follow-up|0|||
105931616|NCT01107457|365407777|FG004|Part B and C|Lost to Follow-up|0|||
105931617|NCT01107457|365407778|FG005|Part B and C|Lost to Follow-up|10|||
105931618|NCT01107457|365407773|FG000|Part B and C|Protocol Violation|0|||
105931619|NCT01107457|365407774|FG001|Part B and C|Protocol Violation|0|||
105931620|NCT01107457|365407775|FG002|Part B and C|Protocol Violation|0|||
105931621|NCT01107457|365407776|FG003|Part B and C|Protocol Violation|0|||
105931622|NCT01107457|365407777|FG004|Part B and C|Protocol Violation|0|||
105931623|NCT01107457|365407778|FG005|Part B and C|Protocol Violation|1|||
105931624|NCT01107457|365407773|FG000|Part B and C|Sponsor Decision|0|||
105931625|NCT01107457|365407774|FG001|Part B and C|Sponsor Decision|0|||
105931626|NCT01107457|365407775|FG002|Part B and C|Sponsor Decision|0|||
105931627|NCT01107457|365407776|FG003|Part B and C|Sponsor Decision|0|||
105931628|NCT01107457|365407777|FG004|Part B and C|Sponsor Decision|0|||
105931629|NCT01107457|365407778|FG005|Part B and C|Sponsor Decision|66|||
105931630|NCT01107457|365407773|FG000|Part B and C|Withdrawal by Subject|0|||
105931631|NCT01107457|365407774|FG001|Part B and C|Withdrawal by Subject|0|||
105931632|NCT01107457|365407775|FG002|Part B and C|Withdrawal by Subject|0|||
105714874|NCT02421887|364615643|FG000|Overall Study|Physician Decision|2|||
105714875|NCT02421887|364615644|FG001|Overall Study|Physician Decision|4|||
105714876|NCT02421887|364615643|FG000|Overall Study|Adverse Event|2|||
105714877|NCT02421887|364615644|FG001|Overall Study|Adverse Event|0|||
105714878|NCT03569202|364615648|FG000|Part 3|Physician Decision|1|||
105714879|NCT03569202|364615649|FG001|Part 3|Physician Decision|0|||
105714880|NCT03569202|364615648|FG000|Part 3|Other|1|||
105931633|NCT01107457|365407776|FG003|Part B and C|Withdrawal by Subject|0|||
105931634|NCT01107457|365407777|FG004|Part B and C|Withdrawal by Subject|0|||
105931635|NCT01107457|365407778|FG005|Part B and C|Withdrawal by Subject|16|||
105931636|NCT01107457|365407773|FG000|Part B and C|Clinical Relapse|0|||
105931637|NCT01107457|365407774|FG001|Part B and C|Clinical Relapse|0|||
105931638|NCT01107457|365407775|FG002|Part B and C|Clinical Relapse|0|||
105931639|NCT01107457|365407776|FG003|Part B and C|Clinical Relapse|0|||
105931640|NCT01107457|365407777|FG004|Part B and C|Clinical Relapse|0|||
105714881|NCT03569202|364615649|FG001|Part 3|Other|1|||
105714882|NCT00420511|364615650|FG000|Overall Study|Adverse Event|1|||
105714883|NCT00420511|364615651|FG001|Overall Study|Adverse Event|1|||
105714884|NCT00420511|364615650|FG000|Overall Study|Lost to Follow-up|1|||
105714885|NCT00420511|364615651|FG001|Overall Study|Lost to Follow-up|0|||
105714886|NCT01467492|364615652|FG000|Overall Study|Withdrawal by Subject|6|||
105714887|NCT01467492|364615653|FG001|Overall Study|Withdrawal by Subject|4|||
105931641|NCT01107457|365407778|FG005|Part B and C|Clinical Relapse|4|||
105931642|NCT02547935|365407779|FG000|Overall Study|Other|0|||
105714888|NCT01467492|364615652|FG000|Overall Study|Study Terminated by Sponsor|6|||
105714889|NCT01467492|364615653|FG001|Overall Study|Study Terminated by Sponsor|4|||
105714890|NCT01467492|364615652|FG000|Overall Study|Adverse Event|4|||
105714891|NCT01467492|364615653|FG001|Overall Study|Adverse Event|3|||
105714892|NCT01467492|364615652|FG000|Overall Study|Lost to Follow-up|3|||
105714893|NCT01467492|364615653|FG001|Overall Study|Lost to Follow-up|2|||
105714894|NCT01467492|364615652|FG000|Overall Study|Undefined|2|||
105714895|NCT01467492|364615653|FG001|Overall Study|Undefined|0|||
105714896|NCT01467492|364615652|FG000|Overall Study|Enrolled But Not Treated|1|||
105714897|NCT01467492|364615653|FG001|Overall Study|Enrolled But Not Treated|0|||
105714898|NCT00491179|364615655|FG000|Overall Study|Adverse Event|5|||
105714899|NCT00491179|364615656|FG001|Overall Study|Adverse Event|1|||
105714900|NCT00491179|364615655|FG000|Overall Study|Withdrawal by Subject|2|||
105714901|NCT00491179|364615656|FG001|Overall Study|Withdrawal by Subject|1|||
105789556|NCT03917654|364883390|FG005|Year 1|Death|0|||
105789557|NCT03917654|364883391|FG006|Year 1|Death|0|||
105931643|NCT02547935|365407780|FG001|Overall Study|Other|1|||
105714902|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
105714903|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
105714904|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
105714905|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
105714906|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
105714907|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
105714908|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
105714909|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
105714910|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
105714911|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
105714912|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
105714913|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
105714914|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105714915|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
105714916|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
105714917|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
105714918|NCT01622569|364615657|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
105714919|NCT01622569|364615658|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
105714920|NCT01622569|364615659|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
105714921|NCT01622569|364615660|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
105714922|NCT01622569|364615657|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
105714923|NCT01622569|364615658|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
105714924|NCT01622569|364615659|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
105714925|NCT01622569|364615660|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
105714926|NCT01622569|364615657|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
105714927|NCT01622569|364615658|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
105714928|NCT01622569|364615659|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
105714929|NCT01622569|364615660|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
105714930|NCT01622569|364615657|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105714931|NCT01622569|364615658|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105714932|NCT01622569|364615659|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
105714933|NCT01622569|364615660|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
105714934|NCT01491178|364615663|FG000|Overall Study|Adverse Event|1016|||
105714935|NCT01491178|364615663|FG000|Overall Study|Improvement of NVAF|210|||
105714936|NCT01491178|364615663|FG000|Overall Study|To conduct invasive treatment|59|||
105714937|NCT01491178|364615663|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
105714938|NCT01491178|364615663|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
105714939|NCT01491178|364615663|FG000|Overall Study|To take a contraindication|20|||
105714940|NCT01491178|364615663|FG000|Overall Study|Other than specified above|657|||
105714941|NCT04142983|364615666|FG000|Overall Study|Lost to Follow-up|73|||
105714942|NCT04142983|364615666|FG000|Overall Study|Withdrawal by Subject|10|||
105714943|NCT04142983|364615666|FG000|Overall Study|Physician Decision|1|||
105714944|NCT04142983|364615666|FG000|Overall Study|Adverse Event|1|||
105714945|NCT04142983|364615666|FG000|Overall Study|No longer eligible|4|||
105714946|NCT04142983|364615666|FG000|Overall Study|Screen Failure|10|||
105714947|NCT00257010|364615667|FG000|Overall Study|Lack of Efficacy|11|||
105714948|NCT00257010|364615667|FG000|Overall Study|Lost to Follow-up|53|||
105714949|NCT00257010|364615667|FG000|Overall Study|Withdrawal by Subject|34|||
105714950|NCT00257010|364615667|FG000|Overall Study|Adverse Event|10|||
105714951|NCT00257010|364615667|FG000|Overall Study|various|11|||
105714952|NCT00257010|364615667|FG000|Overall Study|no headache reported|9|||
105714953|NCT00448708|364615673|FG000|Overall Study|Death|21|||
105714954|NCT00448708|364615674|FG001|Overall Study|Death|17|||
105714955|NCT00448708|364615673|FG000|Overall Study|Withdrawal by Subject|8|||
105789558|NCT03917654|364883392|FG007|Year 1|Death|0|||
105714956|NCT00448708|364615674|FG001|Overall Study|Withdrawal by Subject|4|||
105714957|NCT00448708|364615673|FG000|Overall Study|Lost to Follow-up|6|||
105714958|NCT00448708|364615674|FG001|Overall Study|Lost to Follow-up|8|||
105714959|NCT00448708|364615673|FG000|Overall Study|not listed|0|||
105714960|NCT00448708|364615674|FG001|Overall Study|not listed|2|||
105714961|NCT03665285|364615676|FG000|Overall Study|Started New Anticancer Treatment|1|||
105714962|NCT03665285|364615677|FG001|Overall Study|Started New Anticancer Treatment|1|||
105714963|NCT03665285|364615678|FG002|Overall Study|Started New Anticancer Treatment|2|||
105714964|NCT03665285|364615679|FG003|Overall Study|Started New Anticancer Treatment|4|||
105714965|NCT03665285|364615680|FG004|Overall Study|Started New Anticancer Treatment|1|||
105714966|NCT03665285|364615681|FG005|Overall Study|Started New Anticancer Treatment|1|||
105714967|NCT03665285|364615682|FG006|Overall Study|Started New Anticancer Treatment|2|||
105714968|NCT03665285|364615683|FG007|Overall Study|Started New Anticancer Treatment|15|||
105714969|NCT03665285|364615684|FG008|Overall Study|Started New Anticancer Treatment|1|||
105714970|NCT03665285|364615676|FG000|Overall Study|Disease Progression|0|||
105714971|NCT03665285|364615677|FG001|Overall Study|Disease Progression|0|||
105714972|NCT03665285|364615678|FG002|Overall Study|Disease Progression|3|||
105714973|NCT03665285|364615679|FG003|Overall Study|Disease Progression|1|||
105714974|NCT03665285|364615680|FG004|Overall Study|Disease Progression|0|||
105714975|NCT03665285|364615681|FG005|Overall Study|Disease Progression|0|||
105714976|NCT03665285|364615682|FG006|Overall Study|Disease Progression|0|||
105714977|NCT03665285|364615683|FG007|Overall Study|Disease Progression|7|||
105714978|NCT03665285|364615684|FG008|Overall Study|Disease Progression|1|||
105714979|NCT03665285|364615676|FG000|Overall Study|Hospice|0|||
105714980|NCT03665285|364615677|FG001|Overall Study|Hospice|0|||
105714981|NCT03665285|364615678|FG002|Overall Study|Hospice|0|||
105714982|NCT03665285|364615679|FG003|Overall Study|Hospice|0|||
105714983|NCT03665285|364615680|FG004|Overall Study|Hospice|0|||
105714984|NCT03665285|364615681|FG005|Overall Study|Hospice|0|||
105714985|NCT03665285|364615682|FG006|Overall Study|Hospice|0|||
105714986|NCT03665285|364615683|FG007|Overall Study|Hospice|2|||
105714987|NCT03665285|364615684|FG008|Overall Study|Hospice|0|||
105714988|NCT03665285|364615676|FG000|Overall Study|Withdrawal by Subject|0|||
105714989|NCT03665285|364615677|FG001|Overall Study|Withdrawal by Subject|0|||
105714990|NCT03665285|364615678|FG002|Overall Study|Withdrawal by Subject|0|||
105789559|NCT03917654|364883393|FG008|Year 1|Death|1|||
105714991|NCT03665285|364615679|FG003|Overall Study|Withdrawal by Subject|0|||
105789560|NCT03917654|364883394|FG009|Year 1|Death|1|||
105789561|NCT03917654|364883395|FG010|Year 1|Death|0|||
105714992|NCT03665285|364615680|FG004|Overall Study|Withdrawal by Subject|1|||
105714993|NCT03665285|364615681|FG005|Overall Study|Withdrawal by Subject|0|||
105714994|NCT03665285|364615682|FG006|Overall Study|Withdrawal by Subject|0|||
105714995|NCT03665285|364615683|FG007|Overall Study|Withdrawal by Subject|2|||
105714996|NCT03665285|364615684|FG008|Overall Study|Withdrawal by Subject|0|||
105714997|NCT03665285|364615676|FG000|Overall Study|Physician Decision|0|||
105714998|NCT03665285|364615677|FG001|Overall Study|Physician Decision|0|||
105714999|NCT03665285|364615678|FG002|Overall Study|Physician Decision|0|||
105715000|NCT03665285|364615679|FG003|Overall Study|Physician Decision|0|||
105715001|NCT03665285|364615680|FG004|Overall Study|Physician Decision|0|||
105715002|NCT03665285|364615681|FG005|Overall Study|Physician Decision|0|||
105715003|NCT03665285|364615682|FG006|Overall Study|Physician Decision|0|||
105715004|NCT03665285|364615683|FG007|Overall Study|Physician Decision|2|||
105789562|NCT03917654|364883396|FG011|Year 1|Death|0|||
105789563|NCT03917654|364883385|FG000|Year 1|Lost to Follow-up|0|||
105789564|NCT03917654|364883386|FG001|Year 1|Lost to Follow-up|0|||
105789565|NCT03917654|364883387|FG002|Year 1|Lost to Follow-up|0|||
105789566|NCT03917654|364883388|FG003|Year 1|Lost to Follow-up|0|||
105789567|NCT03917654|364883389|FG004|Year 1|Lost to Follow-up|0|||
105931644|NCT02547935|365407781|FG002|Overall Study|Other|0|||
106136385|NCT01981850|366157943|FG001|Main Phase Stage 1|Various reasons|0|||
106136386|NCT01981850|366157944|FG002|Main Phase Stage 1|Various reasons|2|||
106136387|NCT01981850|366157945|FG003|Main Phase Stage 1|Various reasons|0|||
106136388|NCT01981850|366157946|FG004|Main Phase Stage 1|Various reasons|0|||
106136389|NCT01981850|366157947|FG005|Main Phase Stage 1|Various reasons|0|||
105715005|NCT03665285|364615684|FG008|Overall Study|Physician Decision|0|||
105715006|NCT00763321|364615685|FG000|Open-label Period|Adverse Event|24|||
105715007|NCT00763321|364615686|FG001|Open-label Period|Adverse Event|0|||
105715008|NCT00763321|364615687|FG002|Open-label Period|Adverse Event|0|||
105715009|NCT00763321|364615685|FG000|Open-label Period|Lost to Follow-up|14|||
105715010|NCT00763321|364615686|FG001|Open-label Period|Lost to Follow-up|0|||
105715011|NCT00763321|364615687|FG002|Open-label Period|Lost to Follow-up|0|||
105715012|NCT00763321|364615685|FG000|Open-label Period|Withdrawal by Subject|7|||
105715013|NCT00763321|364615686|FG001|Open-label Period|Withdrawal by Subject|0|||
105715014|NCT00763321|364615687|FG002|Open-label Period|Withdrawal by Subject|0|||
105715015|NCT00763321|364615685|FG000|Open-label Period|Subject noncompliant|7|||
105715016|NCT00763321|364615686|FG001|Open-label Period|Subject noncompliant|0|||
105715017|NCT00763321|364615687|FG002|Open-label Period|Subject noncompliant|0|||
105789568|NCT03917654|364883390|FG005|Year 1|Lost to Follow-up|0|||
105789569|NCT03917654|364883391|FG006|Year 1|Lost to Follow-up|2|||
105789570|NCT03917654|364883392|FG007|Year 1|Lost to Follow-up|0|||
105715018|NCT00763321|364615685|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
105715019|NCT00763321|364615686|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
105715020|NCT00763321|364615687|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
105715021|NCT00763321|364615685|FG000|Open-label Period|Lack of Efficacy|2|||
105715022|NCT00763321|364615686|FG001|Open-label Period|Lack of Efficacy|0|||
105715023|NCT00763321|364615687|FG002|Open-label Period|Lack of Efficacy|0|||
105715024|NCT00763321|364615685|FG000|Open-label Period|Other|4|||
105715025|NCT00763321|364615686|FG001|Open-label Period|Other|0|||
105715026|NCT00763321|364615687|FG002|Open-label Period|Other|0|||
105715027|NCT00763321|364615685|FG000|Double-blind Period|Lack of Efficacy|0|||
105715028|NCT00763321|364615686|FG001|Double-blind Period|Lack of Efficacy|9|||
105715029|NCT00763321|364615687|FG002|Double-blind Period|Lack of Efficacy|17|||
105715030|NCT00763321|364615685|FG000|Double-blind Period|Adverse Event|0|||
105715031|NCT00763321|364615686|FG001|Double-blind Period|Adverse Event|4|||
105715032|NCT00763321|364615687|FG002|Double-blind Period|Adverse Event|4|||
105789571|NCT03917654|364883393|FG008|Year 1|Lost to Follow-up|0|||
105789572|NCT03917654|364883394|FG009|Year 1|Lost to Follow-up|0|||
105789573|NCT03917654|364883395|FG010|Year 1|Lost to Follow-up|0|||
105789574|NCT03917654|364883396|FG011|Year 1|Lost to Follow-up|0|||
105789575|NCT03917654|364883385|FG000|Year 1|Missed visits|0|||
105789576|NCT03917654|364883386|FG001|Year 1|Missed visits|0|||
105789577|NCT03917654|364883387|FG002|Year 1|Missed visits|0|||
105789578|NCT03917654|364883388|FG003|Year 1|Missed visits|0|||
105789579|NCT03917654|364883389|FG004|Year 1|Missed visits|0|||
105789580|NCT03917654|364883390|FG005|Year 1|Missed visits|0|||
105789581|NCT03917654|364883391|FG006|Year 1|Missed visits|0|||
105789582|NCT03917654|364883392|FG007|Year 1|Missed visits|0|||
105789583|NCT03917654|364883393|FG008|Year 1|Missed visits|0|||
105789584|NCT03917654|364883394|FG009|Year 1|Missed visits|0|||
105789585|NCT03917654|364883395|FG010|Year 1|Missed visits|1|||
105789586|NCT03917654|364883396|FG011|Year 1|Missed visits|1|||
105789587|NCT03917654|364883385|FG000|Year 1|Pregnancy|0|||
105789588|NCT03917654|364883386|FG001|Year 1|Pregnancy|0|||
105789589|NCT03917654|364883387|FG002|Year 1|Pregnancy|0|||
105789590|NCT03917654|364883388|FG003|Year 1|Pregnancy|0|||
105789591|NCT03917654|364883389|FG004|Year 1|Pregnancy|0|||
105931645|NCT02547935|365407779|FG000|Overall Study|Withdrawal by Subject|2|||
105931646|NCT02547935|365407780|FG001|Overall Study|Withdrawal by Subject|3|||
105931647|NCT02547935|365407781|FG002|Overall Study|Withdrawal by Subject|4|||
105931648|NCT02547935|365407779|FG000|Overall Study|Screen Failure|2|||
105931649|NCT02547935|365407780|FG001|Overall Study|Screen Failure|0|||
105931650|NCT02547935|365407781|FG002|Overall Study|Screen Failure|0|||
105931651|NCT02547935|365407779|FG000|Overall Study|Physician Decision|0|||
105931652|NCT02547935|365407780|FG001|Overall Study|Physician Decision|1|||
105931653|NCT02547935|365407781|FG002|Overall Study|Physician Decision|0|||
105931654|NCT02547935|365407779|FG000|Overall Study|Lost to Follow-up|0|||
105931655|NCT02547935|365407780|FG001|Overall Study|Lost to Follow-up|2|||
105931656|NCT02547935|365407781|FG002|Overall Study|Lost to Follow-up|1|||
105931657|NCT02547935|365407779|FG000|Overall Study|Death|1|||
105931658|NCT02547935|365407780|FG001|Overall Study|Death|1|||
105931659|NCT02547935|365407781|FG002|Overall Study|Death|0|||
105931660|NCT00694122|365407782|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
105931661|NCT00694122|365407783|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
105931662|NCT00694122|365407782|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
105931663|NCT00694122|365407783|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
105931664|NCT00694122|365407782|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
105931665|NCT00694122|365407783|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
105931666|NCT00105508|365407784|FG000|Overall Study|Prephase Dropout|1|||
105931667|NCT00105508|365407785|FG001|Overall Study|Prephase Dropout|0|||
105931668|NCT00105508|365407784|FG000|Overall Study|Adverse Event|16|||
105931669|NCT00105508|365407785|FG001|Overall Study|Adverse Event|19|||
105931670|NCT00105508|365407784|FG000|Overall Study|Insufficient Efficacy|1|||
105931671|NCT00105508|365407785|FG001|Overall Study|Insufficient Efficacy|0|||
105715033|NCT00763321|364615685|FG000|Double-blind Period|Lost to Follow-up|0|||
105931672|NCT00105508|365407784|FG000|Overall Study|Withdrawal by Subject|10|||
106136390|NCT01981850|366157948|FG006|Main Phase Stage 1|Various reasons|0|||
106136391|NCT01981850|366157949|FG007|Main Phase Stage 1|Various reasons|0|||
105715034|NCT00763321|364615686|FG001|Double-blind Period|Lost to Follow-up|4|||
105789592|NCT03917654|364883390|FG005|Year 1|Pregnancy|0|||
105789593|NCT03917654|364883391|FG006|Year 1|Pregnancy|0|||
105789594|NCT03917654|364883392|FG007|Year 1|Pregnancy|1|||
105789595|NCT03917654|364883393|FG008|Year 1|Pregnancy|0|||
105789596|NCT03917654|364883394|FG009|Year 1|Pregnancy|1|||
105789597|NCT03917654|364883395|FG010|Year 1|Pregnancy|0|||
105789598|NCT03917654|364883396|FG011|Year 1|Pregnancy|0|||
105789599|NCT03917654|364883385|FG000|Year 2|Travel|1|||
105931673|NCT00105508|365407785|FG001|Overall Study|Withdrawal by Subject|6|||
105931674|NCT00105508|365407784|FG000|Overall Study|Lost to Follow-up|3|||
105931675|NCT00105508|365407785|FG001|Overall Study|Lost to Follow-up|0|||
105931676|NCT00105508|365407784|FG000|Overall Study|Protocol Violation|1|||
105931677|NCT00105508|365407785|FG001|Overall Study|Protocol Violation|2|||
105931678|NCT00105508|365407784|FG000|Overall Study|Other|8|||
105789600|NCT03917654|364883386|FG001|Year 2|Travel|0|||
105789601|NCT03917654|364883387|FG002|Year 2|Travel|0|||
105789602|NCT03917654|364883388|FG003|Year 2|Travel|0|||
105931679|NCT00105508|365407785|FG001|Overall Study|Other|9|||
105715035|NCT00763321|364615687|FG002|Double-blind Period|Lost to Follow-up|2|||
105715036|NCT00763321|364615685|FG000|Double-blind Period|Withdrawal by Subject|0|||
105715037|NCT00763321|364615686|FG001|Double-blind Period|Withdrawal by Subject|2|||
105715038|NCT00763321|364615687|FG002|Double-blind Period|Withdrawal by Subject|3|||
105715039|NCT00763321|364615685|FG000|Double-blind Period|Other|0|||
105715040|NCT00763321|364615686|FG001|Double-blind Period|Other|2|||
105715041|NCT00763321|364615687|FG002|Double-blind Period|Other|3|||
105715042|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
105715043|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
105715044|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
105931680|NCT00086307|365407786|FG000|Overall Study|Lack of Efficacy|1|||
105931681|NCT00086307|365407787|FG001|Overall Study|Lack of Efficacy|1|||
105931682|NCT00086307|365407788|FG002|Overall Study|Lack of Efficacy|2|||
105931683|NCT00086307|365407786|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
105931684|NCT00086307|365407787|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
105931685|NCT00086307|365407788|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
105931686|NCT00086307|365407786|FG000|Overall Study|Nausea and headaches|0|||
105931687|NCT00086307|365407787|FG001|Overall Study|Nausea and headaches|0|||
105931688|NCT00086307|365407788|FG002|Overall Study|Nausea and headaches|1|||
105931689|NCT00086307|365407786|FG000|Overall Study|Constipation and sleepiness|0|||
105931690|NCT00086307|365407787|FG001|Overall Study|Constipation and sleepiness|0|||
105931691|NCT00086307|365407788|FG002|Overall Study|Constipation and sleepiness|1|||
105931692|NCT00086307|365407786|FG000|Overall Study|Suicidal ideation|0|||
105931693|NCT00086307|365407787|FG001|Overall Study|Suicidal ideation|0|||
105931694|NCT00086307|365407788|FG002|Overall Study|Suicidal ideation|1|||
105931695|NCT00086307|365407786|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
105931696|NCT00086307|365407787|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
105931697|NCT00086307|365407788|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
105931698|NCT00086307|365407786|FG000|Overall Study|Withdrawal by Subject|0|||
105931699|NCT00086307|365407787|FG001|Overall Study|Withdrawal by Subject|0|||
105931700|NCT00086307|365407788|FG002|Overall Study|Withdrawal by Subject|2|||
105931701|NCT00120874|365407792|FG000|Overall Study|Death|0|||
105931702|NCT00120874|365407793|FG001|Overall Study|Death|1|||
105931703|NCT01245062|365407795|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
105931704|NCT01245062|365407796|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
105931705|NCT01245062|365407797|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
105931706|NCT01245062|365407795|FG000|Randomization and Crossover Phase|Physician Decision|2|||
105931707|NCT01245062|365407796|FG001|Randomization and Crossover Phase|Physician Decision|4|||
105931708|NCT01245062|365407797|FG002|Randomization and Crossover Phase|Physician Decision|0|||
105931709|NCT01245062|365407795|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
105931710|NCT01245062|365407796|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
105931711|NCT01245062|365407797|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
105931712|NCT01245062|365407795|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
105931713|NCT01245062|365407796|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
105931714|NCT01245062|365407797|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
105931715|NCT01245062|365407795|FG000|Cross-over Phase|Lost to Follow-up|0|||
105931716|NCT01245062|365407796|FG001|Cross-over Phase|Lost to Follow-up|0|||
105931717|NCT01245062|365407797|FG002|Cross-over Phase|Lost to Follow-up|1|||
105931718|NCT01245062|365407795|FG000|Cross-over Phase|Physician Decision|0|||
105931719|NCT01245062|365407796|FG001|Cross-over Phase|Physician Decision|0|||
105931720|NCT01245062|365407797|FG002|Cross-over Phase|Physician Decision|1|||
105931721|NCT01245062|365407795|FG000|Cross-over Phase|Withdrew Consent|0|||
105931722|NCT01245062|365407796|FG001|Cross-over Phase|Withdrew Consent|0|||
105931723|NCT01245062|365407797|FG002|Cross-over Phase|Withdrew Consent|4|||
105931724|NCT01245062|365407795|FG000|Cross-over Phase|Study closed/ terminated|0|||
105715045|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Death|28|||
105715046|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Death|0|||
105715047|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Death|0|||
105715048|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
105715049|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
105715050|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
105931725|NCT01245062|365407796|FG001|Cross-over Phase|Study closed/ terminated|0|||
105931726|NCT01245062|365407797|FG002|Cross-over Phase|Study closed/ terminated|11|||
105931727|NCT06025695|365407798|FG000|Overall Study|Adverse Event|5|||
105931728|NCT06025695|365407799|FG001|Overall Study|Adverse Event|6|||
105931729|NCT06025695|365407798|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
105715051|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
105789603|NCT03917654|364883389|FG004|Year 2|Travel|1|||
105789604|NCT03917654|364883390|FG005|Year 2|Travel|1|||
105789605|NCT03917654|364883391|FG006|Year 2|Travel|2|||
105789606|NCT03917654|364883392|FG007|Year 2|Travel|1|||
105789607|NCT03917654|364883393|FG008|Year 2|Travel|0|||
105789608|NCT03917654|364883394|FG009|Year 2|Travel|1|||
105789609|NCT03917654|364883395|FG010|Year 2|Travel|0|||
105789610|NCT03917654|364883396|FG011|Year 2|Travel|1|||
105789611|NCT03917654|364883385|FG000|Year 2|Married|1|||
105789612|NCT03917654|364883386|FG001|Year 2|Married|0|||
105789613|NCT03917654|364883387|FG002|Year 2|Married|0|||
105789614|NCT03917654|364883388|FG003|Year 2|Married|0|||
105789615|NCT03917654|364883389|FG004|Year 2|Married|0|||
105789616|NCT03917654|364883390|FG005|Year 2|Married|0|||
105789617|NCT03917654|364883391|FG006|Year 2|Married|1|||
105789618|NCT03917654|364883392|FG007|Year 2|Married|1|||
105789619|NCT03917654|364883393|FG008|Year 2|Married|0|||
105789620|NCT03917654|364883394|FG009|Year 2|Married|0|||
105789621|NCT03917654|364883395|FG010|Year 2|Married|0|||
105789622|NCT03917654|364883396|FG011|Year 2|Married|0|||
105789623|NCT03917654|364883385|FG000|Year 2|Subject moved away from site|1|||
105789624|NCT03917654|364883386|FG001|Year 2|Subject moved away from site|0|||
105789625|NCT03917654|364883387|FG002|Year 2|Subject moved away from site|0|||
105789626|NCT03917654|364883388|FG003|Year 2|Subject moved away from site|0|||
105789627|NCT03917654|364883389|FG004|Year 2|Subject moved away from site|1|||
105789628|NCT03917654|364883390|FG005|Year 2|Subject moved away from site|0|||
105789629|NCT03917654|364883391|FG006|Year 2|Subject moved away from site|2|||
105789630|NCT03917654|364883392|FG007|Year 2|Subject moved away from site|3|||
105789631|NCT03917654|364883393|FG008|Year 2|Subject moved away from site|0|||
105789632|NCT03917654|364883394|FG009|Year 2|Subject moved away from site|2|||
105789633|NCT03917654|364883395|FG010|Year 2|Subject moved away from site|0|||
105789634|NCT03917654|364883396|FG011|Year 2|Subject moved away from site|1|||
105789635|NCT03917654|364883385|FG000|Year 2|Year 2 Screening failure|0|||
105789636|NCT03917654|364883386|FG001|Year 2|Year 2 Screening failure|1|||
105789637|NCT03917654|364883387|FG002|Year 2|Year 2 Screening failure|0|||
105789638|NCT03917654|364883388|FG003|Year 2|Year 2 Screening failure|0|||
105789639|NCT03917654|364883389|FG004|Year 2|Year 2 Screening failure|2|||
105789640|NCT03917654|364883390|FG005|Year 2|Year 2 Screening failure|0|||
105789641|NCT03917654|364883391|FG006|Year 2|Year 2 Screening failure|4|||
105789642|NCT03917654|364883392|FG007|Year 2|Year 2 Screening failure|3|||
105789643|NCT03917654|364883393|FG008|Year 2|Year 2 Screening failure|10|||
105715052|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
105715053|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
105715054|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
105715055|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
105715056|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
105715057|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
105715058|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
105715059|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
105715060|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
105715061|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
105715062|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
105715063|NCT00820755|364615688|FG000|Period 1: Combination Therapy Phase|Other|11|||
105715064|NCT00820755|364615689|FG001|Period 1: Combination Therapy Phase|Other|0|||
105715065|NCT00820755|364615690|FG002|Period 1: Combination Therapy Phase|Other|0|||
105715066|NCT00820755|364615688|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
105715067|NCT00820755|364615689|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
105715068|NCT00820755|364615690|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
105715069|NCT00946309|364615693|FG000|Overall Study|Protocol Violation|1|||
105715070|NCT00946309|364615694|FG001|Overall Study|Protocol Violation|0|||
105715071|NCT00946309|364615693|FG000|Overall Study|Lost to Follow-up|0|||
105715072|NCT00946309|364615694|FG001|Overall Study|Lost to Follow-up|1|||
105789644|NCT03917654|364883394|FG009|Year 2|Year 2 Screening failure|2|||
105789645|NCT03917654|364883395|FG010|Year 2|Year 2 Screening failure|1|||
105931730|NCT06025695|365407799|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
105931731|NCT06025695|365407798|FG000|Overall Study|Other|23|||
105715073|NCT00946309|364615693|FG000|Overall Study|Procedure cancelled/discontinued|0|||
105789646|NCT03917654|364883396|FG011|Year 2|Year 2 Screening failure|1|||
105789647|NCT03917654|364883385|FG000|Year 2|Death|0|||
105789648|NCT03917654|364883386|FG001|Year 2|Death|0|||
105789649|NCT03917654|364883387|FG002|Year 2|Death|0|||
105789650|NCT03917654|364883388|FG003|Year 2|Death|0|||
105789651|NCT03917654|364883389|FG004|Year 2|Death|0|||
105789652|NCT03917654|364883390|FG005|Year 2|Death|1|||
105789653|NCT03917654|364883391|FG006|Year 2|Death|0|||
105789654|NCT03917654|364883392|FG007|Year 2|Death|0|||
105789655|NCT03917654|364883393|FG008|Year 2|Death|1|||
105789656|NCT03917654|364883394|FG009|Year 2|Death|1|||
105789657|NCT03917654|364883395|FG010|Year 2|Death|0|||
105789658|NCT03917654|364883396|FG011|Year 2|Death|0|||
105789659|NCT03917654|364883385|FG000|Year 2|Withdrawal by Subject|0|||
105789660|NCT03917654|364883386|FG001|Year 2|Withdrawal by Subject|0|||
105789661|NCT03917654|364883387|FG002|Year 2|Withdrawal by Subject|0|||
105789662|NCT03917654|364883388|FG003|Year 2|Withdrawal by Subject|0|||
105789663|NCT03917654|364883389|FG004|Year 2|Withdrawal by Subject|0|||
105789664|NCT03917654|364883390|FG005|Year 2|Withdrawal by Subject|0|||
105789665|NCT03917654|364883391|FG006|Year 2|Withdrawal by Subject|3|||
105789666|NCT03917654|364883392|FG007|Year 2|Withdrawal by Subject|0|||
105789667|NCT03917654|364883393|FG008|Year 2|Withdrawal by Subject|2|||
105789668|NCT03917654|364883394|FG009|Year 2|Withdrawal by Subject|5|||
105789669|NCT03917654|364883395|FG010|Year 2|Withdrawal by Subject|0|||
105789670|NCT03917654|364883396|FG011|Year 2|Withdrawal by Subject|0|||
105789671|NCT03917654|364883385|FG000|Year 2|Spouse/family member request|0|||
105789672|NCT03917654|364883386|FG001|Year 2|Spouse/family member request|0|||
105789673|NCT03917654|364883387|FG002|Year 2|Spouse/family member request|0|||
105789674|NCT03917654|364883388|FG003|Year 2|Spouse/family member request|0|||
105789675|NCT03917654|364883389|FG004|Year 2|Spouse/family member request|0|||
105789676|NCT03917654|364883390|FG005|Year 2|Spouse/family member request|0|||
105789677|NCT03917654|364883391|FG006|Year 2|Spouse/family member request|1|||
105789678|NCT03917654|364883392|FG007|Year 2|Spouse/family member request|0|||
106008630|NCT03597347|365697050|FG002|Overall Study|Withdrawal by Subject|0|||
106008631|NCT03597347|365697048|FG000|Overall Study|Withdrawal due to Covid-19|3|||
105931732|NCT06025695|365407799|FG001|Overall Study|Other|19|||
105931733|NCT06025695|365407798|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
105931734|NCT06025695|365407799|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
105931735|NCT05330429|365407800|FG000|Overall Study|Study Terminated by Sponsor|4|||
105931736|NCT05330429|365407801|FG001|Overall Study|Study Terminated by Sponsor|33|||
105931737|NCT05330429|365407802|FG002|Overall Study|Study Terminated by Sponsor|12|||
105931738|NCT05330429|365407800|FG000|Overall Study|Death|5|||
105931739|NCT05330429|365407801|FG001|Overall Study|Death|2|||
105931740|NCT05330429|365407802|FG002|Overall Study|Death|4|||
105931741|NCT05330429|365407800|FG000|Overall Study|Withdrew Consent|0|||
105931742|NCT05330429|365407801|FG001|Overall Study|Withdrew Consent|5|||
105931743|NCT05330429|365407802|FG002|Overall Study|Withdrew Consent|4|||
105931744|NCT05330429|365407800|FG000|Overall Study|Investigator's Discretion|0|||
105931745|NCT05330429|365407801|FG001|Overall Study|Investigator's Discretion|1|||
105931746|NCT05330429|365407802|FG002|Overall Study|Investigator's Discretion|3|||
105931747|NCT05330429|365407800|FG000|Overall Study|Subject Decision|1|||
105931748|NCT05330429|365407801|FG001|Overall Study|Subject Decision|2|||
105931749|NCT05330429|365407802|FG002|Overall Study|Subject Decision|0|||
105931750|NCT05330429|365407800|FG000|Overall Study|Lost to Follow-up|0|||
105931751|NCT05330429|365407801|FG001|Overall Study|Lost to Follow-up|1|||
105931752|NCT05330429|365407802|FG002|Overall Study|Lost to Follow-up|0|||
105931753|NCT03022630|365410760|FG000|Overall Study|Death|9|||
105931754|NCT03022630|365410761|FG001|Overall Study|Death|7|||
105931755|NCT03022630|365410760|FG000|Overall Study|Withdrawal by Subject|0|||
105931756|NCT03022630|365410761|FG001|Overall Study|Withdrawal by Subject|5|||
105931757|NCT01797185|365410767|FG000|Overall Study|Adverse Event|5|||
105931758|NCT01797185|365410768|FG001|Overall Study|Adverse Event|15|||
105931759|NCT01797185|365410769|FG002|Overall Study|Adverse Event|6|||
106008632|NCT03597347|365697049|FG001|Overall Study|Withdrawal due to Covid-19|0|||
106008633|NCT03597347|365697050|FG002|Overall Study|Withdrawal due to Covid-19|0|||
106008634|NCT03597347|365697048|FG000|Overall Study|Sponsor decision to terminate study|3|||
106008635|NCT03597347|365697049|FG001|Overall Study|Sponsor decision to terminate study|2|||
106008636|NCT03597347|365697050|FG002|Overall Study|Sponsor decision to terminate study|4|||
106008637|NCT00107653|365697051|FG000|Overall Study|Adverse Event|24|||
106008638|NCT00107653|365697052|FG001|Overall Study|Adverse Event|43|||
106008639|NCT00107653|365697051|FG000|Overall Study|Insufficient Therapeutic Response|25|||
106008640|NCT00107653|365697052|FG001|Overall Study|Insufficient Therapeutic Response|11|||
106008641|NCT00107653|365697051|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
106008642|NCT00107653|365697052|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
106008643|NCT00107653|365697051|FG000|Overall Study|Protocol Violation|1|||
106008644|NCT00107653|365697052|FG001|Overall Study|Protocol Violation|0|||
106008645|NCT00107653|365697051|FG000|Overall Study|Withdrawal by Subject|12|||
105789679|NCT03917654|364883393|FG008|Year 2|Spouse/family member request|0|||
105789680|NCT03917654|364883394|FG009|Year 2|Spouse/family member request|0|||
105789681|NCT03917654|364883395|FG010|Year 2|Spouse/family member request|0|||
105789682|NCT03917654|364883396|FG011|Year 2|Spouse/family member request|0|||
105931760|NCT01797185|365410767|FG000|Overall Study|Withdrawal by Subject|6|||
105931761|NCT01797185|365410768|FG001|Overall Study|Withdrawal by Subject|9|||
105931762|NCT01797185|365410769|FG002|Overall Study|Withdrawal by Subject|5|||
105931763|NCT01797185|365410767|FG000|Overall Study|Site terminated|8|||
105931764|NCT01797185|365410768|FG001|Overall Study|Site terminated|4|||
105931765|NCT01797185|365410769|FG002|Overall Study|Site terminated|0|||
105931766|NCT01797185|365410767|FG000|Overall Study|Lost to Follow-up|2|||
105931767|NCT01797185|365410768|FG001|Overall Study|Lost to Follow-up|6|||
106008646|NCT00107653|365697052|FG001|Overall Study|Withdrawal by Subject|13|||
106008647|NCT00107653|365697051|FG000|Overall Study|Lost to Follow-up|13|||
106008648|NCT00107653|365697052|FG001|Overall Study|Lost to Follow-up|5|||
105715074|NCT00946309|364615694|FG001|Overall Study|Procedure cancelled/discontinued|3|||
105715075|NCT00603915|364615696|FG000|Overall Study|Physician Decision|1|||
105715076|NCT02474329|364615697|FG000|Overall Study|Withdraw or did not contribute data.|13|||
105715077|NCT01356589|364615698|FG000|Overall Study|Enrolled, but not treated|3|||
105715078|NCT01356589|364615698|FG000|Overall Study|Dose data not recorded|2|||
105715079|NCT03110900|364615707|FG000|Overall Study|Sponsor withdrew|1|||
105715080|NCT03110900|364615708|FG001|Overall Study|Sponsor withdrew|1|||
105715081|NCT02307370|364615709|FG000|Overall Study|Death|5|||
105715082|NCT02307370|364615709|FG000|Overall Study|Lost to Follow-up|1|||
105715083|NCT02307370|364615709|FG000|Overall Study|Withdrawal by Subject|1|||
105715084|NCT02307370|364615709|FG000|Overall Study|Declined Addendum ICF|6|||
105715085|NCT02307370|364615709|FG000|Overall Study|No response during telephone contact|5|||
105715086|NCT02307370|364615709|FG000|Overall Study|Protocol Violation|1|||
105715087|NCT03064763|364617476|FG000|Overall Study|Lost to Follow-up|1|||
105715088|NCT03064763|364617476|FG000|Overall Study|Death|8|||
105715089|NCT00403260|364617477|FG000|Overall Study|Adverse Event|5|||
105715090|NCT00403260|364617478|FG001|Overall Study|Adverse Event|4|||
105715091|NCT00403260|364617477|FG000|Overall Study|Withdrawal by Subject|5|||
105715092|NCT00403260|364617478|FG001|Overall Study|Withdrawal by Subject|6|||
105715093|NCT00403260|364617477|FG000|Overall Study|Lost to Follow-up|49|||
105715094|NCT00403260|364617478|FG001|Overall Study|Lost to Follow-up|25|||
105715095|NCT00403260|364617477|FG000|Overall Study|Re-appearance of P. falciparum|34|||
105715096|NCT00403260|364617478|FG001|Overall Study|Re-appearance of P. falciparum|25|||
105715097|NCT00403260|364617477|FG000|Overall Study|P. vivax infection|26|||
105715098|NCT00403260|364617478|FG001|Overall Study|P. vivax infection|4|||
105715099|NCT00403260|364617477|FG000|Overall Study|Mixed infection with P. vivax|2|||
105715100|NCT00403260|364617478|FG001|Overall Study|Mixed infection with P. vivax|0|||
105715101|NCT00403260|364617477|FG000|Overall Study|Mixed infection with P. falciparum|1|||
105715102|NCT00403260|364617478|FG001|Overall Study|Mixed infection with P. falciparum|0|||
105715103|NCT00403260|364617477|FG000|Overall Study|P. vivax infection at screening|1|||
105715104|NCT00403260|364617478|FG001|Overall Study|P. vivax infection at screening|0|||
105715105|NCT00403260|364617477|FG000|Overall Study|P. ovale infection|1|||
105715106|NCT00403260|364617478|FG001|Overall Study|P. ovale infection|0|||
105715107|NCT00403260|364617477|FG000|Overall Study|Gametocyte re-appearance|1|||
105715108|NCT00403260|364617478|FG001|Overall Study|Gametocyte re-appearance|1|||
105715109|NCT00403260|364617477|FG000|Overall Study|Withdrawn from study accidentally|0|||
105715110|NCT00403260|364617478|FG001|Overall Study|Withdrawn from study accidentally|1|||
105715111|NCT00935883|364617481|FG000|Treatment Period|Physician Decision|1|||
105715112|NCT00935883|364617482|FG001|Treatment Period|Physician Decision|0|||
105715113|NCT00935883|364617481|FG000|Treatment Period|Withdrawal by Subject|0|||
105715114|NCT00935883|364617482|FG001|Treatment Period|Withdrawal by Subject|2|||
105789683|NCT03917654|364883385|FG000|Year 2|Lost to Follow-up|0|||
105789684|NCT03917654|364883386|FG001|Year 2|Lost to Follow-up|0|||
105789685|NCT03917654|364883387|FG002|Year 2|Lost to Follow-up|0|||
105789686|NCT03917654|364883388|FG003|Year 2|Lost to Follow-up|0|||
105789687|NCT03917654|364883389|FG004|Year 2|Lost to Follow-up|0|||
105789688|NCT03917654|364883390|FG005|Year 2|Lost to Follow-up|0|||
105789689|NCT03917654|364883391|FG006|Year 2|Lost to Follow-up|1|||
105789690|NCT03917654|364883392|FG007|Year 2|Lost to Follow-up|0|||
105715115|NCT01337973|364617485|FG000|Overall Study|Lost to Follow-up|2|||
105715116|NCT01337973|364617486|FG001|Overall Study|Lost to Follow-up|4|||
105715117|NCT01337973|364617487|FG002|Overall Study|Lost to Follow-up|3|||
105715118|NCT01337973|364617485|FG000|Overall Study|Death|1|||
105715119|NCT01337973|364617486|FG001|Overall Study|Death|2|||
105715120|NCT01337973|364617487|FG002|Overall Study|Death|1|||
105715121|NCT01337973|364617485|FG000|Overall Study|Withdrawal by Subject|10|||
105715122|NCT01337973|364617486|FG001|Overall Study|Withdrawal by Subject|8|||
105715123|NCT01337973|364617487|FG002|Overall Study|Withdrawal by Subject|4|||
105715124|NCT01337973|364617485|FG000|Overall Study|missing data on primary outcome|3|||
105715125|NCT01337973|364617486|FG001|Overall Study|missing data on primary outcome|1|||
105715126|NCT01337973|364617487|FG002|Overall Study|missing data on primary outcome|3|||
105715127|NCT00168831|364617491|FG000|Overall Study|Adverse Event|36|||
105715128|NCT00168831|364617492|FG001|Overall Study|Adverse Event|47|||
105715129|NCT00168831|364617493|FG002|Overall Study|Adverse Event|74|||
105715130|NCT00168831|364617491|FG000|Overall Study|Lost to Follow-up|5|||
105715131|NCT00168831|364617492|FG001|Overall Study|Lost to Follow-up|6|||
105715132|NCT00168831|364617493|FG002|Overall Study|Lost to Follow-up|4|||
105715133|NCT00168831|364617491|FG000|Overall Study|Withdrawal by Subject|7|||
105715134|NCT00168831|364617492|FG001|Overall Study|Withdrawal by Subject|14|||
105715135|NCT00168831|364617493|FG002|Overall Study|Withdrawal by Subject|19|||
105715136|NCT00168831|364617491|FG000|Overall Study|Protocol Violation|6|||
105715137|NCT00168831|364617492|FG001|Overall Study|Protocol Violation|11|||
105715138|NCT00168831|364617493|FG002|Overall Study|Protocol Violation|11|||
105715139|NCT00168831|364617491|FG000|Overall Study|Other|6|||
105715140|NCT00168831|364617492|FG001|Overall Study|Other|3|||
105715141|NCT00168831|364617493|FG002|Overall Study|Other|6|||
105789691|NCT03917654|364883393|FG008|Year 2|Lost to Follow-up|1|||
105789692|NCT03917654|364883394|FG009|Year 2|Lost to Follow-up|0|||
105789693|NCT03917654|364883395|FG010|Year 2|Lost to Follow-up|0|||
105931768|NCT01797185|365410769|FG002|Overall Study|Lost to Follow-up|1|||
105931769|NCT01797185|365410767|FG000|Overall Study|Withdrawn per sponsor|5|||
105931770|NCT01797185|365410768|FG001|Overall Study|Withdrawn per sponsor|0|||
105931771|NCT01797185|365410769|FG002|Overall Study|Withdrawn per sponsor|0|||
105931772|NCT01797185|365410767|FG000|Overall Study|Physician Decision|1|||
105931773|NCT01797185|365410768|FG001|Overall Study|Physician Decision|3|||
105931774|NCT01797185|365410769|FG002|Overall Study|Physician Decision|0|||
105931775|NCT01797185|365410767|FG000|Overall Study|Protocol Violation|1|||
105931776|NCT01797185|365410768|FG001|Overall Study|Protocol Violation|1|||
105931777|NCT01797185|365410769|FG002|Overall Study|Protocol Violation|0|||
105931778|NCT01778985|365410770|FG000|Overall Study|Lost to Follow-up|1|||
105931779|NCT01778985|365410771|FG001|Overall Study|Lost to Follow-up|0|||
105931780|NCT01778985|365410770|FG000|Overall Study|Physician Decision|2|||
105931781|NCT01778985|365410771|FG001|Overall Study|Physician Decision|2|||
105931782|NCT01778985|365410770|FG000|Overall Study|Protocol Violation|4|||
105931783|NCT01778985|365410771|FG001|Overall Study|Protocol Violation|1|||
105931784|NCT00723944|365410772|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
105931785|NCT00723944|365410773|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
105931786|NCT00723944|365410772|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
105931787|NCT00723944|365410773|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
105931788|NCT00723944|365410772|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
105931789|NCT00723944|365410773|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
105931790|NCT00456612|365410780|FG000|Overall Study|Withdrawal by Subject|3|||
105931791|NCT03520569|365410781|FG000|Overall Study|Withdrawal by Subject|1|||
105931792|NCT01471574|365410782|FG000|Treatment Period|Lack of Efficacy|12|||
105931793|NCT01471574|365410783|FG001|Treatment Period|Lack of Efficacy|4|||
105931794|NCT01471574|365410784|FG002|Treatment Period|Lack of Efficacy|14|||
105931795|NCT01471574|365410785|FG003|Treatment Period|Lack of Efficacy|1|||
106136392|NCT01981850|366157950|FG008|Main Phase Stage 1|Various reasons|0|||
106136393|NCT01981850|366157951|FG009|Main Phase Stage 1|Various reasons|0|||
106136394|NCT01981850|366157942|FG000|Main Phase Stage 2|Adverse Event|0|||
106136395|NCT01981850|366157943|FG001|Main Phase Stage 2|Adverse Event|0|||
106136396|NCT01981850|366157944|FG002|Main Phase Stage 2|Adverse Event|0|||
106136397|NCT01981850|366157945|FG003|Main Phase Stage 2|Adverse Event|0|||
105715142|NCT01505894|364617495|FG000|Overall Study|Adverse Event|1|||
105715143|NCT01505894|364617496|FG001|Overall Study|Adverse Event|0|||
105931796|NCT01471574|365410782|FG000|Treatment Period|Adverse Event|7|||
105931797|NCT01471574|365410783|FG001|Treatment Period|Adverse Event|3|||
105931798|NCT01471574|365410784|FG002|Treatment Period|Adverse Event|6|||
105931799|NCT01471574|365410785|FG003|Treatment Period|Adverse Event|1|||
105931800|NCT01471574|365410782|FG000|Treatment Period|Withdrawal by Subject|5|||
106136398|NCT01981850|366157946|FG004|Main Phase Stage 2|Adverse Event|6|||
106136399|NCT01981850|366157947|FG005|Main Phase Stage 2|Adverse Event|5|||
106136400|NCT01981850|366157948|FG006|Main Phase Stage 2|Adverse Event|7|||
106136401|NCT01981850|366157949|FG007|Main Phase Stage 2|Adverse Event|0|||
106136402|NCT01981850|366157950|FG008|Main Phase Stage 2|Adverse Event|0|||
106136403|NCT01981850|366157951|FG009|Main Phase Stage 2|Adverse Event|0|||
106136404|NCT01981850|366157942|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
106136405|NCT01981850|366157943|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
106136406|NCT01981850|366157944|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
106136407|NCT01981850|366157945|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
106136408|NCT01981850|366157946|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
106136409|NCT01981850|366157947|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
106136410|NCT01981850|366157948|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
106136411|NCT01981850|366157949|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
106136412|NCT01981850|366157950|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
105715144|NCT01505894|364617497|FG002|Overall Study|Adverse Event|0|||
105715145|NCT01505894|364617498|FG003|Overall Study|Adverse Event|0|||
106136413|NCT01981850|366157951|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
106136414|NCT01981850|366157942|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
106136415|NCT01981850|366157943|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
105931801|NCT01471574|365410783|FG001|Treatment Period|Withdrawal by Subject|1|||
105931802|NCT01471574|365410784|FG002|Treatment Period|Withdrawal by Subject|1|||
106136416|NCT01981850|366157944|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
105715146|NCT01505894|364617499|FG004|Overall Study|Adverse Event|0|||
105715147|NCT01505894|364617500|FG005|Overall Study|Adverse Event|0|||
105715148|NCT01505894|364617501|FG006|Overall Study|Adverse Event|0|||
105715149|NCT01505894|364617502|FG007|Overall Study|Adverse Event|0|||
105715150|NCT01505894|364617503|FG008|Overall Study|Adverse Event|0|||
105715151|NCT01505894|364617495|FG000|Overall Study|Other than specified|0|||
105715152|NCT01505894|364617496|FG001|Overall Study|Other than specified|0|||
105715153|NCT01505894|364617497|FG002|Overall Study|Other than specified|0|||
105715154|NCT01505894|364617498|FG003|Overall Study|Other than specified|0|||
105715155|NCT01505894|364617499|FG004|Overall Study|Other than specified|1|||
105715156|NCT01505894|364617500|FG005|Overall Study|Other than specified|0|||
105715157|NCT01505894|364617501|FG006|Overall Study|Other than specified|0|||
105715158|NCT01505894|364617502|FG007|Overall Study|Other than specified|0|||
105715159|NCT01505894|364617503|FG008|Overall Study|Other than specified|0|||
105715160|NCT02009878|364617504|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
105715161|NCT02009878|364617505|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
105715162|NCT02009878|364617506|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
105715163|NCT03823391|364617507|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
105715164|NCT03823391|364617508|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
105715165|NCT03823391|364617507|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
105715166|NCT03823391|364617508|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
105715167|NCT04269395|364617510|FG000|Overall Study|Lost to Follow-up|1|||
105715168|NCT04269395|364617511|FG001|Overall Study|Lost to Follow-up|0|||
105715169|NCT04269395|364617510|FG000|Overall Study|Study terminated by Sponsor|13|||
105715170|NCT04269395|364617511|FG001|Overall Study|Study terminated by Sponsor|10|||
105715171|NCT00584233|364617512|FG000|Overall Study|Withdrawal by Subject|5|||
105715172|NCT00584233|364617512|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
105715173|NCT02222714|364617513|FG000|Overall Study|Death|0|||
105715174|NCT02222714|364617514|FG001|Overall Study|Death|2|||
105715175|NCT02222714|364617515|FG002|Overall Study|Death|3|||
105715176|NCT02222714|364617516|FG003|Overall Study|Death|4|||
105715177|NCT02222714|364617517|FG004|Overall Study|Death|6|||
105715178|NCT02222714|364617513|FG000|Overall Study|Withdrawal by Subject|0|||
105715179|NCT02222714|364617514|FG001|Overall Study|Withdrawal by Subject|0|||
105715180|NCT02222714|364617515|FG002|Overall Study|Withdrawal by Subject|1|||
105715181|NCT02222714|364617516|FG003|Overall Study|Withdrawal by Subject|0|||
105715182|NCT02222714|364617517|FG004|Overall Study|Withdrawal by Subject|1|||
105715183|NCT01940484|364617519|FG000|Overall Study|Withdrawal by Subject|3|||
105715184|NCT01940484|364617519|FG000|Overall Study|Underwent transplantation|4|||
105715185|NCT01940484|364617519|FG000|Overall Study|Death|2|||
105715186|NCT01940484|364617519|FG000|Overall Study|Adverse Event|1|||
105715187|NCT02658448|364617520|FG000|Overall Study|Lost to Follow-up|1|||
105715188|NCT03106779|364617521|FG000|Overall Study|Lack of Efficacy|33|||
105715189|NCT03106779|364617522|FG001|Overall Study|Lack of Efficacy|24|||
105715190|NCT03106779|364617521|FG000|Overall Study|Adverse Event|8|||
105715191|NCT03106779|364617522|FG001|Overall Study|Adverse Event|16|||
105715192|NCT03106779|364617521|FG000|Overall Study|Physician Decision|10|||
105715193|NCT03106779|364617522|FG001|Overall Study|Physician Decision|6|||
105715194|NCT03106779|364617521|FG000|Overall Study|Patient/guardian decision|4|||
105715195|NCT03106779|364617522|FG001|Overall Study|Patient/guardian decision|3|||
105715196|NCT03106779|364617521|FG000|Overall Study|Progressive disease|1|||
105715197|NCT03106779|364617522|FG001|Overall Study|Progressive disease|3|||
105715198|NCT03106779|364617521|FG000|Overall Study|Lost to Follow-up|1|||
105715199|NCT03106779|364617522|FG001|Overall Study|Lost to Follow-up|2|||
105715200|NCT03106779|364617521|FG000|Overall Study|Death|1|||
105715201|NCT03106779|364617522|FG001|Overall Study|Death|0|||
105715202|NCT03106779|364617521|FG000|Overall Study|Protocol Violation|1|||
105715203|NCT03106779|364617522|FG001|Overall Study|Protocol Violation|0|||
105715204|NCT03106779|364617521|FG000|Overall Study|Not treated|1|||
105715205|NCT03106779|364617522|FG001|Overall Study|Not treated|0|||
105715206|NCT01604512|364617523|FG000|Overall Study|Withdrawal by Subject|3|||
105715207|NCT01604512|364617523|FG000|Overall Study|Not treated|4|||
105715208|NCT05030311|364617524|FG000|Overall Study|Technical problems|0|||
105715209|NCT05030311|364617525|FG001|Overall Study|Technical problems|1|||
105715210|NCT05030311|364617524|FG000|Overall Study|Withdrawal by Subject|31|||
105715211|NCT05030311|364617525|FG001|Overall Study|Withdrawal by Subject|17|||
105715212|NCT05030311|364617524|FG000|Overall Study|Adverse Event|13|||
105715213|NCT05030311|364617525|FG001|Overall Study|Adverse Event|5|||
105715214|NCT05030311|364617524|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105715215|NCT05030311|364617525|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105715216|NCT05030311|364617524|FG000|Overall Study|Physician Decision|5|||
105715217|NCT05030311|364617525|FG001|Overall Study|Physician Decision|2|||
105715218|NCT05030311|364617524|FG000|Overall Study|Lost to Follow-up|5|||
105715219|NCT05030311|364617525|FG001|Overall Study|Lost to Follow-up|1|||
105715220|NCT05030311|364617524|FG000|Overall Study|Protocol Violation|4|||
105715221|NCT05030311|364617525|FG001|Overall Study|Protocol Violation|4|||
105715222|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
105715223|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
105715224|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
105715225|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
105715226|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
105715227|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
105715228|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
105715229|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
105715230|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
105715231|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
105715232|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
105715233|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
105715234|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
105715235|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
105715236|NCT02288247|364617526|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
105715237|NCT02288247|364617527|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
105715238|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
105715239|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
105715240|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
105715241|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
105715242|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
105715243|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
105715244|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
105715245|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
105715246|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
105715247|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
105715248|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
105715249|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
105715250|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
105715251|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
105715252|NCT02288247|364617526|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
105715253|NCT02288247|364617527|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
105715254|NCT04652804|364617528|FG000|Overall Study|Ineligible post randomization|1|||
105715255|NCT04652804|364617529|FG001|Overall Study|Ineligible post randomization|0|||
105715256|NCT04652804|364617530|FG002|Overall Study|Ineligible post randomization|1|||
105715257|NCT04652804|364617531|FG003|Overall Study|Ineligible post randomization|0|||
105715258|NCT04652804|364617532|FG004|Overall Study|Ineligible post randomization|1|||
105715259|NCT04652804|364617533|FG005|Overall Study|Ineligible post randomization|1|||
105715260|NCT04652804|364617528|FG000|Overall Study|Missing SVR lab results|2|||
105715261|NCT04652804|364617529|FG001|Overall Study|Missing SVR lab results|0|||
105715262|NCT04652804|364617530|FG002|Overall Study|Missing SVR lab results|0|||
105715263|NCT04652804|364617531|FG003|Overall Study|Missing SVR lab results|0|||
105715264|NCT04652804|364617532|FG004|Overall Study|Missing SVR lab results|0|||
105715265|NCT04652804|364617533|FG005|Overall Study|Missing SVR lab results|0|||
105715266|NCT04093531|364617534|FG000|Overall Study|failed screening|4|||
105715267|NCT01764633|364617535|FG000|Overall Study|Withdrawal by Subject|105|||
105715268|NCT01764633|364617536|FG001|Overall Study|Withdrawal by Subject|88|||
105715269|NCT01764633|364617535|FG000|Overall Study|Lost to Follow-up|13|||
105715270|NCT01764633|364617536|FG001|Overall Study|Lost to Follow-up|5|||
105715271|NCT00704964|364617537|FG000|Overall Study|Not completed on time|328|||
105715272|NCT02217566|364617540|FG000|Overall Study|Lost to Follow-up|2|||
105715273|NCT02217566|364617540|FG000|Overall Study|Death|3|||
105715274|NCT02217566|364617540|FG000|Overall Study|Early study termination|6|||
105715275|NCT00364689|364617541|FG000|Overall Study|Lost to Follow-up|1|||
105715276|NCT00684957|364617546|FG000|Overall Study|Withdrawal by Subject|1|||
105715277|NCT00684957|364617547|FG001|Overall Study|Withdrawal by Subject|1|||
105715278|NCT00684957|364617546|FG000|Overall Study|Lost to Follow-up|1|||
105715279|NCT00684957|364617547|FG001|Overall Study|Lost to Follow-up|0|||
105715280|NCT00191451|364617548|FG000|Overall Study|Withdrawal by Subject|2|||
105715281|NCT00191451|364617549|FG001|Overall Study|Withdrawal by Subject|3|||
105931803|NCT01471574|365410785|FG003|Treatment Period|Withdrawal by Subject|0|||
105931804|NCT01471574|365410782|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
105931805|NCT01471574|365410783|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
105931806|NCT01471574|365410784|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
105715282|NCT00191451|364617550|FG002|Overall Study|Withdrawal by Subject|5|||
105715283|NCT00191451|364617548|FG000|Overall Study|Physician Decision|2|||
105715284|NCT00191451|364617549|FG001|Overall Study|Physician Decision|9|||
105931807|NCT01471574|365410785|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
105931808|NCT01471574|365410782|FG000|Treatment Period|Lost to Follow-up|1|||
105715285|NCT00191451|364617550|FG002|Overall Study|Physician Decision|6|||
105931809|NCT01471574|365410783|FG001|Treatment Period|Lost to Follow-up|2|||
105931810|NCT01471574|365410784|FG002|Treatment Period|Lost to Follow-up|2|||
105715286|NCT00191451|364617548|FG000|Overall Study|Sponsor Decision|1|||
105715287|NCT00191451|364617549|FG001|Overall Study|Sponsor Decision|0|||
105715288|NCT00191451|364617550|FG002|Overall Study|Sponsor Decision|0|||
105715289|NCT00191451|364617548|FG000|Overall Study|Ineligible|0|||
105715290|NCT00191451|364617549|FG001|Overall Study|Ineligible|1|||
105715291|NCT00191451|364617550|FG002|Overall Study|Ineligible|0|||
105715292|NCT00191451|364617548|FG000|Overall Study|Reason Not Specified|2|||
105715293|NCT00191451|364617549|FG001|Overall Study|Reason Not Specified|1|||
105715294|NCT00191451|364617550|FG002|Overall Study|Reason Not Specified|3|||
105715295|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
105715296|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
105715297|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
105715298|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
105715299|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
105715300|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
105715301|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
105715302|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
105715303|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
105715304|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
105715305|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
105715306|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
105715307|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
105715308|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
105715309|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
105715310|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
105715311|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
105715312|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
105715313|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
105715314|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
105715315|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
105715316|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
105715317|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
105715318|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
105715319|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Death|2|||
105715320|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Death|1|||
105715321|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Death|2|||
105715322|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Graft loss|0|||
105715323|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Graft loss|2|||
105715324|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Graft loss|0|||
105715325|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
105715326|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
105715327|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
105715328|NCT01114529|364617551|FG000|Completed Study Medication at Month 24|Missing|2|||
105715329|NCT01114529|364617552|FG001|Completed Study Medication at Month 24|Missing|0|||
105715330|NCT01114529|364617553|FG002|Completed Study Medication at Month 24|Missing|0|||
105715331|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
105715332|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
105715333|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
105715334|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
105715335|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
105715336|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
105715337|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Death|8|||
105715338|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Death|5|||
105715339|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Death|4|||
105715340|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Other|2|||
105715341|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Other|0|||
105715342|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Other|0|||
105715343|NCT01114529|364617551|FG000|Completed Study Phase at Month 24|Missing|2|||
105715344|NCT01114529|364617552|FG001|Completed Study Phase at Month 24|Missing|0|||
105715345|NCT01114529|364617553|FG002|Completed Study Phase at Month 24|Missing|0|||
105715346|NCT00331409|364617557|FG000|Overall Study|Lack of Efficacy|4|||
105715347|NCT04428411|364617558|FG000|Overall Study|Lost to Follow-up|114|||
105715348|NCT00634569|364617559|FG000|Overall Study|Withdrawal by Subject|0|||
105715349|NCT00634569|364617560|FG001|Overall Study|Withdrawal by Subject|4|||
105715350|NCT00634569|364617559|FG000|Overall Study|Physician Decision|0|||
105715351|NCT00634569|364617560|FG001|Overall Study|Physician Decision|1|||
105715352|NCT01163786|364617561|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
105715353|NCT01163786|364617561|FG000|Treatment With Bortezomib|Adverse Event|2|||
105715354|NCT01163786|364617561|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
105715355|NCT01212185|364617563|FG000|Overall Study|Protocol Violation|2|||
105715356|NCT01212185|364617564|FG001|Overall Study|Protocol Violation|1|||
105715357|NCT02614079|364617565|FG000|Overall Study|Withdrawal by Subject|1|||
105715358|NCT03555266|364617566|FG000|Overall Study|Protocol Violation|6|||
105715359|NCT03555266|364617567|FG001|Overall Study|Protocol Violation|4|||
105715360|NCT00132730|364617571|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
105715361|NCT00132730|364617572|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
105715362|NCT00132730|364617573|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
105715363|NCT00132730|364617574|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
105715364|NCT00132730|364617575|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
105715365|NCT00132730|364617576|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
105715366|NCT00132730|364617571|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
105715367|NCT00132730|364617572|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
105789694|NCT03917654|364883396|FG011|Year 2|Lost to Follow-up|1|||
105931811|NCT01471574|365410785|FG003|Treatment Period|Lost to Follow-up|0|||
105931812|NCT01471574|365410782|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
105931813|NCT01471574|365410783|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
105931814|NCT01471574|365410784|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
105931815|NCT01471574|365410785|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
105931816|NCT01471574|365410782|FG000|Treatment Period|Other|1|||
105931817|NCT01471574|365410783|FG001|Treatment Period|Other|0|||
105931818|NCT01471574|365410784|FG002|Treatment Period|Other|0|||
105931819|NCT01471574|365410785|FG003|Treatment Period|Other|0|||
105931820|NCT01471574|365410782|FG000|Follow-up Period|Withdrawal by Subject|3|||
105931821|NCT01471574|365410783|FG001|Follow-up Period|Withdrawal by Subject|0|||
105931822|NCT01471574|365410784|FG002|Follow-up Period|Withdrawal by Subject|3|||
105931823|NCT01471574|365410785|FG003|Follow-up Period|Withdrawal by Subject|1|||
105931824|NCT01471574|365410782|FG000|Follow-up Period|Lost to Follow-up|4|||
105931825|NCT01471574|365410783|FG001|Follow-up Period|Lost to Follow-up|1|||
105931826|NCT01471574|365410784|FG002|Follow-up Period|Lost to Follow-up|3|||
105931827|NCT01471574|365410785|FG003|Follow-up Period|Lost to Follow-up|2|||
105931828|NCT01471574|365410782|FG000|Follow-up Period|Death|0|||
105931829|NCT01471574|365410783|FG001|Follow-up Period|Death|0|||
105931830|NCT01471574|365410784|FG002|Follow-up Period|Death|1|||
105931831|NCT01471574|365410785|FG003|Follow-up Period|Death|0|||
105931832|NCT01471574|365410782|FG000|Follow-up Period|Follow-up no longer required|0|||
105931833|NCT01471574|365410783|FG001|Follow-up Period|Follow-up no longer required|1|||
105931834|NCT01471574|365410784|FG002|Follow-up Period|Follow-up no longer required|0|||
105931835|NCT01471574|365410785|FG003|Follow-up Period|Follow-up no longer required|0|||
105931836|NCT01783015|365410786|FG000|Blinded Treatment|Adverse Event|0|||
105931837|NCT01783015|365410787|FG001|Blinded Treatment|Adverse Event|1|||
105931838|NCT01783015|365410788|FG002|Blinded Treatment|Adverse Event|0|||
105931839|NCT01783015|365410786|FG000|Blinded Treatment|Protocol Violation|0|||
105931840|NCT01783015|365410787|FG001|Blinded Treatment|Protocol Violation|1|||
105931841|NCT01783015|365410788|FG002|Blinded Treatment|Protocol Violation|0|||
105931842|NCT01783015|365410786|FG000|Blinded Treatment|Withdrawal by Subject|0|||
105931843|NCT01783015|365410787|FG001|Blinded Treatment|Withdrawal by Subject|1|||
105931844|NCT01783015|365410788|FG002|Blinded Treatment|Withdrawal by Subject|0|||
105931845|NCT01783015|365410786|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
105931846|NCT01783015|365410787|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
105931847|NCT01783015|365410788|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
105931848|NCT01783015|365410786|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
105789695|NCT03917654|364883385|FG000|Year 2|Adverse Event|0|||
105789696|NCT03917654|364883386|FG001|Year 2|Adverse Event|0|||
105789697|NCT03917654|364883387|FG002|Year 2|Adverse Event|0|||
105789698|NCT03917654|364883388|FG003|Year 2|Adverse Event|0|||
105789699|NCT03917654|364883389|FG004|Year 2|Adverse Event|0|||
105789700|NCT03917654|364883390|FG005|Year 2|Adverse Event|0|||
105789701|NCT03917654|364883391|FG006|Year 2|Adverse Event|0|||
105789702|NCT03917654|364883392|FG007|Year 2|Adverse Event|0|||
105789703|NCT03917654|364883393|FG008|Year 2|Adverse Event|0|||
105789704|NCT03917654|364883394|FG009|Year 2|Adverse Event|1|||
105789705|NCT03917654|364883395|FG010|Year 2|Adverse Event|0|||
105789706|NCT03917654|364883396|FG011|Year 2|Adverse Event|0|||
105789707|NCT00905437|364883398|FG000|Overall Study|Adverse Event|3|||
105931849|NCT01783015|365410787|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
105931850|NCT01783015|365410788|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
105931851|NCT01562444|365410790|FG000|Overall Study|Did not meet entry criteria|2|||
105931852|NCT01562444|365410791|FG001|Overall Study|Did not meet entry criteria|0|||
105931853|NCT01562444|365410792|FG002|Overall Study|Did not meet entry criteria|3|||
105931854|NCT01562444|365410790|FG000|Overall Study|Did not comply with blood draw schedule|1|||
105931855|NCT01562444|365410791|FG001|Overall Study|Did not comply with blood draw schedule|0|||
105931856|NCT01562444|365410792|FG002|Overall Study|Did not comply with blood draw schedule|1|||
105931857|NCT01562444|365410790|FG000|Overall Study|Unavailable serological results|0|||
105931858|NCT01562444|365410791|FG001|Overall Study|Unavailable serological results|2|||
105715368|NCT00132730|364617573|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
105715369|NCT00132730|364617574|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
105715370|NCT00132730|364617575|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
105715371|NCT00132730|364617576|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
106136417|NCT01981850|366157945|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
106136418|NCT01981850|366157946|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
106136419|NCT01981850|366157947|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
106136420|NCT01981850|366157948|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
106136421|NCT01981850|366157949|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
106136422|NCT01981850|366157950|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
106136423|NCT01981850|366157951|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
106136424|NCT01981850|366157942|FG000|Main Phase Stage 2|Various reasons|0|||
105715372|NCT00132730|364617571|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
105715373|NCT00132730|364617572|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
105715374|NCT00132730|364617573|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
105715375|NCT00132730|364617574|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
105715376|NCT00132730|364617575|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
105715377|NCT00132730|364617576|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
105715378|NCT00132730|364617571|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
105715379|NCT00132730|364617572|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
105715380|NCT00132730|364617573|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
105715381|NCT00132730|364617574|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
105715382|NCT00132730|364617575|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
105715383|NCT00132730|364617576|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
105715384|NCT00132730|364617571|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
105715385|NCT00132730|364617572|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
105715386|NCT00132730|364617573|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
105715387|NCT00132730|364617574|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
105715388|NCT00132730|364617575|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
105715389|NCT00132730|364617576|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
105715390|NCT00132730|364617571|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715391|NCT00132730|364617572|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715392|NCT00132730|364617573|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715393|NCT00132730|364617574|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
105715394|NCT00132730|364617575|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715395|NCT00132730|364617576|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
105715396|NCT00132730|364617571|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
105715397|NCT00132730|364617572|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
105715398|NCT00132730|364617573|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
105715399|NCT00132730|364617574|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
105715400|NCT00132730|364617575|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
105715401|NCT00132730|364617576|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
105715402|NCT00132730|364617571|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
105715403|NCT00132730|364617572|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
105715404|NCT00132730|364617573|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
105715405|NCT00132730|364617574|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
105715406|NCT00132730|364617575|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
105931859|NCT01562444|365410792|FG002|Overall Study|Unavailable serological results|2|||
105931860|NCT01562444|365410790|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
105931861|NCT01562444|365410791|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
105931862|NCT01562444|365410792|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
105931863|NCT01562444|365410790|FG000|Overall Study|Protocol forbidden medication|1|||
105931864|NCT01562444|365410791|FG001|Overall Study|Protocol forbidden medication|0|||
105931865|NCT01562444|365410792|FG002|Overall Study|Protocol forbidden medication|0|||
105931866|NCT04602000|365410793|FG000|Overall Study|Withdrawal by Subject|3|||
105931867|NCT04602000|365410794|FG001|Overall Study|Withdrawal by Subject|6|||
105931868|NCT04602000|365410795|FG002|Overall Study|Withdrawal by Subject|3|||
105931869|NCT04602000|365410796|FG003|Overall Study|Withdrawal by Subject|27|||
105931870|NCT04602000|365410797|FG004|Overall Study|Withdrawal by Subject|39|||
105931871|NCT04602000|365410793|FG000|Overall Study|Physician Decision|1|||
105931872|NCT04602000|365410794|FG001|Overall Study|Physician Decision|0|||
105931873|NCT04602000|365410795|FG002|Overall Study|Physician Decision|0|||
105715407|NCT00132730|364617576|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
105789708|NCT00905437|364883399|FG001|Overall Study|Adverse Event|2|||
105931874|NCT04602000|365410796|FG003|Overall Study|Physician Decision|2|||
105931875|NCT04602000|365410797|FG004|Overall Study|Physician Decision|2|||
106136425|NCT01981850|366157943|FG001|Main Phase Stage 2|Various reasons|0|||
106136426|NCT01981850|366157944|FG002|Main Phase Stage 2|Various reasons|0|||
106136427|NCT01981850|366157945|FG003|Main Phase Stage 2|Various reasons|0|||
106136428|NCT01981850|366157946|FG004|Main Phase Stage 2|Various reasons|2|||
106136429|NCT01981850|366157947|FG005|Main Phase Stage 2|Various reasons|0|||
106136430|NCT01981850|366157948|FG006|Main Phase Stage 2|Various reasons|1|||
106136431|NCT01981850|366157949|FG007|Main Phase Stage 2|Various reasons|0|||
106136432|NCT01981850|366157950|FG008|Main Phase Stage 2|Various reasons|0|||
106136433|NCT01981850|366157951|FG009|Main Phase Stage 2|Various reasons|0|||
106136434|NCT01981850|366157942|FG000|Main Phase Stage 2|Progressive Disease|0|||
106136435|NCT01981850|366157943|FG001|Main Phase Stage 2|Progressive Disease|0|||
106136436|NCT01981850|366157944|FG002|Main Phase Stage 2|Progressive Disease|0|||
105715408|NCT00132730|364617571|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715409|NCT00132730|364617572|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715410|NCT00132730|364617573|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715411|NCT00132730|364617574|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715412|NCT00132730|364617575|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
105715413|NCT00132730|364617576|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
105715414|NCT00132730|364617571|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715415|NCT00132730|364617572|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715416|NCT00132730|364617573|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715417|NCT00132730|364617574|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715418|NCT00132730|364617575|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
105715419|NCT00132730|364617576|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
105715420|NCT00132730|364617571|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105715421|NCT00132730|364617572|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105715422|NCT00132730|364617573|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105789709|NCT00905437|364883398|FG000|Overall Study|Lost to Follow-up|0|||
105931876|NCT04602000|365410793|FG000|Overall Study|Death|0|||
105931877|NCT04602000|365410794|FG001|Overall Study|Death|1|||
105931878|NCT04602000|365410795|FG002|Overall Study|Death|0|||
105931879|NCT04602000|365410796|FG003|Overall Study|Death|1|||
105931880|NCT04602000|365410797|FG004|Overall Study|Death|2|||
105931881|NCT04602000|365410793|FG000|Overall Study|Lost to Follow-up|0|||
105931882|NCT04602000|365410794|FG001|Overall Study|Lost to Follow-up|0|||
105931883|NCT04602000|365410795|FG002|Overall Study|Lost to Follow-up|0|||
106136437|NCT01981850|366157945|FG003|Main Phase Stage 2|Progressive Disease|0|||
106136438|NCT01981850|366157946|FG004|Main Phase Stage 2|Progressive Disease|0|||
106136439|NCT01981850|366157947|FG005|Main Phase Stage 2|Progressive Disease|6|||
106136440|NCT01981850|366157948|FG006|Main Phase Stage 2|Progressive Disease|6|||
106136441|NCT01981850|366157949|FG007|Main Phase Stage 2|Progressive Disease|0|||
106136442|NCT01981850|366157950|FG008|Main Phase Stage 2|Progressive Disease|0|||
106136443|NCT01981850|366157951|FG009|Main Phase Stage 2|Progressive Disease|0|||
106136444|NCT01981850|366157942|FG000|Open Label Extension (OLE)|Adverse Event|0|||
106136445|NCT01981850|366157943|FG001|Open Label Extension (OLE)|Adverse Event|0|||
106136446|NCT01981850|366157944|FG002|Open Label Extension (OLE)|Adverse Event|0|||
106136447|NCT01981850|366157945|FG003|Open Label Extension (OLE)|Adverse Event|0|||
106136448|NCT01981850|366157946|FG004|Open Label Extension (OLE)|Adverse Event|0|||
106136449|NCT01981850|366157947|FG005|Open Label Extension (OLE)|Adverse Event|0|||
106136450|NCT01981850|366157948|FG006|Open Label Extension (OLE)|Adverse Event|0|||
106136451|NCT01981850|366157949|FG007|Open Label Extension (OLE)|Adverse Event|2|||
106136452|NCT01981850|366157950|FG008|Open Label Extension (OLE)|Adverse Event|1|||
106136453|NCT01981850|366157951|FG009|Open Label Extension (OLE)|Adverse Event|8|||
105715423|NCT00132730|364617574|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105715424|NCT00132730|364617575|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
105715425|NCT00132730|364617576|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
105931884|NCT04602000|365410796|FG003|Overall Study|Lost to Follow-up|3|||
105931885|NCT04602000|365410797|FG004|Overall Study|Lost to Follow-up|4|||
105931886|NCT04602000|365410793|FG000|Overall Study|Other|4|||
105931887|NCT04602000|365410794|FG001|Overall Study|Other|1|||
105931888|NCT04602000|365410795|FG002|Overall Study|Other|2|||
106136454|NCT01981850|366157942|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
105789710|NCT00905437|364883399|FG001|Overall Study|Lost to Follow-up|1|||
105931889|NCT04602000|365410796|FG003|Overall Study|Other|5|||
106136455|NCT01981850|366157943|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
106136456|NCT01981850|366157944|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
106136457|NCT01981850|366157945|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
106136458|NCT01981850|366157946|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
106136459|NCT01981850|366157947|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
105931890|NCT04602000|365410797|FG004|Overall Study|Other|4|||
105931891|NCT04602000|365410793|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
105931892|NCT04602000|365410794|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
106136460|NCT01981850|366157948|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
106136461|NCT01981850|366157949|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
106136462|NCT01981850|366157950|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
106136463|NCT01981850|366157951|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
106136464|NCT01981850|366157942|FG000|Open Label Extension (OLE)|Various reasons|0|||
105715426|NCT00132730|364617571|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
105715427|NCT00132730|364617572|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
105789711|NCT00905437|364883398|FG000|Overall Study|Withdrawal by Subject|0|||
105789712|NCT00905437|364883399|FG001|Overall Study|Withdrawal by Subject|1|||
105789713|NCT00905437|364883398|FG000|Overall Study|Other|5|||
105789714|NCT00905437|364883399|FG001|Overall Study|Other|6|||
105789715|NCT00903409|364883400|FG000|Overall Study|Adverse Event|11|||
105789716|NCT00903409|364883401|FG001|Overall Study|Adverse Event|9|||
105789717|NCT00903409|364883400|FG000|Overall Study|Non-compliance with Protocol|1|||
105789718|NCT00903409|364883401|FG001|Overall Study|Non-compliance with Protocol|1|||
105789719|NCT00903409|364883400|FG000|Overall Study|Laboratory Abnormality|2|||
105789720|NCT00903409|364883401|FG001|Overall Study|Laboratory Abnormality|0|||
105715428|NCT00132730|364617573|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
105715429|NCT00132730|364617574|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
105715430|NCT00132730|364617575|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
105715431|NCT00132730|364617576|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
105715432|NCT00090545|364617580|FG000|Overall Study|Disease progression on study|21|||
105715433|NCT00090545|364617581|FG001|Overall Study|Disease progression on study|17|||
105715434|NCT00090545|364617580|FG000|Overall Study|Refused further treatment|1|||
105715435|NCT00090545|364617581|FG001|Overall Study|Refused further treatment|4|||
105715436|NCT00090545|364617580|FG000|Overall Study|Death|0|||
105715437|NCT00090545|364617581|FG001|Overall Study|Death|1|||
105715438|NCT00090545|364617580|FG000|Overall Study|Adverse Event|0|||
105715439|NCT00090545|364617581|FG001|Overall Study|Adverse Event|2|||
105715440|NCT00441545|364617582|FG000|First Intervention|Adverse Event|6|||
105715441|NCT00441545|364617583|FG001|First Intervention|Adverse Event|5|||
105715442|NCT00441545|364617582|FG000|First Intervention|Protocol Violation|2|||
105715443|NCT00441545|364617583|FG001|First Intervention|Protocol Violation|2|||
105715444|NCT00441545|364617582|FG000|First Intervention|Withdrawal by Subject|3|||
105715445|NCT00441545|364617583|FG001|First Intervention|Withdrawal by Subject|3|||
105715446|NCT00441545|364617582|FG000|First Intervention|Kidney transplant|1|||
105715447|NCT00441545|364617583|FG001|First Intervention|Kidney transplant|1|||
105715448|NCT00441545|364617582|FG000|First Intervention|Lack of Efficacy|2|||
105715449|NCT00441545|364617583|FG001|First Intervention|Lack of Efficacy|0|||
105715450|NCT00441545|364617582|FG000|First Intervention|Subject exceeded safety criteria|0|||
105715451|NCT00441545|364617583|FG001|First Intervention|Subject exceeded safety criteria|1|||
105715452|NCT00441545|364617582|FG000|First Intervention|Subject met an exclusionary criteria|1|||
105715453|NCT00441545|364617583|FG001|First Intervention|Subject met an exclusionary criteria|0|||
105715454|NCT00441545|364617582|FG000|First Intervention|Extended hospitalization|1|||
105715455|NCT00441545|364617583|FG001|First Intervention|Extended hospitalization|0|||
105715456|NCT00441545|364617582|FG000|First Intervention|Site error|1|||
105715457|NCT00441545|364617583|FG001|First Intervention|Site error|0|||
105715458|NCT00441545|364617582|FG000|First Intervention|Sponsor's request|1|||
105715459|NCT00441545|364617583|FG001|First Intervention|Sponsor's request|0|||
105715460|NCT00441545|364617582|FG000|Second Intervention|Adverse Event|5|||
105715461|NCT00441545|364617583|FG001|Second Intervention|Adverse Event|2|||
105789721|NCT00903409|364883400|FG000|Overall Study|Withdrawal by Subject|8|||
106136465|NCT01981850|366157943|FG001|Open Label Extension (OLE)|Various reasons|0|||
105715462|NCT00441545|364617582|FG000|Second Intervention|Protocol Violation|4|||
105715463|NCT00441545|364617583|FG001|Second Intervention|Protocol Violation|1|||
105715464|NCT00441545|364617582|FG000|Second Intervention|Withdrawal by Subject|1|||
105715465|NCT00441545|364617583|FG001|Second Intervention|Withdrawal by Subject|1|||
105715466|NCT00441545|364617582|FG000|Second Intervention|Kidney Transplant|1|||
105715467|NCT00441545|364617583|FG001|Second Intervention|Kidney Transplant|1|||
105715468|NCT00441545|364617582|FG000|Second Intervention|Lack of Efficacy|0|||
105715469|NCT00441545|364617583|FG001|Second Intervention|Lack of Efficacy|1|||
105715470|NCT00441545|364617582|FG000|Second Intervention|Subject exceeded safety criteria|1|||
105715471|NCT00441545|364617583|FG001|Second Intervention|Subject exceeded safety criteria|0|||
105715472|NCT00441545|364617582|FG000|Second Intervention|Subject moved|0|||
105715473|NCT00441545|364617583|FG001|Second Intervention|Subject moved|1|||
106136466|NCT01981850|366157944|FG002|Open Label Extension (OLE)|Various reasons|0|||
105715474|NCT01463098|364617585|FG000|Part A (11 Days)|Participant Choice|2|||
105715475|NCT01463098|364617586|FG001|Part A (11 Days)|Participant Choice|0|||
105715476|NCT01463098|364617587|FG002|Part A (11 Days)|Participant Choice|0|||
105715477|NCT01463098|364617588|FG003|Part A (11 Days)|Participant Choice|0|||
105715478|NCT01463098|364617589|FG004|Part A (11 Days)|Participant Choice|0|||
105789722|NCT00903409|364883401|FG001|Overall Study|Withdrawal by Subject|8|||
105789723|NCT00903409|364883400|FG000|Overall Study|Other|2|||
105789724|NCT00903409|364883401|FG001|Overall Study|Other|3|||
105715479|NCT01463098|364617590|FG005|Part A (11 Days)|Participant Choice|0|||
105789725|NCT00903409|364883400|FG000|Overall Study|Lost to Follow-up|2|||
105715480|NCT01463098|364617591|FG006|Part A (11 Days)|Participant Choice|0|||
105715481|NCT01463098|364617592|FG007|Part A (11 Days)|Participant Choice|0|||
105715482|NCT01463098|364617593|FG008|Part A (11 Days)|Participant Choice|1|||
105715483|NCT01463098|364617594|FG009|Part A (11 Days)|Participant Choice|0|||
105715484|NCT01463098|364617595|FG010|Part A (11 Days)|Participant Choice|0|||
105715485|NCT01463098|364617596|FG011|Part A (11 Days)|Participant Choice|0|||
105715486|NCT01463098|364617597|FG012|Part A (11 Days)|Participant Choice|0|||
105715487|NCT01463098|364617598|FG013|Part A (11 Days)|Participant Choice|0|||
105715488|NCT01463098|364617585|FG000|Part A (11 Days)|Lost to Follow-up|0|||
105715489|NCT01463098|364617586|FG001|Part A (11 Days)|Lost to Follow-up|0|||
105715490|NCT01463098|364617587|FG002|Part A (11 Days)|Lost to Follow-up|0|||
105715491|NCT01463098|364617588|FG003|Part A (11 Days)|Lost to Follow-up|0|||
105715492|NCT01463098|364617589|FG004|Part A (11 Days)|Lost to Follow-up|1|||
105715493|NCT01463098|364617590|FG005|Part A (11 Days)|Lost to Follow-up|0|||
105715494|NCT01463098|364617591|FG006|Part A (11 Days)|Lost to Follow-up|0|||
105715495|NCT01463098|364617592|FG007|Part A (11 Days)|Lost to Follow-up|0|||
105715496|NCT01463098|364617593|FG008|Part A (11 Days)|Lost to Follow-up|0|||
105715497|NCT01463098|364617594|FG009|Part A (11 Days)|Lost to Follow-up|0|||
105715498|NCT01463098|364617595|FG010|Part A (11 Days)|Lost to Follow-up|0|||
105715499|NCT01463098|364617596|FG011|Part A (11 Days)|Lost to Follow-up|0|||
105715500|NCT01463098|364617597|FG012|Part A (11 Days)|Lost to Follow-up|0|||
105715501|NCT01463098|364617598|FG013|Part A (11 Days)|Lost to Follow-up|0|||
105715502|NCT01463098|364617585|FG000|Part B (11 Days)|Participant Choice|0|||
105715503|NCT01463098|364617586|FG001|Part B (11 Days)|Participant Choice|0|||
105789726|NCT00903409|364883401|FG001|Overall Study|Lost to Follow-up|6|||
105789727|NCT02268214|364883402|FG000|Overall Study|Subject no longer meets study criteria|0|||
105789728|NCT02268214|364883403|FG001|Overall Study|Subject no longer meets study criteria|2|||
105789729|NCT02268214|364883404|FG002|Overall Study|Subject no longer meets study criteria|0|||
105789730|NCT02268214|364883402|FG000|Overall Study|Pregnancy|2|||
105789731|NCT02268214|364883403|FG001|Overall Study|Pregnancy|2|||
105789732|NCT02268214|364883404|FG002|Overall Study|Pregnancy|1|||
105789733|NCT02268214|364883402|FG000|Overall Study|Lost to Follow-up|3|||
105789734|NCT02268214|364883403|FG001|Overall Study|Lost to Follow-up|3|||
105789735|NCT02268214|364883404|FG002|Overall Study|Lost to Follow-up|4|||
105789736|NCT02268214|364883402|FG000|Overall Study|Lack of Efficacy|1|||
105789737|NCT02268214|364883403|FG001|Overall Study|Lack of Efficacy|0|||
105789738|NCT02268214|364883404|FG002|Overall Study|Lack of Efficacy|2|||
105789739|NCT02268214|364883402|FG000|Overall Study|Adverse Event|11|||
105789740|NCT02268214|364883403|FG001|Overall Study|Adverse Event|14|||
105789741|NCT02268214|364883404|FG002|Overall Study|Adverse Event|9|||
105789742|NCT02268214|364883402|FG000|Overall Study|Withdrawal by Subject|4|||
105789743|NCT02268214|364883403|FG001|Overall Study|Withdrawal by Subject|5|||
105789744|NCT02268214|364883404|FG002|Overall Study|Withdrawal by Subject|10|||
105789745|NCT02268214|364883402|FG000|Overall Study|Subject request to discontinue treatment|10|||
105789746|NCT02268214|364883403|FG001|Overall Study|Subject request to discontinue treatment|8|||
105789747|NCT02268214|364883404|FG002|Overall Study|Subject request to discontinue treatment|6|||
105789748|NCT02268214|364883402|FG000|Overall Study|Poor/non-compliance|2|||
105789749|NCT02268214|364883403|FG001|Overall Study|Poor/non-compliance|1|||
105789750|NCT02268214|364883404|FG002|Overall Study|Poor/non-compliance|2|||
105789751|NCT02268214|364883402|FG000|Overall Study|Other reasons|7|||
105789752|NCT02268214|364883403|FG001|Overall Study|Other reasons|3|||
105789753|NCT02268214|364883404|FG002|Overall Study|Other reasons|3|||
105789754|NCT02268214|364883402|FG000|Overall Study|Not entering long-term period|2|||
105789755|NCT02268214|364883403|FG001|Overall Study|Not entering long-term period|3|||
105789756|NCT02268214|364883404|FG002|Overall Study|Not entering long-term period|5|||
105789757|NCT04625413|364883409|FG000|Overall Study|Hospice|2|||
105789758|NCT04625413|364883409|FG000|Overall Study|Distress|1|||
105789759|NCT04625413|364883409|FG000|Overall Study|Not feeling well|1|||
105789760|NCT01283282|364883413|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
105715504|NCT01463098|364617587|FG002|Part B (11 Days)|Participant Choice|0|||
105715505|NCT01463098|364617588|FG003|Part B (11 Days)|Participant Choice|0|||
105715506|NCT01463098|364617589|FG004|Part B (11 Days)|Participant Choice|0|||
105715507|NCT01463098|364617590|FG005|Part B (11 Days)|Participant Choice|0|||
105715508|NCT01463098|364617591|FG006|Part B (11 Days)|Participant Choice|0|||
105715509|NCT01463098|364617592|FG007|Part B (11 Days)|Participant Choice|0|||
105715510|NCT01463098|364617593|FG008|Part B (11 Days)|Participant Choice|0|||
105715511|NCT01463098|364617594|FG009|Part B (11 Days)|Participant Choice|0|||
105715512|NCT01463098|364617595|FG010|Part B (11 Days)|Participant Choice|0|||
105789761|NCT01283282|364883414|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
105789762|NCT01283282|364883413|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
105789763|NCT01283282|364883414|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
105789764|NCT01283282|364883413|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
105789765|NCT01283282|364883414|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
105789766|NCT00777920|364883415|FG000|Overall Study|Adverse Event|39|||
105715513|NCT01463098|364617596|FG011|Part B (11 Days)|Participant Choice|1|||
105715514|NCT01463098|364617597|FG012|Part B (11 Days)|Participant Choice|0|||
105715515|NCT01463098|364617598|FG013|Part B (11 Days)|Participant Choice|0|||
105715516|NCT00939692|364617606|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
105715517|NCT00939692|364617607|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
105715518|NCT00939692|364617606|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
105715519|NCT00939692|364617607|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
105715520|NCT04451330|364617608|FG000|Overall Study|Adverse Event|1|||
105715521|NCT04451330|364617609|FG001|Overall Study|Adverse Event|2|||
105715522|NCT04451330|364617608|FG000|Overall Study|Lost to Follow-up|5|||
105715523|NCT04451330|364617609|FG001|Overall Study|Lost to Follow-up|0|||
105715524|NCT04451330|364617608|FG000|Overall Study|Withdrawal by Subject|3|||
105715525|NCT04451330|364617609|FG001|Overall Study|Withdrawal by Subject|1|||
105715526|NCT04451330|364617608|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105715527|NCT04451330|364617609|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105715528|NCT04451330|364617608|FG000|Overall Study|Other than specified|0|||
105715529|NCT04451330|364617609|FG001|Overall Study|Other than specified|1|||
105715530|NCT02769624|364617610|FG000|Overall Study|Lost to Follow-up|0|||
105715531|NCT02769624|364617611|FG001|Overall Study|Lost to Follow-up|1|||
105715532|NCT03175549|364617612|FG000|Overall Study|Lost to Follow-up|2|||
105715533|NCT03175549|364617613|FG001|Overall Study|Lost to Follow-up|2|||
105715534|NCT03175549|364617612|FG000|Overall Study|Medication non-compliance|2|||
105715535|NCT03175549|364617613|FG001|Overall Study|Medication non-compliance|2|||
105715536|NCT00130286|364617614|FG000|Overall Study|Withdrawal by Subject|0|||
105715537|NCT00130286|364617615|FG001|Overall Study|Withdrawal by Subject|1|||
105715538|NCT00130286|364617616|FG002|Overall Study|Withdrawal by Subject|2|||
105715539|NCT00130286|364617617|FG003|Overall Study|Withdrawal by Subject|2|||
105715540|NCT00130286|364617614|FG000|Overall Study|Adverse Event|0|||
105931893|NCT04602000|365410795|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
105931894|NCT04602000|365410796|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
105931895|NCT04602000|365410797|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
105931896|NCT03558672|365410803|FG000|Overall Study|Study Early Termination|10|||
105931897|NCT00983957|365410804|FG000|Overall Study|Adverse Event|1|||
105931898|NCT00983957|365410804|FG000|Overall Study|Personal Reasons|1|||
105931899|NCT01027416|365410809|FG000|Overall Study|Withdrawal by Subject|0|||
105931900|NCT01027416|365410810|FG001|Overall Study|Withdrawal by Subject|1|||
105931901|NCT01027416|365410809|FG000|Overall Study|Physician Decision|1|||
105931902|NCT01027416|365410810|FG001|Overall Study|Physician Decision|4|||
105931903|NCT00790933|365410811|FG000|Overall Study|Adverse Event|94|||
105931904|NCT00790933|365410812|FG001|Overall Study|Adverse Event|119|||
105931905|NCT00790933|365410813|FG002|Overall Study|Adverse Event|65|||
105931906|NCT00790933|365410814|FG003|Overall Study|Adverse Event|5|||
105931907|NCT00790933|365410815|FG004|Overall Study|Adverse Event|69|||
105931908|NCT00790933|365410811|FG000|Overall Study|Protocol Violation(s)|8|||
105931909|NCT00790933|365410812|FG001|Overall Study|Protocol Violation(s)|18|||
105931910|NCT00790933|365410813|FG002|Overall Study|Protocol Violation(s)|7|||
105931911|NCT00790933|365410814|FG003|Overall Study|Protocol Violation(s)|0|||
105931912|NCT00790933|365410815|FG004|Overall Study|Protocol Violation(s)|12|||
105931913|NCT00790933|365410811|FG000|Overall Study|Lack of Efficacy|192|||
105931914|NCT00790933|365410812|FG001|Overall Study|Lack of Efficacy|176|||
105931915|NCT00790933|365410813|FG002|Overall Study|Lack of Efficacy|130|||
105931916|NCT00790933|365410814|FG003|Overall Study|Lack of Efficacy|1|||
105715541|NCT00130286|364617615|FG001|Overall Study|Adverse Event|0|||
105715542|NCT00130286|364617616|FG002|Overall Study|Adverse Event|2|||
105715543|NCT00130286|364617617|FG003|Overall Study|Adverse Event|0|||
105715544|NCT00130286|364617614|FG000|Overall Study|Missing lab specimens|0|||
105715545|NCT00130286|364617615|FG001|Overall Study|Missing lab specimens|2|||
105715546|NCT00130286|364617616|FG002|Overall Study|Missing lab specimens|0|||
105715547|NCT00130286|364617617|FG003|Overall Study|Missing lab specimens|0|||
105715548|NCT02154425|364617618|FG000|Screening Period|Adverse Event|1|||
105715549|NCT00508391|364617624|FG000|First Treatment|Withdrawal by Subject|6|||
105715550|NCT00508391|364617625|FG001|First Treatment|Withdrawal by Subject|3|||
105715551|NCT00508391|364617624|FG000|Second Treatment|Withdrawal by Subject|2|||
105715552|NCT00508391|364617625|FG001|Second Treatment|Withdrawal by Subject|0|||
105715553|NCT00865020|364617634|FG000|Overall Study|Withdrawal by Subject|22|||
105715554|NCT00865020|364617635|FG001|Overall Study|Withdrawal by Subject|16|||
105931917|NCT00790933|365410815|FG004|Overall Study|Lack of Efficacy|121|||
105931918|NCT00790933|365410811|FG000|Overall Study|Study Terminated by Sponsor|0|||
105931919|NCT00790933|365410812|FG001|Overall Study|Study Terminated by Sponsor|0|||
105931920|NCT00790933|365410813|FG002|Overall Study|Study Terminated by Sponsor|1|||
105931921|NCT00790933|365410814|FG003|Overall Study|Study Terminated by Sponsor|0|||
105931922|NCT00790933|365410815|FG004|Overall Study|Study Terminated by Sponsor|0|||
105931923|NCT00790933|365410811|FG000|Overall Study|Withdrawal by Subject|123|||
105931924|NCT00790933|365410812|FG001|Overall Study|Withdrawal by Subject|120|||
105931925|NCT00790933|365410813|FG002|Overall Study|Withdrawal by Subject|52|||
105715555|NCT00865020|364617634|FG000|Overall Study|Adverse Event|9|||
105715556|NCT00865020|364617635|FG001|Overall Study|Adverse Event|14|||
105715557|NCT00865020|364617634|FG000|Overall Study|Abnormal test procedure result(s)|6|||
105715558|NCT00865020|364617635|FG001|Overall Study|Abnormal test procedure result(s)|8|||
105715559|NCT00865020|364617634|FG000|Overall Study|Lost to Follow-up|6|||
105715560|NCT00865020|364617635|FG001|Overall Study|Lost to Follow-up|4|||
105715561|NCT00865020|364617634|FG000|Overall Study|Protocol deviation|4|||
105715562|NCT00865020|364617635|FG001|Overall Study|Protocol deviation|1|||
105715563|NCT00865020|364617634|FG000|Overall Study|Administrative problems|0|||
105715564|NCT00865020|364617635|FG001|Overall Study|Administrative problems|2|||
105715565|NCT00865020|364617634|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105715566|NCT00865020|364617635|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105715567|NCT00865020|364617634|FG000|Overall Study|Death|0|||
105715568|NCT00865020|364617635|FG001|Overall Study|Death|1|||
105715569|NCT00865020|364617634|FG000|Overall Study|Randomized but discontinued|2|||
105715570|NCT00865020|364617635|FG001|Overall Study|Randomized but discontinued|4|||
105715571|NCT03641560|364617636|FG000|Overall Study|Withdrawal by Subject|6|||
105715572|NCT03641560|364617636|FG000|Overall Study|Progressive disease|40|||
105715573|NCT03641560|364617636|FG000|Overall Study|Death|6|||
105715574|NCT04002310|364619275|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
105715575|NCT04002310|364619276|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
105715576|NCT04002310|364619277|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
105715577|NCT04002310|364619278|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
105715578|NCT04002310|364619279|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
105715579|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
105715580|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
105715581|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
105715582|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
105715583|NCT02949128|364619280|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
105715584|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
105715585|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
105715586|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
105715587|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
105715588|NCT02949128|364619280|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
105715589|NCT02152345|364619283|FG000|Overall Study|Case Cancellations|2|||
105715590|NCT02152345|364619284|FG001|Overall Study|Case Cancellations|4|||
105715591|NCT02152345|364619283|FG000|Overall Study|Withdrawal by Subject|2|||
105715592|NCT02152345|364619284|FG001|Overall Study|Withdrawal by Subject|1|||
105715593|NCT03160560|364619288|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
105715594|NCT03160560|364619289|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105715595|NCT03160560|364619290|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
105715596|NCT03160560|364619291|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
105715597|NCT03160560|364619288|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
105715598|NCT03160560|364619289|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105715599|NCT03160560|364619290|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105715600|NCT03160560|364619291|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
105715601|NCT02810964|364619293|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
105715602|NCT02810964|364619294|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
105715603|NCT02810964|364619293|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
105715604|NCT02810964|364619294|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
105715605|NCT02810964|364619293|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
105715606|NCT02810964|364619294|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
105715607|NCT02810964|364619293|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
105715608|NCT02810964|364619294|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
105715609|NCT00772629|364619298|FG000|Overall Study|Subject was not vaccinated|1|||
105715610|NCT00772629|364619299|FG001|Overall Study|Subject was not vaccinated|0|||
105715611|NCT02894840|364619302|FG000|Overall Study|Lost to Follow-up|1|||
105715612|NCT02894840|364619303|FG001|Overall Study|Lost to Follow-up|0|||
105715613|NCT02894840|364619304|FG002|Overall Study|Lost to Follow-up|3|||
105715614|NCT02894840|364619305|FG003|Overall Study|Lost to Follow-up|0|||
105715615|NCT05162066|364619310|FG000|Overall Study|Adverse Event|1|||
105715616|NCT05162066|364619311|FG001|Overall Study|Adverse Event|0|||
105715617|NCT05162066|364619312|FG002|Overall Study|Adverse Event|0|||
105715618|NCT05162066|364619310|FG000|Overall Study|Perceived lack of efficacy|1|||
105715619|NCT05162066|364619311|FG001|Overall Study|Perceived lack of efficacy|0|||
105715620|NCT05162066|364619312|FG002|Overall Study|Perceived lack of efficacy|0|||
105715621|NCT01072344|364619313|FG000|Overall Study|Relasped-reached end point|7|||
105715622|NCT01072344|364619314|FG001|Overall Study|Relasped-reached end point|12|||
105715623|NCT01072344|364619313|FG000|Overall Study|Protocol Violation|1|||
105715624|NCT01072344|364619314|FG001|Overall Study|Protocol Violation|2|||
105715625|NCT01072344|364619313|FG000|Overall Study|Lost to Follow-up|3|||
105715626|NCT01072344|364619314|FG001|Overall Study|Lost to Follow-up|4|||
105715627|NCT03969875|364619315|FG000|Overall Study|did not receive allocated intervention|3|||
105715628|NCT03969875|364619316|FG001|Overall Study|did not receive allocated intervention|3|||
105715629|NCT03969875|364619317|FG002|Overall Study|did not receive allocated intervention|4|||
105715630|NCT03969875|364619315|FG000|Overall Study|Protocol Violation|4|||
105715631|NCT03969875|364619316|FG001|Overall Study|Protocol Violation|2|||
105715632|NCT03969875|364619317|FG002|Overall Study|Protocol Violation|2|||
105715633|NCT01871090|364619326|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
105715634|NCT01871090|364619327|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
105715635|NCT01871090|364619326|FG000|Overall Study|Interrogation not completed correctly|1|||
105715636|NCT01871090|364619327|FG001|Overall Study|Interrogation not completed correctly|0|||
105715637|NCT01871090|364619326|FG000|Overall Study|Subject Non-Compliance|0|||
105715638|NCT01871090|364619327|FG001|Overall Study|Subject Non-Compliance|1|||
105715639|NCT00808444|364619333|FG000|Overall Study|Withdrawal by Subject|1|||
105715640|NCT00808444|364619334|FG001|Overall Study|Withdrawal by Subject|0|||
105715641|NCT00808444|364619333|FG000|Overall Study|Lost to Follow-up|0|||
105715642|NCT00808444|364619334|FG001|Overall Study|Lost to Follow-up|1|||
105715643|NCT03502330|364619335|FG000|Overall Study|Adverse Event|2|||
105715644|NCT03502330|364619336|FG001|Overall Study|Adverse Event|1|||
105715645|NCT03502330|364619337|FG002|Overall Study|Adverse Event|0|||
105715646|NCT03502330|364619338|FG003|Overall Study|Adverse Event|0|||
105715647|NCT03502330|364619339|FG004|Overall Study|Adverse Event|1|||
105715648|NCT03502330|364619340|FG005|Overall Study|Adverse Event|0|||
105715649|NCT03502330|364619341|FG006|Overall Study|Adverse Event|1|||
105715650|NCT03502330|364619342|FG007|Overall Study|Adverse Event|1|||
105715651|NCT03502330|364619343|FG008|Overall Study|Adverse Event|0|||
105715652|NCT03502330|364619335|FG000|Overall Study|Lack of Efficacy|1|||
105931926|NCT00790933|365410814|FG003|Overall Study|Withdrawal by Subject|6|||
105931927|NCT00790933|365410815|FG004|Overall Study|Withdrawal by Subject|50|||
105931928|NCT00790933|365410811|FG000|Overall Study|Lost to Follow-up|13|||
105931929|NCT00790933|365410812|FG001|Overall Study|Lost to Follow-up|31|||
105931930|NCT00790933|365410813|FG002|Overall Study|Lost to Follow-up|10|||
105931931|NCT00790933|365410814|FG003|Overall Study|Lost to Follow-up|1|||
105931932|NCT00790933|365410815|FG004|Overall Study|Lost to Follow-up|15|||
105931933|NCT00790933|365410811|FG000|Overall Study|Reason Not Specified|8|||
105931934|NCT00790933|365410812|FG001|Overall Study|Reason Not Specified|16|||
105931935|NCT00790933|365410813|FG002|Overall Study|Reason Not Specified|4|||
105931936|NCT00790933|365410814|FG003|Overall Study|Reason Not Specified|1|||
105931937|NCT00790933|365410815|FG004|Overall Study|Reason Not Specified|9|||
105931938|NCT00676052|365410816|FG000|Overall Study|Adverse Event|0|||
105931939|NCT00676052|365410817|FG001|Overall Study|Adverse Event|1|||
105931940|NCT00676052|365410818|FG002|Overall Study|Adverse Event|1|||
105931941|NCT00676052|365410819|FG003|Overall Study|Adverse Event|2|||
105931942|NCT00676052|365410820|FG004|Overall Study|Adverse Event|2|||
105931943|NCT00676052|365410821|FG005|Overall Study|Adverse Event|2|||
105931944|NCT00676052|365410816|FG000|Overall Study|Lack of Efficacy|2|||
106136467|NCT01981850|366157945|FG003|Open Label Extension (OLE)|Various reasons|0|||
106136468|NCT01981850|366157946|FG004|Open Label Extension (OLE)|Various reasons|0|||
106136469|NCT01981850|366157947|FG005|Open Label Extension (OLE)|Various reasons|0|||
106136470|NCT01981850|366157948|FG006|Open Label Extension (OLE)|Various reasons|0|||
105715653|NCT03502330|364619336|FG001|Overall Study|Lack of Efficacy|5|||
105715654|NCT03502330|364619337|FG002|Overall Study|Lack of Efficacy|3|||
105715655|NCT03502330|364619338|FG003|Overall Study|Lack of Efficacy|5|||
105715656|NCT03502330|364619339|FG004|Overall Study|Lack of Efficacy|1|||
105715657|NCT03502330|364619340|FG005|Overall Study|Lack of Efficacy|5|||
105715658|NCT03502330|364619341|FG006|Overall Study|Lack of Efficacy|5|||
105715659|NCT03502330|364619342|FG007|Overall Study|Lack of Efficacy|6|||
105715660|NCT03502330|364619343|FG008|Overall Study|Lack of Efficacy|0|||
105715661|NCT03502330|364619335|FG000|Overall Study|Physician Decision|0|||
105715662|NCT03502330|364619336|FG001|Overall Study|Physician Decision|0|||
105715663|NCT03502330|364619337|FG002|Overall Study|Physician Decision|0|||
105715664|NCT03502330|364619338|FG003|Overall Study|Physician Decision|0|||
105715665|NCT03502330|364619339|FG004|Overall Study|Physician Decision|1|||
105715666|NCT03502330|364619340|FG005|Overall Study|Physician Decision|0|||
105931945|NCT00676052|365410817|FG001|Overall Study|Lack of Efficacy|2|||
105931946|NCT00676052|365410818|FG002|Overall Study|Lack of Efficacy|1|||
105931947|NCT00676052|365410819|FG003|Overall Study|Lack of Efficacy|1|||
105931948|NCT00676052|365410820|FG004|Overall Study|Lack of Efficacy|2|||
105931949|NCT00676052|365410821|FG005|Overall Study|Lack of Efficacy|1|||
105931950|NCT00676052|365410816|FG000|Overall Study|Protocol Violation|5|||
105931951|NCT00676052|365410817|FG001|Overall Study|Protocol Violation|3|||
105931952|NCT00676052|365410818|FG002|Overall Study|Protocol Violation|2|||
105931953|NCT00676052|365410819|FG003|Overall Study|Protocol Violation|2|||
105931954|NCT00676052|365410820|FG004|Overall Study|Protocol Violation|1|||
106136471|NCT01981850|366157949|FG007|Open Label Extension (OLE)|Various reasons|3|||
106136472|NCT01981850|366157950|FG008|Open Label Extension (OLE)|Various reasons|1|||
106136473|NCT01981850|366157951|FG009|Open Label Extension (OLE)|Various reasons|3|||
106136474|NCT01981850|366157942|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
106136475|NCT01981850|366157943|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
105789767|NCT00777920|364883415|FG000|Overall Study|Withdrawal of Consent|4|||
105789768|NCT00777920|364883415|FG000|Overall Study|Lost to Follow-up|1|||
105789769|NCT00777920|364883415|FG000|Overall Study|Investigator's discretion|1|||
105789770|NCT00777920|364883415|FG000|Overall Study|Clinical status did not improve|1|||
105789771|NCT00777920|364883415|FG000|Overall Study|Other, not specified|4|||
105789772|NCT03878108|364883416|FG000|Overall Study|Adverse Event|1|||
105789773|NCT03878108|364883417|FG001|Overall Study|Adverse Event|0|||
105789774|NCT00795886|364883421|FG000|Overall Study|Death|10|||
105789775|NCT05554471|364883422|FG000|Overall Study|Physician Decision|2|||
105789776|NCT05554471|364883423|FG001|Overall Study|Physician Decision|1|||
105789777|NCT05554471|364883422|FG000|Overall Study|Lost to Follow-up|2|||
105789778|NCT05554471|364883423|FG001|Overall Study|Lost to Follow-up|1|||
105715667|NCT03502330|364619341|FG006|Overall Study|Physician Decision|0|||
105715668|NCT03502330|364619342|FG007|Overall Study|Physician Decision|0|||
105715669|NCT03502330|364619343|FG008|Overall Study|Physician Decision|0|||
105715670|NCT03502330|364619335|FG000|Overall Study|Withdrawal by Subject|0|||
105715671|NCT03502330|364619336|FG001|Overall Study|Withdrawal by Subject|0|||
105715672|NCT03502330|364619337|FG002|Overall Study|Withdrawal by Subject|0|||
105789779|NCT05554471|364883422|FG000|Overall Study|Death|0|||
105789780|NCT05554471|364883423|FG001|Overall Study|Death|1|||
105789781|NCT01608321|364883424|FG000|Overall Study|Withdrawal by Subject|1|||
105789782|NCT01608321|364883425|FG001|Overall Study|Withdrawal by Subject|0|||
105789783|NCT01298661|364883426|FG000|Overall Study|Withdrawal by Subject|2|||
106136476|NCT01981850|366157944|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
106136477|NCT01981850|366157945|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
106136478|NCT01981850|366157946|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
106136479|NCT01981850|366157947|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
106136480|NCT01981850|366157948|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
106136481|NCT01981850|366157949|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
106136482|NCT01981850|366157950|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
105715673|NCT03502330|364619338|FG003|Overall Study|Withdrawal by Subject|0|||
105789784|NCT01298661|364883427|FG001|Overall Study|Withdrawal by Subject|0|||
106136483|NCT01981850|366157951|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
105789785|NCT01298661|364883428|FG002|Overall Study|Withdrawal by Subject|2|||
105789786|NCT01525407|364883429|FG000|Overall Study|Change in recipient treatment plan|2|||
105789787|NCT01525407|364883430|FG001|Overall Study|Change in recipient treatment plan|2|||
105789788|NCT01525407|364883429|FG000|Overall Study|Withdrawal by Subject|0|||
105931955|NCT00676052|365410821|FG005|Overall Study|Protocol Violation|2|||
105931956|NCT00676052|365410816|FG000|Overall Study|Lost to Follow-up|0|||
106136484|NCT01981850|366157942|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
106136485|NCT01981850|366157943|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
106136486|NCT01981850|366157944|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
106136487|NCT01981850|366157945|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
106136488|NCT01981850|366157946|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
106136489|NCT01981850|366157947|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
106136490|NCT01981850|366157948|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
106136491|NCT01981850|366157949|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
106136492|NCT01981850|366157950|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
105715674|NCT03502330|364619339|FG004|Overall Study|Withdrawal by Subject|0|||
105789789|NCT01525407|364883430|FG001|Overall Study|Withdrawal by Subject|1|||
105931957|NCT00676052|365410817|FG001|Overall Study|Lost to Follow-up|0|||
105931958|NCT00676052|365410818|FG002|Overall Study|Lost to Follow-up|0|||
105931959|NCT00676052|365410819|FG003|Overall Study|Lost to Follow-up|0|||
105931960|NCT00676052|365410820|FG004|Overall Study|Lost to Follow-up|1|||
105931961|NCT00676052|365410821|FG005|Overall Study|Lost to Follow-up|0|||
105931962|NCT00676052|365410816|FG000|Overall Study|Physician Decision|1|||
105931963|NCT00676052|365410817|FG001|Overall Study|Physician Decision|1|||
105931964|NCT00676052|365410818|FG002|Overall Study|Physician Decision|1|||
105931965|NCT00676052|365410819|FG003|Overall Study|Physician Decision|0|||
105931966|NCT00676052|365410820|FG004|Overall Study|Physician Decision|0|||
106136493|NCT01981850|366157951|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
106136494|NCT01981850|366157942|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
105715675|NCT03502330|364619340|FG005|Overall Study|Withdrawal by Subject|1|||
105789790|NCT01525407|364883429|FG000|Overall Study|Transplant was delayed|0|||
105715676|NCT03502330|364619341|FG006|Overall Study|Withdrawal by Subject|0|||
105931967|NCT00676052|365410821|FG005|Overall Study|Physician Decision|1|||
105931968|NCT00676052|365410816|FG000|Overall Study|Withdrawal by Subject|1|||
105931969|NCT00676052|365410817|FG001|Overall Study|Withdrawal by Subject|0|||
105931970|NCT00676052|365410818|FG002|Overall Study|Withdrawal by Subject|1|||
105715677|NCT03502330|364619342|FG007|Overall Study|Withdrawal by Subject|1|||
105715678|NCT03502330|364619343|FG008|Overall Study|Withdrawal by Subject|0|||
105715679|NCT03502330|364619335|FG000|Overall Study|Death|0|||
105715680|NCT03502330|364619336|FG001|Overall Study|Death|0|||
105715681|NCT03502330|364619337|FG002|Overall Study|Death|0|||
105715682|NCT03502330|364619338|FG003|Overall Study|Death|0|||
105715683|NCT03502330|364619339|FG004|Overall Study|Death|0|||
105715684|NCT03502330|364619340|FG005|Overall Study|Death|0|||
105715685|NCT03502330|364619341|FG006|Overall Study|Death|2|||
105715686|NCT03502330|364619342|FG007|Overall Study|Death|0|||
105715687|NCT03502330|364619343|FG008|Overall Study|Death|0|||
105715688|NCT01461044|364619344|FG000|Overall Study|Death|58|||
105715689|NCT01461044|364619345|FG001|Overall Study|Death|35|||
105715690|NCT01461044|364619344|FG000|Overall Study|Lost to Follow-up|12|||
105715691|NCT01461044|364619345|FG001|Overall Study|Lost to Follow-up|5|||
105715692|NCT00669617|364619353|FG000|Period 1|Withdrawal by Subject|0|||
105715693|NCT00669617|364619354|FG001|Period 1|Withdrawal by Subject|0|||
105715694|NCT00669617|364619355|FG002|Period 1|Withdrawal by Subject|1|||
105715695|NCT00669617|364619356|FG003|Period 1|Withdrawal by Subject|0|||
105715696|NCT00669617|364619357|FG004|Period 1|Withdrawal by Subject|0|||
105715697|NCT00669617|364619353|FG000|Period 1|Protocol Deviation|0|||
105715698|NCT00669617|364619354|FG001|Period 1|Protocol Deviation|0|||
105715699|NCT00669617|364619355|FG002|Period 1|Protocol Deviation|0|||
105715700|NCT00669617|364619356|FG003|Period 1|Protocol Deviation|0|||
105715701|NCT00669617|364619357|FG004|Period 1|Protocol Deviation|1|||
105715702|NCT00669617|364619353|FG000|Period 3|Lost to Follow-up|1|||
105715703|NCT00669617|364619354|FG001|Period 3|Lost to Follow-up|0|||
105715704|NCT00669617|364619355|FG002|Period 3|Lost to Follow-up|0|||
105715705|NCT00669617|364619356|FG003|Period 3|Lost to Follow-up|0|||
105715706|NCT00669617|364619357|FG004|Period 3|Lost to Follow-up|0|||
105715707|NCT03068325|364619358|FG000|Overall Study|Lost to Follow-up|5|||
105715708|NCT00840827|364619361|FG000|Overall Study|Adverse Event|1|||
105715709|NCT00840827|364619361|FG000|Overall Study|Lack of Efficacy|4|||
105715710|NCT00840827|364619361|FG000|Overall Study|Physician Decision|1|||
105715711|NCT02415712|364619362|FG000|Overall Study|Protocol Violation|16|||
105715712|NCT01668654|364619363|FG000|Overall Study|Study Closed/Terminated|3|||
105715713|NCT01668654|364619363|FG000|Overall Study|Withdrawal by Subject|1|||
105715714|NCT04557384|364619364|FG000|Overall Study|Study Terminated by Sponsor|1|||
105715715|NCT04557384|364619364|FG000|Overall Study|Death|1|||
105715716|NCT03806127|364619366|FG000|Overall Study|Withdrawal by Subject|4|||
105715717|NCT03806127|364619367|FG001|Overall Study|Withdrawal by Subject|5|||
105715718|NCT03806127|364619366|FG000|Overall Study|Protocol Violation|3|||
105715719|NCT03806127|364619367|FG001|Overall Study|Protocol Violation|1|||
105715720|NCT03806127|364619366|FG000|Overall Study|Adverse Event|3|||
105715721|NCT03806127|364619367|FG001|Overall Study|Adverse Event|0|||
105715722|NCT03806127|364619366|FG000|Overall Study|Unable to Complete Procedures|0|||
105715723|NCT03806127|364619367|FG001|Overall Study|Unable to Complete Procedures|1|||
105715724|NCT03806127|364619366|FG000|Overall Study|Pregnancy|0|||
105715725|NCT03806127|364619367|FG001|Overall Study|Pregnancy|1|||
105715726|NCT03806127|364619366|FG000|Overall Study|Lost to Follow-up|5|||
105715727|NCT03806127|364619367|FG001|Overall Study|Lost to Follow-up|1|||
105715728|NCT03806127|364619366|FG000|Overall Study|Physician Decision|1|||
105715729|NCT03806127|364619367|FG001|Overall Study|Physician Decision|1|||
105715730|NCT03806127|364619366|FG000|Overall Study|Could Not Come Due to Covid|1|||
105715731|NCT03806127|364619367|FG001|Overall Study|Could Not Come Due to Covid|0|||
105715732|NCT03806127|364619366|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
105715733|NCT03806127|364619367|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
105715734|NCT03806127|364619366|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
105715735|NCT03806127|364619367|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
105715736|NCT03806127|364619366|FG000|Overall Study|Covid 19 Restrictions|2|||
105715737|NCT03806127|364619367|FG001|Overall Study|Covid 19 Restrictions|0|||
105715738|NCT03806127|364619366|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
105715739|NCT03806127|364619367|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
105715740|NCT03806127|364619366|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
105715741|NCT03806127|364619367|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
105715742|NCT00454779|364619368|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
105715743|NCT00454779|364619369|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
105715744|NCT00454779|364619368|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
105715745|NCT00454779|364619369|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
105715746|NCT00454779|364619368|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
105715747|NCT00454779|364619369|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
105715748|NCT00454779|364619368|FG000|First-line Treatment Phase|Protocol Violation|0|||
105715749|NCT00454779|364619369|FG001|First-line Treatment Phase|Protocol Violation|1|||
105715750|NCT00454779|364619368|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
105715751|NCT00454779|364619369|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
105715752|NCT00454779|364619368|FG000|First-line Treatment Phase|Ongoing|1|||
105715753|NCT00454779|364619369|FG001|First-line Treatment Phase|Ongoing|0|||
105715754|NCT00454779|364619368|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
105715755|NCT00454779|364619369|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
105715756|NCT00454779|364619368|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
105715757|NCT00454779|364619369|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
105715758|NCT00454779|364619368|FG000|Second-line Treatment Phase|Ongoing|0|||
105715759|NCT00454779|364619369|FG001|Second-line Treatment Phase|Ongoing|1|||
105715760|NCT02397473|364619370|FG000|Treatment Phase|Adverse Event|1|||
105715761|NCT02397473|364619371|FG001|Treatment Phase|Adverse Event|2|||
105715762|NCT02397473|364619370|FG000|Treatment Phase|Lack of Efficacy|8|||
105715763|NCT02397473|364619371|FG001|Treatment Phase|Lack of Efficacy|1|||
105715764|NCT02397473|364619370|FG000|Treatment Phase|Lost to Follow-up|1|||
105715765|NCT02397473|364619371|FG001|Treatment Phase|Lost to Follow-up|0|||
105715766|NCT02397473|364619370|FG000|Treatment Phase|Withdrawal by Subject|2|||
105715767|NCT02397473|364619371|FG001|Treatment Phase|Withdrawal by Subject|1|||
105715768|NCT02397473|364619370|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
105715769|NCT02397473|364619371|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
105715770|NCT02397473|364619370|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
105715771|NCT02397473|364619371|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
105715772|NCT02397473|364619370|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
105715773|NCT02397473|364619371|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
105715774|NCT02397473|364619370|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
105715775|NCT02397473|364619371|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
105715776|NCT02397473|364619370|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
105715777|NCT02397473|364619371|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
105715778|NCT05425563|364619372|FG000|Overall Study|Withdrawal by Subject|17|||
105715779|NCT03634800|364619373|FG000|Overall Study|Adverse Event|1|||
105715780|NCT03634800|364619373|FG000|Overall Study|Disease Progression|4|||
105715781|NCT03634800|364619373|FG000|Overall Study|Withdrawal by Subject|1|||
105715782|NCT00643994|364619374|FG000|Overall Study|Death|24|||
105715783|NCT00643994|364619374|FG000|Overall Study|Lost to Follow-up|72|||
105715784|NCT00343512|364619377|FG000|Overall Study|Withdrawal by Subject|2|||
105715785|NCT00440726|364619381|FG000|Phase 1|Dose-Limiting Toxicity|0|||
105715786|NCT00440726|364619382|FG001|Phase 1|Dose-Limiting Toxicity|1|||
105715787|NCT00440726|364619383|FG002|Phase 1|Dose-Limiting Toxicity|0|||
105715788|NCT00440726|364619381|FG000|Phase 1|Physician Decision|1|||
105715789|NCT00440726|364619382|FG001|Phase 1|Physician Decision|0|||
105715790|NCT00440726|364619383|FG002|Phase 1|Physician Decision|0|||
105715791|NCT00440726|364619381|FG000|Phase 2|Death|0|||
105715792|NCT00440726|364619382|FG001|Phase 2|Death|0|||
105715793|NCT00440726|364619383|FG002|Phase 2|Death|1|||
105715794|NCT00440726|364619381|FG000|Phase 2|Adverse Event|0|||
105715795|NCT00440726|364619382|FG001|Phase 2|Adverse Event|0|||
105715796|NCT00440726|364619383|FG002|Phase 2|Adverse Event|1|||
105715797|NCT02167945|364619387|FG000|Overall Study|Adverse Event|16|||
105715798|NCT02167945|364619387|FG000|Overall Study|Withdrew Consent|42|||
105715799|NCT02167945|364619387|FG000|Overall Study|Lost to Follow-up|122|||
105715800|NCT02167945|364619387|FG000|Overall Study|COVID-19 logistical restrictions|6|||
105715801|NCT02167945|364619387|FG000|Overall Study|Other, not specified|63|||
105715802|NCT01554579|364619388|FG000|Overall Study|Adverse Event|6|||
105715803|NCT01554579|364619389|FG001|Overall Study|Adverse Event|25|||
105715804|NCT01554579|364619388|FG000|Overall Study|Lack of Efficacy|2|||
105715805|NCT01554579|364619389|FG001|Overall Study|Lack of Efficacy|1|||
105715806|NCT01554579|364619388|FG000|Overall Study|Withdrawal by Subject|2|||
105715807|NCT01554579|364619389|FG001|Overall Study|Withdrawal by Subject|1|||
105715808|NCT01192347|364619390|FG000|Overall Study|Death|3|||
105715809|NCT01192347|364619390|FG000|Overall Study|Lost to Follow-up|3|||
105715810|NCT01192347|364619390|FG000|Overall Study|Withdrawal by Subject|1|||
105715811|NCT01192347|364619390|FG000|Overall Study|Adverse Event|1|||
105715812|NCT01192347|364619390|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
105715813|NCT01192347|364619390|FG000|Overall Study|Patient seen in different hospital|1|||
105715814|NCT01192347|364619390|FG000|Overall Study|Patient not visiting hospital regularly|1|||
105715815|NCT01192347|364619390|FG000|Overall Study|Patient did not show up for visits|1|||
105715816|NCT00234039|364619391|FG000|Overall Study|Adverse Event|2|||
105715817|NCT00234039|364619391|FG000|Overall Study|Progression/relapse|34|||
105715818|NCT00234039|364619391|FG000|Overall Study|Other - Not Protocol Specified|3|||
106008649|NCT00107653|365697051|FG000|Overall Study|Administrative Reasons|3|||
105715819|NCT00234039|364619391|FG000|Overall Study|Ineligible|9|||
105715820|NCT00234039|364619391|FG000|Overall Study|No Protocol Treatment Received|2|||
105715821|NCT01808612|364619392|FG000|Treatment Period|Adverse Event|8|||
105715822|NCT01808612|364619393|FG001|Treatment Period|Adverse Event|4|||
105715823|NCT01808612|364619394|FG002|Treatment Period|Adverse Event|3|||
105715824|NCT01808612|364619392|FG000|Treatment Period|Lost to Follow-up|2|||
105715825|NCT01808612|364619393|FG001|Treatment Period|Lost to Follow-up|2|||
105715826|NCT01808612|364619394|FG002|Treatment Period|Lost to Follow-up|1|||
105715827|NCT01808612|364619392|FG000|Treatment Period|Protocol Violation|1|||
105715828|NCT01808612|364619393|FG001|Treatment Period|Protocol Violation|0|||
106008650|NCT00107653|365697052|FG001|Overall Study|Administrative Reasons|3|||
105789791|NCT01525407|364883430|FG001|Overall Study|Transplant was delayed|1|||
105789792|NCT01525407|364883429|FG000|Overall Study|Delay in Transplant|1|||
105789793|NCT01525407|364883430|FG001|Overall Study|Delay in Transplant|0|||
105789794|NCT05257109|364883431|FG000|Overall Study|Withdrawal by Subject|1|||
105715829|NCT01808612|364619394|FG002|Treatment Period|Protocol Violation|0|||
105715830|NCT01808612|364619392|FG000|Treatment Period|Withdrawal by Subject|1|||
105715831|NCT01808612|364619393|FG001|Treatment Period|Withdrawal by Subject|0|||
105715832|NCT01808612|364619394|FG002|Treatment Period|Withdrawal by Subject|4|||
105715833|NCT01808612|364619392|FG000|Treatment Period|Physician Decision|1|||
105715834|NCT01808612|364619393|FG001|Treatment Period|Physician Decision|0|||
105715835|NCT01808612|364619394|FG002|Treatment Period|Physician Decision|4|||
105715836|NCT01808612|364619392|FG000|Treatment Period|Sponsor Decision|1|||
105715837|NCT01808612|364619393|FG001|Treatment Period|Sponsor Decision|0|||
105789795|NCT05257109|364883432|FG001|Overall Study|Withdrawal by Subject|0|||
105789796|NCT05257109|364883433|FG002|Overall Study|Withdrawal by Subject|0|||
105789797|NCT05257109|364883434|FG003|Overall Study|Withdrawal by Subject|0|||
105715838|NCT01808612|364619394|FG002|Treatment Period|Sponsor Decision|0|||
105715839|NCT01808612|364619392|FG000|Treatment Period|Lack of Efficacy|1|||
105715840|NCT01808612|364619393|FG001|Treatment Period|Lack of Efficacy|1|||
105715841|NCT01808612|364619394|FG002|Treatment Period|Lack of Efficacy|2|||
105715842|NCT01808612|364619392|FG000|Discontinuation Period|Adverse Event|1|||
105715843|NCT01808612|364619393|FG001|Discontinuation Period|Adverse Event|0|||
105715844|NCT01808612|364619394|FG002|Discontinuation Period|Adverse Event|0|||
105715845|NCT01808612|364619392|FG000|Discontinuation Period|Physician Decision|1|||
105715846|NCT01808612|364619393|FG001|Discontinuation Period|Physician Decision|0|||
105715847|NCT01808612|364619394|FG002|Discontinuation Period|Physician Decision|0|||
105789798|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
105789799|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
105715848|NCT01808612|364619392|FG000|Discontinuation Period|Lost to Follow-up|0|||
105715849|NCT01808612|364619393|FG001|Discontinuation Period|Lost to Follow-up|1|||
105715850|NCT01808612|364619394|FG002|Discontinuation Period|Lost to Follow-up|0|||
105715851|NCT03739528|364619396|FG000|Overall Study|Not treated|8|||
105715852|NCT03739528|364619397|FG001|Overall Study|Not treated|12|||
105715853|NCT03739528|364619396|FG000|Overall Study|Treatment and study discontinued|6|||
105715854|NCT03739528|364619397|FG001|Overall Study|Treatment and study discontinued|2|||
105715855|NCT03739528|364619396|FG000|Overall Study|Treatment discontinued + study completed|1|||
105715856|NCT03739528|364619397|FG001|Overall Study|Treatment discontinued + study completed|3|||
105715857|NCT01046695|364619398|FG000|Overall Study|Subject had a pacemaker|0|||
105715858|NCT01046695|364619399|FG001|Overall Study|Subject had a pacemaker|1|||
105715859|NCT01046695|364619398|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
105715860|NCT01046695|364619399|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
105715861|NCT04303000|364619400|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
105715862|NCT04303000|364619401|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
105715863|NCT04303000|364619402|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
105715864|NCT04178772|364619403|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
105715865|NCT04178772|364619403|FG000|Overall Study|study terminated early due to COVID-19|7|||
105715866|NCT00880256|364619410|FG000|Overall Study|Lost to Follow-up|28|||
105715867|NCT01225562|364619413|FG000|Overall Study|Withdrawal by Subject|52|||
105715868|NCT01225562|364619414|FG001|Overall Study|Withdrawal by Subject|50|||
105715869|NCT01225562|364619415|FG002|Overall Study|Withdrawal by Subject|52|||
105715870|NCT01225562|364619413|FG000|Overall Study|Lost to Follow-up|3|||
105715871|NCT01225562|364619414|FG001|Overall Study|Lost to Follow-up|6|||
105789800|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
105789801|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
105715872|NCT01225562|364619415|FG002|Overall Study|Lost to Follow-up|1|||
105715873|NCT02629159|364619420|FG000|Overall Study|Adverse Event|17|||
105715874|NCT02629159|364619421|FG001|Overall Study|Adverse Event|20|||
105931971|NCT00676052|365410819|FG003|Overall Study|Withdrawal by Subject|0|||
105931972|NCT00676052|365410820|FG004|Overall Study|Withdrawal by Subject|0|||
105931973|NCT00676052|365410821|FG005|Overall Study|Withdrawal by Subject|0|||
105931974|NCT00585585|365410830|FG000|Overall Study|Adverse Event|1|||
105931975|NCT00965094|365410840|FG000|Overall Study|Adverse Event|5|||
105931976|NCT00965094|365410841|FG001|Overall Study|Adverse Event|0|||
105931977|NCT00965094|365410840|FG000|Overall Study|Lost to Follow-up|0|||
105931978|NCT00965094|365410841|FG001|Overall Study|Lost to Follow-up|1|||
105715875|NCT02629159|364619422|FG002|Overall Study|Adverse Event|22|||
105715876|NCT02629159|364619420|FG000|Overall Study|Withdrawal by Subject|22|||
105715877|NCT02629159|364619421|FG001|Overall Study|Withdrawal by Subject|11|||
105715878|NCT02629159|364619422|FG002|Overall Study|Withdrawal by Subject|15|||
105715879|NCT02629159|364619420|FG000|Overall Study|Lost to Follow-up|7|||
105715880|NCT02629159|364619421|FG001|Overall Study|Lost to Follow-up|4|||
105715881|NCT02629159|364619422|FG002|Overall Study|Lost to Follow-up|5|||
105715882|NCT02629159|364619420|FG000|Overall Study|Lack of Efficacy|4|||
105715883|NCT02629159|364619421|FG001|Overall Study|Lack of Efficacy|0|||
105715884|NCT02629159|364619422|FG002|Overall Study|Lack of Efficacy|1|||
105715885|NCT02629159|364619420|FG000|Overall Study|Other|6|||
105715886|NCT02629159|364619421|FG001|Overall Study|Other|4|||
105715887|NCT02629159|364619422|FG002|Overall Study|Other|8|||
105715888|NCT00565617|364619423|FG000|Overall Study|Withdrawal by Subject|1|||
105715889|NCT01890421|364619424|FG000|Overall Study|Adverse Event|1|||
105715890|NCT01890421|364619424|FG000|Overall Study|Other reason|10|||
105715891|NCT01446419|364619425|FG000|Overall Study|Death|1|||
105715892|NCT01446419|364619426|FG001|Overall Study|Death|0|||
105715893|NCT01446419|364619425|FG000|Overall Study|Withdrawal by Subject|1|||
105715894|NCT01446419|364619426|FG001|Overall Study|Withdrawal by Subject|1|||
105715895|NCT01446419|364619425|FG000|Overall Study|Terminated per protocol|3|||
105715896|NCT01446419|364619426|FG001|Overall Study|Terminated per protocol|0|||
105715897|NCT00464178|364619427|FG000|Overall Study|Protocol Violation|1|||
105715898|NCT00464178|364619427|FG000|Overall Study|Withdrawal by Subject|1|||
105715899|NCT04506294|364619428|FG000|Overall Study|Lost to Follow-up|70|||
105715900|NCT04506294|364619429|FG001|Overall Study|Lost to Follow-up|20|||
105715901|NCT04506294|364619428|FG000|Overall Study|Withdrawal by Subject|16|||
105715902|NCT04506294|364619429|FG001|Overall Study|Withdrawal by Subject|2|||
105715903|NCT02317562|364619433|FG000|Overall Study|Physician Decision|1|||
105715904|NCT02317562|364619433|FG000|Overall Study|early termination of the study|8|||
105715905|NCT02317562|364619433|FG000|Overall Study|Lack of Efficacy|4|||
105715906|NCT02317562|364619433|FG000|Overall Study|Withdrawal by Subject|1|||
105715907|NCT00911989|364619434|FG000|Overall Study|Adverse Event|1|||
105715908|NCT02445586|364619437|FG000|Overall Study|Death|14|||
105715909|NCT02445586|364619437|FG000|Overall Study|Withdrawal by Subject|13|||
105715910|NCT02445586|364619437|FG000|Overall Study|Disease Progression|10|||
105715911|NCT02445586|364619437|FG000|Overall Study|Protocol Violation|1|||
105715912|NCT02445586|364619437|FG000|Overall Study|Medical Condition|1|||
105715913|NCT00428597|364619442|FG000|Overall Study|Randomized but not treated|3|||
105715914|NCT00428597|364619443|FG001|Overall Study|Randomized but not treated|3|||
105715915|NCT00428597|364619442|FG000|Overall Study|Objective Progression or Relapse|19|||
105715916|NCT00428597|364619443|FG001|Overall Study|Objective Progression or Relapse|47|||
105715917|NCT00428597|364619442|FG000|Overall Study|Study Terminated by Sponsor|41|||
105715918|NCT00428597|364619443|FG001|Overall Study|Study Terminated by Sponsor|16|||
105715919|NCT00428597|364619442|FG000|Overall Study|Adverse Event|15|||
105715920|NCT00428597|364619443|FG001|Overall Study|Adverse Event|7|||
105715921|NCT00428597|364619442|FG000|Overall Study|Global Deterioration of Health Status|1|||
105715922|NCT00428597|364619443|FG001|Overall Study|Global Deterioration of Health Status|5|||
105715923|NCT00428597|364619442|FG000|Overall Study|Protocol Violation|2|||
105715924|NCT00428597|364619443|FG001|Overall Study|Protocol Violation|1|||
105715925|NCT00428597|364619442|FG000|Overall Study|Withdrawal by Subject|2|||
105715926|NCT00428597|364619443|FG001|Overall Study|Withdrawal by Subject|1|||
105715927|NCT00428597|364619442|FG000|Overall Study|Other|1|||
105715928|NCT00428597|364619443|FG001|Overall Study|Other|1|||
105715929|NCT00428597|364619442|FG000|Overall Study|Lost to Follow-up|0|||
105715930|NCT00428597|364619443|FG001|Overall Study|Lost to Follow-up|1|||
105715931|NCT00428597|364619442|FG000|Overall Study|Pregnancy|1|||
105715932|NCT00428597|364619443|FG001|Overall Study|Pregnancy|0|||
105715933|NCT00428597|364619442|FG000|Overall Study|Death|1|||
105715934|NCT00428597|364619443|FG001|Overall Study|Death|3|||
105715935|NCT03519971|364619444|FG000|Overall Study|Death|142|||
105715936|NCT03519971|364619445|FG001|Overall Study|Death|69|||
105715937|NCT03519971|364619444|FG000|Overall Study|Lost to Follow-up|0|||
105715938|NCT03519971|364619445|FG001|Overall Study|Lost to Follow-up|1|||
105715939|NCT03519971|364619444|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
105715940|NCT03519971|364619445|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
105931979|NCT04233580|365410842|FG000|Overall Study|Adverse Event|3|||
105931980|NCT04233580|365410843|FG001|Overall Study|Adverse Event|3|||
105931981|NCT04233580|365410842|FG000|Overall Study|Withdrawal by Subject|2|||
105715941|NCT03519971|364619444|FG000|Overall Study|Withdrawal by Subject|3|||
105715942|NCT03519971|364619445|FG001|Overall Study|Withdrawal by Subject|2|||
105715943|NCT03519971|364619444|FG000|Overall Study|Other|1|||
105715944|NCT03519971|364619445|FG001|Overall Study|Other|0|||
105715945|NCT01078805|364619449|FG000|Overall Study|Clinically significant abnormal lab|5|||
105715946|NCT01078805|364619449|FG000|Overall Study|Death|134|||
105715947|NCT01078805|364619449|FG000|Overall Study|Lost to Follow-up|676|||
105715948|NCT01078805|364619449|FG000|Overall Study|Physician Decision|169|||
105715949|NCT01078805|364619449|FG000|Overall Study|Serious adverse event|26|||
105715950|NCT01078805|364619449|FG000|Overall Study|Sponsor decision|46|||
105715951|NCT01078805|364619449|FG000|Overall Study|Withdrawal by Subject|739|||
105715952|NCT01078805|364619449|FG000|Overall Study|Other|173|||
105715953|NCT01078805|364619449|FG000|Overall Study|Didn't take study drug|82|||
105715954|NCT01609842|364619450|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
105715955|NCT01609842|364619451|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
105715956|NCT05168267|364619452|FG000|Overall Study|Withdrawal by Subject|2|||
105715957|NCT05168267|364619453|FG001|Overall Study|Withdrawal by Subject|1|||
105715958|NCT05168267|364619452|FG000|Overall Study|Withdrawn by Therapist|1|||
105715959|NCT05168267|364619453|FG001|Overall Study|Withdrawn by Therapist|1|||
105715960|NCT05168267|364619452|FG000|Overall Study|Left Facility|1|||
105715961|NCT05168267|364619453|FG001|Overall Study|Left Facility|0|||
105715962|NCT05702736|364619461|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
105715963|NCT05702736|364619462|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
105715964|NCT05702736|364619461|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
105715965|NCT05702736|364619462|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
105715966|NCT01182428|364619463|FG000|Overall Study|Physician Decision|1|||
105715967|NCT01182428|364619464|FG001|Overall Study|Physician Decision|0|||
105715968|NCT01182428|364619463|FG000|Overall Study|Lost to Follow-up|9|||
105715969|NCT01182428|364619464|FG001|Overall Study|Lost to Follow-up|1|||
105715970|NCT01182428|364619463|FG000|Overall Study|Withdrawal by Subject|1|||
105715971|NCT01182428|364619464|FG001|Overall Study|Withdrawal by Subject|0|||
105715972|NCT03631706|364619465|FG000|Overall Study|Randomized, not treated|1|||
105715973|NCT03631706|364619466|FG001|Overall Study|Randomized, not treated|0|||
105931982|NCT04233580|365410843|FG001|Overall Study|Withdrawal by Subject|1|||
105931983|NCT00378560|365410844|FG000|Overall Study|Adverse Event|1|||
105931984|NCT00378560|365410845|FG001|Overall Study|Adverse Event|0|||
105931985|NCT00378560|365410844|FG000|Overall Study|Lost to Follow-up|24|||
105931986|NCT00378560|365410845|FG001|Overall Study|Lost to Follow-up|29|||
105931987|NCT00378560|365410844|FG000|Overall Study|Protocol Violation|2|||
105931988|NCT00378560|365410845|FG001|Overall Study|Protocol Violation|0|||
105931989|NCT00378560|365410844|FG000|Overall Study|Withdrawal by Subject|17|||
105931990|NCT00378560|365410845|FG001|Overall Study|Withdrawal by Subject|21|||
105931991|NCT00378560|365410844|FG000|Overall Study|Moved|4|||
105931992|NCT00378560|365410845|FG001|Overall Study|Moved|3|||
105931993|NCT00378560|365410844|FG000|Overall Study|Pregnancy|7|||
105931994|NCT00378560|365410845|FG001|Overall Study|Pregnancy|5|||
105931995|NCT00378560|365410844|FG000|Overall Study|Laboratory test values abnormal|1|||
105931996|NCT00378560|365410845|FG001|Overall Study|Laboratory test values abnormal|0|||
105931997|NCT00976391|365410851|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
105931998|NCT00976391|365410852|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
105931999|NCT00976391|365410851|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
105715974|NCT04484285|364621711|FG000|Overall Study|Unable to operate stimulator|3|||
105715975|NCT04484285|364621712|FG001|Overall Study|Unable to operate stimulator|0|||
105715976|NCT06272370|364621713|FG000|Overall Study|Lost to Follow-up|0|||
105715977|NCT06272370|364621714|FG001|Overall Study|Lost to Follow-up|3|||
105715978|NCT06272370|364621715|FG002|Overall Study|Lost to Follow-up|1|||
105715979|NCT06272370|364621716|FG003|Overall Study|Lost to Follow-up|1|||
105715980|NCT05888103|364621717|FG000|Overall Study|Participant decision|3|||
105715981|NCT05888103|364621718|FG001|Overall Study|Participant decision|3|||
105715982|NCT04439175|364621719|FG000|Overall Study|Never started treatment|4|||
105715983|NCT04439175|364621719|FG000|Overall Study|Ineligible|5|||
105715984|NCT04439175|364621719|FG000|Overall Study|Adverse Event|6|||
105715985|NCT04439175|364621719|FG000|Overall Study|Death|4|||
105715986|NCT04439175|364621719|FG000|Overall Study|Disease progression|44|||
105715987|NCT04439175|364621719|FG000|Overall Study|Withdrawal by Subject|4|||
105715988|NCT04439175|364621719|FG000|Overall Study|Alternative Therapy|1|||
105715989|NCT04439175|364621719|FG000|Overall Study|Other|2|||
105715990|NCT05280756|364621720|FG000|Overall Study|Lost to Follow-up|1|||
105715991|NCT05280756|364621721|FG001|Overall Study|Lost to Follow-up|1|||
105932000|NCT00976391|365410852|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
105932001|NCT00976391|365410851|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
105932002|NCT00976391|365410852|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
105932003|NCT00976391|365410851|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
105932004|NCT00976391|365410852|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
105932005|NCT00976391|365410851|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
105932006|NCT00976391|365410852|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
105715992|NCT02363478|364621726|FG000|Overall Study|Lost to Follow-up|4|||
105715993|NCT02363478|364621726|FG000|Overall Study|Adverse Event|4|||
105715994|NCT00542997|364621729|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
105715995|NCT00542997|364621729|FG000|Wash in / Wash Out Period|Adverse Event|3|||
105715996|NCT00542997|364621729|FG000|Efficacy Period|Adverse Event|3|||
105715997|NCT00352534|364621730|FG000|Initial Staging|Ineligible|8|||
105715998|NCT00352534|364621731|FG001|Initial Staging|Ineligible|9|||
105715999|NCT00352534|364621732|FG002|Initial Staging|Ineligible|0|||
105716000|NCT00352534|364621733|FG003|Initial Staging|Ineligible|0|||
105716001|NCT00352534|364621734|FG004|Initial Staging|Ineligible|0|||
105716002|NCT00352534|364621735|FG005|Initial Staging|Ineligible|0|||
105716003|NCT00352534|364621736|FG006|Initial Staging|Ineligible|0|||
105716004|NCT00352534|364621730|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
105716005|NCT00352534|364621731|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
105716006|NCT00352534|364621732|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
105716007|NCT00352534|364621733|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
105716008|NCT00352534|364621734|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
105716009|NCT00352534|364621735|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
105716010|NCT00352534|364621736|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
105716011|NCT00352534|364621730|FG000|Final Risk Group Assignment|Physician Decision|0|||
105716012|NCT00352534|364621731|FG001|Final Risk Group Assignment|Physician Decision|0|||
105716013|NCT00352534|364621732|FG002|Final Risk Group Assignment|Physician Decision|0|||
105716014|NCT00352534|364621733|FG003|Final Risk Group Assignment|Physician Decision|0|||
105716015|NCT00352534|364621734|FG004|Final Risk Group Assignment|Physician Decision|0|||
105716016|NCT00352534|364621735|FG005|Final Risk Group Assignment|Physician Decision|8|||
105716017|NCT00352534|364621736|FG006|Final Risk Group Assignment|Physician Decision|0|||
105716018|NCT00352534|364621730|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716019|NCT00352534|364621731|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716020|NCT00352534|364621732|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716021|NCT00352534|364621733|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716022|NCT00352534|364621734|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716023|NCT00352534|364621735|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
105716024|NCT00352534|364621736|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
105716025|NCT00352534|364621730|FG000|Final Risk Group Assignment|Ineligible|0|||
105716026|NCT00352534|364621731|FG001|Final Risk Group Assignment|Ineligible|0|||
105716027|NCT00352534|364621732|FG002|Final Risk Group Assignment|Ineligible|3|||
105716028|NCT00352534|364621733|FG003|Final Risk Group Assignment|Ineligible|1|||
105716029|NCT00352534|364621734|FG004|Final Risk Group Assignment|Ineligible|0|||
105716030|NCT00352534|364621735|FG005|Final Risk Group Assignment|Ineligible|13|||
105716031|NCT00352534|364621736|FG006|Final Risk Group Assignment|Ineligible|0|||
105716032|NCT00352534|364621730|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716033|NCT00352534|364621731|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716034|NCT00352534|364621732|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716035|NCT00352534|364621733|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716036|NCT00352534|364621734|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716037|NCT00352534|364621735|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
105716038|NCT00352534|364621736|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
105716039|NCT00352534|364621730|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716040|NCT00352534|364621731|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716041|NCT00352534|364621732|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716042|NCT00352534|364621733|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716043|NCT00352534|364621734|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716044|NCT00352534|364621735|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
105716045|NCT00352534|364621736|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
105716046|NCT00352534|364621730|FG000|Final Risk Group Assignment|Death|0|||
105716047|NCT00352534|364621731|FG001|Final Risk Group Assignment|Death|0|||
105716048|NCT00352534|364621732|FG002|Final Risk Group Assignment|Death|0|||
105716049|NCT00352534|364621733|FG003|Final Risk Group Assignment|Death|0|||
105716050|NCT00352534|364621734|FG004|Final Risk Group Assignment|Death|0|||
105716051|NCT00352534|364621735|FG005|Final Risk Group Assignment|Death|2|||
105716052|NCT00352534|364621736|FG006|Final Risk Group Assignment|Death|0|||
105716053|NCT01602341|364621739|FG000|Overall Study|Adverse Event|0|||
105716054|NCT01602341|364621740|FG001|Overall Study|Adverse Event|1|||
105716055|NCT01916980|364621741|FG000|Overall Study|Adverse Event|4|||
105716056|NCT01916980|364621742|FG001|Overall Study|Adverse Event|2|||
105716057|NCT01916980|364621741|FG000|Overall Study|Lack of Efficacy|2|||
105716058|NCT01916980|364621742|FG001|Overall Study|Lack of Efficacy|2|||
105716059|NCT01916980|364621741|FG000|Overall Study|Withdrawal by Subject|1|||
105716060|NCT01916980|364621742|FG001|Overall Study|Withdrawal by Subject|0|||
105716061|NCT02090855|364621743|FG000|Overall Study|no evaluable Standard of Truth results|2|||
105716062|NCT03786432|364621745|FG000|Overall Study|Screen Failure after consent|1|||
105716063|NCT03786432|364621745|FG000|Overall Study|Lost to Follow-up|4|||
105716064|NCT03786432|364621745|FG000|Overall Study|did not complete 12 month CT scan|1|||
105716065|NCT00388947|364621746|FG000|Overall Study|Protocol Violation|47|||
105716066|NCT03038308|364621747|FG000|Overall Study|Surgical resection|1|||
105716067|NCT03038308|364621747|FG000|Overall Study|Withdrawal by Subject|2|||
105716068|NCT03038308|364621747|FG000|Overall Study|Lost to Follow-up|1|||
105716069|NCT00544869|364621749|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
105716070|NCT00544869|364621750|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
105716071|NCT00544869|364621751|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
105716072|NCT00544869|364621749|FG000|Overall Study|Adverse Event|6|||
105716073|NCT00544869|364621750|FG001|Overall Study|Adverse Event|1|||
105716074|NCT00544869|364621751|FG002|Overall Study|Adverse Event|0|||
105716075|NCT00544869|364621749|FG000|Overall Study|Lack of Efficacy|1|||
105716076|NCT00544869|364621750|FG001|Overall Study|Lack of Efficacy|1|||
105716077|NCT00544869|364621751|FG002|Overall Study|Lack of Efficacy|0|||
105716078|NCT00544869|364621749|FG000|Overall Study|Physician Decision|2|||
105716079|NCT00544869|364621750|FG001|Overall Study|Physician Decision|0|||
105716080|NCT00544869|364621751|FG002|Overall Study|Physician Decision|0|||
105716081|NCT00619502|364621752|FG000|Overall Study|Lost to Follow-up|8|||
105716082|NCT00619502|364621753|FG001|Overall Study|Lost to Follow-up|10|||
105716083|NCT01354028|364621754|FG000|Overall Study|Physician Decision|0|||
105716084|NCT01354028|364621755|FG001|Overall Study|Physician Decision|2|||
105716085|NCT01354028|364621754|FG000|Overall Study|Discharged before study start|2|||
105716086|NCT01354028|364621755|FG001|Overall Study|Discharged before study start|2|||
105716087|NCT01354028|364621754|FG000|Overall Study|No quiet alert state|0|||
105716088|NCT01354028|364621755|FG001|Overall Study|No quiet alert state|1|||
105716089|NCT00667576|364621756|FG000|Overall Study|Withdrawal by Subject|1|||
105716090|NCT00667576|364621757|FG001|Overall Study|Withdrawal by Subject|0|||
105716091|NCT00667576|364621758|FG002|Overall Study|Withdrawal by Subject|1|||
105716092|NCT00667576|364621759|FG003|Overall Study|Withdrawal by Subject|1|||
105716093|NCT00667576|364621760|FG004|Overall Study|Withdrawal by Subject|1|||
105716094|NCT00667576|364621756|FG000|Overall Study|Adverse Event|1|||
105716095|NCT00667576|364621757|FG001|Overall Study|Adverse Event|1|||
105716096|NCT00667576|364621758|FG002|Overall Study|Adverse Event|0|||
105716097|NCT00667576|364621759|FG003|Overall Study|Adverse Event|0|||
105716098|NCT00667576|364621760|FG004|Overall Study|Adverse Event|0|||
105716099|NCT00667576|364621756|FG000|Overall Study|Lost to Follow-up|0|||
105716100|NCT00667576|364621757|FG001|Overall Study|Lost to Follow-up|0|||
105716101|NCT00667576|364621758|FG002|Overall Study|Lost to Follow-up|1|||
105716102|NCT00667576|364621759|FG003|Overall Study|Lost to Follow-up|0|||
105716103|NCT00667576|364621760|FG004|Overall Study|Lost to Follow-up|0|||
105716104|NCT00667576|364621756|FG000|Overall Study|Protocol Violation|0|||
105716105|NCT00667576|364621757|FG001|Overall Study|Protocol Violation|0|||
105716106|NCT00667576|364621758|FG002|Overall Study|Protocol Violation|0|||
105716107|NCT00667576|364621759|FG003|Overall Study|Protocol Violation|1|||
105716108|NCT00667576|364621760|FG004|Overall Study|Protocol Violation|0|||
105716109|NCT00667576|364621756|FG000|Overall Study|Physician Decision|0|||
105716110|NCT00667576|364621757|FG001|Overall Study|Physician Decision|0|||
105716111|NCT00667576|364621758|FG002|Overall Study|Physician Decision|0|||
105716112|NCT00667576|364621759|FG003|Overall Study|Physician Decision|1|||
105716113|NCT00667576|364621760|FG004|Overall Study|Physician Decision|0|||
105716114|NCT00667576|364621756|FG000|Overall Study|Missed Visit|0|||
105716115|NCT00667576|364621757|FG001|Overall Study|Missed Visit|0|||
105716116|NCT00667576|364621758|FG002|Overall Study|Missed Visit|0|||
105716117|NCT00667576|364621759|FG003|Overall Study|Missed Visit|1|||
105716118|NCT00667576|364621760|FG004|Overall Study|Missed Visit|0|||
105716119|NCT03968419|364621761|FG000|Treatment Period|Adverse Event|0|||
105716120|NCT03968419|364621762|FG001|Treatment Period|Adverse Event|0|||
105716121|NCT03968419|364621763|FG002|Treatment Period|Adverse Event|1|||
105716122|NCT03968419|364621761|FG000|Safety Follow-up Period|Death|3|||
105716123|NCT03968419|364621762|FG001|Safety Follow-up Period|Death|2|||
105716124|NCT03968419|364621763|FG002|Safety Follow-up Period|Death|1|||
105716125|NCT03968419|364621761|FG000|Safety Follow-up Period|Subject Decision|2|||
105716126|NCT03968419|364621762|FG001|Safety Follow-up Period|Subject Decision|1|||
105716127|NCT03968419|364621763|FG002|Safety Follow-up Period|Subject Decision|0|||
105716128|NCT00925600|364621764|FG000|Overall Study|Withdrawal by Subject|16|||
105716129|NCT00925600|364621765|FG001|Overall Study|Withdrawal by Subject|14|||
105716130|NCT00925600|364621764|FG000|Overall Study|Death|4|||
105716131|NCT00925600|364621765|FG001|Overall Study|Death|3|||
105716132|NCT00925600|364621764|FG000|Overall Study|Lost to Follow-up|2|||
105716133|NCT00925600|364621765|FG001|Overall Study|Lost to Follow-up|2|||
105716134|NCT00925600|364621764|FG000|Overall Study|Disease Progression|1|||
105716135|NCT00925600|364621765|FG001|Overall Study|Disease Progression|3|||
105716136|NCT00925600|364621764|FG000|Overall Study|Administrative Decision|1|||
105716137|NCT00925600|364621765|FG001|Overall Study|Administrative Decision|1|||
105716138|NCT00925600|364621764|FG000|Overall Study|Noncompliance|2|||
105716139|NCT00925600|364621765|FG001|Overall Study|Noncompliance|0|||
105716140|NCT00925600|364621764|FG000|Overall Study|Ineligibility Determined|2|||
105716141|NCT00925600|364621765|FG001|Overall Study|Ineligibility Determined|0|||
105716142|NCT00925600|364621764|FG000|Overall Study|Protocol Deviation|0|||
105716143|NCT00925600|364621765|FG001|Overall Study|Protocol Deviation|1|||
105789802|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
105716144|NCT00925600|364621764|FG000|Overall Study|Requirement for Alternative Therapy|0|||
105716145|NCT00925600|364621765|FG001|Overall Study|Requirement for Alternative Therapy|1|||
105716146|NCT00925600|364621764|FG000|Overall Study|Other|3|||
105716147|NCT00925600|364621765|FG001|Overall Study|Other|1|||
105716148|NCT00925600|364621764|FG000|Overall Study|Adverse Event|1|||
105716149|NCT00925600|364621765|FG001|Overall Study|Adverse Event|2|||
105716150|NCT05512949|364621766|FG000|Overall Study|Lost to Follow-up|4|||
105716151|NCT05512949|364621767|FG001|Overall Study|Lost to Follow-up|6|||
105716152|NCT05512949|364621768|FG002|Overall Study|Lost to Follow-up|2|||
105716153|NCT05512949|364621766|FG000|Overall Study|Protocol Violation|0|||
105716154|NCT05512949|364621767|FG001|Overall Study|Protocol Violation|0|||
105716155|NCT05512949|364621768|FG002|Overall Study|Protocol Violation|1|||
105716156|NCT05512949|364621766|FG000|Overall Study|Withdrawal by Subject|1|||
105716157|NCT05512949|364621767|FG001|Overall Study|Withdrawal by Subject|1|||
105716158|NCT05512949|364621768|FG002|Overall Study|Withdrawal by Subject|2|||
105716159|NCT05512949|364621766|FG000|Overall Study|Completion status unknown|1|||
105716160|NCT05512949|364621767|FG001|Overall Study|Completion status unknown|3|||
105716161|NCT05512949|364621768|FG002|Overall Study|Completion status unknown|0|||
105716162|NCT03593915|364621769|FG000|Overall Study|Adverse Event|0|||
105716163|NCT03593915|364621770|FG001|Overall Study|Adverse Event|0|||
105716164|NCT03593915|364621771|FG002|Overall Study|Adverse Event|0|||
105716165|NCT03593915|364621772|FG003|Overall Study|Adverse Event|1|||
105716166|NCT03593915|364621773|FG004|Overall Study|Adverse Event|0|||
105716167|NCT03593915|364621774|FG005|Overall Study|Adverse Event|0|||
105716168|NCT03593915|364621769|FG000|Overall Study|Physician Decision|0|||
105716169|NCT03593915|364621770|FG001|Overall Study|Physician Decision|0|||
105716170|NCT03593915|364621771|FG002|Overall Study|Physician Decision|0|||
105716171|NCT03593915|364621772|FG003|Overall Study|Physician Decision|0|||
105716172|NCT03593915|364621773|FG004|Overall Study|Physician Decision|0|||
105716173|NCT03593915|364621774|FG005|Overall Study|Physician Decision|1|||
105716174|NCT02002975|364621775|FG000|Overall Study|Case Report Forms Uncollected|135|||
105716175|NCT02002975|364621775|FG000|Overall Study|Protocol Deviation|437|||
105716176|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
105716177|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
105716178|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
105716179|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
105716180|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
105716181|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
105716182|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
105716183|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
105716184|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
105716185|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
105789803|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
105789804|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
105789805|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
105716186|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
105716187|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
105716188|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
105716189|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
105716190|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
105716191|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
105716192|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
105716193|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
105716194|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
105716195|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
105716196|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
105716197|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
105716198|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
105789806|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
105716199|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
105716200|NCT04660643|364621776|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
105716201|NCT04660643|364621777|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
105716202|NCT04660643|364621778|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
105716203|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
105932007|NCT00976391|365410851|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
105716204|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
105716205|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
105716206|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
105716207|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
105716208|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
105716209|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
105716210|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
105716211|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
105716212|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
105716213|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
105716214|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
105716215|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
105716216|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
105716217|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
105716218|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
105716219|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
105716220|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
105716221|NCT04660643|364621776|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
105716222|NCT04660643|364621777|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
105716223|NCT04660643|364621778|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
105716224|NCT00167245|364621783|FG000|Overall Study|Lost to Follow-up|20|||
105716225|NCT00167245|364621784|FG001|Overall Study|Lost to Follow-up|31|||
105716226|NCT00167245|364621783|FG000|Overall Study|Withdrawal by Subject|5|||
105716227|NCT00167245|364621784|FG001|Overall Study|Withdrawal by Subject|8|||
105716228|NCT00167245|364621783|FG000|Overall Study|Incarcerated|3|||
105716229|NCT00167245|364621784|FG001|Overall Study|Incarcerated|2|||
105716230|NCT00167245|364621783|FG000|Overall Study|Drowsy|1|||
105716231|NCT00167245|364621784|FG001|Overall Study|Drowsy|0|||
105716232|NCT01307033|364621785|FG000|8-week Double-blind Period|Adverse Event|2|||
105716233|NCT01307033|364621786|FG001|8-week Double-blind Period|Adverse Event|0|||
105716234|NCT01307033|364621787|FG002|8-week Double-blind Period|Adverse Event|0|||
105716235|NCT01307033|364621788|FG003|8-week Double-blind Period|Adverse Event|0|||
105716236|NCT01307033|364621785|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
105716237|NCT01307033|364621786|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
105716238|NCT01307033|364621787|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
105716239|NCT01307033|364621788|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
105716240|NCT01307033|364621785|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
105716241|NCT01307033|364621786|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
105716242|NCT01307033|364621787|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
105716243|NCT01307033|364621788|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
105716244|NCT01307033|364621785|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
105716245|NCT01307033|364621786|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
105716246|NCT01307033|364621787|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
105716247|NCT01307033|364621788|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
105716248|NCT01307033|364621785|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
105716249|NCT01307033|364621786|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
105716250|NCT01307033|364621787|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
105716251|NCT01307033|364621788|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
105716252|NCT01307033|364621785|FG000|44-week Open-label Extension|Adverse Event|0|||
105716253|NCT01307033|364621786|FG001|44-week Open-label Extension|Adverse Event|0|||
105716254|NCT01307033|364621787|FG002|44-week Open-label Extension|Adverse Event|2|||
105716255|NCT01307033|364621788|FG003|44-week Open-label Extension|Adverse Event|1|||
105716256|NCT01307033|364621785|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
105716257|NCT01307033|364621786|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
105716258|NCT01307033|364621787|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
105716259|NCT01307033|364621788|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
105716260|NCT01307033|364621785|FG000|44-week Open-label Extension|Physician Decision|0|||
105716261|NCT01307033|364621786|FG001|44-week Open-label Extension|Physician Decision|0|||
105789807|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
105789808|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
105789809|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
105716262|NCT01307033|364621787|FG002|44-week Open-label Extension|Physician Decision|1|||
105716263|NCT01307033|364621788|FG003|44-week Open-label Extension|Physician Decision|0|||
105716264|NCT01307033|364621785|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
105716265|NCT01307033|364621786|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
105716266|NCT01307033|364621787|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
105789810|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
105716267|NCT01307033|364621788|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
105716268|NCT01307033|364621785|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
105716269|NCT01307033|364621786|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
105716270|NCT01307033|364621787|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
105716271|NCT01307033|364621788|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
105716272|NCT01307033|364621785|FG000|44-week Open-label Extension|Death|0|||
105716273|NCT01307033|364621786|FG001|44-week Open-label Extension|Death|0|||
105716274|NCT01307033|364621787|FG002|44-week Open-label Extension|Death|0|||
105716275|NCT01307033|364621788|FG003|44-week Open-label Extension|Death|1|||
105716276|NCT01231555|364621789|FG000|Overall Study|Study terminated|8|||
105716277|NCT01231555|364621790|FG001|Overall Study|Study terminated|5|||
105716278|NCT01231555|364621791|FG002|Overall Study|Study terminated|8|||
105716279|NCT01231555|364621789|FG000|Overall Study|Withdrawal by Subject|0|||
105716280|NCT01231555|364621790|FG001|Overall Study|Withdrawal by Subject|2|||
105789811|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
105716281|NCT01231555|364621791|FG002|Overall Study|Withdrawal by Subject|0|||
105716282|NCT00804687|364621792|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
105716283|NCT00804687|364621793|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
105716284|NCT00804687|364621794|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
105716285|NCT00804687|364621795|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
105716286|NCT00804687|364621796|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
105716287|NCT00804687|364621797|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
105716288|NCT00804687|364621792|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716289|NCT00804687|364621793|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716290|NCT00804687|364621794|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716291|NCT00804687|364621795|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716292|NCT00804687|364621796|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
105716293|NCT00804687|364621797|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
105716294|NCT00804687|364621792|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716295|NCT00804687|364621793|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716296|NCT00804687|364621794|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
105789812|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
105789813|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
105789814|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
105789815|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
105789816|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
105789817|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
105789818|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
105789819|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
105789820|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
105789821|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
105789822|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
105789823|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
105789824|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
105789825|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
105789826|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789827|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789828|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789829|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789830|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789831|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789832|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
105789833|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
105789834|NCT00563706|364884920|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789835|NCT00563706|364884921|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789836|NCT00563706|364884922|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105932008|NCT00976391|365410852|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
105932009|NCT00976391|365410851|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
105932010|NCT00976391|365410852|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
105932011|NCT00976391|365410851|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
105932012|NCT00976391|365410852|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
105932013|NCT00976391|365410851|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
105932014|NCT00976391|365410852|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
105932015|NCT00976391|365410851|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
105932016|NCT00976391|365410852|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
105932017|NCT00976391|365410851|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
105932018|NCT00976391|365410852|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
105932019|NCT00976391|365410851|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
105932020|NCT00976391|365410852|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
105932021|NCT00976391|365410851|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
105932022|NCT00976391|365410852|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
105932023|NCT00976391|365410851|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
105932024|NCT00976391|365410852|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
105932025|NCT01371565|365410853|FG000|Overall Study|Withdrawal by Subject|1|||
105932026|NCT01371565|365410853|FG000|Overall Study|Death|1|||
105716297|NCT00804687|364621795|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716298|NCT00804687|364621796|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716299|NCT00804687|364621797|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
105716300|NCT00804687|364621792|FG000|Period 5: Treatment Period|Positive drug test|1|||
105716301|NCT00804687|364621793|FG001|Period 5: Treatment Period|Positive drug test|0|||
105716302|NCT00804687|364621794|FG002|Period 5: Treatment Period|Positive drug test|0|||
105716303|NCT00804687|364621795|FG003|Period 5: Treatment Period|Positive drug test|0|||
105716304|NCT00804687|364621796|FG004|Period 5: Treatment Period|Positive drug test|0|||
105716305|NCT00804687|364621797|FG005|Period 5: Treatment Period|Positive drug test|0|||
105716306|NCT00947531|364621798|FG000|Overall Study|Withdrawal by Subject|10|||
105716307|NCT00947531|364621799|FG001|Overall Study|Withdrawal by Subject|7|||
105789837|NCT00563706|364884923|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789838|NCT00563706|364884924|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789839|NCT00563706|364884925|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105789840|NCT00563706|364884926|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
105716308|NCT00947531|364621798|FG000|Overall Study|Administrative Reason|0|||
105716309|NCT00947531|364621799|FG001|Overall Study|Administrative Reason|1|||
105716310|NCT00947531|364621798|FG000|Overall Study|Adverse Event|2|||
105716311|NCT00947531|364621799|FG001|Overall Study|Adverse Event|2|||
105716312|NCT00947531|364621798|FG000|Overall Study|Lack of Efficacy|1|||
105716313|NCT00947531|364621799|FG001|Overall Study|Lack of Efficacy|0|||
105716314|NCT00947531|364621798|FG000|Overall Study|Other|1|||
105716315|NCT00947531|364621799|FG001|Overall Study|Other|1|||
105716316|NCT01773421|364621801|FG000|Treatment Phase|Other|0|||
105716317|NCT01773421|364621802|FG001|Treatment Phase|Other|0|||
105716318|NCT01773421|364621803|FG002|Treatment Phase|Other|2|||
105716319|NCT01773421|364621804|FG003|Treatment Phase|Other|0|||
105716320|NCT01773421|364621805|FG004|Treatment Phase|Other|0|||
105716321|NCT01773421|364621806|FG005|Treatment Phase|Other|0|||
105716322|NCT01773421|364621807|FG006|Treatment Phase|Other|0|||
105716323|NCT01773421|364621801|FG000|Treatment Phase|Adverse Event|0|||
105716324|NCT01773421|364621802|FG001|Treatment Phase|Adverse Event|0|||
105716325|NCT01773421|364621803|FG002|Treatment Phase|Adverse Event|3|||
105716326|NCT01773421|364621804|FG003|Treatment Phase|Adverse Event|1|||
105716327|NCT01773421|364621805|FG004|Treatment Phase|Adverse Event|0|||
105716328|NCT01773421|364621806|FG005|Treatment Phase|Adverse Event|0|||
105716329|NCT01773421|364621807|FG006|Treatment Phase|Adverse Event|0|||
105716330|NCT01773421|364621801|FG000|Treatment Phase|Withdrawal by Subject|0|||
105716331|NCT01773421|364621802|FG001|Treatment Phase|Withdrawal by Subject|0|||
105716332|NCT01773421|364621803|FG002|Treatment Phase|Withdrawal by Subject|1|||
105716333|NCT01773421|364621804|FG003|Treatment Phase|Withdrawal by Subject|1|||
105716334|NCT01773421|364621805|FG004|Treatment Phase|Withdrawal by Subject|0|||
105716335|NCT01773421|364621806|FG005|Treatment Phase|Withdrawal by Subject|0|||
105716336|NCT01773421|364621807|FG006|Treatment Phase|Withdrawal by Subject|0|||
105716337|NCT01773421|364621801|FG000|Extension Phase|Other|0|||
105716338|NCT01773421|364621802|FG001|Extension Phase|Other|0|||
105716339|NCT01773421|364621803|FG002|Extension Phase|Other|0|||
105716340|NCT01773421|364621804|FG003|Extension Phase|Other|0|||
105716341|NCT01773421|364621805|FG004|Extension Phase|Other|1|||
105716342|NCT01773421|364621806|FG005|Extension Phase|Other|2|||
105716343|NCT01773421|364621807|FG006|Extension Phase|Other|0|||
105716344|NCT01773421|364621801|FG000|Extension Phase|Adverse Event|0|||
105716345|NCT01773421|364621802|FG001|Extension Phase|Adverse Event|0|||
105716346|NCT01773421|364621803|FG002|Extension Phase|Adverse Event|0|||
105716347|NCT01773421|364621804|FG003|Extension Phase|Adverse Event|0|||
105716348|NCT01773421|364621805|FG004|Extension Phase|Adverse Event|2|||
105716349|NCT01773421|364621806|FG005|Extension Phase|Adverse Event|0|||
105716350|NCT01773421|364621807|FG006|Extension Phase|Adverse Event|0|||
105716351|NCT02327260|364621808|FG000|Overall Study|Lost to Follow-up|2|||
105716352|NCT02327260|364621809|FG001|Overall Study|Lost to Follow-up|3|||
105716353|NCT02327260|364621810|FG002|Overall Study|Lost to Follow-up|2|||
105716354|NCT02327260|364621808|FG000|Overall Study|invalid phone number|1|||
105716355|NCT02327260|364621809|FG001|Overall Study|invalid phone number|1|||
105716356|NCT02327260|364621810|FG002|Overall Study|invalid phone number|0|||
105716357|NCT02327260|364621808|FG000|Overall Study|non-adherence to protocol|2|||
105716358|NCT02327260|364621809|FG001|Overall Study|non-adherence to protocol|0|||
105789841|NCT00563706|364884927|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
105932027|NCT01371565|365410853|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
105716359|NCT02327260|364621810|FG002|Overall Study|non-adherence to protocol|0|||
105716360|NCT02327260|364621808|FG000|Overall Study|cognitive concerns|1|||
105716361|NCT02327260|364621809|FG001|Overall Study|cognitive concerns|0|||
105716362|NCT02327260|364621810|FG002|Overall Study|cognitive concerns|0|||
105716363|NCT00688909|364621811|FG000|Overall Study|Adverse Event|28|||
105716364|NCT00688909|364621811|FG000|Overall Study|Patient withdrew consent|2|||
105716365|NCT00688909|364621811|FG000|Overall Study|Administrative problems|1|||
105932028|NCT04270760|365410854|FG000|Overall Study|Withdrawal by Subject|0|||
105716366|NCT00688909|364621811|FG000|Overall Study|Protocol Violation|2|||
105716367|NCT01220414|364621814|FG000|Overall Study|Withdrawal by Subject|1|||
105716368|NCT01220414|364621815|FG001|Overall Study|Withdrawal by Subject|0|||
105716369|NCT01220414|364621816|FG002|Overall Study|Withdrawal by Subject|0|||
105716370|NCT01220414|364621817|FG003|Overall Study|Withdrawal by Subject|1|||
105716371|NCT02804763|364621818|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
105716372|NCT02804763|364621819|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
105932029|NCT04270760|365410855|FG001|Overall Study|Withdrawal by Subject|1|||
105932030|NCT04270760|365410856|FG002|Overall Study|Withdrawal by Subject|3|||
105932031|NCT04270760|365410857|FG003|Overall Study|Withdrawal by Subject|0|||
105932032|NCT04270760|365410858|FG004|Overall Study|Withdrawal by Subject|0|||
105932033|NCT04270760|365410854|FG000|Overall Study|Lost to Follow-up|1|||
105932034|NCT04270760|365410855|FG001|Overall Study|Lost to Follow-up|2|||
105932035|NCT04270760|365410856|FG002|Overall Study|Lost to Follow-up|1|||
105932036|NCT04270760|365410857|FG003|Overall Study|Lost to Follow-up|0|||
105932037|NCT04270760|365410858|FG004|Overall Study|Lost to Follow-up|0|||
105932038|NCT04270760|365410854|FG000|Overall Study|Death|0|||
105716373|NCT02804763|364621820|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
105716374|NCT02804763|364621821|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
105716375|NCT02804763|364621818|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
105716376|NCT02804763|364621819|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
105716377|NCT02804763|364621820|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
105716378|NCT02804763|364621821|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
105716379|NCT02804763|364621818|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
105716380|NCT02804763|364621819|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
105716381|NCT02804763|364621820|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
105716382|NCT02804763|364621821|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
105716383|NCT02804763|364621818|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
105716384|NCT02804763|364621819|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
105716385|NCT02804763|364621820|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
105716386|NCT02804763|364621821|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
105716387|NCT02804763|364621818|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
105716388|NCT02804763|364621819|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
105716389|NCT02804763|364621820|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
105716390|NCT02804763|364621821|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
105716391|NCT02804763|364621818|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
105716392|NCT02804763|364621819|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
105716393|NCT02804763|364621820|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
105716394|NCT02804763|364621821|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
105716395|NCT00700180|364621838|FG000|Overall Study|Death|99|||
105716396|NCT00700180|364621839|FG001|Overall Study|Death|114|||
105716397|NCT00700180|364621838|FG000|Overall Study|Alive on treatment|5|||
105716398|NCT00700180|364621839|FG001|Overall Study|Alive on treatment|3|||
105716399|NCT00700180|364621838|FG000|Overall Study|Alive in follow-up|46|||
105716400|NCT00700180|364621839|FG001|Overall Study|Alive in follow-up|27|||
105716401|NCT00700180|364621838|FG000|Overall Study|Lost to Follow-up|4|||
105716402|NCT00700180|364621839|FG001|Overall Study|Lost to Follow-up|5|||
105716403|NCT02939131|364621841|FG000|Overall Study|Unable to get to clinic|6|||
105716404|NCT02939131|364621842|FG001|Overall Study|Unable to get to clinic|4|||
105716405|NCT02939131|364621841|FG000|Overall Study|Lost to Follow-up|2|||
105716406|NCT02939131|364621842|FG001|Overall Study|Lost to Follow-up|4|||
105716407|NCT02939131|364621841|FG000|Overall Study|severe debilitation|1|||
105716408|NCT02939131|364621842|FG001|Overall Study|severe debilitation|0|||
105716409|NCT02939131|364621841|FG000|Overall Study|Other|0|||
105716410|NCT02939131|364621842|FG001|Overall Study|Other|1|||
105716411|NCT02939131|364621841|FG000|Overall Study|not willing to adhere to protocol|2|||
105716412|NCT02939131|364621842|FG001|Overall Study|not willing to adhere to protocol|0|||
105716413|NCT03588741|364621843|FG000|Overall Study|Withdrawal by Subject|1|||
105716414|NCT03706365|364621845|FG000|Overall Study|Lost to Follow-up|7|||
105716415|NCT03706365|364621846|FG001|Overall Study|Lost to Follow-up|0|||
105716416|NCT03706365|364621845|FG000|Overall Study|Withdrawal by Subject|17|||
105716417|NCT03706365|364621846|FG001|Overall Study|Withdrawal by Subject|15|||
105716418|NCT03706365|364621845|FG000|Overall Study|On Study Treatment|51|||
105716419|NCT03706365|364621846|FG001|Overall Study|On Study Treatment|51|||
105716420|NCT00793793|364621847|FG000|Overall Study|Adverse Event|0|||
105716421|NCT00793793|364621848|FG001|Overall Study|Adverse Event|0|||
105716422|NCT00793793|364621849|FG002|Overall Study|Adverse Event|1|||
105716423|NCT00793793|364621850|FG003|Overall Study|Adverse Event|1|||
105716424|NCT00793793|364621851|FG004|Overall Study|Adverse Event|0|||
105716425|NCT00793793|364621852|FG005|Overall Study|Adverse Event|1|||
105716426|NCT00793793|364621853|FG006|Overall Study|Adverse Event|2|||
105716427|NCT00793793|364621854|FG007|Overall Study|Adverse Event|0|||
105716428|NCT00793793|364621855|FG008|Overall Study|Adverse Event|0|||
105716429|NCT00793793|364621856|FG009|Overall Study|Adverse Event|0|||
105716430|NCT00793793|364621857|FG010|Overall Study|Adverse Event|0|||
105716431|NCT00793793|364621858|FG011|Overall Study|Adverse Event|2|||
105716432|NCT00793793|364621847|FG000|Overall Study|Protocol Violation|0|||
105716433|NCT00793793|364621848|FG001|Overall Study|Protocol Violation|0|||
105716434|NCT00793793|364621849|FG002|Overall Study|Protocol Violation|0|||
105932039|NCT04270760|365410855|FG001|Overall Study|Death|0|||
105789842|NCT00563706|364884928|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
105789843|NCT00706901|364884933|FG000|Overall Study|Lost to Follow-up|2|||
105789844|NCT00706901|364884934|FG001|Overall Study|Lost to Follow-up|3|||
105789845|NCT00706901|364884935|FG002|Overall Study|Lost to Follow-up|2|||
105789846|NCT00706901|364884933|FG000|Overall Study|Withdrawal by Subject|4|||
105789847|NCT00706901|364884934|FG001|Overall Study|Withdrawal by Subject|2|||
105789848|NCT00706901|364884935|FG002|Overall Study|Withdrawal by Subject|5|||
105789849|NCT00706901|364884933|FG000|Overall Study|In Jail|1|||
105789850|NCT00706901|364884934|FG001|Overall Study|In Jail|0|||
105789851|NCT00706901|364884935|FG002|Overall Study|In Jail|1|||
105789852|NCT00706901|364884933|FG000|Overall Study|Death|1|||
105716435|NCT00793793|364621850|FG003|Overall Study|Protocol Violation|1|||
105716436|NCT00793793|364621851|FG004|Overall Study|Protocol Violation|0|||
105716437|NCT00793793|364621852|FG005|Overall Study|Protocol Violation|0|||
105716438|NCT00793793|364621853|FG006|Overall Study|Protocol Violation|0|||
105716439|NCT00793793|364621854|FG007|Overall Study|Protocol Violation|0|||
105716440|NCT00793793|364621855|FG008|Overall Study|Protocol Violation|0|||
105716441|NCT00793793|364621856|FG009|Overall Study|Protocol Violation|0|||
105716442|NCT00793793|364621857|FG010|Overall Study|Protocol Violation|0|||
105716443|NCT00793793|364621858|FG011|Overall Study|Protocol Violation|0|||
105716444|NCT00793793|364621847|FG000|Overall Study|Lost to Follow-up|0|||
105716445|NCT00793793|364621848|FG001|Overall Study|Lost to Follow-up|0|||
105716446|NCT00793793|364621849|FG002|Overall Study|Lost to Follow-up|1|||
105716447|NCT00793793|364621850|FG003|Overall Study|Lost to Follow-up|0|||
105716448|NCT00793793|364621851|FG004|Overall Study|Lost to Follow-up|0|||
105716449|NCT00793793|364621852|FG005|Overall Study|Lost to Follow-up|0|||
105716450|NCT00793793|364621853|FG006|Overall Study|Lost to Follow-up|0|||
105716451|NCT00793793|364621854|FG007|Overall Study|Lost to Follow-up|0|||
105716452|NCT00793793|364621855|FG008|Overall Study|Lost to Follow-up|1|||
105716453|NCT00793793|364621856|FG009|Overall Study|Lost to Follow-up|3|||
105716454|NCT00793793|364621857|FG010|Overall Study|Lost to Follow-up|1|||
105716455|NCT00793793|364621858|FG011|Overall Study|Lost to Follow-up|0|||
105716456|NCT00793793|364621847|FG000|Overall Study|Withdrawal by Subject|0|||
105716457|NCT00793793|364621848|FG001|Overall Study|Withdrawal by Subject|0|||
105716458|NCT00793793|364621849|FG002|Overall Study|Withdrawal by Subject|0|||
105716459|NCT00793793|364621850|FG003|Overall Study|Withdrawal by Subject|0|||
105716460|NCT00793793|364621851|FG004|Overall Study|Withdrawal by Subject|1|||
105716461|NCT00793793|364621852|FG005|Overall Study|Withdrawal by Subject|0|||
105716462|NCT00793793|364621853|FG006|Overall Study|Withdrawal by Subject|0|||
105716463|NCT00793793|364621854|FG007|Overall Study|Withdrawal by Subject|0|||
105716464|NCT00793793|364621855|FG008|Overall Study|Withdrawal by Subject|1|||
105716465|NCT00793793|364621856|FG009|Overall Study|Withdrawal by Subject|0|||
105716466|NCT00793793|364621857|FG010|Overall Study|Withdrawal by Subject|0|||
105716467|NCT00793793|364621858|FG011|Overall Study|Withdrawal by Subject|0|||
105716468|NCT00793793|364621847|FG000|Overall Study|reason not specified|0|||
105716469|NCT00793793|364621848|FG001|Overall Study|reason not specified|1|||
105716470|NCT00793793|364621849|FG002|Overall Study|reason not specified|0|||
105716471|NCT00793793|364621850|FG003|Overall Study|reason not specified|1|||
105716472|NCT00793793|364621851|FG004|Overall Study|reason not specified|1|||
105716473|NCT00793793|364621852|FG005|Overall Study|reason not specified|1|||
105716474|NCT00793793|364621853|FG006|Overall Study|reason not specified|2|||
105716475|NCT00793793|364621854|FG007|Overall Study|reason not specified|0|||
105716476|NCT00793793|364621855|FG008|Overall Study|reason not specified|7|||
105716477|NCT00793793|364621856|FG009|Overall Study|reason not specified|6|||
105716478|NCT00793793|364621857|FG010|Overall Study|reason not specified|2|||
105716479|NCT00793793|364621858|FG011|Overall Study|reason not specified|4|||
105716480|NCT02487108|364621859|FG000|Overall Study|Adverse Event|1|||
105716481|NCT02487108|364621860|FG001|Overall Study|Adverse Event|6|||
105716482|NCT02487108|364621861|FG002|Overall Study|Adverse Event|12|||
105716483|NCT02487108|364621862|FG003|Overall Study|Adverse Event|6|||
105789853|NCT00706901|364884934|FG001|Overall Study|Death|0|||
105789854|NCT00706901|364884935|FG002|Overall Study|Death|0|||
105716484|NCT02487108|364621859|FG000|Overall Study|Withdrawal by Subject|8|||
105716485|NCT02487108|364621860|FG001|Overall Study|Withdrawal by Subject|5|||
105716486|NCT02487108|364621861|FG002|Overall Study|Withdrawal by Subject|5|||
105716487|NCT02487108|364621862|FG003|Overall Study|Withdrawal by Subject|0|||
105716488|NCT02487108|364621859|FG000|Overall Study|Non-compliance to study medication|3|||
105716489|NCT02487108|364621860|FG001|Overall Study|Non-compliance to study medication|2|||
105716490|NCT02487108|364621861|FG002|Overall Study|Non-compliance to study medication|5|||
105789855|NCT01646268|364884936|FG000|Overall Study|Adverse Event|6|||
105789856|NCT01646268|364884937|FG001|Overall Study|Adverse Event|7|||
105789857|NCT01646268|364884936|FG000|Overall Study|Lack of Efficacy|1|||
105789858|NCT01646268|364884937|FG001|Overall Study|Lack of Efficacy|3|||
105789859|NCT01646268|364884936|FG000|Overall Study|Protocol Violation|0|||
105716491|NCT02487108|364621862|FG003|Overall Study|Non-compliance to study medication|4|||
105716492|NCT02487108|364621859|FG000|Overall Study|Protocol Violation|1|||
105716493|NCT02487108|364621860|FG001|Overall Study|Protocol Violation|1|||
105716494|NCT02487108|364621861|FG002|Overall Study|Protocol Violation|2|||
105716495|NCT02487108|364621862|FG003|Overall Study|Protocol Violation|0|||
105716496|NCT02487108|364621859|FG000|Overall Study|Non-compliance to study procedures|0|||
105716497|NCT02487108|364621860|FG001|Overall Study|Non-compliance to study procedures|0|||
105716498|NCT02487108|364621861|FG002|Overall Study|Non-compliance to study procedures|0|||
105716499|NCT02487108|364621862|FG003|Overall Study|Non-compliance to study procedures|1|||
105716500|NCT02487108|364621859|FG000|Overall Study|Other than specified|3|||
105716501|NCT02487108|364621860|FG001|Overall Study|Other than specified|2|||
105716502|NCT02487108|364621861|FG002|Overall Study|Other than specified|2|||
105716503|NCT02487108|364621862|FG003|Overall Study|Other than specified|0|||
105716504|NCT00469612|364621863|FG000|Overall Study|Study terminated before data collected|2|||
105716505|NCT00469612|364621864|FG001|Overall Study|Study terminated before data collected|0|||
105716506|NCT02720757|364621865|FG000|Overall Study|Other reason|5|||
105716507|NCT02720757|364621865|FG000|Overall Study|Loss of contact|4|||
105716508|NCT02720757|364621865|FG000|Overall Study|Informed consent withdrawal|1|||
105716509|NCT02720757|364621865|FG000|Overall Study|Patients wish to withdraw|2|||
105716510|NCT02720757|364621865|FG000|Overall Study|Missing|3|||
105716511|NCT02720757|364621865|FG000|Overall Study|General exclusion|3|||
105716512|NCT00463476|364621866|FG000|Overall Study|Withdrawal by Subject|1|||
105716513|NCT00463476|364621867|FG001|Overall Study|Withdrawal by Subject|2|||
105789860|NCT01646268|364884937|FG001|Overall Study|Protocol Violation|1|||
105932040|NCT04270760|365410856|FG002|Overall Study|Death|0|||
105932041|NCT04270760|365410857|FG003|Overall Study|Death|0|||
105932042|NCT04270760|365410858|FG004|Overall Study|Death|1|||
105932043|NCT00888849|365410865|FG000|Overall Study|Death|4|||
105932044|NCT00888849|365410866|FG001|Overall Study|Death|7|||
105932045|NCT00888849|365410865|FG000|Overall Study|Lost to Follow-up|1|||
105932046|NCT00888849|365410866|FG001|Overall Study|Lost to Follow-up|2|||
105932047|NCT02583477|365410867|FG000|Overall Study|Adverse Event|0|||
105932048|NCT02583477|365410868|FG001|Overall Study|Adverse Event|2|||
105932049|NCT02583477|365410867|FG000|Overall Study|Death|1|||
105932050|NCT02583477|365410868|FG001|Overall Study|Death|16|||
105932051|NCT02583477|365410867|FG000|Overall Study|Study terminated|2|||
105932052|NCT02583477|365410868|FG001|Overall Study|Study terminated|2|||
105932053|NCT00455455|365410873|FG000|Washout|Withdrawal by Subject|0|||
105932054|NCT00455455|365410874|FG001|Washout|Withdrawal by Subject|1|||
105932055|NCT00455455|365410873|FG000|Washout|Withdrawal by Subject|1|||
105932056|NCT00455455|365410874|FG001|Washout|Withdrawal by Subject|0|||
105932057|NCT01370538|365410875|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
105932058|NCT01370538|365410876|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
105932059|NCT01370538|365410875|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105932060|NCT01370538|365410876|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105932061|NCT01370538|365410875|FG000|Overall Study|Adverse Event|1|||
105932062|NCT01370538|365410876|FG001|Overall Study|Adverse Event|0|||
105932063|NCT01370538|365410875|FG000|Overall Study|Protocol Violation|8|||
105932064|NCT01370538|365410876|FG001|Overall Study|Protocol Violation|5|||
105932065|NCT01370538|365410875|FG000|Overall Study|Development of study specific withdrawal|1|||
105932066|NCT01370538|365410876|FG001|Overall Study|Development of study specific withdrawal|1|||
105932067|NCT01370538|365410875|FG000|Overall Study|Lost to follow up|6|||
105932068|NCT01370538|365410876|FG001|Overall Study|Lost to follow up|10|||
105932069|NCT01263028|365410879|FG000|Overall Study|Withdrawal by Subject|1|||
105932070|NCT01263028|365410879|FG000|Overall Study|Adverse Event|1|||
105932071|NCT01263028|365410879|FG000|Overall Study|Study terminated due to low enrollment.|4|||
105932072|NCT00309244|365410880|FG000|Overall Study|Adverse Event|29|||
105932073|NCT00309244|365410881|FG001|Overall Study|Adverse Event|12|||
105932074|NCT00309244|365410880|FG000|Overall Study|Lost to Follow-up|6|||
105932075|NCT00309244|365410881|FG001|Overall Study|Lost to Follow-up|22|||
105932076|NCT00309244|365410880|FG000|Overall Study|Physician Decision|5|||
105932077|NCT00309244|365410881|FG001|Overall Study|Physician Decision|8|||
105932078|NCT00309244|365410880|FG000|Overall Study|Protocol Violation|6|||
105932079|NCT00309244|365410881|FG001|Overall Study|Protocol Violation|3|||
105932080|NCT00309244|365410880|FG000|Overall Study|Withdrawal by Subject|50|||
105789861|NCT01646268|364884936|FG000|Overall Study|Withdrawal by Subject|2|||
105716514|NCT00463476|364621866|FG000|Overall Study|Lost to Follow-up|1|||
105716515|NCT00463476|364621867|FG001|Overall Study|Lost to Follow-up|1|||
105932081|NCT00309244|365410881|FG001|Overall Study|Withdrawal by Subject|32|||
105716516|NCT01001702|364621868|FG000|Overall Study|Lost to Follow-up|7|||
105716517|NCT01001702|364621868|FG000|Overall Study|Adverse Event|7|||
105932082|NCT00309244|365410880|FG000|Overall Study|Various|7|||
105932083|NCT00309244|365410881|FG001|Overall Study|Various|7|||
105932084|NCT00309244|365410880|FG000|Overall Study|Randomized but not dosed|11|||
105932085|NCT00309244|365410881|FG001|Overall Study|Randomized but not dosed|12|||
105932086|NCT00309244|365410880|FG000|Overall Study|Death|4|||
105716518|NCT01001702|364621868|FG000|Overall Study|Sponsor Discontinued Study|4|||
105932087|NCT00309244|365410881|FG001|Overall Study|Death|1|||
105932088|NCT02762604|365410882|FG000|Overall Study|Lost to Follow-up|2|||
105716519|NCT01001702|364621868|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
105789862|NCT01646268|364884937|FG001|Overall Study|Withdrawal by Subject|5|||
105932089|NCT02762604|365410883|FG001|Overall Study|Lost to Follow-up|7|||
105716520|NCT01001702|364621868|FG000|Overall Study|Investigator withdrew Subject|10|||
105716521|NCT01001702|364621868|FG000|Overall Study|Withdrawal by Subject|19|||
105716522|NCT01001702|364621868|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
105716523|NCT02624492|364621869|FG000|Overall Study|Adverse Event|2|||
105716524|NCT02624492|364621870|FG001|Overall Study|Adverse Event|2|||
105716525|NCT02624492|364621871|FG002|Overall Study|Adverse Event|2|||
105716526|NCT02624492|364621869|FG000|Overall Study|Progressive disease|0|||
105716527|NCT02624492|364621870|FG001|Overall Study|Progressive disease|2|||
105716528|NCT02624492|364621871|FG002|Overall Study|Progressive disease|3|||
105716529|NCT03653390|364621872|FG000|Overall Study|Lost to Follow-up|12|||
105716530|NCT03653390|364621873|FG001|Overall Study|Lost to Follow-up|8|||
105716531|NCT03653390|364621874|FG002|Overall Study|Lost to Follow-up|7|||
105716532|NCT03653390|364621872|FG000|Overall Study|Withdrawal by Subject|6|||
105716533|NCT03653390|364621873|FG001|Overall Study|Withdrawal by Subject|1|||
105716534|NCT03653390|364621874|FG002|Overall Study|Withdrawal by Subject|1|||
105716535|NCT03653390|364621872|FG000|Overall Study|Death|1|||
105716536|NCT03653390|364621873|FG001|Overall Study|Death|0|||
105716537|NCT03653390|364621874|FG002|Overall Study|Death|0|||
105716538|NCT03653390|364621872|FG000|Overall Study|Paper Survey Lost|1|||
105716539|NCT03653390|364621873|FG001|Overall Study|Paper Survey Lost|0|||
105716540|NCT03653390|364621874|FG002|Overall Study|Paper Survey Lost|0|||
105716541|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
105716542|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
105932090|NCT02762604|365410882|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
105932091|NCT02762604|365410883|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
105932092|NCT02958527|365410888|FG000|Overall Study|Not collected CRFs|12|||
105932093|NCT01945242|365410889|FG000|Overall Study|Physician Decision|3|||
105932094|NCT01945242|365410890|FG001|Overall Study|Physician Decision|3|||
105932095|NCT04913675|365410891|FG000|Main Study (Up to Week 36)|Death|0|||
105932096|NCT04913675|365410892|FG001|Main Study (Up to Week 36)|Death|2|||
105932097|NCT04913675|365410893|FG002|Main Study (Up to Week 36)|Death|2|||
105932098|NCT04913675|365410894|FG003|Main Study (Up to Week 36)|Death|0|||
105932099|NCT04913675|365410891|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
105932100|NCT04913675|365410892|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
105932101|NCT04913675|365410893|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
105932102|NCT04913675|365410894|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
105932103|NCT04913675|365410891|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
105932104|NCT04913675|365410892|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
105932105|NCT04913675|365410893|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
105932106|NCT04913675|365410894|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
105932107|NCT04913675|365410891|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
105932108|NCT04913675|365410892|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
105932109|NCT04913675|365410893|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
105932110|NCT04913675|365410894|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
105932111|NCT04913675|365410891|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
105932112|NCT04913675|365410892|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
105932113|NCT04913675|365410893|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
105932114|NCT04913675|365410894|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
105932115|NCT02975700|365410895|FG000|Overall Study|Adverse Event|1|||
105932116|NCT02975700|365410895|FG000|Overall Study|Progressive disease|3|||
105932117|NCT02975700|365410895|FG000|Overall Study|Failed screening criteria|2|||
105932118|NCT04518410|365410896|FG000|Overall Study|Lost to Follow-up|1|||
105932119|NCT04518410|365410897|FG001|Overall Study|Lost to Follow-up|1|||
105932120|NCT04518410|365410898|FG002|Overall Study|Lost to Follow-up|8|||
105932121|NCT04518410|365410899|FG003|Overall Study|Lost to Follow-up|5|||
105932122|NCT04518410|365410900|FG004|Overall Study|Lost to Follow-up|92|||
105932123|NCT04518410|365410901|FG005|Overall Study|Lost to Follow-up|25|||
105932124|NCT04518410|365410902|FG006|Overall Study|Lost to Follow-up|25|||
105932125|NCT04518410|365410903|FG007|Overall Study|Lost to Follow-up|3|||
105932126|NCT04518410|365410904|FG008|Overall Study|Lost to Follow-up|2|||
105932127|NCT04518410|365410905|FG009|Overall Study|Lost to Follow-up|13|||
105932128|NCT04518410|365410906|FG010|Overall Study|Lost to Follow-up|9|||
105932129|NCT04518410|365410907|FG011|Overall Study|Lost to Follow-up|13|||
105716543|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
105716544|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
105932130|NCT04518410|365410908|FG012|Overall Study|Lost to Follow-up|9|||
105932131|NCT04518410|365410909|FG013|Overall Study|Lost to Follow-up|13|||
105932132|NCT04518410|365410910|FG014|Overall Study|Lost to Follow-up|8|||
105932133|NCT04518410|365410911|FG015|Overall Study|Lost to Follow-up|10|||
105932134|NCT04518410|365410912|FG016|Overall Study|Lost to Follow-up|6|||
105932135|NCT04518410|365410913|FG017|Overall Study|Lost to Follow-up|13|||
105932136|NCT04518410|365410914|FG018|Overall Study|Lost to Follow-up|21|||
105932137|NCT04518410|365410915|FG019|Overall Study|Lost to Follow-up|6|||
105932138|NCT04518410|365410916|FG020|Overall Study|Lost to Follow-up|7|||
105932139|NCT04518410|365410917|FG021|Overall Study|Lost to Follow-up|21|||
105716545|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
105789863|NCT01646268|364884936|FG000|Overall Study|Other|2|||
105789864|NCT01646268|364884937|FG001|Overall Study|Other|0|||
105789865|NCT01519635|364884942|FG000|Overall Study|Withdrawal by Subject|0|||
105789866|NCT01519635|364884943|FG001|Overall Study|Withdrawal by Subject|1|||
105789867|NCT01519635|364884942|FG000|Overall Study|No possibility to put a catheter|1|||
105789868|NCT01519635|364884943|FG001|Overall Study|No possibility to put a catheter|2|||
105789869|NCT00594568|364884945|FG000|Initial Treatment|Adverse Event|51|||
105789870|NCT00594568|364884946|FG001|Initial Treatment|Adverse Event|121|||
105789871|NCT00594568|364884947|FG002|Initial Treatment|Adverse Event|144|||
105789872|NCT00594568|364884945|FG000|Initial Treatment|Death|6|||
105789873|NCT00594568|364884946|FG001|Initial Treatment|Death|11|||
105789874|NCT00594568|364884947|FG002|Initial Treatment|Death|15|||
105789875|NCT00594568|364884945|FG000|Initial Treatment|Lost to Follow-up|4|||
105789876|NCT00594568|364884946|FG001|Initial Treatment|Lost to Follow-up|1|||
105789877|NCT00594568|364884947|FG002|Initial Treatment|Lost to Follow-up|4|||
105789878|NCT00594568|364884945|FG000|Initial Treatment|Physician Decision|3|||
105789879|NCT00594568|364884946|FG001|Initial Treatment|Physician Decision|2|||
105789880|NCT00594568|364884947|FG002|Initial Treatment|Physician Decision|4|||
105789881|NCT00594568|364884945|FG000|Initial Treatment|Protocol Violation|2|||
105789882|NCT00594568|364884946|FG001|Initial Treatment|Protocol Violation|2|||
105789883|NCT00594568|364884947|FG002|Initial Treatment|Protocol Violation|5|||
105716546|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
105716547|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
105716548|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
105716549|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
105716550|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
105716551|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
105716552|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
105716553|NCT05099640|364621877|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
105716554|NCT05099640|364621878|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
105716555|NCT05099640|364621879|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
105716556|NCT05099640|364621877|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
105716557|NCT05099640|364621878|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
105716558|NCT05099640|364621879|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
105789884|NCT00594568|364884945|FG000|Initial Treatment|Withdrawal by Subject|25|||
105789885|NCT00594568|364884946|FG001|Initial Treatment|Withdrawal by Subject|31|||
105789886|NCT00594568|364884947|FG002|Initial Treatment|Withdrawal by Subject|46|||
105789887|NCT00594568|364884945|FG000|Initial Treatment|Sponsor decision|193|||
105789888|NCT00594568|364884946|FG001|Initial Treatment|Sponsor decision|142|||
105789889|NCT00594568|364884947|FG002|Initial Treatment|Sponsor decision|147|||
105789890|NCT00594568|364884945|FG000|Initial Treatment|Caregiver decision|21|||
105789891|NCT00594568|364884946|FG001|Initial Treatment|Caregiver decision|36|||
105789892|NCT00594568|364884947|FG002|Initial Treatment|Caregiver decision|36|||
105716559|NCT03882424|364621880|FG000|Overall Study|Lost to Follow-up|3|||
105716560|NCT03882424|364621881|FG001|Overall Study|Lost to Follow-up|0|||
105716561|NCT03882424|364621882|FG002|Overall Study|Lost to Follow-up|0|||
105716562|NCT03882424|364621880|FG000|Overall Study|schedule conflict|1|||
105716563|NCT03882424|364621881|FG001|Overall Study|schedule conflict|0|||
105716564|NCT03882424|364621882|FG002|Overall Study|schedule conflict|0|||
105716565|NCT00236080|364621883|FG000|Overall Study|Adverse Event|0|||
105789893|NCT00594568|364884945|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
105789894|NCT00594568|364884946|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
105789895|NCT00594568|364884947|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
105789896|NCT00594568|364884945|FG000|Initial Treatment|Entry criteria exclusion|0|||
105789897|NCT00594568|364884946|FG001|Initial Treatment|Entry criteria exclusion|1|||
105716566|NCT00236080|364621884|FG001|Overall Study|Adverse Event|0|||
105716567|NCT00236080|364621885|FG002|Overall Study|Adverse Event|3|||
105716568|NCT00236080|364621886|FG003|Overall Study|Adverse Event|1|||
105716569|NCT00236080|364621887|FG004|Overall Study|Adverse Event|0|||
105716570|NCT00236080|364621883|FG000|Overall Study|Lost to Follow-up|0|||
105716571|NCT00236080|364621884|FG001|Overall Study|Lost to Follow-up|1|||
105716572|NCT00236080|364621885|FG002|Overall Study|Lost to Follow-up|0|||
105716573|NCT00236080|364621886|FG003|Overall Study|Lost to Follow-up|0|||
105716574|NCT00236080|364621887|FG004|Overall Study|Lost to Follow-up|0|||
105789898|NCT00594568|364884947|FG002|Initial Treatment|Entry criteria exclusion|1|||
105789899|NCT00594568|364884945|FG000|Delayed Start|Death|0|||
105789900|NCT00594568|364884946|FG001|Delayed Start|Death|0|||
105789901|NCT00594568|364884947|FG002|Delayed Start|Death|1|||
105789902|NCT00594568|364884945|FG000|Delayed Start|Adverse Event|12|||
105789903|NCT00594568|364884946|FG001|Delayed Start|Adverse Event|2|||
105789904|NCT00594568|364884947|FG002|Delayed Start|Adverse Event|2|||
105789905|NCT00594568|364884945|FG000|Delayed Start|Withdrawal by Subject|4|||
105789906|NCT00594568|364884946|FG001|Delayed Start|Withdrawal by Subject|3|||
105789907|NCT00594568|364884947|FG002|Delayed Start|Withdrawal by Subject|0|||
105789908|NCT00594568|364884945|FG000|Delayed Start|Physician Decision|0|||
105789909|NCT00594568|364884946|FG001|Delayed Start|Physician Decision|0|||
105932140|NCT04518410|365410918|FG022|Overall Study|Lost to Follow-up|1|||
105932141|NCT04518410|365410919|FG023|Overall Study|Lost to Follow-up|7|||
105716575|NCT00236080|364621883|FG000|Overall Study|Physician Decision|1|||
105716576|NCT00236080|364621884|FG001|Overall Study|Physician Decision|0|||
105716577|NCT00236080|364621885|FG002|Overall Study|Physician Decision|1|||
105716578|NCT00236080|364621886|FG003|Overall Study|Physician Decision|1|||
105716579|NCT00236080|364621887|FG004|Overall Study|Physician Decision|1|||
105716580|NCT00236080|364621883|FG000|Overall Study|Withdrawal by Subject|1|||
105716581|NCT00236080|364621884|FG001|Overall Study|Withdrawal by Subject|0|||
105716582|NCT00236080|364621885|FG002|Overall Study|Withdrawal by Subject|0|||
105716583|NCT00236080|364621886|FG003|Overall Study|Withdrawal by Subject|0|||
105716584|NCT00236080|364621887|FG004|Overall Study|Withdrawal by Subject|0|||
105716585|NCT00236080|364621883|FG000|Overall Study|Miscellaneous|0|||
105716586|NCT00236080|364621884|FG001|Overall Study|Miscellaneous|0|||
105716587|NCT00236080|364621885|FG002|Overall Study|Miscellaneous|1|||
105716588|NCT00236080|364621886|FG003|Overall Study|Miscellaneous|0|||
105716589|NCT00236080|364621887|FG004|Overall Study|Miscellaneous|0|||
105716590|NCT02400255|364621888|FG000|Overall Study|Relapse|4|||
105716591|NCT02400255|364621889|FG001|Overall Study|Relapse|1|||
105716592|NCT02400255|364621890|FG002|Overall Study|Relapse|1|||
105716593|NCT02400255|364621891|FG003|Overall Study|Relapse|2|||
105716594|NCT02400255|364621888|FG000|Overall Study|Adverse Event|6|||
105716595|NCT02400255|364621889|FG001|Overall Study|Adverse Event|3|||
105716596|NCT02400255|364621890|FG002|Overall Study|Adverse Event|0|||
105716597|NCT02400255|364621891|FG003|Overall Study|Adverse Event|0|||
105716598|NCT02400255|364621888|FG000|Overall Study|Physician Decision|6|||
105716599|NCT02400255|364621889|FG001|Overall Study|Physician Decision|0|||
105716600|NCT02400255|364621890|FG002|Overall Study|Physician Decision|0|||
105716601|NCT02400255|364621891|FG003|Overall Study|Physician Decision|0|||
105716602|NCT02400255|364621888|FG000|Overall Study|Loss of insurance|1|||
105716603|NCT02400255|364621889|FG001|Overall Study|Loss of insurance|0|||
105716604|NCT02400255|364621890|FG002|Overall Study|Loss of insurance|0|||
105716605|NCT02400255|364621891|FG003|Overall Study|Loss of insurance|0|||
105716606|NCT01214044|364621892|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
105716607|NCT01214044|364621892|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
105716608|NCT01214044|364621892|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
105716609|NCT01214044|364621892|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
105716610|NCT01214044|364621892|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
105716611|NCT01214044|364621892|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
105716612|NCT00944034|364621893|FG000|Overall Study|Inappropriate enrollment|0|||
105716613|NCT00944034|364621894|FG001|Overall Study|Inappropriate enrollment|1|||
105716614|NCT00944034|364621895|FG002|Overall Study|Inappropriate enrollment|0|||
105932142|NCT04518410|365410920|FG024|Overall Study|Lost to Follow-up|6|||
105932143|NCT04518410|365410896|FG000|Overall Study|Withdrawal by Subject|1|||
105932144|NCT04518410|365410897|FG001|Overall Study|Withdrawal by Subject|2|||
105932145|NCT04518410|365410898|FG002|Overall Study|Withdrawal by Subject|2|||
105932146|NCT04518410|365410899|FG003|Overall Study|Withdrawal by Subject|3|||
105932147|NCT04518410|365410900|FG004|Overall Study|Withdrawal by Subject|20|||
105932148|NCT04518410|365410901|FG005|Overall Study|Withdrawal by Subject|20|||
105932149|NCT04518410|365410902|FG006|Overall Study|Withdrawal by Subject|25|||
105932150|NCT04518410|365410903|FG007|Overall Study|Withdrawal by Subject|6|||
105932151|NCT04518410|365410904|FG008|Overall Study|Withdrawal by Subject|1|||
105932152|NCT04518410|365410905|FG009|Overall Study|Withdrawal by Subject|12|||
105932153|NCT04518410|365410906|FG010|Overall Study|Withdrawal by Subject|5|||
105932154|NCT04518410|365410907|FG011|Overall Study|Withdrawal by Subject|7|||
105932155|NCT04518410|365410908|FG012|Overall Study|Withdrawal by Subject|2|||
105932156|NCT04518410|365410909|FG013|Overall Study|Withdrawal by Subject|13|||
105932157|NCT04518410|365410910|FG014|Overall Study|Withdrawal by Subject|4|||
105716615|NCT00944034|364621896|FG003|Overall Study|Inappropriate enrollment|1|||
105716616|NCT00944034|364621897|FG004|Overall Study|Inappropriate enrollment|2|||
105716617|NCT00944034|364621898|FG005|Overall Study|Inappropriate enrollment|1|||
105716618|NCT00944034|364621899|FG006|Overall Study|Inappropriate enrollment|0|||
105716619|NCT00944034|364621900|FG007|Overall Study|Inappropriate enrollment|0|||
105716620|NCT00944034|364621901|FG008|Overall Study|Inappropriate enrollment|1|||
105716621|NCT00944034|364621902|FG009|Overall Study|Inappropriate enrollment|1|||
105716622|NCT00944034|364621903|FG010|Overall Study|Inappropriate enrollment|0|||
105716623|NCT00944034|364621904|FG011|Overall Study|Inappropriate enrollment|0|||
105716624|NCT00944034|364621893|FG000|Overall Study|Withdrawal by Subject|3|||
105716625|NCT00944034|364621894|FG001|Overall Study|Withdrawal by Subject|2|||
105932158|NCT04518410|365410911|FG015|Overall Study|Withdrawal by Subject|9|||
105932159|NCT04518410|365410912|FG016|Overall Study|Withdrawal by Subject|0|||
105932160|NCT04518410|365410913|FG017|Overall Study|Withdrawal by Subject|15|||
105716626|NCT00944034|364621895|FG002|Overall Study|Withdrawal by Subject|6|||
105716627|NCT00944034|364621896|FG003|Overall Study|Withdrawal by Subject|2|||
105716628|NCT00944034|364621897|FG004|Overall Study|Withdrawal by Subject|5|||
105716629|NCT00944034|364621898|FG005|Overall Study|Withdrawal by Subject|8|||
105789910|NCT00594568|364884947|FG002|Delayed Start|Physician Decision|1|||
105789911|NCT00594568|364884945|FG000|Delayed Start|Lost to Follow-up|0|||
105789912|NCT00594568|364884946|FG001|Delayed Start|Lost to Follow-up|0|||
105789913|NCT00594568|364884947|FG002|Delayed Start|Lost to Follow-up|1|||
105789914|NCT00594568|364884945|FG000|Delayed Start|Caregiver Decision|5|||
105789915|NCT00594568|364884946|FG001|Delayed Start|Caregiver Decision|6|||
105789916|NCT00594568|364884947|FG002|Delayed Start|Caregiver Decision|2|||
105789917|NCT00594568|364884945|FG000|Delayed Start|Sponsor Decision|77|||
105789918|NCT00594568|364884946|FG001|Delayed Start|Sponsor Decision|66|||
105789919|NCT00594568|364884947|FG002|Delayed Start|Sponsor Decision|59|||
105716630|NCT00944034|364621899|FG006|Overall Study|Withdrawal by Subject|2|||
105716631|NCT00944034|364621900|FG007|Overall Study|Withdrawal by Subject|2|||
105716632|NCT00944034|364621901|FG008|Overall Study|Withdrawal by Subject|3|||
105716633|NCT00944034|364621902|FG009|Overall Study|Withdrawal by Subject|4|||
105716634|NCT00944034|364621903|FG010|Overall Study|Withdrawal by Subject|0|||
105716635|NCT00944034|364621904|FG011|Overall Study|Withdrawal by Subject|4|||
105716636|NCT00944034|364621893|FG000|Overall Study|Lost to Follow-up|0|||
105716637|NCT00944034|364621894|FG001|Overall Study|Lost to Follow-up|4|||
105716638|NCT00944034|364621895|FG002|Overall Study|Lost to Follow-up|2|||
105716639|NCT00944034|364621896|FG003|Overall Study|Lost to Follow-up|0|||
105789920|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
105789921|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
105789922|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
105789923|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
105789924|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
105789925|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
105789926|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
105789927|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
105789928|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
105789929|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
105789930|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
105789931|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
105789932|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
105789933|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
105789934|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
105789935|NCT00594568|364884945|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
105789936|NCT00594568|364884946|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
105789937|NCT00594568|364884947|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
105789938|NCT04478994|364884948|FG000|Overall Study|Withdrawal by Subject|1|||
105789939|NCT04478994|364884949|FG001|Overall Study|Withdrawal by Subject|1|||
105716640|NCT00944034|364621897|FG004|Overall Study|Lost to Follow-up|5|||
105716641|NCT00944034|364621898|FG005|Overall Study|Lost to Follow-up|7|||
105716642|NCT00944034|364621899|FG006|Overall Study|Lost to Follow-up|0|||
105716643|NCT00944034|364621900|FG007|Overall Study|Lost to Follow-up|1|||
105716644|NCT00944034|364621901|FG008|Overall Study|Lost to Follow-up|5|||
105789940|NCT00299546|364884950|FG000|Overall Study|Death|3|||
105789941|NCT00299546|364884951|FG001|Overall Study|Death|2|||
105789942|NCT00299546|364884952|FG002|Overall Study|Death|0|||
105789943|NCT00299546|364884950|FG000|Overall Study|Lost to Follow-up|2|||
105789944|NCT00299546|364884951|FG001|Overall Study|Lost to Follow-up|2|||
105789945|NCT00299546|364884952|FG002|Overall Study|Lost to Follow-up|5|||
105789946|NCT00299546|364884950|FG000|Overall Study|Adverse Event|37|||
105789947|NCT00299546|364884951|FG001|Overall Study|Adverse Event|22|||
105789948|NCT00299546|364884952|FG002|Overall Study|Adverse Event|27|||
105789949|NCT00299546|364884950|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
105789950|NCT00299546|364884951|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
105789951|NCT00299546|364884952|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
105932161|NCT04518410|365410914|FG018|Overall Study|Withdrawal by Subject|12|||
105716645|NCT00944034|364621902|FG009|Overall Study|Lost to Follow-up|1|||
105716646|NCT00944034|364621903|FG010|Overall Study|Lost to Follow-up|1|||
105932162|NCT04518410|365410915|FG019|Overall Study|Withdrawal by Subject|9|||
105716647|NCT00944034|364621904|FG011|Overall Study|Lost to Follow-up|0|||
105716648|NCT00944034|364621893|FG000|Overall Study|Death|0|||
105716649|NCT00944034|364621894|FG001|Overall Study|Death|0|||
105716650|NCT00944034|364621895|FG002|Overall Study|Death|1|||
105716651|NCT00944034|364621896|FG003|Overall Study|Death|0|||
105789952|NCT00299546|364884950|FG000|Overall Study|Other|24|||
105716652|NCT00944034|364621897|FG004|Overall Study|Death|0|||
105716653|NCT00944034|364621898|FG005|Overall Study|Death|0|||
105716654|NCT00944034|364621899|FG006|Overall Study|Death|0|||
105789953|NCT00299546|364884951|FG001|Overall Study|Other|26|||
105789954|NCT00299546|364884952|FG002|Overall Study|Other|19|||
105789955|NCT00299546|364884950|FG000|Overall Study|Not treated|0|||
105789956|NCT00299546|364884951|FG001|Overall Study|Not treated|1|||
105789957|NCT00299546|364884952|FG002|Overall Study|Not treated|1|||
105789958|NCT03099265|364884953|FG000|Overall Study|Adverse Event|1|||
105789959|NCT01656850|364884958|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
105716655|NCT00944034|364621900|FG007|Overall Study|Death|0|||
105716656|NCT00944034|364621901|FG008|Overall Study|Death|0|||
105716657|NCT00944034|364621902|FG009|Overall Study|Death|0|||
105716658|NCT00944034|364621903|FG010|Overall Study|Death|0|||
105716659|NCT00944034|364621904|FG011|Overall Study|Death|0|||
105716660|NCT00944034|364621893|FG000|Overall Study|Protocol Violation|2|||
105716661|NCT00944034|364621894|FG001|Overall Study|Protocol Violation|0|||
105716662|NCT00944034|364621895|FG002|Overall Study|Protocol Violation|0|||
105716663|NCT00944034|364621896|FG003|Overall Study|Protocol Violation|1|||
105716664|NCT00944034|364621897|FG004|Overall Study|Protocol Violation|2|||
105716665|NCT00944034|364621898|FG005|Overall Study|Protocol Violation|3|||
105716666|NCT00944034|364621899|FG006|Overall Study|Protocol Violation|0|||
105716667|NCT00944034|364621900|FG007|Overall Study|Protocol Violation|1|||
105716668|NCT00944034|364621901|FG008|Overall Study|Protocol Violation|1|||
105716669|NCT00944034|364621902|FG009|Overall Study|Protocol Violation|4|||
105716670|NCT00944034|364621903|FG010|Overall Study|Protocol Violation|0|||
105716671|NCT00944034|364621904|FG011|Overall Study|Protocol Violation|0|||
105716672|NCT00944034|364621893|FG000|Overall Study|Unable to classify|0|||
105716673|NCT00944034|364621894|FG001|Overall Study|Unable to classify|0|||
105716674|NCT00944034|364621895|FG002|Overall Study|Unable to classify|0|||
105716675|NCT00944034|364621896|FG003|Overall Study|Unable to classify|0|||
105716676|NCT00944034|364621897|FG004|Overall Study|Unable to classify|0|||
105716677|NCT00944034|364621898|FG005|Overall Study|Unable to classify|1|||
105716678|NCT00944034|364621899|FG006|Overall Study|Unable to classify|1|||
105716679|NCT00944034|364621900|FG007|Overall Study|Unable to classify|1|||
105716680|NCT00944034|364621901|FG008|Overall Study|Unable to classify|0|||
105716681|NCT00944034|364621902|FG009|Overall Study|Unable to classify|0|||
105716682|NCT00944034|364621903|FG010|Overall Study|Unable to classify|0|||
105716683|NCT00944034|364621904|FG011|Overall Study|Unable to classify|0|||
105716684|NCT00944034|364621893|FG000|Overall Study|Administrative reason|0|||
105716685|NCT00944034|364621894|FG001|Overall Study|Administrative reason|0|||
105716686|NCT00944034|364621895|FG002|Overall Study|Administrative reason|0|||
105716687|NCT00944034|364621896|FG003|Overall Study|Administrative reason|0|||
105716688|NCT00944034|364621897|FG004|Overall Study|Administrative reason|0|||
105716689|NCT00944034|364621898|FG005|Overall Study|Administrative reason|0|||
105716690|NCT00944034|364621899|FG006|Overall Study|Administrative reason|1|||
105716691|NCT00944034|364621900|FG007|Overall Study|Administrative reason|0|||
105716692|NCT00944034|364621901|FG008|Overall Study|Administrative reason|0|||
105716693|NCT00944034|364621902|FG009|Overall Study|Administrative reason|0|||
105716694|NCT00944034|364621903|FG010|Overall Study|Administrative reason|0|||
105716695|NCT00944034|364621904|FG011|Overall Study|Administrative reason|0|||
105716696|NCT01961544|364621905|FG000|Overall Study|Protocol Violation|1|||
105716697|NCT01961544|364621905|FG000|Overall Study|Withdrawal by Subject|7|||
105716698|NCT01961544|364621905|FG000|Overall Study|Adverse Event|1|||
105716699|NCT01961544|364621905|FG000|Overall Study|Physician Decision|2|||
105716700|NCT01961544|364621905|FG000|Overall Study|Poor Tolerance|1|||
105716701|NCT01961544|364621905|FG000|Overall Study|Aggravation of Steral Pain|1|||
105716702|NCT01500057|364621908|FG000|Overall Study|Lost to Follow-up|6|||
105716703|NCT01500057|364621909|FG001|Overall Study|Lost to Follow-up|4|||
105716704|NCT01960855|364621911|FG000|Overall Study|Subject noncompliant|1|||
105716705|NCT01960855|364621912|FG001|Overall Study|Subject noncompliant|0|||
105716706|NCT01960855|364621913|FG002|Overall Study|Subject noncompliant|0|||
105716707|NCT01960855|364621914|FG003|Overall Study|Subject noncompliant|0|||
105716708|NCT01960855|364621915|FG004|Overall Study|Subject noncompliant|0|||
105716709|NCT01960855|364621911|FG000|Overall Study|Adverse Event|2|||
105716710|NCT01960855|364621912|FG001|Overall Study|Adverse Event|0|||
105716711|NCT01960855|364621913|FG002|Overall Study|Adverse Event|6|||
105716712|NCT01960855|364621914|FG003|Overall Study|Adverse Event|2|||
105716713|NCT01960855|364621915|FG004|Overall Study|Adverse Event|2|||
105716714|NCT01960855|364621911|FG000|Overall Study|Lack of Efficacy|1|||
105932163|NCT04518410|365410916|FG020|Overall Study|Withdrawal by Subject|14|||
105932164|NCT04518410|365410917|FG021|Overall Study|Withdrawal by Subject|3|||
105716715|NCT01960855|364621912|FG001|Overall Study|Lack of Efficacy|1|||
105716716|NCT01960855|364621913|FG002|Overall Study|Lack of Efficacy|0|||
105716717|NCT01960855|364621914|FG003|Overall Study|Lack of Efficacy|0|||
105716718|NCT01960855|364621915|FG004|Overall Study|Lack of Efficacy|0|||
105716719|NCT01960855|364621911|FG000|Overall Study|Other|2|||
105716720|NCT01960855|364621912|FG001|Overall Study|Other|1|||
105716721|NCT01960855|364621913|FG002|Overall Study|Other|1|||
105716722|NCT01960855|364621914|FG003|Overall Study|Other|1|||
105716723|NCT01960855|364621915|FG004|Overall Study|Other|0|||
105716724|NCT01960855|364621911|FG000|Overall Study|Consent withdrawn by subject|3|||
105716725|NCT01960855|364621912|FG001|Overall Study|Consent withdrawn by subject|1|||
105716726|NCT01960855|364621913|FG002|Overall Study|Consent withdrawn by subject|2|||
105716727|NCT01960855|364621914|FG003|Overall Study|Consent withdrawn by subject|1|||
105716728|NCT01960855|364621915|FG004|Overall Study|Consent withdrawn by subject|1|||
105716729|NCT01960855|364621911|FG000|Overall Study|Lost to Follow-up|2|||
105716730|NCT01960855|364621912|FG001|Overall Study|Lost to Follow-up|1|||
105716731|NCT01960855|364621913|FG002|Overall Study|Lost to Follow-up|0|||
106008651|NCT01535040|365697053|FG000|Overall Study|Physician Decision|0|||
105716732|NCT01960855|364621914|FG003|Overall Study|Lost to Follow-up|0|||
105716733|NCT01960855|364621915|FG004|Overall Study|Lost to Follow-up|2|||
105716734|NCT00695565|364621919|FG000|Overall Study|Lost to Follow-up|4|||
105716735|NCT00695565|364621920|FG001|Overall Study|Lost to Follow-up|4|||
105716736|NCT00695565|364621919|FG000|Overall Study|Adverse Event|3|||
105716737|NCT00695565|364621920|FG001|Overall Study|Adverse Event|1|||
105716738|NCT00695565|364621919|FG000|Overall Study|Protocol Violation|3|||
105716739|NCT00695565|364621920|FG001|Overall Study|Protocol Violation|1|||
105716740|NCT00695565|364621919|FG000|Overall Study|Withdrawal by Subject|1|||
105716741|NCT00695565|364621920|FG001|Overall Study|Withdrawal by Subject|1|||
105716742|NCT00695565|364621919|FG000|Overall Study|Lack of Efficacy|1|||
105716743|NCT00695565|364621920|FG001|Overall Study|Lack of Efficacy|1|||
105716744|NCT00695565|364621919|FG000|Overall Study|Subject did not follow instructions|1|||
105716745|NCT00695565|364621920|FG001|Overall Study|Subject did not follow instructions|1|||
105716746|NCT00500682|364621921|FG000|Overall Study|Adverse Event|37|||
105716747|NCT00500682|364621922|FG001|Overall Study|Adverse Event|29|||
105716748|NCT00500682|364621921|FG000|Overall Study|Death|25|||
105716749|NCT00500682|364621922|FG001|Overall Study|Death|16|||
105716750|NCT00500682|364621921|FG000|Overall Study|Lost to Follow-up|11|||
105716751|NCT00500682|364621922|FG001|Overall Study|Lost to Follow-up|11|||
105716752|NCT00500682|364621921|FG000|Overall Study|Physician Decision|6|||
105716753|NCT00500682|364621922|FG001|Overall Study|Physician Decision|10|||
105716754|NCT00500682|364621921|FG000|Overall Study|Pregnancy|2|||
105716755|NCT00500682|364621922|FG001|Overall Study|Pregnancy|0|||
105716756|NCT00500682|364621921|FG000|Overall Study|Protocol Violation|1|||
105716757|NCT00500682|364621922|FG001|Overall Study|Protocol Violation|3|||
105716758|NCT00500682|364621921|FG000|Overall Study|Withdrawal by Subject|80|||
105716759|NCT00500682|364621922|FG001|Overall Study|Withdrawal by Subject|74|||
105716760|NCT00500682|364621921|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
105716761|NCT00500682|364621922|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
105716762|NCT02320487|364621925|FG000|Overall Study|Reason not Specified|1|||
105716763|NCT02320487|364621925|FG000|Overall Study|Physician Decision|5|||
105716764|NCT02320487|364621925|FG000|Overall Study|Withdrawal by Subject|1|||
105716765|NCT02320487|364621925|FG000|Overall Study|Death|3|||
105716766|NCT02320487|364621925|FG000|Overall Study|Adverse Event|11|||
105716767|NCT03344003|364621926|FG000|Overall Study|Switched to alternative treatment|1|||
105716768|NCT03344003|364621927|FG001|Overall Study|Switched to alternative treatment|0|||
105716769|NCT03344003|364621926|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
105716770|NCT03344003|364621927|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
105716771|NCT02661594|364623529|FG000|Overall Study|Protocol Violation|1|||
105716772|NCT02661594|364623530|FG001|Overall Study|Protocol Violation|0|||
105716773|NCT02661594|364623531|FG002|Overall Study|Protocol Violation|1|||
105716774|NCT02661594|364623532|FG003|Overall Study|Protocol Violation|0|||
105716775|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716776|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
105716777|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716778|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716779|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716780|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
105716781|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
105716782|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
105716783|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
105716784|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
105716785|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716786|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716787|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716788|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716789|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716790|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
105716791|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
105716792|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
105716793|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
105716794|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
105716795|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716796|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716797|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716798|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
105716799|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716800|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
105789960|NCT01656850|364884959|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
105789961|NCT02674568|364884960|FG000|Overall Study|Withdrawal by Subject|5|||
105789962|NCT02674568|364884960|FG000|Overall Study|Death|303|||
105789963|NCT02674568|364884960|FG000|Overall Study|Physician Decision|2|||
105789964|NCT02674568|364884960|FG000|Overall Study|Lost to Follow-up|9|||
105789965|NCT02674568|364884960|FG000|Overall Study|Other, Not Specified|20|||
105789966|NCT02916056|364884963|FG000|Overall Study|Adverse Event|6|||
105789967|NCT02916056|364884963|FG000|Overall Study|Lost to Follow-up|1|||
105789968|NCT02916056|364884963|FG000|Overall Study|Other|12|||
105789969|NCT02916056|364884963|FG000|Overall Study|Protocol Violation|1|||
105789970|NCT02916056|364884963|FG000|Overall Study|Withdrawal by Subject|8|||
105789971|NCT02916056|364884963|FG000|Overall Study|Study Terminated by Sponsor|269|||
105789972|NCT00685763|364884965|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
105789973|NCT00685763|364884965|FG000|Overall Study|Protocol Violation|1|||
105789974|NCT01741259|364884968|FG000|Overall Study|Protocol Violation|6|||
105789975|NCT01741259|364884969|FG001|Overall Study|Protocol Violation|4|||
105789976|NCT01741259|364884968|FG000|Overall Study|Withdrawal by Subject|0|||
105789977|NCT01741259|364884969|FG001|Overall Study|Withdrawal by Subject|2|||
105716801|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
105716802|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716803|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716804|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716805|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
105716806|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
105716807|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
105716808|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
105716809|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
105716810|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716811|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
105716812|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
105716813|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
105716814|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716815|NCT00289913|364623533|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
105716816|NCT00289913|364623534|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716817|NCT00289913|364623535|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
105716818|NCT00289913|364623536|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716819|NCT00289913|364623537|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716820|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716821|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716822|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
105716823|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716824|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716825|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
105716826|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
105716827|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
105716828|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
105716829|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
105716830|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
105716831|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
105716832|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
105716833|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
105716834|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
105716835|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
105716836|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
105716837|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
105716838|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105789978|NCT04341727|364884978|FG000|Overall Study|Withdrawal by Subject|0|||
105789979|NCT04341727|364884979|FG001|Overall Study|Withdrawal by Subject|0|||
105789980|NCT04341727|364884980|FG002|Overall Study|Withdrawal by Subject|1|||
105789981|NCT04341727|364884981|FG003|Overall Study|Withdrawal by Subject|0|||
105789982|NCT04341727|364884978|FG000|Overall Study|Lost to Follow-up|0|||
105789983|NCT04341727|364884979|FG001|Overall Study|Lost to Follow-up|0|||
105789984|NCT04341727|364884980|FG002|Overall Study|Lost to Follow-up|0|||
105789985|NCT04341727|364884981|FG003|Overall Study|Lost to Follow-up|1|||
105789986|NCT00564486|364884982|FG000|Overall Study|Adverse Event|0|||
105789987|NCT00564486|364884983|FG001|Overall Study|Adverse Event|1|||
105789988|NCT00564486|364884984|FG002|Overall Study|Adverse Event|0|||
105789989|NCT00564486|364884985|FG003|Overall Study|Adverse Event|0|||
105789990|NCT00564486|364884982|FG000|Overall Study|Withdrawal by Subject|4|||
105789991|NCT00564486|364884983|FG001|Overall Study|Withdrawal by Subject|0|||
105789992|NCT00564486|364884984|FG002|Overall Study|Withdrawal by Subject|0|||
105789993|NCT00564486|364884985|FG003|Overall Study|Withdrawal by Subject|5|||
105789994|NCT00564486|364884982|FG000|Overall Study|Subject refused to have blood drawn|0|||
105789995|NCT00564486|364884983|FG001|Overall Study|Subject refused to have blood drawn|0|||
105789996|NCT00564486|364884984|FG002|Overall Study|Subject refused to have blood drawn|1|||
105789997|NCT00564486|364884985|FG003|Overall Study|Subject refused to have blood drawn|0|||
105789998|NCT00564486|364884982|FG000|Overall Study|Lost to Follow-up|3|||
105789999|NCT00564486|364884983|FG001|Overall Study|Lost to Follow-up|0|||
105790000|NCT00564486|364884984|FG002|Overall Study|Lost to Follow-up|2|||
105790001|NCT00564486|364884985|FG003|Overall Study|Lost to Follow-up|2|||
105790002|NCT00494234|364884994|FG000|Overall Study|Withdrawal by Subject|1|||
105790003|NCT00494234|364884995|FG001|Overall Study|Withdrawal by Subject|0|||
105790004|NCT00494234|364884994|FG000|Overall Study|Disease progression|11|||
105790005|NCT00494234|364884995|FG001|Overall Study|Disease progression|8|||
105790006|NCT00494234|364884994|FG000|Overall Study|Death|2|||
105790007|NCT00494234|364884995|FG001|Overall Study|Death|1|||
105790008|NCT03292731|364884996|FG000|Overall Study|Protocol Violation|4|||
105790009|NCT03292731|364884997|FG001|Overall Study|Protocol Violation|11|||
105790010|NCT03292731|364884998|FG002|Overall Study|Protocol Violation|1|||
105790011|NCT01298362|364885003|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
105790012|NCT01298362|364885004|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
105790013|NCT03237325|364885007|FG000|Overall Study|Lost to Follow-up|3|||
105932165|NCT04518410|365410918|FG022|Overall Study|Withdrawal by Subject|2|||
105932166|NCT04518410|365410919|FG023|Overall Study|Withdrawal by Subject|9|||
105932167|NCT04518410|365410920|FG024|Overall Study|Withdrawal by Subject|8|||
105932168|NCT04518410|365410896|FG000|Overall Study|Other|1|||
105932169|NCT04518410|365410897|FG001|Overall Study|Other|0|||
105932170|NCT04518410|365410898|FG002|Overall Study|Other|0|||
105932171|NCT04518410|365410899|FG003|Overall Study|Other|1|||
105932172|NCT04518410|365410900|FG004|Overall Study|Other|6|||
105932173|NCT04518410|365410901|FG005|Overall Study|Other|6|||
105932174|NCT04518410|365410902|FG006|Overall Study|Other|5|||
105932175|NCT04518410|365410903|FG007|Overall Study|Other|2|||
105932176|NCT04518410|365410904|FG008|Overall Study|Other|0|||
105932177|NCT04518410|365410905|FG009|Overall Study|Other|1|||
105932178|NCT04518410|365410906|FG010|Overall Study|Other|0|||
105932179|NCT04518410|365410907|FG011|Overall Study|Other|2|||
105932180|NCT04518410|365410908|FG012|Overall Study|Other|0|||
105932181|NCT04518410|365410909|FG013|Overall Study|Other|0|||
105932182|NCT04518410|365410910|FG014|Overall Study|Other|0|||
105932183|NCT04518410|365410911|FG015|Overall Study|Other|3|||
105932184|NCT04518410|365410912|FG016|Overall Study|Other|1|||
105932185|NCT04518410|365410913|FG017|Overall Study|Other|1|||
105932186|NCT04518410|365410914|FG018|Overall Study|Other|1|||
105932187|NCT04518410|365410915|FG019|Overall Study|Other|0|||
105932188|NCT04518410|365410916|FG020|Overall Study|Other|1|||
105932189|NCT04518410|365410917|FG021|Overall Study|Other|0|||
105932190|NCT04518410|365410918|FG022|Overall Study|Other|1|||
105932191|NCT04518410|365410919|FG023|Overall Study|Other|2|||
105932192|NCT04518410|365410920|FG024|Overall Study|Other|2|||
105932193|NCT04518410|365410896|FG000|Overall Study|Protocol Violation|0|||
105932194|NCT04518410|365410897|FG001|Overall Study|Protocol Violation|0|||
105932195|NCT04518410|365410898|FG002|Overall Study|Protocol Violation|0|||
105932196|NCT04518410|365410899|FG003|Overall Study|Protocol Violation|2|||
105932197|NCT04518410|365410900|FG004|Overall Study|Protocol Violation|17|||
105932198|NCT04518410|365410901|FG005|Overall Study|Protocol Violation|1|||
105932199|NCT04518410|365410902|FG006|Overall Study|Protocol Violation|2|||
105932200|NCT04518410|365410903|FG007|Overall Study|Protocol Violation|1|||
105932201|NCT04518410|365410904|FG008|Overall Study|Protocol Violation|0|||
105932202|NCT04518410|365410905|FG009|Overall Study|Protocol Violation|0|||
105932203|NCT04518410|365410906|FG010|Overall Study|Protocol Violation|0|||
105790014|NCT03237325|364885008|FG001|Overall Study|Lost to Follow-up|5|||
105790015|NCT03237325|364885007|FG000|Overall Study|Physician Decision|2|||
105790016|NCT03237325|364885008|FG001|Overall Study|Physician Decision|4|||
105790017|NCT03237325|364885007|FG000|Overall Study|Withdrawal by Subject|9|||
105790018|NCT03237325|364885008|FG001|Overall Study|Withdrawal by Subject|12|||
105932204|NCT04518410|365410907|FG011|Overall Study|Protocol Violation|0|||
105932205|NCT04518410|365410908|FG012|Overall Study|Protocol Violation|0|||
105932206|NCT04518410|365410909|FG013|Overall Study|Protocol Violation|0|||
105932207|NCT04518410|365410910|FG014|Overall Study|Protocol Violation|0|||
105932208|NCT04518410|365410911|FG015|Overall Study|Protocol Violation|0|||
105790019|NCT03237325|364885007|FG000|Overall Study|Noncompliance with Study Procedures|1|||
105790020|NCT03237325|364885008|FG001|Overall Study|Noncompliance with Study Procedures|1|||
105790021|NCT03237325|364885007|FG000|Overall Study|Termination by Sponsor|0|||
105790022|NCT03237325|364885008|FG001|Overall Study|Termination by Sponsor|1|||
105790023|NCT03237325|364885007|FG000|Overall Study|Reason other than described|0|||
105790024|NCT03237325|364885008|FG001|Overall Study|Reason other than described|2|||
105790025|NCT02684370|364885009|FG000|Part A|Adverse Event|2|||
105790026|NCT02684370|364885010|FG001|Part A|Adverse Event|0|||
105790027|NCT02684370|364885011|FG002|Part A|Adverse Event|1|||
105790028|NCT02684370|364885012|FG003|Part A|Adverse Event|0|||
105790029|NCT02684370|364885013|FG004|Part A|Adverse Event|0|||
105790030|NCT02684370|364885014|FG005|Part A|Adverse Event|0|||
105790031|NCT02684370|364885009|FG000|Part A|Lost to Follow-up|1|||
105790032|NCT02684370|364885010|FG001|Part A|Lost to Follow-up|1|||
105790033|NCT02684370|364885011|FG002|Part A|Lost to Follow-up|0|||
105790034|NCT02684370|364885012|FG003|Part A|Lost to Follow-up|0|||
105790035|NCT02684370|364885013|FG004|Part A|Lost to Follow-up|0|||
105790036|NCT02684370|364885014|FG005|Part A|Lost to Follow-up|0|||
105790037|NCT02684370|364885009|FG000|Part A|Subject Withdrawal|1|||
105790038|NCT02684370|364885010|FG001|Part A|Subject Withdrawal|0|||
105790039|NCT02684370|364885011|FG002|Part A|Subject Withdrawal|3|||
105790040|NCT02684370|364885012|FG003|Part A|Subject Withdrawal|0|||
105790041|NCT02684370|364885013|FG004|Part A|Subject Withdrawal|0|||
105790042|NCT02684370|364885014|FG005|Part A|Subject Withdrawal|0|||
105790043|NCT02684370|364885009|FG000|Part A|Other|0|||
105790044|NCT02684370|364885010|FG001|Part A|Other|0|||
105790045|NCT02684370|364885011|FG002|Part A|Other|1|||
105790046|NCT02684370|364885012|FG003|Part A|Other|0|||
105790047|NCT02684370|364885013|FG004|Part A|Other|0|||
105790048|NCT02684370|364885014|FG005|Part A|Other|0|||
105790049|NCT02684370|364885009|FG000|Part B|Adverse Event|0|||
105790050|NCT02684370|364885010|FG001|Part B|Adverse Event|0|||
105790051|NCT02684370|364885011|FG002|Part B|Adverse Event|0|||
105790052|NCT02684370|364885012|FG003|Part B|Adverse Event|0|||
105790053|NCT02684370|364885013|FG004|Part B|Adverse Event|2|||
105790054|NCT02684370|364885014|FG005|Part B|Adverse Event|1|||
105790055|NCT02684370|364885009|FG000|Part B|Lost to Follow-up|0|||
105790056|NCT02684370|364885010|FG001|Part B|Lost to Follow-up|0|||
105790057|NCT02684370|364885011|FG002|Part B|Lost to Follow-up|0|||
105790058|NCT02684370|364885012|FG003|Part B|Lost to Follow-up|1|||
105790059|NCT02684370|364885013|FG004|Part B|Lost to Follow-up|2|||
105790060|NCT02684370|364885014|FG005|Part B|Lost to Follow-up|5|||
105790061|NCT02684370|364885009|FG000|Part B|Subject Withdrawal|0|||
105790062|NCT02684370|364885010|FG001|Part B|Subject Withdrawal|0|||
105790063|NCT02684370|364885011|FG002|Part B|Subject Withdrawal|0|||
105790064|NCT02684370|364885012|FG003|Part B|Subject Withdrawal|1|||
105790065|NCT02684370|364885013|FG004|Part B|Subject Withdrawal|1|||
105790066|NCT02684370|364885014|FG005|Part B|Subject Withdrawal|2|||
105790067|NCT01012609|364885015|FG000|Overall Study|Withdrawal by Subject|1|||
105790068|NCT01012609|364885016|FG001|Overall Study|Withdrawal by Subject|1|||
105790069|NCT01453296|364885017|FG000|Treatment Period 1|Adverse Event|0|||
105790070|NCT01453296|364885018|FG001|Treatment Period 1|Adverse Event|1|||
105790071|NCT01453296|364885017|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
105790072|NCT01453296|364885018|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
105790073|NCT01453296|364885017|FG000|Treatment Period 2|Adverse Event|1|||
105790074|NCT01453296|364885018|FG001|Treatment Period 2|Adverse Event|0|||
105790075|NCT01453296|364885017|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105790076|NCT01453296|364885018|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105790077|NCT04139642|364885019|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
105790078|NCT04139642|364885020|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
105790079|NCT00585468|364885021|FG000|First Intervention|Withdrawal by Subject|1|||
105790080|NCT00585468|364885022|FG001|First Intervention|Withdrawal by Subject|1|||
105790081|NCT00762073|364885029|FG000|Overall Study|Lack of Efficacy|1|||
105790082|NCT00762073|364885030|FG001|Overall Study|Lack of Efficacy|1|||
105790083|NCT00762073|364885031|FG002|Overall Study|Lack of Efficacy|0|||
105790084|NCT00762073|364885032|FG003|Overall Study|Lack of Efficacy|0|||
105790085|NCT00762073|364885029|FG000|Overall Study|Adverse Event|1|||
105790086|NCT00762073|364885030|FG001|Overall Study|Adverse Event|0|||
105790087|NCT00762073|364885031|FG002|Overall Study|Adverse Event|1|||
105790088|NCT00762073|364885032|FG003|Overall Study|Adverse Event|1|||
105790089|NCT00762073|364885029|FG000|Overall Study|Significant Subject Noncompliance|0|||
105790090|NCT00762073|364885030|FG001|Overall Study|Significant Subject Noncompliance|1|||
105790091|NCT00762073|364885031|FG002|Overall Study|Significant Subject Noncompliance|0|||
105790092|NCT00762073|364885032|FG003|Overall Study|Significant Subject Noncompliance|1|||
105790093|NCT00762073|364885029|FG000|Overall Study|Withdrawal by Subject|1|||
105790094|NCT00762073|364885030|FG001|Overall Study|Withdrawal by Subject|2|||
105790095|NCT00762073|364885031|FG002|Overall Study|Withdrawal by Subject|1|||
105790096|NCT00762073|364885032|FG003|Overall Study|Withdrawal by Subject|1|||
105790097|NCT00762073|364885029|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
105790098|NCT00762073|364885030|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
105790099|NCT00762073|364885031|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
105716839|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716840|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
105716841|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716842|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
105716843|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716844|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716845|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716846|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
105716847|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
105716848|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
105716849|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
105716850|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
105716851|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
105716852|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
105716853|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
105716854|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
105716855|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
105716856|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
105716857|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
105716858|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
105716859|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
105716860|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
105716861|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
105716862|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
105716863|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
105716864|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
105716865|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
105716866|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
105716867|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
105716868|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
105716869|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
105716870|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
105716871|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
105716872|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
105716873|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
105716874|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
105716875|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
105716876|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
105716877|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
105716878|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
105716879|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
105716880|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
105716881|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
105716882|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
105716883|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
105716884|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
105716885|NCT00289913|364623533|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
105716886|NCT00289913|364623534|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
105716887|NCT00289913|364623535|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
105716888|NCT00289913|364623536|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
105716889|NCT00289913|364623537|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
105716890|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716891|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
105716892|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716893|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716894|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
105716895|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
105716896|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
105716897|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
105716898|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
105716899|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
105716900|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716901|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105790100|NCT00762073|364885032|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
105790101|NCT01068418|364885033|FG000|Overall Study|Physician Decision|12|||
105790102|NCT03155269|364885036|FG000|Overall Study|Withdrawal by Subject|4|||
105790103|NCT03155269|364885037|FG001|Overall Study|Withdrawal by Subject|5|||
105790104|NCT03155269|364885036|FG000|Overall Study|Lost to Follow-up|1|||
105790105|NCT03155269|364885037|FG001|Overall Study|Lost to Follow-up|2|||
105790106|NCT02181673|364885038|FG000|Up to Week 24|Adverse Event|2|||
105790107|NCT02181673|364885039|FG001|Up to Week 24|Adverse Event|0|||
105790108|NCT02181673|364885040|FG002|Up to Week 24|Adverse Event|3|||
105790109|NCT02181673|364885038|FG000|Up to Week 24|Death|1|||
105790110|NCT02181673|364885039|FG001|Up to Week 24|Death|0|||
105790111|NCT02181673|364885040|FG002|Up to Week 24|Death|0|||
105790112|NCT02181673|364885038|FG000|Up to Week 24|Lack of Efficacy|1|||
105790113|NCT02181673|364885039|FG001|Up to Week 24|Lack of Efficacy|0|||
105790114|NCT02181673|364885040|FG002|Up to Week 24|Lack of Efficacy|0|||
105790115|NCT02181673|364885038|FG000|Up to Week 24|Lost to Follow-up|1|||
105790116|NCT02181673|364885039|FG001|Up to Week 24|Lost to Follow-up|0|||
105790117|NCT02181673|364885040|FG002|Up to Week 24|Lost to Follow-up|0|||
105790118|NCT02181673|364885038|FG000|Up to Week 24|Physician Decision|0|||
105790119|NCT02181673|364885039|FG001|Up to Week 24|Physician Decision|0|||
105790120|NCT02181673|364885040|FG002|Up to Week 24|Physician Decision|3|||
105790121|NCT02181673|364885038|FG000|Up to Week 24|Withdrawal by Subject|10|||
105790122|NCT02181673|364885039|FG001|Up to Week 24|Withdrawal by Subject|0|||
105790123|NCT02181673|364885040|FG002|Up to Week 24|Withdrawal by Subject|1|||
105790124|NCT02181673|364885038|FG000|Up to Week 24|Other|2|||
105790125|NCT02181673|364885039|FG001|Up to Week 24|Other|0|||
105790126|NCT02181673|364885040|FG002|Up to Week 24|Other|3|||
105790127|NCT02181673|364885038|FG000|Up to Week 24|Randomized not Treated|0|||
105790128|NCT02181673|364885039|FG001|Up to Week 24|Randomized not Treated|0|||
105790129|NCT02181673|364885040|FG002|Up to Week 24|Randomized not Treated|1|||
105790130|NCT02181673|364885038|FG000|Week 24-Week 60|Adverse Event|0|||
105790131|NCT02181673|364885039|FG001|Week 24-Week 60|Adverse Event|4|||
105790132|NCT02181673|364885040|FG002|Week 24-Week 60|Adverse Event|10|||
105790133|NCT02181673|364885038|FG000|Week 24-Week 60|Other|0|||
105790134|NCT02181673|364885039|FG001|Week 24-Week 60|Other|2|||
105790135|NCT02181673|364885040|FG002|Week 24-Week 60|Other|1|||
105790136|NCT02181673|364885038|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
105790137|NCT02181673|364885039|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
105790138|NCT02181673|364885040|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
105790139|NCT02181673|364885038|FG000|Week 24-Week 60|Pregnancy|0|||
105790140|NCT02181673|364885039|FG001|Week 24-Week 60|Pregnancy|0|||
105790141|NCT02181673|364885040|FG002|Week 24-Week 60|Pregnancy|1|||
105790142|NCT02181673|364885038|FG000|Week 24-Week 60|Lack of Efficacy|0|||
105790143|NCT02181673|364885039|FG001|Week 24-Week 60|Lack of Efficacy|0|||
105790144|NCT02181673|364885040|FG002|Week 24-Week 60|Lack of Efficacy|1|||
105790145|NCT02181673|364885038|FG000|Week 24-Week 60|Lost to Follow-up|0|||
105790146|NCT02181673|364885039|FG001|Week 24-Week 60|Lost to Follow-up|0|||
105790147|NCT02181673|364885040|FG002|Week 24-Week 60|Lost to Follow-up|1|||
105790148|NCT02181673|364885038|FG000|Week 24-Week 60|Physician Decision|0|||
105790149|NCT02181673|364885039|FG001|Week 24-Week 60|Physician Decision|0|||
105790150|NCT02181673|364885040|FG002|Week 24-Week 60|Physician Decision|1|||
105790151|NCT00433771|364885041|FG000|Overall Study|screen fail|14|||
105790152|NCT00433771|364885041|FG000|Overall Study|Treated and later found to be ineligible|2|||
105790153|NCT00433771|364885041|FG000|Overall Study|Death|2|||
105790154|NCT00433771|364885041|FG000|Overall Study|Failure to deploy stent|1|||
105790155|NCT00138658|364885042|FG000|Overall Study|Adverse Event|23|||
105790156|NCT00138658|364885042|FG000|Overall Study|Death|1|||
105790157|NCT00138658|364885042|FG000|Overall Study|Disease Progression|21|||
105790158|NCT00138658|364885042|FG000|Overall Study|Physician Decision|11|||
105932209|NCT04518410|365410912|FG016|Overall Study|Protocol Violation|1|||
105790159|NCT00138658|364885042|FG000|Overall Study|Withdrawal by Subject|5|||
105790160|NCT00539006|364885050|FG000|Pre-treatment|Other|0|||
105790161|NCT00539006|364885051|FG001|Pre-treatment|Other|1|||
105932210|NCT04518410|365410913|FG017|Overall Study|Protocol Violation|1|||
105790162|NCT00539006|364885052|FG002|Pre-treatment|Other|0|||
105790163|NCT00539006|364885053|FG003|Pre-treatment|Other|0|||
105790164|NCT00539006|364885050|FG000|Treatment Period 1|Lost to Follow-up|0|||
105790165|NCT00539006|364885051|FG001|Treatment Period 1|Lost to Follow-up|0|||
105790166|NCT00539006|364885052|FG002|Treatment Period 1|Lost to Follow-up|1|||
105790167|NCT00539006|364885053|FG003|Treatment Period 1|Lost to Follow-up|0|||
105790168|NCT00539006|364885050|FG000|Treatment Period 1|Protocol Violation|0|||
105790169|NCT00539006|364885051|FG001|Treatment Period 1|Protocol Violation|0|||
105790170|NCT00539006|364885052|FG002|Treatment Period 1|Protocol Violation|1|||
105790171|NCT00539006|364885053|FG003|Treatment Period 1|Protocol Violation|0|||
105790172|NCT00539006|364885050|FG000|Treatment Period 1|Lack of Efficacy|0|||
105790173|NCT00539006|364885051|FG001|Treatment Period 1|Lack of Efficacy|0|||
105790174|NCT00539006|364885052|FG002|Treatment Period 1|Lack of Efficacy|0|||
105716902|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716903|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
105716904|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
105716905|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716906|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716907|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716908|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
105716909|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
105716910|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
105716911|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
105716912|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
105716913|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
105716914|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
105716915|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716916|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
105716917|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
105716918|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716919|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
105716920|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
105716921|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
105716922|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
105716923|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
105716924|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
105716925|NCT00289913|364623533|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716926|NCT00289913|364623534|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
105716927|NCT00289913|364623535|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716928|NCT00289913|364623536|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716929|NCT00289913|364623537|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
105716930|NCT00254566|364623538|FG000|Overall Study|Death|1|||
105716931|NCT00254566|364623539|FG001|Overall Study|Death|0|||
105716932|NCT00254566|364623538|FG000|Overall Study|Adverse Event|5|||
105716933|NCT00254566|364623539|FG001|Overall Study|Adverse Event|4|||
105716934|NCT00254566|364623538|FG000|Overall Study|Lack of Efficacy|12|||
105716935|NCT00254566|364623539|FG001|Overall Study|Lack of Efficacy|9|||
105716936|NCT00254566|364623538|FG000|Overall Study|Other|1|||
105716937|NCT00254566|364623539|FG001|Overall Study|Other|5|||
105716938|NCT00254566|364623538|FG000|Overall Study|Withdrawal by Subject|5|||
105716939|NCT00254566|364623539|FG001|Overall Study|Withdrawal by Subject|6|||
105716940|NCT00254566|364623538|FG000|Overall Study|Lost to Follow-up|7|||
105716941|NCT00254566|364623539|FG001|Overall Study|Lost to Follow-up|2|||
105716942|NCT01169779|364623540|FG000|Overall Study|Adverse Event|3|||
105716943|NCT01169779|364623541|FG001|Overall Study|Adverse Event|11|||
105716944|NCT01169779|364623540|FG000|Overall Study|Lack of Efficacy|1|||
105716945|NCT01169779|364623541|FG001|Overall Study|Lack of Efficacy|0|||
105716946|NCT01169779|364623540|FG000|Overall Study|Protocol Violation|1|||
105716947|NCT01169779|364623541|FG001|Overall Study|Protocol Violation|1|||
105716948|NCT01169779|364623540|FG000|Overall Study|Withdrawal by Subject|3|||
105716949|NCT01169779|364623541|FG001|Overall Study|Withdrawal by Subject|2|||
105716950|NCT01169779|364623540|FG000|Overall Study|Familial and personal reasons|3|||
105716951|NCT01169779|364623541|FG001|Overall Study|Familial and personal reasons|3|||
105716952|NCT00548548|364623542|FG000|Overall Study|Death|345|||
105716953|NCT00548548|364623543|FG001|Overall Study|Death|348|||
105716954|NCT00548548|364623542|FG000|Overall Study|Lost to Follow-up|17|||
105716955|NCT00548548|364623543|FG001|Overall Study|Lost to Follow-up|18|||
105716956|NCT01061008|364623546|FG000|Overall Study|Badiocephalic fistula failed|3|||
105716957|NCT01061008|364623547|FG001|Overall Study|Badiocephalic fistula failed|2|||
105716958|NCT01061008|364623546|FG000|Overall Study|Death|1|||
105716959|NCT01061008|364623547|FG001|Overall Study|Death|0|||
105716960|NCT01061008|364623546|FG000|Overall Study|Withdrawal by Subject|1|||
105790175|NCT00539006|364885053|FG003|Treatment Period 1|Lack of Efficacy|1|||
105716961|NCT01061008|364623547|FG001|Overall Study|Withdrawal by Subject|3|||
105716962|NCT01061008|364623546|FG000|Overall Study|Unable to exercise following surgery|1|||
105716963|NCT01061008|364623547|FG001|Overall Study|Unable to exercise following surgery|0|||
105716964|NCT01061008|364623546|FG000|Overall Study|Adverse Event|0|||
105790176|NCT00539006|364885050|FG000|Washout|Adverse Event|2|||
105932211|NCT04518410|365410914|FG018|Overall Study|Protocol Violation|0|||
105716965|NCT01061008|364623547|FG001|Overall Study|Adverse Event|1|||
105716966|NCT00648167|364623550|FG000|Overall Study|Adverse Event|6|||
105716967|NCT00648167|364623550|FG000|Overall Study|unable to swallow tablets|1|||
105716968|NCT01688050|364623551|FG000|Overall Study|Death|7|||
105716969|NCT01688050|364623551|FG000|Overall Study|Conversion to open repair|1|||
105716970|NCT01688050|364623551|FG000|Overall Study|Lost to Follow-up|13|||
105716971|NCT01688050|364623551|FG000|Overall Study|Withdrawal by Subject|10|||
105716972|NCT00927368|364623552|FG000|Overall Study|enrollment in another study|1|||
105716973|NCT00927368|364623553|FG001|Overall Study|enrollment in another study|1|||
105716974|NCT00927368|364623554|FG002|Overall Study|enrollment in another study|2|||
105716975|NCT00927368|364623552|FG000|Overall Study|Lost to Follow-up|4|||
105716976|NCT00927368|364623553|FG001|Overall Study|Lost to Follow-up|0|||
105716977|NCT00927368|364623554|FG002|Overall Study|Lost to Follow-up|0|||
105716978|NCT00927368|364623552|FG000|Overall Study|equipment failure|1|||
105716979|NCT00927368|364623553|FG001|Overall Study|equipment failure|0|||
105716980|NCT00927368|364623554|FG002|Overall Study|equipment failure|0|||
105716981|NCT00927368|364623552|FG000|Overall Study|ineligible post randomization|0|||
105716982|NCT00927368|364623553|FG001|Overall Study|ineligible post randomization|3|||
105716983|NCT00927368|364623554|FG002|Overall Study|ineligible post randomization|1|||
105716984|NCT00927368|364623552|FG000|Overall Study|cancellation of surgery|0|||
105716985|NCT00927368|364623553|FG001|Overall Study|cancellation of surgery|1|||
105716986|NCT00927368|364623554|FG002|Overall Study|cancellation of surgery|2|||
105716987|NCT03683394|364623555|FG000|Overall Study|Withdrawal by Subject|4|||
105716988|NCT03683394|364623556|FG001|Overall Study|Withdrawal by Subject|8|||
105716989|NCT03683394|364623555|FG000|Overall Study|Lost to Follow-up|7|||
105716990|NCT03683394|364623556|FG001|Overall Study|Lost to Follow-up|0|||
105716991|NCT03683394|364623555|FG000|Overall Study|Death|3|||
105716992|NCT03683394|364623556|FG001|Overall Study|Death|1|||
105716993|NCT03072160|364623557|FG000|Overall Study|Adverse Event|3|||
105716994|NCT03072160|364623558|FG001|Overall Study|Adverse Event|1|||
105716995|NCT03072160|364623557|FG000|Overall Study|Refused further treatment|6|||
105716996|NCT03072160|364623558|FG001|Overall Study|Refused further treatment|1|||
105716997|NCT03072160|364623557|FG000|Overall Study|Physician Decision|1|||
105716998|NCT03072160|364623558|FG001|Overall Study|Physician Decision|0|||
105716999|NCT03072160|364623557|FG000|Overall Study|Disease progression on study|1|||
105717000|NCT03072160|364623558|FG001|Overall Study|Disease progression on study|1|||
105717001|NCT03072160|364623557|FG000|Overall Study|No contact|0|||
105717002|NCT03072160|364623558|FG001|Overall Study|No contact|1|||
105717003|NCT04276207|364623559|FG000|Period 1|Withdrawal by Subject|0|||
105717004|NCT04276207|364623560|FG001|Period 1|Withdrawal by Subject|1|||
105717005|NCT00395967|364623562|FG000|Treatment Period|Failed Mobilization|1|||
105717006|NCT00395967|364623562|FG000|Follow-up Period|Death|1|||
105717007|NCT00395967|364623562|FG000|Follow-up Period|Lost to Follow-up|1|||
105717008|NCT03118947|364623563|FG000|Overall Study|Adverse Event|7|||
105717009|NCT03118947|364623563|FG000|Overall Study|Death|3|||
105717010|NCT03118947|364623563|FG000|Overall Study|Lack of Efficacy|4|||
105717011|NCT03118947|364623563|FG000|Overall Study|Non-compliance with study drug|1|||
105717012|NCT03118947|364623563|FG000|Overall Study|Protocol Violation|2|||
105717013|NCT03118947|364623563|FG000|Overall Study|Withdrawal by Subject|3|||
105717014|NCT03118947|364623563|FG000|Overall Study|Withdrawal by caregiver|3|||
105717015|NCT03118947|364623563|FG000|Overall Study|Change in patient's living situation|4|||
105717016|NCT03118947|364623563|FG000|Overall Study|Lost to Follow-up|2|||
105717017|NCT00179959|364623564|FG000|Overall Study|Lost to Follow-up|3|||
105717018|NCT00179959|364623565|FG001|Overall Study|Lost to Follow-up|1|||
105717019|NCT00179959|364623564|FG000|Overall Study|Withdrawal by Subject|3|||
105717020|NCT00179959|364623565|FG001|Overall Study|Withdrawal by Subject|2|||
105717021|NCT01262976|364623566|FG000|Up to Month 2|Serious Adverse Event|0|||
105717022|NCT01262976|364623567|FG001|Up to Month 2|Serious Adverse Event|0|||
105717023|NCT01262976|364623568|FG002|Up to Month 2|Serious Adverse Event|1|||
105717024|NCT01262976|364623569|FG003|Up to Month 2|Serious Adverse Event|0|||
105717025|NCT01262976|364623570|FG004|Up to Month 2|Serious Adverse Event|0|||
105717026|NCT01262976|364623571|FG005|Up to Month 2|Serious Adverse Event|0|||
105717027|NCT01262976|364623566|FG000|Up to Month 2|Withdrawal by Subject|1|||
105717028|NCT01262976|364623567|FG001|Up to Month 2|Withdrawal by Subject|0|||
105717029|NCT01262976|364623568|FG002|Up to Month 2|Withdrawal by Subject|0|||
105717030|NCT01262976|364623569|FG003|Up to Month 2|Withdrawal by Subject|0|||
105717031|NCT01262976|364623570|FG004|Up to Month 2|Withdrawal by Subject|0|||
105717032|NCT01262976|364623571|FG005|Up to Month 2|Withdrawal by Subject|0|||
105717033|NCT01262976|364623566|FG000|Up to Month 2|Migrated/moved from study area|0|||
105717034|NCT01262976|364623567|FG001|Up to Month 2|Migrated/moved from study area|1|||
105717035|NCT01262976|364623568|FG002|Up to Month 2|Migrated/moved from study area|0|||
105717036|NCT01262976|364623569|FG003|Up to Month 2|Migrated/moved from study area|0|||
105932212|NCT04518410|365410915|FG019|Overall Study|Protocol Violation|0|||
105717037|NCT01262976|364623570|FG004|Up to Month 2|Migrated/moved from study area|1|||
105717038|NCT01262976|364623571|FG005|Up to Month 2|Migrated/moved from study area|1|||
105717039|NCT01262976|364623566|FG000|Up to Month 2|Lost to Follow-up|1|||
105932213|NCT04518410|365410916|FG020|Overall Study|Protocol Violation|1|||
105717040|NCT01262976|364623567|FG001|Up to Month 2|Lost to Follow-up|0|||
105717041|NCT01262976|364623568|FG002|Up to Month 2|Lost to Follow-up|0|||
105717042|NCT01262976|364623569|FG003|Up to Month 2|Lost to Follow-up|1|||
105717043|NCT01262976|364623570|FG004|Up to Month 2|Lost to Follow-up|1|||
105717044|NCT01262976|364623571|FG005|Up to Month 2|Lost to Follow-up|1|||
105717045|NCT01262976|364623566|FG000|Up to Month 2|Other|1|||
105790177|NCT00539006|364885051|FG001|Washout|Adverse Event|1|||
105790178|NCT00539006|364885052|FG002|Washout|Adverse Event|0|||
105790179|NCT00539006|364885053|FG003|Washout|Adverse Event|0|||
105790180|NCT00539006|364885050|FG000|Washout|Protocol Violation|1|||
105790181|NCT00539006|364885051|FG001|Washout|Protocol Violation|1|||
105790182|NCT00539006|364885052|FG002|Washout|Protocol Violation|0|||
105790183|NCT00539006|364885053|FG003|Washout|Protocol Violation|0|||
105790184|NCT00539006|364885050|FG000|Washout|Withdrawal by Subject|0|||
105790185|NCT00539006|364885051|FG001|Washout|Withdrawal by Subject|2|||
105790186|NCT00539006|364885052|FG002|Washout|Withdrawal by Subject|0|||
105790187|NCT00539006|364885053|FG003|Washout|Withdrawal by Subject|0|||
105790188|NCT00539006|364885050|FG000|Washout|Failed to meet continuation criteria|16|||
105790189|NCT00539006|364885051|FG001|Washout|Failed to meet continuation criteria|5|||
105790190|NCT00539006|364885052|FG002|Washout|Failed to meet continuation criteria|14|||
105790191|NCT00539006|364885053|FG003|Washout|Failed to meet continuation criteria|6|||
105790192|NCT00539006|364885050|FG000|Washout|Other|1|||
105790193|NCT00539006|364885051|FG001|Washout|Other|1|||
105717046|NCT01262976|364623567|FG001|Up to Month 2|Other|0|||
105717047|NCT01262976|364623568|FG002|Up to Month 2|Other|0|||
105717048|NCT01262976|364623569|FG003|Up to Month 2|Other|1|||
105717049|NCT01262976|364623570|FG004|Up to Month 2|Other|0|||
105717050|NCT01262976|364623571|FG005|Up to Month 2|Other|2|||
105717051|NCT01262976|364623566|FG000|Up to Month 7|Serious Adverse Event|0|||
105717052|NCT01262976|364623567|FG001|Up to Month 7|Serious Adverse Event|0|||
105717053|NCT01262976|364623568|FG002|Up to Month 7|Serious Adverse Event|2|||
105717054|NCT01262976|364623569|FG003|Up to Month 7|Serious Adverse Event|0|||
105932214|NCT04518410|365410917|FG021|Overall Study|Protocol Violation|2|||
105932215|NCT04518410|365410918|FG022|Overall Study|Protocol Violation|0|||
105932216|NCT04518410|365410919|FG023|Overall Study|Protocol Violation|3|||
105932217|NCT04518410|365410920|FG024|Overall Study|Protocol Violation|0|||
105932218|NCT04518410|365410896|FG000|Overall Study|Death|0|||
105932219|NCT04518410|365410897|FG001|Overall Study|Death|0|||
105932220|NCT04518410|365410898|FG002|Overall Study|Death|0|||
105932221|NCT04518410|365410899|FG003|Overall Study|Death|0|||
105932222|NCT04518410|365410900|FG004|Overall Study|Death|12|||
105932223|NCT04518410|365410901|FG005|Overall Study|Death|2|||
105932224|NCT04518410|365410902|FG006|Overall Study|Death|11|||
105932225|NCT04518410|365410903|FG007|Overall Study|Death|0|||
105932226|NCT04518410|365410904|FG008|Overall Study|Death|1|||
105932227|NCT04518410|365410905|FG009|Overall Study|Death|0|||
105932228|NCT04518410|365410906|FG010|Overall Study|Death|0|||
105717055|NCT01262976|364623570|FG004|Up to Month 7|Serious Adverse Event|0|||
105717056|NCT01262976|364623571|FG005|Up to Month 7|Serious Adverse Event|0|||
105717057|NCT01262976|364623566|FG000|Up to Month 7|Withdrawal by Subject|1|||
105717058|NCT01262976|364623567|FG001|Up to Month 7|Withdrawal by Subject|0|||
105717059|NCT01262976|364623568|FG002|Up to Month 7|Withdrawal by Subject|0|||
105717060|NCT01262976|364623569|FG003|Up to Month 7|Withdrawal by Subject|0|||
105790194|NCT00539006|364885052|FG002|Washout|Other|2|||
105790195|NCT00539006|364885053|FG003|Washout|Other|3|||
105790196|NCT00539006|364885050|FG000|Treatment Period 2|Protocol Violation|1|||
105790197|NCT00539006|364885051|FG001|Treatment Period 2|Protocol Violation|0|||
105790198|NCT00539006|364885052|FG002|Treatment Period 2|Protocol Violation|0|||
105790199|NCT00539006|364885053|FG003|Treatment Period 2|Protocol Violation|0|||
105932229|NCT04518410|365410907|FG011|Overall Study|Death|0|||
105932230|NCT04518410|365410908|FG012|Overall Study|Death|0|||
105932231|NCT04518410|365410909|FG013|Overall Study|Death|1|||
105717061|NCT01262976|364623570|FG004|Up to Month 7|Withdrawal by Subject|0|||
105717062|NCT01262976|364623571|FG005|Up to Month 7|Withdrawal by Subject|0|||
105717063|NCT01262976|364623566|FG000|Up to Month 7|Migrated/moved from study area|0|||
105790200|NCT00539006|364885050|FG000|Treatment Period 2|Other|0|||
105790201|NCT00539006|364885051|FG001|Treatment Period 2|Other|1|||
105790202|NCT00539006|364885052|FG002|Treatment Period 2|Other|0|||
105932232|NCT04518410|365410910|FG014|Overall Study|Death|1|||
105932233|NCT04518410|365410911|FG015|Overall Study|Death|0|||
105717064|NCT01262976|364623567|FG001|Up to Month 7|Migrated/moved from study area|0|||
105717065|NCT01262976|364623568|FG002|Up to Month 7|Migrated/moved from study area|1|||
105717066|NCT01262976|364623569|FG003|Up to Month 7|Migrated/moved from study area|3|||
105790203|NCT00539006|364885053|FG003|Treatment Period 2|Other|0|||
105790204|NCT03733301|364885054|FG000|Overall Study|Screen Fail|1|||
105790205|NCT03733301|364885055|FG001|Overall Study|Screen Fail|0|||
105790206|NCT03733301|364885056|FG002|Overall Study|Screen Fail|0|||
105790207|NCT03733301|364885054|FG000|Overall Study|Non-compliance|1|||
105717067|NCT01262976|364623570|FG004|Up to Month 7|Migrated/moved from study area|1|||
105717068|NCT01262976|364623571|FG005|Up to Month 7|Migrated/moved from study area|1|||
105717069|NCT01262976|364623566|FG000|Up to Month 7|Lost to Follow-up|1|||
105717070|NCT01262976|364623567|FG001|Up to Month 7|Lost to Follow-up|0|||
105717071|NCT01262976|364623568|FG002|Up to Month 7|Lost to Follow-up|1|||
105717072|NCT01262976|364623569|FG003|Up to Month 7|Lost to Follow-up|3|||
105717073|NCT01262976|364623570|FG004|Up to Month 7|Lost to Follow-up|1|||
105717074|NCT01262976|364623571|FG005|Up to Month 7|Lost to Follow-up|3|||
105717075|NCT01262976|364623566|FG000|Up to Month 7|Other|3|||
105717076|NCT01262976|364623567|FG001|Up to Month 7|Other|0|||
105717077|NCT01262976|364623568|FG002|Up to Month 7|Other|2|||
105717078|NCT01262976|364623569|FG003|Up to Month 7|Other|0|||
105717079|NCT01262976|364623570|FG004|Up to Month 7|Other|0|||
105717080|NCT01262976|364623571|FG005|Up to Month 7|Other|0|||
105717081|NCT01262976|364623566|FG000|Up to Year 1|Serious Adverse Event|0|||
105717082|NCT01262976|364623567|FG001|Up to Year 1|Serious Adverse Event|0|||
105717083|NCT01262976|364623568|FG002|Up to Year 1|Serious Adverse Event|2|||
105717084|NCT01262976|364623569|FG003|Up to Year 1|Serious Adverse Event|0|||
105717085|NCT01262976|364623570|FG004|Up to Year 1|Serious Adverse Event|0|||
105717086|NCT01262976|364623571|FG005|Up to Year 1|Serious Adverse Event|0|||
105717087|NCT01262976|364623566|FG000|Up to Year 1|Withdrawal by Subject|1|||
105717088|NCT01262976|364623567|FG001|Up to Year 1|Withdrawal by Subject|0|||
105717089|NCT01262976|364623568|FG002|Up to Year 1|Withdrawal by Subject|0|||
105717090|NCT01262976|364623569|FG003|Up to Year 1|Withdrawal by Subject|0|||
105717091|NCT01262976|364623570|FG004|Up to Year 1|Withdrawal by Subject|0|||
105717092|NCT01262976|364623571|FG005|Up to Year 1|Withdrawal by Subject|0|||
105717093|NCT01262976|364623566|FG000|Up to Year 1|Migrated/moved from study area|1|||
105717094|NCT01262976|364623567|FG001|Up to Year 1|Migrated/moved from study area|0|||
105717095|NCT01262976|364623568|FG002|Up to Year 1|Migrated/moved from study area|0|||
105717096|NCT01262976|364623569|FG003|Up to Year 1|Migrated/moved from study area|3|||
105717097|NCT01262976|364623570|FG004|Up to Year 1|Migrated/moved from study area|3|||
105717098|NCT01262976|364623571|FG005|Up to Year 1|Migrated/moved from study area|2|||
105717099|NCT01262976|364623566|FG000|Up to Year 1|Lost to Follow-up|4|||
105717100|NCT01262976|364623567|FG001|Up to Year 1|Lost to Follow-up|0|||
105717101|NCT01262976|364623568|FG002|Up to Year 1|Lost to Follow-up|0|||
105717102|NCT01262976|364623569|FG003|Up to Year 1|Lost to Follow-up|1|||
105790208|NCT03733301|364885055|FG001|Overall Study|Non-compliance|0|||
105790209|NCT03733301|364885056|FG002|Overall Study|Non-compliance|0|||
105790210|NCT03733301|364885054|FG000|Overall Study|Lack of Efficacy|2|||
105932234|NCT04518410|365410912|FG016|Overall Study|Death|0|||
105932235|NCT04518410|365410913|FG017|Overall Study|Death|1|||
105932236|NCT04518410|365410914|FG018|Overall Study|Death|4|||
105932237|NCT04518410|365410915|FG019|Overall Study|Death|4|||
105932238|NCT04518410|365410916|FG020|Overall Study|Death|1|||
105932239|NCT04518410|365410917|FG021|Overall Study|Death|0|||
105932240|NCT04518410|365410918|FG022|Overall Study|Death|0|||
105932241|NCT04518410|365410919|FG023|Overall Study|Death|0|||
105932242|NCT04518410|365410920|FG024|Overall Study|Death|0|||
105932243|NCT04518410|365410896|FG000|Overall Study|Requirement to start alternative therapy|0|||
105932244|NCT04518410|365410897|FG001|Overall Study|Requirement to start alternative therapy|0|||
105932245|NCT04518410|365410898|FG002|Overall Study|Requirement to start alternative therapy|1|||
105932246|NCT04518410|365410899|FG003|Overall Study|Requirement to start alternative therapy|0|||
105932247|NCT04518410|365410900|FG004|Overall Study|Requirement to start alternative therapy|0|||
105932248|NCT04518410|365410901|FG005|Overall Study|Requirement to start alternative therapy|0|||
105932249|NCT04518410|365410902|FG006|Overall Study|Requirement to start alternative therapy|0|||
105932250|NCT04518410|365410903|FG007|Overall Study|Requirement to start alternative therapy|0|||
105932251|NCT04518410|365410904|FG008|Overall Study|Requirement to start alternative therapy|0|||
105932252|NCT04518410|365410905|FG009|Overall Study|Requirement to start alternative therapy|0|||
105932253|NCT04518410|365410906|FG010|Overall Study|Requirement to start alternative therapy|0|||
105932254|NCT04518410|365410907|FG011|Overall Study|Requirement to start alternative therapy|0|||
105932255|NCT04518410|365410908|FG012|Overall Study|Requirement to start alternative therapy|0|||
105932256|NCT04518410|365410909|FG013|Overall Study|Requirement to start alternative therapy|0|||
105932257|NCT04518410|365410910|FG014|Overall Study|Requirement to start alternative therapy|0|||
105932258|NCT04518410|365410911|FG015|Overall Study|Requirement to start alternative therapy|0|||
105717103|NCT01262976|364623570|FG004|Up to Year 1|Lost to Follow-up|6|||
105717104|NCT01262976|364623571|FG005|Up to Year 1|Lost to Follow-up|5|||
105932259|NCT04518410|365410912|FG016|Overall Study|Requirement to start alternative therapy|0|||
105932260|NCT04518410|365410913|FG017|Overall Study|Requirement to start alternative therapy|0|||
105932261|NCT04518410|365410914|FG018|Overall Study|Requirement to start alternative therapy|0|||
105717105|NCT01262976|364623566|FG000|Up to Year 1|Other|3|||
105717106|NCT01262976|364623567|FG001|Up to Year 1|Other|1|||
105717107|NCT01262976|364623568|FG002|Up to Year 1|Other|0|||
105717108|NCT01262976|364623569|FG003|Up to Year 1|Other|0|||
105717109|NCT01262976|364623570|FG004|Up to Year 1|Other|2|||
105717110|NCT01262976|364623571|FG005|Up to Year 1|Other|1|||
105717111|NCT01262976|364623566|FG000|Up to Year 1|Subjects with unknown completion status|0|||
105717112|NCT01262976|364623567|FG001|Up to Year 1|Subjects with unknown completion status|0|||
105717113|NCT01262976|364623568|FG002|Up to Year 1|Subjects with unknown completion status|1|||
105717114|NCT01262976|364623569|FG003|Up to Year 1|Subjects with unknown completion status|0|||
105717115|NCT01262976|364623570|FG004|Up to Year 1|Subjects with unknown completion status|0|||
105717116|NCT01262976|364623571|FG005|Up to Year 1|Subjects with unknown completion status|1|||
105932262|NCT04518410|365410915|FG019|Overall Study|Requirement to start alternative therapy|0|||
105932263|NCT04518410|365410916|FG020|Overall Study|Requirement to start alternative therapy|0|||
105932264|NCT04518410|365410917|FG021|Overall Study|Requirement to start alternative therapy|0|||
105932265|NCT04518410|365410918|FG022|Overall Study|Requirement to start alternative therapy|0|||
105932266|NCT04518410|365410919|FG023|Overall Study|Requirement to start alternative therapy|0|||
105932267|NCT04518410|365410920|FG024|Overall Study|Requirement to start alternative therapy|0|||
105932268|NCT04518410|365410896|FG000|Overall Study|Randomized but not treated|0|||
105932269|NCT04518410|365410897|FG001|Overall Study|Randomized but not treated|0|||
105932270|NCT04518410|365410898|FG002|Overall Study|Randomized but not treated|0|||
105932271|NCT04518410|365410899|FG003|Overall Study|Randomized but not treated|2|||
105932272|NCT04518410|365410900|FG004|Overall Study|Randomized but not treated|6|||
105932273|NCT04518410|365410901|FG005|Overall Study|Randomized but not treated|4|||
105932274|NCT04518410|365410902|FG006|Overall Study|Randomized but not treated|3|||
105932275|NCT04518410|365410903|FG007|Overall Study|Randomized but not treated|3|||
105932276|NCT04518410|365410904|FG008|Overall Study|Randomized but not treated|0|||
105932277|NCT04518410|365410905|FG009|Overall Study|Randomized but not treated|4|||
105932278|NCT04518410|365410906|FG010|Overall Study|Randomized but not treated|0|||
105932279|NCT04518410|365410907|FG011|Overall Study|Randomized but not treated|0|||
105932280|NCT04518410|365410908|FG012|Overall Study|Randomized but not treated|1|||
105932281|NCT04518410|365410909|FG013|Overall Study|Randomized but not treated|3|||
105932282|NCT04518410|365410910|FG014|Overall Study|Randomized but not treated|3|||
105932283|NCT04518410|365410911|FG015|Overall Study|Randomized but not treated|3|||
105932284|NCT04518410|365410912|FG016|Overall Study|Randomized but not treated|4|||
105932285|NCT04518410|365410913|FG017|Overall Study|Randomized but not treated|5|||
105932286|NCT04518410|365410914|FG018|Overall Study|Randomized but not treated|4|||
105932287|NCT04518410|365410915|FG019|Overall Study|Randomized but not treated|0|||
105932288|NCT04518410|365410916|FG020|Overall Study|Randomized but not treated|0|||
105932289|NCT04518410|365410917|FG021|Overall Study|Randomized but not treated|5|||
105932290|NCT04518410|365410918|FG022|Overall Study|Randomized but not treated|0|||
105932291|NCT04518410|365410919|FG023|Overall Study|Randomized but not treated|3|||
105932292|NCT04518410|365410920|FG024|Overall Study|Randomized but not treated|1|||
105932293|NCT04518410|365410896|FG000|Overall Study|Screen Fail but Randomized|0|||
105932294|NCT04518410|365410897|FG001|Overall Study|Screen Fail but Randomized|0|||
105932295|NCT04518410|365410898|FG002|Overall Study|Screen Fail but Randomized|0|||
105932296|NCT04518410|365410899|FG003|Overall Study|Screen Fail but Randomized|0|||
105932297|NCT04518410|365410900|FG004|Overall Study|Screen Fail but Randomized|2|||
105932298|NCT04518410|365410901|FG005|Overall Study|Screen Fail but Randomized|0|||
105932299|NCT04518410|365410902|FG006|Overall Study|Screen Fail but Randomized|0|||
105932300|NCT04518410|365410903|FG007|Overall Study|Screen Fail but Randomized|0|||
105932301|NCT04518410|365410904|FG008|Overall Study|Screen Fail but Randomized|0|||
105932302|NCT04518410|365410905|FG009|Overall Study|Screen Fail but Randomized|0|||
105932303|NCT04518410|365410906|FG010|Overall Study|Screen Fail but Randomized|0|||
105932304|NCT04518410|365410907|FG011|Overall Study|Screen Fail but Randomized|0|||
105932305|NCT04518410|365410908|FG012|Overall Study|Screen Fail but Randomized|0|||
105932306|NCT04518410|365410909|FG013|Overall Study|Screen Fail but Randomized|0|||
105932307|NCT04518410|365410910|FG014|Overall Study|Screen Fail but Randomized|0|||
105932308|NCT04518410|365410911|FG015|Overall Study|Screen Fail but Randomized|0|||
105932309|NCT04518410|365410912|FG016|Overall Study|Screen Fail but Randomized|0|||
105932310|NCT04518410|365410913|FG017|Overall Study|Screen Fail but Randomized|0|||
105932311|NCT04518410|365410914|FG018|Overall Study|Screen Fail but Randomized|0|||
105932312|NCT04518410|365410915|FG019|Overall Study|Screen Fail but Randomized|0|||
105932313|NCT04518410|365410916|FG020|Overall Study|Screen Fail but Randomized|0|||
105932314|NCT04518410|365410917|FG021|Overall Study|Screen Fail but Randomized|0|||
105932315|NCT04518410|365410918|FG022|Overall Study|Screen Fail but Randomized|0|||
105717117|NCT01262976|364623566|FG000|Up to Year 2|Serious Adverse Event|0|||
105717118|NCT01262976|364623567|FG001|Up to Year 2|Serious Adverse Event|0|||
105932316|NCT04518410|365410919|FG023|Overall Study|Screen Fail but Randomized|0|||
105932317|NCT04518410|365410920|FG024|Overall Study|Screen Fail but Randomized|0|||
105932318|NCT04518410|365410896|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105932319|NCT04518410|365410897|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105932320|NCT04518410|365410898|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105932321|NCT04518410|365410899|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105952106|NCT03314935|365488187|FG003|Phase 1|"Captured as Other in Database"|0|||
105790211|NCT03733301|364885055|FG001|Overall Study|Lack of Efficacy|3|||
105717119|NCT01262976|364623568|FG002|Up to Year 2|Serious Adverse Event|2|||
105717120|NCT01262976|364623569|FG003|Up to Year 2|Serious Adverse Event|0|||
105717121|NCT01262976|364623570|FG004|Up to Year 2|Serious Adverse Event|0|||
105717122|NCT01262976|364623571|FG005|Up to Year 2|Serious Adverse Event|0|||
105717123|NCT01262976|364623566|FG000|Up to Year 2|Withdrawal by Subject|1|||
105717124|NCT01262976|364623567|FG001|Up to Year 2|Withdrawal by Subject|0|||
105932322|NCT04518410|365410900|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
105932323|NCT04518410|365410901|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
105932324|NCT04518410|365410902|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
105932325|NCT04518410|365410903|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
105932326|NCT04518410|365410904|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
105932327|NCT04518410|365410905|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
105932328|NCT04518410|365410906|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
105932329|NCT04518410|365410907|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105932330|NCT04518410|365410908|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105932331|NCT04518410|365410909|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
105932332|NCT04518410|365410910|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
105932333|NCT04518410|365410911|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
105932334|NCT04518410|365410912|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
105932335|NCT04518410|365410913|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
105932336|NCT04518410|365410914|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
106008652|NCT01535040|365697054|FG001|Overall Study|Physician Decision|1|||
106008653|NCT01535040|365697053|FG000|Overall Study|Withdrawal by Subject|13|||
105717125|NCT01262976|364623568|FG002|Up to Year 2|Withdrawal by Subject|0|||
105717126|NCT01262976|364623569|FG003|Up to Year 2|Withdrawal by Subject|0|||
105717127|NCT01262976|364623570|FG004|Up to Year 2|Withdrawal by Subject|0|||
105717128|NCT01262976|364623571|FG005|Up to Year 2|Withdrawal by Subject|0|||
105717129|NCT01262976|364623566|FG000|Up to Year 2|Migrated/moved from study area|0|||
105717130|NCT01262976|364623567|FG001|Up to Year 2|Migrated/moved from study area|0|||
105717131|NCT01262976|364623568|FG002|Up to Year 2|Migrated/moved from study area|0|||
105717132|NCT01262976|364623569|FG003|Up to Year 2|Migrated/moved from study area|2|||
105717133|NCT01262976|364623570|FG004|Up to Year 2|Migrated/moved from study area|1|||
105717134|NCT01262976|364623571|FG005|Up to Year 2|Migrated/moved from study area|2|||
105717135|NCT01262976|364623566|FG000|Up to Year 2|Lost to Follow-up|1|||
105717136|NCT01262976|364623567|FG001|Up to Year 2|Lost to Follow-up|1|||
105717137|NCT01262976|364623568|FG002|Up to Year 2|Lost to Follow-up|2|||
105717138|NCT01262976|364623569|FG003|Up to Year 2|Lost to Follow-up|2|||
105717139|NCT01262976|364623570|FG004|Up to Year 2|Lost to Follow-up|3|||
105717140|NCT01262976|364623571|FG005|Up to Year 2|Lost to Follow-up|3|||
105717141|NCT01262976|364623566|FG000|Up to Year 2|Subjects with unknown completion status|0|||
105717142|NCT01262976|364623567|FG001|Up to Year 2|Subjects with unknown completion status|0|||
105717143|NCT01262976|364623568|FG002|Up to Year 2|Subjects with unknown completion status|1|||
105717144|NCT01262976|364623569|FG003|Up to Year 2|Subjects with unknown completion status|0|||
105717145|NCT01262976|364623570|FG004|Up to Year 2|Subjects with unknown completion status|0|||
105717146|NCT01262976|364623571|FG005|Up to Year 2|Subjects with unknown completion status|0|||
105717147|NCT01262976|364623566|FG000|Up to Year 2|Other|3|||
105717148|NCT01262976|364623567|FG001|Up to Year 2|Other|0|||
105717149|NCT01262976|364623568|FG002|Up to Year 2|Other|0|||
105717150|NCT01262976|364623569|FG003|Up to Year 2|Other|0|||
105717151|NCT01262976|364623570|FG004|Up to Year 2|Other|0|||
105717152|NCT01262976|364623571|FG005|Up to Year 2|Other|0|||
105717153|NCT01262976|364623566|FG000|Up to Year 3|Serious Adverse Event|0|||
105717154|NCT01262976|364623567|FG001|Up to Year 3|Serious Adverse Event|0|||
105717155|NCT01262976|364623568|FG002|Up to Year 3|Serious Adverse Event|2|||
105717156|NCT01262976|364623569|FG003|Up to Year 3|Serious Adverse Event|0|||
105717157|NCT01262976|364623570|FG004|Up to Year 3|Serious Adverse Event|0|||
105717158|NCT01262976|364623571|FG005|Up to Year 3|Serious Adverse Event|0|||
105717159|NCT01262976|364623566|FG000|Up to Year 3|Withdrawal by Subject|1|||
105717160|NCT01262976|364623567|FG001|Up to Year 3|Withdrawal by Subject|0|||
105717161|NCT01262976|364623568|FG002|Up to Year 3|Withdrawal by Subject|0|||
105717162|NCT01262976|364623569|FG003|Up to Year 3|Withdrawal by Subject|0|||
105717163|NCT01262976|364623570|FG004|Up to Year 3|Withdrawal by Subject|0|||
105717164|NCT01262976|364623571|FG005|Up to Year 3|Withdrawal by Subject|0|||
105717165|NCT01262976|364623566|FG000|Up to Year 3|Migrated/moved from study area|0|||
105717166|NCT01262976|364623567|FG001|Up to Year 3|Migrated/moved from study area|0|||
105790212|NCT03733301|364885056|FG002|Overall Study|Lack of Efficacy|0|||
105790213|NCT03733301|364885054|FG000|Overall Study|Adverse Event|0|||
105790214|NCT03733301|364885055|FG001|Overall Study|Adverse Event|1|||
105717167|NCT01262976|364623568|FG002|Up to Year 3|Migrated/moved from study area|0|||
105717168|NCT01262976|364623569|FG003|Up to Year 3|Migrated/moved from study area|2|||
105717169|NCT01262976|364623570|FG004|Up to Year 3|Migrated/moved from study area|1|||
105717170|NCT01262976|364623571|FG005|Up to Year 3|Migrated/moved from study area|1|||
105717171|NCT01262976|364623566|FG000|Up to Year 3|Lost to Follow-up|2|||
105717172|NCT01262976|364623567|FG001|Up to Year 3|Lost to Follow-up|2|||
105717173|NCT01262976|364623568|FG002|Up to Year 3|Lost to Follow-up|4|||
105717174|NCT01262976|364623569|FG003|Up to Year 3|Lost to Follow-up|3|||
105717175|NCT01262976|364623570|FG004|Up to Year 3|Lost to Follow-up|1|||
105717176|NCT01262976|364623571|FG005|Up to Year 3|Lost to Follow-up|3|||
105717177|NCT01262976|364623566|FG000|Up to Year 3|Subjects with unknown completion status|0|||
105717178|NCT01262976|364623567|FG001|Up to Year 3|Subjects with unknown completion status|0|||
105717179|NCT01262976|364623568|FG002|Up to Year 3|Subjects with unknown completion status|1|||
105717180|NCT01262976|364623569|FG003|Up to Year 3|Subjects with unknown completion status|0|||
105717181|NCT01262976|364623570|FG004|Up to Year 3|Subjects with unknown completion status|0|||
105717182|NCT01262976|364623571|FG005|Up to Year 3|Subjects with unknown completion status|0|||
105717183|NCT01262976|364623566|FG000|Up to Year 3|Other|3|||
105717184|NCT01262976|364623567|FG001|Up to Year 3|Other|0|||
105717185|NCT01262976|364623568|FG002|Up to Year 3|Other|0|||
105717186|NCT01262976|364623569|FG003|Up to Year 3|Other|0|||
105717187|NCT01262976|364623570|FG004|Up to Year 3|Other|0|||
105717188|NCT01262976|364623571|FG005|Up to Year 3|Other|0|||
105717189|NCT02690194|364623574|FG000|Overall Study|Withdrawal by Subject|1|||
105717190|NCT02690194|364623575|FG001|Overall Study|Withdrawal by Subject|4|||
105717191|NCT02690194|364623576|FG002|Overall Study|Withdrawal by Subject|0|||
105717192|NCT01987908|364623577|FG000|Placebo Lead-in Period|Adverse Event|2|||
105717193|NCT01987908|364623578|FG001|Placebo Lead-in Period|Adverse Event|0|||
105717194|NCT01987908|364623579|FG002|Placebo Lead-in Period|Adverse Event|0|||
105717195|NCT01987908|364623577|FG000|Placebo Lead-in Period|Physician Decision|2|||
105717196|NCT01987908|364623578|FG001|Placebo Lead-in Period|Physician Decision|0|||
105717197|NCT01987908|364623579|FG002|Placebo Lead-in Period|Physician Decision|0|||
105717198|NCT01987908|364623577|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
105717199|NCT01987908|364623578|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
105717200|NCT01987908|364623579|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
105717201|NCT01987908|364623577|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
105717202|NCT01987908|364623578|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
105717203|NCT01987908|364623579|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
105717204|NCT01987908|364623577|FG000|Treatment Period|Adverse Event|0|||
105717205|NCT01987908|364623578|FG001|Treatment Period|Adverse Event|1|||
105717206|NCT01987908|364623579|FG002|Treatment Period|Adverse Event|1|||
105717207|NCT01987908|364623577|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
105717208|NCT01987908|364623578|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
105717209|NCT01987908|364623579|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
105717210|NCT01987908|364623577|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
105717211|NCT01987908|364623578|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
105717212|NCT01987908|364623579|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
105717213|NCT01528787|364623580|FG000|Overall Study|Withdrawal by Subject|0|||
105717214|NCT01528787|364623581|FG001|Overall Study|Withdrawal by Subject|0|||
105717215|NCT01528787|364623582|FG002|Overall Study|Withdrawal by Subject|0|||
105717216|NCT01528787|364623583|FG003|Overall Study|Withdrawal by Subject|1|||
105717217|NCT01528787|364623580|FG000|Overall Study|Family Emergency|0|||
105717218|NCT01528787|364623581|FG001|Overall Study|Family Emergency|0|||
105717219|NCT01528787|364623582|FG002|Overall Study|Family Emergency|1|||
105717220|NCT01528787|364623583|FG003|Overall Study|Family Emergency|0|||
105717221|NCT00354601|364623592|FG000|Overall Study|Protocol Violation|1|||
105717222|NCT00354601|364623592|FG000|Overall Study|progression|1|||
105717223|NCT01551693|364623594|FG000|Overall Study|Disease Progression|1|||
105717224|NCT01551693|364623595|FG001|Overall Study|Disease Progression|0|||
105717225|NCT01551693|364623594|FG000|Overall Study|Adverse Event|0|||
105717226|NCT01551693|364623595|FG001|Overall Study|Adverse Event|1|||
105717227|NCT01551693|364623594|FG000|Overall Study|Withdrawal by Subject|0|||
105717228|NCT01551693|364623595|FG001|Overall Study|Withdrawal by Subject|1|||
105717229|NCT03603652|364623596|FG000|Overall Study|Death|2|||
105717230|NCT03213366|364623599|FG000|Overall Study|Lost to Follow-up|9|||
105717231|NCT03213366|364623600|FG001|Overall Study|Lost to Follow-up|4|||
105717232|NCT00666926|364623601|FG000|Overall Study|Adverse Event|0|||
105717233|NCT00666926|364623602|FG001|Overall Study|Adverse Event|0|||
105717234|NCT00666926|364623603|FG002|Overall Study|Adverse Event|0|||
105717235|NCT00666926|364623604|FG003|Overall Study|Adverse Event|0|||
105717236|NCT00666926|364623605|FG004|Overall Study|Adverse Event|0|||
105790215|NCT03733301|364885056|FG002|Overall Study|Adverse Event|3|||
105790216|NCT03733301|364885054|FG000|Overall Study|Withdrawal by Subject|3|||
105790217|NCT03733301|364885055|FG001|Overall Study|Withdrawal by Subject|5|||
105790218|NCT03733301|364885056|FG002|Overall Study|Withdrawal by Subject|1|||
105790219|NCT04637815|364885057|FG000|Overall Study|Death|1|||
105790220|NCT04637815|364885058|FG001|Overall Study|Death|0|||
105790221|NCT04637815|364885057|FG000|Overall Study|Lost to Follow-up|5|||
105790222|NCT04637815|364885058|FG001|Overall Study|Lost to Follow-up|2|||
105790223|NCT00209560|364885061|FG000|Overall Study|Lack of Efficacy|1|||
105790224|NCT00209560|364885062|FG001|Overall Study|Lack of Efficacy|0|||
105790225|NCT03280628|364886920|FG000|Overall Study|Lost to Follow-up|8|||
105790226|NCT03280628|364886921|FG001|Overall Study|Lost to Follow-up|6|||
105790227|NCT03280628|364886922|FG002|Overall Study|Lost to Follow-up|11|||
105790228|NCT00347776|364886923|FG000|1.5 Month Follow-up|Death|2|||
105790229|NCT00347776|364886924|FG001|1.5 Month Follow-up|Death|0|||
105790230|NCT00347776|364886925|FG002|1.5 Month Follow-up|Death|0|||
105790231|NCT00347776|364886923|FG000|1.5 Month Follow-up|reached the endpoint|12|||
105790232|NCT00347776|364886924|FG001|1.5 Month Follow-up|reached the endpoint|8|||
105790233|NCT00347776|364886925|FG002|1.5 Month Follow-up|reached the endpoint|12|||
105790234|NCT00347776|364886923|FG000|6 Month Follow-up|Death|2|||
105790235|NCT00347776|364886924|FG001|6 Month Follow-up|Death|1|||
105790236|NCT00347776|364886925|FG002|6 Month Follow-up|Death|3|||
105790237|NCT00347776|364886923|FG000|6 Month Follow-up|reached endpont|20|||
105790238|NCT00347776|364886924|FG001|6 Month Follow-up|reached endpont|12|||
105790239|NCT00347776|364886925|FG002|6 Month Follow-up|reached endpont|15|||
105790240|NCT00347776|364886923|FG000|12 Month Follow-up|Lost to Follow-up|7|||
105790241|NCT00347776|364886924|FG001|12 Month Follow-up|Lost to Follow-up|6|||
105790242|NCT00347776|364886925|FG002|12 Month Follow-up|Lost to Follow-up|6|||
105790243|NCT00347776|364886923|FG000|12 Month Follow-up|Death|3|||
105790244|NCT00347776|364886924|FG001|12 Month Follow-up|Death|4|||
105790245|NCT00347776|364886925|FG002|12 Month Follow-up|Death|4|||
105790246|NCT00347776|364886923|FG000|12 Month Follow-up|Reached endpoint|13|||
105790247|NCT00347776|364886924|FG001|12 Month Follow-up|Reached endpoint|6|||
105790248|NCT00347776|364886925|FG002|12 Month Follow-up|Reached endpoint|9|||
105790249|NCT01340794|364886926|FG000|Overall Study|Withdrawal by Subject|0|||
105790250|NCT01340794|364886927|FG001|Overall Study|Withdrawal by Subject|1|||
105790251|NCT00457249|364886928|FG000|Overall Study|Lost to Follow-up|3|||
105790252|NCT00457249|364886929|FG001|Overall Study|Lost to Follow-up|0|||
105790253|NCT00457249|364886928|FG000|Overall Study|Protocol Violation|4|||
105790254|NCT00457249|364886929|FG001|Overall Study|Protocol Violation|1|||
105790255|NCT00457249|364886928|FG000|Overall Study|Withdrawal by Subject|3|||
105790256|NCT00457249|364886929|FG001|Overall Study|Withdrawal by Subject|1|||
105790257|NCT00457249|364886928|FG000|Overall Study|Serious Adverse Events|2|||
105790258|NCT00457249|364886929|FG001|Overall Study|Serious Adverse Events|0|||
105790259|NCT00396318|364886930|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
105717237|NCT00666926|364623606|FG005|Overall Study|Adverse Event|0|||
105717238|NCT00666926|364623607|FG006|Overall Study|Adverse Event|0|||
105717239|NCT00666926|364623608|FG007|Overall Study|Adverse Event|0|||
105717240|NCT00666926|364623609|FG008|Overall Study|Adverse Event|0|||
105717241|NCT00666926|364623610|FG009|Overall Study|Adverse Event|2|||
105717242|NCT00666926|364623611|FG010|Overall Study|Adverse Event|2|||
105717243|NCT00666926|364623612|FG011|Overall Study|Adverse Event|2|||
105717244|NCT00666926|364623613|FG012|Overall Study|Adverse Event|0|||
105717245|NCT00666926|364623614|FG013|Overall Study|Adverse Event|1|||
105717246|NCT00666926|364623615|FG014|Overall Study|Adverse Event|0|||
105717247|NCT00666926|364623616|FG015|Overall Study|Adverse Event|0|||
105717248|NCT00666926|364623601|FG000|Overall Study|Laboratory abnormality|0|||
105717249|NCT00666926|364623602|FG001|Overall Study|Laboratory abnormality|0|||
105717250|NCT00666926|364623603|FG002|Overall Study|Laboratory abnormality|0|||
105717251|NCT00666926|364623604|FG003|Overall Study|Laboratory abnormality|0|||
105717252|NCT00666926|364623605|FG004|Overall Study|Laboratory abnormality|0|||
105717253|NCT00666926|364623606|FG005|Overall Study|Laboratory abnormality|0|||
105790260|NCT00326118|364886931|FG000|Active Phase|Withdrawal by Subject|4|||
105717254|NCT00666926|364623607|FG006|Overall Study|Laboratory abnormality|0|||
105717255|NCT00666926|364623608|FG007|Overall Study|Laboratory abnormality|0|||
105790261|NCT00326118|364886932|FG001|Active Phase|Withdrawal by Subject|1|||
105790262|NCT01118949|364886933|FG000|Overall Study|Adverse Event|5|||
105717256|NCT00666926|364623609|FG008|Overall Study|Laboratory abnormality|0|||
105790263|NCT01118949|364886933|FG000|Overall Study|Withdrawal by Subject|4|||
105952107|NCT03314935|365488188|FG004|Phase 1|"Captured as Other in Database"|0|||
105717257|NCT00666926|364623610|FG009|Overall Study|Laboratory abnormality|0|||
105717258|NCT00666926|364623611|FG010|Overall Study|Laboratory abnormality|1|||
105790264|NCT00290511|364886939|FG000|Overall Study|Adverse Event|1|||
105790265|NCT00290511|364886939|FG000|Overall Study|Death|1|||
105790266|NCT00290511|364886939|FG000|Overall Study|Physician Decision|1|||
105790267|NCT00290511|364886939|FG000|Overall Study|Withdrawal by Subject|1|||
105790268|NCT03255226|364886940|FG000|Overall Study|Adverse Event|2|||
105790269|NCT03255226|364886940|FG000|Overall Study|Physician Decision|3|||
105790270|NCT03255226|364886940|FG000|Overall Study|Withdrawal by Subject|1|||
105790271|NCT03255226|364886940|FG000|Overall Study|Serum or blood sodium increased|4|||
105790272|NCT03255226|364886940|FG000|Overall Study|Serum or blood potassium increased|4|||
105790273|NCT00602927|364886941|FG000|Period 1: 13 Days|Protocol Violation|2|||
105790274|NCT00602927|364886942|FG001|Period 1: 13 Days|Protocol Violation|4|||
105790275|NCT00602927|364886941|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
105790276|NCT00602927|364886942|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
105790277|NCT00602927|364886941|FG000|Period 1: 13 Days|Time|1|||
105790278|NCT00602927|364886942|FG001|Period 1: 13 Days|Time|0|||
105790279|NCT00602927|364886941|FG000|Period 1: 13 Days|Claustrophobia|0|||
105790280|NCT00602927|364886942|FG001|Period 1: 13 Days|Claustrophobia|1|||
105790281|NCT00602927|364886941|FG000|Period 2: 14 Days|Protocol Violation|0|||
105790282|NCT00602927|364886942|FG001|Period 2: 14 Days|Protocol Violation|2|||
105790283|NCT00602927|364886941|FG000|Period 3: 13 Days|Protocol Violation|0|||
105790284|NCT00602927|364886942|FG001|Period 3: 13 Days|Protocol Violation|1|||
105790285|NCT00602927|364886941|FG000|Period 3: 13 Days|MRI data quality|2|||
105790286|NCT00602927|364886942|FG001|Period 3: 13 Days|MRI data quality|2|||
105790287|NCT05378269|364886943|FG000|Overall Study|Protocol Violation|1|||
105790288|NCT05378269|364886944|FG001|Overall Study|Protocol Violation|0|||
105790289|NCT05378269|364886945|FG002|Overall Study|Protocol Violation|2|||
105790290|NCT05378269|364886946|FG003|Overall Study|Protocol Violation|0|||
105790291|NCT05378269|364886947|FG004|Overall Study|Protocol Violation|0|||
105790292|NCT01728376|364886948|FG000|Overall Study|Adverse Event|1|||
105790293|NCT01728376|364886949|FG001|Overall Study|Adverse Event|1|||
105790294|NCT01728376|364886950|FG002|Overall Study|Adverse Event|1|||
105790295|NCT01728376|364886951|FG003|Overall Study|Adverse Event|1|||
105790296|NCT01728376|364886952|FG004|Overall Study|Adverse Event|1|||
105790297|NCT01728376|364886953|FG005|Overall Study|Adverse Event|0|||
105790298|NCT01728376|364886948|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
105790299|NCT01728376|364886949|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
105790300|NCT01728376|364886950|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
105790301|NCT01728376|364886951|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
105790302|NCT01728376|364886952|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
105790303|NCT01728376|364886953|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
105790304|NCT01728376|364886948|FG000|Overall Study|No relevant bacteria|2|||
105790305|NCT01728376|364886949|FG001|Overall Study|No relevant bacteria|0|||
105790306|NCT01728376|364886950|FG002|Overall Study|No relevant bacteria|0|||
105790307|NCT01728376|364886951|FG003|Overall Study|No relevant bacteria|0|||
105790308|NCT01728376|364886952|FG004|Overall Study|No relevant bacteria|1|||
105790309|NCT01728376|364886953|FG005|Overall Study|No relevant bacteria|1|||
105790310|NCT01728376|364886948|FG000|Overall Study|Did not receive treatment|0|||
105790311|NCT01728376|364886949|FG001|Overall Study|Did not receive treatment|1|||
105790312|NCT01728376|364886950|FG002|Overall Study|Did not receive treatment|0|||
105790313|NCT01728376|364886951|FG003|Overall Study|Did not receive treatment|0|||
105790314|NCT01728376|364886952|FG004|Overall Study|Did not receive treatment|0|||
105790315|NCT01728376|364886953|FG005|Overall Study|Did not receive treatment|0|||
105790316|NCT01728376|364886948|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
105790317|NCT01728376|364886949|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
105790318|NCT01728376|364886950|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
105790319|NCT01728376|364886951|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
105790320|NCT01728376|364886952|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
105790321|NCT01728376|364886953|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
105790322|NCT01035229|364886954|FG000|Overall Study|Adverse Event|61|||
105790323|NCT01035229|364886955|FG001|Overall Study|Adverse Event|14|||
105790324|NCT01035229|364886954|FG000|Overall Study|Withdrawal by Subject|20|||
105790325|NCT01035229|364886955|FG001|Overall Study|Withdrawal by Subject|7|||
105790326|NCT01035229|364886954|FG000|Overall Study|Lost to Follow-up|1|||
105790327|NCT01035229|364886955|FG001|Overall Study|Lost to Follow-up|0|||
105790328|NCT01035229|364886954|FG000|Overall Study|Administrative problems|1|||
105790329|NCT01035229|364886955|FG001|Overall Study|Administrative problems|1|||
105790330|NCT01035229|364886954|FG000|Overall Study|Death|13|||
105790331|NCT01035229|364886955|FG001|Overall Study|Death|5|||
105790332|NCT01035229|364886954|FG000|Overall Study|New cancer therapy|2|||
105790333|NCT01035229|364886955|FG001|Overall Study|New cancer therapy|0|||
105790334|NCT01035229|364886954|FG000|Overall Study|Protocol Violation|0|||
105790335|NCT01035229|364886955|FG001|Overall Study|Protocol Violation|2|||
105790336|NCT01035229|364886954|FG000|Overall Study|Sponsor's decision to end study|3|||
105790337|NCT01035229|364886955|FG001|Overall Study|Sponsor's decision to end study|3|||
105790338|NCT01035229|364886954|FG000|Overall Study|Disease Progression|261|||
105790339|NCT01035229|364886955|FG001|Overall Study|Disease Progression|152|||
105790340|NCT03862807|364886966|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
105790341|NCT04362761|364886967|FG000|Part A (48 Weeks)|Adverse Event|2|||
105790342|NCT04362761|364886967|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
105790343|NCT04362761|364886967|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
105790344|NCT04362761|364886967|FG000|Part A (48 Weeks)|Other|5|||
105790345|NCT04362761|364886967|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
105790346|NCT04362761|364886967|FG000|Part B (86 Weeks)|Other|4|||
105790347|NCT00684645|364886968|FG000|Overall Study|Death|2|||
105790348|NCT00684645|364886968|FG000|Overall Study|Progressive disease|67|||
105717259|NCT00666926|364623612|FG011|Overall Study|Laboratory abnormality|0|||
105717260|NCT00666926|364623613|FG012|Overall Study|Laboratory abnormality|0|||
105717261|NCT00666926|364623614|FG013|Overall Study|Laboratory abnormality|0|||
105717262|NCT00666926|364623615|FG014|Overall Study|Laboratory abnormality|0|||
105717263|NCT00666926|364623616|FG015|Overall Study|Laboratory abnormality|1|||
105717264|NCT00666926|364623601|FG000|Overall Study|Lack of Efficacy|0|||
105717265|NCT00666926|364623602|FG001|Overall Study|Lack of Efficacy|0|||
105717266|NCT00666926|364623603|FG002|Overall Study|Lack of Efficacy|0|||
105717267|NCT00666926|364623604|FG003|Overall Study|Lack of Efficacy|0|||
105717268|NCT00666926|364623605|FG004|Overall Study|Lack of Efficacy|0|||
105717269|NCT00666926|364623606|FG005|Overall Study|Lack of Efficacy|1|||
105717270|NCT00666926|364623607|FG006|Overall Study|Lack of Efficacy|0|||
105717271|NCT00666926|364623608|FG007|Overall Study|Lack of Efficacy|0|||
105717272|NCT00666926|364623609|FG008|Overall Study|Lack of Efficacy|0|||
105717273|NCT00666926|364623610|FG009|Overall Study|Lack of Efficacy|0|||
105717274|NCT00666926|364623611|FG010|Overall Study|Lack of Efficacy|0|||
105717275|NCT00666926|364623612|FG011|Overall Study|Lack of Efficacy|1|||
105717276|NCT00666926|364623613|FG012|Overall Study|Lack of Efficacy|0|||
105717277|NCT00666926|364623614|FG013|Overall Study|Lack of Efficacy|0|||
105717278|NCT00666926|364623615|FG014|Overall Study|Lack of Efficacy|0|||
105717279|NCT00666926|364623616|FG015|Overall Study|Lack of Efficacy|0|||
105717280|NCT00666926|364623601|FG000|Overall Study|Lost to Follow-up|0|||
105717281|NCT00666926|364623602|FG001|Overall Study|Lost to Follow-up|0|||
105717282|NCT00666926|364623603|FG002|Overall Study|Lost to Follow-up|0|||
105717283|NCT00666926|364623604|FG003|Overall Study|Lost to Follow-up|1|||
105717284|NCT00666926|364623605|FG004|Overall Study|Lost to Follow-up|0|||
105717285|NCT00666926|364623606|FG005|Overall Study|Lost to Follow-up|0|||
105717286|NCT00666926|364623607|FG006|Overall Study|Lost to Follow-up|0|||
105717287|NCT00666926|364623608|FG007|Overall Study|Lost to Follow-up|0|||
105717288|NCT00666926|364623609|FG008|Overall Study|Lost to Follow-up|0|||
105717289|NCT00666926|364623610|FG009|Overall Study|Lost to Follow-up|0|||
105717290|NCT00666926|364623611|FG010|Overall Study|Lost to Follow-up|0|||
105717291|NCT00666926|364623612|FG011|Overall Study|Lost to Follow-up|0|||
105717292|NCT00666926|364623613|FG012|Overall Study|Lost to Follow-up|0|||
105717293|NCT00666926|364623614|FG013|Overall Study|Lost to Follow-up|0|||
105717294|NCT00666926|364623615|FG014|Overall Study|Lost to Follow-up|0|||
105717295|NCT00666926|364623616|FG015|Overall Study|Lost to Follow-up|0|||
105717296|NCT00666926|364623601|FG000|Overall Study|Other|2|||
105717297|NCT00666926|364623602|FG001|Overall Study|Other|4|||
105717298|NCT00666926|364623603|FG002|Overall Study|Other|3|||
105717299|NCT00666926|364623604|FG003|Overall Study|Other|3|||
105717300|NCT00666926|364623605|FG004|Overall Study|Other|3|||
105717301|NCT00666926|364623606|FG005|Overall Study|Other|3|||
105717302|NCT00666926|364623607|FG006|Overall Study|Other|4|||
105717303|NCT00666926|364623608|FG007|Overall Study|Other|0|||
105717304|NCT00666926|364623609|FG008|Overall Study|Other|3|||
105717305|NCT00666926|364623610|FG009|Overall Study|Other|5|||
105717306|NCT00666926|364623611|FG010|Overall Study|Other|3|||
105717307|NCT00666926|364623612|FG011|Overall Study|Other|26|||
105717308|NCT00666926|364623613|FG012|Overall Study|Other|3|||
105717309|NCT00666926|364623614|FG013|Overall Study|Other|2|||
105717310|NCT00666926|364623615|FG014|Overall Study|Other|4|||
105717311|NCT00666926|364623616|FG015|Overall Study|Other|4|||
105717312|NCT00666926|364623601|FG000|Overall Study|Withdrawal by Subject|0|||
105717313|NCT00666926|364623602|FG001|Overall Study|Withdrawal by Subject|0|||
105717314|NCT00666926|364623603|FG002|Overall Study|Withdrawal by Subject|0|||
105717315|NCT00666926|364623604|FG003|Overall Study|Withdrawal by Subject|0|||
105717316|NCT00666926|364623605|FG004|Overall Study|Withdrawal by Subject|0|||
105717317|NCT00666926|364623606|FG005|Overall Study|Withdrawal by Subject|0|||
105717318|NCT00666926|364623607|FG006|Overall Study|Withdrawal by Subject|0|||
105717319|NCT00666926|364623608|FG007|Overall Study|Withdrawal by Subject|1|||
105717320|NCT00666926|364623609|FG008|Overall Study|Withdrawal by Subject|0|||
105717321|NCT00666926|364623610|FG009|Overall Study|Withdrawal by Subject|3|||
105717322|NCT00666926|364623611|FG010|Overall Study|Withdrawal by Subject|0|||
105717323|NCT00666926|364623612|FG011|Overall Study|Withdrawal by Subject|3|||
105717324|NCT00666926|364623613|FG012|Overall Study|Withdrawal by Subject|0|||
105717325|NCT00666926|364623614|FG013|Overall Study|Withdrawal by Subject|1|||
105717326|NCT00666926|364623615|FG014|Overall Study|Withdrawal by Subject|3|||
105717327|NCT00666926|364623616|FG015|Overall Study|Withdrawal by Subject|3|||
105717328|NCT00666926|364623601|FG000|Overall Study|Death|0|||
105717329|NCT00666926|364623602|FG001|Overall Study|Death|0|||
105717330|NCT00666926|364623603|FG002|Overall Study|Death|0|||
105717331|NCT00666926|364623604|FG003|Overall Study|Death|0|||
105717332|NCT00666926|364623605|FG004|Overall Study|Death|0|||
105717333|NCT00666926|364623606|FG005|Overall Study|Death|0|||
105717334|NCT00666926|364623607|FG006|Overall Study|Death|0|||
105717335|NCT00666926|364623608|FG007|Overall Study|Death|0|||
105717336|NCT00666926|364623609|FG008|Overall Study|Death|0|||
105717337|NCT00666926|364623610|FG009|Overall Study|Death|0|||
105717338|NCT00666926|364623611|FG010|Overall Study|Death|0|||
105717339|NCT00666926|364623612|FG011|Overall Study|Death|1|||
105717340|NCT00666926|364623613|FG012|Overall Study|Death|0|||
105717341|NCT00666926|364623614|FG013|Overall Study|Death|0|||
105717342|NCT00666926|364623615|FG014|Overall Study|Death|0|||
105717343|NCT00666926|364623616|FG015|Overall Study|Death|0|||
105717344|NCT01727258|364623617|FG000|Overall Study|Adverse Event|0|||
105717345|NCT01727258|364623618|FG001|Overall Study|Adverse Event|2|||
105717346|NCT01727258|364623619|FG002|Overall Study|Adverse Event|0|||
105717347|NCT01727258|364623617|FG000|Overall Study|Noncompliance with Study Drug|0|||
105717348|NCT01727258|364623618|FG001|Overall Study|Noncompliance with Study Drug|0|||
105717349|NCT01727258|364623619|FG002|Overall Study|Noncompliance with Study Drug|1|||
105717350|NCT01727258|364623617|FG000|Overall Study|Withdrawal by Subject|1|||
105717351|NCT01727258|364623618|FG001|Overall Study|Withdrawal by Subject|1|||
105717352|NCT01727258|364623619|FG002|Overall Study|Withdrawal by Subject|0|||
105717353|NCT01727258|364623617|FG000|Overall Study|Lost to Follow-up|1|||
105717354|NCT01727258|364623618|FG001|Overall Study|Lost to Follow-up|0|||
105717355|NCT01727258|364623619|FG002|Overall Study|Lost to Follow-up|0|||
105717356|NCT02058147|364623620|FG000|Overall Study|Randomized but not treated|0|||
105717357|NCT02058147|364623621|FG001|Overall Study|Randomized but not treated|0|||
105717358|NCT02058147|364623622|FG002|Overall Study|Randomized but not treated|1|||
105717359|NCT02058147|364623620|FG000|Overall Study|Adverse Event|12|||
105717360|NCT02058147|364623621|FG001|Overall Study|Adverse Event|9|||
105717361|NCT02058147|364623622|FG002|Overall Study|Adverse Event|21|||
105932337|NCT04518410|365410915|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
105932338|NCT04518410|365410916|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
105932339|NCT04518410|365410917|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
105932340|NCT04518410|365410918|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
105932341|NCT04518410|365410919|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
105932342|NCT04518410|365410920|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
105932343|NCT04518410|365410896|FG000|Overall Study|Dual Enrolled Subject|0|||
105932344|NCT04518410|365410897|FG001|Overall Study|Dual Enrolled Subject|0|||
105932345|NCT04518410|365410898|FG002|Overall Study|Dual Enrolled Subject|0|||
105932346|NCT04518410|365410899|FG003|Overall Study|Dual Enrolled Subject|0|||
105932347|NCT04518410|365410900|FG004|Overall Study|Dual Enrolled Subject|0|||
105932348|NCT04518410|365410901|FG005|Overall Study|Dual Enrolled Subject|0|||
105932349|NCT04518410|365410902|FG006|Overall Study|Dual Enrolled Subject|0|||
105932350|NCT04518410|365410903|FG007|Overall Study|Dual Enrolled Subject|0|||
105932351|NCT04518410|365410904|FG008|Overall Study|Dual Enrolled Subject|0|||
105932352|NCT04518410|365410905|FG009|Overall Study|Dual Enrolled Subject|0|||
105932353|NCT04518410|365410906|FG010|Overall Study|Dual Enrolled Subject|0|||
105932354|NCT04518410|365410907|FG011|Overall Study|Dual Enrolled Subject|0|||
105932355|NCT04518410|365410908|FG012|Overall Study|Dual Enrolled Subject|0|||
105932356|NCT04518410|365410909|FG013|Overall Study|Dual Enrolled Subject|0|||
105932357|NCT04518410|365410910|FG014|Overall Study|Dual Enrolled Subject|0|||
105717362|NCT02058147|364623620|FG000|Overall Study|Lack of Efficacy|1|||
105717363|NCT02058147|364623621|FG001|Overall Study|Lack of Efficacy|0|||
105717364|NCT02058147|364623622|FG002|Overall Study|Lack of Efficacy|3|||
105717365|NCT02058147|364623620|FG000|Overall Study|Poor compliance to protocol|8|||
105717366|NCT02058147|364623621|FG001|Overall Study|Poor compliance to protocol|9|||
105717367|NCT02058147|364623622|FG002|Overall Study|Poor compliance to protocol|4|||
105717368|NCT02058147|364623620|FG000|Overall Study|Other than specified|8|||
105717369|NCT02058147|364623621|FG001|Overall Study|Other than specified|9|||
105717370|NCT02058147|364623622|FG002|Overall Study|Other than specified|0|||
105717371|NCT01486199|364623623|FG000|Two Year Period Between Study Days|Physician Decision|1|||
105717372|NCT01486199|364623624|FG001|Two Year Period Between Study Days|Physician Decision|0|||
105717373|NCT02471716|364623625|FG000|Overall Study|Withdrawal by Subject|0|||
105717374|NCT02471716|364623626|FG001|Overall Study|Withdrawal by Subject|1|||
105932358|NCT04518410|365410911|FG015|Overall Study|Dual Enrolled Subject|0|||
105932359|NCT04518410|365410912|FG016|Overall Study|Dual Enrolled Subject|0|||
105932360|NCT04518410|365410913|FG017|Overall Study|Dual Enrolled Subject|1|||
105932361|NCT04518410|365410914|FG018|Overall Study|Dual Enrolled Subject|0|||
105932362|NCT04518410|365410915|FG019|Overall Study|Dual Enrolled Subject|0|||
105932363|NCT04518410|365410916|FG020|Overall Study|Dual Enrolled Subject|0|||
105932364|NCT04518410|365410917|FG021|Overall Study|Dual Enrolled Subject|0|||
105717375|NCT02471716|364623627|FG002|Overall Study|Withdrawal by Subject|0|||
105717376|NCT02471716|364623628|FG003|Overall Study|Withdrawal by Subject|2|||
105717377|NCT02471716|364623629|FG004|Overall Study|Withdrawal by Subject|5|||
105717378|NCT02471716|364623625|FG000|Overall Study|Study Terminiated by sponsor|0|||
105717379|NCT02471716|364623626|FG001|Overall Study|Study Terminiated by sponsor|0|||
105717380|NCT02471716|364623627|FG002|Overall Study|Study Terminiated by sponsor|0|||
105932365|NCT04518410|365410918|FG022|Overall Study|Dual Enrolled Subject|0|||
105932366|NCT04518410|365410919|FG023|Overall Study|Dual Enrolled Subject|0|||
105790349|NCT00684645|364886968|FG000|Overall Study|Adverse Event|27|||
105790350|NCT00684645|364886968|FG000|Overall Study|Lost to Follow-up|3|||
105790351|NCT00684645|364886968|FG000|Overall Study|Other|15|||
105790352|NCT00057330|364886975|FG000|Overall Study|Adverse Event|9|||
105790353|NCT00057330|364886976|FG001|Overall Study|Adverse Event|12|||
105790354|NCT00057330|364886975|FG000|Overall Study|Death|1|||
105790355|NCT00057330|364886976|FG001|Overall Study|Death|0|||
105790356|NCT00057330|364886975|FG000|Overall Study|Protocol Violation|1|||
105790357|NCT00057330|364886976|FG001|Overall Study|Protocol Violation|1|||
105790358|NCT00057330|364886975|FG000|Overall Study|Withdrawal by Subject|115|||
105790359|NCT00057330|364886976|FG001|Overall Study|Withdrawal by Subject|84|||
105790360|NCT00057330|364886975|FG000|Overall Study|Lost to Follow-up|745|||
105790361|NCT00057330|364886976|FG001|Overall Study|Lost to Follow-up|617|||
105790362|NCT00057330|364886975|FG000|Overall Study|Physician Decision|1|||
105790363|NCT00057330|364886976|FG001|Overall Study|Physician Decision|0|||
105790364|NCT00057330|364886975|FG000|Overall Study|Other|260|||
105790365|NCT00057330|364886976|FG001|Overall Study|Other|206|||
105790366|NCT00798707|364886979|FG000|Overall Study|Adverse Event|6|||
105790367|NCT00798707|364886980|FG001|Overall Study|Adverse Event|8|||
105790368|NCT00798707|364886981|FG002|Overall Study|Adverse Event|8|||
105790369|NCT00798707|364886979|FG000|Overall Study|Failed to return|2|||
105790370|NCT00798707|364886980|FG001|Overall Study|Failed to return|2|||
105790371|NCT00798707|364886981|FG002|Overall Study|Failed to return|0|||
105790372|NCT00798707|364886979|FG000|Overall Study|Investigator|0|||
105790373|NCT00798707|364886980|FG001|Overall Study|Investigator|1|||
105790374|NCT00798707|364886981|FG002|Overall Study|Investigator|2|||
105790375|NCT00798707|364886979|FG000|Overall Study|Lack of Efficacy|2|||
105790376|NCT00798707|364886980|FG001|Overall Study|Lack of Efficacy|2|||
105790377|NCT00798707|364886981|FG002|Overall Study|Lack of Efficacy|1|||
105790378|NCT00798707|364886979|FG000|Overall Study|Lost to Follow-up|5|||
105790379|NCT00798707|364886980|FG001|Overall Study|Lost to Follow-up|6|||
105790380|NCT00798707|364886981|FG002|Overall Study|Lost to Follow-up|6|||
105790381|NCT00798707|364886979|FG000|Overall Study|Other|0|||
105790382|NCT00798707|364886980|FG001|Overall Study|Other|1|||
105790383|NCT00798707|364886981|FG002|Overall Study|Other|0|||
105790384|NCT00798707|364886979|FG000|Overall Study|Protocol Violation|4|||
105790385|NCT00798707|364886980|FG001|Overall Study|Protocol Violation|0|||
105790386|NCT00798707|364886981|FG002|Overall Study|Protocol Violation|2|||
105790387|NCT00798707|364886979|FG000|Overall Study|Withdrawal by Subject|3|||
105790388|NCT00798707|364886980|FG001|Overall Study|Withdrawal by Subject|8|||
105790389|NCT00798707|364886981|FG002|Overall Study|Withdrawal by Subject|2|||
105790390|NCT00798707|364886979|FG000|Overall Study|Randomized not treated|4|||
105790391|NCT00798707|364886980|FG001|Overall Study|Randomized not treated|5|||
105790392|NCT00798707|364886981|FG002|Overall Study|Randomized not treated|1|||
105790393|NCT01473589|364886984|FG000|Overall Study|Adverse Event|1|||
105790394|NCT01473589|364886985|FG001|Overall Study|Adverse Event|1|||
105790395|NCT01473589|364886984|FG000|Overall Study|Death|2|||
105790396|NCT01473589|364886985|FG001|Overall Study|Death|0|||
105790397|NCT01473589|364886984|FG000|Overall Study|Lost to Follow-up|2|||
105790398|NCT01473589|364886985|FG001|Overall Study|Lost to Follow-up|2|||
105790399|NCT01473589|364886984|FG000|Overall Study|Protocol Violation|1|||
106136495|NCT01981850|366157943|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
106136496|NCT01981850|366157944|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
105790400|NCT01473589|364886985|FG001|Overall Study|Protocol Violation|0|||
105932367|NCT04518410|365410920|FG024|Overall Study|Dual Enrolled Subject|0|||
105932368|NCT03651336|365410921|FG000|Overall Study|Withdrawal by Subject|4|||
105932369|NCT01341990|365410922|FG000|Overall Study|Adverse Event|0|||
105932370|NCT01341990|365410923|FG001|Overall Study|Adverse Event|1|||
105932371|NCT01341990|365410922|FG000|Overall Study|Torn Study Lens|1|||
105932372|NCT01341990|365410923|FG001|Overall Study|Torn Study Lens|0|||
105932373|NCT01341990|365410922|FG000|Overall Study|Withdrawal by Subject|2|||
105932374|NCT01341990|365410923|FG001|Overall Study|Withdrawal by Subject|0|||
105932375|NCT01125748|365410924|FG000|Overall Study|Adverse Event|0|||
105932376|NCT01125748|365410925|FG001|Overall Study|Adverse Event|2|||
106136497|NCT01981850|366157945|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
106136498|NCT01981850|366157946|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
106136499|NCT01981850|366157947|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
105790401|NCT01473589|364886984|FG000|Overall Study|Withdrawal by Subject|5|||
105790402|NCT01473589|364886985|FG001|Overall Study|Withdrawal by Subject|11|||
105790403|NCT01473589|364886984|FG000|Overall Study|Physician Decision|0|||
105790404|NCT01473589|364886985|FG001|Overall Study|Physician Decision|1|||
105790405|NCT01473589|364886984|FG000|Overall Study|Entry criteria not met|0|||
105790406|NCT01473589|364886985|FG001|Overall Study|Entry criteria not met|1|||
105790407|NCT01607398|364886989|FG000|Overall Study|Adverse Event|0|||
105790408|NCT01607398|364886990|FG001|Overall Study|Adverse Event|2|||
105790409|NCT01607398|364886989|FG000|Overall Study|Severe COPD|2|||
105790410|NCT01607398|364886990|FG001|Overall Study|Severe COPD|0|||
105790411|NCT01491737|364886996|FG000|Overall Study|Withdrawal by Subject|20|||
105932377|NCT01125748|365410924|FG000|Overall Study|Lost to Follow-up|0|||
105932378|NCT01125748|365410925|FG001|Overall Study|Lost to Follow-up|1|||
105717381|NCT02471716|364623628|FG003|Overall Study|Study Terminiated by sponsor|1|||
105717382|NCT02471716|364623629|FG004|Overall Study|Study Terminiated by sponsor|0|||
105717383|NCT02471716|364623625|FG000|Overall Study|Lost to Follow-up|0|||
105717384|NCT02471716|364623626|FG001|Overall Study|Lost to Follow-up|0|||
105717385|NCT02471716|364623627|FG002|Overall Study|Lost to Follow-up|0|||
105717386|NCT02471716|364623628|FG003|Overall Study|Lost to Follow-up|3|||
105717387|NCT02471716|364623629|FG004|Overall Study|Lost to Follow-up|2|||
105717388|NCT02471716|364623625|FG000|Overall Study|Death|0|||
105717389|NCT02471716|364623626|FG001|Overall Study|Death|0|||
105717390|NCT02471716|364623627|FG002|Overall Study|Death|0|||
105717391|NCT02471716|364623628|FG003|Overall Study|Death|1|||
105717392|NCT02471716|364623629|FG004|Overall Study|Death|0|||
105717393|NCT02471716|364623625|FG000|Overall Study|Other|0|||
105717394|NCT02471716|364623626|FG001|Overall Study|Other|0|||
105717395|NCT02471716|364623627|FG002|Overall Study|Other|0|||
105717396|NCT02471716|364623628|FG003|Overall Study|Other|8|||
105717397|NCT02471716|364623629|FG004|Overall Study|Other|9|||
105717398|NCT03604445|364623633|FG000|Overall Study|Death|0|||
105717399|NCT03604445|364623634|FG001|Overall Study|Death|0|||
105717400|NCT03604445|364623635|FG002|Overall Study|Death|0|||
105717401|NCT03604445|364623636|FG003|Overall Study|Death|0|||
105717402|NCT03604445|364623637|FG004|Overall Study|Death|0|||
105717403|NCT03604445|364623638|FG005|Overall Study|Death|0|||
105717404|NCT03604445|364623639|FG006|Overall Study|Death|0|||
105717405|NCT03604445|364623640|FG007|Overall Study|Death|0|||
105717406|NCT03604445|364623641|FG008|Overall Study|Death|1|||
105717407|NCT03604445|364623633|FG000|Overall Study|Withdrawal by Subject|0|||
105717408|NCT03604445|364623634|FG001|Overall Study|Withdrawal by Subject|0|||
105717409|NCT03604445|364623635|FG002|Overall Study|Withdrawal by Subject|0|||
105717410|NCT03604445|364623636|FG003|Overall Study|Withdrawal by Subject|0|||
105717411|NCT03604445|364623637|FG004|Overall Study|Withdrawal by Subject|0|||
105717412|NCT03604445|364623638|FG005|Overall Study|Withdrawal by Subject|0|||
105717413|NCT03604445|364623639|FG006|Overall Study|Withdrawal by Subject|1|||
105717414|NCT03604445|364623640|FG007|Overall Study|Withdrawal by Subject|0|||
105717415|NCT03604445|364623641|FG008|Overall Study|Withdrawal by Subject|0|||
105717416|NCT03604445|364623633|FG000|Overall Study|Missing visit|0|||
105717417|NCT03604445|364623634|FG001|Overall Study|Missing visit|0|||
105717418|NCT03604445|364623635|FG002|Overall Study|Missing visit|0|||
105717419|NCT03604445|364623636|FG003|Overall Study|Missing visit|0|||
105717420|NCT03604445|364623637|FG004|Overall Study|Missing visit|0|||
105717421|NCT03604445|364623638|FG005|Overall Study|Missing visit|1|||
105717422|NCT03604445|364623639|FG006|Overall Study|Missing visit|0|||
105717423|NCT03604445|364623640|FG007|Overall Study|Missing visit|1|||
105717424|NCT03604445|364623641|FG008|Overall Study|Missing visit|0|||
105717425|NCT03604445|364623633|FG000|Overall Study|Adverse Event|0|||
105717426|NCT03604445|364623634|FG001|Overall Study|Adverse Event|0|||
105717427|NCT03604445|364623635|FG002|Overall Study|Adverse Event|0|||
105717428|NCT03604445|364623636|FG003|Overall Study|Adverse Event|1|||
105717429|NCT03604445|364623637|FG004|Overall Study|Adverse Event|0|||
105717430|NCT03604445|364623638|FG005|Overall Study|Adverse Event|0|||
105717431|NCT03604445|364623639|FG006|Overall Study|Adverse Event|0|||
105717432|NCT03604445|364623640|FG007|Overall Study|Adverse Event|0|||
105717433|NCT03604445|364623641|FG008|Overall Study|Adverse Event|1|||
105717434|NCT01014585|364623648|FG000|Overall Study|Adverse Event|0|||
105717435|NCT01014585|364623649|FG001|Overall Study|Adverse Event|2|||
105717436|NCT01014585|364623650|FG002|Overall Study|Adverse Event|0|||
105717437|NCT01014585|364623651|FG003|Overall Study|Adverse Event|3|||
105717438|NCT01014585|364623648|FG000|Overall Study|Withdrawal by Subject|2|||
105790412|NCT01491737|364886997|FG001|Overall Study|Withdrawal by Subject|17|||
105790413|NCT01491737|364886996|FG000|Overall Study|Lost to Follow-up|2|||
105717439|NCT01014585|364623649|FG001|Overall Study|Withdrawal by Subject|0|||
105717440|NCT01014585|364623650|FG002|Overall Study|Withdrawal by Subject|1|||
105717441|NCT01014585|364623651|FG003|Overall Study|Withdrawal by Subject|3|||
105717442|NCT01014585|364623648|FG000|Overall Study|Lost to Follow-up|0|||
105717443|NCT01014585|364623649|FG001|Overall Study|Lost to Follow-up|0|||
105717444|NCT01014585|364623650|FG002|Overall Study|Lost to Follow-up|0|||
105717445|NCT01014585|364623651|FG003|Overall Study|Lost to Follow-up|2|||
105717446|NCT01014585|364623648|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
105717447|NCT01014585|364623649|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
105717448|NCT01014585|364623650|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
105790414|NCT01491737|364886997|FG001|Overall Study|Lost to Follow-up|10|||
105717449|NCT01014585|364623651|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
105717450|NCT00713219|364623655|FG000|Overall Study|Death|1|||
105717451|NCT00713219|364623655|FG000|Overall Study|Protocol Violation|1|||
105717452|NCT02817087|364623656|FG000|Overall Study|Withdrawal by Subject|2|||
105717453|NCT02817087|364623657|FG001|Overall Study|Withdrawal by Subject|0|||
105717454|NCT01557166|364623667|FG000|Overall Study|Adverse Event|20|||
105717455|NCT01557166|364623668|FG001|Overall Study|Adverse Event|6|||
105717456|NCT01557166|364623667|FG000|Overall Study|Lack of Efficacy|2|||
105790415|NCT01491737|364886996|FG000|Overall Study|Death|63|||
105790416|NCT01491737|364886997|FG001|Overall Study|Death|57|||
105790417|NCT01491737|364886996|FG000|Overall Study|Study Termination by Sponsor|36|||
105790418|NCT01491737|364886997|FG001|Overall Study|Study Termination by Sponsor|36|||
105790419|NCT01491737|364886996|FG000|Overall Study|Reason Not Specified|8|||
105790420|NCT01491737|364886997|FG001|Overall Study|Reason Not Specified|9|||
105790421|NCT00297882|364887004|FG000|Day 14|Lack of Efficacy|12|||
105790422|NCT00297882|364887005|FG001|Day 14|Lack of Efficacy|49|||
105790423|NCT00297882|364887004|FG000|Day 28|Lost to Follow-up|13|||
105790424|NCT00297882|364887005|FG001|Day 28|Lost to Follow-up|23|||
105790425|NCT00297882|364887004|FG000|Day 28|Lack of Efficacy|3|||
105790426|NCT00297882|364887005|FG001|Day 28|Lack of Efficacy|0|||
105790427|NCT04242264|364887006|FG000|Overall Study|Lost to Follow-up|2|||
105790428|NCT04242264|364887007|FG001|Overall Study|Lost to Follow-up|2|||
105790429|NCT04242264|364887008|FG002|Overall Study|Lost to Follow-up|1|||
105790430|NCT04242264|364887009|FG003|Overall Study|Lost to Follow-up|1|||
105790431|NCT04242264|364887006|FG000|Overall Study|Withdrawal by Subject|1|||
105790432|NCT04242264|364887007|FG001|Overall Study|Withdrawal by Subject|0|||
105790433|NCT04242264|364887008|FG002|Overall Study|Withdrawal by Subject|0|||
105790434|NCT04242264|364887009|FG003|Overall Study|Withdrawal by Subject|0|||
105790435|NCT00578448|364887010|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
105790436|NCT00578448|364887010|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
105790437|NCT00578448|364887010|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
105790438|NCT00578448|364887010|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
105790439|NCT01976104|364887011|FG000|Overall Study|Adverse Event|0|||
105790440|NCT01976104|364887012|FG001|Overall Study|Adverse Event|0|||
105790441|NCT01976104|364887013|FG002|Overall Study|Adverse Event|1|||
105790442|NCT01976104|364887014|FG003|Overall Study|Adverse Event|0|||
105932379|NCT01125748|365410924|FG000|Overall Study|Physician Decision|8|||
105932380|NCT01125748|365410925|FG001|Overall Study|Physician Decision|7|||
105932381|NCT01125748|365410924|FG000|Overall Study|Patient Decision to Withdraw|2|||
105932382|NCT01125748|365410925|FG001|Overall Study|Patient Decision to Withdraw|4|||
105932383|NCT04401293|365410926|FG000|Overall Study|Withdrawal by Subject|1|||
105932384|NCT04401293|365410927|FG001|Overall Study|Withdrawal by Subject|3|||
105932385|NCT03679884|365410928|FG000|Overall Study|Other|12|||
105932386|NCT03679884|365410929|FG001|Overall Study|Other|12|||
105932387|NCT03679884|365410930|FG002|Overall Study|Other|12|||
105932388|NCT03679884|365410931|FG003|Overall Study|Other|7|||
105932389|NCT03679884|365410932|FG004|Overall Study|Other|8|||
105932390|NCT03679884|365410928|FG000|Overall Study|Lack of Efficacy|15|||
105932391|NCT03679884|365410929|FG001|Overall Study|Lack of Efficacy|29|||
105932392|NCT03679884|365410930|FG002|Overall Study|Lack of Efficacy|13|||
105932393|NCT03679884|365410931|FG003|Overall Study|Lack of Efficacy|29|||
105932394|NCT03679884|365410932|FG004|Overall Study|Lack of Efficacy|10|||
105932395|NCT03679884|365410928|FG000|Overall Study|Death|1|||
105932396|NCT03679884|365410929|FG001|Overall Study|Death|0|||
105932397|NCT03679884|365410930|FG002|Overall Study|Death|0|||
105932398|NCT03679884|365410931|FG003|Overall Study|Death|0|||
105932399|NCT03679884|365410932|FG004|Overall Study|Death|0|||
105932400|NCT03679884|365410928|FG000|Overall Study|Adverse Event|2|||
105932401|NCT03679884|365410929|FG001|Overall Study|Adverse Event|10|||
105932402|NCT03679884|365410930|FG002|Overall Study|Adverse Event|9|||
105932403|NCT03679884|365410931|FG003|Overall Study|Adverse Event|6|||
105932404|NCT03679884|365410932|FG004|Overall Study|Adverse Event|6|||
105932405|NCT03679884|365410928|FG000|Overall Study|Withdrawal by Subject|12|||
105932406|NCT03679884|365410929|FG001|Overall Study|Withdrawal by Subject|23|||
105932407|NCT03679884|365410930|FG002|Overall Study|Withdrawal by Subject|8|||
105932408|NCT03679884|365410931|FG003|Overall Study|Withdrawal by Subject|8|||
105932409|NCT03679884|365410932|FG004|Overall Study|Withdrawal by Subject|9|||
105932410|NCT03679884|365410928|FG000|Overall Study|Lost to Follow-up|1|||
105932411|NCT03679884|365410929|FG001|Overall Study|Lost to Follow-up|4|||
105932412|NCT03679884|365410930|FG002|Overall Study|Lost to Follow-up|2|||
105932413|NCT03679884|365410931|FG003|Overall Study|Lost to Follow-up|0|||
105932414|NCT03679884|365410932|FG004|Overall Study|Lost to Follow-up|3|||
105790443|NCT01976104|364887011|FG000|Overall Study|Lost to Follow-up|3|||
105790444|NCT01976104|364887012|FG001|Overall Study|Lost to Follow-up|0|||
105790445|NCT01976104|364887013|FG002|Overall Study|Lost to Follow-up|1|||
105790446|NCT01976104|364887014|FG003|Overall Study|Lost to Follow-up|1|||
105790447|NCT01976104|364887011|FG000|Overall Study|Subject Choice|0|||
105790448|NCT01976104|364887012|FG001|Overall Study|Subject Choice|1|||
105932415|NCT01026038|365410933|FG000|Overall Study|Lost to Follow-up|1|||
105932416|NCT01026038|365410934|FG001|Overall Study|Lost to Follow-up|1|||
105932417|NCT01026038|365410935|FG002|Overall Study|Lost to Follow-up|0|||
105932418|NCT00683384|365410936|FG000|Overall Study|Death|1|||
105932419|NCT00683384|365410936|FG000|Overall Study|Adverse Event|1|||
105932420|NCT01198548|365410947|FG000|Overall Study|Disease Progression|9|||
105932421|NCT01198548|365410947|FG000|Overall Study|Administrative Decision|1|||
105932422|NCT01800058|365410948|FG000|Overall Study|Lost to Follow-up|1|||
105932423|NCT00290238|365410949|FG000|Overall Study|Study terminated|27|||
105932424|NCT00290238|365410950|FG001|Overall Study|Study terminated|27|||
105932425|NCT00290238|365410949|FG000|Overall Study|Lost to Follow-up|0|||
105717457|NCT01557166|364623668|FG001|Overall Study|Lack of Efficacy|1|||
105717458|NCT01557166|364623667|FG000|Overall Study|Protocol Violation|8|||
105717459|NCT01557166|364623668|FG001|Overall Study|Protocol Violation|5|||
105717460|NCT01557166|364623667|FG000|Overall Study|Withdrawn consent|12|||
105717461|NCT01557166|364623668|FG001|Overall Study|Withdrawn consent|20|||
105717462|NCT01557166|364623667|FG000|Overall Study|Target dose not tolerated|1|||
105717463|NCT01557166|364623668|FG001|Overall Study|Target dose not tolerated|0|||
105932426|NCT00290238|365410950|FG001|Overall Study|Lost to Follow-up|1|||
105932427|NCT00290238|365410949|FG000|Overall Study|Withdrawal by Subject|15|||
105932428|NCT00290238|365410950|FG001|Overall Study|Withdrawal by Subject|13|||
105932429|NCT06868667|365410951|FG000|Overall Study|Death|0|||
105932430|NCT06868667|365410952|FG001|Overall Study|Death|4|||
105932431|NCT06868667|365410951|FG000|Overall Study|Lost to Follow-up|0|||
105932432|NCT06868667|365410952|FG001|Overall Study|Lost to Follow-up|1|||
105932433|NCT06868667|365410951|FG000|Overall Study|Withdrawal by Subject|1|||
105932434|NCT06868667|365410952|FG001|Overall Study|Withdrawal by Subject|0|||
105932435|NCT06868667|365410951|FG000|Overall Study|Ongoing|9|||
105932436|NCT06868667|365410952|FG001|Overall Study|Ongoing|9|||
105932437|NCT06097273|365410953|FG000|Overall Study|Death|2|||
105932438|NCT06097273|365410954|FG001|Overall Study|Death|1|||
105932439|NCT06097273|365410955|FG002|Overall Study|Death|2|||
105717464|NCT01557166|364623667|FG000|Overall Study|Psychiatric disorder|1|||
105717465|NCT01557166|364623668|FG001|Overall Study|Psychiatric disorder|0|||
105717466|NCT01557166|364623667|FG000|Overall Study|Unclassified|2|||
105717467|NCT01557166|364623668|FG001|Overall Study|Unclassified|5|||
105717468|NCT05847686|364624949|FG000|Overall Study|Withdrawal by Subject|3|||
105717469|NCT02554929|364624952|FG000|Overall Study|Lost to Follow-up|4|||
105717470|NCT02554929|364624953|FG001|Overall Study|Lost to Follow-up|4|||
105717471|NCT02554929|364624952|FG000|Overall Study|Withdrawal by Subject|2|||
105717472|NCT02554929|364624953|FG001|Overall Study|Withdrawal by Subject|8|||
105717473|NCT04439279|364624954|FG000|Overall Study|Adverse Event|7|||
105717474|NCT04439279|364624954|FG000|Overall Study|Death|4|||
105717475|NCT04439279|364624954|FG000|Overall Study|Disease progression|17|||
105717476|NCT04439279|364624954|FG000|Overall Study|Complicating disease|3|||
105717477|NCT04439279|364624954|FG000|Overall Study|Withdrawal by Subject|2|||
105717478|NCT04439279|364624954|FG000|Overall Study|Ineligible|1|||
105717479|NCT04439279|364624954|FG000|Overall Study|Treatment still ongoing|1|||
105717480|NCT00546364|364624955|FG000|Overall Study|Disease progression|5|||
105717481|NCT00546364|364624956|FG001|Overall Study|Disease progression|11|||
105717482|NCT00546364|364624957|FG002|Overall Study|Disease progression|8|||
105717483|NCT00546364|364624955|FG000|Overall Study|Completed and off treatment|1|||
105717484|NCT00546364|364624956|FG001|Overall Study|Completed and off treatment|0|||
105717485|NCT00546364|364624957|FG002|Overall Study|Completed and off treatment|2|||
105717486|NCT00546364|364624955|FG000|Overall Study|Administrative reason by sponsor|1|||
105717487|NCT00546364|364624956|FG001|Overall Study|Administrative reason by sponsor|0|||
105717488|NCT00546364|364624957|FG002|Overall Study|Administrative reason by sponsor|0|||
105717489|NCT00546364|364624955|FG000|Overall Study|Poor compliance/noncompliance|0|||
105717490|NCT00546364|364624956|FG001|Overall Study|Poor compliance/noncompliance|0|||
105717491|NCT00546364|364624957|FG002|Overall Study|Poor compliance/noncompliance|1|||
105717492|NCT00546364|364624955|FG000|Overall Study|No longer meets study criteria|1|||
105717493|NCT00546364|364624956|FG001|Overall Study|No longer meets study criteria|1|||
105717494|NCT00546364|364624957|FG002|Overall Study|No longer meets study criteria|0|||
105717495|NCT00546364|364624955|FG000|Overall Study|Withdrawal by Subject|5|||
105717496|NCT00546364|364624956|FG001|Overall Study|Withdrawal by Subject|6|||
105717497|NCT00546364|364624957|FG002|Overall Study|Withdrawal by Subject|3|||
105717498|NCT00546364|364624955|FG000|Overall Study|Prior taxotere|1|||
105717499|NCT00546364|364624956|FG001|Overall Study|Prior taxotere|0|||
105717500|NCT00546364|364624957|FG002|Overall Study|Prior taxotere|0|||
105717501|NCT00546364|364624955|FG000|Overall Study|Mixed response|1|||
105717502|NCT00546364|364624956|FG001|Overall Study|Mixed response|0|||
105717503|NCT00546364|364624957|FG002|Overall Study|Mixed response|0|||
105932440|NCT06097273|365410956|FG003|Overall Study|Death|2|||
105932441|NCT06097273|365410953|FG000|Overall Study|Lost to Follow-up|27|||
105932442|NCT06097273|365410954|FG001|Overall Study|Lost to Follow-up|18|||
105717504|NCT00546364|364624955|FG000|Overall Study|Palliative treatment|1|||
105717505|NCT00546364|364624956|FG001|Overall Study|Palliative treatment|0|||
105717506|NCT00546364|364624957|FG002|Overall Study|Palliative treatment|1|||
105717507|NCT00546364|364624955|FG000|Overall Study|Target lesions resected|1|||
105717508|NCT00546364|364624956|FG001|Overall Study|Target lesions resected|0|||
105717509|NCT00546364|364624957|FG002|Overall Study|Target lesions resected|0|||
105717510|NCT00546364|364624955|FG000|Overall Study|Physician Decision|0|||
105717511|NCT00546364|364624956|FG001|Overall Study|Physician Decision|0|||
105717512|NCT00546364|364624957|FG002|Overall Study|Physician Decision|1|||
105932443|NCT06097273|365410955|FG002|Overall Study|Lost to Follow-up|36|||
105932444|NCT06097273|365410956|FG003|Overall Study|Lost to Follow-up|31|||
105932445|NCT06097273|365410953|FG000|Overall Study|Physician Decision|0|||
105932446|NCT06097273|365410954|FG001|Overall Study|Physician Decision|1|||
105932447|NCT06097273|365410955|FG002|Overall Study|Physician Decision|0|||
105717513|NCT00546364|364624955|FG000|Overall Study|Sponsor decision|0|||
105717514|NCT00546364|364624956|FG001|Overall Study|Sponsor decision|0|||
105717515|NCT00546364|364624957|FG002|Overall Study|Sponsor decision|1|||
105717516|NCT03521791|364624958|FG000|Overall Study|Protocol Violation|7|||
105717517|NCT03521791|364624959|FG001|Overall Study|Protocol Violation|17|||
105717518|NCT01777763|364624972|FG000|Overall Study|Adverse Event|2|||
105717519|NCT01777763|364624973|FG001|Overall Study|Adverse Event|32|||
105717520|NCT01777763|364624972|FG000|Overall Study|Protocol Violation|1|||
105717521|NCT01777763|364624973|FG001|Overall Study|Protocol Violation|7|||
105717522|NCT01777763|364624972|FG000|Overall Study|Withdrawal by Subject|0|||
105717523|NCT01777763|364624973|FG001|Overall Study|Withdrawal by Subject|2|||
105717524|NCT01777763|364624972|FG000|Overall Study|Treatment Failure|1|||
105717525|NCT01777763|364624973|FG001|Overall Study|Treatment Failure|6|||
105717526|NCT01390389|364624974|FG000|Overall Study|Withdrawal by Subject|2|||
105717527|NCT01390389|364624975|FG001|Overall Study|Withdrawal by Subject|0|||
105717528|NCT01390389|364624974|FG000|Overall Study|Screen Fail|2|||
105717529|NCT01390389|364624975|FG001|Overall Study|Screen Fail|1|||
105717530|NCT01974817|364624976|FG000|Overall Study|Death|4|||
105717531|NCT01974817|364624976|FG000|Overall Study|Lost to Follow-up|2|||
105717532|NCT01974817|364624976|FG000|Overall Study|Protocol Violation|2|||
105717533|NCT01171820|364624983|FG000|Overall Study|Death|3|||
105717534|NCT01171820|364624984|FG001|Overall Study|Death|3|||
105717535|NCT01171820|364624983|FG000|Overall Study|Lost to Follow-up|0|||
105717536|NCT01171820|364624984|FG001|Overall Study|Lost to Follow-up|1|||
105717537|NCT01171820|364624983|FG000|Overall Study|Withdrawal by Subject|2|||
105717538|NCT01171820|364624984|FG001|Overall Study|Withdrawal by Subject|0|||
105717539|NCT01171820|364624983|FG000|Overall Study|Physician Decision|0|||
105717540|NCT01171820|364624984|FG001|Overall Study|Physician Decision|1|||
105717541|NCT01171820|364624983|FG000|Overall Study|1-Year Missed Visit|1|||
105717542|NCT01171820|364624984|FG001|Overall Study|1-Year Missed Visit|1|||
105717543|NCT02663895|364624985|FG000|Overall Study|Adverse Event|3|||
105717544|NCT02663895|364624985|FG000|Overall Study|Physician Decision|2|||
105717545|NCT02663895|364624985|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
105717546|NCT02663895|364624985|FG000|Overall Study|Withdrawal by Subject|1|||
105717547|NCT01400932|364624986|FG000|Overall Study|Adverse Event|10|||
105717548|NCT01400932|364624987|FG001|Overall Study|Adverse Event|5|||
105717549|NCT01400932|364624986|FG000|Overall Study|Lack of Efficacy|0|||
105717550|NCT01400932|364624987|FG001|Overall Study|Lack of Efficacy|3|||
105717551|NCT01400932|364624986|FG000|Overall Study|Withdrawal by Subject|2|||
105717552|NCT01400932|364624987|FG001|Overall Study|Withdrawal by Subject|6|||
105717553|NCT01400932|364624986|FG000|Overall Study|Lost to Follow-up|1|||
105717554|NCT01400932|364624987|FG001|Overall Study|Lost to Follow-up|0|||
105717555|NCT01400932|364624986|FG000|Overall Study|Protocol Deviation|0|||
105717556|NCT01400932|364624987|FG001|Overall Study|Protocol Deviation|1|||
105717557|NCT01400932|364624986|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105717558|NCT01400932|364624987|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
105717559|NCT04574999|364624988|FG000|Overall Study|Adverse Event|1|||
105717560|NCT04574999|364624989|FG001|Overall Study|Adverse Event|0|||
105717561|NCT04574999|364624988|FG000|Overall Study|Lack of Efficacy|2|||
105717562|NCT04574999|364624989|FG001|Overall Study|Lack of Efficacy|3|||
105717563|NCT04574999|364624988|FG000|Overall Study|Protocol Violation|1|||
105717564|NCT04574999|364624989|FG001|Overall Study|Protocol Violation|0|||
105717565|NCT04574999|364624988|FG000|Overall Study|Withdrawal by Subject|2|||
105717566|NCT04574999|364624989|FG001|Overall Study|Withdrawal by Subject|2|||
105717567|NCT04574999|364624988|FG000|Overall Study|Lost to Follow-up|1|||
105717568|NCT04574999|364624989|FG001|Overall Study|Lost to Follow-up|0|||
105717569|NCT04574999|364624988|FG000|Overall Study|Personal problems|1|||
105932448|NCT06097273|365410956|FG003|Overall Study|Physician Decision|3|||
105932449|NCT06097273|365410953|FG000|Overall Study|Protocol Violation|1|||
105932450|NCT06097273|365410954|FG001|Overall Study|Protocol Violation|1|||
105932451|NCT06097273|365410955|FG002|Overall Study|Protocol Violation|2|||
105932452|NCT06097273|365410956|FG003|Overall Study|Protocol Violation|1|||
105717570|NCT04574999|364624989|FG001|Overall Study|Personal problems|0|||
105717571|NCT04574999|364624988|FG000|Overall Study|Previous planned surgery|1|||
105717572|NCT04574999|364624989|FG001|Overall Study|Previous planned surgery|0|||
105717573|NCT04656990|364624990|FG000|Baseline|pandemic|20|||
105717574|NCT04656990|364624991|FG001|Baseline|pandemic|24|||
105717575|NCT04656990|364624990|FG000|Follow Up Period|Lost to Follow-up|61|||
105717576|NCT04656990|364624991|FG001|Follow Up Period|Lost to Follow-up|73|||
105717577|NCT00988247|364624992|FG000|Overall Study|Adverse Event|17|||
105717578|NCT00988247|364624993|FG001|Overall Study|Adverse Event|3|||
105790449|NCT01976104|364887013|FG002|Overall Study|Subject Choice|0|||
105717579|NCT00988247|364624992|FG000|Overall Study|Withdrawal by Subject|44|||
105717580|NCT00988247|364624993|FG001|Overall Study|Withdrawal by Subject|13|||
105717581|NCT00988247|364624992|FG000|Overall Study|Pregnancy|1|||
105717582|NCT00988247|364624993|FG001|Overall Study|Pregnancy|2|||
105717583|NCT00988247|364624992|FG000|Overall Study|Lost to Follow-up|11|||
105717584|NCT00988247|364624993|FG001|Overall Study|Lost to Follow-up|2|||
105932453|NCT06097273|365410953|FG000|Overall Study|Withdrawal by Subject|14|||
105932454|NCT06097273|365410954|FG001|Overall Study|Withdrawal by Subject|11|||
105717585|NCT00988247|364624992|FG000|Overall Study|Protocol Violation|4|||
105717586|NCT00988247|364624993|FG001|Overall Study|Protocol Violation|5|||
105717587|NCT00988247|364624992|FG000|Overall Study|Sponsor requested withdrawal|3|||
105717588|NCT00988247|364624993|FG001|Overall Study|Sponsor requested withdrawal|1|||
105717589|NCT00988247|364624992|FG000|Overall Study|Other|3|||
105717590|NCT00988247|364624993|FG001|Overall Study|Other|0|||
105717591|NCT04173741|364624994|FG000|Overall Study|IVC measurement cannot be done|1|||
105717592|NCT04173741|364624995|FG001|Overall Study|IVC measurement cannot be done|1|||
105717593|NCT02522767|364624998|FG000|Double-blind|Withdrawal by Subject|8|||
105717594|NCT02522767|364624999|FG001|Double-blind|Withdrawal by Subject|11|||
105717595|NCT02522767|364624998|FG000|Double-blind|Lost to Follow-up|1|||
105717596|NCT02522767|364624999|FG001|Double-blind|Lost to Follow-up|0|||
105717597|NCT02522767|364624998|FG000|Double-blind|Adverse Event|1|||
105717598|NCT02522767|364624999|FG001|Double-blind|Adverse Event|10|||
105717599|NCT02522767|364624998|FG000|Double-blind|Protocol Violation|0|||
105717600|NCT02522767|364624999|FG001|Double-blind|Protocol Violation|1|||
105717601|NCT02522767|364624998|FG000|Double-blind|Lack of Efficacy|0|||
105717602|NCT02522767|364624999|FG001|Double-blind|Lack of Efficacy|2|||
105717603|NCT02522767|364624998|FG000|Double-blind|Protocol Deviation|1|||
105717604|NCT02522767|364624999|FG001|Double-blind|Protocol Deviation|0|||
105717605|NCT02522767|364624998|FG000|Open-label|Withdrawal by Subject|2|||
105717606|NCT02522767|364624999|FG001|Open-label|Withdrawal by Subject|3|||
105717607|NCT02522767|364624998|FG000|Open-label|Lost to Follow-up|0|||
105717608|NCT02522767|364624999|FG001|Open-label|Lost to Follow-up|1|||
105717609|NCT02522767|364624998|FG000|Open-label|Adverse Event|2|||
105717610|NCT02522767|364624999|FG001|Open-label|Adverse Event|1|||
105717611|NCT02522767|364624998|FG000|Open-label|Lack of Efficacy|1|||
105717612|NCT02522767|364624999|FG001|Open-label|Lack of Efficacy|1|||
105717613|NCT02522767|364624998|FG000|Open-label|Protocol Violation|0|||
105717614|NCT02522767|364624999|FG001|Open-label|Protocol Violation|1|||
105717615|NCT02494596|364625000|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105717616|NCT02494596|364625001|FG001|Overall Study|Insufficient Therapeutic Response|3|||
105717617|NCT02494596|364625002|FG002|Overall Study|Insufficient Therapeutic Response|1|||
105717618|NCT02494596|364625000|FG000|Overall Study|Adverse Event|0|||
105717619|NCT02494596|364625001|FG001|Overall Study|Adverse Event|1|||
105717620|NCT02494596|364625002|FG002|Overall Study|Adverse Event|0|||
105717621|NCT02494596|364625000|FG000|Overall Study|Refused Treatment|0|||
105717622|NCT02494596|364625001|FG001|Overall Study|Refused Treatment|1|||
105717623|NCT02494596|364625002|FG002|Overall Study|Refused Treatment|0|||
105717624|NCT00059202|364625003|FG000|Overall Study|Withdrawal by Subject|5|||
105717625|NCT00059202|364625004|FG001|Overall Study|Withdrawal by Subject|9|||
105932455|NCT06097273|365410955|FG002|Overall Study|Withdrawal by Subject|14|||
105932456|NCT06097273|365410956|FG003|Overall Study|Withdrawal by Subject|15|||
105932457|NCT06097273|365410953|FG000|Overall Study|Other Than Specified|7|||
105932458|NCT06097273|365410954|FG001|Overall Study|Other Than Specified|3|||
105932459|NCT06097273|365410955|FG002|Overall Study|Other Than Specified|11|||
105932460|NCT06097273|365410956|FG003|Overall Study|Other Than Specified|6|||
105932461|NCT03921541|365412428|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
105932462|NCT03921541|365412429|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
105932463|NCT03554473|365412430|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
105932464|NCT03554473|365412431|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
105932465|NCT03554473|365412432|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
105932466|NCT03554473|365412430|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
105932467|NCT03554473|365412431|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
105932468|NCT03554473|365412432|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
105932469|NCT03554473|365412430|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
105932470|NCT03554473|365412431|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
105932471|NCT03554473|365412432|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
105932472|NCT00835978|365412436|FG000|Overall Study|Death|33|||
105932473|NCT00835978|365412437|FG001|Overall Study|Death|40|||
105932474|NCT00835978|365412438|FG002|Overall Study|Death|49|||
105932475|NCT00835978|365412439|FG003|Overall Study|Death|4|||
105717626|NCT00059202|364625003|FG000|Overall Study|Protocol Violation|1|||
105717627|NCT00059202|364625004|FG001|Overall Study|Protocol Violation|3|||
105717628|NCT00059202|364625003|FG000|Overall Study|drug toxicity|0|||
105717629|NCT00059202|364625004|FG001|Overall Study|drug toxicity|3|||
105717630|NCT03502187|364625008|FG000|Overall Study|Withdrawal by Subject|4|||
105717631|NCT03502187|364625009|FG001|Overall Study|Withdrawal by Subject|3|||
105717632|NCT03502187|364625010|FG002|Overall Study|Withdrawal by Subject|3|||
105717633|NCT03502187|364625008|FG000|Overall Study|Lost to Follow-up|5|||
105717634|NCT03502187|364625009|FG001|Overall Study|Lost to Follow-up|4|||
105717635|NCT03502187|364625010|FG002|Overall Study|Lost to Follow-up|5|||
105717636|NCT00214461|364625011|FG000|Overall Study|Adverse Event|0|||
105717637|NCT00214461|364625012|FG001|Overall Study|Adverse Event|0|||
105717638|NCT00214461|364625013|FG002|Overall Study|Adverse Event|1|||
105717639|NCT00214461|364625014|FG003|Overall Study|Adverse Event|1|||
105717640|NCT00214461|364625011|FG000|Overall Study|Withdrawal by Subject|0|||
105717641|NCT00214461|364625012|FG001|Overall Study|Withdrawal by Subject|0|||
105717642|NCT00214461|364625013|FG002|Overall Study|Withdrawal by Subject|1|||
105717643|NCT00214461|364625014|FG003|Overall Study|Withdrawal by Subject|0|||
105717644|NCT02908100|364625015|FG000|Overall Study|Adverse Event|7|||
105717645|NCT02908100|364625016|FG001|Overall Study|Adverse Event|6|||
105717646|NCT02908100|364625017|FG002|Overall Study|Adverse Event|9|||
105717647|NCT02908100|364625015|FG000|Overall Study|Death|2|||
105717648|NCT02908100|364625016|FG001|Overall Study|Death|0|||
105717649|NCT02908100|364625017|FG002|Overall Study|Death|0|||
105932476|NCT00835978|365412436|FG000|Overall Study|Lost to Follow-up|3|||
105932477|NCT00835978|365412437|FG001|Overall Study|Lost to Follow-up|4|||
105932478|NCT00835978|365412438|FG002|Overall Study|Lost to Follow-up|2|||
105932479|NCT00835978|365412439|FG003|Overall Study|Lost to Follow-up|1|||
105932480|NCT00835978|365412436|FG000|Overall Study|Other|5|||
105932481|NCT00835978|365412437|FG001|Overall Study|Other|1|||
105932482|NCT00835978|365412438|FG002|Overall Study|Other|8|||
105932483|NCT00835978|365412439|FG003|Overall Study|Other|0|||
105932484|NCT00835978|365412436|FG000|Overall Study|Objective progression or relapse|2|||
105932485|NCT00835978|365412437|FG001|Overall Study|Objective progression or relapse|0|||
105932486|NCT00835978|365412438|FG002|Overall Study|Objective progression or relapse|1|||
105932487|NCT00835978|365412439|FG003|Overall Study|Objective progression or relapse|0|||
105932488|NCT00835978|365412436|FG000|Overall Study|Adverse Event|1|||
105932489|NCT00835978|365412437|FG001|Overall Study|Adverse Event|0|||
105932490|NCT00835978|365412438|FG002|Overall Study|Adverse Event|1|||
105932491|NCT00835978|365412439|FG003|Overall Study|Adverse Event|0|||
105932492|NCT00835978|365412436|FG000|Overall Study|Withdrawal by Subject|0|||
105932493|NCT00835978|365412437|FG001|Overall Study|Withdrawal by Subject|3|||
105932494|NCT00835978|365412438|FG002|Overall Study|Withdrawal by Subject|0|||
105932495|NCT00835978|365412439|FG003|Overall Study|Withdrawal by Subject|5|||
105932496|NCT00835978|365412436|FG000|Overall Study|Study terminated by sponsor|12|||
105932497|NCT00835978|365412437|FG001|Overall Study|Study terminated by sponsor|8|||
105932498|NCT00835978|365412438|FG002|Overall Study|Study terminated by sponsor|30|||
105932499|NCT00835978|365412439|FG003|Overall Study|Study terminated by sponsor|0|||
105932500|NCT04575324|365412440|FG000|Overall Study|Lost to Follow-up|29|||
105932501|NCT04575324|365412441|FG001|Overall Study|Lost to Follow-up|25|||
105932502|NCT04575324|365412440|FG000|Overall Study|Death|1|||
105932503|NCT04575324|365412441|FG001|Overall Study|Death|2|||
105932504|NCT04575324|365412440|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
105932505|NCT04575324|365412441|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
105932506|NCT01178411|365412449|FG000|Overall Study|Adverse Event|5|||
105932507|NCT01178411|365412449|FG000|Overall Study|Withdrawal by Subject|4|||
105932508|NCT01178411|365412449|FG000|Overall Study|Protocol Violation|1|||
105932509|NCT01178411|365412449|FG000|Overall Study|Progressive disease per RECIST|32|||
105932510|NCT01178411|365412449|FG000|Overall Study|Progressive disease per clinician|9|||
105932511|NCT01178411|365412449|FG000|Overall Study|Physician Decision|6|||
105932512|NCT01178411|365412449|FG000|Overall Study|Death|1|||
105932513|NCT01178411|365412449|FG000|Overall Study|No reason provided|1|||
105932514|NCT01178411|365412449|FG000|Overall Study|Drug manufacturing ended|1|||
105932515|NCT01245751|365412450|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
105932516|NCT01245751|365412451|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
105932517|NCT01245751|365412452|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
105932518|NCT01245751|365412453|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
105932519|NCT01245751|365412450|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
105932520|NCT01245751|365412451|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
105717650|NCT02908100|364625015|FG000|Overall Study|Lack of Efficacy|2|||
105717651|NCT02908100|364625016|FG001|Overall Study|Lack of Efficacy|3|||
105717652|NCT02908100|364625017|FG002|Overall Study|Lack of Efficacy|3|||
105717653|NCT02908100|364625015|FG000|Overall Study|Lost to Follow-up|0|||
105932521|NCT01245751|365412452|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
105932522|NCT01245751|365412453|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
105932523|NCT01245751|365412450|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
105932524|NCT01245751|365412451|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
105932525|NCT01245751|365412452|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
105932526|NCT01245751|365412453|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
105932527|NCT03197935|365412457|FG000|Overall Study|Death due to any cause|26|||
105932528|NCT03197935|365412458|FG001|Overall Study|Death due to any cause|15|||
105932529|NCT03197935|365412457|FG000|Overall Study|Lost to Follow-up|3|||
105932530|NCT03197935|365412458|FG001|Overall Study|Lost to Follow-up|5|||
105932531|NCT03197935|365412457|FG000|Overall Study|Physician Decision|2|||
105717654|NCT02908100|364625016|FG001|Overall Study|Lost to Follow-up|1|||
105717655|NCT02908100|364625017|FG002|Overall Study|Lost to Follow-up|2|||
105790450|NCT01976104|364887014|FG003|Overall Study|Subject Choice|1|||
105790451|NCT01976104|364887011|FG000|Overall Study|Withdrawal by Subject|3|||
105790452|NCT01976104|364887012|FG001|Overall Study|Withdrawal by Subject|0|||
105790453|NCT01976104|364887013|FG002|Overall Study|Withdrawal by Subject|0|||
105790454|NCT01976104|364887014|FG003|Overall Study|Withdrawal by Subject|1|||
105790455|NCT01976104|364887011|FG000|Overall Study|Other|0|||
105790456|NCT01976104|364887012|FG001|Overall Study|Other|1|||
105790457|NCT01976104|364887013|FG002|Overall Study|Other|0|||
105790458|NCT01976104|364887014|FG003|Overall Study|Other|0|||
105790459|NCT03901352|364887020|FG000|Double-blind Phase|Adverse Event|6|||
105790460|NCT03901352|364887021|FG001|Double-blind Phase|Adverse Event|4|||
105790461|NCT03901352|364887020|FG000|Double-blind Phase|Death|1|||
105790462|NCT03901352|364887021|FG001|Double-blind Phase|Death|0|||
105790463|NCT03901352|364887020|FG000|Double-blind Phase|Lack of Efficacy|0|||
105790464|NCT03901352|364887021|FG001|Double-blind Phase|Lack of Efficacy|1|||
105790465|NCT03901352|364887020|FG000|Double-blind Phase|Protocol Violation|0|||
105790466|NCT03901352|364887021|FG001|Double-blind Phase|Protocol Violation|1|||
105790467|NCT03901352|364887020|FG000|Double-blind Phase|Withdrawal by Subject|10|||
105790468|NCT03901352|364887021|FG001|Double-blind Phase|Withdrawal by Subject|8|||
105790469|NCT03901352|364887020|FG000|Open-label Extension Phase|Adverse Event|24|||
105790470|NCT03901352|364887021|FG001|Open-label Extension Phase|Adverse Event|0|||
105790471|NCT03901352|364887020|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
105790472|NCT03901352|364887021|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
105790473|NCT03901352|364887020|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
105790474|NCT03901352|364887021|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
105790475|NCT03901352|364887020|FG000|Open-label Extension Phase|Other|1|||
105790476|NCT03901352|364887021|FG001|Open-label Extension Phase|Other|0|||
105790477|NCT06067191|364887022|FG000|Overall Study|Withdrawal by Subject|0|||
105790478|NCT06067191|364887023|FG001|Overall Study|Withdrawal by Subject|1|||
105790479|NCT02886494|364887025|FG000|Overall Study|Adverse Event|1|||
105790480|NCT02886494|364887026|FG001|Overall Study|Adverse Event|0|||
105790481|NCT02886494|364887025|FG000|Overall Study|Withdrawal by Subject|12|||
105790482|NCT02886494|364887026|FG001|Overall Study|Withdrawal by Subject|3|||
105790483|NCT02886494|364887025|FG000|Overall Study|Protocol Violation|4|||
106008654|NCT01535040|365697054|FG001|Overall Study|Withdrawal by Subject|10|||
106008655|NCT01535040|365697053|FG000|Overall Study|Never Started|9|||
106008656|NCT01535040|365697054|FG001|Overall Study|Never Started|4|||
106008657|NCT01535040|365697053|FG000|Overall Study|Toxicity|7|||
105717656|NCT02908100|364625015|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105717657|NCT02908100|364625016|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105717658|NCT02908100|364625017|FG002|Overall Study|Non-Compliance With Study Drug|2|||
105717659|NCT02908100|364625015|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
105717660|NCT02908100|364625016|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
105717661|NCT02908100|364625017|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
105717662|NCT02908100|364625015|FG000|Overall Study|Physician Decision|0|||
105717663|NCT02908100|364625016|FG001|Overall Study|Physician Decision|1|||
105717664|NCT02908100|364625017|FG002|Overall Study|Physician Decision|0|||
105717665|NCT02908100|364625015|FG000|Overall Study|Pregnancy|1|||
105717666|NCT02908100|364625016|FG001|Overall Study|Pregnancy|2|||
105717667|NCT02908100|364625017|FG002|Overall Study|Pregnancy|0|||
105717668|NCT02908100|364625015|FG000|Overall Study|Withdrawal by Subject|8|||
105717669|NCT02908100|364625016|FG001|Overall Study|Withdrawal by Subject|7|||
105717670|NCT02908100|364625017|FG002|Overall Study|Withdrawal by Subject|5|||
105717671|NCT02908100|364625015|FG000|Overall Study|Randomised in Error|1|||
105717672|NCT02908100|364625016|FG001|Overall Study|Randomised in Error|0|||
105717673|NCT02908100|364625017|FG002|Overall Study|Randomised in Error|0|||
105717674|NCT02024971|364625018|FG000|Overall Study|Data Not Available|30|||
105717675|NCT02024971|364625018|FG000|Overall Study|Lost to Follow-up|6|||
105717676|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
105717677|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
105717678|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
106008658|NCT01535040|365697054|FG001|Overall Study|Toxicity|5|||
106008659|NCT01535040|365697053|FG000|Overall Study|Multiple Reasons|1|||
106008660|NCT01535040|365697054|FG001|Overall Study|Multiple Reasons|1|||
105717679|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
105717680|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
105717681|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
105717682|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
106008661|NCT01074970|365697055|FG000|Overall Study|Never Treated|0|||
106008662|NCT01074970|365697056|FG001|Overall Study|Never Treated|0|||
105790484|NCT02886494|364887026|FG001|Overall Study|Protocol Violation|1|||
105790485|NCT00807040|364887029|FG000|Overall Study|Death|24|||
105790486|NCT00807040|364887030|FG001|Overall Study|Death|29|||
106008663|NCT01074970|365697057|FG002|Overall Study|Never Treated|8|||
105790487|NCT00807040|364887029|FG000|Overall Study|Withdrawal by Subject|8|||
105790488|NCT00807040|364887030|FG001|Overall Study|Withdrawal by Subject|6|||
106008664|NCT01074970|365697058|FG003|Overall Study|Never Treated|1|||
106008665|NCT01074970|365697055|FG000|Overall Study|Adverse Event|1|||
106008666|NCT01074970|365697056|FG001|Overall Study|Adverse Event|0|||
106008667|NCT01074970|365697057|FG002|Overall Study|Adverse Event|4|||
106008668|NCT01074970|365697058|FG003|Overall Study|Adverse Event|3|||
106008669|NCT01074970|365697055|FG000|Overall Study|Disease progression during treatment|3|||
106008670|NCT01074970|365697056|FG001|Overall Study|Disease progression during treatment|1|||
106008671|NCT01074970|365697057|FG002|Overall Study|Disease progression during treatment|2|||
106008672|NCT01074970|365697058|FG003|Overall Study|Disease progression during treatment|9|||
106008673|NCT01074970|365697055|FG000|Overall Study|Lost to Follow-up|0|||
106008674|NCT01074970|365697056|FG001|Overall Study|Lost to Follow-up|0|||
106008675|NCT01074970|365697057|FG002|Overall Study|Lost to Follow-up|1|||
106008676|NCT01074970|365697058|FG003|Overall Study|Lost to Follow-up|0|||
106008677|NCT01074970|365697055|FG000|Overall Study|Withdrawal by Subject|0|||
106008678|NCT01074970|365697056|FG001|Overall Study|Withdrawal by Subject|0|||
106008679|NCT01074970|365697057|FG002|Overall Study|Withdrawal by Subject|6|||
106008680|NCT01074970|365697058|FG003|Overall Study|Withdrawal by Subject|4|||
106008681|NCT01652235|365697063|FG000|Overall Study|Death|9|||
106008682|NCT01652235|365697063|FG000|Overall Study|Lost to Follow-up|5|||
106008683|NCT01652235|365697063|FG000|Overall Study|Withdrawal by Subject|2|||
106008684|NCT01824836|365697064|FG000|Overall Study|Adverse Event|48|||
106008685|NCT01824836|365697064|FG000|Overall Study|Withdrawal by Subject|63|||
106008686|NCT01824836|365697064|FG000|Overall Study|Other complicating disease|116|||
106008687|NCT01824836|365697064|FG000|Overall Study|Disease progression|5|||
106008688|NCT01824836|365697064|FG000|Overall Study|Alternative therapy|2|||
106008689|NCT01824836|365697064|FG000|Overall Study|Depression|1|||
106008690|NCT01824836|365697064|FG000|Overall Study|Non-compliance|3|||
106008691|NCT01824836|365697064|FG000|Overall Study|Patient regained ovarian function|3|||
106008692|NCT01824836|365697064|FG000|Overall Study|Lost to Follow-up|8|||
106008693|NCT01824836|365697064|FG000|Overall Study|Physician Decision|2|||
106008694|NCT01824836|365697064|FG000|Overall Study|Research office was closed|3|||
106008695|NCT01824836|365697064|FG000|Overall Study|Relocation|3|||
106008696|NCT01824836|365697064|FG000|Overall Study|Insurance-related issue|1|||
105717683|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
105717684|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
105717685|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
105717686|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
105717687|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
105717688|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
105717689|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
105717690|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
105717691|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
105717692|NCT02631538|364625019|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
105717693|NCT02631538|364625020|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
105717694|NCT02631538|364625021|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
105717695|NCT02631538|364625022|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
105717696|NCT02631538|364625019|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
105717697|NCT02631538|364625020|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
105717698|NCT02631538|364625021|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
105717699|NCT02631538|364625022|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
105717700|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Death|3|||
105717701|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Death|4|||
105717702|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
105717703|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
105717704|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
105717705|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
105717706|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
105717707|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
105717708|NCT00559273|364625023|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
105717709|NCT00559273|364625024|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
105717710|NCT00559273|364625023|FG000|Evaluation Period (8 Weeks)|Death|1|||
105717711|NCT00559273|364625024|FG001|Evaluation Period (8 Weeks)|Death|3|||
105717712|NCT00559273|364625023|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
105717713|NCT00559273|364625024|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
105717714|NCT00559273|364625023|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
105717715|NCT00559273|364625024|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
105717716|NCT00559273|364625023|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
106008697|NCT01824836|365697064|FG000|Overall Study|Transportation issue|1|||
106008698|NCT01824836|365697064|FG000|Overall Study|Patient transferred care|1|||
106008699|NCT01824836|365697064|FG000|Overall Study|Unknown reasons|4|||
106008700|NCT01824836|365697064|FG000|Overall Study|Never started treatment|16|||
106008701|NCT01844986|365697069|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
106008702|NCT01844986|365697070|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
106136500|NCT01981850|366157948|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
106136501|NCT01981850|366157949|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
106136502|NCT01981850|366157950|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
106136503|NCT01981850|366157951|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
105717717|NCT00559273|364625024|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
105717718|NCT00189462|364625025|FG000|Overall Study|Lack of Efficacy|5|||
105717719|NCT00189462|364625026|FG001|Overall Study|Lack of Efficacy|1|||
105717720|NCT00189462|364625025|FG000|Overall Study|Lost to Follow-up|18|||
105717721|NCT00189462|364625026|FG001|Overall Study|Lost to Follow-up|20|||
105717722|NCT01262625|364625029|FG000|Overall Study|Administrative Error|1|||
105717723|NCT01262625|364625030|FG001|Overall Study|Administrative Error|1|||
105717724|NCT01262625|364625029|FG000|Overall Study|Site Closed|1|||
105717725|NCT01262625|364625030|FG001|Overall Study|Site Closed|0|||
105717726|NCT01869348|364625032|FG000|Overall Study|Withdrawal by Subject|1|||
105717727|NCT01869348|364625033|FG001|Overall Study|Withdrawal by Subject|1|||
105717728|NCT02789657|364625034|FG000|Overall Study|Withdrawal by Subject|2|||
105717729|NCT02789657|364625035|FG001|Overall Study|Withdrawal by Subject|0|||
105717730|NCT02789657|364625036|FG002|Overall Study|Withdrawal by Subject|0|||
105717731|NCT02789657|364625037|FG003|Overall Study|Withdrawal by Subject|0|||
105717732|NCT03075163|364625038|FG000|Overall Study|not eligible for treatment limb|138|||
105717733|NCT03075163|364625039|FG001|Overall Study|not eligible for treatment limb|138|||
105717734|NCT01900002|364625045|FG000|Overall Study|Withdrawal by Subject|2|||
105717735|NCT01900002|364625045|FG000|Overall Study|ineligible for Y-90|4|||
105717736|NCT02908516|364625046|FG000|Overall Study|Study Terminated|3|||
105717737|NCT02908516|364625047|FG001|Overall Study|Study Terminated|3|||
105717738|NCT01384292|364625050|FG000|Part B|Severe non-compliance to protocol|1|||
105717739|NCT01384292|364625051|FG001|Part B|Severe non-compliance to protocol|0|||
105717740|NCT01384292|364625052|FG002|Part B|Severe non-compliance to protocol|0|||
105717741|NCT01948830|364625053|FG000|Overall Study|Physician Decision|1|||
105717742|NCT01948830|364625054|FG001|Overall Study|Physician Decision|3|||
105717743|NCT01948830|364625053|FG000|Overall Study|Protocol deviation|1|||
105717744|NCT01948830|364625054|FG001|Overall Study|Protocol deviation|2|||
105717745|NCT01948830|364625053|FG000|Overall Study|Lost to Follow-up|5|||
105717746|NCT01948830|364625054|FG001|Overall Study|Lost to Follow-up|4|||
105717747|NCT01948830|364625053|FG000|Overall Study|Withdrawal by Subject|14|||
105717748|NCT01948830|364625054|FG001|Overall Study|Withdrawal by Subject|17|||
105717749|NCT01948830|364625053|FG000|Overall Study|Adverse Event|9|||
105717750|NCT01948830|364625054|FG001|Overall Study|Adverse Event|2|||
105717751|NCT01948830|364625053|FG000|Overall Study|Death|3|||
105717752|NCT01948830|364625054|FG001|Overall Study|Death|4|||
105717753|NCT03969888|364625055|FG000|Overall Study|Never Received Study Drug|0|||
105717754|NCT03969888|364625056|FG001|Overall Study|Never Received Study Drug|0|||
105717755|NCT03969888|364625057|FG002|Overall Study|Never Received Study Drug|1|||
105717756|NCT03969888|364625058|FG003|Overall Study|Never Received Study Drug|0|||
105717757|NCT03969888|364625059|FG004|Overall Study|Never Received Study Drug|0|||
105717758|NCT03969888|364625060|FG005|Overall Study|Never Received Study Drug|0|||
105717759|NCT03969888|364625061|FG006|Overall Study|Never Received Study Drug|1|||
105717760|NCT03969888|364625062|FG007|Overall Study|Never Received Study Drug|0|||
105717761|NCT03969888|364625055|FG000|Overall Study|Reason Not Specified|0|||
105717762|NCT03969888|364625056|FG001|Overall Study|Reason Not Specified|0|||
105717763|NCT03969888|364625057|FG002|Overall Study|Reason Not Specified|0|||
105717764|NCT03969888|364625058|FG003|Overall Study|Reason Not Specified|0|||
105932532|NCT03197935|365412458|FG001|Overall Study|Physician Decision|1|||
105932533|NCT03197935|365412457|FG000|Overall Study|Withdrawal by Subject|16|||
105932534|NCT03197935|365412458|FG001|Overall Study|Withdrawal by Subject|8|||
105932535|NCT01502072|365412459|FG000|Overall Study|Withdrawal by Subject|1|||
105932536|NCT01502072|365412460|FG001|Overall Study|Withdrawal by Subject|0|||
105932537|NCT01502072|365412461|FG002|Overall Study|Withdrawal by Subject|0|||
105932538|NCT01502072|365412459|FG000|Overall Study|Death|0|||
105932539|NCT01502072|365412460|FG001|Overall Study|Death|1|||
105932540|NCT01502072|365412461|FG002|Overall Study|Death|0|||
105932541|NCT00899847|365412465|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
105932542|NCT02287025|365412466|FG000|Overall Study|Not treated|2|||
105932543|NCT02287025|365412467|FG001|Overall Study|Not treated|0|||
105932544|NCT02287025|365412466|FG000|Overall Study|Progression of disease|3|||
105717765|NCT03969888|364625059|FG004|Overall Study|Reason Not Specified|0|||
105717766|NCT03969888|364625060|FG005|Overall Study|Reason Not Specified|0|||
105717767|NCT03969888|364625061|FG006|Overall Study|Reason Not Specified|0|||
105717768|NCT03969888|364625062|FG007|Overall Study|Reason Not Specified|1|||
105717769|NCT02867761|364625065|FG000|Overall Study|Participant withdrawn by investigator|0|||
105717770|NCT02867761|364625066|FG001|Overall Study|Participant withdrawn by investigator|1|||
105717771|NCT02867761|364625065|FG000|Overall Study|Lost to Follow-up|25|||
105717772|NCT02867761|364625066|FG001|Overall Study|Lost to Follow-up|18|||
105717773|NCT02867761|364625065|FG000|Overall Study|Unable to complete protocol|3|||
105717774|NCT02867761|364625066|FG001|Overall Study|Unable to complete protocol|7|||
105717775|NCT01931059|364625067|FG000|Day 1|Pregnancy|0|||
105932545|NCT02287025|365412467|FG001|Overall Study|Progression of disease|2|||
105717776|NCT01931059|364625068|FG001|Day 1|Pregnancy|1|||
105717777|NCT01931059|364625067|FG000|Day3|Lost to Follow-up|1|||
105717778|NCT01931059|364625068|FG001|Day3|Lost to Follow-up|0|||
105717779|NCT02440581|364625069|FG000|Overall Study|Death|0|||
105717780|NCT02440581|364625070|FG001|Overall Study|Death|0|||
105717781|NCT02440581|364625071|FG002|Overall Study|Death|7|||
105717782|NCT02440581|364625072|FG003|Overall Study|Death|5|||
105717783|NCT02440581|364625069|FG000|Overall Study|Transplanted|1|||
105717784|NCT02440581|364625070|FG001|Overall Study|Transplanted|0|||
105717785|NCT02440581|364625071|FG002|Overall Study|Transplanted|3|||
105717786|NCT02440581|364625072|FG003|Overall Study|Transplanted|2|||
105717787|NCT02440581|364625069|FG000|Overall Study|Withdrawal by Subject|4|||
105717788|NCT02440581|364625070|FG001|Overall Study|Withdrawal by Subject|11|||
105717789|NCT02440581|364625071|FG002|Overall Study|Withdrawal by Subject|3|||
105717790|NCT02440581|364625072|FG003|Overall Study|Withdrawal by Subject|7|||
105717791|NCT00787787|364625073|FG000|Overall Study|Lack of Efficacy|4|||
105717792|NCT00787787|364625073|FG000|Overall Study|Adverse Event|3|||
105717793|NCT03828487|364625074|FG000|Overall Study|Physician Decision|1|||
105717794|NCT01412957|364625075|FG000|Overall Study|Withdrawal by Subject|6|||
105717795|NCT01412957|364625076|FG001|Overall Study|Withdrawal by Subject|22|||
105717796|NCT01412957|364625075|FG000|Overall Study|Lost to Follow-up|7|||
105717797|NCT01412957|364625076|FG001|Overall Study|Lost to Follow-up|2|||
105717798|NCT01412957|364625075|FG000|Overall Study|Death|136|||
105717799|NCT01412957|364625076|FG001|Overall Study|Death|133|||
105717800|NCT01990261|364625078|FG000|Overall Study|Death Before Treatment Start|2|||
105717801|NCT01990261|364625078|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
105717802|NCT01990261|364625078|FG000|Overall Study|Death From other Causes|1|||
105717803|NCT01990261|364625078|FG000|Overall Study|Disease Progression (PD)|8|||
105717804|NCT01990261|364625078|FG000|Overall Study|PD Before Treatment Start|1|||
105717805|NCT01990261|364625078|FG000|Overall Study|Dossier not Approved|1|||
105717806|NCT01990261|364625078|FG000|Overall Study|Lost to Follow-up|2|||
105717807|NCT04698629|364625087|FG000|Overall Study|Adverse Event|1|||
105717808|NCT00670007|364626850|FG000|Overall Study|Drug abuse|1|||
105717809|NCT00670007|364626850|FG000|Overall Study|Lung transplant|1|||
105717810|NCT00670007|364626850|FG000|Overall Study|Travel/Vacation|1|||
105717811|NCT00670007|364626850|FG000|Overall Study|Adverse event, serious fatal|1|||
105717812|NCT00670007|364626850|FG000|Overall Study|Adverse Event|1|||
105717813|NCT00670007|364626850|FG000|Overall Study|Withdrawal by Subject|4|||
105717814|NCT01070329|364626855|FG000|Overall Study|Adverse Event|13|||
105717815|NCT01070329|364626856|FG001|Overall Study|Adverse Event|10|||
105717816|NCT01070329|364626855|FG000|Overall Study|Lost to Follow-up|22|||
105717817|NCT01070329|364626856|FG001|Overall Study|Lost to Follow-up|12|||
105717818|NCT01070329|364626855|FG000|Overall Study|Withdrawal by Subject|9|||
105717819|NCT01070329|364626856|FG001|Overall Study|Withdrawal by Subject|11|||
105717820|NCT01070329|364626855|FG000|Overall Study|Protocol Violation|3|||
105717821|NCT01070329|364626856|FG001|Overall Study|Protocol Violation|8|||
105717822|NCT01070329|364626855|FG000|Overall Study|Lack of Efficacy|2|||
105717823|NCT01070329|364626856|FG001|Overall Study|Lack of Efficacy|6|||
105717824|NCT01070329|364626855|FG000|Overall Study|Physician Decision|2|||
105717825|NCT01070329|364626856|FG001|Overall Study|Physician Decision|1|||
105717826|NCT01070329|364626855|FG000|Overall Study|Entry Criteria Not Met|1|||
105717827|NCT01070329|364626856|FG001|Overall Study|Entry Criteria Not Met|0|||
105717828|NCT01070329|364626855|FG000|Overall Study|Sponsor Decision|0|||
105717829|NCT01070329|364626856|FG001|Overall Study|Sponsor Decision|1|||
105717830|NCT00605267|364626857|FG000|Overall Study|Adverse Event|0|||
105717831|NCT00605267|364626858|FG001|Overall Study|Adverse Event|1|||
105717832|NCT00605267|364626857|FG000|Overall Study|Lack of Efficacy|1|||
105717833|NCT00605267|364626858|FG001|Overall Study|Lack of Efficacy|5|||
105717834|NCT00605267|364626857|FG000|Overall Study|Withdrawal by Subject|2|||
105717835|NCT00605267|364626858|FG001|Overall Study|Withdrawal by Subject|3|||
105717836|NCT01084551|364626860|FG000|Overall Study|Adverse Event|2|||
105717837|NCT01084551|364626861|FG001|Overall Study|Adverse Event|9|||
105717838|NCT01084551|364626862|FG002|Overall Study|Adverse Event|4|||
105717839|NCT01084551|364626860|FG000|Overall Study|Lack of Efficacy|2|||
105717840|NCT01084551|364626861|FG001|Overall Study|Lack of Efficacy|0|||
105717841|NCT01084551|364626862|FG002|Overall Study|Lack of Efficacy|1|||
105717842|NCT01084551|364626860|FG000|Overall Study|Withdrawal by Subject|2|||
105717843|NCT01084551|364626861|FG001|Overall Study|Withdrawal by Subject|1|||
105717844|NCT01084551|364626862|FG002|Overall Study|Withdrawal by Subject|0|||
105717845|NCT01084551|364626860|FG000|Overall Study|Protocol Violation|2|||
105717846|NCT01084551|364626861|FG001|Overall Study|Protocol Violation|4|||
105717847|NCT01084551|364626862|FG002|Overall Study|Protocol Violation|0|||
105717848|NCT01084551|364626860|FG000|Overall Study|Lost to Follow-up|0|||
105717849|NCT01084551|364626861|FG001|Overall Study|Lost to Follow-up|0|||
105717850|NCT01084551|364626862|FG002|Overall Study|Lost to Follow-up|3|||
105717851|NCT01084551|364626860|FG000|Overall Study|Physician Decision|1|||
105717852|NCT01084551|364626861|FG001|Overall Study|Physician Decision|0|||
105717853|NCT01084551|364626862|FG002|Overall Study|Physician Decision|0|||
105717854|NCT01705691|364626864|FG000|Overall Study|Death|1|||
105717855|NCT01705691|364626865|FG001|Overall Study|Death|2|||
106136504|NCT01835899|366157952|FG000|Overall Study|Adverse Event|0|||
106136505|NCT01835899|366157953|FG001|Overall Study|Adverse Event|0|||
106136506|NCT01835899|366157954|FG002|Overall Study|Adverse Event|1|||
105790489|NCT00807040|364887029|FG000|Overall Study|Lost to Follow-up|4|||
105790490|NCT00807040|364887030|FG001|Overall Study|Lost to Follow-up|6|||
105790491|NCT00890409|364887033|FG000|Overall Study|Lost to Follow-up|20|||
105790492|NCT00890409|364887034|FG001|Overall Study|Lost to Follow-up|21|||
105790493|NCT01067339|364887035|FG000|Overall Study|Withdrawal by Subject|6|||
105790494|NCT01067339|364887036|FG001|Overall Study|Withdrawal by Subject|5|||
105790495|NCT00244881|364887038|FG000|Overall Study|Withdrawal by Subject|3|||
105790496|NCT00077766|364887039|FG000|Overall Study|Adverse Event|1|||
105790497|NCT00077766|364887040|FG001|Overall Study|Adverse Event|1|||
105790498|NCT00077766|364887039|FG000|Overall Study|Withdrawal by Subject|4|||
105790499|NCT00077766|364887040|FG001|Overall Study|Withdrawal by Subject|3|||
105790500|NCT00077766|364887039|FG000|Overall Study|Death|12|||
105790501|NCT00077766|364887040|FG001|Overall Study|Death|10|||
105790502|NCT00077766|364887039|FG000|Overall Study|Lost to Follow-up|2|||
105790503|NCT00077766|364887040|FG001|Overall Study|Lost to Follow-up|0|||
105790504|NCT00077766|364887039|FG000|Overall Study|Protocol Violation|1|||
105932546|NCT02287025|365412466|FG000|Overall Study|Adverse Event|2|||
105932547|NCT02287025|365412467|FG001|Overall Study|Adverse Event|4|||
105932548|NCT02287025|365412466|FG000|Overall Study|Withdrawal by Subject|2|||
105932549|NCT02287025|365412467|FG001|Overall Study|Withdrawal by Subject|2|||
105932550|NCT02287025|365412466|FG000|Overall Study|Screening failed|1|||
105932551|NCT02287025|365412467|FG001|Overall Study|Screening failed|1|||
105932552|NCT00122187|365412468|FG000|Overall Study|Withdrew because of resource limitations|2|||
105932553|NCT00122187|365412469|FG001|Overall Study|Withdrew because of resource limitations|2|||
105932554|NCT00799864|365412472|FG000|Overall Study|Participant reached a virologic endpoint|9|||
105932555|NCT00799864|365412473|FG001|Overall Study|Participant reached a virologic endpoint|2|||
105932556|NCT00799864|365412474|FG002|Overall Study|Participant reached a virologic endpoint|2|||
105932557|NCT00799864|365412475|FG003|Overall Study|Participant reached a virologic endpoint|0|||
105932558|NCT00799864|365412476|FG004|Overall Study|Participant reached a virologic endpoint|0|||
105932559|NCT00799864|365412472|FG000|Overall Study|Other|2|||
106136507|NCT01835899|366157952|FG000|Overall Study|Other than stated above|0|||
106136508|NCT01835899|366157953|FG001|Overall Study|Other than stated above|1|||
106136509|NCT01835899|366157954|FG002|Overall Study|Other than stated above|0|||
106136510|NCT03235349|366157955|FG000|Overall Study|Adverse Event|1|||
106136511|NCT03235349|366157955|FG000|Overall Study|Other|1|||
106136512|NCT03643211|366157957|FG000|Overall Study|Contract violation/deficiency|12|||
105717856|NCT01705691|364626864|FG000|Overall Study|Withdrawal by Subject|1|||
105717857|NCT01705691|364626865|FG001|Overall Study|Withdrawal by Subject|2|||
105717858|NCT01705691|364626864|FG000|Overall Study|Lost to Follow-up|1|||
105717859|NCT01705691|364626865|FG001|Overall Study|Lost to Follow-up|1|||
105717860|NCT01705691|364626864|FG000|Overall Study|Other|0|||
105717861|NCT01705691|364626865|FG001|Overall Study|Other|1|||
105717862|NCT00841763|364626866|FG000|Overall Study|Withdrawal by Subject|60|||
105717863|NCT00841763|364626867|FG001|Overall Study|Withdrawal by Subject|17|||
105717864|NCT00841763|364626868|FG002|Overall Study|Withdrawal by Subject|4|||
105717865|NCT00841763|364626869|FG003|Overall Study|Withdrawal by Subject|1|||
105717866|NCT00841763|364626866|FG000|Overall Study|Adverse Event|9|||
105717867|NCT00841763|364626867|FG001|Overall Study|Adverse Event|10|||
105717868|NCT00841763|364626868|FG002|Overall Study|Adverse Event|3|||
105717869|NCT00841763|364626869|FG003|Overall Study|Adverse Event|2|||
105717870|NCT00841763|364626866|FG000|Overall Study|Lost to Follow-up|63|||
105717871|NCT00841763|364626867|FG001|Overall Study|Lost to Follow-up|25|||
105717872|NCT00841763|364626868|FG002|Overall Study|Lost to Follow-up|0|||
105717873|NCT00841763|364626869|FG003|Overall Study|Lost to Follow-up|0|||
105717874|NCT00841763|364626866|FG000|Overall Study|Protocol Violation|20|||
105717875|NCT00841763|364626867|FG001|Overall Study|Protocol Violation|3|||
105717876|NCT00841763|364626868|FG002|Overall Study|Protocol Violation|1|||
105717877|NCT00841763|364626869|FG003|Overall Study|Protocol Violation|0|||
105717878|NCT00841763|364626866|FG000|Overall Study|Administrative Reasons|3|||
105717879|NCT00841763|364626867|FG001|Overall Study|Administrative Reasons|1|||
105717880|NCT00841763|364626868|FG002|Overall Study|Administrative Reasons|0|||
105717881|NCT00841763|364626869|FG003|Overall Study|Administrative Reasons|0|||
105717882|NCT00841763|364626866|FG000|Overall Study|Unable to Classify|7|||
105717883|NCT00841763|364626867|FG001|Overall Study|Unable to Classify|1|||
105717884|NCT00841763|364626868|FG002|Overall Study|Unable to Classify|0|||
105717885|NCT00841763|364626869|FG003|Overall Study|Unable to Classify|0|||
105717886|NCT01482910|364626870|FG000|Overall Study|Adverse Event|6|||
105717887|NCT01482910|364626871|FG001|Overall Study|Adverse Event|5|||
105790505|NCT00077766|364887040|FG001|Overall Study|Protocol Violation|0|||
105717888|NCT01482910|364626870|FG000|Overall Study|Lost to Follow-up|0|||
105717889|NCT01482910|364626871|FG001|Overall Study|Lost to Follow-up|1|||
105717890|NCT01482910|364626870|FG000|Overall Study|Protocol Violation|1|||
105790506|NCT00077766|364887039|FG000|Overall Study|Kidney Transplantation|9|||
105932560|NCT00799864|365412473|FG001|Overall Study|Other|1|||
106136513|NCT03643211|366157957|FG000|Overall Study|Invalid registration|3|||
106008703|NCT01844986|365697069|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
106008704|NCT01844986|365697070|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
106008705|NCT01844986|365697069|FG000|Overall Study (Global Cohort)|Death|55|||
106008706|NCT01844986|365697070|FG001|Overall Study (Global Cohort)|Death|26|||
106008707|NCT01844986|365697069|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
106008708|NCT01844986|365697070|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
106008709|NCT01844986|365697069|FG000|Overall Study (China Cohort)|Death|10|||
106008710|NCT01844986|365697070|FG001|Overall Study (China Cohort)|Death|6|||
106008711|NCT02994108|365698951|FG000|Intervention Messages|Withdrawal by Subject|2|||
106008712|NCT02994108|365698952|FG001|Intervention Messages|Withdrawal by Subject|0|||
106008713|NCT02994108|365698951|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
106008714|NCT02994108|365698952|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
106008715|NCT02994108|365698951|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
106008716|NCT02994108|365698952|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
106008717|NCT02994108|365698951|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
106008718|NCT02994108|365698952|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
106008719|NCT00079417|365698953|FG000|Overall Study|Physician Decision|2|||
106008720|NCT00079417|365698953|FG000|Overall Study|Ineligible|7|||
106008721|NCT00385671|365698954|FG000|Overall Study|Adverse Event|14|||
106008722|NCT00385671|365698955|FG001|Overall Study|Adverse Event|27|||
106008723|NCT00385671|365698956|FG002|Overall Study|Adverse Event|18|||
106008724|NCT00385671|365698954|FG000|Overall Study|Lack of Efficacy|5|||
105790507|NCT00077766|364887040|FG001|Overall Study|Kidney Transplantation|5|||
105790508|NCT00077766|364887039|FG000|Overall Study|Transplantation|5|||
105790509|NCT00077766|364887040|FG001|Overall Study|Transplantation|1|||
105790510|NCT00077766|364887039|FG000|Overall Study|Investigators Discretion|1|||
105790511|NCT00077766|364887040|FG001|Overall Study|Investigators Discretion|0|||
106008725|NCT00385671|365698955|FG001|Overall Study|Lack of Efficacy|9|||
106008726|NCT00385671|365698956|FG002|Overall Study|Lack of Efficacy|5|||
106008727|NCT00385671|365698954|FG000|Overall Study|Lost to Follow-up|6|||
106008728|NCT00385671|365698955|FG001|Overall Study|Lost to Follow-up|6|||
106136514|NCT03643211|366157957|FG000|Overall Study|No treatment information|2|||
106136515|NCT03643211|366157957|FG000|Overall Study|No adverse event information - No revisit|4|||
105717891|NCT01482910|364626871|FG001|Overall Study|Protocol Violation|1|||
105717892|NCT01482910|364626870|FG000|Overall Study|Withdrawal by Subject|7|||
105717893|NCT01482910|364626871|FG001|Overall Study|Withdrawal by Subject|2|||
105717894|NCT01482910|364626870|FG000|Overall Study|Death|1|||
105717895|NCT01482910|364626871|FG001|Overall Study|Death|0|||
105717896|NCT03370770|364626873|FG000|Overall Study|Patient was followed in another hospital center|1|||
105717897|NCT03370770|364626873|FG000|Overall Study|Progressive Disease|98|||
105717898|NCT03370770|364626873|FG000|Overall Study|Adverse Event|2|||
105717899|NCT03370770|364626873|FG000|Overall Study|Death|5|||
105717900|NCT04067518|364626874|FG000|Overall Study|Adverse Event|1|||
105717901|NCT04067518|364626875|FG001|Overall Study|Adverse Event|3|||
105717902|NCT04067518|364626874|FG000|Overall Study|Screen failures|0|||
105717903|NCT04067518|364626875|FG001|Overall Study|Screen failures|1|||
105717904|NCT04067518|364626874|FG000|Overall Study|Enrolled but not treated|0|||
105717905|NCT04067518|364626875|FG001|Overall Study|Enrolled but not treated|1|||
105717906|NCT00110019|364626876|FG000|Overall Study|Lack of Efficacy|253|||
105717907|NCT00110019|364626877|FG001|Overall Study|Lack of Efficacy|285|||
105717908|NCT00110019|364626876|FG000|Overall Study|Adverse Event|61|||
105717909|NCT00110019|364626877|FG001|Overall Study|Adverse Event|40|||
105790512|NCT00077766|364887039|FG000|Overall Study|Participant's decision|1|||
105790513|NCT00077766|364887040|FG001|Overall Study|Participant's decision|0|||
105790514|NCT00077766|364887039|FG000|Overall Study|Dialysis Discontinued|1|||
105790515|NCT00077766|364887040|FG001|Overall Study|Dialysis Discontinued|0|||
105790516|NCT00077766|364887039|FG000|Overall Study|Dialysis|0|||
105932561|NCT00799864|365412474|FG002|Overall Study|Other|0|||
105932562|NCT00799864|365412475|FG003|Overall Study|Other|0|||
105932563|NCT00799864|365412476|FG004|Overall Study|Other|0|||
105932564|NCT00756444|365412477|FG000|Overall Study|Adverse Event|1|||
105932565|NCT00756444|365412478|FG001|Overall Study|Adverse Event|1|||
105932566|NCT00756444|365412477|FG000|Overall Study|Withdrawal by Subject|6|||
105932567|NCT00756444|365412478|FG001|Overall Study|Withdrawal by Subject|8|||
105932568|NCT00756444|365412477|FG000|Overall Study|Lost to Follow-up|0|||
106008729|NCT00385671|365698956|FG002|Overall Study|Lost to Follow-up|5|||
106008730|NCT00385671|365698954|FG000|Overall Study|Physician Decision|2|||
106008731|NCT00385671|365698955|FG001|Overall Study|Physician Decision|1|||
106008732|NCT00385671|365698956|FG002|Overall Study|Physician Decision|2|||
106008733|NCT00385671|365698954|FG000|Overall Study|Protocol Violation|5|||
106008734|NCT00385671|365698955|FG001|Overall Study|Protocol Violation|2|||
106008735|NCT00385671|365698956|FG002|Overall Study|Protocol Violation|1|||
105717910|NCT00110019|364626876|FG000|Overall Study|Death|13|||
105717911|NCT00110019|364626877|FG001|Overall Study|Death|15|||
105717912|NCT00110019|364626876|FG000|Overall Study|Withdrawal by Subject|21|||
105790517|NCT00077766|364887040|FG001|Overall Study|Dialysis|1|||
105932569|NCT00756444|365412478|FG001|Overall Study|Lost to Follow-up|1|||
105932570|NCT00756444|365412477|FG000|Overall Study|Death|5|||
105717913|NCT00110019|364626877|FG001|Overall Study|Withdrawal by Subject|9|||
105717914|NCT00110019|364626876|FG000|Overall Study|alternative therapy|5|||
105932571|NCT00756444|365412478|FG001|Overall Study|Death|4|||
105932572|NCT00756444|365412477|FG000|Overall Study|Disease Progression|2|||
105932573|NCT00756444|365412478|FG001|Overall Study|Disease Progression|7|||
105932574|NCT00756444|365412477|FG000|Overall Study|Ineligibility Determined|1|||
105932575|NCT00756444|365412478|FG001|Overall Study|Ineligibility Determined|0|||
105932576|NCT00564070|365412479|FG000|Overall Study|Lost to Follow-up|9|||
105932577|NCT00564070|365412480|FG001|Overall Study|Lost to Follow-up|7|||
105932578|NCT00564070|365412479|FG000|Overall Study|Worsening depression, referred to care|3|||
105932579|NCT00564070|365412480|FG001|Overall Study|Worsening depression, referred to care|0|||
105932580|NCT02346370|365412481|FG000|Overall Study|Not treated|1|||
105717915|NCT00110019|364626877|FG001|Overall Study|alternative therapy|1|||
105717916|NCT00110019|364626876|FG000|Overall Study|complicating disease|1|||
105717917|NCT00110019|364626877|FG001|Overall Study|complicating disease|1|||
105717918|NCT00110019|364626876|FG000|Overall Study|symptom deterioration|13|||
105717919|NCT00110019|364626877|FG001|Overall Study|symptom deterioration|16|||
105717920|NCT00110019|364626876|FG000|Overall Study|Not start protocol therapy|17|||
105717921|NCT00110019|364626877|FG001|Overall Study|Not start protocol therapy|16|||
105717922|NCT00110019|364626876|FG000|Overall Study|other reasons|22|||
105717923|NCT00110019|364626877|FG001|Overall Study|other reasons|30|||
105717924|NCT05655377|364626880|FG000|Overall Study|Withdrawal by Subject|2|||
105717925|NCT01109940|364626882|FG000|Overall Study|Administrative problems|2|||
105717926|NCT01109940|364626883|FG001|Overall Study|Administrative problems|0|||
105717927|NCT01109940|364626884|FG002|Overall Study|Administrative problems|0|||
105790518|NCT00077766|364887039|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
105932581|NCT02346370|365412482|FG001|Overall Study|Not treated|0|||
105932582|NCT02346370|365412483|FG002|Overall Study|Not treated|0|||
105932583|NCT02346370|365412481|FG000|Overall Study|Withdrawal of consent|1|||
105932584|NCT02346370|365412482|FG001|Overall Study|Withdrawal of consent|0|||
105932585|NCT02346370|365412483|FG002|Overall Study|Withdrawal of consent|0|||
105932586|NCT02346370|365412481|FG000|Overall Study|Death|1|||
105932587|NCT02346370|365412482|FG001|Overall Study|Death|3|||
105932588|NCT02346370|365412483|FG002|Overall Study|Death|1|||
105932589|NCT02346370|365412481|FG000|Overall Study|Sponsor discontinued study|5|||
105932590|NCT02346370|365412482|FG001|Overall Study|Sponsor discontinued study|0|||
105932591|NCT02346370|365412483|FG002|Overall Study|Sponsor discontinued study|2|||
105932592|NCT02346370|365412481|FG000|Overall Study|Radiologic progression|0|||
105932593|NCT02346370|365412482|FG001|Overall Study|Radiologic progression|0|||
105932594|NCT02346370|365412483|FG002|Overall Study|Radiologic progression|1|||
105932595|NCT02346370|365412481|FG000|Overall Study|Physician Decision|0|||
105932596|NCT02346370|365412482|FG001|Overall Study|Physician Decision|1|||
105932597|NCT02346370|365412483|FG002|Overall Study|Physician Decision|0|||
105932598|NCT03528577|365412484|FG000|Sequence 1|Failed Spirometry|1|||
105932599|NCT03528577|365412484|FG000|Sequence 1|Restricted medication|1|||
105932600|NCT03528577|365412484|FG000|Sequence 2|Adverse Event|1|||
105932601|NCT03528577|365412484|FG000|Sequence 2|Withdrawal by Subject|1|||
105932602|NCT03528577|365412484|FG000|Sequence 2|Failed Spirometry|1|||
105932603|NCT03528577|365412484|FG000|Sequence 3|Failed Spirometry|1|||
105932604|NCT03528577|365412484|FG000|Sequence 4|Failed Spirometry|2|||
105932605|NCT03528577|365412484|FG000|Sequence 4|Adverse Event|1|||
105932606|NCT04098302|365412485|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
105932607|NCT04098302|365412486|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
105932608|NCT04098302|365412487|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
105932609|NCT04098302|365412488|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
105932610|NCT04098302|365412485|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
105932611|NCT04098302|365412486|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
105932612|NCT04098302|365412487|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
105932613|NCT04098302|365412488|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
105932614|NCT04098302|365412485|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
105932615|NCT04098302|365412486|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
105932616|NCT04098302|365412487|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
105790519|NCT00077766|364887040|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
105790520|NCT00077766|364887039|FG000|Overall Study|Started Nocturnal Dialysis|0|||
105717928|NCT01109940|364626885|FG003|Overall Study|Administrative problems|0|||
105790521|NCT00077766|364887040|FG001|Overall Study|Started Nocturnal Dialysis|1|||
105932617|NCT04098302|365412488|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
105932618|NCT04098302|365412485|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
105717929|NCT01109940|364626882|FG000|Overall Study|Serious Adverse Event|2|||
105717930|NCT01109940|364626883|FG001|Overall Study|Serious Adverse Event|1|||
105717931|NCT01109940|364626884|FG002|Overall Study|Serious Adverse Event|0|||
105932619|NCT04098302|365412486|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
105932620|NCT04098302|365412487|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
105717932|NCT01109940|364626885|FG003|Overall Study|Serious Adverse Event|0|||
105717933|NCT01109940|364626882|FG000|Overall Study|Lost to Follow-up|1|||
105717934|NCT01109940|364626883|FG001|Overall Study|Lost to Follow-up|0|||
105717935|NCT01109940|364626884|FG002|Overall Study|Lost to Follow-up|0|||
105717936|NCT01109940|364626885|FG003|Overall Study|Lost to Follow-up|0|||
105717937|NCT01109940|364626882|FG000|Overall Study|Patient withdrew consent|1|||
105717938|NCT01109940|364626883|FG001|Overall Study|Patient withdrew consent|1|||
105717939|NCT01109940|364626884|FG002|Overall Study|Patient withdrew consent|0|||
105717940|NCT01109940|364626885|FG003|Overall Study|Patient withdrew consent|0|||
105717941|NCT01109940|364626882|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105717942|NCT01109940|364626883|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105717943|NCT01109940|364626884|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
105717944|NCT01109940|364626885|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105717945|NCT01552681|364626888|FG000|Overall Study|Withdrawal by Subject|4|||
105717946|NCT01552681|364626889|FG001|Overall Study|Withdrawal by Subject|0|||
105932621|NCT04098302|365412488|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
105932622|NCT04098302|365412485|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
105932623|NCT04098302|365412486|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
105932624|NCT04098302|365412487|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
105932625|NCT04098302|365412488|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
105932626|NCT04098302|365412485|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
105932627|NCT04098302|365412486|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
105932628|NCT04098302|365412487|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
105932629|NCT04098302|365412488|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
105932630|NCT04098302|365412485|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
105932631|NCT04098302|365412486|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
105932632|NCT04098302|365412487|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
105932633|NCT04098302|365412488|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
105932634|NCT04098302|365412485|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
105932635|NCT04098302|365412486|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
105932636|NCT04098302|365412487|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
105932637|NCT04098302|365412488|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
105932638|NCT05061706|365412489|FG000|Overall Study|Adverse Event|29|||
105932639|NCT05061706|365412490|FG001|Overall Study|Adverse Event|1|||
105932640|NCT05061706|365412489|FG000|Overall Study|Lack of Efficacy|0|||
105932641|NCT05061706|365412490|FG001|Overall Study|Lack of Efficacy|1|||
105932642|NCT05061706|365412489|FG000|Overall Study|Lost to Follow-up|2|||
105932643|NCT05061706|365412490|FG001|Overall Study|Lost to Follow-up|2|||
105932644|NCT05061706|365412489|FG000|Overall Study|Protocol Violation|3|||
105932645|NCT05061706|365412490|FG001|Overall Study|Protocol Violation|1|||
105932646|NCT05061706|365412489|FG000|Overall Study|Withdrawal by Subject|3|||
105932647|NCT05061706|365412490|FG001|Overall Study|Withdrawal by Subject|9|||
105932648|NCT00724893|365412492|FG000|Overall Study|Adverse Event|76|||
105932649|NCT00724893|365412493|FG001|Overall Study|Adverse Event|142|||
105932650|NCT00724893|365412492|FG000|Overall Study|Withdrawal by Subject|0|||
105932651|NCT00724893|365412493|FG001|Overall Study|Withdrawal by Subject|1|||
105932652|NCT00724893|365412492|FG000|Overall Study|Lack of virologic response|94|||
105932653|NCT00724893|365412493|FG001|Overall Study|Lack of virologic response|202|||
105932654|NCT00724893|365412492|FG000|Overall Study|Reason not specified|193|||
105932655|NCT00724893|365412493|FG001|Overall Study|Reason not specified|7|||
105932656|NCT00724893|365412492|FG000|Overall Study|Patient choice|0|||
105932657|NCT00724893|365412493|FG001|Overall Study|Patient choice|26|||
105932658|NCT00724893|365412492|FG000|Overall Study|Geographic reasons|0|||
105932659|NCT00724893|365412493|FG001|Overall Study|Geographic reasons|11|||
105932660|NCT00724893|365412492|FG000|Overall Study|Incarceration|0|||
105932661|NCT00724893|365412493|FG001|Overall Study|Incarceration|9|||
105932662|NCT00724893|365412492|FG000|Overall Study|Substance abuse|0|||
105932663|NCT00724893|365412493|FG001|Overall Study|Substance abuse|3|||
105932664|NCT00724893|365412492|FG000|Overall Study|Financial reasons|0|||
105932665|NCT00724893|365412493|FG001|Overall Study|Financial reasons|2|||
105932666|NCT00724893|365412492|FG000|Overall Study|Assigned shorter treatment|0|||
106008736|NCT00385671|365698954|FG000|Overall Study|Sponsor Decision|2|||
105717947|NCT01552681|364626888|FG000|Overall Study|Physician Decision|1|||
105717948|NCT01552681|364626889|FG001|Overall Study|Physician Decision|0|||
105932667|NCT00724893|365412493|FG001|Overall Study|Assigned shorter treatment|2|||
105932668|NCT00724893|365412492|FG000|Overall Study|Lost to Follow-up|0|||
105932669|NCT00724893|365412493|FG001|Overall Study|Lost to Follow-up|52|||
105932670|NCT00724893|365412492|FG000|Overall Study|Unknown, missing data|1|||
105717949|NCT01552681|364626888|FG000|Overall Study|Subject moved away|0|||
105717950|NCT01552681|364626889|FG001|Overall Study|Subject moved away|1|||
105717951|NCT00849667|364626899|FG000|Overall Study|Withdrawal by Subject|16|||
105932671|NCT00724893|365412493|FG001|Overall Study|Unknown, missing data|1|||
105932672|NCT01290731|365412496|FG000|Overall Study|Withdrawal by Subject|1|||
105932673|NCT01279200|365412498|FG000|Overall Study|Withdrawal by Subject|1|||
105932674|NCT01279200|365412499|FG001|Overall Study|Withdrawal by Subject|3|||
105717952|NCT00849667|364626900|FG001|Overall Study|Withdrawal by Subject|33|||
105717953|NCT00849667|364626901|FG002|Overall Study|Withdrawal by Subject|35|||
105717954|NCT00849667|364626899|FG000|Overall Study|Lost to Follow-up|8|||
105717955|NCT00849667|364626900|FG001|Overall Study|Lost to Follow-up|8|||
105717956|NCT00849667|364626901|FG002|Overall Study|Lost to Follow-up|8|||
105717957|NCT00849667|364626899|FG000|Overall Study|Adverse Event|1|||
105717958|NCT00849667|364626900|FG001|Overall Study|Adverse Event|2|||
105717959|NCT00849667|364626901|FG002|Overall Study|Adverse Event|0|||
105717960|NCT00849667|364626899|FG000|Overall Study|Other|18|||
105717961|NCT00849667|364626900|FG001|Overall Study|Other|19|||
105717962|NCT00849667|364626901|FG002|Overall Study|Other|18|||
105717963|NCT00849667|364626899|FG000|Overall Study|Progressive disease|119|||
105717964|NCT00849667|364626900|FG001|Overall Study|Progressive disease|100|||
105717965|NCT00849667|364626901|FG002|Overall Study|Progressive disease|112|||
105717966|NCT00849667|364626899|FG000|Overall Study|Sponsor decision|208|||
105717967|NCT00849667|364626900|FG001|Overall Study|Sponsor decision|204|||
105717968|NCT00849667|364626901|FG002|Overall Study|Sponsor decision|190|||
105717969|NCT00849667|364626899|FG000|Overall Study|Investigator discretion|0|||
105717970|NCT00849667|364626900|FG001|Overall Study|Investigator discretion|0|||
105717971|NCT00849667|364626901|FG002|Overall Study|Investigator discretion|1|||
105932675|NCT01279200|365412498|FG000|Overall Study|Patient withdrawal due to high cost|0|||
105932676|NCT01279200|365412499|FG001|Overall Study|Patient withdrawal due to high cost|1|||
105932677|NCT01279200|365412498|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
105932678|NCT01279200|365412499|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
105932679|NCT01279200|365412498|FG000|Overall Study|ultrasound screening failure|0|||
105932680|NCT01279200|365412499|FG001|Overall Study|ultrasound screening failure|1|||
105932681|NCT01279200|365412498|FG000|Overall Study|Lost to Follow-up|0|||
105932682|NCT01279200|365412499|FG001|Overall Study|Lost to Follow-up|1|||
105932683|NCT01279200|365412498|FG000|Overall Study|Adverse Event|1|||
105932684|NCT01279200|365412499|FG001|Overall Study|Adverse Event|0|||
105932685|NCT01399099|365412500|FG000|Overall Study|Lost to Follow-up|14|||
105717972|NCT00553462|364626905|FG000|Overall Study|Adverse Event|4|||
105717973|NCT00553462|364626905|FG000|Overall Study|Progression|4|||
105717974|NCT00553462|364626905|FG000|Overall Study|Withdrawal by Subject|5|||
105717975|NCT00553462|364626905|FG000|Overall Study|Physician Decision|1|||
105717976|NCT01728779|364626906|FG000|Overall Study|Withdrawal by Subject|1|||
105717977|NCT00624520|364626907|FG000|Overall Study|Withdrawal by Subject|12|||
105717978|NCT00624520|364626908|FG001|Overall Study|Withdrawal by Subject|7|||
105717979|NCT00624520|364626907|FG000|Overall Study|Death|0|||
105717980|NCT00624520|364626908|FG001|Overall Study|Death|1|||
105717981|NCT02796755|364626909|FG000|Overall Study|Adverse Event|2|||
105717982|NCT02796755|364626910|FG001|Overall Study|Adverse Event|0|||
105717983|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
105717984|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
105717985|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Death|1|||
105717986|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Death|0|||
105932686|NCT01399099|365412500|FG000|Overall Study|Physician Decision|1|||
105932687|NCT01399099|365412500|FG000|Overall Study|Protocol Violation|1|||
105932688|NCT01399099|365412500|FG000|Overall Study|Skin Irritation|13|||
105932689|NCT01399099|365412500|FG000|Overall Study|Infection|1|||
105932690|NCT01399099|365412500|FG000|Overall Study|Miscellaneous|4|||
105932691|NCT01668537|365412502|FG000|Overall Study|Request to Discontinue Prematurely|1|||
105932692|NCT01668537|365412503|FG001|Overall Study|Request to Discontinue Prematurely|1|||
105932693|NCT01668537|365412502|FG000|Overall Study|Subject unwilling/unable to comply|5|||
105932694|NCT01668537|365412503|FG001|Overall Study|Subject unwilling/unable to comply|0|||
105932695|NCT01668537|365412502|FG000|Overall Study|Reason Precludes Participation|1|||
105932696|NCT01668537|365412503|FG001|Overall Study|Reason Precludes Participation|0|||
105932697|NCT01668537|365412502|FG000|Overall Study|Lost to Follow-up|13|||
105932698|NCT01668537|365412503|FG001|Overall Study|Lost to Follow-up|6|||
105932699|NCT01668537|365412502|FG000|Overall Study|Other|2|||
105932700|NCT01668537|365412503|FG001|Overall Study|Other|3|||
105932701|NCT01936974|365412505|FG000|Overall Study|Physician Decision|2|||
105932702|NCT01936974|365412506|FG001|Overall Study|Physician Decision|5|||
105932703|NCT01078545|365412509|FG000|Overall Study|Lost to Follow-up|13|||
105932704|NCT01078545|365412509|FG000|Overall Study|Physician Decision|6|||
105932705|NCT01078545|365412509|FG000|Overall Study|Withdrawal by Subject|3|||
105932706|NCT01078545|365412509|FG000|Overall Study|Death|3|||
105932707|NCT01078545|365412509|FG000|Overall Study|Participant moved to another physician|1|||
105790522|NCT00077766|364887039|FG000|Overall Study|Stop Dialysis|0|||
105932708|NCT02280499|365412515|FG000|Overall Study|Death|14|||
105932709|NCT02280499|365412515|FG000|Overall Study|Lost to Follow-up|42|||
105932710|NCT02280499|365412515|FG000|Overall Study|Adverse Event|5|||
105932711|NCT04000724|365412521|FG000|Overall Study|Withdrawal by Subject|5|||
105932712|NCT04000724|365412522|FG001|Overall Study|Withdrawal by Subject|3|||
105932713|NCT04000724|365412523|FG002|Overall Study|Withdrawal by Subject|4|||
105932714|NCT04000724|365412521|FG000|Overall Study|Lost to Follow-up|11|||
105932715|NCT04000724|365412522|FG001|Overall Study|Lost to Follow-up|7|||
105932716|NCT04000724|365412523|FG002|Overall Study|Lost to Follow-up|13|||
105717987|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
105790523|NCT00077766|364887040|FG001|Overall Study|Stop Dialysis|1|||
105790524|NCT00077766|364887039|FG000|Overall Study|Participants Vacation|2|||
105790525|NCT00077766|364887040|FG001|Overall Study|Participants Vacation|1|||
105790526|NCT02335411|364887041|FG000|Overall Study|Death|223|||
105790527|NCT02335411|364887042|FG001|Overall Study|Death|22|||
105790528|NCT02335411|364887043|FG002|Overall Study|Death|26|||
105790529|NCT02335411|364887041|FG000|Overall Study|Physician Decision|3|||
105790530|NCT02335411|364887042|FG001|Overall Study|Physician Decision|0|||
105790531|NCT02335411|364887043|FG002|Overall Study|Physician Decision|0|||
105790532|NCT02335411|364887041|FG000|Overall Study|Protocol Violation|1|||
105790533|NCT02335411|364887042|FG001|Overall Study|Protocol Violation|0|||
105790534|NCT02335411|364887043|FG002|Overall Study|Protocol Violation|0|||
105790535|NCT02335411|364887041|FG000|Overall Study|Withdrawal by Subject|11|||
105790536|NCT02335411|364887042|FG001|Overall Study|Withdrawal by Subject|0|||
105790537|NCT02335411|364887043|FG002|Overall Study|Withdrawal by Subject|3|||
105932717|NCT02366130|365412524|FG000|Overall Study|Withdrawal by Subject|3|||
105932718|NCT02366130|365412524|FG000|Overall Study|Ineligible|6|||
105932719|NCT00567112|365412525|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
105932720|NCT00567112|365412526|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
105932721|NCT00567112|365412527|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
105932722|NCT00567112|365412525|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
105932723|NCT00567112|365412526|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
105932724|NCT00567112|365412527|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
105932725|NCT00567112|365412525|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
105932726|NCT00567112|365412526|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
105932727|NCT00567112|365412527|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
105932728|NCT02945046|365412528|FG000|Overall Study|Adverse Event|1|||
105932729|NCT02945046|365412529|FG001|Overall Study|Adverse Event|0|||
105932730|NCT02945046|365412530|FG002|Overall Study|Adverse Event|2|||
105932731|NCT02945046|365412528|FG000|Overall Study|Withdrawal by Subject|3|||
105932732|NCT02945046|365412529|FG001|Overall Study|Withdrawal by Subject|3|||
105932733|NCT02945046|365412530|FG002|Overall Study|Withdrawal by Subject|3|||
105932734|NCT02945046|365412528|FG000|Overall Study|Protocol Violation|2|||
105932735|NCT02945046|365412529|FG001|Overall Study|Protocol Violation|3|||
105932736|NCT02945046|365412530|FG002|Overall Study|Protocol Violation|2|||
105932737|NCT02945046|365412528|FG000|Overall Study|Lost to Follow-up|1|||
105932738|NCT02945046|365412529|FG001|Overall Study|Lost to Follow-up|1|||
105932739|NCT02945046|365412530|FG002|Overall Study|Lost to Follow-up|0|||
105932740|NCT02945046|365412528|FG000|Overall Study|Lack of Efficacy|1|||
105932741|NCT02945046|365412529|FG001|Overall Study|Lack of Efficacy|2|||
105932742|NCT02945046|365412530|FG002|Overall Study|Lack of Efficacy|1|||
105932743|NCT02945046|365412528|FG000|Overall Study|Other than specified|5|||
105932744|NCT02945046|365412529|FG001|Overall Study|Other than specified|4|||
105932745|NCT02945046|365412530|FG002|Overall Study|Other than specified|7|||
105932746|NCT03113136|365412533|FG000|Overall Study|Lost to Follow-up|22|||
105932747|NCT03113136|365412534|FG001|Overall Study|Lost to Follow-up|47|||
105932748|NCT03113136|365412535|FG002|Overall Study|Lost to Follow-up|54|||
105932749|NCT03113136|365412533|FG000|Overall Study|Withdrawal by Subject|4|||
105932750|NCT03113136|365412534|FG001|Overall Study|Withdrawal by Subject|13|||
105932751|NCT03113136|365412535|FG002|Overall Study|Withdrawal by Subject|14|||
105932752|NCT03113136|365412533|FG000|Overall Study|Ineligible|0|||
105932753|NCT03113136|365412534|FG001|Overall Study|Ineligible|2|||
105932754|NCT03113136|365412535|FG002|Overall Study|Ineligible|1|||
105932755|NCT03113136|365412533|FG000|Overall Study|Study Team Decision|1|||
105932756|NCT03113136|365412534|FG001|Overall Study|Study Team Decision|4|||
105932757|NCT03113136|365412535|FG002|Overall Study|Study Team Decision|0|||
105932758|NCT00545948|365412537|FG000|Overall Study|Not Treated|1|||
105932759|NCT00545948|365412538|FG001|Overall Study|Not Treated|1|||
106136516|NCT04523181|366157959|FG000|Overall Study|Withdrawal by Subject|4|||
106136517|NCT04523181|366157960|FG001|Overall Study|Withdrawal by Subject|5|||
106136518|NCT04523181|366157959|FG000|Overall Study|Lost to Follow-up|2|||
106136519|NCT04523181|366157960|FG001|Overall Study|Lost to Follow-up|3|||
106136520|NCT04523181|366157959|FG000|Overall Study|Physician Decision|1|||
105790538|NCT02335411|364887041|FG000|Overall Study|Sponsor Decision|12|||
105790539|NCT02335411|364887042|FG001|Overall Study|Sponsor Decision|3|||
105790540|NCT02335411|364887043|FG002|Overall Study|Sponsor Decision|2|||
105790541|NCT02335411|364887041|FG000|Overall Study|Adverse Event|9|||
105790542|NCT02335411|364887042|FG001|Overall Study|Adverse Event|0|||
105932760|NCT00545948|365412539|FG002|Overall Study|Not Treated|7|||
105932761|NCT03467945|365412540|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105932762|NCT03467945|365412541|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105932763|NCT03467945|365412542|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105932764|NCT03467945|365412543|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105932765|NCT03467945|365412540|FG000|Treatment Period 3|Withdrawal by Subject|1|||
105932766|NCT03467945|365412541|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105932767|NCT03467945|365412542|FG002|Treatment Period 3|Withdrawal by Subject|2|||
105932768|NCT03467945|365412543|FG003|Treatment Period 3|Withdrawal by Subject|1|||
105932769|NCT02187055|365412546|FG000|Overall Study|Lack of Efficacy|10|||
106136521|NCT04523181|366157960|FG001|Overall Study|Physician Decision|0|||
105932770|NCT02187055|365412547|FG001|Overall Study|Lack of Efficacy|3|||
105932771|NCT02187055|365412548|FG002|Overall Study|Lack of Efficacy|7|||
105932772|NCT02187055|365412546|FG000|Overall Study|Lost to Follow-up|2|||
105932773|NCT02187055|365412547|FG001|Overall Study|Lost to Follow-up|7|||
105932774|NCT02187055|365412548|FG002|Overall Study|Lost to Follow-up|3|||
105932775|NCT02187055|365412546|FG000|Overall Study|No longer meets eligibility criteria|0|||
105932776|NCT02187055|365412547|FG001|Overall Study|No longer meets eligibility criteria|2|||
105932777|NCT02187055|365412548|FG002|Overall Study|No longer meets eligibility criteria|0|||
105932778|NCT02187055|365412546|FG000|Overall Study|No longer willing to participate|6|||
106136522|NCT04523181|366157959|FG000|Overall Study|Transferred to external facility.|1|||
106136523|NCT04523181|366157960|FG001|Overall Study|Transferred to external facility.|1|||
106136524|NCT04305912|366157964|FG000|First Intervention|COVID-19 Suspension|2|||
106136525|NCT04305912|366157965|FG001|First Intervention|COVID-19 Suspension|0|||
106136526|NCT04305912|366157964|FG000|First Intervention|Withdrawal by Subject|0|||
106136527|NCT04305912|366157965|FG001|First Intervention|Withdrawal by Subject|1|||
106136528|NCT04305912|366157964|FG000|Second Intervention|Adverse Event|0|||
106136529|NCT04305912|366157965|FG001|Second Intervention|Adverse Event|1|||
106136540|NCT05096884|366157970|FG000|Overall Study|Excluded based on negative tilt table test|4|||
106136541|NCT05824351|366157971|FG000|Overall Study|Adverse Event|6|||
106136542|NCT04678830|366157972|FG000|Overall Study|Lack of Efficacy|2|||
106136543|NCT04678830|366157973|FG001|Overall Study|Lack of Efficacy|0|||
106136544|NCT04678830|366157972|FG000|Overall Study|Withdrawal by Subject|0|||
106136545|NCT04678830|366157973|FG001|Overall Study|Withdrawal by Subject|1|||
106136546|NCT01543685|366157976|FG000|Overall Study|Lack of Efficacy|1|||
105717988|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
105717989|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
105717990|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
105717991|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
105717992|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
105717993|NCT00110994|364626911|FG000|Double-blind (DB) Treatment|other reasons|2|||
105717994|NCT00110994|364626912|FG001|Double-blind (DB) Treatment|other reasons|3|||
105717995|NCT00110994|364626911|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
105717996|NCT00110994|364626912|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
105717997|NCT00110994|364626911|FG000|Active Follow-up|Other reasons|0|||
105717998|NCT00110994|364626912|FG001|Active Follow-up|Other reasons|2|||
105717999|NCT00110994|364626911|FG000|Long Term Follow-up|Death|19|||
105718000|NCT00110994|364626912|FG001|Long Term Follow-up|Death|17|||
105718001|NCT03433781|364626913|FG000|Overall Study|Progression of Disease|1|||
105718002|NCT03433781|364626914|FG001|Overall Study|Progression of Disease|0|||
105718003|NCT03433781|364626915|FG002|Overall Study|Progression of Disease|0|||
105718004|NCT03433781|364626913|FG000|Overall Study|Physician Decision|0|||
105718005|NCT03433781|364626914|FG001|Overall Study|Physician Decision|1|||
105718006|NCT03433781|364626915|FG002|Overall Study|Physician Decision|0|||
105718007|NCT02772757|364626918|FG000|Overall Study|Withdrawal by Subject|1|||
105718008|NCT02772757|364626919|FG001|Overall Study|Withdrawal by Subject|0|||
105718009|NCT02772757|364626920|FG002|Overall Study|Withdrawal by Subject|1|||
105718010|NCT02772757|364626918|FG000|Overall Study|Protocol Violation|0|||
105718011|NCT02772757|364626919|FG001|Overall Study|Protocol Violation|0|||
105718012|NCT02772757|364626920|FG002|Overall Study|Protocol Violation|1|||
105718013|NCT02772757|364626918|FG000|Overall Study|Physician Decision|0|||
105718014|NCT02772757|364626919|FG001|Overall Study|Physician Decision|3|||
105718015|NCT02772757|364626920|FG002|Overall Study|Physician Decision|3|||
105718016|NCT04698525|364626925|FG000|Overall Study|Lost to Follow-up|1|||
105718017|NCT04698525|364626926|FG001|Overall Study|Lost to Follow-up|2|||
105718018|NCT04698525|364626925|FG000|Overall Study|Three suffered of Covid-19|2|||
105718019|NCT04698525|364626926|FG001|Overall Study|Three suffered of Covid-19|1|||
105718020|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Adverse Event|21|||
105718021|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Adverse Event|6|||
105718022|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
105718023|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
105718024|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
105718025|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
105932779|NCT02187055|365412547|FG001|Overall Study|No longer willing to participate|8|||
106136547|NCT01543685|366157977|FG001|Overall Study|Lack of Efficacy|2|||
106136548|NCT01543685|366157978|FG002|Overall Study|Lack of Efficacy|2|||
105718026|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
105718027|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
105718028|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Physician Decision|0|||
105718029|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Physician Decision|3|||
105718030|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
105718031|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
105718032|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
105718033|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
105718034|NCT00510276|364626928|FG000|Acute Double-Blind Phase|Subject Decision|26|||
105718035|NCT00510276|364626929|FG001|Acute Double-Blind Phase|Subject Decision|28|||
105718036|NCT00510276|364626928|FG000|Extension Open-Label Phase|Adverse Event|9|||
105718037|NCT00510276|364626929|FG001|Extension Open-Label Phase|Adverse Event|18|||
105718038|NCT00510276|364626928|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
105718039|NCT00510276|364626929|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
105718040|NCT00510276|364626928|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
105718041|NCT00510276|364626929|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
105718042|NCT00510276|364626928|FG000|Extension Open-Label Phase|Physician Decision|2|||
105718043|NCT00510276|364626929|FG001|Extension Open-Label Phase|Physician Decision|3|||
105718044|NCT00510276|364626928|FG000|Extension Open-Label Phase|Protocol Violation|0|||
105718045|NCT00510276|364626929|FG001|Extension Open-Label Phase|Protocol Violation|1|||
105718046|NCT00510276|364626928|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
105718047|NCT00510276|364626929|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
105718048|NCT00510276|364626928|FG000|Extension Open-Label Phase|Subject Decision|7|||
106008737|NCT00385671|365698955|FG001|Overall Study|Sponsor Decision|2|||
106008738|NCT00385671|365698956|FG002|Overall Study|Sponsor Decision|1|||
106008739|NCT00385671|365698954|FG000|Overall Study|Withdrawal by Subject|4|||
106008740|NCT00385671|365698955|FG001|Overall Study|Withdrawal by Subject|4|||
106008741|NCT00385671|365698956|FG002|Overall Study|Withdrawal by Subject|4|||
106008742|NCT00092417|365698957|FG000|Overall Study|Lost to Follow-up|2|||
106008743|NCT00092417|365698958|FG001|Overall Study|Lost to Follow-up|0|||
106008744|NCT00092417|365698957|FG000|Overall Study|Withdrawal by Subject|2|||
106136549|NCT01543685|366157979|FG003|Overall Study|Lack of Efficacy|0|||
106136550|NCT01543685|366157980|FG004|Overall Study|Lack of Efficacy|2|||
106136551|NCT01543685|366157976|FG000|Overall Study|Adverse Event|2|||
105718049|NCT00510276|364626929|FG001|Extension Open-Label Phase|Subject Decision|9|||
105718050|NCT00531960|364626935|FG000|Overall Study|Adverse Event|5|||
106136552|NCT01543685|366157977|FG001|Overall Study|Adverse Event|1|||
106136553|NCT01543685|366157978|FG002|Overall Study|Adverse Event|0|||
106136554|NCT01543685|366157979|FG003|Overall Study|Adverse Event|0|||
106136555|NCT01543685|366157980|FG004|Overall Study|Adverse Event|2|||
106136556|NCT00124982|366157983|FG000|Short-term Period|Death|1|||
106136557|NCT00124982|366157984|FG001|Short-term Period|Death|1|||
106136558|NCT00124982|366157985|FG002|Short-term Period|Death|0|||
106136559|NCT00124982|366157983|FG000|Short-term Period|Adverse Event|17|||
106136560|NCT00124982|366157984|FG001|Short-term Period|Adverse Event|22|||
106136561|NCT00124982|366157985|FG002|Short-term Period|Adverse Event|0|||
106136562|NCT00124982|366157983|FG000|Short-term Period|Lack of Efficacy|32|||
106136563|NCT00124982|366157984|FG001|Short-term Period|Lack of Efficacy|73|||
106136564|NCT00124982|366157985|FG002|Short-term Period|Lack of Efficacy|0|||
106136565|NCT00124982|366157983|FG000|Short-term Period|Lost to Follow-up|8|||
106136566|NCT00124982|366157984|FG001|Short-term Period|Lost to Follow-up|5|||
106136567|NCT00124982|366157985|FG002|Short-term Period|Lost to Follow-up|0|||
106136568|NCT00124982|366157983|FG000|Short-term Period|Withdrawal of Consent|7|||
106136569|NCT00124982|366157984|FG001|Short-term Period|Withdrawal of Consent|9|||
106136570|NCT00124982|366157985|FG002|Short-term Period|Withdrawal of Consent|0|||
106136571|NCT00124982|366157983|FG000|Short-term Period|Poor/Non-compliance|3|||
106136572|NCT00124982|366157984|FG001|Short-term Period|Poor/Non-compliance|1|||
106136573|NCT00124982|366157985|FG002|Short-term Period|Poor/Non-compliance|0|||
106136574|NCT00124982|366157983|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
106136575|NCT00124982|366157984|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
106136576|NCT00124982|366157985|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
106136577|NCT00124982|366157983|FG000|Short-term Period|Participant Decision|1|||
105718051|NCT00531960|364626936|FG001|Overall Study|Adverse Event|4|||
105718052|NCT00531960|364626935|FG000|Overall Study|Death|3|||
105718053|NCT00531960|364626936|FG001|Overall Study|Death|2|||
105718054|NCT00531960|364626935|FG000|Overall Study|Lack of Efficacy|42|||
105790543|NCT02335411|364887043|FG002|Overall Study|Adverse Event|0|||
106008745|NCT00092417|365698958|FG001|Overall Study|Withdrawal by Subject|1|||
106008746|NCT00092417|365698957|FG000|Overall Study|Other|1|||
106008747|NCT00092417|365698958|FG001|Overall Study|Other|0|||
106136578|NCT00124982|366157984|FG001|Short-term Period|Participant Decision|0|||
106136579|NCT00124982|366157985|FG002|Short-term Period|Participant Decision|0|||
106136580|NCT00124982|366157983|FG000|Short-term Period|Participant Chose Own Doctor|0|||
106136581|NCT00124982|366157984|FG001|Short-term Period|Participant Chose Own Doctor|1|||
106136582|NCT00124982|366157985|FG002|Short-term Period|Participant Chose Own Doctor|0|||
106136583|NCT00124982|366157983|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
106008748|NCT01972217|365698959|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
106008749|NCT01972217|365698960|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
106008750|NCT01972217|365698961|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
106008751|NCT01972217|365698962|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
106008752|NCT01972217|365698959|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
106008753|NCT01972217|365698960|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
106008754|NCT01972217|365698961|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
106008755|NCT01972217|365698962|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
106008756|NCT01972217|365698959|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
106008757|NCT01972217|365698960|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
106008758|NCT01972217|365698961|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
106008759|NCT01972217|365698962|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
106008760|NCT01972217|365698959|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
106008761|NCT01972217|365698960|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
105790544|NCT00938015|364887044|FG000|Overall Study|Death|2|||
105790545|NCT00938015|364887044|FG000|Overall Study|Lost to Follow-up|32|||
105790546|NCT00938015|364887044|FG000|Overall Study|Adverse Event|32|||
105790547|NCT00938015|364887044|FG000|Overall Study|Non-responder|52|||
106008762|NCT01972217|365698961|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
106008763|NCT01972217|365698962|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
106008764|NCT01972217|365698959|FG000|Part B Double-blind, Randomised Period|Death|0|||
106008765|NCT01972217|365698960|FG001|Part B Double-blind, Randomised Period|Death|0|||
106008766|NCT01972217|365698961|FG002|Part B Double-blind, Randomised Period|Death|43|||
106008767|NCT01972217|365698962|FG003|Part B Double-blind, Randomised Period|Death|44|||
106008768|NCT01972217|365698959|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
106008769|NCT01972217|365698960|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
106008770|NCT01972217|365698961|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
106008771|NCT01972217|365698962|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
106008772|NCT01972217|365698959|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
106008773|NCT01972217|365698960|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
105718055|NCT00531960|364626936|FG001|Overall Study|Lack of Efficacy|41|||
105718056|NCT00531960|364626935|FG000|Overall Study|Violation of Selection Criteria|2|||
105718057|NCT00531960|364626936|FG001|Overall Study|Violation of Selection Criteria|0|||
105718058|NCT00531960|364626935|FG000|Overall Study|Refused Treatment|5|||
105718059|NCT00531960|364626936|FG001|Overall Study|Refused Treatment|6|||
105718060|NCT00531960|364626935|FG000|Overall Study|Other|4|||
105718061|NCT00531960|364626936|FG001|Overall Study|Other|10|||
105718062|NCT03183128|364626939|FG000|Overall Study|Adverse Event|1|||
105718063|NCT03183128|364626940|FG001|Overall Study|Adverse Event|2|||
105718064|NCT03183128|364626939|FG000|Overall Study|Withdrawal by Subject|1|||
105718065|NCT03183128|364626940|FG001|Overall Study|Withdrawal by Subject|8|||
105718066|NCT03183128|364626939|FG000|Overall Study|Protocol Violation|2|||
105718067|NCT03183128|364626940|FG001|Overall Study|Protocol Violation|0|||
105718068|NCT03183128|364626939|FG000|Overall Study|Lack of Efficacy|4|||
105718069|NCT03183128|364626940|FG001|Overall Study|Lack of Efficacy|27|||
105718070|NCT03183128|364626939|FG000|Overall Study|Lost to Follow-up|1|||
105718071|NCT03183128|364626940|FG001|Overall Study|Lost to Follow-up|0|||
105718072|NCT03183128|364626939|FG000|Overall Study|Death|2|||
105718073|NCT03183128|364626940|FG001|Overall Study|Death|0|||
105718074|NCT03183128|364626939|FG000|Overall Study|Physician Decision|1|||
105718075|NCT03183128|364626940|FG001|Overall Study|Physician Decision|0|||
105718076|NCT00330187|364626941|FG000|Overall Study|Lost to Follow-up|12|||
105718077|NCT00330187|364626942|FG001|Overall Study|Lost to Follow-up|13|||
105718078|NCT00330187|364626943|FG002|Overall Study|Lost to Follow-up|14|||
105718079|NCT00330187|364626944|FG003|Overall Study|Lost to Follow-up|10|||
105718080|NCT00330187|364626941|FG000|Overall Study|Withdrawal by Subject|8|||
105790548|NCT00938015|364887044|FG000|Overall Study|Reason not related to Etanercept|29|||
105790549|NCT01886105|364887045|FG000|Overall Study|Lack of Efficacy|3|||
105790550|NCT01876901|364887046|FG000|Overall Study|Protocol Violation|10|||
105790551|NCT01876901|364887047|FG001|Overall Study|Protocol Violation|2|||
106008774|NCT01972217|365698961|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
106008775|NCT01972217|365698962|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
105718081|NCT00330187|364626942|FG001|Overall Study|Withdrawal by Subject|5|||
105790552|NCT01876901|364887046|FG000|Overall Study|No or other surgical intervention|7|||
105718082|NCT00330187|364626943|FG002|Overall Study|Withdrawal by Subject|4|||
105718083|NCT00330187|364626944|FG003|Overall Study|Withdrawal by Subject|4|||
105718084|NCT01481896|364626947|FG000|Overall Study|Lost to Follow-up|12|||
105790553|NCT01876901|364887047|FG001|Overall Study|No or other surgical intervention|5|||
105718085|NCT01818726|364626948|FG000|Overall Study|Administrative reasons|5|||
105718086|NCT01818726|364626949|FG001|Overall Study|Administrative reasons|1|||
105718087|NCT01818726|364626948|FG000|Overall Study|Withdrawal by Subject|0|||
105790554|NCT03186794|364887048|FG000|Overall Study|Physician Decision|2|||
105718088|NCT01818726|364626949|FG001|Overall Study|Withdrawal by Subject|1|||
105718089|NCT01818726|364626948|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
105718090|NCT01818726|364626949|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
105718091|NCT01162421|364626950|FG000|Overall Study|Did not receive study drug|2|||
105718092|NCT01162421|364626951|FG001|Overall Study|Did not receive study drug|1|||
105718093|NCT01162421|364626950|FG000|Overall Study|Adverse Event|2|||
105718094|NCT01162421|364626951|FG001|Overall Study|Adverse Event|5|||
105718095|NCT01162421|364626950|FG000|Overall Study|Lost to Follow-up|0|||
105718096|NCT01162421|364626951|FG001|Overall Study|Lost to Follow-up|2|||
105718097|NCT01162421|364626950|FG000|Overall Study|Lack of Efficacy|2|||
105718098|NCT01162421|364626951|FG001|Overall Study|Lack of Efficacy|2|||
105718099|NCT01162421|364626950|FG000|Overall Study|Other|2|||
105718100|NCT01162421|364626951|FG001|Overall Study|Other|3|||
105718101|NCT03336502|364626952|FG000|Overall Study|Physician Decision|0|||
105718102|NCT03336502|364626953|FG001|Overall Study|Physician Decision|1|||
105718103|NCT03336502|364626952|FG000|Overall Study|Prohibited Drugs|1|||
105718104|NCT03336502|364626953|FG001|Overall Study|Prohibited Drugs|1|||
105718105|NCT03336502|364626952|FG000|Overall Study|Death|1|||
105718106|NCT03336502|364626953|FG001|Overall Study|Death|2|||
105718107|NCT03336502|364626952|FG000|Overall Study|Adverse Event|2|||
105718108|NCT03336502|364626953|FG001|Overall Study|Adverse Event|5|||
105718109|NCT01133171|364626959|FG000|Overall Study|Withdrawal by Subject|1|||
105718110|NCT01133171|364626960|FG001|Overall Study|Withdrawal by Subject|2|||
105718111|NCT01133171|364626961|FG002|Overall Study|Withdrawal by Subject|0|||
105718112|NCT01375764|364626962|FG000|Overall Study|Lost to Follow-up|0|||
105718113|NCT01375764|364626963|FG001|Overall Study|Lost to Follow-up|1|||
105718114|NCT01375764|364626964|FG002|Overall Study|Lost to Follow-up|0|||
105718115|NCT01375764|364626965|FG003|Overall Study|Lost to Follow-up|0|||
105718116|NCT01375764|364626966|FG004|Overall Study|Lost to Follow-up|0|||
105718117|NCT01375764|364626962|FG000|Overall Study|Withdrawal by Subject|2|||
105718118|NCT01375764|364626963|FG001|Overall Study|Withdrawal by Subject|0|||
105718119|NCT01375764|364626964|FG002|Overall Study|Withdrawal by Subject|0|||
105718120|NCT01375764|364626965|FG003|Overall Study|Withdrawal by Subject|0|||
105718121|NCT01375764|364626966|FG004|Overall Study|Withdrawal by Subject|1|||
105718122|NCT01375764|364626962|FG000|Overall Study|Other|0|||
105718123|NCT01375764|364626963|FG001|Overall Study|Other|0|||
105718124|NCT01375764|364626964|FG002|Overall Study|Other|0|||
105932780|NCT02187055|365412548|FG002|Overall Study|No longer willing to participate|10|||
105932781|NCT02187055|365412546|FG000|Overall Study|Other|5|||
105932782|NCT02187055|365412547|FG001|Overall Study|Other|6|||
105932783|NCT02187055|365412548|FG002|Overall Study|Other|3|||
105932784|NCT02187055|365412546|FG000|Overall Study|Protocol Violation|9|||
105932785|NCT02187055|365412547|FG001|Overall Study|Protocol Violation|9|||
105932786|NCT02187055|365412548|FG002|Overall Study|Protocol Violation|4|||
105932787|NCT02187055|365412546|FG000|Overall Study|Pregnancy|3|||
105932788|NCT02187055|365412547|FG001|Overall Study|Pregnancy|1|||
105932789|NCT02187055|365412548|FG002|Overall Study|Pregnancy|0|||
105932790|NCT02187055|365412546|FG000|Overall Study|Withdrawal by Subject|11|||
105932791|NCT02187055|365412547|FG001|Overall Study|Withdrawal by Subject|11|||
105932792|NCT02187055|365412548|FG002|Overall Study|Withdrawal by Subject|11|||
105932793|NCT02187055|365412546|FG000|Overall Study|Adverse Event|21|||
105932794|NCT02187055|365412547|FG001|Overall Study|Adverse Event|26|||
105932795|NCT02187055|365412548|FG002|Overall Study|Adverse Event|36|||
105932796|NCT02187055|365412546|FG000|Overall Study|Death|2|||
105932797|NCT02187055|365412547|FG001|Overall Study|Death|0|||
105932798|NCT02187055|365412548|FG002|Overall Study|Death|0|||
105932799|NCT03520387|365412551|FG000|Pre-Randomization|Withdrawal by Subject|1|||
105932800|NCT03520387|365412552|FG001|Pre-Randomization|Withdrawal by Subject|0|||
105932801|NCT03520387|365412553|FG002|Pre-Randomization|Withdrawal by Subject|0|||
105932802|NCT03520387|365412554|FG003|Pre-Randomization|Withdrawal by Subject|0|||
105932803|NCT03520387|365412555|FG004|Pre-Randomization|Withdrawal by Subject|0|||
105932804|NCT03520387|365412551|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
105932805|NCT03520387|365412552|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
105932806|NCT03520387|365412553|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
105932807|NCT03520387|365412554|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
105718125|NCT01375764|364626965|FG003|Overall Study|Other|1|||
105718126|NCT01375764|364626966|FG004|Overall Study|Other|0|||
105932808|NCT03520387|365412555|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
105932809|NCT03336866|365412556|FG000|Overall Study|Lost to Follow-up|2|||
105932810|NCT03336866|365412557|FG001|Overall Study|Lost to Follow-up|0|||
105932811|NCT03336866|365412558|FG002|Overall Study|Lost to Follow-up|3|||
105932812|NCT03336866|365412556|FG000|Overall Study|Withdrawal by Subject|1|||
105718127|NCT01465659|364626969|FG000|Completed 1 Cycle of Treatment|Death|0|||
105718128|NCT01465659|364626970|FG001|Completed 1 Cycle of Treatment|Death|1|||
105718129|NCT01465659|364626971|FG002|Completed 1 Cycle of Treatment|Death|0|||
105718130|NCT01465659|364626972|FG003|Completed 1 Cycle of Treatment|Death|0|||
105718131|NCT01465659|364626969|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
105932813|NCT03336866|365412557|FG001|Overall Study|Withdrawal by Subject|1|||
105718132|NCT01465659|364626970|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
105718133|NCT01465659|364626971|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
105718134|NCT01465659|364626972|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
105718135|NCT01465659|364626969|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
105718136|NCT01465659|364626970|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
105718137|NCT01465659|364626971|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
105718138|NCT01465659|364626972|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
105718139|NCT01465659|364626969|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
105718140|NCT01465659|364626970|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
105718141|NCT01465659|364626971|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
105718142|NCT01465659|364626972|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
105718143|NCT01465659|364626969|FG000|Completed Follow for 1 Year|Death|6|||
105718144|NCT01465659|364626970|FG001|Completed Follow for 1 Year|Death|3|||
105718145|NCT01465659|364626971|FG002|Completed Follow for 1 Year|Death|2|||
105790555|NCT03186794|364887048|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
105790556|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
105790557|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
105790558|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Death|5|||
105790559|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Death|2|||
105790560|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
105790561|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
105790562|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
105790563|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
105790564|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
105790565|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
105790566|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Relapse|1|||
105790567|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Relapse|0|||
105790568|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
105790569|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
105790570|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
105790571|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
105790572|NCT00111007|364887050|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
105790573|NCT00111007|364887051|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
105790574|NCT00111007|364887050|FG000|Active Follow-up|Adverse Event|1|||
105790575|NCT00111007|364887051|FG001|Active Follow-up|Adverse Event|0|||
105790576|NCT00111007|364887050|FG000|Active Follow-up|Death|2|||
105790577|NCT00111007|364887051|FG001|Active Follow-up|Death|0|||
105790578|NCT00111007|364887050|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
105790579|NCT00111007|364887051|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
105790580|NCT00111007|364887050|FG000|Long Term Follow-up|Death|34|||
105790581|NCT00111007|364887051|FG001|Long Term Follow-up|Death|39|||
105790582|NCT00111007|364887050|FG000|Long Term Follow-up|Lost to Follow-up|1|||
105790583|NCT00111007|364887051|FG001|Long Term Follow-up|Lost to Follow-up|1|||
105790584|NCT00111007|364887050|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
105790585|NCT00111007|364887051|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
105790586|NCT00111007|364887050|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
105790587|NCT00111007|364887051|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
105790588|NCT00111007|364887050|FG000|Long Term Follow-up|Missing|10|||
105790589|NCT00111007|364887051|FG001|Long Term Follow-up|Missing|3|||
105790590|NCT00440193|364887052|FG000|Treatment Period|Adverse Event|74|||
105790591|NCT00440193|364887053|FG001|Treatment Period|Adverse Event|67|||
105790592|NCT00440193|364887052|FG000|Treatment Period|Death|19|||
105790593|NCT00440193|364887053|FG001|Treatment Period|Death|22|||
105790594|NCT00440193|364887052|FG000|Treatment Period|Lack of Efficacy|0|||
105790595|NCT00440193|364887053|FG001|Treatment Period|Lack of Efficacy|1|||
105790596|NCT00440193|364887052|FG000|Treatment Period|Lost to Follow-up|12|||
105790597|NCT00440193|364887053|FG001|Treatment Period|Lost to Follow-up|18|||
105790598|NCT00440193|364887052|FG000|Treatment Period|Physician Decision|3|||
105790599|NCT00440193|364887053|FG001|Treatment Period|Physician Decision|6|||
105790600|NCT00440193|364887052|FG000|Treatment Period|Protocol Violation|16|||
105790601|NCT00440193|364887053|FG001|Treatment Period|Protocol Violation|19|||
105790602|NCT00440193|364887052|FG000|Treatment Period|Withdrawal by Subject|36|||
105790603|NCT00440193|364887053|FG001|Treatment Period|Withdrawal by Subject|77|||
105718146|NCT01465659|364626972|FG003|Completed Follow for 1 Year|Death|4|||
105718147|NCT02149810|364626984|FG000|Overall Study|Physician Decision|1|||
105790604|NCT00440193|364887052|FG000|Treatment Period|Clinical endpoint reached|28|||
105718148|NCT02149810|364626985|FG001|Overall Study|Physician Decision|2|||
105718149|NCT02149810|364626984|FG000|Overall Study|Lost to Follow-up|2|||
105790605|NCT00440193|364887053|FG001|Treatment Period|Clinical endpoint reached|25|||
105790606|NCT00440193|364887052|FG000|Treatment Period|Study terminated by sponsor|102|||
105718150|NCT02149810|364626985|FG001|Overall Study|Lost to Follow-up|1|||
105718151|NCT02149810|364626984|FG000|Overall Study|Withdrawal by Subject|5|||
105718152|NCT02149810|364626985|FG001|Overall Study|Withdrawal by Subject|1|||
105718153|NCT01469000|364626986|FG000|Overall Study|Withdrawal by Subject|16|||
105718154|NCT01469000|364626987|FG001|Overall Study|Withdrawal by Subject|3|||
105718155|NCT01469000|364626986|FG000|Overall Study|Sponsor Decision|4|||
105718156|NCT01469000|364626987|FG001|Overall Study|Sponsor Decision|1|||
105718157|NCT01959165|364626989|FG000|Overall Study|Adverse Event|0|||
105718158|NCT01959165|364626990|FG001|Overall Study|Adverse Event|0|||
105718159|NCT01959165|364626991|FG002|Overall Study|Adverse Event|0|||
105718160|NCT01959165|364626992|FG003|Overall Study|Adverse Event|1|||
105718161|NCT01959165|364626989|FG000|Overall Study|Lack of Efficacy|1|||
105718162|NCT01959165|364626990|FG001|Overall Study|Lack of Efficacy|0|||
105718163|NCT01959165|364626991|FG002|Overall Study|Lack of Efficacy|0|||
105718164|NCT01959165|364626992|FG003|Overall Study|Lack of Efficacy|0|||
105718165|NCT01959165|364626989|FG000|Overall Study|overdose|0|||
105718166|NCT01959165|364626990|FG001|Overall Study|overdose|0|||
105718167|NCT01959165|364626991|FG002|Overall Study|overdose|0|||
105718168|NCT01959165|364626992|FG003|Overall Study|overdose|1|||
105718169|NCT01959165|364626989|FG000|Overall Study|Welfare recipient|0|||
105718170|NCT01959165|364626990|FG001|Overall Study|Welfare recipient|1|||
105718171|NCT01959165|364626991|FG002|Overall Study|Welfare recipient|0|||
105718172|NCT01959165|364626992|FG003|Overall Study|Welfare recipient|0|||
105718173|NCT00769119|364626993|FG000|Overall Study|Voluntary discontinuation|0|||
105718174|NCT00769119|364626994|FG001|Overall Study|Voluntary discontinuation|2|||
105718175|NCT00769119|364626993|FG000|Overall Study|Adverse Event|1|||
105718176|NCT00769119|364626994|FG001|Overall Study|Adverse Event|1|||
105718177|NCT00769119|364626993|FG000|Overall Study|Disallowed medication|1|||
105718178|NCT00769119|364626994|FG001|Overall Study|Disallowed medication|0|||
105718179|NCT00686647|364626997|FG000|Overall Study|Lost to Follow-up|1|||
105718180|NCT00686647|364626997|FG000|Overall Study|Death|1|||
105718181|NCT04082663|364627001|FG000|Overall Study|Adverse Event|6|||
105718182|NCT04082663|364627001|FG000|Overall Study|Lost to Follow-up|1|||
105718183|NCT00578643|364627002|FG000|Overall Study|Death|1|||
105718184|NCT00578643|364627002|FG000|Overall Study|Lost to Follow-up|1|||
105718185|NCT00705263|364627003|FG000|Overall Study|Withdrawal by Subject|2|||
105718186|NCT01752023|364627004|FG000|Overall Study|Physician Decision|2|||
105718187|NCT01752023|364627005|FG001|Overall Study|Physician Decision|1|||
105718188|NCT03430986|364627011|FG000|24-week Control Period|Adverse Event|1|||
105718189|NCT03430986|364627012|FG001|24-week Control Period|Adverse Event|0|||
105718190|NCT03430986|364627011|FG000|24-week Control Period|Lost to Follow-up|2|||
105718191|NCT03430986|364627012|FG001|24-week Control Period|Lost to Follow-up|2|||
105718192|NCT03430986|364627011|FG000|24-week Control Period|Withdrawal by Participant|5|||
105718193|NCT03430986|364627012|FG001|24-week Control Period|Withdrawal by Participant|0|||
105718194|NCT03430986|364627011|FG000|24-week Control Period|Protocol Deviation|0|||
105718195|NCT03430986|364627012|FG001|24-week Control Period|Protocol Deviation|2|||
105718196|NCT03430986|364627011|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
105718197|NCT03430986|364627012|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
105718198|NCT03430986|364627011|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
105718199|NCT03430986|364627012|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
105718200|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
105718201|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
105718202|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
105718203|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718204|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718205|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718206|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718207|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718208|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
105718209|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
105718210|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
105718211|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
105718212|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718213|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718214|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718215|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718216|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718217|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
105718218|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
105718219|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
105718220|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718221|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105790607|NCT00440193|364887053|FG001|Treatment Period|Study terminated by sponsor|94|||
105790608|NCT00440193|364887052|FG000|Treatment Period|Protocol driven decision point|2|||
105790609|NCT00440193|364887053|FG001|Treatment Period|Protocol driven decision point|2|||
105790610|NCT00440193|364887052|FG000|Treatment Period|Switch to commercial drug|0|||
105790611|NCT00440193|364887053|FG001|Treatment Period|Switch to commercial drug|2|||
105790612|NCT00440193|364887052|FG000|Treatment Period|Technical problems|1|||
105790613|NCT00440193|364887053|FG001|Treatment Period|Technical problems|1|||
105790614|NCT00440193|364887052|FG000|Treatment Period|Participant convenience|5|||
105790615|NCT00440193|364887053|FG001|Treatment Period|Participant convenience|2|||
105790616|NCT00440193|364887052|FG000|Treatment Period|Participant did not receive treatment|7|||
105790617|NCT00440193|364887053|FG001|Treatment Period|Participant did not receive treatment|13|||
105790618|NCT00440193|364887052|FG000|Treatment Period|Site closed by investigator|0|||
105790619|NCT00440193|364887053|FG001|Treatment Period|Site closed by investigator|2|||
105790620|NCT00440193|364887052|FG000|Observational Period|Adverse Event|2|||
105790621|NCT00440193|364887053|FG001|Observational Period|Adverse Event|2|||
105790622|NCT00440193|364887052|FG000|Observational Period|Death|15|||
105790623|NCT00440193|364887053|FG001|Observational Period|Death|20|||
105790624|NCT00440193|364887052|FG000|Observational Period|Lost to Follow-up|12|||
105790625|NCT00440193|364887053|FG001|Observational Period|Lost to Follow-up|8|||
105790626|NCT00440193|364887052|FG000|Observational Period|Protocol Violation|1|||
105932814|NCT03336866|365412558|FG002|Overall Study|Withdrawal by Subject|0|||
105932815|NCT03336866|365412556|FG000|Overall Study|Noncompliance with clinic house rules|0|||
105932816|NCT03336866|365412557|FG001|Overall Study|Noncompliance with clinic house rules|0|||
105932817|NCT03336866|365412558|FG002|Overall Study|Noncompliance with clinic house rules|1|||
105932818|NCT00250718|365412559|FG000|Overall Study|Death|1|||
105932819|NCT00250718|365412559|FG000|Overall Study|Adverse Event|1|||
105932820|NCT00250718|365412559|FG000|Overall Study|Withdrawal by Subject|1|||
105932821|NCT00541775|365412560|FG000|Overall Study|Adverse Event|3|||
105932822|NCT00541775|365412561|FG001|Overall Study|Adverse Event|2|||
105932823|NCT00541775|365412562|FG002|Overall Study|Adverse Event|1|||
105932824|NCT00541775|365412560|FG000|Overall Study|Lack of Efficacy|0|||
105932825|NCT00541775|365412561|FG001|Overall Study|Lack of Efficacy|0|||
105932826|NCT00541775|365412562|FG002|Overall Study|Lack of Efficacy|3|||
105932827|NCT00541775|365412560|FG000|Overall Study|Lost to Follow-up|0|||
105932828|NCT00541775|365412561|FG001|Overall Study|Lost to Follow-up|0|||
105932829|NCT00541775|365412562|FG002|Overall Study|Lost to Follow-up|2|||
105932830|NCT00541775|365412560|FG000|Overall Study|Protocol Violation|1|||
105932831|NCT00541775|365412561|FG001|Overall Study|Protocol Violation|0|||
105932832|NCT00541775|365412562|FG002|Overall Study|Protocol Violation|0|||
105932833|NCT00541775|365412560|FG000|Overall Study|Withdrawal by Subject and Other|5|||
105932834|NCT00541775|365412561|FG001|Overall Study|Withdrawal by Subject and Other|0|||
105932835|NCT00541775|365412562|FG002|Overall Study|Withdrawal by Subject and Other|2|||
105932836|NCT05737745|365412565|FG000|Overall Study|Withdrawal by Subject|0|||
105932837|NCT05737745|365412566|FG001|Overall Study|Withdrawal by Subject|6|||
105932838|NCT05737745|365412567|FG002|Overall Study|Withdrawal by Subject|1|||
105932839|NCT01028391|365412568|FG000|Overall Study|Adverse Event|4|||
105932840|NCT01028391|365412569|FG001|Overall Study|Adverse Event|0|||
105718222|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718223|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718224|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718225|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718226|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
105718227|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
105718228|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
105718229|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
105718230|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718231|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718232|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718233|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718234|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718235|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
105718236|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
105718237|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
105718238|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718239|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718240|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718241|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718242|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105790627|NCT00440193|364887053|FG001|Observational Period|Protocol Violation|0|||
105932841|NCT01028391|365412568|FG000|Overall Study|Lack of Efficacy|0|||
105932842|NCT01028391|365412569|FG001|Overall Study|Lack of Efficacy|2|||
105932843|NCT01028391|365412568|FG000|Overall Study|Lost to Follow-up|3|||
105718243|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718244|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
105718245|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105790628|NCT00440193|364887052|FG000|Observational Period|Withdrawal by Subject|11|||
105790629|NCT00440193|364887053|FG001|Observational Period|Withdrawal by Subject|8|||
105790630|NCT00440193|364887052|FG000|Observational Period|Physician Decision|1|||
105790631|NCT00440193|364887053|FG001|Observational Period|Physician Decision|0|||
105790632|NCT00440193|364887052|FG000|Observational Period|Clinical endpoint reached|1|||
105790633|NCT00440193|364887053|FG001|Observational Period|Clinical endpoint reached|0|||
105790634|NCT00440193|364887052|FG000|Observational Period|Participant convenience|2|||
105790635|NCT00440193|364887053|FG001|Observational Period|Participant convenience|0|||
105790636|NCT03075826|364887055|FG000|Overall Study|Withdrawal by Subject|1|||
105790637|NCT03075826|364887055|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
105790638|NCT01071278|364887056|FG000|Overall Study|Premature Discontinuation|254|||
105790639|NCT01071278|364887056|FG000|Overall Study|Completion Status Unknown|459|||
105790640|NCT03078192|364887057|FG000|Overall Study|Withdrawal by Subject|2|||
105932844|NCT01028391|365412569|FG001|Overall Study|Lost to Follow-up|4|||
105932845|NCT01028391|365412568|FG000|Overall Study|Physician Decision|0|||
105932846|NCT01028391|365412569|FG001|Overall Study|Physician Decision|1|||
105932847|NCT01028391|365412568|FG000|Overall Study|Withdrawal by Subject|6|||
105932848|NCT01028391|365412569|FG001|Overall Study|Withdrawal by Subject|3|||
105932849|NCT01028391|365412568|FG000|Overall Study|Needed excluded medication|1|||
105932850|NCT01028391|365412569|FG001|Overall Study|Needed excluded medication|1|||
105932851|NCT03259308|365412570|FG000|Overall Study|Adverse Event|5|||
105932852|NCT03259308|365412571|FG001|Overall Study|Adverse Event|4|||
105932853|NCT03259308|365412572|FG002|Overall Study|Adverse Event|1|||
105932854|NCT03259308|365412570|FG000|Overall Study|Withdrawal by Subject|2|||
105932855|NCT03259308|365412571|FG001|Overall Study|Withdrawal by Subject|1|||
105932856|NCT03259308|365412572|FG002|Overall Study|Withdrawal by Subject|3|||
105932857|NCT03259308|365412570|FG000|Overall Study|Lost to Follow-up|0|||
105932858|NCT03259308|365412571|FG001|Overall Study|Lost to Follow-up|0|||
105932859|NCT03259308|365412572|FG002|Overall Study|Lost to Follow-up|1|||
105932860|NCT03259308|365412570|FG000|Overall Study|Pregnancy|0|||
105718246|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718247|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
105718248|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718249|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718250|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718251|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718252|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718253|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
105718254|NCT01583374|364627016|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718255|NCT01583374|364627017|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
105718256|NCT01583374|364627018|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718257|NCT01583374|364627019|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718258|NCT01583374|364627020|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718259|NCT01583374|364627021|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718260|NCT01583374|364627022|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718261|NCT01583374|364627023|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718262|NCT01583374|364627024|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
105718263|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718264|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718265|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718266|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718267|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718268|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718269|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105790641|NCT03078192|364887058|FG001|Overall Study|Withdrawal by Subject|1|||
105790642|NCT03078192|364887057|FG000|Overall Study|screen failure|0|||
105790643|NCT03078192|364887058|FG001|Overall Study|screen failure|3|||
105932861|NCT03259308|365412571|FG001|Overall Study|Pregnancy|0|||
105932862|NCT03259308|365412572|FG002|Overall Study|Pregnancy|1|||
105932863|NCT03259308|365412570|FG000|Overall Study|Protocol Deviation|0|||
105932864|NCT03259308|365412571|FG001|Overall Study|Protocol Deviation|3|||
105932865|NCT03259308|365412572|FG002|Overall Study|Protocol Deviation|0|||
105932866|NCT03259308|365412570|FG000|Overall Study|Lack of Efficacy|0|||
105932867|NCT03259308|365412571|FG001|Overall Study|Lack of Efficacy|0|||
105932868|NCT03259308|365412572|FG002|Overall Study|Lack of Efficacy|1|||
105932869|NCT00362609|365412573|FG000|Overall Study|Withdrawal by Subject|0|||
105932870|NCT00362609|365412574|FG001|Overall Study|Withdrawal by Subject|1|||
105932871|NCT00362609|365412573|FG000|Overall Study|Protocol Violation|0|||
105932872|NCT00362609|365412574|FG001|Overall Study|Protocol Violation|1|||
105932873|NCT03599713|365412575|FG000|Overall Study|Death|38|||
105790644|NCT02061293|364887059|FG000|Overall Study|Elevated Blood Pressure|1|||
105790645|NCT02061293|364887060|FG001|Overall Study|Elevated Blood Pressure|1|||
105790646|NCT02184988|364887061|FG000|Overall Study|Pregnancy|2|||
105790647|NCT02184988|364887061|FG000|Overall Study|Adverse Event|2|||
105790648|NCT02184988|364887061|FG000|Overall Study|moving away/travelling/unable to complet|6|||
105790649|NCT02184988|364887061|FG000|Overall Study|work scheduling issues|4|||
105790650|NCT02184988|364887061|FG000|Overall Study|various other reasons|9|||
105790651|NCT02184988|364887061|FG000|Overall Study|Lost to Follow-up|32|||
105790652|NCT01058707|364887062|FG000|Overall Study|Disease Progression|15|||
105790653|NCT01058707|364887063|FG001|Overall Study|Disease Progression|20|||
105790654|NCT01058707|364887064|FG002|Overall Study|Disease Progression|20|||
105790655|NCT01058707|364887065|FG003|Overall Study|Disease Progression|15|||
105790656|NCT01058707|364887066|FG004|Overall Study|Disease Progression|23|||
105790657|NCT01058707|364887067|FG005|Overall Study|Disease Progression|10|||
105790658|NCT01058707|364887068|FG006|Overall Study|Disease Progression|12|||
105790659|NCT01058707|364887062|FG000|Overall Study|Adverse Event|11|||
105790660|NCT01058707|364887063|FG001|Overall Study|Adverse Event|4|||
105790661|NCT01058707|364887064|FG002|Overall Study|Adverse Event|7|||
105790662|NCT01058707|364887065|FG003|Overall Study|Adverse Event|6|||
105790663|NCT01058707|364887066|FG004|Overall Study|Adverse Event|7|||
105790664|NCT01058707|364887067|FG005|Overall Study|Adverse Event|3|||
105790665|NCT01058707|364887068|FG006|Overall Study|Adverse Event|1|||
105790666|NCT01058707|364887062|FG000|Overall Study|Subject Decision|5|||
105790667|NCT01058707|364887063|FG001|Overall Study|Subject Decision|3|||
105790668|NCT01058707|364887064|FG002|Overall Study|Subject Decision|3|||
105790669|NCT01058707|364887065|FG003|Overall Study|Subject Decision|1|||
105790670|NCT01058707|364887066|FG004|Overall Study|Subject Decision|2|||
105790671|NCT01058707|364887067|FG005|Overall Study|Subject Decision|3|||
105790672|NCT01058707|364887068|FG006|Overall Study|Subject Decision|6|||
105790673|NCT01058707|364887062|FG000|Overall Study|Lost to Follow-up|0|||
105790674|NCT01058707|364887063|FG001|Overall Study|Lost to Follow-up|0|||
105790675|NCT01058707|364887064|FG002|Overall Study|Lost to Follow-up|1|||
105790676|NCT01058707|364887065|FG003|Overall Study|Lost to Follow-up|0|||
105932874|NCT03599713|365412576|FG001|Overall Study|Death|3|||
105932875|NCT03599713|365412575|FG000|Overall Study|Withdrawal by Subject|17|||
105932876|NCT03599713|365412576|FG001|Overall Study|Withdrawal by Subject|0|||
105932877|NCT03599713|365412575|FG000|Overall Study|Lost to Follow-up|4|||
105932878|NCT03599713|365412576|FG001|Overall Study|Lost to Follow-up|0|||
105932879|NCT03599713|365412575|FG000|Overall Study|Discontinued Due to End of Study|42|||
105932880|NCT03599713|365412576|FG001|Overall Study|Discontinued Due to End of Study|3|||
105932881|NCT02642679|365414277|FG000|Overall Study|Withdrawal by Subject|1|||
105932882|NCT02642679|365414277|FG000|Overall Study|Physician Decision|1|||
105932883|NCT02642679|365414277|FG000|Overall Study|Physician Decision|1|||
105932884|NCT01112267|365414278|FG000|Overall Study|Adverse Event|24|||
105932885|NCT01112267|365414279|FG001|Overall Study|Adverse Event|6|||
105932886|NCT01112267|365414278|FG000|Overall Study|Withdrawal by Subject|3|||
105932887|NCT01112267|365414279|FG001|Overall Study|Withdrawal by Subject|5|||
105932888|NCT01112267|365414278|FG000|Overall Study|Protocol Violation|5|||
105932889|NCT01112267|365414279|FG001|Overall Study|Protocol Violation|3|||
105932890|NCT01112267|365414278|FG000|Overall Study|Participants not compliant|1|||
105932891|NCT01112267|365414279|FG001|Overall Study|Participants not compliant|2|||
105932892|NCT01112267|365414278|FG000|Overall Study|Participants not receive any study drug|1|||
105932893|NCT01112267|365414279|FG001|Overall Study|Participants not receive any study drug|2|||
105932894|NCT03166631|365414281|FG000|Overall Study|Progressive disease|2|||
105932895|NCT03166631|365414282|FG001|Overall Study|Progressive disease|1|||
105932896|NCT03166631|365414283|FG002|Overall Study|Progressive disease|3|||
105932897|NCT03166631|365414284|FG003|Overall Study|Progressive disease|4|||
105932898|NCT03166631|365414285|FG004|Overall Study|Progressive disease|2|||
105932899|NCT03166631|365414286|FG005|Overall Study|Progressive disease|2|||
105790677|NCT01058707|364887066|FG004|Overall Study|Lost to Follow-up|0|||
105790678|NCT01058707|364887067|FG005|Overall Study|Lost to Follow-up|0|||
105790679|NCT01058707|364887068|FG006|Overall Study|Lost to Follow-up|0|||
105790680|NCT01058707|364887062|FG000|Overall Study|Reason Not Specified|0|||
105790681|NCT01058707|364887063|FG001|Overall Study|Reason Not Specified|3|||
105790682|NCT01058707|364887064|FG002|Overall Study|Reason Not Specified|2|||
105790683|NCT01058707|364887065|FG003|Overall Study|Reason Not Specified|0|||
105790684|NCT01058707|364887066|FG004|Overall Study|Reason Not Specified|7|||
105790685|NCT01058707|364887067|FG005|Overall Study|Reason Not Specified|1|||
105790686|NCT01058707|364887068|FG006|Overall Study|Reason Not Specified|7|||
105790687|NCT00483717|364887073|FG000|Overall Study|Protocol Violation|5|||
105790688|NCT00483717|364887074|FG001|Overall Study|Protocol Violation|7|||
105932900|NCT03166631|365414287|FG006|Overall Study|Progressive disease|5|||
105932901|NCT03166631|365414288|FG007|Overall Study|Progressive disease|6|||
105932902|NCT03166631|365414289|FG008|Overall Study|Progressive disease|11|||
105932903|NCT03166631|365414290|FG009|Overall Study|Progressive disease|5|||
105932904|NCT03166631|365414291|FG010|Overall Study|Progressive disease|7|||
105790689|NCT00483717|364887073|FG000|Overall Study|Time of dosing missing|1|||
105790690|NCT00483717|364887074|FG001|Overall Study|Time of dosing missing|1|||
105932905|NCT03166631|365414281|FG000|Overall Study|Physician Decision|0|||
106008776|NCT01972217|365698959|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
106008777|NCT01972217|365698960|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
105790691|NCT00483717|364887073|FG000|Overall Study|No treatment for migraine|16|||
106136584|NCT00124982|366157984|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
106136585|NCT00124982|366157985|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
106136586|NCT00124982|366157983|FG000|Short-term Period|Participant Had Lymphopenia|1|||
106136587|NCT00124982|366157984|FG001|Short-term Period|Participant Had Lymphopenia|0|||
106136588|NCT00124982|366157985|FG002|Short-term Period|Participant Had Lymphopenia|0|||
106136589|NCT00124982|366157983|FG000|Long-term Period|Death|0|||
106136590|NCT00124982|366157984|FG001|Long-term Period|Death|0|||
106136591|NCT00124982|366157985|FG002|Long-term Period|Death|1|||
106136592|NCT00124982|366157983|FG000|Long-term Period|Adverse Event|0|||
106136593|NCT00124982|366157984|FG001|Long-term Period|Adverse Event|0|||
106136594|NCT00124982|366157985|FG002|Long-term Period|Adverse Event|17|||
106136595|NCT00124982|366157983|FG000|Long-term Period|Lack of Efficacy|0|||
106136596|NCT00124982|366157984|FG001|Long-term Period|Lack of Efficacy|0|||
106136597|NCT00124982|366157985|FG002|Long-term Period|Lack of Efficacy|46|||
106136598|NCT00124982|366157983|FG000|Long-term Period|Lost to Follow-up|0|||
106136599|NCT00124982|366157984|FG001|Long-term Period|Lost to Follow-up|0|||
106136600|NCT00124982|366157985|FG002|Long-term Period|Lost to Follow-up|4|||
106136601|NCT00124982|366157983|FG000|Long-term Period|Withdrawal by Subject|0|||
106136602|NCT00124982|366157984|FG001|Long-term Period|Withdrawal by Subject|0|||
106136603|NCT00124982|366157985|FG002|Long-term Period|Withdrawal by Subject|16|||
106136604|NCT00124982|366157983|FG000|Long-term Period|Pregnancy|0|||
106136605|NCT00124982|366157984|FG001|Long-term Period|Pregnancy|0|||
106136606|NCT00124982|366157985|FG002|Long-term Period|Pregnancy|1|||
106136607|NCT00124982|366157983|FG000|Long-term Period|Poor/Non-compliance|0|||
106136608|NCT00124982|366157984|FG001|Long-term Period|Poor/Non-compliance|0|||
106136609|NCT00124982|366157985|FG002|Long-term Period|Poor/Non-compliance|2|||
106136610|NCT00124982|366157983|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
106136611|NCT00124982|366157984|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
106136612|NCT00124982|366157985|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
106136613|NCT00124982|366157983|FG000|Long-term Period|Neurologist Recommendation|0|||
106136614|NCT00124982|366157984|FG001|Long-term Period|Neurologist Recommendation|0|||
106136615|NCT00124982|366157985|FG002|Long-term Period|Neurologist Recommendation|1|||
106136616|NCT01080131|366157992|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
106136617|NCT01080131|366157993|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
106136618|NCT01080131|366157992|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
106136619|NCT01080131|366157993|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
106136620|NCT01080131|366157992|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
106136621|NCT01080131|366157993|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
106136622|NCT01080131|366157992|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
106136623|NCT01080131|366157993|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
106136624|NCT01080131|366157992|FG000|Core Study (0- 12 Weeks)|Death|1|||
106136625|NCT01080131|366157993|FG001|Core Study (0- 12 Weeks)|Death|0|||
106136626|NCT01080131|366157992|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
106136627|NCT01080131|366157993|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
106136628|NCT01080131|366157992|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
106136629|NCT01080131|366157993|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
106136630|NCT01080131|366157992|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
106136631|NCT01080131|366157993|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
106136632|NCT01080131|366157992|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
106136633|NCT01080131|366157993|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
106136634|NCT01080131|366157992|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
106136635|NCT01080131|366157993|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
106136636|NCT01080131|366157992|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
106136637|NCT01080131|366157993|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
106136638|NCT01080131|366157992|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
106136639|NCT01080131|366157993|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
106136640|NCT01080131|366157992|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
106136641|NCT01080131|366157993|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
105718270|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
105718271|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
105718272|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
105718273|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
105718274|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
105718275|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
105718276|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
105718277|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
106136642|NCT00359619|366160189|FG000|Overall Study|Adverse Event|0|||
106136643|NCT00359619|366160190|FG001|Overall Study|Adverse Event|0|||
106136644|NCT00359619|366160191|FG002|Overall Study|Adverse Event|1|||
106136645|NCT00359619|366160192|FG003|Overall Study|Adverse Event|0|||
105932906|NCT03166631|365414282|FG001|Overall Study|Physician Decision|0|||
105932907|NCT03166631|365414283|FG002|Overall Study|Physician Decision|0|||
105932908|NCT03166631|365414284|FG003|Overall Study|Physician Decision|0|||
105932909|NCT03166631|365414285|FG004|Overall Study|Physician Decision|0|||
105932910|NCT03166631|365414286|FG005|Overall Study|Physician Decision|0|||
105932911|NCT03166631|365414287|FG006|Overall Study|Physician Decision|1|||
105932912|NCT03166631|365414288|FG007|Overall Study|Physician Decision|0|||
105932913|NCT03166631|365414289|FG008|Overall Study|Physician Decision|1|||
105932914|NCT03166631|365414290|FG009|Overall Study|Physician Decision|0|||
105932915|NCT03166631|365414291|FG010|Overall Study|Physician Decision|1|||
105932916|NCT03166631|365414281|FG000|Overall Study|Death|0|||
105932917|NCT03166631|365414282|FG001|Overall Study|Death|0|||
105932918|NCT03166631|365414283|FG002|Overall Study|Death|0|||
105932919|NCT03166631|365414284|FG003|Overall Study|Death|0|||
105932920|NCT03166631|365414285|FG004|Overall Study|Death|1|||
105932921|NCT03166631|365414286|FG005|Overall Study|Death|0|||
105932922|NCT03166631|365414287|FG006|Overall Study|Death|1|||
105932923|NCT03166631|365414288|FG007|Overall Study|Death|0|||
105932924|NCT03166631|365414289|FG008|Overall Study|Death|0|||
105932925|NCT03166631|365414290|FG009|Overall Study|Death|0|||
105932926|NCT03166631|365414291|FG010|Overall Study|Death|0|||
105932927|NCT03166631|365414281|FG000|Overall Study|Adverse Event|1|||
105932928|NCT03166631|365414282|FG001|Overall Study|Adverse Event|0|||
105932929|NCT03166631|365414283|FG002|Overall Study|Adverse Event|0|||
105932930|NCT03166631|365414284|FG003|Overall Study|Adverse Event|0|||
105932931|NCT03166631|365414285|FG004|Overall Study|Adverse Event|0|||
105932932|NCT03166631|365414286|FG005|Overall Study|Adverse Event|1|||
105932933|NCT03166631|365414287|FG006|Overall Study|Adverse Event|1|||
105932934|NCT03166631|365414288|FG007|Overall Study|Adverse Event|0|||
105932935|NCT03166631|365414289|FG008|Overall Study|Adverse Event|1|||
105932936|NCT03166631|365414290|FG009|Overall Study|Adverse Event|2|||
105932937|NCT03166631|365414291|FG010|Overall Study|Adverse Event|1|||
105932938|NCT03166631|365414281|FG000|Overall Study|Withdrawal by Subject|0|||
105932939|NCT03166631|365414282|FG001|Overall Study|Withdrawal by Subject|0|||
105932940|NCT03166631|365414283|FG002|Overall Study|Withdrawal by Subject|0|||
105932941|NCT03166631|365414284|FG003|Overall Study|Withdrawal by Subject|0|||
105932942|NCT03166631|365414285|FG004|Overall Study|Withdrawal by Subject|0|||
105932943|NCT03166631|365414286|FG005|Overall Study|Withdrawal by Subject|0|||
105932944|NCT03166631|365414287|FG006|Overall Study|Withdrawal by Subject|0|||
105932945|NCT03166631|365414288|FG007|Overall Study|Withdrawal by Subject|0|||
105932946|NCT03166631|365414289|FG008|Overall Study|Withdrawal by Subject|1|||
105932947|NCT03166631|365414290|FG009|Overall Study|Withdrawal by Subject|1|||
105932948|NCT03166631|365414291|FG010|Overall Study|Withdrawal by Subject|0|||
105932949|NCT00420407|365414292|FG000|Overall Study|Lost to Follow-up|0|||
105932950|NCT00420407|365414293|FG001|Overall Study|Lost to Follow-up|3|||
105932951|NCT00420407|365414292|FG000|Overall Study|Physician Decision|2|||
105932952|NCT00420407|365414293|FG001|Overall Study|Physician Decision|1|||
105932953|NCT00420407|365414292|FG000|Overall Study|subject identified as detainee|1|||
105932954|NCT00420407|365414293|FG001|Overall Study|subject identified as detainee|0|||
105932955|NCT00420407|365414292|FG000|Overall Study|subject identified as Jehovah's witness|1|||
105932956|NCT00420407|365414293|FG001|Overall Study|subject identified as Jehovah's witness|0|||
105932957|NCT00420407|365414292|FG000|Overall Study|Withdrawal by Subject|0|||
105932958|NCT00420407|365414293|FG001|Overall Study|Withdrawal by Subject|2|||
105932959|NCT01500096|365414296|FG000|Overall Study|Lost to Follow-up|1|||
105932960|NCT01500096|365414297|FG001|Overall Study|Lost to Follow-up|0|||
105932961|NCT01500096|365414298|FG002|Overall Study|Lost to Follow-up|0|||
105932962|NCT01500096|365414299|FG003|Overall Study|Lost to Follow-up|2|||
105932963|NCT01567085|365414300|FG000|Overall Study|Death|6|||
105932964|NCT01567085|365414300|FG000|Overall Study|Adverse Event|6|||
105932965|NCT01567085|365414300|FG000|Overall Study|Lost to Follow-up|3|||
105932966|NCT01567085|365414300|FG000|Overall Study|Graft loss|2|||
105718278|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
105932967|NCT01567085|365414300|FG000|Overall Study|Renal transplantectomy|1|||
105718279|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
105718280|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
105718281|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
105718282|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
105718283|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
105932968|NCT01567085|365414300|FG000|Overall Study|Returned to chronic dialysis|1|||
105932969|NCT01567085|365414300|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
105932970|NCT04289298|365414301|FG000|Overall Study|Lost to Follow-up|5|||
105932971|NCT04289298|365414302|FG001|Overall Study|Lost to Follow-up|0|||
105932972|NCT04289298|365414301|FG000|Overall Study|Withdrawal by Subject|2|||
105932973|NCT04289298|365414302|FG001|Overall Study|Withdrawal by Subject|0|||
105932974|NCT01734928|365414303|FG000|Randomization|Physician Decision|0|||
105718284|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
105932975|NCT01734928|365414304|FG001|Randomization|Physician Decision|1|||
106136646|NCT00359619|366160193|FG004|Overall Study|Adverse Event|0|||
106136647|NCT00359619|366160194|FG005|Overall Study|Adverse Event|0|||
106136648|NCT00359619|366160195|FG006|Overall Study|Adverse Event|1|||
105718285|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
105718286|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
105718287|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
105718288|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
105718289|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
105718290|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718291|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
105718292|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
105718293|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718294|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
105718295|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718296|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718297|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718298|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
105718299|NCT01583374|364627016|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718300|NCT01583374|364627017|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718301|NCT01583374|364627018|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
105718302|NCT01583374|364627019|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718303|NCT01583374|364627020|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
105718304|NCT01583374|364627021|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
105718305|NCT01583374|364627022|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718306|NCT01583374|364627023|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718307|NCT01583374|364627024|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
105718308|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
105932976|NCT01734928|365414303|FG000|Randomization|clinical progression|0|||
105932977|NCT01734928|365414304|FG001|Randomization|clinical progression|1|||
105932978|NCT01734928|365414303|FG000|Randomization|progressive disease|0|||
105932979|NCT01734928|365414304|FG001|Randomization|progressive disease|2|||
105932980|NCT01734928|365414303|FG000|Randomization|Withdrew informed consent|0|||
105932981|NCT01734928|365414304|FG001|Randomization|Withdrew informed consent|4|||
105932982|NCT01734928|365414303|FG000|Randomization|Death|1|||
105932983|NCT01734928|365414304|FG001|Randomization|Death|0|||
105932984|NCT01734928|365414303|FG000|Randomization|Randomization error|1|||
105932985|NCT01734928|365414304|FG001|Randomization|Randomization error|0|||
105932986|NCT01734928|365414303|FG000|Randomization|Lost to Follow-up|1|||
105932987|NCT01734928|365414304|FG001|Randomization|Lost to Follow-up|0|||
105932988|NCT01734928|365414303|FG000|Treatment Period|Lost to Follow-up|0|||
105932989|NCT01734928|365414304|FG001|Treatment Period|Lost to Follow-up|2|||
105932990|NCT01734928|365414303|FG000|Treatment Period|Progressive Disease|167|||
105932991|NCT01734928|365414304|FG001|Treatment Period|Progressive Disease|165|||
105932992|NCT01734928|365414303|FG000|Treatment Period|Adverse Event|39|||
105932993|NCT01734928|365414304|FG001|Treatment Period|Adverse Event|52|||
105932994|NCT01734928|365414303|FG000|Treatment Period|Withdrawal of Consent|25|||
105932995|NCT01734928|365414304|FG001|Treatment Period|Withdrawal of Consent|22|||
105932996|NCT01734928|365414303|FG000|Treatment Period|Death|20|||
105932997|NCT01734928|365414304|FG001|Treatment Period|Death|9|||
105932998|NCT01734928|365414303|FG000|Treatment Period|Other Reasons|27|||
105932999|NCT01734928|365414304|FG001|Treatment Period|Other Reasons|19|||
105933000|NCT01734928|365414303|FG000|Treatment Period|Pregnancy|0|||
105933001|NCT01734928|365414304|FG001|Treatment Period|Pregnancy|1|||
105933002|NCT00504231|365414305|FG000|Overall Study|Discrepant chart documentation re route|0|||
105933003|NCT00504231|365414306|FG001|Overall Study|Discrepant chart documentation re route|0|||
105933004|NCT00504231|365414307|FG002|Overall Study|Discrepant chart documentation re route|1|||
105933005|NCT00504231|365414308|FG003|Overall Study|Discrepant chart documentation re route|0|||
105933006|NCT00088881|365414310|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
105933007|NCT00088881|365414310|FG000|Step 1 - R-CHOP|Adverse Event|1|||
105933008|NCT00088881|365414310|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
105933009|NCT00088881|365414310|FG000|Step 1 - R-CHOP|Physician Decision|1|||
105933010|NCT00088881|365414310|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
106008778|NCT01972217|365698961|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
106136649|NCT00359619|366160189|FG000|Overall Study|Withdrawal by Subject|3|||
105933011|NCT00088881|365414310|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
105933012|NCT00088881|365414310|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
105933013|NCT03600350|365414311|FG000|Overall Study|Death|1|||
105718309|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
105718310|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
105718311|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
105718312|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
105933014|NCT03600350|365414311|FG000|Overall Study|On Follow Up|18|||
106136650|NCT00359619|366160190|FG001|Overall Study|Withdrawal by Subject|1|||
106136651|NCT00359619|366160191|FG002|Overall Study|Withdrawal by Subject|4|||
106136652|NCT00359619|366160192|FG003|Overall Study|Withdrawal by Subject|2|||
106136653|NCT00359619|366160193|FG004|Overall Study|Withdrawal by Subject|2|||
105790692|NCT00483717|364887074|FG001|Overall Study|No treatment for migraine|13|||
105790693|NCT00483717|364887073|FG000|Overall Study|Lost to Follow-up|1|||
105790694|NCT00483717|364887074|FG001|Overall Study|Lost to Follow-up|0|||
105790695|NCT00483717|364887073|FG000|Overall Study|Withdrawal by Subject|1|||
105790696|NCT00483717|364887074|FG001|Overall Study|Withdrawal by Subject|0|||
105790697|NCT01682681|364887075|FG000|Overall Study|Lack of Efficacy|62|||
105790698|NCT01682681|364887075|FG000|Overall Study|Withdrawal by Subject|1|||
105790699|NCT01682681|364887075|FG000|Overall Study|Moved to other hospital|10|||
105790700|NCT01682681|364887075|FG000|Overall Study|Lost to Follow-up|174|||
105790701|NCT01682681|364887075|FG000|Overall Study|Adverse Event|46|||
105790702|NCT01682681|364887075|FG000|Overall Study|tapering of topiramate|5|||
105790703|NCT01682681|364887075|FG000|Overall Study|Other|21|||
105790704|NCT01682681|364887075|FG000|Overall Study|Low compliance|13|||
105790705|NCT01843660|364887079|FG000|Overall Study|Other|30|||
105790706|NCT00625846|364888368|FG000|Overall Study|Withdrawal by Subject|2|||
105790707|NCT00625846|364888369|FG001|Overall Study|Withdrawal by Subject|0|||
105790708|NCT00625846|364888370|FG002|Overall Study|Withdrawal by Subject|1|||
105933015|NCT00758043|365414315|FG000|Overall Study|Adverse Event|1|||
105933016|NCT00758043|365414316|FG001|Overall Study|Adverse Event|20|||
105933017|NCT00758043|365414317|FG002|Overall Study|Adverse Event|12|||
105933018|NCT00758043|365414318|FG003|Overall Study|Adverse Event|62|||
105933019|NCT00758043|365414315|FG000|Overall Study|Lack of Efficacy|0|||
105933020|NCT00758043|365414316|FG001|Overall Study|Lack of Efficacy|6|||
105933021|NCT00758043|365414317|FG002|Overall Study|Lack of Efficacy|18|||
105933022|NCT00758043|365414318|FG003|Overall Study|Lack of Efficacy|12|||
105933023|NCT00758043|365414315|FG000|Overall Study|Refused Further Treatment|0|||
105933024|NCT00758043|365414316|FG001|Overall Study|Refused Further Treatment|11|||
105933025|NCT00758043|365414317|FG002|Overall Study|Refused Further Treatment|5|||
105933026|NCT00758043|365414318|FG003|Overall Study|Refused Further Treatment|8|||
105933027|NCT00758043|365414315|FG000|Overall Study|Lost to Follow-up|0|||
105933028|NCT00758043|365414316|FG001|Overall Study|Lost to Follow-up|2|||
105933029|NCT00758043|365414317|FG002|Overall Study|Lost to Follow-up|2|||
105933030|NCT00758043|365414318|FG003|Overall Study|Lost to Follow-up|5|||
105933031|NCT00758043|365414315|FG000|Overall Study|Withdrawal by Subject|0|||
105933032|NCT00758043|365414316|FG001|Overall Study|Withdrawal by Subject|1|||
105933033|NCT00758043|365414317|FG002|Overall Study|Withdrawal by Subject|1|||
105933034|NCT00758043|365414318|FG003|Overall Study|Withdrawal by Subject|4|||
105933035|NCT00758043|365414315|FG000|Overall Study|Required Prohibited Medication|0|||
105933036|NCT00758043|365414316|FG001|Overall Study|Required Prohibited Medication|0|||
105933037|NCT00758043|365414317|FG002|Overall Study|Required Prohibited Medication|1|||
105933038|NCT00758043|365414318|FG003|Overall Study|Required Prohibited Medication|3|||
105933039|NCT00758043|365414315|FG000|Overall Study|Non-Compliant With study Drug|0|||
105933040|NCT00758043|365414316|FG001|Overall Study|Non-Compliant With study Drug|0|||
105933041|NCT00758043|365414317|FG002|Overall Study|Non-Compliant With study Drug|0|||
105933042|NCT00758043|365414318|FG003|Overall Study|Non-Compliant With study Drug|1|||
105933043|NCT00758043|365414315|FG000|Overall Study|Other Reasons|0|||
105933044|NCT00758043|365414316|FG001|Overall Study|Other Reasons|1|||
105933045|NCT00758043|365414317|FG002|Overall Study|Other Reasons|0|||
105933046|NCT00758043|365414318|FG003|Overall Study|Other Reasons|5|||
105933047|NCT00784927|365414319|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
105933048|NCT00784927|365414319|FG000|Overall Study|Protocol Violation|1|||
105933049|NCT00784927|365414319|FG000|Overall Study|Ineligible|1|||
105933050|NCT02082483|365414320|FG000|Overall Study|Lost to Follow-up|1|||
105933051|NCT02082483|365414321|FG001|Overall Study|Lost to Follow-up|1|||
105933052|NCT02082483|365414320|FG000|Overall Study|Withdrawal by Subject|2|||
105933053|NCT02082483|365414321|FG001|Overall Study|Withdrawal by Subject|1|||
105933054|NCT02082483|365414320|FG000|Overall Study|Physician Decision|1|||
105933055|NCT02082483|365414321|FG001|Overall Study|Physician Decision|1|||
105933056|NCT02082483|365414320|FG000|Overall Study|Death|2|||
105933057|NCT02082483|365414321|FG001|Overall Study|Death|3|||
105933058|NCT04027946|365414325|FG000|Overall Study|Screen failures|3|||
105933059|NCT00509600|365414327|FG000|Overall Study|Adverse Event|1|||
105933060|NCT03055195|365414328|FG000|Overall Study|Lack of Efficacy|1|||
105933061|NCT03055195|365414329|FG001|Overall Study|Lack of Efficacy|0|||
105933062|NCT03055195|365414328|FG000|Overall Study|Withdrawal by Subject|6|||
105933063|NCT03055195|365414329|FG001|Overall Study|Withdrawal by Subject|7|||
105933064|NCT03055195|365414328|FG000|Overall Study|Study Terminated by Sponsor|2|||
105790709|NCT00625846|364888371|FG003|Overall Study|Withdrawal by Subject|2|||
105933065|NCT03055195|365414329|FG001|Overall Study|Study Terminated by Sponsor|6|||
105933066|NCT03055195|365414328|FG000|Overall Study|Protocol Violation|2|||
105933067|NCT03055195|365414329|FG001|Overall Study|Protocol Violation|1|||
105933068|NCT03055195|365414328|FG000|Overall Study|Physician Decision|1|||
105933069|NCT03055195|365414329|FG001|Overall Study|Physician Decision|0|||
105933070|NCT02568423|365414330|FG000|Overall Study|Lost to Follow-up|0|||
106136654|NCT00359619|366160194|FG005|Overall Study|Withdrawal by Subject|0|||
106008779|NCT01972217|365698962|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
106008780|NCT01972217|365698959|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
105790710|NCT02353572|364888376|FG000|Overall Study|Withdrawal by Subject|1|||
106008781|NCT01972217|365698960|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
106008782|NCT01972217|365698961|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
106008783|NCT01972217|365698962|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
106008784|NCT01074502|365698964|FG000|Overall Study|Withdrawal by Subject|1|||
106008785|NCT00473564|365698965|FG000|Overall Study|robot surgery aborted in OR|23|||
106008786|NCT00674817|365698966|FG000|Period 1|Withdrawal by Subject|2|||
106008787|NCT00674817|365698966|FG000|Period 1|Protocol Violation|1|||
106008788|NCT00674817|365698966|FG000|Period 3|Adverse Event|1|||
106008789|NCT00674817|365698966|FG000|Period 3|Protocol Violation|1|||
106008790|NCT00674817|365698966|FG000|Period 4|Adverse Event|1|||
106008791|NCT03131219|365698969|FG000|Initial Evaluation Period|Adverse Event|2|||
106008792|NCT03131219|365698970|FG001|Initial Evaluation Period|Adverse Event|0|||
106008793|NCT03131219|365698969|FG000|Initial Evaluation Period|Protocol Violation|1|||
105790711|NCT02353572|364888376|FG000|Overall Study|Study terminated|2|||
105790712|NCT00769132|364888381|FG000|Period 1|Adverse Event|1|||
105790713|NCT00769132|364888382|FG001|Period 1|Adverse Event|0|||
105790714|NCT00769132|364888383|FG002|Period 1|Adverse Event|0|||
105790715|NCT00769132|364888384|FG003|Period 1|Adverse Event|1|||
105790716|NCT00769132|364888381|FG000|Period 2|Withdrawal by Subject|0|||
105790717|NCT00769132|364888382|FG001|Period 2|Withdrawal by Subject|0|||
105790718|NCT00769132|364888383|FG002|Period 2|Withdrawal by Subject|0|||
105790719|NCT00769132|364888384|FG003|Period 2|Withdrawal by Subject|1|||
105790720|NCT00769132|364888381|FG000|Period 3|Withdrawal by Subject|1|||
105790721|NCT00769132|364888382|FG001|Period 3|Withdrawal by Subject|0|||
105790722|NCT00769132|364888383|FG002|Period 3|Withdrawal by Subject|0|||
105790723|NCT00769132|364888384|FG003|Period 3|Withdrawal by Subject|0|||
105790724|NCT00769132|364888381|FG000|Period 4|Withdrawal by Subject|0|||
105790725|NCT00769132|364888382|FG001|Period 4|Withdrawal by Subject|1|||
105790726|NCT00769132|364888383|FG002|Period 4|Withdrawal by Subject|0|||
105790727|NCT00769132|364888384|FG003|Period 4|Withdrawal by Subject|0|||
105790728|NCT02230332|364888387|FG000|Overall Study|Adverse Event|2|||
105790729|NCT02230332|364888388|FG001|Overall Study|Adverse Event|1|||
105790730|NCT02230332|364888387|FG000|Overall Study|Lost to Follow-up|1|||
105790731|NCT02230332|364888388|FG001|Overall Study|Lost to Follow-up|0|||
105790732|NCT02230332|364888387|FG000|Overall Study|Protocol Violation|1|||
105790733|NCT02230332|364888388|FG001|Overall Study|Protocol Violation|0|||
105790734|NCT00557830|364888389|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
105790735|NCT00557830|364888390|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
105790736|NCT00557830|364888391|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
105790737|NCT00557830|364888389|FG000|Screening Treatment Phase|Adverse Event|2|||
105790738|NCT00557830|364888390|FG001|Screening Treatment Phase|Adverse Event|0|||
105790739|NCT00557830|364888391|FG002|Screening Treatment Phase|Adverse Event|0|||
105790740|NCT00557830|364888389|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
105790741|NCT00557830|364888390|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
105790742|NCT00557830|364888391|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
105790743|NCT01803464|364888393|FG000|Overall Study|Incomplete data|0|||
105790744|NCT01803464|364888394|FG001|Overall Study|Incomplete data|0|||
105790745|NCT01803464|364888395|FG002|Overall Study|Incomplete data|4|||
105790746|NCT01803464|364888396|FG003|Overall Study|Incomplete data|0|||
105790747|NCT01803464|364888393|FG000|Overall Study|Withdrawal by Subject|1|||
105790748|NCT01803464|364888394|FG001|Overall Study|Withdrawal by Subject|0|||
105790749|NCT01803464|364888395|FG002|Overall Study|Withdrawal by Subject|0|||
105790750|NCT01803464|364888396|FG003|Overall Study|Withdrawal by Subject|0|||
105790751|NCT03099161|364888397|FG000|Overall Study|Adverse Event|0|||
105790752|NCT03099161|364888398|FG001|Overall Study|Adverse Event|0|||
105790753|NCT03099161|364888399|FG002|Overall Study|Adverse Event|2|||
105790754|NCT03099161|364888397|FG000|Overall Study|Physician Decision|2|||
105790755|NCT03099161|364888398|FG001|Overall Study|Physician Decision|0|||
105790756|NCT03099161|364888399|FG002|Overall Study|Physician Decision|0|||
105790757|NCT03099161|364888397|FG000|Overall Study|Progressive Disease|1|||
105790758|NCT03099161|364888398|FG001|Overall Study|Progressive Disease|4|||
105790759|NCT03099161|364888399|FG002|Overall Study|Progressive Disease|1|||
106008794|NCT03131219|365698970|FG001|Initial Evaluation Period|Protocol Violation|0|||
105790760|NCT01833897|364888400|FG000|Overall Study|Lack of Efficacy|1|||
105790761|NCT01257737|364888402|FG000|Overall Study|Lost to Follow-up|1|||
105790762|NCT01257737|364888403|FG001|Overall Study|Lost to Follow-up|2|||
105790763|NCT01257737|364888402|FG000|Overall Study|Liver transplant|1|||
105790764|NCT01257737|364888403|FG001|Overall Study|Liver transplant|0|||
105790765|NCT01257737|364888402|FG000|Overall Study|Relocation out of the country|0|||
105790766|NCT01257737|364888403|FG001|Overall Study|Relocation out of the country|1|||
105790767|NCT01257737|364888402|FG000|Overall Study|Withdrew from study|0|||
105790768|NCT01257737|364888403|FG001|Overall Study|Withdrew from study|1|||
106008795|NCT03131219|365698969|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
105718313|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
105718314|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
105718315|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
105718316|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
105718317|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
105718318|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
105718319|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
105718320|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
105933071|NCT02568423|365414331|FG001|Overall Study|Lost to Follow-up|2|||
105933072|NCT02568423|365414332|FG002|Overall Study|Lost to Follow-up|0|||
105933073|NCT02568423|365414333|FG003|Overall Study|Lost to Follow-up|0|||
105933074|NCT02568423|365414334|FG004|Overall Study|Lost to Follow-up|0|||
105933075|NCT02568423|365414335|FG005|Overall Study|Lost to Follow-up|0|||
105933076|NCT02568423|365414336|FG006|Overall Study|Lost to Follow-up|0|||
105933077|NCT02568423|365414337|FG007|Overall Study|Lost to Follow-up|0|||
105933078|NCT02568423|365414330|FG000|Overall Study|Physician Decision|0|||
105933079|NCT02568423|365414331|FG001|Overall Study|Physician Decision|0|||
105933080|NCT02568423|365414332|FG002|Overall Study|Physician Decision|0|||
105933081|NCT02568423|365414333|FG003|Overall Study|Physician Decision|0|||
105933082|NCT02568423|365414334|FG004|Overall Study|Physician Decision|0|||
105933083|NCT02568423|365414335|FG005|Overall Study|Physician Decision|1|||
105933084|NCT02568423|365414336|FG006|Overall Study|Physician Decision|0|||
105933085|NCT02568423|365414337|FG007|Overall Study|Physician Decision|0|||
105933086|NCT00245570|365414340|FG000|Washout Between Periods III and IV|Adverse Event|0|||
105933087|NCT00245570|365414341|FG001|Washout Between Periods III and IV|Adverse Event|1|||
105933088|NCT00245570|365414342|FG002|Washout Between Periods III and IV|Adverse Event|0|||
105933089|NCT00245570|365414343|FG003|Washout Between Periods III and IV|Adverse Event|0|||
105933090|NCT00245570|365414344|FG004|Washout Between Periods III and IV|Adverse Event|0|||
105933091|NCT00245570|365414345|FG005|Washout Between Periods III and IV|Adverse Event|0|||
105933092|NCT00103506|365414346|FG000|Overall Study|Study closed by sponsor|34|||
105933093|NCT00103506|365414347|FG001|Overall Study|Study closed by sponsor|37|||
105933094|NCT00103506|365414346|FG000|Overall Study|Death|257|||
105933095|NCT00103506|365414347|FG001|Overall Study|Death|253|||
105933096|NCT00103506|365414346|FG000|Overall Study|Lost to Follow-up|13|||
105933097|NCT00103506|365414347|FG001|Overall Study|Lost to Follow-up|13|||
105933098|NCT00103506|365414346|FG000|Overall Study|Withdrawal by Subject|18|||
105933099|NCT00103506|365414347|FG001|Overall Study|Withdrawal by Subject|21|||
105933100|NCT00574951|365414348|FG000|Overall Study|Ineligible - improper prior treatment|1|||
105933101|NCT00585169|365414360|FG000|Overall Study|Withdrawal by Subject|1|||
105933102|NCT01560988|365414367|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
105933103|NCT01560988|365414368|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
105933104|NCT01560988|365414367|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
105933105|NCT01560988|365414368|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
105933106|NCT01560988|365414367|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
105933107|NCT01560988|365414368|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
105933108|NCT01346709|365414369|FG000|Overall Study|Protocol Violation|35|||
105933109|NCT01346709|365414369|FG000|Overall Study|Lost to Follow-up|31|||
105933110|NCT01346709|365414369|FG000|Overall Study|Missing data in candidate risk factor|285|||
105933111|NCT01433978|365414374|FG000|Core Study|Adverse Event, Non-Fatal|0|||
105933112|NCT01433978|365414375|FG001|Core Study|Adverse Event, Non-Fatal|1|||
105933113|NCT01433978|365414376|FG002|Core Study|Adverse Event, Non-Fatal|0|||
105933114|NCT01433978|365414374|FG000|Core Study|Lack of Efficacy|5|||
105933115|NCT01433978|365414375|FG001|Core Study|Lack of Efficacy|1|||
105933116|NCT01433978|365414376|FG002|Core Study|Lack of Efficacy|0|||
105933117|NCT01433978|365414374|FG000|Core Study|Study Terminated by Sponsor|6|||
105933118|NCT01433978|365414375|FG001|Core Study|Study Terminated by Sponsor|9|||
105933119|NCT01433978|365414376|FG002|Core Study|Study Terminated by Sponsor|0|||
105933120|NCT01433978|365414374|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
105933121|NCT01433978|365414375|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
105933122|NCT01433978|365414376|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
105933123|NCT01433978|365414374|FG000|Extension Phase|Lack of Efficacy|0|||
105718321|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
105718322|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
105933124|NCT01433978|365414375|FG001|Extension Phase|Lack of Efficacy|0|||
105933125|NCT01433978|365414376|FG002|Extension Phase|Lack of Efficacy|1|||
105933126|NCT01433978|365414374|FG000|Extension Phase|Study Terminated by Sponsor|0|||
105933127|NCT01433978|365414375|FG001|Extension Phase|Study Terminated by Sponsor|0|||
105933128|NCT01433978|365414376|FG002|Extension Phase|Study Terminated by Sponsor|4|||
105933129|NCT01773889|365414383|FG000|Overall Study|lack of funding|2|||
105933130|NCT02301429|365414384|FG000|Overall Study|not acceptable vascular anatomy|3|||
105933131|NCT05156125|365414395|FG000|Overall Study|Lack of Efficacy|1|||
106008796|NCT03131219|365698970|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
106008797|NCT03131219|365698969|FG000|Initial Evaluation Period|Physician Decision|1|||
106008798|NCT03131219|365698970|FG001|Initial Evaluation Period|Physician Decision|0|||
106008799|NCT03131219|365698969|FG000|Extension Period|Physician Decision|1|||
106008800|NCT03131219|365698970|FG001|Extension Period|Physician Decision|0|||
106008801|NCT00616759|365698971|FG000|Overall Study|Physician Decision|2|||
106008802|NCT00616759|365698972|FG001|Overall Study|Physician Decision|0|||
106008803|NCT00616759|365698971|FG000|Overall Study|Withdrawal by Subject|1|||
106008804|NCT00616759|365698972|FG001|Overall Study|Withdrawal by Subject|2|||
106008805|NCT02177123|365698974|FG000|Overall Study|Lost to Follow-up|6|||
106008806|NCT02177123|365698974|FG000|Overall Study|Withdrawal by Subject|4|||
106008807|NCT02177123|365698974|FG000|Overall Study|Adverse Event|4|||
106008808|NCT02177123|365698974|FG000|Overall Study|Physician Decision|3|||
106008809|NCT02177123|365698974|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
106008810|NCT02177123|365698974|FG000|Overall Study|Excluded for medical reasons|2|||
106008811|NCT02177123|365698974|FG000|Overall Study|Death|1|||
106008812|NCT02177123|365698974|FG000|Overall Study|Other|1|||
106008813|NCT02177123|365698974|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
106008814|NCT00671658|365698980|FG000|Overall Study|Physician Decision|5|||
106008815|NCT01921205|365698981|FG000|Overall Study|Adverse Event|12|||
106008816|NCT01921205|365698982|FG001|Overall Study|Adverse Event|7|||
106008817|NCT01921205|365698981|FG000|Overall Study|Lack of Efficacy|1|||
106008818|NCT01921205|365698982|FG001|Overall Study|Lack of Efficacy|0|||
106008819|NCT01921205|365698981|FG000|Overall Study|Protocol Violation|1|||
106008820|NCT01921205|365698982|FG001|Overall Study|Protocol Violation|3|||
106008821|NCT01921205|365698981|FG000|Overall Study|Lost to Follow-up|1|||
106008822|NCT01921205|365698982|FG001|Overall Study|Lost to Follow-up|1|||
106008823|NCT01921205|365698981|FG000|Overall Study|Withdrawal by Subject|6|||
106008824|NCT01921205|365698982|FG001|Overall Study|Withdrawal by Subject|5|||
106008825|NCT01921205|365698981|FG000|Overall Study|Use Of Prohibited Medication|0|||
106008826|NCT01921205|365698982|FG001|Overall Study|Use Of Prohibited Medication|1|||
106008827|NCT01921205|365698981|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
106008828|NCT01921205|365698982|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
106008829|NCT01921205|365698981|FG000|Overall Study|Non Compliance Of The Parent|0|||
106008830|NCT01921205|365698982|FG001|Overall Study|Non Compliance Of The Parent|1|||
106008831|NCT01921205|365698981|FG000|Overall Study|Non Compliance Of Child|0|||
106008832|NCT01921205|365698982|FG001|Overall Study|Non Compliance Of Child|1|||
106008833|NCT01527149|365698983|FG000|Overall Study|Death|2|||
106008834|NCT00360230|365698984|FG000|Overall Study|Withdrawal by Subject|1|||
106008835|NCT00360230|365698985|FG001|Overall Study|Withdrawal by Subject|1|||
106008836|NCT00360230|365698986|FG002|Overall Study|Withdrawal by Subject|0|||
106008837|NCT00360230|365698987|FG003|Overall Study|Withdrawal by Subject|1|||
106008838|NCT00360230|365698988|FG004|Overall Study|Withdrawal by Subject|1|||
106008839|NCT00360230|365698989|FG005|Overall Study|Withdrawal by Subject|1|||
106008840|NCT00360230|365698990|FG006|Overall Study|Withdrawal by Subject|0|||
106136655|NCT00359619|366160195|FG006|Overall Study|Withdrawal by Subject|3|||
106136656|NCT00359619|366160189|FG000|Overall Study|Other|1|||
105718323|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
105718324|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
105718325|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
105718326|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718327|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718328|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718329|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718330|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
105718331|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718332|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
105718333|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
105718334|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
105718335|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
105718336|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
105718337|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
105718338|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
105718339|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
106008841|NCT00360230|365698984|FG000|Overall Study|Migrated|4|||
106008842|NCT00360230|365698985|FG001|Overall Study|Migrated|1|||
106008843|NCT00360230|365698986|FG002|Overall Study|Migrated|3|||
106008844|NCT00360230|365698987|FG003|Overall Study|Migrated|1|||
106008845|NCT00360230|365698988|FG004|Overall Study|Migrated|4|||
106008846|NCT00360230|365698989|FG005|Overall Study|Migrated|1|||
106008847|NCT00360230|365698990|FG006|Overall Study|Migrated|1|||
106008848|NCT00360230|365698984|FG000|Overall Study|Other|1|||
105790769|NCT02723786|364888411|FG000|Overall Study|Lost to Follow-up|1|||
105790770|NCT00806416|364888413|FG000|Period 1 - Part I|Adverse Event|0|||
105790771|NCT00806416|364888414|FG001|Period 1 - Part I|Adverse Event|1|||
105790772|NCT00806416|364888415|FG002|Period 1 - Part I|Adverse Event|0|||
105790773|NCT00806416|364888416|FG003|Period 1 - Part I|Adverse Event|0|||
105790774|NCT00806416|364888413|FG000|Period 1 - Part I|Lost to Follow-up|0|||
105790775|NCT00806416|364888414|FG001|Period 1 - Part I|Lost to Follow-up|2|||
105790776|NCT00806416|364888415|FG002|Period 1 - Part I|Lost to Follow-up|0|||
105790777|NCT00806416|364888416|FG003|Period 1 - Part I|Lost to Follow-up|0|||
105790778|NCT00806416|364888413|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
105790779|NCT00806416|364888414|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
105790780|NCT00806416|364888415|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
105790781|NCT00806416|364888416|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
105790782|NCT00806416|364888413|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
105790783|NCT00806416|364888414|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
105790784|NCT00806416|364888415|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
105790785|NCT00806416|364888416|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
105790786|NCT03345485|364888421|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
105790787|NCT03345485|364888422|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
105790788|NCT03345485|364888423|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
105790789|NCT03345485|364888424|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
105790790|NCT03345485|364888425|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
105790791|NCT03345485|364888426|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
105790792|NCT03345485|364888427|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
105790793|NCT03345485|364888428|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
105790794|NCT03345485|364888429|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
105790795|NCT03345485|364888430|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
106136657|NCT00359619|366160190|FG001|Overall Study|Other|0|||
106136658|NCT00359619|366160191|FG002|Overall Study|Other|0|||
105790796|NCT03345485|364888431|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
105790797|NCT03345485|364888432|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
105790798|NCT03345485|364888433|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
105790799|NCT02985515|364888434|FG000|Olfaction Testing|Lost to Follow-up|0|||
105790800|NCT02985515|364888435|FG001|Olfaction Testing|Lost to Follow-up|5|||
105790801|NCT02985515|364888434|FG000|Olfaction Testing|Protocol Violation|0|||
105790802|NCT02985515|364888435|FG001|Olfaction Testing|Protocol Violation|3|||
105790803|NCT01610284|364888438|FG000|Randomization Phase|Adverse Event|1|||
105790804|NCT01610284|364888439|FG001|Randomization Phase|Adverse Event|0|||
105790805|NCT01610284|364888438|FG000|Randomization Phase|Physician Decision|1|||
105790806|NCT01610284|364888439|FG001|Randomization Phase|Physician Decision|1|||
105790807|NCT01610284|364888438|FG000|Randomization Phase|Death|0|||
105790808|NCT01610284|364888439|FG001|Randomization Phase|Death|1|||
105790809|NCT01610284|364888438|FG000|Treatment Phase|Adverse Event|80|||
105790810|NCT01610284|364888439|FG001|Treatment Phase|Adverse Event|12|||
105790811|NCT01610284|364888438|FG000|Treatment Phase|Lost to Follow-up|1|||
105790812|NCT01610284|364888439|FG001|Treatment Phase|Lost to Follow-up|0|||
105790813|NCT01610284|364888438|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
105790814|NCT01610284|364888439|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
105790815|NCT01610284|364888438|FG000|Treatment Phase|Physician Decision|27|||
105933132|NCT05156125|365414396|FG001|Overall Study|Lack of Efficacy|1|||
105933133|NCT05156125|365414397|FG002|Overall Study|Lack of Efficacy|1|||
105933134|NCT05156125|365414395|FG000|Overall Study|Physician Decision|0|||
105933135|NCT05156125|365414396|FG001|Overall Study|Physician Decision|0|||
105933136|NCT05156125|365414397|FG002|Overall Study|Physician Decision|1|||
105933137|NCT05156125|365414395|FG000|Overall Study|Non-compliance|0|||
105933138|NCT05156125|365414396|FG001|Overall Study|Non-compliance|1|||
105933139|NCT05156125|365414397|FG002|Overall Study|Non-compliance|1|||
105933140|NCT05156125|365414395|FG000|Overall Study|Withdrawal by Subject|0|||
105933141|NCT05156125|365414396|FG001|Overall Study|Withdrawal by Subject|0|||
105933142|NCT05156125|365414397|FG002|Overall Study|Withdrawal by Subject|1|||
105933143|NCT05156125|365414395|FG000|Overall Study|Adverse Event|2|||
105933144|NCT05156125|365414396|FG001|Overall Study|Adverse Event|1|||
105933145|NCT05156125|365414397|FG002|Overall Study|Adverse Event|0|||
105933146|NCT02609633|365414398|FG000|Overall Study|Consent Withdrawn|0|||
105790816|NCT01610284|364888439|FG001|Treatment Phase|Physician Decision|24|||
106136659|NCT00359619|366160192|FG003|Overall Study|Other|0|||
105790817|NCT01610284|364888438|FG000|Treatment Phase|Progressive Disease|377|||
105790818|NCT01610284|364888439|FG001|Treatment Phase|Progressive Disease|486|||
105790819|NCT01610284|364888438|FG000|Treatment Phase|Protocol Deviation|2|||
105790820|NCT01610284|364888439|FG001|Treatment Phase|Protocol Deviation|3|||
105933147|NCT02609633|365414399|FG001|Overall Study|Consent Withdrawn|1|||
105933148|NCT02609633|365414398|FG000|Overall Study|Protocol Deviation|1|||
105933149|NCT02609633|365414399|FG001|Overall Study|Protocol Deviation|0|||
105933150|NCT02609633|365414398|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
105933151|NCT02609633|365414399|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
106136660|NCT00359619|366160193|FG004|Overall Study|Other|0|||
105718340|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
105718341|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
105718342|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
105718343|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
105718344|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718345|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718346|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718347|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718348|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
105718349|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718350|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
105718351|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718352|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
105718353|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718354|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
105718355|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718356|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
105718357|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
105718358|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718359|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
105718360|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105718361|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
105933152|NCT02609633|365414398|FG000|Overall Study|Reason not Specified|2|||
105933153|NCT02609633|365414399|FG001|Overall Study|Reason not Specified|1|||
105933154|NCT00337194|365414400|FG000|Overall Study|Adverse Event|5|||
105933155|NCT00337194|365414401|FG001|Overall Study|Adverse Event|1|||
105933156|NCT00337194|365414400|FG000|Overall Study|Death|2|||
105933157|NCT00337194|365414401|FG001|Overall Study|Death|0|||
105933158|NCT00337194|365414400|FG000|Overall Study|Withdrawal by Subject|1|||
105933159|NCT00337194|365414401|FG001|Overall Study|Withdrawal by Subject|0|||
105933160|NCT00337194|365414400|FG000|Overall Study|Disease progression|1|||
105933161|NCT00337194|365414401|FG001|Overall Study|Disease progression|2|||
105933162|NCT00337194|365414400|FG000|Overall Study|Subsequent non-protocol therapy|3|||
105933163|NCT00337194|365414401|FG001|Overall Study|Subsequent non-protocol therapy|1|||
105933164|NCT02018887|365414406|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
105933165|NCT02018887|365414407|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933166|NCT02018887|365414408|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933167|NCT02018887|365414409|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933168|NCT02018887|365414410|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933169|NCT02018887|365414411|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933170|NCT02018887|365414412|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933171|NCT02018887|365414413|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933172|NCT02018887|365414414|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933173|NCT02018887|365414415|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933174|NCT02018887|365414416|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
105933175|NCT02018887|365414406|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105933176|NCT02018887|365414407|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105933177|NCT02018887|365414408|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105933178|NCT02018887|365414409|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105933179|NCT02018887|365414410|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
105933180|NCT02018887|365414411|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105933181|NCT02018887|365414412|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
105933182|NCT02018887|365414413|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
105933183|NCT02018887|365414414|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105933184|NCT02018887|365414415|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105933185|NCT02018887|365414416|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
105933186|NCT02018887|365414406|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
105933187|NCT02018887|365414407|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
105933188|NCT02018887|365414408|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
105933189|NCT02018887|365414409|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
105933190|NCT02018887|365414410|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
105933191|NCT02018887|365414411|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
105718362|NCT01583374|364627016|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
105718363|NCT01583374|364627017|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
105718364|NCT01583374|364627018|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
105933192|NCT02018887|365414412|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
105933193|NCT02018887|365414413|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
105933194|NCT02018887|365414414|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
105933195|NCT02018887|365414415|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
105933196|NCT02018887|365414416|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
105933197|NCT02018887|365414406|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
106008849|NCT00360230|365698985|FG001|Overall Study|Other|0|||
106008850|NCT00360230|365698986|FG002|Overall Study|Other|0|||
106008851|NCT00360230|365698987|FG003|Overall Study|Other|0|||
106008852|NCT00360230|365698988|FG004|Overall Study|Other|0|||
106008853|NCT00360230|365698989|FG005|Overall Study|Other|0|||
106008854|NCT00360230|365698990|FG006|Overall Study|Other|0|||
106008855|NCT00360230|365698984|FG000|Overall Study|Protocol Violation|0|||
106008856|NCT00360230|365698985|FG001|Overall Study|Protocol Violation|0|||
106008857|NCT00360230|365698986|FG002|Overall Study|Protocol Violation|0|||
106008858|NCT00360230|365698987|FG003|Overall Study|Protocol Violation|0|||
106008859|NCT00360230|365698988|FG004|Overall Study|Protocol Violation|0|||
106008860|NCT00360230|365698989|FG005|Overall Study|Protocol Violation|1|||
106008861|NCT00360230|365698990|FG006|Overall Study|Protocol Violation|0|||
106008862|NCT00360230|365698984|FG000|Overall Study|Death|0|||
106008863|NCT00360230|365698985|FG001|Overall Study|Death|1|||
106008864|NCT00360230|365698986|FG002|Overall Study|Death|0|||
106008865|NCT00360230|365698987|FG003|Overall Study|Death|0|||
106008866|NCT00360230|365698988|FG004|Overall Study|Death|0|||
106008867|NCT00360230|365698989|FG005|Overall Study|Death|1|||
106008868|NCT00360230|365698990|FG006|Overall Study|Death|1|||
106008869|NCT00481832|365698992|FG000|Enrollment|Physician Decision|8|||
106008870|NCT00481832|365698992|FG000|Enrollment|Unable to collect enough stem cells|2|||
106008871|NCT00481832|365698992|FG000|Inter-transplant Period|Adverse Event|4|||
105718365|NCT01583374|364627019|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
105718366|NCT01583374|364627020|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
105718367|NCT01583374|364627021|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
105718368|NCT01583374|364627022|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
105718369|NCT01583374|364627023|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
105718370|NCT01583374|364627024|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
105718371|NCT01292057|364627027|FG000|Overall Study|Protocol Violation|1|||
105718372|NCT01292057|364627028|FG001|Overall Study|Protocol Violation|1|||
105718373|NCT01292057|364627027|FG000|Overall Study|Lost to Follow-up|1|||
105718374|NCT01292057|364627028|FG001|Overall Study|Lost to Follow-up|1|||
105718375|NCT01986062|364627029|FG000|Overall Study|Lost to Follow-up|1|||
105718376|NCT01986062|364627030|FG001|Overall Study|Lost to Follow-up|0|||
105718377|NCT01986062|364627029|FG000|Overall Study|Withdrawal by Subject|0|||
105718378|NCT01986062|364627030|FG001|Overall Study|Withdrawal by Subject|1|||
105718379|NCT01827384|364627033|FG000|Overall Study|Switched to alternative treatment|0|||
105718380|NCT01827384|364627034|FG001|Overall Study|Switched to alternative treatment|0|||
105718381|NCT01827384|364627035|FG002|Overall Study|Switched to alternative treatment|0|||
105718382|NCT01827384|364627036|FG003|Overall Study|Switched to alternative treatment|0|||
105718383|NCT01827384|364627037|FG004|Overall Study|Switched to alternative treatment|0|||
105718384|NCT01827384|364627038|FG005|Overall Study|Switched to alternative treatment|0|||
105718385|NCT01827384|364627039|FG006|Overall Study|Switched to alternative treatment|0|||
105718386|NCT01827384|364627040|FG007|Overall Study|Switched to alternative treatment|0|||
105718387|NCT01827384|364627041|FG008|Overall Study|Switched to alternative treatment|0|||
105718388|NCT01827384|364627042|FG009|Overall Study|Switched to alternative treatment|0|||
105718389|NCT01827384|364627043|FG010|Overall Study|Switched to alternative treatment|0|||
105718390|NCT01827384|364627044|FG011|Overall Study|Switched to alternative treatment|0|||
105718391|NCT01827384|364627045|FG012|Overall Study|Switched to alternative treatment|0|||
105718392|NCT01827384|364627046|FG013|Overall Study|Switched to alternative treatment|2|||
105718393|NCT01827384|364627033|FG000|Overall Study|Disease progression before treatment|0|||
105718394|NCT01827384|364627034|FG001|Overall Study|Disease progression before treatment|0|||
105718395|NCT01827384|364627035|FG002|Overall Study|Disease progression before treatment|0|||
105718396|NCT01827384|364627036|FG003|Overall Study|Disease progression before treatment|0|||
105718397|NCT01827384|364627037|FG004|Overall Study|Disease progression before treatment|0|||
105718398|NCT01827384|364627038|FG005|Overall Study|Disease progression before treatment|0|||
105718399|NCT01827384|364627039|FG006|Overall Study|Disease progression before treatment|0|||
105718400|NCT01827384|364627040|FG007|Overall Study|Disease progression before treatment|0|||
105718401|NCT01827384|364627041|FG008|Overall Study|Disease progression before treatment|0|||
105718402|NCT01827384|364627042|FG009|Overall Study|Disease progression before treatment|0|||
105718403|NCT01827384|364627043|FG010|Overall Study|Disease progression before treatment|0|||
106008872|NCT00481832|365698992|FG000|Inter-transplant Period|Death|3|||
106008873|NCT00481832|365698992|FG000|Inter-transplant Period|Physician Decision|4|||
106008874|NCT00481832|365698992|FG000|Inter-transplant Period|Disease relapse|11|||
106008875|NCT00481832|365698992|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
106008876|NCT02558894|365698993|FG000|Overall Study|Death; any cause, entire study duration|28|||
106008877|NCT02558894|365698994|FG001|Overall Study|Death; any cause, entire study duration|31|||
106008878|NCT02558894|365698993|FG000|Overall Study|Withdrawal by Subject|2|||
105718404|NCT01827384|364627044|FG011|Overall Study|Disease progression before treatment|0|||
105718405|NCT01827384|364627045|FG012|Overall Study|Disease progression before treatment|0|||
106008879|NCT02558894|365698994|FG001|Overall Study|Withdrawal by Subject|1|||
106008880|NCT02558894|365698993|FG000|Overall Study|Closure of Part A|2|||
106008881|NCT02558894|365698994|FG001|Overall Study|Closure of Part A|1|||
105790821|NCT01610284|364888438|FG000|Treatment Phase|Study terminated by Sponsor|18|||
105790822|NCT01610284|364888439|FG001|Treatment Phase|Study terminated by Sponsor|15|||
105790823|NCT01610284|364888438|FG000|Treatment Phase|Subject/Guardian Decision|55|||
105790824|NCT01610284|364888439|FG001|Treatment Phase|Subject/Guardian Decision|23|||
105790825|NCT01610284|364888438|FG000|Treatment Phase|Death|6|||
105790826|NCT01610284|364888439|FG001|Treatment Phase|Death|5|||
105790827|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
105790828|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105790829|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
105790830|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
105790831|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
105790832|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
105790833|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
105790834|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
105790835|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
105790836|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
105790837|NCT01610284|364888438|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
105790838|NCT01610284|364888439|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
105790839|NCT01856257|364888440|FG000|Overall Study|Death|2|||
105790840|NCT01856257|364888441|FG001|Overall Study|Death|0|||
105790841|NCT01856257|364888442|FG002|Overall Study|Death|0|||
105790842|NCT01856257|364888443|FG003|Overall Study|Death|0|||
105790843|NCT01856257|364888440|FG000|Overall Study|Physician Decision|0|||
105790844|NCT01856257|364888441|FG001|Overall Study|Physician Decision|0|||
105790845|NCT01856257|364888442|FG002|Overall Study|Physician Decision|0|||
105790846|NCT01856257|364888443|FG003|Overall Study|Physician Decision|1|||
105790847|NCT01856257|364888440|FG000|Overall Study|Withdrawal by Subject|1|||
106008882|NCT01527370|365698996|FG000|Overall Study|Withdrawal by Subject|4|||
106008883|NCT01527370|365698996|FG000|Overall Study|Physician Decision|1|||
106008884|NCT01527370|365698996|FG000|Overall Study|Death|1|||
106008885|NCT02340026|365699005|FG000|Treatment Phase|Withdrawal by Subject|2|||
106008886|NCT02340026|365699006|FG001|Treatment Phase|Withdrawal by Subject|2|||
106008887|NCT02340026|365699005|FG000|Follow-up Phase|Lost to Follow-up|1|||
105790848|NCT01856257|364888441|FG001|Overall Study|Withdrawal by Subject|1|||
106008888|NCT02340026|365699006|FG001|Follow-up Phase|Lost to Follow-up|0|||
106008889|NCT01436149|365699007|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
106008890|NCT01436149|365699008|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
106008891|NCT01436149|365699009|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
106008892|NCT01436149|365699007|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
106008893|NCT01436149|365699008|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
106008894|NCT01436149|365699009|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
106008895|NCT01436149|365699007|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
106008896|NCT01436149|365699008|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
106008897|NCT01436149|365699009|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
106008898|NCT01436149|365699007|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
106008899|NCT01436149|365699008|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
106008900|NCT01436149|365699009|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
106008901|NCT01436149|365699007|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
106008902|NCT01436149|365699008|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
106008903|NCT01436149|365699009|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
106008904|NCT01436149|365699007|FG000|Antidepressant Lead-in Phase|Other|119|||
106008905|NCT01436149|365699008|FG001|Antidepressant Lead-in Phase|Other|0|||
106008906|NCT01436149|365699009|FG002|Antidepressant Lead-in Phase|Other|0|||
106008907|NCT01436149|365699007|FG000|Randomized Phase|Adverse Event|9|||
106008908|NCT01436149|365699008|FG001|Randomized Phase|Adverse Event|10|||
106008909|NCT01436149|365699009|FG002|Randomized Phase|Adverse Event|11|||
106008910|NCT01436149|365699007|FG000|Randomized Phase|Protocol Violation|4|||
106008911|NCT01436149|365699008|FG001|Randomized Phase|Protocol Violation|5|||
106008912|NCT01436149|365699009|FG002|Randomized Phase|Protocol Violation|0|||
106008913|NCT01436149|365699007|FG000|Randomized Phase|Withdrawal by Subject|16|||
106008914|NCT01436149|365699008|FG001|Randomized Phase|Withdrawal by Subject|10|||
106008915|NCT01436149|365699009|FG002|Randomized Phase|Withdrawal by Subject|10|||
106008916|NCT01436149|365699007|FG000|Randomized Phase|Lost to Follow-up|34|||
105790849|NCT01856257|364888442|FG002|Overall Study|Withdrawal by Subject|0|||
105790850|NCT01856257|364888443|FG003|Overall Study|Withdrawal by Subject|0|||
105790851|NCT01856257|364888440|FG000|Overall Study|Donor complication|0|||
105790852|NCT01856257|364888441|FG001|Overall Study|Donor complication|0|||
105790853|NCT01856257|364888442|FG002|Overall Study|Donor complication|0|||
106008917|NCT01436149|365699008|FG001|Randomized Phase|Lost to Follow-up|5|||
106008918|NCT01436149|365699009|FG002|Randomized Phase|Lost to Follow-up|6|||
105790854|NCT01856257|364888443|FG003|Overall Study|Donor complication|1|||
106008919|NCT01436149|365699007|FG000|Randomized Phase|Lack of Efficacy|0|||
106008920|NCT01436149|365699008|FG001|Randomized Phase|Lack of Efficacy|0|||
105790855|NCT01157065|364888444|FG000|Overall Study|Death|0|||
105790856|NCT01157065|364888445|FG001|Overall Study|Death|1|||
105790857|NCT01265875|364888446|FG000|Overall Study|Uncooperative/unreliable|1|||
105790858|NCT04409509|364888447|FG000|Overall Study|Failure to meet randomization requirement|1|||
105790859|NCT04409509|364888448|FG001|Overall Study|Failure to meet randomization requirement|0|||
106008921|NCT01436149|365699009|FG002|Randomized Phase|Lack of Efficacy|1|||
106008922|NCT01436149|365699007|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
106008923|NCT01436149|365699008|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
106008924|NCT01436149|365699009|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
106008925|NCT01436149|365699007|FG000|Randomized Phase|Other|12|||
106008926|NCT01436149|365699008|FG001|Randomized Phase|Other|5|||
106008927|NCT01436149|365699009|FG002|Randomized Phase|Other|11|||
106008928|NCT03019406|365699016|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
106008929|NCT03019406|365699017|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
106008930|NCT03019406|365699018|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
106008931|NCT03019406|365699019|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
106008932|NCT02946580|365699023|FG000|Overall Study|Withdrawal by Subject|1|||
106008933|NCT02946580|365699024|FG001|Overall Study|Withdrawal by Subject|2|||
106008934|NCT02946580|365699023|FG000|Overall Study|Adverse Event|0|||
106008935|NCT02946580|365699024|FG001|Overall Study|Adverse Event|2|||
106008936|NCT02946580|365699023|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
106008937|NCT02946580|365699024|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
106008938|NCT01903460|365699025|FG000|Overall Study|Adverse Event|0|||
106008939|NCT01903460|365699026|FG001|Overall Study|Adverse Event|0|||
106008940|NCT01903460|365699027|FG002|Overall Study|Adverse Event|0|||
106008941|NCT01903460|365699028|FG003|Overall Study|Adverse Event|1|||
106008942|NCT05712460|365699029|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008943|NCT05712460|365699030|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008944|NCT05712460|365699031|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008945|NCT05712460|365699032|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008946|NCT05712460|365699033|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008947|NCT05712460|365699034|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008948|NCT05712460|365699035|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008949|NCT05712460|365699036|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
106008950|NCT05712460|365699037|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008951|NCT05712460|365699038|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008952|NCT05712460|365699039|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008953|NCT05712460|365699040|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
106008954|NCT04408989|365699045|FG000|Overall Study|Lost to Follow-up|0|||
106008955|NCT04408989|365699046|FG001|Overall Study|Lost to Follow-up|0|||
106008956|NCT04408989|365699047|FG002|Overall Study|Lost to Follow-up|1|||
106008957|NCT04408989|365699045|FG000|Overall Study|Withdrawal by Subject|0|||
106008958|NCT04408989|365699046|FG001|Overall Study|Withdrawal by Subject|0|||
105790860|NCT04409509|364888447|FG000|Overall Study|Adverse Event|0|||
105790861|NCT04409509|364888448|FG001|Overall Study|Adverse Event|1|||
105790862|NCT04409509|364888447|FG000|Overall Study|Death|11|||
105933198|NCT02018887|365414407|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
105933199|NCT02018887|365414408|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
105933200|NCT02018887|365414409|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
105933201|NCT02018887|365414410|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
105933202|NCT02018887|365414411|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
105933203|NCT02018887|365414412|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
105933204|NCT02018887|365414413|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
105933205|NCT02018887|365414414|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
105933206|NCT02018887|365414415|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
105933207|NCT02018887|365414416|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
105933208|NCT01111292|365414417|FG000|Treatment|Physician Decision|1|||
105933209|NCT01111292|365414418|FG001|Treatment|Physician Decision|1|||
105933210|NCT01750281|365414419|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
105933211|NCT01750281|365414420|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
105933212|NCT01750281|365414421|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
106008959|NCT04408989|365699047|FG002|Overall Study|Withdrawal by Subject|2|||
105790863|NCT04409509|364888448|FG001|Overall Study|Death|10|||
105790864|NCT04409509|364888447|FG000|Overall Study|Non-compliance with study drug|0|||
105933213|NCT01750281|365414419|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
105933214|NCT01750281|365414420|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
105933215|NCT01750281|365414421|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
105933216|NCT01750281|365414419|FG000|Overall Study|Did not receive treatment|0|||
105933217|NCT01750281|365414420|FG001|Overall Study|Did not receive treatment|1|||
105933218|NCT01750281|365414421|FG002|Overall Study|Did not receive treatment|0|||
106008960|NCT04672239|365699048|FG000|Week 2 Survey|Failed survey check items|1|||
105933219|NCT02959892|365414424|FG000|Overall Study|PET tracer synthesis failure|1|||
105933220|NCT02959892|365414425|FG001|Overall Study|PET tracer synthesis failure|0|||
106008961|NCT04672239|365699049|FG001|Week 2 Survey|Failed survey check items|2|||
106008962|NCT04672239|365699050|FG002|Week 2 Survey|Failed survey check items|3|||
106008963|NCT04672239|365699048|FG000|Week 2 Survey|Partially completed survey|7|||
106008964|NCT04672239|365699049|FG001|Week 2 Survey|Partially completed survey|1|||
106008965|NCT04672239|365699050|FG002|Week 2 Survey|Partially completed survey|4|||
106008966|NCT04672239|365699048|FG000|Week 2 Survey|Withdrawal by Subject|0|||
106008967|NCT04672239|365699049|FG001|Week 2 Survey|Withdrawal by Subject|1|||
106008968|NCT04672239|365699050|FG002|Week 2 Survey|Withdrawal by Subject|0|||
106008969|NCT04672239|365699048|FG000|Week 2 Survey|Lost to Follow-up|3|||
106008970|NCT04672239|365699049|FG001|Week 2 Survey|Lost to Follow-up|2|||
105718406|NCT01827384|364627046|FG013|Overall Study|Disease progression before treatment|4|||
105718407|NCT01827384|364627033|FG000|Overall Study|Ineligible|0|||
105718408|NCT01827384|364627034|FG001|Overall Study|Ineligible|0|||
105718409|NCT01827384|364627035|FG002|Overall Study|Ineligible|0|||
105718410|NCT01827384|364627036|FG003|Overall Study|Ineligible|0|||
105718411|NCT01827384|364627037|FG004|Overall Study|Ineligible|0|||
105933221|NCT02959892|365414424|FG000|Overall Study|Study termination|0|||
105933222|NCT02959892|365414425|FG001|Overall Study|Study termination|1|||
105933223|NCT05529173|365414432|FG000|Overall Study|Physician Decision|3|||
105933224|NCT05529173|365414433|FG001|Overall Study|Physician Decision|6|||
105933225|NCT05529173|365414432|FG000|Overall Study|Sample shipment delay more than one day|4|||
105933226|NCT05529173|365414433|FG001|Overall Study|Sample shipment delay more than one day|0|||
105933227|NCT04865978|365414436|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
105933228|NCT04865978|365414437|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
105933229|NCT04882215|365414438|FG000|Overall Study|Withdrawal by Subject|5|||
105933230|NCT04882215|365414439|FG001|Overall Study|Withdrawal by Subject|0|||
105933231|NCT03835117|365414440|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
105933232|NCT03835117|365414441|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
105933233|NCT00629239|365414443|FG000|Overall Study|Adverse Event|7|||
105933234|NCT00629239|365414444|FG001|Overall Study|Adverse Event|4|||
105933235|NCT00629239|365414443|FG000|Overall Study|Physician Decision|1|||
105933236|NCT00629239|365414444|FG001|Overall Study|Physician Decision|0|||
106008971|NCT04672239|365699050|FG002|Week 2 Survey|Lost to Follow-up|5|||
106008972|NCT04672239|365699048|FG000|Week 6 Survey|Failed survey check items|2|||
106008973|NCT04672239|365699049|FG001|Week 6 Survey|Failed survey check items|2|||
106008974|NCT04672239|365699050|FG002|Week 6 Survey|Failed survey check items|2|||
106008975|NCT04672239|365699048|FG000|Week 6 Survey|Partially completed survey|3|||
106008976|NCT04672239|365699049|FG001|Week 6 Survey|Partially completed survey|3|||
106008977|NCT04672239|365699050|FG002|Week 6 Survey|Partially completed survey|2|||
106008978|NCT04672239|365699048|FG000|Week 6 Survey|Withdrawal by Subject|1|||
106008979|NCT04672239|365699049|FG001|Week 6 Survey|Withdrawal by Subject|1|||
106008980|NCT04672239|365699050|FG002|Week 6 Survey|Withdrawal by Subject|1|||
106008981|NCT04672239|365699048|FG000|Week 6 Survey|Withdrawn by PI|0|||
106008982|NCT04672239|365699049|FG001|Week 6 Survey|Withdrawn by PI|1|||
106008983|NCT04672239|365699050|FG002|Week 6 Survey|Withdrawn by PI|0|||
106136661|NCT00359619|366160194|FG005|Overall Study|Other|0|||
106136662|NCT00359619|366160195|FG006|Overall Study|Other|0|||
106136663|NCT00359619|366160189|FG000|Overall Study|Lost to Follow-up|4|||
106136664|NCT00359619|366160190|FG001|Overall Study|Lost to Follow-up|4|||
106136665|NCT00359619|366160191|FG002|Overall Study|Lost to Follow-up|2|||
106136666|NCT00359619|366160192|FG003|Overall Study|Lost to Follow-up|1|||
106008984|NCT04672239|365699048|FG000|Week 6 Survey|Lost to Follow-up|12|||
106008985|NCT04672239|365699049|FG001|Week 6 Survey|Lost to Follow-up|2|||
106136667|NCT00359619|366160193|FG004|Overall Study|Lost to Follow-up|1|||
105718412|NCT01827384|364627038|FG005|Overall Study|Ineligible|0|||
105718413|NCT01827384|364627039|FG006|Overall Study|Ineligible|0|||
105718414|NCT01827384|364627040|FG007|Overall Study|Ineligible|0|||
105933237|NCT01751685|365414446|FG000|6-mo Followup|Missed study visit|1|||
105933238|NCT01751685|365414447|FG001|6-mo Followup|Missed study visit|0|||
105933239|NCT01751685|365414446|FG000|6-mo Followup|Withdrawal by Subject|2|||
105933240|NCT01751685|365414447|FG001|6-mo Followup|Withdrawal by Subject|2|||
105933241|NCT01751685|365414446|FG000|6-mo Followup|Lost to Follow-up|0|||
105933242|NCT01751685|365414447|FG001|6-mo Followup|Lost to Follow-up|1|||
105933243|NCT01751685|365414446|FG000|12-mo Followup|Lost to Follow-up|5|||
105933244|NCT01751685|365414447|FG001|12-mo Followup|Lost to Follow-up|0|||
105933245|NCT03601052|365414448|FG000|Overall Study|Lost to Follow-up|2|||
106008986|NCT04672239|365699050|FG002|Week 6 Survey|Lost to Follow-up|5|||
106008987|NCT04672239|365699048|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
106008988|NCT04672239|365699049|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
106136668|NCT00359619|366160194|FG005|Overall Study|Lost to Follow-up|5|||
105718415|NCT01827384|364627041|FG008|Overall Study|Ineligible|0|||
105718416|NCT01827384|364627042|FG009|Overall Study|Ineligible|0|||
105933246|NCT00837330|365414449|FG000|Overall Study|Lost to Follow-up|1|||
105933247|NCT00837330|365414450|FG001|Overall Study|Lost to Follow-up|3|||
105933248|NCT01227395|365414451|FG000|Overall Study|Protocol Violation|0|||
105933249|NCT01227395|365414452|FG001|Overall Study|Protocol Violation|1|||
106136669|NCT00359619|366160195|FG006|Overall Study|Lost to Follow-up|0|||
106136670|NCT01419717|366160196|FG000|Overall Study|Protocol-specified Criteria|62|||
105790865|NCT04409509|364888448|FG001|Overall Study|Non-compliance with study drug|1|||
105790866|NCT04409509|364888447|FG000|Overall Study|Lost to Follow-up|0|||
105790867|NCT04409509|364888448|FG001|Overall Study|Lost to Follow-up|3|||
105790868|NCT04409509|364888447|FG000|Overall Study|Withdrawal by Subject|0|||
105790869|NCT04409509|364888448|FG001|Overall Study|Withdrawal by Subject|3|||
105790870|NCT04409509|364888447|FG000|Overall Study|Randomized by mistake|0|||
105790871|NCT04409509|364888448|FG001|Overall Study|Randomized by mistake|1|||
105790872|NCT04409509|364888447|FG000|Overall Study|Other|1|||
105790873|NCT04409509|364888448|FG001|Overall Study|Other|1|||
105790874|NCT02325739|364888449|FG000|Phase I Part|Adverse Event|1|||
105790875|NCT02325739|364888450|FG001|Phase I Part|Adverse Event|0|||
105790876|NCT02325739|364888451|FG002|Phase I Part|Adverse Event|1|||
105790877|NCT02325739|364888452|FG003|Phase I Part|Adverse Event|2|||
105790878|NCT02325739|364888453|FG004|Phase I Part|Adverse Event|3|||
105790879|NCT02325739|364888454|FG005|Phase I Part|Adverse Event|1|||
105790880|NCT02325739|364888455|FG006|Phase I Part|Adverse Event|0|||
105790881|NCT02325739|364888456|FG007|Phase I Part|Adverse Event|2|||
105790882|NCT02325739|364888457|FG008|Phase I Part|Adverse Event|0|||
105790883|NCT02325739|364888458|FG009|Phase I Part|Adverse Event|0|||
105790884|NCT02325739|364888459|FG010|Phase I Part|Adverse Event|0|||
105790885|NCT02325739|364888449|FG000|Phase I Part|Progressive disease|9|||
105790886|NCT02325739|364888450|FG001|Phase I Part|Progressive disease|6|||
105790887|NCT02325739|364888451|FG002|Phase I Part|Progressive disease|3|||
105790888|NCT02325739|364888452|FG003|Phase I Part|Progressive disease|23|||
105790889|NCT02325739|364888453|FG004|Phase I Part|Progressive disease|14|||
105790890|NCT02325739|364888454|FG005|Phase I Part|Progressive disease|6|||
105790891|NCT02325739|364888455|FG006|Phase I Part|Progressive disease|6|||
105790892|NCT02325739|364888456|FG007|Phase I Part|Progressive disease|3|||
105790893|NCT02325739|364888457|FG008|Phase I Part|Progressive disease|0|||
105790894|NCT02325739|364888458|FG009|Phase I Part|Progressive disease|0|||
105790895|NCT02325739|364888459|FG010|Phase I Part|Progressive disease|0|||
105790896|NCT02325739|364888449|FG000|Phase I Part|Subject/guardian decision|1|||
105790897|NCT02325739|364888450|FG001|Phase I Part|Subject/guardian decision|0|||
105790898|NCT02325739|364888451|FG002|Phase I Part|Subject/guardian decision|1|||
105790899|NCT02325739|364888452|FG003|Phase I Part|Subject/guardian decision|1|||
105790900|NCT02325739|364888453|FG004|Phase I Part|Subject/guardian decision|0|||
105790901|NCT02325739|364888454|FG005|Phase I Part|Subject/guardian decision|0|||
105790902|NCT02325739|364888455|FG006|Phase I Part|Subject/guardian decision|0|||
105790903|NCT02325739|364888456|FG007|Phase I Part|Subject/guardian decision|1|||
105790904|NCT02325739|364888457|FG008|Phase I Part|Subject/guardian decision|0|||
105790905|NCT02325739|364888458|FG009|Phase I Part|Subject/guardian decision|0|||
105790906|NCT02325739|364888459|FG010|Phase I Part|Subject/guardian decision|0|||
105790907|NCT02325739|364888449|FG000|Phase I Part|Death|0|||
105790908|NCT02325739|364888450|FG001|Phase I Part|Death|0|||
105790909|NCT02325739|364888451|FG002|Phase I Part|Death|0|||
105790910|NCT02325739|364888452|FG003|Phase I Part|Death|0|||
105933250|NCT00286455|365414459|FG000|Overall Study|Hyperglycemia rescue|19|||
105933251|NCT00286455|365414460|FG001|Overall Study|Hyperglycemia rescue|13|||
105933252|NCT00286455|365414461|FG002|Overall Study|Hyperglycemia rescue|10|||
105933253|NCT00286455|365414459|FG000|Overall Study|Adverse Event|1|||
105933254|NCT00286455|365414460|FG001|Overall Study|Adverse Event|3|||
105933255|NCT00286455|365414461|FG002|Overall Study|Adverse Event|2|||
105933256|NCT00286455|365414459|FG000|Overall Study|Lost to Follow-up|0|||
105933257|NCT00286455|365414460|FG001|Overall Study|Lost to Follow-up|3|||
105933258|NCT00286455|365414461|FG002|Overall Study|Lost to Follow-up|3|||
105933259|NCT00286455|365414459|FG000|Overall Study|Physician Decision|3|||
105933260|NCT00286455|365414460|FG001|Overall Study|Physician Decision|0|||
105933261|NCT00286455|365414461|FG002|Overall Study|Physician Decision|2|||
105933262|NCT00286455|365414459|FG000|Overall Study|Protocol Violation|1|||
105933263|NCT00286455|365414460|FG001|Overall Study|Protocol Violation|1|||
105933264|NCT00286455|365414461|FG002|Overall Study|Protocol Violation|0|||
105933265|NCT00286455|365414459|FG000|Overall Study|Participant Non-compliance|1|||
105933266|NCT00286455|365414460|FG001|Overall Study|Participant Non-compliance|0|||
105933267|NCT00286455|365414461|FG002|Overall Study|Participant Non-compliance|0|||
105933268|NCT00286455|365414459|FG000|Overall Study|Withdrawal by Subject|0|||
105790911|NCT02325739|364888453|FG004|Phase I Part|Death|2|||
105790912|NCT02325739|364888454|FG005|Phase I Part|Death|0|||
105790913|NCT02325739|364888455|FG006|Phase I Part|Death|0|||
105790914|NCT02325739|364888456|FG007|Phase I Part|Death|0|||
105790915|NCT02325739|364888457|FG008|Phase I Part|Death|0|||
105790916|NCT02325739|364888458|FG009|Phase I Part|Death|0|||
105790917|NCT02325739|364888459|FG010|Phase I Part|Death|0|||
105790918|NCT02325739|364888449|FG000|Phase II Part|Adverse Event|0|||
105790919|NCT02325739|364888450|FG001|Phase II Part|Adverse Event|0|||
105790920|NCT02325739|364888451|FG002|Phase II Part|Adverse Event|0|||
105790921|NCT02325739|364888452|FG003|Phase II Part|Adverse Event|0|||
105933269|NCT00286455|365414460|FG001|Overall Study|Withdrawal by Subject|8|||
105933270|NCT00286455|365414461|FG002|Overall Study|Withdrawal by Subject|7|||
105933271|NCT03641924|365416203|FG000|Overall Study|Withdrawal by Subject|26|||
105933272|NCT03641924|365416203|FG000|Overall Study|Lost to Follow-up|16|||
105933273|NCT03641924|365416203|FG000|Overall Study|Protocol Violation|10|||
105933274|NCT00567580|365416204|FG000|Overall Study|Protocol Violation|28|||
105933275|NCT00567580|365416205|FG001|Overall Study|Protocol Violation|24|||
105933276|NCT00567580|365416206|FG002|Overall Study|Protocol Violation|24|||
105933277|NCT02370394|365416215|FG000|Overall Study|Lost to Follow-up|2|||
105933278|NCT02370394|365416216|FG001|Overall Study|Lost to Follow-up|1|||
105933279|NCT02370394|365416215|FG000|Overall Study|Withdrawal by Subject|0|||
105933280|NCT02370394|365416216|FG001|Overall Study|Withdrawal by Subject|1|||
105933281|NCT01108796|365416217|FG000|Overall Study|Adverse Event|0|||
105933282|NCT01108796|365416218|FG001|Overall Study|Adverse Event|1|||
105933283|NCT01108796|365416217|FG000|Overall Study|Lost to Follow-up|7|||
105933284|NCT01108796|365416218|FG001|Overall Study|Lost to Follow-up|6|||
105933285|NCT00454142|365416219|FG000|Overall Study|Withdrawal by Subject|1|||
105933286|NCT01129284|365416221|FG000|Overall Study|Adverse Event|2|||
105933287|NCT01129284|365416222|FG001|Overall Study|Adverse Event|0|||
105933288|NCT01129284|365416223|FG002|Overall Study|Adverse Event|1|||
105933289|NCT03055221|365416224|FG000|Overall Study|Adverse Event|2|||
105933290|NCT03055221|365416224|FG000|Overall Study|Withdrawal by Subject|4|||
105933291|NCT03055221|365416224|FG000|Overall Study|Death|6|||
105933292|NCT03055221|365416224|FG000|Overall Study|Physician Decision|1|||
105933293|NCT03055221|365416224|FG000|Overall Study|Study terminated by Sponsor|3|||
105933294|NCT03055221|365416224|FG000|Overall Study|Lost to Follow-up|4|||
105933295|NCT01960842|365416229|FG000|Overall Study|Adverse Event|1|||
105933296|NCT01960842|365416229|FG000|Overall Study|Withdrawal by Subject|2|||
105718417|NCT01827384|364627043|FG010|Overall Study|Ineligible|0|||
105718418|NCT01827384|364627044|FG011|Overall Study|Ineligible|0|||
105718419|NCT01827384|364627045|FG012|Overall Study|Ineligible|0|||
105718420|NCT01827384|364627046|FG013|Overall Study|Ineligible|19|||
105790922|NCT02325739|364888453|FG004|Phase II Part|Adverse Event|0|||
105790923|NCT02325739|364888454|FG005|Phase II Part|Adverse Event|0|||
105790924|NCT02325739|364888455|FG006|Phase II Part|Adverse Event|0|||
105790925|NCT02325739|364888456|FG007|Phase II Part|Adverse Event|0|||
105790926|NCT02325739|364888457|FG008|Phase II Part|Adverse Event|4|||
105790927|NCT02325739|364888458|FG009|Phase II Part|Adverse Event|5|||
105790928|NCT02325739|364888459|FG010|Phase II Part|Adverse Event|1|||
105790929|NCT02325739|364888449|FG000|Phase II Part|Physician Decision|0|||
105790930|NCT02325739|364888450|FG001|Phase II Part|Physician Decision|0|||
105933297|NCT02391584|365416230|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
105718421|NCT01827384|364627033|FG000|Overall Study|Participant died before treatment|0|||
105718422|NCT01827384|364627034|FG001|Overall Study|Participant died before treatment|0|||
105718423|NCT01827384|364627035|FG002|Overall Study|Participant died before treatment|0|||
105718424|NCT01827384|364627036|FG003|Overall Study|Participant died before treatment|0|||
105718425|NCT01827384|364627037|FG004|Overall Study|Participant died before treatment|0|||
105718426|NCT01827384|364627038|FG005|Overall Study|Participant died before treatment|0|||
105718427|NCT01827384|364627039|FG006|Overall Study|Participant died before treatment|0|||
105718428|NCT01827384|364627040|FG007|Overall Study|Participant died before treatment|0|||
105718429|NCT01827384|364627041|FG008|Overall Study|Participant died before treatment|0|||
105718430|NCT01827384|364627042|FG009|Overall Study|Participant died before treatment|0|||
105718431|NCT01827384|364627043|FG010|Overall Study|Participant died before treatment|0|||
105718432|NCT01827384|364627044|FG011|Overall Study|Participant died before treatment|0|||
105718433|NCT01827384|364627045|FG012|Overall Study|Participant died before treatment|0|||
105718434|NCT01827384|364627046|FG013|Overall Study|Participant died before treatment|5|||
105718435|NCT01827384|364627033|FG000|Overall Study|Insufficient tumor cells|0|||
105718436|NCT01827384|364627034|FG001|Overall Study|Insufficient tumor cells|0|||
105718437|NCT01827384|364627035|FG002|Overall Study|Insufficient tumor cells|0|||
105718438|NCT01827384|364627036|FG003|Overall Study|Insufficient tumor cells|0|||
105718439|NCT01827384|364627037|FG004|Overall Study|Insufficient tumor cells|0|||
105718440|NCT01827384|364627038|FG005|Overall Study|Insufficient tumor cells|0|||
105718441|NCT01827384|364627039|FG006|Overall Study|Insufficient tumor cells|0|||
105718442|NCT01827384|364627040|FG007|Overall Study|Insufficient tumor cells|0|||
105718443|NCT01827384|364627041|FG008|Overall Study|Insufficient tumor cells|0|||
105718444|NCT01827384|364627042|FG009|Overall Study|Insufficient tumor cells|0|||
105718445|NCT01827384|364627043|FG010|Overall Study|Insufficient tumor cells|0|||
105718446|NCT01827384|364627044|FG011|Overall Study|Insufficient tumor cells|0|||
105790931|NCT02325739|364888451|FG002|Phase II Part|Physician Decision|0|||
105718447|NCT01827384|364627045|FG012|Overall Study|Insufficient tumor cells|0|||
105718448|NCT01827384|364627046|FG013|Overall Study|Insufficient tumor cells|13|||
105718449|NCT01827384|364627033|FG000|Overall Study|No actionable mutation|0|||
105718450|NCT01827384|364627034|FG001|Overall Study|No actionable mutation|0|||
105718451|NCT01827384|364627035|FG002|Overall Study|No actionable mutation|0|||
105718452|NCT01827384|364627036|FG003|Overall Study|No actionable mutation|0|||
105718453|NCT01827384|364627037|FG004|Overall Study|No actionable mutation|0|||
105933298|NCT02391584|365416231|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
105933299|NCT02391584|365416230|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
105933300|NCT02391584|365416231|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
105933301|NCT02391584|365416230|FG000|3 Month|Lost to Follow-up|1|||
105933302|NCT02391584|365416231|FG001|3 Month|Lost to Follow-up|0|||
106136671|NCT01419717|366160196|FG000|Overall Study|Adverse Event|19|||
106136672|NCT01419717|366160196|FG000|Overall Study|Death|17|||
105933303|NCT02391584|365416230|FG000|6 Month|Withdrawal by Subject|1|||
105933304|NCT02391584|365416231|FG001|6 Month|Withdrawal by Subject|0|||
105933305|NCT02391584|365416230|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
105933306|NCT02391584|365416231|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
105933307|NCT01716559|365416234|FG000|Overall Study|Adverse Event|11|||
105933308|NCT01716559|365416234|FG000|Overall Study|Death|21|||
105933309|NCT01716559|365416234|FG000|Overall Study|Withdrawal by Subject|4|||
105933310|NCT01716559|365416234|FG000|Overall Study|Other withdrawal reason|75|||
105933311|NCT03636269|365416235|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
105933312|NCT03636269|365416236|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
105933313|NCT03636269|365416237|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
105933314|NCT03636269|365416235|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
105933315|NCT03636269|365416236|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
105933316|NCT03636269|365416237|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
105933317|NCT03636269|365416235|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
105933318|NCT03636269|365416236|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
105933319|NCT03636269|365416237|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
105933320|NCT03636269|365416235|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
105933321|NCT03636269|365416236|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
105933322|NCT03636269|365416237|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
105933323|NCT03636269|365416235|FG000|Period 1: Double-blind Phase|Other|6|||
105933324|NCT03636269|365416236|FG001|Period 1: Double-blind Phase|Other|3|||
105933325|NCT03636269|365416237|FG002|Period 1: Double-blind Phase|Other|0|||
105933326|NCT03636269|365416235|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
105933327|NCT03636269|365416236|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105933328|NCT03636269|365416237|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105933329|NCT03636269|365416235|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
105933330|NCT03636269|365416236|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
105933331|NCT03636269|365416237|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
105933332|NCT03636269|365416235|FG000|Period 2: Open-label Phase|Adverse Event|0|||
105933333|NCT03636269|365416236|FG001|Period 2: Open-label Phase|Adverse Event|0|||
105933334|NCT03636269|365416237|FG002|Period 2: Open-label Phase|Adverse Event|21|||
105933335|NCT03636269|365416235|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
105933336|NCT03636269|365416236|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
105933337|NCT03636269|365416237|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
105933338|NCT03636269|365416235|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
105933339|NCT03636269|365416236|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
105933340|NCT03636269|365416237|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
105933341|NCT03636269|365416235|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
105933342|NCT03636269|365416236|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
105933343|NCT03636269|365416237|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
105933344|NCT03636269|365416235|FG000|Period 2: Open-label Phase|Administrative|0|||
105933345|NCT03636269|365416236|FG001|Period 2: Open-label Phase|Administrative|0|||
105933346|NCT03636269|365416237|FG002|Period 2: Open-label Phase|Administrative|36|||
105933347|NCT03636269|365416235|FG000|Period 2: Open-label Phase|Other|0|||
105933348|NCT03636269|365416236|FG001|Period 2: Open-label Phase|Other|0|||
105933349|NCT03636269|365416237|FG002|Period 2: Open-label Phase|Other|9|||
105933350|NCT03636269|365416235|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
105933351|NCT03636269|365416236|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
105933352|NCT03636269|365416237|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
105933353|NCT02852434|365416238|FG000|Overall Study|Withdrawal by Subject|0|||
105933354|NCT02852434|365416239|FG001|Overall Study|Withdrawal by Subject|1|||
105933355|NCT02852434|365416238|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
105933356|NCT02852434|365416239|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
105933357|NCT03188705|365416240|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
105933358|NCT03188705|365416240|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
105933359|NCT01174459|365416244|FG000|Overall Study|case report form (CRF) not collected|5|||
105933360|NCT01058005|365416245|FG000|Overall Study|Adverse Event|0|||
105933361|NCT01058005|365416246|FG001|Overall Study|Adverse Event|2|||
105933362|NCT01058005|365416247|FG002|Overall Study|Adverse Event|1|||
105933363|NCT01058005|365416245|FG000|Overall Study|Physician Decision|2|||
105933364|NCT01058005|365416246|FG001|Overall Study|Physician Decision|2|||
105933365|NCT01058005|365416247|FG002|Overall Study|Physician Decision|0|||
105933366|NCT01058005|365416245|FG000|Overall Study|Withdrawal by Subject|4|||
105933367|NCT01058005|365416246|FG001|Overall Study|Withdrawal by Subject|5|||
105933368|NCT01058005|365416247|FG002|Overall Study|Withdrawal by Subject|11|||
105933369|NCT01058005|365416245|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
105933370|NCT01058005|365416246|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
105933371|NCT01058005|365416247|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
106136673|NCT01419717|366160196|FG000|Overall Study|Withdrawal by Subject|10|||
106136674|NCT01419717|366160196|FG000|Overall Study|Disease Progression|9|||
106136675|NCT01419717|366160196|FG000|Overall Study|Other|4|||
106136676|NCT01419717|366160196|FG000|Overall Study|Lost to Follow-up|2|||
106136677|NCT01419717|366160196|FG000|Overall Study|Administrative Decision|1|||
106136678|NCT01419717|366160196|FG000|Overall Study|Noncompliance|1|||
106136679|NCT02857283|366160197|FG000|First Exposure|Withdrawal by Subject|1|||
106136680|NCT02857283|366160198|FG001|First Exposure|Withdrawal by Subject|0|||
106136681|NCT04358549|366160201|FG000|Overall Study|Adverse Event|0|||
106136682|NCT04358549|366160202|FG001|Overall Study|Adverse Event|1|||
106136683|NCT04358549|366160201|FG000|Overall Study|Death|1|||
106136684|NCT04358549|366160202|FG001|Overall Study|Death|0|||
106136685|NCT04358549|366160201|FG000|Overall Study|Lost to Follow-up|2|||
106136686|NCT04358549|366160202|FG001|Overall Study|Lost to Follow-up|1|||
106136687|NCT04358549|366160201|FG000|Overall Study|Withdrawal by Subject|6|||
106136688|NCT04358549|366160202|FG001|Overall Study|Withdrawal by Subject|6|||
106136689|NCT04358549|366160201|FG000|Overall Study|Start remdesivir|1|||
106136690|NCT04358549|366160202|FG001|Overall Study|Start remdesivir|0|||
106136691|NCT01257503|366160209|FG000|Overall Study|Lost to Follow-up|7|||
106136692|NCT01257503|366160210|FG001|Overall Study|Lost to Follow-up|10|||
106136693|NCT01257503|366160209|FG000|Overall Study|Over 5 years old at enrollment|0|||
106136694|NCT01257503|366160210|FG001|Overall Study|Over 5 years old at enrollment|1|||
106136695|NCT01257503|366160209|FG000|Overall Study|strep culture positive at enrollment|1|||
106136696|NCT01257503|366160210|FG001|Overall Study|strep culture positive at enrollment|0|||
106136697|NCT01474538|366160217|FG000|Treatment Period 1|Death|1|||
106136698|NCT01474538|366160218|FG001|Treatment Period 1|Death|0|||
106136699|NCT01474538|366160217|FG000|Treatment Period 1|Physician Decision|1|||
106136700|NCT01474538|366160218|FG001|Treatment Period 1|Physician Decision|0|||
106136701|NCT01474538|366160217|FG000|Treatment Period 1|Withdrawal by Subject|1|||
106136702|NCT01474538|366160218|FG001|Treatment Period 1|Withdrawal by Subject|3|||
106136703|NCT01474538|366160217|FG000|Treatment Period 1|Protocol Violation|0|||
106136704|NCT01474538|366160218|FG001|Treatment Period 1|Protocol Violation|1|||
106136705|NCT01474538|366160217|FG000|Treatment Period 2|Death|1|||
106136706|NCT01474538|366160218|FG001|Treatment Period 2|Death|0|||
106136707|NCT01474538|366160217|FG000|Treatment Period 2|Adverse Event|1|||
106136708|NCT01474538|366160218|FG001|Treatment Period 2|Adverse Event|1|||
106136709|NCT01474538|366160217|FG000|Treatment Period 2|Withdrawal by Subject|2|||
106136710|NCT01474538|366160218|FG001|Treatment Period 2|Withdrawal by Subject|0|||
106136711|NCT01474538|366160217|FG000|Treatment Period 2|Sponsor decision|1|||
106136712|NCT01474538|366160218|FG001|Treatment Period 2|Sponsor decision|0|||
106136713|NCT01474538|366160217|FG000|Treatment Period 2|Physician Decision|0|||
106136714|NCT01474538|366160218|FG001|Treatment Period 2|Physician Decision|1|||
106136715|NCT01474538|366160217|FG000|Treatment Period 2|Protocol Violation|1|||
106136716|NCT01474538|366160218|FG001|Treatment Period 2|Protocol Violation|0|||
106136717|NCT00349908|366160221|FG000|Overall Study|Withdrawal by Subject|0|||
106136718|NCT00349908|366160222|FG001|Overall Study|Withdrawal by Subject|4|||
106136719|NCT02072226|366160226|FG000|Overall Study|Lost to Follow-up|11|||
106136720|NCT02072226|366160227|FG001|Overall Study|Lost to Follow-up|7|||
106136721|NCT02072226|366160226|FG000|Overall Study|Patient Non-compliance|2|||
106136722|NCT02072226|366160227|FG001|Overall Study|Patient Non-compliance|3|||
106136723|NCT02072226|366160226|FG000|Overall Study|Death|1|||
106136724|NCT02072226|366160227|FG001|Overall Study|Death|0|||
106136725|NCT02072226|366160226|FG000|Overall Study|Patient Withdrawal of Consent|1|||
106136726|NCT02072226|366160227|FG001|Overall Study|Patient Withdrawal of Consent|0|||
106136727|NCT02534896|366160228|FG000|Overall Study|Adverse Event|2|||
106136728|NCT02534896|366160229|FG001|Overall Study|Adverse Event|1|||
106136729|NCT02534896|366160230|FG002|Overall Study|Adverse Event|1|||
106136730|NCT02534896|366160228|FG000|Overall Study|Insufficient therapeutic response|2|||
106136731|NCT02534896|366160229|FG001|Overall Study|Insufficient therapeutic response|0|||
106136732|NCT02534896|366160230|FG002|Overall Study|Insufficient therapeutic response|0|||
106136733|NCT04381494|366160231|FG000|Overall Study|Early termination of trial|19|||
106136734|NCT04381494|366160231|FG000|Overall Study|Investigator's discretion|1|||
106136735|NCT04381494|366160231|FG000|Overall Study|Withdrawal by Subject|9|||
106136736|NCT04381494|366160231|FG000|Overall Study|NSCLC disease progression|4|||
106136737|NCT04381494|366160231|FG000|Overall Study|Device-Related Adverse Event|2|||
106136738|NCT03396835|366160232|FG000|Overall Study|Withdrawn prior to completion|1|||
106136739|NCT03396835|366160232|FG000|Overall Study|Did not meet criteria for data analysis|1|||
106136740|NCT04310579|366160239|FG000|Overall Study|Adverse Event|0|||
106136741|NCT04310579|366160240|FG001|Overall Study|Adverse Event|0|||
105790932|NCT02325739|364888452|FG003|Phase II Part|Physician Decision|0|||
105790933|NCT02325739|364888453|FG004|Phase II Part|Physician Decision|0|||
106136742|NCT04310579|366160241|FG002|Overall Study|Adverse Event|0|||
106136743|NCT04310579|366160242|FG003|Overall Study|Adverse Event|0|||
106136744|NCT04310579|366160243|FG004|Overall Study|Adverse Event|0|||
106136745|NCT04310579|366160244|FG005|Overall Study|Adverse Event|0|||
106136746|NCT04310579|366160245|FG006|Overall Study|Adverse Event|2|||
106136747|NCT04310579|366160246|FG007|Overall Study|Adverse Event|0|||
106136748|NCT04310579|366160247|FG008|Overall Study|Adverse Event|1|||
106136749|NCT04310579|366160248|FG009|Overall Study|Adverse Event|1|||
106136750|NCT04310579|366160249|FG010|Overall Study|Adverse Event|0|||
106136751|NCT04310579|366160239|FG000|Overall Study|Withdrawal by Subject|0|||
106136752|NCT04310579|366160240|FG001|Overall Study|Withdrawal by Subject|0|||
106136753|NCT04310579|366160241|FG002|Overall Study|Withdrawal by Subject|0|||
106136754|NCT04310579|366160242|FG003|Overall Study|Withdrawal by Subject|0|||
106136755|NCT04310579|366160243|FG004|Overall Study|Withdrawal by Subject|0|||
106136756|NCT04310579|366160244|FG005|Overall Study|Withdrawal by Subject|1|||
106136757|NCT04310579|366160245|FG006|Overall Study|Withdrawal by Subject|0|||
106136758|NCT04310579|366160246|FG007|Overall Study|Withdrawal by Subject|0|||
106136759|NCT04310579|366160247|FG008|Overall Study|Withdrawal by Subject|0|||
106136760|NCT04310579|366160248|FG009|Overall Study|Withdrawal by Subject|0|||
106136761|NCT04310579|366160249|FG010|Overall Study|Withdrawal by Subject|0|||
106136762|NCT04310579|366160239|FG000|Overall Study|Positive COVID-19 test|0|||
106136763|NCT04310579|366160240|FG001|Overall Study|Positive COVID-19 test|0|||
106136764|NCT04310579|366160241|FG002|Overall Study|Positive COVID-19 test|0|||
106136765|NCT04310579|366160242|FG003|Overall Study|Positive COVID-19 test|0|||
106136766|NCT04310579|366160243|FG004|Overall Study|Positive COVID-19 test|0|||
106136767|NCT04310579|366160244|FG005|Overall Study|Positive COVID-19 test|0|||
106136768|NCT04310579|366160245|FG006|Overall Study|Positive COVID-19 test|0|||
106136769|NCT04310579|366160246|FG007|Overall Study|Positive COVID-19 test|0|||
106136770|NCT04310579|366160247|FG008|Overall Study|Positive COVID-19 test|0|||
106136771|NCT04310579|366160248|FG009|Overall Study|Positive COVID-19 test|0|||
106136772|NCT04310579|366160249|FG010|Overall Study|Positive COVID-19 test|1|||
106136773|NCT03467724|366160250|FG000|Overall Study|Lost to Follow-up|5|||
106136774|NCT03467724|366160250|FG000|Overall Study|Withdrawal by Subject|1|||
106136775|NCT03467724|366160250|FG000|Overall Study|Protocol Violation|1|||
106136776|NCT03467724|366160250|FG000|Overall Study|Adverse Event|1|||
106136777|NCT01280591|366160255|FG000|Overall Study|Withdrawal by Subject|0|||
106136778|NCT01280591|366160256|FG001|Overall Study|Withdrawal by Subject|0|||
106136779|NCT01280591|366160257|FG002|Overall Study|Withdrawal by Subject|0|||
106136780|NCT01280591|366160258|FG003|Overall Study|Withdrawal by Subject|2|||
106136781|NCT01280591|366160255|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
106136782|NCT01280591|366160256|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
106136783|NCT01280591|366160257|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
106136784|NCT01280591|366160258|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
106136785|NCT02955069|366160259|FG000|Overall Study|Adverse Event|7|||
106136786|NCT02955069|366160260|FG001|Overall Study|Adverse Event|2|||
106136787|NCT02955069|366160259|FG000|Overall Study|Death|7|||
106136788|NCT02955069|366160260|FG001|Overall Study|Death|3|||
106136789|NCT02955069|366160259|FG000|Overall Study|Physician Decision|10|||
106136790|NCT02955069|366160260|FG001|Overall Study|Physician Decision|2|||
106136791|NCT02955069|366160259|FG000|Overall Study|Progressive disease|64|||
106136792|NCT02955069|366160260|FG001|Overall Study|Progressive disease|13|||
106136793|NCT02955069|366160259|FG000|Overall Study|Study terminated by sponsor|4|||
106136794|NCT02955069|366160260|FG001|Overall Study|Study terminated by sponsor|0|||
106136795|NCT02955069|366160259|FG000|Overall Study|Subject/Guardian decision|3|||
106136796|NCT02955069|366160260|FG001|Overall Study|Subject/Guardian decision|1|||
106136797|NCT01233050|366160265|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
106136798|NCT01233050|366160266|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
106136799|NCT02281318|366160267|FG000|Overall Study|Adverse Event|2|||
106136800|NCT02281318|366160268|FG001|Overall Study|Adverse Event|2|||
106136801|NCT02281318|366160267|FG000|Overall Study|Lack of Efficacy|2|||
106136802|NCT02281318|366160268|FG001|Overall Study|Lack of Efficacy|0|||
106136803|NCT02281318|366160267|FG000|Overall Study|Lost to Follow-up|2|||
106136804|NCT02281318|366160268|FG001|Overall Study|Lost to Follow-up|1|||
106136805|NCT02281318|366160267|FG000|Overall Study|Physician Decision|2|||
106136806|NCT02281318|366160268|FG001|Overall Study|Physician Decision|0|||
106136807|NCT02281318|366160267|FG000|Overall Study|Withdrawal by Subject|6|||
106136808|NCT02281318|366160268|FG001|Overall Study|Withdrawal by Subject|2|||
106136809|NCT03102710|366160272|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
106136810|NCT03102710|366160273|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
106136811|NCT03102710|366160274|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
106136812|NCT03102710|366160272|FG000|Overall Study|Technical issues during final MRI scan|0|||
106136813|NCT03102710|366160273|FG001|Overall Study|Technical issues during final MRI scan|1|||
106136814|NCT03102710|366160274|FG002|Overall Study|Technical issues during final MRI scan|0|||
106136815|NCT03102710|366160272|FG000|Overall Study|Nausea during MRI scan|0|||
106136816|NCT03102710|366160273|FG001|Overall Study|Nausea during MRI scan|1|||
106136817|NCT03102710|366160274|FG002|Overall Study|Nausea during MRI scan|0|||
106136818|NCT03102710|366160272|FG000|Overall Study|Subject unable to attend final session|0|||
106136819|NCT03102710|366160273|FG001|Overall Study|Subject unable to attend final session|1|||
106136820|NCT03102710|366160274|FG002|Overall Study|Subject unable to attend final session|0|||
106136821|NCT00920686|366160275|FG000|Overall Study|Lost to Follow-up|2|||
106136822|NCT00920686|366160276|FG001|Overall Study|Lost to Follow-up|3|||
106136823|NCT00920686|366160277|FG002|Overall Study|Lost to Follow-up|1|||
106136824|NCT00920686|366160275|FG000|Overall Study|Study drug dosing criteria not met|17|||
105933372|NCT01058005|365416245|FG000|Overall Study|Reason Missing|5|||
105933373|NCT01058005|365416246|FG001|Overall Study|Reason Missing|3|||
105933374|NCT01058005|365416247|FG002|Overall Study|Reason Missing|1|||
105933375|NCT00927186|365416249|FG000|12 Months Primary Study|Adverse Event|5|||
105933376|NCT00927186|365416250|FG001|12 Months Primary Study|Adverse Event|2|||
105933377|NCT00927186|365416249|FG000|12 Months Primary Study|Lost to Follow-up|1|||
105933378|NCT00927186|365416250|FG001|12 Months Primary Study|Lost to Follow-up|0|||
105933379|NCT00927186|365416249|FG000|12 Months Primary Study|Protocol Violation|0|||
105933380|NCT00927186|365416250|FG001|12 Months Primary Study|Protocol Violation|1|||
105933381|NCT00927186|365416249|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
105933382|NCT00927186|365416250|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
105933383|NCT01145222|365416251|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
105933384|NCT01145222|365416252|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
105933385|NCT01145222|365416253|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
105933386|NCT01145222|365416254|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
105933387|NCT01145222|365416251|FG000|Overall Study|Poor bowel preparation|0|||
105933388|NCT01145222|365416252|FG001|Overall Study|Poor bowel preparation|0|||
105933389|NCT01145222|365416253|FG002|Overall Study|Poor bowel preparation|0|||
105933390|NCT01145222|365416254|FG003|Overall Study|Poor bowel preparation|1|||
105933391|NCT00604383|365416255|FG000|Overall Study|Withdrawal by Subject|33|||
105933392|NCT00604383|365416256|FG001|Overall Study|Withdrawal by Subject|31|||
105933393|NCT00604383|365416255|FG000|Overall Study|Lost to Follow-up|24|||
105933394|NCT00604383|365416256|FG001|Overall Study|Lost to Follow-up|19|||
105933395|NCT00604383|365416255|FG000|Overall Study|Death|14|||
105933396|NCT00604383|365416256|FG001|Overall Study|Death|22|||
105933397|NCT00604383|365416255|FG000|Overall Study|Adverse Event|16|||
105933398|NCT00604383|365416256|FG001|Overall Study|Adverse Event|9|||
105933399|NCT00604383|365416255|FG000|Overall Study|Physician Decision|0|||
105933400|NCT00604383|365416256|FG001|Overall Study|Physician Decision|3|||
105933401|NCT01698008|365416257|FG000|Overall Study|Withdrawal by Subject|1|||
105933402|NCT01698008|365416258|FG001|Overall Study|Withdrawal by Subject|2|||
105933403|NCT01011283|365416264|FG000|Overall Study|Adverse Event|4|||
105933404|NCT01011283|365416265|FG001|Overall Study|Adverse Event|2|||
105933405|NCT01011283|365416264|FG000|Overall Study|Progressive Disease|0|||
105933406|NCT01011283|365416265|FG001|Overall Study|Progressive Disease|2|||
105933407|NCT01011283|365416264|FG000|Overall Study|Terminated by Sponsor|5|||
105933408|NCT01011283|365416265|FG001|Overall Study|Terminated by Sponsor|5|||
105933409|NCT01011283|365416264|FG000|Overall Study|Other|2|||
105933410|NCT01011283|365416265|FG001|Overall Study|Other|2|||
105933411|NCT01717859|365416267|FG000|Overall Study|Adverse Event|5|||
105933412|NCT01717859|365416267|FG000|Overall Study|Moved out of state|1|||
105933413|NCT01717859|365416267|FG000|Overall Study|Patient concerned about mental health|1|||
105933414|NCT01717859|365416267|FG000|Overall Study|Lost to Follow-up|1|||
105933415|NCT01717859|365416267|FG000|Overall Study|Withdrawal by Subject|2|||
105933416|NCT01623752|365416268|FG000|Phase 1 (78 Weeks)|No Data|249|||
105933417|NCT01623752|365416269|FG001|Phase 1 (78 Weeks)|No Data|66|||
105933418|NCT01623752|365416270|FG002|Phase 1 (78 Weeks)|No Data|2|||
105933419|NCT01623752|365416268|FG000|Phase 1 (78 Weeks)|Other|33|||
105933420|NCT01623752|365416269|FG001|Phase 1 (78 Weeks)|Other|20|||
105933421|NCT01623752|365416270|FG002|Phase 1 (78 Weeks)|Other|0|||
105933422|NCT01623752|365416268|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
105933423|NCT01623752|365416269|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
105933424|NCT01623752|365416270|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
105933425|NCT01623752|365416268|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
105933426|NCT01623752|365416269|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
105933427|NCT01623752|365416270|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
105933428|NCT01623752|365416268|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
105933429|NCT01623752|365416269|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
105933430|NCT01623752|365416270|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
105933431|NCT01623752|365416268|FG000|Phase 2 (78 Weeks)|Other|5|||
105933432|NCT01623752|365416269|FG001|Phase 2 (78 Weeks)|Other|1|||
105933433|NCT01623752|365416270|FG002|Phase 2 (78 Weeks)|Other|0|||
105933434|NCT01623752|365416268|FG000|Phase 2 (78 Weeks)|No Data|43|||
105933435|NCT01623752|365416269|FG001|Phase 2 (78 Weeks)|No Data|11|||
105933436|NCT01623752|365416270|FG002|Phase 2 (78 Weeks)|No Data|0|||
105933437|NCT01623752|365416268|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
105933438|NCT01623752|365416269|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
105933439|NCT01623752|365416270|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
105933440|NCT03994120|365416272|FG000|Overall Study|Lost to Follow-up|3|||
105933441|NCT03994120|365416273|FG001|Overall Study|Lost to Follow-up|1|||
105933442|NCT04053452|365416274|FG000|Overall Study|Withdrawal by Subject|1|||
105933443|NCT04053452|365416275|FG001|Overall Study|Withdrawal by Subject|0|||
105933444|NCT04053452|365416274|FG000|Overall Study|Time restraint due to inpatient needs|1|||
105933445|NCT04053452|365416275|FG001|Overall Study|Time restraint due to inpatient needs|2|||
105933446|NCT00281580|365416282|FG000|Overall Study|Adverse Event|2|||
105933447|NCT00281580|365416283|FG001|Overall Study|Adverse Event|0|||
105933448|NCT00281580|365416284|FG002|Overall Study|Adverse Event|2|||
105718454|NCT01827384|364627038|FG005|Overall Study|No actionable mutation|0|||
105718455|NCT01827384|364627039|FG006|Overall Study|No actionable mutation|0|||
105718456|NCT01827384|364627040|FG007|Overall Study|No actionable mutation|0|||
105718457|NCT01827384|364627041|FG008|Overall Study|No actionable mutation|0|||
105718458|NCT01827384|364627042|FG009|Overall Study|No actionable mutation|0|||
105718459|NCT01827384|364627043|FG010|Overall Study|No actionable mutation|0|||
105933449|NCT00281580|365416285|FG003|Overall Study|Adverse Event|4|||
105933450|NCT00281580|365416286|FG004|Overall Study|Adverse Event|1|||
105933451|NCT00281580|365416287|FG005|Overall Study|Adverse Event|0|||
105933452|NCT00281580|365416288|FG006|Overall Study|Adverse Event|1|||
105933453|NCT00281580|365416289|FG007|Overall Study|Adverse Event|0|||
105933454|NCT00281580|365416290|FG008|Overall Study|Adverse Event|1|||
105933455|NCT00281580|365416291|FG009|Overall Study|Adverse Event|6|||
105933456|NCT00281580|365416292|FG010|Overall Study|Adverse Event|0|||
105933457|NCT00281580|365416293|FG011|Overall Study|Adverse Event|5|||
105933458|NCT00281580|365416294|FG012|Overall Study|Adverse Event|8|||
105933459|NCT00281580|365416295|FG013|Overall Study|Adverse Event|2|||
105933460|NCT00281580|365416296|FG014|Overall Study|Adverse Event|3|||
105933461|NCT00281580|365416297|FG015|Overall Study|Adverse Event|3|||
105933462|NCT00281580|365416282|FG000|Overall Study|Protocol Violation|0|||
105933463|NCT00281580|365416283|FG001|Overall Study|Protocol Violation|0|||
105933464|NCT00281580|365416284|FG002|Overall Study|Protocol Violation|1|||
105933465|NCT00281580|365416285|FG003|Overall Study|Protocol Violation|1|||
105933466|NCT00281580|365416286|FG004|Overall Study|Protocol Violation|0|||
105933467|NCT00281580|365416287|FG005|Overall Study|Protocol Violation|0|||
105933468|NCT00281580|365416288|FG006|Overall Study|Protocol Violation|1|||
105933469|NCT00281580|365416289|FG007|Overall Study|Protocol Violation|0|||
105933470|NCT00281580|365416290|FG008|Overall Study|Protocol Violation|2|||
105933471|NCT00281580|365416291|FG009|Overall Study|Protocol Violation|0|||
105933472|NCT00281580|365416292|FG010|Overall Study|Protocol Violation|1|||
105933473|NCT00281580|365416293|FG011|Overall Study|Protocol Violation|2|||
105933474|NCT00281580|365416294|FG012|Overall Study|Protocol Violation|0|||
105933475|NCT00281580|365416295|FG013|Overall Study|Protocol Violation|1|||
105933476|NCT00281580|365416296|FG014|Overall Study|Protocol Violation|1|||
105933477|NCT00281580|365416297|FG015|Overall Study|Protocol Violation|3|||
105933478|NCT00281580|365416282|FG000|Overall Study|Withdrawal by Subject|3|||
105933479|NCT00281580|365416283|FG001|Overall Study|Withdrawal by Subject|0|||
105933480|NCT00281580|365416284|FG002|Overall Study|Withdrawal by Subject|1|||
105933481|NCT00281580|365416285|FG003|Overall Study|Withdrawal by Subject|1|||
105933482|NCT00281580|365416286|FG004|Overall Study|Withdrawal by Subject|1|||
105933483|NCT00281580|365416287|FG005|Overall Study|Withdrawal by Subject|2|||
105933484|NCT00281580|365416288|FG006|Overall Study|Withdrawal by Subject|2|||
105933485|NCT00281580|365416289|FG007|Overall Study|Withdrawal by Subject|0|||
105933486|NCT00281580|365416290|FG008|Overall Study|Withdrawal by Subject|1|||
105933487|NCT00281580|365416291|FG009|Overall Study|Withdrawal by Subject|4|||
105933488|NCT00281580|365416292|FG010|Overall Study|Withdrawal by Subject|1|||
105933489|NCT00281580|365416293|FG011|Overall Study|Withdrawal by Subject|1|||
105933490|NCT00281580|365416294|FG012|Overall Study|Withdrawal by Subject|2|||
105933491|NCT00281580|365416295|FG013|Overall Study|Withdrawal by Subject|2|||
105933492|NCT00281580|365416296|FG014|Overall Study|Withdrawal by Subject|1|||
105933493|NCT00281580|365416297|FG015|Overall Study|Withdrawal by Subject|5|||
105933494|NCT00281580|365416282|FG000|Overall Study|Lack of Efficacy|2|||
105933495|NCT00281580|365416283|FG001|Overall Study|Lack of Efficacy|1|||
105933496|NCT00281580|365416284|FG002|Overall Study|Lack of Efficacy|1|||
105933497|NCT00281580|365416285|FG003|Overall Study|Lack of Efficacy|6|||
105933498|NCT00281580|365416286|FG004|Overall Study|Lack of Efficacy|2|||
105933499|NCT00281580|365416287|FG005|Overall Study|Lack of Efficacy|0|||
105933500|NCT00281580|365416288|FG006|Overall Study|Lack of Efficacy|0|||
105933501|NCT00281580|365416289|FG007|Overall Study|Lack of Efficacy|0|||
105933502|NCT00281580|365416290|FG008|Overall Study|Lack of Efficacy|0|||
105933503|NCT00281580|365416291|FG009|Overall Study|Lack of Efficacy|0|||
105933504|NCT00281580|365416292|FG010|Overall Study|Lack of Efficacy|0|||
105933505|NCT00281580|365416293|FG011|Overall Study|Lack of Efficacy|1|||
105933506|NCT00281580|365416294|FG012|Overall Study|Lack of Efficacy|0|||
105933507|NCT00281580|365416295|FG013|Overall Study|Lack of Efficacy|2|||
105933508|NCT00281580|365416296|FG014|Overall Study|Lack of Efficacy|1|||
105933509|NCT00281580|365416297|FG015|Overall Study|Lack of Efficacy|0|||
106136825|NCT00920686|366160276|FG001|Overall Study|Study drug dosing criteria not met|19|||
105933510|NCT00281580|365416282|FG000|Overall Study|Lost to Follow-up|0|||
105933511|NCT00281580|365416283|FG001|Overall Study|Lost to Follow-up|0|||
105933512|NCT00281580|365416284|FG002|Overall Study|Lost to Follow-up|0|||
105933513|NCT00281580|365416285|FG003|Overall Study|Lost to Follow-up|3|||
105933514|NCT00281580|365416286|FG004|Overall Study|Lost to Follow-up|0|||
105933515|NCT00281580|365416287|FG005|Overall Study|Lost to Follow-up|1|||
105933516|NCT00281580|365416288|FG006|Overall Study|Lost to Follow-up|0|||
105933517|NCT00281580|365416289|FG007|Overall Study|Lost to Follow-up|1|||
105933518|NCT00281580|365416290|FG008|Overall Study|Lost to Follow-up|2|||
105718460|NCT01827384|364627044|FG011|Overall Study|No actionable mutation|0|||
105933519|NCT00281580|365416291|FG009|Overall Study|Lost to Follow-up|1|||
105933520|NCT00281580|365416292|FG010|Overall Study|Lost to Follow-up|1|||
105933521|NCT00281580|365416293|FG011|Overall Study|Lost to Follow-up|0|||
105933522|NCT00281580|365416294|FG012|Overall Study|Lost to Follow-up|1|||
105933523|NCT00281580|365416295|FG013|Overall Study|Lost to Follow-up|0|||
105933524|NCT00281580|365416296|FG014|Overall Study|Lost to Follow-up|0|||
105933525|NCT00281580|365416297|FG015|Overall Study|Lost to Follow-up|0|||
105933526|NCT00281580|365416282|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
105933527|NCT00281580|365416283|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
105933528|NCT00281580|365416284|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
105933529|NCT00281580|365416285|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
105933530|NCT00281580|365416286|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
106136826|NCT00920686|366160277|FG002|Overall Study|Study drug dosing criteria not met|12|||
106136827|NCT04304534|366160278|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
106136828|NCT04304534|366160279|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
106136829|NCT04304534|366160280|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
106136830|NCT04304534|366160281|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
106136831|NCT04304534|366160278|FG000|Overall Study|Non-Compliance with study drug|0|||
106136832|NCT04304534|366160279|FG001|Overall Study|Non-Compliance with study drug|1|||
106136833|NCT04304534|366160280|FG002|Overall Study|Non-Compliance with study drug|1|||
106136834|NCT04304534|366160281|FG003|Overall Study|Non-Compliance with study drug|1|||
106136835|NCT04304534|366160278|FG000|Overall Study|Lost to Follow-up|0|||
106136836|NCT04304534|366160279|FG001|Overall Study|Lost to Follow-up|1|||
106136837|NCT04304534|366160280|FG002|Overall Study|Lost to Follow-up|2|||
106136838|NCT04304534|366160281|FG003|Overall Study|Lost to Follow-up|3|||
106136839|NCT04304534|366160278|FG000|Overall Study|Unspecific|4|||
106136840|NCT04304534|366160279|FG001|Overall Study|Unspecific|2|||
106136841|NCT04304534|366160280|FG002|Overall Study|Unspecific|2|||
106136842|NCT04304534|366160281|FG003|Overall Study|Unspecific|2|||
106136843|NCT04304534|366160278|FG000|Overall Study|Technical Problems|2|||
106136844|NCT04304534|366160279|FG001|Overall Study|Technical Problems|2|||
106136845|NCT04304534|366160280|FG002|Overall Study|Technical Problems|3|||
106136846|NCT04304534|366160281|FG003|Overall Study|Technical Problems|4|||
106136847|NCT04304534|366160278|FG000|Overall Study|Death|7|||
106136848|NCT04304534|366160279|FG001|Overall Study|Death|2|||
106136849|NCT04304534|366160280|FG002|Overall Study|Death|4|||
106136850|NCT04304534|366160281|FG003|Overall Study|Death|3|||
106136851|NCT04304534|366160278|FG000|Overall Study|Withdrawal by Subject|7|||
106136852|NCT04304534|366160279|FG001|Overall Study|Withdrawal by Subject|2|||
106136853|NCT04304534|366160280|FG002|Overall Study|Withdrawal by Subject|7|||
106136854|NCT04304534|366160281|FG003|Overall Study|Withdrawal by Subject|4|||
106136855|NCT04304534|366160278|FG000|Overall Study|Physician Decision|4|||
106136856|NCT04304534|366160279|FG001|Overall Study|Physician Decision|9|||
106136857|NCT04304534|366160280|FG002|Overall Study|Physician Decision|9|||
106136858|NCT04304534|366160281|FG003|Overall Study|Physician Decision|5|||
106136859|NCT04304534|366160278|FG000|Overall Study|Subject Decision|34|||
106136860|NCT04304534|366160279|FG001|Overall Study|Subject Decision|25|||
106136861|NCT04304534|366160280|FG002|Overall Study|Subject Decision|25|||
106136862|NCT04304534|366160281|FG003|Overall Study|Subject Decision|26|||
106136863|NCT04304534|366160278|FG000|Overall Study|Adverse Event|35|||
106136864|NCT04304534|366160279|FG001|Overall Study|Adverse Event|40|||
106136865|NCT04304534|366160280|FG002|Overall Study|Adverse Event|39|||
106136866|NCT04304534|366160281|FG003|Overall Study|Adverse Event|44|||
106136867|NCT05193318|366160283|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
106136868|NCT05193318|366160283|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
106136869|NCT01833065|366160284|FG000|Overall Study|Adverse Event|6|||
106136870|NCT01833065|366160285|FG001|Overall Study|Adverse Event|1|||
106136871|NCT01833065|366160286|FG002|Overall Study|Adverse Event|0|||
106136872|NCT01833065|366160287|FG003|Overall Study|Adverse Event|2|||
106136873|NCT01833065|366160288|FG004|Overall Study|Adverse Event|3|||
106136874|NCT01833065|366160284|FG000|Overall Study|Protocol Violation|1|||
106136875|NCT01833065|366160285|FG001|Overall Study|Protocol Violation|0|||
106136876|NCT01833065|366160286|FG002|Overall Study|Protocol Violation|0|||
106136877|NCT01833065|366160287|FG003|Overall Study|Protocol Violation|0|||
106136878|NCT01833065|366160288|FG004|Overall Study|Protocol Violation|2|||
106136879|NCT01833065|366160284|FG000|Overall Study|Lost to Follow-up|1|||
106136880|NCT01833065|366160285|FG001|Overall Study|Lost to Follow-up|0|||
106136881|NCT01833065|366160286|FG002|Overall Study|Lost to Follow-up|0|||
106136882|NCT01833065|366160287|FG003|Overall Study|Lost to Follow-up|0|||
106136883|NCT01833065|366160288|FG004|Overall Study|Lost to Follow-up|3|||
106136884|NCT01833065|366160284|FG000|Overall Study|Withdrawal by Subject|6|||
106136885|NCT01833065|366160285|FG001|Overall Study|Withdrawal by Subject|2|||
106136886|NCT01833065|366160286|FG002|Overall Study|Withdrawal by Subject|4|||
106136887|NCT01833065|366160287|FG003|Overall Study|Withdrawal by Subject|3|||
106136888|NCT01833065|366160288|FG004|Overall Study|Withdrawal by Subject|11|||
106136889|NCT01833065|366160284|FG000|Overall Study|Subject's substantial non-compliance|0|||
106136890|NCT01833065|366160285|FG001|Overall Study|Subject's substantial non-compliance|1|||
106136891|NCT01833065|366160286|FG002|Overall Study|Subject's substantial non-compliance|0|||
106008989|NCT04672239|365699050|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
106008990|NCT04672239|365699048|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
106008991|NCT04672239|365699049|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
106008992|NCT04672239|365699050|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
106008993|NCT04672239|365699048|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
106008994|NCT04672239|365699049|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
106008995|NCT04672239|365699050|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
106008996|NCT04672239|365699048|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
106008997|NCT04672239|365699049|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
106008998|NCT04672239|365699050|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
106008999|NCT04672239|365699048|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
106009000|NCT04672239|365699049|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
106009001|NCT04672239|365699050|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
106009002|NCT04672239|365699048|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
106009003|NCT04672239|365699049|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
106136892|NCT01833065|366160287|FG003|Overall Study|Subject's substantial non-compliance|0|||
105718461|NCT01827384|364627045|FG012|Overall Study|No actionable mutation|0|||
105718462|NCT01827384|364627046|FG013|Overall Study|No actionable mutation|73|||
105718463|NCT01827384|364627033|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
105718464|NCT01827384|364627034|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
105718465|NCT01827384|364627035|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
105718466|NCT01827384|364627036|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
105718467|NCT01827384|364627037|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
105718468|NCT01827384|364627038|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
105718469|NCT01827384|364627039|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
105718470|NCT01827384|364627040|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
105718471|NCT01827384|364627041|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
105718472|NCT01827384|364627042|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
105718473|NCT01827384|364627043|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
105718474|NCT01827384|364627044|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
105718475|NCT01827384|364627045|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
105718476|NCT01827384|364627046|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
105718477|NCT02425098|364627048|FG000|Overall Study|Lost to Follow-up|7|||
105718478|NCT02425098|364627049|FG001|Overall Study|Lost to Follow-up|7|||
105718479|NCT02425098|364627048|FG000|Overall Study|Withdrawal by Subject|4|||
105718480|NCT02425098|364627049|FG001|Overall Study|Withdrawal by Subject|8|||
105718481|NCT02425098|364627048|FG000|Overall Study|Pregnancy|2|||
105718482|NCT02425098|364627049|FG001|Overall Study|Pregnancy|0|||
105718483|NCT02425098|364627048|FG000|Overall Study|Reason not Specified|0|||
105718484|NCT02425098|364627049|FG001|Overall Study|Reason not Specified|1|||
105718485|NCT02324270|364628705|FG000|Overall Study|Withdrawal by Subject|0|||
105718486|NCT02324270|364628706|FG001|Overall Study|Withdrawal by Subject|1|||
105718487|NCT02324270|364628707|FG002|Overall Study|Withdrawal by Subject|0|||
105718488|NCT02324270|364628705|FG000|Overall Study|Lost to Follow-up|4|||
105718489|NCT02324270|364628706|FG001|Overall Study|Lost to Follow-up|3|||
105718490|NCT02324270|364628707|FG002|Overall Study|Lost to Follow-up|4|||
105718491|NCT02324270|364628705|FG000|Overall Study|Protocol Violation|0|||
105718492|NCT02324270|364628706|FG001|Overall Study|Protocol Violation|1|||
105718493|NCT02324270|364628707|FG002|Overall Study|Protocol Violation|1|||
105718494|NCT02324270|364628705|FG000|Overall Study|Non Compliance with Study Drug|1|||
105718495|NCT02324270|364628706|FG001|Overall Study|Non Compliance with Study Drug|2|||
105718496|NCT02324270|364628707|FG002|Overall Study|Non Compliance with Study Drug|0|||
106136893|NCT01833065|366160288|FG004|Overall Study|Subject's substantial non-compliance|0|||
106136894|NCT01833065|366160284|FG000|Overall Study|Trial terminated by sponsor|8|||
105718497|NCT00680836|364628708|FG000|Overall Study|Withdrawal by Subject|3|||
106136895|NCT01833065|366160285|FG001|Overall Study|Trial terminated by sponsor|8|||
106136896|NCT01833065|366160286|FG002|Overall Study|Trial terminated by sponsor|7|||
106136897|NCT01833065|366160287|FG003|Overall Study|Trial terminated by sponsor|3|||
106136898|NCT01833065|366160288|FG004|Overall Study|Trial terminated by sponsor|13|||
106136899|NCT01833065|366160284|FG000|Overall Study|Others|2|||
106136900|NCT01833065|366160285|FG001|Overall Study|Others|1|||
106136901|NCT01833065|366160286|FG002|Overall Study|Others|1|||
106136902|NCT01833065|366160287|FG003|Overall Study|Others|1|||
106136903|NCT01833065|366160288|FG004|Overall Study|Others|4|||
106136904|NCT00015457|366160297|FG000|First Intervention|Adverse Event|0|||
105718498|NCT00680836|364628709|FG001|Overall Study|Withdrawal by Subject|0|||
105718499|NCT00680836|364628708|FG000|Overall Study|Lost to Follow-up|3|||
105718500|NCT00680836|364628709|FG001|Overall Study|Lost to Follow-up|1|||
106136905|NCT00015457|366160298|FG001|First Intervention|Adverse Event|2|||
106136906|NCT00015457|366160297|FG000|First Intervention|Lack of Efficacy|0|||
105718501|NCT00680836|364628708|FG000|Overall Study|Physician Decision|2|||
105718502|NCT00680836|364628709|FG001|Overall Study|Physician Decision|1|||
105718503|NCT04187092|364628710|FG000|Overall Study|Lost to Follow-up|1|||
105718504|NCT04187092|364628711|FG001|Overall Study|Lost to Follow-up|1|||
105718505|NCT04187092|364628710|FG000|Overall Study|Withdrawal by Subject|1|||
105718506|NCT04187092|364628711|FG001|Overall Study|Withdrawal by Subject|1|||
105718507|NCT04187092|364628710|FG000|Overall Study|Adverse Event|0|||
105718508|NCT04187092|364628711|FG001|Overall Study|Adverse Event|1|||
105718509|NCT00771472|364628712|FG000|Overall Study|Physician Decision|2|||
105718510|NCT00771472|364628713|FG001|Overall Study|Physician Decision|3|||
105718511|NCT00771472|364628712|FG000|Overall Study|Progressive Disease|3|||
105718512|NCT00771472|364628713|FG001|Overall Study|Progressive Disease|1|||
105718513|NCT00771472|364628712|FG000|Overall Study|Protocol Violation|1|||
105718514|NCT00771472|364628713|FG001|Overall Study|Protocol Violation|0|||
105718515|NCT00880750|364628719|FG000|First Intervention|Adverse Event|1|||
105718516|NCT00880750|364628720|FG001|First Intervention|Adverse Event|0|||
105718517|NCT00880750|364628719|FG000|First Intervention|Unable to collect urine|4|||
105718518|NCT00880750|364628720|FG001|First Intervention|Unable to collect urine|0|||
105718519|NCT00880750|364628719|FG000|First Intervention|Non-compliance with meals|0|||
105718520|NCT00880750|364628720|FG001|First Intervention|Non-compliance with meals|1|||
105718521|NCT00880750|364628719|FG000|First Intervention|Withdrawal by Subject|2|||
105718522|NCT00880750|364628720|FG001|First Intervention|Withdrawal by Subject|0|||
105718523|NCT00880750|364628719|FG000|First Intervention|Lost to Follow-up|2|||
105718524|NCT00880750|364628720|FG001|First Intervention|Lost to Follow-up|0|||
105718525|NCT00880750|364628719|FG000|Second Intervention|Withdrawal by Subject|2|||
105718526|NCT00880750|364628720|FG001|Second Intervention|Withdrawal by Subject|2|||
105718527|NCT00880750|364628719|FG000|Second Intervention|Protocol Violation|1|||
105718528|NCT00880750|364628720|FG001|Second Intervention|Protocol Violation|0|||
105718529|NCT00880750|364628719|FG000|Second Intervention|Unable to collect urine|1|||
105718530|NCT00880750|364628720|FG001|Second Intervention|Unable to collect urine|0|||
105718531|NCT00483327|364628723|FG000|Overall Study|Adverse Event|1|||
105718532|NCT00483327|364628723|FG000|Overall Study|Withdrawal by Subject|3|||
105718533|NCT00483327|364628723|FG000|Overall Study|Lost to Follow-up|4|||
105718534|NCT00483327|364628723|FG000|Overall Study|Patient Non Compliance|2|||
105933531|NCT00281580|365416287|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
105933532|NCT00281580|365416288|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
105718535|NCT01891643|364628724|FG000|Overall Study|Adverse event unrelated to study drug|2|||
105718536|NCT01891643|364628725|FG001|Overall Study|Adverse event unrelated to study drug|5|||
105718537|NCT01891643|364628724|FG000|Overall Study|Disease Progression|4|||
105933533|NCT00281580|365416289|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
105933534|NCT00281580|365416290|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
105933535|NCT00281580|365416291|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
105933536|NCT00281580|365416292|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
105933537|NCT00281580|365416293|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
105933538|NCT00281580|365416294|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
105933539|NCT00281580|365416295|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
105933540|NCT00281580|365416296|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
105933541|NCT00281580|365416297|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
105933542|NCT00225758|365416298|FG000|Overall Study|Adverse Event|4|||
105933543|NCT04263532|365416299|FG000|Overall Study|Withdrawal by Subject|2|||
105933544|NCT04263532|365416300|FG001|Overall Study|Withdrawal by Subject|0|||
105933545|NCT04034056|365416306|FG000|Overall Study|Withdrawal by Subject|2|||
105933546|NCT04034056|365416306|FG000|Overall Study|Reason Not Specified|13|||
105933547|NCT04034056|365416306|FG000|Overall Study|Adverse Event|56|||
105933548|NCT03225989|365416307|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
105933549|NCT03225989|365416308|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
105933550|NCT03225989|365416309|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
105933551|NCT03225989|365416307|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
105933552|NCT03225989|365416308|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
105933553|NCT03225989|365416309|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
105933554|NCT03225989|365416307|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
105718538|NCT01891643|364628725|FG001|Overall Study|Disease Progression|3|||
105718539|NCT01891643|364628724|FG000|Overall Study|Study Drug Toxicity|3|||
105718540|NCT01891643|364628725|FG001|Overall Study|Study Drug Toxicity|0|||
105718541|NCT01891643|364628724|FG000|Overall Study|Maximum Clinical Benefit|0|||
105718542|NCT01891643|364628725|FG001|Overall Study|Maximum Clinical Benefit|1|||
105718543|NCT01891643|364628724|FG000|Overall Study|Poor/Non-compliance|0|||
105718544|NCT01891643|364628725|FG001|Overall Study|Poor/Non-compliance|1|||
105718545|NCT01891643|364628724|FG000|Overall Study|Participant request to discontinue|1|||
105718546|NCT01891643|364628725|FG001|Overall Study|Participant request to discontinue|0|||
105718547|NCT04188197|364628726|FG000|Overall Study|Lost to Follow-up|4|||
105933555|NCT03225989|365416308|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
105718548|NCT04188197|364628727|FG001|Overall Study|Lost to Follow-up|1|||
106009004|NCT04672239|365699050|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
106009005|NCT04672239|365699048|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
106009006|NCT04672239|365699049|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
106009007|NCT04672239|365699050|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
106009008|NCT02018562|365699051|FG000|Overall Study|Withdrawal by Subject|2|||
106009009|NCT02018562|365699052|FG001|Overall Study|Withdrawal by Subject|0|||
106009010|NCT02018562|365699051|FG000|Overall Study|Discharged prior to study completion|1|||
106009011|NCT02018562|365699052|FG001|Overall Study|Discharged prior to study completion|0|||
105933556|NCT03225989|365416309|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
106009012|NCT05194124|365699053|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
106009013|NCT05194124|365699054|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
106009014|NCT05194124|365699055|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
106009015|NCT05194124|365699056|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
106009016|NCT05194124|365699057|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
106009017|NCT05194124|365699058|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
106009018|NCT05194124|365699059|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
106009019|NCT05194124|365699060|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
106009020|NCT05194124|365699061|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
106009021|NCT05194124|365699062|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
106009022|NCT05194124|365699053|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106009023|NCT05194124|365699054|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106009024|NCT05194124|365699055|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106009025|NCT05194124|365699056|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106009026|NCT05194124|365699057|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106009027|NCT05194124|365699058|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106009028|NCT05194124|365699059|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106009029|NCT05194124|365699060|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106009030|NCT05194124|365699061|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
106136907|NCT00015457|366160298|FG001|First Intervention|Lack of Efficacy|1|||
105718549|NCT04188197|364628726|FG000|Overall Study|Withdrawal by Subject|1|||
105718550|NCT04188197|364628727|FG001|Overall Study|Withdrawal by Subject|1|||
105718551|NCT04188197|364628726|FG000|Overall Study|Pregnancy|0|||
105718552|NCT04188197|364628727|FG001|Overall Study|Pregnancy|1|||
105718553|NCT01246206|364628730|FG000|Overall Study|Patient did not receive study regiments.|1|||
105718554|NCT02965716|364628731|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
105718555|NCT02965716|364628732|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
105718556|NCT02965716|364628731|FG000|Overall Study|Progression/Relapse|8|||
105718557|NCT02965716|364628732|FG001|Overall Study|Progression/Relapse|16|||
105718558|NCT02965716|364628731|FG000|Overall Study|Death|1|||
105933557|NCT03225989|365416307|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
105933558|NCT03225989|365416308|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
105933559|NCT03225989|365416309|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
105933560|NCT03225989|365416307|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
105933561|NCT03225989|365416308|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
105933562|NCT03225989|365416309|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
105933563|NCT03225989|365416307|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
105933564|NCT03225989|365416308|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
105933565|NCT03225989|365416309|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
105933566|NCT03225989|365416307|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
105933567|NCT03225989|365416308|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
105933568|NCT03225989|365416309|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
105933569|NCT03225989|365416307|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
105933570|NCT03225989|365416308|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
105933571|NCT03225989|365416309|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
105933572|NCT03225989|365416307|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
105933573|NCT03225989|365416308|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
105933574|NCT03225989|365416309|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
105933575|NCT03225989|365416307|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
105933576|NCT03225989|365416308|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
105933577|NCT03225989|365416309|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
105933578|NCT03225989|365416307|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
105718559|NCT02965716|364628732|FG001|Overall Study|Death|0|||
105718560|NCT02965716|364628731|FG000|Overall Study|Not Protocol Specified|1|||
105933579|NCT03225989|365416308|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
105718561|NCT02965716|364628732|FG001|Overall Study|Not Protocol Specified|3|||
105933580|NCT03225989|365416309|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
105933581|NCT03225989|365416307|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
105790934|NCT02325739|364888454|FG005|Phase II Part|Physician Decision|0|||
105790935|NCT02325739|364888455|FG006|Phase II Part|Physician Decision|0|||
105790936|NCT02325739|364888456|FG007|Phase II Part|Physician Decision|0|||
105790937|NCT02325739|364888457|FG008|Phase II Part|Physician Decision|0|||
105790938|NCT02325739|364888458|FG009|Phase II Part|Physician Decision|1|||
105790939|NCT02325739|364888459|FG010|Phase II Part|Physician Decision|0|||
105790940|NCT02325739|364888449|FG000|Phase II Part|Progressive disease|0|||
105790941|NCT02325739|364888450|FG001|Phase II Part|Progressive disease|0|||
105790942|NCT02325739|364888451|FG002|Phase II Part|Progressive disease|0|||
105790943|NCT02325739|364888452|FG003|Phase II Part|Progressive disease|0|||
105790944|NCT02325739|364888453|FG004|Phase II Part|Progressive disease|0|||
105790945|NCT02325739|364888454|FG005|Phase II Part|Progressive disease|0|||
105790946|NCT02325739|364888455|FG006|Phase II Part|Progressive disease|0|||
105790947|NCT02325739|364888456|FG007|Phase II Part|Progressive disease|0|||
105790948|NCT02325739|364888457|FG008|Phase II Part|Progressive disease|22|||
105790949|NCT02325739|364888458|FG009|Phase II Part|Progressive disease|29|||
105790950|NCT02325739|364888459|FG010|Phase II Part|Progressive disease|18|||
105790951|NCT02325739|364888449|FG000|Phase II Part|Subject/guardian decision|0|||
105790952|NCT02325739|364888450|FG001|Phase II Part|Subject/guardian decision|0|||
105790953|NCT02325739|364888451|FG002|Phase II Part|Subject/guardian decision|0|||
105790954|NCT02325739|364888452|FG003|Phase II Part|Subject/guardian decision|0|||
105790955|NCT02325739|364888453|FG004|Phase II Part|Subject/guardian decision|0|||
105790956|NCT02325739|364888454|FG005|Phase II Part|Subject/guardian decision|0|||
105790957|NCT02325739|364888455|FG006|Phase II Part|Subject/guardian decision|0|||
105790958|NCT02325739|364888456|FG007|Phase II Part|Subject/guardian decision|0|||
105790959|NCT02325739|364888457|FG008|Phase II Part|Subject/guardian decision|4|||
105790960|NCT02325739|364888458|FG009|Phase II Part|Subject/guardian decision|1|||
105790961|NCT02325739|364888459|FG010|Phase II Part|Subject/guardian decision|1|||
105790962|NCT00227591|364888460|FG000|Overall Study|Withdrawal by Subject|1|||
105790963|NCT02341482|364888461|FG000|Overall Study|Adverse Event|1|||
105790964|NCT02057549|364888465|FG000|Overall Study|Lost to Follow-up|1|||
105790965|NCT02057549|364888466|FG001|Overall Study|Lost to Follow-up|0|||
105790966|NCT02057549|364888465|FG000|Overall Study|Physician Decision|1|||
105790967|NCT02057549|364888466|FG001|Overall Study|Physician Decision|0|||
105790968|NCT02057549|364888465|FG000|Overall Study|Withdrawal by Subject|1|||
105790969|NCT02057549|364888466|FG001|Overall Study|Withdrawal by Subject|0|||
105790970|NCT01418365|364888467|FG000|First Intervention|Withdrawal by Subject|0|||
105790971|NCT01418365|364888468|FG001|First Intervention|Withdrawal by Subject|1|||
105790972|NCT01418365|364888467|FG000|First Intervention|Non-compliance|1|||
105790973|NCT01418365|364888468|FG001|First Intervention|Non-compliance|0|||
105790974|NCT01418365|364888467|FG000|Second Intervention|Withdrawal by Subject|0|||
105790975|NCT01418365|364888468|FG001|Second Intervention|Withdrawal by Subject|1|||
105790976|NCT00530621|364888481|FG000|Overall Study|Adverse Event|11|||
105790977|NCT00530621|364888482|FG001|Overall Study|Adverse Event|8|||
105790978|NCT00530621|364888481|FG000|Overall Study|Physician Decision|2|||
105790979|NCT00530621|364888482|FG001|Overall Study|Physician Decision|4|||
105790980|NCT00530621|364888481|FG000|Overall Study|Progressive Disease (PD)|47|||
105790981|NCT00530621|364888482|FG001|Overall Study|Progressive Disease (PD)|40|||
105790982|NCT00530621|364888481|FG000|Overall Study|Sponsor Decision|12|||
105790983|NCT00530621|364888482|FG001|Overall Study|Sponsor Decision|15|||
105790984|NCT00530621|364888481|FG000|Overall Study|Subject Decision|4|||
105790985|NCT00530621|364888482|FG001|Overall Study|Subject Decision|7|||
105790986|NCT00530621|364888481|FG000|Overall Study|Death|3|||
105790987|NCT00530621|364888482|FG001|Overall Study|Death|6|||
105790988|NCT00530621|364888481|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
105790989|NCT00530621|364888482|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
105790990|NCT00518011|364888483|FG000|Overall Study|Death|1|||
105790991|NCT00518011|364888484|FG001|Overall Study|Death|1|||
105790992|NCT00518011|364888483|FG000|Overall Study|Adverse Event|2|||
105790993|NCT00518011|364888484|FG001|Overall Study|Adverse Event|3|||
105790994|NCT00518011|364888483|FG000|Overall Study|Disease Progression|2|||
105790995|NCT00518011|364888484|FG001|Overall Study|Disease Progression|2|||
105790996|NCT00518011|364888483|FG000|Overall Study|Other Reasons|3|||
105933582|NCT03225989|365416308|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
105933583|NCT03225989|365416309|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
105933584|NCT00609973|365416312|FG000|Overall Study|Adverse Event|2|||
105933585|NCT00609973|365416313|FG001|Overall Study|Adverse Event|1|||
105933586|NCT00609973|365416312|FG000|Overall Study|Protocol Violation|4|||
105933587|NCT00609973|365416313|FG001|Overall Study|Protocol Violation|3|||
105790997|NCT00518011|364888484|FG001|Overall Study|Other Reasons|2|||
105790998|NCT00518011|364888483|FG000|Overall Study|Withdrawal by Subject|1|||
105790999|NCT00518011|364888484|FG001|Overall Study|Withdrawal by Subject|0|||
105791000|NCT02596009|364888485|FG000|Overall Study|Administrative problems|0|||
105791001|NCT02596009|364888486|FG001|Overall Study|Administrative problems|1|||
105791002|NCT02596009|364888487|FG002|Overall Study|Administrative problems|0|||
105791003|NCT02596009|364888488|FG003|Overall Study|Administrative problems|0|||
105791004|NCT02596009|364888489|FG004|Overall Study|Administrative problems|0|||
105933588|NCT00609973|365416312|FG000|Overall Study|Lost to Follow-up|2|||
105791005|NCT02596009|364888490|FG005|Overall Study|Administrative problems|0|||
105791006|NCT02998645|364888491|FG000|Treatment Period 1|Adverse Event|6|||
105791007|NCT02998645|364888491|FG000|Treatment Period 1|Death|5|||
105791008|NCT02998645|364888491|FG000|Treatment Period 1|Technical Problems|4|||
105791009|NCT02998645|364888491|FG000|Treatment Period 1|Lack of Efficacy|2|||
105791010|NCT02998645|364888491|FG000|Treatment Period 1|Progressive disease|1|||
105791011|NCT02998645|364888491|FG000|Treatment Period 1|Subject/guardian decision|1|||
105791012|NCT02998645|364888491|FG000|Treatment Period 2|Lack of Efficacy|5|||
105791013|NCT02998645|364888491|FG000|Treatment Period 2|Adverse Event|2|||
105791014|NCT02998645|364888491|FG000|Treatment Period 2|Progressive disease|2|||
105791015|NCT02998645|364888491|FG000|Treatment Period 2|Physician Decision|1|||
105791016|NCT03644927|364888499|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
105791017|NCT03644927|364888500|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
105791018|NCT02864953|364888506|FG000|Overall Study|Adverse Event|22|||
105791019|NCT02864953|364888507|FG001|Overall Study|Adverse Event|19|||
105791020|NCT02864953|364888506|FG000|Overall Study|Withdrawal by Subject|1|||
105791021|NCT02864953|364888507|FG001|Overall Study|Withdrawal by Subject|0|||
105791022|NCT02864953|364888506|FG000|Overall Study|Physician Decision|4|||
105791023|NCT02864953|364888507|FG001|Overall Study|Physician Decision|2|||
105791024|NCT02864953|364888506|FG000|Overall Study|Death|3|||
105791025|NCT02864953|364888507|FG001|Overall Study|Death|13|||
105791026|NCT02864953|364888506|FG000|Overall Study|Reason not specified|14|||
105791027|NCT02864953|364888507|FG001|Overall Study|Reason not specified|12|||
105791028|NCT02864953|364888506|FG000|Overall Study|Withdrew Prior to Dosing|9|||
105791029|NCT02864953|364888507|FG001|Overall Study|Withdrew Prior to Dosing|8|||
105791030|NCT03075215|364888511|FG000|12-Month Primary Endpoint|Death|152|||
105791031|NCT03075215|364888511|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
105791032|NCT03075215|364888511|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
105791033|NCT03075215|364888511|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
105791034|NCT00752895|364888512|FG000|Overall Study|Withdrawal by Subject|8|||
105791035|NCT00752895|364888513|FG001|Overall Study|Withdrawal by Subject|3|||
105791036|NCT03746080|364890499|FG000|Overall Study|In follow up|2|||
105791037|NCT03746080|364890499|FG000|Overall Study|Death|15|||
105791038|NCT02094573|364890500|FG000|Overall Study|Adverse Event|4|||
105791039|NCT02094573|364890501|FG001|Overall Study|Adverse Event|14|||
105791040|NCT02094573|364890500|FG000|Overall Study|Clinical Progressive Disease|9|||
105791041|NCT02094573|364890501|FG001|Overall Study|Clinical Progressive Disease|13|||
105791042|NCT02094573|364890500|FG000|Overall Study|Death|11|||
105791043|NCT02094573|364890501|FG001|Overall Study|Death|3|||
105791044|NCT02094573|364890500|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
105791045|NCT02094573|364890501|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
105791046|NCT02094573|364890500|FG000|Overall Study|Non-compliance with Study Drug|1|||
105791047|NCT02094573|364890501|FG001|Overall Study|Non-compliance with Study Drug|1|||
105791048|NCT02094573|364890500|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
105791049|NCT02094573|364890501|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
105791050|NCT02094573|364890500|FG000|Overall Study|Physician Decision|4|||
105791051|NCT02094573|364890501|FG001|Overall Study|Physician Decision|4|||
105791052|NCT02094573|364890500|FG000|Overall Study|Site Terminated by Sponsor|10|||
105791053|NCT02094573|364890501|FG001|Overall Study|Site Terminated by Sponsor|17|||
105791054|NCT02094573|364890500|FG000|Overall Study|Withdrawal by Subject|6|||
105791055|NCT02094573|364890501|FG001|Overall Study|Withdrawal by Subject|8|||
105791056|NCT02094573|364890500|FG000|Overall Study|Randomized but not Treated|3|||
105791057|NCT02094573|364890501|FG001|Overall Study|Randomized but not Treated|0|||
105791058|NCT02875340|364890502|FG000|Overall Study|Death|2|||
105791059|NCT02875340|364890502|FG000|Overall Study|Withdrawal by Subject|2|||
105791060|NCT02875340|364890502|FG000|Overall Study|Physician Decision|3|||
105791061|NCT02875340|364890502|FG000|Overall Study|Adverse Event|1|||
105791062|NCT01160770|364890505|FG000|Overall Study|Adverse Event|10|||
105791063|NCT01160770|364890505|FG000|Overall Study|Protocol Violation|2|||
105791064|NCT01160770|364890505|FG000|Overall Study|Subject/parent/caregiver request|33|||
105791065|NCT01160770|364890505|FG000|Overall Study|Physician Decision|1|||
105791066|NCT01160770|364890505|FG000|Overall Study|Lost to Follow-up|7|||
105791067|NCT01160770|364890505|FG000|Overall Study|Study termination or sponsor request|1|||
105791068|NCT01160770|364890505|FG000|Overall Study|Death|9|||
105791069|NCT01160770|364890505|FG000|Overall Study|Lack of Efficacy|15|||
105791070|NCT01160770|364890505|FG000|Overall Study|Other Reasons|1|||
105791071|NCT03457727|364890506|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
105791072|NCT03457727|364890507|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
105791073|NCT03457727|364890508|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
105791074|NCT03457727|364890509|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
105791075|NCT01513759|364890510|FG000|Overall Study|Protocol Violation|4|||
105791076|NCT01513759|364890510|FG000|Overall Study|Death during catheter placement|1|||
105791077|NCT03722849|364890514|FG000|Overall Study|Withdrawal by Subject|1|||
105791078|NCT03722849|364890515|FG001|Overall Study|Withdrawal by Subject|1|||
105791079|NCT02118896|364890518|FG000|Overall Study|Death|4|||
106136908|NCT00015457|366160297|FG000|Second Intervention|Withdrawal by Subject|1|||
106136909|NCT00015457|366160298|FG001|Second Intervention|Withdrawal by Subject|0|||
106136910|NCT03095508|366160299|FG000|Overall Study|Adverse Event|0|||
106136911|NCT03095508|366160300|FG001|Overall Study|Adverse Event|1|||
105718562|NCT04047797|364628733|FG000|Overall Study|Progressive Disease|1|||
105718563|NCT03523351|364628734|FG000|Overall Study|Death|13|||
105718564|NCT03523351|364628735|FG001|Overall Study|Death|11|||
105718565|NCT03523351|364628734|FG000|Overall Study|Lost to Follow-up|2|||
105718566|NCT03523351|364628735|FG001|Overall Study|Lost to Follow-up|3|||
105718567|NCT03523351|364628734|FG000|Overall Study|Withdrawal by Subject|4|||
105718568|NCT03523351|364628735|FG001|Overall Study|Withdrawal by Subject|0|||
105718569|NCT03523351|364628734|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
105718570|NCT03523351|364628735|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
105718571|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
105718572|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
105718573|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
105718574|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718575|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718576|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718577|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718578|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105718579|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
105718580|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
105718581|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
105718582|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718583|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718584|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718585|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718586|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105718587|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
105718588|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
105718589|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
105718590|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718591|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718592|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718593|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718594|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105718595|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
105718596|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
105718597|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
105718598|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718599|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718600|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718601|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718602|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105718603|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
105718604|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
105718605|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
105718606|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718607|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718608|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718609|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718610|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105718611|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
105718612|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
105718613|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105718614|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105718615|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105718616|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
106136912|NCT01710514|366160301|FG000|Overall Study|Adverse Event|6|||
105718617|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105791080|NCT02118896|364890519|FG001|Overall Study|Death|0|||
106136913|NCT01710514|366160302|FG001|Overall Study|Adverse Event|7|||
106136914|NCT01710514|366160301|FG000|Overall Study|Withdrawal by Subject|1|||
106136915|NCT01710514|366160302|FG001|Overall Study|Withdrawal by Subject|0|||
106136916|NCT01651949|366160305|FG000|Overall Study|Unknown status|4|||
106136917|NCT01651949|366160306|FG001|Overall Study|Unknown status|4|||
105718618|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105718619|NCT01097629|364628736|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
105718620|NCT01097629|364628737|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
105718621|NCT01097629|364628738|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
105718622|NCT01097629|364628739|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718623|NCT01097629|364628740|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718624|NCT01097629|364628741|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718625|NCT01097629|364628742|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105718626|NCT01097629|364628743|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105933589|NCT00609973|365416313|FG001|Overall Study|Lost to Follow-up|1|||
105933590|NCT00609973|365416312|FG000|Overall Study|Withdrawal by Subject|0|||
105933591|NCT00609973|365416313|FG001|Overall Study|Withdrawal by Subject|1|||
105933592|NCT03892915|365416314|FG000|Overall Study|Lost to Follow-up|6|||
105933593|NCT03892915|365416315|FG001|Overall Study|Lost to Follow-up|12|||
105933594|NCT03892915|365416314|FG000|Overall Study|Death|0|||
105933595|NCT03892915|365416315|FG001|Overall Study|Death|2|||
105933596|NCT03892915|365416314|FG000|Overall Study|Withdrawal by Subject|1|||
105933597|NCT03892915|365416315|FG001|Overall Study|Withdrawal by Subject|1|||
105933598|NCT03892915|365416314|FG000|Overall Study|unsuccessful delivery|13|||
105933599|NCT03892915|365416315|FG001|Overall Study|unsuccessful delivery|18|||
105933600|NCT00191152|365416316|FG000|Initial Treatment|Adverse Event|43|||
105933601|NCT00191152|365416317|FG001|Initial Treatment|Adverse Event|67|||
105933602|NCT00191152|365416316|FG000|Initial Treatment|Physician Decision|40|||
105933603|NCT00191152|365416317|FG001|Initial Treatment|Physician Decision|31|||
105933604|NCT00191152|365416316|FG000|Initial Treatment|Withdrawal by Subject|40|||
105933605|NCT00191152|365416317|FG001|Initial Treatment|Withdrawal by Subject|28|||
105933606|NCT00191152|365416316|FG000|Initial Treatment|Lost to Follow-up|0|||
105933607|NCT00191152|365416317|FG001|Initial Treatment|Lost to Follow-up|6|||
105933608|NCT00191152|365416316|FG000|Initial Treatment|Other|18|||
105933609|NCT00191152|365416317|FG001|Initial Treatment|Other|21|||
105933610|NCT00191152|365416316|FG000|Crossover Treatment|Adverse Event|8|||
105933611|NCT00191152|365416317|FG001|Crossover Treatment|Adverse Event|8|||
105933612|NCT00191152|365416316|FG000|Crossover Treatment|Physician Decision|7|||
105933613|NCT00191152|365416317|FG001|Crossover Treatment|Physician Decision|7|||
105933614|NCT00191152|365416316|FG000|Crossover Treatment|Withdrawal by Subject|6|||
105933615|NCT00191152|365416317|FG001|Crossover Treatment|Withdrawal by Subject|9|||
105718627|NCT01097629|364628736|FG000|DB RO Phase|Withdrawal by Subject|0|||
105718628|NCT01097629|364628737|FG001|DB RO Phase|Withdrawal by Subject|0|||
105718629|NCT01097629|364628738|FG002|DB RO Phase|Withdrawal by Subject|0|||
105718630|NCT01097629|364628739|FG003|DB RO Phase|Withdrawal by Subject|0|||
105718631|NCT01097629|364628740|FG004|DB RO Phase|Withdrawal by Subject|0|||
105718632|NCT01097629|364628741|FG005|DB RO Phase|Withdrawal by Subject|0|||
105718633|NCT01097629|364628742|FG006|DB RO Phase|Withdrawal by Subject|0|||
105718634|NCT01097629|364628743|FG007|DB RO Phase|Withdrawal by Subject|1|||
105718635|NCT01097629|364628736|FG000|DB RO Phase|Protocol Violation|0|||
105718636|NCT01097629|364628737|FG001|DB RO Phase|Protocol Violation|0|||
105718637|NCT01097629|364628738|FG002|DB RO Phase|Protocol Violation|0|||
105718638|NCT01097629|364628739|FG003|DB RO Phase|Protocol Violation|1|||
105718639|NCT01097629|364628740|FG004|DB RO Phase|Protocol Violation|0|||
105718640|NCT01097629|364628741|FG005|DB RO Phase|Protocol Violation|1|||
105718641|NCT01097629|364628742|FG006|DB RO Phase|Protocol Violation|1|||
105718642|NCT01097629|364628743|FG007|DB RO Phase|Protocol Violation|0|||
105718643|NCT01097629|364628736|FG000|DB RO Phase|Lost to Follow-up|0|||
105718644|NCT01097629|364628737|FG001|DB RO Phase|Lost to Follow-up|0|||
105718645|NCT01097629|364628738|FG002|DB RO Phase|Lost to Follow-up|0|||
105933616|NCT00191152|365416316|FG000|Crossover Treatment|Lost to Follow-up|2|||
105933617|NCT00191152|365416317|FG001|Crossover Treatment|Lost to Follow-up|1|||
105933618|NCT00191152|365416316|FG000|Crossover Treatment|Other|4|||
105933619|NCT00191152|365416317|FG001|Crossover Treatment|Other|3|||
105933620|NCT01851369|365416318|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933621|NCT01851369|365416319|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933622|NCT01851369|365416320|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933623|NCT01851369|365416321|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933624|NCT01851369|365416322|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933625|NCT01851369|365416323|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
105933626|NCT01851369|365416324|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105718646|NCT01097629|364628739|FG003|DB RO Phase|Lost to Follow-up|0|||
105718647|NCT01097629|364628740|FG004|DB RO Phase|Lost to Follow-up|0|||
105718648|NCT01097629|364628741|FG005|DB RO Phase|Lost to Follow-up|0|||
105718649|NCT01097629|364628742|FG006|DB RO Phase|Lost to Follow-up|2|||
105718650|NCT01097629|364628743|FG007|DB RO Phase|Lost to Follow-up|0|||
105718651|NCT00365989|364628747|FG000|Overall Study|Withdrawal by Subject|1|||
105718652|NCT00365989|364628747|FG000|Overall Study|Non-compliance|1|||
106009031|NCT05194124|365699062|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
106009032|NCT05720897|365699063|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
106009033|NCT05720897|365699064|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
106009034|NCT00400179|365699065|FG000|Overall Study|Adverse Event|2|||
106009035|NCT00400179|365699066|FG001|Overall Study|Adverse Event|2|||
106009036|NCT00400179|365699065|FG000|Overall Study|Death|1|||
106009037|NCT00400179|365699066|FG001|Overall Study|Death|2|||
106009038|NCT00400179|365699065|FG000|Overall Study|Withdrew Consent|1|||
106009039|NCT00400179|365699066|FG001|Overall Study|Withdrew Consent|5|||
106009040|NCT00400179|365699065|FG000|Overall Study|Disease progression|1|||
106009041|NCT00400179|365699066|FG001|Overall Study|Disease progression|1|||
106009042|NCT00400179|365699065|FG000|Overall Study|Intercurrent illness|0|||
106009043|NCT00400179|365699066|FG001|Overall Study|Intercurrent illness|1|||
106009044|NCT00400179|365699065|FG000|Overall Study|Investigator judgment|0|||
106009045|NCT00400179|365699066|FG001|Overall Study|Investigator judgment|1|||
106009046|NCT00400179|365699065|FG000|Overall Study|Randomization error/patient ineligible|1|||
106009047|NCT00400179|365699066|FG001|Overall Study|Randomization error/patient ineligible|6|||
106009048|NCT04780061|365699067|FG000|Overall Study|Withdrawal by Subject|5|||
106009049|NCT04780061|365699068|FG001|Overall Study|Withdrawal by Subject|8|||
106009050|NCT04780061|365699067|FG000|Overall Study|Adverse Event|2|||
106009051|NCT04780061|365699068|FG001|Overall Study|Adverse Event|2|||
106009052|NCT04780061|365699067|FG000|Overall Study|Lost to Follow-up|1|||
106009053|NCT04780061|365699068|FG001|Overall Study|Lost to Follow-up|5|||
106009054|NCT05138653|365699075|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
106009055|NCT05138653|365699076|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009056|NCT05138653|365699077|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009057|NCT05138653|365699078|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009058|NCT05138653|365699079|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009059|NCT05138653|365699080|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009060|NCT05138653|365699081|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009061|NCT05138653|365699082|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009062|NCT05138653|365699083|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009063|NCT05138653|365699084|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009064|NCT05138653|365699085|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009065|NCT05138653|365699086|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009066|NCT05138653|365699087|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009067|NCT05138653|365699088|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009068|NCT05138653|365699089|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009069|NCT05138653|365699090|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
106009070|NCT05138653|365699075|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009071|NCT05138653|365699076|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
106009072|NCT05138653|365699077|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009073|NCT05138653|365699078|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009074|NCT05138653|365699079|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009075|NCT05138653|365699080|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009076|NCT05138653|365699081|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009077|NCT05138653|365699082|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009078|NCT05138653|365699083|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
106009079|NCT05138653|365699084|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009080|NCT05138653|365699085|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009081|NCT05138653|365699086|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009082|NCT05138653|365699087|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105718653|NCT00623831|364628748|FG000|Overall Study|Withdrawal by Subject|1|||
105718654|NCT00623831|364628749|FG001|Overall Study|Withdrawal by Subject|0|||
105718655|NCT00623831|364628748|FG000|Overall Study|Progressive Disease|0|||
105718656|NCT00623831|364628749|FG001|Overall Study|Progressive Disease|1|||
105718657|NCT00282243|364628750|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
105718658|NCT00282243|364628750|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
105718659|NCT00282243|364628750|FG000|Extension Treatment Period|Adverse Event|15|||
105718660|NCT00282243|364628750|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
105718661|NCT00282243|364628750|FG000|Extension Treatment Period|Non-compliance|2|||
105718662|NCT00282243|364628750|FG000|Extension Treatment Period|Physician Decision|1|||
106009083|NCT05138653|365699088|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009084|NCT05138653|365699089|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
105718663|NCT00317044|364628751|FG000|Overall Study|Protocol Violation|28|||
105718664|NCT00317044|364628752|FG001|Overall Study|Protocol Violation|22|||
105718665|NCT00317044|364628753|FG002|Overall Study|Protocol Violation|20|||
105718666|NCT00317044|364628751|FG000|Overall Study|Adverse Event|4|||
105718667|NCT00317044|364628752|FG001|Overall Study|Adverse Event|7|||
105791081|NCT02118896|364890520|FG002|Overall Study|Death|4|||
105791082|NCT02118896|364890521|FG003|Overall Study|Death|6|||
105791083|NCT02118896|364890522|FG004|Overall Study|Death|3|||
105791084|NCT02118896|364890523|FG005|Overall Study|Death|1|||
105791085|NCT02118896|364890524|FG006|Overall Study|Death|0|||
105791086|NCT02118896|364890525|FG007|Overall Study|Death|0|||
105791087|NCT02118896|364890526|FG008|Overall Study|Death|0|||
105933627|NCT01851369|365416325|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933628|NCT01851369|365416326|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933629|NCT01851369|365416327|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933630|NCT01851369|365416328|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933631|NCT01851369|365416329|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933632|NCT01851369|365416330|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
105933633|NCT00052715|365416331|FG000|Overall Study|wrong histology|1|||
105933634|NCT04584554|365416332|FG000|Overall Study|Withdrawal by Subject|2|||
105933635|NCT04584554|365416333|FG001|Overall Study|Withdrawal by Subject|2|||
105933636|NCT02807181|365416334|FG000|Overall Study|Death|28|||
105933637|NCT02807181|365416335|FG001|Overall Study|Death|24|||
105933638|NCT02807181|365416334|FG000|Overall Study|Withdrawal by Subject|1|||
105933639|NCT02807181|365416335|FG001|Overall Study|Withdrawal by Subject|1|||
105933640|NCT02807181|365416334|FG000|Overall Study|Lost to Follow-up|0|||
105933641|NCT02807181|365416335|FG001|Overall Study|Lost to Follow-up|2|||
105933642|NCT02807181|365416334|FG000|Overall Study|Subject decision|1|||
105933643|NCT02807181|365416335|FG001|Overall Study|Subject decision|0|||
105933644|NCT02807181|365416334|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
105933645|NCT02807181|365416335|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
105933646|NCT02807181|365416334|FG000|Overall Study|In Study|3|||
105933647|NCT02807181|365416335|FG001|Overall Study|In Study|3|||
105933648|NCT02807181|365416334|FG000|Overall Study|Post Progression|3|||
105933649|NCT02807181|365416335|FG001|Overall Study|Post Progression|2|||
105933650|NCT05436288|365416336|FG000|Overall Study|Lost to Follow-up|1|||
105933651|NCT05436288|365416336|FG000|Overall Study|Adverse Event|1|||
105933652|NCT02218268|365416339|FG000|24 Hour Washout|Physician Decision|11|||
105933653|NCT02218268|365416340|FG001|24 Hour Washout|Physician Decision|9|||
105933654|NCT00962650|365416344|FG000|Overall Study|Transgastric DP was not completed|2|||
105933655|NCT00694161|365416348|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
105933656|NCT00694161|365416348|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
105933657|NCT00694161|365416348|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
105933658|NCT03020888|365416353|FG000|Overall Study|Physician Decision|4|||
105933659|NCT03020888|365416353|FG000|Overall Study|Withdrawal by Subject|6|||
105933660|NCT03020888|365416353|FG000|Overall Study|Insurance coverage|2|||
105933661|NCT03020888|365416353|FG000|Overall Study|Lost to Follow-up|1|||
105933662|NCT02205359|365416356|FG000|Overall Study|Death|293|||
105933663|NCT02205359|365416357|FG001|Overall Study|Death|327|||
105933664|NCT02205359|365416356|FG000|Overall Study|Lost to Follow-up|182|||
105933665|NCT02205359|365416357|FG001|Overall Study|Lost to Follow-up|162|||
105933666|NCT02205359|365416356|FG000|Overall Study|Physician Decision|51|||
105933667|NCT02205359|365416357|FG001|Overall Study|Physician Decision|53|||
105933668|NCT02205359|365416356|FG000|Overall Study|Withdrawal by Subject|167|||
105933669|NCT02205359|365416357|FG001|Overall Study|Withdrawal by Subject|169|||
105933670|NCT00300495|365416358|FG000|Overall Study|Protocol Violation|4|||
105933671|NCT00300495|365416359|FG001|Overall Study|Protocol Violation|1|||
105933672|NCT01049828|365416368|FG000|Overall Study|Claustrophibia and Frustration|2|||
105933673|NCT03572218|365416369|FG000|Overall Study|Lost to Follow-up|3|||
105933674|NCT03572218|365416370|FG001|Overall Study|Lost to Follow-up|2|||
105933675|NCT03572218|365416369|FG000|Overall Study|No longer available for study visits|2|||
105933676|NCT03572218|365416370|FG001|Overall Study|No longer available for study visits|1|||
105933677|NCT03572218|365416369|FG000|Overall Study|No longer interested|1|||
105791088|NCT02118896|364890527|FG009|Overall Study|Death|0|||
105933678|NCT03572218|365416370|FG001|Overall Study|No longer interested|2|||
105933679|NCT05788328|365417917|FG000|Treatment Period 4 (5 Days)|Other|1|||
105933680|NCT05788328|365417917|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
105933681|NCT00960856|365417918|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105933682|NCT00960856|365417919|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
105933683|NCT00960856|365417920|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
105933684|NCT00960856|365417921|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
105933685|NCT00960856|365417918|FG000|Washout Period of 7 Days|Adverse Event|0|||
105933686|NCT00960856|365417919|FG001|Washout Period of 7 Days|Adverse Event|0|||
105933687|NCT00960856|365417920|FG002|Washout Period of 7 Days|Adverse Event|1|||
105933688|NCT00960856|365417921|FG003|Washout Period of 7 Days|Adverse Event|0|||
105933689|NCT05938010|365417922|FG000|Overall Study|Lost to Follow-up|2|||
105791089|NCT02118896|364890518|FG000|Overall Study|Adverse Event|5|||
105718668|NCT00317044|364628753|FG002|Overall Study|Adverse Event|4|||
105718669|NCT00317044|364628751|FG000|Overall Study|Withdrawal by Subject|10|||
105718670|NCT00317044|364628752|FG001|Overall Study|Withdrawal by Subject|7|||
105718671|NCT00317044|364628753|FG002|Overall Study|Withdrawal by Subject|12|||
105718672|NCT00317044|364628751|FG000|Overall Study|Lost to Follow-up|0|||
105718673|NCT00317044|364628752|FG001|Overall Study|Lost to Follow-up|2|||
105718674|NCT00317044|364628753|FG002|Overall Study|Lost to Follow-up|3|||
105718675|NCT00317044|364628751|FG000|Overall Study|Multiple Reasons|6|||
105718676|NCT00317044|364628752|FG001|Overall Study|Multiple Reasons|2|||
105718677|NCT00317044|364628753|FG002|Overall Study|Multiple Reasons|6|||
105718678|NCT02863848|364628756|FG000|Overall Study|Lost to Follow-up|1|||
105933690|NCT03548415|365417923|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
105933691|NCT03548415|365417924|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
105933692|NCT03548415|365417925|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
105933693|NCT03548415|365417926|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
105933694|NCT03548415|365417927|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
105933695|NCT00985192|365417928|FG000|Overall Study|Withdrawal by Subject|1|||
105933696|NCT00985192|365417928|FG000|Overall Study|Disease Progression|1|||
105933697|NCT00985192|365417928|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
105933698|NCT01454063|365417929|FG000|Randomized|Adverse Event|1|||
105933699|NCT01454063|365417930|FG001|Randomized|Adverse Event|1|||
105933700|NCT01454063|365417929|FG000|Randomized|Protocol Violation|0|||
105933701|NCT01454063|365417930|FG001|Randomized|Protocol Violation|1|||
105933702|NCT02741193|365417934|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
105933703|NCT02741193|365417934|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
105933704|NCT00720083|365417938|FG000|Overall Study|Ineligible|1|||
105933705|NCT00720083|365417939|FG001|Overall Study|Ineligible|2|||
105933706|NCT00976898|365417940|FG000|Overall Study|Protocol Violation|1|||
105933707|NCT00976898|365417940|FG000|Overall Study|Adverse Event|1|||
105933708|NCT00976898|365417940|FG000|Overall Study|Physician Decision|1|||
105933709|NCT00976898|365417940|FG000|Overall Study|Liver Transplant|1|||
105933710|NCT00976898|365417940|FG000|Overall Study|Progressive Disease|1|||
105933711|NCT04389671|365417946|FG000|Overall Study|Death|7|||
105933712|NCT05463705|365417947|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
105933713|NCT05463705|365417948|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
105933714|NCT05463705|365417949|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
105933715|NCT05463705|365417950|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
105933716|NCT05463705|365417951|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
105933717|NCT05463705|365417952|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
105933718|NCT00621322|365417953|FG000|Overall Study|Lost to Follow-up|0|||
105933719|NCT00621322|365417954|FG001|Overall Study|Lost to Follow-up|0|||
105933720|NCT00621322|365417955|FG002|Overall Study|Lost to Follow-up|0|||
105933721|NCT00621322|365417956|FG003|Overall Study|Lost to Follow-up|0|||
105933722|NCT00621322|365417957|FG004|Overall Study|Lost to Follow-up|1|||
105933723|NCT00621322|365417958|FG005|Overall Study|Lost to Follow-up|0|||
105933724|NCT00621322|365417953|FG000|Overall Study|Physician Decision|0|||
105933725|NCT00621322|365417954|FG001|Overall Study|Physician Decision|0|||
105933726|NCT00621322|365417955|FG002|Overall Study|Physician Decision|1|||
105933727|NCT00621322|365417956|FG003|Overall Study|Physician Decision|1|||
105933728|NCT00621322|365417957|FG004|Overall Study|Physician Decision|0|||
105933729|NCT00621322|365417958|FG005|Overall Study|Physician Decision|0|||
105933730|NCT00621322|365417953|FG000|Overall Study|Withdrawal by Subject|0|||
105933731|NCT00621322|365417954|FG001|Overall Study|Withdrawal by Subject|0|||
105933732|NCT00621322|365417955|FG002|Overall Study|Withdrawal by Subject|0|||
105933733|NCT00621322|365417956|FG003|Overall Study|Withdrawal by Subject|1|||
105933734|NCT00621322|365417957|FG004|Overall Study|Withdrawal by Subject|0|||
105933735|NCT00621322|365417958|FG005|Overall Study|Withdrawal by Subject|2|||
105933736|NCT00621322|365417953|FG000|Overall Study|Migrated/moved from study area|1|||
105933737|NCT00621322|365417954|FG001|Overall Study|Migrated/moved from study area|0|||
105718679|NCT02863848|364628757|FG001|Overall Study|Lost to Follow-up|1|||
105718680|NCT02863848|364628756|FG000|Overall Study|Protocol Violation|1|||
105718681|NCT02863848|364628757|FG001|Overall Study|Protocol Violation|2|||
105718682|NCT02318095|364628758|FG000|Overall Study|Adverse Event|1|||
105718683|NCT02000622|364628762|FG000|Overall Study|Withdrawal by Subject|5|||
105933738|NCT00621322|365417955|FG002|Overall Study|Migrated/moved from study area|1|||
105933739|NCT00621322|365417956|FG003|Overall Study|Migrated/moved from study area|1|||
105933740|NCT00621322|365417957|FG004|Overall Study|Migrated/moved from study area|0|||
105933741|NCT00621322|365417958|FG005|Overall Study|Migrated/moved from study area|2|||
105933742|NCT03071965|365417959|FG000|Overall Study|Adverse Event|0|||
105933743|NCT03071965|365417960|FG001|Overall Study|Adverse Event|0|||
105933744|NCT03071965|365417961|FG002|Overall Study|Adverse Event|1|||
105933745|NCT03071965|365417962|FG003|Overall Study|Adverse Event|0|||
105718684|NCT02000622|364628763|FG001|Overall Study|Withdrawal by Subject|7|||
105718685|NCT02000622|364628762|FG000|Overall Study|Lost to Follow-up|4|||
105933746|NCT03071965|365417959|FG000|Overall Study|Death|0|||
105791090|NCT02118896|364890519|FG001|Overall Study|Adverse Event|4|||
105791091|NCT02118896|364890520|FG002|Overall Study|Adverse Event|4|||
105791092|NCT02118896|364890521|FG003|Overall Study|Adverse Event|5|||
105791093|NCT02118896|364890522|FG004|Overall Study|Adverse Event|5|||
105791094|NCT02118896|364890523|FG005|Overall Study|Adverse Event|9|||
105791095|NCT02118896|364890524|FG006|Overall Study|Adverse Event|1|||
105791096|NCT02118896|364890525|FG007|Overall Study|Adverse Event|1|||
105791097|NCT02118896|364890526|FG008|Overall Study|Adverse Event|4|||
105791098|NCT02118896|364890527|FG009|Overall Study|Adverse Event|0|||
105791099|NCT02118896|364890518|FG000|Overall Study|Consent withdrawn|2|||
105791100|NCT02118896|364890519|FG001|Overall Study|Consent withdrawn|0|||
105791101|NCT02118896|364890520|FG002|Overall Study|Consent withdrawn|3|||
105791102|NCT02118896|364890521|FG003|Overall Study|Consent withdrawn|4|||
105791103|NCT02118896|364890522|FG004|Overall Study|Consent withdrawn|1|||
105791104|NCT02118896|364890523|FG005|Overall Study|Consent withdrawn|4|||
105791105|NCT02118896|364890524|FG006|Overall Study|Consent withdrawn|0|||
105791106|NCT02118896|364890525|FG007|Overall Study|Consent withdrawn|0|||
105791107|NCT02118896|364890526|FG008|Overall Study|Consent withdrawn|0|||
105791108|NCT02118896|364890527|FG009|Overall Study|Consent withdrawn|0|||
105791109|NCT02118896|364890518|FG000|Overall Study|Non-compliance|2|||
105791110|NCT02118896|364890519|FG001|Overall Study|Non-compliance|1|||
105791111|NCT02118896|364890520|FG002|Overall Study|Non-compliance|1|||
105791112|NCT02118896|364890521|FG003|Overall Study|Non-compliance|5|||
105791113|NCT02118896|364890522|FG004|Overall Study|Non-compliance|0|||
105791114|NCT02118896|364890523|FG005|Overall Study|Non-compliance|1|||
105791115|NCT02118896|364890524|FG006|Overall Study|Non-compliance|0|||
105933747|NCT03071965|365417960|FG001|Overall Study|Death|0|||
105933748|NCT03071965|365417961|FG002|Overall Study|Death|1|||
105933749|NCT03071965|365417962|FG003|Overall Study|Death|1|||
105933750|NCT03071965|365417959|FG000|Overall Study|COVID-19|0|||
105933751|NCT03071965|365417960|FG001|Overall Study|COVID-19|1|||
105933752|NCT03071965|365417961|FG002|Overall Study|COVID-19|0|||
105933753|NCT03071965|365417962|FG003|Overall Study|COVID-19|1|||
105933754|NCT03071965|365417959|FG000|Overall Study|Other Health Reason|0|||
105933755|NCT03071965|365417960|FG001|Overall Study|Other Health Reason|0|||
105933756|NCT03071965|365417961|FG002|Overall Study|Other Health Reason|0|||
105933757|NCT03071965|365417962|FG003|Overall Study|Other Health Reason|1|||
105933758|NCT00601107|365417963|FG000|Overall Study|Adverse Event|0|||
105933759|NCT00601107|365417964|FG001|Overall Study|Adverse Event|1|||
105933760|NCT00601107|365417965|FG002|Overall Study|Adverse Event|3|||
105933761|NCT00601107|365417966|FG003|Overall Study|Adverse Event|0|||
105933762|NCT00601107|365417963|FG000|Overall Study|Withdrawal by Subject|5|||
105933763|NCT00601107|365417964|FG001|Overall Study|Withdrawal by Subject|4|||
105933764|NCT00601107|365417965|FG002|Overall Study|Withdrawal by Subject|7|||
105933765|NCT00601107|365417966|FG003|Overall Study|Withdrawal by Subject|4|||
105933766|NCT00601107|365417963|FG000|Overall Study|Lost to Follow-up|3|||
105933767|NCT00601107|365417964|FG001|Overall Study|Lost to Follow-up|3|||
105933768|NCT00601107|365417965|FG002|Overall Study|Lost to Follow-up|0|||
105933769|NCT00601107|365417966|FG003|Overall Study|Lost to Follow-up|3|||
105933770|NCT00601107|365417963|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
105933771|NCT00601107|365417964|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
105933772|NCT00601107|365417965|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
105933773|NCT00601107|365417966|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
105933774|NCT00601107|365417963|FG000|Overall Study|Worsening of Psoriasis|4|||
105933775|NCT00601107|365417964|FG001|Overall Study|Worsening of Psoriasis|1|||
105933776|NCT00601107|365417965|FG002|Overall Study|Worsening of Psoriasis|1|||
105933777|NCT00601107|365417966|FG003|Overall Study|Worsening of Psoriasis|4|||
105933778|NCT00601107|365417963|FG000|Overall Study|Undefined|1|||
105933779|NCT00601107|365417964|FG001|Overall Study|Undefined|0|||
105933780|NCT00601107|365417965|FG002|Overall Study|Undefined|1|||
105933781|NCT00601107|365417966|FG003|Overall Study|Undefined|0|||
105933782|NCT02181738|365417967|FG000|Overall Study|Participant Withdrew Consent|2|||
105933783|NCT02181738|365417968|FG001|Overall Study|Participant Withdrew Consent|1|||
105933784|NCT02181738|365417969|FG002|Overall Study|Participant Withdrew Consent|1|||
105933785|NCT02181738|365417970|FG003|Overall Study|Participant Withdrew Consent|1|||
105933786|NCT02181738|365417967|FG000|Overall Study|Lost to Follow-up|1|||
105933787|NCT02181738|365417968|FG001|Overall Study|Lost to Follow-up|2|||
105933788|NCT02181738|365417969|FG002|Overall Study|Lost to Follow-up|1|||
105933789|NCT02181738|365417970|FG003|Overall Study|Lost to Follow-up|1|||
105933790|NCT02181738|365417967|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
105933791|NCT02181738|365417968|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
105933792|NCT02181738|365417969|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
105933793|NCT02181738|365417970|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
105933794|NCT02181738|365417967|FG000|Overall Study|Poor/Non-Compliance|1|||
105933795|NCT02181738|365417968|FG001|Overall Study|Poor/Non-Compliance|0|||
105933796|NCT02181738|365417969|FG002|Overall Study|Poor/Non-Compliance|2|||
105933797|NCT02181738|365417970|FG003|Overall Study|Poor/Non-Compliance|1|||
105791116|NCT02118896|364890525|FG007|Overall Study|Non-compliance|1|||
105791117|NCT02118896|364890526|FG008|Overall Study|Non-compliance|0|||
106009085|NCT05138653|365699090|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
106009086|NCT05138653|365699075|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009087|NCT05138653|365699076|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
106009088|NCT05138653|365699077|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009089|NCT05138653|365699078|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009090|NCT05138653|365699079|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
105718686|NCT02000622|364628763|FG001|Overall Study|Lost to Follow-up|0|||
105718687|NCT02000622|364628762|FG000|Overall Study|Death|159|||
105718688|NCT02000622|364628763|FG001|Overall Study|Death|73|||
105718689|NCT02000622|364628762|FG000|Overall Study|Withdrawn due to site closure|1|||
106009091|NCT05138653|365699080|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009092|NCT05138653|365699081|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009093|NCT05138653|365699082|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009094|NCT05138653|365699083|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009095|NCT05138653|365699084|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009096|NCT05138653|365699085|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009097|NCT05138653|365699086|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009098|NCT05138653|365699087|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009099|NCT05138653|365699088|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009100|NCT05138653|365699089|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009101|NCT05138653|365699090|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
106009102|NCT05138653|365699075|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009103|NCT05138653|365699076|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009104|NCT05138653|365699077|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009105|NCT05138653|365699078|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009106|NCT05138653|365699079|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009107|NCT05138653|365699080|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009108|NCT05138653|365699081|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
106009109|NCT05138653|365699082|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009110|NCT05138653|365699083|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009111|NCT05138653|365699084|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009112|NCT05138653|365699085|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009113|NCT05138653|365699086|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009114|NCT05138653|365699087|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009115|NCT05138653|365699088|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009116|NCT05138653|365699089|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009117|NCT05138653|365699090|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
106009118|NCT05138653|365699075|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009119|NCT05138653|365699076|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009120|NCT05138653|365699077|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009121|NCT05138653|365699078|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009122|NCT05138653|365699079|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009123|NCT05138653|365699080|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009124|NCT05138653|365699081|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009125|NCT05138653|365699082|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009126|NCT05138653|365699083|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009127|NCT05138653|365699084|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009128|NCT05138653|365699085|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
106009129|NCT05138653|365699086|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009130|NCT05138653|365699087|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
106009131|NCT05138653|365699088|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009132|NCT05138653|365699089|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
106009133|NCT05138653|365699090|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
106009134|NCT05138653|365699075|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009135|NCT05138653|365699076|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009136|NCT05138653|365699077|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009137|NCT05138653|365699078|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009138|NCT05138653|365699079|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
105718690|NCT02000622|364628763|FG001|Overall Study|Withdrawn due to site closure|0|||
105718691|NCT02162862|364628764|FG000|Overall Study|Lost to Follow-up|0|||
105718692|NCT02162862|364628765|FG001|Overall Study|Lost to Follow-up|11|||
105718693|NCT02162862|364628766|FG002|Overall Study|Lost to Follow-up|0|||
105718694|NCT02162862|364628764|FG000|Overall Study|Subject did not feel the med was needed|0|||
105718695|NCT02162862|364628765|FG001|Overall Study|Subject did not feel the med was needed|0|||
105791118|NCT02118896|364890527|FG009|Overall Study|Non-compliance|0|||
105718696|NCT02162862|364628766|FG002|Overall Study|Subject did not feel the med was needed|4|||
105791119|NCT02118896|364890518|FG000|Overall Study|Pregnancy|1|||
105718697|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
105718698|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
105718699|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
105718700|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
105718701|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
105718702|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
105718703|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
105718704|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
105718705|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105718706|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
105718707|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105718708|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
105718709|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
105718710|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105718711|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105718712|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
105718713|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
105718714|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
105718715|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
105718716|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
105718717|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
105718718|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
105718719|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
105718720|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
105718721|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
105718722|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
105718723|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
105718724|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
105718725|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
105718726|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
105718727|NCT05195528|364628767|FG000|Placebo-controlled Treatment Period|Other|0|||
105718728|NCT05195528|364628768|FG001|Placebo-controlled Treatment Period|Other|0|||
105718729|NCT05195528|364628769|FG002|Placebo-controlled Treatment Period|Other|1|||
105718730|NCT05195528|364628770|FG003|Placebo-controlled Treatment Period|Other|0|||
105718731|NCT05195528|364628771|FG004|Placebo-controlled Treatment Period|Other|0|||
105718732|NCT05195528|364628767|FG000|Extension Period|PTE or AE or SAE|0|||
105718733|NCT05195528|364628768|FG001|Extension Period|PTE or AE or SAE|4|||
105718734|NCT05195528|364628769|FG002|Extension Period|PTE or AE or SAE|5|||
105718735|NCT05195528|364628770|FG003|Extension Period|PTE or AE or SAE|4|||
105718736|NCT05195528|364628771|FG004|Extension Period|PTE or AE or SAE|4|||
105718737|NCT05195528|364628767|FG000|Extension Period|Protocol Violation|0|||
105718738|NCT05195528|364628768|FG001|Extension Period|Protocol Violation|2|||
105718739|NCT05195528|364628769|FG002|Extension Period|Protocol Violation|1|||
105718740|NCT05195528|364628770|FG003|Extension Period|Protocol Violation|0|||
105718741|NCT05195528|364628771|FG004|Extension Period|Protocol Violation|1|||
105718742|NCT05195528|364628767|FG000|Extension Period|Lost to Follow-up|0|||
105718743|NCT05195528|364628768|FG001|Extension Period|Lost to Follow-up|6|||
105718744|NCT05195528|364628769|FG002|Extension Period|Lost to Follow-up|13|||
105718745|NCT05195528|364628770|FG003|Extension Period|Lost to Follow-up|3|||
105933798|NCT02181738|365417967|FG000|Overall Study|Disease Progression|28|||
105933799|NCT02181738|365417968|FG001|Overall Study|Disease Progression|35|||
105933800|NCT02181738|365417969|FG002|Overall Study|Disease Progression|40|||
105718746|NCT05195528|364628771|FG004|Extension Period|Lost to Follow-up|7|||
105718747|NCT05195528|364628767|FG000|Extension Period|Withdrawal by Subject|0|||
105718748|NCT05195528|364628768|FG001|Extension Period|Withdrawal by Subject|12|||
105718749|NCT05195528|364628769|FG002|Extension Period|Withdrawal by Subject|9|||
105718750|NCT05195528|364628770|FG003|Extension Period|Withdrawal by Subject|6|||
105718751|NCT05195528|364628771|FG004|Extension Period|Withdrawal by Subject|5|||
105933801|NCT02181738|365417970|FG003|Overall Study|Disease Progression|0|||
105933802|NCT02181738|365417967|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
105933803|NCT02181738|365417968|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
105933804|NCT02181738|365417969|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
105718752|NCT05195528|364628767|FG000|Extension Period|Lack of Efficacy|0|||
105718753|NCT05195528|364628768|FG001|Extension Period|Lack of Efficacy|3|||
105718754|NCT05195528|364628769|FG002|Extension Period|Lack of Efficacy|0|||
105718755|NCT05195528|364628770|FG003|Extension Period|Lack of Efficacy|0|||
105718756|NCT05195528|364628771|FG004|Extension Period|Lack of Efficacy|2|||
105933805|NCT02181738|365417970|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
106009139|NCT05138653|365699080|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009140|NCT05138653|365699081|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009141|NCT05138653|365699082|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009142|NCT05138653|365699083|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009143|NCT05138653|365699084|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009144|NCT05138653|365699085|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009145|NCT05138653|365699086|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009146|NCT05138653|365699087|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009147|NCT05138653|365699088|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009148|NCT05138653|365699089|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
106009149|NCT05138653|365699090|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
106009150|NCT05138653|365699075|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
106009151|NCT05138653|365699076|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
106009152|NCT05138653|365699077|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105718757|NCT05195528|364628767|FG000|Extension Period|Not Treated|0|||
105791120|NCT02118896|364890519|FG001|Overall Study|Pregnancy|1|||
105791121|NCT02118896|364890520|FG002|Overall Study|Pregnancy|0|||
105791122|NCT02118896|364890521|FG003|Overall Study|Pregnancy|0|||
105791123|NCT02118896|364890522|FG004|Overall Study|Pregnancy|1|||
105791124|NCT02118896|364890523|FG005|Overall Study|Pregnancy|3|||
105791125|NCT02118896|364890524|FG006|Overall Study|Pregnancy|1|||
105791126|NCT02118896|364890525|FG007|Overall Study|Pregnancy|0|||
105791127|NCT02118896|364890526|FG008|Overall Study|Pregnancy|0|||
105791128|NCT02118896|364890527|FG009|Overall Study|Pregnancy|0|||
105791129|NCT02118896|364890518|FG000|Overall Study|Lost to Follow-up|1|||
105791130|NCT02118896|364890519|FG001|Overall Study|Lost to Follow-up|2|||
105791131|NCT02118896|364890520|FG002|Overall Study|Lost to Follow-up|1|||
105791132|NCT02118896|364890521|FG003|Overall Study|Lost to Follow-up|0|||
105791133|NCT02118896|364890522|FG004|Overall Study|Lost to Follow-up|2|||
105791134|NCT02118896|364890523|FG005|Overall Study|Lost to Follow-up|1|||
105791135|NCT02118896|364890524|FG006|Overall Study|Lost to Follow-up|0|||
105791136|NCT02118896|364890525|FG007|Overall Study|Lost to Follow-up|0|||
105791137|NCT02118896|364890526|FG008|Overall Study|Lost to Follow-up|0|||
105791138|NCT02118896|364890527|FG009|Overall Study|Lost to Follow-up|0|||
105791139|NCT02118896|364890518|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
105791140|NCT02118896|364890519|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
105791141|NCT02118896|364890520|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
105791142|NCT02118896|364890521|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
105791143|NCT02118896|364890522|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
105791144|NCT02118896|364890523|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
105791145|NCT02118896|364890524|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
105718758|NCT05195528|364628768|FG001|Extension Period|Not Treated|0|||
105718759|NCT05195528|364628769|FG002|Extension Period|Not Treated|2|||
105718760|NCT05195528|364628770|FG003|Extension Period|Not Treated|3|||
105718761|NCT05195528|364628771|FG004|Extension Period|Not Treated|0|||
105718762|NCT05195528|364628767|FG000|Extension Period|Other|0|||
105718763|NCT05195528|364628768|FG001|Extension Period|Other|1|||
105718764|NCT05195528|364628769|FG002|Extension Period|Other|1|||
105718765|NCT05195528|364628770|FG003|Extension Period|Other|0|||
105718766|NCT05195528|364628771|FG004|Extension Period|Other|0|||
105718767|NCT00950170|364628772|FG000|Overall Study|Parent/Legal Guardian Request|1|||
105718768|NCT00950170|364628772|FG000|Overall Study|Adverse Event|2|||
105718769|NCT00950170|364628772|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
105718770|NCT02367521|364628775|FG000|Overall Study|severe headache after intervention|2|||
105718771|NCT02367521|364628776|FG001|Overall Study|severe headache after intervention|0|||
105718772|NCT02367521|364628775|FG000|Overall Study|unable to find transportation|2|||
105718773|NCT02367521|364628776|FG001|Overall Study|unable to find transportation|0|||
105718774|NCT00430755|364628779|FG000|Overall Study|Withdrawal by Subject|53|||
105718775|NCT03575104|364628782|FG000|Overall Study|Adverse Event|4|||
105791146|NCT02118896|364890525|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
105791147|NCT02118896|364890526|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
105791148|NCT02118896|364890527|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
105933806|NCT02181738|365417967|FG000|Overall Study|Study Drug Toxicity|6|||
105933807|NCT02181738|365417968|FG001|Overall Study|Study Drug Toxicity|11|||
105933808|NCT02181738|365417969|FG002|Overall Study|Study Drug Toxicity|8|||
105933809|NCT02181738|365417970|FG003|Overall Study|Study Drug Toxicity|1|||
105933810|NCT02181738|365417967|FG000|Overall Study|Other Reasons|14|||
105718776|NCT03575104|364628783|FG001|Overall Study|Adverse Event|3|||
105718777|NCT03575104|364628784|FG002|Overall Study|Adverse Event|4|||
105718778|NCT03575104|364628782|FG000|Overall Study|Withdrawal by Subject|13|||
105718779|NCT03575104|364628783|FG001|Overall Study|Withdrawal by Subject|16|||
105718780|NCT03575104|364628784|FG002|Overall Study|Withdrawal by Subject|11|||
105933811|NCT02181738|365417968|FG001|Overall Study|Other Reasons|16|||
105933812|NCT02181738|365417969|FG002|Overall Study|Other Reasons|28|||
105933813|NCT02181738|365417970|FG003|Overall Study|Other Reasons|0|||
105933814|NCT02181738|365417967|FG000|Overall Study|Maximum Clinical Benefit|3|||
105933815|NCT02181738|365417968|FG001|Overall Study|Maximum Clinical Benefit|0|||
105933816|NCT02181738|365417969|FG002|Overall Study|Maximum Clinical Benefit|1|||
105718781|NCT03575104|364628782|FG000|Overall Study|Other reasons|6|||
105718782|NCT03575104|364628783|FG001|Overall Study|Other reasons|8|||
105718783|NCT03575104|364628784|FG002|Overall Study|Other reasons|6|||
105718784|NCT03575104|364628782|FG000|Overall Study|Lost to Follow-up|1|||
105718785|NCT03575104|364628783|FG001|Overall Study|Lost to Follow-up|2|||
105718786|NCT03575104|364628784|FG002|Overall Study|Lost to Follow-up|1|||
105718787|NCT04684420|364628785|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105718788|NCT04684420|364628786|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105718789|NCT04684420|364628787|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
105718790|NCT04684420|364628788|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
105718791|NCT04684420|364628785|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
105718792|NCT04684420|364628786|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
105718793|NCT04684420|364628787|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
105718794|NCT04684420|364628788|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
105718795|NCT01279057|364628795|FG000|Overall Study|Adverse Event|1|||
105718796|NCT01279057|364628796|FG001|Overall Study|Adverse Event|0|||
105718797|NCT01279057|364628797|FG002|Overall Study|Adverse Event|1|||
105718798|NCT01279057|364628795|FG000|Overall Study|Insufficient therapeutic response|0|||
105718799|NCT01279057|364628796|FG001|Overall Study|Insufficient therapeutic response|0|||
105718800|NCT01279057|364628797|FG002|Overall Study|Insufficient therapeutic response|1|||
105718801|NCT01279057|364628795|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
105718802|NCT01279057|364628796|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
105718803|NCT01279057|364628797|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
105718804|NCT01279057|364628795|FG000|Overall Study|Withdrew consent|2|||
105718805|NCT01279057|364628796|FG001|Overall Study|Withdrew consent|0|||
105718806|NCT01279057|364628797|FG002|Overall Study|Withdrew consent|1|||
105718807|NCT01279057|364628795|FG000|Overall Study|Pregnancy|0|||
105718808|NCT01279057|364628796|FG001|Overall Study|Pregnancy|1|||
105718809|NCT01279057|364628797|FG002|Overall Study|Pregnancy|0|||
105718810|NCT01279057|364628795|FG000|Overall Study|Other|3|||
105718811|NCT01279057|364628796|FG001|Overall Study|Other|3|||
105718812|NCT01279057|364628797|FG002|Overall Study|Other|0|||
105718813|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
105718814|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
105718815|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
105718816|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
105718817|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
105718818|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
105718819|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
105718820|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
105718821|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
105718822|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
105718823|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
105718824|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
105718825|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
105718826|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
105718827|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
105718828|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
105718829|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
105718830|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
105718831|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
105718832|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
105718833|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
105718834|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
105718835|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
105718836|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
105718837|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
105718838|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
105718839|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
105718840|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
105718841|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
105718842|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
105718843|NCT00849017|364628798|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
105718844|NCT00849017|364628799|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
105718845|NCT00849017|364628800|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
105791149|NCT02118896|364890518|FG000|Overall Study|Prohibited medication|0|||
105718846|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
106136918|NCT01651949|366160307|FG002|Overall Study|Unknown status|0|||
106136919|NCT01651949|366160305|FG000|Overall Study|Lost to Follow-up|30|||
106136920|NCT01651949|366160306|FG001|Overall Study|Lost to Follow-up|56|||
106136921|NCT01651949|366160307|FG002|Overall Study|Lost to Follow-up|20|||
106136922|NCT01651949|366160305|FG000|Overall Study|Protocol Violation|0|||
106136923|NCT01651949|366160306|FG001|Overall Study|Protocol Violation|2|||
106136924|NCT01651949|366160307|FG002|Overall Study|Protocol Violation|1|||
106136925|NCT01651949|366160305|FG000|Overall Study|Physician Decision|0|||
106136926|NCT01651949|366160306|FG001|Overall Study|Physician Decision|2|||
106136927|NCT01651949|366160307|FG002|Overall Study|Physician Decision|0|||
106136928|NCT01651949|366160305|FG000|Overall Study|Adverse Event|0|||
106136929|NCT01651949|366160306|FG001|Overall Study|Adverse Event|2|||
106136930|NCT01651949|366160307|FG002|Overall Study|Adverse Event|1|||
105791150|NCT02118896|364890519|FG001|Overall Study|Prohibited medication|0|||
105791151|NCT02118896|364890520|FG002|Overall Study|Prohibited medication|0|||
105791152|NCT02118896|364890521|FG003|Overall Study|Prohibited medication|0|||
105791153|NCT02118896|364890522|FG004|Overall Study|Prohibited medication|1|||
105791154|NCT02118896|364890523|FG005|Overall Study|Prohibited medication|3|||
105791155|NCT02118896|364890524|FG006|Overall Study|Prohibited medication|0|||
105791156|NCT02118896|364890525|FG007|Overall Study|Prohibited medication|0|||
105791157|NCT02118896|364890526|FG008|Overall Study|Prohibited medication|0|||
105791158|NCT02118896|364890527|FG009|Overall Study|Prohibited medication|0|||
106136931|NCT01651949|366160305|FG000|Overall Study|Screen failure|2|||
106136932|NCT01651949|366160306|FG001|Overall Study|Screen failure|2|||
106136933|NCT01651949|366160307|FG002|Overall Study|Screen failure|0|||
106136934|NCT01651949|366160305|FG000|Overall Study|Withdrawal by Subject|17|||
106136935|NCT01651949|366160306|FG001|Overall Study|Withdrawal by Subject|18|||
106136936|NCT01651949|366160307|FG002|Overall Study|Withdrawal by Subject|9|||
106136937|NCT00502593|366160314|FG000|Overall Study|Withdrawn unspecified reason|1|||
106136938|NCT00502593|366160315|FG001|Overall Study|Withdrawn unspecified reason|1|||
106136939|NCT00502593|366160316|FG002|Overall Study|Withdrawn unspecified reason|3|||
106136940|NCT00502593|366160317|FG003|Overall Study|Withdrawn unspecified reason|1|||
106136941|NCT00502593|366160318|FG004|Overall Study|Withdrawn unspecified reason|2|||
106136942|NCT00502593|366160319|FG005|Overall Study|Withdrawn unspecified reason|0|||
106136943|NCT00502593|366160320|FG006|Overall Study|Withdrawn unspecified reason|2|||
106136944|NCT00502593|366160321|FG007|Overall Study|Withdrawn unspecified reason|0|||
106136945|NCT00502593|366160322|FG008|Overall Study|Withdrawn unspecified reason|0|||
105791159|NCT02118896|364890518|FG000|Overall Study|Miscellaneous|1|||
105791160|NCT02118896|364890519|FG001|Overall Study|Miscellaneous|2|||
105791161|NCT02118896|364890520|FG002|Overall Study|Miscellaneous|0|||
105791162|NCT02118896|364890521|FG003|Overall Study|Miscellaneous|2|||
105791163|NCT02118896|364890522|FG004|Overall Study|Miscellaneous|0|||
105791164|NCT02118896|364890523|FG005|Overall Study|Miscellaneous|4|||
105791165|NCT02118896|364890524|FG006|Overall Study|Miscellaneous|0|||
105791166|NCT02118896|364890525|FG007|Overall Study|Miscellaneous|0|||
105933817|NCT02181738|365417970|FG003|Overall Study|Maximum Clinical Benefit|0|||
105933818|NCT02181738|365417967|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105933819|NCT02181738|365417968|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105933820|NCT02181738|365417969|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
105933821|NCT02181738|365417970|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105933822|NCT00114777|365417974|FG000|Randomization to Month 36|Death|10|||
105933823|NCT00114777|365417975|FG001|Randomization to Month 36|Death|4|||
105933824|NCT00114777|365417976|FG002|Randomization to Month 36|Death|3|||
105933825|NCT00114777|365417974|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
105933826|NCT00114777|365417975|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
105933827|NCT00114777|365417976|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
105933828|NCT00114777|365417974|FG000|Randomization to Month 36|Lack of Efficacy|19|||
105933829|NCT00114777|365417975|FG001|Randomization to Month 36|Lack of Efficacy|15|||
105933830|NCT00114777|365417976|FG002|Randomization to Month 36|Lack of Efficacy|17|||
105933831|NCT00114777|365417974|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
105933832|NCT00114777|365417975|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
105933833|NCT00114777|365417976|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
105933834|NCT00114777|365417974|FG000|Randomization to Month 36|Adverse Event|34|||
105933835|NCT00114777|365417975|FG001|Randomization to Month 36|Adverse Event|35|||
105933836|NCT00114777|365417976|FG002|Randomization to Month 36|Adverse Event|44|||
105933837|NCT00114777|365417974|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
106136946|NCT00502593|366160323|FG009|Overall Study|Withdrawn unspecified reason|0|||
106136947|NCT00502593|366160324|FG010|Overall Study|Withdrawn unspecified reason|0|||
106136948|NCT00502593|366160325|FG011|Overall Study|Withdrawn unspecified reason|0|||
106136949|NCT00502593|366160314|FG000|Overall Study|Withdrawal by Subject|0|||
106136950|NCT00502593|366160315|FG001|Overall Study|Withdrawal by Subject|0|||
106136951|NCT00502593|366160316|FG002|Overall Study|Withdrawal by Subject|6|||
106136952|NCT00502593|366160317|FG003|Overall Study|Withdrawal by Subject|2|||
105791167|NCT02118896|364890526|FG008|Overall Study|Miscellaneous|0|||
105791168|NCT02118896|364890527|FG009|Overall Study|Miscellaneous|0|||
105718847|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
105718848|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
105718849|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
105718850|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
105718851|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
105718852|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
105718853|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
105718854|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
105718855|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
105718856|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
105718857|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
105791169|NCT04221373|364890535|FG000|Overall Study|Physician Decision|4|||
105791170|NCT04221373|364890536|FG001|Overall Study|Physician Decision|0|||
105791171|NCT05102162|364890542|FG000|Overall Study|Withdrawal by Subject|3|||
105791172|NCT05102162|364890543|FG001|Overall Study|Withdrawal by Subject|0|||
105791173|NCT05102162|364890542|FG000|Overall Study|Baseline cultures negative|4|||
105791174|NCT05102162|364890543|FG001|Overall Study|Baseline cultures negative|2|||
105791175|NCT05102162|364890542|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
105791176|NCT05102162|364890543|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
105791177|NCT05102162|364890542|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
105791178|NCT05102162|364890543|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
105791179|NCT00572910|364890546|FG000|Overall Study|Adverse Event|1|||
105791180|NCT00572910|364890547|FG001|Overall Study|Adverse Event|2|||
105791181|NCT00572910|364890548|FG002|Overall Study|Adverse Event|0|||
105791182|NCT00572910|364890549|FG003|Overall Study|Adverse Event|2|||
105791183|NCT00572910|364890550|FG004|Overall Study|Adverse Event|0|||
105791184|NCT00572910|364890551|FG005|Overall Study|Adverse Event|0|||
105791185|NCT00572910|364890552|FG006|Overall Study|Adverse Event|4|||
105791186|NCT00572910|364890553|FG007|Overall Study|Adverse Event|2|||
105791187|NCT00572910|364890554|FG008|Overall Study|Adverse Event|1|||
105791188|NCT00572910|364890555|FG009|Overall Study|Adverse Event|3|||
105791189|NCT00572910|364890556|FG010|Overall Study|Adverse Event|2|||
105791190|NCT00572910|364890546|FG000|Overall Study|Lost to Follow-up|0|||
105791191|NCT00572910|364890547|FG001|Overall Study|Lost to Follow-up|1|||
105791192|NCT00572910|364890548|FG002|Overall Study|Lost to Follow-up|1|||
105791193|NCT00572910|364890549|FG003|Overall Study|Lost to Follow-up|2|||
105791194|NCT00572910|364890550|FG004|Overall Study|Lost to Follow-up|1|||
105791195|NCT00572910|364890551|FG005|Overall Study|Lost to Follow-up|0|||
105791196|NCT00572910|364890552|FG006|Overall Study|Lost to Follow-up|0|||
105791197|NCT00572910|364890553|FG007|Overall Study|Lost to Follow-up|0|||
105791198|NCT00572910|364890554|FG008|Overall Study|Lost to Follow-up|0|||
105791199|NCT00572910|364890555|FG009|Overall Study|Lost to Follow-up|1|||
105791200|NCT00572910|364890556|FG010|Overall Study|Lost to Follow-up|0|||
105791201|NCT00572910|364890546|FG000|Overall Study|Withdrawal by Subject|3|||
105791202|NCT00572910|364890547|FG001|Overall Study|Withdrawal by Subject|0|||
105791203|NCT00572910|364890548|FG002|Overall Study|Withdrawal by Subject|1|||
105791204|NCT00572910|364890549|FG003|Overall Study|Withdrawal by Subject|0|||
105791205|NCT00572910|364890550|FG004|Overall Study|Withdrawal by Subject|1|||
105791206|NCT00572910|364890551|FG005|Overall Study|Withdrawal by Subject|3|||
105791207|NCT00572910|364890552|FG006|Overall Study|Withdrawal by Subject|0|||
105791208|NCT00572910|364890553|FG007|Overall Study|Withdrawal by Subject|2|||
105791209|NCT00572910|364890554|FG008|Overall Study|Withdrawal by Subject|2|||
105791210|NCT00572910|364890555|FG009|Overall Study|Withdrawal by Subject|2|||
105791211|NCT00572910|364890556|FG010|Overall Study|Withdrawal by Subject|1|||
105791212|NCT00669110|364890557|FG000|Overall Study|Adverse Event|4|||
105791213|NCT00669110|364890558|FG001|Overall Study|Adverse Event|3|||
106136953|NCT00502593|366160318|FG004|Overall Study|Withdrawal by Subject|2|||
106136954|NCT00502593|366160319|FG005|Overall Study|Withdrawal by Subject|0|||
106136955|NCT00502593|366160320|FG006|Overall Study|Withdrawal by Subject|3|||
106136956|NCT00502593|366160321|FG007|Overall Study|Withdrawal by Subject|0|||
105718858|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
105718859|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
105791214|NCT00669110|364890557|FG000|Overall Study|Caregiver request|3|||
105791215|NCT00669110|364890558|FG001|Overall Study|Caregiver request|2|||
105791216|NCT00669110|364890557|FG000|Overall Study|Physician Decision|0|||
105791217|NCT00669110|364890558|FG001|Overall Study|Physician Decision|1|||
105718860|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
105718861|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
105791218|NCT00669110|364890557|FG000|Overall Study|Lost to Follow-up|1|||
105791219|NCT00669110|364890558|FG001|Overall Study|Lost to Follow-up|0|||
105791220|NCT00669110|364890557|FG000|Overall Study|Protocol Violation|0|||
105791221|NCT00669110|364890558|FG001|Overall Study|Protocol Violation|5|||
105791222|NCT00669110|364890557|FG000|Overall Study|Withdrawal by Subject|0|||
105791223|NCT00669110|364890558|FG001|Overall Study|Withdrawal by Subject|2|||
105791224|NCT00127192|364890559|FG000|Overall Study|Adverse Event|0|||
105791225|NCT00127192|364890560|FG001|Overall Study|Adverse Event|1|||
105791226|NCT00127192|364890561|FG002|Overall Study|Adverse Event|1|||
105791227|NCT00127192|364890562|FG003|Overall Study|Adverse Event|1|||
105791228|NCT00127192|364890563|FG004|Overall Study|Adverse Event|0|||
105791229|NCT00127192|364890559|FG000|Overall Study|Lack of Efficacy|2|||
105791230|NCT00127192|364890560|FG001|Overall Study|Lack of Efficacy|0|||
105791231|NCT00127192|364890561|FG002|Overall Study|Lack of Efficacy|0|||
105791232|NCT00127192|364890562|FG003|Overall Study|Lack of Efficacy|0|||
105791233|NCT00127192|364890563|FG004|Overall Study|Lack of Efficacy|2|||
105791234|NCT00127192|364890559|FG000|Overall Study|Withdrawal by Subject|0|||
105791235|NCT00127192|364890560|FG001|Overall Study|Withdrawal by Subject|0|||
105791236|NCT00127192|364890561|FG002|Overall Study|Withdrawal by Subject|1|||
105791237|NCT00127192|364890562|FG003|Overall Study|Withdrawal by Subject|0|||
105791238|NCT00127192|364890563|FG004|Overall Study|Withdrawal by Subject|3|||
105791239|NCT00127192|364890559|FG000|Overall Study|Adverse event in pre-treatment period|1|||
105791240|NCT00127192|364890560|FG001|Overall Study|Adverse event in pre-treatment period|0|||
105791241|NCT00127192|364890561|FG002|Overall Study|Adverse event in pre-treatment period|0|||
105791242|NCT00127192|364890562|FG003|Overall Study|Adverse event in pre-treatment period|0|||
105791243|NCT00127192|364890563|FG004|Overall Study|Adverse event in pre-treatment period|0|||
105791244|NCT01870921|364890565|FG000|Overall Study|Subject decision|80|||
105791245|NCT01870921|364890565|FG000|Overall Study|Severe non-compliance to protocol|7|||
105791246|NCT01870921|364890565|FG000|Overall Study|Subject Lost to Follow up|2|||
105791247|NCT01870921|364890565|FG000|Overall Study|Other|1|||
105791248|NCT03359473|364890568|FG000|Overall Study|Adverse Event|0|||
105791249|NCT03359473|364890569|FG001|Overall Study|Adverse Event|2|||
105791250|NCT03359473|364890570|FG002|Overall Study|Adverse Event|5|||
105791251|NCT03359473|364890571|FG003|Overall Study|Adverse Event|3|||
105791252|NCT03359473|364890568|FG000|Overall Study|Lost to Follow-up|0|||
105791253|NCT03359473|364890569|FG001|Overall Study|Lost to Follow-up|1|||
105791254|NCT03359473|364890570|FG002|Overall Study|Lost to Follow-up|0|||
105791255|NCT03359473|364890571|FG003|Overall Study|Lost to Follow-up|0|||
105791256|NCT03359473|364890568|FG000|Overall Study|Physician Decision|0|||
105791257|NCT03359473|364890569|FG001|Overall Study|Physician Decision|1|||
105791258|NCT03359473|364890570|FG002|Overall Study|Physician Decision|0|||
105791259|NCT03359473|364890571|FG003|Overall Study|Physician Decision|1|||
105791260|NCT03359473|364890568|FG000|Overall Study|Withdrawal by Subject|1|||
105791261|NCT03359473|364890569|FG001|Overall Study|Withdrawal by Subject|2|||
105791262|NCT03359473|364890570|FG002|Overall Study|Withdrawal by Subject|1|||
105791263|NCT03359473|364890571|FG003|Overall Study|Withdrawal by Subject|0|||
105791264|NCT03359473|364890568|FG000|Overall Study|Protocol-defined stopping criteria|1|||
105791265|NCT03359473|364890569|FG001|Overall Study|Protocol-defined stopping criteria|0|||
105791266|NCT03359473|364890570|FG002|Overall Study|Protocol-defined stopping criteria|0|||
105791267|NCT03359473|364890571|FG003|Overall Study|Protocol-defined stopping criteria|1|||
105791268|NCT01125358|364890572|FG000|Overall Study|Adverse Event|3|||
105791269|NCT01125358|364890573|FG001|Overall Study|Adverse Event|0|||
105791270|NCT01125358|364890574|FG002|Overall Study|Adverse Event|0|||
105791271|NCT01125358|364890575|FG003|Overall Study|Adverse Event|2|||
105791272|NCT01125358|364890572|FG000|Overall Study|Perceived Lack of Efficacy|6|||
105791273|NCT01125358|364890573|FG001|Overall Study|Perceived Lack of Efficacy|3|||
105791274|NCT01125358|364890574|FG002|Overall Study|Perceived Lack of Efficacy|7|||
105791275|NCT01125358|364890575|FG003|Overall Study|Perceived Lack of Efficacy|4|||
105791276|NCT01125358|364890572|FG000|Overall Study|Protocol Violation|1|||
105791277|NCT01125358|364890573|FG001|Overall Study|Protocol Violation|0|||
105791278|NCT01125358|364890574|FG002|Overall Study|Protocol Violation|0|||
105791279|NCT01125358|364890575|FG003|Overall Study|Protocol Violation|0|||
105791280|NCT01125358|364890572|FG000|Overall Study|Sponsor Decision|0|||
105791281|NCT01125358|364890573|FG001|Overall Study|Sponsor Decision|0|||
105791282|NCT01125358|364890574|FG002|Overall Study|Sponsor Decision|1|||
105791283|NCT01125358|364890575|FG003|Overall Study|Sponsor Decision|1|||
105791284|NCT01125358|364890572|FG000|Overall Study|Withdrawal by Subject|2|||
105791285|NCT01125358|364890573|FG001|Overall Study|Withdrawal by Subject|1|||
105791286|NCT01125358|364890574|FG002|Overall Study|Withdrawal by Subject|1|||
105791287|NCT01125358|364890575|FG003|Overall Study|Withdrawal by Subject|1|||
105791288|NCT00742859|364890576|FG000|Overall Study|Adverse Event|5|||
105791289|NCT00742859|364890577|FG001|Overall Study|Adverse Event|6|||
105791290|NCT00742859|364890578|FG002|Overall Study|Adverse Event|3|||
105791291|NCT00742859|364890579|FG003|Overall Study|Adverse Event|1|||
105791292|NCT00742859|364890576|FG000|Overall Study|Death|1|||
105791293|NCT00742859|364890577|FG001|Overall Study|Death|0|||
105791294|NCT00742859|364890578|FG002|Overall Study|Death|0|||
105791295|NCT00742859|364890579|FG003|Overall Study|Death|1|||
105791296|NCT00742859|364890576|FG000|Overall Study|Physician Decision|1|||
105791297|NCT00742859|364890577|FG001|Overall Study|Physician Decision|2|||
105791298|NCT00742859|364890578|FG002|Overall Study|Physician Decision|0|||
105791299|NCT00742859|364890579|FG003|Overall Study|Physician Decision|0|||
105791300|NCT00742859|364890576|FG000|Overall Study|Withdrawal by Subject|4|||
105791301|NCT00742859|364890577|FG001|Overall Study|Withdrawal by Subject|2|||
105791302|NCT00742859|364890578|FG002|Overall Study|Withdrawal by Subject|4|||
105791303|NCT00742859|364890579|FG003|Overall Study|Withdrawal by Subject|1|||
105933838|NCT00114777|365417975|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
105933839|NCT00114777|365417976|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
105933840|NCT00114777|365417974|FG000|Randomization to Month 36|Other|9|||
105933841|NCT00114777|365417975|FG001|Randomization to Month 36|Other|3|||
105933842|NCT00114777|365417976|FG002|Randomization to Month 36|Other|12|||
105933843|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|Death|8|||
105933844|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|Death|13|||
105933845|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|Death|7|||
105933846|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
105933847|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
105933848|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
105933849|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
105933850|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
105933851|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
105933852|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
105933853|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
105933854|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
105933855|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
105933856|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
105933857|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
105933858|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
105933859|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
105933860|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
105933861|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
105933862|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
105933863|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
105933864|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
105933865|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
105933866|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
105933867|NCT00114777|365417974|FG000|Long-Term Extension to Month 84|Other|2|||
105933868|NCT00114777|365417975|FG001|Long-Term Extension to Month 84|Other|0|||
105933869|NCT00114777|365417976|FG002|Long-Term Extension to Month 84|Other|2|||
105933870|NCT01181128|365417977|FG000|Overall Study|Withdrawal by Subject|2|||
105933871|NCT01181128|365417978|FG001|Overall Study|Withdrawal by Subject|2|||
105933872|NCT01181128|365417979|FG002|Overall Study|Withdrawal by Subject|0|||
105933873|NCT01181128|365417977|FG000|Overall Study|Death|1|||
105933874|NCT01181128|365417978|FG001|Overall Study|Death|0|||
105933875|NCT01181128|365417979|FG002|Overall Study|Death|0|||
105933876|NCT01181128|365417977|FG000|Overall Study|Physician Decision|2|||
105933877|NCT01181128|365417978|FG001|Overall Study|Physician Decision|0|||
105933878|NCT01181128|365417979|FG002|Overall Study|Physician Decision|0|||
105933879|NCT01181128|365417977|FG000|Overall Study|Adverse Event|0|||
105933880|NCT01181128|365417978|FG001|Overall Study|Adverse Event|2|||
105933881|NCT01181128|365417979|FG002|Overall Study|Adverse Event|0|||
105933882|NCT01181128|365417977|FG000|Overall Study|Other|1|||
105933883|NCT01181128|365417978|FG001|Overall Study|Other|1|||
105933884|NCT01181128|365417979|FG002|Overall Study|Other|1|||
105933885|NCT02453191|365417980|FG000|Overall Study|Withdrawal by Subject|1|||
105933886|NCT03364686|365417981|FG000|Overall Study|Physician Decision|2|||
105933887|NCT02336503|365417984|FG000|Overall Study|Lost to Follow-up|0|||
105933888|NCT02336503|365417985|FG001|Overall Study|Lost to Follow-up|3|||
105933889|NCT02336503|365417986|FG002|Overall Study|Lost to Follow-up|0|||
105933890|NCT02336503|365417987|FG003|Overall Study|Lost to Follow-up|2|||
105933891|NCT02336503|365417984|FG000|Overall Study|Withdrawal by Subject|2|||
105933892|NCT02336503|365417985|FG001|Overall Study|Withdrawal by Subject|0|||
105933893|NCT02336503|365417986|FG002|Overall Study|Withdrawal by Subject|0|||
105933894|NCT02336503|365417987|FG003|Overall Study|Withdrawal by Subject|4|||
105933895|NCT02336503|365417984|FG000|Overall Study|Adverse Event|0|||
105933896|NCT02336503|365417985|FG001|Overall Study|Adverse Event|0|||
105933897|NCT02336503|365417986|FG002|Overall Study|Adverse Event|1|||
105933898|NCT02336503|365417987|FG003|Overall Study|Adverse Event|0|||
105933899|NCT01210443|365417999|FG000|Overall Study|Study terminated by sponsor|2|||
105933900|NCT02965456|365418004|FG000|Overall Study|Lost to Follow-up|40|||
105933901|NCT02965456|365418005|FG001|Overall Study|Lost to Follow-up|18|||
105933902|NCT02965456|365418004|FG000|Overall Study|Subject Request|22|||
105933903|NCT02965456|365418005|FG001|Overall Study|Subject Request|13|||
105933904|NCT02965456|365418004|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
105933905|NCT02965456|365418005|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
105933906|NCT02965456|365418004|FG000|Overall Study|Adverse Event|3|||
105933907|NCT02965456|365418005|FG001|Overall Study|Adverse Event|0|||
105933908|NCT02965456|365418004|FG000|Overall Study|Noncompliance with Study Drug|1|||
106009153|NCT05138653|365699078|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105933909|NCT02965456|365418005|FG001|Overall Study|Noncompliance with Study Drug|1|||
105933910|NCT02965456|365418004|FG000|Overall Study|Worsening Condition|0|||
106136957|NCT00502593|366160322|FG008|Overall Study|Withdrawal by Subject|3|||
106136958|NCT00502593|366160323|FG009|Overall Study|Withdrawal by Subject|0|||
106136959|NCT00502593|366160324|FG010|Overall Study|Withdrawal by Subject|1|||
106136960|NCT00502593|366160325|FG011|Overall Study|Withdrawal by Subject|0|||
105718862|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
105718863|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
105933911|NCT02965456|365418005|FG001|Overall Study|Worsening Condition|2|||
105933912|NCT02965456|365418004|FG000|Overall Study|Lack of Efficacy|1|||
105933913|NCT02965456|365418005|FG001|Overall Study|Lack of Efficacy|0|||
105933914|NCT02965456|365418004|FG000|Overall Study|Physician Decision|0|||
105933915|NCT02965456|365418005|FG001|Overall Study|Physician Decision|1|||
105933916|NCT02965456|365418004|FG000|Overall Study|Pregnancy|1|||
105933917|NCT02965456|365418005|FG001|Overall Study|Pregnancy|0|||
105933918|NCT02965456|365418004|FG000|Overall Study|Protocol Violation|0|||
105933919|NCT02965456|365418005|FG001|Overall Study|Protocol Violation|1|||
105933920|NCT02965456|365418004|FG000|Overall Study|Participant ran out of study drug|0|||
105933921|NCT02965456|365418005|FG001|Overall Study|Participant ran out of study drug|1|||
105933922|NCT05507450|365418006|FG000|Overall Study|Death|0|||
105933923|NCT05507450|365418007|FG001|Overall Study|Death|0|||
105933924|NCT05507450|365418008|FG002|Overall Study|Death|1|||
105933925|NCT05507450|365418009|FG003|Overall Study|Death|0|||
105933926|NCT05507450|365418006|FG000|Overall Study|Lost to Follow-up|22|||
105933927|NCT05507450|365418007|FG001|Overall Study|Lost to Follow-up|20|||
105933928|NCT05507450|365418008|FG002|Overall Study|Lost to Follow-up|20|||
105933929|NCT05507450|365418009|FG003|Overall Study|Lost to Follow-up|7|||
105933930|NCT05507450|365418006|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105933931|NCT05507450|365418007|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
105933932|NCT05507450|365418008|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105933933|NCT05507450|365418009|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105933934|NCT05507450|365418006|FG000|Overall Study|Withdrawal by Subject|4|||
105933935|NCT05507450|365418007|FG001|Overall Study|Withdrawal by Subject|11|||
105933936|NCT05507450|365418008|FG002|Overall Study|Withdrawal by Subject|7|||
105933937|NCT05507450|365418009|FG003|Overall Study|Withdrawal by Subject|3|||
105933938|NCT05507450|365418006|FG000|Overall Study|Participant left the country|0|||
105933939|NCT05507450|365418007|FG001|Overall Study|Participant left the country|0|||
105933940|NCT05507450|365418008|FG002|Overall Study|Participant left the country|1|||
105933941|NCT05507450|365418009|FG003|Overall Study|Participant left the country|0|||
105933942|NCT01309100|365418010|FG000|Overall Study|Protocol Violation|1|||
105933943|NCT01309100|365418010|FG000|Overall Study|Positive Slit lamp finding|1|||
105933944|NCT03767894|365418011|FG000|Overall Study|Withdrawal by Subject|1|||
105933945|NCT00407030|365418012|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
105933946|NCT00407030|365418013|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
105933947|NCT00407030|365418014|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
105933948|NCT00407030|365418012|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
105933949|NCT00407030|365418013|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
105933950|NCT00407030|365418014|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
105933951|NCT00407030|365418012|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
105933952|NCT00407030|365418013|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
105933953|NCT00407030|365418014|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
105933954|NCT00407030|365418012|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
105933955|NCT00407030|365418013|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
105933956|NCT00407030|365418014|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
105933957|NCT00407030|365418012|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
105933958|NCT00407030|365418013|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
105933959|NCT00407030|365418014|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
105933960|NCT00407030|365418012|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
105933961|NCT00407030|365418013|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
105933962|NCT00407030|365418014|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
105933963|NCT00407030|365418012|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
105933964|NCT00407030|365418013|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
105933965|NCT00407030|365418014|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
105933966|NCT00407030|365418012|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
105933967|NCT00407030|365418013|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
106136961|NCT00502593|366160314|FG000|Overall Study|Lost to Follow-up|2|||
105933968|NCT00407030|365418014|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
105933969|NCT00407030|365418012|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
106136962|NCT00502593|366160315|FG001|Overall Study|Lost to Follow-up|1|||
105718864|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
105933970|NCT00407030|365418013|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
105933971|NCT00407030|365418014|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
105933972|NCT00407030|365418012|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
106136963|NCT00502593|366160316|FG002|Overall Study|Lost to Follow-up|1|||
106136964|NCT00502593|366160317|FG003|Overall Study|Lost to Follow-up|1|||
105791304|NCT00742859|364890576|FG000|Overall Study|Endpoint|0|||
105791305|NCT00742859|364890577|FG001|Overall Study|Endpoint|1|||
105791306|NCT00742859|364890578|FG002|Overall Study|Endpoint|1|||
105791307|NCT00742859|364890579|FG003|Overall Study|Endpoint|2|||
105791308|NCT00742859|364890576|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
105791309|NCT00742859|364890577|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
105791310|NCT00742859|364890578|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
105791311|NCT00742859|364890579|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
105791312|NCT00742859|364890576|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
105791313|NCT00742859|364890577|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
105791314|NCT00742859|364890578|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
105791315|NCT00742859|364890579|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
105791316|NCT00742859|364890576|FG000|Overall Study|Sponsor request patient out of town|0|||
105791317|NCT00742859|364890577|FG001|Overall Study|Sponsor request patient out of town|0|||
105791318|NCT00742859|364890578|FG002|Overall Study|Sponsor request patient out of town|1|||
105791319|NCT00742859|364890579|FG003|Overall Study|Sponsor request patient out of town|1|||
105791320|NCT00742859|364890576|FG000|Overall Study|Site error|0|||
105791321|NCT00742859|364890577|FG001|Overall Study|Site error|0|||
105791322|NCT00742859|364890578|FG002|Overall Study|Site error|1|||
105791323|NCT00742859|364890579|FG003|Overall Study|Site error|1|||
105791324|NCT03409328|364890585|FG000|Overall Study|Lost to Follow-up|6|||
105791325|NCT03409328|364890586|FG001|Overall Study|Lost to Follow-up|3|||
105791326|NCT01306968|364890587|FG000|Overall Study|Lost to Follow-up|1|||
105791327|NCT01306968|364890588|FG001|Overall Study|Lost to Follow-up|1|||
105791328|NCT01306968|364890589|FG002|Overall Study|Lost to Follow-up|0|||
105791329|NCT01306968|364890590|FG003|Overall Study|Lost to Follow-up|0|||
105791330|NCT01306968|364890587|FG000|Overall Study|Physician Decision|0|||
105791331|NCT01306968|364890588|FG001|Overall Study|Physician Decision|1|||
105791332|NCT01306968|364890589|FG002|Overall Study|Physician Decision|0|||
105791333|NCT01306968|364890590|FG003|Overall Study|Physician Decision|0|||
105791334|NCT01306968|364890587|FG000|Overall Study|Relocated and left active duty|0|||
105791335|NCT01306968|364890588|FG001|Overall Study|Relocated and left active duty|1|||
105791336|NCT01306968|364890589|FG002|Overall Study|Relocated and left active duty|1|||
105791337|NCT01306968|364890590|FG003|Overall Study|Relocated and left active duty|1|||
105791338|NCT01306968|364890587|FG000|Overall Study|Withdrew - time commitment|0|||
105791339|NCT01306968|364890588|FG001|Overall Study|Withdrew - time commitment|0|||
105791340|NCT01306968|364890589|FG002|Overall Study|Withdrew - time commitment|0|||
105791341|NCT01306968|364890590|FG003|Overall Study|Withdrew - time commitment|2|||
105791342|NCT01306968|364890587|FG000|Overall Study|Withdrew over privacy concerns|0|||
105791343|NCT01306968|364890588|FG001|Overall Study|Withdrew over privacy concerns|0|||
105791344|NCT01306968|364890589|FG002|Overall Study|Withdrew over privacy concerns|0|||
105791345|NCT01306968|364890590|FG003|Overall Study|Withdrew over privacy concerns|1|||
105791346|NCT03128931|364890591|FG000|Overall Study|Physician Decision|1|||
105791347|NCT03128931|364890591|FG000|Overall Study|Equipment Issues|3|||
105791348|NCT04993339|364890592|FG000|Overall Study|Lost to Follow-up|0|||
105791349|NCT04993339|364890593|FG001|Overall Study|Lost to Follow-up|1|||
105791350|NCT04993339|364890592|FG000|Overall Study|no MRI scan|3|||
105791351|NCT04993339|364890593|FG001|Overall Study|no MRI scan|1|||
105791352|NCT04798027|364890596|FG000|Overall Study|Protocol Violation|0|||
105791353|NCT04798027|364890597|FG001|Overall Study|Protocol Violation|0|||
105791354|NCT04798027|364890598|FG002|Overall Study|Protocol Violation|0|||
105791355|NCT04798027|364890599|FG003|Overall Study|Protocol Violation|0|||
105791356|NCT04798027|364890600|FG004|Overall Study|Protocol Violation|1|||
105791357|NCT04798027|364890601|FG005|Overall Study|Protocol Violation|0|||
105791358|NCT04798027|364890602|FG006|Overall Study|Protocol Violation|0|||
105791359|NCT04798027|364890603|FG007|Overall Study|Protocol Violation|1|||
105933973|NCT00407030|365418013|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
105933974|NCT00407030|365418014|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
105933975|NCT00407030|365418012|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
105933976|NCT00407030|365418013|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
105933977|NCT00407030|365418014|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
105933978|NCT00407030|365418012|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
105933979|NCT00407030|365418013|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
105933980|NCT00407030|365418014|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
105933981|NCT00407030|365418012|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
105933982|NCT00407030|365418013|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
105791360|NCT04798027|364890604|FG008|Overall Study|Protocol Violation|0|||
105791361|NCT04798027|364890596|FG000|Overall Study|Withdrawal by Subject|1|||
105791362|NCT04798027|364890597|FG001|Overall Study|Withdrawal by Subject|0|||
105791363|NCT04798027|364890598|FG002|Overall Study|Withdrawal by Subject|1|||
105791364|NCT04798027|364890599|FG003|Overall Study|Withdrawal by Subject|1|||
105791365|NCT04798027|364890600|FG004|Overall Study|Withdrawal by Subject|1|||
105791366|NCT04798027|364890601|FG005|Overall Study|Withdrawal by Subject|1|||
105791367|NCT04798027|364890602|FG006|Overall Study|Withdrawal by Subject|3|||
105791368|NCT04798027|364890603|FG007|Overall Study|Withdrawal by Subject|2|||
105933983|NCT00407030|365418014|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
105933984|NCT01489358|365418015|FG000|Overall Study|Lost to Follow-up|0|||
105933985|NCT01489358|365418016|FG001|Overall Study|Lost to Follow-up|0|||
105933986|NCT01489358|365418017|FG002|Overall Study|Lost to Follow-up|2|||
106136965|NCT00502593|366160318|FG004|Overall Study|Lost to Follow-up|0|||
106136966|NCT00502593|366160319|FG005|Overall Study|Lost to Follow-up|0|||
106136967|NCT00502593|366160320|FG006|Overall Study|Lost to Follow-up|0|||
106136968|NCT00502593|366160321|FG007|Overall Study|Lost to Follow-up|0|||
106136969|NCT00502593|366160322|FG008|Overall Study|Lost to Follow-up|3|||
106136970|NCT00502593|366160323|FG009|Overall Study|Lost to Follow-up|0|||
106136971|NCT00502593|366160324|FG010|Overall Study|Lost to Follow-up|1|||
106136972|NCT00502593|366160325|FG011|Overall Study|Lost to Follow-up|0|||
106136973|NCT01253226|366160326|FG000|Overall Study|Adverse Event|0|||
106136974|NCT01253226|366160327|FG001|Overall Study|Adverse Event|0|||
106136975|NCT01253226|366160328|FG002|Overall Study|Adverse Event|1|||
106136976|NCT01253226|366160329|FG003|Overall Study|Adverse Event|0|||
106136977|NCT01253226|366160330|FG004|Overall Study|Adverse Event|0|||
105933987|NCT00736476|365418019|FG000|Overall Study|Adverse Event|1|||
105933988|NCT00736476|365418020|FG001|Overall Study|Adverse Event|0|||
105933989|NCT00472641|365418022|FG000|Overall Study|Lack of Efficacy|3|||
105933990|NCT00472641|365418022|FG000|Overall Study|Adverse Event|3|||
105933991|NCT00472641|365418022|FG000|Overall Study|Lost to Follow-up|1|||
105933992|NCT03808909|365418023|FG000|Overall Study|Lost to Follow-up|3|||
105933993|NCT03808909|365418024|FG001|Overall Study|Lost to Follow-up|0|||
105933994|NCT01827943|365418025|FG000|Overall Study|Protocol Violation|8|||
105718865|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
105718866|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
105718867|NCT00849017|364628798|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
105718868|NCT00849017|364628799|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
105718869|NCT00849017|364628800|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
105718870|NCT04088409|364628801|FG000|Part A|Withdrawal by Subject|2|||
105718871|NCT04088409|364628802|FG001|Part A|Withdrawal by Subject|1|||
105718872|NCT04088409|364628801|FG000|Part A|Did Not Meet Randomization Criteria|2|||
105718873|NCT04088409|364628802|FG001|Part A|Did Not Meet Randomization Criteria|0|||
105718874|NCT04088409|364628801|FG000|Part A|Lack of Efficacy|9|||
105718875|NCT04088409|364628802|FG001|Part A|Lack of Efficacy|0|||
105718876|NCT04088409|364628801|FG000|Part A|Lost to Follow-up|1|||
105718877|NCT04088409|364628802|FG001|Part A|Lost to Follow-up|0|||
105718878|NCT04088409|364628801|FG000|Part A|Adverse Event|1|||
105718879|NCT04088409|364628802|FG001|Part A|Adverse Event|0|||
105718880|NCT04088409|364628801|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
105718881|NCT04088409|364628802|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
105718882|NCT04088409|364628801|FG000|Part B|Ongoing Treatment|10|||
105718883|NCT04088409|364628802|FG001|Part B|Ongoing Treatment|0|||
105718884|NCT00400400|364628803|FG000|Overall Study|Adverse Event|9|||
105718885|NCT00400400|364628804|FG001|Overall Study|Adverse Event|8|||
105718886|NCT00400400|364628803|FG000|Overall Study|Protocol Violation|2|||
105718887|NCT00400400|364628804|FG001|Overall Study|Protocol Violation|0|||
105718888|NCT00400400|364628803|FG000|Overall Study|Withdrawal by Subject|1|||
105718889|NCT00400400|364628804|FG001|Overall Study|Withdrawal by Subject|3|||
105718890|NCT00400400|364628803|FG000|Overall Study|Administrative Problem|1|||
105718891|NCT00400400|364628804|FG001|Overall Study|Administrative Problem|0|||
105718892|NCT00400400|364628803|FG000|Overall Study|Lost to Follow-up|0|||
105718893|NCT00400400|364628804|FG001|Overall Study|Lost to Follow-up|1|||
105718894|NCT00400400|364628803|FG000|Overall Study|Did not receive study drug|1|||
105718895|NCT00400400|364628804|FG001|Overall Study|Did not receive study drug|3|||
105718896|NCT04426695|364628805|FG000|Overall Study|Death|2|||
105718897|NCT04426695|364628806|FG001|Overall Study|Death|0|||
105718898|NCT04426695|364628807|FG002|Overall Study|Death|1|||
105933995|NCT01827943|365418025|FG000|Overall Study|Never treated because of an rapid progression|1|||
105933996|NCT03019588|365418026|FG000|Overall Study|Death|44|||
106136978|NCT01253226|366160326|FG000|Overall Study|Death|0|||
105718899|NCT04426695|364628808|FG003|Overall Study|Death|27|||
105718900|NCT04426695|364628809|FG004|Overall Study|Death|25|||
105718901|NCT04426695|364628810|FG005|Overall Study|Death|21|||
105718902|NCT04426695|364628811|FG006|Overall Study|Death|42|||
105718903|NCT04426695|364628812|FG007|Overall Study|Death|23|||
105718904|NCT04426695|364628813|FG008|Overall Study|Death|37|||
105718905|NCT04426695|364628814|FG009|Overall Study|Death|14|||
105718906|NCT04426695|364628815|FG010|Overall Study|Death|8|||
105718907|NCT04426695|364628816|FG011|Overall Study|Death|7|||
105933997|NCT03019588|365418027|FG001|Overall Study|Death|46|||
105933998|NCT03019588|365418026|FG000|Overall Study|Study terminated by Sponsor|3|||
106009154|NCT05138653|365699079|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
106136979|NCT01253226|366160327|FG001|Overall Study|Death|1|||
106136980|NCT01253226|366160328|FG002|Overall Study|Death|0|||
106136981|NCT01253226|366160329|FG003|Overall Study|Death|0|||
106136982|NCT01253226|366160330|FG004|Overall Study|Death|0|||
105718908|NCT04426695|364628817|FG012|Overall Study|Death|13|||
105718909|NCT04426695|364628818|FG013|Overall Study|Death|25|||
105718910|NCT04426695|364628819|FG014|Overall Study|Death|19|||
105718911|NCT04426695|364628820|FG015|Overall Study|Death|7|||
105718912|NCT04426695|364628821|FG016|Overall Study|Death|8|||
105718913|NCT04426695|364628822|FG017|Overall Study|Death|4|||
105933999|NCT03019588|365418027|FG001|Overall Study|Study terminated by Sponsor|1|||
105934000|NCT04689009|365418028|FG000|Overall Study|Adverse Event|1|||
105934001|NCT04689009|365418029|FG001|Overall Study|Adverse Event|0|||
105934002|NCT04689009|365418028|FG000|Overall Study|Lost to Follow-up|1|||
105934003|NCT04689009|365418029|FG001|Overall Study|Lost to Follow-up|2|||
105934004|NCT04689009|365418028|FG000|Overall Study|Withdrawal by Subject|4|||
105934005|NCT04689009|365418029|FG001|Overall Study|Withdrawal by Subject|3|||
105934006|NCT04689009|365418028|FG000|Overall Study|Protocol Violation|1|||
105934007|NCT04689009|365418029|FG001|Overall Study|Protocol Violation|0|||
105934008|NCT02362412|365418030|FG000|Treatment Period III|Lost to Follow-up|0|||
105934009|NCT02362412|365418031|FG001|Treatment Period III|Lost to Follow-up|1|||
105934010|NCT05652140|365418042|FG000|Overall Study|Lost to Follow-up|7|||
105934011|NCT05652140|365418043|FG001|Overall Study|Lost to Follow-up|16|||
105934012|NCT05652140|365418044|FG002|Overall Study|Lost to Follow-up|22|||
105934013|NCT05652140|365418045|FG003|Overall Study|Lost to Follow-up|31|||
105934014|NCT03462563|365418048|FG000|Overall Study|Death|1|||
105934015|NCT03462563|365418049|FG001|Overall Study|Death|1|||
105934016|NCT03462563|365418048|FG000|Overall Study|Termination of study|2|||
105934017|NCT03462563|365418049|FG001|Overall Study|Termination of study|1|||
105934018|NCT03462563|365418048|FG000|Overall Study|Adverse Event|1|||
105934019|NCT03462563|365418049|FG001|Overall Study|Adverse Event|3|||
105934020|NCT03462563|365418048|FG000|Overall Study|Unspecified reason|10|||
105934021|NCT03462563|365418049|FG001|Overall Study|Unspecified reason|12|||
105934022|NCT03462563|365418048|FG000|Overall Study|Physician Decision|1|||
105934023|NCT03462563|365418049|FG001|Overall Study|Physician Decision|0|||
105934024|NCT01740427|365418050|FG000|Overall Study|Objective Progression or Relapse|286|||
105934025|NCT01740427|365418051|FG001|Overall Study|Objective Progression or Relapse|172|||
105934026|NCT01740427|365418050|FG000|Overall Study|Adverse Event|32|||
105934027|NCT01740427|365418051|FG001|Overall Study|Adverse Event|9|||
105934028|NCT01740427|365418050|FG000|Overall Study|Global Deterioration of Health Status|28|||
105934029|NCT01740427|365418051|FG001|Overall Study|Global Deterioration of Health Status|12|||
105934030|NCT01740427|365418050|FG000|Overall Study|Participant Refused Continued Treatment|27|||
105934031|NCT01740427|365418051|FG001|Overall Study|Participant Refused Continued Treatment|15|||
105934032|NCT01740427|365418050|FG000|Overall Study|Unspecified reasons|52|||
105934033|NCT01740427|365418051|FG001|Overall Study|Unspecified reasons|8|||
105934034|NCT01740427|365418050|FG000|Overall Study|Death|10|||
105934035|NCT01740427|365418051|FG001|Overall Study|Death|3|||
105934036|NCT01740427|365418050|FG000|Overall Study|Protocol Violation|5|||
105934037|NCT01740427|365418051|FG001|Overall Study|Protocol Violation|3|||
105934038|NCT01740427|365418050|FG000|Overall Study|Lost to Follow-up|3|||
105934039|NCT01740427|365418051|FG001|Overall Study|Lost to Follow-up|0|||
105934040|NCT01740427|365418050|FG000|Overall Study|Site Terminated by Sponsor|1|||
105934041|NCT01740427|365418051|FG001|Overall Study|Site Terminated by Sponsor|0|||
105934042|NCT00682435|365418053|FG000|Overall Study|Insufficient data|5|||
105934043|NCT00682435|365418053|FG000|Overall Study|Erroneously enrolled twice|2|||
105934044|NCT01117350|365418055|FG000|Comparative Period|Not Treated|5|||
105934045|NCT01117350|365418056|FG001|Comparative Period|Not Treated|8|||
105934046|NCT01117350|365418055|FG000|Comparative Period|Adverse Event|6|||
105934047|NCT01117350|365418056|FG001|Comparative Period|Adverse Event|33|||
105934048|NCT01117350|365418055|FG000|Comparative Period|Lost to Follow-up|11|||
105934049|NCT01117350|365418056|FG001|Comparative Period|Lost to Follow-up|7|||
105934050|NCT01117350|365418055|FG000|Comparative Period|Withdrawal by Subject|9|||
105934051|NCT01117350|365418056|FG001|Comparative Period|Withdrawal by Subject|13|||
105934052|NCT01117350|365418055|FG000|Comparative Period|Protocol Violation|8|||
105934053|NCT01117350|365418056|FG001|Comparative Period|Protocol Violation|12|||
105934054|NCT01117350|365418055|FG000|Comparative Period|Lack of Efficacy|1|||
105934055|NCT01117350|365418056|FG001|Comparative Period|Lack of Efficacy|0|||
105718914|NCT04426695|364628805|FG000|Overall Study|Lost to Follow-up|2|||
105718915|NCT04426695|364628806|FG001|Overall Study|Lost to Follow-up|4|||
105718916|NCT04426695|364628807|FG002|Overall Study|Lost to Follow-up|1|||
105934056|NCT01117350|365418055|FG000|Comparative Period|Physician Decision|0|||
105934057|NCT01117350|365418056|FG001|Comparative Period|Physician Decision|1|||
105934058|NCT01117350|365418055|FG000|Comparative Period|Move to another city/country|2|||
105934059|NCT01117350|365418056|FG001|Comparative Period|Move to another city/country|1|||
105934060|NCT01117350|365418055|FG000|Extension Period|Not included in extension, not treated|0|||
105934061|NCT01117350|365418056|FG001|Extension Period|Not included in extension, not treated|50|||
106009155|NCT05138653|365699080|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105718917|NCT04426695|364628808|FG003|Overall Study|Lost to Follow-up|19|||
105718918|NCT04426695|364628809|FG004|Overall Study|Lost to Follow-up|10|||
105934062|NCT01117350|365418055|FG000|Extension Period|Adverse Event|0|||
105934063|NCT01117350|365418056|FG001|Extension Period|Adverse Event|2|||
105934064|NCT01117350|365418055|FG000|Extension Period|Protocol Violation|0|||
105934065|NCT01117350|365418056|FG001|Extension Period|Protocol Violation|2|||
105934066|NCT01117350|365418055|FG000|Extension Period|Lost to Follow-up|0|||
105934067|NCT01117350|365418056|FG001|Extension Period|Lost to Follow-up|2|||
105718919|NCT04426695|364628810|FG005|Overall Study|Lost to Follow-up|14|||
105718920|NCT04426695|364628811|FG006|Overall Study|Lost to Follow-up|5|||
105718921|NCT04426695|364628812|FG007|Overall Study|Lost to Follow-up|14|||
105934068|NCT01117350|365418055|FG000|Extension Period|Withdrawal by Subject|0|||
105934069|NCT01117350|365418056|FG001|Extension Period|Withdrawal by Subject|3|||
105934070|NCT01117350|365418055|FG000|Extension Period|Lack of Efficacy|0|||
105934071|NCT01117350|365418056|FG001|Extension Period|Lack of Efficacy|2|||
105934072|NCT01117350|365418055|FG000|Extension Period|Inclusion criteria not respected|0|||
105934073|NCT01117350|365418056|FG001|Extension Period|Inclusion criteria not respected|1|||
105934074|NCT01117350|365418055|FG000|Extension Period|Prohibited medication|0|||
105934075|NCT01117350|365418056|FG001|Extension Period|Prohibited medication|1|||
105934076|NCT00382070|365419488|FG000|Overall Study|No follow up data mapped to Other|17|||
105934077|NCT00382070|365419489|FG001|Overall Study|No follow up data mapped to Other|19|||
105934078|NCT00382070|365419488|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
105934079|NCT00382070|365419489|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
105934080|NCT00382070|365419488|FG000|Overall Study|No clinical assessment|9|||
105934081|NCT00382070|365419489|FG001|Overall Study|No clinical assessment|11|||
105934082|NCT03928704|365419491|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105934083|NCT03928704|365419492|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
105934084|NCT03928704|365419493|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105934085|NCT03928704|365419494|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105934086|NCT03928704|365419495|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105934087|NCT03928704|365419496|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
105934088|NCT03928704|365419491|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
105934089|NCT03928704|365419492|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105934090|NCT03928704|365419493|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105934091|NCT03928704|365419494|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105934092|NCT03928704|365419495|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105934093|NCT03928704|365419496|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
105934094|NCT03928704|365419491|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
105934095|NCT03928704|365419492|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105934096|NCT03928704|365419493|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105934097|NCT03928704|365419494|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105934098|NCT03928704|365419495|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105934099|NCT03928704|365419496|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
105934100|NCT03928704|365419491|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
105934101|NCT03928704|365419492|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
105934102|NCT03928704|365419493|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
105934103|NCT03928704|365419494|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
105718922|NCT04426695|364628813|FG008|Overall Study|Lost to Follow-up|10|||
105718923|NCT04426695|364628814|FG009|Overall Study|Lost to Follow-up|11|||
105718924|NCT04426695|364628815|FG010|Overall Study|Lost to Follow-up|12|||
105718925|NCT04426695|364628816|FG011|Overall Study|Lost to Follow-up|6|||
105718926|NCT04426695|364628817|FG012|Overall Study|Lost to Follow-up|2|||
105718927|NCT04426695|364628818|FG013|Overall Study|Lost to Follow-up|2|||
105934104|NCT03928704|365419495|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
105934105|NCT03928704|365419496|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
105934106|NCT03928704|365419491|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
106136983|NCT01253226|366160326|FG000|Overall Study|Physician Decision|0|||
106136984|NCT01253226|366160327|FG001|Overall Study|Physician Decision|0|||
106136985|NCT01253226|366160328|FG002|Overall Study|Physician Decision|0|||
106136986|NCT01253226|366160329|FG003|Overall Study|Physician Decision|0|||
106136987|NCT01253226|366160330|FG004|Overall Study|Physician Decision|2|||
106136988|NCT01253226|366160326|FG000|Overall Study|Withdrawal by Subject|0|||
106136989|NCT01253226|366160327|FG001|Overall Study|Withdrawal by Subject|0|||
106136990|NCT01253226|366160328|FG002|Overall Study|Withdrawal by Subject|0|||
106136991|NCT01253226|366160329|FG003|Overall Study|Withdrawal by Subject|1|||
106136992|NCT01253226|366160330|FG004|Overall Study|Withdrawal by Subject|0|||
106136993|NCT03593070|366160332|FG000|Overall Study|administrative withdrawal|1|||
106136994|NCT03593070|366160333|FG001|Overall Study|administrative withdrawal|1|||
106136995|NCT04109118|366160334|FG000|Overall Study|Lost to Follow-up|3|||
106136996|NCT02482233|366160337|FG000|Overall Study|Lost to Follow-up|1|||
106136997|NCT02482233|366160338|FG001|Overall Study|Lost to Follow-up|1|||
106136998|NCT04927975|366160339|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
106136999|NCT04927975|366160340|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
106137000|NCT04927975|366160341|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
106137001|NCT04927975|366160342|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
105934107|NCT03928704|365419492|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
105718928|NCT04426695|364628819|FG014|Overall Study|Lost to Follow-up|2|||
105718929|NCT04426695|364628820|FG015|Overall Study|Lost to Follow-up|0|||
105718930|NCT04426695|364628821|FG016|Overall Study|Lost to Follow-up|0|||
105718931|NCT04426695|364628822|FG017|Overall Study|Lost to Follow-up|0|||
105718932|NCT04426695|364628805|FG000|Overall Study|Participant Decision|1|||
105718933|NCT04426695|364628806|FG001|Overall Study|Participant Decision|2|||
105718934|NCT04426695|364628807|FG002|Overall Study|Participant Decision|2|||
105718935|NCT04426695|364628808|FG003|Overall Study|Participant Decision|12|||
105718936|NCT04426695|364628809|FG004|Overall Study|Participant Decision|18|||
105718937|NCT04426695|364628810|FG005|Overall Study|Participant Decision|22|||
105718938|NCT04426695|364628811|FG006|Overall Study|Participant Decision|13|||
105718939|NCT04426695|364628812|FG007|Overall Study|Participant Decision|13|||
105718940|NCT04426695|364628813|FG008|Overall Study|Participant Decision|10|||
105718941|NCT04426695|364628814|FG009|Overall Study|Participant Decision|15|||
105718942|NCT04426695|364628815|FG010|Overall Study|Participant Decision|16|||
105718943|NCT04426695|364628816|FG011|Overall Study|Participant Decision|17|||
105718944|NCT04426695|364628817|FG012|Overall Study|Participant Decision|2|||
105718945|NCT04426695|364628818|FG013|Overall Study|Participant Decision|1|||
105718946|NCT04426695|364628819|FG014|Overall Study|Participant Decision|2|||
105718947|NCT04426695|364628820|FG015|Overall Study|Participant Decision|0|||
105718948|NCT04426695|364628821|FG016|Overall Study|Participant Decision|0|||
105718949|NCT04426695|364628822|FG017|Overall Study|Participant Decision|0|||
105718950|NCT04426695|364628805|FG000|Overall Study|Adverse Event|0|||
105718951|NCT04426695|364628806|FG001|Overall Study|Adverse Event|0|||
105718952|NCT04426695|364628807|FG002|Overall Study|Adverse Event|0|||
105718953|NCT04426695|364628808|FG003|Overall Study|Adverse Event|0|||
105718954|NCT04426695|364628809|FG004|Overall Study|Adverse Event|0|||
105718955|NCT04426695|364628810|FG005|Overall Study|Adverse Event|0|||
105718956|NCT04426695|364628811|FG006|Overall Study|Adverse Event|0|||
105718957|NCT04426695|364628812|FG007|Overall Study|Adverse Event|1|||
105718958|NCT04426695|364628813|FG008|Overall Study|Adverse Event|0|||
105718959|NCT04426695|364628814|FG009|Overall Study|Adverse Event|0|||
105718960|NCT04426695|364628815|FG010|Overall Study|Adverse Event|1|||
105718961|NCT04426695|364628816|FG011|Overall Study|Adverse Event|1|||
105718962|NCT04426695|364628817|FG012|Overall Study|Adverse Event|0|||
105718963|NCT04426695|364628818|FG013|Overall Study|Adverse Event|0|||
105718964|NCT04426695|364628819|FG014|Overall Study|Adverse Event|0|||
105718965|NCT04426695|364628820|FG015|Overall Study|Adverse Event|0|||
105718966|NCT04426695|364628821|FG016|Overall Study|Adverse Event|0|||
105718967|NCT04426695|364628822|FG017|Overall Study|Adverse Event|0|||
105718968|NCT04426695|364628805|FG000|Overall Study|Sponsor Request|0|||
105718969|NCT04426695|364628806|FG001|Overall Study|Sponsor Request|0|||
105718970|NCT04426695|364628807|FG002|Overall Study|Sponsor Request|0|||
105718971|NCT04426695|364628808|FG003|Overall Study|Sponsor Request|0|||
105718972|NCT04426695|364628809|FG004|Overall Study|Sponsor Request|0|||
105718973|NCT04426695|364628810|FG005|Overall Study|Sponsor Request|0|||
105718974|NCT04426695|364628811|FG006|Overall Study|Sponsor Request|1|||
105718975|NCT04426695|364628812|FG007|Overall Study|Sponsor Request|0|||
105718976|NCT04426695|364628813|FG008|Overall Study|Sponsor Request|0|||
105718977|NCT04426695|364628814|FG009|Overall Study|Sponsor Request|0|||
105718978|NCT04426695|364628815|FG010|Overall Study|Sponsor Request|0|||
105718979|NCT04426695|364628816|FG011|Overall Study|Sponsor Request|0|||
105718980|NCT04426695|364628817|FG012|Overall Study|Sponsor Request|0|||
105718981|NCT04426695|364628818|FG013|Overall Study|Sponsor Request|0|||
105718982|NCT04426695|364628819|FG014|Overall Study|Sponsor Request|0|||
105718983|NCT04426695|364628820|FG015|Overall Study|Sponsor Request|0|||
105718984|NCT04426695|364628821|FG016|Overall Study|Sponsor Request|0|||
105718985|NCT04426695|364628822|FG017|Overall Study|Sponsor Request|0|||
105718986|NCT04426695|364628805|FG000|Overall Study|Physician Decision|0|||
105718987|NCT04426695|364628806|FG001|Overall Study|Physician Decision|0|||
105718988|NCT04426695|364628807|FG002|Overall Study|Physician Decision|0|||
105718989|NCT04426695|364628808|FG003|Overall Study|Physician Decision|0|||
105718990|NCT04426695|364628809|FG004|Overall Study|Physician Decision|0|||
105718991|NCT04426695|364628810|FG005|Overall Study|Physician Decision|0|||
105718992|NCT04426695|364628811|FG006|Overall Study|Physician Decision|0|||
105718993|NCT04426695|364628812|FG007|Overall Study|Physician Decision|0|||
105718994|NCT04426695|364628813|FG008|Overall Study|Physician Decision|0|||
105718995|NCT04426695|364628814|FG009|Overall Study|Physician Decision|1|||
105718996|NCT04426695|364628815|FG010|Overall Study|Physician Decision|0|||
105718997|NCT04426695|364628816|FG011|Overall Study|Physician Decision|0|||
105718998|NCT04426695|364628817|FG012|Overall Study|Physician Decision|1|||
105718999|NCT04426695|364628818|FG013|Overall Study|Physician Decision|0|||
105719000|NCT04426695|364628819|FG014|Overall Study|Physician Decision|0|||
105719001|NCT04426695|364628820|FG015|Overall Study|Physician Decision|0|||
105719002|NCT04426695|364628821|FG016|Overall Study|Physician Decision|0|||
105719003|NCT04426695|364628822|FG017|Overall Study|Physician Decision|0|||
105719004|NCT04426695|364628805|FG000|Overall Study|Randomized but Never Treated|3|||
105719005|NCT04426695|364628806|FG001|Overall Study|Randomized but Never Treated|1|||
105719006|NCT04426695|364628807|FG002|Overall Study|Randomized but Never Treated|0|||
105719007|NCT04426695|364628808|FG003|Overall Study|Randomized but Never Treated|4|||
105719008|NCT04426695|364628809|FG004|Overall Study|Randomized but Never Treated|5|||
105719009|NCT04426695|364628810|FG005|Overall Study|Randomized but Never Treated|5|||
105719010|NCT04426695|364628811|FG006|Overall Study|Randomized but Never Treated|4|||
105719011|NCT04426695|364628812|FG007|Overall Study|Randomized but Never Treated|6|||
105719012|NCT04426695|364628813|FG008|Overall Study|Randomized but Never Treated|6|||
105719013|NCT04426695|364628814|FG009|Overall Study|Randomized but Never Treated|3|||
105719014|NCT04426695|364628815|FG010|Overall Study|Randomized but Never Treated|3|||
105719015|NCT04426695|364628816|FG011|Overall Study|Randomized but Never Treated|6|||
105719016|NCT04426695|364628817|FG012|Overall Study|Randomized but Never Treated|1|||
105719017|NCT04426695|364628818|FG013|Overall Study|Randomized but Never Treated|2|||
105719018|NCT04426695|364628819|FG014|Overall Study|Randomized but Never Treated|0|||
105719019|NCT04426695|364628820|FG015|Overall Study|Randomized but Never Treated|0|||
105719020|NCT04426695|364628821|FG016|Overall Study|Randomized but Never Treated|0|||
105719021|NCT04426695|364628822|FG017|Overall Study|Randomized but Never Treated|0|||
105719022|NCT00675025|364628825|FG000|Overall Study|Study Terminated by Sponsor|38|||
105719023|NCT00675025|364628826|FG001|Overall Study|Study Terminated by Sponsor|42|||
105719024|NCT00675025|364628825|FG000|Overall Study|Adverse Event|6|||
105719025|NCT00675025|364628826|FG001|Overall Study|Adverse Event|11|||
105719026|NCT00675025|364628825|FG000|Overall Study|Lost to Follow-up|6|||
105719027|NCT00675025|364628826|FG001|Overall Study|Lost to Follow-up|4|||
105719028|NCT00675025|364628825|FG000|Overall Study|Withdrawal by Subject|4|||
105719029|NCT00675025|364628826|FG001|Overall Study|Withdrawal by Subject|6|||
105719030|NCT00441792|364628827|FG000|Overall Study|Lost to Follow-up|0|||
105719031|NCT00441792|364628828|FG001|Overall Study|Lost to Follow-up|2|||
105719032|NCT01731678|364628831|FG000|Overall Study|Withdrawal by Subject|3|||
105719033|NCT01731678|364628831|FG000|Overall Study|Did not meet inclusion criteria|1|||
105719034|NCT01731678|364628831|FG000|Overall Study|RMT too high, making TMS difficult|3|||
105719035|NCT00888355|364628832|FG000|Overall Study|Adverse Event|10|||
105719036|NCT00888355|364628833|FG001|Overall Study|Adverse Event|0|||
105719037|NCT00888355|364628834|FG002|Overall Study|Adverse Event|3|||
105719038|NCT00888355|364628835|FG003|Overall Study|Adverse Event|3|||
105719039|NCT00888355|364628832|FG000|Overall Study|Lack of Efficacy|9|||
105719040|NCT00888355|364628833|FG001|Overall Study|Lack of Efficacy|2|||
105719041|NCT00888355|364628834|FG002|Overall Study|Lack of Efficacy|5|||
105719042|NCT00888355|364628835|FG003|Overall Study|Lack of Efficacy|2|||
105719043|NCT00888355|364628832|FG000|Overall Study|Lost to Follow-up|0|||
105719044|NCT00888355|364628833|FG001|Overall Study|Lost to Follow-up|2|||
105719045|NCT00888355|364628834|FG002|Overall Study|Lost to Follow-up|2|||
105719046|NCT00888355|364628835|FG003|Overall Study|Lost to Follow-up|0|||
105719047|NCT00888355|364628832|FG000|Overall Study|Protocol Violation|3|||
105719048|NCT00888355|364628833|FG001|Overall Study|Protocol Violation|2|||
105719049|NCT00888355|364628834|FG002|Overall Study|Protocol Violation|1|||
105719050|NCT00888355|364628835|FG003|Overall Study|Protocol Violation|2|||
105719051|NCT00888355|364628832|FG000|Overall Study|Withdrawal by Subject|0|||
105791369|NCT04798027|364890604|FG008|Overall Study|Withdrawal by Subject|2|||
105791370|NCT04798027|364890596|FG000|Overall Study|Lost to Follow-up|1|||
105791371|NCT04798027|364890597|FG001|Overall Study|Lost to Follow-up|3|||
105934108|NCT03928704|365419493|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
105934109|NCT03928704|365419494|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
106137002|NCT04927975|366160343|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
105719052|NCT00888355|364628833|FG001|Overall Study|Withdrawal by Subject|3|||
105719053|NCT00888355|364628834|FG002|Overall Study|Withdrawal by Subject|1|||
105719054|NCT00888355|364628835|FG003|Overall Study|Withdrawal by Subject|3|||
105719055|NCT01573910|364628836|FG000|Overall Study|Adverse Event|4|||
105719056|NCT01573910|364628837|FG001|Overall Study|Adverse Event|4|||
105719057|NCT01573910|364628836|FG000|Overall Study|Lost to Follow-up|2|||
105719058|NCT01573910|364628837|FG001|Overall Study|Lost to Follow-up|1|||
105719059|NCT01573910|364628836|FG000|Overall Study|Withdrawal by Subject|0|||
105719060|NCT01573910|364628837|FG001|Overall Study|Withdrawal by Subject|1|||
105719061|NCT01573910|364628836|FG000|Overall Study|Protocol Violation|3|||
105719062|NCT01573910|364628837|FG001|Overall Study|Protocol Violation|0|||
105719063|NCT01573910|364628836|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
105719064|NCT01573910|364628837|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
105719065|NCT02251912|364628838|FG000|Overall Study|Withdrawal by Subject|2|||
105719066|NCT02251912|364628839|FG001|Overall Study|Withdrawal by Subject|3|||
105719067|NCT02251912|364628838|FG000|Overall Study|Adverse Event|0|||
105719068|NCT02251912|364628839|FG001|Overall Study|Adverse Event|2|||
105719069|NCT00364182|364628842|FG000|First Intervention|Secondary prophylaxis|1|||
105719070|NCT00364182|364628843|FG001|First Intervention|Secondary prophylaxis|0|||
105719071|NCT00364182|364628844|FG002|First Intervention|Secondary prophylaxis|0|||
105719072|NCT00364182|364628842|FG000|First Intervention|Withdrawal by Subject|2|||
105719073|NCT00364182|364628843|FG001|First Intervention|Withdrawal by Subject|0|||
105719074|NCT00364182|364628844|FG002|First Intervention|Withdrawal by Subject|0|||
105719075|NCT00364182|364628842|FG000|Second Intervention|non-compliance|0|||
105719076|NCT00364182|364628843|FG001|Second Intervention|non-compliance|1|||
105719077|NCT00364182|364628844|FG002|Second Intervention|non-compliance|1|||
105719078|NCT00364182|364628842|FG000|Second Intervention|Protocol Violation|0|||
105719079|NCT00364182|364628843|FG001|Second Intervention|Protocol Violation|1|||
105719080|NCT00364182|364628844|FG002|Second Intervention|Protocol Violation|0|||
105719081|NCT00364182|364628842|FG000|Second Intervention|Adverse Event|0|||
105719082|NCT00364182|364628843|FG001|Second Intervention|Adverse Event|0|||
105719083|NCT00364182|364628844|FG002|Second Intervention|Adverse Event|1|||
105719084|NCT00364182|364628842|FG000|Third Intervention|non-compliance|0|||
105719085|NCT00364182|364628843|FG001|Third Intervention|non-compliance|1|||
105719086|NCT00364182|364628844|FG002|Third Intervention|non-compliance|0|||
105719087|NCT00364182|364628842|FG000|Third Intervention|Lost to Follow-up|0|||
105719088|NCT00364182|364628843|FG001|Third Intervention|Lost to Follow-up|0|||
105719089|NCT00364182|364628844|FG002|Third Intervention|Lost to Follow-up|1|||
105719090|NCT02601573|364628848|FG000|Overall Study|Lost to Follow-up|0|||
105719091|NCT02601573|364628849|FG001|Overall Study|Lost to Follow-up|3|||
105719092|NCT02601573|364628850|FG002|Overall Study|Lost to Follow-up|1|||
105719093|NCT02601573|364628851|FG003|Overall Study|Lost to Follow-up|0|||
105719094|NCT02601573|364628852|FG004|Overall Study|Lost to Follow-up|2|||
105719095|NCT02601573|364628848|FG000|Overall Study|Withdrawal by Subject|0|||
105719096|NCT02601573|364628849|FG001|Overall Study|Withdrawal by Subject|1|||
105719097|NCT02601573|364628850|FG002|Overall Study|Withdrawal by Subject|0|||
105719098|NCT02601573|364628851|FG003|Overall Study|Withdrawal by Subject|1|||
105719099|NCT02601573|364628852|FG004|Overall Study|Withdrawal by Subject|0|||
105719100|NCT00712348|364628854|FG000|Overall Study|Withdrawal by Subject|1|||
105719101|NCT00291551|364628855|FG000|Overall Study|Death|7|||
105719102|NCT00291551|364628855|FG000|Overall Study|Withdrawal by Subject|6|||
105719103|NCT01671280|364628856|FG000|Overall Study|Withdrawal by Subject|2|||
105719104|NCT01988090|364628857|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
105719105|NCT01988090|364628858|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
105719106|NCT01988090|364628857|FG000|Start Treament After Randomization|Protocol Violation|0|||
105719107|NCT01988090|364628858|FG001|Start Treament After Randomization|Protocol Violation|1|||
105719108|NCT01988090|364628857|FG000|Complete Study After Start|Withdrawal by Subject|2|||
105719109|NCT01988090|364628858|FG001|Complete Study After Start|Withdrawal by Subject|0|||
105719110|NCT01988090|364628857|FG000|Complete Study After Start|Protocol Violation|1|||
105719111|NCT01988090|364628858|FG001|Complete Study After Start|Protocol Violation|1|||
105719112|NCT03094195|364628859|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
105719113|NCT03094195|364628860|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
105719114|NCT03094195|364628861|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
105719115|NCT03094195|364628862|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105719116|NCT03094195|364628863|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105719117|NCT03094195|364628864|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105719118|NCT03094195|364628865|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105791372|NCT04798027|364890598|FG002|Overall Study|Lost to Follow-up|0|||
105791373|NCT04798027|364890599|FG003|Overall Study|Lost to Follow-up|0|||
105791374|NCT04798027|364890600|FG004|Overall Study|Lost to Follow-up|0|||
105791375|NCT04798027|364890601|FG005|Overall Study|Lost to Follow-up|1|||
105791376|NCT04798027|364890602|FG006|Overall Study|Lost to Follow-up|0|||
105791377|NCT04798027|364890603|FG007|Overall Study|Lost to Follow-up|0|||
105791378|NCT04798027|364890604|FG008|Overall Study|Lost to Follow-up|1|||
105791379|NCT04798027|364890596|FG000|Overall Study|Withdrawal by Sponsor|8|||
105791380|NCT04798027|364890597|FG001|Overall Study|Withdrawal by Sponsor|22|||
105791381|NCT04798027|364890598|FG002|Overall Study|Withdrawal by Sponsor|9|||
105791382|NCT04798027|364890599|FG003|Overall Study|Withdrawal by Sponsor|26|||
105791383|NCT04798027|364890600|FG004|Overall Study|Withdrawal by Sponsor|24|||
105791384|NCT04798027|364890601|FG005|Overall Study|Withdrawal by Sponsor|11|||
105791385|NCT04798027|364890602|FG006|Overall Study|Withdrawal by Sponsor|25|||
105791386|NCT04798027|364890603|FG007|Overall Study|Withdrawal by Sponsor|26|||
105791387|NCT04798027|364890604|FG008|Overall Study|Withdrawal by Sponsor|11|||
105791388|NCT03868059|364890611|FG000|Overall Study|Adverse Event|3|||
105791389|NCT03868059|364890611|FG000|Overall Study|Lost to Follow-up|3|||
105791390|NCT03868059|364890611|FG000|Overall Study|Withdrawal by Subject|6|||
105791391|NCT02949219|364890613|FG000|Overall Study|Withdrawal by Subject|1|||
105791392|NCT03494816|364890614|FG000|Overall Study|Protocol Violation|2|||
105791393|NCT03494816|364890614|FG000|Overall Study|Physician Decision|2|||
105791394|NCT03494816|364890614|FG000|Overall Study|Did not start trial treatment|1|||
105791395|NCT03494816|364890614|FG000|Overall Study|Adverse Event|1|||
105791396|NCT00633217|364890619|FG000|Overall Study|Adverse Event|5|||
105791397|NCT00633217|364890620|FG001|Overall Study|Adverse Event|9|||
105791398|NCT00633217|364890619|FG000|Overall Study|Lack of Efficacy|0|||
105791399|NCT00633217|364890620|FG001|Overall Study|Lack of Efficacy|2|||
105791400|NCT00633217|364890619|FG000|Overall Study|Protocol Violation|3|||
105791401|NCT00633217|364890620|FG001|Overall Study|Protocol Violation|7|||
105791402|NCT00633217|364890619|FG000|Overall Study|Lost to Follow-up|2|||
105791403|NCT00633217|364890620|FG001|Overall Study|Lost to Follow-up|2|||
105791404|NCT00633217|364890619|FG000|Overall Study|Investigator Discretion|2|||
105791405|NCT00633217|364890620|FG001|Overall Study|Investigator Discretion|0|||
105791406|NCT00633217|364890619|FG000|Overall Study|Withdrew Consent|3|||
105791407|NCT00633217|364890620|FG001|Overall Study|Withdrew Consent|3|||
105791408|NCT00314262|364890621|FG000|Overall Study|Adverse Event|2|||
105791409|NCT00314262|364890621|FG000|Overall Study|Withdrawal by Subject|2|||
105791410|NCT00314262|364890621|FG000|Overall Study|Physician Decision|1|||
105791411|NCT00083226|364890622|FG000|Overall Study|Lack of Efficacy|19|||
105934110|NCT03928704|365419495|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
105934111|NCT03928704|365419496|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
105934112|NCT03928704|365419491|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105934113|NCT03928704|365419492|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105934114|NCT03928704|365419493|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
105934115|NCT03928704|365419494|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105934116|NCT03928704|365419495|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105934117|NCT03928704|365419496|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
105934118|NCT03928704|365419491|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
105934119|NCT03928704|365419492|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
105934120|NCT03928704|365419493|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
105934121|NCT03928704|365419494|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
105934122|NCT03928704|365419495|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
105934123|NCT03928704|365419496|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
105934124|NCT03928704|365419491|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105934125|NCT03928704|365419492|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105934126|NCT03928704|365419493|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
105934127|NCT03928704|365419494|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105934128|NCT03928704|365419495|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105934129|NCT03928704|365419496|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
105934130|NCT03928704|365419491|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105791412|NCT00083226|364890622|FG000|Overall Study|Adverse Event|9|||
105791413|NCT00083226|364890622|FG000|Overall Study|Death|4|||
105791414|NCT00083226|364890622|FG000|Overall Study|Withdrawal by Subject|4|||
105791415|NCT00083226|364890622|FG000|Overall Study|Other|2|||
105791416|NCT00083226|364890622|FG000|Overall Study|ineligible or not receiving treatment|4|||
105791417|NCT00909857|364890623|FG000|Overall Study|Withdrawal by Subject|6|||
105791418|NCT00909857|364890624|FG001|Overall Study|Withdrawal by Subject|10|||
105791419|NCT00909857|364890623|FG000|Overall Study|Adverse Event|5|||
105791420|NCT00909857|364890624|FG001|Overall Study|Adverse Event|5|||
105791421|NCT00909857|364890623|FG000|Overall Study|Lost to Follow-up|2|||
105791422|NCT00909857|364890624|FG001|Overall Study|Lost to Follow-up|5|||
105719119|NCT03094195|364628866|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105719120|NCT03094195|364628859|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
105719121|NCT03094195|364628860|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
105719122|NCT03094195|364628861|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
105719123|NCT03094195|364628862|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719124|NCT03094195|364628863|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719125|NCT03094195|364628864|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719126|NCT03094195|364628865|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719127|NCT03094195|364628866|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105719128|NCT03094195|364628859|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719129|NCT03094195|364628860|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719130|NCT03094195|364628861|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
105719131|NCT03094195|364628862|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719132|NCT03094195|364628863|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719133|NCT03094195|364628864|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719134|NCT03094195|364628865|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719135|NCT03094195|364628866|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105719136|NCT03094195|364628859|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719137|NCT03094195|364628860|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
105719138|NCT03094195|364628861|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
105719139|NCT03094195|364628862|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719140|NCT03094195|364628863|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719141|NCT03094195|364628864|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719142|NCT03094195|364628865|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105719143|NCT03094195|364628866|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105934131|NCT03928704|365419492|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105934132|NCT03928704|365419493|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105934133|NCT03928704|365419494|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105934134|NCT03928704|365419495|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
105934135|NCT03928704|365419496|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
105934136|NCT03928704|365419491|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
105934137|NCT03928704|365419492|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
105934138|NCT03928704|365419493|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
105934139|NCT03928704|365419494|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
105934140|NCT03928704|365419495|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
105934141|NCT03928704|365419496|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
105934142|NCT00284934|365419497|FG000|Overall Study|Adverse Event|1|||
105934143|NCT00284934|365419498|FG001|Overall Study|Adverse Event|2|||
105934144|NCT00284934|365419497|FG000|Overall Study|Other reasons|3|||
105934145|NCT00284934|365419498|FG001|Overall Study|Other reasons|1|||
105934146|NCT00326495|365419505|FG000|Overall Study|Switched to alternative treatment|1|||
105934147|NCT00326495|365419505|FG000|Overall Study|Disease progression before treatment|1|||
105934148|NCT00326495|365419505|FG000|Overall Study|Refused further treatment|2|||
105934149|NCT00326495|365419505|FG000|Overall Study|Subject off study before assessment|1|||
105934150|NCT04359680|365419506|FG000|Overall Study|Withdrawal by Subject|29|||
105934151|NCT04359680|365419507|FG001|Overall Study|Withdrawal by Subject|24|||
105934152|NCT04359680|365419506|FG000|Overall Study|Adverse Event|6|||
105934153|NCT04359680|365419507|FG001|Overall Study|Adverse Event|2|||
105934154|NCT04359680|365419506|FG000|Overall Study|Lost to Follow-up|56|||
105934155|NCT04359680|365419507|FG001|Overall Study|Lost to Follow-up|59|||
105934156|NCT04359680|365419506|FG000|Overall Study|Protocol Violation|3|||
105934157|NCT04359680|365419507|FG001|Overall Study|Protocol Violation|5|||
105934158|NCT04359680|365419506|FG000|Overall Study|Physician Decision|1|||
105934159|NCT04359680|365419507|FG001|Overall Study|Physician Decision|1|||
105934160|NCT04359680|365419506|FG000|Overall Study|Sponsor Decision|0|||
105934161|NCT04359680|365419507|FG001|Overall Study|Sponsor Decision|1|||
105934162|NCT00520572|365419508|FG000|Overall Study|Adverse Event|9|||
105934163|NCT00520572|365419509|FG001|Overall Study|Adverse Event|3|||
105934164|NCT00520572|365419510|FG002|Overall Study|Adverse Event|6|||
105934165|NCT00520572|365419511|FG003|Overall Study|Adverse Event|9|||
105719144|NCT01961115|364628867|FG000|Overall Study|Disease Progression|1|||
105934166|NCT00520572|365419512|FG004|Overall Study|Adverse Event|7|||
105934167|NCT00520572|365419513|FG005|Overall Study|Adverse Event|2|||
105719145|NCT01961115|364628868|FG001|Overall Study|Disease Progression|0|||
105934168|NCT00520572|365419508|FG000|Overall Study|Withdrawal by Subject|0|||
105934169|NCT00520572|365419509|FG001|Overall Study|Withdrawal by Subject|9|||
105934170|NCT00520572|365419510|FG002|Overall Study|Withdrawal by Subject|5|||
105719146|NCT01961115|364628869|FG002|Overall Study|Disease Progression|3|||
105719147|NCT01961115|364628867|FG000|Overall Study|Adverse Event|1|||
105719148|NCT01961115|364628868|FG001|Overall Study|Adverse Event|0|||
105719149|NCT01961115|364628869|FG002|Overall Study|Adverse Event|1|||
105719150|NCT03887130|364628870|FG000|Overall Study|Progressive disease|23|||
105719151|NCT03887130|364628871|FG001|Overall Study|Progressive disease|14|||
105719152|NCT03887130|364628872|FG002|Overall Study|Progressive disease|7|||
105719153|NCT03887130|364628870|FG000|Overall Study|Protocol Violation|3|||
105719154|NCT03887130|364628871|FG001|Overall Study|Protocol Violation|1|||
105719155|NCT03887130|364628872|FG002|Overall Study|Protocol Violation|2|||
105719156|NCT03887130|364628870|FG000|Overall Study|Drug related toxicity|7|||
105719157|NCT03887130|364628871|FG001|Overall Study|Drug related toxicity|7|||
105719158|NCT03887130|364628872|FG002|Overall Study|Drug related toxicity|13|||
105719159|NCT03887130|364628870|FG000|Overall Study|Non drug related toxicity|3|||
105719160|NCT03887130|364628871|FG001|Overall Study|Non drug related toxicity|0|||
105719161|NCT03887130|364628872|FG002|Overall Study|Non drug related toxicity|0|||
105719162|NCT03887130|364628870|FG000|Overall Study|Death|2|||
105719163|NCT03887130|364628871|FG001|Overall Study|Death|2|||
105719164|NCT03887130|364628872|FG002|Overall Study|Death|1|||
105719165|NCT03887130|364628870|FG000|Overall Study|Withdrawal by Subject|7|||
105719166|NCT03887130|364628871|FG001|Overall Study|Withdrawal by Subject|6|||
105719167|NCT03887130|364628872|FG002|Overall Study|Withdrawal by Subject|11|||
105719168|NCT03887130|364628870|FG000|Overall Study|other reason|6|||
105719169|NCT03887130|364628871|FG001|Overall Study|other reason|20|||
105719170|NCT03887130|364628872|FG002|Overall Study|other reason|17|||
105719171|NCT05900115|364631617|FG000|Overall Study|Lost to Follow-up|129|||
105719172|NCT05900115|364631618|FG001|Overall Study|Lost to Follow-up|98|||
105719173|NCT00618722|364631619|FG000|Overall Study|Refusal of Treatment|0|||
105719174|NCT00618722|364631620|FG001|Overall Study|Refusal of Treatment|0|||
105719175|NCT00618722|364631621|FG002|Overall Study|Refusal of Treatment|1|||
105719176|NCT00618722|364631622|FG003|Overall Study|Refusal of Treatment|0|||
105719177|NCT00618722|364631619|FG000|Overall Study|Patient Request|1|||
105719178|NCT00618722|364631620|FG001|Overall Study|Patient Request|1|||
105719179|NCT00618722|364631621|FG002|Overall Study|Patient Request|1|||
105719180|NCT00618722|364631622|FG003|Overall Study|Patient Request|1|||
105719181|NCT00618722|364631619|FG000|Overall Study|Inability to Complete Study Procedure|0|||
105719182|NCT00618722|364631620|FG001|Overall Study|Inability to Complete Study Procedure|1|||
105719183|NCT00618722|364631621|FG002|Overall Study|Inability to Complete Study Procedure|0|||
105719184|NCT00618722|364631622|FG003|Overall Study|Inability to Complete Study Procedure|0|||
105719185|NCT00618722|364631619|FG000|Overall Study|Lost to Follow-up|2|||
105719186|NCT00618722|364631620|FG001|Overall Study|Lost to Follow-up|0|||
105719187|NCT00618722|364631621|FG002|Overall Study|Lost to Follow-up|0|||
105719188|NCT00618722|364631622|FG003|Overall Study|Lost to Follow-up|2|||
105719189|NCT00618722|364631619|FG000|Overall Study|Miscellaneous Reasons|0|||
105719190|NCT00618722|364631620|FG001|Overall Study|Miscellaneous Reasons|0|||
105719191|NCT00618722|364631621|FG002|Overall Study|Miscellaneous Reasons|1|||
105719192|NCT00618722|364631622|FG003|Overall Study|Miscellaneous Reasons|1|||
105719193|NCT00200057|364631625|FG000|Overall Study|Lack of Efficacy|3|||
105719194|NCT00200057|364631625|FG000|Overall Study|Exited due to terminal illness of PI|2|||
105719195|NCT00200057|364631625|FG000|Overall Study|Withdrawal by Subject|1|||
105719196|NCT00200057|364631625|FG000|Overall Study|Change in medical condition|1|||
105719197|NCT00200057|364631625|FG000|Overall Study|Infection|1|||
105719198|NCT00200057|364631625|FG000|Overall Study|Death|1|||
105934171|NCT00520572|365419511|FG003|Overall Study|Withdrawal by Subject|2|||
105719199|NCT01059448|364631627|FG000|Overall Study|Adverse Event|1|||
105719200|NCT01059448|364631628|FG001|Overall Study|Adverse Event|3|||
105719201|NCT01059448|364631629|FG002|Overall Study|Adverse Event|0|||
105719202|NCT01059448|364631630|FG003|Overall Study|Adverse Event|1|||
105719203|NCT01059448|364631627|FG000|Overall Study|Withdrawal by Subject|2|||
105719204|NCT01059448|364631628|FG001|Overall Study|Withdrawal by Subject|0|||
105719205|NCT01059448|364631629|FG002|Overall Study|Withdrawal by Subject|2|||
105719206|NCT01059448|364631630|FG003|Overall Study|Withdrawal by Subject|4|||
105719207|NCT01059448|364631627|FG000|Overall Study|Disease Progression|2|||
105791423|NCT00909857|364890623|FG000|Overall Study|Protocol Violation|2|||
105719208|NCT01059448|364631628|FG001|Overall Study|Disease Progression|1|||
105719209|NCT01059448|364631629|FG002|Overall Study|Disease Progression|4|||
105719210|NCT01059448|364631630|FG003|Overall Study|Disease Progression|2|||
105719211|NCT01059448|364631627|FG000|Overall Study|Administrative Decision|43|||
105719212|NCT01059448|364631628|FG001|Overall Study|Administrative Decision|49|||
105791424|NCT00909857|364890624|FG001|Overall Study|Protocol Violation|1|||
105791425|NCT00909857|364890623|FG000|Overall Study|Pregnancy|1|||
105791426|NCT00909857|364890624|FG001|Overall Study|Pregnancy|0|||
105791427|NCT00909857|364890623|FG000|Overall Study|Other|1|||
105791428|NCT00909857|364890624|FG001|Overall Study|Other|0|||
105791429|NCT00909857|364890623|FG000|Overall Study|Did not receive study medication|19|||
105791430|NCT00909857|364890624|FG001|Overall Study|Did not receive study medication|24|||
105791431|NCT00604175|364890625|FG000|Entry Through Week 28|Death|2|||
105791432|NCT00604175|364890626|FG001|Entry Through Week 28|Death|0|||
105791433|NCT00604175|364890627|FG002|Entry Through Week 28|Death|0|||
105791434|NCT00604175|364890625|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
105791435|NCT00604175|364890626|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
105791436|NCT00604175|364890627|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
105791437|NCT00604175|364890625|FG000|Entry Through Week 28|Lost to Follow-up|4|||
105791438|NCT00604175|364890626|FG001|Entry Through Week 28|Lost to Follow-up|3|||
105791439|NCT00604175|364890627|FG002|Entry Through Week 28|Lost to Follow-up|0|||
105791440|NCT00604175|364890625|FG000|Entry Through Week 28|Ineligible|1|||
105791441|NCT00604175|364890626|FG001|Entry Through Week 28|Ineligible|0|||
105791442|NCT00604175|364890627|FG002|Entry Through Week 28|Ineligible|0|||
105791443|NCT00604175|364890625|FG000|Entry Through Week 28|Did not start intervention|2|||
105791444|NCT00604175|364890626|FG001|Entry Through Week 28|Did not start intervention|0|||
105791445|NCT00604175|364890627|FG002|Entry Through Week 28|Did not start intervention|1|||
105791446|NCT00604175|364890625|FG000|Week 29 Through Week 72|Death|0|||
105791447|NCT00604175|364890626|FG001|Week 29 Through Week 72|Death|0|||
105791448|NCT00604175|364890627|FG002|Week 29 Through Week 72|Death|1|||
105791449|NCT00604175|364890625|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
105791450|NCT00604175|364890626|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
105791451|NCT00604175|364890627|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
105791452|NCT00604175|364890625|FG000|Week 29 Through Week 72|Site closure|0|||
105791453|NCT00604175|364890626|FG001|Week 29 Through Week 72|Site closure|1|||
105791454|NCT00604175|364890627|FG002|Week 29 Through Week 72|Site closure|0|||
105791455|NCT00604175|364890625|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
105791456|NCT00604175|364890626|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
105791457|NCT00604175|364890627|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
105791458|NCT02044094|364890628|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
105791459|NCT02044094|364890628|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
105791460|NCT02044094|364890628|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
105791461|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
105791462|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
105791463|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
105791464|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
105791465|NCT02044094|364890628|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
105791466|NCT03353415|364890631|FG000|Masked CGM Wear|Lost to Follow-up|2|||
105791467|NCT03353415|364890631|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
105791468|NCT03205163|364890632|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
105791469|NCT03205163|364890633|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
105791470|NCT02332655|364890634|FG000|Overall Study|Lack of Efficacy|1|||
105791471|NCT01876082|364891905|FG000|Overall Study|Withdrawal by Subject|0|||
105791472|NCT01876082|364891906|FG001|Overall Study|Withdrawal by Subject|2|||
105791473|NCT01876082|364891905|FG000|Overall Study|Protocol Violation|1|||
105791474|NCT01876082|364891906|FG001|Overall Study|Protocol Violation|0|||
105791475|NCT01876082|364891905|FG000|Overall Study|Adverse Event|1|||
105934172|NCT00520572|365419512|FG004|Overall Study|Withdrawal by Subject|2|||
105934173|NCT00520572|365419513|FG005|Overall Study|Withdrawal by Subject|0|||
105719213|NCT01059448|364631629|FG002|Overall Study|Administrative Decision|45|||
105719214|NCT01059448|364631630|FG003|Overall Study|Administrative Decision|46|||
105719215|NCT01059448|364631627|FG000|Overall Study|Lost to Follow-up|0|||
105719216|NCT01059448|364631628|FG001|Overall Study|Lost to Follow-up|0|||
105719217|NCT01059448|364631629|FG002|Overall Study|Lost to Follow-up|2|||
105719218|NCT01059448|364631630|FG003|Overall Study|Lost to Follow-up|0|||
105719219|NCT01059448|364631627|FG000|Overall Study|Death|0|||
105719220|NCT01059448|364631628|FG001|Overall Study|Death|1|||
105719221|NCT01059448|364631629|FG002|Overall Study|Death|0|||
105719222|NCT01059448|364631630|FG003|Overall Study|Death|0|||
105791476|NCT01876082|364891906|FG001|Overall Study|Adverse Event|1|||
105791477|NCT01876082|364891905|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
105791478|NCT01876082|364891906|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
105791479|NCT01392469|364891909|FG000|Overall Study|Adverse Event|2|||
105791480|NCT01392469|364891909|FG000|Overall Study|Withdrawal by Subject|1|||
105791481|NCT01392469|364891909|FG000|Overall Study|Protocol Violation|1|||
105791482|NCT01017731|364891910|FG000|Overall Study|Lost to Follow-up|2|||
105791483|NCT01017731|364891910|FG000|Overall Study|Withdrawal by Subject|3|||
105934174|NCT00520572|365419508|FG000|Overall Study|Protocol Violation|0|||
105719223|NCT01059448|364631627|FG000|Overall Study|Other|1|||
105791484|NCT01017731|364891910|FG000|Overall Study|Physician Decision|2|||
105791485|NCT01017731|364891910|FG000|Overall Study|Adverse Event|1|||
105791486|NCT00359073|364891911|FG000|Overall Study|Withdrawal by Subject|1|||
105791487|NCT00359073|364891912|FG001|Overall Study|Withdrawal by Subject|1|||
105791488|NCT00359073|364891911|FG000|Overall Study|Eligibility criteria no longer met|3|||
105791489|NCT00359073|364891912|FG001|Overall Study|Eligibility criteria no longer met|0|||
105791490|NCT00359073|364891911|FG000|Overall Study|developed RV16 antibody|0|||
105791491|NCT00359073|364891912|FG001|Overall Study|developed RV16 antibody|1|||
105791492|NCT00698009|364891921|FG000|Overall Study|Withdrawal by Subject|1|||
105791493|NCT00929201|364891922|FG000|Period 1|Withdrawal by Subject|0|||
105791494|NCT00929201|364891923|FG001|Period 1|Withdrawal by Subject|1|||
105791495|NCT03606109|364891924|FG000|Overall Study|Lost to Follow-up|2|||
105791496|NCT03606109|364891925|FG001|Overall Study|Lost to Follow-up|1|||
105791497|NCT04311411|364891926|FG000|Overall Study|Adverse Event|2|||
105791498|NCT04311411|364891927|FG001|Overall Study|Adverse Event|3|||
105791499|NCT04311411|364891928|FG002|Overall Study|Adverse Event|2|||
105791500|NCT04311411|364891926|FG000|Overall Study|Withdrawal by Subject|3|||
105791501|NCT04311411|364891927|FG001|Overall Study|Withdrawal by Subject|3|||
105791502|NCT04311411|364891928|FG002|Overall Study|Withdrawal by Subject|0|||
105791503|NCT00630994|364891929|FG000|Overall Study|Adverse Event|1|||
105791504|NCT00630994|364891929|FG000|Overall Study|Disease Progression|1|||
105791505|NCT00630994|364891929|FG000|Overall Study|Lack of Efficacy|1|||
105791506|NCT00630994|364891929|FG000|Overall Study|Other|1|||
105791507|NCT03669640|364891930|FG000|Overall Study|Study Terminated by Sponsor|0|||
105791508|NCT03669640|364891931|FG001|Overall Study|Study Terminated by Sponsor|0|||
105791509|NCT03669640|364891932|FG002|Overall Study|Study Terminated by Sponsor|0|||
105791510|NCT03669640|364891933|FG003|Overall Study|Study Terminated by Sponsor|0|||
105791511|NCT03669640|364891934|FG004|Overall Study|Study Terminated by Sponsor|1|||
105791512|NCT03669640|364891935|FG005|Overall Study|Study Terminated by Sponsor|0|||
105791513|NCT03669640|364891930|FG000|Overall Study|Lost to Follow-up|0|||
105791514|NCT03669640|364891931|FG001|Overall Study|Lost to Follow-up|0|||
105791515|NCT03669640|364891932|FG002|Overall Study|Lost to Follow-up|2|||
105791516|NCT03669640|364891933|FG003|Overall Study|Lost to Follow-up|0|||
105791517|NCT03669640|364891934|FG004|Overall Study|Lost to Follow-up|0|||
105791518|NCT03669640|364891935|FG005|Overall Study|Lost to Follow-up|0|||
105791519|NCT03669640|364891930|FG000|Overall Study|Death|0|||
105791520|NCT03669640|364891931|FG001|Overall Study|Death|0|||
105791521|NCT03669640|364891932|FG002|Overall Study|Death|1|||
105791522|NCT03669640|364891933|FG003|Overall Study|Death|0|||
105791523|NCT03669640|364891934|FG004|Overall Study|Death|0|||
105791524|NCT03669640|364891935|FG005|Overall Study|Death|0|||
105791525|NCT03669640|364891930|FG000|Overall Study|Withdrawal by Subject|1|||
105791526|NCT03669640|364891931|FG001|Overall Study|Withdrawal by Subject|2|||
105791527|NCT03669640|364891932|FG002|Overall Study|Withdrawal by Subject|1|||
105791528|NCT03669640|364891933|FG003|Overall Study|Withdrawal by Subject|0|||
105791529|NCT03669640|364891934|FG004|Overall Study|Withdrawal by Subject|1|||
105791530|NCT03669640|364891935|FG005|Overall Study|Withdrawal by Subject|3|||
105791531|NCT03669640|364891930|FG000|Overall Study|Protocol Violation|1|||
105791532|NCT03669640|364891931|FG001|Overall Study|Protocol Violation|0|||
105791533|NCT03669640|364891932|FG002|Overall Study|Protocol Violation|0|||
105791534|NCT03669640|364891933|FG003|Overall Study|Protocol Violation|0|||
105791535|NCT03669640|364891934|FG004|Overall Study|Protocol Violation|0|||
105791536|NCT03669640|364891935|FG005|Overall Study|Protocol Violation|0|||
105791537|NCT03669640|364891930|FG000|Overall Study|Physician Decision|0|||
105791538|NCT03669640|364891931|FG001|Overall Study|Physician Decision|2|||
105791539|NCT03669640|364891932|FG002|Overall Study|Physician Decision|0|||
105791540|NCT03669640|364891933|FG003|Overall Study|Physician Decision|0|||
105791541|NCT03669640|364891934|FG004|Overall Study|Physician Decision|0|||
105791542|NCT03669640|364891935|FG005|Overall Study|Physician Decision|0|||
105791543|NCT03669640|364891930|FG000|Overall Study|Disease Relapse|1|||
105934175|NCT00520572|365419509|FG001|Overall Study|Protocol Violation|0|||
105791544|NCT03669640|364891931|FG001|Overall Study|Disease Relapse|0|||
105791545|NCT03669640|364891932|FG002|Overall Study|Disease Relapse|0|||
105791546|NCT03669640|364891933|FG003|Overall Study|Disease Relapse|0|||
105791547|NCT03669640|364891934|FG004|Overall Study|Disease Relapse|0|||
105791548|NCT03669640|364891935|FG005|Overall Study|Disease Relapse|0|||
105791549|NCT03669640|364891930|FG000|Overall Study|Adverse Event|2|||
105791550|NCT03669640|364891931|FG001|Overall Study|Adverse Event|1|||
105791551|NCT03669640|364891932|FG002|Overall Study|Adverse Event|0|||
105791552|NCT03669640|364891933|FG003|Overall Study|Adverse Event|0|||
105791553|NCT03669640|364891934|FG004|Overall Study|Adverse Event|1|||
105791554|NCT03669640|364891935|FG005|Overall Study|Adverse Event|0|||
105791555|NCT03286426|364891936|FG000|Overall Study|Physician Decision|3|||
105791556|NCT00826176|364891937|FG000|Overall Study|Lost to Follow-up|1|||
105791557|NCT00826176|364891938|FG001|Overall Study|Lost to Follow-up|0|||
105791558|NCT00826176|364891937|FG000|Overall Study|Subject Withdrew Consent|3|||
105934176|NCT00520572|365419510|FG002|Overall Study|Protocol Violation|1|||
105791559|NCT00826176|364891938|FG001|Overall Study|Subject Withdrew Consent|0|||
105791560|NCT00826176|364891937|FG000|Overall Study|Administrative|9|||
105791561|NCT00826176|364891938|FG001|Overall Study|Administrative|0|||
105791562|NCT04484805|364891940|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
105791563|NCT04484805|364891941|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
105791564|NCT04484805|364891940|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
105791565|NCT04484805|364891941|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
105791566|NCT03927989|364891942|FG000|Overall Study|Withdrawal by Subject|0|||
105791567|NCT03927989|364891943|FG001|Overall Study|Withdrawal by Subject|1|||
105791568|NCT03130777|364891944|FG000|Overall Study|Death|0|||
105791569|NCT03130777|364891945|FG001|Overall Study|Death|1|||
105791570|NCT03130777|364891944|FG000|Overall Study|Did not meet eligibility criteria|1|||
105791571|NCT03130777|364891945|FG001|Overall Study|Did not meet eligibility criteria|0|||
105791572|NCT00924820|364891948|FG000|Overall Study|Death|2|||
105791573|NCT00924820|364891948|FG000|Overall Study|Ineligible, Screen Failure|5|||
105791574|NCT00761969|364891949|FG000|Overall Study|Death|112|||
105791575|NCT00761969|364891950|FG001|Overall Study|Death|47|||
105791576|NCT00761969|364891949|FG000|Overall Study|Lost to Follow-up|88|||
105791577|NCT00761969|364891950|FG001|Overall Study|Lost to Follow-up|93|||
105791578|NCT01826201|364891952|FG000|Overall Study|Non compliance with protocol|4|||
105791579|NCT01615822|364891955|FG000|Period 1|Withdrawal by Subject|0|||
105791580|NCT01615822|364891956|FG001|Period 1|Withdrawal by Subject|1|||
105791581|NCT01615822|364891957|FG002|Period 1|Withdrawal by Subject|0|||
105791582|NCT01615822|364891955|FG000|Period 1|Adverse Event|1|||
105791583|NCT01615822|364891956|FG001|Period 1|Adverse Event|1|||
105791584|NCT01615822|364891957|FG002|Period 1|Adverse Event|0|||
105791585|NCT01615822|364891955|FG000|Period 2|Lost to Follow-up|0|||
105791586|NCT01615822|364891956|FG001|Period 2|Lost to Follow-up|1|||
105791587|NCT01615822|364891957|FG002|Period 2|Lost to Follow-up|2|||
105791588|NCT01965431|364891958|FG000|Overall Study|Adverse Event|0|||
105791589|NCT01965431|364891959|FG001|Overall Study|Adverse Event|1|||
105791590|NCT01965431|364891960|FG002|Overall Study|Adverse Event|0|||
105791591|NCT01965431|364891961|FG003|Overall Study|Adverse Event|0|||
105791592|NCT01965431|364891962|FG004|Overall Study|Adverse Event|0|||
105791593|NCT01965431|364891963|FG005|Overall Study|Adverse Event|0|||
105791594|NCT01965431|364891958|FG000|Overall Study|Other than stated above|6|||
105791595|NCT01965431|364891959|FG001|Overall Study|Other than stated above|5|||
105791596|NCT01965431|364891960|FG002|Overall Study|Other than stated above|6|||
105791597|NCT01965431|364891961|FG003|Overall Study|Other than stated above|6|||
105791598|NCT01965431|364891962|FG004|Overall Study|Other than stated above|6|||
105791599|NCT01965431|364891963|FG005|Overall Study|Other than stated above|6|||
105791600|NCT02787785|364891966|FG000|Overall Study|Death|3|||
105791601|NCT02787785|364891967|FG001|Overall Study|Death|4|||
105791602|NCT02787785|364891966|FG000|Overall Study|Lost to Follow-up|1|||
105791603|NCT02787785|364891967|FG001|Overall Study|Lost to Follow-up|1|||
105791604|NCT02787785|364891966|FG000|Overall Study|Withdrawal by Subject|0|||
105791605|NCT02787785|364891967|FG001|Overall Study|Withdrawal by Subject|5|||
105791606|NCT00902265|364891968|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
105791607|NCT00902265|364891968|FG000|Overall Study|Adverse Event|2|||
105791608|NCT00902265|364891968|FG000|Overall Study|Lack of Efficacy|2|||
105791609|NCT00902265|364891968|FG000|Overall Study|Protocol Violation|1|||
105791610|NCT02050373|364891969|FG000|Overall Study|Adverse Event|4|||
105791611|NCT02050373|364891970|FG001|Overall Study|Adverse Event|7|||
105791612|NCT02050373|364891969|FG000|Overall Study|Death|3|||
105791613|NCT02050373|364891970|FG001|Overall Study|Death|3|||
105791614|NCT03981614|364891971|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
105791615|NCT03981614|364891972|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
105791616|NCT03981614|364891973|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
105791617|NCT03901339|364891974|FG000|Overall Study|Death|220|||
105791618|NCT03901339|364891975|FG001|Overall Study|Death|192|||
105791619|NCT03901339|364891974|FG000|Overall Study|Informed consent withdrawn|13|||
105791620|NCT03901339|364891975|FG001|Overall Study|Informed consent withdrawn|40|||
105791621|NCT03901339|364891974|FG000|Overall Study|Sponsor request|30|||
105791622|NCT03901339|364891975|FG001|Overall Study|Sponsor request|23|||
105791623|NCT03901339|364891974|FG000|Overall Study|Reason not specified|5|||
105791624|NCT03901339|364891975|FG001|Overall Study|Reason not specified|7|||
105791625|NCT03901339|364891974|FG000|Overall Study|Lost to Follow-up|4|||
105791626|NCT03901339|364891975|FG001|Overall Study|Lost to Follow-up|7|||
105791627|NCT03901339|364891974|FG000|Overall Study|Covid19|0|||
105791628|NCT03901339|364891975|FG001|Overall Study|Covid19|2|||
105791629|NCT02861534|364891979|FG000|Overall Study|Death|541|||
105791630|NCT02861534|364891980|FG001|Overall Study|Death|552|||
105791631|NCT02861534|364891979|FG000|Overall Study|Lost to Follow-up|14|||
105791632|NCT02861534|364891980|FG001|Overall Study|Lost to Follow-up|14|||
105791633|NCT02861534|364891979|FG000|Overall Study|Site Terminated by Sponsor|4|||
105791634|NCT02861534|364891980|FG001|Overall Study|Site Terminated by Sponsor|3|||
105791635|NCT02861534|364891979|FG000|Overall Study|Withdrawal by Subject|15|||
105791636|NCT02861534|364891980|FG001|Overall Study|Withdrawal by Subject|18|||
105791637|NCT02860039|364891983|FG000|Overall Study|Death|4|||
105791638|NCT02860039|364891984|FG001|Overall Study|Death|0|||
105719224|NCT01059448|364631628|FG001|Overall Study|Other|1|||
105719225|NCT01059448|364631629|FG002|Overall Study|Other|0|||
105719226|NCT01059448|364631630|FG003|Overall Study|Other|1|||
105719227|NCT00132041|364631631|FG000|Baseline|Ineligible|6|||
105719228|NCT00132041|364631631|FG000|3 Months Post Ablation|Transplant|1|||
105719229|NCT00132041|364631631|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
105719230|NCT00132041|364631631|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
105719231|NCT00132041|364631631|FG000|6 Months Post Ablation|Death|2|||
105719232|NCT00132041|364631631|FG000|6 Months Post Ablation|Transplant|6|||
105719233|NCT00132041|364631631|FG000|9 Months Post Ablation|Death|1|||
105719234|NCT00132041|364631631|FG000|9 Months Post Ablation|Transplant|1|||
105719235|NCT00132041|364631631|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
105719236|NCT00132041|364631631|FG000|12 Months Post Ablation|Death|1|||
105719237|NCT00132041|364631631|FG000|12 Months Post Ablation|Transplant|1|||
105719238|NCT00132041|364631631|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
105719239|NCT00132041|364631631|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
105719240|NCT00132041|364631631|FG000|15 Months Post Ablation|Death|1|||
105719241|NCT00132041|364631631|FG000|15 Months Post Ablation|Transplant|5|||
105719242|NCT00132041|364631631|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
105719243|NCT00132041|364631631|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
105719244|NCT00132041|364631631|FG000|18 Months Post Ablation|Transplant|1|||
105719245|NCT00132041|364631631|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
105719246|NCT00132041|364631631|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
105719247|NCT00832819|364631632|FG000|Overall Study|Adverse Event|0|||
105719248|NCT00832819|364631633|FG001|Overall Study|Adverse Event|1|||
105719249|NCT00832819|364631634|FG002|Overall Study|Adverse Event|0|||
105719250|NCT00832819|364631632|FG000|Overall Study|Protocol Violation|0|||
105719251|NCT00832819|364631633|FG001|Overall Study|Protocol Violation|0|||
105719252|NCT00832819|364631634|FG002|Overall Study|Protocol Violation|1|||
105719253|NCT01276821|364631635|FG000|Overall Study|Protocol Violation|0|||
105719254|NCT01276821|364631636|FG001|Overall Study|Protocol Violation|1|||
105719255|NCT00270894|364631637|FG000|Overall Study|Adverse Event|1|||
105719256|NCT00270894|364631637|FG000|Overall Study|Withdrawal by Subject|1|||
105719257|NCT01748071|364631638|FG000|Overall Study|Adverse Event|2|||
105719258|NCT01748071|364631639|FG001|Overall Study|Adverse Event|2|||
105719259|NCT01748071|364631640|FG002|Overall Study|Adverse Event|0|||
105719260|NCT06441877|364631641|FG000|Overall Study|Withdrawal by Subject|0|||
105719261|NCT06441877|364631642|FG001|Overall Study|Withdrawal by Subject|2|||
105719262|NCT06441877|364631643|FG002|Overall Study|Withdrawal by Subject|0|||
105719263|NCT06441877|364631644|FG003|Overall Study|Withdrawal by Subject|0|||
105719264|NCT00600171|364631645|FG000|Overall Study|Adverse Event|0|||
105719265|NCT00600171|364631646|FG001|Overall Study|Adverse Event|1|||
105719266|NCT00600171|364631647|FG002|Overall Study|Adverse Event|0|||
105719267|NCT00600171|364631648|FG003|Overall Study|Adverse Event|0|||
105719268|NCT00600171|364631649|FG004|Overall Study|Adverse Event|1|||
105719269|NCT00600171|364631650|FG005|Overall Study|Adverse Event|0|||
105719270|NCT00600171|364631645|FG000|Overall Study|Lack of Efficacy|9|||
105719271|NCT00600171|364631646|FG001|Overall Study|Lack of Efficacy|12|||
105719272|NCT00600171|364631647|FG002|Overall Study|Lack of Efficacy|3|||
105719273|NCT00600171|364631648|FG003|Overall Study|Lack of Efficacy|5|||
105719274|NCT00600171|364631649|FG004|Overall Study|Lack of Efficacy|4|||
105719275|NCT00600171|364631650|FG005|Overall Study|Lack of Efficacy|0|||
105719276|NCT00600171|364631645|FG000|Overall Study|Protocol Violation|1|||
105719277|NCT00600171|364631646|FG001|Overall Study|Protocol Violation|2|||
105719278|NCT00600171|364631647|FG002|Overall Study|Protocol Violation|0|||
105719279|NCT00600171|364631648|FG003|Overall Study|Protocol Violation|1|||
105719280|NCT00600171|364631649|FG004|Overall Study|Protocol Violation|0|||
105719281|NCT00600171|364631650|FG005|Overall Study|Protocol Violation|0|||
105719282|NCT00600171|364631645|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
105719283|NCT00600171|364631646|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105719284|NCT00600171|364631647|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
105719285|NCT00600171|364631648|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
105719286|NCT00600171|364631649|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
105719287|NCT00600171|364631650|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
105934177|NCT00520572|365419511|FG003|Overall Study|Protocol Violation|0|||
105934178|NCT00520572|365419512|FG004|Overall Study|Protocol Violation|0|||
105719288|NCT00600171|364631645|FG000|Overall Study|Withdrawal by Subject|3|||
105934179|NCT00520572|365419513|FG005|Overall Study|Protocol Violation|0|||
105719289|NCT00600171|364631646|FG001|Overall Study|Withdrawal by Subject|0|||
105719290|NCT00600171|364631647|FG002|Overall Study|Withdrawal by Subject|0|||
105719291|NCT00600171|364631648|FG003|Overall Study|Withdrawal by Subject|1|||
105719292|NCT00600171|364631649|FG004|Overall Study|Withdrawal by Subject|1|||
105719293|NCT00600171|364631650|FG005|Overall Study|Withdrawal by Subject|1|||
105719294|NCT00600171|364631645|FG000|Overall Study|Physician Decision|0|||
105719295|NCT00600171|364631646|FG001|Overall Study|Physician Decision|1|||
105719296|NCT00600171|364631647|FG002|Overall Study|Physician Decision|0|||
105719297|NCT00600171|364631648|FG003|Overall Study|Physician Decision|1|||
105719298|NCT00600171|364631649|FG004|Overall Study|Physician Decision|0|||
105719299|NCT00600171|364631650|FG005|Overall Study|Physician Decision|2|||
105719300|NCT00600171|364631645|FG000|Overall Study|Lost to Follow-up|0|||
105719301|NCT00600171|364631646|FG001|Overall Study|Lost to Follow-up|0|||
105719302|NCT00600171|364631647|FG002|Overall Study|Lost to Follow-up|0|||
105719303|NCT00600171|364631648|FG003|Overall Study|Lost to Follow-up|1|||
105719304|NCT00600171|364631649|FG004|Overall Study|Lost to Follow-up|0|||
105719305|NCT00600171|364631650|FG005|Overall Study|Lost to Follow-up|0|||
105719306|NCT02913313|364631651|FG000|Overall Study|DISEASE PROGRESSION|1|||
105719307|NCT02913313|364631652|FG001|Overall Study|DISEASE PROGRESSION|2|||
105719308|NCT02913313|364631653|FG002|Overall Study|DISEASE PROGRESSION|2|||
105719309|NCT02913313|364631654|FG003|Overall Study|DISEASE PROGRESSION|4|||
105719310|NCT02913313|364631655|FG004|Overall Study|DISEASE PROGRESSION|6|||
105719311|NCT02913313|364631656|FG005|Overall Study|DISEASE PROGRESSION|4|||
105719312|NCT02913313|364631657|FG006|Overall Study|DISEASE PROGRESSION|19|||
105719313|NCT02913313|364631658|FG007|Overall Study|DISEASE PROGRESSION|3|||
105719314|NCT02913313|364631659|FG008|Overall Study|DISEASE PROGRESSION|4|||
105719315|NCT02913313|364631660|FG009|Overall Study|DISEASE PROGRESSION|4|||
105719316|NCT02913313|364631661|FG010|Overall Study|DISEASE PROGRESSION|11|||
105719317|NCT02913313|364631662|FG011|Overall Study|DISEASE PROGRESSION|5|||
105719318|NCT02913313|364631663|FG012|Overall Study|DISEASE PROGRESSION|14|||
105719319|NCT02913313|364631664|FG013|Overall Study|DISEASE PROGRESSION|3|||
105719320|NCT02913313|364631651|FG000|Overall Study|Not Reported|0|||
105719321|NCT02913313|364631652|FG001|Overall Study|Not Reported|0|||
105719322|NCT02913313|364631653|FG002|Overall Study|Not Reported|0|||
105719323|NCT02913313|364631654|FG003|Overall Study|Not Reported|0|||
105719324|NCT02913313|364631655|FG004|Overall Study|Not Reported|1|||
105719325|NCT02913313|364631656|FG005|Overall Study|Not Reported|0|||
105719326|NCT02913313|364631657|FG006|Overall Study|Not Reported|0|||
105719327|NCT02913313|364631658|FG007|Overall Study|Not Reported|0|||
105719328|NCT02913313|364631659|FG008|Overall Study|Not Reported|0|||
105719329|NCT02913313|364631660|FG009|Overall Study|Not Reported|0|||
105719330|NCT02913313|364631661|FG010|Overall Study|Not Reported|4|||
105719331|NCT02913313|364631662|FG011|Overall Study|Not Reported|0|||
105719332|NCT02913313|364631663|FG012|Overall Study|Not Reported|0|||
105719333|NCT02913313|364631664|FG013|Overall Study|Not Reported|0|||
105719334|NCT02913313|364631651|FG000|Overall Study|Other reasons|0|||
105719335|NCT02913313|364631652|FG001|Overall Study|Other reasons|0|||
105719336|NCT02913313|364631653|FG002|Overall Study|Other reasons|0|||
105719337|NCT02913313|364631654|FG003|Overall Study|Other reasons|0|||
105719338|NCT02913313|364631655|FG004|Overall Study|Other reasons|1|||
105719339|NCT02913313|364631656|FG005|Overall Study|Other reasons|0|||
105719340|NCT02913313|364631657|FG006|Overall Study|Other reasons|0|||
105719341|NCT02913313|364631658|FG007|Overall Study|Other reasons|0|||
105719342|NCT02913313|364631659|FG008|Overall Study|Other reasons|0|||
105719343|NCT02913313|364631660|FG009|Overall Study|Other reasons|0|||
105719344|NCT02913313|364631661|FG010|Overall Study|Other reasons|1|||
105719345|NCT02913313|364631662|FG011|Overall Study|Other reasons|0|||
105719346|NCT02913313|364631663|FG012|Overall Study|Other reasons|0|||
105719347|NCT02913313|364631664|FG013|Overall Study|Other reasons|0|||
105719348|NCT02913313|364631651|FG000|Overall Study|Withdrawal by Subject|0|||
105719349|NCT02913313|364631652|FG001|Overall Study|Withdrawal by Subject|0|||
105719350|NCT02913313|364631653|FG002|Overall Study|Withdrawal by Subject|1|||
105719351|NCT02913313|364631654|FG003|Overall Study|Withdrawal by Subject|0|||
105719352|NCT02913313|364631655|FG004|Overall Study|Withdrawal by Subject|0|||
105719353|NCT02913313|364631656|FG005|Overall Study|Withdrawal by Subject|0|||
105719354|NCT02913313|364631657|FG006|Overall Study|Withdrawal by Subject|1|||
105719355|NCT02913313|364631658|FG007|Overall Study|Withdrawal by Subject|1|||
105719356|NCT02913313|364631659|FG008|Overall Study|Withdrawal by Subject|0|||
105719357|NCT02913313|364631660|FG009|Overall Study|Withdrawal by Subject|0|||
105719358|NCT02913313|364631661|FG010|Overall Study|Withdrawal by Subject|1|||
105791639|NCT02860039|364891983|FG000|Overall Study|Lost to Follow-up|2|||
105719359|NCT02913313|364631662|FG011|Overall Study|Withdrawal by Subject|0|||
105719360|NCT02913313|364631663|FG012|Overall Study|Withdrawal by Subject|0|||
105719361|NCT02913313|364631664|FG013|Overall Study|Withdrawal by Subject|0|||
105719362|NCT02913313|364631651|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719363|NCT02913313|364631652|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719364|NCT02913313|364631653|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719365|NCT02913313|364631654|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719366|NCT02913313|364631655|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719367|NCT02913313|364631656|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719368|NCT02913313|364631657|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719369|NCT02913313|364631658|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719370|NCT02913313|364631659|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719371|NCT02913313|364631660|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719372|NCT02913313|364631661|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
105719373|NCT02913313|364631662|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
105719374|NCT02913313|364631663|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
105719375|NCT02913313|364631664|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
105719376|NCT02913313|364631651|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
105719377|NCT02913313|364631652|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
105719378|NCT02913313|364631653|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
105719379|NCT02913313|364631654|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
105719380|NCT02913313|364631655|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
105719381|NCT02913313|364631656|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
105719382|NCT02913313|364631657|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
105719383|NCT02913313|364631658|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
105719384|NCT02913313|364631659|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
105719385|NCT02913313|364631660|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
105719386|NCT02913313|364631661|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
105719387|NCT02913313|364631662|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
105719388|NCT02913313|364631663|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
105719389|NCT02913313|364631664|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
105719390|NCT02411448|364631669|FG000|Overall Study|Withdrawal by Subject|1|||
105719391|NCT02411448|364631670|FG001|Overall Study|Withdrawal by Subject|14|||
105719392|NCT02411448|364631671|FG002|Overall Study|Withdrawal by Subject|9|||
105719393|NCT02411448|364631669|FG000|Overall Study|Other|0|||
105719394|NCT02411448|364631670|FG001|Overall Study|Other|2|||
105719395|NCT02411448|364631671|FG002|Overall Study|Other|0|||
105719396|NCT02411448|364631669|FG000|Overall Study|Did not receive study treatment|0|||
105719397|NCT02411448|364631670|FG001|Overall Study|Did not receive study treatment|3|||
105719398|NCT02411448|364631671|FG002|Overall Study|Did not receive study treatment|0|||
105719399|NCT02411448|364631669|FG000|Overall Study|Alive on study treatment|3|||
105719400|NCT02411448|364631670|FG001|Overall Study|Alive on study treatment|64|||
105719401|NCT02411448|364631671|FG002|Overall Study|Alive on study treatment|43|||
105719402|NCT02771522|364631678|FG000|Overall Study|Lost to Follow-up|3|||
105719403|NCT02771522|364631678|FG000|Overall Study|Withdrawal by Subject|2|||
105719404|NCT02771522|364631678|FG000|Overall Study|No white spot lesions|3|||
105719405|NCT00934102|364631680|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
105719406|NCT00934102|364631681|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
105719407|NCT00934102|364631682|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
105719408|NCT00792298|364631683|FG000|Treatment Period 1|Adverse Event|0|||
105719409|NCT00792298|364631684|FG001|Treatment Period 1|Adverse Event|1|||
105719410|NCT00792298|364631685|FG002|Treatment Period 1|Adverse Event|0|||
105719411|NCT00792298|364631686|FG003|Treatment Period 1|Adverse Event|1|||
105719412|NCT00792298|364631687|FG004|Treatment Period 1|Adverse Event|0|||
105719413|NCT00792298|364631688|FG005|Treatment Period 1|Adverse Event|1|||
105719414|NCT00792298|364631689|FG006|Treatment Period 1|Adverse Event|1|||
105719415|NCT00792298|364631690|FG007|Treatment Period 1|Adverse Event|0|||
105719416|NCT00792298|364631683|FG000|Treatment Period 1|Lack of Efficacy|0|||
105719417|NCT00792298|364631684|FG001|Treatment Period 1|Lack of Efficacy|0|||
105719418|NCT00792298|364631685|FG002|Treatment Period 1|Lack of Efficacy|1|||
105719419|NCT00792298|364631686|FG003|Treatment Period 1|Lack of Efficacy|0|||
105719420|NCT00792298|364631687|FG004|Treatment Period 1|Lack of Efficacy|0|||
105719421|NCT00792298|364631688|FG005|Treatment Period 1|Lack of Efficacy|0|||
105719422|NCT00792298|364631689|FG006|Treatment Period 1|Lack of Efficacy|0|||
105719423|NCT00792298|364631690|FG007|Treatment Period 1|Lack of Efficacy|0|||
105719424|NCT00792298|364631683|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105719425|NCT00792298|364631684|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105719426|NCT00792298|364631685|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105719427|NCT00792298|364631686|FG003|Treatment Period 1|Withdrawal by Subject|2|||
105719428|NCT00792298|364631687|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105719429|NCT00792298|364631688|FG005|Treatment Period 1|Withdrawal by Subject|2|||
105719430|NCT00792298|364631689|FG006|Treatment Period 1|Withdrawal by Subject|1|||
105719431|NCT00792298|364631690|FG007|Treatment Period 1|Withdrawal by Subject|0|||
105719432|NCT00792298|364631683|FG000|Treatment Period 1|Lost to Follow-up|0|||
105719433|NCT00792298|364631684|FG001|Treatment Period 1|Lost to Follow-up|0|||
105719434|NCT00792298|364631685|FG002|Treatment Period 1|Lost to Follow-up|0|||
105719435|NCT00792298|364631686|FG003|Treatment Period 1|Lost to Follow-up|0|||
105719436|NCT00792298|364631687|FG004|Treatment Period 1|Lost to Follow-up|0|||
105719437|NCT00792298|364631688|FG005|Treatment Period 1|Lost to Follow-up|0|||
105719438|NCT00792298|364631689|FG006|Treatment Period 1|Lost to Follow-up|1|||
105719439|NCT00792298|364631690|FG007|Treatment Period 1|Lost to Follow-up|0|||
105719440|NCT00792298|364631683|FG000|Treatment Period 1|Physician Decision|0|||
105719441|NCT00792298|364631684|FG001|Treatment Period 1|Physician Decision|0|||
105719442|NCT00792298|364631685|FG002|Treatment Period 1|Physician Decision|0|||
105719443|NCT00792298|364631686|FG003|Treatment Period 1|Physician Decision|1|||
105719444|NCT00792298|364631687|FG004|Treatment Period 1|Physician Decision|0|||
105719445|NCT00792298|364631688|FG005|Treatment Period 1|Physician Decision|0|||
105719446|NCT00792298|364631689|FG006|Treatment Period 1|Physician Decision|1|||
105719447|NCT00792298|364631690|FG007|Treatment Period 1|Physician Decision|0|||
105719448|NCT00792298|364631683|FG000|Treatment Period 1|Protocol Violation|0|||
105719449|NCT00792298|364631684|FG001|Treatment Period 1|Protocol Violation|0|||
105719450|NCT00792298|364631685|FG002|Treatment Period 1|Protocol Violation|0|||
105719451|NCT00792298|364631686|FG003|Treatment Period 1|Protocol Violation|0|||
105719452|NCT00792298|364631687|FG004|Treatment Period 1|Protocol Violation|0|||
105719453|NCT00792298|364631688|FG005|Treatment Period 1|Protocol Violation|0|||
105719454|NCT00792298|364631689|FG006|Treatment Period 1|Protocol Violation|0|||
105719455|NCT00792298|364631690|FG007|Treatment Period 1|Protocol Violation|1|||
105934180|NCT00520572|365419508|FG000|Overall Study|Lack of Efficacy|1|||
105934181|NCT00520572|365419509|FG001|Overall Study|Lack of Efficacy|1|||
105934182|NCT00520572|365419510|FG002|Overall Study|Lack of Efficacy|1|||
105934183|NCT00520572|365419511|FG003|Overall Study|Lack of Efficacy|2|||
105934184|NCT00520572|365419512|FG004|Overall Study|Lack of Efficacy|1|||
105934185|NCT00520572|365419513|FG005|Overall Study|Lack of Efficacy|0|||
105934186|NCT00520572|365419508|FG000|Overall Study|Lost to Follow-up|0|||
105934187|NCT00520572|365419509|FG001|Overall Study|Lost to Follow-up|0|||
105934188|NCT00520572|365419510|FG002|Overall Study|Lost to Follow-up|0|||
105934189|NCT00520572|365419511|FG003|Overall Study|Lost to Follow-up|0|||
105934190|NCT00520572|365419512|FG004|Overall Study|Lost to Follow-up|1|||
105934191|NCT00520572|365419513|FG005|Overall Study|Lost to Follow-up|0|||
105934192|NCT00520572|365419508|FG000|Overall Study|Incorrect enrollment|1|||
105934193|NCT00520572|365419509|FG001|Overall Study|Incorrect enrollment|0|||
105934194|NCT00520572|365419510|FG002|Overall Study|Incorrect enrollment|1|||
105934195|NCT00520572|365419511|FG003|Overall Study|Incorrect enrollment|0|||
105934196|NCT00520572|365419512|FG004|Overall Study|Incorrect enrollment|1|||
105934197|NCT00520572|365419513|FG005|Overall Study|Incorrect enrollment|0|||
105934198|NCT00520572|365419508|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
105934199|NCT00520572|365419509|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
105934200|NCT00520572|365419510|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
105934201|NCT00520572|365419511|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
105934202|NCT00520572|365419512|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
105934203|NCT00520572|365419513|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
105934204|NCT00520572|365419508|FG000|Overall Study|Long break in taking Medication|0|||
105934205|NCT00520572|365419509|FG001|Overall Study|Long break in taking Medication|0|||
105934206|NCT00520572|365419510|FG002|Overall Study|Long break in taking Medication|0|||
105934207|NCT00520572|365419511|FG003|Overall Study|Long break in taking Medication|1|||
105934208|NCT00520572|365419512|FG004|Overall Study|Long break in taking Medication|0|||
105934209|NCT00520572|365419513|FG005|Overall Study|Long break in taking Medication|0|||
105934210|NCT00520572|365419508|FG000|Overall Study|Did not receive Treatment|1|||
105934211|NCT00520572|365419509|FG001|Overall Study|Did not receive Treatment|0|||
105934212|NCT00520572|365419510|FG002|Overall Study|Did not receive Treatment|1|||
105934213|NCT00520572|365419511|FG003|Overall Study|Did not receive Treatment|0|||
105934214|NCT00520572|365419512|FG004|Overall Study|Did not receive Treatment|0|||
105934215|NCT00520572|365419513|FG005|Overall Study|Did not receive Treatment|0|||
105934216|NCT03387046|365419519|FG000|Overall Study|Adverse Event|1|||
105934217|NCT03387046|365419520|FG001|Overall Study|Adverse Event|1|||
105934218|NCT01529112|365419521|FG000|Overall Study|Adverse Event|2|||
105934219|NCT01529112|365419522|FG001|Overall Study|Adverse Event|0|||
105934220|NCT01529112|365419521|FG000|Overall Study|Death|59|||
105934221|NCT01529112|365419522|FG001|Overall Study|Death|38|||
105934222|NCT01529112|365419521|FG000|Overall Study|Protocol Violation|1|||
105934223|NCT01529112|365419522|FG001|Overall Study|Protocol Violation|0|||
105934224|NCT01529112|365419521|FG000|Overall Study|Withdrawal by Subject|7|||
105934225|NCT01529112|365419522|FG001|Overall Study|Withdrawal by Subject|3|||
105934226|NCT02255279|365419523|FG000|Overall Study|Lost to Follow-up|2|||
105934227|NCT02255279|365419524|FG001|Overall Study|Lost to Follow-up|2|||
105934228|NCT02255279|365419523|FG000|Overall Study|Protocol Violation|0|||
105934229|NCT02255279|365419524|FG001|Overall Study|Protocol Violation|1|||
105934230|NCT02255279|365419523|FG000|Overall Study|Withdrawal by Subject|3|||
105934231|NCT02255279|365419524|FG001|Overall Study|Withdrawal by Subject|6|||
105934232|NCT03607695|365419525|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
105934233|NCT03607695|365419525|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
105934234|NCT03794544|365419526|FG000|Overall Study|Withdrawal by Subject|1|||
105934235|NCT03794544|365419527|FG001|Overall Study|Withdrawal by Subject|1|||
105934236|NCT03794544|365419528|FG002|Overall Study|Withdrawal by Subject|0|||
105934237|NCT03794544|365419529|FG003|Overall Study|Withdrawal by Subject|0|||
105934238|NCT03794544|365419526|FG000|Overall Study|Death|0|||
105719456|NCT00792298|364631683|FG000|Washout|Adverse Event|0|||
105719457|NCT00792298|364631684|FG001|Washout|Adverse Event|0|||
105719458|NCT00792298|364631685|FG002|Washout|Adverse Event|0|||
105719459|NCT00792298|364631686|FG003|Washout|Adverse Event|0|||
105719460|NCT00792298|364631687|FG004|Washout|Adverse Event|0|||
105934239|NCT03794544|365419527|FG001|Overall Study|Death|0|||
105934240|NCT03794544|365419528|FG002|Overall Study|Death|0|||
105934241|NCT03794544|365419529|FG003|Overall Study|Death|1|||
105791640|NCT02860039|364891984|FG001|Overall Study|Lost to Follow-up|2|||
105791641|NCT02860039|364891983|FG000|Overall Study|Protocol Violation|3|||
105791642|NCT02860039|364891984|FG001|Overall Study|Protocol Violation|1|||
105791643|NCT02860039|364891983|FG000|Overall Study|Withdrawal by Subject|1|||
105791644|NCT02860039|364891984|FG001|Overall Study|Withdrawal by Subject|0|||
105791645|NCT02860039|364891983|FG000|Overall Study|Not otherwise eligible|1|||
105791646|NCT02860039|364891984|FG001|Overall Study|Not otherwise eligible|1|||
105791647|NCT03170271|364891987|FG000|Overall Study|Adverse Event|7|||
105791648|NCT03170271|364891988|FG001|Overall Study|Adverse Event|2|||
105791649|NCT03170271|364891987|FG000|Overall Study|Lost to Follow-up|0|||
105791650|NCT03170271|364891988|FG001|Overall Study|Lost to Follow-up|1|||
105791651|NCT03170271|364891987|FG000|Overall Study|Physician Decision|1|||
105791652|NCT03170271|364891988|FG001|Overall Study|Physician Decision|0|||
105791653|NCT03170271|364891987|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
105791654|NCT03170271|364891988|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
105791655|NCT03170271|364891987|FG000|Overall Study|Withdrawal by Subject|17|||
105791656|NCT03170271|364891988|FG001|Overall Study|Withdrawal by Subject|5|||
105791657|NCT03170271|364891987|FG000|Overall Study|Other|2|||
105791658|NCT03170271|364891988|FG001|Overall Study|Other|2|||
105791659|NCT03170271|364891987|FG000|Overall Study|Randomized in error|4|||
105791660|NCT03170271|364891988|FG001|Overall Study|Randomized in error|0|||
105791661|NCT03123120|364891991|FG000|Overall Study|Lost to Follow-up|0|||
105791662|NCT03123120|364891992|FG001|Overall Study|Lost to Follow-up|1|||
105791663|NCT03123120|364891991|FG000|Overall Study|Withdrawal by Subject|0|||
105791664|NCT03123120|364891992|FG001|Overall Study|Withdrawal by Subject|1|||
105791665|NCT00203892|364891995|FG000|Overall Study|Physician Decision|1|||
105791666|NCT00203892|364891996|FG001|Overall Study|Physician Decision|2|||
105791667|NCT00203892|364891997|FG002|Overall Study|Physician Decision|0|||
105791668|NCT00203892|364891995|FG000|Overall Study|Death|1|||
105791669|NCT00203892|364891996|FG001|Overall Study|Death|0|||
105791670|NCT00203892|364891997|FG002|Overall Study|Death|0|||
105791671|NCT01036594|364892011|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
105791672|NCT01036594|364892012|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
105791673|NCT01036594|364892011|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
105791674|NCT01036594|364892012|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
105791675|NCT01036594|364892011|FG000|Week 12 Evaluation|Adverse Event|5|||
105791676|NCT01036594|364892012|FG001|Week 12 Evaluation|Adverse Event|0|||
105791677|NCT01036594|364892011|FG000|Week 12 Evaluation|Physician Decision|1|||
105791678|NCT01036594|364892012|FG001|Week 12 Evaluation|Physician Decision|0|||
105791679|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
105791680|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
105791681|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
105791682|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
105791683|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
105791684|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
105791685|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
105791686|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
105791687|NCT01036594|364892011|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
105791688|NCT01036594|364892012|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
105791689|NCT02380248|364892020|FG000|Overall Study|Lost to Follow-up|11|||
105791690|NCT02380248|364892020|FG000|Overall Study|Withdrawal by Subject|3|||
105791691|NCT00285012|364892021|FG000|Assigned to Study Treatment (Tx)|Other|2|||
105791692|NCT00285012|364892022|FG001|Assigned to Study Treatment (Tx)|Other|3|||
105791693|NCT00285012|364892021|FG000|Received Study Tx|Death|2|||
105791694|NCT00285012|364892022|FG001|Received Study Tx|Death|1|||
105791695|NCT00285012|364892021|FG000|Received Study Tx|Adverse Event|5|||
105791696|NCT00285012|364892022|FG001|Received Study Tx|Adverse Event|11|||
105791697|NCT00285012|364892021|FG000|Received Study Tx|Lack of Efficacy|0|||
105791698|NCT00285012|364892022|FG001|Received Study Tx|Lack of Efficacy|3|||
105791699|NCT00285012|364892021|FG000|Received Study Tx|Lost to Follow-up|29|||
105791700|NCT00285012|364892022|FG001|Received Study Tx|Lost to Follow-up|31|||
105791701|NCT00285012|364892021|FG000|Received Study Tx|Withdrawal by Subject|31|||
105791702|NCT00285012|364892022|FG001|Received Study Tx|Withdrawal by Subject|43|||
105791703|NCT00285012|364892021|FG000|Received Study Tx|Other|5|||
105791704|NCT00285012|364892022|FG001|Received Study Tx|Other|5|||
105791705|NCT00061568|364892023|FG000|Overall Study|Lost to Follow-up|12|||
105934242|NCT03794544|365419526|FG000|Overall Study|Lost to Follow-up|0|||
105791706|NCT00061568|364892024|FG001|Overall Study|Lost to Follow-up|0|||
105791707|NCT00061568|364892023|FG000|Overall Study|Death|6|||
105791708|NCT00061568|364892024|FG001|Overall Study|Death|0|||
105791709|NCT00061568|364892023|FG000|Overall Study|Withdrawal by Subject|1|||
105791710|NCT00061568|364892024|FG001|Overall Study|Withdrawal by Subject|0|||
105791711|NCT00797316|364892025|FG000|Overall Study|Administrative problems|1|||
105791712|NCT00797316|364892026|FG001|Overall Study|Administrative problems|0|||
105791713|NCT00797316|364892025|FG000|Overall Study|Adverse Event|5|||
105791714|NCT00797316|364892026|FG001|Overall Study|Adverse Event|3|||
105791715|NCT00797316|364892025|FG000|Overall Study|Lost to Follow-up|4|||
105791716|NCT00797316|364892026|FG001|Overall Study|Lost to Follow-up|8|||
105791717|NCT00797316|364892025|FG000|Overall Study|Protocol Deviation|1|||
105791718|NCT00797316|364892026|FG001|Overall Study|Protocol Deviation|2|||
105791719|NCT00797316|364892025|FG000|Overall Study|Patient withdrew consent|12|||
105791720|NCT00797316|364892026|FG001|Overall Study|Patient withdrew consent|6|||
105791721|NCT00797316|364892025|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105791722|NCT00797316|364892026|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
105791723|NCT02873195|364892029|FG000|Overall Study|Ineligible|5|||
105791724|NCT02873195|364892030|FG001|Overall Study|Ineligible|0|||
105791725|NCT00096031|364892037|FG000|Overall Study|Adverse Event|3|||
105791726|NCT00096031|364892037|FG000|Overall Study|Lack of Efficacy|42|||
105791727|NCT00096031|364892037|FG000|Overall Study|Death|4|||
105791728|NCT00096031|364892037|FG000|Overall Study|Withdrawal by Subject|1|||
105791729|NCT00096031|364892037|FG000|Overall Study|Ineligible|8|||
105791730|NCT00096031|364892037|FG000|Overall Study|Not protocol specified|5|||
105791731|NCT01126359|364892038|FG000|First Intervention (20-minutes)|Physician Decision|0|||
105791732|NCT01126359|364892039|FG001|First Intervention (20-minutes)|Physician Decision|1|||
105791733|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
105791734|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
105791735|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
105791736|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
105791737|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
105791738|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
105791739|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
105791740|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
105791741|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
105791742|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
105791743|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
105791744|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
105791745|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
105791746|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
105791747|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
105791748|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
105791749|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
105791750|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
105791751|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105791752|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105791753|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105791754|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
105791755|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105719461|NCT00792298|364631688|FG005|Washout|Adverse Event|1|||
105719462|NCT00792298|364631689|FG006|Washout|Adverse Event|0|||
105719463|NCT00792298|364631690|FG007|Washout|Adverse Event|0|||
105719464|NCT00792298|364631683|FG000|Washout|Withdrawal by Subject|0|||
105719465|NCT00792298|364631684|FG001|Washout|Withdrawal by Subject|0|||
105719466|NCT00792298|364631685|FG002|Washout|Withdrawal by Subject|1|||
105719467|NCT00792298|364631686|FG003|Washout|Withdrawal by Subject|0|||
105719468|NCT00792298|364631687|FG004|Washout|Withdrawal by Subject|0|||
105719469|NCT00792298|364631688|FG005|Washout|Withdrawal by Subject|1|||
105719470|NCT00792298|364631689|FG006|Washout|Withdrawal by Subject|0|||
105719471|NCT00792298|364631690|FG007|Washout|Withdrawal by Subject|0|||
105719472|NCT00792298|364631683|FG000|Treatment Period 2|Lack of Efficacy|0|||
105719473|NCT00792298|364631684|FG001|Treatment Period 2|Lack of Efficacy|0|||
105719474|NCT00792298|364631685|FG002|Treatment Period 2|Lack of Efficacy|0|||
105719475|NCT00792298|364631686|FG003|Treatment Period 2|Lack of Efficacy|0|||
105719476|NCT00792298|364631687|FG004|Treatment Period 2|Lack of Efficacy|1|||
105719477|NCT00792298|364631688|FG005|Treatment Period 2|Lack of Efficacy|0|||
105719478|NCT00792298|364631689|FG006|Treatment Period 2|Lack of Efficacy|0|||
105719479|NCT00792298|364631690|FG007|Treatment Period 2|Lack of Efficacy|0|||
105719480|NCT00792298|364631683|FG000|Treatment Period 2|Physician Decision|0|||
105719481|NCT00792298|364631684|FG001|Treatment Period 2|Physician Decision|0|||
105791756|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
105791757|NCT00902486|364892040|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105791758|NCT00902486|364892041|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105791759|NCT00902486|364892042|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105719482|NCT00792298|364631685|FG002|Treatment Period 2|Physician Decision|0|||
105719483|NCT00792298|364631686|FG003|Treatment Period 2|Physician Decision|0|||
105719484|NCT00792298|364631687|FG004|Treatment Period 2|Physician Decision|0|||
105719485|NCT00792298|364631688|FG005|Treatment Period 2|Physician Decision|0|||
105719486|NCT00792298|364631689|FG006|Treatment Period 2|Physician Decision|1|||
105719487|NCT00792298|364631690|FG007|Treatment Period 2|Physician Decision|0|||
105934243|NCT03794544|365419527|FG001|Overall Study|Lost to Follow-up|1|||
105934244|NCT03794544|365419528|FG002|Overall Study|Lost to Follow-up|1|||
105719488|NCT00792298|364631683|FG000|Treatment Period 2|Pregnancy|0|||
105719489|NCT00792298|364631684|FG001|Treatment Period 2|Pregnancy|0|||
105719490|NCT00792298|364631685|FG002|Treatment Period 2|Pregnancy|1|||
105719491|NCT00792298|364631686|FG003|Treatment Period 2|Pregnancy|0|||
105719492|NCT00792298|364631687|FG004|Treatment Period 2|Pregnancy|0|||
105719493|NCT00792298|364631688|FG005|Treatment Period 2|Pregnancy|0|||
105719494|NCT00792298|364631689|FG006|Treatment Period 2|Pregnancy|0|||
105719495|NCT00792298|364631690|FG007|Treatment Period 2|Pregnancy|0|||
105719496|NCT00792298|364631683|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105719497|NCT00792298|364631684|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105719498|NCT00792298|364631685|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105719499|NCT00792298|364631686|FG003|Treatment Period 2|Withdrawal by Subject|2|||
105719500|NCT00792298|364631687|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105719501|NCT00792298|364631688|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105719502|NCT00792298|364631689|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105719503|NCT00792298|364631690|FG007|Treatment Period 2|Withdrawal by Subject|2|||
105719504|NCT04258579|364631696|FG000|Overall Study|Withdrawal by Subject|7|||
105719505|NCT04258579|364631696|FG000|Overall Study|Lost to Follow-up|3|||
105719506|NCT04258579|364631696|FG000|Overall Study|Protocol Violation|2|||
105719507|NCT04258579|364631696|FG000|Overall Study|Adverse Event|1|||
105719508|NCT02388295|364631697|FG000|Dose Escalation Week 1|Adverse Event|1|||
105719509|NCT02388295|364631698|FG001|Dose Escalation Week 1|Adverse Event|2|||
105719510|NCT02388295|364631699|FG002|Dose Escalation Week 1|Adverse Event|1|||
105719511|NCT02388295|364631697|FG000|Dose Escalation Week 1|Determined not eligible|1|||
105719512|NCT02388295|364631698|FG001|Dose Escalation Week 1|Determined not eligible|1|||
105719513|NCT02388295|364631699|FG002|Dose Escalation Week 1|Determined not eligible|1|||
105719514|NCT02388295|364631697|FG000|Dose Escalation Week 2|Protocol Violation|0|||
105719515|NCT02388295|364631698|FG001|Dose Escalation Week 2|Protocol Violation|1|||
105719516|NCT02388295|364631699|FG002|Dose Escalation Week 2|Protocol Violation|0|||
105719517|NCT02388295|364631697|FG000|Dose Escalation Week 2|Determined not eligible|1|||
105719518|NCT02388295|364631698|FG001|Dose Escalation Week 2|Determined not eligible|1|||
105719519|NCT02388295|364631699|FG002|Dose Escalation Week 2|Determined not eligible|1|||
105719520|NCT02388295|364631697|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
105719521|NCT02388295|364631698|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
105719522|NCT02388295|364631699|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
105719523|NCT04007159|364631700|FG000|Induction Phase|(missed study visits)|16|||
105719524|NCT04007159|364631700|FG000|Induction Phase|Withdrawal by Subject|4|||
105719525|NCT04007159|364631700|FG000|Induction Phase|Adverse Event|2|||
105719526|NCT04007159|364631700|FG000|Challenge Phase|missed study visits|3|||
105719527|NCT02076165|364631701|FG000|Overall Study|Lost to Follow-up|7|||
105719528|NCT02076165|364631702|FG001|Overall Study|Lost to Follow-up|5|||
105719529|NCT02076165|364631701|FG000|Overall Study|Refused follow-up assessment|1|||
105719530|NCT02076165|364631702|FG001|Overall Study|Refused follow-up assessment|1|||
105719531|NCT04134494|364631706|FG000|Overall Study|Lost to Follow-up|2|||
105719532|NCT01756274|364631707|FG000|Overall Study|Protocol Violation|2|||
105719533|NCT01756274|364631707|FG000|Overall Study|Laboratory error|1|||
105719534|NCT01879410|364631713|FG000|Overall Study|Adverse Event|9|||
105719535|NCT01879410|364631714|FG001|Overall Study|Adverse Event|14|||
105719536|NCT01879410|364631713|FG000|Overall Study|Lack of Efficacy|4|||
105719537|NCT01879410|364631714|FG001|Overall Study|Lack of Efficacy|6|||
105719538|NCT01879410|364631713|FG000|Overall Study|Protocol Violation|1|||
105719539|NCT01879410|364631714|FG001|Overall Study|Protocol Violation|7|||
105719540|NCT01879410|364631713|FG000|Overall Study|Lost to Follow-up|2|||
105719541|NCT01879410|364631714|FG001|Overall Study|Lost to Follow-up|1|||
105719542|NCT01879410|364631713|FG000|Overall Study|Withdrawal by Subject|7|||
105719543|NCT01879410|364631714|FG001|Overall Study|Withdrawal by Subject|8|||
105719544|NCT01879410|364631713|FG000|Overall Study|Randomised in Error|1|||
105719545|NCT01879410|364631714|FG001|Overall Study|Randomised in Error|2|||
105719546|NCT02649634|364631715|FG000|Overall Study|Withdrawal by Subject|3|||
105719547|NCT02649634|364631716|FG001|Overall Study|Withdrawal by Subject|5|||
105719548|NCT02649634|364631715|FG000|Overall Study|Lost to Follow-up|0|||
105719549|NCT02649634|364631716|FG001|Overall Study|Lost to Follow-up|1|||
105806514|NCT03038113|364949008|FG008|Overall Study|Withdrawal by Subject|0|||
105934245|NCT03794544|365419529|FG003|Overall Study|Lost to Follow-up|0|||
105719550|NCT01670994|364631717|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
105719551|NCT01670994|364631718|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
105719552|NCT01670994|364631717|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
105719553|NCT01670994|364631718|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
105719554|NCT01670994|364631717|FG000|Overall Study|Patient experienced DLT|0|||
105719555|NCT01670994|364631718|FG001|Overall Study|Patient experienced DLT|1|||
105719556|NCT01318122|364631719|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105719557|NCT01318122|364631720|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
106137003|NCT04927975|366160344|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
106137004|NCT04927975|366160339|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
106137005|NCT04927975|366160340|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
106137006|NCT04927975|366160341|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
106137007|NCT04927975|366160342|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
106137008|NCT04927975|366160343|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
106137009|NCT04927975|366160344|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
106137010|NCT04927975|366160339|FG000|Period 1 (Baseline-Week 24)|Death|0|||
106137011|NCT04927975|366160340|FG001|Period 1 (Baseline-Week 24)|Death|0|||
106137012|NCT04927975|366160341|FG002|Period 1 (Baseline-Week 24)|Death|0|||
106137013|NCT04927975|366160342|FG003|Period 1 (Baseline-Week 24)|Death|0|||
106137014|NCT04927975|366160343|FG004|Period 1 (Baseline-Week 24)|Death|0|||
106137015|NCT04927975|366160344|FG005|Period 1 (Baseline-Week 24)|Death|1|||
106137016|NCT04927975|366160339|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
106137017|NCT04927975|366160340|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
106137018|NCT04927975|366160341|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
106137019|NCT04927975|366160342|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
106137020|NCT04927975|366160343|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
106137021|NCT04927975|366160344|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
106137022|NCT04927975|366160339|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
106137023|NCT04927975|366160340|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
106137024|NCT04927975|366160341|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
106137025|NCT04927975|366160342|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
106137026|NCT04927975|366160343|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
106137027|NCT04927975|366160344|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
106137028|NCT04776213|366160345|FG000|Overall Study|Other|1|||
106137029|NCT04776213|366160345|FG000|Overall Study|Withdrawal by Subject|7|||
106137030|NCT04776213|366160345|FG000|Overall Study|Protocol Violation|1|||
106137031|NCT04776213|366160345|FG000|Overall Study|Lost to Follow-up|2|||
106137032|NCT00712166|366160346|FG000|Overall Study|Noncompliance|0|||
105719558|NCT01318122|364631721|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
105719559|NCT01318122|364631722|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
105719560|NCT01318122|364631719|FG000|Enrolled - Long-Term Extension Study|Other|1|||
105719561|NCT01318122|364631720|FG001|Enrolled - Long-Term Extension Study|Other|0|||
105719562|NCT01318122|364631721|FG002|Enrolled - Long-Term Extension Study|Other|0|||
105719563|NCT01318122|364631722|FG003|Enrolled - Long-Term Extension Study|Other|0|||
106137033|NCT00712166|366160347|FG001|Overall Study|Noncompliance|1|||
106137034|NCT04084769|366160349|FG000|Overall Study|Protocol Violation|1|||
106137035|NCT04084769|366160350|FG001|Overall Study|Protocol Violation|3|||
106137036|NCT04084769|366160351|FG002|Overall Study|Protocol Violation|0|||
106137037|NCT04084769|366160352|FG003|Overall Study|Protocol Violation|1|||
106137038|NCT04084769|366160349|FG000|Overall Study|Withdrawal by Subject|0|||
106137039|NCT04084769|366160350|FG001|Overall Study|Withdrawal by Subject|1|||
106137040|NCT04084769|366160351|FG002|Overall Study|Withdrawal by Subject|0|||
106137041|NCT04084769|366160352|FG003|Overall Study|Withdrawal by Subject|0|||
106137042|NCT04084769|366160349|FG000|Overall Study|Withdrawal by parent/guardian|1|||
106137043|NCT04084769|366160350|FG001|Overall Study|Withdrawal by parent/guardian|0|||
106137044|NCT04084769|366160351|FG002|Overall Study|Withdrawal by parent/guardian|0|||
106137045|NCT04084769|366160352|FG003|Overall Study|Withdrawal by parent/guardian|1|||
106137046|NCT04084769|366160349|FG000|Overall Study|Lost to Follow-up|2|||
106137047|NCT04084769|366160350|FG001|Overall Study|Lost to Follow-up|0|||
106137048|NCT04084769|366160351|FG002|Overall Study|Lost to Follow-up|0|||
105719564|NCT01318122|364631719|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
105719565|NCT01318122|364631720|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
105791760|NCT00902486|364892043|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
106137049|NCT04084769|366160352|FG003|Overall Study|Lost to Follow-up|0|||
106137050|NCT02163915|366160353|FG000|Overall Study|Withdrawal by Subject|2|||
106137051|NCT02163915|366160354|FG001|Overall Study|Withdrawal by Subject|0|||
105791761|NCT00902486|364892044|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105934246|NCT03794544|365419526|FG000|Overall Study|Other|0|||
105934247|NCT03794544|365419527|FG001|Overall Study|Other|1|||
105934248|NCT03794544|365419528|FG002|Overall Study|Other|0|||
105934249|NCT03794544|365419529|FG003|Overall Study|Other|0|||
106137052|NCT02163915|366160355|FG002|Overall Study|Withdrawal by Subject|2|||
106137053|NCT02163915|366160356|FG003|Overall Study|Withdrawal by Subject|2|||
106137054|NCT02163915|366160357|FG004|Overall Study|Withdrawal by Subject|2|||
106137055|NCT02163915|366160353|FG000|Overall Study|Study termination|1|||
106137056|NCT02163915|366160354|FG001|Overall Study|Study termination|0|||
106137057|NCT02163915|366160355|FG002|Overall Study|Study termination|0|||
106137058|NCT02163915|366160356|FG003|Overall Study|Study termination|0|||
106137059|NCT02163915|366160357|FG004|Overall Study|Study termination|2|||
106137060|NCT02163915|366160353|FG000|Overall Study|Physician Decision|0|||
106137061|NCT02163915|366160354|FG001|Overall Study|Physician Decision|0|||
106137062|NCT02163915|366160355|FG002|Overall Study|Physician Decision|0|||
106137063|NCT02163915|366160356|FG003|Overall Study|Physician Decision|1|||
105934250|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
105934251|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
105934252|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
105934253|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
105934254|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
105934255|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
105934256|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
105934257|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
105934258|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
105934259|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
105934260|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
105934261|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
105934262|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
105934263|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
105934264|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
105934265|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
105934266|NCT01755156|365419530|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
105934267|NCT01755156|365419531|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
105934268|NCT01755156|365419530|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
105934269|NCT01755156|365419531|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
105934270|NCT01755156|365419530|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
105934271|NCT01755156|365419531|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
105934272|NCT00090402|365419532|FG000|Overall Study|Death|1|||
105934273|NCT00090402|365419533|FG001|Overall Study|Death|1|||
105934274|NCT00090402|365419534|FG002|Overall Study|Death|0|||
105934275|NCT00090402|365419532|FG000|Overall Study|subject moved|0|||
105934276|NCT00090402|365419533|FG001|Overall Study|subject moved|1|||
105934277|NCT00090402|365419534|FG002|Overall Study|subject moved|0|||
105934278|NCT00090402|365419532|FG000|Overall Study|stopped taking study medication|1|||
105934279|NCT00090402|365419533|FG001|Overall Study|stopped taking study medication|0|||
105934280|NCT00090402|365419534|FG002|Overall Study|stopped taking study medication|1|||
105934281|NCT01093885|365419537|FG000|Overall Study|Adverse Event|4|||
105934282|NCT01093885|365419537|FG000|Overall Study|Lost to Follow-up|1|||
105934283|NCT00710554|365419538|FG000|Overall Study|Adverse Event|24|||
105934284|NCT00710554|365419539|FG001|Overall Study|Adverse Event|7|||
105934285|NCT00710554|365419538|FG000|Overall Study|Withdrawal by Subject|7|||
105934286|NCT00710554|365419539|FG001|Overall Study|Withdrawal by Subject|3|||
105934287|NCT00710554|365419538|FG000|Overall Study|Lost to Follow-up|7|||
105934288|NCT00710554|365419539|FG001|Overall Study|Lost to Follow-up|1|||
105934289|NCT00710554|365419538|FG000|Overall Study|Lack of Efficacy|11|||
105934290|NCT00710554|365419539|FG001|Overall Study|Lack of Efficacy|12|||
105934291|NCT00710554|365419538|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
105934292|NCT00710554|365419539|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
105934293|NCT00292370|365419540|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
105934294|NCT00292370|365419541|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
105934295|NCT00292370|365419542|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
105934296|NCT00292370|365419540|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
105934297|NCT00292370|365419541|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
105934298|NCT00292370|365419542|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
105934299|NCT00292370|365419540|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
105934300|NCT00292370|365419541|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
105934301|NCT00292370|365419542|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
105934302|NCT00292370|365419540|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
105934303|NCT00292370|365419541|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
105934304|NCT00292370|365419542|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
105934305|NCT00292370|365419540|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
105934306|NCT00292370|365419541|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
105934307|NCT00292370|365419542|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
105934308|NCT00292370|365419540|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
105934309|NCT00292370|365419541|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
105934310|NCT00292370|365419542|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
105934311|NCT02565186|365419543|FG000|Overall Study|Adverse Event|113|||
105934312|NCT02565186|365419544|FG001|Overall Study|Adverse Event|148|||
105934313|NCT02565186|365419543|FG000|Overall Study|Lost to Follow-up|102|||
105934314|NCT02565186|365419544|FG001|Overall Study|Lost to Follow-up|93|||
105934315|NCT02565186|365419543|FG000|Overall Study|Non-Compliance|57|||
105934316|NCT02565186|365419544|FG001|Overall Study|Non-Compliance|55|||
105934317|NCT02565186|365419543|FG000|Overall Study|Withdrawal by Subject|229|||
105934318|NCT02565186|365419544|FG001|Overall Study|Withdrawal by Subject|214|||
105934319|NCT02565186|365419543|FG000|Overall Study|Physician Decision|18|||
105934320|NCT02565186|365419544|FG001|Overall Study|Physician Decision|16|||
105934321|NCT02565186|365419543|FG000|Overall Study|Sponsor Request|5|||
105719566|NCT01318122|364631721|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
105719567|NCT01318122|364631722|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
105719568|NCT01318122|364631719|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
105719569|NCT01318122|364631720|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105719570|NCT01318122|364631721|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105719571|NCT01318122|364631722|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105719572|NCT01318122|364631719|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105719573|NCT01318122|364631720|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
105719574|NCT01318122|364631721|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105719575|NCT01318122|364631722|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105719576|NCT01318122|364631719|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105719577|NCT01318122|364631720|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
105719578|NCT01318122|364631721|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
105719579|NCT01318122|364631722|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105719580|NCT04897867|364631725|FG000|Overall Study|Withdrawal of Consent|1|||
105719581|NCT04897867|364631725|FG000|Overall Study|Pregnancy|1|||
105719582|NCT04897867|364631725|FG000|Overall Study|Lost to Follow-up|7|||
105719583|NCT04897867|364631725|FG000|Overall Study|Reason not Specified|2|||
105719584|NCT00802360|364631729|FG000|Overall Study|Stimulation failure|4|||
105719585|NCT00802360|364631730|FG001|Overall Study|Stimulation failure|0|||
105719586|NCT00802360|364631731|FG002|Overall Study|Stimulation failure|3|||
105719587|NCT00802360|364631732|FG003|Overall Study|Stimulation failure|3|||
105719588|NCT00802360|364631729|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
105719589|NCT00802360|364631730|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
105719590|NCT00802360|364631731|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
105934322|NCT02565186|365419544|FG001|Overall Study|Sponsor Request|9|||
105934323|NCT02565186|365419543|FG000|Overall Study|Missing|1|||
105934324|NCT02565186|365419544|FG001|Overall Study|Missing|0|||
105934325|NCT02565186|365419543|FG000|Overall Study|Did Not Receive Study Drug|55|||
105934326|NCT02565186|365419544|FG001|Overall Study|Did Not Receive Study Drug|86|||
105934327|NCT01429623|365419551|FG000|Overall Study|Death|1|||
105934328|NCT01429623|365419552|FG001|Overall Study|Death|0|||
105934329|NCT01429623|365419551|FG000|Overall Study|Adverse Event|7|||
105934330|NCT01429623|365419552|FG001|Overall Study|Adverse Event|14|||
105934331|NCT01429623|365419551|FG000|Overall Study|Withdrawal by Subject|19|||
105934332|NCT01429623|365419552|FG001|Overall Study|Withdrawal by Subject|13|||
105934333|NCT01429623|365419551|FG000|Overall Study|Physician Decision|2|||
105934334|NCT01429623|365419552|FG001|Overall Study|Physician Decision|3|||
105934335|NCT01429623|365419551|FG000|Overall Study|Protocol Violation|3|||
105934336|NCT01429623|365419552|FG001|Overall Study|Protocol Violation|2|||
105934337|NCT01429623|365419551|FG000|Overall Study|Assorted|1|||
105934338|NCT01429623|365419552|FG001|Overall Study|Assorted|2|||
105934339|NCT01429623|365419551|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
105934340|NCT01429623|365419552|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
105934341|NCT01429623|365419551|FG000|Overall Study|No post baseline data|4|||
105934342|NCT01429623|365419552|FG001|Overall Study|No post baseline data|4|||
105934343|NCT02619812|365419553|FG000|Overall Study|Withdrawal by Subject|0|||
105934344|NCT02619812|365419554|FG001|Overall Study|Withdrawal by Subject|0|||
105934345|NCT02619812|365419555|FG002|Overall Study|Withdrawal by Subject|1|||
105934346|NCT02619812|365419556|FG003|Overall Study|Withdrawal by Subject|2|||
105934347|NCT01096186|365419557|FG000|Overall Study|Adverse Event|16|||
105934348|NCT01096186|365419557|FG000|Overall Study|Death|4|||
105934349|NCT01096186|365419557|FG000|Overall Study|Lack of Efficacy|4|||
105934350|NCT01096186|365419557|FG000|Overall Study|Lost to Follow-up|2|||
105934351|NCT01096186|365419557|FG000|Overall Study|Withdrawal by Subject|22|||
105934352|NCT01096186|365419557|FG000|Overall Study|Physician Decision|1|||
105719591|NCT00802360|364631732|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
105719592|NCT00802360|364631729|FG000|Overall Study|Cycle cancelled|0|||
105719593|NCT00802360|364631730|FG001|Overall Study|Cycle cancelled|1|||
105719594|NCT00802360|364631731|FG002|Overall Study|Cycle cancelled|1|||
105719595|NCT00802360|364631732|FG003|Overall Study|Cycle cancelled|1|||
105719596|NCT00802360|364631729|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
105719597|NCT00802360|364631730|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
105719598|NCT00802360|364631731|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
105934353|NCT01096186|365419557|FG000|Overall Study|Noncompliance with study drug|1|||
105934354|NCT01421134|365419558|FG000|Overall Study|Adverse Event|3|||
105934355|NCT01421134|365419559|FG001|Overall Study|Adverse Event|5|||
105934356|NCT01421134|365419558|FG000|Overall Study|Lack of Efficacy|2|||
105934357|NCT01421134|365419559|FG001|Overall Study|Lack of Efficacy|4|||
105934358|NCT01421134|365419558|FG000|Overall Study|Protocol Violation|0|||
105934359|NCT01421134|365419559|FG001|Overall Study|Protocol Violation|3|||
105719599|NCT00802360|364631732|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
105934360|NCT01421134|365419558|FG000|Overall Study|Withdrawal by Subject|1|||
105934361|NCT01421134|365419559|FG001|Overall Study|Withdrawal by Subject|1|||
105934362|NCT01421134|365419558|FG000|Overall Study|Administrative|0|||
105719600|NCT00802360|364631729|FG000|Overall Study|No positive serum pregnancy|17|||
105719601|NCT00802360|364631730|FG001|Overall Study|No positive serum pregnancy|20|||
105719602|NCT00802360|364631731|FG002|Overall Study|No positive serum pregnancy|14|||
105719603|NCT00802360|364631732|FG003|Overall Study|No positive serum pregnancy|10|||
105719604|NCT00802360|364631729|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
105719605|NCT00802360|364631730|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
105719606|NCT00802360|364631731|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
105719607|NCT00802360|364631732|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
105719608|NCT00802360|364631729|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
105719609|NCT00802360|364631730|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
105719610|NCT00802360|364631731|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
105934363|NCT01421134|365419559|FG001|Overall Study|Administrative|1|||
105934364|NCT01421134|365419558|FG000|Overall Study|Lost to Follow-up|1|||
105934365|NCT01421134|365419559|FG001|Overall Study|Lost to Follow-up|1|||
105934366|NCT01061710|365419560|FG000|Overall Study|Protocol Violation|14|||
105934367|NCT01217047|365419562|FG000|Overall Study|Lost to Follow-up|0|||
105934368|NCT01217047|365419563|FG001|Overall Study|Lost to Follow-up|1|||
105934369|NCT01217047|365419564|FG002|Overall Study|Lost to Follow-up|0|||
105934370|NCT06399471|365419565|FG000|Overall Study|Withdrawal by Subject|1|||
105934371|NCT06083493|365419566|FG000|Overall Study|Technical issues with the interventional device|2|||
105934372|NCT06083493|365419567|FG001|Overall Study|Technical issues with the interventional device|2|||
105934373|NCT06083493|365419566|FG000|Overall Study|Performed incorrect visual task|1|||
105934374|NCT06083493|365419567|FG001|Overall Study|Performed incorrect visual task|0|||
105934375|NCT06083493|365419566|FG000|Overall Study|Insufficient baseline performance|0|||
105934376|NCT06083493|365419567|FG001|Overall Study|Insufficient baseline performance|1|||
105791762|NCT00902486|364892045|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
105791763|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
105791764|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
105791765|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
105791766|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
105791767|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
105791768|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
105791769|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
105791770|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
105791771|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
105791772|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
105791773|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
105791774|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
105791775|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791776|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791777|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791778|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791779|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
105791780|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
105791781|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791782|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791783|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791784|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
105791785|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105791786|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
105934377|NCT03671148|365419568|FG000|Overall Study|Adverse Event|3|||
105934378|NCT03671148|365419569|FG001|Overall Study|Adverse Event|2|||
105934379|NCT03671148|365419568|FG000|Overall Study|Withdrawal by Subject|8|||
105934380|NCT03671148|365419569|FG001|Overall Study|Withdrawal by Subject|2|||
105934381|NCT03671148|365419568|FG000|Overall Study|Lost to Follow-up|1|||
105791787|NCT00902486|364892040|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105791788|NCT00902486|364892041|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105934382|NCT03671148|365419569|FG001|Overall Study|Lost to Follow-up|2|||
105934383|NCT03671148|365419568|FG000|Overall Study|Lack of Efficacy|7|||
105934384|NCT03671148|365419569|FG001|Overall Study|Lack of Efficacy|2|||
105934385|NCT03671148|365419568|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
105934386|NCT03671148|365419569|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
105934387|NCT03671148|365419568|FG000|Overall Study|Other|1|||
105934388|NCT03671148|365419569|FG001|Overall Study|Other|0|||
105934389|NCT03671148|365419568|FG000|Overall Study|Incomplete Randomization Visit|1|||
105934390|NCT03671148|365419569|FG001|Overall Study|Incomplete Randomization Visit|0|||
105934391|NCT01362270|365419570|FG000|Overall Study|Withdrawal by Subject|1|||
105934392|NCT01362270|365419571|FG001|Overall Study|Withdrawal by Subject|0|||
105934393|NCT01362270|365419570|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
105934394|NCT01362270|365419571|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
105934395|NCT01362270|365419570|FG000|Overall Study|Met excl. criteria before 1st session|1|||
105934396|NCT01362270|365419571|FG001|Overall Study|Met excl. criteria before 1st session|1|||
105934397|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
105934398|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
105934399|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
105934400|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
105934401|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
105934402|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
105934403|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
105934404|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
105934405|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
105934406|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
105934407|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
105934408|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
105934409|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
105934410|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
105934411|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
105934412|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
105934413|NCT03182244|365419578|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
105934414|NCT03182244|365419579|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
105934415|NCT03182244|365419578|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
105934416|NCT03182244|365419579|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
105934417|NCT03182244|365419578|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
105934418|NCT03182244|365419579|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
105934419|NCT03182244|365419578|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
105934420|NCT03182244|365419579|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
105934421|NCT03182244|365419578|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
105934422|NCT03182244|365419579|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
105934423|NCT03518203|365419580|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
105934424|NCT03518203|365419580|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
105934425|NCT04796207|365419583|FG000|Overall Study|Lost to Follow-up|7|||
105934426|NCT04796207|365419584|FG001|Overall Study|Lost to Follow-up|2|||
105934427|NCT02405962|365419587|FG000|Overall Study|Lost to Follow-up|1|||
105934428|NCT02405962|365419588|FG001|Overall Study|Lost to Follow-up|4|||
105934429|NCT02405962|365419587|FG000|Overall Study|A participant has moved to another place|0|||
105934430|NCT02405962|365419588|FG001|Overall Study|A participant has moved to another place|1|||
105934431|NCT03339453|365419599|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
105934432|NCT03339453|365419600|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
105934433|NCT01348490|365419604|FG000|Overall Study|Death|1|||
105934434|NCT01348490|365419604|FG000|Overall Study|Adverse Event|3|||
105934435|NCT01348490|365419604|FG000|Overall Study|Consent withdrawn|7|||
105934436|NCT01348490|365419604|FG000|Overall Study|Disease progression|3|||
105934437|NCT01348490|365419604|FG000|Overall Study|Lost to Follow-up|1|||
105934438|NCT01348490|365419604|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
105934439|NCT01348490|365419604|FG000|Overall Study|Other Unspecified|8|||
105934440|NCT03632720|365419605|FG000|Overall Study|Adverse Event|2|||
105934441|NCT03632720|365419606|FG001|Overall Study|Adverse Event|0|||
105934442|NCT03632720|365419607|FG002|Overall Study|Adverse Event|0|||
105934443|NCT03632720|365419605|FG000|Overall Study|Lost to Follow-up|0|||
105934444|NCT03632720|365419606|FG001|Overall Study|Lost to Follow-up|1|||
105934445|NCT03632720|365419607|FG002|Overall Study|Lost to Follow-up|0|||
105934446|NCT03632720|365419605|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
105934447|NCT03632720|365419606|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
105934448|NCT03632720|365419607|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
105934449|NCT03632720|365419605|FG000|Overall Study|Screen failure|0|||
105934450|NCT03632720|365419606|FG001|Overall Study|Screen failure|1|||
105934451|NCT03632720|365419607|FG002|Overall Study|Screen failure|0|||
105934452|NCT00954538|365419615|FG000|Part III|Withdrawal by Subject|0|||
105934453|NCT00954538|365419616|FG001|Part III|Withdrawal by Subject|0|||
105719611|NCT00802360|364631732|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
105719612|NCT00802360|364631729|FG000|Overall Study|Other|2|||
105719613|NCT00802360|364631730|FG001|Overall Study|Other|3|||
105719614|NCT00802360|364631731|FG002|Overall Study|Other|6|||
105719615|NCT00802360|364631732|FG003|Overall Study|Other|3|||
105719616|NCT02041962|364631733|FG000|Overall Study|Lost Aetna Coverage|43|||
105719617|NCT02041962|364631734|FG001|Overall Study|Lost Aetna Coverage|40|||
105719618|NCT02041962|364631733|FG000|Overall Study|Death|1|||
105719619|NCT02041962|364631734|FG001|Overall Study|Death|1|||
105934454|NCT00954538|365419617|FG002|Part III|Withdrawal by Subject|0|||
105934455|NCT00954538|365419618|FG003|Part III|Withdrawal by Subject|0|||
105719620|NCT02041962|364631733|FG000|Overall Study|Lost to Follow-up|37|||
105719621|NCT02041962|364631734|FG001|Overall Study|Lost to Follow-up|32|||
105934456|NCT00954538|365419619|FG004|Part III|Withdrawal by Subject|1|||
105934457|NCT00954538|365419620|FG005|Part III|Withdrawal by Subject|0|||
105934458|NCT00450749|365419621|FG000|Overall Study|Withdrawal by Subject|0|||
105934459|NCT00450749|365419622|FG001|Overall Study|Withdrawal by Subject|0|||
105934460|NCT00450749|365419623|FG002|Overall Study|Withdrawal by Subject|2|||
105934461|NCT00450749|365419621|FG000|Overall Study|Noncompliant|0|||
105934462|NCT00450749|365419622|FG001|Overall Study|Noncompliant|1|||
105934463|NCT00450749|365419623|FG002|Overall Study|Noncompliant|0|||
105934464|NCT04941898|365421145|FG000|Overall Study|Protocol Violation|1|||
105934465|NCT00160615|365421146|FG000|Overall Study|Adverse Event|5|||
105934466|NCT00160615|365421147|FG001|Overall Study|Adverse Event|12|||
105934467|NCT00160615|365421146|FG000|Overall Study|Withdrawal by Subject|0|||
105934468|NCT00160615|365421147|FG001|Overall Study|Withdrawal by Subject|2|||
105934469|NCT00160615|365421146|FG000|Overall Study|Lack of Efficacy|11|||
105934470|NCT00160615|365421147|FG001|Overall Study|Lack of Efficacy|23|||
105934471|NCT00160615|365421146|FG000|Overall Study|Patient decision|1|||
105934472|NCT00160615|365421147|FG001|Overall Study|Patient decision|2|||
105934473|NCT00160615|365421146|FG000|Overall Study|Investigator decision|1|||
105934474|NCT00160615|365421147|FG001|Overall Study|Investigator decision|1|||
105719622|NCT02041962|364631733|FG000|Overall Study|Withdrawal by Subject|0|||
105719623|NCT02041962|364631734|FG001|Overall Study|Withdrawal by Subject|11|||
105719624|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
105719625|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
105719626|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
105719627|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
105719628|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
105719629|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
105719630|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
105719631|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
105719632|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
105719633|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
105719634|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
105719635|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
105719636|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719637|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
105719638|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719639|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719640|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719641|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
105719642|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
105719643|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
105719644|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
105719645|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
105719646|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
105719647|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
105719648|NCT01756456|364631735|FG000|Treatment Period: Phase I/II|Other causes|0|||
105719649|NCT01756456|364631736|FG001|Treatment Period: Phase I/II|Other causes|0|||
105719650|NCT01756456|364631737|FG002|Treatment Period: Phase I/II|Other causes|0|||
105719651|NCT01756456|364631738|FG003|Treatment Period: Phase I/II|Other causes|1|||
105719652|NCT01756456|364631739|FG004|Treatment Period: Phase I/II|Other causes|2|||
105719653|NCT01756456|364631740|FG005|Treatment Period: Phase I/II|Other causes|2|||
105719654|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
105719655|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
105719656|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
105719657|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
105719658|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
105719659|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
105719660|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105719661|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
105719662|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105719663|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105719664|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105934475|NCT00160615|365421146|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
105934476|NCT00160615|365421147|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
105934477|NCT00160615|365421146|FG000|Overall Study|Switch to surgical treatment|0|||
105934478|NCT00160615|365421147|FG001|Overall Study|Switch to surgical treatment|2|||
105934479|NCT00160615|365421146|FG000|Overall Study|Non-compliance was suspected|0|||
105934480|NCT00160615|365421147|FG001|Overall Study|Non-compliance was suspected|1|||
105934481|NCT00160615|365421146|FG000|Overall Study|Poor compliance|0|||
105934482|NCT00160615|365421147|FG001|Overall Study|Poor compliance|1|||
105791789|NCT00902486|364892042|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
105791790|NCT00902486|364892043|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105791791|NCT00902486|364892044|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105791792|NCT00902486|364892045|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
105791793|NCT00902486|364892040|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791794|NCT00902486|364892041|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791795|NCT00902486|364892042|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791796|NCT00902486|364892043|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
105791797|NCT00902486|364892044|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791798|NCT00902486|364892045|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
105791799|NCT00005879|364892048|FG000|Overall Study|Withdrawal by Subject|8|||
105791800|NCT00005879|364892049|FG001|Overall Study|Withdrawal by Subject|10|||
105791801|NCT05022121|364892051|FG000|Overall Study|Lack of Efficacy|1|||
105791802|NCT05022121|364892052|FG001|Overall Study|Lack of Efficacy|0|||
105791803|NCT05022121|364892051|FG000|Overall Study|Lost to Follow-up|0|||
105791804|NCT05022121|364892052|FG001|Overall Study|Lost to Follow-up|2|||
105791805|NCT02395536|364892053|FG000|Overall Study|Lost to Follow-up|4|||
105791806|NCT02395536|364892054|FG001|Overall Study|Lost to Follow-up|4|||
105791807|NCT02395536|364892053|FG000|Overall Study|Death|2|||
105791808|NCT02395536|364892054|FG001|Overall Study|Death|0|||
105791809|NCT02395536|364892053|FG000|Overall Study|Physician Decision|4|||
105791810|NCT02395536|364892054|FG001|Overall Study|Physician Decision|6|||
105791811|NCT02395536|364892053|FG000|Overall Study|Withdrawal by Subject|9|||
105791812|NCT02395536|364892054|FG001|Overall Study|Withdrawal by Subject|17|||
105791813|NCT02395536|364892053|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
105791814|NCT02395536|364892054|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
105791815|NCT02395536|364892053|FG000|Overall Study|Insurance issue|0|||
105791816|NCT02395536|364892054|FG001|Overall Study|Insurance issue|1|||
105791817|NCT00131937|364892055|FG000|Overall Study|Adverse Event|3|||
105791818|NCT00131937|364892055|FG000|Overall Study|Withdrawal by Subject|2|||
105791819|NCT00131937|364892055|FG000|Overall Study|Physician Decision|1|||
105791820|NCT00131937|364892055|FG000|Overall Study|Disease Progression|7|||
105791821|NCT00131937|364892055|FG000|Overall Study|Alternative therapy|1|||
105791822|NCT00648739|364894294|FG000|Overall Study|Adverse Event|1|||
105791823|NCT00648739|364894295|FG001|Overall Study|Adverse Event|0|||
105791824|NCT00648739|364894296|FG002|Overall Study|Adverse Event|1|||
105934483|NCT00289978|365421154|FG000|Overall Study|Withdrawal by Subject|31|||
105934484|NCT00289978|365421155|FG001|Overall Study|Withdrawal by Subject|17|||
105934485|NCT00289978|365421156|FG002|Overall Study|Withdrawal by Subject|28|||
105934486|NCT00289978|365421154|FG000|Overall Study|Adverse Event|22|||
105934487|NCT00289978|365421155|FG001|Overall Study|Adverse Event|13|||
105934488|NCT00289978|365421156|FG002|Overall Study|Adverse Event|18|||
105934489|NCT00289978|365421154|FG000|Overall Study|Lack of Efficacy|13|||
105934490|NCT00289978|365421155|FG001|Overall Study|Lack of Efficacy|6|||
105934491|NCT00289978|365421156|FG002|Overall Study|Lack of Efficacy|25|||
105934492|NCT00289978|365421154|FG000|Overall Study|Abnormal laboratory value(s)|20|||
105934493|NCT00289978|365421155|FG001|Overall Study|Abnormal laboratory value(s)|9|||
105934494|NCT00289978|365421156|FG002|Overall Study|Abnormal laboratory value(s)|1|||
105934495|NCT00289978|365421154|FG000|Overall Study|Lost to Follow-up|3|||
105934496|NCT00289978|365421155|FG001|Overall Study|Lost to Follow-up|5|||
105934497|NCT00289978|365421156|FG002|Overall Study|Lost to Follow-up|7|||
105934498|NCT00289978|365421154|FG000|Overall Study|Protocol Violation|5|||
105934499|NCT00289978|365421155|FG001|Overall Study|Protocol Violation|5|||
105934500|NCT00289978|365421156|FG002|Overall Study|Protocol Violation|4|||
105934501|NCT00289978|365421154|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105934502|NCT00289978|365421155|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105934503|NCT00289978|365421156|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105934504|NCT00289978|365421154|FG000|Overall Study|Death|1|||
105934505|NCT00289978|365421155|FG001|Overall Study|Death|0|||
105934506|NCT00289978|365421156|FG002|Overall Study|Death|2|||
105934507|NCT00363467|365421157|FG000|Overall Study|Physician Decision|1|||
105934508|NCT00120250|365421158|FG000|Overall Study|Lost to Follow-up|1|||
105934509|NCT00120250|365421159|FG001|Overall Study|Lost to Follow-up|1|||
105934510|NCT00120250|365421158|FG000|Overall Study|Protocol Violation|0|||
105791825|NCT00648739|364894297|FG003|Overall Study|Adverse Event|2|||
105791826|NCT00648739|364894298|FG004|Overall Study|Adverse Event|1|||
105934511|NCT00120250|365421159|FG001|Overall Study|Protocol Violation|1|||
105934512|NCT01524705|365421160|FG000|Overall Study|Adverse Event|2|||
105934513|NCT01524705|365421161|FG001|Overall Study|Adverse Event|0|||
105791827|NCT00648739|364894299|FG005|Overall Study|Adverse Event|0|||
105791828|NCT00648739|364894300|FG006|Overall Study|Adverse Event|0|||
105791829|NCT00648739|364894294|FG000|Overall Study|Withdrawal by Subject|1|||
105791830|NCT00648739|364894295|FG001|Overall Study|Withdrawal by Subject|0|||
105934514|NCT01524705|365421160|FG000|Overall Study|Death|1|||
105934515|NCT01524705|365421161|FG001|Overall Study|Death|0|||
105934516|NCT01524705|365421160|FG000|Overall Study|Lost to Follow-up|0|||
105934517|NCT01524705|365421161|FG001|Overall Study|Lost to Follow-up|1|||
105934518|NCT01524705|365421160|FG000|Overall Study|Withdrawal by Subject|0|||
105934519|NCT01524705|365421161|FG001|Overall Study|Withdrawal by Subject|1|||
105934520|NCT01524705|365421160|FG000|Overall Study|Pancreatic Cancer|0|||
105934521|NCT01524705|365421161|FG001|Overall Study|Pancreatic Cancer|1|||
105934522|NCT03142451|365421171|FG000|Overall Study|Adverse Event|5|||
105934523|NCT03142451|365421172|FG001|Overall Study|Adverse Event|2|||
105934524|NCT03142451|365421171|FG000|Overall Study|Lost to Follow-up|25|||
105934525|NCT03142451|365421172|FG001|Overall Study|Lost to Follow-up|8|||
105934526|NCT03142451|365421171|FG000|Overall Study|Participant request|24|||
105934527|NCT03142451|365421172|FG001|Overall Study|Participant request|12|||
105934528|NCT03142451|365421171|FG000|Overall Study|Protocol Violation|3|||
105934529|NCT03142451|365421172|FG001|Overall Study|Protocol Violation|1|||
105934530|NCT03142451|365421171|FG000|Overall Study|Other|1|||
105934531|NCT03142451|365421172|FG001|Overall Study|Other|1|||
105934532|NCT01530256|365421173|FG000|Overall Study|Death|2|||
105934533|NCT00710970|365421176|FG000|Overall Study|Never took drug|3|||
105934534|NCT01028560|365421177|FG000|Overall Study|Lack of Efficacy|3|||
105934535|NCT01028560|365421178|FG001|Overall Study|Lack of Efficacy|6|||
105934536|NCT01028560|365421177|FG000|Overall Study|Withdrawal by Subject|7|||
105934537|NCT01028560|365421178|FG001|Overall Study|Withdrawal by Subject|12|||
105934538|NCT01964560|365421181|FG000|Overall Study|Adverse Event|23|||
105934539|NCT01964560|365421181|FG000|Overall Study|Lack of Efficacy|46|||
105934540|NCT01964560|365421181|FG000|Overall Study|Protocol deviation|2|||
105934541|NCT01964560|365421181|FG000|Overall Study|Lost to Follow-up|4|||
105934542|NCT01964560|365421181|FG000|Overall Study|Withdrawal by Subject|64|||
105934543|NCT01964560|365421181|FG000|Overall Study|Surgery-hemispherotomy|1|||
105934544|NCT01964560|365421181|FG000|Overall Study|Surgery|1|||
105934545|NCT01964560|365421181|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
105934546|NCT01964560|365421181|FG000|Overall Study|Patient and Investigator choice|1|||
105934547|NCT01964560|365421181|FG000|Overall Study|Patient was prescribed CBD|1|||
105934548|NCT01964560|365421181|FG000|Overall Study|Participant moved to another country|1|||
105934549|NCT01301001|365421182|FG000|First Intervention|Lost to Follow-up|4|||
105934550|NCT01301001|365421183|FG001|First Intervention|Lost to Follow-up|4|||
105934551|NCT01301001|365421182|FG000|First Intervention|Withdrawal by Subject|1|||
105934552|NCT01301001|365421183|FG001|First Intervention|Withdrawal by Subject|4|||
105934553|NCT01301001|365421182|FG000|First Intervention|Adverse Event|5|||
105934554|NCT01301001|365421183|FG001|First Intervention|Adverse Event|0|||
105934555|NCT01301001|365421182|FG000|First Intervention|Protocol Violation|0|||
105934556|NCT01301001|365421183|FG001|First Intervention|Protocol Violation|1|||
105934557|NCT01301001|365421182|FG000|Second Intervention|Adverse Event|2|||
105934558|NCT01301001|365421183|FG001|Second Intervention|Adverse Event|0|||
105934559|NCT01301001|365421182|FG000|Second Intervention|Withdrawal by Subject|2|||
105934560|NCT01301001|365421183|FG001|Second Intervention|Withdrawal by Subject|0|||
105934561|NCT02533674|365421184|FG000|Dose Level I|Progressive disease|1|||
105934562|NCT02533674|365421185|FG001|Dose Level I|Progressive disease|0|||
105934563|NCT02533674|365421186|FG002|Dose Level I|Progressive disease|0|||
105934564|NCT02533674|365421187|FG003|Dose Level I|Progressive disease|0|||
105934565|NCT02533674|365421188|FG004|Dose Level I|Progressive disease|0|||
105934566|NCT02533674|365421189|FG005|Dose Level I|Progressive disease|0|||
105934567|NCT02533674|365421190|FG006|Dose Level I|Progressive disease|0|||
105934568|NCT02533674|365421191|FG007|Dose Level I|Progressive disease|0|||
105934569|NCT02533674|365421184|FG000|Dose Level I|Withdrawal by Subject|1|||
105934570|NCT02533674|365421185|FG001|Dose Level I|Withdrawal by Subject|0|||
105934571|NCT02533674|365421186|FG002|Dose Level I|Withdrawal by Subject|0|||
105934572|NCT02533674|365421187|FG003|Dose Level I|Withdrawal by Subject|0|||
105934573|NCT02533674|365421188|FG004|Dose Level I|Withdrawal by Subject|0|||
105934574|NCT02533674|365421189|FG005|Dose Level I|Withdrawal by Subject|0|||
105934575|NCT02533674|365421190|FG006|Dose Level I|Withdrawal by Subject|0|||
105934576|NCT02533674|365421191|FG007|Dose Level I|Withdrawal by Subject|0|||
105934577|NCT02533674|365421184|FG000|Dose Level I|Physician Decision|1|||
105934578|NCT02533674|365421185|FG001|Dose Level I|Physician Decision|0|||
105934579|NCT02533674|365421186|FG002|Dose Level I|Physician Decision|0|||
105934580|NCT02533674|365421187|FG003|Dose Level I|Physician Decision|0|||
105934581|NCT02533674|365421188|FG004|Dose Level I|Physician Decision|0|||
105934582|NCT02533674|365421189|FG005|Dose Level I|Physician Decision|0|||
105934583|NCT02533674|365421190|FG006|Dose Level I|Physician Decision|0|||
105934584|NCT02533674|365421191|FG007|Dose Level I|Physician Decision|0|||
105934585|NCT02533674|365421184|FG000|Dose Level I|Death|1|||
105934586|NCT02533674|365421185|FG001|Dose Level I|Death|0|||
105934587|NCT02533674|365421186|FG002|Dose Level I|Death|0|||
105934588|NCT02533674|365421187|FG003|Dose Level I|Death|0|||
105934589|NCT02533674|365421188|FG004|Dose Level I|Death|0|||
105934590|NCT02533674|365421189|FG005|Dose Level I|Death|0|||
105934591|NCT02533674|365421190|FG006|Dose Level I|Death|0|||
105934592|NCT02533674|365421191|FG007|Dose Level I|Death|0|||
105934593|NCT02533674|365421184|FG000|Dose Level I|Never Treated|1|||
105934594|NCT02533674|365421185|FG001|Dose Level I|Never Treated|0|||
105934595|NCT02533674|365421186|FG002|Dose Level I|Never Treated|0|||
105934596|NCT02533674|365421187|FG003|Dose Level I|Never Treated|0|||
105934597|NCT02533674|365421188|FG004|Dose Level I|Never Treated|0|||
105934598|NCT02533674|365421189|FG005|Dose Level I|Never Treated|0|||
105791831|NCT00648739|364894296|FG002|Overall Study|Withdrawal by Subject|1|||
105791832|NCT00648739|364894297|FG003|Overall Study|Withdrawal by Subject|0|||
105791833|NCT00648739|364894298|FG004|Overall Study|Withdrawal by Subject|0|||
105791834|NCT00648739|364894299|FG005|Overall Study|Withdrawal by Subject|2|||
105791835|NCT00648739|364894300|FG006|Overall Study|Withdrawal by Subject|0|||
105791836|NCT00648739|364894294|FG000|Overall Study|Lack of Efficacy|0|||
105719665|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
105719666|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719667|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719668|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719669|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719670|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
105719671|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
105719672|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
105719673|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
105719674|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
105719675|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
105719676|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
105719677|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
105719678|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
105719679|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
105719680|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
105719681|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
105719682|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
105719683|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
105719684|NCT01756456|364631735|FG000|Follow Up Period Phase I/II|Other causes|0|||
105719685|NCT01756456|364631736|FG001|Follow Up Period Phase I/II|Other causes|0|||
105719686|NCT01756456|364631737|FG002|Follow Up Period Phase I/II|Other causes|0|||
105719687|NCT01756456|364631738|FG003|Follow Up Period Phase I/II|Other causes|1|||
105719688|NCT01756456|364631739|FG004|Follow Up Period Phase I/II|Other causes|3|||
105719689|NCT01756456|364631740|FG005|Follow Up Period Phase I/II|Other causes|5|||
105719690|NCT00611247|364631750|FG000|Overall Study|Death|1|||
105719691|NCT00611247|364631751|FG001|Overall Study|Death|5|||
105719692|NCT00611247|364631750|FG000|Overall Study|Lack of Efficacy|1|||
105719693|NCT00611247|364631751|FG001|Overall Study|Lack of Efficacy|16|||
105719694|NCT01285349|364631754|FG000|Overall Study|Lost to Follow-up|27|||
105719695|NCT01285349|364631755|FG001|Overall Study|Lost to Follow-up|20|||
105719696|NCT01285349|364631756|FG002|Overall Study|Lost to Follow-up|27|||
105719697|NCT00243659|364631757|FG000|Overall Study|Withdrawal by Subject|1|||
105719698|NCT00243659|364631758|FG001|Overall Study|Withdrawal by Subject|1|||
105719699|NCT00243659|364631757|FG000|Overall Study|Protocol Violation|1|||
105719700|NCT00243659|364631758|FG001|Overall Study|Protocol Violation|2|||
105719701|NCT03310970|364631759|FG000|Overall Study|Withdrawal by Subject|0|||
105719702|NCT03310970|364631760|FG001|Overall Study|Withdrawal by Subject|1|||
105719703|NCT01273064|364631761|FG000|Overall Study|Adverse Event|5|||
105719704|NCT01273064|364631762|FG001|Overall Study|Adverse Event|1|||
105719705|NCT01273064|364631763|FG002|Overall Study|Adverse Event|3|||
105719706|NCT01273064|364631764|FG003|Overall Study|Adverse Event|2|||
105719707|NCT01273064|364631765|FG004|Overall Study|Adverse Event|1|||
105719708|NCT01273064|364631761|FG000|Overall Study|Withdrawal by Subject|4|||
105719709|NCT01273064|364631762|FG001|Overall Study|Withdrawal by Subject|2|||
105719710|NCT01273064|364631763|FG002|Overall Study|Withdrawal by Subject|2|||
105719711|NCT01273064|364631764|FG003|Overall Study|Withdrawal by Subject|2|||
105719712|NCT01273064|364631765|FG004|Overall Study|Withdrawal by Subject|0|||
105719713|NCT01273064|364631761|FG000|Overall Study|Study Termination|13|||
105719714|NCT01273064|364631762|FG001|Overall Study|Study Termination|27|||
105719715|NCT01273064|364631763|FG002|Overall Study|Study Termination|26|||
105719716|NCT01273064|364631764|FG003|Overall Study|Study Termination|16|||
105719717|NCT01273064|364631765|FG004|Overall Study|Study Termination|8|||
105719718|NCT01273064|364631761|FG000|Overall Study|Lost to Follow-up|1|||
105719719|NCT01273064|364631762|FG001|Overall Study|Lost to Follow-up|0|||
105719720|NCT01273064|364631763|FG002|Overall Study|Lost to Follow-up|0|||
105719721|NCT01273064|364631764|FG003|Overall Study|Lost to Follow-up|0|||
105719722|NCT01273064|364631765|FG004|Overall Study|Lost to Follow-up|0|||
105719723|NCT01273064|364631761|FG000|Overall Study|Physician Decision|0|||
105719724|NCT01273064|364631762|FG001|Overall Study|Physician Decision|0|||
105719725|NCT01273064|364631763|FG002|Overall Study|Physician Decision|0|||
105719726|NCT01273064|364631764|FG003|Overall Study|Physician Decision|0|||
105719727|NCT01273064|364631765|FG004|Overall Study|Physician Decision|1|||
105791837|NCT00648739|364894295|FG001|Overall Study|Lack of Efficacy|0|||
105719728|NCT04666038|364631769|FG000|Overall Study|Progressive Disease|2|||
105719729|NCT04666038|364631770|FG001|Overall Study|Progressive Disease|0|||
105719730|NCT04666038|364631769|FG000|Overall Study|Death|38|||
105719731|NCT04666038|364631770|FG001|Overall Study|Death|32|||
105719732|NCT04666038|364631769|FG000|Overall Study|Withdrawal by Subject|10|||
105719733|NCT04666038|364631770|FG001|Overall Study|Withdrawal by Subject|19|||
105791838|NCT00648739|364894296|FG002|Overall Study|Lack of Efficacy|0|||
105791839|NCT00648739|364894297|FG003|Overall Study|Lack of Efficacy|0|||
105791840|NCT00648739|364894298|FG004|Overall Study|Lack of Efficacy|1|||
105791841|NCT00648739|364894299|FG005|Overall Study|Lack of Efficacy|2|||
105934599|NCT02533674|365421190|FG006|Dose Level I|Never Treated|0|||
105934600|NCT02533674|365421191|FG007|Dose Level I|Never Treated|0|||
105934601|NCT02533674|365421184|FG000|Dose Level II|Progressive disease|0|||
105934602|NCT02533674|365421185|FG001|Dose Level II|Progressive disease|3|||
105934603|NCT02533674|365421186|FG002|Dose Level II|Progressive disease|0|||
105934604|NCT02533674|365421187|FG003|Dose Level II|Progressive disease|0|||
105934605|NCT02533674|365421188|FG004|Dose Level II|Progressive disease|0|||
105934606|NCT02533674|365421189|FG005|Dose Level II|Progressive disease|0|||
105934607|NCT02533674|365421190|FG006|Dose Level II|Progressive disease|0|||
105934608|NCT02533674|365421191|FG007|Dose Level II|Progressive disease|0|||
105934609|NCT02533674|365421184|FG000|Dose Level II|Withdrawal by Subject|0|||
105934610|NCT02533674|365421185|FG001|Dose Level II|Withdrawal by Subject|1|||
105934611|NCT02533674|365421186|FG002|Dose Level II|Withdrawal by Subject|0|||
105934612|NCT02533674|365421187|FG003|Dose Level II|Withdrawal by Subject|0|||
105934613|NCT02533674|365421188|FG004|Dose Level II|Withdrawal by Subject|0|||
105934614|NCT02533674|365421189|FG005|Dose Level II|Withdrawal by Subject|0|||
105934615|NCT02533674|365421190|FG006|Dose Level II|Withdrawal by Subject|0|||
105934616|NCT02533674|365421191|FG007|Dose Level II|Withdrawal by Subject|0|||
105934617|NCT02533674|365421184|FG000|Dose Level II|Treatment-related AE|0|||
105934618|NCT02533674|365421185|FG001|Dose Level II|Treatment-related AE|1|||
105934619|NCT02533674|365421186|FG002|Dose Level II|Treatment-related AE|0|||
105934620|NCT02533674|365421187|FG003|Dose Level II|Treatment-related AE|0|||
105934621|NCT02533674|365421188|FG004|Dose Level II|Treatment-related AE|0|||
105934622|NCT02533674|365421189|FG005|Dose Level II|Treatment-related AE|0|||
105791842|NCT00648739|364894300|FG006|Overall Study|Lack of Efficacy|0|||
105934623|NCT02533674|365421190|FG006|Dose Level II|Treatment-related AE|0|||
105791843|NCT00648739|364894294|FG000|Overall Study|Investigator Considered it Advisable|0|||
105791844|NCT00648739|364894295|FG001|Overall Study|Investigator Considered it Advisable|0|||
105791845|NCT00648739|364894296|FG002|Overall Study|Investigator Considered it Advisable|0|||
105791846|NCT00648739|364894297|FG003|Overall Study|Investigator Considered it Advisable|0|||
105791847|NCT00648739|364894298|FG004|Overall Study|Investigator Considered it Advisable|0|||
105791848|NCT00648739|364894299|FG005|Overall Study|Investigator Considered it Advisable|1|||
105791849|NCT00648739|364894300|FG006|Overall Study|Investigator Considered it Advisable|1|||
105791850|NCT00648739|364894294|FG000|Overall Study|Death|0|||
105791851|NCT00648739|364894295|FG001|Overall Study|Death|1|||
105791852|NCT00648739|364894296|FG002|Overall Study|Death|0|||
105791853|NCT00648739|364894297|FG003|Overall Study|Death|0|||
105791854|NCT00648739|364894298|FG004|Overall Study|Death|0|||
105791855|NCT00648739|364894299|FG005|Overall Study|Death|0|||
105791856|NCT00648739|364894300|FG006|Overall Study|Death|0|||
105791857|NCT00648739|364894294|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
105791858|NCT00648739|364894295|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
105791859|NCT00648739|364894296|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
105791860|NCT00648739|364894297|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
105791861|NCT00648739|364894298|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
105791862|NCT00648739|364894299|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
105791863|NCT00648739|364894300|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
105791864|NCT00648739|364894294|FG000|Overall Study|Follow-up Visits Not Completed|0|||
105791865|NCT00648739|364894295|FG001|Overall Study|Follow-up Visits Not Completed|1|||
105791866|NCT00648739|364894296|FG002|Overall Study|Follow-up Visits Not Completed|0|||
105791867|NCT00648739|364894297|FG003|Overall Study|Follow-up Visits Not Completed|0|||
105791868|NCT00648739|364894298|FG004|Overall Study|Follow-up Visits Not Completed|0|||
105791869|NCT00648739|364894299|FG005|Overall Study|Follow-up Visits Not Completed|0|||
105791870|NCT00648739|364894300|FG006|Overall Study|Follow-up Visits Not Completed|0|||
105791871|NCT03387423|364894301|FG000|Overall Study|Lost to Follow-up|16|||
105791872|NCT03387423|364894302|FG001|Overall Study|Lost to Follow-up|12|||
105791873|NCT03387423|364894303|FG002|Overall Study|Lost to Follow-up|1|||
105791874|NCT03387423|364894304|FG003|Overall Study|Lost to Follow-up|0|||
105791875|NCT03387423|364894301|FG000|Overall Study|Other|0|||
105791876|NCT03387423|364894302|FG001|Overall Study|Other|3|||
105791877|NCT03387423|364894303|FG002|Overall Study|Other|0|||
105791878|NCT03387423|364894304|FG003|Overall Study|Other|0|||
105791879|NCT03387423|364894301|FG000|Overall Study|Administrative Reason|166|||
105791880|NCT03387423|364894302|FG001|Overall Study|Administrative Reason|89|||
105791881|NCT03387423|364894303|FG002|Overall Study|Administrative Reason|17|||
105791882|NCT03387423|364894304|FG003|Overall Study|Administrative Reason|19|||
105791883|NCT03387423|364894301|FG000|Overall Study|Revocation Consent|76|||
105791884|NCT03387423|364894302|FG001|Overall Study|Revocation Consent|32|||
105791885|NCT03387423|364894303|FG002|Overall Study|Revocation Consent|3|||
105791886|NCT03387423|364894304|FG003|Overall Study|Revocation Consent|5|||
105791887|NCT01371006|364894305|FG000|Overall Study|Adverse Event|1|||
105791888|NCT01371006|364894306|FG001|Overall Study|Adverse Event|0|||
105791889|NCT02856282|364894307|FG000|Overall Study|Withdrawal by Subject|1|||
105791890|NCT02074982|364894308|FG000|Overall Study|Adverse Event|15|||
105791891|NCT02074982|364894309|FG001|Overall Study|Adverse Event|7|||
105791892|NCT02074982|364894308|FG000|Overall Study|Lack of Efficacy|6|||
105791893|NCT02074982|364894309|FG001|Overall Study|Lack of Efficacy|1|||
105791894|NCT02074982|364894308|FG000|Overall Study|Lost to Follow-up|9|||
105934624|NCT02533674|365421191|FG007|Dose Level II|Treatment-related AE|0|||
105934625|NCT02533674|365421184|FG000|Dose Level II|Physician Decision|0|||
105934626|NCT02533674|365421185|FG001|Dose Level II|Physician Decision|1|||
105934627|NCT02533674|365421186|FG002|Dose Level II|Physician Decision|0|||
105934628|NCT02533674|365421187|FG003|Dose Level II|Physician Decision|0|||
105934629|NCT02533674|365421188|FG004|Dose Level II|Physician Decision|0|||
105791895|NCT02074982|364894309|FG001|Overall Study|Lost to Follow-up|10|||
105791896|NCT02074982|364894308|FG000|Overall Study|Non-compliance with study treatment|0|||
105791897|NCT02074982|364894309|FG001|Overall Study|Non-compliance with study treatment|2|||
105791898|NCT02074982|364894308|FG000|Overall Study|Physician Decision|1|||
105791899|NCT02074982|364894309|FG001|Overall Study|Physician Decision|1|||
105791900|NCT02074982|364894308|FG000|Overall Study|Pregnancy|1|||
105791901|NCT02074982|364894309|FG001|Overall Study|Pregnancy|2|||
105934630|NCT02533674|365421189|FG005|Dose Level II|Physician Decision|0|||
105934631|NCT02533674|365421190|FG006|Dose Level II|Physician Decision|0|||
105934632|NCT02533674|365421191|FG007|Dose Level II|Physician Decision|0|||
105934633|NCT02533674|365421184|FG000|Dose Level II|Non-treatment-related AE|0|||
105934634|NCT02533674|365421185|FG001|Dose Level II|Non-treatment-related AE|1|||
105934635|NCT02533674|365421186|FG002|Dose Level II|Non-treatment-related AE|0|||
105791902|NCT02074982|364894308|FG000|Overall Study|Protocol deviation|4|||
105791903|NCT02074982|364894309|FG001|Overall Study|Protocol deviation|3|||
105791904|NCT02074982|364894308|FG000|Overall Study|Technical problems|0|||
105791905|NCT02074982|364894309|FG001|Overall Study|Technical problems|2|||
105791906|NCT02074982|364894308|FG000|Overall Study|Subject/guardian decision|15|||
105934636|NCT02533674|365421187|FG003|Dose Level II|Non-treatment-related AE|0|||
105719734|NCT04666038|364631769|FG000|Overall Study|Lost to Follow-up|0|||
105719735|NCT04666038|364631770|FG001|Overall Study|Lost to Follow-up|2|||
105719736|NCT04666038|364631769|FG000|Overall Study|On Study Treatment|46|||
105719737|NCT04666038|364631770|FG001|Overall Study|On Study Treatment|5|||
105719738|NCT04666038|364631769|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
105719739|NCT04666038|364631770|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
105719740|NCT03595280|364631774|FG000|Overall Study|Lost to Follow-up|6|||
105719741|NCT03595280|364631775|FG001|Overall Study|Lost to Follow-up|9|||
105719742|NCT03595280|364631776|FG002|Overall Study|Lost to Follow-up|15|||
105719743|NCT02658812|364631777|FG000|Overall Study|Disease Progression|7|||
105719744|NCT02658812|364631777|FG000|Overall Study|Unrelated to study treatment|1|||
105719745|NCT02658812|364631777|FG000|Overall Study|Adverse Event|1|||
105719746|NCT01818297|364631778|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
105719747|NCT01818297|364631779|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
105719748|NCT01818297|364631778|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
105719749|NCT01818297|364631779|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
105719750|NCT01818297|364631778|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
105719751|NCT01818297|364631779|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
105719752|NCT01512264|364631780|FG000|Overall Study|Lost to Follow-up|0|||
105719753|NCT01512264|364631781|FG001|Overall Study|Lost to Follow-up|0|||
105719754|NCT01512264|364631782|FG002|Overall Study|Lost to Follow-up|0|||
105719755|NCT01512264|364631783|FG003|Overall Study|Lost to Follow-up|1|||
105719756|NCT01194440|364631784|FG000|Baseline (First Dose)|Reason not specified|4|||
105719757|NCT01194440|364631784|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
105719758|NCT01194440|364631784|FG000|Baseline (First Dose)|Change in therapy|1|||
105719759|NCT01194440|364631784|FG000|Baseline (First Dose)|Adverse Event|1|||
105719760|NCT01194440|364631784|FG000|6-months (2nd Dose)|Change in therapy|4|||
105719761|NCT00584870|364631785|FG000|Overall Study|Adverse Event|4|||
105719762|NCT00584870|364631786|FG001|Overall Study|Adverse Event|3|||
105719763|NCT00584870|364631787|FG002|Overall Study|Adverse Event|2|||
105719764|NCT00584870|364631785|FG000|Overall Study|Lost to Follow-up|4|||
105719765|NCT00584870|364631786|FG001|Overall Study|Lost to Follow-up|1|||
105719766|NCT00584870|364631787|FG002|Overall Study|Lost to Follow-up|1|||
105719767|NCT00584870|364631785|FG000|Overall Study|Lack of Efficacy|7|||
105719768|NCT00584870|364631786|FG001|Overall Study|Lack of Efficacy|14|||
105719769|NCT00584870|364631787|FG002|Overall Study|Lack of Efficacy|8|||
105719770|NCT00584870|364631785|FG000|Overall Study|Withdrawal by Subject|10|||
105719771|NCT00584870|364631786|FG001|Overall Study|Withdrawal by Subject|5|||
105719772|NCT00584870|364631787|FG002|Overall Study|Withdrawal by Subject|3|||
105719773|NCT00584870|364631785|FG000|Overall Study|Protocol Violation|1|||
105719774|NCT00584870|364631786|FG001|Overall Study|Protocol Violation|1|||
105719775|NCT00584870|364631787|FG002|Overall Study|Protocol Violation|2|||
105719776|NCT00584870|364631785|FG000|Overall Study|Did not met entrance criteria|1|||
105719777|NCT00584870|364631786|FG001|Overall Study|Did not met entrance criteria|0|||
105719778|NCT00584870|364631787|FG002|Overall Study|Did not met entrance criteria|0|||
105719779|NCT00584870|364631785|FG000|Overall Study|Other|2|||
105719780|NCT00584870|364631786|FG001|Overall Study|Other|0|||
105719781|NCT00584870|364631787|FG002|Overall Study|Other|0|||
105719782|NCT00584870|364631785|FG000|Overall Study|Randomized but not treated|0|||
105719783|NCT00584870|364631786|FG001|Overall Study|Randomized but not treated|1|||
105719784|NCT00584870|364631787|FG002|Overall Study|Randomized but not treated|2|||
105719785|NCT00854828|364631788|FG000|Overall Study|Death|1|||
105719786|NCT00854828|364631789|FG001|Overall Study|Death|0|||
105719787|NCT00854828|364631790|FG002|Overall Study|Death|0|||
105719788|NCT00854828|364631791|FG003|Overall Study|Death|0|||
105719789|NCT00854828|364631788|FG000|Overall Study|Withdrawal by Subject|1|||
105719790|NCT00854828|364631789|FG001|Overall Study|Withdrawal by Subject|1|||
105719791|NCT00854828|364631790|FG002|Overall Study|Withdrawal by Subject|0|||
105719792|NCT00854828|364631791|FG003|Overall Study|Withdrawal by Subject|9|||
105719793|NCT00854828|364631788|FG000|Overall Study|Missed 24mo visit|1|||
105719794|NCT00854828|364631789|FG001|Overall Study|Missed 24mo visit|1|||
105719795|NCT00854828|364631790|FG002|Overall Study|Missed 24mo visit|8|||
105719796|NCT00854828|364631791|FG003|Overall Study|Missed 24mo visit|8|||
105719797|NCT04957290|364631793|FG000|Overall Study|Progressive disease|3|||
105719798|NCT04957290|364631794|FG001|Overall Study|Progressive disease|3|||
106009156|NCT05138653|365699081|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
106009157|NCT05138653|365699082|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105719799|NCT04957290|364631795|FG002|Overall Study|Progressive disease|2|||
105719800|NCT04957290|364631796|FG003|Overall Study|Progressive disease|0|||
105719801|NCT04957290|364631797|FG004|Overall Study|Progressive disease|0|||
105719802|NCT04957290|364631798|FG005|Overall Study|Progressive disease|0|||
105719803|NCT04957290|364631793|FG000|Overall Study|Withdrawal by Subject|1|||
105719804|NCT04957290|364631794|FG001|Overall Study|Withdrawal by Subject|0|||
105719805|NCT04957290|364631795|FG002|Overall Study|Withdrawal by Subject|1|||
105719806|NCT04957290|364631796|FG003|Overall Study|Withdrawal by Subject|0|||
105719807|NCT04957290|364631797|FG004|Overall Study|Withdrawal by Subject|0|||
105719808|NCT04957290|364631798|FG005|Overall Study|Withdrawal by Subject|0|||
105719809|NCT04957290|364631793|FG000|Overall Study|Death|0|||
105719810|NCT04957290|364631794|FG001|Overall Study|Death|2|||
105719811|NCT04957290|364631795|FG002|Overall Study|Death|1|||
105719812|NCT04957290|364631796|FG003|Overall Study|Death|0|||
105719813|NCT04957290|364631797|FG004|Overall Study|Death|0|||
105719814|NCT04957290|364631798|FG005|Overall Study|Death|0|||
105719815|NCT04957290|364631793|FG000|Overall Study|non compliance with study drug|0|||
105719816|NCT04957290|364631794|FG001|Overall Study|non compliance with study drug|1|||
105934637|NCT02533674|365421188|FG004|Dose Level II|Non-treatment-related AE|0|||
105934638|NCT02533674|365421189|FG005|Dose Level II|Non-treatment-related AE|0|||
105934639|NCT02533674|365421190|FG006|Dose Level II|Non-treatment-related AE|0|||
105934640|NCT02533674|365421191|FG007|Dose Level II|Non-treatment-related AE|0|||
105934641|NCT02533674|365421184|FG000|Dose Level III|Progressive disease|0|||
105934642|NCT02533674|365421185|FG001|Dose Level III|Progressive disease|0|||
105934643|NCT02533674|365421186|FG002|Dose Level III|Progressive disease|2|||
105934644|NCT02533674|365421187|FG003|Dose Level III|Progressive disease|0|||
105934645|NCT02533674|365421188|FG004|Dose Level III|Progressive disease|0|||
105934646|NCT02533674|365421189|FG005|Dose Level III|Progressive disease|0|||
105934647|NCT02533674|365421190|FG006|Dose Level III|Progressive disease|0|||
105934648|NCT02533674|365421191|FG007|Dose Level III|Progressive disease|0|||
105934649|NCT02533674|365421184|FG000|Dose Level III|Withdrawal by Subject|0|||
105934650|NCT02533674|365421185|FG001|Dose Level III|Withdrawal by Subject|0|||
105934651|NCT02533674|365421186|FG002|Dose Level III|Withdrawal by Subject|1|||
105934652|NCT02533674|365421187|FG003|Dose Level III|Withdrawal by Subject|0|||
105934653|NCT02533674|365421188|FG004|Dose Level III|Withdrawal by Subject|0|||
105934654|NCT02533674|365421189|FG005|Dose Level III|Withdrawal by Subject|0|||
105934655|NCT02533674|365421190|FG006|Dose Level III|Withdrawal by Subject|0|||
105934656|NCT02533674|365421191|FG007|Dose Level III|Withdrawal by Subject|0|||
105934657|NCT02533674|365421184|FG000|Dose Level III|Treatment-related AE|0|||
105934658|NCT02533674|365421185|FG001|Dose Level III|Treatment-related AE|0|||
105934659|NCT02533674|365421186|FG002|Dose Level III|Treatment-related AE|1|||
105934660|NCT02533674|365421187|FG003|Dose Level III|Treatment-related AE|0|||
105934661|NCT02533674|365421188|FG004|Dose Level III|Treatment-related AE|0|||
105934662|NCT02533674|365421189|FG005|Dose Level III|Treatment-related AE|0|||
105934663|NCT02533674|365421190|FG006|Dose Level III|Treatment-related AE|0|||
105934664|NCT02533674|365421191|FG007|Dose Level III|Treatment-related AE|0|||
105934665|NCT02533674|365421184|FG000|Dose Level IV|Progressive disease|0|||
105934666|NCT02533674|365421185|FG001|Dose Level IV|Progressive disease|0|||
105934667|NCT02533674|365421186|FG002|Dose Level IV|Progressive disease|0|||
105934668|NCT02533674|365421187|FG003|Dose Level IV|Progressive disease|3|||
105934669|NCT02533674|365421188|FG004|Dose Level IV|Progressive disease|0|||
105934670|NCT02533674|365421189|FG005|Dose Level IV|Progressive disease|0|||
105934671|NCT02533674|365421190|FG006|Dose Level IV|Progressive disease|0|||
105934672|NCT02533674|365421191|FG007|Dose Level IV|Progressive disease|0|||
105934673|NCT02533674|365421184|FG000|Dose Level IV|Withdrawal by Subject|0|||
105934674|NCT02533674|365421185|FG001|Dose Level IV|Withdrawal by Subject|0|||
105934675|NCT02533674|365421186|FG002|Dose Level IV|Withdrawal by Subject|0|||
105934676|NCT02533674|365421187|FG003|Dose Level IV|Withdrawal by Subject|1|||
105934677|NCT02533674|365421188|FG004|Dose Level IV|Withdrawal by Subject|0|||
105934678|NCT02533674|365421189|FG005|Dose Level IV|Withdrawal by Subject|0|||
105934679|NCT02533674|365421190|FG006|Dose Level IV|Withdrawal by Subject|0|||
105934680|NCT02533674|365421191|FG007|Dose Level IV|Withdrawal by Subject|0|||
105934681|NCT02533674|365421184|FG000|Dose Level IV|Physician Decision|0|||
105934682|NCT02533674|365421185|FG001|Dose Level IV|Physician Decision|0|||
105934683|NCT02533674|365421186|FG002|Dose Level IV|Physician Decision|0|||
105934684|NCT02533674|365421187|FG003|Dose Level IV|Physician Decision|1|||
105934685|NCT02533674|365421188|FG004|Dose Level IV|Physician Decision|0|||
105934686|NCT02533674|365421189|FG005|Dose Level IV|Physician Decision|0|||
105934687|NCT02533674|365421190|FG006|Dose Level IV|Physician Decision|0|||
105934688|NCT02533674|365421191|FG007|Dose Level IV|Physician Decision|0|||
105934689|NCT02533674|365421184|FG000|Dose Level V|Progressive disease|0|||
105719817|NCT04957290|364631795|FG002|Overall Study|non compliance with study drug|0|||
105934690|NCT02533674|365421185|FG001|Dose Level V|Progressive disease|0|||
105719818|NCT04957290|364631796|FG003|Overall Study|non compliance with study drug|0|||
105934691|NCT02533674|365421186|FG002|Dose Level V|Progressive disease|0|||
105934692|NCT02533674|365421187|FG003|Dose Level V|Progressive disease|0|||
105934693|NCT02533674|365421188|FG004|Dose Level V|Progressive disease|3|||
105934694|NCT02533674|365421189|FG005|Dose Level V|Progressive disease|0|||
105934695|NCT02533674|365421190|FG006|Dose Level V|Progressive disease|0|||
105934696|NCT02533674|365421191|FG007|Dose Level V|Progressive disease|0|||
105719819|NCT04957290|364631797|FG004|Overall Study|non compliance with study drug|0|||
105719820|NCT04957290|364631798|FG005|Overall Study|non compliance with study drug|0|||
105719821|NCT04957290|364631793|FG000|Overall Study|none specified.|0|||
105934697|NCT02533674|365421184|FG000|Dose Level V|Withdrawal by Subject|0|||
105934698|NCT02533674|365421185|FG001|Dose Level V|Withdrawal by Subject|0|||
105934699|NCT02533674|365421186|FG002|Dose Level V|Withdrawal by Subject|0|||
105934700|NCT02533674|365421187|FG003|Dose Level V|Withdrawal by Subject|0|||
106137064|NCT02163915|366160357|FG004|Overall Study|Physician Decision|0|||
105934701|NCT02533674|365421188|FG004|Dose Level V|Withdrawal by Subject|1|||
105934702|NCT02533674|365421189|FG005|Dose Level V|Withdrawal by Subject|0|||
105934703|NCT02533674|365421190|FG006|Dose Level V|Withdrawal by Subject|0|||
105934704|NCT02533674|365421191|FG007|Dose Level V|Withdrawal by Subject|0|||
105719822|NCT04957290|364631794|FG001|Overall Study|none specified.|1|||
105719823|NCT04957290|364631795|FG002|Overall Study|none specified.|2|||
105719824|NCT04957290|364631796|FG003|Overall Study|none specified.|0|||
105934705|NCT02533674|365421184|FG000|Dose Level V|Physician Decision|0|||
105934706|NCT02533674|365421185|FG001|Dose Level V|Physician Decision|0|||
105934707|NCT02533674|365421186|FG002|Dose Level V|Physician Decision|0|||
105934708|NCT02533674|365421187|FG003|Dose Level V|Physician Decision|0|||
105934709|NCT02533674|365421188|FG004|Dose Level V|Physician Decision|1|||
105934710|NCT02533674|365421189|FG005|Dose Level V|Physician Decision|0|||
105934711|NCT02533674|365421190|FG006|Dose Level V|Physician Decision|0|||
105934712|NCT02533674|365421191|FG007|Dose Level V|Physician Decision|0|||
105934713|NCT02533674|365421184|FG000|Dose Level VI|Progressive disease|0|||
105934714|NCT02533674|365421185|FG001|Dose Level VI|Progressive disease|0|||
105934715|NCT02533674|365421186|FG002|Dose Level VI|Progressive disease|0|||
105934716|NCT02533674|365421187|FG003|Dose Level VI|Progressive disease|0|||
105934717|NCT02533674|365421188|FG004|Dose Level VI|Progressive disease|0|||
105934718|NCT02533674|365421189|FG005|Dose Level VI|Progressive disease|7|||
105934719|NCT02533674|365421190|FG006|Dose Level VI|Progressive disease|0|||
105934720|NCT02533674|365421191|FG007|Dose Level VI|Progressive disease|0|||
105934721|NCT02533674|365421184|FG000|Dose Level VI|Withdrawal by Subject|0|||
105934722|NCT02533674|365421185|FG001|Dose Level VI|Withdrawal by Subject|0|||
105934723|NCT02533674|365421186|FG002|Dose Level VI|Withdrawal by Subject|0|||
105934724|NCT02533674|365421187|FG003|Dose Level VI|Withdrawal by Subject|0|||
105934725|NCT02533674|365421188|FG004|Dose Level VI|Withdrawal by Subject|0|||
105934726|NCT02533674|365421189|FG005|Dose Level VI|Withdrawal by Subject|1|||
105934727|NCT02533674|365421190|FG006|Dose Level VI|Withdrawal by Subject|0|||
105934728|NCT02533674|365421191|FG007|Dose Level VI|Withdrawal by Subject|0|||
105934729|NCT02533674|365421184|FG000|Dose Level VI|Treatment-related AE|0|||
105934730|NCT02533674|365421185|FG001|Dose Level VI|Treatment-related AE|0|||
105934731|NCT02533674|365421186|FG002|Dose Level VI|Treatment-related AE|0|||
105934732|NCT02533674|365421187|FG003|Dose Level VI|Treatment-related AE|0|||
105934733|NCT02533674|365421188|FG004|Dose Level VI|Treatment-related AE|0|||
105934734|NCT02533674|365421189|FG005|Dose Level VI|Treatment-related AE|1|||
105934735|NCT02533674|365421190|FG006|Dose Level VI|Treatment-related AE|0|||
105934736|NCT02533674|365421191|FG007|Dose Level VI|Treatment-related AE|0|||
105934737|NCT02533674|365421184|FG000|Dose Level VII|Progressive disease|0|||
105934738|NCT02533674|365421185|FG001|Dose Level VII|Progressive disease|0|||
105934739|NCT02533674|365421186|FG002|Dose Level VII|Progressive disease|0|||
105934740|NCT02533674|365421187|FG003|Dose Level VII|Progressive disease|0|||
105934741|NCT02533674|365421188|FG004|Dose Level VII|Progressive disease|0|||
105934742|NCT02533674|365421189|FG005|Dose Level VII|Progressive disease|0|||
105934743|NCT02533674|365421190|FG006|Dose Level VII|Progressive disease|10|||
105934744|NCT02533674|365421191|FG007|Dose Level VII|Progressive disease|0|||
105934745|NCT02533674|365421184|FG000|Dose Level VII|Withdrawal by Subject|0|||
105934746|NCT02533674|365421185|FG001|Dose Level VII|Withdrawal by Subject|0|||
105934747|NCT02533674|365421186|FG002|Dose Level VII|Withdrawal by Subject|0|||
105934748|NCT02533674|365421187|FG003|Dose Level VII|Withdrawal by Subject|0|||
105934749|NCT02533674|365421188|FG004|Dose Level VII|Withdrawal by Subject|0|||
105934750|NCT02533674|365421189|FG005|Dose Level VII|Withdrawal by Subject|0|||
105934751|NCT02533674|365421190|FG006|Dose Level VII|Withdrawal by Subject|3|||
105934752|NCT02533674|365421191|FG007|Dose Level VII|Withdrawal by Subject|0|||
105934753|NCT02533674|365421184|FG000|Dose Level VII|Treatment-related AE|0|||
105934754|NCT02533674|365421185|FG001|Dose Level VII|Treatment-related AE|0|||
105934755|NCT02533674|365421186|FG002|Dose Level VII|Treatment-related AE|0|||
105934756|NCT02533674|365421187|FG003|Dose Level VII|Treatment-related AE|0|||
105934757|NCT02533674|365421188|FG004|Dose Level VII|Treatment-related AE|0|||
105934758|NCT02533674|365421189|FG005|Dose Level VII|Treatment-related AE|0|||
105934759|NCT02533674|365421190|FG006|Dose Level VII|Treatment-related AE|1|||
105719825|NCT04957290|364631797|FG004|Overall Study|none specified.|0|||
105719826|NCT04957290|364631798|FG005|Overall Study|none specified.|0|||
105719827|NCT04957290|364631793|FG000|Overall Study|unacceptable toxicity|0|||
105719828|NCT04957290|364631794|FG001|Overall Study|unacceptable toxicity|0|||
105791907|NCT02074982|364894309|FG001|Overall Study|Subject/guardian decision|24|||
105934760|NCT02533674|365421191|FG007|Dose Level VII|Treatment-related AE|0|||
105934761|NCT02533674|365421184|FG000|Dose Level VII|Death|0|||
105934762|NCT02533674|365421185|FG001|Dose Level VII|Death|0|||
105934763|NCT02533674|365421186|FG002|Dose Level VII|Death|0|||
105934764|NCT02533674|365421187|FG003|Dose Level VII|Death|0|||
105934765|NCT02533674|365421188|FG004|Dose Level VII|Death|0|||
105719829|NCT04957290|364631795|FG002|Overall Study|unacceptable toxicity|1|||
105791908|NCT02074982|364894308|FG000|Overall Study|Death|0|||
105934766|NCT02533674|365421189|FG005|Dose Level VII|Death|0|||
105791909|NCT02074982|364894309|FG001|Overall Study|Death|2|||
105791910|NCT01819467|364894310|FG000|Overall Study|Physician Decision|20|||
105791911|NCT01819467|364894311|FG001|Overall Study|Physician Decision|9|||
105791912|NCT03256526|364894312|FG000|Overall Study|Adverse Event|1|||
105791913|NCT03256526|364894313|FG001|Overall Study|Adverse Event|0|||
105791914|NCT03256526|364894314|FG002|Overall Study|Adverse Event|1|||
105791915|NCT03256526|364894312|FG000|Overall Study|Lost to Follow-up|1|||
105791916|NCT03256526|364894313|FG001|Overall Study|Lost to Follow-up|0|||
105791917|NCT03256526|364894314|FG002|Overall Study|Lost to Follow-up|2|||
105791918|NCT03533608|364894317|FG000|Overall Study|Withdrawal by Subject|3|||
105791919|NCT03533608|364894317|FG000|Overall Study|Physician Decision|2|||
105791920|NCT02325401|364894322|FG000|Overall Study|Withdrawal by Subject|0|||
105791921|NCT02325401|364894323|FG001|Overall Study|Withdrawal by Subject|1|||
105791922|NCT02325401|364894324|FG002|Overall Study|Withdrawal by Subject|1|||
105791923|NCT01817764|364894325|FG000|Overall Study|Adverse Event|7|||
105791924|NCT01817764|364894326|FG001|Overall Study|Adverse Event|10|||
105791925|NCT01817764|364894325|FG000|Overall Study|Lack of Efficacy|9|||
105791926|NCT01817764|364894326|FG001|Overall Study|Lack of Efficacy|7|||
105791927|NCT01817764|364894325|FG000|Overall Study|Protocol Violation|7|||
105791928|NCT01817764|364894326|FG001|Overall Study|Protocol Violation|5|||
105791929|NCT01817764|364894325|FG000|Overall Study|Lost to Follow-up|1|||
105791930|NCT01817764|364894326|FG001|Overall Study|Lost to Follow-up|4|||
105791931|NCT01817764|364894325|FG000|Overall Study|Withdrawal by Subject|10|||
105791932|NCT01817764|364894326|FG001|Overall Study|Withdrawal by Subject|12|||
105791933|NCT03514121|364894327|FG000|Overall Study|Withdrawal by Subject|0|||
105791934|NCT03514121|364894328|FG001|Overall Study|Withdrawal by Subject|0|||
105791935|NCT03514121|364894329|FG002|Overall Study|Withdrawal by Subject|0|||
105791936|NCT03514121|364894330|FG003|Overall Study|Withdrawal by Subject|0|||
105719830|NCT04957290|364631796|FG003|Overall Study|unacceptable toxicity|0|||
105719831|NCT04957290|364631797|FG004|Overall Study|unacceptable toxicity|0|||
105719832|NCT04957290|364631798|FG005|Overall Study|unacceptable toxicity|0|||
105719833|NCT04957290|364631793|FG000|Overall Study|Adverse Event|0|||
105719834|NCT04957290|364631794|FG001|Overall Study|Adverse Event|0|||
105719835|NCT04957290|364631795|FG002|Overall Study|Adverse Event|1|||
105719836|NCT04957290|364631796|FG003|Overall Study|Adverse Event|0|||
105719837|NCT04957290|364631797|FG004|Overall Study|Adverse Event|0|||
105719838|NCT04957290|364631798|FG005|Overall Study|Adverse Event|0|||
105719839|NCT04957290|364631793|FG000|Overall Study|study terminated by sponsor|0|||
105719840|NCT04957290|364631794|FG001|Overall Study|study terminated by sponsor|0|||
105719841|NCT04957290|364631795|FG002|Overall Study|study terminated by sponsor|2|||
105719842|NCT04957290|364631796|FG003|Overall Study|study terminated by sponsor|0|||
105719843|NCT04957290|364631797|FG004|Overall Study|study terminated by sponsor|0|||
105719844|NCT04957290|364631798|FG005|Overall Study|study terminated by sponsor|0|||
105719845|NCT03682120|364631799|FG000|Overall Study|Lost to Follow-up|11|||
105719846|NCT03682120|364631800|FG001|Overall Study|Lost to Follow-up|4|||
105719847|NCT03682120|364631801|FG002|Overall Study|Lost to Follow-up|5|||
105719848|NCT03682120|364631802|FG003|Overall Study|Lost to Follow-up|2|||
105719849|NCT03682120|364631799|FG000|Overall Study|Physician Decision|1|||
105719850|NCT03682120|364631800|FG001|Overall Study|Physician Decision|0|||
105719851|NCT03682120|364631801|FG002|Overall Study|Physician Decision|0|||
105719852|NCT03682120|364631802|FG003|Overall Study|Physician Decision|0|||
105719853|NCT03682120|364631799|FG000|Overall Study|Withdrawal by Subject|1|||
105719854|NCT03682120|364631800|FG001|Overall Study|Withdrawal by Subject|2|||
105719855|NCT03682120|364631801|FG002|Overall Study|Withdrawal by Subject|3|||
105719856|NCT03682120|364631802|FG003|Overall Study|Withdrawal by Subject|0|||
105719857|NCT03682120|364631799|FG000|Overall Study|Death|0|||
105719858|NCT03682120|364631800|FG001|Overall Study|Death|1|||
105791937|NCT03514121|364894331|FG004|Overall Study|Withdrawal by Subject|1|||
105791938|NCT03514121|364894332|FG005|Overall Study|Withdrawal by Subject|2|||
105791939|NCT03514121|364894333|FG006|Overall Study|Withdrawal by Subject|1|||
105791940|NCT03514121|364894334|FG007|Overall Study|Withdrawal by Subject|1|||
105719859|NCT03682120|364631801|FG002|Overall Study|Death|0|||
105719860|NCT03682120|364631802|FG003|Overall Study|Death|0|||
105719861|NCT03682120|364631799|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
105791941|NCT03514121|364894335|FG008|Overall Study|Withdrawal by Subject|7|||
105791942|NCT03514121|364894336|FG009|Overall Study|Withdrawal by Subject|2|||
105791943|NCT03514121|364894327|FG000|Overall Study|Death|0|||
105791944|NCT03514121|364894328|FG001|Overall Study|Death|0|||
105719862|NCT03682120|364631800|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
105719863|NCT03682120|364631801|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
105719864|NCT03682120|364631802|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
105719865|NCT03158220|364631803|FG000|Overall Study|Screen Failure|0|||
105791945|NCT03514121|364894329|FG002|Overall Study|Death|0|||
105791946|NCT03514121|364894330|FG003|Overall Study|Death|0|||
105791947|NCT03514121|364894331|FG004|Overall Study|Death|0|||
105791948|NCT03514121|364894332|FG005|Overall Study|Death|3|||
105791949|NCT03514121|364894333|FG006|Overall Study|Death|2|||
105791950|NCT03514121|364894334|FG007|Overall Study|Death|1|||
105791951|NCT03514121|364894335|FG008|Overall Study|Death|26|||
105791952|NCT03514121|364894336|FG009|Overall Study|Death|3|||
105791953|NCT03514121|364894327|FG000|Overall Study|Lost to Follow-up|0|||
105791954|NCT03514121|364894328|FG001|Overall Study|Lost to Follow-up|0|||
105791955|NCT03514121|364894329|FG002|Overall Study|Lost to Follow-up|1|||
105791956|NCT03514121|364894330|FG003|Overall Study|Lost to Follow-up|0|||
105791957|NCT03514121|364894331|FG004|Overall Study|Lost to Follow-up|0|||
105791958|NCT03514121|364894332|FG005|Overall Study|Lost to Follow-up|0|||
105791959|NCT03514121|364894333|FG006|Overall Study|Lost to Follow-up|0|||
105791960|NCT03514121|364894334|FG007|Overall Study|Lost to Follow-up|0|||
105791961|NCT03514121|364894335|FG008|Overall Study|Lost to Follow-up|1|||
105791962|NCT03514121|364894336|FG009|Overall Study|Lost to Follow-up|0|||
105791963|NCT03514121|364894327|FG000|Overall Study|Adverse Event|0|||
105791964|NCT03514121|364894328|FG001|Overall Study|Adverse Event|0|||
105791965|NCT03514121|364894329|FG002|Overall Study|Adverse Event|0|||
105791966|NCT03514121|364894330|FG003|Overall Study|Adverse Event|0|||
105791967|NCT03514121|364894331|FG004|Overall Study|Adverse Event|0|||
105791968|NCT03514121|364894332|FG005|Overall Study|Adverse Event|0|||
105791969|NCT03514121|364894333|FG006|Overall Study|Adverse Event|1|||
105791970|NCT03514121|364894334|FG007|Overall Study|Adverse Event|0|||
105791971|NCT03514121|364894335|FG008|Overall Study|Adverse Event|0|||
105791972|NCT03514121|364894336|FG009|Overall Study|Adverse Event|0|||
105791973|NCT03514121|364894327|FG000|Overall Study|Other|0|||
105791974|NCT03514121|364894328|FG001|Overall Study|Other|1|||
105791975|NCT03514121|364894329|FG002|Overall Study|Other|1|||
105791976|NCT03514121|364894330|FG003|Overall Study|Other|0|||
105791977|NCT03514121|364894331|FG004|Overall Study|Other|1|||
105791978|NCT03514121|364894332|FG005|Overall Study|Other|2|||
105791979|NCT03514121|364894333|FG006|Overall Study|Other|3|||
105791980|NCT03514121|364894334|FG007|Overall Study|Other|2|||
105791981|NCT03514121|364894335|FG008|Overall Study|Other|7|||
105791982|NCT03514121|364894336|FG009|Overall Study|Other|3|||
105791983|NCT03514121|364894327|FG000|Overall Study|Study termination by Sponsor|0|||
105791984|NCT03514121|364894328|FG001|Overall Study|Study termination by Sponsor|0|||
105791985|NCT03514121|364894329|FG002|Overall Study|Study termination by Sponsor|0|||
105791986|NCT03514121|364894330|FG003|Overall Study|Study termination by Sponsor|0|||
105719866|NCT03158220|364631804|FG001|Overall Study|Screen Failure|1|||
105719867|NCT03158220|364631803|FG000|Overall Study|Withdrawal by Subject|8|||
105934767|NCT02533674|365421190|FG006|Dose Level VII|Death|2|||
105934768|NCT02533674|365421191|FG007|Dose Level VII|Death|0|||
105934769|NCT02533674|365421184|FG000|Dose Level VIII|Progressive disease|0|||
105934770|NCT02533674|365421185|FG001|Dose Level VIII|Progressive disease|0|||
105934771|NCT02533674|365421186|FG002|Dose Level VIII|Progressive disease|0|||
105934772|NCT02533674|365421187|FG003|Dose Level VIII|Progressive disease|0|||
105934773|NCT02533674|365421188|FG004|Dose Level VIII|Progressive disease|0|||
105934774|NCT02533674|365421189|FG005|Dose Level VIII|Progressive disease|0|||
105934775|NCT02533674|365421190|FG006|Dose Level VIII|Progressive disease|0|||
105934776|NCT02533674|365421191|FG007|Dose Level VIII|Progressive disease|3|||
105719868|NCT03158220|364631804|FG001|Overall Study|Withdrawal by Subject|9|||
105719869|NCT03158220|364631803|FG000|Overall Study|Status unknown|0|||
105934777|NCT02533674|365421184|FG000|Dose Level VIII|Withdrawal by Subject|0|||
105934778|NCT02533674|365421185|FG001|Dose Level VIII|Withdrawal by Subject|0|||
105934779|NCT02533674|365421186|FG002|Dose Level VIII|Withdrawal by Subject|0|||
105719870|NCT03158220|364631804|FG001|Overall Study|Status unknown|1|||
105719871|NCT03158220|364631803|FG000|Overall Study|Lost to Follow-up|8|||
105719872|NCT03158220|364631804|FG001|Overall Study|Lost to Follow-up|5|||
105719873|NCT03158220|364631803|FG000|Overall Study|Physician Decision|1|||
105719874|NCT03158220|364631804|FG001|Overall Study|Physician Decision|0|||
105719875|NCT00996203|364631805|FG000|Overall Study|Adverse Event|3|||
105719876|NCT00996203|364631805|FG000|Overall Study|Lost to Follow-up|1|||
105719877|NCT00996203|364631805|FG000|Overall Study|Lack of Efficacy|1|||
105719878|NCT00996203|364631805|FG000|Overall Study|Protocol Violation|2|||
105719879|NCT03308188|364631806|FG000|Overall Study|Withdrawal by Subject|0|||
105719880|NCT03308188|364631807|FG001|Overall Study|Withdrawal by Subject|3|||
105719881|NCT03308188|364631806|FG000|Overall Study|Death|0|||
105719882|NCT03308188|364631807|FG001|Overall Study|Death|1|||
105719883|NCT01791855|364631808|FG000|Overall Study|Adverse Event|0|||
105791987|NCT03514121|364894331|FG004|Overall Study|Study termination by Sponsor|0|||
105791988|NCT03514121|364894332|FG005|Overall Study|Study termination by Sponsor|0|||
105934780|NCT02533674|365421187|FG003|Dose Level VIII|Withdrawal by Subject|0|||
105719884|NCT01791855|364631809|FG001|Overall Study|Adverse Event|0|||
105719885|NCT01791855|364631810|FG002|Overall Study|Adverse Event|0|||
105791989|NCT03514121|364894333|FG006|Overall Study|Study termination by Sponsor|0|||
105791990|NCT03514121|364894334|FG007|Overall Study|Study termination by Sponsor|0|||
105791991|NCT03514121|364894335|FG008|Overall Study|Study termination by Sponsor|11|||
105791992|NCT03514121|364894336|FG009|Overall Study|Study termination by Sponsor|3|||
105791993|NCT03514121|364894327|FG000|Overall Study|Investigator decision|0|||
105791994|NCT03514121|364894328|FG001|Overall Study|Investigator decision|0|||
105934781|NCT02533674|365421188|FG004|Dose Level VIII|Withdrawal by Subject|0|||
105934782|NCT02533674|365421189|FG005|Dose Level VIII|Withdrawal by Subject|0|||
105934783|NCT02533674|365421190|FG006|Dose Level VIII|Withdrawal by Subject|0|||
105934784|NCT02533674|365421191|FG007|Dose Level VIII|Withdrawal by Subject|1|||
105934785|NCT02533674|365421184|FG000|Dose Level VIII|Treatment-related AE|0|||
105934786|NCT02533674|365421185|FG001|Dose Level VIII|Treatment-related AE|0|||
105934787|NCT02533674|365421186|FG002|Dose Level VIII|Treatment-related AE|0|||
105934788|NCT02533674|365421187|FG003|Dose Level VIII|Treatment-related AE|0|||
105934789|NCT02533674|365421188|FG004|Dose Level VIII|Treatment-related AE|0|||
105934790|NCT02533674|365421189|FG005|Dose Level VIII|Treatment-related AE|0|||
105934791|NCT02533674|365421190|FG006|Dose Level VIII|Treatment-related AE|0|||
105934792|NCT02533674|365421191|FG007|Dose Level VIII|Treatment-related AE|1|||
105934793|NCT02533674|365421184|FG000|Dose Level VIII|Never treated|0|||
105934794|NCT02533674|365421185|FG001|Dose Level VIII|Never treated|0|||
105934795|NCT02533674|365421186|FG002|Dose Level VIII|Never treated|0|||
105934796|NCT02533674|365421187|FG003|Dose Level VIII|Never treated|0|||
105934797|NCT02533674|365421188|FG004|Dose Level VIII|Never treated|0|||
105934798|NCT02533674|365421189|FG005|Dose Level VIII|Never treated|0|||
105934799|NCT02533674|365421190|FG006|Dose Level VIII|Never treated|0|||
105934800|NCT02533674|365421191|FG007|Dose Level VIII|Never treated|1|||
105934801|NCT04821245|365421196|FG000|Overall Study|Withdrawal by Subject|3|||
105934802|NCT04821245|365421196|FG000|Overall Study|Physician Decision|1|||
105934803|NCT04821245|365421196|FG000|Overall Study|Protocol Violation|5|||
105934804|NCT01791205|365421198|FG000|Phase II|Lack of Efficacy|6|||
105934805|NCT01791205|365421199|FG001|Phase II|Lack of Efficacy|0|||
105934806|NCT01791205|365421198|FG000|Phase II|Adverse Event|2|||
105934807|NCT01791205|365421199|FG001|Phase II|Adverse Event|0|||
105934808|NCT01791205|365421198|FG000|Phase II|Safety|1|||
105934809|NCT01791205|365421199|FG001|Phase II|Safety|0|||
105934810|NCT01791205|365421198|FG000|Phase II|Lost to Follow-up|1|||
105934811|NCT01791205|365421199|FG001|Phase II|Lost to Follow-up|0|||
105934812|NCT01791205|365421198|FG000|Phase II|Remission of disease|1|||
105934813|NCT01791205|365421199|FG001|Phase II|Remission of disease|0|||
105934814|NCT01791205|365421198|FG000|Phase II|Physician's decision|1|||
105934815|NCT01791205|365421199|FG001|Phase II|Physician's decision|0|||
105934816|NCT00474968|365421200|FG000|Overall Study|Withdrawal by Subject|8|||
105934817|NCT00474968|365421201|FG001|Overall Study|Withdrawal by Subject|7|||
105934818|NCT00474968|365421200|FG000|Overall Study|Protocol Violation|9|||
105934819|NCT00474968|365421201|FG001|Overall Study|Protocol Violation|8|||
105934820|NCT00474968|365421200|FG000|Overall Study|Sample not collected|1|||
105934821|NCT00474968|365421201|FG001|Overall Study|Sample not collected|1|||
105934822|NCT01520714|365421206|FG000|Overall Study|Protocol Violation|0|||
105934823|NCT01520714|365421207|FG001|Overall Study|Protocol Violation|3|||
105934824|NCT01520714|365421206|FG000|Overall Study|Adverse Event|0|||
105934825|NCT01520714|365421207|FG001|Overall Study|Adverse Event|2|||
105934826|NCT01520714|365421206|FG000|Overall Study|Lack of Efficacy|0|||
105934827|NCT01520714|365421207|FG001|Overall Study|Lack of Efficacy|1|||
105934828|NCT01691482|365421208|FG000|Treatment Period 2|Adverse Event|0|||
105934829|NCT01691482|365421209|FG001|Treatment Period 2|Adverse Event|1|||
105719886|NCT01791855|364631811|FG003|Overall Study|Adverse Event|1|||
105719887|NCT01791855|364631808|FG000|Overall Study|Randomized, not treated|0|||
105719888|NCT01791855|364631809|FG001|Overall Study|Randomized, not treated|1|||
105719889|NCT01791855|364631810|FG002|Overall Study|Randomized, not treated|0|||
105719890|NCT01791855|364631811|FG003|Overall Study|Randomized, not treated|0|||
105719891|NCT03686969|364631812|FG000|Overall Study|Study terminated|1|||
105719892|NCT03686969|364631813|FG001|Overall Study|Study terminated|0|||
105719893|NCT00848120|364631815|FG000|Overall Study|Adverse Event|1|||
105719894|NCT00560755|364631816|FG000|Overall Study|Protocol Violation|15|||
105719895|NCT00560755|364631816|FG000|Overall Study|Withdrawal by Subject|26|||
105719896|NCT00560755|364631816|FG000|Overall Study|Lost to Follow-up|9|||
105719897|NCT00560755|364631816|FG000|Overall Study|Adverse Event|8|||
105719898|NCT00560755|364631816|FG000|Overall Study|Physician Decision|2|||
105934830|NCT01691482|365421208|FG000|Treatment Period 2|Protocol Violation|1|||
105934831|NCT01691482|365421209|FG001|Treatment Period 2|Protocol Violation|1|||
105719899|NCT00772447|364631820|FG000|Overall Study|Withdrawal by Subject|9|||
105719900|NCT00772447|364631821|FG001|Overall Study|Withdrawal by Subject|5|||
105719901|NCT00772447|364631820|FG000|Overall Study|Physician Decision|4|||
105719902|NCT00772447|364631821|FG001|Overall Study|Physician Decision|8|||
105719903|NCT00772447|364631820|FG000|Overall Study|Lost to Follow-up|2|||
105719904|NCT00772447|364631821|FG001|Overall Study|Lost to Follow-up|4|||
105934832|NCT00183391|365421210|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
105934833|NCT00183391|365421211|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
105934834|NCT00183391|365421210|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
105934835|NCT00183391|365421211|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
105934836|NCT01543503|365421212|FG000|Overall Study|Lost to Follow-up|32|||
105934837|NCT01543503|365421213|FG001|Overall Study|Lost to Follow-up|36|||
105934838|NCT01543503|365421212|FG000|Overall Study|Adverse Event|9|||
105791995|NCT03514121|364894329|FG002|Overall Study|Investigator decision|0|||
105791996|NCT03514121|364894330|FG003|Overall Study|Investigator decision|0|||
105791997|NCT03514121|364894331|FG004|Overall Study|Investigator decision|0|||
105791998|NCT03514121|364894332|FG005|Overall Study|Investigator decision|0|||
105791999|NCT03514121|364894333|FG006|Overall Study|Investigator decision|0|||
105792000|NCT03514121|364894334|FG007|Overall Study|Investigator decision|0|||
105792001|NCT03514121|364894335|FG008|Overall Study|Investigator decision|1|||
105792002|NCT03514121|364894336|FG009|Overall Study|Investigator decision|0|||
105792003|NCT04930536|364894337|FG000|Overall Study|Adverse Event|1|||
105792004|NCT04930536|364894338|FG001|Overall Study|Adverse Event|0|||
105792005|NCT04930536|364894337|FG000|Overall Study|Disease Progression|2|||
105792006|NCT04930536|364894338|FG001|Overall Study|Disease Progression|0|||
105792007|NCT04930536|364894337|FG000|Overall Study|Patient Decision|4|||
105792008|NCT04930536|364894338|FG001|Overall Study|Patient Decision|2|||
105719905|NCT00772447|364631820|FG000|Overall Study|incorrect enrolment|3|||
105719906|NCT00772447|364631821|FG001|Overall Study|incorrect enrolment|4|||
105719907|NCT00772447|364631820|FG000|Overall Study|Protocol Violation|0|||
105719908|NCT00772447|364631821|FG001|Overall Study|Protocol Violation|1|||
105719909|NCT00772447|364631820|FG000|Overall Study|all others|2|||
105719910|NCT00772447|364631821|FG001|Overall Study|all others|2|||
105719911|NCT01957137|364631851|FG000|Randomized Portion|Adverse Event|1|||
105719912|NCT01957137|364631851|FG000|Randomized Portion|Withdrawal by Subject|1|||
105719913|NCT00927563|364631852|FG000|Overall Study|Lost to Follow-up|1|||
105719914|NCT00927563|364631852|FG000|Overall Study|Withdrawal by Subject|1|||
105719915|NCT02497001|364631855|FG000|Overall Study|Lost to Follow-up|10|||
105719916|NCT02497001|364631856|FG001|Overall Study|Lost to Follow-up|2|||
105719917|NCT02497001|364631857|FG002|Overall Study|Lost to Follow-up|0|||
105719918|NCT02497001|364631858|FG003|Overall Study|Lost to Follow-up|2|||
105719919|NCT02497001|364631855|FG000|Overall Study|Adverse Event|28|||
105719920|NCT02497001|364631856|FG001|Overall Study|Adverse Event|30|||
105719921|NCT02497001|364631857|FG002|Overall Study|Adverse Event|11|||
105719922|NCT02497001|364631858|FG003|Overall Study|Adverse Event|11|||
105719923|NCT02497001|364631855|FG000|Overall Study|Withdrawal by Subject|14|||
105792009|NCT04930536|364894337|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
105792010|NCT04930536|364894338|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
105792011|NCT00398632|364894339|FG000|Overall Study|Withdrawal by Subject|1|||
105792012|NCT00398632|364894339|FG000|Overall Study|Lack of Efficacy|1|||
105719924|NCT02497001|364631856|FG001|Overall Study|Withdrawal by Subject|37|||
105719925|NCT02497001|364631857|FG002|Overall Study|Withdrawal by Subject|19|||
105792013|NCT03692078|364894343|FG000|Overall Study|Adverse Event|0|||
105792014|NCT03692078|364894344|FG001|Overall Study|Adverse Event|0|||
105792015|NCT03692078|364894345|FG002|Overall Study|Adverse Event|0|||
105792016|NCT03692078|364894346|FG003|Overall Study|Adverse Event|0|||
105792017|NCT03692078|364894347|FG004|Overall Study|Adverse Event|0|||
105792018|NCT03692078|364894348|FG005|Overall Study|Adverse Event|1|||
105792019|NCT03692078|364894349|FG006|Overall Study|Adverse Event|0|||
105792020|NCT03692078|364894343|FG000|Overall Study|Enrollment Closed|5|||
105792021|NCT03692078|364894344|FG001|Overall Study|Enrollment Closed|0|||
105792022|NCT03692078|364894345|FG002|Overall Study|Enrollment Closed|0|||
105792023|NCT03692078|364894346|FG003|Overall Study|Enrollment Closed|0|||
105719926|NCT02497001|364631858|FG003|Overall Study|Withdrawal by Subject|15|||
105719927|NCT02497001|364631855|FG000|Overall Study|Physician Decision|5|||
105719928|NCT02497001|364631856|FG001|Overall Study|Physician Decision|11|||
105719929|NCT02497001|364631857|FG002|Overall Study|Physician Decision|5|||
105719930|NCT02497001|364631858|FG003|Overall Study|Physician Decision|1|||
105719931|NCT02497001|364631855|FG000|Overall Study|subjects that were not treated|1|||
105792024|NCT03692078|364894347|FG004|Overall Study|Enrollment Closed|0|||
105792025|NCT03692078|364894348|FG005|Overall Study|Enrollment Closed|0|||
105792026|NCT03692078|364894349|FG006|Overall Study|Enrollment Closed|0|||
105792027|NCT03692078|364894343|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
105792028|NCT03692078|364894344|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
105934839|NCT01543503|365421213|FG001|Overall Study|Adverse Event|13|||
105934840|NCT01543503|365421212|FG000|Overall Study|Lack of Efficacy|4|||
105719932|NCT02497001|364631856|FG001|Overall Study|subjects that were not treated|2|||
105719933|NCT02497001|364631857|FG002|Overall Study|subjects that were not treated|2|||
105719934|NCT02497001|364631858|FG003|Overall Study|subjects that were not treated|1|||
105719935|NCT02497001|364631855|FG000|Overall Study|Major Protocol Deviation|3|||
105719936|NCT02497001|364631856|FG001|Overall Study|Major Protocol Deviation|4|||
105719937|NCT02497001|364631857|FG002|Overall Study|Major Protocol Deviation|4|||
105719938|NCT02497001|364631858|FG003|Overall Study|Major Protocol Deviation|4|||
105792029|NCT03692078|364894345|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
105792030|NCT03692078|364894346|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
105792031|NCT03692078|364894347|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
105792032|NCT03692078|364894348|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
105934841|NCT01543503|365421213|FG001|Overall Study|Lack of Efficacy|16|||
105719939|NCT02497001|364631855|FG000|Overall Study|Lack of Efficacy|10|||
105719940|NCT02497001|364631856|FG001|Overall Study|Lack of Efficacy|16|||
105934842|NCT01543503|365421212|FG000|Overall Study|Participant withdrew informed consent|8|||
105934843|NCT01543503|365421213|FG001|Overall Study|Participant withdrew informed consent|10|||
105934844|NCT01543503|365421212|FG000|Overall Study|Change of jobs|0|||
105934845|NCT01543503|365421213|FG001|Overall Study|Change of jobs|1|||
105934846|NCT01543503|365421212|FG000|Overall Study|Intolerance to the biologic treatment|0|||
105934847|NCT01543503|365421213|FG001|Overall Study|Intolerance to the biologic treatment|1|||
105934848|NCT01543503|365421212|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
105934849|NCT01543503|365421213|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
105934850|NCT01543503|365421212|FG000|Overall Study|Participant did not complete last visit|0|||
105934851|NCT01543503|365421213|FG001|Overall Study|Participant did not complete last visit|2|||
105934852|NCT01543503|365421212|FG000|Overall Study|Refused to continue treatment|7|||
105934853|NCT01543503|365421213|FG001|Overall Study|Refused to continue treatment|0|||
105934854|NCT01543503|365421212|FG000|Overall Study|Incorrect medication received|1|||
105934855|NCT01543503|365421213|FG001|Overall Study|Incorrect medication received|0|||
105934856|NCT01543503|365421212|FG000|Overall Study|Participant moved to another city|2|||
105934857|NCT01543503|365421213|FG001|Overall Study|Participant moved to another city|0|||
105934858|NCT01543503|365421212|FG000|Overall Study|Participant will not return for visits|0|||
105934859|NCT01543503|365421213|FG001|Overall Study|Participant will not return for visits|2|||
105934860|NCT01543503|365421212|FG000|Overall Study|Participant transferred to another city|1|||
105934861|NCT01543503|365421213|FG001|Overall Study|Participant transferred to another city|0|||
105934862|NCT01543503|365421212|FG000|Overall Study|Participant moved to Scotland|1|||
105934863|NCT01543503|365421213|FG001|Overall Study|Participant moved to Scotland|0|||
105934864|NCT01543503|365421212|FG000|Overall Study|Participant decision to stop treatment|1|||
105934865|NCT01543503|365421213|FG001|Overall Study|Participant decision to stop treatment|0|||
105934866|NCT01543503|365421212|FG000|Overall Study|Investigator did not wish to participate|1|||
105934867|NCT01543503|365421213|FG001|Overall Study|Investigator did not wish to participate|1|||
105934868|NCT01543503|365421212|FG000|Overall Study|Participant recruited after closing date|0|||
105934869|NCT01543503|365421213|FG001|Overall Study|Participant recruited after closing date|1|||
105934870|NCT01543503|365421212|FG000|Overall Study|Site stopped participation|5|||
105934871|NCT01543503|365421213|FG001|Overall Study|Site stopped participation|1|||
105934872|NCT01543503|365421212|FG000|Overall Study|Participant did not attend a visit|1|||
105934873|NCT01543503|365421213|FG001|Overall Study|Participant did not attend a visit|0|||
105934874|NCT01543503|365421212|FG000|Overall Study|Moved to other rheumatologic site|0|||
105934875|NCT01543503|365421213|FG001|Overall Study|Moved to other rheumatologic site|1|||
105934876|NCT01543503|365421212|FG000|Overall Study|Participant consented to another study|0|||
105934877|NCT01543503|365421213|FG001|Overall Study|Participant consented to another study|2|||
105934878|NCT01543503|365421212|FG000|Overall Study|Participant went to United States|1|||
105934879|NCT01543503|365421213|FG001|Overall Study|Participant went to United States|0|||
105934880|NCT01543503|365421212|FG000|Overall Study|Screen failure|1|||
105934881|NCT01543503|365421213|FG001|Overall Study|Screen failure|0|||
105934882|NCT02460380|365421214|FG000|Overall Study|Withdrawal by Subject|10|||
105934883|NCT02460380|365421215|FG001|Overall Study|Withdrawal by Subject|5|||
105934884|NCT02134028|365421216|FG000|Overall Study|Lack of Efficacy|1|||
105934885|NCT02134028|365421217|FG001|Overall Study|Lack of Efficacy|0|||
105934886|NCT02134028|365421218|FG002|Overall Study|Lack of Efficacy|3|||
105934887|NCT02134028|365421219|FG003|Overall Study|Lack of Efficacy|2|||
105934888|NCT02134028|365421220|FG004|Overall Study|Lack of Efficacy|1|||
105934889|NCT02134028|365421221|FG005|Overall Study|Lack of Efficacy|2|||
105934890|NCT02134028|365421222|FG006|Overall Study|Lack of Efficacy|1|||
105934891|NCT02134028|365421223|FG007|Overall Study|Lack of Efficacy|0|||
105934892|NCT02134028|365421216|FG000|Overall Study|Poor compliance to protocol|1|||
105934893|NCT02134028|365421217|FG001|Overall Study|Poor compliance to protocol|1|||
105934894|NCT02134028|365421218|FG002|Overall Study|Poor compliance to protocol|3|||
105934895|NCT02134028|365421219|FG003|Overall Study|Poor compliance to protocol|7|||
105934896|NCT02134028|365421220|FG004|Overall Study|Poor compliance to protocol|1|||
105934897|NCT02134028|365421221|FG005|Overall Study|Poor compliance to protocol|1|||
105934898|NCT02134028|365421222|FG006|Overall Study|Poor compliance to protocol|0|||
105934899|NCT02134028|365421223|FG007|Overall Study|Poor compliance to protocol|0|||
105719941|NCT02497001|364631857|FG002|Overall Study|Lack of Efficacy|6|||
105719942|NCT02497001|364631858|FG003|Overall Study|Lack of Efficacy|6|||
105719943|NCT02497001|364631855|FG000|Overall Study|Protocol Violation|3|||
105719944|NCT02497001|364631856|FG001|Overall Study|Protocol Violation|1|||
105719945|NCT02497001|364631857|FG002|Overall Study|Protocol Violation|3|||
105934900|NCT02134028|365421216|FG000|Overall Study|Other unspecified|4|||
105934901|NCT02134028|365421217|FG001|Overall Study|Other unspecified|22|||
105934902|NCT02134028|365421218|FG002|Overall Study|Other unspecified|33|||
105934903|NCT02134028|365421219|FG003|Overall Study|Other unspecified|64|||
105934904|NCT02134028|365421220|FG004|Overall Study|Other unspecified|8|||
105934905|NCT02134028|365421221|FG005|Overall Study|Other unspecified|6|||
105934906|NCT02134028|365421222|FG006|Overall Study|Other unspecified|2|||
105719946|NCT02497001|364631858|FG003|Overall Study|Protocol Violation|1|||
105719947|NCT02899156|364631861|FG000|Overall Study|Death|1|||
105719948|NCT02899156|364631862|FG001|Overall Study|Death|0|||
105934907|NCT02134028|365421223|FG007|Overall Study|Other unspecified|1|||
105934908|NCT02134028|365421216|FG000|Overall Study|Adverse Event|3|||
105934909|NCT02134028|365421217|FG001|Overall Study|Adverse Event|19|||
105934910|NCT02134028|365421218|FG002|Overall Study|Adverse Event|13|||
105934911|NCT02134028|365421219|FG003|Overall Study|Adverse Event|32|||
105934912|NCT02134028|365421220|FG004|Overall Study|Adverse Event|4|||
105934913|NCT02134028|365421221|FG005|Overall Study|Adverse Event|5|||
105934914|NCT02134028|365421222|FG006|Overall Study|Adverse Event|1|||
105934915|NCT02134028|365421223|FG007|Overall Study|Adverse Event|2|||
105934916|NCT01478087|365421224|FG000|Overall Study|due to sponsor closing study|1|||
105934917|NCT03566550|365421226|FG000|Overall Study|Withdrawal by Subject|0|||
105934918|NCT03566550|365421227|FG001|Overall Study|Withdrawal by Subject|1|||
105934919|NCT04576949|365421228|FG000|Overall Study|Adverse Event|1|||
105934920|NCT04576949|365421229|FG001|Overall Study|Adverse Event|3|||
105934921|NCT04576949|365421230|FG002|Overall Study|Adverse Event|2|||
105934922|NCT04576949|365421228|FG000|Overall Study|Withdrawal by Subject|41|||
105934923|NCT04576949|365421229|FG001|Overall Study|Withdrawal by Subject|26|||
105934924|NCT04576949|365421230|FG002|Overall Study|Withdrawal by Subject|18|||
105934925|NCT04576949|365421228|FG000|Overall Study|Physician Decision|3|||
105934926|NCT04576949|365421229|FG001|Overall Study|Physician Decision|0|||
105934927|NCT04576949|365421230|FG002|Overall Study|Physician Decision|0|||
105934928|NCT04576949|365421228|FG000|Overall Study|Death|0|||
105934929|NCT04576949|365421229|FG001|Overall Study|Death|1|||
105934930|NCT04576949|365421230|FG002|Overall Study|Death|0|||
105934931|NCT04576949|365421228|FG000|Overall Study|Lost to Follow-up|29|||
105934932|NCT04576949|365421229|FG001|Overall Study|Lost to Follow-up|37|||
105934933|NCT04576949|365421230|FG002|Overall Study|Lost to Follow-up|24|||
105934934|NCT04576949|365421228|FG000|Overall Study|Other, Not Specified|2|||
105934935|NCT04576949|365421229|FG001|Overall Study|Other, Not Specified|3|||
105934936|NCT04576949|365421230|FG002|Overall Study|Other, Not Specified|1|||
105934937|NCT04576949|365421228|FG000|Overall Study|Other|1|||
105934938|NCT04576949|365421229|FG001|Overall Study|Other|0|||
105934939|NCT04576949|365421230|FG002|Overall Study|Other|0|||
105934940|NCT00063999|365421231|FG000|Overall Study|Withdrawal by Subject|1|||
105934941|NCT00063999|365421232|FG001|Overall Study|Withdrawal by Subject|0|||
105934942|NCT00063999|365421231|FG000|Overall Study|Ineligible|44|||
105934943|NCT00063999|365421232|FG001|Overall Study|Ineligible|24|||
105934944|NCT01260311|365421233|FG000|Overall Study|Adverse Event|11|||
105934945|NCT01260311|365421233|FG000|Overall Study|Lack of Efficacy|4|||
105934946|NCT01260311|365421233|FG000|Overall Study|Lost to Follow-up|25|||
105934947|NCT01260311|365421233|FG000|Overall Study|Withdrawal by Subject|6|||
105934948|NCT01260311|365421233|FG000|Overall Study|Financial Constraints|77|||
105934949|NCT01260311|365421233|FG000|Overall Study|Gone to Province|2|||
105934950|NCT01260311|365421233|FG000|Overall Study|Medication Stopped|1|||
105934951|NCT01260311|365421233|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
105934952|NCT02829957|365421234|FG000|Overall Study|Lost to Follow-up|2|||
105934953|NCT02829957|365421235|FG001|Overall Study|Lost to Follow-up|1|||
105934954|NCT03511066|365421238|FG000|Overall Study|Withdrawal by Subject|1|||
105934955|NCT03511066|365421239|FG001|Overall Study|Withdrawal by Subject|2|||
105934956|NCT03511066|365421240|FG002|Overall Study|Withdrawal by Subject|3|||
105934957|NCT03511066|365421238|FG000|Overall Study|Lost to Follow-up|2|||
105934958|NCT03511066|365421239|FG001|Overall Study|Lost to Follow-up|3|||
105934959|NCT03511066|365421240|FG002|Overall Study|Lost to Follow-up|0|||
105934960|NCT01089543|365421242|FG000|Overall Study|Withdrawal by Subject|2|||
105934961|NCT01089543|365421243|FG001|Overall Study|Withdrawal by Subject|3|||
105934962|NCT01089543|365421244|FG002|Overall Study|Withdrawal by Subject|3|||
105934963|NCT01089543|365421245|FG003|Overall Study|Withdrawal by Subject|1|||
105934964|NCT01089543|365421242|FG000|Overall Study|Physician Decision|1|||
105934965|NCT01089543|365421243|FG001|Overall Study|Physician Decision|0|||
105934966|NCT01089543|365421244|FG002|Overall Study|Physician Decision|0|||
105934967|NCT01089543|365421245|FG003|Overall Study|Physician Decision|1|||
105934968|NCT01089543|365421242|FG000|Overall Study|Adverse Event|0|||
105934969|NCT01089543|365421243|FG001|Overall Study|Adverse Event|1|||
105934970|NCT01089543|365421244|FG002|Overall Study|Adverse Event|0|||
105934971|NCT01089543|365421245|FG003|Overall Study|Adverse Event|0|||
105934972|NCT04560309|365421246|FG000|Overall Study|Meet drop out criteria|1|||
105934973|NCT04560309|365421247|FG001|Overall Study|Meet drop out criteria|1|||
105934974|NCT04146909|365421248|FG000|Overall Study|Withdrawal by Subject|3|||
105934975|NCT04146909|365421248|FG000|Overall Study|Did not qualify after consented|1|||
105934976|NCT05085405|365421249|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
105934977|NCT05085405|365421250|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
105934978|NCT05085405|365421251|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
105934979|NCT05085405|365421252|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
105934980|NCT05085405|365421253|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
105934981|NCT05085405|365421254|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
106009158|NCT05138653|365699083|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105934982|NCT05085405|365421249|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105934983|NCT05085405|365421250|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105934984|NCT05085405|365421251|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105934985|NCT05085405|365421252|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
105934986|NCT05085405|365421253|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105934987|NCT05085405|365421254|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
105934988|NCT01663987|365421255|FG000|Overall Study|Adverse Event|7|||
105934989|NCT01663987|365421256|FG001|Overall Study|Adverse Event|2|||
105934990|NCT01663987|365421255|FG000|Overall Study|Lost to Follow-up|1|||
105934991|NCT01663987|365421256|FG001|Overall Study|Lost to Follow-up|1|||
105934992|NCT01663987|365421255|FG000|Overall Study|Withdrawal by Subject|2|||
105934993|NCT01663987|365421256|FG001|Overall Study|Withdrawal by Subject|3|||
105934994|NCT01663987|365421255|FG000|Overall Study|Other reason not defined above|3|||
105934995|NCT01663987|365421256|FG001|Overall Study|Other reason not defined above|0|||
105934996|NCT00478140|365421262|FG000|Overall Study|Clinical Disease Progression|1|||
105934997|NCT01871727|365421265|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
105934998|NCT01871727|365421266|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
105934999|NCT01871727|365421267|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
105935000|NCT01871727|365421268|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
105935001|NCT01871727|365421269|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
105935002|NCT01871727|365421265|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
105935003|NCT01871727|365421266|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
105935004|NCT01871727|365421267|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
105935005|NCT01871727|365421268|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
105719949|NCT02899156|364631861|FG000|Overall Study|Physician Decision|0|||
105719950|NCT02899156|364631862|FG001|Overall Study|Physician Decision|1|||
105719951|NCT00054132|364631863|FG000|Overall Study|Not Treated|1|||
105935006|NCT01871727|365421269|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
105935007|NCT01871727|365421265|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
105935008|NCT01871727|365421266|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
105935009|NCT01871727|365421267|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
105935010|NCT01871727|365421268|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
105935011|NCT01871727|365421269|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
105719952|NCT01468987|364631864|FG000|Overall Study|Adverse Event|12|||
105719953|NCT01468987|364631865|FG001|Overall Study|Adverse Event|9|||
105719954|NCT01468987|364631864|FG000|Overall Study|Death|4|||
105935012|NCT01871727|365421265|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
105935013|NCT01871727|365421266|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
105935014|NCT01871727|365421267|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
105935015|NCT01871727|365421268|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
105935016|NCT01871727|365421269|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
105935017|NCT01871727|365421265|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
105935018|NCT01871727|365421266|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
105935019|NCT01871727|365421267|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
105935020|NCT01871727|365421268|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
105935021|NCT01871727|365421269|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
105935022|NCT01871727|365421265|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
105935023|NCT01871727|365421266|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
105935024|NCT01871727|365421267|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
105935025|NCT01871727|365421268|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
105935026|NCT01871727|365421269|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
105935027|NCT01871727|365421265|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
105935028|NCT01871727|365421266|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
105935029|NCT01871727|365421267|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
105935030|NCT01871727|365421268|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
105935031|NCT01871727|365421269|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
105935032|NCT03721107|365421270|FG000|Overall Study|Adverse Event|1|||
105935033|NCT03721107|365421271|FG001|Overall Study|Adverse Event|1|||
105719955|NCT01468987|364631865|FG001|Overall Study|Death|1|||
105719956|NCT01468987|364631864|FG000|Overall Study|Lost to Follow-up|10|||
105719957|NCT01468987|364631865|FG001|Overall Study|Lost to Follow-up|5|||
105719958|NCT01468987|364631864|FG000|Overall Study|Protocol Violation|8|||
105935034|NCT03721107|365421272|FG002|Overall Study|Adverse Event|6|||
105935035|NCT03721107|365421273|FG003|Overall Study|Adverse Event|5|||
105935036|NCT03721107|365421270|FG000|Overall Study|Lost to Follow-up|2|||
105935037|NCT03721107|365421271|FG001|Overall Study|Lost to Follow-up|0|||
105935038|NCT03721107|365421272|FG002|Overall Study|Lost to Follow-up|3|||
106137065|NCT01560949|366160360|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
105935039|NCT03721107|365421273|FG003|Overall Study|Lost to Follow-up|0|||
106137066|NCT01560949|366160360|FG000|Surgery Phase|Physician Decision|3|||
105719959|NCT01468987|364631865|FG001|Overall Study|Protocol Violation|2|||
105935040|NCT03721107|365421270|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
105935041|NCT03721107|365421271|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
105935042|NCT03721107|365421272|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
105935043|NCT03721107|365421273|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
105719960|NCT01468987|364631864|FG000|Overall Study|Withdrawal by Subject|28|||
105719961|NCT01468987|364631865|FG001|Overall Study|Withdrawal by Subject|28|||
105935044|NCT03721107|365421270|FG000|Overall Study|Physician Decision|0|||
105935045|NCT03721107|365421271|FG001|Overall Study|Physician Decision|1|||
105935046|NCT03721107|365421272|FG002|Overall Study|Physician Decision|0|||
105935047|NCT03721107|365421273|FG003|Overall Study|Physician Decision|0|||
105935048|NCT03721107|365421270|FG000|Overall Study|Pregnancy|0|||
105935049|NCT03721107|365421271|FG001|Overall Study|Pregnancy|0|||
105935050|NCT03721107|365421272|FG002|Overall Study|Pregnancy|1|||
105935051|NCT03721107|365421273|FG003|Overall Study|Pregnancy|0|||
105935052|NCT03721107|365421270|FG000|Overall Study|Withdrawal by Subject|1|||
105935053|NCT03721107|365421271|FG001|Overall Study|Withdrawal by Subject|1|||
105935054|NCT03721107|365421272|FG002|Overall Study|Withdrawal by Subject|5|||
105935055|NCT03721107|365421273|FG003|Overall Study|Withdrawal by Subject|5|||
105935056|NCT03721107|365421270|FG000|Overall Study|Other|1|||
105935057|NCT03721107|365421271|FG001|Overall Study|Other|0|||
105935058|NCT03721107|365421272|FG002|Overall Study|Other|0|||
105935059|NCT03721107|365421273|FG003|Overall Study|Other|1|||
105935060|NCT03438656|365421274|FG000|Overall Study|Lost to Follow-up|2|||
105935061|NCT01189227|365421275|FG000|Overall Study|Study terminated due to low accrual|6|||
105935062|NCT01189227|365421276|FG001|Overall Study|Study terminated due to low accrual|3|||
105935063|NCT01487161|365421277|FG000|Overall Study|Adverse Event|1|||
105935064|NCT01487161|365421278|FG001|Overall Study|Adverse Event|0|||
105935065|NCT01487161|365421279|FG002|Overall Study|Adverse Event|0|||
105935066|NCT01487161|365421280|FG003|Overall Study|Adverse Event|0|||
105935067|NCT01487161|365421277|FG000|Overall Study|Withdrawal by Subject|1|||
105935068|NCT01487161|365421278|FG001|Overall Study|Withdrawal by Subject|1|||
105935069|NCT01487161|365421279|FG002|Overall Study|Withdrawal by Subject|1|||
105935070|NCT01487161|365421280|FG003|Overall Study|Withdrawal by Subject|2|||
105935071|NCT01487161|365421277|FG000|Overall Study|missing data|0|||
105935072|NCT01487161|365421278|FG001|Overall Study|missing data|1|||
105935073|NCT01487161|365421279|FG002|Overall Study|missing data|0|||
105935074|NCT01487161|365421280|FG003|Overall Study|missing data|0|||
105935075|NCT03335566|365421281|FG000|Overall Study|Adverse Event|0|||
105935076|NCT03335566|365421282|FG001|Overall Study|Adverse Event|1|||
105935077|NCT03335566|365421281|FG000|Overall Study|Lost to Follow-up|1|||
105935078|NCT03335566|365421282|FG001|Overall Study|Lost to Follow-up|0|||
105935079|NCT03335566|365421281|FG000|Overall Study|Technical Problems|1|||
105935080|NCT03335566|365421282|FG001|Overall Study|Technical Problems|0|||
105935081|NCT03335566|365421281|FG000|Overall Study|Protocol Violation|1|||
105935082|NCT03335566|365421282|FG001|Overall Study|Protocol Violation|0|||
105935083|NCT03335566|365421281|FG000|Overall Study|Other than specified above|1|||
105935084|NCT03335566|365421282|FG001|Overall Study|Other than specified above|2|||
105935085|NCT01084135|365421283|FG000|20 Week|Physician Decision|0|||
105935086|NCT01084135|365421284|FG001|20 Week|Physician Decision|1|||
105935087|NCT00663351|365421285|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
105935088|NCT00663351|365421286|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
105935089|NCT00663351|365421285|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
105935090|NCT00663351|365421286|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
105935091|NCT00663351|365421285|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
105935092|NCT00663351|365421286|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
105935093|NCT00663351|365421285|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
105719962|NCT01468987|364631864|FG000|Overall Study|Physician Decision|8|||
105935094|NCT00663351|365421286|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
105935095|NCT00663351|365421285|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
105935096|NCT00663351|365421286|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
105935097|NCT00663351|365421285|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
105719963|NCT01468987|364631865|FG001|Overall Study|Physician Decision|15|||
105719964|NCT01468987|364631864|FG000|Overall Study|Sponsor Decision|1|||
105719965|NCT01468987|364631865|FG001|Overall Study|Sponsor Decision|0|||
105719966|NCT01795547|364631866|FG000|Overall Study|Adverse Event|16|||
105935098|NCT00663351|365421286|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
105935099|NCT03211832|365421287|FG000|Overall Study|No longer with agency|32|||
105935100|NCT03211832|365421288|FG001|Overall Study|No longer with agency|49|||
105935101|NCT03211832|365421289|FG002|Overall Study|No longer with agency|30|||
105935102|NCT03211832|365421287|FG000|Overall Study|Declined survey|3|||
105935103|NCT03211832|365421288|FG001|Overall Study|Declined survey|3|||
105935104|NCT03211832|365421289|FG002|Overall Study|Declined survey|2|||
105935105|NCT03211832|365421287|FG000|Overall Study|Not available during data collection|1|||
105719967|NCT01795547|364631867|FG001|Overall Study|Adverse Event|27|||
105719968|NCT01795547|364631866|FG000|Overall Study|Lack of Efficacy|8|||
105935106|NCT03211832|365421288|FG001|Overall Study|Not available during data collection|0|||
105935107|NCT03211832|365421289|FG002|Overall Study|Not available during data collection|2|||
105935108|NCT03721965|365421290|FG000|Overall Study|Death|1|||
105935109|NCT03721965|365421290|FG000|Overall Study|Study Terminated by Sponsor|1|||
105935110|NCT02057666|365421293|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
105935111|NCT02057666|365421294|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
105935112|NCT02057666|365421293|FG000|Double Blind Treatment Period|Poor tolerability|7|||
105935113|NCT02057666|365421294|FG001|Double Blind Treatment Period|Poor tolerability|2|||
105935114|NCT02057666|365421293|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
105935115|NCT02057666|365421294|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
105935116|NCT02057666|365421293|FG000|Double Blind Treatment Period|Physician Decision|1|||
105935117|NCT02057666|365421294|FG001|Double Blind Treatment Period|Physician Decision|0|||
105935118|NCT02057666|365421293|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
105935119|NCT02057666|365421294|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
105935120|NCT02057666|365421293|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
105935121|NCT02057666|365421294|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
105935122|NCT02057666|365421293|FG000|Double Blind Treatment Period|Sponsor's request|70|||
105935123|NCT02057666|365421294|FG001|Double Blind Treatment Period|Sponsor's request|34|||
105935124|NCT02057666|365421293|FG000|Open-Label Treatment Period|Poor tolerability|0|||
105935125|NCT02057666|365421294|FG001|Open-Label Treatment Period|Poor tolerability|1|||
105935126|NCT02057666|365421293|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
105935127|NCT02057666|365421294|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
105935128|NCT02057666|365421293|FG000|Open-Label Treatment Period|Sponsor's request|0|||
105935129|NCT02057666|365421294|FG001|Open-Label Treatment Period|Sponsor's request|4|||
105935130|NCT05259722|365421295|FG000|Overall Study|Adverse Event|2|||
105935131|NCT05259722|365421296|FG001|Overall Study|Adverse Event|24|||
105935132|NCT05259722|365421295|FG000|Overall Study|Lost to Follow-up|5|||
105935133|NCT05259722|365421296|FG001|Overall Study|Lost to Follow-up|1|||
105935134|NCT05259722|365421295|FG000|Overall Study|Lack of Efficacy|8|||
105935135|NCT05259722|365421296|FG001|Overall Study|Lack of Efficacy|26|||
105935136|NCT05259722|365421295|FG000|Overall Study|Withdrawal by Subject|15|||
105935137|NCT05259722|365421296|FG001|Overall Study|Withdrawal by Subject|33|||
105935138|NCT05259722|365421295|FG000|Overall Study|Various reasons|3|||
105935139|NCT05259722|365421296|FG001|Overall Study|Various reasons|9|||
105935140|NCT05259722|365421295|FG000|Overall Study|Not exposed to IMP|1|||
105935141|NCT05259722|365421296|FG001|Overall Study|Not exposed to IMP|12|||
105935142|NCT05259722|365421295|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
105935143|NCT05259722|365421296|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
105935144|NCT03069937|365421297|FG000|Overall Study|Second primary malignancy noted|1|||
105935145|NCT01472835|365421300|FG000|Overall Study|Lost to Follow-up|2|||
105935146|NCT01472835|365421301|FG001|Overall Study|Lost to Follow-up|0|||
105935147|NCT04193176|365422865|FG000|Overall Study|Withdrawal by Subject|6|||
105935148|NCT04193176|365422866|FG001|Overall Study|Withdrawal by Subject|10|||
105935149|NCT01902303|365422868|FG000|Overall Study|Adverse Event|0|||
105935150|NCT01902303|365422869|FG001|Overall Study|Adverse Event|1|||
105935151|NCT01902303|365422868|FG000|Overall Study|Lost to Follow-up|0|||
106137067|NCT02486588|366160361|FG000|Overall Study|Randomized in error- ineligible|738|||
106137068|NCT02486588|366160362|FG001|Overall Study|Randomized in error- ineligible|750|||
106137069|NCT02486588|366160363|FG002|Overall Study|Randomized in error- ineligible|755|||
106137070|NCT02486588|366160364|FG003|Overall Study|Randomized in error- ineligible|738|||
106137071|NCT02486588|366160365|FG004|Overall Study|Randomized in error- ineligible|746|||
105719969|NCT01795547|364631867|FG001|Overall Study|Lack of Efficacy|3|||
105719970|NCT01795547|364631866|FG000|Overall Study|Protocol Violation|6|||
105719971|NCT01795547|364631867|FG001|Overall Study|Protocol Violation|4|||
105719972|NCT01795547|364631866|FG000|Overall Study|Lost to Follow-up|2|||
105719973|NCT01795547|364631867|FG001|Overall Study|Lost to Follow-up|5|||
105719974|NCT01795547|364631866|FG000|Overall Study|Withdrawal of consent|7|||
105719975|NCT01795547|364631867|FG001|Overall Study|Withdrawal of consent|12|||
105719976|NCT01795547|364631866|FG000|Overall Study|Not Treated|4|||
105935152|NCT01902303|365422869|FG001|Overall Study|Lost to Follow-up|1|||
106137072|NCT02486588|366160366|FG005|Overall Study|Randomized in error- ineligible|746|||
106137073|NCT04248829|366160367|FG000|Overall Study|Disease progression|44|||
106137074|NCT04248829|366160368|FG001|Overall Study|Disease progression|109|||
105935153|NCT01902303|365422868|FG000|Overall Study|Protocol Violation|2|||
105935154|NCT01902303|365422869|FG001|Overall Study|Protocol Violation|2|||
105935155|NCT01902303|365422868|FG000|Overall Study|subject lost investigational product|0|||
105935156|NCT01902303|365422869|FG001|Overall Study|subject lost investigational product|1|||
105935157|NCT01902303|365422868|FG000|Overall Study|Did not develop a cold sore|21|||
105719977|NCT01795547|364631867|FG001|Overall Study|Not Treated|10|||
105719978|NCT01795547|364631866|FG000|Overall Study|Non-compliance with IMP|1|||
105935158|NCT01902303|365422869|FG001|Overall Study|Did not develop a cold sore|19|||
105935159|NCT02821000|365422870|FG000|Overall Study|Death|89|||
105935160|NCT02821000|365422870|FG000|Overall Study|Sponsor Decision|12|||
105935161|NCT02821000|365422870|FG000|Overall Study|Withdrawal by Subject|2|||
105935162|NCT02545127|365422871|FG000|Overall Study|Lost to Follow-up|1|||
105935163|NCT02545127|365422872|FG001|Overall Study|Lost to Follow-up|0|||
105935164|NCT00394472|365422873|FG000|Overall Study|Protocol Violation|1|||
105935165|NCT00394472|365422874|FG001|Overall Study|Protocol Violation|3|||
105935166|NCT00394472|365422873|FG000|Overall Study|incorrect enrolment|4|||
105935167|NCT00394472|365422874|FG001|Overall Study|incorrect enrolment|2|||
105935168|NCT00394472|365422873|FG000|Overall Study|Adverse Event|4|||
105935169|NCT00394472|365422874|FG001|Overall Study|Adverse Event|2|||
105935170|NCT00394472|365422873|FG000|Overall Study|Withdrawal by Subject|0|||
105935171|NCT00394472|365422874|FG001|Overall Study|Withdrawal by Subject|2|||
105935172|NCT00394472|365422873|FG000|Overall Study|Physician Decision|0|||
105935173|NCT00394472|365422874|FG001|Overall Study|Physician Decision|1|||
105935174|NCT00394472|365422873|FG000|Overall Study|Lost to Follow-up|0|||
105935175|NCT00394472|365422874|FG001|Overall Study|Lost to Follow-up|1|||
105935176|NCT00527748|365422877|FG000|Overall Study|Other|3|||
105935177|NCT02004275|365422879|FG000|Phase 1|Ineligible|0|||
105935178|NCT02004275|365422880|FG001|Phase 1|Ineligible|0|||
105935179|NCT02004275|365422881|FG002|Phase 1|Ineligible|0|||
105935180|NCT02004275|365422882|FG003|Phase 1|Ineligible|1|||
105935181|NCT02004275|365422883|FG004|Phase 1|Ineligible|1|||
105935182|NCT02004275|365422884|FG005|Phase 1|Ineligible|0|||
105935183|NCT02004275|365422879|FG000|Phase 1|Protocol Violation|0|||
105935184|NCT02004275|365422880|FG001|Phase 1|Protocol Violation|0|||
105935185|NCT02004275|365422881|FG002|Phase 1|Protocol Violation|0|||
105935186|NCT02004275|365422882|FG003|Phase 1|Protocol Violation|1|||
105935187|NCT02004275|365422883|FG004|Phase 1|Protocol Violation|0|||
105935188|NCT02004275|365422884|FG005|Phase 1|Protocol Violation|5|||
105935189|NCT02004275|365422879|FG000|Phase 2 Part 1|Ineligible|6|||
105935190|NCT02004275|365422880|FG001|Phase 2 Part 1|Ineligible|9|||
105935191|NCT02004275|365422881|FG002|Phase 2 Part 1|Ineligible|0|||
105935192|NCT02004275|365422882|FG003|Phase 2 Part 1|Ineligible|0|||
105935193|NCT02004275|365422883|FG004|Phase 2 Part 1|Ineligible|0|||
105935194|NCT02004275|365422884|FG005|Phase 2 Part 1|Ineligible|0|||
105935195|NCT02004275|365422879|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
105935196|NCT02004275|365422880|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
105935197|NCT02004275|365422881|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
105935198|NCT02004275|365422882|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
105935199|NCT02004275|365422883|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
105935200|NCT02004275|365422884|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
105935201|NCT04621786|365422885|FG000|Overall Study|Lost to Follow-up|9|||
105719979|NCT01795547|364631867|FG001|Overall Study|Non-compliance with IMP|1|||
105719980|NCT01795547|364631866|FG000|Overall Study|Others|4|||
105719981|NCT01795547|364631867|FG001|Overall Study|Others|1|||
105719982|NCT01795547|364631866|FG000|Overall Study|Not stated|0|||
105719983|NCT01795547|364631867|FG001|Overall Study|Not stated|1|||
105719984|NCT04722991|364631870|FG000|Overall Study|Adverse Event|12|||
105719985|NCT04722991|364631871|FG001|Overall Study|Adverse Event|4|||
105719986|NCT04722991|364631870|FG000|Overall Study|Death|2|||
105719987|NCT04722991|364631871|FG001|Overall Study|Death|0|||
105719988|NCT04722991|364631870|FG000|Overall Study|Lost to Follow-up|1|||
105719989|NCT04722991|364631871|FG001|Overall Study|Lost to Follow-up|1|||
105719990|NCT04722991|364631870|FG000|Overall Study|Withdrawal cirterion met|2|||
105719991|NCT04722991|364631871|FG001|Overall Study|Withdrawal cirterion met|2|||
105719992|NCT04722991|364631870|FG000|Overall Study|Other|1|||
105719993|NCT04722991|364631871|FG001|Overall Study|Other|0|||
105719994|NCT04722991|364631870|FG000|Overall Study|Non-compliance|0|||
105719995|NCT04722991|364631871|FG001|Overall Study|Non-compliance|1|||
105719996|NCT04722991|364631870|FG000|Overall Study|Withdrawal by Subject|0|||
105719997|NCT04722991|364631871|FG001|Overall Study|Withdrawal by Subject|1|||
105719998|NCT03186989|364631872|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105719999|NCT03186989|364631873|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105935202|NCT04621786|365422885|FG000|Overall Study|Protocol Violation|3|||
105935203|NCT01772693|365422891|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
105720000|NCT03186989|364631874|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
105720001|NCT03186989|364631875|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
105935204|NCT01772693|365422892|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
105935205|NCT01772693|365422891|FG000|Overall Study|Withdrawal by Subject|2|||
105935206|NCT01772693|365422892|FG001|Overall Study|Withdrawal by Subject|0|||
105935207|NCT01772693|365422891|FG000|Overall Study|Alternative Treatment|2|||
105935208|NCT01772693|365422892|FG001|Overall Study|Alternative Treatment|0|||
105935209|NCT00290758|365422897|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
105935210|NCT00290758|365422898|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
105720002|NCT03186989|364631876|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
105720003|NCT03186989|364631877|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105935211|NCT00290758|365422897|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
105935212|NCT00290758|365422898|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
105935213|NCT00290758|365422897|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
105935214|NCT00290758|365422898|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
105935215|NCT00290758|365422897|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
105935216|NCT00290758|365422898|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
105935217|NCT00290758|365422897|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
105935218|NCT00290758|365422898|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
105935219|NCT00290758|365422897|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
106137075|NCT04248829|366160367|FG000|Overall Study|Adverse Event|19|||
106137076|NCT04248829|366160368|FG001|Overall Study|Adverse Event|18|||
106137077|NCT04248829|366160367|FG000|Overall Study|Withdrawal by Subject|11|||
106137078|NCT04248829|366160368|FG001|Overall Study|Withdrawal by Subject|2|||
106137079|NCT04248829|366160367|FG000|Overall Study|Lost to Follow-up|0|||
106137080|NCT04248829|366160368|FG001|Overall Study|Lost to Follow-up|1|||
106137081|NCT04248829|366160367|FG000|Overall Study|Death|12|||
106137082|NCT04248829|366160368|FG001|Overall Study|Death|14|||
106137083|NCT04248829|366160367|FG000|Overall Study|Physician Decision|2|||
106137084|NCT04248829|366160368|FG001|Overall Study|Physician Decision|4|||
106137085|NCT04248829|366160367|FG000|Overall Study|Any reason not specifically recorded|0|||
106137086|NCT04248829|366160368|FG001|Overall Study|Any reason not specifically recorded|2|||
106137087|NCT02685033|366160369|FG000|Overall Study|Withdrawal of Consent|0|||
106137088|NCT02685033|366160370|FG001|Overall Study|Withdrawal of Consent|1|||
106137089|NCT02685033|366160369|FG000|Overall Study|Lost to Follow-up|2|||
106137090|NCT02685033|366160370|FG001|Overall Study|Lost to Follow-up|1|||
106137091|NCT02685033|366160369|FG000|Overall Study|Adverse Event|1|||
106137092|NCT02685033|366160370|FG001|Overall Study|Adverse Event|0|||
106137093|NCT02931396|366160371|FG000|Overall Study|Lost to Follow-up|3|||
106137094|NCT02931396|366160372|FG001|Overall Study|Lost to Follow-up|0|||
106137095|NCT02931396|366160371|FG000|Overall Study|Withdrawal by Subject|2|||
106137096|NCT02931396|366160372|FG001|Overall Study|Withdrawal by Subject|0|||
106137097|NCT02132702|366160373|FG000|Overall Study|Protocol Violation|2|||
106137098|NCT02132702|366160373|FG000|Overall Study|Adverse Event|3|||
106137099|NCT02132702|366160373|FG000|Overall Study|Withdrawal by Subject|3|||
106137100|NCT04697069|366160374|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
106137101|NCT04697069|366160375|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
106137102|NCT04697069|366160374|FG000|Overall Study|Study termination|2|||
106137103|NCT04697069|366160375|FG001|Overall Study|Study termination|1|||
106137104|NCT01867580|366160378|FG000|Overall Study|Withdrawal by Subject|2|||
106137105|NCT01867580|366160379|FG001|Overall Study|Withdrawal by Subject|3|||
106137106|NCT01867580|366160378|FG000|Overall Study|Physician Decision|17|||
106137107|NCT01867580|366160379|FG001|Overall Study|Physician Decision|12|||
106137108|NCT01867580|366160378|FG000|Overall Study|Lost to Follow-up|3|||
106137109|NCT01867580|366160379|FG001|Overall Study|Lost to Follow-up|5|||
106137110|NCT01867580|366160378|FG000|Overall Study|Sponsor terminated study|1|||
106137111|NCT01867580|366160379|FG001|Overall Study|Sponsor terminated study|0|||
106137112|NCT01867580|366160378|FG000|Overall Study|Missed follow-up assessment|2|||
106137113|NCT01867580|366160379|FG001|Overall Study|Missed follow-up assessment|1|||
106137114|NCT01867580|366160378|FG000|Overall Study|Interruption to therapy|3|||
106137115|NCT01867580|366160379|FG001|Overall Study|Interruption to therapy|0|||
106137116|NCT01867580|366160378|FG000|Overall Study|Osteomyelitis|0|||
106137117|NCT01867580|366160379|FG001|Overall Study|Osteomyelitis|1|||
106137118|NCT01867580|366160378|FG000|Overall Study|Continuation of therapy|0|||
106137119|NCT01867580|366160379|FG001|Overall Study|Continuation of therapy|1|||
106137120|NCT01867580|366160378|FG000|Overall Study|Wound recurrence|0|||
106137121|NCT01867580|366160379|FG001|Overall Study|Wound recurrence|1|||
106137122|NCT01304147|366160380|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
106137123|NCT01304147|366160381|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
106137124|NCT00708097|366160385|FG000|Period 1|Protocol Violation|0|||
106137125|NCT00708097|366160386|FG001|Period 1|Protocol Violation|1|||
106137126|NCT00708097|366160387|FG002|Period 1|Protocol Violation|0|||
105720004|NCT03186989|364631878|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720005|NCT03186989|364631879|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105935220|NCT00290758|365422898|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
106137127|NCT00708097|366160388|FG003|Period 1|Protocol Violation|2|||
106137128|NCT00708097|366160389|FG004|Period 1|Protocol Violation|0|||
106137129|NCT00708097|366160385|FG000|Period 1|Other Reason|0|||
106137130|NCT00708097|366160386|FG001|Period 1|Other Reason|0|||
106137131|NCT00708097|366160387|FG002|Period 1|Other Reason|0|||
106137132|NCT00708097|366160388|FG003|Period 1|Other Reason|0|||
106137133|NCT00708097|366160389|FG004|Period 1|Other Reason|1|||
106137134|NCT00708097|366160385|FG000|Period 2|Protocol Violation|0|||
106137135|NCT00708097|366160386|FG001|Period 2|Protocol Violation|1|||
106137136|NCT00708097|366160387|FG002|Period 2|Protocol Violation|1|||
106137137|NCT00708097|366160388|FG003|Period 2|Protocol Violation|1|||
106137138|NCT00708097|366160389|FG004|Period 2|Protocol Violation|0|||
105720006|NCT03186989|364631880|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720007|NCT03186989|364631881|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720008|NCT03186989|364631882|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
105720009|NCT03186989|364631872|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720010|NCT03186989|364631873|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720011|NCT03186989|364631874|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720012|NCT03186989|364631875|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720013|NCT03186989|364631876|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720014|NCT03186989|364631877|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
105720015|NCT03186989|364631878|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720016|NCT03186989|364631879|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720017|NCT03186989|364631880|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720018|NCT03186989|364631881|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720019|NCT03186989|364631882|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
105720020|NCT03186989|364631872|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720021|NCT03186989|364631873|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720022|NCT03186989|364631874|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720023|NCT03186989|364631875|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720024|NCT03186989|364631876|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720025|NCT03186989|364631877|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720026|NCT03186989|364631878|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
105720027|NCT03186989|364631879|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720028|NCT03186989|364631880|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720029|NCT03186989|364631881|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720030|NCT03186989|364631882|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
105720031|NCT03186989|364631872|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720032|NCT03186989|364631873|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720033|NCT03186989|364631874|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720034|NCT03186989|364631875|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720035|NCT03186989|364631876|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720036|NCT03186989|364631877|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
105720037|NCT03186989|364631878|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
105720038|NCT03186989|364631879|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720039|NCT03186989|364631880|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
105720040|NCT03186989|364631881|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720041|NCT03186989|364631882|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
105720042|NCT00413959|364631883|FG000|Overall Study|Pt had only one cycle.|1|||
105720043|NCT01459614|364631888|FG000|Overall Study|Adverse Event|1|||
105720044|NCT01459614|364631889|FG001|Overall Study|Adverse Event|0|||
105720045|NCT01506882|364631890|FG000|Overall Study|Lack of Efficacy|4|||
105720046|NCT01506882|364631891|FG001|Overall Study|Lack of Efficacy|3|||
105720047|NCT01506882|364631890|FG000|Overall Study|Lost to Follow-up|1|||
105720048|NCT01506882|364631891|FG001|Overall Study|Lost to Follow-up|0|||
105720049|NCT01506882|364631890|FG000|Overall Study|Withdrawal by Subject|9|||
105720050|NCT01506882|364631891|FG001|Overall Study|Withdrawal by Subject|3|||
105720051|NCT01506882|364631890|FG000|Overall Study|SAE, non-fatal|2|||
105720052|NCT01506882|364631891|FG001|Overall Study|SAE, non-fatal|0|||
105720053|NCT01506882|364631890|FG000|Overall Study|AE, non-serious non-fatal|3|||
105720054|NCT01506882|364631891|FG001|Overall Study|AE, non-serious non-fatal|1|||
105720055|NCT01506882|364631890|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
105720056|NCT01506882|364631891|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
105720057|NCT01506882|364631890|FG000|Overall Study|Other Reason|2|||
105720058|NCT01506882|364631891|FG001|Overall Study|Other Reason|0|||
105720059|NCT00630331|364631892|FG000|Overall Study|Death|2|||
105720060|NCT00630331|364631893|FG001|Overall Study|Death|1|||
105720061|NCT00630331|364631894|FG002|Overall Study|Death|1|||
105720062|NCT00630331|364631892|FG000|Overall Study|Adverse Event|1|||
105720063|NCT00630331|364631893|FG001|Overall Study|Adverse Event|0|||
105720064|NCT00630331|364631894|FG002|Overall Study|Adverse Event|0|||
105720065|NCT00630331|364631892|FG000|Overall Study|Withdrawal by Subject|12|||
105720066|NCT00630331|364631893|FG001|Overall Study|Withdrawal by Subject|7|||
105720067|NCT00630331|364631894|FG002|Overall Study|Withdrawal by Subject|5|||
105720068|NCT00630331|364631892|FG000|Overall Study|Lost to Follow-up|175|||
105935221|NCT00290758|365422897|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
105935222|NCT00290758|365422898|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
105720069|NCT00630331|364631893|FG001|Overall Study|Lost to Follow-up|143|||
105720070|NCT00630331|364631894|FG002|Overall Study|Lost to Follow-up|170|||
105935223|NCT00290758|365422897|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
105935224|NCT00290758|365422898|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
105935225|NCT03436420|365422899|FG000|Overall Study|Lack of Efficacy|3|||
105935226|NCT01259024|365422901|FG000|Overall Study|Physician Decision|1|||
105935227|NCT05587998|365422905|FG000|Overall Study|Withdrawal by Subject|1|||
105935228|NCT05587998|365422906|FG001|Overall Study|Withdrawal by Subject|1|||
105935229|NCT05587998|365422905|FG000|Overall Study|Not treated|3|||
105935230|NCT05587998|365422906|FG001|Overall Study|Not treated|1|||
105935231|NCT05587998|365422905|FG000|Overall Study|Non-compliance with study procedures|0|||
105935232|NCT05587998|365422906|FG001|Overall Study|Non-compliance with study procedures|1|||
105935233|NCT00986102|365422909|FG000|Overall Study|Lost to Follow-up|0|||
105935234|NCT00986102|365422910|FG001|Overall Study|Lost to Follow-up|1|||
105935235|NCT00986102|365422911|FG002|Overall Study|Lost to Follow-up|0|||
105935236|NCT00986102|365422912|FG003|Overall Study|Lost to Follow-up|1|||
105935237|NCT00986102|365422909|FG000|Overall Study|Withdrawal by Subject|1|||
105720071|NCT00630331|364631892|FG000|Overall Study|Inappropriate enrollment|3|||
105720072|NCT00630331|364631893|FG001|Overall Study|Inappropriate enrollment|6|||
105720073|NCT00630331|364631894|FG002|Overall Study|Inappropriate enrollment|3|||
105720074|NCT00630331|364631892|FG000|Overall Study|Unable to classify|9|||
105720075|NCT00630331|364631893|FG001|Overall Study|Unable to classify|4|||
105720076|NCT00630331|364631894|FG002|Overall Study|Unable to classify|3|||
105720077|NCT00630331|364631892|FG000|Overall Study|Protocol Violation|4|||
105720078|NCT00630331|364631893|FG001|Overall Study|Protocol Violation|5|||
105720079|NCT00630331|364631894|FG002|Overall Study|Protocol Violation|6|||
105720080|NCT00821678|364631897|FG000|Overall Study|Withdrawal by Subject|8|||
105720081|NCT00821678|364631898|FG001|Overall Study|Withdrawal by Subject|0|||
105720082|NCT00821678|364631897|FG000|Overall Study|Lost to Follow-up|13|||
105720083|NCT00821678|364631898|FG001|Overall Study|Lost to Follow-up|12|||
105720084|NCT00821678|364631897|FG000|Overall Study|Death|0|||
105720085|NCT00821678|364631898|FG001|Overall Study|Death|2|||
105760740|NCT01079195|364776172|FG000|Overall Study|Lack of Effectiveness|12|||
105760741|NCT01079195|364776172|FG000|Overall Study|Physician Decision|4|||
105760742|NCT01079195|364776172|FG000|Overall Study|Improved Status of Participant|4|||
105760743|NCT01079195|364776172|FG000|Overall Study|No Follow-up Documentation Available|4|||
105760744|NCT01079195|364776172|FG000|Overall Study|Non-compliance|2|||
105760745|NCT02671760|364776174|FG000|Overall Study|Lost to Follow-up|0|||
105760746|NCT02671760|364776175|FG001|Overall Study|Lost to Follow-up|1|||
105760747|NCT02671760|364776176|FG002|Overall Study|Lost to Follow-up|0|||
105760748|NCT01576406|364776183|FG000|Overall Study|Lost to Follow-up|1|||
105760749|NCT01576406|364776184|FG001|Overall Study|Lost to Follow-up|2|||
105760750|NCT01576406|364776185|FG002|Overall Study|Lost to Follow-up|0|||
105760751|NCT01576406|364776186|FG003|Overall Study|Lost to Follow-up|0|||
105760752|NCT01576406|364776187|FG004|Overall Study|Lost to Follow-up|0|||
105760753|NCT01576406|364776188|FG005|Overall Study|Lost to Follow-up|0|||
105760754|NCT01576406|364776183|FG000|Overall Study|Death|3|||
105760755|NCT01576406|364776184|FG001|Overall Study|Death|4|||
105760756|NCT01576406|364776185|FG002|Overall Study|Death|8|||
105935238|NCT00986102|365422910|FG001|Overall Study|Withdrawal by Subject|1|||
105935239|NCT00986102|365422911|FG002|Overall Study|Withdrawal by Subject|0|||
105935240|NCT00986102|365422912|FG003|Overall Study|Withdrawal by Subject|0|||
105935241|NCT03093870|365422916|FG000|Overall Study|Withdrawal by Subject|2|||
105935242|NCT03093870|365422917|FG001|Overall Study|Withdrawal by Subject|6|||
105935243|NCT03093870|365422918|FG002|Overall Study|Withdrawal by Subject|5|||
105935244|NCT03093870|365422916|FG000|Overall Study|Death|1|||
105935245|NCT03093870|365422917|FG001|Overall Study|Death|35|||
105935246|NCT03093870|365422918|FG002|Overall Study|Death|35|||
105760757|NCT01576406|364776186|FG003|Overall Study|Death|5|||
105760758|NCT01576406|364776187|FG004|Overall Study|Death|7|||
105935247|NCT03093870|365422916|FG000|Overall Study|Radiographic disease progression|10|||
105935248|NCT03093870|365422917|FG001|Overall Study|Radiographic disease progression|0|||
105935249|NCT03093870|365422918|FG002|Overall Study|Radiographic disease progression|0|||
105760759|NCT01576406|364776188|FG005|Overall Study|Death|9|||
105760760|NCT01576406|364776183|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
105935250|NCT03093870|365422916|FG000|Overall Study|Clinical disease progression|1|||
105935251|NCT03093870|365422917|FG001|Overall Study|Clinical disease progression|0|||
105935252|NCT03093870|365422918|FG002|Overall Study|Clinical disease progression|0|||
105760761|NCT01576406|364776184|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
105760762|NCT01576406|364776185|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
105760763|NCT01576406|364776186|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
105760764|NCT01576406|364776187|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
105760765|NCT01576406|364776188|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
105760766|NCT01576406|364776183|FG000|Overall Study|Withdrawal the consent|2|||
105760767|NCT01576406|364776184|FG001|Overall Study|Withdrawal the consent|2|||
105792033|NCT03692078|364894349|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
105792034|NCT03692078|364894343|FG000|Overall Study|Withdrawal by Subject|0|||
105792035|NCT03692078|364894344|FG001|Overall Study|Withdrawal by Subject|2|||
105792036|NCT03692078|364894345|FG002|Overall Study|Withdrawal by Subject|0|||
105792037|NCT03692078|364894346|FG003|Overall Study|Withdrawal by Subject|1|||
105792038|NCT03692078|364894347|FG004|Overall Study|Withdrawal by Subject|5|||
105792039|NCT03692078|364894348|FG005|Overall Study|Withdrawal by Subject|3|||
105792040|NCT03692078|364894349|FG006|Overall Study|Withdrawal by Subject|3|||
105792041|NCT03576131|364894350|FG000|Overall Study|Investigator decision|0|||
105792042|NCT03576131|364894351|FG001|Overall Study|Investigator decision|0|||
105792043|NCT03576131|364894352|FG002|Overall Study|Investigator decision|0|||
105792044|NCT03576131|364894353|FG003|Overall Study|Investigator decision|1|||
105792045|NCT03576131|364894354|FG004|Overall Study|Investigator decision|0|||
105792046|NCT03576131|364894355|FG005|Overall Study|Investigator decision|1|||
105792047|NCT03576131|364894356|FG006|Overall Study|Investigator decision|0|||
105792048|NCT03576131|364894357|FG007|Overall Study|Investigator decision|0|||
105792049|NCT03576131|364894350|FG000|Overall Study|Withdrawal by Subject|1|||
105792050|NCT03576131|364894351|FG001|Overall Study|Withdrawal by Subject|1|||
105792051|NCT03576131|364894352|FG002|Overall Study|Withdrawal by Subject|0|||
106137139|NCT00603447|366160390|FG000|Overall Study|Adverse Event|0|||
105792052|NCT03576131|364894353|FG003|Overall Study|Withdrawal by Subject|1|||
105792053|NCT03576131|364894354|FG004|Overall Study|Withdrawal by Subject|2|||
105792054|NCT03576131|364894355|FG005|Overall Study|Withdrawal by Subject|3|||
105792055|NCT03576131|364894356|FG006|Overall Study|Withdrawal by Subject|1|||
105792056|NCT03576131|364894357|FG007|Overall Study|Withdrawal by Subject|0|||
105792057|NCT03576131|364894350|FG000|Overall Study|Death|3|||
105792058|NCT03576131|364894351|FG001|Overall Study|Death|3|||
105792059|NCT03576131|364894352|FG002|Overall Study|Death|1|||
105792060|NCT03576131|364894353|FG003|Overall Study|Death|5|||
105792061|NCT03576131|364894354|FG004|Overall Study|Death|4|||
105792062|NCT03576131|364894355|FG005|Overall Study|Death|1|||
105792063|NCT03576131|364894356|FG006|Overall Study|Death|0|||
105792064|NCT03576131|364894357|FG007|Overall Study|Death|1|||
105792065|NCT03576131|364894350|FG000|Overall Study|New anti-cancer treatment|5|||
105792066|NCT03576131|364894351|FG001|Overall Study|New anti-cancer treatment|1|||
105792067|NCT03576131|364894352|FG002|Overall Study|New anti-cancer treatment|2|||
105792068|NCT03576131|364894353|FG003|Overall Study|New anti-cancer treatment|3|||
105792069|NCT03576131|364894354|FG004|Overall Study|New anti-cancer treatment|0|||
105792070|NCT03576131|364894355|FG005|Overall Study|New anti-cancer treatment|0|||
105792071|NCT03576131|364894356|FG006|Overall Study|New anti-cancer treatment|0|||
105792072|NCT03576131|364894357|FG007|Overall Study|New anti-cancer treatment|0|||
105792073|NCT03576131|364894350|FG000|Overall Study|Unspecified reason|0|||
105792074|NCT03576131|364894351|FG001|Overall Study|Unspecified reason|0|||
105792075|NCT03576131|364894352|FG002|Overall Study|Unspecified reason|1|||
105792076|NCT03576131|364894353|FG003|Overall Study|Unspecified reason|1|||
105792077|NCT03576131|364894354|FG004|Overall Study|Unspecified reason|1|||
105792078|NCT03576131|364894355|FG005|Overall Study|Unspecified reason|1|||
105792079|NCT03576131|364894356|FG006|Overall Study|Unspecified reason|0|||
105792080|NCT03576131|364894357|FG007|Overall Study|Unspecified reason|0|||
105792081|NCT03576131|364894350|FG000|Overall Study|Subject non-compliance|0|||
105792082|NCT03576131|364894351|FG001|Overall Study|Subject non-compliance|0|||
105792083|NCT03576131|364894352|FG002|Overall Study|Subject non-compliance|0|||
105792084|NCT03576131|364894353|FG003|Overall Study|Subject non-compliance|0|||
105792085|NCT03576131|364894354|FG004|Overall Study|Subject non-compliance|0|||
105792086|NCT03576131|364894355|FG005|Overall Study|Subject non-compliance|1|||
105792087|NCT03576131|364894356|FG006|Overall Study|Subject non-compliance|0|||
105792088|NCT03576131|364894357|FG007|Overall Study|Subject non-compliance|0|||
105792089|NCT04285983|364894358|FG000|Overall Study|Protocol Violation|6|||
105792090|NCT01569594|364894361|FG000|Overall Study|Physician Decision|4|||
105792091|NCT01569594|364894361|FG000|Overall Study|Death|13|||
105792092|NCT01569594|364894361|FG000|Overall Study|Lost to Follow-up|22|||
105792093|NCT01569594|364894361|FG000|Overall Study|Adverse Event|2|||
105792094|NCT01569594|364894361|FG000|Overall Study|Withdrawal by Subject|13|||
105792095|NCT01569594|364894361|FG000|Overall Study|Other|4|||
105792096|NCT01569594|364894361|FG000|Overall Study|No ECM used|9|||
105792097|NCT00422058|364894362|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
105792098|NCT00422058|364894363|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
105792099|NCT00422058|364894364|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
105792100|NCT00422058|364894365|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
105792101|NCT00422058|364894366|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
105792102|NCT00422058|364894367|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
105792103|NCT00422058|364894362|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
105792104|NCT00422058|364894363|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
105792105|NCT00422058|364894364|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
105792106|NCT00422058|364894365|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
105792107|NCT00422058|364894366|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
105792108|NCT00422058|364894367|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
105792109|NCT00422058|364894362|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
105792110|NCT00422058|364894363|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
105792111|NCT00422058|364894364|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
105792112|NCT00422058|364894365|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
105792113|NCT00422058|364894366|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
105792114|NCT00422058|364894367|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
105935253|NCT03093870|365422916|FG000|Overall Study|Physician Decision|2|||
105935254|NCT03093870|365422917|FG001|Overall Study|Physician Decision|0|||
105720086|NCT00778830|364633899|FG000|Overall Study|Ongoing at data cut-off|0|||
105720087|NCT00778830|364633900|FG001|Overall Study|Ongoing at data cut-off|1|||
105720088|NCT02338843|364633901|FG000|Overall Study|Adverse Event|2|||
105720089|NCT02338843|364633902|FG001|Overall Study|Adverse Event|1|||
105720090|NCT02338843|364633901|FG000|Overall Study|Death|40|||
105720091|NCT02338843|364633902|FG001|Overall Study|Death|53|||
105720092|NCT02338843|364633901|FG000|Overall Study|Physician Decision|1|||
105720093|NCT02338843|364633902|FG001|Overall Study|Physician Decision|0|||
105720094|NCT02338843|364633901|FG000|Overall Study|Withdrawal by Subject|0|||
105720095|NCT02338843|364633902|FG001|Overall Study|Withdrawal by Subject|2|||
105720096|NCT02338843|364633901|FG000|Overall Study|Subject Recovered|0|||
105720097|NCT02338843|364633902|FG001|Overall Study|Subject Recovered|2|||
105720098|NCT02338843|364633901|FG000|Overall Study|Discontinued prior to randomizat|1|||
105720099|NCT02338843|364633902|FG001|Overall Study|Discontinued prior to randomizat|0|||
105720100|NCT02591615|364633903|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
105720101|NCT02591615|364633904|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
105720102|NCT02591615|364633905|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
105720103|NCT02591615|364633906|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
105720104|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
105720105|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
105720106|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
105720107|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
105720108|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
105720109|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
105720110|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
105720111|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
105720112|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
105720113|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
105720114|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
105720115|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
105720116|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
105720117|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
105720118|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
105720119|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
105720120|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
105720121|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
105720122|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
105935255|NCT03093870|365422918|FG002|Overall Study|Physician Decision|0|||
105935256|NCT03093870|365422916|FG000|Overall Study|Adverse Event|7|||
105935257|NCT03093870|365422917|FG001|Overall Study|Adverse Event|0|||
105935258|NCT03093870|365422918|FG002|Overall Study|Adverse Event|0|||
105935259|NCT03093870|365422916|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
105935260|NCT03093870|365422917|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
105935261|NCT03093870|365422918|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
105935262|NCT03093870|365422916|FG000|Overall Study|Lost to Follow-up|0|||
105935263|NCT03093870|365422917|FG001|Overall Study|Lost to Follow-up|0|||
105935264|NCT03093870|365422918|FG002|Overall Study|Lost to Follow-up|1|||
105935265|NCT01530997|365422919|FG000|Overall Study|Physician Decision|1|||
105935266|NCT01530997|365422919|FG000|Overall Study|Withdrawal by Subject|1|||
105792115|NCT00422058|364894362|FG000|Double-Blind, Week 0-20|Other|11|||
105935267|NCT00819832|365422924|FG000|Overall Study|Sponsor Termination of Study|3|||
105935268|NCT00819832|365422925|FG001|Overall Study|Sponsor Termination of Study|0|||
106137140|NCT00603447|366160391|FG001|Overall Study|Adverse Event|1|||
105720123|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
105720124|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
105720125|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
105720126|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
105720127|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
105720128|NCT02591615|364633903|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
105720129|NCT02591615|364633904|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
105792116|NCT00422058|364894363|FG001|Double-Blind, Week 0-20|Other|3|||
105792117|NCT00422058|364894364|FG002|Double-Blind, Week 0-20|Other|8|||
105792118|NCT00422058|364894365|FG003|Double-Blind, Week 0-20|Other|8|||
105720130|NCT02591615|364633905|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
105720131|NCT02591615|364633906|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
105720132|NCT02591615|364633903|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
105792119|NCT00422058|364894366|FG004|Double-Blind, Week 0-20|Other|4|||
105792120|NCT00422058|364894367|FG005|Double-Blind, Week 0-20|Other|10|||
105720133|NCT02591615|364633904|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
105720134|NCT02591615|364633905|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
105720135|NCT02591615|364633906|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
105720136|NCT02591615|364633903|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
105720137|NCT02591615|364633904|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
105720138|NCT02591615|364633905|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
105720139|NCT02591615|364633906|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
105720140|NCT02591615|364633903|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
105720141|NCT02591615|364633904|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
105720142|NCT02591615|364633905|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
105720143|NCT02591615|364633906|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
105720144|NCT02591615|364633903|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
105720145|NCT02591615|364633904|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
105720146|NCT02591615|364633905|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
105720147|NCT02591615|364633906|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
105720148|NCT02591615|364633903|FG000|Maintenance MK-3475|Adverse Event|0|||
105720149|NCT02591615|364633904|FG001|Maintenance MK-3475|Adverse Event|3|||
105720150|NCT02591615|364633905|FG002|Maintenance MK-3475|Adverse Event|1|||
105720151|NCT02591615|364633906|FG003|Maintenance MK-3475|Adverse Event|2|||
105792121|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
105792122|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
105792123|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
105792124|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
105792125|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
105792126|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
105792127|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
105792128|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
105792129|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
105792130|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
105792131|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
105792132|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
105792133|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
105792134|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
105792135|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
105792136|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
105792137|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
105792138|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
105792139|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
105792140|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
105792141|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
105792142|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
105792143|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
105792144|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
105792145|NCT00422058|364894362|FG000|Open-Label Extension, Week 20-104|Other|13|||
105792146|NCT00422058|364894363|FG001|Open-Label Extension, Week 20-104|Other|14|||
105792147|NCT00422058|364894364|FG002|Open-Label Extension, Week 20-104|Other|6|||
105792148|NCT00422058|364894365|FG003|Open-Label Extension, Week 20-104|Other|13|||
105792149|NCT00422058|364894366|FG004|Open-Label Extension, Week 20-104|Other|16|||
105792150|NCT00422058|364894367|FG005|Open-Label Extension, Week 20-104|Other|18|||
105792151|NCT00054275|364894371|FG000|Overall Study|Withdrawal by Subject|4|||
105792152|NCT00054275|364894371|FG000|Overall Study|Adverse Event|5|||
105792153|NCT00054275|364894371|FG000|Overall Study|Progressive disease in cycle 1|1|||
105792154|NCT00054275|364894371|FG000|Overall Study|Physician Decision|1|||
105792155|NCT02780115|364894372|FG000|Overall Study|Withdrawal by Subject|0|||
105792156|NCT02780115|364894373|FG001|Overall Study|Withdrawal by Subject|1|||
105792157|NCT02780115|364894374|FG002|Overall Study|Withdrawal by Subject|1|||
105792158|NCT02780115|364894375|FG003|Overall Study|Withdrawal by Subject|0|||
106137141|NCT00603447|366160392|FG002|Overall Study|Adverse Event|1|||
106137142|NCT00603447|366160393|FG003|Overall Study|Adverse Event|2|||
105720152|NCT02591615|364633903|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
105792159|NCT02780115|364894376|FG004|Overall Study|Withdrawal by Subject|0|||
105792160|NCT02780115|364894372|FG000|Overall Study|Adverse Event|0|||
105792161|NCT02780115|364894373|FG001|Overall Study|Adverse Event|0|||
106137143|NCT00603447|366160394|FG004|Overall Study|Adverse Event|1|||
105720153|NCT02591615|364633904|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
105935269|NCT00819832|365422926|FG002|Overall Study|Sponsor Termination of Study|0|||
105935270|NCT00819832|365422927|FG003|Overall Study|Sponsor Termination of Study|0|||
105935271|NCT00819832|365422928|FG004|Overall Study|Sponsor Termination of Study|0|||
105935272|NCT00819832|365422929|FG005|Overall Study|Sponsor Termination of Study|0|||
105935273|NCT01063881|365422935|FG000|Overall Study|Adverse Event|12|||
105935274|NCT01063881|365422936|FG001|Overall Study|Adverse Event|2|||
105935275|NCT01063881|365422937|FG002|Overall Study|Adverse Event|0|||
105935276|NCT01063881|365422935|FG000|Overall Study|Lost to Follow-up|13|||
105935277|NCT01063881|365422936|FG001|Overall Study|Lost to Follow-up|7|||
105935278|NCT01063881|365422937|FG002|Overall Study|Lost to Follow-up|1|||
105935279|NCT01063881|365422935|FG000|Overall Study|Withdrawal by Subject|25|||
105935280|NCT01063881|365422936|FG001|Overall Study|Withdrawal by Subject|1|||
105935281|NCT01063881|365422937|FG002|Overall Study|Withdrawal by Subject|0|||
105935282|NCT01063881|365422935|FG000|Overall Study|Reason for not completed not specified|5|||
105935283|NCT01063881|365422936|FG001|Overall Study|Reason for not completed not specified|1|||
105935284|NCT01063881|365422937|FG002|Overall Study|Reason for not completed not specified|0|||
105935285|NCT01452789|365422938|FG000|Overall Study|Withdrawal by Subject|3|||
105935286|NCT01452789|365422939|FG001|Overall Study|Withdrawal by Subject|2|||
105935287|NCT02006654|365422940|FG000|Overall Study|Withdrawal before treatment|4|||
106009159|NCT05138653|365699084|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
106009160|NCT05138653|365699085|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
106009161|NCT05138653|365699086|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
106137144|NCT00603447|366160395|FG005|Overall Study|Adverse Event|2|||
105720154|NCT02591615|364633905|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
105720155|NCT02591615|364633906|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
105720156|NCT02591615|364633903|FG000|Maintenance MK-3475|Death|0|||
105720157|NCT02591615|364633904|FG001|Maintenance MK-3475|Death|1|||
105720158|NCT02591615|364633905|FG002|Maintenance MK-3475|Death|1|||
105720159|NCT02591615|364633906|FG003|Maintenance MK-3475|Death|0|||
105720160|NCT02591615|364633903|FG000|Maintenance MK-3475|Physician discretion|0|||
105720161|NCT02591615|364633904|FG001|Maintenance MK-3475|Physician discretion|0|||
105720162|NCT02591615|364633905|FG002|Maintenance MK-3475|Physician discretion|1|||
105720163|NCT02591615|364633906|FG003|Maintenance MK-3475|Physician discretion|0|||
105720164|NCT02591615|364633903|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
105720165|NCT02591615|364633904|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
105720166|NCT02591615|364633905|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
105720167|NCT02591615|364633906|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
105720168|NCT02591615|364633903|FG000|Maintenance MK-3475|In active treatment|2|||
105720169|NCT02591615|364633904|FG001|Maintenance MK-3475|In active treatment|0|||
105720170|NCT02591615|364633905|FG002|Maintenance MK-3475|In active treatment|0|||
105720171|NCT02591615|364633906|FG003|Maintenance MK-3475|In active treatment|1|||
105720172|NCT02107703|364633907|FG000|Overall Study|Withdrawal by Subject|46|||
105720173|NCT02107703|364633908|FG001|Overall Study|Withdrawal by Subject|21|||
105720174|NCT02107703|364633907|FG000|Overall Study|Lost to Follow-up|20|||
105720175|NCT02107703|364633908|FG001|Overall Study|Lost to Follow-up|9|||
105720176|NCT02107703|364633907|FG000|Overall Study|On study treatment/follow up|48|||
105720177|NCT02107703|364633908|FG001|Overall Study|On study treatment/follow up|5|||
105720178|NCT01583179|364633909|FG000|Overall Study|Screen failure|1|||
105720179|NCT01583179|364633910|FG001|Overall Study|Screen failure|2|||
105720180|NCT03609619|364633912|FG000|Overall Study|Adverse Event|1|||
105720181|NCT03609619|364633913|FG001|Overall Study|Adverse Event|0|||
105720182|NCT03609619|364633912|FG000|Overall Study|Lack of Efficacy|1|||
105720183|NCT03609619|364633913|FG001|Overall Study|Lack of Efficacy|2|||
105720184|NCT03609619|364633912|FG000|Overall Study|Protocol Violation|5|||
105720185|NCT03609619|364633913|FG001|Overall Study|Protocol Violation|0|||
105720186|NCT03609619|364633912|FG000|Overall Study|Withdrawal by Subject|2|||
105720187|NCT03609619|364633913|FG001|Overall Study|Withdrawal by Subject|3|||
105720188|NCT03609619|364633912|FG000|Overall Study|Lost to Follow-up|1|||
105720189|NCT03609619|364633913|FG001|Overall Study|Lost to Follow-up|1|||
105720190|NCT00956943|364633914|FG000|Overall Study|Lost to Follow-up|9|||
105720191|NCT00956943|364633915|FG001|Overall Study|Lost to Follow-up|10|||
105720192|NCT02613208|364633916|FG000|Overall Study|Withdrawal by Subject|1|||
105720193|NCT02613208|364633916|FG000|Overall Study|Change of address|2|||
105935288|NCT02006654|365422941|FG001|Overall Study|Withdrawal before treatment|2|||
105935289|NCT02006654|365422940|FG000|Overall Study|Adverse Event|16|||
105935290|NCT02006654|365422941|FG001|Overall Study|Adverse Event|17|||
105935291|NCT02006654|365422940|FG000|Overall Study|Death|1|||
105935292|NCT02006654|365422941|FG001|Overall Study|Death|0|||
105720194|NCT02613208|364633916|FG000|Overall Study|Physician Decision|2|||
105720195|NCT02613208|364633916|FG000|Overall Study|Lost to Follow-up|5|||
105720196|NCT02613208|364633916|FG000|Overall Study|Death|37|||
105720197|NCT03244059|364633917|FG000|Specific Aim 1|Physician Decision|1|||
105720198|NCT03244059|364633918|FG001|Specific Aim 1|Physician Decision|0|||
105720199|NCT03244059|364633917|FG000|Specific Aim 2|Physician Decision|1|||
105720200|NCT03244059|364633918|FG001|Specific Aim 2|Physician Decision|0|||
105720201|NCT00686127|364633924|FG000|Overall Study|Withdrawal by Subject|14|||
105935293|NCT02006654|365422940|FG000|Overall Study|Withdrawal by Subject|14|||
105935294|NCT02006654|365422941|FG001|Overall Study|Withdrawal by Subject|12|||
105935295|NCT02006654|365422940|FG000|Overall Study|Protocol Violation|5|||
105935296|NCT02006654|365422941|FG001|Overall Study|Protocol Violation|8|||
105935297|NCT02006654|365422940|FG000|Overall Study|Lost to Follow-up|1|||
105935298|NCT02006654|365422941|FG001|Overall Study|Lost to Follow-up|0|||
105935299|NCT02006654|365422940|FG000|Overall Study|patient's will|2|||
105935300|NCT02006654|365422941|FG001|Overall Study|patient's will|1|||
105935301|NCT02006654|365422940|FG000|Overall Study|insufficient compliance|1|||
105935302|NCT02006654|365422941|FG001|Overall Study|insufficient compliance|0|||
105935303|NCT02006654|365422940|FG000|Overall Study|worsening cognitive condition|0|||
105935304|NCT02006654|365422941|FG001|Overall Study|worsening cognitive condition|1|||
105935305|NCT02006654|365422940|FG000|Overall Study|faecal incontinence|0|||
105935306|NCT02006654|365422941|FG001|Overall Study|faecal incontinence|1|||
105935307|NCT02006654|365422940|FG000|Overall Study|mood disorder|0|||
105935308|NCT02006654|365422941|FG001|Overall Study|mood disorder|1|||
105935309|NCT02006654|365422940|FG000|Overall Study|disallowed medication|1|||
105935310|NCT02006654|365422941|FG001|Overall Study|disallowed medication|0|||
105935311|NCT02006654|365422940|FG000|Overall Study|moving out of state|0|||
105935312|NCT02006654|365422941|FG001|Overall Study|moving out of state|1|||
105935313|NCT04193527|365422942|FG000|Overall Study|Other|1|||
105935314|NCT04193527|365422943|FG001|Overall Study|Other|1|||
105935315|NCT04193527|365422944|FG002|Overall Study|Other|0|||
105935316|NCT00560404|365422946|FG000|Overall Study|Adverse Event|2|||
105935317|NCT00560404|365422947|FG001|Overall Study|Adverse Event|3|||
105935318|NCT00560404|365422946|FG000|Overall Study|Death|3|||
105935319|NCT00560404|365422947|FG001|Overall Study|Death|3|||
105935320|NCT00560404|365422946|FG000|Overall Study|Protocol Violation|12|||
105935321|NCT00560404|365422947|FG001|Overall Study|Protocol Violation|7|||
105720202|NCT00686127|364633925|FG001|Overall Study|Withdrawal by Subject|6|||
105720203|NCT00066690|364633926|FG000|Overall Study|Adverse Event|145|||
105720204|NCT00066690|364633927|FG001|Overall Study|Adverse Event|58|||
105720205|NCT00066690|364633928|FG002|Overall Study|Adverse Event|126|||
105720206|NCT00066690|364633926|FG000|Overall Study|Death|3|||
105720207|NCT00066690|364633927|FG001|Overall Study|Death|0|||
105720208|NCT00066690|364633928|FG002|Overall Study|Death|2|||
105720209|NCT00066690|364633926|FG000|Overall Study|Lack of Efficacy|114|||
105720210|NCT00066690|364633927|FG001|Overall Study|Lack of Efficacy|110|||
105720211|NCT00066690|364633928|FG002|Overall Study|Lack of Efficacy|76|||
105720212|NCT00066690|364633926|FG000|Overall Study|Lost to Follow-up|40|||
105720213|NCT00066690|364633927|FG001|Overall Study|Lost to Follow-up|21|||
105720214|NCT00066690|364633928|FG002|Overall Study|Lost to Follow-up|29|||
105720215|NCT00066690|364633926|FG000|Overall Study|Withdrawal by Subject|50|||
105720216|NCT00066690|364633927|FG001|Overall Study|Withdrawal by Subject|55|||
105720217|NCT00066690|364633928|FG002|Overall Study|Withdrawal by Subject|49|||
105720218|NCT00066690|364633926|FG000|Overall Study|Treatment Ongoing|246|||
105720219|NCT00066690|364633927|FG001|Overall Study|Treatment Ongoing|278|||
105720220|NCT00066690|364633928|FG002|Overall Study|Treatment Ongoing|282|||
105720221|NCT00379340|364633931|FG000|Overall Study|Death|0|||
105720222|NCT00379340|364633932|FG001|Overall Study|Death|0|||
105720223|NCT00379340|364633933|FG002|Overall Study|Death|0|||
105720224|NCT00379340|364633934|FG003|Overall Study|Death|2|||
105720225|NCT00379340|364633935|FG004|Overall Study|Death|0|||
105720226|NCT00379340|364633931|FG000|Overall Study|Lack of Efficacy|6|||
105720227|NCT00379340|364633932|FG001|Overall Study|Lack of Efficacy|1|||
105720228|NCT00379340|364633933|FG002|Overall Study|Lack of Efficacy|0|||
105720229|NCT00379340|364633934|FG003|Overall Study|Lack of Efficacy|4|||
105720230|NCT00379340|364633935|FG004|Overall Study|Lack of Efficacy|3|||
105720231|NCT00379340|364633931|FG000|Overall Study|Physician Decision|6|||
105720232|NCT00379340|364633932|FG001|Overall Study|Physician Decision|2|||
105720233|NCT00379340|364633933|FG002|Overall Study|Physician Decision|1|||
105720234|NCT00379340|364633934|FG003|Overall Study|Physician Decision|2|||
105720235|NCT00379340|364633935|FG004|Overall Study|Physician Decision|3|||
105720236|NCT00379340|364633931|FG000|Overall Study|Withdrawal by Subject|0|||
105935322|NCT00560404|365422946|FG000|Overall Study|Administrative Reasons|1|||
105720237|NCT00379340|364633932|FG001|Overall Study|Withdrawal by Subject|0|||
105720238|NCT00379340|364633933|FG002|Overall Study|Withdrawal by Subject|0|||
105720239|NCT00379340|364633934|FG003|Overall Study|Withdrawal by Subject|1|||
105720240|NCT00379340|364633935|FG004|Overall Study|Withdrawal by Subject|0|||
105720241|NCT00379340|364633931|FG000|Overall Study|Refusal of further protocol therapy|1|||
105720242|NCT00379340|364633932|FG001|Overall Study|Refusal of further protocol therapy|0|||
105720243|NCT00379340|364633933|FG002|Overall Study|Refusal of further protocol therapy|1|||
105720244|NCT00379340|364633934|FG003|Overall Study|Refusal of further protocol therapy|1|||
105935323|NCT00560404|365422947|FG001|Overall Study|Administrative Reasons|1|||
105935324|NCT00560404|365422946|FG000|Overall Study|Withdrew Consent|4|||
105935325|NCT00560404|365422947|FG001|Overall Study|Withdrew Consent|0|||
105935326|NCT00560404|365422946|FG000|Overall Study|Failure to return|1|||
105935327|NCT00560404|365422947|FG001|Overall Study|Failure to return|2|||
105935328|NCT00560404|365422946|FG000|Overall Study|Other withdrawal reason|13|||
105935329|NCT00560404|365422947|FG001|Overall Study|Other withdrawal reason|5|||
105935330|NCT01618708|365422948|FG000|Overall Study|Adverse Event|10|||
105720245|NCT00379340|364633935|FG004|Overall Study|Refusal of further protocol therapy|7|||
105792162|NCT02780115|364894374|FG002|Overall Study|Adverse Event|0|||
105792163|NCT02780115|364894375|FG003|Overall Study|Adverse Event|1|||
105720246|NCT00379340|364633931|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
105720247|NCT00379340|364633932|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
105720248|NCT00379340|364633933|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
105720249|NCT00379340|364633934|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
105720250|NCT00379340|364633935|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
105720251|NCT00379340|364633931|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
105720252|NCT00379340|364633932|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
105720253|NCT00379340|364633933|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
105792164|NCT02780115|364894376|FG004|Overall Study|Adverse Event|1|||
105792165|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
105792166|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
105792167|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
105792168|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
105792169|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
105792170|NCT01179191|364894377|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
105792171|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
105792172|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
105792173|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
105792174|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
105792175|NCT01179191|364894377|FG000|Maintenance Phase (8 Weeks)|Other|66|||
105792176|NCT00592007|364894383|FG000|Overall Study|Withdrawal by Subject|1|||
105792177|NCT00592007|364894383|FG000|Overall Study|patient ineligible (out of lab range)|1|||
105792178|NCT00457418|364894384|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
105792179|NCT00457418|364894384|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
105792180|NCT00457418|364894384|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
105792181|NCT00457418|364894384|FG000|Post PK Maintenance|Adverse Event|10|||
105792182|NCT00457418|364894384|FG000|Post PK Maintenance|Progression of Disease|6|||
105792183|NCT00457418|364894384|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
105792184|NCT00457418|364894384|FG000|Post PK Maintenance|Lost to Follow-up|1|||
105792185|NCT04054011|364894385|FG000|Overall Study|COVID|3|||
105792186|NCT00595127|364894386|FG000|Overall Study|Death|6|||
105792187|NCT00595127|364894386|FG000|Overall Study|Relapsed|3|||
105792188|NCT00595127|364894386|FG000|Overall Study|joined another trial|1|||
105792189|NCT01785472|364894387|FG000|Overall Study|Adverse Event|5|||
105792190|NCT01785472|364894388|FG001|Overall Study|Adverse Event|4|||
105720254|NCT00379340|364633934|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
105720255|NCT00379340|364633935|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
105720256|NCT02159807|364633938|FG000|Overall Study|Adverse Event|0|||
105720257|NCT02159807|364633939|FG001|Overall Study|Adverse Event|0|||
105792191|NCT01785472|364894389|FG002|Overall Study|Adverse Event|6|||
105792192|NCT01785472|364894387|FG000|Overall Study|Lack of Efficacy|2|||
105792193|NCT01785472|364894388|FG001|Overall Study|Lack of Efficacy|0|||
105720258|NCT02159807|364633940|FG002|Overall Study|Adverse Event|1|||
105720259|NCT02159807|364633938|FG000|Overall Study|No CSF|1|||
105720260|NCT02159807|364633939|FG001|Overall Study|No CSF|1|||
105720261|NCT02159807|364633940|FG002|Overall Study|No CSF|1|||
105720262|NCT02159807|364633938|FG000|Overall Study|elevated blood pressure|0|||
105720263|NCT02159807|364633939|FG001|Overall Study|elevated blood pressure|0|||
105720264|NCT02159807|364633940|FG002|Overall Study|elevated blood pressure|1|||
105720265|NCT01552902|364633941|FG000|Overall Study|Adverse Event|1|||
105720266|NCT01552902|364633942|FG001|Overall Study|Adverse Event|15|||
105792194|NCT01785472|364894389|FG002|Overall Study|Lack of Efficacy|1|||
105792195|NCT01785472|364894387|FG000|Overall Study|Lost to Follow-up|1|||
105935331|NCT01618708|365422949|FG001|Overall Study|Adverse Event|10|||
105935332|NCT01618708|365422948|FG000|Overall Study|Lost to Follow-up|3|||
105935333|NCT01618708|365422949|FG001|Overall Study|Lost to Follow-up|3|||
105935334|NCT01618708|365422948|FG000|Overall Study|Withdrawal by Subject|17|||
105720267|NCT01552902|364633943|FG002|Overall Study|Adverse Event|14|||
105720268|NCT01552902|364633941|FG000|Overall Study|Protocol Violation|3|||
105720269|NCT01552902|364633942|FG001|Overall Study|Protocol Violation|3|||
105720270|NCT01552902|364633943|FG002|Overall Study|Protocol Violation|3|||
105720271|NCT01552902|364633941|FG000|Overall Study|Lack of Efficacy|4|||
105792196|NCT01785472|364894388|FG001|Overall Study|Lost to Follow-up|2|||
105792197|NCT01785472|364894389|FG002|Overall Study|Lost to Follow-up|0|||
105792198|NCT01785472|364894387|FG000|Overall Study|Physician Decision|1|||
105792199|NCT01785472|364894388|FG001|Overall Study|Physician Decision|1|||
105792200|NCT01785472|364894389|FG002|Overall Study|Physician Decision|1|||
105792201|NCT01785472|364894387|FG000|Overall Study|Protocol deviation|0|||
105935335|NCT01618708|365422949|FG001|Overall Study|Withdrawal by Subject|22|||
105935336|NCT01618708|365422948|FG000|Overall Study|Lack of Efficacy|8|||
105935337|NCT01618708|365422949|FG001|Overall Study|Lack of Efficacy|8|||
105720272|NCT01552902|364633942|FG001|Overall Study|Lack of Efficacy|3|||
105720273|NCT01552902|364633943|FG002|Overall Study|Lack of Efficacy|1|||
105720274|NCT01552902|364633941|FG000|Overall Study|Withdrawal by Subject|1|||
105720275|NCT01552902|364633942|FG001|Overall Study|Withdrawal by Subject|9|||
105720276|NCT01552902|364633943|FG002|Overall Study|Withdrawal by Subject|6|||
105720277|NCT01552902|364633941|FG000|Overall Study|Lost to Follow-up|1|||
105720278|NCT01552902|364633942|FG001|Overall Study|Lost to Follow-up|3|||
105720279|NCT01552902|364633943|FG002|Overall Study|Lost to Follow-up|6|||
105720280|NCT01552902|364633941|FG000|Overall Study|Other|3|||
105720281|NCT01552902|364633942|FG001|Overall Study|Other|4|||
105720282|NCT01552902|364633943|FG002|Overall Study|Other|3|||
105720283|NCT01254669|364633947|FG000|Overall Study|Withdrawal by Subject|0|||
105720284|NCT01254669|364633948|FG001|Overall Study|Withdrawal by Subject|1|||
105720285|NCT01254669|364633947|FG000|Overall Study|time constraint|2|||
105720286|NCT01254669|364633948|FG001|Overall Study|time constraint|2|||
105720287|NCT01254669|364633947|FG000|Overall Study|called to clinic during intervention|1|||
105720288|NCT01254669|364633948|FG001|Overall Study|called to clinic during intervention|1|||
105720289|NCT00542191|364633952|FG000|Overall Study|Death|3|||
105720290|NCT00103012|364633953|FG000|Overall Study|Withdrawal by Subject|2|||
105720291|NCT00103012|364633954|FG001|Overall Study|Withdrawal by Subject|1|||
105720292|NCT00103012|364633955|FG002|Overall Study|Withdrawal by Subject|2|||
105720293|NCT00103012|364633953|FG000|Overall Study|Pregnancy|1|||
105720294|NCT00103012|364633954|FG001|Overall Study|Pregnancy|0|||
105720295|NCT00103012|364633955|FG002|Overall Study|Pregnancy|0|||
105720296|NCT00103012|364633953|FG000|Overall Study|Adverse Event|0|||
105720297|NCT00103012|364633954|FG001|Overall Study|Adverse Event|0|||
105720298|NCT00103012|364633955|FG002|Overall Study|Adverse Event|1|||
105720299|NCT00103012|364633953|FG000|Overall Study|Subject non-compliant with medications|0|||
105720300|NCT00103012|364633954|FG001|Overall Study|Subject non-compliant with medications|0|||
105720301|NCT00103012|364633955|FG002|Overall Study|Subject non-compliant with medications|1|||
105720302|NCT02357420|364633956|FG000|Overall Study|Adverse Event|3|||
105720303|NCT02357420|364633957|FG001|Overall Study|Adverse Event|3|||
105720304|NCT02357420|364633958|FG002|Overall Study|Adverse Event|8|||
105720305|NCT02357420|364633959|FG003|Overall Study|Adverse Event|9|||
105720306|NCT02357420|364633956|FG000|Overall Study|Investigator Decision|1|||
105720307|NCT02357420|364633957|FG001|Overall Study|Investigator Decision|0|||
105720308|NCT02357420|364633958|FG002|Overall Study|Investigator Decision|0|||
105720309|NCT02357420|364633959|FG003|Overall Study|Investigator Decision|0|||
105720310|NCT02357420|364633956|FG000|Overall Study|Prohibited Medication|1|||
105720311|NCT02357420|364633957|FG001|Overall Study|Prohibited Medication|1|||
105720312|NCT02357420|364633958|FG002|Overall Study|Prohibited Medication|0|||
105720313|NCT02357420|364633959|FG003|Overall Study|Prohibited Medication|0|||
105720314|NCT02357420|364633956|FG000|Overall Study|Protocol Non-compliance|0|||
105720315|NCT02357420|364633957|FG001|Overall Study|Protocol Non-compliance|0|||
105720316|NCT02357420|364633958|FG002|Overall Study|Protocol Non-compliance|0|||
105720317|NCT02357420|364633959|FG003|Overall Study|Protocol Non-compliance|1|||
105720318|NCT02357420|364633956|FG000|Overall Study|Withdrawn Consent|4|||
105720319|NCT02357420|364633957|FG001|Overall Study|Withdrawn Consent|8|||
105720320|NCT02357420|364633958|FG002|Overall Study|Withdrawn Consent|6|||
105720321|NCT02357420|364633959|FG003|Overall Study|Withdrawn Consent|6|||
105720322|NCT02357420|364633956|FG000|Overall Study|Lost to Follow-up|3|||
105720323|NCT02357420|364633957|FG001|Overall Study|Lost to Follow-up|0|||
105720324|NCT02357420|364633958|FG002|Overall Study|Lost to Follow-up|2|||
105720325|NCT02357420|364633959|FG003|Overall Study|Lost to Follow-up|3|||
105720326|NCT03624946|364633963|FG000|Overall Study|Lost to Follow-up|0|||
105720327|NCT03624946|364633964|FG001|Overall Study|Lost to Follow-up|1|||
105720328|NCT01925209|364633965|FG000|Treatment Epoch|Physician Decision|1|||
105792202|NCT01785472|364894388|FG001|Overall Study|Protocol deviation|2|||
105792203|NCT01785472|364894389|FG002|Overall Study|Protocol deviation|2|||
105792204|NCT01785472|364894387|FG000|Overall Study|Subject/guardian decision|15|||
105792205|NCT01785472|364894388|FG001|Overall Study|Subject/guardian decision|10|||
105792206|NCT01785472|364894389|FG002|Overall Study|Subject/guardian decision|11|||
105720329|NCT01925209|364633966|FG001|Treatment Epoch|Physician Decision|0|||
105720330|NCT01925209|364633967|FG002|Treatment Epoch|Physician Decision|0|||
105720331|NCT01925209|364633968|FG003|Treatment Epoch|Physician Decision|0|||
105720332|NCT01925209|364633965|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
105720333|NCT01925209|364633966|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
105792207|NCT01785472|364894387|FG000|Overall Study|Technical problems|0|||
105792208|NCT01785472|364894388|FG001|Overall Study|Technical problems|0|||
105792209|NCT01785472|364894389|FG002|Overall Study|Technical problems|1|||
106137145|NCT00603447|366160396|FG006|Overall Study|Adverse Event|10|||
105720334|NCT01925209|364633967|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
105792210|NCT02086968|364894392|FG000|Overall Study|Adverse Event|1|||
106137146|NCT00603447|366160390|FG000|Overall Study|Other|0|||
105720335|NCT01925209|364633968|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
105720336|NCT01925209|364633965|FG000|Treatment Epoch|Death|1|||
105720337|NCT01925209|364633966|FG001|Treatment Epoch|Death|0|||
105720338|NCT01925209|364633967|FG002|Treatment Epoch|Death|0|||
105720339|NCT01925209|364633968|FG003|Treatment Epoch|Death|0|||
105792211|NCT02086968|364894393|FG001|Overall Study|Adverse Event|5|||
106137147|NCT00603447|366160391|FG001|Overall Study|Other|0|||
106137148|NCT00603447|366160392|FG002|Overall Study|Other|1|||
106137149|NCT00603447|366160393|FG003|Overall Study|Other|0|||
106137150|NCT00603447|366160394|FG004|Overall Study|Other|3|||
105720340|NCT01925209|364633965|FG000|Treatment Epoch|Protocol deviation|0|||
105720341|NCT01925209|364633966|FG001|Treatment Epoch|Protocol deviation|0|||
105720342|NCT01925209|364633967|FG002|Treatment Epoch|Protocol deviation|1|||
105720343|NCT01925209|364633968|FG003|Treatment Epoch|Protocol deviation|1|||
105720344|NCT01925209|364633965|FG000|Treatment Epoch|Withdrawal by Subject|4|||
105720345|NCT01925209|364633966|FG001|Treatment Epoch|Withdrawal by Subject|3|||
105720346|NCT01925209|364633967|FG002|Treatment Epoch|Withdrawal by Subject|3|||
105720347|NCT01925209|364633968|FG003|Treatment Epoch|Withdrawal by Subject|2|||
105720348|NCT01925209|364633965|FG000|Treatment Epoch|Adverse Event|3|||
105720349|NCT01925209|364633966|FG001|Treatment Epoch|Adverse Event|5|||
105720350|NCT01925209|364633967|FG002|Treatment Epoch|Adverse Event|3|||
105720351|NCT01925209|364633968|FG003|Treatment Epoch|Adverse Event|1|||
105720352|NCT01925209|364633965|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
105720353|NCT01925209|364633966|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
105720354|NCT01925209|364633967|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
105720355|NCT01925209|364633968|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
105720356|NCT01925209|364633965|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
105720357|NCT01925209|364633966|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
105720358|NCT01925209|364633967|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
105720359|NCT01925209|364633968|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
105720360|NCT01925209|364633965|FG000|Follow-up|Adverse Event|1|||
105720361|NCT01925209|364633966|FG001|Follow-up|Adverse Event|4|||
105720362|NCT01925209|364633967|FG002|Follow-up|Adverse Event|0|||
105720363|NCT01925209|364633968|FG003|Follow-up|Adverse Event|1|||
105720364|NCT01925209|364633965|FG000|Follow-up|Physician Decision|0|||
105720365|NCT01925209|364633966|FG001|Follow-up|Physician Decision|0|||
105720366|NCT01925209|364633967|FG002|Follow-up|Physician Decision|1|||
105720367|NCT01925209|364633968|FG003|Follow-up|Physician Decision|0|||
105720368|NCT01925209|364633965|FG000|Follow-up|Non-compliance with study treatment|0|||
105720369|NCT01925209|364633966|FG001|Follow-up|Non-compliance with study treatment|0|||
105720370|NCT01925209|364633967|FG002|Follow-up|Non-compliance with study treatment|0|||
105720371|NCT01925209|364633968|FG003|Follow-up|Non-compliance with study treatment|1|||
105720372|NCT01925209|364633965|FG000|Follow-up|Withdrawal by Subject|0|||
105720373|NCT01925209|364633966|FG001|Follow-up|Withdrawal by Subject|2|||
105720374|NCT01925209|364633967|FG002|Follow-up|Withdrawal by Subject|0|||
105720375|NCT01925209|364633968|FG003|Follow-up|Withdrawal by Subject|2|||
105720376|NCT01299727|364633972|FG000|Overall Study|Withdrawal by Subject|1|||
105720377|NCT01299727|364633973|FG001|Overall Study|Withdrawal by Subject|0|||
105720378|NCT01299727|364633974|FG002|Overall Study|Withdrawal by Subject|0|||
105720379|NCT01299727|364633972|FG000|Overall Study|Adverse Event|0|||
105720380|NCT01299727|364633973|FG001|Overall Study|Adverse Event|0|||
105720381|NCT01299727|364633974|FG002|Overall Study|Adverse Event|1|||
105720382|NCT01299727|364633972|FG000|Overall Study|Completed the Treatment Period|3|||
105720383|NCT01299727|364633973|FG001|Overall Study|Completed the Treatment Period|4|||
105720384|NCT01299727|364633974|FG002|Overall Study|Completed the Treatment Period|3|||
105720385|NCT03486392|364633980|FG000|Overall Study|Lost to Follow-up|0|||
105720386|NCT03486392|364633981|FG001|Overall Study|Lost to Follow-up|0|||
105720387|NCT03486392|364633982|FG002|Overall Study|Lost to Follow-up|8|||
105720388|NCT03486392|364633983|FG003|Overall Study|Lost to Follow-up|5|||
105720389|NCT03486392|364633984|FG004|Overall Study|Lost to Follow-up|2|||
105720390|NCT03486392|364633980|FG000|Overall Study|Withdrawal by Subject|3|||
105720391|NCT03486392|364633981|FG001|Overall Study|Withdrawal by Subject|0|||
105720392|NCT03486392|364633982|FG002|Overall Study|Withdrawal by Subject|6|||
105720393|NCT03486392|364633983|FG003|Overall Study|Withdrawal by Subject|4|||
105720394|NCT03486392|364633984|FG004|Overall Study|Withdrawal by Subject|1|||
105720395|NCT03486392|364633980|FG000|Overall Study|Death|0|||
105720396|NCT03486392|364633981|FG001|Overall Study|Death|0|||
105720397|NCT03486392|364633982|FG002|Overall Study|Death|0|||
105720398|NCT03486392|364633983|FG003|Overall Study|Death|0|||
105720399|NCT03486392|364633984|FG004|Overall Study|Death|1|||
105720400|NCT03157531|364633986|FG000|Overall Study|Death|2|||
106137151|NCT00603447|366160395|FG005|Overall Study|Other|0|||
106137152|NCT00603447|366160396|FG006|Overall Study|Other|13|||
105720401|NCT03157531|364633986|FG000|Overall Study|Lost to Follow-up|4|||
105720402|NCT00331006|364633987|FG000|Screening Phase|Withdrawal by Subject|1|||
105720403|NCT00331006|364633987|FG000|Screening Phase|enrollment halted|1|||
105720404|NCT00331006|364633987|FG000|Screening Phase|Lost to Follow-up|1|||
105720405|NCT00331006|364633987|FG000|Screening Phase|Ineligible for treatment phase|4|||
105720406|NCT00331006|364633987|FG000|Treatment Phase|Withdrawal by Subject|1|||
105720407|NCT00331006|364633987|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
105720408|NCT00331006|364633987|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
105720409|NCT03804684|364633988|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
106137153|NCT00603447|366160390|FG000|Overall Study|Withdrew Consent|0|||
106137154|NCT00603447|366160391|FG001|Overall Study|Withdrew Consent|2|||
106137155|NCT00603447|366160392|FG002|Overall Study|Withdrew Consent|0|||
106137156|NCT00603447|366160393|FG003|Overall Study|Withdrew Consent|0|||
106137157|NCT00603447|366160394|FG004|Overall Study|Withdrew Consent|1|||
105720410|NCT03804684|364633989|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
105720411|NCT01950819|364633994|FG000|Overall Study|Graft Loss|35|||
105720412|NCT01950819|364633995|FG001|Overall Study|Graft Loss|30|||
105720413|NCT01950819|364633994|FG000|Overall Study|Death|29|||
105720414|NCT01950819|364633995|FG001|Overall Study|Death|34|||
105720415|NCT01950819|364633994|FG000|Overall Study|Subject / Gardian decision|54|||
105720416|NCT01950819|364633995|FG001|Overall Study|Subject / Gardian decision|51|||
105720417|NCT01950819|364633994|FG000|Overall Study|technical problems|2|||
105720418|NCT01950819|364633995|FG001|Overall Study|technical problems|0|||
105720419|NCT01950819|364633994|FG000|Overall Study|Pregnancy|0|||
105720420|NCT01950819|364633995|FG001|Overall Study|Pregnancy|2|||
105720421|NCT01950819|364633994|FG000|Overall Study|Lost to Follow-up|9|||
105720422|NCT01950819|364633995|FG001|Overall Study|Lost to Follow-up|17|||
105720423|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
105720424|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
105720425|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
105720426|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
105720427|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
105720428|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
105720429|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
105720430|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
105720431|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
105720432|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
105720433|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
105720434|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
105720435|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
105720436|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
105720437|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
105720438|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
105720439|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
105720440|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
105720441|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
105720442|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
105720443|NCT01360645|364633997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
105720444|NCT01360645|364633998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
105720445|NCT01360645|364633999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
105720446|NCT01360645|364634000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
105720447|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
105720448|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
105720449|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
105720450|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
105720451|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Adverse Event|0|||
105720452|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Adverse Event|6|||
105720453|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Adverse Event|0|||
105720454|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Adverse Event|0|||
105720455|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105720456|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
105720457|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
105720458|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105720459|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
105720460|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
105720461|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
105720462|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
105720463|NCT01360645|364633997|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
105720464|NCT01360645|364633998|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
105720465|NCT01360645|364633999|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
105720466|NCT01360645|364634000|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
105720467|NCT01360645|364633997|FG000|Phase A+|Lost to Follow-up|0|||
105720468|NCT01360645|364633998|FG001|Phase A+|Lost to Follow-up|0|||
105720469|NCT01360645|364633999|FG002|Phase A+|Lost to Follow-up|0|||
106137158|NCT00603447|366160395|FG005|Overall Study|Withdrew Consent|0|||
106137159|NCT00603447|366160396|FG006|Overall Study|Withdrew Consent|1|||
106137160|NCT00798265|366160397|FG000|Overall Study|Lost to Follow-up|1|||
105720470|NCT01360645|364634000|FG003|Phase A+|Lost to Follow-up|7|||
106137161|NCT00798265|366160398|FG001|Overall Study|Lost to Follow-up|10|||
106137162|NCT00798265|366160397|FG000|Overall Study|Study closing|7|||
105720471|NCT01360645|364633997|FG000|Phase A+|Adverse Event|0|||
105720472|NCT01360645|364633998|FG001|Phase A+|Adverse Event|0|||
105720473|NCT01360645|364633999|FG002|Phase A+|Adverse Event|0|||
106137163|NCT00798265|366160398|FG001|Overall Study|Study closing|6|||
106137164|NCT00798265|366160397|FG000|Overall Study|Withdrawal by Subject|0|||
106137165|NCT00798265|366160398|FG001|Overall Study|Withdrawal by Subject|1|||
106137166|NCT00798265|366160397|FG000|Overall Study|Screen failure|0|||
106137167|NCT00798265|366160398|FG001|Overall Study|Screen failure|1|||
106137168|NCT01537133|366161967|FG000|Overall Study|Withdrawal by Subject|2|||
106137169|NCT01537133|366161968|FG001|Overall Study|Withdrawal by Subject|0|||
106137170|NCT01537133|366161969|FG002|Overall Study|Withdrawal by Subject|0|||
106137171|NCT01537133|366161970|FG003|Overall Study|Withdrawal by Subject|0|||
106137172|NCT01537133|366161967|FG000|Overall Study|Lost to Follow-up|1|||
105792212|NCT02086968|364894392|FG000|Overall Study|Lost to Follow-up|2|||
105792213|NCT02086968|364894393|FG001|Overall Study|Lost to Follow-up|3|||
105792214|NCT02086968|364894392|FG000|Overall Study|Study drug received outside protocol|0|||
105792215|NCT02086968|364894393|FG001|Overall Study|Study drug received outside protocol|1|||
105792216|NCT02086968|364894392|FG000|Overall Study|Physician Decision|4|||
105792217|NCT02086968|364894393|FG001|Overall Study|Physician Decision|0|||
105792218|NCT02086968|364894392|FG000|Overall Study|Withdrawal by Subject|1|||
105792219|NCT02086968|364894393|FG001|Overall Study|Withdrawal by Subject|4|||
105792220|NCT02297438|364894396|FG000|Overall Study|Death|79|||
105792221|NCT02297438|364894397|FG001|Overall Study|Death|86|||
105792222|NCT02297438|364894396|FG000|Overall Study|Lost to Follow-up|9|||
105792223|NCT02297438|364894397|FG001|Overall Study|Lost to Follow-up|7|||
105792224|NCT02297438|364894396|FG000|Overall Study|Withdrawal by Subject|7|||
105792225|NCT02297438|364894397|FG001|Overall Study|Withdrawal by Subject|0|||
105792226|NCT02297438|364894396|FG000|Overall Study|Other|9|||
105792227|NCT02297438|364894397|FG001|Overall Study|Other|5|||
105792228|NCT02297438|364894396|FG000|Overall Study|Ongoing|65|||
105792229|NCT02297438|364894397|FG001|Overall Study|Ongoing|73|||
105792230|NCT04856917|364894400|FG000|Overall Study|Withdrawal by Subject|4|||
105792231|NCT04856917|364894401|FG001|Overall Study|Withdrawal by Subject|3|||
105792232|NCT04856917|364894402|FG002|Overall Study|Withdrawal by Subject|1|||
105792233|NCT04856917|364894400|FG000|Overall Study|Lost to Follow-up|3|||
105792234|NCT04856917|364894401|FG001|Overall Study|Lost to Follow-up|1|||
105792235|NCT04856917|364894402|FG002|Overall Study|Lost to Follow-up|1|||
105792236|NCT04856917|364894400|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
105792237|NCT04856917|364894401|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
105792238|NCT04856917|364894402|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
105792239|NCT04856917|364894400|FG000|Overall Study|Other|1|||
105792240|NCT04856917|364894401|FG001|Overall Study|Other|1|||
105792241|NCT04856917|364894402|FG002|Overall Study|Other|0|||
105792242|NCT00537056|364894404|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
105792243|NCT01244516|364894408|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
105792244|NCT01244516|364894409|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
105792245|NCT01244516|364894410|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
105792246|NCT01244516|364894408|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
105792247|NCT01244516|364894409|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
105792248|NCT01244516|364894410|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
105792249|NCT01244516|364894408|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
105792250|NCT01244516|364894409|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
105792251|NCT01244516|364894410|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
105792252|NCT01244516|364894408|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
105792253|NCT01244516|364894409|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
105792254|NCT01244516|364894410|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
105792255|NCT01244516|364894408|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
105792256|NCT01244516|364894409|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
105792257|NCT01244516|364894410|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
105792258|NCT01244516|364894408|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
105792259|NCT01244516|364894409|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
105792260|NCT01244516|364894410|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
105792261|NCT01244516|364894408|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
105792262|NCT01244516|364894409|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
105792263|NCT01244516|364894410|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
105792264|NCT03466060|364894411|FG000|Period 1|Test Lens Damage|0|||
105935338|NCT01618708|365422948|FG000|Overall Study|Technical problems|2|||
105935339|NCT01618708|365422949|FG001|Overall Study|Technical problems|0|||
105935340|NCT01618708|365422948|FG000|Overall Study|Other than specified above|1|||
105792265|NCT03466060|364894412|FG001|Period 1|Test Lens Damage|2|||
105935341|NCT01618708|365422949|FG001|Overall Study|Other than specified above|1|||
105935342|NCT01618708|365422948|FG000|Overall Study|Randomized but not treated|3|||
105935343|NCT01618708|365422949|FG001|Overall Study|Randomized but not treated|2|||
105935344|NCT01905267|365422950|FG000|Overall Study|Physician Decision|2|||
105935345|NCT01905267|365422951|FG001|Overall Study|Physician Decision|2|||
105935346|NCT03888482|365422952|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
106137173|NCT01537133|366161968|FG001|Overall Study|Lost to Follow-up|0|||
105935347|NCT03888482|365422953|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
105720474|NCT01360645|364634000|FG003|Phase A+|Adverse Event|2|||
105720475|NCT01360645|364633997|FG000|Phase A+|Met Withdrawal Criteria|0|||
105720476|NCT01360645|364633998|FG001|Phase A+|Met Withdrawal Criteria|0|||
105935348|NCT03888482|365422952|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
105935349|NCT03888482|365422953|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
105935350|NCT03163264|365422954|FG000|Overall Study|Withdrawal by Subject|13|||
105720477|NCT01360645|364633999|FG002|Phase A+|Met Withdrawal Criteria|0|||
105720478|NCT01360645|364634000|FG003|Phase A+|Met Withdrawal Criteria|4|||
105720479|NCT01360645|364633997|FG000|Phase A+|Physician Decision|0|||
105720480|NCT01360645|364633998|FG001|Phase A+|Physician Decision|0|||
105720481|NCT01360645|364633999|FG002|Phase A+|Physician Decision|0|||
105720482|NCT01360645|364634000|FG003|Phase A+|Physician Decision|2|||
105720483|NCT01360645|364633997|FG000|Phase A+|Withdrawal by Subject|0|||
105720484|NCT01360645|364633998|FG001|Phase A+|Withdrawal by Subject|0|||
105720485|NCT01360645|364633999|FG002|Phase A+|Withdrawal by Subject|0|||
105720486|NCT01360645|364634000|FG003|Phase A+|Withdrawal by Subject|5|||
105720487|NCT01360645|364633997|FG000|Phase A+|Protocol Deviation|0|||
105720488|NCT01360645|364633998|FG001|Phase A+|Protocol Deviation|0|||
105720489|NCT01360645|364633999|FG002|Phase A+|Protocol Deviation|0|||
105720490|NCT01360645|364634000|FG003|Phase A+|Protocol Deviation|4|||
105720491|NCT00773279|364634001|FG000|Period 1|Adverse Event|2|||
105720492|NCT00773279|364634002|FG001|Period 1|Adverse Event|1|||
105720493|NCT00773279|364634001|FG000|Period 1|Lack of Efficacy|0|||
105720494|NCT00773279|364634002|FG001|Period 1|Lack of Efficacy|2|||
105720495|NCT00773279|364634001|FG000|Period 1|Unclassified|5|||
105935351|NCT03163264|365422955|FG001|Overall Study|Withdrawal by Subject|3|||
105935352|NCT03163264|365422956|FG002|Overall Study|Withdrawal by Subject|4|||
105935353|NCT03163264|365422957|FG003|Overall Study|Withdrawal by Subject|2|||
105935354|NCT03163264|365422954|FG000|Overall Study|Lost to Follow-up|17|||
105935355|NCT03163264|365422955|FG001|Overall Study|Lost to Follow-up|20|||
105935356|NCT03163264|365422956|FG002|Overall Study|Lost to Follow-up|0|||
105935357|NCT03163264|365422957|FG003|Overall Study|Lost to Follow-up|0|||
105935358|NCT03163264|365422954|FG000|Overall Study|Death|0|||
105935359|NCT03163264|365422955|FG001|Overall Study|Death|2|||
105935360|NCT03163264|365422956|FG002|Overall Study|Death|0|||
105935361|NCT03163264|365422957|FG003|Overall Study|Death|0|||
105935362|NCT04648241|365422958|FG000|Overall Study|Lost to Follow-up|1|||
105935363|NCT04648241|365422959|FG001|Overall Study|Lost to Follow-up|0|||
105935364|NCT00498485|365422964|FG000|Overall Study|Adverse Event|1|||
105935365|NCT00498485|365422965|FG001|Overall Study|Adverse Event|5|||
105935366|NCT01108055|365422966|FG000|Overall Study|Ineligible|11|||
105935367|NCT01108055|365422966|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
105935368|NCT03478787|365422967|FG000|Overall Study|Adverse Event|5|||
105720496|NCT00773279|364634002|FG001|Period 1|Unclassified|1|||
105720497|NCT00773279|364634001|FG000|Period 2|Adverse Event|0|||
105720498|NCT00773279|364634002|FG001|Period 2|Adverse Event|1|||
105720499|NCT00773279|364634001|FG000|Period 2|Lack of Efficacy|1|||
105720500|NCT00773279|364634002|FG001|Period 2|Lack of Efficacy|0|||
105720501|NCT00773279|364634001|FG000|Period 2|Protocol Violation|0|||
105720502|NCT00773279|364634002|FG001|Period 2|Protocol Violation|3|||
105720503|NCT00773279|364634001|FG000|Period 2|Unclassified|2|||
105720504|NCT00773279|364634002|FG001|Period 2|Unclassified|2|||
105720505|NCT02211261|364634003|FG000|Overall Study|Withdrawal by Subject|0|||
105720506|NCT02211261|364634004|FG001|Overall Study|Withdrawal by Subject|0|||
105720507|NCT02211261|364634005|FG002|Overall Study|Withdrawal by Subject|1|||
105720508|NCT02211261|364634006|FG003|Overall Study|Withdrawal by Subject|0|||
105720509|NCT02211261|364634007|FG004|Overall Study|Withdrawal by Subject|2|||
105720510|NCT02211261|364634008|FG005|Overall Study|Withdrawal by Subject|0|||
105720511|NCT02211261|364634009|FG006|Overall Study|Withdrawal by Subject|0|||
105720512|NCT02211261|364634010|FG007|Overall Study|Withdrawal by Subject|0|||
105720513|NCT02211261|364634011|FG008|Overall Study|Withdrawal by Subject|0|||
105720514|NCT02211261|364634012|FG009|Overall Study|Withdrawal by Subject|0|||
105720515|NCT02211261|364634013|FG010|Overall Study|Withdrawal by Subject|0|||
105720516|NCT02211261|364634003|FG000|Overall Study|Other|0|||
105935369|NCT03478787|365422968|FG001|Overall Study|Adverse Event|1|||
105935370|NCT03478787|365422967|FG000|Overall Study|Protocol Violation|3|||
105935371|NCT03478787|365422968|FG001|Overall Study|Protocol Violation|0|||
105720517|NCT02211261|364634004|FG001|Overall Study|Other|0|||
105720518|NCT02211261|364634005|FG002|Overall Study|Other|0|||
105720519|NCT02211261|364634006|FG003|Overall Study|Other|0|||
105720520|NCT02211261|364634007|FG004|Overall Study|Other|0|||
105720521|NCT02211261|364634008|FG005|Overall Study|Other|1|||
105720522|NCT02211261|364634009|FG006|Overall Study|Other|0|||
105720523|NCT02211261|364634010|FG007|Overall Study|Other|0|||
105720524|NCT02211261|364634011|FG008|Overall Study|Other|0|||
105720525|NCT02211261|364634012|FG009|Overall Study|Other|2|||
105720526|NCT02211261|364634013|FG010|Overall Study|Other|0|||
105720527|NCT02211261|364634003|FG000|Overall Study|Lost to Follow-up|0|||
105720528|NCT02211261|364634004|FG001|Overall Study|Lost to Follow-up|0|||
105720529|NCT02211261|364634005|FG002|Overall Study|Lost to Follow-up|0|||
105720530|NCT02211261|364634006|FG003|Overall Study|Lost to Follow-up|0|||
105720531|NCT02211261|364634007|FG004|Overall Study|Lost to Follow-up|0|||
105935372|NCT03478787|365422967|FG000|Overall Study|Lack of Efficacy|7|||
105935373|NCT03478787|365422968|FG001|Overall Study|Lack of Efficacy|1|||
105720532|NCT02211261|364634008|FG005|Overall Study|Lost to Follow-up|0|||
105720533|NCT02211261|364634009|FG006|Overall Study|Lost to Follow-up|0|||
105720534|NCT02211261|364634010|FG007|Overall Study|Lost to Follow-up|1|||
105720535|NCT02211261|364634011|FG008|Overall Study|Lost to Follow-up|0|||
105720536|NCT02211261|364634012|FG009|Overall Study|Lost to Follow-up|0|||
105720537|NCT02211261|364634013|FG010|Overall Study|Lost to Follow-up|0|||
105720538|NCT01737931|364634014|FG000|Overall Study|Withdrawal by Subject|0|||
105720539|NCT01737931|364634015|FG001|Overall Study|Withdrawal by Subject|1|||
105720540|NCT01737931|364634016|FG002|Overall Study|Withdrawal by Subject|1|||
105720541|NCT01737931|364634014|FG000|Overall Study|Physician Decision|0|||
105935374|NCT03478787|365422967|FG000|Overall Study|Lost to Follow-up|9|||
105935375|NCT03478787|365422968|FG001|Overall Study|Lost to Follow-up|5|||
105935376|NCT03478787|365422967|FG000|Overall Study|Withdrawal by Subject|2|||
105935377|NCT03478787|365422968|FG001|Overall Study|Withdrawal by Subject|6|||
105935378|NCT03478787|365422967|FG000|Overall Study|Other, Not Specified|3|||
105935379|NCT03478787|365422968|FG001|Overall Study|Other, Not Specified|0|||
105935380|NCT01712074|365422971|FG000|Placebo Run-in Period|Adverse Event|2|||
105935381|NCT01712074|365422972|FG001|Placebo Run-in Period|Adverse Event|0|||
105935382|NCT01712074|365422973|FG002|Placebo Run-in Period|Adverse Event|0|||
105935383|NCT01712074|365422971|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
105720542|NCT01737931|364634015|FG001|Overall Study|Physician Decision|1|||
105720543|NCT01737931|364634016|FG002|Overall Study|Physician Decision|0|||
105720544|NCT04336163|364634017|FG000|Overall Study|Lost to Follow-up|55|||
105720545|NCT04336163|364634018|FG001|Overall Study|Lost to Follow-up|0|||
105720546|NCT03258814|364634019|FG000|Overall Study|Early Termination|4|||
105720547|NCT03258814|364634020|FG001|Overall Study|Early Termination|3|||
105720548|NCT03258814|364634021|FG002|Overall Study|Early Termination|10|||
105720549|NCT00480857|364634022|FG000|Overall Study|Lack of Efficacy|2|||
105720550|NCT02266433|364634023|FG000|Overall Study|Lost to Follow-up|54|||
105720551|NCT02266433|364634024|FG001|Overall Study|Lost to Follow-up|46|||
105720552|NCT02266433|364634023|FG000|Overall Study|Withdrawal by Subject|5|||
105720553|NCT02266433|364634024|FG001|Overall Study|Withdrawal by Subject|7|||
105720554|NCT01015833|364634027|FG000|Overall Study|Death|1|||
105720555|NCT01015833|364634028|FG001|Overall Study|Death|0|||
105720556|NCT01015833|364634027|FG000|Overall Study|Withdrawal by Subject|3|||
105720557|NCT01015833|364634028|FG001|Overall Study|Withdrawal by Subject|2|||
105720558|NCT01015833|364634027|FG000|Overall Study|Adverse Event|0|||
105720559|NCT01015833|364634028|FG001|Overall Study|Adverse Event|1|||
105720560|NCT01015833|364634027|FG000|Overall Study|Physician Decision|2|||
105720561|NCT01015833|364634028|FG001|Overall Study|Physician Decision|0|||
105720562|NCT01015833|364634027|FG000|Overall Study|Symptomatic deterioration|0|||
105720563|NCT01015833|364634028|FG001|Overall Study|Symptomatic deterioration|1|||
105720564|NCT01015833|364634027|FG000|Overall Study|Other|5|||
105935384|NCT01712074|365422972|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
105935385|NCT01712074|365422973|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
105935386|NCT01712074|365422971|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
105935387|NCT01712074|365422972|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
105935388|NCT01712074|365422973|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
105935389|NCT01712074|365422971|FG000|Placebo Run-in Period|Other|1|||
105935390|NCT01712074|365422972|FG001|Placebo Run-in Period|Other|0|||
105935391|NCT01712074|365422973|FG002|Placebo Run-in Period|Other|0|||
105935392|NCT01712074|365422971|FG000|Placebo Run-in Period|No longer willing to participate|1|||
105935393|NCT01712074|365422972|FG001|Placebo Run-in Period|No longer willing to participate|0|||
105935394|NCT01712074|365422973|FG002|Placebo Run-in Period|No longer willing to participate|0|||
105935395|NCT01712074|365422971|FG000|Double Blind Period|Adverse Event|0|||
105935396|NCT01712074|365422972|FG001|Double Blind Period|Adverse Event|2|||
105935397|NCT01712074|365422973|FG002|Double Blind Period|Adverse Event|1|||
105935398|NCT01712074|365422971|FG000|Double Blind Period|No longer willing to participate|0|||
105935399|NCT01712074|365422972|FG001|Double Blind Period|No longer willing to participate|2|||
105935400|NCT01712074|365422973|FG002|Double Blind Period|No longer willing to participate|4|||
105720565|NCT01015833|364634028|FG001|Overall Study|Other|1|||
105935401|NCT01712074|365422971|FG000|Double Blind Period|Death|0|||
105935402|NCT01712074|365422972|FG001|Double Blind Period|Death|1|||
105935403|NCT01712074|365422973|FG002|Double Blind Period|Death|0|||
105935404|NCT01712074|365422971|FG000|Double Blind Period|Lost to Follow-up|0|||
105935405|NCT01712074|365422972|FG001|Double Blind Period|Lost to Follow-up|2|||
105720566|NCT01015833|364634027|FG000|Overall Study|Motor Vehicle Accidents|1|||
105720567|NCT01015833|364634028|FG001|Overall Study|Motor Vehicle Accidents|0|||
105720568|NCT01015833|364634027|FG000|Overall Study|Did not start treatment|1|||
105720569|NCT01015833|364634028|FG001|Overall Study|Did not start treatment|0|||
105720570|NCT00481065|364634029|FG000|Overall Study|Adverse event or death|1|||
105720571|NCT00481065|364634030|FG001|Overall Study|Adverse event or death|1|||
105720572|NCT00481065|364634031|FG002|Overall Study|Adverse event or death|3|||
105720573|NCT00481065|364634032|FG003|Overall Study|Adverse event or death|0|||
105720574|NCT00481065|364634033|FG004|Overall Study|Adverse event or death|2|||
105720575|NCT00481065|364634034|FG005|Overall Study|Adverse event or death|0|||
105720576|NCT00481065|364634035|FG006|Overall Study|Adverse event or death|1|||
105720577|NCT00481065|364634036|FG007|Overall Study|Adverse event or death|1|||
105720578|NCT00481065|364634029|FG000|Overall Study|Withdrawal by Subject|11|||
105720579|NCT00481065|364634030|FG001|Overall Study|Withdrawal by Subject|12|||
105720580|NCT00481065|364634031|FG002|Overall Study|Withdrawal by Subject|7|||
105720581|NCT00481065|364634032|FG003|Overall Study|Withdrawal by Subject|11|||
105720582|NCT00481065|364634033|FG004|Overall Study|Withdrawal by Subject|13|||
105720583|NCT00481065|364634034|FG005|Overall Study|Withdrawal by Subject|12|||
105720584|NCT00481065|364634035|FG006|Overall Study|Withdrawal by Subject|9|||
105720585|NCT00481065|364634036|FG007|Overall Study|Withdrawal by Subject|10|||
105720586|NCT00481065|364634029|FG000|Overall Study|Lost to Follow-up|4|||
105720587|NCT00481065|364634030|FG001|Overall Study|Lost to Follow-up|2|||
105720588|NCT00481065|364634031|FG002|Overall Study|Lost to Follow-up|4|||
105720589|NCT00481065|364634032|FG003|Overall Study|Lost to Follow-up|3|||
105720590|NCT00481065|364634033|FG004|Overall Study|Lost to Follow-up|3|||
105720591|NCT00481065|364634034|FG005|Overall Study|Lost to Follow-up|3|||
105720592|NCT00481065|364634035|FG006|Overall Study|Lost to Follow-up|2|||
105720593|NCT00481065|364634036|FG007|Overall Study|Lost to Follow-up|5|||
105720594|NCT00481065|364634029|FG000|Overall Study|Inappropriate enrollment|4|||
105720595|NCT00481065|364634030|FG001|Overall Study|Inappropriate enrollment|0|||
105720596|NCT00481065|364634031|FG002|Overall Study|Inappropriate enrollment|2|||
105720597|NCT00481065|364634032|FG003|Overall Study|Inappropriate enrollment|0|||
105720598|NCT00481065|364634033|FG004|Overall Study|Inappropriate enrollment|2|||
105720599|NCT00481065|364634034|FG005|Overall Study|Inappropriate enrollment|1|||
105720600|NCT00481065|364634035|FG006|Overall Study|Inappropriate enrollment|0|||
105720601|NCT00481065|364634036|FG007|Overall Study|Inappropriate enrollment|1|||
105720602|NCT00481065|364634029|FG000|Overall Study|Administrative reason|0|||
105720603|NCT00481065|364634030|FG001|Overall Study|Administrative reason|0|||
105720604|NCT00481065|364634031|FG002|Overall Study|Administrative reason|0|||
105720605|NCT00481065|364634032|FG003|Overall Study|Administrative reason|0|||
105720606|NCT00481065|364634033|FG004|Overall Study|Administrative reason|0|||
105720607|NCT00481065|364634034|FG005|Overall Study|Administrative reason|2|||
105720608|NCT00481065|364634035|FG006|Overall Study|Administrative reason|1|||
105720609|NCT00481065|364634036|FG007|Overall Study|Administrative reason|0|||
105720610|NCT00481065|364634029|FG000|Overall Study|Protocol Violation|2|||
105720611|NCT00481065|364634030|FG001|Overall Study|Protocol Violation|1|||
105720612|NCT00481065|364634031|FG002|Overall Study|Protocol Violation|1|||
105720613|NCT00481065|364634032|FG003|Overall Study|Protocol Violation|1|||
105720614|NCT00481065|364634033|FG004|Overall Study|Protocol Violation|2|||
105720615|NCT00481065|364634034|FG005|Overall Study|Protocol Violation|6|||
105720616|NCT00481065|364634035|FG006|Overall Study|Protocol Violation|3|||
105720617|NCT00481065|364634036|FG007|Overall Study|Protocol Violation|2|||
105720618|NCT00481065|364634029|FG000|Overall Study|Unable to classify|0|||
105720619|NCT00481065|364634030|FG001|Overall Study|Unable to classify|1|||
105720620|NCT00481065|364634031|FG002|Overall Study|Unable to classify|2|||
105720621|NCT00481065|364634032|FG003|Overall Study|Unable to classify|0|||
105720622|NCT00481065|364634033|FG004|Overall Study|Unable to classify|1|||
105720623|NCT00481065|364634034|FG005|Overall Study|Unable to classify|0|||
105720624|NCT00481065|364634035|FG006|Overall Study|Unable to classify|0|||
105720625|NCT00481065|364634036|FG007|Overall Study|Unable to classify|0|||
105720626|NCT01439945|364634043|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
105720627|NCT01439945|364634044|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
105720628|NCT01439945|364634045|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
105720629|NCT01439945|364634046|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
105720630|NCT01439945|364634043|FG000|Double-Blind Treatment Phase|Ineligible|1|||
105720631|NCT01439945|364634044|FG001|Double-Blind Treatment Phase|Ineligible|2|||
105720632|NCT01439945|364634045|FG002|Double-Blind Treatment Phase|Ineligible|0|||
105720633|NCT01439945|364634046|FG003|Double-Blind Treatment Phase|Ineligible|1|||
105720634|NCT01497262|364634047|FG000|Overall Study|Abnormal Lab Values|4|||
105720635|NCT01497262|364634047|FG000|Overall Study|Abnormal Test Procedure Result|1|||
105720636|NCT01497262|364634047|FG000|Overall Study|Physician Decision|1|||
105720637|NCT01497262|364634047|FG000|Overall Study|Withdrawal by Subject|2|||
105720638|NCT01497262|364634047|FG000|Overall Study|Adverse Event|2|||
105720639|NCT01497262|364634047|FG000|Overall Study|Protocol Violation|1|||
105720640|NCT02949830|364634048|FG000|Overall Study|Adverse Event|1|||
105720641|NCT02949830|364634048|FG000|Overall Study|Withdrawal by Subject|1|||
105720642|NCT01290887|364634049|FG000|Overall Study|Adverse Event|6|||
105720643|NCT01290887|364634050|FG001|Overall Study|Adverse Event|11|||
105935406|NCT01712074|365422973|FG002|Double Blind Period|Lost to Follow-up|1|||
105720644|NCT01290887|364634049|FG000|Overall Study|Lack of Efficacy|4|||
105720645|NCT01290887|364634050|FG001|Overall Study|Lack of Efficacy|5|||
105720646|NCT01290887|364634049|FG000|Overall Study|Withdrawal by Subject|26|||
105720647|NCT01290887|364634050|FG001|Overall Study|Withdrawal by Subject|32|||
105720648|NCT01290887|364634049|FG000|Overall Study|Protocol Violation|2|||
105720649|NCT01290887|364634050|FG001|Overall Study|Protocol Violation|1|||
105720650|NCT01290887|364634049|FG000|Overall Study|Lost to Follow-up|4|||
105792266|NCT03466060|364894413|FG002|Period 1|Test Lens Damage|0|||
105792267|NCT03466060|364894414|FG003|Period 1|Test Lens Damage|0|||
105792268|NCT03466060|364894415|FG004|Period 1|Test Lens Damage|0|||
105792269|NCT03466060|364894416|FG005|Period 1|Test Lens Damage|0|||
105792270|NCT03466060|364894411|FG000|Period 1|Withdrawal by Subject|0|||
105792271|NCT03466060|364894412|FG001|Period 1|Withdrawal by Subject|0|||
105792272|NCT03466060|364894413|FG002|Period 1|Withdrawal by Subject|2|||
105792273|NCT03466060|364894414|FG003|Period 1|Withdrawal by Subject|0|||
105792274|NCT03466060|364894415|FG004|Period 1|Withdrawal by Subject|0|||
105792275|NCT03466060|364894416|FG005|Period 1|Withdrawal by Subject|0|||
105792276|NCT03466060|364894411|FG000|Period 1|Lost to Follow-up|0|||
105792277|NCT03466060|364894412|FG001|Period 1|Lost to Follow-up|0|||
105792278|NCT03466060|364894413|FG002|Period 1|Lost to Follow-up|0|||
105792279|NCT03466060|364894414|FG003|Period 1|Lost to Follow-up|1|||
105792280|NCT03466060|364894415|FG004|Period 1|Lost to Follow-up|0|||
105792281|NCT03466060|364894416|FG005|Period 1|Lost to Follow-up|0|||
105792282|NCT03466060|364894411|FG000|Period 1|Grade 2 Conjunctivitis|0|||
105792283|NCT03466060|364894412|FG001|Period 1|Grade 2 Conjunctivitis|0|||
105792284|NCT03466060|364894413|FG002|Period 1|Grade 2 Conjunctivitis|1|||
105792285|NCT03466060|364894414|FG003|Period 1|Grade 2 Conjunctivitis|0|||
105792286|NCT03466060|364894415|FG004|Period 1|Grade 2 Conjunctivitis|0|||
105792287|NCT03466060|364894416|FG005|Period 1|Grade 2 Conjunctivitis|0|||
105792288|NCT03466060|364894411|FG000|Period 2|Lens Handling Difficulties|0|||
105792289|NCT03466060|364894412|FG001|Period 2|Lens Handling Difficulties|0|||
105792290|NCT03466060|364894413|FG002|Period 2|Lens Handling Difficulties|1|||
105792291|NCT03466060|364894414|FG003|Period 2|Lens Handling Difficulties|0|||
105792292|NCT03466060|364894415|FG004|Period 2|Lens Handling Difficulties|0|||
105792293|NCT03466060|364894416|FG005|Period 2|Lens Handling Difficulties|0|||
105792294|NCT00556166|364894417|FG000|Overall Study|Withdrawal by Subject|1|||
105792295|NCT05302414|364894418|FG000|Pretest to Posttest|Lost to Follow-up|12|||
105792296|NCT05302414|364894419|FG001|Pretest to Posttest|Lost to Follow-up|8|||
105792297|NCT05302414|364894420|FG002|Pretest to Posttest|Lost to Follow-up|8|||
105792298|NCT05302414|364894418|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
105792299|NCT05302414|364894419|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
105792300|NCT05302414|364894420|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
105792301|NCT01102972|364894423|FG000|Overall Study|Adverse Event|8|||
105792302|NCT01102972|364894424|FG001|Overall Study|Adverse Event|2|||
105792303|NCT01102972|364894423|FG000|Overall Study|Lack of Efficacy|2|||
105792304|NCT01102972|364894424|FG001|Overall Study|Lack of Efficacy|1|||
105792305|NCT01102972|364894423|FG000|Overall Study|Protocol Violation|1|||
105792306|NCT01102972|364894424|FG001|Overall Study|Protocol Violation|0|||
105792307|NCT01102972|364894423|FG000|Overall Study|Lost to Follow-up|10|||
105792308|NCT01102972|364894424|FG001|Overall Study|Lost to Follow-up|5|||
105792309|NCT01102972|364894423|FG000|Overall Study|Investigator Discretion|2|||
105792310|NCT01102972|364894424|FG001|Overall Study|Investigator Discretion|0|||
105792311|NCT01102972|364894423|FG000|Overall Study|Withdrawal by Subject|6|||
105792312|NCT01102972|364894424|FG001|Overall Study|Withdrawal by Subject|6|||
105792313|NCT04935931|364894432|FG000|Overall Study|Withdrawal by Subject|1|||
105792314|NCT05168657|364894433|FG000|Overall Study|Adverse Event|0|||
105792315|NCT05168657|364894434|FG001|Overall Study|Adverse Event|0|||
105792316|NCT05168657|364894435|FG002|Overall Study|Adverse Event|1|||
105792317|NCT05168657|364894436|FG003|Overall Study|Adverse Event|0|||
105792318|NCT05168657|364894437|FG004|Overall Study|Adverse Event|0|||
105792319|NCT05168657|364894438|FG005|Overall Study|Adverse Event|0|||
105792320|NCT05168657|364894439|FG006|Overall Study|Adverse Event|0|||
105792321|NCT05168657|364894440|FG007|Overall Study|Adverse Event|0|||
105792322|NCT00962013|364894441|FG000|Overall Study|Did not have surgery|1|||
105792323|NCT00962013|364894441|FG000|Overall Study|Death|8|||
105792324|NCT00962013|364894441|FG000|Overall Study|Lost to Follow-up|12|||
105792325|NCT00962013|364894441|FG000|Overall Study|Unable/Unwilling to return|6|||
105792326|NCT00962013|364894441|FG000|Overall Study|Withdrawal by Subject|8|||
105792327|NCT00962013|364894441|FG000|Overall Study|Removal of study device|3|||
105792328|NCT00962013|364894441|FG000|Overall Study|Site Termination|24|||
105792329|NCT00962013|364894441|FG000|Overall Study|No 5 year evaluation|6|||
105792330|NCT04797637|364894446|FG000|Overall Study|Lost to Follow-up|23|||
105792331|NCT04797637|364894447|FG001|Overall Study|Lost to Follow-up|32|||
105792332|NCT04797637|364894446|FG000|Overall Study|Withdrawal by Subject|0|||
105792333|NCT04797637|364894447|FG001|Overall Study|Withdrawal by Subject|1|||
105792334|NCT00621309|364894448|FG000|Overall Study|Withdrawal by Subject|2|||
105792335|NCT00621309|364894449|FG001|Overall Study|Withdrawal by Subject|0|||
105792336|NCT00621309|364894450|FG002|Overall Study|Withdrawal by Subject|1|||
105792337|NCT00621309|364894451|FG003|Overall Study|Withdrawal by Subject|1|||
105792338|NCT00621309|364894452|FG004|Overall Study|Withdrawal by Subject|1|||
105792339|NCT00621309|364894453|FG005|Overall Study|Withdrawal by Subject|1|||
105792340|NCT03252756|364894458|FG000|Overall Study|Protocol Violation|2|||
105792341|NCT03252756|364894459|FG001|Overall Study|Protocol Violation|4|||
105792342|NCT03252756|364894458|FG000|Overall Study|COVID-19 Pandemic|1|||
105792343|NCT03252756|364894459|FG001|Overall Study|COVID-19 Pandemic|1|||
105792344|NCT03252756|364894458|FG000|Overall Study|Study Drug Expiration|0|||
105720651|NCT01290887|364634050|FG001|Overall Study|Lost to Follow-up|4|||
105720652|NCT01290887|364634049|FG000|Overall Study|Non-compliance to study procedures|0|||
105720653|NCT01290887|364634050|FG001|Overall Study|Non-compliance to study procedures|1|||
105720654|NCT01290887|364634049|FG000|Overall Study|Non-compliance to study medications|1|||
105720655|NCT01290887|364634050|FG001|Overall Study|Non-compliance to study medications|0|||
105720656|NCT01290887|364634049|FG000|Overall Study|Sponsor closure of study|420|||
105720657|NCT01290887|364634050|FG001|Overall Study|Sponsor closure of study|476|||
105720658|NCT01290887|364634049|FG000|Overall Study|Other|3|||
105720659|NCT01290887|364634050|FG001|Overall Study|Other|6|||
105720660|NCT05032950|364634051|FG000|Overall Study|Adverse Event|0|||
105720661|NCT05032950|364634052|FG001|Overall Study|Adverse Event|0|||
105720662|NCT05032950|364634053|FG002|Overall Study|Adverse Event|1|||
105720663|NCT05032950|364634054|FG003|Overall Study|Adverse Event|1|||
105720664|NCT05032950|364634055|FG004|Overall Study|Adverse Event|0|||
105720665|NCT05032950|364634056|FG005|Overall Study|Adverse Event|0|||
105720666|NCT02116621|364634060|FG000|Baseline|Withdrawal by Subject|0|||
105720667|NCT02116621|364634061|FG001|Baseline|Withdrawal by Subject|4|||
105720668|NCT02116621|364634060|FG000|Three Month Follow-up|Death|1|||
105720669|NCT02116621|364634061|FG001|Three Month Follow-up|Death|1|||
105720670|NCT02116621|364634060|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
105720671|NCT02116621|364634061|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
105720672|NCT02116621|364634060|FG000|Three Month Follow-up|Lost to Follow-up|0|||
105720673|NCT02116621|364634061|FG001|Three Month Follow-up|Lost to Follow-up|1|||
105720674|NCT02116621|364634060|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
105720675|NCT02116621|364634061|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
105720676|NCT02116621|364634060|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
105720677|NCT02116621|364634061|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
105720678|NCT02116621|364634060|FG000|Six Month Follow-up|Lost to Follow-up|2|||
105720679|NCT02116621|364634061|FG001|Six Month Follow-up|Lost to Follow-up|1|||
105720680|NCT02116621|364634060|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
105720681|NCT02116621|364634061|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
105720682|NCT02116621|364634060|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
105720683|NCT02116621|364634061|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
105720684|NCT02116621|364634060|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
105720685|NCT02116621|364634061|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
105720686|NCT02116621|364634060|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
105720687|NCT02116621|364634061|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
105720688|NCT02116621|364634060|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
105720689|NCT02116621|364634061|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
105720690|NCT02901431|364634062|FG000|PK Part|Adverse Event|0|||
105720691|NCT02901431|364634063|FG001|PK Part|Adverse Event|1|||
105720692|NCT02901431|364634064|FG002|PK Part|Adverse Event|0|||
105720693|NCT02901431|364634065|FG003|PK Part|Adverse Event|0|||
105720694|NCT02901431|364634066|FG004|PK Part|Adverse Event|0|||
105720695|NCT02901431|364634067|FG005|PK Part|Adverse Event|0|||
105720696|NCT02901431|364634068|FG006|PK Part|Adverse Event|0|||
105720697|NCT02901431|364634069|FG007|PK Part|Adverse Event|0|||
105720698|NCT02901431|364634070|FG008|PK Part|Adverse Event|0|||
105720699|NCT02901431|364634071|FG009|PK Part|Adverse Event|0|||
105720700|NCT02901431|364634072|FG010|PK Part|Adverse Event|0|||
105720701|NCT02901431|364634073|FG011|PK Part|Adverse Event|0|||
105720702|NCT02901431|364634074|FG012|PK Part|Adverse Event|0|||
105720703|NCT02901431|364634062|FG000|PK Part|Lost to Follow-up|0|||
105720704|NCT02901431|364634063|FG001|PK Part|Lost to Follow-up|0|||
105720705|NCT02901431|364634064|FG002|PK Part|Lost to Follow-up|1|||
105720706|NCT02901431|364634065|FG003|PK Part|Lost to Follow-up|0|||
105720707|NCT02901431|364634066|FG004|PK Part|Lost to Follow-up|0|||
105720708|NCT02901431|364634067|FG005|PK Part|Lost to Follow-up|0|||
105720709|NCT02901431|364634068|FG006|PK Part|Lost to Follow-up|0|||
105720710|NCT02901431|364634069|FG007|PK Part|Lost to Follow-up|0|||
105720711|NCT02901431|364634070|FG008|PK Part|Lost to Follow-up|0|||
105720712|NCT02901431|364634071|FG009|PK Part|Lost to Follow-up|0|||
105720713|NCT02901431|364634072|FG010|PK Part|Lost to Follow-up|0|||
105720714|NCT02901431|364634073|FG011|PK Part|Lost to Follow-up|0|||
105720715|NCT02901431|364634074|FG012|PK Part|Lost to Follow-up|0|||
105720716|NCT02901431|364634062|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
105720717|NCT02901431|364634063|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105792345|NCT03252756|364894459|FG001|Overall Study|Study Drug Expiration|1|||
105792346|NCT03239340|364894460|FG000|Overall Study|Other|26|||
105720718|NCT02901431|364634064|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720719|NCT02901431|364634065|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720720|NCT02901431|364634066|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720721|NCT02901431|364634067|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720722|NCT02901431|364634068|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720723|NCT02901431|364634069|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720724|NCT02901431|364634070|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720725|NCT02901431|364634071|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720726|NCT02901431|364634072|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105792347|NCT03239340|364894460|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
105792348|NCT03239340|364894460|FG000|Overall Study|Death|40|||
105792349|NCT03239340|364894460|FG000|Overall Study|Lost to Follow-up|2|||
105792350|NCT03239340|364894460|FG000|Overall Study|Physician Decision|16|||
105792351|NCT03239340|364894460|FG000|Overall Study|Withdrawal by Subject|27|||
105792352|NCT01640964|364894464|FG000|Overall Study|Lost to Follow-up|0|||
105792353|NCT01640964|364894465|FG001|Overall Study|Lost to Follow-up|0|||
105792354|NCT01640964|364894466|FG002|Overall Study|Lost to Follow-up|1|||
105792355|NCT01640964|364894464|FG000|Overall Study|Protocol Deviation|1|||
105792356|NCT01640964|364894465|FG001|Overall Study|Protocol Deviation|1|||
105792357|NCT01640964|364894466|FG002|Overall Study|Protocol Deviation|2|||
105792358|NCT02787746|364894467|FG000|Overall Study|Adverse Event|42|||
105792359|NCT02787746|364894467|FG000|Overall Study|Withdrawal by Subject|65|||
105792360|NCT02787746|364894467|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
105792361|NCT04822701|364894470|FG000|Overall Study|Not treated|2|||
105792362|NCT04822701|364894471|FG001|Overall Study|Not treated|0|||
105935407|NCT01712074|365422971|FG000|Double Blind Period|Other|0|||
105935408|NCT01712074|365422972|FG001|Double Blind Period|Other|4|||
105935409|NCT01712074|365422973|FG002|Double Blind Period|Other|1|||
105935410|NCT01712074|365422971|FG000|Double Blind Period|Protocol Violation|0|||
105935411|NCT01712074|365422972|FG001|Double Blind Period|Protocol Violation|0|||
105935412|NCT01712074|365422973|FG002|Double Blind Period|Protocol Violation|1|||
105935413|NCT01712074|365422971|FG000|Double Blind Period|No longer met eligibility criteria|0|||
105935414|NCT01712074|365422972|FG001|Double Blind Period|No longer met eligibility criteria|3|||
105935415|NCT01712074|365422973|FG002|Double Blind Period|No longer met eligibility criteria|0|||
105935416|NCT02268851|365422974|FG000|Overall Study|Death|0|||
105935417|NCT02268851|365422975|FG001|Overall Study|Death|0|||
105720727|NCT02901431|364634073|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720728|NCT02901431|364634074|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
105720729|NCT02901431|364634062|FG000|PK Part|Pending dose confirmation|0|||
105720730|NCT02901431|364634063|FG001|PK Part|Pending dose confirmation|1|||
105720731|NCT02901431|364634064|FG002|PK Part|Pending dose confirmation|0|||
105720732|NCT02901431|364634065|FG003|PK Part|Pending dose confirmation|0|||
105720733|NCT02901431|364634066|FG004|PK Part|Pending dose confirmation|0|||
105720734|NCT02901431|364634067|FG005|PK Part|Pending dose confirmation|0|||
105720735|NCT02901431|364634068|FG006|PK Part|Pending dose confirmation|0|||
105720736|NCT02901431|364634069|FG007|PK Part|Pending dose confirmation|0|||
105720737|NCT02901431|364634070|FG008|PK Part|Pending dose confirmation|0|||
105720738|NCT02901431|364634071|FG009|PK Part|Pending dose confirmation|0|||
105720739|NCT02901431|364634072|FG010|PK Part|Pending dose confirmation|0|||
105720740|NCT02901431|364634073|FG011|PK Part|Pending dose confirmation|0|||
105720741|NCT02901431|364634074|FG012|PK Part|Pending dose confirmation|0|||
105720742|NCT02901431|364634062|FG000|PK Part|8 weeks of treatment ran out|2|||
105720743|NCT02901431|364634063|FG001|PK Part|8 weeks of treatment ran out|0|||
105720744|NCT02901431|364634064|FG002|PK Part|8 weeks of treatment ran out|0|||
105720745|NCT02901431|364634065|FG003|PK Part|8 weeks of treatment ran out|0|||
105720746|NCT02901431|364634066|FG004|PK Part|8 weeks of treatment ran out|0|||
105720747|NCT02901431|364634067|FG005|PK Part|8 weeks of treatment ran out|0|||
105720748|NCT02901431|364634068|FG006|PK Part|8 weeks of treatment ran out|0|||
105720749|NCT02901431|364634069|FG007|PK Part|8 weeks of treatment ran out|0|||
105720750|NCT02901431|364634070|FG008|PK Part|8 weeks of treatment ran out|0|||
105720751|NCT02901431|364634071|FG009|PK Part|8 weeks of treatment ran out|0|||
105720752|NCT02901431|364634072|FG010|PK Part|8 weeks of treatment ran out|0|||
105720753|NCT02901431|364634073|FG011|PK Part|8 weeks of treatment ran out|0|||
105720754|NCT02901431|364634074|FG012|PK Part|8 weeks of treatment ran out|0|||
105720755|NCT02901431|364634062|FG000|PK Part|Stopped treatment after 8 weeks|1|||
105720756|NCT02901431|364634063|FG001|PK Part|Stopped treatment after 8 weeks|0|||
105720757|NCT02901431|364634064|FG002|PK Part|Stopped treatment after 8 weeks|1|||
105792363|NCT04822701|364894470|FG000|Overall Study|Lost to Follow-up|1|||
105792364|NCT04822701|364894471|FG001|Overall Study|Lost to Follow-up|0|||
105792365|NCT04822701|364894470|FG000|Overall Study|Withdrawal by Subject|1|||
105935418|NCT02268851|365422976|FG002|Overall Study|Death|0|||
105935419|NCT02268851|365422977|FG003|Overall Study|Death|1|||
105720758|NCT02901431|364634065|FG003|PK Part|Stopped treatment after 8 weeks|0|||
105792366|NCT04822701|364894471|FG001|Overall Study|Withdrawal by Subject|0|||
105792367|NCT03505606|364896337|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
105935420|NCT02268851|365422978|FG004|Overall Study|Death|2|||
105935421|NCT02268851|365422979|FG005|Overall Study|Death|1|||
105720759|NCT02901431|364634066|FG004|PK Part|Stopped treatment after 8 weeks|0|||
105720760|NCT02901431|364634067|FG005|PK Part|Stopped treatment after 8 weeks|0|||
105720761|NCT02901431|364634068|FG006|PK Part|Stopped treatment after 8 weeks|0|||
105720762|NCT02901431|364634069|FG007|PK Part|Stopped treatment after 8 weeks|0|||
105720763|NCT02901431|364634070|FG008|PK Part|Stopped treatment after 8 weeks|0|||
105720764|NCT02901431|364634071|FG009|PK Part|Stopped treatment after 8 weeks|0|||
105720765|NCT02901431|364634072|FG010|PK Part|Stopped treatment after 8 weeks|0|||
105720766|NCT02901431|364634073|FG011|PK Part|Stopped treatment after 8 weeks|0|||
105935422|NCT02268851|365422974|FG000|Overall Study|Adverse Event|0|||
105935423|NCT02268851|365422975|FG001|Overall Study|Adverse Event|0|||
105935424|NCT02268851|365422976|FG002|Overall Study|Adverse Event|0|||
105935425|NCT02268851|365422977|FG003|Overall Study|Adverse Event|0|||
105935426|NCT02268851|365422978|FG004|Overall Study|Adverse Event|2|||
105720767|NCT02901431|364634074|FG012|PK Part|Stopped treatment after 8 weeks|0|||
105720768|NCT02901431|364634062|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
105720769|NCT02901431|364634063|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720770|NCT02901431|364634064|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
105720771|NCT02901431|364634065|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720772|NCT02901431|364634066|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720773|NCT02901431|364634067|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720774|NCT02901431|364634068|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720775|NCT02901431|364634069|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720776|NCT02901431|364634070|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720777|NCT02901431|364634071|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720778|NCT02901431|364634072|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720779|NCT02901431|364634073|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720780|NCT02901431|364634074|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
105720781|NCT02901431|364634062|FG000|PK Part|Discontinued per Sponsor|0|||
105720782|NCT02901431|364634063|FG001|PK Part|Discontinued per Sponsor|3|||
105720783|NCT02901431|364634064|FG002|PK Part|Discontinued per Sponsor|0|||
105720784|NCT02901431|364634065|FG003|PK Part|Discontinued per Sponsor|0|||
105720785|NCT02901431|364634066|FG004|PK Part|Discontinued per Sponsor|0|||
105720786|NCT02901431|364634067|FG005|PK Part|Discontinued per Sponsor|0|||
105720787|NCT02901431|364634068|FG006|PK Part|Discontinued per Sponsor|0|||
105720788|NCT02901431|364634069|FG007|PK Part|Discontinued per Sponsor|0|||
105720789|NCT02901431|364634070|FG008|PK Part|Discontinued per Sponsor|0|||
105720790|NCT02901431|364634071|FG009|PK Part|Discontinued per Sponsor|0|||
105720791|NCT02901431|364634072|FG010|PK Part|Discontinued per Sponsor|0|||
105720792|NCT02901431|364634073|FG011|PK Part|Discontinued per Sponsor|0|||
105720793|NCT02901431|364634074|FG012|PK Part|Discontinued per Sponsor|0|||
105720794|NCT02901431|364634062|FG000|PK Part|Withdrawal by Subject|1|||
105720795|NCT02901431|364634063|FG001|PK Part|Withdrawal by Subject|1|||
105720796|NCT02901431|364634064|FG002|PK Part|Withdrawal by Subject|3|||
105720797|NCT02901431|364634065|FG003|PK Part|Withdrawal by Subject|0|||
105720798|NCT02901431|364634066|FG004|PK Part|Withdrawal by Subject|0|||
105720799|NCT02901431|364634067|FG005|PK Part|Withdrawal by Subject|0|||
105720800|NCT02901431|364634068|FG006|PK Part|Withdrawal by Subject|0|||
105720801|NCT02901431|364634069|FG007|PK Part|Withdrawal by Subject|0|||
105720802|NCT02901431|364634070|FG008|PK Part|Withdrawal by Subject|0|||
105720803|NCT02901431|364634071|FG009|PK Part|Withdrawal by Subject|0|||
105720804|NCT02901431|364634072|FG010|PK Part|Withdrawal by Subject|0|||
105720805|NCT02901431|364634073|FG011|PK Part|Withdrawal by Subject|0|||
105720806|NCT02901431|364634074|FG012|PK Part|Withdrawal by Subject|0|||
105720807|NCT02901431|364634062|FG000|Main Treatment Part|Adverse Event|0|||
105720808|NCT02901431|364634063|FG001|Main Treatment Part|Adverse Event|0|||
105720809|NCT02901431|364634064|FG002|Main Treatment Part|Adverse Event|0|||
105720810|NCT02901431|364634065|FG003|Main Treatment Part|Adverse Event|3|||
105720811|NCT02901431|364634066|FG004|Main Treatment Part|Adverse Event|3|||
105720812|NCT02901431|364634067|FG005|Main Treatment Part|Adverse Event|4|||
105720813|NCT02901431|364634068|FG006|Main Treatment Part|Adverse Event|1|||
105792368|NCT03505606|364896338|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
105935427|NCT02268851|365422979|FG005|Overall Study|Adverse Event|2|||
105935428|NCT02268851|365422974|FG000|Overall Study|Withdrawal by Subject|0|||
105935429|NCT02268851|365422975|FG001|Overall Study|Withdrawal by Subject|0|||
105935430|NCT02268851|365422976|FG002|Overall Study|Withdrawal by Subject|0|||
105935431|NCT02268851|365422977|FG003|Overall Study|Withdrawal by Subject|2|||
105935432|NCT02268851|365422978|FG004|Overall Study|Withdrawal by Subject|0|||
105935433|NCT02268851|365422979|FG005|Overall Study|Withdrawal by Subject|1|||
105935434|NCT02268851|365422974|FG000|Overall Study|Progressive Disease|1|||
105935435|NCT02268851|365422975|FG001|Overall Study|Progressive Disease|3|||
105935436|NCT02268851|365422976|FG002|Overall Study|Progressive Disease|0|||
105935437|NCT02268851|365422977|FG003|Overall Study|Progressive Disease|0|||
105935438|NCT02268851|365422978|FG004|Overall Study|Progressive Disease|1|||
105935439|NCT02268851|365422979|FG005|Overall Study|Progressive Disease|4|||
105935440|NCT02268851|365422974|FG000|Overall Study|Physician Decision|0|||
105935441|NCT02268851|365422975|FG001|Overall Study|Physician Decision|0|||
105935442|NCT02268851|365422976|FG002|Overall Study|Physician Decision|1|||
105935443|NCT02268851|365422977|FG003|Overall Study|Physician Decision|0|||
105720814|NCT02901431|364634069|FG007|Main Treatment Part|Adverse Event|0|||
105720815|NCT02901431|364634070|FG008|Main Treatment Part|Adverse Event|0|||
105720816|NCT02901431|364634071|FG009|Main Treatment Part|Adverse Event|0|||
105720817|NCT02901431|364634072|FG010|Main Treatment Part|Adverse Event|0|||
105720818|NCT02901431|364634073|FG011|Main Treatment Part|Adverse Event|0|||
105720819|NCT02901431|364634074|FG012|Main Treatment Part|Adverse Event|0|||
105720820|NCT02901431|364634062|FG000|Main Treatment Part|Lack of Efficacy|0|||
105935444|NCT02268851|365422978|FG004|Overall Study|Physician Decision|0|||
105792369|NCT03505606|364896339|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
105792370|NCT03505606|364896337|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
105792371|NCT03505606|364896338|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
105792372|NCT03505606|364896339|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
105792373|NCT03505606|364896337|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
105792374|NCT03505606|364896338|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
105792375|NCT03505606|364896339|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
105792376|NCT03505606|364896337|FG000|Overall Study|Poor compliance with refractive correction|0|||
105792377|NCT03505606|364896338|FG001|Overall Study|Poor compliance with refractive correction|0|||
105792378|NCT03505606|364896339|FG002|Overall Study|Poor compliance with refractive correction|1|||
105792379|NCT03505606|364896337|FG000|Overall Study|Insufficient anisometropia|0|||
105792380|NCT03505606|364896338|FG001|Overall Study|Insufficient anisometropia|0|||
105792381|NCT03505606|364896339|FG002|Overall Study|Insufficient anisometropia|2|||
105792382|NCT03505606|364896337|FG000|Overall Study|Ectopia Lentis|0|||
105792383|NCT03505606|364896338|FG001|Overall Study|Ectopia Lentis|0|||
105792384|NCT03505606|364896339|FG002|Overall Study|Ectopia Lentis|1|||
105792385|NCT03505606|364896337|FG000|Overall Study|alternation of amblyopic eye|0|||
105792386|NCT03505606|364896338|FG001|Overall Study|alternation of amblyopic eye|1|||
105792387|NCT03505606|364896339|FG002|Overall Study|alternation of amblyopic eye|0|||
105792388|NCT01808508|364896340|FG000|Overall Study|Lost to Follow-up|1|||
105792389|NCT01808508|364896341|FG001|Overall Study|Lost to Follow-up|0|||
105792390|NCT01808508|364896342|FG002|Overall Study|Lost to Follow-up|0|||
105792391|NCT02525627|364896343|FG000|Overall Study|Revision|1|||
105792392|NCT02525627|364896344|FG001|Overall Study|Revision|1|||
105792393|NCT02525627|364896343|FG000|Overall Study|Withdrawal by Subject|1|||
105792394|NCT02525627|364896344|FG001|Overall Study|Withdrawal by Subject|2|||
105792395|NCT02525627|364896343|FG000|Overall Study|Death|1|||
105792396|NCT02525627|364896344|FG001|Overall Study|Death|0|||
105792397|NCT02525627|364896343|FG000|Overall Study|Site terminated|11|||
105792398|NCT02525627|364896344|FG001|Overall Study|Site terminated|10|||
105792399|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
105935445|NCT02268851|365422979|FG005|Overall Study|Physician Decision|1|||
105935446|NCT02268851|365422974|FG000|Overall Study|Patient Compliance|0|||
105935447|NCT02268851|365422975|FG001|Overall Study|Patient Compliance|0|||
105935448|NCT02268851|365422976|FG002|Overall Study|Patient Compliance|0|||
105935449|NCT02268851|365422977|FG003|Overall Study|Patient Compliance|0|||
105935450|NCT02268851|365422978|FG004|Overall Study|Patient Compliance|1|||
105935451|NCT02268851|365422979|FG005|Overall Study|Patient Compliance|1|||
105935452|NCT02268851|365422974|FG000|Overall Study|Co-Morbid Condition|0|||
105935453|NCT02268851|365422975|FG001|Overall Study|Co-Morbid Condition|0|||
105935454|NCT02268851|365422976|FG002|Overall Study|Co-Morbid Condition|0|||
105935455|NCT02268851|365422977|FG003|Overall Study|Co-Morbid Condition|0|||
105935456|NCT02268851|365422978|FG004|Overall Study|Co-Morbid Condition|1|||
105935457|NCT02268851|365422979|FG005|Overall Study|Co-Morbid Condition|1|||
105935458|NCT02413346|365422980|FG000|Overall Study|Adverse Event|6|||
105935459|NCT02413346|365422981|FG001|Overall Study|Adverse Event|6|||
105935460|NCT02413346|365422980|FG000|Overall Study|Withdrawal by Subject|30|||
105935461|NCT02413346|365422981|FG001|Overall Study|Withdrawal by Subject|40|||
105935462|NCT02413346|365422980|FG000|Overall Study|Lost to Follow-up|17|||
105935463|NCT02413346|365422981|FG001|Overall Study|Lost to Follow-up|21|||
105935464|NCT02413346|365422980|FG000|Overall Study|Protocol Violation|2|||
105935465|NCT02413346|365422981|FG001|Overall Study|Protocol Violation|0|||
105935466|NCT02413346|365422980|FG000|Overall Study|Other Miscellaneous Reasons|4|||
105935467|NCT02413346|365422981|FG001|Overall Study|Other Miscellaneous Reasons|3|||
105935468|NCT00800384|365422986|FG000|Overall Study|Withdrawal by Subject|24|||
105935469|NCT00800384|365422987|FG001|Overall Study|Withdrawal by Subject|17|||
105935470|NCT00800384|365422986|FG000|Overall Study|Lost to Follow-up|17|||
105935471|NCT00800384|365422987|FG001|Overall Study|Lost to Follow-up|26|||
105935472|NCT02186171|365422988|FG000|Overall Study|Withdrawal by Subject|1|||
105935473|NCT02186171|365422989|FG001|Overall Study|Withdrawal by Subject|9|||
105935474|NCT02186171|365422988|FG000|Overall Study|Lost to Follow-up|2|||
105935475|NCT02186171|365422989|FG001|Overall Study|Lost to Follow-up|2|||
105935476|NCT02186171|365422988|FG000|Overall Study|Death|1|||
105792400|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
105792401|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
105935477|NCT02186171|365422989|FG001|Overall Study|Death|2|||
105935478|NCT02186171|365422988|FG000|Overall Study|Protocol-specified Criteria|0|||
105935479|NCT02186171|365422989|FG001|Overall Study|Protocol-specified Criteria|2|||
105935480|NCT02946996|365422992|FG000|Overall Study|non-evaluable|3|||
106137174|NCT01537133|366161969|FG002|Overall Study|Lost to Follow-up|0|||
105792402|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
105935481|NCT02946996|365422993|FG001|Overall Study|non-evaluable|6|||
105935482|NCT02946996|365422994|FG002|Overall Study|non-evaluable|5|||
105935483|NCT00992394|365422997|FG000|Overall Study|Lack of Efficacy|6|||
105935484|NCT00992394|365422998|FG001|Overall Study|Lack of Efficacy|3|||
105935485|NCT00992394|365422997|FG000|Overall Study|Adverse Event|4|||
105792403|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
105792404|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
105792405|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
105792406|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
105792407|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
105792408|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
105792409|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
105792410|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
105792411|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
105792412|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
105792413|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
105792414|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
105792415|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
105792416|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
105792417|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
105792418|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
105792419|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
105792420|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
105792421|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
105792422|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
105792423|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
105792424|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
105792425|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
105792426|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
105792427|NCT01299272|364896348|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
105792428|NCT01299272|364896349|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
105792429|NCT01299272|364896350|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
105792430|NCT01299272|364896351|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
105792431|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
105792432|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
105792433|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
105792434|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
105792435|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
105792436|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
105792437|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
105792438|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
105792439|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
105792440|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
105792441|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
105792442|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
105792443|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
105792444|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
105792445|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
105792446|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
105792447|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
105792448|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
105792449|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
105792450|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
105792451|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
105792452|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
105792453|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
106137175|NCT01537133|366161970|FG003|Overall Study|Lost to Follow-up|0|||
106137176|NCT03895034|366161971|FG000|Overall Study|Lost to Follow-up|2|||
106137177|NCT03441360|366161977|FG000|Overall Study|Radiological disease progression|5|||
106137178|NCT03441360|366161978|FG001|Overall Study|Radiological disease progression|6|||
106137179|NCT03441360|366161979|FG002|Overall Study|Radiological disease progression|4|||
106137180|NCT03441360|366161977|FG000|Overall Study|Clinical disease progression|2|||
106137181|NCT03441360|366161978|FG001|Overall Study|Clinical disease progression|2|||
106137182|NCT03441360|366161979|FG002|Overall Study|Clinical disease progression|0|||
106137183|NCT03441360|366161977|FG000|Overall Study|Adverse Event|1|||
106137184|NCT03441360|366161978|FG001|Overall Study|Adverse Event|0|||
106137185|NCT03441360|366161979|FG002|Overall Study|Adverse Event|1|||
106137186|NCT00943605|366161980|FG000|Overall Study|Study termination|30|||
106137187|NCT00943605|366161981|FG001|Overall Study|Study termination|30|||
106137188|NCT01883492|366161983|FG000|Overall Study|Lost to Follow-up|3|||
105935486|NCT00992394|365422998|FG001|Overall Study|Adverse Event|5|||
106137189|NCT01883492|366161984|FG001|Overall Study|Lost to Follow-up|4|||
105935487|NCT00992394|365422997|FG000|Overall Study|Withdrawal by Subject|8|||
106137190|NCT01883492|366161983|FG000|Overall Study|Surgery on contra-lateral hip|0|||
105792454|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
105792455|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
105792456|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
105792457|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
105792458|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
105792459|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
105792460|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
105792461|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
105792462|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
105792463|NCT01299272|364896348|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
105792464|NCT01299272|364896349|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
105792465|NCT01299272|364896350|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
105792466|NCT01299272|364896351|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
105792467|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
105792468|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
105792469|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
105792470|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
105792471|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
105792472|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
105792473|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
105792474|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
105792475|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
105935488|NCT00992394|365422998|FG001|Overall Study|Withdrawal by Subject|2|||
105935489|NCT00992394|365422997|FG000|Overall Study|Physician Decision|1|||
105792476|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
105792477|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
105792478|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
105792479|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
105792480|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
105792481|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
105792482|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
105792483|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
105792484|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
105935490|NCT00992394|365422998|FG001|Overall Study|Physician Decision|0|||
105935491|NCT00992394|365422997|FG000|Overall Study|Protocol Violation|2|||
105935492|NCT00992394|365422998|FG001|Overall Study|Protocol Violation|4|||
105935493|NCT00992394|365422997|FG000|Overall Study|Lost to Follow-up|2|||
105935494|NCT00992394|365422998|FG001|Overall Study|Lost to Follow-up|0|||
105935495|NCT00992394|365422997|FG000|Overall Study|Other event|1|||
105935496|NCT00992394|365422998|FG001|Overall Study|Other event|0|||
105935497|NCT01905683|365422999|FG000|Overall Study|Protocol Violation|1|||
105935498|NCT01905683|365422999|FG000|Overall Study|Re-injection criteria not met; others|13|||
105935499|NCT01905683|365422999|FG000|Overall Study|Physician Decision|1|||
105935500|NCT01905683|365422999|FG000|Overall Study|Lack of Efficacy|8|||
105935501|NCT01905683|365422999|FG000|Overall Study|Withdrawal by Subject|20|||
105935502|NCT01905683|365422999|FG000|Overall Study|Adverse Event|4|||
105935503|NCT01905683|365422999|FG000|Overall Study|Lost to Follow-up|4|||
105935504|NCT01245049|365423000|FG000|Overall Study|Migrated/moved from study area|0|||
105935505|NCT01245049|365423001|FG001|Overall Study|Migrated/moved from study area|1|||
105935506|NCT01245049|365423000|FG000|Overall Study|Withdrawal by Subject|0|||
105935507|NCT01245049|365423001|FG001|Overall Study|Withdrawal by Subject|1|||
105935508|NCT01245049|365423000|FG000|Overall Study|Lost to Follow-up|1|||
105935509|NCT01245049|365423001|FG001|Overall Study|Lost to Follow-up|2|||
105935510|NCT02151604|365423002|FG000|Overall Study|Lost to Follow-up|3|||
105935511|NCT02151604|365423002|FG000|Overall Study|Withdrawal by Subject|2|||
105935512|NCT02151604|365423002|FG000|Overall Study|Physician Decision|3|||
105935513|NCT02151604|365423002|FG000|Overall Study|Death|1|||
105792485|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
105792486|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
105792487|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
105792488|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
105792489|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
105792490|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
105935514|NCT00537082|365423003|FG000|Overall Study|Adverse Event|6|||
105935515|NCT00537082|365423004|FG001|Overall Study|Adverse Event|6|||
105935516|NCT00537082|365423005|FG002|Overall Study|Adverse Event|3|||
105935517|NCT00537082|365423003|FG000|Overall Study|Protocol Violation|0|||
105935518|NCT00537082|365423004|FG001|Overall Study|Protocol Violation|2|||
105935519|NCT00537082|365423005|FG002|Overall Study|Protocol Violation|1|||
105935520|NCT00537082|365423003|FG000|Overall Study|Lack of Efficacy|0|||
105720821|NCT02901431|364634063|FG001|Main Treatment Part|Lack of Efficacy|0|||
105720822|NCT02901431|364634064|FG002|Main Treatment Part|Lack of Efficacy|0|||
105720823|NCT02901431|364634065|FG003|Main Treatment Part|Lack of Efficacy|1|||
105720824|NCT02901431|364634066|FG004|Main Treatment Part|Lack of Efficacy|0|||
105720825|NCT02901431|364634067|FG005|Main Treatment Part|Lack of Efficacy|0|||
105720826|NCT02901431|364634068|FG006|Main Treatment Part|Lack of Efficacy|0|||
105720827|NCT02901431|364634069|FG007|Main Treatment Part|Lack of Efficacy|0|||
105935521|NCT00537082|365423004|FG001|Overall Study|Lack of Efficacy|0|||
105935522|NCT00537082|365423005|FG002|Overall Study|Lack of Efficacy|2|||
105935523|NCT00537082|365423003|FG000|Overall Study|Withdrawal by Subject|0|||
105935524|NCT00537082|365423004|FG001|Overall Study|Withdrawal by Subject|1|||
105935525|NCT00537082|365423005|FG002|Overall Study|Withdrawal by Subject|0|||
105935526|NCT00537082|365423003|FG000|Overall Study|Discontinued before initiating treatment|3|||
105935527|NCT00537082|365423004|FG001|Overall Study|Discontinued before initiating treatment|0|||
105935528|NCT00537082|365423005|FG002|Overall Study|Discontinued before initiating treatment|0|||
105935529|NCT02568254|365423007|FG000|Period 2|Adverse Event|0|||
105720828|NCT02901431|364634070|FG008|Main Treatment Part|Lack of Efficacy|0|||
105720829|NCT02901431|364634071|FG009|Main Treatment Part|Lack of Efficacy|0|||
105720830|NCT02901431|364634072|FG010|Main Treatment Part|Lack of Efficacy|0|||
105720831|NCT02901431|364634073|FG011|Main Treatment Part|Lack of Efficacy|0|||
105720832|NCT02901431|364634074|FG012|Main Treatment Part|Lack of Efficacy|0|||
105720833|NCT02901431|364634062|FG000|Main Treatment Part|Lost to Follow-up|0|||
105720834|NCT02901431|364634063|FG001|Main Treatment Part|Lost to Follow-up|0|||
105720835|NCT02901431|364634064|FG002|Main Treatment Part|Lost to Follow-up|0|||
105720836|NCT02901431|364634065|FG003|Main Treatment Part|Lost to Follow-up|3|||
105720837|NCT02901431|364634066|FG004|Main Treatment Part|Lost to Follow-up|1|||
105720838|NCT02901431|364634067|FG005|Main Treatment Part|Lost to Follow-up|2|||
105720839|NCT02901431|364634068|FG006|Main Treatment Part|Lost to Follow-up|3|||
105720840|NCT02901431|364634069|FG007|Main Treatment Part|Lost to Follow-up|0|||
105720841|NCT02901431|364634070|FG008|Main Treatment Part|Lost to Follow-up|0|||
105720842|NCT02901431|364634071|FG009|Main Treatment Part|Lost to Follow-up|0|||
105720843|NCT02901431|364634072|FG010|Main Treatment Part|Lost to Follow-up|0|||
105720844|NCT02901431|364634073|FG011|Main Treatment Part|Lost to Follow-up|0|||
105720845|NCT02901431|364634074|FG012|Main Treatment Part|Lost to Follow-up|0|||
105720846|NCT02901431|364634062|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
105720847|NCT02901431|364634063|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
105720848|NCT02901431|364634064|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
105720849|NCT02901431|364634065|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
105720850|NCT02901431|364634066|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
105720851|NCT02901431|364634067|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
105720852|NCT02901431|364634068|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
105720853|NCT02901431|364634069|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
105720854|NCT02901431|364634070|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
105720855|NCT02901431|364634071|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
105720856|NCT02901431|364634072|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
105720857|NCT02901431|364634073|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
105720858|NCT02901431|364634074|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
105720859|NCT02901431|364634062|FG000|Main Treatment Part|Physician Decision|0|||
105720860|NCT02901431|364634063|FG001|Main Treatment Part|Physician Decision|0|||
105720861|NCT02901431|364634064|FG002|Main Treatment Part|Physician Decision|0|||
105720862|NCT02901431|364634065|FG003|Main Treatment Part|Physician Decision|1|||
105720863|NCT02901431|364634066|FG004|Main Treatment Part|Physician Decision|0|||
105720864|NCT02901431|364634067|FG005|Main Treatment Part|Physician Decision|0|||
105720865|NCT02901431|364634068|FG006|Main Treatment Part|Physician Decision|1|||
105720866|NCT02901431|364634069|FG007|Main Treatment Part|Physician Decision|0|||
105720867|NCT02901431|364634070|FG008|Main Treatment Part|Physician Decision|0|||
105720868|NCT02901431|364634071|FG009|Main Treatment Part|Physician Decision|0|||
105720869|NCT02901431|364634072|FG010|Main Treatment Part|Physician Decision|0|||
105720870|NCT02901431|364634073|FG011|Main Treatment Part|Physician Decision|0|||
105720871|NCT02901431|364634074|FG012|Main Treatment Part|Physician Decision|0|||
105935530|NCT02568254|365423008|FG001|Period 2|Adverse Event|0|||
105935531|NCT02568254|365423009|FG002|Period 2|Adverse Event|1|||
105935532|NCT02568254|365423010|FG003|Period 2|Adverse Event|0|||
105720872|NCT02901431|364634062|FG000|Main Treatment Part|Withdrawal by Subject|0|||
105720873|NCT02901431|364634063|FG001|Main Treatment Part|Withdrawal by Subject|0|||
105792491|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
105935533|NCT02568254|365423011|FG004|Period 2|Adverse Event|0|||
105935534|NCT02568254|365423012|FG005|Period 2|Adverse Event|0|||
105720874|NCT02901431|364634064|FG002|Main Treatment Part|Withdrawal by Subject|0|||
105720875|NCT02901431|364634065|FG003|Main Treatment Part|Withdrawal by Subject|18|||
105720876|NCT02901431|364634066|FG004|Main Treatment Part|Withdrawal by Subject|3|||
105720877|NCT02901431|364634067|FG005|Main Treatment Part|Withdrawal by Subject|5|||
105720878|NCT02901431|364634068|FG006|Main Treatment Part|Withdrawal by Subject|6|||
105720879|NCT02901431|364634069|FG007|Main Treatment Part|Withdrawal by Subject|0|||
105720880|NCT02901431|364634070|FG008|Main Treatment Part|Withdrawal by Subject|0|||
105720881|NCT02901431|364634071|FG009|Main Treatment Part|Withdrawal by Subject|0|||
105720882|NCT02901431|364634072|FG010|Main Treatment Part|Withdrawal by Subject|0|||
105720883|NCT02901431|364634073|FG011|Main Treatment Part|Withdrawal by Subject|0|||
105720884|NCT02901431|364634074|FG012|Main Treatment Part|Withdrawal by Subject|0|||
105720885|NCT02901431|364634062|FG000|Open Label Part|Adverse Event|0|||
105720886|NCT02901431|364634063|FG001|Open Label Part|Adverse Event|0|||
105720887|NCT02901431|364634064|FG002|Open Label Part|Adverse Event|0|||
105720888|NCT02901431|364634065|FG003|Open Label Part|Adverse Event|0|||
105720889|NCT02901431|364634066|FG004|Open Label Part|Adverse Event|0|||
105720890|NCT02901431|364634067|FG005|Open Label Part|Adverse Event|0|||
105720891|NCT02901431|364634068|FG006|Open Label Part|Adverse Event|0|||
105720892|NCT02901431|364634069|FG007|Open Label Part|Adverse Event|0|||
105720893|NCT02901431|364634070|FG008|Open Label Part|Adverse Event|4|||
105720894|NCT02901431|364634071|FG009|Open Label Part|Adverse Event|4|||
105720895|NCT02901431|364634072|FG010|Open Label Part|Adverse Event|0|||
105720896|NCT02901431|364634073|FG011|Open Label Part|Adverse Event|4|||
105720897|NCT02901431|364634074|FG012|Open Label Part|Adverse Event|1|||
105720898|NCT02901431|364634062|FG000|Open Label Part|Lost to Follow-up|0|||
105720899|NCT02901431|364634063|FG001|Open Label Part|Lost to Follow-up|0|||
105720900|NCT02901431|364634064|FG002|Open Label Part|Lost to Follow-up|0|||
105720901|NCT02901431|364634065|FG003|Open Label Part|Lost to Follow-up|0|||
105720902|NCT02901431|364634066|FG004|Open Label Part|Lost to Follow-up|0|||
105720903|NCT02901431|364634067|FG005|Open Label Part|Lost to Follow-up|0|||
105720904|NCT02901431|364634068|FG006|Open Label Part|Lost to Follow-up|0|||
105720905|NCT02901431|364634069|FG007|Open Label Part|Lost to Follow-up|0|||
105720906|NCT02901431|364634070|FG008|Open Label Part|Lost to Follow-up|2|||
105720907|NCT02901431|364634071|FG009|Open Label Part|Lost to Follow-up|2|||
105720908|NCT02901431|364634072|FG010|Open Label Part|Lost to Follow-up|1|||
105720909|NCT02901431|364634073|FG011|Open Label Part|Lost to Follow-up|1|||
105720910|NCT02901431|364634074|FG012|Open Label Part|Lost to Follow-up|1|||
105720911|NCT02901431|364634062|FG000|Open Label Part|Physician Decision|0|||
105720912|NCT02901431|364634063|FG001|Open Label Part|Physician Decision|0|||
105720913|NCT02901431|364634064|FG002|Open Label Part|Physician Decision|0|||
105720914|NCT02901431|364634065|FG003|Open Label Part|Physician Decision|0|||
105720915|NCT02901431|364634066|FG004|Open Label Part|Physician Decision|0|||
105720916|NCT02901431|364634067|FG005|Open Label Part|Physician Decision|0|||
105720917|NCT02901431|364634068|FG006|Open Label Part|Physician Decision|0|||
105720918|NCT02901431|364634069|FG007|Open Label Part|Physician Decision|0|||
105720919|NCT02901431|364634070|FG008|Open Label Part|Physician Decision|1|||
105720920|NCT02901431|364634071|FG009|Open Label Part|Physician Decision|1|||
105720921|NCT02901431|364634072|FG010|Open Label Part|Physician Decision|0|||
105720922|NCT02901431|364634073|FG011|Open Label Part|Physician Decision|0|||
105720923|NCT02901431|364634074|FG012|Open Label Part|Physician Decision|0|||
105720924|NCT02901431|364634062|FG000|Open Label Part|Study Terminated By Sponsor|0|||
105720925|NCT02901431|364634063|FG001|Open Label Part|Study Terminated By Sponsor|0|||
105720926|NCT02901431|364634064|FG002|Open Label Part|Study Terminated By Sponsor|0|||
105720927|NCT02901431|364634065|FG003|Open Label Part|Study Terminated By Sponsor|0|||
105720928|NCT02901431|364634066|FG004|Open Label Part|Study Terminated By Sponsor|0|||
105720929|NCT02901431|364634067|FG005|Open Label Part|Study Terminated By Sponsor|0|||
105720930|NCT02901431|364634068|FG006|Open Label Part|Study Terminated By Sponsor|0|||
105720931|NCT02901431|364634069|FG007|Open Label Part|Study Terminated By Sponsor|0|||
105720932|NCT02901431|364634070|FG008|Open Label Part|Study Terminated By Sponsor|35|||
105720933|NCT02901431|364634071|FG009|Open Label Part|Study Terminated By Sponsor|12|||
105720934|NCT02901431|364634072|FG010|Open Label Part|Study Terminated By Sponsor|21|||
105720935|NCT02901431|364634073|FG011|Open Label Part|Study Terminated By Sponsor|31|||
105720936|NCT02901431|364634074|FG012|Open Label Part|Study Terminated By Sponsor|0|||
105720937|NCT02901431|364634062|FG000|Open Label Part|Withdrawal by Subject|0|||
105720938|NCT02901431|364634063|FG001|Open Label Part|Withdrawal by Subject|0|||
105720939|NCT02901431|364634064|FG002|Open Label Part|Withdrawal by Subject|0|||
105720940|NCT02901431|364634065|FG003|Open Label Part|Withdrawal by Subject|0|||
105720941|NCT02901431|364634066|FG004|Open Label Part|Withdrawal by Subject|0|||
105720942|NCT02901431|364634067|FG005|Open Label Part|Withdrawal by Subject|0|||
105720943|NCT02901431|364634068|FG006|Open Label Part|Withdrawal by Subject|0|||
105720944|NCT02901431|364634069|FG007|Open Label Part|Withdrawal by Subject|0|||
105720945|NCT02901431|364634070|FG008|Open Label Part|Withdrawal by Subject|6|||
105720946|NCT02901431|364634071|FG009|Open Label Part|Withdrawal by Subject|5|||
105720947|NCT02901431|364634072|FG010|Open Label Part|Withdrawal by Subject|7|||
105720948|NCT02901431|364634073|FG011|Open Label Part|Withdrawal by Subject|3|||
105720949|NCT02901431|364634074|FG012|Open Label Part|Withdrawal by Subject|1|||
105720950|NCT02330419|364634077|FG000|Overall Study|Lost to Follow-up|3|||
105720951|NCT02330419|364634078|FG001|Overall Study|Lost to Follow-up|7|||
105720952|NCT04640766|364634080|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
105720953|NCT00393718|364636311|FG000|Overall Study|Adverse Event|20|||
105720954|NCT00393718|364636312|FG001|Overall Study|Adverse Event|8|||
105720955|NCT00393718|364636311|FG000|Overall Study|Protocol Violation|1|||
105720956|NCT00393718|364636312|FG001|Overall Study|Protocol Violation|2|||
105935535|NCT02568254|365423007|FG000|Period 3|Unstatisfactory Lens fitting|0|||
105935536|NCT02568254|365423008|FG001|Period 3|Unstatisfactory Lens fitting|0|||
105935537|NCT02568254|365423009|FG002|Period 3|Unstatisfactory Lens fitting|0|||
105935538|NCT02568254|365423010|FG003|Period 3|Unstatisfactory Lens fitting|0|||
105935539|NCT02568254|365423011|FG004|Period 3|Unstatisfactory Lens fitting|1|||
105935540|NCT02568254|365423012|FG005|Period 3|Unstatisfactory Lens fitting|0|||
105935541|NCT04495478|365423013|FG000|Overall Study|Withdrawal by Subject|0|||
105935542|NCT04495478|365423014|FG001|Overall Study|Withdrawal by Subject|0|||
105935543|NCT04495478|365423015|FG002|Overall Study|Withdrawal by Subject|0|||
105935544|NCT04495478|365423016|FG003|Overall Study|Withdrawal by Subject|1|||
105935545|NCT04495478|365423017|FG004|Overall Study|Withdrawal by Subject|0|||
105935546|NCT04495478|365423018|FG005|Overall Study|Withdrawal by Subject|0|||
105935547|NCT04495478|365423019|FG006|Overall Study|Withdrawal by Subject|0|||
105935548|NCT04495478|365423013|FG000|Overall Study|Physician Decision|0|||
105935549|NCT04495478|365423014|FG001|Overall Study|Physician Decision|1|||
105935550|NCT04495478|365423015|FG002|Overall Study|Physician Decision|0|||
105935551|NCT04495478|365423016|FG003|Overall Study|Physician Decision|0|||
105935552|NCT04495478|365423017|FG004|Overall Study|Physician Decision|1|||
105935553|NCT04495478|365423018|FG005|Overall Study|Physician Decision|0|||
105935554|NCT04495478|365423019|FG006|Overall Study|Physician Decision|0|||
105720957|NCT00393718|364636311|FG000|Overall Study|Lack of Efficacy|10|||
105720958|NCT00393718|364636312|FG001|Overall Study|Lack of Efficacy|9|||
105720959|NCT00393718|364636311|FG000|Overall Study|Hypoglycaemia|3|||
105720960|NCT00393718|364636312|FG001|Overall Study|Hypoglycaemia|2|||
105720961|NCT00393718|364636311|FG000|Overall Study|Subject decision|5|||
105720962|NCT00393718|364636312|FG001|Overall Study|Subject decision|0|||
105720963|NCT00393718|364636311|FG000|Overall Study|Withdrawal of consent|2|||
105720964|NCT00393718|364636312|FG001|Overall Study|Withdrawal of consent|1|||
105935555|NCT00655746|365423020|FG000|Overall Study|Withdrawal by Subject|1|||
105935556|NCT03882801|365425147|FG000|Period 1|Adverse Event|0|||
105935557|NCT03882801|365425148|FG001|Period 1|Adverse Event|1|||
105935558|NCT03882801|365425147|FG000|Period 1|Non-compliance with study drug|1|||
105935559|NCT03882801|365425148|FG001|Period 1|Non-compliance with study drug|1|||
105720965|NCT00393718|364636311|FG000|Overall Study|Missed measurement|1|||
105935560|NCT03882801|365425147|FG000|Period 1|Never treated with study drug|1|||
105720966|NCT00393718|364636312|FG001|Overall Study|Missed measurement|0|||
105935561|NCT03882801|365425148|FG001|Period 1|Never treated with study drug|0|||
105935562|NCT03882801|365425147|FG000|Washout Period|Physician Decision|0|||
105935563|NCT03882801|365425148|FG001|Washout Period|Physician Decision|1|||
105935564|NCT03882801|365425147|FG000|Period 2|Non-compliance with study drug|0|||
105935565|NCT03882801|365425148|FG001|Period 2|Non-compliance with study drug|1|||
105935566|NCT03735498|365425149|FG000|Overall Study|Withdrawal by Subject|3|||
105935567|NCT03735498|365425149|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
105935568|NCT00620035|365425150|FG000|Overall Study|Adverse Event|106|||
105935569|NCT00620035|365425150|FG000|Overall Study|Withdrawal of Informed Consent|1|||
105935570|NCT00620035|365425150|FG000|Overall Study|Other Reason|38|||
105935571|NCT01027754|365425152|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
105935572|NCT01027754|365425153|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
105935573|NCT01027754|365425152|FG000|Overall Study|Withdrawal by Subject|0|||
105935574|NCT01027754|365425153|FG001|Overall Study|Withdrawal by Subject|5|||
105935575|NCT01629563|365425154|FG000|Overall Study|Adverse Event|16|||
105935576|NCT01629563|365425155|FG001|Overall Study|Adverse Event|16|||
105720967|NCT00393718|364636311|FG000|Overall Study|Move|1|||
105720968|NCT00393718|364636312|FG001|Overall Study|Move|0|||
105720969|NCT00883493|364636313|FG000|Overall Study|Adverse Event|11|||
105720970|NCT00883493|364636314|FG001|Overall Study|Adverse Event|12|||
105720971|NCT00883493|364636313|FG000|Overall Study|Lack of Efficacy|4|||
105720972|NCT00883493|364636314|FG001|Overall Study|Lack of Efficacy|3|||
105720973|NCT00883493|364636313|FG000|Overall Study|Lost to Follow-up|7|||
105720974|NCT00883493|364636314|FG001|Overall Study|Lost to Follow-up|6|||
105720975|NCT00883493|364636313|FG000|Overall Study|Withdrawal by Subject|11|||
105720976|NCT00883493|364636314|FG001|Overall Study|Withdrawal by Subject|20|||
105720977|NCT00883493|364636313|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
105720978|NCT00883493|364636314|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
105720979|NCT00883493|364636313|FG000|Overall Study|Study specific disc. criteria|2|||
105720980|NCT00883493|364636314|FG001|Overall Study|Study specific disc. criteria|0|||
105720981|NCT00883493|364636313|FG000|Overall Study|Other|5|||
105720982|NCT00883493|364636314|FG001|Overall Study|Other|3|||
105720983|NCT01427309|364636316|FG000|Overall Study|Lost to Follow-up|130|||
105720984|NCT01427309|364636317|FG001|Overall Study|Lost to Follow-up|145|||
105720985|NCT01427309|364636318|FG002|Overall Study|Lost to Follow-up|122|||
105720986|NCT01427309|364636319|FG003|Overall Study|Lost to Follow-up|135|||
105720987|NCT01427309|364636316|FG000|Overall Study|Protocol Violation|42|||
105720988|NCT01427309|364636317|FG001|Overall Study|Protocol Violation|69|||
105720989|NCT01427309|364636318|FG002|Overall Study|Protocol Violation|125|||
105720990|NCT01427309|364636319|FG003|Overall Study|Protocol Violation|124|||
105720991|NCT01427309|364636316|FG000|Overall Study|Adverse Event|0|||
105720992|NCT01427309|364636317|FG001|Overall Study|Adverse Event|0|||
105720993|NCT01427309|364636318|FG002|Overall Study|Adverse Event|3|||
105720994|NCT01427309|364636319|FG003|Overall Study|Adverse Event|1|||
105720995|NCT01427309|364636316|FG000|Overall Study|Serious adverse event|52|||
105720996|NCT01427309|364636317|FG001|Overall Study|Serious adverse event|45|||
105720997|NCT01427309|364636318|FG002|Overall Study|Serious adverse event|50|||
105720998|NCT01427309|364636319|FG003|Overall Study|Serious adverse event|61|||
105720999|NCT01427309|364636316|FG000|Overall Study|Withdrawal by Subject|148|||
105721000|NCT01427309|364636317|FG001|Overall Study|Withdrawal by Subject|148|||
105721001|NCT01427309|364636318|FG002|Overall Study|Withdrawal by Subject|61|||
105721002|NCT01427309|364636319|FG003|Overall Study|Withdrawal by Subject|55|||
105721003|NCT01354132|364636320|FG000|Randomization|Physician Decision|1|||
105721004|NCT01354132|364636321|FG001|Randomization|Physician Decision|0|||
105721005|NCT01354132|364636320|FG000|Randomization|Withdrawal by Subject|0|||
105721006|NCT01354132|364636321|FG001|Randomization|Withdrawal by Subject|1|||
105721007|NCT01354132|364636320|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
105721008|NCT01354132|364636321|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
105721009|NCT01354132|364636320|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
105721010|NCT01354132|364636321|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
105935577|NCT01629563|365425154|FG000|Overall Study|Death|2|||
105935578|NCT01629563|365425155|FG001|Overall Study|Death|0|||
105721011|NCT01354132|364636320|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
105721012|NCT01354132|364636321|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
105721013|NCT00603239|364636322|FG000|Overall Study|Adverse Event|4|||
105721014|NCT00603239|364636323|FG001|Overall Study|Adverse Event|1|||
105721015|NCT00603239|364636322|FG000|Overall Study|Entry criteria not met|0|||
105721016|NCT00603239|364636323|FG001|Overall Study|Entry criteria not met|1|||
105721017|NCT00603239|364636322|FG000|Overall Study|Loss of glucose control|3|||
105721018|NCT00603239|364636323|FG001|Overall Study|Loss of glucose control|0|||
105721019|NCT00603239|364636322|FG000|Overall Study|Lost to Follow-up|2|||
105721020|NCT00603239|364636323|FG001|Overall Study|Lost to Follow-up|1|||
105721021|NCT00603239|364636322|FG000|Overall Study|Physician Decision|2|||
105792492|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
105792493|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
106009162|NCT05138653|365699087|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105792494|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
105721022|NCT00603239|364636323|FG001|Overall Study|Physician Decision|0|||
105721023|NCT00603239|364636322|FG000|Overall Study|Protocol Violation|2|||
105721024|NCT00603239|364636323|FG001|Overall Study|Protocol Violation|0|||
105721025|NCT00603239|364636322|FG000|Overall Study|Subject decision|2|||
105721026|NCT00603239|364636323|FG001|Overall Study|Subject decision|1|||
105721027|NCT03617705|364636324|FG000|Overall Study|Withdrawal by Subject|2|||
105721028|NCT03617705|364636324|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
105721029|NCT03617705|364636324|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
105721030|NCT00928070|364636325|FG000|Overall Study|Lost to Follow-up|1|||
105721031|NCT00928070|364636326|FG001|Overall Study|Lost to Follow-up|2|||
105721032|NCT00928070|364636325|FG000|Overall Study|Withdrawal by Subject|10|||
105721033|NCT00928070|364636326|FG001|Overall Study|Withdrawal by Subject|3|||
105721034|NCT00928070|364636325|FG000|Overall Study|Adverse Event|14|||
105721035|NCT00928070|364636326|FG001|Overall Study|Adverse Event|26|||
105721036|NCT00928070|364636325|FG000|Overall Study|Lack of Efficacy|9|||
105721037|NCT00928070|364636326|FG001|Overall Study|Lack of Efficacy|5|||
105721038|NCT00928070|364636325|FG000|Overall Study|Did not meet entrance criteria|16|||
105721039|NCT00928070|364636326|FG001|Overall Study|Did not meet entrance criteria|9|||
105721040|NCT00928070|364636325|FG000|Overall Study|Protocol Violation|6|||
105721041|NCT00928070|364636326|FG001|Overall Study|Protocol Violation|5|||
105721042|NCT00928070|364636325|FG000|Overall Study|Randomized but not treated|2|||
105721043|NCT00928070|364636326|FG001|Overall Study|Randomized but not treated|2|||
105721044|NCT00928070|364636325|FG000|Overall Study|Other|5|||
105721045|NCT00928070|364636326|FG001|Overall Study|Other|5|||
105721046|NCT04233229|364636327|FG000|Overall Study|Withdrawal by Subject|0|||
105721047|NCT04233229|364636328|FG001|Overall Study|Withdrawal by Subject|1|||
105721048|NCT04233229|364636327|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
105721049|NCT04233229|364636328|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
105721050|NCT04233229|364636327|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
105721051|NCT04233229|364636328|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
105721052|NCT00862251|364636329|FG000|Overall Study|Adverse Event|8|||
105721053|NCT00862251|364636330|FG001|Overall Study|Adverse Event|3|||
105721054|NCT00862251|364636331|FG002|Overall Study|Adverse Event|1|||
105721055|NCT00862251|364636329|FG000|Overall Study|Lost to Follow-up|0|||
105721056|NCT00862251|364636330|FG001|Overall Study|Lost to Follow-up|0|||
105721057|NCT00862251|364636331|FG002|Overall Study|Lost to Follow-up|1|||
105721058|NCT00862251|364636329|FG000|Overall Study|Protocol Violation|2|||
105721059|NCT00862251|364636330|FG001|Overall Study|Protocol Violation|0|||
105721060|NCT00862251|364636331|FG002|Overall Study|Protocol Violation|1|||
105721061|NCT00862251|364636329|FG000|Overall Study|Withdrawal by Subject|9|||
105721062|NCT00862251|364636330|FG001|Overall Study|Withdrawal by Subject|2|||
105721063|NCT00862251|364636331|FG002|Overall Study|Withdrawal by Subject|6|||
105721064|NCT01570244|364636336|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
105721065|NCT03093155|364636340|FG000|Overall Study|Not Eligible|1|||
105721066|NCT03093155|364636341|FG001|Overall Study|Not Eligible|0|||
105721067|NCT03093155|364636340|FG000|Overall Study|Withdrawal by Subject|0|||
105721068|NCT03093155|364636341|FG001|Overall Study|Withdrawal by Subject|1|||
105721069|NCT02429856|364636342|FG000|Overall Study|Death|12|||
105721070|NCT02429856|364636343|FG001|Overall Study|Death|13|||
105721071|NCT02429856|364636342|FG000|Overall Study|Lost to Follow-up|6|||
105721072|NCT02429856|364636343|FG001|Overall Study|Lost to Follow-up|5|||
105721073|NCT02429856|364636342|FG000|Overall Study|Withdrawal by Subject|1|||
105721074|NCT02429856|364636343|FG001|Overall Study|Withdrawal by Subject|1|||
105721075|NCT00888238|364636353|FG000|Washout Period After Period 2|Adverse Event|0|||
105721076|NCT00888238|364636354|FG001|Washout Period After Period 2|Adverse Event|0|||
105721077|NCT00888238|364636355|FG002|Washout Period After Period 2|Adverse Event|1|||
105721078|NCT03751111|364636356|FG000|Overall Study|Lack of Efficacy|9|||
105721079|NCT03751111|364636357|FG001|Overall Study|Lack of Efficacy|30|||
105721080|NCT03751111|364636356|FG000|Overall Study|Adverse Event|3|||
105721081|NCT03751111|364636357|FG001|Overall Study|Adverse Event|2|||
106009163|NCT05138653|365699088|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
106137191|NCT01883492|366161984|FG001|Overall Study|Surgery on contra-lateral hip|1|||
106137192|NCT01883492|366161983|FG000|Overall Study|Poor X-ray quality|7|||
105721082|NCT00974220|364636358|FG000|Treatment Period 1|Adverse Event|2|||
105721083|NCT00974220|364636359|FG001|Treatment Period 1|Adverse Event|1|||
105721084|NCT00974220|364636358|FG000|Treatment Period 1|noncompliant subjects|0|||
105721085|NCT00974220|364636359|FG001|Treatment Period 1|noncompliant subjects|1|||
105721086|NCT02921425|364636360|FG000|Overall Study|Protocol Violation|9|||
105721087|NCT01227967|364636361|FG000|Overall Study|Protocol Violation|3|||
105721088|NCT01227967|364636362|FG001|Overall Study|Protocol Violation|1|||
105721089|NCT01227967|364636361|FG000|Overall Study|Death|0|||
105721090|NCT01227967|364636362|FG001|Overall Study|Death|1|||
105721091|NCT01227967|364636361|FG000|Overall Study|Lost to Follow-up|8|||
105721092|NCT01227967|364636362|FG001|Overall Study|Lost to Follow-up|3|||
105721093|NCT01227967|364636361|FG000|Overall Study|Withdrawal by Subject|4|||
105721094|NCT01227967|364636362|FG001|Overall Study|Withdrawal by Subject|3|||
105721095|NCT01227967|364636361|FG000|Overall Study|Physician Decision|0|||
105721096|NCT01227967|364636362|FG001|Overall Study|Physician Decision|1|||
105721097|NCT01227967|364636361|FG000|Overall Study|Never Started Treatment|0|||
105721098|NCT01227967|364636362|FG001|Overall Study|Never Started Treatment|4|||
105721099|NCT01227967|364636361|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
105721100|NCT01227967|364636362|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
105721101|NCT03068715|364636363|FG000|Overall Study|No longer met inclusion criteria|1|||
105721102|NCT03068715|364636364|FG001|Overall Study|No longer met inclusion criteria|0|||
105721103|NCT00977470|364636368|FG000|Overall Study|Lack of Efficacy|32|||
105721104|NCT00977470|364636369|FG001|Overall Study|Lack of Efficacy|30|||
105721105|NCT00977470|364636368|FG000|Overall Study|Physician Decision|2|||
105721106|NCT00977470|364636369|FG001|Overall Study|Physician Decision|0|||
105721107|NCT00977470|364636368|FG000|Overall Study|Adverse Event|1|||
105721108|NCT00977470|364636369|FG001|Overall Study|Adverse Event|2|||
105721109|NCT00977470|364636368|FG000|Overall Study|Protocol Violation|1|||
105721110|NCT00977470|364636369|FG001|Overall Study|Protocol Violation|0|||
105721111|NCT00977470|364636368|FG000|Overall Study|Withdrawal by Subject|0|||
105721112|NCT00977470|364636369|FG001|Overall Study|Withdrawal by Subject|2|||
105721113|NCT00977470|364636368|FG000|Overall Study|Death|0|||
105721114|NCT00977470|364636369|FG001|Overall Study|Death|2|||
105721115|NCT00977470|364636368|FG000|Overall Study|clinical decline|0|||
105721116|NCT00977470|364636369|FG001|Overall Study|clinical decline|1|||
105721117|NCT00977470|364636368|FG000|Overall Study|prolonged recovery post-surgery|0|||
105721118|NCT00977470|364636369|FG001|Overall Study|prolonged recovery post-surgery|1|||
105721119|NCT00977470|364636368|FG000|Overall Study|Still on-study|2|||
105721120|NCT00977470|364636369|FG001|Overall Study|Still on-study|0|||
105721121|NCT01264939|364636370|FG000|Overall Study|Adverse Event|1|||
105721122|NCT01264939|364636371|FG001|Overall Study|Adverse Event|3|||
105721123|NCT01264939|364636370|FG000|Overall Study|Lost to Follow-up|0|||
105721124|NCT01264939|364636371|FG001|Overall Study|Lost to Follow-up|3|||
105721125|NCT01264939|364636370|FG000|Overall Study|Physician Decision|1|||
105721126|NCT01264939|364636371|FG001|Overall Study|Physician Decision|1|||
105721127|NCT01264939|364636370|FG000|Overall Study|Patient/Guardian Decision|8|||
105721128|NCT01264939|364636371|FG001|Overall Study|Patient/Guardian Decision|10|||
105721129|NCT01264939|364636370|FG000|Overall Study|Disease Progression|8|||
105721130|NCT01264939|364636371|FG001|Overall Study|Disease Progression|11|||
105721131|NCT01107444|364636372|FG000|Overall Study|Withdrawal by Subject|8|||
105721132|NCT01107444|364636373|FG001|Overall Study|Withdrawal by Subject|12|||
105721133|NCT01107444|364636372|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
105721134|NCT01107444|364636373|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
105721135|NCT01171612|364636375|FG000|Overall Study|Lost to Follow-up|51|||
105721136|NCT00737529|364636383|FG000|Overall Study|Disease Progression|95|||
105721137|NCT00737529|364636383|FG000|Overall Study|Adverse Event|24|||
105721138|NCT00737529|364636383|FG000|Overall Study|Withdrawal by Subject|5|||
105721139|NCT00737529|364636383|FG000|Overall Study|Death|4|||
105935579|NCT01629563|365425154|FG000|Overall Study|Lack of Efficacy|2|||
105935580|NCT01629563|365425155|FG001|Overall Study|Lack of Efficacy|3|||
105935581|NCT01629563|365425154|FG000|Overall Study|Lost to Follow-up|1|||
105935582|NCT01629563|365425155|FG001|Overall Study|Lost to Follow-up|0|||
105935583|NCT01629563|365425154|FG000|Overall Study|Pregnancy|1|||
105935584|NCT01629563|365425155|FG001|Overall Study|Pregnancy|2|||
105935585|NCT01629563|365425154|FG000|Overall Study|Protocol Violation|0|||
105935586|NCT01629563|365425155|FG001|Overall Study|Protocol Violation|1|||
105935587|NCT01629563|365425154|FG000|Overall Study|Withdrawal by Subject|27|||
105935588|NCT01629563|365425155|FG001|Overall Study|Withdrawal by Subject|20|||
105721140|NCT00737529|364636383|FG000|Overall Study|Protocol Violation|1|||
105935589|NCT01629563|365425154|FG000|Overall Study|surgery|0|||
105935590|NCT01629563|365425155|FG001|Overall Study|surgery|3|||
105935591|NCT01629563|365425154|FG000|Overall Study|Lack of return of menses|12|||
105935592|NCT01629563|365425155|FG001|Overall Study|Lack of return of menses|7|||
105935593|NCT01629563|365425154|FG000|Overall Study|Protocol Violation|0|||
105935594|NCT01629563|365425155|FG001|Overall Study|Protocol Violation|1|||
105935595|NCT01699685|365425160|FG000|Period 1|Adverse Event|1|||
105721141|NCT00737529|364636383|FG000|Overall Study|Other|4|||
105792495|NCT01299272|364896348|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
105935596|NCT01699685|365425161|FG001|Period 1|Adverse Event|1|||
105935597|NCT01699685|365425160|FG000|Period 1|Medical or ethical, noncompliance|2|||
106137193|NCT01883492|366161984|FG001|Overall Study|Poor X-ray quality|4|||
105935598|NCT01699685|365425161|FG001|Period 1|Medical or ethical, noncompliance|0|||
105721142|NCT01145560|364636384|FG000|Overall Study|Withdrawal by Subject|2|||
105721143|NCT01145560|364636385|FG001|Overall Study|Withdrawal by Subject|1|||
105721144|NCT01145560|364636386|FG002|Overall Study|Withdrawal by Subject|0|||
105721145|NCT01145560|364636384|FG000|Overall Study|Lost to Follow-up|1|||
105721146|NCT01145560|364636385|FG001|Overall Study|Lost to Follow-up|1|||
105721147|NCT01145560|364636386|FG002|Overall Study|Lost to Follow-up|1|||
105721148|NCT01145560|364636384|FG000|Overall Study|No study drug by 24h after organ failure|1|||
105721149|NCT01145560|364636385|FG001|Overall Study|No study drug by 24h after organ failure|0|||
105721150|NCT01145560|364636386|FG002|Overall Study|No study drug by 24h after organ failure|0|||
105721151|NCT01145560|364636384|FG000|Overall Study|Accidental unblinding of study treatment|0|||
105721152|NCT01145560|364636385|FG001|Overall Study|Accidental unblinding of study treatment|1|||
105721153|NCT01145560|364636386|FG002|Overall Study|Accidental unblinding of study treatment|0|||
105721154|NCT01145560|364636384|FG000|Overall Study|False insurance information|0|||
105721155|NCT01145560|364636385|FG001|Overall Study|False insurance information|1|||
105721156|NCT01145560|364636386|FG002|Overall Study|False insurance information|0|||
105721157|NCT01145560|364636384|FG000|Overall Study|Withdrawal of therapy|0|||
105721158|NCT01145560|364636385|FG001|Overall Study|Withdrawal of therapy|0|||
105721159|NCT01145560|364636386|FG002|Overall Study|Withdrawal of therapy|1|||
105721160|NCT04062214|364636389|FG000|Week 12|Death|1|||
105721161|NCT04062214|364636390|FG001|Week 12|Death|1|||
105721162|NCT04062214|364636389|FG000|Week 12|Withdrawal by Subject|14|||
105721163|NCT04062214|364636390|FG001|Week 12|Withdrawal by Subject|13|||
105721164|NCT04062214|364636389|FG000|Week 12|Lost to Follow-up|55|||
105721165|NCT04062214|364636390|FG001|Week 12|Lost to Follow-up|68|||
105721166|NCT04062214|364636389|FG000|Week 12|Intermittent missing|31|||
105721167|NCT04062214|364636390|FG001|Week 12|Intermittent missing|29|||
105721168|NCT04062214|364636389|FG000|Week 36|Withdrawal by Subject|4|||
105721169|NCT04062214|364636390|FG001|Week 36|Withdrawal by Subject|5|||
105721170|NCT04062214|364636389|FG000|Week 36|Lost to Follow-up|50|||
105721171|NCT04062214|364636390|FG001|Week 36|Lost to Follow-up|46|||
105721172|NCT04062214|364636389|FG000|Week 36|Death|0|||
105721173|NCT04062214|364636390|FG001|Week 36|Death|1|||
105721174|NCT02452762|364636391|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
105721175|NCT02452762|364636392|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
105721176|NCT02452762|364636391|FG000|Overall Study|Withdrawal by Subject|1|||
105721177|NCT02452762|364636392|FG001|Overall Study|Withdrawal by Subject|0|||
105721178|NCT02292212|364636394|FG000|ViE Phase|Withdrawal by Subject|1|||
105721179|NCT02292212|364636394|FG000|ViE Phase|Protocol Violation|2|||
105721180|NCT02675075|364636395|FG000|Overall Study|Lost to Follow-up|3|||
105935599|NCT01699685|365425160|FG000|Period 1|Other|0|||
105721181|NCT02675075|364636396|FG001|Overall Study|Lost to Follow-up|0|||
105721182|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105935600|NCT01699685|365425161|FG001|Period 1|Other|1|||
105935601|NCT01699685|365425160|FG000|Period 1|Patient request|0|||
105935602|NCT01699685|365425161|FG001|Period 1|Patient request|1|||
105721183|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721184|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721185|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
105721186|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105935603|NCT01699685|365425160|FG000|Period 2|Lost to Follow-up|1|||
105935604|NCT01699685|365425161|FG001|Period 2|Lost to Follow-up|0|||
105721187|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
105721188|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
106137194|NCT01883492|366161983|FG000|Overall Study|Withdrawal by Subject|1|||
106137195|NCT01883492|366161984|FG001|Overall Study|Withdrawal by Subject|0|||
106137196|NCT01883492|366161983|FG000|Overall Study|inappropriate implant used|1|||
106137197|NCT01883492|366161984|FG001|Overall Study|inappropriate implant used|1|||
106137198|NCT01883492|366161983|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
106137199|NCT01883492|366161984|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
106137200|NCT02232178|366161985|FG000|Overall Study|Lost to Follow-up|0|||
106137201|NCT02232178|366161986|FG001|Overall Study|Lost to Follow-up|1|||
106137202|NCT02232178|366161987|FG002|Overall Study|Lost to Follow-up|0|||
106137203|NCT02232178|366161985|FG000|Overall Study|ineligibility|0|||
106137204|NCT02232178|366161986|FG001|Overall Study|ineligibility|0|||
106137205|NCT02232178|366161987|FG002|Overall Study|ineligibility|1|||
106137206|NCT02232178|366161985|FG000|Overall Study|surgical complication|1|||
106137207|NCT02232178|366161986|FG001|Overall Study|surgical complication|0|||
106137208|NCT02232178|366161987|FG002|Overall Study|surgical complication|0|||
106137209|NCT03357341|366161988|FG000|Overall Study|Withdrawal by Subject|3|||
106137210|NCT03357341|366161989|FG001|Overall Study|Withdrawal by Subject|6|||
106137211|NCT03357341|366161988|FG000|Overall Study|Lost to Follow-up|4|||
106137212|NCT03357341|366161989|FG001|Overall Study|Lost to Follow-up|5|||
106137213|NCT03357341|366161988|FG000|Overall Study|Death|0|||
106137214|NCT03357341|366161989|FG001|Overall Study|Death|1|||
106137215|NCT00817635|366161990|FG000|Overall Study|Adverse Event|1|||
106137216|NCT00817635|366161991|FG001|Overall Study|Adverse Event|0|||
106137217|NCT00817635|366161992|FG002|Overall Study|Adverse Event|0|||
106137218|NCT00817635|366161993|FG003|Overall Study|Adverse Event|1|||
106137219|NCT00817635|366161994|FG004|Overall Study|Adverse Event|1|||
106137220|NCT00817635|366161990|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
106137221|NCT00817635|366161991|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
106137222|NCT00817635|366161992|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
106137223|NCT00817635|366161993|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
106137224|NCT00817635|366161994|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
106137225|NCT00817635|366161990|FG000|Overall Study|Withdrawal by Subject|2|||
106137226|NCT00817635|366161991|FG001|Overall Study|Withdrawal by Subject|1|||
106137227|NCT00817635|366161992|FG002|Overall Study|Withdrawal by Subject|0|||
106137228|NCT00817635|366161993|FG003|Overall Study|Withdrawal by Subject|1|||
106137229|NCT00817635|366161994|FG004|Overall Study|Withdrawal by Subject|2|||
106137230|NCT00817635|366161990|FG000|Overall Study|Lost to Follow-up|0|||
106137231|NCT00817635|366161991|FG001|Overall Study|Lost to Follow-up|1|||
106137232|NCT00817635|366161992|FG002|Overall Study|Lost to Follow-up|0|||
106137233|NCT00817635|366161993|FG003|Overall Study|Lost to Follow-up|1|||
106137234|NCT00817635|366161994|FG004|Overall Study|Lost to Follow-up|0|||
106137235|NCT00817635|366161990|FG000|Overall Study|Administrative Problems|0|||
106137236|NCT00817635|366161991|FG001|Overall Study|Administrative Problems|0|||
106137237|NCT00817635|366161992|FG002|Overall Study|Administrative Problems|0|||
106137238|NCT00817635|366161993|FG003|Overall Study|Administrative Problems|0|||
106137239|NCT00817635|366161994|FG004|Overall Study|Administrative Problems|1|||
106137240|NCT00817635|366161990|FG000|Overall Study|Protocol Violation|5|||
106137241|NCT00817635|366161991|FG001|Overall Study|Protocol Violation|1|||
106137242|NCT00817635|366161992|FG002|Overall Study|Protocol Violation|3|||
106137243|NCT00817635|366161993|FG003|Overall Study|Protocol Violation|2|||
106137244|NCT00817635|366161994|FG004|Overall Study|Protocol Violation|3|||
106137245|NCT04464421|366161997|FG000|Overall Study|Lost to Follow-up|2|||
106137246|NCT04464421|366161998|FG001|Overall Study|Lost to Follow-up|2|||
106137247|NCT01167426|366162000|FG000|Overall Study|Lost to Follow-up|6|||
106137248|NCT01167426|366162000|FG000|Overall Study|Protocol Violation|1|||
106137249|NCT01167426|366162000|FG000|Overall Study|Withdrawal by Subject|2|||
106137250|NCT01167426|366162000|FG000|Overall Study|Sponsor Decision|1|||
106137251|NCT01908634|366162004|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
106137252|NCT01908634|366162004|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
106137253|NCT04176458|366162005|FG000|Overall Study|Covid 19|4|||
106137254|NCT05790408|366162006|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
106137255|NCT01048788|366162007|FG000|Overall Study|Adverse Event|5|||
106137256|NCT01048788|366162008|FG001|Overall Study|Adverse Event|1|||
106137257|NCT01048788|366162009|FG002|Overall Study|Adverse Event|1|||
106137258|NCT01048788|366162007|FG000|Overall Study|Lack of Efficacy|0|||
106137259|NCT01048788|366162008|FG001|Overall Study|Lack of Efficacy|0|||
106137260|NCT01048788|366162009|FG002|Overall Study|Lack of Efficacy|1|||
106137261|NCT01048788|366162007|FG000|Overall Study|Withdrawal by Subject|0|||
106137262|NCT01048788|366162008|FG001|Overall Study|Withdrawal by Subject|1|||
106137263|NCT01048788|366162009|FG002|Overall Study|Withdrawal by Subject|0|||
106137264|NCT00420316|366162010|FG000|Overall Study|Withdrawal by Subject|0|||
106137265|NCT00420316|366162011|FG001|Overall Study|Withdrawal by Subject|1|||
106137266|NCT00420316|366162010|FG000|Overall Study|Lost to Follow-up|12|||
106137267|NCT00420316|366162011|FG001|Overall Study|Lost to Follow-up|8|||
106137268|NCT01196988|366162012|FG000|Overall Study|Adverse Event|1|||
106137269|NCT01196988|366162013|FG001|Overall Study|Adverse Event|2|||
105721189|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
106137270|NCT01196988|366162014|FG002|Overall Study|Adverse Event|0|||
106137271|NCT01196988|366162015|FG003|Overall Study|Adverse Event|0|||
106137272|NCT01196988|366162012|FG000|Overall Study|Withdrawal by Subject|5|||
106137273|NCT01196988|366162013|FG001|Overall Study|Withdrawal by Subject|1|||
106137274|NCT01196988|366162014|FG002|Overall Study|Withdrawal by Subject|4|||
106137275|NCT01196988|366162015|FG003|Overall Study|Withdrawal by Subject|0|||
106137276|NCT01196988|366162012|FG000|Overall Study|Lost to Follow-up|16|||
106137277|NCT01196988|366162013|FG001|Overall Study|Lost to Follow-up|29|||
106137278|NCT01196988|366162014|FG002|Overall Study|Lost to Follow-up|21|||
106137279|NCT01196988|366162015|FG003|Overall Study|Lost to Follow-up|1|||
106137280|NCT01196988|366162012|FG000|Overall Study|Other|2|||
106137281|NCT01196988|366162013|FG001|Overall Study|Other|0|||
106137282|NCT01196988|366162014|FG002|Overall Study|Other|0|||
106137283|NCT01196988|366162015|FG003|Overall Study|Other|0|||
106137284|NCT05419557|366162016|FG000|Overall Study|Lost to Follow-up|11|||
106137285|NCT05419557|366162017|FG001|Overall Study|Lost to Follow-up|4|||
106137286|NCT00558363|366162019|FG000|Overall Study|Physician Decision|18|||
105935605|NCT02181621|365425162|FG000|Overall Study|Adverse Event|1|||
105935606|NCT02181621|365425163|FG001|Overall Study|Adverse Event|0|||
105935607|NCT02181621|365425162|FG000|Overall Study|Previously Enrolled|0|||
105935608|NCT02181621|365425163|FG001|Overall Study|Previously Enrolled|1|||
105935609|NCT02181621|365425162|FG000|Overall Study|Enrollment Hold|1|||
105935610|NCT02181621|365425163|FG001|Overall Study|Enrollment Hold|1|||
105935611|NCT02802865|365425164|FG000|Overall Study|Pregnancy|1|||
105935612|NCT02802865|365425165|FG001|Overall Study|Pregnancy|1|||
105935613|NCT02802865|365425164|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
105792496|NCT01299272|364896349|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
105792497|NCT01299272|364896350|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
105935614|NCT02802865|365425165|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
105721190|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721191|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721192|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721193|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721194|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721195|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721196|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721197|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721198|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721199|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721200|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721201|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721202|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721203|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721204|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
105721205|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721206|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
105721207|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721208|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
105721209|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721210|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721211|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
105721212|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721213|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721214|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721215|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721216|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721217|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721218|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721219|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721220|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721221|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721222|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721223|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721224|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721225|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721226|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721227|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
105721228|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
105721229|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
105721230|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
105721231|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
105721232|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
105721233|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
105721234|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
105721235|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
105721236|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721237|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721238|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105935615|NCT03931785|365425166|FG000|Overall Study|Lost to Follow-up|4|||
105935616|NCT03931785|365425167|FG001|Overall Study|Lost to Follow-up|1|||
105935617|NCT03931785|365425168|FG002|Overall Study|Lost to Follow-up|4|||
105935618|NCT03931785|365425169|FG003|Overall Study|Lost to Follow-up|3|||
105935619|NCT03931785|365425166|FG000|Overall Study|Adverse Event|1|||
105935620|NCT03931785|365425167|FG001|Overall Study|Adverse Event|0|||
105721239|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721240|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721241|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721242|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721243|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721244|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721245|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721246|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721247|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721248|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721249|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721250|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
105721251|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721252|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721253|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
105721254|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721255|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
105721256|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721257|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721258|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721259|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721260|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721261|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721262|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721263|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721264|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721265|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721266|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721267|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721268|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721269|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721270|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721271|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721272|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721273|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
105721274|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
105721275|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721276|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721277|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
105721278|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721279|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721280|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721281|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721282|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721283|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721284|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721285|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721286|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721287|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721288|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721289|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721290|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721291|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721292|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721293|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721294|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721295|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721296|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
105721297|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721298|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721299|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
105721300|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721301|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105792498|NCT01299272|364896351|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
105721302|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721303|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721304|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721305|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721306|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721307|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721308|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721309|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721310|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721311|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721312|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721313|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721314|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721315|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721316|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721317|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721318|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721319|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
105721320|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721321|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721322|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
105721323|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721324|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721325|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721326|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721327|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721328|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721329|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721330|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721331|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721332|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721333|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721334|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721335|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721336|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721337|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721338|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721339|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721340|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721341|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721342|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
105721343|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721344|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721345|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721346|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
105721347|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721348|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721349|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721350|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721351|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721352|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721353|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721354|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721355|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721356|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721357|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721358|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721359|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721360|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721361|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721362|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721363|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721364|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721365|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
105721366|NCT00896532|364636397|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721367|NCT00896532|364636398|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
105721368|NCT00896532|364636399|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721369|NCT00896532|364636400|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
105721370|NCT00896532|364636401|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
105721371|NCT00896532|364636402|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721372|NCT00896532|364636403|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721373|NCT00896532|364636404|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721374|NCT00896532|364636405|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721375|NCT00896532|364636406|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721376|NCT00896532|364636407|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721377|NCT00896532|364636408|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721378|NCT00896532|364636409|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721379|NCT00896532|364636410|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721380|NCT00896532|364636411|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721381|NCT00896532|364636412|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721382|NCT00896532|364636413|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721383|NCT00896532|364636414|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721384|NCT00896532|364636415|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721385|NCT00896532|364636416|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721386|NCT00896532|364636417|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721387|NCT00896532|364636418|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721388|NCT00896532|364636419|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
105721389|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721390|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721391|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721392|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721393|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721394|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721395|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721396|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721397|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
105721398|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721399|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721400|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721401|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721402|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721403|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721404|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721405|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721406|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721407|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721408|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721409|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721410|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721411|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
105721412|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721413|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721414|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105792499|NCT00464308|364896352|FG000|Overall Study|Adverse Event|22|||
105792500|NCT00464308|364896353|FG001|Overall Study|Adverse Event|27|||
105792501|NCT00464308|364896354|FG002|Overall Study|Adverse Event|16|||
105792502|NCT00464308|364896352|FG000|Overall Study|Lost to Follow-up|29|||
105935621|NCT03931785|365425168|FG002|Overall Study|Adverse Event|3|||
105935622|NCT03931785|365425169|FG003|Overall Study|Adverse Event|4|||
105792503|NCT00464308|364896353|FG001|Overall Study|Lost to Follow-up|19|||
105792504|NCT00464308|364896354|FG002|Overall Study|Lost to Follow-up|20|||
105792505|NCT00464308|364896352|FG000|Overall Study|Patient discontinued and other reasons|17|||
105935623|NCT03931785|365425166|FG000|Overall Study|Protocol Violation|0|||
105792506|NCT00464308|364896353|FG001|Overall Study|Patient discontinued and other reasons|17|||
105935624|NCT03931785|365425167|FG001|Overall Study|Protocol Violation|1|||
105721415|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721416|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721417|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105935625|NCT03931785|365425168|FG002|Overall Study|Protocol Violation|0|||
105935626|NCT03931785|365425169|FG003|Overall Study|Protocol Violation|0|||
106137287|NCT00558363|366162020|FG001|Overall Study|Physician Decision|4|||
106137288|NCT00558363|366162019|FG000|Overall Study|Withdrawal by Subject|11|||
106137289|NCT00558363|366162020|FG001|Overall Study|Withdrawal by Subject|4|||
106137290|NCT00558363|366162019|FG000|Overall Study|Adverse Event|5|||
106137291|NCT00558363|366162020|FG001|Overall Study|Adverse Event|5|||
106137292|NCT00558363|366162019|FG000|Overall Study|Lack of Efficacy|2|||
106137293|NCT00558363|366162020|FG001|Overall Study|Lack of Efficacy|2|||
106137294|NCT00558363|366162019|FG000|Overall Study|Protocol Violation|2|||
106137295|NCT00558363|366162020|FG001|Overall Study|Protocol Violation|1|||
106137296|NCT00558363|366162019|FG000|Overall Study|Lost to Follow-up|0|||
106137297|NCT00558363|366162020|FG001|Overall Study|Lost to Follow-up|1|||
106137298|NCT00558363|366162019|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
106137299|NCT00558363|366162020|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
106137300|NCT00558363|366162019|FG000|Overall Study|Randomized in Error|1|||
106137301|NCT00558363|366162020|FG001|Overall Study|Randomized in Error|2|||
106137302|NCT00558363|366162019|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
106137303|NCT00558363|366162020|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
106137304|NCT01313182|366162021|FG000|Overall Study|Protocol Violation|66|||
106137305|NCT01313182|366162022|FG001|Overall Study|Protocol Violation|92|||
106137306|NCT00606580|366162023|FG000|Overall Study|Lost to Follow-up|1|||
106137307|NCT00606580|366162024|FG001|Overall Study|Lost to Follow-up|1|||
106137308|NCT00606580|366162025|FG002|Overall Study|Lost to Follow-up|4|||
106137309|NCT00606580|366162023|FG000|Overall Study|Clinical failures|1|||
106137310|NCT00606580|366162024|FG001|Overall Study|Clinical failures|0|||
106137311|NCT00606580|366162025|FG002|Overall Study|Clinical failures|12|||
106137312|NCT00606580|366162023|FG000|Overall Study|Withdrawal by investigator|0|||
106137313|NCT00606580|366162024|FG001|Overall Study|Withdrawal by investigator|1|||
106137314|NCT00606580|366162025|FG002|Overall Study|Withdrawal by investigator|6|||
106137315|NCT00606580|366162023|FG000|Overall Study|Withdrawal by Subject|0|||
106137316|NCT00606580|366162024|FG001|Overall Study|Withdrawal by Subject|1|||
106137317|NCT00606580|366162025|FG002|Overall Study|Withdrawal by Subject|0|||
106137318|NCT02299635|366162027|FG000|Overall Study|Adverse Event|2|||
106137319|NCT02299635|366162027|FG000|Overall Study|Death|1|||
106137320|NCT02299635|366162027|FG000|Overall Study|Global deterioration of health status|1|||
106137321|NCT02299635|366162027|FG000|Overall Study|Objective progression or relapse|10|||
106137322|NCT02299635|366162027|FG000|Overall Study|Withdrawal by Subject|2|||
106137323|NCT02299635|366162027|FG000|Overall Study|Other|3|||
106137324|NCT00828672|366162028|FG000|Study Treatment|Lost to Follow-up|1|||
106137325|NCT00828672|366162029|FG001|Study Treatment|Lost to Follow-up|0|||
106137326|NCT00828672|366162028|FG000|Study Treatment|Adverse Event|0|||
106137327|NCT00828672|366162029|FG001|Study Treatment|Adverse Event|1|||
106137328|NCT00828672|366162028|FG000|Study Treatment|Complete response, no surgery|1|||
106137329|NCT00828672|366162029|FG001|Study Treatment|Complete response, no surgery|1|||
106137330|NCT00828672|366162028|FG000|Post-surgery (<30 Days)|No central review materials|0|||
106137331|NCT00828672|366162029|FG001|Post-surgery (<30 Days)|No central review materials|1|||
106137332|NCT01250002|366162030|FG000|Overall Study|Change to open surgical procedure|4|||
106137333|NCT01250002|366162031|FG001|Overall Study|Change to open surgical procedure|3|||
106137334|NCT02317705|366162032|FG000|Overall Study|Withdrawal by Subject|3|||
106137335|NCT02317705|366162032|FG000|Overall Study|Physician Decision|1|||
106137336|NCT02317705|366162032|FG000|Overall Study|Drug not usable|1|||
106137337|NCT02219490|366162033|FG000|Overall Study|Adverse Event|24|||
106137338|NCT02219490|366162033|FG000|Overall Study|Withdrew consent|96|||
106137339|NCT02219490|366162033|FG000|Overall Study|Lost to Follow-up|126|||
106137340|NCT02219490|366162033|FG000|Overall Study|COVID-19 infection|2|||
106137341|NCT02219490|366162033|FG000|Overall Study|COVID-19 logistical restrictions|33|||
106137342|NCT02219490|366162033|FG000|Overall Study|Other, not specified|57|||
106137343|NCT01242085|366162041|FG000|Overall Study|Withdrawal by Subject|4|||
106137344|NCT01242085|366162042|FG001|Overall Study|Withdrawal by Subject|2|||
106137345|NCT01242085|366162043|FG002|Overall Study|Withdrawal by Subject|0|||
106137346|NCT01242085|366162041|FG000|Overall Study|medically unable to have surgery|4|||
106137347|NCT01242085|366162042|FG001|Overall Study|medically unable to have surgery|5|||
106137348|NCT01242085|366162043|FG002|Overall Study|medically unable to have surgery|0|||
106137349|NCT01806714|366162048|FG000|Overall Study|No functioning phone number|200|||
106137350|NCT01806714|366162049|FG001|Overall Study|No functioning phone number|170|||
106137351|NCT02469064|366162050|FG000|Overall Study|Request not to receive intervention.|1|||
106137352|NCT02469064|366162051|FG001|Overall Study|Request not to receive intervention.|3|||
106137353|NCT00678795|366162052|FG000|Overall Study|Adverse Event|7|||
106137354|NCT00678795|366162053|FG001|Overall Study|Adverse Event|3|||
106137355|NCT00678795|366162052|FG000|Overall Study|Withdrawal by Subject|3|||
106137356|NCT00678795|366162053|FG001|Overall Study|Withdrawal by Subject|0|||
106137357|NCT00678795|366162052|FG000|Overall Study|Protocol Violation|0|||
105721418|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721419|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721420|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721421|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721422|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721423|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721424|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
105935627|NCT03931785|365425166|FG000|Overall Study|Noncompliance With Study drug|0|||
105935628|NCT03931785|365425167|FG001|Overall Study|Noncompliance With Study drug|1|||
105935629|NCT03931785|365425168|FG002|Overall Study|Noncompliance With Study drug|0|||
105935630|NCT03931785|365425169|FG003|Overall Study|Noncompliance With Study drug|0|||
105935631|NCT03931785|365425166|FG000|Overall Study|Other Not specified|0|||
105721425|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721426|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721427|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721428|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721429|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721430|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721431|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721432|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721433|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721434|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
105721435|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721436|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721437|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105935632|NCT03931785|365425167|FG001|Overall Study|Other Not specified|2|||
105935633|NCT03931785|365425168|FG002|Overall Study|Other Not specified|2|||
105935634|NCT03931785|365425169|FG003|Overall Study|Other Not specified|2|||
105935635|NCT03931785|365425166|FG000|Overall Study|Withdrawal by Subject|0|||
105935636|NCT03931785|365425167|FG001|Overall Study|Withdrawal by Subject|2|||
105935637|NCT03931785|365425168|FG002|Overall Study|Withdrawal by Subject|4|||
105935638|NCT03931785|365425169|FG003|Overall Study|Withdrawal by Subject|1|||
105935639|NCT03931785|365425166|FG000|Overall Study|Pregnancy|0|||
105935640|NCT03931785|365425167|FG001|Overall Study|Pregnancy|0|||
105792507|NCT00464308|364896354|FG002|Overall Study|Patient discontinued and other reasons|23|||
105935641|NCT03931785|365425168|FG002|Overall Study|Pregnancy|0|||
105935642|NCT03931785|365425169|FG003|Overall Study|Pregnancy|1|||
105935643|NCT01803737|365425170|FG000|Overall Study|Lack of Time|1|||
105721438|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721439|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721440|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721441|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721442|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721443|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721444|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721445|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
105721446|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721447|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
105721448|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721449|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721450|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721451|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721452|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721453|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721454|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721455|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105792508|NCT00464308|364896352|FG000|Overall Study|Physician Decision|1|||
105792509|NCT00464308|364896353|FG001|Overall Study|Physician Decision|0|||
105721456|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721457|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
105721458|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721459|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721460|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721461|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721462|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721463|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721464|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721465|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721466|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721467|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721468|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721469|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721470|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
105721471|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
105721472|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721473|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721474|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105935644|NCT01803737|365425171|FG001|Overall Study|Lack of Time|0|||
105935645|NCT01803737|365425170|FG000|Overall Study|Medical Reason|0|||
105935646|NCT01803737|365425171|FG001|Overall Study|Medical Reason|1|||
105935647|NCT01803737|365425170|FG000|Overall Study|Lost to Follow-up|0|||
105935648|NCT01803737|365425171|FG001|Overall Study|Lost to Follow-up|2|||
105935649|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
105935650|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
105935651|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
105935652|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
105935653|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
105935654|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
105935655|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
105935656|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
105935657|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
105935658|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
105935659|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
105935660|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
105935661|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
105935662|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
105935663|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
105721475|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721476|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721477|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105935664|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
105935665|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
105935666|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
105935667|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
105935668|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
105721478|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721479|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721480|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
105721481|NCT00896532|364636397|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
105721482|NCT00896532|364636398|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
105721483|NCT00896532|364636399|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
105721484|NCT00896532|364636400|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
105721485|NCT00896532|364636401|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
105721486|NCT00896532|364636402|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
105721487|NCT00896532|364636403|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
105721488|NCT00896532|364636404|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
105721489|NCT00896532|364636405|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
105935669|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
105935670|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
105935671|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
105935672|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
105721490|NCT00896532|364636406|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
105792510|NCT00464308|364896354|FG002|Overall Study|Physician Decision|0|||
105721491|NCT00896532|364636407|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
105721492|NCT00896532|364636408|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
105721493|NCT00896532|364636409|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
105721494|NCT00896532|364636410|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
105721495|NCT00896532|364636411|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
105721496|NCT00896532|364636412|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
105721497|NCT00896532|364636413|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
105721498|NCT00896532|364636414|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
105721499|NCT00896532|364636415|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
105721500|NCT00896532|364636416|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
105721501|NCT00896532|364636417|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
105721502|NCT00896532|364636418|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
105721503|NCT00896532|364636419|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
105721504|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721505|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721506|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721507|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721508|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721509|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721510|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721511|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721512|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721513|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721514|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721515|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721516|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721517|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721518|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721519|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
105721520|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
105721521|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721522|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721523|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721524|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721525|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721526|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
105721527|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721528|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721529|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721530|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721531|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721532|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721533|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721534|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721535|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721536|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721537|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721538|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721539|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721540|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721541|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721542|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
105721543|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
105721544|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
105721545|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721546|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721547|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721548|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721549|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
105721550|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721551|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721552|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721553|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105935673|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
105935674|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
105935675|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
105792511|NCT01721200|364896355|FG000|Overall Study|Lost to Follow-up|3|||
105792512|NCT01721200|364896356|FG001|Overall Study|Lost to Follow-up|5|||
105792513|NCT03926728|364896357|FG000|Overall Study|Withdrawal by Subject|0|||
105935676|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
105792514|NCT03926728|364896358|FG001|Overall Study|Withdrawal by Subject|1|||
105935677|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
105721554|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721555|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721556|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721557|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721558|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721559|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721560|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721561|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721562|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721563|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721564|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721565|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721566|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
105721567|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721568|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721569|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721570|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721571|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721572|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
105721573|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
105721574|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
105721575|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
105721576|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
105721577|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
105721578|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
105721579|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
105721580|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
105721581|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
105721582|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
105721583|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
105721584|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
105721585|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
105721586|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
105721587|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
105721588|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
105721589|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
105721590|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
105721591|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
105721592|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
105721593|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
105721594|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
105721595|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
105721596|NCT00896532|364636397|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721597|NCT00896532|364636398|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721598|NCT00896532|364636399|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721599|NCT00896532|364636400|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721600|NCT00896532|364636401|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721601|NCT00896532|364636402|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721602|NCT00896532|364636403|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721603|NCT00896532|364636404|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721604|NCT00896532|364636405|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721605|NCT00896532|364636406|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105935678|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
105935679|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
105935680|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
105935681|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
105935682|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
105935683|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
105935684|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
105935685|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
105935686|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
105935687|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
105935688|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
105935689|NCT02596893|365425174|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
106137358|NCT00678795|366162053|FG001|Overall Study|Protocol Violation|1|||
106137359|NCT00678795|366162052|FG000|Overall Study|Lost to Follow-up|0|||
105721606|NCT00896532|364636407|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721607|NCT00896532|364636408|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
106137360|NCT00678795|366162053|FG001|Overall Study|Lost to Follow-up|1|||
106137361|NCT00678795|366162052|FG000|Overall Study|Lack of Efficacy|1|||
106137362|NCT00678795|366162053|FG001|Overall Study|Lack of Efficacy|1|||
106137363|NCT01120275|366162054|FG000|Overall Study|Adverse Event|3|||
106137364|NCT01120275|366162054|FG000|Overall Study|Progression|27|||
106137365|NCT01120275|366162054|FG000|Overall Study|Ineligible|3|||
106137366|NCT01120275|366162054|FG000|Overall Study|Withdrawal by Subject|1|||
106137367|NCT01120275|366162054|FG000|Overall Study|Refusal|1|||
106137368|NCT01120275|366162054|FG000|Overall Study|Not specific|1|||
106137369|NCT01191788|366162058|FG000|Overall Study|Lost to Follow-up|21|||
106137370|NCT01191788|366162059|FG001|Overall Study|Lost to Follow-up|22|||
106137371|NCT03586167|366162060|FG000|Overall Study|Other|1|||
106137372|NCT03586167|366162061|FG001|Overall Study|Other|0|||
106137373|NCT01549652|366162062|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
106137374|NCT01549652|366162063|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
106137375|NCT01549652|366162064|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
106137376|NCT01549652|366162065|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
106137377|NCT01549652|366162062|FG000|Overall Study|Study Drug Titration Failure|5|||
106137378|NCT01549652|366162063|FG001|Overall Study|Study Drug Titration Failure|6|||
106137379|NCT01549652|366162064|FG002|Overall Study|Study Drug Titration Failure|0|||
106137380|NCT01549652|366162065|FG003|Overall Study|Study Drug Titration Failure|0|||
106137381|NCT01549652|366162062|FG000|Overall Study|Withdrawal Effect|0|||
106137382|NCT01549652|366162063|FG001|Overall Study|Withdrawal Effect|2|||
106137383|NCT01549652|366162064|FG002|Overall Study|Withdrawal Effect|0|||
106137384|NCT01549652|366162065|FG003|Overall Study|Withdrawal Effect|0|||
106137385|NCT01549652|366162062|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
106137386|NCT01549652|366162063|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
106137387|NCT01549652|366162064|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
106137388|NCT01549652|366162065|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
106137389|NCT01549652|366162062|FG000|Overall Study|Problem with Infusion|1|||
106137390|NCT01549652|366162063|FG001|Overall Study|Problem with Infusion|0|||
106137391|NCT01549652|366162064|FG002|Overall Study|Problem with Infusion|0|||
106137392|NCT01549652|366162065|FG003|Overall Study|Problem with Infusion|0|||
106137393|NCT01549652|366162062|FG000|Overall Study|Titration Non-Compliance|1|||
106137394|NCT01549652|366162063|FG001|Overall Study|Titration Non-Compliance|3|||
106137395|NCT01549652|366162064|FG002|Overall Study|Titration Non-Compliance|4|||
106137396|NCT01549652|366162065|FG003|Overall Study|Titration Non-Compliance|5|||
106137397|NCT01549652|366162062|FG000|Overall Study|Titration Side Effects|0|||
106137398|NCT01549652|366162063|FG001|Overall Study|Titration Side Effects|0|||
106137399|NCT01549652|366162064|FG002|Overall Study|Titration Side Effects|6|||
106137400|NCT01549652|366162065|FG003|Overall Study|Titration Side Effects|3|||
106137401|NCT01549652|366162062|FG000|Overall Study|Withdrawal by Subject|0|||
106137402|NCT01549652|366162063|FG001|Overall Study|Withdrawal by Subject|0|||
106137403|NCT01549652|366162064|FG002|Overall Study|Withdrawal by Subject|5|||
106137404|NCT01549652|366162065|FG003|Overall Study|Withdrawal by Subject|3|||
106137405|NCT02512042|366162066|FG000|Overall Study|Adverse Event|0|||
106137406|NCT02512042|366162067|FG001|Overall Study|Adverse Event|4|||
106137407|NCT02512042|366162066|FG000|Overall Study|Withdrawal by Subject|6|||
106137408|NCT02512042|366162067|FG001|Overall Study|Withdrawal by Subject|6|||
106137409|NCT02512042|366162066|FG000|Overall Study|Non-compliance with study drug|1|||
106137410|NCT02512042|366162067|FG001|Overall Study|Non-compliance with study drug|2|||
106137411|NCT02512042|366162066|FG000|Overall Study|Lost to Follow-up|5|||
106137412|NCT02512042|366162067|FG001|Overall Study|Lost to Follow-up|2|||
106137413|NCT02512042|366162066|FG000|Overall Study|Other|11|||
106137414|NCT02512042|366162067|FG001|Overall Study|Other|11|||
106137415|NCT00746330|366162070|FG000|Period 1|Abnormal test procedure result|0|||
106137416|NCT00746330|366162071|FG001|Period 1|Abnormal test procedure result|0|||
106137417|NCT00746330|366162072|FG002|Period 1|Abnormal test procedure result|1|||
106137418|NCT00746330|366162073|FG003|Period 1|Abnormal test procedure result|0|||
106137419|NCT00383188|366162074|FG000|Overall Study|Adverse Event|4|||
105792515|NCT03926728|364896359|FG002|Overall Study|Withdrawal by Subject|1|||
105792516|NCT03926728|364896360|FG003|Overall Study|Withdrawal by Subject|0|||
105792517|NCT03926728|364896361|FG004|Overall Study|Withdrawal by Subject|0|||
105792518|NCT03926728|364896362|FG005|Overall Study|Withdrawal by Subject|1|||
105792519|NCT03926728|364896363|FG006|Overall Study|Withdrawal by Subject|1|||
105792520|NCT03926728|364896364|FG007|Overall Study|Withdrawal by Subject|0|||
105792521|NCT03926728|364896365|FG008|Overall Study|Withdrawal by Subject|0|||
105792522|NCT03926728|364896366|FG009|Overall Study|Withdrawal by Subject|1|||
105792523|NCT03926728|364896367|FG010|Overall Study|Withdrawal by Subject|0|||
105792524|NCT03926728|364896368|FG011|Overall Study|Withdrawal by Subject|0|||
105721608|NCT00896532|364636409|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721609|NCT00896532|364636410|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721610|NCT00896532|364636411|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721611|NCT00896532|364636412|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721612|NCT00896532|364636413|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
105721613|NCT00896532|364636414|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721614|NCT00896532|364636415|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721615|NCT00896532|364636416|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721616|NCT00896532|364636417|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721617|NCT00896532|364636418|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721618|NCT00896532|364636419|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
105721619|NCT00896532|364636397|FG000|Months 48-72: Follow-on Phase|Death|0|||
105721620|NCT00896532|364636398|FG001|Months 48-72: Follow-on Phase|Death|0|||
105721621|NCT00896532|364636399|FG002|Months 48-72: Follow-on Phase|Death|0|||
105721622|NCT00896532|364636400|FG003|Months 48-72: Follow-on Phase|Death|0|||
105721623|NCT00896532|364636401|FG004|Months 48-72: Follow-on Phase|Death|0|||
105721624|NCT00896532|364636402|FG005|Months 48-72: Follow-on Phase|Death|0|||
105721625|NCT00896532|364636403|FG006|Months 48-72: Follow-on Phase|Death|0|||
105721626|NCT00896532|364636404|FG007|Months 48-72: Follow-on Phase|Death|0|||
105721627|NCT00896532|364636405|FG008|Months 48-72: Follow-on Phase|Death|0|||
105721628|NCT00896532|364636406|FG009|Months 48-72: Follow-on Phase|Death|0|||
105721629|NCT00896532|364636407|FG010|Months 48-72: Follow-on Phase|Death|0|||
105721630|NCT00896532|364636408|FG011|Months 48-72: Follow-on Phase|Death|0|||
105721631|NCT00896532|364636409|FG012|Months 48-72: Follow-on Phase|Death|0|||
105721632|NCT00896532|364636410|FG013|Months 48-72: Follow-on Phase|Death|0|||
105721633|NCT00896532|364636411|FG014|Months 48-72: Follow-on Phase|Death|0|||
105721634|NCT00896532|364636412|FG015|Months 48-72: Follow-on Phase|Death|0|||
105721635|NCT00896532|364636413|FG016|Months 48-72: Follow-on Phase|Death|0|||
105721636|NCT00896532|364636414|FG017|Months 48-72: Follow-on Phase|Death|0|||
105721637|NCT00896532|364636415|FG018|Months 48-72: Follow-on Phase|Death|1|||
105721638|NCT00896532|364636416|FG019|Months 48-72: Follow-on Phase|Death|0|||
105721639|NCT00896532|364636417|FG020|Months 48-72: Follow-on Phase|Death|0|||
105721640|NCT00896532|364636418|FG021|Months 48-72: Follow-on Phase|Death|0|||
105721641|NCT00896532|364636419|FG022|Months 48-72: Follow-on Phase|Death|0|||
105721642|NCT00896532|364636397|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721643|NCT00896532|364636398|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721644|NCT00896532|364636399|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721645|NCT00896532|364636400|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721646|NCT00896532|364636401|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721647|NCT00896532|364636402|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721648|NCT00896532|364636403|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721649|NCT00896532|364636404|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721650|NCT00896532|364636405|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721651|NCT00896532|364636406|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721652|NCT00896532|364636407|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721653|NCT00896532|364636408|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721654|NCT00896532|364636409|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721655|NCT00896532|364636410|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721656|NCT00896532|364636411|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721657|NCT00896532|364636412|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721658|NCT00896532|364636413|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721659|NCT00896532|364636414|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721660|NCT00896532|364636415|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721661|NCT00896532|364636416|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105792525|NCT03869684|364896371|FG000|Overall Study|Adverse Event|0|||
105792526|NCT03869684|364896372|FG001|Overall Study|Adverse Event|3|||
105792527|NCT03869684|364896373|FG002|Overall Study|Adverse Event|1|||
105792528|NCT03869684|364896371|FG000|Overall Study|Withdrawal by Subject|1|||
105792529|NCT03869684|364896372|FG001|Overall Study|Withdrawal by Subject|0|||
105721662|NCT00896532|364636417|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721663|NCT00896532|364636418|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
105721664|NCT00896532|364636419|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
105721665|NCT00896532|364636397|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721666|NCT00896532|364636398|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721667|NCT00896532|364636399|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105935690|NCT02596893|365425175|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
105935691|NCT02596893|365425176|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
105935692|NCT02596893|365425177|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
105935693|NCT00004228|365425178|FG000|Overall Study|Adverse Event|0|||
105935694|NCT00004228|365425179|FG001|Overall Study|Adverse Event|1|||
105935695|NCT00004228|365425180|FG002|Overall Study|Adverse Event|0|||
105935696|NCT00004228|365425181|FG003|Overall Study|Adverse Event|0|||
105935697|NCT00004228|365425182|FG004|Overall Study|Adverse Event|1|||
105935698|NCT00004228|365425183|FG005|Overall Study|Adverse Event|0|||
105935699|NCT00004228|365425184|FG006|Overall Study|Adverse Event|0|||
105935700|NCT00004228|365425178|FG000|Overall Study|Death|0|||
105721668|NCT00896532|364636400|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721669|NCT00896532|364636401|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721670|NCT00896532|364636402|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721671|NCT00896532|364636403|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721672|NCT00896532|364636404|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721673|NCT00896532|364636405|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721674|NCT00896532|364636406|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721675|NCT00896532|364636407|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721676|NCT00896532|364636408|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721677|NCT00896532|364636409|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721678|NCT00896532|364636410|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721679|NCT00896532|364636411|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105935701|NCT00004228|365425179|FG001|Overall Study|Death|1|||
105935702|NCT00004228|365425180|FG002|Overall Study|Death|2|||
105935703|NCT00004228|365425181|FG003|Overall Study|Death|0|||
105935704|NCT00004228|365425182|FG004|Overall Study|Death|1|||
105935705|NCT00004228|365425183|FG005|Overall Study|Death|0|||
105935706|NCT00004228|365425184|FG006|Overall Study|Death|0|||
105935707|NCT00004228|365425178|FG000|Overall Study|Lack of Efficacy|1|||
105935708|NCT00004228|365425179|FG001|Overall Study|Lack of Efficacy|6|||
105935709|NCT00004228|365425180|FG002|Overall Study|Lack of Efficacy|5|||
105935710|NCT00004228|365425181|FG003|Overall Study|Lack of Efficacy|3|||
105935711|NCT00004228|365425182|FG004|Overall Study|Lack of Efficacy|9|||
105935712|NCT00004228|365425183|FG005|Overall Study|Lack of Efficacy|8|||
105935713|NCT00004228|365425184|FG006|Overall Study|Lack of Efficacy|4|||
105935714|NCT00004228|365425178|FG000|Overall Study|Lost to Follow-up|0|||
105935715|NCT00004228|365425179|FG001|Overall Study|Lost to Follow-up|0|||
105935716|NCT00004228|365425180|FG002|Overall Study|Lost to Follow-up|1|||
105935717|NCT00004228|365425181|FG003|Overall Study|Lost to Follow-up|0|||
105935718|NCT00004228|365425182|FG004|Overall Study|Lost to Follow-up|0|||
105935719|NCT00004228|365425183|FG005|Overall Study|Lost to Follow-up|0|||
105935720|NCT00004228|365425184|FG006|Overall Study|Lost to Follow-up|0|||
105935721|NCT00004228|365425178|FG000|Overall Study|Physician Decision|1|||
105935722|NCT00004228|365425179|FG001|Overall Study|Physician Decision|0|||
105935723|NCT00004228|365425180|FG002|Overall Study|Physician Decision|3|||
105935724|NCT00004228|365425181|FG003|Overall Study|Physician Decision|2|||
105935725|NCT00004228|365425182|FG004|Overall Study|Physician Decision|1|||
105935726|NCT00004228|365425183|FG005|Overall Study|Physician Decision|1|||
105935727|NCT00004228|365425184|FG006|Overall Study|Physician Decision|1|||
105935728|NCT00004228|365425178|FG000|Overall Study|Protocol Violation|0|||
105935729|NCT00004228|365425179|FG001|Overall Study|Protocol Violation|5|||
105935730|NCT00004228|365425180|FG002|Overall Study|Protocol Violation|2|||
105935731|NCT00004228|365425181|FG003|Overall Study|Protocol Violation|1|||
105935732|NCT00004228|365425182|FG004|Overall Study|Protocol Violation|1|||
105935733|NCT00004228|365425183|FG005|Overall Study|Protocol Violation|2|||
105721680|NCT00896532|364636412|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721681|NCT00896532|364636413|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721682|NCT00896532|364636414|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721683|NCT00896532|364636415|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721684|NCT00896532|364636416|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105935734|NCT00004228|365425184|FG006|Overall Study|Protocol Violation|0|||
105935735|NCT00004228|365425178|FG000|Overall Study|Withdrawal by Subject|3|||
105935736|NCT00004228|365425179|FG001|Overall Study|Withdrawal by Subject|0|||
105935737|NCT00004228|365425180|FG002|Overall Study|Withdrawal by Subject|1|||
106009164|NCT05138653|365699089|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105721685|NCT00896532|364636417|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105935738|NCT00004228|365425181|FG003|Overall Study|Withdrawal by Subject|0|||
105935739|NCT00004228|365425182|FG004|Overall Study|Withdrawal by Subject|2|||
106137420|NCT00383188|366162075|FG001|Overall Study|Adverse Event|7|||
106137421|NCT00383188|366162076|FG002|Overall Study|Adverse Event|9|||
106137422|NCT00383188|366162077|FG003|Overall Study|Adverse Event|8|||
106137423|NCT00383188|366162078|FG004|Overall Study|Adverse Event|8|||
106137424|NCT00383188|366162074|FG000|Overall Study|Lack of Efficacy|9|||
106137425|NCT00383188|366162075|FG001|Overall Study|Lack of Efficacy|3|||
106137426|NCT00383188|366162076|FG002|Overall Study|Lack of Efficacy|3|||
105721686|NCT00896532|364636418|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
105721687|NCT00896532|364636419|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
105721688|NCT02411747|364636420|FG000|Overall Study|Withdrawal by Subject|1|||
105721689|NCT02411747|364636421|FG001|Overall Study|Withdrawal by Subject|0|||
105721690|NCT02411747|364636420|FG000|Overall Study|Protocol Violation|2|||
105721691|NCT02411747|364636421|FG001|Overall Study|Protocol Violation|4|||
105721692|NCT01176916|364636422|FG000|Overall Study|Adverse Event|61|||
105721693|NCT01176916|364636422|FG000|Overall Study|Death|1|||
105721694|NCT01176916|364636422|FG000|Overall Study|Lost to Follow-up|15|||
105721695|NCT01176916|364636422|FG000|Overall Study|Objective progression or relapse|17|||
105721696|NCT01176916|364636422|FG000|Overall Study|Protocol Violation|24|||
105721697|NCT01176916|364636422|FG000|Overall Study|Withdrawal by Subject|37|||
105721698|NCT01176916|364636422|FG000|Overall Study|Other|6|||
105721699|NCT01176916|364636422|FG000|Overall Study|Withdrawal prior to Treatment|6|||
105721700|NCT00675597|364636423|FG000|Overall Study|Withdrawal by Subject|3|||
105721701|NCT00631137|364636424|FG000|Overall Study|Withdrawal by Subject|1|||
105721702|NCT00631137|364636425|FG001|Overall Study|Withdrawal by Subject|0|||
105721703|NCT04223609|364636427|FG000|Overall Study|Adverse Event|0|||
105721704|NCT04223609|364636428|FG001|Overall Study|Adverse Event|1|||
105721705|NCT04223609|364636427|FG000|Overall Study|Missed last visit|0|||
105721706|NCT04223609|364636428|FG001|Overall Study|Missed last visit|1|||
105721707|NCT03437447|364636429|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105721708|NCT03437447|364636430|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105721709|NCT03437447|364636431|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105721710|NCT01275222|364636434|FG000|Phase l by Treatment|Adverse Event|1|||
105721711|NCT01275222|364636435|FG001|Phase l by Treatment|Adverse Event|4|||
105721712|NCT01275222|364636436|FG002|Phase l by Treatment|Adverse Event|2|||
105721713|NCT01275222|364636437|FG003|Phase l by Treatment|Adverse Event|3|||
105721714|NCT01275222|364636438|FG004|Phase l by Treatment|Adverse Event|0|||
105721715|NCT01275222|364636439|FG005|Phase l by Treatment|Adverse Event|0|||
105721716|NCT01275222|364636434|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721717|NCT01275222|364636435|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721718|NCT01275222|364636436|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
105721719|NCT01275222|364636437|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721720|NCT01275222|364636438|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721721|NCT01275222|364636439|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
105721722|NCT01275222|364636434|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105721723|NCT01275222|364636435|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105721724|NCT01275222|364636436|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
106137427|NCT00383188|366162077|FG003|Overall Study|Lack of Efficacy|2|||
106137428|NCT00383188|366162078|FG004|Overall Study|Lack of Efficacy|6|||
106137429|NCT00383188|366162074|FG000|Overall Study|Other|3|||
106137430|NCT00383188|366162075|FG001|Overall Study|Other|1|||
106137431|NCT00383188|366162076|FG002|Overall Study|Other|0|||
106137432|NCT00383188|366162077|FG003|Overall Study|Other|2|||
106137433|NCT00383188|366162078|FG004|Overall Study|Other|6|||
106137434|NCT00383188|366162074|FG000|Overall Study|No longer willing to participate|1|||
106137435|NCT00383188|366162075|FG001|Overall Study|No longer willing to participate|0|||
106137436|NCT00383188|366162076|FG002|Overall Study|No longer willing to participate|1|||
106137437|NCT00383188|366162077|FG003|Overall Study|No longer willing to participate|0|||
106137438|NCT00383188|366162078|FG004|Overall Study|No longer willing to participate|2|||
106137439|NCT00383188|366162074|FG000|Overall Study|Lost to Follow-up|0|||
106137440|NCT00383188|366162075|FG001|Overall Study|Lost to Follow-up|0|||
106137441|NCT00383188|366162076|FG002|Overall Study|Lost to Follow-up|0|||
106137442|NCT00383188|366162077|FG003|Overall Study|Lost to Follow-up|0|||
106137443|NCT00383188|366162078|FG004|Overall Study|Lost to Follow-up|1|||
106137444|NCT03523962|366162080|FG000|Closed Fractures|Death|86|||
106137445|NCT03523962|366162081|FG001|Closed Fractures|Death|71|||
106137446|NCT03523962|366162082|FG002|Closed Fractures|Death|0|||
106137447|NCT03523962|366162083|FG003|Closed Fractures|Death|0|||
106137448|NCT03523962|366162080|FG000|Closed Fractures|Lost to Follow-up|62|||
106137449|NCT03523962|366162081|FG001|Closed Fractures|Lost to Follow-up|36|||
106137450|NCT03523962|366162082|FG002|Closed Fractures|Lost to Follow-up|0|||
105721725|NCT01275222|364636437|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
105721726|NCT01275222|364636438|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105721727|NCT01275222|364636439|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
105721728|NCT01275222|364636434|FG000|Phase l by Treatment|Disease progression|12|||
106137451|NCT03523962|366162083|FG003|Closed Fractures|Lost to Follow-up|0|||
106137452|NCT03523962|366162080|FG000|Closed Fractures|Withdrawal by Subject|19|||
105721729|NCT01275222|364636435|FG001|Phase l by Treatment|Disease progression|8|||
105935740|NCT00004228|365425183|FG005|Overall Study|Withdrawal by Subject|1|||
105935741|NCT00004228|365425184|FG006|Overall Study|Withdrawal by Subject|2|||
105935742|NCT00004228|365425178|FG000|Overall Study|Other|0|||
105935743|NCT00004228|365425179|FG001|Overall Study|Other|0|||
105935744|NCT00004228|365425180|FG002|Overall Study|Other|1|||
105935745|NCT00004228|365425181|FG003|Overall Study|Other|0|||
105935746|NCT00004228|365425182|FG004|Overall Study|Other|0|||
105935747|NCT00004228|365425183|FG005|Overall Study|Other|0|||
105935748|NCT00004228|365425184|FG006|Overall Study|Other|0|||
105935749|NCT00004228|365425178|FG000|Overall Study|ineligible|4|||
105935750|NCT00004228|365425179|FG001|Overall Study|ineligible|2|||
105721730|NCT01275222|364636436|FG002|Phase l by Treatment|Disease progression|2|||
105721731|NCT01275222|364636437|FG003|Phase l by Treatment|Disease progression|5|||
105721732|NCT01275222|364636438|FG004|Phase l by Treatment|Disease progression|0|||
105721733|NCT01275222|364636439|FG005|Phase l by Treatment|Disease progression|0|||
105721734|NCT01275222|364636434|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
105721735|NCT01275222|364636435|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
105721736|NCT01275222|364636436|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
105721737|NCT01275222|364636437|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
105721738|NCT01275222|364636438|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
105721739|NCT01275222|364636439|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
105721740|NCT01275222|364636434|FG000|Phase l by Treatment|Death|0|||
105721741|NCT01275222|364636435|FG001|Phase l by Treatment|Death|1|||
105721742|NCT01275222|364636436|FG002|Phase l by Treatment|Death|0|||
105721743|NCT01275222|364636437|FG003|Phase l by Treatment|Death|1|||
105721744|NCT01275222|364636438|FG004|Phase l by Treatment|Death|0|||
105721745|NCT01275222|364636439|FG005|Phase l by Treatment|Death|0|||
105721746|NCT01275222|364636434|FG000|Phase ll by Stratum|Adverse Event|0|||
105721747|NCT01275222|364636435|FG001|Phase ll by Stratum|Adverse Event|0|||
105721748|NCT01275222|364636436|FG002|Phase ll by Stratum|Adverse Event|0|||
105721749|NCT01275222|364636437|FG003|Phase ll by Stratum|Adverse Event|0|||
105721750|NCT01275222|364636438|FG004|Phase ll by Stratum|Adverse Event|2|||
105721751|NCT01275222|364636439|FG005|Phase ll by Stratum|Adverse Event|10|||
105721752|NCT01275222|364636434|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
105721753|NCT01275222|364636435|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
105721754|NCT01275222|364636436|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
105721755|NCT01275222|364636437|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
105721756|NCT01275222|364636438|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
105721757|NCT01275222|364636439|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
105721758|NCT01275222|364636434|FG000|Phase ll by Stratum|Disease progression|0|||
105721759|NCT01275222|364636435|FG001|Phase ll by Stratum|Disease progression|0|||
105721760|NCT01275222|364636436|FG002|Phase ll by Stratum|Disease progression|0|||
105721761|NCT01275222|364636437|FG003|Phase ll by Stratum|Disease progression|0|||
105721762|NCT01275222|364636438|FG004|Phase ll by Stratum|Disease progression|23|||
105721763|NCT01275222|364636439|FG005|Phase ll by Stratum|Disease progression|31|||
105721764|NCT01275222|364636434|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
105721765|NCT01275222|364636435|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
105721766|NCT01275222|364636436|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
105721767|NCT01275222|364636437|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
105721768|NCT01275222|364636438|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
105721769|NCT01275222|364636439|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
105721770|NCT01275222|364636434|FG000|Phase ll by Stratum|Death|0|||
105721771|NCT01275222|364636435|FG001|Phase ll by Stratum|Death|0|||
105721772|NCT01275222|364636436|FG002|Phase ll by Stratum|Death|0|||
105721773|NCT01275222|364636437|FG003|Phase ll by Stratum|Death|0|||
105721774|NCT01275222|364636438|FG004|Phase ll by Stratum|Death|1|||
105721775|NCT01275222|364636439|FG005|Phase ll by Stratum|Death|1|||
105721776|NCT00591734|364636440|FG000|Overall Study|Lack of Efficacy|35|||
105721777|NCT00591734|364636440|FG000|Overall Study|Adverse Event|5|||
105721778|NCT00591734|364636440|FG000|Overall Study|Physician Decision|5|||
105721779|NCT00591734|364636440|FG000|Overall Study|Intercurrent Illness|8|||
105935751|NCT00004228|365425180|FG002|Overall Study|ineligible|4|||
105935752|NCT00004228|365425181|FG003|Overall Study|ineligible|1|||
105935753|NCT00004228|365425182|FG004|Overall Study|ineligible|1|||
105935754|NCT00004228|365425183|FG005|Overall Study|ineligible|2|||
105721780|NCT01661790|364636441|FG000|Overall Study|Lost to Follow-up|0|||
105721781|NCT01661790|364636442|FG001|Overall Study|Lost to Follow-up|2|||
105721782|NCT02764541|364636443|FG000|Overall Study|Withdrawal by Subject|0|||
105721783|NCT02764541|364636444|FG001|Overall Study|Withdrawal by Subject|0|||
105721784|NCT02764541|364636445|FG002|Overall Study|Withdrawal by Subject|0|||
105721785|NCT02764541|364636446|FG003|Overall Study|Withdrawal by Subject|0|||
105721786|NCT02764541|364636447|FG004|Overall Study|Withdrawal by Subject|1|||
105721787|NCT02764541|364636448|FG005|Overall Study|Withdrawal by Subject|1|||
105721788|NCT02764541|364636449|FG006|Overall Study|Withdrawal by Subject|0|||
105721789|NCT02764541|364636450|FG007|Overall Study|Withdrawal by Subject|1|||
105935755|NCT00004228|365425184|FG006|Overall Study|ineligible|5|||
105935756|NCT01013870|365425185|FG000|Overall Study|Lost to Follow-up|1|||
105935757|NCT01013870|365425186|FG001|Overall Study|Lost to Follow-up|3|||
105935758|NCT02242903|365425191|FG000|Overall Study|Withdrawal by Subject|1|||
106137453|NCT03523962|366162081|FG001|Closed Fractures|Withdrawal by Subject|29|||
106137454|NCT03523962|366162082|FG002|Closed Fractures|Withdrawal by Subject|0|||
106137455|NCT03523962|366162083|FG003|Closed Fractures|Withdrawal by Subject|0|||
106137456|NCT03523962|366162080|FG000|Closed Fractures|Incarceration|1|||
106137457|NCT03523962|366162081|FG001|Closed Fractures|Incarceration|4|||
106137458|NCT03523962|366162082|FG002|Closed Fractures|Incarceration|0|||
106137459|NCT03523962|366162083|FG003|Closed Fractures|Incarceration|0|||
106137460|NCT03523962|366162080|FG000|Open Fractures|Death|0|||
106137461|NCT03523962|366162081|FG001|Open Fractures|Death|0|||
106137462|NCT03523962|366162082|FG002|Open Fractures|Death|11|||
106137463|NCT03523962|366162083|FG003|Open Fractures|Death|6|||
106137464|NCT03523962|366162080|FG000|Open Fractures|Lost to Follow-up|0|||
106137465|NCT03523962|366162081|FG001|Open Fractures|Lost to Follow-up|0|||
106137466|NCT03523962|366162082|FG002|Open Fractures|Lost to Follow-up|15|||
106137467|NCT03523962|366162083|FG003|Open Fractures|Lost to Follow-up|8|||
106137468|NCT03523962|366162080|FG000|Open Fractures|Withdrawal by Subject|0|||
106137469|NCT03523962|366162081|FG001|Open Fractures|Withdrawal by Subject|0|||
106137470|NCT03523962|366162082|FG002|Open Fractures|Withdrawal by Subject|6|||
106137471|NCT03523962|366162083|FG003|Open Fractures|Withdrawal by Subject|2|||
106137472|NCT03523962|366162080|FG000|Open Fractures|Incarceration|0|||
106137473|NCT03523962|366162081|FG001|Open Fractures|Incarceration|0|||
106137474|NCT03523962|366162082|FG002|Open Fractures|Incarceration|1|||
106137475|NCT03523962|366162083|FG003|Open Fractures|Incarceration|0|||
105935759|NCT02242903|365425192|FG001|Overall Study|Withdrawal by Subject|0|||
105935760|NCT02242903|365425193|FG002|Overall Study|Withdrawal by Subject|0|||
105935761|NCT02242903|365425194|FG003|Overall Study|Withdrawal by Subject|0|||
106137476|NCT00768651|366162094|FG000|Overall Study|Withdrawal by Subject|1|||
106137477|NCT04771273|366162095|FG000|Dose Escalation Period|Not treated with trial medication|0|||
106137478|NCT04771273|366162096|FG001|Dose Escalation Period|Not treated with trial medication|1|||
106137479|NCT04771273|366162097|FG002|Dose Escalation Period|Not treated with trial medication|1|||
106137480|NCT04771273|366162098|FG003|Dose Escalation Period|Not treated with trial medication|0|||
106137481|NCT04771273|366162095|FG000|Dose Escalation Period|Other reasons than listed|2|||
106137482|NCT04771273|366162096|FG001|Dose Escalation Period|Other reasons than listed|0|||
106137483|NCT04771273|366162097|FG002|Dose Escalation Period|Other reasons than listed|2|||
106137484|NCT04771273|366162098|FG003|Dose Escalation Period|Other reasons than listed|1|||
106137485|NCT04771273|366162095|FG000|Dose Escalation Period|Protocol Violation|0|||
106137486|NCT04771273|366162096|FG001|Dose Escalation Period|Protocol Violation|0|||
106137487|NCT04771273|366162097|FG002|Dose Escalation Period|Protocol Violation|3|||
106137488|NCT04771273|366162098|FG003|Dose Escalation Period|Protocol Violation|1|||
106137489|NCT04771273|366162095|FG000|Dose Escalation Period|Burden of study procedures|1|||
106137490|NCT04771273|366162096|FG001|Dose Escalation Period|Burden of study procedures|0|||
106137491|NCT04771273|366162097|FG002|Dose Escalation Period|Burden of study procedures|0|||
106137492|NCT04771273|366162098|FG003|Dose Escalation Period|Burden of study procedures|0|||
106137493|NCT04771273|366162095|FG000|Dose Escalation Period|Change of residence|0|||
106137494|NCT04771273|366162096|FG001|Dose Escalation Period|Change of residence|0|||
106137495|NCT04771273|366162097|FG002|Dose Escalation Period|Change of residence|0|||
106137496|NCT04771273|366162098|FG003|Dose Escalation Period|Change of residence|1|||
106137497|NCT04771273|366162095|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
106137498|NCT04771273|366162096|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
106137499|NCT04771273|366162097|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
106137500|NCT04771273|366162098|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
106137501|NCT04771273|366162095|FG000|Dose Escalation Period|Adverse Event|8|||
106137502|NCT04771273|366162096|FG001|Dose Escalation Period|Adverse Event|9|||
106137503|NCT04771273|366162097|FG002|Dose Escalation Period|Adverse Event|12|||
106137504|NCT04771273|366162098|FG003|Dose Escalation Period|Adverse Event|2|||
106137505|NCT04771273|366162095|FG000|Maintenance Period|Other than listed|4|||
106137506|NCT04771273|366162096|FG001|Maintenance Period|Other than listed|2|||
106137507|NCT04771273|366162097|FG002|Maintenance Period|Other than listed|0|||
106137508|NCT04771273|366162098|FG003|Maintenance Period|Other than listed|3|||
106137509|NCT04771273|366162095|FG000|Maintenance Period|Burden of study procedures|1|||
106137510|NCT04771273|366162096|FG001|Maintenance Period|Burden of study procedures|0|||
106137511|NCT04771273|366162097|FG002|Maintenance Period|Burden of study procedures|0|||
106137512|NCT04771273|366162098|FG003|Maintenance Period|Burden of study procedures|0|||
106137513|NCT04771273|366162095|FG000|Maintenance Period|Change of residence|0|||
106137514|NCT04771273|366162096|FG001|Maintenance Period|Change of residence|1|||
106137515|NCT04771273|366162097|FG002|Maintenance Period|Change of residence|3|||
106137516|NCT04771273|366162098|FG003|Maintenance Period|Change of residence|0|||
106137517|NCT04771273|366162095|FG000|Maintenance Period|Perceived lack of efficacy|0|||
105935762|NCT02242903|365425195|FG004|Overall Study|Withdrawal by Subject|0|||
106137518|NCT04771273|366162096|FG001|Maintenance Period|Perceived lack of efficacy|0|||
106137519|NCT04771273|366162097|FG002|Maintenance Period|Perceived lack of efficacy|0|||
106137520|NCT04771273|366162098|FG003|Maintenance Period|Perceived lack of efficacy|1|||
106137521|NCT04771273|366162095|FG000|Maintenance Period|Adverse Event|4|||
105935763|NCT02242903|365425196|FG005|Overall Study|Withdrawal by Subject|0|||
105935764|NCT02242903|365425197|FG006|Overall Study|Withdrawal by Subject|0|||
105935765|NCT01975285|365425200|FG000|Overall Study|Failed Block and follow up|2|||
105935766|NCT01975285|365425201|FG001|Overall Study|Failed Block and follow up|2|||
105935767|NCT04914000|365425202|FG000|Overall Study|Lost to Follow-up|8|||
105935768|NCT04914000|365425202|FG000|Overall Study|Withdrawal by Subject|1|||
105935769|NCT00981175|365425203|FG000|Primary Dose Vaccination|Adverse Event|1|||
105721790|NCT02764541|364636443|FG000|Overall Study|Adverse Event|1|||
105721791|NCT02764541|364636444|FG001|Overall Study|Adverse Event|0|||
105721792|NCT02764541|364636445|FG002|Overall Study|Adverse Event|0|||
105721793|NCT02764541|364636446|FG003|Overall Study|Adverse Event|0|||
105721794|NCT02764541|364636447|FG004|Overall Study|Adverse Event|0|||
105721795|NCT02764541|364636448|FG005|Overall Study|Adverse Event|0|||
105721796|NCT02764541|364636449|FG006|Overall Study|Adverse Event|1|||
105721797|NCT02764541|364636450|FG007|Overall Study|Adverse Event|0|||
105721798|NCT02764541|364636443|FG000|Overall Study|Metastasis|1|||
105721799|NCT02764541|364636444|FG001|Overall Study|Metastasis|0|||
105721800|NCT02764541|364636445|FG002|Overall Study|Metastasis|0|||
105721801|NCT02764541|364636446|FG003|Overall Study|Metastasis|0|||
105721802|NCT02764541|364636447|FG004|Overall Study|Metastasis|0|||
105721803|NCT02764541|364636448|FG005|Overall Study|Metastasis|0|||
105721804|NCT02764541|364636449|FG006|Overall Study|Metastasis|0|||
105721805|NCT02764541|364636450|FG007|Overall Study|Metastasis|0|||
105721806|NCT02764541|364636443|FG000|Overall Study|Disease progression|1|||
105721807|NCT02764541|364636444|FG001|Overall Study|Disease progression|1|||
105721808|NCT02764541|364636445|FG002|Overall Study|Disease progression|0|||
105721809|NCT02764541|364636446|FG003|Overall Study|Disease progression|0|||
105721810|NCT02764541|364636447|FG004|Overall Study|Disease progression|0|||
105721811|NCT02764541|364636448|FG005|Overall Study|Disease progression|0|||
105721812|NCT02764541|364636449|FG006|Overall Study|Disease progression|0|||
105721813|NCT02764541|364636450|FG007|Overall Study|Disease progression|1|||
105721814|NCT02764541|364636443|FG000|Overall Study|Protocol Violation|0|||
105721815|NCT02764541|364636444|FG001|Overall Study|Protocol Violation|0|||
105721816|NCT02764541|364636445|FG002|Overall Study|Protocol Violation|0|||
105721817|NCT02764541|364636446|FG003|Overall Study|Protocol Violation|1|||
105721818|NCT02764541|364636447|FG004|Overall Study|Protocol Violation|0|||
105721819|NCT02764541|364636448|FG005|Overall Study|Protocol Violation|1|||
105721820|NCT02764541|364636449|FG006|Overall Study|Protocol Violation|0|||
105721821|NCT02764541|364636450|FG007|Overall Study|Protocol Violation|0|||
105721822|NCT02764541|364636443|FG000|Overall Study|Physician Decision|0|||
105721823|NCT02764541|364636444|FG001|Overall Study|Physician Decision|0|||
105935770|NCT00981175|365425204|FG001|Primary Dose Vaccination|Adverse Event|0|||
106009165|NCT05138653|365699090|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
105721824|NCT02764541|364636445|FG002|Overall Study|Physician Decision|0|||
105721825|NCT02764541|364636446|FG003|Overall Study|Physician Decision|1|||
105721826|NCT02764541|364636447|FG004|Overall Study|Physician Decision|0|||
105721827|NCT02764541|364636448|FG005|Overall Study|Physician Decision|0|||
105721828|NCT02764541|364636449|FG006|Overall Study|Physician Decision|0|||
105721829|NCT02764541|364636450|FG007|Overall Study|Physician Decision|1|||
105721830|NCT02764541|364636443|FG000|Overall Study|Three Cycles completed before surgery|0|||
105721831|NCT02764541|364636444|FG001|Overall Study|Three Cycles completed before surgery|0|||
105721832|NCT02764541|364636445|FG002|Overall Study|Three Cycles completed before surgery|0|||
105721833|NCT02764541|364636446|FG003|Overall Study|Three Cycles completed before surgery|1|||
105721834|NCT02764541|364636447|FG004|Overall Study|Three Cycles completed before surgery|0|||
105721835|NCT02764541|364636448|FG005|Overall Study|Three Cycles completed before surgery|0|||
105721836|NCT02764541|364636449|FG006|Overall Study|Three Cycles completed before surgery|0|||
105721837|NCT02764541|364636450|FG007|Overall Study|Three Cycles completed before surgery|0|||
105721838|NCT02764541|364636443|FG000|Overall Study|Patient Compliance|0|||
105721839|NCT02764541|364636444|FG001|Overall Study|Patient Compliance|0|||
105721840|NCT02764541|364636445|FG002|Overall Study|Patient Compliance|1|||
105721841|NCT02764541|364636446|FG003|Overall Study|Patient Compliance|0|||
105721842|NCT02764541|364636447|FG004|Overall Study|Patient Compliance|0|||
105721843|NCT02764541|364636448|FG005|Overall Study|Patient Compliance|0|||
105721844|NCT02764541|364636449|FG006|Overall Study|Patient Compliance|0|||
105721845|NCT02764541|364636450|FG007|Overall Study|Patient Compliance|0|||
105721846|NCT02764541|364636443|FG000|Overall Study|Death|0|||
105721847|NCT02764541|364636444|FG001|Overall Study|Death|0|||
105721848|NCT02764541|364636445|FG002|Overall Study|Death|0|||
105721849|NCT02764541|364636446|FG003|Overall Study|Death|0|||
105721850|NCT02764541|364636447|FG004|Overall Study|Death|0|||
105721851|NCT02764541|364636448|FG005|Overall Study|Death|0|||
105721852|NCT02764541|364636449|FG006|Overall Study|Death|1|||
105721853|NCT02764541|364636450|FG007|Overall Study|Death|0|||
105721854|NCT02764541|364636443|FG000|Overall Study|Insurance reasons|0|||
105721855|NCT02764541|364636444|FG001|Overall Study|Insurance reasons|0|||
105721856|NCT02764541|364636445|FG002|Overall Study|Insurance reasons|0|||
105721857|NCT02764541|364636446|FG003|Overall Study|Insurance reasons|0|||
105721858|NCT02764541|364636447|FG004|Overall Study|Insurance reasons|0|||
105721859|NCT02764541|364636448|FG005|Overall Study|Insurance reasons|0|||
105721860|NCT02764541|364636449|FG006|Overall Study|Insurance reasons|1|||
105721861|NCT02764541|364636450|FG007|Overall Study|Insurance reasons|0|||
105721862|NCT00355121|364636451|FG000|Overall Study|Did not receive study vaccine|1|||
105721863|NCT00355121|364636452|FG001|Overall Study|Did not receive study vaccine|0|||
105721864|NCT00355121|364636453|FG002|Overall Study|Did not receive study vaccine|1|||
105721865|NCT00355121|364636451|FG000|Overall Study|Adverse Event|0|||
105721866|NCT00355121|364636452|FG001|Overall Study|Adverse Event|1|||
105721867|NCT00355121|364636453|FG002|Overall Study|Adverse Event|0|||
105721868|NCT00355121|364636451|FG000|Overall Study|Protocol Violation|7|||
105721869|NCT00355121|364636452|FG001|Overall Study|Protocol Violation|9|||
105721870|NCT00355121|364636453|FG002|Overall Study|Protocol Violation|1|||
105721871|NCT00355121|364636451|FG000|Overall Study|Lost to Follow-up|4|||
105721872|NCT00355121|364636452|FG001|Overall Study|Lost to Follow-up|7|||
105721873|NCT00355121|364636453|FG002|Overall Study|Lost to Follow-up|1|||
105721874|NCT00355121|364636451|FG000|Overall Study|Withdrawal by Subject|9|||
105721875|NCT00355121|364636452|FG001|Overall Study|Withdrawal by Subject|10|||
105721876|NCT00355121|364636453|FG002|Overall Study|Withdrawal by Subject|2|||
105721877|NCT00355121|364636451|FG000|Overall Study|Serious adverse events|0|||
105721878|NCT00355121|364636452|FG001|Overall Study|Serious adverse events|2|||
105721879|NCT00355121|364636453|FG002|Overall Study|Serious adverse events|0|||
105721880|NCT02040142|364636457|FG000|Overall Study|Lost to Follow-up|5|||
105721881|NCT02040142|364636457|FG000|Overall Study|Death|17|||
105721882|NCT02040142|364636457|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
105721883|NCT03952559|364636464|FG000|Double Blind Treatment Period|Adverse Event|0|||
105721884|NCT03952559|364636465|FG001|Double Blind Treatment Period|Adverse Event|2|||
105721885|NCT03952559|364636466|FG002|Double Blind Treatment Period|Adverse Event|1|||
105721886|NCT03952559|364636467|FG003|Double Blind Treatment Period|Adverse Event|0|||
105721887|NCT03952559|364636468|FG004|Double Blind Treatment Period|Adverse Event|1|||
105721888|NCT03952559|364636464|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
105721889|NCT03952559|364636465|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
105721890|NCT03952559|364636466|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
105721891|NCT03952559|364636467|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
105721892|NCT03952559|364636468|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
105721893|NCT03952559|364636464|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
105721894|NCT03952559|364636465|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
105721895|NCT03952559|364636466|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
105721896|NCT03952559|364636467|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
105721897|NCT03952559|364636468|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
105721898|NCT03952559|364636464|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
105721899|NCT03952559|364636465|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
105721900|NCT03952559|364636466|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
105721901|NCT03952559|364636467|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
105721902|NCT03952559|364636468|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
105721903|NCT01870739|364636469|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
105721904|NCT01870739|364636470|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
105721905|NCT01870739|364636469|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
105721906|NCT01870739|364636470|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
105721907|NCT01870739|364636469|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
105721908|NCT01870739|364636470|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
105721909|NCT01870739|364636469|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
105721910|NCT01870739|364636470|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
105721911|NCT01870739|364636469|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
105721912|NCT01870739|364636470|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
105721913|NCT01870739|364636469|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
105721914|NCT01870739|364636470|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
105721915|NCT01870739|364636469|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
105721916|NCT01870739|364636470|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
105721917|NCT03538743|364636471|FG000|Overall Study|Adverse Event|0|||
105721918|NCT03538743|364636472|FG001|Overall Study|Adverse Event|0|||
105721919|NCT03538743|364636473|FG002|Overall Study|Adverse Event|1|||
105721920|NCT03538743|364636474|FG003|Overall Study|Adverse Event|1|||
105721921|NCT03538743|364636475|FG004|Overall Study|Adverse Event|0|||
105721922|NCT03538743|364636476|FG005|Overall Study|Adverse Event|0|||
105721923|NCT03538743|364636477|FG006|Overall Study|Adverse Event|0|||
105721924|NCT03538743|364636478|FG007|Overall Study|Adverse Event|0|||
105721925|NCT03538743|364636479|FG008|Overall Study|Adverse Event|0|||
105721926|NCT03538743|364636471|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
105721927|NCT03538743|364636472|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
105721928|NCT03538743|364636473|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
105721929|NCT03538743|364636474|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
105721930|NCT03538743|364636475|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
105721931|NCT03538743|364636476|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
105721932|NCT03538743|364636477|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
105721933|NCT03538743|364636478|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
105721934|NCT03538743|364636479|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
105935771|NCT00981175|365425203|FG000|Primary Dose Vaccination|Protocol Violation|0|||
105935772|NCT00981175|365425204|FG001|Primary Dose Vaccination|Protocol Violation|1|||
105935773|NCT00981175|365425203|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
105935774|NCT00981175|365425204|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
105935775|NCT00981175|365425203|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
105935776|NCT00981175|365425204|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
105935777|NCT04189588|365425205|FG000|Overall Study|Death|0|||
105935778|NCT04189588|365425206|FG001|Overall Study|Death|1|||
105935779|NCT04189588|365425205|FG000|Overall Study|Lost to Follow-up|0|||
105935780|NCT04189588|365425206|FG001|Overall Study|Lost to Follow-up|1|||
105935781|NCT02318277|365425207|FG000|Overall Study|Physician Decision|0|||
105935782|NCT02318277|365425208|FG001|Overall Study|Physician Decision|0|||
105935783|NCT02318277|365425209|FG002|Overall Study|Physician Decision|0|||
105935784|NCT02318277|365425210|FG003|Overall Study|Physician Decision|0|||
105935785|NCT02318277|365425211|FG004|Overall Study|Physician Decision|0|||
105935786|NCT02318277|365425212|FG005|Overall Study|Physician Decision|0|||
105935787|NCT02318277|365425213|FG006|Overall Study|Physician Decision|0|||
105935788|NCT02318277|365425214|FG007|Overall Study|Physician Decision|1|||
105935789|NCT02318277|365425207|FG000|Overall Study|Other|0|||
105935790|NCT02318277|365425208|FG001|Overall Study|Other|0|||
105935791|NCT02318277|365425209|FG002|Overall Study|Other|0|||
105935792|NCT02318277|365425210|FG003|Overall Study|Other|0|||
105935793|NCT02318277|365425211|FG004|Overall Study|Other|0|||
105935794|NCT02318277|365425212|FG005|Overall Study|Other|0|||
105935795|NCT02318277|365425213|FG006|Overall Study|Other|1|||
105935796|NCT02318277|365425214|FG007|Overall Study|Other|0|||
105935797|NCT02318277|365425207|FG000|Overall Study|Withdrawal by Subject|0|||
105935798|NCT02318277|365425208|FG001|Overall Study|Withdrawal by Subject|0|||
105935799|NCT02318277|365425209|FG002|Overall Study|Withdrawal by Subject|1|||
105935800|NCT02318277|365425210|FG003|Overall Study|Withdrawal by Subject|0|||
105935801|NCT02318277|365425211|FG004|Overall Study|Withdrawal by Subject|1|||
105935802|NCT02318277|365425212|FG005|Overall Study|Withdrawal by Subject|1|||
105935803|NCT02318277|365425213|FG006|Overall Study|Withdrawal by Subject|6|||
105935804|NCT02318277|365425214|FG007|Overall Study|Withdrawal by Subject|14|||
105935805|NCT02318277|365425207|FG000|Overall Study|Participant trial terminated by sponsor|0|||
105935806|NCT02318277|365425208|FG001|Overall Study|Participant trial terminated by sponsor|0|||
105935807|NCT02318277|365425209|FG002|Overall Study|Participant trial terminated by sponsor|1|||
105935808|NCT02318277|365425210|FG003|Overall Study|Participant trial terminated by sponsor|0|||
105935809|NCT02318277|365425211|FG004|Overall Study|Participant trial terminated by sponsor|1|||
105935810|NCT02318277|365425212|FG005|Overall Study|Participant trial terminated by sponsor|2|||
105721935|NCT03538743|364636471|FG000|Overall Study|Withdrawal by Subject|0|||
105721936|NCT03538743|364636472|FG001|Overall Study|Withdrawal by Subject|0|||
105721937|NCT03538743|364636473|FG002|Overall Study|Withdrawal by Subject|0|||
105721938|NCT03538743|364636474|FG003|Overall Study|Withdrawal by Subject|1|||
105721939|NCT03538743|364636475|FG004|Overall Study|Withdrawal by Subject|0|||
105935811|NCT02318277|365425213|FG006|Overall Study|Participant trial terminated by sponsor|5|||
105935812|NCT02318277|365425214|FG007|Overall Study|Participant trial terminated by sponsor|16|||
105721940|NCT03538743|364636476|FG005|Overall Study|Withdrawal by Subject|0|||
105721941|NCT03538743|364636477|FG006|Overall Study|Withdrawal by Subject|0|||
105721942|NCT03538743|364636478|FG007|Overall Study|Withdrawal by Subject|0|||
105721943|NCT03538743|364636479|FG008|Overall Study|Withdrawal by Subject|0|||
105721944|NCT01955707|364636480|FG000|Overall Study|Adverse Event|1|||
105721945|NCT01955707|364636481|FG001|Overall Study|Adverse Event|2|||
105721946|NCT01955707|364636480|FG000|Overall Study|Lost to Follow-up|2|||
105721947|NCT01955707|364636481|FG001|Overall Study|Lost to Follow-up|1|||
105721948|NCT01955707|364636480|FG000|Overall Study|Withdrawal by Subject|0|||
105721949|NCT01955707|364636481|FG001|Overall Study|Withdrawal by Subject|3|||
105721950|NCT01955707|364636480|FG000|Overall Study|Death|13|||
105721951|NCT01955707|364636481|FG001|Overall Study|Death|14|||
105721952|NCT01955707|364636480|FG000|Overall Study|Other|4|||
105721953|NCT01955707|364636481|FG001|Overall Study|Other|2|||
105721954|NCT01671345|364636482|FG000|Overall Study|Lost to Follow-up|10|||
105721955|NCT01671345|364636483|FG001|Overall Study|Lost to Follow-up|6|||
105721956|NCT01671345|364636482|FG000|Overall Study|visit with non-participating physician|3|||
105721957|NCT01671345|364636483|FG001|Overall Study|visit with non-participating physician|3|||
105721958|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
105721959|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
105721960|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
105721961|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
105721962|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
105721963|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
105721964|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
105721965|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
105721966|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
105721967|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
105721968|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
105721969|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
105721970|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
105721971|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
105721972|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
105721973|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
105721974|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
105721975|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
105721976|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
105721977|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721978|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721979|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721980|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721981|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
105721982|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
105721983|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
105721984|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
105721985|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
105721986|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
105721987|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
105721988|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
105721989|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
105721990|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
105721991|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
105721992|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
105721993|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
105721994|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
105721995|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
105721996|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
105721997|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
105721998|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
105721999|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
105722000|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
105722001|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
105722002|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
105722003|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
105935813|NCT02318277|365425207|FG000|Overall Study|Lost to Follow-up|1|||
105722004|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
105722005|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
105722006|NCT01707992|364636484|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
105792530|NCT03869684|364896373|FG002|Overall Study|Withdrawal by Subject|0|||
105792531|NCT03869684|364896371|FG000|Overall Study|Lost to Follow-up|1|||
105935814|NCT02318277|365425208|FG001|Overall Study|Lost to Follow-up|0|||
105935815|NCT02318277|365425209|FG002|Overall Study|Lost to Follow-up|1|||
105935816|NCT02318277|365425210|FG003|Overall Study|Lost to Follow-up|0|||
105935817|NCT02318277|365425211|FG004|Overall Study|Lost to Follow-up|0|||
105935818|NCT02318277|365425212|FG005|Overall Study|Lost to Follow-up|0|||
105935819|NCT02318277|365425213|FG006|Overall Study|Lost to Follow-up|3|||
105935820|NCT02318277|365425214|FG007|Overall Study|Lost to Follow-up|4|||
105935821|NCT02318277|365425207|FG000|Overall Study|Death|5|||
105935822|NCT02318277|365425208|FG001|Overall Study|Death|3|||
105935823|NCT02318277|365425209|FG002|Overall Study|Death|1|||
105935824|NCT02318277|365425210|FG003|Overall Study|Death|4|||
105935825|NCT02318277|365425211|FG004|Overall Study|Death|6|||
105935826|NCT02318277|365425212|FG005|Overall Study|Death|5|||
105935827|NCT02318277|365425213|FG006|Overall Study|Death|34|||
105935828|NCT02318277|365425214|FG007|Overall Study|Death|58|||
105935829|NCT02318277|365425207|FG000|Overall Study|Transitioned to Hospice|0|||
105935830|NCT02318277|365425208|FG001|Overall Study|Transitioned to Hospice|0|||
105935831|NCT02318277|365425209|FG002|Overall Study|Transitioned to Hospice|0|||
105935832|NCT02318277|365425210|FG003|Overall Study|Transitioned to Hospice|0|||
105935833|NCT02318277|365425211|FG004|Overall Study|Transitioned to Hospice|0|||
105935834|NCT02318277|365425212|FG005|Overall Study|Transitioned to Hospice|1|||
105935835|NCT02318277|365425213|FG006|Overall Study|Transitioned to Hospice|0|||
105935836|NCT02318277|365425214|FG007|Overall Study|Transitioned to Hospice|0|||
105935837|NCT00395512|365425215|FG000|Overall Study|Adverse Event|3|||
105935838|NCT00395512|365425216|FG001|Overall Study|Adverse Event|8|||
105935839|NCT00395512|365425217|FG002|Overall Study|Adverse Event|6|||
105935840|NCT00395512|365425218|FG003|Overall Study|Adverse Event|6|||
105935841|NCT00395512|365425215|FG000|Overall Study|Protocol Violation|2|||
105935842|NCT00395512|365425216|FG001|Overall Study|Protocol Violation|3|||
105935843|NCT00395512|365425217|FG002|Overall Study|Protocol Violation|6|||
105935844|NCT00395512|365425218|FG003|Overall Study|Protocol Violation|7|||
105935845|NCT00395512|365425215|FG000|Overall Study|Lost to Follow-up|2|||
105935846|NCT00395512|365425216|FG001|Overall Study|Lost to Follow-up|6|||
105935847|NCT00395512|365425217|FG002|Overall Study|Lost to Follow-up|5|||
105935848|NCT00395512|365425218|FG003|Overall Study|Lost to Follow-up|5|||
105935849|NCT00395512|365425215|FG000|Overall Study|Withdrawal by Subject|6|||
105935850|NCT00395512|365425216|FG001|Overall Study|Withdrawal by Subject|5|||
105935851|NCT00395512|365425217|FG002|Overall Study|Withdrawal by Subject|5|||
105792532|NCT03869684|364896372|FG001|Overall Study|Lost to Follow-up|0|||
105935852|NCT00395512|365425218|FG003|Overall Study|Withdrawal by Subject|12|||
105935853|NCT00395512|365425215|FG000|Overall Study|Physician Decision|6|||
105935854|NCT00395512|365425216|FG001|Overall Study|Physician Decision|4|||
105935855|NCT00395512|365425217|FG002|Overall Study|Physician Decision|2|||
105722007|NCT01707992|364636485|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
105722008|NCT01707992|364636486|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
105722009|NCT01707992|364636487|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
105722010|NCT01707992|364636488|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
105722011|NCT01707992|364636489|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
105722012|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
105722013|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
105722014|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
105722015|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
105722016|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
105722017|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
105722018|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
105722019|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
105722020|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
105722021|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
105722022|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
105722023|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
105722024|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
105722025|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
105722026|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
105722027|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
105722028|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
105722029|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
105722030|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
105722031|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
105722032|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
105722033|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
105722034|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
105722035|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
105722036|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
105722037|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
105722038|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
105722039|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
105722040|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
105722041|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
105722042|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Death|0|||
105722043|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Death|0|||
105722044|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Death|0|||
105722045|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Death|2|||
105722046|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Death|0|||
105722047|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Death|0|||
105722048|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
105722049|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
105722050|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
105722051|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
105935856|NCT00395512|365425218|FG003|Overall Study|Physician Decision|2|||
105935857|NCT00395512|365425215|FG000|Overall Study|Other|1|||
105935858|NCT00395512|365425216|FG001|Overall Study|Other|1|||
105935859|NCT00395512|365425217|FG002|Overall Study|Other|0|||
105935860|NCT00395512|365425218|FG003|Overall Study|Other|0|||
105935861|NCT00395512|365425215|FG000|Overall Study|Hyperglycemic Rescue|18|||
105935862|NCT00395512|365425216|FG001|Overall Study|Hyperglycemic Rescue|10|||
105935863|NCT00395512|365425217|FG002|Overall Study|Hyperglycemic Rescue|4|||
106137522|NCT04771273|366162096|FG001|Maintenance Period|Adverse Event|5|||
105722052|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
105935864|NCT00395512|365425218|FG003|Overall Study|Hyperglycemic Rescue|6|||
105935865|NCT01986751|365425224|FG000|Overall Study|improperly consented|10|||
106137523|NCT04771273|366162097|FG002|Maintenance Period|Adverse Event|5|||
106137524|NCT04771273|366162098|FG003|Maintenance Period|Adverse Event|0|||
106137525|NCT04436120|366162099|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
106137526|NCT04436120|366162100|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
106137527|NCT04436120|366162101|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
106137528|NCT04436120|366162102|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
106137529|NCT04436120|366162103|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
106137530|NCT04436120|366162104|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
105722053|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
105722054|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
105935866|NCT01986751|365425225|FG001|Overall Study|improperly consented|2|||
105935867|NCT03722030|365425226|FG000|Overall Study|Withdrawal by Subject|1|||
106137531|NCT04436120|366162105|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
106137532|NCT05576662|366162106|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
105722055|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
105722056|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
105722057|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
105722058|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
105722059|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
105722060|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
105722061|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
105722062|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
105722063|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
105722064|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
105722065|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
105722066|NCT01707992|364636484|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722067|NCT01707992|364636485|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722068|NCT01707992|364636486|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722069|NCT01707992|364636487|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722070|NCT01707992|364636488|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
105722071|NCT01707992|364636489|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
105722072|NCT03313050|364636490|FG000|Stage 2: 12 Months|Adverse Event|0|||
106137533|NCT05576662|366162107|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
106137534|NCT05576662|366162106|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
106137535|NCT05576662|366162107|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
106137536|NCT05576662|366162106|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
106137537|NCT05576662|366162107|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
106137538|NCT05576662|366162106|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
106137539|NCT05576662|366162107|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
106137540|NCT03781804|366162108|FG000|Overall Study|Adverse Event|2|||
105722073|NCT03313050|364636491|FG001|Stage 2: 12 Months|Adverse Event|0|||
106137541|NCT03781804|366162109|FG001|Overall Study|Adverse Event|2|||
106137542|NCT03781804|366162110|FG002|Overall Study|Adverse Event|3|||
106137543|NCT03781804|366162108|FG000|Overall Study|Lost to Follow-up|1|||
106137544|NCT03781804|366162109|FG001|Overall Study|Lost to Follow-up|1|||
106137545|NCT03781804|366162110|FG002|Overall Study|Lost to Follow-up|2|||
106137546|NCT03781804|366162108|FG000|Overall Study|Lack of Efficacy|4|||
106137547|NCT03781804|366162109|FG001|Overall Study|Lack of Efficacy|2|||
106137548|NCT03781804|366162110|FG002|Overall Study|Lack of Efficacy|9|||
106137549|NCT03781804|366162108|FG000|Overall Study|Protocol Violation|0|||
106137550|NCT03781804|366162109|FG001|Overall Study|Protocol Violation|0|||
106137551|NCT03781804|366162110|FG002|Overall Study|Protocol Violation|1|||
106137552|NCT03781804|366162108|FG000|Overall Study|Withdrawal by Subject|0|||
106137553|NCT03781804|366162109|FG001|Overall Study|Withdrawal by Subject|1|||
106137554|NCT03781804|366162110|FG002|Overall Study|Withdrawal by Subject|1|||
106137555|NCT03781804|366162108|FG000|Overall Study|Reason not provided|2|||
106137556|NCT03781804|366162109|FG001|Overall Study|Reason not provided|2|||
106137557|NCT03781804|366162110|FG002|Overall Study|Reason not provided|0|||
106137558|NCT00337818|366162111|FG000|Overall Study|Lost to Follow-up|289|||
106137559|NCT00337818|366162112|FG001|Overall Study|Lost to Follow-up|91|||
106137560|NCT00337818|366162113|FG002|Overall Study|Lost to Follow-up|107|||
106137561|NCT00604721|366162117|FG000|Overall Study|Physician Decision|1|||
106137562|NCT00604721|366162117|FG000|Overall Study|Withdrawal by Subject|1|||
106137563|NCT00561574|366162118|FG000|Overall Study|Adverse Event|21|||
106137564|NCT00561574|366162119|FG001|Overall Study|Adverse Event|24|||
106137565|NCT00561574|366162118|FG000|Overall Study|Lack of Efficacy|11|||
106137566|NCT00561574|366162119|FG001|Overall Study|Lack of Efficacy|21|||
106137567|NCT00561574|366162118|FG000|Overall Study|Withdrawal by Subject|4|||
106137568|NCT00561574|366162119|FG001|Overall Study|Withdrawal by Subject|4|||
105722074|NCT03313050|364636492|FG002|Stage 2: 12 Months|Adverse Event|0|||
105722075|NCT03313050|364636493|FG003|Stage 2: 12 Months|Adverse Event|1|||
105722076|NCT03313050|364636490|FG000|Stage 2: 12 Months|Death|0|||
105722077|NCT03313050|364636491|FG001|Stage 2: 12 Months|Death|0|||
105722078|NCT03313050|364636492|FG002|Stage 2: 12 Months|Death|3|||
105722079|NCT03313050|364636493|FG003|Stage 2: 12 Months|Death|0|||
105722080|NCT03313050|364636490|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
105722081|NCT03313050|364636491|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
105722082|NCT03313050|364636492|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
105722083|NCT03313050|364636493|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
105722084|NCT03313050|364636490|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
105722085|NCT03313050|364636491|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
105722086|NCT03313050|364636492|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
105722087|NCT03313050|364636493|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
105722088|NCT03313050|364636490|FG000|Stage 2: 12 Months|Protocol deviation|0|||
105722089|NCT03313050|364636491|FG001|Stage 2: 12 Months|Protocol deviation|0|||
105722090|NCT03313050|364636492|FG002|Stage 2: 12 Months|Protocol deviation|7|||
105722091|NCT03313050|364636493|FG003|Stage 2: 12 Months|Protocol deviation|7|||
105722092|NCT03313050|364636490|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
105722093|NCT03313050|364636491|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
105722094|NCT03313050|364636492|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
105722095|NCT03313050|364636493|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
105722096|NCT03313050|364636490|FG000|Stage 2: 12 Months|Other|0|||
105722097|NCT03313050|364636491|FG001|Stage 2: 12 Months|Other|0|||
105722098|NCT03313050|364636492|FG002|Stage 2: 12 Months|Other|0|||
105722099|NCT03313050|364636493|FG003|Stage 2: 12 Months|Other|1|||
105722100|NCT01291017|364636494|FG000|Overall Study|Lost to Follow-up|2|||
105722101|NCT01291017|364636494|FG000|Overall Study|Withdrawal by Subject|3|||
105722102|NCT02847598|364636495|FG000|Overall Study|Adverse Event|0|||
105722103|NCT02847598|364636496|FG001|Overall Study|Adverse Event|0|||
105722104|NCT02847598|364636497|FG002|Overall Study|Adverse Event|0|||
105722105|NCT02847598|364636498|FG003|Overall Study|Adverse Event|0|||
105722106|NCT02847598|364636499|FG004|Overall Study|Adverse Event|0|||
105722107|NCT02847598|364636500|FG005|Overall Study|Adverse Event|0|||
105722108|NCT02847598|364636501|FG006|Overall Study|Adverse Event|0|||
105722109|NCT02847598|364636502|FG007|Overall Study|Adverse Event|1|||
105722110|NCT02847598|364636495|FG000|Overall Study|Consent withdrawn|2|||
105722111|NCT02847598|364636496|FG001|Overall Study|Consent withdrawn|0|||
105722112|NCT02847598|364636497|FG002|Overall Study|Consent withdrawn|0|||
105722113|NCT02847598|364636498|FG003|Overall Study|Consent withdrawn|4|||
105722114|NCT02847598|364636499|FG004|Overall Study|Consent withdrawn|3|||
105722115|NCT02847598|364636500|FG005|Overall Study|Consent withdrawn|2|||
105722116|NCT02847598|364636501|FG006|Overall Study|Consent withdrawn|1|||
105722117|NCT02847598|364636502|FG007|Overall Study|Consent withdrawn|3|||
105722118|NCT02847598|364636495|FG000|Overall Study|Death|3|||
105722119|NCT02847598|364636496|FG001|Overall Study|Death|0|||
105722120|NCT02847598|364636497|FG002|Overall Study|Death|0|||
105722121|NCT02847598|364636498|FG003|Overall Study|Death|0|||
105722122|NCT02847598|364636499|FG004|Overall Study|Death|0|||
105722123|NCT02847598|364636500|FG005|Overall Study|Death|0|||
105722124|NCT02847598|364636501|FG006|Overall Study|Death|0|||
105722125|NCT02847598|364636502|FG007|Overall Study|Death|0|||
105722126|NCT02847598|364636495|FG000|Overall Study|Lost to Follow-up|0|||
105722127|NCT02847598|364636496|FG001|Overall Study|Lost to Follow-up|0|||
105722128|NCT02847598|364636497|FG002|Overall Study|Lost to Follow-up|0|||
105722129|NCT02847598|364636498|FG003|Overall Study|Lost to Follow-up|0|||
105722130|NCT02847598|364636499|FG004|Overall Study|Lost to Follow-up|0|||
105722131|NCT02847598|364636500|FG005|Overall Study|Lost to Follow-up|1|||
105722132|NCT02847598|364636501|FG006|Overall Study|Lost to Follow-up|1|||
105722133|NCT02847598|364636502|FG007|Overall Study|Lost to Follow-up|0|||
105722134|NCT02292771|364636503|FG000|Overall Study|Withdrawal by Subject|2|||
105722135|NCT02292771|364636504|FG001|Overall Study|Withdrawal by Subject|1|||
105722136|NCT02292771|364636503|FG000|Overall Study|Lost to Follow-up|2|||
105722137|NCT02292771|364636504|FG001|Overall Study|Lost to Follow-up|1|||
105722138|NCT04280081|364636508|FG000|Overall Study|Adverse Event|4|||
105722139|NCT04280081|364636508|FG000|Overall Study|Death|2|||
105722140|NCT04280081|364636508|FG000|Overall Study|Progressive Disease|6|||
105722141|NCT06119191|364636509|FG000|Overall Study|Adverse Event|0|||
105722142|NCT06119191|364636510|FG001|Overall Study|Adverse Event|1|||
105722143|NCT06119191|364636509|FG000|Overall Study|Protocol Violation|1|||
105722144|NCT06119191|364636510|FG001|Overall Study|Protocol Violation|0|||
105722145|NCT02911688|364638624|FG000|Washout|Lost to Follow-up|1|||
105722146|NCT02911688|364638625|FG001|Washout|Lost to Follow-up|1|||
105722147|NCT02911688|364638624|FG000|Washout|Withdrawal by Subject|0|||
105935868|NCT03722030|365425227|FG001|Overall Study|Withdrawal by Subject|0|||
105935869|NCT00676689|365425233|FG000|Overall Study|Screen Failure|2|||
105935870|NCT00676689|365425233|FG000|Overall Study|Death|2|||
105935871|NCT00676689|365425233|FG000|Overall Study|Lost to Follow-up|4|||
105935872|NCT00676689|365425233|FG000|Overall Study|Physician Decision|1|||
105935873|NCT00676689|365425233|FG000|Overall Study|Withdrawal by Subject|3|||
105935874|NCT00676689|365425233|FG000|Overall Study|Continuing FU|49|||
105935875|NCT00366535|365425234|FG000|First Phase: 12 Weeks|Adverse Event|1|||
105722148|NCT02911688|364638625|FG001|Washout|Withdrawal by Subject|1|||
105722149|NCT00809328|364638626|FG000|Overall Study|Lack of Efficacy|18|||
105722150|NCT00809328|364638626|FG000|Overall Study|Adverse Event|6|||
105722151|NCT00809328|364638626|FG000|Overall Study|Protocol Violation|3|||
105722152|NCT00809328|364638626|FG000|Overall Study|Withdrawal by Subject|2|||
105722153|NCT01524991|364638629|FG000|Overall Study|Adverse Event|12|||
105722154|NCT01524991|364638629|FG000|Overall Study|Death|1|||
105722155|NCT01524991|364638629|FG000|Overall Study|Disease ProgressionDu|17|||
105722156|NCT01524991|364638629|FG000|Overall Study|Other complicating disease|1|||
105722157|NCT01524991|364638629|FG000|Overall Study|Withdrawal by Subject|2|||
105722158|NCT01524991|364638629|FG000|Overall Study|Symptomatic Deterioration|1|||
105722159|NCT01805180|364638632|FG000|Lead-in Donor Phase|screen failure|1|||
105722160|NCT01805180|364638633|FG001|Lead-in Donor Phase|screen failure|0|||
105722161|NCT01805180|364638634|FG002|Lead-in Donor Phase|screen failure|0|||
105722162|NCT02472847|364638637|FG000|Overall Study|Withdrawal by Subject|1|||
105722163|NCT02472847|364638638|FG001|Overall Study|Withdrawal by Subject|5|||
105722164|NCT00398112|364638639|FG000|Overall Study|Adverse Event|4|||
105722165|NCT00398112|364638639|FG000|Overall Study|Disease progression|9|||
105722166|NCT00398112|364638639|FG000|Overall Study|Alternative treatment|1|||
105722167|NCT00398112|364638639|FG000|Overall Study|Withdrawal by Subject|3|||
105722168|NCT00398112|364638639|FG000|Overall Study|Death|1|||
105722169|NCT00008385|364638640|FG000|Overall Study|Off treatment reasons not reported|79|||
105722170|NCT00008385|364638641|FG001|Overall Study|Off treatment reasons not reported|70|||
105722171|NCT00008385|364638640|FG000|Overall Study|Progressive disease|52|||
105722172|NCT00008385|364638641|FG001|Overall Study|Progressive disease|117|||
106137569|NCT00561574|366162118|FG000|Overall Study|Reason Unrelated to Trial|6|||
105722173|NCT00008385|364638640|FG000|Overall Study|Adverse Event|8|||
105722174|NCT00008385|364638641|FG001|Overall Study|Adverse Event|20|||
105722175|NCT00008385|364638640|FG000|Overall Study|Death|12|||
105722176|NCT00008385|364638641|FG001|Overall Study|Death|18|||
105722177|NCT00008385|364638640|FG000|Overall Study|Withdrawal by Subject|67|||
105722178|NCT00008385|364638641|FG001|Overall Study|Withdrawal by Subject|157|||
105722179|NCT00008385|364638640|FG000|Overall Study|Start non-protocol therapy|3|||
105722180|NCT00008385|364638641|FG001|Overall Study|Start non-protocol therapy|1|||
105722181|NCT00008385|364638640|FG000|Overall Study|Other complicating disease|17|||
105722182|NCT00008385|364638641|FG001|Overall Study|Other complicating disease|30|||
105722183|NCT00008385|364638640|FG000|Overall Study|Maximum dose reached|0|||
105722184|NCT00008385|364638641|FG001|Overall Study|Maximum dose reached|2|||
105722185|NCT00008385|364638640|FG000|Overall Study|Other|105|||
105722186|NCT00008385|364638641|FG001|Overall Study|Other|212|||
105722187|NCT00008385|364638640|FG000|Overall Study|Not start protocol therapy|44|||
105722188|NCT00008385|364638641|FG001|Overall Study|Not start protocol therapy|175|||
105722189|NCT05148884|364638642|FG000|Overall Study|Withdrawal by Subject|3|||
105722190|NCT05148884|364638643|FG001|Overall Study|Withdrawal by Subject|0|||
105722191|NCT05148884|364638642|FG000|Overall Study|Deep brain stimulation operation|0|||
105722192|NCT05148884|364638643|FG001|Overall Study|Deep brain stimulation operation|1|||
105722193|NCT00582556|364638644|FG000|Overall Study|Withdrawal by Subject|0|||
105722194|NCT00582556|364638645|FG001|Overall Study|Withdrawal by Subject|1|||
105722195|NCT00582556|364638646|FG002|Overall Study|Withdrawal by Subject|1|||
105722196|NCT00582556|364638644|FG000|Overall Study|Physician Decision|0|||
105722197|NCT00582556|364638645|FG001|Overall Study|Physician Decision|0|||
105722198|NCT00582556|364638646|FG002|Overall Study|Physician Decision|1|||
105722199|NCT01993888|364638649|FG000|Overall Study|Death|1|||
105722200|NCT01993888|364638650|FG001|Overall Study|Death|1|||
105722201|NCT01993888|364638649|FG000|Overall Study|Lost to Follow-up|1|||
105722202|NCT01993888|364638650|FG001|Overall Study|Lost to Follow-up|1|||
105722203|NCT01993888|364638649|FG000|Overall Study|Withdrawal by Subject|0|||
105722204|NCT01993888|364638650|FG001|Overall Study|Withdrawal by Subject|1|||
105722205|NCT01341457|364638651|FG000|Overall Study|Adverse Event|2|||
105722206|NCT01341457|364638652|FG001|Overall Study|Adverse Event|0|||
105722207|NCT00851903|364638653|FG000|Overall Study|Withdrawal by Subject|2|||
105722208|NCT03116113|364638656|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722209|NCT03116113|364638657|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722210|NCT03116113|364638658|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722211|NCT03116113|364638659|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722212|NCT03116113|364638660|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722213|NCT03116113|364638661|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722214|NCT03116113|364638662|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
105722215|NCT03116113|364638663|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
105722216|NCT03116113|364638664|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
105722217|NCT03480802|364638667|FG000|Overall Study|Lost to Follow-up|5|||
105722218|NCT03480802|364638668|FG001|Overall Study|Lost to Follow-up|1|||
105722219|NCT03480802|364638667|FG000|Overall Study|Withdrawal by Subject|2|||
105722220|NCT03480802|364638668|FG001|Overall Study|Withdrawal by Subject|1|||
105722221|NCT03480802|364638667|FG000|Overall Study|Relocated|0|||
105722222|NCT03480802|364638668|FG001|Overall Study|Relocated|1|||
105722223|NCT04437511|364638673|FG000|Overall Study|Adverse Event|50|||
105722224|NCT04437511|364638674|FG001|Overall Study|Adverse Event|21|||
105722225|NCT04437511|364638673|FG000|Overall Study|Death|15|||
105722226|NCT04437511|364638674|FG001|Overall Study|Death|10|||
105722227|NCT04437511|364638673|FG000|Overall Study|Lost to Follow-up|11|||
105722228|NCT04437511|364638674|FG001|Overall Study|Lost to Follow-up|11|||
105722229|NCT04437511|364638673|FG000|Overall Study|Physician Decision|19|||
105722230|NCT04437511|364638674|FG001|Overall Study|Physician Decision|10|||
105722231|NCT04437511|364638673|FG000|Overall Study|Progressive Disease|4|||
105722232|NCT04437511|364638674|FG001|Overall Study|Progressive Disease|7|||
105722233|NCT04437511|364638673|FG000|Overall Study|Withdrawal by Subject|111|||
105722234|NCT04437511|364638674|FG001|Overall Study|Withdrawal by Subject|94|||
105722235|NCT04437511|364638673|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
105722236|NCT04437511|364638674|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
105722237|NCT04437511|364638673|FG000|Overall Study|Continuing Study|7|||
106137570|NCT00561574|366162119|FG001|Overall Study|Reason Unrelated to Trial|2|||
105722238|NCT04437511|364638674|FG001|Overall Study|Continuing Study|5|||
106137571|NCT00561574|366162118|FG000|Overall Study|Lost to Follow-up|1|||
105722239|NCT01874353|364638676|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
105722240|NCT01874353|364638677|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
105722241|NCT01874353|364638678|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
105722242|NCT01874353|364638679|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
105722243|NCT01874353|364638676|FG000|Overall Study|Lost to Follow-up|2|||
106137572|NCT00561574|366162119|FG001|Overall Study|Lost to Follow-up|0|||
106137573|NCT00561574|366162118|FG000|Overall Study|Other|5|||
106137574|NCT00561574|366162119|FG001|Overall Study|Other|7|||
106137575|NCT03254394|366162122|FG000|Overall Study|Withdrawal by Subject|0|||
106137576|NCT03254394|366162123|FG001|Overall Study|Withdrawal by Subject|2|||
106137577|NCT02317016|366162124|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
106137578|NCT02317016|366162124|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
106137579|NCT02317016|366162124|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
106137580|NCT02317016|366162124|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
106137581|NCT02317016|366162124|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
106137582|NCT02317016|366162124|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
106137583|NCT02317016|366162124|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
106137584|NCT00536380|366162125|FG000|Overall Study|Adverse Event|0|||
106137585|NCT00536380|366162126|FG001|Overall Study|Adverse Event|2|||
106137586|NCT00536380|366162127|FG002|Overall Study|Adverse Event|2|||
106137587|NCT00536380|366162125|FG000|Overall Study|Lost to Follow-up|0|||
106137588|NCT00536380|366162126|FG001|Overall Study|Lost to Follow-up|0|||
106137589|NCT00536380|366162127|FG002|Overall Study|Lost to Follow-up|1|||
106137590|NCT00536380|366162125|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
106137591|NCT00536380|366162126|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
106137592|NCT00536380|366162127|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
106137593|NCT00536380|366162125|FG000|Overall Study|Withdrawal related to study drug|7|||
106137594|NCT00536380|366162126|FG001|Overall Study|Withdrawal related to study drug|5|||
106137595|NCT00536380|366162127|FG002|Overall Study|Withdrawal related to study drug|2|||
106137596|NCT00536380|366162125|FG000|Overall Study|Noncompliance with protocol|3|||
106137597|NCT00536380|366162126|FG001|Overall Study|Noncompliance with protocol|2|||
106137598|NCT00536380|366162127|FG002|Overall Study|Noncompliance with protocol|2|||
106137599|NCT00536380|366162125|FG000|Overall Study|Did not meet protocol eligibility|0|||
106137600|NCT00536380|366162126|FG001|Overall Study|Did not meet protocol eligibility|0|||
106137601|NCT00536380|366162127|FG002|Overall Study|Did not meet protocol eligibility|1|||
106137602|NCT00536380|366162125|FG000|Overall Study|Administrative|0|||
106137603|NCT00536380|366162126|FG001|Overall Study|Administrative|0|||
106137604|NCT00536380|366162127|FG002|Overall Study|Administrative|1|||
106137605|NCT03354390|366162130|FG000|Level 1|Death|2|||
106137606|NCT03354390|366162131|FG001|Level 1|Death|0|||
106137607|NCT03354390|366162132|FG002|Level 1|Death|0|||
106137608|NCT03354390|366162133|FG003|Level 1|Death|0|||
106137609|NCT03354390|366162130|FG000|Level 1|Physician Decision|1|||
106137610|NCT03354390|366162131|FG001|Level 1|Physician Decision|0|||
106137611|NCT03354390|366162132|FG002|Level 1|Physician Decision|0|||
106137612|NCT03354390|366162133|FG003|Level 1|Physician Decision|0|||
106137613|NCT03354390|366162130|FG000|Level 2|Physician Decision|0|||
105722244|NCT01874353|364638677|FG001|Overall Study|Lost to Follow-up|2|||
105722245|NCT01874353|364638678|FG002|Overall Study|Lost to Follow-up|2|||
105722246|NCT01874353|364638679|FG003|Overall Study|Lost to Follow-up|0|||
105722247|NCT01874353|364638676|FG000|Overall Study|Death|110|||
105722248|NCT01874353|364638677|FG001|Overall Study|Death|60|||
105722249|NCT01874353|364638678|FG002|Overall Study|Death|13|||
105722250|NCT01874353|364638679|FG003|Overall Study|Death|7|||
105722251|NCT01874353|364638676|FG000|Overall Study|Withdrawal by Subject|13|||
105722252|NCT01874353|364638677|FG001|Overall Study|Withdrawal by Subject|11|||
105722253|NCT01874353|364638678|FG002|Overall Study|Withdrawal by Subject|0|||
105722254|NCT01874353|364638679|FG003|Overall Study|Withdrawal by Subject|0|||
105722255|NCT01323478|364638680|FG000|Overall Study|Adverse Event|7|||
106137614|NCT03354390|366162131|FG001|Level 2|Physician Decision|2|||
106137615|NCT03354390|366162132|FG002|Level 2|Physician Decision|0|||
106137616|NCT03354390|366162133|FG003|Level 2|Physician Decision|0|||
106137617|NCT03354390|366162130|FG000|Level 2|Lack of Efficacy|0|||
106137618|NCT03354390|366162131|FG001|Level 2|Lack of Efficacy|1|||
106137619|NCT03354390|366162132|FG002|Level 2|Lack of Efficacy|0|||
106137620|NCT03354390|366162133|FG003|Level 2|Lack of Efficacy|0|||
106137621|NCT03354390|366162130|FG000|Level 2|Lost to Follow-up|0|||
105722256|NCT01323478|364638680|FG000|Overall Study|Lack of Efficacy|4|||
105722257|NCT01323478|364638680|FG000|Overall Study|Non-compliance With Study Product|3|||
105722258|NCT01323478|364638680|FG000|Overall Study|Protocol Violation|1|||
105722259|NCT01323478|364638680|FG000|Overall Study|Withdrawal of Consent|1|||
105722260|NCT01323478|364638680|FG000|Overall Study|Administrative or Other Reasons|8|||
105722261|NCT01256177|364638681|FG000|Overall Study|Withdrawal by Subject|23|||
105722262|NCT01256177|364638682|FG001|Overall Study|Withdrawal by Subject|22|||
105722263|NCT01256177|364638681|FG000|Overall Study|Lost to Follow-up|2|||
105722264|NCT01256177|364638682|FG001|Overall Study|Lost to Follow-up|2|||
105722265|NCT01256177|364638681|FG000|Overall Study|Adverse Event|8|||
105722266|NCT01256177|364638682|FG001|Overall Study|Adverse Event|9|||
105722267|NCT01256177|364638681|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
105722268|NCT01256177|364638682|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
105722269|NCT01256177|364638681|FG000|Overall Study|Condition under Investigation Worsened|1|||
105722270|NCT01256177|364638682|FG001|Overall Study|Condition under Investigation Worsened|0|||
105722271|NCT01256177|364638681|FG000|Overall Study|Lack of Efficacy|11|||
105722272|NCT01256177|364638682|FG001|Overall Study|Lack of Efficacy|2|||
105722273|NCT01256177|364638681|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
105722274|NCT01256177|364638682|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
105722275|NCT01596257|364638684|FG000|Overall Study|Inadequate Collection|23|||
105722276|NCT01596257|364638685|FG001|Overall Study|Inadequate Collection|19|||
105722277|NCT02507349|364638686|FG000|Overall Study|Death|12|||
105722278|NCT02507349|364638687|FG001|Overall Study|Death|16|||
105722279|NCT02507349|364638686|FG000|Overall Study|Withdrawal by Subject|1|||
105722280|NCT02507349|364638687|FG001|Overall Study|Withdrawal by Subject|1|||
105722281|NCT02507349|364638686|FG000|Overall Study|Lost to Follow-up|174|||
105722282|NCT02507349|364638687|FG001|Overall Study|Lost to Follow-up|144|||
105722283|NCT05172544|364638696|FG000|Overall Study|Withdrawal by Subject|1|||
105722284|NCT05172544|364638697|FG001|Overall Study|Withdrawal by Subject|0|||
105722285|NCT05172544|364638698|FG002|Overall Study|Withdrawal by Subject|0|||
105722286|NCT05172544|364638696|FG000|Overall Study|Physician Decision|0|||
105722287|NCT05172544|364638697|FG001|Overall Study|Physician Decision|0|||
105722288|NCT05172544|364638698|FG002|Overall Study|Physician Decision|1|||
105722289|NCT01662648|364638699|FG000|Overall Study|Death|1|||
105722290|NCT01662648|364638700|FG001|Overall Study|Death|3|||
105722291|NCT01662648|364638699|FG000|Overall Study|Adverse Event|40|||
105722292|NCT01662648|364638700|FG001|Overall Study|Adverse Event|37|||
105722293|NCT01662648|364638699|FG000|Overall Study|Lack of Efficacy|17|||
105722294|NCT01662648|364638700|FG001|Overall Study|Lack of Efficacy|16|||
105722295|NCT01662648|364638699|FG000|Overall Study|Participant ineligible to continue trial|1|||
105722296|NCT01662648|364638700|FG001|Overall Study|Participant ineligible to continue trial|1|||
105722297|NCT01662648|364638699|FG000|Overall Study|Lost to Follow-up|24|||
105722298|NCT01662648|364638700|FG001|Overall Study|Lost to Follow-up|36|||
105722299|NCT01662648|364638699|FG000|Overall Study|Withdrawal by Subject|36|||
105722300|NCT01662648|364638700|FG001|Overall Study|Withdrawal by Subject|53|||
105722301|NCT01662648|364638699|FG000|Overall Study|Participant non-compliant|16|||
105722302|NCT01662648|364638700|FG001|Overall Study|Participant non-compliant|20|||
105722303|NCT01662648|364638699|FG000|Overall Study|Other|8|||
105722304|NCT01662648|364638700|FG001|Overall Study|Other|11|||
105722305|NCT01662648|364638699|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
105722306|NCT01662648|364638700|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
105722307|NCT01662648|364638699|FG000|Overall Study|LOE and other reason unspecified|1|||
105722308|NCT01662648|364638700|FG001|Overall Study|LOE and other reason unspecified|0|||
105722309|NCT01662648|364638699|FG000|Overall Study|LOE and Participant non-compliant|0|||
106137622|NCT03354390|366162131|FG001|Level 2|Lost to Follow-up|1|||
106137623|NCT03354390|366162132|FG002|Level 2|Lost to Follow-up|0|||
106137624|NCT03354390|366162133|FG003|Level 2|Lost to Follow-up|0|||
106137625|NCT03354390|366162130|FG000|Level 3|Death|0|||
106137626|NCT03354390|366162131|FG001|Level 3|Death|0|||
105722310|NCT01662648|364638700|FG001|Overall Study|LOE and Participant non-compliant|1|||
105722311|NCT01850615|364638701|FG000|Overall Study|Protocol Violation|4|||
105722312|NCT01850615|364638702|FG001|Overall Study|Protocol Violation|1|||
106137627|NCT03354390|366162132|FG002|Level 3|Death|1|||
105722313|NCT01850615|364638701|FG000|Overall Study|Adverse Event|2|||
105722314|NCT01850615|364638702|FG001|Overall Study|Adverse Event|1|||
105722315|NCT01850615|364638701|FG000|Overall Study|Withdrawal by Subject|3|||
105722316|NCT01850615|364638702|FG001|Overall Study|Withdrawal by Subject|1|||
105722317|NCT01850615|364638701|FG000|Overall Study|Lost to Follow-up|0|||
105722318|NCT01850615|364638702|FG001|Overall Study|Lost to Follow-up|1|||
105722319|NCT01850615|364638701|FG000|Overall Study|Unclassified|0|||
106137628|NCT03354390|366162133|FG003|Level 3|Death|0|||
106137629|NCT03354390|366162130|FG000|Level 3|Physician Decision|0|||
106137630|NCT03354390|366162131|FG001|Level 3|Physician Decision|0|||
105792533|NCT03869684|364896373|FG002|Overall Study|Lost to Follow-up|0|||
105792534|NCT03869684|364896371|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
105792535|NCT03869684|364896372|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
105792536|NCT03869684|364896373|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
105792537|NCT01005680|364896374|FG000|Overall Study|Lost to Follow-up|4|||
105792538|NCT01005680|364896375|FG001|Overall Study|Lost to Follow-up|6|||
105792539|NCT01005680|364896374|FG000|Overall Study|Withdrawal by Subject|1|||
105792540|NCT01005680|364896375|FG001|Overall Study|Withdrawal by Subject|4|||
105792541|NCT01005680|364896374|FG000|Overall Study|Physician Decision|1|||
105792542|NCT01005680|364896375|FG001|Overall Study|Physician Decision|1|||
105792543|NCT04840901|364896378|FG000|Overall Study|Lost to Follow-up|3|||
105792544|NCT04840901|364896379|FG001|Overall Study|Lost to Follow-up|1|||
105792545|NCT04840901|364896378|FG000|Overall Study|Moved|1|||
105792546|NCT04840901|364896379|FG001|Overall Study|Moved|0|||
105792547|NCT04840901|364896378|FG000|Overall Study|Unable to comply with study schedule|0|||
105792548|NCT04840901|364896379|FG001|Overall Study|Unable to comply with study schedule|1|||
105792549|NCT04840901|364896378|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
105792550|NCT04840901|364896379|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
105792551|NCT01268683|364896382|FG000|Overall Study|Lost to Follow-up|1|||
105792552|NCT01268683|364896382|FG000|Overall Study|Death|1|||
105792553|NCT02216214|364896383|FG000|Overall Study|Randomized Never Received Study Drug|1|||
105792554|NCT02216214|364896384|FG001|Overall Study|Randomized Never Received Study Drug|0|||
105792555|NCT02216214|364896383|FG000|Overall Study|Adverse Event|10|||
105792556|NCT02216214|364896384|FG001|Overall Study|Adverse Event|8|||
105792557|NCT02216214|364896383|FG000|Overall Study|Lack of Efficacy|2|||
105792558|NCT02216214|364896384|FG001|Overall Study|Lack of Efficacy|2|||
105792559|NCT02216214|364896383|FG000|Overall Study|Lost to Follow-up|3|||
105792560|NCT02216214|364896384|FG001|Overall Study|Lost to Follow-up|2|||
105792561|NCT02216214|364896383|FG000|Overall Study|Protocol Violation|4|||
105792562|NCT02216214|364896384|FG001|Overall Study|Protocol Violation|2|||
106137631|NCT03354390|366162132|FG002|Level 3|Physician Decision|2|||
106137632|NCT03354390|366162133|FG003|Level 3|Physician Decision|0|||
106137633|NCT03354390|366162130|FG000|Level 4|Death|0|||
106137634|NCT03354390|366162131|FG001|Level 4|Death|0|||
106137635|NCT03354390|366162132|FG002|Level 4|Death|0|||
106137636|NCT03354390|366162133|FG003|Level 4|Death|3|||
106137637|NCT00613301|366163444|FG000|Overall Study|Adverse Event|49|||
106137638|NCT00613301|366163444|FG000|Overall Study|Lost to Follow-up|88|||
106137639|NCT00613301|366163444|FG000|Overall Study|Withdrawal by Subject|5|||
106137640|NCT00613301|366163444|FG000|Overall Study|Death|6|||
106137641|NCT00613301|366163444|FG000|Overall Study|Lack of Efficacy|13|||
106137642|NCT00613301|366163444|FG000|Overall Study|Physician Decision|2|||
106137643|NCT00613301|366163444|FG000|Overall Study|No data was collected|53|||
106137644|NCT00613301|366163444|FG000|Overall Study|Irregularly enrolled patients|12|||
106137645|NCT00762463|366163445|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
105792563|NCT02216214|364896383|FG000|Overall Study|Withdrawal by Subject|22|||
105935876|NCT00366535|365425235|FG001|First Phase: 12 Weeks|Adverse Event|3|||
105935877|NCT00366535|365425234|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
105935878|NCT00366535|365425235|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
105935879|NCT00366535|365425234|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
105935880|NCT00366535|365425235|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
105935881|NCT00366535|365425234|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
105935882|NCT00366535|365425235|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
105935883|NCT02991859|365425242|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935884|NCT02991859|365425243|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
105935885|NCT02991859|365425244|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935886|NCT02991859|365425245|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935887|NCT02991859|365425246|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
105935888|NCT02991859|365425247|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935889|NCT02991859|365425248|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935890|NCT02991859|365425249|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935891|NCT02991859|365425250|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935892|NCT02991859|365425251|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935893|NCT02991859|365425252|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935894|NCT02991859|365425253|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935895|NCT02991859|365425254|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935896|NCT02991859|365425255|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935897|NCT02991859|365425256|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
106137646|NCT00762463|366163446|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
106137647|NCT00762463|366163447|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
106137648|NCT00762463|366163448|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
105722320|NCT01850615|364638702|FG001|Overall Study|Unclassified|1|||
105722321|NCT00332202|364638704|FG000|Overall Study|Adverse Event|72|||
105722322|NCT00332202|364638705|FG001|Overall Study|Adverse Event|28|||
105722323|NCT00332202|364638704|FG000|Overall Study|Lost to Follow-up|2|||
105722324|NCT00332202|364638705|FG001|Overall Study|Lost to Follow-up|1|||
105722325|NCT00332202|364638704|FG000|Overall Study|Physician Decision|6|||
105722326|NCT00332202|364638705|FG001|Overall Study|Physician Decision|8|||
105722327|NCT00332202|364638704|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
105722328|NCT00332202|364638705|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
105722329|NCT00332202|364638704|FG000|Overall Study|Protocol Violation|7|||
105722330|NCT00332202|364638705|FG001|Overall Study|Protocol Violation|2|||
105722331|NCT00332202|364638704|FG000|Overall Study|Sponsor Decision|1|||
105722332|NCT00332202|364638705|FG001|Overall Study|Sponsor Decision|2|||
105722333|NCT00332202|364638704|FG000|Overall Study|Withdrawal by Subject|36|||
105722334|NCT00332202|364638705|FG001|Overall Study|Withdrawal by Subject|17|||
105722335|NCT00332202|364638704|FG000|Overall Study|Progressive Disease|106|||
105722336|NCT00332202|364638705|FG001|Overall Study|Progressive Disease|60|||
105722337|NCT00332202|364638704|FG000|Overall Study|Death|5|||
105722338|NCT00332202|364638705|FG001|Overall Study|Death|2|||
105722339|NCT00490542|364638707|FG000|Overall Study|Lost to Follow-up|3|||
105722340|NCT00490542|364638708|FG001|Overall Study|Lost to Follow-up|0|||
105722341|NCT00490542|364638707|FG000|Overall Study|Adverse Event|3|||
105722342|NCT00490542|364638708|FG001|Overall Study|Adverse Event|3|||
105722343|NCT00490542|364638707|FG000|Overall Study|Lack of Efficacy|1|||
105722344|NCT00490542|364638708|FG001|Overall Study|Lack of Efficacy|1|||
105722345|NCT04696861|364638709|FG000|Overall Study|Death|1|||
105722346|NCT04696861|364638710|FG001|Overall Study|Death|0|||
105722347|NCT04696861|364638709|FG000|Overall Study|Lost to Follow-up|3|||
105722348|NCT04696861|364638710|FG001|Overall Study|Lost to Follow-up|0|||
105722349|NCT01813890|364638712|FG000|Overall Study|Adverse Event|0|||
105722350|NCT01813890|364638713|FG001|Overall Study|Adverse Event|3|||
105722351|NCT01813890|364638714|FG002|Overall Study|Adverse Event|4|||
105722352|NCT01813890|364638712|FG000|Overall Study|Lack of Efficacy|9|||
105722353|NCT01813890|364638713|FG001|Overall Study|Lack of Efficacy|1|||
105722354|NCT01813890|364638714|FG002|Overall Study|Lack of Efficacy|2|||
105722355|NCT04439123|364638715|FG000|Overall Study|Adverse Event|11|||
105722356|NCT04439123|364638715|FG000|Overall Study|Death|1|||
105722357|NCT04439123|364638715|FG000|Overall Study|Disease progression|19|||
105722358|NCT04439123|364638715|FG000|Overall Study|Withdrawal by Subject|2|||
105722359|NCT04439123|364638715|FG000|Overall Study|Still on treatment|2|||
105722360|NCT04343651|364638716|FG000|Overall Study|Physician Decision|2|||
105722361|NCT04343651|364638717|FG001|Overall Study|Physician Decision|1|||
105722362|NCT04343651|364638716|FG000|Overall Study|Lost to Follow-up|2|||
105722363|NCT04343651|364638717|FG001|Overall Study|Lost to Follow-up|1|||
105722364|NCT04343651|364638716|FG000|Overall Study|Protocol Violation|4|||
105722365|NCT04343651|364638717|FG001|Overall Study|Protocol Violation|6|||
105722366|NCT04343651|364638716|FG000|Overall Study|Missing|3|||
105722367|NCT04343651|364638717|FG001|Overall Study|Missing|9|||
105722368|NCT04343651|364638716|FG000|Overall Study|Withdrawal by Subject|0|||
105722369|NCT04343651|364638717|FG001|Overall Study|Withdrawal by Subject|4|||
105722370|NCT04343651|364638716|FG000|Overall Study|Death|0|||
105722371|NCT04343651|364638717|FG001|Overall Study|Death|1|||
105722372|NCT04343651|364638716|FG000|Overall Study|Did not start treatment|1|||
105722373|NCT04343651|364638717|FG001|Overall Study|Did not start treatment|1|||
105722374|NCT04343651|364638716|FG000|Overall Study|Patient did not complete visits 3-6|0|||
105722375|NCT04343651|364638717|FG001|Overall Study|Patient did not complete visits 3-6|1|||
105722376|NCT02246621|364638718|FG000|Overall Study|Withdrawal by Subject|28|||
105722377|NCT02246621|364638719|FG001|Overall Study|Withdrawal by Subject|16|||
105722378|NCT02246621|364638718|FG000|Overall Study|Lost to Follow-up|1|||
105722379|NCT02246621|364638719|FG001|Overall Study|Lost to Follow-up|0|||
105722380|NCT02246621|364638718|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
105722381|NCT02246621|364638719|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
105722382|NCT02875223|364638720|FG000|Overall Study|Other reasons|0|||
105722383|NCT02875223|364638721|FG001|Overall Study|Other reasons|0|||
105722384|NCT02875223|364638722|FG002|Overall Study|Other reasons|1|||
105935898|NCT02991859|365425257|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105935899|NCT02991859|365425258|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
105722385|NCT02875223|364638723|FG003|Overall Study|Other reasons|0|||
105722386|NCT02875223|364638724|FG004|Overall Study|Other reasons|1|||
105722387|NCT02875223|364638725|FG005|Overall Study|Other reasons|2|||
105722388|NCT02875223|364638726|FG006|Overall Study|Other reasons|0|||
105722389|NCT02875223|364638727|FG007|Overall Study|Other reasons|2|||
105722390|NCT02875223|364638728|FG008|Overall Study|Other reasons|0|||
105722391|NCT02875223|364638729|FG009|Overall Study|Other reasons|0|||
105722392|NCT02875223|364638730|FG010|Overall Study|Other reasons|0|||
105722393|NCT02875223|364638731|FG011|Overall Study|Other reasons|0|||
105722394|NCT02875223|364638732|FG012|Overall Study|Other reasons|0|||
105722395|NCT02875223|364638720|FG000|Overall Study|Withdrawal by Subject|0|||
105722396|NCT02875223|364638721|FG001|Overall Study|Withdrawal by Subject|0|||
106137649|NCT00762463|366163445|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
106137650|NCT00762463|366163446|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
106137651|NCT00762463|366163447|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
106137652|NCT00762463|366163448|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
106137653|NCT00762463|366163445|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
106137654|NCT00762463|366163446|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
106137655|NCT00762463|366163447|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
106137656|NCT00762463|366163448|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
106137657|NCT00762463|366163445|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
106137658|NCT00762463|366163446|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
106137659|NCT00762463|366163447|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
106137660|NCT00762463|366163448|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
106137661|NCT00762463|366163445|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
106137662|NCT00762463|366163446|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
106137663|NCT00762463|366163447|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
106137664|NCT00762463|366163448|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
106137665|NCT00762463|366163445|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
106137666|NCT00762463|366163446|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
106137667|NCT00762463|366163447|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
106137668|NCT00762463|366163448|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
106137669|NCT00762463|366163445|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
106137670|NCT00762463|366163446|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
106137671|NCT00762463|366163447|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
105722397|NCT02875223|364638722|FG002|Overall Study|Withdrawal by Subject|0|||
105722398|NCT02875223|364638723|FG003|Overall Study|Withdrawal by Subject|0|||
105722399|NCT02875223|364638724|FG004|Overall Study|Withdrawal by Subject|1|||
105722400|NCT02875223|364638725|FG005|Overall Study|Withdrawal by Subject|1|||
105722401|NCT02875223|364638726|FG006|Overall Study|Withdrawal by Subject|0|||
105722402|NCT02875223|364638727|FG007|Overall Study|Withdrawal by Subject|0|||
105722403|NCT02875223|364638728|FG008|Overall Study|Withdrawal by Subject|1|||
105722404|NCT02875223|364638729|FG009|Overall Study|Withdrawal by Subject|0|||
105722405|NCT02875223|364638730|FG010|Overall Study|Withdrawal by Subject|0|||
105722406|NCT02875223|364638731|FG011|Overall Study|Withdrawal by Subject|0|||
105722407|NCT02875223|364638732|FG012|Overall Study|Withdrawal by Subject|0|||
105722408|NCT02875223|364638720|FG000|Overall Study|Progressive disease|0|||
105722409|NCT02875223|364638721|FG001|Overall Study|Progressive disease|0|||
105722410|NCT02875223|364638722|FG002|Overall Study|Progressive disease|1|||
105722411|NCT02875223|364638723|FG003|Overall Study|Progressive disease|0|||
105722412|NCT02875223|364638724|FG004|Overall Study|Progressive disease|0|||
105722413|NCT02875223|364638725|FG005|Overall Study|Progressive disease|0|||
105722414|NCT02875223|364638726|FG006|Overall Study|Progressive disease|0|||
105722415|NCT02875223|364638727|FG007|Overall Study|Progressive disease|0|||
105722416|NCT02875223|364638728|FG008|Overall Study|Progressive disease|0|||
105722417|NCT02875223|364638729|FG009|Overall Study|Progressive disease|12|||
105722418|NCT02875223|364638730|FG010|Overall Study|Progressive disease|2|||
105722419|NCT02875223|364638731|FG011|Overall Study|Progressive disease|3|||
105722420|NCT02875223|364638732|FG012|Overall Study|Progressive disease|6|||
105722421|NCT02875223|364638720|FG000|Overall Study|Death|4|||
105722422|NCT02875223|364638721|FG001|Overall Study|Death|4|||
105722423|NCT02875223|364638722|FG002|Overall Study|Death|3|||
105722424|NCT02875223|364638723|FG003|Overall Study|Death|4|||
105722425|NCT02875223|364638724|FG004|Overall Study|Death|2|||
105722426|NCT02875223|364638725|FG005|Overall Study|Death|3|||
105722427|NCT02875223|364638726|FG006|Overall Study|Death|5|||
105722428|NCT02875223|364638727|FG007|Overall Study|Death|7|||
105722429|NCT02875223|364638728|FG008|Overall Study|Death|3|||
105722430|NCT02875223|364638729|FG009|Overall Study|Death|2|||
105722431|NCT02875223|364638730|FG010|Overall Study|Death|0|||
105722432|NCT02875223|364638731|FG011|Overall Study|Death|0|||
105722433|NCT02875223|364638732|FG012|Overall Study|Death|0|||
105722434|NCT02875223|364638720|FG000|Overall Study|Lost to Follow-up|0|||
105722435|NCT02875223|364638721|FG001|Overall Study|Lost to Follow-up|1|||
105722436|NCT02875223|364638722|FG002|Overall Study|Lost to Follow-up|1|||
105722437|NCT02875223|364638723|FG003|Overall Study|Lost to Follow-up|0|||
105722438|NCT02875223|364638724|FG004|Overall Study|Lost to Follow-up|1|||
105722439|NCT02875223|364638725|FG005|Overall Study|Lost to Follow-up|0|||
105722440|NCT02875223|364638726|FG006|Overall Study|Lost to Follow-up|1|||
105722441|NCT02875223|364638727|FG007|Overall Study|Lost to Follow-up|1|||
105722442|NCT02875223|364638728|FG008|Overall Study|Lost to Follow-up|0|||
105722443|NCT02875223|364638729|FG009|Overall Study|Lost to Follow-up|0|||
105722444|NCT02875223|364638730|FG010|Overall Study|Lost to Follow-up|0|||
105722445|NCT02875223|364638731|FG011|Overall Study|Lost to Follow-up|0|||
105722446|NCT02875223|364638732|FG012|Overall Study|Lost to Follow-up|0|||
105722447|NCT01565980|364638735|FG000|Overall Study|Death|1|||
105722448|NCT01565980|364638736|FG001|Overall Study|Death|0|||
105722449|NCT01565980|364638735|FG000|Overall Study|Lost to Follow-up|1|||
105722450|NCT01565980|364638736|FG001|Overall Study|Lost to Follow-up|0|||
105722451|NCT01565980|364638735|FG000|Overall Study|health complications|1|||
105722452|NCT01565980|364638736|FG001|Overall Study|health complications|1|||
105722453|NCT01565980|364638735|FG000|Overall Study|stopped medical treatment|1|||
105722454|NCT01565980|364638736|FG001|Overall Study|stopped medical treatment|0|||
105935900|NCT02991859|365425242|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105722455|NCT01565980|364638735|FG000|Overall Study|Withdrawal by Subject|0|||
105722456|NCT01565980|364638736|FG001|Overall Study|Withdrawal by Subject|3|||
105722457|NCT01929135|364638740|FG000|Overall Study|Lost to Follow-up|1|||
105722458|NCT01929135|364638741|FG001|Overall Study|Lost to Follow-up|1|||
105722459|NCT02078219|364638751|FG000|Overall Study|Other|2|||
105722460|NCT02078219|364638752|FG001|Overall Study|Other|2|||
105722461|NCT02078219|364638753|FG002|Overall Study|Other|3|||
105722462|NCT02078219|364638754|FG003|Overall Study|Other|0|||
105722463|NCT02078219|364638755|FG004|Overall Study|Other|1|||
105935901|NCT02991859|365425243|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935902|NCT02991859|365425244|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935903|NCT02991859|365425245|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105722464|NCT02078219|364638751|FG000|Overall Study|Withdrawal by Subject|0|||
105722465|NCT02078219|364638752|FG001|Overall Study|Withdrawal by Subject|1|||
105722466|NCT02078219|364638753|FG002|Overall Study|Withdrawal by Subject|0|||
105722467|NCT02078219|364638754|FG003|Overall Study|Withdrawal by Subject|1|||
105722468|NCT02078219|364638755|FG004|Overall Study|Withdrawal by Subject|1|||
105722469|NCT02078219|364638751|FG000|Overall Study|Protocol Violation|0|||
105722470|NCT02078219|364638752|FG001|Overall Study|Protocol Violation|0|||
105722471|NCT02078219|364638753|FG002|Overall Study|Protocol Violation|0|||
105722472|NCT02078219|364638754|FG003|Overall Study|Protocol Violation|1|||
105792564|NCT02216214|364896384|FG001|Overall Study|Withdrawal by Subject|20|||
105792565|NCT02216214|364896383|FG000|Overall Study|Study Terminated By Sponsor|0|||
105792566|NCT02216214|364896384|FG001|Overall Study|Study Terminated By Sponsor|1|||
105792567|NCT02216214|364896383|FG000|Overall Study|Miscellaneous|1|||
105792568|NCT02216214|364896384|FG001|Overall Study|Miscellaneous|1|||
105792569|NCT00713830|364896387|FG000|Overall Study|Adverse Event|23|||
105792570|NCT00713830|364896388|FG001|Overall Study|Adverse Event|71|||
105792571|NCT00713830|364896387|FG000|Overall Study|Lack of Efficacy|24|||
105792572|NCT00713830|364896388|FG001|Overall Study|Lack of Efficacy|16|||
105792573|NCT00713830|364896387|FG000|Overall Study|Lost to Follow-up|2|||
105935904|NCT02991859|365425246|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105792574|NCT00713830|364896388|FG001|Overall Study|Lost to Follow-up|9|||
105935905|NCT02991859|365425247|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105792575|NCT00713830|364896387|FG000|Overall Study|Withdrawal by Subject|13|||
105935906|NCT02991859|365425248|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935907|NCT02991859|365425249|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105722473|NCT02078219|364638755|FG004|Overall Study|Protocol Violation|0|||
105722474|NCT02078219|364638751|FG000|Overall Study|Death|0|||
105722475|NCT02078219|364638752|FG001|Overall Study|Death|0|||
105722476|NCT02078219|364638753|FG002|Overall Study|Death|0|||
105722477|NCT02078219|364638754|FG003|Overall Study|Death|1|||
105722478|NCT02078219|364638755|FG004|Overall Study|Death|0|||
105722479|NCT02078219|364638751|FG000|Overall Study|Adverse Event|1|||
105722480|NCT02078219|364638752|FG001|Overall Study|Adverse Event|1|||
105722481|NCT02078219|364638753|FG002|Overall Study|Adverse Event|3|||
105722482|NCT02078219|364638754|FG003|Overall Study|Adverse Event|1|||
105722483|NCT02078219|364638755|FG004|Overall Study|Adverse Event|0|||
105722484|NCT03283085|364638762|FG000|Overall Study|Adverse Event|18|||
105722485|NCT03283085|364638763|FG001|Overall Study|Adverse Event|3|||
105722486|NCT03283085|364638764|FG002|Overall Study|Adverse Event|13|||
105722487|NCT03283085|364638765|FG003|Overall Study|Adverse Event|0|||
105722488|NCT03283085|364638766|FG004|Overall Study|Adverse Event|0|||
105722489|NCT03283085|364638767|FG005|Overall Study|Adverse Event|5|||
105722490|NCT03283085|364638762|FG000|Overall Study|Death|0|||
105722491|NCT03283085|364638763|FG001|Overall Study|Death|0|||
105722492|NCT03283085|364638764|FG002|Overall Study|Death|3|||
105722493|NCT03283085|364638765|FG003|Overall Study|Death|1|||
105722494|NCT03283085|364638766|FG004|Overall Study|Death|0|||
105722495|NCT03283085|364638767|FG005|Overall Study|Death|0|||
105722496|NCT03283085|364638762|FG000|Overall Study|Withdrawal by Subject|42|||
105722497|NCT03283085|364638763|FG001|Overall Study|Withdrawal by Subject|21|||
105722498|NCT03283085|364638764|FG002|Overall Study|Withdrawal by Subject|66|||
105722499|NCT03283085|364638765|FG003|Overall Study|Withdrawal by Subject|3|||
105722500|NCT03283085|364638766|FG004|Overall Study|Withdrawal by Subject|3|||
105722501|NCT03283085|364638767|FG005|Overall Study|Withdrawal by Subject|5|||
105722502|NCT03283085|364638762|FG000|Overall Study|Physician Decision|14|||
105722503|NCT03283085|364638763|FG001|Overall Study|Physician Decision|8|||
105722504|NCT03283085|364638764|FG002|Overall Study|Physician Decision|19|||
105722505|NCT03283085|364638765|FG003|Overall Study|Physician Decision|0|||
105722506|NCT03283085|364638766|FG004|Overall Study|Physician Decision|0|||
105722507|NCT03283085|364638767|FG005|Overall Study|Physician Decision|2|||
105722508|NCT03283085|364638762|FG000|Overall Study|Site Terminated by Sponsor|1|||
105722509|NCT03283085|364638763|FG001|Overall Study|Site Terminated by Sponsor|0|||
105722510|NCT03283085|364638764|FG002|Overall Study|Site Terminated by Sponsor|3|||
105722511|NCT03283085|364638765|FG003|Overall Study|Site Terminated by Sponsor|0|||
105722512|NCT03283085|364638766|FG004|Overall Study|Site Terminated by Sponsor|0|||
105722513|NCT03283085|364638767|FG005|Overall Study|Site Terminated by Sponsor|0|||
105722514|NCT03283085|364638762|FG000|Overall Study|Lost to Follow-up|2|||
105722515|NCT03283085|364638763|FG001|Overall Study|Lost to Follow-up|0|||
105722516|NCT03283085|364638764|FG002|Overall Study|Lost to Follow-up|2|||
105935908|NCT02991859|365425250|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935909|NCT02991859|365425251|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935910|NCT02991859|365425252|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935911|NCT02991859|365425253|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935912|NCT02991859|365425254|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
105935913|NCT02991859|365425255|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
105935914|NCT02991859|365425256|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935915|NCT02991859|365425257|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935916|NCT02991859|365425258|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
105935917|NCT02991859|365425242|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935918|NCT02991859|365425243|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935919|NCT02991859|365425244|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105722517|NCT03283085|364638765|FG003|Overall Study|Lost to Follow-up|0|||
105722518|NCT03283085|364638766|FG004|Overall Study|Lost to Follow-up|0|||
105722519|NCT03283085|364638767|FG005|Overall Study|Lost to Follow-up|1|||
105722520|NCT03283085|364638762|FG000|Overall Study|Pregnancy|0|||
105722521|NCT03283085|364638763|FG001|Overall Study|Pregnancy|0|||
105722522|NCT03283085|364638764|FG002|Overall Study|Pregnancy|1|||
105722523|NCT03283085|364638765|FG003|Overall Study|Pregnancy|0|||
105722524|NCT03283085|364638766|FG004|Overall Study|Pregnancy|0|||
105722525|NCT03283085|364638767|FG005|Overall Study|Pregnancy|0|||
105722526|NCT03283085|364638762|FG000|Overall Study|Lack of Efficacy|12|||
105722527|NCT03283085|364638763|FG001|Overall Study|Lack of Efficacy|6|||
105722528|NCT03283085|364638764|FG002|Overall Study|Lack of Efficacy|24|||
105722529|NCT03283085|364638765|FG003|Overall Study|Lack of Efficacy|1|||
105722530|NCT03283085|364638766|FG004|Overall Study|Lack of Efficacy|1|||
105722531|NCT03283085|364638767|FG005|Overall Study|Lack of Efficacy|0|||
105722532|NCT03283085|364638762|FG000|Overall Study|Reason not Specified|0|||
105722533|NCT03283085|364638763|FG001|Overall Study|Reason not Specified|4|||
105722534|NCT03283085|364638764|FG002|Overall Study|Reason not Specified|8|||
105722535|NCT03283085|364638765|FG003|Overall Study|Reason not Specified|0|||
105722536|NCT03283085|364638766|FG004|Overall Study|Reason not Specified|0|||
105722537|NCT03283085|364638767|FG005|Overall Study|Reason not Specified|1|||
105722538|NCT03136107|364638768|FG000|Overall Study|Other (Not specified)|1|||
105722539|NCT01237951|364638773|FG000|Overall Study|Death|1|||
105722540|NCT01817790|364638776|FG000|Overall Study|Adverse Event|0|||
105722541|NCT01817790|364638777|FG001|Overall Study|Adverse Event|2|||
105722542|NCT01817790|364638776|FG000|Overall Study|Lost to Follow-up|0|||
105722543|NCT01817790|364638777|FG001|Overall Study|Lost to Follow-up|1|||
105722544|NCT01817790|364638776|FG000|Overall Study|Protocol Violation|2|||
105722545|NCT01817790|364638777|FG001|Overall Study|Protocol Violation|1|||
105722546|NCT01817790|364638776|FG000|Overall Study|Withdrawal by Subject|1|||
105722547|NCT01817790|364638777|FG001|Overall Study|Withdrawal by Subject|3|||
105722548|NCT01817790|364638776|FG000|Overall Study|Other: Could not attend appointment|1|||
105722549|NCT01817790|364638777|FG001|Overall Study|Other: Could not attend appointment|1|||
105722550|NCT02382133|364638778|FG000|Overall Study|Death|22|||
105722551|NCT02382133|364638778|FG000|Overall Study|transfer out of ICU|4|||
105722552|NCT02382133|364638778|FG000|Overall Study|Physician Decision|2|||
105722553|NCT02382133|364638778|FG000|Overall Study|arterial catheter loss|4|||
105722554|NCT02382133|364638778|FG000|Overall Study|pressure injury both sites|1|||
105722555|NCT00655928|364638779|FG000|Overall Study|Withdrawal by Subject|2|||
105722556|NCT00655928|364638780|FG001|Overall Study|Withdrawal by Subject|1|||
105722557|NCT00655928|364638779|FG000|Overall Study|Physician Decision|1|||
105722558|NCT00655928|364638780|FG001|Overall Study|Physician Decision|1|||
105722559|NCT01976806|364638781|FG000|Overall Study|Lost to Follow-up|1|||
105722560|NCT01976806|364638782|FG001|Overall Study|Lost to Follow-up|4|||
105722561|NCT01976806|364638781|FG000|Overall Study|Adverse Event|1|||
105722562|NCT01976806|364638782|FG001|Overall Study|Adverse Event|1|||
105722563|NCT01976806|364638781|FG000|Overall Study|Withdrawal by Subject|1|||
105722564|NCT01976806|364638782|FG001|Overall Study|Withdrawal by Subject|1|||
105722565|NCT03636906|364638784|FG000|Overall Study|Adverse Event|0|||
105722566|NCT03636906|364638785|FG001|Overall Study|Adverse Event|0|||
105722567|NCT03636906|364638786|FG002|Overall Study|Adverse Event|1|||
105722568|NCT03636906|364638784|FG000|Overall Study|Lost to Follow-up|1|||
105722569|NCT03636906|364638785|FG001|Overall Study|Lost to Follow-up|0|||
105722570|NCT03636906|364638786|FG002|Overall Study|Lost to Follow-up|0|||
105722571|NCT03636906|364638784|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
105722572|NCT03636906|364638785|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
105722573|NCT03636906|364638786|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
105722574|NCT03636906|364638784|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
105722575|NCT03636906|364638785|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
105722576|NCT03636906|364638786|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
105722577|NCT03636906|364638784|FG000|Overall Study|Other|0|||
105722578|NCT03636906|364638785|FG001|Overall Study|Other|0|||
105722579|NCT03636906|364638786|FG002|Overall Study|Other|1|||
105722580|NCT02654002|364638788|FG000|Overall Study|Adverse Event|0|||
105722581|NCT02654002|364638789|FG001|Overall Study|Adverse Event|0|||
105722582|NCT02654002|364638790|FG002|Overall Study|Adverse Event|0|||
105722583|NCT02654002|364638791|FG003|Overall Study|Adverse Event|0|||
105722584|NCT02654002|364638792|FG004|Overall Study|Adverse Event|0|||
105722585|NCT02654002|364638793|FG005|Overall Study|Adverse Event|0|||
105722586|NCT02654002|364638794|FG006|Overall Study|Adverse Event|1|||
105722587|NCT02654002|364638795|FG007|Overall Study|Adverse Event|0|||
105722588|NCT02654002|364638796|FG008|Overall Study|Adverse Event|0|||
105722589|NCT02654002|364638788|FG000|Overall Study|Withdrew Consent|0|||
105722590|NCT02654002|364638789|FG001|Overall Study|Withdrew Consent|0|||
105722591|NCT02654002|364638790|FG002|Overall Study|Withdrew Consent|0|||
105722592|NCT02654002|364638791|FG003|Overall Study|Withdrew Consent|0|||
105722593|NCT02654002|364638792|FG004|Overall Study|Withdrew Consent|0|||
105722594|NCT02654002|364638793|FG005|Overall Study|Withdrew Consent|1|||
105722595|NCT02654002|364638794|FG006|Overall Study|Withdrew Consent|0|||
105722596|NCT02654002|364638795|FG007|Overall Study|Withdrew Consent|1|||
105722597|NCT02654002|364638796|FG008|Overall Study|Withdrew Consent|0|||
105722598|NCT02848833|364638802|FG000|Overall Study|subject who are duplicated|1|||
105722599|NCT02848833|364638802|FG000|Overall Study|have not taken the study drug|11|||
105722600|NCT02848833|364638802|FG000|Overall Study|follow-up failure|6|||
105722601|NCT02848833|364638802|FG000|Overall Study|Protocol Violation|119|||
105722602|NCT03690869|364638803|FG000|Overall Study|Adverse Event|0|||
105722603|NCT03690869|364638804|FG001|Overall Study|Adverse Event|0|||
105722604|NCT03690869|364638805|FG002|Overall Study|Adverse Event|0|||
105722605|NCT03690869|364638806|FG003|Overall Study|Adverse Event|1|||
105722606|NCT03690869|364638807|FG004|Overall Study|Adverse Event|0|||
105722607|NCT03690869|364638808|FG005|Overall Study|Adverse Event|0|||
105722608|NCT03690869|364638809|FG006|Overall Study|Adverse Event|0|||
105722609|NCT03690869|364638810|FG007|Overall Study|Adverse Event|1|||
105722610|NCT03690869|364638811|FG008|Overall Study|Adverse Event|0|||
105722611|NCT03690869|364638812|FG009|Overall Study|Adverse Event|1|||
105722612|NCT03690869|364638803|FG000|Overall Study|Death|1|||
105722613|NCT03690869|364638804|FG001|Overall Study|Death|1|||
105722614|NCT03690869|364638805|FG002|Overall Study|Death|1|||
105722615|NCT03690869|364638806|FG003|Overall Study|Death|4|||
105722616|NCT03690869|364638807|FG004|Overall Study|Death|2|||
105722617|NCT03690869|364638808|FG005|Overall Study|Death|5|||
105722618|NCT03690869|364638809|FG006|Overall Study|Death|3|||
105722619|NCT03690869|364638810|FG007|Overall Study|Death|2|||
105722620|NCT03690869|364638811|FG008|Overall Study|Death|0|||
105722621|NCT03690869|364638812|FG009|Overall Study|Death|3|||
105722622|NCT03690869|364638803|FG000|Overall Study|Lost to Follow-up|0|||
105722623|NCT03690869|364638804|FG001|Overall Study|Lost to Follow-up|0|||
105722624|NCT03690869|364638805|FG002|Overall Study|Lost to Follow-up|1|||
105722625|NCT03690869|364638806|FG003|Overall Study|Lost to Follow-up|0|||
106144117|NCT01317420|366186949|FG000|Overall Study|Reason other than those specified|0|||
105722626|NCT03690869|364638807|FG004|Overall Study|Lost to Follow-up|0|||
105722627|NCT03690869|364638808|FG005|Overall Study|Lost to Follow-up|0|||
105722628|NCT03690869|364638809|FG006|Overall Study|Lost to Follow-up|0|||
105722629|NCT03690869|364638810|FG007|Overall Study|Lost to Follow-up|0|||
105722630|NCT03690869|364638811|FG008|Overall Study|Lost to Follow-up|0|||
105722631|NCT03690869|364638812|FG009|Overall Study|Lost to Follow-up|0|||
105722632|NCT03690869|364638803|FG000|Overall Study|Other Treatment|1|||
105722633|NCT03690869|364638804|FG001|Overall Study|Other Treatment|1|||
105722634|NCT03690869|364638805|FG002|Overall Study|Other Treatment|1|||
105722635|NCT03690869|364638806|FG003|Overall Study|Other Treatment|2|||
105722636|NCT03690869|364638807|FG004|Overall Study|Other Treatment|3|||
105722637|NCT03690869|364638808|FG005|Overall Study|Other Treatment|1|||
105722638|NCT03690869|364638809|FG006|Overall Study|Other Treatment|2|||
105722639|NCT03690869|364638810|FG007|Overall Study|Other Treatment|7|||
105722640|NCT03690869|364638811|FG008|Overall Study|Other Treatment|0|||
105722641|NCT03690869|364638812|FG009|Overall Study|Other Treatment|3|||
105722642|NCT03690869|364638803|FG000|Overall Study|Physician Decision|0|||
105722643|NCT03690869|364638804|FG001|Overall Study|Physician Decision|1|||
105722644|NCT03690869|364638805|FG002|Overall Study|Physician Decision|0|||
105722645|NCT03690869|364638806|FG003|Overall Study|Physician Decision|0|||
105722646|NCT03690869|364638807|FG004|Overall Study|Physician Decision|0|||
105722647|NCT03690869|364638808|FG005|Overall Study|Physician Decision|0|||
105722648|NCT03690869|364638809|FG006|Overall Study|Physician Decision|0|||
105722649|NCT03690869|364638810|FG007|Overall Study|Physician Decision|0|||
105722650|NCT03690869|364638811|FG008|Overall Study|Physician Decision|0|||
105722651|NCT03690869|364638812|FG009|Overall Study|Physician Decision|0|||
105722652|NCT03690869|364638803|FG000|Overall Study|Progressive Disease|1|||
105722653|NCT03690869|364638804|FG001|Overall Study|Progressive Disease|2|||
105722654|NCT03690869|364638805|FG002|Overall Study|Progressive Disease|0|||
105722655|NCT03690869|364638806|FG003|Overall Study|Progressive Disease|1|||
105722656|NCT03690869|364638807|FG004|Overall Study|Progressive Disease|0|||
105722657|NCT03690869|364638808|FG005|Overall Study|Progressive Disease|0|||
105722658|NCT03690869|364638809|FG006|Overall Study|Progressive Disease|0|||
105722659|NCT03690869|364638810|FG007|Overall Study|Progressive Disease|0|||
105722660|NCT03690869|364638811|FG008|Overall Study|Progressive Disease|1|||
105722661|NCT03690869|364638812|FG009|Overall Study|Progressive Disease|1|||
105722662|NCT03690869|364638803|FG000|Overall Study|Subject Decision|0|||
105722663|NCT03690869|364638804|FG001|Overall Study|Subject Decision|0|||
105722664|NCT03690869|364638805|FG002|Overall Study|Subject Decision|0|||
105935920|NCT02991859|365425245|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935921|NCT02991859|365425246|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935922|NCT02991859|365425247|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
105722665|NCT03690869|364638806|FG003|Overall Study|Subject Decision|1|||
105722666|NCT03690869|364638807|FG004|Overall Study|Subject Decision|0|||
105722667|NCT03690869|364638808|FG005|Overall Study|Subject Decision|0|||
105722668|NCT03690869|364638809|FG006|Overall Study|Subject Decision|0|||
105722669|NCT03690869|364638810|FG007|Overall Study|Subject Decision|1|||
105722670|NCT03690869|364638811|FG008|Overall Study|Subject Decision|0|||
105722671|NCT03690869|364638812|FG009|Overall Study|Subject Decision|0|||
105722672|NCT04167345|364638813|FG000|Overall Study|Other|1|||
105722673|NCT04167345|364638814|FG001|Overall Study|Other|1|||
105722674|NCT04167345|364638815|FG002|Overall Study|Other|0|||
105722675|NCT04167345|364638816|FG003|Overall Study|Other|0|||
105722676|NCT04167345|364638817|FG004|Overall Study|Other|0|||
105722677|NCT03124459|364640852|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722678|NCT03124459|364640853|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722679|NCT03124459|364640854|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722680|NCT03124459|364640855|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722681|NCT03124459|364640856|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
105722682|NCT03124459|364640857|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
105722683|NCT03124459|364640852|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105722684|NCT03124459|364640853|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105722685|NCT03124459|364640854|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105722686|NCT03124459|364640855|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105935923|NCT02991859|365425248|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935924|NCT02991859|365425249|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935925|NCT02991859|365425250|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935926|NCT02991859|365425251|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935927|NCT02991859|365425252|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935928|NCT02991859|365425253|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935929|NCT02991859|365425254|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935930|NCT02991859|365425255|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105935931|NCT02991859|365425256|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105722687|NCT03124459|364640856|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
105722688|NCT03124459|364640857|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
105935932|NCT02991859|365425257|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
105722689|NCT03124459|364640852|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
105722690|NCT03124459|364640853|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
105722691|NCT03124459|364640854|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
105722692|NCT03124459|364640855|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
105935933|NCT02991859|365425258|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
106009166|NCT02023086|365699093|FG000|Overall Study|Withdrawal by Subject|2|||
106009167|NCT02023086|365699094|FG001|Overall Study|Withdrawal by Subject|0|||
106009168|NCT05523089|365699097|FG000|Overall Study|Withdrawal by Subject|1|||
106009169|NCT05523089|365699098|FG001|Overall Study|Withdrawal by Subject|0|||
105722693|NCT03124459|364640856|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
105722694|NCT03124459|364640857|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
105722695|NCT03124459|364640852|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
105722696|NCT03124459|364640853|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
105722697|NCT03124459|364640854|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
105722698|NCT03124459|364640855|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
105722699|NCT03124459|364640856|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
105722700|NCT03124459|364640857|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
105722701|NCT03124459|364640852|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105935934|NCT02991859|365425242|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105722702|NCT03124459|364640853|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105722703|NCT03124459|364640854|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105722704|NCT03124459|364640855|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105722705|NCT03124459|364640856|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
105722706|NCT03124459|364640857|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
105722707|NCT03124459|364640852|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722708|NCT03124459|364640853|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722709|NCT03124459|364640854|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722710|NCT03124459|364640855|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722711|NCT03124459|364640856|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
105722712|NCT03124459|364640857|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
105722713|NCT05742984|364640858|FG000|Overall Study|Adverse Event|0|||
105722714|NCT05742984|364640859|FG001|Overall Study|Adverse Event|0|||
105722715|NCT05742984|364640860|FG002|Overall Study|Adverse Event|1|||
105722716|NCT05742984|364640861|FG003|Overall Study|Adverse Event|0|||
105722717|NCT05742984|364640862|FG004|Overall Study|Adverse Event|1|||
105722718|NCT05742984|364640863|FG005|Overall Study|Adverse Event|1|||
105722719|NCT05742984|364640858|FG000|Overall Study|Withdrawal by Subject|0|||
105722720|NCT05742984|364640859|FG001|Overall Study|Withdrawal by Subject|1|||
105722721|NCT05742984|364640860|FG002|Overall Study|Withdrawal by Subject|0|||
105722722|NCT05742984|364640861|FG003|Overall Study|Withdrawal by Subject|0|||
105722723|NCT05742984|364640862|FG004|Overall Study|Withdrawal by Subject|0|||
105722724|NCT05742984|364640863|FG005|Overall Study|Withdrawal by Subject|2|||
105722725|NCT05019131|364640867|FG000|Overall Study|Lost to Follow-up|0|||
105722726|NCT05019131|364640868|FG001|Overall Study|Lost to Follow-up|3|||
105722727|NCT03822884|364640869|FG000|Overall Study|Withdrawal by Subject|0|||
105722728|NCT03822884|364640870|FG001|Overall Study|Withdrawal by Subject|0|||
105722729|NCT03822884|364640871|FG002|Overall Study|Withdrawal by Subject|0|||
105722730|NCT03822884|364640872|FG003|Overall Study|Withdrawal by Subject|0|||
105722731|NCT03822884|364640873|FG004|Overall Study|Withdrawal by Subject|1|||
105722732|NCT03822884|364640874|FG005|Overall Study|Withdrawal by Subject|0|||
105722733|NCT00191854|364640878|FG000|Overall Study|Death|26|||
105722734|NCT00191854|364640879|FG001|Overall Study|Death|23|||
105722735|NCT00191854|364640880|FG002|Overall Study|Death|29|||
105722736|NCT00191854|364640878|FG000|Overall Study|Lost to Follow-up|7|||
105722737|NCT00191854|364640879|FG001|Overall Study|Lost to Follow-up|5|||
105722738|NCT00191854|364640880|FG002|Overall Study|Lost to Follow-up|5|||
105722739|NCT00191854|364640878|FG000|Overall Study|Withdrawal by Subject|4|||
105722740|NCT00191854|364640879|FG001|Overall Study|Withdrawal by Subject|2|||
105722741|NCT00191854|364640880|FG002|Overall Study|Withdrawal by Subject|3|||
105722742|NCT00191854|364640878|FG000|Overall Study|Sponsor Decision|0|||
105722743|NCT00191854|364640879|FG001|Overall Study|Sponsor Decision|0|||
105722744|NCT00191854|364640880|FG002|Overall Study|Sponsor Decision|1|||
105722745|NCT00191854|364640878|FG000|Overall Study|Screen Failure|0|||
105722746|NCT00191854|364640879|FG001|Overall Study|Screen Failure|0|||
105722747|NCT00191854|364640880|FG002|Overall Study|Screen Failure|1|||
105722748|NCT00408005|364640883|FG000|Induction|Adverse Event|19|||
105722749|NCT00408005|364640884|FG001|Induction|Adverse Event|3|||
105722750|NCT00408005|364640885|FG002|Induction|Adverse Event|0|||
105722751|NCT00408005|364640886|FG003|Induction|Adverse Event|0|||
105722752|NCT00408005|364640887|FG004|Induction|Adverse Event|0|||
105722753|NCT00408005|364640888|FG005|Induction|Adverse Event|0|||
105722754|NCT00408005|364640889|FG006|Induction|Adverse Event|0|||
105722755|NCT00408005|364640890|FG007|Induction|Adverse Event|0|||
105722756|NCT00408005|364640883|FG000|Induction|Death|6|||
105722757|NCT00408005|364640884|FG001|Induction|Death|0|||
106137672|NCT00762463|366163448|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
106137673|NCT00762463|366163445|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
105722758|NCT00408005|364640885|FG002|Induction|Death|0|||
105722759|NCT00408005|364640886|FG003|Induction|Death|0|||
105722760|NCT00408005|364640887|FG004|Induction|Death|0|||
105722761|NCT00408005|364640888|FG005|Induction|Death|0|||
105722762|NCT00408005|364640889|FG006|Induction|Death|0|||
105722763|NCT00408005|364640890|FG007|Induction|Death|0|||
105722764|NCT00408005|364640883|FG000|Induction|Physician Decision|83|||
105722765|NCT00408005|364640884|FG001|Induction|Physician Decision|9|||
105722766|NCT00408005|364640885|FG002|Induction|Physician Decision|0|||
105722767|NCT00408005|364640886|FG003|Induction|Physician Decision|0|||
105722768|NCT00408005|364640887|FG004|Induction|Physician Decision|0|||
105722769|NCT00408005|364640888|FG005|Induction|Physician Decision|0|||
105722770|NCT00408005|364640889|FG006|Induction|Physician Decision|0|||
105722771|NCT00408005|364640890|FG007|Induction|Physician Decision|0|||
105722772|NCT00408005|364640883|FG000|Induction|Withdrawal by Subject|2|||
105722773|NCT00408005|364640884|FG001|Induction|Withdrawal by Subject|4|||
105722774|NCT00408005|364640885|FG002|Induction|Withdrawal by Subject|0|||
105722775|NCT00408005|364640886|FG003|Induction|Withdrawal by Subject|0|||
105722776|NCT00408005|364640887|FG004|Induction|Withdrawal by Subject|0|||
105722777|NCT00408005|364640888|FG005|Induction|Withdrawal by Subject|0|||
105722778|NCT00408005|364640889|FG006|Induction|Withdrawal by Subject|0|||
105792576|NCT00713830|364896388|FG001|Overall Study|Withdrawal by Subject|23|||
105792577|NCT00713830|364896387|FG000|Overall Study|Poor Compliance to Protocol|7|||
105792578|NCT00713830|364896388|FG001|Overall Study|Poor Compliance to Protocol|14|||
105792579|NCT00713830|364896387|FG000|Overall Study|Familial and Personal Reasons|9|||
105792580|NCT00713830|364896388|FG001|Overall Study|Familial and Personal Reasons|34|||
105792581|NCT00713830|364896387|FG000|Overall Study|Sponsor Decision|4|||
105792582|NCT00713830|364896388|FG001|Overall Study|Sponsor Decision|10|||
105792583|NCT01988337|364896389|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
105792584|NCT04854707|364896394|FG000|Overall Study|Lack of Efficacy|78|||
105792585|NCT04854707|364896395|FG001|Overall Study|Lack of Efficacy|59|||
105792586|NCT04854707|364896396|FG002|Overall Study|Lack of Efficacy|30|||
105792587|NCT04527549|364896397|FG000|Overall Study|Withdrawal by Subject|1|||
105792588|NCT04527549|364896398|FG001|Overall Study|Withdrawal by Subject|1|||
105792589|NCT02628418|364896401|FG000|Overall Study|Lost to Follow-up|1|||
105792590|NCT02628418|364896402|FG001|Overall Study|Lost to Follow-up|2|||
105792591|NCT00424632|364896403|FG000|Overall Study|Death|0|||
105792592|NCT00424632|364896404|FG001|Overall Study|Death|0|||
105792593|NCT00424632|364896405|FG002|Overall Study|Death|0|||
105792594|NCT00424632|364896406|FG003|Overall Study|Death|0|||
105792595|NCT00424632|364896407|FG004|Overall Study|Death|0|||
105792596|NCT00424632|364896408|FG005|Overall Study|Death|2|||
105792597|NCT00424632|364896409|FG006|Overall Study|Death|0|||
105792598|NCT00424632|364896410|FG007|Overall Study|Death|0|||
105792599|NCT00424632|364896411|FG008|Overall Study|Death|0|||
105792600|NCT00424632|364896412|FG009|Overall Study|Death|0|||
105792601|NCT00424632|364896403|FG000|Overall Study|Adverse Event|0|||
105792602|NCT00424632|364896404|FG001|Overall Study|Adverse Event|0|||
105792603|NCT00424632|364896405|FG002|Overall Study|Adverse Event|0|||
105792604|NCT00424632|364896406|FG003|Overall Study|Adverse Event|0|||
105792605|NCT00424632|364896407|FG004|Overall Study|Adverse Event|0|||
105792606|NCT00424632|364896408|FG005|Overall Study|Adverse Event|0|||
105792607|NCT00424632|364896409|FG006|Overall Study|Adverse Event|0|||
105792608|NCT00424632|364896410|FG007|Overall Study|Adverse Event|0|||
105792609|NCT00424632|364896411|FG008|Overall Study|Adverse Event|3|||
105792610|NCT00424632|364896412|FG009|Overall Study|Adverse Event|2|||
105792611|NCT00424632|364896403|FG000|Overall Study|Global deterioration of health status|0|||
105792612|NCT00424632|364896404|FG001|Overall Study|Global deterioration of health status|0|||
105792613|NCT00424632|364896405|FG002|Overall Study|Global deterioration of health status|0|||
105792614|NCT00424632|364896406|FG003|Overall Study|Global deterioration of health status|1|||
105792615|NCT00424632|364896407|FG004|Overall Study|Global deterioration of health status|1|||
105792616|NCT00424632|364896408|FG005|Overall Study|Global deterioration of health status|0|||
105722779|NCT00408005|364640890|FG007|Induction|Withdrawal by Subject|0|||
105722780|NCT00408005|364640883|FG000|Induction|Ineligible|33|||
105722781|NCT00408005|364640884|FG001|Induction|Ineligible|14|||
105722782|NCT00408005|364640885|FG002|Induction|Ineligible|0|||
105722783|NCT00408005|364640886|FG003|Induction|Ineligible|0|||
105722784|NCT00408005|364640887|FG004|Induction|Ineligible|0|||
105722785|NCT00408005|364640888|FG005|Induction|Ineligible|0|||
105722786|NCT00408005|364640889|FG006|Induction|Ineligible|0|||
105722787|NCT00408005|364640890|FG007|Induction|Ineligible|0|||
105722788|NCT00408005|364640883|FG000|Induction|Refusal of Further Protocol Therapy|225|||
105722789|NCT00408005|364640884|FG001|Induction|Refusal of Further Protocol Therapy|44|||
105722790|NCT00408005|364640885|FG002|Induction|Refusal of Further Protocol Therapy|0|||
105722791|NCT00408005|364640886|FG003|Induction|Refusal of Further Protocol Therapy|0|||
105722792|NCT00408005|364640887|FG004|Induction|Refusal of Further Protocol Therapy|0|||
105722793|NCT00408005|364640888|FG005|Induction|Refusal of Further Protocol Therapy|0|||
105722794|NCT00408005|364640889|FG006|Induction|Refusal of Further Protocol Therapy|0|||
105722795|NCT00408005|364640890|FG007|Induction|Refusal of Further Protocol Therapy|0|||
105722796|NCT00408005|364640883|FG000|Induction|Entered another COG therapeutic protocol|4|||
105722797|NCT00408005|364640884|FG001|Induction|Entered another COG therapeutic protocol|0|||
105722798|NCT00408005|364640885|FG002|Induction|Entered another COG therapeutic protocol|0|||
105722799|NCT00408005|364640886|FG003|Induction|Entered another COG therapeutic protocol|0|||
105722800|NCT00408005|364640887|FG004|Induction|Entered another COG therapeutic protocol|0|||
105722801|NCT00408005|364640888|FG005|Induction|Entered another COG therapeutic protocol|0|||
105722802|NCT00408005|364640889|FG006|Induction|Entered another COG therapeutic protocol|0|||
105792617|NCT00424632|364896409|FG006|Overall Study|Global deterioration of health status|0|||
105935935|NCT02991859|365425243|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935936|NCT02991859|365425244|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105722803|NCT00408005|364640890|FG007|Induction|Entered another COG therapeutic protocol|0|||
105722804|NCT00408005|364640883|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
105722805|NCT00408005|364640884|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
105792618|NCT00424632|364896410|FG007|Overall Study|Global deterioration of health status|0|||
105792619|NCT00424632|364896411|FG008|Overall Study|Global deterioration of health status|0|||
105792620|NCT00424632|364896412|FG009|Overall Study|Global deterioration of health status|0|||
105792621|NCT00424632|364896403|FG000|Overall Study|Objective progression or relapse|1|||
105792622|NCT00424632|364896404|FG001|Overall Study|Objective progression or relapse|1|||
105792623|NCT00424632|364896405|FG002|Overall Study|Objective progression or relapse|1|||
105792624|NCT00424632|364896406|FG003|Overall Study|Objective progression or relapse|2|||
105792625|NCT00424632|364896407|FG004|Overall Study|Objective progression or relapse|2|||
105792626|NCT00424632|364896408|FG005|Overall Study|Objective progression or relapse|13|||
105792627|NCT00424632|364896409|FG006|Overall Study|Objective progression or relapse|7|||
105792628|NCT00424632|364896410|FG007|Overall Study|Objective progression or relapse|3|||
105792629|NCT00424632|364896411|FG008|Overall Study|Objective progression or relapse|12|||
105792630|NCT00424632|364896412|FG009|Overall Study|Objective progression or relapse|4|||
105792631|NCT00424632|364896403|FG000|Overall Study|Other|0|||
105792632|NCT00424632|364896404|FG001|Overall Study|Other|0|||
105792633|NCT00424632|364896405|FG002|Overall Study|Other|0|||
105792634|NCT00424632|364896406|FG003|Overall Study|Other|1|||
105792635|NCT00424632|364896407|FG004|Overall Study|Other|0|||
105792636|NCT00424632|364896408|FG005|Overall Study|Other|0|||
105792637|NCT00424632|364896409|FG006|Overall Study|Other|0|||
105792638|NCT00424632|364896410|FG007|Overall Study|Other|0|||
105792639|NCT00424632|364896411|FG008|Overall Study|Other|1|||
105792640|NCT00424632|364896412|FG009|Overall Study|Other|0|||
105792641|NCT01215955|364896416|FG000|Overall Study|Adverse Event|1|||
105792642|NCT01215955|364896417|FG001|Overall Study|Adverse Event|4|||
105792643|NCT01215955|364896418|FG002|Overall Study|Adverse Event|2|||
105792644|NCT01215955|364896419|FG003|Overall Study|Adverse Event|3|||
105792645|NCT01215955|364896416|FG000|Overall Study|Death|2|||
105792646|NCT01215955|364896417|FG001|Overall Study|Death|0|||
105792647|NCT01215955|364896418|FG002|Overall Study|Death|1|||
105792648|NCT01215955|364896419|FG003|Overall Study|Death|3|||
105792649|NCT01215955|364896416|FG000|Overall Study|Entry Criteria Not Met|1|||
105792650|NCT01215955|364896417|FG001|Overall Study|Entry Criteria Not Met|3|||
105792651|NCT01215955|364896418|FG002|Overall Study|Entry Criteria Not Met|4|||
105792652|NCT01215955|364896419|FG003|Overall Study|Entry Criteria Not Met|7|||
105792653|NCT01215955|364896416|FG000|Overall Study|Lack of Efficacy|1|||
105792654|NCT01215955|364896417|FG001|Overall Study|Lack of Efficacy|2|||
105722806|NCT00408005|364640885|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
105722807|NCT00408005|364640886|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
105722808|NCT00408005|364640887|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
105722809|NCT00408005|364640888|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
105722810|NCT00408005|364640889|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
105722811|NCT00408005|364640890|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
105722812|NCT00408005|364640883|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
105722813|NCT00408005|364640884|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
105722814|NCT00408005|364640885|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
105722815|NCT00408005|364640886|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
105722816|NCT00408005|364640887|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
105722817|NCT00408005|364640888|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
105722818|NCT00408005|364640889|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
105722819|NCT00408005|364640890|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
105722820|NCT00408005|364640883|FG000|Induction|Progressive Disease|0|||
105722821|NCT00408005|364640884|FG001|Induction|Progressive Disease|1|||
105722822|NCT00408005|364640885|FG002|Induction|Progressive Disease|0|||
105722823|NCT00408005|364640886|FG003|Induction|Progressive Disease|0|||
105722824|NCT00408005|364640887|FG004|Induction|Progressive Disease|0|||
105722825|NCT00408005|364640888|FG005|Induction|Progressive Disease|0|||
105722826|NCT00408005|364640889|FG006|Induction|Progressive Disease|0|||
105722827|NCT00408005|364640890|FG007|Induction|Progressive Disease|0|||
105722828|NCT00408005|364640883|FG000|Induction|Inevaluable|18|||
105722829|NCT00408005|364640884|FG001|Induction|Inevaluable|14|||
105722830|NCT00408005|364640885|FG002|Induction|Inevaluable|0|||
105722831|NCT00408005|364640886|FG003|Induction|Inevaluable|0|||
105722832|NCT00408005|364640887|FG004|Induction|Inevaluable|0|||
105722833|NCT00408005|364640888|FG005|Induction|Inevaluable|0|||
105722834|NCT00408005|364640889|FG006|Induction|Inevaluable|0|||
105722835|NCT00408005|364640890|FG007|Induction|Inevaluable|0|||
105722836|NCT00408005|364640883|FG000|Induction|Failed to Complete Randomization|3|||
105722837|NCT00408005|364640884|FG001|Induction|Failed to Complete Randomization|2|||
105722838|NCT00408005|364640885|FG002|Induction|Failed to Complete Randomization|0|||
105722839|NCT00408005|364640886|FG003|Induction|Failed to Complete Randomization|0|||
105722840|NCT00408005|364640887|FG004|Induction|Failed to Complete Randomization|0|||
105722841|NCT00408005|364640888|FG005|Induction|Failed to Complete Randomization|0|||
105722842|NCT00408005|364640889|FG006|Induction|Failed to Complete Randomization|0|||
105792655|NCT01215955|364896418|FG002|Overall Study|Lack of Efficacy|1|||
105792656|NCT01215955|364896419|FG003|Overall Study|Lack of Efficacy|0|||
105792657|NCT01215955|364896416|FG000|Overall Study|Lost to Follow-up|4|||
105792658|NCT01215955|364896417|FG001|Overall Study|Lost to Follow-up|4|||
105792659|NCT01215955|364896418|FG002|Overall Study|Lost to Follow-up|8|||
105792660|NCT01215955|364896419|FG003|Overall Study|Lost to Follow-up|9|||
105792661|NCT01215955|364896416|FG000|Overall Study|Physician Decision|4|||
105722843|NCT00408005|364640890|FG007|Induction|Failed to Complete Randomization|0|||
105722844|NCT00408005|364640883|FG000|Induction|Protocol Deviation|3|||
105722845|NCT00408005|364640884|FG001|Induction|Protocol Deviation|1|||
105722846|NCT00408005|364640885|FG002|Induction|Protocol Deviation|0|||
105722847|NCT00408005|364640886|FG003|Induction|Protocol Deviation|0|||
105722848|NCT00408005|364640887|FG004|Induction|Protocol Deviation|0|||
105722849|NCT00408005|364640888|FG005|Induction|Protocol Deviation|0|||
105722850|NCT00408005|364640889|FG006|Induction|Protocol Deviation|0|||
105722851|NCT00408005|364640890|FG007|Induction|Protocol Deviation|0|||
105722852|NCT00408005|364640883|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
105722853|NCT00408005|364640884|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722854|NCT00408005|364640885|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722855|NCT00408005|364640886|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722856|NCT00408005|364640887|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722857|NCT00408005|364640888|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722858|NCT00408005|364640889|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722859|NCT00408005|364640890|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
105722860|NCT00408005|364640883|FG000|Induction|Recurrent leukemia|1|||
105722861|NCT00408005|364640884|FG001|Induction|Recurrent leukemia|0|||
105722862|NCT00408005|364640885|FG002|Induction|Recurrent leukemia|0|||
105722863|NCT00408005|364640886|FG003|Induction|Recurrent leukemia|0|||
105722864|NCT00408005|364640887|FG004|Induction|Recurrent leukemia|0|||
105722865|NCT00408005|364640888|FG005|Induction|Recurrent leukemia|0|||
105722866|NCT00408005|364640889|FG006|Induction|Recurrent leukemia|0|||
105722867|NCT00408005|364640890|FG007|Induction|Recurrent leukemia|0|||
105722868|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105722869|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105722870|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
105722871|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
105722872|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
105722873|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
105722874|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
105722875|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105722876|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
105722877|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
105722878|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
105722879|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
105722880|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
105722881|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
105722882|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
105722883|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
105722884|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722885|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722886|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
105722887|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722888|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
105722889|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722890|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722891|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
105722892|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
105722893|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
105722894|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
105722895|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
105722896|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
105722897|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
105722898|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
105722899|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
105722900|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105935937|NCT02991859|365425245|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935938|NCT02991859|365425246|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935939|NCT02991859|365425247|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935940|NCT02991859|365425248|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105722901|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105722902|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
105722903|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
105722904|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105722905|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
105722906|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105722907|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
105722908|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
105722909|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
105722910|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
105722911|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
105722912|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
105722913|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
105722914|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
105722915|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
105722916|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722917|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722918|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722919|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722920|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
105722921|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722922|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722923|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
105722924|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
105722925|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
105722926|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
105722927|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
105722928|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
105722929|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
105722930|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
105722931|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
105722932|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722933|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722934|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722935|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722936|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
105722937|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
105722938|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
105722939|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
105722940|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722941|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722942|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722943|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722944|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722945|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
105722946|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722947|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
105722948|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
105722949|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
105722950|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
105722951|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
105722952|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
105722953|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
105722954|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
105722955|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
105722956|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722957|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722958|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722959|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722960|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
105722961|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
105722962|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722963|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
105722964|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
105722965|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
105722966|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
105722967|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
105722968|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
105722969|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
105722970|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
105722971|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
105722972|NCT00408005|364640883|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
105722973|NCT00408005|364640884|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
105722974|NCT00408005|364640885|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
105722975|NCT00408005|364640886|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
105722976|NCT00408005|364640887|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
105722977|NCT00408005|364640888|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
105722978|NCT00408005|364640889|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
105722979|NCT00408005|364640890|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
105722980|NCT06118385|364640891|FG000|Overall Study|Protocol Violation|0|||
105722981|NCT06118385|364640892|FG001|Overall Study|Protocol Violation|0|||
105722982|NCT06118385|364640893|FG002|Overall Study|Protocol Violation|0|||
105722983|NCT06118385|364640894|FG003|Overall Study|Protocol Violation|0|||
105722984|NCT06118385|364640895|FG004|Overall Study|Protocol Violation|0|||
105722985|NCT06118385|364640896|FG005|Overall Study|Protocol Violation|0|||
105722986|NCT06118385|364640897|FG006|Overall Study|Protocol Violation|0|||
105722987|NCT06118385|364640898|FG007|Overall Study|Protocol Violation|0|||
105722988|NCT06118385|364640899|FG008|Overall Study|Protocol Violation|1|||
105722989|NCT06118385|364640900|FG009|Overall Study|Protocol Violation|0|||
105722990|NCT06118385|364640901|FG010|Overall Study|Protocol Violation|0|||
105722991|NCT06118385|364640902|FG011|Overall Study|Protocol Violation|0|||
105722992|NCT06118385|364640891|FG000|Overall Study|Out-of-range blood tests|0|||
105722993|NCT06118385|364640892|FG001|Overall Study|Out-of-range blood tests|0|||
105722994|NCT06118385|364640893|FG002|Overall Study|Out-of-range blood tests|0|||
105722995|NCT06118385|364640894|FG003|Overall Study|Out-of-range blood tests|0|||
105722996|NCT06118385|364640895|FG004|Overall Study|Out-of-range blood tests|0|||
105722997|NCT06118385|364640896|FG005|Overall Study|Out-of-range blood tests|0|||
105722998|NCT06118385|364640897|FG006|Overall Study|Out-of-range blood tests|0|||
105722999|NCT06118385|364640898|FG007|Overall Study|Out-of-range blood tests|0|||
105723000|NCT06118385|364640899|FG008|Overall Study|Out-of-range blood tests|1|||
105723001|NCT06118385|364640900|FG009|Overall Study|Out-of-range blood tests|0|||
105723002|NCT06118385|364640901|FG010|Overall Study|Out-of-range blood tests|0|||
105723003|NCT06118385|364640902|FG011|Overall Study|Out-of-range blood tests|0|||
105723004|NCT01701258|364640903|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
105723005|NCT01701258|364640904|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
105723006|NCT01701258|364640905|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
105723007|NCT01701258|364640906|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
105723008|NCT01701258|364640907|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
105723009|NCT01701258|364640908|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
105723010|NCT01701258|364640909|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
105723011|NCT01701258|364640910|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
105723012|NCT01701258|364640911|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
105723013|NCT01701258|364640912|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
105723014|NCT01701258|364640913|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
105723015|NCT01701258|364640914|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
105723016|NCT01701258|364640915|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
105723017|NCT01701258|364640903|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
105723018|NCT01701258|364640904|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
105723019|NCT01701258|364640905|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
105723020|NCT01701258|364640906|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
105723021|NCT01701258|364640907|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
105723022|NCT01701258|364640908|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
105723023|NCT01701258|364640909|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
105723024|NCT01701258|364640910|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
105723025|NCT01701258|364640911|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
105723026|NCT01701258|364640912|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
105723027|NCT01701258|364640913|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
105723028|NCT01701258|364640914|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
105723029|NCT01701258|364640915|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
105723030|NCT01701258|364640903|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
105723031|NCT01701258|364640904|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
105723032|NCT01701258|364640905|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
105792662|NCT01215955|364896417|FG001|Overall Study|Physician Decision|10|||
105792663|NCT01215955|364896418|FG002|Overall Study|Physician Decision|8|||
105792664|NCT01215955|364896419|FG003|Overall Study|Physician Decision|11|||
105792665|NCT01215955|364896416|FG000|Overall Study|Protocol Violation|17|||
105792666|NCT01215955|364896417|FG001|Overall Study|Protocol Violation|13|||
105792667|NCT01215955|364896418|FG002|Overall Study|Protocol Violation|8|||
105792668|NCT01215955|364896419|FG003|Overall Study|Protocol Violation|8|||
105792669|NCT01215955|364896416|FG000|Overall Study|Sponsor Decision|1|||
105792670|NCT01215955|364896417|FG001|Overall Study|Sponsor Decision|2|||
105792671|NCT01215955|364896418|FG002|Overall Study|Sponsor Decision|0|||
105792672|NCT01215955|364896419|FG003|Overall Study|Sponsor Decision|1|||
105792673|NCT01215955|364896416|FG000|Overall Study|Withdrawal by Subject|14|||
105792674|NCT01215955|364896417|FG001|Overall Study|Withdrawal by Subject|15|||
105792675|NCT01215955|364896418|FG002|Overall Study|Withdrawal by Subject|13|||
105792676|NCT01215955|364896419|FG003|Overall Study|Withdrawal by Subject|9|||
105792677|NCT01215955|364896416|FG000|Overall Study|Quality Issues|0|||
105792678|NCT01215955|364896417|FG001|Overall Study|Quality Issues|0|||
105792679|NCT01215955|364896418|FG002|Overall Study|Quality Issues|3|||
105792680|NCT01215955|364896419|FG003|Overall Study|Quality Issues|2|||
105792681|NCT00445458|364896420|FG000|Overall Study|Disease Progression|3|||
105792682|NCT00445458|364896421|FG001|Overall Study|Disease Progression|4|||
105792683|NCT00445458|364896422|FG002|Overall Study|Disease Progression|54|||
105792684|NCT00445458|364896423|FG003|Overall Study|Disease Progression|27|||
105792685|NCT00445458|364896420|FG000|Overall Study|Withdrawal by Subject|0|||
105792686|NCT00445458|364896421|FG001|Overall Study|Withdrawal by Subject|0|||
105792687|NCT00445458|364896422|FG002|Overall Study|Withdrawal by Subject|7|||
105792688|NCT00445458|364896423|FG003|Overall Study|Withdrawal by Subject|0|||
105792689|NCT00445458|364896420|FG000|Overall Study|Adverse Event|0|||
105792690|NCT00445458|364896421|FG001|Overall Study|Adverse Event|0|||
105792691|NCT00445458|364896422|FG002|Overall Study|Adverse Event|3|||
105792692|NCT00445458|364896423|FG003|Overall Study|Adverse Event|0|||
105792693|NCT00445458|364896420|FG000|Overall Study|Death|0|||
105792694|NCT00445458|364896421|FG001|Overall Study|Death|1|||
105792695|NCT00445458|364896422|FG002|Overall Study|Death|2|||
105792696|NCT00445458|364896423|FG003|Overall Study|Death|0|||
105792697|NCT00445458|364896420|FG000|Overall Study|Physician Decision|0|||
105792698|NCT00445458|364896421|FG001|Overall Study|Physician Decision|0|||
105792699|NCT00445458|364896422|FG002|Overall Study|Physician Decision|1|||
105792700|NCT00445458|364896423|FG003|Overall Study|Physician Decision|1|||
105792701|NCT00445458|364896420|FG000|Overall Study|Surgery|0|||
105792702|NCT00445458|364896421|FG001|Overall Study|Surgery|0|||
105792703|NCT00445458|364896422|FG002|Overall Study|Surgery|1|||
105792704|NCT00445458|364896423|FG003|Overall Study|Surgery|0|||
105792705|NCT03972709|364896424|FG000|Overall Study|Withdrawal by Subject|18|||
105792706|NCT03972709|364896425|FG001|Overall Study|Withdrawal by Subject|7|||
105792707|NCT03972709|364896426|FG002|Overall Study|Withdrawal by Subject|14|||
105792708|NCT03972709|364896424|FG000|Overall Study|Study Terminated by Sponsor|48|||
105792709|NCT03972709|364896425|FG001|Overall Study|Study Terminated by Sponsor|25|||
105792710|NCT03972709|364896426|FG002|Overall Study|Study Terminated by Sponsor|50|||
105792711|NCT03972709|364896424|FG000|Overall Study|Physician Decision|1|||
105792712|NCT03972709|364896425|FG001|Overall Study|Physician Decision|0|||
105792713|NCT03972709|364896426|FG002|Overall Study|Physician Decision|0|||
105792714|NCT03972709|364896424|FG000|Overall Study|COVID-19|0|||
105792715|NCT03972709|364896425|FG001|Overall Study|COVID-19|1|||
105792716|NCT03972709|364896426|FG002|Overall Study|COVID-19|1|||
105792717|NCT03972709|364896424|FG000|Overall Study|Lost to Follow-up|6|||
105792718|NCT03972709|364896425|FG001|Overall Study|Lost to Follow-up|1|||
105792719|NCT03972709|364896426|FG002|Overall Study|Lost to Follow-up|2|||
105792720|NCT03972709|364896424|FG000|Overall Study|Death|5|||
105792721|NCT03972709|364896425|FG001|Overall Study|Death|1|||
105792722|NCT03972709|364896426|FG002|Overall Study|Death|4|||
106137674|NCT00762463|366163446|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
106137675|NCT00762463|366163447|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
106137676|NCT00762463|366163448|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
106137677|NCT01118377|366163451|FG000|Overall Study|Did Not Receive Study Medication|1|||
105792723|NCT03972709|364896424|FG000|Overall Study|Adverse Event|3|||
105792724|NCT03972709|364896425|FG001|Overall Study|Adverse Event|1|||
105792725|NCT03972709|364896426|FG002|Overall Study|Adverse Event|4|||
105792726|NCT03972709|364896424|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
105792727|NCT03972709|364896425|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
105792728|NCT03972709|364896426|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
105792729|NCT03972709|364896424|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
105792730|NCT03972709|364896425|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
105792731|NCT03972709|364896426|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
105792732|NCT03972709|364896424|FG000|Overall Study|Subject Unable to be Contacted|0|||
105792733|NCT03972709|364896425|FG001|Overall Study|Subject Unable to be Contacted|1|||
106137678|NCT01118377|366163451|FG000|Overall Study|Death|38|||
106137679|NCT01118377|366163451|FG000|Overall Study|Failure to Return|3|||
105935941|NCT02991859|365425249|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935942|NCT02991859|365425250|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935943|NCT02991859|365425251|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
105935944|NCT02991859|365425252|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935945|NCT02991859|365425253|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935946|NCT02991859|365425254|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935947|NCT02991859|365425255|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105723033|NCT01701258|364640906|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
105723034|NCT01701258|364640907|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
105723035|NCT01701258|364640908|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
105723036|NCT01701258|364640909|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
105723037|NCT01701258|364640910|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
105723038|NCT01701258|364640911|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
105723039|NCT01701258|364640912|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
105723040|NCT01701258|364640913|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
105723041|NCT01701258|364640914|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
105723042|NCT01701258|364640915|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
105723043|NCT01701258|364640903|FG000|Assessment and Scheduling|Investigator Terminated|2|||
105723044|NCT01701258|364640904|FG001|Assessment and Scheduling|Investigator Terminated|0|||
105723045|NCT01701258|364640905|FG002|Assessment and Scheduling|Investigator Terminated|0|||
105723046|NCT01701258|364640906|FG003|Assessment and Scheduling|Investigator Terminated|0|||
105723047|NCT01701258|364640907|FG004|Assessment and Scheduling|Investigator Terminated|0|||
105723048|NCT01701258|364640908|FG005|Assessment and Scheduling|Investigator Terminated|0|||
105723049|NCT01701258|364640909|FG006|Assessment and Scheduling|Investigator Terminated|0|||
105723050|NCT01701258|364640910|FG007|Assessment and Scheduling|Investigator Terminated|0|||
105723051|NCT01701258|364640911|FG008|Assessment and Scheduling|Investigator Terminated|0|||
105723052|NCT01701258|364640912|FG009|Assessment and Scheduling|Investigator Terminated|0|||
105723053|NCT01701258|364640913|FG010|Assessment and Scheduling|Investigator Terminated|0|||
105723054|NCT01701258|364640914|FG011|Assessment and Scheduling|Investigator Terminated|0|||
105723055|NCT01701258|364640915|FG012|Assessment and Scheduling|Investigator Terminated|0|||
105723056|NCT01848145|364640916|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
105723057|NCT01848145|364640916|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
105723058|NCT01848145|364640916|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
105723059|NCT01848145|364640916|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
105723060|NCT01848145|364640916|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
105723061|NCT01848145|364640916|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
105723062|NCT01848145|364640916|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
105723063|NCT03041311|364640922|FG000|Overall Study|Death|39|||
105723064|NCT03041311|364640923|FG001|Overall Study|Death|42|||
105723065|NCT03041311|364640922|FG000|Overall Study|Lost to Follow-up|0|||
105723066|NCT03041311|364640923|FG001|Overall Study|Lost to Follow-up|1|||
105723067|NCT03041311|364640922|FG000|Overall Study|Withdrawal by Subject|8|||
105723068|NCT03041311|364640923|FG001|Overall Study|Withdrawal by Subject|5|||
105723069|NCT03041311|364640922|FG000|Overall Study|Sponsor Terminated Study|2|||
105723070|NCT03041311|364640923|FG001|Overall Study|Sponsor Terminated Study|4|||
105723071|NCT03041311|364640922|FG000|Overall Study|Disease Progression|3|||
105723072|NCT03041311|364640923|FG001|Overall Study|Disease Progression|1|||
105723073|NCT03041311|364640922|FG000|Overall Study|Randomized in error, did not receive drug|2|||
105723074|NCT03041311|364640923|FG001|Overall Study|Randomized in error, did not receive drug|0|||
105723075|NCT04398732|364640924|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
105723076|NCT00556426|364640925|FG000|Overall Study|Withdrawal by Subject|3|||
105723077|NCT00556426|364640925|FG000|Overall Study|Death|6|||
105723078|NCT00474240|364640929|FG000|Overall Study|Withdrawal by Subject|1|||
105723079|NCT00474240|364640930|FG001|Overall Study|Withdrawal by Subject|1|||
105723080|NCT00474240|364640931|FG002|Overall Study|Withdrawal by Subject|0|||
105723081|NCT00474240|364640932|FG003|Overall Study|Withdrawal by Subject|2|||
105723082|NCT00474240|364640933|FG004|Overall Study|Withdrawal by Subject|3|||
105723083|NCT00474240|364640934|FG005|Overall Study|Withdrawal by Subject|1|||
105723084|NCT00474240|364640929|FG000|Overall Study|Adverse Event|0|||
105723085|NCT00474240|364640930|FG001|Overall Study|Adverse Event|0|||
105723086|NCT00474240|364640931|FG002|Overall Study|Adverse Event|9|||
105723087|NCT00474240|364640932|FG003|Overall Study|Adverse Event|14|||
105723088|NCT00474240|364640933|FG004|Overall Study|Adverse Event|5|||
105723089|NCT00474240|364640934|FG005|Overall Study|Adverse Event|16|||
105723090|NCT00474240|364640929|FG000|Overall Study|Removed due to lab value|0|||
105935948|NCT02991859|365425256|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105723091|NCT00474240|364640930|FG001|Overall Study|Removed due to lab value|0|||
105723092|NCT00474240|364640931|FG002|Overall Study|Removed due to lab value|0|||
105723093|NCT00474240|364640932|FG003|Overall Study|Removed due to lab value|0|||
105723094|NCT00474240|364640933|FG004|Overall Study|Removed due to lab value|0|||
105723095|NCT00474240|364640934|FG005|Overall Study|Removed due to lab value|1|||
105792734|NCT03972709|364896426|FG002|Overall Study|Subject Unable to be Contacted|0|||
105792735|NCT03972709|364896424|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
105792736|NCT03972709|364896425|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
105792737|NCT03972709|364896426|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
105792738|NCT03972709|364896424|FG000|Overall Study|Subject Moved|0|||
105792739|NCT03972709|364896425|FG001|Overall Study|Subject Moved|1|||
105792740|NCT03972709|364896426|FG002|Overall Study|Subject Moved|0|||
105792741|NCT03972709|364896424|FG000|Overall Study|Missed Study Visits|1|||
105792742|NCT03972709|364896425|FG001|Overall Study|Missed Study Visits|0|||
105792743|NCT03972709|364896426|FG002|Overall Study|Missed Study Visits|0|||
105792744|NCT03159611|364896427|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
105792745|NCT03159611|364896428|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
105792746|NCT03159611|364896427|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
105792747|NCT03159611|364896428|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
106137680|NCT00739102|366163452|FG000|Overall Study|Death|5|||
105723096|NCT02054702|364640935|FG000|Overall Study|Lost to Follow-up|3|||
105723097|NCT02054702|364640936|FG001|Overall Study|Lost to Follow-up|5|||
105723098|NCT02054702|364640935|FG000|Overall Study|Adverse Event|3|||
105723099|NCT02054702|364640936|FG001|Overall Study|Adverse Event|1|||
105723100|NCT02054702|364640935|FG000|Overall Study|Met Withdrawal Criteria|4|||
105723101|NCT02054702|364640936|FG001|Overall Study|Met Withdrawal Criteria|1|||
105723102|NCT02054702|364640935|FG000|Overall Study|Physician Decision|0|||
105723103|NCT02054702|364640936|FG001|Overall Study|Physician Decision|1|||
105723104|NCT02054702|364640935|FG000|Overall Study|Withdrawal by Subject|14|||
105723105|NCT02054702|364640936|FG001|Overall Study|Withdrawal by Subject|4|||
105723106|NCT02347631|364640939|FG000|First Intervention (2 Months)|Adverse Event|1|||
105723107|NCT02347631|364640940|FG001|First Intervention (2 Months)|Adverse Event|1|||
105723108|NCT02347631|364640939|FG000|First Intervention (2 Months)|Pregnancy|1|||
105723109|NCT02347631|364640940|FG001|First Intervention (2 Months)|Pregnancy|0|||
105723110|NCT02347631|364640939|FG000|First Intervention (2 Months)|Moved out of area|0|||
105723111|NCT02347631|364640940|FG001|First Intervention (2 Months)|Moved out of area|2|||
105723112|NCT02347631|364640939|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
105723113|NCT02347631|364640940|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
105723114|NCT02347631|364640939|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
105723115|NCT02347631|364640940|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
105723116|NCT02347631|364640939|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
105723117|NCT02347631|364640940|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
105723118|NCT02347631|364640939|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
105723119|NCT02347631|364640940|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
105723120|NCT02347631|364640939|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
105723121|NCT02347631|364640940|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
105723122|NCT02304926|364640942|FG000|Overall Study|Lost to Follow-up|2|||
105723123|NCT02304926|364640943|FG001|Overall Study|Lost to Follow-up|1|||
105723124|NCT01147926|364640952|FG000|Overall Study|Subject Withdrew Consent|9|||
105723125|NCT01147926|364640953|FG001|Overall Study|Subject Withdrew Consent|10|||
105723126|NCT01147926|364640952|FG000|Overall Study|Adverse Event|7|||
105723127|NCT01147926|364640953|FG001|Overall Study|Adverse Event|6|||
105723128|NCT01147926|364640952|FG000|Overall Study|Subject Non-Compliant|5|||
105723129|NCT01147926|364640953|FG001|Overall Study|Subject Non-Compliant|4|||
105723130|NCT01147926|364640952|FG000|Overall Study|Principal investigator left hospital|1|||
105723131|NCT01147926|364640953|FG001|Overall Study|Principal investigator left hospital|3|||
105723132|NCT01147926|364640952|FG000|Overall Study|Selection criteria not met|3|||
105723133|NCT01147926|364640953|FG001|Overall Study|Selection criteria not met|1|||
105723134|NCT01147926|364640952|FG000|Overall Study|Lost to Follow-up|0|||
105723135|NCT01147926|364640953|FG001|Overall Study|Lost to Follow-up|2|||
105723136|NCT01147926|364640952|FG000|Overall Study|Sponsor's Decision|0|||
105723137|NCT01147926|364640953|FG001|Overall Study|Sponsor's Decision|1|||
105723138|NCT01147926|364640952|FG000|Overall Study|Lack of Efficacy|1|||
105723139|NCT01147926|364640953|FG001|Overall Study|Lack of Efficacy|0|||
105723140|NCT01147926|364640952|FG000|Overall Study|Too busy, no time for study|1|||
105723141|NCT01147926|364640953|FG001|Overall Study|Too busy, no time for study|0|||
105723142|NCT01147926|364640952|FG000|Overall Study|Went on holiday|0|||
105723143|NCT01147926|364640953|FG001|Overall Study|Went on holiday|1|||
105723144|NCT01147926|364640952|FG000|Overall Study|Colonoscopy result|0|||
105723145|NCT01147926|364640953|FG001|Overall Study|Colonoscopy result|1|||
105723146|NCT03417440|364640954|FG000|Overall Study|Lost to Follow-up|0|||
105723147|NCT03417440|364640955|FG001|Overall Study|Lost to Follow-up|1|||
105723148|NCT03417440|364640956|FG002|Overall Study|Lost to Follow-up|0|||
105723149|NCT03417440|364640957|FG003|Overall Study|Lost to Follow-up|0|||
105723150|NCT03417440|364640958|FG004|Overall Study|Lost to Follow-up|1|||
105792748|NCT03159611|364896427|FG000|Overall Study|Protocol Violation|7|||
105792749|NCT03159611|364896428|FG001|Overall Study|Protocol Violation|4|||
105792750|NCT03159611|364896427|FG000|Overall Study|Adverse Event|1|||
105792751|NCT03159611|364896428|FG001|Overall Study|Adverse Event|0|||
105792752|NCT03159611|364896427|FG000|Overall Study|Withdrawal by Subject|1|||
105792753|NCT03159611|364896428|FG001|Overall Study|Withdrawal by Subject|1|||
105792754|NCT03159611|364896427|FG000|Overall Study|Non-compliance with protocol requirement|3|||
105792755|NCT03159611|364896428|FG001|Overall Study|Non-compliance with protocol requirement|2|||
105792756|NCT03159611|364896427|FG000|Overall Study|Inability to perform procedures|1|||
105792757|NCT03159611|364896428|FG001|Overall Study|Inability to perform procedures|0|||
105792758|NCT04732728|364896429|FG000|Overall Study|Death|12|||
105792759|NCT04732728|364896429|FG000|Overall Study|Withdrawn|136|||
105792760|NCT01984229|364896430|FG000|Safety Follow-up Period|Adverse Event|1|||
105792761|NCT01984229|364896431|FG001|Safety Follow-up Period|Adverse Event|1|||
105792762|NCT01984229|364896430|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
105792763|NCT01984229|364896431|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
105792764|NCT02575807|364896438|FG000|Overall Study|Death|8|||
105792765|NCT02575807|364896439|FG001|Overall Study|Death|3|||
105792766|NCT02575807|364896440|FG002|Overall Study|Death|7|||
105792767|NCT02575807|364896441|FG003|Overall Study|Death|0|||
105792768|NCT02575807|364896442|FG004|Overall Study|Death|1|||
105792769|NCT02575807|364896438|FG000|Overall Study|Study terminated by Sponsor|0|||
105792770|NCT02575807|364896439|FG001|Overall Study|Study terminated by Sponsor|1|||
105792771|NCT02575807|364896440|FG002|Overall Study|Study terminated by Sponsor|7|||
105792772|NCT02575807|364896441|FG003|Overall Study|Study terminated by Sponsor|0|||
105792773|NCT02575807|364896442|FG004|Overall Study|Study terminated by Sponsor|1|||
105792774|NCT02575807|364896438|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
105792775|NCT02575807|364896439|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
105792776|NCT02575807|364896440|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
105792777|NCT02575807|364896441|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
105792778|NCT02575807|364896442|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
105792779|NCT02575807|364896438|FG000|Overall Study|Terminated due to physician decision|0|||
105792780|NCT02575807|364896439|FG001|Overall Study|Terminated due to physician decision|0|||
105792781|NCT02575807|364896440|FG002|Overall Study|Terminated due to physician decision|1|||
105792782|NCT02575807|364896441|FG003|Overall Study|Terminated due to physician decision|0|||
105792783|NCT02575807|364896442|FG004|Overall Study|Terminated due to physician decision|0|||
105792784|NCT02575807|364896438|FG000|Overall Study|Subject ineligible - medical implant|0|||
105792785|NCT02575807|364896439|FG001|Overall Study|Subject ineligible - medical implant|0|||
105792786|NCT02575807|364896440|FG002|Overall Study|Subject ineligible - medical implant|0|||
105792787|NCT02575807|364896441|FG003|Overall Study|Subject ineligible - medical implant|1|||
105792788|NCT02575807|364896442|FG004|Overall Study|Subject ineligible - medical implant|0|||
105792789|NCT02575807|364896438|FG000|Overall Study|Withdrawal by Subject|0|||
105792790|NCT02575807|364896439|FG001|Overall Study|Withdrawal by Subject|0|||
105792791|NCT02575807|364896440|FG002|Overall Study|Withdrawal by Subject|1|||
105792792|NCT02575807|364896441|FG003|Overall Study|Withdrawal by Subject|1|||
105792793|NCT02575807|364896442|FG004|Overall Study|Withdrawal by Subject|2|||
105792794|NCT03319368|364896443|FG000|Overall Study|Discharge swabs not collected from resident|57|||
105792795|NCT03319368|364896444|FG001|Overall Study|Discharge swabs not collected from resident|46|||
105792796|NCT03000075|364896445|FG000|Part A|Adverse Event|4|||
105792797|NCT03000075|364896446|FG001|Part A|Adverse Event|0|||
105792798|NCT03000075|364896447|FG002|Part A|Adverse Event|0|||
105792799|NCT03000075|364896448|FG003|Part A|Adverse Event|0|||
105792800|NCT03000075|364896449|FG004|Part A|Adverse Event|0|||
105792801|NCT03000075|364896450|FG005|Part A|Adverse Event|0|||
105792802|NCT03000075|364896451|FG006|Part A|Adverse Event|0|||
105792803|NCT03000075|364896445|FG000|Part B|Not dosed due to AE|0|||
105792804|NCT03000075|364896446|FG001|Part B|Not dosed due to AE|0|||
105792805|NCT03000075|364896447|FG002|Part B|Not dosed due to AE|0|||
105792806|NCT03000075|364896448|FG003|Part B|Not dosed due to AE|0|||
105792807|NCT03000075|364896449|FG004|Part B|Not dosed due to AE|0|||
105792808|NCT03000075|364896450|FG005|Part B|Not dosed due to AE|2|||
105792809|NCT03000075|364896451|FG006|Part B|Not dosed due to AE|1|||
105792810|NCT03000075|364896445|FG000|Part B|Adverse Event|0|||
105792811|NCT03000075|364896446|FG001|Part B|Adverse Event|0|||
105792812|NCT03000075|364896447|FG002|Part B|Adverse Event|0|||
105792813|NCT03000075|364896448|FG003|Part B|Adverse Event|0|||
105792814|NCT03000075|364896449|FG004|Part B|Adverse Event|1|||
105792815|NCT03000075|364896450|FG005|Part B|Adverse Event|0|||
105792816|NCT03000075|364896451|FG006|Part B|Adverse Event|0|||
106009170|NCT05523089|365699099|FG002|Overall Study|Withdrawal by Subject|0|||
105792817|NCT02180659|364896452|FG000|Overall Study|Adverse Event|1|||
105792818|NCT02180659|364896453|FG001|Overall Study|Adverse Event|0|||
105792819|NCT02180659|364896452|FG000|Overall Study|Lost to Follow-up|4|||
105792820|NCT02180659|364896453|FG001|Overall Study|Lost to Follow-up|2|||
105792821|NCT02180659|364896452|FG000|Overall Study|Subject incarcerated during conduct|1|||
106009171|NCT05523089|365699097|FG000|Overall Study|Lost to Follow-up|1|||
105792822|NCT02180659|364896453|FG001|Overall Study|Subject incarcerated during conduct|0|||
105792823|NCT02180659|364896452|FG000|Overall Study|Withdrawal by Subject|0|||
106009172|NCT05523089|365699098|FG001|Overall Study|Lost to Follow-up|0|||
105792824|NCT02180659|364896453|FG001|Overall Study|Withdrawal by Subject|2|||
105792825|NCT02180659|364896452|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
106009173|NCT05523089|365699099|FG002|Overall Study|Lost to Follow-up|0|||
105723151|NCT03417440|364640959|FG005|Overall Study|Lost to Follow-up|0|||
105723152|NCT03417440|364640960|FG006|Overall Study|Lost to Follow-up|0|||
105723153|NCT03417440|364640961|FG007|Overall Study|Lost to Follow-up|0|||
105723154|NCT03417440|364640954|FG000|Overall Study|Withdrawal by Subject|2|||
105723155|NCT03417440|364640955|FG001|Overall Study|Withdrawal by Subject|0|||
105723156|NCT03417440|364640956|FG002|Overall Study|Withdrawal by Subject|2|||
105723157|NCT03417440|364640957|FG003|Overall Study|Withdrawal by Subject|1|||
105723158|NCT03417440|364640958|FG004|Overall Study|Withdrawal by Subject|1|||
105723159|NCT03417440|364640959|FG005|Overall Study|Withdrawal by Subject|0|||
105723160|NCT03417440|364640960|FG006|Overall Study|Withdrawal by Subject|0|||
105723161|NCT03417440|364640961|FG007|Overall Study|Withdrawal by Subject|1|||
105723162|NCT01032629|364640968|FG000|Overall Study|Closed Site|21|||
105723163|NCT01032629|364640969|FG001|Overall Study|Closed Site|18|||
105723164|NCT01032629|364640970|FG002|Overall Study|Closed Site|16|||
105723165|NCT01032629|364640968|FG000|Overall Study|Withdrawal by Subject|50|||
105723166|NCT01032629|364640969|FG001|Overall Study|Withdrawal by Subject|36|||
105723167|NCT01032629|364640970|FG002|Overall Study|Withdrawal by Subject|35|||
105723168|NCT01032629|364640968|FG000|Overall Study|Lost to Follow-up|74|||
105723169|NCT01032629|364640969|FG001|Overall Study|Lost to Follow-up|47|||
105723170|NCT01032629|364640970|FG002|Overall Study|Lost to Follow-up|37|||
105723171|NCT03371355|364640971|FG000|Overall Study|Investigator judgment|0|||
105723172|NCT03371355|364640972|FG001|Overall Study|Investigator judgment|0|||
105723173|NCT03371355|364640973|FG002|Overall Study|Investigator judgment|1|||
105723174|NCT03371355|364640974|FG003|Overall Study|Investigator judgment|1|||
105723175|NCT03371355|364640971|FG000|Overall Study|Voluntary withdrawal|1|||
105723176|NCT03371355|364640972|FG001|Overall Study|Voluntary withdrawal|0|||
105723177|NCT03371355|364640973|FG002|Overall Study|Voluntary withdrawal|1|||
105723178|NCT03371355|364640974|FG003|Overall Study|Voluntary withdrawal|2|||
105723179|NCT03371355|364640971|FG000|Overall Study|Adverse Event|0|||
105723180|NCT03371355|364640972|FG001|Overall Study|Adverse Event|1|||
105723181|NCT03371355|364640973|FG002|Overall Study|Adverse Event|2|||
105723182|NCT03371355|364640974|FG003|Overall Study|Adverse Event|3|||
105723183|NCT03371355|364640971|FG000|Overall Study|Reason not Specified|0|||
105723184|NCT03371355|364640972|FG001|Overall Study|Reason not Specified|1|||
105723185|NCT03371355|364640973|FG002|Overall Study|Reason not Specified|0|||
105723186|NCT03371355|364640974|FG003|Overall Study|Reason not Specified|1|||
105723187|NCT03403400|364640977|FG000|Overall Study|Lost to Follow-up|1|||
105723188|NCT03403400|364640978|FG001|Overall Study|Lost to Follow-up|0|||
105723189|NCT03403400|364640979|FG002|Overall Study|Lost to Follow-up|1|||
105723190|NCT03403400|364640977|FG000|Overall Study|Hospitalization|1|||
105723191|NCT03403400|364640978|FG001|Overall Study|Hospitalization|0|||
105723192|NCT03403400|364640979|FG002|Overall Study|Hospitalization|0|||
105723193|NCT03403400|364640977|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
105723194|NCT03403400|364640978|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
105723195|NCT03403400|364640979|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
105723196|NCT01763164|364640980|FG000|Treatment Phase|Participant/Guardian decision|26|||
105723197|NCT01763164|364640981|FG001|Treatment Phase|Participant/Guardian decision|14|||
105723198|NCT01763164|364640980|FG000|Treatment Phase|Protocol Violation|1|||
105723199|NCT01763164|364640981|FG001|Treatment Phase|Protocol Violation|1|||
105723200|NCT01763164|364640980|FG000|Treatment Phase|Progressive Disease|142|||
105723201|NCT01763164|364640981|FG001|Treatment Phase|Progressive Disease|76|||
105723202|NCT01763164|364640980|FG000|Treatment Phase|Physician Decision|24|||
105723203|NCT01763164|364640981|FG001|Treatment Phase|Physician Decision|13|||
105723204|NCT01763164|364640980|FG000|Treatment Phase|Death|10|||
105723205|NCT01763164|364640981|FG001|Treatment Phase|Death|1|||
105723206|NCT01763164|364640980|FG000|Treatment Phase|Adverse Event|66|||
105723207|NCT01763164|364640981|FG001|Treatment Phase|Adverse Event|8|||
105935949|NCT02991859|365425257|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935950|NCT02991859|365425258|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
105935951|NCT02991859|365425242|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935952|NCT02991859|365425243|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935953|NCT02991859|365425244|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935954|NCT02991859|365425245|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935955|NCT02991859|365425246|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935956|NCT02991859|365425247|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935957|NCT02991859|365425248|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935958|NCT02991859|365425249|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105723208|NCT01763164|364640980|FG000|Treatment Phase|Randomized but not Treated|0|||
105723209|NCT01763164|364640981|FG001|Treatment Phase|Randomized but not Treated|19|||
105723210|NCT01763164|364640980|FG000|Treatment Phase|Other|0|||
105723211|NCT01763164|364640981|FG001|Treatment Phase|Other|1|||
105723212|NCT01763164|364640980|FG000|Follow up Phase|New therapy for study indication|12|||
105723213|NCT01763164|364640981|FG001|Follow up Phase|New therapy for study indication|3|||
105723214|NCT01763164|364640980|FG000|Follow up Phase|Death|21|||
105723215|NCT01763164|364640981|FG001|Follow up Phase|Death|4|||
105723216|NCT01763164|364640980|FG000|Follow up Phase|Subject/guardian decision|9|||
105723217|NCT01763164|364640981|FG001|Follow up Phase|Subject/guardian decision|2|||
105723218|NCT01763164|364640980|FG000|Follow up Phase|Progressive disease|127|||
105723219|NCT01763164|364640981|FG001|Follow up Phase|Progressive disease|62|||
105723220|NCT01763164|364640980|FG000|Follow up Phase|Physician Decision|10|||
105723221|NCT01763164|364640981|FG001|Follow up Phase|Physician Decision|3|||
105723222|NCT01763164|364640980|FG000|Follow up Phase|Lost to Follow-up|1|||
105723223|NCT01763164|364640981|FG001|Follow up Phase|Lost to Follow-up|0|||
105723224|NCT01763164|364640980|FG000|Follow up Phase|Adverse Event|17|||
105723225|NCT01763164|364640981|FG001|Follow up Phase|Adverse Event|1|||
105723226|NCT01526148|364640993|FG000|Overall Study|Adverse Event|6|||
105723227|NCT01526148|364640994|FG001|Overall Study|Adverse Event|5|||
105723228|NCT01526148|364640993|FG000|Overall Study|Lost to Follow-up|3|||
105723229|NCT01526148|364640994|FG001|Overall Study|Lost to Follow-up|6|||
105723230|NCT01526148|364640993|FG000|Overall Study|Withdrawal by Subject|2|||
105723231|NCT01526148|364640994|FG001|Overall Study|Withdrawal by Subject|0|||
105723232|NCT01526148|364640993|FG000|Overall Study|Unstable Medical Condition|1|||
105723233|NCT01526148|364640994|FG001|Overall Study|Unstable Medical Condition|0|||
105723234|NCT01526148|364640993|FG000|Overall Study|Unable to discontinue concomitant med|1|||
105723235|NCT01526148|364640994|FG001|Overall Study|Unable to discontinue concomitant med|0|||
105723236|NCT01526148|364640993|FG000|Overall Study|Moved out of state|1|||
105723237|NCT01526148|364640994|FG001|Overall Study|Moved out of state|0|||
105723238|NCT01526148|364640993|FG000|Overall Study|Incarcerated|0|||
105723239|NCT01526148|364640994|FG001|Overall Study|Incarcerated|2|||
105723240|NCT03529409|364640997|FG000|Randomized|Lost to Follow-up|0|||
105723241|NCT03529409|364640998|FG001|Randomized|Lost to Follow-up|0|||
105723242|NCT03529409|364640999|FG002|Randomized|Lost to Follow-up|4|||
105723243|NCT03529409|364640997|FG000|Randomized|Excluded|0|||
105723244|NCT03529409|364640998|FG001|Randomized|Excluded|0|||
105723245|NCT03529409|364640999|FG002|Randomized|Excluded|1|||
105723246|NCT03529409|364640997|FG000|Post-treatment Assessment|Death|1|||
105723247|NCT03529409|364640998|FG001|Post-treatment Assessment|Death|0|||
105723248|NCT03529409|364640999|FG002|Post-treatment Assessment|Death|0|||
105723249|NCT03529409|364640997|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
105723250|NCT03529409|364640998|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
105723251|NCT03529409|364640999|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
105723252|NCT03529409|364640997|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
105723253|NCT03529409|364640998|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
105723254|NCT03529409|364640999|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
105723255|NCT03529409|364640997|FG000|Follow-up Assessment|Death|1|||
105723256|NCT03529409|364640998|FG001|Follow-up Assessment|Death|0|||
105723257|NCT03529409|364640999|FG002|Follow-up Assessment|Death|0|||
105723258|NCT03529409|364640997|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
105723259|NCT03529409|364640998|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
105723260|NCT03529409|364640999|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
105723261|NCT03898063|364641000|FG000|Overall Study|Withdrawal by Subject|10|||
105723262|NCT03898063|364641001|FG001|Overall Study|Withdrawal by Subject|8|||
105723263|NCT02305563|364641002|FG000|Treatment Period|Disease progression|0|||
105723264|NCT02305563|364641003|FG001|Treatment Period|Disease progression|0|||
105723265|NCT02305563|364641004|FG002|Treatment Period|Disease progression|15|||
105723266|NCT02305563|364641005|FG003|Treatment Period|Disease progression|6|||
105723267|NCT02305563|364641006|FG004|Treatment Period|Disease progression|6|||
105723268|NCT02305563|364641002|FG000|Treatment Period|Study drug toxicity|0|||
105723269|NCT02305563|364641003|FG001|Treatment Period|Study drug toxicity|0|||
105723270|NCT02305563|364641004|FG002|Treatment Period|Study drug toxicity|0|||
105723271|NCT02305563|364641005|FG003|Treatment Period|Study drug toxicity|1|||
105723272|NCT02305563|364641006|FG004|Treatment Period|Study drug toxicity|2|||
105723273|NCT02305563|364641002|FG000|Treatment Period|Death|0|||
105723274|NCT02305563|364641003|FG001|Treatment Period|Death|0|||
105723275|NCT02305563|364641004|FG002|Treatment Period|Death|1|||
105723276|NCT02305563|364641005|FG003|Treatment Period|Death|2|||
105723277|NCT02305563|364641006|FG004|Treatment Period|Death|1|||
105723278|NCT02305563|364641002|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
105723279|NCT02305563|364641003|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
105723280|NCT02305563|364641004|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
105723281|NCT02305563|364641005|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
105723282|NCT02305563|364641006|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
105723283|NCT02305563|364641002|FG000|Treatment Period|Participant request to stop therapy|0|||
105723284|NCT02305563|364641003|FG001|Treatment Period|Participant request to stop therapy|2|||
105723285|NCT02305563|364641004|FG002|Treatment Period|Participant request to stop therapy|0|||
105723286|NCT02305563|364641005|FG003|Treatment Period|Participant request to stop therapy|1|||
105723287|NCT02305563|364641006|FG004|Treatment Period|Participant request to stop therapy|0|||
105723288|NCT02305563|364641002|FG000|Treatment Period|Participant withdrew consent|0|||
105723289|NCT02305563|364641003|FG001|Treatment Period|Participant withdrew consent|0|||
105723290|NCT02305563|364641004|FG002|Treatment Period|Participant withdrew consent|1|||
105723291|NCT02305563|364641005|FG003|Treatment Period|Participant withdrew consent|1|||
105723292|NCT02305563|364641006|FG004|Treatment Period|Participant withdrew consent|1|||
105723293|NCT02305563|364641002|FG000|Treatment Period|Maximum clinical benefit|0|||
105723294|NCT02305563|364641003|FG001|Treatment Period|Maximum clinical benefit|0|||
105935959|NCT02991859|365425250|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
105723295|NCT02305563|364641004|FG002|Treatment Period|Maximum clinical benefit|0|||
105723296|NCT02305563|364641005|FG003|Treatment Period|Maximum clinical benefit|0|||
105723297|NCT02305563|364641006|FG004|Treatment Period|Maximum clinical benefit|1|||
105723298|NCT02305563|364641002|FG000|Treatment Period|Poor/non-compliance|0|||
105723299|NCT02305563|364641003|FG001|Treatment Period|Poor/non-compliance|0|||
105723300|NCT02305563|364641004|FG002|Treatment Period|Poor/non-compliance|0|||
105723301|NCT02305563|364641005|FG003|Treatment Period|Poor/non-compliance|0|||
105723302|NCT02305563|364641006|FG004|Treatment Period|Poor/non-compliance|1|||
105723303|NCT02305563|364641002|FG000|Treatment Period|Administrative reason by Sponsor|0|||
105723304|NCT02305563|364641003|FG001|Treatment Period|Administrative reason by Sponsor|0|||
105723305|NCT02305563|364641004|FG002|Treatment Period|Administrative reason by Sponsor|0|||
105723306|NCT02305563|364641005|FG003|Treatment Period|Administrative reason by Sponsor|0|||
105723307|NCT02305563|364641006|FG004|Treatment Period|Administrative reason by Sponsor|1|||
105723308|NCT02305563|364641002|FG000|Treatment Period|other reason|2|||
105723309|NCT02305563|364641003|FG001|Treatment Period|other reason|0|||
105723310|NCT02305563|364641004|FG002|Treatment Period|other reason|2|||
105723311|NCT02305563|364641005|FG003|Treatment Period|other reason|2|||
105723312|NCT02305563|364641006|FG004|Treatment Period|other reason|1|||
105723313|NCT02305563|364641002|FG000|Treatment Period|Randomized but not treated|0|||
105723314|NCT02305563|364641003|FG001|Treatment Period|Randomized but not treated|0|||
105723315|NCT02305563|364641004|FG002|Treatment Period|Randomized but not treated|0|||
105723316|NCT02305563|364641005|FG003|Treatment Period|Randomized but not treated|0|||
105723317|NCT02305563|364641006|FG004|Treatment Period|Randomized but not treated|2|||
105723318|NCT02305563|364641002|FG000|Treatment Period|added ULO, then disease progression|0|||
105723319|NCT02305563|364641003|FG001|Treatment Period|added ULO, then disease progression|0|||
105723320|NCT02305563|364641004|FG002|Treatment Period|added ULO, then disease progression|0|||
105723321|NCT02305563|364641005|FG003|Treatment Period|added ULO, then disease progression|0|||
105723322|NCT02305563|364641006|FG004|Treatment Period|added ULO, then disease progression|4|||
105723323|NCT02305563|364641002|FG000|Treatment Period|added ULO; then other reason|0|||
105723324|NCT02305563|364641003|FG001|Treatment Period|added ULO; then other reason|0|||
105723325|NCT02305563|364641004|FG002|Treatment Period|added ULO; then other reason|0|||
105723326|NCT02305563|364641005|FG003|Treatment Period|added ULO; then other reason|0|||
105723327|NCT02305563|364641006|FG004|Treatment Period|added ULO; then other reason|1|||
105723328|NCT02305563|364641002|FG000|Treatment Period|added ULO, then request to stop|0|||
105723329|NCT02305563|364641003|FG001|Treatment Period|added ULO, then request to stop|0|||
105723330|NCT02305563|364641004|FG002|Treatment Period|added ULO, then request to stop|0|||
105723331|NCT02305563|364641005|FG003|Treatment Period|added ULO, then request to stop|0|||
105723332|NCT02305563|364641006|FG004|Treatment Period|added ULO, then request to stop|1|||
105723333|NCT02305563|364641002|FG000|Follow-up Period|Death|0|||
105723334|NCT02305563|364641003|FG001|Follow-up Period|Death|0|||
105723335|NCT02305563|364641004|FG002|Follow-up Period|Death|5|||
105723336|NCT02305563|364641005|FG003|Follow-up Period|Death|4|||
105723337|NCT02305563|364641006|FG004|Follow-up Period|Death|7|||
105723338|NCT02305563|364641002|FG000|Follow-up Period|Participant withdrew consent|0|||
105723339|NCT02305563|364641003|FG001|Follow-up Period|Participant withdrew consent|0|||
105723340|NCT02305563|364641004|FG002|Follow-up Period|Participant withdrew consent|2|||
105723341|NCT02305563|364641005|FG003|Follow-up Period|Participant withdrew consent|1|||
105723342|NCT02305563|364641006|FG004|Follow-up Period|Participant withdrew consent|0|||
105723343|NCT02305563|364641002|FG000|Follow-up Period|other reason|0|||
105723344|NCT02305563|364641003|FG001|Follow-up Period|other reason|0|||
105723345|NCT02305563|364641004|FG002|Follow-up Period|other reason|0|||
105723346|NCT02305563|364641005|FG003|Follow-up Period|other reason|0|||
105723347|NCT02305563|364641006|FG004|Follow-up Period|other reason|1|||
105723348|NCT02305563|364641002|FG000|Follow-up Period|Followup no longer required per protocol|3|||
105723349|NCT02305563|364641003|FG001|Follow-up Period|Followup no longer required per protocol|3|||
105723350|NCT02305563|364641004|FG002|Follow-up Period|Followup no longer required per protocol|4|||
105723351|NCT02305563|364641005|FG003|Follow-up Period|Followup no longer required per protocol|1|||
105723352|NCT02305563|364641006|FG004|Follow-up Period|Followup no longer required per protocol|4|||
105723353|NCT00642642|364641007|FG000|Treatment & Follow Up|Adverse Event|2|||
105723354|NCT00642642|364641007|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
105723355|NCT00642642|364641007|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
105723356|NCT02959814|364641008|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
105935960|NCT02991859|365425251|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105723357|NCT02959814|364641008|FG000|Overall Study|Excluded based on anatomical criteria|2|||
105723358|NCT02959814|364641008|FG000|Overall Study|Protocol Violation|7|||
105723359|NCT02959814|364641008|FG000|Overall Study|FFR not measured|2|||
105723360|NCT02959814|364641008|FG000|Overall Study|In-procedure QFR not computed|6|||
105723361|NCT02959814|364641008|FG000|Overall Study|Excluded by FFR core-lab|24|||
105723362|NCT01889602|364641011|FG000|First Intervention|Adverse Event|1|||
105723363|NCT01889602|364641012|FG001|First Intervention|Adverse Event|1|||
105723364|NCT01889602|364641013|FG002|First Intervention|Adverse Event|1|||
105723365|NCT01889602|364641011|FG000|First Intervention|Protocol Violation|0|||
105723366|NCT01889602|364641012|FG001|First Intervention|Protocol Violation|1|||
105723367|NCT01889602|364641013|FG002|First Intervention|Protocol Violation|1|||
105723368|NCT01889602|364641011|FG000|First Intervention|Study ending|0|||
105723369|NCT01889602|364641012|FG001|First Intervention|Study ending|1|||
105723370|NCT01889602|364641013|FG002|First Intervention|Study ending|0|||
105723371|NCT01889602|364641011|FG000|Second Intervention|Adverse Event|0|||
105723372|NCT01889602|364641012|FG001|Second Intervention|Adverse Event|0|||
105723373|NCT01889602|364641013|FG002|Second Intervention|Adverse Event|1|||
105723374|NCT01889602|364641011|FG000|Second Intervention|Study ending|1|||
105723375|NCT01889602|364641012|FG001|Second Intervention|Study ending|0|||
105723376|NCT01889602|364641013|FG002|Second Intervention|Study ending|0|||
105723377|NCT01889602|364641011|FG000|Second Intervention|Withdrawal by Subject|0|||
105723378|NCT01889602|364641012|FG001|Second Intervention|Withdrawal by Subject|0|||
105723379|NCT01889602|364641013|FG002|Second Intervention|Withdrawal by Subject|1|||
105723380|NCT01889602|364641011|FG000|Third Intervention|Protocol Violation|1|||
105723381|NCT01889602|364641012|FG001|Third Intervention|Protocol Violation|0|||
105723382|NCT01889602|364641013|FG002|Third Intervention|Protocol Violation|0|||
105723383|NCT01889602|364641011|FG000|Third Intervention|Withdrawal by Subject|2|||
105723384|NCT01889602|364641012|FG001|Third Intervention|Withdrawal by Subject|2|||
105723385|NCT01889602|364641013|FG002|Third Intervention|Withdrawal by Subject|0|||
105723386|NCT00961961|364641014|FG000|Phase I|Withdrawal by Subject|7|||
105723387|NCT00961961|364641015|FG001|Phase I|Withdrawal by Subject|0|||
105723388|NCT00961961|364641016|FG002|Phase I|Withdrawal by Subject|0|||
105723389|NCT00961961|364641017|FG003|Phase I|Withdrawal by Subject|0|||
105723390|NCT00961961|364641014|FG000|Phase I|Lost to Follow-up|10|||
105723391|NCT00961961|364641015|FG001|Phase I|Lost to Follow-up|0|||
105723392|NCT00961961|364641016|FG002|Phase I|Lost to Follow-up|0|||
105723393|NCT00961961|364641017|FG003|Phase I|Lost to Follow-up|0|||
105723394|NCT00961961|364641014|FG000|Phase I|Lack of Efficacy|94|||
105723395|NCT00961961|364641015|FG001|Phase I|Lack of Efficacy|0|||
105723396|NCT00961961|364641016|FG002|Phase I|Lack of Efficacy|0|||
105723397|NCT00961961|364641017|FG003|Phase I|Lack of Efficacy|0|||
105723398|NCT00961961|364641014|FG000|Phase I|Adverse Event|7|||
105723399|NCT00961961|364641015|FG001|Phase I|Adverse Event|0|||
105723400|NCT00961961|364641016|FG002|Phase I|Adverse Event|0|||
105723401|NCT00961961|364641017|FG003|Phase I|Adverse Event|0|||
105723402|NCT00961961|364641014|FG000|Phase I|Physician Decision|8|||
105723403|NCT00961961|364641015|FG001|Phase I|Physician Decision|0|||
105723404|NCT00961961|364641016|FG002|Phase I|Physician Decision|0|||
105723405|NCT00961961|364641017|FG003|Phase I|Physician Decision|0|||
105723406|NCT00961961|364641014|FG000|Phase II|Lost to Follow-up|0|||
105723407|NCT00961961|364641015|FG001|Phase II|Lost to Follow-up|0|||
105723408|NCT00961961|364641016|FG002|Phase II|Lost to Follow-up|10|||
105723409|NCT00961961|364641017|FG003|Phase II|Lost to Follow-up|7|||
105723410|NCT00961961|364641014|FG000|Phase II|Adverse Event|0|||
105723411|NCT00961961|364641015|FG001|Phase II|Adverse Event|0|||
105723412|NCT00961961|364641016|FG002|Phase II|Adverse Event|0|||
105723413|NCT00961961|364641017|FG003|Phase II|Adverse Event|1|||
105723414|NCT00961961|364641014|FG000|Phase II|Physician Decision|0|||
105723415|NCT00961961|364641015|FG001|Phase II|Physician Decision|0|||
105723416|NCT00961961|364641016|FG002|Phase II|Physician Decision|1|||
105723417|NCT00961961|364641017|FG003|Phase II|Physician Decision|0|||
105723418|NCT00961961|364641014|FG000|Phase II|Withdrawal by Subject|0|||
105723419|NCT00961961|364641015|FG001|Phase II|Withdrawal by Subject|0|||
105723420|NCT00961961|364641016|FG002|Phase II|Withdrawal by Subject|1|||
105723421|NCT00961961|364641017|FG003|Phase II|Withdrawal by Subject|0|||
105723422|NCT01511445|364641018|FG000|Overall Study|Lost to Follow-up|3|||
105723423|NCT01511445|364641019|FG001|Overall Study|Lost to Follow-up|1|||
105723424|NCT01511445|364641018|FG000|Overall Study|Protocol Violation|1|||
105723425|NCT01511445|364641019|FG001|Overall Study|Protocol Violation|3|||
105723426|NCT01511445|364641018|FG000|Overall Study|Protocol Violation|1|||
105723427|NCT01511445|364641019|FG001|Overall Study|Protocol Violation|0|||
105723428|NCT01245673|364641022|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
105723429|NCT04752384|364641023|FG000|Overall Study|Withdrawal by Subject|1|||
105723430|NCT04752384|364641023|FG000|Overall Study|Death|1|||
105723431|NCT01468311|364641024|FG000|Overall Study|mobilization failure|1|||
105723432|NCT01468311|364641024|FG000|Overall Study|Withdrawal by Subject|1|||
105723433|NCT00924703|364641025|FG000|Overall Study|Withdrawal by Subject|11|||
105723434|NCT00924703|364641025|FG000|Overall Study|Physician Decision|5|||
105723435|NCT00924703|364641025|FG000|Overall Study|Lost to Follow-up|3|||
105723436|NCT00924703|364641025|FG000|Overall Study|Adverse Event|2|||
105723437|NCT00924703|364641025|FG000|Overall Study|Withdrawal by Sponsor|1|||
105723438|NCT00666562|364641026|FG000|Overall Study|Withdrawal by Subject|0|||
105723439|NCT00666562|364641027|FG001|Overall Study|Withdrawal by Subject|1|||
105723440|NCT00666562|364641028|FG002|Overall Study|Withdrawal by Subject|0|||
105723441|NCT00666562|364641026|FG000|Overall Study|Concomitant Medication|0|||
105723442|NCT00666562|364641027|FG001|Overall Study|Concomitant Medication|1|||
105723443|NCT00666562|364641028|FG002|Overall Study|Concomitant Medication|0|||
105723444|NCT04906707|364641029|FG000|Overall Study|Withdrawal by Subject|2|||
105723445|NCT04906707|364641030|FG001|Overall Study|Withdrawal by Subject|0|||
105723446|NCT04906707|364641029|FG000|Overall Study|Withdrawal due to PI decision|1|||
105723447|NCT04906707|364641030|FG001|Overall Study|Withdrawal due to PI decision|0|||
105723448|NCT04906707|364641029|FG000|Overall Study|Lost to Follow-up|0|||
105723449|NCT04906707|364641030|FG001|Overall Study|Lost to Follow-up|1|||
105723450|NCT00891202|364641032|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
105723451|NCT00891202|364641033|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
105792826|NCT02180659|364896453|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
105792827|NCT00824993|364896454|FG000|Overall Study|Withdrawal by Subject|1|||
105792828|NCT00824993|364896455|FG001|Overall Study|Withdrawal by Subject|1|||
105792829|NCT00824993|364896454|FG000|Overall Study|Malignancy Relapse|9|||
105792830|NCT00824993|364896455|FG001|Overall Study|Malignancy Relapse|10|||
105792831|NCT00824993|364896454|FG000|Overall Study|Rapid Bone Loss|0|||
105792832|NCT00824993|364896455|FG001|Overall Study|Rapid Bone Loss|1|||
105792833|NCT00824993|364896454|FG000|Overall Study|Non-Compliant|2|||
105792834|NCT00824993|364896455|FG001|Overall Study|Non-Compliant|1|||
105792835|NCT00824993|364896454|FG000|Overall Study|Insurance Issue|2|||
105792836|NCT00824993|364896455|FG001|Overall Study|Insurance Issue|1|||
105792837|NCT00824993|364896454|FG000|Overall Study|Death|0|||
105792838|NCT00824993|364896455|FG001|Overall Study|Death|3|||
105792839|NCT01495793|364896456|FG000|Overall Study|Lost to Follow-up|1|||
105792840|NCT01495793|364896456|FG000|Overall Study|Violation of inclusion criteria|1|||
105792841|NCT00834366|364896457|FG000|Treatment Period 1|Adverse Event|1|||
105792842|NCT00834366|364896458|FG001|Treatment Period 1|Adverse Event|1|||
105792843|NCT01275170|364896464|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
105792844|NCT01275170|364896465|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792845|NCT01275170|364896466|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792846|NCT01275170|364896467|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792847|NCT01275170|364896468|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792848|NCT01275170|364896469|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792849|NCT01275170|364896470|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792850|NCT01275170|364896471|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
105792851|NCT03940742|364896472|FG000|Overall Study|Lost to Follow-up|0|||
105792852|NCT03940742|364896473|FG001|Overall Study|Lost to Follow-up|0|||
105792853|NCT03940742|364896474|FG002|Overall Study|Lost to Follow-up|0|||
105792854|NCT03940742|364896475|FG003|Overall Study|Lost to Follow-up|1|||
105792855|NCT03252015|364896479|FG000|Overall Study|Withdrawal by Subject|0|||
105792856|NCT03252015|364896480|FG001|Overall Study|Withdrawal by Subject|1|||
105792857|NCT03252015|364896481|FG002|Overall Study|Withdrawal by Subject|1|||
105792858|NCT03252015|364896482|FG003|Overall Study|Withdrawal by Subject|0|||
105792859|NCT03252015|364896479|FG000|Overall Study|Adverse Event|1|||
105792860|NCT03252015|364896480|FG001|Overall Study|Adverse Event|0|||
105792861|NCT03252015|364896481|FG002|Overall Study|Adverse Event|0|||
105792862|NCT03252015|364896482|FG003|Overall Study|Adverse Event|1|||
105792863|NCT00390572|364896483|FG000|Overall Study|Lost to Follow-up|8|||
105792864|NCT00390572|364896484|FG001|Overall Study|Lost to Follow-up|4|||
105792865|NCT00390572|364896483|FG000|Overall Study|health condition|0|||
105792866|NCT00390572|364896484|FG001|Overall Study|health condition|1|||
105792867|NCT03107715|364896485|FG000|Overall Study|did not deliver at the home hospital|4|||
105792868|NCT03107715|364896486|FG001|Overall Study|did not deliver at the home hospital|6|||
105792869|NCT03107715|364896485|FG000|Overall Study|infant stillborn|0|||
105792870|NCT03107715|364896486|FG001|Overall Study|infant stillborn|1|||
105792871|NCT02149199|364896494|FG000|Overall Study|Study specific withdrawal criteria|4|||
105723452|NCT00891202|364641034|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
105723453|NCT00891202|364641035|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
105792872|NCT02149199|364896495|FG001|Overall Study|Study specific withdrawal criteria|21|||
105792873|NCT02149199|364896496|FG002|Overall Study|Study specific withdrawal criteria|6|||
105792874|NCT02149199|364896494|FG000|Overall Study|Other|20|||
105792875|NCT02149199|364896495|FG001|Overall Study|Other|25|||
105792876|NCT02149199|364896496|FG002|Overall Study|Other|20|||
105792877|NCT02149199|364896494|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
105792878|NCT02149199|364896495|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
105723454|NCT00891202|364641032|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
105723455|NCT00891202|364641033|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
105723456|NCT00891202|364641034|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
105723457|NCT00891202|364641035|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
105723458|NCT00891202|364641032|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
105723459|NCT00891202|364641033|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
105723460|NCT00891202|364641034|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
105723461|NCT00891202|364641035|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
105723462|NCT00891202|364641032|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
105723463|NCT00891202|364641033|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
105723464|NCT00891202|364641034|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
105723465|NCT00891202|364641035|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
105723466|NCT00684177|364641036|FG000|Overall Study|Adverse Event|4|||
105723467|NCT00684177|364641037|FG001|Overall Study|Adverse Event|3|||
105723468|NCT00684177|364641036|FG000|Overall Study|Lack of Efficacy|10|||
105723469|NCT00684177|364641037|FG001|Overall Study|Lack of Efficacy|15|||
105723470|NCT00684177|364641036|FG000|Overall Study|Protocol Violation|1|||
105723471|NCT00684177|364641037|FG001|Overall Study|Protocol Violation|0|||
105723472|NCT00684177|364641036|FG000|Overall Study|Lost to Follow-up|2|||
105723473|NCT00684177|364641037|FG001|Overall Study|Lost to Follow-up|1|||
105723474|NCT00684177|364641036|FG000|Overall Study|Physician Decision|2|||
105723475|NCT00684177|364641037|FG001|Overall Study|Physician Decision|0|||
105723476|NCT00684177|364641036|FG000|Overall Study|Withdrawal by Subject|1|||
105723477|NCT00684177|364641037|FG001|Overall Study|Withdrawal by Subject|2|||
105723478|NCT00684177|364641036|FG000|Overall Study|Other|1|||
105723479|NCT00684177|364641037|FG001|Overall Study|Other|2|||
105723480|NCT04211337|364641038|FG000|Overall Study|On Treatment|175|||
105723481|NCT04211337|364641039|FG001|Overall Study|On Treatment|40|||
105723482|NCT04211337|364641038|FG000|Overall Study|Withdrawal by Subject|0|||
105723483|NCT04211337|364641039|FG001|Overall Study|Withdrawal by Subject|2|||
105723484|NCT04980391|364641050|FG000|Overall Study|Death|0|||
105723485|NCT04980391|364641051|FG001|Overall Study|Death|0|||
105723486|NCT04980391|364641052|FG002|Overall Study|Death|1|||
105723487|NCT04980391|364641053|FG003|Overall Study|Death|1|||
105723488|NCT04980391|364641050|FG000|Overall Study|Lost to Follow-up|3|||
105723489|NCT04980391|364641051|FG001|Overall Study|Lost to Follow-up|3|||
105723490|NCT04980391|364641052|FG002|Overall Study|Lost to Follow-up|2|||
105723491|NCT04980391|364641053|FG003|Overall Study|Lost to Follow-up|3|||
105723492|NCT04980391|364641050|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
105723493|NCT04980391|364641051|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
105723494|NCT04980391|364641052|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
105723495|NCT04980391|364641053|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
105723496|NCT04980391|364641050|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105723497|NCT04980391|364641051|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105723498|NCT04980391|364641052|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105723499|NCT04980391|364641053|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105723500|NCT04980391|364641050|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
105723501|NCT04980391|364641051|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
105723502|NCT04980391|364641052|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
105723503|NCT04980391|364641053|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
105723504|NCT04025632|364642569|FG000|Overall Study|Adverse Event|1|||
105723505|NCT04025632|364642570|FG001|Overall Study|Adverse Event|1|||
105723506|NCT04025632|364642569|FG000|Overall Study|Withdrawal by Subject|1|||
105723507|NCT04025632|364642570|FG001|Overall Study|Withdrawal by Subject|1|||
105723508|NCT04025632|364642569|FG000|Overall Study|Study Terminated by Sponsor|10|||
105723509|NCT04025632|364642570|FG001|Overall Study|Study Terminated by Sponsor|9|||
105723510|NCT04025632|364642569|FG000|Overall Study|Physician Decision|3|||
105723511|NCT04025632|364642570|FG001|Overall Study|Physician Decision|1|||
105723512|NCT00376961|364642571|FG000|Initial Registration|Adverse Event|1|||
105723513|NCT00376961|364642572|FG001|Initial Registration|Adverse Event|0|||
105723514|NCT00376961|364642571|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
105723515|NCT00376961|364642572|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105723516|NCT00376961|364642571|FG000|Initial Registration|Progression/relapse|1|||
105723517|NCT00376961|364642572|FG001|Initial Registration|Progression/relapse|0|||
105723518|NCT00376961|364642571|FG000|Initial Registration|Ineligible|3|||
105723519|NCT00376961|364642572|FG001|Initial Registration|Ineligible|0|||
105723520|NCT00376961|364642571|FG000|Maintenance|Adverse Event|0|||
105723521|NCT00376961|364642572|FG001|Maintenance|Adverse Event|1|||
106009174|NCT05050318|365700784|FG000|Overall Study|Protocol Deviation|1|||
105723522|NCT00376961|364642571|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
105723523|NCT00376961|364642572|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
105723524|NCT00376961|364642571|FG000|Maintenance|Progression/relapse|0|||
105723525|NCT00376961|364642572|FG001|Maintenance|Progression/relapse|18|||
105723526|NCT00376961|364642571|FG000|Maintenance|Ineligible|0|||
105723527|NCT00376961|364642572|FG001|Maintenance|Ineligible|3|||
105723528|NCT02185521|364642582|FG000|Overall Study|Withdrawal by Subject|1|||
105723529|NCT02185521|364642582|FG000|Overall Study|Protocol Violation|1|||
105723530|NCT00496366|364642585|FG000|Overall Study|Death|1|||
105723531|NCT05211336|364642591|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
105723532|NCT05211336|364642592|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
105723533|NCT05211336|364642591|FG000|Overall Study|Progressive disease|0|||
105723534|NCT05211336|364642592|FG001|Overall Study|Progressive disease|4|||
105723535|NCT05211336|364642591|FG000|Overall Study|Death due to myocardial infarction|0|||
105723536|NCT05211336|364642592|FG001|Overall Study|Death due to myocardial infarction|1|||
105723537|NCT05211336|364642591|FG000|Overall Study|Death due to unknown cause|0|||
105723538|NCT05211336|364642592|FG001|Overall Study|Death due to unknown cause|1|||
105723539|NCT05211336|364642591|FG000|Overall Study|Worsening kidney function and quality of response|0|||
105723540|NCT05211336|364642592|FG001|Overall Study|Worsening kidney function and quality of response|1|||
105723541|NCT03902080|364642596|FG000|Overall Study|Adverse Event|17|||
105723542|NCT03902080|364642597|FG001|Overall Study|Adverse Event|15|||
105723543|NCT03902080|364642596|FG000|Overall Study|Withdrawal by Subject|28|||
105723544|NCT03902080|364642597|FG001|Overall Study|Withdrawal by Subject|35|||
105723545|NCT03902080|364642596|FG000|Overall Study|Lost to Follow-up|6|||
105723546|NCT03902080|364642597|FG001|Overall Study|Lost to Follow-up|7|||
105723547|NCT03902080|364642596|FG000|Overall Study|Other|3|||
105723548|NCT03902080|364642597|FG001|Overall Study|Other|5|||
105723549|NCT03902080|364642596|FG000|Overall Study|Non compliance|4|||
105723550|NCT03902080|364642597|FG001|Overall Study|Non compliance|3|||
105723551|NCT03902080|364642596|FG000|Overall Study|Physician Decision|5|||
105723552|NCT03902080|364642597|FG001|Overall Study|Physician Decision|1|||
105723553|NCT03902080|364642596|FG000|Overall Study|Protocol Violation|3|||
105723554|NCT03902080|364642597|FG001|Overall Study|Protocol Violation|3|||
105723555|NCT03902080|364642596|FG000|Overall Study|Lack of Efficacy|1|||
105723556|NCT03902080|364642597|FG001|Overall Study|Lack of Efficacy|3|||
105723557|NCT03902080|364642596|FG000|Overall Study|Withdrawn prior to dosing|0|||
105723558|NCT03902080|364642597|FG001|Overall Study|Withdrawn prior to dosing|1|||
105723559|NCT00332709|364642598|FG000|Overall Study|Adverse Event|11|||
105723560|NCT00332709|364642599|FG001|Overall Study|Adverse Event|14|||
105723561|NCT00332709|364642598|FG000|Overall Study|Withdrawal by Subject|2|||
105723562|NCT00332709|364642599|FG001|Overall Study|Withdrawal by Subject|3|||
105723563|NCT00332709|364642598|FG000|Overall Study|Lost to Follow-up|2|||
105723564|NCT00332709|364642599|FG001|Overall Study|Lost to Follow-up|0|||
105723565|NCT00332709|364642598|FG000|Overall Study|Administrative Problems|0|||
105723566|NCT00332709|364642599|FG001|Overall Study|Administrative Problems|3|||
105723567|NCT00332709|364642598|FG000|Overall Study|Abnormal test procedure result|1|||
105723568|NCT00332709|364642599|FG001|Overall Study|Abnormal test procedure result|0|||
105723569|NCT01409928|364642601|FG000|Overall Study|Physician Decision|12|||
105723570|NCT01703000|364642602|FG000|Overall Study|Death|1|||
105723571|NCT00434967|364642605|FG000|Overall Study|Adverse Event|2|||
105723572|NCT00434967|364642606|FG001|Overall Study|Adverse Event|4|||
105723573|NCT00434967|364642607|FG002|Overall Study|Adverse Event|3|||
105723574|NCT00434967|364642608|FG003|Overall Study|Adverse Event|3|||
105723575|NCT00434967|364642605|FG000|Overall Study|Lost to Follow-up|0|||
105723576|NCT00434967|364642606|FG001|Overall Study|Lost to Follow-up|0|||
105723577|NCT00434967|364642607|FG002|Overall Study|Lost to Follow-up|1|||
105723578|NCT00434967|364642608|FG003|Overall Study|Lost to Follow-up|0|||
105723579|NCT00434967|364642605|FG000|Overall Study|Withdrawal by Subject|2|||
105723580|NCT00434967|364642606|FG001|Overall Study|Withdrawal by Subject|2|||
105723581|NCT00434967|364642607|FG002|Overall Study|Withdrawal by Subject|4|||
105723582|NCT00434967|364642608|FG003|Overall Study|Withdrawal by Subject|6|||
105723583|NCT00434967|364642605|FG000|Overall Study|Randomized in error|0|||
105723584|NCT00434967|364642606|FG001|Overall Study|Randomized in error|0|||
105723585|NCT00434967|364642607|FG002|Overall Study|Randomized in error|0|||
105723586|NCT00434967|364642608|FG003|Overall Study|Randomized in error|1|||
105723587|NCT00434967|364642605|FG000|Overall Study|Protocol Violation|0|||
105723588|NCT00434967|364642606|FG001|Overall Study|Protocol Violation|1|||
105723589|NCT00434967|364642607|FG002|Overall Study|Protocol Violation|0|||
105723590|NCT00434967|364642608|FG003|Overall Study|Protocol Violation|1|||
105723591|NCT00434967|364642605|FG000|Overall Study|Physician Decision|1|||
105723592|NCT00434967|364642606|FG001|Overall Study|Physician Decision|1|||
105723593|NCT00434967|364642607|FG002|Overall Study|Physician Decision|1|||
105723594|NCT00434967|364642608|FG003|Overall Study|Physician Decision|0|||
105723595|NCT00434967|364642605|FG000|Overall Study|Patient Disposition Challenges|2|||
105723596|NCT00434967|364642606|FG001|Overall Study|Patient Disposition Challenges|0|||
105723597|NCT00434967|364642607|FG002|Overall Study|Patient Disposition Challenges|0|||
105723598|NCT00434967|364642608|FG003|Overall Study|Patient Disposition Challenges|3|||
105723599|NCT00432237|364642609|FG000|Overall Study|Adverse Event|0|||
105723600|NCT00432237|364642610|FG001|Overall Study|Adverse Event|0|||
105723601|NCT00432237|364642611|FG002|Overall Study|Adverse Event|0|||
105723602|NCT00432237|364642612|FG003|Overall Study|Adverse Event|1|||
105723603|NCT00432237|364642609|FG000|Overall Study|Lack of Efficacy|0|||
105723604|NCT00432237|364642610|FG001|Overall Study|Lack of Efficacy|0|||
105723605|NCT00432237|364642611|FG002|Overall Study|Lack of Efficacy|0|||
105723606|NCT00432237|364642612|FG003|Overall Study|Lack of Efficacy|1|||
105723607|NCT00432237|364642609|FG000|Overall Study|Lost to Follow-up|10|||
105723608|NCT00432237|364642610|FG001|Overall Study|Lost to Follow-up|10|||
105723609|NCT00432237|364642611|FG002|Overall Study|Lost to Follow-up|18|||
105723610|NCT00432237|364642612|FG003|Overall Study|Lost to Follow-up|18|||
105792879|NCT02149199|364896496|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
105792880|NCT02149199|364896494|FG000|Overall Study|Withdrawal by Subject|75|||
105792881|NCT02149199|364896495|FG001|Overall Study|Withdrawal by Subject|93|||
105792882|NCT02149199|364896496|FG002|Overall Study|Withdrawal by Subject|77|||
105792883|NCT02149199|364896494|FG000|Overall Study|Protocol Violation|16|||
105792884|NCT02149199|364896495|FG001|Overall Study|Protocol Violation|13|||
105792885|NCT02149199|364896496|FG002|Overall Study|Protocol Violation|15|||
105792886|NCT02149199|364896494|FG000|Overall Study|Lost to Follow-up|3|||
105792887|NCT02149199|364896495|FG001|Overall Study|Lost to Follow-up|12|||
105792888|NCT02149199|364896496|FG002|Overall Study|Lost to Follow-up|11|||
105792889|NCT02149199|364896494|FG000|Overall Study|Death|0|||
105792890|NCT02149199|364896495|FG001|Overall Study|Death|0|||
105792891|NCT02149199|364896496|FG002|Overall Study|Death|1|||
105792892|NCT02149199|364896494|FG000|Overall Study|Adverse Event|6|||
105792893|NCT02149199|364896495|FG001|Overall Study|Adverse Event|15|||
105792894|NCT02149199|364896496|FG002|Overall Study|Adverse Event|9|||
105792895|NCT01907516|364896498|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
105792896|NCT01907516|364896499|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
105792897|NCT01907516|364896498|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
105792898|NCT01907516|364896499|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
105792899|NCT01907516|364896498|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
105792900|NCT01907516|364896499|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
105792901|NCT01907516|364896498|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
105792902|NCT01907516|364896499|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
105792903|NCT02392377|364896506|FG000|Overall Study|Withdrawal by Subject|0|||
105792904|NCT02392377|364896507|FG001|Overall Study|Withdrawal by Subject|1|||
105792905|NCT00242567|364898659|FG000|Overall Study|Adverse Event|70|||
105792906|NCT00242567|364898660|FG001|Overall Study|Adverse Event|43|||
105792907|NCT00242567|364898659|FG000|Overall Study|Disease Progression|17|||
105792908|NCT00242567|364898660|FG001|Overall Study|Disease Progression|22|||
105792909|NCT00242567|364898659|FG000|Overall Study|Symptomatic deterioration|9|||
105792910|NCT00242567|364898660|FG001|Overall Study|Symptomatic deterioration|3|||
105792911|NCT00242567|364898659|FG000|Overall Study|Lack of Efficacy|2|||
105792912|NCT00242567|364898660|FG001|Overall Study|Lack of Efficacy|2|||
105792913|NCT00242567|364898659|FG000|Overall Study|Lost to Follow-up|9|||
105792914|NCT00242567|364898660|FG001|Overall Study|Lost to Follow-up|19|||
105792915|NCT00242567|364898659|FG000|Overall Study|Withdrawal by Subject|33|||
105792916|NCT00242567|364898660|FG001|Overall Study|Withdrawal by Subject|28|||
105792917|NCT00242567|364898659|FG000|Overall Study|Protocol Violation|12|||
105792918|NCT00242567|364898660|FG001|Overall Study|Protocol Violation|12|||
105792919|NCT00242567|364898659|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
105792920|NCT00242567|364898660|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
105792921|NCT00242567|364898659|FG000|Overall Study|Other|14|||
105792922|NCT00242567|364898660|FG001|Overall Study|Other|9|||
105792923|NCT01186744|364898661|FG000|Overall Study|Lack of Efficacy|156|||
105792924|NCT01186744|364898662|FG001|Overall Study|Lack of Efficacy|99|||
105792925|NCT01186744|364898663|FG002|Overall Study|Lack of Efficacy|0|||
105792926|NCT01186744|364898664|FG003|Overall Study|Lack of Efficacy|2|||
105792927|NCT01186744|364898665|FG004|Overall Study|Lack of Efficacy|2|||
105792928|NCT01186744|364898666|FG005|Overall Study|Lack of Efficacy|5|||
105792929|NCT01186744|364898661|FG000|Overall Study|Protocol Violation|1|||
105792930|NCT01186744|364898662|FG001|Overall Study|Protocol Violation|2|||
105792931|NCT01186744|364898663|FG002|Overall Study|Protocol Violation|0|||
105792932|NCT01186744|364898664|FG003|Overall Study|Protocol Violation|1|||
105792933|NCT01186744|364898665|FG004|Overall Study|Protocol Violation|1|||
105792934|NCT01186744|364898666|FG005|Overall Study|Protocol Violation|2|||
105792935|NCT01186744|364898661|FG000|Overall Study|Lost to Follow-up|15|||
105792936|NCT01186744|364898662|FG001|Overall Study|Lost to Follow-up|16|||
105792937|NCT01186744|364898663|FG002|Overall Study|Lost to Follow-up|2|||
105792938|NCT01186744|364898664|FG003|Overall Study|Lost to Follow-up|1|||
105792939|NCT01186744|364898665|FG004|Overall Study|Lost to Follow-up|1|||
105792940|NCT01186744|364898666|FG005|Overall Study|Lost to Follow-up|4|||
105792941|NCT01186744|364898661|FG000|Overall Study|Screen failure|1|||
105792942|NCT01186744|364898662|FG001|Overall Study|Screen failure|1|||
105792943|NCT01186744|364898663|FG002|Overall Study|Screen failure|0|||
105792944|NCT01186744|364898664|FG003|Overall Study|Screen failure|1|||
105792945|NCT01186744|364898665|FG004|Overall Study|Screen failure|0|||
105792946|NCT01186744|364898666|FG005|Overall Study|Screen failure|0|||
105792947|NCT01186744|364898661|FG000|Overall Study|Withdrawal by Subject|14|||
105792948|NCT01186744|364898662|FG001|Overall Study|Withdrawal by Subject|10|||
105792949|NCT01186744|364898663|FG002|Overall Study|Withdrawal by Subject|2|||
105792950|NCT01186744|364898664|FG003|Overall Study|Withdrawal by Subject|5|||
105792951|NCT01186744|364898665|FG004|Overall Study|Withdrawal by Subject|0|||
105792952|NCT01186744|364898666|FG005|Overall Study|Withdrawal by Subject|6|||
105792953|NCT01186744|364898661|FG000|Overall Study|Study terminated by Sponsor|1|||
105792954|NCT01186744|364898662|FG001|Overall Study|Study terminated by Sponsor|0|||
105792955|NCT01186744|364898663|FG002|Overall Study|Study terminated by Sponsor|0|||
105723611|NCT00432237|364642609|FG000|Overall Study|Physician Decision|1|||
105723612|NCT00432237|364642610|FG001|Overall Study|Physician Decision|3|||
105723613|NCT00432237|364642611|FG002|Overall Study|Physician Decision|2|||
105723614|NCT00432237|364642612|FG003|Overall Study|Physician Decision|1|||
105723615|NCT00432237|364642609|FG000|Overall Study|Pregnancy|0|||
105723616|NCT00432237|364642610|FG001|Overall Study|Pregnancy|1|||
105723617|NCT00432237|364642611|FG002|Overall Study|Pregnancy|0|||
105723618|NCT00432237|364642612|FG003|Overall Study|Pregnancy|0|||
105723619|NCT00432237|364642609|FG000|Overall Study|Protocol Violation|13|||
105723620|NCT00432237|364642610|FG001|Overall Study|Protocol Violation|10|||
105723621|NCT00432237|364642611|FG002|Overall Study|Protocol Violation|11|||
105723622|NCT00432237|364642612|FG003|Overall Study|Protocol Violation|8|||
105723623|NCT00432237|364642609|FG000|Overall Study|Withdrawal by Subject|5|||
105723624|NCT00432237|364642610|FG001|Overall Study|Withdrawal by Subject|6|||
105723625|NCT00432237|364642611|FG002|Overall Study|Withdrawal by Subject|9|||
105723626|NCT00432237|364642612|FG003|Overall Study|Withdrawal by Subject|11|||
105723627|NCT00432237|364642609|FG000|Overall Study|Lack of Qualifying Event|38|||
105723628|NCT00432237|364642610|FG001|Overall Study|Lack of Qualifying Event|71|||
105723629|NCT00432237|364642611|FG002|Overall Study|Lack of Qualifying Event|69|||
105723630|NCT00432237|364642612|FG003|Overall Study|Lack of Qualifying Event|84|||
105723631|NCT03293654|364642613|FG000|Overall Study|Lost to Follow-up|0|||
105723632|NCT03293654|364642614|FG001|Overall Study|Lost to Follow-up|1|||
105723633|NCT03293654|364642615|FG002|Overall Study|Lost to Follow-up|0|||
105723634|NCT04284787|364642616|FG000|Overall Study|Disease Progression|9|||
105723635|NCT04284787|364642617|FG001|Overall Study|Disease Progression|12|||
105723636|NCT04284787|364642616|FG000|Overall Study|Physician Decision|12|||
105723637|NCT04284787|364642617|FG001|Overall Study|Physician Decision|7|||
105723638|NCT04284787|364642616|FG000|Overall Study|Transplant|5|||
105723639|NCT04284787|364642617|FG001|Overall Study|Transplant|4|||
105723640|NCT04284787|364642616|FG000|Overall Study|Death|1|||
105723641|NCT04284787|364642617|FG001|Overall Study|Death|2|||
105723642|NCT04284787|364642616|FG000|Overall Study|Adverse Event|0|||
105723643|NCT04284787|364642617|FG001|Overall Study|Adverse Event|4|||
105723644|NCT04284787|364642616|FG000|Overall Study|Non-adherence|2|||
105723645|NCT04284787|364642617|FG001|Overall Study|Non-adherence|0|||
105723646|NCT04284787|364642616|FG000|Overall Study|Lack of Efficacy|2|||
105723647|NCT04284787|364642617|FG001|Overall Study|Lack of Efficacy|0|||
105723648|NCT05254418|364642618|FG000|Overall Study|Adverse Event|2|||
105723649|NCT03155997|364642619|FG000|Overall Study|Withdrawal by Subject|119|||
105723650|NCT03155997|364642620|FG001|Overall Study|Withdrawal by Subject|134|||
105935961|NCT02991859|365425252|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935962|NCT02991859|365425253|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935963|NCT02991859|365425254|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935964|NCT02991859|365425255|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935965|NCT02991859|365425256|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105723651|NCT03155997|364642619|FG000|Overall Study|Lost to Follow-up|12|||
105723652|NCT03155997|364642620|FG001|Overall Study|Lost to Follow-up|13|||
105723653|NCT03155997|364642619|FG000|Overall Study|Missing disposition data|0|||
105723654|NCT03155997|364642620|FG001|Overall Study|Missing disposition data|1|||
105723655|NCT03155997|364642619|FG000|Overall Study|On study treatment|2027|||
105723656|NCT03155997|364642620|FG001|Overall Study|On study treatment|2074|||
105723657|NCT03093402|364642622|FG000|Overall Study|Lost to Follow-up|1|||
105723658|NCT03093402|364642623|FG001|Overall Study|Lost to Follow-up|0|||
105723659|NCT03093402|364642624|FG002|Overall Study|Lost to Follow-up|0|||
105723660|NCT03093402|364642625|FG003|Overall Study|Lost to Follow-up|0|||
105723661|NCT03093402|364642622|FG000|Overall Study|Withdrawal by Subject|3|||
105723662|NCT03093402|364642623|FG001|Overall Study|Withdrawal by Subject|3|||
105723663|NCT03093402|364642624|FG002|Overall Study|Withdrawal by Subject|0|||
105723664|NCT03093402|364642625|FG003|Overall Study|Withdrawal by Subject|1|||
105723665|NCT03093402|364642622|FG000|Overall Study|Withdrew prior to dosing|2|||
105723666|NCT03093402|364642623|FG001|Overall Study|Withdrew prior to dosing|1|||
105723667|NCT03093402|364642624|FG002|Overall Study|Withdrew prior to dosing|2|||
105723668|NCT03093402|364642625|FG003|Overall Study|Withdrew prior to dosing|3|||
105723669|NCT03093402|364642622|FG000|Overall Study|Ineligible for study|1|||
105723670|NCT03093402|364642623|FG001|Overall Study|Ineligible for study|0|||
105723671|NCT03093402|364642624|FG002|Overall Study|Ineligible for study|0|||
105723672|NCT03093402|364642625|FG003|Overall Study|Ineligible for study|0|||
105723673|NCT03093402|364642622|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
105723674|NCT03093402|364642623|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
105723675|NCT03093402|364642624|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
105723676|NCT03093402|364642625|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
105723677|NCT02886702|364642628|FG000|Overall Study|Other|4|||
105723678|NCT02886702|364642629|FG001|Overall Study|Other|3|||
105723679|NCT02886702|364642630|FG002|Overall Study|Other|9|||
105723680|NCT02886702|364642628|FG000|Overall Study|Withdrawal by Subject|24|||
105723681|NCT02886702|364642629|FG001|Overall Study|Withdrawal by Subject|18|||
105723682|NCT02886702|364642630|FG002|Overall Study|Withdrawal by Subject|22|||
105792956|NCT01186744|364898664|FG003|Overall Study|Study terminated by Sponsor|0|||
105792957|NCT01186744|364898665|FG004|Overall Study|Study terminated by Sponsor|0|||
105792958|NCT01186744|364898666|FG005|Overall Study|Study terminated by Sponsor|0|||
105792959|NCT01186744|364898661|FG000|Overall Study|Other|9|||
105792960|NCT01186744|364898662|FG001|Overall Study|Other|10|||
105792961|NCT01186744|364898663|FG002|Overall Study|Other|1|||
105792962|NCT01186744|364898664|FG003|Overall Study|Other|2|||
105792963|NCT01186744|364898665|FG004|Overall Study|Other|1|||
105792964|NCT01186744|364898666|FG005|Overall Study|Other|5|||
105792965|NCT01186744|364898661|FG000|Overall Study|Adverse Event|10|||
105792966|NCT01186744|364898662|FG001|Overall Study|Adverse Event|14|||
105792967|NCT01186744|364898663|FG002|Overall Study|Adverse Event|1|||
105792968|NCT01186744|364898664|FG003|Overall Study|Adverse Event|0|||
105792969|NCT01186744|364898665|FG004|Overall Study|Adverse Event|1|||
105792970|NCT01186744|364898666|FG005|Overall Study|Adverse Event|4|||
105792971|NCT01186744|364898661|FG000|Overall Study|Death|1|||
105792972|NCT01186744|364898662|FG001|Overall Study|Death|0|||
105792973|NCT01186744|364898663|FG002|Overall Study|Death|0|||
105792974|NCT01186744|364898664|FG003|Overall Study|Death|0|||
105792975|NCT01186744|364898665|FG004|Overall Study|Death|0|||
105792976|NCT01186744|364898666|FG005|Overall Study|Death|0|||
105792977|NCT02729545|364898667|FG000|Overall Study|Pregnancy|1|||
105792978|NCT02729545|364898668|FG001|Overall Study|Pregnancy|1|||
105792979|NCT02729545|364898667|FG000|Overall Study|Lost to Follow-up|0|||
105792980|NCT02729545|364898668|FG001|Overall Study|Lost to Follow-up|1|||
105792981|NCT02729545|364898667|FG000|Overall Study|Withdrawal by Subject|2|||
105792982|NCT02729545|364898668|FG001|Overall Study|Withdrawal by Subject|3|||
105792983|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
105792984|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
105792985|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
105792986|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
105792987|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
105792988|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
105792989|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
105792990|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
105792991|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
105792992|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
105792993|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
105792994|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
105792995|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
105792996|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
105792997|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
105792998|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
105792999|NCT05553600|364898669|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
105793000|NCT05553600|364898670|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
105793001|NCT05553600|364898671|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
105793002|NCT05553600|364898672|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
105793003|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
105793004|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
105793005|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
105793006|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
105793007|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
105793008|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
105793009|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
105793010|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
105793011|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
105793012|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
105793013|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
105793014|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
105793015|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
105793016|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
105793017|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
105793018|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
105793019|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
105793020|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
105793021|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
105793022|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
105793023|NCT05553600|364898669|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
105723683|NCT02886702|364642628|FG000|Overall Study|Significant Worsening of Condition|0|||
105723684|NCT02886702|364642629|FG001|Overall Study|Significant Worsening of Condition|1|||
105723685|NCT02886702|364642630|FG002|Overall Study|Significant Worsening of Condition|0|||
105723686|NCT02886702|364642628|FG000|Overall Study|Protocol Violation|2|||
105723687|NCT02886702|364642629|FG001|Overall Study|Protocol Violation|2|||
105723688|NCT02886702|364642630|FG002|Overall Study|Protocol Violation|1|||
105723689|NCT02886702|364642628|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105723690|NCT02886702|364642629|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105723691|NCT02886702|364642630|FG002|Overall Study|Non-Compliance With Study Drug|4|||
105723692|NCT02886702|364642628|FG000|Overall Study|Lost to Follow-up|11|||
105723693|NCT02886702|364642629|FG001|Overall Study|Lost to Follow-up|13|||
105723694|NCT02886702|364642630|FG002|Overall Study|Lost to Follow-up|8|||
105723695|NCT02886702|364642628|FG000|Overall Study|Lack of Efficacy|3|||
105723696|NCT02886702|364642629|FG001|Overall Study|Lack of Efficacy|4|||
105723697|NCT02886702|364642630|FG002|Overall Study|Lack of Efficacy|5|||
105723698|NCT02886702|364642628|FG000|Overall Study|Adverse Event|4|||
105723699|NCT02886702|364642629|FG001|Overall Study|Adverse Event|9|||
105723700|NCT02886702|364642630|FG002|Overall Study|Adverse Event|3|||
105723701|NCT02886702|364642628|FG000|Overall Study|Administrative Reasons|0|||
105723702|NCT02886702|364642629|FG001|Overall Study|Administrative Reasons|0|||
105723703|NCT02886702|364642630|FG002|Overall Study|Administrative Reasons|1|||
105723704|NCT00501228|364642634|FG000|Overall Study|Withdrawal by Subject|1|||
105723705|NCT02318784|364642635|FG000|Overall Study|Adverse Event|13|||
105723706|NCT02318784|364642635|FG000|Overall Study|Death|2|||
105723707|NCT02318784|364642635|FG000|Overall Study|Progressive Disease|37|||
105723708|NCT02318784|364642635|FG000|Overall Study|Withdrawal by Subject|10|||
105723709|NCT00781365|364642638|FG000|Overall Study|Withdrawal by Subject|13|||
105723710|NCT00781365|364642639|FG001|Overall Study|Withdrawal by Subject|8|||
105723711|NCT00781365|364642638|FG000|Overall Study|Did Not Attend Visit|20|||
105723712|NCT00781365|364642639|FG001|Overall Study|Did Not Attend Visit|28|||
105723713|NCT00781365|364642638|FG000|Overall Study|Language barrier|1|||
105723714|NCT00781365|364642639|FG001|Overall Study|Language barrier|0|||
105723715|NCT03304522|364642640|FG000|Overall Study|Adverse Event|0|||
105723716|NCT03304522|364642641|FG001|Overall Study|Adverse Event|4|||
105723717|NCT03304522|364642640|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
105723718|NCT03304522|364642641|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
105723719|NCT03304522|364642640|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
105723720|NCT03304522|364642641|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
105723721|NCT03304522|364642640|FG000|Overall Study|Other|0|||
105723722|NCT03304522|364642641|FG001|Overall Study|Other|1|||
105723723|NCT00486603|364642643|FG000|Overall Study|Withdrawal by Subject|1|||
105723724|NCT00486603|364642644|FG001|Overall Study|Withdrawal by Subject|0|||
105723725|NCT00486603|364642645|FG002|Overall Study|Withdrawal by Subject|0|||
105723726|NCT00486603|364642646|FG003|Overall Study|Withdrawal by Subject|0|||
105723727|NCT00486603|364642647|FG004|Overall Study|Withdrawal by Subject|0|||
105723728|NCT00486603|364642643|FG000|Overall Study|Physician Decision|0|||
105723729|NCT00486603|364642644|FG001|Overall Study|Physician Decision|1|||
105723730|NCT00486603|364642645|FG002|Overall Study|Physician Decision|0|||
105723731|NCT00486603|364642646|FG003|Overall Study|Physician Decision|0|||
105723732|NCT00486603|364642647|FG004|Overall Study|Physician Decision|0|||
105723733|NCT01295125|364642650|FG000|Overall Study|Study stopped prematurely|9|||
105723734|NCT01157117|364642651|FG000|Overall Study|Dosing Symptoms|0|||
105723735|NCT01157117|364642652|FG001|Overall Study|Dosing Symptoms|4|||
105723736|NCT01157117|364642653|FG002|Overall Study|Dosing Symptoms|0|||
105723737|NCT01157117|364642651|FG000|Overall Study|Withdrawal by Subject|4|||
105723738|NCT01157117|364642652|FG001|Overall Study|Withdrawal by Subject|1|||
105723739|NCT01157117|364642653|FG002|Overall Study|Withdrawal by Subject|1|||
105723740|NCT01157117|364642651|FG000|Overall Study|Lack of Efficacy|1|||
105723741|NCT01157117|364642652|FG001|Overall Study|Lack of Efficacy|1|||
105723742|NCT01157117|364642653|FG002|Overall Study|Lack of Efficacy|0|||
105723743|NCT01157117|364642651|FG000|Overall Study|Lost to Follow-up|0|||
105723744|NCT01157117|364642652|FG001|Overall Study|Lost to Follow-up|0|||
105723745|NCT01157117|364642653|FG002|Overall Study|Lost to Follow-up|1|||
105723746|NCT01157117|364642651|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
105723747|NCT01157117|364642652|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
105723748|NCT01157117|364642653|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
105723749|NCT03514914|364642654|FG000|Overall Study|Death|3|||
105723750|NCT03514914|364642655|FG001|Overall Study|Death|3|||
105723751|NCT03514914|364642654|FG000|Overall Study|Lost to Follow-up|117|||
105723752|NCT03514914|364642655|FG001|Overall Study|Lost to Follow-up|89|||
105723753|NCT00885365|364642657|FG000|4 Weeks ON Treatment|Adverse Event|2|||
105723754|NCT00885365|364642658|FG001|4 Weeks ON Treatment|Adverse Event|4|||
105723755|NCT00885365|364642657|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
105723756|NCT00885365|364642658|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
105723757|NCT00885365|364642657|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
105723758|NCT00885365|364642658|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
105723759|NCT01824979|364642659|FG000|Overall Study|Withdrawal by Subject|5|||
105723760|NCT01824979|364642660|FG001|Overall Study|Withdrawal by Subject|0|||
105723761|NCT01824979|364642659|FG000|Overall Study|Physician Decision|2|||
105723762|NCT01824979|364642660|FG001|Overall Study|Physician Decision|0|||
105723763|NCT01824979|364642659|FG000|Overall Study|Protocol Violation|6|||
105723764|NCT01824979|364642660|FG001|Overall Study|Protocol Violation|13|||
105723765|NCT01355289|364642661|FG000|Core Study|Adverse Event, Non-Fatal|1|||
105723766|NCT01355289|364642662|FG001|Core Study|Adverse Event, Non-Fatal|0|||
105723767|NCT01355289|364642663|FG002|Core Study|Adverse Event, Non-Fatal|0|||
105723768|NCT01355289|364642664|FG003|Core Study|Adverse Event, Non-Fatal|0|||
105723769|NCT01355289|364642665|FG004|Core Study|Adverse Event, Non-Fatal|0|||
105723770|NCT01355289|364642661|FG000|Core Study|Inadequate Therapeutic Effect|0|||
105723771|NCT01355289|364642662|FG001|Core Study|Inadequate Therapeutic Effect|0|||
105723772|NCT01355289|364642663|FG002|Core Study|Inadequate Therapeutic Effect|0|||
105723773|NCT01355289|364642664|FG003|Core Study|Inadequate Therapeutic Effect|1|||
105723774|NCT01355289|364642665|FG004|Core Study|Inadequate Therapeutic Effect|0|||
105723775|NCT01355289|364642661|FG000|Core Study|Other|0|||
105723776|NCT01355289|364642662|FG001|Core Study|Other|0|||
105723777|NCT01355289|364642663|FG002|Core Study|Other|0|||
105723778|NCT01355289|364642664|FG003|Core Study|Other|1|||
105723779|NCT01355289|364642665|FG004|Core Study|Other|0|||
105723780|NCT01355289|364642661|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
105723781|NCT01355289|364642662|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
105723782|NCT01355289|364642663|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
105723783|NCT01355289|364642664|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
105723784|NCT01355289|364642665|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
105723785|NCT01355289|364642661|FG000|Open Label Extension|Lost to Follow-up|0|||
105723786|NCT01355289|364642662|FG001|Open Label Extension|Lost to Follow-up|0|||
105723787|NCT01355289|364642663|FG002|Open Label Extension|Lost to Follow-up|0|||
105723788|NCT01355289|364642664|FG003|Open Label Extension|Lost to Follow-up|0|||
105723789|NCT01355289|364642665|FG004|Open Label Extension|Lost to Follow-up|1|||
105723790|NCT01355289|364642661|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
105723791|NCT01355289|364642662|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
105723792|NCT01355289|364642663|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
105723793|NCT01355289|364642664|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
105723794|NCT01355289|364642665|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
105723795|NCT01355289|364642661|FG000|Open Label Extension|Other|0|||
105723796|NCT01355289|364642662|FG001|Open Label Extension|Other|0|||
105723797|NCT01355289|364642663|FG002|Open Label Extension|Other|0|||
105723798|NCT01355289|364642664|FG003|Open Label Extension|Other|0|||
105723799|NCT01355289|364642665|FG004|Open Label Extension|Other|3|||
105723800|NCT01451645|364642669|FG000|Overall Study|Protocol Violation|1|||
105723801|NCT01451645|364642670|FG001|Overall Study|Protocol Violation|0|||
105723802|NCT01451645|364642669|FG000|Overall Study|Adverse Event|0|||
106009175|NCT05050318|365700785|FG001|Overall Study|Protocol Deviation|0|||
106009176|NCT05050318|365700786|FG002|Overall Study|Protocol Deviation|0|||
106009177|NCT01112917|365700789|FG000|Overall Study|Death|2|||
106009178|NCT01112917|365700790|FG001|Overall Study|Death|11|||
106009179|NCT01112917|365700789|FG000|Overall Study|Lost to Follow-up|1|||
106009180|NCT01112917|365700790|FG001|Overall Study|Lost to Follow-up|1|||
106009181|NCT01112917|365700789|FG000|Overall Study|Withdrawal by Subject|1|||
106009182|NCT01112917|365700790|FG001|Overall Study|Withdrawal by Subject|3|||
106009183|NCT01112917|365700789|FG000|Overall Study|Unable to Convert Filter|3|||
106009184|NCT01112917|365700790|FG001|Overall Study|Unable to Convert Filter|0|||
106009185|NCT02766023|365700793|FG000|Overall Study|Lost to Follow-up|23|||
106009186|NCT02766023|365700794|FG001|Overall Study|Lost to Follow-up|11|||
106009187|NCT02766023|365700793|FG000|Overall Study|Pregnancy|1|||
106009188|NCT02766023|365700794|FG001|Overall Study|Pregnancy|0|||
106009189|NCT02766023|365700793|FG000|Overall Study|Adverse Event|1|||
106009190|NCT02766023|365700794|FG001|Overall Study|Adverse Event|0|||
106009191|NCT02766023|365700793|FG000|Overall Study|Withdrawal by Subject|4|||
106009192|NCT02766023|365700794|FG001|Overall Study|Withdrawal by Subject|5|||
106009193|NCT02766023|365700793|FG000|Overall Study|Physician Decision|1|||
106009194|NCT02766023|365700794|FG001|Overall Study|Physician Decision|0|||
106009195|NCT02766023|365700793|FG000|Overall Study|Not Eligible at Enrollment|0|||
106009196|NCT02766023|365700794|FG001|Overall Study|Not Eligible at Enrollment|1|||
106009197|NCT03566511|365700795|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
106009198|NCT03566511|365700796|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
106009199|NCT04026113|365700801|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
105723803|NCT01451645|364642670|FG001|Overall Study|Adverse Event|3|||
106009200|NCT04026113|365700802|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
105723804|NCT01451645|364642669|FG000|Overall Study|Withdrawal by Subject|4|||
105723805|NCT01451645|364642670|FG001|Overall Study|Withdrawal by Subject|2|||
105723806|NCT01451645|364642669|FG000|Overall Study|Lost to Follow-up|4|||
105723807|NCT01451645|364642670|FG001|Overall Study|Lost to Follow-up|3|||
106137681|NCT00739102|366163452|FG000|Overall Study|Withdrawal by Subject|10|||
106137682|NCT01368406|366163453|FG000|Overall Study|Lost to Follow-up|8|||
106137683|NCT01368406|366163454|FG001|Overall Study|Lost to Follow-up|4|||
106009201|NCT04026113|365700803|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105935966|NCT02991859|365425257|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935967|NCT02991859|365425258|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
105935968|NCT01065766|365425259|FG000|Overall Study|Assessed before the contracted date|1|||
105935969|NCT01065766|365425259|FG000|Overall Study|Contraindication to administration|6|||
105935970|NCT01065766|365425259|FG000|Overall Study|Violated dosage/administration|25|||
105935971|NCT01608308|365425266|FG000|Overall Study|pretreatment medical and billing reasons|0|||
105935972|NCT01608308|365425267|FG001|Overall Study|pretreatment medical and billing reasons|2|||
105935973|NCT01725308|365425269|FG000|Treatment Period I|Did Not Receive Drug|1|||
105935974|NCT01725308|365425270|FG001|Treatment Period I|Did Not Receive Drug|0|||
105935975|NCT01725308|365425271|FG002|Treatment Period I|Did Not Receive Drug|0|||
105935976|NCT01725308|365425269|FG000|Treatment Period I|Adverse Event|5|||
105935977|NCT01725308|365425270|FG001|Treatment Period I|Adverse Event|4|||
105935978|NCT01725308|365425271|FG002|Treatment Period I|Adverse Event|21|||
105935979|NCT01725308|365425269|FG000|Treatment Period I|Insufficient Response|7|||
105935980|NCT01725308|365425270|FG001|Treatment Period I|Insufficient Response|0|||
105935981|NCT01725308|365425271|FG002|Treatment Period I|Insufficient Response|5|||
105935982|NCT01725308|365425269|FG000|Treatment Period I|Worsening of the Target Disease|8|||
105935983|NCT01725308|365425270|FG001|Treatment Period I|Worsening of the Target Disease|0|||
105935984|NCT01725308|365425271|FG002|Treatment Period I|Worsening of the Target Disease|2|||
105935985|NCT01725308|365425269|FG000|Treatment Period I|Changes in the Episodes|3|||
105935986|NCT01725308|365425270|FG001|Treatment Period I|Changes in the Episodes|0|||
105935987|NCT01725308|365425271|FG002|Treatment Period I|Changes in the Episodes|2|||
105935988|NCT01725308|365425269|FG000|Treatment Period I|Withdrawal of Consent|12|||
105935989|NCT01725308|365425270|FG001|Treatment Period I|Withdrawal of Consent|7|||
105935990|NCT01725308|365425271|FG002|Treatment Period I|Withdrawal of Consent|5|||
105935991|NCT01725308|365425269|FG000|Treatment Period I|Lost to Follow-up|3|||
105935992|NCT01725308|365425270|FG001|Treatment Period I|Lost to Follow-up|2|||
105935993|NCT01725308|365425271|FG002|Treatment Period I|Lost to Follow-up|2|||
105935994|NCT01725308|365425269|FG000|Treatment Period I|Protocol Deviations|3|||
105935995|NCT01725308|365425270|FG001|Treatment Period I|Protocol Deviations|1|||
105935996|NCT01725308|365425271|FG002|Treatment Period I|Protocol Deviations|1|||
105935997|NCT01725308|365425269|FG000|Treatment Period I|Miscellaneous|2|||
105935998|NCT01725308|365425270|FG001|Treatment Period I|Miscellaneous|0|||
105935999|NCT01725308|365425271|FG002|Treatment Period I|Miscellaneous|3|||
105936000|NCT01725308|365425269|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
105936001|NCT01725308|365425270|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
105936002|NCT01725308|365425271|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
105936003|NCT01725308|365425269|FG000|Treatment Period II|Did Not Receive Drug|4|||
105936004|NCT01725308|365425270|FG001|Treatment Period II|Did Not Receive Drug|0|||
105936005|NCT01725308|365425271|FG002|Treatment Period II|Did Not Receive Drug|0|||
105936006|NCT01725308|365425269|FG000|Treatment Period II|Adverse Event|13|||
105936007|NCT01725308|365425270|FG001|Treatment Period II|Adverse Event|8|||
105936008|NCT01725308|365425271|FG002|Treatment Period II|Adverse Event|20|||
105936009|NCT01725308|365425269|FG000|Treatment Period II|Insufficient Response|2|||
105936010|NCT01725308|365425270|FG001|Treatment Period II|Insufficient Response|4|||
105936011|NCT01725308|365425271|FG002|Treatment Period II|Insufficient Response|6|||
105936012|NCT01725308|365425269|FG000|Treatment Period II|Worsening of the Target Disease|1|||
105936013|NCT01725308|365425270|FG001|Treatment Period II|Worsening of the Target Disease|4|||
105936014|NCT01725308|365425271|FG002|Treatment Period II|Worsening of the Target Disease|2|||
105936015|NCT01725308|365425269|FG000|Treatment Period II|Changes in the Episodes|1|||
105936016|NCT01725308|365425270|FG001|Treatment Period II|Changes in the Episodes|0|||
105936017|NCT01725308|365425271|FG002|Treatment Period II|Changes in the Episodes|5|||
105936018|NCT01725308|365425269|FG000|Treatment Period II|Withdrawal of Consent|28|||
105936019|NCT01725308|365425270|FG001|Treatment Period II|Withdrawal of Consent|2|||
105936020|NCT01725308|365425271|FG002|Treatment Period II|Withdrawal of Consent|16|||
105936021|NCT01725308|365425269|FG000|Treatment Period II|Lost to Follow-up|1|||
105936022|NCT01725308|365425270|FG001|Treatment Period II|Lost to Follow-up|5|||
106137684|NCT01368406|366163453|FG000|Overall Study|Withdrawal by Subject|8|||
106137685|NCT01368406|366163454|FG001|Overall Study|Withdrawal by Subject|4|||
105936023|NCT01725308|365425271|FG002|Treatment Period II|Lost to Follow-up|3|||
105936024|NCT01725308|365425269|FG000|Treatment Period II|Protocol Deviations|0|||
105936025|NCT01725308|365425270|FG001|Treatment Period II|Protocol Deviations|0|||
105936026|NCT01725308|365425271|FG002|Treatment Period II|Protocol Deviations|1|||
105936027|NCT01725308|365425269|FG000|Treatment Period II|Miscellaneous|5|||
105936028|NCT01725308|365425270|FG001|Treatment Period II|Miscellaneous|3|||
105936029|NCT01725308|365425271|FG002|Treatment Period II|Miscellaneous|7|||
105936030|NCT06048705|365425272|FG000|Overall Study|Physician Decision|1|||
105936031|NCT06048705|365425273|FG001|Overall Study|Physician Decision|0|||
105936032|NCT06048705|365425274|FG002|Overall Study|Physician Decision|0|||
106137686|NCT01368406|366163453|FG000|Overall Study|relapse of the disease|3|||
106137687|NCT01368406|366163454|FG001|Overall Study|relapse of the disease|2|||
105723808|NCT02706938|364642673|FG000|First Period, 6 Weeks|Adverse Event|8|||
105723809|NCT02706938|364642674|FG001|First Period, 6 Weeks|Adverse Event|0|||
105723810|NCT02706938|364642673|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
105723811|NCT02706938|364642674|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
105723812|NCT02706938|364642673|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
105723813|NCT02706938|364642674|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
105723814|NCT02706938|364642673|FG000|Second Period, 6 Weeks|Adverse Event|0|||
105723815|NCT02706938|364642674|FG001|Second Period, 6 Weeks|Adverse Event|7|||
105723816|NCT02706938|364642673|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
105723817|NCT02706938|364642674|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
105723818|NCT01838044|364642679|FG000|Overall Study|Adverse Event|4|||
105723819|NCT01838044|364642680|FG001|Overall Study|Adverse Event|6|||
105723820|NCT01838044|364642679|FG000|Overall Study|Protocol Violation|3|||
105723821|NCT01838044|364642680|FG001|Overall Study|Protocol Violation|3|||
105723822|NCT01838044|364642679|FG000|Overall Study|Withdrawal by Subject|0|||
105723823|NCT01838044|364642680|FG001|Overall Study|Withdrawal by Subject|2|||
105723824|NCT01838044|364642679|FG000|Overall Study|Insufficient clinical response|1|||
105723825|NCT01838044|364642680|FG001|Overall Study|Insufficient clinical response|2|||
105723826|NCT01838044|364642679|FG000|Overall Study|Medication error without associated AE|0|||
105723827|NCT01838044|364642680|FG001|Overall Study|Medication error without associated AE|1|||
105723828|NCT01838044|364642679|FG000|Overall Study|Lost to Follow-up|0|||
105723829|NCT01838044|364642680|FG001|Overall Study|Lost to Follow-up|2|||
105723830|NCT03838484|364642684|FG000|Overall Study|Lost to Follow-up|0|||
105723831|NCT03838484|364642685|FG001|Overall Study|Lost to Follow-up|1|||
105723832|NCT03838484|364642686|FG002|Overall Study|Lost to Follow-up|0|||
105723833|NCT03838484|364642687|FG003|Overall Study|Lost to Follow-up|0|||
105723834|NCT01413958|364642689|FG000|Overall Study|Lost to Follow-up|0|||
105723835|NCT01413958|364642690|FG001|Overall Study|Lost to Follow-up|1|||
105723836|NCT02207907|364642699|FG000|Overall Study|Lost to Follow-up|3|||
105723837|NCT02207907|364642700|FG001|Overall Study|Lost to Follow-up|1|||
106137688|NCT01368406|366163453|FG000|Overall Study|started working|2|||
105723838|NCT02207907|364642699|FG000|Overall Study|Withdrawal by Subject|5|||
105723839|NCT02207907|364642700|FG001|Overall Study|Withdrawal by Subject|6|||
105723840|NCT02207907|364642699|FG000|Overall Study|Did not meet study criteria|3|||
105723841|NCT02207907|364642700|FG001|Overall Study|Did not meet study criteria|0|||
105723842|NCT02207907|364642699|FG000|Overall Study|Pregnancy|0|||
105723843|NCT02207907|364642700|FG001|Overall Study|Pregnancy|1|||
105723844|NCT00158184|364642701|FG000|Overall Study|personal issues|3|||
105723845|NCT00158184|364642702|FG001|Overall Study|personal issues|1|||
105723846|NCT00158184|364642701|FG000|Overall Study|failed for follow unit/study rules|2|||
105723847|NCT00158184|364642702|FG001|Overall Study|failed for follow unit/study rules|0|||
105723848|NCT00158184|364642701|FG000|Overall Study|Adverse Event|1|||
105723849|NCT00158184|364642702|FG001|Overall Study|Adverse Event|1|||
105723850|NCT02700984|364642703|FG000|Overall Study|Death|2|||
105723851|NCT02700984|364642704|FG001|Overall Study|Death|1|||
105723852|NCT02700984|364642703|FG000|Overall Study|Lost to Follow-up|2|||
105723853|NCT02700984|364642704|FG001|Overall Study|Lost to Follow-up|1|||
105723854|NCT02700984|364642703|FG000|Overall Study|Physician Decision|0|||
105723855|NCT02700984|364642704|FG001|Overall Study|Physician Decision|1|||
105723856|NCT02700984|364642703|FG000|Overall Study|Withdrawal by Subject|8|||
105723857|NCT02700984|364642704|FG001|Overall Study|Withdrawal by Subject|9|||
105723858|NCT02700984|364642703|FG000|Overall Study|Reason not specified|3|||
105723859|NCT02700984|364642704|FG001|Overall Study|Reason not specified|2|||
105723860|NCT05340504|364642705|FG000|Overall Study|Withdrawal by Subject|1|||
105723861|NCT05340504|364642706|FG001|Overall Study|Withdrawal by Subject|0|||
105723862|NCT00473876|364642707|FG000|Overall Study|Lost to Follow-up|3|||
105723863|NCT00473876|364642708|FG001|Overall Study|Lost to Follow-up|1|||
105723864|NCT00348140|364642709|FG000|Overall Study|Adverse Event|46|||
105723865|NCT00348140|364642710|FG001|Overall Study|Adverse Event|49|||
105723866|NCT00348140|364642711|FG002|Overall Study|Adverse Event|78|||
105723867|NCT00348140|364642709|FG000|Overall Study|Lost to Follow-up|4|||
105723868|NCT00348140|364642710|FG001|Overall Study|Lost to Follow-up|4|||
105723869|NCT00348140|364642711|FG002|Overall Study|Lost to Follow-up|4|||
105723870|NCT00348140|364642709|FG000|Overall Study|Protocol Violation|12|||
105723871|NCT00348140|364642710|FG001|Overall Study|Protocol Violation|13|||
105723872|NCT00348140|364642711|FG002|Overall Study|Protocol Violation|14|||
105723873|NCT00348140|364642709|FG000|Overall Study|Withdrawal by Subject|32|||
105723874|NCT00348140|364642710|FG001|Overall Study|Withdrawal by Subject|40|||
105723875|NCT00348140|364642711|FG002|Overall Study|Withdrawal by Subject|40|||
105723876|NCT00348140|364642709|FG000|Overall Study|Non-compliance|8|||
105723877|NCT00348140|364642710|FG001|Overall Study|Non-compliance|13|||
105723878|NCT00348140|364642711|FG002|Overall Study|Non-compliance|5|||
105723879|NCT00348140|364642709|FG000|Overall Study|Participant at risk due to study drug|2|||
105723880|NCT00348140|364642710|FG001|Overall Study|Participant at risk due to study drug|0|||
105723881|NCT00348140|364642711|FG002|Overall Study|Participant at risk due to study drug|0|||
105723882|NCT00348140|364642709|FG000|Overall Study|Conditional medication increased dose|1|||
105793024|NCT05553600|364898670|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
105793025|NCT05553600|364898671|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
105793026|NCT05553600|364898672|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
105793027|NCT05553600|364898669|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
105793028|NCT05553600|364898670|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
105793029|NCT05553600|364898671|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
105793030|NCT05553600|364898672|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
105793031|NCT01956123|364898673|FG000|COS Cycle 2|Protocol Violation|8|||
105793032|NCT01956123|364898674|FG001|COS Cycle 2|Protocol Violation|3|||
105793033|NCT01956123|364898675|FG002|COS Cycle 2|Protocol Violation|0|||
105793034|NCT01956123|364898676|FG003|COS Cycle 2|Protocol Violation|0|||
105793035|NCT01956123|364898673|FG000|COS Cycle 2|Adverse Event|3|||
105793036|NCT01956123|364898674|FG001|COS Cycle 2|Adverse Event|4|||
105793037|NCT01956123|364898675|FG002|COS Cycle 2|Adverse Event|0|||
105793038|NCT01956123|364898676|FG003|COS Cycle 2|Adverse Event|0|||
105793039|NCT01956123|364898673|FG000|COS Cycle 2|Personal Reasons|2|||
105793040|NCT01956123|364898674|FG001|COS Cycle 2|Personal Reasons|0|||
105793041|NCT01956123|364898675|FG002|COS Cycle 2|Personal Reasons|0|||
105793042|NCT01956123|364898676|FG003|COS Cycle 2|Personal Reasons|0|||
105793043|NCT01956123|364898673|FG000|COS Cycle 2|Withdrawal by Subject|1|||
105793044|NCT01956123|364898674|FG001|COS Cycle 2|Withdrawal by Subject|0|||
105793045|NCT01956123|364898675|FG002|COS Cycle 2|Withdrawal by Subject|0|||
105793046|NCT01956123|364898676|FG003|COS Cycle 2|Withdrawal by Subject|0|||
105793047|NCT01956123|364898673|FG000|COS Cycle 3|Protocol Violation|0|||
105793048|NCT01956123|364898674|FG001|COS Cycle 3|Protocol Violation|0|||
105793049|NCT01956123|364898675|FG002|COS Cycle 3|Protocol Violation|2|||
105793050|NCT01956123|364898676|FG003|COS Cycle 3|Protocol Violation|1|||
105793051|NCT01956123|364898673|FG000|COS Cycle 3|Adverse Event|0|||
105793052|NCT01956123|364898674|FG001|COS Cycle 3|Adverse Event|0|||
105793053|NCT01956123|364898675|FG002|COS Cycle 3|Adverse Event|3|||
105793054|NCT01956123|364898676|FG003|COS Cycle 3|Adverse Event|0|||
105793055|NCT01956123|364898673|FG000|COS Cycle 3|Personal Reasons|0|||
105793056|NCT01956123|364898674|FG001|COS Cycle 3|Personal Reasons|0|||
105793057|NCT01956123|364898675|FG002|COS Cycle 3|Personal Reasons|1|||
105793058|NCT01956123|364898676|FG003|COS Cycle 3|Personal Reasons|0|||
105793059|NCT01956123|364898673|FG000|COS Cycle 3|Withdrawal by Subject|0|||
105793060|NCT01956123|364898674|FG001|COS Cycle 3|Withdrawal by Subject|0|||
105793061|NCT01956123|364898675|FG002|COS Cycle 3|Withdrawal by Subject|0|||
105723883|NCT00348140|364642710|FG001|Overall Study|Conditional medication increased dose|0|||
105723884|NCT00348140|364642711|FG002|Overall Study|Conditional medication increased dose|0|||
105723885|NCT00348140|364642709|FG000|Overall Study|Caregiver related|4|||
105723886|NCT00348140|364642710|FG001|Overall Study|Caregiver related|7|||
105723887|NCT00348140|364642711|FG002|Overall Study|Caregiver related|3|||
105723888|NCT00348140|364642709|FG000|Overall Study|Participant hospitalised|3|||
105723889|NCT00348140|364642710|FG001|Overall Study|Participant hospitalised|0|||
105723890|NCT00348140|364642711|FG002|Overall Study|Participant hospitalised|0|||
105723891|NCT00348140|364642709|FG000|Overall Study|Efficacy related|1|||
105723892|NCT00348140|364642710|FG001|Overall Study|Efficacy related|1|||
105723893|NCT00348140|364642711|FG002|Overall Study|Efficacy related|0|||
105723894|NCT00348140|364642709|FG000|Overall Study|Administration related|3|||
105723895|NCT00348140|364642710|FG001|Overall Study|Administration related|1|||
105723896|NCT00348140|364642711|FG002|Overall Study|Administration related|1|||
105723897|NCT00348140|364642709|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
105723898|NCT00348140|364642710|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
105723899|NCT00348140|364642711|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
105723900|NCT00348140|364642709|FG000|Overall Study|Participant unwell|1|||
105723901|NCT00348140|364642710|FG001|Overall Study|Participant unwell|0|||
105723902|NCT00348140|364642711|FG002|Overall Study|Participant unwell|0|||
105723903|NCT00348140|364642709|FG000|Overall Study|Screen failure|1|||
105723904|NCT00348140|364642710|FG001|Overall Study|Screen failure|0|||
105723905|NCT00348140|364642711|FG002|Overall Study|Screen failure|0|||
105793062|NCT01956123|364898676|FG003|COS Cycle 3|Withdrawal by Subject|1|||
105793063|NCT01432600|364898677|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
105793064|NCT01432600|364898678|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
105793065|NCT01432600|364898679|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
105793066|NCT02545868|364898686|FG000|Overall Study|Lack of Efficacy|1|||
105793067|NCT02545868|364898687|FG001|Overall Study|Lack of Efficacy|1|||
105793068|NCT02545868|364898688|FG002|Overall Study|Lack of Efficacy|0|||
105793069|NCT02545868|364898686|FG000|Overall Study|Lost to Follow-up|1|||
105793070|NCT02545868|364898687|FG001|Overall Study|Lost to Follow-up|5|||
105723906|NCT00348140|364642709|FG000|Overall Study|Investigator decided to discontinue|4|||
105723907|NCT00348140|364642710|FG001|Overall Study|Investigator decided to discontinue|1|||
105723908|NCT00348140|364642711|FG002|Overall Study|Investigator decided to discontinue|4|||
105723909|NCT00348140|364642709|FG000|Overall Study|Decided to discontinue on their own|1|||
105723910|NCT00348140|364642710|FG001|Overall Study|Decided to discontinue on their own|4|||
105793071|NCT02545868|364898688|FG002|Overall Study|Lost to Follow-up|1|||
105793072|NCT02545868|364898686|FG000|Overall Study|Non-compliance|1|||
105793073|NCT02545868|364898687|FG001|Overall Study|Non-compliance|1|||
105936033|NCT06048705|365425272|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
105936034|NCT06048705|365425273|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
105936035|NCT06048705|365425274|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
105936036|NCT06048705|365425272|FG000|Overall Study|Death prior to lymphodepletion|0|||
105936037|NCT06048705|365425273|FG001|Overall Study|Death prior to lymphodepletion|0|||
105936038|NCT06048705|365425274|FG002|Overall Study|Death prior to lymphodepletion|1|||
105936039|NCT01016015|365425275|FG000|Overall Study|Not Treated|3|||
105936040|NCT01016015|365425275|FG000|Overall Study|Withdrawal by Subject|1|||
105936041|NCT01016015|365425275|FG000|Overall Study|Adverse Event|15|||
105936042|NCT04565756|365425279|FG000|Overall Study|Withdrawal by Subject|0|||
105936043|NCT04565756|365425280|FG001|Overall Study|Withdrawal by Subject|0|||
105723911|NCT00348140|364642711|FG002|Overall Study|Decided to discontinue on their own|1|||
105723912|NCT00348140|364642709|FG000|Overall Study|Use of prohibited drug|1|||
105723913|NCT00348140|364642710|FG001|Overall Study|Use of prohibited drug|0|||
105723914|NCT00348140|364642711|FG002|Overall Study|Use of prohibited drug|2|||
105723915|NCT00348140|364642709|FG000|Overall Study|Disease progression|1|||
105723916|NCT00348140|364642710|FG001|Overall Study|Disease progression|2|||
105723917|NCT00348140|364642711|FG002|Overall Study|Disease progression|5|||
105723918|NCT00348140|364642709|FG000|Overall Study|Increased risk of cardiac infarction|0|||
105723919|NCT00348140|364642710|FG001|Overall Study|Increased risk of cardiac infarction|1|||
105723920|NCT00348140|364642711|FG002|Overall Study|Increased risk of cardiac infarction|0|||
105723921|NCT00348140|364642709|FG000|Overall Study|Serious adverse event|0|||
105723922|NCT00348140|364642710|FG001|Overall Study|Serious adverse event|1|||
105723923|NCT00348140|364642711|FG002|Overall Study|Serious adverse event|0|||
105723924|NCT00348140|364642709|FG000|Overall Study|Abnormal ECG|0|||
105723925|NCT00348140|364642710|FG001|Overall Study|Abnormal ECG|1|||
105723926|NCT00348140|364642711|FG002|Overall Study|Abnormal ECG|3|||
105723927|NCT00348140|364642709|FG000|Overall Study|Participant died|0|||
105723928|NCT00348140|364642710|FG001|Overall Study|Participant died|1|||
105723929|NCT00348140|364642711|FG002|Overall Study|Participant died|0|||
105723930|NCT00348140|364642709|FG000|Overall Study|Exclusion criteria met|0|||
105723931|NCT00348140|364642710|FG001|Overall Study|Exclusion criteria met|0|||
105723932|NCT00348140|364642711|FG002|Overall Study|Exclusion criteria met|1|||
105723933|NCT00348140|364642709|FG000|Overall Study|Memory declined|0|||
105723934|NCT00348140|364642710|FG001|Overall Study|Memory declined|0|||
105723935|NCT00348140|364642711|FG002|Overall Study|Memory declined|1|||
105723936|NCT00755079|364642716|FG000|Overall Study|Lost to Follow-up|1|||
105723937|NCT00755079|364642717|FG001|Overall Study|Lost to Follow-up|3|||
105723938|NCT00755079|364642716|FG000|Overall Study|Adverse Event|0|||
105723939|NCT00755079|364642717|FG001|Overall Study|Adverse Event|1|||
105723940|NCT00755079|364642716|FG000|Overall Study|Withdrawal by Subject|0|||
105723941|NCT00755079|364642717|FG001|Overall Study|Withdrawal by Subject|2|||
105723942|NCT00706628|364642719|FG000|Overall Study|Other Adverse Event|16|||
105723943|NCT00706628|364642720|FG001|Overall Study|Other Adverse Event|5|||
105723944|NCT00706628|364642721|FG002|Overall Study|Other Adverse Event|5|||
105723945|NCT00706628|364642722|FG003|Overall Study|Other Adverse Event|2|||
105723946|NCT00706628|364642719|FG000|Overall Study|Non compliant with protocol|0|||
105723947|NCT00706628|364642720|FG001|Overall Study|Non compliant with protocol|1|||
105723948|NCT00706628|364642721|FG002|Overall Study|Non compliant with protocol|0|||
105723949|NCT00706628|364642722|FG003|Overall Study|Non compliant with protocol|0|||
105723950|NCT00706628|364642719|FG000|Overall Study|Consent withdrawn|6|||
105723951|NCT00706628|364642720|FG001|Overall Study|Consent withdrawn|1|||
105723952|NCT00706628|364642721|FG002|Overall Study|Consent withdrawn|3|||
105723953|NCT00706628|364642722|FG003|Overall Study|Consent withdrawn|0|||
105723954|NCT00706628|364642719|FG000|Overall Study|Progressive disease|20|||
105723955|NCT00706628|364642720|FG001|Overall Study|Progressive disease|13|||
105723956|NCT00706628|364642721|FG002|Overall Study|Progressive disease|8|||
105723957|NCT00706628|364642722|FG003|Overall Study|Progressive disease|1|||
105723958|NCT00706628|364642719|FG000|Overall Study|Other than those stated above|4|||
105723959|NCT00706628|364642720|FG001|Overall Study|Other than those stated above|0|||
105723960|NCT00706628|364642721|FG002|Overall Study|Other than those stated above|0|||
105723961|NCT00706628|364642722|FG003|Overall Study|Other than those stated above|0|||
105723962|NCT00706628|364642719|FG000|Overall Study|Not treated|1|||
105723963|NCT00706628|364642720|FG001|Overall Study|Not treated|1|||
105723964|NCT00706628|364642721|FG002|Overall Study|Not treated|0|||
105723965|NCT00706628|364642722|FG003|Overall Study|Not treated|0|||
105723966|NCT00868790|364642723|FG000|Period 1|Adverse Event|1|||
105723967|NCT00868790|364642724|FG001|Period 1|Adverse Event|0|||
105723968|NCT00868790|364642725|FG002|Period 1|Adverse Event|0|||
105723969|NCT00868790|364642726|FG003|Period 1|Adverse Event|0|||
105723970|NCT00868790|364642727|FG004|Period 1|Adverse Event|0|||
105723971|NCT00868790|364642728|FG005|Period 1|Adverse Event|0|||
105723972|NCT00868790|364642729|FG006|Period 1|Adverse Event|0|||
105723973|NCT00868790|364642730|FG007|Period 1|Adverse Event|3|||
105723974|NCT00868790|364642731|FG008|Period 1|Adverse Event|1|||
105936044|NCT04565756|365425281|FG002|Overall Study|Withdrawal by Subject|0|||
105936045|NCT04565756|365425282|FG003|Overall Study|Withdrawal by Subject|0|||
105723975|NCT00868790|364642732|FG009|Period 1|Adverse Event|0|||
106137689|NCT01368406|366163454|FG001|Overall Study|started working|3|||
106137690|NCT02759731|366163455|FG000|Overall Study|Did not complete treatment.|8|||
106137691|NCT01466881|366163456|FG000|Overall Study|Ineligible|5|||
106137692|NCT01466881|366163456|FG000|Overall Study|Adverse Event|6|||
106137693|NCT01466881|366163456|FG000|Overall Study|Progression/relapse|20|||
105723976|NCT00868790|364642733|FG010|Period 1|Adverse Event|0|||
105723977|NCT00868790|364642734|FG011|Period 1|Adverse Event|0|||
105723978|NCT00868790|364642735|FG012|Period 1|Adverse Event|0|||
105723979|NCT00868790|364642736|FG013|Period 1|Adverse Event|1|||
105723980|NCT00868790|364642723|FG000|Period 1|Protocol Violation|1|||
105723981|NCT00868790|364642724|FG001|Period 1|Protocol Violation|0|||
105723982|NCT00868790|364642725|FG002|Period 1|Protocol Violation|0|||
105723983|NCT00868790|364642726|FG003|Period 1|Protocol Violation|0|||
105723984|NCT00868790|364642727|FG004|Period 1|Protocol Violation|0|||
105723985|NCT00868790|364642728|FG005|Period 1|Protocol Violation|0|||
105723986|NCT00868790|364642729|FG006|Period 1|Protocol Violation|0|||
105723987|NCT00868790|364642730|FG007|Period 1|Protocol Violation|0|||
105723988|NCT00868790|364642731|FG008|Period 1|Protocol Violation|0|||
105723989|NCT00868790|364642732|FG009|Period 1|Protocol Violation|0|||
105723990|NCT00868790|364642733|FG010|Period 1|Protocol Violation|0|||
105723991|NCT00868790|364642734|FG011|Period 1|Protocol Violation|0|||
105723992|NCT00868790|364642735|FG012|Period 1|Protocol Violation|0|||
105723993|NCT00868790|364642736|FG013|Period 1|Protocol Violation|0|||
105723994|NCT00868790|364642723|FG000|Period 1|Withdrawal by Subject|0|||
105723995|NCT00868790|364642724|FG001|Period 1|Withdrawal by Subject|1|||
105723996|NCT00868790|364642725|FG002|Period 1|Withdrawal by Subject|0|||
105723997|NCT00868790|364642726|FG003|Period 1|Withdrawal by Subject|0|||
105723998|NCT00868790|364642727|FG004|Period 1|Withdrawal by Subject|0|||
105723999|NCT00868790|364642728|FG005|Period 1|Withdrawal by Subject|0|||
105724000|NCT00868790|364642729|FG006|Period 1|Withdrawal by Subject|0|||
105724001|NCT00868790|364642730|FG007|Period 1|Withdrawal by Subject|0|||
105724002|NCT00868790|364642731|FG008|Period 1|Withdrawal by Subject|0|||
105724003|NCT00868790|364642732|FG009|Period 1|Withdrawal by Subject|0|||
105724004|NCT00868790|364642733|FG010|Period 1|Withdrawal by Subject|0|||
105724005|NCT00868790|364642734|FG011|Period 1|Withdrawal by Subject|0|||
105724006|NCT00868790|364642735|FG012|Period 1|Withdrawal by Subject|0|||
105724007|NCT00868790|364642736|FG013|Period 1|Withdrawal by Subject|1|||
105724008|NCT00868790|364642723|FG000|Period 1|Abnormal Triglycerides|0|||
105724009|NCT00868790|364642724|FG001|Period 1|Abnormal Triglycerides|0|||
105724010|NCT00868790|364642725|FG002|Period 1|Abnormal Triglycerides|0|||
105724011|NCT00868790|364642726|FG003|Period 1|Abnormal Triglycerides|0|||
105724012|NCT00868790|364642727|FG004|Period 1|Abnormal Triglycerides|1|||
105724013|NCT00868790|364642728|FG005|Period 1|Abnormal Triglycerides|0|||
105724014|NCT00868790|364642729|FG006|Period 1|Abnormal Triglycerides|0|||
105724015|NCT00868790|364642730|FG007|Period 1|Abnormal Triglycerides|0|||
105724016|NCT00868790|364642731|FG008|Period 1|Abnormal Triglycerides|0|||
105724017|NCT00868790|364642732|FG009|Period 1|Abnormal Triglycerides|0|||
105724018|NCT00868790|364642733|FG010|Period 1|Abnormal Triglycerides|0|||
105724019|NCT00868790|364642734|FG011|Period 1|Abnormal Triglycerides|0|||
105724020|NCT00868790|364642735|FG012|Period 1|Abnormal Triglycerides|0|||
105724021|NCT00868790|364642736|FG013|Period 1|Abnormal Triglycerides|0|||
105724022|NCT00868790|364642723|FG000|Period 1|Lost to Follow-up|0|||
105724023|NCT00868790|364642724|FG001|Period 1|Lost to Follow-up|0|||
105724024|NCT00868790|364642725|FG002|Period 1|Lost to Follow-up|0|||
105724025|NCT00868790|364642726|FG003|Period 1|Lost to Follow-up|0|||
105724026|NCT00868790|364642727|FG004|Period 1|Lost to Follow-up|0|||
105724027|NCT00868790|364642728|FG005|Period 1|Lost to Follow-up|1|||
105724028|NCT00868790|364642729|FG006|Period 1|Lost to Follow-up|0|||
105724029|NCT00868790|364642730|FG007|Period 1|Lost to Follow-up|0|||
105724030|NCT00868790|364642731|FG008|Period 1|Lost to Follow-up|0|||
105724031|NCT00868790|364642732|FG009|Period 1|Lost to Follow-up|0|||
105724032|NCT00868790|364642733|FG010|Period 1|Lost to Follow-up|0|||
105724033|NCT00868790|364642734|FG011|Period 1|Lost to Follow-up|0|||
105724034|NCT00868790|364642735|FG012|Period 1|Lost to Follow-up|0|||
105724035|NCT00868790|364642736|FG013|Period 1|Lost to Follow-up|0|||
105724036|NCT00868790|364642723|FG000|Period 2|Adverse Event|0|||
105724037|NCT00868790|364642724|FG001|Period 2|Adverse Event|0|||
105724038|NCT00868790|364642725|FG002|Period 2|Adverse Event|0|||
105724039|NCT00868790|364642726|FG003|Period 2|Adverse Event|0|||
105724040|NCT00868790|364642727|FG004|Period 2|Adverse Event|0|||
105724041|NCT00868790|364642728|FG005|Period 2|Adverse Event|0|||
106137694|NCT01466881|366163456|FG000|Overall Study|Death|4|||
105724042|NCT00868790|364642729|FG006|Period 2|Adverse Event|0|||
105724043|NCT00868790|364642730|FG007|Period 2|Adverse Event|0|||
105724044|NCT00868790|364642731|FG008|Period 2|Adverse Event|1|||
105724045|NCT00868790|364642732|FG009|Period 2|Adverse Event|0|||
106137695|NCT01466881|366163456|FG000|Overall Study|Other reason not protocol specified|5|||
105724046|NCT00868790|364642733|FG010|Period 2|Adverse Event|0|||
105724047|NCT00868790|364642734|FG011|Period 2|Adverse Event|0|||
105724048|NCT00868790|364642735|FG012|Period 2|Adverse Event|0|||
105724049|NCT00868790|364642736|FG013|Period 2|Adverse Event|0|||
105724050|NCT00868790|364642723|FG000|Period 2|Lost to Follow-up|0|||
106137696|NCT00957229|366163457|FG000|Study Start|Adverse Event|0|||
105793074|NCT02545868|364898688|FG002|Overall Study|Non-compliance|1|||
105793075|NCT02545868|364898686|FG000|Overall Study|Treatment change|21|||
105793076|NCT02545868|364898687|FG001|Overall Study|Treatment change|19|||
105793077|NCT02545868|364898688|FG002|Overall Study|Treatment change|22|||
105793078|NCT02545868|364898686|FG000|Overall Study|Physician Decision|1|||
105793079|NCT02545868|364898687|FG001|Overall Study|Physician Decision|1|||
105793080|NCT02545868|364898688|FG002|Overall Study|Physician Decision|1|||
105724051|NCT00868790|364642724|FG001|Period 2|Lost to Follow-up|1|||
105724052|NCT00868790|364642725|FG002|Period 2|Lost to Follow-up|0|||
105724053|NCT00868790|364642726|FG003|Period 2|Lost to Follow-up|0|||
105724054|NCT00868790|364642727|FG004|Period 2|Lost to Follow-up|0|||
105724055|NCT00868790|364642728|FG005|Period 2|Lost to Follow-up|1|||
105724056|NCT00868790|364642729|FG006|Period 2|Lost to Follow-up|0|||
105724057|NCT00868790|364642730|FG007|Period 2|Lost to Follow-up|0|||
105724058|NCT00868790|364642731|FG008|Period 2|Lost to Follow-up|0|||
105724059|NCT00868790|364642732|FG009|Period 2|Lost to Follow-up|0|||
105724060|NCT00868790|364642733|FG010|Period 2|Lost to Follow-up|0|||
105724061|NCT00868790|364642734|FG011|Period 2|Lost to Follow-up|0|||
105724062|NCT00868790|364642735|FG012|Period 2|Lost to Follow-up|0|||
105724063|NCT00868790|364642736|FG013|Period 2|Lost to Follow-up|0|||
105724064|NCT00868790|364642723|FG000|Period 2|Withdrawal by Subject|0|||
105724065|NCT00868790|364642724|FG001|Period 2|Withdrawal by Subject|0|||
105724066|NCT00868790|364642725|FG002|Period 2|Withdrawal by Subject|0|||
105724067|NCT00868790|364642726|FG003|Period 2|Withdrawal by Subject|0|||
105724068|NCT00868790|364642727|FG004|Period 2|Withdrawal by Subject|0|||
105724069|NCT00868790|364642728|FG005|Period 2|Withdrawal by Subject|0|||
105724070|NCT00868790|364642729|FG006|Period 2|Withdrawal by Subject|0|||
105724071|NCT00868790|364642730|FG007|Period 2|Withdrawal by Subject|0|||
105724072|NCT00868790|364642731|FG008|Period 2|Withdrawal by Subject|1|||
105724073|NCT00868790|364642732|FG009|Period 2|Withdrawal by Subject|0|||
105724074|NCT00868790|364642733|FG010|Period 2|Withdrawal by Subject|0|||
105724075|NCT00868790|364642734|FG011|Period 2|Withdrawal by Subject|0|||
105724076|NCT00868790|364642735|FG012|Period 2|Withdrawal by Subject|0|||
105724077|NCT00868790|364642736|FG013|Period 2|Withdrawal by Subject|1|||
105724078|NCT00868790|364642723|FG000|Period 3|Adverse Event|0|||
105724079|NCT00868790|364642724|FG001|Period 3|Adverse Event|0|||
105724080|NCT00868790|364642725|FG002|Period 3|Adverse Event|0|||
105724081|NCT00868790|364642726|FG003|Period 3|Adverse Event|0|||
105724082|NCT00868790|364642727|FG004|Period 3|Adverse Event|0|||
105724083|NCT00868790|364642728|FG005|Period 3|Adverse Event|0|||
105724084|NCT00868790|364642729|FG006|Period 3|Adverse Event|0|||
105724085|NCT00868790|364642730|FG007|Period 3|Adverse Event|0|||
105724086|NCT00868790|364642731|FG008|Period 3|Adverse Event|0|||
105724087|NCT00868790|364642732|FG009|Period 3|Adverse Event|1|||
105724088|NCT00868790|364642733|FG010|Period 3|Adverse Event|0|||
105724089|NCT00868790|364642734|FG011|Period 3|Adverse Event|0|||
105724090|NCT00868790|364642735|FG012|Period 3|Adverse Event|0|||
105724091|NCT00868790|364642736|FG013|Period 3|Adverse Event|0|||
105724092|NCT00868790|364642723|FG000|Period 3|Protocol Violation|0|||
105724093|NCT00868790|364642724|FG001|Period 3|Protocol Violation|0|||
105724094|NCT00868790|364642725|FG002|Period 3|Protocol Violation|0|||
105724095|NCT00868790|364642726|FG003|Period 3|Protocol Violation|0|||
105724096|NCT00868790|364642727|FG004|Period 3|Protocol Violation|0|||
105724097|NCT00868790|364642728|FG005|Period 3|Protocol Violation|0|||
105724098|NCT00868790|364642729|FG006|Period 3|Protocol Violation|0|||
105724099|NCT00868790|364642730|FG007|Period 3|Protocol Violation|0|||
105724100|NCT00868790|364642731|FG008|Period 3|Protocol Violation|0|||
105724101|NCT00868790|364642732|FG009|Period 3|Protocol Violation|0|||
105793081|NCT02545868|364898686|FG000|Overall Study|Withdrawal by Subject|6|||
105793082|NCT02545868|364898687|FG001|Overall Study|Withdrawal by Subject|7|||
105793083|NCT02545868|364898688|FG002|Overall Study|Withdrawal by Subject|9|||
106137697|NCT00957229|366163458|FG001|Study Start|Adverse Event|3|||
106137698|NCT00957229|366163457|FG000|Study Start|Disease Progression|1|||
106137699|NCT00957229|366163458|FG001|Study Start|Disease Progression|0|||
106137700|NCT00957229|366163457|FG000|Reallocated to or Continued Vismodegib|Death|1|||
105724102|NCT00868790|364642733|FG010|Period 3|Protocol Violation|1|||
105793084|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Adverse Event|2|||
105793085|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Adverse Event|0|||
105793086|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Adverse Event|0|||
105724103|NCT00868790|364642734|FG011|Period 3|Protocol Violation|0|||
105724104|NCT00868790|364642735|FG012|Period 3|Protocol Violation|0|||
105724105|NCT00868790|364642736|FG013|Period 3|Protocol Violation|0|||
105724106|NCT00868790|364642723|FG000|Period 3|Study Terminated by Sponsor|0|||
105724107|NCT00868790|364642724|FG001|Period 3|Study Terminated by Sponsor|0|||
105724108|NCT00868790|364642725|FG002|Period 3|Study Terminated by Sponsor|0|||
105793087|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Adverse Event|0|||
105793088|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
105724109|NCT00868790|364642726|FG003|Period 3|Study Terminated by Sponsor|1|||
105724110|NCT00868790|364642727|FG004|Period 3|Study Terminated by Sponsor|0|||
105724111|NCT00868790|364642728|FG005|Period 3|Study Terminated by Sponsor|0|||
105724112|NCT00868790|364642729|FG006|Period 3|Study Terminated by Sponsor|0|||
106137701|NCT00957229|366163458|FG001|Reallocated to or Continued Vismodegib|Death|1|||
106137702|NCT00957229|366163457|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
105724113|NCT00868790|364642730|FG007|Period 3|Study Terminated by Sponsor|0|||
105724114|NCT00868790|364642731|FG008|Period 3|Study Terminated by Sponsor|0|||
105724115|NCT00868790|364642732|FG009|Period 3|Study Terminated by Sponsor|0|||
105724116|NCT00868790|364642733|FG010|Period 3|Study Terminated by Sponsor|0|||
105724117|NCT00868790|364642734|FG011|Period 3|Study Terminated by Sponsor|0|||
105724118|NCT00868790|364642735|FG012|Period 3|Study Terminated by Sponsor|0|||
105724119|NCT00868790|364642736|FG013|Period 3|Study Terminated by Sponsor|0|||
105724120|NCT00868790|364642723|FG000|Period 4|Adverse Event|0|||
105724121|NCT00868790|364642724|FG001|Period 4|Adverse Event|0|||
105724122|NCT00868790|364642725|FG002|Period 4|Adverse Event|0|||
105724123|NCT00868790|364642726|FG003|Period 4|Adverse Event|0|||
105724124|NCT00868790|364642727|FG004|Period 4|Adverse Event|0|||
105724125|NCT00868790|364642728|FG005|Period 4|Adverse Event|0|||
105724126|NCT00868790|364642729|FG006|Period 4|Adverse Event|0|||
105724127|NCT00868790|364642730|FG007|Period 4|Adverse Event|1|||
105724128|NCT00868790|364642731|FG008|Period 4|Adverse Event|0|||
105724129|NCT00868790|364642732|FG009|Period 4|Adverse Event|0|||
105724130|NCT00868790|364642733|FG010|Period 4|Adverse Event|1|||
105724131|NCT00868790|364642734|FG011|Period 4|Adverse Event|0|||
105724132|NCT00868790|364642735|FG012|Period 4|Adverse Event|1|||
105724133|NCT00868790|364642736|FG013|Period 4|Adverse Event|0|||
105724134|NCT00868790|364642723|FG000|Period 4|Lost to Follow-up|0|||
105724135|NCT00868790|364642724|FG001|Period 4|Lost to Follow-up|0|||
105724136|NCT00868790|364642725|FG002|Period 4|Lost to Follow-up|0|||
105724137|NCT00868790|364642726|FG003|Period 4|Lost to Follow-up|0|||
105724138|NCT00868790|364642727|FG004|Period 4|Lost to Follow-up|0|||
105724139|NCT00868790|364642728|FG005|Period 4|Lost to Follow-up|0|||
105724140|NCT00868790|364642729|FG006|Period 4|Lost to Follow-up|0|||
105724141|NCT00868790|364642730|FG007|Period 4|Lost to Follow-up|1|||
105724142|NCT00868790|364642731|FG008|Period 4|Lost to Follow-up|0|||
105724143|NCT00868790|364642732|FG009|Period 4|Lost to Follow-up|0|||
105724144|NCT00868790|364642733|FG010|Period 4|Lost to Follow-up|0|||
105724145|NCT00868790|364642734|FG011|Period 4|Lost to Follow-up|0|||
105724146|NCT00868790|364642735|FG012|Period 4|Lost to Follow-up|0|||
105724147|NCT00868790|364642736|FG013|Period 4|Lost to Follow-up|0|||
105724148|NCT00868790|364642723|FG000|Period 4|Study Terminated by Sponsor|2|||
105724149|NCT00868790|364642724|FG001|Period 4|Study Terminated by Sponsor|0|||
105724150|NCT00868790|364642725|FG002|Period 4|Study Terminated by Sponsor|0|||
105724151|NCT00868790|364642726|FG003|Period 4|Study Terminated by Sponsor|0|||
105724152|NCT00868790|364642727|FG004|Period 4|Study Terminated by Sponsor|0|||
105724153|NCT00868790|364642728|FG005|Period 4|Study Terminated by Sponsor|0|||
105724154|NCT00868790|364642729|FG006|Period 4|Study Terminated by Sponsor|0|||
105724155|NCT00868790|364642730|FG007|Period 4|Study Terminated by Sponsor|1|||
105724156|NCT00868790|364642731|FG008|Period 4|Study Terminated by Sponsor|2|||
105724157|NCT00868790|364642732|FG009|Period 4|Study Terminated by Sponsor|0|||
105724158|NCT00868790|364642733|FG010|Period 4|Study Terminated by Sponsor|2|||
105724159|NCT00868790|364642734|FG011|Period 4|Study Terminated by Sponsor|1|||
105724160|NCT00868790|364642735|FG012|Period 4|Study Terminated by Sponsor|0|||
105724161|NCT00868790|364642736|FG013|Period 4|Study Terminated by Sponsor|1|||
105724162|NCT00868790|364642723|FG000|Period 4|Abnormal ALT/AST|0|||
105724163|NCT00868790|364642724|FG001|Period 4|Abnormal ALT/AST|0|||
105724164|NCT00868790|364642725|FG002|Period 4|Abnormal ALT/AST|1|||
105936046|NCT04565756|365425283|FG004|Overall Study|Withdrawal by Subject|1|||
105936047|NCT04565756|365425284|FG005|Overall Study|Withdrawal by Subject|0|||
105936048|NCT04565756|365425279|FG000|Overall Study|Protocol Violation|0|||
105936049|NCT04565756|365425280|FG001|Overall Study|Protocol Violation|0|||
105936050|NCT04565756|365425281|FG002|Overall Study|Protocol Violation|0|||
105936051|NCT04565756|365425282|FG003|Overall Study|Protocol Violation|0|||
105936052|NCT04565756|365425283|FG004|Overall Study|Protocol Violation|0|||
105936053|NCT04565756|365425284|FG005|Overall Study|Protocol Violation|1|||
106137703|NCT00957229|366163458|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
106137704|NCT01101165|366163459|FG000|Period 1|Adverse Event|1|||
105724165|NCT00868790|364642726|FG003|Period 4|Abnormal ALT/AST|0|||
105724166|NCT00868790|364642727|FG004|Period 4|Abnormal ALT/AST|0|||
105724167|NCT00868790|364642728|FG005|Period 4|Abnormal ALT/AST|0|||
105724168|NCT00868790|364642729|FG006|Period 4|Abnormal ALT/AST|0|||
105724169|NCT00868790|364642730|FG007|Period 4|Abnormal ALT/AST|0|||
105724170|NCT00868790|364642731|FG008|Period 4|Abnormal ALT/AST|0|||
105724171|NCT00868790|364642732|FG009|Period 4|Abnormal ALT/AST|0|||
105724172|NCT00868790|364642733|FG010|Period 4|Abnormal ALT/AST|0|||
105724173|NCT00868790|364642734|FG011|Period 4|Abnormal ALT/AST|0|||
105724174|NCT00868790|364642735|FG012|Period 4|Abnormal ALT/AST|0|||
105724175|NCT00868790|364642736|FG013|Period 4|Abnormal ALT/AST|0|||
105724176|NCT00868790|364642723|FG000|Post-study|Withdrawal by Subject|0|||
106137705|NCT01101165|366163460|FG001|Period 1|Adverse Event|2|||
105724177|NCT00868790|364642724|FG001|Post-study|Withdrawal by Subject|0|||
105724178|NCT00868790|364642725|FG002|Post-study|Withdrawal by Subject|0|||
105724179|NCT00868790|364642726|FG003|Post-study|Withdrawal by Subject|0|||
105936054|NCT01185366|365425285|FG000|First Line Therapy|Insurance Coverage Denied|1|||
106137706|NCT01101165|366163459|FG000|Period 1|Withdrawal by Subject|0|||
106137707|NCT01101165|366163460|FG001|Period 1|Withdrawal by Subject|2|||
106137708|NCT01101165|366163459|FG000|Period 1|Positive Drug Screen|0|||
106137709|NCT01101165|366163460|FG001|Period 1|Positive Drug Screen|1|||
106137710|NCT01101165|366163459|FG000|Period 1|Lost to Follow-up|1|||
106137711|NCT01101165|366163460|FG001|Period 1|Lost to Follow-up|0|||
106137712|NCT01101165|366163459|FG000|Period 2|Withdrawal by Subject|3|||
106137713|NCT01101165|366163460|FG001|Period 2|Withdrawal by Subject|1|||
106137714|NCT01101165|366163459|FG000|Period 2|Adverse Event|1|||
105793089|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
105793090|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
105793091|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
105793092|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
105793093|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
105793094|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
105793095|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
105793096|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Physician Decision|1|||
105793097|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Physician Decision|0|||
105793098|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Physician Decision|0|||
105793099|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Physician Decision|0|||
105793100|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Pregnancy|1|||
105793101|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Pregnancy|0|||
105793102|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Pregnancy|0|||
105793103|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Pregnancy|0|||
105793104|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
105793105|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
105793106|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
105793107|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
105793108|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
105793109|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
105793110|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
105793111|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
105793112|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
105793113|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
105793114|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
105793115|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
105793116|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
105793117|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
105793118|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
105793119|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
105793120|NCT04057573|364898689|FG000|24-Week Double-Blind Period|Not Treated|1|||
105793121|NCT04057573|364898690|FG001|24-Week Double-Blind Period|Not Treated|0|||
105793122|NCT04057573|364898691|FG002|24-Week Double-Blind Period|Not Treated|0|||
105793123|NCT04057573|364898692|FG003|24-Week Double-Blind Period|Not Treated|0|||
105793124|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
105793125|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
106137715|NCT01101165|366163460|FG001|Period 2|Adverse Event|0|||
105724180|NCT00868790|364642727|FG004|Post-study|Withdrawal by Subject|1|||
105724181|NCT00868790|364642728|FG005|Post-study|Withdrawal by Subject|0|||
105724182|NCT00868790|364642729|FG006|Post-study|Withdrawal by Subject|0|||
105724183|NCT00868790|364642730|FG007|Post-study|Withdrawal by Subject|0|||
105724184|NCT00868790|364642731|FG008|Post-study|Withdrawal by Subject|0|||
105724185|NCT00868790|364642732|FG009|Post-study|Withdrawal by Subject|0|||
105724186|NCT00868790|364642733|FG010|Post-study|Withdrawal by Subject|0|||
105724187|NCT00868790|364642734|FG011|Post-study|Withdrawal by Subject|0|||
105724188|NCT00868790|364642735|FG012|Post-study|Withdrawal by Subject|0|||
105724189|NCT00868790|364642736|FG013|Post-study|Withdrawal by Subject|0|||
105724190|NCT00868790|364642723|FG000|Post-study|Excluded Medication|0|||
105724191|NCT00868790|364642724|FG001|Post-study|Excluded Medication|0|||
105724192|NCT00868790|364642725|FG002|Post-study|Excluded Medication|0|||
105724193|NCT00868790|364642726|FG003|Post-study|Excluded Medication|0|||
105724194|NCT00868790|364642727|FG004|Post-study|Excluded Medication|0|||
106137716|NCT03201809|366163461|FG000|Overall Study|Lost to Follow-up|2|||
106137717|NCT03201809|366163462|FG001|Overall Study|Lost to Follow-up|0|||
105724195|NCT00868790|364642728|FG005|Post-study|Excluded Medication|0|||
105724196|NCT00868790|364642729|FG006|Post-study|Excluded Medication|0|||
105724197|NCT00868790|364642730|FG007|Post-study|Excluded Medication|2|||
105724198|NCT00868790|364642731|FG008|Post-study|Excluded Medication|0|||
105724199|NCT00868790|364642732|FG009|Post-study|Excluded Medication|1|||
105724200|NCT00868790|364642733|FG010|Post-study|Excluded Medication|0|||
105724201|NCT00868790|364642734|FG011|Post-study|Excluded Medication|0|||
105724202|NCT00868790|364642735|FG012|Post-study|Excluded Medication|0|||
105724203|NCT00868790|364642736|FG013|Post-study|Excluded Medication|0|||
105793126|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
105793127|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
105793128|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
105793129|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
105793130|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
106137718|NCT02846415|366163464|FG000|Overall Study|Lost to Follow-up|2|||
105724204|NCT03377634|364642739|FG000|Study Period|Adverse Event|1|||
105724205|NCT03377634|364642740|FG001|Study Period|Adverse Event|0|||
105724206|NCT03377634|364642739|FG000|Study Period|Withdrawal by Subject|1|||
105724207|NCT03377634|364642740|FG001|Study Period|Withdrawal by Subject|0|||
105724208|NCT01475734|364644205|FG000|Overall Study|Withdrawal by Subject|1|||
105724209|NCT01475734|364644206|FG001|Overall Study|Withdrawal by Subject|0|||
105724210|NCT01475734|364644205|FG000|Overall Study|Protocol Violation|1|||
105724211|NCT01475734|364644206|FG001|Overall Study|Protocol Violation|0|||
105724212|NCT01475734|364644205|FG000|Overall Study|Physician Decision|0|||
105724213|NCT01475734|364644206|FG001|Overall Study|Physician Decision|1|||
105724214|NCT01147497|364644217|FG000|Overall Study|failed insertion|2|||
105724215|NCT01147497|364644218|FG001|Overall Study|failed insertion|0|||
105724216|NCT01700829|364644221|FG000|Overall Study|Withdrawal by Subject|1|||
105724217|NCT01700829|364644222|FG001|Overall Study|Withdrawal by Subject|1|||
105724218|NCT03367871|364644223|FG000|Overall Study|Lost to Follow-up|1|||
105724219|NCT02013544|364644225|FG000|Overall Study|Adverse Event|5|||
105724220|NCT02013544|364644226|FG001|Overall Study|Adverse Event|5|||
105724221|NCT02013544|364644225|FG000|Overall Study|Lost to Follow-up|2|||
105724222|NCT02013544|364644226|FG001|Overall Study|Lost to Follow-up|3|||
105724223|NCT02013544|364644225|FG000|Overall Study|Withdrawal by Subject|2|||
105724224|NCT02013544|364644226|FG001|Overall Study|Withdrawal by Subject|8|||
105724225|NCT02013544|364644225|FG000|Overall Study|Physician Decision|0|||
105724226|NCT02013544|364644226|FG001|Overall Study|Physician Decision|1|||
105724227|NCT02013544|364644225|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
105724228|NCT02013544|364644226|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
105724229|NCT00238264|364644227|FG000|Overall Study|Death|7|||
105724230|NCT00238264|364644227|FG000|Overall Study|Lost to Follow-up|18|||
105724231|NCT00238264|364644227|FG000|Overall Study|Withdrawal by Subject|4|||
105724232|NCT00238264|364644227|FG000|Overall Study|Ineligible|7|||
105724233|NCT00891735|364644228|FG000|Overall Study|Adverse Event|2|||
105724234|NCT00891735|364644229|FG001|Overall Study|Adverse Event|0|||
105724235|NCT00891735|364644230|FG002|Overall Study|Adverse Event|2|||
105724236|NCT00891735|364644231|FG003|Overall Study|Adverse Event|0|||
105724237|NCT00891735|364644228|FG000|Overall Study|Death|8|||
105724238|NCT00891735|364644229|FG001|Overall Study|Death|5|||
105724239|NCT00891735|364644230|FG002|Overall Study|Death|4|||
105724240|NCT00891735|364644231|FG003|Overall Study|Death|5|||
105724241|NCT00891735|364644228|FG000|Overall Study|Lost to Follow-up|2|||
105724242|NCT00891735|364644229|FG001|Overall Study|Lost to Follow-up|2|||
105724243|NCT00891735|364644230|FG002|Overall Study|Lost to Follow-up|2|||
105724244|NCT00891735|364644231|FG003|Overall Study|Lost to Follow-up|2|||
105724245|NCT00891735|364644228|FG000|Overall Study|Physician's decision to withdraw patient|1|||
105724246|NCT00891735|364644229|FG001|Overall Study|Physician's decision to withdraw patient|0|||
105724247|NCT00891735|364644230|FG002|Overall Study|Physician's decision to withdraw patient|0|||
105724248|NCT00891735|364644231|FG003|Overall Study|Physician's decision to withdraw patient|0|||
105724249|NCT00891735|364644228|FG000|Overall Study|Patient's decision to withdraw|4|||
105724250|NCT00891735|364644229|FG001|Overall Study|Patient's decision to withdraw|9|||
105724251|NCT00891735|364644230|FG002|Overall Study|Patient's decision to withdraw|4|||
105724252|NCT00891735|364644231|FG003|Overall Study|Patient's decision to withdraw|8|||
105724253|NCT01085682|364644234|FG000|Overall Study|Withdrawal by Subject|25|||
105724254|NCT01085682|364644235|FG001|Overall Study|Withdrawal by Subject|25|||
105724255|NCT00813995|364644236|FG000|Overall Study|Clinical adverse event|9|||
105724256|NCT00813995|364644237|FG001|Overall Study|Clinical adverse event|3|||
105724257|NCT00813995|364644236|FG000|Overall Study|Laboratory adverse event|0|||
105724258|NCT00813995|364644237|FG001|Overall Study|Laboratory adverse event|2|||
105724259|NCT00813995|364644236|FG000|Overall Study|Lack of Efficacy|1|||
105724260|NCT00813995|364644237|FG001|Overall Study|Lack of Efficacy|0|||
105724261|NCT00813995|364644236|FG000|Overall Study|Lost to Follow-up|4|||
105724262|NCT00813995|364644237|FG001|Overall Study|Lost to Follow-up|2|||
105724263|NCT00813995|364644236|FG000|Overall Study|Other reason|2|||
105724264|NCT00813995|364644237|FG001|Overall Study|Other reason|2|||
105724265|NCT00813995|364644236|FG000|Overall Study|Protocol Violation|3|||
105936055|NCT01185366|365425286|FG001|First Line Therapy|Insurance Coverage Denied|1|||
106137719|NCT02846415|366163465|FG001|Overall Study|Lost to Follow-up|0|||
106137720|NCT02846415|366163464|FG000|Overall Study|Withdrawal by Subject|1|||
106137721|NCT02846415|366163465|FG001|Overall Study|Withdrawal by Subject|1|||
105724266|NCT00813995|364644237|FG001|Overall Study|Protocol Violation|2|||
105724267|NCT00813995|364644236|FG000|Overall Study|Subject moved|4|||
105724268|NCT00813995|364644237|FG001|Overall Study|Subject moved|0|||
105724269|NCT00813995|364644236|FG000|Overall Study|Withdrawal by Subject|0|||
105724270|NCT00813995|364644237|FG001|Overall Study|Withdrawal by Subject|5|||
105724271|NCT01614964|364644238|FG000|Overall Study|Withdrawal by Subject|2|||
106137722|NCT00001575|366163469|FG000|Overall Study|Screening failures-Ph I portion|22|||
106137723|NCT00001575|366163469|FG000|Overall Study|Withdrawn/deaths|23|||
105724272|NCT01614964|364644239|FG001|Overall Study|Withdrawal by Subject|0|||
105724273|NCT01614964|364644238|FG000|Overall Study|Lost to Follow-up|3|||
105724274|NCT01614964|364644239|FG001|Overall Study|Lost to Follow-up|0|||
105724275|NCT00619957|364644242|FG000|Month 24 Double-Blind|Adverse Event|9|||
105724276|NCT00619957|364644243|FG001|Month 24 Double-Blind|Adverse Event|7|||
105724277|NCT00619957|364644242|FG000|Month 24 Double-Blind|Protocol Violation|1|||
105724278|NCT00619957|364644243|FG001|Month 24 Double-Blind|Protocol Violation|0|||
105724279|NCT00619957|364644242|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
105724280|NCT00619957|364644243|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
105724281|NCT00619957|364644242|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
105724282|NCT00619957|364644243|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
105724283|NCT00619957|364644242|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
105724284|NCT00619957|364644243|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
105724285|NCT00619957|364644242|FG000|Month 48 Open-Label|Adverse Event|4|||
105724286|NCT00619957|364644243|FG001|Month 48 Open-Label|Adverse Event|4|||
105724287|NCT00619957|364644242|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
105724288|NCT00619957|364644243|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
105724289|NCT00619957|364644242|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
105724290|NCT00619957|364644243|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
105724291|NCT00727402|364644244|FG000|Overall Study|Physician Decision|116|||
105724292|NCT00723957|364644245|FG000|Overall Study|Adverse event unrelated to study drug|1|||
105724293|NCT00723957|364644246|FG001|Overall Study|Adverse event unrelated to study drug|4|||
105724294|NCT00723957|364644245|FG000|Overall Study|Death|3|||
105724295|NCT00723957|364644246|FG001|Overall Study|Death|4|||
105724296|NCT00723957|364644245|FG000|Overall Study|Disease progression|27|||
105724297|NCT00723957|364644246|FG001|Overall Study|Disease progression|25|||
105724298|NCT00723957|364644245|FG000|Overall Study|Maximum clinical benefit|4|||
105724299|NCT00723957|364644246|FG001|Overall Study|Maximum clinical benefit|5|||
105724300|NCT00723957|364644245|FG000|Overall Study|Investigator decision|1|||
105724301|NCT00723957|364644246|FG001|Overall Study|Investigator decision|1|||
105724302|NCT00723957|364644245|FG000|Overall Study|Study drug toxicity|4|||
105724303|NCT00723957|364644246|FG001|Overall Study|Study drug toxicity|6|||
105724304|NCT00723957|364644245|FG000|Overall Study|Withdrawal by Subject|7|||
105724305|NCT00723957|364644246|FG001|Overall Study|Withdrawal by Subject|5|||
105724306|NCT00723957|364644245|FG000|Overall Study|Reason not analyzed|1|||
105724307|NCT00723957|364644246|FG001|Overall Study|Reason not analyzed|0|||
105724308|NCT00723957|364644245|FG000|Overall Study|Never received treatment|3|||
105724309|NCT00723957|364644246|FG001|Overall Study|Never received treatment|3|||
105724310|NCT00519077|364644247|FG000|Overall Study|Death|6|||
105724311|NCT00519077|364644247|FG000|Overall Study|Other|2|||
105724312|NCT05681715|364644250|FG000|Training Period (6-weeks)|Adverse Event|3|||
105724313|NCT05681715|364644251|FG001|Training Period (6-weeks)|Adverse Event|0|||
105724314|NCT05681715|364644252|FG002|Training Period (6-weeks)|Adverse Event|0|||
105724315|NCT05681715|364644250|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
105724316|NCT05681715|364644251|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
105724317|NCT05681715|364644252|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
105724318|NCT05681715|364644250|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
105724319|NCT05681715|364644251|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
105724320|NCT05681715|364644252|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
105724321|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
105724322|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
105724323|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
105724324|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
105724325|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
105724326|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
105724327|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
105724328|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
105724329|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
105724330|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
105724331|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
105724332|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
105724333|NCT05681715|364644250|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
105724334|NCT05681715|364644251|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
105724335|NCT05681715|364644252|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
105724336|NCT01709331|364644253|FG000|Overall Study|Adverse Event|1|||
105793131|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
105793132|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
105793133|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
105793134|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
105793135|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
105793136|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
105793137|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
105793138|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
105793139|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
105793140|NCT04057573|364898689|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
105793141|NCT04057573|364898690|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
105793142|NCT04057573|364898691|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
105724337|NCT03896295|364644260|FG000|Overall Study|Adverse Event|0|||
105724338|NCT03896295|364644261|FG001|Overall Study|Adverse Event|1|||
105724339|NCT03896295|364644260|FG000|Overall Study|COVID-19|7|||
105724340|NCT03896295|364644261|FG001|Overall Study|COVID-19|29|||
105724341|NCT01651780|364644262|FG000|Overall Study|Physician decision: No 30-day visit|2|||
105724342|NCT01651780|364644263|FG001|Overall Study|Physician decision: No 30-day visit|1|||
105724343|NCT01651780|364644262|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
105793143|NCT04057573|364898692|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
105793144|NCT04465916|364898693|FG000|Overall Study|Withdrawal by Subject|0|||
105793145|NCT04465916|364898694|FG001|Overall Study|Withdrawal by Subject|1|||
105793146|NCT03286400|364898695|FG000|Overall Study|Death|10|||
105793147|NCT03286400|364898695|FG000|Overall Study|Lost to Follow-up|10|||
105793148|NCT03286400|364898695|FG000|Overall Study|Physician Decision|1|||
105793149|NCT03286400|364898695|FG000|Overall Study|Scheduling difficulty|4|||
105793150|NCT03079869|364898698|FG000|Overall Study|Adverse Event|6|||
105793151|NCT03079869|364898699|FG001|Overall Study|Adverse Event|8|||
105793152|NCT03079869|364898698|FG000|Overall Study|Withdrawal by Subject|4|||
105793153|NCT03079869|364898699|FG001|Overall Study|Withdrawal by Subject|1|||
105793154|NCT03079869|364898698|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
105793155|NCT03079869|364898699|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
105793156|NCT03976076|364898700|FG000|Overall Study|Withdrawal by Subject|2|||
105793157|NCT02411110|364898704|FG000|Treatment Period 1|Adverse Event|4|||
105793158|NCT02411110|364898705|FG001|Treatment Period 1|Adverse Event|2|||
105793159|NCT02411110|364898704|FG000|Treatment Period 1|Lost to Follow-up|1|||
105793160|NCT02411110|364898705|FG001|Treatment Period 1|Lost to Follow-up|0|||
105793161|NCT02411110|364898704|FG000|Treatment Period 1|Personal Reasons|2|||
105793162|NCT02411110|364898705|FG001|Treatment Period 1|Personal Reasons|5|||
105793163|NCT02411110|364898704|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
105793164|NCT02411110|364898705|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
105793165|NCT02411110|364898704|FG000|Treatment Period 2|Adverse Event|1|||
105793166|NCT02411110|364898705|FG001|Treatment Period 2|Adverse Event|0|||
105793167|NCT02411110|364898704|FG000|Treatment Period 2|Lost to Follow-up|0|||
105793168|NCT02411110|364898705|FG001|Treatment Period 2|Lost to Follow-up|2|||
105793169|NCT02411110|364898704|FG000|Treatment Period 2|Personal Reasons|0|||
105793170|NCT02411110|364898705|FG001|Treatment Period 2|Personal Reasons|2|||
105793171|NCT00759174|364898714|FG000|Overall Study|Other|0|||
105793172|NCT00759174|364898715|FG001|Overall Study|Other|2|||
105793173|NCT01643928|364898716|FG000|Overall Study|Lost to Follow-up|1|||
105793174|NCT01643928|364898717|FG001|Overall Study|Lost to Follow-up|0|||
105793175|NCT01643928|364898718|FG002|Overall Study|Lost to Follow-up|2|||
105793176|NCT01643928|364898719|FG003|Overall Study|Lost to Follow-up|0|||
105793177|NCT01643928|364898720|FG004|Overall Study|Lost to Follow-up|0|||
105793178|NCT01643928|364898716|FG000|Overall Study|Withdrawal by Subject|2|||
105793179|NCT01643928|364898717|FG001|Overall Study|Withdrawal by Subject|0|||
105793180|NCT01643928|364898718|FG002|Overall Study|Withdrawal by Subject|0|||
105793181|NCT01643928|364898719|FG003|Overall Study|Withdrawal by Subject|1|||
105724344|NCT01651780|364644263|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
105724345|NCT01651780|364644262|FG000|Overall Study|Withdrawal by Subject|2|||
105793182|NCT01643928|364898720|FG004|Overall Study|Withdrawal by Subject|0|||
105793183|NCT01643928|364898716|FG000|Overall Study|Pregnancy|0|||
105793184|NCT01643928|364898717|FG001|Overall Study|Pregnancy|0|||
105793185|NCT01643928|364898718|FG002|Overall Study|Pregnancy|0|||
105793186|NCT01643928|364898719|FG003|Overall Study|Pregnancy|1|||
105724346|NCT01651780|364644263|FG001|Overall Study|Withdrawal by Subject|0|||
105724347|NCT01651780|364644262|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
105793187|NCT01643928|364898720|FG004|Overall Study|Pregnancy|0|||
105793188|NCT01643928|364898716|FG000|Overall Study|Other|5|||
105793189|NCT01643928|364898717|FG001|Overall Study|Other|1|||
105793190|NCT01643928|364898718|FG002|Overall Study|Other|1|||
105793191|NCT01643928|364898719|FG003|Overall Study|Other|0|||
105793192|NCT01643928|364898720|FG004|Overall Study|Other|0|||
105793193|NCT01643928|364898716|FG000|Overall Study|Adverse Event|2|||
105793194|NCT01643928|364898717|FG001|Overall Study|Adverse Event|1|||
105793195|NCT01643928|364898718|FG002|Overall Study|Adverse Event|0|||
105793196|NCT01643928|364898719|FG003|Overall Study|Adverse Event|1|||
105793197|NCT01643928|364898720|FG004|Overall Study|Adverse Event|2|||
105793198|NCT00996632|364898725|FG000|Overall Study|Physician Decision|0|||
105793199|NCT00996632|364898726|FG001|Overall Study|Physician Decision|0|||
105793200|NCT05354206|364898727|FG000|Overall Study|Withdrawal by Subject|1|||
105793201|NCT05354206|364898728|FG001|Overall Study|Withdrawal by Subject|0|||
105793202|NCT01414062|364898731|FG000|Overall Study|Lost to Follow-up|3|||
105793203|NCT01414062|364898732|FG001|Overall Study|Lost to Follow-up|2|||
105793204|NCT01414062|364898731|FG000|Overall Study|Left Country|1|||
105793205|NCT01414062|364898732|FG001|Overall Study|Left Country|1|||
105793206|NCT01414062|364898731|FG000|Overall Study|Family Disapproval|1|||
105793207|NCT01414062|364898732|FG001|Overall Study|Family Disapproval|0|||
105793208|NCT01414062|364898731|FG000|Overall Study|Withdrawal by Subject|0|||
105793209|NCT01414062|364898732|FG001|Overall Study|Withdrawal by Subject|1|||
105793210|NCT04936334|364898733|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
105793211|NCT01563029|364898734|FG000|Overall Study|Adverse Event|1|||
105793212|NCT01563029|364898735|FG001|Overall Study|Adverse Event|0|||
105793213|NCT01563029|364898736|FG002|Overall Study|Adverse Event|1|||
105793214|NCT01563029|364898737|FG003|Overall Study|Adverse Event|2|||
105793215|NCT01563029|364898738|FG004|Overall Study|Adverse Event|1|||
105793216|NCT01563029|364898734|FG000|Overall Study|Lack of Efficacy|42|||
105793217|NCT01563029|364898735|FG001|Overall Study|Lack of Efficacy|16|||
105793218|NCT01563029|364898736|FG002|Overall Study|Lack of Efficacy|23|||
105793219|NCT01563029|364898737|FG003|Overall Study|Lack of Efficacy|21|||
105793220|NCT01563029|364898738|FG004|Overall Study|Lack of Efficacy|19|||
105793221|NCT01563029|364898734|FG000|Overall Study|Protocol Violation|1|||
105793222|NCT01563029|364898735|FG001|Overall Study|Protocol Violation|2|||
105793223|NCT01563029|364898736|FG002|Overall Study|Protocol Violation|3|||
105793224|NCT01563029|364898737|FG003|Overall Study|Protocol Violation|1|||
105793225|NCT01563029|364898738|FG004|Overall Study|Protocol Violation|3|||
105793226|NCT01563029|364898734|FG000|Overall Study|Protocol defined stopping criteria|1|||
105793227|NCT01563029|364898735|FG001|Overall Study|Protocol defined stopping criteria|0|||
105793228|NCT01563029|364898736|FG002|Overall Study|Protocol defined stopping criteria|0|||
105793229|NCT01563029|364898737|FG003|Overall Study|Protocol defined stopping criteria|0|||
105793230|NCT01563029|364898738|FG004|Overall Study|Protocol defined stopping criteria|0|||
105793231|NCT01563029|364898734|FG000|Overall Study|Lost to Follow-up|1|||
105793232|NCT01563029|364898735|FG001|Overall Study|Lost to Follow-up|0|||
105793233|NCT01563029|364898736|FG002|Overall Study|Lost to Follow-up|1|||
105793234|NCT01563029|364898737|FG003|Overall Study|Lost to Follow-up|1|||
105793235|NCT01563029|364898738|FG004|Overall Study|Lost to Follow-up|1|||
105724348|NCT01651780|364644263|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105724349|NCT01651780|364644262|FG000|Overall Study|Lost to Follow-up|1|||
105724350|NCT01651780|364644263|FG001|Overall Study|Lost to Follow-up|2|||
105724351|NCT01651780|364644262|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
105724352|NCT01651780|364644263|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
105724353|NCT01628926|364644264|FG000|Overall Study|Adverse Event|13|||
105724354|NCT01628926|364644265|FG001|Overall Study|Adverse Event|11|||
105724355|NCT01628926|364644266|FG002|Overall Study|Adverse Event|9|||
105724356|NCT01628926|364644264|FG000|Overall Study|Lack of Efficacy|2|||
105724357|NCT01628926|364644265|FG001|Overall Study|Lack of Efficacy|1|||
105724358|NCT01628926|364644266|FG002|Overall Study|Lack of Efficacy|5|||
105724359|NCT01628926|364644264|FG000|Overall Study|Withdrawal by Subject|6|||
105724360|NCT01628926|364644265|FG001|Overall Study|Withdrawal by Subject|4|||
105724361|NCT01628926|364644266|FG002|Overall Study|Withdrawal by Subject|2|||
105724362|NCT01628926|364644264|FG000|Overall Study|Protocol Violation|0|||
105724363|NCT01628926|364644265|FG001|Overall Study|Protocol Violation|1|||
105724364|NCT01628926|364644266|FG002|Overall Study|Protocol Violation|0|||
105724365|NCT01628926|364644264|FG000|Overall Study|Discontinuation criteria|3|||
105724366|NCT01628926|364644265|FG001|Overall Study|Discontinuation criteria|4|||
105724367|NCT01628926|364644266|FG002|Overall Study|Discontinuation criteria|0|||
105936056|NCT01185366|365425285|FG000|First Line Therapy|Withdrawal by Subject|1|||
105724368|NCT01628926|364644264|FG000|Overall Study|Physician Decision|2|||
105724369|NCT01628926|364644265|FG001|Overall Study|Physician Decision|2|||
105724370|NCT01628926|364644266|FG002|Overall Study|Physician Decision|1|||
105793236|NCT01563029|364898734|FG000|Overall Study|Physician Decision|3|||
105793237|NCT01563029|364898735|FG001|Overall Study|Physician Decision|5|||
105793238|NCT01563029|364898736|FG002|Overall Study|Physician Decision|2|||
105793239|NCT01563029|364898737|FG003|Overall Study|Physician Decision|4|||
105793240|NCT01563029|364898738|FG004|Overall Study|Physician Decision|2|||
105793241|NCT01563029|364898734|FG000|Overall Study|Withdrawal by Subject|4|||
105793242|NCT01563029|364898735|FG001|Overall Study|Withdrawal by Subject|1|||
105793243|NCT01563029|364898736|FG002|Overall Study|Withdrawal by Subject|3|||
105793244|NCT01563029|364898737|FG003|Overall Study|Withdrawal by Subject|4|||
105793245|NCT01563029|364898738|FG004|Overall Study|Withdrawal by Subject|3|||
105793246|NCT03069365|364898741|FG000|Overall Study|Adverse Event|1|||
105793247|NCT04057118|364898744|FG000|Overall Study|Adverse Event|1|||
105724371|NCT03029832|364644267|FG000|Overall Study|Safety Follow-Up Completed|2|||
105724372|NCT03029832|364644268|FG001|Overall Study|Safety Follow-Up Completed|0|||
105724373|NCT03029832|364644267|FG000|Overall Study|Death due to Disease Progression|1|||
105724374|NCT03029832|364644268|FG001|Overall Study|Death due to Disease Progression|0|||
105724375|NCT03029832|364644267|FG000|Overall Study|Study Terminated By Sponsor|1|||
105724376|NCT03029832|364644268|FG001|Overall Study|Study Terminated By Sponsor|1|||
105724377|NCT01412229|364644269|FG000|Overall Study|Physician Decision|1|||
105724378|NCT04373460|364644270|FG000|Overall Study|Did not receive tranfusion|18|||
105724379|NCT04373460|364644271|FG001|Overall Study|Did not receive tranfusion|26|||
105724380|NCT00454207|364644272|FG000|Overall Study|Adverse Event|3|||
105724381|NCT00454207|364644273|FG001|Overall Study|Adverse Event|1|||
105724382|NCT00454207|364644272|FG000|Overall Study|Lack of Efficacy|1|||
105724383|NCT00454207|364644273|FG001|Overall Study|Lack of Efficacy|0|||
105724384|NCT00454207|364644272|FG000|Overall Study|Protocol Violation|0|||
105724385|NCT00454207|364644273|FG001|Overall Study|Protocol Violation|1|||
105724386|NCT00700804|364644282|FG000|Overall Study|Withdrawal by Subject|1|||
105724387|NCT00700804|364644283|FG001|Overall Study|Withdrawal by Subject|2|||
105724388|NCT00700804|364644282|FG000|Overall Study|Protocol Violation|1|||
105724389|NCT00700804|364644283|FG001|Overall Study|Protocol Violation|1|||
105724390|NCT00700804|364644282|FG000|Overall Study|Loose Stools|1|||
105724391|NCT00700804|364644283|FG001|Overall Study|Loose Stools|1|||
105724392|NCT00151892|364644284|FG000|Overall Study|Lack of Efficacy|50|||
105724393|NCT00151892|364644285|FG001|Overall Study|Lack of Efficacy|57|||
105724394|NCT00151892|364644284|FG000|Overall Study|Patient request|10|||
105724395|NCT00151892|364644285|FG001|Overall Study|Patient request|7|||
105724396|NCT00151892|364644284|FG000|Overall Study|Lost to Follow-up|5|||
105724397|NCT00151892|364644285|FG001|Overall Study|Lost to Follow-up|10|||
105724398|NCT00151892|364644284|FG000|Overall Study|Adverse Event|6|||
105724399|NCT00151892|364644285|FG001|Overall Study|Adverse Event|3|||
105724400|NCT00151892|364644284|FG000|Overall Study|Protocol Violation|3|||
105724401|NCT00151892|364644285|FG001|Overall Study|Protocol Violation|3|||
105724402|NCT00151892|364644284|FG000|Overall Study|Non-compliance|0|||
105724403|NCT00151892|364644285|FG001|Overall Study|Non-compliance|1|||
105724404|NCT00151892|364644284|FG000|Overall Study|Pregnancy|0|||
105724405|NCT00151892|364644285|FG001|Overall Study|Pregnancy|1|||
105724406|NCT00151892|364644284|FG000|Overall Study|Did not return for a visit|1|||
105724407|NCT00151892|364644285|FG001|Overall Study|Did not return for a visit|0|||
105724408|NCT00151892|364644284|FG000|Overall Study|Used prohibited corticosteroids|1|||
105724409|NCT00151892|364644285|FG001|Overall Study|Used prohibited corticosteroids|0|||
105724410|NCT00151892|364644284|FG000|Overall Study|Lack of study medication at center|0|||
105724411|NCT00151892|364644285|FG001|Overall Study|Lack of study medication at center|1|||
105724412|NCT00404092|364644286|FG000|Overall Study|Death|1|||
105724413|NCT00404092|364644287|FG001|Overall Study|Death|0|||
105724414|NCT00404092|364644288|FG002|Overall Study|Death|0|||
105724415|NCT00404092|364644289|FG003|Overall Study|Death|0|||
105724416|NCT00404092|364644286|FG000|Overall Study|Adverse Event|0|||
105724417|NCT00404092|364644287|FG001|Overall Study|Adverse Event|0|||
105724418|NCT00404092|364644288|FG002|Overall Study|Adverse Event|1|||
105724419|NCT00404092|364644289|FG003|Overall Study|Adverse Event|0|||
105724420|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Death|6|||
105724421|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Death|2|||
105724422|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
105724423|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
105724424|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
105724425|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
105724426|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
105724427|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
105724428|NCT00484315|364644292|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
105724429|NCT00484315|364644293|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
105724430|NCT00484315|364644292|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
105724431|NCT00484315|364644293|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
105936057|NCT01185366|365425286|FG001|First Line Therapy|Withdrawal by Subject|0|||
105724432|NCT00484315|364644292|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
105724433|NCT00484315|364644293|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
105724434|NCT00943683|364644294|FG000|Overall Study|Adverse Event|3|||
105724435|NCT00943683|364644295|FG001|Overall Study|Adverse Event|3|||
105936058|NCT01185366|365425285|FG000|First Line Therapy|Lack of Metastatic Site|1|||
105936059|NCT01185366|365425286|FG001|First Line Therapy|Lack of Metastatic Site|0|||
105724436|NCT00943683|364644294|FG000|Overall Study|Lost to Follow-up|1|||
105724437|NCT00943683|364644295|FG001|Overall Study|Lost to Follow-up|1|||
105724438|NCT00943683|364644294|FG000|Overall Study|Protocol Violation|1|||
105724439|NCT00943683|364644295|FG001|Overall Study|Protocol Violation|2|||
105724440|NCT00943683|364644294|FG000|Overall Study|Withdrawal by Subject|1|||
105724441|NCT00943683|364644295|FG001|Overall Study|Withdrawal by Subject|0|||
105724442|NCT00943683|364644294|FG000|Overall Study|Patient Moved|1|||
105724443|NCT00943683|364644295|FG001|Overall Study|Patient Moved|0|||
105724444|NCT02500537|364644296|FG000|Overall Study|Death|2|||
105793248|NCT04057118|364898745|FG001|Overall Study|Adverse Event|0|||
105793249|NCT04057118|364898746|FG002|Overall Study|Adverse Event|1|||
105793250|NCT04057118|364898747|FG003|Overall Study|Adverse Event|1|||
105793251|NCT04057118|364898744|FG000|Overall Study|Physician Decision|0|||
105793252|NCT04057118|364898745|FG001|Overall Study|Physician Decision|0|||
105793253|NCT04057118|364898746|FG002|Overall Study|Physician Decision|1|||
105793254|NCT04057118|364898747|FG003|Overall Study|Physician Decision|1|||
105793255|NCT04057118|364898744|FG000|Overall Study|Withdrawal by Subject|2|||
105793256|NCT04057118|364898745|FG001|Overall Study|Withdrawal by Subject|2|||
105793257|NCT04057118|364898746|FG002|Overall Study|Withdrawal by Subject|0|||
105793258|NCT04057118|364898747|FG003|Overall Study|Withdrawal by Subject|2|||
105793259|NCT04057118|364898744|FG000|Overall Study|Not Specific|0|||
105793260|NCT04057118|364898745|FG001|Overall Study|Not Specific|0|||
105793261|NCT04057118|364898746|FG002|Overall Study|Not Specific|1|||
105793262|NCT04057118|364898747|FG003|Overall Study|Not Specific|1|||
105793263|NCT04635631|364898748|FG000|Overall Study|Adverse Event|1|||
105793264|NCT04635631|364898748|FG000|Overall Study|Progressive disease|13|||
105793265|NCT04635631|364898748|FG000|Overall Study|Withdrawal by Subject|1|||
105793266|NCT00916617|364898754|FG000|Overall Study|Adverse Event|3|||
105793267|NCT00916617|364898755|FG001|Overall Study|Adverse Event|2|||
105793268|NCT00916617|364898756|FG002|Overall Study|Adverse Event|6|||
105793269|NCT00916617|364898757|FG003|Overall Study|Adverse Event|3|||
105793270|NCT00916617|364898754|FG000|Overall Study|Withdrawal by Subject|3|||
105793271|NCT00916617|364898755|FG001|Overall Study|Withdrawal by Subject|2|||
105793272|NCT00916617|364898756|FG002|Overall Study|Withdrawal by Subject|0|||
105793273|NCT00916617|364898757|FG003|Overall Study|Withdrawal by Subject|1|||
105793274|NCT00916617|364898754|FG000|Overall Study|Caregiver Request|3|||
105793275|NCT00916617|364898755|FG001|Overall Study|Caregiver Request|2|||
105793276|NCT00916617|364898756|FG002|Overall Study|Caregiver Request|1|||
105793277|NCT00916617|364898757|FG003|Overall Study|Caregiver Request|0|||
105793278|NCT00916617|364898754|FG000|Overall Study|Physician Decision|1|||
105793279|NCT00916617|364898755|FG001|Overall Study|Physician Decision|1|||
105793280|NCT00916617|364898756|FG002|Overall Study|Physician Decision|0|||
105793281|NCT00916617|364898757|FG003|Overall Study|Physician Decision|0|||
105793282|NCT00916617|364898754|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
105793283|NCT00916617|364898755|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
105793284|NCT00916617|364898756|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
105793285|NCT00916617|364898757|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
105793286|NCT00916617|364898754|FG000|Overall Study|Lost to Follow-up|2|||
105793287|NCT00916617|364898755|FG001|Overall Study|Lost to Follow-up|1|||
105793288|NCT00916617|364898756|FG002|Overall Study|Lost to Follow-up|0|||
105793289|NCT00916617|364898757|FG003|Overall Study|Lost to Follow-up|0|||
105793290|NCT00916617|364898754|FG000|Overall Study|Lack of Efficacy|1|||
105793291|NCT00916617|364898755|FG001|Overall Study|Lack of Efficacy|0|||
105793292|NCT00916617|364898756|FG002|Overall Study|Lack of Efficacy|0|||
105793293|NCT00916617|364898757|FG003|Overall Study|Lack of Efficacy|0|||
105793294|NCT00916617|364898754|FG000|Overall Study|Other|2|||
105793295|NCT00916617|364898755|FG001|Overall Study|Other|0|||
105793296|NCT00916617|364898756|FG002|Overall Study|Other|0|||
105793297|NCT00916617|364898757|FG003|Overall Study|Other|2|||
105793298|NCT00499252|364898759|FG000|Overall Study|Adverse Event|3|||
105793299|NCT00499252|364898759|FG000|Overall Study|Refused further treatment|2|||
105793300|NCT00499252|364898759|FG000|Overall Study|Ineligible|4|||
105793301|NCT00499252|364898759|FG000|Overall Study|<no further label>|3|||
105793302|NCT01569074|364898763|FG000|Overall Study|Study stopped|6|||
105793303|NCT01569074|364898764|FG001|Overall Study|Study stopped|6|||
105793304|NCT01569074|364898765|FG002|Overall Study|Study stopped|8|||
105793305|NCT01569074|364898766|FG003|Overall Study|Study stopped|7|||
105793306|NCT01569074|364898767|FG004|Overall Study|Study stopped|7|||
105793307|NCT01569074|364898763|FG000|Overall Study|Study-specific discontinuation criteria|0|||
105793308|NCT01569074|364898764|FG001|Overall Study|Study-specific discontinuation criteria|1|||
105793309|NCT01569074|364898765|FG002|Overall Study|Study-specific discontinuation criteria|0|||
105793310|NCT01569074|364898766|FG003|Overall Study|Study-specific discontinuation criteria|0|||
105793311|NCT01569074|364898767|FG004|Overall Study|Study-specific discontinuation criteria|0|||
105793312|NCT01569074|364898763|FG000|Overall Study|Severe non-compliance to protocol|0|||
105793313|NCT01569074|364898764|FG001|Overall Study|Severe non-compliance to protocol|0|||
105793314|NCT01569074|364898765|FG002|Overall Study|Severe non-compliance to protocol|1|||
105793315|NCT01569074|364898766|FG003|Overall Study|Severe non-compliance to protocol|0|||
105793316|NCT01569074|364898767|FG004|Overall Study|Severe non-compliance to protocol|0|||
105793317|NCT01569074|364898763|FG000|Overall Study|eg change in circumstances|0|||
105793318|NCT01569074|364898764|FG001|Overall Study|eg change in circumstances|2|||
105793319|NCT01569074|364898765|FG002|Overall Study|eg change in circumstances|0|||
105793320|NCT01569074|364898766|FG003|Overall Study|eg change in circumstances|1|||
105793321|NCT01569074|364898767|FG004|Overall Study|eg change in circumstances|1|||
105793322|NCT01569074|364898763|FG000|Overall Study|Adverse Event|1|||
105793323|NCT01569074|364898764|FG001|Overall Study|Adverse Event|0|||
105793324|NCT01569074|364898765|FG002|Overall Study|Adverse Event|3|||
105793325|NCT01569074|364898766|FG003|Overall Study|Adverse Event|0|||
105724445|NCT02500537|364644297|FG001|Overall Study|Death|0|||
105724446|NCT02500537|364644296|FG000|Overall Study|Lost to Follow-up|0|||
105724447|NCT02500537|364644297|FG001|Overall Study|Lost to Follow-up|1|||
105724448|NCT02500537|364644296|FG000|Overall Study|Withdrawal by Subject|1|||
105724449|NCT02500537|364644297|FG001|Overall Study|Withdrawal by Subject|0|||
105724450|NCT04672083|364644298|FG000|Overall Study|Lost to Follow-up|1|||
105724451|NCT04672083|364644299|FG001|Overall Study|Lost to Follow-up|0|||
105724452|NCT04672083|364644300|FG002|Overall Study|Lost to Follow-up|0|||
105724453|NCT04672083|364644301|FG003|Overall Study|Lost to Follow-up|0|||
105724454|NCT04672083|364644302|FG004|Overall Study|Lost to Follow-up|0|||
105724455|NCT01551745|364644303|FG000|Overall Study|Withdrawal by Subject|1|||
105724456|NCT01551745|364644303|FG000|Overall Study|Disease Progression|2|||
105724457|NCT02048904|364644304|FG000|Overall Study|Withdrawal by Subject|7|||
105724458|NCT02048904|364644304|FG000|Overall Study|Physician Decision|70|||
105724459|NCT00749190|364644305|FG000|Overall Study|Adverse Event|0|||
105724460|NCT00749190|364644306|FG001|Overall Study|Adverse Event|2|||
105724461|NCT00749190|364644307|FG002|Overall Study|Adverse Event|0|||
105724462|NCT00749190|364644308|FG003|Overall Study|Adverse Event|4|||
105724463|NCT00749190|364644309|FG004|Overall Study|Adverse Event|0|||
105724464|NCT00749190|364644310|FG005|Overall Study|Adverse Event|3|||
105724465|NCT00749190|364644311|FG006|Overall Study|Adverse Event|0|||
105724466|NCT00749190|364644305|FG000|Overall Study|Lack of Efficacy|3|||
105936060|NCT01185366|365425285|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
105936061|NCT01185366|365425286|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
105936062|NCT01185366|365425285|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
105936063|NCT01185366|365425286|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
105936064|NCT01185366|365425285|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
105936065|NCT01185366|365425286|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
105936066|NCT01185366|365425285|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
105936067|NCT01185366|365425286|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
105936068|NCT00127933|365425291|FG000|Overall Study|Randomized but not dosed|1|||
105936069|NCT00127933|365425292|FG001|Overall Study|Randomized but not dosed|0|||
105936070|NCT01783938|365425293|FG000|Overall Study|Disease Progression|18|||
105936071|NCT01783938|365425294|FG001|Overall Study|Disease Progression|41|||
105936072|NCT01783938|365425293|FG000|Overall Study|Study Drug Toxicity|27|||
105936073|NCT01783938|365425294|FG001|Overall Study|Study Drug Toxicity|14|||
105936074|NCT01783938|365425293|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
105936075|NCT01783938|365425294|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
105936076|NCT01783938|365425293|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
105936077|NCT01783938|365425294|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
105936078|NCT01783938|365425293|FG000|Overall Study|Participant Withdrew Consent|2|||
105936079|NCT01783938|365425294|FG001|Overall Study|Participant Withdrew Consent|0|||
105936080|NCT01783938|365425293|FG000|Overall Study|Maximum Clinical Benefit|1|||
105936081|NCT01783938|365425294|FG001|Overall Study|Maximum Clinical Benefit|0|||
105936082|NCT01783938|365425293|FG000|Overall Study|Other Reasons|3|||
105936083|NCT01783938|365425294|FG001|Overall Study|Other Reasons|1|||
105936084|NCT00025233|365425295|FG000|Overall Study|Ineligible: wrong cell type|1|||
105936085|NCT00025233|365425295|FG000|Overall Study|Ineligible: wrong primary|1|||
105936086|NCT00025233|365425295|FG000|Overall Study|Ineligible: improper prior treatment|1|||
105936087|NCT00025233|365425295|FG000|Overall Study|Never treated|1|||
105936088|NCT03072875|365425296|FG000|Overall Study|Lost to Follow-up|1|||
105936089|NCT03111732|365425297|FG000|Overall Study|Enrolled in different study|1|||
105936090|NCT03111732|365425297|FG000|Overall Study|Progressive disease|3|||
105936091|NCT03111732|365425297|FG000|Overall Study|Withdrawal by Subject|1|||
105936092|NCT00452400|365425299|FG000|Overall Study|Adverse Event|1|||
105936093|NCT00452400|365425300|FG001|Overall Study|Adverse Event|1|||
105936094|NCT00452400|365425301|FG002|Overall Study|Adverse Event|5|||
105936095|NCT00452400|365425302|FG003|Overall Study|Adverse Event|0|||
105936096|NCT00452400|365425303|FG004|Overall Study|Adverse Event|2|||
105936097|NCT00452400|365425299|FG000|Overall Study|Protocol Violation|0|||
105936098|NCT00452400|365425300|FG001|Overall Study|Protocol Violation|0|||
105936099|NCT00452400|365425301|FG002|Overall Study|Protocol Violation|1|||
105936100|NCT00452400|365425302|FG003|Overall Study|Protocol Violation|0|||
105936101|NCT00452400|365425303|FG004|Overall Study|Protocol Violation|0|||
105936102|NCT00452400|365425299|FG000|Overall Study|Lost to Follow-up|1|||
105724467|NCT00749190|364644306|FG001|Overall Study|Lack of Efficacy|1|||
105724468|NCT00749190|364644307|FG002|Overall Study|Lack of Efficacy|1|||
105724469|NCT00749190|364644308|FG003|Overall Study|Lack of Efficacy|0|||
105724470|NCT00749190|364644309|FG004|Overall Study|Lack of Efficacy|0|||
105724471|NCT00749190|364644310|FG005|Overall Study|Lack of Efficacy|1|||
105724472|NCT00749190|364644311|FG006|Overall Study|Lack of Efficacy|0|||
105936103|NCT00452400|365425300|FG001|Overall Study|Lost to Follow-up|0|||
105936104|NCT00452400|365425301|FG002|Overall Study|Lost to Follow-up|0|||
105936105|NCT00452400|365425302|FG003|Overall Study|Lost to Follow-up|0|||
105936106|NCT00452400|365425303|FG004|Overall Study|Lost to Follow-up|0|||
105936107|NCT00452400|365425299|FG000|Overall Study|Withdrawal by Subject|1|||
105936108|NCT00452400|365425300|FG001|Overall Study|Withdrawal by Subject|0|||
105793326|NCT01569074|364898767|FG004|Overall Study|Adverse Event|0|||
105793327|NCT01360021|364898768|FG000|Overall Study|Eligibility criteria + other|2|||
105793328|NCT01360021|364898769|FG001|Overall Study|Eligibility criteria + other|1|||
105793329|NCT01360021|364898770|FG002|Overall Study|Eligibility criteria + other|1|||
105793330|NCT01360021|364898768|FG000|Overall Study|Protocol Violation|0|||
105793331|NCT01360021|364898769|FG001|Overall Study|Protocol Violation|0|||
105793332|NCT01360021|364898770|FG002|Overall Study|Protocol Violation|1|||
105793333|NCT01360021|364898768|FG000|Overall Study|Withdrawal by Subject|4|||
105793334|NCT01360021|364898769|FG001|Overall Study|Withdrawal by Subject|0|||
105793335|NCT01360021|364898770|FG002|Overall Study|Withdrawal by Subject|2|||
105793336|NCT01360021|364898768|FG000|Overall Study|Adverse Event|2|||
105793337|NCT01360021|364898769|FG001|Overall Study|Adverse Event|3|||
105793338|NCT01360021|364898770|FG002|Overall Study|Adverse Event|3|||
105793339|NCT00110084|364898771|FG000|Overall Study|Adverse Event|9|||
105793340|NCT00110084|364898771|FG000|Overall Study|Death|1|||
105793341|NCT00110084|364898771|FG000|Overall Study|Patient Refusal|10|||
105793342|NCT00110084|364898771|FG000|Overall Study|Alternate Therapy|5|||
105793343|NCT00110084|364898771|FG000|Overall Study|Intercurrent Illness|1|||
105793344|NCT00110084|364898771|FG000|Overall Study|Other|2|||
105793345|NCT03224234|364898772|FG000|Main Study|Lost to Follow-up|5|||
105793346|NCT03224234|364898773|FG001|Main Study|Lost to Follow-up|5|||
105793347|NCT05016765|364898774|FG000|Overall Study|Lost to Follow-up|4|||
105793348|NCT01612780|364898775|FG000|Overall Study|Treatment not completed|1|||
105793349|NCT01612780|364898775|FG000|Overall Study|Withdrawal by Subject|5|||
105793350|NCT03020966|364898776|FG000|Overall Study|Withdrawal by Subject|2|||
105724473|NCT00749190|364644305|FG000|Overall Study|Withdrawal by Subject|2|||
105724474|NCT00749190|364644306|FG001|Overall Study|Withdrawal by Subject|1|||
105724475|NCT00749190|364644307|FG002|Overall Study|Withdrawal by Subject|0|||
105724476|NCT00749190|364644308|FG003|Overall Study|Withdrawal by Subject|0|||
105724477|NCT00749190|364644309|FG004|Overall Study|Withdrawal by Subject|0|||
105724478|NCT00749190|364644310|FG005|Overall Study|Withdrawal by Subject|1|||
105724479|NCT00749190|364644311|FG006|Overall Study|Withdrawal by Subject|0|||
105724480|NCT00749190|364644305|FG000|Overall Study|Protocol Violation|0|||
105724481|NCT00749190|364644306|FG001|Overall Study|Protocol Violation|1|||
105724482|NCT00749190|364644307|FG002|Overall Study|Protocol Violation|0|||
105724483|NCT00749190|364644308|FG003|Overall Study|Protocol Violation|0|||
105724484|NCT00749190|364644309|FG004|Overall Study|Protocol Violation|0|||
105724485|NCT00749190|364644310|FG005|Overall Study|Protocol Violation|0|||
105724486|NCT00749190|364644311|FG006|Overall Study|Protocol Violation|1|||
105724487|NCT00749190|364644305|FG000|Overall Study|Other reason not defined above|0|||
105724488|NCT00749190|364644306|FG001|Overall Study|Other reason not defined above|0|||
105724489|NCT00749190|364644307|FG002|Overall Study|Other reason not defined above|0|||
105724490|NCT00749190|364644308|FG003|Overall Study|Other reason not defined above|1|||
105724491|NCT00749190|364644309|FG004|Overall Study|Other reason not defined above|0|||
105724492|NCT00749190|364644310|FG005|Overall Study|Other reason not defined above|0|||
105724493|NCT00749190|364644311|FG006|Overall Study|Other reason not defined above|0|||
105724494|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
105724495|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
105724496|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
105724497|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
105793351|NCT03020966|364898777|FG001|Overall Study|Withdrawal by Subject|0|||
105793352|NCT03664024|364898781|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
105793353|NCT03664024|364898781|FG000|Overall Study|Lost to Follow-up|2|||
105793354|NCT03664024|364898781|FG000|Overall Study|Withdrawal by Subject|2|||
105724498|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
105724499|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
105724500|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
105724501|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
105724502|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
105724503|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
105724504|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
105724505|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105793355|NCT03664024|364898781|FG000|Overall Study|Death|80|||
105724506|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105724507|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105724508|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
105793356|NCT01060007|364898784|FG000|Overall Study|Withdrawal by Subject|1|||
106137724|NCT00831792|366163470|FG000|Overall Study|Not Eligible|3|||
105724509|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
105793357|NCT01060007|364898784|FG000|Overall Study|Inevaluable for response at surgery|3|||
105793358|NCT01071083|364898797|FG000|Overall Study|Adverse Event|1|||
105793359|NCT01071083|364898798|FG001|Overall Study|Adverse Event|0|||
106137725|NCT00831792|366163470|FG000|Overall Study|Adverse Event|1|||
105793360|NCT01071083|364898799|FG002|Overall Study|Adverse Event|1|||
105793361|NCT01071083|364898800|FG003|Overall Study|Adverse Event|0|||
105724510|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
105724511|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
105724512|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
105724513|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
105724514|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Death|0|||
105724515|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Death|1|||
105724516|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Death|0|||
105724517|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Death|0|||
105724518|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Death|0|||
105724519|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
105724520|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
105724521|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
105724522|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
105724523|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
105724524|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
105724525|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
105724526|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
105724527|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
105724528|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
105724529|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
105724530|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
105724531|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
105724532|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
105724533|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
105724534|NCT05087030|364644320|FG000|Main Period (Week 0 to Week 52)|Other|1|||
105724535|NCT05087030|364644321|FG001|Main Period (Week 0 to Week 52)|Other|2|||
105724536|NCT05087030|364644322|FG002|Main Period (Week 0 to Week 52)|Other|0|||
105724537|NCT05087030|364644323|FG003|Main Period (Week 0 to Week 52)|Other|0|||
105724538|NCT05087030|364644324|FG004|Main Period (Week 0 to Week 52)|Other|0|||
105724539|NCT05087030|364644320|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105724540|NCT05087030|364644321|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105724541|NCT05087030|364644322|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105724542|NCT05087030|364644323|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
105724543|NCT05087030|364644324|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
105724544|NCT04429022|364644329|FG000|Overall Study|Protocol Violation|18|||
105724545|NCT04429022|364644330|FG001|Overall Study|Protocol Violation|1|||
105724546|NCT00998738|364644331|FG000|Overall Study|Uknown|1|||
105724547|NCT00045032|364644333|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
105724548|NCT00045032|364644334|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
105724549|NCT00045032|364644335|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
105724550|NCT00045032|364644333|FG000|Overall Study|Death|22|||
105724551|NCT00045032|364644334|FG001|Overall Study|Death|24|||
105724552|NCT00045032|364644335|FG002|Overall Study|Death|17|||
105724553|NCT00045032|364644333|FG000|Overall Study|Insufficient Therapeutic Response|542|||
105724554|NCT00045032|364644334|FG001|Overall Study|Insufficient Therapeutic Response|437|||
105724555|NCT00045032|364644335|FG002|Overall Study|Insufficient Therapeutic Response|445|||
105724556|NCT00045032|364644333|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
105724557|NCT00045032|364644334|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
105724558|NCT00045032|364644335|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
105724559|NCT00045032|364644333|FG000|Overall Study|Other Protocol Violation|2|||
105724560|NCT00045032|364644334|FG001|Overall Study|Other Protocol Violation|0|||
105724561|NCT00045032|364644335|FG002|Overall Study|Other Protocol Violation|1|||
105724562|NCT00045032|364644333|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
105724563|NCT00045032|364644334|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
105724564|NCT00045032|364644335|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
105724565|NCT00045032|364644333|FG000|Overall Study|Failure to Return|57|||
105724566|NCT00045032|364644334|FG001|Overall Study|Failure to Return|62|||
105724567|NCT00045032|364644335|FG002|Overall Study|Failure to Return|61|||
105724568|NCT00045032|364644333|FG000|Overall Study|Other|93|||
105724569|NCT00045032|364644334|FG001|Overall Study|Other|84|||
105724570|NCT00045032|364644335|FG002|Overall Study|Other|105|||
105724571|NCT02689492|364646426|FG000|Overall Study|Lost to Follow-up|61|||
105724572|NCT02689492|364646426|FG000|Overall Study|Withdrawal by Subject|11|||
105724573|NCT02689492|364646426|FG000|Overall Study|Death|9|||
105724574|NCT02689492|364646426|FG000|Overall Study|Physician Decision|2|||
105724575|NCT02689492|364646426|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
105724576|NCT02689492|364646426|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
106137726|NCT00831792|366163470|FG000|Overall Study|Death|1|||
105724577|NCT02689492|364646426|FG000|Overall Study|Other than listed|1|||
105724578|NCT00500266|364646427|FG000|Overall Study|Death|3|||
105724579|NCT00500266|364646427|FG000|Overall Study|Lost to Follow-up|3|||
105793362|NCT01071083|364898801|FG004|Overall Study|Adverse Event|1|||
105793363|NCT01071083|364898797|FG000|Overall Study|Withdrawal by Subject|3|||
105793364|NCT01071083|364898798|FG001|Overall Study|Withdrawal by Subject|0|||
105793365|NCT01071083|364898799|FG002|Overall Study|Withdrawal by Subject|2|||
105793366|NCT01071083|364898800|FG003|Overall Study|Withdrawal by Subject|0|||
105793367|NCT01071083|364898801|FG004|Overall Study|Withdrawal by Subject|3|||
105793368|NCT01071083|364898797|FG000|Overall Study|Physician Decision|1|||
105793369|NCT01071083|364898798|FG001|Overall Study|Physician Decision|0|||
105793370|NCT01071083|364898799|FG002|Overall Study|Physician Decision|0|||
105793371|NCT01071083|364898800|FG003|Overall Study|Physician Decision|1|||
105793372|NCT01071083|364898801|FG004|Overall Study|Physician Decision|1|||
105793373|NCT01071083|364898797|FG000|Overall Study|Early Rescue|1|||
105793374|NCT01071083|364898798|FG001|Overall Study|Early Rescue|0|||
105793375|NCT01071083|364898799|FG002|Overall Study|Early Rescue|0|||
105793376|NCT01071083|364898800|FG003|Overall Study|Early Rescue|0|||
105793377|NCT01071083|364898801|FG004|Overall Study|Early Rescue|1|||
105793378|NCT01071083|364898797|FG000|Overall Study|Subject Moved|0|||
105793379|NCT01071083|364898798|FG001|Overall Study|Subject Moved|1|||
105793380|NCT01071083|364898799|FG002|Overall Study|Subject Moved|0|||
105793381|NCT01071083|364898800|FG003|Overall Study|Subject Moved|0|||
105793382|NCT01071083|364898801|FG004|Overall Study|Subject Moved|0|||
105793383|NCT01071083|364898797|FG000|Overall Study|Images Not Usable (Motion)|0|||
105793384|NCT01071083|364898798|FG001|Overall Study|Images Not Usable (Motion)|1|||
105793385|NCT01071083|364898799|FG002|Overall Study|Images Not Usable (Motion)|0|||
105793386|NCT01071083|364898800|FG003|Overall Study|Images Not Usable (Motion)|0|||
105724580|NCT00500266|364646427|FG000|Overall Study|Withdrawal by Subject|3|||
105724581|NCT00500266|364646427|FG000|Overall Study|Assigned, not treated|4|||
105724582|NCT00023322|364646428|FG000|Overall Study|Lost to Follow-up|1|||
105724583|NCT00110305|364646429|FG000|Overall Study|Adverse Event|46|||
105724584|NCT00110305|364646430|FG001|Overall Study|Adverse Event|13|||
105724585|NCT00110305|364646429|FG000|Overall Study|Sponsors Decision|1|||
105724586|NCT00110305|364646430|FG001|Overall Study|Sponsors Decision|0|||
105724587|NCT00110305|364646429|FG000|Overall Study|Subject Non-Compliant|9|||
105724588|NCT00110305|364646430|FG001|Overall Study|Subject Non-Compliant|2|||
105724589|NCT00110305|364646429|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
105724590|NCT00110305|364646430|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
105724591|NCT00110305|364646429|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
105724592|NCT00110305|364646430|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
105724593|NCT00110305|364646429|FG000|Overall Study|Protocol Violation|0|||
105724594|NCT00110305|364646430|FG001|Overall Study|Protocol Violation|1|||
105724595|NCT00110305|364646429|FG000|Overall Study|Withdrawal by Subject|7|||
105724596|NCT00110305|364646430|FG001|Overall Study|Withdrawal by Subject|7|||
105724597|NCT00110305|364646429|FG000|Overall Study|Lost to Follow-up|20|||
105724598|NCT00110305|364646430|FG001|Overall Study|Lost to Follow-up|3|||
105724599|NCT00110305|364646429|FG000|Overall Study|Other|8|||
105724600|NCT00110305|364646430|FG001|Overall Study|Other|2|||
105724601|NCT03658889|364646438|FG000|Overall Study|Protocol Violation|2|||
105724602|NCT03658889|364646439|FG001|Overall Study|Protocol Violation|0|||
105724603|NCT01028352|364646442|FG000|Overall Study|Ineligible due to baseline average pain|5|||
105724604|NCT01028352|364646442|FG000|Overall Study|Withdrawal by Subject|1|||
105724605|NCT01903876|364646443|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
105724606|NCT01903876|364646444|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
105724607|NCT01903876|364646443|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
105724608|NCT01903876|364646444|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
105724609|NCT02612909|364646449|FG000|Phase 2|Withdrawal by Subject|2|||
105724610|NCT02612909|364646450|FG001|Phase 2|Withdrawal by Subject|5|||
105724611|NCT02612909|364646451|FG002|Phase 2|Withdrawal by Subject|0|||
105724612|NCT02612909|364646452|FG003|Phase 2|Withdrawal by Subject|0|||
105724613|NCT02612909|364646453|FG004|Phase 2|Withdrawal by Subject|0|||
105724614|NCT02612909|364646449|FG000|Phase 2|Pregnancy|0|||
105724615|NCT02612909|364646450|FG001|Phase 2|Pregnancy|0|||
105724616|NCT02612909|364646451|FG002|Phase 2|Pregnancy|1|||
105793387|NCT01071083|364898801|FG004|Overall Study|Images Not Usable (Motion)|0|||
105724617|NCT02612909|364646452|FG003|Phase 2|Pregnancy|0|||
105724618|NCT02612909|364646453|FG004|Phase 2|Pregnancy|0|||
105724619|NCT02612909|364646449|FG000|Phase 3|Withdrawal by Subject|0|||
105724620|NCT02612909|364646450|FG001|Phase 3|Withdrawal by Subject|0|||
105724621|NCT02612909|364646451|FG002|Phase 3|Withdrawal by Subject|0|||
105936109|NCT00452400|365425301|FG002|Overall Study|Withdrawal by Subject|1|||
105724622|NCT02612909|364646452|FG003|Phase 3|Withdrawal by Subject|1|||
105724623|NCT02612909|364646453|FG004|Phase 3|Withdrawal by Subject|0|||
105724624|NCT01717638|364646454|FG000|Overall Study|Lost to Follow-up|0|||
105724625|NCT01717638|364646455|FG001|Overall Study|Lost to Follow-up|0|||
105724626|NCT01717638|364646456|FG002|Overall Study|Lost to Follow-up|0|||
105724627|NCT01717638|364646457|FG003|Overall Study|Lost to Follow-up|0|||
105724628|NCT01717638|364646458|FG004|Overall Study|Lost to Follow-up|0|||
105793388|NCT01071083|364898797|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
105793389|NCT01071083|364898798|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
105724629|NCT01717638|364646459|FG005|Overall Study|Lost to Follow-up|1|||
105724630|NCT01717638|364646460|FG006|Overall Study|Lost to Follow-up|0|||
105724631|NCT01717638|364646461|FG007|Overall Study|Lost to Follow-up|0|||
105724632|NCT01717638|364646462|FG008|Overall Study|Lost to Follow-up|0|||
105724633|NCT01717638|364646463|FG009|Overall Study|Lost to Follow-up|0|||
105724634|NCT01717638|364646464|FG010|Overall Study|Lost to Follow-up|0|||
105724635|NCT01717638|364646465|FG011|Overall Study|Lost to Follow-up|0|||
105724636|NCT01717638|364646466|FG012|Overall Study|Lost to Follow-up|0|||
105724637|NCT01717638|364646454|FG000|Overall Study|Father in hospital|0|||
105724638|NCT01717638|364646455|FG001|Overall Study|Father in hospital|0|||
105724639|NCT01717638|364646456|FG002|Overall Study|Father in hospital|0|||
105724640|NCT01717638|364646457|FG003|Overall Study|Father in hospital|0|||
105724641|NCT01717638|364646458|FG004|Overall Study|Father in hospital|0|||
105724642|NCT01717638|364646459|FG005|Overall Study|Father in hospital|0|||
105724643|NCT01717638|364646460|FG006|Overall Study|Father in hospital|0|||
105724644|NCT01717638|364646461|FG007|Overall Study|Father in hospital|0|||
105724645|NCT01717638|364646462|FG008|Overall Study|Father in hospital|0|||
105724646|NCT01717638|364646463|FG009|Overall Study|Father in hospital|0|||
105724647|NCT01717638|364646464|FG010|Overall Study|Father in hospital|0|||
105724648|NCT01717638|364646465|FG011|Overall Study|Father in hospital|0|||
105724649|NCT01717638|364646466|FG012|Overall Study|Father in hospital|1|||
105724650|NCT01717638|364646454|FG000|Overall Study|Withdrawal by Subject|0|||
105724651|NCT01717638|364646455|FG001|Overall Study|Withdrawal by Subject|1|||
105724652|NCT01717638|364646456|FG002|Overall Study|Withdrawal by Subject|1|||
105724653|NCT01717638|364646457|FG003|Overall Study|Withdrawal by Subject|0|||
105724654|NCT01717638|364646458|FG004|Overall Study|Withdrawal by Subject|1|||
105724655|NCT01717638|364646459|FG005|Overall Study|Withdrawal by Subject|0|||
105724656|NCT01717638|364646460|FG006|Overall Study|Withdrawal by Subject|2|||
105724657|NCT01717638|364646461|FG007|Overall Study|Withdrawal by Subject|1|||
105724658|NCT01717638|364646462|FG008|Overall Study|Withdrawal by Subject|2|||
105724659|NCT01717638|364646463|FG009|Overall Study|Withdrawal by Subject|1|||
105724660|NCT01717638|364646464|FG010|Overall Study|Withdrawal by Subject|0|||
105724661|NCT01717638|364646465|FG011|Overall Study|Withdrawal by Subject|0|||
105724662|NCT01717638|364646466|FG012|Overall Study|Withdrawal by Subject|18|||
105724663|NCT03312218|364646468|FG000|Overall Study|Never signed in to access the app|54|||
105724664|NCT03312218|364646469|FG001|Overall Study|Never signed in to access the app|58|||
105724665|NCT02300129|364646470|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
105724666|NCT02300129|364646471|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
105724667|NCT02300129|364646472|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
105724668|NCT02300129|364646473|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
105724669|NCT02300129|364646470|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
105724670|NCT02300129|364646471|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
105724671|NCT02300129|364646472|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
105724672|NCT02300129|364646473|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
105724673|NCT02300129|364646470|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
105724674|NCT02300129|364646471|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
105724675|NCT02300129|364646472|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
105724676|NCT02300129|364646473|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
105724677|NCT00450580|364646476|FG000|Overall Study|Adverse Event|5|||
105724678|NCT00450580|364646477|FG001|Overall Study|Adverse Event|7|||
105724679|NCT00450580|364646476|FG000|Overall Study|Lost to Follow-up|4|||
105724680|NCT00450580|364646477|FG001|Overall Study|Lost to Follow-up|5|||
105724681|NCT00450580|364646476|FG000|Overall Study|Withdrawal by Subject|2|||
105724682|NCT00450580|364646477|FG001|Overall Study|Withdrawal by Subject|2|||
105793390|NCT01071083|364898799|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
105793391|NCT01071083|364898800|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
105793392|NCT01071083|364898801|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
105793393|NCT01071083|364898797|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
105793394|NCT01071083|364898798|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
105793395|NCT01071083|364898799|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
105793396|NCT01071083|364898800|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
105793397|NCT01071083|364898801|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
105724683|NCT00450580|364646476|FG000|Overall Study|Protocol Violation|1|||
105724684|NCT00450580|364646477|FG001|Overall Study|Protocol Violation|1|||
105793398|NCT01071083|364898797|FG000|Overall Study|Subject Refused to Continue|1|||
105793399|NCT01071083|364898798|FG001|Overall Study|Subject Refused to Continue|0|||
105793400|NCT01071083|364898799|FG002|Overall Study|Subject Refused to Continue|0|||
105724685|NCT00450580|364646476|FG000|Overall Study|Protocol-defined virologic failure|1|||
105724686|NCT00450580|364646477|FG001|Overall Study|Protocol-defined virologic failure|0|||
105724687|NCT00450580|364646476|FG000|Overall Study|Could not comply with scheduled visits|1|||
105724688|NCT00450580|364646477|FG001|Overall Study|Could not comply with scheduled visits|0|||
105724689|NCT00450580|364646476|FG000|Overall Study|Patient went to Brazil|1|||
105724690|NCT00450580|364646477|FG001|Overall Study|Patient went to Brazil|0|||
105724691|NCT00450580|364646476|FG000|Overall Study|Patient could not swallow Norvir|1|||
105793401|NCT01071083|364898800|FG003|Overall Study|Subject Refused to Continue|0|||
105793402|NCT01071083|364898801|FG004|Overall Study|Subject Refused to Continue|0|||
105793403|NCT03087773|364898804|FG000|Overall Study|Withdrawal by Subject|8|||
105793404|NCT03087773|364898805|FG001|Overall Study|Withdrawal by Subject|4|||
105793405|NCT03087773|364898804|FG000|Overall Study|Lost to Follow-up|12|||
105793406|NCT03087773|364898805|FG001|Overall Study|Lost to Follow-up|8|||
105793407|NCT00728988|364898806|FG000|Overall Study|Not Treated|2|||
105793408|NCT00728988|364898807|FG001|Overall Study|Not Treated|2|||
105724692|NCT00450580|364646477|FG001|Overall Study|Patient could not swallow Norvir|0|||
105724693|NCT00450580|364646476|FG000|Overall Study|Withdrawal due to pregnancy|0|||
105724694|NCT00450580|364646477|FG001|Overall Study|Withdrawal due to pregnancy|1|||
105724695|NCT03539432|364646478|FG000|Overall Study|Lost to Follow-up|0|||
105724696|NCT03539432|364646479|FG001|Overall Study|Lost to Follow-up|1|||
105724697|NCT02443402|364646480|FG000|Overall Study|Withdrawal by Subject|3|||
105724698|NCT02443402|364646481|FG001|Overall Study|Withdrawal by Subject|1|||
105724699|NCT02443402|364646480|FG000|Overall Study|Screen Failure|1|||
105724700|NCT02443402|364646481|FG001|Overall Study|Screen Failure|2|||
105724701|NCT01934504|364646482|FG000|Overall Study|Protocol Deviation|0|||
105724702|NCT01934504|364646483|FG001|Overall Study|Protocol Deviation|0|||
105724703|NCT01934504|364646484|FG002|Overall Study|Protocol Deviation|0|||
105724704|NCT01934504|364646485|FG003|Overall Study|Protocol Deviation|2|||
105724705|NCT01934504|364646482|FG000|Overall Study|Study Terminated by Sponsor|1|||
105724706|NCT01934504|364646483|FG001|Overall Study|Study Terminated by Sponsor|0|||
105724707|NCT01934504|364646484|FG002|Overall Study|Study Terminated by Sponsor|5|||
105724708|NCT01934504|364646485|FG003|Overall Study|Study Terminated by Sponsor|5|||
105724709|NCT04889209|364646488|FG000|All Cohorts Except 15E|Adverse Event|0|||
105724710|NCT04889209|364646489|FG001|All Cohorts Except 15E|Adverse Event|0|||
105724711|NCT04889209|364646490|FG002|All Cohorts Except 15E|Adverse Event|0|||
105724712|NCT04889209|364646491|FG003|All Cohorts Except 15E|Adverse Event|0|||
105724713|NCT04889209|364646492|FG004|All Cohorts Except 15E|Adverse Event|0|||
105724714|NCT04889209|364646493|FG005|All Cohorts Except 15E|Adverse Event|0|||
105724715|NCT04889209|364646494|FG006|All Cohorts Except 15E|Adverse Event|1|||
105724716|NCT04889209|364646495|FG007|All Cohorts Except 15E|Adverse Event|0|||
105724717|NCT04889209|364646496|FG008|All Cohorts Except 15E|Adverse Event|0|||
105724718|NCT04889209|364646497|FG009|All Cohorts Except 15E|Adverse Event|0|||
105724719|NCT04889209|364646498|FG010|All Cohorts Except 15E|Adverse Event|0|||
105724720|NCT04889209|364646499|FG011|All Cohorts Except 15E|Adverse Event|0|||
105724721|NCT04889209|364646500|FG012|All Cohorts Except 15E|Adverse Event|0|||
105724722|NCT04889209|364646501|FG013|All Cohorts Except 15E|Adverse Event|0|||
105724723|NCT04889209|364646502|FG014|All Cohorts Except 15E|Adverse Event|0|||
105724724|NCT04889209|364646503|FG015|All Cohorts Except 15E|Adverse Event|0|||
105724725|NCT04889209|364646504|FG016|All Cohorts Except 15E|Adverse Event|0|||
105724726|NCT04889209|364646505|FG017|All Cohorts Except 15E|Adverse Event|0|||
105724727|NCT04889209|364646488|FG000|All Cohorts Except 15E|Death|0|||
105724728|NCT04889209|364646489|FG001|All Cohorts Except 15E|Death|1|||
105724729|NCT04889209|364646490|FG002|All Cohorts Except 15E|Death|0|||
105724730|NCT04889209|364646491|FG003|All Cohorts Except 15E|Death|0|||
105724731|NCT04889209|364646492|FG004|All Cohorts Except 15E|Death|0|||
105724732|NCT04889209|364646493|FG005|All Cohorts Except 15E|Death|0|||
105724733|NCT04889209|364646494|FG006|All Cohorts Except 15E|Death|0|||
105724734|NCT04889209|364646495|FG007|All Cohorts Except 15E|Death|0|||
105724735|NCT04889209|364646496|FG008|All Cohorts Except 15E|Death|0|||
105724736|NCT04889209|364646497|FG009|All Cohorts Except 15E|Death|0|||
105724737|NCT04889209|364646498|FG010|All Cohorts Except 15E|Death|0|||
105724738|NCT04889209|364646499|FG011|All Cohorts Except 15E|Death|0|||
105724739|NCT04889209|364646500|FG012|All Cohorts Except 15E|Death|0|||
105724740|NCT04889209|364646501|FG013|All Cohorts Except 15E|Death|0|||
105724741|NCT04889209|364646502|FG014|All Cohorts Except 15E|Death|0|||
105724742|NCT04889209|364646503|FG015|All Cohorts Except 15E|Death|0|||
105724743|NCT04889209|364646504|FG016|All Cohorts Except 15E|Death|0|||
105724744|NCT04889209|364646505|FG017|All Cohorts Except 15E|Death|0|||
105793409|NCT00728988|364898806|FG000|Overall Study|Death|1|||
105724745|NCT04889209|364646488|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
105724746|NCT04889209|364646489|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
105724747|NCT04889209|364646490|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
105793410|NCT00728988|364898807|FG001|Overall Study|Death|1|||
105793411|NCT00728988|364898806|FG000|Overall Study|Adverse Event|3|||
105724748|NCT04889209|364646491|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
105724749|NCT04889209|364646492|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
105724750|NCT04889209|364646493|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
105724751|NCT04889209|364646494|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
105793412|NCT00728988|364898807|FG001|Overall Study|Adverse Event|2|||
105724752|NCT04889209|364646495|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
105724753|NCT04889209|364646496|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
105724754|NCT04889209|364646497|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
105793413|NCT00728988|364898806|FG000|Overall Study|Other|85|||
105724755|NCT04889209|364646498|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
105724756|NCT04889209|364646499|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
105793414|NCT00728988|364898807|FG001|Overall Study|Other|77|||
105936110|NCT00452400|365425302|FG003|Overall Study|Withdrawal by Subject|0|||
105936111|NCT00452400|365425303|FG004|Overall Study|Withdrawal by Subject|0|||
105724757|NCT04889209|364646500|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
105724758|NCT04889209|364646501|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
105724759|NCT04889209|364646502|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
105724760|NCT04889209|364646503|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
105724761|NCT04889209|364646504|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
105724762|NCT04889209|364646505|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
105724763|NCT04889209|364646488|FG000|All Cohorts Except 15E|Physician Decision|0|||
105724764|NCT04889209|364646489|FG001|All Cohorts Except 15E|Physician Decision|0|||
105724765|NCT04889209|364646490|FG002|All Cohorts Except 15E|Physician Decision|0|||
105724766|NCT04889209|364646491|FG003|All Cohorts Except 15E|Physician Decision|0|||
105724767|NCT04889209|364646492|FG004|All Cohorts Except 15E|Physician Decision|1|||
105724768|NCT04889209|364646493|FG005|All Cohorts Except 15E|Physician Decision|0|||
105724769|NCT04889209|364646494|FG006|All Cohorts Except 15E|Physician Decision|0|||
105724770|NCT04889209|364646495|FG007|All Cohorts Except 15E|Physician Decision|1|||
105724771|NCT04889209|364646496|FG008|All Cohorts Except 15E|Physician Decision|0|||
105724772|NCT04889209|364646497|FG009|All Cohorts Except 15E|Physician Decision|1|||
105724773|NCT04889209|364646498|FG010|All Cohorts Except 15E|Physician Decision|0|||
105724774|NCT04889209|364646499|FG011|All Cohorts Except 15E|Physician Decision|1|||
105724775|NCT04889209|364646500|FG012|All Cohorts Except 15E|Physician Decision|1|||
105724776|NCT04889209|364646501|FG013|All Cohorts Except 15E|Physician Decision|0|||
105724777|NCT04889209|364646502|FG014|All Cohorts Except 15E|Physician Decision|0|||
105724778|NCT04889209|364646503|FG015|All Cohorts Except 15E|Physician Decision|0|||
105724779|NCT04889209|364646504|FG016|All Cohorts Except 15E|Physician Decision|0|||
105724780|NCT04889209|364646505|FG017|All Cohorts Except 15E|Physician Decision|0|||
105724781|NCT04889209|364646488|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
105724782|NCT04889209|364646489|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
105724783|NCT04889209|364646490|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
105724784|NCT04889209|364646491|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
105724785|NCT04889209|364646492|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
105724786|NCT04889209|364646493|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724787|NCT04889209|364646494|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724788|NCT04889209|364646495|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
105724789|NCT04889209|364646496|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724790|NCT04889209|364646497|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724791|NCT04889209|364646498|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724792|NCT04889209|364646499|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724793|NCT04889209|364646500|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724794|NCT04889209|364646501|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
105724795|NCT04889209|364646502|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
105724796|NCT04889209|364646503|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
105724797|NCT04889209|364646504|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
105724798|NCT04889209|364646505|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
105724799|NCT04889209|364646488|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
105724800|NCT04889209|364646489|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
105724801|NCT04889209|364646490|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724802|NCT04889209|364646491|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105936112|NCT00452400|365425299|FG000|Overall Study|Lack of Efficacy|2|||
105724803|NCT04889209|364646492|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724804|NCT04889209|364646493|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
105724805|NCT04889209|364646494|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724806|NCT04889209|364646495|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
105724807|NCT04889209|364646496|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724808|NCT04889209|364646497|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
105760768|NCT01576406|364776185|FG002|Overall Study|Withdrawal the consent|5|||
105760769|NCT01576406|364776186|FG003|Overall Study|Withdrawal the consent|1|||
105760770|NCT01576406|364776187|FG004|Overall Study|Withdrawal the consent|1|||
105760771|NCT01576406|364776188|FG005|Overall Study|Withdrawal the consent|3|||
105760772|NCT01576406|364776183|FG000|Overall Study|Other|0|||
105793415|NCT00728988|364898806|FG000|Overall Study|Withdrawal by Subject|2|||
105793416|NCT00728988|364898807|FG001|Overall Study|Withdrawal by Subject|6|||
105793417|NCT02756078|364898813|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
105793418|NCT02756078|364898814|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
105793419|NCT02756078|364898813|FG000|Period 1|Lost to Follow-up|0|||
105793420|NCT02756078|364898814|FG001|Period 1|Lost to Follow-up|2|||
105793421|NCT02756078|364898813|FG000|Period 1|Protocol Violation|0|||
105793422|NCT02756078|364898814|FG001|Period 1|Protocol Violation|1|||
105793423|NCT02756078|364898813|FG000|Period 1|Adverse Event|1|||
105793424|NCT02756078|364898814|FG001|Period 1|Adverse Event|10|||
105793425|NCT02756078|364898813|FG000|Period 1|Withdrawal by Subject|6|||
105793426|NCT02756078|364898814|FG001|Period 1|Withdrawal by Subject|6|||
105793427|NCT02756078|364898813|FG000|Period 1|Lens Discomfort|2|||
105793428|NCT02756078|364898814|FG001|Period 1|Lens Discomfort|2|||
105793429|NCT02756078|364898813|FG000|Period 2|Adverse Event|3|||
105793430|NCT02756078|364898814|FG001|Period 2|Adverse Event|5|||
105793431|NCT02756078|364898813|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
105793432|NCT02756078|364898814|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
105793433|NCT02756078|364898813|FG000|Period 2|Withdrawal by Subject|3|||
105793434|NCT02756078|364898814|FG001|Period 2|Withdrawal by Subject|1|||
105793435|NCT03701516|364898818|FG000|Period 1|Lost to Follow-up|0|||
105793436|NCT03701516|364898819|FG001|Period 1|Lost to Follow-up|1|||
105793437|NCT03701516|364898818|FG000|Period 1|Adverse Event|0|||
105793438|NCT03701516|364898819|FG001|Period 1|Adverse Event|2|||
105793439|NCT03701516|364898818|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
105793440|NCT03701516|364898819|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
105793441|NCT03701516|364898818|FG000|Period 1|Non Compliance to Protocol|2|||
105793442|NCT03701516|364898819|FG001|Period 1|Non Compliance to Protocol|1|||
105793443|NCT03701516|364898818|FG000|Period 1|Withdrawal by Subject|0|||
105793444|NCT03701516|364898819|FG001|Period 1|Withdrawal by Subject|1|||
105793445|NCT03701516|364898818|FG000|Period 2|failed to meet all eligibility creiteria|1|||
105793446|NCT03701516|364898819|FG001|Period 2|failed to meet all eligibility creiteria|0|||
105793447|NCT03701516|364898818|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
105793448|NCT03701516|364898819|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
105793449|NCT01591499|364898820|FG000|Baseline Visit|Withdrawal by Subject|0|||
105793450|NCT01591499|364898821|FG001|Baseline Visit|Withdrawal by Subject|2|||
105793451|NCT01591499|364898822|FG002|Baseline Visit|Withdrawal by Subject|0|||
105793452|NCT01591499|364898823|FG003|Baseline Visit|Withdrawal by Subject|2|||
105793453|NCT01591499|364898820|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
105793454|NCT01591499|364898821|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
105793455|NCT01591499|364898822|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
105793456|NCT01591499|364898823|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
105793457|NCT01591499|364898820|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
105793458|NCT01591499|364898821|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
105793459|NCT01591499|364898822|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
105793460|NCT01591499|364898823|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
105793461|NCT02032823|364898824|FG000|Overall Study|Death|75|||
105793462|NCT02032823|364898825|FG001|Overall Study|Death|109|||
105793463|NCT02032823|364898824|FG000|Overall Study|Lost to Follow-up|18|||
105793464|NCT02032823|364898825|FG001|Overall Study|Lost to Follow-up|17|||
105793465|NCT02032823|364898824|FG000|Overall Study|Withdrawal by Subject|70|||
105793466|NCT02032823|364898825|FG001|Overall Study|Withdrawal by Subject|53|||
105793467|NCT02032823|364898824|FG000|Overall Study|Ongoing study at data cut-off|755|||
105793468|NCT02032823|364898825|FG001|Overall Study|Ongoing study at data cut-off|731|||
105793469|NCT02032823|364898824|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
105793470|NCT02032823|364898825|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
105793471|NCT03428217|364898826|FG000|Overall Study|Death|89|||
105793472|NCT03428217|364898827|FG001|Overall Study|Death|93|||
105793473|NCT03428217|364898826|FG000|Overall Study|Withdrawal by Subject|8|||
105793474|NCT03428217|364898827|FG001|Overall Study|Withdrawal by Subject|7|||
105793475|NCT03428217|364898826|FG000|Overall Study|Lost to Follow-up|1|||
105793476|NCT03428217|364898827|FG001|Overall Study|Lost to Follow-up|3|||
105793477|NCT03428217|364898826|FG000|Overall Study|Study terminated by sponsor|124|||
105793478|NCT03428217|364898827|FG001|Overall Study|Study terminated by sponsor|118|||
105793479|NCT03428217|364898826|FG000|Overall Study|Other, Not Specified|1|||
105793480|NCT03428217|364898827|FG001|Overall Study|Other, Not Specified|0|||
105793481|NCT00689273|364898830|FG000|Overall Study|Adverse Event|3|||
105793482|NCT00689273|364898831|FG001|Overall Study|Adverse Event|1|||
105793483|NCT00689273|364898830|FG000|Overall Study|Lack of Efficacy|3|||
105793484|NCT00689273|364898831|FG001|Overall Study|Lack of Efficacy|0|||
105793485|NCT00689273|364898830|FG000|Overall Study|Lost to Follow-up|0|||
105793486|NCT00689273|364898831|FG001|Overall Study|Lost to Follow-up|2|||
105793487|NCT00689273|364898830|FG000|Overall Study|Other|6|||
105793488|NCT00689273|364898831|FG001|Overall Study|Other|2|||
105793489|NCT00689273|364898830|FG000|Overall Study|Randomized but not Treated|1|||
105793490|NCT00689273|364898831|FG001|Overall Study|Randomized but not Treated|0|||
105793491|NCT03526679|364900670|FG000|Overall Study|still under treatment|2|||
105793492|NCT01325701|364900671|FG000|Overall Study|Adverse Event|12|||
105793493|NCT01325701|364900672|FG001|Overall Study|Adverse Event|0|||
105793494|NCT01325701|364900671|FG000|Overall Study|Protocol Violation|1|||
105793495|NCT01325701|364900672|FG001|Overall Study|Protocol Violation|0|||
105793496|NCT01325701|364900671|FG000|Overall Study|Physician Decision|2|||
105793497|NCT01325701|364900672|FG001|Overall Study|Physician Decision|2|||
105793498|NCT01325701|364900671|FG000|Overall Study|Withdrawal by Subject|2|||
105793499|NCT01325701|364900672|FG001|Overall Study|Withdrawal by Subject|1|||
105793500|NCT01325701|364900671|FG000|Overall Study|Rollerover Extension Study|4|||
105793501|NCT01325701|364900672|FG001|Overall Study|Rollerover Extension Study|0|||
105793502|NCT02406742|364900675|FG000|Overall Study|Progression of Disease|5|||
105793503|NCT02406742|364900676|FG001|Overall Study|Progression of Disease|1|||
105793504|NCT02406742|364900677|FG002|Overall Study|Progression of Disease|6|||
105793505|NCT02406742|364900675|FG000|Overall Study|Adverse Event|3|||
105793506|NCT02406742|364900676|FG001|Overall Study|Adverse Event|0|||
105793507|NCT02406742|364900677|FG002|Overall Study|Adverse Event|2|||
105793508|NCT02406742|364900675|FG000|Overall Study|Death|1|||
105793509|NCT02406742|364900676|FG001|Overall Study|Death|0|||
105793510|NCT02406742|364900677|FG002|Overall Study|Death|0|||
105793511|NCT02406742|364900675|FG000|Overall Study|Lack of Efficacy|0|||
105793512|NCT02406742|364900676|FG001|Overall Study|Lack of Efficacy|0|||
105793513|NCT02406742|364900677|FG002|Overall Study|Lack of Efficacy|1|||
105793514|NCT02406742|364900675|FG000|Overall Study|Withdrawal by Participant|1|||
105793515|NCT02406742|364900676|FG001|Overall Study|Withdrawal by Participant|2|||
106009202|NCT04026113|365700804|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
106009203|NCT04026113|365700801|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
106009204|NCT04026113|365700802|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
106009205|NCT04026113|365700803|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
105724809|NCT04889209|364646498|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724810|NCT04889209|364646499|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724811|NCT04889209|364646500|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724812|NCT04889209|364646501|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724813|NCT04889209|364646502|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724814|NCT04889209|364646503|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724815|NCT04889209|364646504|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
105724816|NCT04889209|364646505|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
105724817|NCT04889209|364646488|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724818|NCT04889209|364646489|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724819|NCT04889209|364646490|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724820|NCT04889209|364646491|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
105724821|NCT04889209|364646492|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724822|NCT04889209|364646493|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724823|NCT04889209|364646494|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724824|NCT04889209|364646495|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724825|NCT04889209|364646496|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724826|NCT04889209|364646497|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724827|NCT04889209|364646498|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724828|NCT04889209|364646499|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724829|NCT04889209|364646500|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724830|NCT04889209|364646501|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724831|NCT04889209|364646502|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724832|NCT04889209|364646503|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724833|NCT04889209|364646504|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724834|NCT04889209|364646505|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
105724835|NCT04889209|364646488|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724836|NCT04889209|364646489|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105793516|NCT02406742|364900677|FG002|Overall Study|Withdrawal by Participant|0|||
106009206|NCT04026113|365700804|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
105793517|NCT02406742|364900675|FG000|Overall Study|Physician Decision|1|||
105793518|NCT02406742|364900676|FG001|Overall Study|Physician Decision|2|||
105793519|NCT02406742|364900677|FG002|Overall Study|Physician Decision|1|||
105793520|NCT02406742|364900675|FG000|Overall Study|Transition to other treatment|2|||
106009207|NCT04026113|365700801|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
105793521|NCT02406742|364900676|FG001|Overall Study|Transition to other treatment|0|||
106137727|NCT00831792|366163470|FG000|Overall Study|Lack of Efficacy|1|||
106137728|NCT01744691|366163477|FG000|Overall Study|Progressive Disease|18|||
105724837|NCT04889209|364646490|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724838|NCT04889209|364646491|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724839|NCT04889209|364646492|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724840|NCT04889209|364646493|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724841|NCT04889209|364646494|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724842|NCT04889209|364646495|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724843|NCT04889209|364646496|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724844|NCT04889209|364646497|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724845|NCT04889209|364646498|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724846|NCT04889209|364646499|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724847|NCT04889209|364646500|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724848|NCT04889209|364646501|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724849|NCT04889209|364646502|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724850|NCT04889209|364646503|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724851|NCT04889209|364646504|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
105724852|NCT04889209|364646505|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
105724853|NCT04889209|364646488|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724854|NCT04889209|364646489|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724855|NCT04889209|364646490|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724856|NCT04889209|364646491|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724857|NCT04889209|364646492|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724858|NCT04889209|364646493|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724859|NCT04889209|364646494|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724860|NCT04889209|364646495|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724861|NCT04889209|364646496|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724862|NCT04889209|364646497|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724863|NCT04889209|364646498|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724864|NCT04889209|364646499|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724865|NCT04889209|364646500|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724866|NCT04889209|364646501|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724867|NCT04889209|364646502|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724868|NCT04889209|364646503|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724869|NCT04889209|364646504|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
105724870|NCT04889209|364646505|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
105724871|NCT04889209|364646488|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724872|NCT04889209|364646489|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724873|NCT04889209|364646490|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724874|NCT04889209|364646491|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724875|NCT04889209|364646492|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724876|NCT04889209|364646493|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724877|NCT04889209|364646494|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724878|NCT04889209|364646495|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724879|NCT04889209|364646496|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724880|NCT04889209|364646497|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724881|NCT04889209|364646498|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724882|NCT04889209|364646499|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724883|NCT04889209|364646500|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724884|NCT04889209|364646501|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724885|NCT04889209|364646502|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724886|NCT04889209|364646503|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724887|NCT04889209|364646504|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
105724888|NCT04889209|364646505|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
105724889|NCT04889209|364646488|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724890|NCT04889209|364646489|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724891|NCT04889209|364646490|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105793522|NCT02406742|364900677|FG002|Overall Study|Transition to other treatment|1|||
106137729|NCT01744691|366163477|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
105793523|NCT02406742|364900675|FG000|Overall Study|Other Reasons|1|||
105793524|NCT02406742|364900676|FG001|Overall Study|Other Reasons|11|||
105793525|NCT02406742|364900677|FG002|Overall Study|Other Reasons|5|||
106137730|NCT01744691|366163477|FG000|Overall Study|Withdrawal of consent for treatment|3|||
106137731|NCT01744691|366163477|FG000|Overall Study|Physician Decision|4|||
105724892|NCT04889209|364646491|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724893|NCT04889209|364646492|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724894|NCT04889209|364646493|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724895|NCT04889209|364646494|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724896|NCT04889209|364646495|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724897|NCT04889209|364646496|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724898|NCT04889209|364646497|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724899|NCT04889209|364646498|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724900|NCT04889209|364646499|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724901|NCT04889209|364646500|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724902|NCT04889209|364646501|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724903|NCT04889209|364646502|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
105724904|NCT04889209|364646503|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724905|NCT04889209|364646504|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724906|NCT04889209|364646505|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
105724907|NCT02786901|364646506|FG000|Overall Study|Adverse Event|1|||
105724908|NCT02786901|364646507|FG001|Overall Study|Adverse Event|1|||
105724909|NCT02786901|364646508|FG002|Overall Study|Adverse Event|2|||
105724910|NCT02786901|364646506|FG000|Overall Study|Physician Decision|1|||
105724911|NCT02786901|364646507|FG001|Overall Study|Physician Decision|0|||
105724912|NCT02786901|364646508|FG002|Overall Study|Physician Decision|0|||
105724913|NCT02786901|364646506|FG000|Overall Study|Rescue Therapy Use|71|||
105724914|NCT02786901|364646507|FG001|Overall Study|Rescue Therapy Use|49|||
105724915|NCT02786901|364646508|FG002|Overall Study|Rescue Therapy Use|33|||
105724916|NCT02786901|364646506|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
105724917|NCT02786901|364646507|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
105724918|NCT02786901|364646508|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
105724919|NCT02786901|364646506|FG000|Overall Study|Disallowed medication|1|||
105724920|NCT02786901|364646507|FG001|Overall Study|Disallowed medication|1|||
105724921|NCT02786901|364646508|FG002|Overall Study|Disallowed medication|0|||
105724922|NCT02786901|364646506|FG000|Overall Study|Randomized in error|2|||
105724923|NCT02786901|364646507|FG001|Overall Study|Randomized in error|0|||
105724924|NCT02786901|364646508|FG002|Overall Study|Randomized in error|1|||
105724925|NCT01075178|364646509|FG000|Subject Matching|eligible but not matched|130|||
105724926|NCT01075178|364646510|FG001|Subject Matching|eligible but not matched|403|||
105724927|NCT01075178|364646509|FG000|Subject Chart Review|died before chart review period|0|||
105724928|NCT01075178|364646510|FG001|Subject Chart Review|died before chart review period|2|||
105724929|NCT01075178|364646509|FG000|Subject Chart Review|no data collected due to site closure|3|||
105724930|NCT01075178|364646510|FG001|Subject Chart Review|no data collected due to site closure|4|||
105724931|NCT01075178|364646509|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
105724932|NCT01075178|364646510|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
105724933|NCT00763009|364646512|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
105724934|NCT01111604|364646514|FG000|Overall Study|Lost to Follow-up|0|||
105724935|NCT01111604|364646515|FG001|Overall Study|Lost to Follow-up|0|||
105724936|NCT01111604|364646516|FG002|Overall Study|Lost to Follow-up|1|||
105724937|NCT01111604|364646514|FG000|Overall Study|Withdrew Consent|3|||
105724938|NCT01111604|364646515|FG001|Overall Study|Withdrew Consent|0|||
105724939|NCT01111604|364646516|FG002|Overall Study|Withdrew Consent|2|||
105724940|NCT01111604|364646514|FG000|Overall Study|Withdrawal by Subject|2|||
105724941|NCT01111604|364646515|FG001|Overall Study|Withdrawal by Subject|0|||
105724942|NCT01111604|364646516|FG002|Overall Study|Withdrawal by Subject|0|||
105724943|NCT01111604|364646514|FG000|Overall Study|Death|1|||
105724944|NCT01111604|364646515|FG001|Overall Study|Death|0|||
105724945|NCT01111604|364646516|FG002|Overall Study|Death|0|||
105724946|NCT01111604|364646514|FG000|Overall Study|Met Exclusion Criteria|2|||
105724947|NCT01111604|364646515|FG001|Overall Study|Met Exclusion Criteria|0|||
105724948|NCT01111604|364646516|FG002|Overall Study|Met Exclusion Criteria|0|||
105724949|NCT00316264|364646518|FG000|Overall Study|Lost to Follow-up|0|||
105724950|NCT00316264|364646519|FG001|Overall Study|Lost to Follow-up|1|||
105724951|NCT00316264|364646520|FG002|Overall Study|Lost to Follow-up|0|||
105724952|NCT00316264|364646518|FG000|Overall Study|Withdrawal of Consent|3|||
105724953|NCT00316264|364646519|FG001|Overall Study|Withdrawal of Consent|5|||
105724954|NCT00316264|364646520|FG002|Overall Study|Withdrawal of Consent|6|||
105724955|NCT00316264|364646518|FG000|Overall Study|Death|2|||
105724956|NCT00316264|364646519|FG001|Overall Study|Death|0|||
105724957|NCT00316264|364646520|FG002|Overall Study|Death|0|||
105724958|NCT00316264|364646518|FG000|Overall Study|Other|1|||
105724959|NCT00316264|364646519|FG001|Overall Study|Other|1|||
105724960|NCT00316264|364646520|FG002|Overall Study|Other|0|||
105724961|NCT00607048|364646521|FG000|Overall Study|Adverse Event|0|||
105724962|NCT00607048|364646522|FG001|Overall Study|Adverse Event|1|||
105793526|NCT02367729|364900679|FG000|Overall Study|Organic disorder diagnosed|2|||
105936113|NCT00452400|365425300|FG001|Overall Study|Lack of Efficacy|0|||
105724963|NCT00607048|364646523|FG002|Overall Study|Adverse Event|0|||
105724964|NCT00607048|364646524|FG003|Overall Study|Adverse Event|0|||
105724965|NCT00607048|364646525|FG004|Overall Study|Adverse Event|4|||
105724966|NCT00607048|364646526|FG005|Overall Study|Adverse Event|0|||
105724967|NCT00607048|364646521|FG000|Overall Study|Global deterioration of health|1|||
105724968|NCT00607048|364646522|FG001|Overall Study|Global deterioration of health|0|||
105724969|NCT00607048|364646523|FG002|Overall Study|Global deterioration of health|0|||
105724970|NCT00607048|364646524|FG003|Overall Study|Global deterioration of health|0|||
105724971|NCT00607048|364646525|FG004|Overall Study|Global deterioration of health|0|||
105724972|NCT00607048|364646526|FG005|Overall Study|Global deterioration of health|0|||
105724973|NCT00607048|364646521|FG000|Overall Study|Objective disease progression - relapse|1|||
105724974|NCT00607048|364646522|FG001|Overall Study|Objective disease progression - relapse|2|||
105724975|NCT00607048|364646523|FG002|Overall Study|Objective disease progression - relapse|4|||
105724976|NCT00607048|364646524|FG003|Overall Study|Objective disease progression - relapse|2|||
105724977|NCT00607048|364646525|FG004|Overall Study|Objective disease progression - relapse|2|||
105724978|NCT00607048|364646526|FG005|Overall Study|Objective disease progression - relapse|2|||
105724979|NCT00607048|364646521|FG000|Overall Study|Withdrawal by Subject|0|||
105724980|NCT00607048|364646522|FG001|Overall Study|Withdrawal by Subject|0|||
105724981|NCT00607048|364646523|FG002|Overall Study|Withdrawal by Subject|0|||
105724982|NCT00607048|364646524|FG003|Overall Study|Withdrawal by Subject|1|||
105724983|NCT00607048|364646525|FG004|Overall Study|Withdrawal by Subject|0|||
105724984|NCT00607048|364646526|FG005|Overall Study|Withdrawal by Subject|2|||
105724985|NCT00607048|364646521|FG000|Overall Study|Other|1|||
105724986|NCT00607048|364646522|FG001|Overall Study|Other|1|||
105724987|NCT00607048|364646523|FG002|Overall Study|Other|0|||
105724988|NCT00607048|364646524|FG003|Overall Study|Other|0|||
105724989|NCT00607048|364646525|FG004|Overall Study|Other|0|||
105724990|NCT00607048|364646526|FG005|Overall Study|Other|1|||
105724991|NCT02620020|364646527|FG000|Overall Study|Adverse Event|8|||
105724992|NCT02620020|364646528|FG001|Overall Study|Adverse Event|4|||
105724993|NCT02620020|364646529|FG002|Overall Study|Adverse Event|3|||
105724994|NCT02620020|364646530|FG003|Overall Study|Adverse Event|5|||
105724995|NCT02620020|364646527|FG000|Overall Study|Lost to Follow-up|4|||
105724996|NCT02620020|364646528|FG001|Overall Study|Lost to Follow-up|8|||
105724997|NCT02620020|364646529|FG002|Overall Study|Lost to Follow-up|1|||
105724998|NCT02620020|364646530|FG003|Overall Study|Lost to Follow-up|4|||
105724999|NCT02620020|364646527|FG000|Overall Study|Physician Decision|7|||
105725000|NCT02620020|364646528|FG001|Overall Study|Physician Decision|4|||
105725001|NCT02620020|364646529|FG002|Overall Study|Physician Decision|3|||
105725002|NCT02620020|364646530|FG003|Overall Study|Physician Decision|4|||
105725003|NCT02620020|364646527|FG000|Overall Study|Protocol Violation|5|||
105725004|NCT02620020|364646528|FG001|Overall Study|Protocol Violation|2|||
105725005|NCT02620020|364646529|FG002|Overall Study|Protocol Violation|1|||
105725006|NCT02620020|364646530|FG003|Overall Study|Protocol Violation|1|||
105725007|NCT02620020|364646527|FG000|Overall Study|Withdrawal by Subject|20|||
105725008|NCT02620020|364646528|FG001|Overall Study|Withdrawal by Subject|16|||
105725009|NCT02620020|364646529|FG002|Overall Study|Withdrawal by Subject|17|||
105725010|NCT02620020|364646530|FG003|Overall Study|Withdrawal by Subject|12|||
105725011|NCT02620020|364646527|FG000|Overall Study|Death|0|||
105725012|NCT02620020|364646528|FG001|Overall Study|Death|1|||
105725013|NCT02620020|364646529|FG002|Overall Study|Death|0|||
105725014|NCT02620020|364646530|FG003|Overall Study|Death|0|||
105725015|NCT02868892|364646531|FG000|Overall Study|Investigator left site and no follow-up|6|||
105725016|NCT01025635|364646532|FG000|Overall Study|Withdrawal by Subject|6|||
105725017|NCT01025635|364646533|FG001|Overall Study|Withdrawal by Subject|7|||
105725018|NCT01025635|364646532|FG000|Overall Study|Protocol Violation|4|||
105725019|NCT01025635|364646533|FG001|Overall Study|Protocol Violation|2|||
105725020|NCT01025635|364646532|FG000|Overall Study|Lack of Efficacy|0|||
105725021|NCT01025635|364646533|FG001|Overall Study|Lack of Efficacy|1|||
105725022|NCT01025635|364646532|FG000|Overall Study|Lost to Follow-up|9|||
105725023|NCT01025635|364646533|FG001|Overall Study|Lost to Follow-up|13|||
105725024|NCT01025635|364646532|FG000|Overall Study|Reason not known|4|||
105725025|NCT01025635|364646533|FG001|Overall Study|Reason not known|2|||
105725026|NCT02928952|364646535|FG000|Overall Study|Lost to Follow-up|5|||
105725027|NCT02928952|364646536|FG001|Overall Study|Lost to Follow-up|5|||
105725028|NCT02928952|364646535|FG000|Overall Study|Withdrawal by Subject|5|||
105725029|NCT02928952|364646536|FG001|Overall Study|Withdrawal by Subject|1|||
105725030|NCT02928952|364646535|FG000|Overall Study|Physician Decision|0|||
105725031|NCT02928952|364646536|FG001|Overall Study|Physician Decision|1|||
105725032|NCT02393209|364646541|FG000|Overall Study|Study Terminated by Sponsor|1|||
105725033|NCT02393209|364646542|FG001|Overall Study|Study Terminated by Sponsor|1|||
105725034|NCT02393209|364646543|FG002|Overall Study|Study Terminated by Sponsor|0|||
105725035|NCT02393209|364646544|FG003|Overall Study|Study Terminated by Sponsor|0|||
105725036|NCT02393209|364646541|FG000|Overall Study|Withdrawal by Patient|1|||
105725037|NCT02393209|364646542|FG001|Overall Study|Withdrawal by Patient|0|||
105725038|NCT02393209|364646543|FG002|Overall Study|Withdrawal by Patient|0|||
105725039|NCT02393209|364646544|FG003|Overall Study|Withdrawal by Patient|0|||
105725040|NCT02393209|364646541|FG000|Overall Study|Death|2|||
105725041|NCT02393209|364646542|FG001|Overall Study|Death|2|||
105725042|NCT02393209|364646543|FG002|Overall Study|Death|0|||
105725043|NCT02393209|364646544|FG003|Overall Study|Death|0|||
105725044|NCT02393209|364646541|FG000|Overall Study|Death due to Disease Progression|2|||
105725045|NCT02393209|364646542|FG001|Overall Study|Death due to Disease Progression|2|||
105725046|NCT02393209|364646543|FG002|Overall Study|Death due to Disease Progression|0|||
105725047|NCT02393209|364646544|FG003|Overall Study|Death due to Disease Progression|0|||
105725048|NCT02393209|364646541|FG000|Overall Study|Death from Legionella Infection|0|||
105725049|NCT02393209|364646542|FG001|Overall Study|Death from Legionella Infection|1|||
105725050|NCT02393209|364646543|FG002|Overall Study|Death from Legionella Infection|0|||
105725051|NCT02393209|364646544|FG003|Overall Study|Death from Legionella Infection|0|||
105725052|NCT02393209|364646541|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
105725053|NCT02393209|364646542|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
105725054|NCT02393209|364646543|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
105725055|NCT02393209|364646544|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
105725056|NCT02393209|364646541|FG000|Overall Study|Lost to Follow-up|0|||
105725057|NCT02393209|364646542|FG001|Overall Study|Lost to Follow-up|1|||
105725058|NCT02393209|364646543|FG002|Overall Study|Lost to Follow-up|0|||
105725059|NCT02393209|364646544|FG003|Overall Study|Lost to Follow-up|0|||
105725060|NCT03545282|364646545|FG000|Overall Study|Lost to Follow-up|15|||
105725061|NCT03545282|364646546|FG001|Overall Study|Lost to Follow-up|10|||
105725062|NCT03545282|364646545|FG000|Overall Study|Withdrawal by Subject|2|||
105725063|NCT03545282|364646546|FG001|Overall Study|Withdrawal by Subject|2|||
105725064|NCT02582671|364646547|FG000|Overall Study|Failure to return|1|||
105725065|NCT02582671|364646547|FG000|Overall Study|Other, not specified|1|||
105725066|NCT01287104|364646548|FG000|Overall Study|Patient developed progressive disease|1|||
105725067|NCT01287104|364646549|FG001|Overall Study|Patient developed progressive disease|1|||
105725068|NCT01287104|364646550|FG002|Overall Study|Patient developed progressive disease|3|||
105725069|NCT01287104|364646551|FG003|Overall Study|Patient developed progressive disease|2|||
105725070|NCT01287104|364646548|FG000|Overall Study|Donor anaphylaxis|0|||
105725071|NCT01287104|364646549|FG001|Overall Study|Donor anaphylaxis|1|||
105725072|NCT01287104|364646550|FG002|Overall Study|Donor anaphylaxis|0|||
105725073|NCT01287104|364646551|FG003|Overall Study|Donor anaphylaxis|1|||
105725074|NCT01287104|364646548|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
105725075|NCT01287104|364646549|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
105725076|NCT01287104|364646550|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
105725077|NCT01287104|364646551|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
105725078|NCT01287104|364646548|FG000|Overall Study|Low donor chimerism|0|||
105725079|NCT01287104|364646549|FG001|Overall Study|Low donor chimerism|1|||
105725080|NCT01287104|364646550|FG002|Overall Study|Low donor chimerism|0|||
105725081|NCT01287104|364646551|FG003|Overall Study|Low donor chimerism|0|||
105725082|NCT01287104|364646548|FG000|Overall Study|NK cells did not meet release criteria|0|||
105725083|NCT01287104|364646549|FG001|Overall Study|NK cells did not meet release criteria|1|||
105725084|NCT01287104|364646550|FG002|Overall Study|NK cells did not meet release criteria|0|||
105725085|NCT01287104|364646551|FG003|Overall Study|NK cells did not meet release criteria|0|||
105725086|NCT00098787|364646556|FG000|Overall Study|Never started treatment|3|||
105725087|NCT00098787|364646557|FG001|Overall Study|Never started treatment|2|||
105725088|NCT00098787|364646558|FG002|Overall Study|Never started treatment|1|||
105725089|NCT00098787|364646556|FG000|Overall Study|Ineligible|9|||
105725090|NCT00098787|364646557|FG001|Overall Study|Ineligible|7|||
105725091|NCT00098787|364646558|FG002|Overall Study|Ineligible|3|||
105725092|NCT00098787|364646556|FG000|Overall Study|Disease progression|28|||
105725093|NCT00098787|364646557|FG001|Overall Study|Disease progression|17|||
105725094|NCT00098787|364646558|FG002|Overall Study|Disease progression|23|||
105936114|NCT00452400|365425301|FG002|Overall Study|Lack of Efficacy|0|||
105936115|NCT00452400|365425302|FG003|Overall Study|Lack of Efficacy|0|||
105936116|NCT00452400|365425303|FG004|Overall Study|Lack of Efficacy|0|||
105936117|NCT00452400|365425299|FG000|Overall Study|Other reasons not listed above|0|||
105936118|NCT00452400|365425300|FG001|Overall Study|Other reasons not listed above|0|||
105936119|NCT00452400|365425301|FG002|Overall Study|Other reasons not listed above|0|||
105936120|NCT00452400|365425302|FG003|Overall Study|Other reasons not listed above|1|||
105936121|NCT00452400|365425303|FG004|Overall Study|Other reasons not listed above|1|||
105936122|NCT00562861|365425306|FG000|Overall Study|Adverse Event|1|||
105936123|NCT00562861|365425307|FG001|Overall Study|Adverse Event|1|||
105936124|NCT00562861|365425306|FG000|Overall Study|Lack of Efficacy|5|||
105936125|NCT00562861|365425307|FG001|Overall Study|Lack of Efficacy|5|||
105936126|NCT00562861|365425306|FG000|Overall Study|noncompliance, moved|7|||
105936127|NCT00562861|365425307|FG001|Overall Study|noncompliance, moved|2|||
105936128|NCT00562861|365425306|FG000|Overall Study|Lost to Follow-up|7|||
105936129|NCT00562861|365425307|FG001|Overall Study|Lost to Follow-up|3|||
105936130|NCT01184118|365425308|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
105936131|NCT01184118|365425308|FG000|Overall Study|No physiologic confirmation of asthma|8|||
105936132|NCT01184118|365425308|FG000|Overall Study|FEV1 <60% predicted|2|||
105936133|NCT01184118|365425308|FG000|Overall Study|Exclusionary medical condition|2|||
105936134|NCT01184118|365425308|FG000|Overall Study|Withdrawal by Subject|5|||
105936135|NCT02792257|365425311|FG000|Overall Study|Lost to Follow-up|3|||
106009208|NCT04026113|365700802|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
106009209|NCT04026113|365700803|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
106009210|NCT04026113|365700804|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
106009211|NCT04026113|365700801|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
106009212|NCT04026113|365700802|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
106009213|NCT04026113|365700803|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
106009214|NCT04026113|365700804|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
106009215|NCT04026113|365700801|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
106009216|NCT04026113|365700802|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
106009217|NCT04026113|365700803|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
106009218|NCT04026113|365700804|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
106009219|NCT04026113|365700801|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
106009220|NCT04026113|365700802|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
106009221|NCT04026113|365700803|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
106009222|NCT04026113|365700804|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
106009223|NCT04026113|365700801|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
106009224|NCT04026113|365700802|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
105725095|NCT00098787|364646556|FG000|Overall Study|Adverse Event|8|||
105725096|NCT00098787|364646557|FG001|Overall Study|Adverse Event|17|||
105725097|NCT00098787|364646558|FG002|Overall Study|Adverse Event|8|||
105725098|NCT00098787|364646556|FG000|Overall Study|Death|6|||
105725099|NCT00098787|364646557|FG001|Overall Study|Death|1|||
105725100|NCT00098787|364646558|FG002|Overall Study|Death|0|||
105725101|NCT00098787|364646556|FG000|Overall Study|Withdrawal by Subject|4|||
105725102|NCT00098787|364646557|FG001|Overall Study|Withdrawal by Subject|12|||
105725103|NCT00098787|364646558|FG002|Overall Study|Withdrawal by Subject|6|||
105725104|NCT00098787|364646556|FG000|Overall Study|Alternative therapy|8|||
105725105|NCT00098787|364646557|FG001|Overall Study|Alternative therapy|13|||
105725106|NCT00098787|364646558|FG002|Overall Study|Alternative therapy|13|||
105725107|NCT00098787|364646556|FG000|Overall Study|Other|7|||
105725108|NCT00098787|364646557|FG001|Overall Study|Other|6|||
105725109|NCT00098787|364646558|FG002|Overall Study|Other|9|||
105725110|NCT02203149|364646562|FG000|Part 1|Adverse Event|0|||
105725111|NCT02203149|364646563|FG001|Part 1|Adverse Event|1|||
105725112|NCT02203149|364646564|FG002|Part 1|Adverse Event|0|||
105725113|NCT02203149|364646565|FG003|Part 1|Adverse Event|0|||
105725114|NCT02203149|364646566|FG004|Part 1|Adverse Event|0|||
105725115|NCT02203149|364646562|FG000|Part 2|Death|0|||
105725116|NCT02203149|364646563|FG001|Part 2|Death|0|||
105725117|NCT02203149|364646564|FG002|Part 2|Death|1|||
105725118|NCT02203149|364646565|FG003|Part 2|Death|1|||
105725119|NCT02203149|364646566|FG004|Part 2|Death|0|||
105725120|NCT02203149|364646562|FG000|Part 2|Withdrawal by Subject|0|||
105725121|NCT02203149|364646563|FG001|Part 2|Withdrawal by Subject|0|||
105725122|NCT02203149|364646564|FG002|Part 2|Withdrawal by Subject|0|||
105725123|NCT02203149|364646565|FG003|Part 2|Withdrawal by Subject|1|||
105725124|NCT02203149|364646566|FG004|Part 2|Withdrawal by Subject|0|||
105725125|NCT02203149|364646562|FG000|Part 2|Adverse Event|0|||
105725126|NCT02203149|364646563|FG001|Part 2|Adverse Event|0|||
105725127|NCT02203149|364646564|FG002|Part 2|Adverse Event|0|||
105725128|NCT02203149|364646565|FG003|Part 2|Adverse Event|1|||
105725129|NCT02203149|364646566|FG004|Part 2|Adverse Event|1|||
105725130|NCT01360996|364646567|FG000|Overall Study|Withdrawal by Subject|4|||
105725131|NCT01360996|364646568|FG001|Overall Study|Withdrawal by Subject|3|||
105725132|NCT01360996|364646569|FG002|Overall Study|Withdrawal by Subject|2|||
105725133|NCT01360996|364646567|FG000|Overall Study|Noncompliant|2|||
105725134|NCT01360996|364646568|FG001|Overall Study|Noncompliant|0|||
105725135|NCT01360996|364646569|FG002|Overall Study|Noncompliant|0|||
105725136|NCT03168867|364646571|FG000|Overall Study|Withdrawal by Subject|1|||
105725137|NCT03168867|364646572|FG001|Overall Study|Withdrawal by Subject|5|||
105725138|NCT04964258|364646573|FG000|Overall Study|Lost to Follow-up|1|||
105725139|NCT04964258|364646574|FG001|Overall Study|Lost to Follow-up|0|||
105725140|NCT04964258|364646575|FG002|Overall Study|Lost to Follow-up|0|||
105725141|NCT04964258|364646576|FG003|Overall Study|Lost to Follow-up|0|||
105793527|NCT02367729|364900680|FG001|Overall Study|Organic disorder diagnosed|1|||
105725142|NCT04964258|364646577|FG004|Overall Study|Lost to Follow-up|0|||
105725143|NCT04964258|364646578|FG005|Overall Study|Lost to Follow-up|1|||
105725144|NCT04964258|364646579|FG006|Overall Study|Lost to Follow-up|0|||
105725145|NCT04964258|364646580|FG007|Overall Study|Lost to Follow-up|0|||
105725146|NCT04964258|364646581|FG008|Overall Study|Lost to Follow-up|0|||
105725147|NCT04964258|364646582|FG009|Overall Study|Lost to Follow-up|0|||
105725148|NCT04964258|364646583|FG010|Overall Study|Lost to Follow-up|0|||
105725149|NCT01173653|364646585|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
105725150|NCT01173653|364646586|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
105725151|NCT04439344|364646590|FG000|Overall Study|Never started threapy|3|||
105725152|NCT04439344|364646590|FG000|Overall Study|Ineligible|3|||
106137732|NCT00197015|366163488|FG000|Overall Study|Adverse Event|3|||
106137733|NCT00197015|366163489|FG001|Overall Study|Adverse Event|0|||
106137734|NCT00197015|366163490|FG002|Overall Study|Adverse Event|1|||
106137735|NCT00197015|366163488|FG000|Overall Study|Protocol Violation|0|||
106137736|NCT00197015|366163489|FG001|Overall Study|Protocol Violation|3|||
106137737|NCT00197015|366163490|FG002|Overall Study|Protocol Violation|3|||
106137738|NCT00197015|366163488|FG000|Overall Study|Withdrawal by Subject|17|||
106137739|NCT00197015|366163489|FG001|Overall Study|Withdrawal by Subject|37|||
106137740|NCT00197015|366163490|FG002|Overall Study|Withdrawal by Subject|34|||
106137741|NCT00197015|366163488|FG000|Overall Study|Lost to Follow-up|28|||
106137742|NCT00197015|366163489|FG001|Overall Study|Lost to Follow-up|46|||
106137743|NCT00197015|366163490|FG002|Overall Study|Lost to Follow-up|37|||
106137744|NCT00197015|366163488|FG000|Overall Study|Other|2|||
106137745|NCT00197015|366163489|FG001|Overall Study|Other|3|||
106137746|NCT00197015|366163490|FG002|Overall Study|Other|2|||
106137747|NCT03525119|366163494|FG000|Overall Study|Adverse Event|0|||
106137748|NCT03525119|366163495|FG001|Overall Study|Adverse Event|1|||
106137749|NCT03525119|366163496|FG002|Overall Study|Adverse Event|0|||
106137750|NCT03525119|366163494|FG000|Overall Study|Lost to Follow-up|32|||
105725153|NCT04439344|364646590|FG000|Overall Study|Adverse Event|13|||
105725154|NCT04439344|364646590|FG000|Overall Study|Death|2|||
105725155|NCT04439344|364646590|FG000|Overall Study|Disease progression|29|||
105725156|NCT04439344|364646590|FG000|Overall Study|Withdrawal by Subject|2|||
105725157|NCT04439344|364646590|FG000|Overall Study|Alternative therapy|1|||
105725158|NCT02115308|364646592|FG000|Overall Study|Safety Screening|2|||
105725159|NCT02115308|364646593|FG001|Overall Study|Safety Screening|2|||
105725160|NCT03440944|364646596|FG000|Overall Study|Physician Decision|1|||
105725161|NCT03440944|364646597|FG001|Overall Study|Physician Decision|0|||
105725162|NCT03440944|364646596|FG000|Overall Study|No Acceptable Vasculature|0|||
105725163|NCT03440944|364646597|FG001|Overall Study|No Acceptable Vasculature|1|||
105725164|NCT03871491|364646598|FG000|Overall Study|Withdrawal by Subject|14|||
105725165|NCT03871491|364646599|FG001|Overall Study|Withdrawal by Subject|14|||
105725166|NCT03871491|364646600|FG002|Overall Study|Withdrawal by Subject|14|||
105725167|NCT03871491|364646601|FG003|Overall Study|Withdrawal by Subject|14|||
105725168|NCT03871491|364646598|FG000|Overall Study|Physician Decision|0|||
105725169|NCT03871491|364646599|FG001|Overall Study|Physician Decision|0|||
105725170|NCT03871491|364646600|FG002|Overall Study|Physician Decision|1|||
105725171|NCT03871491|364646601|FG003|Overall Study|Physician Decision|1|||
105725172|NCT03871491|364646598|FG000|Overall Study|Lost to Follow-up|50|||
105725173|NCT03871491|364646599|FG001|Overall Study|Lost to Follow-up|15|||
105725174|NCT03871491|364646600|FG002|Overall Study|Lost to Follow-up|36|||
105725175|NCT03871491|364646601|FG003|Overall Study|Lost to Follow-up|11|||
105725176|NCT02495948|364646604|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
105725177|NCT02495948|364646605|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
105725178|NCT02495948|364646604|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
105725179|NCT02495948|364646605|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
105725180|NCT01444300|364646606|FG000|Overall Study|Adverse Event|4|||
105725181|NCT01444300|364646607|FG001|Overall Study|Adverse Event|0|||
105725182|NCT02582658|364646608|FG000|Overall Study|Failure to Return|10|||
105725183|NCT02582658|364646608|FG000|Overall Study|Insufficient Virological Response|2|||
105725184|NCT02582658|364646608|FG000|Overall Study|Withdrawn Consent|1|||
105725185|NCT02582658|364646608|FG000|Overall Study|Death|1|||
105725186|NCT02582658|364646608|FG000|Overall Study|Not further specified|11|||
105725187|NCT01769105|364646609|FG000|First Intervention|Protocol Violation|2|||
105725188|NCT01769105|364646610|FG001|First Intervention|Protocol Violation|2|||
105725189|NCT01769105|364646609|FG000|Cross-over|Lost to Follow-up|5|||
105725190|NCT01769105|364646610|FG001|Cross-over|Lost to Follow-up|0|||
105725191|NCT04194944|364646611|FG000|Overall Study|Lost to Follow-up|3|||
105936136|NCT02792257|365425312|FG001|Overall Study|Lost to Follow-up|4|||
105936137|NCT02792257|365425311|FG000|Overall Study|Allergy|0|||
106137751|NCT03525119|366163495|FG001|Overall Study|Lost to Follow-up|33|||
106137752|NCT03525119|366163496|FG002|Overall Study|Lost to Follow-up|37|||
106137753|NCT03525119|366163494|FG000|Overall Study|Withdrawal by Subject|5|||
106137754|NCT03525119|366163495|FG001|Overall Study|Withdrawal by Subject|4|||
106137755|NCT03525119|366163496|FG002|Overall Study|Withdrawal by Subject|2|||
105725192|NCT04194944|364646612|FG001|Overall Study|Lost to Follow-up|0|||
105725193|NCT04194944|364646611|FG000|Overall Study|Withdrawal by Subject|2|||
105725194|NCT04194944|364646612|FG001|Overall Study|Withdrawal by Subject|2|||
105725195|NCT04194944|364646611|FG000|Overall Study|On Treatment|93|||
105725196|NCT04194944|364646612|FG001|Overall Study|On Treatment|30|||
105725197|NCT00127127|364648961|FG000|Overall Study|Adverse Event|0|||
105725198|NCT00127127|364648962|FG001|Overall Study|Adverse Event|2|||
105725199|NCT00127127|364648963|FG002|Overall Study|Adverse Event|0|||
105725200|NCT00127127|364648964|FG003|Overall Study|Adverse Event|1|||
106137756|NCT03525119|366163494|FG000|Overall Study|Reason not Specified|2|||
106137757|NCT03525119|366163495|FG001|Overall Study|Reason not Specified|1|||
106137758|NCT03525119|366163496|FG002|Overall Study|Reason not Specified|2|||
105793528|NCT02367729|364900679|FG000|Overall Study|Adverse Event|1|||
105793529|NCT02367729|364900680|FG001|Overall Study|Adverse Event|2|||
105793530|NCT02367729|364900679|FG000|Overall Study|Withdrawal by Subject|0|||
105793531|NCT02367729|364900680|FG001|Overall Study|Withdrawal by Subject|5|||
105793532|NCT00388674|364900681|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
105793533|NCT00388674|364900682|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
105793534|NCT00388674|364900681|FG000|Initial Treatment|Adverse Event|22|||
105793535|NCT00388674|364900682|FG001|Initial Treatment|Adverse Event|87|||
105793536|NCT00388674|364900681|FG000|Initial Treatment|Death|215|||
105793537|NCT00388674|364900682|FG001|Initial Treatment|Death|216|||
105793538|NCT00388674|364900681|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
105793539|NCT00388674|364900682|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
105793540|NCT00388674|364900681|FG000|Initial Treatment|HCC|12|||
105793541|NCT00388674|364900682|FG001|Initial Treatment|HCC|20|||
105793542|NCT00388674|364900681|FG000|Initial Treatment|Lost to Follow-up|526|||
105793543|NCT00388674|364900682|FG001|Initial Treatment|Lost to Follow-up|624|||
105793544|NCT00388674|364900681|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
105793545|NCT00388674|364900682|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
105793546|NCT00388674|364900681|FG000|Initial Treatment|Never Treated with Study Medication|1|||
105793547|NCT00388674|364900682|FG001|Initial Treatment|Never Treated with Study Medication|7|||
105793548|NCT00388674|364900681|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
105793549|NCT00388674|364900682|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
105793550|NCT00388674|364900681|FG000|Initial Treatment|Not Defined|125|||
105793551|NCT00388674|364900682|FG001|Initial Treatment|Not Defined|172|||
105793552|NCT00388674|364900681|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
105793553|NCT00388674|364900682|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
105793554|NCT00388674|364900681|FG000|Initial Treatment|Pregnancy|26|||
105793555|NCT00388674|364900682|FG001|Initial Treatment|Pregnancy|16|||
105793556|NCT00388674|364900681|FG000|Initial Treatment|Study Drug Toxicity|5|||
105793557|NCT00388674|364900682|FG001|Initial Treatment|Study Drug Toxicity|92|||
105793558|NCT00388674|364900681|FG000|Initial Treatment|Participant Request|501|||
105793559|NCT00388674|364900682|FG001|Initial Treatment|Participant Request|673|||
105793560|NCT00388674|364900681|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
105793561|NCT00388674|364900682|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
105793562|NCT00388674|364900681|FG000|Initial Treatment|Not Reported|10|||
105793563|NCT00388674|364900682|FG001|Initial Treatment|Not Reported|12|||
105793564|NCT00388674|364900681|FG000|End of Study|Administrative Reason By Sponsor|299|||
105793565|NCT00388674|364900682|FG001|End of Study|Administrative Reason By Sponsor|253|||
105793566|NCT00388674|364900681|FG000|End of Study|Death|239|||
105793567|NCT00388674|364900682|FG001|End of Study|Death|262|||
105793568|NCT00388674|364900681|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
105793569|NCT00388674|364900682|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
105793570|NCT00388674|364900681|FG000|End of Study|HCC|8|||
105793571|NCT00388674|364900682|FG001|End of Study|HCC|7|||
105793572|NCT00388674|364900681|FG000|End of Study|Lost to Follow-up|587|||
105793573|NCT00388674|364900682|FG001|End of Study|Lost to Follow-up|715|||
105793574|NCT00388674|364900681|FG000|End of Study|Malignancy (Non-HCC)|1|||
105936138|NCT02792257|365425312|FG001|Overall Study|Allergy|1|||
105936139|NCT02792257|365425311|FG000|Overall Study|Protocol Violation|2|||
105936140|NCT02792257|365425312|FG001|Overall Study|Protocol Violation|0|||
105936141|NCT02792257|365425311|FG000|Overall Study|Excessive Agitation|0|||
105936142|NCT02792257|365425312|FG001|Overall Study|Excessive Agitation|1|||
105936143|NCT02792257|365425311|FG000|Overall Study|Not Feeling Well|0|||
105936144|NCT02792257|365425312|FG001|Overall Study|Not Feeling Well|1|||
105936145|NCT00553475|365425313|FG000|Overall Study|Adverse Event|7|||
105936146|NCT00553475|365425314|FG001|Overall Study|Adverse Event|17|||
105936147|NCT00553475|365425315|FG002|Overall Study|Adverse Event|13|||
105936148|NCT00553475|365425313|FG000|Overall Study|Lack of Efficacy|7|||
105936149|NCT00553475|365425314|FG001|Overall Study|Lack of Efficacy|1|||
105936150|NCT00553475|365425315|FG002|Overall Study|Lack of Efficacy|0|||
105936151|NCT00553475|365425313|FG000|Overall Study|Withdrawal by Subject|1|||
105936152|NCT00553475|365425314|FG001|Overall Study|Withdrawal by Subject|1|||
105936153|NCT00553475|365425315|FG002|Overall Study|Withdrawal by Subject|0|||
105936154|NCT00553475|365425313|FG000|Overall Study|Physician Decision|1|||
105936155|NCT00553475|365425314|FG001|Overall Study|Physician Decision|0|||
105936156|NCT00553475|365425315|FG002|Overall Study|Physician Decision|0|||
105793575|NCT00388674|364900682|FG001|End of Study|Malignancy (Non-HCC)|1|||
105793576|NCT00388674|364900681|FG000|End of Study|Non-Study Related Comorbidities|3|||
105793577|NCT00388674|364900682|FG001|End of Study|Non-Study Related Comorbidities|4|||
105793578|NCT00388674|364900681|FG000|End of Study|Not Defined|135|||
105793579|NCT00388674|364900682|FG001|End of Study|Not Defined|214|||
105936157|NCT00553475|365425313|FG000|Overall Study|Due to moving|0|||
105936158|NCT00553475|365425314|FG001|Overall Study|Due to moving|1|||
105936159|NCT00553475|365425315|FG002|Overall Study|Due to moving|0|||
105936160|NCT00507507|365425316|FG000|Treatment Period|Lost to Follow-up|0|||
105936161|NCT00507507|365425317|FG001|Treatment Period|Lost to Follow-up|2|||
105936162|NCT00507507|365425316|FG000|Treatment Period|Physician Decision|4|||
105725201|NCT00127127|364648961|FG000|Overall Study|Lack of Efficacy|1|||
105725202|NCT00127127|364648962|FG001|Overall Study|Lack of Efficacy|3|||
105725203|NCT00127127|364648963|FG002|Overall Study|Lack of Efficacy|0|||
105725204|NCT00127127|364648964|FG003|Overall Study|Lack of Efficacy|2|||
105725205|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
105725206|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
105725207|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
105725208|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
105725209|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
105725210|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
105725211|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
105725212|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
105725213|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
105725214|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
105725215|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
105725216|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
105725217|NCT01412879|364648967|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
105725218|NCT01412879|364648968|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
105725219|NCT01412879|364648969|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
105725220|NCT04840667|364648970|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
105725221|NCT03195894|364648971|FG000|Overall Study|"An example is Started other treatment."|4|||
105725222|NCT03195894|364648972|FG001|Overall Study|"An example is Started other treatment."|5|||
105725223|NCT03195894|364648971|FG000|Overall Study|Withdrawal by Subject|15|||
105725224|NCT03195894|364648972|FG001|Overall Study|Withdrawal by Subject|4|||
105725225|NCT03195894|364648971|FG000|Overall Study|Lost to Follow-up|14|||
105725226|NCT03195894|364648972|FG001|Overall Study|Lost to Follow-up|19|||
105725227|NCT00162773|364648973|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
105725228|NCT04439266|364648976|FG000|Overall Study|Ineligible|1|||
105725229|NCT04439266|364648976|FG000|Overall Study|Adverse Event|1|||
105725230|NCT04439266|364648976|FG000|Overall Study|Death|1|||
105725231|NCT04439266|364648976|FG000|Overall Study|Disease progression|1|||
105725232|NCT04439266|364648976|FG000|Overall Study|Still on treatment|1|||
105725233|NCT02725788|364648979|FG000|Overall Study|Lost to Follow-up|1|||
105725234|NCT02725788|364648980|FG001|Overall Study|Lost to Follow-up|1|||
105725235|NCT02725788|364648979|FG000|Overall Study|Protocol Violation|0|||
105725236|NCT02725788|364648980|FG001|Overall Study|Protocol Violation|1|||
105725237|NCT03049449|364648985|FG000|Overall Study|Did not receive treatment.|0|||
105725238|NCT03049449|364648986|FG001|Overall Study|Did not receive treatment.|0|||
105725239|NCT03049449|364648987|FG002|Overall Study|Did not receive treatment.|0|||
105725240|NCT03049449|364648988|FG003|Overall Study|Did not receive treatment.|0|||
105725241|NCT03049449|364648989|FG004|Overall Study|Did not receive treatment.|0|||
105725242|NCT03049449|364648990|FG005|Overall Study|Did not receive treatment.|0|||
105936163|NCT00507507|365425317|FG001|Treatment Period|Physician Decision|1|||
105936164|NCT00507507|365425316|FG000|Treatment Period|Protocol Violation|1|||
105936165|NCT00507507|365425317|FG001|Treatment Period|Protocol Violation|2|||
105936166|NCT00507507|365425316|FG000|Treatment Period|Adverse Event|1|||
105936167|NCT00507507|365425317|FG001|Treatment Period|Adverse Event|1|||
105936168|NCT00507507|365425316|FG000|Treatment Period|Withdrawal by Subject|46|||
105936169|NCT00507507|365425317|FG001|Treatment Period|Withdrawal by Subject|47|||
105936170|NCT00507507|365425316|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
105936171|NCT00507507|365425317|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
105936172|NCT00507507|365425316|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
105936173|NCT00507507|365425317|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
105936174|NCT00507507|365425316|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
105936175|NCT00507507|365425317|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
105936176|NCT01694771|365425318|FG000|Overall Study|Adverse Event|18|||
105936177|NCT01694771|365425319|FG001|Overall Study|Adverse Event|16|||
105936178|NCT01694771|365425318|FG000|Overall Study|Lack of Efficacy|1|||
105936179|NCT01694771|365425319|FG001|Overall Study|Lack of Efficacy|0|||
105936180|NCT01694771|365425318|FG000|Overall Study|Non compliance protocol|7|||
105936181|NCT01694771|365425319|FG001|Overall Study|Non compliance protocol|6|||
105936182|NCT01694771|365425318|FG000|Overall Study|Lost to Follow-up|2|||
105936183|NCT01694771|365425319|FG001|Overall Study|Lost to Follow-up|3|||
105725243|NCT03049449|364648991|FG006|Overall Study|Did not receive treatment.|0|||
105725244|NCT03049449|364648992|FG007|Overall Study|Did not receive treatment.|0|||
105725245|NCT03049449|364648993|FG008|Overall Study|Did not receive treatment.|1|||
105936184|NCT01694771|365425318|FG000|Overall Study|Consent withdrawn|7|||
105936185|NCT01694771|365425319|FG001|Overall Study|Consent withdrawn|9|||
105936186|NCT01694771|365425318|FG000|Overall Study|Other reasons|5|||
105936187|NCT01694771|365425319|FG001|Overall Study|Other reasons|6|||
105936188|NCT03178942|365425327|FG000|Overall Study|Withdrawal by Subject|2|||
105760773|NCT01576406|364776184|FG001|Overall Study|Other|0|||
105793580|NCT00388674|364900681|FG000|End of Study|Participant Withdrew Consent|437|||
105793581|NCT00388674|364900682|FG001|End of Study|Participant Withdrew Consent|673|||
105793582|NCT00388674|364900681|FG000|End of Study|No Off-Treatment Status Data|22|||
105936189|NCT03178942|365425328|FG001|Overall Study|Withdrawal by Subject|0|||
105936190|NCT03178942|365425327|FG000|Overall Study|Lost to Follow-up|1|||
105936191|NCT03178942|365425328|FG001|Overall Study|Lost to Follow-up|2|||
105936192|NCT01657942|365425329|FG000|Overall Study|Alternative Treatment|7|||
105936193|NCT01657942|365425329|FG000|Overall Study|Lost to Follow-up|1|||
105936194|NCT04971837|365427366|FG000|Overall Study|Long Term Illness|1|||
105936195|NCT04971837|365427366|FG000|Overall Study|BMI too low|9|||
105936196|NCT04971837|365427366|FG000|Overall Study|geographic location|1|||
105936197|NCT04971837|365427366|FG000|Overall Study|Discontinued scheduling conflict|1|||
105936198|NCT05206604|365427367|FG000|Overall Study|Non-compliance with study drug|0|||
105936199|NCT05206604|365427368|FG001|Overall Study|Non-compliance with study drug|0|||
105936200|NCT05206604|365427369|FG002|Overall Study|Non-compliance with study drug|0|||
105936201|NCT05206604|365427370|FG003|Overall Study|Non-compliance with study drug|0|||
105936202|NCT05206604|365427371|FG004|Overall Study|Non-compliance with study drug|0|||
105936203|NCT05206604|365427372|FG005|Overall Study|Non-compliance with study drug|1|||
105936204|NCT05206604|365427373|FG006|Overall Study|Non-compliance with study drug|0|||
105936205|NCT05206604|365427374|FG007|Overall Study|Non-compliance with study drug|0|||
105936206|NCT03787212|365427376|FG000|Period 1|Study Termination|2|||
105936207|NCT03787212|365427377|FG001|Period 1|Study Termination|2|||
105936208|NCT02014103|365427378|FG000|Overall Study|Protocol Violation|7|||
105936209|NCT02014103|365427379|FG001|Overall Study|Protocol Violation|7|||
105936210|NCT02014103|365427378|FG000|Overall Study|Adverse Event|1|||
105936211|NCT02014103|365427379|FG001|Overall Study|Adverse Event|0|||
105936212|NCT02014103|365427378|FG000|Overall Study|Lost venous access|1|||
105936213|NCT02014103|365427379|FG001|Overall Study|Lost venous access|0|||
105936214|NCT02014103|365427378|FG000|Overall Study|Withdrawal by Subject|0|||
105936215|NCT02014103|365427379|FG001|Overall Study|Withdrawal by Subject|2|||
105936216|NCT01557244|365427382|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
105936217|NCT01557244|365427383|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105936218|NCT01557244|365427384|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105936219|NCT01557244|365427385|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105936220|NCT01557244|365427386|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105936221|NCT01557244|365427387|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
105936222|NCT01557244|365427388|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
105936223|NCT01557244|365427382|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
105936224|NCT01557244|365427383|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105936225|NCT01557244|365427384|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
105936226|NCT01557244|365427385|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105936227|NCT01557244|365427386|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105936228|NCT01557244|365427387|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105936229|NCT01557244|365427388|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
105936230|NCT01557244|365427382|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
105936231|NCT01557244|365427383|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105936232|NCT01557244|365427384|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105936233|NCT01557244|365427385|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105936234|NCT01557244|365427386|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105936235|NCT01557244|365427387|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105936236|NCT01557244|365427388|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
105936237|NCT01557244|365427382|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
105936238|NCT01557244|365427383|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105936239|NCT01557244|365427384|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105936240|NCT01557244|365427385|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105936241|NCT01557244|365427386|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105936242|NCT01557244|365427387|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
105793583|NCT00388674|364900682|FG001|End of Study|No Off-Treatment Status Data|30|||
105936243|NCT01557244|365427388|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
105936244|NCT01557244|365427382|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105936245|NCT01557244|365427383|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
105936246|NCT01557244|365427384|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105936247|NCT01557244|365427385|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105793584|NCT00388674|364900681|FG000|End of Study|Not Reported|0|||
105936248|NCT01557244|365427386|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105952108|NCT03314935|365488189|FG005|Phase 1|"Captured as Other in Database"|0|||
106137759|NCT03525119|366163494|FG000|Overall Study|Randomized but not Vaccinated|1|||
105936249|NCT01557244|365427387|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105936250|NCT01557244|365427388|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
105936251|NCT01557244|365427382|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105936252|NCT01557244|365427383|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105936253|NCT01557244|365427384|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105936254|NCT01557244|365427385|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105936255|NCT01557244|365427386|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
105936256|NCT01557244|365427387|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
105936257|NCT01557244|365427388|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
105936258|NCT01557244|365427382|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
105936259|NCT01557244|365427383|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
105936260|NCT01557244|365427384|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
105936261|NCT01557244|365427385|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
105936262|NCT01557244|365427386|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
105936263|NCT01557244|365427387|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
105936264|NCT01557244|365427388|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
105936265|NCT01557244|365427382|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
105936266|NCT01557244|365427383|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105936267|NCT01557244|365427384|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
105936268|NCT01557244|365427385|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105936269|NCT01557244|365427386|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105725246|NCT03049449|364648994|FG009|Overall Study|Did not receive treatment.|0|||
105725247|NCT03049449|364648985|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
105725248|NCT03049449|364648986|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
105936270|NCT01557244|365427387|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105936271|NCT01557244|365427388|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
105936272|NCT01557244|365427382|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
105936273|NCT01557244|365427383|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
105936274|NCT01557244|365427384|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
105936275|NCT01557244|365427385|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
105936276|NCT01557244|365427386|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
105936277|NCT01557244|365427387|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
105936278|NCT01557244|365427388|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
105936279|NCT01557244|365427382|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
105936280|NCT01557244|365427383|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
105936281|NCT01557244|365427384|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105936282|NCT01557244|365427385|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105936283|NCT01557244|365427386|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105936284|NCT01557244|365427387|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105936285|NCT01557244|365427388|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
105936286|NCT01557244|365427382|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105936287|NCT01557244|365427383|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105936288|NCT01557244|365427384|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105936289|NCT01557244|365427385|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
105936290|NCT01557244|365427386|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105936291|NCT01557244|365427387|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105936292|NCT01557244|365427388|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
105936293|NCT01557244|365427382|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
105936294|NCT01557244|365427383|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
105936295|NCT01557244|365427384|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105936296|NCT01557244|365427385|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105936297|NCT01557244|365427386|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105936298|NCT01557244|365427387|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105936299|NCT01557244|365427388|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
105936300|NCT00944645|365427389|FG000|Period 2|Adverse Event|1|||
105936301|NCT00944645|365427390|FG001|Period 2|Adverse Event|0|||
105936302|NCT00944645|365427389|FG000|Period 2|Lost to Follow-up|0|||
105936303|NCT00944645|365427390|FG001|Period 2|Lost to Follow-up|3|||
105936304|NCT00944645|365427389|FG000|Period 2|Withdrawal by Subject|7|||
105936305|NCT00944645|365427390|FG001|Period 2|Withdrawal by Subject|6|||
105936306|NCT03537729|365427391|FG000|Overall Study|Death|2|||
105936307|NCT03537729|365427392|FG001|Overall Study|Death|2|||
106137760|NCT03525119|366163495|FG001|Overall Study|Randomized but not Vaccinated|0|||
105725249|NCT03049449|364648987|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
105725250|NCT03049449|364648988|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
105725251|NCT03049449|364648989|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
105725252|NCT03049449|364648990|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
105725253|NCT03049449|364648991|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
105725254|NCT03049449|364648992|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
105725255|NCT03049449|364648993|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
105725256|NCT03049449|364648994|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
105725257|NCT03049449|364648985|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725258|NCT03049449|364648986|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725259|NCT03049449|364648987|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725260|NCT03049449|364648988|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725261|NCT03049449|364648989|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725262|NCT03049449|364648990|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725263|NCT03049449|364648991|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725264|NCT03049449|364648992|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
105725265|NCT03049449|364648993|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
105725266|NCT03049449|364648994|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
105725267|NCT02731742|364648997|FG000|Overall Study|Death|1|||
105725268|NCT02731742|364648998|FG001|Overall Study|Death|2|||
105725269|NCT02731742|364648999|FG002|Overall Study|Death|5|||
105725270|NCT02731742|364649000|FG003|Overall Study|Death|0|||
105725271|NCT02731742|364648997|FG000|Overall Study|Physician Decision|0|||
105725272|NCT02731742|364648998|FG001|Overall Study|Physician Decision|0|||
105725273|NCT02731742|364648999|FG002|Overall Study|Physician Decision|0|||
105725274|NCT02731742|364649000|FG003|Overall Study|Physician Decision|1|||
105725275|NCT02731742|364648997|FG000|Overall Study|Study Terminated by Sponsor|2|||
105725276|NCT02731742|364648998|FG001|Overall Study|Study Terminated by Sponsor|1|||
105725277|NCT02731742|364648999|FG002|Overall Study|Study Terminated by Sponsor|1|||
105725278|NCT02731742|364649000|FG003|Overall Study|Study Terminated by Sponsor|1|||
105725279|NCT00502840|364649003|FG000|Overall Study|Adverse Event|5|||
105725280|NCT00502840|364649003|FG000|Overall Study|Additional or changed therapy|48|||
105725281|NCT00502840|364649003|FG000|Overall Study|Lack of Efficacy|11|||
105725282|NCT00502840|364649003|FG000|Overall Study|Protocol Violation|4|||
105725283|NCT00502840|364649003|FG000|Overall Study|Withdrawal by Subject|5|||
105725284|NCT00502840|364649003|FG000|Overall Study|Lost to Follow-up|6|||
105725285|NCT00502840|364649003|FG000|Overall Study|Administrative problems|1|||
105725286|NCT00502840|364649003|FG000|Overall Study|Other|20|||
105725287|NCT00331760|364649004|FG000|Overall Study|Ineligible / no protocol treatment|15|||
105725288|NCT00331760|364649005|FG001|Overall Study|Ineligible / no protocol treatment|8|||
105725289|NCT00826514|364649007|FG000|Overall Study|Adverse Event|1|||
105725290|NCT00826514|364649008|FG001|Overall Study|Adverse Event|1|||
105725291|NCT00826514|364649007|FG000|Overall Study|Lack of Efficacy|0|||
105725292|NCT00826514|364649008|FG001|Overall Study|Lack of Efficacy|1|||
105725293|NCT00826514|364649007|FG000|Overall Study|Withdrawal by Subject|2|||
105725294|NCT00826514|364649008|FG001|Overall Study|Withdrawal by Subject|3|||
105725295|NCT03926143|364649011|FG000|Overall Study|Physician Decision|3|||
105725296|NCT03926143|364649011|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
105725297|NCT03926143|364649011|FG000|Overall Study|Adverse Event|2|||
105725298|NCT03926143|364649011|FG000|Overall Study|Progressive disease|3|||
105725299|NCT02978222|364649013|FG000|Overall Study|Withdrawal by Subject|2|||
105725300|NCT02978222|364649014|FG001|Overall Study|Withdrawal by Subject|2|||
105725301|NCT02978222|364649013|FG000|Overall Study|Physician Decision|2|||
105725302|NCT02978222|364649014|FG001|Overall Study|Physician Decision|0|||
105725303|NCT02978222|364649013|FG000|Overall Study|Adverse Event|0|||
105725304|NCT02978222|364649014|FG001|Overall Study|Adverse Event|1|||
105936308|NCT03537729|365427393|FG002|Overall Study|Death|7|||
105936309|NCT03537729|365427391|FG000|Overall Study|Withdrawal by Subject|3|||
105725305|NCT02978222|364649013|FG000|Overall Study|Death|1|||
105725306|NCT02978222|364649014|FG001|Overall Study|Death|0|||
105725307|NCT02978222|364649013|FG000|Overall Study|Disease Progression|32|||
105725308|NCT02978222|364649014|FG001|Overall Study|Disease Progression|32|||
105725309|NCT02978222|364649013|FG000|Overall Study|Early Study Termination|24|||
105725310|NCT02978222|364649014|FG001|Overall Study|Early Study Termination|21|||
105725311|NCT01686568|364649015|FG000|Main Study|Withdrawal by Subject|1|||
105725312|NCT01686568|364649016|FG001|Main Study|Withdrawal by Subject|3|||
105725313|NCT01686568|364649015|FG000|Main Study|Noncompliance with protocol|0|||
105725314|NCT01686568|364649016|FG001|Main Study|Noncompliance with protocol|1|||
105725315|NCT01686568|364649015|FG000|Main Study|Liver enzymes above range of exclusion|1|||
105793585|NCT00388674|364900682|FG001|End of Study|Not Reported|1|||
105793586|NCT01260194|364900691|FG000|Overall Study|Withdrawal of Consent|1|||
105793587|NCT03387735|364900692|FG000|Overall Study|Lost to Follow-up|4|||
105793588|NCT03387735|364900693|FG001|Overall Study|Lost to Follow-up|8|||
105793589|NCT03387735|364900692|FG000|Overall Study|Death|4|||
105793590|NCT03387735|364900693|FG001|Overall Study|Death|8|||
105793591|NCT01447628|364900694|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
105793592|NCT01447628|364900695|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
105793593|NCT01447628|364900696|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
105793594|NCT01447628|364900697|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
105793595|NCT05674721|364900700|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
105793596|NCT05674721|364900701|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
105793597|NCT05674721|364900700|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
105793598|NCT05674721|364900701|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
105793599|NCT03891875|364900702|FG000|Overall Study|Withdrawal by Subject|20|||
105793600|NCT03891875|364900703|FG001|Overall Study|Withdrawal by Subject|3|||
105793601|NCT03891875|364900702|FG000|Overall Study|Adverse Event|10|||
105793602|NCT03891875|364900703|FG001|Overall Study|Adverse Event|4|||
105793603|NCT03891875|364900702|FG000|Overall Study|Physician Decision|1|||
105793604|NCT03891875|364900703|FG001|Overall Study|Physician Decision|1|||
105793605|NCT03891875|364900702|FG000|Overall Study|Protocol Violation|1|||
105793606|NCT03891875|364900703|FG001|Overall Study|Protocol Violation|0|||
105793607|NCT03891875|364900702|FG000|Overall Study|Lost to Follow-up|1|||
105793608|NCT03891875|364900703|FG001|Overall Study|Lost to Follow-up|0|||
105793609|NCT03891875|364900702|FG000|Overall Study|COVID-19 infection|1|||
105793610|NCT03891875|364900703|FG001|Overall Study|COVID-19 infection|0|||
105793611|NCT02017535|364900707|FG000|Overall Study|Withdrawal by Subject|1|||
105793612|NCT02017535|364900708|FG001|Overall Study|Withdrawal by Subject|0|||
105793613|NCT02017535|364900709|FG002|Overall Study|Withdrawal by Subject|0|||
105793614|NCT02017535|364900710|FG003|Overall Study|Withdrawal by Subject|0|||
105793615|NCT04088734|364900711|FG000|Overall Study|Other, Not Specified|5|||
105793616|NCT00835068|364900714|FG000|Overall Study|Death|1|||
105793617|NCT00835068|364900715|FG001|Overall Study|Death|0|||
105793618|NCT00835068|364900714|FG000|Overall Study|Adverse Event|0|||
105793619|NCT00835068|364900715|FG001|Overall Study|Adverse Event|1|||
105793620|NCT00835068|364900714|FG000|Overall Study|Other|8|||
105793621|NCT00835068|364900715|FG001|Overall Study|Other|0|||
105793622|NCT00835068|364900714|FG000|Overall Study|Withdrawal by Subject|1|||
105793623|NCT00835068|364900715|FG001|Overall Study|Withdrawal by Subject|0|||
105793624|NCT00664066|364900716|FG000|Overall Study|Study terminated|3|||
105793625|NCT03014570|364900719|FG000|Overall Study|COVID-19 Restrictions|38|||
105793626|NCT03014570|364900720|FG001|Overall Study|COVID-19 Restrictions|24|||
105793627|NCT03014570|364900719|FG000|Overall Study|Death|70|||
105793628|NCT03014570|364900720|FG001|Overall Study|Death|79|||
105793629|NCT03014570|364900719|FG000|Overall Study|Transfer from facility|11|||
105793630|NCT03014570|364900720|FG001|Overall Study|Transfer from facility|14|||
105793631|NCT03014570|364900719|FG000|Overall Study|Hospitalized|5|||
105793632|NCT03014570|364900720|FG001|Overall Study|Hospitalized|3|||
105793633|NCT03014570|364900719|FG000|Overall Study|Transfer within facility|1|||
105793634|NCT03014570|364900720|FG001|Overall Study|Transfer within facility|0|||
105793635|NCT03014570|364900719|FG000|Overall Study|Site refusal|0|||
105793636|NCT03014570|364900720|FG001|Overall Study|Site refusal|11|||
105793637|NCT00090259|364900721|FG000|Overall Study|Lost to Follow-up|30|||
105793638|NCT00090259|364900722|FG001|Overall Study|Lost to Follow-up|26|||
105793639|NCT00090259|364900721|FG000|Overall Study|Withdrawal by Subject|21|||
105793640|NCT00090259|364900722|FG001|Overall Study|Withdrawal by Subject|15|||
105793641|NCT00090259|364900721|FG000|Overall Study|Investigator site closed|11|||
105793642|NCT00090259|364900722|FG001|Overall Study|Investigator site closed|7|||
105793643|NCT03083639|364900725|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
105793644|NCT03083639|364900726|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
105793645|NCT03083639|364900725|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
105793646|NCT03083639|364900726|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
105793647|NCT02666768|364900728|FG000|Overall Study|Withdrawal by Subject|4|||
105793648|NCT01488071|364900729|FG000|Overall Study|Adverse Event|15|||
105793649|NCT01488071|364900730|FG001|Overall Study|Adverse Event|23|||
105793650|NCT01488071|364900729|FG000|Overall Study|Lack of Efficacy|11|||
105793651|NCT01488071|364900730|FG001|Overall Study|Lack of Efficacy|17|||
105793652|NCT01488071|364900729|FG000|Overall Study|Non-compliance with study drug|2|||
105793653|NCT01488071|364900730|FG001|Overall Study|Non-compliance with study drug|0|||
105793654|NCT01488071|364900729|FG000|Overall Study|Protocol Violation|5|||
105793655|NCT01488071|364900730|FG001|Overall Study|Protocol Violation|7|||
105793656|NCT01488071|364900729|FG000|Overall Study|Withdrawal of Consent|14|||
105793657|NCT01488071|364900730|FG001|Overall Study|Withdrawal of Consent|12|||
105793658|NCT01488071|364900729|FG000|Overall Study|Lost to Follow-up|1|||
105793659|NCT01488071|364900730|FG001|Overall Study|Lost to Follow-up|0|||
105793660|NCT01488071|364900729|FG000|Overall Study|Administrative or Other Reason(s)|5|||
105793661|NCT01488071|364900730|FG001|Overall Study|Administrative or Other Reason(s)|4|||
106009225|NCT04026113|365700803|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
105793662|NCT03889197|364900731|FG000|Overall Study|Withdrawal by Subject|1|||
105793663|NCT03889197|364900732|FG001|Overall Study|Withdrawal by Subject|0|||
105793664|NCT03889197|364900731|FG000|Overall Study|Physician Decision|0|||
105793665|NCT03889197|364900732|FG001|Overall Study|Physician Decision|1|||
105793666|NCT03889197|364900731|FG000|Overall Study|met exclusion criteria|0|||
105793667|NCT03889197|364900732|FG001|Overall Study|met exclusion criteria|1|||
105793668|NCT03889197|364900731|FG000|Overall Study|Protocol Violation|1|||
105793669|NCT03889197|364900732|FG001|Overall Study|Protocol Violation|0|||
105793670|NCT05899218|364900733|FG000|Overall Study|Lost to Follow-up|2|||
105793671|NCT05899218|364900734|FG001|Overall Study|Lost to Follow-up|2|||
105793672|NCT05899218|364900733|FG000|Overall Study|deemed ineligible out of country|1|||
105793673|NCT05899218|364900734|FG001|Overall Study|deemed ineligible out of country|0|||
105793674|NCT02304302|364900737|FG000|Overall Study|Adverse Event|2|||
105793675|NCT02304302|364900738|FG001|Overall Study|Adverse Event|3|||
105793676|NCT02304302|364900737|FG000|Overall Study|Lost to Follow-up|1|||
105793677|NCT02304302|364900738|FG001|Overall Study|Lost to Follow-up|4|||
105793678|NCT02304302|364900737|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
105793679|NCT02304302|364900738|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
105793680|NCT02392559|364900739|FG000|Overall Study|Withdrawal by Subject|0|||
105793681|NCT02392559|364900740|FG001|Overall Study|Withdrawal by Subject|1|||
105793682|NCT01345058|364900741|FG000|Overall Study|Withdrawal by Subject|1|||
105793683|NCT01345058|364900742|FG001|Overall Study|Withdrawal by Subject|0|||
105793684|NCT01345058|364900741|FG000|Overall Study|Participant Reported Increase in Events|1|||
105793685|NCT01345058|364900742|FG001|Overall Study|Participant Reported Increase in Events|0|||
105793686|NCT01345058|364900741|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
105793687|NCT01345058|364900742|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
105793688|NCT01345058|364900741|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
105793689|NCT01345058|364900742|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
105793690|NCT01345058|364900741|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
105793691|NCT01345058|364900742|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
105793692|NCT01892020|364900744|FG000|Period 1|Adverse Event|1|||
105793693|NCT01892020|364900745|FG001|Period 1|Adverse Event|1|||
105793694|NCT01892020|364900744|FG000|Period 1|Protocol Violation|2|||
106009226|NCT04026113|365700804|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
106009227|NCT04026113|365700801|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
106009228|NCT04026113|365700802|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
105725316|NCT01686568|364649016|FG001|Main Study|Liver enzymes above range of exclusion|0|||
105725317|NCT01686568|364649015|FG000|Sub-Study|Not consented for sub-study|2|||
105725318|NCT01686568|364649016|FG001|Sub-Study|Not consented for sub-study|2|||
105725319|NCT01071070|364649018|FG000|Overall Study|Adverse Event|0|||
105725320|NCT01071070|364649019|FG001|Overall Study|Adverse Event|3|||
105725321|NCT01071070|364649018|FG000|Overall Study|Withdrawal by Subject|1|||
105725322|NCT01071070|364649019|FG001|Overall Study|Withdrawal by Subject|0|||
105725323|NCT01071070|364649018|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
105725324|NCT01071070|364649019|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
105725325|NCT01071070|364649018|FG000|Overall Study|Hypercalcemia|1|||
105725326|NCT01071070|364649019|FG001|Overall Study|Hypercalcemia|0|||
105725327|NCT00860470|364649020|FG000|Overall Study|Death|6|||
105725328|NCT00860470|364649021|FG001|Overall Study|Death|10|||
105725329|NCT00860470|364649020|FG000|Overall Study|Moved away|8|||
105725330|NCT00860470|364649021|FG001|Overall Study|Moved away|10|||
105725331|NCT00860470|364649020|FG000|Overall Study|Lost to Follow-up|34|||
105725332|NCT00860470|364649021|FG001|Overall Study|Lost to Follow-up|39|||
105725333|NCT02209506|364649035|FG000|Overall Study|Withdrawal by Subject|0|||
105793695|NCT01892020|364900745|FG001|Period 1|Protocol Violation|4|||
105793696|NCT01892020|364900744|FG000|Period 1|Unclassified|0|||
106009229|NCT04026113|365700803|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
105793697|NCT01892020|364900745|FG001|Period 1|Unclassified|1|||
106009230|NCT04026113|365700804|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
106009231|NCT04026113|365700801|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
106009232|NCT04026113|365700802|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
106009233|NCT04026113|365700803|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
106137761|NCT03525119|366163496|FG002|Overall Study|Randomized but not Vaccinated|2|||
106137762|NCT00586339|366163497|FG000|Overall Study|Withdrawal by Subject|1|||
105725334|NCT02209506|364649036|FG001|Overall Study|Withdrawal by Subject|0|||
105725335|NCT02209506|364649037|FG002|Overall Study|Withdrawal by Subject|0|||
105725336|NCT02209506|364649038|FG003|Overall Study|Withdrawal by Subject|0|||
105725337|NCT02209506|364649039|FG004|Overall Study|Withdrawal by Subject|1|||
105793698|NCT01892020|364900744|FG000|Period 2|Protocol Violation|1|||
105793699|NCT01892020|364900745|FG001|Period 2|Protocol Violation|0|||
105793700|NCT00402779|364900747|FG000|Overall Study|Screen Failure|77|||
105725338|NCT01276288|364649040|FG000|Overall Study|Adverse Event|1|||
105725339|NCT01276288|364649041|FG001|Overall Study|Adverse Event|1|||
106009234|NCT04026113|365700804|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
106009235|NCT02923726|365700806|FG000|Overall Study|Death|196|||
106009236|NCT02923726|365700807|FG001|Overall Study|Death|175|||
106009237|NCT02923726|365700806|FG000|Overall Study|Withdrawal by Subject|337|||
106009238|NCT02923726|365700807|FG001|Overall Study|Withdrawal by Subject|307|||
106009239|NCT00837434|365700810|FG000|Overall Study|Physician Decision|3|||
106009240|NCT00837434|365700811|FG001|Overall Study|Physician Decision|0|||
106009241|NCT00837434|365700810|FG000|Overall Study|Lost to Follow-up|1|||
106009242|NCT00837434|365700811|FG001|Overall Study|Lost to Follow-up|1|||
106009243|NCT00837434|365700810|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
106009244|NCT00837434|365700811|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
106009245|NCT00837434|365700810|FG000|Overall Study|Noncompliant|2|||
106009246|NCT00837434|365700811|FG001|Overall Study|Noncompliant|0|||
106009247|NCT00837434|365700810|FG000|Overall Study|Baseline assessments not done in time|1|||
106009248|NCT00837434|365700811|FG001|Overall Study|Baseline assessments not done in time|0|||
106009249|NCT00837434|365700810|FG000|Overall Study|Unable to obtain study drug|1|||
106009250|NCT00837434|365700811|FG001|Overall Study|Unable to obtain study drug|0|||
106009251|NCT00129402|365700812|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
106009252|NCT00129402|365700813|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
106009253|NCT00129402|365700814|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
105725340|NCT01276288|364649042|FG002|Overall Study|Adverse Event|0|||
105725341|NCT01276288|364649043|FG003|Overall Study|Adverse Event|0|||
105725342|NCT01276288|364649040|FG000|Overall Study|not treated|1|||
105725343|NCT01276288|364649041|FG001|Overall Study|not treated|0|||
105725344|NCT01276288|364649042|FG002|Overall Study|not treated|0|||
105725345|NCT01276288|364649043|FG003|Overall Study|not treated|0|||
105725346|NCT04348851|364649044|FG000|Post-Test 1|Withdrawal by Subject|0|||
105725347|NCT04348851|364649045|FG001|Post-Test 1|Withdrawal by Subject|1|||
105725348|NCT04348851|364649046|FG002|Post-Test 1|Withdrawal by Subject|0|||
105725349|NCT04348851|364649047|FG003|Post-Test 1|Withdrawal by Subject|0|||
105725350|NCT04348851|364649044|FG000|Post-Test 1|Lost to Follow-up|0|||
105725351|NCT04348851|364649045|FG001|Post-Test 1|Lost to Follow-up|1|||
105725352|NCT04348851|364649046|FG002|Post-Test 1|Lost to Follow-up|0|||
105725353|NCT04348851|364649047|FG003|Post-Test 1|Lost to Follow-up|0|||
105725354|NCT04348851|364649044|FG000|Post-Test 2|Stroke survivor death|0|||
105725355|NCT04348851|364649045|FG001|Post-Test 2|Stroke survivor death|1|||
105725356|NCT04348851|364649046|FG002|Post-Test 2|Stroke survivor death|0|||
105725357|NCT04348851|364649047|FG003|Post-Test 2|Stroke survivor death|1|||
105725358|NCT01454076|364649048|FG000|Overall Study|Other|2|||
105725359|NCT01454076|364649049|FG001|Overall Study|Other|0|||
105725360|NCT01454076|364649050|FG002|Overall Study|Other|0|||
105725361|NCT01454076|364649051|FG003|Overall Study|Other|1|||
105725362|NCT01454076|364649052|FG004|Overall Study|Other|2|||
105725363|NCT01454076|364649048|FG000|Overall Study|Withdrawal by Subject|3|||
105725364|NCT01454076|364649049|FG001|Overall Study|Withdrawal by Subject|4|||
105725365|NCT01454076|364649050|FG002|Overall Study|Withdrawal by Subject|2|||
105725366|NCT01454076|364649051|FG003|Overall Study|Withdrawal by Subject|1|||
105725367|NCT01454076|364649052|FG004|Overall Study|Withdrawal by Subject|2|||
105725368|NCT01454076|364649048|FG000|Overall Study|Adverse Event|8|||
105725369|NCT01454076|364649049|FG001|Overall Study|Adverse Event|2|||
105725370|NCT01454076|364649050|FG002|Overall Study|Adverse Event|7|||
105725371|NCT01454076|364649051|FG003|Overall Study|Adverse Event|0|||
105725372|NCT01454076|364649052|FG004|Overall Study|Adverse Event|2|||
105725373|NCT02965378|364649053|FG000|Overall Study|Progression|16|||
105725374|NCT02965378|364649054|FG001|Overall Study|Progression|4|||
105725375|NCT02965378|364649053|FG000|Overall Study|Adverse Event|5|||
105725376|NCT02965378|364649054|FG001|Overall Study|Adverse Event|2|||
105725377|NCT02965378|364649053|FG000|Overall Study|Death|2|||
105725378|NCT02965378|364649054|FG001|Overall Study|Death|0|||
105725379|NCT02965378|364649053|FG000|Overall Study|Refusal|2|||
105725380|NCT02965378|364649054|FG001|Overall Study|Refusal|1|||
105725381|NCT02965378|364649053|FG000|Overall Study|Not protocol specified|0|||
105725382|NCT02965378|364649054|FG001|Overall Study|Not protocol specified|2|||
105725383|NCT05292755|364649059|FG000|Overall Study|Lost to Follow-up|5|||
105725384|NCT05292755|364649060|FG001|Overall Study|Lost to Follow-up|9|||
105725385|NCT04525703|364649061|FG000|Overall Study|Lost to Follow-up|6|||
105725386|NCT04525703|364649062|FG001|Overall Study|Lost to Follow-up|15|||
106009254|NCT00129402|365700815|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
106009255|NCT00129402|365700816|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
106009256|NCT00129402|365700817|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
106009257|NCT00129402|365700818|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
105725387|NCT04525703|364649063|FG002|Overall Study|Lost to Follow-up|8|||
105725388|NCT01478958|364649064|FG000|Overall Study|Withdrawal by Subject|1|||
105725389|NCT01478958|364649065|FG001|Overall Study|Withdrawal by Subject|1|||
105725390|NCT01478958|364649066|FG002|Overall Study|Withdrawal by Subject|1|||
105725391|NCT01478958|364649064|FG000|Overall Study|Weight loss|1|||
105725392|NCT01478958|364649065|FG001|Overall Study|Weight loss|0|||
105725393|NCT01478958|364649066|FG002|Overall Study|Weight loss|0|||
105725394|NCT01478958|364649064|FG000|Overall Study|Re-located|0|||
105725395|NCT01478958|364649065|FG001|Overall Study|Re-located|1|||
105725396|NCT01478958|364649066|FG002|Overall Study|Re-located|0|||
105725397|NCT01478958|364649064|FG000|Overall Study|Unable to comply|0|||
105725398|NCT01478958|364649065|FG001|Overall Study|Unable to comply|0|||
105725399|NCT01478958|364649066|FG002|Overall Study|Unable to comply|2|||
105725400|NCT02909153|364649067|FG000|Overall Study|Withdrawal by Subject|0|||
105725401|NCT02909153|364649068|FG001|Overall Study|Withdrawal by Subject|1|||
105725402|NCT02909153|364649069|FG002|Overall Study|Withdrawal by Subject|0|||
105725403|NCT02909153|364649070|FG003|Overall Study|Withdrawal by Subject|0|||
105725404|NCT02909153|364649071|FG004|Overall Study|Withdrawal by Subject|0|||
105725405|NCT01193686|364649072|FG000|Overall Study|Withdrawal by Subject|4|||
105725406|NCT01193686|364649073|FG001|Overall Study|Withdrawal by Subject|1|||
105725407|NCT01193686|364649072|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
105725408|NCT01193686|364649073|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
105725409|NCT03401749|364649074|FG000|Overall Study|Lost to Follow-up|20|||
105725410|NCT03401749|364649075|FG001|Overall Study|Lost to Follow-up|16|||
105725411|NCT03401749|364649076|FG002|Overall Study|Lost to Follow-up|26|||
105725412|NCT00432809|364649079|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
105725413|NCT00432809|364649080|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
105725414|NCT00432809|364649081|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
105725415|NCT00432809|364649079|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
105725416|NCT00432809|364649080|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
105725417|NCT00432809|364649081|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
105725418|NCT01147809|364649082|FG000|Phase I (168 Days)|Adverse Event|0|||
105725419|NCT01147809|364649083|FG001|Phase I (168 Days)|Adverse Event|0|||
105725420|NCT01147809|364649084|FG002|Phase I (168 Days)|Adverse Event|0|||
105725421|NCT01147809|364649085|FG003|Phase I (168 Days)|Adverse Event|1|||
105725422|NCT01147809|364649086|FG004|Phase I (168 Days)|Adverse Event|0|||
105725423|NCT01147809|364649087|FG005|Phase I (168 Days)|Adverse Event|0|||
105725424|NCT01147809|364649082|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
105725425|NCT01147809|364649083|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
105725426|NCT01147809|364649084|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
105725427|NCT01147809|364649085|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
105725428|NCT01147809|364649086|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
105725429|NCT01147809|364649087|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
105725430|NCT01147809|364649082|FG000|Phase I (168 Days)|Physician Decision|0|||
105725431|NCT01147809|364649083|FG001|Phase I (168 Days)|Physician Decision|1|||
105725432|NCT01147809|364649084|FG002|Phase I (168 Days)|Physician Decision|2|||
105725433|NCT01147809|364649085|FG003|Phase I (168 Days)|Physician Decision|0|||
105725434|NCT01147809|364649086|FG004|Phase I (168 Days)|Physician Decision|0|||
105725435|NCT01147809|364649087|FG005|Phase I (168 Days)|Physician Decision|0|||
105725436|NCT01147809|364649082|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
105725437|NCT01147809|364649083|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
105725438|NCT01147809|364649084|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
105725439|NCT01147809|364649085|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
105725440|NCT01147809|364649086|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
105725441|NCT01147809|364649087|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
105725442|NCT01147809|364649082|FG000|Phase II (168 Days)|Adverse Event|0|||
105725443|NCT01147809|364649083|FG001|Phase II (168 Days)|Adverse Event|0|||
105725444|NCT01147809|364649084|FG002|Phase II (168 Days)|Adverse Event|0|||
105725445|NCT01147809|364649085|FG003|Phase II (168 Days)|Adverse Event|0|||
105725446|NCT01147809|364649086|FG004|Phase II (168 Days)|Adverse Event|3|||
105725447|NCT01147809|364649087|FG005|Phase II (168 Days)|Adverse Event|6|||
105725448|NCT01147809|364649082|FG000|Phase II (168 Days)|Protocol Violation|0|||
105725449|NCT01147809|364649083|FG001|Phase II (168 Days)|Protocol Violation|0|||
105725450|NCT01147809|364649084|FG002|Phase II (168 Days)|Protocol Violation|0|||
105725451|NCT01147809|364649085|FG003|Phase II (168 Days)|Protocol Violation|0|||
105725452|NCT01147809|364649086|FG004|Phase II (168 Days)|Protocol Violation|0|||
105725453|NCT01147809|364649087|FG005|Phase II (168 Days)|Protocol Violation|1|||
105725454|NCT01147809|364649082|FG000|Phase II (168 Days)|Physician Decision|0|||
105725455|NCT01147809|364649083|FG001|Phase II (168 Days)|Physician Decision|0|||
105725456|NCT01147809|364649084|FG002|Phase II (168 Days)|Physician Decision|0|||
106009258|NCT00129402|365700812|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
106009259|NCT00129402|365700813|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
106009260|NCT00129402|365700814|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
106009261|NCT00129402|365700815|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
106009262|NCT00129402|365700816|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
105725457|NCT01147809|364649085|FG003|Phase II (168 Days)|Physician Decision|0|||
105725458|NCT01147809|364649086|FG004|Phase II (168 Days)|Physician Decision|5|||
105725459|NCT01147809|364649087|FG005|Phase II (168 Days)|Physician Decision|11|||
105725460|NCT01147809|364649082|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
105725461|NCT01147809|364649083|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
105725462|NCT01147809|364649084|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
105725463|NCT01147809|364649085|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
105725464|NCT01147809|364649086|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
105793701|NCT00402779|364900748|FG001|Overall Study|Screen Failure|76|||
105793702|NCT02508649|364900751|FG000|Overall Study|Withdrawal by Subject|4|||
105793703|NCT02508649|364900752|FG001|Overall Study|Withdrawal by Subject|6|||
105793704|NCT02508649|364900753|FG002|Overall Study|Withdrawal by Subject|5|||
105793705|NCT02508649|364900754|FG003|Overall Study|Withdrawal by Subject|6|||
105793706|NCT02508649|364900751|FG000|Overall Study|Investigator withdrew the subject|1|||
105793707|NCT02508649|364900752|FG001|Overall Study|Investigator withdrew the subject|2|||
105793708|NCT02508649|364900753|FG002|Overall Study|Investigator withdrew the subject|1|||
105793709|NCT02508649|364900754|FG003|Overall Study|Investigator withdrew the subject|0|||
105793710|NCT02508649|364900751|FG000|Overall Study|Post randomization screening failure|12|||
105793711|NCT02508649|364900752|FG001|Overall Study|Post randomization screening failure|4|||
105793712|NCT02508649|364900753|FG002|Overall Study|Post randomization screening failure|9|||
105793713|NCT02508649|364900754|FG003|Overall Study|Post randomization screening failure|3|||
105793714|NCT02508649|364900751|FG000|Overall Study|Lost to Follow-up|1|||
105793715|NCT02508649|364900752|FG001|Overall Study|Lost to Follow-up|1|||
105793716|NCT02508649|364900753|FG002|Overall Study|Lost to Follow-up|0|||
105793717|NCT02508649|364900754|FG003|Overall Study|Lost to Follow-up|1|||
105793718|NCT00567996|364900755|FG000|Overall Study|Adverse Event|18|||
105793719|NCT00567996|364900756|FG001|Overall Study|Adverse Event|16|||
105793720|NCT00567996|364900757|FG002|Overall Study|Adverse Event|13|||
105793721|NCT00567996|364900755|FG000|Overall Study|Protocol Deviation|9|||
105793722|NCT00567996|364900756|FG001|Overall Study|Protocol Deviation|11|||
105793723|NCT00567996|364900757|FG002|Overall Study|Protocol Deviation|13|||
105793724|NCT00567996|364900755|FG000|Overall Study|Withdrawal by Subject|8|||
105793725|NCT00567996|364900756|FG001|Overall Study|Withdrawal by Subject|12|||
105793726|NCT00567996|364900757|FG002|Overall Study|Withdrawal by Subject|22|||
105793727|NCT00567996|364900755|FG000|Overall Study|Abnormal Lab value(s)|2|||
105793728|NCT00567996|364900756|FG001|Overall Study|Abnormal Lab value(s)|1|||
105793729|NCT00567996|364900757|FG002|Overall Study|Abnormal Lab value(s)|2|||
105793730|NCT00567996|364900755|FG000|Overall Study|Abnormal test procedure result(s)|2|||
105793731|NCT00567996|364900756|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105793732|NCT00567996|364900757|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105793733|NCT00567996|364900755|FG000|Overall Study|Lost to Follow-up|2|||
105793734|NCT00567996|364900756|FG001|Overall Study|Lost to Follow-up|5|||
105793735|NCT00567996|364900757|FG002|Overall Study|Lost to Follow-up|2|||
105793736|NCT00567996|364900755|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105793737|NCT00567996|364900756|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105793738|NCT00567996|364900757|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
105793739|NCT00567996|364900755|FG000|Overall Study|Administrative problems|1|||
105793740|NCT00567996|364900756|FG001|Overall Study|Administrative problems|1|||
105793741|NCT00567996|364900757|FG002|Overall Study|Administrative problems|0|||
105793742|NCT00567996|364900755|FG000|Overall Study|Death|1|||
105793743|NCT00567996|364900756|FG001|Overall Study|Death|0|||
105793744|NCT00567996|364900757|FG002|Overall Study|Death|2|||
105793745|NCT00567996|364900755|FG000|Overall Study|Patient's inability to use the device|0|||
105793746|NCT00567996|364900756|FG001|Overall Study|Patient's inability to use the device|1|||
105793747|NCT00567996|364900757|FG002|Overall Study|Patient's inability to use the device|0|||
105793748|NCT03594175|364900758|FG000|Overall Study|Not treated|8|||
105793749|NCT03594175|364900759|FG001|Overall Study|Not treated|1|||
105793750|NCT03594175|364900760|FG002|Overall Study|Not treated|5|||
105793751|NCT03594175|364900758|FG000|Overall Study|Adverse Event|3|||
105793752|NCT03594175|364900759|FG001|Overall Study|Adverse Event|0|||
105793753|NCT03594175|364900760|FG002|Overall Study|Adverse Event|0|||
105793754|NCT03594175|364900758|FG000|Overall Study|Withdrawal by Subject|3|||
105793755|NCT03594175|364900759|FG001|Overall Study|Withdrawal by Subject|0|||
105793756|NCT03594175|364900760|FG002|Overall Study|Withdrawal by Subject|0|||
105793757|NCT03594175|364900758|FG000|Overall Study|Protocol Violation|2|||
105793758|NCT03594175|364900759|FG001|Overall Study|Protocol Violation|2|||
105793759|NCT03594175|364900760|FG002|Overall Study|Protocol Violation|2|||
105793760|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793761|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793762|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793763|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793764|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793765|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793766|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793767|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793768|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793769|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793770|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105936310|NCT03537729|365427392|FG001|Overall Study|Withdrawal by Subject|3|||
105936311|NCT03537729|365427393|FG002|Overall Study|Withdrawal by Subject|0|||
105793771|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105725465|NCT01147809|364649087|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
105725466|NCT01147809|364649082|FG000|Phase II (168 Days)|Ongoing|0|||
105936312|NCT03537729|365427391|FG000|Overall Study|Subject Moved|8|||
105936313|NCT03537729|365427392|FG001|Overall Study|Subject Moved|5|||
105936314|NCT03537729|365427393|FG002|Overall Study|Subject Moved|4|||
105936315|NCT03537729|365427391|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
105936316|NCT03537729|365427392|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
105936317|NCT03537729|365427393|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
105936318|NCT03537729|365427391|FG000|Overall Study|COVID-19 Site Restrictions|11|||
105936319|NCT03537729|365427392|FG001|Overall Study|COVID-19 Site Restrictions|15|||
105936320|NCT03537729|365427393|FG002|Overall Study|COVID-19 Site Restrictions|18|||
105936321|NCT03537729|365427391|FG000|Overall Study|Decline in Health|5|||
105936322|NCT03537729|365427392|FG001|Overall Study|Decline in Health|9|||
105936323|NCT03537729|365427393|FG002|Overall Study|Decline in Health|4|||
105936324|NCT03537729|365427391|FG000|Overall Study|Determined Ineligible|0|||
105936325|NCT03537729|365427392|FG001|Overall Study|Determined Ineligible|0|||
105936326|NCT03537729|365427393|FG002|Overall Study|Determined Ineligible|1|||
105936327|NCT02562040|365427394|FG000|Overall Study|Lost to Follow-up|20|||
105936328|NCT02562040|365427395|FG001|Overall Study|Lost to Follow-up|28|||
105936329|NCT02562040|365427394|FG000|Overall Study|Withdrawal by Subject|8|||
105936330|NCT02562040|365427395|FG001|Overall Study|Withdrawal by Subject|7|||
105936331|NCT02562040|365427394|FG000|Overall Study|Adverse Event|1|||
105936332|NCT02562040|365427395|FG001|Overall Study|Adverse Event|0|||
105936333|NCT00368849|365427396|FG000|Overall Study|Withdrawal by Subject|0|||
105936334|NCT00368849|365427397|FG001|Overall Study|Withdrawal by Subject|1|||
105936335|NCT00368849|365427396|FG000|Overall Study|Physician Decision|0|||
105936336|NCT00368849|365427397|FG001|Overall Study|Physician Decision|1|||
105936337|NCT02502383|365427403|FG000|Overall Study|Lost to Follow-up|130|||
105936338|NCT02502383|365427404|FG001|Overall Study|Lost to Follow-up|131|||
105936339|NCT02502383|365427403|FG000|Overall Study|Withdrawal by Subject|31|||
105936340|NCT02502383|365427404|FG001|Overall Study|Withdrawal by Subject|24|||
105936341|NCT00432991|365427405|FG000|Overall Study|Protocol Violation|7|||
105936342|NCT00432991|365427406|FG001|Overall Study|Protocol Violation|12|||
105936343|NCT01292473|365427411|FG000|Overall Study|Adverse Event|1|||
105936344|NCT01292473|365427412|FG001|Overall Study|Adverse Event|0|||
105936345|NCT01292473|365427413|FG002|Overall Study|Adverse Event|1|||
105936346|NCT01292473|365427414|FG003|Overall Study|Adverse Event|1|||
105936347|NCT01292473|365427411|FG000|Overall Study|Lost to Follow-up|1|||
105936348|NCT01292473|365427412|FG001|Overall Study|Lost to Follow-up|1|||
105936349|NCT01292473|365427413|FG002|Overall Study|Lost to Follow-up|2|||
105936350|NCT01292473|365427414|FG003|Overall Study|Lost to Follow-up|2|||
105936351|NCT01292473|365427411|FG000|Overall Study|Withdrawal by Subject|3|||
105936352|NCT01292473|365427412|FG001|Overall Study|Withdrawal by Subject|4|||
105936353|NCT01292473|365427413|FG002|Overall Study|Withdrawal by Subject|3|||
105936354|NCT01292473|365427414|FG003|Overall Study|Withdrawal by Subject|3|||
105936355|NCT01292473|365427411|FG000|Overall Study|Physician Decision|0|||
105936356|NCT01292473|365427412|FG001|Overall Study|Physician Decision|1|||
105936357|NCT01292473|365427413|FG002|Overall Study|Physician Decision|0|||
105936358|NCT01292473|365427414|FG003|Overall Study|Physician Decision|0|||
105936359|NCT01292473|365427411|FG000|Overall Study|Disease Progression|0|||
105936360|NCT01292473|365427412|FG001|Overall Study|Disease Progression|1|||
105936361|NCT01292473|365427413|FG002|Overall Study|Disease Progression|3|||
105936362|NCT01292473|365427414|FG003|Overall Study|Disease Progression|6|||
105936363|NCT00348374|365427415|FG000|Overall Study|Adverse Event|1|||
105936364|NCT00348374|365427416|FG001|Overall Study|Adverse Event|4|||
105936365|NCT00348374|365427415|FG000|Overall Study|Lost to Follow-up|1|||
105936366|NCT00348374|365427416|FG001|Overall Study|Lost to Follow-up|3|||
105936367|NCT00348374|365427415|FG000|Overall Study|Withdrawal by Subject|5|||
105936368|NCT00348374|365427416|FG001|Overall Study|Withdrawal by Subject|5|||
105936369|NCT00348374|365427415|FG000|Overall Study|Other|11|||
105936370|NCT00348374|365427416|FG001|Overall Study|Other|12|||
105725467|NCT01147809|364649083|FG001|Phase II (168 Days)|Ongoing|0|||
105725468|NCT01147809|364649084|FG002|Phase II (168 Days)|Ongoing|0|||
105725469|NCT01147809|364649085|FG003|Phase II (168 Days)|Ongoing|0|||
105725470|NCT01147809|364649086|FG004|Phase II (168 Days)|Ongoing|1|||
105725471|NCT01147809|364649087|FG005|Phase II (168 Days)|Ongoing|0|||
105725472|NCT03040024|364649088|FG000|Overall Study|Adverse Event|0|||
105725473|NCT03040024|364649089|FG001|Overall Study|Adverse Event|1|||
105725474|NCT03040024|364649090|FG002|Overall Study|Adverse Event|0|||
105725475|NCT03040024|364649088|FG000|Overall Study|Death|0|||
105725476|NCT03040024|364649089|FG001|Overall Study|Death|1|||
105725477|NCT03040024|364649090|FG002|Overall Study|Death|0|||
105725478|NCT03040024|364649088|FG000|Overall Study|Physician Decision|0|||
105725479|NCT03040024|364649089|FG001|Overall Study|Physician Decision|0|||
105725480|NCT03040024|364649090|FG002|Overall Study|Physician Decision|1|||
105725481|NCT01499290|364649091|FG000|Overall Study|Withdrawal by Subject|22|||
105725482|NCT01499290|364649092|FG001|Overall Study|Withdrawal by Subject|15|||
105725483|NCT01499290|364649091|FG000|Overall Study|Not specified in study report|11|||
105725484|NCT01499290|364649092|FG001|Overall Study|Not specified in study report|5|||
105725485|NCT01499290|364649091|FG000|Overall Study|Condition improved/subject recovered|1|||
105725486|NCT01499290|364649092|FG001|Overall Study|Condition improved/subject recovered|0|||
105725487|NCT01499290|364649091|FG000|Overall Study|Lack of Efficacy|7|||
105725488|NCT01499290|364649092|FG001|Overall Study|Lack of Efficacy|8|||
105725489|NCT01499290|364649091|FG000|Overall Study|Adverse Event|14|||
105725490|NCT01499290|364649092|FG001|Overall Study|Adverse Event|7|||
105725491|NCT04433117|364649093|FG000|Overall Study|Withdrawal by Subject|1|||
105725492|NCT04433117|364649094|FG001|Overall Study|Withdrawal by Subject|0|||
105725493|NCT01051739|364649095|FG000|Overall Study|Death|3|||
105725494|NCT01051739|364649096|FG001|Overall Study|Death|3|||
105725495|NCT01051739|364649095|FG000|Overall Study|Withdrawal by Subject|25|||
105725496|NCT01051739|364649096|FG001|Overall Study|Withdrawal by Subject|10|||
105725497|NCT01967225|364649098|FG000|Overall Study|Adverse Event|3|||
105725498|NCT01967225|364649099|FG001|Overall Study|Adverse Event|1|||
105725499|NCT01967225|364649098|FG000|Overall Study|Withdrawal by Subject|2|||
105725500|NCT01967225|364649099|FG001|Overall Study|Withdrawal by Subject|1|||
105725501|NCT01967225|364649098|FG000|Overall Study|Lack of Efficacy|1|||
105725502|NCT01967225|364649099|FG001|Overall Study|Lack of Efficacy|1|||
105725503|NCT01967225|364649098|FG000|Overall Study|Switching to other therapy|2|||
105725504|NCT01967225|364649099|FG001|Overall Study|Switching to other therapy|0|||
105725505|NCT01967225|364649098|FG000|Overall Study|Protocol driven decision point|1|||
105725506|NCT01967225|364649099|FG001|Overall Study|Protocol driven decision point|0|||
105725507|NCT01967225|364649098|FG000|Overall Study|Logistical difficulties|1|||
105725508|NCT01967225|364649099|FG001|Overall Study|Logistical difficulties|0|||
105725509|NCT01967225|364649098|FG000|Overall Study|Protocol Violation|2|||
105725510|NCT01967225|364649099|FG001|Overall Study|Protocol Violation|0|||
105725511|NCT02209766|364649100|FG000|Overall Study|Withdrawal by Subject|0|||
105725512|NCT02209766|364649101|FG001|Overall Study|Withdrawal by Subject|0|||
105725513|NCT02209766|364649102|FG002|Overall Study|Withdrawal by Subject|0|||
105725514|NCT02209766|364649103|FG003|Overall Study|Withdrawal by Subject|1|||
105725515|NCT02209766|364649104|FG004|Overall Study|Withdrawal by Subject|0|||
105725516|NCT02700451|364649105|FG000|Overall Study|Protocol Violation|2|||
105725517|NCT02700451|364649106|FG001|Overall Study|Protocol Violation|2|||
105725518|NCT02700451|364649107|FG002|Overall Study|Protocol Violation|3|||
105725519|NCT02700451|364649105|FG000|Overall Study|Discontinued intervention|14|||
105725520|NCT02700451|364649106|FG001|Overall Study|Discontinued intervention|15|||
105725521|NCT02700451|364649107|FG002|Overall Study|Discontinued intervention|14|||
105725522|NCT02272790|364649110|FG000|Overall Study|Physician Decision|0|||
105725523|NCT02272790|364649111|FG001|Overall Study|Physician Decision|1|||
105725524|NCT02272790|364649112|FG002|Overall Study|Physician Decision|0|||
105725525|NCT02272790|364649113|FG003|Overall Study|Physician Decision|0|||
105725526|NCT02272790|364649114|FG004|Overall Study|Physician Decision|0|||
105725527|NCT02272790|364649115|FG005|Overall Study|Physician Decision|0|||
105936371|NCT00348374|365427415|FG000|Overall Study|ongoing at date of cutoff|1|||
105936372|NCT00348374|365427416|FG001|Overall Study|ongoing at date of cutoff|1|||
105936373|NCT00348374|365427415|FG000|Overall Study|randomized but did not receive treatment|0|||
105936374|NCT00348374|365427416|FG001|Overall Study|randomized but did not receive treatment|7|||
105725528|NCT01926626|364649118|FG000|Overall Study|Withdrawal by Subject|15|||
105725529|NCT01926626|364649118|FG000|Overall Study|Lost to Follow-up|7|||
105725530|NCT01587989|364649125|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
105725531|NCT01587989|364649126|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
105725532|NCT01587989|364649127|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
105725533|NCT01587989|364649125|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
105725534|NCT01587989|364649126|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
105725535|NCT01587989|364649127|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
105725536|NCT01587989|364649125|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
105725537|NCT01587989|364649126|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
105936375|NCT02123511|365427424|FG000|Overall Study|Cancelled treatment|1|||
105725538|NCT01587989|364649127|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
105725539|NCT01587989|364649125|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
105725540|NCT01587989|364649126|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
105725541|NCT01587989|364649127|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
105725542|NCT01587989|364649125|FG000|Randomized Study Treatment|Screening failure|0|||
105725543|NCT01587989|364649126|FG001|Randomized Study Treatment|Screening failure|1|||
105725544|NCT01587989|364649127|FG002|Randomized Study Treatment|Screening failure|0|||
105725545|NCT01587989|364649125|FG000|Randomized Study Treatment|Physician Decision|0|||
105725546|NCT01587989|364649126|FG001|Randomized Study Treatment|Physician Decision|0|||
105725547|NCT01587989|364649127|FG002|Randomized Study Treatment|Physician Decision|1|||
105725548|NCT03665038|364649131|FG000|Overall Study|Lost to Follow-up|0|||
105725549|NCT03665038|364649132|FG001|Overall Study|Lost to Follow-up|0|||
105725550|NCT03665038|364649133|FG002|Overall Study|Lost to Follow-up|1|||
105725551|NCT03946449|364649138|FG000|Treatment Extension II|Rolled over to another study|0|||
105725552|NCT03946449|364649139|FG001|Treatment Extension II|Rolled over to another study|0|||
105725553|NCT03946449|364649140|FG002|Treatment Extension II|Rolled over to another study|2|||
105725554|NCT03946449|364649138|FG000|Treatment Extension II|Withdrawal by Subject|0|||
105725555|NCT03946449|364649139|FG001|Treatment Extension II|Withdrawal by Subject|0|||
105725556|NCT03946449|364649140|FG002|Treatment Extension II|Withdrawal by Subject|1|||
105725557|NCT02581995|364649141|FG000|Overall Study|Unspecified other|3|||
105725558|NCT02581995|364649141|FG000|Overall Study|Adverse Event|6|||
105725559|NCT02581995|364649141|FG000|Overall Study|Lost to Follow-up|5|||
105725560|NCT02581995|364649141|FG000|Overall Study|Withdrawal by participant|12|||
105725561|NCT02581995|364649141|FG000|Overall Study|Physician Decision|1|||
105725562|NCT02581995|364649141|FG000|Overall Study|Death|4|||
105725563|NCT03896581|364650393|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
105725564|NCT03896581|364650394|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
105725565|NCT03896581|364650393|FG000|Overall Study|Withdrawal by Subject|4|||
105725566|NCT03896581|364650394|FG001|Overall Study|Withdrawal by Subject|1|||
105725567|NCT03896581|364650393|FG000|Overall Study|Lost to Follow-up|1|||
105725568|NCT03896581|364650394|FG001|Overall Study|Lost to Follow-up|0|||
105725569|NCT03896581|364650393|FG000|Overall Study|Lack of Efficacy|2|||
105725570|NCT03896581|364650394|FG001|Overall Study|Lack of Efficacy|1|||
105725571|NCT03896581|364650393|FG000|Overall Study|Adverse event, non-fatal|0|||
105725572|NCT03896581|364650394|FG001|Overall Study|Adverse event, non-fatal|2|||
105725573|NCT03219164|364650395|FG000|Overall Study|Study Terminated by Sponsor|16|||
105725574|NCT03219164|364650396|FG001|Overall Study|Study Terminated by Sponsor|12|||
105725575|NCT03219164|364650395|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
105725576|NCT03219164|364650396|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
105725577|NCT03219164|364650395|FG000|Overall Study|Lost to Follow-up|1|||
105725578|NCT03219164|364650396|FG001|Overall Study|Lost to Follow-up|1|||
105725579|NCT03219164|364650395|FG000|Overall Study|Adverse Event|1|||
105725580|NCT03219164|364650396|FG001|Overall Study|Adverse Event|0|||
105725581|NCT03219164|364650395|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105725582|NCT03219164|364650396|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105725583|NCT03219164|364650395|FG000|Overall Study|Protocol Violation|0|||
105725584|NCT03219164|364650396|FG001|Overall Study|Protocol Violation|1|||
105725585|NCT03219164|364650395|FG000|Overall Study|Withdrew Assent|1|||
105725586|NCT03219164|364650396|FG001|Overall Study|Withdrew Assent|0|||
105725587|NCT00522392|364650400|FG000|Overall Study|Disease progression|0|||
105725588|NCT00522392|364650401|FG001|Overall Study|Disease progression|3|||
105725589|NCT00522392|364650400|FG000|Overall Study|Adverse Event|7|||
105725590|NCT00522392|364650401|FG001|Overall Study|Adverse Event|7|||
105725591|NCT00522392|364650400|FG000|Overall Study|Withdrawal by Subject|1|||
105725592|NCT00522392|364650401|FG001|Overall Study|Withdrawal by Subject|1|||
105725593|NCT00522392|364650400|FG000|Overall Study|Physician Decision|0|||
105725594|NCT00522392|364650401|FG001|Overall Study|Physician Decision|1|||
105725595|NCT00522392|364650400|FG000|Overall Study|Non-compliance|0|||
105725596|NCT00522392|364650401|FG001|Overall Study|Non-compliance|1|||
105725597|NCT02292849|364650404|FG000|Overall Study|Lost to Follow-up|0|||
105725598|NCT02292849|364650405|FG001|Overall Study|Lost to Follow-up|2|||
105725599|NCT02292849|364650406|FG002|Overall Study|Lost to Follow-up|2|||
105725600|NCT02292849|364650404|FG000|Overall Study|Physician Decision|4|||
105725601|NCT02292849|364650405|FG001|Overall Study|Physician Decision|0|||
105725602|NCT02292849|364650406|FG002|Overall Study|Physician Decision|0|||
105725603|NCT04938648|364650407|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
105725604|NCT04938648|364650408|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
105725605|NCT04938648|364650407|FG000|Overall Study|Patient too ill|0|||
105725606|NCT04938648|364650408|FG001|Overall Study|Patient too ill|1|||
105725607|NCT04938648|364650407|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
105725608|NCT04938648|364650408|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
105725609|NCT04938648|364650407|FG000|Overall Study|Patient did not have memory problems|1|||
105725610|NCT04938648|364650408|FG001|Overall Study|Patient did not have memory problems|1|||
105725611|NCT04938648|364650407|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
105936376|NCT02123511|365427425|FG001|Overall Study|Cancelled treatment|0|||
105725612|NCT04938648|364650408|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
105725613|NCT04938648|364650407|FG000|Overall Study|Care partner could not be reached|0|||
105725614|NCT04938648|364650408|FG001|Overall Study|Care partner could not be reached|1|||
105725615|NCT04938648|364650407|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
105725616|NCT04938648|364650408|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
105725617|NCT04938648|364650407|FG000|Overall Study|Withdrawal by Subject|2|||
105725618|NCT04938648|364650408|FG001|Overall Study|Withdrawal by Subject|1|||
105725619|NCT01287754|364650411|FG000|Overall Study|Death|2|||
105725620|NCT01287754|364650412|FG001|Overall Study|Death|12|||
105725621|NCT01287754|364650411|FG000|Overall Study|Lost to Follow-up|1|||
105725622|NCT01287754|364650412|FG001|Overall Study|Lost to Follow-up|6|||
105725623|NCT01287754|364650411|FG000|Overall Study|Protocol Violation|0|||
105725624|NCT01287754|364650412|FG001|Overall Study|Protocol Violation|3|||
105725625|NCT02362035|364650413|FG000|Overall Study|Death|67|||
105725626|NCT02362035|364650413|FG000|Overall Study|Lost to Follow-up|3|||
105725627|NCT02362035|364650413|FG000|Overall Study|Adverse Event|1|||
105725628|NCT02362035|364650413|FG000|Overall Study|Physician Decision|1|||
105725629|NCT02362035|364650413|FG000|Overall Study|Subject started another cancer therapy|10|||
105725630|NCT02362035|364650413|FG000|Overall Study|Study terminated by sponsor|45|||
105725631|NCT02362035|364650413|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
105725632|NCT02362035|364650413|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
105793772|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793773|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
105793774|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
105793775|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
105936377|NCT02123511|365427424|FG000|Overall Study|Incomplete data|1|||
105936378|NCT02123511|365427425|FG001|Overall Study|Incomplete data|3|||
105936379|NCT02123511|365427424|FG000|Overall Study|Ineligible|0|||
105725633|NCT02362035|364650413|FG000|Overall Study|Disease progression|11|||
105725634|NCT02362035|364650413|FG000|Overall Study|Withdrawal by Subject|20|||
105725635|NCT05040971|364650420|FG000|Overall Study|Withdrawal by Subject|0|||
105725636|NCT05040971|364650421|FG001|Overall Study|Withdrawal by Subject|2|||
105725637|NCT05040971|364650420|FG000|Overall Study|Lost to Follow-up|8|||
105725638|NCT05040971|364650421|FG001|Overall Study|Lost to Follow-up|3|||
105725639|NCT05040971|364650420|FG000|Overall Study|Death|2|||
105936380|NCT02123511|365427425|FG001|Overall Study|Ineligible|1|||
105725640|NCT05040971|364650421|FG001|Overall Study|Death|0|||
105725641|NCT02601950|364650422|FG000|Overall Study|Participant enrolled in rollover study|0|||
105725642|NCT02601950|364650423|FG001|Overall Study|Participant enrolled in rollover study|0|||
105725643|NCT02601950|364650424|FG002|Overall Study|Participant enrolled in rollover study|1|||
105725644|NCT02601950|364650425|FG003|Overall Study|Participant enrolled in rollover study|0|||
105725645|NCT02601950|364650426|FG004|Overall Study|Participant enrolled in rollover study|1|||
105725646|NCT02601950|364650427|FG005|Overall Study|Participant enrolled in rollover study|1|||
105725647|NCT02601950|364650428|FG006|Overall Study|Participant enrolled in rollover study|1|||
105725648|NCT02601950|364650429|FG007|Overall Study|Participant enrolled in rollover study|0|||
105725649|NCT02601950|364650422|FG000|Overall Study|Disease progression - radiological|21|||
105725650|NCT02601950|364650423|FG001|Overall Study|Disease progression - radiological|26|||
105725651|NCT02601950|364650424|FG002|Overall Study|Disease progression - radiological|22|||
105725652|NCT02601950|364650425|FG003|Overall Study|Disease progression - radiological|11|||
105725653|NCT02601950|364650426|FG004|Overall Study|Disease progression - radiological|46|||
105725654|NCT02601950|364650427|FG005|Overall Study|Disease progression - radiological|52|||
105725655|NCT02601950|364650428|FG006|Overall Study|Disease progression - radiological|7|||
105725656|NCT02601950|364650429|FG007|Overall Study|Disease progression - radiological|5|||
105725657|NCT02601950|364650422|FG000|Overall Study|Disease progression - clinical|3|||
105725658|NCT02601950|364650423|FG001|Overall Study|Disease progression - clinical|5|||
105725659|NCT02601950|364650424|FG002|Overall Study|Disease progression - clinical|4|||
105725660|NCT02601950|364650425|FG003|Overall Study|Disease progression - clinical|2|||
105725661|NCT02601950|364650426|FG004|Overall Study|Disease progression - clinical|6|||
105725662|NCT02601950|364650427|FG005|Overall Study|Disease progression - clinical|6|||
105725663|NCT02601950|364650428|FG006|Overall Study|Disease progression - clinical|5|||
105725664|NCT02601950|364650429|FG007|Overall Study|Disease progression - clinical|1|||
105725665|NCT02601950|364650422|FG000|Overall Study|Death|6|||
106009263|NCT00129402|365700817|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
106009264|NCT00129402|365700818|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
106009265|NCT00129402|365700812|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
106009266|NCT00129402|365700813|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
106009267|NCT00129402|365700814|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
106009268|NCT00129402|365700815|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
106009269|NCT00129402|365700816|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
106009270|NCT00129402|365700817|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
106009271|NCT00129402|365700818|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
106009272|NCT00129402|365700812|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
106009273|NCT00129402|365700813|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
106009274|NCT00129402|365700814|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
106009275|NCT00129402|365700815|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
106009276|NCT00129402|365700816|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
106009277|NCT00129402|365700817|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
106009278|NCT00129402|365700818|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
106009279|NCT00129402|365700812|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
106009280|NCT00129402|365700813|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
106009281|NCT00129402|365700814|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
106009282|NCT00129402|365700815|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
106009283|NCT00129402|365700816|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
106009284|NCT00129402|365700817|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
106009285|NCT00129402|365700818|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
106009286|NCT00129402|365700812|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
106009287|NCT00129402|365700813|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
106009288|NCT00129402|365700814|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
106009289|NCT00129402|365700815|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
105725666|NCT02601950|364650423|FG001|Overall Study|Death|0|||
105725667|NCT02601950|364650424|FG002|Overall Study|Death|3|||
105725668|NCT02601950|364650425|FG003|Overall Study|Death|1|||
105725669|NCT02601950|364650426|FG004|Overall Study|Death|4|||
105725670|NCT02601950|364650427|FG005|Overall Study|Death|1|||
105725671|NCT02601950|364650428|FG006|Overall Study|Death|0|||
105725672|NCT02601950|364650429|FG007|Overall Study|Death|0|||
105725673|NCT02601950|364650422|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725674|NCT02601950|364650423|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725675|NCT02601950|364650424|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725676|NCT02601950|364650425|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725677|NCT02601950|364650426|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725678|NCT02601950|364650427|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
105725679|NCT02601950|364650428|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725680|NCT02601950|364650429|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
105725681|NCT02601950|364650422|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
105725682|NCT02601950|364650423|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
105725683|NCT02601950|364650424|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
105725684|NCT02601950|364650425|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
105725685|NCT02601950|364650426|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
105725686|NCT02601950|364650427|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
105725687|NCT02601950|364650428|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
106009290|NCT00129402|365700816|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
106009291|NCT00129402|365700817|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
106009292|NCT00129402|365700818|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
106009293|NCT00129402|365700812|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
106009294|NCT00129402|365700813|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
106009295|NCT00129402|365700814|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
106009296|NCT00129402|365700815|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
106009297|NCT00129402|365700816|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
106009298|NCT00129402|365700817|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
106009299|NCT00129402|365700818|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
106009300|NCT00129402|365700812|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
106009301|NCT00129402|365700813|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
106009302|NCT00129402|365700814|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
106009303|NCT00129402|365700815|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
106009304|NCT00129402|365700816|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
106009305|NCT00129402|365700817|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
106009306|NCT00129402|365700818|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
106009307|NCT00129402|365700812|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
106009308|NCT00129402|365700813|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
106009309|NCT00129402|365700814|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
106009310|NCT00129402|365700815|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
106009311|NCT00129402|365700816|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
106009312|NCT00129402|365700817|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
106009313|NCT00129402|365700818|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
106009314|NCT00129402|365700812|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
106009315|NCT00129402|365700813|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
106009316|NCT00129402|365700814|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
106009317|NCT00129402|365700815|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
106009318|NCT00129402|365700816|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
106009319|NCT00129402|365700817|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
106009320|NCT00129402|365700818|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
106009321|NCT00129402|365700812|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
106009322|NCT00129402|365700813|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
106009323|NCT00129402|365700814|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
105725688|NCT02601950|364650429|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
105725689|NCT02601950|364650422|FG000|Overall Study|Non-compliance|0|||
105725690|NCT02601950|364650423|FG001|Overall Study|Non-compliance|1|||
105725691|NCT02601950|364650424|FG002|Overall Study|Non-compliance|0|||
105725692|NCT02601950|364650425|FG003|Overall Study|Non-compliance|0|||
105725693|NCT02601950|364650426|FG004|Overall Study|Non-compliance|0|||
105725694|NCT02601950|364650427|FG005|Overall Study|Non-compliance|1|||
105725695|NCT02601950|364650428|FG006|Overall Study|Non-compliance|1|||
105725696|NCT02601950|364650429|FG007|Overall Study|Non-compliance|0|||
105725697|NCT02601950|364650422|FG000|Overall Study|Participant refused further study treatment|0|||
105725698|NCT02601950|364650423|FG001|Overall Study|Participant refused further study treatment|1|||
105725699|NCT02601950|364650424|FG002|Overall Study|Participant refused further study treatment|1|||
105725700|NCT02601950|364650425|FG003|Overall Study|Participant refused further study treatment|0|||
105725701|NCT02601950|364650426|FG004|Overall Study|Participant refused further study treatment|2|||
105725702|NCT02601950|364650427|FG005|Overall Study|Participant refused further study treatment|2|||
105725703|NCT02601950|364650428|FG006|Overall Study|Participant refused further study treatment|2|||
105725704|NCT02601950|364650429|FG007|Overall Study|Participant refused further study treatment|1|||
105725705|NCT02601950|364650422|FG000|Overall Study|Investigator discretion|1|||
105725706|NCT02601950|364650423|FG001|Overall Study|Investigator discretion|0|||
105725707|NCT02601950|364650424|FG002|Overall Study|Investigator discretion|1|||
105725708|NCT02601950|364650425|FG003|Overall Study|Investigator discretion|0|||
105725709|NCT02601950|364650426|FG004|Overall Study|Investigator discretion|1|||
105793776|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
106009324|NCT00129402|365700815|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
106009325|NCT00129402|365700816|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
106009326|NCT00129402|365700817|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
106009327|NCT00129402|365700818|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
106009328|NCT00129402|365700812|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
106009329|NCT00129402|365700813|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
106009330|NCT00129402|365700814|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
106009331|NCT00129402|365700815|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
106009332|NCT00129402|365700816|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
106009333|NCT00129402|365700817|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
106009334|NCT00129402|365700818|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
106009335|NCT00129402|365700812|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
106009336|NCT00129402|365700813|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
106009337|NCT00129402|365700814|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
106009338|NCT00129402|365700815|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
106009339|NCT00129402|365700816|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
106009340|NCT00129402|365700817|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
106009341|NCT00129402|365700818|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
106009342|NCT02992288|365700823|FG000|Overall Study|Adverse Event|8|||
106009343|NCT02992288|365700824|FG001|Overall Study|Adverse Event|2|||
106009344|NCT02992288|365700825|FG002|Overall Study|Adverse Event|2|||
106009345|NCT02992288|365700826|FG003|Overall Study|Adverse Event|2|||
106009346|NCT02992288|365700827|FG004|Overall Study|Adverse Event|2|||
106009347|NCT02992288|365700828|FG005|Overall Study|Adverse Event|7|||
106009348|NCT02992288|365700823|FG000|Overall Study|Non-compliance with study drug|0|||
106009349|NCT02992288|365700824|FG001|Overall Study|Non-compliance with study drug|1|||
106009350|NCT02992288|365700825|FG002|Overall Study|Non-compliance with study drug|1|||
106009351|NCT02992288|365700826|FG003|Overall Study|Non-compliance with study drug|0|||
106009352|NCT02992288|365700827|FG004|Overall Study|Non-compliance with study drug|1|||
106009353|NCT02992288|365700828|FG005|Overall Study|Non-compliance with study drug|0|||
106009354|NCT02992288|365700823|FG000|Overall Study|Physician Decision|3|||
106009355|NCT02992288|365700824|FG001|Overall Study|Physician Decision|0|||
106009356|NCT02992288|365700825|FG002|Overall Study|Physician Decision|1|||
106009357|NCT02992288|365700826|FG003|Overall Study|Physician Decision|0|||
106009358|NCT02992288|365700827|FG004|Overall Study|Physician Decision|0|||
106009359|NCT02992288|365700828|FG005|Overall Study|Physician Decision|1|||
106009360|NCT02992288|365700823|FG000|Overall Study|Death|2|||
106009361|NCT02992288|365700824|FG001|Overall Study|Death|0|||
106009362|NCT02992288|365700825|FG002|Overall Study|Death|2|||
106009363|NCT02992288|365700826|FG003|Overall Study|Death|1|||
106009364|NCT02992288|365700827|FG004|Overall Study|Death|2|||
106009365|NCT02992288|365700828|FG005|Overall Study|Death|0|||
106009366|NCT02992288|365700823|FG000|Overall Study|Lost to Follow-up|0|||
106009367|NCT02992288|365700824|FG001|Overall Study|Lost to Follow-up|0|||
106009368|NCT02992288|365700825|FG002|Overall Study|Lost to Follow-up|0|||
106009369|NCT02992288|365700826|FG003|Overall Study|Lost to Follow-up|1|||
106009370|NCT02992288|365700827|FG004|Overall Study|Lost to Follow-up|0|||
106009371|NCT02992288|365700828|FG005|Overall Study|Lost to Follow-up|0|||
106009372|NCT02992288|365700823|FG000|Overall Study|Protocol Violation|0|||
106009373|NCT02992288|365700824|FG001|Overall Study|Protocol Violation|0|||
106009374|NCT02992288|365700825|FG002|Overall Study|Protocol Violation|0|||
106009375|NCT02992288|365700826|FG003|Overall Study|Protocol Violation|0|||
106009376|NCT02992288|365700827|FG004|Overall Study|Protocol Violation|0|||
106009377|NCT02992288|365700828|FG005|Overall Study|Protocol Violation|1|||
105725710|NCT02601950|364650427|FG005|Overall Study|Investigator discretion|1|||
105725711|NCT02601950|364650428|FG006|Overall Study|Investigator discretion|1|||
105725712|NCT02601950|364650429|FG007|Overall Study|Investigator discretion|0|||
105725713|NCT02601950|364650422|FG000|Overall Study|Other|0|||
105725714|NCT02601950|364650423|FG001|Overall Study|Other|0|||
106137763|NCT00586339|366163498|FG001|Overall Study|Withdrawal by Subject|3|||
106137764|NCT00586339|366163499|FG002|Overall Study|Withdrawal by Subject|1|||
105725715|NCT02601950|364650424|FG002|Overall Study|Other|0|||
106009378|NCT02992288|365700823|FG000|Overall Study|Withdrawal by Subject|4|||
106137765|NCT00586339|366163497|FG000|Overall Study|Migrated/moved from study area|3|||
106137766|NCT00586339|366163498|FG001|Overall Study|Migrated/moved from study area|2|||
106137767|NCT00586339|366163499|FG002|Overall Study|Migrated/moved from study area|4|||
105725716|NCT02601950|364650425|FG003|Overall Study|Other|0|||
105725717|NCT02601950|364650426|FG004|Overall Study|Other|2|||
105725718|NCT02601950|364650427|FG005|Overall Study|Other|2|||
106009379|NCT02992288|365700824|FG001|Overall Study|Withdrawal by Subject|2|||
106009380|NCT02992288|365700825|FG002|Overall Study|Withdrawal by Subject|1|||
106137768|NCT00586339|366163497|FG000|Overall Study|Lost to Follow-up|3|||
105725719|NCT02601950|364650428|FG006|Overall Study|Other|1|||
105725720|NCT02601950|364650429|FG007|Overall Study|Other|0|||
105793777|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
105725721|NCT05817045|364650430|FG000|Overall Study|Protocol Violation|0|||
105725722|NCT05817045|364650431|FG001|Overall Study|Protocol Violation|3|||
105725723|NCT05817045|364650430|FG000|Overall Study|Withdrawal by Subject|10|||
105725724|NCT05817045|364650431|FG001|Overall Study|Withdrawal by Subject|7|||
105725725|NCT05817045|364650430|FG000|Overall Study|Physician Decision|3|||
105725726|NCT05817045|364650431|FG001|Overall Study|Physician Decision|0|||
105725727|NCT05817045|364650430|FG000|Overall Study|Lost to Follow-up|0|||
105725728|NCT05817045|364650431|FG001|Overall Study|Lost to Follow-up|1|||
105725729|NCT05817045|364650430|FG000|Overall Study|Device Deficiency|1|||
105725730|NCT05817045|364650431|FG001|Overall Study|Device Deficiency|0|||
105725731|NCT05817045|364650430|FG000|Overall Study|System Error|1|||
105725732|NCT05817045|364650431|FG001|Overall Study|System Error|0|||
105725733|NCT01725165|364650434|FG000|Overall Study|Death|11|||
105725734|NCT01725165|364650435|FG001|Overall Study|Death|18|||
105725735|NCT02983604|364650436|FG000|Overall Study|Enrolled but not Treated|0|||
105725736|NCT02983604|364650437|FG001|Overall Study|Enrolled but not Treated|0|||
105725737|NCT02983604|364650438|FG002|Overall Study|Enrolled but not Treated|1|||
105725738|NCT02983604|364650439|FG003|Overall Study|Enrolled but not Treated|0|||
105725739|NCT00355264|364650440|FG000|Extension (Variable Duration)|Adverse Event|1|||
105725740|NCT00355264|364650440|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
105725741|NCT03663166|364650441|FG000|Overall Study|Withdrawal by Subject|1|||
105725742|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
105725743|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
105725744|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
105725745|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
105725746|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
105725747|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
105725748|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
105725749|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
105725750|NCT02537678|364650445|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
105725751|NCT02537678|364650446|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
105725752|NCT02537678|364650445|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
105725753|NCT02537678|364650446|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
105725754|NCT02537678|364650445|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
105725755|NCT02537678|364650446|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
105725756|NCT03075839|364650448|FG000|Overall Study|Lost to Follow-up|4|||
105725757|NCT04052139|364650449|FG000|Overall Study|Lost to Follow-up|2|||
105725758|NCT04052139|364650450|FG001|Overall Study|Lost to Follow-up|0|||
105725759|NCT04052139|364650451|FG002|Overall Study|Lost to Follow-up|0|||
105725760|NCT04052139|364650449|FG000|Overall Study|Withdrawal by Subject|1|||
105725761|NCT04052139|364650450|FG001|Overall Study|Withdrawal by Subject|0|||
105725762|NCT04052139|364650451|FG002|Overall Study|Withdrawal by Subject|0|||
105725763|NCT00707577|364650452|FG000|Overall Study|Withdrawal by Subject|3|||
105725764|NCT00707577|364650453|FG001|Overall Study|Withdrawal by Subject|2|||
105725765|NCT00707577|364650452|FG000|Overall Study|Lost to Follow-up|34|||
105725766|NCT00707577|364650453|FG001|Overall Study|Lost to Follow-up|25|||
105725767|NCT00707577|364650452|FG000|Overall Study|Left employment|13|||
105725768|NCT00707577|364650453|FG001|Overall Study|Left employment|10|||
105936381|NCT02595437|365427426|FG000|Triferic Via IV|Withdrawal by Subject|1|||
105936382|NCT00458705|365427427|FG000|Overall Study|Adverse Event|4|||
105936383|NCT00458705|365427427|FG000|Overall Study|Not Treated|1|||
105936384|NCT02070380|365427435|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
105936385|NCT02070380|365427436|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
105936386|NCT02070380|365427437|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
105936387|NCT02070380|365427438|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
105936388|NCT02070380|365427435|FG000|Second Injection|Image sets missing or technically inadeq|0|||
105936389|NCT02070380|365427436|FG001|Second Injection|Image sets missing or technically inadeq|1|||
105936390|NCT02070380|365427437|FG002|Second Injection|Image sets missing or technically inadeq|0|||
105936391|NCT02070380|365427438|FG003|Second Injection|Image sets missing or technically inadeq|0|||
105936392|NCT02070380|365427435|FG000|Second Injection|Protocol Violation|0|||
105936393|NCT02070380|365427436|FG001|Second Injection|Protocol Violation|1|||
105936394|NCT02070380|365427437|FG002|Second Injection|Protocol Violation|1|||
105936395|NCT02070380|365427438|FG003|Second Injection|Protocol Violation|5|||
105936396|NCT01362530|365427451|FG000|Base Study (Cycle 1)|Adverse Event|2|||
105936397|NCT01362530|365427452|FG001|Base Study (Cycle 1)|Adverse Event|0|||
105936398|NCT01362530|365427451|FG000|Base Study (Cycle 1)|Physician Decision|0|||
105936399|NCT01362530|365427452|FG001|Base Study (Cycle 1)|Physician Decision|1|||
105725769|NCT00707577|364650452|FG000|Overall Study|Pregnancy|4|||
105725770|NCT00707577|364650453|FG001|Overall Study|Pregnancy|1|||
105725771|NCT00190775|364650454|FG000|Overall Study|Adverse Event|57|||
105725772|NCT00190775|364650455|FG001|Overall Study|Adverse Event|22|||
105725773|NCT00190775|364650454|FG000|Overall Study|Satisfactory Response|1|||
105725774|NCT00190775|364650455|FG001|Overall Study|Satisfactory Response|0|||
105725775|NCT00190775|364650454|FG000|Overall Study|Lack of Efficacy|28|||
105725776|NCT00190775|364650455|FG001|Overall Study|Lack of Efficacy|32|||
105725777|NCT00190775|364650454|FG000|Overall Study|Lost to Follow-up|31|||
105725778|NCT00190775|364650455|FG001|Overall Study|Lost to Follow-up|23|||
105725779|NCT00190775|364650454|FG000|Overall Study|Participant Moved|0|||
105725780|NCT00190775|364650455|FG001|Overall Study|Participant Moved|1|||
105725781|NCT00190775|364650454|FG000|Overall Study|Withdrawal by Subject|24|||
105725782|NCT00190775|364650455|FG001|Overall Study|Withdrawal by Subject|13|||
105725783|NCT00190775|364650454|FG000|Overall Study|Sponsor Decision|1|||
105725784|NCT00190775|364650455|FG001|Overall Study|Sponsor Decision|0|||
105725785|NCT00190775|364650454|FG000|Overall Study|Physician Decision|3|||
105725786|NCT00190775|364650455|FG001|Overall Study|Physician Decision|0|||
105725787|NCT00190775|364650454|FG000|Overall Study|Noncompliance|3|||
105725788|NCT00190775|364650455|FG001|Overall Study|Noncompliance|5|||
105725789|NCT00190775|364650454|FG000|Overall Study|Protocol Violation|0|||
105725790|NCT00190775|364650455|FG001|Overall Study|Protocol Violation|1|||
105725791|NCT00190775|364650454|FG000|Overall Study|Exclusion Criteria Met|1|||
105725792|NCT00190775|364650455|FG001|Overall Study|Exclusion Criteria Met|3|||
105725793|NCT00709202|364650461|FG000|Overall Study|Withdrawal by Subject|6|||
105725794|NCT00709202|364650462|FG001|Overall Study|Withdrawal by Subject|6|||
105725795|NCT02344576|364650463|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
105725796|NCT02344576|364650464|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
105725797|NCT02344576|364650465|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
105725798|NCT02344576|364650466|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
105725799|NCT02344576|364650463|FG000|1-Month Follow-Up|Death|13|||
105725800|NCT02344576|364650464|FG001|1-Month Follow-Up|Death|8|||
105725801|NCT02344576|364650465|FG002|1-Month Follow-Up|Death|0|||
105725802|NCT02344576|364650466|FG003|1-Month Follow-Up|Death|0|||
105725803|NCT02344576|364650463|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
105725804|NCT02344576|364650464|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
105725805|NCT02344576|364650465|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
105725806|NCT02344576|364650466|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
105725807|NCT02344576|364650463|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
105725808|NCT02344576|364650464|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
105725809|NCT02344576|364650465|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
105725810|NCT02344576|364650466|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
105725811|NCT02344576|364650463|FG000|6-Month Follow-Up|Death|14|||
105725812|NCT02344576|364650464|FG001|6-Month Follow-Up|Death|14|||
105725813|NCT02344576|364650465|FG002|6-Month Follow-Up|Death|0|||
105725814|NCT02344576|364650466|FG003|6-Month Follow-Up|Death|0|||
105725815|NCT02344576|364650463|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
105725816|NCT02344576|364650464|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
105725817|NCT02344576|364650465|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
105725818|NCT02344576|364650466|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
105725819|NCT02344576|364650463|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
105725820|NCT02344576|364650464|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
105725821|NCT02344576|364650465|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
105725822|NCT02344576|364650466|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
105725823|NCT03832387|364650483|FG000|Overall Study|Protocol Violation|2|||
105725824|NCT03832387|364650484|FG001|Overall Study|Protocol Violation|6|||
105725825|NCT03832387|364650483|FG000|Overall Study|EXCLUSION CRITERIA|3|||
105725826|NCT03832387|364650484|FG001|Overall Study|EXCLUSION CRITERIA|1|||
105725827|NCT02337387|364650485|FG000|Overall Study|Adverse Event|0|||
105725828|NCT02337387|364650486|FG001|Overall Study|Adverse Event|1|||
105725829|NCT02337387|364650487|FG002|Overall Study|Adverse Event|0|||
105725830|NCT02337387|364650488|FG003|Overall Study|Adverse Event|0|||
105936400|NCT01362530|365427451|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
105936401|NCT01362530|365427452|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
105936402|NCT01362530|365427451|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
105936403|NCT01362530|365427452|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
105936404|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
105725831|NCT02337387|364650485|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
105725832|NCT02337387|364650486|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
105725833|NCT02337387|364650487|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
105725834|NCT02337387|364650488|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
105725835|NCT02853760|364650489|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
105725836|NCT02853760|364650490|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
105725837|NCT02853760|364650491|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
105725838|NCT02853760|364650492|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
105725839|NCT02853760|364650493|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
105760774|NCT01576406|364776185|FG002|Overall Study|Other|2|||
105760775|NCT01576406|364776186|FG003|Overall Study|Other|2|||
105760776|NCT01576406|364776187|FG004|Overall Study|Other|0|||
105760777|NCT01576406|364776188|FG005|Overall Study|Other|0|||
105760778|NCT03726333|364776191|FG000|Overall Study|Progressive Disease|0|||
105760779|NCT03726333|364776192|FG001|Overall Study|Progressive Disease|0|||
105725840|NCT02853760|364650494|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
105725841|NCT00981526|364650495|FG000|Overall Study|Withdrawal by Subject|0|||
105725842|NCT00981526|364650496|FG001|Overall Study|Withdrawal by Subject|2|||
105725843|NCT00981526|364650495|FG000|Overall Study|Physician Decision|4|||
105725844|NCT00981526|364650496|FG001|Overall Study|Physician Decision|4|||
105725845|NCT01243268|364650497|FG000|Overall Study|Lost to Follow-up|4|||
105725846|NCT01243268|364650497|FG000|Overall Study|Protocol Violation|51|||
105725847|NCT01243268|364650497|FG000|Overall Study|Deviation with contract date|7|||
105725848|NCT01243268|364650497|FG000|Overall Study|Duplicate subject|2|||
105725849|NCT01564784|364650498|FG000|Overall Study|Other|1|||
105725850|NCT01564784|364650499|FG001|Overall Study|Other|0|||
105725851|NCT01564784|364650498|FG000|Overall Study|Subject refused further follow-up|1|||
105725852|NCT01564784|364650499|FG001|Overall Study|Subject refused further follow-up|6|||
105725853|NCT01564784|364650498|FG000|Overall Study|Lost to Follow-up|1|||
105725854|NCT01564784|364650499|FG001|Overall Study|Lost to Follow-up|1|||
105725855|NCT01564784|364650498|FG000|Overall Study|Death|131|||
105725856|NCT01564784|364650499|FG001|Overall Study|Death|126|||
105725857|NCT00784758|364650500|FG000|Overall Study|Withdrawal by Subject|3|||
105725858|NCT00784758|364650501|FG001|Overall Study|Withdrawal by Subject|0|||
105725859|NCT00784758|364650500|FG000|Overall Study|Adverse Event|1|||
105725860|NCT00784758|364650501|FG001|Overall Study|Adverse Event|0|||
105725861|NCT05202808|364650504|FG000|Overall Study|Lost to Follow-up|3|||
105725862|NCT05202808|364650505|FG001|Overall Study|Lost to Follow-up|1|||
105725863|NCT04439331|364650506|FG000|Overall Study|Never Start Protocol Therapy|2|||
105725864|NCT04439331|364650506|FG000|Overall Study|Ineligible|2|||
105725865|NCT04439331|364650506|FG000|Overall Study|Mutation Status Not Confirmed|1|||
105725866|NCT04439331|364650506|FG000|Overall Study|Adverse Event|1|||
105725867|NCT04439331|364650506|FG000|Overall Study|Death|1|||
105725868|NCT04439331|364650506|FG000|Overall Study|Disease Progression|20|||
105725869|NCT04439331|364650506|FG000|Overall Study|Withdrawal by Subject|6|||
105725870|NCT04439331|364650506|FG000|Overall Study|Physician Decision|1|||
105725871|NCT04439331|364650506|FG000|Overall Study|Other Complicating Disease|1|||
105725872|NCT01822561|364650508|FG000|Overall Study|Withdrawal by Subject|2|||
105725873|NCT01523873|364650517|FG000|Overall Study|Protocol Violation|422|||
105725874|NCT00275561|364650518|FG000|Overall Study|Withdrawal by Subject|0|||
105725875|NCT00275561|364650519|FG001|Overall Study|Withdrawal by Subject|1|||
105725876|NCT00275561|364650518|FG000|Overall Study|Travel|1|||
105725877|NCT00275561|364650519|FG001|Overall Study|Travel|1|||
105725878|NCT00275561|364650518|FG000|Overall Study|Scheduling|1|||
105725879|NCT00275561|364650519|FG001|Overall Study|Scheduling|2|||
105725880|NCT00275561|364650518|FG000|Overall Study|Family Issues|0|||
105725881|NCT00275561|364650519|FG001|Overall Study|Family Issues|2|||
105725882|NCT02711553|364650524|FG000|Overall Study|Withdrawal by Subject|2|||
105725883|NCT02711553|364650525|FG001|Overall Study|Withdrawal by Subject|1|||
105725884|NCT02711553|364650526|FG002|Overall Study|Withdrawal by Subject|1|||
105725885|NCT02711553|364650527|FG003|Overall Study|Withdrawal by Subject|0|||
105725886|NCT02711553|364650524|FG000|Overall Study|Lost to Follow-up|3|||
105725887|NCT02711553|364650525|FG001|Overall Study|Lost to Follow-up|3|||
105725888|NCT02711553|364650526|FG002|Overall Study|Lost to Follow-up|6|||
105725889|NCT02711553|364650527|FG003|Overall Study|Lost to Follow-up|3|||
105725890|NCT02711553|364650524|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
105725891|NCT02711553|364650525|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
105725892|NCT02711553|364650526|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
105725893|NCT02711553|364650527|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
105725894|NCT02029976|364653354|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
105725895|NCT02029976|364653355|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
105725896|NCT02029976|364653354|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
105725897|NCT02029976|364653355|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
105725898|NCT02029976|364653354|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
105725899|NCT02029976|364653355|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
105725900|NCT02029976|364653354|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
105725901|NCT02029976|364653355|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
105725902|NCT02732951|364653356|FG000|Overall Study|Other than listed|1|||
105725903|NCT02732951|364653357|FG001|Overall Study|Other than listed|0|||
105725904|NCT02732951|364653356|FG000|Overall Study|Lost to Follow-up|0|||
105725905|NCT02732951|364653357|FG001|Overall Study|Lost to Follow-up|1|||
105725906|NCT02732951|364653356|FG000|Overall Study|Adverse Event|4|||
105725907|NCT02732951|364653357|FG001|Overall Study|Adverse Event|4|||
105725908|NCT02732951|364653356|FG000|Overall Study|Protocol Violation|0|||
105725909|NCT02732951|364653357|FG001|Overall Study|Protocol Violation|1|||
105725910|NCT01750918|364653358|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
105725911|NCT01750918|364653359|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
105725912|NCT01750918|364653360|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
105725913|NCT01750918|364653361|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
105725914|NCT01750918|364653362|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
105725915|NCT01750918|364653363|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
105725916|NCT01750918|364653364|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
105725917|NCT01750918|364653365|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
105725918|NCT01750918|364653358|FG000|Overall Study|Lost to Follow-up|0|||
105725919|NCT01750918|364653359|FG001|Overall Study|Lost to Follow-up|0|||
105725920|NCT01750918|364653360|FG002|Overall Study|Lost to Follow-up|2|||
105725921|NCT01750918|364653361|FG003|Overall Study|Lost to Follow-up|2|||
105725922|NCT01750918|364653362|FG004|Overall Study|Lost to Follow-up|0|||
105725923|NCT01750918|364653363|FG005|Overall Study|Lost to Follow-up|0|||
105725924|NCT01750918|364653364|FG006|Overall Study|Lost to Follow-up|0|||
105725925|NCT01750918|364653365|FG007|Overall Study|Lost to Follow-up|1|||
105725926|NCT01750918|364653358|FG000|Overall Study|Withdrawal by Subject|0|||
105725927|NCT01750918|364653359|FG001|Overall Study|Withdrawal by Subject|0|||
105725928|NCT01750918|364653360|FG002|Overall Study|Withdrawal by Subject|1|||
105725929|NCT01750918|364653361|FG003|Overall Study|Withdrawal by Subject|2|||
105725930|NCT01750918|364653362|FG004|Overall Study|Withdrawal by Subject|1|||
105725931|NCT01750918|364653363|FG005|Overall Study|Withdrawal by Subject|1|||
105725932|NCT01750918|364653364|FG006|Overall Study|Withdrawal by Subject|2|||
105725933|NCT01750918|364653365|FG007|Overall Study|Withdrawal by Subject|2|||
105725934|NCT00075881|364653367|FG000|Overall Study|Lack of Efficacy|18|||
105725935|NCT00075881|364653367|FG000|Overall Study|Adverse Event|7|||
105725936|NCT00075881|364653367|FG000|Overall Study|Death|1|||
105725937|NCT00075881|364653367|FG000|Overall Study|Withdrawal by Subject|2|||
105725938|NCT00075881|364653367|FG000|Overall Study|Protocol Violation|4|||
105725939|NCT00075881|364653367|FG000|Overall Study|other complicating disease|3|||
105725940|NCT00075881|364653367|FG000|Overall Study|other|4|||
105725941|NCT00075881|364653367|FG000|Overall Study|missing data|2|||
105725942|NCT00075881|364653367|FG000|Overall Study|Ineligible|1|||
105725943|NCT00075881|364653367|FG000|Overall Study|never start protocol therapy|1|||
105725944|NCT05047523|364653374|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725945|NCT05047523|364653375|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725946|NCT05047523|364653376|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
105725947|NCT05047523|364653377|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725948|NCT05047523|364653378|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725949|NCT05047523|364653379|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
105725950|NCT05047523|364653374|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725951|NCT05047523|364653375|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
105725952|NCT05047523|364653376|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725953|NCT05047523|364653377|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725954|NCT05047523|364653378|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725955|NCT05047523|364653379|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
105725956|NCT05047523|364653374|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
105725957|NCT05047523|364653375|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
105725958|NCT05047523|364653376|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
105725959|NCT05047523|364653377|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
105725960|NCT05047523|364653378|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
105725961|NCT05047523|364653379|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
105725962|NCT05047523|364653374|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
105725963|NCT05047523|364653375|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725964|NCT05047523|364653376|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725965|NCT05047523|364653377|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725966|NCT05047523|364653378|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725967|NCT05047523|364653379|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
105725968|NCT05047523|364653374|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
105725969|NCT05047523|364653375|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
105725970|NCT05047523|364653376|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
105725971|NCT05047523|364653377|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
105725972|NCT05047523|364653378|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
105725973|NCT05047523|364653379|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
106137769|NCT00586339|366163498|FG001|Overall Study|Lost to Follow-up|2|||
105725974|NCT05047523|364653374|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
105725975|NCT05047523|364653375|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
105725976|NCT05047523|364653376|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
105725977|NCT05047523|364653377|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
105725978|NCT05047523|364653378|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
105725979|NCT05047523|364653379|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
105725980|NCT00215150|364653385|FG000|Open Label Phase|Lost to Follow-up|7|||
105725981|NCT00215150|364653385|FG000|Open Label Phase|Withdrawal by Subject|1|||
105725982|NCT00215150|364653385|FG000|Open Label Phase|Did not complete a post base visit|13|||
106137770|NCT00586339|366163499|FG002|Overall Study|Lost to Follow-up|1|||
106137771|NCT01972152|366163500|FG000|First Treatment Visit|Lost to Follow-up|0|||
105725983|NCT00215150|364653385|FG000|Open Label Phase|Did not meet randomization criteria|9|||
105725984|NCT00215150|364653385|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
105725985|NCT00215150|364653385|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
105725986|NCT00215150|364653385|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
105725987|NCT00206726|364653386|FG000|Overall Study|Delayed recovery of blood counts|1|||
105725988|NCT00206726|364653386|FG000|Overall Study|Progressive disease or relapsed disease|18|||
105725989|NCT00206726|364653386|FG000|Overall Study|Placed on new protocol|1|||
105725990|NCT00206726|364653386|FG000|Overall Study|Bone marrow transplant|1|||
105725991|NCT00206726|364653386|FG000|Overall Study|Adverse Event|17|||
105725992|NCT00206726|364653386|FG000|Overall Study|Death|4|||
105725993|NCT00206726|364653386|FG000|Overall Study|Protocol Violation|1|||
105725994|NCT00206726|364653386|FG000|Overall Study|Withdrawal by Subject|8|||
105725995|NCT00260208|364653390|FG000|Overall Study|Subject withdrew consent|11|||
105725996|NCT00260208|364653391|FG001|Overall Study|Subject withdrew consent|7|||
105725997|NCT00260208|364653390|FG000|Overall Study|Lost to Follow-up|6|||
105725998|NCT00260208|364653391|FG001|Overall Study|Lost to Follow-up|1|||
105725999|NCT00260208|364653390|FG000|Overall Study|Death|12|||
105726000|NCT00260208|364653391|FG001|Overall Study|Death|10|||
105726001|NCT00260208|364653390|FG000|Overall Study|Missing|18|||
105726002|NCT00260208|364653391|FG001|Overall Study|Missing|16|||
105726003|NCT04317690|364653392|FG000|Overall Study|did not have complete information for primary outcome|0|||
105726004|NCT04317690|364653393|FG001|Overall Study|did not have complete information for primary outcome|4|||
105726005|NCT04317690|364653394|FG002|Overall Study|did not have complete information for primary outcome|0|||
105726006|NCT04317690|364653395|FG003|Overall Study|did not have complete information for primary outcome|2|||
105726007|NCT04317690|364653396|FG004|Overall Study|did not have complete information for primary outcome|0|||
105726008|NCT02091440|364653397|FG000|Overall Study|Death|2|||
105726009|NCT03323749|364653398|FG000|Double-blind Period|Lost to Follow-up|4|||
105726010|NCT03323749|364653399|FG001|Double-blind Period|Lost to Follow-up|5|||
105726011|NCT03323749|364653398|FG000|Double-blind Period|Adverse Event|3|||
105726012|NCT03323749|364653399|FG001|Double-blind Period|Adverse Event|1|||
105726013|NCT03323749|364653398|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
105726014|NCT03323749|364653399|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
105726015|NCT03323749|364653398|FG000|Open-Label Period|Adverse Event|3|||
105726016|NCT03323749|364653399|FG001|Open-Label Period|Adverse Event|10|||
105726017|NCT03323749|364653398|FG000|Open-Label Period|Withdrawal by Subject|7|||
105726018|NCT03323749|364653399|FG001|Open-Label Period|Withdrawal by Subject|5|||
105726019|NCT03263091|364653400|FG000|OL Component|Withdrawal by Subject|1|||
105726020|NCT03263091|364653401|FG001|OL Component|Withdrawal by Subject|1|||
105726021|NCT03263091|364653402|FG002|OL Component|Withdrawal by Subject|0|||
105726022|NCT03263091|364653403|FG003|OL Component|Withdrawal by Subject|0|||
105726023|NCT03263091|364653404|FG004|OL Component|Withdrawal by Subject|0|||
105726024|NCT03263091|364653405|FG005|OL Component|Withdrawal by Subject|0|||
105726025|NCT03263091|364653400|FG000|OL Component|Physician Decision|0|||
105726026|NCT03263091|364653401|FG001|OL Component|Physician Decision|1|||
105726027|NCT03263091|364653402|FG002|OL Component|Physician Decision|2|||
105726028|NCT03263091|364653403|FG003|OL Component|Physician Decision|0|||
105726029|NCT03263091|364653404|FG004|OL Component|Physician Decision|0|||
105726030|NCT03263091|364653405|FG005|OL Component|Physician Decision|0|||
105726031|NCT03263091|364653400|FG000|OL Component|Death|1|||
105726032|NCT03263091|364653401|FG001|OL Component|Death|0|||
105726033|NCT03263091|364653402|FG002|OL Component|Death|0|||
105726034|NCT03263091|364653403|FG003|OL Component|Death|0|||
105726035|NCT03263091|364653404|FG004|OL Component|Death|0|||
105726036|NCT03263091|364653405|FG005|OL Component|Death|0|||
105726037|NCT03263091|364653400|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
105726038|NCT03263091|364653401|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
105726039|NCT03263091|364653402|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
105726040|NCT03263091|364653403|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
105726041|NCT03263091|364653404|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
105726042|NCT03263091|364653405|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
105726043|NCT03263091|364653400|FG000|OL High-EPO Component|Physician Decision|0|||
105726044|NCT03263091|364653401|FG001|OL High-EPO Component|Physician Decision|0|||
105726045|NCT03263091|364653402|FG002|OL High-EPO Component|Physician Decision|0|||
105726046|NCT03263091|364653403|FG003|OL High-EPO Component|Physician Decision|1|||
105726047|NCT03263091|364653404|FG004|OL High-EPO Component|Physician Decision|0|||
105726048|NCT03263091|364653405|FG005|OL High-EPO Component|Physician Decision|0|||
105726049|NCT03263091|364653400|FG000|OL High-EPO Component|Death|0|||
105726050|NCT03263091|364653401|FG001|OL High-EPO Component|Death|0|||
105726051|NCT03263091|364653402|FG002|OL High-EPO Component|Death|0|||
105726052|NCT03263091|364653403|FG003|OL High-EPO Component|Death|3|||
105726053|NCT03263091|364653404|FG004|OL High-EPO Component|Death|0|||
105726054|NCT03263091|364653405|FG005|OL High-EPO Component|Death|0|||
105793778|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
105793779|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793780|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793781|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793782|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793783|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793784|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
105793785|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793786|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793787|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793788|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
105793789|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793790|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793791|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793792|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
105793793|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
105793794|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
105793795|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
105793796|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
105793797|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
105793798|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
105793799|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793800|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793801|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793802|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793803|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
105793804|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793805|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793806|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793807|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793808|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793809|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793810|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793811|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793812|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
105793813|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793814|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793815|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
105793816|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
105793817|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793818|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793819|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793820|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793821|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793822|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793823|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793824|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793825|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793826|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793827|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
105793828|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793829|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793830|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
105793831|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793832|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793833|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
105793834|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
106009381|NCT02992288|365700826|FG003|Overall Study|Withdrawal by Subject|5|||
106009382|NCT02992288|365700827|FG004|Overall Study|Withdrawal by Subject|3|||
106009383|NCT02992288|365700828|FG005|Overall Study|Withdrawal by Subject|4|||
106009384|NCT00456846|365700829|FG000|Overall Study|Adverse Event|2|||
106009385|NCT00456846|365700830|FG001|Overall Study|Adverse Event|15|||
106009386|NCT00456846|365700829|FG000|Overall Study|Physician Decision|11|||
105793835|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
105793836|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793837|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
105793838|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793839|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793840|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793841|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793842|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793843|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793844|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793845|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793846|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793847|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793848|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
105793849|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
105793850|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
105793851|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
105793852|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
105793853|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
105793854|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
105793855|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793856|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793857|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
105793858|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793859|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793860|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793861|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793862|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793863|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793864|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793865|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793866|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793867|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793868|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793869|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793870|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
105793871|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
105793872|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
105793873|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
105793874|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793875|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793876|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793877|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793878|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
105793879|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793880|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793881|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793882|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793883|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
105793884|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793885|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793886|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793887|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793888|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793889|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793890|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793891|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793892|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
105793893|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
105793894|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793895|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793896|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793897|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
106009387|NCT00456846|365700830|FG001|Overall Study|Physician Decision|6|||
106009388|NCT00456846|365700829|FG000|Overall Study|Protocol Deviation|2|||
106009389|NCT00456846|365700830|FG001|Overall Study|Protocol Deviation|0|||
106009390|NCT00456846|365700829|FG000|Overall Study|Participant Discretion|1|||
106009391|NCT00456846|365700830|FG001|Overall Study|Participant Discretion|5|||
105726055|NCT03263091|364653400|FG000|DB Component|Withdrawal by Subject|0|||
105726056|NCT03263091|364653401|FG001|DB Component|Withdrawal by Subject|0|||
105726057|NCT03263091|364653402|FG002|DB Component|Withdrawal by Subject|0|||
105726058|NCT03263091|364653403|FG003|DB Component|Withdrawal by Subject|0|||
105726059|NCT03263091|364653404|FG004|DB Component|Withdrawal by Subject|22|||
105726060|NCT03263091|364653405|FG005|DB Component|Withdrawal by Subject|8|||
105726061|NCT03263091|364653400|FG000|DB Component|Physician Decision|0|||
105726062|NCT03263091|364653401|FG001|DB Component|Physician Decision|0|||
105726063|NCT03263091|364653402|FG002|DB Component|Physician Decision|0|||
105726064|NCT03263091|364653403|FG003|DB Component|Physician Decision|0|||
105726065|NCT03263091|364653404|FG004|DB Component|Physician Decision|3|||
105726066|NCT03263091|364653405|FG005|DB Component|Physician Decision|1|||
105726067|NCT03263091|364653400|FG000|DB Component|Adverse Event|0|||
105726068|NCT03263091|364653401|FG001|DB Component|Adverse Event|0|||
105726069|NCT03263091|364653402|FG002|DB Component|Adverse Event|0|||
105726070|NCT03263091|364653403|FG003|DB Component|Adverse Event|0|||
105726071|NCT03263091|364653404|FG004|DB Component|Adverse Event|2|||
105726072|NCT03263091|364653405|FG005|DB Component|Adverse Event|1|||
105726073|NCT03263091|364653400|FG000|DB Component|Lost to Follow-up|0|||
105726074|NCT03263091|364653401|FG001|DB Component|Lost to Follow-up|0|||
105726075|NCT03263091|364653402|FG002|DB Component|Lost to Follow-up|0|||
105726076|NCT03263091|364653403|FG003|DB Component|Lost to Follow-up|0|||
105726077|NCT03263091|364653404|FG004|DB Component|Lost to Follow-up|2|||
105726078|NCT03263091|364653405|FG005|DB Component|Lost to Follow-up|1|||
105726079|NCT03263091|364653400|FG000|DB Component|Death|0|||
105726080|NCT03263091|364653401|FG001|DB Component|Death|0|||
105726081|NCT03263091|364653402|FG002|DB Component|Death|0|||
105726082|NCT03263091|364653403|FG003|DB Component|Death|0|||
105726083|NCT03263091|364653404|FG004|DB Component|Death|7|||
105726084|NCT03263091|364653405|FG005|DB Component|Death|4|||
105726085|NCT03263091|364653400|FG000|DB Component|Other than specified|0|||
105726086|NCT03263091|364653401|FG001|DB Component|Other than specified|0|||
105726087|NCT03263091|364653402|FG002|DB Component|Other than specified|0|||
105726088|NCT03263091|364653403|FG003|DB Component|Other than specified|0|||
105726089|NCT03263091|364653404|FG004|DB Component|Other than specified|8|||
105726090|NCT03263091|364653405|FG005|DB Component|Other than specified|6|||
105726091|NCT02468193|364653406|FG000|Overall Study|Adverse Event|4|||
105726092|NCT02468193|364653406|FG000|Overall Study|Subject/ Guardian decision|2|||
105726093|NCT01719757|364653407|FG000|Overall Study|Adverse Event|38|||
105726094|NCT01719757|364653407|FG000|Overall Study|Withdrawal by Subject|15|||
105726095|NCT01719757|364653407|FG000|Overall Study|Lost to Follow-up|20|||
105726096|NCT01719757|364653407|FG000|Overall Study|Protocol Violation|1|||
105726097|NCT01719757|364653407|FG000|Overall Study|well controlled pain|27|||
105726098|NCT00824564|364653422|FG000|Overall Study|Lost to Follow-up|5|||
105726099|NCT00824564|364653423|FG001|Overall Study|Lost to Follow-up|7|||
105726100|NCT00824564|364653422|FG000|Overall Study|Withdrawal by Subject|1|||
105726101|NCT00824564|364653423|FG001|Overall Study|Withdrawal by Subject|1|||
105726102|NCT00824564|364653422|FG000|Overall Study|Other|1|||
105726103|NCT00824564|364653423|FG001|Overall Study|Other|2|||
105726104|NCT00824564|364653422|FG000|Overall Study|Randomized, but not treated|1|||
106009392|NCT00456846|365700829|FG000|Overall Study|Other|0|||
105726105|NCT00824564|364653423|FG001|Overall Study|Randomized, but not treated|0|||
105726106|NCT00486902|364653425|FG000|Overall Study|Withdrawal by Subject|1|||
105726107|NCT00486902|364653426|FG001|Overall Study|Withdrawal by Subject|2|||
105726108|NCT00486902|364653425|FG000|Overall Study|decision for postpartum tubal ligation|3|||
105726109|NCT00486902|364653426|FG001|Overall Study|decision for postpartum tubal ligation|1|||
105726110|NCT00486902|364653425|FG000|Overall Study|spinal anesthetic protocal violation|1|||
105726111|NCT00486902|364653426|FG001|Overall Study|spinal anesthetic protocal violation|1|||
105726112|NCT00486902|364653425|FG000|Overall Study|Did not meet inclusion criteria|1|||
105726113|NCT00486902|364653426|FG001|Overall Study|Did not meet inclusion criteria|0|||
105760780|NCT03726333|364776193|FG002|Overall Study|Progressive Disease|1|||
105760781|NCT03726333|364776194|FG003|Overall Study|Progressive Disease|0|||
105760782|NCT03726333|364776195|FG004|Overall Study|Progressive Disease|0|||
105760783|NCT03627494|364776197|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
105760784|NCT03627494|364776198|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
106137772|NCT01972152|366163501|FG001|First Treatment Visit|Lost to Follow-up|1|||
106137773|NCT01972152|366163502|FG002|First Treatment Visit|Lost to Follow-up|0|||
106137774|NCT01972152|366163503|FG003|First Treatment Visit|Lost to Follow-up|0|||
106137775|NCT01972152|366163504|FG004|First Treatment Visit|Lost to Follow-up|0|||
106137776|NCT01972152|366163505|FG005|First Treatment Visit|Lost to Follow-up|0|||
106137777|NCT01972152|366163500|FG000|Second Treatment Visit|Protocol Violation|0|||
106137778|NCT01972152|366163501|FG001|Second Treatment Visit|Protocol Violation|1|||
106137779|NCT01972152|366163502|FG002|Second Treatment Visit|Protocol Violation|0|||
106137780|NCT01972152|366163503|FG003|Second Treatment Visit|Protocol Violation|0|||
106137781|NCT01972152|366163504|FG004|Second Treatment Visit|Protocol Violation|0|||
106137782|NCT01972152|366163505|FG005|Second Treatment Visit|Protocol Violation|0|||
106137783|NCT04163458|366163510|FG000|Overall Study|Protocol Deviation|7|||
106137784|NCT04163458|366163511|FG001|Overall Study|Protocol Deviation|13|||
106137785|NCT04163458|366163510|FG000|Overall Study|Adverse Event|5|||
106137786|NCT04163458|366163511|FG001|Overall Study|Adverse Event|8|||
106137787|NCT04163458|366163510|FG000|Overall Study|Due to COVID-19 pandemic|4|||
106137788|NCT04163458|366163511|FG001|Overall Study|Due to COVID-19 pandemic|2|||
106137789|NCT04163458|366163510|FG000|Overall Study|Participant withdrew consent|2|||
106137790|NCT04163458|366163511|FG001|Overall Study|Participant withdrew consent|3|||
106137791|NCT04163458|366163510|FG000|Overall Study|Randomization failure|2|||
106137792|NCT04163458|366163511|FG001|Overall Study|Randomization failure|2|||
106137793|NCT04163458|366163510|FG000|Overall Study|Other|4|||
106137794|NCT04163458|366163511|FG001|Overall Study|Other|2|||
106137795|NCT01839877|366163513|FG000|Overall Study|Protocol Violation|1|||
106137796|NCT01582945|366163515|FG000|Overall Study|Intolerable side-effects|1|||
106137797|NCT01582945|366163515|FG000|Overall Study|Scheduling conflicts|1|||
106137798|NCT01227707|366163516|FG000|Overall Study|Adverse Event|10|||
106137799|NCT01227707|366163516|FG000|Overall Study|Progression of disease|3|||
106137800|NCT01227707|366163516|FG000|Overall Study|Withdrawal by Subject|1|||
105726114|NCT00486902|364653425|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
105726115|NCT00486902|364653426|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
105726116|NCT03615222|364653431|FG000|Overall Study|Ineligible|26|||
105726117|NCT03615222|364653431|FG000|Overall Study|Withdrawal by Subject|7|||
105726118|NCT03615222|364653431|FG000|Overall Study|Death|1|||
105726119|NCT01552057|364653432|FG000|Overall Study|Adverse Event|14|||
105726120|NCT01552057|364653433|FG001|Overall Study|Adverse Event|15|||
105726121|NCT01552057|364653432|FG000|Overall Study|Lack of Efficacy|8|||
105726122|NCT01552057|364653433|FG001|Overall Study|Lack of Efficacy|23|||
105726123|NCT01552057|364653432|FG000|Overall Study|Withdrawal by Subject|5|||
105726124|NCT01552057|364653433|FG001|Overall Study|Withdrawal by Subject|8|||
105726125|NCT01552057|364653432|FG000|Overall Study|Entry Criteria Not Met|2|||
105726126|NCT01552057|364653433|FG001|Overall Study|Entry Criteria Not Met|2|||
105726127|NCT01552057|364653432|FG000|Overall Study|Physician Decision|1|||
105726128|NCT01552057|364653433|FG001|Overall Study|Physician Decision|0|||
105726129|NCT00476086|364653434|FG000|Overall Study|Alternative therapy|1|||
105726130|NCT00476086|364653434|FG000|Overall Study|Progressive Disease|4|||
105726131|NCT04178590|364653435|FG000|Overall Study|Pregnancy|1|||
105726132|NCT04178590|364653435|FG000|Overall Study|Lost to Follow-up|1|||
105726133|NCT00996840|364653436|FG000|Overall Study|Adverse Event|0|||
105726134|NCT00996840|364653437|FG001|Overall Study|Adverse Event|1|||
105726135|NCT00996840|364653438|FG002|Overall Study|Adverse Event|0|||
105726136|NCT00996840|364653439|FG003|Overall Study|Adverse Event|0|||
105726137|NCT00996840|364653440|FG004|Overall Study|Adverse Event|0|||
105726138|NCT00996840|364653436|FG000|Overall Study|Physician Decision|0|||
105726139|NCT00996840|364653437|FG001|Overall Study|Physician Decision|0|||
105726140|NCT00996840|364653438|FG002|Overall Study|Physician Decision|1|||
105726141|NCT00996840|364653439|FG003|Overall Study|Physician Decision|1|||
105726142|NCT00996840|364653440|FG004|Overall Study|Physician Decision|2|||
105726143|NCT00996840|364653436|FG000|Overall Study|Withdrawal by Subject|1|||
105726144|NCT00996840|364653437|FG001|Overall Study|Withdrawal by Subject|1|||
105726145|NCT00996840|364653438|FG002|Overall Study|Withdrawal by Subject|0|||
106137801|NCT01227707|366163516|FG000|Overall Study|Patient non-compliance|3|||
106137802|NCT01227707|366163516|FG000|Overall Study|Medical decision|6|||
106137803|NCT01227707|366163516|FG000|Overall Study|Death|1|||
106137804|NCT04716933|366163518|FG000|Overall Study|Ongoing|46|||
105726146|NCT00996840|364653439|FG003|Overall Study|Withdrawal by Subject|0|||
105726147|NCT00996840|364653440|FG004|Overall Study|Withdrawal by Subject|0|||
105726148|NCT01389245|364653441|FG000|Overall Study|Protocol Violation|10|||
105726149|NCT01389245|364653441|FG000|Overall Study|Lost to Follow-up|3|||
105726150|NCT01389245|364653441|FG000|Overall Study|Withdrawal by Subject|2|||
106137805|NCT04716933|366163519|FG001|Overall Study|Ongoing|37|||
106137806|NCT04716933|366163518|FG000|Overall Study|Sponsor Decision|55|||
105726151|NCT01485614|364653443|FG000|Randomization|Not Treated|1|||
105726152|NCT01485614|364653444|FG001|Randomization|Not Treated|0|||
105726153|NCT01485614|364653445|FG002|Randomization|Not Treated|0|||
106137807|NCT04716933|366163519|FG001|Overall Study|Sponsor Decision|63|||
106137808|NCT01155869|366163526|FG000|Overall Study|Lost to Follow-up|3|||
106137809|NCT01155869|366163527|FG001|Overall Study|Lost to Follow-up|1|||
106137810|NCT02824432|366163528|FG000|Overall Study|Major Protocol Deviation|1|||
105936405|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
105726154|NCT01485614|364653446|FG003|Randomization|Not Treated|0|||
105726155|NCT01485614|364653443|FG000|Weeks 0-20|Lost to Follow-up|2|||
105726156|NCT01485614|364653444|FG001|Weeks 0-20|Lost to Follow-up|0|||
105726157|NCT01485614|364653445|FG002|Weeks 0-20|Lost to Follow-up|0|||
105726158|NCT01485614|364653446|FG003|Weeks 0-20|Lost to Follow-up|0|||
105726159|NCT01485614|364653443|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
105726160|NCT01485614|364653444|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
105726161|NCT01485614|364653445|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
105726162|NCT01485614|364653446|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
105726163|NCT01485614|364653443|FG000|Weeks 0-20|Withdrawal by Subject|3|||
105726164|NCT01485614|364653444|FG001|Weeks 0-20|Withdrawal by Subject|2|||
105726165|NCT01485614|364653445|FG002|Weeks 0-20|Withdrawal by Subject|1|||
105726166|NCT01485614|364653446|FG003|Weeks 0-20|Withdrawal by Subject|0|||
105726167|NCT01485614|364653443|FG000|Weeks 20-54|Lost to Follow-up|4|||
105726168|NCT01485614|364653444|FG001|Weeks 20-54|Lost to Follow-up|3|||
105726169|NCT01485614|364653445|FG002|Weeks 20-54|Lost to Follow-up|1|||
105726170|NCT01485614|364653446|FG003|Weeks 20-54|Lost to Follow-up|0|||
105726171|NCT01485614|364653443|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
105726172|NCT01485614|364653444|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
105726173|NCT01485614|364653445|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
105726174|NCT01485614|364653446|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
105726175|NCT01485614|364653443|FG000|Weeks 20-54|Withdrawal by Subject|5|||
105726176|NCT01485614|364653444|FG001|Weeks 20-54|Withdrawal by Subject|3|||
105726177|NCT01485614|364653445|FG002|Weeks 20-54|Withdrawal by Subject|0|||
105726178|NCT01485614|364653446|FG003|Weeks 20-54|Withdrawal by Subject|0|||
105726179|NCT04125680|364653447|FG000|Overall Study|Lost to Follow-up|15|||
105726180|NCT01562028|364653448|FG000|Overall Study|Withdrawal by Subject|1|||
105726181|NCT01562028|364653449|FG001|Overall Study|Withdrawal by Subject|1|||
105726182|NCT01562028|364653448|FG000|Overall Study|Lost to Follow-up|2|||
105726183|NCT01562028|364653449|FG001|Overall Study|Lost to Follow-up|1|||
105726184|NCT00364793|364653450|FG000|Overall Study|Adverse Event|2|||
105726185|NCT00364793|364653451|FG001|Overall Study|Adverse Event|0|||
105726186|NCT00364793|364653452|FG002|Overall Study|Adverse Event|0|||
105726187|NCT00364793|364653453|FG003|Overall Study|Adverse Event|0|||
105726188|NCT00364793|364653450|FG000|Overall Study|Death|1|||
105726189|NCT00364793|364653451|FG001|Overall Study|Death|0|||
105726190|NCT00364793|364653452|FG002|Overall Study|Death|1|||
105726191|NCT00364793|364653453|FG003|Overall Study|Death|0|||
105726192|NCT00364793|364653450|FG000|Overall Study|Lack of Efficacy|3|||
105726193|NCT00364793|364653451|FG001|Overall Study|Lack of Efficacy|3|||
105936406|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
105936407|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
105936408|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
105936409|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
105936410|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
105936411|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
105936412|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
105936413|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
105936414|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
105936415|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
105936416|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
105936417|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
105936418|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
105936419|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
106009393|NCT00456846|365700830|FG001|Overall Study|Other|2|||
106009394|NCT02006472|365700834|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
106009395|NCT02006472|365700835|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
106009396|NCT02006472|365700836|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
106009397|NCT02006472|365700837|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
106009398|NCT02006472|365700838|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
105726194|NCT00364793|364653452|FG002|Overall Study|Lack of Efficacy|1|||
105726195|NCT00364793|364653453|FG003|Overall Study|Lack of Efficacy|1|||
105726196|NCT00364793|364653450|FG000|Overall Study|Lost to Follow-up|1|||
105726197|NCT00364793|364653451|FG001|Overall Study|Lost to Follow-up|0|||
105726198|NCT00364793|364653452|FG002|Overall Study|Lost to Follow-up|2|||
106137811|NCT02824432|366163529|FG001|Overall Study|Major Protocol Deviation|0|||
106137812|NCT00554801|366163530|FG000|Overall Study|left area before completion|5|||
106137813|NCT00554801|366163531|FG001|Overall Study|left area before completion|0|||
106137814|NCT00554801|366163530|FG000|Overall Study|Withdrawal by Subject|14|||
106137815|NCT00554801|366163531|FG001|Overall Study|Withdrawal by Subject|0|||
106137816|NCT05826431|366163532|FG000|Overall Study|Withdrawal by Subject|1|||
106137817|NCT01093534|366163533|FG000|Overall Study|Adverse Event|2|||
106137818|NCT01093534|366163534|FG001|Overall Study|Adverse Event|5|||
106137819|NCT01093534|366163535|FG002|Overall Study|Adverse Event|2|||
106137820|NCT01093534|366163533|FG000|Overall Study|Lack of Efficacy|2|||
106137821|NCT01093534|366163534|FG001|Overall Study|Lack of Efficacy|1|||
106137822|NCT01093534|366163535|FG002|Overall Study|Lack of Efficacy|1|||
106137823|NCT01093534|366163533|FG000|Overall Study|Withdrawal by Subject|5|||
106137824|NCT01093534|366163534|FG001|Overall Study|Withdrawal by Subject|7|||
106137825|NCT01093534|366163535|FG002|Overall Study|Withdrawal by Subject|2|||
106137826|NCT01093534|366163533|FG000|Overall Study|Other|1|||
106137827|NCT01093534|366163534|FG001|Overall Study|Other|3|||
106137828|NCT01093534|366163535|FG002|Overall Study|Other|4|||
106137829|NCT00811057|366163538|FG000|Overall Study|Protocol Violation|5|||
106137830|NCT00811057|366163539|FG001|Overall Study|Protocol Violation|10|||
106137831|NCT00811057|366163540|FG002|Overall Study|Protocol Violation|10|||
106137832|NCT03264456|366163548|FG000|Overall Study|Withdrawal by Subject|3|||
106137833|NCT03264456|366163548|FG000|Overall Study|Lost to Follow-up|1|||
106137834|NCT03538054|366163549|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
106137835|NCT03538054|366163549|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
106137836|NCT03538054|366163549|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
106137837|NCT00299702|366163555|FG000|Overall Study|Death|1|||
106137838|NCT00299702|366163556|FG001|Overall Study|Death|0|||
106137839|NCT00299702|366163555|FG000|Overall Study|Adverse Event|0|||
106137840|NCT00299702|366163556|FG001|Overall Study|Adverse Event|4|||
106137841|NCT00299702|366163555|FG000|Overall Study|Lost to Follow-up|18|||
106137842|NCT00299702|366163556|FG001|Overall Study|Lost to Follow-up|10|||
105726199|NCT00364793|364653453|FG003|Overall Study|Lost to Follow-up|0|||
105726200|NCT00364793|364653450|FG000|Overall Study|Poor or non-compliance|1|||
105726201|NCT00364793|364653451|FG001|Overall Study|Poor or non-compliance|1|||
105726202|NCT00364793|364653452|FG002|Overall Study|Poor or non-compliance|0|||
105726203|NCT00364793|364653453|FG003|Overall Study|Poor or non-compliance|1|||
105726204|NCT00364793|364653450|FG000|Overall Study|No longer meets criteria|0|||
105726205|NCT00364793|364653451|FG001|Overall Study|No longer meets criteria|0|||
105726206|NCT00364793|364653452|FG002|Overall Study|No longer meets criteria|0|||
105726207|NCT00364793|364653453|FG003|Overall Study|No longer meets criteria|1|||
105726208|NCT00364793|364653450|FG000|Overall Study|Withdrawal by Subject|0|||
105726209|NCT00364793|364653451|FG001|Overall Study|Withdrawal by Subject|1|||
105726210|NCT00364793|364653452|FG002|Overall Study|Withdrawal by Subject|0|||
105726211|NCT00364793|364653453|FG003|Overall Study|Withdrawal by Subject|0|||
105726212|NCT01919307|364653454|FG000|Overall Study|Withdrawal by Subject|9|||
105726213|NCT02582515|364653457|FG000|Overall Study|Withdrawal by Subject|0|||
105726214|NCT02582515|364653458|FG001|Overall Study|Withdrawal by Subject|1|||
106137843|NCT00299702|366163555|FG000|Overall Study|Withdrawal by Subject|25|||
106137844|NCT00299702|366163556|FG001|Overall Study|Withdrawal by Subject|23|||
106137845|NCT00299702|366163555|FG000|Overall Study|Pregnancy|0|||
106137846|NCT00299702|366163556|FG001|Overall Study|Pregnancy|1|||
106137847|NCT00299702|366163555|FG000|Overall Study|Insufficient Response|4|||
106137848|NCT00299702|366163556|FG001|Overall Study|Insufficient Response|3|||
105726215|NCT00775021|364653462|FG000|First Intervention|Lost to Follow-up|1|||
106137849|NCT00299702|366163555|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
106137850|NCT00299702|366163556|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
106137851|NCT01278862|366163557|FG000|Overall Study|Lost to Follow-up|1|||
106137852|NCT01278862|366163558|FG001|Overall Study|Lost to Follow-up|1|||
105726216|NCT00775021|364653463|FG001|First Intervention|Lost to Follow-up|0|||
106137853|NCT05025449|366164912|FG000|Overall Study|Withdrawal by Subject|1|||
106137854|NCT05025449|366164912|FG000|Overall Study|Patient emergently taken to operating room|1|||
106137855|NCT00569946|366164913|FG000|Overall Study|Adverse Event|16|||
106137856|NCT00569946|366164913|FG000|Overall Study|Objective Progression or Relapse|42|||
106137857|NCT00569946|366164913|FG000|Overall Study|Global Deterioration of Health Status|1|||
106137858|NCT01090024|366164914|FG000|Period 1|Met exclusion criteria|0|||
106137859|NCT01090024|366164915|FG001|Period 1|Met exclusion criteria|0|||
106137860|NCT01090024|366164916|FG002|Period 1|Met exclusion criteria|0|||
105726217|NCT00775021|364653462|FG000|Second Intervention|Adverse Event|0|||
106137861|NCT01090024|366164917|FG003|Period 1|Met exclusion criteria|0|||
106137862|NCT01090024|366164918|FG004|Period 1|Met exclusion criteria|0|||
106137863|NCT01090024|366164919|FG005|Period 1|Met exclusion criteria|0|||
106137864|NCT01090024|366164920|FG006|Period 1|Met exclusion criteria|0|||
106137865|NCT01090024|366164921|FG007|Period 1|Met exclusion criteria|0|||
106137866|NCT01090024|366164922|FG008|Period 1|Met exclusion criteria|0|||
106137867|NCT01090024|366164923|FG009|Period 1|Met exclusion criteria|0|||
106137868|NCT01090024|366164924|FG010|Period 1|Met exclusion criteria|0|||
105793898|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
105793899|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793900|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793901|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793902|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793903|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
105793904|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793905|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793906|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
105793907|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
105793908|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
105793909|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
105793910|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
105793911|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
105793912|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793913|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793914|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793915|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793916|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793917|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793918|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
106009399|NCT02006472|365700834|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
106009400|NCT02006472|365700835|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
106009401|NCT02006472|365700836|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
106009402|NCT02006472|365700837|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
106009403|NCT02006472|365700838|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
106009404|NCT02006472|365700834|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
106009405|NCT02006472|365700835|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
106009406|NCT02006472|365700836|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
106009407|NCT02006472|365700837|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
106009408|NCT02006472|365700838|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
106009409|NCT02006472|365700834|FG000|Period 1 (Through Week 26)|Other|1|||
106009410|NCT02006472|365700835|FG001|Period 1 (Through Week 26)|Other|5|||
106009411|NCT02006472|365700836|FG002|Period 1 (Through Week 26)|Other|0|||
106009412|NCT02006472|365700837|FG003|Period 1 (Through Week 26)|Other|2|||
106009413|NCT02006472|365700838|FG004|Period 1 (Through Week 26)|Other|3|||
106009414|NCT02006472|365700834|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
106009415|NCT02006472|365700835|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
106009416|NCT02006472|365700836|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
106009417|NCT02006472|365700837|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
106009418|NCT02006472|365700838|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
106009419|NCT02006472|365700834|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
106009420|NCT02006472|365700835|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
106009421|NCT02006472|365700836|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
106009422|NCT02006472|365700837|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
105793919|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793920|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793921|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793922|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
105793923|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793924|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793925|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793926|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793927|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793928|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793929|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793930|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
105793931|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
105793932|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
106009423|NCT02006472|365700838|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
106009424|NCT02006472|365700834|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
106009425|NCT02006472|365700835|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
106137869|NCT01090024|366164925|FG011|Period 1|Met exclusion criteria|0|||
105793933|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793934|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
106009426|NCT02006472|365700836|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
106009427|NCT02006472|365700837|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
106009428|NCT02006472|365700838|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
106009429|NCT02006472|365700834|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
106009430|NCT02006472|365700835|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
106137870|NCT01090024|366164926|FG012|Period 1|Met exclusion criteria|0|||
106137871|NCT01090024|366164927|FG013|Period 1|Met exclusion criteria|0|||
106137872|NCT01090024|366164928|FG014|Period 1|Met exclusion criteria|1|||
106137873|NCT01090024|366164929|FG015|Period 1|Met exclusion criteria|0|||
106137874|NCT01090024|366164930|FG016|Period 1|Met exclusion criteria|0|||
106137875|NCT01090024|366164931|FG017|Period 1|Met exclusion criteria|0|||
106137876|NCT01090024|366164914|FG000|Period 1|Adverse Event|0|||
106137877|NCT01090024|366164915|FG001|Period 1|Adverse Event|0|||
106137878|NCT01090024|366164916|FG002|Period 1|Adverse Event|0|||
106137879|NCT01090024|366164917|FG003|Period 1|Adverse Event|0|||
106137880|NCT01090024|366164918|FG004|Period 1|Adverse Event|0|||
106137881|NCT01090024|366164919|FG005|Period 1|Adverse Event|0|||
106137882|NCT01090024|366164920|FG006|Period 1|Adverse Event|0|||
106137883|NCT01090024|366164921|FG007|Period 1|Adverse Event|0|||
106137884|NCT01090024|366164922|FG008|Period 1|Adverse Event|0|||
106137885|NCT01090024|366164923|FG009|Period 1|Adverse Event|1|||
106137886|NCT01090024|366164924|FG010|Period 1|Adverse Event|0|||
106137887|NCT01090024|366164925|FG011|Period 1|Adverse Event|1|||
106137888|NCT01090024|366164926|FG012|Period 1|Adverse Event|0|||
106137889|NCT01090024|366164927|FG013|Period 1|Adverse Event|0|||
106137890|NCT01090024|366164928|FG014|Period 1|Adverse Event|0|||
106137891|NCT01090024|366164929|FG015|Period 1|Adverse Event|0|||
106137892|NCT01090024|366164930|FG016|Period 1|Adverse Event|0|||
106137893|NCT01090024|366164931|FG017|Period 1|Adverse Event|1|||
106137894|NCT01090024|366164914|FG000|Period 1|Withdrawal by Subject|0|||
106137895|NCT01090024|366164915|FG001|Period 1|Withdrawal by Subject|0|||
106137896|NCT01090024|366164916|FG002|Period 1|Withdrawal by Subject|0|||
106137897|NCT01090024|366164917|FG003|Period 1|Withdrawal by Subject|1|||
106137898|NCT01090024|366164918|FG004|Period 1|Withdrawal by Subject|0|||
106137899|NCT01090024|366164919|FG005|Period 1|Withdrawal by Subject|0|||
106137900|NCT01090024|366164920|FG006|Period 1|Withdrawal by Subject|0|||
106137901|NCT01090024|366164921|FG007|Period 1|Withdrawal by Subject|0|||
106137902|NCT01090024|366164922|FG008|Period 1|Withdrawal by Subject|0|||
106137903|NCT01090024|366164923|FG009|Period 1|Withdrawal by Subject|0|||
106137904|NCT01090024|366164924|FG010|Period 1|Withdrawal by Subject|0|||
106137905|NCT01090024|366164925|FG011|Period 1|Withdrawal by Subject|0|||
106137906|NCT01090024|366164926|FG012|Period 1|Withdrawal by Subject|0|||
105726218|NCT00775021|364653463|FG001|Second Intervention|Adverse Event|1|||
105726219|NCT05027802|364653477|FG000|Overall Study|Adverse Event|2|||
105726220|NCT05027802|364653477|FG000|Overall Study|Withdrawal by Subject|18|||
105726221|NCT05027802|364653477|FG000|Overall Study|Death|2|||
105726222|NCT05027802|364653477|FG000|Overall Study|Other|1|||
105726223|NCT00382967|364653478|FG000|Overall Study|Protocol Violation|1|||
105726224|NCT00382967|364653479|FG001|Overall Study|Protocol Violation|1|||
105726225|NCT02690701|364653489|FG000|Treatment Period 1|Adverse Event|2|||
105726226|NCT02690701|364653490|FG001|Treatment Period 1|Adverse Event|2|||
105726227|NCT02690701|364653489|FG000|Treatment Period 1|Withdrawal by Subject|0|||
106009431|NCT02006472|365700836|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
106009432|NCT02006472|365700837|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
106009433|NCT02006472|365700838|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
106009434|NCT02006472|365700834|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
106009435|NCT02006472|365700835|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
106009436|NCT02006472|365700836|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
106009437|NCT02006472|365700837|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
106009438|NCT02006472|365700838|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
106009439|NCT02006472|365700834|FG000|Period 2 (Through Week 52)|Other|0|||
106009440|NCT02006472|365700835|FG001|Period 2 (Through Week 52)|Other|1|||
106009441|NCT02006472|365700836|FG002|Period 2 (Through Week 52)|Other|0|||
106009442|NCT02006472|365700837|FG003|Period 2 (Through Week 52)|Other|1|||
106009443|NCT02006472|365700838|FG004|Period 2 (Through Week 52)|Other|0|||
106009444|NCT02006472|365700834|FG000|Period 2 (Through Week 52)|Not treated|0|||
106009445|NCT02006472|365700835|FG001|Period 2 (Through Week 52)|Not treated|0|||
106009446|NCT02006472|365700836|FG002|Period 2 (Through Week 52)|Not treated|2|||
106009447|NCT02006472|365700837|FG003|Period 2 (Through Week 52)|Not treated|0|||
106137907|NCT01090024|366164927|FG013|Period 1|Withdrawal by Subject|0|||
106137908|NCT01090024|366164928|FG014|Period 1|Withdrawal by Subject|0|||
106137909|NCT01090024|366164929|FG015|Period 1|Withdrawal by Subject|0|||
105726228|NCT02690701|364653490|FG001|Treatment Period 1|Withdrawal by Subject|1|||
106009448|NCT02006472|365700838|FG004|Period 2 (Through Week 52)|Not treated|0|||
106137910|NCT01090024|366164930|FG016|Period 1|Withdrawal by Subject|0|||
106137911|NCT01090024|366164931|FG017|Period 1|Withdrawal by Subject|0|||
106137912|NCT01090024|366164914|FG000|Period 1|Lost to Follow-up|0|||
106009449|NCT02006472|365700834|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
106137913|NCT01090024|366164915|FG001|Period 1|Lost to Follow-up|1|||
106137914|NCT01090024|366164916|FG002|Period 1|Lost to Follow-up|0|||
106137915|NCT01090024|366164917|FG003|Period 1|Lost to Follow-up|0|||
105726229|NCT02690701|364653489|FG000|Treatment Period 2|Adverse Event|2|||
105726230|NCT02690701|364653490|FG001|Treatment Period 2|Adverse Event|0|||
105726231|NCT02690701|364653489|FG000|Treatment Period 2|Lack of Efficacy|1|||
106137916|NCT01090024|366164918|FG004|Period 1|Lost to Follow-up|0|||
106137917|NCT01090024|366164919|FG005|Period 1|Lost to Follow-up|0|||
106137918|NCT01090024|366164920|FG006|Period 1|Lost to Follow-up|0|||
106137919|NCT01090024|366164921|FG007|Period 1|Lost to Follow-up|0|||
106137920|NCT01090024|366164922|FG008|Period 1|Lost to Follow-up|0|||
106137921|NCT01090024|366164923|FG009|Period 1|Lost to Follow-up|0|||
106137922|NCT01090024|366164924|FG010|Period 1|Lost to Follow-up|0|||
106137923|NCT01090024|366164925|FG011|Period 1|Lost to Follow-up|0|||
106137924|NCT01090024|366164926|FG012|Period 1|Lost to Follow-up|0|||
106137925|NCT01090024|366164927|FG013|Period 1|Lost to Follow-up|0|||
106137926|NCT01090024|366164928|FG014|Period 1|Lost to Follow-up|0|||
106137927|NCT01090024|366164929|FG015|Period 1|Lost to Follow-up|0|||
106137928|NCT01090024|366164930|FG016|Period 1|Lost to Follow-up|0|||
106137929|NCT01090024|366164931|FG017|Period 1|Lost to Follow-up|0|||
106137930|NCT01090024|366164914|FG000|Period 2|Lost to Follow-up|0|||
106137931|NCT01090024|366164915|FG001|Period 2|Lost to Follow-up|0|||
106137932|NCT01090024|366164916|FG002|Period 2|Lost to Follow-up|0|||
106137933|NCT01090024|366164917|FG003|Period 2|Lost to Follow-up|1|||
106137934|NCT01090024|366164918|FG004|Period 2|Lost to Follow-up|0|||
106137935|NCT01090024|366164919|FG005|Period 2|Lost to Follow-up|0|||
106137936|NCT01090024|366164920|FG006|Period 2|Lost to Follow-up|0|||
106137937|NCT01090024|366164921|FG007|Period 2|Lost to Follow-up|0|||
106137938|NCT01090024|366164922|FG008|Period 2|Lost to Follow-up|0|||
106137939|NCT01090024|366164923|FG009|Period 2|Lost to Follow-up|0|||
106137940|NCT01090024|366164924|FG010|Period 2|Lost to Follow-up|0|||
106137941|NCT01090024|366164925|FG011|Period 2|Lost to Follow-up|0|||
106137942|NCT01090024|366164926|FG012|Period 2|Lost to Follow-up|0|||
106137943|NCT01090024|366164927|FG013|Period 2|Lost to Follow-up|0|||
106137944|NCT01090024|366164928|FG014|Period 2|Lost to Follow-up|0|||
106137945|NCT01090024|366164929|FG015|Period 2|Lost to Follow-up|0|||
106137946|NCT01090024|366164930|FG016|Period 2|Lost to Follow-up|0|||
106137947|NCT01090024|366164931|FG017|Period 2|Lost to Follow-up|0|||
106137948|NCT01090024|366164914|FG000|Period 2|Adverse Event|1|||
106137949|NCT01090024|366164915|FG001|Period 2|Adverse Event|0|||
106137950|NCT01090024|366164916|FG002|Period 2|Adverse Event|0|||
106137951|NCT01090024|366164917|FG003|Period 2|Adverse Event|0|||
106137952|NCT01090024|366164918|FG004|Period 2|Adverse Event|0|||
106137953|NCT01090024|366164919|FG005|Period 2|Adverse Event|0|||
106137954|NCT01090024|366164920|FG006|Period 2|Adverse Event|0|||
106137955|NCT01090024|366164921|FG007|Period 2|Adverse Event|0|||
106137956|NCT01090024|366164922|FG008|Period 2|Adverse Event|0|||
106137957|NCT01090024|366164923|FG009|Period 2|Adverse Event|0|||
106137958|NCT01090024|366164924|FG010|Period 2|Adverse Event|0|||
106137959|NCT01090024|366164925|FG011|Period 2|Adverse Event|0|||
106137960|NCT01090024|366164926|FG012|Period 2|Adverse Event|0|||
106137961|NCT01090024|366164927|FG013|Period 2|Adverse Event|0|||
106137962|NCT01090024|366164928|FG014|Period 2|Adverse Event|0|||
106137963|NCT01090024|366164929|FG015|Period 2|Adverse Event|0|||
106137964|NCT01090024|366164930|FG016|Period 2|Adverse Event|0|||
106137965|NCT01090024|366164931|FG017|Period 2|Adverse Event|0|||
106137966|NCT01090024|366164914|FG000|Period 3|Withdrawal by Subject|0|||
106137967|NCT01090024|366164915|FG001|Period 3|Withdrawal by Subject|0|||
106137968|NCT01090024|366164916|FG002|Period 3|Withdrawal by Subject|0|||
106137969|NCT01090024|366164917|FG003|Period 3|Withdrawal by Subject|0|||
106137970|NCT01090024|366164918|FG004|Period 3|Withdrawal by Subject|0|||
106137971|NCT01090024|366164919|FG005|Period 3|Withdrawal by Subject|0|||
106137972|NCT01090024|366164920|FG006|Period 3|Withdrawal by Subject|0|||
106137973|NCT01090024|366164921|FG007|Period 3|Withdrawal by Subject|0|||
106137974|NCT01090024|366164922|FG008|Period 3|Withdrawal by Subject|0|||
106137975|NCT01090024|366164923|FG009|Period 3|Withdrawal by Subject|0|||
106137976|NCT01090024|366164924|FG010|Period 3|Withdrawal by Subject|0|||
105726232|NCT02690701|364653490|FG001|Treatment Period 2|Lack of Efficacy|0|||
105726233|NCT02690701|364653489|FG000|Treatment Period 2|Lost to Follow-up|0|||
105726234|NCT02690701|364653490|FG001|Treatment Period 2|Lost to Follow-up|2|||
106137977|NCT01090024|366164925|FG011|Period 3|Withdrawal by Subject|0|||
105726235|NCT02690701|364653489|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105726236|NCT02690701|364653490|FG001|Treatment Period 2|Withdrawal by Subject|2|||
106137978|NCT01090024|366164926|FG012|Period 3|Withdrawal by Subject|0|||
106137979|NCT01090024|366164927|FG013|Period 3|Withdrawal by Subject|0|||
106137980|NCT01090024|366164928|FG014|Period 3|Withdrawal by Subject|0|||
106137981|NCT01090024|366164929|FG015|Period 3|Withdrawal by Subject|1|||
106137982|NCT01090024|366164930|FG016|Period 3|Withdrawal by Subject|0|||
106137983|NCT01090024|366164931|FG017|Period 3|Withdrawal by Subject|0|||
106137984|NCT01090024|366164914|FG000|Period 3|Protocol Violation|0|||
106137985|NCT01090024|366164915|FG001|Period 3|Protocol Violation|0|||
106137986|NCT01090024|366164916|FG002|Period 3|Protocol Violation|0|||
105726237|NCT02690701|364653489|FG000|Treatment Period 2|Protocol Violation|0|||
106137987|NCT01090024|366164917|FG003|Period 3|Protocol Violation|0|||
106137988|NCT01090024|366164918|FG004|Period 3|Protocol Violation|0|||
106137989|NCT01090024|366164919|FG005|Period 3|Protocol Violation|0|||
106137990|NCT01090024|366164920|FG006|Period 3|Protocol Violation|0|||
105726238|NCT02690701|364653490|FG001|Treatment Period 2|Protocol Violation|1|||
106137991|NCT01090024|366164921|FG007|Period 3|Protocol Violation|0|||
106137992|NCT01090024|366164922|FG008|Period 3|Protocol Violation|1|||
106009450|NCT02006472|365700835|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
106009451|NCT02006472|365700836|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
106009452|NCT02006472|365700837|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
106009453|NCT02006472|365700838|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
106009454|NCT02006472|365700834|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
106009455|NCT02006472|365700835|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
106009456|NCT02006472|365700836|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
106009457|NCT02006472|365700837|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
106009458|NCT02006472|365700838|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
106009459|NCT00886379|365700839|FG000|Overall Study|Transferred Schools|0|||
106009460|NCT00886379|365700840|FG001|Overall Study|Transferred Schools|0|||
105726239|NCT01672957|364653492|FG000|Overall Study|Protocol Violation|48|||
105726240|NCT01672957|364653492|FG000|Overall Study|Death|2|||
105726241|NCT01672957|364653492|FG000|Overall Study|ICF Signed After Transplantation|5|||
105726242|NCT01442181|364653494|FG000|Overall Study|patient refused surgery|1|||
105726243|NCT01442181|364653495|FG001|Overall Study|patient refused surgery|0|||
105726244|NCT01442181|364653494|FG000|Overall Study|no insurance for surgery|1|||
105726245|NCT01442181|364653495|FG001|Overall Study|no insurance for surgery|0|||
105726246|NCT01442181|364653494|FG000|Overall Study|low ejection factor|0|||
105726247|NCT01442181|364653495|FG001|Overall Study|low ejection factor|1|||
105726248|NCT01442181|364653494|FG000|Overall Study|Lost to Follow-up|1|||
105726249|NCT01442181|364653495|FG001|Overall Study|Lost to Follow-up|1|||
105726250|NCT01442181|364653494|FG000|Overall Study|patient in an additional study|1|||
105726251|NCT01442181|364653495|FG001|Overall Study|patient in an additional study|0|||
105726252|NCT01442181|364653494|FG000|Overall Study|atrial fibrillation not noted|0|||
106009461|NCT00886379|365700841|FG002|Overall Study|Transferred Schools|2|||
106009462|NCT00886379|365700842|FG003|Overall Study|Transferred Schools|1|||
106009463|NCT00886379|365700843|FG004|Overall Study|Transferred Schools|1|||
105726253|NCT01442181|364653495|FG001|Overall Study|atrial fibrillation not noted|1|||
105726254|NCT01658514|364653496|FG000|Overall Study|Protocol Violation|1|||
105793935|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
105793936|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
105793937|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793938|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
106009464|NCT00886379|365700839|FG000|Overall Study|Final blood draw not obtained|3|||
106009465|NCT00886379|365700840|FG001|Overall Study|Final blood draw not obtained|3|||
106009466|NCT00886379|365700841|FG002|Overall Study|Final blood draw not obtained|4|||
106009467|NCT00886379|365700842|FG003|Overall Study|Final blood draw not obtained|2|||
106009468|NCT00886379|365700843|FG004|Overall Study|Final blood draw not obtained|2|||
106009469|NCT01614886|365700849|FG000|Overall Study|Adverse Event|15|||
106009470|NCT01614886|365700850|FG001|Overall Study|Adverse Event|20|||
106009471|NCT01614886|365700849|FG000|Overall Study|Withdrawal by Subject|4|||
106009472|NCT01614886|365700850|FG001|Overall Study|Withdrawal by Subject|4|||
106009473|NCT01614886|365700849|FG000|Overall Study|Death|1|||
106009474|NCT01614886|365700850|FG001|Overall Study|Death|0|||
106137993|NCT01090024|366164923|FG009|Period 3|Protocol Violation|0|||
105726255|NCT01658514|364653497|FG001|Overall Study|Protocol Violation|0|||
105726256|NCT01658514|364653498|FG002|Overall Study|Protocol Violation|2|||
105726257|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
105726258|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
106137994|NCT01090024|366164924|FG010|Period 3|Protocol Violation|0|||
106137995|NCT01090024|366164925|FG011|Period 3|Protocol Violation|0|||
106137996|NCT01090024|366164926|FG012|Period 3|Protocol Violation|0|||
106137997|NCT01090024|366164927|FG013|Period 3|Protocol Violation|0|||
106137998|NCT01090024|366164928|FG014|Period 3|Protocol Violation|0|||
106137999|NCT01090024|366164929|FG015|Period 3|Protocol Violation|0|||
106138000|NCT01090024|366164930|FG016|Period 3|Protocol Violation|0|||
106138001|NCT01090024|366164931|FG017|Period 3|Protocol Violation|0|||
106138002|NCT01090024|366164914|FG000|Period 3|Adverse Event|0|||
105726259|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
105726260|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
105726261|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
105726262|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
105726263|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
105726264|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
105726265|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
105726266|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
105726267|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
105726268|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
105726269|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
105726270|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
105726271|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
105726272|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
105726273|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
105726274|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
105726275|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
105726276|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
105726277|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
105726278|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
105726279|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
105726280|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
105726281|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
105726282|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
105726283|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
105726284|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
105726285|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
105726286|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
105726287|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
105726288|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
105726289|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
105726290|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
105726291|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
105726292|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
105726293|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
105726294|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
105726295|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
105936420|NCT01362530|365427451|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
105936421|NCT01362530|365427452|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
105936422|NCT01133977|365427453|FG000|Overall Study|Adverse Event|0|||
105936423|NCT01133977|365427454|FG001|Overall Study|Adverse Event|0|||
105936424|NCT01133977|365427455|FG002|Overall Study|Adverse Event|1|||
105936425|NCT01133977|365427456|FG003|Overall Study|Adverse Event|0|||
105936426|NCT01133977|365427457|FG004|Overall Study|Adverse Event|0|||
105726296|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
105726297|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
105726298|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
105936427|NCT01133977|365427453|FG000|Overall Study|Death|1|||
105936428|NCT01133977|365427454|FG001|Overall Study|Death|1|||
105793939|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793940|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
105793941|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793942|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793943|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
105793944|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
105793945|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
105793946|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
105793947|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
105793948|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
105793949|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
105793950|NCT01915498|364900761|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
105793951|NCT01915498|364900762|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
105793952|NCT01915498|364900763|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
105793953|NCT01915498|364900764|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
105793954|NCT01915498|364900765|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
105793955|NCT01915498|364900766|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
105793956|NCT01915498|364900767|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
105793957|NCT01915498|364900768|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
105793958|NCT01915498|364900769|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
105793959|NCT01915498|364900770|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
105793960|NCT01915498|364900771|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
105793961|NCT01915498|364900772|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
105793962|NCT01915498|364900773|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
105793963|NCT01915498|364900774|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
105793964|NCT01915498|364900775|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
105793965|NCT01915498|364900776|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
105793966|NCT01915498|364900777|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
105793967|NCT01915498|364900778|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
105793968|NCT01915498|364900779|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
105793969|NCT01915498|364900761|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793970|NCT01915498|364900762|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793971|NCT01915498|364900763|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793972|NCT01915498|364900764|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793973|NCT01915498|364900765|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793974|NCT01915498|364900766|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793975|NCT01915498|364900767|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793976|NCT01915498|364900768|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793977|NCT01915498|364900769|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793978|NCT01915498|364900770|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793979|NCT01915498|364900771|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793980|NCT01915498|364900772|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793981|NCT01915498|364900773|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793982|NCT01915498|364900774|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793983|NCT01915498|364900775|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793984|NCT01915498|364900776|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793985|NCT01915498|364900777|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793986|NCT01915498|364900778|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
105793987|NCT01915498|364900779|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
105793988|NCT01915498|364900761|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793989|NCT01915498|364900762|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793990|NCT01915498|364900763|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793991|NCT01915498|364900764|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793992|NCT01915498|364900765|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793993|NCT01915498|364900766|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105936429|NCT01133977|365427455|FG002|Overall Study|Death|1|||
105936430|NCT01133977|365427456|FG003|Overall Study|Death|7|||
105936431|NCT01133977|365427457|FG004|Overall Study|Death|3|||
105936432|NCT01133977|365427453|FG000|Overall Study|Started a New Line of Therapy|2|||
105936433|NCT01133977|365427454|FG001|Overall Study|Started a New Line of Therapy|6|||
105936434|NCT01133977|365427455|FG002|Overall Study|Started a New Line of Therapy|4|||
105936435|NCT01133977|365427456|FG003|Overall Study|Started a New Line of Therapy|25|||
105936436|NCT01133977|365427457|FG004|Overall Study|Started a New Line of Therapy|33|||
105936437|NCT01133977|365427453|FG000|Overall Study|Lost to Follow-up|0|||
105936438|NCT01133977|365427454|FG001|Overall Study|Lost to Follow-up|0|||
105936439|NCT01133977|365427455|FG002|Overall Study|Lost to Follow-up|0|||
105726299|NCT00100048|364653499|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726300|NCT00100048|364653500|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726301|NCT00100048|364653501|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726302|NCT00100048|364653502|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
105726303|NCT00100048|364653503|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726304|NCT00100048|364653504|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
105726305|NCT01624142|364653505|FG000|Overall Study|Withdrawal by Subject|14|||
105726306|NCT01624142|364653506|FG001|Overall Study|Withdrawal by Subject|4|||
105726307|NCT01624142|364653505|FG000|Overall Study|Death|3|||
105726308|NCT01624142|364653506|FG001|Overall Study|Death|6|||
105726309|NCT01624142|364653505|FG000|Overall Study|Study Closure|12|||
105726310|NCT01624142|364653506|FG001|Overall Study|Study Closure|6|||
105726311|NCT01624142|364653505|FG000|Overall Study|Lost to Follow-up|2|||
105726312|NCT01624142|364653506|FG001|Overall Study|Lost to Follow-up|0|||
105726313|NCT01624142|364653505|FG000|Overall Study|Other|1|||
105726314|NCT01624142|364653506|FG001|Overall Study|Other|0|||
105726315|NCT02747004|364653507|FG000|Overall Study|Withdrawal by Subject|8|||
105726316|NCT02747004|364653508|FG001|Overall Study|Withdrawal by Subject|5|||
105726317|NCT02747004|364653509|FG002|Overall Study|Withdrawal by Subject|4|||
105726318|NCT02747004|364653507|FG000|Overall Study|Lost to Follow-up|1|||
105726319|NCT02747004|364653508|FG001|Overall Study|Lost to Follow-up|2|||
105726320|NCT02747004|364653509|FG002|Overall Study|Lost to Follow-up|2|||
105726321|NCT02747004|364653507|FG000|Overall Study|on study treatment/follow-up|48|||
105726322|NCT02747004|364653508|FG001|Overall Study|on study treatment/follow-up|42|||
105726323|NCT02747004|364653509|FG002|Overall Study|on study treatment/follow-up|41|||
105726324|NCT00686543|364653510|FG000|Overall Study|Adverse Event|9|||
105726325|NCT00686543|364653511|FG001|Overall Study|Adverse Event|1|||
105726326|NCT00686543|364653512|FG002|Overall Study|Adverse Event|3|||
105936440|NCT01133977|365427456|FG003|Overall Study|Lost to Follow-up|2|||
105936441|NCT01133977|365427457|FG004|Overall Study|Lost to Follow-up|1|||
105936442|NCT01133977|365427453|FG000|Overall Study|Withdrawal by Subject|0|||
105936443|NCT01133977|365427454|FG001|Overall Study|Withdrawal by Subject|0|||
105936444|NCT01133977|365427455|FG002|Overall Study|Withdrawal by Subject|0|||
105936445|NCT01133977|365427456|FG003|Overall Study|Withdrawal by Subject|5|||
105936446|NCT01133977|365427457|FG004|Overall Study|Withdrawal by Subject|1|||
105936447|NCT01034657|365427458|FG000|Core Phase|Withdrawal by Subject|1|||
105726327|NCT00686543|364653513|FG003|Overall Study|Adverse Event|2|||
105726328|NCT00686543|364653510|FG000|Overall Study|Withdrawal by Subject|2|||
105726329|NCT00686543|364653511|FG001|Overall Study|Withdrawal by Subject|0|||
105726330|NCT00686543|364653512|FG002|Overall Study|Withdrawal by Subject|0|||
105726331|NCT00686543|364653513|FG003|Overall Study|Withdrawal by Subject|0|||
105726332|NCT00686543|364653510|FG000|Overall Study|Protocol Violation|3|||
105726333|NCT00686543|364653511|FG001|Overall Study|Protocol Violation|0|||
105726334|NCT00686543|364653512|FG002|Overall Study|Protocol Violation|2|||
105726335|NCT00686543|364653513|FG003|Overall Study|Protocol Violation|1|||
105936448|NCT01034657|365427459|FG001|Core Phase|Withdrawal by Subject|0|||
105936449|NCT01034657|365427460|FG002|Core Phase|Withdrawal by Subject|0|||
105936450|NCT01034657|365427458|FG000|Core Phase|Lack of Efficacy|2|||
105936451|NCT01034657|365427459|FG001|Core Phase|Lack of Efficacy|0|||
105936452|NCT01034657|365427460|FG002|Core Phase|Lack of Efficacy|0|||
105936453|NCT01034657|365427458|FG000|Core Phase|Abnormal laboratory value|1|||
105936454|NCT01034657|365427459|FG001|Core Phase|Abnormal laboratory value|0|||
105936455|NCT01034657|365427460|FG002|Core Phase|Abnormal laboratory value|0|||
105936456|NCT01034657|365427458|FG000|Core Phase|Adverse Event|8|||
105936457|NCT01034657|365427459|FG001|Core Phase|Adverse Event|0|||
105936458|NCT01034657|365427460|FG002|Core Phase|Adverse Event|0|||
105936459|NCT01034657|365427458|FG000|Core Phase|Protocol Violation|2|||
105936460|NCT01034657|365427459|FG001|Core Phase|Protocol Violation|0|||
105936461|NCT01034657|365427460|FG002|Core Phase|Protocol Violation|0|||
105936462|NCT01034657|365427458|FG000|Randomized Phase|Withdrawal by Subject|0|||
105936463|NCT01034657|365427459|FG001|Randomized Phase|Withdrawal by Subject|2|||
105936464|NCT01034657|365427460|FG002|Randomized Phase|Withdrawal by Subject|0|||
105936465|NCT01034657|365427458|FG000|Randomized Phase|Lack of Efficacy|5|||
105936466|NCT01034657|365427459|FG001|Randomized Phase|Lack of Efficacy|1|||
105726336|NCT00609622|364653514|FG000|Overall Study|Adverse Event|14|||
105726337|NCT00609622|364653515|FG001|Overall Study|Adverse Event|10|||
105726338|NCT00609622|364653514|FG000|Overall Study|Withdrawal by Subject|4|||
105726339|NCT00609622|364653515|FG001|Overall Study|Withdrawal by Subject|20|||
105726340|NCT00609622|364653514|FG000|Overall Study|Death|1|||
105936467|NCT01034657|365427460|FG002|Randomized Phase|Lack of Efficacy|0|||
105936468|NCT01034657|365427458|FG000|Randomized Phase|Abnormal laboratory value|0|||
105726341|NCT00609622|364653515|FG001|Overall Study|Death|4|||
105726342|NCT00609622|364653514|FG000|Overall Study|Protocol Violation|1|||
105726343|NCT00609622|364653515|FG001|Overall Study|Protocol Violation|1|||
105726344|NCT00609622|364653514|FG000|Overall Study|Objective progression or relapse|47|||
105936469|NCT01034657|365427459|FG001|Randomized Phase|Abnormal laboratory value|1|||
105726345|NCT00609622|364653515|FG001|Overall Study|Objective progression or relapse|41|||
105726346|NCT00609622|364653514|FG000|Overall Study|Study terminated by sponsor|16|||
105726347|NCT00609622|364653515|FG001|Overall Study|Study terminated by sponsor|3|||
105726348|NCT00609622|364653514|FG000|Overall Study|Other|7|||
105726349|NCT00609622|364653515|FG001|Overall Study|Other|14|||
105726350|NCT00609622|364653514|FG000|Overall Study|Global deterioration of health status|6|||
105726351|NCT00609622|364653515|FG001|Overall Study|Global deterioration of health status|2|||
105726352|NCT00752986|364653519|FG000|Overall Study|Withdrawal by Subject|2|||
105726353|NCT00752986|364653520|FG001|Overall Study|Withdrawal by Subject|1|||
105726354|NCT00752986|364653521|FG002|Overall Study|Withdrawal by Subject|2|||
105726355|NCT00752986|364653519|FG000|Overall Study|Protocol Violation|3|||
105726356|NCT00752986|364653520|FG001|Overall Study|Protocol Violation|0|||
105726357|NCT00752986|364653521|FG002|Overall Study|Protocol Violation|0|||
105726358|NCT00947349|364653526|FG000|Triple Treatment Combination Period|Adverse Event|0|||
105726359|NCT00947349|364653527|FG001|Triple Treatment Combination Period|Adverse Event|1|||
105726360|NCT00947349|364653528|FG002|Triple Treatment Combination Period|Adverse Event|0|||
105726361|NCT00947349|364653529|FG003|Triple Treatment Combination Period|Adverse Event|0|||
105726362|NCT00947349|364653526|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
106009475|NCT01614886|365700849|FG000|Overall Study|Protocol deviation|0|||
106009476|NCT01614886|365700850|FG001|Overall Study|Protocol deviation|2|||
106009477|NCT01207414|365700854|FG000|Overall Study|Adverse Event|25|||
106009478|NCT01207414|365700855|FG001|Overall Study|Adverse Event|39|||
106009479|NCT01207414|365700854|FG000|Overall Study|Abnormal test procedure results|0|||
106009480|NCT01207414|365700855|FG001|Overall Study|Abnormal test procedure results|1|||
106009481|NCT01207414|365700854|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
106009482|NCT01207414|365700855|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105726363|NCT00947349|364653527|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
105793994|NCT01915498|364900767|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105726364|NCT00947349|364653528|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
105726365|NCT00947349|364653529|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
106009483|NCT01207414|365700854|FG000|Overall Study|Patient withdrew consent|14|||
106009484|NCT01207414|365700855|FG001|Overall Study|Patient withdrew consent|11|||
105936470|NCT01034657|365427460|FG002|Randomized Phase|Abnormal laboratory value|0|||
105936471|NCT01034657|365427458|FG000|Randomized Phase|Adverse Event|0|||
105936472|NCT01034657|365427459|FG001|Randomized Phase|Adverse Event|2|||
105936473|NCT01034657|365427460|FG002|Randomized Phase|Adverse Event|1|||
105936474|NCT02773537|365427461|FG000|Overall Study|Lost to Follow-up|0|||
105936475|NCT02773537|365427462|FG001|Overall Study|Lost to Follow-up|1|||
106138003|NCT01090024|366164915|FG001|Period 3|Adverse Event|0|||
106138004|NCT01090024|366164916|FG002|Period 3|Adverse Event|0|||
106138005|NCT01090024|366164917|FG003|Period 3|Adverse Event|0|||
106138006|NCT01090024|366164918|FG004|Period 3|Adverse Event|0|||
106138007|NCT01090024|366164919|FG005|Period 3|Adverse Event|1|||
106138008|NCT01090024|366164920|FG006|Period 3|Adverse Event|0|||
106138009|NCT01090024|366164921|FG007|Period 3|Adverse Event|0|||
106138010|NCT01090024|366164922|FG008|Period 3|Adverse Event|0|||
106138011|NCT01090024|366164923|FG009|Period 3|Adverse Event|0|||
106138012|NCT01090024|366164924|FG010|Period 3|Adverse Event|0|||
106138013|NCT01090024|366164925|FG011|Period 3|Adverse Event|0|||
106138014|NCT01090024|366164926|FG012|Period 3|Adverse Event|0|||
106138015|NCT01090024|366164927|FG013|Period 3|Adverse Event|0|||
106138016|NCT01090024|366164928|FG014|Period 3|Adverse Event|0|||
106138017|NCT01090024|366164929|FG015|Period 3|Adverse Event|0|||
106138018|NCT01090024|366164930|FG016|Period 3|Adverse Event|0|||
106138019|NCT01090024|366164931|FG017|Period 3|Adverse Event|0|||
106138020|NCT00470626|366164932|FG000|Overall Study|Lost to Follow-up|10|||
106138021|NCT00470626|366164932|FG000|Overall Study|Withdrawal by Subject|7|||
106138022|NCT01801930|366164935|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
106138023|NCT01801930|366164936|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
106138024|NCT01801930|366164937|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
106138025|NCT01801930|366164938|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
106138026|NCT01801930|366164935|FG000|Overall Study|DLT occurs|0|||
106138027|NCT01801930|366164936|FG001|Overall Study|DLT occurs|1|||
106138028|NCT01801930|366164937|FG002|Overall Study|DLT occurs|0|||
106138029|NCT01801930|366164938|FG003|Overall Study|DLT occurs|0|||
106138030|NCT02236559|366164939|FG000|Overall Study|Met Exclusion|3|||
106138031|NCT02236559|366164940|FG001|Overall Study|Met Exclusion|6|||
106138032|NCT02236559|366164939|FG000|Overall Study|Did not Meet Inclusion|3|||
106138033|NCT02236559|366164940|FG001|Overall Study|Did not Meet Inclusion|3|||
106138034|NCT02236559|366164939|FG000|Overall Study|Subject Did Not Consent|4|||
106138035|NCT02236559|366164940|FG001|Overall Study|Subject Did Not Consent|2|||
106138036|NCT02236559|366164939|FG000|Overall Study|Physician Decision|1|||
106138037|NCT02236559|366164940|FG001|Overall Study|Physician Decision|1|||
106138038|NCT02236559|366164939|FG000|Overall Study|Withdrawal by Subject|1|||
106138039|NCT02236559|366164940|FG001|Overall Study|Withdrawal by Subject|0|||
106138040|NCT02131324|366164941|FG000|Overall Study|Withdrawal by Subject|1|||
106138041|NCT02131324|366164942|FG001|Overall Study|Withdrawal by Subject|2|||
106138042|NCT02131324|366164941|FG000|Overall Study|Lost to Follow-up|1|||
106138043|NCT02131324|366164942|FG001|Overall Study|Lost to Follow-up|1|||
106138044|NCT00798096|366164944|FG000|Overall Study|Ongoing|2|||
106138045|NCT00927823|366164945|FG000|Continuous Dosing Period|Death|0|||
106138046|NCT00927823|366164946|FG001|Continuous Dosing Period|Death|0|||
106138047|NCT00927823|366164947|FG002|Continuous Dosing Period|Death|6|||
106138048|NCT00927823|366164948|FG003|Continuous Dosing Period|Death|0|||
106138049|NCT00927823|366164945|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
106138050|NCT00927823|366164946|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
106138051|NCT00927823|366164947|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
106138052|NCT00927823|366164948|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
106138053|NCT00927823|366164945|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
106138054|NCT00927823|366164946|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
106138055|NCT00927823|366164947|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
106138056|NCT00927823|366164948|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
106138057|NCT00927823|366164945|FG000|Continuous Dosing Period|Other|1|||
106138058|NCT00927823|366164946|FG001|Continuous Dosing Period|Other|2|||
106138059|NCT00927823|366164947|FG002|Continuous Dosing Period|Other|9|||
106138060|NCT00927823|366164948|FG003|Continuous Dosing Period|Other|3|||
106138061|NCT03670602|366164953|FG000|Overall Study|Lost to Follow-up|1|||
106138062|NCT03670602|366164954|FG001|Overall Study|Lost to Follow-up|0|||
106138063|NCT03670602|366164953|FG000|Overall Study|Withdrawal by Subject|0|||
106138064|NCT03670602|366164954|FG001|Overall Study|Withdrawal by Subject|3|||
106138065|NCT03736785|366164955|FG000|Overall Study|Adverse Event|1|||
106138066|NCT03736785|366164956|FG001|Overall Study|Adverse Event|1|||
106138067|NCT03736785|366164957|FG002|Overall Study|Adverse Event|1|||
106138068|NCT03736785|366164955|FG000|Overall Study|Death|1|||
106138069|NCT03736785|366164956|FG001|Overall Study|Death|0|||
106138070|NCT03736785|366164957|FG002|Overall Study|Death|1|||
106138071|NCT03736785|366164955|FG000|Overall Study|Lost to Follow-up|0|||
105936476|NCT02773537|365427463|FG002|Overall Study|Lost to Follow-up|4|||
105936477|NCT00662038|365427464|FG000|Overall Study|Reason not specified|3|||
106138072|NCT03736785|366164956|FG001|Overall Study|Lost to Follow-up|2|||
106138073|NCT03736785|366164957|FG002|Overall Study|Lost to Follow-up|3|||
105793995|NCT01915498|364900768|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793996|NCT01915498|364900769|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793997|NCT01915498|364900770|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793998|NCT01915498|364900771|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105793999|NCT01915498|364900772|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794000|NCT01915498|364900773|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794001|NCT01915498|364900774|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794002|NCT01915498|364900775|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794003|NCT01915498|364900776|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794004|NCT01915498|364900777|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794005|NCT01915498|364900778|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
105794006|NCT01915498|364900779|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
105794007|NCT01915498|364900761|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794008|NCT01915498|364900762|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794009|NCT01915498|364900763|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794010|NCT01915498|364900764|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794011|NCT01915498|364900765|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794012|NCT01915498|364900766|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794013|NCT01915498|364900767|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794014|NCT01915498|364900768|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794015|NCT01915498|364900769|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794016|NCT01915498|364900770|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794017|NCT01915498|364900771|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794018|NCT01915498|364900772|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794019|NCT01915498|364900773|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794020|NCT01915498|364900774|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794021|NCT01915498|364900775|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794022|NCT01915498|364900776|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794023|NCT01915498|364900777|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794024|NCT01915498|364900778|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
105794025|NCT01915498|364900779|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
105794026|NCT05004181|364900781|FG000|Overall Study|Withdrawal of consent|0|||
105794027|NCT05004181|364900782|FG001|Overall Study|Withdrawal of consent|0|||
105794028|NCT05004181|364900783|FG002|Overall Study|Withdrawal of consent|1|||
105794029|NCT05004181|364900784|FG003|Overall Study|Withdrawal of consent|3|||
105794030|NCT05004181|364900785|FG004|Overall Study|Withdrawal of consent|3|||
105794031|NCT05004181|364900786|FG005|Overall Study|Withdrawal of consent|0|||
105794032|NCT05004181|364900787|FG006|Overall Study|Withdrawal of consent|30|||
105794033|NCT05004181|364900788|FG007|Overall Study|Withdrawal of consent|9|||
105794034|NCT05004181|364900789|FG008|Overall Study|Withdrawal of consent|3|||
105794035|NCT05004181|364900790|FG009|Overall Study|Withdrawal of consent|2|||
105794036|NCT05004181|364900791|FG010|Overall Study|Withdrawal of consent|5|||
105794037|NCT05004181|364900792|FG011|Overall Study|Withdrawal of consent|1|||
105794038|NCT05004181|364900781|FG000|Overall Study|Lost to Follow-up|2|||
105794039|NCT05004181|364900782|FG001|Overall Study|Lost to Follow-up|4|||
105794040|NCT05004181|364900783|FG002|Overall Study|Lost to Follow-up|2|||
105794041|NCT05004181|364900784|FG003|Overall Study|Lost to Follow-up|3|||
105794042|NCT05004181|364900785|FG004|Overall Study|Lost to Follow-up|5|||
105794043|NCT05004181|364900786|FG005|Overall Study|Lost to Follow-up|2|||
105794044|NCT05004181|364900787|FG006|Overall Study|Lost to Follow-up|15|||
105794045|NCT05004181|364900788|FG007|Overall Study|Lost to Follow-up|12|||
105794046|NCT05004181|364900789|FG008|Overall Study|Lost to Follow-up|38|||
105794047|NCT05004181|364900790|FG009|Overall Study|Lost to Follow-up|6|||
105794048|NCT05004181|364900791|FG010|Overall Study|Lost to Follow-up|6|||
105794049|NCT05004181|364900792|FG011|Overall Study|Lost to Follow-up|0|||
105794050|NCT05004181|364900781|FG000|Overall Study|Death|0|||
105794051|NCT05004181|364900782|FG001|Overall Study|Death|0|||
105794052|NCT05004181|364900783|FG002|Overall Study|Death|0|||
105794053|NCT05004181|364900784|FG003|Overall Study|Death|0|||
105794054|NCT05004181|364900785|FG004|Overall Study|Death|0|||
105794055|NCT05004181|364900786|FG005|Overall Study|Death|0|||
105794056|NCT05004181|364900787|FG006|Overall Study|Death|1|||
105794057|NCT05004181|364900788|FG007|Overall Study|Death|0|||
105794058|NCT05004181|364900789|FG008|Overall Study|Death|2|||
105794059|NCT05004181|364900790|FG009|Overall Study|Death|0|||
105794060|NCT05004181|364900791|FG010|Overall Study|Death|0|||
105794061|NCT05004181|364900792|FG011|Overall Study|Death|0|||
105794062|NCT05004181|364900781|FG000|Overall Study|Physician Decision|0|||
105794063|NCT05004181|364900782|FG001|Overall Study|Physician Decision|0|||
105794064|NCT05004181|364900783|FG002|Overall Study|Physician Decision|0|||
105794065|NCT05004181|364900784|FG003|Overall Study|Physician Decision|0|||
106009485|NCT01207414|365700854|FG000|Overall Study|Lost to Follow-up|15|||
106138074|NCT03736785|366164955|FG000|Overall Study|Non compliance with study drug|1|||
106138075|NCT03736785|366164956|FG001|Overall Study|Non compliance with study drug|1|||
106138076|NCT03736785|366164957|FG002|Overall Study|Non compliance with study drug|0|||
106138077|NCT03736785|366164955|FG000|Overall Study|Physician Decision|0|||
106138078|NCT03736785|366164956|FG001|Overall Study|Physician Decision|1|||
106138079|NCT03736785|366164957|FG002|Overall Study|Physician Decision|1|||
106138080|NCT03736785|366164955|FG000|Overall Study|Protocol Violation|1|||
106138081|NCT03736785|366164956|FG001|Overall Study|Protocol Violation|4|||
105794066|NCT05004181|364900785|FG004|Overall Study|Physician Decision|0|||
105794067|NCT05004181|364900786|FG005|Overall Study|Physician Decision|0|||
106138082|NCT03736785|366164957|FG002|Overall Study|Protocol Violation|3|||
105936478|NCT00662038|365427464|FG000|Overall Study|Withdrawn consent|22|||
105936479|NCT00662038|365427464|FG000|Overall Study|Withdrawal by Subject|83|||
105936480|NCT00662038|365427464|FG000|Overall Study|Sponsor decision|1|||
105936481|NCT00662038|365427464|FG000|Overall Study|Physician Decision|19|||
105936482|NCT00662038|365427464|FG000|Overall Study|Lung transplantation|44|||
105936483|NCT00662038|365427464|FG000|Overall Study|Lost to Follow-up|1|||
105936484|NCT00662038|365427464|FG000|Overall Study|Death|95|||
105936485|NCT00662038|365427464|FG000|Overall Study|Adverse Event|358|||
105936486|NCT00662038|365427464|FG000|Overall Study|Continued treatment|5|||
105936487|NCT01896986|365427472|FG000|Overall Study|samples lost|14|||
105936488|NCT01896986|365427473|FG001|Overall Study|samples lost|23|||
105936489|NCT03302936|365427476|FG000|Overall Study|Protocol Violation|3|||
105936490|NCT03302936|365427477|FG001|Overall Study|Protocol Violation|4|||
105936491|NCT01379937|365427478|FG000|Overall Study|Protocol Violation|0|||
105936492|NCT01379937|365427479|FG001|Overall Study|Protocol Violation|0|||
105936493|NCT01379937|365427480|FG002|Overall Study|Protocol Violation|0|||
105936494|NCT01379937|365427481|FG003|Overall Study|Protocol Violation|1|||
105936495|NCT01379937|365427478|FG000|Overall Study|Consent withdrawal|0|||
105936496|NCT01379937|365427479|FG001|Overall Study|Consent withdrawal|1|||
105936497|NCT01379937|365427480|FG002|Overall Study|Consent withdrawal|0|||
105936498|NCT01379937|365427481|FG003|Overall Study|Consent withdrawal|0|||
105936499|NCT01379937|365427478|FG000|Overall Study|Lost to Follow-up|1|||
105936500|NCT01379937|365427479|FG001|Overall Study|Lost to Follow-up|2|||
105936501|NCT01379937|365427480|FG002|Overall Study|Lost to Follow-up|2|||
105936502|NCT01379937|365427481|FG003|Overall Study|Lost to Follow-up|0|||
105936503|NCT04641975|365427490|FG000|Overall Study|Protocol Violation|1|||
105936504|NCT04641975|365427491|FG001|Overall Study|Protocol Violation|2|||
105936505|NCT04641975|365427492|FG002|Overall Study|Protocol Violation|0|||
105936506|NCT04641975|365427493|FG003|Overall Study|Protocol Violation|0|||
105936507|NCT04641975|365427490|FG000|Overall Study|Adverse Event|0|||
105936508|NCT04641975|365427491|FG001|Overall Study|Adverse Event|0|||
105936509|NCT04641975|365427492|FG002|Overall Study|Adverse Event|1|||
105936510|NCT04641975|365427493|FG003|Overall Study|Adverse Event|1|||
105936511|NCT04641975|365427490|FG000|Overall Study|Withdrawal by Subject|1|||
105936512|NCT04641975|365427491|FG001|Overall Study|Withdrawal by Subject|0|||
105936513|NCT04641975|365427492|FG002|Overall Study|Withdrawal by Subject|0|||
106138083|NCT03736785|366164955|FG000|Overall Study|Sponsor Decision|1|||
106138084|NCT03736785|366164956|FG001|Overall Study|Sponsor Decision|0|||
106138085|NCT03736785|366164957|FG002|Overall Study|Sponsor Decision|0|||
106138086|NCT03736785|366164955|FG000|Overall Study|Unknown/Missing data|3|||
106138087|NCT03736785|366164956|FG001|Overall Study|Unknown/Missing data|2|||
106138088|NCT03736785|366164957|FG002|Overall Study|Unknown/Missing data|1|||
106138089|NCT03736785|366164955|FG000|Overall Study|Withdrawal by Subject|9|||
105794068|NCT05004181|364900787|FG006|Overall Study|Physician Decision|2|||
105936514|NCT04641975|365427493|FG003|Overall Study|Withdrawal by Subject|0|||
105936515|NCT01655069|365427495|FG000|Overall Study|Physician Decision|0|||
105936516|NCT01655069|365427496|FG001|Overall Study|Physician Decision|0|||
105936517|NCT01655069|365427497|FG002|Overall Study|Physician Decision|0|||
105936518|NCT01655069|365427498|FG003|Overall Study|Physician Decision|1|||
105936519|NCT01655069|365427495|FG000|Overall Study|Adverse Event|6|||
105936520|NCT01655069|365427496|FG001|Overall Study|Adverse Event|7|||
106138090|NCT03736785|366164956|FG001|Overall Study|Withdrawal by Subject|6|||
105936521|NCT01655069|365427497|FG002|Overall Study|Adverse Event|2|||
105726366|NCT00947349|364653526|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
105726367|NCT00947349|364653527|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
105726368|NCT00947349|364653528|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
105726369|NCT00947349|364653529|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
105726370|NCT00947349|364653526|FG000|Overall Study Standard of Care|Other|0|||
105726371|NCT00947349|364653527|FG001|Overall Study Standard of Care|Other|0|||
105726372|NCT00947349|364653528|FG002|Overall Study Standard of Care|Other|0|||
105726373|NCT00947349|364653529|FG003|Overall Study Standard of Care|Other|1|||
105794069|NCT05004181|364900788|FG007|Overall Study|Physician Decision|0|||
105794070|NCT05004181|364900789|FG008|Overall Study|Physician Decision|7|||
105794071|NCT05004181|364900790|FG009|Overall Study|Physician Decision|0|||
105794072|NCT05004181|364900791|FG010|Overall Study|Physician Decision|0|||
105794073|NCT05004181|364900792|FG011|Overall Study|Physician Decision|0|||
105794074|NCT05004181|364900781|FG000|Overall Study|Withdrawal by Subject|2|||
105794075|NCT05004181|364900782|FG001|Overall Study|Withdrawal by Subject|3|||
105794076|NCT05004181|364900783|FG002|Overall Study|Withdrawal by Subject|2|||
105794077|NCT05004181|364900784|FG003|Overall Study|Withdrawal by Subject|2|||
105794078|NCT05004181|364900785|FG004|Overall Study|Withdrawal by Subject|4|||
105794079|NCT05004181|364900786|FG005|Overall Study|Withdrawal by Subject|2|||
105794080|NCT05004181|364900787|FG006|Overall Study|Withdrawal by Subject|4|||
105794081|NCT05004181|364900788|FG007|Overall Study|Withdrawal by Subject|22|||
105794082|NCT05004181|364900789|FG008|Overall Study|Withdrawal by Subject|8|||
105794083|NCT05004181|364900790|FG009|Overall Study|Withdrawal by Subject|1|||
105794084|NCT05004181|364900791|FG010|Overall Study|Withdrawal by Subject|3|||
105794085|NCT05004181|364900792|FG011|Overall Study|Withdrawal by Subject|2|||
105794086|NCT05004181|364900781|FG000|Overall Study|Protocol Violation|2|||
105794087|NCT05004181|364900782|FG001|Overall Study|Protocol Violation|3|||
105794088|NCT05004181|364900783|FG002|Overall Study|Protocol Violation|0|||
105794089|NCT05004181|364900784|FG003|Overall Study|Protocol Violation|0|||
105794090|NCT05004181|364900785|FG004|Overall Study|Protocol Violation|1|||
105794091|NCT05004181|364900786|FG005|Overall Study|Protocol Violation|0|||
105794092|NCT05004181|364900787|FG006|Overall Study|Protocol Violation|16|||
105794093|NCT05004181|364900788|FG007|Overall Study|Protocol Violation|18|||
105794094|NCT05004181|364900789|FG008|Overall Study|Protocol Violation|2|||
105794095|NCT05004181|364900790|FG009|Overall Study|Protocol Violation|2|||
105794096|NCT05004181|364900791|FG010|Overall Study|Protocol Violation|2|||
105794097|NCT05004181|364900792|FG011|Overall Study|Protocol Violation|1|||
105794098|NCT05004181|364900781|FG000|Overall Study|Not further specified|1|||
105794099|NCT05004181|364900782|FG001|Overall Study|Not further specified|0|||
105794100|NCT05004181|364900783|FG002|Overall Study|Not further specified|0|||
105794101|NCT05004181|364900784|FG003|Overall Study|Not further specified|0|||
105794102|NCT05004181|364900785|FG004|Overall Study|Not further specified|0|||
105794103|NCT05004181|364900786|FG005|Overall Study|Not further specified|0|||
105794104|NCT05004181|364900787|FG006|Overall Study|Not further specified|1|||
105794105|NCT05004181|364900788|FG007|Overall Study|Not further specified|0|||
105794106|NCT05004181|364900789|FG008|Overall Study|Not further specified|2|||
105794107|NCT05004181|364900790|FG009|Overall Study|Not further specified|1|||
105794108|NCT05004181|364900791|FG010|Overall Study|Not further specified|0|||
105794109|NCT05004181|364900792|FG011|Overall Study|Not further specified|1|||
105794110|NCT00883129|364900795|FG000|Overall Study|Adverse Event|7|||
105794111|NCT00883129|364900796|FG001|Overall Study|Adverse Event|15|||
105794112|NCT00883129|364900795|FG000|Overall Study|Withdrawal by Subject|8|||
105794113|NCT00883129|364900796|FG001|Overall Study|Withdrawal by Subject|9|||
105794114|NCT00883129|364900795|FG000|Overall Study|Non-compliance|3|||
105794115|NCT00883129|364900796|FG001|Overall Study|Non-compliance|6|||
105794116|NCT00883129|364900795|FG000|Overall Study|Lost to Follow-up|1|||
105794117|NCT00883129|364900796|FG001|Overall Study|Lost to Follow-up|2|||
105794118|NCT00883129|364900795|FG000|Overall Study|Death|1|||
105794119|NCT00883129|364900796|FG001|Overall Study|Death|2|||
105794120|NCT00883129|364900795|FG000|Overall Study|Defined Treatment Failure|0|||
105794121|NCT00883129|364900796|FG001|Overall Study|Defined Treatment Failure|2|||
105794122|NCT01966107|364900797|FG000|Overall Study|excluded from FAS|21|||
105794123|NCT01966107|364900798|FG001|Overall Study|excluded from FAS|20|||
105794124|NCT01966107|364900797|FG000|Overall Study|discontinued treatment|345|||
105794125|NCT01966107|364900798|FG001|Overall Study|discontinued treatment|372|||
105794126|NCT01966107|364900797|FG000|Overall Study|due to study closure|164|||
105794127|NCT01966107|364900798|FG001|Overall Study|due to study closure|186|||
105794128|NCT01966107|364900797|FG000|Overall Study|withdrew from the study|272|||
105794129|NCT01966107|364900798|FG001|Overall Study|withdrew from the study|303|||
105794130|NCT01556165|364900802|FG000|Overall Study|Adverse Event|5|||
105794131|NCT01556165|364900803|FG001|Overall Study|Adverse Event|3|||
105794132|NCT01556165|364900802|FG000|Overall Study|Protocol Violation|0|||
105794133|NCT01556165|364900803|FG001|Overall Study|Protocol Violation|3|||
105794134|NCT01556165|364900802|FG000|Overall Study|Withdrawal of Consent|7|||
105794135|NCT01556165|364900803|FG001|Overall Study|Withdrawal of Consent|1|||
105794136|NCT00891527|364902165|FG000|Overall Study|Withdrawal by Subject|2|||
105794137|NCT03993288|364902168|FG000|Overall Study|Lost to Follow-up|2|||
105794138|NCT03993288|364902169|FG001|Overall Study|Lost to Follow-up|1|||
105794139|NCT03993288|364902168|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
106138091|NCT03736785|366164957|FG002|Overall Study|Withdrawal by Subject|4|||
106138092|NCT04588480|366164958|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
106138093|NCT04588480|366164959|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
106138094|NCT04588480|366164960|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
106138095|NCT04588480|366164958|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
106138096|NCT04588480|366164959|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
106138097|NCT04588480|366164960|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
106138098|NCT02322216|366164963|FG000|Overall Study|Adverse Event|1|||
106138099|NCT02322216|366164964|FG001|Overall Study|Adverse Event|0|||
106138100|NCT02322216|366164963|FG000|Overall Study|Withdrawal by Subject|1|||
106138101|NCT02322216|366164964|FG001|Overall Study|Withdrawal by Subject|4|||
106138102|NCT03256344|366164971|FG000|Overall Study|Death|6|||
106138103|NCT03256344|366164972|FG001|Overall Study|Death|22|||
106138104|NCT03256344|366164971|FG000|Overall Study|Withdrawal by Subject|3|||
105936522|NCT01655069|365427498|FG003|Overall Study|Adverse Event|3|||
105936523|NCT01655069|365427495|FG000|Overall Study|Lack of Efficacy|0|||
105936524|NCT01655069|365427496|FG001|Overall Study|Lack of Efficacy|1|||
105936525|NCT01655069|365427497|FG002|Overall Study|Lack of Efficacy|0|||
105936526|NCT01655069|365427498|FG003|Overall Study|Lack of Efficacy|0|||
105936527|NCT01655069|365427495|FG000|Overall Study|No Treatment Needed|0|||
105936528|NCT01655069|365427496|FG001|Overall Study|No Treatment Needed|1|||
105936529|NCT01655069|365427497|FG002|Overall Study|No Treatment Needed|0|||
105936530|NCT01655069|365427498|FG003|Overall Study|No Treatment Needed|0|||
105936531|NCT01655069|365427495|FG000|Overall Study|Withdrawal by Subject|2|||
106138105|NCT03256344|366164972|FG001|Overall Study|Withdrawal by Subject|3|||
106138106|NCT03256344|366164971|FG000|Overall Study|Sponsor Decision|1|||
106138107|NCT03256344|366164972|FG001|Overall Study|Sponsor Decision|0|||
106138108|NCT00404079|366164975|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
106138109|NCT00404079|366164976|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
106138110|NCT02057718|366164979|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
106138111|NCT02057718|366164980|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
106138112|NCT02057718|366164979|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
106138113|NCT02057718|366164980|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
106138114|NCT02057718|366164979|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
105726374|NCT00538681|364653530|FG000|Overall Study|Progressive Disease|7|||
105726375|NCT00538681|364653531|FG001|Overall Study|Progressive Disease|0|||
105936532|NCT01655069|365427496|FG001|Overall Study|Withdrawal by Subject|3|||
105936533|NCT01655069|365427497|FG002|Overall Study|Withdrawal by Subject|0|||
105936534|NCT01655069|365427498|FG003|Overall Study|Withdrawal by Subject|0|||
105936535|NCT03473301|365427500|FG000|Overall Study|Protocol Violation|4|||
105936536|NCT03473301|365427501|FG001|Overall Study|Protocol Violation|0|||
105936537|NCT03473301|365427502|FG002|Overall Study|Protocol Violation|0|||
105936538|NCT03473301|365427500|FG000|Overall Study|Withdrawal by Subject|0|||
105936539|NCT03473301|365427501|FG001|Overall Study|Withdrawal by Subject|1|||
105936540|NCT03473301|365427502|FG002|Overall Study|Withdrawal by Subject|0|||
105936541|NCT03473301|365427500|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
105936542|NCT03473301|365427501|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
105936543|NCT03473301|365427502|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
105936544|NCT05287685|365427503|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
105936545|NCT05287685|365427504|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
105936546|NCT05287685|365427503|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
105936547|NCT05287685|365427504|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
105936548|NCT04008069|365427505|FG000|Open-Label Period|Adverse Event|1|||
105936549|NCT04008069|365427506|FG001|Open-Label Period|Adverse Event|0|||
105936550|NCT04008069|365427507|FG002|Open-Label Period|Adverse Event|0|||
105726376|NCT00538681|364653532|FG002|Overall Study|Progressive Disease|1|||
105936551|NCT04008069|365427505|FG000|Open-Label Period|Lack of Efficacy|4|||
105936552|NCT04008069|365427506|FG001|Open-Label Period|Lack of Efficacy|0|||
105936553|NCT04008069|365427507|FG002|Open-Label Period|Lack of Efficacy|0|||
105936554|NCT04008069|365427505|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
105936555|NCT04008069|365427506|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
105936556|NCT04008069|365427507|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
105936557|NCT04008069|365427505|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
105936558|NCT04008069|365427506|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
105936559|NCT04008069|365427507|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
105936560|NCT02739828|365427512|FG000|Overall Study|Adverse Event|1|||
105936561|NCT02739828|365427512|FG000|Overall Study|Lost to Follow-up|4|||
105936562|NCT00066170|365427513|FG000|Overall Study|Adverse Event|2|||
105936563|NCT00066170|365427514|FG001|Overall Study|Adverse Event|4|||
105936564|NCT00066170|365427515|FG002|Overall Study|Adverse Event|1|||
105794140|NCT03993288|364902169|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
105794141|NCT03993288|364902168|FG000|Overall Study|wrong randomization|0|||
105794142|NCT03993288|364902169|FG001|Overall Study|wrong randomization|1|||
105794143|NCT03993288|364902168|FG000|Overall Study|improper enrollment|0|||
105794144|NCT03993288|364902169|FG001|Overall Study|improper enrollment|1|||
105794145|NCT03993288|364902168|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
105794146|NCT03993288|364902169|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
105794147|NCT03993288|364902168|FG000|Overall Study|developed SAE|2|||
105794148|NCT03993288|364902169|FG001|Overall Study|developed SAE|0|||
105794149|NCT03993288|364902168|FG000|Overall Study|consent withdrawal|1|||
105794150|NCT03993288|364902169|FG001|Overall Study|consent withdrawal|0|||
105794151|NCT03993288|364902168|FG000|Overall Study|did not follow the treatment schedule|1|||
105794152|NCT03993288|364902169|FG001|Overall Study|did not follow the treatment schedule|0|||
105794153|NCT03993288|364902168|FG000|Overall Study|did not follow the treatment regimen|1|||
105794154|NCT03993288|364902169|FG001|Overall Study|did not follow the treatment regimen|0|||
105794155|NCT03993288|364902168|FG000|Overall Study|Adverse Event|1|||
105794156|NCT03993288|364902169|FG001|Overall Study|Adverse Event|0|||
105794157|NCT03993288|364902168|FG000|Overall Study|Withdrawal by Subject|1|||
105794158|NCT03993288|364902169|FG001|Overall Study|Withdrawal by Subject|1|||
105794159|NCT00915473|364902171|FG000|Screening|Withdrawal by Subject|1|||
105794160|NCT00915473|364902172|FG001|Screening|Withdrawal by Subject|0|||
105794161|NCT00915473|364902171|FG000|4-week Follow Up|Lost to Follow-up|1|||
105794162|NCT00915473|364902172|FG001|4-week Follow Up|Lost to Follow-up|5|||
105794163|NCT03515837|364902173|FG000|Overall Study|Death|219|||
105794164|NCT03515837|364902174|FG001|Overall Study|Death|227|||
105794165|NCT03515837|364902173|FG000|Overall Study|Lost to Follow-up|0|||
105794166|NCT03515837|364902174|FG001|Overall Study|Lost to Follow-up|1|||
105794167|NCT03515837|364902173|FG000|Overall Study|Withdrawal by Subject|0|||
105794168|NCT03515837|364902174|FG001|Overall Study|Withdrawal by Subject|4|||
105794169|NCT03515837|364902173|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
105936565|NCT00066170|365427516|FG003|Overall Study|Adverse Event|7|||
105936566|NCT00066170|365427513|FG000|Overall Study|Serious Adverse Event|0|||
105936567|NCT00066170|365427514|FG001|Overall Study|Serious Adverse Event|0|||
105936568|NCT00066170|365427515|FG002|Overall Study|Serious Adverse Event|1|||
105936569|NCT00066170|365427516|FG003|Overall Study|Serious Adverse Event|1|||
105936570|NCT00066170|365427513|FG000|Overall Study|Lost to Follow-up|0|||
105936571|NCT00066170|365427514|FG001|Overall Study|Lost to Follow-up|1|||
105936572|NCT00066170|365427515|FG002|Overall Study|Lost to Follow-up|0|||
105936573|NCT00066170|365427516|FG003|Overall Study|Lost to Follow-up|0|||
106009486|NCT01207414|365700855|FG001|Overall Study|Lost to Follow-up|17|||
105794170|NCT03515837|364902174|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
105794171|NCT00819091|364902175|FG000|Overall Study|Adverse Event|3|||
105936574|NCT00066170|365427513|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
105936575|NCT00066170|365427514|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
105936576|NCT00066170|365427515|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
105936577|NCT00066170|365427516|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
106009487|NCT01207414|365700854|FG000|Overall Study|Administrative problems|1|||
106009488|NCT01207414|365700855|FG001|Overall Study|Administrative problems|1|||
106009489|NCT01207414|365700854|FG000|Overall Study|Protocol deviation|12|||
105794172|NCT00819091|364902176|FG001|Overall Study|Adverse Event|5|||
105936578|NCT00066170|365427513|FG000|Overall Study|Protocol Violation|3|||
105936579|NCT00066170|365427514|FG001|Overall Study|Protocol Violation|0|||
105936580|NCT00066170|365427515|FG002|Overall Study|Protocol Violation|0|||
105936581|NCT00066170|365427516|FG003|Overall Study|Protocol Violation|0|||
105936582|NCT00066170|365427513|FG000|Overall Study|Other|1|||
105936583|NCT00066170|365427514|FG001|Overall Study|Other|5|||
105936584|NCT00066170|365427515|FG002|Overall Study|Other|2|||
105936585|NCT00066170|365427516|FG003|Overall Study|Other|0|||
105936586|NCT00098293|365427517|FG000|Double-blind (DB) Phase|Adverse Event|14|||
105936587|NCT00098293|365427518|FG001|Double-blind (DB) Phase|Adverse Event|27|||
105936588|NCT00098293|365427519|FG002|Double-blind (DB) Phase|Adverse Event|60|||
105936589|NCT00098293|365427520|FG003|Double-blind (DB) Phase|Adverse Event|0|||
105936590|NCT00098293|365427521|FG004|Double-blind (DB) Phase|Adverse Event|0|||
105936591|NCT00098293|365427517|FG000|Double-blind (DB) Phase|Pregnancy|0|||
105936592|NCT00098293|365427518|FG001|Double-blind (DB) Phase|Pregnancy|7|||
105936593|NCT00098293|365427519|FG002|Double-blind (DB) Phase|Pregnancy|9|||
105936594|NCT00098293|365427520|FG003|Double-blind (DB) Phase|Pregnancy|0|||
105936595|NCT00098293|365427521|FG004|Double-blind (DB) Phase|Pregnancy|0|||
106009490|NCT01207414|365700855|FG001|Overall Study|Protocol deviation|9|||
106009491|NCT01207414|365700854|FG000|Overall Study|Randomized in error|1|||
106009492|NCT01207414|365700855|FG001|Overall Study|Randomized in error|0|||
106009493|NCT03448406|365700856|FG000|Overall Study|Noncompliance of scheduled visits|1|||
106138115|NCT02057718|366164980|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
106138116|NCT02057718|366164979|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
106138117|NCT02057718|366164980|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
106138118|NCT02057718|366164979|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
106138119|NCT02057718|366164980|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
106138120|NCT02057718|366164979|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
106138121|NCT02057718|366164980|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
106138122|NCT02057718|366164979|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
106138123|NCT02057718|366164980|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
106138124|NCT02057718|366164979|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
106138125|NCT02057718|366164980|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
106138126|NCT02057718|366164979|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
106138127|NCT02057718|366164980|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
106138128|NCT02057718|366164979|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
106138129|NCT02057718|366164980|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
106138130|NCT02057718|366164979|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
106138131|NCT02057718|366164980|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
106138132|NCT00880906|366164983|FG000|Overall Study|Lost to Follow-up|0|||
106138133|NCT00880906|366164984|FG001|Overall Study|Lost to Follow-up|1|||
106138134|NCT00880906|366164983|FG000|Overall Study|Did not meet criteria following patholog|12|||
106138135|NCT00880906|366164984|FG001|Overall Study|Did not meet criteria following patholog|6|||
106138136|NCT00544440|366164987|FG000|Overall Study|Other|1|||
106138137|NCT00544440|366164987|FG000|Overall Study|Adverse Event|1|||
106138138|NCT00544440|366164987|FG000|Overall Study|Withdrawal by Subject|2|||
106138139|NCT00544440|366164987|FG000|Overall Study|Subject Non-compliance|1|||
106138140|NCT00544440|366164987|FG000|Overall Study|Progressive Disease|47|||
106138141|NCT00544440|366164987|FG000|Overall Study|Other|5|||
106138142|NCT00591838|366164995|FG000|Overall Study|Withdrawal by Subject|0|||
106138143|NCT00591838|366164996|FG001|Overall Study|Withdrawal by Subject|0|||
106138144|NCT00591838|366164997|FG002|Overall Study|Withdrawal by Subject|0|||
106138145|NCT00591838|366164998|FG003|Overall Study|Withdrawal by Subject|1|||
106138146|NCT00591838|366164999|FG004|Overall Study|Withdrawal by Subject|0|||
106138147|NCT02982213|366165000|FG000|Overall Study|Did not complete follow up questionnaire|5|||
106138148|NCT02982213|366165001|FG001|Overall Study|Did not complete follow up questionnaire|1|||
106138149|NCT02596035|366165002|FG000|Overall Study|Disease Progression|64|||
106138150|NCT02596035|366165003|FG001|Overall Study|Disease Progression|32|||
106138151|NCT02596035|366165004|FG002|Overall Study|Disease Progression|1|||
106138152|NCT02596035|366165002|FG000|Overall Study|study drug toxicity|12|||
106138153|NCT02596035|366165003|FG001|Overall Study|study drug toxicity|3|||
106138154|NCT02596035|366165004|FG002|Overall Study|study drug toxicity|0|||
106138155|NCT02596035|366165002|FG000|Overall Study|AE unrelated to study drug|5|||
106138156|NCT02596035|366165003|FG001|Overall Study|AE unrelated to study drug|2|||
106138157|NCT02596035|366165004|FG002|Overall Study|AE unrelated to study drug|0|||
106138158|NCT02596035|366165002|FG000|Overall Study|participant request to discontinue study treatment|2|||
105936596|NCT00098293|365427517|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
106009494|NCT03448406|365700857|FG001|Overall Study|Noncompliance of scheduled visits|2|||
105936597|NCT00098293|365427518|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
105936598|NCT00098293|365427519|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
105936599|NCT00098293|365427520|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
105936600|NCT00098293|365427521|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
105936601|NCT00098293|365427517|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
105936602|NCT00098293|365427518|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
105936603|NCT00098293|365427519|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
105936604|NCT00098293|365427520|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
105936605|NCT00098293|365427521|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
105936606|NCT00098293|365427517|FG000|Double-blind (DB) Phase|Death|1|||
105936607|NCT00098293|365427518|FG001|Double-blind (DB) Phase|Death|2|||
105936608|NCT00098293|365427519|FG002|Double-blind (DB) Phase|Death|2|||
105936609|NCT00098293|365427520|FG003|Double-blind (DB) Phase|Death|0|||
105936610|NCT00098293|365427521|FG004|Double-blind (DB) Phase|Death|0|||
106138159|NCT02596035|366165003|FG001|Overall Study|participant request to discontinue study treatment|0|||
106138160|NCT02596035|366165004|FG002|Overall Study|participant request to discontinue study treatment|0|||
106138161|NCT02596035|366165002|FG000|Overall Study|participant withdrew consent|2|||
106138162|NCT02596035|366165003|FG001|Overall Study|participant withdrew consent|2|||
106138163|NCT02596035|366165004|FG002|Overall Study|participant withdrew consent|0|||
106138164|NCT02596035|366165002|FG000|Overall Study|Poor/Non Comlpiance|0|||
106138165|NCT02596035|366165003|FG001|Overall Study|Poor/Non Comlpiance|1|||
106138166|NCT02596035|366165004|FG002|Overall Study|Poor/Non Comlpiance|0|||
106138167|NCT02596035|366165002|FG000|Overall Study|participant no longer meets study criteria|1|||
106138168|NCT02596035|366165003|FG001|Overall Study|participant no longer meets study criteria|0|||
106138169|NCT02596035|366165004|FG002|Overall Study|participant no longer meets study criteria|0|||
106138170|NCT02596035|366165002|FG000|Overall Study|other reasons|11|||
106138171|NCT02596035|366165003|FG001|Overall Study|other reasons|4|||
106138172|NCT02596035|366165004|FG002|Overall Study|other reasons|0|||
106138173|NCT03098030|366165015|FG000|Overall Study|Death|10|||
106138174|NCT03098030|366165016|FG001|Overall Study|Death|156|||
106138175|NCT03098030|366165017|FG002|Overall Study|Death|156|||
106138176|NCT03098030|366165018|FG003|Overall Study|Death|82|||
106138177|NCT03098030|366165015|FG000|Overall Study|Withdrawal by Subject|0|||
106138178|NCT03098030|366165016|FG001|Overall Study|Withdrawal by Subject|7|||
106138179|NCT03098030|366165017|FG002|Overall Study|Withdrawal by Subject|8|||
106138180|NCT03098030|366165018|FG003|Overall Study|Withdrawal by Subject|2|||
106138181|NCT03098030|366165015|FG000|Overall Study|Lost to Follow-up|0|||
106138182|NCT03098030|366165016|FG001|Overall Study|Lost to Follow-up|0|||
106138183|NCT03098030|366165017|FG002|Overall Study|Lost to Follow-up|2|||
106138184|NCT03098030|366165018|FG003|Overall Study|Lost to Follow-up|1|||
106138185|NCT01726023|366165024|FG000|Overall Study|Death|1|||
106138186|NCT01726023|366165025|FG001|Overall Study|Death|1|||
105794173|NCT00819091|364902175|FG000|Overall Study|Protocol Violation|0|||
105794174|NCT00819091|364902176|FG001|Overall Study|Protocol Violation|1|||
105936611|NCT00098293|365427517|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
106138187|NCT01726023|366165024|FG000|Overall Study|Lost to Follow-up|5|||
106138188|NCT01726023|366165025|FG001|Overall Study|Lost to Follow-up|10|||
105794175|NCT00819091|364902175|FG000|Overall Study|Lost to Follow-up|2|||
105936612|NCT00098293|365427518|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
106138189|NCT01726023|366165024|FG000|Overall Study|Other Eligibility criteria|7|||
106138190|NCT01726023|366165025|FG001|Overall Study|Other Eligibility criteria|7|||
106138191|NCT01726023|366165024|FG000|Overall Study|Withdrawal by Subject|16|||
106138192|NCT01726023|366165025|FG001|Overall Study|Withdrawal by Subject|8|||
106138193|NCT03394027|366165026|FG000|Overall Study|Ineligible|3|||
106138194|NCT03394027|366165027|FG001|Overall Study|Ineligible|1|||
105794176|NCT00819091|364902176|FG001|Overall Study|Lost to Follow-up|0|||
105794177|NCT00819091|364902175|FG000|Overall Study|Withdrawal by Subject|1|||
105936613|NCT00098293|365427519|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
105936614|NCT00098293|365427520|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
105936615|NCT00098293|365427521|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
105936616|NCT00098293|365427517|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
105936617|NCT00098293|365427518|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
105936618|NCT00098293|365427519|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
105936619|NCT00098293|365427520|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
105936620|NCT00098293|365427521|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
105936621|NCT00098293|365427517|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
105936622|NCT00098293|365427518|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
105936623|NCT00098293|365427519|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
105936624|NCT00098293|365427520|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
105936625|NCT00098293|365427521|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
105936626|NCT00098293|365427517|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
105794178|NCT00819091|364902176|FG001|Overall Study|Withdrawal by Subject|2|||
105794179|NCT00819091|364902175|FG000|Overall Study|Other|1|||
105794180|NCT00819091|364902176|FG001|Overall Study|Other|2|||
105794181|NCT01788163|364902177|FG000|Overall Study|Other|53|||
105794182|NCT01788163|364902178|FG001|Overall Study|Other|0|||
105794183|NCT01788163|364902179|FG002|Overall Study|Other|0|||
105794184|NCT01788163|364902180|FG003|Overall Study|Other|0|||
105794185|NCT01788163|364902181|FG004|Overall Study|Other|0|||
105794186|NCT01788163|364902182|FG005|Overall Study|Other|7|||
105794187|NCT01788163|364902183|FG006|Overall Study|Other|1|||
105794188|NCT01788163|364902184|FG007|Overall Study|Other|48|||
105794189|NCT01788163|364902185|FG008|Overall Study|Other|15|||
105794190|NCT01788163|364902177|FG000|Overall Study|Withdrawal by Subject|2|||
105794191|NCT01788163|364902178|FG001|Overall Study|Withdrawal by Subject|0|||
105794192|NCT01788163|364902179|FG002|Overall Study|Withdrawal by Subject|0|||
105794193|NCT01788163|364902180|FG003|Overall Study|Withdrawal by Subject|0|||
105794194|NCT01788163|364902181|FG004|Overall Study|Withdrawal by Subject|0|||
105794195|NCT01788163|364902182|FG005|Overall Study|Withdrawal by Subject|0|||
105794196|NCT01788163|364902183|FG006|Overall Study|Withdrawal by Subject|0|||
105794197|NCT01788163|364902184|FG007|Overall Study|Withdrawal by Subject|0|||
105794198|NCT01788163|364902185|FG008|Overall Study|Withdrawal by Subject|1|||
105794199|NCT00545441|364902186|FG000|Overall Study|Fistula draining at 6 months|2|||
105794200|NCT00545441|364902187|FG001|Overall Study|Fistula draining at 6 months|4|||
105794201|NCT00545441|364902186|FG000|Overall Study|Lost to Follow-up|9|||
105794202|NCT00545441|364902187|FG001|Overall Study|Lost to Follow-up|5|||
105794203|NCT00545441|364902186|FG000|Overall Study|Technical failure|0|||
105794204|NCT00545441|364902187|FG001|Overall Study|Technical failure|1|||
105794205|NCT00545441|364902186|FG000|Overall Study|Withdrawal by Subject|1|||
105936627|NCT00098293|365427518|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
105936628|NCT00098293|365427519|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
105936629|NCT00098293|365427520|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
105936630|NCT00098293|365427521|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
105936631|NCT00098293|365427517|FG000|Open-label (OL) Phase|Adverse Event|0|||
105936632|NCT00098293|365427518|FG001|Open-label (OL) Phase|Adverse Event|3|||
105936633|NCT00098293|365427519|FG002|Open-label (OL) Phase|Adverse Event|7|||
105936634|NCT00098293|365427520|FG003|Open-label (OL) Phase|Adverse Event|6|||
105936635|NCT00098293|365427521|FG004|Open-label (OL) Phase|Adverse Event|0|||
105936636|NCT00098293|365427517|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
105936637|NCT00098293|365427518|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
105936638|NCT00098293|365427519|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
105936639|NCT00098293|365427520|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
105936640|NCT00098293|365427521|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
105936641|NCT00098293|365427517|FG000|Open-label (OL) Phase|Pregnancy|0|||
105936642|NCT00098293|365427518|FG001|Open-label (OL) Phase|Pregnancy|1|||
105936643|NCT00098293|365427519|FG002|Open-label (OL) Phase|Pregnancy|0|||
105936644|NCT00098293|365427520|FG003|Open-label (OL) Phase|Pregnancy|3|||
105936645|NCT00098293|365427521|FG004|Open-label (OL) Phase|Pregnancy|0|||
105936646|NCT00098293|365427517|FG000|Open-label (OL) Phase|Protocol Violation|0|||
105936647|NCT00098293|365427518|FG001|Open-label (OL) Phase|Protocol Violation|6|||
105936648|NCT00098293|365427519|FG002|Open-label (OL) Phase|Protocol Violation|13|||
106138195|NCT03394027|366165028|FG002|Overall Study|Ineligible|3|||
106138196|NCT03394027|366165026|FG000|Overall Study|Participant declined to participate before treatment started|0|||
106138197|NCT03394027|366165027|FG001|Overall Study|Participant declined to participate before treatment started|0|||
106138198|NCT03394027|366165028|FG002|Overall Study|Participant declined to participate before treatment started|1|||
106138199|NCT04858425|366165029|FG000|Overall Study|Adverse Event|2|||
106138200|NCT04858425|366165030|FG001|Overall Study|Adverse Event|2|||
106138201|NCT04858425|366165029|FG000|Overall Study|Withdrawal by Subject|3|||
106138202|NCT04858425|366165030|FG001|Overall Study|Withdrawal by Subject|1|||
106138203|NCT04858425|366165029|FG000|Overall Study|Lost to Follow-up|4|||
106138204|NCT04858425|366165030|FG001|Overall Study|Lost to Follow-up|2|||
106138205|NCT04858425|366165029|FG000|Overall Study|Lost to Follow-up|1|||
106138206|NCT04858425|366165030|FG001|Overall Study|Lost to Follow-up|0|||
106138207|NCT03368001|366165031|FG000|Allocation|Lost to Pretest|16|||
106138208|NCT03368001|366165032|FG001|Allocation|Lost to Pretest|25|||
106138209|NCT03368001|366165031|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
106138210|NCT03368001|366165032|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
106138211|NCT03368001|366165031|FG000|Posttest|Lost to Posttest|7|||
106138212|NCT03368001|366165032|FG001|Posttest|Lost to Posttest|11|||
105936649|NCT00098293|365427520|FG003|Open-label (OL) Phase|Protocol Violation|16|||
105936650|NCT00098293|365427521|FG004|Open-label (OL) Phase|Protocol Violation|0|||
105936651|NCT00098293|365427517|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
105936652|NCT00098293|365427518|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
105936653|NCT00098293|365427519|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
105936654|NCT00098293|365427520|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
105936655|NCT00098293|365427521|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
105936656|NCT00098293|365427517|FG000|Open-label (OL) Phase|Death|0|||
105936657|NCT00098293|365427518|FG001|Open-label (OL) Phase|Death|2|||
105936658|NCT00098293|365427519|FG002|Open-label (OL) Phase|Death|3|||
105936659|NCT00098293|365427520|FG003|Open-label (OL) Phase|Death|0|||
105936660|NCT00098293|365427521|FG004|Open-label (OL) Phase|Death|0|||
105936661|NCT00098293|365427517|FG000|Supplemental Phase (SP)|Death|0|||
105936662|NCT00098293|365427518|FG001|Supplemental Phase (SP)|Death|0|||
105936663|NCT00098293|365427519|FG002|Supplemental Phase (SP)|Death|0|||
105936664|NCT00098293|365427520|FG003|Supplemental Phase (SP)|Death|0|||
106138213|NCT03368001|366165031|FG000|Posttest|Discontinued Intervention|6|||
106138214|NCT03368001|366165032|FG001|Posttest|Discontinued Intervention|19|||
106138215|NCT03368001|366165031|FG000|Follow-up|Lost to Follow-up|6|||
106138216|NCT03368001|366165032|FG001|Follow-up|Lost to Follow-up|3|||
106138217|NCT02197234|366165033|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
106138218|NCT02197234|366165033|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
106138219|NCT02197234|366165033|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
106138220|NCT02197234|366165033|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
106138221|NCT02197234|366165033|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
106138222|NCT02197234|366165033|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
106138223|NCT04391309|366165034|FG000|Overall Study|Death|1|||
106138224|NCT04391309|366165035|FG001|Overall Study|Death|1|||
106138225|NCT04391309|366165034|FG000|Overall Study|Lost to Follow-up|3|||
106138226|NCT04391309|366165035|FG001|Overall Study|Lost to Follow-up|2|||
106138227|NCT04391309|366165034|FG000|Overall Study|Withdrawal by Subject|2|||
106138228|NCT04391309|366165035|FG001|Overall Study|Withdrawal by Subject|2|||
106138229|NCT02781584|366165036|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
106138230|NCT02781584|366165037|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
106138231|NCT02781584|366165038|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
106138232|NCT02781584|366165039|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
106138233|NCT02781584|366165040|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
106138234|NCT02781584|366165041|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
106138235|NCT02781584|366165042|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
106138236|NCT02781584|366165043|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
106138237|NCT02781584|366165044|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
106138238|NCT02781584|366165045|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
106138239|NCT02781584|366165046|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
106138240|NCT02781584|366165047|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
106138241|NCT02781584|366165048|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
106138242|NCT02781584|366165036|FG000|Pre-treatment Phase|Adverse Event|0|||
106138243|NCT02781584|366165037|FG001|Pre-treatment Phase|Adverse Event|0|||
106138244|NCT02781584|366165038|FG002|Pre-treatment Phase|Adverse Event|0|||
106138245|NCT02781584|366165039|FG003|Pre-treatment Phase|Adverse Event|0|||
106138246|NCT02781584|366165040|FG004|Pre-treatment Phase|Adverse Event|0|||
106138247|NCT02781584|366165041|FG005|Pre-treatment Phase|Adverse Event|0|||
106138248|NCT02781584|366165042|FG006|Pre-treatment Phase|Adverse Event|0|||
106138249|NCT02781584|366165043|FG007|Pre-treatment Phase|Adverse Event|0|||
106138250|NCT02781584|366165044|FG008|Pre-treatment Phase|Adverse Event|0|||
106138251|NCT02781584|366165045|FG009|Pre-treatment Phase|Adverse Event|0|||
106138252|NCT02781584|366165046|FG010|Pre-treatment Phase|Adverse Event|0|||
106138253|NCT02781584|366165047|FG011|Pre-treatment Phase|Adverse Event|1|||
106138254|NCT02781584|366165048|FG012|Pre-treatment Phase|Adverse Event|0|||
106138255|NCT02781584|366165036|FG000|Treatment Phase|Withdrew Consent|0|||
106138256|NCT02781584|366165037|FG001|Treatment Phase|Withdrew Consent|0|||
106138257|NCT02781584|366165038|FG002|Treatment Phase|Withdrew Consent|0|||
106138258|NCT02781584|366165039|FG003|Treatment Phase|Withdrew Consent|0|||
106138259|NCT02781584|366165040|FG004|Treatment Phase|Withdrew Consent|0|||
106138260|NCT02781584|366165041|FG005|Treatment Phase|Withdrew Consent|1|||
106138261|NCT02781584|366165042|FG006|Treatment Phase|Withdrew Consent|0|||
106138262|NCT02781584|366165043|FG007|Treatment Phase|Withdrew Consent|0|||
105794206|NCT00545441|364902187|FG001|Overall Study|Withdrawal by Subject|1|||
105794207|NCT00545441|364902186|FG000|Overall Study|Persistence or recurrence of fistula|5|||
106138263|NCT02781584|366165044|FG008|Treatment Phase|Withdrew Consent|0|||
106138264|NCT02781584|366165045|FG009|Treatment Phase|Withdrew Consent|0|||
106138265|NCT02781584|366165046|FG010|Treatment Phase|Withdrew Consent|1|||
106138266|NCT02781584|366165047|FG011|Treatment Phase|Withdrew Consent|2|||
106138267|NCT02781584|366165048|FG012|Treatment Phase|Withdrew Consent|0|||
106138268|NCT02781584|366165036|FG000|Treatment Phase|Adverse Event|0|||
106138269|NCT02781584|366165037|FG001|Treatment Phase|Adverse Event|0|||
105936665|NCT00098293|365427521|FG004|Supplemental Phase (SP)|Death|1|||
105936666|NCT00098293|365427517|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
105936667|NCT00098293|365427518|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
105936668|NCT00098293|365427519|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
105936669|NCT00098293|365427520|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
105936670|NCT00098293|365427521|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
105936671|NCT00098293|365427517|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
105936672|NCT00098293|365427518|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
105936673|NCT00098293|365427519|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
105936674|NCT00098293|365427520|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
105936675|NCT00098293|365427521|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
105936676|NCT00098293|365427517|FG000|Supplemental Phase (SP)|Other|0|||
105936677|NCT00098293|365427518|FG001|Supplemental Phase (SP)|Other|0|||
105936678|NCT00098293|365427519|FG002|Supplemental Phase (SP)|Other|0|||
105726377|NCT00538681|364653533|FG003|Overall Study|Progressive Disease|0|||
105726378|NCT00538681|364653530|FG000|Overall Study|Sponsor Decision|1|||
105726379|NCT00538681|364653531|FG001|Overall Study|Sponsor Decision|3|||
105726380|NCT00538681|364653532|FG002|Overall Study|Sponsor Decision|8|||
105726381|NCT00538681|364653533|FG003|Overall Study|Sponsor Decision|9|||
105726382|NCT00538681|364653530|FG000|Overall Study|Adverse Event|1|||
105726383|NCT00538681|364653531|FG001|Overall Study|Adverse Event|1|||
105726384|NCT00538681|364653532|FG002|Overall Study|Adverse Event|1|||
105726385|NCT00538681|364653533|FG003|Overall Study|Adverse Event|0|||
105726386|NCT00538681|364653530|FG000|Overall Study|Death|0|||
105726387|NCT00538681|364653531|FG001|Overall Study|Death|0|||
105726388|NCT00538681|364653532|FG002|Overall Study|Death|1|||
105726389|NCT00538681|364653533|FG003|Overall Study|Death|1|||
105726390|NCT00538681|364653530|FG000|Overall Study|Investigator Decision|0|||
105726391|NCT00538681|364653531|FG001|Overall Study|Investigator Decision|0|||
105726392|NCT00538681|364653532|FG002|Overall Study|Investigator Decision|0|||
105726393|NCT00538681|364653533|FG003|Overall Study|Investigator Decision|1|||
105726394|NCT05369806|364653538|FG000|Overall Study|Lost to Follow-up|1|||
105726395|NCT02370121|364653542|FG000|Overall Study|Lost to Follow-up|1|||
105726396|NCT02370121|364653543|FG001|Overall Study|Lost to Follow-up|1|||
105726397|NCT01392183|364653547|FG000|First Drug Administration|Adverse Event|3|||
105726398|NCT01392183|364653548|FG001|First Drug Administration|Adverse Event|2|||
105726399|NCT01392183|364653547|FG000|First Drug Administration|Death|1|||
105726400|NCT01392183|364653548|FG001|First Drug Administration|Death|0|||
105726401|NCT01392183|364653547|FG000|First Drug Administration|Withdrawal by Subject|10|||
105726402|NCT01392183|364653548|FG001|First Drug Administration|Withdrawal by Subject|17|||
105936679|NCT00098293|365427520|FG003|Supplemental Phase (SP)|Other|0|||
105726403|NCT04321343|364653549|FG000|Overall Study|Adverse Event|0|||
105726404|NCT04321343|364653550|FG001|Overall Study|Adverse Event|0|||
105726405|NCT04321343|364653551|FG002|Overall Study|Adverse Event|1|||
105726406|NCT04321343|364653552|FG003|Overall Study|Adverse Event|0|||
105726407|NCT04321343|364653549|FG000|Overall Study|Death|0|||
105726408|NCT04321343|364653550|FG001|Overall Study|Death|0|||
105936680|NCT00098293|365427521|FG004|Supplemental Phase (SP)|Other|22|||
105936681|NCT02294019|365427524|FG000|Overall Study|Adverse Event|2|||
106138270|NCT02781584|366165038|FG002|Treatment Phase|Adverse Event|0|||
106138271|NCT02781584|366165039|FG003|Treatment Phase|Adverse Event|0|||
106138272|NCT02781584|366165040|FG004|Treatment Phase|Adverse Event|0|||
106138273|NCT02781584|366165041|FG005|Treatment Phase|Adverse Event|0|||
106138274|NCT02781584|366165042|FG006|Treatment Phase|Adverse Event|0|||
106138275|NCT02781584|366165043|FG007|Treatment Phase|Adverse Event|1|||
106138276|NCT02781584|366165044|FG008|Treatment Phase|Adverse Event|0|||
106138277|NCT02781584|366165045|FG009|Treatment Phase|Adverse Event|0|||
106138278|NCT02781584|366165046|FG010|Treatment Phase|Adverse Event|0|||
106138279|NCT02781584|366165047|FG011|Treatment Phase|Adverse Event|0|||
106138280|NCT02781584|366165048|FG012|Treatment Phase|Adverse Event|0|||
106138281|NCT04340362|366165051|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
106138282|NCT02104765|366165056|FG000|Overall Study|Lost to Follow-up|0|||
106138283|NCT02104765|366165057|FG001|Overall Study|Lost to Follow-up|0|||
106138284|NCT02104765|366165058|FG002|Overall Study|Lost to Follow-up|1|||
106138285|NCT02104765|366165059|FG003|Overall Study|Lost to Follow-up|0|||
106138286|NCT02104765|366165060|FG004|Overall Study|Lost to Follow-up|0|||
106138287|NCT02104765|366165061|FG005|Overall Study|Lost to Follow-up|0|||
106138288|NCT02104765|366165062|FG006|Overall Study|Lost to Follow-up|0|||
106138289|NCT02104765|366165056|FG000|Overall Study|Withdrawal by Subject|0|||
106138290|NCT02104765|366165057|FG001|Overall Study|Withdrawal by Subject|0|||
105726409|NCT04321343|364653551|FG002|Overall Study|Death|0|||
105726410|NCT04321343|364653552|FG003|Overall Study|Death|1|||
105726411|NCT04321343|364653549|FG000|Overall Study|Pregnancy|1|||
105726412|NCT04321343|364653550|FG001|Overall Study|Pregnancy|0|||
105726413|NCT04321343|364653551|FG002|Overall Study|Pregnancy|0|||
105726414|NCT04321343|364653552|FG003|Overall Study|Pregnancy|0|||
105726415|NCT04321343|364653549|FG000|Overall Study|Protocol Violation|1|||
105726416|NCT04321343|364653550|FG001|Overall Study|Protocol Violation|1|||
105726417|NCT04321343|364653551|FG002|Overall Study|Protocol Violation|1|||
105726418|NCT04321343|364653552|FG003|Overall Study|Protocol Violation|1|||
105726419|NCT04321343|364653549|FG000|Overall Study|Withdrawal by Subject|0|||
105726420|NCT04321343|364653550|FG001|Overall Study|Withdrawal by Subject|6|||
105726421|NCT04321343|364653551|FG002|Overall Study|Withdrawal by Subject|0|||
105726422|NCT04321343|364653552|FG003|Overall Study|Withdrawal by Subject|2|||
105726423|NCT04321343|364653549|FG000|Overall Study|Lost to Follow-up|2|||
105726424|NCT04321343|364653550|FG001|Overall Study|Lost to Follow-up|2|||
105726425|NCT04321343|364653551|FG002|Overall Study|Lost to Follow-up|1|||
105726426|NCT04321343|364653552|FG003|Overall Study|Lost to Follow-up|3|||
105726427|NCT03476239|364653554|FG000|Overall Study|Withdrawal by Subject|10|||
105726428|NCT03476239|364653554|FG000|Overall Study|Death|80|||
105726429|NCT03476239|364653554|FG000|Overall Study|Lost to Follow-up|8|||
105726430|NCT02328014|364655475|FG000|Overall Study|Adverse Event|1|||
105726431|NCT02328014|364655476|FG001|Overall Study|Adverse Event|0|||
105726432|NCT02328014|364655477|FG002|Overall Study|Adverse Event|0|||
105794208|NCT00545441|364902187|FG001|Overall Study|Persistence or recurrence of fistula|2|||
105794209|NCT00545441|364902186|FG000|Overall Study|Patients were not treated|1|||
105936682|NCT02294019|365427524|FG000|Overall Study|Protocol Violation|68|||
105936683|NCT02294019|365427524|FG000|Overall Study|Lost to Follow-up|31|||
106138291|NCT02104765|366165058|FG002|Overall Study|Withdrawal by Subject|0|||
106138292|NCT02104765|366165059|FG003|Overall Study|Withdrawal by Subject|1|||
106138293|NCT02104765|366165060|FG004|Overall Study|Withdrawal by Subject|1|||
105726433|NCT02328014|364655478|FG003|Overall Study|Adverse Event|1|||
105726434|NCT02328014|364655475|FG000|Overall Study|Death|0|||
105726435|NCT02328014|364655476|FG001|Overall Study|Death|0|||
105726436|NCT02328014|364655477|FG002|Overall Study|Death|0|||
105794210|NCT00545441|364902187|FG001|Overall Study|Patients were not treated|3|||
105726437|NCT02328014|364655478|FG003|Overall Study|Death|4|||
105726438|NCT02328014|364655475|FG000|Overall Study|Physician Decision|0|||
106138294|NCT02104765|366165061|FG005|Overall Study|Withdrawal by Subject|0|||
106138295|NCT02104765|366165062|FG006|Overall Study|Withdrawal by Subject|1|||
106138296|NCT02357784|366165063|FG000|Overall Study|Withdrawal by Subject|1|||
106138297|NCT00995709|366165066|FG000|Overall Study|Adverse Event|4|||
106138298|NCT00995709|366165067|FG001|Overall Study|Adverse Event|2|||
106138299|NCT00995709|366165068|FG002|Overall Study|Adverse Event|0|||
106138300|NCT00995709|366165066|FG000|Overall Study|Lack of Efficacy|0|||
106138301|NCT00995709|366165067|FG001|Overall Study|Lack of Efficacy|1|||
106138302|NCT00995709|366165068|FG002|Overall Study|Lack of Efficacy|4|||
106138303|NCT00995709|366165066|FG000|Overall Study|Withdrawal by Subject|0|||
106138304|NCT00995709|366165067|FG001|Overall Study|Withdrawal by Subject|4|||
106138305|NCT00995709|366165068|FG002|Overall Study|Withdrawal by Subject|1|||
106009495|NCT03448406|365700856|FG000|Overall Study|Withdrawal by Subject|1|||
106009496|NCT03448406|365700857|FG001|Overall Study|Withdrawal by Subject|2|||
106009497|NCT03448406|365700856|FG000|Overall Study|Protocol Violation|1|||
106009498|NCT03448406|365700857|FG001|Overall Study|Protocol Violation|0|||
106009499|NCT03448406|365700856|FG000|Overall Study|Adverse Event|8|||
106138306|NCT00995709|366165066|FG000|Overall Study|Lost to Follow-up|1|||
106009500|NCT03448406|365700857|FG001|Overall Study|Adverse Event|9|||
106009501|NCT01292486|365700858|FG000|Overall Study|Protocol Violation|2|||
106009502|NCT01292486|365700858|FG000|Overall Study|Did not meet screening criteria|2|||
106009503|NCT01292486|365700858|FG000|Overall Study|Adverse Event|1|||
106138307|NCT00995709|366165067|FG001|Overall Study|Lost to Follow-up|0|||
105726439|NCT02328014|364655476|FG001|Overall Study|Physician Decision|0|||
105726440|NCT02328014|364655477|FG002|Overall Study|Physician Decision|0|||
106009504|NCT01292486|365700858|FG000|Overall Study|Physician Decision|1|||
105726441|NCT02328014|364655478|FG003|Overall Study|Physician Decision|1|||
105726442|NCT02328014|364655475|FG000|Overall Study|Disease Progression|1|||
105726443|NCT02328014|364655476|FG001|Overall Study|Disease Progression|0|||
105726444|NCT02328014|364655477|FG002|Overall Study|Disease Progression|1|||
105726445|NCT02328014|364655478|FG003|Overall Study|Disease Progression|3|||
105726446|NCT02328014|364655475|FG000|Overall Study|Study Terminated by Sponsor|4|||
105794211|NCT03443973|364902188|FG000|Double-blind Treatment Period|Adverse Event|5|||
106009505|NCT01435382|365700861|FG000|Overall Study|Lost to Follow-up|1|||
105794212|NCT03443973|364902189|FG001|Double-blind Treatment Period|Adverse Event|19|||
106009506|NCT01435382|365700862|FG001|Overall Study|Lost to Follow-up|0|||
106138308|NCT00995709|366165068|FG002|Overall Study|Lost to Follow-up|0|||
106138309|NCT00995709|366165066|FG000|Overall Study|Death|0|||
106138310|NCT00995709|366165067|FG001|Overall Study|Death|1|||
105726447|NCT02328014|364655476|FG001|Overall Study|Study Terminated by Sponsor|1|||
105726448|NCT02328014|364655477|FG002|Overall Study|Study Terminated by Sponsor|1|||
105726449|NCT02328014|364655478|FG003|Overall Study|Study Terminated by Sponsor|0|||
105726450|NCT02328014|364655475|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
105726451|NCT02328014|364655476|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
105726452|NCT02328014|364655477|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
105726453|NCT02328014|364655478|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
105726454|NCT02328014|364655475|FG000|Overall Study|Withdrawal by Subject|0|||
105726455|NCT02328014|364655476|FG001|Overall Study|Withdrawal by Subject|0|||
105726456|NCT02328014|364655477|FG002|Overall Study|Withdrawal by Subject|0|||
105726457|NCT02328014|364655478|FG003|Overall Study|Withdrawal by Subject|1|||
105726458|NCT01431287|364655479|FG000|Overall Study|not treated|0|||
105726459|NCT01431287|364655480|FG001|Overall Study|not treated|0|||
105726460|NCT01431287|364655481|FG002|Overall Study|not treated|1|||
105726461|NCT01431287|364655482|FG003|Overall Study|not treated|0|||
105726462|NCT01431287|364655483|FG004|Overall Study|not treated|0|||
105726463|NCT01431287|364655479|FG000|Overall Study|Adverse Event|59|||
106138311|NCT00995709|366165068|FG002|Overall Study|Death|0|||
106138312|NCT00995709|366165066|FG000|Overall Study|Protocol Violation|2|||
106138313|NCT00995709|366165067|FG001|Overall Study|Protocol Violation|1|||
106138314|NCT00995709|366165068|FG002|Overall Study|Protocol Violation|0|||
106138315|NCT02698241|366165080|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
106138316|NCT02698241|366165080|FG000|Overall Study|Screening not met|7|||
106138317|NCT02698241|366165080|FG000|Overall Study|Withdrawal by Subject|7|||
106138318|NCT02698241|366165080|FG000|Overall Study|Physician Decision|2|||
106138319|NCT02698241|366165080|FG000|Overall Study|Subject underwent system modification|2|||
106138320|NCT02698241|366165080|FG000|Overall Study|Lost to Follow-up|3|||
106138321|NCT02698241|366165080|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
106138322|NCT02698241|366165080|FG000|Overall Study|geographic and licensing issue|1|||
106138323|NCT02698241|366165080|FG000|Overall Study|Death|2|||
106138324|NCT01837641|366165083|FG000|Overall Study|Sponsor decision|1|||
106138325|NCT01837641|366165084|FG001|Overall Study|Sponsor decision|0|||
106138326|NCT01837641|366165085|FG002|Overall Study|Sponsor decision|0|||
106138327|NCT01837641|366165086|FG003|Overall Study|Sponsor decision|0|||
106138328|NCT01837641|366165087|FG004|Overall Study|Sponsor decision|0|||
106138329|NCT01837641|366165088|FG005|Overall Study|Sponsor decision|1|||
106138330|NCT01837641|366165089|FG006|Overall Study|Sponsor decision|0|||
106138331|NCT01837641|366165090|FG007|Overall Study|Sponsor decision|0|||
106138332|NCT01837641|366165083|FG000|Overall Study|Adverse Event|0|||
106138333|NCT01837641|366165084|FG001|Overall Study|Adverse Event|0|||
106138334|NCT01837641|366165085|FG002|Overall Study|Adverse Event|0|||
106138335|NCT01837641|366165086|FG003|Overall Study|Adverse Event|0|||
106138336|NCT01837641|366165087|FG004|Overall Study|Adverse Event|0|||
106138337|NCT01837641|366165088|FG005|Overall Study|Adverse Event|1|||
106138338|NCT01837641|366165089|FG006|Overall Study|Adverse Event|0|||
106138339|NCT01837641|366165090|FG007|Overall Study|Adverse Event|0|||
106138340|NCT01837641|366165083|FG000|Overall Study|Withdrawal by Subject|0|||
106138341|NCT01837641|366165084|FG001|Overall Study|Withdrawal by Subject|0|||
106138342|NCT01837641|366165085|FG002|Overall Study|Withdrawal by Subject|0|||
106138343|NCT01837641|366165086|FG003|Overall Study|Withdrawal by Subject|0|||
106138344|NCT01837641|366165087|FG004|Overall Study|Withdrawal by Subject|1|||
106138345|NCT01837641|366165088|FG005|Overall Study|Withdrawal by Subject|0|||
106138346|NCT01837641|366165089|FG006|Overall Study|Withdrawal by Subject|1|||
106138347|NCT01837641|366165090|FG007|Overall Study|Withdrawal by Subject|0|||
106138348|NCT01838551|366165092|FG000|Overall Study|Adverse Event|16|||
106138349|NCT01838551|366165092|FG000|Overall Study|Death|1|||
106138350|NCT01838551|366165092|FG000|Overall Study|Lack of Efficacy|10|||
106138351|NCT01838551|366165092|FG000|Overall Study|Physician Decision|4|||
106138352|NCT01838551|366165092|FG000|Overall Study|Withdrawal by Subject|10|||
106138353|NCT01838551|366165092|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
106138354|NCT01773122|366165093|FG000|Overall Study|Due to amended age eligibility criteria|3|||
106138355|NCT01773122|366165094|FG001|Overall Study|Due to amended age eligibility criteria|1|||
106138356|NCT01773122|366165095|FG002|Overall Study|Due to amended age eligibility criteria|0|||
106138357|NCT01773122|366165096|FG003|Overall Study|Due to amended age eligibility criteria|1|||
106138358|NCT02540213|366165097|FG000|Overall Study|Death/adverse event|18|||
106138359|NCT02540213|366165097|FG000|Overall Study|Administrative reasons|3|||
106138360|NCT02540213|366165097|FG000|Overall Study|Kidney transplant|3|||
106138361|NCT02540213|366165097|FG000|Overall Study|Lack of Efficacy|6|||
106138362|NCT02540213|366165097|FG000|Overall Study|Consent withdrawn|7|||
105726464|NCT01431287|364655480|FG001|Overall Study|Adverse Event|57|||
105726465|NCT01431287|364655481|FG002|Overall Study|Adverse Event|53|||
105726466|NCT01431287|364655482|FG003|Overall Study|Adverse Event|33|||
105726467|NCT01431287|364655483|FG004|Overall Study|Adverse Event|41|||
105936684|NCT02294019|365427524|FG000|Overall Study|Other|1|||
106138363|NCT02540213|366165097|FG000|Overall Study|Enrolled but not treated|2|||
106138364|NCT02289560|366165098|FG000|Overall Study|Lost to Follow-up|6|||
106138365|NCT02289560|366165098|FG000|Overall Study|Alternative Treatment|4|||
105794213|NCT03443973|364902190|FG002|Double-blind Treatment Period|Adverse Event|0|||
105794214|NCT03443973|364902191|FG003|Double-blind Treatment Period|Adverse Event|0|||
105794215|NCT03443973|364902188|FG000|Double-blind Treatment Period|Death|5|||
105794216|NCT03443973|364902189|FG001|Double-blind Treatment Period|Death|7|||
105794217|NCT03443973|364902190|FG002|Double-blind Treatment Period|Death|0|||
105794218|NCT03443973|364902191|FG003|Double-blind Treatment Period|Death|0|||
105794219|NCT03443973|364902188|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
105794220|NCT03443973|364902189|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
105794221|NCT03443973|364902190|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
105794222|NCT03443973|364902191|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
105794223|NCT03443973|364902188|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105794224|NCT03443973|364902189|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
105794225|NCT03443973|364902190|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105794226|NCT03443973|364902191|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
105794227|NCT03443973|364902188|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
105794228|NCT03443973|364902189|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
106009507|NCT01435382|365700863|FG002|Overall Study|Lost to Follow-up|1|||
105794229|NCT03443973|364902190|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
105936685|NCT02294019|365427524|FG000|Overall Study|Withdrawal by Subject|1|||
105936686|NCT02554474|365427525|FG000|Overall Study|Protocol Violation|1|||
105936687|NCT02554474|365427526|FG001|Overall Study|Protocol Violation|1|||
105936688|NCT02554474|365427525|FG000|Overall Study|Health issue not related to the study|1|||
105936689|NCT02554474|365427526|FG001|Overall Study|Health issue not related to the study|0|||
105936690|NCT02554474|365427525|FG000|Overall Study|Withdrawal by Subject|1|||
105936691|NCT02554474|365427526|FG001|Overall Study|Withdrawal by Subject|1|||
105936692|NCT00563316|365427527|FG000|Overall Study|Adverse Event|2|||
106138366|NCT02289560|366165098|FG000|Overall Study|Inadequate Treatment|2|||
106138367|NCT02289560|366165098|FG000|Overall Study|Withdrawal by Subject|23|||
106138368|NCT01144182|366165099|FG000|Overall Study|Death|5|||
106138369|NCT01144182|366165100|FG001|Overall Study|Death|6|||
106138370|NCT01144182|366165099|FG000|Overall Study|Withdrawal by Subject|3|||
106138371|NCT01144182|366165100|FG001|Overall Study|Withdrawal by Subject|6|||
106138372|NCT01144182|366165099|FG000|Overall Study|Lost to Follow-up|9|||
106138373|NCT01144182|366165100|FG001|Overall Study|Lost to Follow-up|9|||
106138374|NCT02351180|366165105|FG000|Overall Study|Withdrawal by Subject|1|||
106138375|NCT02351180|366165106|FG001|Overall Study|Withdrawal by Subject|0|||
106138376|NCT01510912|366166916|FG000|Overall Study|Adverse Event|99|||
106138377|NCT01510912|366166916|FG000|Overall Study|Lack of Efficacy|12|||
106138378|NCT01510912|366166916|FG000|Overall Study|Non-compliance with trial drug|23|||
106138379|NCT01510912|366166916|FG000|Overall Study|Withdrawal by Subject|49|||
106138380|NCT01510912|366166916|FG000|Overall Study|Physician Decision|1|||
106138381|NCT01510912|366166916|FG000|Overall Study|Protocol Violation|27|||
106138382|NCT01510912|366166916|FG000|Overall Study|Lost to Follow-up|26|||
106138383|NCT01510912|366166916|FG000|Overall Study|Other, including joint replacement|5|||
106138384|NCT00777556|366166918|FG000|Overall Study|Inappropriate self-selection|34|||
106138385|NCT00777556|366166918|FG000|Overall Study|Dispensed but did not use product|12|||
106138386|NCT00777556|366166918|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
106138387|NCT02689349|366166922|FG000|Overall Study|Not implanted|4|||
106138388|NCT02689349|366166923|FG001|Overall Study|Not implanted|0|||
106138389|NCT02689349|366166922|FG000|Overall Study|Withdrawal by Subject|9|||
106138390|NCT02689349|366166923|FG001|Overall Study|Withdrawal by Subject|0|||
106138391|NCT00954707|366166924|FG000|Overall Study|Death|34|||
106138392|NCT00954707|366166924|FG000|Overall Study|Withdrawal by Subject|100|||
106138393|NCT00954707|366166924|FG000|Overall Study|Lost to Follow-up|33|||
106138394|NCT00309452|366166925|FG000|Overall Study|Withdrawal by Subject|3|||
106138395|NCT00309452|366166926|FG001|Overall Study|Withdrawal by Subject|0|||
106138396|NCT01977612|366166932|FG000|Overall Study|Lost to Follow-up|1|||
106138397|NCT01977612|366166933|FG001|Overall Study|Lost to Follow-up|1|||
106138398|NCT01451814|366166934|FG000|Overall Study|Withdrawal by Subject|1|||
106138399|NCT01451814|366166935|FG001|Overall Study|Withdrawal by Subject|1|||
106138400|NCT01451814|366166934|FG000|Overall Study|Lost to Follow-up|5|||
106138401|NCT01451814|366166935|FG001|Overall Study|Lost to Follow-up|4|||
106138402|NCT01259102|366166938|FG000|Overall Study|Adverse Event|1|||
106138403|NCT01259102|366166939|FG001|Overall Study|Adverse Event|0|||
106138404|NCT01259102|366166940|FG002|Overall Study|Adverse Event|1|||
106138405|NCT01259102|366166941|FG003|Overall Study|Adverse Event|1|||
106138406|NCT01259102|366166942|FG004|Overall Study|Adverse Event|0|||
106138407|NCT01259102|366166938|FG000|Overall Study|Other|0|||
106138408|NCT01259102|366166939|FG001|Overall Study|Other|0|||
106138409|NCT01259102|366166940|FG002|Overall Study|Other|1|||
106138410|NCT01259102|366166941|FG003|Overall Study|Other|1|||
106138411|NCT01259102|366166942|FG004|Overall Study|Other|1|||
106138412|NCT01803646|366166943|FG000|Overall Study|Protocol Violation|1|||
106138413|NCT01803646|366166944|FG001|Overall Study|Protocol Violation|0|||
106138414|NCT01803646|366166943|FG000|Overall Study|Adverse Event|1|||
106138415|NCT01803646|366166944|FG001|Overall Study|Adverse Event|1|||
106138416|NCT01803646|366166943|FG000|Overall Study|Withdrawal by Subject|9|||
106138417|NCT01803646|366166944|FG001|Overall Study|Withdrawal by Subject|6|||
106138418|NCT01803646|366166943|FG000|Overall Study|Randomization error|1|||
106138419|NCT01803646|366166944|FG001|Overall Study|Randomization error|2|||
106138420|NCT01803646|366166943|FG000|Overall Study|Lost to Follow-up|5|||
106138421|NCT01803646|366166944|FG001|Overall Study|Lost to Follow-up|1|||
106138422|NCT01956669|366166946|FG000|Overall Study|Disease Progression|12|||
106138423|NCT01956669|366166947|FG001|Overall Study|Disease Progression|7|||
106138424|NCT01956669|366166948|FG002|Overall Study|Disease Progression|7|||
106138425|NCT01956669|366166949|FG003|Overall Study|Disease Progression|8|||
106138426|NCT01956669|366166950|FG004|Overall Study|Disease Progression|4|||
106138427|NCT01956669|366166951|FG005|Overall Study|Disease Progression|3|||
106138428|NCT01956669|366166952|FG006|Overall Study|Disease Progression|5|||
106138429|NCT01956669|366166946|FG000|Overall Study|Adverse Event|0|||
106138430|NCT01956669|366166947|FG001|Overall Study|Adverse Event|2|||
106138431|NCT01956669|366166948|FG002|Overall Study|Adverse Event|2|||
106138432|NCT01956669|366166949|FG003|Overall Study|Adverse Event|1|||
105936693|NCT00563316|365427527|FG000|Overall Study|Physician Decision|1|||
105936694|NCT00563316|365427527|FG000|Overall Study|Lost to Follow-up|2|||
105936695|NCT00563316|365427527|FG000|Overall Study|Death|1|||
106138433|NCT01956669|366166950|FG004|Overall Study|Adverse Event|0|||
105794230|NCT03443973|364902191|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
105794231|NCT03443973|364902188|FG000|Double-blind Treatment Period|Physician Decision|5|||
105794232|NCT03443973|364902189|FG001|Double-blind Treatment Period|Physician Decision|6|||
105794233|NCT03443973|364902190|FG002|Double-blind Treatment Period|Physician Decision|0|||
105794234|NCT03443973|364902191|FG003|Double-blind Treatment Period|Physician Decision|0|||
105794235|NCT03443973|364902188|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
105794236|NCT03443973|364902189|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
105794237|NCT03443973|364902190|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
105794238|NCT03443973|364902191|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
105794239|NCT03443973|364902188|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
105936696|NCT00563316|365427527|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
105936697|NCT00563316|365427527|FG000|Overall Study|Other|1|||
105936698|NCT02774278|365427530|FG000|Overall Study|Lack of Efficacy|199|||
105936699|NCT02774278|365427530|FG000|Overall Study|Death|29|||
105936700|NCT02774278|365427530|FG000|Overall Study|Adverse event/intercurrent illness|16|||
105936701|NCT02774278|365427530|FG000|Overall Study|Refused treatment/did not cooperate|9|||
105936702|NCT02774278|365427530|FG000|Overall Study|Administrative reasons|6|||
105936703|NCT02774278|365427530|FG000|Overall Study|Withdrawal by Subject|3|||
105936704|NCT02774278|365427530|FG000|Overall Study|Protocol Violation|2|||
105936705|NCT01539525|365427531|FG000|Overall Study|Lost to Follow-up|19|||
105936706|NCT01539525|365427532|FG001|Overall Study|Lost to Follow-up|12|||
105936707|NCT01539525|365427533|FG002|Overall Study|Lost to Follow-up|11|||
105936708|NCT01539525|365427531|FG000|Overall Study|Withdrawal by Subject|0|||
105936709|NCT01539525|365427532|FG001|Overall Study|Withdrawal by Subject|3|||
105936710|NCT01539525|365427533|FG002|Overall Study|Withdrawal by Subject|2|||
105936711|NCT01539525|365427531|FG000|Overall Study|Protocol Violation|1|||
105936712|NCT01539525|365427532|FG001|Overall Study|Protocol Violation|1|||
105936713|NCT01539525|365427533|FG002|Overall Study|Protocol Violation|4|||
105936714|NCT02539394|365427534|FG000|Overall Study|Protocol Violation|1|||
105936715|NCT02539394|365427535|FG001|Overall Study|Protocol Violation|3|||
105936716|NCT02539394|365427534|FG000|Overall Study|Lost to Follow-up|1|||
105936717|NCT02539394|365427535|FG001|Overall Study|Lost to Follow-up|2|||
105936718|NCT02539394|365427534|FG000|Overall Study|Incomplete dataset|6|||
105936719|NCT02539394|365427535|FG001|Overall Study|Incomplete dataset|6|||
105936720|NCT03061214|365427554|FG000|Overall Study|Withdrawal by Subject|21|||
105936721|NCT03061214|365427555|FG001|Overall Study|Withdrawal by Subject|26|||
105936722|NCT03061214|365427556|FG002|Overall Study|Withdrawal by Subject|9|||
105936723|NCT03061214|365427554|FG000|Overall Study|Lost to Follow-up|3|||
105936724|NCT03061214|365427555|FG001|Overall Study|Lost to Follow-up|1|||
105936725|NCT03061214|365427556|FG002|Overall Study|Lost to Follow-up|1|||
105936726|NCT03061214|365427554|FG000|Overall Study|Death|1|||
105936727|NCT03061214|365427555|FG001|Overall Study|Death|1|||
105794240|NCT03443973|364902189|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
105794241|NCT03443973|364902190|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105936728|NCT03061214|365427556|FG002|Overall Study|Death|0|||
105936729|NCT01316900|365427557|FG000|Overall Study|Adverse Event|10|||
105936730|NCT01316900|365427558|FG001|Overall Study|Adverse Event|10|||
105936731|NCT01316900|365427559|FG002|Overall Study|Adverse Event|15|||
105936732|NCT01316900|365427560|FG003|Overall Study|Adverse Event|9|||
105936733|NCT01316900|365427557|FG000|Overall Study|Lack of Efficacy|17|||
105794242|NCT03443973|364902191|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
105794243|NCT03443973|364902188|FG000|Open-label Extension Period|Reason Not Specified|0|||
105794244|NCT03443973|364902189|FG001|Open-label Extension Period|Reason Not Specified|0|||
105794245|NCT03443973|364902190|FG002|Open-label Extension Period|Reason Not Specified|3|||
105794246|NCT03443973|364902191|FG003|Open-label Extension Period|Reason Not Specified|0|||
105794247|NCT03443973|364902188|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
105794248|NCT03443973|364902189|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
105794249|NCT03443973|364902190|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
105794250|NCT03443973|364902191|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
105794251|NCT04651218|364902205|FG000|Overall Study|Withdrawal by Subject|0|||
105794252|NCT04651218|364902206|FG001|Overall Study|Withdrawal by Subject|2|||
105794253|NCT02476851|364902207|FG000|Overall Study|Protocol Violation|1|||
105794254|NCT02476851|364902208|FG001|Overall Study|Protocol Violation|1|||
105794255|NCT00647426|364902211|FG000|Overall Study|Withdrawal by Subject|2|||
105794256|NCT00883740|364902213|FG000|First Intervention|Lost to Follow-up|1|||
105794257|NCT00883740|364902214|FG001|First Intervention|Lost to Follow-up|0|||
105794258|NCT00883740|364902213|FG000|First Intervention|No longer willing to participate|2|||
105794259|NCT00883740|364902214|FG001|First Intervention|No longer willing to participate|0|||
105794260|NCT00883740|364902213|FG000|First Intervention|Protocol Violation|3|||
105794261|NCT00883740|364902214|FG001|First Intervention|Protocol Violation|6|||
105794262|NCT00883740|364902213|FG000|First Intervention|Adverse Event|1|||
105794263|NCT00883740|364902214|FG001|First Intervention|Adverse Event|2|||
105794264|NCT00883740|364902213|FG000|Second Intervention|Protocol Violation|1|||
105794265|NCT00883740|364902214|FG001|Second Intervention|Protocol Violation|0|||
105794266|NCT00883740|364902213|FG000|Second Intervention|No longer willing to participate|0|||
105794267|NCT00883740|364902214|FG001|Second Intervention|No longer willing to participate|1|||
105794268|NCT00568776|364902216|FG000|Overall Study|Adverse Event|8|||
105794269|NCT00568776|364902217|FG001|Overall Study|Adverse Event|8|||
106138434|NCT01956669|366166951|FG005|Overall Study|Adverse Event|0|||
106138435|NCT01956669|366166952|FG006|Overall Study|Adverse Event|0|||
106138436|NCT01956669|366166946|FG000|Overall Study|Physician Decision|0|||
105936734|NCT01316900|365427558|FG001|Overall Study|Lack of Efficacy|9|||
105936735|NCT01316900|365427559|FG002|Overall Study|Lack of Efficacy|5|||
105936736|NCT01316900|365427560|FG003|Overall Study|Lack of Efficacy|7|||
105936737|NCT01316900|365427557|FG000|Overall Study|Protocol Violation|7|||
105936738|NCT01316900|365427558|FG001|Overall Study|Protocol Violation|1|||
105936739|NCT01316900|365427559|FG002|Overall Study|Protocol Violation|4|||
105936740|NCT01316900|365427560|FG003|Overall Study|Protocol Violation|0|||
105936741|NCT01316900|365427557|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
105936742|NCT01316900|365427558|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
105936743|NCT01316900|365427559|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
105936744|NCT01316900|365427560|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
105936745|NCT01316900|365427557|FG000|Overall Study|Lost to Follow-up|1|||
105936746|NCT01316900|365427558|FG001|Overall Study|Lost to Follow-up|0|||
105936747|NCT01316900|365427559|FG002|Overall Study|Lost to Follow-up|1|||
105936748|NCT01316900|365427560|FG003|Overall Study|Lost to Follow-up|1|||
105936749|NCT01316900|365427557|FG000|Overall Study|Withdrawal by Subject|7|||
105936750|NCT01316900|365427558|FG001|Overall Study|Withdrawal by Subject|8|||
105936751|NCT01316900|365427559|FG002|Overall Study|Withdrawal by Subject|6|||
105936752|NCT01316900|365427560|FG003|Overall Study|Withdrawal by Subject|9|||
105936753|NCT00397046|365429366|FG000|Overall Study|Disease Progression|3|||
105936754|NCT00397046|365429367|FG001|Overall Study|Disease Progression|3|||
105936755|NCT00397046|365429368|FG002|Overall Study|Disease Progression|10|||
105936756|NCT00397046|365429369|FG003|Overall Study|Disease Progression|5|||
105936757|NCT02105012|365429371|FG000|Overall Study|Withdrawal by Subject|11|||
105936758|NCT02105012|365429371|FG000|Overall Study|Protocol Specified Criteria|9|||
105936759|NCT02105012|365429371|FG000|Overall Study|Lost to Follow-up|4|||
105936760|NCT02105012|365429371|FG000|Overall Study|Protocol Violation|4|||
105936761|NCT02105012|365429371|FG000|Overall Study|Physician Decision|3|||
105936762|NCT02105012|365429371|FG000|Overall Study|Adverse Event|1|||
105936763|NCT02105012|365429371|FG000|Overall Study|Lack of Efficacy|1|||
105936764|NCT03774810|365429372|FG000|Phase 1|Lack of Efficacy|21|||
105936765|NCT03774810|365429373|FG001|Phase 1|Lack of Efficacy|0|||
106138437|NCT01956669|366166947|FG001|Overall Study|Physician Decision|2|||
105794270|NCT00568776|364902218|FG002|Overall Study|Adverse Event|10|||
105794271|NCT00568776|364902219|FG003|Overall Study|Adverse Event|8|||
105794272|NCT00568776|364902216|FG000|Overall Study|Death|0|||
105794273|NCT00568776|364902217|FG001|Overall Study|Death|1|||
105794274|NCT00568776|364902218|FG002|Overall Study|Death|4|||
105794275|NCT00568776|364902219|FG003|Overall Study|Death|3|||
105794276|NCT00568776|364902216|FG000|Overall Study|Physician Decision|0|||
105794277|NCT00568776|364902217|FG001|Overall Study|Physician Decision|2|||
105794278|NCT00568776|364902218|FG002|Overall Study|Physician Decision|0|||
105794279|NCT00568776|364902219|FG003|Overall Study|Physician Decision|0|||
105936766|NCT03774810|365429374|FG002|Phase 1|Lack of Efficacy|0|||
105936767|NCT03774810|365429375|FG003|Phase 1|Lack of Efficacy|0|||
106138438|NCT01956669|366166948|FG002|Overall Study|Physician Decision|0|||
106138439|NCT01956669|366166949|FG003|Overall Study|Physician Decision|0|||
106138440|NCT01956669|366166950|FG004|Overall Study|Physician Decision|0|||
105794280|NCT00568776|364902216|FG000|Overall Study|Lack of Efficacy|2|||
105794281|NCT00568776|364902217|FG001|Overall Study|Lack of Efficacy|2|||
105794282|NCT00568776|364902218|FG002|Overall Study|Lack of Efficacy|2|||
105794283|NCT00568776|364902219|FG003|Overall Study|Lack of Efficacy|4|||
105794284|NCT00568776|364902216|FG000|Overall Study|Lost to Follow-up|1|||
105794285|NCT00568776|364902217|FG001|Overall Study|Lost to Follow-up|1|||
105794286|NCT00568776|364902218|FG002|Overall Study|Lost to Follow-up|1|||
105794287|NCT00568776|364902219|FG003|Overall Study|Lost to Follow-up|1|||
105794288|NCT00568776|364902216|FG000|Overall Study|Protocol Violation|1|||
105794289|NCT00568776|364902217|FG001|Overall Study|Protocol Violation|0|||
105794290|NCT00568776|364902218|FG002|Overall Study|Protocol Violation|1|||
105794291|NCT00568776|364902219|FG003|Overall Study|Protocol Violation|1|||
105794292|NCT00568776|364902216|FG000|Overall Study|Withdrawal by Subject|13|||
105794293|NCT00568776|364902217|FG001|Overall Study|Withdrawal by Subject|15|||
105794294|NCT00568776|364902218|FG002|Overall Study|Withdrawal by Subject|13|||
105794295|NCT00568776|364902219|FG003|Overall Study|Withdrawal by Subject|7|||
106138441|NCT01956669|366166951|FG005|Overall Study|Physician Decision|1|||
106138442|NCT01956669|366166952|FG006|Overall Study|Physician Decision|0|||
106138443|NCT01956669|366166946|FG000|Overall Study|Withdrawal by Subject|0|||
106138444|NCT01956669|366166947|FG001|Overall Study|Withdrawal by Subject|0|||
106138445|NCT01956669|366166948|FG002|Overall Study|Withdrawal by Subject|1|||
106138446|NCT01956669|366166949|FG003|Overall Study|Withdrawal by Subject|1|||
106138447|NCT01956669|366166950|FG004|Overall Study|Withdrawal by Subject|0|||
106138448|NCT01956669|366166951|FG005|Overall Study|Withdrawal by Subject|0|||
106138449|NCT01956669|366166952|FG006|Overall Study|Withdrawal by Subject|1|||
106138450|NCT01570751|366166953|FG000|Period A (16 Weeks)|Protocol Violation|1|||
106138451|NCT01570751|366166954|FG001|Period A (16 Weeks)|Protocol Violation|1|||
106138452|NCT01570751|366166953|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
106138453|NCT01570751|366166954|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
106138454|NCT01570751|366166953|FG000|Period A (16 Weeks)|Unclassified|2|||
106138455|NCT01570751|366166954|FG001|Period A (16 Weeks)|Unclassified|3|||
106138456|NCT01570751|366166953|FG000|Period B (16 Weeks)|Adverse Event|1|||
106138457|NCT01570751|366166954|FG001|Period B (16 Weeks)|Adverse Event|0|||
106138458|NCT01570751|366166953|FG000|Period B (16 Weeks)|Protocol Violation|0|||
106138459|NCT01570751|366166954|FG001|Period B (16 Weeks)|Protocol Violation|1|||
106138460|NCT01072357|366166955|FG000|Overall Study|Lost to Follow-up|0|||
106138461|NCT01072357|366166956|FG001|Overall Study|Lost to Follow-up|1|||
106138462|NCT00891618|366166957|FG000|Overall Study|Withdrawal by Subject|1|||
106138463|NCT01693614|366166958|FG000|Overall Study|Adverse Event|7|||
106138464|NCT01693614|366166959|FG001|Overall Study|Adverse Event|11|||
106138465|NCT01693614|366166960|FG002|Overall Study|Adverse Event|5|||
106138466|NCT01693614|366166958|FG000|Overall Study|Disease progression|11|||
106138467|NCT01693614|366166959|FG001|Overall Study|Disease progression|8|||
106138468|NCT01693614|366166960|FG002|Overall Study|Disease progression|7|||
106138469|NCT01693614|366166958|FG000|Overall Study|Protocol Violation|5|||
106138470|NCT01693614|366166959|FG001|Overall Study|Protocol Violation|2|||
106138471|NCT01693614|366166960|FG002|Overall Study|Protocol Violation|1|||
106138472|NCT01693614|366166958|FG000|Overall Study|Death|1|||
106138473|NCT01693614|366166959|FG001|Overall Study|Death|0|||
106138474|NCT01693614|366166960|FG002|Overall Study|Death|0|||
106138475|NCT01693614|366166958|FG000|Overall Study|Physician Decision|1|||
106138476|NCT01693614|366166959|FG001|Overall Study|Physician Decision|1|||
106138477|NCT01693614|366166960|FG002|Overall Study|Physician Decision|4|||
106138478|NCT01693614|366166958|FG000|Overall Study|Withdrawal by subject/guardian|0|||
106138479|NCT01693614|366166959|FG001|Overall Study|Withdrawal by subject/guardian|0|||
106138480|NCT01693614|366166960|FG002|Overall Study|Withdrawal by subject/guardian|2|||
106138481|NCT01693614|366166958|FG000|Overall Study|Withdrawal by Subject|1|||
106138482|NCT01693614|366166959|FG001|Overall Study|Withdrawal by Subject|0|||
106138483|NCT01693614|366166960|FG002|Overall Study|Withdrawal by Subject|5|||
106138484|NCT02614560|366166966|FG000|Overall Study|Death|6|||
106138485|NCT02614560|366166967|FG001|Overall Study|Death|2|||
106138486|NCT00868192|366166969|FG000|Overall Study|Ineligible|4|||
106138487|NCT01695317|366166970|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
106138488|NCT01695317|366166971|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
106138489|NCT01695317|366166970|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
106138490|NCT01695317|366166971|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
106138491|NCT04580303|366166972|FG000|Overall Study|Adverse Event|0|||
106138492|NCT04580303|366166973|FG001|Overall Study|Adverse Event|1|||
106138493|NCT04580303|366166974|FG002|Overall Study|Adverse Event|0|||
106138494|NCT04580303|366166975|FG003|Overall Study|Adverse Event|0|||
106138495|NCT04580303|366166972|FG000|Overall Study|Withdrawal by Subject|0|||
105794296|NCT00568776|364902216|FG000|Overall Study|Loss of Caregiver|0|||
105794297|NCT00568776|364902217|FG001|Overall Study|Loss of Caregiver|2|||
106138496|NCT04580303|366166973|FG001|Overall Study|Withdrawal by Subject|0|||
106138497|NCT04580303|366166974|FG002|Overall Study|Withdrawal by Subject|1|||
106138498|NCT04580303|366166975|FG003|Overall Study|Withdrawal by Subject|0|||
106138499|NCT00241644|366166976|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
105794298|NCT00568776|364902218|FG002|Overall Study|Loss of Caregiver|1|||
105936768|NCT03774810|365429376|FG004|Phase 1|Lack of Efficacy|0|||
106138500|NCT00241644|366166977|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
106138501|NCT00241644|366166978|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
106138502|NCT00241644|366166979|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
106138503|NCT00241644|366166976|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
106138504|NCT00241644|366166977|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
106138505|NCT00241644|366166978|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
106138506|NCT00241644|366166979|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
106138507|NCT00241644|366166976|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
106138508|NCT00241644|366166977|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
106138509|NCT00241644|366166978|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
106138510|NCT00241644|366166979|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
106138511|NCT00241644|366166976|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
106138512|NCT00241644|366166977|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
106138513|NCT00241644|366166978|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
106138514|NCT00241644|366166979|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
106138515|NCT00241644|366166976|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
106138516|NCT00241644|366166977|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
106138517|NCT00241644|366166978|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
106138518|NCT00241644|366166979|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
106138519|NCT00241644|366166976|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
106138520|NCT00241644|366166977|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
106138521|NCT00241644|366166978|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
106138522|NCT00241644|366166979|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
106138523|NCT00241644|366166976|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
106138524|NCT00241644|366166977|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
106138525|NCT00241644|366166978|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
106138526|NCT00241644|366166979|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
106138527|NCT00241644|366166976|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
106138528|NCT00241644|366166977|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
106138529|NCT00241644|366166978|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
106138530|NCT00241644|366166979|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
106138531|NCT00241644|366166976|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
106138532|NCT00241644|366166977|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
106138533|NCT00241644|366166978|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
106138534|NCT00241644|366166979|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
106138535|NCT00241644|366166976|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
106138536|NCT00241644|366166977|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
106138537|NCT00241644|366166978|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
106138538|NCT00241644|366166979|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
106138539|NCT00241644|366166976|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
106138540|NCT00241644|366166977|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
106138541|NCT00241644|366166978|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
106138542|NCT00241644|366166979|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
106138543|NCT00241644|366166976|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
106138544|NCT00241644|366166977|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
106138545|NCT00241644|366166978|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
106138546|NCT00241644|366166979|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
106138547|NCT00241644|366166976|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
106138548|NCT00241644|366166977|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
106138549|NCT00241644|366166978|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
106138550|NCT00241644|366166979|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
106138551|NCT00543725|366166980|FG000|Overall Study|Adverse Event|18|||
106138552|NCT00543725|366166981|FG001|Overall Study|Adverse Event|27|||
106138553|NCT00543725|366166980|FG000|Overall Study|Sponsor's Decision|0|||
106138554|NCT00543725|366166981|FG001|Overall Study|Sponsor's Decision|1|||
106138555|NCT00543725|366166980|FG000|Overall Study|Subject Non-Compliant|4|||
106138556|NCT00543725|366166981|FG001|Overall Study|Subject Non-Compliant|4|||
106138557|NCT00543725|366166980|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
106138558|NCT00543725|366166981|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
106138559|NCT00543725|366166980|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
106138560|NCT00543725|366166981|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
106138561|NCT00543725|366166980|FG000|Overall Study|Protocol Violation|0|||
106138562|NCT00543725|366166981|FG001|Overall Study|Protocol Violation|1|||
106138563|NCT00543725|366166980|FG000|Overall Study|Withdrawal by Subject|4|||
106138564|NCT00543725|366166981|FG001|Overall Study|Withdrawal by Subject|13|||
105794299|NCT00568776|364902219|FG003|Overall Study|Loss of Caregiver|2|||
106138565|NCT00543725|366166980|FG000|Overall Study|Lost to Follow-up|15|||
106138566|NCT00543725|366166981|FG001|Overall Study|Lost to Follow-up|11|||
106138567|NCT00543725|366166980|FG000|Overall Study|Other|3|||
106138568|NCT00543725|366166981|FG001|Overall Study|Other|3|||
106138569|NCT00906698|366166982|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
106138570|NCT00906698|366166983|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
106138571|NCT00906698|366166984|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
106138572|NCT00906698|366166985|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
106138573|NCT00906698|366166986|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
106138574|NCT00906698|366166987|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
106138575|NCT00906698|366166982|FG000|Overall Study|Adverse Event|0|||
106138576|NCT00906698|366166983|FG001|Overall Study|Adverse Event|0|||
106138577|NCT00906698|366166984|FG002|Overall Study|Adverse Event|2|||
106138578|NCT00906698|366166985|FG003|Overall Study|Adverse Event|0|||
106138579|NCT00906698|366166986|FG004|Overall Study|Adverse Event|4|||
106138580|NCT00906698|366166987|FG005|Overall Study|Adverse Event|1|||
106138581|NCT00906698|366166982|FG000|Overall Study|Disease progression|3|||
106138582|NCT00906698|366166983|FG001|Overall Study|Disease progression|12|||
106138583|NCT00906698|366166984|FG002|Overall Study|Disease progression|4|||
106138584|NCT00906698|366166985|FG003|Overall Study|Disease progression|4|||
106138585|NCT00906698|366166986|FG004|Overall Study|Disease progression|12|||
106138586|NCT00906698|366166987|FG005|Overall Study|Disease progression|4|||
106138587|NCT00906698|366166982|FG000|Overall Study|Withdrawal by Subject|0|||
106138588|NCT00906698|366166983|FG001|Overall Study|Withdrawal by Subject|0|||
106138589|NCT00906698|366166984|FG002|Overall Study|Withdrawal by Subject|0|||
106138590|NCT00906698|366166985|FG003|Overall Study|Withdrawal by Subject|0|||
106138591|NCT00906698|366166986|FG004|Overall Study|Withdrawal by Subject|1|||
106138592|NCT00906698|366166987|FG005|Overall Study|Withdrawal by Subject|0|||
106138593|NCT00906698|366166982|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
106138594|NCT00906698|366166983|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
106138595|NCT00906698|366166984|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
106138596|NCT00906698|366166985|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
106138597|NCT00906698|366166986|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
106138598|NCT00906698|366166987|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
106138599|NCT01027286|366166988|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
106138600|NCT01027286|366166989|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
106138601|NCT01027286|366166988|FG000|Overall Study|Lost to Follow-up|0|||
106138602|NCT01027286|366166989|FG001|Overall Study|Lost to Follow-up|1|||
106138603|NCT04044664|366166998|FG000|Stage 1|Adverse Event|3|||
106138604|NCT04044664|366166999|FG001|Stage 1|Adverse Event|3|||
106138605|NCT04044664|366167000|FG002|Stage 1|Adverse Event|1|||
106138606|NCT04044664|366166998|FG000|Stage 1|Lost to Follow-up|3|||
106138607|NCT04044664|366166999|FG001|Stage 1|Lost to Follow-up|2|||
106138608|NCT04044664|366167000|FG002|Stage 1|Lost to Follow-up|2|||
106138609|NCT04044664|366166998|FG000|Stage 1|Withdrawal by Subject|9|||
106138610|NCT04044664|366166999|FG001|Stage 1|Withdrawal by Subject|1|||
106138611|NCT04044664|366167000|FG002|Stage 1|Withdrawal by Subject|0|||
106138612|NCT04044664|366166998|FG000|Stage 1|noncompliance, personal reason|2|||
106138613|NCT04044664|366166999|FG001|Stage 1|noncompliance, personal reason|0|||
106138614|NCT04044664|366167000|FG002|Stage 1|noncompliance, personal reason|0|||
106138615|NCT04044664|366166998|FG000|Stage 1|randomization error|0|||
106138616|NCT04044664|366166999|FG001|Stage 1|randomization error|1|||
106138617|NCT04044664|366167000|FG002|Stage 1|randomization error|0|||
106138618|NCT04044664|366166998|FG000|Stage 2|Adverse Event|2|||
106138619|NCT04044664|366166999|FG001|Stage 2|Adverse Event|0|||
106138620|NCT04044664|366167000|FG002|Stage 2|Adverse Event|0|||
106138621|NCT04044664|366166998|FG000|Stage 2|Lost to Follow-up|3|||
106138622|NCT04044664|366166999|FG001|Stage 2|Lost to Follow-up|2|||
106138623|NCT04044664|366167000|FG002|Stage 2|Lost to Follow-up|1|||
106138624|NCT04044664|366166998|FG000|Stage 2|Withdrawal by Subject|3|||
106138625|NCT04044664|366166999|FG001|Stage 2|Withdrawal by Subject|0|||
106138626|NCT04044664|366167000|FG002|Stage 2|Withdrawal by Subject|0|||
106138627|NCT04044664|366166998|FG000|Stage 2|protocol deviation|1|||
106138628|NCT04044664|366166999|FG001|Stage 2|protocol deviation|0|||
106138629|NCT04044664|366167000|FG002|Stage 2|protocol deviation|0|||
106138630|NCT00545844|366167001|FG000|Overall Study|Lost to Follow-up|9|||
106138631|NCT00545844|366167001|FG000|Overall Study|Protocol Violation|1|||
106138632|NCT00545844|366167001|FG000|Overall Study|Withdrawal by Subject|2|||
106138633|NCT03383887|366167002|FG000|Overall Study|Lost to Follow-up|0|||
106138634|NCT03383887|366167003|FG001|Overall Study|Lost to Follow-up|1|||
106138635|NCT02701361|366167008|FG000|Overall Study|Lost to Follow-up|5|||
106138636|NCT02701361|366167009|FG001|Overall Study|Lost to Follow-up|2|||
106138637|NCT02701361|366167010|FG002|Overall Study|Lost to Follow-up|1|||
106138638|NCT02701361|366167008|FG000|Overall Study|Withdrawal by Subject|4|||
106138639|NCT02701361|366167009|FG001|Overall Study|Withdrawal by Subject|0|||
105726468|NCT01431287|364655479|FG000|Overall Study|Non compliant with protocol|6|||
105726469|NCT01431287|364655480|FG001|Overall Study|Non compliant with protocol|6|||
105726470|NCT01431287|364655481|FG002|Overall Study|Non compliant with protocol|5|||
105726471|NCT01431287|364655482|FG003|Overall Study|Non compliant with protocol|6|||
105726472|NCT01431287|364655483|FG004|Overall Study|Non compliant with protocol|5|||
105726473|NCT01431287|364655479|FG000|Overall Study|Lost to Follow-up|0|||
105726474|NCT01431287|364655480|FG001|Overall Study|Lost to Follow-up|3|||
105726475|NCT01431287|364655481|FG002|Overall Study|Lost to Follow-up|2|||
105726476|NCT01431287|364655482|FG003|Overall Study|Lost to Follow-up|3|||
105726477|NCT01431287|364655483|FG004|Overall Study|Lost to Follow-up|1|||
105726478|NCT01431287|364655479|FG000|Overall Study|Consent withdrawn not due to AE|29|||
105726479|NCT01431287|364655480|FG001|Overall Study|Consent withdrawn not due to AE|30|||
105726480|NCT01431287|364655481|FG002|Overall Study|Consent withdrawn not due to AE|34|||
105726481|NCT01431287|364655482|FG003|Overall Study|Consent withdrawn not due to AE|19|||
105726482|NCT01431287|364655483|FG004|Overall Study|Consent withdrawn not due to AE|29|||
105726483|NCT01431287|364655479|FG000|Overall Study|not stated above|4|||
105726484|NCT01431287|364655480|FG001|Overall Study|not stated above|2|||
105726485|NCT01431287|364655481|FG002|Overall Study|not stated above|2|||
105726486|NCT01431287|364655482|FG003|Overall Study|not stated above|2|||
105726487|NCT01431287|364655483|FG004|Overall Study|not stated above|1|||
105726488|NCT03263806|364655484|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
105726489|NCT03263806|364655485|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
105726490|NCT03263806|364655484|FG000|Overall Study|Withdrawal by Subject|0|||
105726491|NCT03263806|364655485|FG001|Overall Study|Withdrawal by Subject|1|||
105726492|NCT03263806|364655484|FG000|Overall Study|Study Termination|5|||
105726493|NCT03263806|364655485|FG001|Overall Study|Study Termination|6|||
105726494|NCT00224016|364655486|FG000|Titration Period|Withdrawal by Subject|0|||
105726495|NCT00224016|364655487|FG001|Titration Period|Withdrawal by Subject|1|||
105726496|NCT00224016|364655486|FG000|Titration Period|Lost to Follow-up|1|||
105726497|NCT00224016|364655487|FG001|Titration Period|Lost to Follow-up|0|||
105726498|NCT00224016|364655486|FG000|Maintenance Period|Withdrawal by Subject|2|||
105726499|NCT00224016|364655487|FG001|Maintenance Period|Withdrawal by Subject|0|||
105726500|NCT00224016|364655486|FG000|Maintenance Period|Lost to Follow-up|0|||
105726501|NCT00224016|364655487|FG001|Maintenance Period|Lost to Follow-up|1|||
105726502|NCT01793792|364655491|FG000|Overall Study|Death|5|||
105726503|NCT01793792|364655491|FG000|Overall Study|Lost to Follow-up|5|||
105726504|NCT01793792|364655491|FG000|Overall Study|Withdrawal by Subject|1|||
105726505|NCT01793792|364655491|FG000|Overall Study|Device Not Implanted|1|||
105726506|NCT02626338|364655494|FG000|Overall Study|Lack of Efficacy|3|||
105726507|NCT02626338|364655495|FG001|Overall Study|Lack of Efficacy|2|||
105726508|NCT02626338|364655496|FG002|Overall Study|Lack of Efficacy|0|||
105726509|NCT00826748|364655497|FG000|Overall Study|Withdrawal by Subject|0|||
105794300|NCT00568776|364902216|FG000|Overall Study|Sponsor Decision|2|||
105794301|NCT00568776|364902217|FG001|Overall Study|Sponsor Decision|2|||
105794302|NCT00568776|364902218|FG002|Overall Study|Sponsor Decision|41|||
105794303|NCT00568776|364902219|FG003|Overall Study|Sponsor Decision|42|||
105794304|NCT00568776|364902216|FG000|Overall Study|Miscellaeneous|3|||
105794305|NCT00568776|364902217|FG001|Overall Study|Miscellaeneous|3|||
105794306|NCT00568776|364902218|FG002|Overall Study|Miscellaeneous|1|||
105794307|NCT00568776|364902219|FG003|Overall Study|Miscellaeneous|4|||
105794308|NCT02742818|364902222|FG000|Overall Study|Adverse Event|0|||
105794309|NCT02742818|364902223|FG001|Overall Study|Adverse Event|1|||
105794310|NCT02742818|364902222|FG000|Overall Study|Protocol Violation|0|||
105794311|NCT02742818|364902223|FG001|Overall Study|Protocol Violation|1|||
105794312|NCT04701658|364902224|FG000|Overall Study|Lost to Follow-up|6|||
105794313|NCT02866695|364902227|FG000|Overall Study|Adverse Event|1|||
105794314|NCT02866695|364902227|FG000|Overall Study|Lost to Follow-up|1|||
105794315|NCT04101721|364902228|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
105794316|NCT04101721|364902229|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
105794317|NCT04101721|364902228|FG000|Overall Study|Death|0|||
105794318|NCT04101721|364902229|FG001|Overall Study|Death|1|||
105794319|NCT04101721|364902228|FG000|Overall Study|Lost to Follow-up|0|||
105794320|NCT04101721|364902229|FG001|Overall Study|Lost to Follow-up|3|||
105794321|NCT02564952|364902230|FG000|Overall Study|Adverse Event|6|||
105794322|NCT02564952|364902230|FG000|Overall Study|Lost to Follow-up|1|||
105794323|NCT02564952|364902230|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
105794324|NCT02564952|364902230|FG000|Overall Study|Withdrawal by Subject|1|||
105794325|NCT02564952|364902230|FG000|Overall Study|Low Efficacy|1|||
105794326|NCT02564952|364902230|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
105794327|NCT02007512|364902231|FG000|Double Blind Treatment Period|Adverse Event|4|||
105794328|NCT02007512|364902232|FG001|Double Blind Treatment Period|Adverse Event|2|||
105794329|NCT02007512|364902233|FG002|Double Blind Treatment Period|Adverse Event|6|||
105794330|NCT02007512|364902234|FG003|Double Blind Treatment Period|Adverse Event|2|||
105794331|NCT02007512|364902231|FG000|Double Blind Treatment Period|Death|1|||
105794332|NCT02007512|364902232|FG001|Double Blind Treatment Period|Death|0|||
105794333|NCT02007512|364902233|FG002|Double Blind Treatment Period|Death|0|||
105794334|NCT02007512|364902234|FG003|Double Blind Treatment Period|Death|0|||
105794335|NCT02007512|364902231|FG000|Double Blind Treatment Period|Disease progression|44|||
105794336|NCT02007512|364902232|FG001|Double Blind Treatment Period|Disease progression|49|||
105794337|NCT02007512|364902233|FG002|Double Blind Treatment Period|Disease progression|45|||
105794338|NCT02007512|364902234|FG003|Double Blind Treatment Period|Disease progression|51|||
105794339|NCT02007512|364902231|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
105794340|NCT02007512|364902232|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
105794341|NCT02007512|364902233|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
105794342|NCT02007512|364902234|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
105794343|NCT02007512|364902231|FG000|Double Blind Treatment Period|Protocol Violation|0|||
105794344|NCT02007512|364902232|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105794345|NCT02007512|364902233|FG002|Double Blind Treatment Period|Protocol Violation|0|||
105794346|NCT02007512|364902234|FG003|Double Blind Treatment Period|Protocol Violation|1|||
105794347|NCT02007512|364902231|FG000|Double Blind Treatment Period|Other|0|||
105794348|NCT02007512|364902232|FG001|Double Blind Treatment Period|Other|0|||
105794349|NCT02007512|364902233|FG002|Double Blind Treatment Period|Other|1|||
105794350|NCT02007512|364902234|FG003|Double Blind Treatment Period|Other|2|||
105794351|NCT02007512|364902231|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
105794352|NCT02007512|364902232|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
105936769|NCT03774810|365429372|FG000|Phase 1|Withdrawal by Subject|9|||
105936770|NCT03774810|365429373|FG001|Phase 1|Withdrawal by Subject|0|||
105936771|NCT03774810|365429374|FG002|Phase 1|Withdrawal by Subject|0|||
105936772|NCT03774810|365429375|FG003|Phase 1|Withdrawal by Subject|0|||
105936773|NCT03774810|365429376|FG004|Phase 1|Withdrawal by Subject|0|||
105936774|NCT03774810|365429372|FG000|Phase 1|Lost to Follow-up|2|||
105936775|NCT03774810|365429373|FG001|Phase 1|Lost to Follow-up|0|||
106009508|NCT01435382|365700864|FG003|Overall Study|Lost to Follow-up|0|||
106009509|NCT01435382|365700861|FG000|Overall Study|Withdrawal by Subject|0|||
105794353|NCT02007512|364902233|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
105794354|NCT02007512|364902234|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
105794355|NCT02007512|364902231|FG000|Open Label Treatment Period|Adverse Event|0|||
105794356|NCT02007512|364902232|FG001|Open Label Treatment Period|Adverse Event|1|||
105936776|NCT03774810|365429374|FG002|Phase 1|Lost to Follow-up|0|||
106009510|NCT01435382|365700862|FG001|Overall Study|Withdrawal by Subject|2|||
106009511|NCT01435382|365700863|FG002|Overall Study|Withdrawal by Subject|0|||
105794357|NCT02007512|364902233|FG002|Open Label Treatment Period|Adverse Event|0|||
105794358|NCT02007512|364902234|FG003|Open Label Treatment Period|Adverse Event|0|||
105794359|NCT02007512|364902231|FG000|Open Label Treatment Period|Other|0|||
105936777|NCT03774810|365429375|FG003|Phase 1|Lost to Follow-up|0|||
105936778|NCT03774810|365429376|FG004|Phase 1|Lost to Follow-up|0|||
105936779|NCT03774810|365429372|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
105794360|NCT02007512|364902232|FG001|Open Label Treatment Period|Other|0|||
105794361|NCT02007512|364902233|FG002|Open Label Treatment Period|Other|0|||
105794362|NCT02007512|364902234|FG003|Open Label Treatment Period|Other|1|||
105794363|NCT02007512|364902231|FG000|Open Label Treatment Period|Disease progression|0|||
105794364|NCT02007512|364902232|FG001|Open Label Treatment Period|Disease progression|17|||
105794365|NCT02007512|364902233|FG002|Open Label Treatment Period|Disease progression|0|||
105794366|NCT02007512|364902234|FG003|Open Label Treatment Period|Disease progression|11|||
105794367|NCT02007512|364902231|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
105794368|NCT02007512|364902232|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
105794369|NCT02007512|364902233|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
105936780|NCT03774810|365429373|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
106138640|NCT02701361|366167010|FG002|Overall Study|Withdrawal by Subject|0|||
106138641|NCT02701361|366167008|FG000|Overall Study|timed out in rehab center|0|||
106138642|NCT02701361|366167009|FG001|Overall Study|timed out in rehab center|1|||
106138643|NCT02701361|366167010|FG002|Overall Study|timed out in rehab center|0|||
106138644|NCT02701361|366167008|FG000|Overall Study|incarceration|0|||
106138645|NCT02701361|366167009|FG001|Overall Study|incarceration|0|||
106138646|NCT02701361|366167010|FG002|Overall Study|incarceration|1|||
106138647|NCT00975806|366167011|FG000|Overall Study|Adverse Event|2|||
106138648|NCT00975806|366167012|FG001|Overall Study|Adverse Event|1|||
106138649|NCT00975806|366167013|FG002|Overall Study|Adverse Event|2|||
106138650|NCT00975806|366167011|FG000|Overall Study|Disease Progression|1|||
106138651|NCT00975806|366167012|FG001|Overall Study|Disease Progression|5|||
106138652|NCT00975806|366167013|FG002|Overall Study|Disease Progression|1|||
106138653|NCT00975806|366167011|FG000|Overall Study|Withdrawal by Subject|1|||
106138654|NCT00975806|366167012|FG001|Overall Study|Withdrawal by Subject|0|||
106138655|NCT00975806|366167013|FG002|Overall Study|Withdrawal by Subject|0|||
106138656|NCT00975806|366167011|FG000|Overall Study|Death|0|||
106138657|NCT00975806|366167012|FG001|Overall Study|Death|1|||
106138658|NCT00975806|366167013|FG002|Overall Study|Death|0|||
106138659|NCT00975806|366167011|FG000|Overall Study|Physician decision and disease related|1|||
106138660|NCT00975806|366167012|FG001|Overall Study|Physician decision and disease related|0|||
106138661|NCT00975806|366167013|FG002|Overall Study|Physician decision and disease related|1|||
106138662|NCT04107805|366167016|FG000|Overall Study|Adverse Event|0|||
106138663|NCT04107805|366167017|FG001|Overall Study|Adverse Event|0|||
106138664|NCT04107805|366167018|FG002|Overall Study|Adverse Event|0|||
106138665|NCT04107805|366167019|FG003|Overall Study|Adverse Event|1|||
106138666|NCT04107805|366167020|FG004|Overall Study|Adverse Event|0|||
106138667|NCT04107805|366167021|FG005|Overall Study|Adverse Event|1|||
106138668|NCT04107805|366167022|FG006|Overall Study|Adverse Event|0|||
106138669|NCT04107805|366167023|FG007|Overall Study|Adverse Event|0|||
106138670|NCT04107805|366167024|FG008|Overall Study|Adverse Event|1|||
106138671|NCT02750709|366167025|FG000|Treatment Period 1|Adverse Event|0|||
106138672|NCT02750709|366167026|FG001|Treatment Period 1|Adverse Event|0|||
106138673|NCT02750709|366167027|FG002|Treatment Period 1|Adverse Event|0|||
106138674|NCT02750709|366167028|FG003|Treatment Period 1|Adverse Event|0|||
106138675|NCT02750709|366167029|FG004|Treatment Period 1|Adverse Event|0|||
106138676|NCT02750709|366167030|FG005|Treatment Period 1|Adverse Event|1|||
106138677|NCT01833832|366167032|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
106138678|NCT01264718|366167038|FG000|Overall Study|Lost to Follow-up|3|||
106138679|NCT01264718|366167039|FG001|Overall Study|Lost to Follow-up|2|||
106138680|NCT01264718|366167038|FG000|Overall Study|Withdrawal by Subject|9|||
106138681|NCT01264718|366167039|FG001|Overall Study|Withdrawal by Subject|15|||
106138682|NCT01264718|366167038|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
106138683|NCT01264718|366167039|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
106138684|NCT01769391|366167042|FG000|Overall Study|Death|10|||
106138685|NCT01769391|366167043|FG001|Overall Study|Death|1|||
106138686|NCT01769391|366167042|FG000|Overall Study|Adverse Event|0|||
106138687|NCT01769391|366167043|FG001|Overall Study|Adverse Event|3|||
106138688|NCT01769391|366167042|FG000|Overall Study|Progressive Disease|1|||
106138689|NCT01769391|366167043|FG001|Overall Study|Progressive Disease|2|||
106138690|NCT01769391|366167042|FG000|Overall Study|Withdrawal by Subject|4|||
106138691|NCT01769391|366167043|FG001|Overall Study|Withdrawal by Subject|3|||
106138692|NCT01769391|366167042|FG000|Overall Study|Investigator Decision|2|||
106138693|NCT01769391|366167043|FG001|Overall Study|Investigator Decision|0|||
106138694|NCT03386929|366167044|FG000|Overall Study|Death|0|||
106138695|NCT03386929|366167045|FG001|Overall Study|Death|0|||
106138696|NCT03386929|366167046|FG002|Overall Study|Death|1|||
106138697|NCT03386929|366167044|FG000|Overall Study|Withdrawal by Subject|0|||
106138698|NCT03386929|366167045|FG001|Overall Study|Withdrawal by Subject|1|||
106138699|NCT03386929|366167046|FG002|Overall Study|Withdrawal by Subject|0|||
106138700|NCT03386929|366167044|FG000|Overall Study|Physician Decision|0|||
106138701|NCT03386929|366167045|FG001|Overall Study|Physician Decision|0|||
106138702|NCT03386929|366167046|FG002|Overall Study|Physician Decision|1|||
106138703|NCT03386929|366167044|FG000|Overall Study|Progression|4|||
106138704|NCT03386929|366167045|FG001|Overall Study|Progression|4|||
106138705|NCT03386929|366167046|FG002|Overall Study|Progression|0|||
106138706|NCT03386929|366167044|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
105726510|NCT00826748|364655498|FG001|Overall Study|Withdrawal by Subject|0|||
106138707|NCT03386929|366167045|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
105726511|NCT00826748|364655499|FG002|Overall Study|Withdrawal by Subject|2|||
105726512|NCT00826748|364655497|FG000|Overall Study|Physician Decision|0|||
105726513|NCT00826748|364655498|FG001|Overall Study|Physician Decision|0|||
105726514|NCT00826748|364655499|FG002|Overall Study|Physician Decision|1|||
105726515|NCT00826748|364655497|FG000|Overall Study|Samples Did Not pass QC|0|||
105726516|NCT00826748|364655498|FG001|Overall Study|Samples Did Not pass QC|0|||
105726517|NCT00826748|364655499|FG002|Overall Study|Samples Did Not pass QC|1|||
105726518|NCT01901224|364655500|FG000|Overall Study|study was not funded and terminated|2|||
105726519|NCT01887912|364655502|FG000|Overall Study|Serious adverse event|400|||
105726520|NCT01887912|364655503|FG001|Overall Study|Serious adverse event|198|||
105726521|NCT01887912|364655502|FG000|Overall Study|Other Adverse Event|34|||
105726522|NCT01887912|364655503|FG001|Overall Study|Other Adverse Event|15|||
105726523|NCT01887912|364655502|FG000|Overall Study|Protocol Violation|67|||
105726524|NCT01887912|364655503|FG001|Overall Study|Protocol Violation|37|||
105726525|NCT01887912|364655502|FG000|Overall Study|Lost to Follow-up|163|||
105726526|NCT01887912|364655503|FG001|Overall Study|Lost to Follow-up|74|||
105726527|NCT01887912|364655502|FG000|Overall Study|Withdrawal by Subject|606|||
105726528|NCT01887912|364655503|FG001|Overall Study|Withdrawal by Subject|349|||
105726529|NCT01887912|364655502|FG000|Overall Study|Other|122|||
105726530|NCT01887912|364655503|FG001|Overall Study|Other|58|||
105726531|NCT04462536|364655505|FG000|Overall Study|Withdrawal by Subject|3|||
105726532|NCT04462536|364655506|FG001|Overall Study|Withdrawal by Subject|9|||
105726533|NCT04462536|364655505|FG000|Overall Study|Lost to Follow-up|2|||
105726534|NCT04462536|364655506|FG001|Overall Study|Lost to Follow-up|4|||
105726535|NCT02688647|364655511|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
105726536|NCT02688647|364655512|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
105726537|NCT02688647|364655511|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
105726538|NCT02688647|364655512|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
105726539|NCT02688647|364655511|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
105726540|NCT02688647|364655512|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
105726541|NCT02688647|364655511|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
105726542|NCT02688647|364655512|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
105726543|NCT02688647|364655511|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
105726544|NCT02688647|364655512|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
105726545|NCT02688647|364655511|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
105726546|NCT02688647|364655512|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
105726547|NCT02688647|364655511|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
105726548|NCT02688647|364655512|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
105726549|NCT00828464|364655513|FG000|Overall Study|Withdrawal by Subject|1|||
105726550|NCT02542267|364655514|FG000|Overall Study|Withdrawal by Subject|10|||
105726551|NCT02542267|364655514|FG000|Overall Study|Physician Decision|6|||
105726552|NCT02542267|364655514|FG000|Overall Study|Lost to Follow-up|4|||
105726553|NCT02542267|364655514|FG000|Overall Study|Death|13|||
105726554|NCT02542267|364655514|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
105726555|NCT02542267|364655514|FG000|Overall Study|Other|9|||
105726556|NCT02197377|364655515|FG000|Overall Study|Insertion Failure|0|||
105726557|NCT02197377|364655516|FG001|Overall Study|Insertion Failure|3|||
105726558|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
105726559|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
105726560|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
105726561|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
105726562|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
105726563|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
105726564|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
105726565|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
105726566|NCT01122927|364655517|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
106009512|NCT01435382|365700864|FG003|Overall Study|Withdrawal by Subject|1|||
106138708|NCT03386929|366167046|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
106138709|NCT03386929|366167044|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
106138710|NCT03386929|366167045|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
106138711|NCT03386929|366167046|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
106138712|NCT00208767|366167050|FG000|Overall Study|Adverse Event|9|||
105726567|NCT01122927|364655518|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
105726568|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
105726569|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
105726570|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
105726571|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
105794370|NCT02007512|364902234|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
105794371|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
105794372|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
105794373|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
105794374|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
105794375|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
105794376|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
105794377|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
105794378|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
105794379|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
105794380|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
105794381|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
105794382|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
105794383|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
105794384|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
105794385|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
105794386|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
105794387|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
105794388|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
105794389|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
105794390|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
105794391|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
105794392|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
105794393|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
105794394|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
105794395|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
105794396|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
105794397|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
105794398|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
105794399|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
105794400|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
105794401|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
105794402|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
105794403|NCT03747939|364902235|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
105794404|NCT03747939|364902236|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
105794405|NCT03747939|364902237|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
105794406|NCT03747939|364902238|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
105794407|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
105794408|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
105794409|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
105794410|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
105794411|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
105794412|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
105794413|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
105794414|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
105794415|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
105794416|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
105794417|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
105794418|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
105794419|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
105794420|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
105794421|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
105794422|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
105794423|NCT03747939|364902235|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
105794424|NCT03747939|364902236|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
105794425|NCT03747939|364902237|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
105794426|NCT03747939|364902238|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
105794427|NCT00185731|364902241|FG000|Overall Study|Withdrawal by Subject|1|||
105794428|NCT00185731|364902241|FG000|Overall Study|Not Eligible|1|||
105794429|NCT02494583|364902244|FG000|Overall Study|Death|224|||
105936781|NCT03774810|365429374|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
105936782|NCT03774810|365429375|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
105936783|NCT03774810|365429376|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
106138713|NCT00208767|366167051|FG001|Overall Study|Adverse Event|1|||
106138714|NCT00208767|366167050|FG000|Overall Study|Withdrawal by Subject|14|||
106138715|NCT00208767|366167051|FG001|Overall Study|Withdrawal by Subject|3|||
105726572|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
105726573|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
105726574|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
105726575|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
105726576|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
105726577|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
105726578|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
105726579|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
105726580|NCT01122927|364655517|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
105726581|NCT01122927|364655518|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
105726582|NCT00629083|364655519|FG000|Overall Study|Adverse Event|0|||
105726583|NCT00629083|364655520|FG001|Overall Study|Adverse Event|2|||
105726584|NCT00629083|364655519|FG000|Overall Study|Lack of Efficacy|3|||
105726585|NCT00629083|364655520|FG001|Overall Study|Lack of Efficacy|1|||
105726586|NCT00629083|364655519|FG000|Overall Study|Withdrawal by Subject|10|||
105726587|NCT00629083|364655520|FG001|Overall Study|Withdrawal by Subject|2|||
106009513|NCT02435992|365700865|FG000|Overall Study|non compliance with protocol|2|||
106009514|NCT02435992|365700866|FG001|Overall Study|non compliance with protocol|0|||
105726588|NCT00629083|364655519|FG000|Overall Study|Lost to Follow-up|12|||
105726589|NCT00629083|364655520|FG001|Overall Study|Lost to Follow-up|8|||
105726590|NCT00629083|364655519|FG000|Overall Study|Moved out of country/state|2|||
106138716|NCT00208767|366167050|FG000|Overall Study|Death|1|||
106138717|NCT00208767|366167051|FG001|Overall Study|Death|0|||
106138718|NCT00208767|366167050|FG000|Overall Study|Lost to Follow-up|3|||
106138719|NCT00208767|366167051|FG001|Overall Study|Lost to Follow-up|3|||
106138720|NCT03418324|366167059|FG000|Overall Study|Death|0|||
106138721|NCT03418324|366167060|FG001|Overall Study|Death|1|||
106138722|NCT03418324|366167059|FG000|Overall Study|Physician Decision|1|||
106138723|NCT03418324|366167060|FG001|Overall Study|Physician Decision|1|||
106138724|NCT01196429|366167061|FG000|Overall Study|Ineligible - inadequate pathology|1|||
106138725|NCT01196429|366167062|FG001|Overall Study|Ineligible - inadequate pathology|0|||
106138726|NCT01196429|366167061|FG000|Overall Study|Ineligible - wrong cell type|1|||
106138727|NCT01196429|366167062|FG001|Overall Study|Ineligible - wrong cell type|0|||
106138728|NCT01196429|366167061|FG000|Overall Study|Refused - Never Treated|1|||
106138729|NCT01196429|366167062|FG001|Overall Study|Refused - Never Treated|0|||
106138730|NCT03121950|366167063|FG000|Overall Study|Withdrawal by Subject|11|||
106138731|NCT03121950|366167064|FG001|Overall Study|Withdrawal by Subject|2|||
106138732|NCT01212757|366167065|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
106138733|NCT01212757|366167066|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
106138734|NCT01212757|366167067|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
106138735|NCT01212757|366167068|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106138736|NCT01212757|366167069|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106138737|NCT01212757|366167070|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106138738|NCT01212757|366167071|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106138739|NCT01212757|366167072|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106138740|NCT01212757|366167073|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
106138741|NCT01212757|366167065|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
106138742|NCT01212757|366167066|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
106138743|NCT01212757|366167067|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
106138744|NCT01212757|366167068|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106138745|NCT01212757|366167069|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106138746|NCT01212757|366167070|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106138747|NCT01212757|366167071|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106138748|NCT01212757|366167072|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106138749|NCT01212757|366167073|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
106138750|NCT01212757|366167065|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
106138751|NCT01212757|366167066|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
106138752|NCT01212757|366167067|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
106138753|NCT01212757|366167068|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106138754|NCT01212757|366167069|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106138755|NCT01212757|366167070|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726591|NCT00629083|364655520|FG001|Overall Study|Moved out of country/state|1|||
105726592|NCT00629083|364655519|FG000|Overall Study|Refused to return for 12 month visit|1|||
105726593|NCT00629083|364655520|FG001|Overall Study|Refused to return for 12 month visit|0|||
105726594|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
105726595|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
105726596|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
105726597|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726598|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726599|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726600|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726601|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726602|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
105726603|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
105726604|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
105726605|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
105726606|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726607|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726608|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726609|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726610|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726611|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
105726612|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
105726613|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
105726614|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
105726615|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726616|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726617|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726618|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726619|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726620|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726621|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726622|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726623|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
105726624|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726625|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726626|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726627|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726628|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726629|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
105726630|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
105726631|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
105726632|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
105726633|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726634|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726635|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726636|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726637|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105794430|NCT02494583|364902245|FG001|Overall Study|Death|214|||
105794431|NCT02494583|364902246|FG002|Overall Study|Death|225|||
105794432|NCT02494583|364902244|FG000|Overall Study|Lost to Follow-up|1|||
105794433|NCT02494583|364902245|FG001|Overall Study|Lost to Follow-up|0|||
105794434|NCT02494583|364902246|FG002|Overall Study|Lost to Follow-up|0|||
105794435|NCT02494583|364902244|FG000|Overall Study|Protocol Violation|1|||
105794436|NCT02494583|364902245|FG001|Overall Study|Protocol Violation|2|||
105794437|NCT02494583|364902246|FG002|Overall Study|Protocol Violation|0|||
105794438|NCT02494583|364902244|FG000|Overall Study|Screen Failure|0|||
105794439|NCT02494583|364902245|FG001|Overall Study|Screen Failure|1|||
105794440|NCT02494583|364902246|FG002|Overall Study|Screen Failure|0|||
105794441|NCT02494583|364902244|FG000|Overall Study|Transferred to Extension Study|15|||
105794442|NCT02494583|364902245|FG001|Overall Study|Transferred to Extension Study|15|||
105794443|NCT02494583|364902246|FG002|Overall Study|Transferred to Extension Study|6|||
105794444|NCT02494583|364902244|FG000|Overall Study|Did Not Continue on Extension Study|8|||
105794445|NCT02494583|364902245|FG001|Overall Study|Did Not Continue on Extension Study|10|||
105794446|NCT02494583|364902246|FG002|Overall Study|Did Not Continue on Extension Study|4|||
105794447|NCT02494583|364902244|FG000|Overall Study|Withdrawal by Subject|7|||
105794448|NCT02494583|364902245|FG001|Overall Study|Withdrawal by Subject|15|||
105794449|NCT02494583|364902246|FG002|Overall Study|Withdrawal by Subject|15|||
105794450|NCT05144477|364902247|FG000|Overall Study|Withdrawal by Subject|1|||
105794451|NCT05144477|364902248|FG001|Overall Study|Withdrawal by Subject|1|||
105794452|NCT01339000|364902249|FG000|Overall Study|study closed due to lack of drug supply|1|||
105794453|NCT01339000|364902250|FG001|Overall Study|study closed due to lack of drug supply|0|||
105794454|NCT03506425|364902254|FG000|Overall Study|Adverse Event|1|||
105794455|NCT03506425|364902255|FG001|Overall Study|Adverse Event|3|||
105794456|NCT03506425|364902256|FG002|Overall Study|Adverse Event|0|||
105794457|NCT03506425|364902254|FG000|Overall Study|Death|1|||
105794458|NCT03506425|364902255|FG001|Overall Study|Death|0|||
105794459|NCT03506425|364902256|FG002|Overall Study|Death|0|||
105794460|NCT03506425|364902254|FG000|Overall Study|Withdrawal by Subject|0|||
105794461|NCT03506425|364902255|FG001|Overall Study|Withdrawal by Subject|0|||
105794462|NCT03506425|364902256|FG002|Overall Study|Withdrawal by Subject|1|||
105794463|NCT05349188|364902257|FG000|Overall Study|Withdrawal by Subject|1|||
105794464|NCT05349188|364902258|FG001|Overall Study|Withdrawal by Subject|0|||
105794465|NCT02643394|364902259|FG000|Overall Study|Protocol Violation|4|||
105794466|NCT02643394|364902260|FG001|Overall Study|Protocol Violation|5|||
105794467|NCT00096200|364902261|FG000|Overall Study|Adverse Event|0|||
105794468|NCT00096200|364902262|FG001|Overall Study|Adverse Event|4|||
105794469|NCT00096200|364902263|FG002|Overall Study|Adverse Event|0|||
105794470|NCT00096200|364902261|FG000|Overall Study|Withdrawal by Subject|1|||
105794471|NCT00096200|364902262|FG001|Overall Study|Withdrawal by Subject|2|||
105794472|NCT00096200|364902263|FG002|Overall Study|Withdrawal by Subject|0|||
105794473|NCT00096200|364902261|FG000|Overall Study|Ineligible pathology|0|||
105794474|NCT00096200|364902262|FG001|Overall Study|Ineligible pathology|1|||
105794475|NCT00096200|364902263|FG002|Overall Study|Ineligible pathology|0|||
105794476|NCT00478673|364902264|FG000|30-Days Post-Procedure|Death|2|||
106009515|NCT02435992|365700867|FG002|Overall Study|non compliance with protocol|1|||
105794477|NCT00478673|364902264|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
105794478|NCT00478673|364902264|FG000|30-Days Post-Procedure|Missed Visit|7|||
105794479|NCT00478673|364902264|FG000|12-Months Post-Procedure|Death|23|||
105794480|NCT00478673|364902264|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
105794481|NCT00478673|364902264|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
106009516|NCT02435992|365700868|FG003|Overall Study|non compliance with protocol|0|||
106009517|NCT02435992|365700869|FG004|Overall Study|non compliance with protocol|0|||
105794482|NCT00478673|364902264|FG000|12-Months Post-Procedure|Missed Visit|25|||
105794483|NCT00478673|364902264|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
105726638|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105726639|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
105726640|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726641|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726642|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726643|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726644|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726645|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726646|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106009518|NCT02435992|365700865|FG000|Overall Study|Adverse Event|11|||
105726647|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
105726648|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
105726649|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
105726650|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726651|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726652|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726653|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726654|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726655|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726656|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
105726657|NCT01307423|364655521|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726658|NCT01307423|364655522|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
105726659|NCT01307423|364655523|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
105726660|NCT01307423|364655524|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726661|NCT01307423|364655525|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726662|NCT01307423|364655526|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726663|NCT01307423|364655527|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726664|NCT01307423|364655528|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726665|NCT01307423|364655529|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
105726666|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726667|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
105726668|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
105726669|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
105726670|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
105726671|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726672|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726673|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726674|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
105726675|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726676|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
105726677|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
105726678|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
105726679|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
105726680|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726681|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726682|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726683|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
105726684|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726685|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726686|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726687|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726688|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726689|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
105726690|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726691|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726692|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
105726693|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726694|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
105726695|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
105726696|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726697|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726698|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
105726699|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
105726700|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726701|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
105726702|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726703|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726704|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726705|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
105726706|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726707|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726708|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726709|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726710|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
105726711|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
105726712|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
105726713|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
105726714|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
105726715|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
105794484|NCT03728257|364902280|FG000|Overall Study|Death|3|||
105794485|NCT03728257|364902281|FG001|Overall Study|Death|0|||
105794486|NCT05789420|364902283|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
105794487|NCT05789420|364902283|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
105794488|NCT03151226|364902284|FG000|Overall Study|Withdrawal by Subject|2|||
105794489|NCT03151226|364902284|FG000|Overall Study|not wear device correctly|1|||
105794490|NCT00391118|364902285|FG000|Overall Study|Adverse Event|3|||
105726716|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
105726717|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
105726718|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
105726719|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
105726720|NCT01307423|364655521|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726721|NCT01307423|364655522|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726722|NCT01307423|364655523|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726723|NCT01307423|364655524|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726724|NCT01307423|364655525|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726725|NCT01307423|364655526|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
105726726|NCT01307423|364655527|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726727|NCT01307423|364655528|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726728|NCT01307423|364655529|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
105726729|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726730|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
105726731|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
105726732|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726733|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726734|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726735|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
105726736|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
105794491|NCT00391118|364902286|FG001|Overall Study|Adverse Event|10|||
105794492|NCT00391118|364902287|FG002|Overall Study|Adverse Event|7|||
105794493|NCT00391118|364902285|FG000|Overall Study|Lost to Follow-up|0|||
105794494|NCT00391118|364902286|FG001|Overall Study|Lost to Follow-up|2|||
105794495|NCT00391118|364902287|FG002|Overall Study|Lost to Follow-up|3|||
105794496|NCT00391118|364902285|FG000|Overall Study|Withdrawal by Subject|0|||
105794497|NCT00391118|364902286|FG001|Overall Study|Withdrawal by Subject|9|||
105794498|NCT00391118|364902287|FG002|Overall Study|Withdrawal by Subject|1|||
105794499|NCT00391118|364902285|FG000|Overall Study|Death|0|||
105794500|NCT00391118|364902286|FG001|Overall Study|Death|1|||
105794501|NCT00391118|364902287|FG002|Overall Study|Death|0|||
105794502|NCT00391118|364902285|FG000|Overall Study|Physician Decision|0|||
105726737|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
105726738|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105794503|NCT00391118|364902286|FG001|Overall Study|Physician Decision|3|||
105794504|NCT00391118|364902287|FG002|Overall Study|Physician Decision|0|||
105794505|NCT00391118|364902285|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
105794506|NCT00391118|364902286|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
105794507|NCT00391118|364902287|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
105794508|NCT00391118|364902285|FG000|Overall Study|Progressive Disease|7|||
105794509|NCT00391118|364902286|FG001|Overall Study|Progressive Disease|26|||
105794510|NCT00391118|364902287|FG002|Overall Study|Progressive Disease|43|||
105794511|NCT00391118|364902285|FG000|Overall Study|Sponsor Decision|0|||
105794512|NCT00391118|364902286|FG001|Overall Study|Sponsor Decision|1|||
105794513|NCT00391118|364902287|FG002|Overall Study|Sponsor Decision|3|||
105794514|NCT00391118|364902285|FG000|Overall Study|Protocol Violation|1|||
105794515|NCT00391118|364902286|FG001|Overall Study|Protocol Violation|0|||
105794516|NCT00391118|364902287|FG002|Overall Study|Protocol Violation|0|||
105794517|NCT05473247|364902288|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
105794518|NCT02340078|364902291|FG000|Overall Study|Protocol Violation|1|||
105794519|NCT04278872|364902292|FG000|Overall Study|Adverse Event|1|||
105794520|NCT04278872|364902293|FG001|Overall Study|Adverse Event|0|||
105794521|NCT04278872|364902292|FG000|Overall Study|Protocol Violation|0|||
105794522|NCT04278872|364902293|FG001|Overall Study|Protocol Violation|1|||
105794523|NCT04278872|364902292|FG000|Overall Study|Study Termination|2|||
105794524|NCT04278872|364902293|FG001|Overall Study|Study Termination|0|||
105794525|NCT00953927|364903750|FG000|Overall Study|Lost to Follow-up|61|||
105794526|NCT00953927|364903751|FG001|Overall Study|Lost to Follow-up|65|||
105794527|NCT00953927|364903750|FG000|Overall Study|Withdrawal by Subject|36|||
105794528|NCT00953927|364903751|FG001|Overall Study|Withdrawal by Subject|25|||
105794529|NCT00953927|364903750|FG000|Overall Study|Death|7|||
105794530|NCT00953927|364903751|FG001|Overall Study|Death|4|||
105794531|NCT00953927|364903750|FG000|Overall Study|Other study discontinuation|1|||
105794532|NCT00953927|364903751|FG001|Overall Study|Other study discontinuation|1|||
105794533|NCT02953262|364903752|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
105794534|NCT02953262|364903753|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
105794535|NCT02953262|364903754|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
105794536|NCT02953262|364903755|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
105794537|NCT01856686|364903756|FG000|Overall Study|Lost to Follow-up|5|||
105794538|NCT01856686|364903757|FG001|Overall Study|Lost to Follow-up|11|||
105794539|NCT00602979|364903761|FG000|Overall Study|Lost to Follow-up|3|||
105794540|NCT00602979|364903762|FG001|Overall Study|Lost to Follow-up|2|||
105794541|NCT00602979|364903763|FG002|Overall Study|Lost to Follow-up|3|||
105794542|NCT00602979|364903764|FG003|Overall Study|Lost to Follow-up|2|||
105794543|NCT00602979|364903765|FG004|Overall Study|Lost to Follow-up|3|||
105794544|NCT00602979|364903761|FG000|Overall Study|Failed Intubation|0|||
105794545|NCT00602979|364903762|FG001|Overall Study|Failed Intubation|1|||
105794546|NCT00602979|364903763|FG002|Overall Study|Failed Intubation|0|||
105794547|NCT00602979|364903764|FG003|Overall Study|Failed Intubation|1|||
105794548|NCT00602979|364903765|FG004|Overall Study|Failed Intubation|0|||
105794549|NCT01052038|364903766|FG000|Overall Study|Lost to Follow-up|2|||
105794550|NCT01052038|364903767|FG001|Overall Study|Lost to Follow-up|3|||
105794551|NCT01052038|364903768|FG002|Overall Study|Lost to Follow-up|1|||
105794552|NCT01052038|364903766|FG000|Overall Study|Protocol Violation|2|||
105794553|NCT01052038|364903767|FG001|Overall Study|Protocol Violation|3|||
105794554|NCT01052038|364903768|FG002|Overall Study|Protocol Violation|3|||
105794555|NCT02499406|364903770|FG000|Overall Study|missed 3 treatment sessions|4|||
105794556|NCT01396161|364903776|FG000|Overall Study|Withdrawal by Subject|0|||
105794557|NCT01396161|364903777|FG001|Overall Study|Withdrawal by Subject|0|||
105794558|NCT01396161|364903778|FG002|Overall Study|Withdrawal by Subject|0|||
105794559|NCT01396161|364903779|FG003|Overall Study|Withdrawal by Subject|0|||
105794560|NCT01396161|364903780|FG004|Overall Study|Withdrawal by Subject|1|||
105794561|NCT01396161|364903781|FG005|Overall Study|Withdrawal by Subject|0|||
105794562|NCT01396161|364903782|FG006|Overall Study|Withdrawal by Subject|0|||
105794563|NCT01396161|364903776|FG000|Overall Study|Other|0|||
105794564|NCT01396161|364903777|FG001|Overall Study|Other|0|||
105794565|NCT01396161|364903778|FG002|Overall Study|Other|0|||
105794566|NCT01396161|364903779|FG003|Overall Study|Other|0|||
105794567|NCT01396161|364903780|FG004|Overall Study|Other|0|||
105794568|NCT01396161|364903781|FG005|Overall Study|Other|0|||
105794569|NCT01396161|364903782|FG006|Overall Study|Other|1|||
105794570|NCT02962739|364903785|FG000|Overall Study|Withdrawal by Subject|0|||
105794571|NCT02962739|364903786|FG001|Overall Study|Withdrawal by Subject|1|||
105794572|NCT02962739|364903787|FG002|Overall Study|Withdrawal by Subject|0|||
105794573|NCT02962739|364903788|FG003|Overall Study|Withdrawal by Subject|0|||
105726739|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
105726740|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
105726741|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105726742|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105726743|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
105726744|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
106009519|NCT02435992|365700866|FG001|Overall Study|Adverse Event|6|||
105794574|NCT02962739|364903789|FG004|Overall Study|Withdrawal by Subject|0|||
105794575|NCT02962739|364903790|FG005|Overall Study|Withdrawal by Subject|0|||
105794576|NCT02962739|364903785|FG000|Overall Study|Protocol Violation|0|||
105794577|NCT02962739|364903786|FG001|Overall Study|Protocol Violation|0|||
105794578|NCT02962739|364903787|FG002|Overall Study|Protocol Violation|1|||
105794579|NCT02962739|364903788|FG003|Overall Study|Protocol Violation|0|||
105794580|NCT02962739|364903789|FG004|Overall Study|Protocol Violation|1|||
105794581|NCT02962739|364903790|FG005|Overall Study|Protocol Violation|0|||
105794582|NCT00734617|364903791|FG000|Overall Study|Adverse Event|4|||
105794583|NCT00734617|364903792|FG001|Overall Study|Adverse Event|7|||
105794584|NCT00734617|364903791|FG000|Overall Study|Withdrawal by Subject|103|||
105794585|NCT00734617|364903792|FG001|Overall Study|Withdrawal by Subject|95|||
105794586|NCT00552617|364903793|FG000|Overall Study|Not Treated|0|||
105794587|NCT00552617|364903794|FG001|Overall Study|Not Treated|0|||
105794588|NCT00552617|364903795|FG002|Overall Study|Not Treated|1|||
105794589|NCT00552617|364903796|FG003|Overall Study|Not Treated|0|||
105794590|NCT00552617|364903797|FG004|Overall Study|Not Treated|0|||
105794591|NCT00552617|364903798|FG005|Overall Study|Not Treated|0|||
105794592|NCT00552617|364903799|FG006|Overall Study|Not Treated|0|||
105794593|NCT00552617|364903800|FG007|Overall Study|Not Treated|0|||
105794594|NCT00552617|364903801|FG008|Overall Study|Not Treated|0|||
105794595|NCT00552617|364903802|FG009|Overall Study|Not Treated|1|||
105794596|NCT00552617|364903793|FG000|Overall Study|Lost to Follow-up|0|||
105794597|NCT00552617|364903794|FG001|Overall Study|Lost to Follow-up|0|||
105794598|NCT00552617|364903795|FG002|Overall Study|Lost to Follow-up|0|||
105794599|NCT00552617|364903796|FG003|Overall Study|Lost to Follow-up|1|||
105794600|NCT00552617|364903797|FG004|Overall Study|Lost to Follow-up|0|||
105794601|NCT00552617|364903798|FG005|Overall Study|Lost to Follow-up|2|||
105794602|NCT00552617|364903799|FG006|Overall Study|Lost to Follow-up|0|||
105794603|NCT00552617|364903800|FG007|Overall Study|Lost to Follow-up|0|||
105794604|NCT00552617|364903801|FG008|Overall Study|Lost to Follow-up|2|||
105794605|NCT00552617|364903802|FG009|Overall Study|Lost to Follow-up|0|||
105794606|NCT01850108|364903803|FG000|Overall Study|Lost to Follow-up|4|||
105794607|NCT01850108|364903803|FG000|Overall Study|Not eligible|1|||
105794608|NCT01850108|364903803|FG000|Overall Study|Failed engraftment|2|||
105794609|NCT01850108|364903803|FG000|Overall Study|Physician Decision|1|||
105794610|NCT02072174|364903804|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
105794611|NCT02072174|364903805|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
105794612|NCT02072174|364903804|FG000|Overall Study|Protocol Violation|16|||
105794613|NCT02072174|364903805|FG001|Overall Study|Protocol Violation|23|||
105794614|NCT02072174|364903804|FG000|Overall Study|Physician Decision|0|||
105794615|NCT02072174|364903805|FG001|Overall Study|Physician Decision|1|||
105794616|NCT02072174|364903804|FG000|Overall Study|Non-compliance with protocol requirement|2|||
105794617|NCT02072174|364903805|FG001|Overall Study|Non-compliance with protocol requirement|0|||
105794618|NCT01787188|364903806|FG000|Overall Study|Adverse Event|2|||
105794619|NCT01787188|364903807|FG001|Overall Study|Adverse Event|4|||
105794620|NCT01787188|364903808|FG002|Overall Study|Adverse Event|6|||
105794621|NCT01787188|364903806|FG000|Overall Study|Lack of Efficacy|7|||
105794622|NCT01787188|364903807|FG001|Overall Study|Lack of Efficacy|3|||
105794623|NCT01787188|364903808|FG002|Overall Study|Lack of Efficacy|5|||
105794624|NCT01787188|364903806|FG000|Overall Study|Non-compliance with Study Drug|0|||
105794625|NCT01787188|364903807|FG001|Overall Study|Non-compliance with Study Drug|1|||
105794626|NCT01787188|364903808|FG002|Overall Study|Non-compliance with Study Drug|0|||
105794627|NCT01787188|364903806|FG000|Overall Study|Withdrawal by Subject|4|||
105794628|NCT01787188|364903807|FG001|Overall Study|Withdrawal by Subject|3|||
105794629|NCT01787188|364903808|FG002|Overall Study|Withdrawal by Subject|2|||
105794630|NCT01787188|364903806|FG000|Overall Study|Protocol Violation|3|||
105794631|NCT01787188|364903807|FG001|Overall Study|Protocol Violation|2|||
105794632|NCT01787188|364903808|FG002|Overall Study|Protocol Violation|3|||
105794633|NCT01787188|364903806|FG000|Overall Study|Lost to Follow-up|1|||
105794634|NCT01787188|364903807|FG001|Overall Study|Lost to Follow-up|2|||
105794635|NCT01787188|364903808|FG002|Overall Study|Lost to Follow-up|2|||
105794636|NCT01787188|364903806|FG000|Overall Study|Other, including patient moved|0|||
105794637|NCT01787188|364903807|FG001|Overall Study|Other, including patient moved|3|||
105794638|NCT01787188|364903808|FG002|Overall Study|Other, including patient moved|0|||
105794639|NCT05013749|364903813|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
105794640|NCT05013749|364903814|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
105794641|NCT05013749|364903813|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
105794642|NCT05013749|364903814|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
105794643|NCT01393626|364903817|FG000|Overall Study|Adverse Event|2|||
105794644|NCT01393626|364903818|FG001|Overall Study|Adverse Event|1|||
105794645|NCT01393626|364903819|FG002|Overall Study|Adverse Event|5|||
105794646|NCT01393626|364903820|FG003|Overall Study|Adverse Event|0|||
105794647|NCT01393626|364903817|FG000|Overall Study|Did not meet entrance criteria|1|||
105794648|NCT01393626|364903818|FG001|Overall Study|Did not meet entrance criteria|0|||
105794649|NCT01393626|364903819|FG002|Overall Study|Did not meet entrance criteria|0|||
105794650|NCT01393626|364903820|FG003|Overall Study|Did not meet entrance criteria|0|||
105794651|NCT01393626|364903817|FG000|Overall Study|Lack of Efficacy|6|||
105794652|NCT01393626|364903818|FG001|Overall Study|Lack of Efficacy|6|||
105794653|NCT01393626|364903819|FG002|Overall Study|Lack of Efficacy|4|||
105794654|NCT01393626|364903820|FG003|Overall Study|Lack of Efficacy|1|||
105794655|NCT01393626|364903817|FG000|Overall Study|Lost to Follow-up|1|||
105794656|NCT01393626|364903818|FG001|Overall Study|Lost to Follow-up|1|||
105794657|NCT01393626|364903819|FG002|Overall Study|Lost to Follow-up|1|||
105794658|NCT01393626|364903820|FG003|Overall Study|Lost to Follow-up|0|||
105794659|NCT01393626|364903817|FG000|Overall Study|Withdrawal by Subject|6|||
105794660|NCT01393626|364903818|FG001|Overall Study|Withdrawal by Subject|4|||
105794661|NCT01393626|364903819|FG002|Overall Study|Withdrawal by Subject|0|||
105794662|NCT01393626|364903820|FG003|Overall Study|Withdrawal by Subject|0|||
105794663|NCT01393626|364903817|FG000|Overall Study|Other|1|||
105794664|NCT01393626|364903818|FG001|Overall Study|Other|0|||
105794665|NCT01393626|364903819|FG002|Overall Study|Other|0|||
105794666|NCT01393626|364903820|FG003|Overall Study|Other|0|||
105794667|NCT01393626|364903817|FG000|Overall Study|Protocol Violation|1|||
105794668|NCT01393626|364903818|FG001|Overall Study|Protocol Violation|0|||
105794669|NCT01393626|364903819|FG002|Overall Study|Protocol Violation|2|||
105794670|NCT01393626|364903820|FG003|Overall Study|Protocol Violation|0|||
105794671|NCT02426125|364903821|FG000|Overall Study|Lost to Follow-up|14|||
105794672|NCT02426125|364903822|FG001|Overall Study|Lost to Follow-up|12|||
105794673|NCT02426125|364903821|FG000|Overall Study|Withdrawal by Subject|13|||
105794674|NCT02426125|364903822|FG001|Overall Study|Withdrawal by Subject|14|||
105794675|NCT02426125|364903821|FG000|Overall Study|Death|185|||
105794676|NCT02426125|364903822|FG001|Overall Study|Death|200|||
105794677|NCT02426125|364903821|FG000|Overall Study|Randomized, But Never Treated|5|||
105794678|NCT02426125|364903822|FG001|Overall Study|Randomized, But Never Treated|2|||
105794679|NCT02858076|364903823|FG000|Overall Study|Death|6|||
105794680|NCT02858076|364903824|FG001|Overall Study|Death|3|||
105794681|NCT02858076|364903823|FG000|Overall Study|Withdrawal by Subject|1|||
105794682|NCT02858076|364903824|FG001|Overall Study|Withdrawal by Subject|5|||
105794683|NCT02858076|364903823|FG000|Overall Study|Lost to Follow-up|2|||
105794684|NCT02858076|364903824|FG001|Overall Study|Lost to Follow-up|7|||
105794685|NCT02858076|364903823|FG000|Overall Study|Completed Out of Window|1|||
105794686|NCT02858076|364903824|FG001|Overall Study|Completed Out of Window|3|||
105794687|NCT00943384|364903827|FG000|Overall Study|Dispositioned prior to treatment|23|||
105794688|NCT00943384|364903827|FG000|Overall Study|Treated off protocol-protocol violation|5|||
105794689|NCT00943384|364903827|FG000|Overall Study|Lost to Follow-up|16|||
105794690|NCT00943384|364903827|FG000|Overall Study|Withdrawal by Subject|5|||
105794691|NCT03151707|364903828|FG000|Overall Study|Lost to Follow-up|6|||
105794692|NCT03332212|364903829|FG000|Overall Study|Not treated|0|||
105794693|NCT03332212|364903830|FG001|Overall Study|Not treated|1|||
105794694|NCT03332212|364903831|FG002|Overall Study|Not treated|0|||
105794695|NCT03332212|364903832|FG003|Overall Study|Not treated|0|||
105794696|NCT03332212|364903829|FG000|Overall Study|Adverse Event|0|||
105794697|NCT03332212|364903830|FG001|Overall Study|Adverse Event|0|||
105794698|NCT03332212|364903831|FG002|Overall Study|Adverse Event|0|||
105794699|NCT03332212|364903832|FG003|Overall Study|Adverse Event|1|||
105794700|NCT03332212|364903829|FG000|Overall Study|worsening of disease under study|1|||
105794701|NCT03332212|364903830|FG001|Overall Study|worsening of disease under study|1|||
105794702|NCT03332212|364903831|FG002|Overall Study|worsening of disease under study|0|||
105794703|NCT03332212|364903832|FG003|Overall Study|worsening of disease under study|0|||
105794704|NCT02125734|364903833|FG000|Period 2|Adverse Event|0|||
105794705|NCT02125734|364903834|FG001|Period 2|Adverse Event|1|||
105794706|NCT01308762|364903835|FG000|Overall Study|Protocol Violation|0|||
105794707|NCT01308762|364903836|FG001|Overall Study|Protocol Violation|1|||
105794708|NCT01308762|364903837|FG002|Overall Study|Protocol Violation|0|||
105794709|NCT00605839|364903838|FG000|Overall Study|Protocol Violation|1|||
105794710|NCT00605839|364903839|FG001|Overall Study|Protocol Violation|0|||
105794711|NCT00605839|364903840|FG002|Overall Study|Protocol Violation|0|||
105794712|NCT02617446|364903841|FG000|Overall Study|Withdrawal by Subject|0|||
105794713|NCT02617446|364903842|FG001|Overall Study|Withdrawal by Subject|2|||
105794714|NCT02617446|364903843|FG002|Overall Study|Withdrawal by Subject|0|||
105794715|NCT02617446|364903841|FG000|Overall Study|Adverse Event|1|||
105794716|NCT02617446|364903842|FG001|Overall Study|Adverse Event|0|||
105794717|NCT02617446|364903843|FG002|Overall Study|Adverse Event|5|||
105794718|NCT02617446|364903841|FG000|Overall Study|Lost to Follow-up|3|||
105794719|NCT02617446|364903842|FG001|Overall Study|Lost to Follow-up|0|||
105794720|NCT02617446|364903843|FG002|Overall Study|Lost to Follow-up|0|||
105794721|NCT02617446|364903841|FG000|Overall Study|Death|0|||
105794722|NCT02617446|364903842|FG001|Overall Study|Death|0|||
105794723|NCT02617446|364903843|FG002|Overall Study|Death|2|||
105794724|NCT00981019|364903844|FG000|Overall Study|Did not respond|65|||
105794725|NCT00981019|364903844|FG000|Overall Study|Did not match target population|94|||
105794726|NCT00981019|364903844|FG000|Overall Study|Inadvertent exclusion|239|||
105794727|NCT00981019|364903844|FG000|Overall Study|Hit the survey after closure|79|||
105794728|NCT00358670|364903845|FG000|Overall Study|Adverse Event|26|||
105794729|NCT00358670|364903846|FG001|Overall Study|Adverse Event|29|||
105794730|NCT00358670|364903845|FG000|Overall Study|Lack of Efficacy|20|||
105794731|NCT00358670|364903846|FG001|Overall Study|Lack of Efficacy|23|||
105794732|NCT00358670|364903845|FG000|Overall Study|Protocol Violation|6|||
105794733|NCT00358670|364903846|FG001|Overall Study|Protocol Violation|9|||
105794734|NCT00358670|364903845|FG000|Overall Study|Lost to Follow-up|4|||
105794735|NCT00358670|364903846|FG001|Overall Study|Lost to Follow-up|5|||
105794736|NCT00358670|364903845|FG000|Overall Study|Withdrawal by Subject|13|||
105794737|NCT00358670|364903846|FG001|Overall Study|Withdrawal by Subject|24|||
105794738|NCT00358670|364903845|FG000|Overall Study|Protocol Defined Clinical Event|0|||
105794739|NCT00358670|364903846|FG001|Overall Study|Protocol Defined Clinical Event|1|||
105794740|NCT00358670|364903845|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
105794741|NCT00358670|364903846|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
105794742|NCT00358670|364903845|FG000|Overall Study|Administrative|153|||
105794743|NCT00358670|364903846|FG001|Overall Study|Administrative|125|||
105794744|NCT00902278|364903847|FG000|Overall Study|Physician Decision|1|||
105794745|NCT00902278|364903848|FG001|Overall Study|Physician Decision|0|||
105794746|NCT00902278|364903849|FG002|Overall Study|Physician Decision|2|||
105794747|NCT00902278|364903850|FG003|Overall Study|Physician Decision|0|||
105794748|NCT00902278|364903851|FG004|Overall Study|Physician Decision|1|||
105794749|NCT00902278|364903847|FG000|Overall Study|Lost to Follow-up|3|||
105794750|NCT00902278|364903848|FG001|Overall Study|Lost to Follow-up|2|||
105794751|NCT00902278|364903849|FG002|Overall Study|Lost to Follow-up|3|||
105794752|NCT00902278|364903850|FG003|Overall Study|Lost to Follow-up|0|||
105794753|NCT00902278|364903851|FG004|Overall Study|Lost to Follow-up|1|||
105794754|NCT00960687|364903852|FG000|Washout Period of 7 Days|Adverse Event|3|||
105794755|NCT00960687|364903853|FG001|Washout Period of 7 Days|Adverse Event|2|||
105794756|NCT00960687|364903852|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
105794757|NCT00960687|364903853|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105794758|NCT02362646|364903854|FG000|Overall Study|Death|15|||
105794759|NCT02362646|364903855|FG001|Overall Study|Death|8|||
105794760|NCT02362646|364903854|FG000|Overall Study|Withdrawal by Subject|2|||
105794761|NCT02362646|364903855|FG001|Overall Study|Withdrawal by Subject|2|||
105794762|NCT02362646|364903854|FG000|Overall Study|received transplant|21|||
105794763|NCT02362646|364903855|FG001|Overall Study|received transplant|14|||
105794764|NCT00865306|364903856|FG000|Controlled Trial|Lost to Follow-up|1|||
105794765|NCT00865306|364903857|FG001|Controlled Trial|Lost to Follow-up|1|||
105794766|NCT00865306|364903856|FG000|Controlled Trial|Difficulty commuting|2|||
105794767|NCT00865306|364903857|FG001|Controlled Trial|Difficulty commuting|0|||
105794768|NCT00865306|364903856|FG000|Controlled Trial|Improved btw baseline and first session|1|||
105794769|NCT00865306|364903857|FG001|Controlled Trial|Improved btw baseline and first session|0|||
105794770|NCT00865306|364903856|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
106009520|NCT02435992|365700867|FG002|Overall Study|Adverse Event|12|||
105794771|NCT00865306|364903857|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
105794772|NCT00865306|364903856|FG000|Controlled Trial|Withdrawal by Subject|0|||
105794773|NCT00865306|364903857|FG001|Controlled Trial|Withdrawal by Subject|1|||
105794774|NCT05083559|364903860|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
105794775|NCT05083559|364903861|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
105794776|NCT05083559|364903860|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
105794777|NCT05083559|364903861|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
105794778|NCT05083559|364903860|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
105794779|NCT05083559|364903861|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
105794780|NCT02704130|364903864|FG000|Overall Study|Physician Decision|5|||
105794781|NCT02704130|364903865|FG001|Overall Study|Physician Decision|3|||
105794782|NCT02181842|364903866|FG000|Overall Study|Case Report Forms Uncollected|2|||
105794783|NCT01216319|364903867|FG000|Overall Study|Lost to Follow-up|2|||
105794784|NCT01216319|364903867|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
105794785|NCT02720094|364903868|FG000|Overall Study|Scheduled exit visit/end of study|2|||
105794786|NCT02720094|364903869|FG001|Overall Study|Scheduled exit visit/end of study|1|||
105794787|NCT02720094|364903868|FG000|Overall Study|Death|4|||
105794788|NCT02720094|364903869|FG001|Overall Study|Death|7|||
105794789|NCT02720094|364903868|FG000|Overall Study|Withdrawal by Subject|55|||
105794790|NCT02720094|364903869|FG001|Overall Study|Withdrawal by Subject|56|||
105794791|NCT02720094|364903868|FG000|Overall Study|Lost to Follow-up|2|||
105794792|NCT02720094|364903869|FG001|Overall Study|Lost to Follow-up|7|||
105794793|NCT02720094|364903868|FG000|Overall Study|Physician Decision|1|||
105794794|NCT02720094|364903869|FG001|Overall Study|Physician Decision|3|||
105794795|NCT02720094|364903868|FG000|Overall Study|Inappropriate enrollment|1|||
105794796|NCT02720094|364903869|FG001|Overall Study|Inappropriate enrollment|3|||
105794797|NCT02720094|364903868|FG000|Overall Study|Ongoing|2210|||
105794798|NCT02720094|364903869|FG001|Overall Study|Ongoing|2203|||
105794799|NCT02720094|364903868|FG000|Overall Study|Relocation|1|||
105794800|NCT02720094|364903869|FG001|Overall Study|Relocation|1|||
105794801|NCT05246111|364903870|FG000|Period 01|NOT ELIGIBLE IC5|1|||
105794802|NCT05246111|364903871|FG001|Period 01|NOT ELIGIBLE IC5|0|||
105794803|NCT02587325|364903872|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
105794804|NCT02587325|364903873|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
105794805|NCT02587325|364903874|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
105794806|NCT02587325|364903875|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
105794807|NCT02587325|364903876|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
105794808|NCT02587325|364903872|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
105794809|NCT02587325|364903873|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
105794810|NCT02587325|364903874|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
105794811|NCT02587325|364903875|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
105794812|NCT02587325|364903876|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
105794813|NCT02587325|364903872|FG000|32-Week Optional Extension Part|Adverse Event|0|||
105794814|NCT02587325|364903873|FG001|32-Week Optional Extension Part|Adverse Event|0|||
105794815|NCT02587325|364903874|FG002|32-Week Optional Extension Part|Adverse Event|1|||
105794816|NCT02587325|364903875|FG003|32-Week Optional Extension Part|Adverse Event|0|||
105794817|NCT02587325|364903876|FG004|32-Week Optional Extension Part|Adverse Event|0|||
105794818|NCT02587325|364903872|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
105794819|NCT02587325|364903873|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
105794820|NCT02587325|364903874|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
105794821|NCT02587325|364903875|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
105794822|NCT02587325|364903876|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
105794823|NCT01831596|364903877|FG000|Overall Study|Other|8|||
105794824|NCT01311505|364903878|FG000|First Intervention Period|Protocol Violation|0|||
105794825|NCT01311505|364903879|FG001|First Intervention Period|Protocol Violation|1|||
105794826|NCT02956005|364903883|FG000|Overall Study|Not eligible|1|||
105794827|NCT02956005|364903883|FG000|Overall Study|Withdrawal by Subject|3|||
105794828|NCT02956005|364903883|FG000|Overall Study|Physician Decision|12|||
105794829|NCT03022799|364903889|FG000|Overall Study|Adverse Event|0|||
105794830|NCT03022799|364903890|FG001|Overall Study|Adverse Event|0|||
105794831|NCT03022799|364903891|FG002|Overall Study|Adverse Event|0|||
105794832|NCT03022799|364903892|FG003|Overall Study|Adverse Event|0|||
105794833|NCT03022799|364903893|FG004|Overall Study|Adverse Event|0|||
105794834|NCT03022799|364903894|FG005|Overall Study|Adverse Event|0|||
105794835|NCT03022799|364903895|FG006|Overall Study|Adverse Event|0|||
105794836|NCT03022799|364903896|FG007|Overall Study|Adverse Event|0|||
106009521|NCT02435992|365700868|FG003|Overall Study|Adverse Event|0|||
105794837|NCT03022799|364903897|FG008|Overall Study|Adverse Event|0|||
105794838|NCT03022799|364903898|FG009|Overall Study|Adverse Event|1|||
105794839|NCT03022799|364903899|FG010|Overall Study|Adverse Event|1|||
105794840|NCT03022799|364903900|FG011|Overall Study|Adverse Event|0|||
105794841|NCT03022799|364903901|FG012|Overall Study|Adverse Event|0|||
105794842|NCT04881448|364903902|FG000|Overall Study|Study cancelled by sponsor|220|||
105936784|NCT03774810|365429372|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
105936785|NCT03774810|365429373|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
105936786|NCT03774810|365429374|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
105936787|NCT03774810|365429375|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
105936788|NCT03774810|365429376|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
106138756|NCT01212757|366167071|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
105726745|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
105726746|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
105726747|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726748|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726749|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
105726750|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726751|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105936789|NCT03774810|365429372|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
105936790|NCT03774810|365429373|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
106138757|NCT01212757|366167072|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106138758|NCT01212757|366167073|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
106138759|NCT01212757|366167065|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
106138760|NCT01212757|366167066|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
106138761|NCT01212757|366167067|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
106138762|NCT01212757|366167068|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
106138763|NCT01212757|366167069|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
106138764|NCT01212757|366167070|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
106138765|NCT01212757|366167071|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
106138766|NCT01212757|366167072|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
106138767|NCT01212757|366167073|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
106138768|NCT01212757|366167065|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
106138769|NCT01212757|366167066|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
106138770|NCT01212757|366167067|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
106138771|NCT01212757|366167068|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106138772|NCT01212757|366167069|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106138773|NCT01212757|366167070|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106138774|NCT01212757|366167071|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106138775|NCT01212757|366167072|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106138776|NCT01212757|366167073|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
106138777|NCT01212757|366167065|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106138778|NCT01212757|366167066|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
106138779|NCT01212757|366167067|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
106138780|NCT01212757|366167068|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106138781|NCT01212757|366167069|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106138782|NCT01212757|366167070|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106138783|NCT01212757|366167071|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106138784|NCT01212757|366167072|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106138785|NCT01212757|366167073|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
106138786|NCT01212757|366167065|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
106138787|NCT01212757|366167066|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
106138788|NCT01212757|366167067|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
106138789|NCT01212757|366167068|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
106138790|NCT01212757|366167069|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
106138791|NCT01212757|366167070|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
106138792|NCT01212757|366167071|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
106138793|NCT01212757|366167072|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
106138794|NCT01212757|366167073|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
106138795|NCT01212757|366167065|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
106138796|NCT01212757|366167066|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
106138797|NCT01212757|366167067|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
106138798|NCT01212757|366167068|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
106138799|NCT01212757|366167069|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
106138800|NCT01212757|366167070|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
106138801|NCT01212757|366167071|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
106138802|NCT01212757|366167072|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
106138803|NCT01212757|366167073|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
106138804|NCT01212757|366167065|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
106138805|NCT01212757|366167066|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
106138806|NCT01212757|366167067|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
106138807|NCT01212757|366167068|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
105726752|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726753|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726754|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726755|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
105726756|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726757|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
105726758|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
105726759|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726760|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726761|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726762|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
105726763|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
105726764|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
105726765|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726766|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
105726767|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726768|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726769|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726770|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726771|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
105726772|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
105726773|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
105726774|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726775|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
105726776|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
105726777|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726778|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726779|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726780|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
105726781|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
105726782|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
105726783|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726784|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
105726785|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
105726786|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726787|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726788|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726789|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
106009522|NCT02435992|365700869|FG004|Overall Study|Adverse Event|0|||
105726790|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
105726791|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
105726792|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726793|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
105726794|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
105726795|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726796|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726797|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726798|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726799|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726800|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
105726801|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105726802|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
105726803|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
105726804|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105726805|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105726806|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105726807|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
105794843|NCT04881448|364903902|FG000|Overall Study|Withdrawal by Subject|2|||
105936791|NCT03774810|365429374|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
105794844|NCT04881448|364903902|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
105726808|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
105726809|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
105726810|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726811|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
105726812|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
105726813|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726814|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726815|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726816|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
105726817|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
105726818|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
105726819|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726820|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
105726821|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726822|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726823|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726824|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726825|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726826|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
105726827|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
105726828|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726829|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
105726830|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726831|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726832|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726833|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726834|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726835|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105794845|NCT03273257|364903903|FG000|Overall Study|Death|0|||
105794846|NCT03273257|364903904|FG001|Overall Study|Death|1|||
105936792|NCT03774810|365429375|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
105936793|NCT03774810|365429376|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
105936794|NCT03774810|365429372|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
105726836|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
105726837|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726838|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
105726839|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726840|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726841|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726842|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
106138808|NCT01212757|366167069|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
106138809|NCT01212757|366167070|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
106138810|NCT01212757|366167071|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
106138811|NCT01212757|366167072|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
106138812|NCT01212757|366167073|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
106138813|NCT01212757|366167065|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
106138814|NCT01212757|366167066|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
106138815|NCT01212757|366167067|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
106138816|NCT01212757|366167068|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
106138817|NCT01212757|366167069|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
106138818|NCT01212757|366167070|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
106138819|NCT01212757|366167071|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
106138820|NCT01212757|366167072|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
106138821|NCT01212757|366167073|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
106138822|NCT01212757|366167065|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
106138823|NCT01212757|366167066|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
106138824|NCT01212757|366167067|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
106138825|NCT01212757|366167068|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
106138826|NCT01212757|366167069|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
106138827|NCT01212757|366167070|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
106138828|NCT01212757|366167071|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
106138829|NCT01212757|366167072|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
106138830|NCT01212757|366167073|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
106138831|NCT01212757|366167065|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
106138832|NCT01212757|366167066|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
106138833|NCT01212757|366167067|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
106138834|NCT01212757|366167068|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
106138835|NCT01212757|366167069|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
106138836|NCT01212757|366167070|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
106138837|NCT01212757|366167071|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
106138838|NCT01212757|366167072|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
106138839|NCT01212757|366167073|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
106138840|NCT01212757|366167065|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
106138841|NCT01212757|366167066|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
106138842|NCT01212757|366167067|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
106138843|NCT01212757|366167068|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
106138844|NCT01212757|366167069|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
106138845|NCT01212757|366167070|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
106138846|NCT01212757|366167071|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
106138847|NCT01212757|366167072|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
106138848|NCT01212757|366167073|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
106138849|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
106138850|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
106138851|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
106138852|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
106138853|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
106138854|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
106138855|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
106138856|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
106138857|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
106138858|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
106138859|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
106138860|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
106138861|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
106138862|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
106138863|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
106138864|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
106138865|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
106138866|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
106138867|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
106138868|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
106138869|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
106138870|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
106138871|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
105936795|NCT03774810|365429373|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
106138872|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
105726843|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726844|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
105726845|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
105726846|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726847|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
105936796|NCT03774810|365429374|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
105936797|NCT03774810|365429375|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
105936798|NCT03774810|365429376|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
105936799|NCT03774810|365429372|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
105936800|NCT03774810|365429373|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
105936801|NCT03774810|365429374|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
105936802|NCT03774810|365429375|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
105726848|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
105936803|NCT03774810|365429376|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
105726849|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726850|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726851|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726852|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105726853|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
105726854|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
105726855|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726856|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726857|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
105794847|NCT03273257|364903903|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
105794848|NCT03273257|364903904|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
105794849|NCT03273257|364903903|FG000|Overall Study|Study terminated|3|||
105794850|NCT03273257|364903904|FG001|Overall Study|Study terminated|2|||
105794851|NCT01238172|364903906|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
105794852|NCT01238172|364903907|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
105794853|NCT01238172|364903906|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
105794854|NCT01238172|364903907|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
105794855|NCT00701558|364903909|FG000|Overall Study|Death|7|||
105794856|NCT00701558|364903909|FG000|Overall Study|Lost to Follow-up|8|||
105794857|NCT01784419|364905928|FG000|Overall Study|Adverse Event|3|||
105794858|NCT00366678|364905929|FG000|Infant Series|Withdrawal by Subject|8|||
105794859|NCT00366678|364905930|FG001|Infant Series|Withdrawal by Subject|6|||
105794860|NCT00366678|364905931|FG002|Infant Series|Withdrawal by Subject|0|||
105794861|NCT00366678|364905929|FG000|Infant Series|Protocol Violation|4|||
105794862|NCT00366678|364905930|FG001|Infant Series|Protocol Violation|3|||
105794863|NCT00366678|364905931|FG002|Infant Series|Protocol Violation|0|||
105794864|NCT00366678|364905929|FG000|Infant Series|Failed to return|1|||
105794865|NCT00366678|364905930|FG001|Infant Series|Failed to return|1|||
105794866|NCT00366678|364905931|FG002|Infant Series|Failed to return|0|||
105794867|NCT00366678|364905929|FG000|Infant Series|Adverse Event|1|||
105794868|NCT00366678|364905930|FG001|Infant Series|Adverse Event|0|||
105794869|NCT00366678|364905931|FG002|Infant Series|Adverse Event|0|||
105794870|NCT00366678|364905929|FG000|After Infant|Withdrawal by Subject|8|||
105794871|NCT00366678|364905930|FG001|After Infant|Withdrawal by Subject|4|||
105794872|NCT00366678|364905931|FG002|After Infant|Withdrawal by Subject|0|||
105794873|NCT00366678|364905929|FG000|After Infant|Lost to Follow-up|2|||
105794874|NCT00366678|364905930|FG001|After Infant|Lost to Follow-up|1|||
105794875|NCT00366678|364905931|FG002|After Infant|Lost to Follow-up|0|||
105794876|NCT00366678|364905929|FG000|After Infant|Failed to return|5|||
105794877|NCT00366678|364905930|FG001|After Infant|Failed to return|5|||
105794878|NCT00366678|364905931|FG002|After Infant|Failed to return|0|||
105794879|NCT00366678|364905929|FG000|After Infant|Adverse Event|1|||
105794880|NCT00366678|364905930|FG001|After Infant|Adverse Event|0|||
105794881|NCT00366678|364905931|FG002|After Infant|Adverse Event|0|||
105794882|NCT00366678|364905929|FG000|After Infant|Protocol Violation|1|||
105794883|NCT00366678|364905930|FG001|After Infant|Protocol Violation|0|||
105794884|NCT00366678|364905931|FG002|After Infant|Protocol Violation|0|||
105794885|NCT00366678|364905929|FG000|Toddler Dose|Protocol Violation|2|||
105794886|NCT00366678|364905930|FG001|Toddler Dose|Protocol Violation|1|||
105794887|NCT00366678|364905931|FG002|Toddler Dose|Protocol Violation|0|||
105794888|NCT00366678|364905929|FG000|Toddler Dose|Failed to return|1|||
105794889|NCT00366678|364905930|FG001|Toddler Dose|Failed to return|0|||
105794890|NCT00366678|364905931|FG002|Toddler Dose|Failed to return|0|||
105794891|NCT00366678|364905929|FG000|Toddler Dose|Withdrawal by Subject|1|||
105794892|NCT00366678|364905930|FG001|Toddler Dose|Withdrawal by Subject|0|||
105794893|NCT00366678|364905931|FG002|Toddler Dose|Withdrawal by Subject|0|||
105794894|NCT00366678|364905929|FG000|Toddler Dose|protocol deviation|1|||
105794895|NCT00366678|364905930|FG001|Toddler Dose|protocol deviation|0|||
105794896|NCT00366678|364905931|FG002|Toddler Dose|protocol deviation|0|||
105794897|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
105794898|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
105794899|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
105794900|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
105794901|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
105794902|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
105794903|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
105794904|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
105794905|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
105794906|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
105794907|NCT01777191|364905932|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
105794908|NCT01777191|364905933|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
105794909|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
105794910|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
105936804|NCT03774810|365429372|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
105794911|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
105794912|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
105794913|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
105794914|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
105794915|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
105794916|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
105794917|NCT01777191|364905932|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
105726858|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726859|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726860|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726861|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726862|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726863|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
105726864|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726865|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726866|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726867|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726868|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726869|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726870|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726871|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
105726872|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
105726873|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726874|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
105794918|NCT01777191|364905933|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
105794919|NCT00934622|364905935|FG000|Overall Study|Lost to Follow-up|7|||
105936805|NCT03774810|365429373|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
105936806|NCT03774810|365429374|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
105936807|NCT03774810|365429375|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
105936808|NCT03774810|365429376|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
105936809|NCT01658735|365429377|FG000|Overall Study|Lack of Efficacy|1|||
105726875|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
105726876|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726877|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726878|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726879|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105936810|NCT01658735|365429378|FG001|Overall Study|Lack of Efficacy|0|||
105936811|NCT01658735|365429379|FG002|Overall Study|Lack of Efficacy|1|||
105936812|NCT01658735|365429377|FG000|Overall Study|Lost to Follow-up|1|||
105936813|NCT01658735|365429378|FG001|Overall Study|Lost to Follow-up|1|||
105936814|NCT01658735|365429379|FG002|Overall Study|Lost to Follow-up|0|||
105936815|NCT01658735|365429377|FG000|Overall Study|Protocol Violation|0|||
105936816|NCT01658735|365429378|FG001|Overall Study|Protocol Violation|1|||
105936817|NCT01658735|365429379|FG002|Overall Study|Protocol Violation|0|||
105936818|NCT01658735|365429377|FG000|Overall Study|Withdrawal by Subject|3|||
105936819|NCT01658735|365429378|FG001|Overall Study|Withdrawal by Subject|5|||
105936820|NCT01658735|365429379|FG002|Overall Study|Withdrawal by Subject|3|||
105726880|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
105726881|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
105726882|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726883|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
105726884|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
105726885|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726886|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726887|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726888|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726889|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726890|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
105726891|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726892|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
105726893|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
105726894|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726895|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726896|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726897|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726898|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
105726899|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
105726900|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726901|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
105726902|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726903|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726904|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726905|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726906|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726907|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105794920|NCT00934622|364905935|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
105794921|NCT01128153|364905942|FG000|Overall Study|Adverse Event|1|||
105794922|NCT01128153|364905943|FG001|Overall Study|Adverse Event|3|||
105936821|NCT03156621|365429380|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
105936822|NCT03156621|365429381|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
105936823|NCT03156621|365429380|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
105936824|NCT03156621|365429381|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
105794923|NCT01128153|364905942|FG000|Overall Study|Condition under investigation worsened|8|||
105794924|NCT01128153|364905943|FG001|Overall Study|Condition under investigation worsened|7|||
105794925|NCT01128153|364905942|FG000|Overall Study|Withdrawal by Subject|2|||
105794926|NCT01128153|364905943|FG001|Overall Study|Withdrawal by Subject|3|||
105794927|NCT01128153|364905942|FG000|Overall Study|Incorrect enrolment to study|2|||
105794928|NCT01128153|364905943|FG001|Overall Study|Incorrect enrolment to study|1|||
105794929|NCT01128153|364905942|FG000|Overall Study|Protocol Violation|2|||
105794930|NCT01128153|364905943|FG001|Overall Study|Protocol Violation|0|||
105794931|NCT01128153|364905942|FG000|Overall Study|Developed discontinuation criteria|1|||
105794932|NCT01128153|364905943|FG001|Overall Study|Developed discontinuation criteria|1|||
105794933|NCT02610842|364905958|FG000|Overall Study|Lost to Follow-up|5|||
105794934|NCT01988493|364905959|FG000|Overall Study|Randomized but not treated|0|||
105794935|NCT01988493|364905960|FG001|Overall Study|Randomized but not treated|0|||
105794936|NCT01988493|364905961|FG002|Overall Study|Randomized but not treated|0|||
105794937|NCT01988493|364905962|FG003|Overall Study|Randomized but not treated|0|||
105794938|NCT01988493|364905963|FG004|Overall Study|Randomized but not treated|1|||
105794939|NCT01766310|364905971|FG000|Overall Study|Lost to Follow-up|1|||
105794940|NCT01766310|364905972|FG001|Overall Study|Lost to Follow-up|3|||
105794941|NCT00481871|364905978|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
105794942|NCT00481871|364905979|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
105794943|NCT00481871|364905980|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
105794944|NCT00481871|364905981|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
105794945|NCT00481871|364905982|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
105794946|NCT01652872|364905986|FG000|Overall Study|Death|36|||
105794947|NCT01652872|364905987|FG001|Overall Study|Death|39|||
105794948|NCT01652872|364905986|FG000|Overall Study|Lost to Follow-up|28|||
105794949|NCT01652872|364905987|FG001|Overall Study|Lost to Follow-up|23|||
105794950|NCT01652872|364905986|FG000|Overall Study|Decision by sponsor|5|||
105794951|NCT01652872|364905987|FG001|Overall Study|Decision by sponsor|7|||
105794952|NCT01652872|364905986|FG000|Overall Study|Withdrawal by Subject|76|||
105794953|NCT01652872|364905987|FG001|Overall Study|Withdrawal by Subject|84|||
105794954|NCT04529096|364905988|FG000|Overall Study|Adverse Event|6|||
105794955|NCT04529096|364905989|FG001|Overall Study|Adverse Event|1|||
105794956|NCT04529096|364905988|FG000|Overall Study|Lack of Efficacy|1|||
105794957|NCT04529096|364905989|FG001|Overall Study|Lack of Efficacy|0|||
105794958|NCT04529096|364905988|FG000|Overall Study|Lost to Follow-up|1|||
105794959|NCT04529096|364905989|FG001|Overall Study|Lost to Follow-up|1|||
105794960|NCT04529096|364905988|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105794961|NCT04529096|364905989|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105794962|NCT04529096|364905988|FG000|Overall Study|Physician Decision|1|||
105794963|NCT04529096|364905989|FG001|Overall Study|Physician Decision|3|||
105794964|NCT04529096|364905988|FG000|Overall Study|Withdrawal by Subject|5|||
105794965|NCT04529096|364905989|FG001|Overall Study|Withdrawal by Subject|0|||
105794966|NCT00995488|364905990|FG000|Overall Study|Withdrawal by Subject|1|||
105794967|NCT01289990|364905994|FG000|Overall Study|Death|0|||
105794968|NCT01289990|364905995|FG001|Overall Study|Death|0|||
105794969|NCT01289990|364905996|FG002|Overall Study|Death|0|||
105794970|NCT01289990|364905997|FG003|Overall Study|Death|1|||
105794971|NCT01289990|364905998|FG004|Overall Study|Death|2|||
105794972|NCT01289990|364905999|FG005|Overall Study|Death|1|||
105794973|NCT01289990|364906000|FG006|Overall Study|Death|0|||
105794974|NCT01289990|364906001|FG007|Overall Study|Death|0|||
105794975|NCT01289990|364906002|FG008|Overall Study|Death|0|||
105794976|NCT01289990|364906003|FG009|Overall Study|Death|0|||
105794977|NCT01289990|364906004|FG010|Overall Study|Death|0|||
105794978|NCT01289990|364906005|FG011|Overall Study|Death|1|||
105794979|NCT01289990|364906006|FG012|Overall Study|Death|0|||
105794980|NCT01289990|364905994|FG000|Overall Study|Lost to Follow-up|3|||
105794981|NCT01289990|364905995|FG001|Overall Study|Lost to Follow-up|2|||
105794982|NCT01289990|364905996|FG002|Overall Study|Lost to Follow-up|5|||
105794983|NCT01289990|364905997|FG003|Overall Study|Lost to Follow-up|5|||
105794984|NCT01289990|364905998|FG004|Overall Study|Lost to Follow-up|3|||
105794985|NCT01289990|364905999|FG005|Overall Study|Lost to Follow-up|4|||
105794986|NCT01289990|364906000|FG006|Overall Study|Lost to Follow-up|2|||
105794987|NCT01289990|364906001|FG007|Overall Study|Lost to Follow-up|2|||
105794988|NCT01289990|364906002|FG008|Overall Study|Lost to Follow-up|1|||
105794989|NCT01289990|364906003|FG009|Overall Study|Lost to Follow-up|4|||
105794990|NCT01289990|364906004|FG010|Overall Study|Lost to Follow-up|2|||
105794991|NCT01289990|364906005|FG011|Overall Study|Lost to Follow-up|1|||
105794992|NCT01289990|364906006|FG012|Overall Study|Lost to Follow-up|2|||
105794993|NCT01289990|364905994|FG000|Overall Study|Withdrawal by Subject|15|||
105794994|NCT01289990|364905995|FG001|Overall Study|Withdrawal by Subject|14|||
105794995|NCT01289990|364905996|FG002|Overall Study|Withdrawal by Subject|12|||
105794996|NCT01289990|364905997|FG003|Overall Study|Withdrawal by Subject|13|||
105794997|NCT01289990|364905998|FG004|Overall Study|Withdrawal by Subject|8|||
105794998|NCT01289990|364905999|FG005|Overall Study|Withdrawal by Subject|7|||
105794999|NCT01289990|364906000|FG006|Overall Study|Withdrawal by Subject|13|||
105795000|NCT01289990|364906001|FG007|Overall Study|Withdrawal by Subject|9|||
105936825|NCT01104870|365429382|FG000|Overall Study|Adverse Event|1|||
105936826|NCT01104870|365429383|FG001|Overall Study|Adverse Event|1|||
105936827|NCT01104870|365429384|FG002|Overall Study|Adverse Event|0|||
105936828|NCT01104870|365429382|FG000|Overall Study|Death|0|||
105936829|NCT01104870|365429383|FG001|Overall Study|Death|0|||
105936830|NCT01104870|365429384|FG002|Overall Study|Death|1|||
105936831|NCT01104870|365429382|FG000|Overall Study|Withdrawal by Subject|0|||
105936832|NCT01104870|365429383|FG001|Overall Study|Withdrawal by Subject|0|||
105936833|NCT01104870|365429384|FG002|Overall Study|Withdrawal by Subject|1|||
105936834|NCT01122680|365429385|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
105936835|NCT01122680|365429386|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
105936836|NCT01122680|365429387|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
105936837|NCT01122680|365429388|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
105936838|NCT01122680|365429385|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
105936839|NCT01122680|365429386|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
105936840|NCT01122680|365429387|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
105936841|NCT01122680|365429388|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
105936842|NCT01122680|365429385|FG000|Period 1 (4 Weeks)|Other|1|||
105936843|NCT01122680|365429386|FG001|Period 1 (4 Weeks)|Other|1|||
105936844|NCT01122680|365429387|FG002|Period 1 (4 Weeks)|Other|0|||
105936845|NCT01122680|365429388|FG003|Period 1 (4 Weeks)|Other|0|||
105936846|NCT01122680|365429385|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
105936847|NCT01122680|365429386|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
105936848|NCT01122680|365429387|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
105936849|NCT01122680|365429388|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
105936850|NCT01122680|365429385|FG000|Period 2 (4 Weeks)|Other|1|||
105936851|NCT01122680|365429386|FG001|Period 2 (4 Weeks)|Other|0|||
105936852|NCT01122680|365429387|FG002|Period 2 (4 Weeks)|Other|0|||
105936853|NCT01122680|365429388|FG003|Period 2 (4 Weeks)|Other|0|||
105936854|NCT01122680|365429385|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
105936855|NCT01122680|365429386|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
105936856|NCT01122680|365429387|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
105936857|NCT01122680|365429388|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
105936858|NCT01122680|365429385|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105936859|NCT01122680|365429386|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
105936860|NCT01122680|365429387|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105936861|NCT01122680|365429388|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
105936862|NCT05122143|365429389|FG000|Overall Study|Adverse Event|1|||
105936863|NCT05122143|365429390|FG001|Overall Study|Adverse Event|0|||
105936864|NCT05122143|365429391|FG002|Overall Study|Adverse Event|0|||
105936865|NCT05122143|365429392|FG003|Overall Study|Adverse Event|0|||
105936866|NCT05122143|365429393|FG004|Overall Study|Adverse Event|1|||
105936867|NCT05122143|365429394|FG005|Overall Study|Adverse Event|0|||
105936868|NCT05122143|365429389|FG000|Overall Study|Protocol non-compliance|0|||
105936869|NCT05122143|365429390|FG001|Overall Study|Protocol non-compliance|0|||
105936870|NCT05122143|365429391|FG002|Overall Study|Protocol non-compliance|1|||
105936871|NCT05122143|365429392|FG003|Overall Study|Protocol non-compliance|0|||
105936872|NCT05122143|365429393|FG004|Overall Study|Protocol non-compliance|0|||
105936873|NCT05122143|365429394|FG005|Overall Study|Protocol non-compliance|0|||
106138873|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
106138874|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
106138875|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
106138876|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106138877|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
106138878|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
106138879|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106138880|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106138881|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106138882|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
106138883|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
106138884|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
106138885|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
106138886|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
106138887|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
106138888|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
106138889|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
106138890|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
106138891|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105936874|NCT05122143|365429389|FG000|Overall Study|Covid contact|0|||
105936875|NCT05122143|365429390|FG001|Overall Study|Covid contact|0|||
105936876|NCT05122143|365429391|FG002|Overall Study|Covid contact|0|||
105936877|NCT05122143|365429392|FG003|Overall Study|Covid contact|0|||
105936878|NCT05122143|365429393|FG004|Overall Study|Covid contact|1|||
105936879|NCT05122143|365429394|FG005|Overall Study|Covid contact|0|||
106138892|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
105936880|NCT01550965|365429398|FG000|Overall Study|Adverse Event|26|||
105936881|NCT01550965|365429398|FG000|Overall Study|Withdrawal by Subject|10|||
105936882|NCT01550965|365429398|FG000|Overall Study|Lost to Follow-up|2|||
106138893|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
106138894|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
106138895|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
106138896|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
106138897|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
106138898|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
106009523|NCT02435992|365700865|FG000|Overall Study|Lack of Efficacy|4|||
106009524|NCT02435992|365700866|FG001|Overall Study|Lack of Efficacy|10|||
106009525|NCT02435992|365700867|FG002|Overall Study|Lack of Efficacy|9|||
106009526|NCT02435992|365700868|FG003|Overall Study|Lack of Efficacy|0|||
106009527|NCT02435992|365700869|FG004|Overall Study|Lack of Efficacy|0|||
106009528|NCT02435992|365700865|FG000|Overall Study|Withdrawal by Subject|10|||
106009529|NCT02435992|365700866|FG001|Overall Study|Withdrawal by Subject|8|||
106009530|NCT02435992|365700867|FG002|Overall Study|Withdrawal by Subject|20|||
106009531|NCT02435992|365700868|FG003|Overall Study|Withdrawal by Subject|0|||
106009532|NCT02435992|365700869|FG004|Overall Study|Withdrawal by Subject|0|||
106138899|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
106138900|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
106138901|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
106138902|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
106138903|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
106138904|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
105795001|NCT01289990|364906002|FG008|Overall Study|Withdrawal by Subject|12|||
106009533|NCT02435992|365700865|FG000|Overall Study|Other Reason|1|||
105795002|NCT01289990|364906003|FG009|Overall Study|Withdrawal by Subject|13|||
106138905|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
106138906|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
105726908|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
105726909|NCT01307423|364655521|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726910|NCT01307423|364655522|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726911|NCT01307423|364655523|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
105726912|NCT01307423|364655524|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726913|NCT01307423|364655525|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726914|NCT01307423|364655526|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726915|NCT01307423|364655527|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
105726916|NCT01307423|364655528|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
105726917|NCT01307423|364655529|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
105726918|NCT00693706|364655530|FG000|Overall Study|Protocol Violation|0|||
105726919|NCT00693706|364655531|FG001|Overall Study|Protocol Violation|1|||
105726920|NCT02371629|364655535|FG000|Overall Study|Patient decision|14|||
105726921|NCT02371629|364655536|FG001|Overall Study|Patient decision|10|||
105726922|NCT02371629|364655535|FG000|Overall Study|Adverse Event|8|||
105726923|NCT02371629|364655536|FG001|Overall Study|Adverse Event|8|||
105726924|NCT02371629|364655535|FG000|Overall Study|Physician Decision|2|||
105795003|NCT01289990|364906004|FG010|Overall Study|Withdrawal by Subject|11|||
105726925|NCT02371629|364655536|FG001|Overall Study|Physician Decision|3|||
105726926|NCT02371629|364655535|FG000|Overall Study|Death|1|||
105726927|NCT02371629|364655536|FG001|Overall Study|Death|1|||
105726928|NCT02371629|364655535|FG000|Overall Study|Noncompliance with study treatment|1|||
105726929|NCT02371629|364655536|FG001|Overall Study|Noncompliance with study treatment|0|||
105726930|NCT02371629|364655535|FG000|Overall Study|Lack of Efficacy|0|||
105726931|NCT02371629|364655536|FG001|Overall Study|Lack of Efficacy|2|||
105726932|NCT02371629|364655535|FG000|Overall Study|Protocol deviation|0|||
105726933|NCT02371629|364655536|FG001|Overall Study|Protocol deviation|1|||
105726934|NCT03406962|364655537|FG000|Overall Study|Death|2|||
105726935|NCT03406962|364655537|FG000|Overall Study|Adverse Event|1|||
105726936|NCT03853694|364655538|FG000|Overall Study|Protocol Violation|3|||
105726937|NCT03853694|364655539|FG001|Overall Study|Protocol Violation|5|||
105726938|NCT03853694|364655540|FG002|Overall Study|Protocol Violation|3|||
105726939|NCT03853694|364655538|FG000|Overall Study|Delivered early|0|||
105726940|NCT03853694|364655539|FG001|Overall Study|Delivered early|1|||
105726941|NCT03853694|364655540|FG002|Overall Study|Delivered early|0|||
105726942|NCT03853694|364655538|FG000|Overall Study|not suitable to proceed|0|||
105726943|NCT03853694|364655539|FG001|Overall Study|not suitable to proceed|1|||
105726944|NCT03853694|364655540|FG002|Overall Study|not suitable to proceed|0|||
105726945|NCT03853694|364655538|FG000|Overall Study|difficult surgery|0|||
105726946|NCT03853694|364655539|FG001|Overall Study|difficult surgery|0|||
105726947|NCT03853694|364655540|FG002|Overall Study|difficult surgery|1|||
105726948|NCT03853694|364655538|FG000|Overall Study|Lost to Follow-up|0|||
105726949|NCT03853694|364655539|FG001|Overall Study|Lost to Follow-up|1|||
105726950|NCT03853694|364655540|FG002|Overall Study|Lost to Follow-up|0|||
105726951|NCT03853694|364655538|FG000|Overall Study|Withdrawal by Subject|0|||
105726952|NCT03853694|364655539|FG001|Overall Study|Withdrawal by Subject|1|||
105726953|NCT03853694|364655540|FG002|Overall Study|Withdrawal by Subject|0|||
105726954|NCT02499952|364655541|FG000|Overall Study|Lost to Follow-up|1|||
105726955|NCT02499952|364655541|FG000|Overall Study|Death|9|||
105726956|NCT05089708|364655542|FG000|Overall Study|Lost to Follow-up|9|||
105726957|NCT05089708|364655543|FG001|Overall Study|Lost to Follow-up|7|||
105726958|NCT05089708|364655542|FG000|Overall Study|Withdrawal by Subject|3|||
105726959|NCT05089708|364655543|FG001|Overall Study|Withdrawal by Subject|1|||
105726960|NCT05089708|364655542|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
105726961|NCT05089708|364655543|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
105726962|NCT05089708|364655542|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
105726963|NCT05089708|364655543|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
105726964|NCT00327444|364655544|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
105726965|NCT00327444|364655545|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
105726966|NCT00327444|364655544|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
105726967|NCT00327444|364655545|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
105726968|NCT00327444|364655544|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
105726969|NCT00327444|364655545|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
105726970|NCT00327444|364655544|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
105726971|NCT00327444|364655545|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
105726972|NCT00327444|364655544|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
105726973|NCT00327444|364655545|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
105726974|NCT00327444|364655544|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
105726975|NCT00327444|364655545|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
105726976|NCT00327444|364655544|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
105726977|NCT00327444|364655545|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
105726978|NCT00327444|364655544|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
105726979|NCT00327444|364655545|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
105726980|NCT03830281|364655546|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
105726981|NCT03830281|364655547|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
105726982|NCT03830281|364655546|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
105726983|NCT03830281|364655547|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
105726984|NCT03830281|364655546|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
105726985|NCT03830281|364655547|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
105726986|NCT03830281|364655546|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
105726987|NCT03830281|364655547|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
105726988|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
105726989|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
105726990|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
105726991|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
105726992|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
105726993|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
105726994|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
105726995|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
105726996|NCT03830281|364655546|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
105726997|NCT03830281|364655547|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
105726998|NCT00201851|364655548|FG000|Overall Study|Lost to Follow-up|2|||
105726999|NCT00201851|364655549|FG001|Overall Study|Lost to Follow-up|1|||
105727000|NCT00201851|364655550|FG002|Overall Study|Lost to Follow-up|0|||
105727001|NCT00201851|364655548|FG000|Overall Study|Ineligible post enrollment|6|||
105727002|NCT00201851|364655549|FG001|Overall Study|Ineligible post enrollment|1|||
105727003|NCT00201851|364655550|FG002|Overall Study|Ineligible post enrollment|1|||
105727004|NCT00144170|364655551|FG000|Overall Study|Adverse Event|84|||
105727005|NCT00144170|364655552|FG001|Overall Study|Adverse Event|41|||
105727006|NCT00144170|364655551|FG000|Overall Study|Protocol Violation|23|||
105727007|NCT00144170|364655552|FG001|Overall Study|Protocol Violation|16|||
105727008|NCT00144170|364655551|FG000|Overall Study|Lost to Follow-up|5|||
105727009|NCT00144170|364655552|FG001|Overall Study|Lost to Follow-up|10|||
105727010|NCT00144170|364655551|FG000|Overall Study|Withdrawal by Subject|29|||
105727011|NCT00144170|364655552|FG001|Overall Study|Withdrawal by Subject|13|||
105727012|NCT00144170|364655551|FG000|Overall Study|Other reason not defined above|211|||
105727013|NCT00144170|364655552|FG001|Overall Study|Other reason not defined above|316|||
105727014|NCT00702143|364655553|FG000|Overall Study|Lost to Follow-up|0|||
105727015|NCT00702143|364655554|FG001|Overall Study|Lost to Follow-up|0|||
105727016|NCT00702143|364655555|FG002|Overall Study|Lost to Follow-up|1|||
105727017|NCT04091217|364655556|FG000|Overall Study|Lost to Follow-up|2|||
105727018|NCT04826900|364655560|FG000|Overall Study|Family factor|1|||
105727019|NCT04826900|364655561|FG001|Overall Study|Family factor|1|||
105727020|NCT00818259|364655562|FG000|Part I|Withdrawal by Subject|1|||
105727021|NCT00818259|364655563|FG001|Part I|Withdrawal by Subject|0|||
105727022|NCT00818259|364655564|FG002|Part I|Withdrawal by Subject|0|||
105727023|NCT00818259|364655565|FG003|Part I|Withdrawal by Subject|0|||
105727024|NCT00818259|364655566|FG004|Part I|Withdrawal by Subject|0|||
105727025|NCT00818259|364655567|FG005|Part I|Withdrawal by Subject|0|||
105727026|NCT00818259|364655568|FG006|Part I|Withdrawal by Subject|0|||
105727027|NCT00818259|364655569|FG007|Part I|Withdrawal by Subject|0|||
105727028|NCT00818259|364655570|FG008|Part I|Withdrawal by Subject|0|||
105727029|NCT00818259|364655562|FG000|Part II|Physician Decision|0|||
105727030|NCT00818259|364655563|FG001|Part II|Physician Decision|0|||
105727031|NCT00818259|364655564|FG002|Part II|Physician Decision|1|||
105727032|NCT00818259|364655565|FG003|Part II|Physician Decision|0|||
105727033|NCT00818259|364655566|FG004|Part II|Physician Decision|0|||
105727034|NCT00818259|364655567|FG005|Part II|Physician Decision|0|||
105727035|NCT00818259|364655568|FG006|Part II|Physician Decision|0|||
105727036|NCT00818259|364655569|FG007|Part II|Physician Decision|0|||
105727037|NCT00818259|364655570|FG008|Part II|Physician Decision|0|||
105727038|NCT00818259|364655562|FG000|Part II|Lack of Efficacy|0|||
105727039|NCT00818259|364655563|FG001|Part II|Lack of Efficacy|0|||
105727040|NCT00818259|364655564|FG002|Part II|Lack of Efficacy|0|||
105727041|NCT00818259|364655565|FG003|Part II|Lack of Efficacy|1|||
105727042|NCT00818259|364655566|FG004|Part II|Lack of Efficacy|0|||
105727043|NCT00818259|364655567|FG005|Part II|Lack of Efficacy|0|||
105727044|NCT00818259|364655568|FG006|Part II|Lack of Efficacy|0|||
105727045|NCT00818259|364655569|FG007|Part II|Lack of Efficacy|0|||
105727046|NCT00818259|364655570|FG008|Part II|Lack of Efficacy|0|||
105727047|NCT00818259|364655562|FG000|Part II|Not Treated|0|||
105727048|NCT00818259|364655563|FG001|Part II|Not Treated|0|||
105727049|NCT00818259|364655564|FG002|Part II|Not Treated|0|||
105727050|NCT00818259|364655565|FG003|Part II|Not Treated|1|||
105727051|NCT00818259|364655566|FG004|Part II|Not Treated|0|||
105727052|NCT00818259|364655567|FG005|Part II|Not Treated|0|||
105727053|NCT00818259|364655568|FG006|Part II|Not Treated|0|||
105727054|NCT00818259|364655569|FG007|Part II|Not Treated|0|||
105727055|NCT00818259|364655570|FG008|Part II|Not Treated|0|||
105727056|NCT00818259|364655562|FG000|Part IV|Physician Decision|0|||
105727057|NCT00818259|364655563|FG001|Part IV|Physician Decision|0|||
105727058|NCT00818259|364655564|FG002|Part IV|Physician Decision|0|||
105727059|NCT00818259|364655565|FG003|Part IV|Physician Decision|0|||
105727060|NCT00818259|364655566|FG004|Part IV|Physician Decision|0|||
105727061|NCT00818259|364655567|FG005|Part IV|Physician Decision|1|||
105727062|NCT00818259|364655568|FG006|Part IV|Physician Decision|0|||
105727063|NCT00818259|364655569|FG007|Part IV|Physician Decision|0|||
105727064|NCT00818259|364655570|FG008|Part IV|Physician Decision|0|||
105727065|NCT00818259|364655562|FG000|Part V|Adverse Event|0|||
105727066|NCT00818259|364655563|FG001|Part V|Adverse Event|0|||
105727067|NCT00818259|364655564|FG002|Part V|Adverse Event|0|||
105727068|NCT00818259|364655565|FG003|Part V|Adverse Event|0|||
105727069|NCT00818259|364655566|FG004|Part V|Adverse Event|0|||
105727070|NCT00818259|364655567|FG005|Part V|Adverse Event|0|||
105727071|NCT00818259|364655568|FG006|Part V|Adverse Event|0|||
105727072|NCT00818259|364655569|FG007|Part V|Adverse Event|1|||
105727073|NCT00818259|364655570|FG008|Part V|Adverse Event|0|||
105727074|NCT02597062|364655572|FG000|Overall Study|Ineligible|1|||
105727075|NCT00741819|364655573|FG000|Overall Study|Adverse Event|3|||
105727076|NCT00741819|364655573|FG000|Overall Study|Withdrawal by Subject|3|||
105727077|NCT00741819|364655573|FG000|Overall Study|Death|1|||
105727078|NCT00741819|364655573|FG000|Overall Study|Disease progression|1|||
105727079|NCT02117687|364655574|FG000|Overall Study|Lost to Follow-up|0|||
105727080|NCT02117687|364655575|FG001|Overall Study|Lost to Follow-up|1|||
106138907|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
106138908|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
106138909|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
106138910|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
106138911|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
106138912|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
106138913|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
106138914|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
105727081|NCT02117687|364655574|FG000|Overall Study|Adverse Event|0|||
105727082|NCT02117687|364655575|FG001|Overall Study|Adverse Event|2|||
105727083|NCT02117687|364655574|FG000|Overall Study|Other Reasons|1|||
105727084|NCT02117687|364655575|FG001|Overall Study|Other Reasons|1|||
105727085|NCT01126580|364655578|FG000|Overall Study|Adverse Event|14|||
105727086|NCT01126580|364655579|FG001|Overall Study|Adverse Event|8|||
105727087|NCT01126580|364655580|FG002|Overall Study|Adverse Event|12|||
105727088|NCT01126580|364655578|FG000|Overall Study|Withdrawal by Subject|11|||
105727089|NCT01126580|364655579|FG001|Overall Study|Withdrawal by Subject|19|||
105727090|NCT01126580|364655580|FG002|Overall Study|Withdrawal by Subject|14|||
105727091|NCT01126580|364655578|FG000|Overall Study|Sponsor Decision|5|||
105727092|NCT01126580|364655579|FG001|Overall Study|Sponsor Decision|4|||
105727093|NCT01126580|364655580|FG002|Overall Study|Sponsor Decision|7|||
105727094|NCT01126580|364655578|FG000|Overall Study|Physician Decision|1|||
105727095|NCT01126580|364655579|FG001|Overall Study|Physician Decision|1|||
105727096|NCT01126580|364655580|FG002|Overall Study|Physician Decision|2|||
105727097|NCT01126580|364655578|FG000|Overall Study|Entry Criteria Not Met|1|||
105727098|NCT01126580|364655579|FG001|Overall Study|Entry Criteria Not Met|1|||
105727099|NCT01126580|364655580|FG002|Overall Study|Entry Criteria Not Met|2|||
105727100|NCT01126580|364655578|FG000|Overall Study|Lack of Efficacy|2|||
105727101|NCT01126580|364655579|FG001|Overall Study|Lack of Efficacy|3|||
105727102|NCT01126580|364655580|FG002|Overall Study|Lack of Efficacy|4|||
105727103|NCT01126580|364655578|FG000|Overall Study|Protocol Violation|0|||
105727104|NCT01126580|364655579|FG001|Overall Study|Protocol Violation|1|||
105727105|NCT01126580|364655580|FG002|Overall Study|Protocol Violation|2|||
105727106|NCT01126580|364655578|FG000|Overall Study|Lost to Follow-up|15|||
105727107|NCT01126580|364655579|FG001|Overall Study|Lost to Follow-up|13|||
105727108|NCT01126580|364655580|FG002|Overall Study|Lost to Follow-up|9|||
105727109|NCT01126580|364655578|FG000|Overall Study|Treatment Non-compliance|0|||
105727110|NCT01126580|364655579|FG001|Overall Study|Treatment Non-compliance|2|||
105727111|NCT01126580|364655580|FG002|Overall Study|Treatment Non-compliance|3|||
105727112|NCT01053429|364655592|FG000|Overall Study|Adverse Event|64|||
105727113|NCT01053429|364655592|FG000|Overall Study|Other|309|||
105727114|NCT01708057|364655593|FG000|Overall Study|Withdrawal due to study termination.|1|||
105727115|NCT01708057|364655594|FG001|Overall Study|Withdrawal due to study termination.|1|||
105727116|NCT01708057|364655595|FG002|Overall Study|Withdrawal due to study termination.|1|||
105727117|NCT02970929|364655597|FG000|Overall Study|Adverse Event|18|||
105727118|NCT02970929|364655597|FG000|Overall Study|Lack of Efficacy|8|||
105727119|NCT02970929|364655597|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
105727120|NCT02970929|364655597|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
105727121|NCT02970929|364655597|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
105727122|NCT02970929|364655597|FG000|Overall Study|LOST TO FOLLOWUP|6|||
105727123|NCT02970929|364655597|FG000|Overall Study|MOVED OUT OF STATE|1|||
105727124|NCT02970929|364655597|FG000|Overall Study|Withdrawal by Subject|16|||
105727125|NCT00628355|364655598|FG000|Overall Study|Withdrawal by Subject|1|||
105727126|NCT00628355|364655599|FG001|Overall Study|Withdrawal by Subject|1|||
105795004|NCT01289990|364906005|FG011|Overall Study|Withdrawal by Subject|13|||
105795005|NCT01289990|364906006|FG012|Overall Study|Withdrawal by Subject|16|||
105795006|NCT01289990|364905994|FG000|Overall Study|discontinued in preceding trial|18|||
106138915|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
106138916|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
106138917|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
105727127|NCT00140855|364655600|FG000|Overall Study|Progressive disease|2|||
105727128|NCT03542682|364655605|FG000|Overall Study|COVID-19 Protocol|0|||
105727129|NCT03542682|364655606|FG001|Overall Study|COVID-19 Protocol|1|||
105727130|NCT00963807|364655608|FG000|Overall Study|Physician Decision|2|||
105727131|NCT00963807|364655608|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
105727132|NCT00963807|364655608|FG000|Overall Study|Disease progression|15|||
105795007|NCT01289990|364905995|FG001|Overall Study|discontinued in preceding trial|20|||
105727133|NCT03430310|364655609|FG000|Overall Study|Protocol Violation|2|||
105727134|NCT03430310|364655610|FG001|Overall Study|Protocol Violation|0|||
105727135|NCT03430310|364655609|FG000|Overall Study|Withdrawal by Subject|3|||
105727136|NCT03430310|364655610|FG001|Overall Study|Withdrawal by Subject|2|||
105727137|NCT03430310|364655609|FG000|Overall Study|COVID shutdown March 2020|0|||
105727138|NCT03430310|364655610|FG001|Overall Study|COVID shutdown March 2020|1|||
105795008|NCT01289990|364905996|FG002|Overall Study|discontinued in preceding trial|41|||
105795009|NCT01289990|364905997|FG003|Overall Study|discontinued in preceding trial|17|||
105795010|NCT01289990|364905998|FG004|Overall Study|discontinued in preceding trial|11|||
105795011|NCT01289990|364905999|FG005|Overall Study|discontinued in preceding trial|12|||
105795012|NCT01289990|364906000|FG006|Overall Study|discontinued in preceding trial|18|||
105795013|NCT01289990|364906001|FG007|Overall Study|discontinued in preceding trial|8|||
105795014|NCT01289990|364906002|FG008|Overall Study|discontinued in preceding trial|17|||
105936883|NCT01550965|365429398|FG000|Overall Study|Lack of Efficacy|59|||
106138918|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
106138919|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
106138920|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
106138921|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106138922|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
106138923|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
106138924|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106138925|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106138926|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106138927|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
106138928|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
106138929|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
106138930|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
106138931|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
106138932|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
106138933|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
106138934|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
106138935|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
106138936|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
106138937|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
106138938|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
105727139|NCT02234622|364655611|FG000|Overall Study|Withdrawal by Subject|16|||
105727140|NCT02234622|364655612|FG001|Overall Study|Withdrawal by Subject|22|||
105727141|NCT02234622|364655611|FG000|Overall Study|Lost to Follow-up|27|||
105727142|NCT02234622|364655612|FG001|Overall Study|Lost to Follow-up|14|||
105727143|NCT01446809|364655616|FG000|Overall Study|Adverse Event|0|||
105727144|NCT01446809|364655617|FG001|Overall Study|Adverse Event|0|||
105727145|NCT01446809|364655618|FG002|Overall Study|Adverse Event|1|||
105727146|NCT01446809|364655616|FG000|Overall Study|Failure to complete study procedures|0|||
105727147|NCT01446809|364655617|FG001|Overall Study|Failure to complete study procedures|0|||
105727148|NCT01446809|364655618|FG002|Overall Study|Failure to complete study procedures|1|||
105727149|NCT01331161|364655619|FG000|Overall Study|Physician Decision|1|||
105727150|NCT01331161|364655620|FG001|Overall Study|Physician Decision|0|||
105727151|NCT01331161|364655619|FG000|Overall Study|Lost to Follow-up|0|||
105727152|NCT01331161|364655620|FG001|Overall Study|Lost to Follow-up|1|||
105727153|NCT01331161|364655619|FG000|Overall Study|Pregnancy|0|||
105727154|NCT01331161|364655620|FG001|Overall Study|Pregnancy|1|||
105727155|NCT01097044|364655621|FG000|Overall Study|Withdrawal by Subject|4|||
105727156|NCT01097044|364655622|FG001|Overall Study|Withdrawal by Subject|4|||
105727157|NCT01097044|364655621|FG000|Overall Study|Lost to Follow-up|1|||
105727158|NCT01097044|364655622|FG001|Overall Study|Lost to Follow-up|0|||
105727159|NCT01097044|364655621|FG000|Overall Study|Withdrawal by Sponsor|0|||
105727160|NCT01097044|364655622|FG001|Overall Study|Withdrawal by Sponsor|1|||
105727161|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
105727162|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
105727163|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
105727164|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
105727165|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
105727166|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105727167|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105727168|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105727169|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
105727170|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
105727171|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
105727172|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
105727173|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
105727174|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
105727175|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
105727176|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
105727177|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
105727178|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
105727179|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
105727180|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
106138939|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105727181|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
105727182|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
105727183|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
105727184|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
105727185|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
105727186|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
105727187|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
105727188|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
105727189|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
105727190|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
105727191|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
105727192|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
105727193|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
105727194|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
105727195|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
105727196|NCT00785577|364655623|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
105727197|NCT00785577|364655624|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
105727198|NCT00785577|364655625|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
105727199|NCT00785577|364655626|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
105727200|NCT00785577|364655627|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
105727201|NCT00785577|364655623|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
105727202|NCT00785577|364655624|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
105727203|NCT00785577|364655625|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
105727204|NCT00785577|364655626|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
105727205|NCT00785577|364655627|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
105727206|NCT00785577|364655623|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
105727207|NCT00785577|364655624|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
105727208|NCT00785577|364655625|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
105727209|NCT00785577|364655626|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
105727210|NCT00785577|364655627|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
105727211|NCT02770807|364655630|FG000|Overall Study|Adverse Event|3|||
105727212|NCT02770807|364655631|FG001|Overall Study|Adverse Event|3|||
105727213|NCT02770807|364655632|FG002|Overall Study|Adverse Event|1|||
105727214|NCT02770807|364655630|FG000|Overall Study|Withdrawal by Subject|7|||
105727215|NCT02770807|364655631|FG001|Overall Study|Withdrawal by Subject|3|||
105727216|NCT02770807|364655632|FG002|Overall Study|Withdrawal by Subject|4|||
105727217|NCT02770807|364655630|FG000|Overall Study|Other|0|||
105727218|NCT02770807|364655631|FG001|Overall Study|Other|1|||
105727219|NCT02770807|364655632|FG002|Overall Study|Other|0|||
105727220|NCT02770807|364655630|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
105727221|NCT02770807|364655631|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
105727222|NCT02770807|364655632|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
105727223|NCT02770807|364655630|FG000|Overall Study|Physician Decision|0|||
105727224|NCT02770807|364655631|FG001|Overall Study|Physician Decision|0|||
105727225|NCT02770807|364655632|FG002|Overall Study|Physician Decision|1|||
105727226|NCT03277196|364655633|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
105727227|NCT03277196|364655633|FG000|Overall Study|Lost to Follow-up|3|||
105727228|NCT03277196|364655633|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
105727229|NCT03277196|364655633|FG000|Overall Study|Other|2|||
105727230|NCT02251743|364657242|FG000|Overall Study|Withdrawal by Subject|1|||
105727231|NCT02251743|364657243|FG001|Overall Study|Withdrawal by Subject|1|||
105727232|NCT00742781|364657244|FG000|Overall Study|Withdrawal by Subject|3|||
105727233|NCT02210780|364657245|FG000|Overall Study|Adverse Event|0|||
105727234|NCT02210780|364657246|FG001|Overall Study|Adverse Event|5|||
105727235|NCT02210780|364657245|FG000|Overall Study|Lost to Follow-up|2|||
105727236|NCT02210780|364657246|FG001|Overall Study|Lost to Follow-up|1|||
105727237|NCT02210780|364657245|FG000|Overall Study|Withdrawal by Subject|1|||
105727238|NCT02210780|364657246|FG001|Overall Study|Withdrawal by Subject|1|||
105727239|NCT02210780|364657245|FG000|Overall Study|Physician Decision|1|||
105727240|NCT02210780|364657246|FG001|Overall Study|Physician Decision|0|||
105727241|NCT02210780|364657245|FG000|Overall Study|Protocol Violation|1|||
105727242|NCT02210780|364657246|FG001|Overall Study|Protocol Violation|0|||
105727243|NCT02210780|364657245|FG000|Overall Study|Other than specified above|0|||
105727244|NCT02210780|364657246|FG001|Overall Study|Other than specified above|1|||
105727245|NCT02360098|364657247|FG000|Overall Study|Physician Decision|7|||
105727246|NCT02966314|364657248|FG000|Overall Study|Lost to Follow-up|1|||
105727247|NCT02966314|364657249|FG001|Overall Study|Lost to Follow-up|0|||
105727248|NCT00049127|364657250|FG000|Overall Study|Withdrawal by Subject|0|||
105727249|NCT00049127|364657251|FG001|Overall Study|Withdrawal by Subject|0|||
105727250|NCT00049127|364657252|FG002|Overall Study|Withdrawal by Subject|1|||
105727251|NCT00049127|364657253|FG003|Overall Study|Withdrawal by Subject|0|||
105727252|NCT00049127|364657254|FG004|Overall Study|Withdrawal by Subject|0|||
105727253|NCT05113940|364657259|FG000|Part A (18 Days)|Adverse Event|0|||
105795015|NCT01289990|364906003|FG009|Overall Study|discontinued in preceding trial|21|||
105795016|NCT01289990|364906004|FG010|Overall Study|discontinued in preceding trial|17|||
105795017|NCT01289990|364906005|FG011|Overall Study|discontinued in preceding trial|17|||
105795018|NCT01289990|364906006|FG012|Overall Study|discontinued in preceding trial|24|||
105795019|NCT01289990|364905994|FG000|Overall Study|did not continue in extension|41|||
105795020|NCT01289990|364905995|FG001|Overall Study|did not continue in extension|45|||
105795021|NCT01289990|364905996|FG002|Overall Study|did not continue in extension|51|||
105795022|NCT01289990|364905997|FG003|Overall Study|did not continue in extension|51|||
105795023|NCT01289990|364905998|FG004|Overall Study|did not continue in extension|48|||
105795024|NCT01289990|364905999|FG005|Overall Study|did not continue in extension|50|||
105795025|NCT01289990|364906000|FG006|Overall Study|did not continue in extension|54|||
105795026|NCT01289990|364906001|FG007|Overall Study|did not continue in extension|36|||
105795027|NCT01289990|364906002|FG008|Overall Study|did not continue in extension|44|||
105795028|NCT01289990|364906003|FG009|Overall Study|did not continue in extension|48|||
105795029|NCT01289990|364906004|FG010|Overall Study|did not continue in extension|45|||
105795030|NCT01289990|364906005|FG011|Overall Study|did not continue in extension|34|||
105795031|NCT01289990|364906006|FG012|Overall Study|did not continue in extension|56|||
105795032|NCT01289990|364905994|FG000|Overall Study|Not treated|0|||
105795033|NCT01289990|364905995|FG001|Overall Study|Not treated|0|||
105795034|NCT01289990|364905996|FG002|Overall Study|Not treated|0|||
105795035|NCT01289990|364905997|FG003|Overall Study|Not treated|0|||
105795036|NCT01289990|364905998|FG004|Overall Study|Not treated|0|||
105795037|NCT01289990|364905999|FG005|Overall Study|Not treated|0|||
105795038|NCT01289990|364906000|FG006|Overall Study|Not treated|1|||
105795039|NCT01289990|364906001|FG007|Overall Study|Not treated|0|||
105795040|NCT01289990|364906002|FG008|Overall Study|Not treated|1|||
105795041|NCT01289990|364906003|FG009|Overall Study|Not treated|0|||
105936884|NCT01550965|365429398|FG000|Overall Study|Other|13|||
105727254|NCT05113940|364657260|FG001|Part A (18 Days)|Adverse Event|0|||
105727255|NCT05113940|364657261|FG002|Part A (18 Days)|Adverse Event|1|||
105727256|NCT05113940|364657262|FG003|Part A (18 Days)|Adverse Event|1|||
105727257|NCT05113940|364657263|FG004|Part A (18 Days)|Adverse Event|1|||
105727258|NCT05113940|364657264|FG005|Part A (18 Days)|Adverse Event|0|||
105936885|NCT03016403|365429399|FG000|Baseline|Death|5|||
105936886|NCT03016403|365429400|FG001|Baseline|Death|8|||
105936887|NCT03016403|365429401|FG002|Baseline|Death|1|||
105936888|NCT03016403|365429402|FG003|Baseline|Death|0|||
105936889|NCT03016403|365429399|FG000|Baseline|Withdrawal by Subject|2|||
105936890|NCT03016403|365429400|FG001|Baseline|Withdrawal by Subject|8|||
105936891|NCT03016403|365429401|FG002|Baseline|Withdrawal by Subject|4|||
105727259|NCT05113940|364657265|FG006|Part A (18 Days)|Adverse Event|0|||
105727260|NCT05113940|364657266|FG007|Part A (18 Days)|Adverse Event|0|||
105727261|NCT05113940|364657267|FG008|Part A (18 Days)|Adverse Event|0|||
105727262|NCT05113940|364657268|FG009|Part A (18 Days)|Adverse Event|0|||
105727263|NCT05113940|364657269|FG010|Part A (18 Days)|Adverse Event|0|||
105727264|NCT05113940|364657270|FG011|Part A (18 Days)|Adverse Event|2|||
105727265|NCT05113940|364657271|FG012|Part A (18 Days)|Adverse Event|0|||
105727266|NCT05113940|364657272|FG013|Part A (18 Days)|Adverse Event|0|||
105727267|NCT05113940|364657273|FG014|Part A (18 Days)|Adverse Event|0|||
105727268|NCT05113940|364657259|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727269|NCT05113940|364657260|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727270|NCT05113940|364657261|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727271|NCT05113940|364657262|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727272|NCT05113940|364657263|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727273|NCT05113940|364657264|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727274|NCT05113940|364657265|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727275|NCT05113940|364657266|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727276|NCT05113940|364657267|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727277|NCT05113940|364657268|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727278|NCT05113940|364657269|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
105936892|NCT03016403|365429402|FG003|Baseline|Withdrawal by Subject|10|||
105727279|NCT05113940|364657270|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727280|NCT05113940|364657271|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727281|NCT05113940|364657272|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
105727282|NCT05113940|364657273|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
105727283|NCT04026568|364657274|FG000|Overall Study|study terminated|0|||
105727284|NCT04026568|364657275|FG001|Overall Study|study terminated|1|||
105727285|NCT02561156|364657276|FG000|Part 2|Adverse Event|0|||
105727286|NCT02561156|364657277|FG001|Part 2|Adverse Event|0|||
105795042|NCT01289990|364906004|FG010|Overall Study|Not treated|1|||
105795043|NCT01289990|364906005|FG011|Overall Study|Not treated|2|||
105795044|NCT01289990|364906006|FG012|Overall Study|Not treated|0|||
105795045|NCT00758706|364906007|FG000|Overall Study|Adverse Event|4|||
105795046|NCT00758706|364906008|FG001|Overall Study|Adverse Event|4|||
105727287|NCT02561156|364657278|FG002|Part 2|Adverse Event|0|||
105795047|NCT01039584|364906009|FG000|Overall Study|Withdrawal by Subject|4|||
105936893|NCT03016403|365429399|FG000|Baseline|Lost to Follow-up|9|||
105936894|NCT03016403|365429400|FG001|Baseline|Lost to Follow-up|11|||
105936895|NCT03016403|365429401|FG002|Baseline|Lost to Follow-up|6|||
105727288|NCT02561156|364657279|FG003|Part 2|Adverse Event|0|||
105727289|NCT02561156|364657280|FG004|Part 2|Adverse Event|0|||
105727290|NCT02561156|364657281|FG005|Part 2|Adverse Event|0|||
105727291|NCT02561156|364657282|FG006|Part 2|Adverse Event|0|||
105727292|NCT02561156|364657283|FG007|Part 2|Adverse Event|0|||
105727293|NCT02561156|364657284|FG008|Part 2|Adverse Event|0|||
105727294|NCT02561156|364657285|FG009|Part 2|Adverse Event|0|||
105727295|NCT02561156|364657286|FG010|Part 2|Adverse Event|0|||
105727296|NCT02561156|364657287|FG011|Part 2|Adverse Event|1|||
105727297|NCT02561156|364657288|FG012|Part 2|Adverse Event|0|||
105727298|NCT04927312|364657289|FG000|Overall Study|Adverse Event|1|||
105727299|NCT04927312|364657289|FG000|Overall Study|Death|1|||
105727300|NCT04927312|364657289|FG000|Overall Study|Withdrawal by Subject|1|||
105727301|NCT04927312|364657289|FG000|Overall Study|Other|1|||
105727302|NCT04919564|364657292|FG000|Overall Study|Lost to Follow-up|1|||
105727303|NCT04919564|364657293|FG001|Overall Study|Lost to Follow-up|0|||
105727304|NCT04919564|364657292|FG000|Overall Study|Physician Decision|1|||
105727305|NCT04919564|364657293|FG001|Overall Study|Physician Decision|1|||
105727306|NCT00929240|364657299|FG000|Initial Treatment Phase|Adverse Event|31|||
105727307|NCT00929240|364657300|FG001|Initial Treatment Phase|Adverse Event|0|||
105727308|NCT00929240|364657301|FG002|Initial Treatment Phase|Adverse Event|0|||
105727309|NCT00929240|364657299|FG000|Initial Treatment Phase|Disease progression|41|||
105727310|NCT00929240|364657300|FG001|Initial Treatment Phase|Disease progression|0|||
105727311|NCT00929240|364657301|FG002|Initial Treatment Phase|Disease progression|0|||
105727312|NCT00929240|364657299|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
105727313|NCT00929240|364657300|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
105727314|NCT00929240|364657301|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
105727315|NCT00929240|364657299|FG000|Initial Treatment Phase|Protocol Violation|5|||
105727316|NCT00929240|364657300|FG001|Initial Treatment Phase|Protocol Violation|0|||
105727317|NCT00929240|364657301|FG002|Initial Treatment Phase|Protocol Violation|0|||
105727318|NCT00929240|364657299|FG000|Initial Treatment Phase|Death|2|||
105727319|NCT00929240|364657300|FG001|Initial Treatment Phase|Death|0|||
105727320|NCT00929240|364657301|FG002|Initial Treatment Phase|Death|0|||
105727321|NCT00929240|364657299|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
105727322|NCT00929240|364657300|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
105727323|NCT00929240|364657301|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
105727324|NCT00929240|364657299|FG000|Initial Treatment Phase|Physician Decision|4|||
105727325|NCT00929240|364657300|FG001|Initial Treatment Phase|Physician Decision|0|||
105727326|NCT00929240|364657301|FG002|Initial Treatment Phase|Physician Decision|0|||
105727327|NCT00929240|364657299|FG000|Maintenance Phase|Disease progression|0|||
105727328|NCT00929240|364657300|FG001|Maintenance Phase|Disease progression|73|||
105727329|NCT00929240|364657301|FG002|Maintenance Phase|Disease progression|60|||
105727330|NCT00929240|364657299|FG000|Maintenance Phase|Adverse Event|0|||
105727331|NCT00929240|364657300|FG001|Maintenance Phase|Adverse Event|9|||
105727332|NCT00929240|364657301|FG002|Maintenance Phase|Adverse Event|12|||
105727333|NCT00929240|364657299|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105727334|NCT00929240|364657300|FG001|Maintenance Phase|Withdrawal by Subject|2|||
105727335|NCT00929240|364657301|FG002|Maintenance Phase|Withdrawal by Subject|6|||
105727336|NCT00929240|364657299|FG000|Maintenance Phase|Protocol Violation|0|||
105727337|NCT00929240|364657300|FG001|Maintenance Phase|Protocol Violation|1|||
105727338|NCT00929240|364657301|FG002|Maintenance Phase|Protocol Violation|0|||
105727339|NCT00929240|364657299|FG000|Maintenance Phase|Health authority/Study termination|0|||
105727340|NCT00929240|364657300|FG001|Maintenance Phase|Health authority/Study termination|1|||
105727341|NCT00929240|364657301|FG002|Maintenance Phase|Health authority/Study termination|2|||
105727342|NCT00929240|364657299|FG000|Maintenance Phase|Physician Decision|0|||
105936896|NCT03016403|365429402|FG003|Baseline|Lost to Follow-up|24|||
105936897|NCT03016403|365429399|FG000|6-week Follow-up|Death|1|||
105936898|NCT03016403|365429400|FG001|6-week Follow-up|Death|4|||
105727343|NCT00929240|364657300|FG001|Maintenance Phase|Physician Decision|2|||
105727344|NCT00929240|364657301|FG002|Maintenance Phase|Physician Decision|1|||
105727345|NCT00929240|364657299|FG000|Maintenance Phase|Change of treatment|0|||
105727346|NCT00929240|364657300|FG001|Maintenance Phase|Change of treatment|4|||
105727347|NCT00929240|364657301|FG002|Maintenance Phase|Change of treatment|0|||
105727348|NCT00929240|364657299|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
105727349|NCT00929240|364657300|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
105936899|NCT03016403|365429401|FG002|6-week Follow-up|Death|0|||
105936900|NCT03016403|365429402|FG003|6-week Follow-up|Death|0|||
105727350|NCT00929240|364657301|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
105727351|NCT00929240|364657299|FG000|Maintenance Phase|Participant not treated|0|||
105727352|NCT00929240|364657300|FG001|Maintenance Phase|Participant not treated|2|||
105727353|NCT00929240|364657301|FG002|Maintenance Phase|Participant not treated|0|||
105936901|NCT03016403|365429399|FG000|6-week Follow-up|Lost to Follow-up|2|||
105727354|NCT00684814|364657302|FG000|Washout Period of 7 Days|Adverse Event|1|||
105727355|NCT00684814|364657303|FG001|Washout Period of 7 Days|Adverse Event|2|||
105936902|NCT03016403|365429400|FG001|6-week Follow-up|Lost to Follow-up|7|||
105936903|NCT03016403|365429401|FG002|6-week Follow-up|Lost to Follow-up|4|||
105936904|NCT03016403|365429402|FG003|6-week Follow-up|Lost to Follow-up|8|||
105936905|NCT03016403|365429399|FG000|6-week Follow-up|Withdrawal by Subject|0|||
105936906|NCT03016403|365429400|FG001|6-week Follow-up|Withdrawal by Subject|2|||
105936907|NCT03016403|365429401|FG002|6-week Follow-up|Withdrawal by Subject|0|||
105936908|NCT03016403|365429402|FG003|6-week Follow-up|Withdrawal by Subject|1|||
105936909|NCT03016403|365429399|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
105727356|NCT00684814|364657302|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
105727357|NCT00684814|364657303|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
105727358|NCT00684814|364657302|FG000|Second Intervention|Adverse Event|1|||
105727359|NCT00684814|364657303|FG001|Second Intervention|Adverse Event|0|||
105727360|NCT02886715|364657306|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105727361|NCT02886715|364657307|FG001|Overall Study|Non-Compliance With Study Drug|2|||
105727362|NCT02886715|364657308|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105727363|NCT02886715|364657306|FG000|Overall Study|Adverse Event|4|||
105727364|NCT02886715|364657307|FG001|Overall Study|Adverse Event|2|||
105727365|NCT02886715|364657308|FG002|Overall Study|Adverse Event|0|||
105727366|NCT02886715|364657306|FG000|Overall Study|Lack of Efficacy|0|||
105727367|NCT02886715|364657307|FG001|Overall Study|Lack of Efficacy|2|||
105727368|NCT02886715|364657308|FG002|Overall Study|Lack of Efficacy|1|||
105727369|NCT02886715|364657306|FG000|Overall Study|Lost to Follow-up|29|||
105727370|NCT02886715|364657307|FG001|Overall Study|Lost to Follow-up|26|||
105727371|NCT02886715|364657308|FG002|Overall Study|Lost to Follow-up|10|||
105727372|NCT02886715|364657306|FG000|Overall Study|Pregnancy|1|||
105727373|NCT02886715|364657307|FG001|Overall Study|Pregnancy|1|||
105727374|NCT02886715|364657308|FG002|Overall Study|Pregnancy|1|||
105727375|NCT02886715|364657306|FG000|Overall Study|Protocol Violation|3|||
105727376|NCT02886715|364657307|FG001|Overall Study|Protocol Violation|2|||
105727377|NCT02886715|364657308|FG002|Overall Study|Protocol Violation|1|||
105727378|NCT02886715|364657306|FG000|Overall Study|Withdrawal by Subject|20|||
105727379|NCT02886715|364657307|FG001|Overall Study|Withdrawal by Subject|18|||
105727380|NCT02886715|364657308|FG002|Overall Study|Withdrawal by Subject|5|||
105727381|NCT02886715|364657306|FG000|Overall Study|missing|7|||
105727382|NCT02886715|364657307|FG001|Overall Study|missing|2|||
105727383|NCT02886715|364657308|FG002|Overall Study|missing|2|||
105727384|NCT00768560|364657311|FG000|Intervention Set 1|Adverse Event|0|||
105727385|NCT00768560|364657312|FG001|Intervention Set 1|Adverse Event|1|||
105727386|NCT00768560|364657313|FG002|Intervention Set 1|Adverse Event|0|||
105727387|NCT00768560|364657314|FG003|Intervention Set 1|Adverse Event|0|||
105727388|NCT00768560|364657315|FG004|Intervention Set 1|Adverse Event|0|||
105727389|NCT00768560|364657316|FG005|Intervention Set 1|Adverse Event|0|||
105727390|NCT01128387|364657317|FG000|Overall Study|Physician Decision|0|||
105727391|NCT01128387|364657318|FG001|Overall Study|Physician Decision|1|||
105727392|NCT02286102|364657322|FG000|Overall Study|Screen Failure|1|||
105727393|NCT02286102|364657323|FG001|Overall Study|Screen Failure|1|||
105727394|NCT01440101|364657324|FG000|Overall Study|Adverse Event|2|||
105727395|NCT01440101|364657325|FG001|Overall Study|Adverse Event|0|||
105727396|NCT01440101|364657326|FG002|Overall Study|Adverse Event|0|||
105727397|NCT01440101|364657324|FG000|Overall Study|Withdrawal by Subject|0|||
105727398|NCT01440101|364657325|FG001|Overall Study|Withdrawal by Subject|3|||
105727399|NCT01440101|364657326|FG002|Overall Study|Withdrawal by Subject|1|||
105727400|NCT01440101|364657324|FG000|Overall Study|Other|0|||
105727401|NCT01440101|364657325|FG001|Overall Study|Other|1|||
105727402|NCT01440101|364657326|FG002|Overall Study|Other|0|||
105727403|NCT00805207|364657327|FG000|Overall Study|Protocol Violation|0|||
105727404|NCT00805207|364657328|FG001|Overall Study|Protocol Violation|0|||
105727405|NCT00805207|364657329|FG002|Overall Study|Protocol Violation|1|||
105727406|NCT00805207|364657330|FG003|Overall Study|Protocol Violation|0|||
105727407|NCT00805207|364657331|FG004|Overall Study|Protocol Violation|0|||
105727408|NCT00805207|364657332|FG005|Overall Study|Protocol Violation|0|||
105727409|NCT00805207|364657333|FG006|Overall Study|Protocol Violation|0|||
105727410|NCT00805207|364657334|FG007|Overall Study|Protocol Violation|0|||
105727411|NCT00805207|364657335|FG008|Overall Study|Protocol Violation|0|||
105727412|NCT00805207|364657327|FG000|Overall Study|Physician Decision|0|||
105727413|NCT00805207|364657328|FG001|Overall Study|Physician Decision|1|||
105727414|NCT00805207|364657329|FG002|Overall Study|Physician Decision|0|||
105727415|NCT00805207|364657330|FG003|Overall Study|Physician Decision|0|||
105727416|NCT00805207|364657331|FG004|Overall Study|Physician Decision|0|||
105727417|NCT00805207|364657332|FG005|Overall Study|Physician Decision|1|||
105727418|NCT00805207|364657333|FG006|Overall Study|Physician Decision|0|||
105727419|NCT00805207|364657334|FG007|Overall Study|Physician Decision|0|||
105727420|NCT00805207|364657335|FG008|Overall Study|Physician Decision|0|||
105727421|NCT00805207|364657327|FG000|Overall Study|Withdrawal by Subject|0|||
105727422|NCT00805207|364657328|FG001|Overall Study|Withdrawal by Subject|1|||
105727423|NCT00805207|364657329|FG002|Overall Study|Withdrawal by Subject|0|||
105727424|NCT00805207|364657330|FG003|Overall Study|Withdrawal by Subject|0|||
105727425|NCT00805207|364657331|FG004|Overall Study|Withdrawal by Subject|1|||
105727426|NCT00805207|364657332|FG005|Overall Study|Withdrawal by Subject|2|||
105727427|NCT00805207|364657333|FG006|Overall Study|Withdrawal by Subject|0|||
105727428|NCT00805207|364657334|FG007|Overall Study|Withdrawal by Subject|0|||
105936910|NCT03016403|365429400|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
105936911|NCT03016403|365429401|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
105936912|NCT03016403|365429402|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
105936913|NCT03016403|365429399|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
105936914|NCT03016403|365429400|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
105727429|NCT00805207|364657335|FG008|Overall Study|Withdrawal by Subject|0|||
105727430|NCT00064701|364657336|FG000|One Year Post-transplant|Did not receive study drug|7|||
105727431|NCT00064701|364657337|FG001|One Year Post-transplant|Did not receive study drug|12|||
105936915|NCT03016403|365429401|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
105936916|NCT03016403|365429402|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
105936917|NCT03016403|365429399|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
105936918|NCT03016403|365429400|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
105936919|NCT03016403|365429401|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
105936920|NCT03016403|365429402|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
105936921|NCT00079781|365429403|FG000|Pre-implant Period|Withdrawal by Subject|2|||
105936922|NCT00079781|365429404|FG001|Pre-implant Period|Withdrawal by Subject|0|||
105936923|NCT00079781|365429405|FG002|Pre-implant Period|Withdrawal by Subject|0|||
105936924|NCT00079781|365429403|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
105936925|NCT00079781|365429404|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
105936926|NCT00079781|365429405|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
105936927|NCT00079781|365429403|FG000|Follow-up Period|Withdrawal by Subject|3|||
106009534|NCT02435992|365700866|FG001|Overall Study|Other Reason|0|||
106009535|NCT02435992|365700867|FG002|Overall Study|Other Reason|0|||
106009536|NCT02435992|365700868|FG003|Overall Study|Other Reason|0|||
105727432|NCT00064701|364657338|FG002|One Year Post-transplant|Did not receive study drug|11|||
105727433|NCT00064701|364657336|FG000|One Year Post-transplant|Adverse Event|23|||
105727434|NCT00064701|364657337|FG001|One Year Post-transplant|Adverse Event|19|||
105727435|NCT00064701|364657338|FG002|One Year Post-transplant|Adverse Event|37|||
105727436|NCT00064701|364657336|FG000|One Year Post-transplant|Rejection|0|||
105727437|NCT00064701|364657337|FG001|One Year Post-transplant|Rejection|1|||
105727438|NCT00064701|364657338|FG002|One Year Post-transplant|Rejection|16|||
105727439|NCT00064701|364657336|FG000|One Year Post-transplant|Non-compliance|4|||
105727440|NCT00064701|364657337|FG001|One Year Post-transplant|Non-compliance|2|||
105727441|NCT00064701|364657338|FG002|One Year Post-transplant|Non-compliance|5|||
105727442|NCT00064701|364657336|FG000|One Year Post-transplant|Graft Failure|3|||
105727443|NCT00064701|364657337|FG001|One Year Post-transplant|Graft Failure|2|||
105727444|NCT00064701|364657338|FG002|One Year Post-transplant|Graft Failure|1|||
105727445|NCT00064701|364657336|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
105727446|NCT00064701|364657337|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
105727447|NCT00064701|364657338|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
105727448|NCT00064701|364657336|FG000|One Year Post-transplant|Lost to Follow-up|1|||
105727449|NCT00064701|364657337|FG001|One Year Post-transplant|Lost to Follow-up|0|||
105727450|NCT00064701|364657338|FG002|One Year Post-transplant|Lost to Follow-up|0|||
105727451|NCT00064701|364657336|FG000|One Year Post-transplant|Converted to rapamycin|1|||
105727452|NCT00064701|364657337|FG001|One Year Post-transplant|Converted to rapamycin|0|||
105727453|NCT00064701|364657338|FG002|One Year Post-transplant|Converted to rapamycin|0|||
105727454|NCT00064701|364657336|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
105727455|NCT00064701|364657337|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
105727456|NCT00064701|364657338|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
105727457|NCT00064701|364657336|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
105727458|NCT00064701|364657337|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
105727459|NCT00064701|364657338|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
105727460|NCT00064701|364657336|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
105727461|NCT00064701|364657337|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
105727462|NCT00064701|364657338|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
105727463|NCT00064701|364657336|FG000|One Year Post-transplant|Poor absorption|0|||
105727464|NCT00064701|364657337|FG001|One Year Post-transplant|Poor absorption|1|||
105727465|NCT00064701|364657338|FG002|One Year Post-transplant|Poor absorption|0|||
105727466|NCT00064701|364657336|FG000|One Year Post-transplant|Pancreas transplant|0|||
105727467|NCT00064701|364657337|FG001|One Year Post-transplant|Pancreas transplant|0|||
105727468|NCT00064701|364657338|FG002|One Year Post-transplant|Pancreas transplant|1|||
105727469|NCT00064701|364657336|FG000|Clinical Continuation Phase|Adverse Event|12|||
105727470|NCT00064701|364657337|FG001|Clinical Continuation Phase|Adverse Event|21|||
105727471|NCT00064701|364657338|FG002|Clinical Continuation Phase|Adverse Event|14|||
105727472|NCT00064701|364657336|FG000|Clinical Continuation Phase|Non-compliance|8|||
105727473|NCT00064701|364657337|FG001|Clinical Continuation Phase|Non-compliance|6|||
105727474|NCT00064701|364657338|FG002|Clinical Continuation Phase|Non-compliance|7|||
105727475|NCT00064701|364657336|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
105727476|NCT00064701|364657337|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
105727477|NCT00064701|364657338|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
105727478|NCT00064701|364657336|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
105727479|NCT00064701|364657337|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
105727480|NCT00064701|364657338|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
105727481|NCT00064701|364657336|FG000|Clinical Continuation Phase|Graft Failure|5|||
105727482|NCT00064701|364657337|FG001|Clinical Continuation Phase|Graft Failure|5|||
105727483|NCT00064701|364657338|FG002|Clinical Continuation Phase|Graft Failure|2|||
105727484|NCT00064701|364657336|FG000|Clinical Continuation Phase|Rejection|1|||
105727485|NCT00064701|364657337|FG001|Clinical Continuation Phase|Rejection|2|||
105727486|NCT00064701|364657338|FG002|Clinical Continuation Phase|Rejection|2|||
105727487|NCT00064701|364657336|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
105727488|NCT00064701|364657337|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
105727489|NCT00064701|364657338|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
105727490|NCT00064701|364657336|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
105727491|NCT00064701|364657337|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
105727492|NCT00064701|364657338|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
105727493|NCT00064701|364657336|FG000|Clinical Continuation Phase|Physician Decision|1|||
105727494|NCT00064701|364657337|FG001|Clinical Continuation Phase|Physician Decision|3|||
105727495|NCT00064701|364657338|FG002|Clinical Continuation Phase|Physician Decision|0|||
105727496|NCT00064701|364657336|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
105727497|NCT00064701|364657337|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
105727498|NCT00064701|364657338|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
105727499|NCT00064701|364657336|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
105727500|NCT00064701|364657337|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
105727501|NCT00064701|364657338|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
105727502|NCT00064701|364657336|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
105727503|NCT00064701|364657337|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
105727504|NCT00064701|364657338|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
105727505|NCT00064701|364657336|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
105727506|NCT00064701|364657337|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
105727507|NCT00064701|364657338|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
105727508|NCT00064701|364657336|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
105727509|NCT00064701|364657337|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
105727510|NCT00064701|364657338|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
105727511|NCT00064701|364657336|FG000|Clinical Continuation Phase|Patient opted out|0|||
105727512|NCT00064701|364657337|FG001|Clinical Continuation Phase|Patient opted out|0|||
105727513|NCT00064701|364657338|FG002|Clinical Continuation Phase|Patient opted out|1|||
105727514|NCT02469246|364657339|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
105727515|NCT02469246|364657340|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
105727516|NCT02469246|364657339|FG000|Double-Blind Phase|Adverse Event|12|||
105727517|NCT02469246|364657340|FG001|Double-Blind Phase|Adverse Event|9|||
105727518|NCT02469246|364657339|FG000|Double-Blind Phase|Death|2|||
105727519|NCT02469246|364657340|FG001|Double-Blind Phase|Death|0|||
105727520|NCT02469246|364657339|FG000|Double-Blind Phase|Lack of Efficacy|2|||
105727521|NCT02469246|364657340|FG001|Double-Blind Phase|Lack of Efficacy|1|||
105727522|NCT02469246|364657339|FG000|Double-Blind Phase|Investigator's Discretion|8|||
105727523|NCT02469246|364657340|FG001|Double-Blind Phase|Investigator's Discretion|8|||
105727524|NCT02469246|364657339|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
105727525|NCT02469246|364657340|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
105727526|NCT02469246|364657339|FG000|Double-Blind Phase|Protocol Violation|1|||
105727527|NCT02469246|364657340|FG001|Double-Blind Phase|Protocol Violation|1|||
105727528|NCT02469246|364657339|FG000|Double-Blind Phase|Withdrew Consent|25|||
105727529|NCT02469246|364657340|FG001|Double-Blind Phase|Withdrew Consent|25|||
105727530|NCT02469246|364657339|FG000|Double-Blind Phase|Lost to Follow-up|9|||
105727531|NCT02469246|364657340|FG001|Double-Blind Phase|Lost to Follow-up|5|||
105727532|NCT01491945|364657344|FG000|Overall Study|Death|30|||
105727533|NCT01491945|364657344|FG000|Overall Study|Withdrwan/LTF|16|||
105727534|NCT01491945|364657344|FG000|Overall Study|Conversion|4|||
105727535|NCT01491945|364657344|FG000|Overall Study|Missed Visit|1|||
105727536|NCT02201940|364657345|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
105727537|NCT02201940|364657346|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
105727538|NCT02201940|364657345|FG000|Overall Study|Lack of Efficacy|2|||
105727539|NCT02201940|364657346|FG001|Overall Study|Lack of Efficacy|113|||
105727540|NCT02201940|364657345|FG000|Overall Study|Lost to Follow-up|5|||
105727541|NCT02201940|364657346|FG001|Overall Study|Lost to Follow-up|0|||
105727542|NCT02201940|364657345|FG000|Overall Study|Withdrew Consent|2|||
105727543|NCT02201940|364657346|FG001|Overall Study|Withdrew Consent|1|||
105727544|NCT02201940|364657345|FG000|Overall Study|Investigator's Discretion|1|||
105727545|NCT02201940|364657346|FG001|Overall Study|Investigator's Discretion|1|||
105727546|NCT02201940|364657345|FG000|Overall Study|Death|1|||
105727547|NCT02201940|364657346|FG001|Overall Study|Death|0|||
105727548|NCT02201940|364657345|FG000|Overall Study|Adverse Event|0|||
105727549|NCT02201940|364657346|FG001|Overall Study|Adverse Event|1|||
105727550|NCT03466411|364657347|FG000|Overall Study|Lost to Follow-up|0|||
105727551|NCT03466411|364657348|FG001|Overall Study|Lost to Follow-up|1|||
105727552|NCT03466411|364657349|FG002|Overall Study|Lost to Follow-up|1|||
105727553|NCT03466411|364657350|FG003|Overall Study|Lost to Follow-up|0|||
105727554|NCT03466411|364657351|FG004|Overall Study|Lost to Follow-up|0|||
105727555|NCT03466411|364657352|FG005|Overall Study|Lost to Follow-up|0|||
105727556|NCT03466411|364657353|FG006|Overall Study|Lost to Follow-up|1|||
105727557|NCT03466411|364657354|FG007|Overall Study|Lost to Follow-up|1|||
105727558|NCT03466411|364657355|FG008|Overall Study|Lost to Follow-up|0|||
105727559|NCT03466411|364657356|FG009|Overall Study|Lost to Follow-up|1|||
105727560|NCT03466411|364657357|FG010|Overall Study|Lost to Follow-up|1|||
105727561|NCT03466411|364657358|FG011|Overall Study|Lost to Follow-up|1|||
105727562|NCT03466411|364657359|FG012|Overall Study|Lost to Follow-up|0|||
105727563|NCT03466411|364657347|FG000|Overall Study|Withdrawal by Subject|14|||
105727564|NCT03466411|364657348|FG001|Overall Study|Withdrawal by Subject|7|||
105727565|NCT03466411|364657349|FG002|Overall Study|Withdrawal by Subject|8|||
105727566|NCT03466411|364657350|FG003|Overall Study|Withdrawal by Subject|4|||
105727567|NCT03466411|364657351|FG004|Overall Study|Withdrawal by Subject|6|||
105727568|NCT03466411|364657352|FG005|Overall Study|Withdrawal by Subject|3|||
105936928|NCT00079781|365429404|FG001|Follow-up Period|Withdrawal by Subject|0|||
105936929|NCT00079781|365429405|FG002|Follow-up Period|Withdrawal by Subject|1|||
105936930|NCT00079781|365429403|FG000|Follow-up Period|Lost to Follow-up|1|||
105936931|NCT00079781|365429404|FG001|Follow-up Period|Lost to Follow-up|0|||
105936932|NCT00079781|365429405|FG002|Follow-up Period|Lost to Follow-up|0|||
105936933|NCT00079781|365429403|FG000|Follow-up Period|Death|0|||
105936934|NCT00079781|365429404|FG001|Follow-up Period|Death|0|||
105936935|NCT00079781|365429405|FG002|Follow-up Period|Death|1|||
105936936|NCT00576407|365429406|FG000|Overall Study|Death|7|||
105936937|NCT00576407|365429406|FG000|Overall Study|Physician Decision|1|||
105936938|NCT01657500|365429409|FG000|Overall Study|set impropperly matched|3|||
105936939|NCT01657500|365429410|FG001|Overall Study|set impropperly matched|3|||
105936940|NCT01657500|365429409|FG000|Overall Study|Lost to Follow-up|2|||
105936941|NCT01657500|365429410|FG001|Overall Study|Lost to Follow-up|2|||
105936942|NCT02067156|365429411|FG000|Overall Study|Lost to Follow-up|4|||
105936943|NCT03142334|365429412|FG000|Overall Study|Death|18|||
105936944|NCT03142334|365429413|FG001|Overall Study|Death|33|||
105936945|NCT03142334|365429412|FG000|Overall Study|Withdrawal by Subject|15|||
105936946|NCT03142334|365429413|FG001|Overall Study|Withdrawal by Subject|11|||
105936947|NCT03142334|365429412|FG000|Overall Study|Ongoing on trial follow up|463|||
105936948|NCT03142334|365429413|FG001|Overall Study|Ongoing on trial follow up|454|||
105936949|NCT03596983|365429414|FG000|Overall Study|Withdrawal by Subject|3|||
105936950|NCT02314247|365429415|FG000|Overall Study|Adverse Event|2|||
105936951|NCT02314247|365429416|FG001|Overall Study|Adverse Event|1|||
105936952|NCT02314247|365429417|FG002|Overall Study|Adverse Event|0|||
105936953|NCT02314247|365429415|FG000|Overall Study|Withdrawal by Subject|1|||
105936954|NCT02314247|365429416|FG001|Overall Study|Withdrawal by Subject|3|||
105936955|NCT02314247|365429417|FG002|Overall Study|Withdrawal by Subject|1|||
105936956|NCT02314247|365429415|FG000|Overall Study|Progression of Disease|6|||
105936957|NCT02314247|365429416|FG001|Overall Study|Progression of Disease|2|||
105936958|NCT02314247|365429417|FG002|Overall Study|Progression of Disease|0|||
105936959|NCT01953354|365429418|FG000|Overall Study|Withdrawal by Subject|0|||
105936960|NCT01953354|365429419|FG001|Overall Study|Withdrawal by Subject|1|||
105936961|NCT01953354|365429418|FG000|Overall Study|Decision of Sponsor|0|||
105936962|NCT01953354|365429419|FG001|Overall Study|Decision of Sponsor|1|||
105936963|NCT01953354|365429418|FG000|Overall Study|Disease Exacerbation|1|||
105936964|NCT01953354|365429419|FG001|Overall Study|Disease Exacerbation|0|||
105936965|NCT01392495|365429420|FG000|Overall Study|Death|3|||
105936966|NCT01392495|365429420|FG000|Overall Study|Administrative problems|8|||
105936967|NCT01392495|365429420|FG000|Overall Study|Withdrawal by Subject|2|||
105936968|NCT01392495|365429420|FG000|Overall Study|Adverse Event|3|||
105936969|NCT02571244|365429421|FG000|Overall Study|Lost to Follow-up|0|||
105936970|NCT02571244|365429422|FG001|Overall Study|Lost to Follow-up|1|||
105936971|NCT02571244|365429421|FG000|Overall Study|Unable to reach out post discharge|3|||
105936972|NCT02571244|365429422|FG001|Overall Study|Unable to reach out post discharge|0|||
105936973|NCT01570192|365429423|FG000|Overall Study|no qualifying organism|6|||
105936974|NCT01570192|365429424|FG001|Overall Study|no qualifying organism|12|||
105936975|NCT01570192|365429423|FG000|Overall Study|changed to palliative care|1|||
105936976|NCT01570192|365429424|FG001|Overall Study|changed to palliative care|0|||
105936977|NCT01570192|365429423|FG000|Overall Study|Physician Decision|0|||
105936978|NCT01570192|365429424|FG001|Overall Study|Physician Decision|1|||
105936979|NCT00806026|365429425|FG000|Overall Study|Death|0|||
105936980|NCT00806026|365429426|FG001|Overall Study|Death|0|||
106009537|NCT02435992|365700869|FG004|Overall Study|Other Reason|0|||
105936981|NCT00806026|365429427|FG002|Overall Study|Death|0|||
105936982|NCT00806026|365429428|FG003|Overall Study|Death|1|||
105936983|NCT00806026|365429429|FG004|Overall Study|Death|0|||
105936984|NCT00806026|365429430|FG005|Overall Study|Death|0|||
105936985|NCT00806026|365429425|FG000|Overall Study|Did not meet entrance criteria|4|||
105795048|NCT01039584|364906010|FG001|Overall Study|Withdrawal by Subject|2|||
105795049|NCT01039584|364906011|FG002|Overall Study|Withdrawal by Subject|1|||
105795050|NCT01039584|364906009|FG000|Overall Study|Protocol Violation|10|||
105795051|NCT01039584|364906010|FG001|Overall Study|Protocol Violation|4|||
105795052|NCT01039584|364906011|FG002|Overall Study|Protocol Violation|6|||
105795053|NCT01039584|364906009|FG000|Overall Study|Lost to Follow-up|5|||
105795054|NCT01039584|364906010|FG001|Overall Study|Lost to Follow-up|3|||
105795055|NCT01039584|364906011|FG002|Overall Study|Lost to Follow-up|4|||
105795056|NCT01039584|364906009|FG000|Overall Study|Negative Baseline culture for Candida|59|||
105795057|NCT01039584|364906010|FG001|Overall Study|Negative Baseline culture for Candida|59|||
105795058|NCT01039584|364906011|FG002|Overall Study|Negative Baseline culture for Candida|24|||
105795059|NCT01039584|364906009|FG000|Overall Study|Lack of Efficacy|7|||
105795060|NCT01039584|364906010|FG001|Overall Study|Lack of Efficacy|6|||
105795061|NCT01039584|364906011|FG002|Overall Study|Lack of Efficacy|10|||
105795062|NCT01039584|364906009|FG000|Overall Study|other|1|||
105795063|NCT01039584|364906010|FG001|Overall Study|other|3|||
105795064|NCT01039584|364906011|FG002|Overall Study|other|1|||
105936986|NCT00806026|365429426|FG001|Overall Study|Did not meet entrance criteria|1|||
105936987|NCT00806026|365429427|FG002|Overall Study|Did not meet entrance criteria|2|||
105936988|NCT00806026|365429428|FG003|Overall Study|Did not meet entrance criteria|1|||
105936989|NCT00806026|365429429|FG004|Overall Study|Did not meet entrance criteria|0|||
105936990|NCT00806026|365429430|FG005|Overall Study|Did not meet entrance criteria|0|||
105936991|NCT00806026|365429425|FG000|Overall Study|Lack of Efficacy|5|||
105936992|NCT00806026|365429426|FG001|Overall Study|Lack of Efficacy|18|||
105936993|NCT00806026|365429427|FG002|Overall Study|Lack of Efficacy|13|||
105936994|NCT00806026|365429428|FG003|Overall Study|Lack of Efficacy|4|||
105936995|NCT00806026|365429429|FG004|Overall Study|Lack of Efficacy|8|||
105936996|NCT00806026|365429430|FG005|Overall Study|Lack of Efficacy|7|||
105936997|NCT00806026|365429425|FG000|Overall Study|Lost to Follow-up|8|||
105936998|NCT00806026|365429426|FG001|Overall Study|Lost to Follow-up|15|||
105936999|NCT00806026|365429427|FG002|Overall Study|Lost to Follow-up|8|||
105937000|NCT00806026|365429428|FG003|Overall Study|Lost to Follow-up|2|||
105937001|NCT00806026|365429429|FG004|Overall Study|Lost to Follow-up|6|||
105937002|NCT00806026|365429430|FG005|Overall Study|Lost to Follow-up|6|||
105937003|NCT00806026|365429425|FG000|Overall Study|Withdrawal by Subject|14|||
105937004|NCT00806026|365429426|FG001|Overall Study|Withdrawal by Subject|17|||
105937005|NCT00806026|365429427|FG002|Overall Study|Withdrawal by Subject|9|||
105937006|NCT00806026|365429428|FG003|Overall Study|Withdrawal by Subject|2|||
105937007|NCT00806026|365429429|FG004|Overall Study|Withdrawal by Subject|5|||
105727569|NCT03466411|364657353|FG006|Overall Study|Withdrawal by Subject|6|||
105727570|NCT03466411|364657354|FG007|Overall Study|Withdrawal by Subject|9|||
105727571|NCT03466411|364657355|FG008|Overall Study|Withdrawal by Subject|6|||
105727572|NCT03466411|364657356|FG009|Overall Study|Withdrawal by Subject|11|||
105727573|NCT03466411|364657357|FG010|Overall Study|Withdrawal by Subject|14|||
105727574|NCT03466411|364657358|FG011|Overall Study|Withdrawal by Subject|12|||
105727575|NCT03466411|364657359|FG012|Overall Study|Withdrawal by Subject|7|||
105727576|NCT03466411|364657347|FG000|Overall Study|Other|1|||
105727577|NCT03466411|364657348|FG001|Overall Study|Other|1|||
105727578|NCT03466411|364657349|FG002|Overall Study|Other|0|||
105727579|NCT03466411|364657350|FG003|Overall Study|Other|1|||
105727580|NCT03466411|364657351|FG004|Overall Study|Other|2|||
105727581|NCT03466411|364657352|FG005|Overall Study|Other|0|||
105727582|NCT03466411|364657353|FG006|Overall Study|Other|0|||
105727583|NCT03466411|364657354|FG007|Overall Study|Other|0|||
105727584|NCT03466411|364657355|FG008|Overall Study|Other|0|||
105727585|NCT03466411|364657356|FG009|Overall Study|Other|1|||
105727586|NCT03466411|364657357|FG010|Overall Study|Other|2|||
105727587|NCT03466411|364657358|FG011|Overall Study|Other|0|||
105727588|NCT03466411|364657359|FG012|Overall Study|Other|0|||
105727589|NCT03466411|364657347|FG000|Overall Study|Randomized but not Treated|0|||
105727590|NCT03466411|364657348|FG001|Overall Study|Randomized but not Treated|0|||
105727591|NCT03466411|364657349|FG002|Overall Study|Randomized but not Treated|0|||
105727592|NCT03466411|364657350|FG003|Overall Study|Randomized but not Treated|0|||
105727593|NCT03466411|364657351|FG004|Overall Study|Randomized but not Treated|0|||
105795065|NCT01039584|364906009|FG000|Overall Study|Pap smear with significant pathology|10|||
105727594|NCT03466411|364657352|FG005|Overall Study|Randomized but not Treated|0|||
105937008|NCT00806026|365429430|FG005|Overall Study|Withdrawal by Subject|3|||
105937009|NCT00806026|365429425|FG000|Overall Study|Other|3|||
105937010|NCT00806026|365429426|FG001|Overall Study|Other|6|||
105937011|NCT00806026|365429427|FG002|Overall Study|Other|8|||
105937012|NCT00806026|365429428|FG003|Overall Study|Other|2|||
105937013|NCT00806026|365429429|FG004|Overall Study|Other|0|||
105795066|NCT01039584|364906010|FG001|Overall Study|Pap smear with significant pathology|10|||
105795067|NCT01039584|364906011|FG002|Overall Study|Pap smear with significant pathology|3|||
105937014|NCT00806026|365429430|FG005|Overall Study|Other|4|||
105937015|NCT00806026|365429425|FG000|Overall Study|Protocol Violation|6|||
105937016|NCT00806026|365429426|FG001|Overall Study|Protocol Violation|9|||
105937017|NCT00806026|365429427|FG002|Overall Study|Protocol Violation|9|||
105937018|NCT00806026|365429428|FG003|Overall Study|Protocol Violation|0|||
105795068|NCT01039584|364906009|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
105795069|NCT01039584|364906010|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
105795070|NCT01039584|364906011|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
105795071|NCT00929864|364906014|FG000|Overall Study|Death|1|||
105795072|NCT00929864|364906015|FG001|Overall Study|Death|1|||
105795073|NCT00929864|364906014|FG000|Overall Study|Adverse Event|11|||
105795074|NCT00929864|364906015|FG001|Overall Study|Adverse Event|30|||
105795075|NCT00929864|364906014|FG000|Overall Study|Lack of Efficacy|19|||
105795076|NCT00929864|364906015|FG001|Overall Study|Lack of Efficacy|16|||
105795077|NCT00929864|364906014|FG000|Overall Study|Lost to Follow-up|7|||
105795078|NCT00929864|364906015|FG001|Overall Study|Lost to Follow-up|12|||
105795079|NCT00929864|364906014|FG000|Overall Study|Withdrawal by Subject|20|||
105795080|NCT00929864|364906015|FG001|Overall Study|Withdrawal by Subject|9|||
105795081|NCT00929864|364906014|FG000|Overall Study|No longer met criteria|2|||
105795082|NCT00929864|364906015|FG001|Overall Study|No longer met criteria|1|||
105795083|NCT00929864|364906014|FG000|Overall Study|Poor or non-compliance|3|||
105795084|NCT00929864|364906015|FG001|Overall Study|Poor or non-compliance|3|||
105795085|NCT00929864|364906014|FG000|Overall Study|Pregnancy|0|||
105795086|NCT00929864|364906015|FG001|Overall Study|Pregnancy|3|||
105795087|NCT00929864|364906014|FG000|Overall Study|Administrative reason by Sponsor|1|||
105795088|NCT00929864|364906015|FG001|Overall Study|Administrative reason by Sponsor|1|||
105795089|NCT00929864|364906014|FG000|Overall Study|Non-specified|2|||
105795090|NCT00929864|364906015|FG001|Overall Study|Non-specified|7|||
105795091|NCT01494649|364906016|FG000|Overall Study|Lost to Follow-up|0|||
105795092|NCT01494649|364906017|FG001|Overall Study|Lost to Follow-up|1|||
105795093|NCT01656967|364906020|FG000|Overall Study|faulty monitor|1|||
105795094|NCT01656967|364906021|FG001|Overall Study|faulty monitor|0|||
105795095|NCT01656967|364906020|FG000|Overall Study|unsuccessful ETT insertion|3|||
105795096|NCT01656967|364906021|FG001|Overall Study|unsuccessful ETT insertion|2|||
105795097|NCT01174368|364906022|FG000|Overall Study|Withdrawal by Subject|1|||
105795098|NCT03454672|364906023|FG000|Overall Study|Adverse Event|1|||
105795099|NCT03454672|364906024|FG001|Overall Study|Adverse Event|1|||
105795100|NCT03454672|364906023|FG000|Overall Study|Lost to Follow-up|1|||
105795101|NCT03454672|364906024|FG001|Overall Study|Lost to Follow-up|3|||
105795102|NCT03454672|364906023|FG000|Overall Study|painful|1|||
105795103|NCT03454672|364906024|FG001|Overall Study|painful|2|||
105795104|NCT03454672|364906023|FG000|Overall Study|Non-compliance|2|||
105795105|NCT03454672|364906024|FG001|Overall Study|Non-compliance|4|||
105795106|NCT03454672|364906023|FG000|Overall Study|personal reasons|3|||
105795107|NCT03454672|364906024|FG001|Overall Study|personal reasons|2|||
105795108|NCT03454672|364906023|FG000|Overall Study|Withdrawal by Subject|1|||
105795109|NCT03454672|364906024|FG001|Overall Study|Withdrawal by Subject|0|||
105795110|NCT05166512|364906025|FG000|Randomized|Lost to Follow-up|2|||
105795111|NCT05166512|364906026|FG001|Randomized|Lost to Follow-up|0|||
105795112|NCT05166512|364906025|FG000|Randomized|Withdrawal by Subject|1|||
105795113|NCT05166512|364906026|FG001|Randomized|Withdrawal by Subject|0|||
105795114|NCT05166512|364906025|FG000|Baseline Data Collection|Lost to Follow-up|0|||
105795115|NCT05166512|364906026|FG001|Baseline Data Collection|Lost to Follow-up|3|||
105795116|NCT05166512|364906025|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
105795117|NCT05166512|364906026|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
105795118|NCT05166512|364906025|FG000|Baseline Data Collection|Protocol Violation|2|||
105795119|NCT05166512|364906026|FG001|Baseline Data Collection|Protocol Violation|0|||
105795120|NCT05166512|364906025|FG000|4 Month Data Collection|Lost to Follow-up|1|||
105795121|NCT05166512|364906026|FG001|4 Month Data Collection|Lost to Follow-up|0|||
105795122|NCT05166512|364906025|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
105795123|NCT05166512|364906026|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
105795124|NCT05166512|364906025|FG000|12 Month Data Collection|Lost to Follow-up|3|||
105795125|NCT05166512|364906026|FG001|12 Month Data Collection|Lost to Follow-up|1|||
105795126|NCT05166512|364906025|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
105795127|NCT05166512|364906026|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
105795128|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
105795129|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
105795130|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
105795131|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
105795132|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
105795133|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
105795134|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
105795135|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
105795136|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
105795137|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
105795138|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
105795139|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
105795140|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
105937019|NCT00806026|365429429|FG004|Overall Study|Protocol Violation|2|||
105937020|NCT00806026|365429430|FG005|Overall Study|Protocol Violation|3|||
105937021|NCT00806026|365429425|FG000|Overall Study|Adverse Event|52|||
105937022|NCT00806026|365429426|FG001|Overall Study|Adverse Event|35|||
105795141|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
105795142|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
105795143|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
105795144|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
105795145|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
105795146|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
105795147|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
105937023|NCT00806026|365429427|FG002|Overall Study|Adverse Event|44|||
105937024|NCT00806026|365429428|FG003|Overall Study|Adverse Event|17|||
105937025|NCT00806026|365429429|FG004|Overall Study|Adverse Event|9|||
105937026|NCT00806026|365429430|FG005|Overall Study|Adverse Event|9|||
105937027|NCT01646216|365429442|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
105937028|NCT01646216|365429443|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
105937029|NCT01646216|365429442|FG000|Overall Study|Did not complete training|0|||
105937030|NCT01646216|365429443|FG001|Overall Study|Did not complete training|2|||
105937031|NCT01646216|365429442|FG000|Overall Study|Investigator decision|1|||
105937032|NCT01646216|365429443|FG001|Overall Study|Investigator decision|1|||
105937033|NCT01340170|365429444|FG000|Overall Study|Lost to Follow-up|2|||
105727595|NCT03466411|364657353|FG006|Overall Study|Randomized but not Treated|1|||
105727596|NCT03466411|364657354|FG007|Overall Study|Randomized but not Treated|0|||
105727597|NCT03466411|364657355|FG008|Overall Study|Randomized but not Treated|0|||
105727598|NCT03466411|364657356|FG009|Overall Study|Randomized but not Treated|0|||
105727599|NCT03466411|364657357|FG010|Overall Study|Randomized but not Treated|0|||
105727600|NCT03466411|364657358|FG011|Overall Study|Randomized but not Treated|0|||
105727601|NCT03466411|364657359|FG012|Overall Study|Randomized but not Treated|0|||
105727602|NCT00074958|364657360|FG000|Overall Study|Adverse Event|1|||
105727603|NCT03770403|364657361|FG000|Overall Study|Adverse Event|8|||
105727604|NCT03770403|364657361|FG000|Overall Study|Death|5|||
105727605|NCT03770403|364657361|FG000|Overall Study|Physician Decision|1|||
105727606|NCT03770403|364657361|FG000|Overall Study|Sponsor decision|1|||
105727607|NCT03770403|364657361|FG000|Overall Study|Study terminated by Sponsor|1|||
105727608|NCT03770403|364657361|FG000|Overall Study|Withdrawal by Subject|13|||
105727609|NCT03770403|364657361|FG000|Overall Study|Other|88|||
105727610|NCT00552110|364657364|FG000|Overall Study|Serious or Life-Threatening AE|0|||
105727611|NCT00552110|364657365|FG001|Overall Study|Serious or Life-Threatening AE|0|||
105727612|NCT00552110|364657366|FG002|Overall Study|Serious or Life-Threatening AE|1|||
105727613|NCT00552110|364657367|FG003|Overall Study|Serious or Life-Threatening AE|0|||
105727614|NCT00552110|364657368|FG004|Overall Study|Serious or Life-Threatening AE|0|||
105727615|NCT00552110|364657364|FG000|Overall Study|Lack of Efficacy|1|||
105727616|NCT00552110|364657365|FG001|Overall Study|Lack of Efficacy|0|||
105727617|NCT00552110|364657366|FG002|Overall Study|Lack of Efficacy|0|||
105727618|NCT00552110|364657367|FG003|Overall Study|Lack of Efficacy|1|||
105727619|NCT00552110|364657368|FG004|Overall Study|Lack of Efficacy|4|||
105727620|NCT00552110|364657364|FG000|Overall Study|Withdrawal by Subject|0|||
105727621|NCT00552110|364657365|FG001|Overall Study|Withdrawal by Subject|2|||
105727622|NCT00552110|364657366|FG002|Overall Study|Withdrawal by Subject|0|||
105727623|NCT00552110|364657367|FG003|Overall Study|Withdrawal by Subject|3|||
105727624|NCT00552110|364657368|FG004|Overall Study|Withdrawal by Subject|2|||
105727625|NCT00552110|364657364|FG000|Overall Study|Lost to Follow-up|0|||
105727626|NCT00552110|364657365|FG001|Overall Study|Lost to Follow-up|0|||
105727627|NCT00552110|364657366|FG002|Overall Study|Lost to Follow-up|0|||
105727628|NCT00552110|364657367|FG003|Overall Study|Lost to Follow-up|1|||
105727629|NCT00552110|364657368|FG004|Overall Study|Lost to Follow-up|1|||
105727630|NCT00552110|364657364|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
105727631|NCT00552110|364657365|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
105727632|NCT00552110|364657366|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
105727633|NCT00552110|364657367|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
105727634|NCT00552110|364657368|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
105727635|NCT00552110|364657364|FG000|Overall Study|Withdrawn per Sponsor|0|||
105727636|NCT00552110|364657365|FG001|Overall Study|Withdrawn per Sponsor|1|||
105795148|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
105727637|NCT00552110|364657366|FG002|Overall Study|Withdrawn per Sponsor|0|||
105727638|NCT00552110|364657367|FG003|Overall Study|Withdrawn per Sponsor|0|||
105727639|NCT00552110|364657368|FG004|Overall Study|Withdrawn per Sponsor|1|||
105727640|NCT00552110|364657364|FG000|Overall Study|Use of Prohibited Medication|1|||
105727641|NCT00552110|364657365|FG001|Overall Study|Use of Prohibited Medication|1|||
105795149|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
105795150|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
105795151|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
105727642|NCT00552110|364657366|FG002|Overall Study|Use of Prohibited Medication|0|||
105727643|NCT00552110|364657367|FG003|Overall Study|Use of Prohibited Medication|0|||
105727644|NCT00552110|364657368|FG004|Overall Study|Use of Prohibited Medication|0|||
105727645|NCT00552110|364657364|FG000|Overall Study|Delay of Study due to Relabeling|0|||
105727646|NCT00552110|364657365|FG001|Overall Study|Delay of Study due to Relabeling|0|||
105937034|NCT01340170|365429445|FG001|Overall Study|Lost to Follow-up|4|||
105727647|NCT00552110|364657366|FG002|Overall Study|Delay of Study due to Relabeling|0|||
105727648|NCT00552110|364657367|FG003|Overall Study|Delay of Study due to Relabeling|1|||
105727649|NCT00552110|364657368|FG004|Overall Study|Delay of Study due to Relabeling|0|||
105727650|NCT00552110|364657364|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
105727651|NCT00552110|364657365|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
105727652|NCT00552110|364657366|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
105727653|NCT00552110|364657367|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
105727654|NCT00552110|364657368|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
105727655|NCT00552110|364657364|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
105727656|NCT00552110|364657365|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
105727657|NCT00552110|364657366|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
105727658|NCT00552110|364657367|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
105727659|NCT00552110|364657368|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
105727660|NCT04325503|364657381|FG000|Overall Study|Withdrawal by Subject|1|||
105727661|NCT04325503|364657381|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
105727662|NCT01856114|364657383|FG000|Overall Study|Withdrawal by Subject|1|||
105727663|NCT01856114|364657384|FG001|Overall Study|Withdrawal by Subject|0|||
105727664|NCT01856114|364657383|FG000|Overall Study|Adverse Event|1|||
105727665|NCT01856114|364657384|FG001|Overall Study|Adverse Event|0|||
105727666|NCT01642212|364657385|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
105727667|NCT01642212|364657386|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
105727668|NCT01642212|364657387|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
105727669|NCT01642212|364657388|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
105727670|NCT01642212|364657389|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
105727671|NCT01642212|364657385|FG000|Double-blind Treatment|Other|0|||
105727672|NCT01642212|364657386|FG001|Double-blind Treatment|Other|2|||
105727673|NCT01642212|364657387|FG002|Double-blind Treatment|Other|1|||
105727674|NCT01642212|364657388|FG003|Double-blind Treatment|Other|0|||
105727675|NCT01642212|364657389|FG004|Double-blind Treatment|Other|0|||
105727676|NCT01642212|364657385|FG000|Double-blind Treatment|Non-compliance|0|||
105727677|NCT01642212|364657386|FG001|Double-blind Treatment|Non-compliance|1|||
105727678|NCT01642212|364657387|FG002|Double-blind Treatment|Non-compliance|0|||
105727679|NCT01642212|364657388|FG003|Double-blind Treatment|Non-compliance|0|||
105727680|NCT01642212|364657389|FG004|Double-blind Treatment|Non-compliance|0|||
105727681|NCT01642212|364657385|FG000|Double-blind Treatment|Adverse Event|0|||
105727682|NCT01642212|364657386|FG001|Double-blind Treatment|Adverse Event|0|||
105727683|NCT01642212|364657387|FG002|Double-blind Treatment|Adverse Event|1|||
105727684|NCT01642212|364657388|FG003|Double-blind Treatment|Adverse Event|0|||
105727685|NCT01642212|364657389|FG004|Double-blind Treatment|Adverse Event|0|||
105727686|NCT01642212|364657385|FG000|Open-label Extension|Adverse Event|0|||
105727687|NCT01642212|364657386|FG001|Open-label Extension|Adverse Event|0|||
105727688|NCT01642212|364657387|FG002|Open-label Extension|Adverse Event|0|||
105727689|NCT01642212|364657388|FG003|Open-label Extension|Adverse Event|3|||
105727690|NCT01642212|364657389|FG004|Open-label Extension|Adverse Event|0|||
105727691|NCT01642212|364657385|FG000|Open-label Extension|Sponsor Decision|0|||
105727692|NCT01642212|364657386|FG001|Open-label Extension|Sponsor Decision|0|||
105727693|NCT01642212|364657387|FG002|Open-label Extension|Sponsor Decision|0|||
105727694|NCT01642212|364657388|FG003|Open-label Extension|Sponsor Decision|7|||
105727695|NCT01642212|364657389|FG004|Open-label Extension|Sponsor Decision|4|||
105727696|NCT01642212|364657385|FG000|Open-label Extension|Consent Withdrawn|0|||
105727697|NCT01642212|364657386|FG001|Open-label Extension|Consent Withdrawn|0|||
105727698|NCT01642212|364657387|FG002|Open-label Extension|Consent Withdrawn|0|||
105727699|NCT01642212|364657388|FG003|Open-label Extension|Consent Withdrawn|0|||
105727700|NCT01642212|364657389|FG004|Open-label Extension|Consent Withdrawn|2|||
105727701|NCT01642212|364657385|FG000|Open-label Extension|Lost to Follow-up|0|||
105727702|NCT01642212|364657386|FG001|Open-label Extension|Lost to Follow-up|0|||
105727703|NCT01642212|364657387|FG002|Open-label Extension|Lost to Follow-up|0|||
105727704|NCT01642212|364657388|FG003|Open-label Extension|Lost to Follow-up|0|||
105727705|NCT01642212|364657389|FG004|Open-label Extension|Lost to Follow-up|1|||
105727706|NCT01642212|364657385|FG000|Open-label Extension|Other|0|||
105727707|NCT01642212|364657386|FG001|Open-label Extension|Other|0|||
105727708|NCT01642212|364657387|FG002|Open-label Extension|Other|0|||
105727709|NCT01642212|364657388|FG003|Open-label Extension|Other|0|||
105727710|NCT01642212|364657389|FG004|Open-label Extension|Other|1|||
105727711|NCT00613626|364657393|FG000|Overall Study|Ineligible|0|||
105727712|NCT00613626|364657394|FG001|Overall Study|Ineligible|1|||
105937035|NCT01340170|365429446|FG002|Overall Study|Lost to Follow-up|0|||
105727713|NCT00613626|364657395|FG002|Overall Study|Ineligible|0|||
105727714|NCT00957853|364657396|FG000|Overall Study|Withdrawal by Subject|1|||
105727715|NCT00957853|364657397|FG001|Overall Study|Withdrawal by Subject|0|||
105937036|NCT01340170|365429444|FG000|Overall Study|Implant failure|1|||
105727716|NCT00957853|364657398|FG002|Overall Study|Withdrawal by Subject|0|||
105727717|NCT00004980|364657399|FG000|Overall Study|Withdrawal by Subject|1|||
105937037|NCT01340170|365429445|FG001|Overall Study|Implant failure|3|||
105727718|NCT00004980|364657400|FG001|Overall Study|Withdrawal by Subject|0|||
105727719|NCT00004980|364657399|FG000|Overall Study|memory difficulties|1|||
105727720|NCT00004980|364657400|FG001|Overall Study|memory difficulties|1|||
105727721|NCT00004980|364657399|FG000|Overall Study|Physician Decision|0|||
105727722|NCT00004980|364657400|FG001|Overall Study|Physician Decision|1|||
105727723|NCT01299025|364657401|FG000|Overall Study|Withdrawal by Subject|2|||
105727724|NCT01299025|364657402|FG001|Overall Study|Withdrawal by Subject|1|||
105727725|NCT01299025|364657401|FG000|Overall Study|Lost to Follow-up|1|||
105727726|NCT01299025|364657402|FG001|Overall Study|Lost to Follow-up|0|||
105727727|NCT03212261|364657403|FG000|Overall Study|Became ineligible d/t tech|2|||
105727728|NCT03212261|364657403|FG000|Overall Study|Tech Trouble- No first study visit|1|||
105727729|NCT03212261|364657403|FG000|Overall Study|Lost to Follow-up|7|||
105727730|NCT03212261|364657403|FG000|Overall Study|Family Emergency|1|||
105727731|NCT03212261|364657403|FG000|Overall Study|Too busy/ No time|5|||
105727732|NCT02722044|364657404|FG000|Overall Study|Adverse Event|2|||
105727733|NCT02722044|364657404|FG000|Overall Study|Physician Decision|1|||
105727734|NCT02722044|364657404|FG000|Overall Study|Withdrawal by Subject|1|||
105727735|NCT02722044|364657404|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
105727736|NCT04885257|364657405|FG000|Overall Study|Withdrawal by Subject|1|||
105727737|NCT04885257|364657406|FG001|Overall Study|Withdrawal by Subject|0|||
105727738|NCT00256295|364657407|FG000|Overall Study|Withdrawal by Subject|3|||
105727739|NCT00256295|364657407|FG000|Overall Study|Death|1|||
105727740|NCT01682044|364657408|FG000|Overall Study|Death|1|||
105727741|NCT01682044|364657408|FG000|Overall Study|Progression|3|||
105727742|NCT03945773|364659550|FG000|Overall Study|Consent Withdrawn|1|||
105727743|NCT03945773|364659551|FG001|Overall Study|Consent Withdrawn|1|||
105727744|NCT03945773|364659550|FG000|Overall Study|Lost to Follow-up|1|||
105727745|NCT03945773|364659551|FG001|Overall Study|Lost to Follow-up|0|||
105727746|NCT03945773|364659550|FG000|Overall Study|Death|46|||
105727747|NCT03945773|364659551|FG001|Overall Study|Death|22|||
105727748|NCT03945773|364659550|FG000|Overall Study|Physician Decision|1|||
105727749|NCT03945773|364659551|FG001|Overall Study|Physician Decision|0|||
105727750|NCT03945773|364659550|FG000|Overall Study|Other|1|||
105727751|NCT03945773|364659551|FG001|Overall Study|Other|0|||
105727752|NCT03945773|364659550|FG000|Overall Study|Ongoing at the time of DCO|4|||
105727753|NCT03945773|364659551|FG001|Overall Study|Ongoing at the time of DCO|3|||
105727754|NCT05630846|364659552|FG000|Overall Study|Death|1|||
105727755|NCT05630846|364659553|FG001|Overall Study|Death|0|||
105727756|NCT05630846|364659554|FG002|Overall Study|Death|0|||
105727757|NCT05630846|364659555|FG003|Overall Study|Death|0|||
105727758|NCT05630846|364659552|FG000|Overall Study|Withdrawal by Subject|3|||
105727759|NCT05630846|364659553|FG001|Overall Study|Withdrawal by Subject|3|||
105727760|NCT05630846|364659554|FG002|Overall Study|Withdrawal by Subject|4|||
105727761|NCT05630846|364659555|FG003|Overall Study|Withdrawal by Subject|1|||
105727762|NCT05630846|364659552|FG000|Overall Study|Lost to Follow-up|6|||
105727763|NCT05630846|364659553|FG001|Overall Study|Lost to Follow-up|5|||
105727764|NCT05630846|364659554|FG002|Overall Study|Lost to Follow-up|2|||
105727765|NCT05630846|364659555|FG003|Overall Study|Lost to Follow-up|5|||
105727766|NCT05630846|364659552|FG000|Overall Study|Other|1|||
105727767|NCT05630846|364659553|FG001|Overall Study|Other|0|||
105727768|NCT05630846|364659554|FG002|Overall Study|Other|0|||
105727769|NCT05630846|364659555|FG003|Overall Study|Other|0|||
105727770|NCT00960076|364659557|FG000|Overall Study|Adverse Event|1|||
105727771|NCT00960076|364659558|FG001|Overall Study|Adverse Event|7|||
105727772|NCT00960076|364659557|FG000|Overall Study|No longer met study criteria|1|||
105727773|NCT00960076|364659558|FG001|Overall Study|No longer met study criteria|5|||
105727774|NCT00960076|364659557|FG000|Overall Study|Withdrawal by Subject|1|||
105727775|NCT00960076|364659558|FG001|Overall Study|Withdrawal by Subject|2|||
105727776|NCT00960076|364659557|FG000|Overall Study|Lost to Follow-up|3|||
105727777|NCT00960076|364659558|FG001|Overall Study|Lost to Follow-up|3|||
105727778|NCT00960076|364659557|FG000|Overall Study|Severe non-compliance to protocol|1|||
105727779|NCT00960076|364659558|FG001|Overall Study|Severe non-compliance to protocol|2|||
105727780|NCT00960076|364659557|FG000|Overall Study|Hyperglycemia|1|||
105727781|NCT00960076|364659558|FG001|Overall Study|Hyperglycemia|5|||
105727782|NCT00960076|364659557|FG000|Overall Study|Did not attend the termination visit|0|||
105727783|NCT00960076|364659558|FG001|Overall Study|Did not attend the termination visit|1|||
105727784|NCT02224664|364659559|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
105727785|NCT02224664|364659560|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
105727786|NCT02224664|364659561|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
105727787|NCT02224664|364659562|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
105727788|NCT02224664|364659563|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
105727789|NCT02224664|364659559|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
105727790|NCT02224664|364659560|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
105727791|NCT02224664|364659561|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
105727792|NCT02224664|364659562|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
105727793|NCT02224664|364659563|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
105727794|NCT02224664|364659559|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
105727795|NCT02224664|364659560|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
105727796|NCT02224664|364659561|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
105727797|NCT02224664|364659562|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
105727798|NCT02224664|364659563|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
105727799|NCT01024244|364659577|FG000|Overall Study|Adverse Event|1|||
105727800|NCT01024244|364659578|FG001|Overall Study|Adverse Event|2|||
105727801|NCT01024244|364659579|FG002|Overall Study|Adverse Event|0|||
105727802|NCT01024244|364659580|FG003|Overall Study|Adverse Event|1|||
105727803|NCT01024244|364659581|FG004|Overall Study|Adverse Event|2|||
105727804|NCT01024244|364659577|FG000|Overall Study|Entry Criteria Not Met|0|||
105727805|NCT01024244|364659578|FG001|Overall Study|Entry Criteria Not Met|1|||
105727806|NCT01024244|364659579|FG002|Overall Study|Entry Criteria Not Met|0|||
105727807|NCT01024244|364659580|FG003|Overall Study|Entry Criteria Not Met|0|||
105727808|NCT01024244|364659581|FG004|Overall Study|Entry Criteria Not Met|0|||
105727809|NCT01024244|364659577|FG000|Overall Study|Lack of Efficacy|1|||
105727810|NCT01024244|364659578|FG001|Overall Study|Lack of Efficacy|0|||
105727811|NCT01024244|364659579|FG002|Overall Study|Lack of Efficacy|0|||
105727812|NCT01024244|364659580|FG003|Overall Study|Lack of Efficacy|0|||
105727813|NCT01024244|364659581|FG004|Overall Study|Lack of Efficacy|0|||
105727814|NCT01024244|364659577|FG000|Overall Study|Protocol Violation|1|||
105727815|NCT01024244|364659578|FG001|Overall Study|Protocol Violation|0|||
105727816|NCT01024244|364659579|FG002|Overall Study|Protocol Violation|0|||
105727817|NCT01024244|364659580|FG003|Overall Study|Protocol Violation|0|||
105727818|NCT01024244|364659581|FG004|Overall Study|Protocol Violation|2|||
105727819|NCT01024244|364659577|FG000|Overall Study|Sponsor Decision|14|||
105727820|NCT01024244|364659578|FG001|Overall Study|Sponsor Decision|7|||
105727821|NCT01024244|364659579|FG002|Overall Study|Sponsor Decision|14|||
105727822|NCT01024244|364659580|FG003|Overall Study|Sponsor Decision|12|||
105727823|NCT01024244|364659581|FG004|Overall Study|Sponsor Decision|10|||
105727824|NCT01024244|364659577|FG000|Overall Study|Withdrawal by Subject|0|||
105727825|NCT01024244|364659578|FG001|Overall Study|Withdrawal by Subject|1|||
105727826|NCT01024244|364659579|FG002|Overall Study|Withdrawal by Subject|0|||
105727827|NCT01024244|364659580|FG003|Overall Study|Withdrawal by Subject|0|||
105727828|NCT01024244|364659581|FG004|Overall Study|Withdrawal by Subject|0|||
105727829|NCT00768222|364659582|FG000|Overall Study|Lost to Follow-up|1|||
105727830|NCT00768222|364659583|FG001|Overall Study|Lost to Follow-up|1|||
105727831|NCT00768222|364659582|FG000|Overall Study|Withdrawal by Subject|3|||
105727832|NCT00768222|364659583|FG001|Overall Study|Withdrawal by Subject|1|||
105727833|NCT00768222|364659582|FG000|Overall Study|Protocol Violation|0|||
105727834|NCT00768222|364659583|FG001|Overall Study|Protocol Violation|2|||
105727835|NCT00278629|364659590|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
105727836|NCT02698410|364659592|FG000|Overall Study|Adverse Event|2|||
105727837|NCT02698410|364659592|FG000|Overall Study|Withdrawal by Subject|1|||
105727838|NCT02698410|364659592|FG000|Overall Study|Other|1|||
105727839|NCT01896232|364659593|FG000|Overall Study|Death|6|||
105727840|NCT01896232|364659594|FG001|Overall Study|Death|10|||
105727841|NCT01896232|364659593|FG000|Overall Study|Withdrawal by Subject|32|||
105727842|NCT01896232|364659594|FG001|Overall Study|Withdrawal by Subject|31|||
105727843|NCT01896232|364659593|FG000|Overall Study|Sponsor Decision|2|||
105727844|NCT01896232|364659594|FG001|Overall Study|Sponsor Decision|0|||
105727845|NCT01896232|364659593|FG000|Overall Study|Lost to Follow-up|9|||
105727846|NCT01896232|364659594|FG001|Overall Study|Lost to Follow-up|12|||
105727847|NCT05224258|364659602|FG000|Overall Study|Withdrawal by Subject|1|||
105727848|NCT05224258|364659603|FG001|Overall Study|Withdrawal by Subject|1|||
105727849|NCT05224258|364659602|FG000|Overall Study|Physician Decision|1|||
105727850|NCT05224258|364659603|FG001|Overall Study|Physician Decision|1|||
105727851|NCT05224258|364659602|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105727852|NCT05224258|364659603|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105727853|NCT05224258|364659602|FG000|Overall Study|Study Product No Longer in Use|1|||
105727854|NCT05224258|364659603|FG001|Overall Study|Study Product No Longer in Use|0|||
105727855|NCT05224258|364659602|FG000|Overall Study|Adverse Event|0|||
105727856|NCT05224258|364659603|FG001|Overall Study|Adverse Event|1|||
105727857|NCT05224258|364659602|FG000|Overall Study|Protocol Deviation|0|||
105727858|NCT05224258|364659603|FG001|Overall Study|Protocol Deviation|1|||
105727859|NCT02665689|364659604|FG000|Overall Study|Adverse Event|1|||
105727860|NCT02665689|364659605|FG001|Overall Study|Adverse Event|0|||
105727861|NCT02665689|364659604|FG000|Overall Study|Trial termination|1|||
105727862|NCT02665689|364659605|FG001|Overall Study|Trial termination|1|||
105727863|NCT02665689|364659604|FG000|Overall Study|Lost to Follow-up|0|||
105727864|NCT02665689|364659605|FG001|Overall Study|Lost to Follow-up|1|||
105727865|NCT00541307|364659606|FG000|Overall Study|Death|5|||
105727866|NCT00541307|364659606|FG000|Overall Study|Physician Decision|3|||
105795152|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
105795153|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
105795154|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
105795155|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
105795156|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
105795157|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
105795158|NCT03985293|364906027|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
105795159|NCT03985293|364906028|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
105795160|NCT03985293|364906029|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
105795161|NCT03985293|364906030|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
105795162|NCT03985293|364906031|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
105795163|NCT03985293|364906032|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
105795164|NCT03985293|364906027|FG000|FOLLOW-UP|Lost to Follow-up|0|||
105795165|NCT03985293|364906028|FG001|FOLLOW-UP|Lost to Follow-up|0|||
105795166|NCT03985293|364906029|FG002|FOLLOW-UP|Lost to Follow-up|1|||
105795167|NCT03985293|364906030|FG003|FOLLOW-UP|Lost to Follow-up|0|||
105795168|NCT03985293|364906031|FG004|FOLLOW-UP|Lost to Follow-up|0|||
105795169|NCT03985293|364906032|FG005|FOLLOW-UP|Lost to Follow-up|0|||
105795170|NCT04449354|364906033|FG000|Overall Study|Withdrawal by Subject|1|||
105795171|NCT01220128|364906034|FG000|Overall Study|Progressive disease|0|||
105795172|NCT01220128|364906035|FG001|Overall Study|Progressive disease|0|||
105795173|NCT01220128|364906036|FG002|Overall Study|Progressive disease|2|||
105795174|NCT01220128|364906037|FG003|Overall Study|Progressive disease|0|||
105795175|NCT01220128|364906038|FG004|Overall Study|Progressive disease|0|||
105795176|NCT01220128|364906039|FG005|Overall Study|Progressive disease|0|||
105795177|NCT01220128|364906040|FG006|Overall Study|Progressive disease|0|||
105795178|NCT01220128|364906034|FG000|Overall Study|Sponsor study termination|0|||
105795179|NCT01220128|364906035|FG001|Overall Study|Sponsor study termination|1|||
105795180|NCT01220128|364906036|FG002|Overall Study|Sponsor study termination|0|||
105795181|NCT01220128|364906037|FG003|Overall Study|Sponsor study termination|0|||
105795182|NCT01220128|364906038|FG004|Overall Study|Sponsor study termination|0|||
105795183|NCT01220128|364906039|FG005|Overall Study|Sponsor study termination|0|||
105795184|NCT01220128|364906040|FG006|Overall Study|Sponsor study termination|1|||
105795185|NCT01220128|364906034|FG000|Overall Study|Adverse event, serious fatal|2|||
105795186|NCT01220128|364906035|FG001|Overall Study|Adverse event, serious fatal|0|||
105795187|NCT01220128|364906036|FG002|Overall Study|Adverse event, serious fatal|0|||
105795188|NCT01220128|364906037|FG003|Overall Study|Adverse event, serious fatal|0|||
105795189|NCT01220128|364906038|FG004|Overall Study|Adverse event, serious fatal|0|||
105795190|NCT01220128|364906039|FG005|Overall Study|Adverse event, serious fatal|0|||
105795191|NCT01220128|364906040|FG006|Overall Study|Adverse event, serious fatal|1|||
105795192|NCT01220128|364906034|FG000|Overall Study|Adverse event, non-fatal|1|||
105795193|NCT01220128|364906035|FG001|Overall Study|Adverse event, non-fatal|0|||
105795194|NCT01220128|364906036|FG002|Overall Study|Adverse event, non-fatal|0|||
105795195|NCT01220128|364906037|FG003|Overall Study|Adverse event, non-fatal|0|||
105795196|NCT01220128|364906038|FG004|Overall Study|Adverse event, non-fatal|0|||
105795197|NCT01220128|364906039|FG005|Overall Study|Adverse event, non-fatal|0|||
105795198|NCT01220128|364906040|FG006|Overall Study|Adverse event, non-fatal|3|||
105795199|NCT01220128|364906034|FG000|Overall Study|Other|0|||
105795200|NCT01220128|364906035|FG001|Overall Study|Other|0|||
105795201|NCT01220128|364906036|FG002|Overall Study|Other|1|||
105795202|NCT01220128|364906037|FG003|Overall Study|Other|0|||
105795203|NCT01220128|364906038|FG004|Overall Study|Other|0|||
105795204|NCT01220128|364906039|FG005|Overall Study|Other|0|||
105795205|NCT01220128|364906040|FG006|Overall Study|Other|0|||
105727867|NCT00541307|364659606|FG000|Overall Study|Withdrawal by Subject|6|||
105727868|NCT00541307|364659606|FG000|Overall Study|Lost to Follow-up|4|||
105727869|NCT00541307|364659606|FG000|Overall Study|Subject returned early (outside window)|1|||
105727870|NCT00541307|364659606|FG000|Overall Study|Surgical Bypass|5|||
105727871|NCT01154101|364659609|FG000|Overall Study|Adverse Event|0|||
105727872|NCT01154101|364659610|FG001|Overall Study|Adverse Event|2|||
105727873|NCT01154101|364659611|FG002|Overall Study|Adverse Event|1|||
105727874|NCT01154101|364659612|FG003|Overall Study|Adverse Event|1|||
105795206|NCT01220128|364906034|FG000|Overall Study|Consent withdrawn by subject|1|||
105795207|NCT01220128|364906035|FG001|Overall Study|Consent withdrawn by subject|0|||
105795208|NCT01220128|364906036|FG002|Overall Study|Consent withdrawn by subject|0|||
105795209|NCT01220128|364906037|FG003|Overall Study|Consent withdrawn by subject|0|||
105795210|NCT01220128|364906038|FG004|Overall Study|Consent withdrawn by subject|0|||
105795211|NCT01220128|364906039|FG005|Overall Study|Consent withdrawn by subject|0|||
105795212|NCT01220128|364906040|FG006|Overall Study|Consent withdrawn by subject|0|||
105795213|NCT02913261|364906047|FG000|Overall Study|Technical problems|0|||
105795214|NCT02913261|364906048|FG001|Overall Study|Technical problems|1|||
105795215|NCT02913261|364906047|FG000|Overall Study|Lack of Efficacy|32|||
106009538|NCT02435992|365700865|FG000|Overall Study|Physician Decision|0|||
105727875|NCT01154101|364659613|FG004|Overall Study|Adverse Event|0|||
105727876|NCT01154101|364659609|FG000|Overall Study|Lost to Follow-up|0|||
105727877|NCT01154101|364659610|FG001|Overall Study|Lost to Follow-up|1|||
105795216|NCT02913261|364906048|FG001|Overall Study|Lack of Efficacy|69|||
105795217|NCT02913261|364906047|FG000|Overall Study|Adverse Event|27|||
105795218|NCT02913261|364906048|FG001|Overall Study|Adverse Event|5|||
105795219|NCT02913261|364906047|FG000|Overall Study|Death|25|||
105795220|NCT02913261|364906048|FG001|Overall Study|Death|22|||
105795221|NCT02913261|364906047|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
105795222|NCT02913261|364906048|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
105795223|NCT02913261|364906047|FG000|Overall Study|Disease relapse|8|||
105795224|NCT02913261|364906048|FG001|Overall Study|Disease relapse|13|||
105795225|NCT02913261|364906047|FG000|Overall Study|Physician Decision|8|||
105795226|NCT02913261|364906048|FG001|Overall Study|Physician Decision|9|||
105795227|NCT02913261|364906047|FG000|Overall Study|Subject/guardian decision|4|||
105795228|NCT02913261|364906048|FG001|Overall Study|Subject/guardian decision|6|||
105795229|NCT02913261|364906047|FG000|Overall Study|Graft loss|2|||
105795230|NCT02913261|364906048|FG001|Overall Study|Graft loss|0|||
105795231|NCT00659581|364906049|FG000|Overall Study|Adverse Event|1006|||
105795232|NCT00659581|364906049|FG000|Overall Study|Lack of Efficacy|1183|||
105795233|NCT00659581|364906049|FG000|Overall Study|Other|6393|||
105727878|NCT01154101|364659611|FG002|Overall Study|Lost to Follow-up|0|||
105727879|NCT01154101|364659612|FG003|Overall Study|Lost to Follow-up|1|||
105727880|NCT01154101|364659613|FG004|Overall Study|Lost to Follow-up|0|||
105727881|NCT01154101|364659609|FG000|Overall Study|Withdrawal by Subject|0|||
105727882|NCT01154101|364659610|FG001|Overall Study|Withdrawal by Subject|1|||
105727883|NCT01154101|364659611|FG002|Overall Study|Withdrawal by Subject|2|||
105727884|NCT01154101|364659612|FG003|Overall Study|Withdrawal by Subject|0|||
105727885|NCT01154101|364659613|FG004|Overall Study|Withdrawal by Subject|1|||
105727886|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
105727887|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
105727888|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
105727889|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
105727890|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
105727891|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
105727892|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
105727893|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727894|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727895|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727896|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727897|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
105727898|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
105727899|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727900|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727901|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727902|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727903|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
105727904|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
105727905|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
105727906|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
105727907|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
105727908|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
105727909|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
105727910|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727911|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
105727912|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727913|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727914|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727915|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
105727916|NCT03895203|364659614|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727917|NCT03895203|364659615|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
105727918|NCT03895203|364659616|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727919|NCT03895203|364659617|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727920|NCT03895203|364659618|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727921|NCT03895203|364659619|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
105727922|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105795234|NCT00000135|364906050|FG000|Overall Study|Death|27|||
105795235|NCT00000135|364906051|FG001|Overall Study|Death|14|||
105795236|NCT04355767|364906053|FG000|Overall Study|Withdrawal by Subject|2|||
105795237|NCT04355767|364906054|FG001|Overall Study|Withdrawal by Subject|2|||
105937038|NCT01340170|365429446|FG002|Overall Study|Implant failure|0|||
105937039|NCT00452530|365429447|FG000|Overall Study|Death|1|||
105937040|NCT00452530|365429448|FG001|Overall Study|Death|0|||
105937041|NCT00452530|365429447|FG000|Overall Study|Adverse Event|40|||
105795238|NCT04355767|364906053|FG000|Overall Study|Death|5|||
105795239|NCT04355767|364906054|FG001|Overall Study|Death|1|||
105795240|NCT00532779|364906055|FG000|Overall Study|Adverse Event|122|||
105795241|NCT00532779|364906056|FG001|Overall Study|Adverse Event|112|||
105795242|NCT00532779|364906057|FG002|Overall Study|Adverse Event|56|||
105795243|NCT00532779|364906055|FG000|Overall Study|Lost to Follow-up|76|||
105795244|NCT00532779|364906056|FG001|Overall Study|Lost to Follow-up|65|||
105795245|NCT00532779|364906057|FG002|Overall Study|Lost to Follow-up|66|||
105795246|NCT00532779|364906055|FG000|Overall Study|Withdrawal by Subject|63|||
105795247|NCT00532779|364906056|FG001|Overall Study|Withdrawal by Subject|60|||
105795248|NCT00532779|364906057|FG002|Overall Study|Withdrawal by Subject|90|||
105795249|NCT00532779|364906055|FG000|Overall Study|Lack of Efficacy|12|||
105795250|NCT00532779|364906056|FG001|Overall Study|Lack of Efficacy|12|||
105795251|NCT00532779|364906057|FG002|Overall Study|Lack of Efficacy|40|||
105795252|NCT00532779|364906055|FG000|Overall Study|Protocol Violation|5|||
105795253|NCT00532779|364906056|FG001|Overall Study|Protocol Violation|9|||
105795254|NCT00532779|364906057|FG002|Overall Study|Protocol Violation|7|||
105795255|NCT00532779|364906055|FG000|Overall Study|Pregnancy|2|||
105795256|NCT00532779|364906056|FG001|Overall Study|Pregnancy|5|||
105795257|NCT00532779|364906057|FG002|Overall Study|Pregnancy|3|||
105795258|NCT00532779|364906055|FG000|Overall Study|Death|0|||
105795259|NCT00532779|364906056|FG001|Overall Study|Death|1|||
105795260|NCT00532779|364906057|FG002|Overall Study|Death|0|||
105795261|NCT00532779|364906055|FG000|Overall Study|Drug noncompliance, moved, other|14|||
105795262|NCT00532779|364906056|FG001|Overall Study|Drug noncompliance, moved, other|23|||
105795263|NCT00532779|364906057|FG002|Overall Study|Drug noncompliance, moved, other|29|||
105795264|NCT02662556|364906059|FG000|Overall Study|Adverse Event|4|||
105795265|NCT02662556|364906059|FG000|Overall Study|Lack of Efficacy|4|||
105795266|NCT02531698|364906066|FG000|Overall Study|Adverse Event|2|||
105795267|NCT02531698|364906067|FG001|Overall Study|Adverse Event|1|||
105795268|NCT02531698|364906066|FG000|Overall Study|Withdrawal by Subject|6|||
105795269|NCT02531698|364906067|FG001|Overall Study|Withdrawal by Subject|1|||
105795270|NCT02531698|364906066|FG000|Overall Study|Protocol Violation|2|||
105795271|NCT02531698|364906067|FG001|Overall Study|Protocol Violation|0|||
105795272|NCT02531698|364906066|FG000|Overall Study|Lost to Follow-up|1|||
105795273|NCT02531698|364906067|FG001|Overall Study|Lost to Follow-up|0|||
105795274|NCT01861717|364906068|FG000|Overall Study|Lost to Follow-up|1|||
105795275|NCT01861717|364906068|FG000|Overall Study|Withdrawal by Subject|1|||
105795276|NCT03033069|364906071|FG000|Overall Study|Adverse Event|6|||
105795277|NCT03033069|364906072|FG001|Overall Study|Adverse Event|7|||
105795278|NCT03033069|364906073|FG002|Overall Study|Adverse Event|4|||
105795279|NCT03033069|364906074|FG003|Overall Study|Adverse Event|6|||
105795280|NCT03033069|364906071|FG000|Overall Study|Lack of Efficacy|0|||
105795281|NCT03033069|364906072|FG001|Overall Study|Lack of Efficacy|0|||
105795282|NCT03033069|364906073|FG002|Overall Study|Lack of Efficacy|1|||
105795283|NCT03033069|364906074|FG003|Overall Study|Lack of Efficacy|0|||
105795284|NCT03033069|364906071|FG000|Overall Study|Lost to Follow-up|6|||
105795285|NCT03033069|364906072|FG001|Overall Study|Lost to Follow-up|5|||
105795286|NCT03033069|364906073|FG002|Overall Study|Lost to Follow-up|5|||
105795287|NCT03033069|364906074|FG003|Overall Study|Lost to Follow-up|6|||
105795288|NCT03033069|364906071|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105795289|NCT03033069|364906072|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105795290|NCT03033069|364906073|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105795291|NCT03033069|364906074|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105795292|NCT03033069|364906071|FG000|Overall Study|Protocol Deviation|0|||
105795293|NCT03033069|364906072|FG001|Overall Study|Protocol Deviation|1|||
105795294|NCT03033069|364906073|FG002|Overall Study|Protocol Deviation|0|||
105795295|NCT03033069|364906074|FG003|Overall Study|Protocol Deviation|0|||
105795296|NCT03033069|364906071|FG000|Overall Study|Withdrawal by Subject|10|||
105795297|NCT03033069|364906072|FG001|Overall Study|Withdrawal by Subject|10|||
105795298|NCT03033069|364906073|FG002|Overall Study|Withdrawal by Subject|11|||
105795299|NCT03033069|364906074|FG003|Overall Study|Withdrawal by Subject|6|||
105795300|NCT03033069|364906071|FG000|Overall Study|Withdrawal By Caregiver|1|||
105795301|NCT03033069|364906072|FG001|Overall Study|Withdrawal By Caregiver|0|||
105795302|NCT03033069|364906073|FG002|Overall Study|Withdrawal By Caregiver|0|||
105795303|NCT03033069|364906074|FG003|Overall Study|Withdrawal By Caregiver|0|||
105795304|NCT03033069|364906071|FG000|Overall Study|Reason not Specified|0|||
105795305|NCT03033069|364906072|FG001|Overall Study|Reason not Specified|1|||
105795306|NCT03033069|364906073|FG002|Overall Study|Reason not Specified|0|||
105795307|NCT03033069|364906074|FG003|Overall Study|Reason not Specified|1|||
105795308|NCT04639310|364906079|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
105795309|NCT04639310|364906080|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
105795310|NCT02038959|364907594|FG000|Overall Study|Withdrawal by Subject|6|||
105795311|NCT02038959|364907595|FG001|Overall Study|Withdrawal by Subject|8|||
105795312|NCT00424515|364907596|FG000|Overall Study|Progressive Disease|10|||
105795313|NCT00424515|364907597|FG001|Overall Study|Progressive Disease|11|||
105795314|NCT00424515|364907596|FG000|Overall Study|Adverse Event|0|||
105795315|NCT00424515|364907597|FG001|Overall Study|Adverse Event|1|||
105937042|NCT00452530|365429448|FG001|Overall Study|Adverse Event|44|||
105937043|NCT00452530|365429447|FG000|Overall Study|Withdrawal by Subject|68|||
105937044|NCT00452530|365429448|FG001|Overall Study|Withdrawal by Subject|57|||
105937045|NCT00452530|365429447|FG000|Overall Study|Lost to Follow-up|1|||
105937046|NCT00452530|365429448|FG001|Overall Study|Lost to Follow-up|0|||
105937047|NCT00452530|365429447|FG000|Overall Study|Poor compliance/noncompliance|1|||
105937048|NCT00452530|365429448|FG001|Overall Study|Poor compliance/noncompliance|2|||
105937049|NCT00452530|365429447|FG000|Overall Study|No longer met study criteria|18|||
105937050|NCT00452530|365429448|FG001|Overall Study|No longer met study criteria|22|||
105937051|NCT00452530|365429447|FG000|Overall Study|Other|7|||
105937052|NCT00452530|365429448|FG001|Overall Study|Other|11|||
105937053|NCT00754559|365429449|FG000|Overall Study|Adverse Event|15|||
105937054|NCT00754559|365429449|FG000|Overall Study|Protocol Violation|11|||
105937055|NCT00754559|365429449|FG000|Overall Study|Lack of Efficacy|10|||
105937056|NCT00754559|365429449|FG000|Overall Study|Lost to Follow-up|2|||
105937057|NCT00754559|365429449|FG000|Overall Study|Administrative reason|1|||
105937058|NCT00754559|365429449|FG000|Overall Study|Other|5|||
105937059|NCT00754559|365429449|FG000|Overall Study|Withdrawal by Subject|3|||
105937060|NCT01248468|365429450|FG000|Overall Study|Administrative problem|1|||
105937061|NCT01248468|365429451|FG001|Overall Study|Administrative problem|0|||
105937062|NCT01248468|365429452|FG002|Overall Study|Administrative problem|0|||
105937063|NCT01248468|365429450|FG000|Overall Study|Lost to Follow-up|9|||
105937064|NCT01248468|365429451|FG001|Overall Study|Lost to Follow-up|12|||
105937065|NCT01248468|365429452|FG002|Overall Study|Lost to Follow-up|4|||
105937066|NCT01248468|365429450|FG000|Overall Study|Pregnancy|1|||
105937067|NCT01248468|365429451|FG001|Overall Study|Pregnancy|0|||
105937068|NCT01248468|365429452|FG002|Overall Study|Pregnancy|0|||
105937069|NCT01248468|365429450|FG000|Overall Study|Withdrawal by Subject|4|||
105937070|NCT01248468|365429451|FG001|Overall Study|Withdrawal by Subject|2|||
105937071|NCT01248468|365429452|FG002|Overall Study|Withdrawal by Subject|0|||
105937072|NCT00345592|365429453|FG000|Overall Study|Death|14|||
105937073|NCT00345592|365429454|FG001|Overall Study|Death|16|||
105937074|NCT00345592|365429453|FG000|Overall Study|Withdrawal by Subject|11|||
105937075|NCT00345592|365429454|FG001|Overall Study|Withdrawal by Subject|8|||
105937076|NCT02191397|365429455|FG000|Overall Study|Adverse Event|28|||
105937077|NCT02191397|365429456|FG001|Overall Study|Adverse Event|17|||
105727923|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105727924|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105727925|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
105727926|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105727927|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
105727928|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
105727929|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
105727930|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
105727931|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
105727932|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
105727933|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
105727934|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
105727935|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
105727936|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
105727937|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
105727938|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
105727939|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
105727940|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
105727941|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
105727942|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
105727943|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
105727944|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
105727945|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
105727946|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
105727947|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
105727948|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
105937078|NCT02191397|365429455|FG000|Overall Study|Lack of Efficacy|10|||
105937079|NCT02191397|365429456|FG001|Overall Study|Lack of Efficacy|5|||
105727949|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
105727950|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
105937080|NCT02191397|365429455|FG000|Overall Study|Protocol Violation|0|||
105937081|NCT02191397|365429456|FG001|Overall Study|Protocol Violation|3|||
105937082|NCT02191397|365429455|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
105937083|NCT02191397|365429456|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
105937084|NCT02191397|365429455|FG000|Overall Study|Lost to Follow-up|10|||
105937085|NCT02191397|365429456|FG001|Overall Study|Lost to Follow-up|11|||
105937086|NCT02191397|365429455|FG000|Overall Study|Physician Decision|8|||
105795316|NCT00424515|364907596|FG000|Overall Study|Intercurrent Illness|0|||
105795317|NCT00424515|364907597|FG001|Overall Study|Intercurrent Illness|1|||
105795318|NCT00424515|364907596|FG000|Overall Study|Withdrawal by Subject|1|||
105795319|NCT00424515|364907597|FG001|Overall Study|Withdrawal by Subject|0|||
105795320|NCT04071366|364907598|FG000|Part 1: Open-label (29 Days)|Death|4|||
105795321|NCT04071366|364907599|FG001|Part 1: Open-label (29 Days)|Death|2|||
105795322|NCT04071366|364907600|FG002|Part 1: Open-label (29 Days)|Death|8|||
105795323|NCT04071366|364907601|FG003|Part 1: Open-label (29 Days)|Death|0|||
105795324|NCT04071366|364907602|FG004|Part 1: Open-label (29 Days)|Death|0|||
105795325|NCT04071366|364907598|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
105795326|NCT04071366|364907599|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
105795327|NCT04071366|364907600|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
105795328|NCT04071366|364907601|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
105795329|NCT04071366|364907602|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
105795330|NCT04071366|364907598|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
105795331|NCT04071366|364907599|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
105795332|NCT04071366|364907600|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
105727951|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
105727952|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727953|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727954|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727955|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
105727956|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727957|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
105727958|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727959|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727960|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727961|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
105727962|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727963|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
105727964|NCT03895203|364659614|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727965|NCT03895203|364659615|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727966|NCT03895203|364659616|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727967|NCT03895203|364659617|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727968|NCT03895203|364659618|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
105727969|NCT03895203|364659619|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
105727970|NCT00733902|364659620|FG000|Overall Study|Death|0|||
105727971|NCT00733902|364659621|FG001|Overall Study|Death|0|||
105727972|NCT00733902|364659622|FG002|Overall Study|Death|0|||
105727973|NCT00733902|364659623|FG003|Overall Study|Death|1|||
105727974|NCT00733902|364659620|FG000|Overall Study|Adverse Event|3|||
105727975|NCT00733902|364659621|FG001|Overall Study|Adverse Event|4|||
105727976|NCT00733902|364659622|FG002|Overall Study|Adverse Event|7|||
105727977|NCT00733902|364659623|FG003|Overall Study|Adverse Event|11|||
105727978|NCT00733902|364659620|FG000|Overall Study|Lack of Efficacy|56|||
105727979|NCT00733902|364659621|FG001|Overall Study|Lack of Efficacy|21|||
105727980|NCT00733902|364659622|FG002|Overall Study|Lack of Efficacy|34|||
105727981|NCT00733902|364659623|FG003|Overall Study|Lack of Efficacy|23|||
105727982|NCT00733902|364659620|FG000|Overall Study|Protocol Violation|4|||
105727983|NCT00733902|364659621|FG001|Overall Study|Protocol Violation|6|||
105727984|NCT00733902|364659622|FG002|Overall Study|Protocol Violation|3|||
105727985|NCT00733902|364659623|FG003|Overall Study|Protocol Violation|3|||
105727986|NCT00733902|364659620|FG000|Overall Study|Withdrawal by Subject|10|||
105727987|NCT00733902|364659621|FG001|Overall Study|Withdrawal by Subject|5|||
105727988|NCT00733902|364659622|FG002|Overall Study|Withdrawal by Subject|4|||
105727989|NCT00733902|364659623|FG003|Overall Study|Withdrawal by Subject|16|||
105727990|NCT00733902|364659620|FG000|Overall Study|Entered extension study|89|||
105727991|NCT00733902|364659621|FG001|Overall Study|Entered extension study|124|||
105727992|NCT00733902|364659622|FG002|Overall Study|Entered extension study|111|||
105727993|NCT00733902|364659623|FG003|Overall Study|Entered extension study|109|||
105727994|NCT00733902|364659620|FG000|Overall Study|Randomized but not treated|2|||
105727995|NCT00733902|364659621|FG001|Overall Study|Randomized but not treated|2|||
105727996|NCT00733902|364659622|FG002|Overall Study|Randomized but not treated|2|||
105795333|NCT04071366|364907601|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
105795334|NCT04071366|364907602|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
105795335|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Death|0|||
105795336|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Death|0|||
105795337|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Death|0|||
105795338|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Death|2|||
105795339|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Death|2|||
105727997|NCT00733902|364659623|FG003|Overall Study|Randomized but not treated|1|||
105727998|NCT00886938|364659624|FG000|Overall Study|Adverse Event|1|||
105727999|NCT00886938|364659624|FG000|Overall Study|Withdrawal by Subject|1|||
105728000|NCT00391976|364659625|FG000|Overall Study|Adverse Event|0|||
105728001|NCT00391976|364659626|FG001|Overall Study|Adverse Event|0|||
105728002|NCT00391976|364659627|FG002|Overall Study|Adverse Event|1|||
105728003|NCT00391976|364659625|FG000|Overall Study|Withdrawal of consent|0|||
105728004|NCT00391976|364659626|FG001|Overall Study|Withdrawal of consent|1|||
105728005|NCT00391976|364659627|FG002|Overall Study|Withdrawal of consent|1|||
105728006|NCT00391976|364659625|FG000|Overall Study|Lost to Follow-up|1|||
105728007|NCT00391976|364659626|FG001|Overall Study|Lost to Follow-up|2|||
105728008|NCT00391976|364659627|FG002|Overall Study|Lost to Follow-up|0|||
105728009|NCT00391976|364659625|FG000|Overall Study|Inappropriate enrollment|1|||
105728010|NCT00391976|364659626|FG001|Overall Study|Inappropriate enrollment|1|||
105728011|NCT00391976|364659627|FG002|Overall Study|Inappropriate enrollment|0|||
105728012|NCT00391976|364659625|FG000|Overall Study|Protocol deviation/violation|4|||
105728013|NCT00391976|364659626|FG001|Overall Study|Protocol deviation/violation|2|||
105728014|NCT00391976|364659627|FG002|Overall Study|Protocol deviation/violation|1|||
105728015|NCT00391976|364659625|FG000|Overall Study|Recurrence/no eradication of infection|21|||
105728016|NCT00391976|364659626|FG001|Overall Study|Recurrence/no eradication of infection|19|||
105728017|NCT00391976|364659627|FG002|Overall Study|Recurrence/no eradication of infection|0|||
105728018|NCT00391976|364659625|FG000|Overall Study|Unable to classify|0|||
105728019|NCT00391976|364659626|FG001|Overall Study|Unable to classify|0|||
105937087|NCT02191397|365429456|FG001|Overall Study|Physician Decision|3|||
105937088|NCT02191397|365429455|FG000|Overall Study|Withdrawal by Subject|22|||
105937089|NCT02191397|365429456|FG001|Overall Study|Withdrawal by Subject|27|||
105795340|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
105795341|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
105795342|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
105795343|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
105795344|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
105795345|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
105795346|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
105795347|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
105795348|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
105795349|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
105795350|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
105795351|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
105795352|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
105795353|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
105795354|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
105795355|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
105795356|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
105795357|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
105795358|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
105795359|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
105795360|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
105795361|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
105795362|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
105795363|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
105795364|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
105795365|NCT04071366|364907598|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
105795366|NCT04071366|364907599|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
105795367|NCT04071366|364907600|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
105795368|NCT04071366|364907601|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
105795369|NCT04071366|364907602|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
105795370|NCT02209454|364907607|FG000|Second Period|Adverse Event|1|||
105795371|NCT02209454|364907608|FG001|Second Period|Adverse Event|0|||
105795372|NCT02675426|364907609|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
105795373|NCT02675426|364907610|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
105795374|NCT02675426|364907611|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
105795375|NCT02675426|364907612|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
105795376|NCT02675426|364907609|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
105937090|NCT02176525|365429458|FG000|Overall Study|Adverse Event|0|||
105937091|NCT02176525|365429459|FG001|Overall Study|Adverse Event|0|||
105937092|NCT02176525|365429460|FG002|Overall Study|Adverse Event|0|||
105937093|NCT02176525|365429461|FG003|Overall Study|Adverse Event|1|||
105795377|NCT02675426|364907610|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
105795378|NCT02675426|364907611|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
105795379|NCT02675426|364907612|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
105937094|NCT02176525|365429462|FG004|Overall Study|Adverse Event|1|||
105937095|NCT02176525|365429463|FG005|Overall Study|Adverse Event|0|||
105795380|NCT02675426|364907609|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
105795381|NCT02675426|364907610|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
105795382|NCT02675426|364907611|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
105795383|NCT02675426|364907612|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
105795384|NCT02675426|364907609|FG000|Period 1: Week 1 to Week 12|Other|2|||
105937096|NCT02176525|365429464|FG006|Overall Study|Adverse Event|1|||
105937097|NCT02176525|365429465|FG007|Overall Study|Adverse Event|0|||
105937098|NCT02176525|365429458|FG000|Overall Study|not treated|1|||
105937099|NCT02176525|365429459|FG001|Overall Study|not treated|0|||
105937100|NCT02176525|365429460|FG002|Overall Study|not treated|0|||
105937101|NCT02176525|365429461|FG003|Overall Study|not treated|0|||
105937102|NCT02176525|365429462|FG004|Overall Study|not treated|0|||
105937103|NCT02176525|365429463|FG005|Overall Study|not treated|1|||
105728020|NCT00391976|364659627|FG002|Overall Study|Unable to classify|1|||
105728021|NCT00391976|364659625|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
105728022|NCT00391976|364659626|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
105728023|NCT00391976|364659627|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
105728024|NCT05127486|364659628|FG000|Overall Study|Adverse Event|2|||
105728025|NCT05127486|364659629|FG001|Overall Study|Adverse Event|4|||
105728026|NCT05127486|364659628|FG000|Overall Study|Lack of Efficacy|1|||
105728027|NCT05127486|364659629|FG001|Overall Study|Lack of Efficacy|0|||
105728028|NCT05127486|364659628|FG000|Overall Study|Pregnancy|0|||
105728029|NCT05127486|364659629|FG001|Overall Study|Pregnancy|1|||
105728030|NCT05127486|364659628|FG000|Overall Study|Physician Decision|4|||
105728031|NCT05127486|364659629|FG001|Overall Study|Physician Decision|1|||
105728032|NCT05127486|364659628|FG000|Overall Study|Withdrawal by Subject|14|||
105728033|NCT05127486|364659629|FG001|Overall Study|Withdrawal by Subject|13|||
105728034|NCT05127486|364659628|FG000|Overall Study|Lost to Follow-up|5|||
105728035|NCT05127486|364659629|FG001|Overall Study|Lost to Follow-up|8|||
105728036|NCT00363415|364659630|FG000|Overall Study|Progressive Disease|196|||
105728037|NCT00363415|364659631|FG001|Overall Study|Progressive Disease|107|||
105728038|NCT00363415|364659630|FG000|Overall Study|Sponsor Decision|67|||
105728039|NCT00363415|364659631|FG001|Overall Study|Sponsor Decision|31|||
105728040|NCT00363415|364659630|FG000|Overall Study|Death|32|||
105728041|NCT00363415|364659631|FG001|Overall Study|Death|29|||
105728042|NCT00363415|364659630|FG000|Overall Study|Adverse Event|24|||
105728043|NCT00363415|364659631|FG001|Overall Study|Adverse Event|15|||
105728044|NCT00363415|364659630|FG000|Overall Study|Physician Decision|18|||
105728045|NCT00363415|364659631|FG001|Overall Study|Physician Decision|35|||
105728046|NCT00363415|364659630|FG000|Overall Study|Entry Criteria Not Met|11|||
105728047|NCT00363415|364659631|FG001|Overall Study|Entry Criteria Not Met|10|||
105728048|NCT00363415|364659630|FG000|Overall Study|Withdrawal by Subject|9|||
105728049|NCT00363415|364659631|FG001|Overall Study|Withdrawal by Subject|15|||
105728050|NCT00363415|364659630|FG000|Overall Study|Lost to Follow-up|3|||
105728051|NCT00363415|364659631|FG001|Overall Study|Lost to Follow-up|3|||
105728052|NCT00363415|364659630|FG000|Overall Study|Protocol Violation|1|||
105728053|NCT00363415|364659631|FG001|Overall Study|Protocol Violation|4|||
105728054|NCT01242111|364659632|FG000|Overall Study|Adverse Event|1|||
105728055|NCT01242111|364659632|FG000|Overall Study|Withdrawal by Subject|1|||
105728056|NCT01242111|364659632|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
105728057|NCT00870688|364659633|FG000|Overall Study|Lost to Follow-up|2|||
105728058|NCT00870688|364659633|FG000|Overall Study|Death, Unrelated|1|||
105728059|NCT00870688|364659633|FG000|Overall Study|Granules in the Stools|1|||
105728060|NCT01021007|364659634|FG000|Overall Study|Lost to Follow-up|1|||
105728061|NCT01021007|364659635|FG001|Overall Study|Lost to Follow-up|1|||
105728062|NCT01021007|364659634|FG000|Overall Study|Adverse Event|1|||
105728063|NCT01021007|364659635|FG001|Overall Study|Adverse Event|3|||
105728064|NCT03801902|364659636|FG000|Overall Study|Did not receive protocol treatment.|1|||
105728065|NCT03801902|364659637|FG001|Overall Study|Did not receive protocol treatment.|0|||
105728066|NCT03801902|364659638|FG002|Overall Study|Did not receive protocol treatment.|0|||
105728067|NCT03801902|364659639|FG003|Overall Study|Did not receive protocol treatment.|0|||
105728068|NCT00001337|364659640|FG000|Overall Study|Switched to alternate treatment|2|||
105795385|NCT02675426|364907610|FG001|Period 1: Week 1 to Week 12|Other|1|||
105937104|NCT02176525|365429464|FG006|Overall Study|not treated|0|||
105937105|NCT02176525|365429465|FG007|Overall Study|not treated|0|||
105728069|NCT00001337|364659641|FG001|Overall Study|Switched to alternate treatment|2|||
105728070|NCT00001337|364659642|FG002|Overall Study|Switched to alternate treatment|0|||
105728071|NCT00001337|364659640|FG000|Overall Study|Refused further treatment|2|||
105728072|NCT00001337|364659641|FG001|Overall Study|Refused further treatment|1|||
105728073|NCT00001337|364659642|FG002|Overall Study|Refused further treatment|0|||
105728074|NCT00001337|364659640|FG000|Overall Study|Began other Tx|1|||
105728075|NCT00001337|364659641|FG001|Overall Study|Began other Tx|0|||
105728076|NCT00001337|364659642|FG002|Overall Study|Began other Tx|0|||
105728077|NCT00001337|364659640|FG000|Overall Study|Physician Decision|3|||
105728078|NCT00001337|364659641|FG001|Overall Study|Physician Decision|1|||
105795386|NCT02675426|364907611|FG002|Period 1: Week 1 to Week 12|Other|0|||
105937106|NCT02100644|365429466|FG000|LTG Escalation Phase|Adverse Event|9|||
105937107|NCT02100644|365429467|FG001|LTG Escalation Phase|Adverse Event|0|||
105795387|NCT02675426|364907612|FG003|Period 1: Week 1 to Week 12|Other|2|||
105795388|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
105795389|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
105795390|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
105795391|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
105795392|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
105795393|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
105795394|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
105795395|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
105795396|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
105795397|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
105795398|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
105795399|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
105795400|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
105795401|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
105795402|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
105795403|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
105795404|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
105795405|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
105795406|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
105795407|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
105795408|NCT02675426|364907609|FG000|Period 2: Week 12 to Week 260|Other|8|||
105795409|NCT02675426|364907610|FG001|Period 2: Week 12 to Week 260|Other|12|||
105795410|NCT02675426|364907611|FG002|Period 2: Week 12 to Week 260|Other|23|||
105795411|NCT02675426|364907612|FG003|Period 2: Week 12 to Week 260|Other|15|||
105795412|NCT02237118|364907617|FG000|Overall Study|Protocol Violation|0|||
105795413|NCT02237118|364907618|FG001|Overall Study|Protocol Violation|1|||
105795414|NCT02237118|364907617|FG000|Overall Study|consent withdrawn|1|||
105795415|NCT02237118|364907618|FG001|Overall Study|consent withdrawn|0|||
105795416|NCT04292171|364907621|FG000|Overall Study|Pharmacy error|2|||
105795417|NCT04292171|364907622|FG001|Overall Study|Pharmacy error|0|||
105795418|NCT04292171|364907621|FG000|Overall Study|Delivered prior to procedure|0|||
105795419|NCT04292171|364907622|FG001|Overall Study|Delivered prior to procedure|1|||
105795420|NCT02253654|364907623|FG000|Overall Study|Withdrawal by Subject|12|||
105795421|NCT02253654|364907624|FG001|Overall Study|Withdrawal by Subject|4|||
105795422|NCT02253654|364907623|FG000|Overall Study|Decision by Sponsor|1|||
105795423|NCT02253654|364907624|FG001|Overall Study|Decision by Sponsor|1|||
105795424|NCT02253654|364907623|FG000|Overall Study|Lost to Follow-up|2|||
105795425|NCT02253654|364907624|FG001|Overall Study|Lost to Follow-up|5|||
105795426|NCT02253654|364907623|FG000|Overall Study|Death|4|||
105795427|NCT02253654|364907624|FG001|Overall Study|Death|7|||
105795428|NCT02253654|364907623|FG000|Overall Study|Did Not Receive Study Treatment|4|||
105795429|NCT02253654|364907624|FG001|Overall Study|Did Not Receive Study Treatment|1|||
105795430|NCT04723173|364907625|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
105795431|NCT02996448|364907626|FG000|Overall Study|Study terminated due to adverse effects|3|||
105795432|NCT02703454|364907632|FG000|Overall Study|Not treated|1|||
105795433|NCT02703454|364907633|FG001|Overall Study|Not treated|3|||
105795434|NCT02703454|364907632|FG000|Overall Study|Withdrawal by Subject|4|||
105795435|NCT02703454|364907633|FG001|Overall Study|Withdrawal by Subject|3|||
105795436|NCT02703454|364907632|FG000|Overall Study|Lost to Follow-up|1|||
105795437|NCT02703454|364907633|FG001|Overall Study|Lost to Follow-up|2|||
105795438|NCT02703454|364907632|FG000|Overall Study|Study discontinuation|5|||
105795439|NCT02703454|364907633|FG001|Overall Study|Study discontinuation|8|||
105795440|NCT00791154|364907634|FG000|Overall Study|Noncompliance|0|||
105795441|NCT00791154|364907635|FG001|Overall Study|Noncompliance|1|||
105795442|NCT00791154|364907636|FG002|Overall Study|Noncompliance|0|||
105795443|NCT00791154|364907637|FG003|Overall Study|Noncompliance|0|||
105795444|NCT00791154|364907638|FG004|Overall Study|Noncompliance|1|||
105795445|NCT00791154|364907639|FG005|Overall Study|Noncompliance|1|||
105795446|NCT00791154|364907640|FG006|Overall Study|Noncompliance|1|||
105795447|NCT00791154|364907634|FG000|Overall Study|Adverse Event|0|||
105795448|NCT00791154|364907635|FG001|Overall Study|Adverse Event|0|||
105795449|NCT00791154|364907636|FG002|Overall Study|Adverse Event|0|||
105795450|NCT00791154|364907637|FG003|Overall Study|Adverse Event|0|||
105795451|NCT00791154|364907638|FG004|Overall Study|Adverse Event|2|||
105795452|NCT00791154|364907639|FG005|Overall Study|Adverse Event|0|||
105795453|NCT00791154|364907640|FG006|Overall Study|Adverse Event|1|||
105795454|NCT00791154|364907634|FG000|Overall Study|Full Consent withdrawn|1|||
105795455|NCT00791154|364907635|FG001|Overall Study|Full Consent withdrawn|3|||
105795456|NCT00791154|364907636|FG002|Overall Study|Full Consent withdrawn|0|||
105795457|NCT00791154|364907637|FG003|Overall Study|Full Consent withdrawn|0|||
105795458|NCT00791154|364907638|FG004|Overall Study|Full Consent withdrawn|1|||
105937108|NCT02100644|365429468|FG002|LTG Escalation Phase|Adverse Event|0|||
105795459|NCT00791154|364907639|FG005|Overall Study|Full Consent withdrawn|3|||
105795460|NCT00791154|364907640|FG006|Overall Study|Full Consent withdrawn|1|||
105795461|NCT00791154|364907634|FG000|Overall Study|Lost to Follow-up|0|||
105795462|NCT00791154|364907635|FG001|Overall Study|Lost to Follow-up|0|||
105795463|NCT00791154|364907636|FG002|Overall Study|Lost to Follow-up|0|||
105795464|NCT00791154|364907637|FG003|Overall Study|Lost to Follow-up|1|||
105795465|NCT00791154|364907638|FG004|Overall Study|Lost to Follow-up|2|||
105795466|NCT00791154|364907639|FG005|Overall Study|Lost to Follow-up|0|||
105795467|NCT00791154|364907640|FG006|Overall Study|Lost to Follow-up|4|||
105795468|NCT00791154|364907634|FG000|Overall Study|Death|5|||
105795469|NCT00791154|364907635|FG001|Overall Study|Death|4|||
105795470|NCT00791154|364907636|FG002|Overall Study|Death|4|||
105795471|NCT00791154|364907637|FG003|Overall Study|Death|7|||
105795472|NCT00791154|364907638|FG004|Overall Study|Death|54|||
105795473|NCT00791154|364907639|FG005|Overall Study|Death|54|||
105795474|NCT00791154|364907640|FG006|Overall Study|Death|52|||
105795475|NCT00791154|364907634|FG000|Overall Study|Other event|0|||
105795476|NCT00791154|364907635|FG001|Overall Study|Other event|0|||
105795477|NCT00791154|364907636|FG002|Overall Study|Other event|2|||
105795478|NCT00791154|364907637|FG003|Overall Study|Other event|0|||
105795479|NCT00791154|364907638|FG004|Overall Study|Other event|2|||
105795480|NCT00791154|364907639|FG005|Overall Study|Other event|4|||
105795481|NCT00791154|364907640|FG006|Overall Study|Other event|2|||
105795482|NCT02284373|364907641|FG000|Overall Study|Withdrawal by Subject|0|||
105795483|NCT02284373|364907642|FG001|Overall Study|Withdrawal by Subject|1|||
105795484|NCT02284373|364907643|FG002|Overall Study|Withdrawal by Subject|0|||
105795485|NCT02284373|364907641|FG000|Overall Study|Other|0|||
105795486|NCT02284373|364907642|FG001|Overall Study|Other|1|||
105728079|NCT00001337|364659642|FG002|Overall Study|Physician Decision|0|||
105728080|NCT00001337|364659640|FG000|Overall Study|Doesn't have NHL|0|||
105728081|NCT00001337|364659641|FG001|Overall Study|Doesn't have NHL|1|||
105728082|NCT00001337|364659642|FG002|Overall Study|Doesn't have NHL|0|||
105728083|NCT00001337|364659640|FG000|Overall Study|Non protocol tx needed|3|||
105728084|NCT00001337|364659641|FG001|Overall Study|Non protocol tx needed|1|||
105728085|NCT00001337|364659642|FG002|Overall Study|Non protocol tx needed|0|||
105728086|NCT00001337|364659640|FG000|Overall Study|Protocol change|1|||
105728087|NCT00001337|364659641|FG001|Overall Study|Protocol change|0|||
105728088|NCT00001337|364659642|FG002|Overall Study|Protocol change|0|||
105728089|NCT00001337|364659640|FG000|Overall Study|2nd primary disease|0|||
105728090|NCT00001337|364659641|FG001|Overall Study|2nd primary disease|0|||
105728091|NCT00001337|364659642|FG002|Overall Study|2nd primary disease|1|||
105728092|NCT00001337|364659640|FG000|Overall Study|Death during follow up period|9|||
105728093|NCT00001337|364659641|FG001|Overall Study|Death during follow up period|4|||
105728094|NCT00001337|364659642|FG002|Overall Study|Death during follow up period|0|||
105728095|NCT00001337|364659640|FG000|Overall Study|Death on study|19|||
105728096|NCT00001337|364659641|FG001|Overall Study|Death on study|9|||
105728097|NCT00001337|364659642|FG002|Overall Study|Death on study|0|||
105728098|NCT00001337|364659640|FG000|Overall Study|Disease progression during follow-up period|3|||
105728099|NCT00001337|364659641|FG001|Overall Study|Disease progression during follow-up period|1|||
105728100|NCT00001337|364659642|FG002|Overall Study|Disease progression during follow-up period|0|||
105728101|NCT00001337|364659640|FG000|Overall Study|Disease progression on study|33|||
105728102|NCT00001337|364659641|FG001|Overall Study|Disease progression on study|41|||
105728103|NCT00001337|364659642|FG002|Overall Study|Disease progression on study|0|||
105728104|NCT00001337|364659640|FG000|Overall Study|Lost to further follow-up|10|||
105728105|NCT00001337|364659641|FG001|Overall Study|Lost to further follow-up|6|||
105728106|NCT00001337|364659642|FG002|Overall Study|Lost to further follow-up|0|||
105728107|NCT00001337|364659640|FG000|Overall Study|2nd malignancy|1|||
105728108|NCT00001337|364659641|FG001|Overall Study|2nd malignancy|0|||
105728109|NCT00001337|364659642|FG002|Overall Study|2nd malignancy|0|||
105728110|NCT00001337|364659640|FG000|Overall Study|Treatment for second lymphoma|0|||
105728111|NCT00001337|364659641|FG001|Overall Study|Treatment for second lymphoma|1|||
105795487|NCT02284373|364907643|FG002|Overall Study|Other|0|||
105937109|NCT02100644|365429466|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
105728112|NCT00001337|364659642|FG002|Overall Study|Treatment for second lymphoma|0|||
105728113|NCT00001337|364659640|FG000|Overall Study|Transfer to transplant|0|||
105728114|NCT00001337|364659641|FG001|Overall Study|Transfer to transplant|1|||
105728115|NCT00001337|364659642|FG002|Overall Study|Transfer to transplant|0|||
105795488|NCT02284373|364907641|FG000|Overall Study|Lost to Follow-up|0|||
105795489|NCT02284373|364907642|FG001|Overall Study|Lost to Follow-up|1|||
105795490|NCT02284373|364907643|FG002|Overall Study|Lost to Follow-up|0|||
105795491|NCT01652573|364907644|FG000|Overall Study|Adverse Event|0|||
105795492|NCT01652573|364907645|FG001|Overall Study|Adverse Event|1|||
105795493|NCT00468312|364907648|FG000|Overall Study|Adverse Event|2|||
105795494|NCT00468312|364907649|FG001|Overall Study|Adverse Event|1|||
105795495|NCT00468312|364907648|FG000|Overall Study|Lack of Efficacy|0|||
105795496|NCT00468312|364907649|FG001|Overall Study|Lack of Efficacy|1|||
105795497|NCT00468312|364907648|FG000|Overall Study|Withdrawal by Subject|0|||
105795498|NCT00468312|364907649|FG001|Overall Study|Withdrawal by Subject|1|||
105795499|NCT00468312|364907648|FG000|Overall Study|Protocol Violation|2|||
105728116|NCT06161012|364659643|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
105728117|NCT06161012|364659644|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
105728118|NCT03619213|364659645|FG000|Overall Study|Lost to Follow-up|2|||
105728119|NCT03619213|364659646|FG001|Overall Study|Lost to Follow-up|1|||
105728120|NCT03619213|364659645|FG000|Overall Study|Withdrawal by Subject|8|||
105728121|NCT03619213|364659646|FG001|Overall Study|Withdrawal by Subject|10|||
105728122|NCT00442598|364659647|FG000|Overall Study|Adverse Event|1|||
105728123|NCT00442598|364659648|FG001|Overall Study|Adverse Event|0|||
105728124|NCT00442598|364659649|FG002|Overall Study|Adverse Event|0|||
105728125|NCT00442598|364659647|FG000|Overall Study|Tumor progression|3|||
105728126|NCT00442598|364659648|FG001|Overall Study|Tumor progression|4|||
105728127|NCT00442598|364659649|FG002|Overall Study|Tumor progression|0|||
105728128|NCT00442598|364659647|FG000|Overall Study|Clinical deterioration|1|||
105728129|NCT00442598|364659648|FG001|Overall Study|Clinical deterioration|2|||
105728130|NCT00442598|364659649|FG002|Overall Study|Clinical deterioration|0|||
105728131|NCT00442598|364659647|FG000|Overall Study|CA125 progression|0|||
105728132|NCT00442598|364659648|FG001|Overall Study|CA125 progression|1|||
105728133|NCT00442598|364659649|FG002|Overall Study|CA125 progression|0|||
105937110|NCT02100644|365429467|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
105937111|NCT02100644|365429468|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
105937112|NCT02100644|365429466|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
105937113|NCT02100644|365429467|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
105937114|NCT02100644|365429468|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
105937115|NCT00468546|365429469|FG000|Week 24 Analysis|Lack of Efficacy|83|||
105728134|NCT00442598|364659647|FG000|Overall Study|Reduced creatinine clearance|1|||
105728135|NCT00442598|364659648|FG001|Overall Study|Reduced creatinine clearance|0|||
105728136|NCT00442598|364659649|FG002|Overall Study|Reduced creatinine clearance|0|||
105728137|NCT00442598|364659647|FG000|Overall Study|Death|0|||
105728138|NCT00442598|364659648|FG001|Overall Study|Death|1|||
105728139|NCT00442598|364659649|FG002|Overall Study|Death|0|||
105728140|NCT01262898|364659650|FG000|Overall Study|Protocol Violation|1|||
105728141|NCT01262898|364659651|FG001|Overall Study|Protocol Violation|1|||
105728142|NCT01262898|364659652|FG002|Overall Study|Protocol Violation|0|||
105728143|NCT01262898|364659653|FG003|Overall Study|Protocol Violation|0|||
105728144|NCT01262898|364659650|FG000|Overall Study|Lost to Follow-up|1|||
105728145|NCT01262898|364659651|FG001|Overall Study|Lost to Follow-up|0|||
105728146|NCT01262898|364659652|FG002|Overall Study|Lost to Follow-up|0|||
105728147|NCT01262898|364659653|FG003|Overall Study|Lost to Follow-up|0|||
105728148|NCT01262898|364659650|FG000|Overall Study|Withdrawal by Subject|1|||
105728149|NCT01262898|364659651|FG001|Overall Study|Withdrawal by Subject|1|||
105728150|NCT01262898|364659652|FG002|Overall Study|Withdrawal by Subject|0|||
105728151|NCT01262898|364659653|FG003|Overall Study|Withdrawal by Subject|0|||
105728152|NCT02599402|364659654|FG000|Overall Study|Disease progression|153|||
105728153|NCT02599402|364659654|FG000|Overall Study|Study drug toxicity|201|||
105728154|NCT02599402|364659654|FG000|Overall Study|Death|26|||
105728155|NCT02599402|364659654|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
105728156|NCT02599402|364659654|FG000|Overall Study|Participant request to discontinue study treatment|13|||
105728157|NCT02599402|364659654|FG000|Overall Study|Participant withdrew consent|5|||
105728158|NCT02599402|364659654|FG000|Overall Study|Lost to Follow-up|1|||
105728159|NCT02599402|364659654|FG000|Overall Study|Maximum Clinical Benefit|7|||
105728160|NCT02599402|364659654|FG000|Overall Study|Poor/non-compliance|1|||
105728161|NCT02599402|364659654|FG000|Overall Study|Pregnancy|1|||
105728162|NCT02599402|364659654|FG000|Overall Study|Participant no longer met study criteria|7|||
105728163|NCT02599402|364659654|FG000|Overall Study|Other Reasons|95|||
105728164|NCT01974323|364659655|FG000|Overall Study|Other Reasons|25|||
105728165|NCT01974323|364659656|FG001|Overall Study|Other Reasons|28|||
105728166|NCT01974323|364659655|FG000|Overall Study|Protocol Violation|2|||
105728167|NCT01974323|364659656|FG001|Overall Study|Protocol Violation|2|||
105728168|NCT01974323|364659655|FG000|Overall Study|Personal Reasons|15|||
105728169|NCT01974323|364659656|FG001|Overall Study|Personal Reasons|19|||
105728170|NCT01974323|364659655|FG000|Overall Study|Lost to Follow-up|45|||
105728171|NCT01974323|364659656|FG001|Overall Study|Lost to Follow-up|40|||
105728172|NCT01974323|364659655|FG000|Overall Study|Pregnancy|2|||
105728173|NCT01974323|364659656|FG001|Overall Study|Pregnancy|1|||
105728174|NCT01974323|364659655|FG000|Overall Study|Lack of Efficacy|1|||
105728175|NCT01974323|364659656|FG001|Overall Study|Lack of Efficacy|1|||
105728176|NCT01974323|364659655|FG000|Overall Study|Adverse Event|2|||
105728177|NCT01974323|364659656|FG001|Overall Study|Adverse Event|2|||
105728178|NCT00461175|364659657|FG000|Overall Study|Protocol Violation|522|||
105728179|NCT00461175|364659658|FG001|Overall Study|Protocol Violation|365|||
105728180|NCT00809133|364659659|FG000|Overall Study|Progressive disease|2|||
105728181|NCT00809133|364659660|FG001|Overall Study|Progressive disease|5|||
105728182|NCT00809133|364659661|FG002|Overall Study|Progressive disease|5|||
105728183|NCT00809133|364659662|FG003|Overall Study|Progressive disease|3|||
105728184|NCT00809133|364659663|FG004|Overall Study|Progressive disease|4|||
105728185|NCT00809133|364659664|FG005|Overall Study|Progressive disease|1|||
105728186|NCT00809133|364659665|FG006|Overall Study|Progressive disease|3|||
105937116|NCT00468546|365429470|FG001|Week 24 Analysis|Lack of Efficacy|37|||
105795500|NCT00468312|364907649|FG001|Overall Study|Protocol Violation|1|||
105795501|NCT00468312|364907648|FG000|Overall Study|Did not meet protocol eligibility|0|||
105795502|NCT00468312|364907649|FG001|Overall Study|Did not meet protocol eligibility|1|||
105795503|NCT00414011|364907650|FG000|Overall Study|Physician Decision|3|||
105795504|NCT00414011|364907650|FG000|Overall Study|Withdrawal by Subject|2|||
105795505|NCT00306852|364907656|FG000|Overall Study|Death|14|||
105795506|NCT00306852|364907657|FG001|Overall Study|Death|14|||
105795507|NCT00306852|364907656|FG000|Overall Study|Lost to Follow-up|15|||
105795508|NCT00306852|364907657|FG001|Overall Study|Lost to Follow-up|24|||
105795509|NCT00817778|364907658|FG000|Overall Study|Adverse Event|1|||
105795510|NCT00817778|364907659|FG001|Overall Study|Adverse Event|0|||
105795511|NCT00817778|364907658|FG000|Overall Study|Withdrawal by Subject|1|||
105795512|NCT00817778|364907659|FG001|Overall Study|Withdrawal by Subject|1|||
105795513|NCT00817778|364907658|FG000|Overall Study|Protocol Violation|0|||
105795514|NCT00817778|364907659|FG001|Overall Study|Protocol Violation|1|||
105795515|NCT00817778|364907658|FG000|Overall Study|Study-specific discontinuation criteria|0|||
105795516|NCT00817778|364907659|FG001|Overall Study|Study-specific discontinuation criteria|1|||
105795517|NCT00817778|364907658|FG000|Overall Study|Poor venous access|1|||
105795518|NCT00817778|364907659|FG001|Overall Study|Poor venous access|0|||
105795519|NCT03343054|364907660|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
105795520|NCT03343054|364907661|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
105795521|NCT03343054|364907662|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
105795522|NCT03343054|364907660|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
105795523|NCT03343054|364907661|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
105795524|NCT03343054|364907662|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
105795525|NCT03343054|364907660|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
105795526|NCT03343054|364907661|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
105795527|NCT03343054|364907662|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
105795528|NCT03343054|364907660|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
105795529|NCT03343054|364907661|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
105795530|NCT03343054|364907662|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
105795531|NCT01890109|364907663|FG000|Overall Study|Withdrawal by Subject|0|||
105795532|NCT01890109|364907664|FG001|Overall Study|Withdrawal by Subject|3|||
105795533|NCT01890109|364907663|FG000|Overall Study|Lost to Follow-up|1|||
105795534|NCT01890109|364907664|FG001|Overall Study|Lost to Follow-up|2|||
105795535|NCT01286207|364907665|FG000|Overall Study|Adverse Event|27|||
105795536|NCT01286207|364907666|FG001|Overall Study|Adverse Event|41|||
105795537|NCT01286207|364907667|FG002|Overall Study|Adverse Event|8|||
105795538|NCT01286207|364907665|FG000|Overall Study|Lost to Follow-up|49|||
105795539|NCT01286207|364907666|FG001|Overall Study|Lost to Follow-up|43|||
105795540|NCT01286207|364907667|FG002|Overall Study|Lost to Follow-up|20|||
105795541|NCT01286207|364907665|FG000|Overall Study|Withdrawal by Subject|93|||
105795542|NCT01286207|364907666|FG001|Overall Study|Withdrawal by Subject|79|||
105795543|NCT01286207|364907667|FG002|Overall Study|Withdrawal by Subject|41|||
105795544|NCT01286207|364907665|FG000|Overall Study|Lack of Response|92|||
105795545|NCT01286207|364907666|FG001|Overall Study|Lack of Response|38|||
105795546|NCT01286207|364907667|FG002|Overall Study|Lack of Response|8|||
105795547|NCT01286207|364907665|FG000|Overall Study|Other|37|||
105795548|NCT01286207|364907666|FG001|Overall Study|Other|47|||
105795549|NCT01286207|364907667|FG002|Overall Study|Other|13|||
105795550|NCT00981409|364907668|FG000|Overall Study|Adverse Event|4|||
105795551|NCT00981409|364907669|FG001|Overall Study|Adverse Event|0|||
105795552|NCT00981409|364907668|FG000|Overall Study|Protocol Violation|0|||
105795553|NCT00981409|364907669|FG001|Overall Study|Protocol Violation|1|||
105795554|NCT00981409|364907668|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
105795555|NCT00981409|364907669|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
105795556|NCT00078312|364907674|FG000|Overall Study|Adverse Event|43|||
105795557|NCT00078312|364907674|FG000|Overall Study|Lack of Efficacy|15|||
105795558|NCT00078312|364907674|FG000|Overall Study|Lost to Follow-up|41|||
105795559|NCT00078312|364907674|FG000|Overall Study|Physician Decision|9|||
105795560|NCT00078312|364907674|FG000|Overall Study|Protocol Violation|3|||
105795561|NCT00078312|364907674|FG000|Overall Study|Withdrawal by Subject|33|||
106138940|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
106138941|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105795562|NCT00078312|364907674|FG000|Overall Study|Miscellaneous|33|||
105795563|NCT01296152|364907676|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
105795564|NCT00589693|364907677|FG000|Overall Study|randomized in error|12|||
105795565|NCT00589693|364907678|FG001|Overall Study|randomized in error|6|||
105795566|NCT00589693|364907677|FG000|Overall Study|Adverse Event|4|||
105795567|NCT00589693|364907678|FG001|Overall Study|Adverse Event|4|||
105795568|NCT00589693|364907677|FG000|Overall Study|Death|26|||
105795569|NCT00589693|364907678|FG001|Overall Study|Death|16|||
105937117|NCT00468546|365429469|FG000|Week 24 Analysis|Refused treatment|5|||
105795570|NCT00589693|364907677|FG000|Overall Study|Lack of Efficacy|0|||
105795571|NCT00589693|364907678|FG001|Overall Study|Lack of Efficacy|1|||
105795572|NCT00589693|364907677|FG000|Overall Study|Lost to Follow-up|1|||
105795573|NCT00589693|364907678|FG001|Overall Study|Lost to Follow-up|0|||
105795574|NCT00589693|364907677|FG000|Overall Study|Physician Decision|0|||
105795575|NCT00589693|364907678|FG001|Overall Study|Physician Decision|1|||
105795576|NCT00589693|364907677|FG000|Overall Study|Protocol Violation|1|||
105795577|NCT00589693|364907678|FG001|Overall Study|Protocol Violation|1|||
105795578|NCT00755937|364907679|FG000|Recruitment|Unknown if infliximab received|164|||
105795579|NCT00755937|364907679|FG000|Observational Follow-up|Lost to Follow-up|148|||
105795580|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
105795581|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
105795582|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
105795583|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
105795584|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
105795585|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
105795586|NCT00566631|364907680|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
105795587|NCT00566631|364907680|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
105795588|NCT00566631|364907680|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
105795589|NCT00566631|364907680|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
105795590|NCT00566631|364907680|FG000|Part 2: Extension Phase|Adverse Event|11|||
105795591|NCT00566631|364907680|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
105795592|NCT00566631|364907680|FG000|Part 2: Extension Phase|Death|1|||
105795593|NCT00566631|364907680|FG000|Part 2: Extension Phase|Other|5|||
105795594|NCT01346501|364907682|FG000|Overall Study|Initiated Other Biological Agents|3|||
105795595|NCT01346501|364907683|FG001|Overall Study|Initiated Other Biological Agents|1|||
105795596|NCT01346501|364907682|FG000|Overall Study|Other|8|||
105795597|NCT01346501|364907683|FG001|Overall Study|Other|12|||
105795598|NCT00756652|364907684|FG000|Original Phase|Withdrawal by Subject|864|||
105795599|NCT00756652|364907685|FG001|Original Phase|Withdrawal by Subject|23|||
105795600|NCT00756652|364907684|FG000|Original Phase|Lost to Follow-up|601|||
105795601|NCT00756652|364907685|FG001|Original Phase|Lost to Follow-up|0|||
105795602|NCT00756652|364907684|FG000|Original Phase|Other Discontinuation|797|||
105795603|NCT00756652|364907685|FG001|Original Phase|Other Discontinuation|5|||
105795604|NCT00756652|364907684|FG000|Original Phase|Participant Noncompliance|18622|||
105795605|NCT00756652|364907685|FG001|Original Phase|Participant Noncompliance|424|||
105795606|NCT00756652|364907684|FG000|Original Phase|Unknown Discontinuation Reason|2|||
105795607|NCT00756652|364907685|FG001|Original Phase|Unknown Discontinuation Reason|0|||
105795608|NCT00756652|364907684|FG000|Original Phase|Participants without data|3259|||
105795609|NCT00756652|364907685|FG001|Original Phase|Participants without data|466|||
105795610|NCT00756652|364907684|FG000|Original Phase|Death|168|||
105795611|NCT00756652|364907685|FG001|Original Phase|Death|1|||
105795612|NCT00756652|364907684|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
105795613|NCT00756652|364907685|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
105795614|NCT00756652|364907684|FG000|Re-Op Phase|Withdrawal by Subject|62|||
105795615|NCT00756652|364907685|FG001|Re-Op Phase|Withdrawal by Subject|0|||
105795616|NCT00756652|364907684|FG000|Re-Op Phase|Death|6|||
105795617|NCT00756652|364907685|FG001|Re-Op Phase|Death|0|||
105795618|NCT00756652|364907684|FG000|Re-Op Phase|Lost to Follow-up|340|||
105795619|NCT00756652|364907685|FG001|Re-Op Phase|Lost to Follow-up|0|||
105795620|NCT00756652|364907684|FG000|Re-Op Phase|Site Closed|2454|||
105795621|NCT00756652|364907685|FG001|Re-Op Phase|Site Closed|0|||
105795622|NCT00756652|364907684|FG000|Re-Op Phase|Withdrawn after explant|14|||
105795623|NCT00756652|364907685|FG001|Re-Op Phase|Withdrawn after explant|0|||
105795624|NCT04736576|364907686|FG000|Overall Study|Progressive disease|3|||
105795625|NCT04736576|364907687|FG001|Overall Study|Progressive disease|1|||
105795626|NCT04736576|364907686|FG000|Overall Study|Death|1|||
105795627|NCT04736576|364907687|FG001|Overall Study|Death|0|||
105795628|NCT01523301|364907690|FG000|Overall Study|Adverse Event|25|||
105795629|NCT01523301|364907691|FG001|Overall Study|Adverse Event|16|||
105795630|NCT01523301|364907690|FG000|Overall Study|Lack of Efficacy|0|||
105795631|NCT01523301|364907691|FG001|Overall Study|Lack of Efficacy|2|||
105795632|NCT01523301|364907690|FG000|Overall Study|Protocol Violation|3|||
105795633|NCT01523301|364907691|FG001|Overall Study|Protocol Violation|4|||
105795634|NCT01523301|364907690|FG000|Overall Study|Lost to Follow-up|1|||
105795635|NCT01523301|364907691|FG001|Overall Study|Lost to Follow-up|0|||
105795636|NCT01523301|364907690|FG000|Overall Study|Withdrawal by Subject|6|||
105795637|NCT01523301|364907691|FG001|Overall Study|Withdrawal by Subject|8|||
106009539|NCT02435992|365700866|FG001|Overall Study|Physician Decision|0|||
105795638|NCT01523301|364907690|FG000|Overall Study|Other Reason|0|||
105795639|NCT01523301|364907691|FG001|Overall Study|Other Reason|2|||
105795640|NCT03273712|364907694|FG000|Overall Study|Death|5|||
105795641|NCT03273712|364907694|FG000|Overall Study|Adverse Event|1|||
105795642|NCT03273712|364907694|FG000|Overall Study|Disease Progression|1|||
105795643|NCT02268045|364907695|FG000|Overall Study|Death|4|||
105795644|NCT02268045|364907696|FG001|Overall Study|Death|4|||
105795645|NCT02268045|364907695|FG000|Overall Study|Disease Progression|2|||
105795646|NCT02268045|364907696|FG001|Overall Study|Disease Progression|1|||
105795647|NCT02268045|364907695|FG000|Overall Study|Adverse Event|7|||
105937118|NCT00468546|365429470|FG001|Week 24 Analysis|Refused treatment|5|||
105937119|NCT00468546|365429469|FG000|Week 24 Analysis|Adverse Event|1|||
105937120|NCT00468546|365429470|FG001|Week 24 Analysis|Adverse Event|8|||
105937121|NCT00468546|365429469|FG000|Week 24 Analysis|Failure to return|3|||
105937122|NCT00468546|365429470|FG001|Week 24 Analysis|Failure to return|4|||
105937123|NCT00468546|365429469|FG000|Week 24 Analysis|Rescue therapy|2|||
105937124|NCT00468546|365429470|FG001|Week 24 Analysis|Rescue therapy|0|||
105937125|NCT00468546|365429469|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
105937126|NCT00468546|365429470|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
105937127|NCT00468546|365429469|FG000|Week 24 Analysis|Due to clinical hold|1|||
105937128|NCT00468546|365429470|FG001|Week 24 Analysis|Due to clinical hold|0|||
105937129|NCT00468546|365429469|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
105937130|NCT00468546|365429470|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
105937131|NCT00468546|365429469|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
105937132|NCT00468546|365429470|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
105937133|NCT00468546|365429469|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
105937134|NCT00468546|365429470|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
105937135|NCT00468546|365429469|FG000|Week 24 to Week 104 Analysis|Death|1|||
105937136|NCT00468546|365429470|FG001|Week 24 to Week 104 Analysis|Death|0|||
105937137|NCT00468546|365429469|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
105937138|NCT00468546|365429470|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
105728187|NCT00809133|364659666|FG007|Overall Study|Progressive disease|3|||
105728188|NCT00809133|364659667|FG008|Overall Study|Progressive disease|3|||
105728189|NCT00809133|364659668|FG009|Overall Study|Progressive disease|9|||
105728190|NCT00809133|364659669|FG010|Overall Study|Progressive disease|5|||
105728191|NCT00809133|364659670|FG011|Overall Study|Progressive disease|7|||
105728192|NCT00809133|364659671|FG012|Overall Study|Progressive disease|5|||
105728193|NCT00809133|364659672|FG013|Overall Study|Progressive disease|4|||
105728194|NCT00809133|364659659|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728195|NCT00809133|364659660|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728196|NCT00809133|364659661|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728197|NCT00809133|364659662|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728198|NCT00809133|364659663|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728199|NCT00809133|364659664|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105728200|NCT00809133|364659665|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105728201|NCT00809133|364659666|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105728202|NCT00809133|364659667|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728203|NCT00809133|364659668|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728204|NCT00809133|364659669|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728205|NCT00809133|364659670|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728206|NCT00809133|364659671|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105728207|NCT00809133|364659672|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
105728208|NCT00809133|364659659|FG000|Overall Study|Other adverse event|1|||
105728209|NCT00809133|364659660|FG001|Overall Study|Other adverse event|1|||
105728210|NCT00809133|364659661|FG002|Overall Study|Other adverse event|1|||
105728211|NCT00809133|364659662|FG003|Overall Study|Other adverse event|0|||
105728212|NCT00809133|364659663|FG004|Overall Study|Other adverse event|0|||
105728213|NCT00809133|364659664|FG005|Overall Study|Other adverse event|3|||
105728214|NCT00809133|364659665|FG006|Overall Study|Other adverse event|2|||
105728215|NCT00809133|364659666|FG007|Overall Study|Other adverse event|4|||
105728216|NCT00809133|364659667|FG008|Overall Study|Other adverse event|0|||
105937139|NCT00468546|365429469|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
105937140|NCT00468546|365429470|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
105937141|NCT00468546|365429469|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
105937142|NCT00468546|365429470|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
105937143|NCT00468546|365429469|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
105937144|NCT00468546|365429470|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
105937145|NCT00468546|365429469|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
105937146|NCT00468546|365429470|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
105937147|NCT00468546|365429469|FG000|Week 24 to Week 104 Analysis|Other|17|||
105937148|NCT00468546|365429470|FG001|Week 24 to Week 104 Analysis|Other|14|||
105937149|NCT04629521|365429471|FG000|Overall Study|Death|1|||
105937150|NCT04629521|365429471|FG000|Overall Study|Lost to Follow-up|3|||
105937151|NCT04629521|365429471|FG000|Overall Study|Subject withdrew consent|3|||
105728217|NCT00809133|364659668|FG009|Overall Study|Other adverse event|0|||
105728218|NCT00809133|364659669|FG010|Overall Study|Other adverse event|1|||
105728219|NCT00809133|364659670|FG011|Overall Study|Other adverse event|1|||
105728220|NCT00809133|364659671|FG012|Overall Study|Other adverse event|0|||
105728221|NCT00809133|364659672|FG013|Overall Study|Other adverse event|1|||
105728222|NCT00809133|364659659|FG000|Overall Study|Lost to Follow-up|0|||
105728223|NCT00809133|364659660|FG001|Overall Study|Lost to Follow-up|0|||
105728224|NCT00809133|364659661|FG002|Overall Study|Lost to Follow-up|0|||
105728225|NCT00809133|364659662|FG003|Overall Study|Lost to Follow-up|0|||
105728226|NCT00809133|364659663|FG004|Overall Study|Lost to Follow-up|0|||
105937152|NCT04629521|365429471|FG000|Overall Study|Enrolled in error|1|||
105795648|NCT02268045|364907696|FG001|Overall Study|Adverse Event|7|||
105795649|NCT02268045|364907695|FG000|Overall Study|Withdrawal by Subject|2|||
105795650|NCT02268045|364907696|FG001|Overall Study|Withdrawal by Subject|6|||
105795651|NCT02268045|364907695|FG000|Overall Study|Physician Decision|0|||
105795652|NCT02268045|364907696|FG001|Overall Study|Physician Decision|1|||
105795653|NCT02268045|364907695|FG000|Overall Study|Protocol Violation|1|||
105795654|NCT02268045|364907696|FG001|Overall Study|Protocol Violation|1|||
105795655|NCT00646282|364907697|FG000|Overall Study|Protocol terminated|4|||
105795656|NCT00646282|364907698|FG001|Overall Study|Protocol terminated|4|||
105795657|NCT00530088|364907704|FG000|Overall Study|Disease Progression|4|||
105795658|NCT00530088|364907704|FG000|Overall Study|Physician Decision|4|||
105795659|NCT00530088|364907704|FG000|Overall Study|Other Not Specified|2|||
105795660|NCT02058368|364907708|FG000|Overall Study|Adverse Event|15|||
105795661|NCT02058368|364907709|FG001|Overall Study|Adverse Event|20|||
105795662|NCT02058368|364907708|FG000|Overall Study|Lack of Efficacy|0|||
105795663|NCT02058368|364907709|FG001|Overall Study|Lack of Efficacy|1|||
105795664|NCT02058368|364907708|FG000|Overall Study|Protocol Violation|0|||
105795665|NCT02058368|364907709|FG001|Overall Study|Protocol Violation|4|||
105795666|NCT02058368|364907708|FG000|Overall Study|Lost to Follow-up|2|||
105795667|NCT02058368|364907709|FG001|Overall Study|Lost to Follow-up|0|||
105795668|NCT02058368|364907708|FG000|Overall Study|Physician Decision|2|||
105795669|NCT02058368|364907709|FG001|Overall Study|Physician Decision|3|||
105795670|NCT02058368|364907708|FG000|Overall Study|Withdrawal by Subject|22|||
105795671|NCT02058368|364907709|FG001|Overall Study|Withdrawal by Subject|26|||
105795672|NCT04529499|364907710|FG000|Overall Study|Withdrawal by Subject|9|||
105795673|NCT04529499|364907711|FG001|Overall Study|Withdrawal by Subject|11|||
105795674|NCT04529499|364907710|FG000|Overall Study|Physician Decision|1|||
105795675|NCT04529499|364907711|FG001|Overall Study|Physician Decision|2|||
105795676|NCT04529499|364907710|FG000|Overall Study|Adverse Event|4|||
105795677|NCT04529499|364907711|FG001|Overall Study|Adverse Event|4|||
105795678|NCT04529499|364907710|FG000|Overall Study|Death|14|||
105795679|NCT04529499|364907711|FG001|Overall Study|Death|11|||
105795680|NCT04529499|364907710|FG000|Overall Study|Lost to Follow-up|1|||
105795681|NCT04529499|364907711|FG001|Overall Study|Lost to Follow-up|1|||
105795682|NCT04529499|364907710|FG000|Overall Study|Others|7|||
105795683|NCT04529499|364907711|FG001|Overall Study|Others|11|||
105795684|NCT00683904|364907712|FG000|Dose Level 1|Disease progression|2|||
105795685|NCT00683904|364907713|FG001|Dose Level 1|Disease progression|0|||
105795686|NCT00683904|364907712|FG000|Dose Level 1|Adverse Event|1|||
105795687|NCT00683904|364907713|FG001|Dose Level 1|Adverse Event|0|||
105795688|NCT00683904|364907712|FG000|Dose Level 2|Adverse Event|0|||
105795689|NCT00683904|364907713|FG001|Dose Level 2|Adverse Event|2|||
105795690|NCT03672396|364907714|FG000|Overall Study|Withdrawal by Subject|4|||
105795691|NCT03672396|364907714|FG000|Overall Study|Physician Decision|1|||
105795692|NCT03672396|364907714|FG000|Overall Study|Adverse Event|1|||
105795693|NCT01211613|364909213|FG000|Overall Study|Lost to Follow-up|2|||
105795694|NCT01211613|364909214|FG001|Overall Study|Lost to Follow-up|2|||
105795695|NCT01211613|364909215|FG002|Overall Study|Lost to Follow-up|2|||
105795696|NCT01211613|364909213|FG000|Overall Study|Withdrawal by Subject|1|||
105795697|NCT01211613|364909214|FG001|Overall Study|Withdrawal by Subject|0|||
105795698|NCT01211613|364909215|FG002|Overall Study|Withdrawal by Subject|0|||
105795699|NCT01020773|364909216|FG000|Overall Study|Withdrawal by Subject|4|||
105795700|NCT01020773|364909217|FG001|Overall Study|Withdrawal by Subject|3|||
105795701|NCT01389024|364909218|FG000|Overall Study|Withdrawal by Subject|0|||
105795702|NCT01389024|364909219|FG001|Overall Study|Withdrawal by Subject|1|||
105795703|NCT01389024|364909218|FG000|Overall Study|Lost to Follow-up|1|||
105795704|NCT01389024|364909219|FG001|Overall Study|Lost to Follow-up|0|||
105795705|NCT03853213|364909222|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
105795706|NCT03853213|364909223|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
105795707|NCT03853213|364909222|FG000|Overall Study|Other (e.g., too busy)|0|||
105795708|NCT03853213|364909223|FG001|Overall Study|Other (e.g., too busy)|2|||
105795709|NCT03302299|364909224|FG000|Overall Study|Protocol Violation|1|||
105795710|NCT01458132|364909225|FG000|Overall Study|Other|15|||
105795711|NCT01458132|364909226|FG001|Overall Study|Other|3|||
105795712|NCT01964898|364909233|FG000|Overall Study|ineligible post-randomization|1|||
105795713|NCT01964898|364909234|FG001|Overall Study|ineligible post-randomization|1|||
105795714|NCT01964898|364909233|FG000|Overall Study|did not receive the allocated interventi|2|||
106138942|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105795715|NCT01964898|364909234|FG001|Overall Study|did not receive the allocated interventi|1|||
105795716|NCT01964898|364909233|FG000|Overall Study|Lost to Follow-up|3|||
105795717|NCT01964898|364909234|FG001|Overall Study|Lost to Follow-up|5|||
105795718|NCT01964898|364909233|FG000|Overall Study|Withdrawal by Subject|1|||
105795719|NCT01964898|364909234|FG001|Overall Study|Withdrawal by Subject|0|||
105795720|NCT00833976|364909236|FG000|Overall Study|Withdrawal by Subject|5|||
105795721|NCT00833976|364909236|FG000|Overall Study|Lost to Follow-up|4|||
105795722|NCT00833976|364909236|FG000|Overall Study|Did not meet eligibility criteria|41|||
105795723|NCT00833976|364909236|FG000|Overall Study|Physician Decision|1|||
105795724|NCT03911960|364909237|FG000|Overall Study|Lost to Follow-up|5|||
105795725|NCT03911960|364909238|FG001|Overall Study|Lost to Follow-up|3|||
105795726|NCT00391092|364909239|FG000|Overall Study|Death|78|||
105795727|NCT00391092|364909240|FG001|Overall Study|Death|81|||
105795728|NCT00391092|364909239|FG000|Overall Study|Lost to Follow-up|13|||
105795729|NCT00391092|364909240|FG001|Overall Study|Lost to Follow-up|18|||
105795730|NCT00391092|364909239|FG000|Overall Study|Alive on treatment|29|||
105728227|NCT00809133|364659664|FG005|Overall Study|Lost to Follow-up|1|||
105728228|NCT00809133|364659665|FG006|Overall Study|Lost to Follow-up|0|||
105728229|NCT00809133|364659666|FG007|Overall Study|Lost to Follow-up|0|||
105728230|NCT00809133|364659667|FG008|Overall Study|Lost to Follow-up|0|||
105728231|NCT00809133|364659668|FG009|Overall Study|Lost to Follow-up|0|||
105728232|NCT00809133|364659669|FG010|Overall Study|Lost to Follow-up|0|||
105728233|NCT00809133|364659670|FG011|Overall Study|Lost to Follow-up|0|||
105728234|NCT00809133|364659671|FG012|Overall Study|Lost to Follow-up|0|||
105728235|NCT00809133|364659672|FG013|Overall Study|Lost to Follow-up|0|||
105728236|NCT00809133|364659659|FG000|Overall Study|Consent withdrawn|0|||
105728237|NCT00809133|364659660|FG001|Overall Study|Consent withdrawn|0|||
105728238|NCT00809133|364659661|FG002|Overall Study|Consent withdrawn|0|||
105728239|NCT00809133|364659662|FG003|Overall Study|Consent withdrawn|0|||
105728240|NCT00809133|364659663|FG004|Overall Study|Consent withdrawn|1|||
105728241|NCT00809133|364659664|FG005|Overall Study|Consent withdrawn|0|||
105728242|NCT00809133|364659665|FG006|Overall Study|Consent withdrawn|0|||
105728243|NCT00809133|364659666|FG007|Overall Study|Consent withdrawn|0|||
105728244|NCT00809133|364659667|FG008|Overall Study|Consent withdrawn|0|||
105728245|NCT00809133|364659668|FG009|Overall Study|Consent withdrawn|0|||
105728246|NCT00809133|364659669|FG010|Overall Study|Consent withdrawn|0|||
105728247|NCT00809133|364659670|FG011|Overall Study|Consent withdrawn|0|||
105728248|NCT00809133|364659671|FG012|Overall Study|Consent withdrawn|0|||
105728249|NCT00809133|364659672|FG013|Overall Study|Consent withdrawn|0|||
105728250|NCT00809133|364659659|FG000|Overall Study|Other not mentioned above|0|||
105728251|NCT00809133|364659660|FG001|Overall Study|Other not mentioned above|1|||
105728252|NCT00809133|364659661|FG002|Overall Study|Other not mentioned above|0|||
105728253|NCT00809133|364659662|FG003|Overall Study|Other not mentioned above|0|||
105728254|NCT00809133|364659663|FG004|Overall Study|Other not mentioned above|0|||
105937153|NCT03760068|365429472|FG000|Overall Study|Withdrawal by Subject|7|||
105937154|NCT03760068|365429473|FG001|Overall Study|Withdrawal by Subject|8|||
105937155|NCT03760068|365429472|FG000|Overall Study|Adverse Event|1|||
105937156|NCT03760068|365429473|FG001|Overall Study|Adverse Event|2|||
105795731|NCT00391092|364909240|FG001|Overall Study|Alive on treatment|33|||
105795732|NCT00391092|364909239|FG000|Overall Study|Alive in follow-up|88|||
105795733|NCT00391092|364909240|FG001|Overall Study|Alive in follow-up|84|||
105795734|NCT00265239|364909241|FG000|Overall Study|Adverse Event|2|||
105795735|NCT00265239|364909242|FG001|Overall Study|Adverse Event|1|||
105795736|NCT02803138|364909245|FG000|Overall Study|Failure to return|38|||
105795737|NCT02803138|364909245|FG000|Overall Study|Insufficient virological response|2|||
105795738|NCT02803138|364909245|FG000|Overall Study|Withdrawn consent|1|||
105795739|NCT02803138|364909245|FG000|Overall Study|Death|1|||
105795740|NCT02803138|364909245|FG000|Overall Study|Other, not specified|28|||
105795741|NCT01678924|364909248|FG000|Overall Study|Adverse Event|1|||
105795742|NCT01678924|364909249|FG001|Overall Study|Adverse Event|1|||
105795743|NCT01678924|364909250|FG002|Overall Study|Adverse Event|0|||
105795744|NCT01678924|364909251|FG003|Overall Study|Adverse Event|1|||
105795745|NCT01678924|364909248|FG000|Overall Study|Lack of Efficacy|7|||
105795746|NCT01678924|364909249|FG001|Overall Study|Lack of Efficacy|2|||
105795747|NCT01678924|364909250|FG002|Overall Study|Lack of Efficacy|0|||
105795748|NCT01678924|364909251|FG003|Overall Study|Lack of Efficacy|5|||
105795749|NCT01678924|364909248|FG000|Overall Study|Lost to Follow-up|0|||
105795750|NCT01678924|364909249|FG001|Overall Study|Lost to Follow-up|4|||
105795751|NCT01678924|364909250|FG002|Overall Study|Lost to Follow-up|0|||
105795752|NCT01678924|364909251|FG003|Overall Study|Lost to Follow-up|2|||
105795753|NCT01678924|364909248|FG000|Overall Study|Personal Reasons|2|||
105795754|NCT01678924|364909249|FG001|Overall Study|Personal Reasons|2|||
105937157|NCT03760068|365429472|FG000|Overall Study|Administrative Decision by Sponsor|0|||
105937158|NCT03760068|365429473|FG001|Overall Study|Administrative Decision by Sponsor|2|||
105937159|NCT03760068|365429472|FG000|Overall Study|Physician Decision|1|||
105937160|NCT03760068|365429473|FG001|Overall Study|Physician Decision|2|||
105937161|NCT03760068|365429472|FG000|Overall Study|Lost to Follow-up|4|||
105795755|NCT01678924|364909250|FG002|Overall Study|Personal Reasons|2|||
105795756|NCT01678924|364909251|FG003|Overall Study|Personal Reasons|7|||
105728255|NCT00809133|364659664|FG005|Overall Study|Other not mentioned above|1|||
105795757|NCT01678924|364909248|FG000|Overall Study|Withdrawal by Subject|0|||
105795758|NCT01678924|364909249|FG001|Overall Study|Withdrawal by Subject|3|||
105795759|NCT01678924|364909250|FG002|Overall Study|Withdrawal by Subject|0|||
105937162|NCT03760068|365429473|FG001|Overall Study|Lost to Follow-up|9|||
105728256|NCT00809133|364659665|FG006|Overall Study|Other not mentioned above|0|||
105728257|NCT00809133|364659666|FG007|Overall Study|Other not mentioned above|0|||
105795760|NCT01678924|364909251|FG003|Overall Study|Withdrawal by Subject|2|||
106138943|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
106138944|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
105728258|NCT00809133|364659667|FG008|Overall Study|Other not mentioned above|0|||
105728259|NCT00809133|364659668|FG009|Overall Study|Other not mentioned above|0|||
105728260|NCT00809133|364659669|FG010|Overall Study|Other not mentioned above|0|||
105728261|NCT00809133|364659670|FG011|Overall Study|Other not mentioned above|0|||
105728262|NCT00809133|364659671|FG012|Overall Study|Other not mentioned above|0|||
105728263|NCT00809133|364659672|FG013|Overall Study|Other not mentioned above|0|||
105728264|NCT00833092|364659673|FG000|Overall Study|Withdrawal by Subject|2|||
105728265|NCT00833092|364659674|FG001|Overall Study|Withdrawal by Subject|3|||
105728266|NCT00833092|364659673|FG000|Overall Study|Protocol Violation|2|||
105728267|NCT00833092|364659674|FG001|Overall Study|Protocol Violation|1|||
105728268|NCT00833092|364659673|FG000|Overall Study|Diarrhea|0|||
105728269|NCT00833092|364659674|FG001|Overall Study|Diarrhea|2|||
105728270|NCT00833092|364659673|FG000|Overall Study|constipation|0|||
105728271|NCT00833092|364659674|FG001|Overall Study|constipation|1|||
105728272|NCT00619229|364659675|FG000|Overall Study|Withdrawal by Subject|1|||
105728273|NCT00619229|364659676|FG001|Overall Study|Withdrawal by Subject|1|||
105728274|NCT00619229|364659675|FG000|Overall Study|Lost to Follow-up|1|||
105728275|NCT00619229|364659676|FG001|Overall Study|Lost to Follow-up|0|||
105728276|NCT00619229|364659675|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
105728277|NCT00619229|364659676|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
105728278|NCT00619229|364659675|FG000|Overall Study|Investigator planned Cataract Operation|1|||
105728279|NCT00619229|364659676|FG001|Overall Study|Investigator planned Cataract Operation|0|||
105728280|NCT00087438|364659678|FG000|Overall Study|Ineligible / No protocol treatment|4|||
105728281|NCT00466505|364659679|FG000|Overall Study|disease progression|13|||
105728282|NCT00466505|364659679|FG000|Overall Study|Adverse Event|4|||
105728283|NCT00699192|364659680|FG000|Overall Study|Missing|1|||
105728284|NCT00699192|364659681|FG001|Overall Study|Missing|1|||
105728285|NCT00699192|364659682|FG002|Overall Study|Missing|1|||
105728286|NCT00699192|364659680|FG000|Overall Study|Adverse Event|9|||
105728287|NCT00699192|364659681|FG001|Overall Study|Adverse Event|4|||
105728288|NCT00699192|364659682|FG002|Overall Study|Adverse Event|3|||
105728289|NCT00699192|364659680|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105728290|NCT00699192|364659681|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105728291|NCT00699192|364659682|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105728292|NCT00699192|364659680|FG000|Overall Study|Lack of Efficacy|0|||
105728293|NCT00699192|364659681|FG001|Overall Study|Lack of Efficacy|0|||
105728294|NCT00699192|364659682|FG002|Overall Study|Lack of Efficacy|1|||
105728295|NCT00699192|364659680|FG000|Overall Study|Withdrawal by Subject|3|||
105728296|NCT00699192|364659681|FG001|Overall Study|Withdrawal by Subject|2|||
105728297|NCT00699192|364659682|FG002|Overall Study|Withdrawal by Subject|4|||
105728298|NCT00699192|364659680|FG000|Overall Study|Administrative problems|1|||
105728299|NCT00699192|364659681|FG001|Overall Study|Administrative problems|3|||
105728300|NCT00699192|364659682|FG002|Overall Study|Administrative problems|1|||
105728301|NCT00699192|364659680|FG000|Overall Study|Protocol Violation|2|||
105728302|NCT00699192|364659681|FG001|Overall Study|Protocol Violation|2|||
105728303|NCT00699192|364659682|FG002|Overall Study|Protocol Violation|0|||
105728304|NCT01773473|364659683|FG000|Overall Study|Adverse Event|3|||
105728305|NCT01773473|364659684|FG001|Overall Study|Adverse Event|2|||
105728306|NCT01773473|364659683|FG000|Overall Study|Protocol Violation|0|||
105728307|NCT01773473|364659684|FG001|Overall Study|Protocol Violation|4|||
105728308|NCT01773473|364659683|FG000|Overall Study|Physician Decision|3|||
105728309|NCT01773473|364659684|FG001|Overall Study|Physician Decision|5|||
105728310|NCT01773473|364659683|FG000|Overall Study|Sponsor Decision|2|||
105728311|NCT01773473|364659684|FG001|Overall Study|Sponsor Decision|0|||
105728312|NCT01773473|364659683|FG000|Overall Study|Lack of Efficacy|0|||
105728313|NCT01773473|364659684|FG001|Overall Study|Lack of Efficacy|1|||
105728314|NCT01773473|364659683|FG000|Overall Study|Non-Compliance with study drug|1|||
105728315|NCT01773473|364659684|FG001|Overall Study|Non-Compliance with study drug|4|||
105728316|NCT01773473|364659683|FG000|Overall Study|Withdrawal by Subject|5|||
105728317|NCT01773473|364659684|FG001|Overall Study|Withdrawal by Subject|3|||
105937163|NCT03760068|365429472|FG000|Overall Study|Subject Moved Out of State|1|||
105937164|NCT03760068|365429473|FG001|Overall Study|Subject Moved Out of State|0|||
105937165|NCT01898091|365429474|FG000|Overall Study|Lost to Follow-up|1|||
105937166|NCT01898091|365429475|FG001|Overall Study|Lost to Follow-up|1|||
105937167|NCT01898091|365429474|FG000|Overall Study|Withdrawal by Subject|1|||
105937168|NCT01898091|365429475|FG001|Overall Study|Withdrawal by Subject|5|||
105937169|NCT02369159|365429476|FG000|Overall Study|Adverse Event|0|||
105937170|NCT02369159|365429477|FG001|Overall Study|Adverse Event|1|||
105795761|NCT01678924|364909248|FG000|Overall Study|Unable to attend scheduled visits|0|||
105937171|NCT02369159|365429476|FG000|Overall Study|Lost to Follow-up|1|||
105728318|NCT01773473|364659683|FG000|Overall Study|Lost to Follow-up|2|||
105728319|NCT01773473|364659684|FG001|Overall Study|Lost to Follow-up|0|||
105728320|NCT01931865|364659685|FG000|Overall Study|Lost to Follow-up|2|||
105728321|NCT01931865|364659685|FG000|Overall Study|Withdrawal by Subject|2|||
105728322|NCT00283387|364659686|FG000|First Intervention|Subject non-compliant|1|||
105795762|NCT01678924|364909249|FG001|Overall Study|Unable to attend scheduled visits|0|||
105795763|NCT01678924|364909250|FG002|Overall Study|Unable to attend scheduled visits|0|||
105795764|NCT01678924|364909251|FG003|Overall Study|Unable to attend scheduled visits|1|||
105795765|NCT00021229|364909255|FG000|Overall Study|Adverse Event|10|||
105795766|NCT00021229|364909256|FG001|Overall Study|Adverse Event|5|||
105795767|NCT00021229|364909257|FG002|Overall Study|Adverse Event|2|||
105795768|NCT00021229|364909255|FG000|Overall Study|Death|0|||
105795769|NCT00021229|364909256|FG001|Overall Study|Death|1|||
105795770|NCT00021229|364909257|FG002|Overall Study|Death|0|||
105795771|NCT00021229|364909255|FG000|Overall Study|Withdrawal by Subject|7|||
105937172|NCT02369159|365429477|FG001|Overall Study|Lost to Follow-up|1|||
105937173|NCT02369159|365429476|FG000|Overall Study|Withdrawal by Subject|7|||
105937174|NCT02369159|365429477|FG001|Overall Study|Withdrawal by Subject|0|||
105937175|NCT00425854|365429480|FG000|Overall Study|Progressive Disease|19|||
105937176|NCT00425854|365429481|FG001|Overall Study|Progressive Disease|12|||
105937177|NCT00425854|365429480|FG000|Overall Study|Dose reduction toxicity AE|8|||
105937178|NCT00425854|365429481|FG001|Overall Study|Dose reduction toxicity AE|7|||
105937179|NCT00425854|365429480|FG000|Overall Study|Other Adverse Event|2|||
105937180|NCT00425854|365429481|FG001|Overall Study|Other Adverse Event|2|||
105937181|NCT03511209|365429486|FG000|Overall Study|Withdrawal by Subject|2|||
105937182|NCT03511209|365429487|FG001|Overall Study|Withdrawal by Subject|4|||
105937183|NCT03511209|365429486|FG000|Overall Study|Death|1|||
105937184|NCT03511209|365429487|FG001|Overall Study|Death|0|||
105937185|NCT03511209|365429486|FG000|Overall Study|Lost to Follow-up|0|||
105937186|NCT03511209|365429487|FG001|Overall Study|Lost to Follow-up|2|||
105937187|NCT03769116|365429490|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
105937188|NCT03769116|365429491|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
105937189|NCT03769116|365429490|FG000|Part 3 - Open Label|Physician Decision|1|||
105937190|NCT03769116|365429491|FG001|Part 3 - Open Label|Physician Decision|0|||
105937191|NCT03769116|365429490|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
105937192|NCT03769116|365429491|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
105937193|NCT01602666|365429492|FG000|Induction Chemotherapy|Death|2|||
105937194|NCT01602666|365429493|FG001|Induction Chemotherapy|Death|1|||
105937195|NCT01602666|365429492|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
105937196|NCT01602666|365429493|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
105937197|NCT01602666|365429492|FG000|Induction Chemotherapy|Physician Decision|12|||
105937198|NCT01602666|365429493|FG001|Induction Chemotherapy|Physician Decision|5|||
105937199|NCT01602666|365429492|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
105937200|NCT01602666|365429493|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
105937201|NCT01602666|365429492|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
105937202|NCT01602666|365429493|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
105937203|NCT01602666|365429492|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
105937204|NCT01602666|365429493|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
105937205|NCT01602666|365429492|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
105937206|NCT01602666|365429493|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
105937207|NCT01602666|365429492|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
105937208|NCT01602666|365429493|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
105937209|NCT01602666|365429492|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
105937210|NCT01602666|365429493|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
105937211|NCT01602666|365429492|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
105937212|NCT01602666|365429493|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
105937213|NCT01602666|365429492|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
105937214|NCT01602666|365429493|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
105937215|NCT02489045|365429494|FG000|Overall Study|unable to collect usable data|53|||
105937216|NCT02489045|365429494|FG000|Follow-up|Lost to Follow-up|10|||
105937217|NCT03769467|365429497|FG000|Overall Study|Adverse Event|1|||
105937218|NCT03769467|365429498|FG001|Overall Study|Adverse Event|1|||
105937219|NCT03769467|365429499|FG002|Overall Study|Adverse Event|0|||
105937220|NCT03769467|365429497|FG000|Overall Study|Death|3|||
105795772|NCT00021229|364909256|FG001|Overall Study|Withdrawal by Subject|7|||
105795773|NCT00021229|364909257|FG002|Overall Study|Withdrawal by Subject|1|||
105795774|NCT00021229|364909255|FG000|Overall Study|Progressive Disease|15|||
105795775|NCT00021229|364909256|FG001|Overall Study|Progressive Disease|19|||
105795776|NCT00021229|364909257|FG002|Overall Study|Progressive Disease|12|||
105937221|NCT03769467|365429498|FG001|Overall Study|Death|3|||
105937222|NCT03769467|365429499|FG002|Overall Study|Death|0|||
105937223|NCT03769467|365429497|FG000|Overall Study|Study Terminated By Sponsor|2|||
105937224|NCT03769467|365429498|FG001|Overall Study|Study Terminated By Sponsor|1|||
105795777|NCT00021229|364909255|FG000|Overall Study|Protocol Violation|1|||
105795778|NCT00021229|364909256|FG001|Overall Study|Protocol Violation|1|||
105795779|NCT00021229|364909257|FG002|Overall Study|Protocol Violation|0|||
105795780|NCT00021229|364909255|FG000|Overall Study|Physician Decision|0|||
105937225|NCT03769467|365429499|FG002|Overall Study|Study Terminated By Sponsor|0|||
105937226|NCT03769467|365429497|FG000|Overall Study|Withdrawal by Subject|0|||
106009540|NCT02435992|365700867|FG002|Overall Study|Physician Decision|1|||
105937227|NCT03769467|365429498|FG001|Overall Study|Withdrawal by Subject|1|||
105937228|NCT03769467|365429499|FG002|Overall Study|Withdrawal by Subject|0|||
105937229|NCT04754399|365429500|FG000|Overall Study|Adverse Event|5|||
105937230|NCT04754399|365429500|FG000|Overall Study|Withdrawal by Subject|6|||
105728323|NCT00283387|364659687|FG001|First Intervention|Subject non-compliant|1|||
105728324|NCT00283387|364659686|FG000|First Intervention|Withdrawal by Subject|0|||
105728325|NCT00283387|364659687|FG001|First Intervention|Withdrawal by Subject|1|||
105728326|NCT00222105|364659689|FG000|Overall Study|Removed due to wrong diagnosis|1|||
105728327|NCT00222105|364659689|FG000|Overall Study|Withdrawal by Subject|1|||
105728328|NCT00222105|364659689|FG000|Overall Study|Adverse Event|8|||
105728329|NCT00222105|364659689|FG000|Overall Study|Treatment delays|2|||
105728330|NCT00222105|364659689|FG000|Overall Study|Death|2|||
105728331|NCT00503399|364659690|FG000|Overall Study|Death|2|||
105728332|NCT00503399|364659691|FG001|Overall Study|Death|1|||
105728333|NCT00503399|364659690|FG000|Overall Study|Protocol Violation|1|||
105728334|NCT00503399|364659691|FG001|Overall Study|Protocol Violation|0|||
105728335|NCT00503399|364659690|FG000|Overall Study|Withdrawal by Subject|4|||
105728336|NCT00503399|364659691|FG001|Overall Study|Withdrawal by Subject|2|||
105728337|NCT00503399|364659690|FG000|Overall Study|Adverse Event|0|||
105728338|NCT00503399|364659691|FG001|Overall Study|Adverse Event|3|||
105728339|NCT00503399|364659690|FG000|Overall Study|Lost to Follow-up|0|||
105728340|NCT00503399|364659691|FG001|Overall Study|Lost to Follow-up|2|||
105728341|NCT01676961|364659692|FG000|Overall Study|Death|3|||
105728342|NCT01676961|364659692|FG000|Overall Study|Lost to Follow-up|1|||
105728343|NCT01676961|364659692|FG000|Overall Study|Withdrawal by Subject|1|||
105728344|NCT03812510|364659693|FG000|Overall Study|Lost to Follow-up|39|||
105728345|NCT03812510|364659693|FG000|Overall Study|Withdrawal by Subject|42|||
105728346|NCT03812510|364659693|FG000|Overall Study|Physician Decision|2|||
105728347|NCT03812510|364659693|FG000|Overall Study|Study Terminated by Sponsor|9|||
105728348|NCT03812510|364659693|FG000|Overall Study|Did Not Start Study Medication|55|||
105728349|NCT03812510|364659693|FG000|Overall Study|Adverse Event|5|||
105728350|NCT00195650|364659696|FG000|Overall Study|Adverse Event|194|||
105728351|NCT00195650|364659696|FG000|Overall Study|Lack of Efficacy|99|||
105728352|NCT00195650|364659696|FG000|Overall Study|Withdrawal by Subject|67|||
105728353|NCT00195650|364659696|FG000|Overall Study|Lost to Follow-up|44|||
105728354|NCT00195650|364659696|FG000|Overall Study|Death|23|||
105728355|NCT00195650|364659696|FG000|Overall Study|Protocol Violation|15|||
105728356|NCT00195650|364659696|FG000|Overall Study|Administrative reasons|83|||
105728357|NCT01120626|364659697|FG000|Overall Study|Withdrawal by Subject|1|||
105728358|NCT01120626|364659698|FG001|Overall Study|Withdrawal by Subject|0|||
105728359|NCT03427073|364659699|FG000|Overall Study|Disease Progression|1|||
105728360|NCT03427073|364659700|FG001|Overall Study|Disease Progression|1|||
105728361|NCT03427073|364659701|FG002|Overall Study|Disease Progression|1|||
105728362|NCT03427073|364659702|FG003|Overall Study|Disease Progression|3|||
105728363|NCT03427073|364659703|FG004|Overall Study|Disease Progression|3|||
105728364|NCT03427073|364659704|FG005|Overall Study|Disease Progression|4|||
105728365|NCT03427073|364659705|FG006|Overall Study|Disease Progression|2|||
105728366|NCT03427073|364659706|FG007|Overall Study|Disease Progression|3|||
105728367|NCT03427073|364659699|FG000|Overall Study|Physician Decision|0|||
105728368|NCT03427073|364659700|FG001|Overall Study|Physician Decision|0|||
105728369|NCT03427073|364659701|FG002|Overall Study|Physician Decision|0|||
105728370|NCT03427073|364659702|FG003|Overall Study|Physician Decision|0|||
105728371|NCT03427073|364659703|FG004|Overall Study|Physician Decision|0|||
105728372|NCT03427073|364659704|FG005|Overall Study|Physician Decision|0|||
105728373|NCT03427073|364659705|FG006|Overall Study|Physician Decision|1|||
105728374|NCT03427073|364659706|FG007|Overall Study|Physician Decision|1|||
105728375|NCT02635204|364659707|FG000|Overall Study|Adverse Event|1|||
105728376|NCT02635204|364659708|FG001|Overall Study|Adverse Event|0|||
105728377|NCT02635204|364659707|FG000|Overall Study|Lost to Follow-up|1|||
105728378|NCT02635204|364659708|FG001|Overall Study|Lost to Follow-up|1|||
105728379|NCT00858832|364659709|FG000|Overall Study|became ineligible: delivered vaginally|1|||
105728380|NCT00858832|364659710|FG001|Overall Study|became ineligible: delivered vaginally|0|||
105728381|NCT00858832|364659709|FG000|Overall Study|Adverse Event|0|||
105728382|NCT00858832|364659710|FG001|Overall Study|Adverse Event|1|||
105728383|NCT01244737|364659711|FG000|Overall Study|Physician Decision|2|||
105728384|NCT01244737|364659712|FG001|Overall Study|Physician Decision|18|||
105728385|NCT01244737|364659713|FG002|Overall Study|Physician Decision|5|||
105728386|NCT01244737|364659711|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
105728387|NCT01244737|364659712|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
105728388|NCT01244737|364659713|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
105728389|NCT01244737|364659711|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
105728390|NCT01244737|364659712|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
105728391|NCT01244737|364659713|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
105795781|NCT00021229|364909256|FG001|Overall Study|Physician Decision|0|||
105795782|NCT00021229|364909257|FG002|Overall Study|Physician Decision|1|||
105795783|NCT00021229|364909255|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
105795784|NCT00021229|364909256|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
105795785|NCT00021229|364909257|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
105728392|NCT01244737|364659711|FG000|Overall Study|MIB immunopathology results not available|3|||
105728393|NCT01244737|364659712|FG001|Overall Study|MIB immunopathology results not available|2|||
105728394|NCT01244737|364659713|FG002|Overall Study|MIB immunopathology results not available|0|||
105728395|NCT01244737|364659711|FG000|Overall Study|PET data failure|0|||
105728396|NCT01244737|364659712|FG001|Overall Study|PET data failure|1|||
105728397|NCT01244737|364659713|FG002|Overall Study|PET data failure|0|||
105728398|NCT01244737|364659711|FG000|Overall Study|Withdrawal by Subject|0|||
105728399|NCT01244737|364659712|FG001|Overall Study|Withdrawal by Subject|0|||
105728400|NCT01244737|364659713|FG002|Overall Study|Withdrawal by Subject|1|||
105728401|NCT00389207|364659716|FG000|Overall Study|Adverse Event|26|||
105728402|NCT00389207|364659717|FG001|Overall Study|Adverse Event|32|||
105728403|NCT00389207|364659718|FG002|Overall Study|Adverse Event|10|||
105728404|NCT00389207|364659716|FG000|Overall Study|Protocol Violation|3|||
105728405|NCT00389207|364659717|FG001|Overall Study|Protocol Violation|1|||
105728406|NCT00389207|364659718|FG002|Overall Study|Protocol Violation|4|||
105728407|NCT00389207|364659716|FG000|Overall Study|Lost to Follow-up|12|||
105728408|NCT00389207|364659717|FG001|Overall Study|Lost to Follow-up|9|||
105728409|NCT00389207|364659718|FG002|Overall Study|Lost to Follow-up|7|||
105728410|NCT00389207|364659716|FG000|Overall Study|Withdrawal by Subject|5|||
105728411|NCT00389207|364659717|FG001|Overall Study|Withdrawal by Subject|7|||
105728412|NCT00389207|364659718|FG002|Overall Study|Withdrawal by Subject|11|||
105728413|NCT00389207|364659716|FG000|Overall Study|Other|17|||
105728414|NCT00389207|364659717|FG001|Overall Study|Other|23|||
105728415|NCT00389207|364659718|FG002|Overall Study|Other|9|||
105728416|NCT05564052|364659720|FG000|Overall Study|Withdrawal by Subject|0|||
105728417|NCT05564052|364659721|FG001|Overall Study|Withdrawal by Subject|0|||
105728418|NCT05564052|364659722|FG002|Overall Study|Withdrawal by Subject|0|||
105728419|NCT05564052|364659723|FG003|Overall Study|Withdrawal by Subject|1|||
105728420|NCT05564052|364659720|FG000|Overall Study|Ongoing|8|||
105728421|NCT05564052|364659721|FG001|Overall Study|Ongoing|5|||
105728422|NCT05564052|364659722|FG002|Overall Study|Ongoing|4|||
105728423|NCT05564052|364659723|FG003|Overall Study|Ongoing|1|||
105728424|NCT05480514|364659726|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
105728425|NCT05480514|364659727|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
105728426|NCT05480514|364659726|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
105728427|NCT05480514|364659727|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
105728428|NCT05480514|364659726|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
105728429|NCT05480514|364659727|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
105728430|NCT05480514|364659726|FG000|Period 1|Covid-19 Related|1|||
105728431|NCT05480514|364659727|FG001|Period 1|Covid-19 Related|0|||
105728432|NCT05480514|364659726|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
105728433|NCT05480514|364659727|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
105728434|NCT03815175|364659728|FG000|Overall Study|Subject Lost to Follow-up|6|||
105728435|NCT03815175|364659728|FG000|Overall Study|Subject Withdrew Consent|48|||
105728436|NCT03815175|364659728|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
105728437|NCT03815175|364659728|FG000|Overall Study|Death|86|||
105728438|NCT03815175|364659728|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
105728439|NCT03815175|364659728|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
105728440|NCT03815175|364659728|FG000|Overall Study|Other Status Change Reason|1|||
105728441|NCT03815175|364659728|FG000|Overall Study|Missed Visit|12|||
105728442|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
105728443|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
105728444|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
105728445|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105728446|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105728447|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105728448|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105795786|NCT03284424|364909258|FG000|Overall Study|Death|70|||
105795787|NCT03284424|364909259|FG001|Overall Study|Death|24|||
105795788|NCT03284424|364909258|FG000|Overall Study|Lost to Follow-up|3|||
105728449|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728450|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728451|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
105728452|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105795789|NCT03284424|364909259|FG001|Overall Study|Lost to Follow-up|1|||
105728453|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728454|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728455|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
105728456|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
105795790|NCT03284424|364909258|FG000|Overall Study|Physician Decision|1|||
105728457|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728458|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
105728459|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728460|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728461|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728462|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105728463|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
105728464|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728465|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
105728466|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728467|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728468|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728469|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105728470|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
105728471|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
105728472|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
105728473|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105728474|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105728475|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105728476|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105728477|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728478|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728479|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
105728480|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728481|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728482|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105728483|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
105795791|NCT03284424|364909259|FG001|Overall Study|Physician Decision|2|||
105795792|NCT03284424|364909258|FG000|Overall Study|Withdrawal by Subject|4|||
105795793|NCT03284424|364909259|FG001|Overall Study|Withdrawal by Subject|5|||
105795794|NCT03284424|364909258|FG000|Overall Study|Sponsor's decision|27|||
105795795|NCT03284424|364909259|FG001|Overall Study|Sponsor's decision|22|||
105795796|NCT02016755|364909260|FG000|Overall Study|Major amputation of index limb|2|||
105795797|NCT02016755|364909260|FG000|Overall Study|Adverse Event|2|||
105795798|NCT02016755|364909260|FG000|Overall Study|Physician Decision|1|||
105795799|NCT02016755|364909260|FG000|Overall Study|Death|2|||
105795800|NCT01461369|364909261|FG000|Overall Study|Lack of Efficacy|2|||
105795801|NCT01461369|364909262|FG001|Overall Study|Lack of Efficacy|0|||
105795802|NCT01461369|364909263|FG002|Overall Study|Lack of Efficacy|6|||
105795803|NCT01461369|364909261|FG000|Overall Study|Lost to Follow-up|0|||
105795804|NCT01461369|364909262|FG001|Overall Study|Lost to Follow-up|0|||
105795805|NCT01461369|364909263|FG002|Overall Study|Lost to Follow-up|3|||
105795806|NCT01461369|364909261|FG000|Overall Study|Adverse Event|9|||
105795807|NCT01461369|364909262|FG001|Overall Study|Adverse Event|12|||
105795808|NCT01461369|364909263|FG002|Overall Study|Adverse Event|4|||
105795809|NCT01461369|364909261|FG000|Overall Study|Protocol Violation|1|||
105795810|NCT01461369|364909262|FG001|Overall Study|Protocol Violation|2|||
105795811|NCT01461369|364909263|FG002|Overall Study|Protocol Violation|2|||
105795812|NCT01461369|364909261|FG000|Overall Study|Withdrawal by Subject|1|||
105795813|NCT01461369|364909262|FG001|Overall Study|Withdrawal by Subject|3|||
105795814|NCT01461369|364909263|FG002|Overall Study|Withdrawal by Subject|2|||
105795815|NCT00765999|364909264|FG000|Overall Study|Adverse Event|203|||
105795816|NCT00765999|364909264|FG000|Overall Study|Insufficient Therapeutic Response|100|||
105795817|NCT00765999|364909264|FG000|Overall Study|Protocol Violation|95|||
105795818|NCT00765999|364909264|FG000|Overall Study|Consent Withdrawn|202|||
105795819|NCT00765999|364909264|FG000|Overall Study|Lost to Follow-up|131|||
105795820|NCT00765999|364909264|FG000|Overall Study|Study Terminated by Sponsor|2|||
105937231|NCT02614066|365429501|FG000|Overall Study|Death|6|||
105937232|NCT02614066|365429502|FG001|Overall Study|Death|14|||
105937233|NCT02614066|365429503|FG002|Overall Study|Death|11|||
105937234|NCT02614066|365429504|FG003|Overall Study|Death|29|||
105795821|NCT00765999|364909264|FG000|Overall Study|Other Miscellaneous Reasons|51|||
105795822|NCT02626182|364909272|FG000|Overall Study|Adverse Event|2|||
105795823|NCT02626182|364909273|FG001|Overall Study|Adverse Event|0|||
105937235|NCT02614066|365429501|FG000|Overall Study|Full consent withdrawn|0|||
105795824|NCT03578276|364909274|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
105937236|NCT02614066|365429502|FG001|Overall Study|Full consent withdrawn|1|||
105937237|NCT02614066|365429503|FG002|Overall Study|Full consent withdrawn|0|||
105937238|NCT02614066|365429504|FG003|Overall Study|Full consent withdrawn|8|||
106138945|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
106138946|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
106138947|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
106138948|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
106138949|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
106138950|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
106138951|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
106138952|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
106138953|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105728484|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728485|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728486|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
105728487|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728488|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728489|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
106138954|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
105728490|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
105728491|NCT04242498|364659734|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728492|NCT04242498|364659735|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
105728493|NCT04242498|364659736|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
105728494|NCT04242498|364659737|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728495|NCT04242498|364659738|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728496|NCT04242498|364659739|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728497|NCT04242498|364659740|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105728498|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105728499|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105728500|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105728501|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105728502|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
105728503|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
105728504|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
105728505|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105728506|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105728507|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105728508|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105728509|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
105728510|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
105728511|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
105728512|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105728513|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105728514|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105728515|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105728516|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105795825|NCT03578276|364909275|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
105795826|NCT03372369|364909276|FG000|Qualification Period|Withdrawal by Subject|16|||
105795827|NCT03372369|364909277|FG001|Qualification Period|Withdrawal by Subject|13|||
105937239|NCT02614066|365429501|FG000|Overall Study|Lost to Follow-up|0|||
105937240|NCT02614066|365429502|FG001|Overall Study|Lost to Follow-up|2|||
105937241|NCT02614066|365429503|FG002|Overall Study|Lost to Follow-up|2|||
105937242|NCT02614066|365429504|FG003|Overall Study|Lost to Follow-up|2|||
105937243|NCT02614066|365429501|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
105937244|NCT02614066|365429502|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
105937245|NCT02614066|365429503|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
105937246|NCT02614066|365429504|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
105937247|NCT02614066|365429501|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
105937248|NCT02614066|365429502|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
105937249|NCT02614066|365429503|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
105937250|NCT02614066|365429504|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
105937251|NCT02614066|365429501|FG000|Overall Study|Reason not specified|0|||
106138955|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
106138956|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
105795828|NCT03372369|364909276|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
106138957|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
106138958|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
105937252|NCT02614066|365429502|FG001|Overall Study|Reason not specified|2|||
105937253|NCT02614066|365429503|FG002|Overall Study|Reason not specified|1|||
105937254|NCT02614066|365429504|FG003|Overall Study|Reason not specified|1|||
105937255|NCT03624036|365429505|FG000|Overall Study|Death|2|||
105937256|NCT03624036|365429506|FG001|Overall Study|Death|3|||
105937257|NCT03624036|365429507|FG002|Overall Study|Death|0|||
105937258|NCT03624036|365429508|FG003|Overall Study|Death|1|||
105937259|NCT03624036|365429505|FG000|Overall Study|Withdrawal by Subject|1|||
105937260|NCT03624036|365429506|FG001|Overall Study|Withdrawal by Subject|0|||
105937261|NCT03624036|365429507|FG002|Overall Study|Withdrawal by Subject|1|||
105937262|NCT03624036|365429508|FG003|Overall Study|Withdrawal by Subject|0|||
105937263|NCT03624036|365429505|FG000|Overall Study|Enrolled but Never Treated|1|||
105937264|NCT03624036|365429506|FG001|Overall Study|Enrolled but Never Treated|0|||
105937265|NCT03624036|365429507|FG002|Overall Study|Enrolled but Never Treated|0|||
105937266|NCT03624036|365429508|FG003|Overall Study|Enrolled but Never Treated|0|||
105937267|NCT03624036|365429505|FG000|Overall Study|Reason not Specified|3|||
105937268|NCT03624036|365429506|FG001|Overall Study|Reason not Specified|0|||
105937269|NCT03624036|365429507|FG002|Overall Study|Reason not Specified|2|||
105728517|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
105728518|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
105728519|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105728520|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105728521|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105728522|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
105728523|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
105728524|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
105728525|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
105728526|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105728527|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105728528|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105728529|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
105728530|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
105728531|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
105728532|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
105728533|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728534|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728535|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728536|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728537|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
105728538|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728539|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
105728540|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728541|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728542|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728543|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728544|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728545|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
105728546|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
105728547|NCT04242498|364659734|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728548|NCT04242498|364659735|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728549|NCT04242498|364659736|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728550|NCT04242498|364659737|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728551|NCT04242498|364659738|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
105728552|NCT04242498|364659739|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
105728553|NCT04242498|364659740|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
105728554|NCT03372941|364659741|FG000|Overall Study|Lost to Follow-up|2|||
105728555|NCT03372941|364659742|FG001|Overall Study|Lost to Follow-up|4|||
105937270|NCT03624036|365429508|FG003|Overall Study|Reason not Specified|2|||
105937271|NCT01943825|365429513|FG000|Overall Study|Lost to Follow-up|9|||
105728556|NCT01731002|364659743|FG000|Overall Study|Adverse Event|0|||
105728557|NCT01731002|364659744|FG001|Overall Study|Adverse Event|2|||
105728558|NCT01731002|364659745|FG002|Overall Study|Adverse Event|2|||
105728559|NCT01731002|364659743|FG000|Overall Study|Non-Compliant|0|||
105728560|NCT01731002|364659744|FG001|Overall Study|Non-Compliant|1|||
105728561|NCT01731002|364659745|FG002|Overall Study|Non-Compliant|0|||
105728562|NCT01731002|364659743|FG000|Overall Study|Lost to Follow-up|1|||
105728563|NCT01731002|364659744|FG001|Overall Study|Lost to Follow-up|0|||
105728564|NCT01731002|364659745|FG002|Overall Study|Lost to Follow-up|0|||
105728565|NCT01731002|364659743|FG000|Overall Study|Test Agent Discontinuation|0|||
105728566|NCT01731002|364659744|FG001|Overall Study|Test Agent Discontinuation|1|||
105728567|NCT01731002|364659745|FG002|Overall Study|Test Agent Discontinuation|0|||
105728568|NCT01731002|364659743|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
105728569|NCT01731002|364659744|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
105728570|NCT01731002|364659745|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
105728571|NCT01731002|364659743|FG000|Overall Study|Elevated IOP|1|||
105728572|NCT01731002|364659744|FG001|Overall Study|Elevated IOP|0|||
105728573|NCT01731002|364659745|FG002|Overall Study|Elevated IOP|0|||
105728574|NCT01731002|364659743|FG000|Overall Study|Inappropriate use of study medications|0|||
105728575|NCT01731002|364659744|FG001|Overall Study|Inappropriate use of study medications|0|||
105728576|NCT01731002|364659745|FG002|Overall Study|Inappropriate use of study medications|1|||
105728577|NCT02031679|364661110|FG000|Overall Study|Protocol Violation|0|||
105728578|NCT02031679|364661111|FG001|Overall Study|Protocol Violation|1|||
105728579|NCT02031679|364661110|FG000|Overall Study|Lack of Efficacy|0|||
105728580|NCT02031679|364661111|FG001|Overall Study|Lack of Efficacy|1|||
105728581|NCT03019549|364661112|FG000|Washout|DId not meet genotype criteria|11|||
105728582|NCT03019549|364661112|FG000|Period 2|Adverse Event|2|||
105728583|NCT03019549|364661112|FG000|Period 2|Physician Decision|2|||
105728584|NCT03019549|364661112|FG000|Period 2|Withdrawal by Subject|1|||
105728585|NCT04030195|364661113|FG000|Overall Study|Withdrawal by Subject|2|||
105728586|NCT04030195|364661114|FG001|Overall Study|Withdrawal by Subject|0|||
105728587|NCT04030195|364661115|FG002|Overall Study|Withdrawal by Subject|0|||
105728588|NCT02109029|364661116|FG000|Part B|Adverse Event|0|||
105728589|NCT02109029|364661117|FG001|Part B|Adverse Event|0|||
105728590|NCT02109029|364661118|FG002|Part B|Adverse Event|0|||
105728591|NCT02109029|364661119|FG003|Part B|Adverse Event|0|||
105728592|NCT02109029|364661120|FG004|Part B|Adverse Event|1|||
105728593|NCT02109029|364661121|FG005|Part B|Adverse Event|1|||
105728594|NCT01445171|364661122|FG000|Overall Study|Lost to Follow-up|11|||
105728595|NCT01445171|364661122|FG000|Overall Study|Withdrawal by Subject|16|||
105728596|NCT01445171|364661122|FG000|Overall Study|Death|51|||
105728597|NCT01445171|364661122|FG000|Overall Study|Subjects declined to return for followup|9|||
105728598|NCT01445171|364661122|FG000|Overall Study|Consented but did not receive device|8|||
105728599|NCT01609933|364661133|FG000|Overall Study|Adverse Event|1|||
105728600|NCT01609933|364661133|FG000|Overall Study|Withdrawal by Subject|3|||
105728601|NCT01252966|364661134|FG000|Overall Study|Lost to Follow-up|16|||
105728602|NCT01252966|364661135|FG001|Overall Study|Lost to Follow-up|10|||
105728603|NCT01252966|364661134|FG000|Overall Study|Withdrawal by Subject|7|||
105728604|NCT01252966|364661135|FG001|Overall Study|Withdrawal by Subject|3|||
105728605|NCT02017444|364661136|FG000|Overall Study|Physician Decision|1|||
105728606|NCT02017444|364661137|FG001|Overall Study|Physician Decision|0|||
105728607|NCT02017444|364661136|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
105728608|NCT02017444|364661137|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
105728609|NCT00886821|364661146|FG000|Stage 2|Adverse Event|0|||
105728610|NCT00886821|364661147|FG001|Stage 2|Adverse Event|0|||
105728611|NCT00886821|364661148|FG002|Stage 2|Adverse Event|0|||
105728612|NCT00886821|364661149|FG003|Stage 2|Adverse Event|0|||
105728613|NCT00886821|364661150|FG004|Stage 2|Adverse Event|0|||
105728614|NCT00886821|364661151|FG005|Stage 2|Adverse Event|0|||
105728615|NCT00886821|364661152|FG006|Stage 2|Adverse Event|0|||
105728616|NCT00886821|364661153|FG007|Stage 2|Adverse Event|0|||
105728617|NCT00886821|364661154|FG008|Stage 2|Adverse Event|0|||
105728618|NCT00886821|364661155|FG009|Stage 2|Adverse Event|0|||
105728619|NCT00886821|364661156|FG010|Stage 2|Adverse Event|0|||
105728620|NCT00886821|364661157|FG011|Stage 2|Adverse Event|1|||
105728621|NCT00886821|364661158|FG012|Stage 2|Adverse Event|3|||
105728622|NCT00886821|364661159|FG013|Stage 2|Adverse Event|0|||
105728623|NCT00886821|364661146|FG000|Stage 2|Lost to Follow-up|0|||
105728624|NCT00886821|364661147|FG001|Stage 2|Lost to Follow-up|0|||
105728625|NCT00886821|364661148|FG002|Stage 2|Lost to Follow-up|0|||
105728626|NCT00886821|364661149|FG003|Stage 2|Lost to Follow-up|0|||
105728627|NCT00886821|364661150|FG004|Stage 2|Lost to Follow-up|0|||
105728628|NCT00886821|364661151|FG005|Stage 2|Lost to Follow-up|0|||
105728629|NCT00886821|364661152|FG006|Stage 2|Lost to Follow-up|0|||
105728630|NCT00886821|364661153|FG007|Stage 2|Lost to Follow-up|0|||
105728631|NCT00886821|364661154|FG008|Stage 2|Lost to Follow-up|0|||
105728632|NCT00886821|364661155|FG009|Stage 2|Lost to Follow-up|0|||
105728633|NCT00886821|364661156|FG010|Stage 2|Lost to Follow-up|0|||
105728634|NCT00886821|364661157|FG011|Stage 2|Lost to Follow-up|0|||
105728635|NCT00886821|364661158|FG012|Stage 2|Lost to Follow-up|2|||
105728636|NCT00886821|364661159|FG013|Stage 2|Lost to Follow-up|1|||
105728637|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
105728638|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
105728639|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
105728640|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
105728641|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
105728642|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
105728643|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
105728644|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
105728645|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
105728646|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
105728647|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
105728648|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
105728649|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
105728650|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
105728651|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
105728652|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
105728653|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
105728654|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
105728655|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
105728656|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
105728657|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
105728658|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
105728659|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
105728660|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
105728661|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
105728662|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
105728663|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
105728664|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
105728665|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
105728666|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
105728667|NCT02660580|364661160|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
105728668|NCT02660580|364661161|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
105728669|NCT02660580|364661162|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
105728670|NCT02660580|364661163|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
105728671|NCT02660580|364661164|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
105728672|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
105728673|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
105728674|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
105728675|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
105728676|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
105728677|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
105728678|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
105728679|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
105728680|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
105728681|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
105728682|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
105728683|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
105728684|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
105728685|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
105728686|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
105728687|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
105728688|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
105728689|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
105728690|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
105728691|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
105728692|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
105728693|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
105728694|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
105728695|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
105728696|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
105795829|NCT03372369|364909277|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
105728697|NCT02660580|364661160|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
105728698|NCT02660580|364661161|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
105728699|NCT02660580|364661162|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
105728700|NCT02660580|364661163|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
105728701|NCT02660580|364661164|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
105728702|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Adverse Event|18|||
105728703|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Adverse Event|2|||
105728704|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Death|3|||
105728705|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Death|0|||
105728706|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
105728707|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
105728708|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
105728709|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
105728710|NCT00377962|364661165|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
105728711|NCT00377962|364661166|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
105728712|NCT00377962|364661165|FG000|Extension Study: 12-24 Months|Death|1|||
105728713|NCT00377962|364661166|FG001|Extension Study: 12-24 Months|Death|1|||
105728714|NCT00377962|364661165|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
105728715|NCT00377962|364661166|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
105728716|NCT00377962|364661165|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
105728717|NCT00377962|364661166|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
105728718|NCT00377962|364661165|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
105728719|NCT00377962|364661166|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
105728720|NCT03368859|364661171|FG000|Overall Study|Withdrew Consent|5|||
105728721|NCT03368859|364661172|FG001|Overall Study|Withdrew Consent|4|||
105728722|NCT03368859|364661171|FG000|Overall Study|Death|12|||
105728723|NCT03368859|364661172|FG001|Overall Study|Death|6|||
105728724|NCT03368859|364661171|FG000|Overall Study|Study terminated by Sponsor|18|||
105728725|NCT03368859|364661172|FG001|Overall Study|Study terminated by Sponsor|23|||
105728726|NCT03368859|364661171|FG000|Overall Study|Other|1|||
105728727|NCT03368859|364661172|FG001|Overall Study|Other|1|||
105728728|NCT01713348|364661173|FG000|Overall Study|Withdrawal by Subject|3|||
105728729|NCT01713348|364661174|FG001|Overall Study|Withdrawal by Subject|2|||
105728730|NCT01713348|364661175|FG002|Overall Study|Withdrawal by Subject|2|||
105728731|NCT01713348|364661176|FG003|Overall Study|Withdrawal by Subject|0|||
105728732|NCT01713348|364661173|FG000|Overall Study|Lost to Follow-up|1|||
105728733|NCT01713348|364661174|FG001|Overall Study|Lost to Follow-up|0|||
105728734|NCT01713348|364661175|FG002|Overall Study|Lost to Follow-up|0|||
105728735|NCT01713348|364661176|FG003|Overall Study|Lost to Follow-up|0|||
105728736|NCT01324830|364661183|FG000|Overall Study|Progressive Disease|3|||
105728737|NCT01324830|364661184|FG001|Overall Study|Progressive Disease|2|||
105728738|NCT01324830|364661185|FG002|Overall Study|Progressive Disease|3|||
105728739|NCT01324830|364661186|FG003|Overall Study|Progressive Disease|3|||
105728740|NCT01324830|364661187|FG004|Overall Study|Progressive Disease|6|||
105728741|NCT01324830|364661188|FG005|Overall Study|Progressive Disease|6|||
105728742|NCT01324830|364661189|FG006|Overall Study|Progressive Disease|3|||
105728743|NCT01324830|364661190|FG007|Overall Study|Progressive Disease|3|||
105728744|NCT01324830|364661191|FG008|Overall Study|Progressive Disease|3|||
105728745|NCT01324830|364661192|FG009|Overall Study|Progressive Disease|6|||
105728746|NCT01324830|364661193|FG010|Overall Study|Progressive Disease|2|||
105728747|NCT01324830|364661194|FG011|Overall Study|Progressive Disease|1|||
105728748|NCT01324830|364661195|FG012|Overall Study|Progressive Disease|1|||
105728749|NCT01324830|364661196|FG013|Overall Study|Progressive Disease|1|||
105728750|NCT01324830|364661197|FG014|Overall Study|Progressive Disease|1|||
105728751|NCT01324830|364661198|FG015|Overall Study|Progressive Disease|3|||
105728752|NCT01324830|364661199|FG016|Overall Study|Progressive Disease|2|||
105728753|NCT01324830|364661200|FG017|Overall Study|Progressive Disease|3|||
105728754|NCT01324830|364661201|FG018|Overall Study|Progressive Disease|4|||
105728755|NCT01324830|364661183|FG000|Overall Study|Dose limiting toxicity|0|||
105728756|NCT01324830|364661184|FG001|Overall Study|Dose limiting toxicity|0|||
105728757|NCT01324830|364661185|FG002|Overall Study|Dose limiting toxicity|0|||
105728758|NCT01324830|364661186|FG003|Overall Study|Dose limiting toxicity|0|||
105728759|NCT01324830|364661187|FG004|Overall Study|Dose limiting toxicity|1|||
105728760|NCT01324830|364661188|FG005|Overall Study|Dose limiting toxicity|0|||
105795830|NCT03372369|364909276|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
105728761|NCT01324830|364661189|FG006|Overall Study|Dose limiting toxicity|0|||
105728762|NCT01324830|364661190|FG007|Overall Study|Dose limiting toxicity|0|||
105728763|NCT01324830|364661191|FG008|Overall Study|Dose limiting toxicity|0|||
105728764|NCT01324830|364661192|FG009|Overall Study|Dose limiting toxicity|0|||
105728765|NCT01324830|364661193|FG010|Overall Study|Dose limiting toxicity|0|||
105728766|NCT01324830|364661194|FG011|Overall Study|Dose limiting toxicity|0|||
105728767|NCT01324830|364661195|FG012|Overall Study|Dose limiting toxicity|0|||
105728768|NCT01324830|364661196|FG013|Overall Study|Dose limiting toxicity|0|||
105728769|NCT01324830|364661197|FG014|Overall Study|Dose limiting toxicity|0|||
105728770|NCT01324830|364661198|FG015|Overall Study|Dose limiting toxicity|0|||
105728771|NCT01324830|364661199|FG016|Overall Study|Dose limiting toxicity|1|||
105728772|NCT01324830|364661200|FG017|Overall Study|Dose limiting toxicity|1|||
106138959|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105795831|NCT03372369|364909277|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
105795832|NCT02923115|364909280|FG000|Overall Study|Lost to Follow-up|0|||
105795833|NCT02923115|364909281|FG001|Overall Study|Lost to Follow-up|0|||
105795834|NCT02923115|364909282|FG002|Overall Study|Lost to Follow-up|0|||
105795835|NCT02923115|364909283|FG003|Overall Study|Lost to Follow-up|1|||
105795836|NCT02923115|364909284|FG004|Overall Study|Lost to Follow-up|0|||
105795837|NCT02923115|364909285|FG005|Overall Study|Lost to Follow-up|0|||
105795838|NCT02923115|364909280|FG000|Overall Study|Withdrawal by Subject|0|||
105795839|NCT02923115|364909281|FG001|Overall Study|Withdrawal by Subject|1|||
105795840|NCT02923115|364909282|FG002|Overall Study|Withdrawal by Subject|0|||
105795841|NCT02923115|364909283|FG003|Overall Study|Withdrawal by Subject|0|||
105795842|NCT02923115|364909284|FG004|Overall Study|Withdrawal by Subject|0|||
105795843|NCT02923115|364909285|FG005|Overall Study|Withdrawal by Subject|0|||
105795844|NCT02923115|364909280|FG000|Overall Study|Randomized, but not dosed|0|||
105795845|NCT02923115|364909281|FG001|Overall Study|Randomized, but not dosed|0|||
105795846|NCT02923115|364909282|FG002|Overall Study|Randomized, but not dosed|3|||
105795847|NCT02923115|364909283|FG003|Overall Study|Randomized, but not dosed|1|||
105795848|NCT02923115|364909284|FG004|Overall Study|Randomized, but not dosed|5|||
105795849|NCT02923115|364909285|FG005|Overall Study|Randomized, but not dosed|0|||
105795850|NCT03451331|364909292|FG000|Overall Study|Withdrawal by Subject|1|||
105795851|NCT03451331|364909293|FG001|Overall Study|Withdrawal by Subject|0|||
105795852|NCT03451331|364909292|FG000|Overall Study|Unable to start treatment.|1|||
105795853|NCT03451331|364909293|FG001|Overall Study|Unable to start treatment.|1|||
105795854|NCT00038467|364909294|FG000|Overall Study|Adverse Event|170|||
105937272|NCT01943825|365429514|FG001|Overall Study|Lost to Follow-up|3|||
105937273|NCT01943825|365429515|FG002|Overall Study|Lost to Follow-up|12|||
105937274|NCT01943825|365429516|FG003|Overall Study|Lost to Follow-up|8|||
105937275|NCT01943825|365429513|FG000|Overall Study|Withdrawal by Subject|1|||
105937276|NCT01943825|365429514|FG001|Overall Study|Withdrawal by Subject|0|||
105937277|NCT01943825|365429515|FG002|Overall Study|Withdrawal by Subject|3|||
105937278|NCT01943825|365429516|FG003|Overall Study|Withdrawal by Subject|2|||
105937279|NCT01943825|365429513|FG000|Overall Study|Other than specified above|0|||
105937280|NCT01943825|365429514|FG001|Overall Study|Other than specified above|1|||
105937281|NCT01943825|365429515|FG002|Overall Study|Other than specified above|0|||
105937282|NCT01943825|365429516|FG003|Overall Study|Other than specified above|1|||
105937283|NCT01684033|365429517|FG000|Period 1, First 30 Days|Adverse Event|1|||
105937284|NCT01684033|365429518|FG001|Period 1, First 30 Days|Adverse Event|1|||
105937285|NCT01684033|365429517|FG000|Period 1, First 30 Days|Noncompliance|1|||
105937286|NCT01684033|365429518|FG001|Period 1, First 30 Days|Noncompliance|0|||
105937287|NCT01684033|365429517|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
105937288|NCT01684033|365429518|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
105937289|NCT01684033|365429517|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
105937290|NCT01684033|365429518|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
105937291|NCT01684033|365429517|FG000|Period 2, Second 30 Days|Adverse Event|1|||
105937292|NCT01684033|365429518|FG001|Period 2, Second 30 Days|Adverse Event|0|||
105937293|NCT00236197|365429519|FG000|Overall Study|Withdrawal by Subject|3|||
105937294|NCT00236197|365429520|FG001|Overall Study|Withdrawal by Subject|2|||
105937295|NCT00236197|365429519|FG000|Overall Study|Lost to Follow-up|1|||
105937296|NCT00236197|365429520|FG001|Overall Study|Lost to Follow-up|5|||
105937297|NCT00236197|365429519|FG000|Overall Study|Protocol Violation|0|||
105937298|NCT00236197|365429520|FG001|Overall Study|Protocol Violation|3|||
105937299|NCT00236197|365429519|FG000|Overall Study|Medication non-compliance|1|||
105937300|NCT00236197|365429520|FG001|Overall Study|Medication non-compliance|2|||
105937301|NCT00236197|365429519|FG000|Overall Study|Other|0|||
105937302|NCT00236197|365429520|FG001|Overall Study|Other|2|||
105937303|NCT02916433|365429521|FG000|Overall Study|Withdrawal by Subject|1|||
105937304|NCT02916433|365429522|FG001|Overall Study|Withdrawal by Subject|0|||
105937305|NCT02916433|365429521|FG000|Overall Study|Physician Decision|1|||
105937306|NCT02916433|365429522|FG001|Overall Study|Physician Decision|0|||
105937307|NCT03760666|365429523|FG000|Overall Study|Adverse Event|2|||
105937308|NCT03760666|365429524|FG001|Overall Study|Adverse Event|4|||
106138960|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
106138961|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
106009541|NCT02435992|365700868|FG003|Overall Study|Physician Decision|0|||
105795855|NCT00038467|364909295|FG001|Overall Study|Adverse Event|145|||
105795856|NCT00038467|364909294|FG000|Overall Study|Withdrawal by Subject|150|||
105937309|NCT03760666|365429525|FG002|Overall Study|Adverse Event|1|||
105937310|NCT03760666|365429523|FG000|Overall Study|AML Disease Progression|3|||
105937311|NCT03760666|365429524|FG001|Overall Study|AML Disease Progression|3|||
106138962|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
105937312|NCT03760666|365429525|FG002|Overall Study|AML Disease Progression|0|||
105937313|NCT03760666|365429523|FG000|Overall Study|Physician Decision|0|||
105937314|NCT03760666|365429524|FG001|Overall Study|Physician Decision|3|||
105937315|NCT03760666|365429525|FG002|Overall Study|Physician Decision|0|||
105937316|NCT03760666|365429523|FG000|Overall Study|Withdrawal by Subject|0|||
105937317|NCT03760666|365429524|FG001|Overall Study|Withdrawal by Subject|1|||
105795857|NCT00038467|364909295|FG001|Overall Study|Withdrawal by Subject|107|||
105795858|NCT00038467|364909294|FG000|Overall Study|Protocol Violation|19|||
105795859|NCT00038467|364909295|FG001|Overall Study|Protocol Violation|22|||
105795860|NCT00038467|364909294|FG000|Overall Study|Death|22|||
105795861|NCT00038467|364909295|FG001|Overall Study|Death|16|||
105795862|NCT00038467|364909294|FG000|Overall Study|Lost to Follow-up|15|||
105795863|NCT00038467|364909295|FG001|Overall Study|Lost to Follow-up|10|||
105795864|NCT00038467|364909294|FG000|Overall Study|Recurrence|109|||
105795865|NCT00038467|364909295|FG001|Overall Study|Recurrence|179|||
105795866|NCT00038467|364909294|FG000|Overall Study|Randomized, but not treated|31|||
105795867|NCT00038467|364909295|FG001|Overall Study|Randomized, but not treated|35|||
105795868|NCT00038467|364909294|FG000|Overall Study|Other|26|||
105795869|NCT00038467|364909295|FG001|Overall Study|Other|28|||
105795870|NCT04330482|364909296|FG000|Overall Study|Lost to Follow-up|2|||
105795871|NCT04330482|364909297|FG001|Overall Study|Lost to Follow-up|1|||
105795872|NCT04330482|364909296|FG000|Overall Study|Withdrawal by Subject|0|||
105795873|NCT04330482|364909297|FG001|Overall Study|Withdrawal by Subject|3|||
105795874|NCT05180630|364909298|FG000|First Intervention|Physician Decision|0|||
105795875|NCT05180630|364909299|FG001|First Intervention|Physician Decision|0|||
105795876|NCT05180630|364909300|FG002|First Intervention|Physician Decision|3|||
105795877|NCT00944125|364909308|FG000|3 to 6 Months|Withdrawal by Subject|0|||
105795878|NCT00944125|364909309|FG001|3 to 6 Months|Withdrawal by Subject|2|||
105795879|NCT00944125|364909308|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
105795880|NCT00944125|364909309|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
105795881|NCT00446134|364909310|FG000|Overall Study|Adverse Event|7|||
105795882|NCT00446134|364909311|FG001|Overall Study|Adverse Event|17|||
105795883|NCT00446134|364909312|FG002|Overall Study|Adverse Event|13|||
105795884|NCT00446134|364909313|FG003|Overall Study|Adverse Event|18|||
105795885|NCT00446134|364909310|FG000|Overall Study|Lack of Efficacy|19|||
105795886|NCT00446134|364909311|FG001|Overall Study|Lack of Efficacy|19|||
105795887|NCT00446134|364909312|FG002|Overall Study|Lack of Efficacy|24|||
105795888|NCT00446134|364909313|FG003|Overall Study|Lack of Efficacy|19|||
105795889|NCT00446134|364909310|FG000|Overall Study|Protocol Violation|0|||
105795890|NCT00446134|364909311|FG001|Overall Study|Protocol Violation|2|||
105795891|NCT00446134|364909312|FG002|Overall Study|Protocol Violation|1|||
105795892|NCT00446134|364909313|FG003|Overall Study|Protocol Violation|0|||
105795893|NCT00446134|364909310|FG000|Overall Study|Lost to Follow-up|1|||
105795894|NCT00446134|364909311|FG001|Overall Study|Lost to Follow-up|3|||
105795895|NCT00446134|364909312|FG002|Overall Study|Lost to Follow-up|1|||
105795896|NCT00446134|364909313|FG003|Overall Study|Lost to Follow-up|1|||
105795897|NCT00446134|364909310|FG000|Overall Study|Withdrawal by Subject|3|||
105795898|NCT00446134|364909311|FG001|Overall Study|Withdrawal by Subject|3|||
105795899|NCT00446134|364909312|FG002|Overall Study|Withdrawal by Subject|1|||
105795900|NCT00446134|364909313|FG003|Overall Study|Withdrawal by Subject|3|||
105795901|NCT00446134|364909310|FG000|Overall Study|Physician Decision|0|||
105795902|NCT00446134|364909311|FG001|Overall Study|Physician Decision|0|||
105795903|NCT00446134|364909312|FG002|Overall Study|Physician Decision|0|||
105795904|NCT00446134|364909313|FG003|Overall Study|Physician Decision|2|||
105795905|NCT00446134|364909310|FG000|Overall Study|Adverse Event-Diarrhea|1|||
105795906|NCT00446134|364909311|FG001|Overall Study|Adverse Event-Diarrhea|1|||
105795907|NCT00446134|364909312|FG002|Overall Study|Adverse Event-Diarrhea|2|||
105795908|NCT00446134|364909313|FG003|Overall Study|Adverse Event-Diarrhea|0|||
105795909|NCT00446134|364909310|FG000|Overall Study|Reason Not Completed|3|||
105795910|NCT00446134|364909311|FG001|Overall Study|Reason Not Completed|0|||
105795911|NCT00446134|364909312|FG002|Overall Study|Reason Not Completed|1|||
105795912|NCT00446134|364909313|FG003|Overall Study|Reason Not Completed|2|||
105795913|NCT02524665|364909314|FG000|Overall Study|Lost to Follow-up|1|||
105795914|NCT01500434|364909315|FG000|Overall Study|Death|1|||
105795915|NCT01500434|364909315|FG000|Overall Study|Withdrawal by Subject|1|||
105795916|NCT01500434|364909315|FG000|Overall Study|Missed 12-month follow-up|5|||
105795917|NCT02602080|364909316|FG000|Overall Study|Protocol Violation|6|||
105795918|NCT02602080|364909317|FG001|Overall Study|Protocol Violation|1|||
105795919|NCT02602080|364909318|FG002|Overall Study|Protocol Violation|3|||
105795920|NCT01185639|364909325|FG000|Overall Study|Progressed and didn't receive therapy|2|||
106138963|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
106138964|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
106138965|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
106138966|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
106138967|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
105795921|NCT02200614|364909326|FG000|Double Blind Treatment|Adverse Event|86|||
105795922|NCT02200614|364909327|FG001|Double Blind Treatment|Adverse Event|48|||
105795923|NCT02200614|364909326|FG000|Double Blind Treatment|Confirmed metastasis|120|||
105937318|NCT03760666|365429525|FG002|Overall Study|Withdrawal by Subject|0|||
106138968|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
105795924|NCT02200614|364909327|FG001|Double Blind Treatment|Confirmed metastasis|140|||
105795925|NCT02200614|364909326|FG000|Double Blind Treatment|Judgment of the investigator|59|||
105937319|NCT03289741|365429527|FG000|Overall Study|Adverse Event|1|||
105728773|NCT01324830|364661201|FG018|Overall Study|Dose limiting toxicity|1|||
105728774|NCT01324830|364661183|FG000|Overall Study|Reason not mentioned above|0|||
105728775|NCT01324830|364661184|FG001|Overall Study|Reason not mentioned above|0|||
105728776|NCT01324830|364661185|FG002|Overall Study|Reason not mentioned above|0|||
105728777|NCT01324830|364661186|FG003|Overall Study|Reason not mentioned above|0|||
105728778|NCT01324830|364661187|FG004|Overall Study|Reason not mentioned above|0|||
105728779|NCT01324830|364661188|FG005|Overall Study|Reason not mentioned above|0|||
105728780|NCT01324830|364661189|FG006|Overall Study|Reason not mentioned above|0|||
105728781|NCT01324830|364661190|FG007|Overall Study|Reason not mentioned above|0|||
105728782|NCT01324830|364661191|FG008|Overall Study|Reason not mentioned above|0|||
105728783|NCT01324830|364661192|FG009|Overall Study|Reason not mentioned above|0|||
105728784|NCT01324830|364661193|FG010|Overall Study|Reason not mentioned above|0|||
105728785|NCT01324830|364661194|FG011|Overall Study|Reason not mentioned above|0|||
105728786|NCT01324830|364661195|FG012|Overall Study|Reason not mentioned above|0|||
105728787|NCT01324830|364661196|FG013|Overall Study|Reason not mentioned above|0|||
105728788|NCT01324830|364661197|FG014|Overall Study|Reason not mentioned above|0|||
105728789|NCT01324830|364661198|FG015|Overall Study|Reason not mentioned above|0|||
105728790|NCT01324830|364661199|FG016|Overall Study|Reason not mentioned above|0|||
105728791|NCT01324830|364661200|FG017|Overall Study|Reason not mentioned above|1|||
105728792|NCT01324830|364661201|FG018|Overall Study|Reason not mentioned above|0|||
105728793|NCT01324830|364661183|FG000|Overall Study|Adverse Event, serious fatal|0|||
105728794|NCT01324830|364661184|FG001|Overall Study|Adverse Event, serious fatal|1|||
105728795|NCT01324830|364661185|FG002|Overall Study|Adverse Event, serious fatal|0|||
105728796|NCT01324830|364661186|FG003|Overall Study|Adverse Event, serious fatal|0|||
105728797|NCT01324830|364661187|FG004|Overall Study|Adverse Event, serious fatal|0|||
105728798|NCT01324830|364661188|FG005|Overall Study|Adverse Event, serious fatal|0|||
105728799|NCT01324830|364661189|FG006|Overall Study|Adverse Event, serious fatal|0|||
105728800|NCT01324830|364661190|FG007|Overall Study|Adverse Event, serious fatal|0|||
105728801|NCT01324830|364661191|FG008|Overall Study|Adverse Event, serious fatal|0|||
105728802|NCT01324830|364661192|FG009|Overall Study|Adverse Event, serious fatal|0|||
105728803|NCT01324830|364661193|FG010|Overall Study|Adverse Event, serious fatal|0|||
105728804|NCT01324830|364661194|FG011|Overall Study|Adverse Event, serious fatal|0|||
105728805|NCT01324830|364661195|FG012|Overall Study|Adverse Event, serious fatal|0|||
105728806|NCT01324830|364661196|FG013|Overall Study|Adverse Event, serious fatal|0|||
105728807|NCT01324830|364661197|FG014|Overall Study|Adverse Event, serious fatal|0|||
105728808|NCT01324830|364661198|FG015|Overall Study|Adverse Event, serious fatal|0|||
105728809|NCT01324830|364661199|FG016|Overall Study|Adverse Event, serious fatal|0|||
105728810|NCT01324830|364661200|FG017|Overall Study|Adverse Event, serious fatal|0|||
105728811|NCT01324830|364661201|FG018|Overall Study|Adverse Event, serious fatal|0|||
105728812|NCT01324830|364661183|FG000|Overall Study|Adverse Event, non-fatal|0|||
105728813|NCT01324830|364661184|FG001|Overall Study|Adverse Event, non-fatal|0|||
105728814|NCT01324830|364661185|FG002|Overall Study|Adverse Event, non-fatal|0|||
105728815|NCT01324830|364661186|FG003|Overall Study|Adverse Event, non-fatal|0|||
105728816|NCT01324830|364661187|FG004|Overall Study|Adverse Event, non-fatal|0|||
105728817|NCT01324830|364661188|FG005|Overall Study|Adverse Event, non-fatal|0|||
105728818|NCT01324830|364661189|FG006|Overall Study|Adverse Event, non-fatal|0|||
105728819|NCT01324830|364661190|FG007|Overall Study|Adverse Event, non-fatal|0|||
105728820|NCT01324830|364661191|FG008|Overall Study|Adverse Event, non-fatal|2|||
105728821|NCT01324830|364661192|FG009|Overall Study|Adverse Event, non-fatal|0|||
105728822|NCT01324830|364661193|FG010|Overall Study|Adverse Event, non-fatal|1|||
105728823|NCT01324830|364661194|FG011|Overall Study|Adverse Event, non-fatal|0|||
105728824|NCT01324830|364661195|FG012|Overall Study|Adverse Event, non-fatal|0|||
105728825|NCT01324830|364661196|FG013|Overall Study|Adverse Event, non-fatal|0|||
105728826|NCT01324830|364661197|FG014|Overall Study|Adverse Event, non-fatal|0|||
105728827|NCT01324830|364661198|FG015|Overall Study|Adverse Event, non-fatal|0|||
105728828|NCT01324830|364661199|FG016|Overall Study|Adverse Event, non-fatal|0|||
105728829|NCT01324830|364661200|FG017|Overall Study|Adverse Event, non-fatal|1|||
105728830|NCT01324830|364661201|FG018|Overall Study|Adverse Event, non-fatal|0|||
105728831|NCT01324830|364661183|FG000|Overall Study|Withdrawal by Subject|0|||
105728832|NCT01324830|364661184|FG001|Overall Study|Withdrawal by Subject|0|||
105728833|NCT01324830|364661185|FG002|Overall Study|Withdrawal by Subject|0|||
105728834|NCT01324830|364661186|FG003|Overall Study|Withdrawal by Subject|0|||
105937320|NCT03289741|365429528|FG001|Overall Study|Adverse Event|1|||
105728835|NCT01324830|364661187|FG004|Overall Study|Withdrawal by Subject|0|||
105728836|NCT01324830|364661188|FG005|Overall Study|Withdrawal by Subject|1|||
105728837|NCT01324830|364661189|FG006|Overall Study|Withdrawal by Subject|0|||
105728838|NCT01324830|364661190|FG007|Overall Study|Withdrawal by Subject|0|||
105728839|NCT01324830|364661191|FG008|Overall Study|Withdrawal by Subject|0|||
105728840|NCT01324830|364661192|FG009|Overall Study|Withdrawal by Subject|0|||
105728841|NCT01324830|364661193|FG010|Overall Study|Withdrawal by Subject|1|||
105728842|NCT01324830|364661194|FG011|Overall Study|Withdrawal by Subject|0|||
105937321|NCT03289741|365429527|FG000|Overall Study|Physician Decision|2|||
105728843|NCT01324830|364661195|FG012|Overall Study|Withdrawal by Subject|0|||
105937322|NCT03289741|365429528|FG001|Overall Study|Physician Decision|2|||
105728844|NCT01324830|364661196|FG013|Overall Study|Withdrawal by Subject|0|||
105728845|NCT01324830|364661197|FG014|Overall Study|Withdrawal by Subject|0|||
105728846|NCT01324830|364661198|FG015|Overall Study|Withdrawal by Subject|0|||
105728847|NCT01324830|364661199|FG016|Overall Study|Withdrawal by Subject|0|||
105728848|NCT01324830|364661200|FG017|Overall Study|Withdrawal by Subject|0|||
105728849|NCT01324830|364661201|FG018|Overall Study|Withdrawal by Subject|1|||
105728850|NCT00942409|364661202|FG000|Overall Study|Lack of Efficacy|1|||
105728851|NCT00942409|364661202|FG000|Overall Study|study drug unavailable|2|||
105728852|NCT00097539|364661203|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
105728853|NCT00097539|364661204|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
105728854|NCT00097539|364661205|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
105728855|NCT00097539|364661206|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
105728856|NCT00097539|364661207|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
105728857|NCT00097539|364661208|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
105728858|NCT00097539|364661209|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
105728859|NCT00097539|364661203|FG000|Overall Study|Withdrawal by Subject|925|||
105728860|NCT00097539|364661204|FG001|Overall Study|Withdrawal by Subject|323|||
105728861|NCT00097539|364661205|FG002|Overall Study|Withdrawal by Subject|346|||
105728862|NCT00097539|364661206|FG003|Overall Study|Withdrawal by Subject|217|||
105728863|NCT00097539|364661207|FG004|Overall Study|Withdrawal by Subject|68|||
105728864|NCT00097539|364661208|FG005|Overall Study|Withdrawal by Subject|229|||
105728865|NCT00097539|364661209|FG006|Overall Study|Withdrawal by Subject|3|||
105728866|NCT00097539|364661203|FG000|Overall Study|Participant Non-compliant|2140|||
105728867|NCT00097539|364661204|FG001|Overall Study|Participant Non-compliant|567|||
105728868|NCT00097539|364661205|FG002|Overall Study|Participant Non-compliant|1067|||
105728869|NCT00097539|364661206|FG003|Overall Study|Participant Non-compliant|353|||
105728870|NCT00097539|364661207|FG004|Overall Study|Participant Non-compliant|136|||
105728871|NCT00097539|364661208|FG005|Overall Study|Participant Non-compliant|543|||
105728872|NCT00097539|364661209|FG006|Overall Study|Participant Non-compliant|18|||
105937323|NCT03289741|365429527|FG000|Overall Study|Withdrawal by Subject|1|||
105937324|NCT03289741|365429528|FG001|Overall Study|Withdrawal by Subject|0|||
105937325|NCT02931539|365429530|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
105937326|NCT02931539|365429531|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
105728873|NCT00097539|364661203|FG000|Overall Study|Lack of Efficacy|249|||
105728874|NCT00097539|364661204|FG001|Overall Study|Lack of Efficacy|122|||
105728875|NCT00097539|364661205|FG002|Overall Study|Lack of Efficacy|202|||
105728876|NCT00097539|364661206|FG003|Overall Study|Lack of Efficacy|105|||
105937327|NCT02931539|365429532|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
105937328|NCT02931539|365429530|FG000|Period 1: Treatment Phase|Adverse Event|5|||
105937329|NCT02931539|365429531|FG001|Period 1: Treatment Phase|Adverse Event|1|||
105937330|NCT02931539|365429532|FG002|Period 1: Treatment Phase|Adverse Event|0|||
105937331|NCT02931539|365429530|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
105937332|NCT02931539|365429531|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
105937333|NCT02931539|365429532|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
105937334|NCT02931539|365429530|FG000|Period 1: Treatment Phase|Death|8|||
105937335|NCT02931539|365429531|FG001|Period 1: Treatment Phase|Death|24|||
105937336|NCT02931539|365429532|FG002|Period 1: Treatment Phase|Death|0|||
105937337|NCT02931539|365429530|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
105937338|NCT02931539|365429531|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
105937339|NCT02931539|365429532|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
105937340|NCT02931539|365429530|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
105937341|NCT02931539|365429531|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
105937342|NCT02931539|365429532|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
105937343|NCT02931539|365429530|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
105937344|NCT02931539|365429531|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
105937345|NCT02931539|365429532|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
105937346|NCT02931539|365429530|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
105937347|NCT02931539|365429531|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
106009542|NCT02435992|365700869|FG004|Overall Study|Physician Decision|0|||
106138969|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
106138970|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
106138971|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
106138972|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
106138973|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
106138974|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
106138975|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
106138976|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
106138977|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
106138978|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
105795926|NCT02200614|364909327|FG001|Double Blind Treatment|Judgment of the investigator|99|||
105728877|NCT00097539|364661207|FG004|Overall Study|Lack of Efficacy|45|||
105728878|NCT00097539|364661208|FG005|Overall Study|Lack of Efficacy|228|||
105728879|NCT00097539|364661209|FG006|Overall Study|Lack of Efficacy|5|||
105728880|NCT00097539|364661203|FG000|Overall Study|Adverse Event|78|||
105728881|NCT00097539|364661204|FG001|Overall Study|Adverse Event|133|||
105728882|NCT00097539|364661205|FG002|Overall Study|Adverse Event|37|||
105728883|NCT00097539|364661206|FG003|Overall Study|Adverse Event|27|||
105728884|NCT00097539|364661207|FG004|Overall Study|Adverse Event|30|||
105728885|NCT00097539|364661208|FG005|Overall Study|Adverse Event|59|||
105728886|NCT00097539|364661209|FG006|Overall Study|Adverse Event|1|||
105728887|NCT00097539|364661203|FG000|Overall Study|Death|2|||
105728888|NCT00097539|364661204|FG001|Overall Study|Death|7|||
105728889|NCT00097539|364661205|FG002|Overall Study|Death|0|||
105728890|NCT00097539|364661206|FG003|Overall Study|Death|0|||
105728891|NCT00097539|364661207|FG004|Overall Study|Death|1|||
105728892|NCT00097539|364661208|FG005|Overall Study|Death|3|||
105728893|NCT00097539|364661209|FG006|Overall Study|Death|0|||
105728894|NCT00097539|364661203|FG000|Overall Study|Reasons Other Than Above|3602|||
105728895|NCT00097539|364661204|FG001|Overall Study|Reasons Other Than Above|1382|||
105728896|NCT00097539|364661205|FG002|Overall Study|Reasons Other Than Above|1757|||
105728897|NCT00097539|364661206|FG003|Overall Study|Reasons Other Than Above|692|||
105728898|NCT00097539|364661207|FG004|Overall Study|Reasons Other Than Above|361|||
105728899|NCT00097539|364661208|FG005|Overall Study|Reasons Other Than Above|1244|||
105728900|NCT00097539|364661209|FG006|Overall Study|Reasons Other Than Above|34|||
105728901|NCT00097539|364661203|FG000|Overall Study|Reason not Specified|111|||
105728902|NCT00097539|364661204|FG001|Overall Study|Reason not Specified|49|||
105728903|NCT00097539|364661205|FG002|Overall Study|Reason not Specified|53|||
105728904|NCT00097539|364661206|FG003|Overall Study|Reason not Specified|21|||
105728905|NCT00097539|364661207|FG004|Overall Study|Reason not Specified|11|||
105728906|NCT00097539|364661208|FG005|Overall Study|Reason not Specified|40|||
105728907|NCT00097539|364661209|FG006|Overall Study|Reason not Specified|2|||
105728908|NCT01241786|364661211|FG000|Overall Study|Lack of Efficacy|5|||
105728909|NCT02317510|364661215|FG000|Overall Study|Adverse Event|0|||
105728910|NCT02317510|364661216|FG001|Overall Study|Adverse Event|1|||
105728911|NCT00472303|364661217|FG000|Titration Phase|Adverse Event|22|||
105728912|NCT00472303|364661218|FG001|Titration Phase|Adverse Event|12|||
105728913|NCT00472303|364661219|FG002|Titration Phase|Adverse Event|0|||
105728914|NCT00472303|364661217|FG000|Titration Phase|Death|4|||
105728915|NCT00472303|364661218|FG001|Titration Phase|Death|2|||
105728916|NCT00472303|364661219|FG002|Titration Phase|Death|0|||
105728917|NCT00472303|364661217|FG000|Titration Phase|Lack of Efficacy|10|||
105728918|NCT00472303|364661218|FG001|Titration Phase|Lack of Efficacy|0|||
105728919|NCT00472303|364661219|FG002|Titration Phase|Lack of Efficacy|0|||
105728920|NCT00472303|364661217|FG000|Titration Phase|Withdrawal by Subject|16|||
105728921|NCT00472303|364661218|FG001|Titration Phase|Withdrawal by Subject|13|||
105728922|NCT00472303|364661219|FG002|Titration Phase|Withdrawal by Subject|0|||
105728923|NCT00472303|364661217|FG000|Titration Phase|Trial Medication non-compliant|4|||
105728924|NCT00472303|364661218|FG001|Titration Phase|Trial Medication non-compliant|1|||
105728925|NCT00472303|364661219|FG002|Titration Phase|Trial Medication non-compliant|0|||
105728926|NCT00472303|364661217|FG000|Titration Phase|Other|3|||
105728927|NCT00472303|364661218|FG001|Titration Phase|Other|1|||
105728928|NCT00472303|364661219|FG002|Titration Phase|Other|0|||
105728929|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
105728930|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
105728931|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
105728932|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
105728933|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
105728934|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
105728935|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
105728936|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
105728937|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
105728938|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
105728939|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
105728940|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
105728941|NCT00472303|364661217|FG000|Discontinuations After Titration Phase|Other|5|||
105728942|NCT00472303|364661218|FG001|Discontinuations After Titration Phase|Other|0|||
105728943|NCT00472303|364661219|FG002|Discontinuations After Titration Phase|Other|0|||
105728944|NCT00472303|364661217|FG000|Maintenance Phase|Adverse Event|5|||
105728945|NCT00472303|364661218|FG001|Maintenance Phase|Adverse Event|6|||
105728946|NCT00472303|364661219|FG002|Maintenance Phase|Adverse Event|6|||
105728947|NCT00472303|364661217|FG000|Maintenance Phase|Death|3|||
105937348|NCT02931539|365429532|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
105728948|NCT00472303|364661218|FG001|Maintenance Phase|Death|0|||
105728949|NCT00472303|364661219|FG002|Maintenance Phase|Death|2|||
105728950|NCT00472303|364661217|FG000|Maintenance Phase|Lack of Efficacy|2|||
105728951|NCT00472303|364661218|FG001|Maintenance Phase|Lack of Efficacy|2|||
105728952|NCT00472303|364661219|FG002|Maintenance Phase|Lack of Efficacy|4|||
105795927|NCT02200614|364909326|FG000|Double Blind Treatment|Metastasis by local reading|1|||
105795928|NCT02200614|364909327|FG001|Double Blind Treatment|Metastasis by local reading|3|||
105795929|NCT02200614|364909326|FG000|Double Blind Treatment|Other reason|6|||
105795930|NCT02200614|364909327|FG001|Double Blind Treatment|Other reason|2|||
105795931|NCT02200614|364909326|FG000|Double Blind Treatment|Personal reason|77|||
105795932|NCT02200614|364909327|FG001|Double Blind Treatment|Personal reason|85|||
105795933|NCT02200614|364909326|FG000|Double Blind Treatment|Protocol deviation|14|||
105795934|NCT02200614|364909327|FG001|Double Blind Treatment|Protocol deviation|7|||
105795935|NCT02200614|364909326|FG000|Double Blind Treatment|Not treated|1|||
105795936|NCT02200614|364909327|FG001|Double Blind Treatment|Not treated|0|||
105795937|NCT02200614|364909326|FG000|Open Label|Adverse Event|41|||
105795938|NCT02200614|364909327|FG001|Open Label|Adverse Event|11|||
105795939|NCT02200614|364909326|FG000|Open Label|Confirmed metastasis|1|||
105795940|NCT02200614|364909327|FG001|Open Label|Confirmed metastasis|0|||
105795941|NCT02200614|364909326|FG000|Open Label|Judgment of the investigator|29|||
105795942|NCT02200614|364909327|FG001|Open Label|Judgment of the investigator|2|||
105795943|NCT02200614|364909326|FG000|Open Label|Metastasis by local reading|138|||
105795944|NCT02200614|364909327|FG001|Open Label|Metastasis by local reading|27|||
105795945|NCT02200614|364909326|FG000|Open Label|Other reason|22|||
105795946|NCT02200614|364909327|FG001|Open Label|Other reason|4|||
105795947|NCT02200614|364909326|FG000|Open Label|Personal reason|60|||
105795948|NCT02200614|364909327|FG001|Open Label|Personal reason|8|||
105795949|NCT02200614|364909326|FG000|Open Label|Protocol deviation|3|||
105795950|NCT02200614|364909327|FG001|Open Label|Protocol deviation|2|||
105795951|NCT02200614|364909326|FG000|Open Label|Missing|2|||
105795952|NCT02200614|364909327|FG001|Open Label|Missing|2|||
105795953|NCT01898884|364909328|FG000|Multiple Dose Period|Adverse Event|0|||
105795954|NCT01898884|364909329|FG001|Multiple Dose Period|Adverse Event|0|||
105795955|NCT01898884|364909330|FG002|Multiple Dose Period|Adverse Event|0|||
105795956|NCT01898884|364909331|FG003|Multiple Dose Period|Adverse Event|0|||
105795957|NCT01898884|364909332|FG004|Multiple Dose Period|Adverse Event|0|||
105795958|NCT01898884|364909333|FG005|Multiple Dose Period|Adverse Event|0|||
105795959|NCT01898884|364909334|FG006|Multiple Dose Period|Adverse Event|1|||
105795960|NCT01898884|364909335|FG007|Multiple Dose Period|Adverse Event|0|||
105795961|NCT01898884|364909336|FG008|Multiple Dose Period|Adverse Event|0|||
105795962|NCT01898884|364909328|FG000|Multiple Dose Period|Randomized Not Treated|0|||
105795963|NCT01898884|364909329|FG001|Multiple Dose Period|Randomized Not Treated|0|||
105795964|NCT01898884|364909330|FG002|Multiple Dose Period|Randomized Not Treated|0|||
105795965|NCT01898884|364909331|FG003|Multiple Dose Period|Randomized Not Treated|0|||
105795966|NCT01898884|364909332|FG004|Multiple Dose Period|Randomized Not Treated|0|||
105795967|NCT01898884|364909333|FG005|Multiple Dose Period|Randomized Not Treated|0|||
105795968|NCT01898884|364909334|FG006|Multiple Dose Period|Randomized Not Treated|0|||
105795969|NCT01898884|364909335|FG007|Multiple Dose Period|Randomized Not Treated|0|||
105795970|NCT01898884|364909336|FG008|Multiple Dose Period|Randomized Not Treated|1|||
105795971|NCT00759759|364909337|FG000|Overall Study|didn't return for period 2|1|||
105795972|NCT00759759|364909338|FG001|Overall Study|didn't return for period 2|0|||
105795973|NCT00759759|364909337|FG000|Overall Study|Didn't receive drug in period 2|1|||
105795974|NCT00759759|364909338|FG001|Overall Study|Didn't receive drug in period 2|0|||
105795975|NCT00759759|364909337|FG000|Overall Study|Withdrawal by Subject|2|||
105795976|NCT00759759|364909338|FG001|Overall Study|Withdrawal by Subject|1|||
105795977|NCT00434148|364909339|FG000|Overall Study|Adverse Event|18|||
105795978|NCT00434148|364909340|FG001|Overall Study|Adverse Event|18|||
105795979|NCT00434148|364909339|FG000|Overall Study|Lack of Efficacy|25|||
105795980|NCT00434148|364909340|FG001|Overall Study|Lack of Efficacy|28|||
105795981|NCT00434148|364909339|FG000|Overall Study|Withdrawal by Subject|15|||
105795982|NCT00434148|364909340|FG001|Overall Study|Withdrawal by Subject|15|||
105795983|NCT00434148|364909339|FG000|Overall Study|Protocol Violation|4|||
105795984|NCT00434148|364909340|FG001|Overall Study|Protocol Violation|0|||
105795985|NCT00434148|364909339|FG000|Overall Study|Administrative problems|6|||
105795986|NCT00434148|364909340|FG001|Overall Study|Administrative problems|10|||
105795987|NCT00434148|364909339|FG000|Overall Study|Lost to Follow-up|0|||
105795988|NCT00434148|364909340|FG001|Overall Study|Lost to Follow-up|1|||
105937349|NCT03681093|365431403|FG000|Overall Study|Subject decision|0|||
105937350|NCT03681093|365431404|FG001|Overall Study|Subject decision|2|||
105795989|NCT00434148|364909339|FG000|Overall Study|Condition no longer requires study drug|1|||
105795990|NCT00434148|364909340|FG001|Overall Study|Condition no longer requires study drug|0|||
105795991|NCT00434148|364909339|FG000|Overall Study|Abnormal test procedure result|0|||
105937351|NCT03681093|365431405|FG002|Overall Study|Subject decision|1|||
105795992|NCT00434148|364909340|FG001|Overall Study|Abnormal test procedure result|1|||
105795993|NCT03185949|364909343|FG000|ITT Analysis|Withdrawal by Subject|4|||
105795994|NCT03185949|364909344|FG001|ITT Analysis|Withdrawal by Subject|3|||
105795995|NCT03185949|364909343|FG000|PP Analysis|Protocol Violation|2|||
105937352|NCT01213251|365431406|FG000|Overall Study|Death|2|||
105795996|NCT03185949|364909344|FG001|PP Analysis|Protocol Violation|2|||
105937353|NCT01213251|365431407|FG001|Overall Study|Death|1|||
106138979|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
106138980|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
106138981|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
105795997|NCT03185949|364909343|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
105795998|NCT03185949|364909344|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
105795999|NCT05458895|364909346|FG000|Overall Study|Withdrawal by Subject|8|||
105796000|NCT05458895|364909346|FG000|Overall Study|Lost to Follow-up|17|||
105796001|NCT05458895|364909346|FG000|Overall Study|Pregnancy|2|||
105796002|NCT05458895|364909346|FG000|Overall Study|Withdrawal by Study Team|1|||
105796003|NCT04318535|364911312|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
105796004|NCT04318535|364911313|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
105796005|NCT04318535|364911314|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
105796006|NCT02428231|364911315|FG000|Overall Study|Other|10|||
105796007|NCT02428231|364911316|FG001|Overall Study|Other|16|||
105796008|NCT02428231|364911315|FG000|Overall Study|Required Symptomatic Therapy|0|||
105796009|NCT02428231|364911316|FG001|Overall Study|Required Symptomatic Therapy|1|||
105796010|NCT02428231|364911315|FG000|Overall Study|Adverse Event|3|||
106138982|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
106138983|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
106138984|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105796011|NCT02428231|364911316|FG001|Overall Study|Adverse Event|0|||
105796012|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
105937354|NCT01213251|365431408|FG002|Overall Study|Death|2|||
105937355|NCT01213251|365431406|FG000|Overall Study|Exit|3|||
105937356|NCT01213251|365431407|FG001|Overall Study|Exit|2|||
105937357|NCT01213251|365431408|FG002|Overall Study|Exit|8|||
105937358|NCT01213251|365431406|FG000|Overall Study|Protocol Violation|1|||
105937359|NCT01213251|365431407|FG001|Overall Study|Protocol Violation|1|||
105937360|NCT01213251|365431408|FG002|Overall Study|Protocol Violation|0|||
105937361|NCT01213251|365431406|FG000|Overall Study|Missed 18-Month Follow-up|0|||
105937362|NCT01213251|365431407|FG001|Overall Study|Missed 18-Month Follow-up|0|||
105937363|NCT01213251|365431408|FG002|Overall Study|Missed 18-Month Follow-up|1|||
105937364|NCT02529488|365431409|FG000|Overall Study|Adverse Event|1|||
105937365|NCT02529488|365431409|FG000|Overall Study|Death|3|||
105937366|NCT02698787|365431410|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
105937367|NCT02698787|365431411|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
105937368|NCT01882829|365431416|FG000|Overall Study|Adverse Event|4|||
105937369|NCT01882829|365431416|FG000|Overall Study|Protocol Violation|1|||
105937370|NCT01882829|365431416|FG000|Overall Study|Withdrawal by Subject|1|||
105937371|NCT03312114|365431420|FG000|Overall Study|All the five enrolled dropped out of the|5|||
105937372|NCT03635996|365431426|FG000|Overall Study|Study terminated by Sponsor|94|||
105937373|NCT03635996|365431426|FG000|Overall Study|Withdrawal by Subject|20|||
105937374|NCT03635996|365431426|FG000|Overall Study|Ablation|26|||
105937375|NCT03635996|365431426|FG000|Overall Study|Adverse Event|7|||
105937376|NCT03635996|365431426|FG000|Overall Study|Physician Decision|3|||
105937377|NCT03635996|365431426|FG000|Overall Study|Prohibited medication|5|||
105937378|NCT03635996|365431426|FG000|Overall Study|Did not meet eligibility criteria|5|||
105937379|NCT03635996|365431426|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
105937380|NCT03635996|365431426|FG000|Overall Study|Protocol Violation|1|||
105937381|NCT03635996|365431426|FG000|Overall Study|Lost to Follow-up|1|||
105937382|NCT02933151|365431427|FG000|Overall Study|Lost to Follow-up|19|||
106138985|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
106138986|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
106138987|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106138988|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
106138989|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105796013|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105796014|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105796015|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
105796016|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
105937383|NCT02933151|365431428|FG001|Overall Study|Lost to Follow-up|18|||
105937384|NCT02933151|365431427|FG000|Overall Study|Death|1732|||
105937385|NCT02933151|365431428|FG001|Overall Study|Death|1827|||
106138990|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
105937386|NCT02933151|365431427|FG000|Overall Study|Transplant|210|||
105937387|NCT02933151|365431428|FG001|Overall Study|Transplant|278|||
105937388|NCT02933151|365431427|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
105937389|NCT02933151|365431428|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
105937390|NCT02933151|365431427|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
105937391|NCT02933151|365431428|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
105937392|NCT02933151|365431427|FG000|Overall Study|Recovered Kidney Function|47|||
106138991|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
106138992|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
106138993|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
106138994|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
106138995|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
106138996|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
106138997|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
105728953|NCT00472303|364661217|FG000|Maintenance Phase|Withdrawal by Subject|6|||
105728954|NCT00472303|364661218|FG001|Maintenance Phase|Withdrawal by Subject|7|||
105728955|NCT00472303|364661219|FG002|Maintenance Phase|Withdrawal by Subject|3|||
105728956|NCT00472303|364661217|FG000|Maintenance Phase|Trial medication non-compliant|0|||
105728957|NCT00472303|364661218|FG001|Maintenance Phase|Trial medication non-compliant|0|||
105728958|NCT00472303|364661219|FG002|Maintenance Phase|Trial medication non-compliant|1|||
105728959|NCT00472303|364661217|FG000|Maintenance Phase|Resolution of pain|0|||
105728960|NCT00472303|364661218|FG001|Maintenance Phase|Resolution of pain|0|||
105728961|NCT00472303|364661219|FG002|Maintenance Phase|Resolution of pain|1|||
105728962|NCT00472303|364661217|FG000|Maintenance Phase|Other|1|||
105728963|NCT00472303|364661218|FG001|Maintenance Phase|Other|1|||
105728964|NCT00472303|364661219|FG002|Maintenance Phase|Other|0|||
105728965|NCT01238120|364661220|FG000|Overall Study|Withdrawal by Subject|4|||
105728966|NCT01238120|364661221|FG001|Overall Study|Withdrawal by Subject|1|||
105728967|NCT01238120|364661222|FG002|Overall Study|Withdrawal by Subject|2|||
105728968|NCT01238120|364661223|FG003|Overall Study|Withdrawal by Subject|5|||
105728969|NCT01238120|364661220|FG000|Overall Study|Lost to Follow-up|2|||
105728970|NCT01238120|364661221|FG001|Overall Study|Lost to Follow-up|0|||
105728971|NCT01238120|364661222|FG002|Overall Study|Lost to Follow-up|1|||
105728972|NCT01238120|364661223|FG003|Overall Study|Lost to Follow-up|1|||
105728973|NCT01238120|364661220|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
105728974|NCT01238120|364661221|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
105728975|NCT01238120|364661222|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
105728976|NCT01238120|364661223|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
105728977|NCT01535235|364661224|FG000|Overall Study|Adverse Event|1|||
105728978|NCT01535235|364661225|FG001|Overall Study|Adverse Event|0|||
105728979|NCT02835495|364661228|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
105728980|NCT02835495|364661229|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
105728981|NCT02835495|364661228|FG000|Overall Study|Declined in-person follow-up visit|4|||
105728982|NCT02835495|364661229|FG001|Overall Study|Declined in-person follow-up visit|2|||
105728983|NCT02318602|364661230|FG000|Overall Study|Adverse Event|0|||
105728984|NCT02318602|364661231|FG001|Overall Study|Adverse Event|1|||
105728985|NCT02318602|364661232|FG002|Overall Study|Adverse Event|1|||
105728986|NCT02318602|364661230|FG000|Overall Study|Withdrawal by Subject|0|||
105728987|NCT02318602|364661231|FG001|Overall Study|Withdrawal by Subject|3|||
105728988|NCT02318602|364661232|FG002|Overall Study|Withdrawal by Subject|0|||
105728989|NCT02318602|364661230|FG000|Overall Study|Death|1|||
105728990|NCT02318602|364661231|FG001|Overall Study|Death|0|||
105728991|NCT02318602|364661232|FG002|Overall Study|Death|0|||
105728992|NCT02318602|364661230|FG000|Overall Study|Guardian decision to withdraw|0|||
105728993|NCT02318602|364661231|FG001|Overall Study|Guardian decision to withdraw|0|||
105728994|NCT02318602|364661232|FG002|Overall Study|Guardian decision to withdraw|1|||
105728995|NCT01697345|364661236|FG000|Overall Study|Withdrawal by Subject|1|||
105728996|NCT01826214|364662710|FG000|Overall Study|Adverse Event|7|||
105728997|NCT01826214|364662711|FG001|Overall Study|Adverse Event|6|||
105728998|NCT01826214|364662710|FG000|Overall Study|Death|3|||
105728999|NCT01826214|364662711|FG001|Overall Study|Death|1|||
105729000|NCT01826214|364662710|FG000|Overall Study|Lost to Follow-up|1|||
105729001|NCT01826214|364662711|FG001|Overall Study|Lost to Follow-up|0|||
105729002|NCT01826214|364662710|FG000|Overall Study|Physician Decision|0|||
105729003|NCT01826214|364662711|FG001|Overall Study|Physician Decision|2|||
105729004|NCT01826214|364662710|FG000|Overall Study|Progressive disease|22|||
105729005|NCT01826214|364662711|FG001|Overall Study|Progressive disease|21|||
105729006|NCT01826214|364662710|FG000|Overall Study|Study terminated by Sponsor|0|||
105729007|NCT01826214|364662711|FG001|Overall Study|Study terminated by Sponsor|1|||
105729008|NCT01826214|364662710|FG000|Overall Study|Subject/guardian decision|2|||
105729009|NCT01826214|364662711|FG001|Overall Study|Subject/guardian decision|3|||
105729010|NCT03311126|364662712|FG000|Induction|Death|1|||
105729011|NCT03311126|364662712|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
105729012|NCT00469079|364662720|FG000|Overall Study|Lack of Efficacy|3|||
105729013|NCT00469079|364662721|FG001|Overall Study|Lack of Efficacy|8|||
106138998|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
106138999|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
106139000|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
105729014|NCT00469079|364662722|FG002|Overall Study|Lack of Efficacy|5|||
105729015|NCT00469079|364662720|FG000|Overall Study|Adverse Event|1|||
105729016|NCT00469079|364662721|FG001|Overall Study|Adverse Event|3|||
105729017|NCT00469079|364662722|FG002|Overall Study|Adverse Event|2|||
105729018|NCT00469079|364662720|FG000|Overall Study|Lost to Follow-up|4|||
105729019|NCT00469079|364662721|FG001|Overall Study|Lost to Follow-up|8|||
105937393|NCT02933151|365431428|FG001|Overall Study|Recovered Kidney Function|29|||
105937394|NCT01654250|365431429|FG000|Overall Study|Lost to Follow-up|1|||
105937395|NCT01654250|365431430|FG001|Overall Study|Lost to Follow-up|0|||
105937396|NCT01862029|365431431|FG000|Overall Study|Physician Decision|1|||
105937397|NCT04605588|365431433|FG000|Overall Study|Withdrawal by Subject|1|||
105937398|NCT04605588|365431434|FG001|Overall Study|Withdrawal by Subject|0|||
105937399|NCT01230814|365431435|FG000|Overall Study|Lost to Follow-up|11|||
105937400|NCT01230814|365431436|FG001|Overall Study|Lost to Follow-up|3|||
105729020|NCT00469079|364662722|FG002|Overall Study|Lost to Follow-up|10|||
105729021|NCT00469079|364662720|FG000|Overall Study|Withdrawal by Subject|1|||
105729022|NCT00469079|364662721|FG001|Overall Study|Withdrawal by Subject|2|||
105729023|NCT00469079|364662722|FG002|Overall Study|Withdrawal by Subject|2|||
105729024|NCT00469079|364662720|FG000|Overall Study|Ineligible|0|||
105729025|NCT00469079|364662721|FG001|Overall Study|Ineligible|1|||
105729026|NCT00469079|364662722|FG002|Overall Study|Ineligible|0|||
105729027|NCT00942162|364662723|FG000|Overall Study|Death|45|||
105729028|NCT00942162|364662724|FG001|Overall Study|Death|35|||
105729029|NCT00942162|364662725|FG002|Overall Study|Death|0|||
105729030|NCT00942162|364662723|FG000|Overall Study|Withdrawal by Subject|7|||
105729031|NCT00942162|364662724|FG001|Overall Study|Withdrawal by Subject|2|||
105729032|NCT00942162|364662725|FG002|Overall Study|Withdrawal by Subject|0|||
105729033|NCT00942162|364662723|FG000|Overall Study|Lost to Follow-up|4|||
105729034|NCT00942162|364662724|FG001|Overall Study|Lost to Follow-up|0|||
105729035|NCT00942162|364662725|FG002|Overall Study|Lost to Follow-up|0|||
105729036|NCT00942162|364662723|FG000|Overall Study|Other|14|||
105729037|NCT00942162|364662724|FG001|Overall Study|Other|13|||
105729038|NCT00942162|364662725|FG002|Overall Study|Other|2|||
105729039|NCT03874234|364662729|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729040|NCT03874234|364662730|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729041|NCT03874234|364662731|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729042|NCT03874234|364662732|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
105729043|NCT03874234|364662733|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729044|NCT03874234|364662734|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729045|NCT03874234|364662735|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729046|NCT03874234|364662736|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729047|NCT03874234|364662737|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729048|NCT03874234|364662738|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729049|NCT03874234|364662739|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729050|NCT03874234|364662740|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729051|NCT03874234|364662741|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
105729052|NCT03874234|364662729|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
105729053|NCT03874234|364662730|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729054|NCT03874234|364662731|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729055|NCT03874234|364662732|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729056|NCT03874234|364662733|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729057|NCT03874234|364662734|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729058|NCT03874234|364662735|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729059|NCT03874234|364662736|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729060|NCT03874234|364662737|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729061|NCT03874234|364662738|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729062|NCT03874234|364662739|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729063|NCT03874234|364662740|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729064|NCT03874234|364662741|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
105729065|NCT03874234|364662729|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729066|NCT03874234|364662730|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729067|NCT03874234|364662731|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729068|NCT03874234|364662732|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
105729069|NCT03874234|364662733|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729070|NCT03874234|364662734|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729071|NCT03874234|364662735|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729072|NCT03874234|364662736|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729073|NCT03874234|364662737|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729074|NCT03874234|364662738|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729075|NCT03874234|364662739|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729076|NCT03874234|364662740|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729077|NCT03874234|364662741|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
105729078|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729079|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729080|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729081|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105937401|NCT01230814|365431435|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
106009543|NCT00260533|365700870|FG000|Overall Study|Other|3|||
105937402|NCT01230814|365431436|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
105937403|NCT00504556|365431437|FG000|Overall Study|Adverse Event|11|||
105937404|NCT00504556|365431438|FG001|Overall Study|Adverse Event|11|||
105937405|NCT00504556|365431439|FG002|Overall Study|Adverse Event|14|||
105937406|NCT00504556|365431440|FG003|Overall Study|Adverse Event|13|||
105937407|NCT00504556|365431441|FG004|Overall Study|Adverse Event|5|||
105937408|NCT00504556|365431437|FG000|Overall Study|Death|3|||
105937409|NCT00504556|365431438|FG001|Overall Study|Death|3|||
105937410|NCT00504556|365431439|FG002|Overall Study|Death|1|||
105937411|NCT00504556|365431440|FG003|Overall Study|Death|0|||
105937412|NCT00504556|365431441|FG004|Overall Study|Death|2|||
105937413|NCT00504556|365431437|FG000|Overall Study|Protocol Violation|1|||
105937414|NCT00504556|365431438|FG001|Overall Study|Protocol Violation|3|||
105937415|NCT00504556|365431439|FG002|Overall Study|Protocol Violation|2|||
105937416|NCT00504556|365431440|FG003|Overall Study|Protocol Violation|1|||
105937417|NCT00504556|365431441|FG004|Overall Study|Protocol Violation|2|||
105937418|NCT00504556|365431437|FG000|Overall Study|Lost to Follow-up|0|||
105937419|NCT00504556|365431438|FG001|Overall Study|Lost to Follow-up|0|||
105937420|NCT00504556|365431439|FG002|Overall Study|Lost to Follow-up|1|||
105937421|NCT00504556|365431440|FG003|Overall Study|Lost to Follow-up|1|||
105937422|NCT00504556|365431441|FG004|Overall Study|Lost to Follow-up|1|||
105937423|NCT00504556|365431437|FG000|Overall Study|Withdrawal by Subject|16|||
105937424|NCT00504556|365431438|FG001|Overall Study|Withdrawal by Subject|16|||
105937425|NCT00504556|365431439|FG002|Overall Study|Withdrawal by Subject|7|||
105937426|NCT00504556|365431440|FG003|Overall Study|Withdrawal by Subject|8|||
105937427|NCT00504556|365431441|FG004|Overall Study|Withdrawal by Subject|12|||
105937428|NCT00504556|365431437|FG000|Overall Study|administrative reasons|0|||
105937429|NCT00504556|365431438|FG001|Overall Study|administrative reasons|2|||
105937430|NCT00504556|365431439|FG002|Overall Study|administrative reasons|2|||
105937431|NCT00504556|365431440|FG003|Overall Study|administrative reasons|1|||
105937432|NCT00504556|365431441|FG004|Overall Study|administrative reasons|2|||
105937433|NCT00504556|365431437|FG000|Overall Study|did not meet entry criteria|2|||
105937434|NCT00504556|365431438|FG001|Overall Study|did not meet entry criteria|0|||
105937435|NCT00504556|365431439|FG002|Overall Study|did not meet entry criteria|1|||
105937436|NCT00504556|365431440|FG003|Overall Study|did not meet entry criteria|1|||
105937437|NCT00504556|365431441|FG004|Overall Study|did not meet entry criteria|0|||
105937438|NCT00504556|365431437|FG000|Overall Study|data monitor committee decision|0|||
105937439|NCT00504556|365431438|FG001|Overall Study|data monitor committee decision|0|||
105937440|NCT00504556|365431439|FG002|Overall Study|data monitor committee decision|0|||
105937441|NCT00504556|365431440|FG003|Overall Study|data monitor committee decision|100|||
105937442|NCT00504556|365431441|FG004|Overall Study|data monitor committee decision|0|||
105937443|NCT00504556|365431437|FG000|Overall Study|Other|2|||
105937444|NCT00504556|365431438|FG001|Overall Study|Other|2|||
105937445|NCT00504556|365431439|FG002|Overall Study|Other|2|||
105937446|NCT00504556|365431440|FG003|Overall Study|Other|3|||
105937447|NCT00504556|365431441|FG004|Overall Study|Other|0|||
105937448|NCT00504556|365431437|FG000|Overall Study|not in safety analysis set|0|||
105937449|NCT00504556|365431438|FG001|Overall Study|not in safety analysis set|1|||
105937450|NCT00504556|365431439|FG002|Overall Study|not in safety analysis set|1|||
105937451|NCT00504556|365431440|FG003|Overall Study|not in safety analysis set|0|||
105937452|NCT00504556|365431441|FG004|Overall Study|not in safety analysis set|1|||
105937453|NCT03280615|365431442|FG000|Overall Study|Lost to Follow-up|1|||
105937454|NCT03280615|365431443|FG001|Overall Study|Lost to Follow-up|2|||
105937455|NCT03280615|365431442|FG000|Overall Study|Adverse Event|1|||
105937456|NCT03280615|365431443|FG001|Overall Study|Adverse Event|1|||
105937457|NCT03280615|365431442|FG000|Overall Study|Withdrawal by Subject|2|||
105937458|NCT03280615|365431443|FG001|Overall Study|Withdrawal by Subject|2|||
105937459|NCT00107614|365431448|FG000|Overall Study|Physician Decision|10|||
105937460|NCT00107614|365431448|FG000|Overall Study|Death|2|||
105937461|NCT00185614|365431449|FG000|Inter-treatment Period|Physician Decision|1|||
105937462|NCT00185614|365431449|FG000|Inter-treatment Period|Relapse|2|||
105937463|NCT00185614|365431449|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
105937464|NCT01052428|365431450|FG000|Overall Study|Death|1|||
105937465|NCT01052428|365431451|FG001|Overall Study|Death|0|||
105937466|NCT01052428|365431450|FG000|Overall Study|Withdrawal by Subject|0|||
105937467|NCT01052428|365431451|FG001|Overall Study|Withdrawal by Subject|1|||
105937468|NCT02365064|365431452|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
105937469|NCT02365064|365431453|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
105937470|NCT02365064|365431452|FG000|Overall Study|Withdrawal by Subject|6|||
105937471|NCT02365064|365431453|FG001|Overall Study|Withdrawal by Subject|9|||
105937472|NCT02365064|365431452|FG000|Overall Study|Treatment intolerance|2|||
105937473|NCT02365064|365431453|FG001|Overall Study|Treatment intolerance|4|||
105937474|NCT00866775|365431457|FG000|Overall Study|Adverse Event|5|||
105937475|NCT00866775|365431458|FG001|Overall Study|Adverse Event|19|||
105937476|NCT00866775|365431457|FG000|Overall Study|Death|1|||
105937477|NCT00866775|365431458|FG001|Overall Study|Death|0|||
105937478|NCT00866775|365431457|FG000|Overall Study|Lost to Follow-up|0|||
105937479|NCT00866775|365431458|FG001|Overall Study|Lost to Follow-up|4|||
105937480|NCT00866775|365431457|FG000|Overall Study|Physician Decision|0|||
105937481|NCT00866775|365431458|FG001|Overall Study|Physician Decision|3|||
105937482|NCT00866775|365431457|FG000|Overall Study|Protocol Violation|3|||
105937483|NCT00866775|365431458|FG001|Overall Study|Protocol Violation|4|||
105937484|NCT00866775|365431457|FG000|Overall Study|Withdrawal by Subject|4|||
105937485|NCT00866775|365431458|FG001|Overall Study|Withdrawal by Subject|4|||
105937486|NCT00866775|365431457|FG000|Overall Study|met exit criteria|23|||
106139001|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
106139002|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
106139003|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
106139004|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
106139005|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
106139006|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
106139007|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
106139008|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
106139009|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
106139010|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
106139011|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106139012|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
106139013|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
106139014|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106139015|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106139016|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106139017|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
106139018|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
106139019|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
106139020|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
106139021|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
106139022|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
106139023|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
106139024|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
106139025|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
106139026|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
105729082|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
105729083|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729084|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729085|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729086|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729087|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729088|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729089|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729090|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
105729091|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729092|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729093|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729094|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729095|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729096|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729097|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729098|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
105729099|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729100|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729101|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729102|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729103|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
105729104|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729105|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729106|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729107|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729108|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
105729109|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
105729110|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729111|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729112|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
106139027|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
106139028|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
105937487|NCT00866775|365431458|FG001|Overall Study|met exit criteria|17|||
105796017|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105796018|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105796019|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
105796020|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
105796021|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
105796022|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
105796023|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
105796024|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
105796025|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
105796026|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
105796027|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
105796028|NCT01336608|364911317|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
105796029|NCT01336608|364911318|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105796030|NCT01336608|364911319|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105796031|NCT01336608|364911320|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
105796032|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
105796033|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
105796034|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
105796035|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
105796036|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105796037|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
105796038|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105796039|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
105796040|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
105796041|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
105796042|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
105796043|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
105796044|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105796045|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
105796046|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
105796047|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
105796048|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
105796049|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
105937488|NCT00866775|365431457|FG000|Overall Study|discontinued due to communication error|0|||
105937489|NCT00866775|365431458|FG001|Overall Study|discontinued due to communication error|1|||
105937490|NCT00605657|365431459|FG000|Overall Study|Adverse Event|1|||
105937491|NCT00605657|365431459|FG000|Overall Study|Protocol Violation|1|||
105937492|NCT02180672|365431462|FG000|Overall Study|Lost to Follow-up|5|||
105937493|NCT02180672|365431463|FG001|Overall Study|Lost to Follow-up|7|||
105937494|NCT00912509|365431467|FG000|Overall Study|Lost to Follow-up|1|||
105937495|NCT00912509|365431468|FG001|Overall Study|Lost to Follow-up|0|||
105937496|NCT00912509|365431467|FG000|Overall Study|Lack of Efficacy|4|||
105937497|NCT00912509|365431468|FG001|Overall Study|Lack of Efficacy|3|||
105937498|NCT00493285|365431469|FG000|Overall Study|Lost to Follow-up|0|||
105937499|NCT00493285|365431470|FG001|Overall Study|Lost to Follow-up|0|||
105937500|NCT00493285|365431471|FG002|Overall Study|Lost to Follow-up|0|||
105937501|NCT00493285|365431472|FG003|Overall Study|Lost to Follow-up|0|||
105937502|NCT00493285|365431473|FG004|Overall Study|Lost to Follow-up|1|||
105937503|NCT00493285|365431474|FG005|Overall Study|Lost to Follow-up|0|||
105937504|NCT02094885|365431477|FG000|Overall Study|Death|1|||
105937505|NCT02094885|365431478|FG001|Overall Study|Death|5|||
105937506|NCT02094885|365431477|FG000|Overall Study|Withdrawn due to age|1|||
105937507|NCT02094885|365431478|FG001|Overall Study|Withdrawn due to age|0|||
105937508|NCT03021005|365431479|FG000|Overall Study|Lost to Follow-up|39|||
105937509|NCT03021005|365431480|FG001|Overall Study|Lost to Follow-up|26|||
105937510|NCT00215553|365431488|FG000|Overall Study|Adverse Event|0|||
105937511|NCT00215553|365431489|FG001|Overall Study|Adverse Event|1|||
105937512|NCT00215553|365431490|FG002|Overall Study|Adverse Event|2|||
105937513|NCT00215553|365431491|FG003|Overall Study|Adverse Event|1|||
105937514|NCT00215553|365431492|FG004|Overall Study|Adverse Event|2|||
106009544|NCT00260533|365700871|FG001|Overall Study|Other|3|||
105937515|NCT00215553|365431493|FG005|Overall Study|Adverse Event|6|||
105937516|NCT00215553|365431494|FG006|Overall Study|Adverse Event|0|||
105937517|NCT03757715|365431500|FG000|Overall Study|Lost to Follow-up|4|||
105796050|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
105796051|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
105796052|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105796053|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
105796054|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105796055|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105796056|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
105796057|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
105796058|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
105796059|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
105796060|NCT01336608|364911317|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105796061|NCT01336608|364911318|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
105796062|NCT01336608|364911319|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
105796063|NCT01336608|364911320|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
105796064|NCT03044431|364911321|FG000|Overall Study|Lost to Follow-up|59|||
105796065|NCT03456726|364911322|FG000|Overall Study|Disease Progression|6|||
105796066|NCT03456726|364911323|FG001|Overall Study|Disease Progression|1|||
105796067|NCT03456726|364911322|FG000|Overall Study|Adverse Event|4|||
105796068|NCT03456726|364911323|FG001|Overall Study|Adverse Event|2|||
105796069|NCT03456726|364911322|FG000|Overall Study|Withdrawal by Subject|1|||
105796070|NCT03456726|364911323|FG001|Overall Study|Withdrawal by Subject|0|||
105796071|NCT03456726|364911322|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
105796072|NCT03456726|364911323|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
105796073|NCT04470622|364911324|FG000|Overall Study|Withdrawal by Subject|0|||
105796074|NCT04470622|364911325|FG001|Overall Study|Withdrawal by Subject|1|||
105796075|NCT04470622|364911324|FG000|Overall Study|Screen Failure|0|||
105796076|NCT04470622|364911325|FG001|Overall Study|Screen Failure|1|||
105796077|NCT04470622|364911324|FG000|Overall Study|Death|0|||
105796078|NCT04470622|364911325|FG001|Overall Study|Death|1|||
105796079|NCT02437890|364911326|FG000|Overall Study|Non-compliance to study drug|0|||
105796080|NCT02437890|364911327|FG001|Overall Study|Non-compliance to study drug|1|||
105796081|NCT02437890|364911328|FG002|Overall Study|Non-compliance to study drug|0|||
105796082|NCT02437890|364911329|FG003|Overall Study|Non-compliance to study drug|0|||
105796083|NCT02437890|364911330|FG004|Overall Study|Non-compliance to study drug|1|||
105796084|NCT02437890|364911326|FG000|Overall Study|Sponsor's decision|1|||
105796085|NCT02437890|364911327|FG001|Overall Study|Sponsor's decision|1|||
105796086|NCT02437890|364911328|FG002|Overall Study|Sponsor's decision|4|||
105796087|NCT02437890|364911329|FG003|Overall Study|Sponsor's decision|0|||
105796088|NCT02437890|364911330|FG004|Overall Study|Sponsor's decision|2|||
105796089|NCT02437890|364911326|FG000|Overall Study|Physician Decision|0|||
105796090|NCT02437890|364911327|FG001|Overall Study|Physician Decision|0|||
105796091|NCT02437890|364911328|FG002|Overall Study|Physician Decision|0|||
105796092|NCT02437890|364911329|FG003|Overall Study|Physician Decision|1|||
105796093|NCT02437890|364911330|FG004|Overall Study|Physician Decision|0|||
105796094|NCT02437890|364911326|FG000|Overall Study|Unable to attend visit(s)|1|||
105796095|NCT02437890|364911327|FG001|Overall Study|Unable to attend visit(s)|0|||
105796096|NCT02437890|364911328|FG002|Overall Study|Unable to attend visit(s)|0|||
105796097|NCT02437890|364911329|FG003|Overall Study|Unable to attend visit(s)|0|||
105796098|NCT02437890|364911330|FG004|Overall Study|Unable to attend visit(s)|0|||
105729113|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729114|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729115|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729116|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
105729117|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729118|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729119|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729120|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105796099|NCT02437890|364911326|FG000|Overall Study|Lack of Efficacy|1|||
105796100|NCT02437890|364911327|FG001|Overall Study|Lack of Efficacy|3|||
105796101|NCT02437890|364911328|FG002|Overall Study|Lack of Efficacy|0|||
105796102|NCT02437890|364911329|FG003|Overall Study|Lack of Efficacy|3|||
105729121|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729122|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105796103|NCT02437890|364911330|FG004|Overall Study|Lack of Efficacy|1|||
105796104|NCT02437890|364911326|FG000|Overall Study|Adverse Event|4|||
105796105|NCT02437890|364911327|FG001|Overall Study|Adverse Event|9|||
105796106|NCT02437890|364911328|FG002|Overall Study|Adverse Event|5|||
105796107|NCT02437890|364911329|FG003|Overall Study|Adverse Event|11|||
105796108|NCT02437890|364911330|FG004|Overall Study|Adverse Event|7|||
105796109|NCT02437890|364911326|FG000|Overall Study|Withdrawal by Subject|1|||
105937518|NCT03757715|365431501|FG001|Overall Study|Lost to Follow-up|9|||
105937519|NCT03757715|365431500|FG000|Overall Study|Withdrawal by Subject|1|||
105796110|NCT02437890|364911327|FG001|Overall Study|Withdrawal by Subject|2|||
105796111|NCT02437890|364911328|FG002|Overall Study|Withdrawal by Subject|6|||
105796112|NCT02437890|364911329|FG003|Overall Study|Withdrawal by Subject|5|||
105796113|NCT02437890|364911330|FG004|Overall Study|Withdrawal by Subject|5|||
105796114|NCT02437890|364911326|FG000|Overall Study|Death|0|||
105796115|NCT02437890|364911327|FG001|Overall Study|Death|0|||
105796116|NCT02437890|364911328|FG002|Overall Study|Death|0|||
105796117|NCT02437890|364911329|FG003|Overall Study|Death|2|||
105796118|NCT02437890|364911330|FG004|Overall Study|Death|0|||
105796119|NCT02328547|364911331|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
105796120|NCT02328547|364911332|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
106139029|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
105729123|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
105729124|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729125|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729126|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729127|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729128|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729129|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
105729130|NCT03874234|364662729|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729131|NCT03874234|364662730|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729132|NCT03874234|364662731|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729133|NCT03874234|364662732|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729134|NCT03874234|364662733|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
105729135|NCT03874234|364662734|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729136|NCT03874234|364662735|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729137|NCT03874234|364662736|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729138|NCT03874234|364662737|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729139|NCT03874234|364662738|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729140|NCT03874234|364662739|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729141|NCT03874234|364662740|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729142|NCT03874234|364662741|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
105729143|NCT02799381|364662749|FG000|Overall Study|Withdrew consent|3|||
105729144|NCT02799381|364662750|FG001|Overall Study|Withdrew consent|2|||
105729145|NCT02799381|364662749|FG000|Overall Study|Adverse Event|0|||
105729146|NCT02799381|364662750|FG001|Overall Study|Adverse Event|1|||
105729147|NCT02799381|364662749|FG000|Overall Study|Participant did not take any study drug|1|||
105729148|NCT02799381|364662750|FG001|Overall Study|Participant did not take any study drug|0|||
105729149|NCT00783289|364662751|FG000|Overall Study|Protocol Violation|0|||
105729150|NCT00783289|364662752|FG001|Overall Study|Protocol Violation|1|||
105729151|NCT00783289|364662753|FG002|Overall Study|Protocol Violation|0|||
105729152|NCT00783289|364662754|FG003|Overall Study|Protocol Violation|0|||
105729153|NCT03952130|364662756|FG000|Overall Study|Adverse Event|0|||
105729154|NCT03952130|364662757|FG001|Overall Study|Adverse Event|1|||
105729155|NCT03952130|364662756|FG000|Overall Study|Lost to Follow-up|1|||
105729156|NCT03952130|364662757|FG001|Overall Study|Lost to Follow-up|0|||
105729157|NCT03952130|364662756|FG000|Overall Study|Withdrawal by Subject|1|||
105729158|NCT03952130|364662757|FG001|Overall Study|Withdrawal by Subject|5|||
105729159|NCT00506389|364662758|FG000|In-treatment Period|Other|3|||
105729160|NCT00506389|364662759|FG001|In-treatment Period|Other|3|||
105729161|NCT00506389|364662760|FG002|In-treatment Period|Other|4|||
105729162|NCT00506389|364662758|FG000|In-treatment Period|Lost to Follow-up|0|||
105729163|NCT00506389|364662759|FG001|In-treatment Period|Lost to Follow-up|0|||
105729164|NCT00506389|364662760|FG002|In-treatment Period|Lost to Follow-up|1|||
105729165|NCT00506389|364662758|FG000|In-treatment Period|Lack of compliance|1|||
105729166|NCT00506389|364662759|FG001|In-treatment Period|Lack of compliance|0|||
105729167|NCT00506389|364662760|FG002|In-treatment Period|Lack of compliance|0|||
105729168|NCT00506389|364662758|FG000|In-treatment Period|Reasons not related to trial|4|||
105729169|NCT00506389|364662759|FG001|In-treatment Period|Reasons not related to trial|1|||
105729170|NCT00506389|364662760|FG002|In-treatment Period|Reasons not related to trial|0|||
105729171|NCT00506389|364662758|FG000|In-treatment Period|Withdrawal by Subject|3|||
106139030|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
106139031|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
105729172|NCT00506389|364662759|FG001|In-treatment Period|Withdrawal by Subject|3|||
105729173|NCT00506389|364662760|FG002|In-treatment Period|Withdrawal by Subject|4|||
105729174|NCT00506389|364662758|FG000|In-treatment Period|Lack of Efficacy|0|||
105729175|NCT00506389|364662759|FG001|In-treatment Period|Lack of Efficacy|2|||
105729176|NCT00506389|364662760|FG002|In-treatment Period|Lack of Efficacy|0|||
105729177|NCT00506389|364662758|FG000|In-treatment Period|Adverse Event|11|||
105729178|NCT00506389|364662759|FG001|In-treatment Period|Adverse Event|5|||
105729179|NCT00506389|364662760|FG002|In-treatment Period|Adverse Event|2|||
105796121|NCT02328547|364911331|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
105796122|NCT02328547|364911332|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
105729180|NCT00506389|364662758|FG000|In-treatment Period|Randomized but not treated|4|||
105729181|NCT00506389|364662759|FG001|In-treatment Period|Randomized but not treated|1|||
105729182|NCT00506389|364662760|FG002|In-treatment Period|Randomized but not treated|1|||
105729183|NCT00265941|364662763|FG000|Overall Study|Protocol Violation|22|||
105729184|NCT00265941|364662764|FG001|Overall Study|Protocol Violation|25|||
105729185|NCT00265941|364662763|FG000|Overall Study|Lost to Follow-up|1|||
105729186|NCT00265941|364662764|FG001|Overall Study|Lost to Follow-up|1|||
105729187|NCT01381094|364662765|FG000|Overall Study|Adverse Event|1|||
105729188|NCT01381094|364662766|FG001|Overall Study|Adverse Event|2|||
105729189|NCT01381094|364662767|FG002|Overall Study|Adverse Event|0|||
105729190|NCT01381094|364662768|FG003|Overall Study|Adverse Event|1|||
105729191|NCT01381094|364662769|FG004|Overall Study|Adverse Event|0|||
105729192|NCT01381094|364662765|FG000|Overall Study|Lost to Follow-up|0|||
105729193|NCT01381094|364662766|FG001|Overall Study|Lost to Follow-up|0|||
105729194|NCT01381094|364662767|FG002|Overall Study|Lost to Follow-up|0|||
105729195|NCT01381094|364662768|FG003|Overall Study|Lost to Follow-up|0|||
105729196|NCT01381094|364662769|FG004|Overall Study|Lost to Follow-up|1|||
105729197|NCT01381094|364662765|FG000|Overall Study|Withdrawal of informed consent|0|||
105729198|NCT01381094|364662766|FG001|Overall Study|Withdrawal of informed consent|1|||
105729199|NCT01381094|364662767|FG002|Overall Study|Withdrawal of informed consent|0|||
105729200|NCT01381094|364662768|FG003|Overall Study|Withdrawal of informed consent|0|||
105729201|NCT01381094|364662769|FG004|Overall Study|Withdrawal of informed consent|0|||
105729202|NCT01381094|364662765|FG000|Overall Study|Participant given Aranesp injection|1|||
105729203|NCT01381094|364662766|FG001|Overall Study|Participant given Aranesp injection|0|||
105729204|NCT01381094|364662767|FG002|Overall Study|Participant given Aranesp injection|0|||
105729205|NCT01381094|364662768|FG003|Overall Study|Participant given Aranesp injection|0|||
105729206|NCT01381094|364662769|FG004|Overall Study|Participant given Aranesp injection|0|||
105729207|NCT02900092|364662772|FG000|Overall Study|Adverse Event|1|||
105729208|NCT05408858|364662773|FG000|Overall Study|no longer met eligibility criteria|1|||
105729209|NCT00817414|364662776|FG000|Overall Study|Adverse Event|1|||
105729210|NCT00817414|364662777|FG001|Overall Study|Adverse Event|1|||
105729211|NCT00817414|364662778|FG002|Overall Study|Adverse Event|1|||
105937520|NCT03757715|365431501|FG001|Overall Study|Withdrawal by Subject|1|||
105937521|NCT04985682|365431502|FG000|Overall Study|Withdrawal by Subject|1|||
105937522|NCT04829214|365431508|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
105937523|NCT04829214|365431509|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
105937524|NCT04829214|365431508|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
105937525|NCT04829214|365431509|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
105937526|NCT04135352|365431510|FG000|Overall Study|Not treated-randomization error|0|||
105937527|NCT04135352|365431511|FG001|Overall Study|Not treated-randomization error|0|||
105937528|NCT04135352|365431512|FG002|Overall Study|Not treated-randomization error|1|||
105937529|NCT04135352|365431513|FG003|Overall Study|Not treated-randomization error|0|||
105937530|NCT04135352|365431514|FG004|Overall Study|Not treated-randomization error|0|||
105937531|NCT04135352|365431515|FG005|Overall Study|Not treated-randomization error|0|||
105937532|NCT04135352|365431516|FG006|Overall Study|Not treated-randomization error|0|||
105937533|NCT04135352|365431517|FG007|Overall Study|Not treated-randomization error|0|||
105937534|NCT04135352|365431510|FG000|Overall Study|Withdrawal by Subject|0|||
105937535|NCT04135352|365431511|FG001|Overall Study|Withdrawal by Subject|0|||
105937536|NCT04135352|365431512|FG002|Overall Study|Withdrawal by Subject|2|||
105937537|NCT04135352|365431513|FG003|Overall Study|Withdrawal by Subject|0|||
105937538|NCT04135352|365431514|FG004|Overall Study|Withdrawal by Subject|0|||
105937539|NCT04135352|365431515|FG005|Overall Study|Withdrawal by Subject|0|||
105937540|NCT04135352|365431516|FG006|Overall Study|Withdrawal by Subject|0|||
105937541|NCT04135352|365431517|FG007|Overall Study|Withdrawal by Subject|0|||
105937542|NCT04135352|365431510|FG000|Overall Study|Sponsor Decision|0|||
105937543|NCT04135352|365431511|FG001|Overall Study|Sponsor Decision|0|||
105937544|NCT04135352|365431512|FG002|Overall Study|Sponsor Decision|2|||
105937545|NCT04135352|365431513|FG003|Overall Study|Sponsor Decision|5|||
105937546|NCT04135352|365431514|FG004|Overall Study|Sponsor Decision|1|||
105937547|NCT04135352|365431515|FG005|Overall Study|Sponsor Decision|4|||
105937548|NCT04135352|365431516|FG006|Overall Study|Sponsor Decision|0|||
105937549|NCT04135352|365431517|FG007|Overall Study|Sponsor Decision|0|||
105937550|NCT04135352|365431510|FG000|Overall Study|Physician Decision|0|||
105729212|NCT00817414|364662779|FG003|Overall Study|Adverse Event|0|||
105796123|NCT02414854|364911333|FG000|Overall Study|Adverse Event|9|||
105937551|NCT04135352|365431511|FG001|Overall Study|Physician Decision|0|||
105729213|NCT00817414|364662780|FG004|Overall Study|Adverse Event|0|||
105729214|NCT00817414|364662776|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
105729215|NCT00817414|364662777|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
105729216|NCT00817414|364662778|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
105729217|NCT00817414|364662779|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
105729218|NCT00817414|364662780|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
105937552|NCT04135352|365431512|FG002|Overall Study|Physician Decision|1|||
105937553|NCT04135352|365431513|FG003|Overall Study|Physician Decision|0|||
105729219|NCT00817414|364662776|FG000|Overall Study|Withdrawal by Subject|1|||
105729220|NCT00817414|364662777|FG001|Overall Study|Withdrawal by Subject|1|||
105729221|NCT00817414|364662778|FG002|Overall Study|Withdrawal by Subject|0|||
105729222|NCT00817414|364662779|FG003|Overall Study|Withdrawal by Subject|0|||
105729223|NCT00817414|364662780|FG004|Overall Study|Withdrawal by Subject|0|||
105729224|NCT00817414|364662776|FG000|Overall Study|Lost to Follow-up|0|||
105729225|NCT00817414|364662777|FG001|Overall Study|Lost to Follow-up|0|||
105729226|NCT00817414|364662778|FG002|Overall Study|Lost to Follow-up|1|||
105729227|NCT00817414|364662779|FG003|Overall Study|Lost to Follow-up|1|||
105729228|NCT00817414|364662780|FG004|Overall Study|Lost to Follow-up|1|||
105729229|NCT00817414|364662776|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
105729230|NCT00817414|364662777|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
105729231|NCT00817414|364662778|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
105729232|NCT00817414|364662779|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
105729233|NCT00817414|364662780|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
105729234|NCT00817414|364662776|FG000|Overall Study|Protocol Violation|0|||
105729235|NCT00817414|364662777|FG001|Overall Study|Protocol Violation|0|||
105729236|NCT00817414|364662778|FG002|Overall Study|Protocol Violation|0|||
105729237|NCT00817414|364662779|FG003|Overall Study|Protocol Violation|0|||
105729238|NCT00817414|364662780|FG004|Overall Study|Protocol Violation|1|||
105729239|NCT02586805|364662784|FG000|Overall Study|Withdrawal by Subject|3|||
105729240|NCT02586805|364662785|FG001|Overall Study|Withdrawal by Subject|1|||
105729241|NCT02586805|364662786|FG002|Overall Study|Withdrawal by Subject|1|||
105729242|NCT02586805|364662787|FG003|Overall Study|Withdrawal by Subject|2|||
105729243|NCT02586805|364662784|FG000|Overall Study|Adverse Event|2|||
105729244|NCT02586805|364662785|FG001|Overall Study|Adverse Event|0|||
105729245|NCT02586805|364662786|FG002|Overall Study|Adverse Event|1|||
105729246|NCT02586805|364662787|FG003|Overall Study|Adverse Event|0|||
105729247|NCT02586805|364662784|FG000|Overall Study|Lost to Follow-up|0|||
105729248|NCT02586805|364662785|FG001|Overall Study|Lost to Follow-up|0|||
105729249|NCT02586805|364662786|FG002|Overall Study|Lost to Follow-up|1|||
105729250|NCT02586805|364662787|FG003|Overall Study|Lost to Follow-up|0|||
105729251|NCT02586805|364662784|FG000|Overall Study|Physician Decision|1|||
105729252|NCT02586805|364662785|FG001|Overall Study|Physician Decision|0|||
105729253|NCT02586805|364662786|FG002|Overall Study|Physician Decision|0|||
105729254|NCT02586805|364662787|FG003|Overall Study|Physician Decision|0|||
105729255|NCT02504541|364662795|FG000|Overall Study|Adverse Event|4|||
105729256|NCT02504541|364662795|FG000|Overall Study|Withdrawal by Subject|4|||
105729257|NCT02504541|364662795|FG000|Overall Study|Lost to Follow-up|1|||
105729258|NCT02504541|364662795|FG000|Overall Study|Met Stopping Criteria|1|||
105729259|NCT02504541|364662795|FG000|Overall Study|Protocol Violation|2|||
105729260|NCT02504541|364662795|FG000|Overall Study|Termination by Sponsor|1|||
105729261|NCT02504541|364662795|FG000|Overall Study|Other|2|||
105729262|NCT02504541|364662795|FG000|Overall Study|Multiple|5|||
105729263|NCT03182738|364662801|FG000|Overall Study|Lost to Follow-up|9|||
105729264|NCT03182738|364662802|FG001|Overall Study|Lost to Follow-up|3|||
105729265|NCT03182738|364662801|FG000|Overall Study|Pregnancy|0|||
105729266|NCT03182738|364662802|FG001|Overall Study|Pregnancy|1|||
105729267|NCT03182738|364662801|FG000|Overall Study|Withdrawal by Subject|0|||
105729268|NCT03182738|364662802|FG001|Overall Study|Withdrawal by Subject|1|||
105729269|NCT00356915|364662803|FG000|Overall Study|Non compliance|1|||
105729270|NCT00356915|364662804|FG001|Overall Study|Non compliance|2|||
105729271|NCT00356915|364662805|FG002|Overall Study|Non compliance|1|||
105729272|NCT00356915|364662803|FG000|Overall Study|Protocol Violation|2|||
105729273|NCT00356915|364662804|FG001|Overall Study|Protocol Violation|3|||
105729274|NCT00356915|364662805|FG002|Overall Study|Protocol Violation|2|||
105729275|NCT00356915|364662803|FG000|Overall Study|Withdrawal by Subject|14|||
105729276|NCT00356915|364662804|FG001|Overall Study|Withdrawal by Subject|14|||
105729277|NCT00356915|364662805|FG002|Overall Study|Withdrawal by Subject|10|||
106139032|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
106139033|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
105729278|NCT00356915|364662803|FG000|Overall Study|Lack of Efficacy|0|||
105729279|NCT00356915|364662804|FG001|Overall Study|Lack of Efficacy|0|||
105729280|NCT00356915|364662805|FG002|Overall Study|Lack of Efficacy|3|||
106139034|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
106139035|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
105729281|NCT00356915|364662803|FG000|Overall Study|Lost to Follow-up|27|||
105729282|NCT00356915|364662804|FG001|Overall Study|Lost to Follow-up|34|||
105729283|NCT00356915|364662805|FG002|Overall Study|Lost to Follow-up|14|||
105729284|NCT00356915|364662803|FG000|Overall Study|Administrative Decision|0|||
105729285|NCT00356915|364662804|FG001|Overall Study|Administrative Decision|0|||
105729286|NCT00356915|364662805|FG002|Overall Study|Administrative Decision|1|||
105729287|NCT00356915|364662803|FG000|Overall Study|Physician Decision|0|||
105729288|NCT00356915|364662804|FG001|Overall Study|Physician Decision|2|||
105729289|NCT00356915|364662805|FG002|Overall Study|Physician Decision|0|||
105729290|NCT00356915|364662803|FG000|Overall Study|Adverse Event|21|||
105729291|NCT00356915|364662804|FG001|Overall Study|Adverse Event|31|||
105729292|NCT00356915|364662805|FG002|Overall Study|Adverse Event|8|||
105796124|NCT02414854|364911334|FG001|Overall Study|Adverse Event|7|||
105796125|NCT02414854|364911335|FG002|Overall Study|Adverse Event|1|||
105796126|NCT02414854|364911336|FG003|Overall Study|Adverse Event|12|||
105796127|NCT02414854|364911333|FG000|Overall Study|Poor compliance to protocol|1|||
105796128|NCT02414854|364911334|FG001|Overall Study|Poor compliance to protocol|1|||
105796129|NCT02414854|364911335|FG002|Overall Study|Poor compliance to protocol|2|||
105796130|NCT02414854|364911336|FG003|Overall Study|Poor compliance to protocol|2|||
105796131|NCT02414854|364911333|FG000|Overall Study|Other than specified above|12|||
105796132|NCT02414854|364911334|FG001|Overall Study|Other than specified above|37|||
105796133|NCT02414854|364911335|FG002|Overall Study|Other than specified above|17|||
105796134|NCT02414854|364911336|FG003|Overall Study|Other than specified above|37|||
105796135|NCT02576054|364911337|FG000|Overall Study|Withdrawal by Subject|1|||
105796136|NCT00344305|364911341|FG000|Overall Study|Lost to Follow-up|2|||
105796137|NCT00344305|364911342|FG001|Overall Study|Lost to Follow-up|0|||
105796138|NCT00344305|364911341|FG000|Overall Study|Participant was not contacted in window|0|||
105796139|NCT00344305|364911342|FG001|Overall Study|Participant was not contacted in window|1|||
105796140|NCT01190098|364911343|FG000|Overall Study|Adverse Event|2|||
105796141|NCT01190098|364911344|FG001|Overall Study|Adverse Event|0|||
105796142|NCT01190098|364911343|FG000|Overall Study|Patient coomorbidity|0|||
105796143|NCT01190098|364911344|FG001|Overall Study|Patient coomorbidity|1|||
105796144|NCT01190098|364911343|FG000|Overall Study|Lack of transportation|1|||
105796145|NCT01190098|364911344|FG001|Overall Study|Lack of transportation|0|||
105796146|NCT01190098|364911343|FG000|Overall Study|Other|0|||
105796147|NCT01190098|364911344|FG001|Overall Study|Other|1|||
105796148|NCT02957682|364911345|FG000|Overall Study|Adverse Event|64|||
105796149|NCT02957682|364911346|FG001|Overall Study|Adverse Event|67|||
105796150|NCT02957682|364911345|FG000|Overall Study|Poor Compliance to Protocol|30|||
105796151|NCT02957682|364911346|FG001|Overall Study|Poor Compliance to Protocol|26|||
105796152|NCT02957682|364911345|FG000|Overall Study|Physician Decision|4|||
105796153|NCT02957682|364911346|FG001|Overall Study|Physician Decision|4|||
105796154|NCT02957682|364911345|FG000|Overall Study|Study Terminated by Sponsor|4|||
105796155|NCT02957682|364911346|FG001|Overall Study|Study Terminated by Sponsor|3|||
105796156|NCT02957682|364911345|FG000|Overall Study|Subject Moved|10|||
105796157|NCT02957682|364911346|FG001|Overall Study|Subject Moved|16|||
105796158|NCT02957682|364911345|FG000|Overall Study|Withdrawal by Subject|64|||
105796159|NCT02957682|364911346|FG001|Overall Study|Withdrawal by Subject|33|||
105796160|NCT02957682|364911345|FG000|Overall Study|Related to IMP Administration|3|||
105796161|NCT02957682|364911346|FG001|Overall Study|Related to IMP Administration|6|||
105796162|NCT02957682|364911345|FG000|Overall Study|Non-disclosed|16|||
105796163|NCT02957682|364911346|FG001|Overall Study|Non-disclosed|12|||
105796164|NCT02957682|364911345|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
105796165|NCT02957682|364911346|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
105796166|NCT00606801|364911348|FG000|Intervention|Protocol Violation|3|||
105796167|NCT00606801|364911349|FG001|Intervention|Protocol Violation|3|||
105796168|NCT02082262|364911350|FG000|Overall Study|Withdrawal by Subject|3|||
105796169|NCT02082262|364911350|FG000|Overall Study|Adverse Event|48|||
105796170|NCT00740480|364911353|FG000|Overall Study|Adverse Event|1|||
105796171|NCT00740480|364911353|FG000|Overall Study|Physician Decision|1|||
105796172|NCT01222715|364911358|FG000|Overall Study|Adverse Event|0|||
105796173|NCT01222715|364911359|FG001|Overall Study|Adverse Event|4|||
105796174|NCT01222715|364911358|FG000|Overall Study|Death|0|||
105796175|NCT01222715|364911359|FG001|Overall Study|Death|1|||
105796176|NCT01222715|364911358|FG000|Overall Study|Lack of Efficacy|22|||
105796177|NCT01222715|364911359|FG001|Overall Study|Lack of Efficacy|14|||
105796178|NCT01222715|364911358|FG000|Overall Study|Physician Decision|12|||
105796179|NCT01222715|364911359|FG001|Overall Study|Physician Decision|2|||
105796180|NCT01222715|364911358|FG000|Overall Study|Refusal of further protocol therapy|0|||
105796181|NCT01222715|364911359|FG001|Overall Study|Refusal of further protocol therapy|4|||
105796182|NCT01222715|364911358|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
105796183|NCT01222715|364911359|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
105796184|NCT01222715|364911358|FG000|Overall Study|Ineligible|0|||
105796185|NCT01222715|364911359|FG001|Overall Study|Ineligible|1|||
105796186|NCT01222715|364911358|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
106139036|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
105796187|NCT01222715|364911359|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
105796188|NCT01508325|364911360|FG000|Overall Study|Withdrawal by Subject|8|||
105937554|NCT04135352|365431514|FG004|Overall Study|Physician Decision|1|||
105796189|NCT01508325|364911361|FG001|Overall Study|Withdrawal by Subject|9|||
105796190|NCT01508325|364911360|FG000|Overall Study|Protocol Violation|0|||
105796191|NCT01508325|364911361|FG001|Overall Study|Protocol Violation|3|||
105796192|NCT01508325|364911360|FG000|Overall Study|Physician Decision|2|||
105796193|NCT01508325|364911361|FG001|Overall Study|Physician Decision|1|||
105796194|NCT01508325|364911360|FG000|Overall Study|Adverse Event|1|||
105796195|NCT01508325|364911361|FG001|Overall Study|Adverse Event|0|||
105796196|NCT01508325|364911360|FG000|Overall Study|Lost to Follow-up|5|||
105796197|NCT01508325|364911361|FG001|Overall Study|Lost to Follow-up|6|||
105796198|NCT01508325|364911360|FG000|Overall Study|Other|2|||
106139037|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
106139038|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
106139039|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
106139040|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
106139041|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
106139042|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
106139043|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
106139044|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
106139045|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
106139046|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
105729293|NCT00356915|364662803|FG000|Overall Study|Miscellaneous reasons|11|||
105729294|NCT00356915|364662804|FG001|Overall Study|Miscellaneous reasons|8|||
105729295|NCT00356915|364662805|FG002|Overall Study|Miscellaneous reasons|3|||
105729296|NCT00509106|364662807|FG000|Overall Study|Adverse Event|3|||
105729297|NCT00509106|364662808|FG001|Overall Study|Adverse Event|2|||
105729298|NCT00509106|364662807|FG000|Overall Study|Noncompliance|0|||
105729299|NCT00509106|364662808|FG001|Overall Study|Noncompliance|1|||
105729300|NCT00509106|364662807|FG000|Overall Study|At the request of sponsor/investigator|1|||
105729301|NCT00509106|364662808|FG001|Overall Study|At the request of sponsor/investigator|2|||
105729302|NCT00509106|364662807|FG000|Overall Study|Withdrew consent|4|||
105729303|NCT00509106|364662808|FG001|Overall Study|Withdrew consent|8|||
105729304|NCT00509106|364662807|FG000|Overall Study|Lost to Follow-up|16|||
105729305|NCT00509106|364662808|FG001|Overall Study|Lost to Follow-up|10|||
105729306|NCT00509106|364662807|FG000|Overall Study|Other|1|||
105729307|NCT00509106|364662808|FG001|Overall Study|Other|0|||
105729308|NCT00509106|364662807|FG000|Overall Study|Death|6|||
105729309|NCT00509106|364662808|FG001|Overall Study|Death|6|||
105729310|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
105729311|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
105729312|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
105729313|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
105729314|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
105729315|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
105729316|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
105729317|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
105729318|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
105729319|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
105729320|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Death|0|||
105729321|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Death|0|||
105729322|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Death|0|||
105729323|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Death|0|||
105729324|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Death|0|||
105729325|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Death|1|||
105729326|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Death|0|||
105729327|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Death|0|||
105729328|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Death|0|||
105729329|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Death|0|||
105729330|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
105729331|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
105729332|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
105729333|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
105729334|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
105729335|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
105796199|NCT01508325|364911361|FG001|Overall Study|Other|2|||
105796200|NCT01392170|364911362|FG000|Overall Study|Withdrawal by Subject|1|||
105796201|NCT01392170|364911362|FG000|Overall Study|Ineligible|1|||
105796202|NCT01383954|364911364|FG000|Overall Study|Lack of Efficacy|2|||
105796203|NCT01383954|364911364|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
105796204|NCT01383954|364911364|FG000|Overall Study|Adverse Event|1|||
105796205|NCT01383954|364911364|FG000|Overall Study|Reason Not Specified|9|||
105796206|NCT00450177|364911365|FG000|Overall Study|Adverse Event|7|||
106139047|NCT01212757|366167065|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
106139048|NCT01212757|366167066|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
105729336|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
105729337|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
105729338|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
105729339|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
105729340|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
105729341|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
105796207|NCT00450177|364911366|FG001|Overall Study|Adverse Event|4|||
105796208|NCT00450177|364911365|FG000|Overall Study|Withdrawal by Subject|1|||
105937555|NCT04135352|365431515|FG005|Overall Study|Physician Decision|0|||
105937556|NCT04135352|365431516|FG006|Overall Study|Physician Decision|0|||
105729342|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
105729343|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729344|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
105729345|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
105729346|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729347|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729348|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729349|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
105729350|NCT00488631|364662820|FG000|Double Blind Period (Week 0-54)|Other|6|||
105729351|NCT00488631|364662821|FG001|Double Blind Period (Week 0-54)|Other|12|||
105729352|NCT00488631|364662822|FG002|Double Blind Period (Week 0-54)|Other|10|||
105729353|NCT00488631|364662823|FG003|Double Blind Period (Week 0-54)|Other|11|||
105729354|NCT00488631|364662824|FG004|Double Blind Period (Week 0-54)|Other|14|||
105729355|NCT00488631|364662825|FG005|Double Blind Period (Week 0-54)|Other|34|||
105729356|NCT00488631|364662826|FG006|Double Blind Period (Week 0-54)|Other|0|||
105729357|NCT00488631|364662827|FG007|Double Blind Period (Week 0-54)|Other|0|||
105729358|NCT00488631|364662828|FG008|Double Blind Period (Week 0-54)|Other|0|||
105729359|NCT00488631|364662829|FG009|Double Blind Period (Week 0-54)|Other|0|||
105729360|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729361|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729362|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729363|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729364|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729365|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729366|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
105729367|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
105729368|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
105729369|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
105729370|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
105729371|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
105729372|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
105729373|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
105729374|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
105729375|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
105729376|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
105729377|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
105729378|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
105729379|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
105729380|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729381|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729382|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729383|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729384|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729385|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
105729386|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
105729387|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
105729388|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
105729389|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
105729390|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729391|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729392|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729393|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729394|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729395|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729396|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
105729397|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105729398|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
105729399|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
105937557|NCT04135352|365431517|FG007|Overall Study|Physician Decision|0|||
105937558|NCT04135352|365431510|FG000|Overall Study|Death|3|||
105937559|NCT04135352|365431511|FG001|Overall Study|Death|4|||
106139049|NCT01212757|366167067|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
106139050|NCT01212757|366167068|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105937560|NCT04135352|365431512|FG002|Overall Study|Death|7|||
105937561|NCT04135352|365431513|FG003|Overall Study|Death|0|||
105796209|NCT00450177|364911366|FG001|Overall Study|Withdrawal by Subject|6|||
105796210|NCT00450177|364911365|FG000|Overall Study|Withdrawal by Primary Team|1|||
105796211|NCT00450177|364911366|FG001|Overall Study|Withdrawal by Primary Team|1|||
105796212|NCT04056299|364911375|FG000|Overall Study|Sponsor discontinued study|3|||
105796213|NCT04056299|364911376|FG001|Overall Study|Sponsor discontinued study|3|||
105796214|NCT01227954|364911377|FG000|Overall Study|Protocol Violation|6|||
105796215|NCT01227954|364911377|FG000|Overall Study|No protocol treatment|7|||
105796216|NCT01791127|364911380|FG000|Overall Study|Death|356|||
105796217|NCT01791127|364911380|FG000|Overall Study|Patient has withdrawn from study|293|||
105796218|NCT01791127|364911380|FG000|Overall Study|Lost to Follow-up|42|||
105796219|NCT01791127|364911380|FG000|Overall Study|All Siello leads are explanted|31|||
105796220|NCT01791127|364911380|FG000|Overall Study|Completion of 30 day safety registry|1|||
105796221|NCT01791127|364911380|FG000|Overall Study|Study terminated for EP Passion|749|||
105796222|NCT03333382|364911381|FG000|Overall Study|Lost to Follow-up|1|||
105796223|NCT03333382|364911382|FG001|Overall Study|Lost to Follow-up|0|||
105796224|NCT04247594|364911383|FG000|Overall Study|Withdrawal by Subject|4|||
105796225|NCT03231709|364911390|FG000|Treatment Period 1|Reason not Specified|0|||
105796226|NCT03231709|364911391|FG001|Treatment Period 1|Reason not Specified|1|||
105796227|NCT03231709|364911390|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
105796228|NCT03231709|364911391|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
105796229|NCT02419469|364911392|FG000|Overall Study|Withdrawal by Subject|1|||
105796230|NCT04991311|364911393|FG000|Overall Study|Adverse Event|1|||
105796231|NCT01238822|364911394|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
105796232|NCT00720304|364911399|FG000|Overall Study|Withdrawal by Subject|14|||
105796233|NCT00720304|364911400|FG001|Overall Study|Withdrawal by Subject|1|||
105796234|NCT00720304|364911399|FG000|Overall Study|Death|1|||
105796235|NCT00720304|364911400|FG001|Overall Study|Death|0|||
105796236|NCT00720304|364911399|FG000|Overall Study|Physician Decision|5|||
105796237|NCT00720304|364911400|FG001|Overall Study|Physician Decision|2|||
105796238|NCT00720304|364911399|FG000|Overall Study|Adverse Event|3|||
105796239|NCT00720304|364911400|FG001|Overall Study|Adverse Event|1|||
105796240|NCT00720304|364911399|FG000|Overall Study|Disease progression|6|||
105796241|NCT00720304|364911400|FG001|Overall Study|Disease progression|1|||
105796242|NCT00996918|364911403|FG000|Overall Study|Lack of Efficacy|1|||
105796243|NCT00996918|364911404|FG001|Overall Study|Lack of Efficacy|1|||
105796244|NCT00996918|364911405|FG002|Overall Study|Lack of Efficacy|2|||
105796245|NCT00996918|364911406|FG003|Overall Study|Lack of Efficacy|2|||
105796246|NCT00996918|364911407|FG004|Overall Study|Lack of Efficacy|0|||
105796247|NCT00996918|364911403|FG000|Overall Study|Adverse Event|2|||
105796248|NCT00996918|364911404|FG001|Overall Study|Adverse Event|5|||
105796249|NCT00996918|364911405|FG002|Overall Study|Adverse Event|2|||
105796250|NCT00996918|364911406|FG003|Overall Study|Adverse Event|6|||
105796251|NCT00996918|364911407|FG004|Overall Study|Adverse Event|0|||
105796252|NCT00996918|364911403|FG000|Overall Study|Withdrawal by Subject|1|||
105796253|NCT00996918|364911404|FG001|Overall Study|Withdrawal by Subject|4|||
105796254|NCT00996918|364911405|FG002|Overall Study|Withdrawal by Subject|3|||
105796255|NCT00996918|364911406|FG003|Overall Study|Withdrawal by Subject|3|||
105796256|NCT00996918|364911407|FG004|Overall Study|Withdrawal by Subject|2|||
105796257|NCT00996918|364911403|FG000|Overall Study|Physician Decision|1|||
105796258|NCT00996918|364911404|FG001|Overall Study|Physician Decision|0|||
105796259|NCT00996918|364911405|FG002|Overall Study|Physician Decision|0|||
105796260|NCT00996918|364911406|FG003|Overall Study|Physician Decision|0|||
105796261|NCT00996918|364911407|FG004|Overall Study|Physician Decision|0|||
105796262|NCT00996918|364911403|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
105796263|NCT00996918|364911404|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
105796264|NCT00996918|364911405|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
105937562|NCT04135352|365431514|FG004|Overall Study|Death|3|||
105937563|NCT04135352|365431515|FG005|Overall Study|Death|1|||
105937564|NCT04135352|365431516|FG006|Overall Study|Death|0|||
106139051|NCT01212757|366167069|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
106139052|NCT01212757|366167070|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
106139053|NCT01212757|366167071|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105796265|NCT00996918|364911406|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
105796266|NCT00996918|364911407|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
105796267|NCT00996918|364911403|FG000|Overall Study|Loss of Caregiver|0|||
105796268|NCT00996918|364911404|FG001|Overall Study|Loss of Caregiver|1|||
105796269|NCT00996918|364911405|FG002|Overall Study|Loss of Caregiver|0|||
105796270|NCT00996918|364911406|FG003|Overall Study|Loss of Caregiver|0|||
105796271|NCT00996918|364911407|FG004|Overall Study|Loss of Caregiver|0|||
105796272|NCT00996918|364911403|FG000|Overall Study|Other|3|||
106139054|NCT01212757|366167072|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
105796273|NCT00996918|364911404|FG001|Overall Study|Other|1|||
105796274|NCT00996918|364911405|FG002|Overall Study|Other|0|||
105796275|NCT00996918|364911406|FG003|Overall Study|Other|0|||
105796276|NCT00996918|364911407|FG004|Overall Study|Other|0|||
105796277|NCT02487979|364911415|FG000|Overall Study|Physician Decision|2|||
105796278|NCT02487979|364911415|FG000|Overall Study|Withdrawal by Subject|2|||
105937565|NCT04135352|365431517|FG007|Overall Study|Death|0|||
105729400|NCT00488631|364662820|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729401|NCT00488631|364662821|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729402|NCT00488631|364662822|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729403|NCT00488631|364662823|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729404|NCT00488631|364662824|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729405|NCT00488631|364662825|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729406|NCT00488631|364662826|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
105729407|NCT00488631|364662827|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
105729408|NCT00488631|364662828|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
105729409|NCT00488631|364662829|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
105729410|NCT01873950|364662830|FG000|Period 5|Withdrawal by Subject|0|||
105729411|NCT01873950|364662831|FG001|Period 5|Withdrawal by Subject|0|||
105729412|NCT01873950|364662832|FG002|Period 5|Withdrawal by Subject|0|||
105729413|NCT01873950|364662833|FG003|Period 5|Withdrawal by Subject|1|||
105729414|NCT01873950|364662834|FG004|Period 5|Withdrawal by Subject|0|||
105729415|NCT01794780|364662836|FG000|Overall Study|Adverse Event|0|||
105729416|NCT01794780|364662837|FG001|Overall Study|Adverse Event|1|||
105729417|NCT01794780|364662838|FG002|Overall Study|Adverse Event|2|||
105729418|NCT01794780|364662839|FG003|Overall Study|Adverse Event|0|||
105729419|NCT01794780|364662840|FG004|Overall Study|Adverse Event|0|||
105729420|NCT01794780|364662841|FG005|Overall Study|Adverse Event|0|||
105729421|NCT01794780|364662842|FG006|Overall Study|Adverse Event|0|||
105729422|NCT01794780|364662843|FG007|Overall Study|Adverse Event|0|||
105729423|NCT01794780|364662836|FG000|Overall Study|Death|0|||
105729424|NCT01794780|364662837|FG001|Overall Study|Death|2|||
105729425|NCT01794780|364662838|FG002|Overall Study|Death|14|||
105729426|NCT01794780|364662839|FG003|Overall Study|Death|1|||
105729427|NCT01794780|364662840|FG004|Overall Study|Death|0|||
105729428|NCT01794780|364662841|FG005|Overall Study|Death|9|||
105729429|NCT01794780|364662842|FG006|Overall Study|Death|4|||
105729430|NCT01794780|364662843|FG007|Overall Study|Death|0|||
105729431|NCT01794780|364662836|FG000|Overall Study|Lost to Follow-up|10|||
105729432|NCT01794780|364662837|FG001|Overall Study|Lost to Follow-up|64|||
105729433|NCT01794780|364662838|FG002|Overall Study|Lost to Follow-up|165|||
105729434|NCT01794780|364662839|FG003|Overall Study|Lost to Follow-up|53|||
105729435|NCT01794780|364662840|FG004|Overall Study|Lost to Follow-up|2|||
105729436|NCT01794780|364662841|FG005|Overall Study|Lost to Follow-up|99|||
105729437|NCT01794780|364662842|FG006|Overall Study|Lost to Follow-up|30|||
105729438|NCT01794780|364662843|FG007|Overall Study|Lost to Follow-up|5|||
105729439|NCT01794780|364662836|FG000|Overall Study|Withdrew informed consent|7|||
105729440|NCT01794780|364662837|FG001|Overall Study|Withdrew informed consent|17|||
105729441|NCT01794780|364662838|FG002|Overall Study|Withdrew informed consent|36|||
105729442|NCT01794780|364662839|FG003|Overall Study|Withdrew informed consent|9|||
105729443|NCT01794780|364662840|FG004|Overall Study|Withdrew informed consent|0|||
105729444|NCT01794780|364662841|FG005|Overall Study|Withdrew informed consent|48|||
105729445|NCT01794780|364662842|FG006|Overall Study|Withdrew informed consent|4|||
105729446|NCT01794780|364662843|FG007|Overall Study|Withdrew informed consent|3|||
105729447|NCT01794780|364662836|FG000|Overall Study|Other|0|||
105729448|NCT01794780|364662837|FG001|Overall Study|Other|12|||
105729449|NCT01794780|364662838|FG002|Overall Study|Other|25|||
105729450|NCT01794780|364662839|FG003|Overall Study|Other|20|||
105729451|NCT01794780|364662840|FG004|Overall Study|Other|1|||
105729452|NCT01794780|364662841|FG005|Overall Study|Other|24|||
105729453|NCT01794780|364662842|FG006|Overall Study|Other|4|||
105729454|NCT01794780|364662843|FG007|Overall Study|Other|1|||
105729455|NCT00824421|364662844|FG000|Overall Study|Adverse Event|6|||
105729456|NCT00824421|364662845|FG001|Overall Study|Adverse Event|6|||
105729457|NCT00824421|364662846|FG002|Overall Study|Adverse Event|6|||
105729458|NCT00824421|364662844|FG000|Overall Study|Death|0|||
105729459|NCT00824421|364662845|FG001|Overall Study|Death|1|||
105729460|NCT00824421|364662846|FG002|Overall Study|Death|0|||
105729461|NCT00824421|364662844|FG000|Overall Study|Lack of Efficacy|5|||
105729462|NCT00824421|364662845|FG001|Overall Study|Lack of Efficacy|7|||
105729463|NCT00824421|364662846|FG002|Overall Study|Lack of Efficacy|4|||
105796279|NCT02487979|364911415|FG000|Overall Study|Progressive Disease|17|||
105729464|NCT00824421|364662844|FG000|Overall Study|Lost to Follow-up|2|||
105729465|NCT00824421|364662845|FG001|Overall Study|Lost to Follow-up|3|||
105729466|NCT00824421|364662846|FG002|Overall Study|Lost to Follow-up|0|||
105729467|NCT00824421|364662844|FG000|Overall Study|Pregnancy|1|||
105729468|NCT00824421|364662845|FG001|Overall Study|Pregnancy|0|||
105729469|NCT00824421|364662846|FG002|Overall Study|Pregnancy|1|||
105729470|NCT00824421|364662844|FG000|Overall Study|Withdrawal by Subject|2|||
105729471|NCT00824421|364662845|FG001|Overall Study|Withdrawal by Subject|3|||
105729472|NCT00824421|364662846|FG002|Overall Study|Withdrawal by Subject|3|||
105729473|NCT00824421|364662844|FG000|Overall Study|Randomized but not Treated|1|||
105729474|NCT00824421|364662845|FG001|Overall Study|Randomized but not Treated|1|||
105729475|NCT00824421|364662846|FG002|Overall Study|Randomized but not Treated|0|||
105796280|NCT04333199|364911418|FG000|Evaluated Patients|Lost to Follow-up|0|||
105729476|NCT00824421|364662844|FG000|Overall Study|Other|0|||
105796281|NCT04333199|364911419|FG001|Evaluated Patients|Lost to Follow-up|1|||
105796282|NCT04333199|364911420|FG002|Evaluated Patients|Lost to Follow-up|2|||
105796283|NCT00627458|364911421|FG000|Overall Study|Migrated from study area|1|||
105796284|NCT00627458|364911422|FG001|Overall Study|Migrated from study area|0|||
105796285|NCT00627458|364911423|FG002|Overall Study|Migrated from study area|1|||
105796286|NCT00627458|364911421|FG000|Overall Study|Withdrawal by Subject|2|||
105796287|NCT00627458|364911422|FG001|Overall Study|Withdrawal by Subject|6|||
105796288|NCT00627458|364911423|FG002|Overall Study|Withdrawal by Subject|5|||
105796289|NCT00627458|364911421|FG000|Overall Study|Lost to Follow-up|1|||
105796290|NCT00627458|364911422|FG001|Overall Study|Lost to Follow-up|1|||
105796291|NCT00627458|364911423|FG002|Overall Study|Lost to Follow-up|0|||
105796292|NCT00963599|364911427|FG000|Overall Study|Adverse Event|2|||
105796293|NCT00963599|364911428|FG001|Overall Study|Adverse Event|0|||
105796294|NCT00963599|364911429|FG002|Overall Study|Adverse Event|1|||
105796295|NCT00963599|364911430|FG003|Overall Study|Adverse Event|2|||
105796296|NCT00963599|364911427|FG000|Overall Study|Lack of Efficacy|0|||
105796297|NCT00963599|364911428|FG001|Overall Study|Lack of Efficacy|2|||
105796298|NCT00963599|364911429|FG002|Overall Study|Lack of Efficacy|1|||
105796299|NCT00963599|364911430|FG003|Overall Study|Lack of Efficacy|4|||
105796300|NCT00963599|364911427|FG000|Overall Study|Lost to Follow-up|0|||
105796301|NCT00963599|364911428|FG001|Overall Study|Lost to Follow-up|1|||
105796302|NCT00963599|364911429|FG002|Overall Study|Lost to Follow-up|1|||
105796303|NCT00963599|364911430|FG003|Overall Study|Lost to Follow-up|1|||
105796304|NCT00963599|364911427|FG000|Overall Study|Protocol Violation|2|||
105796305|NCT00963599|364911428|FG001|Overall Study|Protocol Violation|2|||
105796306|NCT00963599|364911429|FG002|Overall Study|Protocol Violation|3|||
105796307|NCT00963599|364911430|FG003|Overall Study|Protocol Violation|4|||
105796308|NCT00963599|364911427|FG000|Overall Study|Withdrawal by Subject|2|||
105796309|NCT00963599|364911428|FG001|Overall Study|Withdrawal by Subject|1|||
105796310|NCT00963599|364911429|FG002|Overall Study|Withdrawal by Subject|3|||
105796311|NCT00963599|364911430|FG003|Overall Study|Withdrawal by Subject|3|||
105796312|NCT03959137|364911431|FG000|Overall Study|Protocol Violation|6|||
105796313|NCT00190684|364911435|FG000|Overall Study|Adverse Event|86|||
105796314|NCT00190684|364911435|FG000|Overall Study|Satisfactory response|80|||
105796315|NCT00190684|364911435|FG000|Overall Study|Lack of efficacy|204|||
105796316|NCT00190684|364911435|FG000|Overall Study|Lost to Follow-up|232|||
105796317|NCT00190684|364911435|FG000|Overall Study|Patient moved|60|||
105796318|NCT00190684|364911435|FG000|Overall Study|Patient Decision|432|||
105796319|NCT00190684|364911435|FG000|Overall Study|Clinical relapse|67|||
105796320|NCT00190684|364911435|FG000|Overall Study|Sponsor's decision|17|||
105796321|NCT00190684|364911435|FG000|Overall Study|Physician Decision|84|||
105796322|NCT00190684|364911435|FG000|Overall Study|Protocol Violation|123|||
105796323|NCT00190684|364911435|FG000|Overall Study|Study Period III Completed|103|||
105796324|NCT00190684|364911435|FG000|Overall Study|Study Period V Completed|1|||
105796325|NCT01155284|364911436|FG000|Overall Study|Withdrawal by Subject|4|||
105796326|NCT01155284|364911437|FG001|Overall Study|Withdrawal by Subject|3|||
105796327|NCT01155284|364911436|FG000|Overall Study|Lost to Follow-up|1|||
105796328|NCT01155284|364911437|FG001|Overall Study|Lost to Follow-up|2|||
105796329|NCT01155284|364911436|FG000|Overall Study|Physician Decision|1|||
105796330|NCT01155284|364911437|FG001|Overall Study|Physician Decision|0|||
105796331|NCT01155284|364911436|FG000|Overall Study|Adverse Event|1|||
105796332|NCT01155284|364911437|FG001|Overall Study|Adverse Event|0|||
105796333|NCT00886782|364911438|FG000|Overall Study|Disease progression|3|||
105796334|NCT00886782|364911439|FG001|Overall Study|Disease progression|3|||
105796335|NCT00886782|364911440|FG002|Overall Study|Disease progression|3|||
105796336|NCT00886782|364911438|FG000|Overall Study|Study drug toxicity|0|||
105796337|NCT00886782|364911439|FG001|Overall Study|Study drug toxicity|0|||
105796338|NCT00886782|364911440|FG002|Overall Study|Study drug toxicity|1|||
105796339|NCT00886782|364911438|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
105796340|NCT00886782|364911439|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
106139055|NCT01212757|366167073|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
106139056|NCT05052983|366167074|FG000|Overall Study|Lack of Efficacy|3|||
106139057|NCT05052983|366167075|FG001|Overall Study|Lack of Efficacy|12|||
105796341|NCT00886782|364911440|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
106139058|NCT05052983|366167074|FG000|Overall Study|Adverse Event|1|||
105796342|NCT01154673|364911441|FG000|Overall Study|Lost to Follow-up|1|||
105796343|NCT01154673|364911442|FG001|Overall Study|Lost to Follow-up|0|||
105796344|NCT01154673|364911441|FG000|Overall Study|moved out of province|1|||
106139059|NCT05052983|366167075|FG001|Overall Study|Adverse Event|0|||
105796345|NCT01154673|364911442|FG001|Overall Study|moved out of province|0|||
105796346|NCT03467971|364911443|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105796347|NCT03467971|364911444|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105796348|NCT01358708|364911445|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
105796349|NCT01358708|364911446|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105796350|NCT01358708|364911445|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
105796351|NCT01358708|364911446|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
105796352|NCT00051636|364911447|FG000|Period 1 - Core|Adverse Event|2|||
105796353|NCT00051636|364911448|FG001|Period 1 - Core|Adverse Event|2|||
105729477|NCT00824421|364662845|FG001|Overall Study|Other|1|||
105729478|NCT00824421|364662846|FG002|Overall Study|Other|0|||
105729479|NCT00927485|364662847|FG000|Overall Study|Adverse Event|4|||
105729480|NCT00927485|364662848|FG001|Overall Study|Adverse Event|2|||
105729481|NCT00927485|364662847|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
105729482|NCT00927485|364662848|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
105729483|NCT03293680|364662858|FG000|Overall Study|Death|1|||
105729484|NCT03293680|364662858|FG000|Overall Study|Did not meet inclusion criteria|8|||
105729485|NCT00636818|364662859|FG000|Overall Study|Adverse Event|1|||
105729486|NCT00636818|364662859|FG000|Overall Study|Lost to Follow-up|2|||
105729487|NCT00636818|364662859|FG000|Overall Study|Entry Criteria Exclusion|3|||
105729488|NCT00636818|364662859|FG000|Overall Study|Protocol Violation|1|||
105729489|NCT00636818|364662859|FG000|Overall Study|Withdrawal by Subject|4|||
105729490|NCT03228186|364662860|FG000|Overall Study|Patient never started treatment|1|||
105729491|NCT01023789|364662862|FG000|3 - Year Visit|Death|29|||
105729492|NCT01023789|364662862|FG000|3 - Year Visit|Withdrawal of consent|1|||
105729493|NCT01023789|364662862|FG000|3 - Year Visit|Lost to Follow-up|13|||
105729494|NCT03772327|364662863|FG000|Overall Study|Lost to Follow-up|3|||
105729495|NCT03772327|364662864|FG001|Overall Study|Lost to Follow-up|4|||
105729496|NCT03772327|364662863|FG000|Overall Study|Withdrawal by Subject|2|||
105729497|NCT03772327|364662864|FG001|Overall Study|Withdrawal by Subject|3|||
105729498|NCT00749203|364662865|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
105729499|NCT00749203|364662866|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
105729500|NCT00749203|364662865|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
105729501|NCT00749203|364662866|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
105729502|NCT00749203|364662865|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
105729503|NCT00749203|364662866|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
105729504|NCT00749203|364662865|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
105729505|NCT00749203|364662866|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
105729506|NCT00749203|364662865|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
105729507|NCT00749203|364662866|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
105729508|NCT00749203|364662865|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
105729509|NCT00749203|364662866|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
105729510|NCT04233424|364662868|FG000|Overall Study|Death|15|||
105729511|NCT04233424|364662869|FG001|Overall Study|Death|16|||
105729512|NCT04233424|364662868|FG000|Overall Study|Withdrawal by Subject|2|||
105729513|NCT04233424|364662869|FG001|Overall Study|Withdrawal by Subject|8|||
105729514|NCT04233424|364662868|FG000|Overall Study|Physician Decision|1|||
105729515|NCT04233424|364662869|FG001|Overall Study|Physician Decision|3|||
105729516|NCT04233424|364662868|FG000|Overall Study|Protocol Violation|3|||
105729517|NCT04233424|364662869|FG001|Overall Study|Protocol Violation|1|||
105729518|NCT04233424|364662868|FG000|Overall Study|Lost to Follow-up|1|||
105729519|NCT04233424|364662869|FG001|Overall Study|Lost to Follow-up|3|||
105729520|NCT04233424|364662868|FG000|Overall Study|subject refuse to visit site|2|||
105729521|NCT04233424|364662869|FG001|Overall Study|subject refuse to visit site|0|||
105729522|NCT01006356|364664130|FG000|Overall Study|Adverse Event|6|||
105729523|NCT01006356|364664130|FG000|Overall Study|Physician Decision|1|||
105729524|NCT01006356|364664130|FG000|Overall Study|Paticipants did not cooperate|6|||
105729525|NCT01006356|364664130|FG000|Overall Study|Withdrawal by Subject|1|||
105729526|NCT01006356|364664130|FG000|Overall Study|Choice by participants|2|||
105729527|NCT01006356|364664130|FG000|Overall Study|Protocol Violation|3|||
105729528|NCT01006356|364664130|FG000|Overall Study|Other|23|||
105729529|NCT01821963|364664131|FG000|Overall Study|Adverse Event|1|||
105729530|NCT00686205|364664134|FG000|Overall Study|Protocol Violation|127|||
105729531|NCT00686205|364664135|FG001|Overall Study|Protocol Violation|0|||
105729532|NCT00686205|364664134|FG000|Overall Study|Withdrawal by Subject|2|||
105729533|NCT00686205|364664135|FG001|Overall Study|Withdrawal by Subject|0|||
105729534|NCT00686205|364664134|FG000|Overall Study|Specimen handling procedure altered|5878|||
105729535|NCT00686205|364664135|FG001|Overall Study|Specimen handling procedure altered|0|||
105729536|NCT00686205|364664134|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
105729537|NCT00686205|364664135|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
105729538|NCT03095703|364664138|FG000|Overall Study|Withdrawal by Subject|1|||
105729539|NCT01503021|364664141|FG000|Overall Study|Adverse Event|7|||
105729540|NCT01503021|364664142|FG001|Overall Study|Adverse Event|6|||
105729541|NCT01503021|364664141|FG000|Overall Study|Death|0|||
105729542|NCT01503021|364664142|FG001|Overall Study|Death|2|||
105729543|NCT01503021|364664141|FG000|Overall Study|Lost to Follow-up|2|||
105729544|NCT01503021|364664142|FG001|Overall Study|Lost to Follow-up|0|||
105729545|NCT01503021|364664141|FG000|Overall Study|Physician Decision|3|||
105729546|NCT01503021|364664142|FG001|Overall Study|Physician Decision|0|||
105729547|NCT01503021|364664141|FG000|Overall Study|Protocol Violation|1|||
105729548|NCT01503021|364664142|FG001|Overall Study|Protocol Violation|3|||
105729549|NCT01503021|364664141|FG000|Overall Study|Withdrawal by Subject|9|||
105729550|NCT01503021|364664142|FG001|Overall Study|Withdrawal by Subject|8|||
105729551|NCT01503021|364664141|FG000|Overall Study|Moved, received transplant, etc.|5|||
105729552|NCT01503021|364664142|FG001|Overall Study|Moved, received transplant, etc.|7|||
105796354|NCT00051636|364911447|FG000|Period 1 - Core|Protocol Violation|1|||
105796355|NCT00051636|364911448|FG001|Period 1 - Core|Protocol Violation|0|||
105796356|NCT00051636|364911447|FG000|Period 1 - Core|Withdrawal by Subject|1|||
105796357|NCT00051636|364911448|FG001|Period 1 - Core|Withdrawal by Subject|2|||
105796358|NCT00051636|364911447|FG000|Period 1 - Core|Lost to Follow-up|0|||
105796359|NCT00051636|364911448|FG001|Period 1 - Core|Lost to Follow-up|2|||
105796360|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
105796361|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
105796362|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
105796363|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
105796364|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
105796365|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
105796366|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|Death|4|||
105796367|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|Death|5|||
105796368|NCT00051636|364911447|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
105796369|NCT00051636|364911448|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
105796370|NCT00975884|364911449|FG000|Overall Study|Adverse Event|1|||
105796371|NCT00975884|364911450|FG001|Overall Study|Adverse Event|0|||
105796372|NCT00975884|364911449|FG000|Overall Study|Lost to Follow-up|5|||
105796373|NCT00975884|364911450|FG001|Overall Study|Lost to Follow-up|3|||
105796374|NCT00975884|364911449|FG000|Overall Study|Withdrawal by Subject|9|||
105796375|NCT00975884|364911450|FG001|Overall Study|Withdrawal by Subject|9|||
105796376|NCT00975884|364911449|FG000|Overall Study|Other|1|||
105796377|NCT00975884|364911450|FG001|Overall Study|Other|3|||
105796378|NCT01901146|364912983|FG000|Neoadjuvant Phase|Death|1|||
105796379|NCT01901146|364912984|FG001|Neoadjuvant Phase|Death|2|||
105796380|NCT01901146|364912985|FG002|Neoadjuvant Phase|Death|0|||
105796381|NCT01901146|364912986|FG003|Neoadjuvant Phase|Death|0|||
105796382|NCT01901146|364912987|FG004|Neoadjuvant Phase|Death|0|||
105796383|NCT01901146|364912983|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
105796384|NCT01901146|364912984|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
105796385|NCT01901146|364912985|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
105796386|NCT01901146|364912986|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
105796387|NCT01901146|364912987|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
105796388|NCT01901146|364912983|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
105796389|NCT01901146|364912984|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
105796390|NCT01901146|364912985|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
105796391|NCT01901146|364912986|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
105796392|NCT01901146|364912987|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
105796393|NCT01901146|364912983|FG000|Neoadjuvant Phase|Physician Decision|1|||
105796394|NCT01901146|364912984|FG001|Neoadjuvant Phase|Physician Decision|2|||
105796395|NCT01901146|364912985|FG002|Neoadjuvant Phase|Physician Decision|0|||
105796396|NCT01901146|364912986|FG003|Neoadjuvant Phase|Physician Decision|0|||
105796397|NCT01901146|364912987|FG004|Neoadjuvant Phase|Physician Decision|0|||
105796398|NCT01901146|364912983|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
105796399|NCT01901146|364912984|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
105796400|NCT01901146|364912985|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
105796401|NCT01901146|364912986|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
105796402|NCT01901146|364912987|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
105796403|NCT01901146|364912983|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
105796404|NCT01901146|364912984|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
105796405|NCT01901146|364912985|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
105796406|NCT01901146|364912986|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
105796407|NCT01901146|364912987|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
105796408|NCT01901146|364912983|FG000|Adjuvant Phase|Other|0|||
105796409|NCT01901146|364912984|FG001|Adjuvant Phase|Other|0|||
105796410|NCT01901146|364912985|FG002|Adjuvant Phase|Other|1|||
105796411|NCT01901146|364912986|FG003|Adjuvant Phase|Other|0|||
105796412|NCT01901146|364912987|FG004|Adjuvant Phase|Other|0|||
105796413|NCT01901146|364912983|FG000|Adjuvant Phase|Death|0|||
105796414|NCT01901146|364912984|FG001|Adjuvant Phase|Death|0|||
105796415|NCT01901146|364912985|FG002|Adjuvant Phase|Death|0|||
105796416|NCT01901146|364912986|FG003|Adjuvant Phase|Death|0|||
105796417|NCT01901146|364912987|FG004|Adjuvant Phase|Death|3|||
105796418|NCT01901146|364912983|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
105796419|NCT01901146|364912984|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
105937566|NCT03878602|365431518|FG000|Overall Study|cord blood donation|7|||
106139060|NCT03425643|366167076|FG000|Overall Study|Withdrawal by Subject|10|||
106139061|NCT03425643|366167077|FG001|Overall Study|Withdrawal by Subject|12|||
106139062|NCT03425643|366167076|FG000|Overall Study|Lost to Follow-up|2|||
106139063|NCT03425643|366167077|FG001|Overall Study|Lost to Follow-up|0|||
105796420|NCT01901146|364912985|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
105796421|NCT01901146|364912986|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
106139064|NCT03425643|366167076|FG000|Overall Study|Death|109|||
105729553|NCT00504257|364664145|FG000|Overall Study|Withdrawal by Subject|2|||
105729554|NCT00504257|364664145|FG000|Overall Study|ineligible histology|2|||
105729555|NCT03584009|364664150|FG000|Overall Study|Death|25|||
105729556|NCT03584009|364664151|FG001|Overall Study|Death|18|||
105729557|NCT03584009|364664150|FG000|Overall Study|Lost to Follow-up|0|||
105729558|NCT03584009|364664151|FG001|Overall Study|Lost to Follow-up|1|||
105729559|NCT03584009|364664150|FG000|Overall Study|Physician Decision|1|||
105729560|NCT03584009|364664151|FG001|Overall Study|Physician Decision|1|||
105937567|NCT03878602|365431519|FG001|Overall Study|cord blood donation|1|||
105937568|NCT03878602|365431518|FG000|Overall Study|incomplete data collection|2|||
105937569|NCT03878602|365431519|FG001|Overall Study|incomplete data collection|0|||
105937570|NCT01370642|365431521|FG000|Overall Study|Adverse Event|2|||
105937571|NCT01370642|365431522|FG001|Overall Study|Adverse Event|1|||
105937572|NCT01370642|365431523|FG002|Overall Study|Adverse Event|1|||
105937573|NCT01370642|365431521|FG000|Overall Study|Detectable HCV RNA|0|||
105937574|NCT01370642|365431522|FG001|Overall Study|Detectable HCV RNA|0|||
105937575|NCT01370642|365431523|FG002|Overall Study|Detectable HCV RNA|22|||
105729561|NCT03584009|364664150|FG000|Overall Study|Study Terminated by Sponsor|22|||
105729562|NCT03584009|364664151|FG001|Overall Study|Study Terminated by Sponsor|30|||
105729563|NCT03584009|364664150|FG000|Overall Study|Withdrawal by Subject|3|||
105729564|NCT03584009|364664151|FG001|Overall Study|Withdrawal by Subject|2|||
105729565|NCT04112914|364664154|FG000|Overall Study|Lost to Follow-up|13|||
105729566|NCT04112914|364664155|FG001|Overall Study|Lost to Follow-up|9|||
105729567|NCT04112914|364664154|FG000|Overall Study|Withdrawal by Subject|1|||
105729568|NCT04112914|364664155|FG001|Overall Study|Withdrawal by Subject|0|||
105729569|NCT00117312|364664156|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
105729570|NCT00117312|364664157|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
105729571|NCT00117312|364664158|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
105729572|NCT00117312|364664159|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
105729573|NCT00117312|364664156|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
105729574|NCT00117312|364664157|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
105729575|NCT00117312|364664158|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
105729576|NCT00117312|364664159|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
105729577|NCT00117312|364664156|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
105729578|NCT00117312|364664157|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
105729579|NCT00117312|364664158|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
105729580|NCT00117312|364664159|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
105729581|NCT00117312|364664156|FG000|Overall Study|Other|0|||
105729582|NCT00117312|364664157|FG001|Overall Study|Other|1|||
105729583|NCT00117312|364664158|FG002|Overall Study|Other|3|||
105729584|NCT00117312|364664159|FG003|Overall Study|Other|1|||
105729585|NCT00117312|364664156|FG000|Overall Study|Patient choice|0|||
105729586|NCT00117312|364664157|FG001|Overall Study|Patient choice|0|||
105729587|NCT00117312|364664158|FG002|Overall Study|Patient choice|2|||
105729588|NCT00117312|364664159|FG003|Overall Study|Patient choice|1|||
105729589|NCT00117312|364664156|FG000|Overall Study|Adverse Event|0|||
105729590|NCT00117312|364664157|FG001|Overall Study|Adverse Event|2|||
105729591|NCT00117312|364664158|FG002|Overall Study|Adverse Event|0|||
105729592|NCT00117312|364664159|FG003|Overall Study|Adverse Event|0|||
105729593|NCT00117312|364664156|FG000|Overall Study|Protocol Violation|0|||
105729594|NCT00117312|364664157|FG001|Overall Study|Protocol Violation|1|||
105729595|NCT00117312|364664158|FG002|Overall Study|Protocol Violation|3|||
105729596|NCT00117312|364664159|FG003|Overall Study|Protocol Violation|0|||
105729597|NCT00117312|364664156|FG000|Overall Study|PSA decrease <=50%|0|||
105729598|NCT00117312|364664157|FG001|Overall Study|PSA decrease <=50%|2|||
105729599|NCT00117312|364664158|FG002|Overall Study|PSA decrease <=50%|2|||
105729600|NCT00117312|364664159|FG003|Overall Study|PSA decrease <=50%|4|||
105937576|NCT01370642|365431521|FG000|Overall Study|Lost to Follow-up|0|||
105937577|NCT01370642|365431522|FG001|Overall Study|Lost to Follow-up|0|||
105937578|NCT01370642|365431523|FG002|Overall Study|Lost to Follow-up|1|||
105729601|NCT00117312|364664156|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
105729602|NCT00117312|364664157|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
105729603|NCT00117312|364664158|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
105729604|NCT00117312|364664159|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
105729605|NCT00117312|364664156|FG000|Overall Study|Hepatic abnormality|0|||
105729606|NCT00117312|364664157|FG001|Overall Study|Hepatic abnormality|1|||
105729607|NCT00117312|364664158|FG002|Overall Study|Hepatic abnormality|0|||
105729608|NCT00117312|364664159|FG003|Overall Study|Hepatic abnormality|1|||
105729609|NCT00117312|364664156|FG000|Overall Study|Withdrawal by Subject|0|||
105729610|NCT00117312|364664157|FG001|Overall Study|Withdrawal by Subject|2|||
105729611|NCT00117312|364664158|FG002|Overall Study|Withdrawal by Subject|0|||
105729612|NCT00117312|364664159|FG003|Overall Study|Withdrawal by Subject|0|||
105729613|NCT03486314|364664162|FG000|Part A|Adverse Event|1|||
105729614|NCT03486314|364664163|FG001|Part A|Adverse Event|0|||
105729615|NCT03486314|364664164|FG002|Part A|Adverse Event|0|||
105937579|NCT01370642|365431521|FG000|Overall Study|Physician Decision|4|||
105937580|NCT01370642|365431522|FG001|Overall Study|Physician Decision|1|||
105937581|NCT01370642|365431523|FG002|Overall Study|Physician Decision|2|||
106009545|NCT01310777|365700872|FG000|Overall Study|Adverse Event|23|||
105796422|NCT01901146|364912987|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
105796423|NCT01901146|364912983|FG000|Adjuvant Phase|Physician Decision|0|||
105796424|NCT01901146|364912984|FG001|Adjuvant Phase|Physician Decision|0|||
105796425|NCT01901146|364912985|FG002|Adjuvant Phase|Physician Decision|9|||
105796426|NCT01901146|364912986|FG003|Adjuvant Phase|Physician Decision|2|||
105796427|NCT01901146|364912987|FG004|Adjuvant Phase|Physician Decision|4|||
105796428|NCT01901146|364912983|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
105796429|NCT01901146|364912984|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
105796430|NCT01901146|364912985|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
105796431|NCT01901146|364912986|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
105796432|NCT01901146|364912987|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
105796433|NCT00297492|364912991|FG000|Set Quit Date|Lost to Follow-up|7|||
105796434|NCT00297492|364912992|FG001|Set Quit Date|Lost to Follow-up|13|||
105796435|NCT00297492|364912993|FG002|Set Quit Date|Lost to Follow-up|5|||
105796436|NCT00297492|364912991|FG000|6 Month Follow-up|Lost to Follow-up|63|||
105796437|NCT00297492|364912992|FG001|6 Month Follow-up|Lost to Follow-up|49|||
105796438|NCT00297492|364912993|FG002|6 Month Follow-up|Lost to Follow-up|27|||
105796439|NCT02156466|364912996|FG000|Overall Study|Adverse Event|0|||
105796440|NCT02156466|364912997|FG001|Overall Study|Adverse Event|0|||
105796441|NCT02156466|364912998|FG002|Overall Study|Adverse Event|1|||
105796442|NCT02156466|364912999|FG003|Overall Study|Adverse Event|1|||
105796443|NCT02156466|364913000|FG004|Overall Study|Adverse Event|0|||
105796444|NCT02156466|364912996|FG000|Overall Study|Quantiferon Positivity|0|||
105796445|NCT02156466|364912997|FG001|Overall Study|Quantiferon Positivity|0|||
105796446|NCT02156466|364912998|FG002|Overall Study|Quantiferon Positivity|0|||
105796447|NCT02156466|364912999|FG003|Overall Study|Quantiferon Positivity|1|||
105796448|NCT02156466|364913000|FG004|Overall Study|Quantiferon Positivity|0|||
105796449|NCT00399490|364913007|FG000|Overall Study|Adverse Event|19|||
105796450|NCT00399490|364913007|FG000|Overall Study|Lack of Efficacy|31|||
105796451|NCT00399490|364913007|FG000|Overall Study|Lost to Follow-up|5|||
105796452|NCT00399490|364913007|FG000|Overall Study|Withdrawal by Subject|18|||
105796453|NCT00399490|364913007|FG000|Overall Study|Other|25|||
105796454|NCT02162511|364913009|FG000|Overall Study|Lack of Efficacy|0|||
105796455|NCT02162511|364913010|FG001|Overall Study|Lack of Efficacy|0|||
105796456|NCT02162511|364913011|FG002|Overall Study|Lack of Efficacy|2|||
105796457|NCT01408576|364913012|FG000|Overall Study|Lack of Efficacy|17|||
105796458|NCT01408576|364913013|FG001|Overall Study|Lack of Efficacy|30|||
105796459|NCT01408576|364913014|FG002|Overall Study|Lack of Efficacy|48|||
105796460|NCT01408576|364913012|FG000|Overall Study|Protocol Violation|1|||
105796461|NCT01408576|364913013|FG001|Overall Study|Protocol Violation|2|||
105796462|NCT01408576|364913014|FG002|Overall Study|Protocol Violation|2|||
105796463|NCT01408576|364913012|FG000|Overall Study|Lost to Follow-up|10|||
105796464|NCT01408576|364913013|FG001|Overall Study|Lost to Follow-up|9|||
105796465|NCT01408576|364913014|FG002|Overall Study|Lost to Follow-up|17|||
105796466|NCT01408576|364913012|FG000|Overall Study|Withdrawal by Subject|34|||
105796467|NCT01408576|364913013|FG001|Overall Study|Withdrawal by Subject|60|||
105796468|NCT01408576|364913014|FG002|Overall Study|Withdrawal by Subject|66|||
105796469|NCT01408576|364913012|FG000|Overall Study|Sponsor terminated study|89|||
105796470|NCT01408576|364913013|FG001|Overall Study|Sponsor terminated study|333|||
105796471|NCT01408576|364913014|FG002|Overall Study|Sponsor terminated study|330|||
105796472|NCT01408576|364913012|FG000|Overall Study|AE, serious fatal|4|||
105796473|NCT01408576|364913013|FG001|Overall Study|AE, serious fatal|4|||
105796474|NCT01408576|364913014|FG002|Overall Study|AE, serious fatal|1|||
105796475|NCT01408576|364913012|FG000|Overall Study|SAE, non-fatal|11|||
105796476|NCT01408576|364913013|FG001|Overall Study|SAE, non-fatal|23|||
105796477|NCT01408576|364913014|FG002|Overall Study|SAE, non-fatal|14|||
105796478|NCT01408576|364913012|FG000|Overall Study|AE, non-serious non-fatal|12|||
105796479|NCT01408576|364913013|FG001|Overall Study|AE, non-serious non-fatal|19|||
105796480|NCT01408576|364913014|FG002|Overall Study|AE, non-serious non-fatal|11|||
105796481|NCT01408576|364913012|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105796482|NCT01408576|364913013|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105796483|NCT01408576|364913014|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105796484|NCT01408576|364913012|FG000|Overall Study|AE, unknown type|0|||
105796485|NCT01408576|364913013|FG001|Overall Study|AE, unknown type|1|||
105796486|NCT01408576|364913014|FG002|Overall Study|AE, unknown type|0|||
105796487|NCT01408576|364913012|FG000|Overall Study|Other|10|||
105796488|NCT01408576|364913013|FG001|Overall Study|Other|16|||
105796489|NCT01408576|364913014|FG002|Overall Study|Other|18|||
105796490|NCT01399125|364913020|FG000|Overall Study|Adverse Event|32|||
105796491|NCT01399125|364913021|FG001|Overall Study|Adverse Event|30|||
105796492|NCT01399125|364913020|FG000|Overall Study|Abnormal Lab values|0|||
105796493|NCT01399125|364913021|FG001|Overall Study|Abnormal Lab values|1|||
105796494|NCT01399125|364913020|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105796495|NCT01399125|364913021|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
105796496|NCT01399125|364913020|FG000|Overall Study|Withdrawal by Subject|5|||
105796497|NCT01399125|364913021|FG001|Overall Study|Withdrawal by Subject|8|||
105796498|NCT01399125|364913020|FG000|Overall Study|Lost to Follow-up|2|||
105729616|NCT03486314|364664162|FG000|Part A|Symptomatic Deterioration|2|||
105729617|NCT03486314|364664163|FG001|Part A|Symptomatic Deterioration|0|||
105729618|NCT03486314|364664164|FG002|Part A|Symptomatic Deterioration|0|||
105729619|NCT01985321|364664165|FG000|Overall Study|Protocol Violation|4|||
105729620|NCT01985321|364664166|FG001|Overall Study|Protocol Violation|3|||
105729621|NCT01985321|364664165|FG000|Overall Study|Withdrawal by Subject|1|||
105729622|NCT01985321|364664166|FG001|Overall Study|Withdrawal by Subject|0|||
105729623|NCT01985321|364664165|FG000|Overall Study|Lost to Follow-up|5|||
105729624|NCT01985321|364664166|FG001|Overall Study|Lost to Follow-up|2|||
105729625|NCT01985321|364664165|FG000|Overall Study|Subject treated wrong type of sore|1|||
105729626|NCT01985321|364664166|FG001|Overall Study|Subject treated wrong type of sore|0|||
105729627|NCT04246047|364664172|FG000|Overall Study|Death|50|||
105729628|NCT04246047|364664173|FG001|Overall Study|Death|77|||
106009546|NCT01310777|365700873|FG001|Overall Study|Adverse Event|1|||
106009547|NCT01310777|365700874|FG002|Overall Study|Adverse Event|15|||
105729629|NCT04246047|364664172|FG000|Overall Study|Lost to Follow-up|1|||
105729630|NCT04246047|364664173|FG001|Overall Study|Lost to Follow-up|3|||
105729631|NCT04246047|364664172|FG000|Overall Study|Physician Decision|4|||
105729632|NCT04246047|364664173|FG001|Overall Study|Physician Decision|10|||
105729633|NCT04246047|364664172|FG000|Overall Study|Withdrawal by Subject|19|||
105729634|NCT04246047|364664173|FG001|Overall Study|Withdrawal by Subject|26|||
105729635|NCT04246047|364664172|FG000|Overall Study|Ongoing|169|||
105729636|NCT04246047|364664173|FG001|Overall Study|Ongoing|135|||
105729637|NCT02604264|364664177|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
105729638|NCT02604264|364664178|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
105729639|NCT03192904|364664179|FG000|Overall Study|Physician Decision|3|||
105729640|NCT03192904|364664180|FG001|Overall Study|Physician Decision|1|||
105729641|NCT03192904|364664179|FG000|Overall Study|Lost to Follow-up|0|||
105729642|NCT03192904|364664180|FG001|Overall Study|Lost to Follow-up|1|||
105729643|NCT05139030|364664181|FG000|Overall Study|Withdrawal by Subject|1|||
105729644|NCT05139030|364664182|FG001|Overall Study|Withdrawal by Subject|3|||
105729645|NCT05139030|364664181|FG000|Overall Study|Adverse Event|0|||
105729646|NCT05139030|364664182|FG001|Overall Study|Adverse Event|1|||
105729647|NCT05139030|364664181|FG000|Overall Study|Failure to meet continuation criteria|0|||
105729648|NCT05139030|364664182|FG001|Overall Study|Failure to meet continuation criteria|1|||
105729649|NCT04003610|364664183|FG000|Overall Study|Lost to Follow-up|0|||
105729650|NCT04003610|364664184|FG001|Overall Study|Lost to Follow-up|1|||
105729651|NCT04003610|364664185|FG002|Overall Study|Lost to Follow-up|0|||
105729652|NCT04003610|364664183|FG000|Overall Study|Death|0|||
105729653|NCT04003610|364664184|FG001|Overall Study|Death|0|||
105729654|NCT04003610|364664185|FG002|Overall Study|Death|3|||
105729655|NCT04003610|364664183|FG000|Overall Study|Study Terminated by Sponsor|0|||
105729656|NCT04003610|364664184|FG001|Overall Study|Study Terminated by Sponsor|0|||
105729657|NCT04003610|364664185|FG002|Overall Study|Study Terminated by Sponsor|3|||
105729658|NCT00424398|364664186|FG000|Overall Study|Withdrawal by Subject|2|||
105729659|NCT00424398|364664187|FG001|Overall Study|Withdrawal by Subject|1|||
105729660|NCT00424398|364664188|FG002|Overall Study|Withdrawal by Subject|0|||
105729661|NCT00424398|364664186|FG000|Overall Study|Subject met exclusion criteria|1|||
105729662|NCT00424398|364664187|FG001|Overall Study|Subject met exclusion criteria|0|||
105729663|NCT00424398|364664188|FG002|Overall Study|Subject met exclusion criteria|0|||
105729664|NCT01309737|364664189|FG000|Week 0 to 16|Death|1|||
105729665|NCT01309737|364664190|FG001|Week 0 to 16|Death|0|||
105729666|NCT01309737|364664191|FG002|Week 0 to 16|Death|1|||
105729667|NCT01309737|364664192|FG003|Week 0 to 16|Death|0|||
105729668|NCT01309737|364664193|FG004|Week 0 to 16|Death|0|||
105729669|NCT01309737|364664189|FG000|Week 0 to 16|Adverse Event|11|||
105729670|NCT01309737|364664190|FG001|Week 0 to 16|Adverse Event|10|||
105729671|NCT01309737|364664191|FG002|Week 0 to 16|Adverse Event|5|||
105729672|NCT01309737|364664192|FG003|Week 0 to 16|Adverse Event|0|||
105729673|NCT01309737|364664193|FG004|Week 0 to 16|Adverse Event|0|||
106009548|NCT01310777|365700872|FG000|Overall Study|Lost to Follow-up|0|||
105729674|NCT01309737|364664189|FG000|Week 0 to 16|Lack of Efficacy|15|||
105729675|NCT01309737|364664190|FG001|Week 0 to 16|Lack of Efficacy|2|||
105729676|NCT01309737|364664191|FG002|Week 0 to 16|Lack of Efficacy|24|||
105729677|NCT01309737|364664192|FG003|Week 0 to 16|Lack of Efficacy|0|||
105729678|NCT01309737|364664193|FG004|Week 0 to 16|Lack of Efficacy|0|||
105729679|NCT01309737|364664189|FG000|Week 0 to 16|Lost to Follow-up|7|||
105729680|NCT01309737|364664190|FG001|Week 0 to 16|Lost to Follow-up|8|||
105729681|NCT01309737|364664191|FG002|Week 0 to 16|Lost to Follow-up|3|||
105729682|NCT01309737|364664192|FG003|Week 0 to 16|Lost to Follow-up|0|||
105729683|NCT01309737|364664193|FG004|Week 0 to 16|Lost to Follow-up|0|||
105729684|NCT01309737|364664189|FG000|Week 0 to 16|Withdrawal by Subject|7|||
105729685|NCT01309737|364664190|FG001|Week 0 to 16|Withdrawal by Subject|6|||
105729686|NCT01309737|364664191|FG002|Week 0 to 16|Withdrawal by Subject|7|||
105729687|NCT01309737|364664192|FG003|Week 0 to 16|Withdrawal by Subject|0|||
105729688|NCT01309737|364664193|FG004|Week 0 to 16|Withdrawal by Subject|0|||
105729689|NCT01309737|364664189|FG000|Week 0 to 16|Other|10|||
105729690|NCT01309737|364664190|FG001|Week 0 to 16|Other|14|||
105729691|NCT01309737|364664191|FG002|Week 0 to 16|Other|4|||
105796499|NCT01399125|364913021|FG001|Overall Study|Lost to Follow-up|3|||
105796500|NCT01399125|364913020|FG000|Overall Study|Administrative Problems|7|||
105796501|NCT01399125|364913021|FG001|Overall Study|Administrative Problems|11|||
105796502|NCT01399125|364913020|FG000|Overall Study|Death|0|||
105796503|NCT01399125|364913021|FG001|Overall Study|Death|1|||
105796504|NCT01399125|364913020|FG000|Overall Study|Protocol Deviation|5|||
105796505|NCT01399125|364913021|FG001|Overall Study|Protocol Deviation|2|||
105796506|NCT00337129|364913022|FG000|Overall Study|Adverse Event|4|||
105796507|NCT00337129|364913022|FG000|Overall Study|Withdrawal by Subject|1|||
105796508|NCT00337129|364913022|FG000|Overall Study|Lack of Efficacy|32|||
105796509|NCT00337129|364913022|FG000|Overall Study|Death|2|||
105796510|NCT00337129|364913022|FG000|Overall Study|not protocol specified|1|||
105796511|NCT00563524|364913025|FG000|Overall Study|Adverse Event|0|||
105796512|NCT00563524|364913026|FG001|Overall Study|Adverse Event|1|||
105796513|NCT00563524|364913027|FG002|Overall Study|Adverse Event|0|||
105937582|NCT01370642|365431521|FG000|Overall Study|Withdrawal by Subject|2|||
105729692|NCT01309737|364664192|FG003|Week 0 to 16|Other|0|||
105729693|NCT01309737|364664193|FG004|Week 0 to 16|Other|0|||
105729694|NCT01309737|364664189|FG000|Week 0 to 16|Randomized, but not treated|1|||
105729695|NCT01309737|364664190|FG001|Week 0 to 16|Randomized, but not treated|0|||
105729696|NCT01309737|364664191|FG002|Week 0 to 16|Randomized, but not treated|0|||
105729697|NCT01309737|364664192|FG003|Week 0 to 16|Randomized, but not treated|0|||
105729698|NCT01309737|364664193|FG004|Week 0 to 16|Randomized, but not treated|0|||
105729699|NCT01309737|364664189|FG000|Week 16 to 52|Death|0|||
105729700|NCT01309737|364664190|FG001|Week 16 to 52|Death|0|||
105729701|NCT01309737|364664191|FG002|Week 16 to 52|Death|0|||
105729702|NCT01309737|364664192|FG003|Week 16 to 52|Death|0|||
105729703|NCT01309737|364664193|FG004|Week 16 to 52|Death|1|||
105729704|NCT01309737|364664189|FG000|Week 16 to 52|Adverse Event|7|||
105729705|NCT01309737|364664190|FG001|Week 16 to 52|Adverse Event|7|||
105729706|NCT01309737|364664191|FG002|Week 16 to 52|Adverse Event|0|||
105729707|NCT01309737|364664192|FG003|Week 16 to 52|Adverse Event|6|||
105729708|NCT01309737|364664193|FG004|Week 16 to 52|Adverse Event|5|||
105729709|NCT01309737|364664189|FG000|Week 16 to 52|Lack of Efficacy|107|||
105729710|NCT01309737|364664190|FG001|Week 16 to 52|Lack of Efficacy|76|||
105729711|NCT01309737|364664191|FG002|Week 16 to 52|Lack of Efficacy|0|||
105729712|NCT01309737|364664192|FG003|Week 16 to 52|Lack of Efficacy|25|||
105729713|NCT01309737|364664193|FG004|Week 16 to 52|Lack of Efficacy|21|||
105729714|NCT01309737|364664189|FG000|Week 16 to 52|Lost to Follow-up|4|||
105729715|NCT01309737|364664190|FG001|Week 16 to 52|Lost to Follow-up|2|||
105729716|NCT01309737|364664191|FG002|Week 16 to 52|Lost to Follow-up|0|||
105729717|NCT01309737|364664192|FG003|Week 16 to 52|Lost to Follow-up|1|||
105729718|NCT01309737|364664193|FG004|Week 16 to 52|Lost to Follow-up|4|||
105729719|NCT01309737|364664189|FG000|Week 16 to 52|Withdrawal by Subject|5|||
105729720|NCT01309737|364664190|FG001|Week 16 to 52|Withdrawal by Subject|6|||
105729721|NCT01309737|364664191|FG002|Week 16 to 52|Withdrawal by Subject|0|||
105729722|NCT01309737|364664192|FG003|Week 16 to 52|Withdrawal by Subject|0|||
105729723|NCT01309737|364664193|FG004|Week 16 to 52|Withdrawal by Subject|2|||
105729724|NCT01309737|364664189|FG000|Week 16 to 52|Other|10|||
105729725|NCT01309737|364664190|FG001|Week 16 to 52|Other|12|||
105729726|NCT01309737|364664191|FG002|Week 16 to 52|Other|0|||
105729727|NCT01309737|364664192|FG003|Week 16 to 52|Other|2|||
105729728|NCT01309737|364664193|FG004|Week 16 to 52|Other|0|||
105729729|NCT02502864|364664194|FG000|Overall Study|Withdrawal by Subject|1|||
105729730|NCT02333227|364664196|FG000|Overall Study|Lost to Follow-up|137|||
105729731|NCT02333227|364664197|FG001|Overall Study|Lost to Follow-up|106|||
105729732|NCT02333227|364664196|FG000|Overall Study|Pregnancy Interrupted|42|||
105729733|NCT02333227|364664197|FG001|Overall Study|Pregnancy Interrupted|89|||
105729734|NCT02333227|364664196|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
105729735|NCT02333227|364664197|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
105729736|NCT00816036|364664198|FG000|Overall Study|Death|47|||
105729737|NCT00816036|364664199|FG001|Overall Study|Death|28|||
105937583|NCT01370642|365431522|FG001|Overall Study|Withdrawal by Subject|4|||
105729738|NCT00816036|364664198|FG000|Overall Study|Lost to Follow-up|75|||
105729739|NCT00816036|364664199|FG001|Overall Study|Lost to Follow-up|57|||
105729740|NCT00816036|364664198|FG000|Overall Study|Withdrawal by Subject|54|||
105729741|NCT00816036|364664199|FG001|Overall Study|Withdrawal by Subject|23|||
105796514|NCT00563524|364913028|FG003|Overall Study|Adverse Event|0|||
105729742|NCT01624194|364664200|FG000|Overall Study|Lost to Follow-up|1|||
105729743|NCT01624194|364664201|FG001|Overall Study|Lost to Follow-up|0|||
105729744|NCT01624194|364664200|FG000|Overall Study|Withdrawal by Subject|1|||
105729745|NCT01624194|364664201|FG001|Overall Study|Withdrawal by Subject|0|||
105729746|NCT01076179|364664202|FG000|Overall Study|Withdrawal by Subject|1|||
105796515|NCT00563524|364913029|FG004|Overall Study|Adverse Event|2|||
105796516|NCT00563524|364913030|FG005|Overall Study|Adverse Event|0|||
105729747|NCT03459040|364664203|FG000|Overall Study|Death|8|||
105729748|NCT03459040|364664203|FG000|Overall Study|Withdrawal by Subject|1|||
105729749|NCT03577990|364664206|FG000|Overall Study|Lost to Follow-up|4|||
105937584|NCT01370642|365431523|FG002|Overall Study|Withdrawal by Subject|3|||
105729750|NCT03577990|364664207|FG001|Overall Study|Lost to Follow-up|6|||
105729751|NCT03577990|364664206|FG000|Overall Study|Withdrawal by Subject|4|||
105729752|NCT03577990|364664207|FG001|Overall Study|Withdrawal by Subject|7|||
105729753|NCT02493751|364664208|FG000|Overall Study|Withdrawal by Subject|2|||
105729754|NCT02493751|364664209|FG001|Overall Study|Withdrawal by Subject|8|||
105729755|NCT02493751|364664208|FG000|Overall Study|Death|6|||
105729756|NCT02493751|364664209|FG001|Overall Study|Death|13|||
105729757|NCT02493751|364664208|FG000|Overall Study|Lost to Follow-up|2|||
105729758|NCT02493751|364664209|FG001|Overall Study|Lost to Follow-up|3|||
105729759|NCT02493751|364664208|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
105729760|NCT02493751|364664209|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
105729761|NCT03822468|364664210|FG000|Treatment Period|Progressive disease|98|||
105729762|NCT03822468|364664211|FG001|Treatment Period|Progressive disease|94|||
105729763|NCT03822468|364664210|FG000|Treatment Period|Adverse Event|21|||
105729764|NCT03822468|364664211|FG001|Treatment Period|Adverse Event|24|||
105729765|NCT03822468|364664210|FG000|Treatment Period|Withdrawal by Subject|9|||
105729766|NCT03822468|364664211|FG001|Treatment Period|Withdrawal by Subject|5|||
105729767|NCT03822468|364664210|FG000|Treatment Period|Physician Decision|9|||
105729768|NCT03822468|364664211|FG001|Treatment Period|Physician Decision|7|||
105729769|NCT03822468|364664210|FG000|Treatment Period|Protocol Violation|2|||
105729770|NCT03822468|364664211|FG001|Treatment Period|Protocol Violation|1|||
105729771|NCT03822468|364664210|FG000|Treatment Period|Death|2|||
105729772|NCT03822468|364664211|FG001|Treatment Period|Death|3|||
105729773|NCT03822468|364664210|FG000|Treatment Period|Lost to Follow-up|1|||
105729774|NCT03822468|364664211|FG001|Treatment Period|Lost to Follow-up|1|||
105729775|NCT03822468|364664210|FG000|Treatment Period|Sponsor decision|46|||
105729776|NCT03822468|364664211|FG001|Treatment Period|Sponsor decision|53|||
105729777|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
105729778|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
105729779|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
105729780|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
105729781|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Death|1|||
105729782|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Death|0|||
105729783|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105729784|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
105729785|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
105729786|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105729787|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
105729788|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105729789|NCT03822468|364664210|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
105729790|NCT03822468|364664211|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
105729791|NCT05121103|364664212|FG000|Overall Study|Progressive disease|2|||
105729792|NCT05121103|364664213|FG001|Overall Study|Progressive disease|1|||
105937585|NCT01796470|365431524|FG000|Overall Study|Adverse Event|4|||
105937586|NCT01796470|365431525|FG001|Overall Study|Adverse Event|2|||
105937587|NCT01796470|365431526|FG002|Overall Study|Adverse Event|2|||
105937588|NCT01796470|365431527|FG003|Overall Study|Adverse Event|1|||
105937589|NCT01796470|365431528|FG004|Overall Study|Adverse Event|3|||
105937590|NCT01796470|365431524|FG000|Overall Study|Death|2|||
105937591|NCT01796470|365431525|FG001|Overall Study|Death|0|||
105937592|NCT01796470|365431526|FG002|Overall Study|Death|0|||
105937593|NCT01796470|365431527|FG003|Overall Study|Death|0|||
105937594|NCT01796470|365431528|FG004|Overall Study|Death|1|||
105937595|NCT01796470|365431524|FG000|Overall Study|Initiated New Therapy|9|||
105937596|NCT01796470|365431525|FG001|Overall Study|Initiated New Therapy|0|||
105937597|NCT01796470|365431526|FG002|Overall Study|Initiated New Therapy|0|||
105937598|NCT01796470|365431527|FG003|Overall Study|Initiated New Therapy|0|||
105937599|NCT01796470|365431528|FG004|Overall Study|Initiated New Therapy|2|||
105937600|NCT01796470|365431524|FG000|Overall Study|Lost to Follow-up|0|||
105937601|NCT01796470|365431525|FG001|Overall Study|Lost to Follow-up|1|||
105937602|NCT01796470|365431526|FG002|Overall Study|Lost to Follow-up|0|||
105937603|NCT01796470|365431527|FG003|Overall Study|Lost to Follow-up|0|||
105729793|NCT05121103|364664214|FG002|Overall Study|Progressive disease|6|||
105729794|NCT05121103|364664212|FG000|Overall Study|Physician Decision|2|||
105729795|NCT05121103|364664213|FG001|Overall Study|Physician Decision|1|||
105729796|NCT05121103|364664214|FG002|Overall Study|Physician Decision|0|||
105729797|NCT05121103|364664212|FG000|Overall Study|Withdrawal by Subject|0|||
105729798|NCT05121103|364664213|FG001|Overall Study|Withdrawal by Subject|1|||
105729799|NCT05121103|364664214|FG002|Overall Study|Withdrawal by Subject|0|||
105729800|NCT03248128|364664215|FG000|Overall Study|Lost to Follow-up|1|||
105729801|NCT03248128|364664216|FG001|Overall Study|Lost to Follow-up|0|||
105937604|NCT01796470|365431528|FG004|Overall Study|Lost to Follow-up|0|||
105937605|NCT01796470|365431524|FG000|Overall Study|Physician Decision|5|||
105937606|NCT01796470|365431525|FG001|Overall Study|Physician Decision|4|||
105937607|NCT01796470|365431526|FG002|Overall Study|Physician Decision|1|||
105937608|NCT01796470|365431527|FG003|Overall Study|Physician Decision|0|||
105796517|NCT00563524|364913025|FG000|Overall Study|Lost to Follow-up|1|||
105796518|NCT00563524|364913026|FG001|Overall Study|Lost to Follow-up|0|||
105796519|NCT00563524|364913027|FG002|Overall Study|Lost to Follow-up|0|||
105796520|NCT00563524|364913028|FG003|Overall Study|Lost to Follow-up|0|||
105796521|NCT00563524|364913029|FG004|Overall Study|Lost to Follow-up|0|||
105796522|NCT00563524|364913030|FG005|Overall Study|Lost to Follow-up|0|||
105796523|NCT00563524|364913025|FG000|Overall Study|Protocol Violation|0|||
105796524|NCT00563524|364913026|FG001|Overall Study|Protocol Violation|1|||
105796525|NCT00563524|364913027|FG002|Overall Study|Protocol Violation|0|||
105796526|NCT00563524|364913028|FG003|Overall Study|Protocol Violation|0|||
105796527|NCT00563524|364913029|FG004|Overall Study|Protocol Violation|0|||
105796528|NCT00563524|364913030|FG005|Overall Study|Protocol Violation|0|||
105796529|NCT00563524|364913025|FG000|Overall Study|Withdrawal by Subject|1|||
105796530|NCT00563524|364913026|FG001|Overall Study|Withdrawal by Subject|1|||
105796531|NCT00563524|364913027|FG002|Overall Study|Withdrawal by Subject|3|||
105796532|NCT00563524|364913028|FG003|Overall Study|Withdrawal by Subject|0|||
105796533|NCT00563524|364913029|FG004|Overall Study|Withdrawal by Subject|0|||
105796534|NCT00563524|364913030|FG005|Overall Study|Withdrawal by Subject|1|||
105796535|NCT02239601|364913033|FG000|Overall Study|Withdrawal by Subject|3|||
105796536|NCT02239601|364913034|FG001|Overall Study|Withdrawal by Subject|4|||
105796537|NCT02239601|364913033|FG000|Overall Study|Protocol Violation|4|||
105796538|NCT02239601|364913034|FG001|Overall Study|Protocol Violation|2|||
105796539|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
105796540|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
105796541|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
105796542|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
105796543|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
105796544|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
105796545|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
105796546|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
105796547|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105796548|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105796549|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
105796550|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105796551|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105796552|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105796553|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105796554|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
105796555|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
105796556|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
105796557|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
105796558|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
105796559|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
105796560|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
105796561|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
105796562|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
105796563|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
105796564|NCT04682639|364913035|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
105796565|NCT04682639|364913036|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
105796566|NCT04682639|364913037|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
105796567|NCT04682639|364913038|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105796568|NCT04682639|364913039|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105796569|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
105796570|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
105796571|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
105796572|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
105796573|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
105796574|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Other|1|||
105796575|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Other|2|||
105796576|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Other|0|||
105796577|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Other|0|||
105796578|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Other|1|||
105796579|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
105796580|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
105796581|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
105796582|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
105796583|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
105796584|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
105796585|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
105796586|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105937609|NCT01796470|365431528|FG004|Overall Study|Physician Decision|1|||
105796587|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105796588|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105796589|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
105796590|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
105796591|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105796592|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105796593|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105796594|NCT04682639|364913035|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
105796595|NCT04682639|364913036|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
105796596|NCT04682639|364913037|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
105796597|NCT04682639|364913038|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
105796598|NCT04682639|364913039|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
105796599|NCT00763269|364913040|FG000|Overall Study|Lost to Follow-up|12|||
105796600|NCT00763269|364913041|FG001|Overall Study|Lost to Follow-up|13|||
105796601|NCT03543046|364913044|FG000|Overall Study|Adverse Event|1|||
105796602|NCT03543046|364913045|FG001|Overall Study|Adverse Event|1|||
105796603|NCT03543046|364913044|FG000|Overall Study|Physician Decision|1|||
105796604|NCT03543046|364913045|FG001|Overall Study|Physician Decision|1|||
105796605|NCT03543046|364913044|FG000|Overall Study|Protocol Violation|1|||
105796606|NCT03543046|364913045|FG001|Overall Study|Protocol Violation|0|||
105796607|NCT03174925|364913050|FG000|Overall Study|Elastographic images not retrievable|2|||
105796608|NCT03174925|364913050|FG000|Overall Study|Elastography image not interpretable|1|||
105796609|NCT02019979|364913052|FG000|Overall Study|study terminated|14|||
105796610|NCT00572156|364913053|FG000|Overall Study|Adverse Event|3|||
105796611|NCT00572156|364913054|FG001|Overall Study|Adverse Event|1|||
105796612|NCT00572156|364913055|FG002|Overall Study|Adverse Event|5|||
105796613|NCT00572156|364913056|FG003|Overall Study|Adverse Event|1|||
105796614|NCT00572156|364913053|FG000|Overall Study|Lost to Follow-up|1|||
105796615|NCT00572156|364913054|FG001|Overall Study|Lost to Follow-up|1|||
105796616|NCT00572156|364913055|FG002|Overall Study|Lost to Follow-up|1|||
105796617|NCT00572156|364913056|FG003|Overall Study|Lost to Follow-up|0|||
105796618|NCT00572156|364913053|FG000|Overall Study|Protocol Violation|1|||
105796619|NCT00572156|364913054|FG001|Overall Study|Protocol Violation|2|||
105796620|NCT00572156|364913055|FG002|Overall Study|Protocol Violation|0|||
105796621|NCT00572156|364913056|FG003|Overall Study|Protocol Violation|2|||
105796622|NCT00572156|364913053|FG000|Overall Study|Patient/Parent Decision|1|||
105796623|NCT00572156|364913054|FG001|Overall Study|Patient/Parent Decision|6|||
105796624|NCT00572156|364913055|FG002|Overall Study|Patient/Parent Decision|4|||
105796625|NCT00572156|364913056|FG003|Overall Study|Patient/Parent Decision|3|||
105796626|NCT00572156|364913053|FG000|Overall Study|Sponsor Decision|20|||
105796627|NCT00572156|364913054|FG001|Overall Study|Sponsor Decision|16|||
105796628|NCT00572156|364913055|FG002|Overall Study|Sponsor Decision|17|||
105796629|NCT00572156|364913056|FG003|Overall Study|Sponsor Decision|19|||
105796630|NCT02261974|364913057|FG000|Overall Study|Withdrawal by Subject|3|||
105796631|NCT02261974|364913058|FG001|Overall Study|Withdrawal by Subject|2|||
105796632|NCT02261974|364913057|FG000|Overall Study|Pregnancy|0|||
105796633|NCT02261974|364913058|FG001|Overall Study|Pregnancy|1|||
105796634|NCT02261974|364913057|FG000|Overall Study|Missed treatment cut-off date|6|||
105796635|NCT02261974|364913058|FG001|Overall Study|Missed treatment cut-off date|3|||
105796636|NCT02261974|364913057|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
105796637|NCT02261974|364913058|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
105796638|NCT02261974|364913057|FG000|Overall Study|Lost to Follow-up|2|||
105796639|NCT02261974|364913058|FG001|Overall Study|Lost to Follow-up|0|||
105796640|NCT02261974|364913057|FG000|Overall Study|Adverse Event|1|||
105796641|NCT02261974|364913058|FG001|Overall Study|Adverse Event|0|||
105796642|NCT02030834|364913062|FG000|Overall Study|Death|4|||
105796643|NCT02030834|364913063|FG001|Overall Study|Death|0|||
105796644|NCT02030834|364913064|FG002|Overall Study|Death|0|||
105796645|NCT02030834|364913062|FG000|Overall Study|Manufacturing failure|2|||
105796646|NCT02030834|364913063|FG001|Overall Study|Manufacturing failure|0|||
105796647|NCT02030834|364913064|FG002|Overall Study|Manufacturing failure|1|||
105796648|NCT02030834|364913062|FG000|Overall Study|Disease progression|2|||
105796649|NCT02030834|364913063|FG001|Overall Study|Disease progression|0|||
105796650|NCT02030834|364913064|FG002|Overall Study|Disease progression|2|||
105796651|NCT02030834|364913062|FG000|Overall Study|Lost to Follow-up|1|||
105796652|NCT02030834|364913063|FG001|Overall Study|Lost to Follow-up|0|||
105796653|NCT02030834|364913064|FG002|Overall Study|Lost to Follow-up|0|||
105796654|NCT02030834|364913062|FG000|Overall Study|Withdrawal by Subject|1|||
105796655|NCT02030834|364913063|FG001|Overall Study|Withdrawal by Subject|0|||
106139065|NCT03425643|366167077|FG001|Overall Study|Death|141|||
105796656|NCT02030834|364913064|FG002|Overall Study|Withdrawal by Subject|0|||
105796657|NCT02030834|364913062|FG000|Overall Study|Lack of funding|1|||
105796658|NCT02030834|364913063|FG001|Overall Study|Lack of funding|0|||
105796659|NCT02030834|364913064|FG002|Overall Study|Lack of funding|0|||
105796660|NCT00103259|364913067|FG000|Overall Study|Death|3|||
106139066|NCT03425643|366167076|FG000|Overall Study|Ongoing in study|276|||
105796661|NCT00103259|364913068|FG001|Overall Study|Death|2|||
105796662|NCT00103259|364913067|FG000|Overall Study|Withdrawal by Subject|2|||
105729802|NCT03248128|364664215|FG000|Overall Study|Withdrawal by Subject|16|||
105729803|NCT03248128|364664216|FG001|Overall Study|Withdrawal by Subject|14|||
105729804|NCT03248128|364664215|FG000|Overall Study|Site Closed|4|||
105729805|NCT03248128|364664216|FG001|Overall Study|Site Closed|3|||
105729806|NCT03248128|364664215|FG000|Overall Study|Randomized, but did not receive treatment|1|||
105729807|NCT03248128|364664216|FG001|Overall Study|Randomized, but did not receive treatment|3|||
105729808|NCT03878446|364664217|FG000|Overall Study|Withdrawn by parent or guardian|1|||
105729809|NCT03878446|364664218|FG001|Overall Study|Withdrawn by parent or guardian|0|||
105729810|NCT03878446|364664219|FG002|Overall Study|Withdrawn by parent or guardian|0|||
105729811|NCT03878446|364664220|FG003|Overall Study|Withdrawn by parent or guardian|0|||
105729812|NCT03878446|364664221|FG004|Overall Study|Withdrawn by parent or guardian|0|||
105729813|NCT04526665|364664222|FG000|Overall Study|Withdrawal by Subject|6|||
105729814|NCT04526665|364664223|FG001|Overall Study|Withdrawal by Subject|3|||
105729815|NCT04526665|364664222|FG000|Overall Study|Adverse Event|4|||
105729816|NCT04526665|364664223|FG001|Overall Study|Adverse Event|1|||
105729817|NCT04526665|364664222|FG000|Overall Study|Physician Decision|2|||
105729818|NCT04526665|364664223|FG001|Overall Study|Physician Decision|2|||
105729819|NCT04526665|364664222|FG000|Overall Study|Death|2|||
105729820|NCT04526665|364664223|FG001|Overall Study|Death|0|||
105729821|NCT04526665|364664222|FG000|Overall Study|Other|0|||
105729822|NCT04526665|364664223|FG001|Overall Study|Other|1|||
105729823|NCT00473694|364665758|FG000|Overall Study|Adverse Event|0|||
105729824|NCT00473694|364665759|FG001|Overall Study|Adverse Event|1|||
105729825|NCT00473694|364665760|FG002|Overall Study|Adverse Event|0|||
105729826|NCT00473694|364665761|FG003|Overall Study|Adverse Event|0|||
105729827|NCT00473694|364665758|FG000|Overall Study|Participants did not receive treatment|11|||
105729828|NCT00473694|364665759|FG001|Overall Study|Participants did not receive treatment|3|||
105729829|NCT00473694|364665760|FG002|Overall Study|Participants did not receive treatment|5|||
105729830|NCT00473694|364665761|FG003|Overall Study|Participants did not receive treatment|6|||
105729831|NCT00473694|364665758|FG000|Overall Study|Lost to Follow-up|0|||
105729832|NCT00473694|364665759|FG001|Overall Study|Lost to Follow-up|0|||
105729833|NCT00473694|364665760|FG002|Overall Study|Lost to Follow-up|0|||
105729834|NCT00473694|364665761|FG003|Overall Study|Lost to Follow-up|1|||
105729835|NCT02579603|364665767|FG000|Overall Study|Not treated|1|||
105729836|NCT02579603|364665768|FG001|Overall Study|Not treated|0|||
105729837|NCT02579603|364665767|FG000|Overall Study|Adverse Event|2|||
105729838|NCT02579603|364665768|FG001|Overall Study|Adverse Event|2|||
105729839|NCT02579603|364665767|FG000|Overall Study|Other than stated|1|||
105729840|NCT02579603|364665768|FG001|Overall Study|Other than stated|0|||
105729841|NCT02981472|364665769|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
105729842|NCT02981472|364665770|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
105729843|NCT02981472|364665769|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105729844|NCT02981472|364665770|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105729845|NCT02981472|364665769|FG000|Treatment Period|Adverse Event|6|||
105729846|NCT02981472|364665770|FG001|Treatment Period|Adverse Event|1|||
105729847|NCT02981472|364665769|FG000|Treatment Period|Participant withdrew consent|1|||
105729848|NCT02981472|364665770|FG001|Treatment Period|Participant withdrew consent|0|||
105729849|NCT02981472|364665769|FG000|Treatment Period|Lost to Follow-up|0|||
105729850|NCT02981472|364665770|FG001|Treatment Period|Lost to Follow-up|1|||
105729851|NCT00621023|364665772|FG000|Overall Study|Death|5|||
105729852|NCT00621023|364665772|FG000|Overall Study|Follow up discontinued|1|||
105729853|NCT00613314|364665783|FG000|Overall Study|Adverse Event|5|||
105729854|NCT00613314|364665783|FG000|Overall Study|Protocol Violation|14|||
105729855|NCT00613314|364665783|FG000|Overall Study|Lost to Follow-up|46|||
105729856|NCT00613314|364665783|FG000|Overall Study|Other reason not defined above|90|||
105729857|NCT01531725|364665788|FG000|Overall Study|Protocol Violation|5|||
105729858|NCT03596164|364665797|FG000|Overall Study|Adverse Event|0|||
105729859|NCT03596164|364665798|FG001|Overall Study|Adverse Event|1|||
105729860|NCT03596164|364665797|FG000|Overall Study|Death|1|||
105729861|NCT03596164|364665798|FG001|Overall Study|Death|0|||
105729862|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
105729863|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
105729864|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
105729865|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
105729866|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
105729867|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
105729868|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
105729869|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
105729870|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
105729871|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
105796663|NCT00103259|364913068|FG001|Overall Study|Withdrawal by Subject|3|||
105796664|NCT00103259|364913067|FG000|Overall Study|alternative therapy|1|||
105796665|NCT00103259|364913068|FG001|Overall Study|alternative therapy|0|||
105796666|NCT00103259|364913067|FG000|Overall Study|other (reasons were not specified)|2|||
105796667|NCT00103259|364913068|FG001|Overall Study|other (reasons were not specified)|1|||
105796668|NCT00103259|364913067|FG000|Overall Study|ineligible/no protocol therapy|4|||
105796669|NCT00103259|364913068|FG001|Overall Study|ineligible/no protocol therapy|6|||
105796670|NCT03496207|364913085|FG000|Base Study|Adverse Event|0|||
105796671|NCT03496207|364913086|FG001|Base Study|Adverse Event|0|||
105796672|NCT03496207|364913087|FG002|Base Study|Adverse Event|1|||
105796673|NCT03496207|364913088|FG003|Base Study|Adverse Event|1|||
105796674|NCT03496207|364913089|FG004|Base Study|Adverse Event|4|||
105796675|NCT03496207|364913085|FG000|Base Study|Death|0|||
105796676|NCT03496207|364913086|FG001|Base Study|Death|0|||
105796677|NCT03496207|364913087|FG002|Base Study|Death|0|||
105796678|NCT03496207|364913088|FG003|Base Study|Death|0|||
105937610|NCT01796470|365431524|FG000|Overall Study|Progressive Disease|7|||
105937611|NCT01796470|365431525|FG001|Overall Study|Progressive Disease|7|||
105937612|NCT01796470|365431526|FG002|Overall Study|Progressive Disease|3|||
105937613|NCT01796470|365431527|FG003|Overall Study|Progressive Disease|2|||
105729872|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
105729873|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
105729874|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
105729875|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
105729876|NCT00446030|364665799|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
105729877|NCT00446030|364665800|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
105729878|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
105729879|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
105729880|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
105729881|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
105729882|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
105729883|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
105729884|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
105729885|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
105729886|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
105729887|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
105729888|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
105729889|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
105729890|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
105729891|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
105729892|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
105729893|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
105729894|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
105729895|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
105729896|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
105729897|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
105729898|NCT00446030|364665799|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
105729899|NCT00446030|364665800|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
105729900|NCT01073943|364665809|FG000|Overall Study|Withdrawal by Subject|8|||
105729901|NCT01073943|364665810|FG001|Overall Study|Withdrawal by Subject|2|||
105729902|NCT01073943|364665809|FG000|Overall Study|Protocol Violation|2|||
105729903|NCT01073943|364665810|FG001|Overall Study|Protocol Violation|1|||
105729904|NCT01073943|364665809|FG000|Overall Study|Adverse Event|1|||
105729905|NCT01073943|364665810|FG001|Overall Study|Adverse Event|1|||
105729906|NCT01073943|364665809|FG000|Overall Study|Lost to Follow-up|0|||
105729907|NCT01073943|364665810|FG001|Overall Study|Lost to Follow-up|2|||
105729908|NCT01073943|364665809|FG000|Overall Study|Power outage; colonoscopy not done|1|||
105729909|NCT01073943|364665810|FG001|Overall Study|Power outage; colonoscopy not done|0|||
105729910|NCT01073943|364665809|FG000|Overall Study|Subject forgot|0|||
105729911|NCT01073943|364665810|FG001|Overall Study|Subject forgot|1|||
105729912|NCT01073943|364665809|FG000|Overall Study|Unable to return for follow-up|0|||
105937614|NCT01796470|365431528|FG004|Overall Study|Progressive Disease|0|||
105937615|NCT01796470|365431524|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
105796679|NCT03496207|364913089|FG004|Base Study|Death|1|||
105796680|NCT03496207|364913085|FG000|Base Study|Withdrawal by Subject|0|||
105796681|NCT03496207|364913086|FG001|Base Study|Withdrawal by Subject|0|||
105729913|NCT01073943|364665810|FG001|Overall Study|Unable to return for follow-up|1|||
105729914|NCT01073943|364665809|FG000|Overall Study|Could not tolerate prep|1|||
105729915|NCT01073943|364665810|FG001|Overall Study|Could not tolerate prep|0|||
105729916|NCT01193335|364665812|FG000|After Infant Series|Lost to Follow-up|1|||
105796682|NCT03496207|364913087|FG002|Base Study|Withdrawal by Subject|1|||
105796683|NCT03496207|364913088|FG003|Base Study|Withdrawal by Subject|0|||
105796684|NCT03496207|364913089|FG004|Base Study|Withdrawal by Subject|1|||
105937616|NCT01796470|365431525|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
105729917|NCT01193335|364665813|FG001|After Infant Series|Lost to Follow-up|2|||
105729918|NCT01193335|364665812|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
105729919|NCT01193335|364665813|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
105729920|NCT01193335|364665812|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
105729921|NCT01193335|364665813|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
105729922|NCT01193335|364665812|FG000|1-Year Follow-up|Lost to Follow-up|4|||
105729923|NCT01193335|364665813|FG001|1-Year Follow-up|Lost to Follow-up|0|||
105729924|NCT01193335|364665812|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
105729925|NCT01193335|364665813|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
105729926|NCT01193335|364665812|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
105729927|NCT01193335|364665813|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
105729928|NCT00730236|364665814|FG000|Overall Study|Adverse Event|4|||
105729929|NCT00730236|364665814|FG000|Overall Study|Withdrawal by Subject|1|||
105729930|NCT00730236|364665814|FG000|Overall Study|Non-compliance|1|||
105729931|NCT01772134|364665815|FG000|Overall Study|Adverse Event|6|||
105729932|NCT01772134|364665816|FG001|Overall Study|Adverse Event|5|||
105729933|NCT01772134|364665817|FG002|Overall Study|Adverse Event|10|||
105729934|NCT01772134|364665815|FG000|Overall Study|Withdrew Consent|3|||
105729935|NCT01772134|364665816|FG001|Overall Study|Withdrew Consent|1|||
105729936|NCT01772134|364665817|FG002|Overall Study|Withdrew Consent|5|||
105729937|NCT01772134|364665815|FG000|Overall Study|Lost to Follow-up|2|||
105729938|NCT01772134|364665816|FG001|Overall Study|Lost to Follow-up|0|||
105729939|NCT01772134|364665817|FG002|Overall Study|Lost to Follow-up|0|||
105729940|NCT01772134|364665815|FG000|Overall Study|Protocol Deviation|4|||
105729941|NCT01772134|364665816|FG001|Overall Study|Protocol Deviation|3|||
105729942|NCT01772134|364665817|FG002|Overall Study|Protocol Deviation|3|||
105729943|NCT01772134|364665815|FG000|Overall Study|Lack of Efficacy|11|||
105729944|NCT01772134|364665816|FG001|Overall Study|Lack of Efficacy|5|||
105729945|NCT01772134|364665817|FG002|Overall Study|Lack of Efficacy|3|||
105729946|NCT01772134|364665815|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
105729947|NCT01772134|364665816|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
105729948|NCT01772134|364665817|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
105729949|NCT01772134|364665815|FG000|Overall Study|Randomized Study Medication Not Received|2|||
105729950|NCT01772134|364665816|FG001|Overall Study|Randomized Study Medication Not Received|0|||
105729951|NCT01772134|364665817|FG002|Overall Study|Randomized Study Medication Not Received|1|||
105729952|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
105729953|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
105729954|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
105729955|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
105729956|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
105729957|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
105729958|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Personal issues|2|||
105729959|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Personal issues|0|||
105729960|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Personal issues|0|||
105729961|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Too busy|7|||
105729962|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Too busy|1|||
105729963|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Too busy|0|||
105729964|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Pain|2|||
105729965|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Pain|0|||
105729966|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Pain|0|||
105729967|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Moved|1|||
105729968|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Moved|0|||
105729969|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Moved|0|||
105729970|NCT00594399|364665819|FG000|Initial 3 Month Counseling|Family illness|1|||
105729971|NCT00594399|364665820|FG001|Initial 3 Month Counseling|Family illness|0|||
105729972|NCT00594399|364665821|FG002|Initial 3 Month Counseling|Family illness|0|||
105729973|NCT00594399|364665819|FG000|Rerandomization Arm 1 Only|Death|2|||
105729974|NCT00594399|364665820|FG001|Rerandomization Arm 1 Only|Death|1|||
105729975|NCT00594399|364665821|FG002|Rerandomization Arm 1 Only|Death|0|||
105729976|NCT00594399|364665819|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
105729977|NCT00594399|364665820|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
105729978|NCT00594399|364665821|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
105729979|NCT02388776|364665822|FG000|Overall Study|Death|1|||
105729980|NCT02388776|364665822|FG000|Overall Study|Lost to Follow-up|1|||
105729981|NCT03826914|364665823|FG000|Overall Study|Withdrawal by Subject|1|||
105729982|NCT03826914|364665824|FG001|Overall Study|Withdrawal by Subject|1|||
105729983|NCT02034123|364665831|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729984|NCT02034123|364665832|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729985|NCT02034123|364665833|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729986|NCT02034123|364665834|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729987|NCT02034123|364665835|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
105729988|NCT02034123|364665836|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729989|NCT02034123|364665837|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729990|NCT02034123|364665838|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
105796685|NCT03496207|364913085|FG000|Extension Period|Adverse Event|0|||
105796686|NCT03496207|364913086|FG001|Extension Period|Adverse Event|0|||
105796687|NCT03496207|364913087|FG002|Extension Period|Adverse Event|0|||
105796688|NCT03496207|364913088|FG003|Extension Period|Adverse Event|1|||
105796689|NCT03496207|364913089|FG004|Extension Period|Adverse Event|1|||
105796690|NCT03496207|364913085|FG000|Extension Period|Death|1|||
105796691|NCT03496207|364913086|FG001|Extension Period|Death|0|||
105796692|NCT03496207|364913087|FG002|Extension Period|Death|0|||
105729991|NCT02034123|364665839|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
105729992|NCT02034123|364665840|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729993|NCT02034123|364665841|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729994|NCT02034123|364665842|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729995|NCT02034123|364665843|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729996|NCT02034123|364665844|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729997|NCT02034123|364665845|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729998|NCT02034123|364665846|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105729999|NCT02034123|364665847|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105730000|NCT02034123|364665848|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
105730001|NCT02034123|364665831|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730002|NCT02034123|364665832|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730003|NCT02034123|364665833|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730004|NCT02034123|364665834|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
105730005|NCT02034123|364665835|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730006|NCT02034123|364665836|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730007|NCT02034123|364665837|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730008|NCT02034123|364665838|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730009|NCT02034123|364665839|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730010|NCT02034123|364665840|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730011|NCT02034123|364665841|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730012|NCT02034123|364665842|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730013|NCT02034123|364665843|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730014|NCT02034123|364665844|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730015|NCT02034123|364665845|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730016|NCT02034123|364665846|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730017|NCT02034123|364665847|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730018|NCT02034123|364665848|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
105730019|NCT02034123|364665831|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730020|NCT02034123|364665832|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730021|NCT02034123|364665833|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730022|NCT02034123|364665834|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730023|NCT02034123|364665835|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730024|NCT02034123|364665836|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730025|NCT02034123|364665837|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730026|NCT02034123|364665838|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730027|NCT02034123|364665839|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
105730028|NCT02034123|364665840|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730029|NCT02034123|364665841|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730030|NCT02034123|364665842|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730031|NCT02034123|364665843|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730032|NCT02034123|364665844|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730033|NCT02034123|364665845|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730034|NCT02034123|364665846|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730035|NCT02034123|364665847|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730036|NCT02034123|364665848|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
105730037|NCT02034123|364665831|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730038|NCT02034123|364665832|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730039|NCT02034123|364665833|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730040|NCT02034123|364665834|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
105730041|NCT02034123|364665835|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
105796693|NCT03496207|364913088|FG003|Extension Period|Death|1|||
105796694|NCT03496207|364913089|FG004|Extension Period|Death|2|||
105796695|NCT03496207|364913085|FG000|Extension Period|Withdrawal by Subject|1|||
105796696|NCT03496207|364913086|FG001|Extension Period|Withdrawal by Subject|0|||
105796697|NCT03496207|364913087|FG002|Extension Period|Withdrawal by Subject|0|||
105796698|NCT03496207|364913088|FG003|Extension Period|Withdrawal by Subject|1|||
105796699|NCT03496207|364913089|FG004|Extension Period|Withdrawal by Subject|1|||
105730042|NCT02034123|364665836|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730043|NCT02034123|364665837|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730044|NCT02034123|364665838|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730045|NCT02034123|364665839|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730046|NCT02034123|364665840|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730047|NCT02034123|364665841|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730048|NCT02034123|364665842|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730049|NCT02034123|364665843|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730050|NCT02034123|364665844|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730051|NCT02034123|364665845|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730052|NCT02034123|364665846|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730053|NCT02034123|364665847|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730054|NCT02034123|364665848|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
105730055|NCT02240706|364665849|FG000|Overall Study|Lack of Efficacy|2|||
105730056|NCT02240706|364665850|FG001|Overall Study|Lack of Efficacy|2|||
105730057|NCT02240706|364665851|FG002|Overall Study|Lack of Efficacy|2|||
105730058|NCT02240706|364665852|FG003|Overall Study|Lack of Efficacy|2|||
105730059|NCT02240706|364665853|FG004|Overall Study|Lack of Efficacy|5|||
105730060|NCT02240706|364665854|FG005|Overall Study|Lack of Efficacy|0|||
105730061|NCT02240706|364665855|FG006|Overall Study|Lack of Efficacy|0|||
105730062|NCT02240706|364665849|FG000|Overall Study|Adverse Event|1|||
105730063|NCT02240706|364665850|FG001|Overall Study|Adverse Event|0|||
105730064|NCT02240706|364665851|FG002|Overall Study|Adverse Event|1|||
105730065|NCT02240706|364665852|FG003|Overall Study|Adverse Event|0|||
105730066|NCT02240706|364665853|FG004|Overall Study|Adverse Event|2|||
105730067|NCT02240706|364665854|FG005|Overall Study|Adverse Event|0|||
105730068|NCT02240706|364665855|FG006|Overall Study|Adverse Event|0|||
105730069|NCT02240706|364665849|FG000|Overall Study|Progressive disease|0|||
105730070|NCT02240706|364665850|FG001|Overall Study|Progressive disease|0|||
105730071|NCT02240706|364665851|FG002|Overall Study|Progressive disease|0|||
105730072|NCT02240706|364665852|FG003|Overall Study|Progressive disease|0|||
105730073|NCT02240706|364665853|FG004|Overall Study|Progressive disease|1|||
105730074|NCT02240706|364665854|FG005|Overall Study|Progressive disease|0|||
105730075|NCT02240706|364665855|FG006|Overall Study|Progressive disease|0|||
105730076|NCT02240706|364665849|FG000|Overall Study|Dose limiting toxicity|0|||
105730077|NCT02240706|364665850|FG001|Overall Study|Dose limiting toxicity|0|||
105730078|NCT02240706|364665851|FG002|Overall Study|Dose limiting toxicity|0|||
105730079|NCT02240706|364665852|FG003|Overall Study|Dose limiting toxicity|0|||
105730080|NCT02240706|364665853|FG004|Overall Study|Dose limiting toxicity|1|||
105730081|NCT02240706|364665854|FG005|Overall Study|Dose limiting toxicity|0|||
105730082|NCT02240706|364665855|FG006|Overall Study|Dose limiting toxicity|0|||
105730083|NCT02240706|364665849|FG000|Overall Study|Refused to continue taking medication|0|||
105730084|NCT02240706|364665850|FG001|Overall Study|Refused to continue taking medication|1|||
105730085|NCT02240706|364665851|FG002|Overall Study|Refused to continue taking medication|3|||
105730086|NCT02240706|364665852|FG003|Overall Study|Refused to continue taking medication|1|||
105730087|NCT02240706|364665853|FG004|Overall Study|Refused to continue taking medication|2|||
105730088|NCT02240706|364665854|FG005|Overall Study|Refused to continue taking medication|0|||
105730089|NCT02240706|364665855|FG006|Overall Study|Refused to continue taking medication|0|||
105730090|NCT02240706|364665849|FG000|Overall Study|Insurance billing concerns|0|||
105730091|NCT02240706|364665850|FG001|Overall Study|Insurance billing concerns|0|||
105730092|NCT02240706|364665851|FG002|Overall Study|Insurance billing concerns|0|||
105730093|NCT02240706|364665852|FG003|Overall Study|Insurance billing concerns|1|||
105730094|NCT02240706|364665853|FG004|Overall Study|Insurance billing concerns|0|||
105730095|NCT02240706|364665854|FG005|Overall Study|Insurance billing concerns|0|||
105730096|NCT02240706|364665855|FG006|Overall Study|Insurance billing concerns|0|||
105730097|NCT05300087|364665860|FG000|Overall Study|Withdrawal by Subject|0|||
105730098|NCT05300087|364665861|FG001|Overall Study|Withdrawal by Subject|1|||
105730099|NCT04488822|364665862|FG000|Overall Study|Adverse Event|8|||
105730100|NCT04488822|364665862|FG000|Overall Study|Withdrawal by Subject|1|||
105730101|NCT01662999|364665863|FG000|Period 3|Withdrawal by Subject|0|||
105730102|NCT01662999|364665864|FG001|Period 3|Withdrawal by Subject|1|||
105730103|NCT01662999|364665865|FG002|Period 3|Withdrawal by Subject|0|||
105730104|NCT01662999|364665866|FG003|Period 3|Withdrawal by Subject|0|||
105730105|NCT01662999|364665867|FG004|Period 3|Withdrawal by Subject|0|||
105730106|NCT01662999|364665868|FG005|Period 3|Withdrawal by Subject|0|||
105730107|NCT02932267|364665874|FG000|Overall Study|Withdrawal by Subject|3|||
105730108|NCT02932267|364665874|FG000|Overall Study|Lost to Follow-up|4|||
105730109|NCT02932267|364665874|FG000|Overall Study|Pregnancy|1|||
105730110|NCT04725682|364665881|FG000|Overall Study|Withdrawal by Subject|7|||
105730111|NCT04725682|364665882|FG001|Overall Study|Withdrawal by Subject|5|||
105730112|NCT04725682|364665881|FG000|Overall Study|Failed to comply with the requirements|2|||
105730113|NCT04725682|364665882|FG001|Overall Study|Failed to comply with the requirements|1|||
105730114|NCT04725682|364665881|FG000|Overall Study|Adverse Event|1|||
105937617|NCT01796470|365431526|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
105730115|NCT04725682|364665882|FG001|Overall Study|Adverse Event|1|||
105730116|NCT04725682|364665881|FG000|Overall Study|Death|0|||
105730117|NCT04725682|364665882|FG001|Overall Study|Death|1|||
105730118|NCT03598777|364665885|FG000|Overall Study|Study Terminated by Sponsor|3|||
105730119|NCT03598777|364665886|FG001|Overall Study|Study Terminated by Sponsor|0|||
105730120|NCT03598777|364665887|FG002|Overall Study|Study Terminated by Sponsor|0|||
105730121|NCT03598777|364665888|FG003|Overall Study|Study Terminated by Sponsor|0|||
105730122|NCT03598777|364665889|FG004|Overall Study|Study Terminated by Sponsor|15|||
105730123|NCT03598777|364665885|FG000|Overall Study|Withdrawal by Subject|1|||
105730124|NCT03598777|364665886|FG001|Overall Study|Withdrawal by Subject|1|||
105730125|NCT03598777|364665887|FG002|Overall Study|Withdrawal by Subject|0|||
105730126|NCT03598777|364665888|FG003|Overall Study|Withdrawal by Subject|0|||
105730127|NCT03598777|364665889|FG004|Overall Study|Withdrawal by Subject|0|||
105730128|NCT03598777|364665885|FG000|Overall Study|Adverse Event|1|||
105730129|NCT03598777|364665886|FG001|Overall Study|Adverse Event|0|||
105730130|NCT03598777|364665887|FG002|Overall Study|Adverse Event|0|||
105730131|NCT03598777|364665888|FG003|Overall Study|Adverse Event|0|||
105730132|NCT03598777|364665889|FG004|Overall Study|Adverse Event|0|||
105730133|NCT03598777|364665885|FG000|Overall Study|Lost to Follow-up|1|||
105730134|NCT03598777|364665886|FG001|Overall Study|Lost to Follow-up|0|||
105730135|NCT03598777|364665887|FG002|Overall Study|Lost to Follow-up|0|||
105730136|NCT03598777|364665888|FG003|Overall Study|Lost to Follow-up|0|||
105730137|NCT03598777|364665889|FG004|Overall Study|Lost to Follow-up|0|||
105730138|NCT04090164|364665890|FG000|Overall Study|incomplete data on file|245|||
105730139|NCT04090164|364665891|FG001|Overall Study|incomplete data on file|0|||
105730140|NCT01650805|364665892|FG000|Overall Study|Withdrawal by Subject|1|||
105730141|NCT01650805|364665893|FG001|Overall Study|Withdrawal by Subject|0|||
105730142|NCT01877655|364665896|FG000|Overall Study|Death|57|||
105730143|NCT01877655|364665897|FG001|Overall Study|Death|52|||
105730144|NCT01877655|364665896|FG000|Overall Study|Withdrawal by Subject|18|||
105730145|NCT01877655|364665897|FG001|Overall Study|Withdrawal by Subject|26|||
105730146|NCT01877655|364665896|FG000|Overall Study|Physician Decision|11|||
105730147|NCT01877655|364665897|FG001|Overall Study|Physician Decision|10|||
105730148|NCT01877655|364665896|FG000|Overall Study|Miscellaneous|4|||
105730149|NCT01877655|364665897|FG001|Overall Study|Miscellaneous|4|||
105730150|NCT01877655|364665896|FG000|Overall Study|Randomized but Never Received Drug|8|||
105730151|NCT01877655|364665897|FG001|Overall Study|Randomized but Never Received Drug|5|||
105730152|NCT01901328|364665898|FG000|Overall Study|Lost to Follow-up|1|||
105730153|NCT01901328|364665899|FG001|Overall Study|Lost to Follow-up|0|||
105730154|NCT01901328|364665898|FG000|Overall Study|Physician Decision|0|||
105730155|NCT01901328|364665899|FG001|Overall Study|Physician Decision|1|||
105730156|NCT01901328|364665898|FG000|Overall Study|Protocol Violation|1|||
105730157|NCT01901328|364665899|FG001|Overall Study|Protocol Violation|1|||
105730158|NCT01901328|364665898|FG000|Overall Study|Study Terminated by Sponsor|19|||
105730159|NCT01901328|364665899|FG001|Overall Study|Study Terminated by Sponsor|16|||
105730160|NCT01901328|364665898|FG000|Overall Study|Withdrawal by Subject|1|||
105730161|NCT01901328|364665899|FG001|Overall Study|Withdrawal by Subject|2|||
105730162|NCT01901328|364665898|FG000|Overall Study|Lack of Efficacy|0|||
105730163|NCT01901328|364665899|FG001|Overall Study|Lack of Efficacy|1|||
105730164|NCT03232073|364665903|FG000|Overall Study|Death|1|||
105730165|NCT03232073|364665904|FG001|Overall Study|Death|0|||
105730166|NCT03232073|364665903|FG000|Overall Study|Adverse Event|7|||
105730167|NCT03232073|364665904|FG001|Overall Study|Adverse Event|12|||
105730168|NCT03232073|364665903|FG000|Overall Study|Lost to Follow-up|6|||
105730169|NCT03232073|364665904|FG001|Overall Study|Lost to Follow-up|6|||
105730170|NCT03232073|364665903|FG000|Overall Study|Lack of Efficacy|10|||
105730171|NCT03232073|364665904|FG001|Overall Study|Lack of Efficacy|8|||
105730172|NCT03232073|364665903|FG000|Overall Study|Physician Decision|9|||
105730173|NCT03232073|364665904|FG001|Overall Study|Physician Decision|2|||
105730174|NCT03232073|364665903|FG000|Overall Study|Withdrawal by Subject|54|||
105730175|NCT03232073|364665904|FG001|Overall Study|Withdrawal by Subject|39|||
105730176|NCT03439345|364667563|FG000|Overall Study|Lost to Follow-up|0|||
105730177|NCT03439345|364667564|FG001|Overall Study|Lost to Follow-up|1|||
105730178|NCT03439345|364667563|FG000|Overall Study|Consent withdrawn|0|||
105730179|NCT03439345|364667564|FG001|Overall Study|Consent withdrawn|1|||
105730180|NCT02143414|364667565|FG000|Induction|Adverse Event|1|||
105730181|NCT02143414|364667566|FG001|Induction|Adverse Event|2|||
105730182|NCT02143414|364667565|FG000|Induction|Death|1|||
105730183|NCT02143414|364667566|FG001|Induction|Death|2|||
105730184|NCT02143414|364667565|FG000|Induction|Patient refusal|1|||
105730185|NCT02143414|364667566|FG001|Induction|Patient refusal|1|||
105730186|NCT02143414|364667565|FG000|Induction|Refractory|1|||
105730187|NCT02143414|364667566|FG001|Induction|Refractory|0|||
105730188|NCT02143414|364667565|FG000|Induction|Began alternative treatment|1|||
105730189|NCT02143414|364667566|FG001|Induction|Began alternative treatment|0|||
105730190|NCT02143414|364667565|FG000|Induction|Ineligible for postremission|5|||
105796700|NCT03496207|364913085|FG000|Extension Period|Elevated hemoglobin levels|0|||
105796701|NCT03496207|364913086|FG001|Extension Period|Elevated hemoglobin levels|0|||
105796702|NCT03496207|364913087|FG002|Extension Period|Elevated hemoglobin levels|0|||
105796703|NCT03496207|364913088|FG003|Extension Period|Elevated hemoglobin levels|0|||
105796704|NCT03496207|364913089|FG004|Extension Period|Elevated hemoglobin levels|1|||
105796705|NCT01169987|364913090|FG000|Overall Study|Withdrawal by Subject|3|||
105796706|NCT01169987|364913090|FG000|Overall Study|Lost to Follow-up|24|||
105796707|NCT01169987|364913090|FG000|Overall Study|Other|4|||
105796708|NCT01556490|364913099|FG000|Randomized Patients Summary|Protocol Violation|22|||
105796709|NCT01556490|364913100|FG001|Randomized Patients Summary|Protocol Violation|23|||
105796710|NCT01556490|364913099|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
105796711|NCT01556490|364913100|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
105796712|NCT02441179|364913102|FG000|Overall Study|Withdrawal by Subject|1|||
105796713|NCT02441179|364913103|FG001|Overall Study|Withdrawal by Subject|1|||
105796714|NCT03091400|364913104|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
105796715|NCT03091400|364913105|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
105796716|NCT00479765|364913108|FG000|Overall Study|study terminated|4|||
105796717|NCT03056001|364913109|FG000|Overall Study|Death|24|||
105796718|NCT04816877|364913112|FG000|Overall Study|Withdrawal by Subject|1|||
105796719|NCT04816877|364913113|FG001|Overall Study|Withdrawal by Subject|0|||
105796720|NCT00828516|364913114|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
105796721|NCT00378482|364913117|FG000|Overall Study|Lost to Follow-up|1|||
105796722|NCT00378482|364913117|FG000|Overall Study|Lack of Efficacy|8|||
105796723|NCT00378482|364913117|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
105796724|NCT00378482|364913117|FG000|Overall Study|Withdrawal by Subject|4|||
105796725|NCT00378482|364913117|FG000|Overall Study|Adverse Event|9|||
105796726|NCT05166421|364913120|FG000|Overall Study|Other|3|||
105796727|NCT05166421|364913121|FG001|Overall Study|Other|1|||
105796728|NCT05166421|364913122|FG002|Overall Study|Other|1|||
105796729|NCT05166421|364913120|FG000|Overall Study|Withdrawal by Subject|5|||
105796730|NCT05166421|364913121|FG001|Overall Study|Withdrawal by Subject|3|||
105796731|NCT05166421|364913122|FG002|Overall Study|Withdrawal by Subject|6|||
105796732|NCT05166421|364913120|FG000|Overall Study|Lost to Follow-up|4|||
105796733|NCT05166421|364913121|FG001|Overall Study|Lost to Follow-up|1|||
105796734|NCT05166421|364913122|FG002|Overall Study|Lost to Follow-up|7|||
105796735|NCT00080288|364914537|FG000|Overall Study|Adverse Event|7|||
105796736|NCT00080288|364914538|FG001|Overall Study|Adverse Event|4|||
105796737|NCT00080288|364914537|FG000|Overall Study|Lost to Follow-up|3|||
105796738|NCT00080288|364914538|FG001|Overall Study|Lost to Follow-up|5|||
105796739|NCT00080288|364914537|FG000|Overall Study|Physician Decision|6|||
105796740|NCT00080288|364914538|FG001|Overall Study|Physician Decision|2|||
105796741|NCT00080288|364914537|FG000|Overall Study|Withdrawal by Subject|3|||
105796742|NCT00080288|364914538|FG001|Overall Study|Withdrawal by Subject|16|||
105796743|NCT00080288|364914537|FG000|Overall Study|Miscellaneous|11|||
105796744|NCT00080288|364914538|FG001|Overall Study|Miscellaneous|11|||
105796745|NCT01614925|364914539|FG000|Overall Study|Withdrawal by Subject|1|||
105796746|NCT01614925|364914540|FG001|Overall Study|Withdrawal by Subject|0|||
105796747|NCT01614925|364914539|FG000|Overall Study|Protocol Violation|3|||
105796748|NCT01614925|364914540|FG001|Overall Study|Protocol Violation|2|||
105796749|NCT03349437|364914541|FG000|Screening|Screen Fail|4|||
105796750|NCT03349437|364914542|FG001|Screening|Screen Fail|0|||
105796751|NCT03349437|364914543|FG002|Screening|Screen Fail|0|||
105796752|NCT03349437|364914541|FG000|Screening|Withdrawn|1|||
105796753|NCT03349437|364914542|FG001|Screening|Withdrawn|0|||
105796754|NCT03349437|364914543|FG002|Screening|Withdrawn|0|||
105796755|NCT03591107|364914544|FG000|Overall Study|Same patient in both arms|1|||
105796756|NCT03591107|364914545|FG001|Overall Study|Same patient in both arms|1|||
105796757|NCT03591107|364914544|FG000|Overall Study|Sought care at other clinics|0|||
105730191|NCT02143414|364667566|FG001|Induction|Ineligible for postremission|1|||
105730192|NCT02143414|364667565|FG000|Post-remission|Adverse Event|0|||
105730193|NCT02143414|364667566|FG001|Post-remission|Adverse Event|2|||
105730194|NCT02143414|364667565|FG000|Post-remission|Disease progression/relapse|5|||
105730195|NCT02143414|364667566|FG001|Post-remission|Disease progression/relapse|0|||
105730196|NCT02143414|364667565|FG000|Maintenance|Adverse Event|4|||
105730197|NCT02143414|364667566|FG001|Maintenance|Adverse Event|6|||
105730198|NCT02143414|364667565|FG000|Maintenance|Disease progression/relapse|3|||
105730199|NCT02143414|364667566|FG001|Maintenance|Disease progression/relapse|2|||
105730200|NCT02143414|364667565|FG000|Maintenance|Patient refusal|2|||
105730201|NCT02143414|364667566|FG001|Maintenance|Patient refusal|1|||
105796758|NCT03591107|364914545|FG001|Overall Study|Sought care at other clinics|2|||
105796759|NCT03591107|364914544|FG000|Overall Study|Discharged from clinic|0|||
105796760|NCT03591107|364914545|FG001|Overall Study|Discharged from clinic|1|||
105730202|NCT02143414|364667565|FG000|Maintenance|Physician Decision|1|||
105796761|NCT03591107|364914544|FG000|Overall Study|Withdrawal by Subject|0|||
105796762|NCT03591107|364914545|FG001|Overall Study|Withdrawal by Subject|1|||
105796763|NCT02766088|364914548|FG000|Overall Study|Sponsor study termination|498|||
105796764|NCT02766088|364914548|FG000|Overall Study|Migrated/moved from the study area|1|||
105796765|NCT02766088|364914548|FG000|Overall Study|Lost to Follow-up|5|||
105796766|NCT02766088|364914548|FG000|Overall Study|Other|1|||
105796767|NCT02766088|364914548|FG000|Overall Study|Death|1|||
105796768|NCT01537549|364914549|FG000|Overall Study|Lost to Follow-up|1|||
105796769|NCT01537549|364914549|FG000|Overall Study|Withdrawal by Subject|2|||
105796770|NCT04388527|364914551|FG000|Overall Study|Death|14|||
105796771|NCT04388527|364914551|FG000|Overall Study|Withdrawal by Subject|2|||
105796772|NCT04388527|364914551|FG000|Overall Study|Lost to Follow-up|1|||
105796773|NCT00520494|364914554|FG000|Overall Study|Withdrawal by Subject|1|||
105796774|NCT03471182|364914555|FG000|Overall Study|Withdrawal by Subject|1|||
105796775|NCT03471182|364914556|FG001|Overall Study|Withdrawal by Subject|1|||
105796776|NCT03471182|364914557|FG002|Overall Study|Withdrawal by Subject|0|||
105796777|NCT03471182|364914555|FG000|Overall Study|Technical failure|2|||
105796778|NCT03471182|364914556|FG001|Overall Study|Technical failure|0|||
105796779|NCT03471182|364914557|FG002|Overall Study|Technical failure|0|||
105796780|NCT02773446|364914562|FG000|First Admission|Withdrawal by Subject|0|||
105796781|NCT02773446|364914563|FG001|First Admission|Withdrawal by Subject|0|||
105796782|NCT02773446|364914564|FG002|First Admission|Withdrawal by Subject|0|||
105796783|NCT02773446|364914565|FG003|First Admission|Withdrawal by Subject|1|||
105796784|NCT02773446|364914566|FG004|First Admission|Withdrawal by Subject|0|||
105796785|NCT02773446|364914567|FG005|First Admission|Withdrawal by Subject|0|||
105796786|NCT02773446|364914562|FG000|First Admission|Lost to Follow-up|1|||
105796787|NCT02773446|364914563|FG001|First Admission|Lost to Follow-up|0|||
105796788|NCT02773446|364914564|FG002|First Admission|Lost to Follow-up|0|||
105796789|NCT02773446|364914565|FG003|First Admission|Lost to Follow-up|0|||
105796790|NCT02773446|364914566|FG004|First Admission|Lost to Follow-up|0|||
105796791|NCT02773446|364914567|FG005|First Admission|Lost to Follow-up|0|||
105796792|NCT01682512|364914568|FG000|Overall Study|Adverse Event|6|||
105796793|NCT01682512|364914569|FG001|Overall Study|Adverse Event|5|||
105796794|NCT01682512|364914570|FG002|Overall Study|Adverse Event|2|||
105796795|NCT01682512|364914568|FG000|Overall Study|Withdrawal by Subject|2|||
105796796|NCT01682512|364914569|FG001|Overall Study|Withdrawal by Subject|6|||
105796797|NCT01682512|364914570|FG002|Overall Study|Withdrawal by Subject|3|||
105796798|NCT01682512|364914568|FG000|Overall Study|Physician Decision|0|||
105796799|NCT01682512|364914569|FG001|Overall Study|Physician Decision|2|||
105796800|NCT01682512|364914570|FG002|Overall Study|Physician Decision|0|||
105796801|NCT01682512|364914568|FG000|Overall Study|Study terminated by sponsor|46|||
105796802|NCT01682512|364914569|FG001|Overall Study|Study terminated by sponsor|43|||
105796803|NCT01682512|364914570|FG002|Overall Study|Study terminated by sponsor|0|||
105796804|NCT01682512|364914568|FG000|Overall Study|Lost to Follow-up|3|||
105796805|NCT01682512|364914569|FG001|Overall Study|Lost to Follow-up|0|||
105796806|NCT01682512|364914570|FG002|Overall Study|Lost to Follow-up|2|||
105796807|NCT01682512|364914568|FG000|Overall Study|Protocol Violation|2|||
105796808|NCT01682512|364914569|FG001|Overall Study|Protocol Violation|3|||
105796809|NCT01682512|364914570|FG002|Overall Study|Protocol Violation|2|||
105796810|NCT01682512|364914568|FG000|Overall Study|Primary lack of efficacy|10|||
105796811|NCT01682512|364914569|FG001|Overall Study|Primary lack of efficacy|7|||
105796812|NCT01682512|364914570|FG002|Overall Study|Primary lack of efficacy|7|||
105796813|NCT01682512|364914568|FG000|Overall Study|Secondary lack of efficacy|1|||
105796814|NCT01682512|364914569|FG001|Overall Study|Secondary lack of efficacy|1|||
105796815|NCT01682512|364914570|FG002|Overall Study|Secondary lack of efficacy|0|||
105796816|NCT01682512|364914568|FG000|Overall Study|Other than stated above|2|||
105796817|NCT01682512|364914569|FG001|Overall Study|Other than stated above|4|||
105796818|NCT01682512|364914570|FG002|Overall Study|Other than stated above|2|||
105796819|NCT01333475|364914571|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
105796820|NCT01333475|364914572|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
105796821|NCT01333475|364914571|FG000|Overall Study|Toxicity|1|||
105796822|NCT01333475|364914572|FG001|Overall Study|Toxicity|3|||
105796823|NCT01466673|364914573|FG000|Overall Study|Non-compliance with study treatment|2|||
105796824|NCT01466673|364914574|FG001|Overall Study|Non-compliance with study treatment|0|||
105796825|NCT01466673|364914573|FG000|Overall Study|Lost to Follow-up|3|||
105796826|NCT01466673|364914574|FG001|Overall Study|Lost to Follow-up|5|||
105796827|NCT01466673|364914573|FG000|Overall Study|Adverse Event|2|||
105796828|NCT01466673|364914574|FG001|Overall Study|Adverse Event|1|||
105796829|NCT00854607|364914575|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
105796830|NCT00965263|364914576|FG000|Overall Study|Physician Decision|2|||
105796831|NCT00965263|364914577|FG001|Overall Study|Physician Decision|0|||
105796832|NCT00965263|364914576|FG000|Overall Study|Family emergency|0|||
105796833|NCT00965263|364914577|FG001|Overall Study|Family emergency|1|||
105796834|NCT00965263|364914576|FG000|Overall Study|Protocol Violation|0|||
105796835|NCT00965263|364914577|FG001|Overall Study|Protocol Violation|2|||
105796836|NCT04476017|364914578|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
105796837|NCT04476017|364914579|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
105730203|NCT02143414|364667566|FG001|Maintenance|Physician Decision|0|||
105730204|NCT02143414|364667565|FG000|Maintenance|Death|0|||
105730205|NCT02143414|364667566|FG001|Maintenance|Death|1|||
105730206|NCT02143414|364667565|FG000|Maintenance|On protocol treatment|0|||
105730207|NCT02143414|364667566|FG001|Maintenance|On protocol treatment|6|||
105730208|NCT03528681|364667570|FG000|Open-Label Phase|Physician Decision|2|||
105730209|NCT03528681|364667571|FG001|Open-Label Phase|Physician Decision|0|||
105730210|NCT03528681|364667572|FG002|Open-Label Phase|Physician Decision|0|||
105730211|NCT03528681|364667573|FG003|Open-Label Phase|Physician Decision|0|||
105730212|NCT03528681|364667570|FG000|Open-Label Phase|Withdrawal by Subject|8|||
105730213|NCT03528681|364667571|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105730214|NCT03528681|364667572|FG002|Open-Label Phase|Withdrawal by Subject|0|||
105730215|NCT03528681|364667573|FG003|Open-Label Phase|Withdrawal by Subject|0|||
105730216|NCT03528681|364667570|FG000|Open-Label Phase|(Not collected)|4|||
105730217|NCT03528681|364667571|FG001|Open-Label Phase|(Not collected)|0|||
105730218|NCT03528681|364667572|FG002|Open-Label Phase|(Not collected)|0|||
105730219|NCT03528681|364667573|FG003|Open-Label Phase|(Not collected)|0|||
105730220|NCT03528681|364667570|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
105730221|NCT03528681|364667571|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
105730222|NCT03528681|364667572|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
105730223|NCT03528681|364667573|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
105730224|NCT03528681|364667570|FG000|Randomized Treatment Phase|Physician Decision|0|||
105730225|NCT03528681|364667571|FG001|Randomized Treatment Phase|Physician Decision|5|||
105730226|NCT03528681|364667572|FG002|Randomized Treatment Phase|Physician Decision|1|||
105730227|NCT03528681|364667573|FG003|Randomized Treatment Phase|Physician Decision|2|||
105730228|NCT03528681|364667570|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
105730229|NCT03528681|364667571|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
105730230|NCT03528681|364667572|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
105730231|NCT03528681|364667573|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
105730232|NCT03528681|364667570|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
105730233|NCT03528681|364667571|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
105730234|NCT03528681|364667572|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
105730235|NCT03528681|364667573|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
105730236|NCT03528681|364667570|FG000|Randomized Treatment Phase|(Not collected)|0|||
105730237|NCT03528681|364667571|FG001|Randomized Treatment Phase|(Not collected)|4|||
105730238|NCT03528681|364667572|FG002|Randomized Treatment Phase|(Not collected)|6|||
105730239|NCT03528681|364667573|FG003|Randomized Treatment Phase|(Not collected)|5|||
105730240|NCT02243176|364667574|FG000|Overall Study|Other reason|1|||
105730241|NCT02243176|364667575|FG001|Overall Study|Other reason|2|||
105730242|NCT02243176|364667574|FG000|Overall Study|protocol specified withdrawal critera|1|||
105730243|NCT02243176|364667575|FG001|Overall Study|protocol specified withdrawal critera|3|||
105730244|NCT02243176|364667574|FG000|Overall Study|Protocol Violation|2|||
105730245|NCT02243176|364667575|FG001|Overall Study|Protocol Violation|1|||
105730246|NCT02243176|364667574|FG000|Overall Study|Withdrawal by Subject|8|||
105730247|NCT02243176|364667575|FG001|Overall Study|Withdrawal by Subject|7|||
105730248|NCT02243176|364667574|FG000|Overall Study|Adverse Event|2|||
105730249|NCT02243176|364667575|FG001|Overall Study|Adverse Event|2|||
105730250|NCT01056107|364667576|FG000|Overall Study|Withdrawal by Subject|0|||
105730251|NCT01056107|364667577|FG001|Overall Study|Withdrawal by Subject|1|||
105730252|NCT01056107|364667578|FG002|Overall Study|Withdrawal by Subject|3|||
105730253|NCT01056107|364667579|FG003|Overall Study|Withdrawal by Subject|0|||
105730254|NCT03404960|364667580|FG000|Overall Study|Adverse Event|0|||
105730255|NCT03404960|364667581|FG001|Overall Study|Adverse Event|2|||
105730256|NCT03404960|364667580|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
105730257|NCT03404960|364667581|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
105730258|NCT03404960|364667580|FG000|Overall Study|Bowel obstruction|0|||
105730259|NCT03404960|364667581|FG001|Overall Study|Bowel obstruction|1|||
105730260|NCT03404960|364667580|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
105730261|NCT03404960|364667581|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
105730262|NCT02629393|364667582|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
105730263|NCT02629393|364667582|FG000|Overall Study|Physician Decision|1|||
105730264|NCT00374556|364667585|FG000|Overall Study|Lost to Follow-up|1|||
105730265|NCT00374556|364667586|FG001|Overall Study|Lost to Follow-up|0|||
105730266|NCT00374556|364667585|FG000|Overall Study|Removed at baseline due to medical cond|0|||
105730267|NCT00374556|364667586|FG001|Overall Study|Removed at baseline due to medical cond|1|||
105730268|NCT03716726|364667587|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
105730269|NCT03716726|364667588|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
105730270|NCT03716726|364667587|FG000|12 Months Followup|Lost to Follow-up|10|||
105730271|NCT03716726|364667588|FG001|12 Months Followup|Lost to Follow-up|17|||
105730272|NCT01756157|364667591|FG000|First Intervention Period|Withdrawal by Subject|1|||
105730273|NCT01756157|364667592|FG001|First Intervention Period|Withdrawal by Subject|0|||
105730274|NCT01756157|364667591|FG000|First Intervention Period|Lost to Follow-up|0|||
105730275|NCT01756157|364667592|FG001|First Intervention Period|Lost to Follow-up|2|||
105730276|NCT04430348|364667593|FG000|Overall Study|Death|3|||
105730277|NCT04430348|364667594|FG001|Overall Study|Death|2|||
105730278|NCT04430348|364667595|FG002|Overall Study|Death|2|||
105730279|NCT04430348|364667596|FG003|Overall Study|Death|2|||
105730280|NCT04430348|364667597|FG004|Overall Study|Death|2|||
105730281|NCT04430348|364667598|FG005|Overall Study|Death|3|||
105730282|NCT04430348|364667593|FG000|Overall Study|Lost to Follow-up|0|||
105730283|NCT04430348|364667594|FG001|Overall Study|Lost to Follow-up|0|||
105730284|NCT04430348|364667595|FG002|Overall Study|Lost to Follow-up|0|||
105730285|NCT04430348|364667596|FG003|Overall Study|Lost to Follow-up|1|||
105730286|NCT04430348|364667597|FG004|Overall Study|Lost to Follow-up|0|||
105730287|NCT04430348|364667598|FG005|Overall Study|Lost to Follow-up|0|||
105730288|NCT04430348|364667593|FG000|Overall Study|Adverse Event|0|||
105730289|NCT04430348|364667594|FG001|Overall Study|Adverse Event|0|||
105730290|NCT04430348|364667595|FG002|Overall Study|Adverse Event|0|||
105730291|NCT04430348|364667596|FG003|Overall Study|Adverse Event|0|||
105730292|NCT04430348|364667597|FG004|Overall Study|Adverse Event|0|||
105730293|NCT04430348|364667598|FG005|Overall Study|Adverse Event|1|||
105730294|NCT04430348|364667593|FG000|Overall Study|Withdrawal by Subject|0|||
105730295|NCT04430348|364667594|FG001|Overall Study|Withdrawal by Subject|1|||
105730296|NCT04430348|364667595|FG002|Overall Study|Withdrawal by Subject|0|||
105730297|NCT04430348|364667596|FG003|Overall Study|Withdrawal by Subject|0|||
105730298|NCT04430348|364667597|FG004|Overall Study|Withdrawal by Subject|0|||
105730299|NCT04430348|364667598|FG005|Overall Study|Withdrawal by Subject|1|||
105730300|NCT04430348|364667593|FG000|Overall Study|Study Terminated by Sponsor|0|||
105730301|NCT04430348|364667594|FG001|Overall Study|Study Terminated by Sponsor|0|||
105730302|NCT04430348|364667595|FG002|Overall Study|Study Terminated by Sponsor|2|||
105730303|NCT04430348|364667596|FG003|Overall Study|Study Terminated by Sponsor|0|||
105730304|NCT04430348|364667597|FG004|Overall Study|Study Terminated by Sponsor|1|||
105730305|NCT04430348|364667598|FG005|Overall Study|Study Terminated by Sponsor|1|||
105730306|NCT04331899|364667608|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
105730307|NCT04331899|364667609|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
105730308|NCT00719810|364667612|FG000|Overall Study|Adverse Event|0|||
105730309|NCT00719810|364667613|FG001|Overall Study|Adverse Event|2|||
105730310|NCT00719810|364667614|FG002|Overall Study|Adverse Event|3|||
105730311|NCT00719810|364667612|FG000|Overall Study|Lost to Follow-up|2|||
105730312|NCT00719810|364667613|FG001|Overall Study|Lost to Follow-up|0|||
105730313|NCT00719810|364667614|FG002|Overall Study|Lost to Follow-up|3|||
105730314|NCT00719810|364667612|FG000|Overall Study|Physician Decision|0|||
105730315|NCT00719810|364667613|FG001|Overall Study|Physician Decision|1|||
105730316|NCT00719810|364667614|FG002|Overall Study|Physician Decision|0|||
105730317|NCT00719810|364667612|FG000|Overall Study|Withdrawal by Subject|1|||
105730318|NCT00719810|364667613|FG001|Overall Study|Withdrawal by Subject|1|||
105730319|NCT00719810|364667614|FG002|Overall Study|Withdrawal by Subject|2|||
105730320|NCT02024464|364667617|FG000|Overall Study|Discontinued|5|||
105730321|NCT02024464|364667618|FG001|Overall Study|Discontinued|4|||
105730322|NCT02024464|364667617|FG000|Overall Study|Missed Visits|1|||
105730323|NCT02024464|364667618|FG001|Overall Study|Missed Visits|0|||
105730324|NCT02024464|364667617|FG000|Overall Study|Lost to Follow-up|4|||
105730325|NCT02024464|364667618|FG001|Overall Study|Lost to Follow-up|7|||
105730326|NCT03976401|364667621|FG000|Overall Study|Adverse Event|2|||
105730327|NCT03976401|364667622|FG001|Overall Study|Adverse Event|0|||
105730328|NCT03976401|364667623|FG002|Overall Study|Adverse Event|4|||
105730329|NCT03976401|364667624|FG003|Overall Study|Adverse Event|1|||
105730330|NCT03976401|364667625|FG004|Overall Study|Adverse Event|1|||
105730331|NCT03976401|364667626|FG005|Overall Study|Adverse Event|0|||
105730332|NCT03976401|364667621|FG000|Overall Study|Withdrawal by Subject|0|||
105730333|NCT03976401|364667622|FG001|Overall Study|Withdrawal by Subject|1|||
105730334|NCT03976401|364667623|FG002|Overall Study|Withdrawal by Subject|0|||
105730335|NCT03976401|364667624|FG003|Overall Study|Withdrawal by Subject|0|||
105730336|NCT03976401|364667625|FG004|Overall Study|Withdrawal by Subject|0|||
105730337|NCT03976401|364667626|FG005|Overall Study|Withdrawal by Subject|1|||
105730338|NCT03976401|364667621|FG000|Overall Study|Physician Decision|0|||
105730339|NCT03976401|364667622|FG001|Overall Study|Physician Decision|0|||
105730340|NCT03976401|364667623|FG002|Overall Study|Physician Decision|1|||
105730341|NCT03976401|364667624|FG003|Overall Study|Physician Decision|0|||
105730342|NCT03976401|364667625|FG004|Overall Study|Physician Decision|0|||
105730343|NCT03976401|364667626|FG005|Overall Study|Physician Decision|0|||
105730344|NCT03976401|364667621|FG000|Overall Study|Lost to Follow-up|1|||
105730345|NCT03976401|364667622|FG001|Overall Study|Lost to Follow-up|2|||
105730346|NCT03976401|364667623|FG002|Overall Study|Lost to Follow-up|0|||
105730347|NCT03976401|364667624|FG003|Overall Study|Lost to Follow-up|0|||
105730348|NCT03976401|364667625|FG004|Overall Study|Lost to Follow-up|0|||
105730349|NCT03976401|364667626|FG005|Overall Study|Lost to Follow-up|0|||
105730350|NCT03976401|364667621|FG000|Overall Study|Protocol Violation|0|||
105730351|NCT03976401|364667622|FG001|Overall Study|Protocol Violation|1|||
105730352|NCT03976401|364667623|FG002|Overall Study|Protocol Violation|0|||
105730353|NCT03976401|364667624|FG003|Overall Study|Protocol Violation|0|||
105730354|NCT03976401|364667625|FG004|Overall Study|Protocol Violation|0|||
105730355|NCT03976401|364667626|FG005|Overall Study|Protocol Violation|0|||
105796838|NCT01612702|364914580|FG000|Overall Study|Protocol Violation|11|||
105796839|NCT01612702|364914581|FG001|Overall Study|Protocol Violation|11|||
105796840|NCT03070431|364914582|FG000|Overall Study|Withdrawal by Subject|2|||
105796841|NCT03070431|364914582|FG000|Overall Study|Lost to Follow-up|2|||
105796842|NCT03674827|364914583|FG000|Treatment Phase|Adverse Event|0|||
105796843|NCT03674827|364914584|FG001|Treatment Phase|Adverse Event|0|||
105796844|NCT03674827|364914585|FG002|Treatment Phase|Adverse Event|0|||
105796845|NCT03674827|364914586|FG003|Treatment Phase|Adverse Event|0|||
105796846|NCT03674827|364914587|FG004|Treatment Phase|Adverse Event|0|||
105796847|NCT03674827|364914588|FG005|Treatment Phase|Adverse Event|2|||
105796848|NCT03674827|364914583|FG000|Treatment Phase|Death|2|||
105796849|NCT03674827|364914584|FG001|Treatment Phase|Death|0|||
105796850|NCT03674827|364914585|FG002|Treatment Phase|Death|0|||
105796851|NCT03674827|364914586|FG003|Treatment Phase|Death|0|||
105796852|NCT03674827|364914587|FG004|Treatment Phase|Death|1|||
105796853|NCT03674827|364914588|FG005|Treatment Phase|Death|0|||
105796854|NCT03674827|364914583|FG000|Treatment Phase|Progressive Disease|0|||
105796855|NCT03674827|364914584|FG001|Treatment Phase|Progressive Disease|4|||
105796856|NCT03674827|364914585|FG002|Treatment Phase|Progressive Disease|3|||
105796857|NCT03674827|364914586|FG003|Treatment Phase|Progressive Disease|4|||
105796858|NCT03674827|364914587|FG004|Treatment Phase|Progressive Disease|4|||
105796859|NCT03674827|364914588|FG005|Treatment Phase|Progressive Disease|9|||
105796860|NCT03674827|364914583|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
105796861|NCT03674827|364914584|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
105796862|NCT03674827|364914585|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
105796863|NCT03674827|364914586|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
105796864|NCT03674827|364914587|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
105796865|NCT03674827|364914588|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
105796866|NCT03674827|364914583|FG000|Treatment Phase|Withdrawal by Subject|0|||
105796867|NCT03674827|364914584|FG001|Treatment Phase|Withdrawal by Subject|0|||
105796868|NCT03674827|364914585|FG002|Treatment Phase|Withdrawal by Subject|0|||
105796869|NCT03674827|364914586|FG003|Treatment Phase|Withdrawal by Subject|0|||
105796870|NCT03674827|364914587|FG004|Treatment Phase|Withdrawal by Subject|0|||
105730356|NCT03976401|364667621|FG000|Overall Study|Withdrew Consent|0|||
105730357|NCT03976401|364667622|FG001|Overall Study|Withdrew Consent|0|||
105730358|NCT03976401|364667623|FG002|Overall Study|Withdrew Consent|0|||
105730359|NCT03976401|364667624|FG003|Overall Study|Withdrew Consent|1|||
105730360|NCT03976401|364667625|FG004|Overall Study|Withdrew Consent|0|||
105730361|NCT03976401|364667626|FG005|Overall Study|Withdrew Consent|0|||
105730362|NCT01973283|364667633|FG000|Overall Study|Lost to Follow-up|4|||
105730363|NCT03941548|364667635|FG000|Overall Study|Adverse Event|0|||
105730364|NCT03941548|364667636|FG001|Overall Study|Adverse Event|1|||
105730365|NCT03941548|364667635|FG000|Overall Study|Lost to Follow-up|0|||
105730366|NCT03941548|364667636|FG001|Overall Study|Lost to Follow-up|1|||
105730367|NCT03941548|364667635|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
105730368|NCT03941548|364667636|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
105730369|NCT03717922|364667639|FG000|Overall Study|Lost to Follow-up|2|||
105730370|NCT03717922|364667640|FG001|Overall Study|Lost to Follow-up|2|||
105796871|NCT03674827|364914588|FG005|Treatment Phase|Withdrawal by Subject|1|||
105796872|NCT03674827|364914583|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
105796873|NCT03674827|364914584|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
105796874|NCT03674827|364914585|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
105796875|NCT03674827|364914586|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
105796876|NCT03674827|364914587|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
105796877|NCT03674827|364914588|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
105796878|NCT03674827|364914583|FG000|Treatment Phase|Other|0|||
105796879|NCT03674827|364914584|FG001|Treatment Phase|Other|1|||
105796880|NCT03674827|364914585|FG002|Treatment Phase|Other|0|||
105796881|NCT03674827|364914586|FG003|Treatment Phase|Other|0|||
105796882|NCT03674827|364914587|FG004|Treatment Phase|Other|0|||
105796883|NCT03674827|364914588|FG005|Treatment Phase|Other|1|||
105796884|NCT03674827|364914583|FG000|Long-Term Follow-up Phase|Death|2|||
105796885|NCT03674827|364914584|FG001|Long-Term Follow-up Phase|Death|4|||
105796886|NCT03674827|364914585|FG002|Long-Term Follow-up Phase|Death|2|||
105796887|NCT03674827|364914586|FG003|Long-Term Follow-up Phase|Death|3|||
105796888|NCT03674827|364914587|FG004|Long-Term Follow-up Phase|Death|2|||
105796889|NCT03674827|364914588|FG005|Long-Term Follow-up Phase|Death|6|||
105730371|NCT02015819|364667646|FG000|Overall Study|Rickham catheter was misaligned|0|||
105730372|NCT02015819|364667647|FG001|Overall Study|Rickham catheter was misaligned|0|||
105730373|NCT02015819|364667648|FG002|Overall Study|Rickham catheter was misaligned|0|||
105730374|NCT02015819|364667649|FG003|Overall Study|Rickham catheter was misaligned|1|||
105730375|NCT03230097|364667650|FG000|Overall Study|Adverse Event|2|||
105796890|NCT03674827|364914583|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
105796891|NCT03674827|364914584|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
105796892|NCT03674827|364914585|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
105796893|NCT03674827|364914586|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
105730376|NCT03230097|364667651|FG001|Overall Study|Adverse Event|1|||
105730377|NCT03230097|364667650|FG000|Overall Study|non-compliance|0|||
105730378|NCT03230097|364667651|FG001|Overall Study|non-compliance|1|||
105730379|NCT03230097|364667650|FG000|Overall Study|Lost to Follow-up|2|||
105730380|NCT03230097|364667651|FG001|Overall Study|Lost to Follow-up|4|||
105730381|NCT03230097|364667650|FG000|Overall Study|Withdrawal by Subject|7|||
105730382|NCT03230097|364667651|FG001|Overall Study|Withdrawal by Subject|3|||
105730383|NCT03230097|364667650|FG000|Overall Study|Trial termination|4|||
105730384|NCT03230097|364667651|FG001|Overall Study|Trial termination|5|||
105730385|NCT03230097|364667650|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
105730386|NCT03230097|364667651|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
105730387|NCT03230097|364667650|FG000|Overall Study|outcome event|0|||
105730388|NCT03230097|364667651|FG001|Overall Study|outcome event|1|||
105730389|NCT01697215|364667657|FG000|Overall Study|Physician Decision|5|||
105730390|NCT01697215|364667657|FG000|Overall Study|Malfunction|9|||
105730391|NCT01697215|364667657|FG000|Overall Study|CXR not available|9|||
105730392|NCT04899271|364667658|FG000|Overall Study|Lost to Follow-up|1|||
105730393|NCT04899271|364667659|FG001|Overall Study|Lost to Follow-up|0|||
105730394|NCT04899271|364667658|FG000|Overall Study|Subject request/consent withdrawal|2|||
105730395|NCT04899271|364667659|FG001|Overall Study|Subject request/consent withdrawal|0|||
105730396|NCT01929083|364667660|FG000|Intervention 1|Lost to Follow-up|2|||
105730397|NCT01929083|364667661|FG001|Intervention 1|Lost to Follow-up|0|||
105730398|NCT01929083|364667660|FG000|Intervention 1|Nonadherent to study medications|1|||
105730399|NCT01929083|364667661|FG001|Intervention 1|Nonadherent to study medications|0|||
105730400|NCT01929083|364667660|FG000|Intervention 2|Adverse Event|0|||
105730401|NCT01929083|364667661|FG001|Intervention 2|Adverse Event|1|||
105730402|NCT00900796|364667664|FG000|Phase 1|Lacked sufficient information|4|||
105730403|NCT00900796|364667664|FG000|Phase 1|Missing information at Week 16|7|||
105730404|NCT00900796|364667664|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
105730405|NCT00900796|364667664|FG000|Phase 2|Lost to Follow-up|5|||
105730406|NCT02945657|364667665|FG000|Overall Study|Adverse Event|1|||
105730407|NCT02945657|364667665|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
105730408|NCT01859403|364667675|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
105730409|NCT01859403|364667676|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
105730410|NCT01859403|364667675|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
105730411|NCT01859403|364667676|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
105730412|NCT01859403|364667675|FG000|Primary Endpoint Measure|Physician Decision|0|||
105730413|NCT01859403|364667676|FG001|Primary Endpoint Measure|Physician Decision|1|||
105730414|NCT01859403|364667675|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
105730415|NCT01859403|364667676|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
105730416|NCT00811252|364667681|FG000|Overall Study|Adverse Event|6|||
105730417|NCT00811252|364667682|FG001|Overall Study|Adverse Event|10|||
105730418|NCT00811252|364667683|FG002|Overall Study|Adverse Event|15|||
105730419|NCT00811252|364667681|FG000|Overall Study|Lack of Efficacy|7|||
105730420|NCT00811252|364667682|FG001|Overall Study|Lack of Efficacy|2|||
105730421|NCT00811252|364667683|FG002|Overall Study|Lack of Efficacy|0|||
105730422|NCT00811252|364667681|FG000|Overall Study|Protocol Violation|3|||
105730423|NCT00811252|364667682|FG001|Overall Study|Protocol Violation|3|||
105730424|NCT00811252|364667683|FG002|Overall Study|Protocol Violation|2|||
105730425|NCT00811252|364667681|FG000|Overall Study|Withdrawal of Consent|1|||
105730426|NCT00811252|364667682|FG001|Overall Study|Withdrawal of Consent|2|||
105730427|NCT00811252|364667683|FG002|Overall Study|Withdrawal of Consent|2|||
105730428|NCT00811252|364667681|FG000|Overall Study|Lost to Follow-up|0|||
105796894|NCT03674827|364914587|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
105796895|NCT03674827|364914588|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
105730429|NCT00811252|364667682|FG001|Overall Study|Lost to Follow-up|0|||
105730430|NCT00811252|364667683|FG002|Overall Study|Lost to Follow-up|2|||
105730431|NCT00811252|364667681|FG000|Overall Study|Administrative or Other Reasons|0|||
105730432|NCT00811252|364667682|FG001|Overall Study|Administrative or Other Reasons|3|||
105730433|NCT00811252|364667683|FG002|Overall Study|Administrative or Other Reasons|2|||
105730434|NCT00813748|364667684|FG000|Skin Test Substudy|Physician Decision|0|||
105730435|NCT00813748|364667685|FG001|Skin Test Substudy|Physician Decision|1|||
105730436|NCT00892437|364667686|FG000|Randomized Phase|Randomized but not treated|6|||
105730437|NCT00892437|364667687|FG001|Randomized Phase|Randomized but not treated|0|||
105730438|NCT00892437|364667686|FG000|Randomized Phase|Adverse Event|2|||
105796896|NCT03674827|364914583|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
105730439|NCT00892437|364667687|FG001|Randomized Phase|Adverse Event|2|||
105730440|NCT00892437|364667686|FG000|Randomized Phase|Lost to Follow-up|1|||
105730441|NCT00892437|364667687|FG001|Randomized Phase|Lost to Follow-up|3|||
105730442|NCT00892437|364667686|FG000|Randomized Phase|Investigator's Discretion|1|||
105730443|NCT00892437|364667687|FG001|Randomized Phase|Investigator's Discretion|0|||
105730444|NCT00892437|364667686|FG000|Randomized Phase|Withdrew Consent|1|||
105730445|NCT00892437|364667687|FG001|Randomized Phase|Withdrew Consent|0|||
105730446|NCT00892437|364667686|FG000|Open-Label Extension Phase|Adverse Event|4|||
105730447|NCT00892437|364667687|FG001|Open-Label Extension Phase|Adverse Event|2|||
105796897|NCT03674827|364914584|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
105796898|NCT03674827|364914585|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
105796899|NCT03674827|364914586|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
105796900|NCT03674827|364914587|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
105796901|NCT03674827|364914588|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
105796902|NCT02624518|364914589|FG000|Overall Study|Physician Decision|1|||
105796903|NCT00370396|364914590|FG000|Overall Study|Withdrawal by Subject|0|||
105796904|NCT00370396|364914591|FG001|Overall Study|Withdrawal by Subject|0|||
105796905|NCT00370396|364914592|FG002|Overall Study|Withdrawal by Subject|1|||
105730448|NCT00892437|364667686|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
105730449|NCT00892437|364667687|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
105730450|NCT00892437|364667686|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
105730451|NCT00892437|364667687|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
105730452|NCT00892437|364667686|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
105730453|NCT00892437|364667687|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
105730454|NCT00892437|364667686|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
105730455|NCT00892437|364667687|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
105730456|NCT02750410|364667688|FG000|Double-Blind Treatment Period|Adverse Event|2|||
105730457|NCT02750410|364667689|FG001|Double-Blind Treatment Period|Adverse Event|2|||
105730458|NCT02750410|364667688|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105730459|NCT02750410|364667689|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105730460|NCT02750410|364667688|FG000|Open-Label Extension Period|Adverse Event|5|||
105730461|NCT02750410|364667689|FG001|Open-Label Extension Period|Adverse Event|3|||
105730462|NCT02750410|364667688|FG000|Open-Label Extension Period|Protocol Violation|0|||
105730463|NCT02750410|364667689|FG001|Open-Label Extension Period|Protocol Violation|1|||
105730464|NCT02750410|364667688|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
105730465|NCT02750410|364667689|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
105730466|NCT02500550|364667697|FG000|Overall Study|Death|7|||
105730467|NCT00659438|364667698|FG000|Overall Study|Withdrawal by Subject|2|||
105730468|NCT00659438|364667699|FG001|Overall Study|Withdrawal by Subject|2|||
105730469|NCT00659438|364667698|FG000|Overall Study|Death|11|||
105730470|NCT00659438|364667699|FG001|Overall Study|Death|6|||
105730471|NCT00659438|364667698|FG000|Overall Study|Lost to Follow-up|1|||
105730472|NCT00659438|364667699|FG001|Overall Study|Lost to Follow-up|0|||
105730473|NCT00246259|364667700|FG000|Overall Study|Other|3|||
105730474|NCT00246259|364667701|FG001|Overall Study|Other|3|||
105730475|NCT00246259|364667700|FG000|Overall Study|Not stable by Week 18|2|||
105730476|NCT00246259|364667701|FG001|Overall Study|Not stable by Week 18|1|||
105730477|NCT00246259|364667700|FG000|Overall Study|Participant non-compliant|4|||
105730478|NCT00246259|364667701|FG001|Overall Study|Participant non-compliant|9|||
105730479|NCT00246259|364667700|FG000|Overall Study|Lack of Efficacy|2|||
105730480|NCT00246259|364667701|FG001|Overall Study|Lack of Efficacy|2|||
105730481|NCT00246259|364667700|FG000|Overall Study|Investigator withdrew participant|2|||
105730482|NCT00246259|364667701|FG001|Overall Study|Investigator withdrew participant|0|||
105730483|NCT00246259|364667700|FG000|Overall Study|Adverse Event|5|||
105730484|NCT00246259|364667701|FG001|Overall Study|Adverse Event|0|||
105730485|NCT00246259|364667700|FG000|Overall Study|Lost to Follow-up|3|||
105730486|NCT00246259|364667701|FG001|Overall Study|Lost to Follow-up|4|||
105730487|NCT00246259|364667700|FG000|Overall Study|Withdrawal by Subject|5|||
105730488|NCT00246259|364667701|FG001|Overall Study|Withdrawal by Subject|1|||
105730489|NCT00246259|364667700|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
105730490|NCT00246259|364667701|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
105730491|NCT03133767|364667708|FG000|Overall Study|Lost to Follow-up|38|||
105730492|NCT03133767|364667709|FG001|Overall Study|Lost to Follow-up|24|||
105730493|NCT03133767|364667708|FG000|Overall Study|Protocol Violation|0|||
105730494|NCT03133767|364667709|FG001|Overall Study|Protocol Violation|1|||
105730495|NCT03517436|364667710|FG000|Overall Study|Death|3|||
105730496|NCT03517436|364667710|FG000|Overall Study|Withdrawal by Subject|4|||
105730497|NCT03517436|364667710|FG000|Overall Study|Did not receive study valve.|1|||
105730498|NCT02698189|364667713|FG000|Overall Study|Physician Decision|3|||
105730499|NCT02698189|364667714|FG001|Overall Study|Physician Decision|0|||
105730500|NCT02698189|364667713|FG000|Overall Study|Progressive disease|0|||
105730501|NCT02698189|364667714|FG001|Overall Study|Progressive disease|5|||
105730502|NCT02698189|364667713|FG000|Overall Study|Study terminated by sponsor|0|||
105796906|NCT00370396|364914590|FG000|Overall Study|Lost to Follow-up|11|||
106009549|NCT01310777|365700873|FG001|Overall Study|Lost to Follow-up|4|||
105730503|NCT02698189|364667714|FG001|Overall Study|Study terminated by sponsor|1|||
105730504|NCT03301857|364667720|FG000|Overall Study|Death|0|||
105730505|NCT03301857|364667721|FG001|Overall Study|Death|2|||
105730506|NCT03301857|364667720|FG000|Overall Study|Lost to Follow-up|4|||
105730507|NCT03301857|364667721|FG001|Overall Study|Lost to Follow-up|2|||
106009550|NCT01310777|365700874|FG002|Overall Study|Lost to Follow-up|1|||
105730508|NCT03301857|364667720|FG000|Overall Study|Decision by Sponsor|6|||
105730509|NCT03301857|364667721|FG001|Overall Study|Decision by Sponsor|0|||
105730510|NCT03301857|364667720|FG000|Overall Study|Withdrawal by Subject|12|||
105730511|NCT03301857|364667721|FG001|Overall Study|Withdrawal by Subject|4|||
105796907|NCT00370396|364914591|FG001|Overall Study|Lost to Follow-up|1|||
105796908|NCT00370396|364914592|FG002|Overall Study|Lost to Follow-up|0|||
105796909|NCT00061945|364914594|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
105796910|NCT00061945|364914595|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
105796911|NCT00061945|364914594|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
105796912|NCT00061945|364914595|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
105796913|NCT00061945|364914594|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
105796914|NCT00061945|364914595|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
105796915|NCT00061945|364914594|FG000|Course IV: Alemtuzumab|Early exits|6|||
105796916|NCT00061945|364914595|FG001|Course IV: Alemtuzumab|Early exits|15|||
105796917|NCT03611751|364914596|FG000|Pre-treatment|Randomized but not treated|1|||
105796918|NCT03611751|364914597|FG001|Pre-treatment|Randomized but not treated|1|||
105796919|NCT03611751|364914598|FG002|Pre-treatment|Randomized but not treated|0|||
105796920|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
105796921|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
105796922|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
105796923|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
105796924|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
105796925|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
105796926|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
105796927|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
105796928|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
105796929|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
105796930|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
105796931|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
105796932|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
105796933|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
105796934|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
105796935|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
105796936|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
105796937|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
105796938|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
105796939|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
105796940|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
105796941|NCT03611751|364914596|FG000|Treatment Week 0 - Week 16|Death|0|||
105796942|NCT03611751|364914597|FG001|Treatment Week 0 - Week 16|Death|0|||
105796943|NCT03611751|364914598|FG002|Treatment Week 0 - Week 16|Death|1|||
105796944|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
105796945|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
105796946|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
105796947|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
105796948|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
105796949|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
105796950|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
105796951|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
105796952|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
105796953|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
105796954|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
105796955|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
105796956|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
105796957|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
105796958|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
105796959|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
105796960|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
105796961|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
105796962|NCT03611751|364914596|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
105796963|NCT03611751|364914597|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
105796964|NCT03611751|364914598|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
105796965|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
105796966|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
105796967|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
105796968|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
105796969|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
105796970|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
105796971|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
105796972|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
105796973|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
105796974|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
105796975|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
105796976|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
105796977|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
106009551|NCT01310777|365700872|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
105796978|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
105796979|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
105796980|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
105796981|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
105796982|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
105796983|NCT03611751|364914596|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
105796984|NCT03611751|364914597|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
105796985|NCT03611751|364914598|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
105796986|NCT01238211|364914599|FG000|Overall Study|Continues active treatment|31|||
105796987|NCT01238211|364914599|FG000|Overall Study|Adverse Event|7|||
105796988|NCT01238211|364914599|FG000|Overall Study|Death|4|||
105796989|NCT01238211|364914599|FG000|Overall Study|Relapse/Progression|2|||
105796990|NCT01238211|364914599|FG000|Overall Study|Withdrawal by Subject|7|||
105796991|NCT01238211|364914599|FG000|Overall Study|Non-protocol treatment|4|||
105796992|NCT01238211|364914599|FG000|Overall Study|Investigator/Patient Decision|3|||
105796993|NCT03707522|364914602|FG000|Overall Study|Lost to Follow-up|24|||
105796994|NCT03707522|364914603|FG001|Overall Study|Lost to Follow-up|27|||
105796995|NCT03707522|364914604|FG002|Overall Study|Lost to Follow-up|41|||
105796996|NCT03707522|364914605|FG003|Overall Study|Lost to Follow-up|36|||
105796997|NCT00725725|364914611|FG000|Overall Study|Adverse Event|1|||
105796998|NCT00725725|364914612|FG001|Overall Study|Adverse Event|3|||
105796999|NCT00725725|364914613|FG002|Overall Study|Adverse Event|2|||
105797000|NCT00725725|364914611|FG000|Overall Study|Lost to Follow-up|2|||
105797001|NCT00725725|364914612|FG001|Overall Study|Lost to Follow-up|0|||
105797002|NCT00725725|364914613|FG002|Overall Study|Lost to Follow-up|2|||
105797003|NCT00725725|364914611|FG000|Overall Study|Withdrawal by Subject|1|||
105797004|NCT00725725|364914612|FG001|Overall Study|Withdrawal by Subject|0|||
105797005|NCT00725725|364914613|FG002|Overall Study|Withdrawal by Subject|1|||
105797006|NCT00725725|364914611|FG000|Overall Study|Protocol Violation|0|||
105797007|NCT00725725|364914612|FG001|Overall Study|Protocol Violation|1|||
105797008|NCT00725725|364914613|FG002|Overall Study|Protocol Violation|0|||
105797009|NCT01619085|364914614|FG000|Overall Study|Adverse Event|231|||
105797010|NCT01619085|364914614|FG000|Overall Study|Protocol Violation|4|||
105797011|NCT01619085|364914614|FG000|Overall Study|Lost to Follow-up|3|||
105797012|NCT01619085|364914614|FG000|Overall Study|Withdrawal by Subject|45|||
105797013|NCT01619085|364914614|FG000|Overall Study|Other than specified|96|||
105797014|NCT01619085|364914614|FG000|Overall Study|Not treated|1|||
105797015|NCT01619085|364914614|FG000|Overall Study|Death|145|||
105797016|NCT03125915|364914615|FG000|1 Month Follow up|Lost to Follow-up|3|||
105797017|NCT03125915|364914616|FG001|1 Month Follow up|Lost to Follow-up|3|||
105797018|NCT03125915|364914617|FG002|1 Month Follow up|Lost to Follow-up|2|||
105797019|NCT03125915|364914618|FG003|1 Month Follow up|Lost to Follow-up|3|||
105797020|NCT03125915|364914615|FG000|3 Month Follow-up|Lost to Follow-up|6|||
105797021|NCT03125915|364914616|FG001|3 Month Follow-up|Lost to Follow-up|4|||
105797022|NCT03125915|364914617|FG002|3 Month Follow-up|Lost to Follow-up|4|||
105797023|NCT03125915|364914618|FG003|3 Month Follow-up|Lost to Follow-up|2|||
105797024|NCT03125915|364914615|FG000|6 Month Follow-up|Lost to Follow-up|7|||
105797025|NCT03125915|364914616|FG001|6 Month Follow-up|Lost to Follow-up|3|||
105797026|NCT03125915|364914617|FG002|6 Month Follow-up|Lost to Follow-up|6|||
105797027|NCT03125915|364914618|FG003|6 Month Follow-up|Lost to Follow-up|3|||
105797028|NCT00743119|364914619|FG000|Overall Study|unreliable|3|||
105797029|NCT00743119|364914619|FG000|Overall Study|Withdrawal by Subject|1|||
105797030|NCT03909971|364914620|FG000|Overall Study|Other Reasons Not Specified|0|||
105797031|NCT03909971|364914621|FG001|Overall Study|Other Reasons Not Specified|1|||
105797032|NCT03909971|364914620|FG000|Overall Study|Global Deterioration of Health Status|2|||
105797033|NCT03909971|364914621|FG001|Overall Study|Global Deterioration of Health Status|1|||
105797034|NCT03909971|364914620|FG000|Overall Study|Progressive Disease|6|||
105797035|NCT03909971|364914621|FG001|Overall Study|Progressive Disease|14|||
105797036|NCT03909971|364914620|FG000|Overall Study|Death|2|||
105797037|NCT03909971|364914621|FG001|Overall Study|Death|6|||
105937618|NCT01796470|365431527|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
105937619|NCT01796470|365431528|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
105937620|NCT01796470|365431524|FG000|Overall Study|Withdrawal by Subject|7|||
105937621|NCT01796470|365431525|FG001|Overall Study|Withdrawal by Subject|0|||
105797042|NCT02176642|364914625|FG000|Overall Study|Withdrawal by Subject|0|||
106139067|NCT03425643|366167077|FG001|Overall Study|Ongoing in study|247|||
105797043|NCT02176642|364914626|FG001|Overall Study|Withdrawal by Subject|1|||
105797044|NCT00295620|364914628|FG000|Overall Study|Lost to Follow-up|9|||
105797045|NCT00295620|364914629|FG001|Overall Study|Lost to Follow-up|5|||
105797046|NCT00295620|364914628|FG000|Overall Study|Withdrawal by Subject|37|||
106139068|NCT03141788|366167078|FG000|Overall Study|Lost to Follow-up|1|||
106139069|NCT03141788|366167078|FG000|Overall Study|Protocol Violation|3|||
105797047|NCT00295620|364914629|FG001|Overall Study|Withdrawal by Subject|50|||
105797048|NCT00295620|364914628|FG000|Overall Study|Death|206|||
105797049|NCT00295620|364914629|FG001|Overall Study|Death|207|||
105797050|NCT00295620|364914628|FG000|Overall Study|Other reasons|10|||
105797051|NCT00295620|364914629|FG001|Overall Study|Other reasons|9|||
105937622|NCT01796470|365431526|FG002|Overall Study|Withdrawal by Subject|0|||
105730512|NCT00855439|364667722|FG000|Overall Study|Withdrawal by Subject|2|||
105730513|NCT00855439|364667723|FG001|Overall Study|Withdrawal by Subject|0|||
105730514|NCT00855439|364667722|FG000|Overall Study|Pregnancy|1|||
105730515|NCT00855439|364667723|FG001|Overall Study|Pregnancy|0|||
105730516|NCT01914679|364667726|FG000|Overall Study|Lack of Efficacy|1|||
105730517|NCT01914679|364667726|FG000|Overall Study|Sponsor terminated study|4|||
105730518|NCT01591330|364667732|FG000|Period 1|Adverse Event|1|||
105730519|NCT01591330|364667733|FG001|Period 1|Adverse Event|0|||
105730520|NCT01591330|364667734|FG002|Period 1|Adverse Event|0|||
105730521|NCT01591330|364667735|FG003|Period 1|Adverse Event|0|||
105730522|NCT01591330|364667732|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
105730523|NCT01591330|364667733|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
105730524|NCT01591330|364667734|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
105730525|NCT01591330|364667735|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
105730526|NCT01591330|364667732|FG000|Period 2|Adverse Event|1|||
105730527|NCT01591330|364667733|FG001|Period 2|Adverse Event|0|||
105730528|NCT01591330|364667734|FG002|Period 2|Adverse Event|0|||
105730529|NCT01591330|364667735|FG003|Period 2|Adverse Event|0|||
105730530|NCT00002850|364667738|FG000|Overall Study|Death|4|||
105730531|NCT00002850|364667739|FG001|Overall Study|Death|1|||
105730532|NCT00002850|364667740|FG002|Overall Study|Death|3|||
105730533|NCT00002850|364667738|FG000|Overall Study|Protocol Violation|1|||
105730534|NCT00002850|364667739|FG001|Overall Study|Protocol Violation|0|||
105730535|NCT00002850|364667740|FG002|Overall Study|Protocol Violation|1|||
105730536|NCT00002850|364667738|FG000|Overall Study|Withdrawal by Subject|0|||
105730537|NCT00002850|364667739|FG001|Overall Study|Withdrawal by Subject|1|||
105730538|NCT00002850|364667740|FG002|Overall Study|Withdrawal by Subject|0|||
105730539|NCT01450540|364667741|FG000|Overall Study|Withdrawal by Subject|19|||
105730540|NCT01450540|364667742|FG001|Overall Study|Withdrawal by Subject|13|||
105730541|NCT01450540|364667741|FG000|Overall Study|protocol deviation|3|||
105730542|NCT01450540|364667742|FG001|Overall Study|protocol deviation|23|||
105730543|NCT04800315|364667751|FG000|Randomization|Did not receive study treatment|1|||
105730544|NCT04800315|364667752|FG001|Randomization|Did not receive study treatment|0|||
105730545|NCT04800315|364667753|FG002|Randomization|Did not receive study treatment|0|||
105730546|NCT04800315|364667754|FG003|Randomization|Did not receive study treatment|0|||
105730547|NCT04800315|364667751|FG000|Treatment Period|Adverse Event|4|||
105730548|NCT04800315|364667752|FG001|Treatment Period|Adverse Event|2|||
105730549|NCT04800315|364667753|FG002|Treatment Period|Adverse Event|1|||
105730550|NCT04800315|364667754|FG003|Treatment Period|Adverse Event|2|||
105730551|NCT04800315|364667751|FG000|Treatment Period|Lack of Efficacy|1|||
105730552|NCT04800315|364667752|FG001|Treatment Period|Lack of Efficacy|0|||
105730553|NCT04800315|364667753|FG002|Treatment Period|Lack of Efficacy|0|||
105730554|NCT04800315|364667754|FG003|Treatment Period|Lack of Efficacy|3|||
105730555|NCT04800315|364667751|FG000|Treatment Period|Lost to Follow-up|0|||
105730556|NCT04800315|364667752|FG001|Treatment Period|Lost to Follow-up|1|||
105730557|NCT04800315|364667753|FG002|Treatment Period|Lost to Follow-up|2|||
105730558|NCT04800315|364667754|FG003|Treatment Period|Lost to Follow-up|2|||
105730559|NCT04800315|364667751|FG000|Treatment Period|Withdrawal by participant|0|||
105730560|NCT04800315|364667752|FG001|Treatment Period|Withdrawal by participant|0|||
105730561|NCT04800315|364667753|FG002|Treatment Period|Withdrawal by participant|0|||
105730562|NCT04800315|364667754|FG003|Treatment Period|Withdrawal by participant|4|||
105730563|NCT04800315|364667751|FG000|Treatment Period|Other Reasons|0|||
105730564|NCT04800315|364667752|FG001|Treatment Period|Other Reasons|2|||
105730565|NCT04800315|364667753|FG002|Treatment Period|Other Reasons|0|||
105730566|NCT04800315|364667754|FG003|Treatment Period|Other Reasons|1|||
105730567|NCT04909463|364669236|FG000|Overall Study|Withdrawal by Subject|0|||
105730568|NCT04909463|364669237|FG001|Overall Study|Withdrawal by Subject|1|||
105730569|NCT04909463|364669238|FG002|Overall Study|Withdrawal by Subject|0|||
105730570|NCT04909463|364669239|FG003|Overall Study|Withdrawal by Subject|0|||
105730571|NCT04909463|364669236|FG000|Overall Study|Lost to Follow-up|2|||
105730572|NCT04909463|364669237|FG001|Overall Study|Lost to Follow-up|1|||
105730573|NCT04909463|364669238|FG002|Overall Study|Lost to Follow-up|1|||
105730574|NCT04909463|364669239|FG003|Overall Study|Lost to Follow-up|0|||
105730575|NCT00853632|364669240|FG000|Overall Study|Death|88|||
105730576|NCT00853632|364669240|FG000|Overall Study|Withdrawal by Subject|45|||
105730577|NCT00853632|364669240|FG000|Overall Study|Lost to Follow-up|30|||
105730578|NCT00853632|364669240|FG000|Overall Study|Reoperation/Explant|17|||
105730579|NCT00853632|364669240|FG000|Overall Study|Exit with other reason|22|||
105730580|NCT02128490|364669246|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105730581|NCT02128490|364669247|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
105730582|NCT02128490|364669248|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
105730583|NCT02128490|364669249|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
105730584|NCT02128490|364669250|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
105730585|NCT02128490|364669246|FG000|Overall Study|Major Protocol Deviation|1|||
105730586|NCT02128490|364669247|FG001|Overall Study|Major Protocol Deviation|2|||
105730587|NCT02128490|364669248|FG002|Overall Study|Major Protocol Deviation|0|||
105730588|NCT02128490|364669249|FG003|Overall Study|Major Protocol Deviation|2|||
105730589|NCT02128490|364669250|FG004|Overall Study|Major Protocol Deviation|2|||
105730590|NCT02128490|364669246|FG000|Overall Study|Lost to Follow-up|0|||
105730591|NCT02128490|364669247|FG001|Overall Study|Lost to Follow-up|0|||
105730592|NCT02128490|364669248|FG002|Overall Study|Lost to Follow-up|1|||
105730593|NCT02128490|364669249|FG003|Overall Study|Lost to Follow-up|1|||
105730594|NCT02128490|364669250|FG004|Overall Study|Lost to Follow-up|1|||
105730595|NCT02128490|364669246|FG000|Overall Study|Voluntary Withdrawal|3|||
105730596|NCT02128490|364669247|FG001|Overall Study|Voluntary Withdrawal|3|||
105730597|NCT02128490|364669248|FG002|Overall Study|Voluntary Withdrawal|1|||
105730598|NCT02128490|364669249|FG003|Overall Study|Voluntary Withdrawal|1|||
105730599|NCT02128490|364669250|FG004|Overall Study|Voluntary Withdrawal|2|||
105730600|NCT02128490|364669246|FG000|Overall Study|Lack of Efficacy|0|||
105730601|NCT02128490|364669247|FG001|Overall Study|Lack of Efficacy|1|||
105730602|NCT02128490|364669248|FG002|Overall Study|Lack of Efficacy|0|||
105730603|NCT02128490|364669249|FG003|Overall Study|Lack of Efficacy|0|||
105730604|NCT02128490|364669250|FG004|Overall Study|Lack of Efficacy|0|||
105730605|NCT02128490|364669246|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
105730606|NCT02128490|364669247|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
105730607|NCT02128490|364669248|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
105730608|NCT02128490|364669249|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
105730609|NCT02128490|364669250|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
105730610|NCT02128490|364669246|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105730611|NCT02128490|364669247|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105730612|NCT02128490|364669248|FG002|Overall Study|Other Miscellaneous Reasons|2|||
105730613|NCT02128490|364669249|FG003|Overall Study|Other Miscellaneous Reasons|1|||
105730614|NCT02128490|364669250|FG004|Overall Study|Other Miscellaneous Reasons|1|||
105730615|NCT04024228|364669252|FG000|Overall Study|Adverse Event|1|||
105730616|NCT04024228|364669253|FG001|Overall Study|Adverse Event|0|||
105730617|NCT04024228|364669252|FG000|Overall Study|Protocol Deviation|0|||
105730618|NCT04024228|364669253|FG001|Overall Study|Protocol Deviation|2|||
105730619|NCT04024228|364669252|FG000|Overall Study|Withdrawal by Subject|3|||
105730620|NCT04024228|364669253|FG001|Overall Study|Withdrawal by Subject|4|||
105730621|NCT01614457|364669256|FG000|Overall Study|Non-Compliance|1|||
105730622|NCT01614457|364669257|FG001|Overall Study|Non-Compliance|0|||
105730623|NCT01614457|364669256|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
105730624|NCT01614457|364669257|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
105730625|NCT01584024|364669265|FG000|Overall Study|Lost to Follow-up|10|||
105730626|NCT01584024|364669265|FG000|Overall Study|Withdrawal by Subject|3|||
105730627|NCT01217606|364669266|FG000|Initial Treatment Phase|Other Reasons|0|||
105730628|NCT01217606|364669267|FG001|Initial Treatment Phase|Other Reasons|2|||
105730629|NCT01217606|364669266|FG000|Initial Treatment Phase|Protocol Violation|3|||
105730630|NCT01217606|364669267|FG001|Initial Treatment Phase|Protocol Violation|2|||
105730631|NCT01217606|364669266|FG000|Initial Treatment Phase|Personal Reasons|0|||
105730632|NCT01217606|364669267|FG001|Initial Treatment Phase|Personal Reasons|2|||
105730633|NCT01217606|364669266|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
105730634|NCT01217606|364669267|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
105730635|NCT01217606|364669266|FG000|Initial Treatment Phase|Adverse Event|10|||
105730636|NCT01217606|364669267|FG001|Initial Treatment Phase|Adverse Event|6|||
105730637|NCT01217606|364669266|FG000|9-Month Masked Extension|Adverse Event|3|||
105730638|NCT01217606|364669267|FG001|9-Month Masked Extension|Adverse Event|6|||
105730639|NCT01217606|364669266|FG000|9-Month Masked Extension|Other Reasons|4|||
105730640|NCT01217606|364669267|FG001|9-Month Masked Extension|Other Reasons|4|||
105730641|NCT01217606|364669266|FG000|9-Month Masked Extension|Personal Reasons|2|||
105730642|NCT01217606|364669267|FG001|9-Month Masked Extension|Personal Reasons|1|||
105730643|NCT01217606|364669266|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
105730644|NCT01217606|364669267|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
105730645|NCT01217606|364669266|FG000|9-Month Masked Extension|Pregnancy|1|||
105730646|NCT01217606|364669267|FG001|9-Month Masked Extension|Pregnancy|0|||
105730647|NCT01217606|364669266|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
105730648|NCT01217606|364669267|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
105730649|NCT02586207|364669271|FG000|Overall Study|Physician Decision|1|||
105730650|NCT02586207|364669271|FG000|Overall Study|Withdrawal by Subject|1|||
105730651|NCT02424539|364669272|FG000|Overall Study|Adverse Event|0|||
105730652|NCT02424539|364669273|FG001|Overall Study|Adverse Event|0|||
105730653|NCT02424539|364669274|FG002|Overall Study|Adverse Event|1|||
105730654|NCT02424539|364669272|FG000|Overall Study|Physician Decision|0|||
105730655|NCT02424539|364669273|FG001|Overall Study|Physician Decision|0|||
105730656|NCT02424539|364669274|FG002|Overall Study|Physician Decision|1|||
105730657|NCT02424539|364669272|FG000|Overall Study|Withdrawal by Subject|3|||
105730658|NCT02424539|364669273|FG001|Overall Study|Withdrawal by Subject|1|||
105730659|NCT02424539|364669274|FG002|Overall Study|Withdrawal by Subject|0|||
105730660|NCT02424539|364669272|FG000|Overall Study|Other: Reached stopping criteria|11|||
105730661|NCT02424539|364669273|FG001|Overall Study|Other: Reached stopping criteria|7|||
105730662|NCT02424539|364669274|FG002|Overall Study|Other: Reached stopping criteria|6|||
105730663|NCT04893265|364669277|FG000|Overall Study|Withdrawal by Subject|2|||
105730664|NCT04893265|364669278|FG001|Overall Study|Withdrawal by Subject|5|||
105730665|NCT04893265|364669277|FG000|Overall Study|Lost to Follow-up|0|||
105730666|NCT04893265|364669278|FG001|Overall Study|Lost to Follow-up|4|||
105730667|NCT00573131|364669280|FG000|Overall Study|Withdrawal by Subject|10|||
105730668|NCT00573131|364669281|FG001|Overall Study|Withdrawal by Subject|8|||
105730669|NCT03090191|364669284|FG000|Overall Study|Adverse Event|90|||
105730670|NCT03090191|364669285|FG001|Overall Study|Adverse Event|72|||
105730671|NCT03090191|364669284|FG000|Overall Study|Death|365|||
105730672|NCT03090191|364669285|FG001|Overall Study|Death|358|||
105730673|NCT03090191|364669284|FG000|Overall Study|Lost to Follow-up|382|||
105730674|NCT03090191|364669285|FG001|Overall Study|Lost to Follow-up|394|||
105730675|NCT03090191|364669284|FG000|Overall Study|Physician Decision|77|||
105730676|NCT03090191|364669285|FG001|Overall Study|Physician Decision|66|||
105730677|NCT03090191|364669284|FG000|Overall Study|Protocol Violation|43|||
105730678|NCT03090191|364669285|FG001|Overall Study|Protocol Violation|52|||
105730679|NCT03090191|364669284|FG000|Overall Study|Withdrawal by Subject|2160|||
105730680|NCT03090191|364669285|FG001|Overall Study|Withdrawal by Subject|2133|||
105730681|NCT03090191|364669284|FG000|Overall Study|Site terminated|7|||
105730682|NCT03090191|364669285|FG001|Overall Study|Site terminated|8|||
105730683|NCT03090191|364669284|FG000|Overall Study|Other|66|||
105730684|NCT03090191|364669285|FG001|Overall Study|Other|60|||
105730685|NCT03090191|364669284|FG000|Overall Study|Withdrawn before any study vaccination|43|||
105730686|NCT03090191|364669285|FG001|Overall Study|Withdrawn before any study vaccination|52|||
105730687|NCT00893789|364669287|FG000|Overall Study|Withdrawal by Subject|3|||
105730688|NCT00893789|364669288|FG001|Overall Study|Withdrawal by Subject|1|||
105730689|NCT00893789|364669289|FG002|Overall Study|Withdrawal by Subject|3|||
105730690|NCT00893789|364669290|FG003|Overall Study|Withdrawal by Subject|1|||
105730691|NCT00893789|364669287|FG000|Overall Study|Noncompliance With Study Drug|1|||
105730692|NCT00893789|364669288|FG001|Overall Study|Noncompliance With Study Drug|0|||
105730693|NCT00893789|364669289|FG002|Overall Study|Noncompliance With Study Drug|1|||
105730694|NCT00893789|364669290|FG003|Overall Study|Noncompliance With Study Drug|2|||
105730695|NCT00893789|364669287|FG000|Overall Study|Noncompliance With Study Procedures|1|||
105730696|NCT00893789|364669288|FG001|Overall Study|Noncompliance With Study Procedures|0|||
105730697|NCT00893789|364669289|FG002|Overall Study|Noncompliance With Study Procedures|0|||
105730698|NCT00893789|364669290|FG003|Overall Study|Noncompliance With Study Procedures|0|||
105730699|NCT00893789|364669287|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
105730700|NCT00893789|364669288|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
105730701|NCT00893789|364669289|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
105730702|NCT00893789|364669290|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
105730703|NCT00893789|364669287|FG000|Overall Study|Adverse Event|0|||
105730704|NCT00893789|364669288|FG001|Overall Study|Adverse Event|2|||
105730705|NCT00893789|364669289|FG002|Overall Study|Adverse Event|1|||
105730706|NCT00893789|364669290|FG003|Overall Study|Adverse Event|5|||
105730707|NCT00893789|364669287|FG000|Overall Study|Protocol Violation|0|||
105730708|NCT00893789|364669288|FG001|Overall Study|Protocol Violation|1|||
105730709|NCT00893789|364669289|FG002|Overall Study|Protocol Violation|1|||
105730710|NCT00893789|364669290|FG003|Overall Study|Protocol Violation|4|||
105730711|NCT00893789|364669287|FG000|Overall Study|Lost to Follow-up|0|||
105730712|NCT00893789|364669288|FG001|Overall Study|Lost to Follow-up|0|||
105730713|NCT00893789|364669289|FG002|Overall Study|Lost to Follow-up|0|||
105730714|NCT00893789|364669290|FG003|Overall Study|Lost to Follow-up|1|||
105730715|NCT04723537|364669295|FG000|Overall Study|Withdrawal by Subject|3|||
105730716|NCT04723537|364669296|FG001|Overall Study|Withdrawal by Subject|0|||
105730717|NCT04723537|364669297|FG002|Overall Study|Withdrawal by Subject|0|||
105730718|NCT04723537|364669295|FG000|Overall Study|Physician Decision|0|||
105730719|NCT04723537|364669296|FG001|Overall Study|Physician Decision|0|||
105730720|NCT04723537|364669297|FG002|Overall Study|Physician Decision|1|||
105730721|NCT04723537|364669295|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
105730722|NCT04723537|364669296|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
105730723|NCT04723537|364669297|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
106139070|NCT03141788|366167078|FG000|Overall Study|Withdrawal by Subject|4|||
106139071|NCT05526911|366168524|FG000|Overall Study|Adverse Event|2|||
106139072|NCT02030028|366168525|FG000|Overall Study|Withdrawal by Subject|4|||
106139073|NCT02030028|366168525|FG000|Overall Study|lack of transportation|1|||
106139074|NCT00567879|366168527|FG000|Overall Study|Adverse Event|2|||
106139075|NCT00567879|366168528|FG001|Overall Study|Adverse Event|0|||
106139076|NCT00567879|366168529|FG002|Overall Study|Adverse Event|1|||
106139077|NCT00567879|366168530|FG003|Overall Study|Adverse Event|0|||
106139078|NCT00567879|366168531|FG004|Overall Study|Adverse Event|1|||
106139079|NCT00567879|366168532|FG005|Overall Study|Adverse Event|0|||
106139080|NCT00567879|366168527|FG000|Overall Study|Abnormal test procedure(s)|0|||
106139081|NCT00567879|366168528|FG001|Overall Study|Abnormal test procedure(s)|0|||
106139082|NCT00567879|366168529|FG002|Overall Study|Abnormal test procedure(s)|1|||
106139083|NCT00567879|366168530|FG003|Overall Study|Abnormal test procedure(s)|0|||
105730724|NCT02432807|364669298|FG000|Overall Study|Adverse Event|0|||
105730725|NCT02432807|364669299|FG001|Overall Study|Adverse Event|2|||
105730726|NCT02432807|364669298|FG000|Overall Study|Lost to Follow-up|1|||
106139084|NCT00567879|366168531|FG004|Overall Study|Abnormal test procedure(s)|0|||
106139085|NCT00567879|366168532|FG005|Overall Study|Abnormal test procedure(s)|0|||
106139086|NCT00567879|366168527|FG000|Overall Study|Withdrawal by Subject|0|||
106139087|NCT00567879|366168528|FG001|Overall Study|Withdrawal by Subject|0|||
105730727|NCT02432807|364669299|FG001|Overall Study|Lost to Follow-up|0|||
105730728|NCT02432807|364669298|FG000|Overall Study|Withdrawal by Subject|1|||
105730729|NCT02432807|364669299|FG001|Overall Study|Withdrawal by Subject|1|||
105730730|NCT02432807|364669298|FG000|Overall Study|Other|1|||
105730731|NCT02432807|364669299|FG001|Overall Study|Other|1|||
105730732|NCT04419506|364669300|FG000|Overall Study|Adverse Event|0|||
105730733|NCT04419506|364669301|FG001|Overall Study|Adverse Event|10|||
105730734|NCT04419506|364669302|FG002|Overall Study|Adverse Event|0|||
105730735|NCT04419506|364669303|FG003|Overall Study|Adverse Event|3|||
105730736|NCT04419506|364669300|FG000|Overall Study|Withdrawal by Subject|0|||
105730737|NCT04419506|364669301|FG001|Overall Study|Withdrawal by Subject|0|||
105730738|NCT04419506|364669302|FG002|Overall Study|Withdrawal by Subject|0|||
105730739|NCT04419506|364669303|FG003|Overall Study|Withdrawal by Subject|1|||
105730740|NCT04419506|364669300|FG000|Overall Study|poor-compliance|0|||
105730741|NCT04419506|364669301|FG001|Overall Study|poor-compliance|0|||
105730742|NCT04419506|364669302|FG002|Overall Study|poor-compliance|0|||
105730743|NCT04419506|364669303|FG003|Overall Study|poor-compliance|1|||
105730744|NCT02337829|364669304|FG000|Overall Study|Death|0|||
105730745|NCT02337829|364669305|FG001|Overall Study|Death|1|||
105730746|NCT02337829|364669306|FG002|Overall Study|Death|0|||
105730747|NCT02337829|364669307|FG003|Overall Study|Death|0|||
105730748|NCT02337829|364669304|FG000|Overall Study|Study terminated by sponsor|12|||
105730749|NCT02337829|364669305|FG001|Overall Study|Study terminated by sponsor|10|||
105730750|NCT02337829|364669306|FG002|Overall Study|Study terminated by sponsor|5|||
105730751|NCT02337829|364669307|FG003|Overall Study|Study terminated by sponsor|6|||
105730752|NCT02337829|364669304|FG000|Overall Study|discontinued for other reasons|6|||
105730753|NCT02337829|364669305|FG001|Overall Study|discontinued for other reasons|3|||
105730754|NCT02337829|364669306|FG002|Overall Study|discontinued for other reasons|1|||
105730755|NCT02337829|364669307|FG003|Overall Study|discontinued for other reasons|4|||
105730756|NCT01845025|364669308|FG000|Overall Study|Adverse Event|6|||
105730757|NCT01845025|364669309|FG001|Overall Study|Adverse Event|3|||
105730758|NCT01845025|364669308|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105730759|NCT01845025|364669309|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105730760|NCT01845025|364669308|FG000|Overall Study|Withdrawal by Subject|48|||
105730761|NCT01845025|364669309|FG001|Overall Study|Withdrawal by Subject|44|||
105730762|NCT01845025|364669308|FG000|Overall Study|Lost to Follow-up|13|||
105730763|NCT01845025|364669309|FG001|Overall Study|Lost to Follow-up|13|||
105730764|NCT01845025|364669308|FG000|Overall Study|Administrative problems|8|||
105730765|NCT01845025|364669309|FG001|Overall Study|Administrative problems|8|||
105730766|NCT01845025|364669308|FG000|Overall Study|Death|2|||
105730767|NCT01845025|364669309|FG001|Overall Study|Death|0|||
105730768|NCT01845025|364669308|FG000|Overall Study|Protocol deviation|3|||
105730769|NCT01845025|364669309|FG001|Overall Study|Protocol deviation|6|||
105730770|NCT01845025|364669308|FG000|Overall Study|Missing|1|||
105730771|NCT01845025|364669309|FG001|Overall Study|Missing|1|||
105730772|NCT01486264|364669312|FG000|Overall Study|Death|1|||
105730773|NCT01486264|364669313|FG001|Overall Study|Death|1|||
105730774|NCT01486264|364669312|FG000|Overall Study|Adverse Event|3|||
105730775|NCT01486264|364669313|FG001|Overall Study|Adverse Event|3|||
105730776|NCT01486264|364669312|FG000|Overall Study|Lack of Efficacy|6|||
105730777|NCT01486264|364669313|FG001|Overall Study|Lack of Efficacy|10|||
105730778|NCT01486264|364669312|FG000|Overall Study|Withdrawal by Subject|7|||
105730779|NCT01486264|364669313|FG001|Overall Study|Withdrawal by Subject|18|||
105730780|NCT01486264|364669312|FG000|Overall Study|Physician Decision|1|||
105730781|NCT01486264|364669313|FG001|Overall Study|Physician Decision|1|||
105730782|NCT01486264|364669312|FG000|Overall Study|Protocol Violation|3|||
105730783|NCT01486264|364669313|FG001|Overall Study|Protocol Violation|0|||
105730784|NCT01486264|364669312|FG000|Overall Study|Lost to Follow-up|3|||
106139088|NCT00567879|366168529|FG002|Overall Study|Withdrawal by Subject|3|||
105730785|NCT01486264|364669313|FG001|Overall Study|Lost to Follow-up|2|||
105730786|NCT01486264|364669312|FG000|Overall Study|Other|5|||
105730787|NCT01486264|364669313|FG001|Overall Study|Other|11|||
105730788|NCT01486264|364669312|FG000|Overall Study|Not treated|0|||
105730789|NCT01486264|364669313|FG001|Overall Study|Not treated|1|||
105730790|NCT01829048|364669316|FG000|Overall Study|Withdrawal by Subject|0|||
105730791|NCT01829048|364669317|FG001|Overall Study|Withdrawal by Subject|0|||
105730792|NCT01829048|364669318|FG002|Overall Study|Withdrawal by Subject|0|||
105730793|NCT01829048|364669319|FG003|Overall Study|Withdrawal by Subject|2|||
105730794|NCT01829048|364669320|FG004|Overall Study|Withdrawal by Subject|0|||
105730795|NCT03185130|364669323|FG000|Overall Study|Withdrawal by Subject|0|||
105797052|NCT00295620|364914628|FG000|Overall Study|Discontinuation by sponsor|580|||
105797053|NCT00295620|364914629|FG001|Overall Study|Discontinuation by sponsor|593|||
105730796|NCT03185130|364669324|FG001|Overall Study|Withdrawal by Subject|2|||
105730797|NCT01486238|364669334|FG000|Overall Study|Death|0|||
105730798|NCT01486238|364669335|FG001|Overall Study|Death|2|||
105730799|NCT01486238|364669334|FG000|Overall Study|Withdrawal by Subject|2|||
105730800|NCT01486238|364669335|FG001|Overall Study|Withdrawal by Subject|1|||
105730801|NCT01486238|364669334|FG000|Overall Study|Lost to Follow-up|0|||
105730802|NCT01486238|364669335|FG001|Overall Study|Lost to Follow-up|3|||
105730803|NCT02120417|364669342|FG000|Overall Study|Death|5|||
105730804|NCT02120417|364669343|FG001|Overall Study|Death|1|||
105730805|NCT02120417|364669342|FG000|Overall Study|Adverse Event|3|||
105730806|NCT02120417|364669343|FG001|Overall Study|Adverse Event|9|||
105730807|NCT02120417|364669342|FG000|Overall Study|Participant decision|4|||
105730808|NCT02120417|364669343|FG001|Overall Study|Participant decision|4|||
105730809|NCT02120417|364669342|FG000|Overall Study|Disease progression|41|||
105730810|NCT02120417|364669343|FG001|Overall Study|Disease progression|45|||
105730811|NCT02120417|364669342|FG000|Overall Study|Noncompliance with study treatment|0|||
105730812|NCT02120417|364669343|FG001|Overall Study|Noncompliance with study treatment|2|||
105730813|NCT02120417|364669342|FG000|Overall Study|Physician Decision|2|||
105730814|NCT02120417|364669343|FG001|Overall Study|Physician Decision|3|||
105730815|NCT02120417|364669342|FG000|Overall Study|Other unspecified|5|||
105730816|NCT02120417|364669343|FG001|Overall Study|Other unspecified|4|||
105730817|NCT01733329|364669344|FG000|Overall Study|Protocol Violation|1|||
105730818|NCT01733329|364669345|FG001|Overall Study|Protocol Violation|1|||
105730819|NCT01733329|364669344|FG000|Overall Study|Uterine artery injury|1|||
105730820|NCT01733329|364669345|FG001|Overall Study|Uterine artery injury|0|||
105730821|NCT00542828|364669346|FG000|Overall Study|Physician Decision|1|||
105730822|NCT00542828|364669346|FG000|Overall Study|Need for Prohibited Treatment|3|||
105730823|NCT00542828|364669346|FG000|Overall Study|Study Prematurely Discontinued|7|||
105730824|NCT00542828|364669346|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
105730825|NCT05502289|364669349|FG000|Period 1|Out Of Window|1|||
105730826|NCT05502289|364669350|FG001|Period 1|Out Of Window|0|||
105730827|NCT03633331|364669358|FG000|Overall Study|Withdrawal by Subject|1|||
105730828|NCT00971321|364669359|FG000|Up to Month 7|Withdrawal by Subject|1|||
105730829|NCT00971321|364669360|FG001|Up to Month 7|Withdrawal by Subject|0|||
105730830|NCT00971321|364669359|FG000|Up to Month 7|Migrated/moved from study area|3|||
105730831|NCT00971321|364669360|FG001|Up to Month 7|Migrated/moved from study area|2|||
105730832|NCT00971321|364669359|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
105730833|NCT00971321|364669360|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
105730834|NCT00971321|364669359|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
105730835|NCT00971321|364669360|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
105730836|NCT00971321|364669359|FG000|Up to Month 11-12|Lost to Follow-up|1|||
105730837|NCT00971321|364669360|FG001|Up to Month 11-12|Lost to Follow-up|0|||
105730838|NCT01824602|364669361|FG000|Overall Study|Withdrawal by Subject|0|||
105730839|NCT01824602|364669362|FG001|Overall Study|Withdrawal by Subject|0|||
105730840|NCT01824602|364669363|FG002|Overall Study|Withdrawal by Subject|1|||
105730841|NCT01824602|364669364|FG003|Overall Study|Withdrawal by Subject|2|||
105730842|NCT01824602|364669361|FG000|Overall Study|Patient non-compliance|0|||
105730843|NCT01824602|364669362|FG001|Overall Study|Patient non-compliance|0|||
105730844|NCT01824602|364669363|FG002|Overall Study|Patient non-compliance|1|||
105730845|NCT01824602|364669364|FG003|Overall Study|Patient non-compliance|0|||
105730846|NCT01824602|364669361|FG000|Overall Study|Adverse Event|1|||
105730847|NCT01824602|364669362|FG001|Overall Study|Adverse Event|0|||
105730848|NCT01824602|364669363|FG002|Overall Study|Adverse Event|2|||
105730849|NCT01824602|364669364|FG003|Overall Study|Adverse Event|2|||
105730850|NCT01824602|364669361|FG000|Overall Study|Treatment failure|0|||
105730851|NCT01824602|364669362|FG001|Overall Study|Treatment failure|0|||
105730852|NCT01824602|364669363|FG002|Overall Study|Treatment failure|0|||
105730853|NCT01824602|364669364|FG003|Overall Study|Treatment failure|1|||
105730854|NCT02485717|364669367|FG000|Overall Study|Lost to Follow-up|6|||
105730855|NCT02485717|364669368|FG001|Overall Study|Lost to Follow-up|0|||
105730856|NCT02485717|364669369|FG002|Overall Study|Lost to Follow-up|0|||
105730857|NCT02485717|364669367|FG000|Overall Study|Withdrawal by Subject|0|||
105730858|NCT02485717|364669368|FG001|Overall Study|Withdrawal by Subject|0|||
105730859|NCT02485717|364669369|FG002|Overall Study|Withdrawal by Subject|1|||
105730860|NCT02485717|364669367|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
105730861|NCT02485717|364669368|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
105730862|NCT02485717|364669369|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
105730863|NCT02485717|364669367|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
105730864|NCT02485717|364669368|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
105730865|NCT02485717|364669369|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
105730866|NCT00761215|364669370|FG000|Overall Study|Randomized but didn't receive drug|1|||
105730867|NCT00761215|364669371|FG001|Overall Study|Randomized but didn't receive drug|1|||
105730868|NCT00761215|364669372|FG002|Overall Study|Randomized but didn't receive drug|2|||
105730869|NCT00761215|364669370|FG000|Overall Study|Lost to Follow-up|6|||
105730870|NCT00761215|364669371|FG001|Overall Study|Lost to Follow-up|3|||
105730871|NCT00761215|364669372|FG002|Overall Study|Lost to Follow-up|6|||
105730872|NCT00761215|364669370|FG000|Overall Study|Withdrawal by Subject|1|||
105730873|NCT00761215|364669371|FG001|Overall Study|Withdrawal by Subject|0|||
105730874|NCT00761215|364669372|FG002|Overall Study|Withdrawal by Subject|0|||
105730875|NCT00761215|364669370|FG000|Overall Study|Bacteremia|1|||
105730876|NCT00761215|364669371|FG001|Overall Study|Bacteremia|0|||
105730877|NCT00761215|364669372|FG002|Overall Study|Bacteremia|0|||
105730878|NCT00519532|364669373|FG000|Overall Study|Adverse Event|11|||
105730879|NCT00519532|364669373|FG000|Overall Study|Withdrawal by Subject|5|||
105730880|NCT00519532|364669373|FG000|Overall Study|Lost to Follow-up|2|||
105730881|NCT00667277|364669374|FG000|Overall Study|Withdrawal by Subject|2|||
105730882|NCT03138564|364669375|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
105730883|NCT03138564|364669376|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
105730884|NCT03138564|364669375|FG000|Overall Study|Lost to Follow-up|16|||
105730885|NCT03138564|364669376|FG001|Overall Study|Lost to Follow-up|2|||
105730886|NCT03138564|364669375|FG000|Overall Study|Withdrawal by Subject|48|||
105730887|NCT03138564|364669376|FG001|Overall Study|Withdrawal by Subject|4|||
105730888|NCT03138564|364669375|FG000|Overall Study|No longer met eligibility criteria|2|||
105730889|NCT03138564|364669376|FG001|Overall Study|No longer met eligibility criteria|0|||
105730890|NCT03138564|364669375|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
105730891|NCT03138564|364669376|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
105730892|NCT03138564|364669375|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
105730893|NCT03138564|364669376|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
105730894|NCT03138564|364669375|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
105730895|NCT03138564|364669376|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
105730896|NCT03138564|364669375|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
105730897|NCT03138564|364669376|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
105730898|NCT00814710|364669377|FG000|Overall Study|Adverse Event|1|||
105730899|NCT00814710|364669378|FG001|Overall Study|Adverse Event|0|||
105730900|NCT00814710|364669377|FG000|Overall Study|Lost to Follow-up|7|||
105730901|NCT00814710|364669378|FG001|Overall Study|Lost to Follow-up|3|||
105730902|NCT01450137|364669380|FG000|Up to Week 12|Adverse Event|2|||
105730903|NCT01450137|364669381|FG001|Up to Week 12|Adverse Event|1|||
105730904|NCT01450137|364669380|FG000|Up to Week 12|Withdrawal by Subject|0|||
105730905|NCT01450137|364669381|FG001|Up to Week 12|Withdrawal by Subject|2|||
105730906|NCT01450137|364669380|FG000|Week 12 to Study End|Death|0|||
105730907|NCT01450137|364669381|FG001|Week 12 to Study End|Death|1|||
105730908|NCT01450137|364669380|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
105730909|NCT01450137|364669381|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
105730910|NCT04458857|364669382|FG000|Overall Study|Adverse Event|0|||
105730911|NCT04458857|364669383|FG001|Overall Study|Adverse Event|1|||
105730912|NCT04458857|364669384|FG002|Overall Study|Adverse Event|0|||
105730913|NCT04458857|364669382|FG000|Overall Study|Withdrawal by Subject|2|||
105730914|NCT04458857|364669383|FG001|Overall Study|Withdrawal by Subject|0|||
105730915|NCT04458857|364669384|FG002|Overall Study|Withdrawal by Subject|0|||
105730916|NCT04458857|364669382|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105730917|NCT04458857|364669383|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105730918|NCT04458857|364669384|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105730919|NCT04458857|364669382|FG000|Overall Study|Non-compliance with study drug|0|||
105730920|NCT04458857|364669383|FG001|Overall Study|Non-compliance with study drug|1|||
105730921|NCT04458857|364669384|FG002|Overall Study|Non-compliance with study drug|0|||
105730922|NCT04458857|364669382|FG000|Overall Study|Lost to Follow-up|4|||
105730923|NCT04458857|364669383|FG001|Overall Study|Lost to Follow-up|1|||
105730924|NCT04458857|364669384|FG002|Overall Study|Lost to Follow-up|0|||
105730925|NCT03851510|364669385|FG000|Overall Study|Screen Fail|1|||
105730926|NCT03851510|364669385|FG000|Overall Study|Adverse Event|1|||
105730927|NCT03851510|364669385|FG000|Overall Study|Withdrawal by Subject|1|||
105730928|NCT03191786|364669386|FG000|Overall Study|Death|236|||
105730929|NCT03191786|364669387|FG001|Overall Study|Death|127|||
105730930|NCT03191786|364669386|FG000|Overall Study|Lost to Follow-up|9|||
105730931|NCT03191786|364669387|FG001|Overall Study|Lost to Follow-up|3|||
105730932|NCT03191786|364669386|FG000|Overall Study|Physician Decision|1|||
105730933|NCT03191786|364669387|FG001|Overall Study|Physician Decision|0|||
105730934|NCT03191786|364669386|FG000|Overall Study|Moved to Post Trial Access Program|30|||
105730935|NCT03191786|364669387|FG001|Overall Study|Moved to Post Trial Access Program|5|||
105730936|NCT03191786|364669386|FG000|Overall Study|Withdrawal by Subject|26|||
105730937|NCT03191786|364669387|FG001|Overall Study|Withdrawal by Subject|16|||
105730938|NCT03937986|364671526|FG000|Overall Study|COVID-19 Pandemic|1|||
105730939|NCT01981187|364671527|FG000|Overall Study|Participant/guardian decision|2|||
105730940|NCT01981187|364671527|FG000|Overall Study|Physician Decision|1|||
105730941|NCT01981187|364671527|FG000|Overall Study|Disease progression|2|||
105730942|NCT01981187|364671527|FG000|Overall Study|Adverse Event|7|||
105730943|NCT02413255|364671528|FG000|Overall Study|Voluntary Withdrawal|0|||
105730944|NCT02413255|364671529|FG001|Overall Study|Voluntary Withdrawal|0|||
105730945|NCT02413255|364671530|FG002|Overall Study|Voluntary Withdrawal|0|||
105730946|NCT02413255|364671531|FG003|Overall Study|Voluntary Withdrawal|0|||
105730947|NCT02413255|364671532|FG004|Overall Study|Voluntary Withdrawal|0|||
105730948|NCT02413255|364671533|FG005|Overall Study|Voluntary Withdrawal|0|||
105730949|NCT02413255|364671534|FG006|Overall Study|Voluntary Withdrawal|0|||
105730950|NCT02413255|364671535|FG007|Overall Study|Voluntary Withdrawal|0|||
105730951|NCT02413255|364671536|FG008|Overall Study|Voluntary Withdrawal|0|||
105730952|NCT02413255|364671537|FG009|Overall Study|Voluntary Withdrawal|0|||
105730953|NCT02413255|364671538|FG010|Overall Study|Voluntary Withdrawal|0|||
105730954|NCT02413255|364671539|FG011|Overall Study|Voluntary Withdrawal|0|||
105730955|NCT02413255|364671540|FG012|Overall Study|Voluntary Withdrawal|0|||
105730956|NCT02413255|364671541|FG013|Overall Study|Voluntary Withdrawal|0|||
105730957|NCT02413255|364671542|FG014|Overall Study|Voluntary Withdrawal|1|||
105730958|NCT02413255|364671543|FG015|Overall Study|Voluntary Withdrawal|0|||
105730959|NCT02413255|364671544|FG016|Overall Study|Voluntary Withdrawal|0|||
105730960|NCT02333331|364671545|FG000|Overall Study|Adverse Event|1|||
105730961|NCT02333331|364671546|FG001|Overall Study|Adverse Event|0|||
105730962|NCT02333331|364671547|FG002|Overall Study|Adverse Event|4|||
105730963|NCT02333331|364671548|FG003|Overall Study|Adverse Event|1|||
105730964|NCT02333331|364671545|FG000|Overall Study|Death|0|||
105730965|NCT02333331|364671546|FG001|Overall Study|Death|0|||
105730966|NCT02333331|364671547|FG002|Overall Study|Death|2|||
105730967|NCT02333331|364671548|FG003|Overall Study|Death|0|||
105730968|NCT02333331|364671545|FG000|Overall Study|Lost to Follow-up|0|||
105730969|NCT02333331|364671546|FG001|Overall Study|Lost to Follow-up|0|||
105730970|NCT02333331|364671547|FG002|Overall Study|Lost to Follow-up|1|||
105730971|NCT02333331|364671548|FG003|Overall Study|Lost to Follow-up|0|||
105730972|NCT02333331|364671545|FG000|Overall Study|Physician Decision|0|||
105730973|NCT02333331|364671546|FG001|Overall Study|Physician Decision|1|||
105730974|NCT02333331|364671547|FG002|Overall Study|Physician Decision|0|||
105730975|NCT02333331|364671548|FG003|Overall Study|Physician Decision|0|||
105730976|NCT02333331|364671545|FG000|Overall Study|Protocol Deviation|0|||
105730977|NCT02333331|364671546|FG001|Overall Study|Protocol Deviation|3|||
105730978|NCT02333331|364671547|FG002|Overall Study|Protocol Deviation|2|||
105730979|NCT02333331|364671548|FG003|Overall Study|Protocol Deviation|1|||
105730980|NCT02333331|364671545|FG000|Overall Study|Patient/Guardian Decision|1|||
105730981|NCT02333331|364671546|FG001|Overall Study|Patient/Guardian Decision|2|||
105730982|NCT02333331|364671547|FG002|Overall Study|Patient/Guardian Decision|9|||
105730983|NCT02333331|364671548|FG003|Overall Study|Patient/Guardian Decision|1|||
105730984|NCT05882890|364671549|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
105730985|NCT02158533|364671551|FG000|Stage 1|Adverse Event|6|||
105730986|NCT02158533|364671552|FG001|Stage 1|Adverse Event|4|||
105730987|NCT02158533|364671553|FG002|Stage 1|Adverse Event|7|||
105730988|NCT02158533|364671554|FG003|Stage 1|Adverse Event|0|||
105730989|NCT02158533|364671555|FG004|Stage 1|Adverse Event|0|||
105730990|NCT02158533|364671556|FG005|Stage 1|Adverse Event|0|||
105730991|NCT02158533|364671551|FG000|Stage 1|Withdrawal by Subject|3|||
105730992|NCT02158533|364671552|FG001|Stage 1|Withdrawal by Subject|2|||
105730993|NCT02158533|364671553|FG002|Stage 1|Withdrawal by Subject|1|||
105730994|NCT02158533|364671554|FG003|Stage 1|Withdrawal by Subject|0|||
105730995|NCT02158533|364671555|FG004|Stage 1|Withdrawal by Subject|0|||
105730996|NCT02158533|364671556|FG005|Stage 1|Withdrawal by Subject|0|||
105730997|NCT02158533|364671551|FG000|Stage 1|Lack of Efficacy|1|||
105730998|NCT02158533|364671552|FG001|Stage 1|Lack of Efficacy|0|||
105730999|NCT02158533|364671553|FG002|Stage 1|Lack of Efficacy|0|||
105731000|NCT02158533|364671554|FG003|Stage 1|Lack of Efficacy|0|||
105731001|NCT02158533|364671555|FG004|Stage 1|Lack of Efficacy|0|||
105731002|NCT02158533|364671556|FG005|Stage 1|Lack of Efficacy|0|||
105731003|NCT02158533|364671551|FG000|Stage 1|Lost to Follow-up|3|||
105731004|NCT02158533|364671552|FG001|Stage 1|Lost to Follow-up|1|||
105731005|NCT02158533|364671553|FG002|Stage 1|Lost to Follow-up|0|||
105731006|NCT02158533|364671554|FG003|Stage 1|Lost to Follow-up|0|||
105731007|NCT02158533|364671555|FG004|Stage 1|Lost to Follow-up|0|||
105731008|NCT02158533|364671556|FG005|Stage 1|Lost to Follow-up|0|||
105731009|NCT02158533|364671551|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731010|NCT02158533|364671552|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
105731011|NCT02158533|364671553|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731012|NCT02158533|364671554|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731013|NCT02158533|364671555|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731014|NCT02158533|364671556|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
105731015|NCT02158533|364671551|FG000|Stage 1|Non-compliance with study visits|1|||
105731016|NCT02158533|364671552|FG001|Stage 1|Non-compliance with study visits|0|||
105731017|NCT02158533|364671553|FG002|Stage 1|Non-compliance with study visits|0|||
105937623|NCT01796470|365431527|FG003|Overall Study|Withdrawal by Subject|0|||
105731018|NCT02158533|364671554|FG003|Stage 1|Non-compliance with study visits|0|||
105731019|NCT02158533|364671555|FG004|Stage 1|Non-compliance with study visits|0|||
105731020|NCT02158533|364671556|FG005|Stage 1|Non-compliance with study visits|0|||
105731021|NCT02158533|364671551|FG000|Stage 2|Adverse Event|0|||
105937624|NCT01796470|365431528|FG004|Overall Study|Withdrawal by Subject|1|||
105731022|NCT02158533|364671552|FG001|Stage 2|Adverse Event|0|||
105731023|NCT02158533|364671553|FG002|Stage 2|Adverse Event|0|||
105731024|NCT02158533|364671554|FG003|Stage 2|Adverse Event|0|||
105731025|NCT02158533|364671555|FG004|Stage 2|Adverse Event|0|||
105731026|NCT02158533|364671556|FG005|Stage 2|Adverse Event|1|||
105731027|NCT02158533|364671551|FG000|Stage 2|Lack of Efficacy|0|||
105937625|NCT00147537|365431535|FG000|Phase 1b|Death|0|||
105937626|NCT00147537|365431536|FG001|Phase 1b|Death|1|||
105937627|NCT00147537|365431537|FG002|Phase 1b|Death|2|||
105937628|NCT00147537|365431538|FG003|Phase 1b|Death|1|||
105937629|NCT00147537|365431539|FG004|Phase 1b|Death|2|||
105937630|NCT00147537|365431540|FG005|Phase 1b|Death|2|||
105937631|NCT00147537|365431541|FG006|Phase 1b|Death|1|||
105937632|NCT00147537|365431542|FG007|Phase 1b|Death|3|||
105937633|NCT00147537|365431543|FG008|Phase 1b|Death|9|||
105937634|NCT00147537|365431544|FG009|Phase 1b|Death|0|||
105937635|NCT00147537|365431545|FG010|Phase 1b|Death|0|||
105937636|NCT00147537|365431535|FG000|Phase 1b|Lost to Follow-up|2|||
105937637|NCT00147537|365431536|FG001|Phase 1b|Lost to Follow-up|1|||
105937638|NCT00147537|365431537|FG002|Phase 1b|Lost to Follow-up|0|||
105937639|NCT00147537|365431538|FG003|Phase 1b|Lost to Follow-up|0|||
105937640|NCT00147537|365431539|FG004|Phase 1b|Lost to Follow-up|0|||
105937641|NCT00147537|365431540|FG005|Phase 1b|Lost to Follow-up|0|||
105731028|NCT02158533|364671552|FG001|Stage 2|Lack of Efficacy|0|||
105731029|NCT02158533|364671553|FG002|Stage 2|Lack of Efficacy|0|||
105731030|NCT02158533|364671554|FG003|Stage 2|Lack of Efficacy|0|||
105731031|NCT02158533|364671555|FG004|Stage 2|Lack of Efficacy|1|||
105731032|NCT02158533|364671556|FG005|Stage 2|Lack of Efficacy|0|||
105731033|NCT02158533|364671551|FG000|Stage 2|Lost to Follow-up|0|||
105731034|NCT02158533|364671552|FG001|Stage 2|Lost to Follow-up|0|||
105731035|NCT02158533|364671553|FG002|Stage 2|Lost to Follow-up|0|||
105731036|NCT02158533|364671554|FG003|Stage 2|Lost to Follow-up|1|||
105731037|NCT02158533|364671555|FG004|Stage 2|Lost to Follow-up|1|||
105731038|NCT02158533|364671556|FG005|Stage 2|Lost to Follow-up|2|||
105731039|NCT02158533|364671551|FG000|Stage 2|Withdrawal by Subject|0|||
105731040|NCT02158533|364671552|FG001|Stage 2|Withdrawal by Subject|0|||
105731041|NCT02158533|364671553|FG002|Stage 2|Withdrawal by Subject|0|||
105731042|NCT02158533|364671554|FG003|Stage 2|Withdrawal by Subject|0|||
105731043|NCT02158533|364671555|FG004|Stage 2|Withdrawal by Subject|1|||
105731044|NCT02158533|364671556|FG005|Stage 2|Withdrawal by Subject|2|||
105731045|NCT02158533|364671551|FG000|Stage 2|Physician Decision|0|||
105731046|NCT02158533|364671552|FG001|Stage 2|Physician Decision|0|||
105731047|NCT02158533|364671553|FG002|Stage 2|Physician Decision|0|||
105731048|NCT02158533|364671554|FG003|Stage 2|Physician Decision|0|||
105731049|NCT02158533|364671555|FG004|Stage 2|Physician Decision|1|||
105731050|NCT02158533|364671556|FG005|Stage 2|Physician Decision|0|||
105731051|NCT02158533|364671551|FG000|Stage 2|Pregnancy|0|||
105731052|NCT02158533|364671552|FG001|Stage 2|Pregnancy|0|||
105731053|NCT02158533|364671553|FG002|Stage 2|Pregnancy|0|||
105731054|NCT02158533|364671554|FG003|Stage 2|Pregnancy|1|||
105731055|NCT02158533|364671555|FG004|Stage 2|Pregnancy|0|||
105731056|NCT02158533|364671556|FG005|Stage 2|Pregnancy|0|||
105731057|NCT02158533|364671551|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
105731058|NCT02158533|364671552|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
105731059|NCT02158533|364671553|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
105731060|NCT02158533|364671554|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
105731061|NCT02158533|364671555|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
105731062|NCT02158533|364671556|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
105731063|NCT02158533|364671551|FG000|Stage 2|Non-adherence with study visits|0|||
105731064|NCT02158533|364671552|FG001|Stage 2|Non-adherence with study visits|0|||
105731065|NCT02158533|364671553|FG002|Stage 2|Non-adherence with study visits|0|||
105731066|NCT02158533|364671554|FG003|Stage 2|Non-adherence with study visits|0|||
105731067|NCT02158533|364671555|FG004|Stage 2|Non-adherence with study visits|0|||
105731068|NCT02158533|364671556|FG005|Stage 2|Non-adherence with study visits|1|||
105731069|NCT04329949|364671561|FG000|Overall Study|Death|36|||
105731070|NCT04329949|364671561|FG000|Overall Study|Withdrawal by Subject|4|||
105731071|NCT04329949|364671561|FG000|Overall Study|Termination of study by sponsor|3|||
105731072|NCT02037919|364671562|FG000|Overall Study|Lost to Follow-up|30|||
105731073|NCT02037919|364671563|FG001|Overall Study|Lost to Follow-up|45|||
105731074|NCT00345605|364671570|FG000|Arm 1|Adverse Event|0|||
105731075|NCT00345605|364671571|FG001|Arm 1|Adverse Event|1|||
106139089|NCT00567879|366168530|FG003|Overall Study|Withdrawal by Subject|1|||
106139090|NCT00567879|366168531|FG004|Overall Study|Withdrawal by Subject|0|||
105731076|NCT00345605|364671570|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
105731077|NCT00345605|364671571|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
105731078|NCT01335971|364671572|FG000|Overall Study|Withdrawal by Subject|1|||
105731079|NCT01335971|364671573|FG001|Overall Study|Withdrawal by Subject|0|||
105731080|NCT01335971|364671574|FG002|Overall Study|Withdrawal by Subject|0|||
105937642|NCT00147537|365431541|FG006|Phase 1b|Lost to Follow-up|2|||
105937643|NCT00147537|365431542|FG007|Phase 1b|Lost to Follow-up|0|||
105937644|NCT00147537|365431543|FG008|Phase 1b|Lost to Follow-up|1|||
105731081|NCT01335971|364671572|FG000|Overall Study|Did not complete bronchoscopy|1|||
105731082|NCT01335971|364671573|FG001|Overall Study|Did not complete bronchoscopy|1|||
105731083|NCT01335971|364671574|FG002|Overall Study|Did not complete bronchoscopy|1|||
105731084|NCT00384956|364671575|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
105731085|NCT00917384|364671583|FG000|Overall Study|Lost to Follow-up|4|||
105937645|NCT00147537|365431544|FG009|Phase 1b|Lost to Follow-up|0|||
105937646|NCT00147537|365431545|FG010|Phase 1b|Lost to Follow-up|0|||
105937647|NCT00147537|365431535|FG000|Phase 1b|Other|0|||
106139091|NCT00567879|366168532|FG005|Overall Study|Withdrawal by Subject|0|||
106139092|NCT00567879|366168527|FG000|Overall Study|New cancer therapy|0|||
106139093|NCT00567879|366168528|FG001|Overall Study|New cancer therapy|0|||
106139094|NCT00567879|366168529|FG002|Overall Study|New cancer therapy|1|||
106139095|NCT00567879|366168530|FG003|Overall Study|New cancer therapy|0|||
106139096|NCT00567879|366168531|FG004|Overall Study|New cancer therapy|0|||
106139097|NCT00567879|366168532|FG005|Overall Study|New cancer therapy|0|||
106139098|NCT00567879|366168527|FG000|Overall Study|Disease progression|5|||
106139099|NCT00567879|366168528|FG001|Overall Study|Disease progression|7|||
106139100|NCT00567879|366168529|FG002|Overall Study|Disease progression|15|||
106139101|NCT00567879|366168530|FG003|Overall Study|Disease progression|5|||
106139102|NCT00567879|366168531|FG004|Overall Study|Disease progression|11|||
106139103|NCT00567879|366168532|FG005|Overall Study|Disease progression|3|||
106139104|NCT05298111|366168535|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
106139105|NCT05298111|366168536|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
106139106|NCT02380742|366168537|FG000|Overall Study|Withdrawal by Subject|1|||
106139107|NCT02380742|366168538|FG001|Overall Study|Withdrawal by Subject|0|||
106139108|NCT03518112|366168541|FG000|Overall Study|Withdrawal by Subject|1|||
106139109|NCT02930343|366168542|FG000|Overall Study|Lost to Follow-up|9|||
106139110|NCT02930343|366168543|FG001|Overall Study|Lost to Follow-up|7|||
106139111|NCT02987543|366168544|FG000|Overall Study|Ongoing study at data cut off|49|||
106139112|NCT02987543|366168545|FG001|Overall Study|Ongoing study at data cut off|21|||
106139113|NCT02987543|366168546|FG002|Overall Study|Ongoing study at data cut off|19|||
106139114|NCT02987543|366168547|FG003|Overall Study|Ongoing study at data cut off|12|||
106139115|NCT02987543|366168544|FG000|Overall Study|Death|88|||
106139116|NCT02987543|366168545|FG001|Overall Study|Death|54|||
106139117|NCT02987543|366168546|FG002|Overall Study|Death|67|||
106139118|NCT02987543|366168547|FG003|Overall Study|Death|28|||
106139119|NCT02987543|366168544|FG000|Overall Study|Lost to Follow-up|3|||
106139120|NCT02987543|366168545|FG001|Overall Study|Lost to Follow-up|0|||
106139121|NCT02987543|366168546|FG002|Overall Study|Lost to Follow-up|1|||
105731086|NCT00917384|364671584|FG001|Overall Study|Lost to Follow-up|2|||
105731087|NCT00917384|364671583|FG000|Overall Study|Withdrawal by Subject|10|||
105731088|NCT00917384|364671584|FG001|Overall Study|Withdrawal by Subject|2|||
105731089|NCT05299892|364671586|FG000|Overall Study|Withdrawal by Subject|2|||
106139122|NCT02987543|366168547|FG003|Overall Study|Lost to Follow-up|0|||
105731090|NCT03180736|364671587|FG000|Overall Study|Adverse Event|3|||
105731091|NCT03180736|364671588|FG001|Overall Study|Adverse Event|4|||
105731092|NCT03180736|364671587|FG000|Overall Study|Death|10|||
105731093|NCT03180736|364671588|FG001|Overall Study|Death|7|||
105731094|NCT03180736|364671587|FG000|Overall Study|Withdrawal by Subject|5|||
105731095|NCT03180736|364671588|FG001|Overall Study|Withdrawal by Subject|12|||
105731096|NCT03180736|364671587|FG000|Overall Study|Lost to Follow-up|1|||
105731097|NCT03180736|364671588|FG001|Overall Study|Lost to Follow-up|0|||
105731098|NCT03180736|364671587|FG000|Overall Study|Lack of Efficacy|66|||
105731099|NCT03180736|364671588|FG001|Overall Study|Lack of Efficacy|87|||
105731100|NCT03180736|364671587|FG000|Overall Study|Physician Decision|4|||
105731101|NCT03180736|364671588|FG001|Overall Study|Physician Decision|7|||
105731102|NCT03180736|364671587|FG000|Overall Study|randomized but not treated|2|||
105731103|NCT03180736|364671588|FG001|Overall Study|randomized but not treated|3|||
105731104|NCT03351244|364671592|FG000|Overall Study|Adverse Event|7|||
105731105|NCT03351244|364671593|FG001|Overall Study|Adverse Event|11|||
105731106|NCT03351244|364671594|FG002|Overall Study|Adverse Event|12|||
105731107|NCT03351244|364671592|FG000|Overall Study|Investigator's decision|0|||
105731108|NCT03351244|364671593|FG001|Overall Study|Investigator's decision|0|||
105731109|NCT03351244|364671594|FG002|Overall Study|Investigator's decision|2|||
105731110|NCT03351244|364671592|FG000|Overall Study|System error|0|||
105731111|NCT03351244|364671593|FG001|Overall Study|System error|0|||
105731112|NCT03351244|364671594|FG002|Overall Study|System error|2|||
105731113|NCT03351244|364671592|FG000|Overall Study|COVID-19 restrictions|3|||
105731114|NCT03351244|364671593|FG001|Overall Study|COVID-19 restrictions|0|||
105731115|NCT03351244|364671594|FG002|Overall Study|COVID-19 restrictions|1|||
105731116|NCT03351244|364671592|FG000|Overall Study|Non-compliance|2|||
105731117|NCT03351244|364671593|FG001|Overall Study|Non-compliance|5|||
105731118|NCT03351244|364671594|FG002|Overall Study|Non-compliance|0|||
105731119|NCT03351244|364671592|FG000|Overall Study|Withdrawal by Subject|11|||
106139123|NCT02987543|366168544|FG000|Overall Study|Screen failure|0|||
105731120|NCT03351244|364671593|FG001|Overall Study|Withdrawal by Subject|16|||
105731121|NCT03351244|364671594|FG002|Overall Study|Withdrawal by Subject|13|||
105731122|NCT03351244|364671592|FG000|Overall Study|Lost to Follow-up|2|||
105731123|NCT03351244|364671593|FG001|Overall Study|Lost to Follow-up|6|||
105731124|NCT03351244|364671594|FG002|Overall Study|Lost to Follow-up|4|||
106139124|NCT02987543|366168545|FG001|Overall Study|Screen failure|0|||
105731125|NCT03351244|364671592|FG000|Overall Study|Protocol Violation|2|||
105731126|NCT03351244|364671593|FG001|Overall Study|Protocol Violation|2|||
106139125|NCT02987543|366168546|FG002|Overall Study|Screen failure|0|||
106139126|NCT02987543|366168547|FG003|Overall Study|Screen failure|1|||
106139127|NCT02987543|366168544|FG000|Overall Study|Withdrawal by Subject|21|||
106139128|NCT02987543|366168545|FG001|Overall Study|Withdrawal by Subject|7|||
106139129|NCT02987543|366168546|FG002|Overall Study|Withdrawal by Subject|7|||
106139130|NCT02987543|366168547|FG003|Overall Study|Withdrawal by Subject|6|||
106139131|NCT02987543|366168544|FG000|Overall Study|Study terminated by sponsor|1|||
106139132|NCT02987543|366168545|FG001|Overall Study|Study terminated by sponsor|0|||
106139133|NCT02987543|366168546|FG002|Overall Study|Study terminated by sponsor|0|||
106139134|NCT02987543|366168547|FG003|Overall Study|Study terminated by sponsor|0|||
106139135|NCT02987543|366168544|FG000|Overall Study|Investigator decision|0|||
106139136|NCT02987543|366168545|FG001|Overall Study|Investigator decision|1|||
106139137|NCT02987543|366168546|FG002|Overall Study|Investigator decision|0|||
105731127|NCT03351244|364671594|FG002|Overall Study|Protocol Violation|0|||
105731128|NCT03794986|364671595|FG000|Overall Study|0 Sessions Attended|34|||
105731129|NCT03794986|364671596|FG001|Overall Study|0 Sessions Attended|37|||
105731130|NCT03794986|364671595|FG000|Overall Study|Withdrawal by Subject|4|||
105731131|NCT03794986|364671596|FG001|Overall Study|Withdrawal by Subject|6|||
105731132|NCT03794986|364671595|FG000|Overall Study|Protocol Violation|1|||
105731133|NCT03794986|364671596|FG001|Overall Study|Protocol Violation|0|||
105731134|NCT00728416|364671598|FG000|Overall Study|Adverse Event|1|||
105731135|NCT00728416|364671599|FG001|Overall Study|Adverse Event|1|||
105731136|NCT00728416|364671598|FG000|Overall Study|Treatment Failure|0|||
105731137|NCT00728416|364671599|FG001|Overall Study|Treatment Failure|1|||
105731138|NCT00728416|364671598|FG000|Overall Study|Withdrawal by Subject|1|||
105731139|NCT00728416|364671599|FG001|Overall Study|Withdrawal by Subject|0|||
105731140|NCT04375878|364671602|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
105731141|NCT04375878|364671603|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
105731142|NCT04375878|364671604|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
105731143|NCT04375878|364671605|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
105731144|NCT04375878|364671606|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
105731145|NCT04375878|364671607|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
105731146|NCT04375878|364671602|FG000|Crossover First and Second Interventions|Adverse Event|0|||
105731147|NCT04375878|364671603|FG001|Crossover First and Second Interventions|Adverse Event|0|||
105731148|NCT04375878|364671604|FG002|Crossover First and Second Interventions|Adverse Event|1|||
105731149|NCT04375878|364671605|FG003|Crossover First and Second Interventions|Adverse Event|0|||
105731150|NCT04375878|364671606|FG004|Crossover First and Second Interventions|Adverse Event|0|||
105731151|NCT04375878|364671607|FG005|Crossover First and Second Interventions|Adverse Event|0|||
105731152|NCT04375878|364671602|FG000|Extension Phase|Withdrawal by Subject|0|||
105731153|NCT04375878|364671603|FG001|Extension Phase|Withdrawal by Subject|0|||
105731154|NCT04375878|364671604|FG002|Extension Phase|Withdrawal by Subject|0|||
105731155|NCT04375878|364671605|FG003|Extension Phase|Withdrawal by Subject|0|||
105731156|NCT04375878|364671606|FG004|Extension Phase|Withdrawal by Subject|1|||
105731157|NCT04375878|364671607|FG005|Extension Phase|Withdrawal by Subject|0|||
105731158|NCT01254344|364671608|FG000|Overall Study|Adverse Event|2|||
105731159|NCT01254344|364671609|FG001|Overall Study|Adverse Event|5|||
105731160|NCT01254344|364671608|FG000|Overall Study|Physician Decision|7|||
105731161|NCT01254344|364671609|FG001|Overall Study|Physician Decision|4|||
105731162|NCT01254344|364671608|FG000|Overall Study|Protocol Violation|1|||
105731163|NCT01254344|364671609|FG001|Overall Study|Protocol Violation|4|||
105731164|NCT01254344|364671608|FG000|Overall Study|Withdrawal by Subject|3|||
105731165|NCT01254344|364671609|FG001|Overall Study|Withdrawal by Subject|6|||
105731166|NCT03022461|364671610|FG000|Overall Study|Death|3|||
105731167|NCT00754390|364671611|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
105731168|NCT00754390|364671611|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
105731169|NCT00754390|364671611|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
105731170|NCT00754390|364671611|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
105731171|NCT01856673|364671614|FG000|Overall Study|Withdrawal by Subject|44|||
105731172|NCT01856673|364671615|FG001|Overall Study|Withdrawal by Subject|50|||
105731173|NCT01856673|364671616|FG002|Overall Study|Withdrawal by Subject|33|||
105731174|NCT01856673|364671614|FG000|Overall Study|Lost to Follow-up|31|||
105731175|NCT01856673|364671615|FG001|Overall Study|Lost to Follow-up|34|||
105731176|NCT01856673|364671616|FG002|Overall Study|Lost to Follow-up|0|||
105731177|NCT01856673|364671614|FG000|Overall Study|Unknown reasons|9|||
105731178|NCT01856673|364671615|FG001|Overall Study|Unknown reasons|0|||
105731179|NCT01856673|364671616|FG002|Overall Study|Unknown reasons|0|||
106139138|NCT02987543|366168547|FG003|Overall Study|Investigator decision|0|||
105731180|NCT01856673|364671614|FG000|Overall Study|Psychologist decision|1|||
105731181|NCT01856673|364671615|FG001|Overall Study|Psychologist decision|0|||
105731182|NCT01856673|364671616|FG002|Overall Study|Psychologist decision|0|||
105731183|NCT01856673|364671614|FG000|Overall Study|Paperwork errors|8|||
105731184|NCT01856673|364671615|FG001|Overall Study|Paperwork errors|0|||
105731185|NCT01856673|364671616|FG002|Overall Study|Paperwork errors|0|||
105731186|NCT01856673|364671614|FG000|Overall Study|Death|1|||
105731187|NCT01856673|364671615|FG001|Overall Study|Death|1|||
105937648|NCT00147537|365431536|FG001|Phase 1b|Other|0|||
105937649|NCT00147537|365431537|FG002|Phase 1b|Other|2|||
105731188|NCT01856673|364671616|FG002|Overall Study|Death|0|||
105937650|NCT00147537|365431538|FG003|Phase 1b|Other|1|||
106139139|NCT02987543|366168544|FG000|Overall Study|Disease progression|0|||
106139140|NCT02987543|366168545|FG001|Overall Study|Disease progression|0|||
106139141|NCT02987543|366168546|FG002|Overall Study|Disease progression|0|||
106139142|NCT02987543|366168547|FG003|Overall Study|Disease progression|1|||
106139143|NCT00109967|366168548|FG000|Overall Study|Cancel Prior to Treatment|2|||
106139144|NCT00109967|366168549|FG001|Overall Study|Cancel Prior to Treatment|0|||
106139145|NCT00109967|366168548|FG000|Overall Study|Adverse Event|12|||
106139146|NCT00109967|366168549|FG001|Overall Study|Adverse Event|1|||
106139147|NCT00109967|366168548|FG000|Overall Study|Withdrawal by Subject|5|||
106139148|NCT00109967|366168549|FG001|Overall Study|Withdrawal by Subject|0|||
106139149|NCT00109967|366168548|FG000|Overall Study|Physician Decision|1|||
106139150|NCT00109967|366168549|FG001|Overall Study|Physician Decision|3|||
106139151|NCT00109967|366168548|FG000|Overall Study|Death|0|||
106139152|NCT00109967|366168549|FG001|Overall Study|Death|2|||
106139153|NCT01897233|366168550|FG000|Part B (24 Weeks)|Adverse Event|1|||
106139154|NCT01897233|366168550|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
106139155|NCT01897233|366168550|FG000|Part B (24 Weeks)|Physician Decision|1|||
105731189|NCT01856673|364671614|FG000|Overall Study|Protocol Violation|1|||
105731190|NCT01856673|364671615|FG001|Overall Study|Protocol Violation|0|||
105731191|NCT01856673|364671616|FG002|Overall Study|Protocol Violation|1|||
105731192|NCT01273818|364671617|FG000|Overall Study|Physician Decision|13|||
105731193|NCT01273818|364671618|FG001|Overall Study|Physician Decision|2|||
105731194|NCT01273818|364671619|FG002|Overall Study|Physician Decision|9|||
105731195|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Adverse Event|12|||
105731196|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Adverse Event|3|||
105731197|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Adverse Event|4|||
105731198|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Adverse Event|2|||
105731199|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
105731200|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
105731201|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
105731202|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
105731203|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
105731204|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
105731205|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
105731206|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
105731207|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
105731208|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
105731209|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
105731210|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
105731211|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
105731212|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
105731213|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
105731214|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
105731215|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
105731216|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
105731217|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
105731218|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
105731219|NCT02436239|364671624|FG000|Open-Lable Treatment Period|Other Reason|1|||
105731220|NCT02436239|364671625|FG001|Open-Lable Treatment Period|Other Reason|1|||
105731221|NCT02436239|364671626|FG002|Open-Lable Treatment Period|Other Reason|0|||
105731222|NCT02436239|364671627|FG003|Open-Lable Treatment Period|Other Reason|0|||
105731223|NCT02436239|364671624|FG000|Down-Taper Period|Withdrawal by Subject|4|||
105731224|NCT02436239|364671625|FG001|Down-Taper Period|Withdrawal by Subject|4|||
105731225|NCT02436239|364671626|FG002|Down-Taper Period|Withdrawal by Subject|1|||
105731226|NCT02436239|364671627|FG003|Down-Taper Period|Withdrawal by Subject|2|||
105731227|NCT00104871|364671631|FG000|Overall Study|Not evaluable|1|||
105731228|NCT01548638|364671632|FG000|Overall Study|Protocol Violation|3|||
105731229|NCT01548638|364671632|FG000|Overall Study|Withdrawal by Subject|1|||
105731230|NCT05593432|364671633|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
105731231|NCT05593432|364671634|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
105731232|NCT05593432|364671635|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
105731233|NCT05593432|364671636|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
105731234|NCT05593432|364671633|FG000|16-Week OLE Period|Lack of Efficacy|0|||
106139156|NCT03439124|366168551|FG000|Overall Study|Adverse Event|2|||
106139157|NCT03439124|366168552|FG001|Overall Study|Adverse Event|0|||
106139158|NCT03439124|366168551|FG000|Overall Study|Lost to Follow-up|1|||
106139159|NCT03439124|366168552|FG001|Overall Study|Lost to Follow-up|0|||
106139160|NCT03439124|366168551|FG000|Overall Study|Other reasons|1|||
106139161|NCT03439124|366168552|FG001|Overall Study|Other reasons|0|||
105731235|NCT05593432|364671634|FG001|16-Week OLE Period|Lack of Efficacy|0|||
105731236|NCT05593432|364671635|FG002|16-Week OLE Period|Lack of Efficacy|0|||
105731237|NCT05593432|364671636|FG003|16-Week OLE Period|Lack of Efficacy|1|||
106139162|NCT01117480|366168553|FG000|Overall Study|Protocol Violation|8|||
106139163|NCT01117480|366168553|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
106139164|NCT03646123|366168554|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
106139165|NCT03646123|366168555|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
106139166|NCT03646123|366168556|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
106139167|NCT03646123|366168554|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
106139168|NCT03646123|366168555|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
106139169|NCT03646123|366168556|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
106139170|NCT03646123|366168554|FG000|Overall Study|Non-compliance to study protocol|1|||
106139171|NCT03646123|366168555|FG001|Overall Study|Non-compliance to study protocol|0|||
106139172|NCT03646123|366168556|FG002|Overall Study|Non-compliance to study protocol|0|||
106139173|NCT03646123|366168554|FG000|Overall Study|Ineligible due to progression during screening|0|||
106139174|NCT03646123|366168555|FG001|Overall Study|Ineligible due to progression during screening|0|||
106139175|NCT03646123|366168556|FG002|Overall Study|Ineligible due to progression during screening|1|||
106139176|NCT03646123|366168554|FG000|Overall Study|Withdrawal by Subject|2|||
106139177|NCT03646123|366168555|FG001|Overall Study|Withdrawal by Subject|1|||
106139178|NCT03646123|366168556|FG002|Overall Study|Withdrawal by Subject|3|||
106139179|NCT03646123|366168554|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
106139180|NCT03646123|366168555|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
106139181|NCT03646123|366168556|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
106139182|NCT03646123|366168554|FG000|Overall Study|Death|2|||
106139183|NCT03646123|366168555|FG001|Overall Study|Death|1|||
106139184|NCT03646123|366168556|FG002|Overall Study|Death|1|||
106139185|NCT03646123|366168554|FG000|Overall Study|Lost to Follow-up|4|||
106139186|NCT03646123|366168555|FG001|Overall Study|Lost to Follow-up|7|||
106139187|NCT03646123|366168556|FG002|Overall Study|Lost to Follow-up|6|||
106139188|NCT03646123|366168554|FG000|Overall Study|Participants in long term follow-up|0|||
106139189|NCT03646123|366168555|FG001|Overall Study|Participants in long term follow-up|48|||
106139190|NCT03646123|366168556|FG002|Overall Study|Participants in long term follow-up|144|||
106139191|NCT00686517|366168557|FG000|Treatment|Serious Adverse Event|1|||
106139192|NCT00686517|366168558|FG001|Treatment|Serious Adverse Event|2|||
106139193|NCT00686517|366168559|FG002|Treatment|Serious Adverse Event|1|||
106139194|NCT00686517|366168557|FG000|Treatment|Adverse Event|2|||
106139195|NCT00686517|366168558|FG001|Treatment|Adverse Event|0|||
106139196|NCT00686517|366168559|FG002|Treatment|Adverse Event|0|||
106139197|NCT00686517|366168557|FG000|Treatment|Poor Protocol Compliance|1|||
106139198|NCT00686517|366168558|FG001|Treatment|Poor Protocol Compliance|0|||
106139199|NCT00686517|366168559|FG002|Treatment|Poor Protocol Compliance|0|||
106139200|NCT00686517|366168557|FG000|Treatment|Protocol Violation|2|||
106139201|NCT00686517|366168558|FG001|Treatment|Protocol Violation|1|||
106139202|NCT00686517|366168559|FG002|Treatment|Protocol Violation|0|||
106139203|NCT01131494|366168562|FG000|Overall Study|Withdrawal by Subject|2|||
106139204|NCT00464672|366168567|FG000|Overall Study|withdrawal of consent|0|||
106139205|NCT00464672|366168568|FG001|Overall Study|withdrawal of consent|0|||
106139206|NCT00464672|366168569|FG002|Overall Study|withdrawal of consent|0|||
106139207|NCT00464672|366168570|FG003|Overall Study|withdrawal of consent|1|||
106139208|NCT00464672|366168571|FG004|Overall Study|withdrawal of consent|9|||
106139209|NCT00464672|366168572|FG005|Overall Study|withdrawal of consent|4|||
106139210|NCT00464672|366168567|FG000|Overall Study|Lost to Follow-up|25|||
106139211|NCT00464672|366168568|FG001|Overall Study|Lost to Follow-up|10|||
106139212|NCT00464672|366168569|FG002|Overall Study|Lost to Follow-up|0|||
106139213|NCT00464672|366168570|FG003|Overall Study|Lost to Follow-up|0|||
106139214|NCT00464672|366168571|FG004|Overall Study|Lost to Follow-up|1|||
106139215|NCT00464672|366168572|FG005|Overall Study|Lost to Follow-up|0|||
106139216|NCT01178762|366168573|FG000|Overall Study|Lost to Follow-up|15|||
106139217|NCT02377362|366168574|FG000|Part A Second Treatment|Protocol Violation|0|||
106139218|NCT02377362|366168575|FG001|Part A Second Treatment|Protocol Violation|0|||
106139219|NCT02377362|366168576|FG002|Part A Second Treatment|Protocol Violation|0|||
106139220|NCT02377362|366168577|FG003|Part A Second Treatment|Protocol Violation|0|||
105731238|NCT05593432|364671633|FG000|16-Week OLE Period|Lost to Follow-up|0|||
105731239|NCT05593432|364671634|FG001|16-Week OLE Period|Lost to Follow-up|0|||
105731240|NCT05593432|364671635|FG002|16-Week OLE Period|Lost to Follow-up|1|||
105731241|NCT05593432|364671636|FG003|16-Week OLE Period|Lost to Follow-up|2|||
105731242|NCT05593432|364671633|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
105731243|NCT05593432|364671634|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
105731244|NCT05593432|364671635|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
105731245|NCT05593432|364671636|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
106139221|NCT02377362|366168578|FG004|Part A Second Treatment|Protocol Violation|1|||
106139222|NCT02377362|366168579|FG005|Part A Second Treatment|Protocol Violation|0|||
106139223|NCT02377362|366168580|FG006|Part A Second Treatment|Protocol Violation|0|||
106139224|NCT02377362|366168581|FG007|Part A Second Treatment|Protocol Violation|0|||
106139225|NCT02377362|366168582|FG008|Part A Second Treatment|Protocol Violation|0|||
105731246|NCT03885284|364671637|FG000|Overall Study|Disease Progression|1|||
105731247|NCT03885284|364671638|FG001|Overall Study|Disease Progression|3|||
106139226|NCT02377362|366168583|FG009|Part A Second Treatment|Protocol Violation|0|||
106139227|NCT02377362|366168584|FG010|Part A Second Treatment|Protocol Violation|0|||
106139228|NCT02377362|366168585|FG011|Part A Second Treatment|Protocol Violation|0|||
106139229|NCT02377362|366168586|FG012|Part A Second Treatment|Protocol Violation|0|||
106139230|NCT02377362|366168574|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139231|NCT02377362|366168575|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139232|NCT02377362|366168576|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139233|NCT02377362|366168577|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
106139234|NCT02377362|366168578|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
106139235|NCT02377362|366168579|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
106139236|NCT02377362|366168580|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139237|NCT02377362|366168581|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139238|NCT02377362|366168582|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139239|NCT02377362|366168583|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139240|NCT02377362|366168584|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139241|NCT02377362|366168585|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139242|NCT02377362|366168586|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
106139243|NCT02377362|366168574|FG000|Part B Overall|Protocol Violation|0|||
106139244|NCT02377362|366168575|FG001|Part B Overall|Protocol Violation|0|||
106139245|NCT02377362|366168576|FG002|Part B Overall|Protocol Violation|0|||
106139246|NCT02377362|366168577|FG003|Part B Overall|Protocol Violation|0|||
106139247|NCT02377362|366168578|FG004|Part B Overall|Protocol Violation|0|||
106139248|NCT02377362|366168579|FG005|Part B Overall|Protocol Violation|0|||
106139249|NCT02377362|366168580|FG006|Part B Overall|Protocol Violation|0|||
106139250|NCT02377362|366168581|FG007|Part B Overall|Protocol Violation|0|||
106139251|NCT02377362|366168582|FG008|Part B Overall|Protocol Violation|0|||
106139252|NCT02377362|366168583|FG009|Part B Overall|Protocol Violation|1|||
106139253|NCT02377362|366168584|FG010|Part B Overall|Protocol Violation|0|||
106139254|NCT02377362|366168585|FG011|Part B Overall|Protocol Violation|0|||
106139255|NCT02377362|366168586|FG012|Part B Overall|Protocol Violation|0|||
106139256|NCT02377362|366168574|FG000|Part B Overall|Adverse Event|0|||
106139257|NCT02377362|366168575|FG001|Part B Overall|Adverse Event|0|||
106139258|NCT02377362|366168576|FG002|Part B Overall|Adverse Event|0|||
106139259|NCT02377362|366168577|FG003|Part B Overall|Adverse Event|0|||
106139260|NCT02377362|366168578|FG004|Part B Overall|Adverse Event|0|||
106139261|NCT02377362|366168579|FG005|Part B Overall|Adverse Event|0|||
106139262|NCT02377362|366168580|FG006|Part B Overall|Adverse Event|1|||
106139263|NCT02377362|366168581|FG007|Part B Overall|Adverse Event|1|||
106139264|NCT02377362|366168582|FG008|Part B Overall|Adverse Event|0|||
106139265|NCT02377362|366168583|FG009|Part B Overall|Adverse Event|0|||
106139266|NCT02377362|366168584|FG010|Part B Overall|Adverse Event|0|||
106139267|NCT02377362|366168585|FG011|Part B Overall|Adverse Event|0|||
106139268|NCT02377362|366168586|FG012|Part B Overall|Adverse Event|0|||
106139269|NCT02377362|366168574|FG000|Part B Overall|Withdrawal by Subject|0|||
106139270|NCT02377362|366168575|FG001|Part B Overall|Withdrawal by Subject|0|||
106139271|NCT02377362|366168576|FG002|Part B Overall|Withdrawal by Subject|0|||
106139272|NCT02377362|366168577|FG003|Part B Overall|Withdrawal by Subject|0|||
106139273|NCT02377362|366168578|FG004|Part B Overall|Withdrawal by Subject|0|||
106139274|NCT02377362|366168579|FG005|Part B Overall|Withdrawal by Subject|0|||
106139275|NCT02377362|366168580|FG006|Part B Overall|Withdrawal by Subject|1|||
106139276|NCT02377362|366168581|FG007|Part B Overall|Withdrawal by Subject|0|||
105731248|NCT03885284|364671637|FG000|Overall Study|Physician Decision|0|||
105731249|NCT03885284|364671638|FG001|Overall Study|Physician Decision|1|||
105731250|NCT01926886|364671640|FG000|Overall Study|Administrative/other|1|||
105731251|NCT01926886|364671641|FG001|Overall Study|Administrative/other|0|||
105731252|NCT01926886|364671640|FG000|Overall Study|Adverse event/intercurrent illness|4|||
105731253|NCT01926886|364671641|FG001|Overall Study|Adverse event/intercurrent illness|0|||
105731254|NCT01926886|364671640|FG000|Overall Study|Disease progression/recurrence|4|||
105731255|NCT01926886|364671641|FG001|Overall Study|Disease progression/recurrence|0|||
105731256|NCT01926886|364671640|FG000|Overall Study|Withdrawal by Subject|15|||
105731257|NCT01926886|364671641|FG001|Overall Study|Withdrawal by Subject|0|||
105731258|NCT01926886|364671640|FG000|Overall Study|Failure to return|3|||
105731259|NCT01926886|364671641|FG001|Overall Study|Failure to return|0|||
105731260|NCT01926886|364671640|FG000|Overall Study|Recurrence of disease|1|||
106139277|NCT02377362|366168582|FG008|Part B Overall|Withdrawal by Subject|0|||
106139278|NCT02377362|366168583|FG009|Part B Overall|Withdrawal by Subject|0|||
106139279|NCT02377362|366168584|FG010|Part B Overall|Withdrawal by Subject|0|||
106139280|NCT02377362|366168585|FG011|Part B Overall|Withdrawal by Subject|1|||
106139281|NCT02377362|366168586|FG012|Part B Overall|Withdrawal by Subject|0|||
106139282|NCT00094809|366168587|FG000|Overall Study|Protocol deviation|2|||
105731261|NCT01926886|364671641|FG001|Overall Study|Recurrence of disease|0|||
105731262|NCT01926886|364671640|FG000|Overall Study|Progression of disease|2|||
105797054|NCT00295620|364914628|FG000|Overall Study|Protocol Violation|30|||
105797055|NCT00295620|364914629|FG001|Overall Study|Protocol Violation|32|||
105797056|NCT00217971|364914630|FG000|Overall Study|Adverse Event|1|||
105797057|NCT00217971|364914631|FG001|Overall Study|Adverse Event|1|||
105797058|NCT00217971|364914630|FG000|Overall Study|Lost to Follow-up|15|||
105797059|NCT00217971|364914631|FG001|Overall Study|Lost to Follow-up|19|||
105797060|NCT00217971|364914630|FG000|Overall Study|Physician Decision|0|||
105797061|NCT00217971|364914631|FG001|Overall Study|Physician Decision|1|||
105797062|NCT00217971|364914630|FG000|Overall Study|Withdrawal by Subject|7|||
105797063|NCT00217971|364914631|FG001|Overall Study|Withdrawal by Subject|12|||
105797064|NCT00217971|364914630|FG000|Overall Study|non compliant|1|||
105797065|NCT00217971|364914631|FG001|Overall Study|non compliant|0|||
105797066|NCT02989610|364914632|FG000|Overall Study|Withdrawal by Subject|20|||
105797067|NCT02989610|364914632|FG000|Overall Study|Departure of PI from Site|8|||
105797068|NCT02989610|364914632|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
105797069|NCT02989610|364914632|FG000|Overall Study|Lost to Follow-up|3|||
105797070|NCT02989610|364914632|FG000|Overall Study|Death|3|||
105797071|NCT02989610|364914632|FG000|Overall Study|System Explant|3|||
105797072|NCT02989610|364914632|FG000|Overall Study|Subject Non-Compliance|2|||
105797073|NCT02989610|364914632|FG000|Overall Study|System Revision|2|||
105797074|NCT02989610|364914632|FG000|Overall Study|PI Left, Study Closing|1|||
105797075|NCT02989610|364914632|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
105797076|NCT02989610|364914632|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
105797077|NCT00808015|364914637|FG000|Overall Study|Death|1|||
105797078|NCT00808015|364914637|FG000|Overall Study|Lack of Efficacy|58|||
105797079|NCT00808015|364914637|FG000|Overall Study|Lost to Follow-up|76|||
105797080|NCT00808015|364914637|FG000|Overall Study|Participants not willing to participate|158|||
105797081|NCT00808015|364914637|FG000|Overall Study|Adverse Event|22|||
105797082|NCT00808015|364914637|FG000|Overall Study|Other|25|||
105797083|NCT00808015|364914637|FG000|Overall Study|Enrolled but not treated|4|||
105797084|NCT04508621|364914638|FG000|Overall Study|Adverse Event|39|||
105797085|NCT04508621|364914639|FG001|Overall Study|Adverse Event|16|||
105797086|NCT04508621|364914638|FG000|Overall Study|Lack of Efficacy|2|||
105797087|NCT04508621|364914639|FG001|Overall Study|Lack of Efficacy|8|||
105797088|NCT04508621|364914638|FG000|Overall Study|Physician Decision|0|||
105797089|NCT04508621|364914639|FG001|Overall Study|Physician Decision|1|||
105797090|NCT04508621|364914638|FG000|Overall Study|Withdrawal by Subject|10|||
105797091|NCT04508621|364914639|FG001|Overall Study|Withdrawal by Subject|14|||
105797092|NCT04508621|364914638|FG000|Overall Study|Lost to Follow-up|12|||
105797093|NCT04508621|364914639|FG001|Overall Study|Lost to Follow-up|9|||
105797094|NCT04508621|364914638|FG000|Overall Study|COVID-19 related crisis|3|||
105797095|NCT04508621|364914639|FG001|Overall Study|COVID-19 related crisis|0|||
105797096|NCT04508621|364914638|FG000|Overall Study|Subject non-compliance|1|||
105797097|NCT04508621|364914639|FG001|Overall Study|Subject non-compliance|0|||
105797098|NCT00084617|364914653|FG000|Overall Study|Withdrawal by Subject|7|||
105797099|NCT00084617|364914653|FG000|Overall Study|Lack of Efficacy|1|||
105797100|NCT00084617|364914653|FG000|Overall Study|Protocol Violation|1|||
105797101|NCT00928135|364914654|FG000|Overall Study|Withdrawal by Subject|1|||
105797102|NCT00928135|364914655|FG001|Overall Study|Withdrawal by Subject|0|||
105797103|NCT01999322|364914656|FG000|Overall Study|Adverse Event|1|||
105797104|NCT01999322|364914657|FG001|Overall Study|Adverse Event|0|||
105797105|NCT03338673|364914660|FG000|Overall Study|Lost to Follow-up|1|||
105797106|NCT03338673|364914661|FG001|Overall Study|Lost to Follow-up|1|||
105797107|NCT00990093|364914665|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
105797108|NCT00990093|364914666|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
105797109|NCT00990093|364914665|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
105797110|NCT00990093|364914666|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
105797111|NCT00990093|364914665|FG000|Test Period 1 (1-14 Days)|Other|1|||
105797112|NCT00990093|364914666|FG001|Test Period 1 (1-14 Days)|Other|0|||
105797113|NCT00990093|364914665|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
105797114|NCT00990093|364914666|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
105797115|NCT00990093|364914665|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
106139283|NCT00094809|366168588|FG001|Overall Study|Protocol deviation|2|||
106139284|NCT00094809|366168587|FG000|Overall Study|Noncompliance|1|||
106139285|NCT00094809|366168588|FG001|Overall Study|Noncompliance|0|||
106139286|NCT00094809|366168587|FG000|Overall Study|Adverse Event|3|||
106139287|NCT00094809|366168588|FG001|Overall Study|Adverse Event|1|||
106139288|NCT00094809|366168587|FG000|Overall Study|Withdrawal by Subject|8|||
106139289|NCT00094809|366168588|FG001|Overall Study|Withdrawal by Subject|9|||
105797116|NCT00990093|364914666|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
105797117|NCT00990093|364914665|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
105797118|NCT00990093|364914666|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
105797119|NCT00990093|364914665|FG000|Test Period 2 (15-28 Days)|Other|0|||
105797120|NCT00990093|364914666|FG001|Test Period 2 (15-28 Days)|Other|1|||
105797121|NCT04556838|364914671|FG000|Overall Study|Withdrawal by Subject|3|||
106139290|NCT00094809|366168587|FG000|Overall Study|Disease progression|3|||
106139291|NCT00094809|366168588|FG001|Overall Study|Disease progression|3|||
106139292|NCT00094809|366168587|FG000|Overall Study|Physician Decision|3|||
106139293|NCT00094809|366168588|FG001|Overall Study|Physician Decision|5|||
106139294|NCT00094809|366168587|FG000|Overall Study|Lost to Follow-up|6|||
106139295|NCT00094809|366168588|FG001|Overall Study|Lost to Follow-up|6|||
106139296|NCT00094809|366168587|FG000|Overall Study|Death|19|||
106139297|NCT00094809|366168588|FG001|Overall Study|Death|25|||
106139298|NCT00094809|366168587|FG000|Overall Study|Protocol-specified criteria|1|||
106139299|NCT00094809|366168588|FG001|Overall Study|Protocol-specified criteria|1|||
105731263|NCT01926886|364671641|FG001|Overall Study|Progression of disease|0|||
105731264|NCT01926886|364671640|FG000|Overall Study|Death|1|||
105731265|NCT01926886|364671641|FG001|Overall Study|Death|0|||
105731266|NCT01926886|364671640|FG000|Overall Study|Did not cooperate|1|||
105731267|NCT01926886|364671641|FG001|Overall Study|Did not cooperate|0|||
105731268|NCT02609399|364671642|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
105731269|NCT02609399|364671643|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
105731270|NCT02609399|364671642|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
105731271|NCT02609399|364671643|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
105731272|NCT02609399|364671642|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
105731273|NCT02609399|364671643|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
105731274|NCT00995371|364671644|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
105731275|NCT00995371|364671645|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
105731276|NCT03875235|364671646|FG000|Overall Study|Ongoing study treatment|63|||
105731277|NCT03875235|364671647|FG001|Overall Study|Ongoing study treatment|20|||
105731278|NCT03875235|364671646|FG000|Overall Study|Off treatment|77|||
105731279|NCT03875235|364671647|FG001|Overall Study|Off treatment|91|||
105731280|NCT03875235|364671646|FG000|Overall Study|Withdrawal by Subject|3|||
105731281|NCT03875235|364671647|FG001|Overall Study|Withdrawal by Subject|10|||
105731282|NCT03875235|364671646|FG000|Overall Study|Death|198|||
105731283|NCT03875235|364671647|FG001|Overall Study|Death|223|||
105731284|NCT01687673|364671648|FG000|Overall Study|Physician Decision|1|||
105731285|NCT00618956|364671649|FG000|Overall Study|Adverse Event|10|||
105731286|NCT00618956|364671650|FG001|Overall Study|Adverse Event|34|||
105731287|NCT00618956|364671649|FG000|Overall Study|Lack of Efficacy|2|||
105731288|NCT00618956|364671650|FG001|Overall Study|Lack of Efficacy|1|||
105731289|NCT00618956|364671649|FG000|Overall Study|Withdrawal by Subject|5|||
105731290|NCT00618956|364671650|FG001|Overall Study|Withdrawal by Subject|7|||
105731291|NCT00618956|364671649|FG000|Overall Study|Lost to Follow-up|4|||
105731292|NCT00618956|364671650|FG001|Overall Study|Lost to Follow-up|5|||
105731293|NCT00618956|364671649|FG000|Overall Study|Protocol Violation|2|||
105731294|NCT00618956|364671650|FG001|Overall Study|Protocol Violation|2|||
105731295|NCT00618956|364671649|FG000|Overall Study|did not meet criteria, non-compliance|2|||
105731296|NCT00618956|364671650|FG001|Overall Study|did not meet criteria, non-compliance|1|||
105731297|NCT01151137|364671651|FG000|Overall Study|Death|15|||
105731298|NCT01151137|364671652|FG001|Overall Study|Death|27|||
105731299|NCT01151137|364671651|FG000|Overall Study|Lost to Follow-up|1|||
105731300|NCT01151137|364671652|FG001|Overall Study|Lost to Follow-up|1|||
105731301|NCT02452359|364671658|FG000|Overall Study|Adverse Event|1|||
105731302|NCT02452359|364671658|FG000|Overall Study|Lost to Follow-up|15|||
105731303|NCT02452359|364671658|FG000|Overall Study|Pregnancy|1|||
105731304|NCT02452359|364671658|FG000|Overall Study|Withdrawal by Subject|4|||
105731305|NCT00630032|364671665|FG000|Overall Study|Death|55|||
105731306|NCT00630032|364671666|FG001|Overall Study|Death|49|||
105731307|NCT00630032|364671665|FG000|Overall Study|Withdrawal by Subject|3|||
105731308|NCT00630032|364671666|FG001|Overall Study|Withdrawal by Subject|2|||
105731309|NCT00630032|364671665|FG000|Overall Study|Lost to Follow-up|18|||
105731310|NCT00630032|364671666|FG001|Overall Study|Lost to Follow-up|31|||
105731311|NCT00630032|364671665|FG000|Overall Study|Protocol Violation|1|||
105731312|NCT00630032|364671666|FG001|Overall Study|Protocol Violation|0|||
105731313|NCT00630032|364671665|FG000|Overall Study|Patient has moved|1|||
106139300|NCT00094809|366168587|FG000|Overall Study|Other|2|||
105731314|NCT00630032|364671666|FG001|Overall Study|Patient has moved|1|||
105731315|NCT00630032|364671665|FG000|Overall Study|Disease progression|1|||
105731316|NCT00630032|364671666|FG001|Overall Study|Disease progression|1|||
105731317|NCT00630032|364671665|FG000|Overall Study|End of monitoring in US centers|11|||
105731318|NCT00630032|364671666|FG001|Overall Study|End of monitoring in US centers|11|||
105731319|NCT00538733|364671667|FG000|Overall Study|Adverse Event|8|||
105731320|NCT00538733|364671667|FG000|Overall Study|Death|1|||
105731321|NCT00538733|364671667|FG000|Overall Study|declined to participate|2|||
105731322|NCT00538733|364671667|FG000|Overall Study|still on therapy|1|||
105731323|NCT02975349|364671672|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731324|NCT02975349|364671673|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731325|NCT02975349|364671674|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731326|NCT02975349|364671675|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
105731327|NCT02975349|364671676|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
106139301|NCT00094809|366168588|FG001|Overall Study|Other|4|||
106139302|NCT00094809|366168587|FG000|Overall Study|Informed consent signed after treatment|1|||
106139303|NCT00094809|366168588|FG001|Overall Study|Informed consent signed after treatment|0|||
105797122|NCT04556838|364914672|FG001|Overall Study|Withdrawal by Subject|1|||
105797123|NCT04556838|364914673|FG002|Overall Study|Withdrawal by Subject|2|||
105797124|NCT04556838|364914671|FG000|Overall Study|Adverse Event|0|||
105797125|NCT04556838|364914672|FG001|Overall Study|Adverse Event|1|||
105797126|NCT04556838|364914673|FG002|Overall Study|Adverse Event|1|||
105797127|NCT04556838|364914671|FG000|Overall Study|Lost to Follow-up|0|||
105797128|NCT04556838|364914672|FG001|Overall Study|Lost to Follow-up|0|||
105797129|NCT04556838|364914673|FG002|Overall Study|Lost to Follow-up|2|||
105797130|NCT04556838|364914671|FG000|Overall Study|Subject travel|0|||
105797131|NCT04556838|364914672|FG001|Overall Study|Subject travel|1|||
105797132|NCT04556838|364914673|FG002|Overall Study|Subject travel|0|||
105797133|NCT04556838|364914671|FG000|Overall Study|Physician Decision|1|||
105797134|NCT04556838|364914672|FG001|Overall Study|Physician Decision|0|||
105797135|NCT04556838|364914673|FG002|Overall Study|Physician Decision|0|||
105797136|NCT02367781|364914676|FG000|Overall Study|Withdrawal by Subject|20|||
105797137|NCT02367781|364914677|FG001|Overall Study|Withdrawal by Subject|13|||
105731328|NCT02975349|364671677|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731329|NCT02975349|364671678|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105731330|NCT02975349|364671672|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105731331|NCT02975349|364671673|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731332|NCT02975349|364671674|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731333|NCT02975349|364671675|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731334|NCT02975349|364671676|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731335|NCT02975349|364671677|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731336|NCT02975349|364671678|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105731337|NCT02975349|364671672|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
105731338|NCT02975349|364671673|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
105731339|NCT02975349|364671674|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
105731340|NCT02975349|364671675|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
105731341|NCT02975349|364671676|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
105731342|NCT02975349|364671677|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
105731343|NCT02975349|364671678|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
105731344|NCT02975349|364671672|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
105731345|NCT02975349|364671673|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
105731346|NCT02975349|364671674|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
105731347|NCT02975349|364671675|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
105731348|NCT02975349|364671676|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
105731349|NCT02975349|364671677|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
105731350|NCT02975349|364671678|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
105731351|NCT02975349|364671672|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
105731352|NCT02975349|364671673|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
105731353|NCT02975349|364671674|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
105731354|NCT02975349|364671675|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
105731355|NCT02975349|364671676|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
105731356|NCT02975349|364671677|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
105731357|NCT02975349|364671678|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
105731358|NCT02975349|364671672|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731359|NCT02975349|364671673|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731360|NCT02975349|364671674|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731361|NCT02975349|364671675|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
105731362|NCT02975349|364671676|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731363|NCT02975349|364671677|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731364|NCT02975349|364671678|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
105731365|NCT02975349|364671672|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731366|NCT02975349|364671673|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
105731367|NCT02975349|364671674|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731368|NCT02975349|364671675|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731369|NCT02975349|364671676|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731370|NCT02975349|364671677|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731371|NCT02975349|364671678|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
105731372|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
105797138|NCT02367781|364914676|FG000|Overall Study|Protocol Violation|0|||
105731373|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
105731374|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
105797139|NCT02367781|364914677|FG001|Overall Study|Protocol Violation|1|||
105797140|NCT02367781|364914676|FG000|Overall Study|Physician Decision|7|||
105797141|NCT02367781|364914677|FG001|Overall Study|Physician Decision|0|||
106139304|NCT00094809|366168587|FG000|Overall Study|Study drug not received|2|||
106139305|NCT00094809|366168588|FG001|Overall Study|Study drug not received|8|||
105797142|NCT02367781|364914676|FG000|Overall Study|Randomized in Error|5|||
106139306|NCT00094809|366168587|FG000|Overall Study|Other|1|||
106139307|NCT00094809|366168588|FG001|Overall Study|Other|1|||
106139308|NCT04889664|366168589|FG000|Screen|Lost to Follow-up|1|||
106139309|NCT04889664|366168589|FG000|Screen|Failed to meet screening criteria|1|||
106139310|NCT04889664|366168589|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
106139311|NCT02155829|366168590|FG000|Overall Study|Adverse Event|1|||
106139312|NCT02155829|366168591|FG001|Overall Study|Adverse Event|0|||
106139313|NCT02155829|366168590|FG000|Overall Study|Withdrawal by Subject|3|||
106139314|NCT02155829|366168591|FG001|Overall Study|Withdrawal by Subject|3|||
106139315|NCT02155829|366168590|FG000|Overall Study|Protocol Violation|2|||
106139316|NCT02155829|366168591|FG001|Overall Study|Protocol Violation|0|||
106139317|NCT01585038|366168592|FG000|Overall Study|Adverse Event|2|||
106139318|NCT01585038|366168593|FG001|Overall Study|Adverse Event|2|||
106139319|NCT01191086|366168602|FG000|Overall Study|Adverse Event|20|||
105731375|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
105731376|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
105731377|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
105731378|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
105731379|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731380|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731381|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731382|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731383|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
105731384|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731385|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
105731386|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731387|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731388|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731389|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731390|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
105731391|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
105731392|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
105731393|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
105731394|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
105731395|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
105731396|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
105731397|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
105731398|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
105731399|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
105731400|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
105731401|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
105731402|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
105731403|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
105731404|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
105731405|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
105731406|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
105731407|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731408|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731409|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
105731410|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731411|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731412|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
105731413|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
105731414|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
105731415|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
105731416|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
105731417|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
105731418|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
105731419|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
105731420|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
105731421|NCT02975349|364671672|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
105731422|NCT02975349|364671673|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
105731423|NCT02975349|364671674|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
106139320|NCT01191086|366168602|FG000|Overall Study|Lack of Efficacy|10|||
106139321|NCT01191086|366168602|FG000|Overall Study|Lost to Follow-up|4|||
106139322|NCT01191086|366168602|FG000|Overall Study|Physician Decision|2|||
106139323|NCT01191086|366168602|FG000|Overall Study|Withdrawal by Subject|24|||
106139324|NCT01191086|366168602|FG000|Overall Study|Discontinuation criterion met|1|||
106139325|NCT01191086|366168602|FG000|Overall Study|Other|1|||
105731424|NCT02975349|364671675|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
105731425|NCT02975349|364671676|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
105731426|NCT02975349|364671677|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
105731427|NCT02975349|364671678|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
105731428|NCT03091192|364671681|FG000|Overall Study|Study terminated by sponsor|21|||
105731429|NCT03091192|364671682|FG001|Overall Study|Study terminated by sponsor|14|||
105731430|NCT03091192|364671681|FG000|Overall Study|Death|9|||
105731431|NCT03091192|364671682|FG001|Overall Study|Death|13|||
105731432|NCT03091192|364671681|FG000|Overall Study|Withdrawal by Subject|2|||
105731433|NCT03091192|364671682|FG001|Overall Study|Withdrawal by Subject|0|||
105731434|NCT03091192|364671681|FG000|Overall Study|Lost to Follow-up|1|||
105731435|NCT03091192|364671682|FG001|Overall Study|Lost to Follow-up|0|||
105731436|NCT03497689|364671683|FG000|Overall Study|Adverse Event|2|||
105731437|NCT03497689|364671683|FG000|Overall Study|Death|1|||
105731438|NCT03497689|364671683|FG000|Overall Study|Physician Decision|1|||
105731439|NCT03497689|364671683|FG000|Overall Study|Withdrawal by Subject|1|||
105731440|NCT03497689|364671683|FG000|Overall Study|Protocol Violation|2|||
105731441|NCT04358458|364671684|FG000|Overall Study|Death|1|||
105731442|NCT04358458|364671685|FG001|Overall Study|Death|1|||
105731443|NCT04358458|364671686|FG002|Overall Study|Death|3|||
105731444|NCT04358458|364671687|FG003|Overall Study|Death|8|||
105731445|NCT04358458|364671688|FG004|Overall Study|Death|1|||
105731446|NCT04358458|364671689|FG005|Overall Study|Death|6|||
105731447|NCT04358458|364671690|FG006|Overall Study|Death|2|||
105731448|NCT04358458|364671691|FG007|Overall Study|Death|3|||
105731449|NCT04358458|364671684|FG000|Overall Study|Lost to Follow-up|0|||
105731450|NCT04358458|364671685|FG001|Overall Study|Lost to Follow-up|0|||
105731451|NCT04358458|364671686|FG002|Overall Study|Lost to Follow-up|0|||
105731452|NCT04358458|364671687|FG003|Overall Study|Lost to Follow-up|0|||
105731453|NCT04358458|364671688|FG004|Overall Study|Lost to Follow-up|0|||
105731454|NCT04358458|364671689|FG005|Overall Study|Lost to Follow-up|0|||
105731455|NCT04358458|364671690|FG006|Overall Study|Lost to Follow-up|0|||
105731456|NCT04358458|364671691|FG007|Overall Study|Lost to Follow-up|1|||
105731457|NCT04358458|364671684|FG000|Overall Study|Site is closing study participation|0|||
105731458|NCT04358458|364671685|FG001|Overall Study|Site is closing study participation|0|||
105731459|NCT04358458|364671686|FG002|Overall Study|Site is closing study participation|0|||
105731460|NCT04358458|364671687|FG003|Overall Study|Site is closing study participation|1|||
105731461|NCT04358458|364671688|FG004|Overall Study|Site is closing study participation|0|||
105731462|NCT04358458|364671689|FG005|Overall Study|Site is closing study participation|0|||
105731463|NCT04358458|364671690|FG006|Overall Study|Site is closing study participation|0|||
105731464|NCT04358458|364671691|FG007|Overall Study|Site is closing study participation|0|||
105731465|NCT04358458|364671684|FG000|Overall Study|Sponsor request|2|||
105731466|NCT04358458|364671685|FG001|Overall Study|Sponsor request|3|||
105731467|NCT04358458|364671686|FG002|Overall Study|Sponsor request|3|||
105731468|NCT04358458|364671687|FG003|Overall Study|Sponsor request|0|||
105731469|NCT04358458|364671688|FG004|Overall Study|Sponsor request|2|||
105731470|NCT04358458|364671689|FG005|Overall Study|Sponsor request|3|||
105731471|NCT04358458|364671690|FG006|Overall Study|Sponsor request|1|||
105731472|NCT04358458|364671691|FG007|Overall Study|Sponsor request|1|||
105731473|NCT04358458|364671684|FG000|Overall Study|Withdrawal by Subject|0|||
105731474|NCT04358458|364671685|FG001|Overall Study|Withdrawal by Subject|0|||
105731475|NCT04358458|364671686|FG002|Overall Study|Withdrawal by Subject|1|||
105731476|NCT04358458|364671687|FG003|Overall Study|Withdrawal by Subject|1|||
105731477|NCT04358458|364671688|FG004|Overall Study|Withdrawal by Subject|0|||
105731478|NCT04358458|364671689|FG005|Overall Study|Withdrawal by Subject|1|||
105731479|NCT04358458|364671690|FG006|Overall Study|Withdrawal by Subject|0|||
105731480|NCT04358458|364671691|FG007|Overall Study|Withdrawal by Subject|1|||
105731481|NCT05847881|364671692|FG000|Overall Study|Principal Investigator Decision|8|||
105731482|NCT05847881|364671692|FG000|Overall Study|Withdrawal by Subject|2|||
105731483|NCT05635838|364673707|FG000|16-Week DBVC Period|Adverse Event|2|||
105731484|NCT05635838|364673708|FG001|16-Week DBVC Period|Adverse Event|0|||
105731485|NCT05635838|364673709|FG002|16-Week DBVC Period|Adverse Event|0|||
105731486|NCT05635838|364673710|FG003|16-Week DBVC Period|Adverse Event|0|||
105731487|NCT05635838|364673707|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
105731488|NCT05635838|364673708|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
105731489|NCT05635838|364673709|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
105731490|NCT05635838|364673710|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
105731491|NCT05635838|364673707|FG000|16-Week DBVC Period|Physician Decision|0|||
105731492|NCT05635838|364673708|FG001|16-Week DBVC Period|Physician Decision|1|||
105731493|NCT05635838|364673709|FG002|16-Week DBVC Period|Physician Decision|0|||
105731494|NCT05635838|364673710|FG003|16-Week DBVC Period|Physician Decision|0|||
105731495|NCT05635838|364673707|FG000|16-Week DBVC Period|Protocol Violation|1|||
105731496|NCT05635838|364673708|FG001|16-Week DBVC Period|Protocol Violation|0|||
106139326|NCT00290732|366168605|FG000|Overall Study|Inability to instill drug intraductally.|0|||
105731497|NCT05635838|364673709|FG002|16-Week DBVC Period|Protocol Violation|0|||
105731498|NCT05635838|364673710|FG003|16-Week DBVC Period|Protocol Violation|0|||
105937651|NCT00147537|365431539|FG004|Phase 1b|Other|1|||
105797143|NCT02367781|364914677|FG001|Overall Study|Randomized in Error|4|||
105797144|NCT02367781|364914676|FG000|Overall Study|Non-Compliance|1|||
105797145|NCT02367781|364914677|FG001|Overall Study|Non-Compliance|0|||
105797146|NCT02367781|364914676|FG000|Overall Study|Lost to Follow-up|1|||
105797147|NCT02367781|364914677|FG001|Overall Study|Lost to Follow-up|2|||
105797148|NCT02367781|364914676|FG000|Overall Study|Death|330|||
105797149|NCT02367781|364914677|FG001|Overall Study|Death|176|||
105797150|NCT02367781|364914676|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
105797151|NCT02367781|364914677|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
105797152|NCT02367781|364914676|FG000|Overall Study|Prolonged Hospitalization|1|||
105797153|NCT02367781|364914677|FG001|Overall Study|Prolonged Hospitalization|0|||
105797154|NCT02367781|364914676|FG000|Overall Study|Death Prior First Dose|1|||
105797155|NCT02367781|364914677|FG001|Overall Study|Death Prior First Dose|0|||
105797156|NCT02367781|364914676|FG000|Overall Study|Administrative-Change Facility|1|||
105797157|NCT02367781|364914677|FG001|Overall Study|Administrative-Change Facility|0|||
105797158|NCT02367781|364914676|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
105797159|NCT02367781|364914677|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
105797160|NCT02367781|364914676|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
105797161|NCT02367781|364914677|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
105797162|NCT02367781|364914676|FG000|Overall Study|Study Terminated by Sponsor|3|||
105797163|NCT02367781|364914677|FG001|Overall Study|Study Terminated by Sponsor|1|||
105797164|NCT02367781|364914676|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
105797165|NCT02367781|364914677|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
105797166|NCT02367781|364914676|FG000|Overall Study|Sponsor Decision|2|||
105797167|NCT02367781|364914677|FG001|Overall Study|Sponsor Decision|0|||
105797168|NCT02367781|364914676|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
105797169|NCT02367781|364914677|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
105797170|NCT02623426|364914678|FG000|Overall Study|Lost to Follow-up|0|||
105797171|NCT02623426|364914679|FG001|Overall Study|Lost to Follow-up|0|||
105797172|NCT02623426|364914680|FG002|Overall Study|Lost to Follow-up|1|||
106139327|NCT00290732|366168606|FG001|Overall Study|Inability to instill drug intraductally.|1|||
105797173|NCT02623426|364914678|FG000|Overall Study|Withdrawal by Subject|1|||
105797174|NCT02623426|364914679|FG001|Overall Study|Withdrawal by Subject|2|||
105797175|NCT02623426|364914680|FG002|Overall Study|Withdrawal by Subject|2|||
105797176|NCT02842086|364914681|FG000|Overall Study|Randomized but Never Treated|6|||
105797177|NCT02842086|364914682|FG001|Overall Study|Randomized but Never Treated|6|||
105797178|NCT02842086|364914681|FG000|Overall Study|Still in Double-Blind Phase|7|||
105797179|NCT02842086|364914682|FG001|Overall Study|Still in Double-Blind Phase|3|||
105797180|NCT02842086|364914681|FG000|Overall Study|Adverse Event|18|||
105797181|NCT02842086|364914682|FG001|Overall Study|Adverse Event|20|||
105797182|NCT02842086|364914681|FG000|Overall Study|Death|3|||
105797183|NCT02842086|364914682|FG001|Overall Study|Death|3|||
105797184|NCT02842086|364914681|FG000|Overall Study|Investigator's Discretion|9|||
105797185|NCT02842086|364914682|FG001|Overall Study|Investigator's Discretion|13|||
105797186|NCT02842086|364914681|FG000|Overall Study|Non-Compliance with Study Drug|9|||
105797187|NCT02842086|364914682|FG001|Overall Study|Non-Compliance with Study Drug|8|||
105797188|NCT02842086|364914681|FG000|Overall Study|Protocol Violation|8|||
105797189|NCT02842086|364914682|FG001|Overall Study|Protocol Violation|4|||
105797190|NCT02842086|364914681|FG000|Overall Study|Withdrew Consent|205|||
105797191|NCT02842086|364914682|FG001|Overall Study|Withdrew Consent|194|||
105797192|NCT02842086|364914681|FG000|Overall Study|Lost to Follow-up|274|||
106139328|NCT00290732|366168607|FG002|Overall Study|Inability to instill drug intraductally.|1|||
106139329|NCT00290732|366168608|FG003|Overall Study|Inability to instill drug intraductally.|0|||
105731499|NCT05635838|364673707|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
105731500|NCT05635838|364673708|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
105731501|NCT05635838|364673709|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
105731502|NCT05635838|364673710|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
105731503|NCT05635838|364673707|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
105731504|NCT05635838|364673708|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
105731505|NCT05635838|364673709|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
105731506|NCT05635838|364673710|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
105731507|NCT05635838|364673707|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
105731508|NCT05635838|364673708|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
105797193|NCT02842086|364914682|FG001|Overall Study|Lost to Follow-up|236|||
105797194|NCT02842086|364914681|FG000|Overall Study|HIV-1 Infection|5|||
105797195|NCT02842086|364914682|FG001|Overall Study|HIV-1 Infection|6|||
105797196|NCT03751124|364914683|FG000|Overall Study|Adverse Event|4|||
105797197|NCT03751124|364914684|FG001|Overall Study|Adverse Event|3|||
105797198|NCT03751124|364914683|FG000|Overall Study|Protocol Deviation|0|||
105797199|NCT03751124|364914684|FG001|Overall Study|Protocol Deviation|1|||
105937652|NCT00147537|365431540|FG005|Phase 1b|Other|1|||
105731509|NCT05635838|364673709|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
105937653|NCT00147537|365431541|FG006|Phase 1b|Other|14|||
105731510|NCT05635838|364673710|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
105731511|NCT05635838|364673707|FG000|16-Week OLE Period|Adverse Event|0|||
105731512|NCT05635838|364673708|FG001|16-Week OLE Period|Adverse Event|0|||
105731513|NCT05635838|364673709|FG002|16-Week OLE Period|Adverse Event|0|||
105731514|NCT05635838|364673710|FG003|16-Week OLE Period|Adverse Event|2|||
105731515|NCT05635838|364673707|FG000|16-Week OLE Period|Lost to Follow-up|0|||
105731516|NCT05635838|364673708|FG001|16-Week OLE Period|Lost to Follow-up|0|||
105731517|NCT05635838|364673709|FG002|16-Week OLE Period|Lost to Follow-up|1|||
105731518|NCT05635838|364673710|FG003|16-Week OLE Period|Lost to Follow-up|3|||
105731519|NCT05635838|364673707|FG000|16-Week OLE Period|Physician Decision|0|||
105731520|NCT05635838|364673708|FG001|16-Week OLE Period|Physician Decision|0|||
105731521|NCT05635838|364673709|FG002|16-Week OLE Period|Physician Decision|0|||
105731522|NCT05635838|364673710|FG003|16-Week OLE Period|Physician Decision|1|||
105731523|NCT05635838|364673707|FG000|16-Week OLE Period|Protocol Violation|0|||
105731524|NCT05635838|364673708|FG001|16-Week OLE Period|Protocol Violation|0|||
105731525|NCT05635838|364673709|FG002|16-Week OLE Period|Protocol Violation|1|||
105731526|NCT05635838|364673710|FG003|16-Week OLE Period|Protocol Violation|1|||
105731527|NCT05635838|364673707|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
105731528|NCT05635838|364673708|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
105731529|NCT05635838|364673709|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
105731530|NCT05635838|364673710|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
105731531|NCT05635838|364673707|FG000|16-Week OLE Period|Pregnancy|0|||
105731532|NCT05635838|364673708|FG001|16-Week OLE Period|Pregnancy|0|||
105731533|NCT05635838|364673709|FG002|16-Week OLE Period|Pregnancy|1|||
105731534|NCT05635838|364673710|FG003|16-Week OLE Period|Pregnancy|0|||
105731535|NCT01672892|364673712|FG000|Overall Study|Protocol Violation|7|||
105731536|NCT01672892|364673713|FG001|Overall Study|Protocol Violation|3|||
105731537|NCT02342171|364673719|FG000|Overall Study|Death|4|||
105731538|NCT02342171|364673720|FG001|Overall Study|Death|87|||
105731539|NCT02342171|364673719|FG000|Overall Study|Received favipiravir|10|||
105731540|NCT02342171|364673720|FG001|Overall Study|Received favipiravir|0|||
105731541|NCT02342171|364673719|FG000|Overall Study|Missing cycle treshold value|1|||
105731542|NCT02342171|364673720|FG001|Overall Study|Missing cycle treshold value|0|||
105731543|NCT02342171|364673719|FG000|Overall Study|Unknown outcome|0|||
105731544|NCT02342171|364673720|FG001|Overall Study|Unknown outcome|1|||
105731545|NCT02342171|364673719|FG000|Overall Study|Missing age data|0|||
105731546|NCT02342171|364673720|FG001|Overall Study|Missing age data|1|||
105731547|NCT04426630|364673721|FG000|Overall Study|Death|4|||
105731548|NCT04426630|364673721|FG000|Overall Study|Lost to Follow-up|2|||
105731549|NCT02082184|364673725|FG000|Overall Study|Adverse Event|1|||
105731550|NCT02082184|364673726|FG001|Overall Study|Adverse Event|0|||
105731551|NCT02082184|364673725|FG000|Overall Study|Medical diagnosis|1|||
105731552|NCT02082184|364673726|FG001|Overall Study|Medical diagnosis|2|||
105797200|NCT03751124|364914683|FG000|Overall Study|Lost to Follow-up|6|||
105937654|NCT00147537|365431542|FG007|Phase 1b|Other|4|||
105937655|NCT00147537|365431543|FG008|Phase 1b|Other|4|||
105937656|NCT00147537|365431544|FG009|Phase 1b|Other|0|||
105937657|NCT00147537|365431545|FG010|Phase 1b|Other|0|||
105937658|NCT00147537|365431535|FG000|Phase 1b|Withdrawal by Subject|0|||
105937659|NCT00147537|365431536|FG001|Phase 1b|Withdrawal by Subject|0|||
105937660|NCT00147537|365431537|FG002|Phase 1b|Withdrawal by Subject|0|||
105937661|NCT00147537|365431538|FG003|Phase 1b|Withdrawal by Subject|0|||
105937662|NCT00147537|365431539|FG004|Phase 1b|Withdrawal by Subject|0|||
105937663|NCT00147537|365431540|FG005|Phase 1b|Withdrawal by Subject|0|||
105937664|NCT00147537|365431541|FG006|Phase 1b|Withdrawal by Subject|0|||
105937665|NCT00147537|365431542|FG007|Phase 1b|Withdrawal by Subject|0|||
105937666|NCT00147537|365431543|FG008|Phase 1b|Withdrawal by Subject|2|||
105937667|NCT00147537|365431544|FG009|Phase 1b|Withdrawal by Subject|0|||
105937668|NCT00147537|365431545|FG010|Phase 1b|Withdrawal by Subject|0|||
105937669|NCT00147537|365431535|FG000|Phase 1b|Randomized but not treated|0|||
105937670|NCT00147537|365431536|FG001|Phase 1b|Randomized but not treated|0|||
105937671|NCT00147537|365431537|FG002|Phase 1b|Randomized but not treated|0|||
105937672|NCT00147537|365431538|FG003|Phase 1b|Randomized but not treated|0|||
105937673|NCT00147537|365431539|FG004|Phase 1b|Randomized but not treated|0|||
105937674|NCT00147537|365431540|FG005|Phase 1b|Randomized but not treated|0|||
105731553|NCT02082184|364673725|FG000|Overall Study|Device associated symptoms|5|||
105731554|NCT02082184|364673726|FG001|Overall Study|Device associated symptoms|0|||
105731555|NCT02082184|364673725|FG000|Overall Study|Withdrawal by Subject|3|||
105731556|NCT02082184|364673726|FG001|Overall Study|Withdrawal by Subject|2|||
105797201|NCT03751124|364914684|FG001|Overall Study|Lost to Follow-up|4|||
105937675|NCT00147537|365431541|FG006|Phase 1b|Randomized but not treated|1|||
105731557|NCT02082184|364673725|FG000|Overall Study|Protocol Violation|0|||
105731558|NCT02082184|364673726|FG001|Overall Study|Protocol Violation|6|||
105731559|NCT02082184|364673725|FG000|Overall Study|Lost to Follow-up|0|||
105731560|NCT02082184|364673726|FG001|Overall Study|Lost to Follow-up|2|||
105797202|NCT03751124|364914683|FG000|Overall Study|Withdrawal by Subject|6|||
105937676|NCT00147537|365431542|FG007|Phase 1b|Randomized but not treated|0|||
105797203|NCT03751124|364914684|FG001|Overall Study|Withdrawal by Subject|8|||
105797204|NCT03751124|364914683|FG000|Overall Study|Lack of Efficacy|1|||
105797205|NCT03751124|364914684|FG001|Overall Study|Lack of Efficacy|1|||
105797206|NCT03751124|364914683|FG000|Overall Study|Pregnancy|0|||
105797207|NCT03751124|364914684|FG001|Overall Study|Pregnancy|1|||
105797208|NCT03751124|364914683|FG000|Overall Study|Other|9|||
105937677|NCT00147537|365431543|FG008|Phase 1b|Randomized but not treated|1|||
105937678|NCT00147537|365431544|FG009|Phase 1b|Randomized but not treated|0|||
105937679|NCT00147537|365431545|FG010|Phase 1b|Randomized but not treated|0|||
105937680|NCT00147537|365431535|FG000|Phase 2|Death|0|||
105937681|NCT00147537|365431536|FG001|Phase 2|Death|0|||
105937682|NCT00147537|365431537|FG002|Phase 2|Death|0|||
105937683|NCT00147537|365431538|FG003|Phase 2|Death|0|||
105937684|NCT00147537|365431539|FG004|Phase 2|Death|0|||
105937685|NCT00147537|365431540|FG005|Phase 2|Death|0|||
105937686|NCT00147537|365431541|FG006|Phase 2|Death|0|||
105937687|NCT00147537|365431542|FG007|Phase 2|Death|0|||
105937688|NCT00147537|365431543|FG008|Phase 2|Death|0|||
105937689|NCT00147537|365431544|FG009|Phase 2|Death|85|||
105937690|NCT00147537|365431545|FG010|Phase 2|Death|31|||
105937691|NCT00147537|365431535|FG000|Phase 2|Lost to Follow-up|0|||
105937692|NCT00147537|365431536|FG001|Phase 2|Lost to Follow-up|0|||
105937693|NCT00147537|365431537|FG002|Phase 2|Lost to Follow-up|0|||
105937694|NCT00147537|365431538|FG003|Phase 2|Lost to Follow-up|0|||
105937695|NCT00147537|365431539|FG004|Phase 2|Lost to Follow-up|0|||
105937696|NCT00147537|365431540|FG005|Phase 2|Lost to Follow-up|0|||
105937697|NCT00147537|365431541|FG006|Phase 2|Lost to Follow-up|0|||
105937698|NCT00147537|365431542|FG007|Phase 2|Lost to Follow-up|0|||
105937699|NCT00147537|365431543|FG008|Phase 2|Lost to Follow-up|0|||
105937700|NCT00147537|365431544|FG009|Phase 2|Lost to Follow-up|12|||
105937701|NCT00147537|365431545|FG010|Phase 2|Lost to Follow-up|4|||
105937702|NCT00147537|365431535|FG000|Phase 2|Other|0|||
105937703|NCT00147537|365431536|FG001|Phase 2|Other|0|||
105937704|NCT00147537|365431537|FG002|Phase 2|Other|0|||
105937705|NCT00147537|365431538|FG003|Phase 2|Other|0|||
105937706|NCT00147537|365431539|FG004|Phase 2|Other|0|||
105937707|NCT00147537|365431540|FG005|Phase 2|Other|0|||
105937708|NCT00147537|365431541|FG006|Phase 2|Other|0|||
105937709|NCT00147537|365431542|FG007|Phase 2|Other|0|||
105937710|NCT00147537|365431543|FG008|Phase 2|Other|0|||
105937711|NCT00147537|365431544|FG009|Phase 2|Other|47|||
105937712|NCT00147537|365431545|FG010|Phase 2|Other|12|||
105937713|NCT00147537|365431535|FG000|Phase 2|Withdrawal by Subject|0|||
105937714|NCT00147537|365431536|FG001|Phase 2|Withdrawal by Subject|0|||
105937715|NCT00147537|365431537|FG002|Phase 2|Withdrawal by Subject|0|||
105937716|NCT00147537|365431538|FG003|Phase 2|Withdrawal by Subject|0|||
105937717|NCT00147537|365431539|FG004|Phase 2|Withdrawal by Subject|0|||
105937718|NCT00147537|365431540|FG005|Phase 2|Withdrawal by Subject|0|||
105937719|NCT00147537|365431541|FG006|Phase 2|Withdrawal by Subject|0|||
105937720|NCT00147537|365431542|FG007|Phase 2|Withdrawal by Subject|0|||
105937721|NCT00147537|365431543|FG008|Phase 2|Withdrawal by Subject|0|||
105937722|NCT00147537|365431544|FG009|Phase 2|Withdrawal by Subject|16|||
105937723|NCT00147537|365431545|FG010|Phase 2|Withdrawal by Subject|4|||
105937724|NCT00147537|365431535|FG000|Phase 2|Randomized but not treated|0|||
105937725|NCT00147537|365431536|FG001|Phase 2|Randomized but not treated|0|||
105937726|NCT00147537|365431537|FG002|Phase 2|Randomized but not treated|0|||
105937727|NCT00147537|365431538|FG003|Phase 2|Randomized but not treated|0|||
105937728|NCT00147537|365431539|FG004|Phase 2|Randomized but not treated|0|||
105937729|NCT00147537|365431540|FG005|Phase 2|Randomized but not treated|0|||
105937730|NCT00147537|365431541|FG006|Phase 2|Randomized but not treated|0|||
105937731|NCT00147537|365431542|FG007|Phase 2|Randomized but not treated|0|||
106139330|NCT00290732|366168609|FG004|Overall Study|Inability to instill drug intraductally.|0|||
106139331|NCT01370694|366168610|FG000|Overall Study|Switched to rituximab|4|||
106139332|NCT01370694|366168610|FG000|Overall Study|Progressive disease|2|||
106139333|NCT02393716|366168612|FG000|Overall Study|Death|29|||
105937732|NCT00147537|365431543|FG008|Phase 2|Randomized but not treated|0|||
105937733|NCT00147537|365431544|FG009|Phase 2|Randomized but not treated|1|||
105797209|NCT03751124|364914684|FG001|Overall Study|Other|9|||
105937734|NCT00147537|365431545|FG010|Phase 2|Randomized but not treated|1|||
105937735|NCT01927861|365431546|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
105797210|NCT03751124|364914683|FG000|Overall Study|Participants who did not receive any study drug|0|||
105937736|NCT01927861|365431547|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
105937737|NCT01927861|365431546|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
105937738|NCT01927861|365431547|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
105937739|NCT00987935|365431548|FG000|Overall Study|Progressive disease|3|||
105937740|NCT00987935|365431549|FG001|Overall Study|Progressive disease|2|||
105937741|NCT00987935|365431550|FG002|Overall Study|Progressive disease|3|||
105937742|NCT00987935|365431551|FG003|Overall Study|Progressive disease|2|||
105937743|NCT00987935|365431552|FG004|Overall Study|Progressive disease|5|||
105937744|NCT00987935|365431553|FG005|Overall Study|Progressive disease|3|||
105937745|NCT00987935|365431554|FG006|Overall Study|Progressive disease|9|||
105937746|NCT00987935|365431555|FG007|Overall Study|Progressive disease|48|||
105937747|NCT00987935|365431556|FG008|Overall Study|Progressive disease|23|||
106139334|NCT02393716|366168612|FG000|Overall Study|Withdrawal by Subject|8|||
106139335|NCT02393716|366168612|FG000|Overall Study|Device Explanted|8|||
106139336|NCT02393716|366168612|FG000|Overall Study|Missed visit|16|||
106139337|NCT02046616|366168613|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
106139338|NCT02046616|366168613|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
106139339|NCT02046616|366168613|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
106139340|NCT02046616|366168613|FG000|24-Week Treatment Period|Physician Decision|3|||
106139341|NCT02046616|366168613|FG000|24-Week Treatment Period|Other|1|||
106139342|NCT02046616|366168613|FG000|8-Week FU Period|Lost to Follow-up|1|||
106139343|NCT02736799|366168614|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
106139344|NCT02736799|366168615|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
106139345|NCT02736799|366168616|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
106139346|NCT02736799|366168617|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
106139347|NCT02595398|366168618|FG000|Overall Study|Non-compliance|1|||
106139348|NCT02595398|366168619|FG001|Overall Study|Non-compliance|0|||
106139349|NCT02595398|366168618|FG000|Overall Study|Withdrawal by Subject|2|||
106139350|NCT02595398|366168619|FG001|Overall Study|Withdrawal by Subject|1|||
106139351|NCT02595398|366168618|FG000|Overall Study|Lost to Follow-up|1|||
106139352|NCT02595398|366168619|FG001|Overall Study|Lost to Follow-up|0|||
106139353|NCT01156116|366168621|FG000|Overall Study|Withdrawal by Subject|3|||
106139354|NCT01156116|366168622|FG001|Overall Study|Withdrawal by Subject|1|||
106139355|NCT01156116|366168621|FG000|Overall Study|CPAP intolerance|2|||
106139356|NCT01156116|366168622|FG001|Overall Study|CPAP intolerance|0|||
106139357|NCT01193153|366168623|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
106139358|NCT01193153|366168624|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
106139359|NCT01193153|366168623|FG000|Open-label Lead in Period|Pregnancy|1|||
106139360|NCT01193153|366168624|FG001|Open-label Lead in Period|Pregnancy|0|||
106139361|NCT01193153|366168623|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
106139362|NCT01193153|366168624|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
106139363|NCT01193153|366168623|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
106139364|NCT01193153|366168624|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
106139365|NCT01193153|366168623|FG000|Open-label Lead in Period|Other|14|||
106139366|NCT01193153|366168624|FG001|Open-label Lead in Period|Other|0|||
106139367|NCT01193153|366168623|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
106139368|NCT01193153|366168624|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
106139369|NCT01193153|366168623|FG000|Open-label Lead in Period|Adverse Event|41|||
106139370|NCT01193153|366168624|FG001|Open-label Lead in Period|Adverse Event|0|||
106139371|NCT01193153|366168623|FG000|Open-label Lead in Period|Death|1|||
106139372|NCT01193153|366168624|FG001|Open-label Lead in Period|Death|0|||
106139373|NCT01193153|366168623|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
106139374|NCT01193153|366168624|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
106139375|NCT01193153|366168623|FG000|Open-label Stabilization Period|Adverse Event|9|||
106139376|NCT01193153|366168624|FG001|Open-label Stabilization Period|Adverse Event|0|||
106139377|NCT01193153|366168623|FG000|Open-label Stabilization Period|Death|2|||
106139378|NCT01193153|366168624|FG001|Open-label Stabilization Period|Death|0|||
106139379|NCT01193153|366168623|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
106139380|NCT01193153|366168624|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
106139381|NCT01193153|366168623|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
106139382|NCT01193153|366168624|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
106139383|NCT01193153|366168623|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
106139384|NCT01193153|366168624|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
106139385|NCT01193153|366168623|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
106139386|NCT01193153|366168624|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
106139387|NCT01193153|366168623|FG000|Open-label Stabilization Period|Other|8|||
106139388|NCT01193153|366168624|FG001|Open-label Stabilization Period|Other|0|||
106139389|NCT01193153|366168623|FG000|Double Blind Relapse Prevention Period|Other|2|||
106139390|NCT01193153|366168624|FG001|Double Blind Relapse Prevention Period|Other|3|||
106139391|NCT01193153|366168623|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
106139392|NCT01193153|366168624|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
106139393|NCT01193153|366168623|FG000|Double Blind Relapse Prevention Period|Death|2|||
106139394|NCT01193153|366168624|FG001|Double Blind Relapse Prevention Period|Death|0|||
106139395|NCT01193153|366168623|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
106139396|NCT01193153|366168624|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
106139397|NCT01193153|366168623|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
106139398|NCT01193153|366168624|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
106139399|NCT01193153|366168623|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
106139400|NCT01193153|366168624|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
106139401|NCT01193153|366168623|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
106139402|NCT01193153|366168624|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
106139403|NCT01193153|366168623|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
105731561|NCT02082184|364673725|FG000|Overall Study|Subject non-compliance|0|||
105731562|NCT02082184|364673726|FG001|Overall Study|Subject non-compliance|1|||
105731563|NCT02559505|364673729|FG000|Overall Study|Lost to Follow-up|23|||
105731564|NCT02559505|364673730|FG001|Overall Study|Lost to Follow-up|20|||
105731565|NCT02559505|364673729|FG000|Overall Study|Withdrawal by Subject|4|||
105731566|NCT02559505|364673730|FG001|Overall Study|Withdrawal by Subject|2|||
105731567|NCT00698516|364673731|FG000|Overall Study|Study Termination|2|||
105731568|NCT00698516|364673731|FG000|Overall Study|Withdrawal by Subject|3|||
105731569|NCT02213926|364673732|FG000|Overall Study|Death|59|||
105731570|NCT02213926|364673732|FG000|Overall Study|Withdrawal by Subject|10|||
105731571|NCT02213926|364673732|FG000|Overall Study|study terminated by sponsor|51|||
105731572|NCT02213926|364673732|FG000|Overall Study|Lost to Follow-up|3|||
105731573|NCT02213926|364673732|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
105731574|NCT03715465|364673736|FG000|Overall Study|Withdrawal by Subject|1|||
105731575|NCT03715465|364673737|FG001|Overall Study|Withdrawal by Subject|2|||
105731576|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
105731577|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
105731578|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105731579|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
105731580|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
105731581|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
105731582|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
105731583|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
105731584|NCT00756002|364673738|FG000|Double-Blind Treatment Period|Other|2|||
105731585|NCT00756002|364673739|FG001|Double-Blind Treatment Period|Other|2|||
105731586|NCT01451515|364673742|FG000|Overall Study|Death|0|||
105731587|NCT01451515|364673743|FG001|Overall Study|Death|1|||
105731588|NCT01451515|364673744|FG002|Overall Study|Death|0|||
105731589|NCT01451515|364673742|FG000|Overall Study|Withdrawal by Subject|0|||
105731590|NCT01451515|364673743|FG001|Overall Study|Withdrawal by Subject|1|||
105731591|NCT01451515|364673744|FG002|Overall Study|Withdrawal by Subject|0|||
105731592|NCT01451515|364673742|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
105731593|NCT01451515|364673743|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
105731594|NCT01451515|364673744|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
105731595|NCT01451515|364673742|FG000|Overall Study|Relapse (except CNS)|1|||
105731596|NCT01451515|364673743|FG001|Overall Study|Relapse (except CNS)|1|||
105731597|NCT01451515|364673744|FG002|Overall Study|Relapse (except CNS)|0|||
105731598|NCT02397655|364673745|FG000|Overall Study|data not completed|1301|||
105731599|NCT00440401|364673748|FG000|Overall Study|Adverse Event|2|||
105731600|NCT00440401|364673749|FG001|Overall Study|Adverse Event|1|||
105731601|NCT00440401|364673748|FG000|Overall Study|Other|2|||
105731602|NCT00440401|364673749|FG001|Overall Study|Other|5|||
105731603|NCT01925703|364673750|FG000|Overall Study|Physician Decision|1|||
105731604|NCT01925703|364673750|FG000|Overall Study|Lost to Follow-up|2|||
105731605|NCT01925703|364673750|FG000|Overall Study|Discharge prior to full iron repletion|1|||
105731606|NCT00500071|364673754|FG000|Screening and Washout Phase|Protocol Violation|1|||
105731607|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
105731608|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
105731609|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
105731610|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
105731611|NCT00500071|364673754|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
105731612|NCT00500071|364673754|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
105731613|NCT00881205|364673755|FG000|Overall Study|Adverse Event|8|||
105731614|NCT00881205|364673756|FG001|Overall Study|Adverse Event|3|||
105731615|NCT00881205|364673755|FG000|Overall Study|Withdrawal by Subject|1|||
105731616|NCT00881205|364673756|FG001|Overall Study|Withdrawal by Subject|2|||
105731617|NCT00881205|364673755|FG000|Overall Study|Lost to Follow-up|0|||
105731618|NCT00881205|364673756|FG001|Overall Study|Lost to Follow-up|1|||
105731619|NCT00881205|364673755|FG000|Overall Study|Administrative problems|1|||
105731620|NCT00881205|364673756|FG001|Overall Study|Administrative problems|1|||
105731621|NCT00881205|364673755|FG000|Overall Study|Condition no longer requires drug|1|||
105731622|NCT00881205|364673756|FG001|Overall Study|Condition no longer requires drug|0|||
105731623|NCT02580058|364673757|FG000|Overall Study|Adverse Event|16|||
105731624|NCT02580058|364673758|FG001|Overall Study|Adverse Event|30|||
105797211|NCT03751124|364914684|FG001|Overall Study|Participants who did not receive any study drug|1|||
106009552|NCT01310777|365700873|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
105731625|NCT02580058|364673759|FG002|Overall Study|Adverse Event|20|||
105731626|NCT02580058|364673757|FG000|Overall Study|Death|4|||
105731627|NCT02580058|364673758|FG001|Overall Study|Death|4|||
105731628|NCT02580058|364673759|FG002|Overall Study|Death|5|||
105731629|NCT02580058|364673757|FG000|Overall Study|Physician Decision|1|||
105731630|NCT02580058|364673758|FG001|Overall Study|Physician Decision|3|||
105731631|NCT02580058|364673759|FG002|Overall Study|Physician Decision|11|||
105731632|NCT02580058|364673757|FG000|Overall Study|Other|5|||
105731633|NCT02580058|364673758|FG001|Overall Study|Other|1|||
106139404|NCT01193153|366168624|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
106139405|NCT01648140|366168625|FG000|Overall Study|Physician Decision|1|||
106139406|NCT01648140|366168626|FG001|Overall Study|Physician Decision|0|||
106139407|NCT01648140|366168627|FG002|Overall Study|Physician Decision|0|||
106139408|NCT01648140|366168628|FG003|Overall Study|Physician Decision|0|||
106139409|NCT01648140|366168625|FG000|Overall Study|Lack of Efficacy|4|||
106139410|NCT01648140|366168626|FG001|Overall Study|Lack of Efficacy|7|||
106139411|NCT01648140|366168627|FG002|Overall Study|Lack of Efficacy|1|||
106139412|NCT01648140|366168628|FG003|Overall Study|Lack of Efficacy|0|||
106139413|NCT01648140|366168625|FG000|Overall Study|Adverse Event|3|||
106139414|NCT01648140|366168626|FG001|Overall Study|Adverse Event|1|||
106139415|NCT01648140|366168627|FG002|Overall Study|Adverse Event|2|||
106139416|NCT01648140|366168628|FG003|Overall Study|Adverse Event|0|||
106139417|NCT01648140|366168625|FG000|Overall Study|Withdrawal by Subject|2|||
106139418|NCT01648140|366168626|FG001|Overall Study|Withdrawal by Subject|3|||
106139419|NCT01648140|366168627|FG002|Overall Study|Withdrawal by Subject|3|||
106139420|NCT01648140|366168628|FG003|Overall Study|Withdrawal by Subject|2|||
106139421|NCT01648140|366168625|FG000|Overall Study|Lost to Follow-up|2|||
105731634|NCT02580058|364673759|FG002|Overall Study|Other|3|||
105731635|NCT02580058|364673757|FG000|Overall Study|Withdrawal by Subject|4|||
105731636|NCT02580058|364673758|FG001|Overall Study|Withdrawal by Subject|7|||
105731637|NCT02580058|364673759|FG002|Overall Study|Withdrawal by Subject|31|||
105731638|NCT02580058|364673757|FG000|Overall Study|Global Deterioration of Health Status|19|||
105731639|NCT02580058|364673758|FG001|Overall Study|Global Deterioration of Health Status|18|||
105731640|NCT02580058|364673759|FG002|Overall Study|Global Deterioration of Health Status|24|||
105731641|NCT02580058|364673757|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
105731642|NCT02580058|364673758|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105731643|NCT02580058|364673759|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
105731644|NCT02580058|364673757|FG000|Overall Study|Progressive Disease|137|||
105731645|NCT02580058|364673758|FG001|Overall Study|Progressive Disease|125|||
105731646|NCT02580058|364673759|FG002|Overall Study|Progressive Disease|94|||
105731647|NCT02580058|364673757|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105731648|NCT02580058|364673758|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105731649|NCT02580058|364673759|FG002|Overall Study|Non-Compliance With Study Drug|0|||
105731650|NCT05370157|364673760|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
105731651|NCT05370157|364673761|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
105731652|NCT05370157|364673760|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
105731653|NCT05370157|364673761|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
105731654|NCT00849212|364673762|FG000|Overall Study|Lack of Efficacy|1|||
105731655|NCT00849212|364673762|FG000|Overall Study|Withdrawal by Subject|3|||
105731656|NCT00849212|364673762|FG000|Overall Study|Adverse Event|2|||
105731657|NCT00849212|364673762|FG000|Overall Study|Miscellaneous|1|||
105731658|NCT01364467|364673763|FG000|Overall Study|Lost to Follow-up|1|||
105731659|NCT01364467|364673764|FG001|Overall Study|Lost to Follow-up|2|||
105731660|NCT01499576|364673765|FG000|Overall Study|Physician Decision|12|||
105731661|NCT01499576|364673765|FG000|Overall Study|Withdrawal by Subject|9|||
105731662|NCT00847613|364673772|FG000|Overall Study|Ongoing at cut-off date|250|||
105731663|NCT00847613|364673773|FG001|Overall Study|Ongoing at cut-off date|265|||
105731664|NCT00847613|364673774|FG002|Overall Study|Ongoing at cut-off date|64|||
105731665|NCT00847613|364673775|FG003|Overall Study|Ongoing at cut-off date|64|||
105731666|NCT00847613|364673772|FG000|Overall Study|Death|1|||
105731667|NCT00847613|364673773|FG001|Overall Study|Death|1|||
105731668|NCT00847613|364673774|FG002|Overall Study|Death|0|||
105731669|NCT00847613|364673775|FG003|Overall Study|Death|0|||
105731670|NCT00847613|364673772|FG000|Overall Study|Adverse Event|36|||
106139422|NCT01648140|366168626|FG001|Overall Study|Lost to Follow-up|1|||
106139423|NCT01648140|366168627|FG002|Overall Study|Lost to Follow-up|2|||
106139424|NCT01648140|366168628|FG003|Overall Study|Lost to Follow-up|0|||
105731671|NCT00847613|364673773|FG001|Overall Study|Adverse Event|26|||
105731672|NCT00847613|364673774|FG002|Overall Study|Adverse Event|5|||
106139425|NCT00542386|366168629|FG000|Overall Study|Adverse Event|1|||
106139426|NCT00542386|366168630|FG001|Overall Study|Adverse Event|7|||
106139427|NCT00542386|366168631|FG002|Overall Study|Adverse Event|7|||
106139428|NCT00542386|366168632|FG003|Overall Study|Adverse Event|8|||
105731673|NCT00847613|364673775|FG003|Overall Study|Adverse Event|6|||
105731674|NCT00847613|364673772|FG000|Overall Study|Lack of Efficacy|7|||
105731675|NCT00847613|364673773|FG001|Overall Study|Lack of Efficacy|3|||
105731676|NCT00847613|364673774|FG002|Overall Study|Lack of Efficacy|3|||
105731677|NCT00847613|364673775|FG003|Overall Study|Lack of Efficacy|1|||
105731678|NCT00847613|364673772|FG000|Overall Study|Study terminated by Sponsor|1|||
105731679|NCT00847613|364673773|FG001|Overall Study|Study terminated by Sponsor|0|||
105731680|NCT00847613|364673774|FG002|Overall Study|Study terminated by Sponsor|2|||
105731681|NCT00847613|364673775|FG003|Overall Study|Study terminated by Sponsor|1|||
106139429|NCT00542386|366168633|FG004|Overall Study|Adverse Event|13|||
106139430|NCT00542386|366168634|FG005|Overall Study|Adverse Event|4|||
106139431|NCT00542386|366168629|FG000|Overall Study|Death|0|||
106139432|NCT00542386|366168630|FG001|Overall Study|Death|0|||
106139433|NCT00542386|366168631|FG002|Overall Study|Death|1|||
106139434|NCT00542386|366168632|FG003|Overall Study|Death|2|||
106139435|NCT00542386|366168633|FG004|Overall Study|Death|1|||
106139436|NCT00542386|366168634|FG005|Overall Study|Death|2|||
106139437|NCT00542386|366168629|FG000|Overall Study|Lack of Efficacy|32|||
106139438|NCT00542386|366168630|FG001|Overall Study|Lack of Efficacy|12|||
106139439|NCT00542386|366168631|FG002|Overall Study|Lack of Efficacy|10|||
106139440|NCT00542386|366168632|FG003|Overall Study|Lack of Efficacy|13|||
106139441|NCT00542386|366168633|FG004|Overall Study|Lack of Efficacy|7|||
106139442|NCT00542386|366168634|FG005|Overall Study|Lack of Efficacy|31|||
106139443|NCT00542386|366168629|FG000|Overall Study|Physician Decision|1|||
106139444|NCT00542386|366168630|FG001|Overall Study|Physician Decision|0|||
106139445|NCT00542386|366168631|FG002|Overall Study|Physician Decision|0|||
106139446|NCT00542386|366168632|FG003|Overall Study|Physician Decision|1|||
106139447|NCT00542386|366168633|FG004|Overall Study|Physician Decision|0|||
106139448|NCT00542386|366168634|FG005|Overall Study|Physician Decision|0|||
106139449|NCT00542386|366168629|FG000|Overall Study|Protocol Violation|0|||
106139450|NCT00542386|366168630|FG001|Overall Study|Protocol Violation|0|||
106139451|NCT00542386|366168631|FG002|Overall Study|Protocol Violation|1|||
106139452|NCT00542386|366168632|FG003|Overall Study|Protocol Violation|0|||
106139453|NCT00542386|366168633|FG004|Overall Study|Protocol Violation|0|||
106139454|NCT00542386|366168634|FG005|Overall Study|Protocol Violation|4|||
106139455|NCT00542386|366168629|FG000|Overall Study|Withdrawal by Subject|5|||
106139456|NCT00542386|366168630|FG001|Overall Study|Withdrawal by Subject|8|||
106139457|NCT00542386|366168631|FG002|Overall Study|Withdrawal by Subject|10|||
106139458|NCT00542386|366168632|FG003|Overall Study|Withdrawal by Subject|11|||
106139459|NCT00542386|366168633|FG004|Overall Study|Withdrawal by Subject|15|||
106139460|NCT00542386|366168634|FG005|Overall Study|Withdrawal by Subject|7|||
106139461|NCT00542386|366168629|FG000|Overall Study|Other Reasons|4|||
106139462|NCT00542386|366168630|FG001|Overall Study|Other Reasons|1|||
106139463|NCT00542386|366168631|FG002|Overall Study|Other Reasons|4|||
106139464|NCT00542386|366168632|FG003|Overall Study|Other Reasons|3|||
106139465|NCT00542386|366168633|FG004|Overall Study|Other Reasons|4|||
106139466|NCT00542386|366168634|FG005|Overall Study|Other Reasons|2|||
106139467|NCT02503202|366168635|FG000|Base Study: Up to Month 6|Death|1|||
106139468|NCT02503202|366168636|FG001|Base Study: Up to Month 6|Death|1|||
106139469|NCT02503202|366168637|FG002|Base Study: Up to Month 6|Death|0|||
106139470|NCT02503202|366168638|FG003|Base Study: Up to Month 6|Death|0|||
106139471|NCT02503202|366168639|FG004|Base Study: Up to Month 6|Death|0|||
105731682|NCT00847613|364673772|FG000|Overall Study|Lost to Follow-up|5|||
105731683|NCT00847613|364673773|FG001|Overall Study|Lost to Follow-up|0|||
105731684|NCT00847613|364673774|FG002|Overall Study|Lost to Follow-up|0|||
105731685|NCT00847613|364673775|FG003|Overall Study|Lost to Follow-up|3|||
105731686|NCT00847613|364673772|FG000|Overall Study|Protocol Violation|6|||
105731687|NCT00847613|364673773|FG001|Overall Study|Protocol Violation|6|||
105731688|NCT00847613|364673774|FG002|Overall Study|Protocol Violation|3|||
105731689|NCT00847613|364673775|FG003|Overall Study|Protocol Violation|1|||
105731690|NCT00847613|364673772|FG000|Overall Study|Pregnancy|1|||
105731691|NCT00847613|364673773|FG001|Overall Study|Pregnancy|1|||
105731692|NCT00847613|364673774|FG002|Overall Study|Pregnancy|0|||
105731693|NCT00847613|364673775|FG003|Overall Study|Pregnancy|0|||
105731694|NCT00847613|364673772|FG000|Overall Study|Site closure|1|||
105731695|NCT00847613|364673773|FG001|Overall Study|Site closure|0|||
105731696|NCT00847613|364673774|FG002|Overall Study|Site closure|0|||
105731697|NCT00847613|364673775|FG003|Overall Study|Site closure|1|||
105731698|NCT00847613|364673772|FG000|Overall Study|Withdrawal by Subject|8|||
105731699|NCT00847613|364673773|FG001|Overall Study|Withdrawal by Subject|11|||
105731700|NCT00847613|364673774|FG002|Overall Study|Withdrawal by Subject|2|||
106139472|NCT02503202|366168635|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
106139473|NCT02503202|366168636|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
106139474|NCT02503202|366168637|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
106139475|NCT02503202|366168638|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
106139476|NCT02503202|366168639|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
106139477|NCT02503202|366168635|FG000|Base Study: Up to Month 6|Physician Decision|0|||
106139478|NCT02503202|366168636|FG001|Base Study: Up to Month 6|Physician Decision|0|||
106139479|NCT02503202|366168637|FG002|Base Study: Up to Month 6|Physician Decision|0|||
105731701|NCT00847613|364673775|FG003|Overall Study|Withdrawal by Subject|2|||
105731702|NCT00847613|364673772|FG000|Overall Study|Participant moved|4|||
106139480|NCT02503202|366168638|FG003|Base Study: Up to Month 6|Physician Decision|0|||
106139481|NCT02503202|366168639|FG004|Base Study: Up to Month 6|Physician Decision|1|||
105731703|NCT00847613|364673773|FG001|Overall Study|Participant moved|1|||
105731704|NCT00847613|364673774|FG002|Overall Study|Participant moved|0|||
105731705|NCT00847613|364673775|FG003|Overall Study|Participant moved|0|||
105731706|NCT00847613|364673772|FG000|Overall Study|Sponsor request|0|||
105731707|NCT00847613|364673773|FG001|Overall Study|Sponsor request|1|||
105731708|NCT00847613|364673774|FG002|Overall Study|Sponsor request|0|||
105731709|NCT00847613|364673775|FG003|Overall Study|Sponsor request|0|||
105731710|NCT00847613|364673772|FG000|Overall Study|Randomized, but not treated|0|||
105731711|NCT00847613|364673773|FG001|Overall Study|Randomized, but not treated|3|||
105731712|NCT00847613|364673774|FG002|Overall Study|Randomized, but not treated|0|||
105731713|NCT00847613|364673775|FG003|Overall Study|Randomized, but not treated|0|||
105731714|NCT00847613|364673772|FG000|Overall Study|Other|1|||
105937748|NCT00987935|365431548|FG000|Overall Study|Adverse Event|0|||
105731715|NCT00847613|364673773|FG001|Overall Study|Other|1|||
105731716|NCT00847613|364673774|FG002|Overall Study|Other|2|||
105731717|NCT00847613|364673775|FG003|Overall Study|Other|0|||
105731718|NCT01633060|364673776|FG000|Randomization Phase|Protocol deviation|1|||
105731719|NCT01633060|364673777|FG001|Randomization Phase|Protocol deviation|2|||
105731720|NCT01633060|364673776|FG000|Randomization Phase|Technical problem|0|||
105731721|NCT01633060|364673777|FG001|Randomization Phase|Technical problem|1|||
105731722|NCT01633060|364673776|FG000|Treatment Phase|Adverse Event|24|||
105731723|NCT01633060|364673777|FG001|Treatment Phase|Adverse Event|3|||
105731724|NCT01633060|364673776|FG000|Treatment Phase|Lost to Follow-up|1|||
105731725|NCT01633060|364673777|FG001|Treatment Phase|Lost to Follow-up|0|||
105731726|NCT01633060|364673776|FG000|Treatment Phase|Physician Decision|16|||
105731727|NCT01633060|364673777|FG001|Treatment Phase|Physician Decision|7|||
105731728|NCT01633060|364673776|FG000|Treatment Phase|Progressive Disease|210|||
105731729|NCT01633060|364673777|FG001|Treatment Phase|Progressive Disease|120|||
105731730|NCT01633060|364673776|FG000|Treatment Phase|Protocol Deviation|1|||
105731731|NCT01633060|364673777|FG001|Treatment Phase|Protocol Deviation|0|||
105731732|NCT01633060|364673776|FG000|Treatment Phase|Study Terminated by sponsor|7|||
105731733|NCT01633060|364673777|FG001|Treatment Phase|Study Terminated by sponsor|3|||
105731734|NCT01633060|364673776|FG000|Treatment Phase|Subject/guardian decision|25|||
105731735|NCT01633060|364673777|FG001|Treatment Phase|Subject/guardian decision|4|||
105731736|NCT01633060|364673776|FG000|Treatment Phase|Death|4|||
105731737|NCT01633060|364673777|FG001|Treatment Phase|Death|3|||
105731738|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
105731739|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105731740|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
105731741|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
105731742|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
105731743|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
105731744|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
105731745|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
105731746|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
105731747|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
105731748|NCT01633060|364673776|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
105731749|NCT01633060|364673777|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
105731750|NCT01982630|364673778|FG000|Overall Study|Adverse Event|2|||
105731751|NCT01982630|364673779|FG001|Overall Study|Adverse Event|0|||
105731752|NCT01982630|364673780|FG002|Overall Study|Adverse Event|1|||
105731753|NCT01982630|364673781|FG003|Overall Study|Adverse Event|0|||
105937749|NCT00987935|365431549|FG001|Overall Study|Adverse Event|1|||
105937750|NCT00987935|365431550|FG002|Overall Study|Adverse Event|0|||
105937751|NCT00987935|365431551|FG003|Overall Study|Adverse Event|1|||
105937752|NCT00987935|365431552|FG004|Overall Study|Adverse Event|1|||
105937753|NCT00987935|365431553|FG005|Overall Study|Adverse Event|0|||
105937754|NCT00987935|365431554|FG006|Overall Study|Adverse Event|2|||
105937755|NCT00987935|365431555|FG007|Overall Study|Adverse Event|10|||
105937756|NCT00987935|365431556|FG008|Overall Study|Adverse Event|6|||
105937757|NCT00987935|365431548|FG000|Overall Study|Refused to continue taking trial med.|1|||
105937758|NCT00987935|365431549|FG001|Overall Study|Refused to continue taking trial med.|0|||
105731754|NCT01982630|364673782|FG004|Overall Study|Adverse Event|1|||
105731755|NCT01982630|364673783|FG005|Overall Study|Adverse Event|2|||
105937759|NCT00987935|365431550|FG002|Overall Study|Refused to continue taking trial med.|0|||
105937760|NCT00987935|365431551|FG003|Overall Study|Refused to continue taking trial med.|0|||
106009553|NCT01310777|365700874|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
105797212|NCT00555399|364914693|FG000|Overall Study|Withdrawal by Subject|0|||
105937761|NCT00987935|365431552|FG004|Overall Study|Refused to continue taking trial med.|1|||
105731756|NCT01982630|364673784|FG006|Overall Study|Adverse Event|1|||
105731757|NCT01982630|364673785|FG007|Overall Study|Adverse Event|0|||
105731758|NCT01982630|364673778|FG000|Overall Study|Physician Decision|1|||
105731759|NCT01982630|364673779|FG001|Overall Study|Physician Decision|0|||
105731760|NCT01982630|364673780|FG002|Overall Study|Physician Decision|2|||
105731761|NCT01982630|364673781|FG003|Overall Study|Physician Decision|1|||
105731762|NCT01982630|364673782|FG004|Overall Study|Physician Decision|2|||
105731763|NCT01982630|364673783|FG005|Overall Study|Physician Decision|0|||
105731764|NCT01982630|364673784|FG006|Overall Study|Physician Decision|0|||
105937762|NCT00987935|365431553|FG005|Overall Study|Refused to continue taking trial med.|0|||
105797213|NCT00555399|364914694|FG001|Overall Study|Withdrawal by Subject|0|||
105797214|NCT00555399|364914695|FG002|Overall Study|Withdrawal by Subject|1|||
105797215|NCT00555399|364914696|FG003|Overall Study|Withdrawal by Subject|0|||
105797216|NCT00555399|364914697|FG004|Overall Study|Withdrawal by Subject|0|||
105797217|NCT00555399|364914698|FG005|Overall Study|Withdrawal by Subject|0|||
105797218|NCT00555399|364914699|FG006|Overall Study|Withdrawal by Subject|0|||
105797219|NCT00555399|364914700|FG007|Overall Study|Withdrawal by Subject|0|||
105797220|NCT00555399|364914701|FG008|Overall Study|Withdrawal by Subject|0|||
105797221|NCT00555399|364914702|FG009|Overall Study|Withdrawal by Subject|0|||
105797222|NCT00555399|364914703|FG010|Overall Study|Withdrawal by Subject|0|||
105797223|NCT00555399|364914704|FG011|Overall Study|Withdrawal by Subject|1|||
105797224|NCT00555399|364914693|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
105797225|NCT00555399|364914694|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
105797226|NCT00555399|364914695|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
105797227|NCT00555399|364914696|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
105797228|NCT00555399|364914697|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
105797229|NCT00555399|364914698|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
105797230|NCT00555399|364914699|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
105797231|NCT00555399|364914700|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
105797232|NCT00555399|364914701|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
105797233|NCT00555399|364914702|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
105797234|NCT00555399|364914703|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
105797235|NCT00555399|364914704|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
105797236|NCT00303316|364915895|FG000|Overall Study|Protocol Violation|1|||
105797237|NCT00303316|364915896|FG001|Overall Study|Protocol Violation|0|||
105797238|NCT00303316|364915895|FG000|Overall Study|Lost to Follow-up|0|||
105797239|NCT00303316|364915896|FG001|Overall Study|Lost to Follow-up|1|||
105797240|NCT00303316|364915895|FG000|Overall Study|Withdrawal by Subject|1|||
105797241|NCT00303316|364915896|FG001|Overall Study|Withdrawal by Subject|2|||
105797242|NCT01160198|364915900|FG000|Overall Study|Withdrawal by Subject|2|||
105797243|NCT01160198|364915901|FG001|Overall Study|Withdrawal by Subject|1|||
105797244|NCT01160198|364915902|FG002|Overall Study|Withdrawal by Subject|0|||
105797245|NCT01160198|364915900|FG000|Overall Study|Adverse Event|0|||
105797246|NCT01160198|364915901|FG001|Overall Study|Adverse Event|1|||
105797247|NCT01160198|364915902|FG002|Overall Study|Adverse Event|0|||
105797248|NCT01160198|364915900|FG000|Overall Study|Lost to Follow-up|0|||
105797249|NCT01160198|364915901|FG001|Overall Study|Lost to Follow-up|1|||
105797250|NCT01160198|364915902|FG002|Overall Study|Lost to Follow-up|0|||
105797251|NCT01160198|364915900|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
105797252|NCT01160198|364915901|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
105797253|NCT01160198|364915902|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
105797254|NCT02360397|364915905|FG000|Overall Study|Incomplete screening|3|||
105797255|NCT02360397|364915905|FG000|Overall Study|Adverse Event|1|||
105797256|NCT01637961|364915908|FG000|Overall Study|Ineligible: wrong primary|1|||
105797257|NCT01637961|364915908|FG000|Overall Study|Ineligible: inadequate pathology|1|||
105797258|NCT03555890|364915913|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105797259|NCT03555890|364915914|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105797260|NCT03555890|364915915|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105797261|NCT03555890|364915916|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
105797262|NCT00550420|364915922|FG000|Overall Study|Adverse Event|28|||
105797263|NCT00550420|364915922|FG000|Overall Study|Lost to Follow-up|8|||
105797264|NCT00550420|364915922|FG000|Overall Study|Protocol Violation|11|||
105797265|NCT00550420|364915922|FG000|Overall Study|Withdrawal by Subject|30|||
105797266|NCT00550420|364915922|FG000|Overall Study|Still in study at termination|206|||
105797267|NCT00550420|364915922|FG000|Overall Study|Missing|2|||
105797268|NCT00550420|364915922|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
105797269|NCT00550420|364915922|FG000|Overall Study|Investigators opinion|1|||
105797270|NCT00550420|364915922|FG000|Overall Study|Lack of curative effect|1|||
105797271|NCT00550420|364915922|FG000|Overall Study|Unethical stop of enrollment|2|||
105797272|NCT00550420|364915922|FG000|Overall Study|Caregiver's decision to withdraw|1|||
105797273|NCT00550420|364915922|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
105797274|NCT00550420|364915922|FG000|Overall Study|Exclusion criteria|1|||
105797275|NCT00550420|364915922|FG000|Overall Study|Prohibited medicine|1|||
105797276|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
105797277|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
105797278|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
105937763|NCT00987935|365431554|FG006|Overall Study|Refused to continue taking trial med.|4|||
105937764|NCT00987935|365431555|FG007|Overall Study|Refused to continue taking trial med.|4|||
105797279|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
105797280|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
105797281|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
105797282|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
105797283|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
105797284|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797285|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797286|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797287|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
105797288|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
105797289|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797290|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797291|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
105797292|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
105797293|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
105797294|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
105797295|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
105797296|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
105797297|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
105797298|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
105797299|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
105797300|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
105797301|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797302|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
105797303|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797304|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
105797305|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797306|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797307|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
105797308|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
105797309|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
105797310|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
105797311|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
105797312|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
105797313|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
105797314|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
105797315|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
105797316|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
105797317|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
105797318|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
105797319|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
105797320|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
105797321|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
105797322|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
105797323|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
105797324|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
105797325|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
105797326|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797327|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
105797328|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797329|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797330|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797331|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
105797332|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
105797333|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
105797334|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
105797335|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
105797336|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
105797337|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
105797338|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
105797339|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
105937765|NCT00987935|365431556|FG008|Overall Study|Refused to continue taking trial med.|2|||
105937766|NCT00987935|365431548|FG000|Overall Study|Reason other than those specified above|0|||
105797340|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
105797341|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
105797342|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
105797343|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
105797344|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
105797345|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
105797346|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
105797347|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
105797348|NCT04440163|364915924|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
105797349|NCT04440163|364915925|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
105797350|NCT04440163|364915926|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
105797351|NCT04440163|364915927|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
105797352|NCT04440163|364915928|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
105797353|NCT04440163|364915929|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
105797354|NCT04440163|364915930|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
105797355|NCT04440163|364915931|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
105797356|NCT04440163|364915924|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
105797357|NCT04440163|364915925|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
105797358|NCT04440163|364915926|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
105797359|NCT04440163|364915927|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
106139482|NCT02503202|366168635|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
105731765|NCT01982630|364673785|FG007|Overall Study|Physician Decision|0|||
105731766|NCT01982630|364673778|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731767|NCT01982630|364673779|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731768|NCT01982630|364673780|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
105731769|NCT01982630|364673781|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731770|NCT01982630|364673782|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731771|NCT01982630|364673783|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731772|NCT01982630|364673784|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731773|NCT01982630|364673785|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
105731774|NCT01982630|364673778|FG000|Overall Study|Withdrawal by Subject|0|||
105731775|NCT01982630|364673779|FG001|Overall Study|Withdrawal by Subject|0|||
105731776|NCT01982630|364673780|FG002|Overall Study|Withdrawal by Subject|0|||
105731777|NCT01982630|364673781|FG003|Overall Study|Withdrawal by Subject|0|||
105731778|NCT01982630|364673782|FG004|Overall Study|Withdrawal by Subject|0|||
105731779|NCT01982630|364673783|FG005|Overall Study|Withdrawal by Subject|1|||
105731780|NCT01982630|364673784|FG006|Overall Study|Withdrawal by Subject|0|||
105731781|NCT01982630|364673785|FG007|Overall Study|Withdrawal by Subject|0|||
105731782|NCT01009294|364673789|FG000|Overall Study|Study discontinued by Sponsor|6|||
105731783|NCT03233048|364673790|FG000|Overall Study|Withdrawal by Subject|1|||
105731784|NCT00561353|364673791|FG000|Overall Study|Subject reached a virologic endpoint|2|||
105731785|NCT00561353|364673792|FG001|Overall Study|Subject reached a virologic endpoint|1|||
105731786|NCT00561353|364673793|FG002|Overall Study|Subject reached a virologic endpoint|1|||
105731787|NCT00561353|364673794|FG003|Overall Study|Subject reached a virologic endpoint|4|||
105731788|NCT00561353|364673795|FG004|Overall Study|Subject reached a virologic endpoint|1|||
105731789|NCT00561353|364673796|FG005|Overall Study|Subject reached a virologic endpoint|3|||
105731790|NCT00561353|364673797|FG006|Overall Study|Subject reached a virologic endpoint|4|||
105731791|NCT00561353|364673798|FG007|Overall Study|Subject reached a virologic endpoint|4|||
105731792|NCT00561353|364673799|FG008|Overall Study|Subject reached a virologic endpoint|5|||
105731793|NCT00561353|364673800|FG009|Overall Study|Subject reached a virologic endpoint|0|||
105731794|NCT00561353|364673791|FG000|Overall Study|Subject ineligible to continue the trial|0|||
105731795|NCT00561353|364673792|FG001|Overall Study|Subject ineligible to continue the trial|0|||
105731796|NCT00561353|364673793|FG002|Overall Study|Subject ineligible to continue the trial|0|||
105731797|NCT00561353|364673794|FG003|Overall Study|Subject ineligible to continue the trial|0|||
105731798|NCT00561353|364673795|FG004|Overall Study|Subject ineligible to continue the trial|0|||
105731799|NCT00561353|364673796|FG005|Overall Study|Subject ineligible to continue the trial|1|||
105731800|NCT00561353|364673797|FG006|Overall Study|Subject ineligible to continue the trial|1|||
105731801|NCT00561353|364673798|FG007|Overall Study|Subject ineligible to continue the trial|0|||
105731802|NCT00561353|364673799|FG008|Overall Study|Subject ineligible to continue the trial|2|||
105731803|NCT00561353|364673800|FG009|Overall Study|Subject ineligible to continue the trial|1|||
105731804|NCT00561353|364673791|FG000|Overall Study|Other|1|||
105731805|NCT00561353|364673792|FG001|Overall Study|Other|0|||
105731806|NCT00561353|364673793|FG002|Overall Study|Other|1|||
105797360|NCT04440163|364915928|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
105797361|NCT04440163|364915929|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
105797362|NCT04440163|364915930|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
105731807|NCT00561353|364673794|FG003|Overall Study|Other|0|||
105731808|NCT00561353|364673795|FG004|Overall Study|Other|0|||
105731809|NCT00561353|364673796|FG005|Overall Study|Other|2|||
105731810|NCT00561353|364673797|FG006|Overall Study|Other|0|||
105731811|NCT00561353|364673798|FG007|Overall Study|Other|0|||
105731812|NCT00561353|364673799|FG008|Overall Study|Other|0|||
105731813|NCT00561353|364673800|FG009|Overall Study|Other|0|||
105731814|NCT00561353|364673791|FG000|Overall Study|Adverse Event|0|||
105731815|NCT00561353|364673792|FG001|Overall Study|Adverse Event|0|||
105731816|NCT00561353|364673793|FG002|Overall Study|Adverse Event|0|||
105731817|NCT00561353|364673794|FG003|Overall Study|Adverse Event|2|||
105731818|NCT00561353|364673795|FG004|Overall Study|Adverse Event|0|||
105731819|NCT00561353|364673796|FG005|Overall Study|Adverse Event|0|||
105731820|NCT00561353|364673797|FG006|Overall Study|Adverse Event|1|||
105731821|NCT00561353|364673798|FG007|Overall Study|Adverse Event|0|||
105731822|NCT00561353|364673799|FG008|Overall Study|Adverse Event|0|||
105731823|NCT00561353|364673800|FG009|Overall Study|Adverse Event|1|||
105731824|NCT00561353|364673791|FG000|Overall Study|Lost to Follow-up|2|||
105731825|NCT00561353|364673792|FG001|Overall Study|Lost to Follow-up|0|||
105731826|NCT00561353|364673793|FG002|Overall Study|Lost to Follow-up|1|||
105731827|NCT00561353|364673794|FG003|Overall Study|Lost to Follow-up|0|||
105731828|NCT00561353|364673795|FG004|Overall Study|Lost to Follow-up|0|||
105731829|NCT00561353|364673796|FG005|Overall Study|Lost to Follow-up|0|||
105731830|NCT00561353|364673797|FG006|Overall Study|Lost to Follow-up|0|||
105731831|NCT00561353|364673798|FG007|Overall Study|Lost to Follow-up|0|||
105731832|NCT00561353|364673799|FG008|Overall Study|Lost to Follow-up|0|||
105731833|NCT00561353|364673800|FG009|Overall Study|Lost to Follow-up|0|||
105731834|NCT00561353|364673791|FG000|Overall Study|Withdrawal by Subject|0|||
105731835|NCT00561353|364673792|FG001|Overall Study|Withdrawal by Subject|2|||
105731836|NCT00561353|364673793|FG002|Overall Study|Withdrawal by Subject|0|||
105731837|NCT00561353|364673794|FG003|Overall Study|Withdrawal by Subject|0|||
105731838|NCT00561353|364673795|FG004|Overall Study|Withdrawal by Subject|0|||
105731839|NCT00561353|364673796|FG005|Overall Study|Withdrawal by Subject|0|||
105731840|NCT00561353|364673797|FG006|Overall Study|Withdrawal by Subject|0|||
105731841|NCT00561353|364673798|FG007|Overall Study|Withdrawal by Subject|0|||
105731842|NCT00561353|364673799|FG008|Overall Study|Withdrawal by Subject|0|||
105731843|NCT00561353|364673800|FG009|Overall Study|Withdrawal by Subject|0|||
105731844|NCT00195351|364673801|FG000|Overall Study|Lost to Follow-up|9|||
105731845|NCT00195351|364673802|FG001|Overall Study|Lost to Follow-up|9|||
105731846|NCT00195351|364673801|FG000|Overall Study|Withdrawal by Subject|6|||
105731847|NCT00195351|364673802|FG001|Overall Study|Withdrawal by Subject|3|||
105731848|NCT00195351|364673801|FG000|Overall Study|Protocol Deviation|3|||
105731849|NCT00195351|364673802|FG001|Overall Study|Protocol Deviation|2|||
105731850|NCT00195351|364673801|FG000|Overall Study|Death|3|||
105731851|NCT00195351|364673802|FG001|Overall Study|Death|1|||
105731852|NCT00195351|364673801|FG000|Overall Study|Lack of Efficacy|0|||
105731853|NCT00195351|364673802|FG001|Overall Study|Lack of Efficacy|1|||
105731854|NCT02111369|364673803|FG000|Overall Study|Lost to Follow-up|2|||
105731855|NCT02111369|364673803|FG000|Overall Study|Withdrawal by Subject|1|||
105731856|NCT03240081|364673807|FG000|Overall Study|Withdrawal by Subject|0|||
105731857|NCT03240081|364673808|FG001|Overall Study|Withdrawal by Subject|2|||
105731858|NCT03240081|364673807|FG000|Overall Study|Lost to Follow-up|0|||
105731859|NCT03240081|364673808|FG001|Overall Study|Lost to Follow-up|1|||
105731860|NCT00820040|364673809|FG000|Overall Study|Death|1|||
105731861|NCT00820040|364673809|FG000|Overall Study|Sponsor terminated study|1|||
105731862|NCT00820040|364673809|FG000|Overall Study|Screen failure|1|||
105731863|NCT00883753|364673810|FG000|Overall Study|Adverse Event|37|||
105731864|NCT00883753|364673810|FG000|Overall Study|Death|2|||
105731865|NCT00883753|364673810|FG000|Overall Study|Insufficient therapeutic response|16|||
105731866|NCT00883753|364673810|FG000|Overall Study|Lost to Follow-up|4|||
105731867|NCT00883753|364673810|FG000|Overall Study|Violation of selection criteria at entry|7|||
105731868|NCT00883753|364673810|FG000|Overall Study|Protocol Violation|2|||
105731869|NCT00883753|364673810|FG000|Overall Study|Refused treatment|4|||
105731870|NCT00883753|364673810|FG000|Overall Study|Withdrew consent|10|||
105731871|NCT00883753|364673810|FG000|Overall Study|Investigator's decision|17|||
105731872|NCT00883753|364673810|FG000|Overall Study|Administrative/Other|8|||
105731873|NCT04332419|364673811|FG000|Overall Study|Withdrawal by Subject|1|||
105731874|NCT01480180|364673812|FG000|Main Phase|Withdrawal criteria|12|||
105731875|NCT01480180|364673813|FG001|Main Phase|Withdrawal criteria|1|||
105731876|NCT01480180|364673814|FG002|Main Phase|Withdrawal criteria|0|||
105731877|NCT01480180|364673815|FG003|Main Phase|Withdrawal criteria|0|||
105731878|NCT01480180|364673816|FG004|Main Phase|Withdrawal criteria|0|||
105731879|NCT01480180|364673817|FG005|Main Phase|Withdrawal criteria|0|||
105731880|NCT01480180|364673812|FG000|Main Phase|Lack of Efficacy|1|||
105731881|NCT01480180|364673813|FG001|Main Phase|Lack of Efficacy|0|||
105731882|NCT01480180|364673814|FG002|Main Phase|Lack of Efficacy|0|||
105731883|NCT01480180|364673815|FG003|Main Phase|Lack of Efficacy|0|||
105731884|NCT01480180|364673816|FG004|Main Phase|Lack of Efficacy|0|||
105731885|NCT01480180|364673817|FG005|Main Phase|Lack of Efficacy|0|||
105731886|NCT01480180|364673812|FG000|Main Phase|Non-compliance|3|||
105797363|NCT04440163|364915931|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
105797364|NCT04440163|364915924|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797365|NCT04440163|364915925|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797366|NCT04440163|364915926|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797367|NCT04440163|364915927|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
105797368|NCT04440163|364915928|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797369|NCT04440163|364915929|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797370|NCT04440163|364915930|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797371|NCT04440163|364915931|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
105797372|NCT02748616|364915932|FG000|Overall Study|Lost to Follow-up|1|||
105797373|NCT02748616|364915932|FG000|Overall Study|Withdrawal by Subject|2|||
105797374|NCT02748616|364915932|FG000|Overall Study|Physician Decision|2|||
105797375|NCT02748616|364915932|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
105797376|NCT00782275|364915933|FG000|Overall Study|Adverse Event|11|||
105797377|NCT00782275|364915933|FG000|Overall Study|Withdrawal by Subject|1|||
105797378|NCT00782275|364915933|FG000|Overall Study|Progressive Disease|21|||
105797379|NCT00782275|364915933|FG000|Overall Study|Physician Decision|4|||
105797380|NCT00782275|364915933|FG000|Overall Study|Not started treatment|1|||
105797381|NCT00782275|364915933|FG000|Overall Study|Other|3|||
105797382|NCT02018042|364915934|FG000|Overall Study|Withdrawal by Subject|1|||
105797383|NCT03876873|364915940|FG000|Overall Study|Physician Decision|0|||
105797384|NCT03876873|364915941|FG001|Overall Study|Physician Decision|1|||
105797385|NCT03402126|364915945|FG000|Overall Study|Lost to Follow-up|6|||
105797386|NCT03402126|364915945|FG000|Overall Study|Protocol Violation|10|||
105797387|NCT03402126|364915945|FG000|Overall Study|Sponsor request/Study termination|29|||
105797388|NCT03402126|364915945|FG000|Overall Study|Study product no longer in use|1|||
105797389|NCT03402126|364915945|FG000|Overall Study|Technical problems|1|||
105797390|NCT03402126|364915945|FG000|Overall Study|Withdrawal by Subject|6|||
105797391|NCT03402126|364915945|FG000|Overall Study|Physician Decision|2|||
105797392|NCT03402126|364915945|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
105797393|NCT03402126|364915945|FG000|Overall Study|Death|4|||
105797394|NCT02117479|364915948|FG000|Overall Study|Death|13|||
105797395|NCT02117479|364915949|FG001|Overall Study|Death|8|||
105797396|NCT02117479|364915948|FG000|Overall Study|Adverse Event|8|||
105797397|NCT02117479|364915949|FG001|Overall Study|Adverse Event|16|||
105797398|NCT02117479|364915948|FG000|Overall Study|Subject decision|8|||
105797399|NCT02117479|364915949|FG001|Overall Study|Subject decision|9|||
105797400|NCT02117479|364915948|FG000|Overall Study|Disease progression|104|||
105797401|NCT02117479|364915949|FG001|Overall Study|Disease progression|108|||
105797402|NCT02117479|364915948|FG000|Overall Study|Noncompliance with study treatment|1|||
105797403|NCT02117479|364915949|FG001|Overall Study|Noncompliance with study treatment|0|||
105797404|NCT02117479|364915948|FG000|Overall Study|Study terminated by the sponsor|4|||
105797405|NCT02117479|364915949|FG001|Overall Study|Study terminated by the sponsor|6|||
105797406|NCT02117479|364915948|FG000|Overall Study|Physician Decision|7|||
105797407|NCT02117479|364915949|FG001|Overall Study|Physician Decision|2|||
105797408|NCT02117479|364915948|FG000|Overall Study|Other unspecified|11|||
105797409|NCT02117479|364915949|FG001|Overall Study|Other unspecified|7|||
105797410|NCT00447694|364915952|FG000|Overall Study|Adverse Event|2|||
105797411|NCT00447694|364915952|FG000|Overall Study|Abnormal laboratory value|1|||
105797412|NCT00447694|364915952|FG000|Overall Study|Abnormal test procedure result|1|||
105797413|NCT00447694|364915952|FG000|Overall Study|Withdrawal by Subject|2|||
105797414|NCT00709735|364915953|FG000|Overall Study|Lost to Follow-up|1|||
105797415|NCT00709735|364915954|FG001|Overall Study|Lost to Follow-up|1|||
105797416|NCT00709735|364915953|FG000|Overall Study|Relapse into Opioid Abuse|0|||
105797417|NCT00709735|364915954|FG001|Overall Study|Relapse into Opioid Abuse|1|||
105797418|NCT00709735|364915953|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
105797419|NCT00709735|364915954|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
105797420|NCT04440007|364915955|FG000|Overall Study|Adverse Event|0|||
105797421|NCT04440007|364915956|FG001|Overall Study|Adverse Event|1|||
105797422|NCT04440007|364915955|FG000|Overall Study|Lost to Follow-up|1|||
105797423|NCT04440007|364915956|FG001|Overall Study|Lost to Follow-up|3|||
105797424|NCT04440007|364915955|FG000|Overall Study|Death|7|||
105797425|NCT04440007|364915956|FG001|Overall Study|Death|2|||
105797426|NCT04440007|364915955|FG000|Overall Study|Physician Decision|1|||
105797427|NCT04440007|364915956|FG001|Overall Study|Physician Decision|1|||
105937767|NCT00987935|365431549|FG001|Overall Study|Reason other than those specified above|0|||
105937768|NCT00987935|365431550|FG002|Overall Study|Reason other than those specified above|0|||
105797428|NCT04440007|364915955|FG000|Overall Study|Withdrawal by Subject|2|||
105797429|NCT04440007|364915956|FG001|Overall Study|Withdrawal by Subject|1|||
105797430|NCT04440007|364915955|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
105797431|NCT04440007|364915956|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
105797432|NCT04440007|364915955|FG000|Overall Study|Discontinued prior to dosing|0|||
105797433|NCT04440007|364915956|FG001|Overall Study|Discontinued prior to dosing|2|||
105797434|NCT02725671|364915957|FG000|Overall Study|Lost to Follow-up|1|||
105731887|NCT01480180|364673813|FG001|Main Phase|Non-compliance|0|||
105731888|NCT01480180|364673814|FG002|Main Phase|Non-compliance|0|||
105731889|NCT01480180|364673815|FG003|Main Phase|Non-compliance|0|||
105731890|NCT01480180|364673816|FG004|Main Phase|Non-compliance|0|||
105731891|NCT01480180|364673817|FG005|Main Phase|Non-compliance|0|||
105731892|NCT01480180|364673812|FG000|Main Phase|Unclassified|3|||
105731893|NCT01480180|364673813|FG001|Main Phase|Unclassified|0|||
105731894|NCT01480180|364673814|FG002|Main Phase|Unclassified|0|||
105731895|NCT01480180|364673815|FG003|Main Phase|Unclassified|0|||
105731896|NCT01480180|364673816|FG004|Main Phase|Unclassified|0|||
105731897|NCT01480180|364673817|FG005|Main Phase|Unclassified|0|||
105731898|NCT01480180|364673812|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
105731899|NCT01480180|364673813|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
105731900|NCT01480180|364673814|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
105731901|NCT01480180|364673815|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
105731902|NCT01480180|364673816|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
105731903|NCT01480180|364673817|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
105731904|NCT01480180|364673812|FG000|Extension Phase, Part 1|Unclassified|0|||
105731905|NCT01480180|364673813|FG001|Extension Phase, Part 1|Unclassified|0|||
105731906|NCT01480180|364673814|FG002|Extension Phase, Part 1|Unclassified|1|||
105731907|NCT01480180|364673815|FG003|Extension Phase, Part 1|Unclassified|0|||
105731908|NCT01480180|364673816|FG004|Extension Phase, Part 1|Unclassified|0|||
105731909|NCT01480180|364673817|FG005|Extension Phase, Part 1|Unclassified|0|||
105731910|NCT01480180|364673812|FG000|Extension Phase, Part 1|Adverse Event|0|||
105731911|NCT01480180|364673813|FG001|Extension Phase, Part 1|Adverse Event|0|||
105731912|NCT01480180|364673814|FG002|Extension Phase, Part 1|Adverse Event|4|||
105731913|NCT01480180|364673815|FG003|Extension Phase, Part 1|Adverse Event|1|||
105731914|NCT01480180|364673816|FG004|Extension Phase, Part 1|Adverse Event|0|||
105731915|NCT01480180|364673817|FG005|Extension Phase, Part 1|Adverse Event|0|||
105731916|NCT01480180|364673812|FG000|Extension Phase, Part 1|Change of treatment|0|||
105731917|NCT01480180|364673813|FG001|Extension Phase, Part 1|Change of treatment|0|||
105731918|NCT01480180|364673814|FG002|Extension Phase, Part 1|Change of treatment|0|||
105731919|NCT01480180|364673815|FG003|Extension Phase, Part 1|Change of treatment|9|||
105731920|NCT01480180|364673816|FG004|Extension Phase, Part 1|Change of treatment|0|||
105731921|NCT01480180|364673817|FG005|Extension Phase, Part 1|Change of treatment|0|||
105731922|NCT01480180|364673812|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
105731923|NCT01480180|364673813|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
105731924|NCT01480180|364673814|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
105731925|NCT01480180|364673815|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
105731926|NCT01480180|364673816|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
105731927|NCT01480180|364673817|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
105731928|NCT01480180|364673812|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
105731929|NCT01480180|364673813|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
105731930|NCT01480180|364673814|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
105731931|NCT01480180|364673815|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
105731932|NCT01480180|364673816|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
105731933|NCT01480180|364673817|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
105731934|NCT01480180|364673812|FG000|Extension Phase, Part 2|Unclassified|0|||
105731935|NCT01480180|364673813|FG001|Extension Phase, Part 2|Unclassified|0|||
105731936|NCT01480180|364673814|FG002|Extension Phase, Part 2|Unclassified|3|||
105731937|NCT01480180|364673815|FG003|Extension Phase, Part 2|Unclassified|1|||
105731938|NCT01480180|364673816|FG004|Extension Phase, Part 2|Unclassified|1|||
105731939|NCT01480180|364673817|FG005|Extension Phase, Part 2|Unclassified|0|||
105731940|NCT01259466|364673820|FG000|Overall Study|Withdrawal by Subject|1|||
105731941|NCT01259466|364673821|FG001|Overall Study|Withdrawal by Subject|9|||
105731942|NCT02296840|364673825|FG000|Overall Study|Adverse Event|1|||
105731943|NCT02296840|364673826|FG001|Overall Study|Adverse Event|1|||
105731944|NCT02296840|364673825|FG000|Overall Study|Protocol Violation|2|||
105731945|NCT02296840|364673826|FG001|Overall Study|Protocol Violation|1|||
105731946|NCT02296840|364673825|FG000|Overall Study|Lost to Follow-up|6|||
105731947|NCT02296840|364673826|FG001|Overall Study|Lost to Follow-up|17|||
105731948|NCT02498821|364673829|FG000|Overall Study|Screen failure|3|||
105731949|NCT02498821|364673830|FG001|Overall Study|Screen failure|5|||
105731950|NCT00828451|364673831|FG000|Overall Study|Death|2|||
105731951|NCT00828451|364673831|FG000|Overall Study|Lack of intravenous line|7|||
105731952|NCT00828451|364673831|FG000|Overall Study|Withdrawal by Subject|1|||
105731953|NCT00828451|364673831|FG000|Overall Study|Deterioration in clinical status|1|||
105731954|NCT01716169|364673833|FG000|Overall Study|Adverse Event|1|||
105731955|NCT01716169|364673833|FG000|Overall Study|Lost to Follow-up|1|||
105731956|NCT01716169|364673833|FG000|Overall Study|Withdrawal by Subject|1|||
105731957|NCT01716169|364673833|FG000|Overall Study|inconsistent dressing application|1|||
105731958|NCT03443024|364673834|FG000|Overall Study|Adverse Event|2|||
105731959|NCT03443024|364673835|FG001|Overall Study|Adverse Event|4|||
105731960|NCT03443024|364673836|FG002|Overall Study|Adverse Event|3|||
105731961|NCT03443024|364673837|FG003|Overall Study|Adverse Event|1|||
105731962|NCT03443024|364673834|FG000|Overall Study|Lost to Follow-up|9|||
106139483|NCT02503202|366168636|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
106139484|NCT02503202|366168637|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
106139485|NCT02503202|366168638|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
106139486|NCT02503202|366168639|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
106139487|NCT02503202|366168635|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
105731963|NCT03443024|364673835|FG001|Overall Study|Lost to Follow-up|9|||
105731964|NCT03443024|364673836|FG002|Overall Study|Lost to Follow-up|7|||
105731965|NCT03443024|364673837|FG003|Overall Study|Lost to Follow-up|5|||
105731966|NCT03443024|364673834|FG000|Overall Study|Withdrawal by Subject|8|||
105731967|NCT03443024|364673835|FG001|Overall Study|Withdrawal by Subject|15|||
105731968|NCT03443024|364673836|FG002|Overall Study|Withdrawal by Subject|9|||
105731969|NCT03443024|364673837|FG003|Overall Study|Withdrawal by Subject|23|||
105731970|NCT03443024|364673834|FG000|Overall Study|Physician Decision|1|||
105731971|NCT03443024|364673835|FG001|Overall Study|Physician Decision|2|||
105731972|NCT03443024|364673836|FG002|Overall Study|Physician Decision|0|||
105731973|NCT03443024|364673837|FG003|Overall Study|Physician Decision|1|||
105731974|NCT03443024|364673834|FG000|Overall Study|Sponsor Decision|1|||
105731975|NCT03443024|364673835|FG001|Overall Study|Sponsor Decision|1|||
105731976|NCT03443024|364673836|FG002|Overall Study|Sponsor Decision|0|||
105731977|NCT03443024|364673837|FG003|Overall Study|Sponsor Decision|0|||
105731978|NCT03443024|364673834|FG000|Overall Study|Protocol Deviation|0|||
105731979|NCT03443024|364673835|FG001|Overall Study|Protocol Deviation|0|||
105731980|NCT03443024|364673836|FG002|Overall Study|Protocol Deviation|0|||
105731981|NCT03443024|364673837|FG003|Overall Study|Protocol Deviation|2|||
105731982|NCT00624338|364673839|FG000|Overall Study|Adverse Event|14|||
105731983|NCT00624338|364673840|FG001|Overall Study|Adverse Event|14|||
105731984|NCT00624338|364673841|FG002|Overall Study|Adverse Event|18|||
105731985|NCT00624338|364673839|FG000|Overall Study|Lost to Follow-up|1|||
105731986|NCT00624338|364673840|FG001|Overall Study|Lost to Follow-up|0|||
105731987|NCT00624338|364673841|FG002|Overall Study|Lost to Follow-up|0|||
105731988|NCT00624338|364673839|FG000|Overall Study|Lack of Efficacy|11|||
105731989|NCT00624338|364673840|FG001|Overall Study|Lack of Efficacy|3|||
105731990|NCT00624338|364673841|FG002|Overall Study|Lack of Efficacy|14|||
105731991|NCT00624338|364673839|FG000|Overall Study|Protocol Violation|3|||
105731992|NCT00624338|364673840|FG001|Overall Study|Protocol Violation|3|||
105731993|NCT00624338|364673841|FG002|Overall Study|Protocol Violation|2|||
105731994|NCT00624338|364673839|FG000|Overall Study|Death|0|||
105731995|NCT00624338|364673840|FG001|Overall Study|Death|2|||
105731996|NCT00624338|364673841|FG002|Overall Study|Death|0|||
105731997|NCT00624338|364673839|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
105731998|NCT00624338|364673840|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
105731999|NCT00624338|364673841|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
105732000|NCT00624338|364673839|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
105732001|NCT00624338|364673840|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
105732002|NCT00624338|364673841|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
105732003|NCT00624338|364673839|FG000|Overall Study|Other|15|||
105732004|NCT00624338|364673840|FG001|Overall Study|Other|5|||
105732005|NCT00624338|364673841|FG002|Overall Study|Other|9|||
105732006|NCT00624338|364673839|FG000|Overall Study|Randomized but not treated|2|||
105732007|NCT00624338|364673840|FG001|Overall Study|Randomized but not treated|1|||
105732008|NCT00624338|364673841|FG002|Overall Study|Randomized but not treated|3|||
105732009|NCT01476787|364673849|FG000|Treatment|Progression|64|||
105732010|NCT01476787|364673850|FG001|Treatment|Progression|71|||
105732011|NCT01476787|364673849|FG000|Treatment|Toxicity|44|||
105732012|NCT01476787|364673850|FG001|Treatment|Toxicity|16|||
105732013|NCT01476787|364673849|FG000|Treatment|Death|0|||
105732014|NCT01476787|364673850|FG001|Treatment|Death|1|||
105732015|NCT01476787|364673849|FG000|Treatment|Withdrawal by Subject|3|||
105732016|NCT01476787|364673850|FG001|Treatment|Withdrawal by Subject|14|||
105732017|NCT01476787|364673849|FG000|Treatment|Major protocol violation|1|||
105732018|NCT01476787|364673850|FG001|Treatment|Major protocol violation|6|||
106139488|NCT02503202|366168636|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
106139489|NCT02503202|366168637|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
105732019|NCT01476787|364673849|FG000|Treatment|Other reasons|10|||
105732020|NCT01476787|364673850|FG001|Treatment|Other reasons|22|||
105732021|NCT01476787|364673849|FG000|Treatment|Concurrent illness|12|||
105732022|NCT01476787|364673850|FG001|Treatment|Concurrent illness|9|||
105732023|NCT01476787|364673849|FG000|Treatment|Insufficient response|15|||
105732024|NCT01476787|364673850|FG001|Treatment|Insufficient response|3|||
105732025|NCT01476787|364673849|FG000|Treatment|Voluntary treatment discontinuation|8|||
105732026|NCT01476787|364673850|FG001|Treatment|Voluntary treatment discontinuation|4|||
105732027|NCT02453841|364673859|FG000|Overall Study|Protocol Violation|1|||
105732028|NCT02453841|364673859|FG000|Overall Study|Unable to obtain blood samples|2|||
105732029|NCT02006576|364673860|FG000|Overall Study|Withdrawal by Subject|4|||
105732030|NCT02006576|364673861|FG001|Overall Study|Withdrawal by Subject|6|||
105732031|NCT02006576|364673862|FG002|Overall Study|Withdrawal by Subject|2|||
105732032|NCT02006576|364673860|FG000|Overall Study|Death|0|||
105797435|NCT00666718|364915958|FG000|Overall Study|Adverse Event|0|||
105797436|NCT00666718|364915959|FG001|Overall Study|Adverse Event|1|||
105797437|NCT00666718|364915958|FG000|Overall Study|Death|1|||
105797438|NCT00666718|364915959|FG001|Overall Study|Death|0|||
105797439|NCT00666718|364915958|FG000|Overall Study|Lost to Follow-up|1|||
105797440|NCT00666718|364915959|FG001|Overall Study|Lost to Follow-up|0|||
105797441|NCT00666718|364915958|FG000|Overall Study|Entry Criteria Not Met|2|||
105797442|NCT00666718|364915959|FG001|Overall Study|Entry Criteria Not Met|0|||
105797443|NCT00666718|364915958|FG000|Overall Study|Protocol Violation|1|||
105797444|NCT00666718|364915959|FG001|Overall Study|Protocol Violation|3|||
105797445|NCT00666718|364915958|FG000|Overall Study|Withdrawal by Subject|7|||
105797446|NCT00666718|364915959|FG001|Overall Study|Withdrawal by Subject|12|||
105797447|NCT00666718|364915958|FG000|Overall Study|Physician Decision|0|||
105797448|NCT00666718|364915959|FG001|Overall Study|Physician Decision|2|||
105797449|NCT00829439|364915966|FG000|Overall Study|Adverse Event|0|||
105797450|NCT00829439|364915967|FG001|Overall Study|Adverse Event|0|||
105797451|NCT00829439|364915968|FG002|Overall Study|Adverse Event|1|||
105797452|NCT00829439|364915969|FG003|Overall Study|Adverse Event|0|||
105797453|NCT00386100|364915970|FG000|Overall Study|Did not receive study medication|6|||
105797454|NCT00386100|364915971|FG001|Overall Study|Did not receive study medication|4|||
105797455|NCT00386100|364915970|FG000|Overall Study|Adverse Event|15|||
105797456|NCT00386100|364915971|FG001|Overall Study|Adverse Event|25|||
105797457|NCT00386100|364915970|FG000|Overall Study|Death|0|||
105797458|NCT00386100|364915971|FG001|Overall Study|Death|1|||
105797459|NCT00386100|364915970|FG000|Overall Study|Insufficient therapeutic effect|30|||
105797460|NCT00386100|364915971|FG001|Overall Study|Insufficient therapeutic effect|6|||
105797461|NCT00386100|364915970|FG000|Overall Study|Lost to Follow-up|29|||
105797462|NCT00386100|364915971|FG001|Overall Study|Lost to Follow-up|29|||
105797463|NCT00386100|364915970|FG000|Overall Study|Non-compliance|18|||
105797464|NCT00386100|364915971|FG001|Overall Study|Non-compliance|19|||
105797465|NCT00386100|364915970|FG000|Overall Study|Protocol Violation|5|||
105797466|NCT00386100|364915971|FG001|Overall Study|Protocol Violation|3|||
105797467|NCT00386100|364915970|FG000|Overall Study|Withdrawal by Subject|32|||
105797468|NCT00386100|364915971|FG001|Overall Study|Withdrawal by Subject|31|||
105797469|NCT00386100|364915970|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
105797470|NCT00386100|364915971|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
105797471|NCT00386100|364915970|FG000|Overall Study|BMD <2.5|1|||
105797472|NCT00386100|364915971|FG001|Overall Study|BMD <2.5|0|||
105797473|NCT00386100|364915970|FG000|Overall Study|Consecutive elevated Hba1C|1|||
105797474|NCT00386100|364915971|FG001|Overall Study|Consecutive elevated Hba1C|0|||
105797475|NCT00386100|364915970|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
105797476|NCT00386100|364915971|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
105797477|NCT00386100|364915970|FG000|Overall Study|Laboratory findings|1|||
105797478|NCT00386100|364915971|FG001|Overall Study|Laboratory findings|0|||
105797479|NCT00386100|364915970|FG000|Overall Study|Participant's concern due to CPK levels|1|||
105797480|NCT00386100|364915971|FG001|Overall Study|Participant's concern due to CPK levels|0|||
105797481|NCT00386100|364915970|FG000|Overall Study|Participant moving out of state|2|||
105797482|NCT00386100|364915971|FG001|Overall Study|Participant moving out of state|0|||
105797483|NCT00386100|364915970|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
105797484|NCT00386100|364915971|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
105797485|NCT00386100|364915970|FG000|Overall Study|Didn't meet entry criteria|1|||
105797486|NCT00386100|364915971|FG001|Overall Study|Didn't meet entry criteria|1|||
105797487|NCT00386100|364915970|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
105797488|NCT00386100|364915971|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
105797489|NCT00386100|364915970|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
105797490|NCT00386100|364915971|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
105797491|NCT00386100|364915970|FG000|Overall Study|Bad metabolic control & patient security|1|||
105797492|NCT00386100|364915971|FG001|Overall Study|Bad metabolic control & patient security|0|||
105797493|NCT00386100|364915970|FG000|Overall Study|Bone loss by DXA bone scan|1|||
105797494|NCT00386100|364915971|FG001|Overall Study|Bone loss by DXA bone scan|0|||
105797495|NCT00386100|364915970|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
105797496|NCT00386100|364915971|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
105797497|NCT00386100|364915970|FG000|Overall Study|7.6% bone loss|1|||
105797498|NCT00386100|364915971|FG001|Overall Study|7.6% bone loss|0|||
105797499|NCT00386100|364915970|FG000|Overall Study|Osteoporosis|0|||
105797500|NCT00386100|364915971|FG001|Overall Study|Osteoporosis|1|||
105797501|NCT00386100|364915970|FG000|Overall Study|Positive pregnancy test|1|||
105797502|NCT00386100|364915971|FG001|Overall Study|Positive pregnancy test|3|||
105797503|NCT00386100|364915970|FG000|Overall Study|Out of country for 5 months|1|||
105797504|NCT00386100|364915971|FG001|Overall Study|Out of country for 5 months|0|||
105797505|NCT00386100|364915970|FG000|Overall Study|Hb1Ac >8%|0|||
105797506|NCT00386100|364915971|FG001|Overall Study|Hb1Ac >8%|1|||
105797507|NCT00386100|364915970|FG000|Overall Study|Participant randomized in error|1|||
105797508|NCT00386100|364915971|FG001|Overall Study|Participant randomized in error|0|||
105797509|NCT02525562|364915972|FG000|Overall Study|Death|9|||
105732033|NCT02006576|364673861|FG001|Overall Study|Death|0|||
105732034|NCT02006576|364673862|FG002|Overall Study|Death|1|||
105732035|NCT02006576|364673860|FG000|Overall Study|Lost to Follow-up|1|||
105732036|NCT02006576|364673861|FG001|Overall Study|Lost to Follow-up|0|||
105732037|NCT02006576|364673862|FG002|Overall Study|Lost to Follow-up|1|||
105732038|NCT02006576|364673860|FG000|Overall Study|Screen Failure, too sick, other|13|||
105732039|NCT02006576|364673861|FG001|Overall Study|Screen Failure, too sick, other|1|||
105732040|NCT02006576|364673862|FG002|Overall Study|Screen Failure, too sick, other|13|||
105732041|NCT03567187|364673863|FG000|Overall Study|Lost to Follow-up|18|||
105732042|NCT04513158|364673864|FG000|Overall Study|Screen Failure|1|||
105732043|NCT01084252|364675951|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732044|NCT01084252|364675952|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732045|NCT01084252|364675953|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732046|NCT01084252|364675954|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732047|NCT01084252|364675955|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732048|NCT01084252|364675956|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732049|NCT01084252|364675957|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732050|NCT01084252|364675958|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732051|NCT01084252|364675959|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732052|NCT01084252|364675960|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732053|NCT01084252|364675961|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732054|NCT01084252|364675962|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732055|NCT01084252|364675963|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
105732056|NCT01084252|364675964|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
105732057|NCT04493619|364675965|FG000|Overall Study|Death|4|||
105732058|NCT04493619|364675966|FG001|Overall Study|Death|3|||
105732059|NCT04493619|364675967|FG002|Overall Study|Death|3|||
105732060|NCT04493619|364675968|FG003|Overall Study|Death|4|||
105732061|NCT04493619|364675965|FG000|Overall Study|Study discontinued early|10|||
105732062|NCT04493619|364675966|FG001|Overall Study|Study discontinued early|0|||
105732063|NCT04493619|364675967|FG002|Overall Study|Study discontinued early|4|||
105732064|NCT04493619|364675968|FG003|Overall Study|Study discontinued early|8|||
105732065|NCT04493619|364675965|FG000|Overall Study|Lost to Follow-up|0|||
105732066|NCT04493619|364675966|FG001|Overall Study|Lost to Follow-up|0|||
105732067|NCT04493619|364675967|FG002|Overall Study|Lost to Follow-up|0|||
105732068|NCT04493619|364675968|FG003|Overall Study|Lost to Follow-up|1|||
105732069|NCT00955110|364675972|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
105732070|NCT00955110|364675972|FG000|Treatment Phase|Adverse Event|2|||
105732071|NCT00955110|364675972|FG000|Treatment Phase|Administrative reasons|2|||
105732072|NCT00955110|364675972|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
105732073|NCT00955110|364675972|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
105732074|NCT03518840|364675975|FG000|Overall Study|Lost to Follow-up|6|||
105732075|NCT05165394|364675981|FG000|Overall Study|Withdrawal by Subject|5|||
105732076|NCT05165394|364675982|FG001|Overall Study|Withdrawal by Subject|1|||
105732077|NCT05165394|364675981|FG000|Overall Study|Lost to Follow-up|1|||
105732078|NCT05165394|364675982|FG001|Overall Study|Lost to Follow-up|2|||
105732079|NCT05165394|364675981|FG000|Overall Study|Other Than Specified|0|||
105732080|NCT05165394|364675982|FG001|Overall Study|Other Than Specified|1|||
105732081|NCT00875420|364675985|FG000|Overall Study|Adverse Event|0|||
105732082|NCT00875420|364675986|FG001|Overall Study|Adverse Event|1|||
105732083|NCT00875420|364675987|FG002|Overall Study|Adverse Event|1|||
105732084|NCT00875420|364675988|FG003|Overall Study|Adverse Event|0|||
105732085|NCT00875420|364675989|FG004|Overall Study|Adverse Event|0|||
105732086|NCT00875420|364675985|FG000|Overall Study|Inability to complete study procedures|1|||
105732087|NCT00875420|364675986|FG001|Overall Study|Inability to complete study procedures|0|||
105732088|NCT00875420|364675987|FG002|Overall Study|Inability to complete study procedures|1|||
105732089|NCT00875420|364675988|FG003|Overall Study|Inability to complete study procedures|1|||
106139490|NCT02503202|366168638|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
105732090|NCT00875420|364675989|FG004|Overall Study|Inability to complete study procedures|1|||
105732091|NCT00875420|364675985|FG000|Overall Study|Lost to Follow-up|1|||
105732092|NCT00875420|364675986|FG001|Overall Study|Lost to Follow-up|0|||
105732093|NCT00875420|364675987|FG002|Overall Study|Lost to Follow-up|0|||
105732094|NCT00875420|364675988|FG003|Overall Study|Lost to Follow-up|0|||
105732095|NCT00875420|364675989|FG004|Overall Study|Lost to Follow-up|0|||
105732096|NCT00875420|364675985|FG000|Overall Study|Personal reason|0|||
105732097|NCT00875420|364675986|FG001|Overall Study|Personal reason|0|||
105732098|NCT00875420|364675987|FG002|Overall Study|Personal reason|0|||
105937769|NCT00987935|365431551|FG003|Overall Study|Reason other than those specified above|0|||
105732099|NCT00875420|364675988|FG003|Overall Study|Personal reason|0|||
105732100|NCT00875420|364675989|FG004|Overall Study|Personal reason|1|||
105732101|NCT00875420|364675985|FG000|Overall Study|Prohibited medication|0|||
105732102|NCT00875420|364675986|FG001|Overall Study|Prohibited medication|0|||
105732103|NCT00875420|364675987|FG002|Overall Study|Prohibited medication|0|||
105732104|NCT00875420|364675988|FG003|Overall Study|Prohibited medication|1|||
105732105|NCT00875420|364675989|FG004|Overall Study|Prohibited medication|0|||
105732106|NCT00875420|364675985|FG000|Overall Study|Sponsor decision|0|||
105732107|NCT00875420|364675986|FG001|Overall Study|Sponsor decision|1|||
105732108|NCT00875420|364675987|FG002|Overall Study|Sponsor decision|0|||
105732109|NCT00875420|364675988|FG003|Overall Study|Sponsor decision|0|||
105732110|NCT00875420|364675989|FG004|Overall Study|Sponsor decision|0|||
105732111|NCT00875420|364675985|FG000|Overall Study|Withdrawal by Subject|0|||
105732112|NCT00875420|364675986|FG001|Overall Study|Withdrawal by Subject|0|||
105732113|NCT00875420|364675987|FG002|Overall Study|Withdrawal by Subject|1|||
105732114|NCT00875420|364675988|FG003|Overall Study|Withdrawal by Subject|0|||
105732115|NCT00875420|364675989|FG004|Overall Study|Withdrawal by Subject|0|||
105732116|NCT00001259|364675992|FG000|Study 2|Adverse Event|0|||
105732117|NCT00001259|364675993|FG001|Study 2|Adverse Event|0|||
105732118|NCT00001259|364675994|FG002|Study 2|Adverse Event|0|||
105732119|NCT00001259|364675995|FG003|Study 2|Adverse Event|0|||
105732120|NCT00001259|364675996|FG004|Study 2|Adverse Event|2|||
105732121|NCT00001259|364675997|FG005|Study 2|Adverse Event|0|||
105732122|NCT00001259|364675998|FG006|Study 2|Adverse Event|0|||
105732123|NCT03705494|364675999|FG000|Overall Study|Lost to Follow-up|2|||
105732124|NCT03705494|364676000|FG001|Overall Study|Lost to Follow-up|1|||
105732125|NCT03705494|364675999|FG000|Overall Study|Withdrawal by Subject|5|||
105732126|NCT03705494|364676000|FG001|Overall Study|Withdrawal by Subject|2|||
105732127|NCT03704051|364676006|FG000|Overall Study|Withdrawal by Subject|4|||
105732128|NCT03704051|364676007|FG001|Overall Study|Withdrawal by Subject|0|||
105732129|NCT01266148|364676008|FG000|Overall Study|Adverse Event|2|||
105732130|NCT01266148|364676009|FG001|Overall Study|Adverse Event|0|||
105732131|NCT01266148|364676008|FG000|Overall Study|Ongoing rejection|1|||
105732132|NCT01266148|364676009|FG001|Overall Study|Ongoing rejection|0|||
105732133|NCT01266148|364676008|FG000|Overall Study|2 2R rejections|1|||
105732134|NCT01266148|364676009|FG001|Overall Study|2 2R rejections|0|||
105732135|NCT01266148|364676008|FG000|Overall Study|Death|2|||
105732136|NCT01266148|364676009|FG001|Overall Study|Death|3|||
105732137|NCT01266148|364676008|FG000|Overall Study|missing mGFR value + AE|1|||
105732138|NCT01266148|364676009|FG001|Overall Study|missing mGFR value + AE|0|||
105732139|NCT00914628|364676010|FG000|Overall Study|Death|35|||
105732140|NCT00914628|364676011|FG001|Overall Study|Death|17|||
105732141|NCT00914628|364676010|FG000|Overall Study|Medical decision|4|||
105732142|NCT00914628|364676011|FG001|Overall Study|Medical decision|0|||
105732143|NCT00914628|364676010|FG000|Overall Study|Protocol Violation|1|||
105732144|NCT00914628|364676011|FG001|Overall Study|Protocol Violation|0|||
105732145|NCT00914628|364676010|FG000|Overall Study|Lack of Efficacy|1|||
105732146|NCT00914628|364676011|FG001|Overall Study|Lack of Efficacy|0|||
105732147|NCT00914628|364676010|FG000|Overall Study|non-randomized|1|||
105732148|NCT00914628|364676011|FG001|Overall Study|non-randomized|0|||
105732149|NCT00914628|364676010|FG000|Overall Study|Relapse|1|||
105732150|NCT00914628|364676011|FG001|Overall Study|Relapse|2|||
105732151|NCT00914628|364676010|FG000|Overall Study|Study terminated by Sponsor|14|||
105732152|NCT00914628|364676011|FG001|Overall Study|Study terminated by Sponsor|8|||
105732153|NCT00914628|364676010|FG000|Overall Study|Patients who did not receive a single dose|7|||
105732154|NCT00914628|364676011|FG001|Overall Study|Patients who did not receive a single dose|1|||
105732155|NCT01416181|364676016|FG000|Part 1|Other|10|||
105732156|NCT01416181|364676017|FG001|Part 1|Other|24|||
105732157|NCT01416181|364676016|FG000|Part 1|Death|0|||
105732158|NCT01416181|364676017|FG001|Part 1|Death|1|||
105732159|NCT01416181|364676016|FG000|Part 1|Investigator Decision|7|||
105732160|NCT01416181|364676017|FG001|Part 1|Investigator Decision|6|||
105732161|NCT01416181|364676016|FG000|Part 1|Withdrawal by Subject|74|||
105732162|NCT01416181|364676017|FG001|Part 1|Withdrawal by Subject|48|||
105732163|NCT01416181|364676016|FG000|Part 1|Lack of Efficacy|16|||
105732164|NCT01416181|364676017|FG001|Part 1|Lack of Efficacy|8|||
105732165|NCT01416181|364676016|FG000|Part 1|Lost to Follow-up|1|||
105732166|NCT01416181|364676017|FG001|Part 1|Lost to Follow-up|1|||
105732167|NCT01416181|364676016|FG000|Part 1|Adverse Event|15|||
105732168|NCT01416181|364676017|FG001|Part 1|Adverse Event|18|||
105732169|NCT01416181|364676016|FG000|Part 1|Ongoing in Follow-Up|14|||
105732170|NCT01416181|364676017|FG001|Part 1|Ongoing in Follow-Up|8|||
105732171|NCT01416181|364676016|FG000|Part 2|Adverse Event|11|||
105732172|NCT01416181|364676017|FG001|Part 2|Adverse Event|4|||
105732173|NCT01416181|364676016|FG000|Part 2|Other|234|||
105797510|NCT02525562|364915973|FG001|Overall Study|Death|0|||
105732174|NCT01416181|364676017|FG001|Part 2|Other|267|||
105732175|NCT01416181|364676016|FG000|Part 2|Investigator Decision|6|||
105732176|NCT01416181|364676017|FG001|Part 2|Investigator Decision|7|||
105732177|NCT01416181|364676016|FG000|Part 2|Withdrawal by Subject|14|||
105732178|NCT01416181|364676017|FG001|Part 2|Withdrawal by Subject|5|||
105732179|NCT01416181|364676016|FG000|Part 2|Lack of Efficacy|4|||
105732180|NCT01416181|364676017|FG001|Part 2|Lack of Efficacy|1|||
105732181|NCT01416181|364676016|FG000|Part 2|Lost to Follow-up|2|||
105732182|NCT01416181|364676017|FG001|Part 2|Lost to Follow-up|2|||
105732183|NCT01157169|364676020|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
105732184|NCT01157169|364676021|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
105732185|NCT01157169|364676020|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
106009554|NCT01310777|365700872|FG000|Overall Study|Inadequate Control of IOP|5|||
105732186|NCT01157169|364676021|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
105732187|NCT02786537|364676022|FG000|As Randomized|Adverse Event|0|||
105732188|NCT02786537|364676023|FG001|As Randomized|Adverse Event|11|||
105732189|NCT02786537|364676024|FG002|As Randomized|Adverse Event|0|||
105732190|NCT02786537|364676025|FG003|As Randomized|Adverse Event|4|||
105732191|NCT02786537|364676026|FG004|As Randomized|Adverse Event|6|||
105732192|NCT02786537|364676027|FG005|As Randomized|Adverse Event|2|||
105732193|NCT02786537|364676022|FG000|As Randomized|Lack of Efficacy|0|||
105732194|NCT02786537|364676023|FG001|As Randomized|Lack of Efficacy|0|||
105732195|NCT02786537|364676024|FG002|As Randomized|Lack of Efficacy|0|||
105732196|NCT02786537|364676025|FG003|As Randomized|Lack of Efficacy|1|||
105732197|NCT02786537|364676026|FG004|As Randomized|Lack of Efficacy|0|||
105732198|NCT02786537|364676027|FG005|As Randomized|Lack of Efficacy|0|||
105732199|NCT02786537|364676022|FG000|As Randomized|Withdrawal by Subject|1|||
105732200|NCT02786537|364676023|FG001|As Randomized|Withdrawal by Subject|2|||
105732201|NCT02786537|364676024|FG002|As Randomized|Withdrawal by Subject|0|||
105732202|NCT02786537|364676025|FG003|As Randomized|Withdrawal by Subject|1|||
105732203|NCT02786537|364676026|FG004|As Randomized|Withdrawal by Subject|1|||
105732204|NCT02786537|364676027|FG005|As Randomized|Withdrawal by Subject|0|||
105732205|NCT02786537|364676022|FG000|As Randomized|Death|0|||
105732206|NCT02786537|364676023|FG001|As Randomized|Death|2|||
105732207|NCT02786537|364676024|FG002|As Randomized|Death|0|||
105732208|NCT02786537|364676025|FG003|As Randomized|Death|3|||
105732209|NCT02786537|364676026|FG004|As Randomized|Death|1|||
105732210|NCT02786537|364676027|FG005|As Randomized|Death|0|||
105732211|NCT02786537|364676022|FG000|As Randomized|Non-compliance with study drug|1|||
105732212|NCT02786537|364676023|FG001|As Randomized|Non-compliance with study drug|11|||
105732213|NCT02786537|364676024|FG002|As Randomized|Non-compliance with study drug|0|||
105732214|NCT02786537|364676025|FG003|As Randomized|Non-compliance with study drug|1|||
105732215|NCT02786537|364676026|FG004|As Randomized|Non-compliance with study drug|0|||
105732216|NCT02786537|364676027|FG005|As Randomized|Non-compliance with study drug|1|||
105732217|NCT02786537|364676022|FG000|As Randomized|Lost to treatment follow-up|4|||
105732218|NCT02786537|364676023|FG001|As Randomized|Lost to treatment follow-up|32|||
105732219|NCT02786537|364676024|FG002|As Randomized|Lost to treatment follow-up|0|||
105732220|NCT02786537|364676025|FG003|As Randomized|Lost to treatment follow-up|24|||
105732221|NCT02786537|364676026|FG004|As Randomized|Lost to treatment follow-up|4|||
105732222|NCT02786537|364676027|FG005|As Randomized|Lost to treatment follow-up|4|||
105732223|NCT02786537|364676022|FG000|As Randomized|Incarceration|0|||
105732224|NCT02786537|364676023|FG001|As Randomized|Incarceration|1|||
105732225|NCT02786537|364676024|FG002|As Randomized|Incarceration|0|||
105732226|NCT02786537|364676025|FG003|As Randomized|Incarceration|0|||
105732227|NCT02786537|364676026|FG004|As Randomized|Incarceration|0|||
105732228|NCT02786537|364676027|FG005|As Randomized|Incarceration|0|||
105732229|NCT02786537|364676022|FG000|As Randomized|Opiate Dependency Relapse|0|||
105732230|NCT02786537|364676023|FG001|As Randomized|Opiate Dependency Relapse|1|||
105732231|NCT02786537|364676024|FG002|As Randomized|Opiate Dependency Relapse|0|||
105732232|NCT02786537|364676025|FG003|As Randomized|Opiate Dependency Relapse|0|||
105732233|NCT02786537|364676026|FG004|As Randomized|Opiate Dependency Relapse|0|||
105732234|NCT02786537|364676027|FG005|As Randomized|Opiate Dependency Relapse|0|||
105732235|NCT02786537|364676022|FG000|As Randomized|HCV drugs stolen from pt|0|||
105732236|NCT02786537|364676023|FG001|As Randomized|HCV drugs stolen from pt|1|||
105732237|NCT02786537|364676024|FG002|As Randomized|HCV drugs stolen from pt|0|||
105732238|NCT02786537|364676025|FG003|As Randomized|HCV drugs stolen from pt|0|||
105732239|NCT02786537|364676026|FG004|As Randomized|HCV drugs stolen from pt|0|||
105732240|NCT02786537|364676027|FG005|As Randomized|HCV drugs stolen from pt|0|||
105732241|NCT02786537|364676022|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
105732242|NCT02786537|364676023|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
105732243|NCT02786537|364676024|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
105732244|NCT02786537|364676025|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
105732245|NCT02786537|364676026|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
105732246|NCT02786537|364676027|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
105732247|NCT02786537|364676022|FG000|As Randomized|Subject lost insurance|0|||
105732248|NCT02786537|364676023|FG001|As Randomized|Subject lost insurance|0|||
105732249|NCT02786537|364676024|FG002|As Randomized|Subject lost insurance|0|||
105732250|NCT02786537|364676025|FG003|As Randomized|Subject lost insurance|1|||
105732251|NCT02786537|364676026|FG004|As Randomized|Subject lost insurance|0|||
105732252|NCT02786537|364676027|FG005|As Randomized|Subject lost insurance|0|||
105732253|NCT02786537|364676022|FG000|As Treated|Adverse Event|0|||
105732254|NCT02786537|364676023|FG001|As Treated|Adverse Event|11|||
105732255|NCT02786537|364676024|FG002|As Treated|Adverse Event|0|||
105732256|NCT02786537|364676025|FG003|As Treated|Adverse Event|4|||
105732257|NCT02786537|364676026|FG004|As Treated|Adverse Event|6|||
105732258|NCT02786537|364676027|FG005|As Treated|Adverse Event|2|||
105732259|NCT02786537|364676022|FG000|As Treated|Death|0|||
105732260|NCT02786537|364676023|FG001|As Treated|Death|2|||
106139491|NCT02503202|366168639|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
106139492|NCT02503202|366168635|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
106139493|NCT02503202|366168636|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
106139494|NCT02503202|366168637|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
106139495|NCT02503202|366168638|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
106139496|NCT02503202|366168639|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
105732261|NCT02786537|364676024|FG002|As Treated|Death|0|||
105732262|NCT02786537|364676025|FG003|As Treated|Death|3|||
105732263|NCT02786537|364676026|FG004|As Treated|Death|1|||
105732264|NCT02786537|364676027|FG005|As Treated|Death|0|||
105732265|NCT02786537|364676022|FG000|As Treated|Lack of Efficacy|0|||
105732266|NCT02786537|364676023|FG001|As Treated|Lack of Efficacy|0|||
105732267|NCT02786537|364676024|FG002|As Treated|Lack of Efficacy|0|||
105732268|NCT02786537|364676025|FG003|As Treated|Lack of Efficacy|1|||
105732269|NCT02786537|364676026|FG004|As Treated|Lack of Efficacy|0|||
105732270|NCT02786537|364676027|FG005|As Treated|Lack of Efficacy|0|||
105732271|NCT02786537|364676022|FG000|As Treated|Lost to Follow-up|4|||
105732272|NCT02786537|364676023|FG001|As Treated|Lost to Follow-up|32|||
105732273|NCT02786537|364676024|FG002|As Treated|Lost to Follow-up|0|||
105732274|NCT02786537|364676025|FG003|As Treated|Lost to Follow-up|25|||
105732275|NCT02786537|364676026|FG004|As Treated|Lost to Follow-up|4|||
105732276|NCT02786537|364676027|FG005|As Treated|Lost to Follow-up|4|||
105732277|NCT02786537|364676022|FG000|As Treated|Non-compliance with study drug|1|||
105732278|NCT02786537|364676023|FG001|As Treated|Non-compliance with study drug|11|||
105732279|NCT02786537|364676024|FG002|As Treated|Non-compliance with study drug|0|||
105732280|NCT02786537|364676025|FG003|As Treated|Non-compliance with study drug|1|||
105732281|NCT02786537|364676026|FG004|As Treated|Non-compliance with study drug|0|||
105732282|NCT02786537|364676027|FG005|As Treated|Non-compliance with study drug|1|||
105732283|NCT02786537|364676022|FG000|As Treated|Lost insurance|0|||
105732284|NCT02786537|364676023|FG001|As Treated|Lost insurance|0|||
105732285|NCT02786537|364676024|FG002|As Treated|Lost insurance|0|||
105732286|NCT02786537|364676025|FG003|As Treated|Lost insurance|1|||
105732287|NCT02786537|364676026|FG004|As Treated|Lost insurance|0|||
105732288|NCT02786537|364676027|FG005|As Treated|Lost insurance|0|||
105732289|NCT02786537|364676022|FG000|As Treated|Withdrawal by Subject|1|||
105732290|NCT02786537|364676023|FG001|As Treated|Withdrawal by Subject|2|||
105732291|NCT02786537|364676024|FG002|As Treated|Withdrawal by Subject|0|||
105732292|NCT02786537|364676025|FG003|As Treated|Withdrawal by Subject|0|||
105732293|NCT02786537|364676026|FG004|As Treated|Withdrawal by Subject|1|||
105732294|NCT02786537|364676027|FG005|As Treated|Withdrawal by Subject|0|||
105732295|NCT02786537|364676022|FG000|As Treated|Incarceration|0|||
105732296|NCT02786537|364676023|FG001|As Treated|Incarceration|1|||
105732297|NCT02786537|364676024|FG002|As Treated|Incarceration|0|||
105732298|NCT02786537|364676025|FG003|As Treated|Incarceration|0|||
105732299|NCT02786537|364676026|FG004|As Treated|Incarceration|0|||
105732300|NCT02786537|364676027|FG005|As Treated|Incarceration|0|||
105732301|NCT02786537|364676022|FG000|As Treated|Opiate dependency relapse|0|||
105732302|NCT02786537|364676023|FG001|As Treated|Opiate dependency relapse|1|||
105732303|NCT02786537|364676024|FG002|As Treated|Opiate dependency relapse|0|||
105732304|NCT02786537|364676025|FG003|As Treated|Opiate dependency relapse|0|||
105732305|NCT02786537|364676026|FG004|As Treated|Opiate dependency relapse|0|||
105732306|NCT02786537|364676027|FG005|As Treated|Opiate dependency relapse|0|||
105732307|NCT02786537|364676022|FG000|As Treated|Drugs stolen from patient|0|||
105732308|NCT02786537|364676023|FG001|As Treated|Drugs stolen from patient|1|||
105732309|NCT02786537|364676024|FG002|As Treated|Drugs stolen from patient|0|||
105732310|NCT02786537|364676025|FG003|As Treated|Drugs stolen from patient|0|||
105732311|NCT02786537|364676026|FG004|As Treated|Drugs stolen from patient|0|||
105732312|NCT02786537|364676027|FG005|As Treated|Drugs stolen from patient|0|||
105732313|NCT02786537|364676022|FG000|As Treated|Advised to stop tx after loss of meds|0|||
105732314|NCT02786537|364676023|FG001|As Treated|Advised to stop tx after loss of meds|1|||
105732315|NCT02786537|364676024|FG002|As Treated|Advised to stop tx after loss of meds|0|||
105732316|NCT02786537|364676025|FG003|As Treated|Advised to stop tx after loss of meds|0|||
105732317|NCT02786537|364676026|FG004|As Treated|Advised to stop tx after loss of meds|0|||
105732318|NCT02786537|364676027|FG005|As Treated|Advised to stop tx after loss of meds|0|||
105732319|NCT03199911|364676030|FG000|Overall Study|Lost to Follow-up|5|||
105732320|NCT03199911|364676031|FG001|Overall Study|Lost to Follow-up|5|||
105732321|NCT03199911|364676030|FG000|Overall Study|Did not proceed with surgery|2|||
105732322|NCT03199911|364676031|FG001|Overall Study|Did not proceed with surgery|1|||
105732323|NCT05309668|364676033|FG000|Overall Study|Ongoing at data cut-off|14|||
105797511|NCT02525562|364915974|FG002|Overall Study|Death|0|||
106139497|NCT02503202|366168635|FG000|Extension: Month 6 to 24|Death|1|||
105732324|NCT05309668|364676034|FG001|Overall Study|Ongoing at data cut-off|17|||
105732325|NCT05309668|364676035|FG002|Overall Study|Ongoing at data cut-off|4|||
105732326|NCT01059812|364676040|FG000|Overall Study|Adverse Event|9|||
105732327|NCT01059812|364676041|FG001|Overall Study|Adverse Event|5|||
105732328|NCT01059812|364676040|FG000|Overall Study|Lack of Efficacy|2|||
105732329|NCT01059812|364676041|FG001|Overall Study|Lack of Efficacy|2|||
105732330|NCT01059812|364676040|FG000|Overall Study|Protocol Violation|3|||
105732331|NCT01059812|364676041|FG001|Overall Study|Protocol Violation|1|||
105797512|NCT02525562|364915972|FG000|Overall Study|Lost to Follow-up|19|||
105797513|NCT02525562|364915973|FG001|Overall Study|Lost to Follow-up|0|||
105797514|NCT02525562|364915974|FG002|Overall Study|Lost to Follow-up|0|||
105797515|NCT02525562|364915972|FG000|Overall Study|Withdrawal by Subject|37|||
105797516|NCT02525562|364915973|FG001|Overall Study|Withdrawal by Subject|0|||
105797517|NCT02525562|364915974|FG002|Overall Study|Withdrawal by Subject|0|||
105797518|NCT02525562|364915972|FG000|Overall Study|Revision/Removal of Study Device|4|||
105797519|NCT02525562|364915973|FG001|Overall Study|Revision/Removal of Study Device|0|||
105797520|NCT02525562|364915974|FG002|Overall Study|Revision/Removal of Study Device|0|||
105797521|NCT02525562|364915972|FG000|Overall Study|Study Closed by Sponsor|154|||
105797522|NCT02525562|364915973|FG001|Overall Study|Study Closed by Sponsor|0|||
105797523|NCT02525562|364915974|FG002|Overall Study|Study Closed by Sponsor|0|||
105797524|NCT01706770|364915977|FG000|Overall Study|Lost to Follow-up|1|||
105797525|NCT01706770|364915978|FG001|Overall Study|Lost to Follow-up|0|||
105797526|NCT01706770|364915977|FG000|Overall Study|Physician Decision|1|||
105797527|NCT01706770|364915978|FG001|Overall Study|Physician Decision|0|||
105797528|NCT00123487|364915980|FG000|Randomized|Death prior to starting treatment|0|||
105797529|NCT00123487|364915981|FG001|Randomized|Death prior to starting treatment|1|||
105797530|NCT00123487|364915980|FG000|Randomized|SAE prior to starting treatment|1|||
105797531|NCT00123487|364915981|FG001|Randomized|SAE prior to starting treatment|0|||
105797532|NCT00123487|364915980|FG000|Treated With Study Drug|Adverse Event|23|||
105797533|NCT00123487|364915981|FG001|Treated With Study Drug|Adverse Event|22|||
105797534|NCT00123487|364915980|FG000|Treated With Study Drug|Disease Progression|141|||
105797535|NCT00123487|364915981|FG001|Treated With Study Drug|Disease Progression|122|||
105797536|NCT00123487|364915980|FG000|Treated With Study Drug|Physician Decision|8|||
105797537|NCT00123487|364915981|FG001|Treated With Study Drug|Physician Decision|9|||
105797538|NCT00123487|364915980|FG000|Treated With Study Drug|Other|59|||
105797539|NCT00123487|364915981|FG001|Treated With Study Drug|Other|58|||
105797540|NCT00123487|364915980|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
105797541|NCT00123487|364915981|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
105797542|NCT00123487|364915980|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
105797543|NCT00123487|364915981|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
105797544|NCT00123487|364915980|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
105797545|NCT00123487|364915981|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
105797546|NCT01749033|364915982|FG000|Overall Study|Did not receive allocated intervention|3|||
105797547|NCT01749033|364915983|FG001|Overall Study|Did not receive allocated intervention|3|||
105797548|NCT01749033|364915984|FG002|Overall Study|Did not receive allocated intervention|0|||
105797549|NCT01749033|364915982|FG000|Overall Study|Lost to Follow-up|0|||
105797550|NCT01749033|364915983|FG001|Overall Study|Lost to Follow-up|2|||
105797551|NCT01749033|364915984|FG002|Overall Study|Lost to Follow-up|1|||
105797552|NCT00068237|364915985|FG000|Overall Study|Ineligible|3|||
105797553|NCT00068237|364915985|FG000|Overall Study|No protocol treatment received|2|||
105797554|NCT04428502|364915986|FG000|Overall Study|Did not meet entrance criteria|14|||
105797555|NCT03125629|364915987|FG000|Overall Study|Withdrawal by Subject|2|||
105797556|NCT03125629|364915987|FG000|Overall Study|Equipment malfunction|1|||
105797557|NCT02574260|364915994|FG000|Overall Study|Disease Progression|1|||
105797558|NCT01066039|364915995|FG000|Overall Study|Adverse Event|6|||
105797559|NCT01066039|364915995|FG000|Overall Study|Withdrawal by Subject|17|||
105797560|NCT01066039|364915995|FG000|Overall Study|Protocol Violation|2|||
105797561|NCT01066039|364915995|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
105797562|NCT01066039|364915995|FG000|Overall Study|Investigator's Request|1|||
105797563|NCT01066039|364915995|FG000|Overall Study|Dropout due to Insulin Administration|1|||
105797564|NCT01066039|364915995|FG000|Overall Study|Additional Antihypertensive Required|4|||
105797565|NCT01066039|364915995|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
105797566|NCT01066039|364915995|FG000|Overall Study|Failure to Control Blood Pressure|1|||
105797567|NCT01066039|364915995|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
105797568|NCT00995930|364915996|FG000|Overall Study|Protocol deviation|2|||
105797569|NCT00995930|364915997|FG001|Overall Study|Protocol deviation|5|||
105797570|NCT00995930|364915996|FG000|Overall Study|Death|0|||
105797571|NCT00995930|364915997|FG001|Overall Study|Death|1|||
105797572|NCT00995930|364915996|FG000|Overall Study|Administrative problems|4|||
105937770|NCT00987935|365431552|FG004|Overall Study|Reason other than those specified above|0|||
105937771|NCT00987935|365431553|FG005|Overall Study|Reason other than those specified above|0|||
105937772|NCT00987935|365431554|FG006|Overall Study|Reason other than those specified above|0|||
105797573|NCT00995930|364915997|FG001|Overall Study|Administrative problems|2|||
105797574|NCT00995930|364915996|FG000|Overall Study|Lost to Follow-up|1|||
105797575|NCT00995930|364915997|FG001|Overall Study|Lost to Follow-up|2|||
105797576|NCT00995930|364915996|FG000|Overall Study|Withdrawal by Subject|3|||
105797577|NCT00995930|364915997|FG001|Overall Study|Withdrawal by Subject|4|||
105797578|NCT00995930|364915996|FG000|Overall Study|Adverse Event|11|||
105797579|NCT00995930|364915997|FG001|Overall Study|Adverse Event|14|||
105797580|NCT05003167|364915998|FG000|Overall Study|Withdrawal by Subject|1|||
105797581|NCT03120520|364916005|FG000|Overall Study|Lost to Follow-up|1|||
105797582|NCT03120520|364916006|FG001|Overall Study|Lost to Follow-up|1|||
106139498|NCT02503202|366168636|FG001|Extension: Month 6 to 24|Death|0|||
106139499|NCT02503202|366168637|FG002|Extension: Month 6 to 24|Death|0|||
106139500|NCT02503202|366168638|FG003|Extension: Month 6 to 24|Death|0|||
106139501|NCT02503202|366168639|FG004|Extension: Month 6 to 24|Death|0|||
106139502|NCT02503202|366168635|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
106139503|NCT02503202|366168636|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
106139504|NCT02503202|366168637|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
106139505|NCT02503202|366168638|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
106139506|NCT02503202|366168639|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
106139507|NCT02503202|366168635|FG000|Extension: Month 6 to 24|Physician Decision|1|||
106139508|NCT02503202|366168636|FG001|Extension: Month 6 to 24|Physician Decision|0|||
106139509|NCT02503202|366168637|FG002|Extension: Month 6 to 24|Physician Decision|1|||
106139510|NCT02503202|366168638|FG003|Extension: Month 6 to 24|Physician Decision|3|||
106139511|NCT02503202|366168639|FG004|Extension: Month 6 to 24|Physician Decision|0|||
106139512|NCT02503202|366168635|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
106139513|NCT02503202|366168636|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
106139514|NCT02503202|366168637|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
106139515|NCT02503202|366168638|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
106139516|NCT02503202|366168639|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
106139517|NCT00906035|366168642|FG000|Overall Study|Withdrawal by Subject|2|||
106139518|NCT00906035|366168643|FG001|Overall Study|Withdrawal by Subject|3|||
106139519|NCT00906035|366168644|FG002|Overall Study|Withdrawal by Subject|0|||
106139520|NCT03058991|366168645|FG000|Overall Study|Lost to Follow-up|17|||
106139521|NCT03058991|366168646|FG001|Overall Study|Lost to Follow-up|12|||
106139522|NCT03058991|366168647|FG002|Overall Study|Lost to Follow-up|12|||
106139523|NCT03058991|366168645|FG000|Overall Study|Withdrawal by Subject|1|||
106139524|NCT03058991|366168646|FG001|Overall Study|Withdrawal by Subject|0|||
106139525|NCT03058991|366168647|FG002|Overall Study|Withdrawal by Subject|0|||
106139526|NCT03621761|366168648|FG000|Overall Study|Lost to Follow-up|1|||
106139527|NCT03621761|366168649|FG001|Overall Study|Lost to Follow-up|1|||
106139528|NCT03621761|366168650|FG002|Overall Study|Lost to Follow-up|2|||
106139529|NCT03621761|366168648|FG000|Overall Study|Withdrawal by Subject|2|||
106139530|NCT03621761|366168649|FG001|Overall Study|Withdrawal by Subject|1|||
106139531|NCT03621761|366168650|FG002|Overall Study|Withdrawal by Subject|1|||
106139532|NCT03621761|366168648|FG000|Overall Study|Became Ineligible|0|||
106139533|NCT03621761|366168649|FG001|Overall Study|Became Ineligible|2|||
106139534|NCT03621761|366168650|FG002|Overall Study|Became Ineligible|0|||
106139535|NCT01050569|366168652|FG000|Overall Study|Lost to Follow-up|20|||
106139536|NCT01050569|366168653|FG001|Overall Study|Lost to Follow-up|14|||
106139537|NCT01050569|366168654|FG002|Overall Study|Lost to Follow-up|16|||
106139538|NCT01050569|366168652|FG000|Overall Study|Withdrawal by Subject|9|||
106139539|NCT01050569|366168653|FG001|Overall Study|Withdrawal by Subject|3|||
105732332|NCT01059812|364676040|FG000|Overall Study|Withdrawal Criteria|9|||
105732333|NCT01059812|364676041|FG001|Overall Study|Withdrawal Criteria|4|||
105732334|NCT01059812|364676040|FG000|Overall Study|Unclassified|14|||
105732335|NCT01059812|364676041|FG001|Overall Study|Unclassified|4|||
105732336|NCT01389128|364676042|FG000|Overall Study|Fetal distress|1|||
105732337|NCT01389128|364676043|FG001|Overall Study|Fetal distress|0|||
105732338|NCT01389128|364676042|FG000|Overall Study|Cervix dilation stop|1|||
105732339|NCT01389128|364676043|FG001|Overall Study|Cervix dilation stop|2|||
105732340|NCT01389128|364676042|FG000|Overall Study|Rapid labor evolution|3|||
105732341|NCT01389128|364676043|FG001|Overall Study|Rapid labor evolution|2|||
105732342|NCT01389128|364676042|FG000|Overall Study|Intolerance to procedure|0|||
105732343|NCT01389128|364676043|FG001|Overall Study|Intolerance to procedure|2|||
105732344|NCT00149214|364676044|FG000|Overall Study|Adverse Event|12|||
105732345|NCT00149214|364676045|FG001|Overall Study|Adverse Event|9|||
105732346|NCT00149214|364676044|FG000|Overall Study|Withdrawal by Subject|4|||
106139540|NCT01050569|366168654|FG002|Overall Study|Withdrawal by Subject|11|||
106139541|NCT01050569|366168652|FG000|Overall Study|Lack of Efficacy|5|||
106139542|NCT01050569|366168653|FG001|Overall Study|Lack of Efficacy|4|||
106139543|NCT01050569|366168654|FG002|Overall Study|Lack of Efficacy|3|||
106139544|NCT01050569|366168652|FG000|Overall Study|Adverse Event|1|||
106139545|NCT01050569|366168653|FG001|Overall Study|Adverse Event|0|||
106139546|NCT01050569|366168654|FG002|Overall Study|Adverse Event|0|||
106139547|NCT01050569|366168652|FG000|Overall Study|Physician Decision|3|||
106139548|NCT01050569|366168653|FG001|Overall Study|Physician Decision|3|||
106139549|NCT01050569|366168654|FG002|Overall Study|Physician Decision|3|||
106139550|NCT01959412|366168655|FG000|Overall Study|Protocol deviation|1|||
106139551|NCT01959412|366168656|FG001|Overall Study|Protocol deviation|1|||
106139552|NCT01959412|366168657|FG002|Overall Study|Protocol deviation|0|||
105732347|NCT00149214|364676045|FG001|Overall Study|Withdrawal by Subject|1|||
105732348|NCT00149214|364676044|FG000|Overall Study|Physician Decision|3|||
105732349|NCT00149214|364676045|FG001|Overall Study|Physician Decision|3|||
105732350|NCT00149214|364676044|FG000|Overall Study|Sponsor Decision|0|||
105937773|NCT00987935|365431555|FG007|Overall Study|Reason other than those specified above|0|||
105937774|NCT00987935|365431556|FG008|Overall Study|Reason other than those specified above|1|||
105937775|NCT00728182|365431560|FG000|Overall Study|Adverse Event|1|||
105937776|NCT00728182|365431561|FG001|Overall Study|Adverse Event|0|||
105937777|NCT00728182|365431560|FG000|Overall Study|Lost to Follow-up|2|||
105937778|NCT00728182|365431561|FG001|Overall Study|Lost to Follow-up|0|||
105937779|NCT00728182|365431560|FG000|Overall Study|Death|0|||
105937780|NCT00728182|365431561|FG001|Overall Study|Death|2|||
105937781|NCT00728182|365431560|FG000|Overall Study|Protocol Noncompliance|0|||
105937782|NCT00728182|365431561|FG001|Overall Study|Protocol Noncompliance|1|||
105937783|NCT01630811|365431567|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
105937784|NCT01630811|365431568|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
105937785|NCT04128228|365431573|FG000|Overall Study|Withdrawal by Subject|3|||
105937786|NCT04128228|365431574|FG001|Overall Study|Withdrawal by Subject|3|||
105937787|NCT04128228|365431575|FG002|Overall Study|Withdrawal by Subject|0|||
105937788|NCT04128228|365431576|FG003|Overall Study|Withdrawal by Subject|0|||
105937789|NCT04128228|365431573|FG000|Overall Study|noncompliance|2|||
105937790|NCT04128228|365431574|FG001|Overall Study|noncompliance|2|||
105937791|NCT04128228|365431575|FG002|Overall Study|noncompliance|0|||
105937792|NCT04128228|365431576|FG003|Overall Study|noncompliance|0|||
105937793|NCT00231465|365431577|FG000|Overall Study|Completed only one cycle|1|||
105937794|NCT00231465|365431577|FG000|Overall Study|Did not have follow up CT scans|1|||
105937795|NCT02536339|365431581|FG000|Overall Study|Death|20|||
105937796|NCT02536339|365431581|FG000|Overall Study|Withdrawal by Subject|3|||
105937797|NCT02536339|365431581|FG000|Overall Study|Lost to Follow-up|2|||
105937798|NCT02536339|365431581|FG000|Overall Study|Treatment discontinued|2|||
105937799|NCT02536339|365431581|FG000|Overall Study|Physician Decision|1|||
105937800|NCT03449147|365431582|FG000|52-week Treatment Period|Death|0|||
105937801|NCT03449147|365431583|FG001|52-week Treatment Period|Death|1|||
105937802|NCT03449147|365431584|FG002|52-week Treatment Period|Death|0|||
105937803|NCT03449147|365431582|FG000|52-week Treatment Period|Lost to Follow-up|6|||
105937804|NCT03449147|365431583|FG001|52-week Treatment Period|Lost to Follow-up|2|||
105732351|NCT00149214|364676045|FG001|Overall Study|Sponsor Decision|1|||
105732352|NCT00149214|364676044|FG000|Overall Study|Progressive Disease|7|||
105732353|NCT00149214|364676045|FG001|Overall Study|Progressive Disease|3|||
105732354|NCT01736683|364676047|FG000|Overall Study|Disease Relapse|0|||
105732355|NCT01736683|364676048|FG001|Overall Study|Disease Relapse|0|||
105732356|NCT01736683|364676049|FG002|Overall Study|Disease Relapse|2|||
105732357|NCT01736683|364676050|FG003|Overall Study|Disease Relapse|1|||
105732358|NCT01736683|364676051|FG004|Overall Study|Disease Relapse|0|||
105732359|NCT01736683|364676047|FG000|Overall Study|Adverse Event|0|||
105732360|NCT01736683|364676048|FG001|Overall Study|Adverse Event|2|||
105732361|NCT01736683|364676049|FG002|Overall Study|Adverse Event|2|||
105732362|NCT01736683|364676050|FG003|Overall Study|Adverse Event|3|||
105732363|NCT01736683|364676051|FG004|Overall Study|Adverse Event|2|||
105732364|NCT01736683|364676047|FG000|Overall Study|Withdrawal by Subject|0|||
105732365|NCT01736683|364676048|FG001|Overall Study|Withdrawal by Subject|0|||
105732366|NCT01736683|364676049|FG002|Overall Study|Withdrawal by Subject|3|||
105732367|NCT01736683|364676050|FG003|Overall Study|Withdrawal by Subject|1|||
105732368|NCT01736683|364676051|FG004|Overall Study|Withdrawal by Subject|1|||
105732369|NCT01736683|364676047|FG000|Overall Study|Lack of Therapeutic Effect|7|||
105732370|NCT01736683|364676048|FG001|Overall Study|Lack of Therapeutic Effect|4|||
105732371|NCT01736683|364676049|FG002|Overall Study|Lack of Therapeutic Effect|13|||
105732372|NCT01736683|364676050|FG003|Overall Study|Lack of Therapeutic Effect|20|||
105732373|NCT01736683|364676051|FG004|Overall Study|Lack of Therapeutic Effect|1|||
105732374|NCT01736683|364676047|FG000|Overall Study|Progressive Disease|0|||
105732375|NCT01736683|364676048|FG001|Overall Study|Progressive Disease|0|||
105732376|NCT01736683|364676049|FG002|Overall Study|Progressive Disease|0|||
105732377|NCT01736683|364676050|FG003|Overall Study|Progressive Disease|1|||
105732378|NCT01736683|364676051|FG004|Overall Study|Progressive Disease|0|||
105732379|NCT01736683|364676047|FG000|Overall Study|Other|0|||
105732380|NCT01736683|364676048|FG001|Overall Study|Other|0|||
105732381|NCT01736683|364676049|FG002|Overall Study|Other|1|||
105732382|NCT01736683|364676050|FG003|Overall Study|Other|9|||
105937805|NCT03449147|365431584|FG002|52-week Treatment Period|Lost to Follow-up|5|||
105937806|NCT03449147|365431582|FG000|52-week Treatment Period|Other|0|||
105937807|NCT03449147|365431583|FG001|52-week Treatment Period|Other|1|||
105937808|NCT03449147|365431584|FG002|52-week Treatment Period|Other|2|||
106009555|NCT01310777|365700873|FG001|Overall Study|Inadequate Control of IOP|7|||
105732383|NCT01736683|364676051|FG004|Overall Study|Other|1|||
105732384|NCT01458340|364676054|FG000|Overall Study|Adverse Event|5|||
105732385|NCT01458340|364676055|FG001|Overall Study|Adverse Event|4|||
105732386|NCT01458340|364676056|FG002|Overall Study|Adverse Event|2|||
105732387|NCT01458340|364676054|FG000|Overall Study|Lost to Follow-up|3|||
105732388|NCT01458340|364676055|FG001|Overall Study|Lost to Follow-up|3|||
105937809|NCT03449147|365431582|FG000|52-week Treatment Period|Physician Decision|1|||
105937810|NCT03449147|365431583|FG001|52-week Treatment Period|Physician Decision|0|||
105937811|NCT03449147|365431584|FG002|52-week Treatment Period|Physician Decision|3|||
105797583|NCT03120520|364916007|FG002|Overall Study|Lost to Follow-up|1|||
105797584|NCT03120520|364916008|FG003|Overall Study|Lost to Follow-up|1|||
105797585|NCT03120520|364916005|FG000|Overall Study|Withdrawal by Subject|3|||
105797586|NCT03120520|364916006|FG001|Overall Study|Withdrawal by Subject|2|||
105797587|NCT03120520|364916007|FG002|Overall Study|Withdrawal by Subject|3|||
105797588|NCT03120520|364916008|FG003|Overall Study|Withdrawal by Subject|2|||
105797589|NCT03120520|364916005|FG000|Overall Study|Other|0|||
105797590|NCT03120520|364916006|FG001|Overall Study|Other|1|||
105797591|NCT03120520|364916007|FG002|Overall Study|Other|0|||
105797592|NCT03120520|364916008|FG003|Overall Study|Other|0|||
105797593|NCT04385199|364916009|FG000|Overall Study|Withdrawal by Subject|1|||
105797594|NCT04385199|364916010|FG001|Overall Study|Withdrawal by Subject|0|||
105797595|NCT00267020|364917519|FG000|Overall Study|Adverse Event|22|||
105797596|NCT00267020|364917520|FG001|Overall Study|Adverse Event|5|||
105797597|NCT00267020|364917519|FG000|Overall Study|Death|2|||
105797598|NCT00267020|364917520|FG001|Overall Study|Death|1|||
105797599|NCT00267020|364917519|FG000|Overall Study|Withdrawal by Subject|17|||
105797600|NCT00267020|364917520|FG001|Overall Study|Withdrawal by Subject|7|||
105797601|NCT00267020|364917519|FG000|Overall Study|Physician Decision|3|||
105797602|NCT00267020|364917520|FG001|Overall Study|Physician Decision|2|||
105797603|NCT00267020|364917519|FG000|Overall Study|Disease Progression|39|||
105797604|NCT00267020|364917520|FG001|Overall Study|Disease Progression|25|||
105797605|NCT00267020|364917519|FG000|Overall Study|Unrelated Complication|1|||
105797606|NCT00267020|364917520|FG001|Overall Study|Unrelated Complication|1|||
105797607|NCT00267020|364917519|FG000|Overall Study|Sponsor Request|1|||
105797608|NCT00267020|364917520|FG001|Overall Study|Sponsor Request|0|||
105797609|NCT00267020|364917519|FG000|Overall Study|Other|1|||
105797610|NCT00267020|364917520|FG001|Overall Study|Other|2|||
105797611|NCT00858234|364917521|FG000|Overall Study|Adverse Event|6|||
105797612|NCT00858234|364917521|FG000|Overall Study|Progressive disease|2|||
105797613|NCT00858234|364917521|FG000|Overall Study|Status unknown|1|||
105797614|NCT00640614|364917524|FG000|Overall Study|Lost to Follow-up|1|||
105797615|NCT00640614|364917525|FG001|Overall Study|Lost to Follow-up|0|||
105797616|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
105797617|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
105797618|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
105732389|NCT01458340|364676056|FG002|Overall Study|Lost to Follow-up|10|||
105732390|NCT01458340|364676054|FG000|Overall Study|Miscellaneous|0|||
105732391|NCT01458340|364676055|FG001|Overall Study|Miscellaneous|1|||
105732392|NCT01458340|364676056|FG002|Overall Study|Miscellaneous|0|||
105732393|NCT01458340|364676054|FG000|Overall Study|Physician Decision|1|||
105732394|NCT01458340|364676055|FG001|Overall Study|Physician Decision|1|||
105732395|NCT01458340|364676056|FG002|Overall Study|Physician Decision|2|||
105732396|NCT01458340|364676054|FG000|Overall Study|Protocol Violation|6|||
105732397|NCT01458340|364676055|FG001|Overall Study|Protocol Violation|6|||
105732398|NCT01458340|364676056|FG002|Overall Study|Protocol Violation|5|||
105732399|NCT01458340|364676054|FG000|Overall Study|Withdrawal by Subject|12|||
105732400|NCT01458340|364676055|FG001|Overall Study|Withdrawal by Subject|6|||
105732401|NCT01458340|364676056|FG002|Overall Study|Withdrawal by Subject|4|||
105732402|NCT03056287|364676058|FG000|Overall Study|Withdrawal by Subject|0|||
105732403|NCT03056287|364676059|FG001|Overall Study|Withdrawal by Subject|1|||
105732404|NCT03056287|364676060|FG002|Overall Study|Withdrawal by Subject|0|||
105732405|NCT03056287|364676061|FG003|Overall Study|Withdrawal by Subject|0|||
105732406|NCT03056287|364676058|FG000|Overall Study|move out of area|0|||
105732407|NCT03056287|364676059|FG001|Overall Study|move out of area|0|||
105732408|NCT03056287|364676060|FG002|Overall Study|move out of area|1|||
105732409|NCT03056287|364676061|FG003|Overall Study|move out of area|1|||
105732410|NCT02442349|364676062|FG000|Overall Study|Death|95|||
105732411|NCT02442349|364676062|FG000|Overall Study|Withdrawal by Subject|27|||
105732412|NCT02442349|364676062|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
105732413|NCT02442349|364676062|FG000|Overall Study|Lost to Follow-up|1|||
105732414|NCT02286960|364676065|FG000|Overall Study|Lost to Follow-up|3|||
105732415|NCT02286960|364676066|FG001|Overall Study|Lost to Follow-up|3|||
105732416|NCT01165229|364676070|FG000|Overall Study|Serious Adverse Event|456|||
105732417|NCT01165229|364676071|FG001|Overall Study|Serious Adverse Event|487|||
105732418|NCT01165229|364676070|FG000|Overall Study|Non-Serious Adverse Event|47|||
105732419|NCT01165229|364676071|FG001|Overall Study|Non-Serious Adverse Event|15|||
105732420|NCT01165229|364676070|FG000|Overall Study|Protocol Violation|6|||
105732421|NCT01165229|364676071|FG001|Overall Study|Protocol Violation|8|||
105797619|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Death|1|||
105797620|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
105797621|NCT00529802|364917527|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
105797622|NCT00529802|364917527|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
105797623|NCT01858558|364917528|FG000|Overall Study|Death|1|||
105797624|NCT01858558|364917529|FG001|Overall Study|Death|1|||
105797625|NCT01858558|364917528|FG000|Overall Study|Lost to Follow-up|1|||
105797626|NCT01858558|364917529|FG001|Overall Study|Lost to Follow-up|0|||
105732422|NCT01165229|364676070|FG000|Overall Study|Withdrawal by Subject|387|||
106139553|NCT01959412|366168658|FG003|Overall Study|Protocol deviation|1|||
105732423|NCT01165229|364676071|FG001|Overall Study|Withdrawal by Subject|396|||
105732424|NCT01165229|364676070|FG000|Overall Study|Migrated/moved from study area|51|||
105732425|NCT01165229|364676071|FG001|Overall Study|Migrated/moved from study area|46|||
105732426|NCT01165229|364676070|FG000|Overall Study|Lost to Follow-up|123|||
105732427|NCT01165229|364676071|FG001|Overall Study|Lost to Follow-up|133|||
105732428|NCT01165229|364676070|FG000|Overall Study|Suspected HZ Episode|2|||
105732429|NCT01165229|364676071|FG001|Overall Study|Suspected HZ Episode|2|||
105732430|NCT01165229|364676070|FG000|Overall Study|No reason from the subject|108|||
105732431|NCT01165229|364676071|FG001|Overall Study|No reason from the subject|102|||
105732432|NCT01165229|364676070|FG000|Overall Study|Unknown completion status|0|||
105732433|NCT01165229|364676071|FG001|Overall Study|Unknown completion status|1|||
105732434|NCT00474253|364676072|FG000|Overall Study|Withdrew consent|2|||
105732435|NCT00474253|364676073|FG001|Overall Study|Withdrew consent|0|||
105732436|NCT00474253|364676072|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
105732437|NCT00474253|364676073|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
105732438|NCT00474253|364676072|FG000|Overall Study|Lost to Follow-up|1|||
105732439|NCT00474253|364676073|FG001|Overall Study|Lost to Follow-up|0|||
105732440|NCT00474253|364676072|FG000|Overall Study|Discharged prior to study completion|0|||
105732441|NCT00474253|364676073|FG001|Overall Study|Discharged prior to study completion|1|||
105732442|NCT00550238|364676077|FG000|Overall Study|Adverse Event|88|||
105732443|NCT00550238|364676077|FG000|Overall Study|Death|34|||
105732444|NCT00550238|364676077|FG000|Overall Study|Disease progression|46|||
105732445|NCT00550238|364676077|FG000|Overall Study|Withdrawal by Subject|167|||
105732446|NCT00550238|364676077|FG000|Overall Study|Physician Decision|31|||
105732447|NCT00550238|364676077|FG000|Overall Study|Patient noncompliance|25|||
105732448|NCT00550238|364676077|FG000|Overall Study|Lost to Follow-up|13|||
105732449|NCT00550238|364676077|FG000|Overall Study|Sponsor decision|55|||
105732450|NCT05421754|364676078|FG000|Overall Study|Technical issue with sensor|1|||
105732451|NCT00465569|364676079|FG000|Overall Study|persistent eczema during dose escalation|1|||
105732452|NCT00465569|364676080|FG001|Overall Study|persistent eczema during dose escalation|0|||
105732453|NCT04334148|364676082|FG000|Overall Study|positive nasal swab at baseline|0|||
105732454|NCT04334148|364676083|FG001|Overall Study|positive nasal swab at baseline|1|||
105732455|NCT00095303|364676086|FG000|Main Study|Lost to Follow-up|91|||
105732456|NCT00095303|364676087|FG001|Main Study|Lost to Follow-up|87|||
105732457|NCT00095303|364676086|FG000|Follow Up Study|Lost to Follow-up|59|||
105732458|NCT00095303|364676087|FG001|Follow Up Study|Lost to Follow-up|58|||
105732459|NCT01634243|364676088|FG000|Overall Study|Adverse Event|5|||
105732460|NCT01634243|364676089|FG001|Overall Study|Adverse Event|5|||
105732461|NCT01634243|364676088|FG000|Overall Study|Lack of Efficacy|1|||
105732462|NCT01634243|364676089|FG001|Overall Study|Lack of Efficacy|0|||
105732463|NCT00467649|364676097|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
105732464|NCT00467649|364676098|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
105732465|NCT00467649|364676099|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
105732466|NCT00467649|364676100|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
105732467|NCT00467649|364676101|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
105732468|NCT00467649|364676102|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
105732469|NCT00467649|364676097|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
105732470|NCT00467649|364676098|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732471|NCT00467649|364676099|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732472|NCT00467649|364676100|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732473|NCT00467649|364676101|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732474|NCT00467649|364676102|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
105732475|NCT00467649|364676097|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
105732476|NCT00467649|364676098|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
105732477|NCT00467649|364676099|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
105732478|NCT00467649|364676100|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
105732479|NCT00467649|364676101|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
105732480|NCT00467649|364676102|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
105732481|NCT00467649|364676097|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
106139554|NCT01959412|366168659|FG004|Overall Study|Protocol deviation|3|||
105732482|NCT00467649|364676098|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
105732483|NCT00467649|364676099|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
105732484|NCT00467649|364676100|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
105732485|NCT00467649|364676101|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
105732486|NCT00467649|364676102|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
105732487|NCT00467649|364676097|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105732488|NCT00467649|364676098|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105732489|NCT00467649|364676099|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105732490|NCT00467649|364676100|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
106139555|NCT01959412|366168660|FG005|Overall Study|Protocol deviation|0|||
105732491|NCT00467649|364676101|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105797627|NCT01858558|364917528|FG000|Overall Study|Disease progression|3|||
105797628|NCT01858558|364917529|FG001|Overall Study|Disease progression|1|||
105797629|NCT01858558|364917528|FG000|Overall Study|Product contamination|2|||
105797630|NCT01858558|364917529|FG001|Overall Study|Product contamination|0|||
105797631|NCT01858558|364917528|FG000|Overall Study|Failed expansion of cell product|2|||
105797632|NCT01858558|364917529|FG001|Overall Study|Failed expansion of cell product|0|||
105797633|NCT01142466|364917530|FG000|Overall Study|Adverse Event|2|||
105797634|NCT01142466|364917531|FG001|Overall Study|Adverse Event|1|||
105797635|NCT01142466|364917530|FG000|Overall Study|Withdrawal by Subject|1|||
105797636|NCT01142466|364917531|FG001|Overall Study|Withdrawal by Subject|1|||
105797637|NCT00343642|364917532|FG000|Overall Study|Lost to Follow-up|0|||
105797638|NCT00343642|364917533|FG001|Overall Study|Lost to Follow-up|1|||
105797639|NCT00343642|364917534|FG002|Overall Study|Lost to Follow-up|0|||
105797640|NCT00343642|364917532|FG000|Overall Study|Pregnancy|1|||
105797641|NCT00343642|364917533|FG001|Overall Study|Pregnancy|0|||
105797642|NCT00343642|364917534|FG002|Overall Study|Pregnancy|2|||
105797643|NCT00343642|364917532|FG000|Overall Study|Withdrawal by Subject|2|||
105797644|NCT00343642|364917533|FG001|Overall Study|Withdrawal by Subject|3|||
105797645|NCT00343642|364917534|FG002|Overall Study|Withdrawal by Subject|4|||
105797646|NCT00343642|364917532|FG000|Overall Study|Adverse Event|0|||
105797647|NCT00343642|364917533|FG001|Overall Study|Adverse Event|0|||
105797648|NCT00343642|364917534|FG002|Overall Study|Adverse Event|1|||
105797649|NCT00343642|364917532|FG000|Overall Study|Flare up|6|||
105797650|NCT00343642|364917533|FG001|Overall Study|Flare up|4|||
105797651|NCT00343642|364917534|FG002|Overall Study|Flare up|0|||
105797652|NCT00700310|364917537|FG000|Overall Study|Adverse Event|6|||
105797653|NCT00700310|364917538|FG001|Overall Study|Adverse Event|10|||
105797654|NCT00700310|364917539|FG002|Overall Study|Adverse Event|5|||
105797655|NCT00700310|364917540|FG003|Overall Study|Adverse Event|11|||
105797656|NCT00700310|364917537|FG000|Overall Study|Lost to Follow-up|4|||
105797657|NCT00700310|364917538|FG001|Overall Study|Lost to Follow-up|1|||
105797658|NCT00700310|364917539|FG002|Overall Study|Lost to Follow-up|0|||
105797659|NCT00700310|364917540|FG003|Overall Study|Lost to Follow-up|1|||
105797660|NCT00700310|364917537|FG000|Overall Study|Withdrawal by Subject|8|||
105797661|NCT00700310|364917538|FG001|Overall Study|Withdrawal by Subject|9|||
105797662|NCT00700310|364917539|FG002|Overall Study|Withdrawal by Subject|8|||
105797663|NCT00700310|364917540|FG003|Overall Study|Withdrawal by Subject|8|||
105797664|NCT00700310|364917537|FG000|Overall Study|Lack of Efficacy|0|||
105797665|NCT00700310|364917538|FG001|Overall Study|Lack of Efficacy|3|||
105797666|NCT00700310|364917539|FG002|Overall Study|Lack of Efficacy|0|||
105797667|NCT00700310|364917540|FG003|Overall Study|Lack of Efficacy|1|||
105797668|NCT00700310|364917537|FG000|Overall Study|Administrative/Other|1|||
105797669|NCT00700310|364917538|FG001|Overall Study|Administrative/Other|3|||
105797670|NCT00700310|364917539|FG002|Overall Study|Administrative/Other|1|||
105797671|NCT00700310|364917540|FG003|Overall Study|Administrative/Other|3|||
105797672|NCT00700310|364917537|FG000|Overall Study|Randomized, Not Treated|2|||
105797673|NCT00700310|364917538|FG001|Overall Study|Randomized, Not Treated|0|||
105797674|NCT00700310|364917539|FG002|Overall Study|Randomized, Not Treated|2|||
105797675|NCT00700310|364917540|FG003|Overall Study|Randomized, Not Treated|2|||
105797676|NCT02598622|364917545|FG000|Overall Study|Withdrawal by Subject|3|||
105797677|NCT02598622|364917546|FG001|Overall Study|Withdrawal by Subject|0|||
105797678|NCT02598622|364917545|FG000|Overall Study|Physician Decision|3|||
105797679|NCT02598622|364917546|FG001|Overall Study|Physician Decision|0|||
105797680|NCT00681824|364917550|FG000|Overall Study|withdrawn by investigator|0|||
105797681|NCT00681824|364917551|FG001|Overall Study|withdrawn by investigator|0|||
105797682|NCT00681824|364917552|FG002|Overall Study|withdrawn by investigator|1|||
105797683|NCT00681824|364917550|FG000|Overall Study|scheduling conflict|1|||
105797684|NCT00681824|364917551|FG001|Overall Study|scheduling conflict|0|||
105797685|NCT00681824|364917552|FG002|Overall Study|scheduling conflict|0|||
105797686|NCT00681824|364917550|FG000|Overall Study|Death|0|||
105797687|NCT00681824|364917551|FG001|Overall Study|Death|1|||
105797688|NCT00681824|364917552|FG002|Overall Study|Death|0|||
105797689|NCT03724916|364917553|FG000|Overall Study|Withdrawal by Subject|0|||
105797690|NCT03724916|364917554|FG001|Overall Study|Withdrawal by Subject|1|||
105797691|NCT03724916|364917555|FG002|Overall Study|Withdrawal by Subject|1|||
105797692|NCT03724916|364917556|FG003|Overall Study|Withdrawal by Subject|2|||
105797693|NCT03724916|364917553|FG000|Overall Study|Randomized but not Treated|1|||
105797694|NCT03724916|364917554|FG001|Overall Study|Randomized but not Treated|0|||
105797695|NCT03724916|364917555|FG002|Overall Study|Randomized but not Treated|0|||
105797696|NCT03724916|364917556|FG003|Overall Study|Randomized but not Treated|0|||
105797697|NCT04575038|364917557|FG000|Overall Study|Withdrawal by Subject|1|||
105797698|NCT04575038|364917558|FG001|Overall Study|Withdrawal by Subject|1|||
105797699|NCT01586624|364917562|FG000|Overall Study|Adverse Event|3|||
105797700|NCT01586624|364917563|FG001|Overall Study|Adverse Event|0|||
105797701|NCT01586624|364917564|FG002|Overall Study|Adverse Event|2|||
105797702|NCT01586624|364917565|FG003|Overall Study|Adverse Event|1|||
105797703|NCT01586624|364917566|FG004|Overall Study|Adverse Event|3|||
105797704|NCT01586624|364917567|FG005|Overall Study|Adverse Event|3|||
105797705|NCT01586624|364917568|FG006|Overall Study|Adverse Event|2|||
105797706|NCT01586624|364917569|FG007|Overall Study|Adverse Event|3|||
105797707|NCT01586624|364917562|FG000|Overall Study|Physician Decision|0|||
105797708|NCT01586624|364917563|FG001|Overall Study|Physician Decision|1|||
105797709|NCT01586624|364917564|FG002|Overall Study|Physician Decision|1|||
105797710|NCT01586624|364917565|FG003|Overall Study|Physician Decision|0|||
105797711|NCT01586624|364917566|FG004|Overall Study|Physician Decision|2|||
105797712|NCT01586624|364917567|FG005|Overall Study|Physician Decision|0|||
105797713|NCT01586624|364917568|FG006|Overall Study|Physician Decision|1|||
105797714|NCT01586624|364917569|FG007|Overall Study|Physician Decision|1|||
105797715|NCT01586624|364917562|FG000|Overall Study|Withdrawal by Subject|0|||
105797716|NCT01586624|364917563|FG001|Overall Study|Withdrawal by Subject|0|||
105797717|NCT01586624|364917564|FG002|Overall Study|Withdrawal by Subject|0|||
105797718|NCT01586624|364917565|FG003|Overall Study|Withdrawal by Subject|1|||
105797719|NCT01586624|364917566|FG004|Overall Study|Withdrawal by Subject|0|||
105797720|NCT01586624|364917567|FG005|Overall Study|Withdrawal by Subject|0|||
105797721|NCT01586624|364917568|FG006|Overall Study|Withdrawal by Subject|0|||
105797722|NCT01586624|364917569|FG007|Overall Study|Withdrawal by Subject|0|||
105797723|NCT01586624|364917562|FG000|Overall Study|Evidence of disease progression|1|||
105797724|NCT01586624|364917563|FG001|Overall Study|Evidence of disease progression|3|||
105797725|NCT01586624|364917564|FG002|Overall Study|Evidence of disease progression|2|||
105797726|NCT01586624|364917565|FG003|Overall Study|Evidence of disease progression|5|||
105797727|NCT01586624|364917566|FG004|Overall Study|Evidence of disease progression|3|||
105797728|NCT01586624|364917567|FG005|Overall Study|Evidence of disease progression|5|||
105797729|NCT01586624|364917568|FG006|Overall Study|Evidence of disease progression|4|||
105797730|NCT01586624|364917569|FG007|Overall Study|Evidence of disease progression|6|||
105797731|NCT01586624|364917562|FG000|Overall Study|Screen failure (no treatment received)|0|||
105797732|NCT01586624|364917563|FG001|Overall Study|Screen failure (no treatment received)|0|||
105797733|NCT01586624|364917564|FG002|Overall Study|Screen failure (no treatment received)|0|||
106139556|NCT01959412|366168655|FG000|Overall Study|Adverse Event|0|||
106139557|NCT01959412|366168656|FG001|Overall Study|Adverse Event|0|||
106139558|NCT01959412|366168657|FG002|Overall Study|Adverse Event|0|||
106139559|NCT01959412|366168658|FG003|Overall Study|Adverse Event|1|||
106139560|NCT01959412|366168659|FG004|Overall Study|Adverse Event|0|||
106139561|NCT01959412|366168660|FG005|Overall Study|Adverse Event|0|||
105797734|NCT01586624|364917565|FG003|Overall Study|Screen failure (no treatment received)|0|||
105797735|NCT01586624|364917566|FG004|Overall Study|Screen failure (no treatment received)|0|||
106139562|NCT00079183|366168666|FG000|Overall Study|Withdrawal by Subject|4|||
106139563|NCT00079183|366168666|FG000|Overall Study|Study medication non-compliance|2|||
106139564|NCT00079183|366168666|FG000|Overall Study|Specimen collection non-compliance|1|||
106139565|NCT01194258|366168667|FG000|Titration Period|Withdrawal by Subject|6|||
106139566|NCT01194258|366168668|FG001|Titration Period|Withdrawal by Subject|0|||
106139567|NCT01194258|366168669|FG002|Titration Period|Withdrawal by Subject|0|||
106139568|NCT01194258|366168670|FG003|Titration Period|Withdrawal by Subject|0|||
106139569|NCT01194258|366168671|FG004|Titration Period|Withdrawal by Subject|0|||
106139570|NCT01194258|366168667|FG000|Titration Period|Lost to Follow-up|2|||
106139571|NCT01194258|366168668|FG001|Titration Period|Lost to Follow-up|0|||
106139572|NCT01194258|366168669|FG002|Titration Period|Lost to Follow-up|0|||
106139573|NCT01194258|366168670|FG003|Titration Period|Lost to Follow-up|0|||
106139574|NCT01194258|366168671|FG004|Titration Period|Lost to Follow-up|0|||
106139575|NCT01194258|366168667|FG000|Titration Period|Titration failure|3|||
106139576|NCT01194258|366168668|FG001|Titration Period|Titration failure|0|||
106139577|NCT01194258|366168669|FG002|Titration Period|Titration failure|0|||
105797736|NCT01586624|364917567|FG005|Overall Study|Screen failure (no treatment received)|0|||
105797737|NCT01586624|364917568|FG006|Overall Study|Screen failure (no treatment received)|1|||
105797738|NCT01586624|364917569|FG007|Overall Study|Screen failure (no treatment received)|0|||
105797739|NCT01954082|364917579|FG000|Overall Study|Study Suspension|42|||
105797740|NCT01954082|364917580|FG001|Overall Study|Study Suspension|36|||
105797741|NCT01954082|364917579|FG000|Overall Study|Adverse Event|10|||
105797742|NCT01954082|364917580|FG001|Overall Study|Adverse Event|4|||
105797743|NCT01954082|364917579|FG000|Overall Study|Intolerance|0|||
105797744|NCT01954082|364917580|FG001|Overall Study|Intolerance|1|||
105797745|NCT01954082|364917579|FG000|Overall Study|Non-compliance|6|||
105797746|NCT01954082|364917580|FG001|Overall Study|Non-compliance|4|||
105797747|NCT01954082|364917579|FG000|Overall Study|Physician Decision|2|||
105797748|NCT01954082|364917580|FG001|Overall Study|Physician Decision|0|||
105797749|NCT01954082|364917579|FG000|Overall Study|Parent Decision|1|||
106139578|NCT01194258|366168670|FG003|Titration Period|Titration failure|0|||
105797750|NCT01954082|364917580|FG001|Overall Study|Parent Decision|0|||
106139579|NCT01194258|366168671|FG004|Titration Period|Titration failure|0|||
106139580|NCT01194258|366168667|FG000|Period 1 (12 Weeks)|Death|0|||
106139581|NCT01194258|366168668|FG001|Period 1 (12 Weeks)|Death|0|||
106139582|NCT01194258|366168669|FG002|Period 1 (12 Weeks)|Death|0|||
106139583|NCT01194258|366168670|FG003|Period 1 (12 Weeks)|Death|0|||
106139584|NCT01194258|366168671|FG004|Period 1 (12 Weeks)|Death|1|||
106139585|NCT01194258|366168667|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
106139586|NCT01194258|366168668|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
106139587|NCT01194258|366168669|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
106139588|NCT01194258|366168670|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
106139589|NCT01194258|366168671|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
105732492|NCT00467649|364676102|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
105732493|NCT00467649|364676097|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105732494|NCT00467649|364676098|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105732495|NCT00467649|364676099|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
106009556|NCT01310777|365700874|FG002|Overall Study|Inadequate Control of IOP|10|||
106009557|NCT01310777|365700872|FG000|Overall Study|Other|4|||
106009558|NCT01310777|365700873|FG001|Overall Study|Other|1|||
106139590|NCT01194258|366168667|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
105732496|NCT00467649|364676100|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
105732497|NCT00467649|364676101|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105732498|NCT00467649|364676102|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
105732499|NCT00467649|364676097|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732500|NCT00467649|364676098|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732501|NCT00467649|364676099|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732502|NCT00467649|364676100|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732503|NCT00467649|364676101|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
105732504|NCT00467649|364676102|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
105732505|NCT00845429|364676103|FG000|Overall Study|Protocol Violation|5|||
105732506|NCT00845429|364676104|FG001|Overall Study|Protocol Violation|4|||
105732507|NCT00845429|364676105|FG002|Overall Study|Protocol Violation|7|||
105732508|NCT00845429|364676103|FG000|Overall Study|Lost to Follow-up|7|||
105732509|NCT00845429|364676104|FG001|Overall Study|Lost to Follow-up|9|||
105732510|NCT00845429|364676105|FG002|Overall Study|Lost to Follow-up|10|||
105732511|NCT00845429|364676103|FG000|Overall Study|Withdrawal by Subject|2|||
105732512|NCT00845429|364676104|FG001|Overall Study|Withdrawal by Subject|2|||
105732513|NCT00845429|364676105|FG002|Overall Study|Withdrawal by Subject|2|||
105732514|NCT00845429|364676103|FG000|Overall Study|Serious adverse event|0|||
105732515|NCT00845429|364676104|FG001|Overall Study|Serious adverse event|0|||
105732516|NCT00845429|364676105|FG002|Overall Study|Serious adverse event|1|||
105732517|NCT00986349|364676109|FG000|Overall Study|Unsuccessful implant procedure|3|||
105732518|NCT00986349|364676109|FG000|Overall Study|Adverse Event|2|||
105732519|NCT00986349|364676109|FG000|Overall Study|Physician Decision|1|||
105732520|NCT00986349|364676109|FG000|Overall Study|device migration|1|||
105732521|NCT00587223|364676110|FG000|Overall Study|Adverse Event|1|||
105732522|NCT02111811|364676113|FG000|Treatment Phase|Lost to Follow-up|22|||
105732523|NCT02111811|364676114|FG001|Treatment Phase|Lost to Follow-up|18|||
105732524|NCT02111811|364676113|FG000|Treatment Phase|Death|2|||
105732525|NCT02111811|364676114|FG001|Treatment Phase|Death|0|||
105732526|NCT02111811|364676113|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
105732527|NCT02111811|364676114|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
105732528|NCT02111811|364676113|FG000|Follow up Period (Aim 2)|Death|2|||
105732529|NCT02111811|364676114|FG001|Follow up Period (Aim 2)|Death|0|||
105732530|NCT05897853|364676120|FG000|Overall Study|Lost to Follow-up|2|||
105732531|NCT05897853|364676121|FG001|Overall Study|Lost to Follow-up|0|||
105732532|NCT05897853|364676120|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
105732533|NCT05897853|364676121|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
105732534|NCT02986373|364676122|FG000|Overall Study|Adverse Event|4|||
105732535|NCT02986373|364676122|FG000|Overall Study|Lost to Follow-up|1|||
105732536|NCT02986373|364676122|FG000|Overall Study|Withdrawal by Subject|10|||
105732537|NCT02986373|364676122|FG000|Overall Study|Other|24|||
105732538|NCT00753922|364676126|FG000|Overall Study|Lost to Follow-up|155|||
105732539|NCT00753922|364676127|FG001|Overall Study|Lost to Follow-up|24|||
105732540|NCT00753922|364676128|FG002|Overall Study|Lost to Follow-up|28|||
105732541|NCT00753922|364676129|FG003|Overall Study|Lost to Follow-up|5|||
105732542|NCT00753922|364676126|FG000|Overall Study|Withdrawal by Subject|9|||
105732543|NCT00753922|364676127|FG001|Overall Study|Withdrawal by Subject|11|||
105732544|NCT00753922|364676128|FG002|Overall Study|Withdrawal by Subject|4|||
105732545|NCT00753922|364676129|FG003|Overall Study|Withdrawal by Subject|2|||
105732546|NCT00753922|364676126|FG000|Overall Study|Patient Non-compliance|55|||
105732547|NCT00753922|364676127|FG001|Overall Study|Patient Non-compliance|22|||
106139591|NCT01194258|366168668|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
106139592|NCT01194258|366168669|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
105732548|NCT00753922|364676128|FG002|Overall Study|Patient Non-compliance|14|||
105732549|NCT00753922|364676129|FG003|Overall Study|Patient Non-compliance|11|||
105732550|NCT00753922|364676126|FG000|Overall Study|Patients Not Completing Visit|11|||
105732551|NCT00753922|364676127|FG001|Overall Study|Patients Not Completing Visit|0|||
106009559|NCT01310777|365700874|FG002|Overall Study|Other|2|||
105797751|NCT01954082|364917579|FG000|Overall Study|Withdrawal by Subject|0|||
105797752|NCT01954082|364917580|FG001|Overall Study|Withdrawal by Subject|1|||
105797753|NCT01954082|364917579|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
105797754|NCT01954082|364917580|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
105797755|NCT01954082|364917579|FG000|Overall Study|Redirection of Care|0|||
105797756|NCT01954082|364917580|FG001|Overall Study|Redirection of Care|2|||
105797757|NCT01954082|364917579|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
105797758|NCT01954082|364917580|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
105797759|NCT01954082|364917579|FG000|Overall Study|Comfort Care|0|||
105797760|NCT01954082|364917580|FG001|Overall Study|Comfort Care|1|||
105797761|NCT01954082|364917579|FG000|Overall Study|Infant Moved|0|||
105797762|NCT01954082|364917580|FG001|Overall Study|Infant Moved|1|||
105797763|NCT01954082|364917579|FG000|Overall Study|Randomized not Treated|4|||
105797764|NCT01954082|364917580|FG001|Overall Study|Randomized not Treated|2|||
105797765|NCT01875991|364917581|FG000|Overall Study|Withdrawal by Subject|6|||
105797766|NCT01875991|364917582|FG001|Overall Study|Withdrawal by Subject|6|||
105797767|NCT01875991|364917581|FG000|Overall Study|Sponsor Decision|1|||
105797768|NCT01875991|364917582|FG001|Overall Study|Sponsor Decision|0|||
105797769|NCT00923195|364917587|FG000|Overall Study|Death|0|||
105797770|NCT00923195|364917588|FG001|Overall Study|Death|1|||
105797771|NCT01106352|364917589|FG000|Overall Study|Subjects untreated|0|||
105797772|NCT01106352|364917590|FG001|Overall Study|Subjects untreated|0|||
105797773|NCT01106352|364917591|FG002|Overall Study|Subjects untreated|0|||
105797774|NCT01106352|364917592|FG003|Overall Study|Subjects untreated|3|||
105797775|NCT01106352|364917593|FG004|Overall Study|Subjects untreated|4|||
105797776|NCT01106352|364917589|FG000|Overall Study|Sponsor Decision|1|||
105797777|NCT01106352|364917590|FG001|Overall Study|Sponsor Decision|0|||
105797778|NCT01106352|364917591|FG002|Overall Study|Sponsor Decision|0|||
105797779|NCT01106352|364917592|FG003|Overall Study|Sponsor Decision|0|||
105797780|NCT01106352|364917593|FG004|Overall Study|Sponsor Decision|0|||
105797781|NCT01106352|364917589|FG000|Overall Study|Too ill to come in for the visit|0|||
105797782|NCT01106352|364917590|FG001|Overall Study|Too ill to come in for the visit|0|||
105797783|NCT01106352|364917591|FG002|Overall Study|Too ill to come in for the visit|1|||
105797784|NCT01106352|364917592|FG003|Overall Study|Too ill to come in for the visit|0|||
105797785|NCT01106352|364917593|FG004|Overall Study|Too ill to come in for the visit|0|||
105797786|NCT01106352|364917589|FG000|Overall Study|Lost to Follow-up|0|||
105797787|NCT01106352|364917590|FG001|Overall Study|Lost to Follow-up|0|||
105797788|NCT01106352|364917591|FG002|Overall Study|Lost to Follow-up|0|||
105797789|NCT01106352|364917592|FG003|Overall Study|Lost to Follow-up|0|||
105797790|NCT01106352|364917593|FG004|Overall Study|Lost to Follow-up|1|||
105797791|NCT01106352|364917589|FG000|Overall Study|Death|0|||
105797792|NCT01106352|364917590|FG001|Overall Study|Death|0|||
105797793|NCT01106352|364917591|FG002|Overall Study|Death|1|||
105797794|NCT01106352|364917592|FG003|Overall Study|Death|3|||
105797795|NCT01106352|364917593|FG004|Overall Study|Death|1|||
105797796|NCT01106352|364917589|FG000|Overall Study|Disease progression|0|||
105797797|NCT01106352|364917590|FG001|Overall Study|Disease progression|0|||
106139593|NCT01194258|366168670|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
106139594|NCT01194258|366168671|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
105732552|NCT00753922|364676128|FG002|Overall Study|Patients Not Completing Visit|1|||
105732553|NCT00753922|364676129|FG003|Overall Study|Patients Not Completing Visit|0|||
105732554|NCT00753922|364676126|FG000|Overall Study|Death|2|||
105732555|NCT00753922|364676127|FG001|Overall Study|Death|23|||
105732556|NCT00753922|364676128|FG002|Overall Study|Death|2|||
105732557|NCT00753922|364676129|FG003|Overall Study|Death|1|||
105732558|NCT00753922|364676126|FG000|Overall Study|Discontinuation Due to Explantation|14|||
105732559|NCT00753922|364676127|FG001|Overall Study|Discontinuation Due to Explantation|14|||
105732560|NCT00753922|364676128|FG002|Overall Study|Discontinuation Due to Explantation|14|||
105732561|NCT00753922|364676129|FG003|Overall Study|Discontinuation Due to Explantation|4|||
105732562|NCT00586690|364676138|FG000|Overall Study|Death|2|||
105732563|NCT00586690|364676139|FG001|Overall Study|Death|0|||
105732564|NCT00586690|364676138|FG000|Overall Study|Disease Progression|10|||
105797798|NCT01106352|364917591|FG002|Overall Study|Disease progression|0|||
105797799|NCT01106352|364917592|FG003|Overall Study|Disease progression|1|||
105797800|NCT01106352|364917593|FG004|Overall Study|Disease progression|0|||
105797801|NCT01106352|364917589|FG000|Overall Study|Withdrawal by Subject|0|||
105797802|NCT01106352|364917590|FG001|Overall Study|Withdrawal by Subject|0|||
105797803|NCT01106352|364917591|FG002|Overall Study|Withdrawal by Subject|0|||
105797804|NCT01106352|364917592|FG003|Overall Study|Withdrawal by Subject|3|||
105797805|NCT01106352|364917593|FG004|Overall Study|Withdrawal by Subject|2|||
105797806|NCT01106352|364917589|FG000|Overall Study|Went on hospice|0|||
105797807|NCT01106352|364917590|FG001|Overall Study|Went on hospice|0|||
105797808|NCT01106352|364917591|FG002|Overall Study|Went on hospice|0|||
105797809|NCT01106352|364917592|FG003|Overall Study|Went on hospice|1|||
105732565|NCT00586690|364676139|FG001|Overall Study|Disease Progression|0|||
105732566|NCT00586690|364676138|FG000|Overall Study|Adverse Event|1|||
105797810|NCT01106352|364917593|FG004|Overall Study|Went on hospice|0|||
105797811|NCT01106352|364917589|FG000|Overall Study|Subject entered hospice|0|||
106009560|NCT02491684|365700875|FG000|Treatment Phase|Adverse Event|2|||
105797812|NCT01106352|364917590|FG001|Overall Study|Subject entered hospice|0|||
105797813|NCT01106352|364917591|FG002|Overall Study|Subject entered hospice|0|||
105797814|NCT01106352|364917592|FG003|Overall Study|Subject entered hospice|1|||
105797815|NCT01106352|364917593|FG004|Overall Study|Subject entered hospice|0|||
105797816|NCT01106352|364917589|FG000|Overall Study|Home hospice since July 2013|0|||
105797817|NCT01106352|364917590|FG001|Overall Study|Home hospice since July 2013|0|||
105797818|NCT01106352|364917591|FG002|Overall Study|Home hospice since July 2013|0|||
105797819|NCT01106352|364917592|FG003|Overall Study|Home hospice since July 2013|1|||
105797820|NCT01106352|364917593|FG004|Overall Study|Home hospice since July 2013|0|||
105797821|NCT03547531|364917594|FG000|Overall Study|not coming in data collection : sick|2|||
105797822|NCT03547531|364917595|FG001|Overall Study|not coming in data collection : sick|2|||
105797823|NCT03547531|364917594|FG000|Overall Study|having family occasion|0|||
105797824|NCT03547531|364917595|FG001|Overall Study|having family occasion|2|||
105797825|NCT02444182|364917603|FG000|Overall Study|non-compliance|2|||
105797826|NCT02444182|364917604|FG001|Overall Study|non-compliance|1|||
105797827|NCT02444182|364917603|FG000|Overall Study|Lost to Follow-up|0|||
105797828|NCT02444182|364917604|FG001|Overall Study|Lost to Follow-up|4|||
105797829|NCT01959230|364917605|FG000|Overall Study|Failure to follow study procedures|0|||
105797830|NCT01959230|364917606|FG001|Overall Study|Failure to follow study procedures|1|||
105797831|NCT01959230|364917605|FG000|Overall Study|Administrative reasons|2|||
105797832|NCT01959230|364917606|FG001|Overall Study|Administrative reasons|0|||
105797833|NCT01959230|364917605|FG000|Overall Study|Withdrawal by Subject|2|||
105797834|NCT01959230|364917606|FG001|Overall Study|Withdrawal by Subject|0|||
105797835|NCT01453374|364917609|FG000|Overall Study|Adverse Event|7|||
105797836|NCT01453374|364917609|FG000|Overall Study|Lack of Efficacy|1|||
105797837|NCT01453374|364917609|FG000|Overall Study|Lost to Follow-up|3|||
105797838|NCT01453374|364917609|FG000|Overall Study|Withdrawal by Subject|5|||
105797839|NCT01453374|364917609|FG000|Overall Study|Incarcerated|2|||
105797840|NCT00810615|364917611|FG000|Overall Study|Withdrawal by Subject|1|||
105797841|NCT00810615|364917612|FG001|Overall Study|Withdrawal by Subject|1|||
105797842|NCT02567266|364917613|FG000|Overall Study|Withdrawal by Subject|10|||
105797843|NCT02567266|364917614|FG001|Overall Study|Withdrawal by Subject|7|||
105797844|NCT02567266|364917615|FG002|Overall Study|Withdrawal by Subject|6|||
105797845|NCT02567266|364917613|FG000|Overall Study|Lost to Follow-up|13|||
105797846|NCT02567266|364917614|FG001|Overall Study|Lost to Follow-up|8|||
105797847|NCT02567266|364917615|FG002|Overall Study|Lost to Follow-up|10|||
105797848|NCT02643966|364917616|FG000|First Screening Round|ineligible|1|||
105797849|NCT02643966|364917616|FG000|First Screening Round|excluded from analysis|2|||
105797850|NCT02643966|364917616|FG000|First Screening Round|Lost to Follow-up|56|||
105797851|NCT02643966|364917616|FG000|First Screening Round|Withdrawal by Subject|28|||
105797852|NCT02643966|364917616|FG000|First Screening Round|Death|1|||
105797853|NCT02643966|364917616|FG000|Between First and Second Screening|Lost to Follow-up|65|||
105797854|NCT02643966|364917616|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
105797855|NCT02643966|364917616|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
105797856|NCT02643966|364917616|FG000|Second Screening Round|Withdrawal by Subject|20|||
105797857|NCT02643966|364917616|FG000|Second Screening Round|Lost to Follow-up|57|||
105797858|NCT02643966|364917616|FG000|Second Screening Round|Physician Decision|2|||
105797859|NCT02643966|364917616|FG000|Second Screening Round|Death|4|||
105797860|NCT02643966|364917616|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
105797861|NCT02643966|364917616|FG000|Between Second and Third Screening|Death|1|||
105797862|NCT02643966|364917616|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
105797863|NCT02643966|364917616|FG000|Third Screening Round|PI excluded|2|||
105797864|NCT02643966|364917616|FG000|Third Screening Round|Lost to Follow-up|241|||
105797865|NCT01946282|364917617|FG000|Year 1|Did not return FIT kit|4186|||
105797866|NCT01946282|364917618|FG001|Year 1|Did not return FIT kit|608|||
105797867|NCT01946282|364917619|FG002|Year 1|Did not return FIT kit|654|||
105797868|NCT01946282|364917617|FG000|Year 2|Did not return FIT kit|803|||
105797869|NCT01946282|364917618|FG001|Year 2|Did not return FIT kit|131|||
105797870|NCT01946282|364917619|FG002|Year 2|Did not return FIT kit|115|||
105797871|NCT01946282|364917617|FG000|Year 3|Did not return FIT kit|288|||
105797872|NCT01946282|364917618|FG001|Year 3|Did not return FIT kit|43|||
105797873|NCT01946282|364917619|FG002|Year 3|Did not return FIT kit|30|||
105797874|NCT03636542|364917620|FG000|Overall Study|Lost to Follow-up|1|||
105797875|NCT03636542|364917621|FG001|Overall Study|Lost to Follow-up|1|||
105797876|NCT03636542|364917620|FG000|Overall Study|Physician Decision|0|||
105797877|NCT03636542|364917621|FG001|Overall Study|Physician Decision|1|||
105797878|NCT03636542|364917620|FG000|Overall Study|Withdrawal by Subject|1|||
105797879|NCT03636542|364917621|FG001|Overall Study|Withdrawal by Subject|0|||
105797880|NCT00411762|364917624|FG000|Overall Study|Withdrawal by Subject|5|||
105937812|NCT03449147|365431582|FG000|52-week Treatment Period|Screen Failure|1|||
105797881|NCT01364298|364917625|FG000|Overall Study|Adverse Event|3|||
105797882|NCT01364298|364917626|FG001|Overall Study|Adverse Event|4|||
105797883|NCT01364298|364917625|FG000|Overall Study|Lack of adherence to treatment|1|||
105797884|NCT01364298|364917626|FG001|Overall Study|Lack of adherence to treatment|3|||
105797885|NCT01364298|364917625|FG000|Overall Study|Lack of Efficacy|1|||
106009561|NCT02491684|365700876|FG001|Treatment Phase|Adverse Event|2|||
106139595|NCT01194258|366168667|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
106139596|NCT01194258|366168668|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105732567|NCT00586690|364676139|FG001|Overall Study|Adverse Event|0|||
105732568|NCT00586690|364676138|FG000|Overall Study|Lack of Efficacy|2|||
105732569|NCT00586690|364676139|FG001|Overall Study|Lack of Efficacy|0|||
105732570|NCT00586690|364676138|FG000|Overall Study|Lab can't accommodate|1|||
105732571|NCT00586690|364676139|FG001|Overall Study|Lab can't accommodate|0|||
105732572|NCT02426086|364676142|FG000|Overall Study|Death|33|||
105732573|NCT02426086|364676143|FG001|Overall Study|Death|36|||
105732574|NCT02426086|364676142|FG000|Overall Study|Lost to Follow-up|2|||
105732575|NCT02426086|364676143|FG001|Overall Study|Lost to Follow-up|0|||
105732576|NCT02426086|364676142|FG000|Overall Study|Study Terminated by Sponsor|5|||
105732577|NCT02426086|364676143|FG001|Overall Study|Study Terminated by Sponsor|14|||
105732578|NCT02426086|364676142|FG000|Overall Study|Withdrawal by Subject|8|||
105732579|NCT02426086|364676143|FG001|Overall Study|Withdrawal by Subject|9|||
105732580|NCT00524303|364676144|FG000|Overall Study|Lost to Follow-up|6|||
105732581|NCT00524303|364676145|FG001|Overall Study|Lost to Follow-up|0|||
105732582|NCT00524303|364676146|FG002|Overall Study|Lost to Follow-up|3|||
105732583|NCT00524303|364676144|FG000|Overall Study|Protocol Violation|0|||
105732584|NCT00524303|364676145|FG001|Overall Study|Protocol Violation|1|||
105732585|NCT00524303|364676146|FG002|Overall Study|Protocol Violation|1|||
105732586|NCT00524303|364676144|FG000|Overall Study|Withdrawal by Subject|3|||
105732587|NCT00524303|364676145|FG001|Overall Study|Withdrawal by Subject|0|||
105732588|NCT00524303|364676146|FG002|Overall Study|Withdrawal by Subject|4|||
105732589|NCT00524303|364676144|FG000|Overall Study|Death|0|||
105732590|NCT00524303|364676145|FG001|Overall Study|Death|2|||
105732591|NCT00524303|364676146|FG002|Overall Study|Death|3|||
105732592|NCT00524303|364676144|FG000|Overall Study|Adverse Event|1|||
105732593|NCT00524303|364676145|FG001|Overall Study|Adverse Event|2|||
105732594|NCT00524303|364676146|FG002|Overall Study|Adverse Event|3|||
105732595|NCT00524303|364676144|FG000|Overall Study|Did not Complete Study Dosing|1|||
105732596|NCT00524303|364676145|FG001|Overall Study|Did not Complete Study Dosing|0|||
105732597|NCT00524303|364676146|FG002|Overall Study|Did not Complete Study Dosing|0|||
105732598|NCT00524303|364676144|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
105732599|NCT00524303|364676145|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
105732600|NCT00524303|364676146|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
105732601|NCT00524303|364676144|FG000|Overall Study|Disease Progression|0|||
105732602|NCT00524303|364676145|FG001|Overall Study|Disease Progression|4|||
105732603|NCT00524303|364676146|FG002|Overall Study|Disease Progression|1|||
105732604|NCT00524303|364676144|FG000|Overall Study|Disease Recurrence|0|||
105732605|NCT00524303|364676145|FG001|Overall Study|Disease Recurrence|1|||
105732606|NCT00524303|364676146|FG002|Overall Study|Disease Recurrence|0|||
105732607|NCT00524303|364676144|FG000|Overall Study|Sponsor Request|0|||
105732608|NCT00524303|364676145|FG001|Overall Study|Sponsor Request|0|||
105732609|NCT00524303|364676146|FG002|Overall Study|Sponsor Request|1|||
105732610|NCT00524303|364676144|FG000|Overall Study|Physician Decision|0|||
105732611|NCT00524303|364676145|FG001|Overall Study|Physician Decision|0|||
105732612|NCT00524303|364676146|FG002|Overall Study|Physician Decision|1|||
105732613|NCT00524303|364676144|FG000|Overall Study|Completed 5 years|0|||
105732614|NCT00524303|364676145|FG001|Overall Study|Completed 5 years|0|||
105732615|NCT00524303|364676146|FG002|Overall Study|Completed 5 years|1|||
105732616|NCT01739595|364676151|FG000|Overall Study|Adverse Event|3|||
105732617|NCT01739595|364676152|FG001|Overall Study|Adverse Event|0|||
105732618|NCT01739595|364676153|FG002|Overall Study|Adverse Event|0|||
105732619|NCT01739595|364676151|FG000|Overall Study|Lost to Follow-up|2|||
105732620|NCT01739595|364676152|FG001|Overall Study|Lost to Follow-up|0|||
105732621|NCT01739595|364676153|FG002|Overall Study|Lost to Follow-up|0|||
105732622|NCT01739595|364676151|FG000|Overall Study|Withdrawal by Subject|2|||
105732623|NCT01739595|364676152|FG001|Overall Study|Withdrawal by Subject|1|||
105732624|NCT01739595|364676153|FG002|Overall Study|Withdrawal by Subject|2|||
105732625|NCT01739595|364676151|FG000|Overall Study|Eligibility issue|3|||
105732626|NCT01739595|364676152|FG001|Overall Study|Eligibility issue|0|||
105732627|NCT01739595|364676153|FG002|Overall Study|Eligibility issue|0|||
105732628|NCT01739595|364676151|FG000|Overall Study|Protocol Violation|1|||
106139597|NCT01194258|366168669|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
106139598|NCT01194258|366168670|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105732629|NCT01739595|364676152|FG001|Overall Study|Protocol Violation|0|||
105732630|NCT01739595|364676153|FG002|Overall Study|Protocol Violation|0|||
105797886|NCT01364298|364917626|FG001|Overall Study|Lack of Efficacy|0|||
106139599|NCT01194258|366168671|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105732631|NCT01739595|364676151|FG000|Overall Study|Lab assessment|1|||
105732632|NCT01739595|364676152|FG001|Overall Study|Lab assessment|0|||
105732633|NCT01739595|364676153|FG002|Overall Study|Lab assessment|0|||
105732634|NCT01739595|364676151|FG000|Overall Study|Drug discrepancy|1|||
105732635|NCT01739595|364676152|FG001|Overall Study|Drug discrepancy|0|||
105732636|NCT01739595|364676153|FG002|Overall Study|Drug discrepancy|0|||
105732637|NCT03750838|364676162|FG000|Overall Study|Lost to Follow-up|10|||
105732638|NCT03750838|364676163|FG001|Overall Study|Lost to Follow-up|6|||
105732639|NCT00778999|364676165|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
105732640|NCT00778999|364676166|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
105732641|NCT00778999|364676165|FG000|Overall Study|Did not receive recFSH|14|||
105732642|NCT00778999|364676166|FG001|Overall Study|Did not receive recFSH|20|||
105732643|NCT02032875|364676167|FG000|Treatment Period|Adverse Event|1|||
105732644|NCT02032875|364676168|FG001|Treatment Period|Adverse Event|0|||
105732645|NCT02032875|364676167|FG000|Treatment Period|Liver transplant, No extension needed|0|||
105732646|NCT02032875|364676168|FG001|Treatment Period|Liver transplant, No extension needed|1|||
105732647|NCT02032875|364676167|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
105732648|NCT02032875|364676168|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
105732649|NCT02032875|364676167|FG000|Follow-up Period|Death|0|||
105732650|NCT02032875|364676168|FG001|Follow-up Period|Death|1|||
105732651|NCT02032875|364676167|FG000|Follow-up Period|Virologic Relapse|3|||
105732652|NCT02032875|364676168|FG001|Follow-up Period|Virologic Relapse|10|||
105732653|NCT01853228|364677745|FG000|Phase 1|Lack of Efficacy|8|||
105732654|NCT01853228|364677746|FG001|Phase 1|Lack of Efficacy|0|||
105732655|NCT01853228|364677745|FG000|Phase 1|Other|1|||
105732656|NCT01853228|364677746|FG001|Phase 1|Other|0|||
105732657|NCT01853228|364677745|FG000|Phase 2|Physician Decision|0|||
105732658|NCT01853228|364677746|FG001|Phase 2|Physician Decision|1|||
105732659|NCT01853228|364677745|FG000|Phase 2|Proceed To Transplant|0|||
105732660|NCT01853228|364677746|FG001|Phase 2|Proceed To Transplant|3|||
105732661|NCT01853228|364677745|FG000|Phase 2|Lack of Efficacy|0|||
105732662|NCT01853228|364677746|FG001|Phase 2|Lack of Efficacy|4|||
105732663|NCT03167619|364677748|FG000|Overall Study|Death|11|||
105732664|NCT03167619|364677749|FG001|Overall Study|Death|8|||
105732665|NCT03167619|364677748|FG000|Overall Study|Withdrawal by Subject|1|||
105732666|NCT03167619|364677749|FG001|Overall Study|Withdrawal by Subject|2|||
105732667|NCT03167619|364677748|FG000|Overall Study|Physician Decision|0|||
105732668|NCT03167619|364677749|FG001|Overall Study|Physician Decision|1|||
105732669|NCT01348919|364677752|FG000|Overall Study|Adverse Event|3|||
105732670|NCT01348919|364677753|FG001|Overall Study|Adverse Event|1|||
105732671|NCT01348919|364677754|FG002|Overall Study|Adverse Event|0|||
105732672|NCT01348919|364677752|FG000|Overall Study|Withdrawal by Subject|0|||
105732673|NCT01348919|364677753|FG001|Overall Study|Withdrawal by Subject|1|||
105732674|NCT01348919|364677754|FG002|Overall Study|Withdrawal by Subject|0|||
105732675|NCT01348919|364677752|FG000|Overall Study|Disease progression|0|||
105732676|NCT01348919|364677753|FG001|Overall Study|Disease progression|1|||
105732677|NCT01348919|364677754|FG002|Overall Study|Disease progression|1|||
105732678|NCT01123889|364677755|FG000|Overall Study|Lost to Follow-up|3|||
105732679|NCT01123889|364677756|FG001|Overall Study|Lost to Follow-up|1|||
105732680|NCT02638012|364677761|FG000|Overall Study|Lost to Follow-up|1|||
105732681|NCT03846947|364677762|FG000|Overall Study|technical issues with imaging sequence|2|||
105732682|NCT00174941|364677764|FG000|Overall Study|Adverse Event|1|||
105732683|NCT00174941|364677765|FG001|Overall Study|Adverse Event|10|||
105732684|NCT00174941|364677766|FG002|Overall Study|Adverse Event|2|||
105732685|NCT00174941|364677767|FG003|Overall Study|Adverse Event|13|||
105732686|NCT00174941|364677764|FG000|Overall Study|Protocol Violation|0|||
105732687|NCT00174941|364677765|FG001|Overall Study|Protocol Violation|1|||
105732688|NCT00174941|364677766|FG002|Overall Study|Protocol Violation|0|||
105732689|NCT00174941|364677767|FG003|Overall Study|Protocol Violation|1|||
105732690|NCT00174941|364677764|FG000|Overall Study|Lost to Follow-up|0|||
105732691|NCT00174941|364677765|FG001|Overall Study|Lost to Follow-up|3|||
105732692|NCT00174941|364677766|FG002|Overall Study|Lost to Follow-up|2|||
105732693|NCT00174941|364677767|FG003|Overall Study|Lost to Follow-up|5|||
105732694|NCT00174941|364677764|FG000|Overall Study|Personal Reason(s)|0|||
105732695|NCT00174941|364677765|FG001|Overall Study|Personal Reason(s)|14|||
105732696|NCT00174941|364677766|FG002|Overall Study|Personal Reason(s)|8|||
105732697|NCT00174941|364677767|FG003|Overall Study|Personal Reason(s)|22|||
105732698|NCT00174941|364677764|FG000|Overall Study|Gout Flare|0|||
105732699|NCT00174941|364677765|FG001|Overall Study|Gout Flare|4|||
105732700|NCT00174941|364677766|FG002|Overall Study|Gout Flare|4|||
105732701|NCT00174941|364677767|FG003|Overall Study|Gout Flare|8|||
105732702|NCT00174941|364677764|FG000|Overall Study|Reason Not Specified|1|||
105732703|NCT00174941|364677765|FG001|Overall Study|Reason Not Specified|6|||
105732704|NCT00174941|364677766|FG002|Overall Study|Reason Not Specified|2|||
105797887|NCT01364298|364917625|FG000|Overall Study|Lost to Follow-up|5|||
105732705|NCT00174941|364677767|FG003|Overall Study|Reason Not Specified|9|||
105732706|NCT03126227|364677768|FG000|Overall Study|Adverse Event|43|||
105732707|NCT03126227|364677769|FG001|Overall Study|Adverse Event|4|||
105732708|NCT03126227|364677768|FG000|Overall Study|Death|0|||
105732709|NCT03126227|364677769|FG001|Overall Study|Death|1|||
105732710|NCT03126227|364677768|FG000|Overall Study|Lost to Follow-up|0|||
105732711|NCT03126227|364677769|FG001|Overall Study|Lost to Follow-up|1|||
105732712|NCT03126227|364677768|FG000|Overall Study|Physician Decision|2|||
105732713|NCT03126227|364677769|FG001|Overall Study|Physician Decision|0|||
105732714|NCT03126227|364677768|FG000|Overall Study|Protocol Violation|1|||
105732715|NCT03126227|364677769|FG001|Overall Study|Protocol Violation|0|||
105732716|NCT03126227|364677768|FG000|Overall Study|Withdrawal by Subject|19|||
105732717|NCT03126227|364677769|FG001|Overall Study|Withdrawal by Subject|3|||
105732718|NCT03126227|364677768|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
105732719|NCT03126227|364677769|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
105732720|NCT03126227|364677768|FG000|Overall Study|Lack of dosing compliance|2|||
105732721|NCT03126227|364677769|FG001|Overall Study|Lack of dosing compliance|0|||
105732722|NCT03126227|364677768|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
105732723|NCT03126227|364677769|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
105732724|NCT03126227|364677768|FG000|Overall Study|Scheduling conflict|1|||
105732725|NCT03126227|364677769|FG001|Overall Study|Scheduling conflict|0|||
105732726|NCT00947154|364677776|FG000|Overall Study|Lost to Follow-up|1|||
105732727|NCT01121406|364677781|FG000|Overall Study|Progressive disease RECIST|44|||
105732728|NCT01121406|364677782|FG001|Overall Study|Progressive disease RECIST|28|||
105732729|NCT01121406|364677781|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
105732730|NCT01121406|364677782|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
105732731|NCT01121406|364677781|FG000|Overall Study|Other AE|3|||
105732732|NCT01121406|364677782|FG001|Overall Study|Other AE|10|||
105732733|NCT01121406|364677781|FG000|Overall Study|Non-compliant with protocol|0|||
105732734|NCT01121406|364677782|FG001|Overall Study|Non-compliant with protocol|2|||
105732735|NCT01121406|364677781|FG000|Overall Study|Lost to Follow-up|0|||
105732736|NCT01121406|364677782|FG001|Overall Study|Lost to Follow-up|1|||
105732737|NCT01121406|364677781|FG000|Overall Study|Refused continuation of study med.|1|||
105732738|NCT01121406|364677782|FG001|Overall Study|Refused continuation of study med.|2|||
105732739|NCT01121406|364677781|FG000|Overall Study|Reason other than specified above|2|||
105732740|NCT01121406|364677782|FG001|Overall Study|Reason other than specified above|6|||
105732741|NCT01121406|364677781|FG000|Overall Study|Not treated|1|||
105732742|NCT01121406|364677782|FG001|Overall Study|Not treated|0|||
105732743|NCT00592683|364677790|FG000|Overall Study|Found ineligible|0|||
105732744|NCT00592683|364677791|FG001|Overall Study|Found ineligible|1|||
105732745|NCT00592683|364677790|FG000|Overall Study|Withdrawal by Subject|1|||
105732746|NCT00592683|364677791|FG001|Overall Study|Withdrawal by Subject|0|||
105732747|NCT00592683|364677790|FG000|Overall Study|Adverse Event|0|||
105732748|NCT00592683|364677791|FG001|Overall Study|Adverse Event|2|||
105732749|NCT00592683|364677790|FG000|Overall Study|Protocol Violation|1|||
105732750|NCT00592683|364677791|FG001|Overall Study|Protocol Violation|0|||
105732751|NCT00592683|364677790|FG000|Overall Study|Study drug expired|1|||
105732752|NCT00592683|364677791|FG001|Overall Study|Study drug expired|0|||
105732753|NCT00592683|364677790|FG000|Overall Study|Other|1|||
105732754|NCT00592683|364677791|FG001|Overall Study|Other|0|||
105732755|NCT00592683|364677790|FG000|Overall Study|Lost to Follow-up|0|||
105732756|NCT00592683|364677791|FG001|Overall Study|Lost to Follow-up|1|||
105732757|NCT05309083|364677792|FG000|Overall Study|Withdrawal by Subject|2|||
105732758|NCT00479466|364677794|FG000|Overall Study|Adverse Event|5|||
105732759|NCT00479466|364677795|FG001|Overall Study|Adverse Event|1|||
105732760|NCT00479466|364677796|FG002|Overall Study|Adverse Event|0|||
105732761|NCT00479466|364677797|FG003|Overall Study|Adverse Event|1|||
105732762|NCT00479466|364677798|FG004|Overall Study|Adverse Event|2|||
105732763|NCT00479466|364677799|FG005|Overall Study|Adverse Event|0|||
105732764|NCT00479466|364677794|FG000|Overall Study|Hyperglycemia|0|||
105732765|NCT00479466|364677795|FG001|Overall Study|Hyperglycemia|0|||
105732766|NCT00479466|364677796|FG002|Overall Study|Hyperglycemia|0|||
105732767|NCT00479466|364677797|FG003|Overall Study|Hyperglycemia|0|||
105732768|NCT00479466|364677798|FG004|Overall Study|Hyperglycemia|0|||
105732769|NCT00479466|364677799|FG005|Overall Study|Hyperglycemia|1|||
105732770|NCT00479466|364677794|FG000|Overall Study|Lack of Efficacy|2|||
105732771|NCT00479466|364677795|FG001|Overall Study|Lack of Efficacy|0|||
105732772|NCT00479466|364677796|FG002|Overall Study|Lack of Efficacy|1|||
105732773|NCT00479466|364677797|FG003|Overall Study|Lack of Efficacy|0|||
105732774|NCT00479466|364677798|FG004|Overall Study|Lack of Efficacy|0|||
105732775|NCT00479466|364677799|FG005|Overall Study|Lack of Efficacy|0|||
105732776|NCT00479466|364677794|FG000|Overall Study|Lost to Follow-up|0|||
105732777|NCT00479466|364677795|FG001|Overall Study|Lost to Follow-up|1|||
105732778|NCT00479466|364677796|FG002|Overall Study|Lost to Follow-up|1|||
105732779|NCT00479466|364677797|FG003|Overall Study|Lost to Follow-up|0|||
105732780|NCT00479466|364677798|FG004|Overall Study|Lost to Follow-up|2|||
105732781|NCT00479466|364677799|FG005|Overall Study|Lost to Follow-up|2|||
105732782|NCT00479466|364677794|FG000|Overall Study|Physician Decision|2|||
105732783|NCT00479466|364677795|FG001|Overall Study|Physician Decision|1|||
105732784|NCT00479466|364677796|FG002|Overall Study|Physician Decision|1|||
105732785|NCT00479466|364677797|FG003|Overall Study|Physician Decision|0|||
105732786|NCT00479466|364677798|FG004|Overall Study|Physician Decision|0|||
105732787|NCT00479466|364677799|FG005|Overall Study|Physician Decision|0|||
105732788|NCT00479466|364677794|FG000|Overall Study|Pregnancy|0|||
105732789|NCT00479466|364677795|FG001|Overall Study|Pregnancy|0|||
105732790|NCT00479466|364677796|FG002|Overall Study|Pregnancy|0|||
105732791|NCT00479466|364677797|FG003|Overall Study|Pregnancy|0|||
105732792|NCT00479466|364677798|FG004|Overall Study|Pregnancy|1|||
106009562|NCT02491684|365700875|FG000|Treatment Phase|Incorrect randomisation|1|||
105732793|NCT00479466|364677799|FG005|Overall Study|Pregnancy|0|||
105732794|NCT00479466|364677794|FG000|Overall Study|Protocol Violation|1|||
105732795|NCT00479466|364677795|FG001|Overall Study|Protocol Violation|0|||
105732796|NCT00479466|364677796|FG002|Overall Study|Protocol Violation|0|||
105732797|NCT00479466|364677797|FG003|Overall Study|Protocol Violation|0|||
105732798|NCT00479466|364677798|FG004|Overall Study|Protocol Violation|0|||
105732799|NCT00479466|364677799|FG005|Overall Study|Protocol Violation|0|||
105732800|NCT00479466|364677794|FG000|Overall Study|Withdrawal by Subject|3|||
105732801|NCT00479466|364677795|FG001|Overall Study|Withdrawal by Subject|5|||
105732802|NCT00479466|364677796|FG002|Overall Study|Withdrawal by Subject|0|||
105732803|NCT00479466|364677797|FG003|Overall Study|Withdrawal by Subject|2|||
105732804|NCT00479466|364677798|FG004|Overall Study|Withdrawal by Subject|3|||
105732805|NCT00479466|364677799|FG005|Overall Study|Withdrawal by Subject|1|||
105732806|NCT04283461|364677800|FG000|Overall Study|Enrolled in separate trial|0|||
105732807|NCT04283461|364677801|FG001|Overall Study|Enrolled in separate trial|0|||
105732808|NCT04283461|364677802|FG002|Overall Study|Enrolled in separate trial|8|||
105732809|NCT04283461|364677803|FG003|Overall Study|Enrolled in separate trial|13|||
105732810|NCT04283461|364677804|FG004|Overall Study|Enrolled in separate trial|12|||
105732811|NCT04283461|364677805|FG005|Overall Study|Enrolled in separate trial|0|||
105732812|NCT04283461|364677806|FG006|Overall Study|Enrolled in separate trial|0|||
105732813|NCT04283461|364677807|FG007|Overall Study|Enrolled in separate trial|8|||
105732814|NCT04283461|364677808|FG008|Overall Study|Enrolled in separate trial|0|||
105732815|NCT04283461|364677809|FG009|Overall Study|Enrolled in separate trial|0|||
105732816|NCT04283461|364677810|FG010|Overall Study|Enrolled in separate trial|0|||
105732817|NCT04283461|364677811|FG011|Overall Study|Enrolled in separate trial|7|||
105732818|NCT04283461|364677812|FG012|Overall Study|Enrolled in separate trial|0|||
105732819|NCT02299934|364677813|FG000|Overall Study|Termination of study|13|||
105732820|NCT04651777|364677814|FG000|Overall Study|Adverse Event|1|||
105732821|NCT04651777|364677814|FG000|Overall Study|Withdrawal by Subject|2|||
105732822|NCT00519623|364677815|FG000|Overall Study|Adverse Event|1|||
105732823|NCT00184054|364677816|FG000|Overall Study|Adverse Event|1|||
105732824|NCT04925570|364677817|FG000|Overall Study|Protocol Violation|24|||
105732825|NCT04925570|364677818|FG001|Overall Study|Protocol Violation|30|||
105732826|NCT04925570|364677817|FG000|Overall Study|Withdrawal by Subject|0|||
105732827|NCT04925570|364677818|FG001|Overall Study|Withdrawal by Subject|2|||
105732828|NCT00144300|364677821|FG000|Overall Study|Adverse Event|18|||
105732829|NCT00144300|364677822|FG001|Overall Study|Adverse Event|16|||
105732830|NCT00144300|364677821|FG000|Overall Study|Protocol Violation|1|||
105732831|NCT00144300|364677822|FG001|Overall Study|Protocol Violation|3|||
105732832|NCT00144300|364677821|FG000|Overall Study|Lost to Follow-up|3|||
105732833|NCT00144300|364677822|FG001|Overall Study|Lost to Follow-up|0|||
105732834|NCT00144300|364677821|FG000|Overall Study|Withdrawal by Subject|6|||
105732835|NCT00144300|364677822|FG001|Overall Study|Withdrawal by Subject|6|||
105732836|NCT00144300|364677821|FG000|Overall Study|Other reason (not specified)|1|||
105732837|NCT00144300|364677822|FG001|Overall Study|Other reason (not specified)|3|||
105732838|NCT03478683|364677825|FG000|Overall Study|Adverse Event|5|||
105732839|NCT03478683|364677826|FG001|Overall Study|Adverse Event|3|||
105732840|NCT03478683|364677825|FG000|Overall Study|Lost to Follow-up|0|||
105732841|NCT03478683|364677826|FG001|Overall Study|Lost to Follow-up|5|||
105732842|NCT03478683|364677825|FG000|Overall Study|Physician Decision|1|||
105732843|NCT03478683|364677826|FG001|Overall Study|Physician Decision|3|||
105732844|NCT03478683|364677825|FG000|Overall Study|Withdrawal by Subject|7|||
105732845|NCT03478683|364677826|FG001|Overall Study|Withdrawal by Subject|7|||
105732846|NCT01607892|364677829|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
105732847|NCT01607892|364677830|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
105732848|NCT01607892|364677831|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
105732849|NCT01607892|364677832|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
105732850|NCT01607892|364677833|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
105732851|NCT01607892|364677829|FG000|Overall Study|Death|4|||
105732852|NCT01607892|364677830|FG001|Overall Study|Death|2|||
105732853|NCT01607892|364677831|FG002|Overall Study|Death|8|||
105732854|NCT01607892|364677832|FG003|Overall Study|Death|10|||
105732855|NCT01607892|364677833|FG004|Overall Study|Death|3|||
105732856|NCT01607892|364677829|FG000|Overall Study|Investigator discretion|2|||
105732857|NCT01607892|364677830|FG001|Overall Study|Investigator discretion|4|||
105732858|NCT01607892|364677831|FG002|Overall Study|Investigator discretion|4|||
105732859|NCT01607892|364677832|FG003|Overall Study|Investigator discretion|8|||
105732860|NCT01607892|364677833|FG004|Overall Study|Investigator discretion|0|||
105732861|NCT01607892|364677829|FG000|Overall Study|Other treatments became available|1|||
105732862|NCT01607892|364677830|FG001|Overall Study|Other treatments became available|1|||
105732863|NCT01607892|364677831|FG002|Overall Study|Other treatments became available|0|||
105732864|NCT01607892|364677832|FG003|Overall Study|Other treatments became available|0|||
105732865|NCT01607892|364677833|FG004|Overall Study|Other treatments became available|2|||
105732866|NCT01607892|364677829|FG000|Overall Study|Intercurrent illness|1|||
105732867|NCT01607892|364677830|FG001|Overall Study|Intercurrent illness|0|||
106139600|NCT04246762|366168672|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
106139601|NCT03247543|366168673|FG000|Overall Study|Adverse Event|3|||
106139602|NCT03247543|366168674|FG001|Overall Study|Adverse Event|6|||
106139603|NCT03247543|366168675|FG002|Overall Study|Adverse Event|4|||
106139604|NCT03247543|366168673|FG000|Overall Study|Lost to Follow-up|10|||
106139605|NCT03247543|366168674|FG001|Overall Study|Lost to Follow-up|7|||
106139606|NCT03247543|366168675|FG002|Overall Study|Lost to Follow-up|8|||
106139607|NCT03247543|366168673|FG000|Overall Study|Consent withdrawn by caregiver|2|||
106139608|NCT03247543|366168674|FG001|Overall Study|Consent withdrawn by caregiver|2|||
106139609|NCT03247543|366168675|FG002|Overall Study|Consent withdrawn by caregiver|9|||
106139610|NCT03247543|366168673|FG000|Overall Study|Withdrawal by Subject|0|||
106139611|NCT03247543|366168674|FG001|Overall Study|Withdrawal by Subject|0|||
106139612|NCT03247543|366168675|FG002|Overall Study|Withdrawal by Subject|1|||
106139613|NCT03247543|366168673|FG000|Overall Study|Failure to Follow study procedures|1|||
106139614|NCT03247543|366168674|FG001|Overall Study|Failure to Follow study procedures|3|||
106139615|NCT03247543|366168675|FG002|Overall Study|Failure to Follow study procedures|1|||
106139616|NCT03247543|366168673|FG000|Overall Study|Lack of Efficacy|1|||
105937813|NCT03449147|365431583|FG001|52-week Treatment Period|Screen Failure|2|||
105937814|NCT03449147|365431584|FG002|52-week Treatment Period|Screen Failure|0|||
106139617|NCT03247543|366168674|FG001|Overall Study|Lack of Efficacy|0|||
106139618|NCT03247543|366168675|FG002|Overall Study|Lack of Efficacy|0|||
106139619|NCT03247543|366168673|FG000|Overall Study|Non-compliance with study visits|0|||
106139620|NCT03247543|366168674|FG001|Overall Study|Non-compliance with study visits|1|||
106139621|NCT03247543|366168675|FG002|Overall Study|Non-compliance with study visits|0|||
105732868|NCT01607892|364677831|FG002|Overall Study|Intercurrent illness|0|||
105937815|NCT03449147|365431582|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
105937816|NCT03449147|365431583|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
105937817|NCT03449147|365431584|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
105937818|NCT03449147|365431582|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
105937819|NCT03449147|365431583|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
105937820|NCT03449147|365431584|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
105937821|NCT03449147|365431582|FG000|12-Week Off-Treatment Durability Period|Other|0|||
105937822|NCT03449147|365431583|FG001|12-Week Off-Treatment Durability Period|Other|1|||
105937823|NCT03449147|365431584|FG002|12-Week Off-Treatment Durability Period|Other|0|||
105937824|NCT02037984|365431585|FG000|Overall Study|Lack of Efficacy|0|||
105937825|NCT02037984|365431586|FG001|Overall Study|Lack of Efficacy|0|||
106139622|NCT01321606|366168678|FG000|Overall Study|Lost to Follow-up|0|||
106139623|NCT01321606|366168679|FG001|Overall Study|Lost to Follow-up|0|||
106139624|NCT01321606|366168680|FG002|Overall Study|Lost to Follow-up|0|||
106139625|NCT01321606|366168681|FG003|Overall Study|Lost to Follow-up|1|||
105732869|NCT01607892|364677832|FG003|Overall Study|Intercurrent illness|3|||
105732870|NCT01607892|364677833|FG004|Overall Study|Intercurrent illness|0|||
105732871|NCT01607892|364677829|FG000|Overall Study|Non-Compliance with study procedures|0|||
105732872|NCT01607892|364677830|FG001|Overall Study|Non-Compliance with study procedures|0|||
105732873|NCT01607892|364677831|FG002|Overall Study|Non-Compliance with study procedures|1|||
105732874|NCT01607892|364677832|FG003|Overall Study|Non-Compliance with study procedures|0|||
105732875|NCT01607892|364677833|FG004|Overall Study|Non-Compliance with study procedures|0|||
105732876|NCT01607892|364677829|FG000|Overall Study|Consent withdrawn by participant|9|||
105732877|NCT01607892|364677830|FG001|Overall Study|Consent withdrawn by participant|4|||
105732878|NCT01607892|364677831|FG002|Overall Study|Consent withdrawn by participant|24|||
105732879|NCT01607892|364677832|FG003|Overall Study|Consent withdrawn by participant|14|||
105732880|NCT01607892|364677833|FG004|Overall Study|Consent withdrawn by participant|4|||
105732881|NCT01607892|364677829|FG000|Overall Study|Disease progression|38|||
105732882|NCT01607892|364677830|FG001|Overall Study|Disease progression|13|||
105732883|NCT01607892|364677831|FG002|Overall Study|Disease progression|37|||
105732884|NCT01607892|364677832|FG003|Overall Study|Disease progression|57|||
105732885|NCT01607892|364677833|FG004|Overall Study|Disease progression|9|||
105732886|NCT01607892|364677829|FG000|Overall Study|Incidence or severity of Adverse events|3|||
105732887|NCT01607892|364677830|FG001|Overall Study|Incidence or severity of Adverse events|3|||
105732888|NCT01607892|364677831|FG002|Overall Study|Incidence or severity of Adverse events|7|||
105732889|NCT01607892|364677832|FG003|Overall Study|Incidence or severity of Adverse events|2|||
105732890|NCT01607892|364677833|FG004|Overall Study|Incidence or severity of Adverse events|6|||
105732891|NCT01887210|364677834|FG000|Overall Study|Withdrawal by Subject|1|||
105732892|NCT01887210|364677835|FG001|Overall Study|Withdrawal by Subject|3|||
105732893|NCT01887210|364677834|FG000|Overall Study|Lost to Follow-up|0|||
105732894|NCT01887210|364677835|FG001|Overall Study|Lost to Follow-up|1|||
106139626|NCT03310983|366168684|FG000|Overall Study|Lost to Follow-up|15|||
105732895|NCT00840463|364677839|FG000|Overall Study|Adverse Event|1|||
105937826|NCT02037984|365431587|FG002|Overall Study|Lack of Efficacy|3|||
105937827|NCT02037984|365431588|FG003|Overall Study|Lack of Efficacy|10|||
105937828|NCT02037984|365431589|FG004|Overall Study|Lack of Efficacy|2|||
106139627|NCT03310983|366168685|FG001|Overall Study|Lost to Follow-up|17|||
106139628|NCT04536077|366168686|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
105732896|NCT00840463|364677840|FG001|Overall Study|Adverse Event|0|||
105732897|NCT03414359|364677841|FG000|Overall Study|Lack of Efficacy|1|||
105732898|NCT03414359|364677842|FG001|Overall Study|Lack of Efficacy|1|||
105732899|NCT03414359|364677841|FG000|Overall Study|Protocol Violation|0|||
105732900|NCT03414359|364677842|FG001|Overall Study|Protocol Violation|1|||
105732901|NCT02273973|364677843|FG000|Overall Study|Adverse Event|4|||
105732902|NCT02273973|364677844|FG001|Overall Study|Adverse Event|0|||
105732903|NCT02273973|364677843|FG000|Overall Study|Withdrawal by Subject|2|||
105732904|NCT02273973|364677844|FG001|Overall Study|Withdrawal by Subject|3|||
105732905|NCT02273973|364677843|FG000|Overall Study|Death|1|||
105732906|NCT02273973|364677844|FG001|Overall Study|Death|0|||
105732907|NCT02273973|364677843|FG000|Overall Study|Non-compliance|1|||
105732908|NCT02273973|364677844|FG001|Overall Study|Non-compliance|0|||
105732909|NCT02273973|364677843|FG000|Overall Study|Protocol Violation|1|||
105732910|NCT02273973|364677844|FG001|Overall Study|Protocol Violation|0|||
105732911|NCT02273973|364677843|FG000|Overall Study|Progression of disease|0|||
105732912|NCT02273973|364677844|FG001|Overall Study|Progression of disease|2|||
105732913|NCT02273973|364677843|FG000|Overall Study|Lost to Follow-up|0|||
105732914|NCT02273973|364677844|FG001|Overall Study|Lost to Follow-up|1|||
105732915|NCT02273973|364677843|FG000|Overall Study|Physician Decision|0|||
105732916|NCT02273973|364677844|FG001|Overall Study|Physician Decision|1|||
105732917|NCT02273973|364677843|FG000|Overall Study|Reason not specified|0|||
105732918|NCT02273973|364677844|FG001|Overall Study|Reason not specified|1|||
105732919|NCT02704429|364677847|FG000|Part A: 24 Weeks|Adverse Event|3|||
105732920|NCT02704429|364677848|FG001|Part A: 24 Weeks|Adverse Event|0|||
105732921|NCT02704429|364677847|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
105732922|NCT02704429|364677848|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
105732923|NCT01287117|364677852|FG000|Overall Study|Adverse Event|2|||
105732924|NCT01287117|364677853|FG001|Overall Study|Adverse Event|1|||
105732925|NCT01287117|364677854|FG002|Overall Study|Adverse Event|1|||
105732926|NCT01287117|364677855|FG003|Overall Study|Adverse Event|1|||
105732927|NCT01287117|364677852|FG000|Overall Study|Lost to Follow-up|1|||
105732928|NCT01287117|364677853|FG001|Overall Study|Lost to Follow-up|1|||
105732929|NCT01287117|364677854|FG002|Overall Study|Lost to Follow-up|0|||
105732930|NCT01287117|364677855|FG003|Overall Study|Lost to Follow-up|0|||
105732931|NCT01287117|364677852|FG000|Overall Study|Physician Decision|0|||
105732932|NCT01287117|364677853|FG001|Overall Study|Physician Decision|1|||
105732933|NCT01287117|364677854|FG002|Overall Study|Physician Decision|1|||
105732934|NCT01287117|364677855|FG003|Overall Study|Physician Decision|1|||
105732935|NCT01287117|364677852|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
105732936|NCT01287117|364677853|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
105732937|NCT01287117|364677854|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
105732938|NCT01287117|364677855|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
105732939|NCT01287117|364677852|FG000|Overall Study|Disease Progression|10|||
105732940|NCT01287117|364677853|FG001|Overall Study|Disease Progression|5|||
105732941|NCT01287117|364677854|FG002|Overall Study|Disease Progression|6|||
105732942|NCT01287117|364677855|FG003|Overall Study|Disease Progression|5|||
105732943|NCT02032524|364677858|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
105732944|NCT02032524|364677859|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
105732945|NCT02032524|364677860|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
105732946|NCT02032524|364677861|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
105732947|NCT02032524|364677862|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
105732948|NCT02032524|364677863|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
105732949|NCT02032524|364677858|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
105732950|NCT02032524|364677859|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
105732951|NCT02032524|364677860|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
105732952|NCT02032524|364677861|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
105732953|NCT02032524|364677862|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
105732954|NCT02032524|364677863|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
105732955|NCT02032524|364677858|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
105732956|NCT02032524|364677859|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
105732957|NCT02032524|364677860|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
105732958|NCT02032524|364677861|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
105732959|NCT02032524|364677862|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
105732960|NCT02032524|364677863|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
105732961|NCT02032524|364677858|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
105732962|NCT02032524|364677859|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
105732963|NCT02032524|364677860|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
105732964|NCT02032524|364677861|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
105732965|NCT02032524|364677862|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
105732966|NCT02032524|364677863|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
105732967|NCT02032524|364677858|FG000|Period 2: LTS13769 Study|Other|0|||
105732968|NCT02032524|364677859|FG001|Period 2: LTS13769 Study|Other|0|||
105732969|NCT02032524|364677860|FG002|Period 2: LTS13769 Study|Other|0|||
105732970|NCT02032524|364677861|FG003|Period 2: LTS13769 Study|Other|0|||
105732971|NCT02032524|364677862|FG004|Period 2: LTS13769 Study|Other|0|||
105732972|NCT02032524|364677863|FG005|Period 2: LTS13769 Study|Other|1|||
105797888|NCT01364298|364917626|FG001|Overall Study|Lost to Follow-up|10|||
105797889|NCT01364298|364917625|FG000|Overall Study|Withdrawal by Subject|3|||
105797890|NCT01364298|364917626|FG001|Overall Study|Withdrawal by Subject|3|||
105797891|NCT01364298|364917625|FG000|Overall Study|Other|1|||
105797892|NCT01364298|364917626|FG001|Overall Study|Other|3|||
105797893|NCT00420849|364917627|FG000|Overall Study|Lack of Efficacy|154|||
106139629|NCT04536077|366168687|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
106139630|NCT04536077|366168686|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
106139631|NCT04536077|366168687|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
106139632|NCT03586544|366168688|FG000|First Intervention|Adverse Event|0|||
106139633|NCT03586544|366168689|FG001|First Intervention|Adverse Event|1|||
106139634|NCT03586544|366168688|FG000|Second Intervention|Withdrawal by Subject|0|||
106139635|NCT03586544|366168689|FG001|Second Intervention|Withdrawal by Subject|1|||
105732973|NCT00907738|364677871|FG000|Overall Study|Adverse Event|2|||
105732974|NCT00907738|364677872|FG001|Overall Study|Adverse Event|0|||
105732975|NCT00907738|364677873|FG002|Overall Study|Adverse Event|1|||
105732976|NCT00907738|364677874|FG003|Overall Study|Adverse Event|0|||
105732977|NCT00907738|364677875|FG004|Overall Study|Adverse Event|0|||
105732978|NCT00907738|364677871|FG000|Overall Study|not specified or withdrew consent|3|||
105732979|NCT00907738|364677872|FG001|Overall Study|not specified or withdrew consent|0|||
105732980|NCT00907738|364677873|FG002|Overall Study|not specified or withdrew consent|0|||
105732981|NCT00907738|364677874|FG003|Overall Study|not specified or withdrew consent|0|||
105732982|NCT00907738|364677875|FG004|Overall Study|not specified or withdrew consent|0|||
105732983|NCT00907738|364677871|FG000|Overall Study|Disease progression|8|||
105732984|NCT00907738|364677872|FG001|Overall Study|Disease progression|1|||
105732985|NCT00907738|364677873|FG002|Overall Study|Disease progression|6|||
105732986|NCT00907738|364677874|FG003|Overall Study|Disease progression|4|||
105732987|NCT00907738|364677875|FG004|Overall Study|Disease progression|2|||
105732988|NCT02031146|364679274|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
105732989|NCT02031146|364679275|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
105732990|NCT02031146|364679276|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
105732991|NCT02031146|364679277|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
105732992|NCT02031146|364679278|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
105732993|NCT02031146|364679279|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
105732994|NCT02031146|364679280|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
105732995|NCT01518699|364679281|FG000|Period 2|Protocol Violation|1|||
105732996|NCT01518699|364679282|FG001|Period 2|Protocol Violation|1|||
105732997|NCT01518699|364679283|FG002|Period 2|Protocol Violation|0|||
105732998|NCT01518699|364679284|FG003|Period 2|Protocol Violation|0|||
105732999|NCT01518699|364679285|FG004|Period 2|Protocol Violation|0|||
105733000|NCT01518699|364679286|FG005|Period 2|Protocol Violation|0|||
105733001|NCT01518699|364679281|FG000|Period 2|Lost to Follow-up|0|||
105733002|NCT01518699|364679282|FG001|Period 2|Lost to Follow-up|1|||
105733003|NCT01518699|364679283|FG002|Period 2|Lost to Follow-up|0|||
105733004|NCT01518699|364679284|FG003|Period 2|Lost to Follow-up|0|||
105733005|NCT01518699|364679285|FG004|Period 2|Lost to Follow-up|0|||
105733006|NCT01518699|364679286|FG005|Period 2|Lost to Follow-up|0|||
105733007|NCT01518699|364679281|FG000|Period 2|Adverse Event|1|||
105733008|NCT01518699|364679282|FG001|Period 2|Adverse Event|0|||
105733009|NCT01518699|364679283|FG002|Period 2|Adverse Event|0|||
105733010|NCT01518699|364679284|FG003|Period 2|Adverse Event|0|||
105733011|NCT01518699|364679285|FG004|Period 2|Adverse Event|0|||
105733012|NCT01518699|364679286|FG005|Period 2|Adverse Event|0|||
105733013|NCT00443560|364679288|FG000|Overall Study|No intrathecal dose|58|||
105733014|NCT00443560|364679289|FG001|Overall Study|No intrathecal dose|26|||
105733015|NCT00443560|364679288|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
105733016|NCT00443560|364679289|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
105733017|NCT01943539|364679290|FG000|Overall Study|Non-compliance with at-home intervention|4|||
105733018|NCT01943539|364679291|FG001|Overall Study|Non-compliance with at-home intervention|0|||
105733019|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
105733020|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105733021|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105733022|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105733023|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
105733024|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
105733025|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
105733026|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
105733027|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
105733028|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
105797894|NCT00420849|364917627|FG000|Overall Study|Adverse Event|107|||
105797895|NCT00420849|364917627|FG000|Overall Study|Withdrawal by Subject|28|||
105733029|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
105733030|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105733031|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105733032|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105733033|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
105733034|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
105733035|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
105733036|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
105733037|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
105733038|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
105733039|NCT01009463|364679294|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
105733040|NCT01009463|364679295|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105733041|NCT01009463|364679296|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105733042|NCT01009463|364679297|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105733043|NCT01009463|364679298|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
105733044|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
105733045|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
105733046|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
105733047|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
105733048|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
105733049|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105733050|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
105733051|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
105733052|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
105733053|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
105733054|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
105733055|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
105733056|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
105733057|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
105733058|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
105733059|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
105733060|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
105733061|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
105733062|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
105733063|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
105733064|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105733065|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
105733066|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
105733067|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
105733068|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
105733069|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105733070|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
105733071|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105733072|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
105733073|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
105733074|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105733075|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
105733076|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
105733077|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
105733078|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
105733079|NCT01009463|364679294|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
105733080|NCT01009463|364679295|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
105733081|NCT01009463|364679296|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
105733082|NCT01009463|364679297|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
105733083|NCT01009463|364679298|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
105733084|NCT01966731|364679313|FG000|Overall Study|Death|2|||
105733085|NCT01966731|364679313|FG000|Overall Study|Lost to Follow-up|1|||
105733086|NCT01966731|364679313|FG000|Overall Study|Physician Decision|2|||
105733087|NCT01966731|364679313|FG000|Overall Study|Follow up is not complete|600|||
105733088|NCT01966731|364679313|FG000|Overall Study|Screening Failure|29|||
105733089|NCT01966731|364679313|FG000|Overall Study|Found to be ineligible|1|||
105733090|NCT02088034|364679314|FG000|Overall Study|Lost to Follow-up|1|||
105733091|NCT02088034|364679315|FG001|Overall Study|Lost to Follow-up|1|||
105733092|NCT02088034|364679316|FG002|Overall Study|Lost to Follow-up|0|||
105733093|NCT02088034|364679314|FG000|Overall Study|Pregnancy|2|||
105797896|NCT00420849|364917627|FG000|Overall Study|Death|18|||
105797897|NCT00420849|364917627|FG000|Overall Study|Other|14|||
105797898|NCT00420849|364917627|FG000|Overall Study|Transplant|8|||
105797899|NCT00420849|364917627|FG000|Overall Study|Protocol Violation|1|||
105797900|NCT00420849|364917627|FG000|Overall Study|Lost to Follow-up|1|||
105797901|NCT02139306|364917628|FG000|Overall Study|Withdrawal by Subject|4|||
105797902|NCT02139306|364917629|FG001|Overall Study|Withdrawal by Subject|6|||
105797903|NCT02139306|364917628|FG000|Overall Study|Adverse Event|3|||
105797904|NCT02139306|364917629|FG001|Overall Study|Adverse Event|4|||
105797905|NCT02139306|364917628|FG000|Overall Study|Physician Decision|0|||
105797906|NCT02139306|364917629|FG001|Overall Study|Physician Decision|1|||
105797907|NCT02139306|364917628|FG000|Overall Study|Other Unspecified|2|||
105797908|NCT02139306|364917629|FG001|Overall Study|Other Unspecified|3|||
105797909|NCT02139306|364917628|FG000|Overall Study|Protocol Violation|4|||
105797910|NCT02139306|364917629|FG001|Overall Study|Protocol Violation|0|||
105797911|NCT01021137|364917634|FG000|Overall Study|Lost to Follow-up|9|||
105797912|NCT01021137|364917635|FG001|Overall Study|Lost to Follow-up|4|||
105797913|NCT01021137|364917636|FG002|Overall Study|Lost to Follow-up|2|||
105797914|NCT01021137|364917637|FG003|Overall Study|Lost to Follow-up|6|||
105797915|NCT01021137|364917634|FG000|Overall Study|Withdrawal by Subject|1|||
105797916|NCT01021137|364917635|FG001|Overall Study|Withdrawal by Subject|0|||
105797917|NCT01021137|364917636|FG002|Overall Study|Withdrawal by Subject|0|||
105797918|NCT01021137|364917637|FG003|Overall Study|Withdrawal by Subject|3|||
105797919|NCT03439293|364917638|FG000|Overall Study|Death|22|||
105797920|NCT03439293|364917638|FG000|Overall Study|Withdrawal by Subject|8|||
105797921|NCT03439293|364917638|FG000|Overall Study|Lost to Follow-up|2|||
105797922|NCT03439293|364917638|FG000|Overall Study|Reason Not Specified|28|||
105797923|NCT03439293|364917638|FG000|Overall Study|Missing|1|||
105797924|NCT03499249|364917646|FG000|Overall Study|Physician Decision|1|||
105797925|NCT01374906|364917647|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105797926|NCT01374906|364917648|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105797927|NCT01374906|364917647|FG000|Overall Study|Administrative problems|2|||
105797928|NCT01374906|364917648|FG001|Overall Study|Administrative problems|2|||
105797929|NCT01374906|364917647|FG000|Overall Study|Adverse Event|10|||
105797930|NCT01374906|364917648|FG001|Overall Study|Adverse Event|11|||
105797931|NCT01374906|364917647|FG000|Overall Study|Death|0|||
105797932|NCT01374906|364917648|FG001|Overall Study|Death|2|||
105797933|NCT01374906|364917647|FG000|Overall Study|Protocol Violation|2|||
105797934|NCT01374906|364917648|FG001|Overall Study|Protocol Violation|2|||
105797935|NCT01374906|364917647|FG000|Overall Study|Withdrawal by Subject|15|||
105797936|NCT01374906|364917648|FG001|Overall Study|Withdrawal by Subject|9|||
105797937|NCT01374906|364917647|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
105797938|NCT01374906|364917648|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
105797939|NCT00665626|364917654|FG000|Overall Study|Lack of Efficacy|8|||
105797940|NCT00665626|364917655|FG001|Overall Study|Lack of Efficacy|5|||
105797941|NCT00665626|364917654|FG000|Overall Study|Lost to Follow-up|0|||
105797942|NCT00665626|364917655|FG001|Overall Study|Lost to Follow-up|2|||
105797943|NCT00665626|364917654|FG000|Overall Study|Withdrawal by Subject|0|||
105797944|NCT00665626|364917655|FG001|Overall Study|Withdrawal by Subject|1|||
105797945|NCT00665626|364917654|FG000|Overall Study|Protocol Violation|0|||
105797946|NCT00665626|364917655|FG001|Overall Study|Protocol Violation|2|||
105797947|NCT00665626|364917654|FG000|Overall Study|Adverse Event|1|||
105797948|NCT00665626|364917655|FG001|Overall Study|Adverse Event|9|||
105797949|NCT00665626|364917654|FG000|Overall Study|Due to exclusion criteria|0|||
105797950|NCT00665626|364917655|FG001|Overall Study|Due to exclusion criteria|1|||
105797951|NCT00665626|364917654|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
105797952|NCT00665626|364917655|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
105797953|NCT00665626|364917654|FG000|Overall Study|Unably to comply with dosing regimen|0|||
105797954|NCT00665626|364917655|FG001|Overall Study|Unably to comply with dosing regimen|1|||
105797955|NCT00665626|364917654|FG000|Overall Study|Death|1|||
105797956|NCT00665626|364917655|FG001|Overall Study|Death|0|||
105797957|NCT00585039|364917656|FG000|Overall Study|medication spilled|2|||
105797958|NCT00585039|364917657|FG001|Overall Study|medication spilled|0|||
105797959|NCT04147611|364917658|FG000|Overall Study|Physician Decision|0|||
105797960|NCT04147611|364917659|FG001|Overall Study|Physician Decision|1|||
106139636|NCT00741988|366168690|FG000|Overall Study|Adverse Event|2|||
106139637|NCT00741988|366168691|FG001|Overall Study|Adverse Event|4|||
106139638|NCT00741988|366168690|FG000|Overall Study|Lack of Efficacy|2|||
105797961|NCT02046369|364917660|FG000|Overall Study|Adverse Event|3|||
105797962|NCT02046369|364917661|FG001|Overall Study|Adverse Event|3|||
105797963|NCT02046369|364917660|FG000|Overall Study|Lack of Efficacy|3|||
105797964|NCT02046369|364917661|FG001|Overall Study|Lack of Efficacy|3|||
105797965|NCT02046369|364917660|FG000|Overall Study|Lost to Follow-up|3|||
105797966|NCT02046369|364917661|FG001|Overall Study|Lost to Follow-up|3|||
105797967|NCT02046369|364917660|FG000|Overall Study|Protocol Violation|1|||
105797968|NCT02046369|364917661|FG001|Overall Study|Protocol Violation|2|||
105797969|NCT02046369|364917660|FG000|Overall Study|Withdrawal by Subject|3|||
105797970|NCT02046369|364917661|FG001|Overall Study|Withdrawal by Subject|6|||
105797971|NCT02046369|364917660|FG000|Overall Study|never received study drug|0|||
106139639|NCT00741988|366168691|FG001|Overall Study|Lack of Efficacy|0|||
105797972|NCT02046369|364917661|FG001|Overall Study|never received study drug|1|||
105797973|NCT02046369|364917660|FG000|Overall Study|non compliance|1|||
105797974|NCT02046369|364917661|FG001|Overall Study|non compliance|0|||
105797975|NCT01529749|364917662|FG000|Overall Study|Lost to Follow-up|0|||
105797976|NCT01529749|364917663|FG001|Overall Study|Lost to Follow-up|1|||
105797977|NCT01529749|364917664|FG002|Overall Study|Lost to Follow-up|1|||
105797978|NCT01529749|364917665|FG003|Overall Study|Lost to Follow-up|0|||
105797979|NCT01529749|364917662|FG000|Overall Study|Physician Decision|0|||
105797980|NCT01529749|364917663|FG001|Overall Study|Physician Decision|0|||
105797981|NCT01529749|364917664|FG002|Overall Study|Physician Decision|0|||
105797982|NCT01529749|364917665|FG003|Overall Study|Physician Decision|1|||
105797983|NCT01529749|364917662|FG000|Overall Study|Withdrawal by Subject|0|||
105797984|NCT01529749|364917663|FG001|Overall Study|Withdrawal by Subject|1|||
105797985|NCT01529749|364917664|FG002|Overall Study|Withdrawal by Subject|1|||
105797986|NCT01529749|364917665|FG003|Overall Study|Withdrawal by Subject|0|||
105797987|NCT01529749|364917662|FG000|Overall Study|Protocol Violation|0|||
105797988|NCT01529749|364917663|FG001|Overall Study|Protocol Violation|0|||
105797989|NCT01529749|364917664|FG002|Overall Study|Protocol Violation|0|||
105797990|NCT01529749|364917665|FG003|Overall Study|Protocol Violation|1|||
105797991|NCT03724968|364919187|FG000|Overall Study|Insurance issues|0|||
105797992|NCT03724968|364919188|FG001|Overall Study|Insurance issues|1|||
105797993|NCT03724968|364919187|FG000|Overall Study|Study closed|0|||
105797994|NCT03724968|364919188|FG001|Overall Study|Study closed|1|||
105797995|NCT03053622|364919192|FG000|Overall Study|Lost to Follow-up|0|||
105797996|NCT03053622|364919193|FG001|Overall Study|Lost to Follow-up|0|||
105797997|NCT03053622|364919194|FG002|Overall Study|Lost to Follow-up|0|||
105797998|NCT03053622|364919195|FG003|Overall Study|Lost to Follow-up|1|||
105797999|NCT01422720|364919196|FG000|Overall Study|Adverse Event|16|||
105798000|NCT01422720|364919196|FG000|Overall Study|Lack of Efficacy|1|||
105798001|NCT01422720|364919196|FG000|Overall Study|Withdrawal by Subject|4|||
105798002|NCT01422720|364919196|FG000|Overall Study|Ineligibility|1|||
105798003|NCT01726335|364919197|FG000|Overall Study|Lost to Follow-up|2|||
105798004|NCT01726335|364919197|FG000|Overall Study|Withdrawal by Subject|15|||
105798005|NCT01726335|364919197|FG000|Overall Study|Adverse Event|4|||
105798006|NCT01726335|364919197|FG000|Overall Study|Lost to Follow-up|2|||
105798007|NCT01726335|364919197|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
105798008|NCT01074307|364919198|FG000|Overall Study|No primary endpoint evaluation|14|||
105798009|NCT01074307|364919199|FG001|Overall Study|No primary endpoint evaluation|6|||
105798010|NCT01074307|364919198|FG000|Overall Study|Exclusion criterion|0|||
105798011|NCT01074307|364919199|FG001|Overall Study|Exclusion criterion|1|||
105798012|NCT01074307|364919198|FG000|Overall Study|Protocol Violation|8|||
105798013|NCT01074307|364919199|FG001|Overall Study|Protocol Violation|5|||
105798014|NCT01796860|364919200|FG000|Overall Study|Withdrawal by Subject|3|||
105798015|NCT01084603|364919208|FG000|Baseline|Withdrawal by Subject|2|||
105798016|NCT01084603|364919208|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
105798017|NCT01084603|364919208|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
105798018|NCT01084603|364919208|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
105798019|NCT01084603|364919208|FG000|Washout Period 4|Adverse Event|1|||
105798020|NCT04335110|364919209|FG000|Overall Study|Withdrawal by Subject|1|||
105798021|NCT04335110|364919210|FG001|Overall Study|Withdrawal by Subject|1|||
105798022|NCT04335110|364919209|FG000|Overall Study|Death|0|||
105798023|NCT04335110|364919210|FG001|Overall Study|Death|1|||
105798024|NCT00350519|364919212|FG000|Overall Study|Death|0|||
105798025|NCT00350519|364919213|FG001|Overall Study|Death|1|||
105798026|NCT00350519|364919212|FG000|Overall Study|Physician Decision|0|||
105798027|NCT00350519|364919213|FG001|Overall Study|Physician Decision|1|||
105798028|NCT00350519|364919212|FG000|Overall Study|Protocol Violation|1|||
105798029|NCT00350519|364919213|FG001|Overall Study|Protocol Violation|2|||
105798030|NCT00350519|364919212|FG000|Overall Study|Withdrawal by Subject|3|||
105798031|NCT00350519|364919213|FG001|Overall Study|Withdrawal by Subject|2|||
105798032|NCT03101293|364919216|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
105798033|NCT03101293|364919217|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
105798034|NCT00068406|364919224|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
105798035|NCT00068406|364919224|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
105798036|NCT02609178|364919228|FG000|First Crown|Withdrawal by Subject|0|||
105798037|NCT02609178|364919229|FG001|First Crown|Withdrawal by Subject|0|||
105798038|NCT02609178|364919230|FG002|First Crown|Withdrawal by Subject|1|||
105798039|NCT02609178|364919231|FG003|First Crown|Withdrawal by Subject|1|||
105798040|NCT02609178|364919232|FG004|First Crown|Withdrawal by Subject|0|||
105798041|NCT02609178|364919233|FG005|First Crown|Withdrawal by Subject|0|||
105798042|NCT00331773|364919234|FG000|Overall Study|Withdrawal by Subject|6|||
105798043|NCT00331773|364919235|FG001|Overall Study|Withdrawal by Subject|4|||
105798044|NCT00331773|364919234|FG000|Overall Study|Protocol Violation|10|||
105798045|NCT00331773|364919235|FG001|Overall Study|Protocol Violation|3|||
105798046|NCT00289731|364919236|FG000|Overall Study|Adverse Event|1|||
105798047|NCT00289731|364919237|FG001|Overall Study|Adverse Event|2|||
105798048|NCT00289731|364919238|FG002|Overall Study|Adverse Event|2|||
105798049|NCT00289731|364919236|FG000|Overall Study|Other|1|||
105798050|NCT00289731|364919237|FG001|Overall Study|Other|0|||
105798051|NCT00289731|364919238|FG002|Overall Study|Other|0|||
105798052|NCT04378010|364919239|FG000|Overall Study|Adverse Event|8|||
105798053|NCT04378010|364919240|FG001|Overall Study|Adverse Event|14|||
105798054|NCT04378010|364919241|FG002|Overall Study|Adverse Event|4|||
105798055|NCT04378010|364919239|FG000|Overall Study|Withdrawal by Subject|0|||
105798056|NCT04378010|364919240|FG001|Overall Study|Withdrawal by Subject|2|||
105798057|NCT04378010|364919241|FG002|Overall Study|Withdrawal by Subject|1|||
105798058|NCT04378010|364919239|FG000|Overall Study|Protocol Violation|2|||
105798059|NCT04378010|364919240|FG001|Overall Study|Protocol Violation|1|||
105798060|NCT04378010|364919241|FG002|Overall Study|Protocol Violation|4|||
105798061|NCT04378010|364919239|FG000|Overall Study|Study terminated by Sponsor|22|||
105798062|NCT04378010|364919240|FG001|Overall Study|Study terminated by Sponsor|16|||
105798063|NCT04378010|364919241|FG002|Overall Study|Study terminated by Sponsor|22|||
105798064|NCT04378010|364919239|FG000|Overall Study|Subject inability to complete study visit|0|||
105798065|NCT04378010|364919240|FG001|Overall Study|Subject inability to complete study visit|0|||
105798066|NCT04378010|364919241|FG002|Overall Study|Subject inability to complete study visit|1|||
105798067|NCT04378010|364919239|FG000|Overall Study|Subject never dosed|0|||
105798068|NCT04378010|364919240|FG001|Overall Study|Subject never dosed|1|||
105798069|NCT04378010|364919241|FG002|Overall Study|Subject never dosed|0|||
105798070|NCT02513459|364919242|FG000|Overall Study|Adverse Event|7|||
105798071|NCT02513459|364919242|FG000|Overall Study|Withdrew consent|5|||
105798072|NCT02513459|364919242|FG000|Overall Study|Loss of efficacy|2|||
105798073|NCT02513459|364919242|FG000|Overall Study|Pregnancy|2|||
105798074|NCT02513459|364919242|FG000|Overall Study|Subject decision|2|||
105798075|NCT02513459|364919242|FG000|Overall Study|Lack of response|1|||
105798076|NCT02513459|364919242|FG000|Overall Study|Reproductive plans|1|||
105798077|NCT02513459|364919242|FG000|Overall Study|Surgery planned-- not done|1|||
105798078|NCT00379587|364919243|FG000|Overall Study|Lost to Follow-up|2|||
105798079|NCT03237611|364919244|FG000|Overall Study|Withdrawal by Subject|1|||
105798080|NCT03237611|364919244|FG000|Overall Study|Ineligible|1|||
105798081|NCT01440595|364919249|FG000|Overall Study|Lost to Follow-up|0|||
105798082|NCT01440595|364919250|FG001|Overall Study|Lost to Follow-up|1|||
105798083|NCT01440595|364919251|FG002|Overall Study|Lost to Follow-up|0|||
105798084|NCT01440595|364919249|FG000|Overall Study|Study terminated by sponsor.|1|||
105798085|NCT01440595|364919250|FG001|Overall Study|Study terminated by sponsor.|2|||
105798086|NCT01440595|364919251|FG002|Overall Study|Study terminated by sponsor.|1|||
105798087|NCT01347879|364919252|FG000|Overall Study|Adverse Event|0|||
105798088|NCT01347879|364919253|FG001|Overall Study|Adverse Event|12|||
105798089|NCT01347879|364919252|FG000|Overall Study|Lost to Follow-up|2|||
105798090|NCT01347879|364919253|FG001|Overall Study|Lost to Follow-up|0|||
105798091|NCT01347879|364919252|FG000|Overall Study|Withdrawal by Subject|3|||
105798092|NCT01347879|364919253|FG001|Overall Study|Withdrawal by Subject|2|||
105798093|NCT01347879|364919252|FG000|Overall Study|Other|2|||
105798094|NCT01347879|364919253|FG001|Overall Study|Other|3|||
105798095|NCT01223196|364919254|FG000|Overall Study|Lost to Follow-up|2|||
105798096|NCT01223196|364919255|FG001|Overall Study|Lost to Follow-up|0|||
105798097|NCT01223196|364919254|FG000|Overall Study|Physician Decision|1|||
105798098|NCT01223196|364919255|FG001|Overall Study|Physician Decision|0|||
105798099|NCT01223196|364919254|FG000|Overall Study|Withdrawal by Subject|1|||
105798100|NCT01223196|364919255|FG001|Overall Study|Withdrawal by Subject|0|||
105798101|NCT02629133|364919256|FG000|Overall Study|Lost to Follow-up|3|||
105798102|NCT02629133|364919257|FG001|Overall Study|Lost to Follow-up|1|||
105798103|NCT02629133|364919256|FG000|Overall Study|Withdrawal by Subject|1|||
105798104|NCT02629133|364919257|FG001|Overall Study|Withdrawal by Subject|1|||
105798105|NCT02598193|364919258|FG000|Overall Study|Adverse Event|13|||
105798106|NCT02598193|364919258|FG000|Overall Study|Withdrawal by Subject|1|||
105798107|NCT02598193|364919258|FG000|Overall Study|Listed in active lung transplant list|1|||
105798108|NCT02598193|364919258|FG000|Overall Study|Does not want to take Nintedanib|1|||
105798109|NCT00837577|364919261|FG000|Double-blind Period|Clinical Adverse Event|1|||
105798110|NCT00837577|364919262|FG001|Double-blind Period|Clinical Adverse Event|0|||
105798111|NCT00837577|364919261|FG000|Double-blind Period|Withdrawal by Subject|1|||
105798112|NCT00837577|364919262|FG001|Double-blind Period|Withdrawal by Subject|0|||
105798113|NCT00837577|364919261|FG000|Open-label Period|Clinical Adverse Event|2|||
105798114|NCT00837577|364919262|FG001|Open-label Period|Clinical Adverse Event|2|||
105798115|NCT00837577|364919261|FG000|Open-label Period|Laboratory Adverse Event|0|||
105798116|NCT00837577|364919262|FG001|Open-label Period|Laboratory Adverse Event|1|||
105798117|NCT00837577|364919261|FG000|Open-label Period|Lack of Efficacy|4|||
105798118|NCT00837577|364919262|FG001|Open-label Period|Lack of Efficacy|3|||
105798119|NCT00837577|364919261|FG000|Open-label Period|Withdrawal by Subject|1|||
105798120|NCT00837577|364919262|FG001|Open-label Period|Withdrawal by Subject|2|||
105798121|NCT00837577|364919261|FG000|Open-label Period|Other Reason|1|||
105798122|NCT00837577|364919262|FG001|Open-label Period|Other Reason|1|||
105798123|NCT00068445|364919270|FG000|Randomization|Cancel|1|||
105798124|NCT00068445|364919271|FG001|Randomization|Cancel|3|||
105733094|NCT02088034|364679315|FG001|Overall Study|Pregnancy|1|||
105733095|NCT02088034|364679316|FG002|Overall Study|Pregnancy|2|||
105733096|NCT01937312|364679318|FG000|Overall Study|Adverse Event|10|||
105733097|NCT01937312|364679319|FG001|Overall Study|Adverse Event|1|||
105733098|NCT01937312|364679318|FG000|Overall Study|Lack of Efficacy|0|||
105733099|NCT01937312|364679319|FG001|Overall Study|Lack of Efficacy|1|||
105733100|NCT01937312|364679318|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
105733101|NCT01937312|364679319|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
105733102|NCT03215277|364679321|FG000|Overall Study|Adverse Event|2|||
105733103|NCT03215277|364679322|FG001|Overall Study|Adverse Event|3|||
105733104|NCT03215277|364679321|FG000|Overall Study|Death|1|||
105733105|NCT03215277|364679322|FG001|Overall Study|Death|0|||
105733106|NCT03215277|364679321|FG000|Overall Study|Lost to Follow-up|0|||
105733107|NCT03215277|364679322|FG001|Overall Study|Lost to Follow-up|1|||
105733108|NCT03215277|364679321|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
105733109|NCT03215277|364679322|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
105733110|NCT00201201|364679328|FG000|Overall Study|Death|0|||
105733111|NCT00201201|364679329|FG001|Overall Study|Death|2|||
105733112|NCT00201201|364679328|FG000|Overall Study|Withdrawal by Subject|5|||
105733113|NCT00201201|364679329|FG001|Overall Study|Withdrawal by Subject|5|||
105733114|NCT00609609|364679337|FG000|Overall Study|Withdrawal by Subject|2|||
105733115|NCT00609609|364679338|FG001|Overall Study|Withdrawal by Subject|0|||
105733116|NCT00609609|364679337|FG000|Overall Study|Progression|4|||
105733117|NCT00609609|364679338|FG001|Overall Study|Progression|2|||
105733118|NCT00670111|364679340|FG000|Enrollment to One Month|Testing Failure|0|||
105733119|NCT00670111|364679341|FG001|Enrollment to One Month|Testing Failure|0|||
105937829|NCT02037984|365431590|FG005|Overall Study|Lack of Efficacy|2|||
105937830|NCT02037984|365431591|FG006|Overall Study|Lack of Efficacy|4|||
105937831|NCT02037984|365431592|FG007|Overall Study|Lack of Efficacy|3|||
105937832|NCT02037984|365431585|FG000|Overall Study|Lost to Follow-up|1|||
105937833|NCT02037984|365431586|FG001|Overall Study|Lost to Follow-up|0|||
105937834|NCT02037984|365431587|FG002|Overall Study|Lost to Follow-up|3|||
105937835|NCT02037984|365431588|FG003|Overall Study|Lost to Follow-up|5|||
105937836|NCT02037984|365431589|FG004|Overall Study|Lost to Follow-up|2|||
105937837|NCT02037984|365431590|FG005|Overall Study|Lost to Follow-up|2|||
105937838|NCT02037984|365431591|FG006|Overall Study|Lost to Follow-up|2|||
105937839|NCT02037984|365431592|FG007|Overall Study|Lost to Follow-up|4|||
105937840|NCT02037984|365431585|FG000|Overall Study|Physician Decision|0|||
105937841|NCT02037984|365431586|FG001|Overall Study|Physician Decision|0|||
105937842|NCT02037984|365431587|FG002|Overall Study|Physician Decision|0|||
105937843|NCT02037984|365431588|FG003|Overall Study|Physician Decision|0|||
105937844|NCT02037984|365431589|FG004|Overall Study|Physician Decision|0|||
105937845|NCT02037984|365431590|FG005|Overall Study|Physician Decision|0|||
105937846|NCT02037984|365431591|FG006|Overall Study|Physician Decision|1|||
105937847|NCT02037984|365431592|FG007|Overall Study|Physician Decision|0|||
105937848|NCT02037984|365431585|FG000|Overall Study|Protocol Violation|0|||
105937849|NCT02037984|365431586|FG001|Overall Study|Protocol Violation|0|||
105937850|NCT02037984|365431587|FG002|Overall Study|Protocol Violation|0|||
105937851|NCT02037984|365431588|FG003|Overall Study|Protocol Violation|0|||
105937852|NCT02037984|365431589|FG004|Overall Study|Protocol Violation|0|||
105937853|NCT02037984|365431590|FG005|Overall Study|Protocol Violation|1|||
105937854|NCT02037984|365431591|FG006|Overall Study|Protocol Violation|2|||
105937855|NCT02037984|365431592|FG007|Overall Study|Protocol Violation|0|||
105937856|NCT02037984|365431585|FG000|Overall Study|Technical Problems|0|||
105937857|NCT02037984|365431586|FG001|Overall Study|Technical Problems|0|||
105937858|NCT02037984|365431587|FG002|Overall Study|Technical Problems|3|||
105937859|NCT02037984|365431588|FG003|Overall Study|Technical Problems|3|||
105937860|NCT02037984|365431589|FG004|Overall Study|Technical Problems|2|||
105937861|NCT02037984|365431590|FG005|Overall Study|Technical Problems|3|||
105733120|NCT00670111|364679342|FG002|Enrollment to One Month|Testing Failure|13|||
105733121|NCT00670111|364679340|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
105733122|NCT00670111|364679341|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
105733123|NCT00670111|364679342|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
105733124|NCT00670111|364679340|FG000|Enrollment to One Month|Physician Decision|1|||
105733125|NCT00670111|364679341|FG001|Enrollment to One Month|Physician Decision|0|||
105733126|NCT00670111|364679342|FG002|Enrollment to One Month|Physician Decision|0|||
105733127|NCT03000452|364679344|FG000|Treatment Period|Death|1|||
105937862|NCT02037984|365431591|FG006|Overall Study|Technical Problems|4|||
105937863|NCT02037984|365431592|FG007|Overall Study|Technical Problems|2|||
105937864|NCT02037984|365431585|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105937865|NCT02037984|365431586|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105937866|NCT02037984|365431587|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
105937867|NCT02037984|365431588|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
105733128|NCT03000452|364679344|FG000|Treatment Period|Progressive Disease (PD)|14|||
105733129|NCT03000452|364679344|FG000|Treatment Period|Physician Decision|1|||
105733130|NCT03000452|364679344|FG000|Treatment Period|Miscellaneous|2|||
105733131|NCT03000452|364679344|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
105733132|NCT03000452|364679344|FG000|Follow-Up Period|Death|3|||
105733133|NCT03000452|364679344|FG000|Follow-Up Period|Withdrawal by Subject|3|||
105733134|NCT00593112|364679345|FG000|Overall Study|Scan Anxiety|3|||
105733135|NCT00593112|364679346|FG001|Overall Study|Scan Anxiety|0|||
105733136|NCT00593112|364679345|FG000|Overall Study|Abnormal Scan|1|||
105733137|NCT00593112|364679346|FG001|Overall Study|Abnormal Scan|0|||
105733138|NCT00593112|364679345|FG000|Overall Study|Unreadable Scan|1|||
105733139|NCT00593112|364679346|FG001|Overall Study|Unreadable Scan|0|||
105733140|NCT00593112|364679345|FG000|Overall Study|Withdrawal by Subject|5|||
105733141|NCT00593112|364679346|FG001|Overall Study|Withdrawal by Subject|0|||
105733142|NCT00852930|364679347|FG000|Overall Study|Withdrawal by Subject|1|||
105733143|NCT00852930|364679348|FG001|Overall Study|Withdrawal by Subject|1|||
105733144|NCT00852930|364679349|FG002|Overall Study|Withdrawal by Subject|1|||
105733145|NCT00852930|364679347|FG000|Overall Study|Physician Decision|0|||
105733146|NCT00852930|364679348|FG001|Overall Study|Physician Decision|0|||
105733147|NCT00852930|364679349|FG002|Overall Study|Physician Decision|1|||
105733148|NCT01325493|364679350|FG000|Overall Study|Protocol Violation|0|||
105733149|NCT01325493|364679351|FG001|Overall Study|Protocol Violation|1|||
105733150|NCT01325493|364679350|FG000|Overall Study|loss of neuromonitoring signals|0|||
105733151|NCT01325493|364679351|FG001|Overall Study|loss of neuromonitoring signals|2|||
105733152|NCT01325493|364679350|FG000|Overall Study|Allergy|1|||
105733153|NCT01325493|364679351|FG001|Overall Study|Allergy|0|||
105733154|NCT00482001|364679352|FG000|Overall Study|Protocol Violation|1|||
105733155|NCT00482001|364679353|FG001|Overall Study|Protocol Violation|1|||
105733156|NCT04786210|364679354|FG000|Overall Study|Lost to Follow-up|2|||
105733157|NCT04786210|364679354|FG000|Overall Study|Withdrawal by Subject|4|||
105733158|NCT03700892|364679359|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
105733159|NCT03700892|364679360|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
105733160|NCT03700892|364679361|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
105733161|NCT04814823|364679362|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
105733162|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
105733163|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
105733164|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
105733165|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|Death|2|||
105733166|NCT03396471|364679377|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
105733167|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Death|9|||
105733168|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
105733169|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
105733170|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|study terminated|1|||
105733171|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
105733172|NCT03396471|364679377|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
105733173|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
105733174|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
105733175|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
105733176|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
105733177|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
105733178|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
105733179|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
105733180|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
105733181|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733182|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733183|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733184|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733185|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
105733186|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
105733187|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
105733188|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
105733189|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
105733190|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
105733191|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
105733192|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
105733193|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
105733194|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733195|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733196|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733197|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733198|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
105733199|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
105733200|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
105733201|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
105733202|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
105733203|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
105733204|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
105733205|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
105733206|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
105733207|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733208|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733209|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733210|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733211|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
105733212|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733213|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733214|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733215|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733216|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733217|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
105733218|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733219|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733220|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733221|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733222|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733223|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733224|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
105733225|NCT00923091|364679378|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733226|NCT00923091|364679379|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
105733227|NCT00923091|364679380|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733228|NCT00923091|364679381|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
105733229|NCT00923091|364679382|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733230|NCT00923091|364679383|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
105733231|NCT00923091|364679384|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733232|NCT00923091|364679385|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733233|NCT00923091|364679386|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733234|NCT00923091|364679387|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733235|NCT00923091|364679388|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733236|NCT00923091|364679389|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733237|NCT00923091|364679390|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
105733238|NCT00923091|364679378|FG000|Period III (Single-Blind)|Adverse Event|5|||
105733239|NCT00923091|364679379|FG001|Period III (Single-Blind)|Adverse Event|0|||
105733240|NCT00923091|364679380|FG002|Period III (Single-Blind)|Adverse Event|0|||
105733241|NCT00923091|364679381|FG003|Period III (Single-Blind)|Adverse Event|0|||
105733242|NCT00923091|364679382|FG004|Period III (Single-Blind)|Adverse Event|0|||
105733243|NCT00923091|364679383|FG005|Period III (Single-Blind)|Adverse Event|0|||
105733244|NCT00923091|364679384|FG006|Period III (Single-Blind)|Adverse Event|0|||
105733245|NCT00923091|364679385|FG007|Period III (Single-Blind)|Adverse Event|0|||
105733246|NCT00923091|364679386|FG008|Period III (Single-Blind)|Adverse Event|0|||
105733247|NCT00923091|364679387|FG009|Period III (Single-Blind)|Adverse Event|0|||
105733248|NCT00923091|364679388|FG010|Period III (Single-Blind)|Adverse Event|0|||
105733249|NCT00923091|364679389|FG011|Period III (Single-Blind)|Adverse Event|0|||
105733250|NCT00923091|364679390|FG012|Period III (Single-Blind)|Adverse Event|0|||
105733251|NCT00923091|364679378|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
105733252|NCT00923091|364679379|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733253|NCT00923091|364679380|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733254|NCT00923091|364679381|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733255|NCT00923091|364679382|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733256|NCT00923091|364679383|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733257|NCT00923091|364679384|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733258|NCT00923091|364679385|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733259|NCT00923091|364679386|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733260|NCT00923091|364679387|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733261|NCT00923091|364679388|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733262|NCT00923091|364679389|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
105733263|NCT00923091|364679390|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
105798125|NCT00068445|364919270|FG000|Randomization|Ineligible|1|||
105798126|NCT00068445|364919271|FG001|Randomization|Ineligible|1|||
105798127|NCT00068445|364919270|FG000|Treatment|Refused Further Treatment|13|||
105798128|NCT00068445|364919271|FG001|Treatment|Refused Further Treatment|10|||
105798129|NCT00068445|364919270|FG000|Treatment|Adverse Event|7|||
105798130|NCT00068445|364919271|FG001|Treatment|Adverse Event|1|||
105798131|NCT00068445|364919270|FG000|Treatment|Other (Specifics not available)|9|||
105798132|NCT00068445|364919271|FG001|Treatment|Other (Specifics not available)|5|||
105798133|NCT00423488|364919275|FG000|Overall Study|No evidence of study drug intake|2|||
105798134|NCT00423488|364919276|FG001|Overall Study|No evidence of study drug intake|1|||
105798135|NCT00423488|364919275|FG000|Overall Study|No post baseline data|3|||
105798136|NCT00423488|364919276|FG001|Overall Study|No post baseline data|0|||
105798137|NCT02164539|364919277|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
105798138|NCT02164539|364919278|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
105798139|NCT02164539|364919279|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
105798140|NCT02164539|364919280|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
105798141|NCT02164539|364919281|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
105798142|NCT02164539|364919282|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
105798143|NCT02164539|364919283|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
105798144|NCT02164539|364919277|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
105798145|NCT02164539|364919278|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
105798146|NCT02164539|364919279|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
105798147|NCT02164539|364919280|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
105798148|NCT02164539|364919281|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
105798149|NCT02164539|364919282|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
105798150|NCT02164539|364919283|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
105798151|NCT02164539|364919277|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
105798152|NCT02164539|364919278|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
105798153|NCT02164539|364919279|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
105798154|NCT02164539|364919280|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
105798155|NCT02164539|364919281|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
105798156|NCT02164539|364919282|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
105798157|NCT02164539|364919283|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
105798158|NCT02164539|364919277|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
105798159|NCT02164539|364919278|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798160|NCT02164539|364919279|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798161|NCT02164539|364919280|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798162|NCT02164539|364919281|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798163|NCT02164539|364919282|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798164|NCT02164539|364919283|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
105798165|NCT02164539|364919277|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
105798166|NCT02164539|364919278|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
105798167|NCT02164539|364919279|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
105798168|NCT02164539|364919280|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
105798169|NCT02164539|364919281|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
105798170|NCT02164539|364919282|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
105798171|NCT02164539|364919283|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
105798172|NCT02164539|364919277|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
105798173|NCT02164539|364919278|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
105798174|NCT02164539|364919279|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
105798175|NCT02164539|364919280|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
105798176|NCT02164539|364919281|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
105798177|NCT02164539|364919282|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
105798178|NCT02164539|364919283|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
105798179|NCT01255722|364919284|FG000|Overall Study|Adverse Event|0|||
105798180|NCT01255722|364919285|FG001|Overall Study|Adverse Event|1|||
105798181|NCT01255722|364919286|FG002|Overall Study|Adverse Event|1|||
105798182|NCT01255722|364919284|FG000|Overall Study|asymptomatic patient|1|||
105798183|NCT01255722|364919285|FG001|Overall Study|asymptomatic patient|0|||
105798184|NCT01255722|364919286|FG002|Overall Study|asymptomatic patient|0|||
105798185|NCT01255722|364919284|FG000|Overall Study|beta-blocker contraindicated|2|||
105798186|NCT01255722|364919285|FG001|Overall Study|beta-blocker contraindicated|0|||
105798187|NCT01255722|364919286|FG002|Overall Study|beta-blocker contraindicated|0|||
105798188|NCT03835975|364919289|FG000|Overall Study|Lost to Follow-up|1|||
105798189|NCT03835975|364919290|FG001|Overall Study|Lost to Follow-up|1|||
105798190|NCT03835975|364919291|FG002|Overall Study|Lost to Follow-up|0|||
105798191|NCT03835975|364919292|FG003|Overall Study|Lost to Follow-up|0|||
105798192|NCT03835975|364919293|FG004|Overall Study|Lost to Follow-up|0|||
105798193|NCT03835975|364919289|FG000|Overall Study|No longer met eligibility criteria|0|||
105798194|NCT03835975|364919290|FG001|Overall Study|No longer met eligibility criteria|1|||
105798195|NCT03835975|364919291|FG002|Overall Study|No longer met eligibility criteria|0|||
105798196|NCT03835975|364919292|FG003|Overall Study|No longer met eligibility criteria|0|||
105798197|NCT03835975|364919293|FG004|Overall Study|No longer met eligibility criteria|0|||
105798198|NCT03835975|364919289|FG000|Overall Study|Protocol Violation|1|||
105733264|NCT00923091|364679378|FG000|Period III (Single-Blind)|Protocol Violation|3|||
105733265|NCT00923091|364679379|FG001|Period III (Single-Blind)|Protocol Violation|0|||
105733266|NCT00923091|364679380|FG002|Period III (Single-Blind)|Protocol Violation|0|||
105733267|NCT00923091|364679381|FG003|Period III (Single-Blind)|Protocol Violation|0|||
105733268|NCT00923091|364679382|FG004|Period III (Single-Blind)|Protocol Violation|0|||
105733269|NCT00923091|364679383|FG005|Period III (Single-Blind)|Protocol Violation|0|||
105733270|NCT00923091|364679384|FG006|Period III (Single-Blind)|Protocol Violation|0|||
105733271|NCT00923091|364679385|FG007|Period III (Single-Blind)|Protocol Violation|0|||
105733272|NCT00923091|364679386|FG008|Period III (Single-Blind)|Protocol Violation|0|||
105733273|NCT00923091|364679387|FG009|Period III (Single-Blind)|Protocol Violation|0|||
105733274|NCT00923091|364679388|FG010|Period III (Single-Blind)|Protocol Violation|0|||
105733275|NCT00923091|364679389|FG011|Period III (Single-Blind)|Protocol Violation|0|||
105733276|NCT00923091|364679390|FG012|Period III (Single-Blind)|Protocol Violation|0|||
105733277|NCT00923091|364679378|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
105733278|NCT00923091|364679379|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
105733279|NCT00923091|364679380|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
105733280|NCT00923091|364679381|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
105733281|NCT00923091|364679382|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
105733282|NCT00923091|364679383|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
105733283|NCT00923091|364679384|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
105733284|NCT00923091|364679385|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
105733285|NCT00923091|364679386|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
105733286|NCT00923091|364679387|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
105733287|NCT00923091|364679388|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
105733288|NCT00923091|364679389|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
105733289|NCT00923091|364679390|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
105733290|NCT00923091|364679378|FG000|Period IV (Double-Blind)|Adverse Event|2|||
105733291|NCT00923091|364679379|FG001|Period IV (Double-Blind)|Adverse Event|0|||
105733292|NCT00923091|364679380|FG002|Period IV (Double-Blind)|Adverse Event|0|||
105733293|NCT00923091|364679381|FG003|Period IV (Double-Blind)|Adverse Event|0|||
105733294|NCT00923091|364679382|FG004|Period IV (Double-Blind)|Adverse Event|0|||
105733295|NCT00923091|364679383|FG005|Period IV (Double-Blind)|Adverse Event|0|||
105733296|NCT00923091|364679384|FG006|Period IV (Double-Blind)|Adverse Event|0|||
105733297|NCT00923091|364679385|FG007|Period IV (Double-Blind)|Adverse Event|0|||
105733298|NCT00923091|364679386|FG008|Period IV (Double-Blind)|Adverse Event|0|||
105733299|NCT00923091|364679387|FG009|Period IV (Double-Blind)|Adverse Event|0|||
105733300|NCT00923091|364679388|FG010|Period IV (Double-Blind)|Adverse Event|0|||
105733301|NCT00923091|364679389|FG011|Period IV (Double-Blind)|Adverse Event|0|||
105733302|NCT00923091|364679390|FG012|Period IV (Double-Blind)|Adverse Event|0|||
105733303|NCT00923091|364679378|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733304|NCT00923091|364679379|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
105733305|NCT00923091|364679380|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733306|NCT00923091|364679381|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733307|NCT00923091|364679382|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733308|NCT00923091|364679383|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733309|NCT00923091|364679384|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733310|NCT00923091|364679385|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733311|NCT00923091|364679386|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733312|NCT00923091|364679387|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733313|NCT00923091|364679388|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733314|NCT00923091|364679389|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733315|NCT00923091|364679390|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
105733316|NCT00923091|364679378|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
105733317|NCT00923091|364679379|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
105733318|NCT00923091|364679380|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
105733319|NCT00923091|364679381|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
105733320|NCT00923091|364679382|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
105733321|NCT00923091|364679383|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
105733322|NCT00923091|364679384|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
105733323|NCT00923091|364679385|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
105733324|NCT00923091|364679386|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
105733325|NCT00923091|364679387|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
105733326|NCT00923091|364679388|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
105733327|NCT00923091|364679389|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
105733328|NCT00923091|364679390|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
105733329|NCT00923091|364679378|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733330|NCT00923091|364679379|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733331|NCT00923091|364679380|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733332|NCT00923091|364679381|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
105798199|NCT03835975|364919290|FG001|Overall Study|Protocol Violation|1|||
105937868|NCT02037984|365431589|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
106139640|NCT00906282|366168692|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
105733333|NCT00923091|364679382|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733334|NCT00923091|364679383|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733335|NCT00923091|364679384|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733336|NCT00923091|364679385|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733337|NCT00923091|364679386|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
105733338|NCT00923091|364679387|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733339|NCT00923091|364679388|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733340|NCT00923091|364679389|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
105733341|NCT00923091|364679390|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
105733342|NCT00923091|364679378|FG000|Period V (Double -Blind)|Protocol Violation|0|||
105733343|NCT00923091|364679379|FG001|Period V (Double -Blind)|Protocol Violation|0|||
105733344|NCT00923091|364679380|FG002|Period V (Double -Blind)|Protocol Violation|0|||
105733345|NCT00923091|364679381|FG003|Period V (Double -Blind)|Protocol Violation|0|||
105733346|NCT00923091|364679382|FG004|Period V (Double -Blind)|Protocol Violation|0|||
105733347|NCT00923091|364679383|FG005|Period V (Double -Blind)|Protocol Violation|0|||
105733348|NCT00923091|364679384|FG006|Period V (Double -Blind)|Protocol Violation|0|||
105733349|NCT00923091|364679385|FG007|Period V (Double -Blind)|Protocol Violation|0|||
105733350|NCT00923091|364679386|FG008|Period V (Double -Blind)|Protocol Violation|0|||
105733351|NCT00923091|364679387|FG009|Period V (Double -Blind)|Protocol Violation|0|||
105733352|NCT00923091|364679388|FG010|Period V (Double -Blind)|Protocol Violation|0|||
105733353|NCT00923091|364679389|FG011|Period V (Double -Blind)|Protocol Violation|0|||
105733354|NCT00923091|364679390|FG012|Period V (Double -Blind)|Protocol Violation|1|||
105733355|NCT00923091|364679378|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
105733356|NCT00923091|364679379|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
105733357|NCT00923091|364679380|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
105733358|NCT00923091|364679381|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
105733359|NCT00923091|364679382|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
105733360|NCT00923091|364679383|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
105733361|NCT00923091|364679384|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
105733362|NCT00923091|364679385|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
105733363|NCT00923091|364679386|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
105733364|NCT00923091|364679387|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
105733365|NCT00923091|364679388|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
105733366|NCT00923091|364679389|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
105733367|NCT00923091|364679390|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
105733368|NCT00923091|364679378|FG000|Period VI (Open-Label)|Adverse Event|17|||
105733369|NCT00923091|364679379|FG001|Period VI (Open-Label)|Adverse Event|0|||
105733370|NCT00923091|364679380|FG002|Period VI (Open-Label)|Adverse Event|4|||
105733371|NCT00923091|364679381|FG003|Period VI (Open-Label)|Adverse Event|1|||
105733372|NCT00923091|364679382|FG004|Period VI (Open-Label)|Adverse Event|1|||
105733373|NCT00923091|364679383|FG005|Period VI (Open-Label)|Adverse Event|0|||
105733374|NCT00923091|364679384|FG006|Period VI (Open-Label)|Adverse Event|0|||
105733375|NCT00923091|364679385|FG007|Period VI (Open-Label)|Adverse Event|0|||
105733376|NCT00923091|364679386|FG008|Period VI (Open-Label)|Adverse Event|0|||
105733377|NCT00923091|364679387|FG009|Period VI (Open-Label)|Adverse Event|0|||
105733378|NCT00923091|364679388|FG010|Period VI (Open-Label)|Adverse Event|0|||
105733379|NCT00923091|364679389|FG011|Period VI (Open-Label)|Adverse Event|0|||
105733380|NCT00923091|364679390|FG012|Period VI (Open-Label)|Adverse Event|0|||
105733381|NCT00923091|364679378|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
105733382|NCT00923091|364679379|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
105733383|NCT00923091|364679380|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
105733384|NCT00923091|364679381|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733385|NCT00923091|364679382|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
105733386|NCT00923091|364679383|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733387|NCT00923091|364679384|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733388|NCT00923091|364679385|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733389|NCT00923091|364679386|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733390|NCT00923091|364679387|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733391|NCT00923091|364679388|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733392|NCT00923091|364679389|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733393|NCT00923091|364679390|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
105733394|NCT00923091|364679378|FG000|Period VI (Open-Label)|Protocol Violation|6|||
105733395|NCT00923091|364679379|FG001|Period VI (Open-Label)|Protocol Violation|1|||
105733396|NCT00923091|364679380|FG002|Period VI (Open-Label)|Protocol Violation|3|||
105733397|NCT00923091|364679381|FG003|Period VI (Open-Label)|Protocol Violation|1|||
105733398|NCT00923091|364679382|FG004|Period VI (Open-Label)|Protocol Violation|4|||
105733399|NCT00923091|364679383|FG005|Period VI (Open-Label)|Protocol Violation|0|||
105733400|NCT00923091|364679384|FG006|Period VI (Open-Label)|Protocol Violation|0|||
105733401|NCT00923091|364679385|FG007|Period VI (Open-Label)|Protocol Violation|0|||
105733402|NCT00923091|364679386|FG008|Period VI (Open-Label)|Protocol Violation|0|||
105798200|NCT03835975|364919291|FG002|Overall Study|Protocol Violation|2|||
105798201|NCT03835975|364919292|FG003|Overall Study|Protocol Violation|0|||
105798202|NCT03835975|364919293|FG004|Overall Study|Protocol Violation|0|||
105798203|NCT03835975|364919289|FG000|Overall Study|Withdrawal by Subject|1|||
105798204|NCT03835975|364919290|FG001|Overall Study|Withdrawal by Subject|0|||
105798205|NCT03835975|364919291|FG002|Overall Study|Withdrawal by Subject|1|||
105798206|NCT03835975|364919292|FG003|Overall Study|Withdrawal by Subject|1|||
105798207|NCT03835975|364919293|FG004|Overall Study|Withdrawal by Subject|0|||
105798208|NCT03031431|364919294|FG000|Overall Study|Infant removed by maternal request|1|||
105798209|NCT01027884|364919299|FG000|Overall Study|Adverse Event|2|||
105798210|NCT01027884|364919300|FG001|Overall Study|Adverse Event|1|||
105798211|NCT01027884|364919299|FG000|Overall Study|Protocol Violation|1|||
105798212|NCT01027884|364919300|FG001|Overall Study|Protocol Violation|0|||
105798213|NCT01027884|364919299|FG000|Overall Study|Non-compliance|1|||
105798214|NCT01027884|364919300|FG001|Overall Study|Non-compliance|1|||
105798215|NCT01027884|364919299|FG000|Overall Study|Withdrawal by Subject|0|||
105798216|NCT01027884|364919300|FG001|Overall Study|Withdrawal by Subject|1|||
105798217|NCT01027884|364919299|FG000|Overall Study|Lost to Follow-up|0|||
105798218|NCT01027884|364919300|FG001|Overall Study|Lost to Follow-up|1|||
105798219|NCT01027884|364919299|FG000|Overall Study|Spinal fixation surgery|0|||
105798220|NCT01027884|364919300|FG001|Overall Study|Spinal fixation surgery|3|||
105798221|NCT01542736|364919301|FG000|Overall Study|Death|1|||
105798222|NCT00527397|364919302|FG000|Overall Study|Adverse Event|3|||
105798223|NCT00527397|364919302|FG000|Overall Study|Lack of Efficacy|1|||
105798224|NCT00527397|364919302|FG000|Overall Study|Protocol Violation|1|||
105798225|NCT00527397|364919302|FG000|Overall Study|Withdrawal by Subject|6|||
105798226|NCT00527397|364919302|FG000|Overall Study|Study terminated by sponsor|13|||
105798227|NCT01783483|364919303|FG000|Overall Study|Death|3|||
105798228|NCT01783483|364919304|FG001|Overall Study|Death|3|||
105798229|NCT01783483|364919303|FG000|Overall Study|Lost to Follow-up|14|||
105798230|NCT01783483|364919304|FG001|Overall Study|Lost to Follow-up|10|||
105798231|NCT01783483|364919303|FG000|Overall Study|Withdrawal by Subject|2|||
105798232|NCT01783483|364919304|FG001|Overall Study|Withdrawal by Subject|1|||
105798233|NCT01783483|364919303|FG000|Overall Study|Physician Decision|1|||
105798234|NCT01783483|364919304|FG001|Overall Study|Physician Decision|1|||
105798235|NCT01462695|364919305|FG000|Overall Study|Adverse Event|1|||
105798236|NCT01462695|364919306|FG001|Overall Study|Adverse Event|1|||
105798237|NCT01462695|364919305|FG000|Overall Study|Death|2|||
105798238|NCT01462695|364919306|FG001|Overall Study|Death|0|||
105798239|NCT01462695|364919305|FG000|Overall Study|Lack of Efficacy|6|||
105798240|NCT01462695|364919306|FG001|Overall Study|Lack of Efficacy|12|||
105798241|NCT01462695|364919305|FG000|Overall Study|Physician Decision|5|||
105798242|NCT01462695|364919306|FG001|Overall Study|Physician Decision|0|||
105798243|NCT01462695|364919305|FG000|Overall Study|Withdrawal by Subject|2|||
105798244|NCT01462695|364919306|FG001|Overall Study|Withdrawal by Subject|0|||
105798245|NCT01462695|364919305|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
105798246|NCT01462695|364919306|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
105798247|NCT02400905|364919307|FG000|Overall Study|Death|24|||
105798248|NCT02400905|364919307|FG000|Overall Study|Lost to Follow-up|18|||
105798249|NCT02400905|364919307|FG000|Overall Study|Withdrawal by Subject|16|||
105798250|NCT02400905|364919307|FG000|Overall Study|Physician Decision|4|||
105798251|NCT02400905|364919307|FG000|Overall Study|Other|1|||
105798252|NCT03276962|364919308|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
105798253|NCT03276962|364919309|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
105798254|NCT03276962|364919310|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
105798255|NCT03276962|364919311|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
105798256|NCT03276962|364919312|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
105798257|NCT03276962|364919308|FG000|Overall Study|Protocol Deviation|2|||
105798258|NCT03276962|364919309|FG001|Overall Study|Protocol Deviation|0|||
105798259|NCT03276962|364919310|FG002|Overall Study|Protocol Deviation|1|||
105798260|NCT03276962|364919311|FG003|Overall Study|Protocol Deviation|2|||
106139641|NCT00906282|366168692|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
106139642|NCT00906282|366168692|FG000|Preoperative Chemotherapy|Progressive disease|6|||
105798261|NCT03276962|364919312|FG004|Overall Study|Protocol Deviation|1|||
105798262|NCT03276962|364919308|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
105798263|NCT03276962|364919309|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
105798264|NCT03276962|364919310|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
105798265|NCT03276962|364919311|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
105798266|NCT03276962|364919312|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
105798267|NCT03276962|364919308|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
105798268|NCT03276962|364919309|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
105798269|NCT03276962|364919310|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
105798270|NCT03276962|364919311|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
105798271|NCT03276962|364919312|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
105798272|NCT03276962|364919308|FG000|Overall Study|Lost to Follow-up|10|||
105733403|NCT00923091|364679387|FG009|Period VI (Open-Label)|Protocol Violation|0|||
105733404|NCT00923091|364679388|FG010|Period VI (Open-Label)|Protocol Violation|0|||
105733405|NCT00923091|364679389|FG011|Period VI (Open-Label)|Protocol Violation|0|||
105733406|NCT00923091|364679390|FG012|Period VI (Open-Label)|Protocol Violation|0|||
105733407|NCT00923091|364679378|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
105733408|NCT00923091|364679379|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
105733409|NCT00923091|364679380|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
105733410|NCT00923091|364679381|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
105733411|NCT00923091|364679382|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
105733412|NCT00923091|364679383|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
105733413|NCT00923091|364679384|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
105733414|NCT00923091|364679385|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
105733415|NCT00923091|364679386|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
105733416|NCT00923091|364679387|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
105733417|NCT00923091|364679388|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
105733418|NCT00923091|364679389|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
105733419|NCT00923091|364679390|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
105733420|NCT00923091|364679378|FG000|Period VI (Open-Label)|Other Reason|0|||
105733421|NCT00923091|364679379|FG001|Period VI (Open-Label)|Other Reason|0|||
105733422|NCT00923091|364679380|FG002|Period VI (Open-Label)|Other Reason|0|||
105733423|NCT00923091|364679381|FG003|Period VI (Open-Label)|Other Reason|1|||
105733424|NCT00923091|364679382|FG004|Period VI (Open-Label)|Other Reason|1|||
105733425|NCT00923091|364679383|FG005|Period VI (Open-Label)|Other Reason|0|||
105733426|NCT00923091|364679384|FG006|Period VI (Open-Label)|Other Reason|0|||
105733427|NCT00923091|364679385|FG007|Period VI (Open-Label)|Other Reason|0|||
105733428|NCT00923091|364679386|FG008|Period VI (Open-Label)|Other Reason|0|||
105733429|NCT00923091|364679387|FG009|Period VI (Open-Label)|Other Reason|0|||
105733430|NCT00923091|364679388|FG010|Period VI (Open-Label)|Other Reason|0|||
105733431|NCT00923091|364679389|FG011|Period VI (Open-Label)|Other Reason|0|||
105733432|NCT00923091|364679390|FG012|Period VI (Open-Label)|Other Reason|0|||
105733433|NCT01743027|364679398|FG000|Overall Study|Adverse Event|2|||
105733434|NCT01743027|364679399|FG001|Overall Study|Adverse Event|0|||
105733435|NCT01743027|364679400|FG002|Overall Study|Adverse Event|0|||
105733436|NCT01743027|364679401|FG003|Overall Study|Adverse Event|0|||
105733437|NCT01743027|364679398|FG000|Overall Study|Lost to Follow-up|0|||
105733438|NCT01743027|364679399|FG001|Overall Study|Lost to Follow-up|0|||
105733439|NCT01743027|364679400|FG002|Overall Study|Lost to Follow-up|2|||
105733440|NCT01743027|364679401|FG003|Overall Study|Lost to Follow-up|0|||
105733441|NCT01743027|364679398|FG000|Overall Study|Progressive Disease|1|||
105733442|NCT01743027|364679399|FG001|Overall Study|Progressive Disease|4|||
105733443|NCT01743027|364679400|FG002|Overall Study|Progressive Disease|3|||
105733444|NCT01743027|364679401|FG003|Overall Study|Progressive Disease|0|||
105733445|NCT01743027|364679398|FG000|Overall Study|Protocol Violation|1|||
105733446|NCT01743027|364679399|FG001|Overall Study|Protocol Violation|1|||
105733447|NCT01743027|364679400|FG002|Overall Study|Protocol Violation|1|||
105733448|NCT01743027|364679401|FG003|Overall Study|Protocol Violation|0|||
105733449|NCT01743027|364679398|FG000|Overall Study|Withdrawal by Subject|1|||
105733450|NCT01743027|364679399|FG001|Overall Study|Withdrawal by Subject|0|||
105733451|NCT01743027|364679400|FG002|Overall Study|Withdrawal by Subject|3|||
105733452|NCT01743027|364679401|FG003|Overall Study|Withdrawal by Subject|1|||
105733453|NCT01088412|364679406|FG000|Overall Study|Adverse Event|38|||
105733454|NCT01088412|364679407|FG001|Overall Study|Adverse Event|0|||
105733455|NCT01088412|364679408|FG002|Overall Study|Adverse Event|0|||
105733456|NCT01088412|364679406|FG000|Overall Study|Death|42|||
105733457|NCT01088412|364679407|FG001|Overall Study|Death|6|||
105733458|NCT01088412|364679408|FG002|Overall Study|Death|0|||
105733459|NCT01088412|364679406|FG000|Overall Study|Other Reason per Case Report Form|2089|||
105733460|NCT01088412|364679407|FG001|Overall Study|Other Reason per Case Report Form|103|||
105733461|NCT01088412|364679408|FG002|Overall Study|Other Reason per Case Report Form|9|||
105733462|NCT01088412|364679406|FG000|Overall Study|Withdrawal by Subject|1761|||
105733463|NCT01088412|364679407|FG001|Overall Study|Withdrawal by Subject|25|||
105733464|NCT01088412|364679408|FG002|Overall Study|Withdrawal by Subject|1|||
105733465|NCT01088412|364679406|FG000|Overall Study|Received Another GH Product|79|||
105733466|NCT01088412|364679407|FG001|Overall Study|Received Another GH Product|0|||
105733467|NCT01088412|364679408|FG002|Overall Study|Received Another GH Product|0|||
105733468|NCT01088412|364679406|FG000|Overall Study|Participant Moved|601|||
105733469|NCT01088412|364679407|FG001|Overall Study|Participant Moved|21|||
105733470|NCT01088412|364679408|FG002|Overall Study|Participant Moved|2|||
105733471|NCT01088412|364679406|FG000|Overall Study|Physician Decision|1041|||
105733472|NCT01088412|364679407|FG001|Overall Study|Physician Decision|8|||
105733473|NCT01088412|364679408|FG002|Overall Study|Physician Decision|4|||
105733474|NCT01088412|364679406|FG000|Overall Study|Sponsor Decision|4467|||
105733475|NCT01088412|364679407|FG001|Overall Study|Sponsor Decision|79|||
105733476|NCT01088412|364679408|FG002|Overall Study|Sponsor Decision|23|||
105733477|NCT01088412|364679406|FG000|Overall Study|Third Party Required to Change Brand|487|||
105733478|NCT01088412|364679407|FG001|Overall Study|Third Party Required to Change Brand|0|||
105733479|NCT01088412|364679408|FG002|Overall Study|Third Party Required to Change Brand|0|||
105733480|NCT01088412|364679406|FG000|Overall Study|Lost to Follow-up|3052|||
105733481|NCT01088412|364679407|FG001|Overall Study|Lost to Follow-up|130|||
105733482|NCT01088412|364679408|FG002|Overall Study|Lost to Follow-up|11|||
105733483|NCT01088412|364679406|FG000|Overall Study|Study Summary Not Completed|4360|||
105733484|NCT01088412|364679407|FG001|Overall Study|Study Summary Not Completed|64|||
105733485|NCT01088412|364679408|FG002|Overall Study|Study Summary Not Completed|22|||
105733486|NCT02782715|364679409|FG000|Overall Study|Withdrawal by Subject|1|||
105733487|NCT00069121|364679410|FG000|Overall Study|Death|286|||
105733488|NCT00069121|364679411|FG001|Overall Study|Death|242|||
105733489|NCT00069121|364679410|FG000|Overall Study|Withdrawal by Subject|18|||
105733490|NCT00069121|364679411|FG001|Overall Study|Withdrawal by Subject|20|||
105733491|NCT00069121|364679410|FG000|Overall Study|Lost to Follow-up|63|||
105733492|NCT00069121|364679411|FG001|Overall Study|Lost to Follow-up|63|||
105733493|NCT02190591|364679412|FG000|Overall Study|Withdrawal by Subject|1|||
105733494|NCT02190591|364679413|FG001|Overall Study|Withdrawal by Subject|8|||
105733495|NCT02190591|364679412|FG000|Overall Study|Protocol Violation|1|||
105733496|NCT02190591|364679413|FG001|Overall Study|Protocol Violation|0|||
105733497|NCT02190591|364679412|FG000|Overall Study|did not use peanut ball as instructed|0|||
105733498|NCT02190591|364679413|FG001|Overall Study|did not use peanut ball as instructed|2|||
105733499|NCT02190591|364679412|FG000|Overall Study|face presentation so she was ineligible|0|||
105733500|NCT02190591|364679413|FG001|Overall Study|face presentation so she was ineligible|1|||
105733501|NCT00857246|364679414|FG000|Induction Regimen|Adverse Event|1|||
105733502|NCT00857246|364679414|FG000|Induction Regimen|disease-related complications|1|||
105733503|NCT00857246|364679414|FG000|Induction Regimen|Withdrawal by Subject|1|||
105733504|NCT00857246|364679414|FG000|Surgery (Curative)|disease progression|6|||
105733505|NCT00857246|364679414|FG000|ChemoRT|Withdrawal by Subject|1|||
105733506|NCT00857246|364679414|FG000|ChemoRT|Adverse Event|2|||
105733507|NCT00072189|364679415|FG000|Overall Study|Withdrawal by Subject|1|||
105733508|NCT01919411|364679416|FG000|Overall Study|Lost to Follow-up|2|||
105733509|NCT01919411|364679417|FG001|Overall Study|Lost to Follow-up|4|||
105733510|NCT01919411|364679416|FG000|Overall Study|Physician Decision|1|||
105733511|NCT01919411|364679417|FG001|Overall Study|Physician Decision|0|||
105733512|NCT01919411|364679416|FG000|Overall Study|Protocol Violation|2|||
105733513|NCT01919411|364679417|FG001|Overall Study|Protocol Violation|1|||
105733514|NCT01933672|364679418|FG000|Metformin Run-in Period|Adverse Event|1|||
105733515|NCT01933672|364679419|FG001|Metformin Run-in Period|Adverse Event|0|||
105733516|NCT01933672|364679420|FG002|Metformin Run-in Period|Adverse Event|0|||
105733517|NCT01933672|364679421|FG003|Metformin Run-in Period|Adverse Event|0|||
105733518|NCT01933672|364679422|FG004|Metformin Run-in Period|Adverse Event|0|||
105733519|NCT01933672|364679423|FG005|Metformin Run-in Period|Adverse Event|0|||
105733520|NCT01933672|364679424|FG006|Metformin Run-in Period|Adverse Event|0|||
105733521|NCT01933672|364679418|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
105733522|NCT01933672|364679419|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733523|NCT01933672|364679420|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733524|NCT01933672|364679421|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733525|NCT01933672|364679422|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733526|NCT01933672|364679423|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733527|NCT01933672|364679424|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
105733528|NCT01933672|364679418|FG000|Metformin Run-in Period|Other|5|||
105733529|NCT01933672|364679419|FG001|Metformin Run-in Period|Other|0|||
105733530|NCT01933672|364679420|FG002|Metformin Run-in Period|Other|0|||
105733531|NCT01933672|364679421|FG003|Metformin Run-in Period|Other|0|||
105733532|NCT01933672|364679422|FG004|Metformin Run-in Period|Other|0|||
105733533|NCT01933672|364679423|FG005|Metformin Run-in Period|Other|0|||
105733534|NCT01933672|364679424|FG006|Metformin Run-in Period|Other|0|||
105733535|NCT01933672|364679418|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733536|NCT01933672|364679419|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733537|NCT01933672|364679420|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733538|NCT01933672|364679421|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733539|NCT01933672|364679422|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
105733540|NCT01933672|364679423|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733541|NCT01933672|364679424|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733542|NCT01933672|364679418|FG000|First Intervention Period (12-16 Days)|Other|0|||
105733543|NCT01933672|364679419|FG001|First Intervention Period (12-16 Days)|Other|0|||
105733544|NCT01933672|364679420|FG002|First Intervention Period (12-16 Days)|Other|1|||
105733545|NCT01933672|364679421|FG003|First Intervention Period (12-16 Days)|Other|0|||
105733546|NCT01933672|364679422|FG004|First Intervention Period (12-16 Days)|Other|0|||
105733547|NCT01933672|364679423|FG005|First Intervention Period (12-16 Days)|Other|1|||
105733548|NCT01933672|364679424|FG006|First Intervention Period (12-16 Days)|Other|0|||
105733549|NCT01933672|364679418|FG000|Second Intervention Period (12-16 Days)|Other|0|||
105733550|NCT01933672|364679419|FG001|Second Intervention Period (12-16 Days)|Other|1|||
105733551|NCT01933672|364679420|FG002|Second Intervention Period (12-16 Days)|Other|1|||
105733552|NCT01933672|364679421|FG003|Second Intervention Period (12-16 Days)|Other|0|||
105733553|NCT01933672|364679422|FG004|Second Intervention Period (12-16 Days)|Other|0|||
105733554|NCT01933672|364679423|FG005|Second Intervention Period (12-16 Days)|Other|0|||
105733555|NCT01933672|364679424|FG006|Second Intervention Period (12-16 Days)|Other|0|||
105733556|NCT01933672|364679418|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733557|NCT01933672|364679419|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733558|NCT01933672|364679420|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733559|NCT01933672|364679421|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
105733560|NCT01933672|364679422|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733561|NCT01933672|364679423|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733562|NCT01933672|364679424|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
105733563|NCT01933672|364679418|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733564|NCT01933672|364679419|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
105733565|NCT01933672|364679420|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733566|NCT01933672|364679421|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733567|NCT01933672|364679422|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733568|NCT01933672|364679423|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733569|NCT01933672|364679424|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
105733570|NCT00853905|364679425|FG000|Overall Study|Lost to Follow-up|1|||
105733571|NCT00853905|364679426|FG001|Overall Study|Lost to Follow-up|3|||
105733572|NCT00853905|364679425|FG000|Overall Study|Withdrawal by Subject|0|||
105733573|NCT00853905|364679426|FG001|Overall Study|Withdrawal by Subject|1|||
105733574|NCT00853905|364679425|FG000|Overall Study|never had surgery|1|||
105733575|NCT00853905|364679426|FG001|Overall Study|never had surgery|0|||
105733576|NCT00393458|364679432|FG000|Overall Study|Adverse Event|35|||
105733577|NCT00393458|364679433|FG001|Overall Study|Adverse Event|24|||
105733578|NCT00393458|364679434|FG002|Overall Study|Adverse Event|40|||
105733579|NCT00393458|364679435|FG003|Overall Study|Adverse Event|35|||
105733580|NCT00393458|364679432|FG000|Overall Study|Subject withdrew consent|27|||
105733581|NCT00393458|364679433|FG001|Overall Study|Subject withdrew consent|40|||
105733582|NCT00393458|364679434|FG002|Overall Study|Subject withdrew consent|33|||
105733583|NCT00393458|364679435|FG003|Overall Study|Subject withdrew consent|50|||
105733584|NCT00393458|364679432|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
105733585|NCT00393458|364679433|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
105733586|NCT00393458|364679434|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
105733587|NCT00393458|364679435|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
105733588|NCT00393458|364679432|FG000|Overall Study|Protocol deviation|11|||
105733589|NCT00393458|364679433|FG001|Overall Study|Protocol deviation|11|||
105733590|NCT00393458|364679434|FG002|Overall Study|Protocol deviation|11|||
105733591|NCT00393458|364679435|FG003|Overall Study|Protocol deviation|10|||
105733592|NCT00393458|364679432|FG000|Overall Study|Administrative problems|7|||
105733593|NCT00393458|364679433|FG001|Overall Study|Administrative problems|8|||
105733594|NCT00393458|364679434|FG002|Overall Study|Administrative problems|5|||
105733595|NCT00393458|364679435|FG003|Overall Study|Administrative problems|2|||
105733596|NCT00393458|364679432|FG000|Overall Study|Lost to Follow-up|5|||
105733597|NCT00393458|364679433|FG001|Overall Study|Lost to Follow-up|6|||
105733598|NCT00393458|364679434|FG002|Overall Study|Lost to Follow-up|5|||
105733599|NCT00393458|364679435|FG003|Overall Study|Lost to Follow-up|3|||
105733600|NCT00393458|364679432|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105733601|NCT00393458|364679433|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105733602|NCT00393458|364679434|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105733603|NCT00393458|364679435|FG003|Overall Study|Abnormal laboratory value(s)|0|||
106139643|NCT00906282|366168692|FG000|Preoperative Chemotherapy|Toxicity|1|||
106139644|NCT00172185|366170367|FG000|Overall Study|Adverse Event|0|||
106139645|NCT00172185|366170368|FG001|Overall Study|Adverse Event|1|||
106139646|NCT00172185|366170369|FG002|Overall Study|Adverse Event|3|||
106139647|NCT00172185|366170370|FG003|Overall Study|Adverse Event|4|||
106139648|NCT00172185|366170367|FG000|Overall Study|Physician Decision|0|||
106139649|NCT00172185|366170368|FG001|Overall Study|Physician Decision|0|||
106139650|NCT00172185|366170369|FG002|Overall Study|Physician Decision|1|||
106139651|NCT00172185|366170370|FG003|Overall Study|Physician Decision|0|||
106139652|NCT00172185|366170367|FG000|Overall Study|SPONSOR Decision|0|||
106139653|NCT00172185|366170368|FG001|Overall Study|SPONSOR Decision|1|||
106139654|NCT00172185|366170369|FG002|Overall Study|SPONSOR Decision|0|||
106139655|NCT00172185|366170370|FG003|Overall Study|SPONSOR Decision|0|||
105798273|NCT03276962|364919309|FG001|Overall Study|Lost to Follow-up|10|||
105798274|NCT03276962|364919310|FG002|Overall Study|Lost to Follow-up|4|||
105798275|NCT03276962|364919311|FG003|Overall Study|Lost to Follow-up|6|||
105798276|NCT03276962|364919312|FG004|Overall Study|Lost to Follow-up|10|||
105798277|NCT03276962|364919308|FG000|Overall Study|Other|0|||
105798278|NCT03276962|364919309|FG001|Overall Study|Other|2|||
105798279|NCT03276962|364919310|FG002|Overall Study|Other|0|||
105798280|NCT03276962|364919311|FG003|Overall Study|Other|2|||
105798281|NCT03276962|364919312|FG004|Overall Study|Other|1|||
105798282|NCT02702271|364919313|FG000|Overall Study|Death|36|||
105798283|NCT02702271|364919314|FG001|Overall Study|Death|7|||
105798284|NCT02702271|364919313|FG000|Overall Study|Lost to Follow-up|12|||
105798285|NCT02702271|364919314|FG001|Overall Study|Lost to Follow-up|0|||
105798286|NCT02702271|364919313|FG000|Overall Study|Withdrawal by Subject|8|||
105798287|NCT02702271|364919314|FG001|Overall Study|Withdrawal by Subject|1|||
105798288|NCT02702271|364919313|FG000|Overall Study|Physician Decision|2|||
105798289|NCT02702271|364919314|FG001|Overall Study|Physician Decision|0|||
105798290|NCT02702271|364919313|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
105798291|NCT02702271|364919314|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
105798292|NCT02713243|364919315|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
105798293|NCT02713243|364919316|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
105798294|NCT02713243|364919315|FG000|Overall Study|Administrative problems|0|||
105798295|NCT02713243|364919316|FG001|Overall Study|Administrative problems|1|||
105798296|NCT02713243|364919315|FG000|Overall Study|Protocol deviation|0|||
105798297|NCT02713243|364919316|FG001|Overall Study|Protocol deviation|1|||
105798298|NCT04363736|364919317|FG000|Overall Study|Withdrawal by Subject|1|||
105798299|NCT04363736|364919318|FG001|Overall Study|Withdrawal by Subject|0|||
105798300|NCT04363736|364919317|FG000|Overall Study|Lost to Follow-up|10|||
105798301|NCT04363736|364919318|FG001|Overall Study|Lost to Follow-up|7|||
105798302|NCT04363736|364919317|FG000|Overall Study|Death|8|||
105798303|NCT04363736|364919318|FG001|Overall Study|Death|6|||
105798304|NCT03056352|364919319|FG000|Overall Study|Lost to Follow-up|1|||
105798305|NCT03797222|364919322|FG000|Overall Study|Withdrawal by Subject|1|||
105798306|NCT04071626|364919326|FG000|Overall Study|Withdrawal by Subject|1|||
105798307|NCT04071626|364919327|FG001|Overall Study|Withdrawal by Subject|1|||
105798308|NCT04071626|364919326|FG000|Overall Study|Protocol Violation|0|||
105798309|NCT04071626|364919327|FG001|Overall Study|Protocol Violation|1|||
105798310|NCT04523831|364919330|FG000|Overall Study|Lost to Follow-up|15|||
105798311|NCT04523831|364919331|FG001|Overall Study|Lost to Follow-up|17|||
105798312|NCT04523831|364919330|FG000|Overall Study|Death|0|||
105798313|NCT04523831|364919331|FG001|Overall Study|Death|3|||
105798314|NCT04523831|364919330|FG000|Overall Study|Adverse Event|2|||
105798315|NCT04523831|364919331|FG001|Overall Study|Adverse Event|0|||
105798316|NCT01458119|364919332|FG000|Overall Study|Physician Decision|4|||
105798317|NCT01458119|364919332|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
105798318|NCT01458119|364919332|FG000|Overall Study|Pregnancy|1|||
105798319|NCT01458119|364919332|FG000|Overall Study|Death|2|||
105798320|NCT01458119|364919332|FG000|Overall Study|Adverse Event|1|||
105798321|NCT01458119|364919332|FG000|Overall Study|Consent Withdrawn by Participant|8|||
106139656|NCT00172185|366170367|FG000|Overall Study|Withdrawal by Subject|0|||
106139657|NCT00172185|366170368|FG001|Overall Study|Withdrawal by Subject|0|||
106139658|NCT00172185|366170369|FG002|Overall Study|Withdrawal by Subject|1|||
106139659|NCT00172185|366170370|FG003|Overall Study|Withdrawal by Subject|0|||
105798322|NCT01458119|364919332|FG000|Overall Study|Non-compliance With Study Drug|3|||
105798323|NCT00435825|364919333|FG000|Overall Study|Abnormality of Laboratory Test|0|||
106139660|NCT01677936|366170371|FG000|Overall Study|Lost to Follow-up|4|||
106139661|NCT01677936|366170372|FG001|Overall Study|Lost to Follow-up|1|||
106139662|NCT01677936|366170371|FG000|Overall Study|Protocol Violation|3|||
105798324|NCT00435825|364919334|FG001|Overall Study|Abnormality of Laboratory Test|1|||
105798325|NCT00435825|364919335|FG002|Overall Study|Abnormality of Laboratory Test|0|||
105798326|NCT00435825|364919336|FG003|Overall Study|Abnormality of Laboratory Test|0|||
105798327|NCT00435825|364919333|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105798328|NCT00435825|364919334|FG001|Overall Study|Insufficient Therapeutic Response|1|||
105798329|NCT00435825|364919335|FG002|Overall Study|Insufficient Therapeutic Response|0|||
105798330|NCT00435825|364919336|FG003|Overall Study|Insufficient Therapeutic Response|3|||
105798331|NCT00435825|364919333|FG000|Overall Study|Other Protocol Violation|1|||
106139663|NCT01677936|366170372|FG001|Overall Study|Protocol Violation|0|||
106139664|NCT01677936|366170371|FG000|Overall Study|Adverse Event|1|||
105798332|NCT00435825|364919334|FG001|Overall Study|Other Protocol Violation|0|||
105798333|NCT00435825|364919335|FG002|Overall Study|Other Protocol Violation|0|||
105798334|NCT00435825|364919336|FG003|Overall Study|Other Protocol Violation|0|||
105798335|NCT00435825|364919333|FG000|Overall Study|Refused treatment|2|||
105798336|NCT00435825|364919334|FG001|Overall Study|Refused treatment|0|||
105798337|NCT00435825|364919335|FG002|Overall Study|Refused treatment|0|||
105798338|NCT00435825|364919336|FG003|Overall Study|Refused treatment|5|||
105798339|NCT00435825|364919333|FG000|Overall Study|Failure to return|5|||
105798340|NCT00435825|364919334|FG001|Overall Study|Failure to return|0|||
105798341|NCT00435825|364919335|FG002|Overall Study|Failure to return|4|||
105798342|NCT00435825|364919336|FG003|Overall Study|Failure to return|0|||
105798343|NCT00435825|364919333|FG000|Overall Study|Did not receive study drug|1|||
105798344|NCT00435825|364919334|FG001|Overall Study|Did not receive study drug|0|||
105798345|NCT00435825|364919335|FG002|Overall Study|Did not receive study drug|2|||
105798346|NCT00435825|364919336|FG003|Overall Study|Did not receive study drug|0|||
105798347|NCT00435825|364919333|FG000|Overall Study|Did not enter follow-up|0|||
105798348|NCT00435825|364919334|FG001|Overall Study|Did not enter follow-up|4|||
105798349|NCT00435825|364919335|FG002|Overall Study|Did not enter follow-up|1|||
105798350|NCT00435825|364919336|FG003|Overall Study|Did not enter follow-up|3|||
105798351|NCT00435825|364919333|FG000|Overall Study|Did not complete full follow-up period|6|||
105798352|NCT00435825|364919334|FG001|Overall Study|Did not complete full follow-up period|6|||
105798353|NCT00435825|364919335|FG002|Overall Study|Did not complete full follow-up period|4|||
105798354|NCT00435825|364919336|FG003|Overall Study|Did not complete full follow-up period|5|||
105798355|NCT00530439|364919337|FG000|Overall Study|GDM|9|||
105798356|NCT00530439|364919338|FG001|Overall Study|GDM|3|||
105798357|NCT00530439|364919337|FG000|Overall Study|Withdraw|18|||
105798358|NCT00530439|364919338|FG001|Overall Study|Withdraw|14|||
105798359|NCT00530439|364919337|FG000|Overall Study|Missed abortion|1|||
105798360|NCT00530439|364919338|FG001|Overall Study|Missed abortion|4|||
105798361|NCT00530439|364919337|FG000|Overall Study|Misclassification|2|||
105798362|NCT00530439|364919338|FG001|Overall Study|Misclassification|0|||
105798363|NCT00530439|364919337|FG000|Overall Study|Twin pregnancy|0|||
105798364|NCT00530439|364919338|FG001|Overall Study|Twin pregnancy|2|||
105798365|NCT00530439|364919337|FG000|Overall Study|Severe malformation/abortion|0|||
105798366|NCT00530439|364919338|FG001|Overall Study|Severe malformation/abortion|3|||
105798367|NCT00430638|364919339|FG000|Overall Study|Adverse Event|15|||
105798368|NCT00430638|364919340|FG001|Overall Study|Adverse Event|15|||
105798369|NCT00430638|364919339|FG000|Overall Study|Uncontrolled blood pressure|48|||
105733604|NCT00393458|364679432|FG000|Overall Study|Death|1|||
105733605|NCT00393458|364679433|FG001|Overall Study|Death|1|||
105733606|NCT00393458|364679434|FG002|Overall Study|Death|5|||
105798370|NCT00430638|364919340|FG001|Overall Study|Uncontrolled blood pressure|13|||
105798371|NCT00430638|364919339|FG000|Overall Study|Lost to Follow-up|1|||
105798372|NCT00430638|364919340|FG001|Overall Study|Lost to Follow-up|7|||
105798373|NCT00430638|364919339|FG000|Overall Study|Protocol Violation|6|||
105733607|NCT00393458|364679435|FG003|Overall Study|Death|5|||
105733608|NCT00393458|364679432|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105733609|NCT00393458|364679433|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105798374|NCT00430638|364919340|FG001|Overall Study|Protocol Violation|4|||
105798375|NCT00430638|364919339|FG000|Overall Study|Withdrawal by Subject|4|||
105798376|NCT00430638|364919340|FG001|Overall Study|Withdrawal by Subject|6|||
105733610|NCT00393458|364679434|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105733611|NCT00393458|364679435|FG003|Overall Study|Abnormal test procedure result(s)|2|||
105733612|NCT00393458|364679432|FG000|Overall Study|Subject no longer requires study drug|0|||
105733613|NCT00393458|364679433|FG001|Overall Study|Subject no longer requires study drug|1|||
105733614|NCT00393458|364679434|FG002|Overall Study|Subject no longer requires study drug|0|||
105733615|NCT00393458|364679435|FG003|Overall Study|Subject no longer requires study drug|0|||
105798377|NCT00430638|364919339|FG000|Overall Study|Non-compliant|2|||
105733616|NCT02104180|364679436|FG000|Overall Study|Protocol Violation|1|||
105733617|NCT02104180|364679437|FG001|Overall Study|Protocol Violation|0|||
105733618|NCT01524289|364679438|FG000|Overall Study|Lost to Follow-up|0|||
105733619|NCT01524289|364679439|FG001|Overall Study|Lost to Follow-up|1|||
105733620|NCT01524289|364679438|FG000|Overall Study|Physician Decision|1|||
105733621|NCT01524289|364679439|FG001|Overall Study|Physician Decision|0|||
105733622|NCT01524289|364679438|FG000|Overall Study|Protocol Violation|5|||
105733623|NCT01524289|364679439|FG001|Overall Study|Protocol Violation|1|||
105733624|NCT01524289|364679438|FG000|Overall Study|Withdrawal by Subject|11|||
105733625|NCT01524289|364679439|FG001|Overall Study|Withdrawal by Subject|7|||
105733626|NCT01524289|364679438|FG000|Overall Study|Adverse Event|12|||
105733627|NCT01524289|364679439|FG001|Overall Study|Adverse Event|5|||
105733628|NCT01524289|364679438|FG000|Overall Study|Did not take study medication|1|||
105733629|NCT01524289|364679439|FG001|Overall Study|Did not take study medication|0|||
105733630|NCT00377299|364679444|FG000|Overall Study|Lost to Follow-up|14|||
105733631|NCT00377299|364679445|FG001|Overall Study|Lost to Follow-up|19|||
105733632|NCT00377299|364679444|FG000|Overall Study|Adverse Event|0|||
105733633|NCT00377299|364679445|FG001|Overall Study|Adverse Event|1|||
105733634|NCT00377299|364679444|FG000|Overall Study|Withdrawal by Subject|5|||
105733635|NCT00377299|364679445|FG001|Overall Study|Withdrawal by Subject|4|||
105733636|NCT00638846|364679448|FG000|Overall Study|Adverse Event|0|||
105733637|NCT00638846|364679449|FG001|Overall Study|Adverse Event|1|||
105733638|NCT00638846|364679448|FG000|Overall Study|Lost to Follow-up|3|||
105733639|NCT00638846|364679449|FG001|Overall Study|Lost to Follow-up|2|||
105733640|NCT00638846|364679448|FG000|Overall Study|lens issue|1|||
105733641|NCT00638846|364679449|FG001|Overall Study|lens issue|3|||
105733642|NCT00035815|364679450|FG000|Overall Study|Withdrawal by Subject|17|||
105733643|NCT00035815|364679451|FG001|Overall Study|Withdrawal by Subject|11|||
105733644|NCT04285723|364679454|FG000|Overall Study|Subject decision|1|||
105733645|NCT04285723|364679455|FG001|Overall Study|Subject decision|2|||
105733646|NCT04285723|364679454|FG000|Overall Study|Physician Decision|1|||
105733647|NCT04285723|364679455|FG001|Overall Study|Physician Decision|0|||
105733648|NCT04285723|364679454|FG000|Overall Study|No efficiency|1|||
105733649|NCT04285723|364679455|FG001|Overall Study|No efficiency|0|||
105733650|NCT02903511|364679456|FG000|Overall Study|Withdrawal by Subject|1|||
105733651|NCT02903511|364679457|FG001|Overall Study|Withdrawal by Subject|0|||
105733652|NCT02903511|364679456|FG000|Overall Study|Lost to Follow-up|3|||
105733653|NCT02903511|364679457|FG001|Overall Study|Lost to Follow-up|2|||
105733654|NCT02839746|364680999|FG000|Overall Study|Not met selection criteria|12|||
105733655|NCT02517515|364681000|FG000|Overall Study|Adverse Event|0|||
105733656|NCT02517515|364681001|FG001|Overall Study|Adverse Event|1|||
105733657|NCT02517515|364681000|FG000|Overall Study|Withdrew Consent|0|||
105733658|NCT02517515|364681001|FG001|Overall Study|Withdrew Consent|1|||
105733659|NCT02517515|364681000|FG000|Overall Study|Lost to Follow-up|1|||
105733660|NCT02517515|364681001|FG001|Overall Study|Lost to Follow-up|0|||
105733661|NCT02517515|364681000|FG000|Overall Study|Other|1|||
105733662|NCT02517515|364681001|FG001|Overall Study|Other|0|||
105733663|NCT00151411|364681002|FG000|Overall Study|Lost to Follow-up|15|||
105733664|NCT00151411|364681003|FG001|Overall Study|Lost to Follow-up|19|||
105733665|NCT00151411|364681002|FG000|Overall Study|Withdrawal by Subject|12|||
105733666|NCT00151411|364681003|FG001|Overall Study|Withdrawal by Subject|20|||
105733667|NCT00151411|364681002|FG000|Overall Study|Adverse Event|6|||
105733668|NCT00151411|364681003|FG001|Overall Study|Adverse Event|0|||
105733669|NCT00151411|364681002|FG000|Overall Study|Pregnancy|0|||
105733670|NCT00151411|364681003|FG001|Overall Study|Pregnancy|4|||
105733671|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
105733672|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
105733673|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
105733674|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
105733675|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
105733676|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
105733677|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
105733678|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
105733679|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
105733680|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
105733681|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
105733682|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
105733683|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
105733684|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
105733685|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
105733686|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
105733687|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
105733688|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
105733689|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
105733690|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
105733691|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
105733692|NCT00092547|364681008|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
105733693|NCT00092547|364681009|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
105733694|NCT00092547|364681010|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
105733695|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
105733696|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
105733697|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
105733698|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
105733699|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
105733700|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
105733701|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
105733702|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
105733703|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
105733704|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
105733705|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
105733706|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
105733707|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
105733708|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
105733709|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
105733710|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
105733711|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
105733712|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
105733713|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
105733714|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
105733715|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
105733716|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
105733717|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
105733718|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
105733719|NCT00092547|364681008|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
105733720|NCT00092547|364681009|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
105733721|NCT00092547|364681010|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
105733722|NCT00092547|364681008|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
105733723|NCT00092547|364681009|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
105733724|NCT00092547|364681010|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
105733725|NCT00092547|364681008|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
105733726|NCT00092547|364681009|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
105733727|NCT00092547|364681010|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
105733728|NCT00092547|364681008|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
105733729|NCT00092547|364681009|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
105733730|NCT00092547|364681010|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
105733731|NCT00092547|364681008|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
105733732|NCT00092547|364681009|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
105733733|NCT00092547|364681010|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
105733734|NCT00634543|364681012|FG000|Overall Study|Other|1|||
105733735|NCT00634543|364681013|FG001|Overall Study|Other|2|||
105733736|NCT00634543|364681012|FG000|Overall Study|Protocol Violation|3|||
105733737|NCT00634543|364681013|FG001|Overall Study|Protocol Violation|3|||
105733738|NCT00634543|364681012|FG000|Overall Study|Adverse Event|11|||
105733739|NCT00634543|364681013|FG001|Overall Study|Adverse Event|11|||
105733740|NCT00634543|364681012|FG000|Overall Study|Withdrawal by Subject|4|||
105733741|NCT00634543|364681013|FG001|Overall Study|Withdrawal by Subject|4|||
105733742|NCT00634543|364681012|FG000|Overall Study|Lost to Follow-up|0|||
105733743|NCT00634543|364681013|FG001|Overall Study|Lost to Follow-up|1|||
105733744|NCT02138110|364681016|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
105733745|NCT02138110|364681016|FG000|Overall Scaffold Implantation|Death|3|||
105733746|NCT02401256|364681017|FG000|Overall Study|Adverse Event|5|||
105733747|NCT02401256|364681017|FG000|Overall Study|Withdrawal by Subject|12|||
105733748|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
105733749|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
105733750|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
105733751|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
105733752|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
105733753|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
105733754|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
105733755|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
105733756|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
105733757|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
105733758|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
105733759|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
105733760|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
106009563|NCT02491684|365700876|FG001|Treatment Phase|Incorrect randomisation|0|||
106009564|NCT02491684|365700875|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
106009565|NCT02491684|365700876|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
106009566|NCT02383576|365700877|FG000|Overall Study|Death|53|||
106009567|NCT02383576|365700878|FG001|Overall Study|Death|33|||
106009568|NCT02383576|365700877|FG000|Overall Study|Lost to Follow-up|7|||
106009569|NCT02383576|365700878|FG001|Overall Study|Lost to Follow-up|1|||
106009570|NCT02383576|365700877|FG000|Overall Study|Withdrew Consent|1|||
106009571|NCT02383576|365700878|FG001|Overall Study|Withdrew Consent|6|||
106009572|NCT02383576|365700877|FG000|Overall Study|Investigator's Decision|0|||
106009573|NCT02383576|365700878|FG001|Overall Study|Investigator's Decision|1|||
106009574|NCT02383576|365700877|FG000|Overall Study|Administrative/Other|2|||
106009575|NCT02383576|365700878|FG001|Overall Study|Administrative/Other|4|||
106009576|NCT04914364|365700879|FG000|Overall Study|No longer eligible for study|1|||
106009577|NCT04914364|365700879|FG000|Overall Study|Lost to Follow-up|2|||
106009578|NCT02435212|365700882|FG000|Core Phase|Adverse Event|8|||
106009579|NCT02435212|365700883|FG001|Core Phase|Adverse Event|5|||
106009580|NCT02435212|365700882|FG000|Core Phase|Withdrawal by Subject|3|||
106009581|NCT02435212|365700883|FG001|Core Phase|Withdrawal by Subject|0|||
106009582|NCT02435212|365700882|FG000|Core Phase|Withdrawal by parent/guardian|9|||
106009583|NCT02435212|365700883|FG001|Core Phase|Withdrawal by parent/guardian|4|||
106009584|NCT02435212|365700882|FG000|Core Phase|Protocol Violation|1|||
106009585|NCT02435212|365700883|FG001|Core Phase|Protocol Violation|2|||
106009586|NCT02435212|365700882|FG000|Core Phase|Physician Decision|3|||
106009587|NCT02435212|365700883|FG001|Core Phase|Physician Decision|0|||
106009588|NCT02435212|365700882|FG000|Core Phase|Lost to Follow-up|0|||
106009589|NCT02435212|365700883|FG001|Core Phase|Lost to Follow-up|1|||
106009590|NCT02435212|365700882|FG000|Core Phase|Lack of Efficacy|0|||
106009591|NCT02435212|365700883|FG001|Core Phase|Lack of Efficacy|1|||
106009592|NCT02435212|365700882|FG000|Core Phase|Recovery|1|||
106009593|NCT02435212|365700883|FG001|Core Phase|Recovery|0|||
106009594|NCT02435212|365700882|FG000|Optional Extension Phase|Adverse Event|3|||
106009595|NCT02435212|365700883|FG001|Optional Extension Phase|Adverse Event|9|||
106009596|NCT02435212|365700882|FG000|Optional Extension Phase|Physician Decision|6|||
106009597|NCT02435212|365700883|FG001|Optional Extension Phase|Physician Decision|8|||
106009598|NCT02435212|365700882|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
106009599|NCT02435212|365700883|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
106009600|NCT02435212|365700882|FG000|Optional Extension Phase|Lack of Efficacy|2|||
106009601|NCT02435212|365700883|FG001|Optional Extension Phase|Lack of Efficacy|3|||
106009602|NCT02435212|365700882|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
106009603|NCT02435212|365700883|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
106009604|NCT02435212|365700882|FG000|Optional Extension Phase|Protocol Violation|0|||
106009605|NCT02435212|365700883|FG001|Optional Extension Phase|Protocol Violation|1|||
106009606|NCT02435212|365700882|FG000|Optional Extension Phase|Recovery|1|||
106009607|NCT02435212|365700883|FG001|Optional Extension Phase|Recovery|1|||
106009608|NCT02435212|365700882|FG000|Optional Extension Phase|Death|1|||
106009609|NCT02435212|365700883|FG001|Optional Extension Phase|Death|0|||
106009610|NCT02435212|365700882|FG000|Optional Extension Phase|Technical problems|2|||
106009611|NCT02435212|365700883|FG001|Optional Extension Phase|Technical problems|0|||
106009612|NCT00107198|365700884|FG000|Overall Study|Lack of Efficacy|28|||
106009613|NCT00107198|365700884|FG000|Overall Study|Lost to Follow-up|12|||
106009614|NCT00107198|365700884|FG000|Overall Study|Protocol Violation|1|||
106009615|NCT00107198|365700884|FG000|Overall Study|Withdrawal by Subject|6|||
106009616|NCT00107198|365700884|FG000|Overall Study|Ineligible|5|||
106009617|NCT04711850|365700885|FG000|Overall Study|Graft loss|2|||
106009618|NCT04711850|365700886|FG001|Overall Study|Graft loss|1|||
105733761|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
105798378|NCT00430638|364919340|FG001|Overall Study|Non-compliant|1|||
106009619|NCT04711850|365700885|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
106009620|NCT04711850|365700886|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
106009621|NCT04711850|365700885|FG000|Overall Study|Study terminated by sponsor|5|||
106009622|NCT04711850|365700886|FG001|Overall Study|Study terminated by sponsor|3|||
106009623|NCT04711850|365700885|FG000|Overall Study|Sponsor decision|0|||
106009624|NCT04711850|365700886|FG001|Overall Study|Sponsor decision|2|||
106009625|NCT03094416|365700910|FG000|Run-in|Screening failure|8|||
106009626|NCT03094416|365700910|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
106009627|NCT03094416|365700910|FG000|Run-in|Withdrawal by Subject|3|||
106009628|NCT03094416|365700910|FG000|Treatment Period|Withdrawal by Subject|2|||
106009629|NCT03104868|365700911|FG000|6 Week Follow up|Lost to Follow-up|5|||
106009630|NCT03104868|365700912|FG001|6 Week Follow up|Lost to Follow-up|8|||
105798379|NCT00430638|364919339|FG000|Overall Study|Other|2|||
105798380|NCT00430638|364919340|FG001|Overall Study|Other|2|||
105798381|NCT01010230|364919341|FG000|Overall Study|Withdrawal by Subject|6|||
105798382|NCT01010230|364919342|FG001|Overall Study|Withdrawal by Subject|5|||
105798383|NCT01010230|364919341|FG000|Overall Study|Lost to Follow-up|4|||
105798384|NCT01010230|364919342|FG001|Overall Study|Lost to Follow-up|2|||
105798385|NCT01629693|364919345|FG000|Overall Study|Lost to Follow-up|2|||
105798386|NCT01629693|364919346|FG001|Overall Study|Lost to Follow-up|4|||
105798387|NCT01629693|364919345|FG000|Overall Study|Withdrawal by Subject|2|||
105798388|NCT01629693|364919346|FG001|Overall Study|Withdrawal by Subject|2|||
105798389|NCT01629693|364919345|FG000|Overall Study|Adverse Event|1|||
105798390|NCT01629693|364919346|FG001|Overall Study|Adverse Event|0|||
105798391|NCT01629693|364919345|FG000|Overall Study|Investigator decision|0|||
105798392|NCT01629693|364919346|FG001|Overall Study|Investigator decision|1|||
105798393|NCT01629693|364919345|FG000|Overall Study|Poor comfort of study lenses|0|||
105798394|NCT01629693|364919346|FG001|Overall Study|Poor comfort of study lenses|2|||
105798395|NCT01629693|364919345|FG000|Overall Study|Subject decision unrelated to AE|0|||
105798396|NCT01629693|364919346|FG001|Overall Study|Subject decision unrelated to AE|1|||
105798397|NCT01225991|364919349|FG000|Overall Study|Withdrawal by Subject|6|||
105798398|NCT00789828|364919350|FG000|Core Period (48 Weeks)|Administrative problems|0|||
105798399|NCT00789828|364919351|FG001|Core Period (48 Weeks)|Administrative problems|1|||
105798400|NCT00789828|364919350|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
105798401|NCT00789828|364919351|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
105798402|NCT00789828|364919350|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
105798403|NCT00789828|364919351|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
105798404|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
105798405|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
105798406|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
105798407|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
105798408|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
105798409|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
105798410|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
105798411|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
105798412|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Death|1|||
105798413|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Death|0|||
105798414|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
105798415|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
105798416|NCT00789828|364919350|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
105798417|NCT00789828|364919351|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
105798418|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
105798419|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
105798420|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
105798421|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
105798422|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
105798423|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
105798424|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
105798425|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
105798426|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
105798427|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
105798428|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
105798429|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
105798430|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
105798431|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
105798432|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
105798433|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
105798434|NCT05788237|364919352|FG000|SSA (Approximately 2 Months)|Death|0|||
105798435|NCT05788237|364919353|FG001|SSA (Approximately 2 Months)|Death|1|||
105798436|NCT05788237|364919354|FG002|SSA (Approximately 2 Months)|Death|0|||
105733762|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
105733763|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
105733764|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
105733765|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
105733766|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Death|0|||
105733767|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Death|1|||
105733768|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Death|0|||
105733769|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
105733770|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
105733771|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
105733772|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
105733773|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
105733774|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
105733775|NCT00430781|364681018|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
105733776|NCT00430781|364681019|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
105733777|NCT00430781|364681020|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
105733778|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
105733779|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
105733780|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
105733781|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
105733782|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
105733783|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
105733784|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
105733785|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
105733786|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
105733787|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
105733788|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
105733789|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
105733790|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Other|0|||
105733791|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Other|1|||
105733792|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Other|0|||
105733793|NCT00430781|364681018|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
105733794|NCT00430781|364681019|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
105733795|NCT00430781|364681020|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
105733796|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
105733797|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
105733798|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
105733799|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
105733800|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
105733801|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
105733802|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
105733803|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
105733804|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
105733805|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
105733806|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
105733807|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
105733808|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
105733809|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
105733810|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
105733811|NCT00430781|364681018|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
105733812|NCT00430781|364681019|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
105733813|NCT00430781|364681020|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
105733814|NCT00882713|364681021|FG000|Overall Study|Adverse Event|2|||
105733815|NCT00882713|364681021|FG000|Overall Study|Death|3|||
105733816|NCT00882713|364681021|FG000|Overall Study|Administrative reasons|4|||
105733817|NCT00882713|364681021|FG000|Overall Study|refused treatment/withdrew consent|4|||
105733818|NCT00882713|364681021|FG000|Overall Study|Blood transfusion|2|||
105733819|NCT00882713|364681021|FG000|Overall Study|Insufficient therapeutic response|3|||
105733820|NCT00882713|364681021|FG000|Overall Study|Failure to return|2|||
105733821|NCT00882713|364681021|FG000|Overall Study|Other - Reasons|2|||
105733822|NCT03515538|364681024|FG000|Overall Study|Lack of Efficacy|2|||
105733823|NCT03515538|364681025|FG001|Overall Study|Lack of Efficacy|0|||
105733824|NCT03515538|364681026|FG002|Overall Study|Lack of Efficacy|2|||
105733825|NCT03515538|364681027|FG003|Overall Study|Lack of Efficacy|0|||
105733826|NCT03515538|364681024|FG000|Overall Study|Death|0|||
105733827|NCT03515538|364681025|FG001|Overall Study|Death|0|||
105733828|NCT03515538|364681026|FG002|Overall Study|Death|1|||
105733829|NCT03515538|364681027|FG003|Overall Study|Death|0|||
105733830|NCT03515538|364681024|FG000|Overall Study|Protocol Violation|0|||
105733831|NCT03515538|364681025|FG001|Overall Study|Protocol Violation|0|||
105733832|NCT03515538|364681026|FG002|Overall Study|Protocol Violation|0|||
105733833|NCT03515538|364681027|FG003|Overall Study|Protocol Violation|1|||
105733834|NCT03515538|364681024|FG000|Overall Study|Screen failure (baseline dropout)|0|||
105733835|NCT03515538|364681025|FG001|Overall Study|Screen failure (baseline dropout)|1|||
105733836|NCT03515538|364681026|FG002|Overall Study|Screen failure (baseline dropout)|0|||
105733837|NCT03515538|364681027|FG003|Overall Study|Screen failure (baseline dropout)|0|||
105733838|NCT03515538|364681024|FG000|Overall Study|Withdrawal by Subject|2|||
105733839|NCT03515538|364681025|FG001|Overall Study|Withdrawal by Subject|2|||
105733840|NCT03515538|364681026|FG002|Overall Study|Withdrawal by Subject|1|||
105733841|NCT03515538|364681027|FG003|Overall Study|Withdrawal by Subject|3|||
105733842|NCT03515538|364681024|FG000|Overall Study|Physician Decision|1|||
105733843|NCT03515538|364681025|FG001|Overall Study|Physician Decision|0|||
105733844|NCT03515538|364681026|FG002|Overall Study|Physician Decision|0|||
105733845|NCT03515538|364681027|FG003|Overall Study|Physician Decision|1|||
105733846|NCT00098345|364681029|FG000|Overall Study|Adverse Event|7|||
105733847|NCT00098345|364681029|FG000|Overall Study|Withdrawal by Subject|2|||
105733848|NCT00098345|364681029|FG000|Overall Study|progression|4|||
105733849|NCT03707977|364681030|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
105733850|NCT03707977|364681031|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
105733851|NCT03707977|364681032|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
105733852|NCT03707977|364681030|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
105733853|NCT03707977|364681031|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
105733854|NCT03707977|364681032|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
105733855|NCT01380093|364681035|FG000|Naloxone Challenge Phase|Screen failures|21|||
105733856|NCT01380093|364681036|FG001|Naloxone Challenge Phase|Screen failures|0|||
105733857|NCT01380093|364681037|FG002|Naloxone Challenge Phase|Screen failures|0|||
105733858|NCT01380093|364681038|FG003|Naloxone Challenge Phase|Screen failures|0|||
105733859|NCT01380093|364681039|FG004|Naloxone Challenge Phase|Screen failures|0|||
105733860|NCT01380093|364681040|FG005|Naloxone Challenge Phase|Screen failures|0|||
105733861|NCT01380093|364681041|FG006|Naloxone Challenge Phase|Screen failures|0|||
105733862|NCT01380093|364681042|FG007|Naloxone Challenge Phase|Screen failures|0|||
105733863|NCT01380093|364681043|FG008|Naloxone Challenge Phase|Screen failures|0|||
105733864|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733865|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
105733866|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733867|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733868|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733869|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733870|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733871|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733872|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
105733873|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733874|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
105733875|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
105733876|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733877|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733878|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733879|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733880|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733881|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
105733882|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733883|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
105733884|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733885|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733886|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733887|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733888|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733889|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733890|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
105733891|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733892|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
105733893|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
106139665|NCT01677936|366170372|FG001|Overall Study|Adverse Event|0|||
106139666|NCT01677936|366170371|FG000|Overall Study|Lost to Follow-up|1|||
106139667|NCT01677936|366170372|FG001|Overall Study|Lost to Follow-up|0|||
106139668|NCT01677936|366170371|FG000|Overall Study|Protocol Violation|0|||
106139669|NCT01677936|366170372|FG001|Overall Study|Protocol Violation|4|||
105733894|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733895|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733896|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733897|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733898|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733899|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
105733900|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733901|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
105733902|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
105733903|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733904|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733905|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733906|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733907|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733908|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
105733909|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733910|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733911|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
105733912|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733913|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733914|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733915|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733916|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733917|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
105733918|NCT01380093|364681035|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733919|NCT01380093|364681036|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733920|NCT01380093|364681037|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
105733921|NCT01380093|364681038|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733922|NCT01380093|364681039|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733923|NCT01380093|364681040|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733924|NCT01380093|364681041|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733925|NCT01380093|364681042|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733926|NCT01380093|364681043|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
105733927|NCT01380093|364681035|FG000|Treatment Phase: Second Intervention|Other|0|||
105733928|NCT01380093|364681036|FG001|Treatment Phase: Second Intervention|Other|0|||
105733929|NCT01380093|364681037|FG002|Treatment Phase: Second Intervention|Other|0|||
105733930|NCT01380093|364681038|FG003|Treatment Phase: Second Intervention|Other|1|||
105733931|NCT01380093|364681039|FG004|Treatment Phase: Second Intervention|Other|0|||
105733932|NCT01380093|364681040|FG005|Treatment Phase: Second Intervention|Other|0|||
105733933|NCT01380093|364681041|FG006|Treatment Phase: Second Intervention|Other|0|||
105733934|NCT01380093|364681042|FG007|Treatment Phase: Second Intervention|Other|0|||
105733935|NCT01380093|364681043|FG008|Treatment Phase: Second Intervention|Other|0|||
105733936|NCT01380093|364681035|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
105733937|NCT01380093|364681036|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
105733938|NCT01380093|364681037|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
105733939|NCT01380093|364681038|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
105733940|NCT01380093|364681039|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
105733941|NCT01380093|364681040|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
105733942|NCT01380093|364681041|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
105733943|NCT01380093|364681042|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
105733944|NCT01380093|364681043|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
105733945|NCT01380093|364681035|FG000|Treatment Phase: Third Intervention|Other|0|||
105733946|NCT01380093|364681036|FG001|Treatment Phase: Third Intervention|Other|0|||
105733947|NCT01380093|364681037|FG002|Treatment Phase: Third Intervention|Other|0|||
105733948|NCT01380093|364681038|FG003|Treatment Phase: Third Intervention|Other|0|||
105733949|NCT01380093|364681039|FG004|Treatment Phase: Third Intervention|Other|0|||
105733950|NCT01380093|364681040|FG005|Treatment Phase: Third Intervention|Other|0|||
105733951|NCT01380093|364681041|FG006|Treatment Phase: Third Intervention|Other|0|||
105733952|NCT01380093|364681042|FG007|Treatment Phase: Third Intervention|Other|0|||
105733953|NCT01380093|364681043|FG008|Treatment Phase: Third Intervention|Other|1|||
105733954|NCT00308620|364681044|FG000|Overall Study|Death|1|||
105733955|NCT00308620|364681045|FG001|Overall Study|Death|1|||
105733956|NCT00308620|364681046|FG002|Overall Study|Death|0|||
105733957|NCT00308620|364681044|FG000|Overall Study|Lost to Follow-up|0|||
105733958|NCT00308620|364681045|FG001|Overall Study|Lost to Follow-up|0|||
105733959|NCT00308620|364681046|FG002|Overall Study|Lost to Follow-up|1|||
105733960|NCT03952650|364681047|FG000|Overall Study|TRAVEL|0|||
105733961|NCT03952650|364681048|FG001|Overall Study|TRAVEL|4|||
105733962|NCT03952650|364681049|FG002|Overall Study|TRAVEL|0|||
105733963|NCT03952650|364681050|FG003|Overall Study|TRAVEL|4|||
106139670|NCT04057196|366170375|FG000|Overall Study|Withdrawal by Subject|3|||
106139671|NCT04057196|366170375|FG000|Overall Study|Death|3|||
105733964|NCT03952650|364681051|FG004|Overall Study|TRAVEL|0|||
105733965|NCT03952650|364681052|FG005|Overall Study|TRAVEL|3|||
105733966|NCT03952650|364681053|FG006|Overall Study|TRAVEL|2|||
105733967|NCT03952650|364681047|FG000|Overall Study|Withdrawal by Subject|0|||
105733968|NCT03952650|364681048|FG001|Overall Study|Withdrawal by Subject|2|||
105733969|NCT03952650|364681049|FG002|Overall Study|Withdrawal by Subject|0|||
105733970|NCT03952650|364681050|FG003|Overall Study|Withdrawal by Subject|3|||
105733971|NCT03952650|364681051|FG004|Overall Study|Withdrawal by Subject|0|||
105733972|NCT03952650|364681052|FG005|Overall Study|Withdrawal by Subject|1|||
105733973|NCT03952650|364681053|FG006|Overall Study|Withdrawal by Subject|1|||
105733974|NCT03952650|364681047|FG000|Overall Study|Lost to Follow-up|0|||
105733975|NCT03952650|364681048|FG001|Overall Study|Lost to Follow-up|1|||
105733976|NCT03952650|364681049|FG002|Overall Study|Lost to Follow-up|0|||
105733977|NCT03952650|364681050|FG003|Overall Study|Lost to Follow-up|0|||
105733978|NCT03952650|364681051|FG004|Overall Study|Lost to Follow-up|0|||
105733979|NCT03952650|364681052|FG005|Overall Study|Lost to Follow-up|1|||
105733980|NCT03952650|364681053|FG006|Overall Study|Lost to Follow-up|1|||
105798437|NCT05788237|364919355|FG003|SSA (Approximately 2 Months)|Death|0|||
105733981|NCT03952650|364681047|FG000|Overall Study|Received wrong vaccine and travelled|0|||
105733982|NCT03952650|364681048|FG001|Overall Study|Received wrong vaccine and travelled|0|||
105733983|NCT03952650|364681049|FG002|Overall Study|Received wrong vaccine and travelled|0|||
105733984|NCT03952650|364681050|FG003|Overall Study|Received wrong vaccine and travelled|0|||
105937869|NCT02037984|365431590|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
105937870|NCT02037984|365431591|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
105937871|NCT02037984|365431592|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
105937872|NCT02037984|365431585|FG000|Overall Study|Withdrawal by Subject|0|||
105937873|NCT02037984|365431586|FG001|Overall Study|Withdrawal by Subject|0|||
105937874|NCT02037984|365431587|FG002|Overall Study|Withdrawal by Subject|0|||
105937875|NCT02037984|365431588|FG003|Overall Study|Withdrawal by Subject|1|||
105937876|NCT02037984|365431589|FG004|Overall Study|Withdrawal by Subject|1|||
105937877|NCT02037984|365431590|FG005|Overall Study|Withdrawal by Subject|3|||
105937878|NCT02037984|365431591|FG006|Overall Study|Withdrawal by Subject|0|||
105937879|NCT02037984|365431592|FG007|Overall Study|Withdrawal by Subject|1|||
105937880|NCT01569763|365432920|FG000|Overall Study|Lack of Efficacy|2|||
105937881|NCT01569763|365432921|FG001|Overall Study|Lack of Efficacy|7|||
105937882|NCT01569763|365432920|FG000|Overall Study|Adverse Event|1|||
105937883|NCT01569763|365432921|FG001|Overall Study|Adverse Event|0|||
105937884|NCT01197300|365432925|FG000|Overall Study|Lost to Follow-up|0|||
105937885|NCT01197300|365432926|FG001|Overall Study|Lost to Follow-up|1|||
105937886|NCT01197300|365432925|FG000|Overall Study|Protocol Violation|0|||
105937887|NCT01197300|365432926|FG001|Overall Study|Protocol Violation|1|||
105937888|NCT03211858|365432928|FG000|Overall Study|Adverse Event|8|||
105937889|NCT03211858|365432929|FG001|Overall Study|Adverse Event|6|||
105937890|NCT03211858|365432928|FG000|Overall Study|Lack of Efficacy|0|||
105937891|NCT03211858|365432929|FG001|Overall Study|Lack of Efficacy|4|||
105937892|NCT03211858|365432928|FG000|Overall Study|Poor compliance to protocol|6|||
105937893|NCT03211858|365432929|FG001|Overall Study|Poor compliance to protocol|2|||
105937894|NCT03211858|365432928|FG000|Overall Study|Non-serious Hypoglycemia|1|||
105937895|NCT03211858|365432929|FG001|Overall Study|Non-serious Hypoglycemia|0|||
106139672|NCT03068468|366170376|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
106139673|NCT03068468|366170377|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
106139674|NCT03068468|366170378|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
106139675|NCT03068468|366170379|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
106139676|NCT03068468|366170376|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
106139677|NCT03068468|366170377|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
106139678|NCT03068468|366170378|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
106139679|NCT03068468|366170379|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
106139680|NCT03068468|366170376|FG000|Placebo-Controlled Period|Adverse Event|16|||
106139681|NCT03068468|366170377|FG001|Placebo-Controlled Period|Adverse Event|21|||
106139682|NCT03068468|366170378|FG002|Placebo-Controlled Period|Adverse Event|0|||
106139683|NCT03068468|366170379|FG003|Placebo-Controlled Period|Adverse Event|0|||
106139684|NCT03068468|366170376|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
106139685|NCT03068468|366170377|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
105733985|NCT03952650|364681051|FG004|Overall Study|Received wrong vaccine and travelled|0|||
105733986|NCT03952650|364681052|FG005|Overall Study|Received wrong vaccine and travelled|1|||
105733987|NCT03952650|364681053|FG006|Overall Study|Received wrong vaccine and travelled|0|||
105937896|NCT03211858|365432928|FG000|Overall Study|Other than specified above|22|||
105937897|NCT03211858|365432929|FG001|Overall Study|Other than specified above|21|||
105937898|NCT01748552|365432930|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
105937899|NCT01748552|365432931|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
105937900|NCT01748552|365432932|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
105937901|NCT01748552|365432933|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
105733988|NCT03952650|364681047|FG000|Overall Study|Unable to make study visit|0|||
105733989|NCT03952650|364681048|FG001|Overall Study|Unable to make study visit|0|||
105733990|NCT03952650|364681049|FG002|Overall Study|Unable to make study visit|0|||
105733991|NCT03952650|364681050|FG003|Overall Study|Unable to make study visit|0|||
105733992|NCT03952650|364681051|FG004|Overall Study|Unable to make study visit|0|||
105798438|NCT05788237|364919352|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
105798439|NCT05788237|364919353|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
105798440|NCT05788237|364919354|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
105798441|NCT05788237|364919355|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
105798442|NCT05788237|364919352|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
105798443|NCT05788237|364919353|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
105798444|NCT05788237|364919354|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
105798445|NCT05788237|364919355|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
105798446|NCT05788237|364919352|FG000|SSB (Approximately 1 Month)|Other|0|||
105798447|NCT05788237|364919353|FG001|SSB (Approximately 1 Month)|Other|0|||
105798448|NCT05788237|364919354|FG002|SSB (Approximately 1 Month)|Other|0|||
106139686|NCT03068468|366170378|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
105733993|NCT03952650|364681052|FG005|Overall Study|Unable to make study visit|1|||
105733994|NCT03952650|364681053|FG006|Overall Study|Unable to make study visit|0|||
106139687|NCT03068468|366170379|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
106139688|NCT03068468|366170376|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
105733995|NCT03988751|364681062|FG000|Overall Study|Withdrawal by Subject|1|||
105733996|NCT03988751|364681063|FG001|Overall Study|Withdrawal by Subject|0|||
105733997|NCT03988751|364681062|FG000|Overall Study|Protocol Violation|0|||
105733998|NCT03988751|364681063|FG001|Overall Study|Protocol Violation|1|||
105733999|NCT00844883|364681064|FG000|Overall Study|Bridged to liver transplant|3|||
105734000|NCT00844883|364681064|FG000|Overall Study|Bridged to resection|1|||
105734001|NCT02623361|364681065|FG000|Overall Study|Protocol Violation|0|||
105734002|NCT02623361|364681066|FG001|Overall Study|Protocol Violation|1|||
105734003|NCT02623361|364681065|FG000|Overall Study|Withdrawal by Subject|0|||
105734004|NCT02623361|364681066|FG001|Overall Study|Withdrawal by Subject|1|||
105734005|NCT03043365|364681067|FG000|Weeks 0 to Week 8|Adverse Event|1|||
105734006|NCT03043365|364681068|FG001|Weeks 0 to Week 8|Adverse Event|3|||
105734007|NCT03043365|364681067|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
105734008|NCT03043365|364681068|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
105734009|NCT03043365|364681067|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
105734010|NCT03043365|364681068|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
105734011|NCT03065530|364681069|FG000|Overall Study|Lack of Efficacy|1|||
105734012|NCT03065530|364681070|FG001|Overall Study|Lack of Efficacy|1|||
105734013|NCT03065530|364681071|FG002|Overall Study|Lack of Efficacy|0|||
105734014|NCT03065530|364681072|FG003|Overall Study|Lack of Efficacy|1|||
105734015|NCT03065530|364681069|FG000|Overall Study|Protocol Violation|1|||
105734016|NCT03065530|364681070|FG001|Overall Study|Protocol Violation|0|||
105734017|NCT03065530|364681071|FG002|Overall Study|Protocol Violation|1|||
105734018|NCT03065530|364681072|FG003|Overall Study|Protocol Violation|1|||
105734019|NCT02498652|364681073|FG000|Overall Study|Protocol Violation|0|||
105734020|NCT02498652|364681074|FG001|Overall Study|Protocol Violation|1|||
105734021|NCT02723630|364681075|FG000|Intervention Period 1|Adverse Event|1|||
105734022|NCT02723630|364681076|FG001|Intervention Period 1|Adverse Event|0|||
105734023|NCT02723630|364681077|FG002|Intervention Period 1|Adverse Event|0|||
105734024|NCT02723630|364681078|FG003|Intervention Period 1|Adverse Event|0|||
105734025|NCT02723630|364681079|FG004|Intervention Period 1|Adverse Event|0|||
105734026|NCT02723630|364681080|FG005|Intervention Period 1|Adverse Event|0|||
105734027|NCT02723630|364681075|FG000|Intervention Period 3|consumption of restricted item|0|||
105734028|NCT02723630|364681076|FG001|Intervention Period 3|consumption of restricted item|1|||
105734029|NCT02723630|364681077|FG002|Intervention Period 3|consumption of restricted item|0|||
105734030|NCT02723630|364681078|FG003|Intervention Period 3|consumption of restricted item|0|||
105734031|NCT02723630|364681079|FG004|Intervention Period 3|consumption of restricted item|0|||
105734032|NCT02723630|364681080|FG005|Intervention Period 3|consumption of restricted item|0|||
105798449|NCT05788237|364919355|FG003|SSB (Approximately 1 Month)|Other|1|||
105798450|NCT02239692|364920879|FG000|Overall Study|Incomplete colonoscopy|1|||
106139689|NCT03068468|366170377|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
106139690|NCT03068468|366170378|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
106139691|NCT03068468|366170379|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105734033|NCT03455543|364681081|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
105734034|NCT03455543|364681082|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
105734035|NCT03455543|364681083|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
105734036|NCT03455543|364681081|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
105734037|NCT03455543|364681082|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
105734038|NCT03455543|364681083|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
105798451|NCT02239692|364920880|FG001|Overall Study|Incomplete colonoscopy|2|||
105798452|NCT02239692|364920879|FG000|Overall Study|Adverse Event|0|||
105798453|NCT02239692|364920880|FG001|Overall Study|Adverse Event|1|||
105798454|NCT02239692|364920879|FG000|Overall Study|Physician Decision|0|||
105798455|NCT02239692|364920880|FG001|Overall Study|Physician Decision|1|||
105798456|NCT02239692|364920879|FG000|Overall Study|Lost to Follow-up|1|||
105798457|NCT02239692|364920880|FG001|Overall Study|Lost to Follow-up|4|||
105798458|NCT02239692|364920879|FG000|Overall Study|Withdrawal by Subject|3|||
105798459|NCT02239692|364920880|FG001|Overall Study|Withdrawal by Subject|5|||
105798460|NCT02239692|364920879|FG000|Overall Study|Other reason|1|||
105798461|NCT02239692|364920880|FG001|Overall Study|Other reason|0|||
105798462|NCT00569231|364920885|FG000|Overall Study|Study unrelated surgery|1|||
105798463|NCT00569231|364920885|FG000|Overall Study|Airfare expense|2|||
105798464|NCT00569231|364920885|FG000|Overall Study|Withdrawal by Subject|1|||
105798465|NCT00569231|364920885|FG000|Overall Study|Car accident injury|1|||
105798466|NCT00569231|364920885|FG000|Overall Study|Non-compliance|2|||
105798467|NCT00305110|364920888|FG000|Overall Study|Missing data|29|||
105798468|NCT01467570|364920891|FG000|Overall Study|Lost to Follow-up|8|||
105798469|NCT01467570|364920892|FG001|Overall Study|Lost to Follow-up|9|||
105798470|NCT01835470|364920893|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
105798471|NCT01835470|364920893|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
105798472|NCT00304954|364920894|FG000|Overall Study|Withdrawal by Subject|0|||
105798473|NCT00304954|364920895|FG001|Overall Study|Withdrawal by Subject|0|||
105798474|NCT00304954|364920896|FG002|Overall Study|Withdrawal by Subject|1|||
105798475|NCT00304954|364920897|FG003|Overall Study|Withdrawal by Subject|0|||
105798476|NCT00304954|364920894|FG000|Overall Study|Adverse Event|1|||
105798477|NCT00304954|364920895|FG001|Overall Study|Adverse Event|0|||
105798478|NCT00304954|364920896|FG002|Overall Study|Adverse Event|0|||
105798479|NCT00304954|364920897|FG003|Overall Study|Adverse Event|0|||
105798480|NCT01440647|364920898|FG000|Overall Study|Death|2|||
105798481|NCT01440647|364920899|FG001|Overall Study|Death|3|||
105798482|NCT02595528|364920924|FG000|Overall Study|Withdrawal by Subject|1|||
105798483|NCT02595528|364920925|FG001|Overall Study|Withdrawal by Subject|2|||
105798484|NCT02595528|364920926|FG002|Overall Study|Withdrawal by Subject|1|||
105798485|NCT02595528|364920927|FG003|Overall Study|Withdrawal by Subject|3|||
105798486|NCT02595528|364920924|FG000|Overall Study|Lost to Follow-up|1|||
105798487|NCT02595528|364920925|FG001|Overall Study|Lost to Follow-up|1|||
105798488|NCT02595528|364920926|FG002|Overall Study|Lost to Follow-up|0|||
105798489|NCT02595528|364920927|FG003|Overall Study|Lost to Follow-up|1|||
105798490|NCT03862625|364920928|FG000|Overall Study|Lost to Follow-up|0|||
105798491|NCT03862625|364920929|FG001|Overall Study|Lost to Follow-up|1|||
105798492|NCT04023994|364920940|FG000|Overall Study|Lost to Follow-up|0|||
105798493|NCT04023994|364920941|FG001|Overall Study|Lost to Follow-up|1|||
105798494|NCT04023994|364920942|FG002|Overall Study|Lost to Follow-up|2|||
105798495|NCT04023994|364920943|FG003|Overall Study|Lost to Follow-up|0|||
105798496|NCT04023994|364920944|FG004|Overall Study|Lost to Follow-up|0|||
105798497|NCT04023994|364920945|FG005|Overall Study|Lost to Follow-up|0|||
105798498|NCT04023994|364920940|FG000|Overall Study|Withdrawal by Subject|0|||
105798499|NCT04023994|364920941|FG001|Overall Study|Withdrawal by Subject|0|||
105798500|NCT04023994|364920942|FG002|Overall Study|Withdrawal by Subject|0|||
105798501|NCT04023994|364920943|FG003|Overall Study|Withdrawal by Subject|1|||
105798502|NCT04023994|364920944|FG004|Overall Study|Withdrawal by Subject|0|||
105798503|NCT04023994|364920945|FG005|Overall Study|Withdrawal by Subject|0|||
105798504|NCT01377233|364920946|FG000|Open-label|Adverse Event|1|||
105798505|NCT01377233|364920947|FG001|Open-label|Adverse Event|0|||
105798506|NCT01377233|364920948|FG002|Open-label|Adverse Event|0|||
105798507|NCT01377233|364920949|FG003|Open-label|Adverse Event|0|||
105734039|NCT03455543|364681081|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
105734040|NCT03455543|364681082|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
105734041|NCT03455543|364681083|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
105734042|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
105734043|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
105734044|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
105734045|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
105798508|NCT01377233|364920950|FG004|Open-label|Adverse Event|0|||
105798509|NCT01377233|364920946|FG000|Open-label|Withdrawal by Subject|3|||
105798510|NCT01377233|364920947|FG001|Open-label|Withdrawal by Subject|0|||
105937902|NCT01748552|365432934|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
105734046|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
105734047|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
105798511|NCT01377233|364920948|FG002|Open-label|Withdrawal by Subject|0|||
105798512|NCT01377233|364920949|FG003|Open-label|Withdrawal by Subject|0|||
105798513|NCT01377233|364920950|FG004|Open-label|Withdrawal by Subject|0|||
105798514|NCT01377233|364920946|FG000|Double-blind|Adverse Event|0|||
105798515|NCT01377233|364920947|FG001|Double-blind|Adverse Event|1|||
105798516|NCT01377233|364920948|FG002|Double-blind|Adverse Event|2|||
105798517|NCT01377233|364920949|FG003|Double-blind|Adverse Event|2|||
105798518|NCT01377233|364920950|FG004|Double-blind|Adverse Event|0|||
105798519|NCT01377233|364920946|FG000|Double-blind|Protocol Violation|0|||
105798520|NCT01377233|364920947|FG001|Double-blind|Protocol Violation|0|||
105798521|NCT01377233|364920948|FG002|Double-blind|Protocol Violation|0|||
105798522|NCT01377233|364920949|FG003|Double-blind|Protocol Violation|0|||
105798523|NCT01377233|364920950|FG004|Double-blind|Protocol Violation|1|||
105798524|NCT01377233|364920946|FG000|Double-blind|Withdrawal by Subject|0|||
105798525|NCT01377233|364920947|FG001|Double-blind|Withdrawal by Subject|0|||
105798526|NCT01377233|364920948|FG002|Double-blind|Withdrawal by Subject|0|||
105798527|NCT01377233|364920949|FG003|Double-blind|Withdrawal by Subject|1|||
105798528|NCT01377233|364920950|FG004|Double-blind|Withdrawal by Subject|0|||
105798529|NCT01377233|364920946|FG000|Double-blind|Administrative or other|0|||
105798530|NCT01377233|364920947|FG001|Double-blind|Administrative or other|0|||
105798531|NCT01377233|364920948|FG002|Double-blind|Administrative or other|0|||
105798532|NCT01377233|364920949|FG003|Double-blind|Administrative or other|1|||
105798533|NCT01377233|364920950|FG004|Double-blind|Administrative or other|1|||
105798534|NCT01785875|364920951|FG000|Overall Study|Withdrawal by Subject|41|||
105798535|NCT01785875|364920952|FG001|Overall Study|Withdrawal by Subject|34|||
105798536|NCT01785875|364920953|FG002|Overall Study|Withdrawal by Subject|36|||
105798537|NCT01785875|364920951|FG000|Overall Study|Lost to Follow-up|19|||
105798538|NCT01785875|364920952|FG001|Overall Study|Lost to Follow-up|22|||
105798539|NCT01785875|364920953|FG002|Overall Study|Lost to Follow-up|6|||
105798540|NCT01785875|364920951|FG000|Overall Study|Death|27|||
105798541|NCT01785875|364920952|FG001|Overall Study|Death|16|||
105798542|NCT01785875|364920953|FG002|Overall Study|Death|7|||
105798543|NCT01785875|364920951|FG000|Overall Study|Sponsor Decision|0|||
105798544|NCT01785875|364920952|FG001|Overall Study|Sponsor Decision|2|||
105798545|NCT01785875|364920953|FG002|Overall Study|Sponsor Decision|0|||
105798546|NCT01785875|364920951|FG000|Overall Study|Protocol Specified Criteria|207|||
105798547|NCT01785875|364920952|FG001|Overall Study|Protocol Specified Criteria|214|||
105798548|NCT01785875|364920953|FG002|Overall Study|Protocol Specified Criteria|55|||
105798549|NCT01785875|364920951|FG000|Overall Study|Missing|0|||
105798550|NCT01785875|364920952|FG001|Overall Study|Missing|1|||
105798551|NCT01785875|364920953|FG002|Overall Study|Missing|3|||
105798552|NCT01814761|364920956|FG000|Overall Study|Other Reasons|1|||
105798553|NCT01814761|364920957|FG001|Overall Study|Other Reasons|10|||
105798554|NCT01814761|364920956|FG000|Overall Study|Ocular Adverse Event|6|||
105798555|NCT01814761|364920957|FG001|Overall Study|Ocular Adverse Event|15|||
105798556|NCT01814761|364920956|FG000|Overall Study|Lost to Follow-up|1|||
105798557|NCT01814761|364920957|FG001|Overall Study|Lost to Follow-up|5|||
105798558|NCT03137082|364920958|FG000|Overall Study|Withdrawal by Subject|1|||
105798559|NCT03137082|364920959|FG001|Overall Study|Withdrawal by Subject|1|||
105798560|NCT03137082|364920958|FG000|Overall Study|Lost to Follow-up|1|||
105798561|NCT03137082|364920959|FG001|Overall Study|Lost to Follow-up|0|||
105798562|NCT00417027|364920960|FG000|Overall Study|Protocol Violation|0|||
105798563|NCT00417027|364920961|FG001|Overall Study|Protocol Violation|5|||
105798564|NCT00417027|364920962|FG002|Overall Study|Protocol Violation|5|||
105798565|NCT00707174|364920963|FG000|Overall Study|Adverse Event|1|||
105798566|NCT00707174|364920964|FG001|Overall Study|Adverse Event|6|||
105798567|NCT00707174|364920963|FG000|Overall Study|Withdrawal by Subject|4|||
105798568|NCT00707174|364920964|FG001|Overall Study|Withdrawal by Subject|1|||
105798569|NCT00467818|364920965|FG000|Overall Study|Adverse Event|1|||
105798570|NCT00467818|364920966|FG001|Overall Study|Adverse Event|0|||
105798571|NCT00467818|364920965|FG000|Overall Study|Lost to Follow-up|2|||
105798572|NCT00467818|364920966|FG001|Overall Study|Lost to Follow-up|2|||
105798573|NCT01017029|364920967|FG000|Overall Study|Lost to Follow-up|1|||
105798574|NCT01017029|364920968|FG001|Overall Study|Lost to Follow-up|0|||
105798575|NCT01017029|364920967|FG000|Overall Study|Administrative problem|0|||
105798576|NCT01017029|364920968|FG001|Overall Study|Administrative problem|1|||
105798577|NCT01017029|364920967|FG000|Overall Study|Death|3|||
105798578|NCT01017029|364920968|FG001|Overall Study|Death|1|||
105798579|NCT00618774|364920971|FG000|Overall Study|Adverse Event|5|||
105798580|NCT00618774|364920972|FG001|Overall Study|Adverse Event|3|||
105798581|NCT00618774|364920971|FG000|Overall Study|Withdrawal by Subject|1|||
105798582|NCT00618774|364920972|FG001|Overall Study|Withdrawal by Subject|0|||
105798583|NCT02753400|364920974|FG000|Overall Study|Adverse Event|3|||
105798584|NCT02753400|364920975|FG001|Overall Study|Adverse Event|0|||
105798585|NCT02753400|364920974|FG000|Overall Study|Withdrawal by Subject|2|||
105798586|NCT02753400|364920975|FG001|Overall Study|Withdrawal by Subject|1|||
105798587|NCT00447603|364920976|FG000|Screening|Withdrawal by Subject|1|||
105798588|NCT00447603|364920977|FG001|Screening|Withdrawal by Subject|0|||
105798589|NCT00447603|364920978|FG002|Screening|Withdrawal by Subject|0|||
105798590|NCT00447603|364920976|FG000|Screening|Protocol Violation|1|||
105798591|NCT00447603|364920977|FG001|Screening|Protocol Violation|0|||
105798592|NCT00447603|364920978|FG002|Screening|Protocol Violation|0|||
105798593|NCT00447603|364920976|FG000|Screening|Screen Failure|4|||
105798594|NCT00447603|364920977|FG001|Screening|Screen Failure|0|||
105798595|NCT00447603|364920978|FG002|Screening|Screen Failure|0|||
105798596|NCT00447603|364920976|FG000|Screening|Study Terminated by Sponsor|15|||
105798597|NCT00447603|364920977|FG001|Screening|Study Terminated by Sponsor|0|||
105798598|NCT00447603|364920978|FG002|Screening|Study Terminated by Sponsor|0|||
105798599|NCT00447603|364920976|FG000|Filter Period|Adverse Event|0|||
105734048|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
105734049|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
105734050|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
105734051|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
105734052|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
105734053|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
105734054|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
105734055|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
105734056|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
106009631|NCT03104868|365700911|FG000|6 Week Follow up|Death|1|||
106009632|NCT03104868|365700912|FG001|6 Week Follow up|Death|1|||
106009633|NCT03104868|365700911|FG000|6 Week Follow up|Withdrawal by Subject|7|||
106009634|NCT03104868|365700912|FG001|6 Week Follow up|Withdrawal by Subject|6|||
105734057|NCT03455543|364681081|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
105734058|NCT03455543|364681082|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
106009635|NCT03104868|365700911|FG000|6 Week Follow up|Completed Later Timepoint|24|||
106009636|NCT03104868|365700912|FG001|6 Week Follow up|Completed Later Timepoint|22|||
106009637|NCT03104868|365700911|FG000|6 Month Follow up|Lost to Follow-up|2|||
106009638|NCT03104868|365700912|FG001|6 Month Follow up|Lost to Follow-up|2|||
106009639|NCT03104868|365700911|FG000|6 Month Follow up|Death|0|||
106009640|NCT03104868|365700912|FG001|6 Month Follow up|Death|1|||
106009641|NCT03104868|365700911|FG000|6 Month Follow up|Completed Later Timepoint|22|||
106009642|NCT03104868|365700912|FG001|6 Month Follow up|Completed Later Timepoint|32|||
106009643|NCT03104868|365700911|FG000|12 Month Follow up|Lost to Follow-up|1|||
106009644|NCT03104868|365700912|FG001|12 Month Follow up|Lost to Follow-up|2|||
106009645|NCT03104868|365700911|FG000|12 Month Follow up|Death|0|||
106009646|NCT03104868|365700912|FG001|12 Month Follow up|Death|1|||
106009647|NCT03104868|365700911|FG000|12 Month Follow up|Withdrawal by Subject|0|||
106009648|NCT03104868|365700912|FG001|12 Month Follow up|Withdrawal by Subject|3|||
106009649|NCT03104868|365700911|FG000|12 Month Follow up|Completed Later Timepoint|32|||
106009650|NCT03104868|365700912|FG001|12 Month Follow up|Completed Later Timepoint|29|||
105734059|NCT03455543|364681083|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
105734060|NCT02873221|364681084|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
105734061|NCT02873221|364681085|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
105734062|NCT02873221|364681086|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
105734063|NCT02873221|364681084|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
105734064|NCT02873221|364681085|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
105734065|NCT02873221|364681086|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
105734066|NCT02873221|364681084|FG000|Treatment Period|Protocol Violation|2|||
105734067|NCT02873221|364681085|FG001|Treatment Period|Protocol Violation|5|||
105734068|NCT02873221|364681086|FG002|Treatment Period|Protocol Violation|8|||
105734069|NCT02873221|364681084|FG000|Treatment Period|Pregnancy|4|||
105734070|NCT02873221|364681085|FG001|Treatment Period|Pregnancy|6|||
105734071|NCT02873221|364681086|FG002|Treatment Period|Pregnancy|3|||
105734072|NCT02873221|364681084|FG000|Treatment Period|Lack of Qualifying Event|0|||
105734073|NCT02873221|364681085|FG001|Treatment Period|Lack of Qualifying Event|3|||
105734074|NCT02873221|364681086|FG002|Treatment Period|Lack of Qualifying Event|1|||
105734075|NCT02873221|364681084|FG000|Treatment Period|Withdrawal of Consent|52|||
105734076|NCT02873221|364681085|FG001|Treatment Period|Withdrawal of Consent|51|||
105734077|NCT02873221|364681086|FG002|Treatment Period|Withdrawal of Consent|41|||
105734078|NCT02873221|364681084|FG000|Treatment Period|Lack of Efficacy|0|||
105734079|NCT02873221|364681085|FG001|Treatment Period|Lack of Efficacy|17|||
105734080|NCT02873221|364681086|FG002|Treatment Period|Lack of Efficacy|12|||
105734081|NCT02873221|364681084|FG000|Treatment Period|Adverse Event|4|||
105734082|NCT02873221|364681085|FG001|Treatment Period|Adverse Event|9|||
105734083|NCT02873221|364681086|FG002|Treatment Period|Adverse Event|11|||
105734084|NCT02873221|364681084|FG000|Treatment Period|Lost to Follow-up|26|||
105734085|NCT02873221|364681085|FG001|Treatment Period|Lost to Follow-up|30|||
105734086|NCT02873221|364681086|FG002|Treatment Period|Lost to Follow-up|26|||
106009651|NCT03104868|365700911|FG000|18 Month Follow up|Lost to Follow-up|7|||
106009652|NCT03104868|365700912|FG001|18 Month Follow up|Lost to Follow-up|11|||
106009653|NCT03104868|365700911|FG000|18 Month Follow up|Death|2|||
105734087|NCT02873221|364681084|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
105734088|NCT02873221|364681085|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
105734089|NCT02873221|364681086|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
105734090|NCT02873221|364681084|FG000|Safety Follow-up Period|Protocol Violation|0|||
105734091|NCT02873221|364681085|FG001|Safety Follow-up Period|Protocol Violation|0|||
105734092|NCT02873221|364681086|FG002|Safety Follow-up Period|Protocol Violation|1|||
105734093|NCT02873221|364681084|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
105734094|NCT02873221|364681085|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
105734095|NCT02873221|364681086|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
106009654|NCT03104868|365700912|FG001|18 Month Follow up|Death|1|||
105734096|NCT02873221|364681084|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
105734097|NCT02873221|364681085|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
105734098|NCT02873221|364681086|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
105734099|NCT00779038|364681087|FG000|Overall Study|Study Prematurely Terminated|13|||
105734100|NCT05372315|364681090|FG000|Overall Study|Withdrawal by Subject|1|||
105734101|NCT05372315|364681091|FG001|Overall Study|Withdrawal by Subject|0|||
105734102|NCT00537745|364681092|FG000|Overall Study|Did not meet eligibility criteria|2|||
105734103|NCT00537745|364681092|FG000|Overall Study|Withdrawal by Subject|2|||
105734104|NCT00537745|364681092|FG000|Overall Study|Subject unable to provide Interlock info|1|||
105734105|NCT01512368|364681093|FG000|Overall Study|Protocol Violation|3|||
105734106|NCT01508676|364681094|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
105734107|NCT01508676|364681095|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
105734108|NCT01508676|364681094|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
105734109|NCT01508676|364681095|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
105734110|NCT01508676|364681094|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
105734111|NCT01508676|364681095|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
105734112|NCT01508676|364681094|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
105734113|NCT01508676|364681095|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
105734114|NCT01508676|364681094|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
105734115|NCT01508676|364681095|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
105734116|NCT00922935|364681096|FG000|Overall Study|Protocol Violation|0|||
105734117|NCT00922935|364681097|FG001|Overall Study|Protocol Violation|3|||
105734118|NCT00922935|364681098|FG002|Overall Study|Protocol Violation|0|||
105734119|NCT00922935|364681096|FG000|Overall Study|Physician Decision|1|||
105734120|NCT00922935|364681097|FG001|Overall Study|Physician Decision|1|||
105734121|NCT00922935|364681098|FG002|Overall Study|Physician Decision|0|||
105734122|NCT00922935|364681096|FG000|Overall Study|Lost to Follow-up|0|||
105734123|NCT00922935|364681097|FG001|Overall Study|Lost to Follow-up|1|||
105734124|NCT00922935|364681098|FG002|Overall Study|Lost to Follow-up|0|||
105734125|NCT02532543|364681099|FG000|Overall Study|Lost to Follow-up|0|||
105734126|NCT02532543|364681100|FG001|Overall Study|Lost to Follow-up|0|||
105734127|NCT02532543|364681101|FG002|Overall Study|Lost to Follow-up|1|||
105734128|NCT02532543|364681102|FG003|Overall Study|Lost to Follow-up|0|||
105734129|NCT02614794|364681104|FG000|Overall Study|Death|258|||
105734130|NCT02614794|364681105|FG001|Overall Study|Death|151|||
105937903|NCT01748552|365432935|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
105937904|NCT01748552|365432936|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
105937905|NCT01748552|365432937|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
105937906|NCT01748552|365432938|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
105937907|NCT01748552|365432939|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
105937908|NCT01748552|365432940|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
105937909|NCT01748552|365432941|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
105937910|NCT01748552|365432930|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937911|NCT01748552|365432931|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937912|NCT01748552|365432932|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937913|NCT01748552|365432933|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937914|NCT01748552|365432934|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937915|NCT01748552|365432935|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937916|NCT01748552|365432936|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
105937917|NCT01748552|365432937|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
105937918|NCT01748552|365432938|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
105937919|NCT01748552|365432939|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937920|NCT01748552|365432940|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937921|NCT01748552|365432941|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
105937922|NCT01428713|365432948|FG000|Overall Study|Non-compliance|2|||
105937923|NCT01428713|365432949|FG001|Overall Study|Non-compliance|2|||
105937924|NCT01428713|365432948|FG000|Overall Study|Withdrawal by Subject|1|||
105937925|NCT01428713|365432949|FG001|Overall Study|Withdrawal by Subject|1|||
105937926|NCT01428713|365432948|FG000|Overall Study|Adverse Event|0|||
105937927|NCT01428713|365432949|FG001|Overall Study|Adverse Event|2|||
105937928|NCT00903344|365432950|FG000|Overall Study|Pregnancy|2|||
105937929|NCT00903344|365432951|FG001|Overall Study|Pregnancy|3|||
105937930|NCT00903344|365432950|FG000|Overall Study|Lost to Follow-up|3|||
105937931|NCT00903344|365432951|FG001|Overall Study|Lost to Follow-up|0|||
105937932|NCT03048019|365432952|FG000|Overall Study|Adverse Event|1|||
105734131|NCT02614794|364681104|FG000|Overall Study|Study closure by Sponsor|119|||
105734132|NCT02614794|364681105|FG001|Overall Study|Study closure by Sponsor|45|||
105734133|NCT02614794|364681104|FG000|Overall Study|Withdrawal by Subject|24|||
105734134|NCT02614794|364681105|FG001|Overall Study|Withdrawal by Subject|5|||
105734135|NCT02614794|364681104|FG000|Overall Study|Lost to Follow-up|7|||
105734136|NCT02614794|364681105|FG001|Overall Study|Lost to Follow-up|0|||
105734137|NCT02614794|364681104|FG000|Overall Study|Physician Decision|1|||
105734138|NCT02614794|364681105|FG001|Overall Study|Physician Decision|1|||
105734139|NCT02614794|364681104|FG000|Overall Study|Hospital closure|1|||
105937933|NCT03048019|365432953|FG001|Overall Study|Adverse Event|0|||
106139692|NCT03068468|366170376|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
105734140|NCT02614794|364681105|FG001|Overall Study|Hospital closure|0|||
105734141|NCT03237845|364681110|FG000|Overall Study|Adverse Event|0|||
105734142|NCT03237845|364681111|FG001|Overall Study|Adverse Event|1|||
105734143|NCT03237845|364681110|FG000|Overall Study|Lost to Follow-up|13|||
105734144|NCT03237845|364681111|FG001|Overall Study|Lost to Follow-up|10|||
105734145|NCT03237845|364681110|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
105734146|NCT03237845|364681111|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
105734147|NCT03237845|364681110|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
105734148|NCT03237845|364681111|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
105734149|NCT03237845|364681110|FG000|Overall Study|Physician Decision|1|||
105734150|NCT03237845|364681111|FG001|Overall Study|Physician Decision|2|||
105734151|NCT03237845|364681110|FG000|Overall Study|Pregnancy|1|||
105734152|NCT03237845|364681111|FG001|Overall Study|Pregnancy|0|||
105734153|NCT03237845|364681110|FG000|Overall Study|Protocol Deviation|0|||
105734154|NCT03237845|364681111|FG001|Overall Study|Protocol Deviation|1|||
105734155|NCT03237845|364681110|FG000|Overall Study|Technical Problems|8|||
105734156|NCT03237845|364681111|FG001|Overall Study|Technical Problems|1|||
105734157|NCT03237845|364681110|FG000|Overall Study|Withdrawal by Subject|3|||
105734158|NCT03237845|364681111|FG001|Overall Study|Withdrawal by Subject|3|||
105734159|NCT03237845|364681110|FG000|Overall Study|Other Reasons|4|||
105734160|NCT03237845|364681111|FG001|Overall Study|Other Reasons|0|||
105734161|NCT00258154|364681112|FG000|Overall Study|Adverse Event|1|||
105734162|NCT00258154|364681113|FG001|Overall Study|Adverse Event|0|||
105734163|NCT00258154|364681112|FG000|Overall Study|Lost to Follow-up|0|||
105734164|NCT00258154|364681113|FG001|Overall Study|Lost to Follow-up|1|||
105734165|NCT00258154|364681112|FG000|Overall Study|Protocol Violation|2|||
105734166|NCT00258154|364681113|FG001|Overall Study|Protocol Violation|1|||
105734167|NCT00258154|364681112|FG000|Overall Study|Withdrawal by Subject|3|||
105734168|NCT00258154|364681113|FG001|Overall Study|Withdrawal by Subject|4|||
105734169|NCT00258154|364681112|FG000|Overall Study|Patient Moved|3|||
105734170|NCT00258154|364681113|FG001|Overall Study|Patient Moved|1|||
105734171|NCT00414440|364681122|FG000|Core Period|Withdrawal by Subject|70|||
105734172|NCT00414440|364681123|FG001|Core Period|Withdrawal by Subject|32|||
105734173|NCT00414440|364681122|FG000|Extension Period|Lost to Follow-up|44|||
105734174|NCT00414440|364681123|FG001|Extension Period|Lost to Follow-up|52|||
105734175|NCT00414440|364681122|FG000|Extension Period|Did not consent to continue follow up|61|||
105734176|NCT00414440|364681123|FG001|Extension Period|Did not consent to continue follow up|54|||
105734177|NCT00414440|364681122|FG000|Extension Period|Other|1|||
105734178|NCT00414440|364681123|FG001|Extension Period|Other|1|||
105734179|NCT00414440|364681122|FG000|Extension Period|Administrative|16|||
105937934|NCT00871000|365432954|FG000|Overall Study|Withdrawal by Subject|1|||
105937935|NCT00871000|365432955|FG001|Overall Study|Withdrawal by Subject|0|||
105937936|NCT02168439|365432956|FG000|Overall Study|Protocol Violation|0|||
105937937|NCT02168439|365432957|FG001|Overall Study|Protocol Violation|2|||
105937938|NCT04432298|365432960|FG000|Overall Study|Other than specified|1|||
105937939|NCT04432298|365432961|FG001|Overall Study|Other than specified|0|||
105937940|NCT04432298|365432960|FG000|Overall Study|Lost to Follow-up|0|||
105937941|NCT04432298|365432961|FG001|Overall Study|Lost to Follow-up|1|||
105937942|NCT04432298|365432960|FG000|Overall Study|Death|3|||
105937943|NCT04432298|365432961|FG001|Overall Study|Death|2|||
105937944|NCT04432298|365432960|FG000|Overall Study|Withdrawal by Subject|2|||
105937945|NCT04432298|365432961|FG001|Overall Study|Withdrawal by Subject|0|||
105937946|NCT03574389|365432962|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
105937947|NCT03574389|365432963|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
105937948|NCT03574389|365432964|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
105937949|NCT03574389|365432965|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
105937950|NCT03574389|365432966|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
105937951|NCT03574389|365432967|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
105937952|NCT03574389|365432968|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
105937953|NCT03574389|365432962|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
105937954|NCT03574389|365432963|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
105937955|NCT03574389|365432964|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
105937956|NCT03574389|365432965|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
105937957|NCT03574389|365432966|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
105937958|NCT03574389|365432967|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
105937959|NCT03574389|365432968|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
105937960|NCT03574389|365432962|FG000|Vaccination Period|Other|6|||
105937961|NCT03574389|365432963|FG001|Vaccination Period|Other|0|||
105937962|NCT03574389|365432964|FG002|Vaccination Period|Other|0|||
105937963|NCT03574389|365432965|FG003|Vaccination Period|Other|0|||
105734180|NCT00414440|364681123|FG001|Extension Period|Administrative|16|||
105937964|NCT03574389|365432966|FG004|Vaccination Period|Other|0|||
105937965|NCT03574389|365432967|FG005|Vaccination Period|Other|0|||
105937966|NCT03574389|365432968|FG006|Vaccination Period|Other|0|||
105734181|NCT00414440|364681122|FG000|Extension Period|Death|1|||
105734182|NCT00414440|364681123|FG001|Extension Period|Death|2|||
105734183|NCT00414440|364681122|FG000|Extension Period|Withdrawal by Subject|9|||
105734184|NCT00414440|364681123|FG001|Extension Period|Withdrawal by Subject|7|||
105734185|NCT00414440|364681122|FG000|Extension Period|Not included in follow up period|18|||
105734186|NCT00414440|364681123|FG001|Extension Period|Not included in follow up period|8|||
105734187|NCT04222725|364681124|FG000|Overall Study|Adverse Event|0|||
105734188|NCT04222725|364681125|FG001|Overall Study|Adverse Event|1|||
105734189|NCT04222725|364681126|FG002|Overall Study|Adverse Event|0|||
105734190|NCT04222725|364681127|FG003|Overall Study|Adverse Event|0|||
105734191|NCT03368404|364681133|FG000|Overall Study|Adverse Event|2|||
105734192|NCT03368404|364681134|FG001|Overall Study|Adverse Event|1|||
105734193|NCT03368404|364681133|FG000|Overall Study|Withdrawal by Subject|1|||
105937967|NCT03574389|365432962|FG000|Vaccination Period|Adverse Event|0|||
105937968|NCT03574389|365432963|FG001|Vaccination Period|Adverse Event|1|||
105937969|NCT03574389|365432964|FG002|Vaccination Period|Adverse Event|0|||
105937970|NCT03574389|365432965|FG003|Vaccination Period|Adverse Event|0|||
105937971|NCT03574389|365432966|FG004|Vaccination Period|Adverse Event|0|||
105937972|NCT03574389|365432967|FG005|Vaccination Period|Adverse Event|0|||
105937973|NCT03574389|365432968|FG006|Vaccination Period|Adverse Event|0|||
105937974|NCT03574389|365432962|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
105937975|NCT03574389|365432963|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
105937976|NCT03574389|365432964|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
105937977|NCT03574389|365432965|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
105937978|NCT03574389|365432966|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
105937979|NCT03574389|365432967|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
105937980|NCT03574389|365432968|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
105937981|NCT02715856|365432969|FG000|Overall Study|Software Issues|12|||
105937982|NCT02715856|365432970|FG001|Overall Study|Software Issues|7|||
105937983|NCT02715856|365432969|FG000|Overall Study|Death|6|||
105937984|NCT02715856|365432970|FG001|Overall Study|Death|5|||
105937985|NCT02715856|365432969|FG000|Overall Study|Non- Compliant|0|||
105937986|NCT02715856|365432970|FG001|Overall Study|Non- Compliant|40|||
105937987|NCT04535362|365432973|FG000|Overall Study|Lost to Follow-up|3|||
105937988|NCT04535362|365432974|FG001|Overall Study|Lost to Follow-up|1|||
105937989|NCT00889005|365432975|FG000|Overall Study|Lost to Follow-up|4|||
105937990|NCT00889005|365432976|FG001|Overall Study|Lost to Follow-up|2|||
105937991|NCT00889005|365432975|FG000|Overall Study|Withdrawal by Subject|4|||
105937992|NCT00889005|365432976|FG001|Overall Study|Withdrawal by Subject|0|||
105937993|NCT00756314|365432977|FG000|Overall Study|Lost to Follow-up|2|||
105937994|NCT00756314|365432978|FG001|Overall Study|Lost to Follow-up|59|||
105937995|NCT00692237|365432982|FG000|Overall Study|Withdrawal by Subject|1|||
105937996|NCT00692237|365432983|FG001|Overall Study|Withdrawal by Subject|3|||
105937997|NCT00692237|365432982|FG000|Overall Study|Adverse Event|0|||
105937998|NCT00692237|365432983|FG001|Overall Study|Adverse Event|1|||
105937999|NCT00276380|365432988|FG000|Overall Study|Adverse Event|5|||
105938000|NCT00276380|365432989|FG001|Overall Study|Adverse Event|3|||
105938001|NCT00276380|365432988|FG000|Overall Study|Lost to Follow-up|1|||
105938002|NCT00276380|365432989|FG001|Overall Study|Lost to Follow-up|1|||
105938003|NCT00276380|365432988|FG000|Overall Study|Withdrawal by Subject|3|||
105938004|NCT00276380|365432989|FG001|Overall Study|Withdrawal by Subject|6|||
105938005|NCT00276380|365432988|FG000|Overall Study|Death|5|||
105938006|NCT00276380|365432989|FG001|Overall Study|Death|3|||
105938007|NCT00276380|365432988|FG000|Overall Study|Abnormal aPPT Levels|0|||
105938008|NCT00276380|365432989|FG001|Overall Study|Abnormal aPPT Levels|1|||
105938009|NCT01689649|365432990|FG000|Overall Study|Lack of Efficacy|3|||
105938010|NCT01689649|365432990|FG000|Overall Study|Non-compliance|11|||
105938011|NCT01689649|365432990|FG000|Overall Study|Protocol Violation|3|||
105938012|NCT01689649|365432990|FG000|Overall Study|Lost to Follow-up|5|||
105938013|NCT05071027|365432993|FG000|Overall Study|Lost to Follow-up|1|||
105938014|NCT05071027|365432994|FG001|Overall Study|Lost to Follow-up|4|||
105938015|NCT04576481|365432995|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
105938016|NCT04576481|365432996|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
105938017|NCT04576481|365432997|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
105938018|NCT04576481|365432998|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
105938019|NCT00595075|365433000|FG000|Overall Study|Withdrawal by Subject|1|||
105938020|NCT00595075|365433001|FG001|Overall Study|Withdrawal by Subject|0|||
105938021|NCT00511199|365433002|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
105938022|NCT00511199|365433003|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
105938023|NCT00511199|365433002|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
105734194|NCT03368404|364681134|FG001|Overall Study|Withdrawal by Subject|1|||
105938024|NCT00511199|365433003|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
105938025|NCT00511199|365433002|FG000|Overall Study|Withdrawal of Informed Consent|19|||
105938026|NCT00511199|365433003|FG001|Overall Study|Withdrawal of Informed Consent|4|||
105938027|NCT00511199|365433002|FG000|Overall Study|Pregnancy|6|||
105938028|NCT00511199|365433003|FG001|Overall Study|Pregnancy|3|||
105938029|NCT00511199|365433002|FG000|Overall Study|Pregnancy Wish|16|||
106009655|NCT03104868|365700911|FG000|18 Month Follow up|Withdrawal by Subject|1|||
106009656|NCT03104868|365700912|FG001|18 Month Follow up|Withdrawal by Subject|2|||
106009657|NCT03104868|365700911|FG000|18 Month Follow up|Graft Loss|1|||
106009658|NCT03104868|365700912|FG001|18 Month Follow up|Graft Loss|1|||
106009659|NCT03104868|365700911|FG000|18 Month Follow up|Completed Later Timepoint|19|||
106009660|NCT03104868|365700912|FG001|18 Month Follow up|Completed Later Timepoint|20|||
106009661|NCT03104868|365700911|FG000|24 Month Follow up|Lost to Follow-up|15|||
106009662|NCT03104868|365700912|FG001|24 Month Follow up|Lost to Follow-up|16|||
106009663|NCT03104868|365700911|FG000|24 Month Follow up|Death|3|||
106009664|NCT03104868|365700912|FG001|24 Month Follow up|Death|2|||
106009665|NCT03104868|365700911|FG000|24 Month Follow up|Withdrawal by Subject|1|||
106009666|NCT03104868|365700912|FG001|24 Month Follow up|Withdrawal by Subject|0|||
106009667|NCT03104868|365700911|FG000|24 Month Follow up|Graft Loss|2|||
106009668|NCT03104868|365700912|FG001|24 Month Follow up|Graft Loss|0|||
106009669|NCT00829426|365700916|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
106009670|NCT00829426|365700917|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105734195|NCT00964795|364681135|FG000|Overall Study|Withdrawal by Subject|79|||
106009671|NCT04606134|365700932|FG000|Overall Study|Adverse Event|0|||
106009672|NCT04606134|365700933|FG001|Overall Study|Adverse Event|1|||
106009673|NCT01099267|365700934|FG000|MDS-003 Study|Adverse Event|37|||
106009674|NCT01099267|365700934|FG000|MDS-003 Study|Lack of Efficacy|52|||
106009675|NCT01099267|365700934|FG000|MDS-003 Study|Withdrawal by Subject|8|||
106009676|NCT01099267|365700934|FG000|MDS-003 Study|Lost to Follow-up|1|||
106009677|NCT01099267|365700934|FG000|MDS-003 Study|Death|11|||
106009678|NCT01099267|365700934|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
106009679|NCT01099267|365700934|FG000|MDS-003 Study|Disease Progression|7|||
106009680|NCT01099267|365700934|FG000|MDS-003 Study|Investigator Decision|2|||
106009681|NCT01099267|365700934|FG000|MDS-003 Study|Non-Compliance|2|||
106009682|NCT01099267|365700934|FG000|MDS-003 Study|Loss of Response|1|||
106009683|NCT01099267|365700934|FG000|MDS-003 Study|Secondary Malign Disease|1|||
106009684|NCT05477108|365700937|FG000|Overall Study|Participants randomized, not treated|1|||
106009685|NCT05477108|365700938|FG001|Overall Study|Participants randomized, not treated|1|||
106009686|NCT05477108|365700939|FG002|Overall Study|Participants randomized, not treated|1|||
106009687|NCT05477108|365700937|FG000|Overall Study|Physician Decision|0|||
106009688|NCT05477108|365700938|FG001|Overall Study|Physician Decision|0|||
106009689|NCT05477108|365700939|FG002|Overall Study|Physician Decision|1|||
106009690|NCT05477108|365700937|FG000|Overall Study|withdrawn from study|0|||
106009691|NCT05477108|365700938|FG001|Overall Study|withdrawn from study|0|||
106009692|NCT05477108|365700939|FG002|Overall Study|withdrawn from study|1|||
106009693|NCT01838395|365700943|FG000|Overall Study|Withdrawal by Subject|0|||
106009694|NCT01838395|365700944|FG001|Overall Study|Withdrawal by Subject|0|||
105734196|NCT00964795|364681135|FG000|Overall Study|Adverse Event|12|||
105734197|NCT00964795|364681135|FG000|Overall Study|Death|14|||
105734198|NCT00964795|364681135|FG000|Overall Study|Lost to Follow-up|7|||
105734199|NCT00964795|364681135|FG000|Overall Study|Termination of Study by Sponsor|169|||
105734200|NCT00964795|364681135|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
105734201|NCT00964795|364681135|FG000|Overall Study|Other|23|||
105734202|NCT00231478|364681137|FG000|Overall Study|Protocol Violation|3|||
105734203|NCT00231478|364681138|FG001|Overall Study|Protocol Violation|2|||
105734204|NCT00231478|364681137|FG000|Overall Study|Refused Treatment|1|||
105734205|NCT00231478|364681138|FG001|Overall Study|Refused Treatment|1|||
105734206|NCT00231478|364681137|FG000|Overall Study|Withdrawal by Subject|1|||
105734207|NCT00231478|364681138|FG001|Overall Study|Withdrawal by Subject|0|||
105734208|NCT00231478|364681137|FG000|Overall Study|Adverse Event|0|||
105734209|NCT00231478|364681138|FG001|Overall Study|Adverse Event|1|||
105734210|NCT00231478|364681137|FG000|Overall Study|Administrative|3|||
105734211|NCT00231478|364681138|FG001|Overall Study|Administrative|2|||
105734212|NCT02114203|364682644|FG000|Overall Study|Adverse Event|0|||
105734213|NCT02114203|364682645|FG001|Overall Study|Adverse Event|1|||
105734214|NCT02114203|364682646|FG002|Overall Study|Adverse Event|0|||
105734215|NCT02114203|364682644|FG000|Overall Study|Withdrawal by Subject|0|||
105734216|NCT02114203|364682645|FG001|Overall Study|Withdrawal by Subject|1|||
105734217|NCT02114203|364682646|FG002|Overall Study|Withdrawal by Subject|0|||
105734218|NCT04329923|364682656|FG000|Overall Study|Withdrawal by Subject|1|||
105734219|NCT04329923|364682657|FG001|Overall Study|Withdrawal by Subject|4|||
105734220|NCT04329923|364682658|FG002|Overall Study|Withdrawal by Subject|1|||
105734221|NCT04329923|364682659|FG003|Overall Study|Withdrawal by Subject|1|||
105734222|NCT04329923|364682660|FG004|Overall Study|Withdrawal by Subject|1|||
105734223|NCT04329923|364682661|FG005|Overall Study|Withdrawal by Subject|1|||
105734224|NCT04329923|364682656|FG000|Overall Study|early termination of study|0|||
106009695|NCT01838395|365700945|FG002|Overall Study|Withdrawal by Subject|0|||
106009696|NCT01838395|365700946|FG003|Overall Study|Withdrawal by Subject|0|||
106009697|NCT01838395|365700947|FG004|Overall Study|Withdrawal by Subject|1|||
106009698|NCT01838395|365700948|FG005|Overall Study|Withdrawal by Subject|0|||
105734225|NCT04329923|364682657|FG001|Overall Study|early termination of study|0|||
105734226|NCT04329923|364682658|FG002|Overall Study|early termination of study|0|||
105734227|NCT04329923|364682659|FG003|Overall Study|early termination of study|0|||
105938030|NCT00511199|365433003|FG001|Overall Study|Pregnancy Wish|8|||
105938031|NCT00511199|365433002|FG000|Overall Study|Lost to Follow-up|40|||
105938032|NCT00511199|365433003|FG001|Overall Study|Lost to Follow-up|17|||
105938033|NCT00511199|365433002|FG000|Overall Study|Other Reason|78|||
105938034|NCT00511199|365433003|FG001|Overall Study|Other Reason|37|||
105938035|NCT04223687|365433004|FG000|Overall Study|Missing primary outcome|1|||
105938036|NCT04223687|365433005|FG001|Overall Study|Missing primary outcome|0|||
106009699|NCT01838395|365700943|FG000|Overall Study|Death|0|||
105798600|NCT00447603|364920977|FG001|Filter Period|Adverse Event|0|||
106009700|NCT01838395|365700944|FG001|Overall Study|Death|0|||
106009701|NCT01838395|365700945|FG002|Overall Study|Death|1|||
106009702|NCT01838395|365700946|FG003|Overall Study|Death|0|||
106009703|NCT01838395|365700947|FG004|Overall Study|Death|0|||
106009704|NCT01838395|365700948|FG005|Overall Study|Death|0|||
106009705|NCT01838395|365700943|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
106009706|NCT01838395|365700944|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
106009707|NCT01838395|365700945|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
106009708|NCT01838395|365700946|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
106009709|NCT01838395|365700947|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
106009710|NCT01838395|365700948|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
106009711|NCT02532517|365700949|FG000|Overall Study|Did not complete 24-Month visit|4|||
106009712|NCT02532517|365700949|FG000|Overall Study|Failed Angiographic eligibility|1|||
106009713|NCT02532517|365700949|FG000|Overall Study|Lost to Follow-up|4|||
106009714|NCT02532517|365700949|FG000|Overall Study|Withdrawal by Subject|4|||
106009715|NCT02532517|365700949|FG000|Overall Study|Death|4|||
106009716|NCT03312231|365700950|FG000|Overall Study|Lost to Follow-up|2|||
106009717|NCT03312231|365700951|FG001|Overall Study|Lost to Follow-up|6|||
106009718|NCT03312231|365700952|FG002|Overall Study|Lost to Follow-up|1|||
106009719|NCT03312231|365700953|FG003|Overall Study|Lost to Follow-up|3|||
106009720|NCT03312231|365700954|FG004|Overall Study|Lost to Follow-up|1|||
106009721|NCT03312231|365700950|FG000|Overall Study|Withdrawal by Subject|0|||
106009722|NCT03312231|365700951|FG001|Overall Study|Withdrawal by Subject|3|||
106009723|NCT03312231|365700952|FG002|Overall Study|Withdrawal by Subject|1|||
106009724|NCT03312231|365700953|FG003|Overall Study|Withdrawal by Subject|0|||
106009725|NCT03312231|365700954|FG004|Overall Study|Withdrawal by Subject|0|||
106009726|NCT03312231|365700950|FG000|Overall Study|Death|0|||
106009727|NCT03312231|365700951|FG001|Overall Study|Death|1|||
106009728|NCT03312231|365700952|FG002|Overall Study|Death|1|||
106009729|NCT03312231|365700953|FG003|Overall Study|Death|0|||
106009730|NCT03312231|365700954|FG004|Overall Study|Death|0|||
106009731|NCT03312231|365700950|FG000|Overall Study|Study Vaccination not Received|1|||
106009732|NCT03312231|365700951|FG001|Overall Study|Study Vaccination not Received|1|||
106009733|NCT03312231|365700952|FG002|Overall Study|Study Vaccination not Received|1|||
106009734|NCT03312231|365700953|FG003|Overall Study|Study Vaccination not Received|0|||
106009735|NCT03312231|365700954|FG004|Overall Study|Study Vaccination not Received|0|||
106009736|NCT03157830|365700955|FG000|Overall Study|Lost to Follow-up|1|||
106009737|NCT03157830|365700955|FG000|Overall Study|Withdrawal by Subject|1|||
106009738|NCT03694353|365700959|FG000|Overall Study|Withdrawal by Subject|1|||
106009739|NCT03694353|365700959|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
106009740|NCT03804528|365700960|FG000|Overall Study|Time Commitment|18|||
106009741|NCT03804528|365700960|FG000|Overall Study|Health Reasons|5|||
106009742|NCT00651742|365700961|FG000|Overall Study|Objective Disease Progression|22|||
106009743|NCT00651742|365700961|FG000|Overall Study|Toxicity|3|||
106009744|NCT00651742|365700961|FG000|Overall Study|Investigator Judgment|1|||
106009745|NCT00651742|365700961|FG000|Overall Study|Withdrawal of Consent|1|||
106009746|NCT00651742|365700961|FG000|Overall Study|Enrolled but not treated|1|||
106009747|NCT04050553|365700962|FG000|Period 1|Physician Decision|2|||
106009748|NCT04050553|365700963|FG001|Period 1|Physician Decision|2|||
106009749|NCT04050553|365700962|FG000|Period 1|Adverse Event|1|||
106009750|NCT04050553|365700963|FG001|Period 1|Adverse Event|1|||
106009751|NCT04050553|365700962|FG000|Period 1|Withdrawal by Subject|0|||
105798601|NCT00447603|364920978|FG002|Filter Period|Adverse Event|1|||
105938037|NCT00968968|365433016|FG000|Overall Study|Study closed/terminated|10|||
106009752|NCT04050553|365700963|FG001|Period 1|Withdrawal by Subject|1|||
106009753|NCT04050553|365700962|FG000|Wash-out|Adverse Event|0|||
106009754|NCT04050553|365700963|FG001|Wash-out|Adverse Event|1|||
106009755|NCT04050553|365700962|FG000|Wash-out|Withdrawal by Subject|0|||
106009756|NCT04050553|365700963|FG001|Wash-out|Withdrawal by Subject|1|||
106009757|NCT05430854|365700964|FG000|Overall Study|Trial terminated by Sponsor|39|||
105798602|NCT00447603|364920976|FG000|Filter Period|Screen Failure|0|||
106009758|NCT05430854|365700965|FG001|Overall Study|Trial terminated by Sponsor|50|||
106009759|NCT05430854|365700966|FG002|Overall Study|Trial terminated by Sponsor|46|||
106009760|NCT05430854|365700964|FG000|Overall Study|Withdrawal by Subject|0|||
106139693|NCT03068468|366170377|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
105938038|NCT00968968|365433017|FG001|Overall Study|Study closed/terminated|10|||
105938039|NCT00968968|365433016|FG000|Overall Study|Protocol defined stopping criteria|3|||
105938040|NCT00968968|365433017|FG001|Overall Study|Protocol defined stopping criteria|1|||
105938041|NCT00968968|365433016|FG000|Overall Study|Withdrawal by Subject|2|||
105938042|NCT00968968|365433017|FG001|Overall Study|Withdrawal by Subject|0|||
105938043|NCT00968968|365433016|FG000|Overall Study|Physician Decision|1|||
105938044|NCT00968968|365433017|FG001|Overall Study|Physician Decision|2|||
105938045|NCT00968968|365433016|FG000|Overall Study|Lost to Follow-up|0|||
105734228|NCT04329923|364682660|FG004|Overall Study|early termination of study|1|||
105734229|NCT04329923|364682661|FG005|Overall Study|early termination of study|2|||
105734230|NCT04329923|364682656|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734231|NCT04329923|364682657|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734232|NCT04329923|364682658|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734233|NCT04329923|364682659|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734234|NCT04329923|364682660|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
105734235|NCT04329923|364682661|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
105734236|NCT01272180|364682662|FG000|Overall Study|Adverse Event|0|||
105734237|NCT01272180|364682663|FG001|Overall Study|Adverse Event|0|||
105734238|NCT01272180|364682664|FG002|Overall Study|Adverse Event|1|||
105734239|NCT01272180|364682665|FG003|Overall Study|Adverse Event|0|||
105734240|NCT01272180|364682662|FG000|Overall Study|Withdrawal by Subject|2|||
105734241|NCT01272180|364682663|FG001|Overall Study|Withdrawal by Subject|6|||
105734242|NCT01272180|364682664|FG002|Overall Study|Withdrawal by Subject|3|||
105734243|NCT01272180|364682665|FG003|Overall Study|Withdrawal by Subject|2|||
105734244|NCT01272180|364682662|FG000|Overall Study|Lost to Follow-up|15|||
105734245|NCT01272180|364682663|FG001|Overall Study|Lost to Follow-up|14|||
105734246|NCT01272180|364682664|FG002|Overall Study|Lost to Follow-up|8|||
105734247|NCT01272180|364682665|FG003|Overall Study|Lost to Follow-up|10|||
105734248|NCT01272180|364682662|FG000|Overall Study|Inappropriate enrollment|0|||
105734249|NCT01272180|364682663|FG001|Overall Study|Inappropriate enrollment|0|||
105734250|NCT01272180|364682664|FG002|Overall Study|Inappropriate enrollment|1|||
105734251|NCT01272180|364682665|FG003|Overall Study|Inappropriate enrollment|1|||
105734252|NCT01272180|364682662|FG000|Overall Study|Protocol Violation|0|||
105734253|NCT01272180|364682663|FG001|Overall Study|Protocol Violation|1|||
105734254|NCT01272180|364682664|FG002|Overall Study|Protocol Violation|0|||
105734255|NCT01272180|364682665|FG003|Overall Study|Protocol Violation|1|||
105734256|NCT01126619|364682668|FG000|Overall Study|Not eligible for the study|2|||
105734257|NCT01126619|364682668|FG000|Overall Study|Investigator decision|4|||
105734258|NCT01126619|364682668|FG000|Overall Study|Serious adverse event|1|||
105734259|NCT01126619|364682668|FG000|Overall Study|Withdrawal by Subject|9|||
105734260|NCT01126619|364682668|FG000|Overall Study|Non-compliance|1|||
105734261|NCT02564120|364682669|FG000|Overall Study|Did not return release forms|160|||
105734262|NCT02564120|364682669|FG000|Overall Study|Death|58|||
105734263|NCT02564120|364682669|FG000|Overall Study|Withdrawal by Subject|204|||
105734264|NCT02564120|364682669|FG000|Overall Study|Other medical condition|24|||
105734265|NCT03842709|364682670|FG000|Overall Study|Withdrawal by Subject|3|||
105734266|NCT03842709|364682671|FG001|Overall Study|Withdrawal by Subject|3|||
105734267|NCT03842709|364682670|FG000|Overall Study|Lost to Follow-up|1|||
105734268|NCT03842709|364682671|FG001|Overall Study|Lost to Follow-up|0|||
105734269|NCT01025336|364682674|FG000|Overall Study|Protocol Violation|0|||
105734270|NCT01025336|364682675|FG001|Overall Study|Protocol Violation|0|||
105734271|NCT01025336|364682676|FG002|Overall Study|Protocol Violation|0|||
105734272|NCT01025336|364682677|FG003|Overall Study|Protocol Violation|2|||
105734273|NCT01025336|364682678|FG004|Overall Study|Protocol Violation|0|||
105734274|NCT01357239|364682681|FG000|Stratum: All Patients|Adverse Event|0|||
105734275|NCT01357239|364682682|FG001|Stratum: All Patients|Adverse Event|0|||
105734276|NCT01357239|364682683|FG002|Stratum: All Patients|Adverse Event|1|||
105734277|NCT01357239|364682684|FG003|Stratum: All Patients|Adverse Event|1|||
105734278|NCT01357239|364682681|FG000|Stratum: All Patients|Subject withdrew consent|0|||
105734279|NCT01357239|364682682|FG001|Stratum: All Patients|Subject withdrew consent|0|||
105734280|NCT01357239|364682683|FG002|Stratum: All Patients|Subject withdrew consent|1|||
105734281|NCT01357239|364682684|FG003|Stratum: All Patients|Subject withdrew consent|1|||
105734282|NCT01357239|364682681|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
105734283|NCT01357239|364682682|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
105734284|NCT01357239|364682683|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
105938046|NCT00968968|365433017|FG001|Overall Study|Lost to Follow-up|1|||
105734285|NCT01357239|364682684|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
105734286|NCT01357239|364682681|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
105734287|NCT01357239|364682682|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
105734288|NCT01357239|364682683|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
105938047|NCT00930176|365433028|FG000|Overall Study|Death|1|||
105938048|NCT00401830|365433029|FG000|Overall Study|Adverse Event|10|||
105734289|NCT01357239|364682684|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
105734290|NCT01357239|364682681|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
105734291|NCT01357239|364682682|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
105734292|NCT01357239|364682683|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
105734293|NCT01357239|364682684|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
105938049|NCT00401830|365433030|FG001|Overall Study|Adverse Event|18|||
106009761|NCT05430854|365700965|FG001|Overall Study|Withdrawal by Subject|3|||
106009762|NCT05430854|365700966|FG002|Overall Study|Withdrawal by Subject|0|||
106009763|NCT04314284|365700967|FG000|Overall Study|Withdrawal by Subject|4|||
106009764|NCT04314284|365700968|FG001|Overall Study|Withdrawal by Subject|7|||
106139694|NCT03068468|366170378|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
106139695|NCT03068468|366170379|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
106139696|NCT03068468|366170376|FG000|Placebo-Controlled Period|Death|0|||
106139697|NCT03068468|366170377|FG001|Placebo-Controlled Period|Death|1|||
106139698|NCT03068468|366170378|FG002|Placebo-Controlled Period|Death|0|||
106139699|NCT03068468|366170379|FG003|Placebo-Controlled Period|Death|0|||
106139700|NCT03068468|366170376|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
106009765|NCT04314284|365700967|FG000|Overall Study|Consented but did not complete survey|0|||
106009766|NCT04314284|365700968|FG001|Overall Study|Consented but did not complete survey|6|||
106009767|NCT01295814|365702379|FG000|Overall Study|Lack of Efficacy|0|||
106009768|NCT01295814|365702380|FG001|Overall Study|Lack of Efficacy|2|||
106009769|NCT01295814|365702379|FG000|Overall Study|Withdrawal by Subject|2|||
106009770|NCT01295814|365702380|FG001|Overall Study|Withdrawal by Subject|0|||
106009771|NCT00751296|365702382|FG000|Overall Study|Adverse Event|2|||
106009772|NCT01456039|365702385|FG000|Phase 1 (First Step)|Disease Progression|1|||
106009773|NCT01456039|365702386|FG001|Phase 1 (First Step)|Disease Progression|1|||
106009774|NCT01456039|365702387|FG002|Phase 1 (First Step)|Disease Progression|0|||
106009775|NCT01456039|365702385|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
106009776|NCT01456039|365702386|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
106009777|NCT01456039|365702387|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
106009778|NCT01456039|365702385|FG000|Phase 1 (First Step)|Adverse Event|0|||
106009779|NCT01456039|365702386|FG001|Phase 1 (First Step)|Adverse Event|3|||
106009780|NCT01456039|365702387|FG002|Phase 1 (First Step)|Adverse Event|0|||
106009781|NCT01456039|365702385|FG000|Phase 1 (First Step)|Other|0|||
106009782|NCT01456039|365702386|FG001|Phase 1 (First Step)|Other|1|||
106009783|NCT01456039|365702387|FG002|Phase 1 (First Step)|Other|0|||
106009784|NCT01456039|365702385|FG000|Phase 2 (Second Step)|Disease Progression|0|||
106009785|NCT01456039|365702386|FG001|Phase 2 (Second Step)|Disease Progression|0|||
106009786|NCT01456039|365702387|FG002|Phase 2 (Second Step)|Disease Progression|17|||
106009787|NCT01456039|365702385|FG000|Phase 2 (Second Step)|Adverse Event|0|||
106009788|NCT01456039|365702386|FG001|Phase 2 (Second Step)|Adverse Event|0|||
106009789|NCT01456039|365702387|FG002|Phase 2 (Second Step)|Adverse Event|10|||
106009790|NCT01456039|365702385|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
106009791|NCT01456039|365702386|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
106009792|NCT01456039|365702387|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
106009793|NCT01456039|365702385|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
106009794|NCT01456039|365702386|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
106139701|NCT03068468|366170377|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
106139702|NCT03068468|366170378|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
106139703|NCT03068468|366170379|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
106139704|NCT03068468|366170376|FG000|Open-Label Extension Period|Adverse Event|0|||
106139705|NCT03068468|366170377|FG001|Open-Label Extension Period|Adverse Event|0|||
106139706|NCT03068468|366170378|FG002|Open-Label Extension Period|Adverse Event|13|||
106139707|NCT03068468|366170379|FG003|Open-Label Extension Period|Adverse Event|17|||
106139708|NCT03068468|366170376|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
106139709|NCT03068468|366170377|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
106139710|NCT03068468|366170378|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
106139711|NCT03068468|366170379|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
105734294|NCT00637728|364682685|FG000|Double-blind Phase|Adverse Event|1|||
105734295|NCT00637728|364682686|FG001|Double-blind Phase|Adverse Event|0|||
105734296|NCT00637728|364682687|FG002|Double-blind Phase|Adverse Event|0|||
105734297|NCT00637728|364682685|FG000|Double-blind Phase|Non-compliance|2|||
105734298|NCT00637728|364682686|FG001|Double-blind Phase|Non-compliance|0|||
105734299|NCT00637728|364682687|FG002|Double-blind Phase|Non-compliance|0|||
105734300|NCT00637728|364682685|FG000|Double-blind Phase|Study Discontinued|1|||
105734301|NCT00637728|364682686|FG001|Double-blind Phase|Study Discontinued|1|||
105798603|NCT00447603|364920977|FG001|Filter Period|Screen Failure|3|||
105798604|NCT00447603|364920978|FG002|Filter Period|Screen Failure|4|||
106009795|NCT01456039|365702387|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
106009796|NCT01456039|365702385|FG000|Phase 2 (Second Step)|Other|0|||
106139712|NCT03068468|366170376|FG000|Open-Label Extension Period|Death|0|||
106139713|NCT03068468|366170377|FG001|Open-Label Extension Period|Death|0|||
106139714|NCT03068468|366170378|FG002|Open-Label Extension Period|Death|0|||
106139715|NCT03068468|366170379|FG003|Open-Label Extension Period|Death|1|||
106139716|NCT03068468|366170376|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
106139717|NCT03068468|366170377|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
106009797|NCT01456039|365702386|FG001|Phase 2 (Second Step)|Other|0|||
106009798|NCT01456039|365702387|FG002|Phase 2 (Second Step)|Other|1|||
106009799|NCT01021020|365702388|FG000|Period I|Protocol Violation|1|||
106009800|NCT01021020|365702388|FG000|Period I|Withdrawal by Subject|1|||
105734302|NCT00637728|364682687|FG002|Double-blind Phase|Study Discontinued|0|||
105734303|NCT02441803|364682688|FG000|Overall Study|Physician Decision|0|||
105798605|NCT00447603|364920976|FG000|Filter Period|Study terminated by Sponsor|0|||
105798606|NCT00447603|364920977|FG001|Filter Period|Study terminated by Sponsor|1|||
105798607|NCT00447603|364920978|FG002|Filter Period|Study terminated by Sponsor|10|||
105798608|NCT00736333|364920985|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
105798609|NCT00736333|364920985|FG000|Overall Study|Data Missing|2|||
105798610|NCT00736333|364920985|FG000|Overall Study|Tumor Progression|75|||
105798611|NCT00736333|364920985|FG000|Overall Study|Toxicity|6|||
105798612|NCT00736333|364920985|FG000|Overall Study|Withdrawal by Subject|10|||
105798613|NCT00736333|364920985|FG000|Overall Study|Death|7|||
105798614|NCT00736333|364920985|FG000|Overall Study|Other|4|||
105798615|NCT03944707|364920986|FG000|Overall Study|Adverse Event|0|||
105798616|NCT03944707|364920987|FG001|Overall Study|Adverse Event|2|||
105798617|NCT03944707|364920986|FG000|Overall Study|Study terminated by sponsor|12|||
105798618|NCT03944707|364920987|FG001|Overall Study|Study terminated by sponsor|7|||
105798619|NCT03944707|364920986|FG000|Overall Study|Subject decision|0|||
105798620|NCT03944707|364920987|FG001|Overall Study|Subject decision|1|||
105798621|NCT00751998|364920993|FG000|Overall Study|Lost to Follow-up|7|||
105798622|NCT00751998|364920993|FG000|Overall Study|Death|11|||
105798623|NCT00751998|364920993|FG000|Overall Study|Withdrawal by Subject|2|||
105798624|NCT03216954|364920995|FG000|Overall Study|Adverse Event|0|||
106009801|NCT01021020|365702388|FG000|14 Day Washout Period A|Physician Decision|1|||
106009802|NCT00992108|365702396|FG000|Overall Study|Lost to Follow-up|0|||
106009803|NCT00992108|365702397|FG001|Overall Study|Lost to Follow-up|1|||
106009804|NCT04106557|365702399|FG000|Overall Study|Physician Decision|0|||
106009805|NCT04106557|365702400|FG001|Overall Study|Physician Decision|1|||
106009806|NCT04106557|365702401|FG002|Overall Study|Physician Decision|0|||
106009807|NCT04106557|365702399|FG000|Overall Study|Protocol Violation|0|||
106009808|NCT04106557|365702400|FG001|Overall Study|Protocol Violation|1|||
106009809|NCT04106557|365702401|FG002|Overall Study|Protocol Violation|0|||
106009810|NCT03780244|365702404|FG000|Overall Study|Lost to Follow-up|1|||
106009811|NCT03780244|365702405|FG001|Overall Study|Lost to Follow-up|0|||
106009812|NCT02151058|365702407|FG000|Overall Study|Withdrawal by Subject|1|||
106009813|NCT02151058|365702408|FG001|Overall Study|Withdrawal by Subject|1|||
106009814|NCT02151058|365702409|FG002|Overall Study|Withdrawal by Subject|3|||
106009815|NCT02151058|365702407|FG000|Overall Study|Lost to Follow-up|1|||
106009816|NCT02151058|365702408|FG001|Overall Study|Lost to Follow-up|0|||
106009817|NCT02151058|365702409|FG002|Overall Study|Lost to Follow-up|2|||
106009818|NCT01280903|365702412|FG000|Overall Study|Lost to Follow-up|23|||
106009819|NCT01280903|365702413|FG001|Overall Study|Lost to Follow-up|16|||
106009820|NCT03453164|365702414|FG000|Overall Study|Lack of Efficacy|16|||
106009821|NCT03453164|365702414|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
106009822|NCT01942837|365702415|FG000|Overall Study|Death|1|||
105734304|NCT02441803|364682689|FG001|Overall Study|Physician Decision|2|||
105734305|NCT02441803|364682690|FG002|Overall Study|Physician Decision|2|||
105734306|NCT04983901|364682691|FG000|Overall Study|Death|1|||
105734307|NCT04983901|364682692|FG001|Overall Study|Death|4|||
105734308|NCT04983901|364682691|FG000|Overall Study|Lost to Follow-up|3|||
105734309|NCT04983901|364682692|FG001|Overall Study|Lost to Follow-up|0|||
105734310|NCT04983901|364682691|FG000|Overall Study|Protocol Violation|1|||
105734311|NCT04983901|364682692|FG001|Overall Study|Protocol Violation|0|||
105734312|NCT04983901|364682691|FG000|Overall Study|Withdrawal by Subject|1|||
105734313|NCT04983901|364682692|FG001|Overall Study|Withdrawal by Subject|2|||
105734314|NCT00949650|364682693|FG000|Overall Study|Progressive disease|188|||
105734315|NCT00949650|364682694|FG001|Overall Study|Progressive disease|19|||
105734316|NCT00949650|364682693|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
105734317|NCT00949650|364682694|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
105734318|NCT00949650|364682693|FG000|Overall Study|Other Adverse Event (AE)|28|||
105734319|NCT00949650|364682694|FG001|Overall Study|Other Adverse Event (AE)|17|||
105734320|NCT00949650|364682693|FG000|Overall Study|Protocol Violation|1|||
105734321|NCT00949650|364682694|FG001|Overall Study|Protocol Violation|4|||
105734322|NCT00949650|364682693|FG000|Overall Study|Refusal to continue medication|7|||
105734323|NCT00949650|364682694|FG001|Overall Study|Refusal to continue medication|11|||
105734324|NCT00949650|364682693|FG000|Overall Study|Not treated|1|||
105734325|NCT00949650|364682694|FG001|Overall Study|Not treated|4|||
105734326|NCT00949650|364682693|FG000|Overall Study|Other not specified above|5|||
105798625|NCT03216954|364920996|FG001|Overall Study|Adverse Event|0|||
105798626|NCT03216954|364920997|FG002|Overall Study|Adverse Event|1|||
106009823|NCT01942837|365702415|FG000|Overall Study|Symptomatic or radiographic progression|49|||
106009824|NCT01942837|365702415|FG000|Overall Study|Adverse Event|6|||
106009825|NCT01942837|365702415|FG000|Overall Study|Physician Decision|3|||
105734327|NCT00949650|364682694|FG001|Overall Study|Other not specified above|0|||
105734328|NCT01208181|364682700|FG000|Part 1|Withdrawal by Subject|11|||
105734329|NCT01208181|364682701|FG001|Part 1|Withdrawal by Subject|10|||
105734330|NCT01208181|364682702|FG002|Part 1|Withdrawal by Subject|0|||
105734331|NCT01208181|364682703|FG003|Part 1|Withdrawal by Subject|0|||
105798627|NCT03216954|364920998|FG003|Overall Study|Adverse Event|0|||
106009826|NCT01942837|365702415|FG000|Overall Study|Withdrawal by Subject|2|||
106009827|NCT01942837|365702415|FG000|Overall Study|Intercurrent Illness|1|||
106009828|NCT01942837|365702415|FG000|Overall Study|On treatment|3|||
105798628|NCT03216954|364920999|FG004|Overall Study|Adverse Event|1|||
105798629|NCT03216954|364920995|FG000|Overall Study|Withdrawal by Subject|2|||
105798630|NCT03216954|364920996|FG001|Overall Study|Withdrawal by Subject|0|||
105798631|NCT03216954|364920997|FG002|Overall Study|Withdrawal by Subject|0|||
105798632|NCT03216954|364920998|FG003|Overall Study|Withdrawal by Subject|0|||
105798633|NCT03216954|364920999|FG004|Overall Study|Withdrawal by Subject|0|||
105798634|NCT03216954|364920995|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
105798635|NCT03216954|364920996|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
105798636|NCT03216954|364920997|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
105798637|NCT03216954|364920998|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
105798638|NCT03216954|364920999|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
105798639|NCT01610167|364921000|FG000|Overall Study|Scheduling conflict.|0|||
105798640|NCT01610167|364921001|FG001|Overall Study|Scheduling conflict.|0|||
105798641|NCT01610167|364921002|FG002|Overall Study|Scheduling conflict.|2|||
105798642|NCT01050673|364921005|FG000|Overall Study|Physician Decision|4|||
105798643|NCT01050673|364921006|FG001|Overall Study|Physician Decision|5|||
105798644|NCT02191579|364921012|FG000|Treatment 1|Multiple Reasons Specified|27|||
105798645|NCT02191579|364921013|FG001|Treatment 1|Multiple Reasons Specified|58|||
105798646|NCT02191579|364921012|FG000|Treatment 2|Multiple Reasons Specified|0|||
105798647|NCT02191579|364921013|FG001|Treatment 2|Multiple Reasons Specified|25|||
105798648|NCT00383019|364921017|FG000|Overall Study|Adverse Event|5|||
105798649|NCT00383019|364921018|FG001|Overall Study|Adverse Event|1|||
105938050|NCT00401830|365433029|FG000|Overall Study|Lack of Efficacy|11|||
106009829|NCT01942837|365702415|FG000|Overall Study|Never initiate the treatment|2|||
106009830|NCT00124943|365702418|FG000|Phase II|Adverse Event|0|||
106009831|NCT00124943|365702419|FG001|Phase II|Adverse Event|2|||
106009832|NCT00124943|365702420|FG002|Phase II|Adverse Event|0|||
106009833|NCT00124943|365702421|FG003|Phase II|Adverse Event|1|||
106009834|NCT00124943|365702418|FG000|Phase II|Protocol Violation|0|||
106009835|NCT00124943|365702419|FG001|Phase II|Protocol Violation|0|||
106009836|NCT00124943|365702420|FG002|Phase II|Protocol Violation|0|||
106009837|NCT00124943|365702421|FG003|Phase II|Protocol Violation|1|||
106009838|NCT00124943|365702418|FG000|Phase II|Lost to Follow-up|0|||
106009839|NCT00124943|365702419|FG001|Phase II|Lost to Follow-up|0|||
106009840|NCT00124943|365702420|FG002|Phase II|Lost to Follow-up|0|||
106009841|NCT00124943|365702421|FG003|Phase II|Lost to Follow-up|1|||
106009842|NCT00124943|365702418|FG000|Phase II|Withdrawal by Subject|0|||
106009843|NCT00124943|365702419|FG001|Phase II|Withdrawal by Subject|0|||
106009844|NCT00124943|365702420|FG002|Phase II|Withdrawal by Subject|0|||
106009845|NCT00124943|365702421|FG003|Phase II|Withdrawal by Subject|2|||
106009846|NCT03304626|365702428|FG000|Overall Study|Adverse Event|1|||
106009847|NCT03304626|365702429|FG001|Overall Study|Adverse Event|0|||
106009848|NCT03304626|365702428|FG000|Overall Study|Lack of Efficacy|1|||
106009849|NCT03304626|365702429|FG001|Overall Study|Lack of Efficacy|1|||
106009850|NCT00853307|365702432|FG000|Overall Study|Adverse Event|1|||
106009851|NCT00853307|365702433|FG001|Overall Study|Adverse Event|2|||
106009852|NCT00853307|365702432|FG000|Overall Study|Withdrawal by Subject|1|||
106009853|NCT00853307|365702433|FG001|Overall Study|Withdrawal by Subject|2|||
106009854|NCT00853307|365702432|FG000|Overall Study|Reason Not Specified|0|||
106009855|NCT00853307|365702433|FG001|Overall Study|Reason Not Specified|1|||
106009856|NCT04945733|365702437|FG000|Overall Study|Physician Decision|1|||
106009857|NCT04945733|365702438|FG001|Overall Study|Physician Decision|3|||
106009858|NCT04945733|365702439|FG002|Overall Study|Physician Decision|0|||
106139718|NCT03068468|366170378|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
105938051|NCT00401830|365433030|FG001|Overall Study|Lack of Efficacy|5|||
105938052|NCT00401830|365433029|FG000|Overall Study|Withdrawal by Subject|4|||
105938053|NCT00401830|365433030|FG001|Overall Study|Withdrawal by Subject|3|||
105938054|NCT00401830|365433029|FG000|Overall Study|Protocol Violation|3|||
105938055|NCT00401830|365433030|FG001|Overall Study|Protocol Violation|3|||
105938056|NCT00401830|365433029|FG000|Overall Study|Non-compliance with drug study|1|||
105938057|NCT00401830|365433030|FG001|Overall Study|Non-compliance with drug study|0|||
105938058|NCT00401830|365433029|FG000|Overall Study|Lost to Follow-up|1|||
105938059|NCT00401830|365433030|FG001|Overall Study|Lost to Follow-up|3|||
105938060|NCT00401830|365433029|FG000|Overall Study|Other: Personal / Family problems|1|||
105938061|NCT00401830|365433030|FG001|Overall Study|Other: Personal / Family problems|0|||
105938062|NCT01720602|365433031|FG000|Overall Study|Adverse Event|3|||
105938063|NCT01720602|365433031|FG000|Overall Study|Progressive disease on therapy|2|||
106009859|NCT04945733|365702437|FG000|Overall Study|Withdrawal by Subject|3|||
106009860|NCT04945733|365702438|FG001|Overall Study|Withdrawal by Subject|3|||
106009861|NCT04945733|365702439|FG002|Overall Study|Withdrawal by Subject|0|||
105938064|NCT03378635|365433034|FG000|Overall Study|Adverse Event|1|||
105938065|NCT03378635|365433035|FG001|Overall Study|Adverse Event|0|||
105938066|NCT03378635|365433036|FG002|Overall Study|Adverse Event|0|||
105938067|NCT03378635|365433034|FG000|Overall Study|Withdrawal by Subject|1|||
106009862|NCT00726063|365702440|FG000|Overall Study|Adverse Event|9|||
106009863|NCT00726063|365702441|FG001|Overall Study|Adverse Event|7|||
105798650|NCT00383019|364921017|FG000|Overall Study|Withdrawal by Subject|0|||
105798651|NCT00383019|364921018|FG001|Overall Study|Withdrawal by Subject|1|||
105798652|NCT03940586|364921019|FG000|Overall Study|Death|3|||
105798653|NCT03940586|364921020|FG001|Overall Study|Death|2|||
105798654|NCT03940586|364921021|FG002|Overall Study|Death|0|||
105798655|NCT03940586|364921019|FG000|Overall Study|Physician Decision|1|||
105798656|NCT03940586|364921020|FG001|Overall Study|Physician Decision|0|||
105798657|NCT03940586|364921021|FG002|Overall Study|Physician Decision|1|||
105798658|NCT03940586|364921019|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
105798659|NCT03940586|364921020|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
105798660|NCT03940586|364921021|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
105798661|NCT03940586|364921019|FG000|Overall Study|Not Treated|0|||
105798662|NCT03940586|364921020|FG001|Overall Study|Not Treated|2|||
105798663|NCT03940586|364921021|FG002|Overall Study|Not Treated|0|||
105798664|NCT02766400|364921022|FG000|Overall Study|Death|1|||
105798665|NCT02766400|364921023|FG001|Overall Study|Death|2|||
105798666|NCT02766400|364921022|FG000|Overall Study|Withdrawal by Subject|1|||
105798667|NCT02766400|364921023|FG001|Overall Study|Withdrawal by Subject|0|||
105798668|NCT01309828|364921029|FG000|Overall Study|Adverse Event|10|||
105798669|NCT01309828|364921030|FG001|Overall Study|Adverse Event|11|||
105798670|NCT01309828|364921029|FG000|Overall Study|Voluntary Withdrawal|5|||
105798671|NCT01309828|364921030|FG001|Overall Study|Voluntary Withdrawal|4|||
105798672|NCT01309828|364921029|FG000|Overall Study|Major Protocol Deviation|0|||
105798673|NCT01309828|364921030|FG001|Overall Study|Major Protocol Deviation|1|||
105798674|NCT01309828|364921029|FG000|Overall Study|Other|1|||
105798675|NCT01309828|364921030|FG001|Overall Study|Other|0|||
105798676|NCT02556632|364921031|FG000|Overall Study|Lost to Follow-up|1|||
105798677|NCT02556632|364921032|FG001|Overall Study|Lost to Follow-up|0|||
105798678|NCT02556632|364921033|FG002|Overall Study|Lost to Follow-up|0|||
105798679|NCT02556632|364921031|FG000|Overall Study|Disliked Intervention|1|||
105798680|NCT02556632|364921032|FG001|Overall Study|Disliked Intervention|1|||
105798681|NCT02556632|364921033|FG002|Overall Study|Disliked Intervention|1|||
105798682|NCT02556632|364921031|FG000|Overall Study|No Reason|1|||
105938068|NCT03378635|365433035|FG001|Overall Study|Withdrawal by Subject|0|||
105938069|NCT03378635|365433036|FG002|Overall Study|Withdrawal by Subject|0|||
105798683|NCT02556632|364921032|FG001|Overall Study|No Reason|0|||
105798684|NCT02556632|364921033|FG002|Overall Study|No Reason|1|||
105798685|NCT02556632|364921031|FG000|Overall Study|Personal Issues|0|||
105798686|NCT02556632|364921032|FG001|Overall Study|Personal Issues|1|||
105798687|NCT02556632|364921033|FG002|Overall Study|Personal Issues|1|||
105798688|NCT02556632|364921031|FG000|Overall Study|Changed Mind|0|||
105798689|NCT02556632|364921032|FG001|Overall Study|Changed Mind|1|||
105798690|NCT02556632|364921033|FG002|Overall Study|Changed Mind|0|||
105938070|NCT01835431|365433037|FG000|Overall Study|Adverse Event|1|||
105938071|NCT01835431|365433038|FG001|Overall Study|Adverse Event|0|||
105938072|NCT01835431|365433037|FG000|Overall Study|other|0|||
105938073|NCT01835431|365433038|FG001|Overall Study|other|2|||
105938074|NCT01835431|365433037|FG000|Overall Study|Withdrawal by Subject|6|||
105938075|NCT01835431|365433038|FG001|Overall Study|Withdrawal by Subject|10|||
105938076|NCT01835431|365433037|FG000|Overall Study|Protocol Violation|1|||
105938077|NCT01835431|365433038|FG001|Overall Study|Protocol Violation|0|||
105938078|NCT00655356|365433039|FG000|Overall Study|Withdrawal by Subject|3|||
105938079|NCT00655356|365433040|FG001|Overall Study|Withdrawal by Subject|4|||
105938080|NCT00655356|365433039|FG000|Overall Study|Sponsor Request|10|||
105938081|NCT00655356|365433040|FG001|Overall Study|Sponsor Request|4|||
105938082|NCT00655356|365433039|FG000|Overall Study|Adverse Event|1|||
105938083|NCT00655356|365433040|FG001|Overall Study|Adverse Event|1|||
105938084|NCT00655356|365433039|FG000|Overall Study|Protocol Violation|2|||
105938085|NCT00655356|365433040|FG001|Overall Study|Protocol Violation|1|||
105938086|NCT00655356|365433039|FG000|Overall Study|Other Reason|1|||
105938087|NCT00655356|365433040|FG001|Overall Study|Other Reason|0|||
105938088|NCT00421408|365433041|FG000|Overall Study|Lost to Follow-up|30|||
105938089|NCT00421408|365433042|FG001|Overall Study|Lost to Follow-up|20|||
105938090|NCT00421408|365433041|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
105798691|NCT02556632|364921031|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
105938091|NCT00421408|365433042|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
105938092|NCT04105725|365433043|FG000|Primary Intervention|Lost to Follow-up|0|||
105938093|NCT04105725|365433044|FG001|Primary Intervention|Lost to Follow-up|2|||
105938094|NCT04105725|365433043|FG000|Primary Intervention|Withdrawal by Subject|0|||
105938095|NCT04105725|365433044|FG001|Primary Intervention|Withdrawal by Subject|1|||
105798692|NCT02556632|364921032|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
105798693|NCT02556632|364921033|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
105798694|NCT02556632|364921031|FG000|Overall Study|Unrelated Adverse Event|1|||
105798695|NCT02556632|364921032|FG001|Overall Study|Unrelated Adverse Event|0|||
105798696|NCT02556632|364921033|FG002|Overall Study|Unrelated Adverse Event|3|||
105798697|NCT02556632|364921031|FG000|Overall Study|Related Adverse Event|0|||
105798698|NCT02556632|364921032|FG001|Overall Study|Related Adverse Event|1|||
105938096|NCT04634331|365433047|FG000|Overall Study|Withdrawal by Subject|2|||
105938097|NCT04634331|365433048|FG001|Overall Study|Withdrawal by Subject|2|||
106139719|NCT03068468|366170379|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
105734332|NCT01208181|364682704|FG004|Part 1|Withdrawal by Subject|0|||
105734333|NCT01208181|364682700|FG000|Part 1|Technical problem|5|||
105734334|NCT01208181|364682701|FG001|Part 1|Technical problem|0|||
105734335|NCT01208181|364682702|FG002|Part 1|Technical problem|0|||
105734336|NCT01208181|364682703|FG003|Part 1|Technical problem|0|||
105734337|NCT01208181|364682704|FG004|Part 1|Technical problem|0|||
105734338|NCT01208181|364682700|FG000|Part 1|Protocol Violation|10|||
105734339|NCT01208181|364682701|FG001|Part 1|Protocol Violation|5|||
105734340|NCT01208181|364682702|FG002|Part 1|Protocol Violation|0|||
105734341|NCT01208181|364682703|FG003|Part 1|Protocol Violation|0|||
105734342|NCT01208181|364682704|FG004|Part 1|Protocol Violation|0|||
105734343|NCT01208181|364682700|FG000|Part 1|Physician Decision|4|||
105734344|NCT01208181|364682701|FG001|Part 1|Physician Decision|0|||
105734345|NCT01208181|364682702|FG002|Part 1|Physician Decision|0|||
105734346|NCT01208181|364682703|FG003|Part 1|Physician Decision|0|||
105734347|NCT01208181|364682704|FG004|Part 1|Physician Decision|0|||
105734348|NCT01208181|364682700|FG000|Part 1|Non-compliance with study drug|1|||
105734349|NCT01208181|364682701|FG001|Part 1|Non-compliance with study drug|1|||
105734350|NCT01208181|364682702|FG002|Part 1|Non-compliance with study drug|0|||
105734351|NCT01208181|364682703|FG003|Part 1|Non-compliance with study drug|0|||
105734352|NCT01208181|364682704|FG004|Part 1|Non-compliance with study drug|0|||
105734353|NCT01208181|364682700|FG000|Part 1|Lost to Follow-up|5|||
105734354|NCT01208181|364682701|FG001|Part 1|Lost to Follow-up|3|||
105734355|NCT01208181|364682702|FG002|Part 1|Lost to Follow-up|0|||
105734356|NCT01208181|364682703|FG003|Part 1|Lost to Follow-up|0|||
105734357|NCT01208181|364682704|FG004|Part 1|Lost to Follow-up|1|||
105734358|NCT01208181|364682700|FG000|Part 1|Lack of Efficacy|37|||
105734359|NCT01208181|364682701|FG001|Part 1|Lack of Efficacy|12|||
105734360|NCT01208181|364682702|FG002|Part 1|Lack of Efficacy|0|||
105734361|NCT01208181|364682703|FG003|Part 1|Lack of Efficacy|0|||
105734362|NCT01208181|364682704|FG004|Part 1|Lack of Efficacy|17|||
105734363|NCT01208181|364682700|FG000|Part 1|Adverse Event|26|||
105734364|NCT01208181|364682701|FG001|Part 1|Adverse Event|24|||
105734365|NCT01208181|364682702|FG002|Part 1|Adverse Event|0|||
105734366|NCT01208181|364682703|FG003|Part 1|Adverse Event|0|||
105734367|NCT01208181|364682704|FG004|Part 1|Adverse Event|4|||
105734368|NCT01208181|364682700|FG000|Part 2|Adverse Event|0|||
105734369|NCT01208181|364682701|FG001|Part 2|Adverse Event|0|||
105734370|NCT01208181|364682702|FG002|Part 2|Adverse Event|6|||
105734371|NCT01208181|364682703|FG003|Part 2|Adverse Event|7|||
105734372|NCT01208181|364682704|FG004|Part 2|Adverse Event|0|||
105734373|NCT01208181|364682700|FG000|Part 2|Withdrawal by Subject|0|||
105734374|NCT01208181|364682701|FG001|Part 2|Withdrawal by Subject|0|||
105734375|NCT01208181|364682702|FG002|Part 2|Withdrawal by Subject|1|||
105734376|NCT01208181|364682703|FG003|Part 2|Withdrawal by Subject|1|||
105734377|NCT01208181|364682704|FG004|Part 2|Withdrawal by Subject|0|||
105734378|NCT01208181|364682700|FG000|Part 2|Protocol Violation|0|||
105734379|NCT01208181|364682701|FG001|Part 2|Protocol Violation|0|||
105734380|NCT01208181|364682702|FG002|Part 2|Protocol Violation|1|||
105734381|NCT01208181|364682703|FG003|Part 2|Protocol Violation|0|||
105734382|NCT01208181|364682704|FG004|Part 2|Protocol Violation|0|||
105734383|NCT01208181|364682700|FG000|Part 2|Physician Decision|0|||
105734384|NCT01208181|364682701|FG001|Part 2|Physician Decision|0|||
105734385|NCT01208181|364682702|FG002|Part 2|Physician Decision|1|||
105734386|NCT01208181|364682703|FG003|Part 2|Physician Decision|2|||
105734387|NCT01208181|364682704|FG004|Part 2|Physician Decision|0|||
105734388|NCT01208181|364682700|FG000|Part 2|Non-compliance with study drug|0|||
105734389|NCT01208181|364682701|FG001|Part 2|Non-compliance with study drug|0|||
105734390|NCT01208181|364682702|FG002|Part 2|Non-compliance with study drug|1|||
105734391|NCT01208181|364682703|FG003|Part 2|Non-compliance with study drug|1|||
105734392|NCT01208181|364682704|FG004|Part 2|Non-compliance with study drug|0|||
105734393|NCT01208181|364682700|FG000|Part 2|Lost to Follow-up|0|||
105734394|NCT01208181|364682701|FG001|Part 2|Lost to Follow-up|0|||
105734395|NCT01208181|364682702|FG002|Part 2|Lost to Follow-up|1|||
105734396|NCT01208181|364682703|FG003|Part 2|Lost to Follow-up|2|||
105734397|NCT01208181|364682704|FG004|Part 2|Lost to Follow-up|0|||
105734398|NCT01208181|364682700|FG000|Part 2|Lack of Efficacy|0|||
105734399|NCT01208181|364682701|FG001|Part 2|Lack of Efficacy|0|||
105734400|NCT01208181|364682702|FG002|Part 2|Lack of Efficacy|5|||
105734401|NCT01208181|364682703|FG003|Part 2|Lack of Efficacy|7|||
105734402|NCT01208181|364682704|FG004|Part 2|Lack of Efficacy|0|||
105734403|NCT00942708|364682705|FG000|Overall Study|Withdrawal by Subject|1|||
105734404|NCT01457339|364682706|FG000|Period 3 (100 mg)|Adverse Event|0|||
105734405|NCT01457339|364682707|FG001|Period 3 (100 mg)|Adverse Event|1|||
105734406|NCT01457339|364682706|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
105734407|NCT01457339|364682707|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
105734408|NCT01457339|364682706|FG000|Period 6 (250 mg)|Family Emergency|1|||
105734409|NCT01457339|364682707|FG001|Period 6 (250 mg)|Family Emergency|0|||
105734410|NCT01457339|364682706|FG000|Period 6 (250 mg)|Personal appointment|0|||
105734411|NCT01457339|364682707|FG001|Period 6 (250 mg)|Personal appointment|1|||
105734412|NCT00196937|364682711|FG000|Overall Study|Serious Adverse Event|1|||
105734413|NCT00196937|364682712|FG001|Overall Study|Serious Adverse Event|0|||
106009864|NCT02007096|365702442|FG000|Overall Study|medication not available|2|||
106009865|NCT02007096|365702443|FG001|Overall Study|medication not available|0|||
106009866|NCT02007096|365702442|FG000|Overall Study|did not inject saline|0|||
106009867|NCT02007096|365702443|FG001|Overall Study|did not inject saline|3|||
106009868|NCT02007096|365702442|FG000|Overall Study|did not follow postoperative protocol|8|||
106009869|NCT02007096|365702443|FG001|Overall Study|did not follow postoperative protocol|11|||
106009870|NCT02007096|365702442|FG000|Overall Study|converted to open surgery|1|||
106009871|NCT02007096|365702443|FG001|Overall Study|converted to open surgery|1|||
106009872|NCT02007096|365702442|FG000|Overall Study|no mesh placed|0|||
106009873|NCT02007096|365702443|FG001|Overall Study|no mesh placed|1|||
106009874|NCT01231984|365702446|FG000|Study Period 1|Withdrawal by Subject|0|||
106009875|NCT01231984|365702447|FG001|Study Period 1|Withdrawal by Subject|0|||
106009876|NCT01231984|365702448|FG002|Study Period 1|Withdrawal by Subject|0|||
106009877|NCT01231984|365702449|FG003|Study Period 1|Withdrawal by Subject|1|||
106009878|NCT01231984|365702446|FG000|Study Period 1|Lost to Follow-up|1|||
106009879|NCT01231984|365702447|FG001|Study Period 1|Lost to Follow-up|1|||
106009880|NCT01231984|365702448|FG002|Study Period 1|Lost to Follow-up|1|||
106009881|NCT01231984|365702449|FG003|Study Period 1|Lost to Follow-up|0|||
106009882|NCT01231984|365702446|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
106009883|NCT01231984|365702447|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
106009884|NCT01231984|365702448|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
106009885|NCT01231984|365702449|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
106009886|NCT01231984|365702446|FG000|Study Period 1|Screen Failure|0|||
106009887|NCT01231984|365702447|FG001|Study Period 1|Screen Failure|0|||
106009888|NCT01231984|365702448|FG002|Study Period 1|Screen Failure|0|||
106009889|NCT01231984|365702449|FG003|Study Period 1|Screen Failure|1|||
106009890|NCT01231984|365702446|FG000|Study Period 1|Non-compliance with study requirements|5|||
105734414|NCT00196937|364682713|FG002|Overall Study|Serious Adverse Event|0|||
105734415|NCT00196937|364682711|FG000|Overall Study|Non-serious adverse event|1|||
105734416|NCT00196937|364682712|FG001|Overall Study|Non-serious adverse event|1|||
105734417|NCT00196937|364682713|FG002|Overall Study|Non-serious adverse event|1|||
105734418|NCT00196937|364682711|FG000|Overall Study|Withdrawal by Subject|0|||
105734419|NCT00196937|364682712|FG001|Overall Study|Withdrawal by Subject|0|||
105734420|NCT00196937|364682713|FG002|Overall Study|Withdrawal by Subject|2|||
105734421|NCT00196937|364682711|FG000|Overall Study|Lost to Follow-up|4|||
105734422|NCT00196937|364682712|FG001|Overall Study|Lost to Follow-up|3|||
105734423|NCT00196937|364682713|FG002|Overall Study|Lost to Follow-up|3|||
105734424|NCT00196937|364682711|FG000|Overall Study|Other|3|||
105734425|NCT00196937|364682712|FG001|Overall Study|Other|1|||
105734426|NCT00196937|364682713|FG002|Overall Study|Other|1|||
105734427|NCT01164501|364682714|FG000|Overall Study|Not treated|2|||
105734428|NCT01164501|364682715|FG001|Overall Study|Not treated|0|||
105734429|NCT01164501|364682716|FG002|Overall Study|Not treated|1|||
105734430|NCT01164501|364682714|FG000|Overall Study|Adverse Event|18|||
105734431|NCT01164501|364682715|FG001|Overall Study|Adverse Event|4|||
105734432|NCT01164501|364682716|FG002|Overall Study|Adverse Event|21|||
105734433|NCT01164501|364682714|FG000|Overall Study|Lack of Efficacy|0|||
105734434|NCT01164501|364682715|FG001|Overall Study|Lack of Efficacy|0|||
105734435|NCT01164501|364682716|FG002|Overall Study|Lack of Efficacy|1|||
105734436|NCT01164501|364682714|FG000|Overall Study|Non compliant with protocol|1|||
105734437|NCT01164501|364682715|FG001|Overall Study|Non compliant with protocol|1|||
105734438|NCT01164501|364682716|FG002|Overall Study|Non compliant with protocol|4|||
105734439|NCT01164501|364682714|FG000|Overall Study|Lost to Follow-up|3|||
105734440|NCT01164501|364682715|FG001|Overall Study|Lost to Follow-up|0|||
105734441|NCT01164501|364682716|FG002|Overall Study|Lost to Follow-up|3|||
105734442|NCT01164501|364682714|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
105734443|NCT01164501|364682715|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
105734444|NCT01164501|364682716|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
106009891|NCT01231984|365702447|FG001|Study Period 1|Non-compliance with study requirements|0|||
106009892|NCT01231984|365702448|FG002|Study Period 1|Non-compliance with study requirements|2|||
106009893|NCT01231984|365702449|FG003|Study Period 1|Non-compliance with study requirements|1|||
106009894|NCT01231984|365702446|FG000|Study Period 1|Protocol Violation|3|||
106009895|NCT01231984|365702447|FG001|Study Period 1|Protocol Violation|4|||
106009896|NCT01231984|365702448|FG002|Study Period 1|Protocol Violation|2|||
106009897|NCT01231984|365702449|FG003|Study Period 1|Protocol Violation|3|||
105734445|NCT01164501|364682714|FG000|Overall Study|Other reason not defined above|9|||
105734446|NCT01164501|364682715|FG001|Overall Study|Other reason not defined above|1|||
105734447|NCT01164501|364682716|FG002|Overall Study|Other reason not defined above|4|||
105734448|NCT02522377|364682717|FG000|Overall Study|Withdrawal by Subject|1|||
105734449|NCT02522377|364682718|FG001|Overall Study|Withdrawal by Subject|0|||
105734450|NCT02522377|364682717|FG000|Overall Study|Remission Achieved|3|||
105734451|NCT02522377|364682718|FG001|Overall Study|Remission Achieved|0|||
106009898|NCT01231984|365702446|FG000|Study Period 1|Adverse Event|1|||
106009899|NCT01231984|365702447|FG001|Study Period 1|Adverse Event|0|||
106009900|NCT01231984|365702448|FG002|Study Period 1|Adverse Event|0|||
105734452|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Other|0|||
105798699|NCT02556632|364921033|FG002|Overall Study|Related Adverse Event|0|||
105798700|NCT02556632|364921031|FG000|Overall Study|Possibly Related Adverse Event|0|||
105798701|NCT02556632|364921032|FG001|Overall Study|Possibly Related Adverse Event|0|||
105798702|NCT02556632|364921033|FG002|Overall Study|Possibly Related Adverse Event|1|||
105798703|NCT02556632|364921031|FG000|Overall Study|Did Not Start RT|0|||
105798704|NCT02556632|364921032|FG001|Overall Study|Did Not Start RT|1|||
105798705|NCT02556632|364921033|FG002|Overall Study|Did Not Start RT|0|||
105798706|NCT02556632|364921031|FG000|Overall Study|Ineligible|0|||
105798707|NCT02556632|364921032|FG001|Overall Study|Ineligible|1|||
105798708|NCT02556632|364921033|FG002|Overall Study|Ineligible|0|||
105798709|NCT02556632|364921031|FG000|Overall Study|Disliked Study Procedures|0|||
105798710|NCT02556632|364921032|FG001|Overall Study|Disliked Study Procedures|0|||
105798711|NCT02556632|364921033|FG002|Overall Study|Disliked Study Procedures|1|||
105798712|NCT02556632|364921031|FG000|Overall Study|Treatment or Change Delay|0|||
105798713|NCT02556632|364921032|FG001|Overall Study|Treatment or Change Delay|0|||
105798714|NCT02556632|364921033|FG002|Overall Study|Treatment or Change Delay|1|||
105798715|NCT01625286|364921034|FG000|Overall Study|Adverse Event|0|||
105798716|NCT01625286|364921035|FG001|Overall Study|Adverse Event|0|||
105798717|NCT01625286|364921036|FG002|Overall Study|Adverse Event|0|||
105798718|NCT01625286|364921037|FG003|Overall Study|Adverse Event|0|||
105798719|NCT01625286|364921038|FG004|Overall Study|Adverse Event|1|||
105798720|NCT01625286|364921039|FG005|Overall Study|Adverse Event|2|||
105798721|NCT01625286|364921040|FG006|Overall Study|Adverse Event|1|||
105798722|NCT01625286|364921034|FG000|Overall Study|Death|0|||
105798723|NCT01625286|364921035|FG001|Overall Study|Death|0|||
105798724|NCT01625286|364921036|FG002|Overall Study|Death|1|||
105798725|NCT01625286|364921037|FG003|Overall Study|Death|1|||
105798726|NCT01625286|364921038|FG004|Overall Study|Death|0|||
106139720|NCT03068468|366170376|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
106139721|NCT03068468|366170377|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
106139722|NCT03068468|366170378|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
106139723|NCT03068468|366170379|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
106139724|NCT03068468|366170376|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
106139725|NCT03068468|366170377|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
106139726|NCT03068468|366170378|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
106139727|NCT03068468|366170379|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
106139728|NCT03068468|366170376|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
106139729|NCT03068468|366170377|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
106139730|NCT03068468|366170378|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
105734453|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Other|0|||
105734454|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Other|1|||
105734455|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Other|4|||
105734456|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
105734457|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
105734458|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
105734459|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
105734460|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
105734461|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
105734462|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
105734463|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
105734464|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
105734465|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
105734466|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
105734467|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
105734468|NCT02515669|364682723|FG000|228 Week Open-Label Phase|Missing|0|||
105798727|NCT01625286|364921039|FG005|Overall Study|Death|11|||
105798728|NCT01625286|364921040|FG006|Overall Study|Death|16|||
105798729|NCT01625286|364921034|FG000|Overall Study|Withdrawal by Subject|0|||
105798730|NCT01625286|364921035|FG001|Overall Study|Withdrawal by Subject|1|||
105798731|NCT01625286|364921036|FG002|Overall Study|Withdrawal by Subject|0|||
105938098|NCT02766478|365433050|FG000|Overall Study|Withdrawal by Subject|1|||
105938099|NCT02766478|365433051|FG001|Overall Study|Withdrawal by Subject|1|||
105938100|NCT05626686|365433052|FG000|Overall Study|Protocol Violation|3|||
105938101|NCT05626686|365433052|FG000|Overall Study|Withdrawal by Subject|3|||
105938102|NCT00089583|365433053|FG000|Overall Study|Adverse Event|0|||
105938103|NCT00089583|365433054|FG001|Overall Study|Adverse Event|3|||
105938104|NCT00089583|365433053|FG000|Overall Study|Insufficient Viral Load Response|5|||
105938105|NCT00089583|365433054|FG001|Overall Study|Insufficient Viral Load Response|5|||
105938106|NCT00089583|365433053|FG000|Overall Study|Withdrawal by Subject|0|||
105938107|NCT00089583|365433054|FG001|Overall Study|Withdrawal by Subject|4|||
105938108|NCT00089583|365433053|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
105938109|NCT00089583|365433054|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
105938110|NCT00089583|365433053|FG000|Overall Study|Participant Refused Study Medication|0|||
105734469|NCT02515669|364682724|FG001|228 Week Open-Label Phase|Missing|2|||
105734470|NCT02515669|364682725|FG002|228 Week Open-Label Phase|Missing|2|||
105734471|NCT02515669|364682726|FG003|228 Week Open-Label Phase|Missing|2|||
105734472|NCT01282814|364682727|FG000|First Intervention|Emesis During Dosing Interval|0|||
105734473|NCT01282814|364682728|FG001|First Intervention|Emesis During Dosing Interval|3|||
105734474|NCT01282814|364682727|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
105734475|NCT01282814|364682728|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105734476|NCT01444391|364682729|FG000|Overall Study|Death|1|||
105734477|NCT01089725|364682730|FG000|Overall Study|Adverse Event|1|||
105734478|NCT01089725|364682731|FG001|Overall Study|Adverse Event|1|||
105734479|NCT01089725|364682732|FG002|Overall Study|Adverse Event|0|||
105734480|NCT01089725|364682733|FG003|Overall Study|Adverse Event|0|||
105734481|NCT01089725|364682734|FG004|Overall Study|Adverse Event|2|||
105734482|NCT01089725|364682730|FG000|Overall Study|Lack of Efficacy|4|||
105734483|NCT01089725|364682731|FG001|Overall Study|Lack of Efficacy|3|||
105734484|NCT01089725|364682732|FG002|Overall Study|Lack of Efficacy|1|||
105734485|NCT01089725|364682733|FG003|Overall Study|Lack of Efficacy|0|||
105734486|NCT01089725|364682734|FG004|Overall Study|Lack of Efficacy|4|||
105734487|NCT01089725|364682730|FG000|Overall Study|Lost to Follow-up|2|||
105734488|NCT01089725|364682731|FG001|Overall Study|Lost to Follow-up|2|||
105734489|NCT01089725|364682732|FG002|Overall Study|Lost to Follow-up|0|||
105734490|NCT01089725|364682733|FG003|Overall Study|Lost to Follow-up|3|||
105734491|NCT01089725|364682734|FG004|Overall Study|Lost to Follow-up|0|||
105734492|NCT01089725|364682730|FG000|Overall Study|Protocol Violation|0|||
105734493|NCT01089725|364682731|FG001|Overall Study|Protocol Violation|0|||
105734494|NCT01089725|364682732|FG002|Overall Study|Protocol Violation|1|||
105734495|NCT01089725|364682733|FG003|Overall Study|Protocol Violation|1|||
105734496|NCT01089725|364682734|FG004|Overall Study|Protocol Violation|0|||
105734497|NCT01089725|364682730|FG000|Overall Study|Withdrawal by Subject|5|||
105734498|NCT01089725|364682731|FG001|Overall Study|Withdrawal by Subject|5|||
105734499|NCT01089725|364682732|FG002|Overall Study|Withdrawal by Subject|4|||
105734500|NCT01089725|364682733|FG003|Overall Study|Withdrawal by Subject|5|||
105734501|NCT01089725|364682734|FG004|Overall Study|Withdrawal by Subject|4|||
105734502|NCT01089725|364682730|FG000|Overall Study|Study Terminated by Sponsor|51|||
105938111|NCT00089583|365433054|FG001|Overall Study|Participant Refused Study Medication|2|||
105938112|NCT00089583|365433053|FG000|Overall Study|Non-Compliance|0|||
105938113|NCT00089583|365433054|FG001|Overall Study|Non-Compliance|4|||
105938114|NCT00089583|365433053|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
105938115|NCT00089583|365433054|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
105938116|NCT00089583|365433053|FG000|Overall Study|Participant Management Criteria Met|0|||
105938117|NCT00089583|365433054|FG001|Overall Study|Participant Management Criteria Met|1|||
105938118|NCT00089583|365433053|FG000|Overall Study|Reason Not Provided|0|||
105938119|NCT00089583|365433054|FG001|Overall Study|Reason Not Provided|1|||
105938120|NCT00089583|365433053|FG000|Overall Study|Protocol Violation|0|||
105938121|NCT00089583|365433054|FG001|Overall Study|Protocol Violation|3|||
105938122|NCT00089583|365433053|FG000|Overall Study|Principal Investigator Decision|0|||
105938123|NCT00089583|365433054|FG001|Overall Study|Principal Investigator Decision|10|||
105938124|NCT00089583|365433053|FG000|Overall Study|Start of Disallowed Medication|0|||
105938125|NCT00089583|365433054|FG001|Overall Study|Start of Disallowed Medication|1|||
105938126|NCT00089583|365433053|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
105938127|NCT00089583|365433054|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
105938128|NCT00089583|365433053|FG000|Overall Study|Participant Incarcerated|0|||
105938129|NCT00089583|365433054|FG001|Overall Study|Participant Incarcerated|1|||
105938130|NCT01412983|365433055|FG000|1st Period|Ineligible|0|||
105938131|NCT01412983|365433056|FG001|1st Period|Ineligible|1|||
105938132|NCT01412983|365433055|FG000|1st Period|Positive slit lamp finding|0|||
105938133|NCT01412983|365433056|FG001|1st Period|Positive slit lamp finding|1|||
105938134|NCT01412983|365433055|FG000|1st Period|Unacceptable lens movement|0|||
105938135|NCT01412983|365433056|FG001|1st Period|Unacceptable lens movement|1|||
105938136|NCT01412983|365433055|FG000|1st Period|Inability to maintain wear|0|||
105938137|NCT01412983|365433056|FG001|1st Period|Inability to maintain wear|1|||
105938138|NCT01623154|365433057|FG000|Overall Study|Did not drink Pranactin Citric|4|||
105938139|NCT00890097|365433060|FG000|Overall Study|Adverse Event|21|||
105938140|NCT00890097|365433061|FG001|Overall Study|Adverse Event|32|||
105734503|NCT01089725|364682731|FG001|Overall Study|Study Terminated by Sponsor|56|||
105734504|NCT01089725|364682732|FG002|Overall Study|Study Terminated by Sponsor|53|||
105938141|NCT00890097|365433062|FG002|Overall Study|Adverse Event|28|||
105938142|NCT00890097|365433060|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
105938143|NCT00890097|365433061|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
105734505|NCT01089725|364682733|FG003|Overall Study|Study Terminated by Sponsor|68|||
105734506|NCT01089725|364682734|FG004|Overall Study|Study Terminated by Sponsor|68|||
105734507|NCT01089725|364682730|FG000|Overall Study|Randomized, but not treated|0|||
105938144|NCT00890097|365433062|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
105938145|NCT00890097|365433060|FG000|Overall Study|Withdrew Consent|9|||
105938146|NCT00890097|365433061|FG001|Overall Study|Withdrew Consent|6|||
105938147|NCT00890097|365433062|FG002|Overall Study|Withdrew Consent|9|||
105938148|NCT00890097|365433060|FG000|Overall Study|Lost to Follow-up|5|||
106009901|NCT01231984|365702449|FG003|Study Period 1|Adverse Event|0|||
106009902|NCT01231984|365702446|FG000|Study Period 1|Other|0|||
106009903|NCT01231984|365702447|FG001|Study Period 1|Other|0|||
106009904|NCT01231984|365702448|FG002|Study Period 1|Other|0|||
106009905|NCT01231984|365702449|FG003|Study Period 1|Other|1|||
106009906|NCT01231984|365702446|FG000|Study Period 2|Withdrawal by Subject|1|||
106009907|NCT01231984|365702447|FG001|Study Period 2|Withdrawal by Subject|1|||
106009908|NCT01231984|365702448|FG002|Study Period 2|Withdrawal by Subject|0|||
106009909|NCT01231984|365702449|FG003|Study Period 2|Withdrawal by Subject|0|||
106009910|NCT01231984|365702446|FG000|Study Period 2|Lost to Follow-up|1|||
106009911|NCT01231984|365702447|FG001|Study Period 2|Lost to Follow-up|0|||
106009912|NCT01231984|365702448|FG002|Study Period 2|Lost to Follow-up|0|||
106009913|NCT01231984|365702449|FG003|Study Period 2|Lost to Follow-up|3|||
106009914|NCT01231984|365702446|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
106009915|NCT01231984|365702447|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
106009916|NCT01231984|365702448|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
106009917|NCT01231984|365702449|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
106009918|NCT04385277|365702450|FG000|Overall Study|Physician Decision|2|||
106009919|NCT04385277|365702450|FG000|Overall Study|Ineligible|1|||
106009920|NCT04385277|365702450|FG000|Overall Study|Patient/Parent Refusal|2|||
106009921|NCT03363841|365702451|FG000|Overall Study|Adverse Event|1|||
106009922|NCT03363841|365702451|FG000|Overall Study|Withdrawal by Subject|1|||
106009923|NCT03363841|365702451|FG000|Overall Study|Death|7|||
106009924|NCT03363841|365702451|FG000|Overall Study|Physician Decision|1|||
106009925|NCT02939287|365702454|FG000|Overall Study|met exclusion criteria|1|||
106009926|NCT02939287|365702455|FG001|Overall Study|met exclusion criteria|1|||
106009927|NCT02939287|365702456|FG002|Overall Study|met exclusion criteria|1|||
106009928|NCT02939287|365702454|FG000|Overall Study|Did not complete survey|2|||
106009929|NCT02939287|365702455|FG001|Overall Study|Did not complete survey|2|||
106009930|NCT02939287|365702456|FG002|Overall Study|Did not complete survey|0|||
106009931|NCT02939287|365702454|FG000|Overall Study|Withdrawal by Subject|1|||
106009932|NCT02939287|365702455|FG001|Overall Study|Withdrawal by Subject|1|||
106009933|NCT02939287|365702456|FG002|Overall Study|Withdrawal by Subject|0|||
106009934|NCT02903771|365702457|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
106009935|NCT02903771|365702458|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
106009936|NCT02903771|365702459|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
106009937|NCT02903771|365702460|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
106009938|NCT02903771|365702461|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
106009939|NCT02903771|365702462|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
106009940|NCT02903771|365702463|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
106009941|NCT02903771|365702457|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
106009942|NCT02903771|365702458|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
106009943|NCT02903771|365702459|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
106009944|NCT02903771|365702460|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
106009945|NCT02903771|365702461|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
106009946|NCT02903771|365702462|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
106009947|NCT02903771|365702463|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
106009948|NCT02903771|365702457|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
106009949|NCT02903771|365702458|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
106009950|NCT02903771|365702459|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
106009951|NCT02903771|365702460|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
106009952|NCT02903771|365702461|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
106009953|NCT02903771|365702462|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
106009954|NCT02903771|365702463|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
106009955|NCT02903771|365702457|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
105734508|NCT01089725|364682731|FG001|Overall Study|Randomized, but not treated|1|||
105734509|NCT01089725|364682732|FG002|Overall Study|Randomized, but not treated|2|||
105734510|NCT01089725|364682733|FG003|Overall Study|Randomized, but not treated|1|||
105734511|NCT01089725|364682734|FG004|Overall Study|Randomized, but not treated|2|||
105734512|NCT01089725|364682730|FG000|Overall Study|Other|3|||
105734513|NCT01089725|364682731|FG001|Overall Study|Other|0|||
105734514|NCT01089725|364682732|FG002|Overall Study|Other|0|||
105734515|NCT01089725|364682733|FG003|Overall Study|Other|1|||
105734516|NCT01089725|364682734|FG004|Overall Study|Other|0|||
105734517|NCT02725177|364682738|FG000|Overall Study|Physician Decision|4|||
105734518|NCT02725177|364682738|FG000|Overall Study|Adverse Event|1|||
105734519|NCT00793585|364682739|FG000|Overall Study|Adverse Event|1|||
105734520|NCT00793585|364682740|FG001|Overall Study|Adverse Event|1|||
105734521|NCT00793585|364682739|FG000|Overall Study|Protocol Violation|1|||
105734522|NCT00793585|364682740|FG001|Overall Study|Protocol Violation|2|||
105734523|NCT02332915|364682741|FG000|Overall Study|Moved out of region|3|||
105734524|NCT02332915|364682742|FG001|Overall Study|Moved out of region|0|||
105734525|NCT02332915|364682741|FG000|Overall Study|Unrelated illness|1|||
105734526|NCT02332915|364682742|FG001|Overall Study|Unrelated illness|1|||
105734527|NCT02332915|364682741|FG000|Overall Study|Travel distance prohibitive|0|||
105798732|NCT01625286|364921037|FG003|Overall Study|Withdrawal by Subject|1|||
105798733|NCT01625286|364921038|FG004|Overall Study|Withdrawal by Subject|0|||
105798734|NCT01625286|364921039|FG005|Overall Study|Withdrawal by Subject|0|||
105798735|NCT01625286|364921040|FG006|Overall Study|Withdrawal by Subject|1|||
105798736|NCT01625286|364921034|FG000|Overall Study|Any reason not specifically recorded|0|||
105798737|NCT01625286|364921035|FG001|Overall Study|Any reason not specifically recorded|0|||
105798738|NCT01625286|364921036|FG002|Overall Study|Any reason not specifically recorded|0|||
105798739|NCT01625286|364921037|FG003|Overall Study|Any reason not specifically recorded|0|||
105798740|NCT01625286|364921038|FG004|Overall Study|Any reason not specifically recorded|0|||
105798741|NCT01625286|364921039|FG005|Overall Study|Any reason not specifically recorded|1|||
105798742|NCT01625286|364921040|FG006|Overall Study|Any reason not specifically recorded|0|||
105798743|NCT01625286|364921034|FG000|Overall Study|Progressive disease|6|||
105798744|NCT01625286|364921035|FG001|Overall Study|Progressive disease|3|||
105798745|NCT01625286|364921036|FG002|Overall Study|Progressive disease|4|||
105798746|NCT01625286|364921037|FG003|Overall Study|Progressive disease|5|||
105798747|NCT01625286|364921038|FG004|Overall Study|Progressive disease|5|||
105798748|NCT01625286|364921039|FG005|Overall Study|Progressive disease|0|||
105798749|NCT01625286|364921040|FG006|Overall Study|Progressive disease|0|||
105798750|NCT01625286|364921034|FG000|Overall Study|Lost to Follow-up|0|||
105798751|NCT01625286|364921035|FG001|Overall Study|Lost to Follow-up|0|||
105798752|NCT01625286|364921036|FG002|Overall Study|Lost to Follow-up|0|||
105798753|NCT01625286|364921037|FG003|Overall Study|Lost to Follow-up|0|||
105798754|NCT01625286|364921038|FG004|Overall Study|Lost to Follow-up|0|||
105798755|NCT01625286|364921039|FG005|Overall Study|Lost to Follow-up|0|||
105798756|NCT01625286|364921040|FG006|Overall Study|Lost to Follow-up|1|||
105798757|NCT02475980|364921041|FG000|Overall Study|Lost to Follow-up|4|||
105798758|NCT02475980|364921041|FG000|Overall Study|Withdrawal by Subject|1|||
105798759|NCT04128696|364921042|FG000|Overall Study|Lost to Follow-up|3|||
105798760|NCT04128696|364921043|FG001|Overall Study|Lost to Follow-up|7|||
105798761|NCT04128696|364921042|FG000|Overall Study|Withdrawal by Subject|12|||
105798762|NCT04128696|364921043|FG001|Overall Study|Withdrawal by Subject|11|||
105798763|NCT04128696|364921042|FG000|Overall Study|Study Closed/Terminated|26|||
105798764|NCT04128696|364921043|FG001|Overall Study|Study Closed/Terminated|38|||
105798765|NCT04128696|364921042|FG000|Overall Study|Physician Decision|2|||
105798766|NCT04128696|364921043|FG001|Overall Study|Physician Decision|3|||
105798767|NCT01585831|364921046|FG000|Overall Study|Physician Decision|0|||
105798768|NCT01585831|364921047|FG001|Overall Study|Physician Decision|1|||
105798769|NCT01585831|364921046|FG000|Overall Study|Withdrawal by Subject|2|||
105798770|NCT01585831|364921047|FG001|Overall Study|Withdrawal by Subject|1|||
105798771|NCT02904200|364921048|FG000|Overall Study|Withdrawal by Subject|1|||
105798772|NCT02904200|364921049|FG001|Overall Study|Withdrawal by Subject|0|||
105798773|NCT01272193|364922577|FG000|Overall Study|Adverse Event|1|||
105798774|NCT01272193|364922578|FG001|Overall Study|Adverse Event|1|||
105798775|NCT01272193|364922577|FG000|Overall Study|Lack of Efficacy|0|||
105798776|NCT01272193|364922578|FG001|Overall Study|Lack of Efficacy|3|||
105798777|NCT01272193|364922577|FG000|Overall Study|Withdrawal Criteria|1|||
105798778|NCT01272193|364922578|FG001|Overall Study|Withdrawal Criteria|1|||
106009956|NCT02903771|365702458|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
106009957|NCT02903771|365702459|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
106009958|NCT02903771|365702460|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
106009959|NCT02903771|365702461|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
106009960|NCT02903771|365702462|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
106009961|NCT02903771|365702463|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
106009962|NCT02903771|365702457|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
106009963|NCT02903771|365702458|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
106009964|NCT02903771|365702459|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
106009965|NCT02903771|365702460|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
105798779|NCT01272193|364922577|FG000|Overall Study|Unclassified|8|||
105798780|NCT01272193|364922578|FG001|Overall Study|Unclassified|7|||
105798781|NCT00736099|364922583|FG000|Overall Study|Adverse Event|61|||
105798782|NCT00736099|364922584|FG001|Overall Study|Adverse Event|18|||
105798783|NCT00736099|364922583|FG000|Overall Study|Protocol Violation|10|||
105798784|NCT00736099|364922584|FG001|Overall Study|Protocol Violation|4|||
105798785|NCT00736099|364922583|FG000|Overall Study|Lost to Follow-up|12|||
105798786|NCT00736099|364922584|FG001|Overall Study|Lost to Follow-up|5|||
106009966|NCT02903771|365702461|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
106009967|NCT02903771|365702462|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
106009968|NCT02903771|365702463|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
105798787|NCT00736099|364922583|FG000|Overall Study|Withdrawal by Subject|42|||
105798788|NCT00736099|364922584|FG001|Overall Study|Withdrawal by Subject|13|||
105798789|NCT00736099|364922583|FG000|Overall Study|Lack of Efficacy|15|||
105798790|NCT00736099|364922584|FG001|Overall Study|Lack of Efficacy|8|||
105798791|NCT00736099|364922583|FG000|Overall Study|Other reason|43|||
105798792|NCT00736099|364922584|FG001|Overall Study|Other reason|10|||
105798793|NCT01613131|364922587|FG000|Overall Study|Withdrawal by Subject|3|||
106009969|NCT02903771|365702457|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
105798794|NCT01613131|364922588|FG001|Overall Study|Withdrawal by Subject|5|||
105798795|NCT02454972|364922589|FG000|Overall Study|Progressive disease|17|||
106009970|NCT02903771|365702458|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
105798796|NCT02454972|364922590|FG001|Overall Study|Progressive disease|16|||
105798797|NCT02454972|364922591|FG002|Overall Study|Progressive disease|59|||
105798798|NCT02454972|364922592|FG003|Overall Study|Progressive disease|23|||
105798799|NCT02454972|364922593|FG004|Overall Study|Progressive disease|16|||
105798800|NCT02454972|364922594|FG005|Overall Study|Progressive disease|12|||
105798801|NCT02454972|364922595|FG006|Overall Study|Progressive disease|19|||
105798802|NCT02454972|364922596|FG007|Overall Study|Progressive disease|27|||
105798803|NCT02454972|364922597|FG008|Overall Study|Progressive disease|0|||
105798804|NCT02454972|364922589|FG000|Overall Study|Death|0|||
105798805|NCT02454972|364922590|FG001|Overall Study|Death|0|||
105798806|NCT02454972|364922591|FG002|Overall Study|Death|5|||
105798807|NCT02454972|364922592|FG003|Overall Study|Death|1|||
105798808|NCT02454972|364922593|FG004|Overall Study|Death|0|||
105798809|NCT02454972|364922594|FG005|Overall Study|Death|0|||
105798810|NCT02454972|364922595|FG006|Overall Study|Death|0|||
105798811|NCT02454972|364922596|FG007|Overall Study|Death|0|||
105798812|NCT02454972|364922597|FG008|Overall Study|Death|95|||
105798813|NCT02454972|364922589|FG000|Overall Study|Physician Decision|0|||
105798814|NCT02454972|364922590|FG001|Overall Study|Physician Decision|1|||
105798815|NCT02454972|364922591|FG002|Overall Study|Physician Decision|2|||
105798816|NCT02454972|364922592|FG003|Overall Study|Physician Decision|1|||
105798817|NCT02454972|364922593|FG004|Overall Study|Physician Decision|2|||
105798818|NCT02454972|364922594|FG005|Overall Study|Physician Decision|0|||
105798819|NCT02454972|364922595|FG006|Overall Study|Physician Decision|0|||
105798820|NCT02454972|364922596|FG007|Overall Study|Physician Decision|1|||
105798821|NCT02454972|364922597|FG008|Overall Study|Physician Decision|0|||
105798822|NCT02454972|364922589|FG000|Overall Study|Non treatment-related adverse event|2|||
105798823|NCT02454972|364922590|FG001|Overall Study|Non treatment-related adverse event|0|||
105798824|NCT02454972|364922591|FG002|Overall Study|Non treatment-related adverse event|1|||
105798825|NCT02454972|364922592|FG003|Overall Study|Non treatment-related adverse event|0|||
105798826|NCT02454972|364922593|FG004|Overall Study|Non treatment-related adverse event|0|||
105798827|NCT02454972|364922594|FG005|Overall Study|Non treatment-related adverse event|1|||
105798828|NCT02454972|364922595|FG006|Overall Study|Non treatment-related adverse event|0|||
105798829|NCT02454972|364922596|FG007|Overall Study|Non treatment-related adverse event|1|||
105798830|NCT02454972|364922597|FG008|Overall Study|Non treatment-related adverse event|0|||
105798831|NCT02454972|364922589|FG000|Overall Study|Treatment-related adverse events|0|||
105798832|NCT02454972|364922590|FG001|Overall Study|Treatment-related adverse events|1|||
105798833|NCT02454972|364922591|FG002|Overall Study|Treatment-related adverse events|1|||
106009971|NCT02903771|365702459|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
106009972|NCT02903771|365702460|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
106009973|NCT02903771|365702461|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
106009974|NCT02903771|365702462|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
106009975|NCT02903771|365702463|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
106009976|NCT02903771|365702457|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
106009977|NCT02903771|365702458|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
106009978|NCT02903771|365702459|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
106009979|NCT02903771|365702460|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
106009980|NCT02903771|365702461|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
106009981|NCT02903771|365702462|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
106009982|NCT02903771|365702463|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
106009983|NCT02903771|365702457|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
106009984|NCT02903771|365702458|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
106009985|NCT02903771|365702459|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
106009986|NCT02903771|365702460|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
105798834|NCT02454972|364922592|FG003|Overall Study|Treatment-related adverse events|0|||
105798835|NCT02454972|364922593|FG004|Overall Study|Treatment-related adverse events|2|||
105798836|NCT02454972|364922594|FG005|Overall Study|Treatment-related adverse events|0|||
105798837|NCT02454972|364922595|FG006|Overall Study|Treatment-related adverse events|0|||
105798838|NCT02454972|364922596|FG007|Overall Study|Treatment-related adverse events|2|||
105798839|NCT02454972|364922597|FG008|Overall Study|Treatment-related adverse events|0|||
105798840|NCT02454972|364922589|FG000|Overall Study|Patient moves to compassionate use|0|||
105798841|NCT02454972|364922590|FG001|Overall Study|Patient moves to compassionate use|0|||
105798842|NCT02454972|364922591|FG002|Overall Study|Patient moves to compassionate use|0|||
105798843|NCT02454972|364922592|FG003|Overall Study|Patient moves to compassionate use|0|||
106009987|NCT02903771|365702461|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
106009988|NCT02903771|365702462|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
105798844|NCT02454972|364922593|FG004|Overall Study|Patient moves to compassionate use|0|||
105798845|NCT02454972|364922594|FG005|Overall Study|Patient moves to compassionate use|0|||
105798846|NCT02454972|364922595|FG006|Overall Study|Patient moves to compassionate use|2|||
105798847|NCT02454972|364922596|FG007|Overall Study|Patient moves to compassionate use|0|||
105734528|NCT02332915|364682742|FG001|Overall Study|Travel distance prohibitive|1|||
105734529|NCT02332915|364682741|FG000|Overall Study|did not meet inclusion criteria|2|||
105734530|NCT02332915|364682742|FG001|Overall Study|did not meet inclusion criteria|4|||
105734531|NCT01769404|364682743|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
105734532|NCT01769404|364682744|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
105734533|NCT01769404|364682743|FG000|Treatment Period 1|Withdrawal by Subject|3|||
105734534|NCT01769404|364682744|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105734535|NCT01769404|364682743|FG000|Treatment Period 1|Sponsor decision|1|||
105734536|NCT01769404|364682744|FG001|Treatment Period 1|Sponsor decision|0|||
105734537|NCT01769404|364682743|FG000|Treatment Period 2|Sponsor decision|7|||
105734538|NCT01769404|364682744|FG001|Treatment Period 2|Sponsor decision|0|||
105734539|NCT01821677|364682745|FG000|Overall Study|Adverse Event|4|||
105734540|NCT01821677|364682746|FG001|Overall Study|Adverse Event|6|||
105734541|NCT01821677|364682747|FG002|Overall Study|Adverse Event|5|||
105734542|NCT01821677|364682745|FG000|Overall Study|Physician Decision|1|||
105734543|NCT01821677|364682746|FG001|Overall Study|Physician Decision|4|||
105734544|NCT01821677|364682747|FG002|Overall Study|Physician Decision|1|||
105734545|NCT01821677|364682745|FG000|Overall Study|Non-compliance|0|||
105938149|NCT00890097|365433061|FG001|Overall Study|Lost to Follow-up|5|||
105938150|NCT00890097|365433062|FG002|Overall Study|Lost to Follow-up|5|||
105938151|NCT00890097|365433060|FG000|Overall Study|Noncompliance|0|||
105938152|NCT00890097|365433061|FG001|Overall Study|Noncompliance|4|||
105938153|NCT00890097|365433062|FG002|Overall Study|Noncompliance|4|||
105938154|NCT00890097|365433060|FG000|Overall Study|Sponsor Decision|7|||
105938155|NCT00890097|365433061|FG001|Overall Study|Sponsor Decision|11|||
105938156|NCT00890097|365433062|FG002|Overall Study|Sponsor Decision|7|||
105938157|NCT00890097|365433060|FG000|Overall Study|Did not attend final visit|2|||
105938158|NCT00890097|365433061|FG001|Overall Study|Did not attend final visit|3|||
105938159|NCT00890097|365433062|FG002|Overall Study|Did not attend final visit|0|||
105938160|NCT00890097|365433060|FG000|Overall Study|Subject Decision|3|||
105938161|NCT00890097|365433061|FG001|Overall Study|Subject Decision|2|||
105938162|NCT00890097|365433062|FG002|Overall Study|Subject Decision|6|||
105938163|NCT00890097|365433060|FG000|Overall Study|Randomization Error|2|||
105938164|NCT00890097|365433061|FG001|Overall Study|Randomization Error|0|||
105938165|NCT00890097|365433062|FG002|Overall Study|Randomization Error|0|||
105938166|NCT00890097|365433060|FG000|Overall Study|Failed inclusion criteria|3|||
105938167|NCT00890097|365433061|FG001|Overall Study|Failed inclusion criteria|4|||
105938168|NCT00890097|365433062|FG002|Overall Study|Failed inclusion criteria|0|||
105938169|NCT00890097|365433060|FG000|Overall Study|Transportation|0|||
105938170|NCT00890097|365433061|FG001|Overall Study|Transportation|2|||
105938171|NCT00890097|365433062|FG002|Overall Study|Transportation|0|||
105938172|NCT00890097|365433060|FG000|Overall Study|Subject Moved|0|||
105938173|NCT00890097|365433061|FG001|Overall Study|Subject Moved|4|||
105938174|NCT00890097|365433062|FG002|Overall Study|Subject Moved|0|||
105938175|NCT00890097|365433060|FG000|Overall Study|Protocol Deviation|1|||
105938176|NCT00890097|365433061|FG001|Overall Study|Protocol Deviation|1|||
105938177|NCT00890097|365433062|FG002|Overall Study|Protocol Deviation|1|||
105938178|NCT04349098|365433063|FG000|Overall Study|Death|16|||
105938179|NCT04349098|365433064|FG001|Overall Study|Death|8|||
105938180|NCT04349098|365433063|FG000|Overall Study|Lost to Follow-up|11|||
105938181|NCT04349098|365433064|FG001|Overall Study|Lost to Follow-up|8|||
105938182|NCT04349098|365433063|FG000|Overall Study|Withdrawal by Subject|8|||
105938183|NCT04349098|365433064|FG001|Overall Study|Withdrawal by Subject|5|||
105938184|NCT04349098|365433063|FG000|Overall Study|Other|3|||
105938185|NCT04349098|365433064|FG001|Overall Study|Other|5|||
105938186|NCT01691092|365433066|FG000|Overall Study|Lost to Follow-up|10|||
105938187|NCT01691092|365433066|FG000|Overall Study|Physician Decision|4|||
105938188|NCT01691092|365433066|FG000|Overall Study|Withdrawal by Subject|3|||
105938189|NCT01691092|365433066|FG000|Overall Study|non-compliance|3|||
105938190|NCT01691092|365433066|FG000|Overall Study|used for different study|2|||
105938191|NCT01691092|365433066|FG000|Overall Study|screen fail|19|||
105938192|NCT01793129|365434953|FG000|Overall Study|Lost to Follow-up|3|||
105938193|NCT01793129|365434954|FG001|Overall Study|Lost to Follow-up|7|||
105938194|NCT01793129|365434953|FG000|Overall Study|Withdrawal by Subject|0|||
105938195|NCT01793129|365434954|FG001|Overall Study|Withdrawal by Subject|2|||
105938196|NCT02469961|365434955|FG000|Overall Study|Physician Decision|4|||
105938197|NCT02469961|365434956|FG001|Overall Study|Physician Decision|1|||
105938198|NCT05130281|365434959|FG000|Overall Study|Withdrawal by Subject|0|||
105938199|NCT05130281|365434960|FG001|Overall Study|Withdrawal by Subject|0|||
105734546|NCT01821677|364682746|FG001|Overall Study|Non-compliance|1|||
105734547|NCT01821677|364682747|FG002|Overall Study|Non-compliance|2|||
105798848|NCT02454972|364922597|FG008|Overall Study|Patient moves to compassionate use|0|||
105938200|NCT05130281|365434961|FG002|Overall Study|Withdrawal by Subject|1|||
105938201|NCT05058456|365434962|FG000|Overall Study|Death|1|||
105734548|NCT01821677|364682745|FG000|Overall Study|Lost to Follow-up|2|||
105938202|NCT05058456|365434962|FG000|Overall Study|End of Study data not yet due for release|34|||
105938203|NCT01832038|365434964|FG000|Overall Study|Death|5|||
105938204|NCT01832038|365434964|FG000|Overall Study|Adverse Event|50|||
105938205|NCT01832038|365434964|FG000|Overall Study|Lack of Efficacy|81|||
105938206|NCT01832038|365434964|FG000|Overall Study|Protocol Violation|7|||
105734549|NCT01821677|364682746|FG001|Overall Study|Lost to Follow-up|1|||
105734550|NCT01821677|364682747|FG002|Overall Study|Lost to Follow-up|3|||
105734551|NCT01821677|364682745|FG000|Overall Study|Protocol Violation|0|||
105734552|NCT01821677|364682746|FG001|Overall Study|Protocol Violation|0|||
105734553|NCT01821677|364682747|FG002|Overall Study|Protocol Violation|2|||
105734554|NCT01821677|364682745|FG000|Overall Study|Withdrawal by Subject|7|||
105734555|NCT01821677|364682746|FG001|Overall Study|Withdrawal by Subject|3|||
105734556|NCT01821677|364682747|FG002|Overall Study|Withdrawal by Subject|2|||
105734557|NCT01821677|364682745|FG000|Overall Study|Other|9|||
105734558|NCT01821677|364682746|FG001|Overall Study|Other|0|||
105734559|NCT01821677|364682747|FG002|Overall Study|Other|0|||
105734560|NCT00095121|364682751|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
105734561|NCT00095121|364682752|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
105734562|NCT00095121|364682751|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
105734563|NCT00095121|364682752|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
105734564|NCT02209597|364682755|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
105734565|NCT02209597|364682755|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
105734566|NCT02209597|364682755|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
105734567|NCT02209597|364682755|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
105734568|NCT03067311|364682759|FG000|Overall Study|Lost to Follow-up|1|||
105734569|NCT03067311|364682760|FG001|Overall Study|Lost to Follow-up|1|||
105734570|NCT03067311|364682759|FG000|Overall Study|Moved away|1|||
105734571|NCT03067311|364682760|FG001|Overall Study|Moved away|1|||
105734572|NCT01507246|364682761|FG000|Overall Study|Required different surgical procedures|2|||
105734573|NCT01507246|364682762|FG001|Overall Study|Required different surgical procedures|1|||
105734574|NCT00969618|364682766|FG000|Overall Study|Adverse Event|29|||
105734575|NCT00969618|364682766|FG000|Overall Study|Entry Criteria Not Met|3|||
105734576|NCT00969618|364682766|FG000|Overall Study|Lack of Efficacy|2|||
105734577|NCT00969618|364682766|FG000|Overall Study|Lost to Follow-up|7|||
105734578|NCT00969618|364682766|FG000|Overall Study|Physician Decision|1|||
105734579|NCT00969618|364682766|FG000|Overall Study|Protocol Violation|9|||
105734580|NCT00969618|364682766|FG000|Overall Study|Withdrawal by Subject|27|||
105734581|NCT05363293|364682769|FG000|Overall Study|Withdrawal by Subject|1|||
105734582|NCT05363293|364682770|FG001|Overall Study|Withdrawal by Subject|0|||
105734583|NCT05363293|364682771|FG002|Overall Study|Withdrawal by Subject|0|||
105734584|NCT05363293|364682772|FG003|Overall Study|Withdrawal by Subject|0|||
105734585|NCT05363293|364682773|FG004|Overall Study|Withdrawal by Subject|0|||
105734586|NCT05363293|364682774|FG005|Overall Study|Withdrawal by Subject|0|||
105734587|NCT05363293|364682775|FG006|Overall Study|Withdrawal by Subject|0|||
105734588|NCT05363293|364682776|FG007|Overall Study|Withdrawal by Subject|0|||
105734589|NCT05363293|364682777|FG008|Overall Study|Withdrawal by Subject|0|||
105734590|NCT05363293|364682778|FG009|Overall Study|Withdrawal by Subject|0|||
105734591|NCT01318902|364682779|FG000|Overall Study|Symptomatic Deterioration|0|||
105734592|NCT01318902|364682780|FG001|Overall Study|Symptomatic Deterioration|1|||
105734593|NCT01318902|364682781|FG002|Overall Study|Symptomatic Deterioration|1|||
105734594|NCT01318902|364682782|FG003|Overall Study|Symptomatic Deterioration|2|||
105734595|NCT01318902|364682779|FG000|Overall Study|Withdrawal by Patient|0|||
105734596|NCT01318902|364682780|FG001|Overall Study|Withdrawal by Patient|1|||
105938207|NCT01832038|365434964|FG000|Overall Study|Lost to Follow-up|10|||
105938208|NCT01832038|365434964|FG000|Overall Study|Withdrawal by Subject|49|||
105938209|NCT01832038|365434964|FG000|Overall Study|Visit non-compliance|2|||
105938210|NCT01832038|365434964|FG000|Overall Study|Subject refused to return visit|2|||
105938211|NCT01832038|365434964|FG000|Overall Study|Not convenient to come back to site|2|||
105938212|NCT01832038|365434964|FG000|Overall Study|Participant was asked to quit|5|||
105938213|NCT01832038|365434964|FG000|Overall Study|Back home|1|||
105938214|NCT01832038|365434964|FG000|Overall Study|Pregnancy|1|||
105938215|NCT01832038|365434964|FG000|Overall Study|Low compliance|3|||
105938216|NCT01832038|365434964|FG000|Overall Study|Prohibit procedure|2|||
105938217|NCT01832038|365434964|FG000|Overall Study|Not possible to visit the hospital|1|||
105938218|NCT01832038|365434964|FG000|Overall Study|Changes of implementation system|3|||
105938219|NCT01832038|365434964|FG000|Overall Study|Plan to pregnancy|7|||
105938220|NCT01832038|365434964|FG000|Overall Study|Bad mood and has suicidal thought|1|||
105938221|NCT01832038|365434964|FG000|Overall Study|Prohibited concomitant medication|1|||
105938222|NCT01832038|365434964|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
105938223|NCT01832038|365434964|FG000|Overall Study|Subject considered the efficacy was poor|1|||
105938224|NCT03810365|365434966|FG000|Overall Study|Lost to Follow-up|2|||
105938225|NCT03810365|365434967|FG001|Overall Study|Lost to Follow-up|2|||
105938226|NCT03810365|365434966|FG000|Overall Study|Withdrawal by Subject|4|||
105938227|NCT03810365|365434967|FG001|Overall Study|Withdrawal by Subject|5|||
105938228|NCT01386645|365434971|FG000|Overall Study|Physician Decision|0|||
105938229|NCT01386645|365434972|FG001|Overall Study|Physician Decision|0|||
105938230|NCT01386645|365434973|FG002|Overall Study|Physician Decision|1|||
105938231|NCT01386645|365434971|FG000|Overall Study|Withdrawal by Subject|0|||
105798849|NCT02454972|364922589|FG000|Overall Study|Withdrawal by Subject|0|||
105798850|NCT02454972|364922590|FG001|Overall Study|Withdrawal by Subject|1|||
105798851|NCT02454972|364922591|FG002|Overall Study|Withdrawal by Subject|5|||
105798852|NCT02454972|364922592|FG003|Overall Study|Withdrawal by Subject|2|||
105798853|NCT02454972|364922593|FG004|Overall Study|Withdrawal by Subject|3|||
105798854|NCT02454972|364922594|FG005|Overall Study|Withdrawal by Subject|2|||
106139731|NCT03068468|366170379|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
106139732|NCT03068468|366170376|FG000|Open-Label Extension Period|Reason not Specified|0|||
106139733|NCT03068468|366170377|FG001|Open-Label Extension Period|Reason not Specified|0|||
106139734|NCT03068468|366170378|FG002|Open-Label Extension Period|Reason not Specified|1|||
106139735|NCT03068468|366170379|FG003|Open-Label Extension Period|Reason not Specified|4|||
106139736|NCT03140176|366170384|FG000|Overall Study|Reason missing|23|||
106139737|NCT03140176|366170384|FG000|Overall Study|Death|33|||
106139738|NCT03140176|366170384|FG000|Overall Study|Disease progression|1|||
106139739|NCT03140176|366170384|FG000|Overall Study|Physician Decision|1|||
106139740|NCT03140176|366170384|FG000|Overall Study|Withdrawal by Subject|1|||
106139741|NCT03140176|366170384|FG000|Overall Study|Lost to Follow-up|15|||
106139742|NCT01091454|366170386|FG000|Overall Study|Ineligible|1|||
105798855|NCT02454972|364922595|FG006|Overall Study|Withdrawal by Subject|0|||
105798856|NCT02454972|364922596|FG007|Overall Study|Withdrawal by Subject|1|||
105798857|NCT02454972|364922597|FG008|Overall Study|Withdrawal by Subject|2|||
105798858|NCT02454972|364922589|FG000|Overall Study|Multiple delay/holds on treatment|0|||
105798859|NCT02454972|364922590|FG001|Overall Study|Multiple delay/holds on treatment|0|||
105798860|NCT02454972|364922591|FG002|Overall Study|Multiple delay/holds on treatment|0|||
105798861|NCT02454972|364922592|FG003|Overall Study|Multiple delay/holds on treatment|1|||
105798862|NCT02454972|364922593|FG004|Overall Study|Multiple delay/holds on treatment|0|||
105798863|NCT02454972|364922594|FG005|Overall Study|Multiple delay/holds on treatment|0|||
105798864|NCT02454972|364922595|FG006|Overall Study|Multiple delay/holds on treatment|0|||
106139743|NCT03784963|366170387|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
106139744|NCT03784963|366170388|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
106139745|NCT03784963|366170389|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
106139746|NCT03784963|366170390|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
105798865|NCT02454972|364922596|FG007|Overall Study|Multiple delay/holds on treatment|0|||
105798866|NCT02454972|364922597|FG008|Overall Study|Multiple delay/holds on treatment|0|||
105798867|NCT02454972|364922589|FG000|Overall Study|Never treated|0|||
105798868|NCT02454972|364922590|FG001|Overall Study|Never treated|0|||
105798869|NCT02454972|364922591|FG002|Overall Study|Never treated|3|||
105798870|NCT02454972|364922592|FG003|Overall Study|Never treated|1|||
105798871|NCT02454972|364922593|FG004|Overall Study|Never treated|1|||
105798872|NCT02454972|364922594|FG005|Overall Study|Never treated|0|||
105798873|NCT02454972|364922595|FG006|Overall Study|Never treated|0|||
105798874|NCT02454972|364922596|FG007|Overall Study|Never treated|0|||
105798875|NCT02454972|364922597|FG008|Overall Study|Never treated|5|||
105798876|NCT02454972|364922589|FG000|Overall Study|Lost to Follow-up|0|||
105798877|NCT02454972|364922590|FG001|Overall Study|Lost to Follow-up|0|||
105798878|NCT02454972|364922591|FG002|Overall Study|Lost to Follow-up|0|||
105798879|NCT02454972|364922592|FG003|Overall Study|Lost to Follow-up|0|||
105798880|NCT02454972|364922593|FG004|Overall Study|Lost to Follow-up|0|||
105798881|NCT02454972|364922594|FG005|Overall Study|Lost to Follow-up|0|||
105798882|NCT02454972|364922595|FG006|Overall Study|Lost to Follow-up|0|||
105798883|NCT02454972|364922596|FG007|Overall Study|Lost to Follow-up|0|||
105798884|NCT02454972|364922597|FG008|Overall Study|Lost to Follow-up|2|||
105798885|NCT02454972|364922589|FG000|Overall Study|Study termination|0|||
105798886|NCT02454972|364922590|FG001|Overall Study|Study termination|0|||
105798887|NCT02454972|364922591|FG002|Overall Study|Study termination|0|||
105798888|NCT02454972|364922592|FG003|Overall Study|Study termination|0|||
105798889|NCT02454972|364922593|FG004|Overall Study|Study termination|0|||
105938232|NCT01386645|365434972|FG001|Overall Study|Withdrawal by Subject|1|||
105938233|NCT01386645|365434973|FG002|Overall Study|Withdrawal by Subject|1|||
105938234|NCT02410200|365434976|FG000|Overall Study|Adverse Event|2|||
106139747|NCT03179787|366170391|FG000|Overall Study|Lost to Follow-up|15|||
105938235|NCT01897896|365434977|FG000|Overall Study|Death|1|||
105938236|NCT01897896|365434978|FG001|Overall Study|Death|0|||
105938237|NCT01897896|365434977|FG000|Overall Study|Adverse Event|11|||
105938238|NCT01897896|365434978|FG001|Overall Study|Adverse Event|1|||
105938239|NCT01897896|365434977|FG000|Overall Study|Lost to Follow-up|1|||
105938240|NCT01897896|365434978|FG001|Overall Study|Lost to Follow-up|0|||
105938241|NCT01897896|365434977|FG000|Overall Study|Non-compliance with study drug dosing|1|||
105938242|NCT01897896|365434978|FG001|Overall Study|Non-compliance with study drug dosing|1|||
106139748|NCT03179787|366170391|FG000|Overall Study|Case report failures|2|||
105798890|NCT02454972|364922594|FG005|Overall Study|Study termination|0|||
105798891|NCT02454972|364922595|FG006|Overall Study|Study termination|0|||
105798892|NCT02454972|364922596|FG007|Overall Study|Study termination|0|||
105938243|NCT01897896|365434977|FG000|Overall Study|Withdrawal by Subject|7|||
106139749|NCT03179787|366170391|FG000|Overall Study|Treatment not administered|1|||
106139750|NCT00157014|366170392|FG000|Overall Study|Death|4|||
106139751|NCT00157014|366170393|FG001|Overall Study|Death|2|||
106139752|NCT00157014|366170394|FG002|Overall Study|Death|1|||
106139753|NCT00157014|366170395|FG003|Overall Study|Death|1|||
106139754|NCT00157014|366170392|FG000|Overall Study|Physician Decision|0|||
106139755|NCT00157014|366170393|FG001|Overall Study|Physician Decision|1|||
106139756|NCT00157014|366170394|FG002|Overall Study|Physician Decision|0|||
106139757|NCT00157014|366170395|FG003|Overall Study|Physician Decision|0|||
106139758|NCT00157014|366170392|FG000|Overall Study|Medications withdrawn on family request|0|||
106139759|NCT00157014|366170393|FG001|Overall Study|Medications withdrawn on family request|1|||
106139760|NCT00157014|366170394|FG002|Overall Study|Medications withdrawn on family request|0|||
106139761|NCT00157014|366170395|FG003|Overall Study|Medications withdrawn on family request|0|||
106139762|NCT00157014|366170392|FG000|Overall Study|Patient withdrawn by investigator|1|||
106139763|NCT00157014|366170393|FG001|Overall Study|Patient withdrawn by investigator|0|||
106139764|NCT00157014|366170394|FG002|Overall Study|Patient withdrawn by investigator|0|||
106139765|NCT00157014|366170395|FG003|Overall Study|Patient withdrawn by investigator|0|||
106139766|NCT00157014|366170392|FG000|Overall Study|Patient unable to return in nursing home|1|||
106139767|NCT00157014|366170393|FG001|Overall Study|Patient unable to return in nursing home|0|||
106139768|NCT00157014|366170394|FG002|Overall Study|Patient unable to return in nursing home|0|||
106139769|NCT00157014|366170395|FG003|Overall Study|Patient unable to return in nursing home|0|||
106139770|NCT00157014|366170392|FG000|Overall Study|Patient would not receive transplant|0|||
106139771|NCT00157014|366170393|FG001|Overall Study|Patient would not receive transplant|1|||
106139772|NCT00157014|366170394|FG002|Overall Study|Patient would not receive transplant|0|||
106139773|NCT00157014|366170395|FG003|Overall Study|Patient would not receive transplant|0|||
105734597|NCT01318902|364682781|FG002|Overall Study|Withdrawal by Patient|0|||
105734598|NCT01318902|364682782|FG003|Overall Study|Withdrawal by Patient|3|||
105734599|NCT01318902|364682779|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
105734600|NCT01318902|364682780|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
105734601|NCT01318902|364682781|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
105734602|NCT01318902|364682782|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
105734603|NCT01318902|364682779|FG000|Overall Study|Adverse Event|0|||
105734604|NCT01318902|364682780|FG001|Overall Study|Adverse Event|1|||
105734605|NCT01318902|364682781|FG002|Overall Study|Adverse Event|0|||
105734606|NCT01318902|364682782|FG003|Overall Study|Adverse Event|0|||
105734607|NCT01318902|364682779|FG000|Overall Study|Terminated by Sponsor|0|||
105734608|NCT01318902|364682780|FG001|Overall Study|Terminated by Sponsor|0|||
105734609|NCT01318902|364682781|FG002|Overall Study|Terminated by Sponsor|1|||
105734610|NCT01318902|364682782|FG003|Overall Study|Terminated by Sponsor|0|||
105734611|NCT02089737|364684275|FG000|Overall Study|Survey form not completed|5|||
105734612|NCT02089737|364684275|FG000|Overall Study|Not treated|1|||
105734613|NCT00744055|364684276|FG000|Overall Study|Withdrawal by Subject|6|||
105734614|NCT00744055|364684277|FG001|Overall Study|Withdrawal by Subject|9|||
105734615|NCT00744055|364684276|FG000|Overall Study|Lack of Efficacy|0|||
105734616|NCT00744055|364684277|FG001|Overall Study|Lack of Efficacy|1|||
105734617|NCT00744055|364684276|FG000|Overall Study|Physician Decision|0|||
105734618|NCT00744055|364684277|FG001|Overall Study|Physician Decision|2|||
105734619|NCT00744055|364684276|FG000|Overall Study|Protocol Violation|1|||
105734620|NCT00744055|364684277|FG001|Overall Study|Protocol Violation|1|||
105734621|NCT00744055|364684276|FG000|Overall Study|Lost to Follow-up|0|||
105734622|NCT00744055|364684277|FG001|Overall Study|Lost to Follow-up|1|||
105734623|NCT02767570|364684278|FG000|Overall Study|Lost to Follow-up|3|||
105734624|NCT02767570|364684279|FG001|Overall Study|Lost to Follow-up|0|||
105734625|NCT02767570|364684278|FG000|Overall Study|COVID shutdown|2|||
105734626|NCT02767570|364684279|FG001|Overall Study|COVID shutdown|5|||
105734627|NCT02767570|364684278|FG000|Overall Study|Increased pain|2|||
105734628|NCT02767570|364684279|FG001|Overall Study|Increased pain|0|||
105734629|NCT02767570|364684278|FG000|Overall Study|Withdrawal by Subject|1|||
105734630|NCT02767570|364684279|FG001|Overall Study|Withdrawal by Subject|3|||
105734631|NCT02767570|364684278|FG000|Overall Study|Unrelated medical issue|1|||
105734632|NCT02767570|364684279|FG001|Overall Study|Unrelated medical issue|1|||
105734633|NCT02767570|364684278|FG000|Overall Study|Received intra-articular injection|0|||
105734634|NCT02767570|364684279|FG001|Overall Study|Received intra-articular injection|1|||
105734635|NCT01712438|364684280|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
105798893|NCT02454972|364922597|FG008|Overall Study|Study termination|6|||
105734636|NCT01712438|364684280|FG000|Overall Study|Ongoing ITI treatment|6|||
105734637|NCT01712438|364684280|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
105734638|NCT01712438|364684280|FG000|Overall Study|Prematurely Discontinued|25|||
105734639|NCT01981122|364684281|FG000|Overall Study|Withdrawal by Subject|0|||
105734640|NCT01981122|364684282|FG001|Overall Study|Withdrawal by Subject|2|||
105734641|NCT01981122|364684281|FG000|Overall Study|Protocol Violation|0|||
105734642|NCT01981122|364684282|FG001|Overall Study|Protocol Violation|1|||
105734643|NCT01981122|364684281|FG000|Overall Study|Lost to Follow-up|0|||
105734644|NCT01981122|364684282|FG001|Overall Study|Lost to Follow-up|1|||
105938244|NCT01897896|365434978|FG001|Overall Study|Withdrawal by Subject|1|||
106009989|NCT02903771|365702463|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
106009990|NCT02903771|365702457|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
106009991|NCT02903771|365702458|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
106009992|NCT02903771|365702459|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
106009993|NCT02903771|365702460|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
106009994|NCT02903771|365702461|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
106009995|NCT02903771|365702462|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
106009996|NCT02903771|365702463|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
106009997|NCT02903771|365702457|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
106009998|NCT02903771|365702458|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
106009999|NCT02903771|365702459|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
106010000|NCT02903771|365702460|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
106010001|NCT02903771|365702461|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
106010002|NCT02903771|365702462|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
106010003|NCT02903771|365702463|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
106010004|NCT02903771|365702457|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
106010005|NCT02903771|365702458|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
106010006|NCT02903771|365702459|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
106010007|NCT02903771|365702460|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
106010008|NCT02903771|365702461|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
106010009|NCT02903771|365702462|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
106010010|NCT02903771|365702463|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
106010011|NCT00581308|365702464|FG000|Pre Discharge|Lost to Follow-up|1|||
106010012|NCT00581308|365702464|FG000|Pre Discharge|Device Removed|1|||
106010013|NCT00581308|365702464|FG000|Month 1|Lost to Follow-up|3|||
106010014|NCT00581308|365702464|FG000|Month 1|Withdrawal by Subject|2|||
106010015|NCT00581308|365702464|FG000|Month 1|Device Removed|2|||
106010016|NCT00581308|365702464|FG000|Month 1|Uknown|1|||
106010017|NCT00581308|365702464|FG000|Month 6|Lost to Follow-up|1|||
106010018|NCT00581308|365702464|FG000|Month 6|Withdrawal by Subject|2|||
106010019|NCT00581308|365702464|FG000|Month 12|Death|1|||
106010020|NCT00581308|365702464|FG000|Month 12|Lost to Follow-up|14|||
106010021|NCT00581308|365702464|FG000|Month 12|Withdrawal by Subject|3|||
106010022|NCT00581308|365702464|FG000|Month 12|Device Removed|1|||
106010023|NCT00581308|365702464|FG000|Month 12|Other|1|||
106010024|NCT04558125|365702465|FG000|Overall Study|Death|1|||
106010025|NCT02738801|365702469|FG000|Overall Study|Adverse Event|1|||
106010026|NCT02738801|365702470|FG001|Overall Study|Adverse Event|1|||
106010027|NCT02738801|365702469|FG000|Overall Study|Withdrawal by Subject|0|||
106010028|NCT02738801|365702470|FG001|Overall Study|Withdrawal by Subject|1|||
106010029|NCT03279081|365702471|FG000|Overall Study|Withdrawal by Subject|12|||
106010030|NCT03279081|365702472|FG001|Overall Study|Withdrawal by Subject|20|||
106010031|NCT03279081|365702471|FG000|Overall Study|Physician Decision|4|||
105734645|NCT01981122|364684281|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
105734646|NCT01981122|364684282|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
105734647|NCT01981122|364684281|FG000|Overall Study|Death|14|||
105734648|NCT01981122|364684282|FG001|Overall Study|Death|15|||
105734649|NCT04328623|364684285|FG000|Overall Study|Protocol Violation|0|||
105734650|NCT04328623|364684286|FG001|Overall Study|Protocol Violation|1|||
105734651|NCT00849693|364684287|FG000|Acute Treatment Phase|Adverse Event|12|||
105734652|NCT00849693|364684288|FG001|Acute Treatment Phase|Adverse Event|7|||
105734653|NCT00849693|364684289|FG002|Acute Treatment Phase|Adverse Event|6|||
105734654|NCT00849693|364684290|FG003|Acute Treatment Phase|Adverse Event|4|||
105734655|NCT00849693|364684287|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
105734656|NCT00849693|364684288|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
105734657|NCT00849693|364684289|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
105734658|NCT00849693|364684290|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
105734659|NCT00849693|364684287|FG000|Acute Treatment Phase|Protocol Violation|1|||
105734660|NCT00849693|364684288|FG001|Acute Treatment Phase|Protocol Violation|5|||
105734661|NCT00849693|364684289|FG002|Acute Treatment Phase|Protocol Violation|2|||
105734662|NCT00849693|364684290|FG003|Acute Treatment Phase|Protocol Violation|6|||
105734663|NCT00849693|364684287|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
105734664|NCT00849693|364684288|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
105734665|NCT00849693|364684289|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
105734666|NCT00849693|364684290|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
106010032|NCT03279081|365702472|FG001|Overall Study|Physician Decision|1|||
106010033|NCT03279081|365702471|FG000|Overall Study|Lost to Follow-up|8|||
106010034|NCT03279081|365702472|FG001|Overall Study|Lost to Follow-up|8|||
105734667|NCT00849693|364684287|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
105734668|NCT00849693|364684288|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
105734669|NCT00849693|364684289|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
105798894|NCT00544557|364922598|FG000|Overall Study|Adverse Event|140|||
106010035|NCT03279081|365702471|FG000|Overall Study|Death|0|||
105734670|NCT00849693|364684290|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
105734671|NCT00849693|364684287|FG000|Acute Treatment Phase|Physician Decision|2|||
105734672|NCT00849693|364684288|FG001|Acute Treatment Phase|Physician Decision|1|||
105734673|NCT00849693|364684289|FG002|Acute Treatment Phase|Physician Decision|2|||
105734674|NCT00849693|364684290|FG003|Acute Treatment Phase|Physician Decision|1|||
105734675|NCT00849693|364684287|FG000|Acute Treatment Phase|Sponsor decision|0|||
105734676|NCT00849693|364684288|FG001|Acute Treatment Phase|Sponsor decision|0|||
105734677|NCT00849693|364684289|FG002|Acute Treatment Phase|Sponsor decision|1|||
105734678|NCT00849693|364684290|FG003|Acute Treatment Phase|Sponsor decision|0|||
105734679|NCT00849693|364684287|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
105734680|NCT00849693|364684288|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
105734681|NCT00849693|364684289|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
105734682|NCT00849693|364684290|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
105734683|NCT00849693|364684287|FG000|Extension Phase|Adverse Event|4|||
105734684|NCT00849693|364684288|FG001|Extension Phase|Adverse Event|6|||
105734685|NCT00849693|364684289|FG002|Extension Phase|Adverse Event|3|||
105734686|NCT00849693|364684290|FG003|Extension Phase|Adverse Event|7|||
105734687|NCT00849693|364684287|FG000|Extension Phase|Lost to Follow-up|7|||
105734688|NCT00849693|364684288|FG001|Extension Phase|Lost to Follow-up|5|||
105734689|NCT00849693|364684289|FG002|Extension Phase|Lost to Follow-up|6|||
105734690|NCT00849693|364684290|FG003|Extension Phase|Lost to Follow-up|6|||
105734691|NCT00849693|364684287|FG000|Extension Phase|Protocol Violation|0|||
105734692|NCT00849693|364684288|FG001|Extension Phase|Protocol Violation|3|||
105734693|NCT00849693|364684289|FG002|Extension Phase|Protocol Violation|2|||
105734694|NCT00849693|364684290|FG003|Extension Phase|Protocol Violation|3|||
105734695|NCT00849693|364684287|FG000|Extension Phase|Withdrawal by Subject|6|||
105734696|NCT00849693|364684288|FG001|Extension Phase|Withdrawal by Subject|9|||
105734697|NCT00849693|364684289|FG002|Extension Phase|Withdrawal by Subject|10|||
105734698|NCT00849693|364684290|FG003|Extension Phase|Withdrawal by Subject|15|||
105734699|NCT00849693|364684287|FG000|Extension Phase|Parent or caregiver decision|9|||
105734700|NCT00849693|364684288|FG001|Extension Phase|Parent or caregiver decision|4|||
105734701|NCT00849693|364684289|FG002|Extension Phase|Parent or caregiver decision|10|||
105734702|NCT00849693|364684290|FG003|Extension Phase|Parent or caregiver decision|5|||
105734703|NCT00849693|364684287|FG000|Extension Phase|Physician Decision|1|||
105734704|NCT00849693|364684288|FG001|Extension Phase|Physician Decision|1|||
105734705|NCT00849693|364684289|FG002|Extension Phase|Physician Decision|2|||
105734706|NCT00849693|364684290|FG003|Extension Phase|Physician Decision|0|||
105734707|NCT00849693|364684287|FG000|Extension Phase|Sponsor decision|1|||
105734708|NCT00849693|364684288|FG001|Extension Phase|Sponsor decision|0|||
105734709|NCT00849693|364684289|FG002|Extension Phase|Sponsor decision|0|||
105734710|NCT00849693|364684290|FG003|Extension Phase|Sponsor decision|1|||
106010036|NCT03279081|365702472|FG001|Overall Study|Death|1|||
106010037|NCT03279081|365702471|FG000|Overall Study|Adverse Event|1|||
106010038|NCT03279081|365702472|FG001|Overall Study|Adverse Event|0|||
106010039|NCT03279081|365702471|FG000|Overall Study|Reason not Specified|14|||
106010040|NCT03279081|365702472|FG001|Overall Study|Reason not Specified|4|||
106010041|NCT04531176|365702473|FG000|Overall Study|Study was stopped early|24|||
106010042|NCT04531176|365702474|FG001|Overall Study|Study was stopped early|26|||
106010043|NCT04531176|365702475|FG002|Overall Study|Study was stopped early|24|||
106010044|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
106010045|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
106010046|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
106010047|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
106010048|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
106010049|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
106010050|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
105734711|NCT00849693|364684287|FG000|Extension Phase|Lack of Efficacy|2|||
105734712|NCT00849693|364684288|FG001|Extension Phase|Lack of Efficacy|2|||
105734713|NCT00849693|364684289|FG002|Extension Phase|Lack of Efficacy|2|||
105734714|NCT00849693|364684290|FG003|Extension Phase|Lack of Efficacy|1|||
105734715|NCT02465034|364684291|FG000|Overall Study|Withdrawal by Subject|1|||
105798895|NCT00544557|364922598|FG000|Overall Study|Lack of Efficacy|196|||
105798896|NCT00544557|364922598|FG000|Overall Study|Other|98|||
106010051|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
106010052|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
105734716|NCT02465034|364684292|FG001|Overall Study|Withdrawal by Subject|1|||
105734717|NCT02465034|364684291|FG000|Overall Study|Screen fail|2|||
105734718|NCT02465034|364684292|FG001|Overall Study|Screen fail|0|||
105734719|NCT02465034|364684291|FG000|Overall Study|Could not be scheduled for study visit|0|||
106010053|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
105734720|NCT02465034|364684292|FG001|Overall Study|Could not be scheduled for study visit|5|||
105734721|NCT01334125|364684293|FG000|Overall Study|Lost to Follow-up|3|||
105734722|NCT01334125|364684294|FG001|Overall Study|Lost to Follow-up|3|||
105734723|NCT04220866|364684295|FG000|Overall Study|Death|4|||
106010054|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
106139774|NCT00157014|366170392|FG000|Overall Study|Withdrawal by Subject|1|||
106139775|NCT00157014|366170393|FG001|Overall Study|Withdrawal by Subject|0|||
106139776|NCT00157014|366170394|FG002|Overall Study|Withdrawal by Subject|0|||
106139777|NCT00157014|366170395|FG003|Overall Study|Withdrawal by Subject|0|||
106139778|NCT01362491|366170396|FG000|Overall Study|Ineligible|1|||
106139779|NCT01362491|366170397|FG001|Overall Study|Ineligible|0|||
106139780|NCT01362491|366170398|FG002|Overall Study|Ineligible|0|||
106139781|NCT03181958|366170399|FG000|Overall Study|Lost to Follow-up|17|||
106139782|NCT03181958|366170400|FG001|Overall Study|Lost to Follow-up|21|||
106139783|NCT03181958|366170401|FG002|Overall Study|Lost to Follow-up|15|||
106139784|NCT04867902|366170402|FG000|Overall Study|Lost to Follow-up|1|||
106139785|NCT04867902|366170402|FG000|Overall Study|Withdrawal by Subject|2|||
106139786|NCT04867902|366170402|FG000|Overall Study|Protocol Violation|1|||
106139787|NCT05355116|366170403|FG000|Overall Study|Withdrawal by Subject|2|||
106139788|NCT00149630|366170404|FG000|Overall Study|Incarceration|2|||
106139789|NCT00149630|366170405|FG001|Overall Study|Incarceration|0|||
106139790|NCT00149630|366170404|FG000|Overall Study|Treatment Programs|4|||
106139791|NCT00149630|366170405|FG001|Overall Study|Treatment Programs|5|||
106139792|NCT00149630|366170404|FG000|Overall Study|Adverse Event|2|||
106139793|NCT00149630|366170405|FG001|Overall Study|Adverse Event|0|||
106139794|NCT01185522|366170407|FG000|Overall Study|Lack of Efficacy|28|||
106139795|NCT01185522|366170407|FG000|Overall Study|Lost to Follow-up|19|||
106139796|NCT01185522|366170407|FG000|Overall Study|Withdrawal by Subject|10|||
106139797|NCT01185522|366170407|FG000|Overall Study|Poor tolerance|39|||
106139798|NCT01185522|366170407|FG000|Overall Study|Other reasons|12|||
106139799|NCT00771667|366170408|FG000|Induction Phase|Adverse Event|5|||
106139800|NCT00771667|366170409|FG001|Induction Phase|Adverse Event|2|||
106139801|NCT00771667|366170410|FG002|Induction Phase|Adverse Event|4|||
106139802|NCT00771667|366170411|FG003|Induction Phase|Adverse Event|1|||
106139803|NCT00771667|366170412|FG004|Induction Phase|Adverse Event|0|||
105734724|NCT04220866|364684296|FG001|Overall Study|Death|5|||
105734725|NCT04220866|364684295|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
105734726|NCT04220866|364684296|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
105734727|NCT04220866|364684295|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
105734728|NCT04220866|364684296|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
105734729|NCT04220866|364684295|FG000|Overall Study|Withdrawal by Subject|0|||
105734730|NCT04220866|364684296|FG001|Overall Study|Withdrawal by Subject|1|||
105734731|NCT01408537|364684299|FG000|Overall Study|Withdrawal by Subject|2|||
105734732|NCT01408537|364684299|FG000|Overall Study|Protocol Violation|3|||
105734733|NCT01408537|364684299|FG000|Overall Study|Lost to Follow-up|3|||
105734734|NCT02760602|364684300|FG000|Overall Study|Withdrawal by Subject|1|||
105734735|NCT02760602|364684301|FG001|Overall Study|Withdrawal by Subject|0|||
105734736|NCT02760602|364684300|FG000|Overall Study|Terminated by sponsor|12|||
105734737|NCT02760602|364684301|FG001|Overall Study|Terminated by sponsor|13|||
105734738|NCT00791128|364684302|FG000|Overall Study|Adverse Event|4|||
105734739|NCT00791128|364684302|FG000|Overall Study|Device migration|2|||
105734740|NCT00791128|364684302|FG000|Overall Study|non-compliance by subject|2|||
105734741|NCT00791128|364684302|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
105734742|NCT04655586|364684303|FG000|Overall Study|Physician Decision|1|||
105734743|NCT04655586|364684304|FG001|Overall Study|Physician Decision|3|||
105734744|NCT04655586|364684305|FG002|Overall Study|Physician Decision|4|||
105734745|NCT04655586|364684303|FG000|Overall Study|Withdrawal by Subject|1|||
105734746|NCT04655586|364684304|FG001|Overall Study|Withdrawal by Subject|3|||
105734747|NCT04655586|364684305|FG002|Overall Study|Withdrawal by Subject|1|||
105734748|NCT01260181|364684306|FG000|Overall Study|Decision of Investigator|1|||
105734749|NCT01588197|364684307|FG000|Overall Study|Lack of Efficacy|0|||
105734750|NCT01588197|364684308|FG001|Overall Study|Lack of Efficacy|1|||
105734751|NCT01588197|364684307|FG000|Overall Study|No MRI|1|||
105734752|NCT01588197|364684308|FG001|Overall Study|No MRI|0|||
105734753|NCT01938625|364684309|FG000|Overall Study|Withdrawal by Subject|0|||
105734754|NCT01938625|364684310|FG001|Overall Study|Withdrawal by Subject|1|||
105734755|NCT01938625|364684309|FG000|Overall Study|Adverse Event|0|||
106139804|NCT00771667|366170413|FG005|Induction Phase|Adverse Event|0|||
106139805|NCT00771667|366170414|FG006|Induction Phase|Adverse Event|0|||
106139806|NCT00771667|366170415|FG007|Induction Phase|Adverse Event|0|||
106139807|NCT00771667|366170416|FG008|Induction Phase|Adverse Event|0|||
105734756|NCT01938625|364684310|FG001|Overall Study|Adverse Event|1|||
105734757|NCT00546351|364684313|FG000|Overall Study|Adverse Event|76|||
105734758|NCT00546351|364684313|FG000|Overall Study|Lack of Efficacy|15|||
105734759|NCT00546351|364684313|FG000|Overall Study|Withdrawal by Subject|109|||
105734760|NCT00546351|364684313|FG000|Overall Study|Lost to Follow-up|9|||
106139808|NCT00771667|366170417|FG009|Induction Phase|Adverse Event|0|||
106139809|NCT00771667|366170408|FG000|Induction Phase|Lack of Efficacy|9|||
106139810|NCT00771667|366170409|FG001|Induction Phase|Lack of Efficacy|2|||
106139811|NCT00771667|366170410|FG002|Induction Phase|Lack of Efficacy|4|||
105734761|NCT00546351|364684313|FG000|Overall Study|Protocol Deviation|1|||
106139812|NCT00771667|366170411|FG003|Induction Phase|Lack of Efficacy|3|||
106139813|NCT00771667|366170412|FG004|Induction Phase|Lack of Efficacy|0|||
105798897|NCT00623623|364922602|FG000|Overall Study|Previous enrolment into this study|1|||
105798898|NCT00623623|364922603|FG001|Overall Study|Previous enrolment into this study|1|||
105798899|NCT01759381|364922604|FG000|Overall Study|Death|1|||
105798900|NCT01759381|364922605|FG001|Overall Study|Death|0|||
105798901|NCT01313728|364922606|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
105798902|NCT02983227|364922607|FG000|Overall Study|Adverse Event|21|||
105798903|NCT02983227|364922608|FG001|Overall Study|Adverse Event|3|||
105798904|NCT02983227|364922607|FG000|Overall Study|Death|3|||
105798905|NCT02983227|364922608|FG001|Overall Study|Death|0|||
105798906|NCT02983227|364922607|FG000|Overall Study|Lack of Efficacy|8|||
105798907|NCT02983227|364922608|FG001|Overall Study|Lack of Efficacy|1|||
105798908|NCT02983227|364922607|FG000|Overall Study|Lost to Follow-up|3|||
105798909|NCT02983227|364922608|FG001|Overall Study|Lost to Follow-up|0|||
105798910|NCT02983227|364922607|FG000|Overall Study|Multiple Reasons|2|||
105734762|NCT00546351|364684313|FG000|Overall Study|Unsatisfactory compliance|9|||
105734763|NCT00546351|364684313|FG000|Overall Study|Other reasons for premature termination|17|||
105734764|NCT04734873|364684314|FG000|Overall Study|Lost to Follow-up|1|||
105734765|NCT04734873|364684315|FG001|Overall Study|Lost to Follow-up|3|||
105734766|NCT04734873|364684316|FG002|Overall Study|Lost to Follow-up|2|||
105734767|NCT04734873|364684314|FG000|Overall Study|Randomized but not dosed|1|||
105734768|NCT04734873|364684315|FG001|Overall Study|Randomized but not dosed|0|||
105734769|NCT04734873|364684316|FG002|Overall Study|Randomized but not dosed|1|||
105734770|NCT02424149|364684317|FG000|Overall Study|surgery cancelled|2|||
105734771|NCT02424149|364684318|FG001|Overall Study|surgery cancelled|0|||
105734772|NCT02424149|364684317|FG000|Overall Study|Withdrawal by Subject|0|||
105734773|NCT02424149|364684318|FG001|Overall Study|Withdrawal by Subject|1|||
105734774|NCT00650585|364684328|FG000|Overall Study|Lost to Follow-up|505|||
105734775|NCT00650585|364684329|FG001|Overall Study|Lost to Follow-up|482|||
105734776|NCT00650585|364684328|FG000|Overall Study|No parental consent|935|||
105734777|NCT00650585|364684329|FG001|Overall Study|No parental consent|866|||
105734778|NCT00650585|364684328|FG000|Overall Study|Excluded/ruled ineligible|357|||
105734779|NCT00650585|364684329|FG001|Overall Study|Excluded/ruled ineligible|129|||
105734780|NCT01070303|364684330|FG000|Overall Study|Adverse Event|39|||
105734781|NCT01070303|364684330|FG000|Overall Study|Withdrawal by Subject|20|||
105734782|NCT01070303|364684330|FG000|Overall Study|Lost to Follow-up|9|||
105734783|NCT01070303|364684330|FG000|Overall Study|Protocol Violation|0|||
105734784|NCT01070303|364684330|FG000|Overall Study|Lack of Efficacy|2|||
105734785|NCT01070303|364684330|FG000|Overall Study|Administrative Reason|1|||
105734786|NCT01070303|364684330|FG000|Overall Study|Other|18|||
105734787|NCT02460822|364684333|FG000|Overall Study|Withdrawal by Subject|1|||
105734788|NCT03114969|364684338|FG000|Overall Study|Lost to Follow-up|0|||
105734789|NCT03114969|364684339|FG001|Overall Study|Lost to Follow-up|0|||
105734790|NCT03114969|364684340|FG002|Overall Study|Lost to Follow-up|3|||
105734791|NCT03114969|364684341|FG003|Overall Study|Lost to Follow-up|2|||
105734792|NCT03114969|364684342|FG004|Overall Study|Lost to Follow-up|0|||
105938245|NCT01897896|365434977|FG000|Overall Study|Require drug that interfere with study|1|||
105938246|NCT01897896|365434978|FG001|Overall Study|Require drug that interfere with study|4|||
105938247|NCT01897896|365434977|FG000|Overall Study|Protocol Violation|1|||
105938248|NCT01897896|365434978|FG001|Overall Study|Protocol Violation|1|||
105938249|NCT01897896|365434977|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
105938250|NCT01897896|365434978|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
105938251|NCT01897896|365434977|FG000|Overall Study|Caregiver can no longer participate|0|||
105938252|NCT01897896|365434978|FG001|Overall Study|Caregiver can no longer participate|2|||
105938253|NCT01897896|365434977|FG000|Overall Study|Other than specified|2|||
105938254|NCT01897896|365434978|FG001|Overall Study|Other than specified|1|||
105938255|NCT00101400|365434979|FG000|Survival Follow-Up|Alive|7|||
105938256|NCT03160573|365434980|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
105938257|NCT03160573|365434981|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
105938258|NCT03160573|365434982|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
105938259|NCT03160573|365434983|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
105938260|NCT00862277|365435008|FG000|Overall Study|Protocol Violation|1|||
105938261|NCT00862277|365435009|FG001|Overall Study|Protocol Violation|2|||
105938262|NCT00862277|365435010|FG002|Overall Study|Protocol Violation|5|||
106010055|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
105734793|NCT03114969|364684343|FG005|Overall Study|Lost to Follow-up|0|||
105734794|NCT03114969|364684344|FG006|Overall Study|Lost to Follow-up|0|||
105734795|NCT03114969|364684345|FG007|Overall Study|Lost to Follow-up|0|||
105734796|NCT03114969|364684346|FG008|Overall Study|Lost to Follow-up|0|||
105798911|NCT02983227|364922608|FG001|Overall Study|Multiple Reasons|1|||
105798912|NCT02983227|364922607|FG000|Overall Study|Physician Decision|3|||
105734797|NCT03114969|364684338|FG000|Overall Study|Adverse Event|0|||
105734798|NCT03114969|364684339|FG001|Overall Study|Adverse Event|0|||
105734799|NCT03114969|364684340|FG002|Overall Study|Adverse Event|1|||
105734800|NCT03114969|364684341|FG003|Overall Study|Adverse Event|0|||
105798913|NCT02983227|364922608|FG001|Overall Study|Physician Decision|1|||
105798914|NCT02983227|364922607|FG000|Overall Study|Withdrawal by Subject|19|||
105798915|NCT02983227|364922608|FG001|Overall Study|Withdrawal by Subject|8|||
105798916|NCT02354976|364922610|FG000|Overall Study|Other - reason not specified|1|||
105798917|NCT02354976|364922611|FG001|Overall Study|Other - reason not specified|0|||
105798918|NCT02354976|364922612|FG002|Overall Study|Other - reason not specified|1|||
105798919|NCT02354976|364922610|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
105798920|NCT02354976|364922611|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
105798921|NCT02354976|364922612|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
105798922|NCT02354976|364922610|FG000|Overall Study|Adverse Event|1|||
105798923|NCT02354976|364922611|FG001|Overall Study|Adverse Event|0|||
105798924|NCT02354976|364922612|FG002|Overall Study|Adverse Event|2|||
105798925|NCT00986154|364922613|FG000|Overall Study|Death|136|||
105798926|NCT00986154|364922614|FG001|Overall Study|Death|127|||
105798927|NCT00986154|364922613|FG000|Overall Study|Lost to Follow-up|7|||
105798928|NCT00986154|364922614|FG001|Overall Study|Lost to Follow-up|4|||
105798929|NCT00986154|364922613|FG000|Overall Study|Withdrawal by Subject|32|||
105798930|NCT00986154|364922614|FG001|Overall Study|Withdrawal by Subject|33|||
105798931|NCT00986154|364922613|FG000|Overall Study|investigator/subject decide not continue|6|||
105798932|NCT00986154|364922614|FG001|Overall Study|investigator/subject decide not continue|3|||
105798933|NCT00986154|364922613|FG000|Overall Study|never received study drug|25|||
105798934|NCT00986154|364922614|FG001|Overall Study|never received study drug|27|||
105798935|NCT03726437|364922615|FG000|Overall Study|Lost to Follow-up|85|||
105798936|NCT03726437|364922616|FG001|Overall Study|Lost to Follow-up|76|||
105798937|NCT03118765|364922617|FG000|Overall Study|Withdrawal by Subject|0|||
105798938|NCT03118765|364922618|FG001|Overall Study|Withdrawal by Subject|0|||
105798939|NCT03118765|364922619|FG002|Overall Study|Withdrawal by Subject|1|||
105798940|NCT03118765|364922620|FG003|Overall Study|Withdrawal by Subject|0|||
105798941|NCT03118765|364922621|FG004|Overall Study|Withdrawal by Subject|0|||
105798942|NCT03118765|364922617|FG000|Overall Study|Adverse Event|1|||
105798943|NCT03118765|364922618|FG001|Overall Study|Adverse Event|1|||
105798944|NCT03118765|364922619|FG002|Overall Study|Adverse Event|1|||
105798945|NCT03118765|364922620|FG003|Overall Study|Adverse Event|1|||
105798946|NCT03118765|364922621|FG004|Overall Study|Adverse Event|1|||
105798947|NCT03118765|364922617|FG000|Overall Study|Non compliance with Study Procedures|0|||
105798948|NCT03118765|364922618|FG001|Overall Study|Non compliance with Study Procedures|0|||
105798949|NCT03118765|364922619|FG002|Overall Study|Non compliance with Study Procedures|0|||
105798950|NCT03118765|364922620|FG003|Overall Study|Non compliance with Study Procedures|1|||
105798951|NCT03118765|364922621|FG004|Overall Study|Non compliance with Study Procedures|0|||
105798952|NCT03118765|364922617|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
105798953|NCT03118765|364922618|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
105798954|NCT03118765|364922619|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
105798955|NCT03118765|364922620|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
105798956|NCT03118765|364922621|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
105798957|NCT03118765|364922617|FG000|Overall Study|COPD Exacerbation|1|||
105798958|NCT03118765|364922618|FG001|Overall Study|COPD Exacerbation|0|||
105798959|NCT03118765|364922619|FG002|Overall Study|COPD Exacerbation|0|||
105798960|NCT03118765|364922620|FG003|Overall Study|COPD Exacerbation|1|||
105798961|NCT03118765|364922621|FG004|Overall Study|COPD Exacerbation|0|||
105798962|NCT03118765|364922617|FG000|Overall Study|Lost to Follow-up|1|||
105798963|NCT03118765|364922618|FG001|Overall Study|Lost to Follow-up|0|||
105798964|NCT03118765|364922619|FG002|Overall Study|Lost to Follow-up|1|||
105798965|NCT03118765|364922620|FG003|Overall Study|Lost to Follow-up|0|||
105798966|NCT03118765|364922621|FG004|Overall Study|Lost to Follow-up|0|||
105938263|NCT01730729|365435011|FG000|Overall Study|Adverse Event|1|||
105938264|NCT01730729|365435011|FG000|Overall Study|Death|1|||
105938265|NCT01730729|365435011|FG000|Overall Study|Progressive Disease|12|||
105938266|NCT00382863|365435012|FG000|Overall Study|Death|9|||
105938267|NCT00382863|365435013|FG001|Overall Study|Death|9|||
105938268|NCT00382863|365435012|FG000|Overall Study|Lost to Follow-up|1|||
105938269|NCT00382863|365435013|FG001|Overall Study|Lost to Follow-up|2|||
105938270|NCT00382863|365435012|FG000|Overall Study|Withdrawal by Subject|5|||
105938271|NCT00382863|365435013|FG001|Overall Study|Withdrawal by Subject|25|||
106139814|NCT00771667|366170413|FG005|Induction Phase|Lack of Efficacy|0|||
105734801|NCT03114969|364684342|FG004|Overall Study|Adverse Event|0|||
105798967|NCT03118765|364922617|FG000|Overall Study|Sponsor Decision|1|||
105798968|NCT03118765|364922618|FG001|Overall Study|Sponsor Decision|0|||
105938272|NCT03400787|365435019|FG000|Overall Study|Lost to Follow-up|1|||
105734802|NCT03114969|364684343|FG005|Overall Study|Adverse Event|1|||
105734803|NCT03114969|364684344|FG006|Overall Study|Adverse Event|1|||
105734804|NCT03114969|364684345|FG007|Overall Study|Adverse Event|0|||
105734805|NCT03114969|364684346|FG008|Overall Study|Adverse Event|2|||
105734806|NCT04601272|364684347|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
105734807|NCT04601272|364684348|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
105734808|NCT04601272|364684349|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
105938273|NCT03400787|365435020|FG001|Overall Study|Lost to Follow-up|0|||
105938274|NCT03400787|365435019|FG000|Overall Study|Death|1|||
105938275|NCT03400787|365435020|FG001|Overall Study|Death|0|||
105734809|NCT02168946|364684350|FG000|Overall Study|Adverse Event|8|||
105734810|NCT02168946|364684351|FG001|Overall Study|Adverse Event|5|||
105734811|NCT02168946|364684350|FG000|Overall Study|Lost to Follow-up|3|||
105734812|NCT02168946|364684351|FG001|Overall Study|Lost to Follow-up|0|||
105734813|NCT02168946|364684350|FG000|Overall Study|Subject unable to come back for visits|1|||
105734814|NCT02168946|364684351|FG001|Overall Study|Subject unable to come back for visits|0|||
105734815|NCT02075255|364684358|FG000|Overall Study|Study specific withdrawal criteria|0|||
105734816|NCT02075255|364684359|FG001|Overall Study|Study specific withdrawal criteria|1|||
105734817|NCT02075255|364684360|FG002|Overall Study|Study specific withdrawal criteria|1|||
105734818|NCT02075255|364684358|FG000|Overall Study|Withdrawal by Subject|4|||
105734819|NCT02075255|364684359|FG001|Overall Study|Withdrawal by Subject|1|||
105734820|NCT02075255|364684360|FG002|Overall Study|Withdrawal by Subject|0|||
105734821|NCT02075255|364684358|FG000|Overall Study|Lost to Follow-up|0|||
105734822|NCT02075255|364684359|FG001|Overall Study|Lost to Follow-up|0|||
105734823|NCT02075255|364684360|FG002|Overall Study|Lost to Follow-up|1|||
105734824|NCT02075255|364684358|FG000|Overall Study|Adverse Event|0|||
105734825|NCT02075255|364684359|FG001|Overall Study|Adverse Event|0|||
105734826|NCT02075255|364684360|FG002|Overall Study|Adverse Event|1|||
105734827|NCT02075255|364684358|FG000|Overall Study|Death|0|||
105734828|NCT02075255|364684359|FG001|Overall Study|Death|2|||
105734829|NCT02075255|364684360|FG002|Overall Study|Death|0|||
105734830|NCT03503773|364684361|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
105734831|NCT03503773|364684362|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
105734832|NCT03503773|364684361|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
105734833|NCT03503773|364684362|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
105734834|NCT03503773|364684361|FG000|Overall Study|Not completing the primary ABPM|3|||
105734835|NCT03503773|364684362|FG001|Overall Study|Not completing the primary ABPM|1|||
105734836|NCT03503773|364684361|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105734837|NCT03503773|364684362|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105734838|NCT00658333|364684365|FG000|Overall Study|Adverse Event|2|||
105734839|NCT00658333|364684366|FG001|Overall Study|Adverse Event|1|||
105734840|NCT00553787|364684368|FG000|Overall Study|Adverse Event|34|||
105734841|NCT00553787|364684369|FG001|Overall Study|Adverse Event|21|||
105734842|NCT00553787|364684370|FG002|Overall Study|Adverse Event|67|||
105734843|NCT00553787|364684368|FG000|Overall Study|Lost to Follow-up|132|||
105734844|NCT00553787|364684369|FG001|Overall Study|Lost to Follow-up|44|||
105734845|NCT00553787|364684370|FG002|Overall Study|Lost to Follow-up|78|||
105734846|NCT00553787|364684368|FG000|Overall Study|Withdrawal by Subject|151|||
105734847|NCT00553787|364684369|FG001|Overall Study|Withdrawal by Subject|40|||
105734848|NCT00553787|364684370|FG002|Overall Study|Withdrawal by Subject|83|||
105734849|NCT00553787|364684368|FG000|Overall Study|Lack of Efficacy|31|||
105734850|NCT00553787|364684369|FG001|Overall Study|Lack of Efficacy|1|||
105734851|NCT00553787|364684370|FG002|Overall Study|Lack of Efficacy|3|||
105734852|NCT00553787|364684368|FG000|Overall Study|Pregnancy|0|||
105734853|NCT00553787|364684369|FG001|Overall Study|Pregnancy|1|||
105734854|NCT00553787|364684370|FG002|Overall Study|Pregnancy|2|||
105734855|NCT00553787|364684368|FG000|Overall Study|non compliance|4|||
105734856|NCT00553787|364684369|FG001|Overall Study|non compliance|0|||
105734857|NCT00553787|364684370|FG002|Overall Study|non compliance|11|||
105734858|NCT00553787|364684368|FG000|Overall Study|Requirement for restricted medication|8|||
105734859|NCT00553787|364684369|FG001|Overall Study|Requirement for restricted medication|7|||
105734860|NCT00553787|364684370|FG002|Overall Study|Requirement for restricted medication|5|||
105734861|NCT00553787|364684368|FG000|Overall Study|Other|18|||
105734862|NCT00553787|364684369|FG001|Overall Study|Other|10|||
105734863|NCT00553787|364684370|FG002|Overall Study|Other|13|||
105734864|NCT02285010|364684371|FG000|Overall Study|not abdominal hysterectomy|2|||
105734865|NCT02285010|364684372|FG001|Overall Study|not abdominal hysterectomy|0|||
105734866|NCT02285010|364684371|FG000|Overall Study|Not spinal anesthesia|3|||
105734867|NCT02285010|364684372|FG001|Overall Study|Not spinal anesthesia|1|||
105734868|NCT00003641|364684373|FG000|Overall Study|Withdrawal by Subject|0|||
105734869|NCT00003641|364684374|FG001|Overall Study|Withdrawal by Subject|100|||
105734870|NCT00003641|364684373|FG000|Overall Study|Adverse Event|0|||
105734871|NCT00003641|364684374|FG001|Overall Study|Adverse Event|38|||
105734872|NCT00003641|364684373|FG000|Overall Study|Disease progression|0|||
105734873|NCT00003641|364684374|FG001|Overall Study|Disease progression|2|||
105734874|NCT00003641|364684373|FG000|Overall Study|Unknown/missing|0|||
105734875|NCT00003641|364684374|FG001|Overall Study|Unknown/missing|22|||
105734876|NCT00003641|364684373|FG000|Overall Study|Should not receive interferon therapy|2|||
105734877|NCT00003641|364684374|FG001|Overall Study|Should not receive interferon therapy|0|||
105734878|NCT00003641|364684373|FG000|Overall Study|Never started interferon|567|||
105734879|NCT00003641|364684374|FG001|Overall Study|Never started interferon|12|||
105734880|NCT00514449|364684375|FG000|Overall Study|Withdrawal by Subject|1|||
105734881|NCT00514449|364684376|FG001|Overall Study|Withdrawal by Subject|2|||
105734882|NCT00514449|364684375|FG000|Overall Study|Protocol Violation|1|||
105734883|NCT00514449|364684376|FG001|Overall Study|Protocol Violation|2|||
105734884|NCT00514449|364684375|FG000|Overall Study|Lost to Follow-up|1|||
105734885|NCT00514449|364684376|FG001|Overall Study|Lost to Follow-up|0|||
105734886|NCT01426386|364684379|FG000|Overall Study|Adverse Event|0|||
105734887|NCT01426386|364684380|FG001|Overall Study|Adverse Event|1|||
105734888|NCT01426386|364684381|FG002|Overall Study|Adverse Event|0|||
105734889|NCT01426386|364684382|FG003|Overall Study|Adverse Event|0|||
105734890|NCT01426386|364684383|FG004|Overall Study|Adverse Event|0|||
105734891|NCT01426386|364684384|FG005|Overall Study|Adverse Event|0|||
105734892|NCT01426386|364684379|FG000|Overall Study|Did not attend scheduled visit|1|||
105734893|NCT01426386|364684380|FG001|Overall Study|Did not attend scheduled visit|4|||
105734894|NCT01426386|364684381|FG002|Overall Study|Did not attend scheduled visit|0|||
105734895|NCT01426386|364684382|FG003|Overall Study|Did not attend scheduled visit|0|||
105734896|NCT01426386|364684383|FG004|Overall Study|Did not attend scheduled visit|2|||
105734897|NCT01426386|364684384|FG005|Overall Study|Did not attend scheduled visit|1|||
105734898|NCT01426386|364684379|FG000|Overall Study|Poor response|2|||
105734899|NCT01426386|364684380|FG001|Overall Study|Poor response|1|||
105734900|NCT01426386|364684381|FG002|Overall Study|Poor response|2|||
105734901|NCT01426386|364684382|FG003|Overall Study|Poor response|0|||
105734902|NCT01426386|364684383|FG004|Overall Study|Poor response|1|||
105734903|NCT01426386|364684384|FG005|Overall Study|Poor response|0|||
105734904|NCT01426386|364684379|FG000|Overall Study|Personal reasons|0|||
105734905|NCT01426386|364684380|FG001|Overall Study|Personal reasons|0|||
105734906|NCT01426386|364684381|FG002|Overall Study|Personal reasons|0|||
105734907|NCT01426386|364684382|FG003|Overall Study|Personal reasons|0|||
105734908|NCT01426386|364684383|FG004|Overall Study|Personal reasons|1|||
105734909|NCT01426386|364684384|FG005|Overall Study|Personal reasons|0|||
105734910|NCT03694522|364684385|FG000|Overall Study|Withdrawal by Subject|8|||
105734911|NCT03694522|364684386|FG001|Overall Study|Withdrawal by Subject|10|||
105734912|NCT03694522|364684385|FG000|Overall Study|Physician Decision|53|||
105734913|NCT03694522|364684386|FG001|Overall Study|Physician Decision|54|||
105734914|NCT03694522|364684385|FG000|Overall Study|Other|1|||
105734915|NCT03694522|364684386|FG001|Overall Study|Other|1|||
105734916|NCT03694522|364684385|FG000|Overall Study|Lost to Follow-up|0|||
105734917|NCT03694522|364684386|FG001|Overall Study|Lost to Follow-up|1|||
105734918|NCT02983292|364684387|FG000|Overall Study|Participant unwell & cannot travel|2|||
105734919|NCT02983292|364684387|FG000|Overall Study|Lost to Follow-up|3|||
105734920|NCT02983292|364684387|FG000|Overall Study|Participant withdrew consent|2|||
105734921|NCT02983292|364684387|FG000|Overall Study|Revision|7|||
105734922|NCT02983292|364684387|FG000|Overall Study|Death|1|||
105734923|NCT02983292|364684387|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
105734924|NCT02983292|364684387|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
105734925|NCT02983292|364684387|FG000|Overall Study|Participant relocation|1|||
105734926|NCT01158950|364684389|FG000|1st Intervention (1 Day)|Physician Decision|1|||
105734927|NCT01158950|364684390|FG001|1st Intervention (1 Day)|Physician Decision|2|||
105734928|NCT05258058|364684402|FG000|Overall Study|Withdrawal by Subject|2|||
105734929|NCT04579393|364684407|FG000|Overall Study|Withdrawal by Subject|2|||
105734930|NCT04579393|364684408|FG001|Overall Study|Withdrawal by Subject|2|||
105734931|NCT04579393|364684407|FG000|Overall Study|Death|1|||
106139815|NCT00771667|366170414|FG006|Induction Phase|Lack of Efficacy|0|||
106139816|NCT00771667|366170415|FG007|Induction Phase|Lack of Efficacy|0|||
106139817|NCT00771667|366170416|FG008|Induction Phase|Lack of Efficacy|0|||
106139818|NCT00771667|366170417|FG009|Induction Phase|Lack of Efficacy|0|||
106139819|NCT00771667|366170408|FG000|Induction Phase|Lost to Follow-up|1|||
106139820|NCT00771667|366170409|FG001|Induction Phase|Lost to Follow-up|0|||
106139821|NCT00771667|366170410|FG002|Induction Phase|Lost to Follow-up|1|||
106139822|NCT00771667|366170411|FG003|Induction Phase|Lost to Follow-up|0|||
105734932|NCT04579393|364684408|FG001|Overall Study|Death|3|||
105734933|NCT00847561|364684409|FG000|Overall Study|Withdrawal by Subject|4|||
105734934|NCT00847561|364684410|FG001|Overall Study|Withdrawal by Subject|3|||
105734935|NCT00847561|364684409|FG000|Overall Study|Unable to schedule|9|||
105734936|NCT00847561|364684410|FG001|Overall Study|Unable to schedule|1|||
105734937|NCT01333189|364684412|FG000|Overall Study|Time constraints|1|||
105734938|NCT01333189|364684413|FG001|Overall Study|Time constraints|0|||
105734939|NCT01333189|364684412|FG000|Overall Study|Adverse Event|1|||
105734940|NCT01333189|364684413|FG001|Overall Study|Adverse Event|0|||
105734941|NCT01333189|364684412|FG000|Overall Study|Transportation difficulties|0|||
106139823|NCT00771667|366170412|FG004|Induction Phase|Lost to Follow-up|0|||
105734942|NCT01333189|364684413|FG001|Overall Study|Transportation difficulties|1|||
106139824|NCT00771667|366170413|FG005|Induction Phase|Lost to Follow-up|0|||
106139825|NCT00771667|366170414|FG006|Induction Phase|Lost to Follow-up|0|||
105734943|NCT01333189|364684412|FG000|Overall Study|Moved from region|0|||
105734944|NCT01333189|364684413|FG001|Overall Study|Moved from region|1|||
105734945|NCT03022422|364684414|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
105734946|NCT03022422|364684415|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
105734947|NCT03022422|364684416|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
105734948|NCT03022422|364684417|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
105734949|NCT03022422|364684418|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
105734950|NCT03022422|364684419|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
105734951|NCT02403206|364684420|FG000|Overall Study|Lost to Follow-up|4|||
105798969|NCT03118765|364922619|FG002|Overall Study|Sponsor Decision|1|||
105798970|NCT03118765|364922620|FG003|Overall Study|Sponsor Decision|0|||
105798971|NCT03118765|364922621|FG004|Overall Study|Sponsor Decision|1|||
105798972|NCT00849524|364922622|FG000|Overall Study|Lack of Efficacy|3|||
105798973|NCT01507831|364922625|FG000|Overall Study|Randomized but not treated|0|||
105798974|NCT01507831|364922626|FG001|Overall Study|Randomized but not treated|3|||
105798975|NCT01507831|364922625|FG000|Overall Study|Adverse Event|48|||
105798976|NCT01507831|364922626|FG001|Overall Study|Adverse Event|113|||
105938276|NCT03400787|365435019|FG000|Overall Study|Protocol Violation|0|||
105938277|NCT03400787|365435020|FG001|Overall Study|Protocol Violation|2|||
105938278|NCT03400787|365435019|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
105938279|NCT03400787|365435020|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
105938280|NCT02451007|365435021|FG000|Overall Study|Withdrawal by Subject|4|||
105938281|NCT02451007|365435021|FG000|Overall Study|Adverse Event|1|||
105938282|NCT02451007|365435021|FG000|Overall Study|Disease Progression|2|||
105938283|NCT01423084|365435025|FG000|Overall Study|Adverse Event|0|||
105938284|NCT01423084|365435026|FG001|Overall Study|Adverse Event|1|||
105938285|NCT01423084|365435025|FG000|Overall Study|Withdrawal by Subject|2|||
105938286|NCT01423084|365435026|FG001|Overall Study|Withdrawal by Subject|3|||
105938287|NCT01661595|365435027|FG000|Phase 1: Week 0-4|Adverse Event|1|||
105938288|NCT01661595|365435028|FG001|Phase 1: Week 0-4|Adverse Event|0|||
105938289|NCT01661595|365435029|FG002|Phase 1: Week 0-4|Adverse Event|0|||
105938290|NCT01661595|365435030|FG003|Phase 1: Week 0-4|Adverse Event|0|||
105938291|NCT01661595|365435027|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
105938292|NCT01661595|365435028|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
105938293|NCT01661595|365435029|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
105938294|NCT01661595|365435030|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
105938295|NCT02837952|365435031|FG000|Overall Study|Adverse Event|0|||
105938296|NCT02837952|365435032|FG001|Overall Study|Adverse Event|1|||
105938297|NCT02837952|365435031|FG000|Overall Study|Withdrawal by Subject|4|||
105938298|NCT02837952|365435032|FG001|Overall Study|Withdrawal by Subject|5|||
105938299|NCT02837952|365435031|FG000|Overall Study|Medication Error|1|||
105938300|NCT02837952|365435032|FG001|Overall Study|Medication Error|0|||
105938301|NCT01682603|365435033|FG000|Overall Study|Lost to Follow-up|3|||
105938302|NCT01840163|365435034|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
105938303|NCT01840163|365435035|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
105938304|NCT01840163|365435034|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
105938305|NCT01840163|365435035|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
105938306|NCT01840163|365435034|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
105938307|NCT01840163|365435035|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
105938308|NCT00993473|365435036|FG000|Overall Study|Adverse Event|0|||
105938309|NCT00993473|365435037|FG001|Overall Study|Adverse Event|2|||
105938310|NCT00993473|365435036|FG000|Overall Study|Protocol Violation|1|||
105938311|NCT00993473|365435037|FG001|Overall Study|Protocol Violation|2|||
105938312|NCT00993473|365435036|FG000|Overall Study|Lost to Follow-up|1|||
105938313|NCT00993473|365435037|FG001|Overall Study|Lost to Follow-up|0|||
105938314|NCT00993473|365435036|FG000|Overall Study|Withdrawal by Subject|1|||
105938315|NCT00993473|365435037|FG001|Overall Study|Withdrawal by Subject|5|||
105938316|NCT00993473|365435036|FG000|Overall Study|Technical problem with CGM device|0|||
105938317|NCT00993473|365435037|FG001|Overall Study|Technical problem with CGM device|1|||
105734952|NCT02403206|364684421|FG001|Overall Study|Lost to Follow-up|3|||
105734953|NCT02403206|364684420|FG000|Overall Study|Physician Decision|2|||
105734954|NCT02403206|364684421|FG001|Overall Study|Physician Decision|0|||
105734955|NCT02403206|364684420|FG000|Overall Study|Withdrawal by Subject|3|||
105798977|NCT01507831|364922625|FG000|Overall Study|Death|6|||
105798978|NCT01507831|364922626|FG001|Overall Study|Death|2|||
105798979|NCT01507831|364922625|FG000|Overall Study|Poor compliance to protocol|38|||
105938318|NCT00993473|365435036|FG000|Overall Study|Family event|1|||
105938319|NCT00993473|365435037|FG001|Overall Study|Family event|0|||
105938320|NCT01633112|365435038|FG000|Overall Study|Lack of Efficacy|1|||
105938321|NCT01633112|365435039|FG001|Overall Study|Lack of Efficacy|6|||
105734956|NCT02403206|364684421|FG001|Overall Study|Withdrawal by Subject|3|||
105798980|NCT01507831|364922626|FG001|Overall Study|Poor compliance to protocol|60|||
105938322|NCT01633112|365435040|FG002|Overall Study|Lack of Efficacy|13|||
105938323|NCT01633112|365435038|FG000|Overall Study|Abnormal laboratory value(s)|3|||
105938324|NCT01633112|365435039|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105798981|NCT01507831|364922625|FG000|Overall Study|Physician Decision|0|||
105798982|NCT01507831|364922626|FG001|Overall Study|Physician Decision|4|||
105798983|NCT01507831|364922625|FG000|Overall Study|Participant moved|5|||
105798984|NCT01507831|364922626|FG001|Overall Study|Participant moved|19|||
105798985|NCT01507831|364922625|FG000|Overall Study|Consent withdrawn by participant|34|||
105798986|NCT01507831|364922626|FG001|Overall Study|Consent withdrawn by participant|72|||
105798987|NCT01507831|364922625|FG000|Overall Study|Related to study drug administration|5|||
105798988|NCT01507831|364922626|FG001|Overall Study|Related to study drug administration|14|||
105798989|NCT01507831|364922625|FG000|Overall Study|Last visit outside protocol visit window|51|||
105798990|NCT01507831|364922626|FG001|Overall Study|Last visit outside protocol visit window|143|||
105798991|NCT01507831|364922625|FG000|Overall Study|Selection criteria finally not met|0|||
105798992|NCT01507831|364922626|FG001|Overall Study|Selection criteria finally not met|1|||
105798993|NCT01507831|364922625|FG000|Overall Study|Site closure|0|||
105798994|NCT01507831|364922626|FG001|Overall Study|Site closure|3|||
105798995|NCT01507831|364922625|FG000|Overall Study|Potential lost to follow-up|3|||
105798996|NCT01507831|364922626|FG001|Overall Study|Potential lost to follow-up|0|||
105798997|NCT01507831|364922625|FG000|Overall Study|Other|3|||
105798998|NCT01507831|364922626|FG001|Overall Study|Other|6|||
105798999|NCT06371079|364922629|FG000|Overall Study|Missing data|88|||
105799000|NCT06371079|364922630|FG001|Overall Study|Missing data|247|||
105799001|NCT01864525|364922633|FG000|Overall Study|Adverse Event|1|||
105799002|NCT01864525|364922634|FG001|Overall Study|Adverse Event|0|||
105799003|NCT03712228|364922637|FG000|Treatment Period 1|Lack of Efficacy|0|||
105799004|NCT03712228|364922638|FG001|Treatment Period 1|Lack of Efficacy|0|||
106139826|NCT00771667|366170415|FG007|Induction Phase|Lost to Follow-up|0|||
105734957|NCT02403206|364684420|FG000|Overall Study|Reason not given|2|||
105799005|NCT03712228|364922639|FG002|Treatment Period 1|Lack of Efficacy|0|||
105799006|NCT03712228|364922640|FG003|Treatment Period 1|Lack of Efficacy|0|||
105734958|NCT02403206|364684421|FG001|Overall Study|Reason not given|4|||
105799007|NCT03712228|364922641|FG004|Treatment Period 1|Lack of Efficacy|0|||
105799008|NCT03712228|364922642|FG005|Treatment Period 1|Lack of Efficacy|1|||
105799009|NCT03712228|364922637|FG000|Treatment Period 2|Pregnancy|0|||
105799010|NCT03712228|364922638|FG001|Treatment Period 2|Pregnancy|0|||
105799011|NCT03712228|364922639|FG002|Treatment Period 2|Pregnancy|0|||
105799012|NCT03712228|364922640|FG003|Treatment Period 2|Pregnancy|1|||
105799013|NCT03712228|364922641|FG004|Treatment Period 2|Pregnancy|0|||
105799014|NCT03712228|364922642|FG005|Treatment Period 2|Pregnancy|0|||
105799015|NCT03712228|364922637|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105799016|NCT03712228|364922638|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105799017|NCT03712228|364922639|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105799018|NCT03712228|364922640|FG003|Treatment Period 2|Withdrawal by Subject|1|||
105799019|NCT03712228|364922641|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105799020|NCT03712228|364922642|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105799021|NCT00363129|364922643|FG000|Overall Study|Withdrawal by Subject|11|||
105799022|NCT00363129|364922644|FG001|Overall Study|Withdrawal by Subject|18|||
105799023|NCT00363129|364922643|FG000|Overall Study|Adverse Event|8|||
105799024|NCT00363129|364922644|FG001|Overall Study|Adverse Event|3|||
105799025|NCT00363129|364922643|FG000|Overall Study|Alternate Treatment|2|||
105799026|NCT00363129|364922644|FG001|Overall Study|Alternate Treatment|4|||
105799027|NCT00363129|364922643|FG000|Overall Study|Other Medical Problems|2|||
105799028|NCT00363129|364922644|FG001|Overall Study|Other Medical Problems|4|||
105799029|NCT00363129|364922643|FG000|Overall Study|Death|0|||
105799030|NCT00363129|364922644|FG001|Overall Study|Death|1|||
105799031|NCT00363129|364922643|FG000|Overall Study|Other Reasons|6|||
105734959|NCT00957372|364684422|FG000|PART I|Lost to Follow-up|0|||
105734960|NCT00957372|364684423|FG001|PART I|Lost to Follow-up|0|||
105734961|NCT00957372|364684424|FG002|PART I|Lost to Follow-up|1|||
105734962|NCT00957372|364684425|FG003|PART I|Lost to Follow-up|0|||
105734963|NCT00957372|364684422|FG000|PART II|Withdrawal by Subject|0|||
105734964|NCT00957372|364684423|FG001|PART II|Withdrawal by Subject|0|||
105734965|NCT00957372|364684424|FG002|PART II|Withdrawal by Subject|0|||
105734966|NCT00957372|364684425|FG003|PART II|Withdrawal by Subject|8|||
105734967|NCT00957372|364684422|FG000|PART II|Physician Decision|0|||
105734968|NCT00957372|364684423|FG001|PART II|Physician Decision|0|||
105734969|NCT00957372|364684424|FG002|PART II|Physician Decision|0|||
105799032|NCT00363129|364922644|FG001|Overall Study|Other Reasons|3|||
105799033|NCT03296553|364922646|FG000|Overall Study|Withdrawal by Subject|1|||
105799034|NCT03296553|364922647|FG001|Overall Study|Withdrawal by Subject|1|||
105799035|NCT03296553|364922646|FG000|Overall Study|Death|1|||
105799036|NCT03296553|364922647|FG001|Overall Study|Death|0|||
105799037|NCT02295280|364922648|FG000|Overall Study|Adverse Event|0|||
105799038|NCT02295280|364922649|FG001|Overall Study|Adverse Event|1|||
106139827|NCT00771667|366170416|FG008|Induction Phase|Lost to Follow-up|0|||
106139828|NCT00771667|366170417|FG009|Induction Phase|Lost to Follow-up|0|||
105734970|NCT00957372|364684425|FG003|PART II|Physician Decision|1|||
105734971|NCT00957372|364684422|FG000|PART II|Pregnancy|0|||
105734972|NCT00957372|364684423|FG001|PART II|Pregnancy|0|||
105734973|NCT00957372|364684424|FG002|PART II|Pregnancy|0|||
105799039|NCT00558519|364922650|FG000|Overall Study|Ph+|20|||
106139829|NCT00771667|366170408|FG000|Induction Phase|Other|4|||
105938325|NCT01633112|365435040|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105938326|NCT01633112|365435038|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105938327|NCT01633112|365435039|FG001|Overall Study|Abnormal test procedure result(s)|1|||
106010056|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
106010057|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
106010058|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
106010059|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
106010060|NCT03773978|365702476|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
106010061|NCT03773978|365702477|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
106010062|NCT03773978|365702476|FG000|DBW Period|Adverse Event|2|||
106010063|NCT03773978|365702477|FG001|DBW Period|Adverse Event|2|||
106010064|NCT03773978|365702476|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
106010065|NCT03773978|365702477|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
106010066|NCT03773978|365702476|FG000|DBW Period|Withdrawal by Subject|2|||
106010067|NCT03773978|365702477|FG001|DBW Period|Withdrawal by Subject|1|||
106010068|NCT03773978|365702476|FG000|DBW Period|Due to epidemic or pandemic|5|||
106010069|NCT03773978|365702477|FG001|DBW Period|Due to epidemic or pandemic|6|||
106010070|NCT03773978|365702476|FG000|DBW Period|Study team decision|1|||
106010071|NCT03773978|365702477|FG001|DBW Period|Study team decision|0|||
106010072|NCT01502293|365702480|FG000|Overall Study|Progressive Disease|20|||
106010073|NCT01502293|365702481|FG001|Overall Study|Progressive Disease|12|||
106010074|NCT01502293|365702482|FG002|Overall Study|Progressive Disease|2|||
106010075|NCT01502293|365702480|FG000|Overall Study|Withdrawal by Subject|3|||
106010076|NCT01502293|365702481|FG001|Overall Study|Withdrawal by Subject|3|||
106010077|NCT01502293|365702482|FG002|Overall Study|Withdrawal by Subject|1|||
106010078|NCT01502293|365702480|FG000|Overall Study|Adverse Event|0|||
106010079|NCT01502293|365702481|FG001|Overall Study|Adverse Event|2|||
106010080|NCT01502293|365702482|FG002|Overall Study|Adverse Event|0|||
106010081|NCT01502293|365702480|FG000|Overall Study|Reason Not Specified|2|||
106010082|NCT01502293|365702481|FG001|Overall Study|Reason Not Specified|0|||
106010083|NCT01502293|365702482|FG002|Overall Study|Reason Not Specified|0|||
106010084|NCT01502293|365702480|FG000|Overall Study|Physician Decision|0|||
106010085|NCT01502293|365702481|FG001|Overall Study|Physician Decision|0|||
106010086|NCT01502293|365702482|FG002|Overall Study|Physician Decision|1|||
106010087|NCT00774046|365702486|FG000|Screening|Not eligible|56|||
106010088|NCT00774046|365702486|FG000|Enrollment|Desired other therapy/refused|28|||
106010089|NCT00774046|365702486|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
106010090|NCT00762164|365702487|FG000|Overall Study|Lost to Follow-up|1|||
105734974|NCT00957372|364684425|FG003|PART II|Pregnancy|1|||
105734975|NCT00957372|364684422|FG000|PART II|Not Know|0|||
105734976|NCT00957372|364684423|FG001|PART II|Not Know|0|||
105734977|NCT00957372|364684424|FG002|PART II|Not Know|0|||
105734978|NCT00957372|364684425|FG003|PART II|Not Know|20|||
105734979|NCT00957372|364684422|FG000|PART II|Adverse Event|0|||
105734980|NCT00957372|364684423|FG001|PART II|Adverse Event|0|||
105734981|NCT00957372|364684424|FG002|PART II|Adverse Event|0|||
105734982|NCT00957372|364684425|FG003|PART II|Adverse Event|10|||
105938328|NCT01633112|365435040|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105938329|NCT01633112|365435038|FG000|Overall Study|Administrative problems|1|||
105938330|NCT01633112|365435039|FG001|Overall Study|Administrative problems|2|||
105938331|NCT01633112|365435040|FG002|Overall Study|Administrative problems|5|||
105938332|NCT01633112|365435038|FG000|Overall Study|Adverse Event|16|||
105938333|NCT01633112|365435039|FG001|Overall Study|Adverse Event|18|||
105938334|NCT01633112|365435040|FG002|Overall Study|Adverse Event|20|||
105938335|NCT01633112|365435038|FG000|Overall Study|Lost to Follow-up|7|||
105938336|NCT01633112|365435039|FG001|Overall Study|Lost to Follow-up|19|||
106010091|NCT00762164|365702488|FG001|Overall Study|Lost to Follow-up|1|||
105734983|NCT00957372|364684422|FG000|PART II|Patient non-compliance|0|||
105734984|NCT00957372|364684423|FG001|PART II|Patient non-compliance|0|||
105734985|NCT00957372|364684424|FG002|PART II|Patient non-compliance|0|||
105734986|NCT00957372|364684425|FG003|PART II|Patient non-compliance|4|||
105734987|NCT00408681|364684426|FG000|Overall Study|Lack of Efficacy|2|||
105734988|NCT00408681|364684426|FG000|Overall Study|Adverse Event|7|||
105734989|NCT01676116|364684430|FG000|Overall Study|Withdrawal criteria|2|||
105734990|NCT01676116|364684431|FG001|Overall Study|Withdrawal criteria|14|||
105734991|NCT01676116|364684430|FG000|Overall Study|Adverse Event|1|||
105734992|NCT01676116|364684431|FG001|Overall Study|Adverse Event|2|||
105734993|NCT01676116|364684430|FG000|Overall Study|Unclassified|4|||
105734994|NCT01676116|364684431|FG001|Overall Study|Unclassified|10|||
105734995|NCT01676116|364684430|FG000|Overall Study|Protocol Violation|9|||
105938337|NCT01633112|365435040|FG002|Overall Study|Lost to Follow-up|6|||
105938338|NCT01633112|365435038|FG000|Overall Study|Protocol Violation|4|||
105938339|NCT01633112|365435039|FG001|Overall Study|Protocol Violation|0|||
106010092|NCT00762164|365702487|FG000|Overall Study|Discontinued medication|2|||
106010093|NCT00762164|365702488|FG001|Overall Study|Discontinued medication|0|||
106010094|NCT00762164|365702487|FG000|Overall Study|Withdrawal by Subject|0|||
106010095|NCT00762164|365702488|FG001|Overall Study|Withdrawal by Subject|1|||
106010096|NCT02246530|365702500|FG000|Overall Study|Lost to Follow-up|4|||
106139830|NCT00771667|366170409|FG001|Induction Phase|Other|6|||
106139831|NCT00771667|366170410|FG002|Induction Phase|Other|3|||
106139832|NCT00771667|366170411|FG003|Induction Phase|Other|4|||
106139833|NCT00771667|366170412|FG004|Induction Phase|Other|0|||
106139834|NCT00771667|366170413|FG005|Induction Phase|Other|0|||
106139835|NCT00771667|366170414|FG006|Induction Phase|Other|0|||
106139836|NCT00771667|366170415|FG007|Induction Phase|Other|0|||
106139837|NCT00771667|366170416|FG008|Induction Phase|Other|0|||
106139838|NCT00771667|366170417|FG009|Induction Phase|Other|0|||
106139839|NCT00771667|366170408|FG000|Maintenance Phase|Adverse Event|0|||
106139840|NCT00771667|366170409|FG001|Maintenance Phase|Adverse Event|0|||
106139841|NCT00771667|366170410|FG002|Maintenance Phase|Adverse Event|0|||
106139842|NCT00771667|366170411|FG003|Maintenance Phase|Adverse Event|0|||
106139843|NCT00771667|366170412|FG004|Maintenance Phase|Adverse Event|1|||
106139844|NCT00771667|366170413|FG005|Maintenance Phase|Adverse Event|3|||
106139845|NCT00771667|366170414|FG006|Maintenance Phase|Adverse Event|5|||
106139846|NCT00771667|366170415|FG007|Maintenance Phase|Adverse Event|1|||
106139847|NCT00771667|366170416|FG008|Maintenance Phase|Adverse Event|8|||
106139848|NCT00771667|366170417|FG009|Maintenance Phase|Adverse Event|7|||
106139849|NCT00771667|366170408|FG000|Maintenance Phase|Lack of Efficacy|0|||
106139850|NCT00771667|366170409|FG001|Maintenance Phase|Lack of Efficacy|0|||
106139851|NCT00771667|366170410|FG002|Maintenance Phase|Lack of Efficacy|0|||
106139852|NCT00771667|366170411|FG003|Maintenance Phase|Lack of Efficacy|0|||
106139853|NCT00771667|366170412|FG004|Maintenance Phase|Lack of Efficacy|1|||
106139854|NCT00771667|366170413|FG005|Maintenance Phase|Lack of Efficacy|3|||
106139855|NCT00771667|366170414|FG006|Maintenance Phase|Lack of Efficacy|3|||
106139856|NCT00771667|366170415|FG007|Maintenance Phase|Lack of Efficacy|2|||
106139857|NCT00771667|366170416|FG008|Maintenance Phase|Lack of Efficacy|11|||
106139858|NCT00771667|366170417|FG009|Maintenance Phase|Lack of Efficacy|7|||
105734996|NCT01676116|364684431|FG001|Overall Study|Protocol Violation|3|||
105734997|NCT00893113|364686167|FG000|Overall Study|Lost to Follow-up|4|||
105734998|NCT00893113|364686168|FG001|Overall Study|Lost to Follow-up|8|||
105734999|NCT00893113|364686167|FG000|Overall Study|Early Termination|1|||
105735000|NCT00893113|364686168|FG001|Overall Study|Early Termination|1|||
105735001|NCT00893113|364686167|FG000|Overall Study|Withdrew Consent|8|||
105735002|NCT00893113|364686168|FG001|Overall Study|Withdrew Consent|7|||
105735003|NCT02495077|364686169|FG000|Overall Study|Adverse Event|0|||
105735004|NCT02495077|364686170|FG001|Overall Study|Adverse Event|1|||
105735005|NCT02495077|364686171|FG002|Overall Study|Adverse Event|1|||
105735006|NCT02495077|364686172|FG003|Overall Study|Adverse Event|0|||
105735007|NCT02495077|364686169|FG000|Overall Study|Death|3|||
105938340|NCT01633112|365435040|FG002|Overall Study|Protocol Violation|2|||
105938341|NCT01633112|365435038|FG000|Overall Study|Subject no longer requires study drug|0|||
105938342|NCT01633112|365435039|FG001|Overall Study|Subject no longer requires study drug|0|||
105938343|NCT01633112|365435040|FG002|Overall Study|Subject no longer requires study drug|1|||
105938344|NCT01633112|365435038|FG000|Overall Study|Withdrawal by Subject|20|||
105938345|NCT01633112|365435039|FG001|Overall Study|Withdrawal by Subject|12|||
106139859|NCT00771667|366170408|FG000|Maintenance Phase|Other|0|||
105735008|NCT02495077|364686170|FG001|Overall Study|Death|5|||
105735009|NCT02495077|364686171|FG002|Overall Study|Death|0|||
105938346|NCT01633112|365435040|FG002|Overall Study|Withdrawal by Subject|41|||
105938347|NCT01633112|365435038|FG000|Overall Study|missing Study Completion CRF|1|||
105938348|NCT01633112|365435039|FG001|Overall Study|missing Study Completion CRF|1|||
105938349|NCT01633112|365435040|FG002|Overall Study|missing Study Completion CRF|4|||
105938350|NCT00128492|365435043|FG000|Overall Study|AE unrelated to study|2|||
105938351|NCT00128492|365435044|FG001|Overall Study|AE unrelated to study|9|||
105938352|NCT00128492|365435043|FG000|Overall Study|Study drug intolerance (AE)|2|||
105938353|NCT00128492|365435044|FG001|Overall Study|Study drug intolerance (AE)|8|||
105938354|NCT00128492|365435043|FG000|Overall Study|AE related to study|1|||
105938355|NCT00128492|365435044|FG001|Overall Study|AE related to study|4|||
105938356|NCT00128492|365435043|FG000|Overall Study|Death|1|||
105938357|NCT00128492|365435044|FG001|Overall Study|Death|0|||
105938358|NCT00128492|365435043|FG000|Overall Study|Lost to Follow-up|1|||
105938359|NCT00128492|365435044|FG001|Overall Study|Lost to Follow-up|5|||
105938360|NCT00128492|365435043|FG000|Overall Study|Noncompliance|0|||
105938361|NCT00128492|365435044|FG001|Overall Study|Noncompliance|5|||
105938362|NCT00128492|365435043|FG000|Overall Study|Personal or administrative|10|||
106010097|NCT02246530|365702501|FG001|Overall Study|Lost to Follow-up|0|||
106139860|NCT00771667|366170409|FG001|Maintenance Phase|Other|0|||
106139861|NCT00771667|366170410|FG002|Maintenance Phase|Other|0|||
105735010|NCT02495077|364686172|FG003|Overall Study|Death|0|||
105938363|NCT00128492|365435044|FG001|Overall Study|Personal or administrative|22|||
105938364|NCT00128492|365435043|FG000|Overall Study|Withdrawal by Subject|3|||
105938365|NCT00128492|365435044|FG001|Overall Study|Withdrawal by Subject|5|||
105938366|NCT00128492|365435043|FG000|Overall Study|Pregnancy|0|||
105938367|NCT00128492|365435044|FG001|Overall Study|Pregnancy|1|||
106139862|NCT00771667|366170411|FG003|Maintenance Phase|Other|0|||
106139863|NCT00771667|366170412|FG004|Maintenance Phase|Other|0|||
106139864|NCT00771667|366170413|FG005|Maintenance Phase|Other|1|||
106139865|NCT00771667|366170414|FG006|Maintenance Phase|Other|2|||
106010098|NCT02201953|365702503|FG000|Overall Study|Randomized but Never Treated|1|||
106010099|NCT02201953|365702504|FG001|Overall Study|Randomized but Never Treated|5|||
106010100|NCT02201953|365702503|FG000|Overall Study|Lack of Efficacy|9|||
106010101|NCT02201953|365702504|FG001|Overall Study|Lack of Efficacy|30|||
106010102|NCT02201953|365702503|FG000|Overall Study|Lost to Follow-up|8|||
106010103|NCT02201953|365702504|FG001|Overall Study|Lost to Follow-up|8|||
106010104|NCT02201953|365702503|FG000|Overall Study|Withdrew Consent|2|||
106010105|NCT02201953|365702504|FG001|Overall Study|Withdrew Consent|5|||
106010106|NCT02201953|365702503|FG000|Overall Study|Adverse Event|0|||
106010107|NCT02201953|365702504|FG001|Overall Study|Adverse Event|5|||
106010108|NCT02201953|365702503|FG000|Overall Study|Death|0|||
106010109|NCT02201953|365702504|FG001|Overall Study|Death|3|||
106010110|NCT00489307|365702505|FG000|Overall Study|Death|1|||
106010111|NCT00489307|365702506|FG001|Overall Study|Death|1|||
106010112|NCT00489307|365702505|FG000|Overall Study|Lost to Follow-up|2|||
106010113|NCT00489307|365702506|FG001|Overall Study|Lost to Follow-up|2|||
106010114|NCT00489307|365702505|FG000|Overall Study|Physician Decision|1|||
106010115|NCT00489307|365702506|FG001|Overall Study|Physician Decision|0|||
106010116|NCT00489307|365702505|FG000|Overall Study|Withdrawal by Subject|2|||
106010117|NCT00489307|365702506|FG001|Overall Study|Withdrawal by Subject|4|||
106010118|NCT00489307|365702505|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
106010119|NCT00489307|365702506|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
106010120|NCT00489307|365702505|FG000|Overall Study|Surgery after assignment|1|||
106010121|NCT00489307|365702506|FG001|Overall Study|Surgery after assignment|0|||
106010122|NCT00489307|365702505|FG000|Overall Study|Did not fill up the forms|2|||
106010123|NCT00489307|365702506|FG001|Overall Study|Did not fill up the forms|1|||
106010124|NCT00489307|365702505|FG000|Overall Study|Patient or family refusal|5|||
106010125|NCT00489307|365702506|FG001|Overall Study|Patient or family refusal|9|||
106010126|NCT03204188|365702507|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
106010127|NCT03204188|365702507|FG000|Immunotherapy Phase (1 Year)|Death|1|||
106010128|NCT03204188|365702507|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
106010129|NCT03204188|365702507|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
106010130|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
106010131|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
106010132|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
106010133|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Death|9|||
106010134|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Death|0|||
106010135|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Death|0|||
106010136|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
106010137|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
106010138|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
106010139|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
106010140|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
106010141|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
106010142|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Other|135|||
106010143|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Other|0|||
106010144|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Other|0|||
106010145|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
106010146|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
106010147|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
106010148|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
106010149|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
106010150|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
105938368|NCT00159874|365435045|FG000|Overall Study|Adverse Event|2|||
105938369|NCT00159874|365435046|FG001|Overall Study|Adverse Event|2|||
105938370|NCT00159874|365435047|FG002|Overall Study|Adverse Event|5|||
105938371|NCT00159874|365435048|FG003|Overall Study|Adverse Event|1|||
105938372|NCT00159874|365435049|FG004|Overall Study|Adverse Event|1|||
105938373|NCT00159874|365435050|FG005|Overall Study|Adverse Event|2|||
105938374|NCT00159874|365435051|FG006|Overall Study|Adverse Event|0|||
105938375|NCT00159874|365435045|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
105938376|NCT00159874|365435046|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
105938377|NCT00159874|365435047|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
105938378|NCT00159874|365435048|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
105938379|NCT00159874|365435049|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
105938380|NCT00159874|365435050|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
106010151|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
106010152|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
106010153|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
106010154|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Other|3|||
106010155|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Other|0|||
105938381|NCT00159874|365435051|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
105938382|NCT00159874|365435045|FG000|Overall Study|Lack of Efficacy|2|||
105735011|NCT02495077|364686169|FG000|Overall Study|Lost to Follow-up|6|||
105735012|NCT02495077|364686170|FG001|Overall Study|Lost to Follow-up|4|||
105735013|NCT02495077|364686171|FG002|Overall Study|Lost to Follow-up|0|||
105735014|NCT02495077|364686172|FG003|Overall Study|Lost to Follow-up|0|||
105735015|NCT02495077|364686169|FG000|Overall Study|Physician Decision|2|||
105735016|NCT02495077|364686170|FG001|Overall Study|Physician Decision|1|||
105735017|NCT02495077|364686171|FG002|Overall Study|Physician Decision|4|||
105735018|NCT02495077|364686172|FG003|Overall Study|Physician Decision|0|||
106010156|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Other|0|||
106010157|NCT02118584|365703990|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
106010158|NCT02118584|365703991|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
106010159|NCT02118584|365703992|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
106010160|NCT02118584|365703990|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
106010161|NCT02118584|365703991|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
106010162|NCT02118584|365703992|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
106010163|NCT02118584|365703990|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
106010164|NCT02118584|365703991|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
106010165|NCT02118584|365703992|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
106010166|NCT02118584|365703990|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
106010167|NCT02118584|365703991|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
106010168|NCT02118584|365703992|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
106010169|NCT02118584|365703990|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
106010170|NCT02118584|365703991|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
106010171|NCT02118584|365703992|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
106010172|NCT02118584|365703990|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
106010173|NCT02118584|365703991|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
106010174|NCT02118584|365703992|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
106010175|NCT02118584|365703990|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
106010176|NCT02118584|365703991|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
106010177|NCT02118584|365703992|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
106010178|NCT02118584|365703990|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
106010179|NCT02118584|365703991|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
106010180|NCT02118584|365703992|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
106010181|NCT02118584|365703990|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
106010182|NCT02118584|365703991|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
106010183|NCT02118584|365703992|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
106010184|NCT03331315|365703998|FG000|Overall Study|Physician Decision|18|||
106010185|NCT03331315|365703999|FG001|Overall Study|Physician Decision|14|||
106010186|NCT03137381|365704000|FG000|Overall Study|Adverse Event|3|||
106010187|NCT03137381|365704001|FG001|Overall Study|Adverse Event|0|||
106010188|NCT03137381|365704002|FG002|Overall Study|Adverse Event|2|||
105735019|NCT02495077|364686169|FG000|Overall Study|Protocol Violation|0|||
105735020|NCT02495077|364686170|FG001|Overall Study|Protocol Violation|1|||
105735021|NCT02495077|364686171|FG002|Overall Study|Protocol Violation|0|||
105735022|NCT02495077|364686172|FG003|Overall Study|Protocol Violation|0|||
105735023|NCT02495077|364686169|FG000|Overall Study|Screen Failure|0|||
105735024|NCT02495077|364686170|FG001|Overall Study|Screen Failure|0|||
105735025|NCT02495077|364686171|FG002|Overall Study|Screen Failure|0|||
105735026|NCT02495077|364686172|FG003|Overall Study|Screen Failure|48|||
105735027|NCT02495077|364686169|FG000|Overall Study|Withdrawal by Subject|7|||
105735028|NCT02495077|364686170|FG001|Overall Study|Withdrawal by Subject|7|||
105735029|NCT02495077|364686171|FG002|Overall Study|Withdrawal by Subject|7|||
105735030|NCT02495077|364686172|FG003|Overall Study|Withdrawal by Subject|0|||
105735031|NCT02495077|364686169|FG000|Overall Study|Covid-19 research restrictions|1|||
105735032|NCT02495077|364686170|FG001|Overall Study|Covid-19 research restrictions|0|||
105735033|NCT02495077|364686171|FG002|Overall Study|Covid-19 research restrictions|0|||
105735034|NCT02495077|364686172|FG003|Overall Study|Covid-19 research restrictions|0|||
105735035|NCT02495077|364686169|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
105735036|NCT02495077|364686170|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
105735037|NCT02495077|364686171|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
105735038|NCT02495077|364686172|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
105735039|NCT02495077|364686169|FG000|Overall Study|Incarcerated|0|||
105735040|NCT02495077|364686170|FG001|Overall Study|Incarcerated|1|||
105735041|NCT02495077|364686171|FG002|Overall Study|Incarcerated|0|||
105735042|NCT02495077|364686172|FG003|Overall Study|Incarcerated|0|||
105735043|NCT02495077|364686169|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
106010189|NCT03137381|365704003|FG003|Overall Study|Adverse Event|0|||
106010190|NCT03137381|365704000|FG000|Overall Study|Lost to Follow-up|2|||
105735044|NCT02495077|364686170|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
105735045|NCT02495077|364686171|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
105799040|NCT00558519|364922650|FG000|Overall Study|Ineligible|1|||
105799041|NCT00558519|364922650|FG000|Overall Study|Insufficient data|1|||
105799042|NCT00558519|364922650|FG000|Overall Study|Never received treatment|1|||
105799043|NCT00575328|364922651|FG000|Overall Study|Adverse Event|1|||
105799044|NCT00575328|364922652|FG001|Overall Study|Adverse Event|1|||
106139866|NCT00771667|366170415|FG007|Maintenance Phase|Other|2|||
106139867|NCT00771667|366170416|FG008|Maintenance Phase|Other|3|||
106139868|NCT00771667|366170417|FG009|Maintenance Phase|Other|3|||
106139869|NCT00130637|366170418|FG000|Overall Study|Adverse Event|2|||
106139870|NCT00130637|366170418|FG000|Overall Study|Withdrawal by Subject|1|||
106139871|NCT03939819|366170419|FG000|Overall Study|Death|2|||
105799045|NCT00575328|364922651|FG000|Overall Study|Lost to Follow-up|2|||
105799046|NCT00575328|364922652|FG001|Overall Study|Lost to Follow-up|1|||
105799047|NCT02124746|364922653|FG000|Overall Study|Adverse Event|2|||
105799048|NCT02124746|364922654|FG001|Overall Study|Adverse Event|1|||
105799049|NCT02124746|364922655|FG002|Overall Study|Adverse Event|2|||
105799050|NCT02124746|364922653|FG000|Overall Study|Death|2|||
105799051|NCT02124746|364922654|FG001|Overall Study|Death|1|||
105799052|NCT02124746|364922655|FG002|Overall Study|Death|3|||
105799053|NCT02124746|364922653|FG000|Overall Study|Lack of Efficacy|3|||
105799054|NCT02124746|364922654|FG001|Overall Study|Lack of Efficacy|2|||
105799055|NCT02124746|364922655|FG002|Overall Study|Lack of Efficacy|2|||
105799056|NCT02124746|364922653|FG000|Overall Study|Physician Decision|6|||
105799057|NCT02124746|364922654|FG001|Overall Study|Physician Decision|4|||
105799058|NCT02124746|364922655|FG002|Overall Study|Physician Decision|5|||
105799059|NCT02124746|364922653|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105799060|NCT02124746|364922654|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105799061|NCT02124746|364922655|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105799062|NCT02124746|364922653|FG000|Overall Study|Withdrawal by Subject|3|||
105799063|NCT02124746|364922654|FG001|Overall Study|Withdrawal by Subject|3|||
105799064|NCT02124746|364922655|FG002|Overall Study|Withdrawal by Subject|0|||
105799065|NCT02124746|364922653|FG000|Overall Study|Study Terminated by Sponsor|0|||
106139872|NCT03939819|366170420|FG001|Overall Study|Death|0|||
106139873|NCT01186848|366170421|FG000|Overall Study|Lost to Follow-up|4|||
106139874|NCT01186848|366170421|FG000|Overall Study|Withdrawal by Subject|2|||
106139875|NCT01186848|366170421|FG000|Overall Study|Adverse Event|2|||
106139876|NCT04567888|366170437|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
106139877|NCT04567888|366170438|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
105799066|NCT02124746|364922654|FG001|Overall Study|Study Terminated by Sponsor|0|||
105799067|NCT02124746|364922655|FG002|Overall Study|Study Terminated by Sponsor|6|||
105799068|NCT02124746|364922653|FG000|Overall Study|Disease Progression|3|||
105799069|NCT02124746|364922654|FG001|Overall Study|Disease Progression|6|||
105799070|NCT02124746|364922655|FG002|Overall Study|Disease Progression|4|||
105799071|NCT00065065|364922656|FG000|Overall Study|Adverse Event|3|||
105799072|NCT00065065|364922657|FG001|Overall Study|Adverse Event|2|||
105799073|NCT00065065|364922656|FG000|Overall Study|Withdrawal by Subject|1|||
105799074|NCT00065065|364922657|FG001|Overall Study|Withdrawal by Subject|5|||
105799075|NCT00065065|364922656|FG000|Overall Study|Lack of Efficacy|4|||
105799076|NCT00065065|364922657|FG001|Overall Study|Lack of Efficacy|11|||
105799077|NCT00065065|364922656|FG000|Overall Study|Other|2|||
105799078|NCT00065065|364922657|FG001|Overall Study|Other|2|||
105799079|NCT05478603|364922673|FG000|Overall Study|Withdrawal by Subject|0|||
105799080|NCT05478603|364922674|FG001|Overall Study|Withdrawal by Subject|1|||
106139878|NCT04567888|366170437|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
106139879|NCT04567888|366170438|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
106139880|NCT04567888|366170437|FG000|Overall Study|Reported Unusual Birth Year|2|||
106139881|NCT04567888|366170438|FG001|Overall Study|Reported Unusual Birth Year|3|||
106139882|NCT04567888|366170437|FG000|Overall Study|Duplicate Responses|0|||
105799081|NCT05478603|364922675|FG002|Overall Study|Withdrawal by Subject|0|||
105799082|NCT05478603|364922676|FG003|Overall Study|Withdrawal by Subject|0|||
106139883|NCT04567888|366170438|FG001|Overall Study|Duplicate Responses|1|||
106139884|NCT00414648|366170439|FG000|Overall Study|Adverse Event|5|||
106139885|NCT00414648|366170440|FG001|Overall Study|Adverse Event|5|||
106139886|NCT00414648|366170439|FG000|Overall Study|Death|0|||
106139887|NCT00414648|366170440|FG001|Overall Study|Death|1|||
105799083|NCT02472977|364922677|FG000|Overall Study|Disease progression|4|||
105799084|NCT02472977|364922678|FG001|Overall Study|Disease progression|25|||
105799085|NCT02472977|364922679|FG002|Overall Study|Disease progression|6|||
105799086|NCT02472977|364922677|FG000|Overall Study|Withdrawal by Subject|0|||
105799087|NCT02472977|364922678|FG001|Overall Study|Withdrawal by Subject|1|||
106139888|NCT00414648|366170439|FG000|Overall Study|Lack of Efficacy|0|||
105799088|NCT02472977|364922679|FG002|Overall Study|Withdrawal by Subject|0|||
106010191|NCT03137381|365704001|FG001|Overall Study|Lost to Follow-up|1|||
106139889|NCT00414648|366170440|FG001|Overall Study|Lack of Efficacy|2|||
105799089|NCT02472977|364922677|FG000|Overall Study|Study drug toxicity|2|||
105799090|NCT02472977|364922678|FG001|Overall Study|Study drug toxicity|0|||
105799091|NCT02472977|364922679|FG002|Overall Study|Study drug toxicity|2|||
106139890|NCT00414648|366170439|FG000|Overall Study|Withdrawal by Subject|0|||
106139891|NCT00414648|366170440|FG001|Overall Study|Withdrawal by Subject|1|||
106139892|NCT02613364|366170441|FG000|Overall Study|Other|19|||
106139893|NCT02613364|366170442|FG001|Overall Study|Other|29|||
106139894|NCT02613364|366170443|FG002|Overall Study|Other|17|||
106139895|NCT02613364|366170441|FG000|Overall Study|Too time consuming|21|||
106139896|NCT02613364|366170442|FG001|Overall Study|Too time consuming|26|||
106139897|NCT02613364|366170443|FG002|Overall Study|Too time consuming|26|||
106139898|NCT02613364|366170441|FG000|Overall Study|Withdrawal by Subject|13|||
106139899|NCT02613364|366170442|FG001|Overall Study|Withdrawal by Subject|18|||
106139900|NCT02613364|366170443|FG002|Overall Study|Withdrawal by Subject|17|||
106139901|NCT02613364|366170441|FG000|Overall Study|Medical|12|||
106139902|NCT02613364|366170442|FG001|Overall Study|Medical|13|||
106139903|NCT02613364|366170443|FG002|Overall Study|Medical|9|||
106139904|NCT02613364|366170441|FG000|Overall Study|Disliked Study Procedure|1|||
106139905|NCT02613364|366170442|FG001|Overall Study|Disliked Study Procedure|1|||
106139906|NCT02613364|366170443|FG002|Overall Study|Disliked Study Procedure|4|||
106139907|NCT02613364|366170441|FG000|Overall Study|Disliked Intervention|0|||
106139908|NCT02613364|366170442|FG001|Overall Study|Disliked Intervention|3|||
106139909|NCT02613364|366170443|FG002|Overall Study|Disliked Intervention|3|||
106139910|NCT01235949|366170444|FG000|Primary Phase|Migrated/moved from study area|1|||
106139911|NCT01235949|366170445|FG001|Primary Phase|Migrated/moved from study area|1|||
106139912|NCT01235949|366170446|FG002|Primary Phase|Migrated/moved from study area|0|||
106139913|NCT01235949|366170447|FG003|Primary Phase|Migrated/moved from study area|0|||
106139914|NCT01235949|366170448|FG004|Primary Phase|Migrated/moved from study area|1|||
106139915|NCT01235949|366170449|FG005|Primary Phase|Migrated/moved from study area|2|||
106139916|NCT01235949|366170450|FG006|Primary Phase|Migrated/moved from study area|0|||
106139917|NCT01235949|366170451|FG007|Primary Phase|Migrated/moved from study area|0|||
106139918|NCT01235949|366170452|FG008|Primary Phase|Migrated/moved from study area|0|||
105735046|NCT02495077|364686172|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
105735047|NCT02495077|364686169|FG000|Overall Study|Timing of transplant and randomization|0|||
105735048|NCT02495077|364686170|FG001|Overall Study|Timing of transplant and randomization|0|||
105735049|NCT02495077|364686171|FG002|Overall Study|Timing of transplant and randomization|5|||
105735050|NCT02495077|364686172|FG003|Overall Study|Timing of transplant and randomization|0|||
105735051|NCT00128206|364686173|FG000|Overall Study|Lost to Follow-up|137|||
105735052|NCT00128206|364686174|FG001|Overall Study|Lost to Follow-up|118|||
105735053|NCT00128206|364686173|FG000|Overall Study|Adverse Event|0|||
105735054|NCT00128206|364686174|FG001|Overall Study|Adverse Event|2|||
105735055|NCT03270085|364686175|FG000|Overall Study|Withdrawal by Subject|1|||
105735056|NCT03270085|364686176|FG001|Overall Study|Withdrawal by Subject|0|||
105735057|NCT02400346|364686182|FG000|Overall Study|Adverse Event|24|||
105735058|NCT02400346|364686182|FG000|Overall Study|Lack of Efficacy|9|||
105735059|NCT02400346|364686182|FG000|Overall Study|Non-compliance with IMP|1|||
105735060|NCT02400346|364686182|FG000|Overall Study|Withdrawal by Subject|7|||
105735061|NCT02400346|364686182|FG000|Overall Study|Administrative or other reason(s)|2|||
105735062|NCT02400346|364686182|FG000|Overall Study|Lost to Follow-up|1|||
105735063|NCT01269125|364686185|FG000|Overall Study|Adverse Event|3|||
105735064|NCT01269125|364686186|FG001|Overall Study|Adverse Event|5|||
105735065|NCT01269125|364686187|FG002|Overall Study|Adverse Event|0|||
105735066|NCT01269125|364686185|FG000|Overall Study|Lost to Follow-up|4|||
105735067|NCT01269125|364686186|FG001|Overall Study|Lost to Follow-up|0|||
105735068|NCT01269125|364686187|FG002|Overall Study|Lost to Follow-up|0|||
105735069|NCT03635190|364686188|FG000|Overall Study|Lost to Follow-up|4|||
105735070|NCT03635190|364686188|FG000|Overall Study|Death|3|||
105735071|NCT03635190|364686188|FG000|Overall Study|Withdrawal by Subject|1|||
105735072|NCT03635190|364686188|FG000|Overall Study|Patient moved and did not return for follow up|1|||
105735073|NCT03692910|364686191|FG000|Overall Study|Lost to Follow-up|4|||
105735074|NCT03692910|364686192|FG001|Overall Study|Lost to Follow-up|0|||
105735075|NCT03692910|364686193|FG002|Overall Study|Lost to Follow-up|0|||
105735076|NCT03692910|364686191|FG000|Overall Study|Withdrawal by Subject|2|||
105735077|NCT03692910|364686192|FG001|Overall Study|Withdrawal by Subject|0|||
105735078|NCT03692910|364686193|FG002|Overall Study|Withdrawal by Subject|0|||
105735079|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
105735080|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
105799092|NCT02472977|364922677|FG000|Overall Study|Subject request to discontinue treatment|0|||
105799093|NCT02472977|364922678|FG001|Overall Study|Subject request to discontinue treatment|1|||
105799094|NCT02472977|364922679|FG002|Overall Study|Subject request to discontinue treatment|0|||
106139919|NCT01235949|366170453|FG009|Primary Phase|Migrated/moved from study area|0|||
106139920|NCT01235949|366170454|FG010|Primary Phase|Migrated/moved from study area|0|||
106139921|NCT01235949|366170455|FG011|Primary Phase|Migrated/moved from study area|0|||
105735081|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
105735082|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
105735083|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
105735084|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
106139922|NCT01235949|366170456|FG012|Primary Phase|Migrated/moved from study area|0|||
106139923|NCT01235949|366170457|FG013|Primary Phase|Migrated/moved from study area|0|||
106139924|NCT01235949|366170458|FG014|Primary Phase|Migrated/moved from study area|0|||
105735085|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
106010192|NCT03137381|365704002|FG002|Overall Study|Lost to Follow-up|1|||
106010193|NCT03137381|365704003|FG003|Overall Study|Lost to Follow-up|0|||
106010194|NCT03137381|365704000|FG000|Overall Study|Protocol deviation|1|||
106010195|NCT03137381|365704001|FG001|Overall Study|Protocol deviation|1|||
106010196|NCT03137381|365704002|FG002|Overall Study|Protocol deviation|0|||
106010197|NCT03137381|365704003|FG003|Overall Study|Protocol deviation|1|||
106010198|NCT03137381|365704000|FG000|Overall Study|Withdrawal by Investigator|0|||
106010199|NCT03137381|365704001|FG001|Overall Study|Withdrawal by Investigator|1|||
106010200|NCT03137381|365704002|FG002|Overall Study|Withdrawal by Investigator|1|||
106010201|NCT03137381|365704003|FG003|Overall Study|Withdrawal by Investigator|0|||
106010202|NCT03137381|365704000|FG000|Overall Study|Withdrawal by Subject|3|||
106010203|NCT03137381|365704001|FG001|Overall Study|Withdrawal by Subject|4|||
106010204|NCT03137381|365704002|FG002|Overall Study|Withdrawal by Subject|3|||
106010205|NCT03137381|365704003|FG003|Overall Study|Withdrawal by Subject|0|||
106010206|NCT03137381|365704000|FG000|Overall Study|Pregnancy|0|||
106010207|NCT03137381|365704001|FG001|Overall Study|Pregnancy|0|||
106010208|NCT03137381|365704002|FG002|Overall Study|Pregnancy|1|||
106010209|NCT03137381|365704003|FG003|Overall Study|Pregnancy|0|||
106010210|NCT00459316|365704008|FG000|Steps 1 & 2|Other eligibility failure|1|||
106010211|NCT00459316|365704009|FG001|Steps 1 & 2|Other eligibility failure|1|||
106010212|NCT00459316|365704010|FG002|Steps 1 & 2|Other eligibility failure|0|||
106010213|NCT00459316|365704008|FG000|Steps 1 & 2|Death|1|||
106010214|NCT00459316|365704009|FG001|Steps 1 & 2|Death|1|||
106010215|NCT00459316|365704010|FG002|Steps 1 & 2|Death|0|||
106010216|NCT00459316|365704008|FG000|Steps 1 & 2|Not able to get to clinic|7|||
106010217|NCT00459316|365704009|FG001|Steps 1 & 2|Not able to get to clinic|4|||
106010218|NCT00459316|365704010|FG002|Steps 1 & 2|Not able to get to clinic|0|||
106010219|NCT00459316|365704008|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
106010220|NCT00459316|365704009|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
106010221|NCT00459316|365704010|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
106010222|NCT00459316|365704008|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
106010223|NCT00459316|365704009|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
106010224|NCT00459316|365704010|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
106010225|NCT00459316|365704008|FG000|Steps 1 & 2|Lost to Follow-up|5|||
106010226|NCT00459316|365704009|FG001|Steps 1 & 2|Lost to Follow-up|0|||
106010227|NCT00459316|365704010|FG002|Steps 1 & 2|Lost to Follow-up|2|||
105735086|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
105735087|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
105735088|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
105735089|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
105735090|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
105735091|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
105735092|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
105735093|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
105735094|NCT01330381|364686194|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
105735095|NCT01330381|364686195|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
105735096|NCT01330381|364686196|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
105735097|NCT01330381|364686194|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
105735098|NCT01330381|364686195|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
105735099|NCT01330381|364686196|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
105735100|NCT01330381|364686194|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
105735101|NCT01330381|364686195|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
105735102|NCT01330381|364686196|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
105735103|NCT01330381|364686194|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
105735104|NCT01330381|364686195|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
105735105|NCT01330381|364686196|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
105735106|NCT01330381|364686194|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
105735107|NCT01330381|364686195|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
105735108|NCT01330381|364686196|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
105735109|NCT01362322|364686201|FG000|Overall Study|Withdrawal by Subject|3|||
105735110|NCT01362322|364686202|FG001|Overall Study|Withdrawal by Subject|1|||
105735111|NCT01362322|364686201|FG000|Overall Study|Lost to Follow-up|2|||
105735112|NCT01362322|364686202|FG001|Overall Study|Lost to Follow-up|6|||
105735113|NCT03060577|364686203|FG000|Overall Study|Withdrawal by Subject|25|||
105735114|NCT03060577|364686204|FG001|Overall Study|Withdrawal by Subject|5|||
106010228|NCT00459316|365704008|FG000|Step 3|Withdrawal by Subject|3|||
106010229|NCT00459316|365704009|FG001|Step 3|Withdrawal by Subject|0|||
106010230|NCT00459316|365704010|FG002|Step 3|Withdrawal by Subject|1|||
106010231|NCT01748292|365704011|FG000|Overall Study|Adverse Event|2|||
105735115|NCT03060577|364686203|FG000|Overall Study|Physician Decision|4|||
106010232|NCT01748292|365704012|FG001|Overall Study|Adverse Event|4|||
106010233|NCT01748292|365704011|FG000|Overall Study|Lost to Follow-up|0|||
105735116|NCT03060577|364686204|FG001|Overall Study|Physician Decision|3|||
105735117|NCT03060577|364686203|FG000|Overall Study|Lost to Follow-up|3|||
105735118|NCT03060577|364686204|FG001|Overall Study|Lost to Follow-up|0|||
105735119|NCT03060577|364686203|FG000|Overall Study|Death|7|||
105735120|NCT03060577|364686204|FG001|Overall Study|Death|1|||
105735121|NCT03060577|364686203|FG000|Overall Study|Adverse Event|9|||
105735122|NCT03060577|364686204|FG001|Overall Study|Adverse Event|1|||
105735123|NCT03060577|364686203|FG000|Overall Study|Inclusion/Exclusion|1|||
105735124|NCT03060577|364686204|FG001|Overall Study|Inclusion/Exclusion|0|||
105735125|NCT03060577|364686203|FG000|Overall Study|Other|8|||
105735126|NCT03060577|364686204|FG001|Overall Study|Other|2|||
105735127|NCT02413398|364686208|FG000|Overall Study|Lost to Follow-up|2|||
105735128|NCT02413398|364686209|FG001|Overall Study|Lost to Follow-up|4|||
105735129|NCT02413398|364686208|FG000|Overall Study|Withdrawal by Subject|1|||
105735130|NCT02413398|364686209|FG001|Overall Study|Withdrawal by Subject|1|||
105735131|NCT02413398|364686208|FG000|Overall Study|Other Eligibility criteria|1|||
105735132|NCT02413398|364686209|FG001|Overall Study|Other Eligibility criteria|2|||
105735133|NCT01494038|364686210|FG000|Overall Study|Protocol Violation|1|||
105735134|NCT01494038|364686211|FG001|Overall Study|Protocol Violation|1|||
105735135|NCT01494038|364686210|FG000|Overall Study|Lost to Follow-up|18|||
105735136|NCT01494038|364686211|FG001|Overall Study|Lost to Follow-up|20|||
105735137|NCT01494038|364686210|FG000|Overall Study|Withdrawal by Subject|44|||
105735138|NCT01494038|364686211|FG001|Overall Study|Withdrawal by Subject|34|||
105735139|NCT01494038|364686210|FG000|Overall Study|Not able to get to clinic|21|||
105735140|NCT01494038|364686211|FG001|Overall Study|Not able to get to clinic|15|||
105735141|NCT01494038|364686210|FG000|Overall Study|Not willing to adhere to reqs|2|||
105735142|NCT01494038|364686211|FG001|Overall Study|Not willing to adhere to reqs|9|||
105735143|NCT01494038|364686210|FG000|Overall Study|Death|2|||
105735144|NCT01494038|364686211|FG001|Overall Study|Death|4|||
105735145|NCT02874794|364686215|FG000|Overall Study|Physician Decision|3|||
105735146|NCT02874794|364686216|FG001|Overall Study|Physician Decision|2|||
105735147|NCT02874794|364686215|FG000|Overall Study|Withdrawal by Subject|2|||
105735148|NCT02874794|364686216|FG001|Overall Study|Withdrawal by Subject|8|||
105735149|NCT02874794|364686215|FG000|Overall Study|Death|2|||
105735150|NCT02874794|364686216|FG001|Overall Study|Death|1|||
105735151|NCT00537940|364686217|FG000|Overall Study|Adverse Event|20|||
105735152|NCT00537940|364686218|FG001|Overall Study|Adverse Event|19|||
105938383|NCT00159874|365435046|FG001|Overall Study|Lack of Efficacy|0|||
105938384|NCT00159874|365435047|FG002|Overall Study|Lack of Efficacy|1|||
105938385|NCT00159874|365435048|FG003|Overall Study|Lack of Efficacy|1|||
105938386|NCT00159874|365435049|FG004|Overall Study|Lack of Efficacy|0|||
105938387|NCT00159874|365435050|FG005|Overall Study|Lack of Efficacy|3|||
105938388|NCT00159874|365435051|FG006|Overall Study|Lack of Efficacy|0|||
105938389|NCT00159874|365435045|FG000|Overall Study|Lost to Follow-up|1|||
105938390|NCT00159874|365435046|FG001|Overall Study|Lost to Follow-up|0|||
105938391|NCT00159874|365435047|FG002|Overall Study|Lost to Follow-up|3|||
105938392|NCT00159874|365435048|FG003|Overall Study|Lost to Follow-up|0|||
105938393|NCT00159874|365435049|FG004|Overall Study|Lost to Follow-up|1|||
105938394|NCT00159874|365435050|FG005|Overall Study|Lost to Follow-up|2|||
105938395|NCT00159874|365435051|FG006|Overall Study|Lost to Follow-up|1|||
105938396|NCT00159874|365435045|FG000|Overall Study|Other|8|||
105938397|NCT00159874|365435046|FG001|Overall Study|Other|8|||
105938398|NCT00159874|365435047|FG002|Overall Study|Other|8|||
105938399|NCT00159874|365435048|FG003|Overall Study|Other|0|||
105938400|NCT00159874|365435049|FG004|Overall Study|Other|2|||
105938401|NCT00159874|365435050|FG005|Overall Study|Other|1|||
105938402|NCT00159874|365435051|FG006|Overall Study|Other|3|||
105938403|NCT00159874|365435045|FG000|Overall Study|Protocol Violation|0|||
105938404|NCT00159874|365435046|FG001|Overall Study|Protocol Violation|5|||
105938405|NCT00159874|365435047|FG002|Overall Study|Protocol Violation|2|||
105938406|NCT00159874|365435048|FG003|Overall Study|Protocol Violation|0|||
105938407|NCT00159874|365435049|FG004|Overall Study|Protocol Violation|0|||
105938408|NCT00159874|365435050|FG005|Overall Study|Protocol Violation|0|||
105938409|NCT00159874|365435051|FG006|Overall Study|Protocol Violation|0|||
105938410|NCT00159874|365435045|FG000|Overall Study|Death|3|||
105938411|NCT00159874|365435046|FG001|Overall Study|Death|8|||
105938412|NCT00159874|365435047|FG002|Overall Study|Death|15|||
105938413|NCT00159874|365435048|FG003|Overall Study|Death|0|||
105735153|NCT00537940|364686217|FG000|Overall Study|Lack of Efficacy|8|||
105735154|NCT00537940|364686218|FG001|Overall Study|Lack of Efficacy|16|||
105735155|NCT00537940|364686217|FG000|Overall Study|Lost to Follow-up|23|||
105735156|NCT00537940|364686218|FG001|Overall Study|Lost to Follow-up|29|||
105735157|NCT00537940|364686217|FG000|Overall Study|Withdrawal by Subject|113|||
105735158|NCT00537940|364686218|FG001|Overall Study|Withdrawal by Subject|95|||
105938414|NCT00159874|365435049|FG004|Overall Study|Death|1|||
105938415|NCT00159874|365435050|FG005|Overall Study|Death|2|||
105938416|NCT00159874|365435051|FG006|Overall Study|Death|0|||
105938417|NCT00159874|365435045|FG000|Overall Study|Withdrawal by Subject|2|||
105938418|NCT00159874|365435046|FG001|Overall Study|Withdrawal by Subject|6|||
105938419|NCT00159874|365435047|FG002|Overall Study|Withdrawal by Subject|8|||
105938420|NCT00159874|365435048|FG003|Overall Study|Withdrawal by Subject|4|||
105735159|NCT00537940|364686217|FG000|Overall Study|Protocol Violation|6|||
105735160|NCT00537940|364686218|FG001|Overall Study|Protocol Violation|4|||
105735161|NCT00537940|364686217|FG000|Overall Study|Pregnancy|1|||
105735162|NCT00537940|364686218|FG001|Overall Study|Pregnancy|1|||
105735163|NCT00537940|364686217|FG000|Overall Study|Study terminated by sponsor|2|||
105735164|NCT00537940|364686218|FG001|Overall Study|Study terminated by sponsor|3|||
105735165|NCT00537940|364686217|FG000|Overall Study|Other|10|||
105735166|NCT00537940|364686218|FG001|Overall Study|Other|12|||
105735167|NCT01539837|364686219|FG000|Overall Study|reduce neutrophil level|0|||
105735168|NCT01539837|364686220|FG001|Overall Study|reduce neutrophil level|1|||
105735169|NCT01539837|364686221|FG002|Overall Study|reduce neutrophil level|1|||
105735170|NCT01539837|364686219|FG000|Overall Study|bad compliance|0|||
105735171|NCT01539837|364686220|FG001|Overall Study|bad compliance|0|||
105735172|NCT01539837|364686221|FG002|Overall Study|bad compliance|1|||
105735173|NCT01062399|364686224|FG000|Overall Study|Protocol Violation|0|||
105735174|NCT01062399|364686225|FG001|Overall Study|Protocol Violation|1|||
105735175|NCT01062399|364686226|FG002|Overall Study|Protocol Violation|0|||
105735176|NCT01062399|364686227|FG003|Overall Study|Protocol Violation|6|||
105735177|NCT01062399|364686228|FG004|Overall Study|Protocol Violation|4|||
105735178|NCT00685178|364686237|FG000|Overall Study|Adverse Event|1|||
105735179|NCT00685178|364686238|FG001|Overall Study|Adverse Event|5|||
105735180|NCT00685178|364686239|FG002|Overall Study|Adverse Event|2|||
105735181|NCT00685178|364686240|FG003|Overall Study|Adverse Event|4|||
105938421|NCT00159874|365435049|FG004|Overall Study|Withdrawal by Subject|3|||
105735182|NCT00685178|364686237|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
105735183|NCT00685178|364686238|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
105735184|NCT00685178|364686239|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
105735185|NCT00685178|364686240|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
105735186|NCT00685178|364686237|FG000|Overall Study|voluntary study discharge|4|||
105735187|NCT00685178|364686238|FG001|Overall Study|voluntary study discharge|5|||
105735188|NCT00685178|364686239|FG002|Overall Study|voluntary study discharge|1|||
105799095|NCT04288115|364922681|FG000|Overall Study|Withdrawal by Subject|0|||
105938422|NCT00159874|365435050|FG005|Overall Study|Withdrawal by Subject|2|||
105938423|NCT00159874|365435051|FG006|Overall Study|Withdrawal by Subject|1|||
105938424|NCT00159874|365435045|FG000|Overall Study|Pregnancy|1|||
105938425|NCT00159874|365435046|FG001|Overall Study|Pregnancy|1|||
105938426|NCT00159874|365435047|FG002|Overall Study|Pregnancy|0|||
105938427|NCT00159874|365435048|FG003|Overall Study|Pregnancy|0|||
105938428|NCT00159874|365435049|FG004|Overall Study|Pregnancy|0|||
105938429|NCT00159874|365435050|FG005|Overall Study|Pregnancy|0|||
105938430|NCT00159874|365435051|FG006|Overall Study|Pregnancy|0|||
105938431|NCT01475825|365435054|FG000|Overall Study|Adverse Event|41|||
105938432|NCT01475825|365435055|FG001|Overall Study|Adverse Event|15|||
105938433|NCT01475825|365435056|FG002|Overall Study|Adverse Event|27|||
105938434|NCT01475825|365435057|FG003|Overall Study|Adverse Event|11|||
105938435|NCT01475825|365435054|FG000|Overall Study|Death|1|||
105938436|NCT01475825|365435055|FG001|Overall Study|Death|0|||
105938437|NCT01475825|365435056|FG002|Overall Study|Death|1|||
105938438|NCT01475825|365435057|FG003|Overall Study|Death|0|||
105938439|NCT01475825|365435054|FG000|Overall Study|Lack of Efficacy|0|||
105938440|NCT01475825|365435055|FG001|Overall Study|Lack of Efficacy|0|||
105938441|NCT01475825|365435056|FG002|Overall Study|Lack of Efficacy|1|||
105938442|NCT01475825|365435057|FG003|Overall Study|Lack of Efficacy|0|||
105938443|NCT01475825|365435054|FG000|Overall Study|Lost to Follow-up|0|||
105938444|NCT01475825|365435055|FG001|Overall Study|Lost to Follow-up|0|||
105938445|NCT01475825|365435056|FG002|Overall Study|Lost to Follow-up|3|||
105938446|NCT01475825|365435057|FG003|Overall Study|Lost to Follow-up|1|||
105938447|NCT01475825|365435054|FG000|Overall Study|Non-compliance with Study Drug|1|||
105938448|NCT01475825|365435055|FG001|Overall Study|Non-compliance with Study Drug|2|||
105938449|NCT01475825|365435056|FG002|Overall Study|Non-compliance with Study Drug|4|||
105938450|NCT01475825|365435057|FG003|Overall Study|Non-compliance with Study Drug|0|||
105938451|NCT01475825|365435054|FG000|Overall Study|Other: Not available|0|||
105938452|NCT01475825|365435055|FG001|Overall Study|Other: Not available|0|||
105938453|NCT01475825|365435056|FG002|Overall Study|Other: Not available|2|||
105938454|NCT01475825|365435057|FG003|Overall Study|Other: Not available|0|||
105938455|NCT01475825|365435054|FG000|Overall Study|Protocol Violation|1|||
105938456|NCT01475825|365435055|FG001|Overall Study|Protocol Violation|0|||
105938457|NCT01475825|365435056|FG002|Overall Study|Protocol Violation|0|||
105938458|NCT01475825|365435057|FG003|Overall Study|Protocol Violation|0|||
105938459|NCT01475825|365435054|FG000|Overall Study|Physician Decision|0|||
105938460|NCT01475825|365435055|FG001|Overall Study|Physician Decision|1|||
105938461|NCT01475825|365435056|FG002|Overall Study|Physician Decision|0|||
105938462|NCT01475825|365435057|FG003|Overall Study|Physician Decision|0|||
105735189|NCT00685178|364686240|FG003|Overall Study|voluntary study discharge|1|||
105938463|NCT01475825|365435054|FG000|Overall Study|Withdrawal by Subject|8|||
105938464|NCT01475825|365435055|FG001|Overall Study|Withdrawal by Subject|3|||
105938465|NCT01475825|365435056|FG002|Overall Study|Withdrawal by Subject|11|||
105938466|NCT01475825|365435057|FG003|Overall Study|Withdrawal by Subject|7|||
105938467|NCT01475825|365435054|FG000|Overall Study|Did not enter OLC|15|||
105799096|NCT04288115|364922682|FG001|Overall Study|Withdrawal by Subject|1|||
105799097|NCT04288115|364922681|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
106010234|NCT01748292|365704012|FG001|Overall Study|Lost to Follow-up|3|||
106010235|NCT01748292|365704011|FG000|Overall Study|Death|0|||
106010236|NCT01748292|365704012|FG001|Overall Study|Death|3|||
106010237|NCT01748292|365704011|FG000|Overall Study|Withdrawal by Subject|0|||
106010238|NCT01748292|365704012|FG001|Overall Study|Withdrawal by Subject|2|||
106010239|NCT00910650|365704015|FG000|Overall Study|Death|2|||
106010240|NCT03367793|365704016|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
106010241|NCT03367793|365704017|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
106010242|NCT03367793|365704018|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
106010243|NCT03367793|365704019|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
106010244|NCT03367793|365704020|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
106010245|NCT03367793|365704021|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
106010246|NCT00423579|365704022|FG000|Overall Study|Lost to Follow-up|3|||
106010247|NCT00423579|365704023|FG001|Overall Study|Lost to Follow-up|0|||
105799098|NCT04288115|364922682|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
105799099|NCT00291330|364922683|FG000|Overall Study|Adverse Event|47|||
106010248|NCT00423579|365704022|FG000|Overall Study|Protocol Violation|1|||
106010249|NCT00423579|365704023|FG001|Overall Study|Protocol Violation|3|||
106010250|NCT00423579|365704022|FG000|Overall Study|Diagnosis of diabetes|0|||
106010251|NCT00423579|365704023|FG001|Overall Study|Diagnosis of diabetes|1|||
106010252|NCT01761877|365704024|FG000|Overall Study|Adverse Event|7|||
105799100|NCT00291330|364922684|FG001|Overall Study|Adverse Event|40|||
105799101|NCT00291330|364922683|FG000|Overall Study|Protocol Violation|13|||
105799102|NCT00291330|364922684|FG001|Overall Study|Protocol Violation|20|||
105799103|NCT00291330|364922683|FG000|Overall Study|Lost to Follow-up|16|||
105799104|NCT00291330|364922684|FG001|Overall Study|Lost to Follow-up|11|||
105799105|NCT00291330|364922683|FG000|Overall Study|Withdrawal by Subject|22|||
105799106|NCT00291330|364922684|FG001|Overall Study|Withdrawal by Subject|25|||
105799107|NCT00291330|364922683|FG000|Overall Study|Other|3|||
105799108|NCT00291330|364922684|FG001|Overall Study|Other|1|||
105799109|NCT01829295|364922685|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
105799110|NCT01829295|364922686|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
105799111|NCT01829295|364922687|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
105799112|NCT01829295|364922688|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
105799113|NCT01829295|364922685|FG000|6-12 Months|Adverse Event|0|||
105799114|NCT01829295|364922686|FG001|6-12 Months|Adverse Event|0|||
105799115|NCT01829295|364922687|FG002|6-12 Months|Adverse Event|3|||
105799116|NCT01829295|364922688|FG003|6-12 Months|Adverse Event|2|||
105799117|NCT01829295|364922685|FG000|6-12 Months|Lost to Follow-up|2|||
105799118|NCT01829295|364922686|FG001|6-12 Months|Lost to Follow-up|0|||
105799119|NCT01829295|364922687|FG002|6-12 Months|Lost to Follow-up|0|||
105799120|NCT01829295|364922688|FG003|6-12 Months|Lost to Follow-up|0|||
106010253|NCT01761877|365704025|FG001|Overall Study|Adverse Event|0|||
106010254|NCT01761877|365704024|FG000|Overall Study|Withdrawal by Subject|6|||
106010255|NCT01761877|365704025|FG001|Overall Study|Withdrawal by Subject|4|||
106010256|NCT01761877|365704024|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
106010257|NCT01761877|365704025|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
106010258|NCT01761877|365704024|FG000|Overall Study|Death|0|||
106010259|NCT01761877|365704025|FG001|Overall Study|Death|1|||
106010260|NCT01761877|365704024|FG000|Overall Study|MRI intolerant|1|||
106010261|NCT01761877|365704025|FG001|Overall Study|MRI intolerant|6|||
106010262|NCT03879772|365704026|FG000|Overall Study|Adverse Event|2|||
106010263|NCT03879772|365704027|FG001|Overall Study|Adverse Event|2|||
106010264|NCT03879772|365704028|FG002|Overall Study|Adverse Event|3|||
106010265|NCT03879772|365704029|FG003|Overall Study|Adverse Event|4|||
106010266|NCT03879772|365704030|FG004|Overall Study|Adverse Event|3|||
106010267|NCT03879772|365704026|FG000|Overall Study|Treatment Failure|1|||
106010268|NCT03879772|365704027|FG001|Overall Study|Treatment Failure|0|||
106010269|NCT03879772|365704028|FG002|Overall Study|Treatment Failure|0|||
106010270|NCT03879772|365704029|FG003|Overall Study|Treatment Failure|2|||
106010271|NCT03879772|365704030|FG004|Overall Study|Treatment Failure|1|||
106010272|NCT03879772|365704026|FG000|Overall Study|Lost to Follow-up|0|||
106010273|NCT03879772|365704027|FG001|Overall Study|Lost to Follow-up|0|||
106139925|NCT01235949|366170459|FG015|Primary Phase|Migrated/moved from study area|0|||
105799121|NCT01829295|364922685|FG000|6-12 Months|Withdrawal by Subject|2|||
105799122|NCT01829295|364922686|FG001|6-12 Months|Withdrawal by Subject|2|||
106010274|NCT03879772|365704028|FG002|Overall Study|Lost to Follow-up|0|||
106010275|NCT03879772|365704029|FG003|Overall Study|Lost to Follow-up|0|||
106139926|NCT01235949|366170460|FG016|Primary Phase|Migrated/moved from study area|0|||
105799123|NCT01829295|364922687|FG002|6-12 Months|Withdrawal by Subject|0|||
105799124|NCT01829295|364922688|FG003|6-12 Months|Withdrawal by Subject|0|||
106010276|NCT03879772|365704030|FG004|Overall Study|Lost to Follow-up|1|||
106010277|NCT03879772|365704026|FG000|Overall Study|Withdrawal by Subject|0|||
106010278|NCT03879772|365704027|FG001|Overall Study|Withdrawal by Subject|1|||
106139927|NCT01235949|366170461|FG017|Primary Phase|Migrated/moved from study area|0|||
106139928|NCT01235949|366170444|FG000|Primary Phase|Adverse Event|0|||
106139929|NCT01235949|366170445|FG001|Primary Phase|Adverse Event|0|||
105735190|NCT00685178|364686237|FG000|Overall Study|incarcerated|1|||
105735191|NCT00685178|364686238|FG001|Overall Study|incarcerated|3|||
105735192|NCT00685178|364686239|FG002|Overall Study|incarcerated|7|||
105735193|NCT00685178|364686240|FG003|Overall Study|incarcerated|0|||
105735194|NCT00685178|364686237|FG000|Overall Study|administrative (disciplinary) discharge|0|||
105735195|NCT00685178|364686238|FG001|Overall Study|administrative (disciplinary) discharge|1|||
105735196|NCT00685178|364686239|FG002|Overall Study|administrative (disciplinary) discharge|0|||
105735197|NCT00685178|364686240|FG003|Overall Study|administrative (disciplinary) discharge|2|||
105735198|NCT00685178|364686237|FG000|Overall Study|Pregnancy|0|||
105735199|NCT00685178|364686238|FG001|Overall Study|Pregnancy|0|||
105735200|NCT00685178|364686239|FG002|Overall Study|Pregnancy|0|||
105735201|NCT00685178|364686240|FG003|Overall Study|Pregnancy|1|||
105735202|NCT04275310|364686242|FG000|Overall Study|Non-randomized due to running out of funding|4|||
105735203|NCT04275310|364686243|FG001|Overall Study|Non-randomized due to running out of funding|0|||
105735204|NCT03088605|364686244|FG000|Overall Study|Withdrawal by Subject|1|||
105735205|NCT03088605|364686245|FG001|Overall Study|Withdrawal by Subject|0|||
105735206|NCT01183858|364686252|FG000|Overall Study|Death not related to Progressive Disease|5|||
105735207|NCT01183858|364686253|FG001|Overall Study|Death not related to Progressive Disease|6|||
105735208|NCT01183858|364686252|FG000|Overall Study|Adverse Event|14|||
105735209|NCT01183858|364686253|FG001|Overall Study|Adverse Event|11|||
105735210|NCT01183858|364686252|FG000|Overall Study|Investigator's Decision|0|||
105735211|NCT01183858|364686253|FG001|Overall Study|Investigator's Decision|3|||
105735212|NCT01183858|364686252|FG000|Overall Study|Insufficient Therapeutic Response|2|||
105735213|NCT01183858|364686253|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105735214|NCT01183858|364686252|FG000|Overall Study|Refused Treatment|1|||
105735215|NCT01183858|364686253|FG001|Overall Study|Refused Treatment|4|||
105735216|NCT01183858|364686252|FG000|Overall Study|Withdrew Consent|4|||
105735217|NCT01183858|364686253|FG001|Overall Study|Withdrew Consent|4|||
105735218|NCT01183858|364686252|FG000|Overall Study|Discontinued Smoking|3|||
105735219|NCT01183858|364686253|FG001|Overall Study|Discontinued Smoking|1|||
105735220|NCT01183858|364686252|FG000|Overall Study|Protocol Violation|1|||
105735221|NCT01183858|364686253|FG001|Overall Study|Protocol Violation|0|||
105735222|NCT01183858|364686252|FG000|Overall Study|Administrative/Other|6|||
105735223|NCT01183858|364686253|FG001|Overall Study|Administrative/Other|6|||
105735224|NCT01183858|364686252|FG000|Overall Study|Progressive Disease|112|||
105735225|NCT01183858|364686253|FG001|Overall Study|Progressive Disease|115|||
105735226|NCT01183858|364686252|FG000|Overall Study|Death related to Progressive Disease|4|||
105735227|NCT01183858|364686253|FG001|Overall Study|Death related to Progressive Disease|5|||
105735228|NCT01183858|364686252|FG000|Overall Study|Lost to Follow-up|1|||
105735229|NCT01183858|364686253|FG001|Overall Study|Lost to Follow-up|1|||
105735230|NCT02046564|364686254|FG000|Overall Study|Adverse Event|6|||
105735231|NCT02046564|364686255|FG001|Overall Study|Adverse Event|3|||
105735232|NCT02046564|364686254|FG000|Overall Study|Physician Decision|0|||
105735233|NCT02046564|364686255|FG001|Overall Study|Physician Decision|1|||
105735234|NCT02046564|364686254|FG000|Overall Study|Protocol Violation|3|||
105735235|NCT02046564|364686255|FG001|Overall Study|Protocol Violation|1|||
105735236|NCT02046564|364686254|FG000|Overall Study|Withdrawal by Subject|4|||
105735237|NCT02046564|364686255|FG001|Overall Study|Withdrawal by Subject|10|||
105735238|NCT02046564|364686254|FG000|Overall Study|Subject met withdrawal criteria|2|||
105735239|NCT02046564|364686255|FG001|Overall Study|Subject met withdrawal criteria|5|||
105735240|NCT02747043|364686256|FG000|Overall Study|Other|1|||
105735241|NCT02747043|364686257|FG001|Overall Study|Other|1|||
105735242|NCT02747043|364686256|FG000|Overall Study|Adverse Event|3|||
105735243|NCT02747043|364686257|FG001|Overall Study|Adverse Event|1|||
105735244|NCT02747043|364686256|FG000|Overall Study|Withdrawal by Subject|1|||
105735245|NCT02747043|364686257|FG001|Overall Study|Withdrawal by Subject|1|||
105735246|NCT02747043|364686256|FG000|Overall Study|Physician Decision|1|||
105735247|NCT02747043|364686257|FG001|Overall Study|Physician Decision|1|||
105735248|NCT02747043|364686256|FG000|Overall Study|Protocol Violation|0|||
105735249|NCT02747043|364686257|FG001|Overall Study|Protocol Violation|1|||
105938468|NCT01475825|365435055|FG001|Overall Study|Did not enter OLC|11|||
105938469|NCT01475825|365435056|FG002|Overall Study|Did not enter OLC|15|||
105938470|NCT01475825|365435057|FG003|Overall Study|Did not enter OLC|11|||
105938471|NCT02244957|365435058|FG000|Overall Study|Lack of Efficacy|1|||
105938472|NCT02244957|365435059|FG001|Overall Study|Lack of Efficacy|0|||
105938473|NCT01347086|365435061|FG000|Overall Study|failed screening visit|0|||
105938474|NCT01347086|365435062|FG001|Overall Study|failed screening visit|0|||
105938475|NCT01347086|365435063|FG002|Overall Study|failed screening visit|1|||
105938476|NCT01347086|365435064|FG003|Overall Study|failed screening visit|0|||
105735250|NCT02747043|364686256|FG000|Overall Study|Disease progression|4|||
105938477|NCT01347086|365435065|FG004|Overall Study|failed screening visit|0|||
105938478|NCT01347086|365435066|FG005|Overall Study|failed screening visit|0|||
106139930|NCT01235949|366170446|FG002|Primary Phase|Adverse Event|0|||
105735251|NCT02747043|364686257|FG001|Overall Study|Disease progression|0|||
105735252|NCT01295905|364686260|FG000|Overall Study|Did not meet inclusion criteria|1|||
106010279|NCT03879772|365704028|FG002|Overall Study|Withdrawal by Subject|3|||
106010280|NCT03879772|365704029|FG003|Overall Study|Withdrawal by Subject|1|||
106010281|NCT03879772|365704030|FG004|Overall Study|Withdrawal by Subject|1|||
106010282|NCT03879772|365704026|FG000|Overall Study|Protocol Violation|0|||
106010283|NCT03879772|365704027|FG001|Overall Study|Protocol Violation|0|||
106010284|NCT03879772|365704028|FG002|Overall Study|Protocol Violation|3|||
106010285|NCT03879772|365704029|FG003|Overall Study|Protocol Violation|1|||
106010286|NCT03879772|365704030|FG004|Overall Study|Protocol Violation|2|||
106010287|NCT03879772|365704026|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
106010288|NCT03879772|365704027|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
106010289|NCT03879772|365704028|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
106010290|NCT03879772|365704029|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
106010291|NCT03879772|365704030|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
106010292|NCT03697252|365704032|FG000|Overall Study|Adverse Event|3|||
105735253|NCT01295905|364686261|FG001|Overall Study|Did not meet inclusion criteria|0|||
105735254|NCT01295905|364686260|FG000|Overall Study|Met exclusion criteria|1|||
105735255|NCT01295905|364686261|FG001|Overall Study|Met exclusion criteria|0|||
106010293|NCT03697252|365704033|FG001|Overall Study|Adverse Event|2|||
106010294|NCT03697252|365704032|FG000|Overall Study|Withdrawal by Subject|14|||
106010295|NCT03697252|365704033|FG001|Overall Study|Withdrawal by Subject|14|||
106010296|NCT03697252|365704032|FG000|Overall Study|Lost to Follow-up|0|||
106010297|NCT03697252|365704033|FG001|Overall Study|Lost to Follow-up|1|||
105735256|NCT00641147|364686267|FG000|Completed 4 Months.|Physician Decision|1|||
105735257|NCT00641147|364686268|FG001|Completed 4 Months.|Physician Decision|0|||
105735258|NCT00641147|364686267|FG000|Completed 4 Months.|Adverse Event|1|||
106010298|NCT03697252|365704032|FG000|Overall Study|Physician Decision|1|||
106010299|NCT03697252|365704033|FG001|Overall Study|Physician Decision|1|||
106010300|NCT03697252|365704032|FG000|Overall Study|Other|0|||
106010301|NCT03697252|365704033|FG001|Overall Study|Other|1|||
106010302|NCT03125395|365704034|FG000|Overall Study|Adverse Event|2|||
106010303|NCT03125395|365704034|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
106010304|NCT03125395|365704034|FG000|Overall Study|Physician Decision|2|||
106010305|NCT03125395|365704034|FG000|Overall Study|Commercial drug is available|5|||
106010306|NCT01780506|365704035|FG000|Double-Blind Phase|Randomized but not Treated|3|||
106010307|NCT01780506|365704036|FG001|Double-Blind Phase|Randomized but not Treated|2|||
106010308|NCT01780506|365704035|FG000|Double-Blind Phase|Adverse Event|4|||
106010309|NCT01780506|365704036|FG001|Double-Blind Phase|Adverse Event|14|||
106010310|NCT01780506|365704035|FG000|Double-Blind Phase|Death|1|||
106010311|NCT01780506|365704036|FG001|Double-Blind Phase|Death|2|||
106010312|NCT01780506|365704035|FG000|Double-Blind Phase|Pregnancy|2|||
106010313|NCT01780506|365704036|FG001|Double-Blind Phase|Pregnancy|1|||
105735259|NCT00641147|364686268|FG001|Completed 4 Months.|Adverse Event|0|||
105735260|NCT00641147|364686267|FG000|Completed 8 Months.|Physician Decision|2|||
105735261|NCT00641147|364686268|FG001|Completed 8 Months.|Physician Decision|1|||
105735262|NCT00641147|364686267|FG000|Completed 8 Months.|non compliance|1|||
105735263|NCT00641147|364686268|FG001|Completed 8 Months.|non compliance|0|||
105735264|NCT00641147|364686267|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
105735265|NCT00641147|364686268|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
105735266|NCT00641147|364686267|FG000|Completed 12 Months.|Physician Decision|1|||
105735267|NCT00641147|364686268|FG001|Completed 12 Months.|Physician Decision|1|||
105735268|NCT00641147|364686267|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
105735269|NCT00641147|364686268|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
105735270|NCT00641147|364686267|FG000|Completed 16 Months.|Physician Decision|1|||
105735271|NCT00641147|364686268|FG001|Completed 16 Months.|Physician Decision|0|||
105735272|NCT00641147|364686267|FG000|Completed 16 Months.|Lost to Follow-up|1|||
105735273|NCT00641147|364686268|FG001|Completed 16 Months.|Lost to Follow-up|0|||
105735274|NCT02296125|364686271|FG000|Overall Study|Withdrawal by Subject|18|||
105735275|NCT02296125|364686272|FG001|Overall Study|Withdrawal by Subject|8|||
105735276|NCT02296125|364686273|FG002|Overall Study|Withdrawal by Subject|6|||
105735277|NCT02296125|364686274|FG003|Overall Study|Withdrawal by Subject|2|||
105735278|NCT02296125|364686271|FG000|Overall Study|Adverse Event|41|||
105735279|NCT02296125|364686272|FG001|Overall Study|Adverse Event|52|||
105735280|NCT02296125|364686273|FG002|Overall Study|Adverse Event|9|||
105735281|NCT02296125|364686274|FG003|Overall Study|Adverse Event|4|||
105735282|NCT02296125|364686271|FG000|Overall Study|Severe non-compliance to protocol|0|||
105735283|NCT02296125|364686272|FG001|Overall Study|Severe non-compliance to protocol|1|||
105735284|NCT02296125|364686273|FG002|Overall Study|Severe non-compliance to protocol|0|||
106010314|NCT01780506|365704035|FG000|Double-Blind Phase|Lack of Efficacy|1|||
106010315|NCT01780506|365704036|FG001|Double-Blind Phase|Lack of Efficacy|1|||
106010316|NCT01780506|365704035|FG000|Double-Blind Phase|Investigator's Discretion|5|||
106010317|NCT01780506|365704036|FG001|Double-Blind Phase|Investigator's Discretion|2|||
106010318|NCT01780506|365704035|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
106010319|NCT01780506|365704036|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
105799125|NCT03182686|364922689|FG000|Overall Study|Lost to Follow-up|2|||
105799126|NCT03182686|364922690|FG001|Overall Study|Lost to Follow-up|0|||
105799127|NCT03182686|364922689|FG000|Overall Study|Adverse Event|2|||
105799128|NCT03182686|364922690|FG001|Overall Study|Adverse Event|0|||
105799129|NCT03182686|364922689|FG000|Overall Study|Withdrawal by Subject|3|||
105799130|NCT03182686|364922690|FG001|Overall Study|Withdrawal by Subject|0|||
105799131|NCT00869089|364922691|FG000|Overall Study|Lost to Follow-up|1|||
105799132|NCT00869089|364922691|FG000|Overall Study|Withdrawal by Subject|1|||
105799133|NCT00869089|364922691|FG000|Overall Study|Screen Fail|1|||
105799134|NCT01154127|364922692|FG000|Period 1 (21 Days)|Adverse Event|3|||
105799135|NCT01154127|364922693|FG001|Period 1 (21 Days)|Adverse Event|4|||
105799136|NCT01154127|364922692|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
105799137|NCT01154127|364922693|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
105799138|NCT01154127|364922692|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
105799139|NCT01154127|364922693|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
105799140|NCT01154127|364922692|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
105799141|NCT01154127|364922693|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
105799142|NCT01154127|364922692|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
105799143|NCT01154127|364922693|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
105799144|NCT01697449|364922694|FG000|Overall Study|Disease progression|47|||
105799145|NCT01697449|364922694|FG000|Overall Study|Adverse Event|7|||
105799146|NCT01697449|364922694|FG000|Overall Study|Lost to Follow-up|5|||
105799147|NCT01697449|364922694|FG000|Overall Study|Withdrawal by Subject|2|||
105938479|NCT01347086|365435067|FG006|Overall Study|failed screening visit|1|||
105735285|NCT02296125|364686274|FG003|Overall Study|Severe non-compliance to protocol|0|||
105735286|NCT02296125|364686271|FG000|Overall Study|Condition under investigation worsened|153|||
105735287|NCT02296125|364686272|FG001|Overall Study|Condition under investigation worsened|199|||
105735288|NCT02296125|364686273|FG002|Overall Study|Condition under investigation worsened|39|||
105735289|NCT02296125|364686274|FG003|Overall Study|Condition under investigation worsened|56|||
105735290|NCT02296125|364686271|FG000|Overall Study|Any reason not specifically recorded|6|||
105735291|NCT02296125|364686272|FG001|Overall Study|Any reason not specifically recorded|4|||
105735292|NCT02296125|364686273|FG002|Overall Study|Any reason not specifically recorded|2|||
105735293|NCT02296125|364686274|FG003|Overall Study|Any reason not specifically recorded|0|||
106010320|NCT01780506|365704035|FG000|Double-Blind Phase|Protocol Violation|4|||
106010321|NCT01780506|365704036|FG001|Double-Blind Phase|Protocol Violation|3|||
106010322|NCT01780506|365704035|FG000|Double-Blind Phase|Withdrew Consent|23|||
106010323|NCT01780506|365704036|FG001|Double-Blind Phase|Withdrew Consent|24|||
106010324|NCT01780506|365704035|FG000|Double-Blind Phase|Lost to Follow-up|23|||
106010325|NCT01780506|365704036|FG001|Double-Blind Phase|Lost to Follow-up|26|||
106010326|NCT01780506|365704035|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
106139931|NCT01235949|366170447|FG003|Primary Phase|Adverse Event|1|||
105735294|NCT01844076|364686275|FG000|Overall Study|Adverse Event|1|||
105938480|NCT01347086|365435068|FG007|Overall Study|failed screening visit|1|||
105938481|NCT01347086|365435069|FG008|Overall Study|failed screening visit|0|||
105938482|NCT01347086|365435070|FG009|Overall Study|failed screening visit|1|||
105938483|NCT00395447|365435072|FG000|Overall Study|Death|37|||
105938484|NCT00395447|365435073|FG001|Overall Study|Death|32|||
105938485|NCT00395447|365435072|FG000|Overall Study|Lost to Follow-up|52|||
105938486|NCT00395447|365435073|FG001|Overall Study|Lost to Follow-up|43|||
105938487|NCT00395447|365435072|FG000|Overall Study|Withdrawal by Subject|24|||
105938488|NCT00395447|365435073|FG001|Overall Study|Withdrawal by Subject|19|||
105938489|NCT00395447|365435072|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
105938490|NCT00395447|365435073|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
105938491|NCT03766906|365435074|FG000|Overall Study|Withdrawal by Subject|6|||
105938492|NCT02624687|365435079|FG000|Overall Study|Withdrawal by Subject|1|||
105938493|NCT02624687|365435080|FG001|Overall Study|Withdrawal by Subject|1|||
105938494|NCT02624687|365435079|FG000|Overall Study|medical leave from work|0|||
105938495|NCT02624687|365435080|FG001|Overall Study|medical leave from work|1|||
105938496|NCT01546987|365435081|FG000|Overall Study|Protocol Violation|3|||
105938497|NCT01546987|365435082|FG001|Overall Study|Protocol Violation|4|||
106139932|NCT01235949|366170448|FG004|Primary Phase|Adverse Event|0|||
106139933|NCT01235949|366170449|FG005|Primary Phase|Adverse Event|0|||
105735295|NCT01844076|364686276|FG001|Overall Study|Adverse Event|0|||
105735296|NCT01844076|364686277|FG002|Overall Study|Adverse Event|0|||
105735297|NCT01844076|364686278|FG003|Overall Study|Adverse Event|0|||
105799148|NCT01697449|364922694|FG000|Overall Study|Physician Decision|1|||
105799149|NCT01697449|364922694|FG000|Overall Study|Death|2|||
105799150|NCT01697449|364922694|FG000|Overall Study|Other|1|||
105799151|NCT01697449|364922694|FG000|Overall Study|Missing|25|||
105938498|NCT02771145|365435083|FG000|Overall Study|Adverse Event|3|||
105938499|NCT02771145|365435083|FG000|Overall Study|Lost to Follow-up|1|||
105938500|NCT02264821|365435084|FG000|Overall Study|Protocol Violation|1|||
105735298|NCT01844076|364686275|FG000|Overall Study|Withdrawal by Subject|1|||
105938501|NCT02264821|365435085|FG001|Overall Study|Protocol Violation|3|||
105938502|NCT02264821|365435086|FG002|Overall Study|Protocol Violation|6|||
106010327|NCT01780506|365704036|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
105735299|NCT01844076|364686276|FG001|Overall Study|Withdrawal by Subject|0|||
105735300|NCT01844076|364686277|FG002|Overall Study|Withdrawal by Subject|0|||
105735301|NCT01844076|364686278|FG003|Overall Study|Withdrawal by Subject|0|||
105735302|NCT00635102|364686281|FG000|Overall Study|Withdrawal by Subject|7|||
105735303|NCT00635102|364686282|FG001|Overall Study|Withdrawal by Subject|8|||
105735304|NCT00091793|364686283|FG000|Overall Study|Adverse Event|1|||
105735305|NCT00091793|364686284|FG001|Overall Study|Adverse Event|2|||
105735306|NCT00091793|364686283|FG000|Overall Study|Withdrawal by Subject|10|||
105735307|NCT00091793|364686284|FG001|Overall Study|Withdrawal by Subject|15|||
105735308|NCT00091793|364686283|FG000|Overall Study|Ineligibility determined|2|||
105735309|NCT00091793|364686284|FG001|Overall Study|Ineligibility determined|0|||
105735310|NCT00091793|364686283|FG000|Overall Study|Lost to Follow-up|7|||
105735311|NCT00091793|364686284|FG001|Overall Study|Lost to Follow-up|5|||
105735312|NCT00091793|364686283|FG000|Overall Study|Noncompliance|2|||
105735313|NCT00091793|364686284|FG001|Overall Study|Noncompliance|0|||
105735314|NCT00091793|364686283|FG000|Overall Study|Other|2|||
105735315|NCT00091793|364686284|FG001|Overall Study|Other|0|||
105735316|NCT00545818|364686287|FG000|Overall Study|Protocol Violation|1|||
105735317|NCT00545818|364686288|FG001|Overall Study|Protocol Violation|0|||
105735318|NCT00545818|364686287|FG000|Overall Study|Adverse Event|1|||
105735319|NCT00545818|364686288|FG001|Overall Study|Adverse Event|1|||
105735320|NCT00545818|364686287|FG000|Overall Study|Lost to Follow-up|1|||
105735321|NCT00545818|364686288|FG001|Overall Study|Lost to Follow-up|6|||
105735322|NCT01396525|364686292|FG000|Overall Study|Withdrawal by Subject|8|||
105735323|NCT01396525|364686292|FG000|Overall Study|Death|14|||
105735324|NCT01396525|364686292|FG000|Overall Study|Lost to Follow-up|4|||
105735325|NCT00104104|364686298|FG000|Overall Study|Adverse Event|8|||
105735326|NCT00104104|364686299|FG001|Overall Study|Adverse Event|8|||
105735327|NCT00104104|364686298|FG000|Overall Study|Abnormal laboratory value(s)|20|||
105735328|NCT00104104|364686299|FG001|Overall Study|Abnormal laboratory value(s)|14|||
105735329|NCT00104104|364686298|FG000|Overall Study|Lack of Efficacy|0|||
105735330|NCT00104104|364686299|FG001|Overall Study|Lack of Efficacy|3|||
105735331|NCT00104104|364686298|FG000|Overall Study|Condition no longer requires study drug|7|||
105735332|NCT00104104|364686299|FG001|Overall Study|Condition no longer requires study drug|4|||
105735333|NCT00104104|364686298|FG000|Overall Study|Protocol Violation|5|||
105735334|NCT00104104|364686299|FG001|Overall Study|Protocol Violation|2|||
105735335|NCT00104104|364686298|FG000|Overall Study|Withdrawal by Subject|11|||
105735336|NCT00104104|364686299|FG001|Overall Study|Withdrawal by Subject|15|||
105735337|NCT00104104|364686298|FG000|Overall Study|Lost to Follow-up|3|||
105735338|NCT00104104|364686299|FG001|Overall Study|Lost to Follow-up|7|||
105735339|NCT00104104|364686298|FG000|Overall Study|Administrative problems|12|||
105735340|NCT00104104|364686299|FG001|Overall Study|Administrative problems|13|||
105735341|NCT00104104|364686298|FG000|Overall Study|Death|9|||
105735342|NCT00104104|364686299|FG001|Overall Study|Death|6|||
105938503|NCT02662582|365435087|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
105938504|NCT02662582|365435088|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
105938505|NCT02662582|365435087|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
105938506|NCT02662582|365435088|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
105938507|NCT02662582|365435087|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
105938508|NCT02662582|365435088|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
105938509|NCT02662582|365435087|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105938510|NCT02662582|365435088|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105938511|NCT05463952|365435089|FG000|Treatment|Progressive disease|4|||
105938512|NCT05463952|365435089|FG000|Treatment|Ongoing|2|||
105938513|NCT05261490|365435090|FG000|Overall Study|Other|1|||
105938514|NCT05261490|365435091|FG001|Overall Study|Other|0|||
105938515|NCT05261490|365435092|FG002|Overall Study|Other|0|||
105938516|NCT05261490|365435090|FG000|Overall Study|Study Terminated by Sponsor|1|||
105938517|NCT05261490|365435091|FG001|Overall Study|Study Terminated by Sponsor|1|||
105938518|NCT05261490|365435092|FG002|Overall Study|Study Terminated by Sponsor|4|||
105938519|NCT05261490|365435090|FG000|Overall Study|Death|1|||
105938520|NCT05261490|365435091|FG001|Overall Study|Death|2|||
105938521|NCT05261490|365435092|FG002|Overall Study|Death|0|||
105938522|NCT01696214|365435104|FG000|Overall Study|Lost to Follow-up|1|||
105938523|NCT01696214|365435105|FG001|Overall Study|Lost to Follow-up|0|||
106139934|NCT01235949|366170450|FG006|Primary Phase|Adverse Event|0|||
106139935|NCT01235949|366170451|FG007|Primary Phase|Adverse Event|0|||
105735343|NCT01787591|364686300|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
105735344|NCT01787591|364686301|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
105735345|NCT01787591|364686302|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
105735346|NCT01787591|364686303|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
105735347|NCT01707147|364686307|FG000|Overall Study|Administered Trajenta prior to contract|5|||
105735348|NCT01707147|364686307|FG000|Overall Study|Patients who have not taken Trajenta|1|||
105938524|NCT01696214|365435106|FG002|Overall Study|Lost to Follow-up|0|||
105938525|NCT01696214|365435107|FG003|Overall Study|Lost to Follow-up|0|||
105938526|NCT01682720|365435109|FG000|Overall Study|Randomized but Not Treated|0|||
105938527|NCT01682720|365435110|FG001|Overall Study|Randomized but Not Treated|1|||
106010328|NCT02224560|365704040|FG000|Overall Study|Protocol Deviation|1|||
106010329|NCT02224560|365704041|FG001|Overall Study|Protocol Deviation|0|||
106010330|NCT02224560|365704042|FG002|Overall Study|Protocol Deviation|0|||
106010331|NCT02224560|365704040|FG000|Overall Study|Withdrawal by Subject|2|||
106010332|NCT02224560|365704041|FG001|Overall Study|Withdrawal by Subject|0|||
106010333|NCT02224560|365704042|FG002|Overall Study|Withdrawal by Subject|1|||
106010334|NCT02224560|365704040|FG000|Overall Study|Met Withdrawal Criteria|1|||
106010335|NCT02224560|365704041|FG001|Overall Study|Met Withdrawal Criteria|0|||
106010336|NCT02224560|365704042|FG002|Overall Study|Met Withdrawal Criteria|0|||
106010337|NCT02224560|365704040|FG000|Overall Study|Adverse Event|4|||
106010338|NCT02224560|365704041|FG001|Overall Study|Adverse Event|1|||
106010339|NCT02224560|365704042|FG002|Overall Study|Adverse Event|1|||
106010340|NCT02224560|365704040|FG000|Overall Study|Withdrawn by Investigator|1|||
106139936|NCT01235949|366170452|FG008|Primary Phase|Adverse Event|0|||
106139937|NCT01235949|366170453|FG009|Primary Phase|Adverse Event|0|||
106139938|NCT01235949|366170454|FG010|Primary Phase|Adverse Event|0|||
106139939|NCT01235949|366170455|FG011|Primary Phase|Adverse Event|0|||
106139940|NCT01235949|366170456|FG012|Primary Phase|Adverse Event|0|||
105735349|NCT01707147|364686307|FG000|Overall Study|Follow-up failure|17|||
105735350|NCT01707147|364686307|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
105735351|NCT02489630|364686310|FG000|Overall Study|Oversedation|1|||
105735352|NCT02489630|364686311|FG001|Overall Study|Oversedation|1|||
105735353|NCT02489630|364686310|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
105735354|NCT02489630|364686311|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
105735355|NCT01326962|364686312|FG000|Overall Study|Adverse Event|1|||
105735356|NCT01326962|364686312|FG000|Overall Study|Withdrawal by Subject|1|||
105735357|NCT01326962|364686312|FG000|Overall Study|Lost to Follow-up|3|||
105735358|NCT01326962|364686312|FG000|Overall Study|Other|2|||
105735359|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Adverse Event|37|||
105735360|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Adverse Event|0|||
105735361|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Adverse Event|0|||
105735362|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Adverse Event|0|||
105735363|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Death|2|||
105735364|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Death|0|||
105735365|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Death|0|||
105735366|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Death|0|||
105735367|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
105735368|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
105735369|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
105735370|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
105735371|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
105735372|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
105735373|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
105735374|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
105735375|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
105735376|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
105735377|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
105735378|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
105735379|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
105735380|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
105735381|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
105735382|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
105735383|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Physician Decision|4|||
105735384|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Physician Decision|0|||
105735385|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Physician Decision|0|||
105735386|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Physician Decision|0|||
105735387|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Pregnancy|1|||
105735388|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Pregnancy|0|||
105735389|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Pregnancy|0|||
105735390|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Pregnancy|0|||
105735391|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
105735392|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
105735393|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
105735394|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
105735395|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
105735396|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
105735397|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
105735398|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
105735399|NCT01855789|364686315|FG000|1) Baseline up to Week 24|Other|4|||
105735400|NCT01855789|364686316|FG001|1) Baseline up to Week 24|Other|0|||
105735401|NCT01855789|364686317|FG002|1) Baseline up to Week 24|Other|0|||
105735402|NCT01855789|364686318|FG003|1) Baseline up to Week 24|Other|0|||
106010341|NCT02224560|365704041|FG001|Overall Study|Withdrawn by Investigator|1|||
106010342|NCT02224560|365704042|FG002|Overall Study|Withdrawn by Investigator|0|||
105735403|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
105735404|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
105735405|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
105735406|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
105735407|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
105735408|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
105735409|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
105735410|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
105735411|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
105735412|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
105735413|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
105735414|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
105735415|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
105735416|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
105735417|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
105735418|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
105735419|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
105735420|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
105735421|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
105735422|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
105735423|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
105735424|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
105735425|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
105735426|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
105735427|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
105735428|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
105735429|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
105735430|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
105735431|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
105735432|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
105735433|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
105735434|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
105735435|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
106010343|NCT02461758|365704043|FG000|Overall Study|Lost to Follow-up|0|||
106010344|NCT02461758|365704044|FG001|Overall Study|Lost to Follow-up|1|||
106010345|NCT02461758|365704045|FG002|Overall Study|Lost to Follow-up|1|||
106010346|NCT02461758|365704046|FG003|Overall Study|Lost to Follow-up|0|||
106010347|NCT04030143|365704047|FG000|Overall Study|Adverse Event|5|||
106010348|NCT04030143|365704048|FG001|Overall Study|Adverse Event|10|||
106010349|NCT04030143|365704047|FG000|Overall Study|Lost to Follow-up|3|||
106010350|NCT04030143|365704048|FG001|Overall Study|Lost to Follow-up|7|||
106010351|NCT04030143|365704047|FG000|Overall Study|Protocol Deviation|2|||
106010352|NCT04030143|365704048|FG001|Overall Study|Protocol Deviation|2|||
106010353|NCT04030143|365704047|FG000|Overall Study|Withdrawal by Subject|16|||
106010354|NCT04030143|365704048|FG001|Overall Study|Withdrawal by Subject|18|||
106010355|NCT04030143|365704047|FG000|Overall Study|Physician Decision|1|||
106010356|NCT04030143|365704048|FG001|Overall Study|Physician Decision|1|||
106010357|NCT04030143|365704047|FG000|Overall Study|Due to Covid-19|2|||
106010358|NCT04030143|365704048|FG001|Overall Study|Due to Covid-19|3|||
106010359|NCT04030143|365704047|FG000|Overall Study|Not Due to Covid-19|1|||
106010360|NCT04030143|365704048|FG001|Overall Study|Not Due to Covid-19|1|||
106010361|NCT00412984|365704049|FG000|Overall Study|Death|331|||
106010362|NCT00412984|365704050|FG001|Overall Study|Death|349|||
106010363|NCT00412984|365704049|FG000|Overall Study|Adverse Event|679|||
106010364|NCT00412984|365704050|FG001|Overall Study|Adverse Event|738|||
106010365|NCT00412984|365704049|FG000|Overall Study|Withdrawal by Subject|921|||
106010366|NCT00412984|365704050|FG001|Overall Study|Withdrawal by Subject|989|||
106010367|NCT00412984|365704049|FG000|Overall Study|Lost to Follow-up|51|||
106010368|NCT00412984|365704050|FG001|Overall Study|Lost to Follow-up|39|||
106010369|NCT00412984|365704049|FG000|Overall Study|Poor/Noncompliance|57|||
106010370|NCT00412984|365704050|FG001|Overall Study|Poor/Noncompliance|77|||
106010371|NCT00412984|365704049|FG000|Overall Study|Pregnancy|1|||
106139941|NCT01235949|366170457|FG013|Primary Phase|Adverse Event|0|||
106139942|NCT01235949|366170458|FG014|Primary Phase|Adverse Event|0|||
105735436|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
106010372|NCT00412984|365704050|FG001|Overall Study|Pregnancy|0|||
106010373|NCT00412984|365704049|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
106010374|NCT00412984|365704050|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
106010375|NCT00412984|365704049|FG000|Overall Study|Administrative Reason by Sponsor|11|||
106139943|NCT01235949|366170459|FG015|Primary Phase|Adverse Event|0|||
106010376|NCT00412984|365704050|FG001|Overall Study|Administrative Reason by Sponsor|8|||
106010377|NCT00412984|365704049|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
106010378|NCT00412984|365704050|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
105938528|NCT01682720|365435111|FG002|Overall Study|Randomized but Not Treated|1|||
105938529|NCT01682720|365435112|FG003|Overall Study|Randomized but Not Treated|0|||
105938530|NCT01682720|365435109|FG000|Overall Study|Terminated by Sponsor|83|||
105938531|NCT01682720|365435110|FG001|Overall Study|Terminated by Sponsor|0|||
106139944|NCT01235949|366170460|FG016|Primary Phase|Adverse Event|0|||
106139945|NCT01235949|366170461|FG017|Primary Phase|Adverse Event|0|||
106139946|NCT01235949|366170444|FG000|Primary Phase|Withdrawal by Subject|3|||
106139947|NCT01235949|366170445|FG001|Primary Phase|Withdrawal by Subject|2|||
106139948|NCT01235949|366170446|FG002|Primary Phase|Withdrawal by Subject|2|||
106139949|NCT01235949|366170447|FG003|Primary Phase|Withdrawal by Subject|0|||
106139950|NCT01235949|366170448|FG004|Primary Phase|Withdrawal by Subject|0|||
106139951|NCT01235949|366170449|FG005|Primary Phase|Withdrawal by Subject|3|||
105938532|NCT01682720|365435111|FG002|Overall Study|Terminated by Sponsor|0|||
105938533|NCT01682720|365435112|FG003|Overall Study|Terminated by Sponsor|0|||
105735437|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
105938534|NCT01682720|365435109|FG000|Overall Study|Efficacy Failure|0|||
105938535|NCT01682720|365435110|FG001|Overall Study|Efficacy Failure|3|||
105938536|NCT01682720|365435111|FG002|Overall Study|Efficacy Failure|3|||
105938537|NCT01682720|365435112|FG003|Overall Study|Efficacy Failure|30|||
105938538|NCT01682720|365435109|FG000|Overall Study|Lost to Follow-up|1|||
105938539|NCT01682720|365435110|FG001|Overall Study|Lost to Follow-up|1|||
105938540|NCT01682720|365435111|FG002|Overall Study|Lost to Follow-up|0|||
105938541|NCT01682720|365435112|FG003|Overall Study|Lost to Follow-up|6|||
105938542|NCT01682720|365435109|FG000|Overall Study|Subject Withdrew Consent|0|||
105938543|NCT01682720|365435110|FG001|Overall Study|Subject Withdrew Consent|0|||
105938544|NCT01682720|365435111|FG002|Overall Study|Subject Withdrew Consent|2|||
105938545|NCT01682720|365435112|FG003|Overall Study|Subject Withdrew Consent|2|||
105938546|NCT01682720|365435109|FG000|Overall Study|Adverse Event|1|||
105938547|NCT01682720|365435110|FG001|Overall Study|Adverse Event|0|||
105938548|NCT01682720|365435111|FG002|Overall Study|Adverse Event|1|||
105938549|NCT01682720|365435112|FG003|Overall Study|Adverse Event|1|||
105938550|NCT02965976|365435113|FG000|Overall Study|Withdrawal by Subject|2|||
105938551|NCT02965976|365435114|FG001|Overall Study|Withdrawal by Subject|0|||
105938552|NCT01687595|365435115|FG000|Overall Study|Withdrawal by Subject|8|||
105938553|NCT01687595|365435116|FG001|Overall Study|Withdrawal by Subject|0|||
105938554|NCT01687595|365435115|FG000|Overall Study|Lost to Follow-up|3|||
105938555|NCT01687595|365435116|FG001|Overall Study|Lost to Follow-up|1|||
105938556|NCT01687595|365435115|FG000|Overall Study|Investigator's decision|1|||
105938557|NCT01687595|365435116|FG001|Overall Study|Investigator's decision|0|||
105938558|NCT01687595|365435115|FG000|Overall Study|Sponsor's decision|1|||
105938559|NCT01687595|365435116|FG001|Overall Study|Sponsor's decision|0|||
105938560|NCT01687595|365435115|FG000|Overall Study|Noncompliance|1|||
105938561|NCT01687595|365435116|FG001|Overall Study|Noncompliance|2|||
105938562|NCT01687595|365435115|FG000|Overall Study|Other than specified|56|||
105938563|NCT01687595|365435116|FG001|Overall Study|Other than specified|7|||
105938564|NCT04191616|365435119|FG000|Overall Study|Death|26|||
105938565|NCT04191616|365435119|FG000|Overall Study|Withdrawal by Subject|1|||
105735438|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
105735439|NCT01855789|364686315|FG000|2) Week 24 up to End of Study|Other|0|||
105735440|NCT01855789|364686316|FG001|2) Week 24 up to End of Study|Other|0|||
105735441|NCT01855789|364686317|FG002|2) Week 24 up to End of Study|Other|0|||
105735442|NCT01855789|364686318|FG003|2) Week 24 up to End of Study|Other|1|||
105735443|NCT02369510|364686319|FG000|Overall Study|Spilled Medication|1|||
105735444|NCT02369510|364686320|FG001|Overall Study|Spilled Medication|2|||
105938566|NCT04191616|365435119|FG000|Overall Study|Sponsor decision|2|||
105938567|NCT04191616|365435119|FG000|Overall Study|Continuing study|25|||
105938568|NCT02395627|365435120|FG000|Overall Study|Withdrawal by Subject|0|||
105938569|NCT02395627|365435121|FG001|Overall Study|Withdrawal by Subject|2|||
105938570|NCT02395627|365435122|FG002|Overall Study|Withdrawal by Subject|0|||
105938571|NCT02395627|365435120|FG000|Overall Study|Did not receive pembrolizumab|3|||
105938572|NCT02395627|365435121|FG001|Overall Study|Did not receive pembrolizumab|1|||
105938573|NCT02395627|365435122|FG002|Overall Study|Did not receive pembrolizumab|0|||
105938574|NCT01313676|365436701|FG000|Overall Study|Adverse Event|395|||
105938575|NCT01313676|365436702|FG001|Overall Study|Adverse Event|365|||
105938576|NCT01313676|365436703|FG002|Overall Study|Adverse Event|372|||
105938577|NCT01313676|365436704|FG003|Overall Study|Adverse Event|333|||
105938578|NCT01313676|365436701|FG000|Overall Study|Lack of Efficacy|98|||
105938579|NCT01313676|365436702|FG001|Overall Study|Lack of Efficacy|90|||
105938580|NCT01313676|365436703|FG002|Overall Study|Lack of Efficacy|65|||
105938581|NCT01313676|365436704|FG003|Overall Study|Lack of Efficacy|46|||
105938582|NCT01313676|365436701|FG000|Overall Study|Protocol Violation|37|||
105938583|NCT01313676|365436702|FG001|Overall Study|Protocol Violation|44|||
105938584|NCT01313676|365436703|FG002|Overall Study|Protocol Violation|46|||
105938585|NCT01313676|365436704|FG003|Overall Study|Protocol Violation|44|||
105938586|NCT01313676|365436701|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
105938587|NCT01313676|365436702|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
105938588|NCT01313676|365436703|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
105735445|NCT02369510|364686321|FG002|Overall Study|Spilled Medication|1|||
105735446|NCT02369510|364686319|FG000|Overall Study|Epidural Activation|1|||
105735447|NCT02369510|364686320|FG001|Overall Study|Epidural Activation|1|||
105735448|NCT02369510|364686321|FG002|Overall Study|Epidural Activation|5|||
105735449|NCT03459846|364686324|FG000|Overall Study|Death|52|||
105735450|NCT03459846|364686325|FG001|Overall Study|Death|46|||
105735451|NCT03459846|364686324|FG000|Overall Study|Study terminated by sponsor|24|||
105735452|NCT03459846|364686325|FG001|Overall Study|Study terminated by sponsor|28|||
105735453|NCT03459846|364686324|FG000|Overall Study|Withdrawal by Subject|2|||
105735454|NCT03459846|364686325|FG001|Overall Study|Withdrawal by Subject|2|||
105735455|NCT01589094|364686328|FG000|Overall Study|Did not receive treatment|2|||
105735456|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
105735457|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
105735458|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
105735459|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
105735460|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
105735461|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105735462|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105735463|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
105735464|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
105735465|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
105735466|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
105735467|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
105735468|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
105735469|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
105735470|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
105735471|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
105735472|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
105735473|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
105735474|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
105735475|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
105735476|NCT01894516|364687672|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
105735477|NCT01894516|364687673|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
105735478|NCT01894516|364687674|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
105735479|NCT01894516|364687675|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
105735480|NCT01894516|364687672|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
105735481|NCT01894516|364687673|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
105735482|NCT01894516|364687674|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
105735483|NCT01894516|364687675|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
105735484|NCT01894516|364687672|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105735485|NCT01894516|364687673|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105735486|NCT01894516|364687674|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
105735487|NCT01894516|364687675|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
105735488|NCT01582282|364687676|FG000|Overall Study|Adverse Event|1|||
105735489|NCT01582282|364687677|FG001|Overall Study|Adverse Event|1|||
105735490|NCT01582282|364687678|FG002|Overall Study|Adverse Event|0|||
105735491|NCT01582282|364687676|FG000|Overall Study|Lost to Follow-up|1|||
105735492|NCT01582282|364687677|FG001|Overall Study|Lost to Follow-up|0|||
105735493|NCT01582282|364687678|FG002|Overall Study|Lost to Follow-up|0|||
105735494|NCT01582282|364687676|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
105735495|NCT01582282|364687677|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
105735496|NCT01582282|364687678|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
105938589|NCT01313676|365436704|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
105938590|NCT01313676|365436701|FG000|Overall Study|Study Closed/terminated|7|||
105938591|NCT01313676|365436702|FG001|Overall Study|Study Closed/terminated|6|||
105938592|NCT01313676|365436703|FG002|Overall Study|Study Closed/terminated|9|||
105938593|NCT01313676|365436704|FG003|Overall Study|Study Closed/terminated|9|||
105938594|NCT01313676|365436701|FG000|Overall Study|Lost to Follow-up|0|||
105938595|NCT01313676|365436702|FG001|Overall Study|Lost to Follow-up|0|||
105938596|NCT01313676|365436703|FG002|Overall Study|Lost to Follow-up|1|||
105938597|NCT01313676|365436704|FG003|Overall Study|Lost to Follow-up|0|||
105938598|NCT01313676|365436701|FG000|Overall Study|Physician Decision|53|||
105938599|NCT01313676|365436702|FG001|Overall Study|Physician Decision|64|||
105938600|NCT01313676|365436703|FG002|Overall Study|Physician Decision|62|||
105938601|NCT01313676|365436704|FG003|Overall Study|Physician Decision|48|||
105938602|NCT01313676|365436701|FG000|Overall Study|Decision by Participant or Proxy|643|||
105938603|NCT01313676|365436702|FG001|Overall Study|Decision by Participant or Proxy|527|||
105938604|NCT01313676|365436703|FG002|Overall Study|Decision by Participant or Proxy|515|||
105938605|NCT01313676|365436704|FG003|Overall Study|Decision by Participant or Proxy|492|||
105735497|NCT01486316|364687679|FG000|Overall Study|Device explanted with/without re-implant|3|||
105735498|NCT01486316|364687680|FG001|Overall Study|Device explanted with/without re-implant|2|||
106139952|NCT01235949|366170450|FG006|Primary Phase|Withdrawal by Subject|0|||
105735499|NCT01486316|364687681|FG002|Overall Study|Device explanted with/without re-implant|0|||
105735500|NCT01486316|364687682|FG003|Overall Study|Device explanted with/without re-implant|2|||
105735501|NCT01486316|364687679|FG000|Overall Study|Not meeting eligibility criteria|0|||
105735502|NCT01486316|364687680|FG001|Overall Study|Not meeting eligibility criteria|0|||
105735503|NCT01486316|364687681|FG002|Overall Study|Not meeting eligibility criteria|1|||
105735504|NCT01486316|364687682|FG003|Overall Study|Not meeting eligibility criteria|0|||
105735505|NCT01486316|364687679|FG000|Overall Study|Withdrawal by Subject|1|||
105735506|NCT01486316|364687680|FG001|Overall Study|Withdrawal by Subject|0|||
105735507|NCT01486316|364687681|FG002|Overall Study|Withdrawal by Subject|3|||
105735508|NCT01486316|364687682|FG003|Overall Study|Withdrawal by Subject|0|||
105735509|NCT01486316|364687679|FG000|Overall Study|Physician Decision|0|||
105735510|NCT01486316|364687680|FG001|Overall Study|Physician Decision|0|||
105735511|NCT01486316|364687681|FG002|Overall Study|Physician Decision|1|||
105735512|NCT01486316|364687682|FG003|Overall Study|Physician Decision|0|||
105735513|NCT01486316|364687679|FG000|Overall Study|Death|0|||
105735514|NCT01486316|364687680|FG001|Overall Study|Death|1|||
105735515|NCT01486316|364687681|FG002|Overall Study|Death|0|||
105735516|NCT01486316|364687682|FG003|Overall Study|Death|0|||
105735517|NCT03191396|364687685|FG000|Overall Study|Lost to Follow-up|0|||
105735518|NCT03191396|364687686|FG001|Overall Study|Lost to Follow-up|3|||
105735519|NCT03191396|364687685|FG000|Overall Study|Withdrawal by Subject|3|||
105735520|NCT03191396|364687686|FG001|Overall Study|Withdrawal by Subject|2|||
105735521|NCT02742649|364687687|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
105735522|NCT02742649|364687688|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
105735523|NCT02742649|364687689|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
105735524|NCT02742649|364687690|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
105735525|NCT02742649|364687691|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
105735526|NCT02742649|364687687|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105735527|NCT02742649|364687688|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105735528|NCT02742649|364687689|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105735529|NCT02742649|364687690|FG003|Double-Blind Treatment Period|Adverse Event|0|||
105735530|NCT02742649|364687691|FG004|Double-Blind Treatment Period|Adverse Event|0|||
105735531|NCT02742649|364687687|FG000|Open-Label Period|Lost to Follow-up|0|||
105735532|NCT02742649|364687688|FG001|Open-Label Period|Lost to Follow-up|0|||
105735533|NCT02742649|364687689|FG002|Open-Label Period|Lost to Follow-up|0|||
105735534|NCT02742649|364687690|FG003|Open-Label Period|Lost to Follow-up|0|||
105735535|NCT02742649|364687691|FG004|Open-Label Period|Lost to Follow-up|1|||
105735536|NCT01650779|364687701|FG000|Overall Study|Withdrawal by Subject|1|||
105735537|NCT00283712|364687708|FG000|Overall Study|Death|0|||
105735538|NCT00283712|364687709|FG001|Overall Study|Death|1|||
105735539|NCT00984659|364687710|FG000|2-week Run-in Period|Adverse Event|8|||
105735540|NCT00984659|364687711|FG001|2-week Run-in Period|Adverse Event|0|||
105735541|NCT00984659|364687712|FG002|2-week Run-in Period|Adverse Event|0|||
105735542|NCT00984659|364687713|FG003|2-week Run-in Period|Adverse Event|0|||
105735543|NCT00984659|364687710|FG000|2-week Run-in Period|Protocol Violation|5|||
105735544|NCT00984659|364687711|FG001|2-week Run-in Period|Protocol Violation|0|||
105735545|NCT00984659|364687712|FG002|2-week Run-in Period|Protocol Violation|0|||
105735546|NCT00984659|364687713|FG003|2-week Run-in Period|Protocol Violation|0|||
105735547|NCT00984659|364687710|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
105735548|NCT00984659|364687711|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
105938606|NCT01313676|365436701|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
105938607|NCT01313676|365436702|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
105938608|NCT01313676|365436703|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
105938609|NCT01313676|365436704|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
105938610|NCT01313676|365436701|FG000|Overall Study|Investigator Site Closed|12|||
105938611|NCT01313676|365436702|FG001|Overall Study|Investigator Site Closed|11|||
105938612|NCT01313676|365436703|FG002|Overall Study|Investigator Site Closed|15|||
105938613|NCT01313676|365436704|FG003|Overall Study|Investigator Site Closed|10|||
105938614|NCT01313676|365436701|FG000|Overall Study|Missing|1|||
105938615|NCT01313676|365436702|FG001|Overall Study|Missing|1|||
106139953|NCT01235949|366170451|FG007|Primary Phase|Withdrawal by Subject|0|||
105735549|NCT00984659|364687712|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
105735550|NCT00984659|364687713|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
105735551|NCT00984659|364687710|FG000|2-week Run-in Period|Lost to Follow-up|3|||
105735552|NCT00984659|364687711|FG001|2-week Run-in Period|Lost to Follow-up|0|||
105735553|NCT00984659|364687712|FG002|2-week Run-in Period|Lost to Follow-up|0|||
105735554|NCT00984659|364687713|FG003|2-week Run-in Period|Lost to Follow-up|0|||
105938616|NCT01313676|365436703|FG002|Overall Study|Missing|1|||
105938617|NCT01313676|365436704|FG003|Overall Study|Missing|0|||
105938618|NCT05333965|365436708|FG000|First Intervention|Adverse Event|0|||
105735555|NCT00984659|364687710|FG000|2-week Run-in Period|Physician Decision|10|||
105735556|NCT00984659|364687711|FG001|2-week Run-in Period|Physician Decision|0|||
105735557|NCT00984659|364687712|FG002|2-week Run-in Period|Physician Decision|0|||
106010379|NCT00412984|365704049|FG000|Overall Study|Other Reason|80|||
106010380|NCT00412984|365704050|FG001|Overall Study|Other Reason|92|||
106010381|NCT00412984|365704049|FG000|Overall Study|Not Reported|11|||
106010382|NCT00412984|365704050|FG001|Overall Study|Not Reported|12|||
106010383|NCT01550003|365704051|FG000|Overall Study|Adverse Event|0|||
106010384|NCT01550003|365704052|FG001|Overall Study|Adverse Event|9|||
106010385|NCT01550003|365704053|FG002|Overall Study|Adverse Event|15|||
106010386|NCT01550003|365704051|FG000|Overall Study|Lack of Efficacy|4|||
106010387|NCT01550003|365704052|FG001|Overall Study|Lack of Efficacy|11|||
106010388|NCT01550003|365704053|FG002|Overall Study|Lack of Efficacy|15|||
106010389|NCT01550003|365704051|FG000|Overall Study|Protocol Violation|0|||
106010390|NCT01550003|365704052|FG001|Overall Study|Protocol Violation|3|||
106010391|NCT01550003|365704053|FG002|Overall Study|Protocol Violation|2|||
106010392|NCT01550003|365704051|FG000|Overall Study|Lost to Follow-up|1|||
106010393|NCT01550003|365704052|FG001|Overall Study|Lost to Follow-up|4|||
106010394|NCT01550003|365704053|FG002|Overall Study|Lost to Follow-up|8|||
106010395|NCT01550003|365704051|FG000|Overall Study|Consent withdrawn|2|||
106010396|NCT01550003|365704052|FG001|Overall Study|Consent withdrawn|11|||
106010397|NCT01550003|365704053|FG002|Overall Study|Consent withdrawn|23|||
106010398|NCT01550003|365704051|FG000|Overall Study|Missing|1|||
106010399|NCT01550003|365704052|FG001|Overall Study|Missing|0|||
106010400|NCT01550003|365704053|FG002|Overall Study|Missing|2|||
106139954|NCT01235949|366170452|FG008|Primary Phase|Withdrawal by Subject|0|||
106139955|NCT01235949|366170453|FG009|Primary Phase|Withdrawal by Subject|0|||
105735558|NCT00984659|364687713|FG003|2-week Run-in Period|Physician Decision|0|||
105735559|NCT00984659|364687710|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
105735560|NCT00984659|364687711|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
105735561|NCT00984659|364687712|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
105735562|NCT00984659|364687713|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
105735563|NCT00984659|364687710|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
105735564|NCT00984659|364687711|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105735565|NCT00984659|364687712|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105735566|NCT00984659|364687713|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
105735567|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
105735568|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
105735569|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
105735570|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
105735571|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
105735572|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
105735573|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
105735574|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
105735575|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
105735576|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
105735577|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
105735578|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
105735579|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
105735580|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
105735581|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
105735582|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
105735583|NCT00984659|364687710|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105735584|NCT00984659|364687711|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
105735585|NCT00984659|364687712|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
105735586|NCT00984659|364687713|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
105735587|NCT01342640|364687715|FG000|Overall Study|Adverse Event|3|||
105735588|NCT01342640|364687715|FG000|Overall Study|Protocol Violation|16|||
105735589|NCT01342640|364687715|FG000|Overall Study|Lost to Follow-up|21|||
105735590|NCT01342640|364687715|FG000|Overall Study|Other|1|||
106139956|NCT01235949|366170454|FG010|Primary Phase|Withdrawal by Subject|0|||
106139957|NCT01235949|366170455|FG011|Primary Phase|Withdrawal by Subject|0|||
106139958|NCT01235949|366170456|FG012|Primary Phase|Withdrawal by Subject|0|||
105735591|NCT00891657|364687716|FG000|Overall Study|Withdrawal by Subject|1|||
105735592|NCT00891657|364687717|FG001|Overall Study|Withdrawal by Subject|1|||
105735593|NCT03133481|364687718|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
105735594|NCT03133481|364687719|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
105735595|NCT01050062|364687720|FG000|Overall Study|Adverse Event|75|||
105735596|NCT01050062|364687721|FG001|Overall Study|Adverse Event|22|||
106010401|NCT01550003|365704051|FG000|Overall Study|Study closure as announced by sponsor|7|||
106010402|NCT01550003|365704052|FG001|Overall Study|Study closure as announced by sponsor|6|||
106010403|NCT01550003|365704053|FG002|Overall Study|Study closure as announced by sponsor|24|||
106010404|NCT01550003|365704051|FG000|Overall Study|Protocol Noncompliance|1|||
106010405|NCT01550003|365704052|FG001|Overall Study|Protocol Noncompliance|0|||
106139959|NCT01235949|366170457|FG013|Primary Phase|Withdrawal by Subject|0|||
106139960|NCT01235949|366170458|FG014|Primary Phase|Withdrawal by Subject|0|||
106139961|NCT01235949|366170459|FG015|Primary Phase|Withdrawal by Subject|0|||
106139962|NCT01235949|366170460|FG016|Primary Phase|Withdrawal by Subject|0|||
106139963|NCT01235949|366170461|FG017|Primary Phase|Withdrawal by Subject|0|||
106139964|NCT01235949|366170444|FG000|Primary Phase|Lost to Follow-up|0|||
106139965|NCT01235949|366170445|FG001|Primary Phase|Lost to Follow-up|0|||
106139966|NCT01235949|366170446|FG002|Primary Phase|Lost to Follow-up|1|||
106139967|NCT01235949|366170447|FG003|Primary Phase|Lost to Follow-up|1|||
106139968|NCT01235949|366170448|FG004|Primary Phase|Lost to Follow-up|0|||
106139969|NCT01235949|366170449|FG005|Primary Phase|Lost to Follow-up|2|||
106139970|NCT01235949|366170450|FG006|Primary Phase|Lost to Follow-up|0|||
106139971|NCT01235949|366170451|FG007|Primary Phase|Lost to Follow-up|0|||
106139972|NCT01235949|366170452|FG008|Primary Phase|Lost to Follow-up|0|||
106139973|NCT01235949|366170453|FG009|Primary Phase|Lost to Follow-up|0|||
106139974|NCT01235949|366170454|FG010|Primary Phase|Lost to Follow-up|0|||
106139975|NCT01235949|366170455|FG011|Primary Phase|Lost to Follow-up|0|||
106139976|NCT01235949|366170456|FG012|Primary Phase|Lost to Follow-up|0|||
106139977|NCT01235949|366170457|FG013|Primary Phase|Lost to Follow-up|0|||
106139978|NCT01235949|366170458|FG014|Primary Phase|Lost to Follow-up|0|||
106139979|NCT01235949|366170459|FG015|Primary Phase|Lost to Follow-up|0|||
106139980|NCT01235949|366170460|FG016|Primary Phase|Lost to Follow-up|0|||
106139981|NCT01235949|366170461|FG017|Primary Phase|Lost to Follow-up|0|||
106139982|NCT01235949|366170444|FG000|Booster Phase|Migrated/moved from study area|0|||
106139983|NCT01235949|366170445|FG001|Booster Phase|Migrated/moved from study area|0|||
106139984|NCT01235949|366170446|FG002|Booster Phase|Migrated/moved from study area|0|||
106139985|NCT01235949|366170447|FG003|Booster Phase|Migrated/moved from study area|0|||
106139986|NCT01235949|366170448|FG004|Booster Phase|Migrated/moved from study area|0|||
106139987|NCT01235949|366170449|FG005|Booster Phase|Migrated/moved from study area|0|||
106139988|NCT01235949|366170450|FG006|Booster Phase|Migrated/moved from study area|0|||
106139989|NCT01235949|366170451|FG007|Booster Phase|Migrated/moved from study area|0|||
106139990|NCT01235949|366170452|FG008|Booster Phase|Migrated/moved from study area|0|||
106139991|NCT01235949|366170453|FG009|Booster Phase|Migrated/moved from study area|0|||
106139992|NCT01235949|366170454|FG010|Booster Phase|Migrated/moved from study area|0|||
106139993|NCT01235949|366170455|FG011|Booster Phase|Migrated/moved from study area|1|||
106139994|NCT01235949|366170456|FG012|Booster Phase|Migrated/moved from study area|1|||
106139995|NCT01235949|366170457|FG013|Booster Phase|Migrated/moved from study area|0|||
106139996|NCT01235949|366170458|FG014|Booster Phase|Migrated/moved from study area|0|||
106139997|NCT01235949|366170459|FG015|Booster Phase|Migrated/moved from study area|0|||
106139998|NCT01235949|366170460|FG016|Booster Phase|Migrated/moved from study area|0|||
106139999|NCT01235949|366170461|FG017|Booster Phase|Migrated/moved from study area|1|||
106140000|NCT01235949|366170444|FG000|Booster Phase|Adverse Event|0|||
106140001|NCT01235949|366170445|FG001|Booster Phase|Adverse Event|0|||
106140002|NCT01235949|366170446|FG002|Booster Phase|Adverse Event|0|||
106140003|NCT01235949|366170447|FG003|Booster Phase|Adverse Event|0|||
106140004|NCT01235949|366170448|FG004|Booster Phase|Adverse Event|0|||
106140005|NCT01235949|366170449|FG005|Booster Phase|Adverse Event|0|||
106140006|NCT01235949|366170450|FG006|Booster Phase|Adverse Event|0|||
106140007|NCT01235949|366170451|FG007|Booster Phase|Adverse Event|0|||
106140008|NCT01235949|366170452|FG008|Booster Phase|Adverse Event|0|||
106140009|NCT01235949|366170453|FG009|Booster Phase|Adverse Event|0|||
106140010|NCT01235949|366170454|FG010|Booster Phase|Adverse Event|0|||
106140011|NCT01235949|366170455|FG011|Booster Phase|Adverse Event|0|||
106140012|NCT01235949|366170456|FG012|Booster Phase|Adverse Event|0|||
105735597|NCT01050062|364687720|FG000|Overall Study|Lost to Follow-up|83|||
105735598|NCT01050062|364687721|FG001|Overall Study|Lost to Follow-up|35|||
105735599|NCT01050062|364687720|FG000|Overall Study|Lack of Efficacy|22|||
105735600|NCT01050062|364687721|FG001|Overall Study|Lack of Efficacy|35|||
105735601|NCT01050062|364687720|FG000|Overall Study|Physician Decision|74|||
105735602|NCT01050062|364687721|FG001|Overall Study|Physician Decision|9|||
105735603|NCT01050062|364687720|FG000|Overall Study|Others|17|||
105735604|NCT01050062|364687721|FG001|Overall Study|Others|11|||
105735605|NCT03894540|364687726|FG000|Overall Study|Adverse Event|0|||
105735606|NCT03894540|364687727|FG001|Overall Study|Adverse Event|0|||
105938619|NCT05333965|365436709|FG001|First Intervention|Adverse Event|1|||
106140013|NCT01235949|366170457|FG013|Booster Phase|Adverse Event|0|||
106140014|NCT01235949|366170458|FG014|Booster Phase|Adverse Event|0|||
106140015|NCT01235949|366170459|FG015|Booster Phase|Adverse Event|1|||
105735607|NCT03894540|364687728|FG002|Overall Study|Adverse Event|0|||
106140016|NCT01235949|366170460|FG016|Booster Phase|Adverse Event|0|||
106140017|NCT01235949|366170461|FG017|Booster Phase|Adverse Event|0|||
106140018|NCT01235949|366170444|FG000|Booster Phase|Withdrawal by Subject|0|||
106140019|NCT01235949|366170445|FG001|Booster Phase|Withdrawal by Subject|0|||
105799152|NCT01169844|364922696|FG000|Overall Study|Adverse Event|0|||
106140020|NCT01235949|366170446|FG002|Booster Phase|Withdrawal by Subject|0|||
106140021|NCT01235949|366170447|FG003|Booster Phase|Withdrawal by Subject|0|||
105735608|NCT03894540|364687729|FG003|Overall Study|Adverse Event|0|||
105735609|NCT03894540|364687730|FG004|Overall Study|Adverse Event|1|||
105735610|NCT03894540|364687731|FG005|Overall Study|Adverse Event|0|||
106140022|NCT01235949|366170448|FG004|Booster Phase|Withdrawal by Subject|0|||
106140023|NCT01235949|366170449|FG005|Booster Phase|Withdrawal by Subject|0|||
105735611|NCT03894540|364687726|FG000|Overall Study|Withdrawal by Subject|0|||
106140024|NCT01235949|366170450|FG006|Booster Phase|Withdrawal by Subject|0|||
106140025|NCT01235949|366170451|FG007|Booster Phase|Withdrawal by Subject|1|||
106140026|NCT01235949|366170452|FG008|Booster Phase|Withdrawal by Subject|1|||
106140027|NCT01235949|366170453|FG009|Booster Phase|Withdrawal by Subject|0|||
106140028|NCT01235949|366170454|FG010|Booster Phase|Withdrawal by Subject|1|||
106140029|NCT01235949|366170455|FG011|Booster Phase|Withdrawal by Subject|1|||
106140030|NCT01235949|366170456|FG012|Booster Phase|Withdrawal by Subject|2|||
106140031|NCT01235949|366170457|FG013|Booster Phase|Withdrawal by Subject|0|||
106140032|NCT01235949|366170458|FG014|Booster Phase|Withdrawal by Subject|2|||
106140033|NCT01235949|366170459|FG015|Booster Phase|Withdrawal by Subject|0|||
106140034|NCT01235949|366170460|FG016|Booster Phase|Withdrawal by Subject|0|||
106140035|NCT01235949|366170461|FG017|Booster Phase|Withdrawal by Subject|0|||
106140036|NCT01235949|366170444|FG000|Booster Phase|Lost to Follow-up|0|||
106140037|NCT01235949|366170445|FG001|Booster Phase|Lost to Follow-up|0|||
106140038|NCT01235949|366170446|FG002|Booster Phase|Lost to Follow-up|0|||
106140039|NCT01235949|366170447|FG003|Booster Phase|Lost to Follow-up|0|||
106140040|NCT01235949|366170448|FG004|Booster Phase|Lost to Follow-up|0|||
106140041|NCT01235949|366170449|FG005|Booster Phase|Lost to Follow-up|0|||
106140042|NCT01235949|366170450|FG006|Booster Phase|Lost to Follow-up|0|||
106140043|NCT01235949|366170451|FG007|Booster Phase|Lost to Follow-up|0|||
106140044|NCT01235949|366170452|FG008|Booster Phase|Lost to Follow-up|1|||
106140045|NCT01235949|366170453|FG009|Booster Phase|Lost to Follow-up|1|||
106140046|NCT01235949|366170454|FG010|Booster Phase|Lost to Follow-up|1|||
106140047|NCT01235949|366170455|FG011|Booster Phase|Lost to Follow-up|1|||
106140048|NCT01235949|366170456|FG012|Booster Phase|Lost to Follow-up|0|||
105735612|NCT03894540|364687727|FG001|Overall Study|Withdrawal by Subject|0|||
105735613|NCT03894540|364687728|FG002|Overall Study|Withdrawal by Subject|0|||
105735614|NCT03894540|364687729|FG003|Overall Study|Withdrawal by Subject|0|||
105735615|NCT03894540|364687730|FG004|Overall Study|Withdrawal by Subject|1|||
105735616|NCT03894540|364687731|FG005|Overall Study|Withdrawal by Subject|0|||
105735617|NCT03894540|364687726|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
105735618|NCT03894540|364687727|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
105735619|NCT03894540|364687728|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
105735620|NCT03894540|364687729|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
105735621|NCT03894540|364687730|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
105735622|NCT03894540|364687731|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
105735623|NCT03894540|364687726|FG000|Overall Study|Progressive Disease Clinical|1|||
105735624|NCT03894540|364687727|FG001|Overall Study|Progressive Disease Clinical|1|||
105735625|NCT03894540|364687728|FG002|Overall Study|Progressive Disease Clinical|0|||
105735626|NCT03894540|364687729|FG003|Overall Study|Progressive Disease Clinical|1|||
105735627|NCT03894540|364687730|FG004|Overall Study|Progressive Disease Clinical|5|||
105735628|NCT03894540|364687731|FG005|Overall Study|Progressive Disease Clinical|1|||
105735629|NCT03894540|364687726|FG000|Overall Study|Study termination by sponsor|0|||
105735630|NCT03894540|364687727|FG001|Overall Study|Study termination by sponsor|0|||
105735631|NCT03894540|364687728|FG002|Overall Study|Study termination by sponsor|0|||
105735632|NCT03894540|364687729|FG003|Overall Study|Study termination by sponsor|0|||
105735633|NCT03894540|364687730|FG004|Overall Study|Study termination by sponsor|2|||
105735634|NCT03894540|364687731|FG005|Overall Study|Study termination by sponsor|0|||
105735635|NCT00537823|364687732|FG000|Overall Study|Adverse Event|2|||
105735636|NCT00537823|364687733|FG001|Overall Study|Adverse Event|0|||
105735637|NCT01184989|364687738|FG000|Overall Study|Adverse Event|11|||
105735638|NCT01184989|364687738|FG000|Overall Study|Withdrawal by Subject|1|||
105735639|NCT02927171|364687739|FG000|Overall Study|Lost to Follow-up|0|||
105735640|NCT02927171|364687740|FG001|Overall Study|Lost to Follow-up|1|||
105735641|NCT01570491|364687743|FG000|Overall Study|Lost to Follow-up|3|||
105735642|NCT01570491|364687744|FG001|Overall Study|Lost to Follow-up|1|||
106140049|NCT01235949|366170457|FG013|Booster Phase|Lost to Follow-up|0|||
106140050|NCT01235949|366170458|FG014|Booster Phase|Lost to Follow-up|0|||
105735643|NCT01570491|364687743|FG000|Overall Study|treatment: not given or discontinued|2|||
105735644|NCT01570491|364687744|FG001|Overall Study|treatment: not given or discontinued|0|||
105735645|NCT02240628|364687747|FG000|Overall Study|Physician Decision|6|||
105735646|NCT02240628|364687748|FG001|Overall Study|Physician Decision|5|||
105735647|NCT02717546|364687749|FG000|Overall Study|Lost to Follow-up|12|||
106140051|NCT01235949|366170459|FG015|Booster Phase|Lost to Follow-up|0|||
106140052|NCT01235949|366170460|FG016|Booster Phase|Lost to Follow-up|0|||
106140053|NCT01235949|366170461|FG017|Booster Phase|Lost to Follow-up|1|||
106140054|NCT00754936|366170462|FG000|Overall Study|Lost to Follow-up|3|||
106140055|NCT00754936|366170462|FG000|Overall Study|Physician Decision|1|||
106140056|NCT00754936|366170462|FG000|Overall Study|Withdrawal by Subject|2|||
106140057|NCT00754936|366170462|FG000|Overall Study|Side Effects|3|||
105735648|NCT00850499|364687751|FG000|Overall Study|Adverse Event|3|||
105735649|NCT00850499|364687752|FG001|Overall Study|Adverse Event|1|||
105735650|NCT00850499|364687751|FG000|Overall Study|Lack of Efficacy|0|||
105735651|NCT00850499|364687752|FG001|Overall Study|Lack of Efficacy|1|||
105735652|NCT04498910|364687753|FG000|Overall Study|Lost to Follow-up|0|||
105735653|NCT04498910|364687754|FG001|Overall Study|Lost to Follow-up|1|||
105735654|NCT04498910|364687753|FG000|Overall Study|Withdrawal by Subject|2|||
105735655|NCT04498910|364687754|FG001|Overall Study|Withdrawal by Subject|1|||
105735656|NCT04498910|364687753|FG000|Overall Study|Adverse Event|1|||
105735657|NCT04498910|364687754|FG001|Overall Study|Adverse Event|0|||
105735658|NCT01849848|364687755|FG000|Overall Study|Physician Decision|1|||
105735659|NCT01849848|364687755|FG000|Overall Study|Progression of the primary disease|3|||
105735660|NCT01873742|364687763|FG000|Overall Study|Lost to Follow-up|68|||
105735661|NCT01873742|364687764|FG001|Overall Study|Lost to Follow-up|76|||
105735662|NCT01478347|364687769|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
105735663|NCT01478347|364687769|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
105735664|NCT01478347|364687769|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
105735665|NCT02760407|364687770|FG000|Overall Study|Death|2|||
105735666|NCT02760407|364687771|FG001|Overall Study|Death|3|||
105735667|NCT02760407|364687772|FG002|Overall Study|Death|1|||
105735668|NCT02760407|364687773|FG003|Overall Study|Death|1|||
105735669|NCT02760407|364687770|FG000|Overall Study|Lost to Follow-up|1|||
105735670|NCT02760407|364687771|FG001|Overall Study|Lost to Follow-up|7|||
105735671|NCT02760407|364687772|FG002|Overall Study|Lost to Follow-up|4|||
105735672|NCT02760407|364687773|FG003|Overall Study|Lost to Follow-up|6|||
105735673|NCT02760407|364687770|FG000|Overall Study|Withdrawal by Subject|25|||
105735674|NCT02760407|364687771|FG001|Overall Study|Withdrawal by Subject|31|||
105735675|NCT02760407|364687772|FG002|Overall Study|Withdrawal by Subject|37|||
105735676|NCT02760407|364687773|FG003|Overall Study|Withdrawal by Subject|25|||
105735677|NCT02760407|364687770|FG000|Overall Study|Violation of Eligibility criteria|0|||
105735678|NCT02760407|364687771|FG001|Overall Study|Violation of Eligibility criteria|0|||
105735679|NCT02760407|364687772|FG002|Overall Study|Violation of Eligibility criteria|1|||
105735680|NCT02760407|364687773|FG003|Overall Study|Violation of Eligibility criteria|1|||
105735681|NCT02760407|364687770|FG000|Overall Study|Personal reasons|0|||
105735682|NCT02760407|364687771|FG001|Overall Study|Personal reasons|0|||
105735683|NCT02760407|364687772|FG002|Overall Study|Personal reasons|0|||
105735684|NCT02760407|364687773|FG003|Overall Study|Personal reasons|1|||
105735685|NCT02760407|364687770|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
105735686|NCT02760407|364687771|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
105735687|NCT02760407|364687772|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
105735688|NCT02760407|364687773|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
105735689|NCT02760407|364687770|FG000|Overall Study|Use of prohibited Medication|0|||
105735690|NCT02760407|364687771|FG001|Overall Study|Use of prohibited Medication|0|||
105735691|NCT02760407|364687772|FG002|Overall Study|Use of prohibited Medication|1|||
105735692|NCT02760407|364687773|FG003|Overall Study|Use of prohibited Medication|0|||
105735693|NCT02760407|364687770|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
105735694|NCT02760407|364687771|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
105735695|NCT02760407|364687772|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
105735696|NCT02760407|364687773|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
105735697|NCT02760407|364687770|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
105735698|NCT02760407|364687771|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
105735699|NCT02760407|364687772|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
105735700|NCT02760407|364687773|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
105735701|NCT02760407|364687770|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
105735702|NCT02760407|364687771|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
105735703|NCT02760407|364687772|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
105735704|NCT02760407|364687773|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
105735705|NCT02760407|364687770|FG000|Overall Study|Inadequately Enrolled|0|||
105735706|NCT02760407|364687771|FG001|Overall Study|Inadequately Enrolled|0|||
105735707|NCT02760407|364687772|FG002|Overall Study|Inadequately Enrolled|0|||
105735708|NCT02760407|364687773|FG003|Overall Study|Inadequately Enrolled|1|||
105735709|NCT02760407|364687770|FG000|Overall Study|Withdrawal By PI's Decision|0|||
105735710|NCT02760407|364687771|FG001|Overall Study|Withdrawal By PI's Decision|1|||
105735711|NCT02760407|364687772|FG002|Overall Study|Withdrawal By PI's Decision|0|||
105735712|NCT02760407|364687773|FG003|Overall Study|Withdrawal By PI's Decision|0|||
105799153|NCT01169844|364922697|FG001|Overall Study|Adverse Event|1|||
105799154|NCT01169844|364922696|FG000|Overall Study|Patient withdrew consent|4|||
105799155|NCT01169844|364922697|FG001|Overall Study|Patient withdrew consent|0|||
105799156|NCT01169844|364922696|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105735713|NCT02760407|364687770|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
105735714|NCT02760407|364687771|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
105735715|NCT02760407|364687772|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
105735716|NCT02760407|364687773|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
105735717|NCT02760407|364687770|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
105735718|NCT02760407|364687771|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
105735719|NCT02760407|364687772|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
105735720|NCT02760407|364687773|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
105735721|NCT02760407|364687770|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
105735722|NCT02760407|364687771|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
105735723|NCT02760407|364687772|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
105735724|NCT02760407|364687773|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
105735725|NCT02760407|364687770|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
105735726|NCT02760407|364687771|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
105735727|NCT02760407|364687772|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
105735728|NCT02760407|364687773|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
105735729|NCT02760407|364687770|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
105735730|NCT02760407|364687771|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
105735731|NCT02760407|364687772|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
105735732|NCT02760407|364687773|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
105735733|NCT02760407|364687770|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
105735734|NCT02760407|364687771|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
105735735|NCT02760407|364687772|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
105735736|NCT02760407|364687773|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
105735737|NCT02760407|364687770|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
105735738|NCT02760407|364687771|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
105735739|NCT02760407|364687772|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
105735740|NCT02760407|364687773|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
105735741|NCT02760407|364687770|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
105735742|NCT02760407|364687771|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
105735743|NCT02760407|364687772|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
105735744|NCT02760407|364687773|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
105735745|NCT02760407|364687770|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
105735746|NCT02760407|364687771|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
105938620|NCT05333965|365436708|FG000|First Intervention|Withdrawal by Subject|0|||
105938621|NCT05333965|365436709|FG001|First Intervention|Withdrawal by Subject|1|||
105938622|NCT01500135|365436712|FG000|Overall Study|Withdrawal of Consent|4|||
105938623|NCT01500135|365436713|FG001|Overall Study|Withdrawal of Consent|0|||
105938624|NCT01500135|365436712|FG000|Overall Study|Lost to Follow-up|6|||
105938625|NCT01500135|365436713|FG001|Overall Study|Lost to Follow-up|4|||
105938626|NCT01500135|365436712|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
105938627|NCT01500135|365436713|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
105938628|NCT01500135|365436712|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
105938629|NCT01500135|365436713|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
105938630|NCT01500135|365436712|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
105938631|NCT01500135|365436713|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
105938632|NCT01500135|365436712|FG000|Overall Study|Participant was a Safety Concern|1|||
105938633|NCT01500135|365436713|FG001|Overall Study|Participant was a Safety Concern|0|||
105938634|NCT01500135|365436712|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
105938635|NCT01500135|365436713|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
105938636|NCT02872142|365436717|FG000|Overall Study|Adverse Event|2|||
105938637|NCT02872142|365436717|FG000|Overall Study|Death|1|||
105938638|NCT02872142|365436717|FG000|Overall Study|Participant Decision|3|||
105938639|NCT04893811|365436724|FG000|Vaccination Phase|Death|1|||
105938640|NCT04893811|365436725|FG001|Vaccination Phase|Death|0|||
105938641|NCT04893811|365436724|FG000|Vaccination Phase|Lost to Follow-up|1|||
105938642|NCT04893811|365436725|FG001|Vaccination Phase|Lost to Follow-up|1|||
105938643|NCT04893811|365436724|FG000|Vaccination Phase|Protocol Violation|2|||
105938644|NCT04893811|365436725|FG001|Vaccination Phase|Protocol Violation|0|||
105938645|NCT04893811|365436724|FG000|Vaccination Phase|Withdrawal by Subject|2|||
105938646|NCT04893811|365436725|FG001|Vaccination Phase|Withdrawal by Subject|1|||
105938647|NCT04893811|365436724|FG000|Vaccination Phase|Other|0|||
105938648|NCT04893811|365436725|FG001|Vaccination Phase|Other|1|||
106140058|NCT00754936|366170462|FG000|Overall Study|Inter-current medical events|3|||
106140059|NCT00436644|366170463|FG000|Overall Study|Adverse Event|2|||
106140060|NCT00436644|366170463|FG000|Overall Study|Death|1|||
105735747|NCT02760407|364687772|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
105735748|NCT02760407|364687773|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
105735749|NCT01645930|364687774|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
105938649|NCT04893811|365436724|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
105938650|NCT04893811|365436725|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
105938651|NCT04893811|365436724|FG000|Follow-up Phase|Lost to Follow-up|0|||
105938652|NCT04893811|365436725|FG001|Follow-up Phase|Lost to Follow-up|1|||
105938653|NCT04204902|365436726|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
105938654|NCT04204902|365436727|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
105938655|NCT03180138|365436728|FG000|Overall Study|Mobile-phone could not be verified|2|||
105938656|NCT03180138|365436729|FG001|Overall Study|Mobile-phone could not be verified|13|||
105938657|NCT03180138|365436730|FG002|Overall Study|Mobile-phone could not be verified|15|||
105735750|NCT01645930|364687774|FG000|Overall Study|Progressive Disease|12|||
105735751|NCT01645930|364687774|FG000|Overall Study|Adverse Event|4|||
105735752|NCT01645930|364687774|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
105735753|NCT01645930|364687774|FG000|Overall Study|Withdrawal by Participant|2|||
105735754|NCT01645930|364687774|FG000|Overall Study|Reason not Defined|1|||
105735755|NCT01748760|364687775|FG000|Overall Study|Withdrawal by Subject|1|||
105735756|NCT01748760|364687776|FG001|Overall Study|Withdrawal by Subject|1|||
105735757|NCT01748760|364687775|FG000|Overall Study|Lost to Follow-up|5|||
105735758|NCT01748760|364687776|FG001|Overall Study|Lost to Follow-up|1|||
105735759|NCT03245814|364687777|FG000|Overall Study|Lost to Follow-up|5|||
105735760|NCT03245814|364687778|FG001|Overall Study|Lost to Follow-up|8|||
105735761|NCT03245814|364687777|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
105735762|NCT03245814|364687778|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
105735763|NCT01096667|364687779|FG000|Overall Study|Lost to Follow-up|1|||
105735764|NCT01096667|364687780|FG001|Overall Study|Lost to Follow-up|1|||
105735765|NCT01096667|364687781|FG002|Overall Study|Lost to Follow-up|1|||
105735766|NCT01096667|364687782|FG003|Overall Study|Lost to Follow-up|0|||
105735767|NCT01096667|364687783|FG004|Overall Study|Lost to Follow-up|0|||
105735768|NCT01096667|364687779|FG000|Overall Study|Withdrawal by Subject|1|||
105735769|NCT01096667|364687780|FG001|Overall Study|Withdrawal by Subject|0|||
105735770|NCT01096667|364687781|FG002|Overall Study|Withdrawal by Subject|0|||
105735771|NCT01096667|364687782|FG003|Overall Study|Withdrawal by Subject|1|||
105735772|NCT01096667|364687783|FG004|Overall Study|Withdrawal by Subject|0|||
105735773|NCT01096667|364687779|FG000|Overall Study|Reason not available|0|||
105735774|NCT01096667|364687780|FG001|Overall Study|Reason not available|1|||
105735775|NCT01096667|364687781|FG002|Overall Study|Reason not available|1|||
105735776|NCT01096667|364687782|FG003|Overall Study|Reason not available|1|||
105735777|NCT01096667|364687783|FG004|Overall Study|Reason not available|0|||
105735778|NCT01096667|364687779|FG000|Overall Study|Protocol Violation|0|||
105735779|NCT01096667|364687780|FG001|Overall Study|Protocol Violation|0|||
105735780|NCT01096667|364687781|FG002|Overall Study|Protocol Violation|0|||
105735781|NCT01096667|364687782|FG003|Overall Study|Protocol Violation|1|||
105735782|NCT01096667|364687783|FG004|Overall Study|Protocol Violation|0|||
105735783|NCT01096667|364687779|FG000|Overall Study|Not treated|1|||
105938658|NCT03180138|365436728|FG000|Overall Study|No prior immunization records|17|||
105938659|NCT03180138|365436729|FG001|Overall Study|No prior immunization records|0|||
105938660|NCT03180138|365436730|FG002|Overall Study|No prior immunization records|6|||
105938661|NCT03180138|365436728|FG000|Overall Study|Found to be >24 mon after randomization|3|||
105938662|NCT03180138|365436729|FG001|Overall Study|Found to be >24 mon after randomization|0|||
105735784|NCT01096667|364687780|FG001|Overall Study|Not treated|0|||
105735785|NCT01096667|364687781|FG002|Overall Study|Not treated|0|||
105735786|NCT01096667|364687782|FG003|Overall Study|Not treated|0|||
105735787|NCT01096667|364687783|FG004|Overall Study|Not treated|0|||
105735788|NCT00306891|364687784|FG000|Part A|Withdrawal by Subject|1|||
105735789|NCT00306891|364687785|FG001|Part A|Withdrawal by Subject|1|||
106140061|NCT00619645|366170464|FG000|Overall Study|Adverse Event|1|||
106140062|NCT04364269|366170466|FG000|Overall Study|Adverse Event|1|||
105735790|NCT00306891|364687786|FG002|Part A|Withdrawal by Subject|0|||
105735791|NCT00306891|364687787|FG003|Part A|Withdrawal by Subject|0|||
105938663|NCT03180138|365436730|FG002|Overall Study|Found to be >24 mon after randomization|3|||
105938664|NCT01714063|365436731|FG000|Overall Study|Equipment malfunction|2|||
105938665|NCT02852005|365436736|FG000|Overall Study|Lost to Follow-up|0|||
106140063|NCT04364269|366170467|FG001|Overall Study|Adverse Event|0|||
105735792|NCT00306891|364687784|FG000|Part A|Condition under investigation worsened|2|||
105735793|NCT00306891|364687785|FG001|Part A|Condition under investigation worsened|2|||
105735794|NCT00306891|364687786|FG002|Part A|Condition under investigation worsened|0|||
105735795|NCT00306891|364687787|FG003|Part A|Condition under investigation worsened|0|||
105735796|NCT00306891|364687784|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
105735797|NCT00306891|364687785|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
106140064|NCT04364269|366170468|FG002|Overall Study|Adverse Event|0|||
105938666|NCT02852005|365436737|FG001|Overall Study|Lost to Follow-up|0|||
105938667|NCT02852005|365436738|FG002|Overall Study|Lost to Follow-up|0|||
105938668|NCT02852005|365436739|FG003|Overall Study|Lost to Follow-up|0|||
105938669|NCT02852005|365436740|FG004|Overall Study|Lost to Follow-up|1|||
105938670|NCT02852005|365436736|FG000|Overall Study|Withdrawal by Subject|1|||
105938671|NCT02852005|365436737|FG001|Overall Study|Withdrawal by Subject|0|||
105735798|NCT00306891|364687786|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
105735799|NCT00306891|364687787|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
105735800|NCT00306891|364687784|FG000|Part A|Partial bowel obstruction|1|||
105735801|NCT00306891|364687785|FG001|Part A|Partial bowel obstruction|0|||
105735802|NCT00306891|364687786|FG002|Part A|Partial bowel obstruction|0|||
105735803|NCT00306891|364687787|FG003|Part A|Partial bowel obstruction|0|||
105735804|NCT00306891|364687784|FG000|Part A|Reaccumul. of ascites following drainage|0|||
105735805|NCT00306891|364687785|FG001|Part A|Reaccumul. of ascites following drainage|1|||
105735806|NCT00306891|364687786|FG002|Part A|Reaccumul. of ascites following drainage|0|||
105735807|NCT00306891|364687787|FG003|Part A|Reaccumul. of ascites following drainage|0|||
105735808|NCT00306891|364687784|FG000|Part A|Suspicion of second malignancy|0|||
105735809|NCT00306891|364687785|FG001|Part A|Suspicion of second malignancy|1|||
105735810|NCT00306891|364687786|FG002|Part A|Suspicion of second malignancy|0|||
105735811|NCT00306891|364687787|FG003|Part A|Suspicion of second malignancy|0|||
105735812|NCT00306891|364687784|FG000|Part A|QTC interval outwith elig. criteria|1|||
105735813|NCT00306891|364687785|FG001|Part A|QTC interval outwith elig. criteria|0|||
105735814|NCT00306891|364687786|FG002|Part A|QTC interval outwith elig. criteria|0|||
105735815|NCT00306891|364687787|FG003|Part A|QTC interval outwith elig. criteria|0|||
105735816|NCT00306891|364687784|FG000|Part B|Death|0|||
105735817|NCT00306891|364687785|FG001|Part B|Death|0|||
105735818|NCT00306891|364687786|FG002|Part B|Death|1|||
105735819|NCT00306891|364687787|FG003|Part B|Death|2|||
105735820|NCT00306891|364687784|FG000|Part B|Adverse Event|0|||
105735821|NCT00306891|364687785|FG001|Part B|Adverse Event|0|||
105735822|NCT00306891|364687786|FG002|Part B|Adverse Event|5|||
105735823|NCT00306891|364687787|FG003|Part B|Adverse Event|5|||
105735824|NCT00306891|364687784|FG000|Part B|Withdrawal by Subject|0|||
105735825|NCT00306891|364687785|FG001|Part B|Withdrawal by Subject|0|||
105735826|NCT00306891|364687786|FG002|Part B|Withdrawal by Subject|3|||
105735827|NCT00306891|364687787|FG003|Part B|Withdrawal by Subject|1|||
105735828|NCT00306891|364687784|FG000|Part B|Condition under investigation worsened|0|||
105735829|NCT00306891|364687785|FG001|Part B|Condition under investigation worsened|0|||
105735830|NCT00306891|364687786|FG002|Part B|Condition under investigation worsened|2|||
105735831|NCT00306891|364687787|FG003|Part B|Condition under investigation worsened|8|||
105735832|NCT00306891|364687784|FG000|Part B|Development of study specific disc crit.|0|||
105735833|NCT00306891|364687785|FG001|Part B|Development of study specific disc crit.|0|||
105735834|NCT00306891|364687786|FG002|Part B|Development of study specific disc crit.|0|||
105735835|NCT00306891|364687787|FG003|Part B|Development of study specific disc crit.|1|||
105735836|NCT00673673|364687788|FG000|Overall Study|Progressive disease|27|||
105735837|NCT00673673|364687788|FG000|Overall Study|Adverse Event|4|||
105735838|NCT00673673|364687788|FG000|Overall Study|Withdrawal by Subject|3|||
105735839|NCT00673673|364687788|FG000|Overall Study|Investigators' discretion|2|||
105735840|NCT02263365|364687789|FG000|Overall Study|Physician Decision|22|||
105735841|NCT02263365|364687790|FG001|Overall Study|Physician Decision|18|||
105735842|NCT04542291|364687794|FG000|Overall Study|Adverse Event|1|||
105735843|NCT04542291|364687794|FG000|Overall Study|Physician Decision|2|||
105735844|NCT04538950|364687795|FG000|Overall Study|Pulmonary Issues|2|||
105735845|NCT04538950|364687795|FG000|Overall Study|illness|2|||
105735846|NCT02795156|364687801|FG000|Overall Study|Progressive Disease|22|||
105735847|NCT02795156|364687802|FG001|Overall Study|Progressive Disease|7|||
105735848|NCT02795156|364687803|FG002|Overall Study|Progressive Disease|34|||
105735849|NCT02795156|364687804|FG003|Overall Study|Progressive Disease|7|||
105735850|NCT02795156|364687801|FG000|Overall Study|Adverse Event|13|||
105735851|NCT02795156|364687802|FG001|Overall Study|Adverse Event|2|||
105735852|NCT02795156|364687803|FG002|Overall Study|Adverse Event|3|||
105735853|NCT02795156|364687804|FG003|Overall Study|Adverse Event|2|||
105735854|NCT02795156|364687801|FG000|Overall Study|Death|1|||
105938672|NCT02852005|365436738|FG002|Overall Study|Withdrawal by Subject|0|||
105938673|NCT02852005|365436739|FG003|Overall Study|Withdrawal by Subject|0|||
105735855|NCT02795156|364687802|FG001|Overall Study|Death|1|||
105735856|NCT02795156|364687803|FG002|Overall Study|Death|1|||
105735857|NCT02795156|364687804|FG003|Overall Study|Death|0|||
105735858|NCT02795156|364687801|FG000|Overall Study|Physician Decision|1|||
105735859|NCT02795156|364687802|FG001|Overall Study|Physician Decision|0|||
105735860|NCT02795156|364687803|FG002|Overall Study|Physician Decision|1|||
105735861|NCT02795156|364687804|FG003|Overall Study|Physician Decision|0|||
105735862|NCT02795156|364687801|FG000|Overall Study|Withdrawal by Subject|2|||
105799157|NCT01169844|364922697|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105735863|NCT02795156|364687802|FG001|Overall Study|Withdrawal by Subject|0|||
105735864|NCT02795156|364687803|FG002|Overall Study|Withdrawal by Subject|3|||
105735865|NCT02795156|364687804|FG003|Overall Study|Withdrawal by Subject|0|||
105938674|NCT02852005|365436740|FG004|Overall Study|Withdrawal by Subject|0|||
106010406|NCT01550003|365704053|FG002|Overall Study|Protocol Noncompliance|0|||
106010407|NCT01550003|365704051|FG000|Overall Study|Study closure|0|||
106010408|NCT01550003|365704052|FG001|Overall Study|Study closure|1|||
106010409|NCT01550003|365704053|FG002|Overall Study|Study closure|1|||
106010410|NCT01550003|365704051|FG000|Overall Study|Patient reached adulthood|0|||
106010411|NCT01550003|365704052|FG001|Overall Study|Patient reached adulthood|1|||
105735866|NCT00469014|364687805|FG000|Initial Phase Randomization|Disease Progression|0|||
105735867|NCT00469014|364687806|FG001|Initial Phase Randomization|Disease Progression|1|||
105735868|NCT00469014|364687807|FG002|Initial Phase Randomization|Disease Progression|1|||
105735869|NCT00469014|364687808|FG003|Initial Phase Randomization|Disease Progression|0|||
105735870|NCT00469014|364687805|FG000|Initial Phase Randomization|No Response|1|||
105735871|NCT00469014|364687806|FG001|Initial Phase Randomization|No Response|0|||
105735872|NCT00469014|364687807|FG002|Initial Phase Randomization|No Response|0|||
105735873|NCT00469014|364687808|FG003|Initial Phase Randomization|No Response|1|||
105735874|NCT00469014|364687805|FG000|Adaptive Randomization|Not Evaluable|1|||
105735875|NCT00469014|364687806|FG001|Adaptive Randomization|Not Evaluable|0|||
105735876|NCT00469014|364687807|FG002|Adaptive Randomization|Not Evaluable|0|||
105735877|NCT00469014|364687808|FG003|Adaptive Randomization|Not Evaluable|1|||
105735878|NCT00469014|364687805|FG000|Adaptive Randomization|No Response|0|||
105735879|NCT00469014|364687806|FG001|Adaptive Randomization|No Response|1|||
105735880|NCT00469014|364687807|FG002|Adaptive Randomization|No Response|0|||
105735881|NCT00469014|364687808|FG003|Adaptive Randomization|No Response|0|||
105735882|NCT00469014|364687805|FG000|Adaptive Randomization|Death|0|||
105735883|NCT00469014|364687806|FG001|Adaptive Randomization|Death|0|||
105735884|NCT00469014|364687807|FG002|Adaptive Randomization|Death|1|||
105735885|NCT00469014|364687808|FG003|Adaptive Randomization|Death|0|||
105735886|NCT03825042|364689539|FG000|Overall Study|Adverse Event|1|||
105735887|NCT03825042|364689540|FG001|Overall Study|Adverse Event|0|||
105735888|NCT03825042|364689539|FG000|Overall Study|Withdrawal by Subject|1|||
105735889|NCT03825042|364689540|FG001|Overall Study|Withdrawal by Subject|0|||
105735890|NCT00417612|364689543|FG000|Overall Study|Errant diagnosis|0|||
105735891|NCT00417612|364689544|FG001|Overall Study|Errant diagnosis|1|||
105735892|NCT00417612|364689543|FG000|Overall Study|Adverse Event|2|||
105735893|NCT00417612|364689544|FG001|Overall Study|Adverse Event|0|||
105735894|NCT00417612|364689543|FG000|Overall Study|Protocol Violation|0|||
105735895|NCT00417612|364689544|FG001|Overall Study|Protocol Violation|2|||
105735896|NCT00417612|364689543|FG000|Overall Study|Lost to Follow-up|1|||
105735897|NCT00417612|364689544|FG001|Overall Study|Lost to Follow-up|0|||
105735898|NCT00663858|364689545|FG000|Overall Study|Adverse Event|9|||
105735899|NCT00663858|364689546|FG001|Overall Study|Adverse Event|1|||
105735900|NCT00663858|364689547|FG002|Overall Study|Adverse Event|6|||
105735901|NCT00663858|364689545|FG000|Overall Study|Lack of Efficacy|5|||
105735902|NCT00663858|364689546|FG001|Overall Study|Lack of Efficacy|1|||
105735903|NCT00663858|364689547|FG002|Overall Study|Lack of Efficacy|3|||
105735904|NCT00663858|364689545|FG000|Overall Study|Withdrawal by Subject|7|||
105735905|NCT00663858|364689546|FG001|Overall Study|Withdrawal by Subject|3|||
105735906|NCT00663858|364689547|FG002|Overall Study|Withdrawal by Subject|3|||
105735907|NCT00663858|364689545|FG000|Overall Study|Protocol Violation|5|||
105735908|NCT00663858|364689546|FG001|Overall Study|Protocol Violation|3|||
105735909|NCT00663858|364689547|FG002|Overall Study|Protocol Violation|4|||
105735910|NCT00663858|364689545|FG000|Overall Study|Other|8|||
105735911|NCT00663858|364689546|FG001|Overall Study|Other|2|||
105735912|NCT00663858|364689547|FG002|Overall Study|Other|4|||
105735913|NCT03216265|364689552|FG000|Overall Study|Adverse Event|2|||
105735914|NCT03216265|364689553|FG001|Overall Study|Adverse Event|0|||
105735915|NCT03216265|364689554|FG002|Overall Study|Adverse Event|2|||
105735916|NCT03216265|364689552|FG000|Overall Study|Lost to Follow-up|0|||
105735917|NCT03216265|364689553|FG001|Overall Study|Lost to Follow-up|1|||
105735918|NCT03216265|364689554|FG002|Overall Study|Lost to Follow-up|0|||
105735919|NCT03216265|364689552|FG000|Overall Study|Withdrawal by Subject|0|||
105735920|NCT03216265|364689553|FG001|Overall Study|Withdrawal by Subject|0|||
105735921|NCT03216265|364689554|FG002|Overall Study|Withdrawal by Subject|1|||
105735922|NCT01978912|364689557|FG000|Overall Study|Adverse Event|0|||
105799158|NCT05037409|364922698|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
106010412|NCT01550003|365704053|FG002|Overall Study|Patient reached adulthood|0|||
106010413|NCT01550003|365704051|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
105735923|NCT01978912|364689558|FG001|Overall Study|Adverse Event|1|||
105735924|NCT01978912|364689559|FG002|Overall Study|Adverse Event|0|||
105735925|NCT01978912|364689560|FG003|Overall Study|Adverse Event|0|||
105735926|NCT01978912|364689557|FG000|Overall Study|Lost to Follow-up|1|||
105735927|NCT01978912|364689558|FG001|Overall Study|Lost to Follow-up|1|||
105735928|NCT01978912|364689559|FG002|Overall Study|Lost to Follow-up|0|||
105735929|NCT01978912|364689560|FG003|Overall Study|Lost to Follow-up|1|||
105735930|NCT01978912|364689557|FG000|Overall Study|Withdrawal by Subject|1|||
105735931|NCT01978912|364689558|FG001|Overall Study|Withdrawal by Subject|0|||
105735932|NCT01978912|364689559|FG002|Overall Study|Withdrawal by Subject|2|||
105735933|NCT01978912|364689560|FG003|Overall Study|Withdrawal by Subject|2|||
105735934|NCT01978912|364689557|FG000|Overall Study|Lumbar Surgery|1|||
105799159|NCT05037409|364922699|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
105938675|NCT00979407|365436741|FG000|Overall Study|Withdrawal by Subject|3|||
105938676|NCT00979407|365436742|FG001|Overall Study|Withdrawal by Subject|4|||
106010414|NCT01550003|365704052|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
106010415|NCT01550003|365704053|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
106010416|NCT01550003|365704051|FG000|Overall Study|Sponsor's order|0|||
106010417|NCT01550003|365704052|FG001|Overall Study|Sponsor's order|3|||
106010418|NCT01550003|365704053|FG002|Overall Study|Sponsor's order|3|||
106010419|NCT01550003|365704051|FG000|Overall Study|Sponsor's decision|1|||
106010420|NCT01550003|365704052|FG001|Overall Study|Sponsor's decision|5|||
106010421|NCT01550003|365704053|FG002|Overall Study|Sponsor's decision|4|||
106010422|NCT01550003|365704051|FG000|Overall Study|Subject mother passed away|0|||
106010423|NCT01550003|365704052|FG001|Overall Study|Subject mother passed away|1|||
106010424|NCT01550003|365704053|FG002|Overall Study|Subject mother passed away|0|||
106010425|NCT01550003|365704051|FG000|Overall Study|Discontinuation|0|||
106010426|NCT01550003|365704052|FG001|Overall Study|Discontinuation|1|||
105735935|NCT01978912|364689558|FG001|Overall Study|Lumbar Surgery|0|||
105735936|NCT01978912|364689559|FG002|Overall Study|Lumbar Surgery|1|||
105735937|NCT01978912|364689560|FG003|Overall Study|Lumbar Surgery|0|||
105735938|NCT01978912|364689557|FG000|Overall Study|Intradiscal Steroid Injection|0|||
105735939|NCT01978912|364689558|FG001|Overall Study|Intradiscal Steroid Injection|1|||
105735940|NCT01978912|364689559|FG002|Overall Study|Intradiscal Steroid Injection|0|||
105735941|NCT01978912|364689560|FG003|Overall Study|Intradiscal Steroid Injection|0|||
105735942|NCT00224107|364689561|FG000|Overall Study|Adverse Event|20|||
105735943|NCT00224107|364689562|FG001|Overall Study|Adverse Event|6|||
105735944|NCT00224107|364689561|FG000|Overall Study|Protocol Violation|2|||
105735945|NCT00224107|364689562|FG001|Overall Study|Protocol Violation|3|||
105735946|NCT00224107|364689561|FG000|Overall Study|Withdrawal by Subject|1|||
105735947|NCT00224107|364689562|FG001|Overall Study|Withdrawal by Subject|4|||
105735948|NCT00224107|364689561|FG000|Overall Study|Lack of Efficacy|2|||
105735949|NCT00224107|364689562|FG001|Overall Study|Lack of Efficacy|0|||
105735950|NCT00224107|364689561|FG000|Overall Study|Lost to Follow-up|4|||
105735951|NCT00224107|364689562|FG001|Overall Study|Lost to Follow-up|0|||
105735952|NCT00224107|364689561|FG000|Overall Study|Physician Decision|1|||
105938677|NCT00979407|365436741|FG000|Overall Study|Lost to Follow-up|3|||
105938678|NCT00979407|365436742|FG001|Overall Study|Lost to Follow-up|3|||
105938679|NCT01166646|365436743|FG000|Overall Study|Protocol Violation|0|||
105938680|NCT01166646|365436744|FG001|Overall Study|Protocol Violation|1|||
105938681|NCT01166646|365436743|FG000|Overall Study|Adverse Event|1|||
105938682|NCT01166646|365436744|FG001|Overall Study|Adverse Event|0|||
105938683|NCT02420314|365436745|FG000|Overall Study|Withdrawal by Subject|1|||
105735953|NCT00224107|364689562|FG001|Overall Study|Physician Decision|0|||
105735954|NCT00224107|364689561|FG000|Overall Study|Other|1|||
105735955|NCT00224107|364689562|FG001|Overall Study|Other|1|||
105735956|NCT01371838|364689563|FG000|Overall Study|Withdrawal by Subject|27|||
105735957|NCT01371838|364689564|FG001|Overall Study|Withdrawal by Subject|33|||
105735958|NCT01371838|364689563|FG000|Overall Study|Lost to Follow-up|10|||
105735959|NCT01371838|364689564|FG001|Overall Study|Lost to Follow-up|20|||
105735960|NCT01371838|364689563|FG000|Overall Study|Death|3|||
105735961|NCT01371838|364689564|FG001|Overall Study|Death|4|||
105735962|NCT01371838|364689563|FG000|Overall Study|Protocol Violation|3|||
105735963|NCT01371838|364689564|FG001|Overall Study|Protocol Violation|0|||
105735964|NCT01371838|364689563|FG000|Overall Study|Investigator Decision|3|||
105735965|NCT01371838|364689564|FG001|Overall Study|Investigator Decision|8|||
105735966|NCT01371838|364689563|FG000|Overall Study|Last follow-up visit not conducted|2|||
105735967|NCT01371838|364689564|FG001|Overall Study|Last follow-up visit not conducted|0|||
105735968|NCT01371838|364689563|FG000|Overall Study|Lack of therapeutic response|0|||
105735969|NCT01371838|364689564|FG001|Overall Study|Lack of therapeutic response|1|||
105735970|NCT01371838|364689563|FG000|Overall Study|Surgery|1|||
105799160|NCT05037409|364922700|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
105735971|NCT01371838|364689564|FG001|Overall Study|Surgery|0|||
105735972|NCT00077623|364689565|FG000|Overall Study|Adverse Event|1|||
105735973|NCT00077623|364689566|FG001|Overall Study|Adverse Event|0|||
105799161|NCT01201356|364922704|FG000|Overall Study|Adverse Event|170|||
105938684|NCT02420314|365436745|FG000|Overall Study|Protocol Violation|1|||
105799162|NCT01201356|364922704|FG000|Overall Study|Abnormal laboratory value(s)|51|||
105938685|NCT01335685|365436753|FG000|Overall Study|Study Terminated by Sponsor|2|||
105938686|NCT01335685|365436754|FG001|Overall Study|Study Terminated by Sponsor|1|||
105735974|NCT00077623|364689567|FG002|Overall Study|Adverse Event|1|||
105735975|NCT00077623|364689565|FG000|Overall Study|Withdrawal by Subject|2|||
105735976|NCT00077623|364689566|FG001|Overall Study|Withdrawal by Subject|10|||
105735977|NCT00077623|364689567|FG002|Overall Study|Withdrawal by Subject|1|||
105735978|NCT00077623|364689565|FG000|Overall Study|Other-Non safety reason|18|||
105735979|NCT00077623|364689566|FG001|Overall Study|Other-Non safety reason|15|||
105735980|NCT00077623|364689567|FG002|Overall Study|Other-Non safety reason|19|||
106010427|NCT01550003|365704053|FG002|Overall Study|Discontinuation|0|||
106010428|NCT01550003|365704051|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
105735981|NCT00077623|364689565|FG000|Overall Study|Insufficient therapeutic response|2|||
105735982|NCT00077623|364689566|FG001|Overall Study|Insufficient therapeutic response|0|||
105735983|NCT00077623|364689567|FG002|Overall Study|Insufficient therapeutic response|0|||
105735984|NCT00077623|364689565|FG000|Overall Study|Death|12|||
105735985|NCT00077623|364689566|FG001|Overall Study|Death|18|||
105735986|NCT00077623|364689567|FG002|Overall Study|Death|11|||
105735987|NCT00077623|364689565|FG000|Overall Study|Failure to return|1|||
105735988|NCT00077623|364689566|FG001|Overall Study|Failure to return|0|||
105735989|NCT00077623|364689567|FG002|Overall Study|Failure to return|0|||
105735990|NCT00401973|364689574|FG000|Overall Study|Adverse Event|2|||
105735991|NCT00401973|364689575|FG001|Overall Study|Adverse Event|8|||
105735992|NCT00401973|364689576|FG002|Overall Study|Adverse Event|4|||
105735993|NCT00401973|364689574|FG000|Overall Study|Clinical Relapse|0|||
105735994|NCT00401973|364689575|FG001|Overall Study|Clinical Relapse|1|||
105735995|NCT00401973|364689576|FG002|Overall Study|Clinical Relapse|1|||
105735996|NCT00401973|364689574|FG000|Overall Study|Lack of Efficacy|0|||
105735997|NCT00401973|364689575|FG001|Overall Study|Lack of Efficacy|0|||
105735998|NCT00401973|364689576|FG002|Overall Study|Lack of Efficacy|3|||
105735999|NCT00401973|364689574|FG000|Overall Study|Lost to Follow-up|2|||
105736000|NCT00401973|364689575|FG001|Overall Study|Lost to Follow-up|2|||
105736001|NCT00401973|364689576|FG002|Overall Study|Lost to Follow-up|2|||
105736002|NCT00401973|364689574|FG000|Overall Study|Physician Decision|2|||
105736003|NCT00401973|364689575|FG001|Overall Study|Physician Decision|0|||
105736004|NCT00401973|364689576|FG002|Overall Study|Physician Decision|1|||
105736005|NCT00401973|364689574|FG000|Overall Study|Protocol Violation|1|||
105736006|NCT00401973|364689575|FG001|Overall Study|Protocol Violation|2|||
105736007|NCT00401973|364689576|FG002|Overall Study|Protocol Violation|3|||
105736008|NCT00401973|364689574|FG000|Overall Study|Sponsor Decision|0|||
106010429|NCT01550003|365704052|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
105736009|NCT00401973|364689575|FG001|Overall Study|Sponsor Decision|1|||
105736010|NCT00401973|364689576|FG002|Overall Study|Sponsor Decision|0|||
105736011|NCT00401973|364689574|FG000|Overall Study|Withdrawal by Subject|4|||
105736012|NCT00401973|364689575|FG001|Overall Study|Withdrawal by Subject|12|||
105736013|NCT00401973|364689576|FG002|Overall Study|Withdrawal by Subject|9|||
105736014|NCT00641043|364689577|FG000|Overall Study|Adverse Event|6|||
105736015|NCT00641043|364689578|FG001|Overall Study|Adverse Event|4|||
105736016|NCT00641043|364689577|FG000|Overall Study|Protocol Violation|2|||
105736017|NCT00641043|364689578|FG001|Overall Study|Protocol Violation|3|||
105736018|NCT00641043|364689577|FG000|Overall Study|Lost to Follow-up|3|||
105736019|NCT00641043|364689578|FG001|Overall Study|Lost to Follow-up|2|||
105736020|NCT00641043|364689577|FG000|Overall Study|Withdrawal by Subject|4|||
105736021|NCT00641043|364689578|FG001|Overall Study|Withdrawal by Subject|4|||
105736022|NCT00641043|364689577|FG000|Overall Study|Other incl. lack of efficacy|4|||
105736023|NCT00641043|364689578|FG001|Overall Study|Other incl. lack of efficacy|2|||
105736024|NCT05523362|364689579|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
105736025|NCT05523362|364689579|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
105736026|NCT05523362|364689579|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
105736027|NCT05523362|364689579|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
105736028|NCT00474630|364689580|FG000|Overall Study|Adverse Event|98|||
105736029|NCT00474630|364689581|FG001|Overall Study|Adverse Event|26|||
105736030|NCT00474630|364689580|FG000|Overall Study|Lost to Follow-up|22|||
105736031|NCT00474630|364689581|FG001|Overall Study|Lost to Follow-up|15|||
106010430|NCT01550003|365704053|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
106010431|NCT01550003|365704051|FG000|Overall Study|Site closure|0|||
106010432|NCT01550003|365704052|FG001|Overall Study|Site closure|2|||
106010433|NCT01550003|365704053|FG002|Overall Study|Site closure|0|||
106010434|NCT01550003|365704051|FG000|Overall Study|Pregnancy|0|||
106010435|NCT01550003|365704052|FG001|Overall Study|Pregnancy|1|||
106140065|NCT04364269|366170466|FG000|Overall Study|Withdrawal by Subject|0|||
106140066|NCT04364269|366170467|FG001|Overall Study|Withdrawal by Subject|1|||
106140067|NCT04364269|366170468|FG002|Overall Study|Withdrawal by Subject|0|||
106140068|NCT04173572|366170469|FG000|Overall Study|Withdrawal by Subject|1|||
105736032|NCT00474630|364689580|FG000|Overall Study|Withdrawal by Subject|21|||
105736033|NCT00474630|364689581|FG001|Overall Study|Withdrawal by Subject|15|||
105736034|NCT00474630|364689580|FG000|Overall Study|Protocol Violation|3|||
105736035|NCT00474630|364689581|FG001|Overall Study|Protocol Violation|4|||
105736036|NCT00474630|364689580|FG000|Overall Study|Lack of Efficacy|5|||
105736037|NCT00474630|364689581|FG001|Overall Study|Lack of Efficacy|6|||
105736038|NCT00474630|364689580|FG000|Overall Study|Drug noncompliance, other|11|||
105736039|NCT00474630|364689581|FG001|Overall Study|Drug noncompliance, other|4|||
105736040|NCT04075604|364689582|FG000|Overall Study|Adverse Event|0|||
105736041|NCT04075604|364689583|FG001|Overall Study|Adverse Event|0|||
105736042|NCT04075604|364689584|FG002|Overall Study|Adverse Event|3|||
105736043|NCT04075604|364689582|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105736044|NCT04075604|364689583|FG001|Overall Study|Participant request to discontinue study treatment|0|||
106010436|NCT01550003|365704053|FG002|Overall Study|Pregnancy|0|||
106140069|NCT04173572|366170470|FG001|Overall Study|Withdrawal by Subject|5|||
105736045|NCT04075604|364689584|FG002|Overall Study|Participant request to discontinue study treatment|1|||
105736046|NCT04075604|364689582|FG000|Overall Study|Participant withdrew consent|0|||
105736047|NCT04075604|364689583|FG001|Overall Study|Participant withdrew consent|0|||
105736048|NCT04075604|364689584|FG002|Overall Study|Participant withdrew consent|1|||
105736049|NCT04075604|364689582|FG000|Overall Study|Other reasons|1|||
105736050|NCT04075604|364689583|FG001|Overall Study|Other reasons|0|||
105736051|NCT04075604|364689584|FG002|Overall Study|Other reasons|0|||
105736052|NCT04075604|364689582|FG000|Overall Study|Disease progression|0|||
105736053|NCT04075604|364689583|FG001|Overall Study|Disease progression|1|||
105736054|NCT04075604|364689584|FG002|Overall Study|Disease progression|0|||
105736055|NCT04075604|364689582|FG000|Overall Study|Study drug toxicity|0|||
105736056|NCT04075604|364689583|FG001|Overall Study|Study drug toxicity|5|||
105736057|NCT04075604|364689584|FG002|Overall Study|Study drug toxicity|1|||
105736058|NCT02225223|364689588|FG000|Overall Study|Death|10|||
105736059|NCT02225223|364689589|FG001|Overall Study|Death|1|||
105736060|NCT02225223|364689588|FG000|Overall Study|Lost to Follow-up|5|||
105736061|NCT02225223|364689589|FG001|Overall Study|Lost to Follow-up|0|||
105736062|NCT02225223|364689588|FG000|Overall Study|Other|1|||
105736063|NCT02225223|364689589|FG001|Overall Study|Other|2|||
105736064|NCT02225223|364689588|FG000|Overall Study|Physician Decision|1|||
105736065|NCT02225223|364689589|FG001|Overall Study|Physician Decision|0|||
105736066|NCT02225223|364689588|FG000|Overall Study|Withdrawal by Subject|2|||
105736067|NCT02225223|364689589|FG001|Overall Study|Withdrawal by Subject|2|||
105736068|NCT03334214|364689593|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
105736069|NCT03334214|364689594|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
105736070|NCT03334214|364689593|FG000|Overall Study|Withdrawal by Subject|0|||
105736071|NCT03334214|364689594|FG001|Overall Study|Withdrawal by Subject|1|||
105736072|NCT03334214|364689593|FG000|Overall Study|Other|1|||
105736073|NCT03334214|364689594|FG001|Overall Study|Other|0|||
105736074|NCT03047213|364689595|FG000|Overall Study|Withdrawal by Subject|2|||
105736075|NCT03047213|364689596|FG001|Overall Study|Withdrawal by Subject|0|||
105736076|NCT03047213|364689595|FG000|Overall Study|Adverse Event|2|||
105736077|NCT03047213|364689596|FG001|Overall Study|Adverse Event|0|||
105736078|NCT04530825|364689599|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
105736079|NCT04530825|364689600|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
105736080|NCT04530825|364689601|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
105736081|NCT04530825|364689602|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
105736082|NCT04530825|364689599|FG000|Overall Study|Did not complete follow-up|3|||
105736083|NCT04530825|364689600|FG001|Overall Study|Did not complete follow-up|0|||
105736084|NCT04530825|364689601|FG002|Overall Study|Did not complete follow-up|0|||
105736085|NCT04530825|364689602|FG003|Overall Study|Did not complete follow-up|0|||
105736086|NCT04101422|364689604|FG000|Overall Study|Ineligible|1|||
105736087|NCT04101422|364689605|FG001|Overall Study|Ineligible|0|||
105736088|NCT04101422|364689606|FG002|Overall Study|Ineligible|9|||
105736089|NCT04101422|364689607|FG003|Overall Study|Ineligible|0|||
105736090|NCT04101422|364689604|FG000|Overall Study|Withdrawal by Subject|0|||
105736091|NCT04101422|364689605|FG001|Overall Study|Withdrawal by Subject|0|||
105938687|NCT01335685|365436755|FG002|Overall Study|Study Terminated by Sponsor|1|||
105938688|NCT01335685|365436756|FG003|Overall Study|Study Terminated by Sponsor|10|||
105938689|NCT01335685|365436757|FG004|Overall Study|Study Terminated by Sponsor|0|||
105938690|NCT01335685|365436758|FG005|Overall Study|Study Terminated by Sponsor|4|||
105938691|NCT01335685|365436759|FG006|Overall Study|Study Terminated by Sponsor|2|||
105938692|NCT01335685|365436760|FG007|Overall Study|Study Terminated by Sponsor|3|||
105938693|NCT01335685|365436753|FG000|Overall Study|Withdrawal by Subject|1|||
105938694|NCT01335685|365436754|FG001|Overall Study|Withdrawal by Subject|0|||
105938695|NCT01335685|365436755|FG002|Overall Study|Withdrawal by Subject|0|||
105938696|NCT01335685|365436756|FG003|Overall Study|Withdrawal by Subject|1|||
105938697|NCT01335685|365436757|FG004|Overall Study|Withdrawal by Subject|0|||
105938698|NCT01335685|365436758|FG005|Overall Study|Withdrawal by Subject|0|||
105938699|NCT01335685|365436759|FG006|Overall Study|Withdrawal by Subject|0|||
105938700|NCT01335685|365436760|FG007|Overall Study|Withdrawal by Subject|0|||
105938701|NCT01335685|365436753|FG000|Overall Study|Reason not Specified|0|||
105938702|NCT01335685|365436754|FG001|Overall Study|Reason not Specified|0|||
105938703|NCT01335685|365436755|FG002|Overall Study|Reason not Specified|1|||
105938704|NCT01335685|365436756|FG003|Overall Study|Reason not Specified|0|||
105938705|NCT01335685|365436757|FG004|Overall Study|Reason not Specified|0|||
105938706|NCT01335685|365436758|FG005|Overall Study|Reason not Specified|1|||
105938707|NCT01335685|365436759|FG006|Overall Study|Reason not Specified|0|||
105938708|NCT01335685|365436760|FG007|Overall Study|Reason not Specified|0|||
105736092|NCT04101422|364689606|FG002|Overall Study|Withdrawal by Subject|1|||
105736093|NCT04101422|364689607|FG003|Overall Study|Withdrawal by Subject|0|||
105736094|NCT04101422|364689604|FG000|Overall Study|Not attending to the stimuli|0|||
105736095|NCT04101422|364689605|FG001|Overall Study|Not attending to the stimuli|0|||
105736096|NCT04101422|364689606|FG002|Overall Study|Not attending to the stimuli|4|||
105938709|NCT01848457|365436763|FG000|Overall Study|Death|1|||
105938710|NCT01848457|365436764|FG001|Overall Study|Death|0|||
105799163|NCT01201356|364922704|FG000|Overall Study|Abnormal test procedure result(s)|3|||
105799164|NCT01201356|364922704|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
105799165|NCT01201356|364922704|FG000|Overall Study|Condition no longer requires study drug|12|||
105799166|NCT01201356|364922704|FG000|Overall Study|Withdrawal by Subject|144|||
105799167|NCT01201356|364922704|FG000|Overall Study|Lost to Follow-up|50|||
106010437|NCT01550003|365704051|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
105799168|NCT01201356|364922704|FG000|Overall Study|administrative problems|74|||
105799169|NCT01201356|364922704|FG000|Overall Study|Death|16|||
105799170|NCT01201356|364922704|FG000|Overall Study|Protocol Violation|12|||
105799171|NCT04079842|364922705|FG000|Overall Study|Request of subject|2|||
105799172|NCT04079842|364922705|FG000|Overall Study|Unable to draw Arterial samples|1|||
105799173|NCT04444752|364922706|FG000|Overall Study|Adverse Event|1|||
105799174|NCT04444752|364922707|FG001|Overall Study|Adverse Event|0|||
105799175|NCT04444752|364922708|FG002|Overall Study|Adverse Event|0|||
105799176|NCT04444752|364922709|FG003|Overall Study|Adverse Event|2|||
105799177|NCT04444752|364922706|FG000|Overall Study|Lost to Follow-up|2|||
105938711|NCT01848457|365436765|FG002|Overall Study|Death|0|||
106010438|NCT01550003|365704052|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
106010439|NCT01550003|365704053|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
106010440|NCT01550003|365704051|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
106010441|NCT01550003|365704052|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
106010442|NCT01550003|365704053|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
106010443|NCT01550003|365704051|FG000|Overall Study|Switching to adult rheumatologist|0|||
106010444|NCT01550003|365704052|FG001|Overall Study|Switching to adult rheumatologist|0|||
106010445|NCT01550003|365704053|FG002|Overall Study|Switching to adult rheumatologist|1|||
106010446|NCT01550003|365704051|FG000|Overall Study|Patient transition to adult care|0|||
106010447|NCT01550003|365704052|FG001|Overall Study|Patient transition to adult care|0|||
106010448|NCT01550003|365704053|FG002|Overall Study|Patient transition to adult care|1|||
106010449|NCT01550003|365704051|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
106010450|NCT01550003|365704052|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
106010451|NCT01550003|365704053|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
106010452|NCT01550003|365704051|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
106010453|NCT01550003|365704052|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
105938712|NCT01848457|365436766|FG003|Overall Study|Death|0|||
105938713|NCT03777020|365436767|FG000|Overall Study|Withdrawal by Subject|4|||
105938714|NCT03777020|365436768|FG001|Overall Study|Withdrawal by Subject|4|||
105938715|NCT03777020|365436767|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
105938716|NCT03777020|365436768|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
105938717|NCT00489476|365436771|FG000|Overall Study|Lost to Follow-up|0|||
105938718|NCT00489476|365436772|FG001|Overall Study|Lost to Follow-up|1|||
105938719|NCT00489476|365436773|FG002|Overall Study|Lost to Follow-up|0|||
105938720|NCT00489476|365436774|FG003|Overall Study|Lost to Follow-up|0|||
105938721|NCT01272219|365436787|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
105938722|NCT01272219|365436788|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
105938723|NCT01272219|365436789|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
105938724|NCT01272219|365436790|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
105938725|NCT01272219|365436791|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
105938726|NCT01272219|365436792|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
105938727|NCT01272219|365436787|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
105938728|NCT01272219|365436788|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
105938729|NCT01272219|365436789|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
105938730|NCT01272219|365436790|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
105938731|NCT01272219|365436791|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
105938732|NCT01272219|365436792|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
105938733|NCT01272219|365436787|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
105938734|NCT01272219|365436788|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
105938735|NCT01272219|365436789|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
105938736|NCT01272219|365436790|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
105938737|NCT01272219|365436791|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
105938738|NCT01272219|365436792|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
105938739|NCT01272219|365436787|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
105938740|NCT01272219|365436788|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
106010454|NCT01550003|365704053|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
106010455|NCT01550003|365704051|FG000|Overall Study|Per Sponsor request|1|||
106010456|NCT01550003|365704052|FG001|Overall Study|Per Sponsor request|0|||
105799178|NCT04444752|364922707|FG001|Overall Study|Lost to Follow-up|6|||
105799179|NCT04444752|364922708|FG002|Overall Study|Lost to Follow-up|2|||
105799180|NCT04444752|364922709|FG003|Overall Study|Lost to Follow-up|5|||
105938741|NCT01272219|365436789|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
105799181|NCT04444752|364922706|FG000|Overall Study|Physician Decision|0|||
105938742|NCT01272219|365436790|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
106010457|NCT01550003|365704053|FG002|Overall Study|Per Sponsor request|1|||
106010458|NCT01550003|365704051|FG000|Overall Study|Patient not compliance|0|||
106010459|NCT01550003|365704052|FG001|Overall Study|Patient not compliance|0|||
106010460|NCT01550003|365704053|FG002|Overall Study|Patient not compliance|1|||
105736097|NCT04101422|364689607|FG003|Overall Study|Not attending to the stimuli|0|||
105736098|NCT04101422|364689604|FG000|Overall Study|Did not download app|0|||
105736099|NCT04101422|364689605|FG001|Overall Study|Did not download app|0|||
105736100|NCT04101422|364689606|FG002|Overall Study|Did not download app|0|||
105736101|NCT04101422|364689607|FG003|Overall Study|Did not download app|17|||
105736102|NCT04101422|364689604|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
105736103|NCT04101422|364689605|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
105736104|NCT04101422|364689606|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
105736105|NCT04101422|364689607|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
105736106|NCT02640612|364689608|FG000|Overall Study|Adverse Event|6|||
105736107|NCT02640612|364689609|FG001|Overall Study|Adverse Event|7|||
105736108|NCT02640612|364689610|FG002|Overall Study|Adverse Event|2|||
105736109|NCT02640612|364689608|FG000|Overall Study|Death|1|||
105736110|NCT02640612|364689609|FG001|Overall Study|Death|0|||
105736111|NCT02640612|364689610|FG002|Overall Study|Death|0|||
105736112|NCT02640612|364689608|FG000|Overall Study|Withdrawal by Subject|10|||
105736113|NCT02640612|364689609|FG001|Overall Study|Withdrawal by Subject|3|||
105736114|NCT02640612|364689610|FG002|Overall Study|Withdrawal by Subject|3|||
105736115|NCT02640612|364689608|FG000|Overall Study|Lost to Follow-up|4|||
105736116|NCT02640612|364689609|FG001|Overall Study|Lost to Follow-up|1|||
105736117|NCT02640612|364689610|FG002|Overall Study|Lost to Follow-up|1|||
105736118|NCT02640612|364689608|FG000|Overall Study|Protocol Violation|0|||
105736119|NCT02640612|364689609|FG001|Overall Study|Protocol Violation|2|||
105736120|NCT02640612|364689610|FG002|Overall Study|Protocol Violation|0|||
105736121|NCT02640612|364689608|FG000|Overall Study|Lack of Efficacy|1|||
105736122|NCT02640612|364689609|FG001|Overall Study|Lack of Efficacy|1|||
105736123|NCT02640612|364689610|FG002|Overall Study|Lack of Efficacy|0|||
105736124|NCT01720667|364689611|FG000|Overall Study|Adverse Event|1|||
105736125|NCT01720667|364689612|FG001|Overall Study|Adverse Event|1|||
105736126|NCT01720667|364689611|FG000|Overall Study|Withdrawal by Subject|3|||
105736127|NCT01720667|364689612|FG001|Overall Study|Withdrawal by Subject|0|||
105736128|NCT04407507|364689613|FG000|Overall Study|Withdrawal by Subject|0|||
105736129|NCT04407507|364689614|FG001|Overall Study|Withdrawal by Subject|1|||
105736130|NCT00552305|364689615|FG000|Overall Study|Adverse Event|43|||
105736131|NCT00552305|364689615|FG000|Overall Study|Lack of Efficacy|120|||
105736132|NCT00552305|364689615|FG000|Overall Study|Lost to Follow-up|4|||
105736133|NCT00552305|364689615|FG000|Overall Study|Protocol Violation|3|||
105736134|NCT00552305|364689615|FG000|Overall Study|Withdrawal by Subject|44|||
105736135|NCT00552305|364689615|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
105736136|NCT00552305|364689615|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
105736137|NCT00552305|364689615|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
105736138|NCT00552305|364689615|FG000|Overall Study|Unsatisfactory compliance|11|||
105736139|NCT00552305|364689615|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
105736140|NCT00552305|364689615|FG000|Overall Study|AE/Other: prohibited drug required|1|||
105736141|NCT00552305|364689615|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
105736142|NCT00552305|364689615|FG000|Overall Study|Other: Site closed|4|||
105736143|NCT00552305|364689615|FG000|Overall Study|Other: Personal problems|1|||
105736144|NCT00552305|364689615|FG000|Overall Study|Other: Unable to attend visits|1|||
105736145|NCT00552305|364689615|FG000|Overall Study|Other: Subject underwent surgery|4|||
105736146|NCT00552305|364689615|FG000|Overall Study|Other: Subject became pregnant|1|||
105736147|NCT00552305|364689615|FG000|Overall Study|Other: Health problems, not drug related|1|||
105736148|NCT00552305|364689615|FG000|Overall Study|Other: Subject moved from area|2|||
105736149|NCT00552305|364689615|FG000|Overall Study|Other: Subject incarcerated|1|||
105736150|NCT00552305|364689615|FG000|Overall Study|Other: Subject went to rehab|1|||
105736151|NCT02117050|364689619|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
105736152|NCT03865407|364689620|FG000|Overall Study|Adverse Event|1|||
105736153|NCT03865407|364689621|FG001|Overall Study|Adverse Event|0|||
105736154|NCT03865407|364689620|FG000|Overall Study|Withdrawal by Subject|1|||
105736155|NCT03865407|364689621|FG001|Overall Study|Withdrawal by Subject|0|||
105736156|NCT03865407|364689620|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
105736157|NCT03865407|364689621|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
106010461|NCT01550003|365704051|FG000|Overall Study|Non-compliance|0|||
105736158|NCT01507545|364689627|FG000|Overall Study|Withdrawal by Subject|6|||
105736159|NCT01507545|364689628|FG001|Overall Study|Withdrawal by Subject|2|||
105736160|NCT01507545|364689627|FG000|Overall Study|Lost to Follow-up|1|||
105736161|NCT01507545|364689628|FG001|Overall Study|Lost to Follow-up|0|||
105736162|NCT01507545|364689627|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
105736163|NCT01507545|364689628|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
105736164|NCT01507545|364689627|FG000|Overall Study|Progressive disease|60|||
105736165|NCT01507545|364689628|FG001|Overall Study|Progressive disease|27|||
105938743|NCT01272219|365436791|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
105938744|NCT01272219|365436792|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
105938745|NCT01272219|365436787|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
105938746|NCT01272219|365436788|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
105938747|NCT01272219|365436789|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
106140070|NCT04173572|366170469|FG000|Overall Study|Lost to Follow-up|3|||
106140071|NCT04173572|366170470|FG001|Overall Study|Lost to Follow-up|1|||
106140072|NCT00371566|366170471|FG000|Treatment Phase|Withdrawal by Subject|0|||
106140073|NCT00371566|366170472|FG001|Treatment Phase|Withdrawal by Subject|1|||
106140074|NCT00371566|366170471|FG000|Treatment Phase|Adverse Event|0|||
106140075|NCT00371566|366170472|FG001|Treatment Phase|Adverse Event|1|||
106140076|NCT00371566|366170471|FG000|Treatment Phase|Protocol Violation|0|||
106140077|NCT00371566|366170472|FG001|Treatment Phase|Protocol Violation|1|||
106140078|NCT00371566|366170471|FG000|Chemoradiation Phase|Physician Decision|2|||
106140079|NCT00371566|366170472|FG001|Chemoradiation Phase|Physician Decision|0|||
106140080|NCT00371566|366170471|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
106140081|NCT00371566|366170472|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
106140082|NCT00371566|366170471|FG000|Chemoradiation Phase|Non compliant|0|||
106140083|NCT00371566|366170472|FG001|Chemoradiation Phase|Non compliant|1|||
106140084|NCT00371566|366170471|FG000|Chemoradiation Phase|Progressive Disease|1|||
106140085|NCT00371566|366170472|FG001|Chemoradiation Phase|Progressive Disease|1|||
106140086|NCT00371566|366170471|FG000|Chemoradiation Phase|Death|2|||
106140087|NCT00371566|366170472|FG001|Chemoradiation Phase|Death|0|||
106140088|NCT00371566|366170471|FG000|Follow Up Phase|Death|0|||
106140089|NCT00371566|366170472|FG001|Follow Up Phase|Death|5|||
106140090|NCT00371566|366170471|FG000|Follow Up Phase|Disease progression|1|||
106140091|NCT00371566|366170472|FG001|Follow Up Phase|Disease progression|0|||
106140092|NCT00371566|366170471|FG000|Follow Up Phase|Withdrawal by Subject|0|||
106140093|NCT00371566|366170472|FG001|Follow Up Phase|Withdrawal by Subject|1|||
106140094|NCT00371566|366170471|FG000|Follow Up Phase|Physician Decision|1|||
106140095|NCT00371566|366170472|FG001|Follow Up Phase|Physician Decision|1|||
106140096|NCT00371566|366170471|FG000|Follow Up Phase|Lost to Follow-up|1|||
106140097|NCT00371566|366170472|FG001|Follow Up Phase|Lost to Follow-up|0|||
106140098|NCT00972504|366170473|FG000|Overall Study|Adverse Event|2|||
106140099|NCT00972504|366170473|FG000|Overall Study|Investigator discretion|1|||
106140100|NCT00597519|366170474|FG000|Overall Study|Death|1|||
106140101|NCT02954848|366170475|FG000|Overall Study|Randomized but Not Treated|0|||
106140102|NCT02954848|366170476|FG001|Overall Study|Randomized but Not Treated|1|||
106140103|NCT02954848|366170475|FG000|Overall Study|Adverse Event|2|||
106140104|NCT02954848|366170476|FG001|Overall Study|Adverse Event|3|||
106140105|NCT02954848|366170475|FG000|Overall Study|Withdrawal by Participant|0|||
106140106|NCT02954848|366170476|FG001|Overall Study|Withdrawal by Participant|1|||
105736166|NCT01507545|364689627|FG000|Overall Study|Other|6|||
105736167|NCT01507545|364689628|FG001|Overall Study|Other|4|||
105736168|NCT00450866|364689629|FG000|Overall Study|Adverse Event|0|||
105736169|NCT00450866|364689630|FG001|Overall Study|Adverse Event|1|||
105736170|NCT00450866|364689629|FG000|Overall Study|Withdrawal by Subject|5|||
105736171|NCT00450866|364689630|FG001|Overall Study|Withdrawal by Subject|2|||
105736172|NCT00450866|364689629|FG000|Overall Study|Death|1|||
105736173|NCT00450866|364689630|FG001|Overall Study|Death|0|||
105736174|NCT00450866|364689629|FG000|Overall Study|Physician Decision|1|||
105736175|NCT00450866|364689630|FG001|Overall Study|Physician Decision|0|||
105736176|NCT00790296|364689632|FG000|Overall Study|Did not meet study eligibility criteria|1|||
105736177|NCT00790296|364689633|FG001|Overall Study|Did not meet study eligibility criteria|1|||
105736178|NCT00790296|364689632|FG000|Overall Study|Adverse Event|0|||
105736179|NCT00790296|364689633|FG001|Overall Study|Adverse Event|1|||
105736180|NCT01671488|364689634|FG000|Overall Study|Withdrawal by Subject|1|||
105736181|NCT01022853|364689635|FG000|Overall Study|Progressive disease|2|||
105736182|NCT01022853|364689636|FG001|Overall Study|Progressive disease|3|||
105736183|NCT01022853|364689637|FG002|Overall Study|Progressive disease|11|||
105736184|NCT01022853|364689638|FG003|Overall Study|Progressive disease|7|||
105736185|NCT01022853|364689639|FG004|Overall Study|Progressive disease|1|||
105938748|NCT01272219|365436790|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
105938749|NCT01272219|365436791|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
106140107|NCT00835380|366170481|FG000|Overall Study|Withdrawal by Subject|2|||
106140108|NCT02914522|366170482|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
106140109|NCT02914522|366170483|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
106140110|NCT02914522|366170484|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
106140111|NCT02914522|366170485|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
106140112|NCT02914522|366170486|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
105736186|NCT01022853|364689635|FG000|Overall Study|Dose-limiting toxicity|0|||
105736187|NCT01022853|364689636|FG001|Overall Study|Dose-limiting toxicity|0|||
105736188|NCT01022853|364689637|FG002|Overall Study|Dose-limiting toxicity|0|||
105938750|NCT01272219|365436792|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
106140113|NCT02914522|366170487|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
105736189|NCT01022853|364689638|FG003|Overall Study|Dose-limiting toxicity|0|||
106010462|NCT01550003|365704052|FG001|Overall Study|Non-compliance|0|||
106010463|NCT01550003|365704053|FG002|Overall Study|Non-compliance|1|||
106010464|NCT01550003|365704051|FG000|Overall Study|Study closed|0|||
106010465|NCT01550003|365704052|FG001|Overall Study|Study closed|1|||
106010466|NCT01550003|365704053|FG002|Overall Study|Study closed|0|||
105736190|NCT01022853|364689639|FG004|Overall Study|Dose-limiting toxicity|1|||
106010467|NCT01550003|365704051|FG000|Overall Study|Transitioned to adult rheumatology|0|||
106010468|NCT01550003|365704052|FG001|Overall Study|Transitioned to adult rheumatology|0|||
106010469|NCT01550003|365704053|FG002|Overall Study|Transitioned to adult rheumatology|1|||
105736191|NCT01022853|364689635|FG000|Overall Study|Withdrawal by Subject|0|||
105736192|NCT01022853|364689636|FG001|Overall Study|Withdrawal by Subject|1|||
105736193|NCT01022853|364689637|FG002|Overall Study|Withdrawal by Subject|1|||
105938751|NCT01272219|365436787|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
105938752|NCT01272219|365436788|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
105938753|NCT01272219|365436789|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
105938754|NCT01272219|365436790|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
105938755|NCT01272219|365436791|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
105938756|NCT01272219|365436792|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
105938757|NCT01272219|365436787|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105938758|NCT01272219|365436788|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105938759|NCT01272219|365436789|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105938760|NCT01272219|365436790|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
105938761|NCT01272219|365436791|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105938762|NCT01272219|365436792|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
105938763|NCT01272219|365436787|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
105938764|NCT01272219|365436788|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
105938765|NCT01272219|365436789|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
105938766|NCT01272219|365436790|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
105938767|NCT01272219|365436791|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
105938768|NCT01272219|365436792|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
105938769|NCT01272219|365436787|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
105938770|NCT01272219|365436788|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
105938771|NCT01272219|365436789|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
105938772|NCT01272219|365436790|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
105938773|NCT01272219|365436791|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
106010470|NCT00871975|365704054|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
106010471|NCT00871975|365704054|FG000|Overall Study|Catheters could not be inserted|1|||
106010472|NCT00871975|365704054|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
106010473|NCT00871975|365704054|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
106010474|NCT04189952|365704055|FG000|Follow-up Period|Death|1|||
106010475|NCT04189952|365704055|FG000|Follow-up Period|Withdrawal by Subject|1|||
106010476|NCT00453206|365704063|FG000|Overall Study|Death|1|||
106010477|NCT00888173|365704066|FG000|Overall Study|Wrong Primary|1|||
106010478|NCT00888173|365704066|FG000|Overall Study|Ineligible: required test not done|1|||
106010479|NCT01488890|365704069|FG000|Overall Study|Serious adverse event|2|||
106010480|NCT01488890|365704070|FG001|Overall Study|Serious adverse event|0|||
106010481|NCT01488890|365704071|FG002|Overall Study|Serious adverse event|0|||
106010482|NCT01488890|365704072|FG003|Overall Study|Serious adverse event|0|||
106010483|NCT01488890|365704069|FG000|Overall Study|Protocol Violation|3|||
106010484|NCT01488890|365704070|FG001|Overall Study|Protocol Violation|0|||
105938774|NCT01272219|365436792|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
105938775|NCT01272219|365436787|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
105938776|NCT01272219|365436788|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
106010485|NCT01488890|365704071|FG002|Overall Study|Protocol Violation|4|||
106010486|NCT01488890|365704072|FG003|Overall Study|Protocol Violation|0|||
106010487|NCT01488890|365704069|FG000|Overall Study|Lost to Follow-up|13|||
106010488|NCT01488890|365704070|FG001|Overall Study|Lost to Follow-up|10|||
106140114|NCT02914522|366170488|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
105736194|NCT01022853|364689638|FG003|Overall Study|Withdrawal by Subject|1|||
105736195|NCT01022853|364689639|FG004|Overall Study|Withdrawal by Subject|0|||
105736196|NCT01022853|364689635|FG000|Overall Study|Other not stated above|1|||
105736197|NCT01022853|364689636|FG001|Overall Study|Other not stated above|0|||
105736198|NCT01022853|364689637|FG002|Overall Study|Other not stated above|1|||
105736199|NCT01022853|364689638|FG003|Overall Study|Other not stated above|0|||
105736200|NCT01022853|364689639|FG004|Overall Study|Other not stated above|0|||
105736201|NCT01971476|364689640|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
105736202|NCT01971476|364689641|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
105736203|NCT01971476|364689642|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
105736204|NCT01971476|364689640|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
105736205|NCT01971476|364689641|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
106140115|NCT02914522|366170489|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
106140116|NCT02914522|366170490|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
105736206|NCT01971476|364689642|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
105736207|NCT01971476|364689640|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
105736208|NCT01971476|364689641|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
105736209|NCT01971476|364689642|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
105736210|NCT02675517|364689646|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
105736211|NCT02675517|364689646|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
105736212|NCT01751646|364689651|FG000|Overall Study|Lost to Follow-up|5|||
105736213|NCT01751646|364689652|FG001|Overall Study|Lost to Follow-up|1|||
105736214|NCT01751646|364689651|FG000|Overall Study|Withdrawal by Subject|0|||
105736215|NCT01751646|364689652|FG001|Overall Study|Withdrawal by Subject|4|||
105736216|NCT01751646|364689651|FG000|Overall Study|Starting hormone therapy|1|||
105736217|NCT01751646|364689652|FG001|Overall Study|Starting hormone therapy|0|||
105736218|NCT01751646|364689651|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
105736219|NCT01751646|364689652|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
105736220|NCT01751646|364689651|FG000|Overall Study|Inadvertent enrollment|1|||
105736221|NCT01751646|364689652|FG001|Overall Study|Inadvertent enrollment|1|||
105736222|NCT01751646|364689651|FG000|Overall Study|Moved out of the area|1|||
105736223|NCT01751646|364689652|FG001|Overall Study|Moved out of the area|5|||
105736224|NCT01751646|364689651|FG000|Overall Study|Inability to attend required visits|0|||
105736225|NCT01751646|364689652|FG001|Overall Study|Inability to attend required visits|1|||
105736226|NCT01751646|364689651|FG000|Overall Study|Off study due to multiple obligations|0|||
105736227|NCT01751646|364689652|FG001|Overall Study|Off study due to multiple obligations|1|||
105736228|NCT01751646|364689651|FG000|Overall Study|Fails to comply with study requirements|0|||
105736229|NCT01751646|364689652|FG001|Overall Study|Fails to comply with study requirements|1|||
105736230|NCT01751646|364689651|FG000|Overall Study|Childcare issues|1|||
105736231|NCT01751646|364689652|FG001|Overall Study|Childcare issues|1|||
105736232|NCT00945191|364689653|FG000|Overall Study|Did not achieve a complete response|18|||
105736233|NCT00945191|364689653|FG000|Overall Study|Participant relocated to another state|1|||
105736234|NCT00945191|364689653|FG000|Overall Study|Disease progression|3|||
105736235|NCT00945191|364689653|FG000|Overall Study|Serious adverse event or adverse event|1|||
105736236|NCT00945191|364689653|FG000|Overall Study|Investigator's discretion|1|||
105736237|NCT00206518|364689654|FG000|Overall Study|Lack of Efficacy|6|||
105736238|NCT00206518|364689655|FG001|Overall Study|Lack of Efficacy|4|||
105736239|NCT00206518|364689654|FG000|Overall Study|Adverse Event|2|||
105736240|NCT00206518|364689655|FG001|Overall Study|Adverse Event|1|||
105736241|NCT00206518|364689654|FG000|Overall Study|Physician Decision|1|||
105736242|NCT00206518|364689655|FG001|Overall Study|Physician Decision|0|||
105736243|NCT00206518|364689654|FG000|Overall Study|Protocol Violation|1|||
105736244|NCT00206518|364689655|FG001|Overall Study|Protocol Violation|1|||
105736245|NCT02335450|364689656|FG000|Overall Study|Pregnancy|1|||
105736246|NCT02973815|364689661|FG000|Post Intervention|Death|1|||
105736247|NCT02973815|364689662|FG001|Post Intervention|Death|0|||
105736248|NCT02973815|364689661|FG000|Post Intervention|Lost to Follow-up|7|||
105736249|NCT02973815|364689662|FG001|Post Intervention|Lost to Follow-up|24|||
105736250|NCT02973815|364689661|FG000|Follow-up|Lost to Follow-up|2|||
105736251|NCT02973815|364689662|FG001|Follow-up|Lost to Follow-up|0|||
105736252|NCT02613572|364689663|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
105736253|NCT02613572|364689664|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
105736254|NCT02613572|364689665|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
105736255|NCT02613572|364689663|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
105736256|NCT02613572|364689664|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
105736257|NCT02613572|364689665|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
105736258|NCT01004146|364689670|FG000|Overall Study|Withdrawal by Subject|4|||
105736259|NCT01004146|364689671|FG001|Overall Study|Withdrawal by Subject|5|||
105938777|NCT01272219|365436789|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
105938778|NCT01272219|365436790|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
105938779|NCT01272219|365436791|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
105938780|NCT01272219|365436792|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
105938781|NCT01272219|365436787|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
105938782|NCT01272219|365436788|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
105938783|NCT01272219|365436789|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
105938784|NCT01272219|365436790|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
105938785|NCT01272219|365436791|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
105938786|NCT01272219|365436792|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
105938787|NCT01272219|365436787|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
105938788|NCT01272219|365436788|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
105938789|NCT01272219|365436789|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
105938790|NCT01272219|365436790|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
105938791|NCT01272219|365436791|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
106010489|NCT01488890|365704071|FG002|Overall Study|Lost to Follow-up|20|||
105736260|NCT05253807|364689676|FG000|Overall Study|Death|1|||
105736261|NCT05253807|364689677|FG001|Overall Study|Death|4|||
105736262|NCT05253807|364689676|FG000|Overall Study|Withdrawal by Subject|1|||
105736263|NCT05253807|364689677|FG001|Overall Study|Withdrawal by Subject|0|||
105736264|NCT05253807|364689676|FG000|Overall Study|Study Terminated by Sponsor|1|||
105736265|NCT05253807|364689677|FG001|Overall Study|Study Terminated by Sponsor|1|||
105736266|NCT00447421|364689678|FG000|Overall Study|Lack of Efficacy|1|||
105736267|NCT00447421|364689678|FG000|Overall Study|Adverse Event|3|||
105736268|NCT00447421|364689678|FG000|Overall Study|Sponsor Decision|2|||
105736269|NCT02124798|364689680|FG000|Overall Study|Adverse Event|3|||
105736270|NCT02124798|364689680|FG000|Overall Study|Lost to Follow-up|1|||
105736271|NCT01797432|364689683|FG000|Overall Study|Lost to Follow-up|1|||
105736272|NCT01797432|364689683|FG000|Overall Study|Adverse Event|1|||
105736273|NCT01797432|364689683|FG000|Overall Study|Withdrawal by Subject|1|||
105736274|NCT01797432|364689683|FG000|Overall Study|lived too far from study site|1|||
105736275|NCT02792777|364689684|FG000|Overall Study|Withdrawal by Subject|2|||
105736276|NCT02792777|364689685|FG001|Overall Study|Withdrawal by Subject|0|||
105736277|NCT02792777|364689684|FG000|Overall Study|Recording malfunction|2|||
105736278|NCT02792777|364689685|FG001|Overall Study|Recording malfunction|0|||
105736279|NCT02792777|364689684|FG000|Overall Study|Later determined to be ineligible|2|||
105736280|NCT02792777|364689685|FG001|Overall Study|Later determined to be ineligible|0|||
105736281|NCT02792777|364689684|FG000|Overall Study|Participant interviewed twice|1|||
105736282|NCT02792777|364689685|FG001|Overall Study|Participant interviewed twice|0|||
105736283|NCT02053246|364689686|FG000|Overall Study|Withdrawal by Subject|3|||
105736284|NCT02053246|364689686|FG000|Overall Study|Physician Decision|1|||
105736285|NCT02707757|364689687|FG000|Overall Study|Protocol Violation|3|||
105736286|NCT02707757|364689688|FG001|Overall Study|Protocol Violation|2|||
105736287|NCT02707757|364689687|FG000|Overall Study|Withdrawal by Subject|2|||
105736288|NCT02707757|364689688|FG001|Overall Study|Withdrawal by Subject|0|||
105736289|NCT02707757|364689687|FG000|Overall Study|Death|0|||
105736290|NCT02707757|364689688|FG001|Overall Study|Death|1|||
105736291|NCT02707757|364689687|FG000|Overall Study|Adverse Event|6|||
105736292|NCT02707757|364689688|FG001|Overall Study|Adverse Event|4|||
105736293|NCT02707757|364689687|FG000|Overall Study|Renal transplant/elective operation|1|||
105736294|NCT02707757|364689688|FG001|Overall Study|Renal transplant/elective operation|5|||
105736295|NCT03429556|364689689|FG000|Overall Study|Lost to Follow-up|0|||
105736296|NCT03429556|364689690|FG001|Overall Study|Lost to Follow-up|1|||
105736297|NCT03429556|364689691|FG002|Overall Study|Lost to Follow-up|0|||
105736298|NCT03429556|364689692|FG003|Overall Study|Lost to Follow-up|0|||
106010490|NCT01488890|365704072|FG003|Overall Study|Lost to Follow-up|3|||
106140117|NCT02914522|366170491|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
105736299|NCT02746679|364689705|FG000|Overall Study|Lost to Follow-up|4|||
105736300|NCT02746679|364689706|FG001|Overall Study|Lost to Follow-up|6|||
105938792|NCT01272219|365436792|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
105938793|NCT01272219|365436787|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
105938794|NCT01272219|365436788|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
105938795|NCT01272219|365436789|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
105938796|NCT01272219|365436790|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
105938797|NCT01272219|365436791|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
105938798|NCT01272219|365436792|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
105938799|NCT01272219|365436787|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
105938800|NCT01272219|365436788|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
105938801|NCT01272219|365436789|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
105938802|NCT01272219|365436790|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
105938803|NCT01272219|365436791|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
105938804|NCT01272219|365436792|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
105938805|NCT01272219|365436787|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
105938806|NCT01272219|365436788|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
105938807|NCT01272219|365436789|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
105938808|NCT01272219|365436790|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
105938809|NCT01272219|365436791|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
105938810|NCT01272219|365436792|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
105938811|NCT01272219|365436787|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
105938812|NCT01272219|365436788|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
105938813|NCT01272219|365436789|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
105938814|NCT01272219|365436790|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
105736301|NCT01118143|364689707|FG000|Overall Study|Withdrawal by Subject|2|||
105736302|NCT01118143|364689708|FG001|Overall Study|Withdrawal by Subject|5|||
105736303|NCT03268746|364691065|FG000|Overall Study|Withdrawal by Subject|1|||
105736304|NCT01629667|364691066|FG000|Overall Study|Lost to Follow-up|0|||
105736305|NCT01629667|364691067|FG001|Overall Study|Lost to Follow-up|1|||
105736306|NCT01629667|364691068|FG002|Overall Study|Lost to Follow-up|1|||
105799182|NCT04444752|364922707|FG001|Overall Study|Physician Decision|0|||
106140118|NCT02914522|366170492|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
106140119|NCT02914522|366170482|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
106140120|NCT02914522|366170483|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
106140121|NCT02914522|366170484|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
106140122|NCT02914522|366170485|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
106140123|NCT02914522|366170486|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
106140124|NCT02914522|366170487|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
106140125|NCT02914522|366170488|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
106140126|NCT02914522|366170489|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
106140127|NCT02914522|366170490|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
106140128|NCT02914522|366170491|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
106140129|NCT02914522|366170492|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
106140130|NCT02914522|366170482|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
106140131|NCT02914522|366170483|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
106140132|NCT02914522|366170484|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
106140133|NCT02914522|366170485|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
106140134|NCT02914522|366170486|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
106140135|NCT02914522|366170487|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
106140136|NCT02914522|366170488|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
106140137|NCT02914522|366170489|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
106140138|NCT02914522|366170490|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
106140139|NCT02914522|366170491|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
106140140|NCT02914522|366170492|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
106140141|NCT02914522|366170482|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
106140142|NCT02914522|366170483|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
106140143|NCT02914522|366170484|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
106140144|NCT02914522|366170485|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
106140145|NCT02914522|366170486|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
106140146|NCT02914522|366170487|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
106140147|NCT02914522|366170488|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
106140148|NCT02914522|366170489|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
106140149|NCT02914522|366170490|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
106140150|NCT02914522|366170491|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
106140151|NCT02914522|366170492|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
106140152|NCT02914522|366170482|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140153|NCT02914522|366170483|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140154|NCT02914522|366170484|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140155|NCT02914522|366170485|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140156|NCT02914522|366170486|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
106140157|NCT02914522|366170487|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140158|NCT02914522|366170488|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140159|NCT02914522|366170489|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140160|NCT02914522|366170490|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140161|NCT02914522|366170491|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140162|NCT02914522|366170492|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
106140163|NCT02914522|366170482|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
106140164|NCT02914522|366170483|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140165|NCT02914522|366170484|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140166|NCT02914522|366170485|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140167|NCT02914522|366170486|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140168|NCT02914522|366170487|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140169|NCT02914522|366170488|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140170|NCT02914522|366170489|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140171|NCT02914522|366170490|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140172|NCT02914522|366170491|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
105736307|NCT01629667|364691066|FG000|Overall Study|Withdrawal by Subject|31|||
105736308|NCT01629667|364691067|FG001|Overall Study|Withdrawal by Subject|20|||
105736309|NCT01629667|364691068|FG002|Overall Study|Withdrawal by Subject|28|||
105736310|NCT01629667|364691066|FG000|Overall Study|Death|1|||
105736311|NCT01629667|364691067|FG001|Overall Study|Death|5|||
105736312|NCT01629667|364691068|FG002|Overall Study|Death|3|||
105736313|NCT01629667|364691066|FG000|Overall Study|Randomized, not treated|2|||
105736314|NCT01629667|364691067|FG001|Overall Study|Randomized, not treated|1|||
105736315|NCT01629667|364691068|FG002|Overall Study|Randomized, not treated|0|||
106140173|NCT02914522|366170492|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
106140174|NCT02914522|366170482|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
106140175|NCT02914522|366170483|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
105736316|NCT01629667|364691066|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
105736317|NCT01629667|364691067|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
106140176|NCT02914522|366170484|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
106140177|NCT02914522|366170485|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
106140178|NCT02914522|366170486|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
106140179|NCT02914522|366170487|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
106140180|NCT02914522|366170488|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
106140181|NCT02914522|366170489|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
106140182|NCT02914522|366170490|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
105736318|NCT01629667|364691068|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
105736319|NCT01629667|364691066|FG000|Overall Study|Requiring lung transplant|2|||
105736320|NCT01629667|364691067|FG001|Overall Study|Requiring lung transplant|1|||
105736321|NCT01629667|364691068|FG002|Overall Study|Requiring lung transplant|3|||
105736322|NCT01629667|364691066|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
105736323|NCT01629667|364691067|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
105736324|NCT01629667|364691068|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
105736325|NCT01629667|364691066|FG000|Overall Study|Started other medicine|1|||
105736326|NCT01629667|364691067|FG001|Overall Study|Started other medicine|0|||
105736327|NCT01629667|364691068|FG002|Overall Study|Started other medicine|1|||
105736328|NCT01629667|364691066|FG000|Overall Study|Site error in safety follow-up|0|||
105736329|NCT01629667|364691067|FG001|Overall Study|Site error in safety follow-up|0|||
105736330|NCT01629667|364691068|FG002|Overall Study|Site error in safety follow-up|1|||
105736331|NCT01629667|364691066|FG000|Overall Study|Enrolled in another clinical study|0|||
105736332|NCT01629667|364691067|FG001|Overall Study|Enrolled in another clinical study|1|||
105736333|NCT01629667|364691068|FG002|Overall Study|Enrolled in another clinical study|0|||
105736334|NCT01629667|364691066|FG000|Overall Study|Code break|1|||
106140183|NCT02914522|366170491|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
106140184|NCT02914522|366170492|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
106140185|NCT02914522|366170482|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
106140186|NCT02914522|366170483|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
106140187|NCT02914522|366170484|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
106140188|NCT02914522|366170485|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
105736335|NCT01629667|364691067|FG001|Overall Study|Code break|0|||
105938815|NCT01272219|365436791|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
105938816|NCT01272219|365436792|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
105938817|NCT04818086|365436795|FG000|Overall Study|Physician Decision|1|||
105938818|NCT04818086|365436796|FG001|Overall Study|Physician Decision|0|||
105938819|NCT04818086|365436795|FG000|Overall Study|Withdrawal by Subject|0|||
105938820|NCT04818086|365436796|FG001|Overall Study|Withdrawal by Subject|1|||
105938821|NCT00215657|365436802|FG000|Overall Study|Adverse Event|5|||
105938822|NCT00215657|365436803|FG001|Overall Study|Adverse Event|1|||
105938823|NCT00215657|365436804|FG002|Overall Study|Adverse Event|3|||
105938824|NCT00215657|365436805|FG003|Overall Study|Adverse Event|0|||
105938825|NCT00215657|365436806|FG004|Overall Study|Adverse Event|3|||
105938826|NCT00215657|365436807|FG005|Overall Study|Adverse Event|1|||
105938827|NCT00215657|365436808|FG006|Overall Study|Adverse Event|0|||
105938828|NCT00215657|365436809|FG007|Overall Study|Adverse Event|3|||
105938829|NCT00215657|365436802|FG000|Overall Study|Withdrawal by Subject|6|||
105938830|NCT00215657|365436803|FG001|Overall Study|Withdrawal by Subject|3|||
105938831|NCT00215657|365436804|FG002|Overall Study|Withdrawal by Subject|3|||
105938832|NCT00215657|365436805|FG003|Overall Study|Withdrawal by Subject|1|||
105938833|NCT00215657|365436806|FG004|Overall Study|Withdrawal by Subject|6|||
105938834|NCT00215657|365436807|FG005|Overall Study|Withdrawal by Subject|1|||
105938835|NCT00215657|365436808|FG006|Overall Study|Withdrawal by Subject|10|||
105938836|NCT00215657|365436809|FG007|Overall Study|Withdrawal by Subject|3|||
105938837|NCT00215657|365436802|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
105938838|NCT00215657|365436803|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
105938839|NCT00215657|365436804|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
105938840|NCT00215657|365436805|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
105938841|NCT00215657|365436806|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
105938842|NCT00215657|365436807|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
105938843|NCT00215657|365436808|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
105938844|NCT00215657|365436809|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
105938845|NCT00215657|365436802|FG000|Overall Study|Insufficient testosterone response|5|||
105938846|NCT00215657|365436803|FG001|Overall Study|Insufficient testosterone response|4|||
105938847|NCT00215657|365436804|FG002|Overall Study|Insufficient testosterone response|1|||
105938848|NCT00215657|365436805|FG003|Overall Study|Insufficient testosterone response|12|||
106140189|NCT02914522|366170486|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
105736336|NCT01629667|364691068|FG002|Overall Study|Code break|0|||
105736337|NCT01319929|364691070|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
105938849|NCT00215657|365436806|FG004|Overall Study|Insufficient testosterone response|8|||
105938850|NCT00215657|365436807|FG005|Overall Study|Insufficient testosterone response|12|||
105938851|NCT00215657|365436808|FG006|Overall Study|Insufficient testosterone response|4|||
105938852|NCT00215657|365436809|FG007|Overall Study|Insufficient testosterone response|7|||
105938853|NCT00215657|365436802|FG000|Overall Study|Other|3|||
105736338|NCT01319929|364691071|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
105736339|NCT01319929|364691070|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
105736340|NCT01319929|364691071|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
105736341|NCT01319929|364691070|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
105736342|NCT01319929|364691071|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
105736343|NCT01319929|364691070|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
106010491|NCT01488890|365704069|FG000|Overall Study|Withdrawal by Subject|14|||
106010492|NCT01488890|365704070|FG001|Overall Study|Withdrawal by Subject|10|||
106010493|NCT01488890|365704071|FG002|Overall Study|Withdrawal by Subject|11|||
106010494|NCT01488890|365704072|FG003|Overall Study|Withdrawal by Subject|2|||
106010495|NCT02694185|365704073|FG000|Overall Study|Withdrawal by Subject|45|||
106010496|NCT02694185|365704074|FG001|Overall Study|Withdrawal by Subject|0|||
106010497|NCT05082857|365704075|FG000|Overall Study|participants relocated and could not continue|2|||
106010498|NCT05082857|365704076|FG001|Overall Study|participants relocated and could not continue|1|||
106010499|NCT05082857|365704075|FG000|Overall Study|Lost to Follow-up|1|||
106010500|NCT05082857|365704076|FG001|Overall Study|Lost to Follow-up|3|||
106010501|NCT00791934|365704080|FG000|Overall Study|Withdrawal by Subject|2|||
106010502|NCT00791934|365704080|FG000|Overall Study|Did not consent for extended follow-up|13|||
106010503|NCT04825678|365704087|FG000|Overall Study|Decision by Sponsor|2|||
106010504|NCT04825678|365704088|FG001|Overall Study|Decision by Sponsor|3|||
106010505|NCT04825678|365704087|FG000|Overall Study|Withdrawal of Consent From Study|7|||
106010506|NCT04825678|365704088|FG001|Overall Study|Withdrawal of Consent From Study|9|||
106010507|NCT04825678|365704087|FG000|Overall Study|Lost to Follow-up|3|||
106010508|NCT04825678|365704088|FG001|Overall Study|Lost to Follow-up|4|||
106010509|NCT04825678|365704087|FG000|Overall Study|Never Received Investigational Product|1|||
106010510|NCT04825678|365704088|FG001|Overall Study|Never Received Investigational Product|1|||
106010511|NCT02195518|365704089|FG000|Overall Study|Adverse Event|1|||
106010512|NCT02195518|365704089|FG000|Overall Study|Protocol Violation|4|||
106010513|NCT02195518|365704089|FG000|Overall Study|Pregnancy|2|||
106010514|NCT02195518|365704089|FG000|Overall Study|Withdrawal by Subject|1|||
106010515|NCT02195518|365704089|FG000|Overall Study|Lost to Follow-up|1|||
106010516|NCT00734149|365704090|FG000|Overall Study|Withdrawal by Subject|1|||
106010517|NCT04482647|365704093|FG000|Overall Study|Time constraints|2|||
106010518|NCT04482647|365704093|FG000|Overall Study|Health issues|1|||
106010519|NCT04482647|365704093|FG000|Overall Study|Death in the family|1|||
106010520|NCT04482647|365704093|FG000|Overall Study|Disliked the intervention|1|||
106010521|NCT04482647|365704093|FG000|Overall Study|No reasons specified|7|||
106010522|NCT02855125|365704094|FG000|Overall Study|Withdrawal by Subject|2|||
106010523|NCT02855125|365704095|FG001|Overall Study|Withdrawal by Subject|2|||
106010524|NCT02855125|365704094|FG000|Overall Study|Clinical Disease Progression|5|||
106010525|NCT02855125|365704095|FG001|Overall Study|Clinical Disease Progression|4|||
106010526|NCT02855125|365704094|FG000|Overall Study|Radiologic Disease Progression|36|||
106010527|NCT02855125|365704095|FG001|Overall Study|Radiologic Disease Progression|39|||
106010528|NCT02855125|365704094|FG000|Overall Study|Adverse Event|11|||
106010529|NCT02855125|365704095|FG001|Overall Study|Adverse Event|7|||
106010530|NCT02855125|365704094|FG000|Overall Study|Physician Decision|1|||
106010531|NCT02855125|365704095|FG001|Overall Study|Physician Decision|0|||
106010532|NCT02855125|365704094|FG000|Overall Study|On Treatment|9|||
106010533|NCT02855125|365704095|FG001|Overall Study|On Treatment|11|||
106010534|NCT02855125|365704094|FG000|Overall Study|Randomized but not treated|0|||
106010535|NCT02855125|365704095|FG001|Overall Study|Randomized but not treated|1|||
106010536|NCT03472885|365704097|FG000|24-Week Treatment Period|Adverse Event|1|||
106010537|NCT04467905|365704098|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
106010538|NCT04467905|365704099|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
106010539|NCT04467905|365704100|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
106010540|NCT04467905|365704098|FG000|Overall Study|Conversion to SR|0|||
106010541|NCT04467905|365704099|FG001|Overall Study|Conversion to SR|0|||
106010542|NCT04467905|365704100|FG002|Overall Study|Conversion to SR|3|||
106010543|NCT04467905|365704098|FG000|Overall Study|Technical issue with Holter ECG|0|||
106010544|NCT04467905|365704099|FG001|Overall Study|Technical issue with Holter ECG|0|||
106010545|NCT04467905|365704100|FG002|Overall Study|Technical issue with Holter ECG|3|||
106010546|NCT04467905|365704098|FG000|Overall Study|Hemodynamic instability|0|||
106010547|NCT04467905|365704099|FG001|Overall Study|Hemodynamic instability|0|||
106010548|NCT04467905|365704100|FG002|Overall Study|Hemodynamic instability|1|||
105736344|NCT01319929|364691071|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
105736345|NCT01319929|364691070|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
105799183|NCT04444752|364922708|FG002|Overall Study|Physician Decision|0|||
106010549|NCT04467905|365704098|FG000|Overall Study|Site misinterpretation of protocol|0|||
106010550|NCT04467905|365704099|FG001|Overall Study|Site misinterpretation of protocol|0|||
106010551|NCT04467905|365704100|FG002|Overall Study|Site misinterpretation of protocol|1|||
106010552|NCT04586205|365704103|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
106010553|NCT04586205|365704104|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
106010554|NCT04944992|365705728|FG000|Overall Study|Lost to Follow-up|1|||
106010555|NCT04944992|365705729|FG001|Overall Study|Lost to Follow-up|1|||
106010556|NCT04944992|365705728|FG000|Overall Study|Physician Decision|1|||
106010557|NCT04944992|365705729|FG001|Overall Study|Physician Decision|0|||
106010558|NCT04944992|365705728|FG000|Overall Study|Withdrawal by Subject|6|||
106010559|NCT04944992|365705729|FG001|Overall Study|Withdrawal by Subject|1|||
106010560|NCT00303069|365705730|FG000|Overall Study|Lost to Follow-up|1|||
106010561|NCT00303069|365705731|FG001|Overall Study|Lost to Follow-up|0|||
106010562|NCT00303069|365705732|FG002|Overall Study|Lost to Follow-up|0|||
106010563|NCT00303069|365705733|FG003|Overall Study|Lost to Follow-up|2|||
106010564|NCT00303069|365705730|FG000|Overall Study|subject moved|1|||
106010565|NCT00303069|365705731|FG001|Overall Study|subject moved|0|||
106010566|NCT00303069|365705732|FG002|Overall Study|subject moved|0|||
106010567|NCT00303069|365705733|FG003|Overall Study|subject moved|0|||
106010568|NCT00303069|365705730|FG000|Overall Study|Recruitment into Army Reserves|0|||
106010569|NCT00303069|365705731|FG001|Overall Study|Recruitment into Army Reserves|0|||
106010570|NCT00303069|365705732|FG002|Overall Study|Recruitment into Army Reserves|1|||
106010571|NCT00303069|365705733|FG003|Overall Study|Recruitment into Army Reserves|0|||
106010572|NCT00425269|365705734|FG000|Overall Study|Pregnancy|5|||
106010573|NCT00425269|365705735|FG001|Overall Study|Pregnancy|7|||
106010574|NCT00425269|365705734|FG000|Overall Study|Lost to Follow-up|9|||
106010575|NCT00425269|365705735|FG001|Overall Study|Lost to Follow-up|9|||
106010576|NCT00425269|365705734|FG000|Overall Study|moved or medical reason|5|||
106010577|NCT00425269|365705735|FG001|Overall Study|moved or medical reason|4|||
106010578|NCT04218240|365705736|FG000|Overall Study|Withdrawal by Subject|6|||
106010579|NCT04218240|365705737|FG001|Overall Study|Withdrawal by Subject|0|||
106010580|NCT04218240|365705736|FG000|Overall Study|Lack of Efficacy|24|||
106010581|NCT04218240|365705737|FG001|Overall Study|Lack of Efficacy|19|||
106010582|NCT04218240|365705736|FG000|Overall Study|Physician Decision|0|||
106010583|NCT04218240|365705737|FG001|Overall Study|Physician Decision|1|||
106010584|NCT04218240|365705736|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
106010585|NCT04218240|365705737|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
106010586|NCT04097678|365705738|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
106010587|NCT04097678|365705739|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
106010588|NCT03694678|365705740|FG000|Overall Study|Withdrawal by Subject|2|||
106010589|NCT03694678|365705741|FG001|Overall Study|Withdrawal by Subject|0|||
106010590|NCT03694678|365705740|FG000|Overall Study|Lost to Follow-up|2|||
106010591|NCT03694678|365705741|FG001|Overall Study|Lost to Follow-up|3|||
106010592|NCT05966142|365705742|FG000|Overall Study|Death|3|||
106010593|NCT05966142|365705743|FG001|Overall Study|Death|3|||
106010594|NCT05966142|365705742|FG000|Overall Study|Lost to Follow-up|55|||
106010595|NCT05966142|365705743|FG001|Overall Study|Lost to Follow-up|52|||
106010596|NCT05966142|365705742|FG000|Overall Study|Physician Decision|1|||
106010597|NCT05966142|365705743|FG001|Overall Study|Physician Decision|0|||
106010598|NCT05966142|365705742|FG000|Overall Study|Withdrawal by Subject|9|||
106010599|NCT05966142|365705743|FG001|Overall Study|Withdrawal by Subject|8|||
106010600|NCT05966142|365705742|FG000|Overall Study|Duplicate Enrollment|1|||
106010601|NCT05966142|365705743|FG001|Overall Study|Duplicate Enrollment|0|||
106010602|NCT05966142|365705742|FG000|Overall Study|Study Logistical Reason|1|||
106010603|NCT05966142|365705743|FG001|Overall Study|Study Logistical Reason|0|||
106010604|NCT05966142|365705742|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
106010605|NCT05966142|365705743|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
106010606|NCT01210313|365705748|FG000|Overall Study|Withdrawal by Subject|3|||
106010607|NCT01210313|365705748|FG000|Overall Study|Adverse Event|2|||
106010608|NCT01210313|365705748|FG000|Overall Study|Distant recurrence|4|||
106010609|NCT01210313|365705748|FG000|Overall Study|Non-compliance|7|||
106010610|NCT00283296|365705751|FG000|Overall Study|in-home trial not completed|5|||
106010611|NCT02589938|365705754|FG000|Overall Study|Withdrawal by Subject|11|||
106010612|NCT02589938|365705755|FG001|Overall Study|Withdrawal by Subject|5|||
106010613|NCT02589938|365705756|FG002|Overall Study|Withdrawal by Subject|6|||
106010614|NCT02589938|365705754|FG000|Overall Study|Lost to Follow-up|3|||
106010615|NCT02589938|365705755|FG001|Overall Study|Lost to Follow-up|3|||
106010616|NCT02589938|365705756|FG002|Overall Study|Lost to Follow-up|3|||
106140190|NCT02914522|366170487|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
106140191|NCT02914522|366170488|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
106140192|NCT02914522|366170489|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
106010617|NCT02589938|365705754|FG000|Overall Study|Death|1|||
106010618|NCT02589938|365705755|FG001|Overall Study|Death|0|||
106010619|NCT02589938|365705756|FG002|Overall Study|Death|1|||
106010620|NCT02589938|365705754|FG000|Overall Study|Protocol Violation|6|||
106010621|NCT02589938|365705755|FG001|Overall Study|Protocol Violation|2|||
106010622|NCT02589938|365705756|FG002|Overall Study|Protocol Violation|3|||
106010623|NCT02589938|365705754|FG000|Overall Study|Physician Decision|1|||
106010624|NCT02589938|365705755|FG001|Overall Study|Physician Decision|0|||
106010625|NCT02589938|365705756|FG002|Overall Study|Physician Decision|0|||
106010626|NCT02589938|365705754|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
106010627|NCT02589938|365705755|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
106140193|NCT02914522|366170490|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
106010628|NCT02589938|365705756|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
106010629|NCT03558737|365705757|FG000|Overall Study|Death|1|||
106010630|NCT03558737|365705758|FG001|Overall Study|Death|1|||
106010631|NCT01318915|365705761|FG000|Overall Study|Lost to Follow-up|1|||
106010632|NCT00632229|365705762|FG000|Overall Study|Adverse Event|6|||
106010633|NCT00632229|365705763|FG001|Overall Study|Adverse Event|0|||
106010634|NCT00632229|365705762|FG000|Overall Study|Lost to Follow-up|0|||
106010635|NCT00632229|365705763|FG001|Overall Study|Lost to Follow-up|3|||
106010636|NCT00632229|365705762|FG000|Overall Study|Lack of Efficacy|0|||
106010637|NCT00632229|365705763|FG001|Overall Study|Lack of Efficacy|2|||
106010638|NCT00632229|365705762|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
106140194|NCT02914522|366170491|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
106140195|NCT02914522|366170492|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
106140196|NCT02914522|366170482|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
106140197|NCT02914522|366170483|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
106140198|NCT02914522|366170484|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
106140199|NCT02914522|366170485|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
106140200|NCT02914522|366170486|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
106140201|NCT02914522|366170487|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
106140202|NCT02914522|366170488|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
106140203|NCT02914522|366170489|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
106140204|NCT02914522|366170490|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
106140205|NCT02914522|366170491|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
106140206|NCT02914522|366170492|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
106140207|NCT02914522|366170482|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
106140208|NCT02914522|366170483|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
106140209|NCT02914522|366170484|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
106140210|NCT02914522|366170485|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
106140211|NCT02914522|366170486|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
106140212|NCT02914522|366170487|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
106140213|NCT02914522|366170488|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
106140214|NCT02914522|366170489|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
106140215|NCT02914522|366170490|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
106140216|NCT02914522|366170491|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
106140217|NCT02914522|366170492|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
106140218|NCT02914522|366170482|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
106140219|NCT02914522|366170483|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
106140220|NCT02914522|366170484|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
106140221|NCT02914522|366170485|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
106140222|NCT02914522|366170486|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
106140223|NCT02914522|366170487|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
106140224|NCT02914522|366170488|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
106140225|NCT02914522|366170489|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
106140226|NCT02914522|366170490|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
106140227|NCT02914522|366170491|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
106140228|NCT02914522|366170492|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
106140229|NCT02914522|366170482|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
106140230|NCT02914522|366170483|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
106140231|NCT02914522|366170484|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
106140232|NCT02914522|366170485|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
106140233|NCT02914522|366170486|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
106140234|NCT02914522|366170487|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
105799184|NCT04444752|364922709|FG003|Overall Study|Physician Decision|2|||
106140235|NCT02914522|366170488|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
106140236|NCT02914522|366170489|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
106140237|NCT02914522|366170490|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
106140238|NCT02914522|366170491|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
106140239|NCT02914522|366170492|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
106140240|NCT02914522|366170482|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
106140241|NCT02914522|366170483|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
105799185|NCT04444752|364922706|FG000|Overall Study|Pregnancy|0|||
105799186|NCT04444752|364922707|FG001|Overall Study|Pregnancy|0|||
106010639|NCT00632229|365705763|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
106010640|NCT05386329|365705767|FG000|Overall Study|Lost to Follow-up|3|||
105736346|NCT01319929|364691071|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
106010641|NCT00888134|365705768|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
106010642|NCT00888134|365705768|FG000|Follow-up|being followed for long-term survival|1|||
106010643|NCT03224819|365705772|FG000|Overall Study|Withdrawal by Subject|0|||
106010644|NCT03224819|365705773|FG001|Overall Study|Withdrawal by Subject|0|||
106010645|NCT03224819|365705774|FG002|Overall Study|Withdrawal by Subject|0|||
106010646|NCT03224819|365705775|FG003|Overall Study|Withdrawal by Subject|0|||
106010647|NCT03224819|365705776|FG004|Overall Study|Withdrawal by Subject|0|||
106010648|NCT03224819|365705777|FG005|Overall Study|Withdrawal by Subject|0|||
106010649|NCT03224819|365705778|FG006|Overall Study|Withdrawal by Subject|0|||
106010650|NCT03224819|365705779|FG007|Overall Study|Withdrawal by Subject|0|||
106010651|NCT03224819|365705780|FG008|Overall Study|Withdrawal by Subject|0|||
106010652|NCT03224819|365705781|FG009|Overall Study|Withdrawal by Subject|0|||
106010653|NCT03224819|365705782|FG010|Overall Study|Withdrawal by Subject|0|||
106010654|NCT03224819|365705783|FG011|Overall Study|Withdrawal by Subject|0|||
106010655|NCT03224819|365705784|FG012|Overall Study|Withdrawal by Subject|1|||
106010656|NCT03224819|365705785|FG013|Overall Study|Withdrawal by Subject|0|||
106010657|NCT03224819|365705772|FG000|Overall Study|Sponsor Decision|0|||
106010658|NCT03224819|365705773|FG001|Overall Study|Sponsor Decision|0|||
106010659|NCT03224819|365705774|FG002|Overall Study|Sponsor Decision|0|||
106010660|NCT03224819|365705775|FG003|Overall Study|Sponsor Decision|1|||
106010661|NCT03224819|365705776|FG004|Overall Study|Sponsor Decision|1|||
106010662|NCT03224819|365705777|FG005|Overall Study|Sponsor Decision|2|||
106010663|NCT03224819|365705778|FG006|Overall Study|Sponsor Decision|1|||
106010664|NCT03224819|365705779|FG007|Overall Study|Sponsor Decision|1|||
106010665|NCT03224819|365705780|FG008|Overall Study|Sponsor Decision|1|||
106010666|NCT03224819|365705781|FG009|Overall Study|Sponsor Decision|2|||
106010667|NCT03224819|365705782|FG010|Overall Study|Sponsor Decision|1|||
106010668|NCT03224819|365705783|FG011|Overall Study|Sponsor Decision|1|||
106010669|NCT03224819|365705784|FG012|Overall Study|Sponsor Decision|1|||
106010670|NCT03224819|365705785|FG013|Overall Study|Sponsor Decision|0|||
106010671|NCT03224819|365705772|FG000|Overall Study|Lost to Follow-up|0|||
106010672|NCT03224819|365705773|FG001|Overall Study|Lost to Follow-up|0|||
106010673|NCT03224819|365705774|FG002|Overall Study|Lost to Follow-up|0|||
106010674|NCT03224819|365705775|FG003|Overall Study|Lost to Follow-up|0|||
106010675|NCT03224819|365705776|FG004|Overall Study|Lost to Follow-up|0|||
106010676|NCT03224819|365705777|FG005|Overall Study|Lost to Follow-up|0|||
106010677|NCT03224819|365705778|FG006|Overall Study|Lost to Follow-up|0|||
106010678|NCT03224819|365705779|FG007|Overall Study|Lost to Follow-up|0|||
106010679|NCT03224819|365705780|FG008|Overall Study|Lost to Follow-up|1|||
106010680|NCT03224819|365705781|FG009|Overall Study|Lost to Follow-up|0|||
105736347|NCT01749735|364691072|FG000|Overall Study|Withdrawal by Subject|1|||
105736348|NCT01749735|364691073|FG001|Overall Study|Withdrawal by Subject|0|||
105736349|NCT01645280|364691074|FG000|Overall Study|Death|0|||
105736350|NCT01645280|364691075|FG001|Overall Study|Death|1|||
105736351|NCT01645280|364691076|FG002|Overall Study|Death|0|||
105736352|NCT01645280|364691077|FG003|Overall Study|Death|0|||
105736353|NCT01645280|364691078|FG004|Overall Study|Death|0|||
105736354|NCT01645280|364691074|FG000|Overall Study|Withdrawal by Subject|4|||
105736355|NCT01645280|364691075|FG001|Overall Study|Withdrawal by Subject|0|||
105736356|NCT01645280|364691076|FG002|Overall Study|Withdrawal by Subject|2|||
105736357|NCT01645280|364691077|FG003|Overall Study|Withdrawal by Subject|4|||
105736358|NCT01645280|364691078|FG004|Overall Study|Withdrawal by Subject|5|||
105736359|NCT01645280|364691074|FG000|Overall Study|Lost to Follow-up|0|||
105736360|NCT01645280|364691075|FG001|Overall Study|Lost to Follow-up|0|||
105736361|NCT01645280|364691076|FG002|Overall Study|Lost to Follow-up|0|||
105736362|NCT01645280|364691077|FG003|Overall Study|Lost to Follow-up|2|||
105736363|NCT01645280|364691078|FG004|Overall Study|Lost to Follow-up|1|||
105736364|NCT01645280|364691074|FG000|Overall Study|Other|1|||
105736365|NCT01645280|364691075|FG001|Overall Study|Other|1|||
106010681|NCT03224819|365705782|FG010|Overall Study|Lost to Follow-up|0|||
106010682|NCT03224819|365705783|FG011|Overall Study|Lost to Follow-up|0|||
106010683|NCT03224819|365705784|FG012|Overall Study|Lost to Follow-up|0|||
105736366|NCT01645280|364691076|FG002|Overall Study|Other|2|||
105736367|NCT01645280|364691077|FG003|Overall Study|Other|0|||
105736368|NCT01645280|364691078|FG004|Overall Study|Other|0|||
105736369|NCT01645280|364691074|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
105736370|NCT01645280|364691075|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
105736371|NCT01645280|364691076|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
106010684|NCT03224819|365705785|FG013|Overall Study|Lost to Follow-up|0|||
106010685|NCT03224819|365705772|FG000|Overall Study|Death|0|||
106010686|NCT03224819|365705773|FG001|Overall Study|Death|1|||
106010687|NCT03224819|365705774|FG002|Overall Study|Death|0|||
106010688|NCT03224819|365705775|FG003|Overall Study|Death|0|||
106010689|NCT03224819|365705776|FG004|Overall Study|Death|0|||
106010690|NCT03224819|365705777|FG005|Overall Study|Death|0|||
106010691|NCT03224819|365705778|FG006|Overall Study|Death|0|||
106010692|NCT03224819|365705779|FG007|Overall Study|Death|1|||
106010693|NCT03224819|365705780|FG008|Overall Study|Death|0|||
106010694|NCT03224819|365705781|FG009|Overall Study|Death|0|||
105799187|NCT04444752|364922708|FG002|Overall Study|Pregnancy|0|||
105799188|NCT04444752|364922709|FG003|Overall Study|Pregnancy|1|||
105799189|NCT04444752|364922706|FG000|Overall Study|Withdrawal by Subject|6|||
105799190|NCT04444752|364922707|FG001|Overall Study|Withdrawal by Subject|5|||
105799191|NCT04444752|364922708|FG002|Overall Study|Withdrawal by Subject|3|||
105799192|NCT04444752|364922709|FG003|Overall Study|Withdrawal by Subject|4|||
105799193|NCT04444752|364922706|FG000|Overall Study|Protocol Violation|1|||
105799194|NCT04444752|364922707|FG001|Overall Study|Protocol Violation|1|||
105799195|NCT04444752|364922708|FG002|Overall Study|Protocol Violation|0|||
105799196|NCT04444752|364922709|FG003|Overall Study|Protocol Violation|0|||
105799197|NCT04444752|364922706|FG000|Overall Study|Patient moving out of town|1|||
105799198|NCT04444752|364922707|FG001|Overall Study|Patient moving out of town|0|||
105799199|NCT04444752|364922708|FG002|Overall Study|Patient moving out of town|0|||
105799200|NCT04444752|364922709|FG003|Overall Study|Patient moving out of town|1|||
105799201|NCT04444752|364922706|FG000|Overall Study|Lack of Efficacy|0|||
105938854|NCT00215657|365436803|FG001|Overall Study|Other|1|||
105938855|NCT00215657|365436804|FG002|Overall Study|Other|2|||
105938856|NCT00215657|365436805|FG003|Overall Study|Other|3|||
105938857|NCT00215657|365436806|FG004|Overall Study|Other|5|||
105938858|NCT00215657|365436807|FG005|Overall Study|Other|4|||
105938859|NCT00215657|365436808|FG006|Overall Study|Other|6|||
105938860|NCT00215657|365436809|FG007|Overall Study|Other|1|||
105938861|NCT00420056|365436810|FG000|Overall Study|Objective progression or relapse|17|||
105938862|NCT01390584|365436811|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
105938863|NCT01390584|365436812|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
105938864|NCT01390584|365436813|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
105938865|NCT04090749|365436814|FG000|Open Label Pilot|Lost to Follow-up|1|||
105938866|NCT04090749|365436815|FG001|Open Label Pilot|Lost to Follow-up|0|||
105938867|NCT04090749|365436816|FG002|Open Label Pilot|Lost to Follow-up|0|||
105938868|NCT04090749|365436814|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
105938869|NCT04090749|365436815|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
105938870|NCT04090749|365436816|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
105938871|NCT04090749|365436814|FG000|Pilot Trial|Lost to Follow-up|0|||
105938872|NCT04090749|365436815|FG001|Pilot Trial|Lost to Follow-up|1|||
105938873|NCT04090749|365436816|FG002|Pilot Trial|Lost to Follow-up|1|||
105938874|NCT03425188|365436818|FG000|Overall Study|Withdrawal by Subject|1|||
105938875|NCT01044459|365436819|FG000|Overall Study|Withdrawal by Subject|21|||
105938876|NCT01044459|365436820|FG001|Overall Study|Withdrawal by Subject|28|||
105938877|NCT01044459|365436819|FG000|Overall Study|Terminated by Sponsor|22|||
105938878|NCT01044459|365436820|FG001|Overall Study|Terminated by Sponsor|21|||
105938879|NCT01044459|365436819|FG000|Overall Study|Adverse Event|22|||
105938880|NCT01044459|365436820|FG001|Overall Study|Adverse Event|20|||
105938881|NCT01044459|365436819|FG000|Overall Study|Lack of Efficacy|23|||
105938882|NCT01044459|365436820|FG001|Overall Study|Lack of Efficacy|12|||
105938883|NCT01044459|365436819|FG000|Overall Study|Protocol Violation|11|||
105938884|NCT01044459|365436820|FG001|Overall Study|Protocol Violation|16|||
105938885|NCT01044459|365436819|FG000|Overall Study|Other Reason|7|||
105938886|NCT01044459|365436820|FG001|Overall Study|Other Reason|14|||
105938887|NCT01044459|365436819|FG000|Overall Study|COPD exacerbation|9|||
105938888|NCT01044459|365436820|FG001|Overall Study|COPD exacerbation|8|||
105938889|NCT01044459|365436819|FG000|Overall Study|Lost to Follow-up|18|||
105938890|NCT01044459|365436820|FG001|Overall Study|Lost to Follow-up|12|||
105938891|NCT01093573|365436821|FG000|Overall Study|Physician Decision|0|||
105938892|NCT01093573|365436822|FG001|Overall Study|Physician Decision|0|||
105938893|NCT01093573|365436823|FG002|Overall Study|Physician Decision|1|||
105938894|NCT01093573|365436821|FG000|Overall Study|Insurance Denied|0|||
105938895|NCT01093573|365436822|FG001|Overall Study|Insurance Denied|0|||
105938896|NCT01093573|365436823|FG002|Overall Study|Insurance Denied|1|||
105938897|NCT00289900|365436824|FG000|Overall Study|Adverse Event|28|||
105938898|NCT00289900|365436825|FG001|Overall Study|Adverse Event|40|||
105938899|NCT00289900|365436826|FG002|Overall Study|Adverse Event|13|||
105938900|NCT00289900|365436827|FG003|Overall Study|Adverse Event|19|||
106010695|NCT03224819|365705782|FG010|Overall Study|Death|0|||
105799202|NCT04444752|364922707|FG001|Overall Study|Lack of Efficacy|0|||
105799203|NCT04444752|364922708|FG002|Overall Study|Lack of Efficacy|0|||
105799204|NCT04444752|364922709|FG003|Overall Study|Lack of Efficacy|1|||
105799205|NCT04444752|364922706|FG000|Overall Study|Death|0|||
105799206|NCT04444752|364922707|FG001|Overall Study|Death|0|||
106010696|NCT03224819|365705783|FG011|Overall Study|Death|1|||
105799207|NCT04444752|364922708|FG002|Overall Study|Death|1|||
105799208|NCT04444752|364922709|FG003|Overall Study|Death|0|||
105938901|NCT00289900|365436828|FG004|Overall Study|Adverse Event|20|||
105938902|NCT00289900|365436829|FG005|Overall Study|Adverse Event|33|||
105938903|NCT00289900|365436824|FG000|Overall Study|Lost to Follow-up|7|||
105938904|NCT00289900|365436825|FG001|Overall Study|Lost to Follow-up|7|||
105938905|NCT00289900|365436826|FG002|Overall Study|Lost to Follow-up|8|||
105938906|NCT00289900|365436827|FG003|Overall Study|Lost to Follow-up|8|||
105938907|NCT00289900|365436828|FG004|Overall Study|Lost to Follow-up|4|||
105938908|NCT00289900|365436829|FG005|Overall Study|Lost to Follow-up|8|||
106010697|NCT03224819|365705784|FG012|Overall Study|Death|0|||
105799209|NCT00579254|364922710|FG000|Overall Study|Lost to Follow-up|39|||
106010698|NCT03224819|365705785|FG013|Overall Study|Death|0|||
106010699|NCT03783078|365705786|FG000|Overall Study|Death|31|||
106010700|NCT03783078|365705786|FG000|Overall Study|Sponsor Decision|23|||
106010701|NCT03783078|365705786|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
106010702|NCT04973449|365705789|FG000|Overall Study|Withdrawal by Subject|3|||
106010703|NCT04973449|365705790|FG001|Overall Study|Withdrawal by Subject|3|||
106010704|NCT04973449|365705791|FG002|Overall Study|Withdrawal by Subject|2|||
106010705|NCT04973449|365705792|FG003|Overall Study|Withdrawal by Subject|5|||
106010706|NCT04973449|365705793|FG004|Overall Study|Withdrawal by Subject|5|||
106010707|NCT04973449|365705794|FG005|Overall Study|Withdrawal by Subject|4|||
106010708|NCT04973449|365705795|FG006|Overall Study|Withdrawal by Subject|7|||
106010709|NCT04973449|365705796|FG007|Overall Study|Withdrawal by Subject|5|||
106010710|NCT04973449|365705789|FG000|Overall Study|Lost to Follow-up|15|||
106010711|NCT04973449|365705790|FG001|Overall Study|Lost to Follow-up|16|||
106010712|NCT04973449|365705791|FG002|Overall Study|Lost to Follow-up|16|||
106010713|NCT04973449|365705792|FG003|Overall Study|Lost to Follow-up|13|||
106010714|NCT04973449|365705793|FG004|Overall Study|Lost to Follow-up|5|||
106010715|NCT04973449|365705794|FG005|Overall Study|Lost to Follow-up|6|||
106010716|NCT04973449|365705795|FG006|Overall Study|Lost to Follow-up|10|||
106010717|NCT04973449|365705796|FG007|Overall Study|Lost to Follow-up|6|||
106010718|NCT04973449|365705789|FG000|Overall Study|Death|1|||
106010719|NCT04973449|365705790|FG001|Overall Study|Death|0|||
106010720|NCT04973449|365705791|FG002|Overall Study|Death|0|||
106010721|NCT04973449|365705792|FG003|Overall Study|Death|0|||
106010722|NCT04973449|365705793|FG004|Overall Study|Death|0|||
106010723|NCT04973449|365705794|FG005|Overall Study|Death|1|||
106010724|NCT04973449|365705795|FG006|Overall Study|Death|0|||
106010725|NCT04973449|365705796|FG007|Overall Study|Death|0|||
106010726|NCT04973449|365705789|FG000|Overall Study|Other|1|||
106010727|NCT04973449|365705790|FG001|Overall Study|Other|1|||
106010728|NCT04973449|365705791|FG002|Overall Study|Other|2|||
106010729|NCT04973449|365705792|FG003|Overall Study|Other|1|||
106010730|NCT04973449|365705793|FG004|Overall Study|Other|4|||
106010731|NCT04973449|365705794|FG005|Overall Study|Other|0|||
106010732|NCT04973449|365705795|FG006|Overall Study|Other|2|||
106010733|NCT04973449|365705796|FG007|Overall Study|Other|2|||
106010734|NCT02651675|365705797|FG000|Overall Study|Death|0|||
106010735|NCT02651675|365705798|FG001|Overall Study|Death|0|||
106010736|NCT02651675|365705799|FG002|Overall Study|Death|1|||
106010737|NCT03674411|365705800|FG000|Overall Study|Non-treatment|4|||
106010738|NCT00474812|365705803|FG000|Overall Study|Withdrawal by Subject|5|||
106010739|NCT00474812|365705803|FG000|Overall Study|No Initiation of treatment|2|||
106140242|NCT02914522|366170484|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
106140243|NCT02914522|366170485|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
106140244|NCT02914522|366170486|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
106140245|NCT02914522|366170487|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
105799210|NCT00579254|364922710|FG000|Overall Study|Discontinued when study terminated|73|||
105938909|NCT00289900|365436824|FG000|Overall Study|Participant had flushing|18|||
105938910|NCT00289900|365436825|FG001|Overall Study|Participant had flushing|42|||
105938911|NCT00289900|365436826|FG002|Overall Study|Participant had flushing|1|||
105938912|NCT00289900|365436827|FG003|Overall Study|Participant had flushing|2|||
105938913|NCT00289900|365436828|FG004|Overall Study|Participant had flushing|0|||
105938914|NCT00289900|365436829|FG005|Overall Study|Participant had flushing|4|||
105938915|NCT00289900|365436824|FG000|Overall Study|Other|0|||
105938916|NCT00289900|365436825|FG001|Overall Study|Other|0|||
105938917|NCT00289900|365436826|FG002|Overall Study|Other|0|||
105938918|NCT00289900|365436827|FG003|Overall Study|Other|5|||
105938919|NCT00289900|365436828|FG004|Overall Study|Other|1|||
105938920|NCT00289900|365436829|FG005|Overall Study|Other|0|||
105938921|NCT00289900|365436824|FG000|Overall Study|Participant moved|1|||
105938922|NCT00289900|365436825|FG001|Overall Study|Participant moved|0|||
105938923|NCT00289900|365436826|FG002|Overall Study|Participant moved|0|||
105938924|NCT00289900|365436827|FG003|Overall Study|Participant moved|1|||
106010740|NCT01506596|365705804|FG000|Overall Study|ineligible pathology|1|||
106010741|NCT00771758|365705806|FG000|Overall Study|Adverse Event|2|||
106010742|NCT00771758|365705807|FG001|Overall Study|Adverse Event|8|||
106010743|NCT00771758|365705808|FG002|Overall Study|Adverse Event|1|||
106140246|NCT02914522|366170488|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
105938925|NCT00289900|365436828|FG004|Overall Study|Participant moved|1|||
105938926|NCT00289900|365436829|FG005|Overall Study|Participant moved|1|||
106010744|NCT00771758|365705806|FG000|Overall Study|Lack of Efficacy|0|||
106010745|NCT00771758|365705807|FG001|Overall Study|Lack of Efficacy|2|||
106010746|NCT00771758|365705808|FG002|Overall Study|Lack of Efficacy|1|||
106010747|NCT00771758|365705806|FG000|Overall Study|Lost to Follow-up|1|||
106010748|NCT00771758|365705807|FG001|Overall Study|Lost to Follow-up|0|||
106010749|NCT00771758|365705808|FG002|Overall Study|Lost to Follow-up|0|||
106010750|NCT00771758|365705806|FG000|Overall Study|Protocol Violation|1|||
106010751|NCT00771758|365705807|FG001|Overall Study|Protocol Violation|0|||
106010752|NCT00771758|365705808|FG002|Overall Study|Protocol Violation|0|||
106010753|NCT00771758|365705806|FG000|Overall Study|Withdrawal by Subject|1|||
106140247|NCT02914522|366170489|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
106140248|NCT02914522|366170490|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
106140249|NCT02914522|366170491|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
106140250|NCT02914522|366170492|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
106140251|NCT02914522|366170482|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140252|NCT02914522|366170483|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140253|NCT02914522|366170484|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140254|NCT02914522|366170485|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140255|NCT02914522|366170486|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140256|NCT02914522|366170487|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140257|NCT02914522|366170488|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140258|NCT02914522|366170489|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
106140259|NCT02914522|366170490|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
106140260|NCT02914522|366170491|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140261|NCT02914522|366170492|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
106140262|NCT02914522|366170482|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140263|NCT02914522|366170483|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140264|NCT02914522|366170484|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140265|NCT02914522|366170485|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140266|NCT02914522|366170486|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140267|NCT02914522|366170487|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140268|NCT02914522|366170488|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140269|NCT02914522|366170489|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140270|NCT02914522|366170490|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
106140271|NCT02914522|366170491|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
106140272|NCT02914522|366170492|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
106140273|NCT02914522|366170482|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140274|NCT02914522|366170483|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140275|NCT02914522|366170484|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140276|NCT02914522|366170485|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140277|NCT02914522|366170486|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140278|NCT02914522|366170487|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140279|NCT02914522|366170488|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140280|NCT02914522|366170489|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140281|NCT02914522|366170490|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140282|NCT02914522|366170491|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
106140283|NCT02914522|366170492|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
106140284|NCT01161498|366170494|FG000|Overall Study|Disease Progression|0|||
106140285|NCT01161498|366170495|FG001|Overall Study|Disease Progression|1|||
106140286|NCT00988637|366170496|FG000|Overall Study|Lost to Follow-up|2|||
106140287|NCT00988637|366170497|FG001|Overall Study|Lost to Follow-up|1|||
106140288|NCT00988637|366170496|FG000|Overall Study|Withdrawal by Subject|1|||
106140289|NCT00988637|366170497|FG001|Overall Study|Withdrawal by Subject|1|||
106140290|NCT00988637|366170496|FG000|Overall Study|non-compliance with study drug|0|||
106140291|NCT00988637|366170497|FG001|Overall Study|non-compliance with study drug|1|||
106140292|NCT05484726|366170505|FG000|Overall Study|Protocol Violation|3|||
106140293|NCT05484726|366170506|FG001|Overall Study|Protocol Violation|3|||
106140294|NCT05484726|366170505|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
106140295|NCT05484726|366170506|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
106140296|NCT05484726|366170505|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
106140297|NCT05484726|366170506|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
106140298|NCT05484726|366170505|FG000|Overall Study|continued need of mechanical ventilation|2|||
106140299|NCT05484726|366170506|FG001|Overall Study|continued need of mechanical ventilation|3|||
106140300|NCT05484726|366170505|FG000|Overall Study|Withdrawal by Subject|2|||
106140301|NCT05484726|366170506|FG001|Overall Study|Withdrawal by Subject|3|||
106140302|NCT05484726|366170505|FG000|Overall Study|IVH (G III & IV)|2|||
105736372|NCT01645280|364691077|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
105736373|NCT01645280|364691078|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
105736374|NCT00234104|364691079|FG000|Overall Study|Adverse Event|4|||
105736375|NCT00234104|364691080|FG001|Overall Study|Adverse Event|0|||
105736376|NCT00234104|364691081|FG002|Overall Study|Adverse Event|3|||
105736377|NCT00234104|364691082|FG003|Overall Study|Adverse Event|5|||
105736378|NCT00234104|364691079|FG000|Overall Study|Protocol Violation|0|||
105736379|NCT00234104|364691080|FG001|Overall Study|Protocol Violation|0|||
106140303|NCT05484726|366170506|FG001|Overall Study|IVH (G III & IV)|1|||
105736380|NCT00234104|364691081|FG002|Overall Study|Protocol Violation|0|||
105736381|NCT00234104|364691082|FG003|Overall Study|Protocol Violation|1|||
105736382|NCT00234104|364691079|FG000|Overall Study|Physician Decision|0|||
105736383|NCT00234104|364691080|FG001|Overall Study|Physician Decision|1|||
105736384|NCT00234104|364691081|FG002|Overall Study|Physician Decision|2|||
105736385|NCT00234104|364691082|FG003|Overall Study|Physician Decision|2|||
105736386|NCT00546819|364691085|FG000|Overall Study|Adverse Event|2|||
105736387|NCT00546819|364691086|FG001|Overall Study|Adverse Event|3|||
105736388|NCT00546819|364691085|FG000|Overall Study|Lost to Follow-up|2|||
105736389|NCT00546819|364691086|FG001|Overall Study|Lost to Follow-up|1|||
105736390|NCT00546819|364691085|FG000|Overall Study|Withdrawal by Subject|4|||
105736391|NCT00546819|364691086|FG001|Overall Study|Withdrawal by Subject|2|||
105736392|NCT00858702|364691089|FG000|Overall Study|Lack of Efficacy|1|||
105736393|NCT00858702|364691090|FG001|Overall Study|Lack of Efficacy|0|||
105736394|NCT00858702|364691089|FG000|Overall Study|Protocol Violation|1|||
105736395|NCT00858702|364691090|FG001|Overall Study|Protocol Violation|1|||
105736396|NCT00858702|364691089|FG000|Overall Study|Other|2|||
105736397|NCT00858702|364691090|FG001|Overall Study|Other|1|||
106010754|NCT00771758|365705807|FG001|Overall Study|Withdrawal by Subject|0|||
106010755|NCT00771758|365705808|FG002|Overall Study|Withdrawal by Subject|0|||
106010756|NCT00771758|365705806|FG000|Overall Study|Other|3|||
105799211|NCT01606137|364922711|FG000|Overall Study|Adverse Event|85|||
106010757|NCT00771758|365705807|FG001|Overall Study|Other|2|||
106010758|NCT00771758|365705808|FG002|Overall Study|Other|0|||
106010759|NCT00935584|365705809|FG000|Overall Study|Withdrawal by Subject|9|||
106010760|NCT00935584|365705810|FG001|Overall Study|Withdrawal by Subject|0|||
106010761|NCT00935584|365705809|FG000|Overall Study|Death|3|||
106010762|NCT00935584|365705810|FG001|Overall Study|Death|0|||
106010763|NCT00935584|365705809|FG000|Overall Study|Lost to Follow-up|8|||
106010764|NCT00935584|365705810|FG001|Overall Study|Lost to Follow-up|0|||
106010765|NCT00935584|365705809|FG000|Overall Study|No show|9|||
106010766|NCT00935584|365705810|FG001|Overall Study|No show|0|||
106010767|NCT00935584|365705809|FG000|Overall Study|Relocated|3|||
106010768|NCT00935584|365705810|FG001|Overall Study|Relocated|0|||
106010769|NCT00935584|365705809|FG000|Overall Study|Patient changed provider|3|||
106010770|NCT00935584|365705810|FG001|Overall Study|Patient changed provider|0|||
106010771|NCT00935584|365705809|FG000|Overall Study|Provider dropped out of study|14|||
106010772|NCT00935584|365705810|FG001|Overall Study|Provider dropped out of study|4|||
106010773|NCT05408429|365705824|FG000|Overall Study|Lost to Follow-up|1|||
106010774|NCT05408429|365705825|FG001|Overall Study|Lost to Follow-up|1|||
106010775|NCT05408429|365705826|FG002|Overall Study|Lost to Follow-up|0|||
106010776|NCT05408429|365705824|FG000|Overall Study|Withdrawal by Subject|5|||
106010777|NCT05408429|365705825|FG001|Overall Study|Withdrawal by Subject|0|||
106010778|NCT05408429|365705826|FG002|Overall Study|Withdrawal by Subject|1|||
106010779|NCT05972993|365705829|FG000|Overall Study|Lost to Follow-up|2|||
106010780|NCT05972993|365705830|FG001|Overall Study|Lost to Follow-up|0|||
106010781|NCT05972993|365705831|FG002|Overall Study|Lost to Follow-up|1|||
106010782|NCT05972993|365705832|FG003|Overall Study|Lost to Follow-up|0|||
106010783|NCT05972993|365705833|FG004|Overall Study|Lost to Follow-up|0|||
106010784|NCT05972993|365705834|FG005|Overall Study|Lost to Follow-up|0|||
106010785|NCT05972993|365705835|FG006|Overall Study|Lost to Follow-up|0|||
106010786|NCT05972993|365705836|FG007|Overall Study|Lost to Follow-up|2|||
106010787|NCT05972993|365705837|FG008|Overall Study|Lost to Follow-up|0|||
106010788|NCT05565742|365705843|FG000|Overall Study|Withdrawal by Subject|0|||
106010789|NCT05565742|365705844|FG001|Overall Study|Withdrawal by Subject|0|||
106010790|NCT05565742|365705845|FG002|Overall Study|Withdrawal by Subject|2|||
106010791|NCT05565742|365705846|FG003|Overall Study|Withdrawal by Subject|2|||
106010792|NCT05565742|365705847|FG004|Overall Study|Withdrawal by Subject|2|||
106010793|NCT05565742|365705843|FG000|Overall Study|Death|1|||
106010794|NCT05565742|365705844|FG001|Overall Study|Death|0|||
106010795|NCT05565742|365705845|FG002|Overall Study|Death|0|||
106010796|NCT05565742|365705846|FG003|Overall Study|Death|0|||
106010797|NCT05565742|365705847|FG004|Overall Study|Death|0|||
106010798|NCT05565742|365705843|FG000|Overall Study|Participant Travelled Abroad|0|||
106010799|NCT05565742|365705844|FG001|Overall Study|Participant Travelled Abroad|0|||
106010800|NCT05565742|365705845|FG002|Overall Study|Participant Travelled Abroad|0|||
106010801|NCT05565742|365705846|FG003|Overall Study|Participant Travelled Abroad|0|||
106010802|NCT05565742|365705847|FG004|Overall Study|Participant Travelled Abroad|1|||
106010803|NCT01231906|365705848|FG000|Overall Study|Lack of Efficacy|75|||
106140304|NCT05484726|366170505|FG000|Overall Study|NEC (stage II & III)|2|||
106140305|NCT05484726|366170506|FG001|Overall Study|NEC (stage II & III)|3|||
105736398|NCT00858702|364691089|FG000|Overall Study|Withdrawal by Subject|1|||
105736399|NCT00858702|364691090|FG001|Overall Study|Withdrawal by Subject|0|||
106140306|NCT00823979|366170509|FG000|Overall Study|Lack of Efficacy|13|||
105736400|NCT02859415|364691093|FG000|Overall Study|Physician Decision|1|||
105736401|NCT02859415|364691094|FG001|Overall Study|Physician Decision|0|||
106010804|NCT01231906|365705849|FG001|Overall Study|Lack of Efficacy|68|||
106010805|NCT01231906|365705848|FG000|Overall Study|Lost to Follow-up|1|||
105736402|NCT02859415|364691093|FG000|Overall Study|Off treatment due to cardiac event|0|||
106010806|NCT01231906|365705849|FG001|Overall Study|Lost to Follow-up|0|||
106010807|NCT01231906|365705848|FG000|Overall Study|Physician Decision|34|||
106010808|NCT01231906|365705849|FG001|Overall Study|Physician Decision|24|||
105736403|NCT02859415|364691094|FG001|Overall Study|Off treatment due to cardiac event|1|||
105736404|NCT01174784|364691095|FG000|Overall Study|Screen fails|4|||
105736405|NCT03671369|364691100|FG000|Overall Study|Other|1|||
105736406|NCT03671369|364691100|FG000|Overall Study|Withdrawal by Subject|289|||
105736407|NCT03671369|364691100|FG000|Overall Study|Not willing to be vaccinated|1|||
105736408|NCT02732912|364691101|FG000|Overall Study|Discharged before night|2|||
105736409|NCT02732912|364691102|FG001|Overall Study|Discharged before night|6|||
105736410|NCT02732912|364691101|FG000|Overall Study|Incomplete completion of questionnaire|2|||
105736411|NCT02732912|364691102|FG001|Overall Study|Incomplete completion of questionnaire|3|||
105736412|NCT02732912|364691101|FG000|Overall Study|No outcome; discharged or refused|6|||
105736413|NCT02732912|364691102|FG001|Overall Study|No outcome; discharged or refused|9|||
105736414|NCT01214434|364691104|FG000|Overall Study|Withdrawal by Subject|1|||
105736415|NCT01214434|364691105|FG001|Overall Study|Withdrawal by Subject|0|||
105736416|NCT01214434|364691104|FG000|Overall Study|Lost to Follow-up|2|||
105736417|NCT01214434|364691105|FG001|Overall Study|Lost to Follow-up|2|||
105736418|NCT01214434|364691104|FG000|Overall Study|Site error|1|||
105736419|NCT01214434|364691105|FG001|Overall Study|Site error|0|||
105736420|NCT03792750|364691106|FG000|Overall Study|Death|3|||
105736421|NCT00793104|364691107|FG000|Overall Study|Lost to Follow-up|1|||
105736422|NCT02619253|364691108|FG000|Overall Study|Adverse Event|0|||
105736423|NCT02619253|364691109|FG001|Overall Study|Adverse Event|0|||
105736424|NCT02619253|364691110|FG002|Overall Study|Adverse Event|1|||
105736425|NCT02619253|364691111|FG003|Overall Study|Adverse Event|1|||
105736426|NCT02619253|364691112|FG004|Overall Study|Adverse Event|3|||
105736427|NCT02619253|364691108|FG000|Overall Study|Alternative Therapy|0|||
105736428|NCT02619253|364691109|FG001|Overall Study|Alternative Therapy|0|||
105736429|NCT02619253|364691110|FG002|Overall Study|Alternative Therapy|1|||
105736430|NCT02619253|364691111|FG003|Overall Study|Alternative Therapy|0|||
105938927|NCT00289900|365436824|FG000|Overall Study|Withdrawal by Subject|10|||
105938928|NCT00289900|365436825|FG001|Overall Study|Withdrawal by Subject|21|||
105938929|NCT00289900|365436826|FG002|Overall Study|Withdrawal by Subject|8|||
105938930|NCT00289900|365436827|FG003|Overall Study|Withdrawal by Subject|18|||
105938931|NCT00289900|365436828|FG004|Overall Study|Withdrawal by Subject|12|||
105938932|NCT00289900|365436829|FG005|Overall Study|Withdrawal by Subject|11|||
105938933|NCT00289900|365436824|FG000|Overall Study|Protocol Violation|3|||
105938934|NCT00289900|365436825|FG001|Overall Study|Protocol Violation|9|||
105938935|NCT00289900|365436826|FG002|Overall Study|Protocol Violation|2|||
105938936|NCT00289900|365436827|FG003|Overall Study|Protocol Violation|6|||
105938937|NCT00289900|365436828|FG004|Overall Study|Protocol Violation|7|||
105938938|NCT00289900|365436829|FG005|Overall Study|Protocol Violation|4|||
105938939|NCT00289900|365436824|FG000|Overall Study|site terminated|1|||
105938940|NCT00289900|365436825|FG001|Overall Study|site terminated|0|||
105938941|NCT00289900|365436826|FG002|Overall Study|site terminated|1|||
105938942|NCT00289900|365436827|FG003|Overall Study|site terminated|0|||
105938943|NCT00289900|365436828|FG004|Overall Study|site terminated|0|||
105938944|NCT00289900|365436829|FG005|Overall Study|site terminated|0|||
105938945|NCT00289900|365436824|FG000|Overall Study|Not treated|0|||
105938946|NCT00289900|365436825|FG001|Overall Study|Not treated|1|||
105938947|NCT00289900|365436826|FG002|Overall Study|Not treated|0|||
105938948|NCT00289900|365436827|FG003|Overall Study|Not treated|0|||
105938949|NCT00289900|365436828|FG004|Overall Study|Not treated|0|||
105938950|NCT00289900|365436829|FG005|Overall Study|Not treated|0|||
105938951|NCT01703221|365436832|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
105938952|NCT01703221|365436833|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
105938953|NCT01703221|365436834|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105938954|NCT01703221|365436832|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
105938955|NCT01703221|365436833|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
105938956|NCT01703221|365436834|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
105938957|NCT01703221|365436832|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
105938958|NCT01703221|365436833|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105938959|NCT01703221|365436834|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105938960|NCT01703221|365436832|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
105938961|NCT01703221|365436833|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105938962|NCT01703221|365436834|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105938963|NCT01703221|365436832|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105938964|NCT01703221|365436833|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105938965|NCT01703221|365436834|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
105938966|NCT01703221|365436832|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
105736431|NCT02619253|364691112|FG004|Overall Study|Alternative Therapy|0|||
105938967|NCT01703221|365436833|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
105938968|NCT01703221|365436834|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
105938969|NCT01703221|365436832|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
105736432|NCT02619253|364691108|FG000|Overall Study|Death|0|||
105736433|NCT02619253|364691109|FG001|Overall Study|Death|0|||
105736434|NCT02619253|364691110|FG002|Overall Study|Death|0|||
105736435|NCT02619253|364691111|FG003|Overall Study|Death|1|||
105736436|NCT02619253|364691112|FG004|Overall Study|Death|0|||
105938970|NCT01703221|365436833|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
106010809|NCT01231906|365705848|FG000|Overall Study|Withdrawal by Subject|0|||
105736437|NCT02619253|364691108|FG000|Overall Study|Disease Progression|4|||
105736438|NCT02619253|364691109|FG001|Overall Study|Disease Progression|2|||
105736439|NCT02619253|364691110|FG002|Overall Study|Disease Progression|8|||
105736440|NCT02619253|364691111|FG003|Overall Study|Disease Progression|9|||
105736441|NCT02619253|364691112|FG004|Overall Study|Disease Progression|10|||
105736442|NCT02619253|364691108|FG000|Overall Study|Needed a disqualifying therapy|0|||
105736443|NCT02619253|364691109|FG001|Overall Study|Needed a disqualifying therapy|0|||
105736444|NCT02619253|364691110|FG002|Overall Study|Needed a disqualifying therapy|1|||
105736445|NCT02619253|364691111|FG003|Overall Study|Needed a disqualifying therapy|0|||
105736446|NCT02619253|364691112|FG004|Overall Study|Needed a disqualifying therapy|0|||
105736447|NCT02619253|364691108|FG000|Overall Study|Transferred to hospice|0|||
105736448|NCT02619253|364691109|FG001|Overall Study|Transferred to hospice|0|||
105736449|NCT02619253|364691110|FG002|Overall Study|Transferred to hospice|1|||
105736450|NCT02619253|364691111|FG003|Overall Study|Transferred to hospice|0|||
105736451|NCT02619253|364691112|FG004|Overall Study|Transferred to hospice|0|||
105736452|NCT02619253|364691108|FG000|Overall Study|Physician Decision|0|||
105736453|NCT02619253|364691109|FG001|Overall Study|Physician Decision|1|||
105736454|NCT02619253|364691110|FG002|Overall Study|Physician Decision|2|||
105736455|NCT02619253|364691111|FG003|Overall Study|Physician Decision|3|||
105736456|NCT02619253|364691112|FG004|Overall Study|Physician Decision|0|||
105736457|NCT02619253|364691108|FG000|Overall Study|Withdrawal by Subject|0|||
105736458|NCT02619253|364691109|FG001|Overall Study|Withdrawal by Subject|1|||
105736459|NCT02619253|364691110|FG002|Overall Study|Withdrawal by Subject|0|||
105736460|NCT02619253|364691111|FG003|Overall Study|Withdrawal by Subject|0|||
105736461|NCT02619253|364691112|FG004|Overall Study|Withdrawal by Subject|2|||
105736462|NCT00970294|364691114|FG000|Overall Study|Physician Decision|4|||
105736463|NCT00970294|364691114|FG000|Overall Study|Withdrawal by Subject|1|||
105736464|NCT01056523|364691115|FG000|Overall Study|Death|1|||
105736465|NCT01056523|364691116|FG001|Overall Study|Death|0|||
105736466|NCT01056523|364691117|FG002|Overall Study|Death|2|||
105736467|NCT01056523|364691118|FG003|Overall Study|Death|3|||
106010810|NCT01231906|365705849|FG001|Overall Study|Withdrawal by Subject|4|||
106010811|NCT01231906|365705848|FG000|Overall Study|Ineligible|10|||
106010812|NCT01231906|365705849|FG001|Overall Study|Ineligible|3|||
106010813|NCT01231906|365705848|FG000|Overall Study|No treatment|1|||
106010814|NCT01231906|365705849|FG001|Overall Study|No treatment|2|||
106010815|NCT02681523|365705852|FG000|Overall Study|Adverse Event|1|||
105736468|NCT01056523|364691119|FG004|Overall Study|Death|0|||
105736469|NCT01056523|364691120|FG005|Overall Study|Death|0|||
105736470|NCT01056523|364691121|FG006|Overall Study|Death|1|||
105736471|NCT00487279|364691122|FG000|Overall Study|Death|1|||
105736472|NCT00487279|364691123|FG001|Overall Study|Death|0|||
106010816|NCT02681523|365705852|FG000|Overall Study|Patient Non-compliance|1|||
106010817|NCT02638220|365705853|FG000|Overall Study|Lost to Follow-up|6|||
106010818|NCT02638220|365705853|FG000|Overall Study|Withdrawal by Subject|3|||
106010819|NCT02638220|365705853|FG000|Overall Study|Physician Decision|1|||
106010820|NCT02638220|365705853|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
106010821|NCT04988477|365705857|FG000|Overall Study|Death|1|||
106010822|NCT04988477|365705858|FG001|Overall Study|Death|0|||
106010823|NCT04988477|365705859|FG002|Overall Study|Death|0|||
105736473|NCT00487279|364691122|FG000|Overall Study|Withdrawal by Subject|0|||
105736474|NCT00487279|364691123|FG001|Overall Study|Withdrawal by Subject|2|||
105736475|NCT00501852|364691124|FG000|Overall Study|Adverse Event|3|||
105736476|NCT00501852|364691124|FG000|Overall Study|Withdrawal by Subject|2|||
105736477|NCT01171521|364691125|FG000|Overall Study|Lost to Follow-up|5|||
105736478|NCT01171521|364691125|FG000|Overall Study|screen failure|1|||
105736479|NCT01416610|364691126|FG000|Overall Study|Adverse Event|4|||
105736480|NCT01416610|364691126|FG000|Overall Study|Adverse Event -Patient decision|3|||
105736481|NCT01416610|364691126|FG000|Overall Study|Lack of Efficacy|4|||
105736482|NCT01416610|364691126|FG000|Overall Study|No reason given|5|||
105736483|NCT01416610|364691126|FG000|Overall Study|Withdrawal by Subject|13|||
105736484|NCT01416610|364691126|FG000|Overall Study|Lost to Follow-up|7|||
105736485|NCT01416610|364691126|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
105736486|NCT01927562|364691128|FG000|Overall Study|Lost to Follow-up|30|||
105736487|NCT01927562|364691128|FG000|Overall Study|Withdrawal by Subject|3|||
105736488|NCT01927562|364691128|FG000|Overall Study|Physician Decision|5|||
105736489|NCT00642616|364691133|FG000|Overall Study|Adverse Event|2|||
105736490|NCT00642616|364691134|FG001|Overall Study|Adverse Event|0|||
105736491|NCT00642616|364691135|FG002|Overall Study|Adverse Event|1|||
105736492|NCT00642616|364691136|FG003|Overall Study|Adverse Event|0|||
105736493|NCT00642616|364691133|FG000|Overall Study|Study Terminated by Sponsor|7|||
105736494|NCT00642616|364691134|FG001|Overall Study|Study Terminated by Sponsor|6|||
105736495|NCT00642616|364691135|FG002|Overall Study|Study Terminated by Sponsor|4|||
106010824|NCT04988477|365705857|FG000|Overall Study|Lost to Follow-up|5|||
106010825|NCT04988477|365705858|FG001|Overall Study|Lost to Follow-up|2|||
105736496|NCT00642616|364691136|FG003|Overall Study|Study Terminated by Sponsor|5|||
105736497|NCT00642616|364691133|FG000|Overall Study|Withdrawal by Subject|0|||
106010826|NCT04988477|365705859|FG002|Overall Study|Lost to Follow-up|0|||
106010827|NCT04988477|365705857|FG000|Overall Study|Withdrawal by Subject|2|||
106010828|NCT04988477|365705858|FG001|Overall Study|Withdrawal by Subject|0|||
106010829|NCT04988477|365705859|FG002|Overall Study|Withdrawal by Subject|0|||
106010830|NCT02318706|365707199|FG000|Double-blind Phase|Adverse Event|7|||
106010831|NCT02318706|365707200|FG001|Double-blind Phase|Adverse Event|4|||
106010832|NCT02318706|365707201|FG002|Double-blind Phase|Adverse Event|3|||
106010833|NCT02318706|365707202|FG003|Double-blind Phase|Adverse Event|10|||
106010834|NCT02318706|365707203|FG004|Double-blind Phase|Adverse Event|0|||
106010835|NCT02318706|365707199|FG000|Double-blind Phase|Lost to Follow-up|1|||
106010836|NCT02318706|365707200|FG001|Double-blind Phase|Lost to Follow-up|0|||
106010837|NCT02318706|365707201|FG002|Double-blind Phase|Lost to Follow-up|0|||
106010838|NCT02318706|365707202|FG003|Double-blind Phase|Lost to Follow-up|0|||
106010839|NCT02318706|365707203|FG004|Double-blind Phase|Lost to Follow-up|0|||
106010840|NCT02318706|365707199|FG000|Double-blind Phase|Protocol Violation|4|||
106010841|NCT02318706|365707200|FG001|Double-blind Phase|Protocol Violation|2|||
106010842|NCT02318706|365707201|FG002|Double-blind Phase|Protocol Violation|4|||
106010843|NCT02318706|365707202|FG003|Double-blind Phase|Protocol Violation|3|||
106010844|NCT02318706|365707203|FG004|Double-blind Phase|Protocol Violation|0|||
106010845|NCT02318706|365707199|FG000|Double-blind Phase|Withdrawal by Subject|9|||
106010846|NCT02318706|365707200|FG001|Double-blind Phase|Withdrawal by Subject|5|||
106010847|NCT02318706|365707201|FG002|Double-blind Phase|Withdrawal by Subject|7|||
106010848|NCT02318706|365707202|FG003|Double-blind Phase|Withdrawal by Subject|10|||
106010849|NCT02318706|365707203|FG004|Double-blind Phase|Withdrawal by Subject|0|||
106010850|NCT02318706|365707199|FG000|Double-blind Phase|Other|4|||
106010851|NCT02318706|365707200|FG001|Double-blind Phase|Other|1|||
106010852|NCT02318706|365707201|FG002|Double-blind Phase|Other|2|||
106010853|NCT02318706|365707202|FG003|Double-blind Phase|Other|1|||
106010854|NCT02318706|365707203|FG004|Double-blind Phase|Other|0|||
106010855|NCT02318706|365707199|FG000|Double-blind Phase|Death|0|||
106010856|NCT02318706|365707200|FG001|Double-blind Phase|Death|0|||
106010857|NCT02318706|365707201|FG002|Double-blind Phase|Death|2|||
106010858|NCT02318706|365707202|FG003|Double-blind Phase|Death|0|||
106010859|NCT02318706|365707203|FG004|Double-blind Phase|Death|0|||
106010860|NCT02318706|365707199|FG000|Open-label Extension Phase|Adverse Event|0|||
106010861|NCT02318706|365707200|FG001|Open-label Extension Phase|Adverse Event|0|||
106010862|NCT02318706|365707201|FG002|Open-label Extension Phase|Adverse Event|0|||
106010863|NCT02318706|365707202|FG003|Open-label Extension Phase|Adverse Event|0|||
106010864|NCT02318706|365707203|FG004|Open-label Extension Phase|Adverse Event|21|||
106010865|NCT02318706|365707199|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
106010866|NCT02318706|365707200|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
106010867|NCT02318706|365707201|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
106010868|NCT02318706|365707202|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
106010869|NCT02318706|365707203|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
106010870|NCT02318706|365707199|FG000|Open-label Extension Phase|Death|0|||
106010871|NCT02318706|365707200|FG001|Open-label Extension Phase|Death|0|||
106010872|NCT02318706|365707201|FG002|Open-label Extension Phase|Death|0|||
106010873|NCT02318706|365707202|FG003|Open-label Extension Phase|Death|0|||
106010874|NCT02318706|365707203|FG004|Open-label Extension Phase|Death|1|||
106010875|NCT02318706|365707199|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
106010876|NCT02318706|365707200|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
106010877|NCT02318706|365707201|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
106010878|NCT02318706|365707202|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
106010879|NCT02318706|365707203|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
106010880|NCT00906204|365707206|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
106010881|NCT00906204|365707207|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
106010882|NCT00906204|365707206|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
106010883|NCT00906204|365707207|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
106010884|NCT00906204|365707206|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
106010885|NCT00906204|365707207|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
106010886|NCT00906204|365707206|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
106010887|NCT00906204|365707207|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
106010888|NCT00906204|365707206|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
106010889|NCT00906204|365707207|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
106010890|NCT04328077|365707208|FG000|Overall Study|Lost to Follow-up|0|||
106010891|NCT04328077|365707209|FG001|Overall Study|Lost to Follow-up|1|||
106010892|NCT04328077|365707210|FG002|Overall Study|Lost to Follow-up|0|||
106010893|NCT04328077|365707211|FG003|Overall Study|Lost to Follow-up|0|||
106010894|NCT04328077|365707208|FG000|Overall Study|Withdrawal by Subject|0|||
106010895|NCT04328077|365707209|FG001|Overall Study|Withdrawal by Subject|1|||
106010896|NCT04328077|365707210|FG002|Overall Study|Withdrawal by Subject|1|||
106010897|NCT04328077|365707211|FG003|Overall Study|Withdrawal by Subject|3|||
106010898|NCT05291520|365707212|FG000|Overall Study|Lost to Follow-up|0|||
106010899|NCT05291520|365707213|FG001|Overall Study|Lost to Follow-up|0|||
106010900|NCT05291520|365707214|FG002|Overall Study|Lost to Follow-up|1|||
106010901|NCT01347112|365707215|FG000|Overall Study|Withdrawal by Subject|1|||
106010902|NCT01347112|365707216|FG001|Overall Study|Withdrawal by Subject|7|||
105736498|NCT00642616|364691134|FG001|Overall Study|Withdrawal by Subject|1|||
105736499|NCT00642616|364691135|FG002|Overall Study|Withdrawal by Subject|1|||
105736500|NCT00642616|364691136|FG003|Overall Study|Withdrawal by Subject|1|||
105736501|NCT00642616|364691133|FG000|Overall Study|Protocol Violation|0|||
105736502|NCT00642616|364691134|FG001|Overall Study|Protocol Violation|0|||
105736503|NCT00642616|364691135|FG002|Overall Study|Protocol Violation|2|||
105736504|NCT00642616|364691136|FG003|Overall Study|Protocol Violation|0|||
105736505|NCT00642616|364691133|FG000|Overall Study|Physician Decision|0|||
105736506|NCT00642616|364691134|FG001|Overall Study|Physician Decision|0|||
105736507|NCT00642616|364691135|FG002|Overall Study|Physician Decision|1|||
105736508|NCT00642616|364691136|FG003|Overall Study|Physician Decision|1|||
105736509|NCT00492921|364691137|FG000|Overall Study|Death|1|||
105736510|NCT00492921|364691138|FG001|Overall Study|Death|0|||
105736511|NCT00492921|364691139|FG002|Overall Study|Death|1|||
106010903|NCT01347112|365707215|FG000|Overall Study|Lost to Follow-up|3|||
106010904|NCT01347112|365707216|FG001|Overall Study|Lost to Follow-up|5|||
106010905|NCT00696072|365707221|FG000|Overall Study|continuing active treatment|10|||
106010906|NCT00696072|365707222|FG001|Overall Study|continuing active treatment|13|||
106010907|NCT00696072|365707221|FG000|Overall Study|Adverse Event|10|||
106010908|NCT00696072|365707222|FG001|Overall Study|Adverse Event|6|||
106010909|NCT00696072|365707221|FG000|Overall Study|Patient Request|3|||
106010910|NCT00696072|365707222|FG001|Overall Study|Patient Request|7|||
106010911|NCT00696072|365707221|FG000|Overall Study|Investigator Request|1|||
106010912|NCT00696072|365707222|FG001|Overall Study|Investigator Request|4|||
106010913|NCT00696072|365707221|FG000|Overall Study|Sponsor Request|0|||
106010914|NCT00696072|365707222|FG001|Overall Study|Sponsor Request|1|||
106010915|NCT00696072|365707221|FG000|Overall Study|Disease Progression|32|||
106010916|NCT00696072|365707222|FG001|Overall Study|Disease Progression|30|||
106010917|NCT00696072|365707221|FG000|Overall Study|Non-specified|1|||
106010918|NCT00696072|365707222|FG001|Overall Study|Non-specified|2|||
106010919|NCT00148317|365707235|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
106010920|NCT00148317|365707235|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
106010921|NCT00148317|365707235|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
106010922|NCT04639245|365707236|FG000|Overall Study|Death|1|||
106010923|NCT02419001|365707237|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
106010924|NCT02419001|365707238|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
106010925|NCT02326155|365707239|FG000|Overall Study|Adverse Event|21|||
106010926|NCT02326155|365707240|FG001|Overall Study|Adverse Event|5|||
106010927|NCT02326155|365707239|FG000|Overall Study|Death|3|||
106010928|NCT02326155|365707240|FG001|Overall Study|Death|0|||
106010929|NCT02326155|365707239|FG000|Overall Study|Lack of Efficacy|49|||
106010930|NCT02326155|365707240|FG001|Overall Study|Lack of Efficacy|5|||
106010931|NCT02326155|365707239|FG000|Overall Study|Lost to Follow-up|14|||
106010932|NCT02326155|365707240|FG001|Overall Study|Lost to Follow-up|3|||
106010933|NCT02326155|365707239|FG000|Overall Study|Protocol Violation|2|||
106010934|NCT02326155|365707240|FG001|Overall Study|Protocol Violation|0|||
106010935|NCT02326155|365707239|FG000|Overall Study|Withdrawal by Subject|34|||
106010936|NCT02326155|365707240|FG001|Overall Study|Withdrawal by Subject|11|||
106010937|NCT02326155|365707239|FG000|Overall Study|Disease progression|37|||
106010938|NCT02326155|365707240|FG001|Overall Study|Disease progression|4|||
106010939|NCT02326155|365707239|FG000|Overall Study|Study close|188|||
106010940|NCT02326155|365707240|FG001|Overall Study|Study close|21|||
106010941|NCT02326155|365707239|FG000|Overall Study|except for study close|46|||
106010942|NCT02326155|365707240|FG001|Overall Study|except for study close|13|||
106010943|NCT01209689|365707241|FG000|Overall Study|Insufficient Therapeutic Response|7|||
106010944|NCT01209689|365707242|FG001|Overall Study|Insufficient Therapeutic Response|2|||
106010945|NCT01209689|365707241|FG000|Overall Study|Refused Treatment|8|||
106010946|NCT01209689|365707242|FG001|Overall Study|Refused Treatment|3|||
106010947|NCT01209689|365707241|FG000|Overall Study|Adverse Event|4|||
106010948|NCT01209689|365707242|FG001|Overall Study|Adverse Event|0|||
106010949|NCT01209689|365707241|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
106010950|NCT01209689|365707242|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
106010951|NCT01209689|365707241|FG000|Overall Study|Failure to Return|3|||
106010952|NCT01209689|365707242|FG001|Overall Study|Failure to Return|0|||
106010953|NCT01209689|365707241|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
106010954|NCT01209689|365707242|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
106010955|NCT03591406|365707243|FG000|Overall Study|Adverse Event|5|||
106010956|NCT03591406|365707244|FG001|Overall Study|Adverse Event|3|||
106010957|NCT03591406|365707243|FG000|Overall Study|Protocol Violation|2|||
105736512|NCT00399802|364691140|FG000|Overall Study|Adverse Event|0|||
106010958|NCT03591406|365707244|FG001|Overall Study|Protocol Violation|1|||
105736513|NCT00399802|364691141|FG001|Overall Study|Adverse Event|2|||
105736514|NCT00399802|364691140|FG000|Overall Study|Participant discontinued by mistake|0|||
106010959|NCT03591406|365707243|FG000|Overall Study|Withdrawal by Subject|0|||
106010960|NCT03591406|365707244|FG001|Overall Study|Withdrawal by Subject|5|||
106010961|NCT01083771|365707245|FG000|Overall Study|non-compliant|2|||
106010962|NCT01083771|365707245|FG000|Overall Study|Withdrawal by Subject|3|||
105736515|NCT00399802|364691141|FG001|Overall Study|Participant discontinued by mistake|1|||
105799212|NCT01606137|364922711|FG000|Overall Study|Withdrawal by Subject|74|||
105799213|NCT01606137|364922711|FG000|Overall Study|Lack of Efficacy|56|||
105799214|NCT01606137|364922711|FG000|Overall Study|Lost to Follow-up|15|||
105799215|NCT01606137|364922711|FG000|Overall Study|Protocol Violation|1|||
105799216|NCT01606137|364922711|FG000|Overall Study|Patient non-compliance|9|||
105799217|NCT01606137|364922711|FG000|Overall Study|Death|1|||
105799218|NCT01606137|364922711|FG000|Overall Study|Decreased/no pain|4|||
105938971|NCT01703221|365436834|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
105938972|NCT01703221|365436832|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
105938973|NCT01703221|365436833|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
105938974|NCT01703221|365436834|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
105938975|NCT01152385|365436835|FG000|Overall Study|Withdrawal by Subject|3|||
105938976|NCT01152385|365436836|FG001|Overall Study|Withdrawal by Subject|1|||
105938977|NCT01152385|365436837|FG002|Overall Study|Withdrawal by Subject|1|||
105938978|NCT01152385|365436838|FG003|Overall Study|Withdrawal by Subject|1|||
105938979|NCT01152385|365436835|FG000|Overall Study|Protocol Violation|0|||
105938980|NCT01152385|365436836|FG001|Overall Study|Protocol Violation|0|||
105938981|NCT01152385|365436837|FG002|Overall Study|Protocol Violation|0|||
105938982|NCT01152385|365436838|FG003|Overall Study|Protocol Violation|1|||
105938983|NCT01152385|365436835|FG000|Overall Study|Adverse Event|1|||
105938984|NCT01152385|365436836|FG001|Overall Study|Adverse Event|1|||
105938985|NCT01152385|365436837|FG002|Overall Study|Adverse Event|0|||
105938986|NCT01152385|365436838|FG003|Overall Study|Adverse Event|0|||
105938987|NCT01152385|365436835|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105938988|NCT01152385|365436836|FG001|Overall Study|Study-specific withdrawal criteria|1|||
105938989|NCT01152385|365436837|FG002|Overall Study|Study-specific withdrawal criteria|2|||
105938990|NCT01152385|365436838|FG003|Overall Study|Study-specific withdrawal criteria|0|||
105938991|NCT01152385|365436835|FG000|Overall Study|Other|4|||
105938992|NCT01152385|365436836|FG001|Overall Study|Other|3|||
105938993|NCT01152385|365436837|FG002|Overall Study|Other|2|||
105938994|NCT01152385|365436838|FG003|Overall Study|Other|3|||
105938995|NCT05486065|365436839|FG000|Overall Study|Withdrawal by Subject|1|||
105938996|NCT05486065|365436840|FG001|Overall Study|Withdrawal by Subject|5|||
105938997|NCT05486065|365436841|FG002|Overall Study|Withdrawal by Subject|4|||
105938998|NCT05486065|365436842|FG003|Overall Study|Withdrawal by Subject|3|||
105938999|NCT05486065|365436839|FG000|Overall Study|Lost to Follow-up|4|||
105939000|NCT05486065|365436840|FG001|Overall Study|Lost to Follow-up|2|||
105939001|NCT05486065|365436841|FG002|Overall Study|Lost to Follow-up|2|||
105939002|NCT05486065|365436842|FG003|Overall Study|Lost to Follow-up|2|||
105939003|NCT05486065|365436839|FG000|Overall Study|Physician Decision|0|||
105939004|NCT05486065|365436840|FG001|Overall Study|Physician Decision|1|||
105939005|NCT05486065|365436841|FG002|Overall Study|Physician Decision|1|||
105939006|NCT05486065|365436842|FG003|Overall Study|Physician Decision|0|||
105939007|NCT05486065|365436839|FG000|Overall Study|Failure to meet randomization criteria|0|||
105939008|NCT05486065|365436840|FG001|Overall Study|Failure to meet randomization criteria|0|||
105939009|NCT05486065|365436841|FG002|Overall Study|Failure to meet randomization criteria|0|||
105939010|NCT05486065|365436842|FG003|Overall Study|Failure to meet randomization criteria|1|||
105939011|NCT02656173|365436843|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
105939012|NCT02656173|365436844|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
105939013|NCT02656173|365436843|FG000|Overall Study|Adverse Event|7|||
105939014|NCT02656173|365436844|FG001|Overall Study|Adverse Event|5|||
105939015|NCT02656173|365436843|FG000|Overall Study|Withdrawal by Subject|1|||
105939016|NCT02656173|365436844|FG001|Overall Study|Withdrawal by Subject|3|||
105939017|NCT02656173|365436843|FG000|Overall Study|Protocol Violation|0|||
105939018|NCT02656173|365436844|FG001|Overall Study|Protocol Violation|1|||
105939019|NCT02656173|365436843|FG000|Overall Study|Miscellaneous|2|||
105939020|NCT02656173|365436844|FG001|Overall Study|Miscellaneous|0|||
105939021|NCT01064622|365436845|FG000|Randomized Phase II|Withdrawal by Subject|2|||
105939022|NCT01064622|365436846|FG001|Randomized Phase II|Withdrawal by Subject|2|||
105939023|NCT01064622|365436845|FG000|Randomized Phase II|Protocol Violation|0|||
105939024|NCT01064622|365436846|FG001|Randomized Phase II|Protocol Violation|1|||
105799219|NCT01606137|364922711|FG000|Overall Study|Issues with driving|4|||
105939025|NCT04398706|365436847|FG000|Overall Study|Adverse Event|0|||
105939026|NCT04398706|365436848|FG001|Overall Study|Adverse Event|0|||
105939027|NCT04398706|365436849|FG002|Overall Study|Adverse Event|0|||
105939028|NCT04398706|365436850|FG003|Overall Study|Adverse Event|0|||
105939029|NCT04398706|365436851|FG004|Overall Study|Adverse Event|0|||
105939030|NCT04398706|365436852|FG005|Overall Study|Adverse Event|1|||
105799220|NCT01606137|364922711|FG000|Overall Study|multiple sclerosis less stable|1|||
105939031|NCT04398706|365436853|FG006|Overall Study|Adverse Event|1|||
105939032|NCT04398706|365436854|FG007|Overall Study|Adverse Event|0|||
105939033|NCT04398706|365436847|FG000|Overall Study|Lost to Follow-up|0|||
105799221|NCT01606137|364922711|FG000|Overall Study|Increased bilirubin|1|||
105799222|NCT01606137|364922711|FG000|Overall Study|Spray causes nausea|1|||
105799223|NCT01606137|364922711|FG000|Overall Study|Not enough improvement|4|||
105799224|NCT01606137|364922711|FG000|Overall Study|Wanted to try another treatment|1|||
105799225|NCT01606137|364922711|FG000|Overall Study|Patient leaving country|1|||
105799226|NCT01606137|364922711|FG000|Overall Study|Personal reasons|1|||
105799227|NCT01606137|364922711|FG000|Overall Study|Unable to tolerate study med. taste|1|||
105799228|NCT01606137|364922711|FG000|Overall Study|Patient moving|1|||
105799229|NCT01606137|364922711|FG000|Overall Study|Unable to collect consistent data|1|||
105799230|NCT02094937|364922712|FG000|8 Weeks in Period 1|Adverse Event|9|||
105799231|NCT02094937|364922713|FG001|8 Weeks in Period 1|Adverse Event|0|||
105799232|NCT02094937|364922714|FG002|8 Weeks in Period 1|Adverse Event|0|||
105799233|NCT02094937|364922715|FG003|8 Weeks in Period 1|Adverse Event|0|||
105799234|NCT02094937|364922712|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
105799235|NCT02094937|364922713|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
105799236|NCT02094937|364922714|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
105799237|NCT02094937|364922715|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
105799238|NCT02094937|364922712|FG000|8 Weeks in Period 1|Protocol Violation|2|||
105799239|NCT02094937|364922713|FG001|8 Weeks in Period 1|Protocol Violation|0|||
105799240|NCT02094937|364922714|FG002|8 Weeks in Period 1|Protocol Violation|0|||
105799241|NCT02094937|364922715|FG003|8 Weeks in Period 1|Protocol Violation|0|||
105799242|NCT02094937|364922712|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
105799243|NCT02094937|364922713|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
105799244|NCT02094937|364922714|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
105799245|NCT02094937|364922715|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
105799246|NCT02094937|364922712|FG000|8 Weeks in Period 1|Physician Decision|1|||
105799247|NCT02094937|364922713|FG001|8 Weeks in Period 1|Physician Decision|0|||
105799248|NCT02094937|364922714|FG002|8 Weeks in Period 1|Physician Decision|0|||
105799249|NCT02094937|364922715|FG003|8 Weeks in Period 1|Physician Decision|0|||
105799250|NCT02094937|364922712|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
105799251|NCT02094937|364922713|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
105799252|NCT02094937|364922714|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
105799253|NCT02094937|364922715|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
105799254|NCT02094937|364922712|FG000|12 Weeks in Period 2|Adverse Event|0|||
105799255|NCT02094937|364922713|FG001|12 Weeks in Period 2|Adverse Event|2|||
105799256|NCT02094937|364922714|FG002|12 Weeks in Period 2|Adverse Event|4|||
105799257|NCT02094937|364922715|FG003|12 Weeks in Period 2|Adverse Event|1|||
105799258|NCT02094937|364922712|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
105799259|NCT02094937|364922713|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
105799260|NCT02094937|364922714|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
105799261|NCT02094937|364922715|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
105799262|NCT02094937|364922712|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
105799263|NCT02094937|364922713|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
105799264|NCT02094937|364922714|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
105799265|NCT02094937|364922715|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
105799266|NCT02094937|364922712|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
105799267|NCT02094937|364922713|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
105799268|NCT02094937|364922714|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
105799269|NCT02094937|364922715|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
105799270|NCT02094937|364922712|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
105939034|NCT04398706|365436848|FG001|Overall Study|Lost to Follow-up|1|||
105939035|NCT04398706|365436849|FG002|Overall Study|Lost to Follow-up|2|||
105939036|NCT04398706|365436850|FG003|Overall Study|Lost to Follow-up|1|||
105939037|NCT04398706|365436851|FG004|Overall Study|Lost to Follow-up|6|||
105939038|NCT04398706|365436852|FG005|Overall Study|Lost to Follow-up|3|||
105939039|NCT04398706|365436853|FG006|Overall Study|Lost to Follow-up|8|||
105939040|NCT04398706|365436854|FG007|Overall Study|Lost to Follow-up|2|||
105939041|NCT04398706|365436847|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105939042|NCT04398706|365436848|FG001|Overall Study|Withdrawal by parent/guardian|2|||
105939043|NCT04398706|365436849|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105939044|NCT04398706|365436850|FG003|Overall Study|Withdrawal by parent/guardian|2|||
105939045|NCT04398706|365436851|FG004|Overall Study|Withdrawal by parent/guardian|19|||
105939046|NCT04398706|365436852|FG005|Overall Study|Withdrawal by parent/guardian|23|||
105939047|NCT04398706|365436853|FG006|Overall Study|Withdrawal by parent/guardian|13|||
105939048|NCT04398706|365436854|FG007|Overall Study|Withdrawal by parent/guardian|11|||
105939049|NCT04398706|365436847|FG000|Overall Study|Protocol deviation|0|||
105939050|NCT04398706|365436848|FG001|Overall Study|Protocol deviation|1|||
105939051|NCT04398706|365436849|FG002|Overall Study|Protocol deviation|0|||
105939052|NCT04398706|365436850|FG003|Overall Study|Protocol deviation|0|||
105939053|NCT04398706|365436851|FG004|Overall Study|Protocol deviation|6|||
105939054|NCT04398706|365436852|FG005|Overall Study|Protocol deviation|4|||
105939055|NCT04398706|365436853|FG006|Overall Study|Protocol deviation|6|||
105939056|NCT04398706|365436854|FG007|Overall Study|Protocol deviation|3|||
105799271|NCT02094937|364922713|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
106010963|NCT00371150|365707251|FG000|Overall Study|Lost to Follow-up|3|||
106010964|NCT00371150|365707252|FG001|Overall Study|Lost to Follow-up|2|||
106010965|NCT02536976|365707253|FG000|Overall Study|Physician Decision|0|||
106010966|NCT02536976|365707254|FG001|Overall Study|Physician Decision|1|||
106010967|NCT00804908|365707255|FG000|Overall Study|Other|115|||
106010968|NCT00804908|365707256|FG001|Overall Study|Other|116|||
106010969|NCT00804908|365707257|FG002|Overall Study|Other|114|||
106010970|NCT00321620|365707261|FG000|Overall Study|Death|269|||
106010971|NCT00321620|365707262|FG001|Overall Study|Death|294|||
106010972|NCT00321620|365707261|FG000|Overall Study|Withdrawal by Subject|164|||
106010973|NCT00321620|365707262|FG001|Overall Study|Withdrawal by Subject|147|||
106010974|NCT00321620|365707261|FG000|Overall Study|Disease progression|113|||
106010975|NCT00321620|365707262|FG001|Overall Study|Disease progression|117|||
106010976|NCT00321620|365707261|FG000|Overall Study|Adverse Event|43|||
106010977|NCT00321620|365707262|FG001|Overall Study|Adverse Event|56|||
106010978|NCT00321620|365707261|FG000|Overall Study|Lost to Follow-up|13|||
106010979|NCT00321620|365707262|FG001|Overall Study|Lost to Follow-up|9|||
106010980|NCT00321620|365707261|FG000|Overall Study|Physician Decision|4|||
106010981|NCT00321620|365707262|FG001|Overall Study|Physician Decision|1|||
106010982|NCT00321620|365707261|FG000|Overall Study|Noncompliance|14|||
106010983|NCT00321620|365707262|FG001|Overall Study|Noncompliance|7|||
106010984|NCT00321620|365707261|FG000|Overall Study|Protocol deviation|4|||
106010985|NCT00321620|365707262|FG001|Overall Study|Protocol deviation|3|||
105736516|NCT00542815|364691142|FG000|Overall Study|Adverse Event|19|||
105736517|NCT00542815|364691143|FG001|Overall Study|Adverse Event|6|||
105736518|NCT00542815|364691144|FG002|Overall Study|Adverse Event|9|||
105736519|NCT00542815|364691142|FG000|Overall Study|Death|10|||
105736520|NCT00542815|364691143|FG001|Overall Study|Death|7|||
105736521|NCT00542815|364691144|FG002|Overall Study|Death|3|||
105736522|NCT00542815|364691142|FG000|Overall Study|Lack of Efficacy|9|||
105736523|NCT00542815|364691143|FG001|Overall Study|Lack of Efficacy|2|||
105736524|NCT00542815|364691144|FG002|Overall Study|Lack of Efficacy|0|||
105736525|NCT00542815|364691142|FG000|Overall Study|Physician Decision|2|||
105736526|NCT00542815|364691143|FG001|Overall Study|Physician Decision|1|||
105736527|NCT00542815|364691144|FG002|Overall Study|Physician Decision|0|||
105736528|NCT00542815|364691142|FG000|Overall Study|Protocol Violation|1|||
105736529|NCT00542815|364691143|FG001|Overall Study|Protocol Violation|1|||
105736530|NCT00542815|364691144|FG002|Overall Study|Protocol Violation|2|||
105736531|NCT00542815|364691142|FG000|Overall Study|Withdrawal by Subject|41|||
105736532|NCT00542815|364691143|FG001|Overall Study|Withdrawal by Subject|5|||
105736533|NCT00542815|364691144|FG002|Overall Study|Withdrawal by Subject|8|||
105736534|NCT00542815|364691142|FG000|Overall Study|Other reasons|24|||
105736535|NCT00542815|364691143|FG001|Overall Study|Other reasons|10|||
105736536|NCT00542815|364691144|FG002|Overall Study|Other reasons|10|||
105736537|NCT00652093|364691145|FG000|Overall Study|Withdrawal by Subject|0|||
105736538|NCT00652093|364691146|FG001|Overall Study|Withdrawal by Subject|0|||
105736539|NCT00652093|364691147|FG002|Overall Study|Withdrawal by Subject|1|||
105736540|NCT00652093|364691148|FG003|Overall Study|Withdrawal by Subject|0|||
105736541|NCT00652093|364691149|FG004|Overall Study|Withdrawal by Subject|1|||
105736542|NCT00652093|364691150|FG005|Overall Study|Withdrawal by Subject|0|||
105736543|NCT00652093|364691145|FG000|Overall Study|Physician Decision|0|||
105736544|NCT00652093|364691146|FG001|Overall Study|Physician Decision|0|||
105736545|NCT00652093|364691147|FG002|Overall Study|Physician Decision|0|||
105736546|NCT00652093|364691148|FG003|Overall Study|Physician Decision|0|||
105736547|NCT00652093|364691149|FG004|Overall Study|Physician Decision|1|||
105736548|NCT00652093|364691150|FG005|Overall Study|Physician Decision|0|||
105736549|NCT00734929|364691151|FG000|Overall Study|Lost to Follow-up|1|||
105736550|NCT00734929|364691152|FG001|Overall Study|Lost to Follow-up|2|||
105736551|NCT00734929|364691151|FG000|Overall Study|No intervention/ screen fail|5|||
105736552|NCT00734929|364691152|FG001|Overall Study|No intervention/ screen fail|3|||
105736553|NCT03176966|364691156|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
105736554|NCT03176966|364691157|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
105736555|NCT03176966|364691156|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
105736556|NCT03176966|364691157|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
105736557|NCT03176966|364691156|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
105736558|NCT03176966|364691157|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
106010986|NCT00321620|365707261|FG000|Overall Study|Ineligibility determined|2|||
106140307|NCT00823979|366170510|FG001|Overall Study|Lack of Efficacy|16|||
106140308|NCT00823979|366170511|FG002|Overall Study|Lack of Efficacy|9|||
105736559|NCT03176966|364691156|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
105736560|NCT03176966|364691157|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
105736561|NCT03176966|364691156|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
106010987|NCT00321620|365707262|FG001|Overall Study|Ineligibility determined|3|||
106010988|NCT00321620|365707261|FG000|Overall Study|Participant request|75|||
106010989|NCT00321620|365707262|FG001|Overall Study|Participant request|52|||
106010990|NCT00321620|365707261|FG000|Overall Study|Other|42|||
106010991|NCT00321620|365707262|FG001|Overall Study|Other|33|||
106140309|NCT00823979|366170509|FG000|Overall Study|Lost to Follow-up|2|||
106140310|NCT00823979|366170510|FG001|Overall Study|Lost to Follow-up|1|||
105736562|NCT03176966|364691157|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
105736563|NCT03176966|364691156|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
105736564|NCT03176966|364691157|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
105736565|NCT03176966|364691156|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
105736566|NCT03176966|364691157|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
105736567|NCT01520922|364691158|FG000|Treatment Phase|Physician Decision|2|||
105736568|NCT01520922|364691159|FG001|Treatment Phase|Physician Decision|1|||
105939057|NCT03927846|365436858|FG000|Overall Study|Lost to Follow-up|10|||
105939058|NCT03927846|365436859|FG001|Overall Study|Lost to Follow-up|11|||
105939059|NCT03878069|365436860|FG000|Overall Study|Death|0|||
105939060|NCT03878069|365436861|FG001|Overall Study|Death|1|||
105939061|NCT03878069|365436862|FG002|Overall Study|Death|0|||
105939062|NCT00834587|365436863|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105939063|NCT00834587|365436864|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105939064|NCT00176254|365436865|FG000|Overall Study|Lost to Follow-up|1|||
105939065|NCT02613507|365436867|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
105939066|NCT02613507|365436868|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
105939067|NCT02613507|365436867|FG000|Pre-Treamtent|Participant withdrew consent|0|||
105939068|NCT02613507|365436868|FG001|Pre-Treamtent|Participant withdrew consent|4|||
105939069|NCT02613507|365436867|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
105939070|NCT02613507|365436868|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
105939071|NCT02613507|365436867|FG000|Treatment|Not reported|3|||
105939072|NCT02613507|365436868|FG001|Treatment|Not reported|0|||
105939073|NCT02613507|365436867|FG000|Treatment|Other reasons|8|||
105939074|NCT02613507|365436868|FG001|Treatment|Other reasons|0|||
105939075|NCT02613507|365436867|FG000|Treatment|Participant no longer meets criteria|3|||
105939076|NCT02613507|365436868|FG001|Treatment|Participant no longer meets criteria|0|||
105939077|NCT02613507|365436867|FG000|Treatment|Maximum clinical benefit|5|||
105939078|NCT02613507|365436868|FG001|Treatment|Maximum clinical benefit|10|||
105939079|NCT02613507|365436867|FG000|Treatment|Lost to Follow-up|1|||
105939080|NCT02613507|365436868|FG001|Treatment|Lost to Follow-up|0|||
105939081|NCT02613507|365436867|FG000|Treatment|Participant withdrew consent|0|||
105939082|NCT02613507|365436868|FG001|Treatment|Participant withdrew consent|2|||
105939083|NCT02613507|365436867|FG000|Treatment|Participant request to discontinue study treatment|13|||
105939084|NCT02613507|365436868|FG001|Treatment|Participant request to discontinue study treatment|17|||
105939085|NCT02613507|365436867|FG000|Treatment|Adverse event unrelated to study drug|20|||
105939086|NCT02613507|365436868|FG001|Treatment|Adverse event unrelated to study drug|3|||
105939087|NCT02613507|365436867|FG000|Treatment|Death|2|||
105939088|NCT02613507|365436868|FG001|Treatment|Death|0|||
105939089|NCT02613507|365436867|FG000|Treatment|Study drug toxicity|19|||
105939090|NCT02613507|365436868|FG001|Treatment|Study drug toxicity|14|||
105939091|NCT02613507|365436867|FG000|Treatment|Disease progression|263|||
105939092|NCT02613507|365436868|FG001|Treatment|Disease progression|110|||
105939093|NCT03941093|365436869|FG000|Overall Study|Protocol Violation|0|||
105939094|NCT03941093|365436870|FG001|Overall Study|Protocol Violation|1|||
105939095|NCT03941093|365436869|FG000|Overall Study|Withdrawal by Subject|9|||
105939096|NCT03941093|365436870|FG001|Overall Study|Withdrawal by Subject|6|||
105939097|NCT03493945|365437944|FG000|Phase I Dose Escalation|Ineligible|0|||
105939098|NCT03493945|365437945|FG001|Phase I Dose Escalation|Ineligible|0|||
105939099|NCT03493945|365437946|FG002|Phase I Dose Escalation|Ineligible|1|||
105939100|NCT03493945|365437947|FG003|Phase I Dose Escalation|Ineligible|0|||
105939101|NCT03493945|365437948|FG004|Phase I Dose Escalation|Ineligible|0|||
105939102|NCT03493945|365437949|FG005|Phase I Dose Escalation|Ineligible|0|||
105939103|NCT03493945|365437950|FG006|Phase I Dose Escalation|Ineligible|0|||
105939104|NCT03493945|365437944|FG000|Phase I Dose Escalation|New therapy|0|||
105939105|NCT03493945|365437945|FG001|Phase I Dose Escalation|New therapy|1|||
105939106|NCT03493945|365437946|FG002|Phase I Dose Escalation|New therapy|0|||
105939107|NCT03493945|365437947|FG003|Phase I Dose Escalation|New therapy|0|||
105939108|NCT03493945|365437948|FG004|Phase I Dose Escalation|New therapy|0|||
105939109|NCT03493945|365437949|FG005|Phase I Dose Escalation|New therapy|0|||
105939110|NCT03493945|365437950|FG006|Phase I Dose Escalation|New therapy|0|||
105939111|NCT03493945|365437944|FG000|Phase II Dose Expansion|Refused further treatment|0|||
105939112|NCT03493945|365437945|FG001|Phase II Dose Expansion|Refused further treatment|0|||
105939113|NCT03493945|365437946|FG002|Phase II Dose Expansion|Refused further treatment|0|||
105939114|NCT03493945|365437947|FG003|Phase II Dose Expansion|Refused further treatment|0|||
105736569|NCT01520922|364691158|FG000|Treatment Phase|Progression|0|||
105736570|NCT01520922|364691159|FG001|Treatment Phase|Progression|2|||
105736571|NCT01520922|364691158|FG000|Treatment Phase|Adverse Event|3|||
105939115|NCT03493945|365437948|FG004|Phase II Dose Expansion|Refused further treatment|1|||
105939116|NCT03493945|365437949|FG005|Phase II Dose Expansion|Refused further treatment|1|||
105939117|NCT03493945|365437950|FG006|Phase II Dose Expansion|Refused further treatment|0|||
105939118|NCT03493945|365437944|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
105939119|NCT03493945|365437945|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
105939120|NCT03493945|365437946|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
106140311|NCT00823979|366170511|FG002|Overall Study|Lost to Follow-up|0|||
106140312|NCT00823979|366170509|FG000|Overall Study|Withdrawal by Subject|2|||
106140313|NCT00823979|366170510|FG001|Overall Study|Withdrawal by Subject|3|||
106140314|NCT00823979|366170511|FG002|Overall Study|Withdrawal by Subject|2|||
106140315|NCT00823979|366170509|FG000|Overall Study|Protocol Violation|1|||
106140316|NCT00823979|366170510|FG001|Overall Study|Protocol Violation|1|||
106140317|NCT00823979|366170511|FG002|Overall Study|Protocol Violation|0|||
106140318|NCT00823979|366170509|FG000|Overall Study|Pregnancy|0|||
106140319|NCT00823979|366170510|FG001|Overall Study|Pregnancy|1|||
106140320|NCT00823979|366170511|FG002|Overall Study|Pregnancy|0|||
106140321|NCT00823979|366170509|FG000|Overall Study|Adverse Event|0|||
106140322|NCT00823979|366170510|FG001|Overall Study|Adverse Event|2|||
106140323|NCT00823979|366170511|FG002|Overall Study|Adverse Event|4|||
106140324|NCT00823979|366170509|FG000|Overall Study|Other|2|||
106140325|NCT00823979|366170510|FG001|Overall Study|Other|0|||
106140326|NCT00823979|366170511|FG002|Overall Study|Other|1|||
106140327|NCT00823979|366170509|FG000|Overall Study|Randomized but not Treated|4|||
106140328|NCT00823979|366170510|FG001|Overall Study|Randomized but not Treated|3|||
106140329|NCT00823979|366170511|FG002|Overall Study|Randomized but not Treated|1|||
106140330|NCT00823979|366170509|FG000|Overall Study|Study Terminated by Sponsor|5|||
106140331|NCT00823979|366170510|FG001|Overall Study|Study Terminated by Sponsor|5|||
106140332|NCT00823979|366170511|FG002|Overall Study|Study Terminated by Sponsor|7|||
106140333|NCT02770248|366170513|FG000|Overall Study|Adverse Event|0|||
106140334|NCT02770248|366170514|FG001|Overall Study|Adverse Event|1|||
106140335|NCT02770248|366170513|FG000|Overall Study|Randomized in error, prior to treatment|0|||
106140336|NCT02770248|366170514|FG001|Overall Study|Randomized in error, prior to treatment|1|||
106140337|NCT01768676|366170515|FG000|Overall Study|Adverse Event|3|||
106140338|NCT01768676|366170516|FG001|Overall Study|Adverse Event|3|||
106010992|NCT03337477|365707263|FG000|Overall Study|not categorized into the listed ones|11|||
106010993|NCT03337477|365707264|FG001|Overall Study|not categorized into the listed ones|9|||
106010994|NCT03337477|365707263|FG000|Overall Study|Withdrawal by Subject|0|||
106140339|NCT01768676|366170515|FG000|Overall Study|Lost to Follow-up|13|||
105736572|NCT01520922|364691159|FG001|Treatment Phase|Adverse Event|5|||
105736573|NCT01520922|364691158|FG000|Follow up|Lost to Follow-up|0|||
106010995|NCT03337477|365707264|FG001|Overall Study|Withdrawal by Subject|1|||
106010996|NCT03337477|365707263|FG000|Overall Study|Death|0|||
106010997|NCT03337477|365707264|FG001|Overall Study|Death|1|||
106010998|NCT03337477|365707263|FG000|Overall Study|Lost to Follow-up|0|||
106010999|NCT03337477|365707264|FG001|Overall Study|Lost to Follow-up|2|||
106011000|NCT03819114|365707268|FG000|Overall Study|Protocol Violation|0|||
106011001|NCT03819114|365707269|FG001|Overall Study|Protocol Violation|1|||
106011002|NCT03819114|365707270|FG002|Overall Study|Protocol Violation|1|||
106011003|NCT03819114|365707271|FG003|Overall Study|Protocol Violation|0|||
106011004|NCT03819114|365707268|FG000|Overall Study|Lost to Follow-up|0|||
106011005|NCT03819114|365707269|FG001|Overall Study|Lost to Follow-up|0|||
106011006|NCT03819114|365707270|FG002|Overall Study|Lost to Follow-up|1|||
106011007|NCT03819114|365707271|FG003|Overall Study|Lost to Follow-up|0|||
106011008|NCT00408317|365707272|FG000|First Intervention Period|Adverse Event|0|||
106011009|NCT00408317|365707273|FG001|First Intervention Period|Adverse Event|1|||
106011010|NCT00408317|365707272|FG000|Second Intervention Period|Adverse Event|2|||
106011011|NCT00408317|365707273|FG001|Second Intervention Period|Adverse Event|0|||
106011012|NCT00408317|365707272|FG000|Second Intervention Period|Protocol Violation|0|||
106011013|NCT00408317|365707273|FG001|Second Intervention Period|Protocol Violation|1|||
106011014|NCT00408317|365707272|FG000|Second Intervention Period|Withdrawal of consent|0|||
106011015|NCT00408317|365707273|FG001|Second Intervention Period|Withdrawal of consent|1|||
106011016|NCT01747876|365707275|FG000|Overall Study|Adverse Event|1|||
106011017|NCT01747876|365707276|FG001|Overall Study|Adverse Event|0|||
106011018|NCT01747876|365707277|FG002|Overall Study|Adverse Event|2|||
106011019|NCT01747876|365707275|FG000|Overall Study|Withdrawal by Subject|0|||
106011020|NCT01747876|365707276|FG001|Overall Study|Withdrawal by Subject|1|||
106140340|NCT01768676|366170516|FG001|Overall Study|Lost to Follow-up|16|||
106140341|NCT01768676|366170515|FG000|Overall Study|Protocol Violation|1|||
105736574|NCT01520922|364691159|FG001|Follow up|Lost to Follow-up|1|||
105736575|NCT01520922|364691158|FG000|Survival Follow-up|Withdrawal by Subject|1|||
105736576|NCT01520922|364691159|FG001|Survival Follow-up|Withdrawal by Subject|0|||
106011021|NCT01747876|365707277|FG002|Overall Study|Withdrawal by Subject|1|||
106011022|NCT01747876|365707275|FG000|Overall Study|Disease progression|4|||
106011023|NCT01747876|365707276|FG001|Overall Study|Disease progression|13|||
106011024|NCT01747876|365707277|FG002|Overall Study|Disease progression|8|||
106011025|NCT01747876|365707275|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
106011026|NCT01747876|365707276|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
106140342|NCT01768676|366170516|FG001|Overall Study|Protocol Violation|1|||
106140343|NCT01768676|366170515|FG000|Overall Study|Physician Decision|4|||
106140344|NCT01768676|366170516|FG001|Overall Study|Physician Decision|1|||
106140345|NCT01768676|366170515|FG000|Overall Study|Withdrawal by Subject|3|||
106011027|NCT01747876|365707277|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
106140346|NCT01768676|366170516|FG001|Overall Study|Withdrawal by Subject|10|||
106140347|NCT04133363|366170517|FG000|Overall Study|Lost to Follow-up|2|||
106140348|NCT04133363|366170518|FG001|Overall Study|Lost to Follow-up|1|||
106140349|NCT04133363|366170519|FG002|Overall Study|Lost to Follow-up|4|||
106140350|NCT03227757|366172462|FG000|Overall Study|Death|25|||
106140351|NCT03227757|366172462|FG000|Overall Study|Withdrawal|10|||
106140352|NCT03227757|366172462|FG000|Overall Study|Missed visits|1|||
106140353|NCT03227757|366172462|FG000|Overall Study|Lost to Follow-up|2|||
106140354|NCT02738840|366172463|FG000|Overall Study|MRI Scan not Performed|5|||
106140355|NCT02738840|366172463|FG000|Overall Study|Lost to Follow-up|1|||
106140356|NCT02738840|366172463|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
106140357|NCT02738840|366172463|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
106140358|NCT01645111|366172466|FG000|Overall Study|Did not require Clevidipine|15|||
106140359|NCT04048135|366172467|FG000|Overall Study|Withdrawal by Subject|1|||
106140360|NCT04048135|366172468|FG001|Overall Study|Withdrawal by Subject|1|||
106140361|NCT04048135|366172469|FG002|Overall Study|Withdrawal by Subject|1|||
106140362|NCT04048135|366172470|FG003|Overall Study|Withdrawal by Subject|2|||
106140363|NCT04048135|366172471|FG004|Overall Study|Withdrawal by Subject|0|||
106140364|NCT04048135|366172472|FG005|Overall Study|Withdrawal by Subject|0|||
106140365|NCT04048135|366172473|FG006|Overall Study|Withdrawal by Subject|1|||
105736577|NCT03090737|364691174|FG000|Overall Study|Other reasons|1|||
105736578|NCT03090737|364691174|FG000|Overall Study|Completed treatment as per protocol|17|||
105736579|NCT03090737|364691174|FG000|Overall Study|Maximum clinical benefit|2|||
105736580|NCT03090737|364691174|FG000|Overall Study|Adverse event unrelated to study drug|7|||
106011028|NCT03822117|365707278|FG000|Overall Study|Death|18|||
106011029|NCT03822117|365707279|FG001|Overall Study|Death|17|||
106011030|NCT03822117|365707280|FG002|Overall Study|Death|12|||
106011031|NCT03822117|365707281|FG003|Overall Study|Death|4|||
106011032|NCT03822117|365707278|FG000|Overall Study|Lost to Follow-up|1|||
106011033|NCT03822117|365707279|FG001|Overall Study|Lost to Follow-up|2|||
106011034|NCT03822117|365707280|FG002|Overall Study|Lost to Follow-up|3|||
106011035|NCT03822117|365707281|FG003|Overall Study|Lost to Follow-up|0|||
106011036|NCT03822117|365707278|FG000|Overall Study|Study Terminated by Sponsor|25|||
106011037|NCT03822117|365707279|FG001|Overall Study|Study Terminated by Sponsor|11|||
106011038|NCT03822117|365707280|FG002|Overall Study|Study Terminated by Sponsor|6|||
106011039|NCT03822117|365707281|FG003|Overall Study|Study Terminated by Sponsor|0|||
106011040|NCT03822117|365707278|FG000|Overall Study|Withdrawal by Subject|4|||
106011041|NCT03822117|365707279|FG001|Overall Study|Withdrawal by Subject|0|||
106011042|NCT03822117|365707280|FG002|Overall Study|Withdrawal by Subject|3|||
106011043|NCT03822117|365707281|FG003|Overall Study|Withdrawal by Subject|0|||
106011044|NCT03822117|365707278|FG000|Overall Study|Disease Progression|1|||
106011045|NCT03822117|365707279|FG001|Overall Study|Disease Progression|2|||
106011046|NCT03822117|365707280|FG002|Overall Study|Disease Progression|1|||
106011047|NCT03822117|365707281|FG003|Overall Study|Disease Progression|0|||
106011048|NCT03822117|365707278|FG000|Overall Study|Never Returned to Hospital|0|||
106011049|NCT03822117|365707279|FG001|Overall Study|Never Returned to Hospital|0|||
106011050|NCT03822117|365707280|FG002|Overall Study|Never Returned to Hospital|1|||
106011051|NCT03822117|365707281|FG003|Overall Study|Never Returned to Hospital|0|||
106011052|NCT00914316|365707282|FG000|Phase 1|Physician Decision|4|||
106011053|NCT00914316|365707283|FG001|Phase 1|Physician Decision|0|||
106011054|NCT00914316|365707284|FG002|Phase 1|Physician Decision|1|||
106011055|NCT00914316|365707285|FG003|Phase 1|Physician Decision|2|||
106011056|NCT00914316|365707282|FG000|Phase 1|Withdrawal by Subject|0|||
106011057|NCT00914316|365707283|FG001|Phase 1|Withdrawal by Subject|2|||
106011058|NCT00914316|365707284|FG002|Phase 1|Withdrawal by Subject|4|||
106011059|NCT00914316|365707285|FG003|Phase 1|Withdrawal by Subject|0|||
106011060|NCT00914316|365707282|FG000|Phase 1|Adverse Event|1|||
106011061|NCT00914316|365707283|FG001|Phase 1|Adverse Event|0|||
106011062|NCT00914316|365707284|FG002|Phase 1|Adverse Event|0|||
106011063|NCT00914316|365707285|FG003|Phase 1|Adverse Event|0|||
106011064|NCT00914316|365707282|FG000|Phase 2|Withdrawal by Subject|1|||
106011065|NCT00914316|365707283|FG001|Phase 2|Withdrawal by Subject|0|||
106011066|NCT00914316|365707284|FG002|Phase 2|Withdrawal by Subject|1|||
106140366|NCT04048135|366172474|FG007|Overall Study|Withdrawal by Subject|1|||
106140367|NCT04048135|366172467|FG000|Overall Study|Adverse Event|0|||
105736581|NCT03090737|364691174|FG000|Overall Study|Study drug toxicity|4|||
105736582|NCT03090737|364691174|FG000|Overall Study|Disease progression|98|||
105736583|NCT00227877|364691175|FG000|Pre-visit Assessment|Technical difficulties|7|||
106011067|NCT00914316|365707285|FG003|Phase 2|Withdrawal by Subject|0|||
106011068|NCT01213472|365707292|FG000|Overall Study|Recurrence/Progressive disease|25|||
106011069|NCT01213472|365707292|FG000|Overall Study|Withdrawal by Subject|1|||
106140368|NCT04048135|366172468|FG001|Overall Study|Adverse Event|0|||
106140369|NCT04048135|366172469|FG002|Overall Study|Adverse Event|0|||
106140370|NCT04048135|366172470|FG003|Overall Study|Adverse Event|1|||
106140371|NCT04048135|366172471|FG004|Overall Study|Adverse Event|1|||
106140372|NCT04048135|366172472|FG005|Overall Study|Adverse Event|0|||
106011070|NCT01213472|365707292|FG000|Overall Study|Physician Decision|1|||
106011071|NCT03406780|365707293|FG000|Overall Study|Withdrawal by Subject|1|||
106011072|NCT03406780|365707294|FG001|Overall Study|Withdrawal by Subject|1|||
106011073|NCT03406780|365707293|FG000|Overall Study|Other|0|||
106011074|NCT03406780|365707294|FG001|Overall Study|Other|2|||
105736584|NCT00227877|364691176|FG001|Pre-visit Assessment|Technical difficulties|3|||
105736585|NCT00227877|364691177|FG002|Pre-visit Assessment|Technical difficulties|0|||
105736586|NCT00227877|364691178|FG003|Pre-visit Assessment|Technical difficulties|0|||
105736587|NCT00227877|364691175|FG000|Post-visit Checklist|Lost to Follow-up|24|||
105736588|NCT00227877|364691176|FG001|Post-visit Checklist|Lost to Follow-up|13|||
105736589|NCT00227877|364691177|FG002|Post-visit Checklist|Lost to Follow-up|1|||
105736590|NCT00227877|364691178|FG003|Post-visit Checklist|Lost to Follow-up|0|||
105736591|NCT00227877|364691175|FG000|3-months Follow-up|Completed late|135|||
105736592|NCT00227877|364691176|FG001|3-months Follow-up|Completed late|128|||
105736593|NCT00227877|364691177|FG002|3-months Follow-up|Completed late|34|||
105736594|NCT00227877|364691178|FG003|3-months Follow-up|Completed late|8|||
105736595|NCT00227877|364691175|FG000|3-months Follow-up|Lost to Follow-up|178|||
105736596|NCT00227877|364691176|FG001|3-months Follow-up|Lost to Follow-up|139|||
105736597|NCT00227877|364691177|FG002|3-months Follow-up|Lost to Follow-up|18|||
105736598|NCT00227877|364691178|FG003|3-months Follow-up|Lost to Follow-up|13|||
105736599|NCT00227877|364691175|FG000|12-months Follow-up|Completed late|78|||
105736600|NCT00227877|364691176|FG001|12-months Follow-up|Completed late|74|||
105736601|NCT00227877|364691177|FG002|12-months Follow-up|Completed late|1|||
105736602|NCT00227877|364691178|FG003|12-months Follow-up|Completed late|0|||
105736603|NCT00227877|364691175|FG000|12-months Follow-up|Lost to Follow-up|232|||
105736604|NCT00227877|364691176|FG001|12-months Follow-up|Lost to Follow-up|189|||
105736605|NCT00227877|364691177|FG002|12-months Follow-up|Lost to Follow-up|30|||
105736606|NCT00227877|364691178|FG003|12-months Follow-up|Lost to Follow-up|26|||
105736607|NCT02269319|364691180|FG000|Overall Study|Lost to Follow-up|4|||
105736608|NCT02269319|364691181|FG001|Overall Study|Lost to Follow-up|3|||
105736609|NCT02269319|364691180|FG000|Overall Study|Adverse Event|0|||
105736610|NCT02269319|364691181|FG001|Overall Study|Adverse Event|1|||
105736611|NCT02269319|364691180|FG000|Overall Study|Instructions not followed|1|||
105736612|NCT02269319|364691181|FG001|Overall Study|Instructions not followed|0|||
105736613|NCT04430582|364691183|FG000|Overall Study|Found to meet exclusionary criteria|1|||
105736614|NCT04430582|364691184|FG001|Overall Study|Found to meet exclusionary criteria|0|||
105736615|NCT04430582|364691183|FG000|Overall Study|Withdrawal by Subject|0|||
105736616|NCT04430582|364691184|FG001|Overall Study|Withdrawal by Subject|1|||
105736617|NCT02522481|364691185|FG000|Overall Study|discontinued|1|||
105736618|NCT02522481|364691185|FG000|Overall Study|Not dosed|2|||
105736619|NCT00404768|364691186|FG000|Part A and B|Withdrawn due to labor progression|1|||
105736620|NCT00404768|364691187|FG001|Part A and B|Withdrawn due to labor progression|0|||
105736621|NCT00404768|364691188|FG002|Part A and B|Withdrawn due to labor progression|0|||
105736622|NCT00404768|364691189|FG003|Part A and B|Withdrawn due to labor progression|0|||
105736623|NCT00404768|364691186|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
105736624|NCT00404768|364691187|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
105736625|NCT00404768|364691188|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
105736626|NCT00404768|364691189|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
105736627|NCT00404768|364691186|FG000|Part C|Adverse Event|0|||
105736628|NCT00404768|364691187|FG001|Part C|Adverse Event|0|||
105736629|NCT00404768|364691188|FG002|Part C|Adverse Event|0|||
105736630|NCT00404768|364691189|FG003|Part C|Adverse Event|3|||
105736631|NCT00404768|364691186|FG000|Part C|Lost to Follow-up|0|||
105736632|NCT00404768|364691187|FG001|Part C|Lost to Follow-up|0|||
105939121|NCT03493945|365437947|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
105939122|NCT03493945|365437948|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
105939123|NCT03493945|365437949|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
105939124|NCT03493945|365437950|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
105939125|NCT01926509|365437951|FG000|Overall Study|vital sign met discontinuation criteria|1|||
105939126|NCT01926509|365437952|FG001|Overall Study|vital sign met discontinuation criteria|0|||
105939127|NCT01926509|365437953|FG002|Overall Study|vital sign met discontinuation criteria|0|||
105939128|NCT01926509|365437954|FG003|Overall Study|vital sign met discontinuation criteria|0|||
105939129|NCT04744831|365437955|FG000|Overall Study|Progressive Disease|31|||
105939130|NCT04744831|365437956|FG001|Overall Study|Progressive Disease|27|||
105939131|NCT04744831|365437957|FG002|Overall Study|Progressive Disease|25|||
105939132|NCT04744831|365437955|FG000|Overall Study|Adverse Event|3|||
105939133|NCT04744831|365437956|FG001|Overall Study|Adverse Event|3|||
105939134|NCT04744831|365437957|FG002|Overall Study|Adverse Event|3|||
105939135|NCT04744831|365437955|FG000|Overall Study|Clinical Progression|3|||
105939136|NCT04744831|365437956|FG001|Overall Study|Clinical Progression|2|||
105939137|NCT04744831|365437957|FG002|Overall Study|Clinical Progression|5|||
105939138|NCT04744831|365437955|FG000|Overall Study|Other|0|||
105939139|NCT04744831|365437956|FG001|Overall Study|Other|2|||
105939140|NCT04744831|365437957|FG002|Overall Study|Other|1|||
105939141|NCT04744831|365437955|FG000|Overall Study|Death|0|||
105736633|NCT00404768|364691188|FG002|Part C|Lost to Follow-up|3|||
105736634|NCT00404768|364691189|FG003|Part C|Lost to Follow-up|1|||
105736635|NCT00404768|364691186|FG000|Part C|Withdrawal by Subject|0|||
105736636|NCT00404768|364691187|FG001|Part C|Withdrawal by Subject|0|||
105736637|NCT00404768|364691188|FG002|Part C|Withdrawal by Subject|2|||
105939142|NCT04744831|365437956|FG001|Overall Study|Death|2|||
105939143|NCT04744831|365437957|FG002|Overall Study|Death|1|||
105736638|NCT00404768|364691189|FG003|Part C|Withdrawal by Subject|1|||
105736639|NCT00404768|364691186|FG000|Part C|Early withdrawal from study medication|0|||
106140373|NCT04048135|366172473|FG006|Overall Study|Adverse Event|0|||
106140374|NCT04048135|366172474|FG007|Overall Study|Adverse Event|0|||
106140375|NCT04048135|366172467|FG000|Overall Study|Protocol Violation|0|||
106140376|NCT04048135|366172468|FG001|Overall Study|Protocol Violation|0|||
106140377|NCT04048135|366172469|FG002|Overall Study|Protocol Violation|0|||
106140378|NCT04048135|366172470|FG003|Overall Study|Protocol Violation|0|||
106140379|NCT04048135|366172471|FG004|Overall Study|Protocol Violation|0|||
106140380|NCT04048135|366172472|FG005|Overall Study|Protocol Violation|1|||
106140381|NCT04048135|366172473|FG006|Overall Study|Protocol Violation|0|||
106140382|NCT04048135|366172474|FG007|Overall Study|Protocol Violation|0|||
106140383|NCT01249092|366172477|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
106140384|NCT01249092|366172477|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
106140385|NCT01546155|366172478|FG000|Overall Study|could not tolerate long scan duration|3|||
106140386|NCT01025843|366172482|FG000|Washout 4|Withdrawal by Subject|0|||
106140387|NCT01025843|366172483|FG001|Washout 4|Withdrawal by Subject|0|||
106140388|NCT01025843|366172484|FG002|Washout 4|Withdrawal by Subject|1|||
106140389|NCT01025843|366172485|FG003|Washout 4|Withdrawal by Subject|1|||
106140390|NCT01025843|366172486|FG004|Washout 4|Withdrawal by Subject|0|||
106140391|NCT01025843|366172487|FG005|Washout 4|Withdrawal by Subject|0|||
106140392|NCT01025843|366172488|FG006|Washout 4|Withdrawal by Subject|0|||
106140393|NCT01025843|366172489|FG007|Washout 4|Withdrawal by Subject|0|||
106140394|NCT01025843|366172490|FG008|Washout 4|Withdrawal by Subject|0|||
105736640|NCT00404768|364691187|FG001|Part C|Early withdrawal from study medication|0|||
105736641|NCT00404768|364691188|FG002|Part C|Early withdrawal from study medication|1|||
105939144|NCT03004183|365437958|FG000|Overall Study|Adverse Event|7|||
105939145|NCT03004183|365437958|FG000|Overall Study|Lost to Follow-up|1|||
105736642|NCT00404768|364691189|FG003|Part C|Early withdrawal from study medication|0|||
105736643|NCT00404768|364691186|FG000|Part C|Participant did not respond to therapy|0|||
105939146|NCT03004183|365437958|FG000|Overall Study|Physician Decision|40|||
105939147|NCT03004183|365437958|FG000|Overall Study|Withdrawal by Subject|1|||
105736644|NCT00404768|364691187|FG001|Part C|Participant did not respond to therapy|0|||
105736645|NCT00404768|364691188|FG002|Part C|Participant did not respond to therapy|1|||
105736646|NCT00404768|364691189|FG003|Part C|Participant did not respond to therapy|1|||
105736647|NCT00404768|364691186|FG000|Part C|Physician withdrew the study medication|0|||
105736648|NCT00404768|364691187|FG001|Part C|Physician withdrew the study medication|0|||
105736649|NCT00404768|364691188|FG002|Part C|Physician withdrew the study medication|1|||
105736650|NCT00404768|364691189|FG003|Part C|Physician withdrew the study medication|0|||
105736651|NCT00404768|364691186|FG000|Part C|Participant delivered baby|0|||
105736652|NCT00404768|364691187|FG001|Part C|Participant delivered baby|0|||
105736653|NCT00404768|364691188|FG002|Part C|Participant delivered baby|0|||
105736654|NCT00404768|364691189|FG003|Part C|Participant delivered baby|1|||
105736655|NCT00404768|364691186|FG000|Part C|Unsatisfactory uterine response to IP|0|||
105736656|NCT00404768|364691187|FG001|Part C|Unsatisfactory uterine response to IP|0|||
105736657|NCT00404768|364691188|FG002|Part C|Unsatisfactory uterine response to IP|0|||
105736658|NCT00404768|364691189|FG003|Part C|Unsatisfactory uterine response to IP|1|||
105939148|NCT03004183|365437958|FG000|Overall Study|COVID-19|1|||
105939149|NCT05401409|365437959|FG000|Overall Study|Lost to Follow-up|1|||
105939150|NCT05401409|365437960|FG001|Overall Study|Lost to Follow-up|0|||
105939151|NCT06844812|365437961|FG000|Overall Study|Lost to Follow-up|5|||
105939152|NCT06844812|365437961|FG000|Overall Study|stigmatization concerns|2|||
105939153|NCT06844812|365437961|FG000|Overall Study|medication refusal|2|||
105939154|NCT06844812|365437961|FG000|Overall Study|concerns about possible side effects|2|||
105939155|NCT06844812|365437961|FG000|Overall Study|wanting to seek another specialist opinion|2|||
105939156|NCT06844812|365437961|FG000|Overall Study|side effects (dizziness)|1|||
105939157|NCT02144337|365437962|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
105939158|NCT02144337|365437963|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
105736659|NCT00404768|364691186|FG000|Part C|Active labor|0|||
105736660|NCT00404768|364691187|FG001|Part C|Active labor|0|||
105736661|NCT00404768|364691188|FG002|Part C|Active labor|0|||
105736662|NCT00404768|364691189|FG003|Part C|Active labor|1|||
105736663|NCT00404768|364691186|FG000|Part C|Lack of Efficacy|0|||
105939159|NCT02144337|365437962|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
105939160|NCT02144337|365437963|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
105736664|NCT00404768|364691187|FG001|Part C|Lack of Efficacy|0|||
105736665|NCT00404768|364691188|FG002|Part C|Lack of Efficacy|0|||
105939161|NCT02144337|365437962|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
106140395|NCT01025843|366172491|FG009|Washout 4|Withdrawal by Subject|0|||
106140396|NCT02577523|366172496|FG000|Overall Study|Adverse Event|1|||
106140397|NCT02577523|366172497|FG001|Overall Study|Adverse Event|1|||
106140398|NCT02577523|366172496|FG000|Overall Study|Lack of Efficacy|1|||
106140399|NCT02577523|366172497|FG001|Overall Study|Lack of Efficacy|1|||
106140400|NCT02577523|366172496|FG000|Overall Study|Withdrawal by Subject|1|||
106140401|NCT02577523|366172497|FG001|Overall Study|Withdrawal by Subject|0|||
105939162|NCT02144337|365437963|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
105799272|NCT02094937|364922714|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
105799273|NCT02094937|364922715|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
106011075|NCT02085460|365707296|FG000|Overall Study|Adverse Event|2|||
106011076|NCT02085460|365707297|FG001|Overall Study|Adverse Event|2|||
106011077|NCT02085460|365707298|FG002|Overall Study|Adverse Event|1|||
106011078|NCT02085460|365707296|FG000|Overall Study|Physician Decision|1|||
106011079|NCT02085460|365707297|FG001|Overall Study|Physician Decision|1|||
106011080|NCT02085460|365707298|FG002|Overall Study|Physician Decision|2|||
106011081|NCT02085460|365707296|FG000|Overall Study|Withdrawal by Subject|11|||
106011082|NCT02085460|365707297|FG001|Overall Study|Withdrawal by Subject|5|||
106011083|NCT02085460|365707298|FG002|Overall Study|Withdrawal by Subject|7|||
106011084|NCT01709721|365707299|FG000|Open Label Phase|Withdrawal by Subject|0|||
106011085|NCT01709721|365707300|FG001|Open Label Phase|Withdrawal by Subject|0|||
106011086|NCT01709721|365707301|FG002|Open Label Phase|Withdrawal by Subject|5|||
106011087|NCT01709721|365707299|FG000|Open Label Phase|Adverse Event|0|||
106011088|NCT01709721|365707300|FG001|Open Label Phase|Adverse Event|0|||
106011089|NCT01709721|365707301|FG002|Open Label Phase|Adverse Event|8|||
106011090|NCT01709721|365707299|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
106011091|NCT01709721|365707300|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
106011092|NCT01709721|365707301|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
106011093|NCT01709721|365707299|FG000|Open Label Phase|Investigator Decision|0|||
106011094|NCT01709721|365707300|FG001|Open Label Phase|Investigator Decision|0|||
106011095|NCT01709721|365707301|FG002|Open Label Phase|Investigator Decision|1|||
106011096|NCT01709721|365707299|FG000|Open Label Phase|Sponsor Decision|0|||
106011097|NCT01709721|365707300|FG001|Open Label Phase|Sponsor Decision|0|||
106011098|NCT01709721|365707301|FG002|Open Label Phase|Sponsor Decision|2|||
106011099|NCT01709721|365707299|FG000|Open Label Phase|Protocol Violation|0|||
106011100|NCT01709721|365707300|FG001|Open Label Phase|Protocol Violation|0|||
106011101|NCT01709721|365707301|FG002|Open Label Phase|Protocol Violation|1|||
106011102|NCT01709721|365707299|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
106011103|NCT01709721|365707300|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
106011104|NCT01709721|365707301|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
106011105|NCT01709721|365707299|FG000|Open Label Phase|Inadequate Pain Control|0|||
106011106|NCT01709721|365707300|FG001|Open Label Phase|Inadequate Pain Control|0|||
106011107|NCT01709721|365707301|FG002|Open Label Phase|Inadequate Pain Control|37|||
106011108|NCT01709721|365707299|FG000|Open Label Phase|Other, Specify in text field in database|0|||
106011109|NCT01709721|365707300|FG001|Open Label Phase|Other, Specify in text field in database|0|||
106011110|NCT01709721|365707301|FG002|Open Label Phase|Other, Specify in text field in database|14|||
106011111|NCT01709721|365707299|FG000|Randomized Phase|Adverse Event|0|||
106011112|NCT01709721|365707300|FG001|Randomized Phase|Adverse Event|1|||
106011113|NCT01709721|365707301|FG002|Randomized Phase|Adverse Event|0|||
106011114|NCT01709721|365707299|FG000|Randomized Phase|Lost to Follow-up|1|||
106011115|NCT01709721|365707300|FG001|Randomized Phase|Lost to Follow-up|0|||
106011116|NCT01709721|365707301|FG002|Randomized Phase|Lost to Follow-up|0|||
106011117|NCT01709721|365707299|FG000|Randomized Phase|Inadequate Pain Control|1|||
106011118|NCT01709721|365707300|FG001|Randomized Phase|Inadequate Pain Control|2|||
106011119|NCT01709721|365707301|FG002|Randomized Phase|Inadequate Pain Control|0|||
106011120|NCT01709721|365707299|FG000|Randomized Phase|Other, Specify text field in database|1|||
106011121|NCT01709721|365707300|FG001|Randomized Phase|Other, Specify text field in database|3|||
106011122|NCT01709721|365707301|FG002|Randomized Phase|Other, Specify text field in database|0|||
106011123|NCT01499940|365707302|FG000|Overall Study|Study was withdrawn before completion.|9|||
106011124|NCT05249582|365707303|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
106011125|NCT05249582|365707304|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
106011126|NCT05249582|365707303|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
106011127|NCT05249582|365707304|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
106011128|NCT05249582|365707303|FG000|Overall Study|Declined to use virtual reality headset|1|||
106011129|NCT05249582|365707304|FG001|Overall Study|Declined to use virtual reality headset|0|||
106011130|NCT03675126|365707305|FG000|Overall Study|Study Terminated by Sponsor|9|||
106011131|NCT03675126|365707305|FG000|Overall Study|Death|2|||
106011132|NCT03675126|365707305|FG000|Overall Study|Withdrawal by Subject|4|||
106011133|NCT00001959|365707306|FG000|Overall Study|newly diagnosed colon cancer|1|||
106011134|NCT00001959|365707306|FG000|Overall Study|disabling sedation|1|||
106011135|NCT00001959|365707306|FG000|Overall Study|non-compliance|1|||
106011136|NCT01353898|365707310|FG000|Overall Study|Study site terminated|0|||
106011137|NCT01353898|365707311|FG001|Overall Study|Study site terminated|0|||
106011138|NCT01353898|365707312|FG002|Overall Study|Study site terminated|0|||
106011139|NCT01353898|365707313|FG003|Overall Study|Study site terminated|0|||
106011140|NCT01353898|365707314|FG004|Overall Study|Study site terminated|0|||
106011141|NCT01353898|365707315|FG005|Overall Study|Study site terminated|1|||
105799274|NCT01133392|364922716|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
105799275|NCT01133392|364922717|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
105939163|NCT02144337|365437962|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
105939164|NCT02144337|365437963|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
106140402|NCT04860258|366172500|FG000|Overall Study|Withdrawal by Subject|0|||
106140403|NCT04860258|366172501|FG001|Overall Study|Withdrawal by Subject|0|||
105939165|NCT02144337|365437962|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
105939166|NCT02144337|365437963|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
105939167|NCT02402907|365437966|FG000|Overall Study|Delivered vaginally|9|||
105939168|NCT02402907|365437967|FG001|Overall Study|Delivered vaginally|3|||
105939169|NCT02402907|365437966|FG000|Overall Study|Delivered outside of Sinai|1|||
105939170|NCT02402907|365437967|FG001|Overall Study|Delivered outside of Sinai|1|||
106140404|NCT04860258|366172502|FG002|Overall Study|Withdrawal by Subject|4|||
106140405|NCT04860258|366172503|FG003|Overall Study|Withdrawal by Subject|1|||
106140406|NCT04860258|366172504|FG004|Overall Study|Withdrawal by Subject|4|||
106140407|NCT04860258|366172505|FG005|Overall Study|Withdrawal by Subject|1|||
106140408|NCT04860258|366172506|FG006|Overall Study|Withdrawal by Subject|0|||
106140409|NCT00357396|366172507|FG000|Overall Study|Adverse Event|1|||
106140410|NCT00357396|366172508|FG001|Overall Study|Adverse Event|0|||
106140411|NCT02810080|366172509|FG000|Overall Study|Adverse Event|3|||
106140412|NCT02810080|366172510|FG001|Overall Study|Adverse Event|0|||
106140413|NCT02810080|366172509|FG000|Overall Study|Death|0|||
106140414|NCT02810080|366172510|FG001|Overall Study|Death|2|||
106140415|NCT02810080|366172509|FG000|Overall Study|Physician Decision|4|||
106140416|NCT02810080|366172510|FG001|Overall Study|Physician Decision|0|||
106140417|NCT02810080|366172509|FG000|Overall Study|Withdrawal by Subject|0|||
106140418|NCT02810080|366172510|FG001|Overall Study|Withdrawal by Subject|2|||
106140419|NCT01616654|366172511|FG000|Overall Study|Lack of Efficacy|1|||
106140420|NCT01616654|366172512|FG001|Overall Study|Lack of Efficacy|0|||
106140421|NCT01616654|366172513|FG002|Overall Study|Lack of Efficacy|0|||
106140422|NCT01616654|366172514|FG003|Overall Study|Lack of Efficacy|0|||
106140423|NCT01616654|366172515|FG004|Overall Study|Lack of Efficacy|1|||
106140424|NCT01616654|366172511|FG000|Overall Study|Adverse Event|0|||
106140425|NCT01616654|366172512|FG001|Overall Study|Adverse Event|1|||
106140426|NCT01616654|366172513|FG002|Overall Study|Adverse Event|2|||
106140427|NCT01616654|366172514|FG003|Overall Study|Adverse Event|1|||
106140428|NCT01616654|366172515|FG004|Overall Study|Adverse Event|0|||
106140429|NCT01616654|366172511|FG000|Overall Study|Withdrawal by Subject|2|||
106140430|NCT01616654|366172512|FG001|Overall Study|Withdrawal by Subject|2|||
106140431|NCT01616654|366172513|FG002|Overall Study|Withdrawal by Subject|3|||
106140432|NCT01616654|366172514|FG003|Overall Study|Withdrawal by Subject|1|||
106140433|NCT01616654|366172515|FG004|Overall Study|Withdrawal by Subject|5|||
106140434|NCT01616654|366172511|FG000|Overall Study|Protocol Violation|0|||
106140435|NCT01616654|366172512|FG001|Overall Study|Protocol Violation|5|||
106140436|NCT01616654|366172513|FG002|Overall Study|Protocol Violation|2|||
106140437|NCT01616654|366172514|FG003|Overall Study|Protocol Violation|4|||
106140438|NCT01616654|366172515|FG004|Overall Study|Protocol Violation|4|||
106140439|NCT01616654|366172511|FG000|Overall Study|Lost to Follow-up|1|||
106140440|NCT01616654|366172512|FG001|Overall Study|Lost to Follow-up|0|||
106140441|NCT01616654|366172513|FG002|Overall Study|Lost to Follow-up|3|||
106140442|NCT01616654|366172514|FG003|Overall Study|Lost to Follow-up|2|||
106140443|NCT01616654|366172515|FG004|Overall Study|Lost to Follow-up|1|||
106140444|NCT01616654|366172511|FG000|Overall Study|Pregnancy|1|||
106140445|NCT01616654|366172512|FG001|Overall Study|Pregnancy|0|||
106140446|NCT01616654|366172513|FG002|Overall Study|Pregnancy|0|||
106140447|NCT01616654|366172514|FG003|Overall Study|Pregnancy|0|||
106140448|NCT01616654|366172515|FG004|Overall Study|Pregnancy|1|||
106140449|NCT03923491|366172519|FG000|Overall Study|Lost to Follow-up|5|||
105736666|NCT00404768|364691189|FG003|Part C|Lack of Efficacy|2|||
105736667|NCT00404768|364691186|FG000|Part C|Treatment failure|0|||
105736668|NCT00404768|364691187|FG001|Part C|Treatment failure|0|||
105736669|NCT00404768|364691188|FG002|Part C|Treatment failure|0|||
105736670|NCT00404768|364691189|FG003|Part C|Treatment failure|1|||
105736671|NCT00404768|364691186|FG000|Part C|Investigator discretion|0|||
105736672|NCT00404768|364691187|FG001|Part C|Investigator discretion|0|||
105736673|NCT00404768|364691188|FG002|Part C|Investigator discretion|0|||
106140450|NCT03923491|366172520|FG001|Overall Study|Lost to Follow-up|8|||
106140451|NCT03923491|366172519|FG000|Overall Study|Withdrawal by Subject|4|||
106140452|NCT03923491|366172520|FG001|Overall Study|Withdrawal by Subject|6|||
106140453|NCT02174562|366172523|FG000|Overall Study|Withdrawal by Subject|7|||
106140454|NCT02174562|366172524|FG001|Overall Study|Withdrawal by Subject|2|||
105736674|NCT00404768|364691189|FG003|Part C|Investigator discretion|1|||
105736675|NCT00404768|364691186|FG000|Part C|Researcher suspended study medication|0|||
106140455|NCT02174562|366172523|FG000|Overall Study|Death|2|||
106140456|NCT02174562|366172524|FG001|Overall Study|Death|0|||
106140457|NCT02174562|366172523|FG000|Overall Study|Lost to Follow-up|0|||
105736676|NCT00404768|364691187|FG001|Part C|Researcher suspended study medication|0|||
105736677|NCT00404768|364691188|FG002|Part C|Researcher suspended study medication|0|||
105939171|NCT02402907|365437966|FG000|Overall Study|Lost to follow up after C-Section|10|||
105939172|NCT02402907|365437967|FG001|Overall Study|Lost to follow up after C-Section|23|||
105939173|NCT00203242|365437970|FG000|Overall Study|Lost to Follow-up|1|||
105736678|NCT00404768|364691189|FG003|Part C|Researcher suspended study medication|1|||
105736679|NCT04773041|364691192|FG000|Overall Study|Unable to data match|1|||
105736680|NCT04773041|364691193|FG001|Overall Study|Unable to data match|0|||
105939174|NCT00449787|365437971|FG000|Overall Study|Lost to Follow-up|10|||
105939175|NCT00449787|365437972|FG001|Overall Study|Lost to Follow-up|8|||
105939176|NCT00449787|365437971|FG000|Overall Study|Did not require medication|95|||
105939177|NCT00449787|365437972|FG001|Overall Study|Did not require medication|92|||
105939178|NCT03701074|365437973|FG000|Overall Study|Physician Decision|1|||
105736681|NCT04773041|364691194|FG002|Overall Study|Unable to data match|0|||
105736682|NCT02112448|364691198|FG000|Overall Study|lab values precluding use of ketorolac|2|||
105736683|NCT02112448|364691199|FG001|Overall Study|lab values precluding use of ketorolac|2|||
105736684|NCT02112448|364691198|FG000|Overall Study|Protocol Violation|1|||
105939179|NCT03701074|365437974|FG001|Overall Study|Physician Decision|0|||
105939180|NCT00661687|365437977|FG000|Overall Study|Study related symptoms and complaints|5|||
106140458|NCT02174562|366172524|FG001|Overall Study|Lost to Follow-up|3|||
106140459|NCT00864682|366172530|FG000|Overall Study|Protocol Violation|2|||
106140460|NCT00864682|366172531|FG001|Overall Study|Protocol Violation|1|||
106140461|NCT00864682|366172532|FG002|Overall Study|Protocol Violation|2|||
106140462|NCT00246012|366172533|FG000|Overall Study|Adverse Event|0|||
106140463|NCT00246012|366172534|FG001|Overall Study|Adverse Event|0|||
106140464|NCT00246012|366172535|FG002|Overall Study|Adverse Event|0|||
106140465|NCT00246012|366172536|FG003|Overall Study|Adverse Event|0|||
106140466|NCT00246012|366172537|FG004|Overall Study|Adverse Event|0|||
106140467|NCT00246012|366172538|FG005|Overall Study|Adverse Event|1|||
106140468|NCT00246012|366172539|FG006|Overall Study|Adverse Event|0|||
106140469|NCT00246012|366172540|FG007|Overall Study|Adverse Event|0|||
106140470|NCT00246012|366172541|FG008|Overall Study|Adverse Event|2|||
106140471|NCT00246012|366172533|FG000|Overall Study|Withdrawal by Subject|0|||
106140472|NCT00246012|366172534|FG001|Overall Study|Withdrawal by Subject|0|||
106140473|NCT00246012|366172535|FG002|Overall Study|Withdrawal by Subject|0|||
106140474|NCT00246012|366172536|FG003|Overall Study|Withdrawal by Subject|0|||
106140475|NCT00246012|366172537|FG004|Overall Study|Withdrawal by Subject|0|||
106140476|NCT00246012|366172538|FG005|Overall Study|Withdrawal by Subject|1|||
106140477|NCT00246012|366172539|FG006|Overall Study|Withdrawal by Subject|0|||
106140478|NCT00246012|366172540|FG007|Overall Study|Withdrawal by Subject|0|||
106140479|NCT00246012|366172541|FG008|Overall Study|Withdrawal by Subject|0|||
106140480|NCT00246012|366172533|FG000|Overall Study|Disease progression|3|||
106140481|NCT00246012|366172534|FG001|Overall Study|Disease progression|1|||
106140482|NCT00246012|366172535|FG002|Overall Study|Disease progression|2|||
106140483|NCT00246012|366172536|FG003|Overall Study|Disease progression|3|||
106140484|NCT00246012|366172537|FG004|Overall Study|Disease progression|3|||
106140485|NCT00246012|366172538|FG005|Overall Study|Disease progression|25|||
106140486|NCT00246012|366172539|FG006|Overall Study|Disease progression|30|||
105736685|NCT02112448|364691199|FG001|Overall Study|Protocol Violation|2|||
105736686|NCT02112448|364691198|FG000|Overall Study|Physician Decision|4|||
105736687|NCT02112448|364691199|FG001|Overall Study|Physician Decision|6|||
105736688|NCT02112448|364691198|FG000|Overall Study|required heparin so could not use ketoro|1|||
105736689|NCT02112448|364691199|FG001|Overall Study|required heparin so could not use ketoro|0|||
105736690|NCT05243550|364693250|FG000|Overall Study|Ongoing in the Study|171|||
105736691|NCT05243550|364693250|FG000|Overall Study|Withdrawal by Subject|10|||
105736692|NCT05243550|364693250|FG000|Overall Study|Lost to Follow-up|7|||
105736693|NCT05243550|364693250|FG000|Overall Study|Adverse Event|3|||
105736694|NCT05243550|364693250|FG000|Overall Study|Noncompliance|1|||
105736695|NCT05243550|364693250|FG000|Overall Study|Physician Decision|1|||
105736696|NCT05243550|364693250|FG000|Overall Study|Other Reason|4|||
105736697|NCT01543490|364693266|FG000|Overall Study|Adverse Event|4|||
105736698|NCT01543490|364693267|FG001|Overall Study|Adverse Event|0|||
105736699|NCT01543490|364693266|FG000|Overall Study|Physician Decision|1|||
105736700|NCT01543490|364693267|FG001|Overall Study|Physician Decision|0|||
105736701|NCT01543490|364693266|FG000|Overall Study|Lack of Efficacy|3|||
105736702|NCT01543490|364693267|FG001|Overall Study|Lack of Efficacy|3|||
105736703|NCT01543490|364693266|FG000|Overall Study|Lost to Follow-up|5|||
105736704|NCT01543490|364693267|FG001|Overall Study|Lost to Follow-up|0|||
105736705|NCT01543490|364693266|FG000|Overall Study|Withdrawal by Subject|2|||
105736706|NCT01543490|364693267|FG001|Overall Study|Withdrawal by Subject|0|||
105736707|NCT01543490|364693266|FG000|Overall Study|Other-Various Administrative Reasons|1|||
105736708|NCT01543490|364693267|FG001|Overall Study|Other-Various Administrative Reasons|2|||
105736709|NCT01597622|364693268|FG000|Overall Study|Adverse Event|7|||
105736710|NCT01597622|364693268|FG000|Overall Study|Lack of Efficacy|3|||
105736711|NCT01597622|364693268|FG000|Overall Study|Protocol Violation|1|||
105736712|NCT01597622|364693268|FG000|Overall Study|Lost to Follow-up|1|||
105736713|NCT01597622|364693268|FG000|Overall Study|Investigator Discretion|5|||
105736714|NCT01597622|364693268|FG000|Overall Study|Withdrawal by Subject|20|||
106140487|NCT00246012|366172540|FG007|Overall Study|Disease progression|27|||
106140488|NCT00246012|366172541|FG008|Overall Study|Disease progression|26|||
105736715|NCT01597622|364693268|FG000|Overall Study|Death|1|||
105939181|NCT00661687|365437977|FG000|Overall Study|Positive slit lamp findings|4|||
105736716|NCT01040832|364693270|FG000|Overall Study|Adverse Event|4|||
105736717|NCT01040832|364693271|FG001|Overall Study|Adverse Event|5|||
105736718|NCT01040832|364693270|FG000|Overall Study|Death|4|||
105736719|NCT01040832|364693271|FG001|Overall Study|Death|6|||
105736720|NCT01040832|364693270|FG000|Overall Study|Withdrawal by Subject|2|||
105736721|NCT01040832|364693271|FG001|Overall Study|Withdrawal by Subject|3|||
105736722|NCT01040832|364693270|FG000|Overall Study|Progressive disease|32|||
105736723|NCT01040832|364693271|FG001|Overall Study|Progressive disease|17|||
105736724|NCT01040832|364693270|FG000|Overall Study|Symptomatic deterioration|2|||
106140489|NCT00246012|366172533|FG000|Overall Study|Other|0|||
106140490|NCT00246012|366172534|FG001|Overall Study|Other|0|||
106140491|NCT00246012|366172535|FG002|Overall Study|Other|0|||
106140492|NCT00246012|366172536|FG003|Overall Study|Other|0|||
106140493|NCT00246012|366172537|FG004|Overall Study|Other|0|||
106140494|NCT00246012|366172538|FG005|Overall Study|Other|0|||
106140495|NCT00246012|366172539|FG006|Overall Study|Other|0|||
106140496|NCT00246012|366172540|FG007|Overall Study|Other|1|||
105736725|NCT01040832|364693271|FG001|Overall Study|Symptomatic deterioration|5|||
105736726|NCT01040832|364693270|FG000|Overall Study|Other|2|||
105736727|NCT01040832|364693271|FG001|Overall Study|Other|1|||
105736728|NCT01300286|364693272|FG000|Overall Study|did not get dosed|1|||
105736729|NCT02601001|364693275|FG000|Dosing Period 2|Adverse Event|0|||
105736730|NCT02601001|364693276|FG001|Dosing Period 2|Adverse Event|0|||
105736731|NCT02601001|364693277|FG002|Dosing Period 2|Adverse Event|0|||
105736732|NCT02601001|364693278|FG003|Dosing Period 2|Adverse Event|0|||
105736733|NCT02601001|364693279|FG004|Dosing Period 2|Adverse Event|0|||
105736734|NCT02601001|364693280|FG005|Dosing Period 2|Adverse Event|0|||
105736735|NCT02601001|364693281|FG006|Dosing Period 2|Adverse Event|1|||
105736736|NCT01277289|364693284|FG000|Overall Study|fragile vein|1|||
105736737|NCT01277289|364693285|FG001|Overall Study|fragile vein|0|||
105736738|NCT01277289|364693284|FG000|Overall Study|Physician Decision|1|||
105736739|NCT01277289|364693285|FG001|Overall Study|Physician Decision|0|||
105736740|NCT01277289|364693284|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
105736741|NCT01277289|364693285|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
105736742|NCT01277289|364693284|FG000|Overall Study|Protocol Violation|1|||
105736743|NCT01277289|364693285|FG001|Overall Study|Protocol Violation|1|||
105736744|NCT01277289|364693284|FG000|Overall Study|Adverse Event|2|||
105736745|NCT01277289|364693285|FG001|Overall Study|Adverse Event|1|||
105736746|NCT01277289|364693284|FG000|Overall Study|consent withdrawn|1|||
105736747|NCT01277289|364693285|FG001|Overall Study|consent withdrawn|1|||
105736748|NCT01277289|364693284|FG000|Overall Study|premature closure of the study|4|||
105736749|NCT01277289|364693285|FG001|Overall Study|premature closure of the study|2|||
105736750|NCT01013883|364693286|FG000|Overall Study|Lost to Follow-up|2|||
105736751|NCT01013883|364693287|FG001|Overall Study|Lost to Follow-up|2|||
105736752|NCT02584634|364693289|FG000|Overall Study|Adverse Event|3|||
105736753|NCT02584634|364693290|FG001|Overall Study|Adverse Event|5|||
105736754|NCT02584634|364693289|FG000|Overall Study|Death|0|||
105736755|NCT02584634|364693290|FG001|Overall Study|Death|1|||
105799276|NCT01133392|364922716|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
105799277|NCT01133392|364922717|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
106011142|NCT05135767|365707316|FG000|Baseline|Lost to Follow-up|1|||
106011143|NCT05135767|365707317|FG001|Baseline|Lost to Follow-up|1|||
106011144|NCT05135767|365707316|FG000|Baseline|Withdrawal by Subject|0|||
106011145|NCT05135767|365707317|FG001|Baseline|Withdrawal by Subject|2|||
106011146|NCT05135767|365707316|FG000|Active Study Phase|Lost to Follow-up|2|||
106011147|NCT05135767|365707317|FG001|Active Study Phase|Lost to Follow-up|0|||
106011148|NCT03818256|365707323|FG000|Overall Study|Withdrawal by Subject|2|||
106011149|NCT03818256|365707324|FG001|Overall Study|Withdrawal by Subject|2|||
106011150|NCT03818256|365707323|FG000|Overall Study|Adverse Event|3|||
106011151|NCT03818256|365707324|FG001|Overall Study|Adverse Event|1|||
106011152|NCT03818256|365707323|FG000|Overall Study|Lost to Follow-up|0|||
106011153|NCT03818256|365707324|FG001|Overall Study|Lost to Follow-up|5|||
106011154|NCT03818256|365707323|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
106011155|NCT03818256|365707324|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
106011156|NCT03818256|365707323|FG000|Overall Study|Not reporting for scheduled visits|1|||
106011157|NCT03818256|365707324|FG001|Overall Study|Not reporting for scheduled visits|0|||
106011158|NCT03818256|365707323|FG000|Overall Study|Non-compliant with investigational product|1|||
106011159|NCT03818256|365707324|FG001|Overall Study|Non-compliant with investigational product|0|||
106011160|NCT04163341|365707330|FG000|Overall Study|Withdrawal by Subject|2|||
106011161|NCT04163341|365707331|FG001|Overall Study|Withdrawal by Subject|0|||
106011162|NCT04163341|365707330|FG000|Overall Study|Lost to Follow-up|3|||
106011163|NCT04163341|365707331|FG001|Overall Study|Lost to Follow-up|4|||
106011164|NCT02484391|365707332|FG000|Overall Study|Lack of Efficacy|15|||
106011165|NCT02484391|365707333|FG001|Overall Study|Lack of Efficacy|14|||
106011166|NCT02484391|365707334|FG002|Overall Study|Lack of Efficacy|3|||
106011167|NCT02484391|365707332|FG000|Overall Study|Lost to Follow-up|0|||
106011168|NCT02484391|365707333|FG001|Overall Study|Lost to Follow-up|0|||
105736756|NCT02584634|364693289|FG000|Overall Study|Lost to Follow-up|0|||
105736757|NCT02584634|364693290|FG001|Overall Study|Lost to Follow-up|1|||
105736758|NCT02584634|364693289|FG000|Overall Study|Physician Decision|1|||
105736759|NCT02584634|364693290|FG001|Overall Study|Physician Decision|2|||
105736760|NCT02584634|364693289|FG000|Overall Study|Progressive disease|7|||
105799278|NCT01759537|364922718|FG000|Overall Study|Death|1|||
106011169|NCT02484391|365707334|FG002|Overall Study|Lost to Follow-up|2|||
106011170|NCT02484391|365707332|FG000|Overall Study|Physician Decision|1|||
106011171|NCT02484391|365707333|FG001|Overall Study|Physician Decision|3|||
106011172|NCT02484391|365707334|FG002|Overall Study|Physician Decision|0|||
106011173|NCT02484391|365707332|FG000|Overall Study|Went to Transplant|5|||
105736761|NCT02584634|364693290|FG001|Overall Study|Progressive disease|15|||
105736762|NCT02584634|364693289|FG000|Overall Study|Withdrawal by Subject|1|||
105736763|NCT02584634|364693290|FG001|Overall Study|Withdrawal by Subject|1|||
105736764|NCT02584634|364693289|FG000|Overall Study|Other|0|||
105799279|NCT01759537|364922719|FG001|Overall Study|Death|1|||
105736765|NCT02584634|364693290|FG001|Overall Study|Other|6|||
105736766|NCT03666143|364693292|FG000|Overall Study|Death|158|||
106140497|NCT00246012|366172541|FG008|Overall Study|Other|0|||
106140498|NCT00246012|366172533|FG000|Overall Study|Randomly assigned but not treated|0|||
106140499|NCT00246012|366172534|FG001|Overall Study|Randomly assigned but not treated|0|||
106140500|NCT00246012|366172535|FG002|Overall Study|Randomly assigned but not treated|0|||
106140501|NCT00246012|366172536|FG003|Overall Study|Randomly assigned but not treated|0|||
106140502|NCT00246012|366172537|FG004|Overall Study|Randomly assigned but not treated|0|||
106140503|NCT00246012|366172538|FG005|Overall Study|Randomly assigned but not treated|1|||
106140504|NCT00246012|366172539|FG006|Overall Study|Randomly assigned but not treated|1|||
106140505|NCT00246012|366172540|FG007|Overall Study|Randomly assigned but not treated|0|||
105736767|NCT03666143|364693292|FG000|Overall Study|Sponsor Decision|31|||
105736768|NCT03666143|364693292|FG000|Overall Study|Withdrawal by Subject|11|||
105736769|NCT03666143|364693292|FG000|Overall Study|Lost to Follow-up|5|||
105736770|NCT03666143|364693292|FG000|Overall Study|Physician Decision|1|||
105736771|NCT03666143|364693292|FG000|Overall Study|Rolled into extension study|9|||
105736772|NCT03666143|364693292|FG000|Overall Study|Progressive Disease|1|||
105736773|NCT01103349|364693293|FG000|Overall Study|Adverse Event|8|||
105736774|NCT01103349|364693294|FG001|Overall Study|Adverse Event|5|||
106011174|NCT02484391|365707333|FG001|Overall Study|Went to Transplant|3|||
106011175|NCT02484391|365707334|FG002|Overall Study|Went to Transplant|2|||
106011176|NCT01899040|365707335|FG000|Overall Study|Randomized in error|0|||
106011177|NCT01899040|365707336|FG001|Overall Study|Randomized in error|1|||
106011178|NCT01899040|365707337|FG002|Overall Study|Randomized in error|1|||
106011179|NCT01899040|365707335|FG000|Overall Study|Adverse Event|3|||
106011180|NCT01899040|365707336|FG001|Overall Study|Adverse Event|1|||
106011181|NCT01899040|365707337|FG002|Overall Study|Adverse Event|2|||
106011182|NCT01899040|365707335|FG000|Overall Study|Unspecified reasons|4|||
106011183|NCT01899040|365707336|FG001|Overall Study|Unspecified reasons|4|||
106011184|NCT01899040|365707337|FG002|Overall Study|Unspecified reasons|0|||
106011185|NCT01899040|365707335|FG000|Overall Study|Compliance issues|1|||
106011186|NCT01899040|365707336|FG001|Overall Study|Compliance issues|2|||
106011187|NCT01899040|365707337|FG002|Overall Study|Compliance issues|0|||
106011188|NCT04730804|365707347|FG000|Overall Study|Physician Decision|0|||
106011189|NCT04730804|365707348|FG001|Overall Study|Physician Decision|0|||
106011190|NCT04730804|365707349|FG002|Overall Study|Physician Decision|0|||
106011191|NCT04730804|365707350|FG003|Overall Study|Physician Decision|0|||
106011192|NCT04730804|365707351|FG004|Overall Study|Physician Decision|0|||
106011193|NCT04730804|365707352|FG005|Overall Study|Physician Decision|1|||
106011194|NCT04730804|365707347|FG000|Overall Study|Withdrawal by Subject|0|||
106011195|NCT04730804|365707348|FG001|Overall Study|Withdrawal by Subject|0|||
106011196|NCT04730804|365707349|FG002|Overall Study|Withdrawal by Subject|0|||
106011197|NCT04730804|365707350|FG003|Overall Study|Withdrawal by Subject|0|||
106011198|NCT04730804|365707351|FG004|Overall Study|Withdrawal by Subject|1|||
106011199|NCT04730804|365707352|FG005|Overall Study|Withdrawal by Subject|2|||
106011200|NCT02081677|365708727|FG000|Overall Study|Adverse Event|0|||
106011201|NCT02081677|365708728|FG001|Overall Study|Adverse Event|0|||
106011202|NCT02081677|365708729|FG002|Overall Study|Adverse Event|1|||
106011203|NCT02081677|365708730|FG003|Overall Study|Adverse Event|0|||
106011204|NCT02081677|365708727|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
106011205|NCT02081677|365708728|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
106011206|NCT02081677|365708729|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
106011207|NCT02081677|365708730|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
106011208|NCT02081677|365708727|FG000|Overall Study|Not comfortable with lens care system|1|||
106011209|NCT02081677|365708728|FG001|Overall Study|Not comfortable with lens care system|0|||
106011210|NCT02081677|365708729|FG002|Overall Study|Not comfortable with lens care system|0|||
106011211|NCT02081677|365708730|FG003|Overall Study|Not comfortable with lens care system|0|||
106011212|NCT02081677|365708727|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
106011213|NCT02081677|365708728|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
106011214|NCT02081677|365708729|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
106011215|NCT02081677|365708730|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
106011216|NCT01615939|365708731|FG000|Overall Study|Lost to Follow-up|5|||
106011217|NCT01615939|365708732|FG001|Overall Study|Lost to Follow-up|0|||
106140506|NCT00246012|366172541|FG008|Overall Study|Randomly assigned but not treated|0|||
105736775|NCT01103349|364693295|FG002|Overall Study|Adverse Event|3|||
105736776|NCT01103349|364693293|FG000|Overall Study|Consent withdrawn|1|||
105736777|NCT01103349|364693294|FG001|Overall Study|Consent withdrawn|0|||
105736778|NCT01103349|364693295|FG002|Overall Study|Consent withdrawn|0|||
105736779|NCT01103349|364693293|FG000|Overall Study|Incorrectly included in the trial|1|||
105736780|NCT01103349|364693294|FG001|Overall Study|Incorrectly included in the trial|0|||
105736781|NCT01103349|364693295|FG002|Overall Study|Incorrectly included in the trial|0|||
105736782|NCT01103349|364693293|FG000|Overall Study|Withdrawal by Subject|1|||
105736783|NCT01103349|364693294|FG001|Overall Study|Withdrawal by Subject|1|||
105736784|NCT01103349|364693295|FG002|Overall Study|Withdrawal by Subject|0|||
106011218|NCT03414983|365708739|FG000|Pre-Treatment|Other reasons|1|||
106011219|NCT03414983|365708740|FG001|Pre-Treatment|Other reasons|0|||
106011220|NCT03414983|365708739|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
105939182|NCT00661687|365437977|FG000|Overall Study|Inability to maintain wearing schedule|3|||
105939183|NCT00661687|365437977|FG000|Overall Study|Physician Decision|1|||
105939184|NCT00661687|365437977|FG000|Overall Study|Adverse Event|2|||
105939185|NCT02462057|365437982|FG000|Overall Study|Left Vitality|32|||
105939186|NCT02462057|365437983|FG001|Overall Study|Left Vitality|27|||
105939187|NCT02462057|365437984|FG002|Overall Study|Left Vitality|23|||
105939188|NCT02462057|365437985|FG003|Overall Study|Left Vitality|35|||
105939189|NCT02462057|365437986|FG004|Overall Study|Left Vitality|33|||
105939190|NCT02462057|365437982|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
105939191|NCT02462057|365437983|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
105939192|NCT02462057|365437984|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
105939193|NCT02462057|365437985|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
105939194|NCT02462057|365437986|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
105939195|NCT02336555|365437987|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105939196|NCT02336555|365437988|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105939197|NCT02336555|365437987|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
105939198|NCT02336555|365437988|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
105939199|NCT02336555|365437987|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
105939200|NCT02336555|365437988|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
105939201|NCT01959919|365437992|FG000|Overall Study|Did not meet the eligibility criteria|2|||
105939202|NCT01908699|365437993|FG000|Overall Study|Adverse Event|8|||
105939203|NCT01908699|365437994|FG001|Overall Study|Adverse Event|12|||
105939204|NCT01908699|365437993|FG000|Overall Study|Lack of Efficacy|2|||
105939205|NCT01908699|365437994|FG001|Overall Study|Lack of Efficacy|2|||
105939206|NCT01908699|365437993|FG000|Overall Study|Lost to Follow-up|2|||
105939207|NCT01908699|365437994|FG001|Overall Study|Lost to Follow-up|4|||
105939208|NCT01908699|365437993|FG000|Overall Study|Physician Decision|8|||
105939209|NCT01908699|365437994|FG001|Overall Study|Physician Decision|8|||
105939210|NCT01908699|365437993|FG000|Overall Study|Withdrawal by Subject|15|||
105939211|NCT01908699|365437994|FG001|Overall Study|Withdrawal by Subject|10|||
105939212|NCT01908699|365437993|FG000|Overall Study|Pregnancy|0|||
105939213|NCT01908699|365437994|FG001|Overall Study|Pregnancy|1|||
105939214|NCT01908699|365437993|FG000|Overall Study|Randomized in Error|1|||
105939215|NCT01908699|365437994|FG001|Overall Study|Randomized in Error|0|||
105939216|NCT01908699|365437993|FG000|Overall Study|Death|9|||
105939217|NCT01908699|365437994|FG001|Overall Study|Death|12|||
105939218|NCT01908699|365437993|FG000|Overall Study|Progressive Disease|30|||
105939219|NCT01908699|365437994|FG001|Overall Study|Progressive Disease|29|||
105939220|NCT03791060|365437995|FG000|Overall Study|Withdrawal by Subject|1|||
105939221|NCT05345405|365437996|FG000|Overall Study|Withdrawal by Subject|2|||
105939222|NCT05345405|365437997|FG001|Overall Study|Withdrawal by Subject|0|||
105939223|NCT05345405|365437998|FG002|Overall Study|Withdrawal by Subject|0|||
105939224|NCT05345405|365437996|FG000|Overall Study|Did not meet eligibility criteria|0|||
106011221|NCT03414983|365708740|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
106011222|NCT03414983|365708739|FG000|Pre-Treatment|Participant withdrew consent|1|||
106011223|NCT03414983|365708740|FG001|Pre-Treatment|Participant withdrew consent|3|||
106011224|NCT03414983|365708739|FG000|Treatment|Participant withdrew consent|4|||
105736785|NCT01103349|364693293|FG000|Overall Study|did not want to take trial medication|0|||
105736786|NCT01103349|364693294|FG001|Overall Study|did not want to take trial medication|1|||
105736787|NCT01103349|364693295|FG002|Overall Study|did not want to take trial medication|0|||
105736788|NCT01103349|364693293|FG000|Overall Study|forgot to take medication|0|||
105736789|NCT01103349|364693294|FG001|Overall Study|forgot to take medication|0|||
105736790|NCT01103349|364693295|FG002|Overall Study|forgot to take medication|1|||
105736791|NCT00090285|364693296|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
105736792|NCT00090285|364693297|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
105736793|NCT00090285|364693298|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105736794|NCT00090285|364693299|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105736795|NCT00090285|364693300|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105736796|NCT00090285|364693301|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
105736797|NCT00090285|364693296|FG000|Base Study Vaccination Period|Adverse Event|2|||
105736798|NCT00090285|364693297|FG001|Base Study Vaccination Period|Adverse Event|4|||
105736799|NCT00090285|364693298|FG002|Base Study Vaccination Period|Adverse Event|0|||
105736800|NCT00090285|364693299|FG003|Base Study Vaccination Period|Adverse Event|0|||
105736801|NCT00090285|364693300|FG004|Base Study Vaccination Period|Adverse Event|0|||
105736802|NCT00090285|364693301|FG005|Base Study Vaccination Period|Adverse Event|0|||
105799280|NCT01759537|364922718|FG000|Overall Study|Pregnancy|1|||
105799281|NCT01759537|364922719|FG001|Overall Study|Pregnancy|1|||
105939225|NCT05345405|365437997|FG001|Overall Study|Did not meet eligibility criteria|2|||
105939226|NCT05345405|365437998|FG002|Overall Study|Did not meet eligibility criteria|0|||
105939227|NCT05345405|365437996|FG000|Overall Study|Lost to Follow-up|0|||
105939228|NCT05345405|365437997|FG001|Overall Study|Lost to Follow-up|0|||
105939229|NCT05345405|365437998|FG002|Overall Study|Lost to Follow-up|1|||
105939230|NCT01592747|365438003|FG000|Overall Study|Loss of Therapeutic Response|107|||
105736803|NCT00090285|364693296|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
105736804|NCT00090285|364693297|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
105736805|NCT00090285|364693298|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
105736806|NCT00090285|364693299|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
105736807|NCT00090285|364693300|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
105736808|NCT00090285|364693301|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
105736809|NCT00090285|364693296|FG000|Base Study Vaccination Period|Protocol Violation|2|||
105736810|NCT00090285|364693297|FG001|Base Study Vaccination Period|Protocol Violation|3|||
105736811|NCT00090285|364693298|FG002|Base Study Vaccination Period|Protocol Violation|0|||
105736812|NCT00090285|364693299|FG003|Base Study Vaccination Period|Protocol Violation|0|||
105736813|NCT00090285|364693300|FG004|Base Study Vaccination Period|Protocol Violation|0|||
105736814|NCT00090285|364693301|FG005|Base Study Vaccination Period|Protocol Violation|0|||
105736815|NCT00090285|364693296|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
105736816|NCT00090285|364693297|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
105736817|NCT00090285|364693298|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
105736818|NCT00090285|364693299|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
105736819|NCT00090285|364693300|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
105736820|NCT00090285|364693301|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
105736821|NCT00090285|364693296|FG000|Base Study Vaccination Period|Uncooperative|2|||
105736822|NCT00090285|364693297|FG001|Base Study Vaccination Period|Uncooperative|2|||
105736823|NCT00090285|364693298|FG002|Base Study Vaccination Period|Uncooperative|0|||
105736824|NCT00090285|364693299|FG003|Base Study Vaccination Period|Uncooperative|0|||
105736825|NCT00090285|364693300|FG004|Base Study Vaccination Period|Uncooperative|0|||
105736826|NCT00090285|364693301|FG005|Base Study Vaccination Period|Uncooperative|0|||
105736827|NCT00090285|364693296|FG000|Base Study Vaccination Period|Moved|20|||
105736828|NCT00090285|364693297|FG001|Base Study Vaccination Period|Moved|21|||
105736829|NCT00090285|364693298|FG002|Base Study Vaccination Period|Moved|0|||
105736830|NCT00090285|364693299|FG003|Base Study Vaccination Period|Moved|0|||
105736831|NCT00090285|364693300|FG004|Base Study Vaccination Period|Moved|0|||
105736832|NCT00090285|364693301|FG005|Base Study Vaccination Period|Moved|0|||
105736833|NCT00090285|364693296|FG000|Base Study Vaccination Period|Site Terminated|1|||
105736834|NCT00090285|364693297|FG001|Base Study Vaccination Period|Site Terminated|0|||
105736835|NCT00090285|364693298|FG002|Base Study Vaccination Period|Site Terminated|0|||
105736836|NCT00090285|364693299|FG003|Base Study Vaccination Period|Site Terminated|0|||
105736837|NCT00090285|364693300|FG004|Base Study Vaccination Period|Site Terminated|0|||
105736838|NCT00090285|364693301|FG005|Base Study Vaccination Period|Site Terminated|0|||
105736839|NCT00090285|364693296|FG000|Base Study Vaccination Period|Other|2|||
105736840|NCT00090285|364693297|FG001|Base Study Vaccination Period|Other|2|||
106011225|NCT03414983|365708740|FG001|Treatment|Participant withdrew consent|3|||
106011226|NCT03414983|365708739|FG000|Treatment|Participant request to discontinue study treatment|8|||
106011227|NCT03414983|365708740|FG001|Treatment|Participant request to discontinue study treatment|10|||
106011228|NCT03414983|365708739|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
106011229|NCT03414983|365708740|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
106011230|NCT03414983|365708739|FG000|Treatment|Death|0|||
106011231|NCT03414983|365708740|FG001|Treatment|Death|1|||
106011232|NCT03414983|365708739|FG000|Treatment|Study Drug Toxicity|10|||
106011233|NCT03414983|365708740|FG001|Treatment|Study Drug Toxicity|5|||
106011234|NCT03414983|365708739|FG000|Treatment|Disease Progression|75|||
106140507|NCT00559949|366172543|FG000|Overall Study|Progressive Disease during cycle 1|1|||
106140508|NCT00559949|366172543|FG000|Overall Study|Adverse Event|1|||
106140509|NCT00559949|366172543|FG000|Overall Study|Withdrawal by Subject|4|||
106140510|NCT00559949|366172543|FG000|Overall Study|No disease evaluation per protocol|1|||
106140511|NCT01183780|366172544|FG000|Overall Study|Withdrawal by Subject|25|||
106140512|NCT01183780|366172545|FG001|Overall Study|Withdrawal by Subject|14|||
106140513|NCT01183780|366172544|FG000|Overall Study|Lost to Follow-up|6|||
106140514|NCT01183780|366172545|FG001|Overall Study|Lost to Follow-up|11|||
106140515|NCT04379713|366172548|FG000|Overall Study|Adverse Event|2|||
106140516|NCT04379713|366172549|FG001|Overall Study|Adverse Event|0|||
106140517|NCT04379713|366172548|FG000|Overall Study|Physician Decision|2|||
106140518|NCT04379713|366172549|FG001|Overall Study|Physician Decision|1|||
106140519|NCT04379713|366172548|FG000|Overall Study|Protocol Violation|11|||
106140520|NCT04379713|366172549|FG001|Overall Study|Protocol Violation|6|||
106140521|NCT04379713|366172548|FG000|Overall Study|No longer met eligibility criteria|14|||
106140522|NCT04379713|366172549|FG001|Overall Study|No longer met eligibility criteria|11|||
106140523|NCT04379713|366172548|FG000|Overall Study|Withdrawal by parent/guardian|36|||
106140524|NCT04379713|366172549|FG001|Overall Study|Withdrawal by parent/guardian|15|||
106140525|NCT04379713|366172548|FG000|Overall Study|Lost to Follow-up|31|||
106140526|NCT04379713|366172549|FG001|Overall Study|Lost to Follow-up|21|||
105736841|NCT00090285|364693298|FG002|Base Study Vaccination Period|Other|0|||
106011235|NCT03414983|365708740|FG001|Treatment|Disease Progression|29|||
106011236|NCT03414983|365708739|FG000|Treatment|Not reported|1|||
106011237|NCT03414983|365708740|FG001|Treatment|Not reported|0|||
106140527|NCT02148133|366172552|FG000|Overall Study|Investigator discretion|1|||
106011238|NCT03414983|365708739|FG000|Treatment|Other reasons|3|||
106011239|NCT03414983|365708740|FG001|Treatment|Other reasons|2|||
106011240|NCT03414983|365708739|FG000|Treatment|Poor/non-compliance|2|||
106011241|NCT03414983|365708740|FG001|Treatment|Poor/non-compliance|0|||
106011242|NCT03414983|365708739|FG000|Treatment|Maximum clinical benefit|5|||
106011243|NCT03414983|365708740|FG001|Treatment|Maximum clinical benefit|9|||
106011244|NCT03414983|365708739|FG000|Treatment|Lost to Follow-up|0|||
106011245|NCT03414983|365708740|FG001|Treatment|Lost to Follow-up|1|||
106011246|NCT03414983|365708739|FG000|Treatment|Administrative reasons by sponsor|1|||
106011247|NCT03414983|365708740|FG001|Treatment|Administrative reasons by sponsor|0|||
106011248|NCT02608684|365708741|FG000|Overall Study|Physician Decision|2|||
106011249|NCT02608684|365708741|FG000|Overall Study|Withdrawal by Subject|1|||
106011250|NCT01084655|365708746|FG000|Overall Study|Radiographic disease progression|3|||
106011251|NCT01084655|365708747|FG001|Overall Study|Radiographic disease progression|2|||
106011252|NCT01084655|365708748|FG002|Overall Study|Radiographic disease progression|8|||
106011253|NCT01084655|365708746|FG000|Overall Study|Withdrawal by Subject|1|||
106011254|NCT01084655|365708747|FG001|Overall Study|Withdrawal by Subject|0|||
106011255|NCT01084655|365708748|FG002|Overall Study|Withdrawal by Subject|4|||
106011256|NCT01084655|365708746|FG000|Overall Study|Adverse Event|2|||
106011257|NCT01084655|365708747|FG001|Overall Study|Adverse Event|1|||
106011258|NCT01084655|365708748|FG002|Overall Study|Adverse Event|2|||
106011259|NCT01084655|365708746|FG000|Overall Study|Other|0|||
106011260|NCT01084655|365708747|FG001|Overall Study|Other|3|||
106011261|NCT01084655|365708748|FG002|Overall Study|Other|2|||
106011262|NCT01084655|365708746|FG000|Overall Study|Symptomatic deterioration|0|||
106011263|NCT01084655|365708747|FG001|Overall Study|Symptomatic deterioration|0|||
106011264|NCT01084655|365708748|FG002|Overall Study|Symptomatic deterioration|2|||
106011265|NCT01084655|365708746|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
106011266|NCT01084655|365708747|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
106011267|NCT01084655|365708748|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
106011268|NCT03829228|365708750|FG000|Overall Study|Protocol Violation|1|||
106011269|NCT03181932|365708756|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
106011270|NCT03181932|365708757|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
106011271|NCT03181932|365708756|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
106011272|NCT03181932|365708757|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
106011273|NCT03181932|365708756|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
106011274|NCT03181932|365708757|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
106011275|NCT03181932|365708756|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
106011276|NCT03181932|365708757|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
106011277|NCT03181932|365708756|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
106011278|NCT03181932|365708757|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
105799282|NCT01759537|364922718|FG000|Overall Study|Lost to Follow-up|9|||
105939231|NCT01592747|365438004|FG001|Overall Study|Loss of Therapeutic Response|108|||
105939232|NCT01592747|365438005|FG002|Overall Study|Loss of Therapeutic Response|100|||
105939233|NCT01592747|365438003|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
105939234|NCT01592747|365438004|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
105939235|NCT01592747|365438005|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
105939236|NCT01592747|365438003|FG000|Overall Study|Adverse Event|1|||
105939237|NCT01592747|365438004|FG001|Overall Study|Adverse Event|0|||
105939238|NCT01592747|365438005|FG002|Overall Study|Adverse Event|0|||
105939239|NCT01592747|365438003|FG000|Overall Study|Protocol Violation|4|||
105799283|NCT01759537|364922719|FG001|Overall Study|Lost to Follow-up|9|||
106011279|NCT03181932|365708756|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
106011280|NCT03181932|365708757|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
106011281|NCT03181932|365708756|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
106011282|NCT03181932|365708757|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
106011283|NCT03181932|365708756|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
106011284|NCT03181932|365708757|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
106011285|NCT03181932|365708756|FG000|Period 2 (Open-label Period)|Reason missing|2|||
106011286|NCT03181932|365708757|FG001|Period 2 (Open-label Period)|Reason missing|0|||
106011287|NCT01198795|365708758|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
106011288|NCT01198795|365708758|FG000|Overall Study|Withdrawal by Subject|17|||
106011289|NCT01198795|365708758|FG000|Overall Study|Lost to Follow-up|15|||
106011290|NCT01198795|365708758|FG000|Overall Study|Adverse Event|9|||
106011291|NCT01198795|365708758|FG000|Overall Study|Lack of Efficacy|5|||
106011292|NCT01198795|365708758|FG000|Overall Study|Protocol Violation|2|||
106011293|NCT01198795|365708758|FG000|Overall Study|Other Reason|4|||
106011294|NCT03038100|365708759|FG000|Overall Study|Death|289|||
106011295|NCT03038100|365708760|FG001|Overall Study|Death|272|||
105939240|NCT01592747|365438004|FG001|Overall Study|Protocol Violation|0|||
105939241|NCT01592747|365438005|FG002|Overall Study|Protocol Violation|4|||
105939242|NCT01592747|365438003|FG000|Overall Study|Lack of Efficacy|0|||
106011296|NCT03038100|365708759|FG000|Overall Study|Lost to Follow-up|9|||
106011297|NCT03038100|365708760|FG001|Overall Study|Lost to Follow-up|10|||
106011298|NCT03038100|365708759|FG000|Overall Study|Protocol Deviation|1|||
106140528|NCT02148133|366172552|FG000|Overall Study|Lack of Efficacy|1|||
106140529|NCT02148133|366172552|FG000|Overall Study|Protocol deviation|1|||
106140530|NCT02148133|366172552|FG000|Overall Study|Protocol-defined stopping criteria|2|||
106140531|NCT03808883|366172553|FG000|Overall Study|Withdrawal by Subject|2|||
106140532|NCT03808883|366172554|FG001|Overall Study|Withdrawal by Subject|0|||
106140533|NCT03808883|366172553|FG000|Overall Study|Did not complete pre test or post test survey|4|||
106140534|NCT03808883|366172554|FG001|Overall Study|Did not complete pre test or post test survey|3|||
106140535|NCT00158054|366172555|FG000|Overall Study|Refused to continue|3|||
105939243|NCT01592747|365438004|FG001|Overall Study|Lack of Efficacy|1|||
105736842|NCT00090285|364693299|FG003|Base Study Vaccination Period|Other|0|||
105736843|NCT00090285|364693300|FG004|Base Study Vaccination Period|Other|0|||
105736844|NCT00090285|364693301|FG005|Base Study Vaccination Period|Other|0|||
105736845|NCT00090285|364693296|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
105736846|NCT00090285|364693297|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
105736847|NCT00090285|364693298|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
105736848|NCT00090285|364693299|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
105736849|NCT00090285|364693300|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
105736850|NCT00090285|364693301|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
105736851|NCT00090285|364693296|FG000|Base Study Vaccination Period|HIV positive|1|||
105736852|NCT00090285|364693297|FG001|Base Study Vaccination Period|HIV positive|1|||
105736853|NCT00090285|364693298|FG002|Base Study Vaccination Period|HIV positive|0|||
105736854|NCT00090285|364693299|FG003|Base Study Vaccination Period|HIV positive|0|||
105736855|NCT00090285|364693300|FG004|Base Study Vaccination Period|HIV positive|0|||
105736856|NCT00090285|364693301|FG005|Base Study Vaccination Period|HIV positive|0|||
105736857|NCT00090285|364693296|FG000|Base Study Follow-up Period|Adverse Event|3|||
105736858|NCT00090285|364693297|FG001|Base Study Follow-up Period|Adverse Event|10|||
105736859|NCT00090285|364693298|FG002|Base Study Follow-up Period|Adverse Event|0|||
105736860|NCT00090285|364693299|FG003|Base Study Follow-up Period|Adverse Event|0|||
105736861|NCT00090285|364693300|FG004|Base Study Follow-up Period|Adverse Event|0|||
105736862|NCT00090285|364693301|FG005|Base Study Follow-up Period|Adverse Event|0|||
105736863|NCT00090285|364693296|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
105736864|NCT00090285|364693297|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
105736865|NCT00090285|364693298|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
105736866|NCT00090285|364693299|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
105736867|NCT00090285|364693300|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
105736868|NCT00090285|364693301|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
105736869|NCT00090285|364693296|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
105736870|NCT00090285|364693297|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
105736871|NCT00090285|364693298|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
105736872|NCT00090285|364693299|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
105736873|NCT00090285|364693300|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
105736874|NCT00090285|364693301|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
105736875|NCT00090285|364693296|FG000|Base Study Follow-up Period|Moved|41|||
105736876|NCT00090285|364693297|FG001|Base Study Follow-up Period|Moved|36|||
105736877|NCT00090285|364693298|FG002|Base Study Follow-up Period|Moved|0|||
105939244|NCT01592747|365438005|FG002|Overall Study|Lack of Efficacy|0|||
105939245|NCT01592747|365438003|FG000|Overall Study|Withdrawal by Subject|2|||
105939246|NCT01592747|365438004|FG001|Overall Study|Withdrawal by Subject|0|||
105939247|NCT01592747|365438005|FG002|Overall Study|Withdrawal by Subject|2|||
105939248|NCT01592747|365438003|FG000|Overall Study|Lost to Follow-up|1|||
105939249|NCT01592747|365438004|FG001|Overall Study|Lost to Follow-up|0|||
105939250|NCT01592747|365438005|FG002|Overall Study|Lost to Follow-up|1|||
105939251|NCT01592747|365438003|FG000|Overall Study|Other Reasons|1|||
105939252|NCT01592747|365438004|FG001|Overall Study|Other Reasons|1|||
105939253|NCT01592747|365438005|FG002|Overall Study|Other Reasons|0|||
105939254|NCT00814983|365438009|FG000|Overall Study|Screen failure|1|||
105939255|NCT00814983|365438010|FG001|Overall Study|Screen failure|0|||
105939256|NCT00814983|365438009|FG000|Overall Study|Withdrawal by Subject|1|||
105736878|NCT00090285|364693299|FG003|Base Study Follow-up Period|Moved|0|||
105736879|NCT00090285|364693300|FG004|Base Study Follow-up Period|Moved|0|||
105736880|NCT00090285|364693301|FG005|Base Study Follow-up Period|Moved|0|||
105736881|NCT00090285|364693296|FG000|Base Study Follow-up Period|Other|2|||
105736882|NCT00090285|364693297|FG001|Base Study Follow-up Period|Other|0|||
105736883|NCT00090285|364693298|FG002|Base Study Follow-up Period|Other|0|||
105736884|NCT00090285|364693299|FG003|Base Study Follow-up Period|Other|0|||
105799284|NCT01759537|364922718|FG000|Overall Study|Accident involving jaw fracture|1|||
105939257|NCT00814983|365438010|FG001|Overall Study|Withdrawal by Subject|0|||
105939258|NCT00814983|365438009|FG000|Overall Study|Graft failure|1|||
105939259|NCT00814983|365438010|FG001|Overall Study|Graft failure|0|||
105736885|NCT00090285|364693300|FG004|Base Study Follow-up Period|Other|0|||
105736886|NCT00090285|364693301|FG005|Base Study Follow-up Period|Other|0|||
105736887|NCT00090285|364693296|FG000|Base Study Follow-up Period|Protocol Violation|1|||
105939260|NCT03111108|365438013|FG000|Overall Study|Death|0|||
106140536|NCT00158054|366172556|FG001|Overall Study|Refused to continue|0|||
106011299|NCT03038100|365708760|FG001|Overall Study|Protocol Deviation|4|||
106011300|NCT03038100|365708759|FG000|Overall Study|Withdrawal by Subject|45|||
106011301|NCT03038100|365708760|FG001|Overall Study|Withdrawal by Subject|51|||
106011302|NCT03038100|365708759|FG000|Overall Study|Study Terminated By Sponsor|305|||
106011303|NCT03038100|365708760|FG001|Overall Study|Study Terminated By Sponsor|311|||
106011304|NCT03038100|365708759|FG000|Overall Study|Physician Decision|1|||
106011305|NCT03038100|365708760|FG001|Overall Study|Physician Decision|3|||
106011306|NCT00744497|365708761|FG000|Overall Study|Withdrawal by Subject|21|||
106011307|NCT00744497|365708762|FG001|Overall Study|Withdrawal by Subject|18|||
106011308|NCT00744497|365708761|FG000|Overall Study|Death|11|||
106011309|NCT00744497|365708762|FG001|Overall Study|Death|9|||
106011310|NCT00744497|365708761|FG000|Overall Study|Lost to Follow-up|4|||
106011311|NCT00744497|365708762|FG001|Overall Study|Lost to Follow-up|2|||
106011312|NCT00744497|365708761|FG000|Overall Study|Poor compliance/noncompliance|9|||
106011313|NCT00744497|365708762|FG001|Overall Study|Poor compliance/noncompliance|5|||
106011314|NCT00744497|365708761|FG000|Overall Study|No longer meets study criteria|7|||
106011315|NCT00744497|365708762|FG001|Overall Study|No longer meets study criteria|3|||
106011316|NCT00744497|365708761|FG000|Overall Study|Administrative Reason By Sponsor|25|||
106011317|NCT00744497|365708762|FG001|Overall Study|Administrative Reason By Sponsor|8|||
106011318|NCT00744497|365708761|FG000|Overall Study|Disease progression|312|||
106140537|NCT00158054|366172555|FG000|Overall Study|Unavailable for follow up|7|||
106140538|NCT00158054|366172556|FG001|Overall Study|Unavailable for follow up|3|||
105736888|NCT00090285|364693297|FG001|Base Study Follow-up Period|Protocol Violation|0|||
105736889|NCT00090285|364693298|FG002|Base Study Follow-up Period|Protocol Violation|0|||
105736890|NCT00090285|364693299|FG003|Base Study Follow-up Period|Protocol Violation|0|||
105736891|NCT00090285|364693300|FG004|Base Study Follow-up Period|Protocol Violation|0|||
105736892|NCT00090285|364693301|FG005|Base Study Follow-up Period|Protocol Violation|0|||
105736893|NCT00090285|364693296|FG000|Base Study Follow-up Period|Uncooperative|3|||
105736894|NCT00090285|364693297|FG001|Base Study Follow-up Period|Uncooperative|4|||
105736895|NCT00090285|364693298|FG002|Base Study Follow-up Period|Uncooperative|0|||
105736896|NCT00090285|364693299|FG003|Base Study Follow-up Period|Uncooperative|0|||
105736897|NCT00090285|364693300|FG004|Base Study Follow-up Period|Uncooperative|0|||
105736898|NCT00090285|364693301|FG005|Base Study Follow-up Period|Uncooperative|0|||
105736899|NCT00090285|364693296|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
105736900|NCT00090285|364693297|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
105736901|NCT00090285|364693298|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
105736902|NCT00090285|364693299|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
105736903|NCT00090285|364693300|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
105736904|NCT00090285|364693301|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
105736905|NCT00090285|364693296|FG000|Extension 1|Adverse Event|0|||
105736906|NCT00090285|364693297|FG001|Extension 1|Adverse Event|0|||
105736907|NCT00090285|364693298|FG002|Extension 1|Adverse Event|2|||
105736908|NCT00090285|364693299|FG003|Extension 1|Adverse Event|0|||
105736909|NCT00090285|364693300|FG004|Extension 1|Adverse Event|0|||
105736910|NCT00090285|364693301|FG005|Extension 1|Adverse Event|0|||
105736911|NCT00090285|364693296|FG000|Extension 1|Lost to Follow-up|0|||
105736912|NCT00090285|364693297|FG001|Extension 1|Lost to Follow-up|0|||
105736913|NCT00090285|364693298|FG002|Extension 1|Lost to Follow-up|35|||
105736914|NCT00090285|364693299|FG003|Extension 1|Lost to Follow-up|0|||
105736915|NCT00090285|364693300|FG004|Extension 1|Lost to Follow-up|0|||
105736916|NCT00090285|364693301|FG005|Extension 1|Lost to Follow-up|0|||
105736917|NCT00090285|364693296|FG000|Extension 1|Withdrawal by Subject|0|||
105736918|NCT00090285|364693297|FG001|Extension 1|Withdrawal by Subject|0|||
105736919|NCT00090285|364693298|FG002|Extension 1|Withdrawal by Subject|13|||
105736920|NCT00090285|364693299|FG003|Extension 1|Withdrawal by Subject|1|||
105736921|NCT00090285|364693300|FG004|Extension 1|Withdrawal by Subject|0|||
105736922|NCT00090285|364693301|FG005|Extension 1|Withdrawal by Subject|0|||
105736923|NCT00090285|364693296|FG000|Extension 1|Other|0|||
105736924|NCT00090285|364693297|FG001|Extension 1|Other|0|||
105736925|NCT00090285|364693298|FG002|Extension 1|Other|4|||
105736926|NCT00090285|364693299|FG003|Extension 1|Other|0|||
105736927|NCT00090285|364693300|FG004|Extension 1|Other|0|||
105736928|NCT00090285|364693301|FG005|Extension 1|Other|0|||
105736929|NCT00090285|364693296|FG000|Extension 1|Moved|0|||
105736930|NCT00090285|364693297|FG001|Extension 1|Moved|0|||
106011319|NCT00744497|365708762|FG001|Overall Study|Disease progression|219|||
106011320|NCT00744497|365708761|FG000|Overall Study|Study drug toxicity|68|||
106011321|NCT00744497|365708762|FG001|Overall Study|Study drug toxicity|141|||
106140539|NCT00509769|366172565|FG000|Overall Study|Progressive disease|77|||
106011322|NCT00744497|365708761|FG000|Overall Study|Adverse event unrelated to study drug|78|||
106011323|NCT00744497|365708762|FG001|Overall Study|Adverse event unrelated to study drug|122|||
105736931|NCT00090285|364693298|FG002|Extension 1|Moved|3|||
105736932|NCT00090285|364693299|FG003|Extension 1|Moved|0|||
105736933|NCT00090285|364693300|FG004|Extension 1|Moved|0|||
105736934|NCT00090285|364693301|FG005|Extension 1|Moved|0|||
105736935|NCT00090285|364693296|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
105736936|NCT00090285|364693297|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
105736937|NCT00090285|364693298|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
105736938|NCT00090285|364693299|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
105736939|NCT00090285|364693300|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
105736940|NCT00090285|364693301|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
105736941|NCT00090285|364693296|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105736942|NCT00090285|364693297|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105736943|NCT00090285|364693298|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105736944|NCT00090285|364693299|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
105736945|NCT00090285|364693300|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
105736946|NCT00090285|364693301|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
105736947|NCT00090285|364693296|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105736948|NCT00090285|364693297|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105736949|NCT00090285|364693298|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105736950|NCT00090285|364693299|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
105736951|NCT00090285|364693300|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
105736952|NCT00090285|364693301|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
105736953|NCT00090285|364693296|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
105736954|NCT00090285|364693297|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
105736955|NCT00090285|364693298|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
105736956|NCT00090285|364693299|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
105736957|NCT00090285|364693300|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
105736958|NCT00090285|364693301|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
105736959|NCT01936649|364693306|FG000|Overall Study|Withdrawal by Subject|4|||
105939261|NCT03111108|365438014|FG001|Overall Study|Death|1|||
105939262|NCT03111108|365438013|FG000|Overall Study|Withdrawal by Subject|1|||
105939263|NCT03111108|365438014|FG001|Overall Study|Withdrawal by Subject|0|||
105939264|NCT01514357|365438015|FG000|Overall Study|Screen failure|2|||
105939265|NCT01514357|365438016|FG001|Overall Study|Screen failure|0|||
105939266|NCT01514357|365438015|FG000|Overall Study|Withdrawal by Subject|2|||
105939267|NCT01514357|365438016|FG001|Overall Study|Withdrawal by Subject|0|||
105939268|NCT00552279|365438017|FG000|Overall Study|Adverse Event|0|||
105939269|NCT00552279|365438018|FG001|Overall Study|Adverse Event|1|||
105939270|NCT00552279|365438017|FG000|Overall Study|Withdrawal by Subject|12|||
105939271|NCT00552279|365438018|FG001|Overall Study|Withdrawal by Subject|1|||
105939272|NCT00552279|365438017|FG000|Overall Study|Lost to Follow-up|1|||
105939273|NCT00552279|365438018|FG001|Overall Study|Lost to Follow-up|0|||
105939274|NCT00552279|365438017|FG000|Overall Study|Other|1|||
105939275|NCT00552279|365438018|FG001|Overall Study|Other|1|||
105939276|NCT01651208|365438022|FG000|Overall Study|Lost to Follow-up|14|||
105939277|NCT01651208|365438023|FG001|Overall Study|Lost to Follow-up|16|||
105939278|NCT03268499|365438029|FG000|Overall Study|Withdrawal by Subject|2|||
106011324|NCT00744497|365708761|FG000|Overall Study|Patient requested to stop study drug|65|||
105736960|NCT01936649|364693306|FG000|Overall Study|Physician Decision|2|||
106011325|NCT00744497|365708762|FG001|Overall Study|Patient requested to stop study drug|80|||
106011326|NCT00744497|365708761|FG000|Overall Study|Maximum clinical benefit|141|||
106011327|NCT00744497|365708762|FG001|Overall Study|Maximum clinical benefit|142|||
106011328|NCT00744497|365708761|FG000|Overall Study|Not defined|19|||
106011329|NCT00744497|365708762|FG001|Overall Study|Not defined|13|||
106011330|NCT03250273|365708766|FG000|Overall Study|Disease Progression|2|||
106011331|NCT03250273|365708767|FG001|Overall Study|Disease Progression|11|||
106011332|NCT03250273|365708766|FG000|Overall Study|Death|0|||
106011333|NCT03250273|365708767|FG001|Overall Study|Death|1|||
106011334|NCT04154904|365708768|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
106011335|NCT04154904|365708769|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
106011336|NCT04154904|365708770|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
106011337|NCT02392624|365708771|FG000|Overall Study|Withdrawal by Subject|15|||
106011338|NCT02392624|365708772|FG001|Overall Study|Withdrawal by Subject|12|||
106011339|NCT02392624|365708773|FG002|Overall Study|Withdrawal by Subject|9|||
106011340|NCT02392624|365708771|FG000|Overall Study|Adverse Event|4|||
106011341|NCT02392624|365708772|FG001|Overall Study|Adverse Event|1|||
106011342|NCT02392624|365708773|FG002|Overall Study|Adverse Event|2|||
106011343|NCT02392624|365708771|FG000|Overall Study|Pregnancy|1|||
106011344|NCT02392624|365708772|FG001|Overall Study|Pregnancy|0|||
106011345|NCT02392624|365708773|FG002|Overall Study|Pregnancy|0|||
106011346|NCT02392624|365708771|FG000|Overall Study|Protocol Violation|0|||
106011347|NCT02392624|365708772|FG001|Overall Study|Protocol Violation|0|||
106011348|NCT02392624|365708773|FG002|Overall Study|Protocol Violation|1|||
105939279|NCT03268499|365438030|FG001|Overall Study|Withdrawal by Subject|1|||
105939280|NCT01725282|365438031|FG000|Overall Study|Adverse Event|1|||
105939281|NCT01725282|365438032|FG001|Overall Study|Adverse Event|3|||
106011349|NCT02392624|365708771|FG000|Overall Study|Sponsor/Investigator Decision|2|||
106011350|NCT02392624|365708772|FG001|Overall Study|Sponsor/Investigator Decision|1|||
105736961|NCT01936649|364693306|FG000|Overall Study|Protocol Violation|2|||
105939282|NCT01725282|365438033|FG002|Overall Study|Adverse Event|6|||
105939283|NCT01725282|365438034|FG003|Overall Study|Adverse Event|4|||
105939284|NCT01725282|365438031|FG000|Overall Study|Exacerbation of Target Disease|1|||
106011351|NCT02392624|365708773|FG002|Overall Study|Sponsor/Investigator Decision|0|||
106011352|NCT02392624|365708771|FG000|Overall Study|Other|49|||
105939285|NCT01725282|365438032|FG001|Overall Study|Exacerbation of Target Disease|0|||
105939286|NCT01725282|365438033|FG002|Overall Study|Exacerbation of Target Disease|0|||
105939287|NCT01725282|365438034|FG003|Overall Study|Exacerbation of Target Disease|1|||
105939288|NCT01725282|365438031|FG000|Overall Study|Met Exclusion Criteria|0|||
105939289|NCT01725282|365438032|FG001|Overall Study|Met Exclusion Criteria|0|||
105939290|NCT01725282|365438033|FG002|Overall Study|Met Exclusion Criteria|1|||
105939291|NCT01725282|365438034|FG003|Overall Study|Met Exclusion Criteria|0|||
105939292|NCT01725282|365438031|FG000|Overall Study|Study Site Withdrawal|0|||
105939293|NCT01725282|365438032|FG001|Overall Study|Study Site Withdrawal|1|||
105939294|NCT01725282|365438033|FG002|Overall Study|Study Site Withdrawal|0|||
105939295|NCT01725282|365438034|FG003|Overall Study|Study Site Withdrawal|0|||
105939296|NCT01725282|365438031|FG000|Overall Study|Withdrawal by Subject|0|||
105939297|NCT01725282|365438032|FG001|Overall Study|Withdrawal by Subject|0|||
106140540|NCT00509769|366172565|FG000|Overall Study|Adverse Event|4|||
105939298|NCT01725282|365438033|FG002|Overall Study|Withdrawal by Subject|1|||
105939299|NCT01725282|365438034|FG003|Overall Study|Withdrawal by Subject|1|||
105939300|NCT01725282|365438031|FG000|Overall Study|Lack of Efficacy|0|||
105939301|NCT01725282|365438032|FG001|Overall Study|Lack of Efficacy|1|||
105939302|NCT01725282|365438033|FG002|Overall Study|Lack of Efficacy|0|||
105939303|NCT01725282|365438034|FG003|Overall Study|Lack of Efficacy|1|||
105939304|NCT00489359|365438035|FG000|Overall Study|Death|0|||
105939305|NCT00489359|365438036|FG001|Overall Study|Death|2|||
105939306|NCT00489359|365438035|FG000|Overall Study|Progressive Disease|5|||
105939307|NCT00489359|365438036|FG001|Overall Study|Progressive Disease|6|||
105939308|NCT00489359|365438035|FG000|Overall Study|Lost to Follow-up|1|||
105939309|NCT00489359|365438036|FG001|Overall Study|Lost to Follow-up|0|||
105939310|NCT00489359|365438035|FG000|Overall Study|Withdrawal by Subject|1|||
105939311|NCT00489359|365438036|FG001|Overall Study|Withdrawal by Subject|5|||
105939312|NCT00489359|365438035|FG000|Overall Study|Adverse Event|0|||
105939313|NCT00489359|365438036|FG001|Overall Study|Adverse Event|16|||
105939314|NCT04191733|365438040|FG000|Overall Study|Withdrawn due to study closure|13|||
105939315|NCT04191733|365438041|FG001|Overall Study|Withdrawn due to study closure|14|||
105939316|NCT04191733|365438040|FG000|Overall Study|Withdrawal by Subject|2|||
105939317|NCT04191733|365438041|FG001|Overall Study|Withdrawal by Subject|4|||
105939318|NCT04191733|365438040|FG000|Overall Study|Physician Decision|1|||
105939319|NCT04191733|365438041|FG001|Overall Study|Physician Decision|1|||
105939320|NCT04191733|365438040|FG000|Overall Study|Lost to Follow-up|5|||
105939321|NCT04191733|365438041|FG001|Overall Study|Lost to Follow-up|6|||
105939322|NCT04191733|365438040|FG000|Overall Study|Death|0|||
105939323|NCT04191733|365438041|FG001|Overall Study|Death|1|||
105939324|NCT01903733|365438044|FG000|Overall Study|Death|23|||
105939325|NCT01903733|365438045|FG001|Overall Study|Death|54|||
105939326|NCT01903733|365438046|FG002|Overall Study|Death|30|||
105939327|NCT01903733|365438047|FG003|Overall Study|Death|98|||
105939328|NCT01903733|365438044|FG000|Overall Study|Participant refused further follow-up|35|||
105939329|NCT01903733|365438045|FG001|Overall Study|Participant refused further follow-up|38|||
105939330|NCT01903733|365438046|FG002|Overall Study|Participant refused further follow-up|13|||
105939331|NCT01903733|365438047|FG003|Overall Study|Participant refused further follow-up|9|||
105939332|NCT01903733|365438044|FG000|Overall Study|Lost to Follow-up|18|||
105939333|NCT01903733|365438045|FG001|Overall Study|Lost to Follow-up|19|||
105939334|NCT01903733|365438046|FG002|Overall Study|Lost to Follow-up|6|||
105939335|NCT01903733|365438047|FG003|Overall Study|Lost to Follow-up|9|||
105939336|NCT01903733|365438044|FG000|Overall Study|Other|10|||
106140541|NCT00509769|366172565|FG000|Overall Study|Patient's decision|1|||
106140542|NCT00509769|366172565|FG000|Overall Study|Physician Decision|8|||
105736962|NCT01936649|364693306|FG000|Overall Study|Other than specified above|5|||
105736963|NCT00328198|364693309|FG000|Treatment|Adverse Event|21|||
105736964|NCT00328198|364693309|FG000|Treatment|Death|1|||
105736965|NCT00328198|364693309|FG000|Treatment|Physician Decision|5|||
105736966|NCT00328198|364693309|FG000|Treatment|Withdrawal by Subject|5|||
105736967|NCT00328198|364693309|FG000|Treatment|Evidence of disease progression|2|||
105736968|NCT00328198|364693309|FG000|Treatment|Non-compliance|1|||
105736969|NCT00328198|364693309|FG000|Treatment|Confirmed complete response, MRD -|3|||
105736970|NCT00328198|364693309|FG000|Follow-up|Lost to Follow-up|4|||
105736971|NCT00328198|364693309|FG000|Follow-up|Death|31|||
105736972|NCT02385123|364693310|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
105736973|NCT03472534|364693311|FG000|Overall Study|Withdrawal by Subject|9|||
105736974|NCT03472534|364693311|FG000|Overall Study|Adverse Event|2|||
105736975|NCT00909090|364693315|FG000|Overall Study|Lost to Follow-up|17|||
105736976|NCT00909090|364693316|FG001|Overall Study|Lost to Follow-up|17|||
105736977|NCT00859898|364693317|FG000|Overall Study|Lack of Efficacy|0|||
105736978|NCT00859898|364693318|FG001|Overall Study|Lack of Efficacy|1|||
105939337|NCT01903733|365438045|FG001|Overall Study|Other|15|||
105939338|NCT01903733|365438046|FG002|Overall Study|Other|12|||
105939339|NCT01903733|365438047|FG003|Overall Study|Other|3|||
105939340|NCT01903733|365438044|FG000|Overall Study|Missing|2|||
105939341|NCT01903733|365438045|FG001|Overall Study|Missing|0|||
105939342|NCT01903733|365438046|FG002|Overall Study|Missing|0|||
105939343|NCT01903733|365438047|FG003|Overall Study|Missing|0|||
105939344|NCT01903733|365438044|FG000|Overall Study|Investigator request|18|||
105939345|NCT01903733|365438045|FG001|Overall Study|Investigator request|0|||
105939346|NCT01903733|365438046|FG002|Overall Study|Investigator request|0|||
105939347|NCT01903733|365438047|FG003|Overall Study|Investigator request|0|||
105939348|NCT00069953|365438048|FG000|Overall Study|Protocol Violation|2|||
105939349|NCT04042311|365438049|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
105939350|NCT04042311|365438049|FG000|Overall Study|Unable to tolerate|4|||
105939351|NCT04042311|365438049|FG000|Overall Study|Concurrent illness|2|||
105939352|NCT04042311|365438049|FG000|Overall Study|Adverse Event|2|||
105939353|NCT04042311|365438049|FG000|Overall Study|No longer meeting inclusion criteria|2|||
105939354|NCT04042311|365438049|FG000|Overall Study|No reason given|1|||
105939355|NCT04042311|365438049|FG000|Overall Study|Withdrawal by Subject|4|||
105939356|NCT00974233|365438051|FG000|Induction Chemoimmunotherapy|Death|2|||
105939357|NCT00974233|365438051|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
105939358|NCT00974233|365438051|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
105939359|NCT00974233|365438051|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
105939360|NCT00974233|365438051|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
105939361|NCT00974233|365438051|FG000|Maintenance Lenalidomide|Adverse Event|8|||
105939362|NCT00836901|365439533|FG000|First Intervention|Withdrawal by Subject|1|||
105939363|NCT00836901|365439534|FG001|First Intervention|Withdrawal by Subject|0|||
105939364|NCT01437189|365439536|FG000|Overall Study|Adverse Event|3|||
105939365|NCT01437189|365439536|FG000|Overall Study|Lack of Efficacy|4|||
105939366|NCT01437189|365439536|FG000|Overall Study|Withdrawal by Subject|8|||
105939367|NCT01853280|365439537|FG000|Overall Study|Lack of Efficacy|2|||
105939368|NCT01853280|365439538|FG001|Overall Study|Lack of Efficacy|2|||
105939369|NCT01853280|365439537|FG000|Overall Study|Lost to Follow-up|0|||
105939370|NCT01853280|365439538|FG001|Overall Study|Lost to Follow-up|1|||
105939371|NCT01853280|365439537|FG000|Overall Study|Physician Decision|0|||
105939372|NCT01853280|365439538|FG001|Overall Study|Physician Decision|1|||
105939373|NCT01853280|365439537|FG000|Overall Study|Withdrawal by Subject|0|||
105939374|NCT01853280|365439538|FG001|Overall Study|Withdrawal by Subject|1|||
105939375|NCT01853280|365439537|FG000|Overall Study|Ineligible|0|||
105939376|NCT01853280|365439538|FG001|Overall Study|Ineligible|1|||
105939377|NCT00104884|365439539|FG000|Overall Study|Disease progression|4|||
105939378|NCT03032484|365439540|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
105939379|NCT03032484|365439541|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
105939380|NCT03032484|365439540|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
105939381|NCT03032484|365439541|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
105939382|NCT01229111|365439542|FG000|Overall Study|Death|1|||
105939383|NCT00835549|365439545|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
105939384|NCT00835549|365439546|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105939385|NCT03760081|365439550|FG000|Overall Study|Miscellaneous|0|||
105939386|NCT03760081|365439551|FG001|Overall Study|Miscellaneous|1|||
105939387|NCT03760081|365439550|FG000|Overall Study|Progressive Disease|5|||
105939388|NCT03760081|365439551|FG001|Overall Study|Progressive Disease|10|||
105939389|NCT03760081|365439550|FG000|Overall Study|Death|1|||
105939390|NCT03760081|365439551|FG001|Overall Study|Death|1|||
105939391|NCT03533491|365439553|FG000|Overall Study|Lost to Follow-up|2|||
105939392|NCT01946880|365439555|FG000|Overall Study|Lost to Follow-up|1|||
105939393|NCT01946880|365439556|FG001|Overall Study|Lost to Follow-up|0|||
105939394|NCT01946880|365439555|FG000|Overall Study|Physician Decision|1|||
106011353|NCT02392624|365708772|FG001|Overall Study|Other|1|||
106011354|NCT02392624|365708773|FG002|Overall Study|Other|1|||
105736979|NCT00859898|364693319|FG002|Overall Study|Lack of Efficacy|1|||
105736980|NCT00859898|364693317|FG000|Overall Study|Adverse Event|4|||
105736981|NCT00859898|364693318|FG001|Overall Study|Adverse Event|9|||
105736982|NCT00859898|364693319|FG002|Overall Study|Adverse Event|8|||
105939395|NCT01946880|365439556|FG001|Overall Study|Physician Decision|1|||
105939396|NCT01946880|365439555|FG000|Overall Study|Withdrawal by Subject|3|||
105939397|NCT01946880|365439556|FG001|Overall Study|Withdrawal by Subject|2|||
105939398|NCT01946880|365439555|FG000|Overall Study|Met Primary Endpoint|1|||
105939399|NCT01946880|365439556|FG001|Overall Study|Met Primary Endpoint|0|||
105939400|NCT01946880|365439555|FG000|Overall Study|Personal and Family Issues|1|||
105939401|NCT01946880|365439556|FG001|Overall Study|Personal and Family Issues|0|||
105939402|NCT02633527|365439558|FG000|Overall Study|Failed to meet eligibility|0|||
105939403|NCT02633527|365439559|FG001|Overall Study|Failed to meet eligibility|1|||
105939404|NCT02633527|365439560|FG002|Overall Study|Failed to meet eligibility|1|||
105939405|NCT02633527|365439561|FG003|Overall Study|Failed to meet eligibility|0|||
105939406|NCT02633527|365439562|FG004|Overall Study|Failed to meet eligibility|1|||
105939407|NCT02633527|365439558|FG000|Overall Study|Adverse Event|0|||
105939408|NCT02633527|365439559|FG001|Overall Study|Adverse Event|4|||
105939409|NCT02633527|365439560|FG002|Overall Study|Adverse Event|3|||
105939410|NCT02633527|365439561|FG003|Overall Study|Adverse Event|1|||
105939411|NCT02633527|365439562|FG004|Overall Study|Adverse Event|5|||
105939412|NCT02633527|365439558|FG000|Overall Study|Lost to Follow-up|1|||
105939413|NCT02633527|365439559|FG001|Overall Study|Lost to Follow-up|2|||
105939414|NCT02633527|365439560|FG002|Overall Study|Lost to Follow-up|5|||
106011355|NCT00936715|365708774|FG000|Overall Study|Investigators Discretion|1|||
106011356|NCT00936715|365708774|FG000|Overall Study|Protocol Violation|1|||
106011357|NCT00936715|365708774|FG000|Overall Study|Safety or Tolerability Reasons|4|||
106011358|NCT01462370|365708775|FG000|Overall Study|Lack of Qualifying Event|1|||
106011359|NCT01462370|365708776|FG001|Overall Study|Lack of Qualifying Event|1|||
106011360|NCT01462370|365708775|FG000|Overall Study|Physician Decision|0|||
106011361|NCT01462370|365708776|FG001|Overall Study|Physician Decision|1|||
106011362|NCT01462370|365708775|FG000|Overall Study|Withdrawal by Subject|0|||
106011363|NCT01462370|365708776|FG001|Overall Study|Withdrawal by Subject|3|||
106011364|NCT01337960|365708777|FG000|Overall Study|Lost to Follow-up|1|||
106011365|NCT01337960|365708778|FG001|Overall Study|Lost to Follow-up|0|||
106011366|NCT01337960|365708779|FG002|Overall Study|Lost to Follow-up|0|||
106011367|NCT01337960|365708777|FG000|Overall Study|Withdrawal by Subject|1|||
106011368|NCT01337960|365708778|FG001|Overall Study|Withdrawal by Subject|0|||
106011369|NCT01337960|365708779|FG002|Overall Study|Withdrawal by Subject|0|||
106011370|NCT05101122|365708780|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
106011371|NCT05101122|365708780|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
106011372|NCT05101122|365708780|FG000|AD313 80/5|Withdrawal by Subject|1|||
106011373|NCT05101122|365708780|FG000|AD313 80/10|Physician Decision|1|||
106011374|NCT02703597|365708790|FG000|Assignment to Baseline|Lost to Follow-up|17|||
106011375|NCT02703597|365708791|FG001|Assignment to Baseline|Lost to Follow-up|16|||
106011376|NCT02703597|365708790|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
106011377|NCT02703597|365708791|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
106011378|NCT02703597|365708790|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
106011379|NCT02703597|365708791|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
106011380|NCT02703597|365708790|FG000|First Post-test to First Follow-up|Site drop out|0|||
106011381|NCT02703597|365708791|FG001|First Post-test to First Follow-up|Site drop out|58|||
106011382|NCT02703597|365708790|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
106011383|NCT02703597|365708791|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
106011384|NCT02703597|365708790|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
106011385|NCT02703597|365708791|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
106011386|NCT02703597|365708790|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
106011387|NCT02703597|365708791|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
106011388|NCT00763035|365708792|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
106011389|NCT00763035|365708793|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
106011390|NCT00763035|365708792|FG000|First Intervention|Adverse Event|0|||
106011391|NCT00763035|365708793|FG001|First Intervention|Adverse Event|1|||
106011392|NCT00763035|365708792|FG000|Second Intervention|Adverse Event|1|||
106011393|NCT00763035|365708793|FG001|Second Intervention|Adverse Event|0|||
106011394|NCT00763035|365708792|FG000|Second Intervention|Physician Decision|2|||
106011395|NCT00763035|365708793|FG001|Second Intervention|Physician Decision|0|||
106011396|NCT02606643|365708794|FG000|Overall Study|did not meet inclusion criteria|1|||
106011397|NCT02606643|365708795|FG001|Overall Study|did not meet inclusion criteria|3|||
106011398|NCT02131259|365708796|FG000|Overall Study|Progressive disease|751|||
106011399|NCT02131259|365708796|FG000|Overall Study|Adverse Event|341|||
106011400|NCT02131259|365708796|FG000|Overall Study|Lost to Follow-up|7|||
106011401|NCT02131259|365708796|FG000|Overall Study|Relocation|32|||
106011402|NCT02131259|365708796|FG000|Overall Study|Other|63|||
106011403|NCT02131259|365708796|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
106011404|NCT02131259|365708796|FG000|Overall Study|Progressive disease/relocation|1|||
106011405|NCT02131259|365708796|FG000|Overall Study|Progressive disease/other|2|||
106011406|NCT02131259|365708796|FG000|Overall Study|AE/lost to follow-up|1|||
106011407|NCT02131259|365708796|FG000|Overall Study|AE/other|1|||
106011408|NCT02131259|365708796|FG000|Overall Study|Progressive disease/AE/other|1|||
106011409|NCT02131259|365708796|FG000|Overall Study|Missing|3|||
106011410|NCT02351817|365708799|FG000|Period 1|Adverse Event|1|||
106011411|NCT02351817|365708800|FG001|Period 1|Adverse Event|2|||
106011412|NCT02351817|365708799|FG000|Period 1|Lack of Efficacy|0|||
106011413|NCT02351817|365708800|FG001|Period 1|Lack of Efficacy|1|||
106011414|NCT02351817|365708799|FG000|Period 2|Adverse Event|0|||
106011415|NCT02351817|365708800|FG001|Period 2|Adverse Event|2|||
106011416|NCT02351817|365708799|FG000|Period 2|Protocol Violation|1|||
106011417|NCT02351817|365708800|FG001|Period 2|Protocol Violation|0|||
106011418|NCT03219723|365708801|FG000|Overall Study|Case Report Forms Uncollected|6|||
106011419|NCT03219723|365708801|FG000|Overall Study|Protocol Deviation|4|||
106011420|NCT02488915|365708802|FG000|Overall Study|Death|21|||
106011421|NCT02488915|365708802|FG000|Overall Study|Lost to Follow-up|4|||
106011422|NCT02488915|365708802|FG000|Overall Study|Withdrawal by Subject|1|||
106011423|NCT01980017|365708803|FG000|Overall Study|Lost to Follow-up|30|||
106011424|NCT01980017|365708804|FG001|Overall Study|Lost to Follow-up|21|||
106011425|NCT01980017|365708803|FG000|Overall Study|Death|0|||
106011426|NCT01980017|365708804|FG001|Overall Study|Death|1|||
106011427|NCT03044106|365708805|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
106011428|NCT03044106|365708806|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
106011429|NCT02057250|365708807|FG000|AID Assessment Phase|Adverse Event|3|||
105939415|NCT02633527|365439561|FG003|Overall Study|Lost to Follow-up|5|||
105939416|NCT02633527|365439562|FG004|Overall Study|Lost to Follow-up|4|||
105939417|NCT02633527|365439558|FG000|Overall Study|Withdrawal by Subject|0|||
105939418|NCT02633527|365439559|FG001|Overall Study|Withdrawal by Subject|3|||
105939419|NCT02633527|365439560|FG002|Overall Study|Withdrawal by Subject|5|||
105939420|NCT02633527|365439561|FG003|Overall Study|Withdrawal by Subject|4|||
105939421|NCT02633527|365439562|FG004|Overall Study|Withdrawal by Subject|4|||
105939422|NCT02633527|365439558|FG000|Overall Study|Protocol Violation|0|||
105939423|NCT02633527|365439559|FG001|Overall Study|Protocol Violation|1|||
105939424|NCT02633527|365439560|FG002|Overall Study|Protocol Violation|1|||
105939425|NCT02633527|365439561|FG003|Overall Study|Protocol Violation|1|||
105939426|NCT02633527|365439562|FG004|Overall Study|Protocol Violation|1|||
105939427|NCT02633527|365439558|FG000|Overall Study|Physician Decision|0|||
105939428|NCT02633527|365439559|FG001|Overall Study|Physician Decision|0|||
105939429|NCT02633527|365439560|FG002|Overall Study|Physician Decision|0|||
105939430|NCT02633527|365439561|FG003|Overall Study|Physician Decision|0|||
105939431|NCT02633527|365439562|FG004|Overall Study|Physician Decision|1|||
105939432|NCT02633527|365439558|FG000|Overall Study|Administrative reason|1|||
105939433|NCT02633527|365439559|FG001|Overall Study|Administrative reason|0|||
105939434|NCT02633527|365439560|FG002|Overall Study|Administrative reason|0|||
105939435|NCT02633527|365439561|FG003|Overall Study|Administrative reason|1|||
105939436|NCT02633527|365439562|FG004|Overall Study|Administrative reason|0|||
105939437|NCT02633527|365439558|FG000|Overall Study|Multiple reasons|1|||
105939438|NCT02633527|365439559|FG001|Overall Study|Multiple reasons|0|||
105939439|NCT02633527|365439560|FG002|Overall Study|Multiple reasons|2|||
105939440|NCT02633527|365439561|FG003|Overall Study|Multiple reasons|2|||
105939441|NCT02633527|365439562|FG004|Overall Study|Multiple reasons|1|||
105939442|NCT04525183|365439567|FG000|Overall Study|Withdrawal by Subject|0|||
105939443|NCT04525183|365439568|FG001|Overall Study|Withdrawal by Subject|0|||
105939444|NCT04525183|365439569|FG002|Overall Study|Withdrawal by Subject|3|||
105939445|NCT04525183|365439567|FG000|Overall Study|Study non-compliance|0|||
105939446|NCT04525183|365439568|FG001|Overall Study|Study non-compliance|0|||
105939447|NCT04525183|365439569|FG002|Overall Study|Study non-compliance|1|||
105939448|NCT04525183|365439567|FG000|Overall Study|Recurrent disease before starting on study|0|||
105939449|NCT04525183|365439568|FG001|Overall Study|Recurrent disease before starting on study|0|||
105939450|NCT04525183|365439569|FG002|Overall Study|Recurrent disease before starting on study|1|||
105939451|NCT04918771|365439570|FG000|Overall Study|Withdrawal by Subject|4|||
105939452|NCT04918771|365439571|FG001|Overall Study|Withdrawal by Subject|5|||
105939453|NCT04918771|365439570|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
105939454|NCT04918771|365439571|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
105939455|NCT05430919|365439572|FG000|Overall Study|Protocol Violation|0|||
105939456|NCT05430919|365439573|FG001|Overall Study|Protocol Violation|0|||
105939457|NCT05430919|365439574|FG002|Overall Study|Protocol Violation|1|||
105939458|NCT05430919|365439575|FG003|Overall Study|Protocol Violation|0|||
105939459|NCT05430919|365439572|FG000|Overall Study|Lost to Follow-up|0|||
105939460|NCT05430919|365439573|FG001|Overall Study|Lost to Follow-up|1|||
105939461|NCT05430919|365439574|FG002|Overall Study|Lost to Follow-up|0|||
105939462|NCT05430919|365439575|FG003|Overall Study|Lost to Follow-up|0|||
105939463|NCT05430919|365439572|FG000|Overall Study|Withdrawal by Subject|3|||
105939464|NCT05430919|365439573|FG001|Overall Study|Withdrawal by Subject|0|||
105939465|NCT05430919|365439574|FG002|Overall Study|Withdrawal by Subject|0|||
105939466|NCT05430919|365439575|FG003|Overall Study|Withdrawal by Subject|1|||
105939467|NCT03460704|365439580|FG000|Overall Study|Withdrawal by Subject|11|||
105939468|NCT03460704|365439581|FG001|Overall Study|Withdrawal by Subject|14|||
105939469|NCT03460704|365439580|FG000|Overall Study|Study terminated by the Sponsor|29|||
105939470|NCT03460704|365439581|FG001|Overall Study|Study terminated by the Sponsor|19|||
105939471|NCT03460704|365439580|FG000|Overall Study|Adverse Event|10|||
105939472|NCT03460704|365439581|FG001|Overall Study|Adverse Event|5|||
105939473|NCT03460704|365439580|FG000|Overall Study|Death|3|||
105939474|NCT03460704|365439581|FG001|Overall Study|Death|2|||
106011430|NCT02057250|365708808|FG001|AID Assessment Phase|Adverse Event|2|||
106011431|NCT02057250|365708809|FG002|AID Assessment Phase|Adverse Event|6|||
106011432|NCT02057250|365708810|FG003|AID Assessment Phase|Adverse Event|1|||
106140543|NCT00509769|366172565|FG000|Overall Study|Use of prohibited therapies during study|1|||
105939475|NCT03460704|365439580|FG000|Overall Study|Non-Compliance with Study Drug|3|||
105939476|NCT03460704|365439581|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105939477|NCT03460704|365439580|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105939478|NCT03460704|365439581|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
105939479|NCT03460704|365439580|FG000|Overall Study|Other|2|||
105939480|NCT03460704|365439581|FG001|Overall Study|Other|1|||
105939481|NCT02913326|365439586|FG000|Overall Study|Reason not listed|0|||
105939482|NCT02913326|365439587|FG001|Overall Study|Reason not listed|1|||
105939483|NCT02913326|365439586|FG000|Overall Study|Lost to Follow-up|0|||
105939484|NCT02913326|365439587|FG001|Overall Study|Lost to Follow-up|1|||
105939485|NCT02913326|365439586|FG000|Overall Study|Adverse Event|1|||
105939486|NCT02913326|365439587|FG001|Overall Study|Adverse Event|0|||
105939487|NCT00803049|365439588|FG000|Overall Study|Adverse Event|21|||
105799285|NCT01759537|364922719|FG001|Overall Study|Accident involving jaw fracture|1|||
105799286|NCT01759537|364922718|FG000|Overall Study|Subcrestal implant too coronal|1|||
105799287|NCT01759537|364922719|FG001|Overall Study|Subcrestal implant too coronal|1|||
105799288|NCT00420290|364922720|FG000|Overall Study|Adverse Event|3|||
105799289|NCT00420290|364922721|FG001|Overall Study|Adverse Event|1|||
105799290|NCT00420290|364922720|FG000|Overall Study|Withdrawal by Subject|0|||
105799291|NCT00420290|364922721|FG001|Overall Study|Withdrawal by Subject|2|||
105799292|NCT00420290|364922720|FG000|Overall Study|did not meet inclusion/exclusion|1|||
105799293|NCT00420290|364922721|FG001|Overall Study|did not meet inclusion/exclusion|1|||
105799294|NCT01963676|364924507|FG000|Overall Study|Withdrawal by Subject|1|||
105799295|NCT01963676|364924508|FG001|Overall Study|Withdrawal by Subject|0|||
105799296|NCT01246973|364924513|FG000|Overall Study|Other|38|||
105799297|NCT01246973|364924514|FG001|Overall Study|Other|25|||
105799298|NCT01246973|364924513|FG000|Overall Study|Adverse Event|16|||
105799299|NCT01246973|364924514|FG001|Overall Study|Adverse Event|9|||
105799300|NCT01246973|364924513|FG000|Overall Study|Withdrawal by Subject|7|||
105799301|NCT01246973|364924514|FG001|Overall Study|Withdrawal by Subject|13|||
105799302|NCT02496221|364924517|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
105799303|NCT02496221|364924518|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
105799304|NCT02496221|364924517|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
105799305|NCT02496221|364924518|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
105799306|NCT02496221|364924517|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
105799307|NCT02496221|364924518|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
105799308|NCT02464059|364924519|FG000|Overall Study|Lost to Follow-up|6|||
105799309|NCT00802529|364924523|FG000|Overall Study|Lost to Follow-up|0|||
105799310|NCT00802529|364924524|FG001|Overall Study|Lost to Follow-up|1|||
105799311|NCT01902134|364924525|FG000|Overall Study|Adverse Event|3|||
105799312|NCT01902134|364924526|FG001|Overall Study|Adverse Event|1|||
105799313|NCT01902134|364924527|FG002|Overall Study|Adverse Event|2|||
105799314|NCT01902134|364924528|FG003|Overall Study|Adverse Event|1|||
106011433|NCT02057250|365708811|FG004|AID Assessment Phase|Adverse Event|0|||
106011434|NCT02057250|365708807|FG000|AID Assessment Phase|Other than specified above|1|||
106011435|NCT02057250|365708808|FG001|AID Assessment Phase|Other than specified above|1|||
106011436|NCT02057250|365708809|FG002|AID Assessment Phase|Other than specified above|1|||
106011437|NCT02057250|365708810|FG003|AID Assessment Phase|Other than specified above|1|||
106011438|NCT02057250|365708811|FG004|AID Assessment Phase|Other than specified above|0|||
106011439|NCT02057250|365708807|FG000|Extension Phase|Adverse Event|0|||
106011440|NCT02057250|365708808|FG001|Extension Phase|Adverse Event|0|||
106011441|NCT02057250|365708809|FG002|Extension Phase|Adverse Event|0|||
106011442|NCT02057250|365708810|FG003|Extension Phase|Adverse Event|0|||
106011443|NCT02057250|365708811|FG004|Extension Phase|Adverse Event|15|||
106011444|NCT02057250|365708807|FG000|Extension Phase|Lack of Efficacy|0|||
106011445|NCT02057250|365708808|FG001|Extension Phase|Lack of Efficacy|0|||
106011446|NCT02057250|365708809|FG002|Extension Phase|Lack of Efficacy|0|||
106011447|NCT02057250|365708810|FG003|Extension Phase|Lack of Efficacy|0|||
106011448|NCT02057250|365708811|FG004|Extension Phase|Lack of Efficacy|10|||
106011449|NCT02057250|365708807|FG000|Extension Phase|Entered in this period but not treated|0|||
106011450|NCT02057250|365708808|FG001|Extension Phase|Entered in this period but not treated|0|||
106011451|NCT02057250|365708809|FG002|Extension Phase|Entered in this period but not treated|0|||
106011452|NCT02057250|365708810|FG003|Extension Phase|Entered in this period but not treated|0|||
106011453|NCT02057250|365708811|FG004|Extension Phase|Entered in this period but not treated|4|||
106011454|NCT02057250|365708807|FG000|Extension Phase|Other than specified above|0|||
106011455|NCT02057250|365708808|FG001|Extension Phase|Other than specified above|0|||
106011456|NCT02057250|365708809|FG002|Extension Phase|Other than specified above|0|||
106011457|NCT02057250|365708810|FG003|Extension Phase|Other than specified above|0|||
106011458|NCT02057250|365708811|FG004|Extension Phase|Other than specified above|7|||
106011459|NCT00684021|365708813|FG000|Overall Study|MRI Contraindicated|1|||
106011460|NCT00684021|365708814|FG001|Overall Study|MRI Contraindicated|1|||
106011461|NCT00684021|365708815|FG002|Overall Study|MRI Contraindicated|1|||
106011462|NCT00684021|365708816|FG003|Overall Study|MRI Contraindicated|0|||
106011463|NCT00684021|365708813|FG000|Overall Study|MRI not performed|0|||
106011464|NCT00684021|365708814|FG001|Overall Study|MRI not performed|1|||
106011465|NCT00684021|365708815|FG002|Overall Study|MRI not performed|1|||
106011466|NCT00684021|365708816|FG003|Overall Study|MRI not performed|2|||
106011467|NCT00684021|365708813|FG000|Overall Study|Death|1|||
106011468|NCT00684021|365708814|FG001|Overall Study|Death|0|||
106011469|NCT00684021|365708815|FG002|Overall Study|Death|0|||
106011470|NCT00684021|365708816|FG003|Overall Study|Death|0|||
106011471|NCT04596267|365708823|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
106011472|NCT04596267|365708824|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
106011473|NCT04596267|365708823|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
106011474|NCT04596267|365708824|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
105799315|NCT01902134|364924529|FG004|Overall Study|Adverse Event|1|||
105799316|NCT01902134|364924530|FG005|Overall Study|Adverse Event|3|||
105799317|NCT01902134|364924525|FG000|Overall Study|Lack of Efficacy|0|||
105799318|NCT01902134|364924526|FG001|Overall Study|Lack of Efficacy|0|||
105799319|NCT01902134|364924527|FG002|Overall Study|Lack of Efficacy|2|||
105799320|NCT01902134|364924528|FG003|Overall Study|Lack of Efficacy|0|||
105799321|NCT01902134|364924529|FG004|Overall Study|Lack of Efficacy|0|||
105799322|NCT01902134|364924530|FG005|Overall Study|Lack of Efficacy|1|||
105799323|NCT01902134|364924525|FG000|Overall Study|Physician Decision|0|||
105799324|NCT01902134|364924526|FG001|Overall Study|Physician Decision|1|||
105799325|NCT01902134|364924527|FG002|Overall Study|Physician Decision|0|||
105799326|NCT01902134|364924528|FG003|Overall Study|Physician Decision|0|||
105799327|NCT01902134|364924529|FG004|Overall Study|Physician Decision|0|||
105799328|NCT01902134|364924530|FG005|Overall Study|Physician Decision|0|||
105799329|NCT01902134|364924525|FG000|Overall Study|Protocol Violation|0|||
105799330|NCT01902134|364924526|FG001|Overall Study|Protocol Violation|0|||
105799331|NCT01902134|364924527|FG002|Overall Study|Protocol Violation|0|||
105799332|NCT01902134|364924528|FG003|Overall Study|Protocol Violation|0|||
105799333|NCT01902134|364924529|FG004|Overall Study|Protocol Violation|0|||
105799334|NCT01902134|364924530|FG005|Overall Study|Protocol Violation|1|||
105799335|NCT01902134|364924525|FG000|Overall Study|Withdrawal by Subject|4|||
105799336|NCT01902134|364924526|FG001|Overall Study|Withdrawal by Subject|8|||
105799337|NCT01902134|364924527|FG002|Overall Study|Withdrawal by Subject|9|||
105799338|NCT01902134|364924528|FG003|Overall Study|Withdrawal by Subject|1|||
105799339|NCT01902134|364924529|FG004|Overall Study|Withdrawal by Subject|5|||
105939488|NCT00803049|365439589|FG001|Overall Study|Adverse Event|33|||
105939489|NCT00803049|365439590|FG002|Overall Study|Adverse Event|13|||
105939490|NCT00803049|365439591|FG003|Overall Study|Adverse Event|27|||
105939491|NCT00803049|365439588|FG000|Overall Study|Lack of Efficacy|10|||
105939492|NCT00803049|365439589|FG001|Overall Study|Lack of Efficacy|19|||
105939493|NCT00803049|365439590|FG002|Overall Study|Lack of Efficacy|6|||
105939494|NCT00803049|365439591|FG003|Overall Study|Lack of Efficacy|13|||
105939495|NCT00803049|365439588|FG000|Overall Study|Lost to Follow-up|0|||
105939496|NCT00803049|365439589|FG001|Overall Study|Lost to Follow-up|2|||
105939497|NCT00803049|365439590|FG002|Overall Study|Lost to Follow-up|0|||
105939498|NCT00803049|365439591|FG003|Overall Study|Lost to Follow-up|3|||
105939499|NCT00803049|365439588|FG000|Overall Study|Death|2|||
105939500|NCT00803049|365439589|FG001|Overall Study|Death|1|||
105939501|NCT00803049|365439590|FG002|Overall Study|Death|0|||
105939502|NCT00803049|365439591|FG003|Overall Study|Death|2|||
105939503|NCT00803049|365439588|FG000|Overall Study|Progressive Disease|6|||
105939504|NCT00803049|365439589|FG001|Overall Study|Progressive Disease|10|||
105939505|NCT00803049|365439590|FG002|Overall Study|Progressive Disease|6|||
105939506|NCT00803049|365439591|FG003|Overall Study|Progressive Disease|6|||
105939507|NCT00803049|365439588|FG000|Overall Study|Withdrawal by Subject|19|||
105939508|NCT00803049|365439589|FG001|Overall Study|Withdrawal by Subject|43|||
105939509|NCT00803049|365439590|FG002|Overall Study|Withdrawal by Subject|16|||
105939510|NCT00803049|365439591|FG003|Overall Study|Withdrawal by Subject|44|||
105939511|NCT00803049|365439588|FG000|Overall Study|Protocol Violation|0|||
105939512|NCT00803049|365439589|FG001|Overall Study|Protocol Violation|1|||
105939513|NCT00803049|365439590|FG002|Overall Study|Protocol Violation|1|||
105939514|NCT00803049|365439591|FG003|Overall Study|Protocol Violation|0|||
105939515|NCT00803049|365439588|FG000|Overall Study|Randomized and Not Treated|0|||
105939516|NCT00803049|365439589|FG001|Overall Study|Randomized and Not Treated|0|||
105939517|NCT00803049|365439590|FG002|Overall Study|Randomized and Not Treated|0|||
105939518|NCT00803049|365439591|FG003|Overall Study|Randomized and Not Treated|2|||
105939519|NCT00803049|365439588|FG000|Overall Study|Other than Specified Above|3|||
105939520|NCT00803049|365439589|FG001|Overall Study|Other than Specified Above|9|||
105939521|NCT00803049|365439590|FG002|Overall Study|Other than Specified Above|2|||
105939522|NCT00803049|365439591|FG003|Overall Study|Other than Specified Above|5|||
105939523|NCT01514422|365439592|FG000|Overall Study|Lost to Follow-up|1|||
105939524|NCT02514746|365439593|FG000|Overall Study|Chronically Ill|1|||
105939525|NCT02514746|365439594|FG001|Overall Study|Chronically Ill|2|||
105939526|NCT02514746|365439593|FG000|Overall Study|Physician Decision|4|||
105939527|NCT02514746|365439594|FG001|Overall Study|Physician Decision|2|||
105939528|NCT02514746|365439593|FG000|Overall Study|Withdrawal by Subject|12|||
105939529|NCT02514746|365439594|FG001|Overall Study|Withdrawal by Subject|10|||
105939530|NCT02514746|365439593|FG000|Overall Study|Other|5|||
105939531|NCT02514746|365439594|FG001|Overall Study|Other|1|||
105939532|NCT04003142|365439600|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
105939533|NCT04003142|365439601|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
105799340|NCT01902134|364924530|FG005|Overall Study|Withdrawal by Subject|4|||
105799341|NCT01902134|364924525|FG000|Overall Study|no compliance|1|||
105799342|NCT01902134|364924526|FG001|Overall Study|no compliance|0|||
105799343|NCT01902134|364924527|FG002|Overall Study|no compliance|0|||
105799344|NCT01902134|364924528|FG003|Overall Study|no compliance|0|||
105939534|NCT04003142|365439602|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
105939535|NCT04003142|365439603|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
105939536|NCT04003142|365439604|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
105939537|NCT04003142|365439600|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
105799345|NCT01902134|364924529|FG004|Overall Study|no compliance|0|||
105799346|NCT01902134|364924530|FG005|Overall Study|no compliance|0|||
105799347|NCT01902134|364924525|FG000|Overall Study|Other|0|||
105799348|NCT01902134|364924526|FG001|Overall Study|Other|1|||
105799349|NCT01902134|364924527|FG002|Overall Study|Other|2|||
105799350|NCT01902134|364924528|FG003|Overall Study|Other|0|||
105799351|NCT01902134|364924529|FG004|Overall Study|Other|1|||
105799352|NCT01902134|364924530|FG005|Overall Study|Other|0|||
105799353|NCT00678379|364924531|FG000|Overall Study|Injection performed after tonsillectomy|2|||
105799354|NCT00678379|364924532|FG001|Overall Study|Injection performed after tonsillectomy|0|||
106011475|NCT00071058|365708825|FG000|Overall Study|brain tumor-removed from study|1|||
106011476|NCT01188343|365708826|FG000|Overall Study|Not vaccinated|0|||
106011477|NCT01188343|365708827|FG001|Overall Study|Not vaccinated|2|||
106011478|NCT01188343|365708828|FG002|Overall Study|Not vaccinated|1|||
106011479|NCT01188343|365708826|FG000|Overall Study|Withdrawal by Subject|1|||
106011480|NCT01188343|365708827|FG001|Overall Study|Withdrawal by Subject|24|||
106011481|NCT01188343|365708828|FG002|Overall Study|Withdrawal by Subject|0|||
106011482|NCT03521570|365708831|FG000|Overall Study|Not eligible|11|||
106011483|NCT01033019|365708832|FG000|Overall Study|Withdrawal by Subject|1|||
106011484|NCT01033019|365708833|FG001|Overall Study|Withdrawal by Subject|0|||
106011485|NCT03592186|365708834|FG000|Overall Study|Withdrawal by Subject|1|||
106011486|NCT03592186|365708835|FG001|Overall Study|Withdrawal by Subject|0|||
106011487|NCT03592186|365708834|FG000|Overall Study|Lost to Follow-up|16|||
106011488|NCT03592186|365708835|FG001|Overall Study|Lost to Follow-up|11|||
106011489|NCT01052493|365708838|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
106011490|NCT01052493|365708839|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
106011491|NCT01052493|365708840|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
106011492|NCT01498068|365708843|FG000|Overall Study|Withdrawal by Subject|1|||
106011493|NCT01498068|365708844|FG001|Overall Study|Withdrawal by Subject|1|||
106011494|NCT03866577|365708851|FG000|Overall Study|Protocol Violation|0|||
106011495|NCT03866577|365708852|FG001|Overall Study|Protocol Violation|0|||
106011496|NCT03866577|365708853|FG002|Overall Study|Protocol Violation|0|||
106011497|NCT03866577|365708854|FG003|Overall Study|Protocol Violation|0|||
106011498|NCT03866577|365708855|FG004|Overall Study|Protocol Violation|0|||
106011499|NCT03866577|365708856|FG005|Overall Study|Protocol Violation|0|||
106011500|NCT03866577|365708857|FG006|Overall Study|Protocol Violation|0|||
106011501|NCT03866577|365708858|FG007|Overall Study|Protocol Violation|0|||
106011502|NCT03866577|365708859|FG008|Overall Study|Protocol Violation|0|||
106011503|NCT03866577|365708860|FG009|Overall Study|Protocol Violation|0|||
106011504|NCT03866577|365708861|FG010|Overall Study|Protocol Violation|0|||
106011505|NCT03866577|365708862|FG011|Overall Study|Protocol Violation|1|||
106011506|NCT03866577|365708863|FG012|Overall Study|Protocol Violation|0|||
106011507|NCT03866577|365708851|FG000|Overall Study|Withdrawal by Subject|0|||
106011508|NCT03866577|365708852|FG001|Overall Study|Withdrawal by Subject|0|||
106011509|NCT03866577|365708853|FG002|Overall Study|Withdrawal by Subject|0|||
106011510|NCT03866577|365708854|FG003|Overall Study|Withdrawal by Subject|0|||
106011511|NCT03866577|365708855|FG004|Overall Study|Withdrawal by Subject|0|||
106011512|NCT03866577|365708856|FG005|Overall Study|Withdrawal by Subject|0|||
106011513|NCT03866577|365708857|FG006|Overall Study|Withdrawal by Subject|0|||
106011514|NCT03866577|365708858|FG007|Overall Study|Withdrawal by Subject|0|||
106011515|NCT03866577|365708859|FG008|Overall Study|Withdrawal by Subject|1|||
106011516|NCT03866577|365708860|FG009|Overall Study|Withdrawal by Subject|1|||
106011517|NCT03866577|365708861|FG010|Overall Study|Withdrawal by Subject|0|||
106011518|NCT03866577|365708862|FG011|Overall Study|Withdrawal by Subject|0|||
106011519|NCT03866577|365708863|FG012|Overall Study|Withdrawal by Subject|0|||
106011520|NCT03866577|365708851|FG000|Overall Study|Not qualified for IVIg infusion|0|||
106011521|NCT03866577|365708852|FG001|Overall Study|Not qualified for IVIg infusion|0|||
106011522|NCT03866577|365708853|FG002|Overall Study|Not qualified for IVIg infusion|0|||
106011523|NCT03866577|365708854|FG003|Overall Study|Not qualified for IVIg infusion|0|||
106011524|NCT03866577|365708855|FG004|Overall Study|Not qualified for IVIg infusion|0|||
106011525|NCT03866577|365708856|FG005|Overall Study|Not qualified for IVIg infusion|0|||
106011526|NCT03866577|365708857|FG006|Overall Study|Not qualified for IVIg infusion|0|||
106011527|NCT03866577|365708858|FG007|Overall Study|Not qualified for IVIg infusion|0|||
106011528|NCT03866577|365708859|FG008|Overall Study|Not qualified for IVIg infusion|0|||
106011529|NCT03866577|365708860|FG009|Overall Study|Not qualified for IVIg infusion|1|||
106011530|NCT03866577|365708861|FG010|Overall Study|Not qualified for IVIg infusion|0|||
106011531|NCT03866577|365708862|FG011|Overall Study|Not qualified for IVIg infusion|0|||
106011532|NCT03866577|365708863|FG012|Overall Study|Not qualified for IVIg infusion|0|||
106011533|NCT05530252|365708864|FG000|Overall Study|Lost to Follow-up|1|||
106011534|NCT05530252|365708865|FG001|Overall Study|Lost to Follow-up|1|||
106011535|NCT05530252|365708866|FG002|Overall Study|Lost to Follow-up|1|||
106011536|NCT05615922|365708867|FG000|Overall Study|Lost to Follow-up|1|||
106011537|NCT03043794|365708868|FG000|Overall Study|Lost to Follow-up|1|||
105799355|NCT00678379|364924533|FG002|Overall Study|Injection performed after tonsillectomy|1|||
105799356|NCT00678379|364924531|FG000|Overall Study|Incomplete Data|4|||
105799357|NCT00678379|364924532|FG001|Overall Study|Incomplete Data|3|||
105939538|NCT04003142|365439601|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
106011538|NCT02514083|365708869|FG000|Overall Study|Adverse Event|1|||
106011539|NCT02892344|365710356|FG000|Overall Study|Protocol deviation|3|||
106011540|NCT02892344|365710357|FG001|Overall Study|Protocol deviation|4|||
106011541|NCT02892344|365710356|FG000|Overall Study|Adverse Event|1|||
106011542|NCT02892344|365710357|FG001|Overall Study|Adverse Event|8|||
106011543|NCT02892344|365710356|FG000|Overall Study|Lost to Follow-up|0|||
106011544|NCT02892344|365710357|FG001|Overall Study|Lost to Follow-up|1|||
106140544|NCT02371746|366172566|FG000|Overall Study|Consent withdrawn|0|||
106140545|NCT02371746|366172567|FG001|Overall Study|Consent withdrawn|0|||
106140546|NCT02371746|366172568|FG002|Overall Study|Consent withdrawn|0|||
105939539|NCT04003142|365439602|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
105939540|NCT04003142|365439603|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
105939541|NCT04003142|365439604|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
105939542|NCT04003142|365439600|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
105939543|NCT04003142|365439601|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
105939544|NCT04003142|365439602|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
105939545|NCT04003142|365439603|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
105939546|NCT04003142|365439604|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
105939547|NCT04003142|365439600|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
105939548|NCT04003142|365439601|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
105939549|NCT04003142|365439602|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
105939550|NCT04003142|365439603|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
105939551|NCT04003142|365439604|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
105939552|NCT04003142|365439600|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
105939553|NCT04003142|365439601|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
105939554|NCT04003142|365439602|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
105939555|NCT04003142|365439603|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
105939556|NCT04003142|365439604|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
105939557|NCT04003142|365439600|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
105939558|NCT04003142|365439601|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
105939559|NCT04003142|365439602|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
105939560|NCT04003142|365439603|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
105939561|NCT04003142|365439604|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
105939562|NCT04003142|365439600|FG000|Extension Period (40 Weeks)|Death|0|||
105939563|NCT04003142|365439601|FG001|Extension Period (40 Weeks)|Death|0|||
105939564|NCT04003142|365439602|FG002|Extension Period (40 Weeks)|Death|0|||
105939565|NCT04003142|365439603|FG003|Extension Period (40 Weeks)|Death|0|||
105939566|NCT04003142|365439604|FG004|Extension Period (40 Weeks)|Death|1|||
105939567|NCT04003142|365439600|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
105939568|NCT04003142|365439601|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
105939569|NCT04003142|365439602|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
105939570|NCT04003142|365439603|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
105939571|NCT04003142|365439604|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
105939572|NCT04003142|365439600|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
105939573|NCT04003142|365439601|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
105939574|NCT04003142|365439602|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
105939575|NCT04003142|365439603|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
105939576|NCT04003142|365439604|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
105939577|NCT04003142|365439600|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
105939578|NCT04003142|365439601|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
105939579|NCT04003142|365439602|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
105939580|NCT04003142|365439603|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
105939581|NCT04003142|365439604|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
105939582|NCT04003142|365439600|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
105939583|NCT04003142|365439601|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
105939584|NCT04003142|365439602|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
105939585|NCT04003142|365439603|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
105939586|NCT04003142|365439604|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
105939587|NCT03382873|365439605|FG000|Overall Study|Lost to Follow-up|9|||
105939588|NCT03382873|365439606|FG001|Overall Study|Lost to Follow-up|10|||
105939589|NCT03382873|365439605|FG000|Overall Study|Withdrawal by Subject|6|||
105939590|NCT03382873|365439606|FG001|Overall Study|Withdrawal by Subject|11|||
106011545|NCT02892344|365710356|FG000|Overall Study|Non-compliance with study treatment|0|||
106011546|NCT02892344|365710357|FG001|Overall Study|Non-compliance with study treatment|1|||
105939591|NCT03382873|365439605|FG000|Overall Study|Visit not completed due to pandemic|16|||
105939592|NCT03382873|365439606|FG001|Overall Study|Visit not completed due to pandemic|41|||
105939593|NCT03996395|365439607|FG000|Overall Study|Lost to Follow-up|4|||
105939594|NCT03996395|365439607|FG000|Overall Study|Withdrawal by Subject|1|||
106011547|NCT02892344|365710356|FG000|Overall Study|Physician Decision|0|||
105939595|NCT03996395|365439607|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
105939596|NCT02061085|365439608|FG000|Overall Study|Adverse Event|8|||
105939597|NCT03301415|365439614|FG000|Overall Study|Lost to Follow-up|2|||
106011548|NCT02892344|365710357|FG001|Overall Study|Physician Decision|2|||
106011549|NCT02892344|365710356|FG000|Overall Study|Subject/guardian decision|0|||
106011550|NCT02892344|365710357|FG001|Overall Study|Subject/guardian decision|4|||
106011551|NCT02892344|365710356|FG000|Overall Study|Technical problems|0|||
106011552|NCT02892344|365710357|FG001|Overall Study|Technical problems|1|||
106011553|NCT01586364|365710358|FG000|Overall Study|Withdrawal by Subject|40|||
106011554|NCT01586364|365710358|FG000|Overall Study|Adverse Event|37|||
106140547|NCT02371746|366172569|FG003|Overall Study|Consent withdrawn|0|||
105736983|NCT00859898|364693317|FG000|Overall Study|Withdrawal by Subject|11|||
105736984|NCT00859898|364693318|FG001|Overall Study|Withdrawal by Subject|8|||
105736985|NCT00859898|364693319|FG002|Overall Study|Withdrawal by Subject|11|||
105736986|NCT00859898|364693317|FG000|Overall Study|Death|0|||
105939598|NCT03301415|365439614|FG000|Overall Study|Unable to comply with visit schedule|2|||
105939599|NCT03247673|365439617|FG000|Overall Study|Withdrawal by Subject|1|||
105939600|NCT03247673|365439618|FG001|Overall Study|Withdrawal by Subject|0|||
105939601|NCT03247673|365439619|FG002|Overall Study|Withdrawal by Subject|3|||
105939602|NCT03247673|365439617|FG000|Overall Study|Lost to Follow-up|0|||
105939603|NCT03247673|365439618|FG001|Overall Study|Lost to Follow-up|0|||
105939604|NCT03247673|365439619|FG002|Overall Study|Lost to Follow-up|1|||
105939605|NCT01887600|365439620|FG000|Overall Study|Death|39|||
105939606|NCT01887600|365439621|FG001|Overall Study|Death|16|||
105939607|NCT01887600|365439620|FG000|Overall Study|Lack of Efficacy|3|||
105939608|NCT01887600|365439621|FG001|Overall Study|Lack of Efficacy|26|||
105939609|NCT01887600|365439620|FG000|Overall Study|Lost to Follow-up|5|||
105939610|NCT01887600|365439621|FG001|Overall Study|Lost to Follow-up|1|||
105939611|NCT01887600|365439620|FG000|Overall Study|Physician Decision|7|||
105939612|NCT01887600|365439621|FG001|Overall Study|Physician Decision|8|||
105939613|NCT01887600|365439620|FG000|Overall Study|Protocol Deviation|3|||
105939614|NCT01887600|365439621|FG001|Overall Study|Protocol Deviation|0|||
105939615|NCT01887600|365439620|FG000|Overall Study|Withdrawal by Subject|58|||
105939616|NCT01887600|365439621|FG001|Overall Study|Withdrawal by Subject|52|||
105939617|NCT01887600|365439620|FG000|Overall Study|Adverse Event|21|||
105939618|NCT01887600|365439621|FG001|Overall Study|Adverse Event|9|||
105939619|NCT01887600|365439620|FG000|Overall Study|Non-compliance with study drug|3|||
105939620|NCT01887600|365439621|FG001|Overall Study|Non-compliance with study drug|0|||
105939621|NCT01887600|365439620|FG000|Overall Study|Miscellaneous|6|||
105939622|NCT01887600|365439621|FG001|Overall Study|Miscellaneous|2|||
105939623|NCT01887600|365439620|FG000|Overall Study|Progressive Disease|1|||
105939624|NCT01887600|365439621|FG001|Overall Study|Progressive Disease|0|||
105939625|NCT03688139|365439622|FG000|Overall Study|Lost to Follow-up|2|||
105939626|NCT03688139|365439623|FG001|Overall Study|Lost to Follow-up|0|||
105939627|NCT03688139|365439622|FG000|Overall Study|Physician Decision|0|||
105939628|NCT03688139|365439623|FG001|Overall Study|Physician Decision|1|||
105939629|NCT03688139|365439622|FG000|Overall Study|Withdrawal by Subject|2|||
105939630|NCT03688139|365439623|FG001|Overall Study|Withdrawal by Subject|3|||
105939631|NCT02184442|365439627|FG000|Overall Study|Death|61|||
105939632|NCT02184442|365439628|FG001|Overall Study|Death|65|||
105939633|NCT02184442|365439627|FG000|Overall Study|Withdrawal by Subject|3|||
105939634|NCT02184442|365439628|FG001|Overall Study|Withdrawal by Subject|11|||
105939635|NCT01852214|365439629|FG000|Period 1|Adverse Event|1|||
105939636|NCT01852214|365439630|FG001|Period 1|Adverse Event|2|||
105939637|NCT01852214|365439629|FG000|Period 1|Withdrawal by Subject|0|||
105939638|NCT01852214|365439630|FG001|Period 1|Withdrawal by Subject|1|||
105939639|NCT01852214|365439629|FG000|Washout Period|Withdrawal by Subject|0|||
105939640|NCT01852214|365439630|FG001|Washout Period|Withdrawal by Subject|1|||
105939641|NCT04091438|365439631|FG000|Treatment Period 1 (1 Day)|Other|1|||
105939642|NCT04091438|365439632|FG001|Treatment Period 1 (1 Day)|Other|0|||
105939643|NCT04091438|365439631|FG000|Washout Period (1 Day)|Protocol deviation|0|||
105939644|NCT04091438|365439632|FG001|Washout Period (1 Day)|Protocol deviation|1|||
105939645|NCT04091438|365439631|FG000|Washout Period (1 Day)|Other|0|||
105939646|NCT04091438|365439632|FG001|Washout Period (1 Day)|Other|1|||
105939647|NCT05346640|365439635|FG000|Overall Study|Lack of Efficacy|2|||
105939648|NCT05346640|365439635|FG000|Overall Study|Lost to Follow-up|14|||
105939649|NCT05346640|365439635|FG000|Overall Study|Protocol Violation|4|||
105939650|NCT05346640|365439635|FG000|Overall Study|Withdrawal by Subject|2|||
106011555|NCT01586364|365710358|FG000|Overall Study|Lost to Follow-up|17|||
106011556|NCT01586364|365710358|FG000|Overall Study|Protocol Violation|16|||
106140548|NCT02371746|366172570|FG004|Overall Study|Consent withdrawn|0|||
105939651|NCT05346640|365439635|FG000|Overall Study|Physiological Complications|3|||
105939652|NCT05346640|365439635|FG000|Overall Study|Other Reason|3|||
105939653|NCT00480025|365439636|FG000|Overall Study|Protocol Violation|12|||
105939654|NCT00480025|365439637|FG001|Overall Study|Protocol Violation|7|||
105939655|NCT00480025|365439636|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
105939656|NCT00480025|365439637|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
106011557|NCT01586364|365710358|FG000|Overall Study|Lack of Efficacy|1|||
105939657|NCT00480025|365439636|FG000|Overall Study|Disease Progression / Recurrence|449|||
105939658|NCT00480025|365439637|FG001|Overall Study|Disease Progression / Recurrence|224|||
105939659|NCT00480025|365439636|FG000|Overall Study|Adverse Event|44|||
105939660|NCT00480025|365439637|FG001|Overall Study|Adverse Event|12|||
105939661|NCT00480025|365439636|FG000|Overall Study|Other|70|||
105939662|NCT00480025|365439637|FG001|Overall Study|Other|29|||
105939663|NCT00480025|365439636|FG000|Overall Study|SAE including intercurrent illness|76|||
105939664|NCT00480025|365439637|FG001|Overall Study|SAE including intercurrent illness|42|||
105939665|NCT00787800|365439638|FG000|Overall Study|Withdrawal by Subject|3|||
105939666|NCT00787800|365439639|FG001|Overall Study|Withdrawal by Subject|5|||
105939667|NCT00787800|365439638|FG000|Overall Study|Death|0|||
105939668|NCT00787800|365439639|FG001|Overall Study|Death|2|||
105736987|NCT00859898|364693318|FG001|Overall Study|Death|0|||
105736988|NCT00859898|364693319|FG002|Overall Study|Death|1|||
105736989|NCT00859898|364693317|FG000|Overall Study|Lost to Follow-up|10|||
105736990|NCT00859898|364693318|FG001|Overall Study|Lost to Follow-up|11|||
105736991|NCT00859898|364693319|FG002|Overall Study|Lost to Follow-up|5|||
105736992|NCT00859898|364693317|FG000|Overall Study|poor/non-compliance|2|||
105736993|NCT00859898|364693318|FG001|Overall Study|poor/non-compliance|0|||
105736994|NCT00859898|364693319|FG002|Overall Study|poor/non-compliance|0|||
105799358|NCT00678379|364924533|FG002|Overall Study|Incomplete Data|3|||
105799359|NCT02290028|364924536|FG000|Overall Study|Death|217|||
105939669|NCT02496156|365439643|FG000|Overall Study|Lost to Follow-up|5|||
105939670|NCT02496156|365439644|FG001|Overall Study|Lost to Follow-up|0|||
105939671|NCT02496156|365439643|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
105939672|NCT02496156|365439644|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
105939673|NCT00461812|365439645|FG000|Overall Study|study terminated|10|||
105939674|NCT03193437|365439652|FG000|Overall Study|Adverse Event|4|||
105939675|NCT03193437|365439652|FG000|Overall Study|Withdrawal by Subject|2|||
105939676|NCT03193437|365439652|FG000|Overall Study|Disease Progression|2|||
105939677|NCT03810495|365439655|FG000|Overall Study|Lost to Follow-up|2|||
105939678|NCT03810495|365439655|FG000|Overall Study|Withdrawal by Subject|1|||
105939679|NCT03164356|365439656|FG000|Overall Study|Lost to Follow-up|1|||
105939680|NCT03164356|365439657|FG001|Overall Study|Lost to Follow-up|1|||
105939681|NCT03164356|365439658|FG002|Overall Study|Lost to Follow-up|2|||
105939682|NCT03164356|365439659|FG003|Overall Study|Lost to Follow-up|1|||
105939683|NCT03164356|365439656|FG000|Overall Study|Physician Decision|0|||
105939684|NCT03164356|365439657|FG001|Overall Study|Physician Decision|0|||
105939685|NCT03164356|365439658|FG002|Overall Study|Physician Decision|3|||
105939686|NCT03164356|365439659|FG003|Overall Study|Physician Decision|0|||
105939687|NCT03164356|365439656|FG000|Overall Study|Protocol Violation|2|||
105939688|NCT03164356|365439657|FG001|Overall Study|Protocol Violation|1|||
105939689|NCT03164356|365439658|FG002|Overall Study|Protocol Violation|0|||
105939690|NCT03164356|365439659|FG003|Overall Study|Protocol Violation|0|||
105939691|NCT03164356|365439656|FG000|Overall Study|Withdrawal by Subject|1|||
105939692|NCT03164356|365439657|FG001|Overall Study|Withdrawal by Subject|0|||
105939693|NCT03164356|365439658|FG002|Overall Study|Withdrawal by Subject|0|||
105939694|NCT03164356|365439659|FG003|Overall Study|Withdrawal by Subject|0|||
105939695|NCT03164356|365439656|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
105939696|NCT03164356|365439657|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
105939697|NCT03164356|365439658|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
105939698|NCT03164356|365439659|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
105939699|NCT03164356|365439656|FG000|Overall Study|Subject Incarcerated|0|||
105939700|NCT03164356|365439657|FG001|Overall Study|Subject Incarcerated|1|||
105939701|NCT03164356|365439658|FG002|Overall Study|Subject Incarcerated|0|||
105939702|NCT03164356|365439659|FG003|Overall Study|Subject Incarcerated|0|||
105939703|NCT03164356|365439656|FG000|Overall Study|Prosthetist unable to participate|0|||
105939704|NCT03164356|365439657|FG001|Overall Study|Prosthetist unable to participate|2|||
105939705|NCT03164356|365439658|FG002|Overall Study|Prosthetist unable to participate|1|||
105939706|NCT03164356|365439659|FG003|Overall Study|Prosthetist unable to participate|0|||
105952109|NCT03314935|365488190|FG006|Phase 1|"Captured as Other in Database"|1|||
105952110|NCT03314935|365488191|FG007|Phase 1|"Captured as Other in Database"|1|||
105952111|NCT03314935|365488192|FG008|Phase 1|"Captured as Other in Database"|1|||
105952112|NCT03314935|365488193|FG009|Phase 1|"Captured as Other in Database"|0|||
105952113|NCT03314935|365488194|FG010|Phase 1|"Captured as Other in Database"|0|||
105799360|NCT02290028|364924536|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
105952114|NCT03314935|365488195|FG011|Phase 1|"Captured as Other in Database"|0|||
105952115|NCT03314935|365488196|FG012|Phase 1|"Captured as Other in Database"|0|||
105952116|NCT03314935|365488197|FG013|Phase 1|"Captured as Other in Database"|0|||
105952117|NCT03314935|365488198|FG014|Phase 1|"Captured as Other in Database"|0|||
105952118|NCT03314935|365488184|FG000|Phase 1|Lost to Follow-up|0|||
105952119|NCT03314935|365488185|FG001|Phase 1|Lost to Follow-up|0|||
105952120|NCT03314935|365488186|FG002|Phase 1|Lost to Follow-up|0|||
105952121|NCT03314935|365488187|FG003|Phase 1|Lost to Follow-up|0|||
105952122|NCT03314935|365488188|FG004|Phase 1|Lost to Follow-up|0|||
105952123|NCT03314935|365488189|FG005|Phase 1|Lost to Follow-up|0|||
105952124|NCT03314935|365488190|FG006|Phase 1|Lost to Follow-up|0|||
105952125|NCT03314935|365488191|FG007|Phase 1|Lost to Follow-up|0|||
105952126|NCT03314935|365488192|FG008|Phase 1|Lost to Follow-up|1|||
105952127|NCT03314935|365488193|FG009|Phase 1|Lost to Follow-up|0|||
105952128|NCT03314935|365488194|FG010|Phase 1|Lost to Follow-up|0|||
105799361|NCT02290028|364924536|FG000|Overall Study|No longer under care of study physician|76|||
105799362|NCT02290028|364924536|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
105799363|NCT02290028|364924536|FG000|Overall Study|Withdrawal by Subject|52|||
105799364|NCT02290028|364924536|FG000|Overall Study|Study site closure|44|||
105799365|NCT02290028|364924536|FG000|Overall Study|Lost to Follow-up|34|||
105799366|NCT02290028|364924536|FG000|Overall Study|Miscellaneous|10|||
105799367|NCT02290028|364924536|FG000|Overall Study|Transition to EP PASSION|1295|||
105799368|NCT02290028|364924536|FG000|Overall Study|Planned study completion at 12 months|257|||
105799369|NCT03202511|364924537|FG000|Overall Study|Withdrawal by Subject|1|||
105799370|NCT03202511|364924538|FG001|Overall Study|Withdrawal by Subject|0|||
105799371|NCT04126733|364924554|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
105799372|NCT04126733|364924554|FG000|Treatment Period|Adverse Event|8|||
105799373|NCT04126733|364924554|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
105799374|NCT04126733|364924554|FG000|Treatment Period|Physician Decision|5|||
105799375|NCT04126733|364924554|FG000|Treatment Period|Death|1|||
105799376|NCT04126733|364924554|FG000|Treatment Period|Other Reasons|2|||
105799377|NCT04126733|364924554|FG000|Active Follow-up Period|Death|13|||
105799378|NCT04126733|364924554|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
105799379|NCT04126733|364924554|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
105799380|NCT04126733|364924554|FG000|Active Follow-up Period|Other Reasons|1|||
105799381|NCT04126733|364924554|FG000|Long-term Follow-up Period|Death|22|||
105799382|NCT04126733|364924554|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
105799383|NCT04126733|364924554|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
105799384|NCT02622074|364924555|FG000|Overall Study|Death|4|||
105799385|NCT02622074|364924556|FG001|Overall Study|Death|0|||
105799386|NCT02622074|364924557|FG002|Overall Study|Death|0|||
105799387|NCT02622074|364924558|FG003|Overall Study|Death|1|||
105799388|NCT02622074|364924559|FG004|Overall Study|Death|1|||
105799389|NCT02622074|364924560|FG005|Overall Study|Death|0|||
105799390|NCT02622074|364924555|FG000|Overall Study|Withdrawal by Subject|0|||
105799391|NCT02622074|364924556|FG001|Overall Study|Withdrawal by Subject|1|||
105799392|NCT02622074|364924557|FG002|Overall Study|Withdrawal by Subject|0|||
105799393|NCT02622074|364924558|FG003|Overall Study|Withdrawal by Subject|0|||
105799394|NCT02622074|364924559|FG004|Overall Study|Withdrawal by Subject|0|||
105799395|NCT02622074|364924560|FG005|Overall Study|Withdrawal by Subject|0|||
105799396|NCT02981602|364924561|FG000|Overall Study|Adverse Event|0|||
105799397|NCT02981602|364924562|FG001|Overall Study|Adverse Event|0|||
105799398|NCT02981602|364924563|FG002|Overall Study|Adverse Event|0|||
105799399|NCT02981602|364924564|FG003|Overall Study|Adverse Event|1|||
105799400|NCT02981602|364924565|FG004|Overall Study|Adverse Event|0|||
105799401|NCT02410837|364924566|FG000|Overall Study|Death|387|||
105799402|NCT02410837|364924566|FG000|Overall Study|Lost to Follow-up|50|||
105799403|NCT02410837|364924566|FG000|Overall Study|Withdrawal by Subject|44|||
105799404|NCT02410837|364924566|FG000|Overall Study|Physician Decision|6|||
105799405|NCT02410837|364924566|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
105799406|NCT01896700|364924567|FG000|Overall Study|Adverse Event|4|||
105799407|NCT01896700|364924568|FG001|Overall Study|Adverse Event|5|||
105799408|NCT01896700|364924567|FG000|Overall Study|Withdrawal by Subject|0|||
105799409|NCT01896700|364924568|FG001|Overall Study|Withdrawal by Subject|1|||
105799410|NCT00267007|364924570|FG000|Overall Study|Withdrawal by Subject|6|||
105799411|NCT00267007|364924571|FG001|Overall Study|Withdrawal by Subject|0|||
105799412|NCT00267007|364924570|FG000|Overall Study|Lost to Follow-up|1|||
105799413|NCT00267007|364924571|FG001|Overall Study|Lost to Follow-up|0|||
105799414|NCT00267007|364924570|FG000|Overall Study|Non-compliance|0|||
105799415|NCT00267007|364924571|FG001|Overall Study|Non-compliance|1|||
105799416|NCT00267007|364924570|FG000|Overall Study|Adverse Event|1|||
105799417|NCT00267007|364924571|FG001|Overall Study|Adverse Event|0|||
105799418|NCT01493531|364924576|FG000|Overall Study|Adverse Event|4|||
105799419|NCT01493531|364924577|FG001|Overall Study|Adverse Event|12|||
105799420|NCT01493531|364924578|FG002|Overall Study|Adverse Event|9|||
105799421|NCT01493531|364924576|FG000|Overall Study|Gout flare|3|||
105799422|NCT01493531|364924577|FG001|Overall Study|Gout flare|0|||
105799423|NCT01493531|364924578|FG002|Overall Study|Gout flare|2|||
105939707|NCT05520333|365441205|FG000|Overall Study|Lost to Follow-up|3|||
105939708|NCT05520333|365441206|FG001|Overall Study|Lost to Follow-up|6|||
105939709|NCT02457546|365441208|FG000|Overall Study|Other reasons|4|||
105939710|NCT02457546|365441209|FG001|Overall Study|Other reasons|1|||
105939711|NCT02457546|365441208|FG000|Overall Study|Refused to complete study/procedures|1|||
105952129|NCT03314935|365488195|FG011|Phase 1|Lost to Follow-up|0|||
106140549|NCT02371746|366172571|FG005|Overall Study|Consent withdrawn|0|||
106140550|NCT02371746|366172572|FG006|Overall Study|Consent withdrawn|1|||
105799424|NCT01493531|364924576|FG000|Overall Study|Protocol Violation|8|||
105799425|NCT01493531|364924577|FG001|Overall Study|Protocol Violation|15|||
105799426|NCT01493531|364924578|FG002|Overall Study|Protocol Violation|12|||
105799427|NCT01493531|364924576|FG000|Overall Study|Sponsor terminated study|5|||
105799428|NCT01493531|364924577|FG001|Overall Study|Sponsor terminated study|2|||
105799429|NCT01493531|364924578|FG002|Overall Study|Sponsor terminated study|3|||
105799430|NCT01493531|364924576|FG000|Overall Study|Lost to Follow-up|5|||
105736995|NCT00859898|364693317|FG000|Overall Study|No longer meets criteria|0|||
105736996|NCT00859898|364693318|FG001|Overall Study|No longer meets criteria|1|||
105736997|NCT00859898|364693319|FG002|Overall Study|No longer meets criteria|0|||
105736998|NCT00859898|364693317|FG000|Overall Study|non-specified|1|||
105736999|NCT00859898|364693318|FG001|Overall Study|non-specified|1|||
105737000|NCT00859898|364693319|FG002|Overall Study|non-specified|1|||
105737001|NCT04045613|364693321|FG000|Overall Study|Adverse Event|2|||
105737002|NCT04045613|364693322|FG001|Overall Study|Adverse Event|2|||
105737003|NCT04045613|364693323|FG002|Overall Study|Adverse Event|1|||
105737004|NCT04045613|364693324|FG003|Overall Study|Adverse Event|1|||
105737005|NCT04045613|364693325|FG004|Overall Study|Adverse Event|0|||
105737006|NCT04045613|364693326|FG005|Overall Study|Adverse Event|0|||
105737007|NCT04045613|364693327|FG006|Overall Study|Adverse Event|1|||
105737008|NCT04045613|364693321|FG000|Overall Study|Withdrawal by Subject|0|||
105737009|NCT04045613|364693322|FG001|Overall Study|Withdrawal by Subject|5|||
105737010|NCT04045613|364693323|FG002|Overall Study|Withdrawal by Subject|0|||
105737011|NCT04045613|364693324|FG003|Overall Study|Withdrawal by Subject|0|||
105737012|NCT04045613|364693325|FG004|Overall Study|Withdrawal by Subject|0|||
105737013|NCT04045613|364693326|FG005|Overall Study|Withdrawal by Subject|1|||
105737014|NCT04045613|364693327|FG006|Overall Study|Withdrawal by Subject|0|||
105737015|NCT04045613|364693321|FG000|Overall Study|Physician Decision|2|||
105737016|NCT04045613|364693322|FG001|Overall Study|Physician Decision|0|||
105737017|NCT04045613|364693323|FG002|Overall Study|Physician Decision|0|||
105737018|NCT04045613|364693324|FG003|Overall Study|Physician Decision|0|||
105737019|NCT04045613|364693325|FG004|Overall Study|Physician Decision|1|||
105737020|NCT04045613|364693326|FG005|Overall Study|Physician Decision|0|||
105737021|NCT04045613|364693327|FG006|Overall Study|Physician Decision|0|||
105737022|NCT04045613|364693321|FG000|Overall Study|Death|3|||
105737023|NCT04045613|364693322|FG001|Overall Study|Death|0|||
105737024|NCT04045613|364693323|FG002|Overall Study|Death|0|||
105737025|NCT04045613|364693324|FG003|Overall Study|Death|0|||
105737026|NCT04045613|364693325|FG004|Overall Study|Death|0|||
105737027|NCT04045613|364693326|FG005|Overall Study|Death|0|||
105737028|NCT04045613|364693327|FG006|Overall Study|Death|1|||
105737029|NCT04045613|364693321|FG000|Overall Study|Other reasons|0|||
105737030|NCT04045613|364693322|FG001|Overall Study|Other reasons|1|||
105737031|NCT04045613|364693323|FG002|Overall Study|Other reasons|0|||
105737032|NCT04045613|364693324|FG003|Overall Study|Other reasons|0|||
105737033|NCT04045613|364693325|FG004|Overall Study|Other reasons|0|||
105737034|NCT04045613|364693326|FG005|Overall Study|Other reasons|0|||
105737035|NCT04045613|364693327|FG006|Overall Study|Other reasons|1|||
105737036|NCT04045613|364693321|FG000|Overall Study|Progressive disease: Clinical progression|1|||
105737037|NCT04045613|364693322|FG001|Overall Study|Progressive disease: Clinical progression|0|||
105737038|NCT04045613|364693323|FG002|Overall Study|Progressive disease: Clinical progression|3|||
105737039|NCT04045613|364693324|FG003|Overall Study|Progressive disease: Clinical progression|1|||
105939712|NCT02457546|365441209|FG001|Overall Study|Refused to complete study/procedures|1|||
105939713|NCT02457546|365441208|FG000|Overall Study|Lost to Follow-up|4|||
105939714|NCT02457546|365441209|FG001|Overall Study|Lost to Follow-up|1|||
105939715|NCT02457546|365441208|FG000|Overall Study|Adverse Event|0|||
105939716|NCT02457546|365441209|FG001|Overall Study|Adverse Event|1|||
105939717|NCT05069415|365441210|FG000|Overall Study|Withdrawal by Subject|2|||
105939718|NCT05069415|365441211|FG001|Overall Study|Withdrawal by Subject|0|||
105939719|NCT05069415|365441210|FG000|Overall Study|Adverse Event|2|||
105939720|NCT05069415|365441211|FG001|Overall Study|Adverse Event|0|||
105939721|NCT01697501|365441214|FG000|Overall Study|Protocol Violation|2|||
105939722|NCT00668642|365441217|FG000|First Off-cycle|Cancer progression|1|||
105939723|NCT00668642|365441218|FG001|First Off-cycle|Cancer progression|0|||
105939724|NCT00668642|365441217|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
106140551|NCT00612586|366172573|FG000|Overall Study|Adverse Event|6|||
106140552|NCT00612586|366172574|FG001|Overall Study|Adverse Event|2|||
106140553|NCT00612586|366172573|FG000|Overall Study|Death|1|||
105737040|NCT04045613|364693325|FG004|Overall Study|Progressive disease: Clinical progression|1|||
105737041|NCT04045613|364693326|FG005|Overall Study|Progressive disease: Clinical progression|3|||
105737042|NCT04045613|364693327|FG006|Overall Study|Progressive disease: Clinical progression|3|||
105737043|NCT04045613|364693321|FG000|Overall Study|Progressive disease: Radiological progression|24|||
105737044|NCT04045613|364693322|FG001|Overall Study|Progressive disease: Radiological progression|6|||
105737045|NCT04045613|364693323|FG002|Overall Study|Progressive disease: Radiological progression|8|||
105939725|NCT00668642|365441218|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
105939726|NCT02003898|365441219|FG000|Overall Study|Death|3|||
106140554|NCT00612586|366172574|FG001|Overall Study|Death|0|||
106140555|NCT00612586|366172573|FG000|Overall Study|Entry Criteria Not Met|0|||
105737046|NCT04045613|364693324|FG003|Overall Study|Progressive disease: Radiological progression|0|||
105737047|NCT04045613|364693325|FG004|Overall Study|Progressive disease: Radiological progression|6|||
105737048|NCT04045613|364693326|FG005|Overall Study|Progressive disease: Radiological progression|6|||
105799431|NCT01493531|364924577|FG001|Overall Study|Lost to Follow-up|7|||
106140556|NCT00612586|366172574|FG001|Overall Study|Entry Criteria Not Met|2|||
105939727|NCT02003898|365441219|FG000|Overall Study|Lost to Follow-up|12|||
105737049|NCT04045613|364693327|FG006|Overall Study|Progressive disease: Radiological progression|11|||
105737050|NCT00491530|364693328|FG000|Overall Study|Adverse Event|6|||
105737051|NCT00491530|364693329|FG001|Overall Study|Adverse Event|1|||
105737052|NCT00491530|364693330|FG002|Overall Study|Adverse Event|2|||
105737053|NCT00491530|364693328|FG000|Overall Study|Withdrawal by Subject|3|||
105737054|NCT00491530|364693329|FG001|Overall Study|Withdrawal by Subject|0|||
105737055|NCT00491530|364693330|FG002|Overall Study|Withdrawal by Subject|0|||
105737056|NCT00491530|364693328|FG000|Overall Study|Lost to Follow-up|3|||
105737057|NCT00491530|364693329|FG001|Overall Study|Lost to Follow-up|2|||
105737058|NCT00491530|364693330|FG002|Overall Study|Lost to Follow-up|2|||
105737059|NCT00491530|364693328|FG000|Overall Study|Lack of Efficacy|0|||
105737060|NCT00491530|364693329|FG001|Overall Study|Lack of Efficacy|1|||
105939728|NCT02003898|365441219|FG000|Overall Study|Withdrawal by Subject|52|||
105939729|NCT03412591|365441220|FG000|Overall Study|Withdrawal by Subject|1|||
105939730|NCT03412591|365441221|FG001|Overall Study|Withdrawal by Subject|8|||
105939731|NCT03412591|365441220|FG000|Overall Study|Adverse Event|0|||
105939732|NCT03412591|365441221|FG001|Overall Study|Adverse Event|1|||
105939733|NCT00770679|365441224|FG000|Overall Study|Lost to Follow-up|3|||
105939734|NCT00770679|365441224|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
105939735|NCT05166902|365441225|FG000|First Intervention|Lost to Follow-up|0|||
105939736|NCT05166902|365441226|FG001|First Intervention|Lost to Follow-up|1|||
105939737|NCT00414609|365441227|FG000|Core Study|Adverse Event|9|||
105939738|NCT00414609|365441228|FG001|Core Study|Adverse Event|11|||
105939739|NCT00414609|365441229|FG002|Core Study|Adverse Event|0|||
105939740|NCT00414609|365441227|FG000|Core Study|Abnormal laboratory values|0|||
106011558|NCT01586364|365710358|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
106011559|NCT01586364|365710358|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
106011560|NCT01586364|365710358|FG000|Overall Study|Other-Site closure due to PI illness|1|||
106011561|NCT01586364|365710358|FG000|Overall Study|Other-PI discretion, site closing|2|||
106011562|NCT01586364|365710358|FG000|Overall Study|Other-Not specified|1|||
106011563|NCT02121535|365710359|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
106011564|NCT02121535|365710360|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
106011565|NCT02121535|365710359|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
105737061|NCT00491530|364693330|FG002|Overall Study|Lack of Efficacy|0|||
105737062|NCT00491530|364693328|FG000|Overall Study|Investigator Discretion|0|||
105737063|NCT00491530|364693329|FG001|Overall Study|Investigator Discretion|1|||
105737064|NCT00491530|364693330|FG002|Overall Study|Investigator Discretion|0|||
105737065|NCT00491530|364693328|FG000|Overall Study|Patient Request|0|||
105737066|NCT00491530|364693329|FG001|Overall Study|Patient Request|1|||
105737067|NCT00491530|364693330|FG002|Overall Study|Patient Request|0|||
105737068|NCT00491530|364693328|FG000|Overall Study|Use of Prohibited Medication|0|||
105737069|NCT00491530|364693329|FG001|Overall Study|Use of Prohibited Medication|0|||
105737070|NCT00491530|364693330|FG002|Overall Study|Use of Prohibited Medication|1|||
105737071|NCT02612077|364693336|FG000|Overall Study|Adverse Event|3|||
105737072|NCT02612077|364693336|FG000|Overall Study|Withdrawal by Subject|9|||
105737073|NCT02612077|364693336|FG000|Overall Study|Protocol Violation|28|||
105737074|NCT02612077|364693336|FG000|Overall Study|Lost to Follow-up|20|||
105737075|NCT02612077|364693336|FG000|Overall Study|Death|377|||
105737076|NCT02612077|364693336|FG000|Overall Study|Moved or Changed Medical Team|23|||
105737077|NCT02612077|364693336|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
105737078|NCT02612077|364693336|FG000|Overall Study|Disease Progression|3|||
105737079|NCT02612077|364693336|FG000|Overall Study|Unknown reason|2|||
105737080|NCT01753518|364693337|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
105737081|NCT01753518|364693338|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
105737082|NCT01753518|364693337|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
105737083|NCT01753518|364693338|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
105737084|NCT01753518|364693337|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
105737085|NCT01753518|364693338|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
105737086|NCT01753518|364693337|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
105737087|NCT01753518|364693338|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
105737088|NCT00425438|364693342|FG000|Overall Study|Termination by Sponsor|25|||
105737089|NCT00425438|364693343|FG001|Overall Study|Termination by Sponsor|27|||
105737090|NCT02902809|364693344|FG000|Overall Study|Discontinuation of asthma program|28|||
105737091|NCT00532259|364693345|FG000|Overall Study|Withdrawal by Subject|2|||
105939741|NCT00414609|365441228|FG001|Core Study|Abnormal laboratory values|1|||
105737092|NCT00532259|364693345|FG000|Overall Study|Adverse Event|1|||
105737093|NCT00532259|364693345|FG000|Overall Study|Death|1|||
105737094|NCT00532259|364693345|FG000|Overall Study|Lack of Efficacy|21|||
105737095|NCT00532259|364693345|FG000|Overall Study|Lost to Follow-up|3|||
105737096|NCT00532259|364693345|FG000|Overall Study|Physician Decision|3|||
105737097|NCT00532259|364693345|FG000|Overall Study|Protocol Violation|1|||
105737098|NCT01188798|364693348|FG000|Overall Study|Death|0|||
105939742|NCT00414609|365441229|FG002|Core Study|Abnormal laboratory values|0|||
105939743|NCT00414609|365441227|FG000|Core Study|Abnormal test procedure results|1|||
105939744|NCT00414609|365441228|FG001|Core Study|Abnormal test procedure results|1|||
105737099|NCT01188798|364693349|FG001|Overall Study|Death|1|||
105737100|NCT01188798|364693348|FG000|Overall Study|Required additional transplant|1|||
105737101|NCT01188798|364693349|FG001|Overall Study|Required additional transplant|1|||
105737102|NCT01188798|364693348|FG000|Overall Study|Protocol closure|1|||
105737103|NCT01188798|364693349|FG001|Overall Study|Protocol closure|1|||
105737104|NCT02795767|364693350|FG000|Overall Study|Received Commercial Emicizumab|1|||
105737105|NCT02795767|364693351|FG001|Overall Study|Received Commercial Emicizumab|0|||
105737106|NCT02795767|364693352|FG002|Overall Study|Received Commercial Emicizumab|0|||
105737107|NCT03662334|364693353|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
105737108|NCT03662334|364693354|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
105737109|NCT03494725|364693359|FG000|Overall Study|Withdrawal by Subject|0|||
105737110|NCT03494725|364693360|FG001|Overall Study|Withdrawal by Subject|2|||
105737111|NCT03494725|364693359|FG000|Overall Study|Antibiotic use|1|||
105737112|NCT03494725|364693360|FG001|Overall Study|Antibiotic use|0|||
105737113|NCT00301067|364693363|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
105737114|NCT00301067|364693364|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
105737115|NCT00301067|364693365|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
105737116|NCT00301067|364693366|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
105737117|NCT00301067|364693363|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
105737118|NCT00301067|364693364|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
105737119|NCT00301067|364693365|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
105939745|NCT00414609|365441229|FG002|Core Study|Abnormal test procedure results|0|||
105737120|NCT00301067|364693366|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
105939746|NCT00414609|365441227|FG000|Core Study|Protocol deviation|0|||
105939747|NCT00414609|365441228|FG001|Core Study|Protocol deviation|1|||
105939748|NCT00414609|365441229|FG002|Core Study|Protocol deviation|0|||
105939749|NCT00414609|365441227|FG000|Core Study|Patient withdrew consent|10|||
105939750|NCT00414609|365441228|FG001|Core Study|Patient withdrew consent|11|||
105939751|NCT00414609|365441229|FG002|Core Study|Patient withdrew consent|0|||
105939752|NCT00414609|365441227|FG000|Core Study|Lost to Follow-up|7|||
105939753|NCT00414609|365441228|FG001|Core Study|Lost to Follow-up|4|||
105939754|NCT00414609|365441229|FG002|Core Study|Lost to Follow-up|0|||
105939755|NCT00414609|365441227|FG000|Core Study|Administrative problems|0|||
105939756|NCT00414609|365441228|FG001|Core Study|Administrative problems|2|||
105939757|NCT00414609|365441229|FG002|Core Study|Administrative problems|0|||
105939758|NCT00414609|365441227|FG000|Core Study|Death|7|||
105939759|NCT00414609|365441228|FG001|Core Study|Death|14|||
105939760|NCT00414609|365441229|FG002|Core Study|Death|0|||
105939761|NCT00414609|365441227|FG000|Extension Study|Adverse Event|0|||
105939762|NCT00414609|365441228|FG001|Extension Study|Adverse Event|0|||
105939763|NCT00414609|365441229|FG002|Extension Study|Adverse Event|14|||
105939764|NCT00414609|365441227|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
105939765|NCT00414609|365441228|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
105939766|NCT00414609|365441229|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
105939767|NCT00414609|365441227|FG000|Extension Study|Withdrawal by Subject|0|||
105939768|NCT00414609|365441228|FG001|Extension Study|Withdrawal by Subject|0|||
105939769|NCT00414609|365441229|FG002|Extension Study|Withdrawal by Subject|13|||
105939770|NCT00414609|365441227|FG000|Extension Study|Lost to Follow-up|0|||
105939771|NCT00414609|365441228|FG001|Extension Study|Lost to Follow-up|0|||
105939772|NCT00414609|365441229|FG002|Extension Study|Lost to Follow-up|10|||
105939773|NCT00414609|365441227|FG000|Extension Study|Administrative problems|0|||
105939774|NCT00414609|365441228|FG001|Extension Study|Administrative problems|0|||
105939775|NCT00414609|365441229|FG002|Extension Study|Administrative problems|1|||
105939776|NCT00414609|365441227|FG000|Extension Study|Death|0|||
105939777|NCT00414609|365441228|FG001|Extension Study|Death|0|||
105939778|NCT00414609|365441229|FG002|Extension Study|Death|17|||
105939779|NCT00266032|365441230|FG000|Treatment|Adverse Event|42|||
105939780|NCT00266032|365441231|FG001|Treatment|Adverse Event|26|||
105939781|NCT00266032|365441232|FG002|Treatment|Adverse Event|10|||
105939782|NCT00266032|365441230|FG000|Treatment|Lost to Follow-up|19|||
105939783|NCT00266032|365441231|FG001|Treatment|Lost to Follow-up|4|||
105939784|NCT00266032|365441232|FG002|Treatment|Lost to Follow-up|2|||
105939785|NCT00266032|365441230|FG000|Treatment|Pregnancy|3|||
105737121|NCT00301067|364693363|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
105737122|NCT00301067|364693364|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
105939786|NCT00266032|365441231|FG001|Treatment|Pregnancy|2|||
105939787|NCT00266032|365441232|FG002|Treatment|Pregnancy|2|||
105939788|NCT00266032|365441230|FG000|Treatment|Protocol Violation|6|||
105939789|NCT00266032|365441231|FG001|Treatment|Protocol Violation|14|||
105939790|NCT00266032|365441232|FG002|Treatment|Protocol Violation|13|||
105939791|NCT00266032|365441230|FG000|Treatment|Withdrawal by Subject|28|||
105939792|NCT00266032|365441231|FG001|Treatment|Withdrawal by Subject|13|||
105939793|NCT00266032|365441232|FG002|Treatment|Withdrawal by Subject|12|||
105939794|NCT00266032|365441230|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
105939795|NCT00266032|365441231|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
105939796|NCT00266032|365441232|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
105939797|NCT00266032|365441230|FG000|Open-label Safety Extension|Adverse Event|5|||
105939798|NCT00266032|365441231|FG001|Open-label Safety Extension|Adverse Event|0|||
105737123|NCT00301067|364693365|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
105737124|NCT00301067|364693366|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
105737125|NCT00301067|364693363|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
105737126|NCT00301067|364693364|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
105737127|NCT00301067|364693365|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
105737128|NCT00301067|364693366|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
105737129|NCT00301067|364693363|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
105737130|NCT00301067|364693364|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
105939799|NCT00266032|365441232|FG002|Open-label Safety Extension|Adverse Event|4|||
105939800|NCT00266032|365441230|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
105939801|NCT00266032|365441231|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
105939802|NCT00266032|365441232|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
105939803|NCT00266032|365441230|FG000|Open-label Safety Extension|Pregnancy|4|||
105939804|NCT00266032|365441231|FG001|Open-label Safety Extension|Pregnancy|1|||
105939805|NCT00266032|365441232|FG002|Open-label Safety Extension|Pregnancy|2|||
105939806|NCT00266032|365441230|FG000|Open-label Safety Extension|Protocol Violation|1|||
105737131|NCT00301067|364693365|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
105737132|NCT00301067|364693366|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
105737133|NCT00301067|364693363|FG000|Follow up Until Death|Alive at last data cut point|1|||
105737134|NCT00301067|364693364|FG001|Follow up Until Death|Alive at last data cut point|0|||
105737135|NCT00301067|364693365|FG002|Follow up Until Death|Alive at last data cut point|0|||
105737136|NCT00301067|364693366|FG003|Follow up Until Death|Alive at last data cut point|1|||
105737137|NCT03303339|364693367|FG000|Overall Study|Death|2|||
105939807|NCT00266032|365441231|FG001|Open-label Safety Extension|Protocol Violation|3|||
105939808|NCT00266032|365441232|FG002|Open-label Safety Extension|Protocol Violation|2|||
105939809|NCT00266032|365441230|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
105737138|NCT03303339|364693368|FG001|Overall Study|Death|2|||
105737139|NCT03303339|364693369|FG002|Overall Study|Death|2|||
105737140|NCT03303339|364693370|FG003|Overall Study|Death|1|||
105737141|NCT03303339|364693371|FG004|Overall Study|Death|4|||
105737142|NCT03303339|364693372|FG005|Overall Study|Death|2|||
105737143|NCT03303339|364693373|FG006|Overall Study|Death|2|||
105737144|NCT03303339|364693374|FG007|Overall Study|Death|2|||
105737145|NCT03303339|364693375|FG008|Overall Study|Death|3|||
105799432|NCT01493531|364924578|FG002|Overall Study|Lost to Follow-up|11|||
105799433|NCT01493531|364924576|FG000|Overall Study|Withdrawal by Subject|16|||
105939810|NCT00266032|365441231|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
105939811|NCT00266032|365441232|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
105939812|NCT00266032|365441230|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
105939813|NCT00266032|365441231|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
105939814|NCT00266032|365441232|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
105939815|NCT02605967|365441233|FG000|Overall Study|subject / guardian decision|1|||
105939816|NCT02605967|365441234|FG001|Overall Study|subject / guardian decision|2|||
105939817|NCT02605967|365441233|FG000|Overall Study|Physician Decision|10|||
105939818|NCT02605967|365441234|FG001|Overall Study|Physician Decision|1|||
105939819|NCT02605967|365441233|FG000|Overall Study|Death|4|||
105939820|NCT02605967|365441234|FG001|Overall Study|Death|2|||
105939821|NCT02605967|365441233|FG000|Overall Study|Adverse Event|1|||
105939822|NCT02605967|365441234|FG001|Overall Study|Adverse Event|0|||
105939823|NCT02605967|365441233|FG000|Overall Study|progressive disease|66|||
105939824|NCT02605967|365441234|FG001|Overall Study|progressive disease|35|||
105939825|NCT01903720|365441235|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
105939826|NCT01903720|365441235|FG000|Overall Study|Adverse Event|1|||
105939827|NCT01903720|365441235|FG000|Overall Study|Rescinding of informed consent|2|||
105939828|NCT01903720|365441235|FG000|Overall Study|Lost to Follow-up|2|||
105939829|NCT01903720|365441235|FG000|Overall Study|Treatment with alternative drug|1|||
105939830|NCT03627468|365441236|FG000|Overall Study|Adverse Event|5|||
105939831|NCT03627468|365441237|FG001|Overall Study|Adverse Event|33|||
105939832|NCT03627468|365441236|FG000|Overall Study|Withdrawal by Subject|13|||
105939833|NCT03627468|365441237|FG001|Overall Study|Withdrawal by Subject|23|||
105939834|NCT03627468|365441236|FG000|Overall Study|Physician Decision|1|||
105737146|NCT03303339|364693376|FG009|Overall Study|Death|3|||
105737147|NCT03303339|364693377|FG010|Overall Study|Death|4|||
105737148|NCT03303339|364693378|FG011|Overall Study|Death|24|||
105737149|NCT03303339|364693367|FG000|Overall Study|Study Terminated by Sponsor|0|||
105939835|NCT03627468|365441237|FG001|Overall Study|Physician Decision|0|||
105939836|NCT03627468|365441236|FG000|Overall Study|Protocol Violation|0|||
105939837|NCT03627468|365441237|FG001|Overall Study|Protocol Violation|2|||
105939838|NCT03627468|365441236|FG000|Overall Study|Lost to Follow-up|10|||
105737150|NCT03303339|364693368|FG001|Overall Study|Study Terminated by Sponsor|0|||
105737151|NCT03303339|364693369|FG002|Overall Study|Study Terminated by Sponsor|0|||
105737152|NCT03303339|364693370|FG003|Overall Study|Study Terminated by Sponsor|0|||
105737153|NCT03303339|364693371|FG004|Overall Study|Study Terminated by Sponsor|0|||
105737154|NCT03303339|364693372|FG005|Overall Study|Study Terminated by Sponsor|0|||
105737155|NCT03303339|364693373|FG006|Overall Study|Study Terminated by Sponsor|0|||
105737156|NCT03303339|364693374|FG007|Overall Study|Study Terminated by Sponsor|0|||
105737157|NCT03303339|364693375|FG008|Overall Study|Study Terminated by Sponsor|1|||
105737158|NCT03303339|364693376|FG009|Overall Study|Study Terminated by Sponsor|0|||
105737159|NCT03303339|364693377|FG010|Overall Study|Study Terminated by Sponsor|1|||
105737160|NCT03303339|364693378|FG011|Overall Study|Study Terminated by Sponsor|1|||
105737161|NCT03303339|364693367|FG000|Overall Study|Withdrawal by Subject|1|||
105737162|NCT03303339|364693368|FG001|Overall Study|Withdrawal by Subject|0|||
105737163|NCT03303339|364693369|FG002|Overall Study|Withdrawal by Subject|0|||
105737164|NCT03303339|364693370|FG003|Overall Study|Withdrawal by Subject|0|||
105737165|NCT03303339|364693371|FG004|Overall Study|Withdrawal by Subject|0|||
105737166|NCT03303339|364693372|FG005|Overall Study|Withdrawal by Subject|1|||
105737167|NCT03303339|364693373|FG006|Overall Study|Withdrawal by Subject|1|||
105939839|NCT03627468|365441237|FG001|Overall Study|Lost to Follow-up|16|||
105939840|NCT03627468|365441236|FG000|Overall Study|Death|1|||
105939841|NCT03627468|365441237|FG001|Overall Study|Death|0|||
105939842|NCT03627468|365441236|FG000|Overall Study|Pregnancy|1|||
105939843|NCT03627468|365441237|FG001|Overall Study|Pregnancy|1|||
105939844|NCT03627468|365441236|FG000|Overall Study|Lack of Efficacy|0|||
105939845|NCT03627468|365441237|FG001|Overall Study|Lack of Efficacy|2|||
105939846|NCT03627468|365441236|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
105939847|NCT03627468|365441237|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
105939848|NCT00309946|365441238|FG000|Overall Study|Withdrawal by Subject|1|||
105939849|NCT00619918|365441239|FG000|Overall Study|Withdrawal by Subject|4|||
105939850|NCT00619918|365441240|FG001|Overall Study|Withdrawal by Subject|3|||
105939851|NCT00619918|365441239|FG000|Overall Study|Physician Decision|2|||
105939852|NCT00619918|365441240|FG001|Overall Study|Physician Decision|4|||
105939853|NCT00619918|365441239|FG000|Overall Study|Transfer to outside facility|3|||
105939854|NCT00619918|365441240|FG001|Overall Study|Transfer to outside facility|3|||
105939855|NCT00619918|365441239|FG000|Overall Study|Left before receiving first dose|7|||
105939856|NCT00619918|365441240|FG001|Overall Study|Left before receiving first dose|6|||
105939857|NCT00619918|365441239|FG000|Overall Study|ICU admission|4|||
105939858|NCT00619918|365441240|FG001|Overall Study|ICU admission|6|||
105939859|NCT03411044|365441241|FG000|Overall Study|Death|30|||
105939860|NCT03411044|365441241|FG000|Overall Study|Withdrawal by Subject|48|||
105939861|NCT03411044|365441241|FG000|Overall Study|Lost to Follow-up|78|||
105939862|NCT03411044|365441241|FG000|Overall Study|Adverse Event|30|||
105939863|NCT03411044|365441241|FG000|Overall Study|Missing status|4|||
105939864|NCT03715829|365441242|FG000|Dose Ranging Period|Adverse Event|2|||
105939865|NCT03715829|365441243|FG001|Dose Ranging Period|Adverse Event|4|||
105939866|NCT03715829|365441244|FG002|Dose Ranging Period|Adverse Event|5|||
105939867|NCT03715829|365441245|FG003|Dose Ranging Period|Adverse Event|2|||
105939868|NCT03715829|365441246|FG004|Dose Ranging Period|Adverse Event|3|||
105939869|NCT03715829|365441247|FG005|Dose Ranging Period|Adverse Event|3|||
105939870|NCT03715829|365441248|FG006|Dose Ranging Period|Adverse Event|0|||
105939871|NCT03715829|365441249|FG007|Dose Ranging Period|Adverse Event|0|||
105939872|NCT03715829|365441250|FG008|Dose Ranging Period|Adverse Event|0|||
105939873|NCT03715829|365441251|FG009|Dose Ranging Period|Adverse Event|0|||
105939874|NCT03715829|365441252|FG010|Dose Ranging Period|Adverse Event|0|||
105939875|NCT03715829|365441242|FG000|Dose Ranging Period|Lack of Efficacy|0|||
105939876|NCT03715829|365441243|FG001|Dose Ranging Period|Lack of Efficacy|1|||
105939877|NCT03715829|365441244|FG002|Dose Ranging Period|Lack of Efficacy|0|||
105939878|NCT03715829|365441245|FG003|Dose Ranging Period|Lack of Efficacy|1|||
105939879|NCT03715829|365441246|FG004|Dose Ranging Period|Lack of Efficacy|0|||
105939880|NCT03715829|365441247|FG005|Dose Ranging Period|Lack of Efficacy|0|||
105939881|NCT03715829|365441248|FG006|Dose Ranging Period|Lack of Efficacy|0|||
105737168|NCT03303339|364693374|FG007|Overall Study|Withdrawal by Subject|0|||
105737169|NCT03303339|364693375|FG008|Overall Study|Withdrawal by Subject|0|||
105939882|NCT03715829|365441249|FG007|Dose Ranging Period|Lack of Efficacy|0|||
105939883|NCT03715829|365441250|FG008|Dose Ranging Period|Lack of Efficacy|0|||
105737170|NCT03303339|364693376|FG009|Overall Study|Withdrawal by Subject|0|||
105939884|NCT03715829|365441251|FG009|Dose Ranging Period|Lack of Efficacy|0|||
105939885|NCT03715829|365441252|FG010|Dose Ranging Period|Lack of Efficacy|0|||
105939886|NCT03715829|365441242|FG000|Dose Ranging Period|Lost to Follow-up|2|||
105939887|NCT03715829|365441243|FG001|Dose Ranging Period|Lost to Follow-up|0|||
105737171|NCT03303339|364693377|FG010|Overall Study|Withdrawal by Subject|0|||
105737172|NCT03303339|364693378|FG011|Overall Study|Withdrawal by Subject|2|||
105939888|NCT03715829|365441244|FG002|Dose Ranging Period|Lost to Follow-up|1|||
105939889|NCT03715829|365441245|FG003|Dose Ranging Period|Lost to Follow-up|1|||
105939890|NCT03715829|365441246|FG004|Dose Ranging Period|Lost to Follow-up|1|||
105939891|NCT03715829|365441247|FG005|Dose Ranging Period|Lost to Follow-up|2|||
105939892|NCT03715829|365441248|FG006|Dose Ranging Period|Lost to Follow-up|0|||
105737173|NCT03303339|364693367|FG000|Overall Study|Physician Decision|0|||
105737174|NCT03303339|364693368|FG001|Overall Study|Physician Decision|0|||
105737175|NCT03303339|364693369|FG002|Overall Study|Physician Decision|0|||
105737176|NCT03303339|364693370|FG003|Overall Study|Physician Decision|0|||
105737177|NCT03303339|364693371|FG004|Overall Study|Physician Decision|1|||
105737178|NCT03303339|364693372|FG005|Overall Study|Physician Decision|0|||
105737179|NCT03303339|364693373|FG006|Overall Study|Physician Decision|0|||
105737180|NCT03303339|364693374|FG007|Overall Study|Physician Decision|0|||
105737181|NCT03303339|364693375|FG008|Overall Study|Physician Decision|0|||
105737182|NCT03303339|364693376|FG009|Overall Study|Physician Decision|0|||
105737183|NCT03303339|364693377|FG010|Overall Study|Physician Decision|0|||
105737184|NCT03303339|364693378|FG011|Overall Study|Physician Decision|0|||
105737185|NCT03303339|364693367|FG000|Overall Study|Safety/Non-compliance|0|||
105737186|NCT03303339|364693368|FG001|Overall Study|Safety/Non-compliance|0|||
105737187|NCT03303339|364693369|FG002|Overall Study|Safety/Non-compliance|0|||
105737188|NCT03303339|364693370|FG003|Overall Study|Safety/Non-compliance|0|||
105737189|NCT03303339|364693371|FG004|Overall Study|Safety/Non-compliance|0|||
105737190|NCT03303339|364693372|FG005|Overall Study|Safety/Non-compliance|0|||
105737191|NCT03303339|364693373|FG006|Overall Study|Safety/Non-compliance|0|||
105737192|NCT03303339|364693374|FG007|Overall Study|Safety/Non-compliance|0|||
105737193|NCT03303339|364693375|FG008|Overall Study|Safety/Non-compliance|0|||
105737194|NCT03303339|364693376|FG009|Overall Study|Safety/Non-compliance|0|||
105737195|NCT03303339|364693377|FG010|Overall Study|Safety/Non-compliance|0|||
105737196|NCT03303339|364693378|FG011|Overall Study|Safety/Non-compliance|1|||
106011566|NCT02121535|365710360|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
106011567|NCT00091949|365710361|FG000|Overall Study|Withdrawal by Subject|117|||
106011568|NCT00091949|365710362|FG001|Overall Study|Withdrawal by Subject|110|||
106011569|NCT00091949|365710361|FG000|Overall Study|Lost to Follow-up|58|||
106011570|NCT00091949|365710362|FG001|Overall Study|Lost to Follow-up|41|||
106011571|NCT01520506|365710363|FG000|Overall Study|Missed Visit|4|||
106011572|NCT01520506|365710363|FG000|Overall Study|Lost to Follow-up|1|||
106011573|NCT01520506|365710363|FG000|Overall Study|Withdrawal by Subject|1|||
106011574|NCT01256788|365710364|FG000|Overall Study|Lost to Follow-up|5|||
106011575|NCT01256788|365710365|FG001|Overall Study|Lost to Follow-up|8|||
106011576|NCT01256788|365710366|FG002|Overall Study|Lost to Follow-up|3|||
106011577|NCT02083354|365710367|FG000|Overall Study|Withdrawal by Subject|9|||
106011578|NCT02083354|365710367|FG000|Overall Study|Lost to Follow-up|1|||
106011579|NCT02083354|365710367|FG000|Overall Study|Adverse Event|3|||
106011580|NCT02083354|365710367|FG000|Overall Study|Disease progression|46|||
106011581|NCT02083354|365710367|FG000|Overall Study|Study closed/terminated|5|||
106011582|NCT03312634|365710368|FG000|Overall Study|Adverse Event|11|||
106011583|NCT03312634|365710369|FG001|Overall Study|Adverse Event|0|||
106011584|NCT03312634|365710368|FG000|Overall Study|Sponsor request|2|||
106011585|NCT03312634|365710369|FG001|Overall Study|Sponsor request|0|||
106011586|NCT03312634|365710368|FG000|Overall Study|Withdrawal by Subject|31|||
106011587|NCT03312634|365710369|FG001|Overall Study|Withdrawal by Subject|9|||
106011588|NCT03312634|365710368|FG000|Overall Study|Enrolled in an interventional study|0|||
106011589|NCT03312634|365710369|FG001|Overall Study|Enrolled in an interventional study|52|||
106011590|NCT03312634|365710368|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
106011591|NCT03312634|365710369|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
106011592|NCT03312634|365710368|FG000|Overall Study|Death|0|||
106011593|NCT03312634|365710369|FG001|Overall Study|Death|1|||
106011594|NCT03312634|365710368|FG000|Overall Study|Non-compliance|0|||
105737197|NCT00149825|364693379|FG000|Overall Study|Intolerance to medication side effects|1|||
105737198|NCT00149825|364693380|FG001|Overall Study|Intolerance to medication side effects|2|||
105737199|NCT00149825|364693379|FG000|Overall Study|Time commitments|2|||
105737200|NCT00149825|364693380|FG001|Overall Study|Time commitments|1|||
105737201|NCT00149825|364693379|FG000|Overall Study|Not liking insomnia therapy|1|||
105737202|NCT00149825|364693380|FG001|Overall Study|Not liking insomnia therapy|0|||
105737203|NCT00149825|364693379|FG000|Overall Study|Other|1|||
106011595|NCT03312634|365710369|FG001|Overall Study|Non-compliance|2|||
106011596|NCT03312634|365710368|FG000|Overall Study|Lost to Follow-up|0|||
106011597|NCT03312634|365710369|FG001|Overall Study|Lost to Follow-up|1|||
105737204|NCT00149825|364693380|FG001|Overall Study|Other|0|||
105737205|NCT01359982|364693381|FG000|Overall Study|Adverse Event|2|||
105737206|NCT01359982|364693382|FG001|Overall Study|Adverse Event|0|||
105737207|NCT01359982|364693383|FG002|Overall Study|Adverse Event|0|||
106011598|NCT03312634|365710368|FG000|Overall Study|Enrolled into non-interventional study|0|||
106011599|NCT03312634|365710369|FG001|Overall Study|Enrolled into non-interventional study|5|||
106011600|NCT03312634|365710368|FG000|Overall Study|Worsening clinical condition|0|||
105737208|NCT01359982|364693384|FG003|Overall Study|Adverse Event|1|||
106011601|NCT03312634|365710369|FG001|Overall Study|Worsening clinical condition|1|||
105737209|NCT01359982|364693385|FG004|Overall Study|Adverse Event|0|||
105737210|NCT01359982|364693386|FG005|Overall Study|Adverse Event|0|||
105737211|NCT01359982|364693381|FG000|Overall Study|Death|1|||
105737212|NCT01359982|364693382|FG001|Overall Study|Death|0|||
105737213|NCT01359982|364693383|FG002|Overall Study|Death|0|||
105737214|NCT01359982|364693384|FG003|Overall Study|Death|0|||
106011602|NCT03312634|365710368|FG000|Overall Study|Participant did not want to travel|0|||
106011603|NCT03312634|365710369|FG001|Overall Study|Participant did not want to travel|1|||
106011604|NCT03312634|365710368|FG000|Overall Study|Physician Decision|1|||
106011605|NCT03312634|365710369|FG001|Overall Study|Physician Decision|0|||
106011606|NCT03312634|365710368|FG000|Overall Study|Other|13|||
106011607|NCT03312634|365710369|FG001|Overall Study|Other|0|||
106011608|NCT05366738|365710370|FG000|Overall Study|Adverse Event|0|||
106011609|NCT05366738|365710371|FG001|Overall Study|Adverse Event|1|||
106011610|NCT05366738|365710372|FG002|Overall Study|Adverse Event|0|||
106011611|NCT00755183|365710379|FG000|Overall Study|Adverse Event|5|||
106011612|NCT00755183|365710380|FG001|Overall Study|Adverse Event|2|||
106011613|NCT00755183|365710379|FG000|Overall Study|Protocol Violation|0|||
106011614|NCT00755183|365710380|FG001|Overall Study|Protocol Violation|1|||
106011615|NCT00755183|365710379|FG000|Overall Study|Withdrawal by Subject|0|||
106011616|NCT00755183|365710380|FG001|Overall Study|Withdrawal by Subject|2|||
106011617|NCT00755183|365710379|FG000|Overall Study|Administrative|2|||
106011618|NCT00755183|365710380|FG001|Overall Study|Administrative|1|||
106011619|NCT00535496|365710381|FG000|Overall Study|Lost to Follow-up|0|||
106011620|NCT00535496|365710382|FG001|Overall Study|Lost to Follow-up|1|||
106011621|NCT00535496|365710383|FG002|Overall Study|Lost to Follow-up|0|||
106011622|NCT00535496|365710384|FG003|Overall Study|Lost to Follow-up|0|||
106011623|NCT00535496|365710381|FG000|Overall Study|Not treated with sugammadex|0|||
106011624|NCT00535496|365710382|FG001|Overall Study|Not treated with sugammadex|1|||
106011625|NCT00535496|365710383|FG002|Overall Study|Not treated with sugammadex|0|||
106011626|NCT00535496|365710384|FG003|Overall Study|Not treated with sugammadex|0|||
106011627|NCT05024032|365710385|FG000|Overall Study|Withdrawal by Subject|0|||
106011628|NCT05024032|365710386|FG001|Overall Study|Withdrawal by Subject|3|||
106011629|NCT05024032|365710387|FG002|Overall Study|Withdrawal by Subject|4|||
106011630|NCT05024032|365710385|FG000|Overall Study|Adverse Event|0|||
106011631|NCT05024032|365710386|FG001|Overall Study|Adverse Event|1|||
106011632|NCT05024032|365710387|FG002|Overall Study|Adverse Event|0|||
106011633|NCT05024032|365710385|FG000|Overall Study|Protocol Deviation|1|||
106011634|NCT05024032|365710386|FG001|Overall Study|Protocol Deviation|0|||
106011635|NCT05024032|365710387|FG002|Overall Study|Protocol Deviation|0|||
106011636|NCT02066181|365710388|FG000|Overall Study|Withdrawal by Subject|1|||
106011637|NCT02066181|365710389|FG001|Overall Study|Withdrawal by Subject|1|||
106011638|NCT02851615|365710392|FG000|Overall Study|Cognitive Issue|1|||
106011639|NCT02851615|365710393|FG001|Overall Study|Cognitive Issue|0|||
106011640|NCT02851615|365710392|FG000|Overall Study|Lost to Follow-up|0|||
106011641|NCT02851615|365710393|FG001|Overall Study|Lost to Follow-up|4|||
106011642|NCT00313014|365710394|FG000|Overall Study|Withdrawal by Subject|11|||
106011643|NCT00313014|365710395|FG001|Overall Study|Withdrawal by Subject|7|||
106011644|NCT00313014|365710396|FG002|Overall Study|Withdrawal by Subject|5|||
105737215|NCT01359982|364693385|FG004|Overall Study|Death|0|||
105737216|NCT01359982|364693386|FG005|Overall Study|Death|0|||
105737217|NCT00465738|364693398|FG000|Overall Study|Lost to Follow-up|2|||
105737218|NCT00465738|364693399|FG001|Overall Study|Lost to Follow-up|0|||
105737219|NCT00465738|364693398|FG000|Overall Study|Adverse Event|0|||
105737220|NCT00465738|364693399|FG001|Overall Study|Adverse Event|1|||
105737221|NCT00465738|364693398|FG000|Overall Study|Withdrawal by Subject|2|||
105737222|NCT00465738|364693399|FG001|Overall Study|Withdrawal by Subject|0|||
105939893|NCT03715829|365441249|FG007|Dose Ranging Period|Lost to Follow-up|0|||
105939894|NCT03715829|365441250|FG008|Dose Ranging Period|Lost to Follow-up|0|||
105939895|NCT03715829|365441251|FG009|Dose Ranging Period|Lost to Follow-up|0|||
105939896|NCT03715829|365441252|FG010|Dose Ranging Period|Lost to Follow-up|0|||
105939897|NCT03715829|365441242|FG000|Dose Ranging Period|Protocol Violation|0|||
105939898|NCT03715829|365441243|FG001|Dose Ranging Period|Protocol Violation|0|||
105939899|NCT03715829|365441244|FG002|Dose Ranging Period|Protocol Violation|0|||
105939900|NCT03715829|365441245|FG003|Dose Ranging Period|Protocol Violation|1|||
105939901|NCT03715829|365441246|FG004|Dose Ranging Period|Protocol Violation|0|||
105939902|NCT03715829|365441247|FG005|Dose Ranging Period|Protocol Violation|0|||
105939903|NCT03715829|365441248|FG006|Dose Ranging Period|Protocol Violation|0|||
105939904|NCT03715829|365441249|FG007|Dose Ranging Period|Protocol Violation|0|||
105939905|NCT03715829|365441250|FG008|Dose Ranging Period|Protocol Violation|0|||
105939906|NCT03715829|365441251|FG009|Dose Ranging Period|Protocol Violation|0|||
105939907|NCT03715829|365441252|FG010|Dose Ranging Period|Protocol Violation|0|||
105939908|NCT03715829|365441242|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
105939909|NCT03715829|365441243|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
105939910|NCT03715829|365441244|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
105939911|NCT03715829|365441245|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
105939912|NCT03715829|365441246|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
106011645|NCT00313014|365710394|FG000|Overall Study|Adverse Event|14|||
106011646|NCT00313014|365710395|FG001|Overall Study|Adverse Event|29|||
106011647|NCT00313014|365710396|FG002|Overall Study|Adverse Event|16|||
106011648|NCT00313014|365710394|FG000|Overall Study|Lost to Follow-up|7|||
105939913|NCT03715829|365441247|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
105939914|NCT03715829|365441248|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
105939915|NCT03715829|365441249|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
105799434|NCT01493531|364924577|FG001|Overall Study|Withdrawal by Subject|13|||
105799435|NCT01493531|364924578|FG002|Overall Study|Withdrawal by Subject|11|||
105799436|NCT01493531|364924576|FG000|Overall Study|Death|0|||
105799437|NCT01493531|364924577|FG001|Overall Study|Death|1|||
105799438|NCT01493531|364924578|FG002|Overall Study|Death|0|||
106011649|NCT00313014|365710395|FG001|Overall Study|Lost to Follow-up|6|||
106011650|NCT00313014|365710396|FG002|Overall Study|Lost to Follow-up|10|||
106011651|NCT00313014|365710394|FG000|Overall Study|Administrative|9|||
106011652|NCT00313014|365710395|FG001|Overall Study|Administrative|6|||
106011653|NCT00313014|365710396|FG002|Overall Study|Administrative|14|||
106011654|NCT00313014|365710394|FG000|Overall Study|Lack of Efficacy|52|||
106011655|NCT00313014|365710395|FG001|Overall Study|Lack of Efficacy|25|||
106011656|NCT00313014|365710396|FG002|Overall Study|Lack of Efficacy|16|||
106011657|NCT02141295|365710400|FG000|Overall Study|Adverse Event|1|||
106011658|NCT02141295|365710401|FG001|Overall Study|Adverse Event|18|||
106011659|NCT02141295|365710402|FG002|Overall Study|Adverse Event|11|||
106011660|NCT02141295|365710400|FG000|Overall Study|Physician Decision|2|||
106011661|NCT02141295|365710401|FG001|Overall Study|Physician Decision|19|||
106011662|NCT02141295|365710402|FG002|Overall Study|Physician Decision|14|||
106011663|NCT02141295|365710400|FG000|Overall Study|Study terminated by sponsor|0|||
106011664|NCT02141295|365710401|FG001|Overall Study|Study terminated by sponsor|6|||
106011665|NCT02141295|365710402|FG002|Overall Study|Study terminated by sponsor|6|||
106011666|NCT02141295|365710400|FG000|Overall Study|Non-compliance|0|||
106011667|NCT02141295|365710401|FG001|Overall Study|Non-compliance|1|||
106011668|NCT02141295|365710402|FG002|Overall Study|Non-compliance|0|||
106011669|NCT02141295|365710400|FG000|Overall Study|Progressive disease|3|||
106011670|NCT02141295|365710401|FG001|Overall Study|Progressive disease|32|||
106011671|NCT02141295|365710402|FG002|Overall Study|Progressive disease|50|||
106011672|NCT02141295|365710400|FG000|Overall Study|Reason not specified|0|||
106011673|NCT02141295|365710401|FG001|Overall Study|Reason not specified|9|||
106011674|NCT02141295|365710402|FG002|Overall Study|Reason not specified|10|||
106011675|NCT02141295|365710400|FG000|Overall Study|Withdrawal by Subject|0|||
105799439|NCT01825876|364924581|FG000|Period 2|Withdrawal by Subject|0|||
105799440|NCT01825876|364924582|FG001|Period 2|Withdrawal by Subject|1|||
106011676|NCT02141295|365710401|FG001|Overall Study|Withdrawal by Subject|9|||
106140557|NCT00612586|366172573|FG000|Overall Study|Withdrawal by Subject|7|||
106140558|NCT00612586|366172574|FG001|Overall Study|Withdrawal by Subject|9|||
105737223|NCT00465738|364693398|FG000|Overall Study|Other|2|||
105737224|NCT00465738|364693399|FG001|Overall Study|Other|5|||
105737225|NCT01618656|364693404|FG000|Overall Study|Withdrawal by Subject|7|||
105737226|NCT01618656|364693405|FG001|Overall Study|Withdrawal by Subject|3|||
105737227|NCT01618656|364693404|FG000|Overall Study|Physician Decision|1|||
105737228|NCT01618656|364693405|FG001|Overall Study|Physician Decision|1|||
105737229|NCT01276847|364693406|FG000|Overall Study|Withdrawal by Subject|1|||
105737230|NCT01276847|364693407|FG001|Overall Study|Withdrawal by Subject|0|||
105737231|NCT01276847|364693408|FG002|Overall Study|Withdrawal by Subject|0|||
105737232|NCT01696877|364693409|FG000|Overall Study|Adverse Event|0|||
105737233|NCT01696877|364693410|FG001|Overall Study|Adverse Event|1|||
105737234|NCT01863758|364693411|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
105737235|NCT01863758|364693411|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
105737236|NCT02961764|364693412|FG000|Overall Study|Protocol Violation|0|||
105737237|NCT02961764|364693413|FG001|Overall Study|Protocol Violation|1|||
105737238|NCT02961764|364693412|FG000|Overall Study|Death|2|||
105737239|NCT02961764|364693413|FG001|Overall Study|Death|0|||
105737240|NCT02961764|364693412|FG000|Overall Study|Lost to Follow-up|35|||
105737241|NCT02961764|364693413|FG001|Overall Study|Lost to Follow-up|24|||
105737242|NCT02961764|364693412|FG000|Overall Study|Withdrawal by Subject|2|||
105737243|NCT02961764|364693413|FG001|Overall Study|Withdrawal by Subject|0|||
105737244|NCT00751881|364693414|FG000|Core Treatment Period|Not treated|1|||
105737245|NCT00751881|364693415|FG001|Core Treatment Period|Not treated|1|||
105737246|NCT00751881|364693416|FG002|Core Treatment Period|Not treated|2|||
105737247|NCT00751881|364693414|FG000|Core Treatment Period|Adverse Event|26|||
105737248|NCT00751881|364693415|FG001|Core Treatment Period|Adverse Event|54|||
105737249|NCT00751881|364693416|FG002|Core Treatment Period|Adverse Event|58|||
105737250|NCT00751881|364693414|FG000|Core Treatment Period|Lack of Efficacy|37|||
105737251|NCT00751881|364693415|FG001|Core Treatment Period|Lack of Efficacy|30|||
105737252|NCT00751881|364693416|FG002|Core Treatment Period|Lack of Efficacy|20|||
105737253|NCT00751881|364693414|FG000|Core Treatment Period|Poor compliance to protocol|15|||
105737254|NCT00751881|364693415|FG001|Core Treatment Period|Poor compliance to protocol|3|||
105799441|NCT01205529|364924583|FG000|Overall Study|Procedure Cancelled|4|||
106011677|NCT02141295|365710402|FG002|Overall Study|Withdrawal by Subject|4|||
106011678|NCT02345070|365710404|FG000|Overall Study|Adverse Event|12|||
106011679|NCT02345070|365710405|FG001|Overall Study|Adverse Event|8|||
106011680|NCT02345070|365710406|FG002|Overall Study|Adverse Event|16|||
106011681|NCT02345070|365710404|FG000|Overall Study|Poor compliance to protocol|2|||
106011682|NCT02345070|365710405|FG001|Overall Study|Poor compliance to protocol|0|||
106011683|NCT02345070|365710406|FG002|Overall Study|Poor compliance to protocol|0|||
106011684|NCT02345070|365710404|FG000|Overall Study|Other than specified above|6|||
106140559|NCT00612586|366172573|FG000|Overall Study|Physician Decision|1|||
106140560|NCT00612586|366172574|FG001|Overall Study|Physician Decision|2|||
106140561|NCT00612586|366172573|FG000|Overall Study|Sponsor Decision|1|||
106140562|NCT00612586|366172574|FG001|Overall Study|Sponsor Decision|1|||
106140563|NCT00612586|366172573|FG000|Overall Study|Progressive Disease|26|||
106140564|NCT00612586|366172574|FG001|Overall Study|Progressive Disease|24|||
106140565|NCT00612586|366172573|FG000|Overall Study|Randomized and Not Treated|1|||
106140566|NCT00612586|366172574|FG001|Overall Study|Randomized and Not Treated|1|||
106140567|NCT00949975|366172580|FG000|Overall Study|Voluntary discontinuation|6|||
106140568|NCT00949975|366172581|FG001|Overall Study|Voluntary discontinuation|5|||
106140569|NCT00949975|366172582|FG002|Overall Study|Voluntary discontinuation|3|||
106140570|NCT00949975|366172583|FG003|Overall Study|Voluntary discontinuation|6|||
106140571|NCT00949975|366172580|FG000|Overall Study|Adverse Event|11|||
106140572|NCT00949975|366172581|FG001|Overall Study|Adverse Event|11|||
106140573|NCT00949975|366172582|FG002|Overall Study|Adverse Event|10|||
106140574|NCT00949975|366172583|FG003|Overall Study|Adverse Event|10|||
106140575|NCT00949975|366172580|FG000|Overall Study|Safety reason|0|||
106140576|NCT00949975|366172581|FG001|Overall Study|Safety reason|1|||
106140577|NCT00949975|366172582|FG002|Overall Study|Safety reason|0|||
106140578|NCT00949975|366172583|FG003|Overall Study|Safety reason|0|||
106140579|NCT00949975|366172580|FG000|Overall Study|Study-specific criteria|0|||
106140580|NCT00949975|366172581|FG001|Overall Study|Study-specific criteria|1|||
106140581|NCT00949975|366172582|FG002|Overall Study|Study-specific criteria|1|||
106140582|NCT00949975|366172583|FG003|Overall Study|Study-specific criteria|0|||
106140583|NCT00949975|366172580|FG000|Overall Study|Incorrect enrolment|5|||
106140584|NCT00949975|366172581|FG001|Overall Study|Incorrect enrolment|10|||
106140585|NCT00949975|366172582|FG002|Overall Study|Incorrect enrolment|4|||
106140586|NCT00949975|366172583|FG003|Overall Study|Incorrect enrolment|7|||
106140587|NCT00949975|366172580|FG000|Overall Study|Severe non-compliance|3|||
106140588|NCT00949975|366172581|FG001|Overall Study|Severe non-compliance|1|||
106140589|NCT00949975|366172582|FG002|Overall Study|Severe non-compliance|0|||
106140590|NCT00949975|366172583|FG003|Overall Study|Severe non-compliance|2|||
106140591|NCT00949975|366172580|FG000|Overall Study|Lost to Follow-up|1|||
106140592|NCT00949975|366172581|FG001|Overall Study|Lost to Follow-up|0|||
106140593|NCT00949975|366172582|FG002|Overall Study|Lost to Follow-up|1|||
105737255|NCT00751881|364693416|FG002|Core Treatment Period|Poor compliance to protocol|4|||
105737256|NCT00751881|364693414|FG000|Core Treatment Period|Lost to Follow-up|6|||
105737257|NCT00751881|364693415|FG001|Core Treatment Period|Lost to Follow-up|4|||
105737258|NCT00751881|364693416|FG002|Core Treatment Period|Lost to Follow-up|3|||
105737259|NCT00751881|364693414|FG000|Core Treatment Period|Other: protocol deviation|3|||
105737260|NCT00751881|364693415|FG001|Core Treatment Period|Other: protocol deviation|3|||
105737261|NCT00751881|364693416|FG002|Core Treatment Period|Other: protocol deviation|7|||
105737262|NCT00751881|364693414|FG000|Core Treatment Period|Other: wish to parent|5|||
105737263|NCT00751881|364693415|FG001|Core Treatment Period|Other: wish to parent|7|||
105737264|NCT00751881|364693416|FG002|Core Treatment Period|Other: wish to parent|4|||
105737265|NCT00751881|364693414|FG000|Core Treatment Period|Other: personal/family constraints|6|||
105737266|NCT00751881|364693415|FG001|Core Treatment Period|Other: personal/family constraints|7|||
105737267|NCT00751881|364693416|FG002|Core Treatment Period|Other: personal/family constraints|10|||
105737268|NCT00751881|364693414|FG000|Core Treatment Period|Other: MS treatment change|6|||
105737269|NCT00751881|364693415|FG001|Core Treatment Period|Other: MS treatment change|4|||
105737270|NCT00751881|364693416|FG002|Core Treatment Period|Other: MS treatment change|4|||
105737271|NCT00751881|364693414|FG000|Core Treatment Period|Other: tolerability complaints|2|||
105737272|NCT00751881|364693415|FG001|Core Treatment Period|Other: tolerability complaints|0|||
105737273|NCT00751881|364693416|FG002|Core Treatment Period|Other: tolerability complaints|0|||
105737274|NCT00751881|364693414|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
105737275|NCT00751881|364693415|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
105737276|NCT00751881|364693416|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
105737277|NCT00751881|364693414|FG000|Extension Study Period|Adverse Event|18|||
105737278|NCT00751881|364693415|FG001|Extension Study Period|Adverse Event|20|||
105737279|NCT00751881|364693416|FG002|Extension Study Period|Adverse Event|21|||
105737280|NCT00751881|364693414|FG000|Extension Study Period|Lack of Efficacy|14|||
105737281|NCT00751881|364693415|FG001|Extension Study Period|Lack of Efficacy|10|||
105737282|NCT00751881|364693416|FG002|Extension Study Period|Lack of Efficacy|20|||
105737283|NCT00751881|364693414|FG000|Extension Study Period|Lost to Follow-up|4|||
105939916|NCT03715829|365441250|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
106140594|NCT00949975|366172583|FG003|Overall Study|Lost to Follow-up|3|||
106140595|NCT00949975|366172580|FG000|Overall Study|Other|1|||
106140596|NCT00949975|366172581|FG001|Overall Study|Other|0|||
106140597|NCT00949975|366172582|FG002|Overall Study|Other|0|||
106140598|NCT00949975|366172583|FG003|Overall Study|Other|0|||
106140599|NCT02873754|366172584|FG000|Overall Study|Lost to Follow-up|5|||
106140600|NCT02873754|366172584|FG000|Overall Study|Couldn't complete study procedures|1|||
106140601|NCT00410124|366172597|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
105737284|NCT00751881|364693415|FG001|Extension Study Period|Lost to Follow-up|9|||
105952130|NCT03314935|365488196|FG012|Phase 1|Lost to Follow-up|0|||
106011685|NCT02345070|365710405|FG001|Overall Study|Other than specified above|3|||
106011686|NCT02345070|365710406|FG002|Overall Study|Other than specified above|7|||
106011687|NCT01710501|365710407|FG000|Overall Study|Lost to Follow-up|2|||
106011688|NCT01710501|365710408|FG001|Overall Study|Lost to Follow-up|0|||
106011689|NCT01710501|365710409|FG002|Overall Study|Lost to Follow-up|0|||
106011690|NCT01389596|365710412|FG000|Overall Study|Protocol Violation|3|||
106011691|NCT01389596|365710413|FG001|Overall Study|Protocol Violation|4|||
106011692|NCT01389596|365710414|FG002|Overall Study|Protocol Violation|3|||
106011693|NCT01389596|365710412|FG000|Overall Study|Withdrawal by Subject|1|||
106011694|NCT01389596|365710413|FG001|Overall Study|Withdrawal by Subject|2|||
106011695|NCT01389596|365710414|FG002|Overall Study|Withdrawal by Subject|2|||
106011696|NCT01389596|365710412|FG000|Overall Study|Insufficient Clinical Response|3|||
106011697|NCT01389596|365710413|FG001|Overall Study|Insufficient Clinical Response|4|||
106011698|NCT01389596|365710414|FG002|Overall Study|Insufficient Clinical Response|5|||
106011699|NCT01389596|365710412|FG000|Overall Study|Adverse Event|1|||
106011700|NCT01389596|365710413|FG001|Overall Study|Adverse Event|4|||
106011701|NCT01389596|365710414|FG002|Overall Study|Adverse Event|0|||
106011702|NCT01389596|365710412|FG000|Overall Study|Death|0|||
106011703|NCT01389596|365710413|FG001|Overall Study|Death|1|||
106011704|NCT01389596|365710414|FG002|Overall Study|Death|0|||
106011705|NCT01389596|365710412|FG000|Overall Study|Other Unspecified|2|||
106011706|NCT01389596|365710413|FG001|Overall Study|Other Unspecified|1|||
106011707|NCT01389596|365710414|FG002|Overall Study|Other Unspecified|0|||
106011708|NCT01709084|365710415|FG000|Overall Study|Lost to Follow-up|4|||
106011709|NCT01709084|365710416|FG001|Overall Study|Lost to Follow-up|7|||
106011710|NCT01709084|365710415|FG000|Overall Study|Withdrawal by Subject|2|||
106011711|NCT01709084|365710416|FG001|Overall Study|Withdrawal by Subject|2|||
106011712|NCT01709084|365710415|FG000|Overall Study|Adverse Event|5|||
106011713|NCT01709084|365710416|FG001|Overall Study|Adverse Event|0|||
106011714|NCT01709084|365710415|FG000|Overall Study|Other|5|||
106011715|NCT01709084|365710416|FG001|Overall Study|Other|3|||
106011716|NCT01709084|365710415|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
106011717|NCT01709084|365710416|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
106011718|NCT01709084|365710415|FG000|Overall Study|Not Treated|0|||
106011719|NCT01709084|365710416|FG001|Overall Study|Not Treated|2|||
106011720|NCT01281124|365710423|FG000|Overall Study|Death|1|||
106011721|NCT01285323|365710426|FG000|Overall Study|Adverse Event|9|||
106011722|NCT01285323|365710427|FG001|Overall Study|Adverse Event|8|||
106011723|NCT01285323|365710426|FG000|Overall Study|Lack of Efficacy|4|||
106011724|NCT01285323|365710427|FG001|Overall Study|Lack of Efficacy|2|||
106011725|NCT01285323|365710426|FG000|Overall Study|Withdrawal by Subject|15|||
106011726|NCT01285323|365710427|FG001|Overall Study|Withdrawal by Subject|11|||
106011727|NCT01285323|365710426|FG000|Overall Study|Protocol Violation|1|||
106011728|NCT01285323|365710427|FG001|Overall Study|Protocol Violation|2|||
106011729|NCT01285323|365710426|FG000|Overall Study|Non-compliance with study procedures|2|||
106011730|NCT01285323|365710427|FG001|Overall Study|Non-compliance with study procedures|3|||
106011731|NCT01285323|365710426|FG000|Overall Study|Lost to Follow-up|1|||
106011732|NCT01285323|365710427|FG001|Overall Study|Lost to Follow-up|1|||
106011733|NCT01285323|365710426|FG000|Overall Study|Other|1|||
106011734|NCT01285323|365710427|FG001|Overall Study|Other|3|||
106011735|NCT02161016|365710428|FG000|Overall Study|withdrawn by IRB|1|||
106011736|NCT00003475|365710429|FG000|Overall Study|Not evaluable|13|||
106011737|NCT03818321|365710432|FG000|Overall Study|Withdrawal by Subject|1|||
106011738|NCT03818321|365710433|FG001|Overall Study|Withdrawal by Subject|2|||
106011739|NCT03345784|365710434|FG000|Overall Study|Withdrawal by Subject|2|||
106011740|NCT03345784|365710435|FG001|Overall Study|Withdrawal by Subject|1|||
106011741|NCT00929695|365710444|FG000|Overall Study|Death|2|||
106011742|NCT00929695|365710445|FG001|Overall Study|Death|1|||
106011743|NCT00929695|365710444|FG000|Overall Study|Withdrawal by Subject|0|||
106011744|NCT00929695|365710445|FG001|Overall Study|Withdrawal by Subject|2|||
106011745|NCT00929695|365710444|FG000|Overall Study|discharge home|4|||
106011746|NCT00929695|365710445|FG001|Overall Study|discharge home|3|||
106011747|NCT00929695|365710444|FG000|Overall Study|incorrect stratification|2|||
106011748|NCT00929695|365710445|FG001|Overall Study|incorrect stratification|0|||
106011749|NCT00389610|365710446|FG000|Overall Study|Disease Progression|0|||
106011750|NCT00389610|365710447|FG001|Overall Study|Disease Progression|19|||
106011751|NCT00389610|365710446|FG000|Overall Study|Death|0|||
106011752|NCT00389610|365710447|FG001|Overall Study|Death|1|||
106011753|NCT00389610|365710446|FG000|Overall Study|Physician Decision|0|||
106011754|NCT00389610|365710447|FG001|Overall Study|Physician Decision|1|||
106011755|NCT00389610|365710446|FG000|Overall Study|Withdrawal by Subject|0|||
106011756|NCT00389610|365710447|FG001|Overall Study|Withdrawal by Subject|1|||
106011757|NCT00887809|365710448|FG000|Overall Study|Patient Not Treated|3|||
106011758|NCT00887809|365710449|FG001|Overall Study|Patient Not Treated|0|||
106011759|NCT00887809|365710448|FG000|Overall Study|Death|1|||
106011760|NCT00887809|365710449|FG001|Overall Study|Death|0|||
106011761|NCT02000440|365710450|FG000|Overall Study|Adverse Event|3|||
106011762|NCT02000440|365710450|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
106011763|NCT01690143|365710453|FG000|Overall Study|Withdrawal by Subject|1|||
105737285|NCT00751881|364693416|FG002|Extension Study Period|Lost to Follow-up|6|||
105737286|NCT00751881|364693414|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
105737287|NCT00751881|364693415|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
105737288|NCT00751881|364693416|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
105737289|NCT00751881|364693414|FG000|Extension Study Period|Other than specified above|26|||
105737290|NCT00751881|364693415|FG001|Extension Study Period|Other than specified above|30|||
105737291|NCT00751881|364693416|FG002|Extension Study Period|Other than specified above|18|||
105737292|NCT01422304|364693419|FG000|Overall Study|Adverse Event|0|||
105737293|NCT01422304|364693420|FG001|Overall Study|Adverse Event|1|||
105737294|NCT01422304|364693419|FG000|Overall Study|Lost to Follow-up|14|||
105737295|NCT01422304|364693420|FG001|Overall Study|Lost to Follow-up|20|||
105737296|NCT01422304|364693419|FG000|Overall Study|Never Entered Follow-up|2|||
105737297|NCT01422304|364693420|FG001|Overall Study|Never Entered Follow-up|1|||
105737298|NCT01422304|364693419|FG000|Overall Study|Protocol Violation|1|||
105737299|NCT01422304|364693420|FG001|Overall Study|Protocol Violation|0|||
105737300|NCT01422304|364693419|FG000|Overall Study|Withdrawal by Subject|4|||
105737301|NCT01422304|364693420|FG001|Overall Study|Withdrawal by Subject|2|||
105737302|NCT01422304|364693419|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
105737303|NCT01422304|364693420|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
105737304|NCT01422304|364693419|FG000|Overall Study|Not Treated|3|||
105737305|NCT01422304|364693420|FG001|Overall Study|Not Treated|11|||
105737306|NCT04770155|364693421|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737307|NCT04770155|364693422|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737308|NCT04770155|364693423|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
106011764|NCT03995368|365710454|FG000|Overall Study|Lost to Follow-up|1|||
106011765|NCT03995368|365710455|FG001|Overall Study|Lost to Follow-up|4|||
106011766|NCT03995368|365710456|FG002|Overall Study|Lost to Follow-up|1|||
106011767|NCT03995368|365710454|FG000|Overall Study|Did not meet inclusion criteria|1|||
106011768|NCT03995368|365710455|FG001|Overall Study|Did not meet inclusion criteria|6|||
106011769|NCT03995368|365710456|FG002|Overall Study|Did not meet inclusion criteria|3|||
106011770|NCT03995368|365710454|FG000|Overall Study|Withdrawal by Subject|0|||
106011771|NCT03995368|365710455|FG001|Overall Study|Withdrawal by Subject|1|||
106011772|NCT03995368|365710456|FG002|Overall Study|Withdrawal by Subject|1|||
106011773|NCT00307801|365710457|FG000|Overall Study|Adverse Event|12|||
106011774|NCT00307801|365710458|FG001|Overall Study|Adverse Event|4|||
106011775|NCT00307801|365710457|FG000|Overall Study|Withdrawal by Subject|9|||
106011776|NCT00307801|365710458|FG001|Overall Study|Withdrawal by Subject|4|||
106011777|NCT00307801|365710457|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
106011778|NCT00307801|365710458|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
105737309|NCT04770155|364693424|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
106011779|NCT00307801|365710457|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
106011780|NCT00307801|365710458|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
106011781|NCT00307801|365710457|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
106011782|NCT00307801|365710458|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
106011783|NCT00307801|365710457|FG000|Overall Study|Wrong Randomization|1|||
105737310|NCT04770155|364693425|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737311|NCT04770155|364693426|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737312|NCT04770155|364693427|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737313|NCT04770155|364693428|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
105737314|NCT03321929|364693433|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
105737315|NCT00866294|364693434|FG000|Overall Study|Adverse Event|12|||
105737316|NCT00866294|364693435|FG001|Overall Study|Adverse Event|13|||
105737317|NCT00866294|364693436|FG002|Overall Study|Adverse Event|9|||
105737318|NCT00866294|364693434|FG000|Overall Study|Lack of Efficacy|7|||
105737319|NCT00866294|364693435|FG001|Overall Study|Lack of Efficacy|1|||
105737320|NCT00866294|364693436|FG002|Overall Study|Lack of Efficacy|0|||
105737321|NCT00866294|364693434|FG000|Overall Study|Protocol Violation|2|||
105737322|NCT00866294|364693435|FG001|Overall Study|Protocol Violation|0|||
105737323|NCT00866294|364693436|FG002|Overall Study|Protocol Violation|0|||
105737324|NCT00866294|364693434|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
105737325|NCT00866294|364693435|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105737326|NCT00866294|364693436|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
105737327|NCT00866294|364693434|FG000|Overall Study|Lost to Follow-up|1|||
105737328|NCT00866294|364693435|FG001|Overall Study|Lost to Follow-up|3|||
105737329|NCT00866294|364693436|FG002|Overall Study|Lost to Follow-up|0|||
105737330|NCT00866294|364693434|FG000|Overall Study|Physician Decision|6|||
105737331|NCT00866294|364693435|FG001|Overall Study|Physician Decision|2|||
105737332|NCT00866294|364693436|FG002|Overall Study|Physician Decision|1|||
106011784|NCT00307801|365710458|FG001|Overall Study|Wrong Randomization|0|||
105737333|NCT02119104|364693437|FG000|Overall Study|Protocol Violation|16|||
105737334|NCT01632878|364693438|FG000|Screening|Physician Decision|268|||
105737335|NCT01632878|364693438|FG000|Treatment|Lost to Follow-up|41|||
105737336|NCT01632878|364693438|FG000|Treatment|Withdrawal by Subject|36|||
105737337|NCT01632878|364693438|FG000|Treatment|Physician Decision|34|||
105737338|NCT01632878|364693438|FG000|Treatment|missing information|4|||
105737339|NCT01632878|364693438|FG000|Treatment|no information on study completion|43|||
105737340|NCT00515463|364693443|FG000|Overall Study|Physician Decision|4|||
105737341|NCT00515463|364693444|FG001|Overall Study|Physician Decision|2|||
105737342|NCT00515463|364693443|FG000|Overall Study|Adverse Event|1|||
105737343|NCT00515463|364693444|FG001|Overall Study|Adverse Event|2|||
105737344|NCT00515463|364693443|FG000|Overall Study|Withdrawal by Subject|3|||
105737345|NCT00515463|364693444|FG001|Overall Study|Withdrawal by Subject|4|||
105737346|NCT00515463|364693443|FG000|Overall Study|Lost to Follow-up|6|||
105737347|NCT00515463|364693444|FG001|Overall Study|Lost to Follow-up|5|||
105737348|NCT00515463|364693443|FG000|Overall Study|Other|0|||
105737349|NCT00515463|364693444|FG001|Overall Study|Other|1|||
105737350|NCT00081289|364693445|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
105737351|NCT00081289|364693446|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
105737352|NCT00081289|364693445|FG000|Overall Study|Ineligible / no protocol treatment|3|||
105737353|NCT00081289|364693446|FG001|Overall Study|Ineligible / no protocol treatment|4|||
105737354|NCT02190435|364693447|FG000|Overall Study|First 12 patients were lead-ins|12|||
105737355|NCT02190435|364693448|FG001|Overall Study|First 12 patients were lead-ins|0|||
105737356|NCT02190435|364693447|FG000|Overall Study|3 consented screen fails|3|||
105737357|NCT02190435|364693448|FG001|Overall Study|3 consented screen fails|0|||
105737358|NCT03575468|364693449|FG000|Overall Study|Withdrawal by Subject|3|||
105737359|NCT03575468|364693450|FG001|Overall Study|Withdrawal by Subject|0|||
105737360|NCT03575468|364693449|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
105737361|NCT03575468|364693450|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
105737362|NCT03575468|364693449|FG000|Overall Study|Lost to Follow-up|13|||
105737363|NCT03575468|364693450|FG001|Overall Study|Lost to Follow-up|17|||
105737364|NCT03069690|364694676|FG000|Pregnancy Intervention|Pregnancy loss|9|||
105737365|NCT03069690|364694677|FG001|Pregnancy Intervention|Pregnancy loss|4|||
105737366|NCT03069690|364694678|FG002|Pregnancy Intervention|Pregnancy loss|0|||
105737367|NCT03069690|364694679|FG003|Pregnancy Intervention|Pregnancy loss|0|||
105737368|NCT03069690|364694680|FG004|Pregnancy Intervention|Pregnancy loss|0|||
105737369|NCT03069690|364694681|FG005|Pregnancy Intervention|Pregnancy loss|0|||
105737370|NCT03069690|364694676|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
105737371|NCT03069690|364694677|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
105737372|NCT03069690|364694678|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
105737373|NCT03069690|364694679|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
105737374|NCT03069690|364694680|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
105737375|NCT03069690|364694681|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
105737376|NCT03069690|364694676|FG000|Postpartum Intervention|Lost to Follow-up|0|||
105737377|NCT03069690|364694677|FG001|Postpartum Intervention|Lost to Follow-up|0|||
105737378|NCT03069690|364694678|FG002|Postpartum Intervention|Lost to Follow-up|5|||
105737379|NCT03069690|364694679|FG003|Postpartum Intervention|Lost to Follow-up|5|||
105737380|NCT03069690|364694680|FG004|Postpartum Intervention|Lost to Follow-up|2|||
105737381|NCT03069690|364694681|FG005|Postpartum Intervention|Lost to Follow-up|4|||
105737382|NCT01372878|364694684|FG000|Overall Study|Withdrawal by Subject|63|||
105737383|NCT01372878|364694684|FG000|Overall Study|Protocol Violation|17|||
105737384|NCT01372878|364694684|FG000|Overall Study|incomplete study procedure|104|||
105737385|NCT00718861|364694688|FG000|Overall Study|Withdrawal by Subject|15|||
105737386|NCT00718861|364694689|FG001|Overall Study|Withdrawal by Subject|10|||
105737387|NCT00718861|364694688|FG000|Overall Study|Adverse Event|2|||
105737388|NCT00718861|364694689|FG001|Overall Study|Adverse Event|1|||
105737389|NCT00718861|364694688|FG000|Overall Study|Lost to Follow-up|2|||
105737390|NCT00718861|364694689|FG001|Overall Study|Lost to Follow-up|1|||
105737391|NCT00718861|364694688|FG000|Overall Study|Administrative Problems|1|||
105737392|NCT00718861|364694689|FG001|Overall Study|Administrative Problems|1|||
105737393|NCT00718861|364694688|FG000|Overall Study|Death|1|||
105939917|NCT03715829|365441251|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
105939918|NCT03715829|365441252|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
105939919|NCT03715829|365441242|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939920|NCT03715829|365441243|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939921|NCT03715829|365441244|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
105952131|NCT03314935|365488197|FG013|Phase 1|Lost to Follow-up|0|||
105737394|NCT00718861|364694689|FG001|Overall Study|Death|5|||
105737395|NCT01221233|364694690|FG000|Overall Study|Withdrawal by Subject|3|||
105737396|NCT01221233|364694691|FG001|Overall Study|Withdrawal by Subject|1|||
105737397|NCT02345434|364694692|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
105737398|NCT02345434|364694693|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
105737399|NCT01505491|364694694|FG000|Overall Study|Other reason not listed|1|||
105737400|NCT01505491|364694695|FG001|Overall Study|Other reason not listed|0|||
105737401|NCT01505491|364694696|FG002|Overall Study|Other reason not listed|0|||
106140602|NCT00410124|366172598|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
106140603|NCT00410124|366172597|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
106140604|NCT00410124|366172598|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
106140605|NCT00410124|366172597|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
106140606|NCT00410124|366172598|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
106140607|NCT00410124|366172597|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
106140608|NCT00410124|366172598|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
106140609|NCT00410124|366172597|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
106140610|NCT00410124|366172598|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
106140611|NCT00410124|366172597|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
106140612|NCT00410124|366172598|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
106140613|NCT00410124|366172597|FG000|Core Phase Double Blind (15 Months)|Death|7|||
106140614|NCT00410124|366172598|FG001|Core Phase Double Blind (15 Months)|Death|4|||
106140615|NCT00410124|366172597|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
106140616|NCT00410124|366172598|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
105737402|NCT01505491|364694694|FG000|Overall Study|Withdrawal by Subject|1|||
105737403|NCT01505491|364694695|FG001|Overall Study|Withdrawal by Subject|1|||
105737404|NCT01505491|364694696|FG002|Overall Study|Withdrawal by Subject|4|||
105737405|NCT01505491|364694694|FG000|Overall Study|Lost to Follow-up|0|||
105737406|NCT01505491|364694695|FG001|Overall Study|Lost to Follow-up|0|||
105737407|NCT01505491|364694696|FG002|Overall Study|Lost to Follow-up|1|||
105737408|NCT02926573|364694697|FG000|Overall Study|Nausea|1|||
105737409|NCT02926573|364694698|FG001|Overall Study|Nausea|0|||
105737410|NCT02926573|364694697|FG000|Overall Study|Remain intubated|2|||
105737411|NCT02926573|364694698|FG001|Overall Study|Remain intubated|2|||
105737412|NCT02926573|364694697|FG000|Overall Study|Change in surgery plan|3|||
105737413|NCT02926573|364694698|FG001|Overall Study|Change in surgery plan|1|||
105737414|NCT02926573|364694697|FG000|Overall Study|Change to outpatient status|5|||
105737415|NCT02926573|364694698|FG001|Overall Study|Change to outpatient status|1|||
105737416|NCT02926573|364694697|FG000|Overall Study|Withdrawal by Subject|0|||
105737417|NCT02926573|364694698|FG001|Overall Study|Withdrawal by Subject|2|||
105737418|NCT02926573|364694697|FG000|Overall Study|Return to operating room|0|||
105737419|NCT02926573|364694698|FG001|Overall Study|Return to operating room|2|||
105737420|NCT02926573|364694697|FG000|Overall Study|Delirium|0|||
105737421|NCT02926573|364694698|FG001|Overall Study|Delirium|1|||
105737422|NCT02052960|364694699|FG000|Overall Study|Adverse Event|19|||
105737423|NCT02052960|364694700|FG001|Overall Study|Adverse Event|17|||
105737424|NCT02052960|364694699|FG000|Overall Study|Protocol Violation|4|||
105737425|NCT02052960|364694700|FG001|Overall Study|Protocol Violation|3|||
105737426|NCT02052960|364694699|FG000|Overall Study|Withdrawal by Subject|6|||
105737427|NCT02052960|364694700|FG001|Overall Study|Withdrawal by Subject|11|||
105737428|NCT02052960|364694699|FG000|Overall Study|Other|25|||
105737429|NCT02052960|364694700|FG001|Overall Study|Other|15|||
105737430|NCT01302041|364694703|FG000|Overall Study|Death|5|||
105737431|NCT01302041|364694703|FG000|Overall Study|Withdrawal by Subject|4|||
105737432|NCT01302041|364694703|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
105737433|NCT01302041|364694703|FG000|Overall Study|Other-Miscellaneous Reason|2|||
105737434|NCT03849560|364694704|FG000|Overall Study|Withdrawal by Subject|1|||
105737435|NCT03849560|364694705|FG001|Overall Study|Withdrawal by Subject|0|||
105737436|NCT03849560|364694706|FG002|Overall Study|Withdrawal by Subject|0|||
105737437|NCT04382651|364694707|FG000|Overall Study|Death|26|||
105737438|NCT04382651|364694708|FG001|Overall Study|Death|23|||
105737439|NCT04382651|364694707|FG000|Overall Study|Lost to Follow-up|3|||
105737440|NCT04382651|364694708|FG001|Overall Study|Lost to Follow-up|4|||
105737441|NCT04382651|364694707|FG000|Overall Study|Withdrawal by Subject|2|||
105737442|NCT04382651|364694708|FG001|Overall Study|Withdrawal by Subject|0|||
105737443|NCT04382651|364694707|FG000|Overall Study|Physician Decision|0|||
105737444|NCT04382651|364694708|FG001|Overall Study|Physician Decision|1|||
105737445|NCT02416908|364694713|FG000|Dose Escalation Phase|Adverse Event|0|||
105737446|NCT02416908|364694714|FG001|Dose Escalation Phase|Adverse Event|0|||
105737447|NCT02416908|364694715|FG002|Dose Escalation Phase|Adverse Event|3|||
105737448|NCT02416908|364694716|FG003|Dose Escalation Phase|Adverse Event|0|||
105737449|NCT02416908|364694713|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
106140617|NCT00410124|366172597|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
106140618|NCT00410124|366172598|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
106140619|NCT00410124|366172597|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
105737450|NCT02416908|364694714|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
105737451|NCT02416908|364694715|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
105737452|NCT02416908|364694716|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
105737453|NCT00611130|364694721|FG000|Overall Study|Lost to Follow-up|25|||
105737454|NCT00611130|364694722|FG001|Overall Study|Lost to Follow-up|29|||
105737455|NCT00611130|364694721|FG000|Overall Study|Protocol noncompliance|7|||
105737456|NCT00611130|364694722|FG001|Overall Study|Protocol noncompliance|6|||
105737457|NCT00611130|364694721|FG000|Overall Study|Withdrawal by Subject|6|||
106140620|NCT00410124|366172598|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
106140621|NCT00410124|366172597|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
106140622|NCT00410124|366172598|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
106140623|NCT00410124|366172597|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
106140624|NCT00410124|366172598|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
106140625|NCT00410124|366172597|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
106140626|NCT00410124|366172598|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
106140627|NCT00410124|366172597|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
106140628|NCT00410124|366172598|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
106140629|NCT00410124|366172597|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
106140630|NCT00410124|366172598|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
106140631|NCT00410124|366172597|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
106140632|NCT00410124|366172598|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
106140633|NCT00716144|366172599|FG000|Overall Study|Withdrawal by Subject|4|||
106140634|NCT00716144|366172600|FG001|Overall Study|Withdrawal by Subject|2|||
105737458|NCT00611130|364694722|FG001|Overall Study|Withdrawal by Subject|5|||
105737459|NCT00611130|364694721|FG000|Overall Study|Other|5|||
105737460|NCT00611130|364694722|FG001|Overall Study|Other|4|||
105737461|NCT00611130|364694721|FG000|Overall Study|Incarceration|3|||
105737462|NCT00611130|364694722|FG001|Overall Study|Incarceration|2|||
105737463|NCT00611130|364694721|FG000|Overall Study|Administrative|1|||
105939922|NCT03715829|365441245|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939923|NCT03715829|365441246|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939924|NCT03715829|365441247|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939925|NCT03715829|365441248|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939926|NCT03715829|365441249|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939927|NCT03715829|365441250|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939928|NCT03715829|365441251|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939929|NCT03715829|365441252|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
105939930|NCT03715829|365441242|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105939931|NCT03715829|365441243|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
106011785|NCT00307801|365710457|FG000|Overall Study|Lack of Efficacy|0|||
106011786|NCT00307801|365710458|FG001|Overall Study|Lack of Efficacy|2|||
106011787|NCT00307801|365710457|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
106011788|NCT00307801|365710458|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
106011789|NCT00307801|365710457|FG000|Overall Study|Frustration with e-diary|1|||
106011790|NCT00307801|365710458|FG001|Overall Study|Frustration with e-diary|0|||
106011791|NCT00307801|365710457|FG000|Overall Study|Protocol Violation|3|||
106011792|NCT00307801|365710458|FG001|Overall Study|Protocol Violation|2|||
106011793|NCT00307801|365710457|FG000|Overall Study|No reason specified|2|||
106011794|NCT00307801|365710458|FG001|Overall Study|No reason specified|0|||
106011795|NCT00307801|365710457|FG000|Overall Study|Pregnancy|0|||
105939932|NCT03715829|365441244|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
105939933|NCT03715829|365441245|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105939934|NCT03715829|365441246|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
105939935|NCT03715829|365441247|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105939936|NCT03715829|365441248|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105939937|NCT03715829|365441249|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105939938|NCT03715829|365441250|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105939939|NCT03715829|365441251|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105939940|NCT03715829|365441252|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
105939941|NCT03715829|365441242|FG000|Dose Ranging Period|Other|0|||
105939942|NCT03715829|365441243|FG001|Dose Ranging Period|Other|0|||
105939943|NCT03715829|365441244|FG002|Dose Ranging Period|Other|2|||
105939944|NCT03715829|365441245|FG003|Dose Ranging Period|Other|0|||
105939945|NCT03715829|365441246|FG004|Dose Ranging Period|Other|0|||
105939946|NCT03715829|365441247|FG005|Dose Ranging Period|Other|3|||
105939947|NCT03715829|365441248|FG006|Dose Ranging Period|Other|0|||
105939948|NCT03715829|365441249|FG007|Dose Ranging Period|Other|0|||
105939949|NCT03715829|365441250|FG008|Dose Ranging Period|Other|0|||
105939950|NCT03715829|365441251|FG009|Dose Ranging Period|Other|0|||
105939951|NCT03715829|365441252|FG010|Dose Ranging Period|Other|0|||
106011796|NCT00307801|365710458|FG001|Overall Study|Pregnancy|1|||
105737464|NCT00611130|364694722|FG001|Overall Study|Administrative|1|||
105737465|NCT00611130|364694721|FG000|Overall Study|Adverse Event|1|||
105939952|NCT03715829|365441242|FG000|Extension Period|Adverse Event|0|||
105939953|NCT03715829|365441243|FG001|Extension Period|Adverse Event|0|||
105939954|NCT03715829|365441244|FG002|Extension Period|Adverse Event|0|||
105939955|NCT03715829|365441245|FG003|Extension Period|Adverse Event|0|||
106011797|NCT00551642|365710463|FG000|Treatment Period|Protocol Deviation|6|||
105737466|NCT00611130|364694722|FG001|Overall Study|Adverse Event|0|||
105737467|NCT00611130|364694721|FG000|Overall Study|Death|1|||
105737468|NCT00611130|364694722|FG001|Overall Study|Death|0|||
105737469|NCT00700752|364694723|FG000|First Intervention|Withdrawal by Subject|0|||
105737470|NCT00700752|364694724|FG001|First Intervention|Withdrawal by Subject|2|||
105737471|NCT01302769|364694725|FG000|Overall Study|Lost to Follow-up|1|||
105737472|NCT01302769|364694726|FG001|Overall Study|Lost to Follow-up|1|||
105737473|NCT01097330|364694730|FG000|Overall Study|Study terminated early|7|||
105737474|NCT01097330|364694731|FG001|Overall Study|Study terminated early|5|||
105737475|NCT02853331|364694737|FG000|Overall Study|Death|59|||
105737476|NCT02853331|364694738|FG001|Overall Study|Death|95|||
105737477|NCT02853331|364694737|FG000|Overall Study|Withdrawal by Subject|5|||
105737478|NCT02853331|364694738|FG001|Overall Study|Withdrawal by Subject|9|||
105737479|NCT02853331|364694737|FG000|Overall Study|Ongoing in study|368|||
105737480|NCT02853331|364694738|FG001|Overall Study|Ongoing in study|325|||
105737481|NCT04156646|364694739|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
105737482|NCT04156646|364694740|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
105737483|NCT00510692|364694746|FG000|Overall Study|Adverse Event|1|||
105737484|NCT00510692|364694747|FG001|Overall Study|Adverse Event|3|||
105737485|NCT00510692|364694746|FG000|Overall Study|Withdrawal by Subject|1|||
105737486|NCT00510692|364694747|FG001|Overall Study|Withdrawal by Subject|0|||
105737487|NCT01845077|364694748|FG000|Washout Period|Lost to Follow-up|0|||
105737488|NCT01845077|364694749|FG001|Washout Period|Lost to Follow-up|1|||
105737489|NCT01845077|364694750|FG002|Washout Period|Lost to Follow-up|0|||
105737490|NCT01845077|364694751|FG003|Washout Period|Lost to Follow-up|1|||
105737491|NCT01845077|364694752|FG004|Washout Period|Lost to Follow-up|0|||
105737492|NCT01845077|364694753|FG005|Washout Period|Lost to Follow-up|1|||
105737493|NCT01845077|364694748|FG000|Washout Period|Adverse Event|1|||
105737494|NCT01845077|364694749|FG001|Washout Period|Adverse Event|0|||
105737495|NCT01845077|364694750|FG002|Washout Period|Adverse Event|0|||
105737496|NCT01845077|364694751|FG003|Washout Period|Adverse Event|0|||
105737497|NCT01845077|364694752|FG004|Washout Period|Adverse Event|0|||
105737498|NCT01845077|364694753|FG005|Washout Period|Adverse Event|0|||
105737499|NCT01845077|364694748|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737500|NCT01845077|364694749|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737501|NCT01845077|364694750|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
105737502|NCT01845077|364694751|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737503|NCT01845077|364694752|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737504|NCT01845077|364694753|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
105737505|NCT01845077|364694748|FG000|Washout Period|Protocol Violation|0|||
105737506|NCT01845077|364694749|FG001|Washout Period|Protocol Violation|0|||
105737507|NCT01845077|364694750|FG002|Washout Period|Protocol Violation|0|||
105737508|NCT01845077|364694751|FG003|Washout Period|Protocol Violation|1|||
105737509|NCT01845077|364694752|FG004|Washout Period|Protocol Violation|1|||
105737510|NCT01845077|364694753|FG005|Washout Period|Protocol Violation|0|||
105737511|NCT01001494|364694762|FG000|Overall Study|Adverse Event|8|||
105737512|NCT01001494|364694763|FG001|Overall Study|Adverse Event|4|||
105737513|NCT01001494|364694764|FG002|Overall Study|Adverse Event|6|||
105737514|NCT01001494|364694762|FG000|Overall Study|Protocol Violation|0|||
105737515|NCT01001494|364694763|FG001|Overall Study|Protocol Violation|1|||
105737516|NCT01001494|364694764|FG002|Overall Study|Protocol Violation|1|||
105737517|NCT01001494|364694762|FG000|Overall Study|Lost to Follow-up|2|||
105737518|NCT01001494|364694763|FG001|Overall Study|Lost to Follow-up|0|||
105737519|NCT01001494|364694764|FG002|Overall Study|Lost to Follow-up|1|||
105737520|NCT01001494|364694762|FG000|Overall Study|Withdrawal by Subject|9|||
105737521|NCT01001494|364694763|FG001|Overall Study|Withdrawal by Subject|7|||
105737522|NCT01001494|364694764|FG002|Overall Study|Withdrawal by Subject|17|||
105737523|NCT01001494|364694762|FG000|Overall Study|COPD exacerbation|3|||
105737524|NCT01001494|364694763|FG001|Overall Study|COPD exacerbation|4|||
105737525|NCT01001494|364694764|FG002|Overall Study|COPD exacerbation|5|||
105737526|NCT01001494|364694762|FG000|Overall Study|Lack of Efficacy|2|||
105737527|NCT01001494|364694763|FG001|Overall Study|Lack of Efficacy|0|||
105799442|NCT01205529|364924583|FG000|Overall Study|Withdrawal by Subject|2|||
105799443|NCT01205529|364924583|FG000|Overall Study|Physician Decision|4|||
105737528|NCT01001494|364694764|FG002|Overall Study|Lack of Efficacy|8|||
105737529|NCT01001494|364694762|FG000|Overall Study|Other|0|||
105737530|NCT01001494|364694763|FG001|Overall Study|Other|1|||
105737531|NCT01001494|364694764|FG002|Overall Study|Other|3|||
105737532|NCT02519231|364694765|FG000|Overall Study|Lost to Follow-up|2|||
105737533|NCT02519231|364694766|FG001|Overall Study|Lost to Follow-up|5|||
105799444|NCT01205529|364924583|FG000|Overall Study|Unstable post op|15|||
105737534|NCT02519231|364694765|FG000|Overall Study|Withdrawal by Subject|0|||
105737535|NCT02519231|364694766|FG001|Overall Study|Withdrawal by Subject|1|||
105737536|NCT00815308|364694768|FG000|Overall Study|Adverse Event|4|||
105737537|NCT00815308|364694768|FG000|Overall Study|Withdrawal by Subject|0|||
105737538|NCT00815308|364694768|FG000|Overall Study|Protocol Violation|6|||
105737539|NCT01137435|364694769|FG000|Overall Study|Lost to Follow-up|24|||
105737540|NCT01137435|364694769|FG000|Overall Study|Off label usage|4|||
105737541|NCT01765764|364694776|FG000|Treatment Period|Adverse Event|1|||
105799445|NCT01205529|364924583|FG000|Overall Study|No longer met criteria|30|||
105939956|NCT03715829|365441246|FG004|Extension Period|Adverse Event|0|||
106011798|NCT00551642|365710464|FG001|Treatment Period|Protocol Deviation|11|||
106011799|NCT00551642|365710463|FG000|Treatment Period|Delivery device failure|1|||
106011800|NCT00551642|365710464|FG001|Treatment Period|Delivery device failure|3|||
106011801|NCT00551642|365710463|FG000|Treatment Period|Physician Decision|0|||
106011802|NCT00551642|365710464|FG001|Treatment Period|Physician Decision|1|||
106011803|NCT00551642|365710463|FG000|Treatment Period|Death|33|||
106011804|NCT00551642|365710464|FG001|Treatment Period|Death|31|||
106011805|NCT00551642|365710463|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
106011806|NCT00551642|365710464|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
106011807|NCT00551642|365710463|FG000|Treatment Period|Adverse Event|15|||
106011808|NCT00551642|365710464|FG001|Treatment Period|Adverse Event|12|||
106011809|NCT00551642|365710463|FG000|Treatment Period|Withdrawal by Subject|2|||
106011810|NCT00551642|365710464|FG001|Treatment Period|Withdrawal by Subject|1|||
106011811|NCT00904982|365710467|FG000|Overall Study|Withdrawal by Subject|2|||
106011812|NCT00904982|365710468|FG001|Overall Study|Withdrawal by Subject|0|||
106011813|NCT00904982|365710469|FG002|Overall Study|Withdrawal by Subject|0|||
105939957|NCT03715829|365441247|FG005|Extension Period|Adverse Event|0|||
105939958|NCT03715829|365441248|FG006|Extension Period|Adverse Event|3|||
105939959|NCT03715829|365441249|FG007|Extension Period|Adverse Event|1|||
105939960|NCT03715829|365441250|FG008|Extension Period|Adverse Event|6|||
105939961|NCT03715829|365441251|FG009|Extension Period|Adverse Event|0|||
105939962|NCT03715829|365441252|FG010|Extension Period|Adverse Event|0|||
105939963|NCT03715829|365441242|FG000|Extension Period|Lack of Efficacy|0|||
105939964|NCT03715829|365441243|FG001|Extension Period|Lack of Efficacy|0|||
105939965|NCT03715829|365441244|FG002|Extension Period|Lack of Efficacy|0|||
105939966|NCT03715829|365441245|FG003|Extension Period|Lack of Efficacy|0|||
105939967|NCT03715829|365441246|FG004|Extension Period|Lack of Efficacy|0|||
105939968|NCT03715829|365441247|FG005|Extension Period|Lack of Efficacy|0|||
105939969|NCT03715829|365441248|FG006|Extension Period|Lack of Efficacy|1|||
105939970|NCT03715829|365441249|FG007|Extension Period|Lack of Efficacy|9|||
105939971|NCT03715829|365441250|FG008|Extension Period|Lack of Efficacy|2|||
105939972|NCT03715829|365441251|FG009|Extension Period|Lack of Efficacy|0|||
105939973|NCT03715829|365441252|FG010|Extension Period|Lack of Efficacy|0|||
105939974|NCT03715829|365441242|FG000|Extension Period|Lost to Follow-up|0|||
105939975|NCT03715829|365441243|FG001|Extension Period|Lost to Follow-up|0|||
105939976|NCT03715829|365441244|FG002|Extension Period|Lost to Follow-up|0|||
105939977|NCT03715829|365441245|FG003|Extension Period|Lost to Follow-up|0|||
105939978|NCT03715829|365441246|FG004|Extension Period|Lost to Follow-up|0|||
105939979|NCT03715829|365441247|FG005|Extension Period|Lost to Follow-up|0|||
105939980|NCT03715829|365441248|FG006|Extension Period|Lost to Follow-up|0|||
105939981|NCT03715829|365441249|FG007|Extension Period|Lost to Follow-up|0|||
105939982|NCT03715829|365441250|FG008|Extension Period|Lost to Follow-up|2|||
105939983|NCT03715829|365441251|FG009|Extension Period|Lost to Follow-up|0|||
105939984|NCT03715829|365441252|FG010|Extension Period|Lost to Follow-up|0|||
105939985|NCT03715829|365441242|FG000|Extension Period|Protocol Violation|0|||
105939986|NCT03715829|365441243|FG001|Extension Period|Protocol Violation|0|||
105939987|NCT03715829|365441244|FG002|Extension Period|Protocol Violation|0|||
105939988|NCT03715829|365441245|FG003|Extension Period|Protocol Violation|0|||
105939989|NCT03715829|365441246|FG004|Extension Period|Protocol Violation|0|||
105939990|NCT03715829|365441247|FG005|Extension Period|Protocol Violation|0|||
105939991|NCT03715829|365441248|FG006|Extension Period|Protocol Violation|0|||
105939992|NCT03715829|365441249|FG007|Extension Period|Protocol Violation|0|||
105939993|NCT03715829|365441250|FG008|Extension Period|Protocol Violation|1|||
105939994|NCT03715829|365441251|FG009|Extension Period|Protocol Violation|0|||
105939995|NCT03715829|365441252|FG010|Extension Period|Protocol Violation|0|||
105939996|NCT03715829|365441242|FG000|Extension Period|Withdrawal by Subject|0|||
105939997|NCT03715829|365441243|FG001|Extension Period|Withdrawal by Subject|0|||
105939998|NCT03715829|365441244|FG002|Extension Period|Withdrawal by Subject|0|||
105939999|NCT03715829|365441245|FG003|Extension Period|Withdrawal by Subject|0|||
105940000|NCT03715829|365441246|FG004|Extension Period|Withdrawal by Subject|0|||
105940001|NCT03715829|365441247|FG005|Extension Period|Withdrawal by Subject|0|||
105940002|NCT03715829|365441248|FG006|Extension Period|Withdrawal by Subject|3|||
105940003|NCT03715829|365441249|FG007|Extension Period|Withdrawal by Subject|3|||
105940004|NCT03715829|365441250|FG008|Extension Period|Withdrawal by Subject|12|||
105940005|NCT03715829|365441251|FG009|Extension Period|Withdrawal by Subject|3|||
105940006|NCT03715829|365441252|FG010|Extension Period|Withdrawal by Subject|0|||
106011814|NCT00904982|365710470|FG003|Overall Study|Withdrawal by Subject|0|||
106011815|NCT03011099|365710474|FG000|Overall Study|Withdrawal by Subject|0|||
105940007|NCT03715829|365441242|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
105940008|NCT03715829|365441243|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
105940009|NCT03715829|365441244|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
105940010|NCT03715829|365441245|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
105940011|NCT03715829|365441246|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
105940012|NCT03715829|365441247|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
106140635|NCT00716144|366172601|FG002|Overall Study|Withdrawal by Subject|6|||
106140636|NCT00716144|366172602|FG003|Overall Study|Withdrawal by Subject|6|||
106140637|NCT00716144|366172599|FG000|Overall Study|Lost to Follow-up|2|||
106140638|NCT00716144|366172600|FG001|Overall Study|Lost to Follow-up|2|||
106140639|NCT00716144|366172601|FG002|Overall Study|Lost to Follow-up|1|||
106140640|NCT00716144|366172602|FG003|Overall Study|Lost to Follow-up|2|||
106140641|NCT00716144|366172599|FG000|Overall Study|Adverse Event|0|||
106140642|NCT00716144|366172600|FG001|Overall Study|Adverse Event|0|||
106140643|NCT00716144|366172601|FG002|Overall Study|Adverse Event|0|||
106140644|NCT00716144|366172602|FG003|Overall Study|Adverse Event|2|||
106140645|NCT00716144|366172599|FG000|Overall Study|Non-compliance|1|||
106140646|NCT00716144|366172600|FG001|Overall Study|Non-compliance|0|||
106140647|NCT00716144|366172601|FG002|Overall Study|Non-compliance|0|||
106140648|NCT00716144|366172602|FG003|Overall Study|Non-compliance|0|||
106140649|NCT00716144|366172599|FG000|Overall Study|Protocol Violation|2|||
106140650|NCT00716144|366172600|FG001|Overall Study|Protocol Violation|0|||
106140651|NCT00716144|366172601|FG002|Overall Study|Protocol Violation|1|||
106140652|NCT00716144|366172602|FG003|Overall Study|Protocol Violation|0|||
106140653|NCT00716144|366172599|FG000|Overall Study|Physician Decision|0|||
106140654|NCT00716144|366172600|FG001|Overall Study|Physician Decision|1|||
106140655|NCT00716144|366172601|FG002|Overall Study|Physician Decision|2|||
106140656|NCT00716144|366172602|FG003|Overall Study|Physician Decision|2|||
106140657|NCT00716144|366172599|FG000|Overall Study|Intercurrent illness|0|||
106140658|NCT00716144|366172600|FG001|Overall Study|Intercurrent illness|0|||
106140659|NCT00716144|366172601|FG002|Overall Study|Intercurrent illness|1|||
106140660|NCT00716144|366172602|FG003|Overall Study|Intercurrent illness|0|||
106140661|NCT00716144|366172599|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
106140662|NCT00716144|366172600|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
106140663|NCT00716144|366172601|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
106140664|NCT00716144|366172602|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
106140665|NCT00716144|366172599|FG000|Overall Study|Adverse event: left foot pain|0|||
106140666|NCT00716144|366172600|FG001|Overall Study|Adverse event: left foot pain|1|||
106140667|NCT00716144|366172601|FG002|Overall Study|Adverse event: left foot pain|0|||
106140668|NCT00716144|366172602|FG003|Overall Study|Adverse event: left foot pain|0|||
106140669|NCT00716144|366172599|FG000|Overall Study|Clinical Depression|0|||
106140670|NCT00716144|366172600|FG001|Overall Study|Clinical Depression|1|||
106140671|NCT00716144|366172601|FG002|Overall Study|Clinical Depression|0|||
106140672|NCT00716144|366172602|FG003|Overall Study|Clinical Depression|0|||
106140673|NCT00909363|366172603|FG000|Overall Study|Withdrawal by Subject|1|||
106140674|NCT00909363|366172604|FG001|Overall Study|Withdrawal by Subject|0|||
106140675|NCT00909363|366172605|FG002|Overall Study|Withdrawal by Subject|0|||
106140676|NCT00909363|366172603|FG000|Overall Study|Lack of Efficacy|1|||
106140677|NCT00909363|366172604|FG001|Overall Study|Lack of Efficacy|0|||
106140678|NCT00909363|366172605|FG002|Overall Study|Lack of Efficacy|0|||
106140679|NCT05641311|366172606|FG000|Dosing Period 1|Adverse Event|1|||
106140680|NCT05641311|366172607|FG001|Dosing Period 1|Adverse Event|0|||
106140681|NCT00082810|366172609|FG000|Overall Study|Adverse Event|3|||
106140682|NCT00082810|366172609|FG000|Overall Study|Progressive disease|24|||
106140683|NCT00082810|366172609|FG000|Overall Study|Withdrawal by Subject|4|||
106140684|NCT02950558|366172610|FG000|Overall Study|Lost to Follow-up|2|||
106140685|NCT02950558|366172611|FG001|Overall Study|Lost to Follow-up|0|||
106140686|NCT02059980|366172616|FG000|Overall Study|Lost to Follow-up|2|||
106140687|NCT02059980|366172617|FG001|Overall Study|Lost to Follow-up|1|||
106140688|NCT02341625|366172618|FG000|Overall Study|Disease Progression|2|||
106140689|NCT02341625|366172619|FG001|Overall Study|Disease Progression|2|||
106140690|NCT02341625|366172620|FG002|Overall Study|Disease Progression|3|||
106140691|NCT02341625|366172621|FG003|Overall Study|Disease Progression|6|||
106140692|NCT02341625|366172622|FG004|Overall Study|Disease Progression|7|||
106140693|NCT02341625|366172623|FG005|Overall Study|Disease Progression|7|||
106140694|NCT02341625|366172624|FG006|Overall Study|Disease Progression|28|||
106140695|NCT02341625|366172625|FG007|Overall Study|Disease Progression|5|||
106140696|NCT02341625|366172626|FG008|Overall Study|Disease Progression|4|||
106140697|NCT02341625|366172627|FG009|Overall Study|Disease Progression|19|||
106140698|NCT02341625|366172618|FG000|Overall Study|Study Drug Toxicity|0|||
106140699|NCT02341625|366172619|FG001|Overall Study|Study Drug Toxicity|0|||
106140700|NCT02341625|366172620|FG002|Overall Study|Study Drug Toxicity|0|||
105737542|NCT01765764|364694777|FG001|Treatment Period|Adverse Event|2|||
106140701|NCT02341625|366172621|FG003|Overall Study|Study Drug Toxicity|1|||
106140702|NCT02341625|366172622|FG004|Overall Study|Study Drug Toxicity|0|||
106140703|NCT02341625|366172623|FG005|Overall Study|Study Drug Toxicity|3|||
106140704|NCT02341625|366172624|FG006|Overall Study|Study Drug Toxicity|10|||
106140705|NCT02341625|366172625|FG007|Overall Study|Study Drug Toxicity|0|||
105737543|NCT01765764|364694778|FG002|Treatment Period|Adverse Event|1|||
106140706|NCT02341625|366172626|FG008|Overall Study|Study Drug Toxicity|0|||
106140707|NCT02341625|366172627|FG009|Overall Study|Study Drug Toxicity|3|||
106140708|NCT02341625|366172618|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
106140709|NCT02341625|366172619|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
106140710|NCT02341625|366172620|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
105737544|NCT01765764|364694776|FG000|Treatment Period|Lost to Follow-up|0|||
105737545|NCT01765764|364694777|FG001|Treatment Period|Lost to Follow-up|3|||
105737546|NCT01765764|364694778|FG002|Treatment Period|Lost to Follow-up|2|||
105737547|NCT01765764|364694776|FG000|Treatment Period|Personal Reasons|1|||
105737548|NCT01765764|364694777|FG001|Treatment Period|Personal Reasons|2|||
105737549|NCT01765764|364694778|FG002|Treatment Period|Personal Reasons|1|||
105737550|NCT01765764|364694776|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
105737551|NCT01765764|364694777|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
105737552|NCT01765764|364694778|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
105737553|NCT00916721|364694779|FG000|Overall Study|Lost to Follow-up|0|||
105737554|NCT00916721|364694780|FG001|Overall Study|Lost to Follow-up|1|||
105737555|NCT00916721|364694779|FG000|Overall Study|Adverse Event|6|||
105737556|NCT00916721|364694780|FG001|Overall Study|Adverse Event|3|||
105737557|NCT00916721|364694779|FG000|Overall Study|Withdrawal by Subject|2|||
105737558|NCT00916721|364694780|FG001|Overall Study|Withdrawal by Subject|2|||
105737559|NCT00916721|364694779|FG000|Overall Study|Protocol Violation|2|||
105737560|NCT00916721|364694780|FG001|Overall Study|Protocol Violation|4|||
105737561|NCT00839098|364694783|FG000|Overall Study|Withdrawal by Subject|2|||
105737562|NCT00839098|364694784|FG001|Overall Study|Withdrawal by Subject|1|||
105737563|NCT00839098|364694785|FG002|Overall Study|Withdrawal by Subject|7|||
105737564|NCT00365976|364694788|FG000|Overall Study|Withdrawal by Subject|1|||
105737565|NCT00365976|364694789|FG001|Overall Study|Withdrawal by Subject|5|||
105737566|NCT00336492|364694790|FG000|Overall Study|Adverse Event|4|||
105737567|NCT00336492|364694791|FG001|Overall Study|Adverse Event|3|||
105737568|NCT00336492|364694792|FG002|Overall Study|Adverse Event|6|||
105737569|NCT00336492|364694790|FG000|Overall Study|Lack of Efficacy|6|||
105737570|NCT00336492|364694791|FG001|Overall Study|Lack of Efficacy|1|||
105737571|NCT00336492|364694792|FG002|Overall Study|Lack of Efficacy|4|||
105737572|NCT00336492|364694790|FG000|Overall Study|Other|5|||
105737573|NCT00336492|364694791|FG001|Overall Study|Other|0|||
105737574|NCT00336492|364694792|FG002|Overall Study|Other|1|||
105737575|NCT01781026|364694795|FG000|Overall Study|Lack of Efficacy|2|||
105737576|NCT03123939|364694799|FG000|Overall Study|Lack of Efficacy|6|||
105737577|NCT03123939|364694799|FG000|Overall Study|Death|5|||
105737578|NCT03123939|364694799|FG000|Overall Study|Physician Decision|2|||
105737579|NCT03123939|364694799|FG000|Overall Study|Subject/guardian decision|2|||
105737580|NCT03123939|364694799|FG000|Overall Study|Lost to Follow-up|1|||
105737581|NCT03123939|364694799|FG000|Overall Study|New therapy for study indication|1|||
105737582|NCT03123939|364694799|FG000|Overall Study|Protocol deviation|1|||
105737583|NCT03123939|364694799|FG000|Overall Study|Progressive disease|18|||
105737584|NCT03123939|364694799|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
105737585|NCT03123939|364694799|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
105737586|NCT01991977|364696700|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
105737587|NCT01991977|364696700|FG000|Overall Study|Withdrew after start of treatment|5|||
105737588|NCT02699515|364696707|FG000|Overall Study|Death|3|||
105737589|NCT02699515|364696708|FG001|Overall Study|Death|3|||
105737590|NCT02699515|364696709|FG002|Overall Study|Death|3|||
105737591|NCT02699515|364696710|FG003|Overall Study|Death|23|||
105737592|NCT02699515|364696711|FG004|Overall Study|Death|22|||
105737593|NCT02699515|364696712|FG005|Overall Study|Death|23|||
105737594|NCT02699515|364696713|FG006|Overall Study|Death|3|||
105737595|NCT02699515|364696714|FG007|Overall Study|Death|5|||
105940013|NCT03715829|365441248|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
105940014|NCT03715829|365441249|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
105940015|NCT03715829|365441250|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
105940016|NCT03715829|365441251|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
105940017|NCT03715829|365441252|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
105940018|NCT03715829|365441242|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940019|NCT03715829|365441243|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940020|NCT03715829|365441244|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
106011816|NCT03011099|365710475|FG001|Overall Study|Withdrawal by Subject|2|||
106011817|NCT02072668|365710480|FG000|Second Intervention|Lost to Follow-up|1|||
105737596|NCT02699515|364696707|FG000|Overall Study|Withdrawal by Subject|0|||
105737597|NCT02699515|364696708|FG001|Overall Study|Withdrawal by Subject|0|||
105737598|NCT02699515|364696709|FG002|Overall Study|Withdrawal by Subject|3|||
105737599|NCT02699515|364696710|FG003|Overall Study|Withdrawal by Subject|1|||
105737600|NCT02699515|364696711|FG004|Overall Study|Withdrawal by Subject|5|||
105737601|NCT02699515|364696712|FG005|Overall Study|Withdrawal by Subject|3|||
105737602|NCT02699515|364696713|FG006|Overall Study|Withdrawal by Subject|0|||
105737603|NCT02699515|364696714|FG007|Overall Study|Withdrawal by Subject|1|||
105737604|NCT02699515|364696707|FG000|Overall Study|Other|1|||
105737605|NCT02699515|364696708|FG001|Overall Study|Other|0|||
105737606|NCT02699515|364696709|FG002|Overall Study|Other|1|||
105737607|NCT02699515|364696710|FG003|Overall Study|Other|6|||
105737608|NCT02699515|364696711|FG004|Overall Study|Other|4|||
105737609|NCT02699515|364696712|FG005|Overall Study|Other|3|||
106140711|NCT02341625|366172621|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
106140712|NCT02341625|366172622|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
106140713|NCT02341625|366172623|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
106140714|NCT02341625|366172624|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
106140715|NCT02341625|366172625|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
106140716|NCT02341625|366172626|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
106140717|NCT02341625|366172627|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
105737610|NCT02699515|364696713|FG006|Overall Study|Other|0|||
106011818|NCT02072668|365710481|FG001|Second Intervention|Lost to Follow-up|0|||
106011819|NCT02668653|365710482|FG000|Overall Study|Refractory disease|41|||
106011820|NCT02668653|365710483|FG001|Overall Study|Refractory disease|70|||
106011821|NCT02668653|365710482|FG000|Overall Study|Relapse|44|||
106011822|NCT02668653|365710483|FG001|Overall Study|Relapse|65|||
106011823|NCT02668653|365710482|FG000|Overall Study|Adverse Event|58|||
106011824|NCT02668653|365710483|FG001|Overall Study|Adverse Event|23|||
106011825|NCT02668653|365710482|FG000|Overall Study|Subject decision to stop study drug|25|||
106011826|NCT02668653|365710483|FG001|Overall Study|Subject decision to stop study drug|23|||
106011827|NCT02668653|365710482|FG000|Overall Study|Other reasons not specified|16|||
106140718|NCT02341625|366172618|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105737611|NCT02699515|364696714|FG007|Overall Study|Other|0|||
105737612|NCT00375934|364696717|FG000|Overall Study|Adverse Event|1|||
105737613|NCT00375934|364696718|FG001|Overall Study|Adverse Event|1|||
105737614|NCT00375934|364696717|FG000|Overall Study|Withdrawal by Subject|2|||
105737615|NCT00375934|364696718|FG001|Overall Study|Withdrawal by Subject|2|||
105737616|NCT00375934|364696717|FG000|Overall Study|Lack of Efficacy|0|||
105737617|NCT00375934|364696718|FG001|Overall Study|Lack of Efficacy|2|||
105737618|NCT00375934|364696717|FG000|Overall Study|Physician Decision|0|||
105737619|NCT00375934|364696718|FG001|Overall Study|Physician Decision|1|||
105737620|NCT02452970|364696719|FG000|Overall Study|Adverse Event|1|||
105737621|NCT03953898|364696720|FG000|Overall Study|Lack of Efficacy|8|||
105737622|NCT03953898|364696720|FG000|Overall Study|Death|3|||
105940021|NCT03715829|365441245|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940022|NCT03715829|365441246|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940023|NCT03715829|365441247|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940024|NCT03715829|365441248|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940025|NCT03715829|365441249|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940026|NCT03715829|365441250|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
105940027|NCT03715829|365441251|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940028|NCT03715829|365441252|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
105940029|NCT03715829|365441242|FG000|Extension Period|Other|0|||
105940030|NCT03715829|365441243|FG001|Extension Period|Other|0|||
105940031|NCT03715829|365441244|FG002|Extension Period|Other|0|||
105940032|NCT03715829|365441245|FG003|Extension Period|Other|0|||
105940033|NCT03715829|365441246|FG004|Extension Period|Other|0|||
105940034|NCT03715829|365441247|FG005|Extension Period|Other|0|||
105940035|NCT03715829|365441248|FG006|Extension Period|Other|1|||
105940036|NCT03715829|365441249|FG007|Extension Period|Other|2|||
105940037|NCT03715829|365441250|FG008|Extension Period|Other|4|||
105940038|NCT03715829|365441251|FG009|Extension Period|Other|0|||
105940039|NCT03715829|365441252|FG010|Extension Period|Other|0|||
105940040|NCT05451329|365441253|FG000|Overall Study|Adverse Event|1|||
105940041|NCT05451329|365441254|FG001|Overall Study|Adverse Event|1|||
105940042|NCT05451329|365441255|FG002|Overall Study|Adverse Event|0|||
105940043|NCT05451329|365441253|FG000|Overall Study|Withdrawal by Subject|1|||
105940044|NCT05451329|365441254|FG001|Overall Study|Withdrawal by Subject|0|||
105940045|NCT05451329|365441255|FG002|Overall Study|Withdrawal by Subject|0|||
105940046|NCT05451329|365441253|FG000|Overall Study|Investigational Product Lot exchange|1|||
105940047|NCT05451329|365441254|FG001|Overall Study|Investigational Product Lot exchange|1|||
105940048|NCT05451329|365441255|FG002|Overall Study|Investigational Product Lot exchange|0|||
105940049|NCT02655601|365441258|FG000|Overall Study|Adverse Event|0|||
105940050|NCT02655601|365441259|FG001|Overall Study|Adverse Event|0|||
105940051|NCT02655601|365441260|FG002|Overall Study|Adverse Event|0|||
105940052|NCT02655601|365441261|FG003|Overall Study|Adverse Event|1|||
106011828|NCT02668653|365710483|FG001|Overall Study|Other reasons not specified|11|||
105737623|NCT03953898|364696720|FG000|Overall Study|Withdrawal by Subject|2|||
106011829|NCT02668653|365710482|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
106011830|NCT02668653|365710483|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
105940053|NCT02655601|365441262|FG004|Overall Study|Adverse Event|1|||
105940054|NCT02655601|365441263|FG005|Overall Study|Adverse Event|0|||
105940055|NCT02655601|365441258|FG000|Overall Study|Physician Decision|0|||
106011831|NCT02668653|365710482|FG000|Overall Study|Investigator decision|10|||
105737624|NCT03953898|364696720|FG000|Overall Study|Adverse Event|1|||
105940056|NCT02655601|365441259|FG001|Overall Study|Physician Decision|0|||
105940057|NCT02655601|365441260|FG002|Overall Study|Physician Decision|0|||
105940058|NCT02655601|365441261|FG003|Overall Study|Physician Decision|0|||
106011832|NCT02668653|365710483|FG001|Overall Study|Investigator decision|7|||
105737625|NCT04359823|364696721|FG000|Overall Study|Lost to Follow-up|0|||
105737626|NCT04359823|364696722|FG001|Overall Study|Lost to Follow-up|1|||
105737627|NCT04359823|364696721|FG000|Overall Study|Withdrawal by Subject|0|||
105940059|NCT02655601|365441262|FG004|Overall Study|Physician Decision|1|||
105940060|NCT02655601|365441263|FG005|Overall Study|Physician Decision|1|||
105940061|NCT02655601|365441258|FG000|Overall Study|Withdrawal by Subject|0|||
105940062|NCT02655601|365441259|FG001|Overall Study|Withdrawal by Subject|0|||
105940063|NCT02655601|365441260|FG002|Overall Study|Withdrawal by Subject|0|||
105940064|NCT02655601|365441261|FG003|Overall Study|Withdrawal by Subject|0|||
105940065|NCT02655601|365441262|FG004|Overall Study|Withdrawal by Subject|4|||
105940066|NCT02655601|365441263|FG005|Overall Study|Withdrawal by Subject|8|||
105940067|NCT02655601|365441258|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
105940068|NCT02655601|365441259|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105940069|NCT02655601|365441260|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105940070|NCT02655601|365441261|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105940071|NCT02655601|365441262|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
105940072|NCT02655601|365441263|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
106011833|NCT02668653|365710482|FG000|Overall Study|Failure to meet continuation criteria|5|||
106011834|NCT02668653|365710483|FG001|Overall Study|Failure to meet continuation criteria|12|||
106011835|NCT02668653|365710482|FG000|Overall Study|Lost to Follow-up|1|||
106011836|NCT02668653|365710483|FG001|Overall Study|Lost to Follow-up|0|||
106011837|NCT02668653|365710482|FG000|Overall Study|Pregnancy|0|||
106011838|NCT02668653|365710483|FG001|Overall Study|Pregnancy|1|||
106011839|NCT02668653|365710482|FG000|Overall Study|Death|0|||
106011840|NCT02668653|365710483|FG001|Overall Study|Death|1|||
106011841|NCT03987503|365710484|FG000|Overall Study|Lost to Follow-up|20|||
106011842|NCT03987503|365710484|FG000|Overall Study|Withdrawal by Subject|2|||
106011843|NCT00926237|365710485|FG000|Overall Study|Withdrawal by Subject|2|||
106011844|NCT00926237|365710486|FG001|Overall Study|Withdrawal by Subject|1|||
106011845|NCT04949490|365710488|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
106011846|NCT04949490|365710489|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
106011847|NCT04949490|365710490|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
106011848|NCT04949490|365710491|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
106011849|NCT04949490|365710492|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
106011850|NCT04949490|365710493|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
106011851|NCT04949490|365710488|FG000|Group A and Group B|Withdrawal by Subject|0|||
106011852|NCT04949490|365710489|FG001|Group A and Group B|Withdrawal by Subject|0|||
106011853|NCT04949490|365710490|FG002|Group A and Group B|Withdrawal by Subject|1|||
106011854|NCT04949490|365710491|FG003|Group A and Group B|Withdrawal by Subject|0|||
106011855|NCT04949490|365710492|FG004|Group A and Group B|Withdrawal by Subject|0|||
106011856|NCT04949490|365710493|FG005|Group A and Group B|Withdrawal by Subject|0|||
106011857|NCT04949490|365710488|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
106011858|NCT04949490|365710489|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
106011859|NCT04949490|365710490|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
106011860|NCT04949490|365710491|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
106011861|NCT04949490|365710492|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
106011862|NCT04949490|365710493|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
106011863|NCT04949490|365710488|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
106011864|NCT04949490|365710489|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
106011865|NCT04949490|365710490|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
106011866|NCT04949490|365710491|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
106011867|NCT04949490|365710492|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
106011868|NCT04949490|365710493|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
106011869|NCT04721977|365710494|FG000|Overall Study|Death|15|||
106011870|NCT04721977|365710494|FG000|Overall Study|Ongoing|51|||
106011871|NCT02864394|365710496|FG000|Overall Study|Death|184|||
106011872|NCT02864394|365710497|FG001|Overall Study|Death|189|||
106011873|NCT02864394|365710496|FG000|Overall Study|Lost to Follow-up|0|||
106011874|NCT02864394|365710497|FG001|Overall Study|Lost to Follow-up|2|||
106011875|NCT02864394|365710496|FG000|Overall Study|Sponsor Decision|26|||
106011876|NCT02864394|365710497|FG001|Overall Study|Sponsor Decision|11|||
106011877|NCT02864394|365710496|FG000|Overall Study|Withdrawal by Subject|3|||
106011878|NCT02864394|365710497|FG001|Overall Study|Withdrawal by Subject|10|||
106011879|NCT01597596|365712701|FG000|Overall Study|Study terminated by sponsor|1|||
106011880|NCT01597596|365712702|FG001|Overall Study|Study terminated by sponsor|0|||
106011881|NCT01597596|365712701|FG000|Overall Study|Physician Decision|0|||
106011882|NCT01597596|365712702|FG001|Overall Study|Physician Decision|1|||
106011883|NCT00939393|365712708|FG000|Overall Study|Withdrawal by Subject|1|||
105737628|NCT04359823|364696722|FG001|Overall Study|Withdrawal by Subject|1|||
105737629|NCT02531035|364696723|FG000|Overall Study|Death|0|||
106140719|NCT02341625|366172619|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
106140720|NCT02341625|366172620|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
106140721|NCT02341625|366172621|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
106140722|NCT02341625|366172622|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
105737630|NCT02531035|364696724|FG001|Overall Study|Death|1|||
105737631|NCT02531035|364696723|FG000|Overall Study|Protocol Violation|1|||
105737632|NCT02531035|364696724|FG001|Overall Study|Protocol Violation|1|||
105737633|NCT02531035|364696723|FG000|Overall Study|Noncompliance with study drug|8|||
105737634|NCT02531035|364696724|FG001|Overall Study|Noncompliance with study drug|3|||
105737635|NCT02531035|364696723|FG000|Overall Study|Physician Decision|1|||
105737636|NCT02531035|364696724|FG001|Overall Study|Physician Decision|0|||
105737637|NCT02531035|364696723|FG000|Overall Study|Adverse Event|16|||
105737638|NCT02531035|364696724|FG001|Overall Study|Adverse Event|45|||
105737639|NCT02531035|364696723|FG000|Overall Study|Other|3|||
105737640|NCT02531035|364696724|FG001|Overall Study|Other|2|||
105737641|NCT02531035|364696723|FG000|Overall Study|Withdrawal by Subject|42|||
105737642|NCT02531035|364696724|FG001|Overall Study|Withdrawal by Subject|32|||
105737643|NCT02531035|364696723|FG000|Overall Study|Lost to Follow-up|8|||
105737644|NCT02531035|364696724|FG001|Overall Study|Lost to Follow-up|10|||
105737645|NCT02531035|364696723|FG000|Overall Study|Randomized, not treated|2|||
105737646|NCT02531035|364696724|FG001|Overall Study|Randomized, not treated|1|||
105737647|NCT04168645|364696729|FG000|Overall Study|Lost to Follow-up|23|||
105737648|NCT04168645|364696730|FG001|Overall Study|Lost to Follow-up|28|||
105737649|NCT04168645|364696731|FG002|Overall Study|Lost to Follow-up|15|||
105737650|NCT04168645|364696732|FG003|Overall Study|Lost to Follow-up|12|||
105737651|NCT04168645|364696729|FG000|Overall Study|Death|1|||
105737652|NCT04168645|364696730|FG001|Overall Study|Death|1|||
105737653|NCT04168645|364696731|FG002|Overall Study|Death|0|||
105737654|NCT04168645|364696732|FG003|Overall Study|Death|0|||
105737655|NCT04168645|364696729|FG000|Overall Study|Withdrawal by Subject|5|||
105737656|NCT04168645|364696730|FG001|Overall Study|Withdrawal by Subject|2|||
105737657|NCT04168645|364696731|FG002|Overall Study|Withdrawal by Subject|2|||
105737658|NCT04168645|364696732|FG003|Overall Study|Withdrawal by Subject|2|||
105737659|NCT04168645|364696729|FG000|Overall Study|Administrative Withdrawal|3|||
105737660|NCT04168645|364696730|FG001|Overall Study|Administrative Withdrawal|1|||
105737661|NCT04168645|364696731|FG002|Overall Study|Administrative Withdrawal|1|||
105737662|NCT04168645|364696732|FG003|Overall Study|Administrative Withdrawal|3|||
105737663|NCT03032068|364696743|FG000|Overall Study|Adverse Event|1|||
105737664|NCT03132805|364696746|FG000|Overall Study|Lost to Follow-up|142|||
105940073|NCT01681849|365441270|FG000|Overall Study|Protocol Violation|2|||
105940074|NCT01681849|365441271|FG001|Overall Study|Protocol Violation|0|||
105940075|NCT01681849|365441272|FG002|Overall Study|Protocol Violation|0|||
105940076|NCT01681849|365441270|FG000|Overall Study|Withdrawal by Subject|3|||
105940077|NCT01681849|365441271|FG001|Overall Study|Withdrawal by Subject|5|||
105940078|NCT01681849|365441272|FG002|Overall Study|Withdrawal by Subject|33|||
105940079|NCT01681849|365441270|FG000|Overall Study|Lost to Follow-up|3|||
105940080|NCT01681849|365441271|FG001|Overall Study|Lost to Follow-up|2|||
105940081|NCT01681849|365441272|FG002|Overall Study|Lost to Follow-up|6|||
105940082|NCT01922895|365441275|FG000|Overall Study|Death|0|||
105940083|NCT01922895|365441276|FG001|Overall Study|Death|1|||
105940084|NCT01922895|365441275|FG000|Overall Study|Withdrawal by Subject|1|||
105737665|NCT03132805|364696747|FG001|Overall Study|Lost to Follow-up|141|||
105737666|NCT03132805|364696748|FG002|Overall Study|Lost to Follow-up|113|||
105737667|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
105737668|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
105940085|NCT01922895|365441276|FG001|Overall Study|Withdrawal by Subject|2|||
105940086|NCT01922895|365441275|FG000|Overall Study|Lost to Follow-up|5|||
105940087|NCT01922895|365441276|FG001|Overall Study|Lost to Follow-up|11|||
105952132|NCT03314935|365488198|FG014|Phase 1|Lost to Follow-up|0|||
105952133|NCT03314935|365488184|FG000|Phase 2|Death|0|||
105952134|NCT03314935|365488185|FG001|Phase 2|Death|0|||
105952135|NCT03314935|365488186|FG002|Phase 2|Death|0|||
105952136|NCT03314935|365488187|FG003|Phase 2|Death|0|||
105952137|NCT03314935|365488188|FG004|Phase 2|Death|0|||
105952138|NCT03314935|365488189|FG005|Phase 2|Death|0|||
105952139|NCT03314935|365488190|FG006|Phase 2|Death|0|||
105952140|NCT03314935|365488191|FG007|Phase 2|Death|0|||
105952141|NCT03314935|365488192|FG008|Phase 2|Death|0|||
105952142|NCT03314935|365488193|FG009|Phase 2|Death|5|||
105952143|NCT03314935|365488194|FG010|Phase 2|Death|20|||
105952144|NCT03314935|365488195|FG011|Phase 2|Death|6|||
105952145|NCT03314935|365488196|FG012|Phase 2|Death|7|||
105952146|NCT03314935|365488197|FG013|Phase 2|Death|6|||
105952147|NCT03314935|365488198|FG014|Phase 2|Death|17|||
105952148|NCT03314935|365488184|FG000|Phase 2|Withdrawal by Subject|0|||
105952149|NCT03314935|365488185|FG001|Phase 2|Withdrawal by Subject|0|||
105952150|NCT03314935|365488186|FG002|Phase 2|Withdrawal by Subject|0|||
105952151|NCT03314935|365488187|FG003|Phase 2|Withdrawal by Subject|0|||
105952152|NCT03314935|365488188|FG004|Phase 2|Withdrawal by Subject|0|||
105952153|NCT03314935|365488189|FG005|Phase 2|Withdrawal by Subject|0|||
105952154|NCT03314935|365488190|FG006|Phase 2|Withdrawal by Subject|0|||
106011884|NCT00939393|365712709|FG001|Overall Study|Withdrawal by Subject|0|||
106011885|NCT00939393|365712708|FG000|Overall Study|Lost to Follow-up|3|||
106011886|NCT00939393|365712709|FG001|Overall Study|Lost to Follow-up|0|||
106011887|NCT02144610|365712714|FG000|Overall Study|Physician Decision|1|||
106011888|NCT02144610|365712715|FG001|Overall Study|Physician Decision|0|||
106011889|NCT02144610|365712714|FG000|Overall Study|Withdrawal by Subject|1|||
106011890|NCT02144610|365712715|FG001|Overall Study|Withdrawal by Subject|5|||
106011891|NCT02144610|365712714|FG000|Overall Study|Death|2|||
106011892|NCT02144610|365712715|FG001|Overall Study|Death|2|||
106011893|NCT02144610|365712714|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
106011894|NCT02144610|365712715|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
106011895|NCT02144610|365712714|FG000|Overall Study|Other|0|||
106011896|NCT02144610|365712715|FG001|Overall Study|Other|1|||
106011897|NCT01054885|365712716|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
106011898|NCT01054885|365712717|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
106011899|NCT01054885|365712718|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
106011900|NCT01054885|365712719|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
106011901|NCT01054885|365712720|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
106011902|NCT01054885|365712721|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
106011903|NCT01054885|365712722|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
106011904|NCT01054885|365712716|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
105737669|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
105737670|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
105737671|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
105737672|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
105737673|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
105737674|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
105737675|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
105737676|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
105737677|NCT00710034|364696749|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
105737678|NCT00710034|364696750|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
105737679|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
105737680|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
105737681|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
105737682|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
105737683|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
105737684|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
105737685|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
105737686|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
105737687|NCT00710034|364696749|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
105737688|NCT00710034|364696750|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
105737689|NCT03918642|364696751|FG000|Overall Study|Lost to Follow-up|12|||
105737690|NCT03918642|364696752|FG001|Overall Study|Lost to Follow-up|10|||
105737691|NCT01283581|364696753|FG000|Overall Study|Lost to Follow-up|8|||
105737692|NCT01283581|364696754|FG001|Overall Study|Lost to Follow-up|6|||
105737693|NCT01283581|364696755|FG002|Overall Study|Lost to Follow-up|8|||
105737694|NCT01283581|364696753|FG000|Overall Study|Withdrawal by Subject|2|||
105737695|NCT01283581|364696754|FG001|Overall Study|Withdrawal by Subject|5|||
105737696|NCT01283581|364696755|FG002|Overall Study|Withdrawal by Subject|2|||
105737697|NCT01283581|364696753|FG000|Overall Study|Adverse Event|1|||
105737698|NCT01283581|364696754|FG001|Overall Study|Adverse Event|1|||
105737699|NCT01283581|364696755|FG002|Overall Study|Adverse Event|4|||
105737700|NCT01283581|364696753|FG000|Overall Study|Physician Decision|0|||
105737701|NCT01283581|364696754|FG001|Overall Study|Physician Decision|1|||
105737702|NCT01283581|364696755|FG002|Overall Study|Physician Decision|2|||
105737703|NCT01283581|364696753|FG000|Overall Study|Protocol Violation|0|||
105737704|NCT01283581|364696754|FG001|Overall Study|Protocol Violation|1|||
105737705|NCT01283581|364696755|FG002|Overall Study|Protocol Violation|2|||
105737706|NCT01283581|364696753|FG000|Overall Study|Noncompliance|1|||
105799446|NCT01325532|364924590|FG000|Overall Study|Withdrawal by Subject|2|||
105799447|NCT01325532|364924591|FG001|Overall Study|Withdrawal by Subject|0|||
106011905|NCT01054885|365712717|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
106011906|NCT01054885|365712718|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
106011907|NCT01054885|365712719|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
106011908|NCT01054885|365712720|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
106011909|NCT01054885|365712721|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
105799448|NCT03012815|364924592|FG000|Overall Study|Lost to Follow-up|1|||
106011910|NCT01054885|365712722|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
105737707|NCT01283581|364696754|FG001|Overall Study|Noncompliance|0|||
105737708|NCT01283581|364696755|FG002|Overall Study|Noncompliance|0|||
105799449|NCT03012815|364924593|FG001|Overall Study|Lost to Follow-up|0|||
105799450|NCT03012815|364924592|FG000|Overall Study|Physician Decision|3|||
106011911|NCT01054885|365712716|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
106011912|NCT01054885|365712717|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
106011913|NCT01054885|365712718|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
106011914|NCT01054885|365712719|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
106011915|NCT01054885|365712720|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
106011916|NCT01054885|365712721|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
106011917|NCT01054885|365712722|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
106011918|NCT01054885|365712716|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
106011919|NCT01054885|365712717|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
106011920|NCT01054885|365712718|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
106011921|NCT01054885|365712719|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
106011922|NCT01054885|365712720|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
106011923|NCT01054885|365712721|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
106011924|NCT01054885|365712722|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
106011925|NCT01054885|365712716|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
106011926|NCT01054885|365712717|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
106011927|NCT01054885|365712718|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
106011928|NCT01054885|365712719|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
106011929|NCT01054885|365712720|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
105737709|NCT01283581|364696753|FG000|Overall Study|Investigator unblinded|0|||
105737710|NCT01283581|364696754|FG001|Overall Study|Investigator unblinded|0|||
105737711|NCT01283581|364696755|FG002|Overall Study|Investigator unblinded|1|||
105737712|NCT01283581|364696753|FG000|Overall Study|"Early termination"|0|||
105737713|NCT01283581|364696754|FG001|Overall Study|"Early termination"|0|||
105737714|NCT01283581|364696755|FG002|Overall Study|"Early termination"|1|||
105737715|NCT00486226|364696756|FG000|Overall Study|Death|3|||
105737716|NCT00486226|364696756|FG000|Overall Study|Adverse Event|1|||
105737717|NCT00486226|364696756|FG000|Overall Study|Withdrawal by Subject|1|||
105737718|NCT00486226|364696756|FG000|Overall Study|Lost to Follow-up|8|||
105737719|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
105737720|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
105737721|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
105737722|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
105737723|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
105737724|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
105737725|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
105737726|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
105737727|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
105737728|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
105737729|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
105737730|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
105737731|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
105737732|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
105737733|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
105737734|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
105737735|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
105940088|NCT02251041|365441277|FG000|Overall Study|Did not receive intervention|15|||
105940089|NCT02251041|365441278|FG001|Overall Study|Did not receive intervention|4|||
105940090|NCT01421459|365441279|FG000|Overall Study|Adverse Event|6|||
105940091|NCT01421459|365441280|FG001|Overall Study|Adverse Event|10|||
105940092|NCT01421459|365441279|FG000|Overall Study|Death|1|||
105940093|NCT01421459|365441280|FG001|Overall Study|Death|1|||
105940094|NCT01421459|365441279|FG000|Overall Study|Lack of Efficacy|1|||
105940095|NCT01421459|365441280|FG001|Overall Study|Lack of Efficacy|2|||
105940096|NCT01421459|365441279|FG000|Overall Study|Lost to Follow-up|8|||
105940097|NCT01421459|365441280|FG001|Overall Study|Lost to Follow-up|9|||
105940098|NCT01421459|365441279|FG000|Overall Study|Physician Decision|9|||
105940099|NCT01421459|365441280|FG001|Overall Study|Physician Decision|9|||
105940100|NCT01421459|365441279|FG000|Overall Study|Protocol Violation|8|||
105940101|NCT01421459|365441280|FG001|Overall Study|Protocol Violation|5|||
105940102|NCT01421459|365441279|FG000|Overall Study|Withdrawal by Subject|12|||
106011930|NCT01054885|365712721|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
106011931|NCT01054885|365712722|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
105737736|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
105737737|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
105737738|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
105737739|NCT01259492|364696762|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
105737740|NCT01259492|364696763|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
105737741|NCT01259492|364696764|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
105737742|NCT01259492|364696765|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
105940103|NCT01421459|365441280|FG001|Overall Study|Withdrawal by Subject|16|||
105940104|NCT04818229|365441283|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
105940105|NCT04818229|365441284|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
106140723|NCT02341625|366172623|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
106140724|NCT02341625|366172624|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
106140725|NCT02341625|366172625|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
106140726|NCT02341625|366172626|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
106140727|NCT02341625|366172627|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
106140728|NCT02341625|366172618|FG000|Overall Study|Participant Withdrew Consent|0|||
106140729|NCT02341625|366172619|FG001|Overall Study|Participant Withdrew Consent|0|||
106140730|NCT02341625|366172620|FG002|Overall Study|Participant Withdrew Consent|0|||
106140731|NCT02341625|366172621|FG003|Overall Study|Participant Withdrew Consent|1|||
106140732|NCT02341625|366172622|FG004|Overall Study|Participant Withdrew Consent|0|||
106140733|NCT02341625|366172623|FG005|Overall Study|Participant Withdrew Consent|0|||
106140734|NCT02341625|366172624|FG006|Overall Study|Participant Withdrew Consent|0|||
106140735|NCT02341625|366172625|FG007|Overall Study|Participant Withdrew Consent|0|||
106140736|NCT02341625|366172626|FG008|Overall Study|Participant Withdrew Consent|0|||
106140737|NCT02341625|366172627|FG009|Overall Study|Participant Withdrew Consent|0|||
106140738|NCT02341625|366172618|FG000|Overall Study|Completed Treatment as per Protocol|0|||
106140739|NCT02341625|366172619|FG001|Overall Study|Completed Treatment as per Protocol|0|||
106140740|NCT02341625|366172620|FG002|Overall Study|Completed Treatment as per Protocol|0|||
106140741|NCT02341625|366172621|FG003|Overall Study|Completed Treatment as per Protocol|0|||
106140742|NCT02341625|366172622|FG004|Overall Study|Completed Treatment as per Protocol|0|||
106140743|NCT02341625|366172623|FG005|Overall Study|Completed Treatment as per Protocol|0|||
106140744|NCT02341625|366172624|FG006|Overall Study|Completed Treatment as per Protocol|0|||
106140745|NCT02341625|366172625|FG007|Overall Study|Completed Treatment as per Protocol|0|||
105737743|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
105737744|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
105737745|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
105737746|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
105737747|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
105737748|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
105737749|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
105737750|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
105737751|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
105737752|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
105737753|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
105737754|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
105737755|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
105737756|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
105737757|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
105737758|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
105737759|NCT01259492|364696762|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
105737760|NCT01259492|364696763|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
105737761|NCT01259492|364696764|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
105737762|NCT01259492|364696765|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
105737763|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
105737764|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
105737765|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
105737766|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
105737767|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
105737768|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
105737769|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
105737770|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
105737771|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
105737772|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
105737773|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
105737774|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
105737775|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
105737776|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
105737777|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
105737778|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
105940106|NCT04818229|365441285|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
106140746|NCT02341625|366172626|FG008|Overall Study|Completed Treatment as per Protocol|0|||
106140747|NCT02341625|366172627|FG009|Overall Study|Completed Treatment as per Protocol|1|||
106140748|NCT02341625|366172618|FG000|Overall Study|Other Reasons|0|||
106140749|NCT02341625|366172619|FG001|Overall Study|Other Reasons|0|||
106140750|NCT02341625|366172620|FG002|Overall Study|Other Reasons|0|||
105940107|NCT04818229|365441283|FG000|Overall Study|Adverse Event|3|||
105940108|NCT04818229|365441284|FG001|Overall Study|Adverse Event|1|||
106140751|NCT02341625|366172621|FG003|Overall Study|Other Reasons|0|||
105940109|NCT04818229|365441285|FG002|Overall Study|Adverse Event|1|||
105940110|NCT04818229|365441283|FG000|Overall Study|Withdrawal by Subject|0|||
105940111|NCT04818229|365441284|FG001|Overall Study|Withdrawal by Subject|0|||
105940112|NCT04818229|365441285|FG002|Overall Study|Withdrawal by Subject|2|||
105940113|NCT04818229|365441283|FG000|Overall Study|Lost to Follow-up|0|||
105940114|NCT04818229|365441284|FG001|Overall Study|Lost to Follow-up|0|||
105940115|NCT04818229|365441285|FG002|Overall Study|Lost to Follow-up|1|||
105940116|NCT03186378|365441286|FG000|Overall Study|Lost to Follow-up|1|||
105940117|NCT03186378|365441287|FG001|Overall Study|Lost to Follow-up|0|||
105940118|NCT02181413|365441288|FG000|Overall Study|Withdrawal by Subject|45|||
105940119|NCT02181413|365441289|FG001|Overall Study|Withdrawal by Subject|61|||
105940120|NCT02181413|365441288|FG000|Overall Study|Reason Not Specified|2|||
105940121|NCT02181413|365441289|FG001|Overall Study|Reason Not Specified|5|||
105940122|NCT02181413|365441288|FG000|Overall Study|Lost to Follow-up|8|||
105940123|NCT02181413|365441289|FG001|Overall Study|Lost to Follow-up|7|||
105940124|NCT00050011|365441293|FG000|Overall Study|Adverse Event|41|||
105940125|NCT00050011|365441294|FG001|Overall Study|Adverse Event|46|||
105799451|NCT03012815|364924593|FG001|Overall Study|Physician Decision|2|||
105799452|NCT03012815|364924592|FG000|Overall Study|Adverse Event|1|||
105799453|NCT03012815|364924593|FG001|Overall Study|Adverse Event|0|||
105799454|NCT01252238|364924594|FG000|Overall Study|Sponsor terminated study|4|||
105799455|NCT01252238|364924595|FG001|Overall Study|Sponsor terminated study|4|||
105799456|NCT01252238|364924596|FG002|Overall Study|Sponsor terminated study|4|||
105799457|NCT01814137|364924597|FG000|Overall Study|Adverse Event|0|||
105799458|NCT01814137|364924598|FG001|Overall Study|Adverse Event|1|||
105799459|NCT01814137|364924597|FG000|Overall Study|Withdrawal by Subject|2|||
105799460|NCT01814137|364924598|FG001|Overall Study|Withdrawal by Subject|2|||
105799461|NCT01814137|364924597|FG000|Overall Study|Physician Decision|1|||
105799462|NCT01814137|364924598|FG001|Overall Study|Physician Decision|1|||
105799463|NCT01814137|364924597|FG000|Overall Study|Unclassified|2|||
105799464|NCT01814137|364924598|FG001|Overall Study|Unclassified|1|||
105799465|NCT01271933|364924606|FG000|Single-Blind Phase|Lack of Efficacy|37|||
105799466|NCT01271933|364924607|FG001|Single-Blind Phase|Lack of Efficacy|0|||
105799467|NCT01271933|364924608|FG002|Single-Blind Phase|Lack of Efficacy|0|||
105799468|NCT01271933|364924606|FG000|Single-Blind Phase|Lost to Follow-up|10|||
105799469|NCT01271933|364924607|FG001|Single-Blind Phase|Lost to Follow-up|0|||
105799470|NCT01271933|364924608|FG002|Single-Blind Phase|Lost to Follow-up|0|||
105799471|NCT01271933|364924606|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
105799472|NCT01271933|364924607|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
105799473|NCT01271933|364924608|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
105799474|NCT01271933|364924606|FG000|Single-Blind Phase|Protocol Violation|3|||
105799475|NCT01271933|364924607|FG001|Single-Blind Phase|Protocol Violation|0|||
105799476|NCT01271933|364924608|FG002|Single-Blind Phase|Protocol Violation|0|||
105940126|NCT00050011|365441293|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105940127|NCT00050011|365441294|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105940128|NCT00050011|365441293|FG000|Overall Study|Abnormal test procedure results|0|||
105940129|NCT00050011|365441294|FG001|Overall Study|Abnormal test procedure results|1|||
105940130|NCT00050011|365441293|FG000|Overall Study|Lack of Efficacy|16|||
105940131|NCT00050011|365441294|FG001|Overall Study|Lack of Efficacy|21|||
105940132|NCT00050011|365441293|FG000|Overall Study|Participant condition no longer required|1|||
105940133|NCT00050011|365441294|FG001|Overall Study|Participant condition no longer required|0|||
105940134|NCT00050011|365441293|FG000|Overall Study|Protocol Violation|4|||
105940135|NCT00050011|365441294|FG001|Overall Study|Protocol Violation|10|||
105940136|NCT00050011|365441293|FG000|Overall Study|Withdrawal by Subject|34|||
105940137|NCT00050011|365441294|FG001|Overall Study|Withdrawal by Subject|26|||
105940138|NCT00050011|365441293|FG000|Overall Study|Lost to Follow-up|7|||
105940139|NCT00050011|365441294|FG001|Overall Study|Lost to Follow-up|9|||
105940140|NCT00050011|365441293|FG000|Overall Study|Administrative problems|10|||
105940141|NCT00050011|365441294|FG001|Overall Study|Administrative problems|6|||
105940142|NCT00050011|365441293|FG000|Overall Study|Death|7|||
105940143|NCT00050011|365441294|FG001|Overall Study|Death|4|||
105940144|NCT00050011|365441293|FG000|Overall Study|Unknown - Reason is missing|0|||
105940145|NCT00050011|365441294|FG001|Overall Study|Unknown - Reason is missing|2|||
105940146|NCT04903093|365441301|FG000|Overall Study|Withdrawal by Subject|0|||
105940147|NCT04903093|365441302|FG001|Overall Study|Withdrawal by Subject|0|||
105940148|NCT04903093|365441303|FG002|Overall Study|Withdrawal by Subject|0|||
105940149|NCT04903093|365441304|FG003|Overall Study|Withdrawal by Subject|1|||
105940150|NCT04903093|365441305|FG004|Overall Study|Withdrawal by Subject|0|||
106011932|NCT01054885|365712716|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
105940151|NCT04903093|365441306|FG005|Overall Study|Withdrawal by Subject|0|||
106140752|NCT02341625|366172622|FG004|Overall Study|Other Reasons|1|||
105799477|NCT01271933|364924606|FG000|Single-Blind Phase|Adverse Event|52|||
105940152|NCT02544763|365441307|FG000|Overall Study|Adverse Event|8|||
105940153|NCT02544763|365441308|FG001|Overall Study|Adverse Event|8|||
105940154|NCT02544763|365441309|FG002|Overall Study|Adverse Event|0|||
105940155|NCT02544763|365441307|FG000|Overall Study|Withdrawn by parent/guardian|1|||
105940156|NCT02544763|365441308|FG001|Overall Study|Withdrawn by parent/guardian|1|||
105737779|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
105737780|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
105799478|NCT01271933|364924607|FG001|Single-Blind Phase|Adverse Event|0|||
106011933|NCT01054885|365712717|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
106011934|NCT01054885|365712718|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
106011935|NCT01054885|365712719|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
106011936|NCT01054885|365712720|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
106011937|NCT01054885|365712721|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
106011938|NCT01054885|365712722|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
106011939|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
106011940|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
106011941|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
106011942|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
106011943|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
106011944|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
106011945|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
106011946|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
106011947|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
106011948|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
106011949|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
106011950|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
106011951|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
106011952|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
106011953|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
106011954|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
106011955|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
106011956|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
106011957|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
106011958|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
106011959|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
106011960|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
106011961|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
106011962|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
106011963|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
106011964|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
106011965|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
106011966|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
106011967|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
106011968|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
106011969|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
106011970|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
106011971|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
106140753|NCT02341625|366172623|FG005|Overall Study|Other Reasons|0|||
106140754|NCT02341625|366172624|FG006|Overall Study|Other Reasons|5|||
106140755|NCT02341625|366172625|FG007|Overall Study|Other Reasons|0|||
106140756|NCT02341625|366172626|FG008|Overall Study|Other Reasons|0|||
105940157|NCT02544763|365441309|FG002|Overall Study|Withdrawn by parent/guardian|1|||
105940158|NCT02544763|365441307|FG000|Overall Study|Met withdrawal criteria|0|||
105940159|NCT02544763|365441308|FG001|Overall Study|Met withdrawal criteria|2|||
105940160|NCT02544763|365441309|FG002|Overall Study|Met withdrawal criteria|0|||
105940161|NCT02544763|365441307|FG000|Overall Study|Physician Decision|0|||
105940162|NCT02544763|365441308|FG001|Overall Study|Physician Decision|1|||
105940163|NCT02544763|365441309|FG002|Overall Study|Physician Decision|0|||
105940164|NCT02544763|365441307|FG000|Overall Study|Difficulties taking IMP|1|||
105940165|NCT02544763|365441308|FG001|Overall Study|Difficulties taking IMP|0|||
105940166|NCT02544763|365441309|FG002|Overall Study|Difficulties taking IMP|0|||
105940167|NCT02097225|365441310|FG000|Dose Level 4|Adverse Event|0|||
105940168|NCT02097225|365441311|FG001|Dose Level 4|Adverse Event|0|||
105940169|NCT02097225|365441312|FG002|Dose Level 4|Adverse Event|0|||
105940170|NCT02097225|365441313|FG003|Dose Level 4|Adverse Event|0|||
105940171|NCT02097225|365441314|FG004|Dose Level 4|Adverse Event|1|||
105940172|NCT01027351|365441316|FG000|Overall Study|Withdrawal by Subject|1|||
105940173|NCT01027351|365441317|FG001|Overall Study|Withdrawal by Subject|0|||
105940174|NCT01027351|365441318|FG002|Overall Study|Withdrawal by Subject|1|||
105940175|NCT01027351|365441319|FG003|Overall Study|Withdrawal by Subject|0|||
105940176|NCT01027351|365441320|FG004|Overall Study|Withdrawal by Subject|3|||
105799479|NCT01271933|364924608|FG002|Single-Blind Phase|Adverse Event|0|||
105799480|NCT01271933|364924606|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
105799481|NCT01271933|364924607|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
105799482|NCT01271933|364924608|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
105799483|NCT01271933|364924606|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
105799484|NCT01271933|364924607|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
105799485|NCT01271933|364924608|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
105799486|NCT01271933|364924606|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
105799487|NCT01271933|364924607|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
105799488|NCT01271933|364924608|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
105799489|NCT01271933|364924606|FG000|Double-Blind Phase|Randomized but not treated|0|||
105799490|NCT01271933|364924607|FG001|Double-Blind Phase|Randomized but not treated|0|||
105799491|NCT01271933|364924608|FG002|Double-Blind Phase|Randomized but not treated|1|||
105799492|NCT01271933|364924606|FG000|Double-Blind Phase|Lack of Efficacy|0|||
105799493|NCT01271933|364924607|FG001|Double-Blind Phase|Lack of Efficacy|6|||
105799494|NCT01271933|364924608|FG002|Double-Blind Phase|Lack of Efficacy|9|||
105799495|NCT01271933|364924606|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105799496|NCT01271933|364924607|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105799497|NCT01271933|364924608|FG002|Double-Blind Phase|Lost to Follow-up|1|||
105799498|NCT01271933|364924606|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105799499|NCT01271933|364924607|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
105799500|NCT01271933|364924608|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
105799501|NCT01271933|364924606|FG000|Double-Blind Phase|Adverse Event|0|||
105799502|NCT01271933|364924607|FG001|Double-Blind Phase|Adverse Event|3|||
105799503|NCT01271933|364924608|FG002|Double-Blind Phase|Adverse Event|0|||
105799504|NCT01271933|364924606|FG000|Double-Blind Phase|Participant request-personal reason|0|||
105799505|NCT01271933|364924607|FG001|Double-Blind Phase|Participant request-personal reason|1|||
106011972|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
106011973|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
106011974|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
106011975|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
106011976|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
106011977|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
106011978|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
106011979|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
106011980|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
106011981|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
106011982|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
106011983|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
106011984|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
106011985|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
106011986|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
105799506|NCT01271933|364924608|FG002|Double-Blind Phase|Participant request-personal reason|0|||
105799507|NCT01256398|364924609|FG000|Overall Study|Withdrawal by Subject|1|||
105799508|NCT04380701|364924614|FG000|Overall Study|Pregnancy|0|||
105799509|NCT04380701|364924615|FG001|Overall Study|Pregnancy|0|||
105799510|NCT04380701|364924616|FG002|Overall Study|Pregnancy|0|||
105799511|NCT04380701|364924617|FG003|Overall Study|Pregnancy|0|||
105799512|NCT04380701|364924618|FG004|Overall Study|Pregnancy|0|||
105799513|NCT04380701|364924619|FG005|Overall Study|Pregnancy|0|||
105799514|NCT04380701|364924620|FG006|Overall Study|Pregnancy|0|||
105799515|NCT04380701|364924621|FG007|Overall Study|Pregnancy|0|||
105799516|NCT04380701|364924622|FG008|Overall Study|Pregnancy|0|||
105799517|NCT04380701|364924623|FG009|Overall Study|Pregnancy|0|||
105799518|NCT04380701|364924624|FG010|Overall Study|Pregnancy|0|||
105799519|NCT04380701|364924625|FG011|Overall Study|Pregnancy|0|||
105799520|NCT04380701|364924626|FG012|Overall Study|Pregnancy|0|||
105799521|NCT04380701|364924627|FG013|Overall Study|Pregnancy|0|||
105799522|NCT04380701|364924628|FG014|Overall Study|Pregnancy|0|||
105799523|NCT04380701|364924629|FG015|Overall Study|Pregnancy|0|||
105799524|NCT04380701|364924630|FG016|Overall Study|Pregnancy|0|||
105799525|NCT04380701|364924631|FG017|Overall Study|Pregnancy|0|||
106011987|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
106011988|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
106011989|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
106011990|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
106011991|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
105799526|NCT04380701|364924632|FG018|Overall Study|Pregnancy|0|||
105799527|NCT04380701|364924633|FG019|Overall Study|Pregnancy|0|||
105799528|NCT04380701|364924634|FG020|Overall Study|Pregnancy|0|||
105799529|NCT04380701|364924635|FG021|Overall Study|Pregnancy|0|||
105799530|NCT04380701|364924636|FG022|Overall Study|Pregnancy|0|||
105799531|NCT04380701|364924637|FG023|Overall Study|Pregnancy|0|||
106140757|NCT02341625|366172627|FG009|Overall Study|Other Reasons|2|||
106140758|NCT02341625|366172618|FG000|Overall Study|Not Reported|0|||
106140759|NCT02341625|366172619|FG001|Overall Study|Not Reported|0|||
106140760|NCT02341625|366172620|FG002|Overall Study|Not Reported|0|||
106140761|NCT02341625|366172621|FG003|Overall Study|Not Reported|0|||
106140762|NCT02341625|366172622|FG004|Overall Study|Not Reported|0|||
106140763|NCT02341625|366172623|FG005|Overall Study|Not Reported|0|||
106140764|NCT02341625|366172624|FG006|Overall Study|Not Reported|0|||
106140765|NCT02341625|366172625|FG007|Overall Study|Not Reported|0|||
106140766|NCT02341625|366172626|FG008|Overall Study|Not Reported|0|||
106140767|NCT02341625|366172627|FG009|Overall Study|Not Reported|3|||
106140768|NCT00367055|366172628|FG000|Overall Study|Adverse Event|6|||
106140769|NCT00367055|366172629|FG001|Overall Study|Adverse Event|3|||
106140770|NCT00367055|366172628|FG000|Overall Study|Patient's Willing|3|||
106140771|NCT00367055|366172629|FG001|Overall Study|Patient's Willing|2|||
106140772|NCT00367055|366172628|FG000|Overall Study|Lack of Efficacy|1|||
106140773|NCT00367055|366172629|FG001|Overall Study|Lack of Efficacy|2|||
106140774|NCT00367055|366172628|FG000|Overall Study|Lost to Follow-up|1|||
106140775|NCT00367055|366172629|FG001|Overall Study|Lost to Follow-up|1|||
106140776|NCT00367055|366172628|FG000|Overall Study|Protocol Violation|0|||
106140777|NCT00367055|366172629|FG001|Overall Study|Protocol Violation|1|||
106140778|NCT00367055|366172628|FG000|Overall Study|Stopping Criterion Met|0|||
106140779|NCT00367055|366172629|FG001|Overall Study|Stopping Criterion Met|1|||
106140780|NCT00367055|366172628|FG000|Overall Study|Participant Living too Far from Hospital|0|||
106140781|NCT00367055|366172629|FG001|Overall Study|Participant Living too Far from Hospital|1|||
106140782|NCT03523091|366172630|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
106140783|NCT03523091|366172631|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
106140784|NCT03523091|366172630|FG000|Overall Study|Withdrawal by Subject|0|||
106140785|NCT03523091|366172631|FG001|Overall Study|Withdrawal by Subject|3|||
106140786|NCT03523091|366172630|FG000|Overall Study|Increase Botox dose|0|||
106140787|NCT03523091|366172631|FG001|Overall Study|Increase Botox dose|1|||
106140788|NCT05019729|366172632|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
106140789|NCT05019729|366172633|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
106140790|NCT05019729|366172634|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
106140791|NCT05019729|366172635|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
106140792|NCT05019729|366172636|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
106140793|NCT05019729|366172637|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
106140794|NCT04222959|366172641|FG000|Overall Study|Lost to Follow-up|76|||
106140795|NCT04222959|366172642|FG001|Overall Study|Lost to Follow-up|28|||
106140796|NCT00387465|366172643|FG000|Overall Study|Withdrawal by Subject|0|||
106140797|NCT00387465|366172644|FG001|Overall Study|Withdrawal by Subject|1|||
106140798|NCT00387465|366172645|FG002|Overall Study|Withdrawal by Subject|0|||
106140799|NCT00849147|366172649|FG000|Overall Study|Withdrawal by Subject|1|||
106140800|NCT00849147|366172649|FG000|Overall Study|Protocol Violation|2|||
106140801|NCT00849147|366172649|FG000|Overall Study|Disease Relapse/Progression|2|||
106140802|NCT01311648|366174343|FG000|Main Study|Protocol Violation|0|||
106140803|NCT01311648|366174344|FG001|Main Study|Protocol Violation|1|||
106140804|NCT01311648|366174343|FG000|Main Study|Adverse Event|0|||
106140805|NCT01311648|366174344|FG001|Main Study|Adverse Event|1|||
106140806|NCT01311648|366174343|FG000|Main Study|Inhibitor management|0|||
106140807|NCT01311648|366174344|FG001|Main Study|Inhibitor management|17|||
106140808|NCT01311648|366174343|FG000|Main Study|Withdrawal by Subject|0|||
106140809|NCT01311648|366174344|FG001|Main Study|Withdrawal by Subject|2|||
106140810|NCT01311648|366174343|FG000|Extension Study|Physician Decision|0|||
106140811|NCT01311648|366174344|FG001|Extension Study|Physician Decision|1|||
106140812|NCT01311648|366174343|FG000|Extension Study|ITI therapy with marketed product|0|||
106140813|NCT01311648|366174344|FG001|Extension Study|ITI therapy with marketed product|1|||
106140814|NCT01311648|366174343|FG000|Extension Study|Incorrect visit planning|0|||
106140815|NCT01311648|366174344|FG001|Extension Study|Incorrect visit planning|1|||
106140816|NCT01311648|366174343|FG000|Extension Study|Family's decision|0|||
106140817|NCT01311648|366174344|FG001|Extension Study|Family's decision|1|||
106140818|NCT01311648|366174343|FG000|Extension Study|Failure of ITI therapy|0|||
106140819|NCT01311648|366174344|FG001|Extension Study|Failure of ITI therapy|3|||
106140820|NCT01311648|366174343|FG000|Extension Study|Long travel|0|||
106140821|NCT01311648|366174344|FG001|Extension Study|Long travel|1|||
106140822|NCT01311648|366174343|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
106140823|NCT01311648|366174344|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
106140824|NCT01311648|366174343|FG000|Extension Study|Withdrawal by Subject|0|||
106140825|NCT01311648|366174344|FG001|Extension Study|Withdrawal by Subject|1|||
106140826|NCT01311648|366174343|FG000|Extension Study|Inhibitor management|0|||
106140827|NCT01311648|366174344|FG001|Extension Study|Inhibitor management|2|||
106140828|NCT01331824|366174347|FG000|Overall Study|Adverse Event|2|||
106140829|NCT01331824|366174347|FG000|Overall Study|Death|1|||
106140830|NCT01331824|366174347|FG000|Overall Study|Disease Progression|9|||
106140831|NCT01331824|366174347|FG000|Overall Study|Withdrawal by Subject|1|||
105940177|NCT01027351|365441321|FG005|Overall Study|Withdrawal by Subject|5|||
105940178|NCT01027351|365441316|FG000|Overall Study|Lost to Follow-up|1|||
105940179|NCT01027351|365441317|FG001|Overall Study|Lost to Follow-up|1|||
105940180|NCT01027351|365441318|FG002|Overall Study|Lost to Follow-up|0|||
105940181|NCT01027351|365441319|FG003|Overall Study|Lost to Follow-up|1|||
105940182|NCT01027351|365441320|FG004|Overall Study|Lost to Follow-up|6|||
105940183|NCT01027351|365441321|FG005|Overall Study|Lost to Follow-up|0|||
105940184|NCT01027351|365441316|FG000|Overall Study|Inappropriate enrollment|0|||
105940185|NCT01027351|365441317|FG001|Overall Study|Inappropriate enrollment|0|||
105940186|NCT01027351|365441318|FG002|Overall Study|Inappropriate enrollment|0|||
105940187|NCT01027351|365441319|FG003|Overall Study|Inappropriate enrollment|0|||
105940188|NCT01027351|365441320|FG004|Overall Study|Inappropriate enrollment|1|||
105940189|NCT01027351|365441321|FG005|Overall Study|Inappropriate enrollment|0|||
105737781|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
105737782|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
105737783|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
105940190|NCT01027351|365441316|FG000|Overall Study|Protocol Violation|1|||
105940191|NCT01027351|365441317|FG001|Overall Study|Protocol Violation|0|||
105940192|NCT01027351|365441318|FG002|Overall Study|Protocol Violation|0|||
105940193|NCT01027351|365441319|FG003|Overall Study|Protocol Violation|1|||
105940194|NCT01027351|365441320|FG004|Overall Study|Protocol Violation|1|||
105940195|NCT01027351|365441321|FG005|Overall Study|Protocol Violation|0|||
105940196|NCT02971137|365441322|FG000|Overall Study|Lost to Follow-up|44|||
105940197|NCT02971137|365441323|FG001|Overall Study|Lost to Follow-up|56|||
105940198|NCT04755231|365441324|FG000|Overall Study|Lost to Follow-up|5|||
105940199|NCT04755231|365441324|FG000|Overall Study|Withdrawal by Subject|5|||
105940200|NCT00911157|365441325|FG000|Overall Study|Adverse Event|4|||
105940201|NCT00911157|365441326|FG001|Overall Study|Adverse Event|1|||
105940202|NCT00911157|365441325|FG000|Overall Study|Withdrawal by Subject|1|||
105940203|NCT00911157|365441326|FG001|Overall Study|Withdrawal by Subject|1|||
105940204|NCT00911157|365441325|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
105940205|NCT00911157|365441326|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
105940206|NCT00911157|365441325|FG000|Overall Study|Need to treat for lung cancer|1|||
105940207|NCT00911157|365441326|FG001|Overall Study|Need to treat for lung cancer|0|||
105940208|NCT02691494|365441330|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
105940209|NCT02691494|365441331|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
105940210|NCT02691494|365441332|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
105940211|NCT02691494|365441330|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
105940212|NCT02691494|365441331|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
105940213|NCT02691494|365441332|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
105940214|NCT02691494|365441330|FG000|Post-Treatment Follow-Up Period|Other|2|||
105940215|NCT02691494|365441331|FG001|Post-Treatment Follow-Up Period|Other|1|||
105940216|NCT02691494|365441332|FG002|Post-Treatment Follow-Up Period|Other|1|||
105940217|NCT02691494|365441330|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
105940218|NCT02691494|365441331|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
105940219|NCT02691494|365441332|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
105940220|NCT02691494|365441330|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
105940221|NCT02691494|365441331|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
105940222|NCT02691494|365441332|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
105940223|NCT03359395|365441339|FG000|First Intervention A / B|Withdrawal by Subject|1|||
105940224|NCT03359395|365441340|FG001|First Intervention A / B|Withdrawal by Subject|0|||
105940225|NCT03359395|365441339|FG000|First Intervention A / B|Lost to Follow-up|2|||
105940226|NCT03359395|365441340|FG001|First Intervention A / B|Lost to Follow-up|3|||
105940227|NCT03359395|365441339|FG000|Second Intervention B/A|Exclusion criteria|0|||
105940228|NCT03359395|365441340|FG001|Second Intervention B/A|Exclusion criteria|1|||
105940229|NCT03359395|365441339|FG000|Second Intervention B/A|Lost to Follow-up|3|||
105940230|NCT03359395|365441340|FG001|Second Intervention B/A|Lost to Follow-up|2|||
105940231|NCT05943990|365441344|FG000|Overall Study|Study Terminated by Sponsor|0|||
105940232|NCT05943990|365441345|FG001|Overall Study|Study Terminated by Sponsor|0|||
105940233|NCT05943990|365441346|FG002|Overall Study|Study Terminated by Sponsor|1|||
105940234|NCT02113878|365442884|FG000|Overall Study|Adverse Event|1|||
105940235|NCT02113878|365442885|FG001|Overall Study|Adverse Event|0|||
105940236|NCT02113878|365442884|FG000|Overall Study|Withdrawal by Subject|1|||
105940237|NCT02113878|365442885|FG001|Overall Study|Withdrawal by Subject|0|||
105940238|NCT02113878|365442884|FG000|Overall Study|patient non-compliance|1|||
105737784|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
105940239|NCT02113878|365442885|FG001|Overall Study|patient non-compliance|0|||
105940240|NCT02730169|365442890|FG000|Overall Study|Protocol Violation|1|||
105940241|NCT02730169|365442891|FG001|Overall Study|Protocol Violation|0|||
105940242|NCT02730169|365442892|FG002|Overall Study|Protocol Violation|0|||
105940243|NCT02730169|365442893|FG003|Overall Study|Protocol Violation|1|||
105940244|NCT02730169|365442890|FG000|Overall Study|Adverse Event|2|||
105940245|NCT02730169|365442891|FG001|Overall Study|Adverse Event|3|||
105799532|NCT04380701|364924638|FG024|Overall Study|Pregnancy|0|||
105799533|NCT04380701|364924639|FG025|Overall Study|Pregnancy|0|||
105799534|NCT04380701|364924640|FG026|Overall Study|Pregnancy|0|||
105799535|NCT04380701|364924641|FG027|Overall Study|Pregnancy|0|||
105799536|NCT04380701|364924642|FG028|Overall Study|Pregnancy|0|||
105799537|NCT04380701|364924643|FG029|Overall Study|Pregnancy|0|||
105799538|NCT04380701|364924644|FG030|Overall Study|Pregnancy|0|||
105799539|NCT04380701|364924645|FG031|Overall Study|Pregnancy|0|||
105940246|NCT02730169|365442892|FG002|Overall Study|Adverse Event|3|||
105940247|NCT02730169|365442893|FG003|Overall Study|Adverse Event|0|||
105940248|NCT02730169|365442890|FG000|Overall Study|Adverse Event of Special Interest|0|||
105940249|NCT02730169|365442891|FG001|Overall Study|Adverse Event of Special Interest|1|||
105940250|NCT02730169|365442892|FG002|Overall Study|Adverse Event of Special Interest|2|||
105940251|NCT02730169|365442893|FG003|Overall Study|Adverse Event of Special Interest|0|||
105940252|NCT02730169|365442890|FG000|Overall Study|Withdrawal by Subject|6|||
105940253|NCT02730169|365442891|FG001|Overall Study|Withdrawal by Subject|11|||
105940254|NCT02730169|365442892|FG002|Overall Study|Withdrawal by Subject|6|||
105940255|NCT02730169|365442893|FG003|Overall Study|Withdrawal by Subject|8|||
105940256|NCT02730169|365442890|FG000|Overall Study|Lost to Follow-up|5|||
105940257|NCT02730169|365442891|FG001|Overall Study|Lost to Follow-up|6|||
105940258|NCT02730169|365442892|FG002|Overall Study|Lost to Follow-up|5|||
105940259|NCT02730169|365442893|FG003|Overall Study|Lost to Follow-up|6|||
105940260|NCT02730169|365442890|FG000|Overall Study|Other|0|||
105940261|NCT02730169|365442891|FG001|Overall Study|Other|0|||
105940262|NCT02730169|365442892|FG002|Overall Study|Other|1|||
105940263|NCT02730169|365442893|FG003|Overall Study|Other|1|||
105940264|NCT00581100|365442894|FG000|Overall Study|Death|1|||
105940265|NCT00581100|365442895|FG001|Overall Study|Death|0|||
105940266|NCT00581100|365442894|FG000|Overall Study|Adverse Event|2|||
105940267|NCT00581100|365442895|FG001|Overall Study|Adverse Event|1|||
105940268|NCT00581100|365442894|FG000|Overall Study|Withdrawal by Subject|1|||
105940269|NCT00581100|365442895|FG001|Overall Study|Withdrawal by Subject|4|||
105940270|NCT00581100|365442894|FG000|Overall Study|Other|3|||
105940271|NCT00581100|365442895|FG001|Overall Study|Other|0|||
105940272|NCT04616196|365442906|FG000|Overall Study|Progressive Disease|3|||
105940273|NCT04616196|365442907|FG001|Overall Study|Progressive Disease|0|||
105940274|NCT04616196|365442908|FG002|Overall Study|Progressive Disease|4|||
105940275|NCT04616196|365442909|FG003|Overall Study|Progressive Disease|1|||
105940276|NCT04616196|365442906|FG000|Overall Study|Death|2|||
105940277|NCT04616196|365442907|FG001|Overall Study|Death|4|||
105940278|NCT04616196|365442908|FG002|Overall Study|Death|1|||
105940279|NCT04616196|365442909|FG003|Overall Study|Death|0|||
105940280|NCT04616196|365442906|FG000|Overall Study|Withdrawal by Subject|0|||
105940281|NCT04616196|365442907|FG001|Overall Study|Withdrawal by Subject|2|||
105940282|NCT04616196|365442908|FG002|Overall Study|Withdrawal by Subject|0|||
105940283|NCT04616196|365442909|FG003|Overall Study|Withdrawal by Subject|0|||
105940284|NCT04616196|365442906|FG000|Overall Study|Lost to Follow-up|1|||
105940285|NCT04616196|365442907|FG001|Overall Study|Lost to Follow-up|0|||
105940286|NCT04616196|365442908|FG002|Overall Study|Lost to Follow-up|0|||
105940287|NCT04616196|365442909|FG003|Overall Study|Lost to Follow-up|0|||
105940288|NCT04616196|365442906|FG000|Overall Study|Sponsor request|2|||
105940289|NCT04616196|365442907|FG001|Overall Study|Sponsor request|1|||
105940290|NCT04616196|365442908|FG002|Overall Study|Sponsor request|1|||
105940291|NCT04616196|365442909|FG003|Overall Study|Sponsor request|2|||
105940292|NCT02371889|365442910|FG000|Overall Study|Adverse medication effect|11|||
105940293|NCT02371889|365442911|FG001|Overall Study|Adverse medication effect|2|||
105940294|NCT02371889|365442910|FG000|Overall Study|Lost to Follow-up|6|||
105940295|NCT02371889|365442911|FG001|Overall Study|Lost to Follow-up|5|||
105940296|NCT02371889|365442910|FG000|Overall Study|Personal time constraints|2|||
105940297|NCT02371889|365442911|FG001|Overall Study|Personal time constraints|4|||
105940298|NCT02371889|365442910|FG000|Overall Study|Lack of Efficacy|0|||
105940299|NCT02371889|365442911|FG001|Overall Study|Lack of Efficacy|2|||
105940300|NCT02371889|365442910|FG000|Overall Study|Relapse|0|||
105940301|NCT02371889|365442911|FG001|Overall Study|Relapse|1|||
105940302|NCT00003907|365442912|FG000|Overall Study|Adverse Event|2|||
105940303|NCT00003907|365442913|FG001|Overall Study|Adverse Event|11|||
105940304|NCT00003907|365442912|FG000|Overall Study|Death|2|||
105940305|NCT00003907|365442913|FG001|Overall Study|Death|0|||
105940306|NCT00003907|365442912|FG000|Overall Study|Withdrawal by Subject|1|||
105940307|NCT00003907|365442913|FG001|Overall Study|Withdrawal by Subject|3|||
105940308|NCT00003907|365442912|FG000|Overall Study|Progressive disease|4|||
105940309|NCT00003907|365442913|FG001|Overall Study|Progressive disease|4|||
105940310|NCT00003907|365442912|FG000|Overall Study|Complicating disease|1|||
105940311|NCT00003907|365442913|FG001|Overall Study|Complicating disease|0|||
105940312|NCT00003907|365442912|FG000|Overall Study|Other|1|||
105940313|NCT00003907|365442913|FG001|Overall Study|Other|3|||
105799540|NCT04380701|364924646|FG032|Overall Study|Pregnancy|1|||
105799541|NCT04380701|364924647|FG033|Overall Study|Pregnancy|0|||
105799542|NCT04380701|364924614|FG000|Overall Study|Lost to Follow-up|0|||
105799543|NCT04380701|364924615|FG001|Overall Study|Lost to Follow-up|0|||
105940314|NCT00003907|365442912|FG000|Overall Study|ineligible or not treated|2|||
106140832|NCT03837028|366174350|FG000|Overall Study|Lost to Follow-up|4|||
106140833|NCT03837028|366174351|FG001|Overall Study|Lost to Follow-up|0|||
106140834|NCT03837028|366174352|FG002|Overall Study|Lost to Follow-up|2|||
106140835|NCT03837028|366174353|FG003|Overall Study|Lost to Follow-up|0|||
106140836|NCT03837028|366174350|FG000|Overall Study|Withdrawal by Subject|12|||
106140837|NCT03837028|366174351|FG001|Overall Study|Withdrawal by Subject|11|||
106140838|NCT03837028|366174352|FG002|Overall Study|Withdrawal by Subject|11|||
106140839|NCT03837028|366174353|FG003|Overall Study|Withdrawal by Subject|7|||
106140840|NCT00646451|366174354|FG000|Overall Study|Adverse Event|3|||
106140841|NCT00646451|366174355|FG001|Overall Study|Adverse Event|0|||
106140842|NCT00646451|366174354|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
106140843|NCT00646451|366174355|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
106140844|NCT02974634|366174356|FG000|Overall Study|Advanced disease|12|||
106140845|NCT02974634|366174357|FG001|Overall Study|Advanced disease|3|||
106140846|NCT02974634|366174356|FG000|Overall Study|Noncompliance|3|||
106140847|NCT02974634|366174357|FG001|Overall Study|Noncompliance|7|||
106140848|NCT02974634|366174356|FG000|Overall Study|intervention technology related issues|5|||
106140849|NCT02974634|366174357|FG001|Overall Study|intervention technology related issues|0|||
106140850|NCT02974634|366174356|FG000|Overall Study|Death|8|||
106140851|NCT02974634|366174357|FG001|Overall Study|Death|11|||
106140852|NCT00486759|366174358|FG000|Treatment|Adverse event/intercurrent illness|86|||
106140853|NCT00486759|366174359|FG001|Treatment|Adverse event/intercurrent illness|39|||
106140854|NCT00486759|366174358|FG000|Treatment|Insufficient therapeutic response|37|||
106140855|NCT00486759|366174359|FG001|Treatment|Insufficient therapeutic response|39|||
106140856|NCT00486759|366174358|FG000|Treatment|Death|17|||
106140857|NCT00486759|366174359|FG001|Treatment|Death|10|||
106140858|NCT00486759|366174358|FG000|Treatment|Withdrew consent|15|||
106140859|NCT00486759|366174359|FG001|Treatment|Withdrew consent|12|||
106140860|NCT00486759|366174358|FG000|Treatment|Administrative/reason not specified|17|||
106140861|NCT00486759|366174359|FG001|Treatment|Administrative/reason not specified|21|||
106140862|NCT00486759|366174358|FG000|Treatment|Refused treatment|10|||
106140863|NCT00486759|366174359|FG001|Treatment|Refused treatment|7|||
106140864|NCT00486759|366174358|FG000|Treatment|Violation of selection criteria at entry|3|||
106140865|NCT00486759|366174359|FG001|Treatment|Violation of selection criteria at entry|3|||
106140866|NCT00486759|366174358|FG000|Treatment|Other protocol violation|1|||
106140867|NCT00486759|366174359|FG001|Treatment|Other protocol violation|5|||
106140868|NCT00486759|366174358|FG000|Treatment|Failure to return|1|||
105737785|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
105737786|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
105737787|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
105737788|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
105737789|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
105737790|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
105737791|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
105737792|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
105737793|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
105737794|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
105737795|NCT01259492|364696762|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
105737796|NCT01259492|364696763|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
105737797|NCT01259492|364696764|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
105737798|NCT01259492|364696765|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
105737799|NCT01988012|364696778|FG000|Overall Study|Adverse Event|5|||
105737800|NCT01988012|364696778|FG000|Overall Study|Insufficient Therapeutic Response|3|||
105737801|NCT01988012|364696778|FG000|Overall Study|Patient Withdrawal of Consent|4|||
105737802|NCT01988012|364696778|FG000|Overall Study|Lost to Follow-up|1|||
105737803|NCT01988012|364696778|FG000|Overall Study|Physician Decision|1|||
105737804|NCT01988012|364696778|FG000|Overall Study|Protocol Violation|1|||
106140869|NCT00486759|366174359|FG001|Treatment|Failure to return|1|||
106140870|NCT00486759|366174358|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
106140871|NCT00486759|366174359|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
106140872|NCT00486759|366174358|FG000|Safety Follow-up|Death|40|||
105737805|NCT01058369|364696779|FG000|Overall Study|Adverse Event|1|||
105737806|NCT01058369|364696779|FG000|Overall Study|Early termination study|1|||
105737807|NCT00089843|364696780|FG000|Overall Study|Withdrawal by Subject|1|||
105737808|NCT00089843|364696781|FG001|Overall Study|Withdrawal by Subject|4|||
105799544|NCT04380701|364924616|FG002|Overall Study|Lost to Follow-up|0|||
106140873|NCT00486759|366174359|FG001|Safety Follow-up|Death|29|||
106140874|NCT00486759|366174358|FG000|Safety Follow-up|Withdrew consent|32|||
106140875|NCT00486759|366174359|FG001|Safety Follow-up|Withdrew consent|23|||
106140876|NCT00486759|366174358|FG000|Safety Follow-up|Failure to return|9|||
106140877|NCT00486759|366174359|FG001|Safety Follow-up|Failure to return|6|||
106140878|NCT00486759|366174358|FG000|Safety Follow-up|Administrative/not specified|8|||
106140879|NCT00486759|366174359|FG001|Safety Follow-up|Administrative/not specified|6|||
105940315|NCT00003907|365442913|FG001|Overall Study|ineligible or not treated|2|||
105940316|NCT01517178|365442914|FG000|Period 1|Adverse Event|1|||
105940317|NCT01517178|365442915|FG001|Period 1|Adverse Event|2|||
105940318|NCT01517178|365442914|FG000|Period 1|Lack of Efficacy|0|||
106011992|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
105940319|NCT01517178|365442915|FG001|Period 1|Lack of Efficacy|1|||
105940320|NCT01517178|365442914|FG000|Period 1|E.g. study termination|3|||
105940321|NCT01517178|365442915|FG001|Period 1|E.g. study termination|1|||
105940322|NCT01517178|365442914|FG000|Period 1|Withdrawal by Subject|0|||
105940323|NCT01517178|365442915|FG001|Period 1|Withdrawal by Subject|1|||
105940324|NCT01517178|365442914|FG000|Period 2|Adverse Event|1|||
105940325|NCT01517178|365442915|FG001|Period 2|Adverse Event|0|||
105940326|NCT01517178|365442914|FG000|Period 2|Withdrawal by Subject|3|||
105940327|NCT01517178|365442915|FG001|Period 2|Withdrawal by Subject|0|||
105940328|NCT01517178|365442914|FG000|Period 2|E.g. study termination|2|||
105940329|NCT01517178|365442915|FG001|Period 2|E.g. study termination|2|||
105940330|NCT01050218|365442916|FG000|Overall Study|Adverse Event|37|||
105940331|NCT01050218|365442916|FG000|Overall Study|Lack of Efficacy|8|||
105940332|NCT01050218|365442916|FG000|Overall Study|Protocol Violation|3|||
105940333|NCT01050218|365442916|FG000|Overall Study|Withdrawal by Subject|18|||
105940334|NCT01050218|365442916|FG000|Overall Study|Discontinued by sponsor|18|||
105940335|NCT01050218|365442916|FG000|Overall Study|Compliance|2|||
105940336|NCT01050218|365442916|FG000|Overall Study|Failed to return|7|||
105940337|NCT01050218|365442916|FG000|Overall Study|Serious Adverse Event|1|||
105940338|NCT01050218|365442916|FG000|Overall Study|Family emergency|1|||
105940339|NCT03707821|365442917|FG000|Overall Study|Protocol Violation|0|||
106011993|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
106011994|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
106011995|NCT01054885|365712716|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
106011996|NCT01054885|365712717|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
106011997|NCT01054885|365712718|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
106011998|NCT01054885|365712719|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
106011999|NCT01054885|365712720|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
106012000|NCT01054885|365712721|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
106012001|NCT01054885|365712722|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
106012002|NCT01399372|365712723|FG000|Overall Study|Protocol Violation|3|||
106012003|NCT01399372|365712724|FG001|Overall Study|Protocol Violation|1|||
106012004|NCT01421719|365712725|FG000|Overall Study|Withdrawal by Subject|4|||
106012005|NCT01803607|365712729|FG000|Overall Study|Adverse Event|5|||
106012006|NCT01803607|365712730|FG001|Overall Study|Adverse Event|3|||
106012007|NCT01803607|365712729|FG000|Overall Study|Lack of Efficacy|0|||
106012008|NCT01803607|365712730|FG001|Overall Study|Lack of Efficacy|1|||
106012009|NCT01803607|365712729|FG000|Overall Study|Protocol Violation|3|||
106012010|NCT01803607|365712730|FG001|Overall Study|Protocol Violation|2|||
106012011|NCT01803607|365712729|FG000|Overall Study|Study terminated by sponsor|54|||
106012012|NCT01803607|365712730|FG001|Overall Study|Study terminated by sponsor|56|||
106012013|NCT01803607|365712729|FG000|Overall Study|Withdrawal by Subject|6|||
106012014|NCT01803607|365712730|FG001|Overall Study|Withdrawal by Subject|5|||
106012015|NCT00918255|365712736|FG000|Overall Study|Adverse Event|1|||
106012016|NCT00918255|365712737|FG001|Overall Study|Adverse Event|0|||
106012017|NCT00918255|365712738|FG002|Overall Study|Adverse Event|0|||
105737809|NCT00089843|364696782|FG002|Overall Study|Withdrawal by Subject|5|||
105737810|NCT00089843|364696783|FG003|Overall Study|Withdrawal by Subject|6|||
105737811|NCT00089843|364696780|FG000|Overall Study|Physician Decision|1|||
105737812|NCT00089843|364696781|FG001|Overall Study|Physician Decision|0|||
105737813|NCT00089843|364696782|FG002|Overall Study|Physician Decision|0|||
105737814|NCT00089843|364696783|FG003|Overall Study|Physician Decision|1|||
105737815|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
105737816|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
105737817|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
105737818|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
105737819|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
105737820|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
105737821|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
105737822|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
105737823|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
105737824|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
105737825|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
105737826|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
105737827|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
105940340|NCT03707821|365442918|FG001|Overall Study|Protocol Violation|1|||
106012018|NCT00918255|365712736|FG000|Overall Study|Withdrawal by Subject|1|||
106012019|NCT00918255|365712737|FG001|Overall Study|Withdrawal by Subject|0|||
106012020|NCT00918255|365712738|FG002|Overall Study|Withdrawal by Subject|2|||
106012021|NCT00918255|365712736|FG000|Overall Study|Lack of Efficacy|1|||
106012022|NCT00918255|365712737|FG001|Overall Study|Lack of Efficacy|0|||
106012023|NCT00918255|365712738|FG002|Overall Study|Lack of Efficacy|0|||
105799545|NCT04380701|364924617|FG003|Overall Study|Lost to Follow-up|0|||
105799546|NCT04380701|364924618|FG004|Overall Study|Lost to Follow-up|0|||
105799547|NCT04380701|364924619|FG005|Overall Study|Lost to Follow-up|0|||
105799548|NCT04380701|364924620|FG006|Overall Study|Lost to Follow-up|0|||
105799549|NCT04380701|364924621|FG007|Overall Study|Lost to Follow-up|0|||
106012024|NCT00918255|365712736|FG000|Overall Study|Lost to Follow-up|1|||
106012025|NCT00918255|365712737|FG001|Overall Study|Lost to Follow-up|0|||
105799550|NCT04380701|364924622|FG008|Overall Study|Lost to Follow-up|0|||
105799551|NCT04380701|364924623|FG009|Overall Study|Lost to Follow-up|0|||
105799552|NCT04380701|364924624|FG010|Overall Study|Lost to Follow-up|0|||
105799553|NCT04380701|364924625|FG011|Overall Study|Lost to Follow-up|0|||
105799554|NCT04380701|364924626|FG012|Overall Study|Lost to Follow-up|0|||
105799555|NCT04380701|364924627|FG013|Overall Study|Lost to Follow-up|0|||
105799556|NCT04380701|364924628|FG014|Overall Study|Lost to Follow-up|0|||
105799557|NCT04380701|364924629|FG015|Overall Study|Lost to Follow-up|0|||
105799558|NCT04380701|364924630|FG016|Overall Study|Lost to Follow-up|0|||
105799559|NCT04380701|364924631|FG017|Overall Study|Lost to Follow-up|0|||
105799560|NCT04380701|364924632|FG018|Overall Study|Lost to Follow-up|0|||
105799561|NCT04380701|364924633|FG019|Overall Study|Lost to Follow-up|0|||
105799562|NCT04380701|364924634|FG020|Overall Study|Lost to Follow-up|1|||
105799563|NCT04380701|364924635|FG021|Overall Study|Lost to Follow-up|0|||
105799564|NCT04380701|364924636|FG022|Overall Study|Lost to Follow-up|0|||
105799565|NCT04380701|364924637|FG023|Overall Study|Lost to Follow-up|1|||
105799566|NCT04380701|364924638|FG024|Overall Study|Lost to Follow-up|0|||
105799567|NCT04380701|364924639|FG025|Overall Study|Lost to Follow-up|0|||
105799568|NCT04380701|364924640|FG026|Overall Study|Lost to Follow-up|0|||
105799569|NCT04380701|364924641|FG027|Overall Study|Lost to Follow-up|0|||
105799570|NCT04380701|364924642|FG028|Overall Study|Lost to Follow-up|0|||
105799571|NCT04380701|364924643|FG029|Overall Study|Lost to Follow-up|1|||
105799572|NCT04380701|364924644|FG030|Overall Study|Lost to Follow-up|0|||
105799573|NCT04380701|364924645|FG031|Overall Study|Lost to Follow-up|0|||
105799574|NCT04380701|364924646|FG032|Overall Study|Lost to Follow-up|0|||
105799575|NCT04380701|364924647|FG033|Overall Study|Lost to Follow-up|1|||
106012026|NCT00918255|365712738|FG002|Overall Study|Lost to Follow-up|2|||
106012027|NCT00918255|365712736|FG000|Overall Study|Exceeded allowed number of interventions|0|||
106012028|NCT00918255|365712737|FG001|Overall Study|Exceeded allowed number of interventions|0|||
106012029|NCT00918255|365712738|FG002|Overall Study|Exceeded allowed number of interventions|1|||
106012030|NCT00918255|365712736|FG000|Overall Study|Non-compliance|1|||
106012031|NCT00918255|365712737|FG001|Overall Study|Non-compliance|0|||
106012032|NCT00918255|365712738|FG002|Overall Study|Non-compliance|0|||
106012033|NCT00918255|365712736|FG000|Overall Study|Investigator discretion|1|||
106012034|NCT00918255|365712737|FG001|Overall Study|Investigator discretion|0|||
106012035|NCT00918255|365712738|FG002|Overall Study|Investigator discretion|0|||
106012036|NCT02038933|365712771|FG000|Overall Study|Disease progression|104|||
106012037|NCT02038933|365712771|FG000|Overall Study|Study drug toxicity|6|||
106012038|NCT02038933|365712771|FG000|Overall Study|Adverse event unrelated to study drug|6|||
106012039|NCT02038933|365712771|FG000|Overall Study|Participant request to discontinue treatment|2|||
106012040|NCT02038933|365712771|FG000|Overall Study|Lost to Follow-up|1|||
106012041|NCT02038933|365712771|FG000|Overall Study|Other reasons|2|||
106012042|NCT02492763|365712774|FG000|Overall Study|Withdrawal by Subject|0|||
106012043|NCT02492763|365712775|FG001|Overall Study|Withdrawal by Subject|2|||
106012044|NCT02492763|365712776|FG002|Overall Study|Withdrawal by Subject|1|||
106012045|NCT02492763|365712777|FG003|Overall Study|Withdrawal by Subject|0|||
106012046|NCT02492763|365712774|FG000|Overall Study|Adverse Event|3|||
106012047|NCT02492763|365712775|FG001|Overall Study|Adverse Event|1|||
106012048|NCT02492763|365712776|FG002|Overall Study|Adverse Event|1|||
106012049|NCT02492763|365712777|FG003|Overall Study|Adverse Event|2|||
106012050|NCT02492763|365712774|FG000|Overall Study|Death|0|||
106012051|NCT02492763|365712775|FG001|Overall Study|Death|0|||
106012052|NCT02492763|365712776|FG002|Overall Study|Death|1|||
105799576|NCT04380701|364924614|FG000|Overall Study|Private reason(s)|0|||
105799577|NCT04380701|364924615|FG001|Overall Study|Private reason(s)|0|||
105799578|NCT04380701|364924616|FG002|Overall Study|Private reason(s)|0|||
105799579|NCT04380701|364924617|FG003|Overall Study|Private reason(s)|0|||
105799580|NCT04380701|364924618|FG004|Overall Study|Private reason(s)|0|||
105799581|NCT04380701|364924619|FG005|Overall Study|Private reason(s)|0|||
105799582|NCT04380701|364924620|FG006|Overall Study|Private reason(s)|1|||
105799583|NCT04380701|364924621|FG007|Overall Study|Private reason(s)|0|||
106012053|NCT02492763|365712777|FG003|Overall Study|Death|0|||
106012054|NCT02492763|365712774|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
106012055|NCT02492763|365712775|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
106012056|NCT02492763|365712776|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
106012057|NCT02492763|365712777|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
106012058|NCT02492763|365712774|FG000|Overall Study|Lost to Follow-up|0|||
106012059|NCT02492763|365712775|FG001|Overall Study|Lost to Follow-up|0|||
106012060|NCT02492763|365712776|FG002|Overall Study|Lost to Follow-up|1|||
105799584|NCT04380701|364924622|FG008|Overall Study|Private reason(s)|1|||
105799585|NCT04380701|364924623|FG009|Overall Study|Private reason(s)|1|||
105799586|NCT04380701|364924624|FG010|Overall Study|Private reason(s)|0|||
105799587|NCT04380701|364924625|FG011|Overall Study|Private reason(s)|0|||
105799588|NCT04380701|364924626|FG012|Overall Study|Private reason(s)|0|||
105799589|NCT04380701|364924627|FG013|Overall Study|Private reason(s)|0|||
105799590|NCT04380701|364924628|FG014|Overall Study|Private reason(s)|0|||
105799591|NCT04380701|364924629|FG015|Overall Study|Private reason(s)|0|||
105799592|NCT04380701|364924630|FG016|Overall Study|Private reason(s)|0|||
105799593|NCT04380701|364924631|FG017|Overall Study|Private reason(s)|0|||
105799594|NCT04380701|364924632|FG018|Overall Study|Private reason(s)|0|||
105799595|NCT04380701|364924633|FG019|Overall Study|Private reason(s)|0|||
105799596|NCT04380701|364924634|FG020|Overall Study|Private reason(s)|0|||
105799597|NCT04380701|364924635|FG021|Overall Study|Private reason(s)|0|||
105799598|NCT04380701|364924636|FG022|Overall Study|Private reason(s)|0|||
105799599|NCT04380701|364924637|FG023|Overall Study|Private reason(s)|1|||
105799600|NCT04380701|364924638|FG024|Overall Study|Private reason(s)|0|||
105799601|NCT04380701|364924639|FG025|Overall Study|Private reason(s)|0|||
106012061|NCT02492763|365712777|FG003|Overall Study|Lost to Follow-up|0|||
106012062|NCT02492763|365712774|FG000|Overall Study|Non-Compliance With Study Drug|0|||
106012063|NCT02492763|365712775|FG001|Overall Study|Non-Compliance With Study Drug|1|||
106012064|NCT02492763|365712776|FG002|Overall Study|Non-Compliance With Study Drug|0|||
106012065|NCT02492763|365712777|FG003|Overall Study|Non-Compliance With Study Drug|0|||
106012066|NCT02492763|365712774|FG000|Overall Study|Screen Failure|0|||
106012067|NCT02492763|365712775|FG001|Overall Study|Screen Failure|0|||
106012068|NCT02492763|365712776|FG002|Overall Study|Screen Failure|0|||
106012069|NCT02492763|365712777|FG003|Overall Study|Screen Failure|1|||
106012070|NCT02492763|365712774|FG000|Overall Study|Study Terminated by Sponsor|13|||
106012071|NCT02492763|365712775|FG001|Overall Study|Study Terminated by Sponsor|10|||
106012072|NCT02492763|365712776|FG002|Overall Study|Study Terminated by Sponsor|6|||
106012073|NCT02492763|365712777|FG003|Overall Study|Study Terminated by Sponsor|10|||
106012074|NCT02113982|365712778|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
106012075|NCT02113982|365712779|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
106012076|NCT02113982|365712780|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
106012077|NCT02113982|365712781|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
106012078|NCT02113982|365712782|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
106012079|NCT02113982|365712783|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
106012080|NCT02113982|365712784|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
106012081|NCT02113982|365712785|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
106012082|NCT02113982|365712786|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
106012083|NCT02113982|365712787|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
106012084|NCT02113982|365712788|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
106012085|NCT02113982|365712789|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
106012086|NCT02113982|365712790|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
106012087|NCT02113982|365712791|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
106012088|NCT02113982|365712778|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
106012089|NCT02113982|365712779|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
106012090|NCT02113982|365712780|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
106012091|NCT02113982|365712781|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
106012092|NCT02113982|365712782|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
106012093|NCT02113982|365712783|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
106012094|NCT02113982|365712784|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
106140880|NCT00486759|366174358|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
106140881|NCT00486759|366174359|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
106140882|NCT00486759|366174358|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
105799602|NCT04380701|364924640|FG026|Overall Study|Private reason(s)|0|||
105799603|NCT04380701|364924641|FG027|Overall Study|Private reason(s)|0|||
105799604|NCT04380701|364924642|FG028|Overall Study|Private reason(s)|0|||
105799605|NCT04380701|364924643|FG029|Overall Study|Private reason(s)|1|||
105799606|NCT04380701|364924644|FG030|Overall Study|Private reason(s)|0|||
105799607|NCT04380701|364924645|FG031|Overall Study|Private reason(s)|0|||
105799608|NCT04380701|364924646|FG032|Overall Study|Private reason(s)|0|||
105799609|NCT04380701|364924647|FG033|Overall Study|Private reason(s)|0|||
105799610|NCT04380701|364924614|FG000|Overall Study|Withdrawal by Subject|0|||
105799611|NCT04380701|364924615|FG001|Overall Study|Withdrawal by Subject|0|||
106012095|NCT02113982|365712785|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
106012096|NCT02113982|365712786|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
106012097|NCT02113982|365712787|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
106012098|NCT02113982|365712788|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
106012099|NCT02113982|365712789|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
106012100|NCT02113982|365712790|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
106012101|NCT02113982|365712791|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
106012102|NCT02113982|365712778|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
105799612|NCT04380701|364924616|FG002|Overall Study|Withdrawal by Subject|0|||
105799613|NCT04380701|364924617|FG003|Overall Study|Withdrawal by Subject|0|||
106012103|NCT02113982|365712779|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106140883|NCT00486759|366174359|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
106140884|NCT00918957|366174362|FG000|Overall Study|Adverse Event|2|||
106140885|NCT00918957|366174363|FG001|Overall Study|Adverse Event|0|||
105737828|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
105737829|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
105737830|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
105737831|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
105737832|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
105737833|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
106140886|NCT00918957|366174362|FG000|Overall Study|Withdrawal by Subject|1|||
106140887|NCT00918957|366174363|FG001|Overall Study|Withdrawal by Subject|0|||
106140888|NCT00487578|366174364|FG000|Overall Study|Adverse Event|1|||
106140889|NCT00487578|366174365|FG001|Overall Study|Adverse Event|2|||
106140890|NCT00487578|366174364|FG000|Overall Study|Lack of Efficacy|0|||
106140891|NCT00487578|366174365|FG001|Overall Study|Lack of Efficacy|1|||
106140892|NCT00487578|366174364|FG000|Overall Study|Lost to Follow-up|0|||
106140893|NCT00487578|366174365|FG001|Overall Study|Lost to Follow-up|1|||
106140894|NCT01499134|366174366|FG000|Overall Study|Withdrawal by Subject|0|||
106140895|NCT01499134|366174367|FG001|Overall Study|Withdrawal by Subject|1|||
106140896|NCT02385669|366174377|FG000|Overall Study|Adverse Event|2|||
106140897|NCT02477670|366174378|FG000|Stage 1|Adverse Event|2|||
106140898|NCT02477670|366174379|FG001|Stage 1|Adverse Event|7|||
106140899|NCT02477670|366174380|FG002|Stage 1|Adverse Event|0|||
106140900|NCT02477670|366174381|FG003|Stage 1|Adverse Event|0|||
106140901|NCT02477670|366174382|FG004|Stage 1|Adverse Event|0|||
106140902|NCT02477670|366174383|FG005|Stage 1|Adverse Event|0|||
106140903|NCT02477670|366174384|FG006|Stage 1|Adverse Event|0|||
106140904|NCT02477670|366174378|FG000|Stage 1|Lost to Follow-up|0|||
106140905|NCT02477670|366174379|FG001|Stage 1|Lost to Follow-up|2|||
106140906|NCT02477670|366174380|FG002|Stage 1|Lost to Follow-up|0|||
106140907|NCT02477670|366174381|FG003|Stage 1|Lost to Follow-up|0|||
106140908|NCT02477670|366174382|FG004|Stage 1|Lost to Follow-up|0|||
106140909|NCT02477670|366174383|FG005|Stage 1|Lost to Follow-up|0|||
106140910|NCT02477670|366174384|FG006|Stage 1|Lost to Follow-up|0|||
106140911|NCT02477670|366174378|FG000|Stage 1|Withdrawal by Subject|1|||
106140912|NCT02477670|366174379|FG001|Stage 1|Withdrawal by Subject|2|||
106140913|NCT02477670|366174380|FG002|Stage 1|Withdrawal by Subject|0|||
106140914|NCT02477670|366174381|FG003|Stage 1|Withdrawal by Subject|0|||
106140915|NCT02477670|366174382|FG004|Stage 1|Withdrawal by Subject|0|||
106140916|NCT02477670|366174383|FG005|Stage 1|Withdrawal by Subject|0|||
106140917|NCT02477670|366174384|FG006|Stage 1|Withdrawal by Subject|0|||
106140918|NCT02477670|366174378|FG000|Stage 1|Non-compliance with Study Drug|1|||
106140919|NCT02477670|366174379|FG001|Stage 1|Non-compliance with Study Drug|2|||
106140920|NCT02477670|366174380|FG002|Stage 1|Non-compliance with Study Drug|0|||
106140921|NCT02477670|366174381|FG003|Stage 1|Non-compliance with Study Drug|0|||
106140922|NCT02477670|366174382|FG004|Stage 1|Non-compliance with Study Drug|0|||
106140923|NCT02477670|366174383|FG005|Stage 1|Non-compliance with Study Drug|0|||
106140924|NCT02477670|366174384|FG006|Stage 1|Non-compliance with Study Drug|0|||
106140925|NCT02477670|366174378|FG000|Stage 2|Adverse Event|0|||
106140926|NCT02477670|366174379|FG001|Stage 2|Adverse Event|0|||
106140927|NCT02477670|366174380|FG002|Stage 2|Adverse Event|1|||
106140928|NCT02477670|366174381|FG003|Stage 2|Adverse Event|0|||
106140929|NCT02477670|366174382|FG004|Stage 2|Adverse Event|0|||
106140930|NCT02477670|366174383|FG005|Stage 2|Adverse Event|0|||
106140931|NCT02477670|366174384|FG006|Stage 2|Adverse Event|0|||
106140932|NCT02477670|366174378|FG000|Stage 2|Antipsychotic Medication Changed|0|||
106140933|NCT02477670|366174379|FG001|Stage 2|Antipsychotic Medication Changed|0|||
106140934|NCT02477670|366174380|FG002|Stage 2|Antipsychotic Medication Changed|1|||
106140935|NCT02477670|366174381|FG003|Stage 2|Antipsychotic Medication Changed|0|||
106140936|NCT02477670|366174382|FG004|Stage 2|Antipsychotic Medication Changed|0|||
106140937|NCT02477670|366174383|FG005|Stage 2|Antipsychotic Medication Changed|0|||
106140938|NCT02477670|366174384|FG006|Stage 2|Antipsychotic Medication Changed|0|||
106140939|NCT02477670|366174378|FG000|Stage 2|Withdrawal by Subject|0|||
106140940|NCT02477670|366174379|FG001|Stage 2|Withdrawal by Subject|0|||
106140941|NCT02477670|366174380|FG002|Stage 2|Withdrawal by Subject|0|||
106140942|NCT02477670|366174381|FG003|Stage 2|Withdrawal by Subject|1|||
106140943|NCT02477670|366174382|FG004|Stage 2|Withdrawal by Subject|0|||
106140944|NCT02477670|366174383|FG005|Stage 2|Withdrawal by Subject|0|||
106140945|NCT02477670|366174384|FG006|Stage 2|Withdrawal by Subject|0|||
106140946|NCT01281813|366174385|FG000|Overall Study|Adverse Event|0|||
106140947|NCT01281813|366174386|FG001|Overall Study|Adverse Event|0|||
106140948|NCT01281813|366174387|FG002|Overall Study|Adverse Event|10|||
106140949|NCT01281813|366174385|FG000|Overall Study|Lost to Follow-up|0|||
105952155|NCT03314935|365488191|FG007|Phase 2|Withdrawal by Subject|0|||
106140950|NCT01281813|366174386|FG001|Overall Study|Lost to Follow-up|0|||
106140951|NCT01281813|366174387|FG002|Overall Study|Lost to Follow-up|31|||
106140952|NCT01281813|366174385|FG000|Overall Study|Withdrawal by Subject|0|||
105952156|NCT03314935|365488192|FG008|Phase 2|Withdrawal by Subject|0|||
105952157|NCT03314935|365488193|FG009|Phase 2|Withdrawal by Subject|1|||
105952158|NCT03314935|365488194|FG010|Phase 2|Withdrawal by Subject|4|||
105737834|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
105737835|NCT04003155|364696784|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
105737836|NCT04003155|364696785|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
105737837|NCT04003155|364696786|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
106140953|NCT01281813|366174386|FG001|Overall Study|Withdrawal by Subject|0|||
106140954|NCT01281813|366174387|FG002|Overall Study|Withdrawal by Subject|13|||
106140955|NCT01281813|366174385|FG000|Overall Study|Subject Non-Compliant|0|||
106140956|NCT01281813|366174386|FG001|Overall Study|Subject Non-Compliant|0|||
106140957|NCT01281813|366174387|FG002|Overall Study|Subject Non-Compliant|6|||
106140958|NCT01281813|366174385|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
106140959|NCT01281813|366174386|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
106140960|NCT01281813|366174387|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
106140961|NCT01281813|366174385|FG000|Overall Study|Sponsor's Decision|4|||
106140962|NCT01281813|366174386|FG001|Overall Study|Sponsor's Decision|3|||
106140963|NCT01281813|366174387|FG002|Overall Study|Sponsor's Decision|7|||
106140964|NCT01281813|366174385|FG000|Overall Study|Switched to Commercially Available Medication|0|||
106140965|NCT01281813|366174386|FG001|Overall Study|Switched to Commercially Available Medication|0|||
106140966|NCT01281813|366174387|FG002|Overall Study|Switched to Commercially Available Medication|26|||
106140967|NCT01281813|366174385|FG000|Overall Study|Other|0|||
106140968|NCT01281813|366174386|FG001|Overall Study|Other|1|||
106140969|NCT01281813|366174387|FG002|Overall Study|Other|39|||
106140970|NCT00970307|366174388|FG000|Overall Study|Serious Adverse Event|1|||
106140971|NCT00970307|366174389|FG001|Overall Study|Serious Adverse Event|0|||
106140972|NCT00970307|366174390|FG002|Overall Study|Serious Adverse Event|0|||
106140973|NCT00970307|366174388|FG000|Overall Study|Withdrawal by Subject|2|||
106140974|NCT00970307|366174389|FG001|Overall Study|Withdrawal by Subject|3|||
106140975|NCT00970307|366174390|FG002|Overall Study|Withdrawal by Subject|2|||
106140976|NCT03546907|366174391|FG000|Overall Study|Lack of Efficacy|1|||
106140977|NCT03546907|366174392|FG001|Overall Study|Lack of Efficacy|1|||
106140978|NCT03546907|366174391|FG000|Overall Study|Withdrawal by Subject|8|||
106140979|NCT03546907|366174392|FG001|Overall Study|Withdrawal by Subject|9|||
106140980|NCT03546907|366174391|FG000|Overall Study|Adverse events (AEs)|7|||
106140981|NCT03546907|366174392|FG001|Overall Study|Adverse events (AEs)|10|||
106140982|NCT03546907|366174391|FG000|Overall Study|Other-unspecified|1|||
106140983|NCT03546907|366174392|FG001|Overall Study|Other-unspecified|1|||
106140984|NCT04033432|366174399|FG000|Overall Study|Progressive Disease|8|||
106140985|NCT04033432|366174399|FG000|Overall Study|Adverse Event|4|||
106140986|NCT04033432|366174399|FG000|Overall Study|Death|1|||
106140987|NCT02192606|366174403|FG000|Overall Study|surgery type was changed|1|||
106140988|NCT02192606|366174404|FG001|Overall Study|surgery type was changed|1|||
106140989|NCT02192606|366174403|FG000|Overall Study|Physician Decision|1|||
106140990|NCT02192606|366174404|FG001|Overall Study|Physician Decision|2|||
106140991|NCT02192606|366174403|FG000|Overall Study|3D equipment rep unable to join|0|||
106140992|NCT02192606|366174404|FG001|Overall Study|3D equipment rep unable to join|1|||
106140993|NCT01171625|366174405|FG000|Overall Study|On-Protocol|67|||
106140994|NCT01171625|366174405|FG000|Overall Study|Death|38|||
106140995|NCT01171625|366174405|FG000|Overall Study|Withdrawal by Subject|31|||
106140996|NCT01171625|366174405|FG000|Overall Study|Explanted|10|||
106140997|NCT01171625|366174405|FG000|Overall Study|Lost to Follow-up|5|||
106140998|NCT01171625|366174405|FG000|Overall Study|Patient received valve-in-valve|3|||
106140999|NCT01171625|366174405|FG000|Overall Study|Other|1|||
106141000|NCT01171625|366174405|FG000|Overall Study|Consented but did not receive device|25|||
106141001|NCT00419094|366174406|FG000|Overall Study|Adverse Event|3|||
106141002|NCT00419094|366174407|FG001|Overall Study|Adverse Event|7|||
106141003|NCT00419094|366174406|FG000|Overall Study|Lack of Efficacy|1|||
106141004|NCT00419094|366174407|FG001|Overall Study|Lack of Efficacy|0|||
106141005|NCT00419094|366174406|FG000|Overall Study|Lost to Follow-up|0|||
106141006|NCT00419094|366174407|FG001|Overall Study|Lost to Follow-up|2|||
106141007|NCT00419094|366174406|FG000|Overall Study|Protocol Violation|1|||
106141008|NCT00419094|366174407|FG001|Overall Study|Protocol Violation|14|||
106141009|NCT00419094|366174406|FG000|Overall Study|Withdrawal of consent|1|||
106141010|NCT00419094|366174407|FG001|Overall Study|Withdrawal of consent|5|||
106141011|NCT00419094|366174406|FG000|Overall Study|Other: Error determining exit criteria|1|||
106141012|NCT00419094|366174407|FG001|Overall Study|Other: Error determining exit criteria|0|||
105737838|NCT04003155|364696787|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
105737839|NCT04003155|364696788|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
106141013|NCT00419094|366174406|FG000|Overall Study|Other: Patient non-compliant|0|||
106141014|NCT00419094|366174407|FG001|Overall Study|Other: Patient non-compliant|1|||
106141015|NCT00419094|366174406|FG000|Overall Study|Other: No contact for extended period|0|||
106141016|NCT00419094|366174407|FG001|Overall Study|Other: No contact for extended period|1|||
106141017|NCT00486330|366174412|FG000|Overall Study|Adverse Event|2|||
106141018|NCT01290224|366174413|FG000|Overall Study|Adverse Event|1|||
106141019|NCT01290224|366174413|FG000|Overall Study|Refused Further Treatment|4|||
106141020|NCT00853827|366174414|FG000|Single Blind Period (1 Week)|Other|4|||
106141021|NCT00853827|366174415|FG001|Single Blind Period (1 Week)|Other|0|||
105737840|NCT04003155|364696784|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
105737841|NCT04003155|364696785|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
105737842|NCT04003155|364696786|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
105737843|NCT04003155|364696787|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
105737844|NCT04003155|364696788|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
105737845|NCT04003155|364696784|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
105737846|NCT04003155|364696785|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
105737847|NCT04003155|364696786|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
105737848|NCT04003155|364696787|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
105737849|NCT04003155|364696788|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
105737850|NCT04003155|364696784|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
105737851|NCT04003155|364696785|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
105737852|NCT04003155|364696786|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
105737853|NCT04003155|364696787|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
105737854|NCT04003155|364696788|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
105737855|NCT04003155|364696784|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
105737856|NCT04003155|364696785|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
105737857|NCT04003155|364696786|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
105737858|NCT04003155|364696787|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
105737859|NCT04003155|364696788|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
105799614|NCT04380701|364924618|FG004|Overall Study|Withdrawal by Subject|0|||
105799615|NCT04380701|364924619|FG005|Overall Study|Withdrawal by Subject|0|||
105799616|NCT04380701|364924620|FG006|Overall Study|Withdrawal by Subject|1|||
105799617|NCT04380701|364924621|FG007|Overall Study|Withdrawal by Subject|1|||
106141022|NCT00853827|366174414|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
106141023|NCT00853827|366174415|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
106141024|NCT00853827|366174414|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
106141025|NCT00853827|366174415|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
106141026|NCT00853827|366174414|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
106141027|NCT00853827|366174415|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
106141028|NCT00853827|366174414|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
106141029|NCT00853827|366174415|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
106141030|NCT00853827|366174414|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
106141031|NCT00853827|366174415|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
106141032|NCT00853827|366174414|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
106141033|NCT00853827|366174415|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
106141034|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
106141035|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
106141036|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
106141037|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
106141038|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
106141039|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
106141040|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
106141041|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
106141042|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
106141043|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
106141044|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
106141045|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
106141046|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
106141047|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
106141048|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
106141049|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
106141050|NCT00853827|366174414|FG000|Double Blind Period (103 Weeks)|Death|1|||
106141051|NCT00853827|366174415|FG001|Double Blind Period (103 Weeks)|Death|6|||
106141052|NCT00771849|366174416|FG000|Overall Study|Lost to Follow-up|1|||
106141053|NCT00771849|366174417|FG001|Overall Study|Lost to Follow-up|2|||
106141054|NCT00771849|366174416|FG000|Overall Study|Withdrawal by Subject|1|||
106141055|NCT00771849|366174417|FG001|Overall Study|Withdrawal by Subject|1|||
106141056|NCT00771849|366174416|FG000|Overall Study|Not vaccinated|0|||
106141057|NCT00771849|366174417|FG001|Overall Study|Not vaccinated|1|||
106141058|NCT00608907|366174421|FG000|Overall Study|Adverse Event|6|||
106141059|NCT00608907|366174422|FG001|Overall Study|Adverse Event|0|||
105737860|NCT03042611|364696789|FG000|Core Phase|Withdrawal by Subject|13|||
105737861|NCT03042611|364696790|FG001|Core Phase|Withdrawal by Subject|4|||
105737862|NCT03042611|364696791|FG002|Core Phase|Withdrawal by Subject|0|||
105799618|NCT04380701|364924622|FG008|Overall Study|Withdrawal by Subject|0|||
106141060|NCT00608907|366174423|FG002|Overall Study|Adverse Event|1|||
106141061|NCT00608907|366174421|FG000|Overall Study|Death|1|||
106141062|NCT00608907|366174422|FG001|Overall Study|Death|0|||
106141063|NCT00608907|366174423|FG002|Overall Study|Death|0|||
105737863|NCT03042611|364696792|FG003|Core Phase|Withdrawal by Subject|0|||
105737864|NCT03042611|364696789|FG000|Core Phase|Death|232|||
105737865|NCT03042611|364696790|FG001|Core Phase|Death|110|||
105737866|NCT03042611|364696791|FG002|Core Phase|Death|0|||
105737867|NCT03042611|364696792|FG003|Core Phase|Death|0|||
105952159|NCT03314935|365488195|FG011|Phase 2|Withdrawal by Subject|0|||
106141064|NCT00608907|366174421|FG000|Overall Study|Withdrawal by Subject|4|||
106141065|NCT00608907|366174422|FG001|Overall Study|Withdrawal by Subject|0|||
106141066|NCT00608907|366174423|FG002|Overall Study|Withdrawal by Subject|0|||
106141067|NCT00608907|366174421|FG000|Overall Study|Progressive Disease|1|||
106141068|NCT00608907|366174422|FG001|Overall Study|Progressive Disease|0|||
106141069|NCT00608907|366174423|FG002|Overall Study|Progressive Disease|0|||
106141070|NCT01689519|366174430|FG000|Intent to Treat|Death|157|||
106141071|NCT01689519|366174431|FG001|Intent to Treat|Death|167|||
106141072|NCT01689519|366174430|FG000|Intent to Treat|Lost to Follow-up|4|||
106141073|NCT01689519|366174431|FG001|Intent to Treat|Lost to Follow-up|8|||
106141074|NCT01689519|366174430|FG000|Intent to Treat|Other|2|||
106141075|NCT01689519|366174431|FG001|Intent to Treat|Other|4|||
106141076|NCT01689519|366174430|FG000|Intent to Treat|Physician Decision|4|||
106141077|NCT01689519|366174431|FG001|Intent to Treat|Physician Decision|1|||
106141078|NCT01689519|366174430|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
106141079|NCT01689519|366174431|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
106141080|NCT01689519|366174430|FG000|Intent to Treat|Withdrawal by Subject|21|||
106141081|NCT01689519|366174431|FG001|Intent to Treat|Withdrawal by Subject|20|||
106141082|NCT01689519|366174430|FG000|Safety Population|Death|158|||
106141083|NCT01689519|366174431|FG001|Safety Population|Death|165|||
106141084|NCT01689519|366174430|FG000|Safety Population|Lost to Follow-up|4|||
106141085|NCT01689519|366174431|FG001|Safety Population|Lost to Follow-up|8|||
106141086|NCT01689519|366174430|FG000|Safety Population|Other|2|||
106141087|NCT01689519|366174431|FG001|Safety Population|Other|4|||
106141088|NCT01689519|366174430|FG000|Safety Population|Physician Decision|4|||
106141089|NCT01689519|366174431|FG001|Safety Population|Physician Decision|1|||
106141090|NCT01689519|366174430|FG000|Safety Population|Study Terminated By Sponsor|60|||
106141091|NCT01689519|366174431|FG001|Safety Population|Study Terminated By Sponsor|47|||
106141092|NCT01689519|366174430|FG000|Safety Population|Withdrawal by Subject|20|||
106141093|NCT01689519|366174431|FG001|Safety Population|Withdrawal by Subject|20|||
106141094|NCT03987451|366174435|FG000|Overall Study|Lost to Follow-up|1|||
106141095|NCT03987451|366174436|FG001|Overall Study|Lost to Follow-up|0|||
106141096|NCT03987451|366174435|FG000|Overall Study|Withdrawal by Subject|1|||
105737868|NCT03042611|364696789|FG000|Core Phase|Lost to Follow-up|4|||
105737869|NCT03042611|364696790|FG001|Core Phase|Lost to Follow-up|7|||
105737870|NCT03042611|364696791|FG002|Core Phase|Lost to Follow-up|0|||
105737871|NCT03042611|364696792|FG003|Core Phase|Lost to Follow-up|0|||
105737872|NCT03042611|364696789|FG000|Core Phase|Physician Decision|7|||
105737873|NCT03042611|364696790|FG001|Core Phase|Physician Decision|2|||
105737874|NCT03042611|364696791|FG002|Core Phase|Physician Decision|0|||
105737875|NCT03042611|364696792|FG003|Core Phase|Physician Decision|0|||
105737876|NCT03042611|364696789|FG000|Core Phase|Study Closed|0|||
105737877|NCT03042611|364696790|FG001|Core Phase|Study Closed|1|||
105737878|NCT03042611|364696791|FG002|Core Phase|Study Closed|0|||
105737879|NCT03042611|364696792|FG003|Core Phase|Study Closed|0|||
105737880|NCT03042611|364696789|FG000|Extension Phase|Death|0|||
105737881|NCT03042611|364696790|FG001|Extension Phase|Death|0|||
105737882|NCT03042611|364696791|FG002|Extension Phase|Death|34|||
105737883|NCT03042611|364696792|FG003|Extension Phase|Death|16|||
105737884|NCT03042611|364696789|FG000|Extension Phase|Lost to Follow-up|0|||
105737885|NCT03042611|364696790|FG001|Extension Phase|Lost to Follow-up|0|||
105737886|NCT03042611|364696791|FG002|Extension Phase|Lost to Follow-up|1|||
105737887|NCT03042611|364696792|FG003|Extension Phase|Lost to Follow-up|1|||
105737888|NCT03042611|364696789|FG000|Extension Phase|Study Closed|0|||
105737889|NCT03042611|364696790|FG001|Extension Phase|Study Closed|0|||
105737890|NCT03042611|364696791|FG002|Extension Phase|Study Closed|17|||
105737891|NCT03042611|364696792|FG003|Extension Phase|Study Closed|11|||
105737892|NCT02421120|364696793|FG000|Overall Study|Adverse Event|1|||
105737893|NCT02345161|364696796|FG000|Overall Study|Withdrawal by Subject|25|||
105737894|NCT02345161|364696797|FG001|Overall Study|Withdrawal by Subject|33|||
105737895|NCT02345161|364696796|FG000|Overall Study|Adverse Event|16|||
105737896|NCT02345161|364696797|FG001|Overall Study|Adverse Event|19|||
105737897|NCT02345161|364696796|FG000|Overall Study|Physician Decision|4|||
105737898|NCT02345161|364696797|FG001|Overall Study|Physician Decision|4|||
105737899|NCT02345161|364696796|FG000|Overall Study|Lost to Follow-up|0|||
105737900|NCT02345161|364696797|FG001|Overall Study|Lost to Follow-up|1|||
105737901|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
105737902|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
105737903|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
105737904|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
105737905|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
105737906|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
105737907|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
105737908|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
105737909|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
105737910|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
105799619|NCT04380701|364924623|FG009|Overall Study|Withdrawal by Subject|0|||
105799620|NCT04380701|364924624|FG010|Overall Study|Withdrawal by Subject|0|||
105799621|NCT04380701|364924625|FG011|Overall Study|Withdrawal by Subject|1|||
105799622|NCT04380701|364924626|FG012|Overall Study|Withdrawal by Subject|0|||
105799623|NCT04380701|364924627|FG013|Overall Study|Withdrawal by Subject|1|||
105799624|NCT04380701|364924628|FG014|Overall Study|Withdrawal by Subject|0|||
105799625|NCT04380701|364924629|FG015|Overall Study|Withdrawal by Subject|0|||
105799626|NCT04380701|364924630|FG016|Overall Study|Withdrawal by Subject|1|||
105799627|NCT04380701|364924631|FG017|Overall Study|Withdrawal by Subject|0|||
105799628|NCT04380701|364924632|FG018|Overall Study|Withdrawal by Subject|0|||
105799629|NCT04380701|364924633|FG019|Overall Study|Withdrawal by Subject|0|||
105799630|NCT04380701|364924634|FG020|Overall Study|Withdrawal by Subject|0|||
105799631|NCT04380701|364924635|FG021|Overall Study|Withdrawal by Subject|0|||
105799632|NCT04380701|364924636|FG022|Overall Study|Withdrawal by Subject|2|||
105799633|NCT04380701|364924637|FG023|Overall Study|Withdrawal by Subject|2|||
105799634|NCT04380701|364924638|FG024|Overall Study|Withdrawal by Subject|1|||
105799635|NCT04380701|364924639|FG025|Overall Study|Withdrawal by Subject|1|||
105799636|NCT04380701|364924640|FG026|Overall Study|Withdrawal by Subject|0|||
105799637|NCT04380701|364924641|FG027|Overall Study|Withdrawal by Subject|0|||
105940341|NCT03707821|365442917|FG000|Overall Study|Unsatisfactory Visual Response|1|||
105940342|NCT03707821|365442918|FG001|Overall Study|Unsatisfactory Visual Response|0|||
105940343|NCT03707821|365442917|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
105940344|NCT03707821|365442918|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
105940345|NCT03523585|365442919|FG000|Overall Study|Progressive Disease|174|||
105940346|NCT03523585|365442920|FG001|Overall Study|Progressive Disease|64|||
105940347|NCT03523585|365442921|FG002|Overall Study|Progressive Disease|77|||
105940348|NCT03523585|365442919|FG000|Overall Study|Adverse Event|74|||
105940349|NCT03523585|365442920|FG001|Overall Study|Adverse Event|5|||
105940350|NCT03523585|365442921|FG002|Overall Study|Adverse Event|9|||
105940351|NCT03523585|365442919|FG000|Overall Study|Withdrawal by Subject|30|||
105940352|NCT03523585|365442920|FG001|Overall Study|Withdrawal by Subject|11|||
105940353|NCT03523585|365442921|FG002|Overall Study|Withdrawal by Subject|6|||
105940354|NCT03523585|365442919|FG000|Overall Study|Clinical Progression|23|||
105940355|NCT03523585|365442920|FG001|Overall Study|Clinical Progression|5|||
105940356|NCT03523585|365442921|FG002|Overall Study|Clinical Progression|10|||
105940357|NCT03523585|365442919|FG000|Overall Study|Death|4|||
105940358|NCT03523585|365442920|FG001|Overall Study|Death|0|||
105940359|NCT03523585|365442921|FG002|Overall Study|Death|1|||
105940360|NCT03523585|365442919|FG000|Overall Study|Physician Decision|2|||
105940361|NCT03523585|365442920|FG001|Overall Study|Physician Decision|1|||
105940362|NCT03523585|365442921|FG002|Overall Study|Physician Decision|0|||
105940363|NCT03523585|365442919|FG000|Overall Study|Lost to Follow-up|1|||
105940364|NCT03523585|365442920|FG001|Overall Study|Lost to Follow-up|0|||
105940365|NCT03523585|365442921|FG002|Overall Study|Lost to Follow-up|0|||
105940366|NCT03523585|365442919|FG000|Overall Study|Miscellaneous|1|||
105940367|NCT03523585|365442920|FG001|Overall Study|Miscellaneous|0|||
105940368|NCT03523585|365442921|FG002|Overall Study|Miscellaneous|0|||
105940369|NCT03523585|365442919|FG000|Overall Study|Protocol Deviation|1|||
105940370|NCT03523585|365442920|FG001|Overall Study|Protocol Deviation|0|||
105940371|NCT03523585|365442921|FG002|Overall Study|Protocol Deviation|1|||
105940372|NCT03523585|365442919|FG000|Overall Study|Randomized But Not Treated|2|||
105940373|NCT03523585|365442920|FG001|Overall Study|Randomized But Not Treated|4|||
105940374|NCT03523585|365442921|FG002|Overall Study|Randomized But Not Treated|3|||
105940375|NCT02150863|365442924|FG000|Overall Study|Lost to Follow-up|0|||
105940376|NCT02150863|365442925|FG001|Overall Study|Lost to Follow-up|1|||
105940377|NCT02150863|365442926|FG002|Overall Study|Lost to Follow-up|0|||
105940378|NCT00830336|365442927|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
105940379|NCT00830336|365442928|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
105940380|NCT03654326|365442933|FG000|Overall Study|Withdrawal by Subject|5|||
106141097|NCT03987451|366174436|FG001|Overall Study|Withdrawal by Subject|1|||
105799638|NCT04380701|364924642|FG028|Overall Study|Withdrawal by Subject|0|||
105799639|NCT04380701|364924643|FG029|Overall Study|Withdrawal by Subject|0|||
105799640|NCT04380701|364924644|FG030|Overall Study|Withdrawal by Subject|0|||
105799641|NCT04380701|364924645|FG031|Overall Study|Withdrawal by Subject|0|||
105799642|NCT04380701|364924646|FG032|Overall Study|Withdrawal by Subject|0|||
105799643|NCT04380701|364924647|FG033|Overall Study|Withdrawal by Subject|0|||
105940381|NCT03654326|365442934|FG001|Overall Study|Withdrawal by Subject|3|||
105940382|NCT03654326|365442933|FG000|Overall Study|Physician Decision|0|||
105940383|NCT03654326|365442934|FG001|Overall Study|Physician Decision|1|||
105940384|NCT03654326|365442933|FG000|Overall Study|Unable to adhere to study schedule|0|||
105940385|NCT03654326|365442934|FG001|Overall Study|Unable to adhere to study schedule|1|||
105940386|NCT03654326|365442933|FG000|Overall Study|Lost to Follow-up|1|||
105940387|NCT03654326|365442934|FG001|Overall Study|Lost to Follow-up|1|||
105940388|NCT04102514|365442935|FG000|Overall Study|Death|3|||
105940389|NCT04102514|365442936|FG001|Overall Study|Death|0|||
105940390|NCT04102514|365442937|FG002|Overall Study|Death|0|||
105940391|NCT04102514|365442938|FG003|Overall Study|Death|0|||
105940392|NCT04102514|365442935|FG000|Overall Study|Lost to Follow-up|0|||
106141098|NCT00855465|366174439|FG000|Treatment Period|Adverse Event|4|||
106141099|NCT00855465|366174440|FG001|Treatment Period|Adverse Event|2|||
106141100|NCT00855465|366174439|FG000|Treatment Period|Death|2|||
105737911|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
105737912|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
105737913|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
105737914|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
105737915|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
105737916|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
105737917|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
105737918|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
105737919|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
105737920|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
105940393|NCT04102514|365442936|FG001|Overall Study|Lost to Follow-up|0|||
105940394|NCT04102514|365442937|FG002|Overall Study|Lost to Follow-up|3|||
105940395|NCT04102514|365442938|FG003|Overall Study|Lost to Follow-up|0|||
105940396|NCT04102514|365442935|FG000|Overall Study|Physician Decision|0|||
105940397|NCT04102514|365442936|FG001|Overall Study|Physician Decision|0|||
105940398|NCT04102514|365442937|FG002|Overall Study|Physician Decision|1|||
105940399|NCT04102514|365442938|FG003|Overall Study|Physician Decision|0|||
105940400|NCT04102514|365442935|FG000|Overall Study|Withdrawal by Subject|7|||
105940401|NCT04102514|365442936|FG001|Overall Study|Withdrawal by Subject|13|||
105940402|NCT04102514|365442937|FG002|Overall Study|Withdrawal by Subject|7|||
105940403|NCT04102514|365442938|FG003|Overall Study|Withdrawal by Subject|14|||
105940404|NCT04102514|365442935|FG000|Overall Study|Moved to longterm care facility|6|||
105940405|NCT04102514|365442936|FG001|Overall Study|Moved to longterm care facility|0|||
105940406|NCT04102514|365442937|FG002|Overall Study|Moved to longterm care facility|4|||
105940407|NCT04102514|365442938|FG003|Overall Study|Moved to longterm care facility|0|||
105940408|NCT00456365|365442957|FG000|Overall Study|Lost to Follow-up|1|||
105940409|NCT00456365|365442958|FG001|Overall Study|Lost to Follow-up|3|||
105940410|NCT00456365|365442957|FG000|Overall Study|Withdrawal by Subject|4|||
105940411|NCT00456365|365442958|FG001|Overall Study|Withdrawal by Subject|7|||
105940412|NCT00456365|365442957|FG000|Overall Study|Pregnancy|1|||
105940413|NCT00456365|365442958|FG001|Overall Study|Pregnancy|1|||
105940414|NCT00456365|365442957|FG000|Overall Study|oncologic diagnosis|1|||
105940415|NCT00456365|365442958|FG001|Overall Study|oncologic diagnosis|1|||
105940416|NCT02202577|365442959|FG000|Overall Study|Lost to Follow-up|6|||
105940417|NCT02202577|365442960|FG001|Overall Study|Lost to Follow-up|16|||
105940418|NCT02202577|365442959|FG000|Overall Study|Protocol Violation|7|||
105940419|NCT02202577|365442960|FG001|Overall Study|Protocol Violation|3|||
105940420|NCT02034565|365442961|FG000|Overall Study|Adverse Event|1|||
105940421|NCT02034565|365442962|FG001|Overall Study|Adverse Event|0|||
105940422|NCT01422382|365442970|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
105940423|NCT04003389|365442972|FG000|Overall Study|Adverse Event|27|||
105940424|NCT04003389|365442973|FG001|Overall Study|Adverse Event|34|||
105940425|NCT04003389|365442974|FG002|Overall Study|Adverse Event|28|||
105940426|NCT04003389|365442972|FG000|Overall Study|Lost to Follow-up|39|||
105940427|NCT04003389|365442973|FG001|Overall Study|Lost to Follow-up|30|||
105940428|NCT04003389|365442974|FG002|Overall Study|Lost to Follow-up|33|||
105940429|NCT04003389|365442972|FG000|Overall Study|Protocol Violation|1|||
105940430|NCT04003389|365442973|FG001|Overall Study|Protocol Violation|6|||
105940431|NCT04003389|365442974|FG002|Overall Study|Protocol Violation|5|||
105940432|NCT04003389|365442972|FG000|Overall Study|Withdrawal by Subject|119|||
105940433|NCT04003389|365442973|FG001|Overall Study|Withdrawal by Subject|79|||
105940434|NCT04003389|365442974|FG002|Overall Study|Withdrawal by Subject|85|||
105940435|NCT04003389|365442972|FG000|Overall Study|Miscellaneous|14|||
105940436|NCT04003389|365442973|FG001|Overall Study|Miscellaneous|11|||
105940437|NCT04003389|365442974|FG002|Overall Study|Miscellaneous|14|||
105940438|NCT04003389|365442972|FG000|Overall Study|Participant did not receive study drug|1|||
105940439|NCT04003389|365442973|FG001|Overall Study|Participant did not receive study drug|0|||
105940440|NCT04003389|365442974|FG002|Overall Study|Participant did not receive study drug|0|||
105940441|NCT04439903|365442977|FG000|Overall Study|Withdrawal by Subject|2|||
105940442|NCT04439903|365442977|FG000|Overall Study|Screen Failure|1|||
105940443|NCT02899754|365442978|FG000|Overall Study|Lost to Follow-up|7|||
105940444|NCT02899754|365442979|FG001|Overall Study|Lost to Follow-up|9|||
105940445|NCT04806373|365442980|FG000|Overall Study|Withdrawal by Subject|1|||
105737921|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
105940446|NCT04806373|365442981|FG001|Overall Study|Withdrawal by Subject|1|||
105940447|NCT03973489|365442982|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
105940448|NCT03973489|365442983|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105940449|NCT03973489|365442984|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105940450|NCT03973489|365442985|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105940451|NCT03973489|365442986|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
106141101|NCT00855465|366174440|FG001|Treatment Period|Death|2|||
106141102|NCT00855465|366174439|FG000|Treatment Period|Lack of Efficacy|2|||
106012104|NCT02113982|365712780|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012105|NCT02113982|365712781|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012106|NCT02113982|365712782|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012107|NCT02113982|365712783|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012108|NCT02113982|365712784|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
106012109|NCT02113982|365712785|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012110|NCT02113982|365712786|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012111|NCT02113982|365712787|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012112|NCT02113982|365712788|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012113|NCT02113982|365712789|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012114|NCT02113982|365712790|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012115|NCT02113982|365712791|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
106012116|NCT02113982|365712778|FG000|Stage 1: Dose Escalation|Transplant|0|||
106012117|NCT02113982|365712779|FG001|Stage 1: Dose Escalation|Transplant|1|||
106012118|NCT02113982|365712780|FG002|Stage 1: Dose Escalation|Transplant|0|||
106012119|NCT02113982|365712781|FG003|Stage 1: Dose Escalation|Transplant|0|||
106012120|NCT02113982|365712782|FG004|Stage 1: Dose Escalation|Transplant|0|||
106012121|NCT02113982|365712783|FG005|Stage 1: Dose Escalation|Transplant|1|||
106012122|NCT02113982|365712784|FG006|Stage 1: Dose Escalation|Transplant|0|||
106012123|NCT02113982|365712785|FG007|Stage 1: Dose Escalation|Transplant|0|||
106012124|NCT02113982|365712786|FG008|Stage 1: Dose Escalation|Transplant|0|||
106012125|NCT02113982|365712787|FG009|Stage 1: Dose Escalation|Transplant|0|||
106012126|NCT02113982|365712788|FG010|Stage 1: Dose Escalation|Transplant|0|||
106012127|NCT02113982|365712789|FG011|Stage 1: Dose Escalation|Transplant|0|||
106012128|NCT02113982|365712790|FG012|Stage 1: Dose Escalation|Transplant|0|||
106012129|NCT02113982|365712791|FG013|Stage 1: Dose Escalation|Transplant|0|||
106012130|NCT02113982|365712778|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
106012131|NCT02113982|365712779|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
106012132|NCT02113982|365712780|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
106012133|NCT02113982|365712781|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
106012134|NCT02113982|365712782|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
106012135|NCT02113982|365712783|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
106012136|NCT02113982|365712784|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
106012137|NCT02113982|365712785|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
106012138|NCT02113982|365712786|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
106012139|NCT02113982|365712787|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
106012140|NCT02113982|365712788|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
106012141|NCT02113982|365712789|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
106012142|NCT02113982|365712790|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
106012143|NCT02113982|365712791|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
106012144|NCT02113982|365712778|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
106012145|NCT02113982|365712779|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
106012146|NCT02113982|365712780|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
106012147|NCT02113982|365712781|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
106012148|NCT02113982|365712782|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
106012149|NCT02113982|365712783|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
106012150|NCT02113982|365712784|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
106012151|NCT02113982|365712785|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
106012152|NCT02113982|365712786|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
106012153|NCT02113982|365712787|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
106012154|NCT02113982|365712788|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
106012155|NCT02113982|365712789|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
106012156|NCT02113982|365712790|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
106012157|NCT02113982|365712791|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
106012158|NCT02113982|365712778|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
106012159|NCT02113982|365712779|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
106012160|NCT02113982|365712780|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
106012161|NCT02113982|365712781|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
106012162|NCT02113982|365712782|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
106012163|NCT02113982|365712783|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
106012164|NCT02113982|365712784|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
106012165|NCT02113982|365712785|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
106012166|NCT02113982|365712786|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
106012167|NCT02113982|365712787|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
106012168|NCT02113982|365712788|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
106012169|NCT02113982|365712789|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
106012170|NCT02113982|365712790|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
106012171|NCT02113982|365712791|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
106012172|NCT02113982|365712778|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
106012173|NCT02113982|365712779|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
106012174|NCT02113982|365712780|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
105737922|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
106012175|NCT02113982|365712781|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
106012176|NCT02113982|365712782|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
106012177|NCT02113982|365712783|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
106012178|NCT02113982|365712784|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
106012179|NCT02113982|365712785|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
106012180|NCT02113982|365712786|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
106012181|NCT02113982|365712787|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
106012182|NCT02113982|365712788|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
106012183|NCT02113982|365712789|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
106012184|NCT02113982|365712790|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
106012185|NCT02113982|365712791|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
106012186|NCT02113982|365712778|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012187|NCT02113982|365712779|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012188|NCT02113982|365712780|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012189|NCT02113982|365712781|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012190|NCT02113982|365712782|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012191|NCT02113982|365712783|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012192|NCT02113982|365712784|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012193|NCT02113982|365712785|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
106012194|NCT02113982|365712786|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012195|NCT02113982|365712787|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
106012196|NCT02113982|365712788|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
106012197|NCT02113982|365712789|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
106141103|NCT00855465|366174440|FG001|Treatment Period|Lack of Efficacy|1|||
106141104|NCT00855465|366174439|FG000|Treatment Period|Non-compliance|1|||
106141105|NCT00855465|366174440|FG001|Treatment Period|Non-compliance|0|||
106141106|NCT00855465|366174439|FG000|Treatment Period|Protocol Violation|2|||
106141107|NCT00855465|366174440|FG001|Treatment Period|Protocol Violation|0|||
106141108|NCT00855465|366174439|FG000|Treatment Period|Withdrawal by Subject|2|||
106141109|NCT00855465|366174440|FG001|Treatment Period|Withdrawal by Subject|0|||
106141110|NCT00855465|366174439|FG000|Treatment Period|Not treated|1|||
106141111|NCT00855465|366174440|FG001|Treatment Period|Not treated|0|||
106141112|NCT00855465|366174439|FG000|Follow-up Period (FUP)|Adverse Event|0|||
106141113|NCT00855465|366174440|FG001|Follow-up Period (FUP)|Adverse Event|1|||
106141114|NCT00855465|366174439|FG000|Follow-up Period (FUP)|Death|0|||
106141115|NCT00855465|366174440|FG001|Follow-up Period (FUP)|Death|1|||
106141116|NCT00855465|366174439|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
106141117|NCT00855465|366174440|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
106141118|NCT00855465|366174439|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
106141119|NCT00855465|366174440|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
106141120|NCT00855465|366174439|FG000|Follow-up Period (FUP)|Missing|1|||
106141121|NCT00855465|366174440|FG001|Follow-up Period (FUP)|Missing|0|||
106141122|NCT00770965|366174441|FG000|Safety Set|Withdrawal by Subject|0|||
106141123|NCT00770965|366174442|FG001|Safety Set|Withdrawal by Subject|0|||
106141124|NCT00770965|366174443|FG002|Safety Set|Withdrawal by Subject|0|||
106141125|NCT00770965|366174444|FG003|Safety Set|Withdrawal by Subject|1|||
106141126|NCT00770965|366174441|FG000|Safety Set|Protocol deviation|0|||
106141127|NCT00770965|366174442|FG001|Safety Set|Protocol deviation|0|||
106141128|NCT00770965|366174443|FG002|Safety Set|Protocol deviation|1|||
106141129|NCT00770965|366174444|FG003|Safety Set|Protocol deviation|0|||
106141130|NCT00770965|366174441|FG000|Excluded Set|Administrative problems|14|||
106141131|NCT00770965|366174442|FG001|Excluded Set|Administrative problems|12|||
106141132|NCT00770965|366174443|FG002|Excluded Set|Administrative problems|12|||
106141133|NCT00770965|366174444|FG003|Excluded Set|Administrative problems|10|||
106141134|NCT00770965|366174441|FG000|Excluded Set|Withdrawal by Subject|1|||
106141135|NCT00770965|366174442|FG001|Excluded Set|Withdrawal by Subject|1|||
106141136|NCT00770965|366174443|FG002|Excluded Set|Withdrawal by Subject|2|||
106141137|NCT00770965|366174444|FG003|Excluded Set|Withdrawal by Subject|3|||
106141138|NCT03743246|366174445|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
106141139|NCT03743246|366174446|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
106141140|NCT03743246|366174447|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
106141141|NCT03743246|366174448|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
105737923|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
106141142|NCT03743246|366174445|FG000|Pre-Treatment Period|Death|0|||
106141143|NCT03743246|366174446|FG001|Pre-Treatment Period|Death|1|||
106141144|NCT03743246|366174447|FG002|Pre-Treatment Period|Death|0|||
105737924|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
106012198|NCT02113982|365712790|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012199|NCT02113982|365712791|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
106012200|NCT02113982|365712778|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106141145|NCT03743246|366174448|FG003|Pre-Treatment Period|Death|1|||
106141146|NCT03743246|366174445|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
106141147|NCT03743246|366174446|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
106141148|NCT03743246|366174447|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
106141149|NCT03743246|366174448|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
106141150|NCT03743246|366174445|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
106141151|NCT03743246|366174446|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
106141152|NCT03743246|366174447|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
106141153|NCT03743246|366174448|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
106141154|NCT03743246|366174445|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
106141155|NCT03743246|366174446|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
106141156|NCT03743246|366174447|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
106141157|NCT03743246|366174448|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
106141158|NCT03743246|366174445|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
106141159|NCT03743246|366174446|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
106141160|NCT03743246|366174447|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
106141161|NCT03743246|366174448|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
106141162|NCT03743246|366174445|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
106141163|NCT03743246|366174446|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
106141164|NCT03743246|366174447|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
106141165|NCT03743246|366174448|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
106141166|NCT03743246|366174445|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
106141167|NCT03743246|366174446|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
106141168|NCT03743246|366174447|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
106141169|NCT03743246|366174448|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
106141170|NCT03743246|366174445|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
106141171|NCT03743246|366174446|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
106141172|NCT03743246|366174447|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
106141173|NCT03743246|366174448|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
106141174|NCT02045836|366174450|FG000|Overall Study|Adverse Event|4|||
106141175|NCT02045836|366174451|FG001|Overall Study|Adverse Event|4|||
106141176|NCT02045836|366174450|FG000|Overall Study|Withdrawal by Subject|1|||
106141177|NCT02045836|366174451|FG001|Overall Study|Withdrawal by Subject|1|||
106141178|NCT02045836|366174450|FG000|Overall Study|Lost to Follow-up|4|||
106141179|NCT02045836|366174451|FG001|Overall Study|Lost to Follow-up|7|||
106141180|NCT02045836|366174450|FG000|Overall Study|Migrated from study area|0|||
106141181|NCT02045836|366174451|FG001|Overall Study|Migrated from study area|2|||
106141182|NCT03920215|366174452|FG000|Overall Study|Lost to Follow-up|1|||
106141183|NCT03920215|366174453|FG001|Overall Study|Lost to Follow-up|2|||
106141184|NCT03920215|366174454|FG002|Overall Study|Lost to Follow-up|0|||
106141185|NCT03920215|366174455|FG003|Overall Study|Lost to Follow-up|0|||
106141186|NCT03920215|366174452|FG000|Overall Study|Death|0|||
106141187|NCT03920215|366174453|FG001|Overall Study|Death|0|||
106141188|NCT03920215|366174454|FG002|Overall Study|Death|0|||
106141189|NCT03920215|366174455|FG003|Overall Study|Death|1|||
106141190|NCT00756730|366174456|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
106141191|NCT00756730|366174457|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
106141192|NCT00756730|366174456|FG000|Overall Study|persistent low-level viremmia|0|||
106141193|NCT00756730|366174457|FG001|Overall Study|persistent low-level viremmia|1|||
106141194|NCT01081145|366174458|FG000|Open-Label Phase|Lack of Efficacy|56|||
106141195|NCT01081145|366174459|FG001|Open-Label Phase|Lack of Efficacy|0|||
105737925|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
105737926|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
105737927|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
105737928|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
105737929|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
105737930|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
105737931|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
105799644|NCT04380701|364924614|FG000|Overall Study|Adverse Event|0|||
106141196|NCT01081145|366174458|FG000|Open-Label Phase|Response criteria not met|46|||
105737932|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
105737933|NCT00958568|364696803|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
105799645|NCT04380701|364924615|FG001|Overall Study|Adverse Event|0|||
105799646|NCT04380701|364924616|FG002|Overall Study|Adverse Event|0|||
105799647|NCT04380701|364924617|FG003|Overall Study|Adverse Event|0|||
106141197|NCT01081145|366174459|FG001|Open-Label Phase|Response criteria not met|0|||
106141198|NCT01081145|366174458|FG000|Open-Label Phase|Adverse Event|42|||
106141199|NCT01081145|366174459|FG001|Open-Label Phase|Adverse Event|0|||
106141200|NCT01081145|366174458|FG000|Open-Label Phase|Withdrawal by Subject|41|||
106141201|NCT01081145|366174459|FG001|Open-Label Phase|Withdrawal by Subject|0|||
106141202|NCT01081145|366174458|FG000|Open-Label Phase|Other|12|||
105799648|NCT04380701|364924618|FG004|Overall Study|Adverse Event|0|||
106141203|NCT01081145|366174459|FG001|Open-Label Phase|Other|0|||
105799649|NCT04380701|364924619|FG005|Overall Study|Adverse Event|1|||
105737934|NCT00958568|364696804|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
105737935|NCT00958568|364696805|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
105737936|NCT00958568|364696806|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
105940452|NCT03973489|365442987|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105940453|NCT03973489|365442988|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105940454|NCT03973489|365442989|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
105940455|NCT03973489|365442982|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105940456|NCT03973489|365442983|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105940457|NCT03973489|365442984|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105940458|NCT03973489|365442985|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
105940459|NCT03973489|365442986|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
105940460|NCT03973489|365442987|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105940461|NCT03973489|365442988|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105940462|NCT03973489|365442989|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
105940463|NCT03973489|365442982|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
105940464|NCT03973489|365442983|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
105940465|NCT03973489|365442984|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
105940466|NCT03973489|365442985|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
105940467|NCT03973489|365442986|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
105940468|NCT03973489|365442987|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
105940469|NCT03973489|365442988|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
105940470|NCT03973489|365442989|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
105940471|NCT03973489|365442982|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
105940472|NCT03973489|365442983|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105940473|NCT03973489|365442984|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105940474|NCT03973489|365442985|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
105940475|NCT03973489|365442986|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105940476|NCT03973489|365442987|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105940477|NCT03973489|365442988|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105940478|NCT03973489|365442989|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
105940479|NCT03973489|365442982|FG000|Second Intervention (1 Day)|Adverse Event|0|||
105940480|NCT03973489|365442983|FG001|Second Intervention (1 Day)|Adverse Event|0|||
105940481|NCT03973489|365442984|FG002|Second Intervention (1 Day)|Adverse Event|0|||
105940482|NCT03973489|365442985|FG003|Second Intervention (1 Day)|Adverse Event|1|||
105940483|NCT03973489|365442986|FG004|Second Intervention (1 Day)|Adverse Event|0|||
105940484|NCT03973489|365442987|FG005|Second Intervention (1 Day)|Adverse Event|0|||
105940485|NCT03973489|365442988|FG006|Second Intervention (1 Day)|Adverse Event|0|||
105940486|NCT03973489|365442989|FG007|Second Intervention (1 Day)|Adverse Event|0|||
105940487|NCT00392288|365442990|FG000|Overall Study|Adverse Event|17|||
105940488|NCT00392288|365442991|FG001|Overall Study|Adverse Event|7|||
105940489|NCT00392288|365442992|FG002|Overall Study|Adverse Event|8|||
105940490|NCT00392288|365442990|FG000|Overall Study|Lack of Efficacy|8|||
105940491|NCT00392288|365442991|FG001|Overall Study|Lack of Efficacy|5|||
105940492|NCT00392288|365442992|FG002|Overall Study|Lack of Efficacy|3|||
105940493|NCT00392288|365442990|FG000|Overall Study|Protocol Violation|1|||
105940494|NCT00392288|365442991|FG001|Overall Study|Protocol Violation|3|||
105940495|NCT00392288|365442992|FG002|Overall Study|Protocol Violation|1|||
105940496|NCT00392288|365442990|FG000|Overall Study|Lost to Follow-up|1|||
105940497|NCT00392288|365442991|FG001|Overall Study|Lost to Follow-up|1|||
105940498|NCT00392288|365442992|FG002|Overall Study|Lost to Follow-up|1|||
105940499|NCT00392288|365442990|FG000|Overall Study|Withdrawal by Subject|1|||
105940500|NCT00392288|365442991|FG001|Overall Study|Withdrawal by Subject|0|||
105940501|NCT00392288|365442992|FG002|Overall Study|Withdrawal by Subject|2|||
105940502|NCT00392288|365442990|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
105940503|NCT00392288|365442991|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
105940504|NCT00392288|365442992|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
105940505|NCT00392288|365442990|FG000|Overall Study|Other|3|||
105940506|NCT00392288|365442991|FG001|Overall Study|Other|4|||
105940507|NCT00392288|365442992|FG002|Overall Study|Other|1|||
105940508|NCT02757963|365442993|FG000|Overall Study|Adverse Event|3|||
105940509|NCT02757963|365442993|FG000|Overall Study|Reached Stopping Criteria|1054|||
105940510|NCT02757963|365442993|FG000|Overall Study|Lost to Follow-up|5|||
105940511|NCT02757963|365442993|FG000|Overall Study|Physician Decision|1|||
105940512|NCT02757963|365442993|FG000|Overall Study|Withdrawal by Subject|34|||
105940513|NCT02528305|365442998|FG000|Overall Study|Withdrawal by Subject|1|||
105940514|NCT02528305|365442998|FG000|Overall Study|Adverse Event|1|||
105940515|NCT02528305|365442998|FG000|Overall Study|Physician Decision|1|||
105940516|NCT04309500|365443003|FG000|Overall Study|Lost to Follow-up|1|||
105940517|NCT04309500|365443004|FG001|Overall Study|Lost to Follow-up|0|||
105940518|NCT04309500|365443005|FG002|Overall Study|Lost to Follow-up|0|||
105737937|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
105737938|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
105737939|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
105737940|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
105737941|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
105737942|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
105737943|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
105737944|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
105737945|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
105737946|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
105737947|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
105737948|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
105737949|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
105737950|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
105737951|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
105737952|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
105737953|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
105737954|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
105737955|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
105737956|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
105737957|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
105737958|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
105737959|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
105737960|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
105737961|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
105737962|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
105737963|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
105737964|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
105737965|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
105737966|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
105737967|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
105737968|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
105737969|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
105737970|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
105737971|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
105737972|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
105737973|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
105737974|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
105940519|NCT04309500|365443006|FG003|Overall Study|Lost to Follow-up|0|||
105940520|NCT03726879|365443007|FG000|Overall Study|Death|11|||
105940521|NCT03726879|365443008|FG001|Overall Study|Death|13|||
105940522|NCT03726879|365443007|FG000|Overall Study|Physician Decision|0|||
105940523|NCT03726879|365443008|FG001|Overall Study|Physician Decision|2|||
105940524|NCT03726879|365443007|FG000|Overall Study|Protocol Violation|0|||
105940525|NCT03726879|365443008|FG001|Overall Study|Protocol Violation|1|||
105940526|NCT03726879|365443007|FG000|Overall Study|Withdrawal by Subject|5|||
105940527|NCT03726879|365443008|FG001|Overall Study|Withdrawal by Subject|6|||
105799650|NCT04380701|364924620|FG006|Overall Study|Adverse Event|0|||
105940528|NCT03726879|365443007|FG000|Overall Study|TSH result is unstable|0|||
105940529|NCT03726879|365443008|FG001|Overall Study|TSH result is unstable|1|||
105940530|NCT03726879|365443007|FG000|Overall Study|Disease relapse|1|||
105940531|NCT03726879|365443008|FG001|Overall Study|Disease relapse|0|||
105940532|NCT03726879|365443007|FG000|Overall Study|Lost to Follow-up|3|||
105940533|NCT03726879|365443008|FG001|Overall Study|Lost to Follow-up|0|||
105940534|NCT01308788|365443013|FG000|2-year Treatment|medication change by treating physician|4|||
105940535|NCT01308788|365443014|FG001|2-year Treatment|medication change by treating physician|11|||
105940536|NCT02414841|365443016|FG000|Overall Study|Withdrawal by Subject|7|||
105940537|NCT02414841|365443017|FG001|Overall Study|Withdrawal by Subject|5|||
105940538|NCT02414841|365443016|FG000|Overall Study|Lost to Follow-up|13|||
105940539|NCT02414841|365443017|FG001|Overall Study|Lost to Follow-up|6|||
106012201|NCT02113982|365712779|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012202|NCT02113982|365712780|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012203|NCT02113982|365712781|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
105940540|NCT02414841|365443016|FG000|Overall Study|Death|17|||
105940541|NCT02414841|365443017|FG001|Overall Study|Death|14|||
105940542|NCT02414841|365443016|FG000|Overall Study|Received a Kidney Transplant|13|||
105940543|NCT02414841|365443017|FG001|Overall Study|Received a Kidney Transplant|4|||
105940544|NCT02414841|365443016|FG000|Overall Study|Randomized But Not Treated|6|||
106141204|NCT01081145|366174458|FG000|Open-Label Phase|Lost to Follow-up|11|||
106141205|NCT01081145|366174459|FG001|Open-Label Phase|Lost to Follow-up|0|||
106141206|NCT01081145|366174458|FG000|Open-Label Phase|Protocol Violation|4|||
106141207|NCT01081145|366174459|FG001|Open-Label Phase|Protocol Violation|0|||
106141208|NCT01081145|366174458|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
106141209|NCT01081145|366174459|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
106141210|NCT01081145|366174458|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
106141211|NCT01081145|366174459|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
106141212|NCT01081145|366174458|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
106141213|NCT01081145|366174459|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
106141214|NCT01081145|366174458|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
106141215|NCT01081145|366174459|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
106141216|NCT01081145|366174458|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
105737975|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
105737976|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
106141217|NCT01081145|366174459|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
106141218|NCT01081145|366174458|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
106141219|NCT01081145|366174459|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
106141220|NCT01081145|366174458|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
106141221|NCT01081145|366174459|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
106141222|NCT01697319|366174476|FG000|Primary Phase|Withdrawal by Subject|1|||
106141223|NCT01697319|366174476|FG000|Extension Phase|Terminated by Sponsor|15|||
106141224|NCT00038103|366174478|FG000|Overall Study|Adverse Event|5|||
106141225|NCT00038103|366174479|FG001|Overall Study|Adverse Event|6|||
106141226|NCT00038103|366174478|FG000|Overall Study|Lack of Efficacy|48|||
106141227|NCT00038103|366174479|FG001|Overall Study|Lack of Efficacy|41|||
106141228|NCT00038103|366174478|FG000|Overall Study|Withdrawal by Subject|0|||
106141229|NCT00038103|366174479|FG001|Overall Study|Withdrawal by Subject|3|||
106141230|NCT00038103|366174478|FG000|Overall Study|Lost to Follow-up|0|||
106141231|NCT00038103|366174479|FG001|Overall Study|Lost to Follow-up|3|||
106141232|NCT00038103|366174478|FG000|Overall Study|Protocol Violation|0|||
106141233|NCT00038103|366174479|FG001|Overall Study|Protocol Violation|2|||
106141234|NCT00038103|366174478|FG000|Overall Study|Sponsor Decision|0|||
106141235|NCT00038103|366174479|FG001|Overall Study|Sponsor Decision|1|||
106141236|NCT00038103|366174478|FG000|Overall Study|Randomized/never treated|2|||
106141237|NCT00038103|366174479|FG001|Overall Study|Randomized/never treated|0|||
106141238|NCT01123083|366174480|FG000|Overall Study|Investigator recommendation|1|||
106141239|NCT01123083|366174481|FG001|Overall Study|Investigator recommendation|1|||
106141240|NCT01123083|366174480|FG000|Overall Study|Administrative reasons|0|||
106141241|NCT01123083|366174481|FG001|Overall Study|Administrative reasons|4|||
106141242|NCT01123083|366174480|FG000|Overall Study|Lost to Follow-up|2|||
106141243|NCT01123083|366174481|FG001|Overall Study|Lost to Follow-up|6|||
106141244|NCT01123083|366174480|FG000|Overall Study|Adverse Event|1|||
105737977|NCT00958568|364696803|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
105737978|NCT00958568|364696804|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
105737979|NCT00958568|364696805|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
105737980|NCT00958568|364696806|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
105737981|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
105799651|NCT04380701|364924621|FG007|Overall Study|Adverse Event|0|||
105940545|NCT02414841|365443017|FG001|Overall Study|Randomized But Not Treated|4|||
105940546|NCT00964678|365443033|FG000|Overall Study|Physician Decision|4|||
105940547|NCT03439072|365444961|FG000|Overall Study|Withdrawal by Subject|2|||
105940548|NCT03439072|365444962|FG001|Overall Study|Withdrawal by Subject|3|||
105940549|NCT03439072|365444961|FG000|Overall Study|Physician Decision|0|||
105940550|NCT03439072|365444962|FG001|Overall Study|Physician Decision|1|||
105940551|NCT02272985|365444965|FG000|Overall Study|Withdrawal by Subject|1|||
105940552|NCT02272985|365444965|FG000|Overall Study|hip fracture|1|||
105940553|NCT02272985|365444965|FG000|Overall Study|kidney transplantation|1|||
105940554|NCT04157738|365444971|FG000|Overall Study|Moved out of state|0|||
105940555|NCT04157738|365444972|FG001|Overall Study|Moved out of state|2|||
105940556|NCT04157738|365444971|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
105940557|NCT04157738|365444972|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
105940558|NCT00160563|365444973|FG000|Overall Study|Adverse Event|1|||
105940559|NCT00160563|365444974|FG001|Overall Study|Adverse Event|1|||
105940560|NCT00160563|365444975|FG002|Overall Study|Adverse Event|1|||
105940561|NCT00160563|365444973|FG000|Overall Study|Lost to Follow-up|1|||
105940562|NCT00160563|365444974|FG001|Overall Study|Lost to Follow-up|1|||
106141245|NCT01123083|366174481|FG001|Overall Study|Adverse Event|0|||
105940563|NCT00160563|365444975|FG002|Overall Study|Lost to Follow-up|2|||
105940564|NCT00160563|365444973|FG000|Overall Study|Protocol Violation|0|||
105940565|NCT00160563|365444974|FG001|Overall Study|Protocol Violation|0|||
105940566|NCT00160563|365444975|FG002|Overall Study|Protocol Violation|3|||
105737982|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
105737983|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
105737984|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
105737985|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
105737986|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
105737987|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
105737988|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
105737989|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
105737990|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
105737991|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
105737992|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
105737993|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
105737994|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
105737995|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
105737996|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
105737997|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
105737998|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
105737999|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
105738000|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
105738001|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
105738002|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
105738003|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
105738004|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
105738005|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
105738006|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
105738007|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
105738008|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
105738009|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
105738010|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
105738011|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
105738012|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
105738013|NCT00958568|364696803|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
105738014|NCT00958568|364696804|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
105738015|NCT00958568|364696805|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
105738016|NCT00958568|364696806|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
105738017|NCT00915005|364696807|FG000|Overall Study|Withdrawal by Subject|4|||
105738018|NCT00915005|364696808|FG001|Overall Study|Withdrawal by Subject|4|||
105738019|NCT00915005|364696807|FG000|Overall Study|Patient preferred protons therapy|6|||
105738020|NCT00915005|364696808|FG001|Overall Study|Patient preferred protons therapy|0|||
105738021|NCT00915005|364696807|FG000|Overall Study|Insurance denial|3|||
105738022|NCT00915005|364696808|FG001|Overall Study|Insurance denial|15|||
105738023|NCT00907478|364696811|FG000|Overall Study|Ineligibility determined|0|||
105738024|NCT00907478|364696812|FG001|Overall Study|Ineligibility determined|0|||
105738025|NCT00907478|364696813|FG002|Overall Study|Ineligibility determined|1|||
105940567|NCT00160563|365444973|FG000|Overall Study|Withdrawal by Subject|1|||
105940568|NCT00160563|365444974|FG001|Overall Study|Withdrawal by Subject|2|||
105940569|NCT00160563|365444975|FG002|Overall Study|Withdrawal by Subject|3|||
105940570|NCT00160563|365444973|FG000|Overall Study|Other (listed in the study report)|48|||
105940571|NCT00160563|365444974|FG001|Overall Study|Other (listed in the study report)|40|||
105940572|NCT00160563|365444975|FG002|Overall Study|Other (listed in the study report)|81|||
105940573|NCT00160563|365444973|FG000|Overall Study|Missing reason|0|||
105940574|NCT00160563|365444974|FG001|Overall Study|Missing reason|1|||
105940575|NCT00160563|365444975|FG002|Overall Study|Missing reason|0|||
105940576|NCT00752219|365444976|FG000|Overall Study|Clinical failure|0|||
105940577|NCT00752219|365444977|FG001|Overall Study|Clinical failure|1|||
105940578|NCT00752219|365444976|FG000|Overall Study|Adverse Event|5|||
105940579|NCT00752219|365444977|FG001|Overall Study|Adverse Event|3|||
105940580|NCT00752219|365444976|FG000|Overall Study|Protocol deviation|1|||
105940581|NCT00752219|365444977|FG001|Overall Study|Protocol deviation|0|||
105940582|NCT00752219|365444976|FG000|Overall Study|Lost to Follow-up|1|||
105940583|NCT00752219|365444977|FG001|Overall Study|Lost to Follow-up|2|||
105940584|NCT00752219|365444976|FG000|Overall Study|Randomized but not treated|1|||
105940585|NCT00752219|365444977|FG001|Overall Study|Randomized but not treated|0|||
105940586|NCT00752219|365444976|FG000|Overall Study|Other|3|||
105738026|NCT00907478|364696811|FG000|Overall Study|Noncompliance|0|||
105738027|NCT00907478|364696812|FG001|Overall Study|Noncompliance|0|||
105738028|NCT00907478|364696813|FG002|Overall Study|Noncompliance|1|||
105940587|NCT00752219|365444977|FG001|Overall Study|Other|0|||
105940588|NCT04691115|365444978|FG000|Overall Study|Withdrawal by Subject|0|||
105940589|NCT04691115|365444979|FG001|Overall Study|Withdrawal by Subject|0|||
105940590|NCT04691115|365444980|FG002|Overall Study|Withdrawal by Subject|0|||
105799652|NCT04380701|364924622|FG008|Overall Study|Adverse Event|0|||
105799653|NCT04380701|364924623|FG009|Overall Study|Adverse Event|0|||
105799654|NCT04380701|364924624|FG010|Overall Study|Adverse Event|0|||
105799655|NCT04380701|364924625|FG011|Overall Study|Adverse Event|0|||
105799656|NCT04380701|364924626|FG012|Overall Study|Adverse Event|0|||
105799657|NCT04380701|364924627|FG013|Overall Study|Adverse Event|0|||
105799658|NCT04380701|364924628|FG014|Overall Study|Adverse Event|0|||
105799659|NCT04380701|364924629|FG015|Overall Study|Adverse Event|1|||
105799660|NCT04380701|364924630|FG016|Overall Study|Adverse Event|0|||
105799661|NCT04380701|364924631|FG017|Overall Study|Adverse Event|0|||
105799662|NCT04380701|364924632|FG018|Overall Study|Adverse Event|0|||
105799663|NCT04380701|364924633|FG019|Overall Study|Adverse Event|1|||
105799664|NCT04380701|364924634|FG020|Overall Study|Adverse Event|0|||
105799665|NCT04380701|364924635|FG021|Overall Study|Adverse Event|0|||
105799666|NCT04380701|364924636|FG022|Overall Study|Adverse Event|0|||
105799667|NCT04380701|364924637|FG023|Overall Study|Adverse Event|0|||
105799668|NCT04380701|364924638|FG024|Overall Study|Adverse Event|0|||
105799669|NCT04380701|364924639|FG025|Overall Study|Adverse Event|0|||
105799670|NCT04380701|364924640|FG026|Overall Study|Adverse Event|0|||
105799671|NCT04380701|364924641|FG027|Overall Study|Adverse Event|0|||
105799672|NCT04380701|364924642|FG028|Overall Study|Adverse Event|0|||
105799673|NCT04380701|364924643|FG029|Overall Study|Adverse Event|0|||
105799674|NCT04380701|364924644|FG030|Overall Study|Adverse Event|0|||
105799675|NCT04380701|364924645|FG031|Overall Study|Adverse Event|0|||
105799676|NCT04380701|364924646|FG032|Overall Study|Adverse Event|0|||
105799677|NCT04380701|364924647|FG033|Overall Study|Adverse Event|0|||
105799678|NCT04380701|364924614|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
105799679|NCT04380701|364924615|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
105799680|NCT04380701|364924616|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
105799681|NCT04380701|364924617|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
105799682|NCT04380701|364924618|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
105799683|NCT04380701|364924619|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
105799684|NCT04380701|364924620|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
105799685|NCT04380701|364924621|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
105799686|NCT04380701|364924622|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
105799687|NCT04380701|364924623|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
105799688|NCT04380701|364924624|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
105799689|NCT04380701|364924625|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
105799690|NCT04380701|364924626|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
105799691|NCT04380701|364924627|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
105799692|NCT04380701|364924628|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
105799693|NCT04380701|364924629|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
105799694|NCT04380701|364924630|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
105799695|NCT04380701|364924631|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
105799696|NCT04380701|364924632|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
105738029|NCT00907478|364696811|FG000|Overall Study|Adverse Event|3|||
105738030|NCT00907478|364696812|FG001|Overall Study|Adverse Event|1|||
105738031|NCT00907478|364696813|FG002|Overall Study|Adverse Event|2|||
105738032|NCT00907478|364696811|FG000|Overall Study|Withdrawal by Subject|8|||
105738033|NCT00907478|364696812|FG001|Overall Study|Withdrawal by Subject|9|||
105738034|NCT00907478|364696813|FG002|Overall Study|Withdrawal by Subject|6|||
105738035|NCT00907478|364696811|FG000|Overall Study|Requirement for alternative therapy|1|||
105738036|NCT00907478|364696812|FG001|Overall Study|Requirement for alternative therapy|2|||
105738037|NCT00907478|364696813|FG002|Overall Study|Requirement for alternative therapy|3|||
105738038|NCT00907478|364696811|FG000|Overall Study|Physician Decision|2|||
105738039|NCT00907478|364696812|FG001|Overall Study|Physician Decision|0|||
105799697|NCT04380701|364924633|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
105799698|NCT04380701|364924634|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
105799699|NCT04380701|364924635|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
105799700|NCT04380701|364924636|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
105799701|NCT04380701|364924637|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
105940591|NCT04691115|365444981|FG003|Overall Study|Withdrawal by Subject|0|||
105940592|NCT04691115|365444982|FG004|Overall Study|Withdrawal by Subject|0|||
105940593|NCT04691115|365444983|FG005|Overall Study|Withdrawal by Subject|1|||
105940594|NCT04691115|365444984|FG006|Overall Study|Withdrawal by Subject|0|||
105940595|NCT04691115|365444985|FG007|Overall Study|Withdrawal by Subject|0|||
105940596|NCT04691115|365444986|FG008|Overall Study|Withdrawal by Subject|0|||
105940597|NCT04691115|365444987|FG009|Overall Study|Withdrawal by Subject|0|||
105940598|NCT04691115|365444988|FG010|Overall Study|Withdrawal by Subject|0|||
105940599|NCT04691115|365444989|FG011|Overall Study|Withdrawal by Subject|0|||
105940600|NCT04691115|365444990|FG012|Overall Study|Withdrawal by Subject|0|||
105940601|NCT04691115|365444991|FG013|Overall Study|Withdrawal by Subject|0|||
105940602|NCT00347269|365444992|FG000|Overall Study|Lost to Follow-up|74|||
105940603|NCT00347269|365444993|FG001|Overall Study|Lost to Follow-up|65|||
105738040|NCT00907478|364696813|FG002|Overall Study|Physician Decision|3|||
105940604|NCT00347269|365444992|FG000|Overall Study|Withdrawal by Subject|18|||
105738041|NCT00907478|364696811|FG000|Overall Study|Death|4|||
105738042|NCT00907478|364696812|FG001|Overall Study|Death|2|||
105738043|NCT00907478|364696813|FG002|Overall Study|Death|1|||
105738044|NCT00907478|364696811|FG000|Overall Study|Protocol-specified criteria|5|||
105738045|NCT00907478|364696812|FG001|Overall Study|Protocol-specified criteria|2|||
105738046|NCT00907478|364696813|FG002|Overall Study|Protocol-specified criteria|3|||
105738047|NCT00907478|364696811|FG000|Overall Study|Pregnancy|0|||
105738048|NCT00907478|364696812|FG001|Overall Study|Pregnancy|1|||
105738049|NCT00907478|364696813|FG002|Overall Study|Pregnancy|1|||
105738050|NCT00907478|364696811|FG000|Overall Study|Lost to Follow-up|1|||
105738051|NCT00907478|364696812|FG001|Overall Study|Lost to Follow-up|0|||
105738052|NCT00907478|364696813|FG002|Overall Study|Lost to Follow-up|0|||
105738053|NCT00907478|364696811|FG000|Overall Study|Other|3|||
105738054|NCT00907478|364696812|FG001|Overall Study|Other|0|||
105738055|NCT00907478|364696813|FG002|Overall Study|Other|1|||
105738056|NCT02639182|364696818|FG000|Overall Study|Disease Progression|50|||
105738057|NCT02639182|364696819|FG001|Overall Study|Disease Progression|49|||
105738058|NCT02639182|364696818|FG000|Overall Study|Adverse Event|7|||
105738059|NCT02639182|364696819|FG001|Overall Study|Adverse Event|5|||
105738060|NCT02639182|364696818|FG000|Overall Study|Physician Decision|3|||
105738061|NCT02639182|364696819|FG001|Overall Study|Physician Decision|3|||
105738062|NCT02639182|364696818|FG000|Overall Study|Withdrew Consent|5|||
105738063|NCT02639182|364696819|FG001|Overall Study|Withdrew Consent|4|||
105738064|NCT02639182|364696818|FG000|Overall Study|Lost to Follow-up|0|||
105738065|NCT02639182|364696819|FG001|Overall Study|Lost to Follow-up|1|||
105738066|NCT02639182|364696818|FG000|Overall Study|Study Closure|1|||
105738067|NCT02639182|364696819|FG001|Overall Study|Study Closure|2|||
105738068|NCT02639182|364696818|FG000|Overall Study|Sponsor Ended Study|0|||
105738069|NCT02639182|364696819|FG001|Overall Study|Sponsor Ended Study|1|||
105738070|NCT02639182|364696818|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
105738071|NCT02639182|364696819|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
105738072|NCT02546856|364696822|FG000|4 Months Evaluation|Death|2|||
106012204|NCT02113982|365712782|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012205|NCT02113982|365712783|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012206|NCT02113982|365712784|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012207|NCT02113982|365712785|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
106012208|NCT02113982|365712786|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012209|NCT02113982|365712787|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
106012210|NCT02113982|365712788|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012211|NCT02113982|365712789|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012212|NCT02113982|365712790|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012213|NCT02113982|365712791|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
106012214|NCT02113982|365712778|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012215|NCT02113982|365712779|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012216|NCT02113982|365712780|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012217|NCT02113982|365712781|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012218|NCT02113982|365712782|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012219|NCT02113982|365712783|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012220|NCT02113982|365712784|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012221|NCT02113982|365712785|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
106012222|NCT02113982|365712786|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012223|NCT02113982|365712787|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012224|NCT02113982|365712788|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012225|NCT02113982|365712789|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012226|NCT02113982|365712790|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012227|NCT02113982|365712791|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
106012228|NCT02113982|365712778|FG000|Stage 2: Cohort Expansion|Transplant|0|||
106012229|NCT02113982|365712779|FG001|Stage 2: Cohort Expansion|Transplant|0|||
106012230|NCT02113982|365712780|FG002|Stage 2: Cohort Expansion|Transplant|0|||
106141246|NCT01123083|366174480|FG000|Overall Study|Withdrew for another reason not covered|0|||
106141247|NCT01123083|366174481|FG001|Overall Study|Withdrew for another reason not covered|1|||
106141248|NCT01123083|366174480|FG000|Overall Study|Participant/legal representative request|7|||
105738073|NCT02546856|364696823|FG001|4 Months Evaluation|Death|3|||
105738074|NCT02546856|364696822|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
105738075|NCT02546856|364696823|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
105738076|NCT02546856|364696822|FG000|4 Months Evaluation|Lost to Follow-up|3|||
105738077|NCT02546856|364696823|FG001|4 Months Evaluation|Lost to Follow-up|3|||
105738078|NCT02546856|364696822|FG000|4 Months Evaluation|Physician Decision|3|||
105738079|NCT02546856|364696823|FG001|4 Months Evaluation|Physician Decision|0|||
106012231|NCT02113982|365712781|FG003|Stage 2: Cohort Expansion|Transplant|0|||
106012232|NCT02113982|365712782|FG004|Stage 2: Cohort Expansion|Transplant|0|||
106012233|NCT02113982|365712783|FG005|Stage 2: Cohort Expansion|Transplant|0|||
105738080|NCT02546856|364696822|FG000|4 Months Evaluation|Working or living abroad|5|||
105738081|NCT02546856|364696823|FG001|4 Months Evaluation|Working or living abroad|1|||
106012234|NCT02113982|365712784|FG006|Stage 2: Cohort Expansion|Transplant|0|||
106012235|NCT02113982|365712785|FG007|Stage 2: Cohort Expansion|Transplant|0|||
106012236|NCT02113982|365712786|FG008|Stage 2: Cohort Expansion|Transplant|0|||
106012237|NCT02113982|365712787|FG009|Stage 2: Cohort Expansion|Transplant|4|||
106012238|NCT02113982|365712788|FG010|Stage 2: Cohort Expansion|Transplant|2|||
106012239|NCT02113982|365712789|FG011|Stage 2: Cohort Expansion|Transplant|0|||
106012240|NCT02113982|365712790|FG012|Stage 2: Cohort Expansion|Transplant|0|||
106012241|NCT02113982|365712791|FG013|Stage 2: Cohort Expansion|Transplant|0|||
106012242|NCT02113982|365712778|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
106012243|NCT02113982|365712779|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
106012244|NCT02113982|365712780|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
106012245|NCT02113982|365712781|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
106012246|NCT02113982|365712782|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
106012247|NCT02113982|365712783|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
106012248|NCT02113982|365712784|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
106012249|NCT02113982|365712785|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
106012250|NCT02113982|365712786|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
106012251|NCT02113982|365712787|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
106012252|NCT02113982|365712788|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
106012253|NCT02113982|365712789|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
106012254|NCT02113982|365712790|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
106012255|NCT02113982|365712791|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
106012256|NCT02113982|365712778|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
106012257|NCT02113982|365712779|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
106012258|NCT02113982|365712780|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
106012259|NCT02113982|365712781|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
106012260|NCT02113982|365712782|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
106012261|NCT02113982|365712783|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
106012262|NCT02113982|365712784|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
106012263|NCT02113982|365712785|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
106012264|NCT02113982|365712786|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
106012265|NCT02113982|365712787|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
106012266|NCT02113982|365712788|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
106012267|NCT02113982|365712789|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
106012268|NCT02113982|365712790|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
106012269|NCT02113982|365712791|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
106012270|NCT02113982|365712778|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012271|NCT02113982|365712779|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012272|NCT02113982|365712780|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012273|NCT02113982|365712781|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012274|NCT02113982|365712782|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012275|NCT02113982|365712783|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012276|NCT02113982|365712784|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012277|NCT02113982|365712785|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012278|NCT02113982|365712786|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012279|NCT02113982|365712787|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012280|NCT02113982|365712788|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012281|NCT02113982|365712789|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
106012282|NCT02113982|365712790|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012283|NCT02113982|365712791|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
106012284|NCT02113982|365712778|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012285|NCT02113982|365712779|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012286|NCT02113982|365712780|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012287|NCT02113982|365712781|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012288|NCT02113982|365712782|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012289|NCT02113982|365712783|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012290|NCT02113982|365712784|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012291|NCT02113982|365712785|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012292|NCT02113982|365712786|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012293|NCT02113982|365712787|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012294|NCT02113982|365712788|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012295|NCT02113982|365712789|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
106012296|NCT02113982|365712790|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012297|NCT02113982|365712791|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
106012298|NCT02113982|365712778|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012299|NCT02113982|365712779|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105738082|NCT02546856|364696822|FG000|4 Months Evaluation|reasons not due to titration|4|||
106012300|NCT02113982|365712780|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012301|NCT02113982|365712781|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012302|NCT02113982|365712782|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012303|NCT02113982|365712783|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012304|NCT02113982|365712784|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012305|NCT02113982|365712785|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
105738083|NCT02546856|364696823|FG001|4 Months Evaluation|reasons not due to titration|1|||
105738084|NCT02546856|364696822|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
105738085|NCT02546856|364696823|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
105738086|NCT02546856|364696822|FG000|6 Months Evaluation|Death|1|||
105738087|NCT02546856|364696823|FG001|6 Months Evaluation|Death|1|||
105738088|NCT02546856|364696822|FG000|6 Months Evaluation|Lost to Follow-up|1|||
105738089|NCT02546856|364696823|FG001|6 Months Evaluation|Lost to Follow-up|1|||
105738090|NCT02546856|364696822|FG000|6 Months Evaluation|Working or living abroad|6|||
105738091|NCT02546856|364696823|FG001|6 Months Evaluation|Working or living abroad|4|||
105738092|NCT02546856|364696822|FG000|6 Months Evaluation|reasons not due to titration|0|||
105738093|NCT02546856|364696823|FG001|6 Months Evaluation|reasons not due to titration|1|||
105738094|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
105738095|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
105738096|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105738097|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
105738098|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105738099|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
105738100|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
105738101|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
105738102|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105738103|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
105738104|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
105738105|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105738106|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
105738107|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
105738108|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
105738109|NCT00611455|364696826|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
105738110|NCT00611455|364696827|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
105738111|NCT00611455|364696828|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
105738112|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
105738113|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
105738114|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
105738115|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
105940605|NCT00347269|365444993|FG001|Overall Study|Withdrawal by Subject|38|||
105940606|NCT00347269|365444992|FG000|Overall Study|Death|2|||
105940607|NCT00347269|365444993|FG001|Overall Study|Death|3|||
105940608|NCT00835042|365444994|FG000|First Intervention|Withdrawal by Subject|3|||
105940609|NCT00835042|365444995|FG001|First Intervention|Withdrawal by Subject|0|||
105940610|NCT00835042|365444994|FG000|First Intervention|Adverse Event|1|||
105940611|NCT00835042|365444995|FG001|First Intervention|Adverse Event|2|||
105940612|NCT00835042|365444994|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
105940613|NCT00835042|365444995|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
105940614|NCT04725188|365444996|FG000|Overall Study|Death|44|||
105940615|NCT04725188|365444997|FG001|Overall Study|Death|46|||
105940616|NCT04725188|365444998|FG002|Overall Study|Death|48|||
105940617|NCT04725188|365444996|FG000|Overall Study|Lost to Follow-up|0|||
105940618|NCT04725188|365444997|FG001|Overall Study|Lost to Follow-up|0|||
105940619|NCT04725188|365444998|FG002|Overall Study|Lost to Follow-up|1|||
105940620|NCT04725188|365444996|FG000|Overall Study|Withdrawal by Subject|2|||
105940621|NCT04725188|365444997|FG001|Overall Study|Withdrawal by Subject|2|||
105940622|NCT04725188|365444998|FG002|Overall Study|Withdrawal by Subject|1|||
105940623|NCT04725188|365444996|FG000|Overall Study|Participants ongoing in the study|41|||
105940624|NCT04725188|365444997|FG001|Overall Study|Participants ongoing in the study|35|||
105940625|NCT04725188|365444998|FG002|Overall Study|Participants ongoing in the study|35|||
105940626|NCT04064567|365445004|FG000|Overall Study|Lost to Follow-up|23|||
105940627|NCT04064567|365445005|FG001|Overall Study|Lost to Follow-up|22|||
105940628|NCT04064567|365445004|FG000|Overall Study|Withdrawal by Subject|0|||
105940629|NCT04064567|365445005|FG001|Overall Study|Withdrawal by Subject|1|||
105940630|NCT04064567|365445004|FG000|Overall Study|Reincarcerated|7|||
105940631|NCT04064567|365445005|FG001|Overall Study|Reincarcerated|10|||
105940632|NCT04064567|365445004|FG000|Overall Study|Moved out of U.S.|0|||
105940633|NCT04064567|365445005|FG001|Overall Study|Moved out of U.S.|1|||
105940634|NCT05524948|365445010|FG000|Overall Study|Withdrawal by Subject|1|||
105940635|NCT05524948|365445011|FG001|Overall Study|Withdrawal by Subject|0|||
105940636|NCT05524948|365445010|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
105940637|NCT05524948|365445011|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
105940638|NCT05418426|365445012|FG000|Overall Study|Adverse Event|0|||
105940639|NCT05418426|365445013|FG001|Overall Study|Adverse Event|1|||
105940640|NCT05418426|365445014|FG002|Overall Study|Adverse Event|0|||
105940641|NCT05418426|365445012|FG000|Overall Study|Withdrawal by Subject|0|||
106141249|NCT01123083|366174481|FG001|Overall Study|Participant/legal representative request|3|||
106141250|NCT03545984|366174482|FG000|Overall Study|CSF cases not present during rotation|11|||
106141251|NCT03545984|366174483|FG001|Overall Study|CSF cases not present during rotation|9|||
106141252|NCT01751724|366174484|FG000|Overall Study|extubated bef.start assigned treatment|1|||
106141253|NCT01751724|366174485|FG001|Overall Study|extubated bef.start assigned treatment|0|||
106141254|NCT01751724|366174484|FG000|Overall Study|withdrawn by parent|0|||
106141255|NCT01751724|366174485|FG001|Overall Study|withdrawn by parent|2|||
106141256|NCT03768206|366174486|FG000|Overall Study|Lost to Follow-up|2|||
106141257|NCT03768206|366174487|FG001|Overall Study|Lost to Follow-up|1|||
105738116|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
105738117|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
105738118|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
105738119|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
106141258|NCT03768206|366174486|FG000|Overall Study|Withdrawal by Subject|0|||
106141259|NCT03768206|366174487|FG001|Overall Study|Withdrawal by Subject|1|||
106141260|NCT01390402|366174488|FG000|Overall Study|Death|1|||
106141261|NCT01390402|366174488|FG000|Overall Study|Disease Progression|4|||
106141262|NCT02812966|366174489|FG000|Overall Study|Death|1|||
106141263|NCT02812966|366174490|FG001|Overall Study|Death|0|||
106141264|NCT01144468|366175910|FG000|Overall Study|Lost to Follow-up|4|||
106141265|NCT01144468|366175911|FG001|Overall Study|Lost to Follow-up|7|||
106141266|NCT01144468|366175910|FG000|Overall Study|Adverse Event|3|||
106141267|NCT01144468|366175911|FG001|Overall Study|Adverse Event|2|||
106141268|NCT01144468|366175910|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
106141269|NCT01144468|366175911|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
106141270|NCT02960659|366175912|FG000|Overall Study|Withdrawal by Subject|1|||
106141271|NCT02960659|366175913|FG001|Overall Study|Withdrawal by Subject|0|||
106141272|NCT02960659|366175912|FG000|Overall Study|Poor compliance|0|||
106141273|NCT02960659|366175913|FG001|Overall Study|Poor compliance|1|||
106141274|NCT04199728|366175914|FG000|Overall Study|Adverse Event|1|||
106141275|NCT04199728|366175915|FG001|Overall Study|Adverse Event|0|||
106141276|NCT04199728|366175914|FG000|Overall Study|Withdrawal by Subject|8|||
106012306|NCT02113982|365712786|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012307|NCT02113982|365712787|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012308|NCT02113982|365712788|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012309|NCT02113982|365712789|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
106012310|NCT02113982|365712790|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012311|NCT02113982|365712791|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
106012312|NCT02113982|365712778|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
106012313|NCT02113982|365712779|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
106012314|NCT02113982|365712780|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
106012315|NCT02113982|365712781|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
106012316|NCT02113982|365712782|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
106012317|NCT02113982|365712783|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
106012318|NCT02113982|365712784|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
106141277|NCT04199728|366175915|FG001|Overall Study|Withdrawal by Subject|3|||
106141278|NCT04199728|366175914|FG000|Overall Study|Screen fail after consent|0|||
106141279|NCT04199728|366175915|FG001|Overall Study|Screen fail after consent|1|||
106141280|NCT04199728|366175914|FG000|Overall Study|Early withdraw criteria met|0|||
105738120|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
105738121|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
105738122|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
105738123|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
105738124|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
105738125|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
105738126|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
105738127|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
105738128|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
105738129|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
106012319|NCT02113982|365712785|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
106012320|NCT02113982|365712786|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
106012321|NCT02113982|365712787|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
106012322|NCT02113982|365712788|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
106012323|NCT02113982|365712789|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
106141281|NCT04199728|366175915|FG001|Overall Study|Early withdraw criteria met|1|||
105738130|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
105738131|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
106012324|NCT02113982|365712790|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
106012325|NCT02113982|365712791|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
106141282|NCT04199728|366175914|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
106012326|NCT02113982|365712778|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012327|NCT02113982|365712779|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012328|NCT02113982|365712780|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012329|NCT02113982|365712781|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012330|NCT02113982|365712782|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012331|NCT02113982|365712783|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012332|NCT02113982|365712784|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012333|NCT02113982|365712785|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012334|NCT02113982|365712786|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012335|NCT02113982|365712787|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012336|NCT02113982|365712788|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012337|NCT02113982|365712789|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012338|NCT02113982|365712790|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
106012339|NCT02113982|365712791|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
106012340|NCT02113982|365712778|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012341|NCT02113982|365712779|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012342|NCT02113982|365712780|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012343|NCT02113982|365712781|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012344|NCT02113982|365712782|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012345|NCT02113982|365712783|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012346|NCT02113982|365712784|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012347|NCT02113982|365712785|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012348|NCT02113982|365712786|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012349|NCT02113982|365712787|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012350|NCT02113982|365712788|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012351|NCT02113982|365712789|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
106012352|NCT02113982|365712790|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
106012353|NCT02113982|365712791|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
106012354|NCT02113982|365712778|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012355|NCT02113982|365712779|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012356|NCT02113982|365712780|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012357|NCT02113982|365712781|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012358|NCT02113982|365712782|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012359|NCT02113982|365712783|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012360|NCT02113982|365712784|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012361|NCT02113982|365712785|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012362|NCT02113982|365712786|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012363|NCT02113982|365712787|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012364|NCT02113982|365712788|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012365|NCT02113982|365712789|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
106012366|NCT02113982|365712790|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
106012367|NCT02113982|365712791|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
106012368|NCT02113982|365712778|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
105738132|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
105738133|NCT00611455|364696826|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
105738134|NCT00611455|364696827|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
105738135|NCT00611455|364696828|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
105738136|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
105738137|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
105738138|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
105738139|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
105738140|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
105738141|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
105738142|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
105738143|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
105738144|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
105738145|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
105738146|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
105738147|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
105738148|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
105738149|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
105738150|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
105738151|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
106012369|NCT02113982|365712779|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106141283|NCT04199728|366175915|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
106141284|NCT01875250|366175916|FG000|Overall Study|Adverse Event|2|||
106141285|NCT01875250|366175917|FG001|Overall Study|Adverse Event|0|||
106141286|NCT03712930|366175918|FG000|Overall Study|Death|7|||
106141287|NCT03712930|366175918|FG000|Overall Study|Physician Decision|1|||
106141288|NCT03712930|366175918|FG000|Overall Study|Study Terminated by Sponsor|3|||
106141289|NCT03712930|366175918|FG000|Overall Study|Progressive Disease|2|||
106141290|NCT00377455|366175919|FG000|Overall Study|Withdrawal by Subject|1|||
106141291|NCT02001623|366175920|FG000|Overall Study|Disease Progression|2|||
106141292|NCT02001623|366175921|FG001|Overall Study|Disease Progression|2|||
106141293|NCT02001623|366175922|FG002|Overall Study|Disease Progression|3|||
106141294|NCT02001623|366175923|FG003|Overall Study|Disease Progression|2|||
106141295|NCT02001623|366175924|FG004|Overall Study|Disease Progression|3|||
106141296|NCT02001623|366175925|FG005|Overall Study|Disease Progression|2|||
106141297|NCT02001623|366175926|FG006|Overall Study|Disease Progression|3|||
106141298|NCT02001623|366175927|FG007|Overall Study|Disease Progression|3|||
106141299|NCT02001623|366175928|FG008|Overall Study|Disease Progression|7|||
106141300|NCT02001623|366175929|FG009|Overall Study|Disease Progression|40|||
106141301|NCT02001623|366175930|FG010|Overall Study|Disease Progression|5|||
106141302|NCT02001623|366175931|FG011|Overall Study|Disease Progression|9|||
106141303|NCT02001623|366175932|FG012|Overall Study|Disease Progression|9|||
106141304|NCT02001623|366175933|FG013|Overall Study|Disease Progression|20|||
106141305|NCT02001623|366175934|FG014|Overall Study|Disease Progression|9|||
106141306|NCT02001623|366175920|FG000|Overall Study|Physician Decision|0|||
106141307|NCT02001623|366175921|FG001|Overall Study|Physician Decision|0|||
106141308|NCT02001623|366175922|FG002|Overall Study|Physician Decision|0|||
106141309|NCT02001623|366175923|FG003|Overall Study|Physician Decision|0|||
106141310|NCT02001623|366175924|FG004|Overall Study|Physician Decision|0|||
106141311|NCT02001623|366175925|FG005|Overall Study|Physician Decision|0|||
106141312|NCT02001623|366175926|FG006|Overall Study|Physician Decision|0|||
106141313|NCT02001623|366175927|FG007|Overall Study|Physician Decision|0|||
106141314|NCT02001623|366175928|FG008|Overall Study|Physician Decision|3|||
106141315|NCT02001623|366175929|FG009|Overall Study|Physician Decision|2|||
106141316|NCT02001623|366175930|FG010|Overall Study|Physician Decision|3|||
106141317|NCT02001623|366175931|FG011|Overall Study|Physician Decision|3|||
106141318|NCT02001623|366175932|FG012|Overall Study|Physician Decision|1|||
106141319|NCT02001623|366175933|FG013|Overall Study|Physician Decision|2|||
106141320|NCT02001623|366175934|FG014|Overall Study|Physician Decision|1|||
106141321|NCT02001623|366175920|FG000|Overall Study|Death|0|||
106141322|NCT02001623|366175921|FG001|Overall Study|Death|1|||
106141323|NCT02001623|366175922|FG002|Overall Study|Death|0|||
106141324|NCT02001623|366175923|FG003|Overall Study|Death|0|||
106141325|NCT02001623|366175924|FG004|Overall Study|Death|0|||
106141326|NCT02001623|366175925|FG005|Overall Study|Death|0|||
106141327|NCT02001623|366175926|FG006|Overall Study|Death|0|||
106141328|NCT02001623|366175927|FG007|Overall Study|Death|0|||
106141329|NCT02001623|366175928|FG008|Overall Study|Death|0|||
105738152|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
105738153|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
105738154|NCT00611455|364696826|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
105738155|NCT00611455|364696827|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
105738156|NCT00611455|364696828|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
105738157|NCT01797783|364696829|FG000|Overall Study|Adverse Event|1|||
106141330|NCT02001623|366175929|FG009|Overall Study|Death|0|||
106141331|NCT02001623|366175930|FG010|Overall Study|Death|0|||
106141332|NCT02001623|366175931|FG011|Overall Study|Death|0|||
105738158|NCT01797783|364696830|FG001|Overall Study|Adverse Event|1|||
105738159|NCT01797783|364696829|FG000|Overall Study|Withdrawal by Subject|1|||
105738160|NCT01797783|364696830|FG001|Overall Study|Withdrawal by Subject|0|||
105738161|NCT00138151|364696831|FG000|Overall Study|Withdrawal by Subject|3|||
105738162|NCT00138151|364696831|FG000|Overall Study|Physician Decision|1|||
106141333|NCT02001623|366175932|FG012|Overall Study|Death|0|||
106141334|NCT02001623|366175933|FG013|Overall Study|Death|0|||
106141335|NCT02001623|366175934|FG014|Overall Study|Death|0|||
106141336|NCT02001623|366175920|FG000|Overall Study|Adverse Event|0|||
105738163|NCT04983940|364696837|FG000|Overall Study|Lost to Follow-up|14|||
105738164|NCT04983940|364696837|FG000|Overall Study|Lack of Efficacy|2|||
105738165|NCT01734993|364696838|FG000|Overall Study|Adverse Event|1|||
106141337|NCT02001623|366175921|FG001|Overall Study|Adverse Event|0|||
106141338|NCT02001623|366175922|FG002|Overall Study|Adverse Event|0|||
106141339|NCT02001623|366175923|FG003|Overall Study|Adverse Event|0|||
106141340|NCT02001623|366175924|FG004|Overall Study|Adverse Event|0|||
106141341|NCT02001623|366175925|FG005|Overall Study|Adverse Event|1|||
106141342|NCT02001623|366175926|FG006|Overall Study|Adverse Event|0|||
106141343|NCT02001623|366175927|FG007|Overall Study|Adverse Event|3|||
105738166|NCT01734993|364696838|FG000|Overall Study|Lack of Efficacy|1|||
106141344|NCT02001623|366175928|FG008|Overall Study|Adverse Event|4|||
106141345|NCT02001623|366175929|FG009|Overall Study|Adverse Event|6|||
106141346|NCT02001623|366175930|FG010|Overall Study|Adverse Event|4|||
106012370|NCT02113982|365712780|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012371|NCT02113982|365712781|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012372|NCT02113982|365712782|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012373|NCT02113982|365712783|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012374|NCT02113982|365712784|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012375|NCT02113982|365712785|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012376|NCT02113982|365712786|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012377|NCT02113982|365712787|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012378|NCT02113982|365712788|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012379|NCT02113982|365712789|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
106012380|NCT02113982|365712790|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
106012381|NCT02113982|365712791|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
106012382|NCT02113982|365712778|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012383|NCT02113982|365712779|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012384|NCT02113982|365712780|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012385|NCT02113982|365712781|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012386|NCT02113982|365712782|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012387|NCT02113982|365712783|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012388|NCT02113982|365712784|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012389|NCT02113982|365712785|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012390|NCT02113982|365712786|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012391|NCT02113982|365712787|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012392|NCT02113982|365712788|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012393|NCT02113982|365712789|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012394|NCT02113982|365712790|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
106012395|NCT02113982|365712791|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
106012396|NCT02113982|365712778|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012397|NCT02113982|365712779|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012398|NCT02113982|365712780|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012399|NCT02113982|365712781|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012400|NCT02113982|365712782|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012401|NCT02113982|365712783|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012402|NCT02113982|365712784|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012403|NCT02113982|365712785|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012404|NCT02113982|365712786|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012405|NCT02113982|365712787|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012406|NCT02113982|365712788|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012407|NCT02113982|365712789|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012408|NCT02113982|365712790|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
106012409|NCT02113982|365712791|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
106012410|NCT02113982|365712778|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012411|NCT02113982|365712779|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012412|NCT02113982|365712780|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012413|NCT02113982|365712781|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012414|NCT02113982|365712782|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012415|NCT02113982|365712783|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012416|NCT02113982|365712784|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012417|NCT02113982|365712785|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012418|NCT02113982|365712786|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012419|NCT02113982|365712787|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012420|NCT02113982|365712788|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012421|NCT02113982|365712789|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012422|NCT02113982|365712790|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
106012423|NCT02113982|365712791|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
106012424|NCT01936870|365712794|FG000|Overall Study|No Visit After Treatment|176|||
106012425|NCT01936870|365712794|FG000|Overall Study|Protocol Violation|12|||
106012426|NCT01936870|365712794|FG000|Overall Study|No Drug Administration|1|||
106012427|NCT01600716|365712797|FG000|Overall Study|Other Reasons|3|||
106012428|NCT01600716|365712798|FG001|Overall Study|Other Reasons|1|||
106012429|NCT01600716|365712797|FG000|Overall Study|Personal Reasons|0|||
106012430|NCT01600716|365712798|FG001|Overall Study|Personal Reasons|2|||
106012431|NCT01600716|365712797|FG000|Overall Study|Lost to Follow-up|0|||
106012432|NCT01600716|365712798|FG001|Overall Study|Lost to Follow-up|2|||
106012433|NCT01600716|365712797|FG000|Overall Study|Pregnancy|1|||
106141347|NCT02001623|366175931|FG011|Overall Study|Adverse Event|0|||
106141348|NCT02001623|366175932|FG012|Overall Study|Adverse Event|3|||
106141349|NCT02001623|366175933|FG013|Overall Study|Adverse Event|5|||
106141350|NCT02001623|366175934|FG014|Overall Study|Adverse Event|6|||
106012434|NCT01600716|365712798|FG001|Overall Study|Pregnancy|0|||
105738167|NCT03461289|364696839|FG000|Overall Study|Death|1|||
105738168|NCT04799782|364696840|FG000|Washout|Physician Decision|2|||
105738169|NCT04799782|364696841|FG001|Washout|Physician Decision|0|||
105738170|NCT04799782|364696840|FG000|Washout|Withdrawal by Subject|0|||
105738171|NCT04799782|364696841|FG001|Washout|Withdrawal by Subject|2|||
105738172|NCT04799782|364696840|FG000|Washout|Lost to Follow-up|0|||
105738173|NCT04799782|364696841|FG001|Washout|Lost to Follow-up|1|||
105738174|NCT01903434|364696842|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
105738175|NCT01903434|364696843|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
105738176|NCT01903434|364696842|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
105799702|NCT04380701|364924638|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
106012435|NCT01600716|365712797|FG000|Overall Study|Lack of Efficacy|2|||
106012436|NCT01600716|365712798|FG001|Overall Study|Lack of Efficacy|1|||
106012437|NCT01600716|365712797|FG000|Overall Study|Adverse Event|1|||
106012438|NCT01600716|365712798|FG001|Overall Study|Adverse Event|1|||
106012439|NCT02379728|365712799|FG000|Overall Study|Lost to Follow-up|1|||
106012440|NCT02379728|365712800|FG001|Overall Study|Lost to Follow-up|0|||
106012441|NCT02379728|365712801|FG002|Overall Study|Lost to Follow-up|3|||
106012442|NCT02379728|365712802|FG003|Overall Study|Lost to Follow-up|0|||
106012443|NCT02379728|365712799|FG000|Overall Study|Withdrawal by Subject|5|||
106012444|NCT02379728|365712800|FG001|Overall Study|Withdrawal by Subject|0|||
106012445|NCT02379728|365712801|FG002|Overall Study|Withdrawal by Subject|5|||
106012446|NCT02379728|365712802|FG003|Overall Study|Withdrawal by Subject|3|||
106012447|NCT02379728|365712799|FG000|Overall Study|Protocol Violation|0|||
106012448|NCT02379728|365712800|FG001|Overall Study|Protocol Violation|0|||
106012449|NCT02379728|365712801|FG002|Overall Study|Protocol Violation|2|||
106012450|NCT02379728|365712802|FG003|Overall Study|Protocol Violation|0|||
106012451|NCT01907854|365712803|FG000|Overall Study|Protocol Violation|1|||
106012452|NCT01907854|365712804|FG001|Overall Study|Protocol Violation|1|||
106012453|NCT01907854|365712803|FG000|Overall Study|Withdrawal by Subject|9|||
106012454|NCT01907854|365712804|FG001|Overall Study|Withdrawal by Subject|7|||
106012455|NCT01907854|365712803|FG000|Overall Study|Lost to Follow-up|2|||
106012456|NCT01907854|365712804|FG001|Overall Study|Lost to Follow-up|2|||
106012457|NCT01907854|365712803|FG000|Overall Study|Unclassified|4|||
106012458|NCT01907854|365712804|FG001|Overall Study|Unclassified|3|||
106012459|NCT02796170|365712805|FG000|Overall Study|Lost to Follow-up|3|||
106012460|NCT02796170|365712806|FG001|Overall Study|Lost to Follow-up|0|||
106012461|NCT04313244|365712809|FG000|Overall Study|Withdrawal of Consent|3|||
106012462|NCT04313244|365712810|FG001|Overall Study|Withdrawal of Consent|3|||
106012463|NCT04313244|365712809|FG000|Overall Study|Met Exclusion Criteria|1|||
106012464|NCT04313244|365712810|FG001|Overall Study|Met Exclusion Criteria|0|||
106012465|NCT04313244|365712809|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
106012466|NCT04313244|365712810|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
106012467|NCT01472289|365712811|FG000|Overall Study|Death|2|||
106012468|NCT03112603|365712812|FG000|End of Randomization Period|Lost to Follow-up|3|||
106012469|NCT03112603|365712813|FG001|End of Randomization Period|Lost to Follow-up|0|||
106012470|NCT03112603|365712814|FG002|End of Randomization Period|Lost to Follow-up|0|||
106012471|NCT03112603|365712812|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
106012472|NCT03112603|365712813|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
106012473|NCT03112603|365712814|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
106012474|NCT03112603|365712812|FG000|End of Randomization Period|Physician Decision|43|||
106012475|NCT03112603|365712813|FG001|End of Randomization Period|Physician Decision|18|||
106012476|NCT03112603|365712814|FG002|End of Randomization Period|Physician Decision|0|||
106012477|NCT03112603|365712812|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
106012478|NCT03112603|365712813|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
106012479|NCT03112603|365712814|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
106012480|NCT03112603|365712812|FG000|End of Randomization Period|Death|10|||
106012481|NCT03112603|365712813|FG001|End of Randomization Period|Death|7|||
106012482|NCT03112603|365712814|FG002|End of Randomization Period|Death|0|||
106012483|NCT03112603|365712812|FG000|End of Randomization Period|Disease Relapse|12|||
106012484|NCT03112603|365712813|FG001|End of Randomization Period|Disease Relapse|7|||
106012485|NCT03112603|365712814|FG002|End of Randomization Period|Disease Relapse|0|||
106012486|NCT03112603|365712812|FG000|End of Randomization Period|Lack of Efficacy|25|||
106012487|NCT03112603|365712813|FG001|End of Randomization Period|Lack of Efficacy|77|||
106012488|NCT03112603|365712814|FG002|End of Randomization Period|Lack of Efficacy|0|||
105738177|NCT01903434|364696843|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
106012489|NCT03112603|365712812|FG000|End of Randomization Period|Adverse Event|32|||
106012490|NCT03112603|365712813|FG001|End of Randomization Period|Adverse Event|12|||
106012491|NCT03112603|365712814|FG002|End of Randomization Period|Adverse Event|0|||
106012492|NCT03112603|365712812|FG000|End of Cross Over Period|Death|0|||
106012493|NCT03112603|365712813|FG001|End of Cross Over Period|Death|0|||
106012494|NCT03112603|365712814|FG002|End of Cross Over Period|Death|2|||
106012495|NCT03112603|365712812|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
105738178|NCT00530712|364696844|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
105738179|NCT00530712|364696844|FG000|30 Day Follow-up Visit|Missed Visit|5|||
106141351|NCT02001623|366175920|FG000|Overall Study|Other - Miscellaneous|0|||
106141352|NCT02001623|366175921|FG001|Overall Study|Other - Miscellaneous|0|||
106141353|NCT02001623|366175922|FG002|Overall Study|Other - Miscellaneous|0|||
106141354|NCT02001623|366175923|FG003|Overall Study|Other - Miscellaneous|0|||
106141355|NCT02001623|366175924|FG004|Overall Study|Other - Miscellaneous|0|||
106141356|NCT02001623|366175925|FG005|Overall Study|Other - Miscellaneous|0|||
106141357|NCT02001623|366175926|FG006|Overall Study|Other - Miscellaneous|0|||
106141358|NCT02001623|366175927|FG007|Overall Study|Other - Miscellaneous|0|||
106141359|NCT02001623|366175928|FG008|Overall Study|Other - Miscellaneous|0|||
106141360|NCT02001623|366175929|FG009|Overall Study|Other - Miscellaneous|1|||
106141361|NCT02001623|366175930|FG010|Overall Study|Other - Miscellaneous|0|||
106141362|NCT02001623|366175931|FG011|Overall Study|Other - Miscellaneous|0|||
106141363|NCT02001623|366175932|FG012|Overall Study|Other - Miscellaneous|0|||
106141364|NCT02001623|366175933|FG013|Overall Study|Other - Miscellaneous|1|||
106141365|NCT02001623|366175934|FG014|Overall Study|Other - Miscellaneous|0|||
106141366|NCT02001623|366175920|FG000|Overall Study|Withdrawal by Subject|1|||
106141367|NCT02001623|366175921|FG001|Overall Study|Withdrawal by Subject|0|||
106141368|NCT02001623|366175922|FG002|Overall Study|Withdrawal by Subject|0|||
106141369|NCT02001623|366175923|FG003|Overall Study|Withdrawal by Subject|0|||
106141370|NCT02001623|366175924|FG004|Overall Study|Withdrawal by Subject|0|||
106141371|NCT02001623|366175925|FG005|Overall Study|Withdrawal by Subject|0|||
106141372|NCT02001623|366175926|FG006|Overall Study|Withdrawal by Subject|0|||
106141373|NCT02001623|366175927|FG007|Overall Study|Withdrawal by Subject|0|||
106141374|NCT02001623|366175928|FG008|Overall Study|Withdrawal by Subject|1|||
106141375|NCT02001623|366175929|FG009|Overall Study|Withdrawal by Subject|3|||
106141376|NCT02001623|366175930|FG010|Overall Study|Withdrawal by Subject|2|||
106141377|NCT02001623|366175931|FG011|Overall Study|Withdrawal by Subject|2|||
106141378|NCT02001623|366175932|FG012|Overall Study|Withdrawal by Subject|1|||
106141379|NCT02001623|366175933|FG013|Overall Study|Withdrawal by Subject|5|||
106141380|NCT02001623|366175934|FG014|Overall Study|Withdrawal by Subject|2|||
106141381|NCT02001623|366175920|FG000|Overall Study|Lost to Follow-up|0|||
106141382|NCT02001623|366175921|FG001|Overall Study|Lost to Follow-up|0|||
106141383|NCT02001623|366175922|FG002|Overall Study|Lost to Follow-up|0|||
106141384|NCT02001623|366175923|FG003|Overall Study|Lost to Follow-up|0|||
106141385|NCT02001623|366175924|FG004|Overall Study|Lost to Follow-up|0|||
106141386|NCT02001623|366175925|FG005|Overall Study|Lost to Follow-up|0|||
106141387|NCT02001623|366175926|FG006|Overall Study|Lost to Follow-up|0|||
106141388|NCT02001623|366175927|FG007|Overall Study|Lost to Follow-up|0|||
106141389|NCT02001623|366175928|FG008|Overall Study|Lost to Follow-up|0|||
106141390|NCT02001623|366175929|FG009|Overall Study|Lost to Follow-up|1|||
106141391|NCT02001623|366175930|FG010|Overall Study|Lost to Follow-up|0|||
106141392|NCT02001623|366175931|FG011|Overall Study|Lost to Follow-up|0|||
106141393|NCT02001623|366175932|FG012|Overall Study|Lost to Follow-up|0|||
106141394|NCT02001623|366175933|FG013|Overall Study|Lost to Follow-up|0|||
106141395|NCT02001623|366175934|FG014|Overall Study|Lost to Follow-up|0|||
106141396|NCT02001623|366175920|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
106141397|NCT02001623|366175921|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
106141398|NCT02001623|366175922|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
106141399|NCT02001623|366175923|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
106141400|NCT02001623|366175924|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
106141401|NCT02001623|366175925|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
106141402|NCT02001623|366175926|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
106141403|NCT02001623|366175927|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
106141404|NCT02001623|366175928|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
106141405|NCT02001623|366175929|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
106141406|NCT02001623|366175930|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
106141407|NCT02001623|366175931|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
106141408|NCT02001623|366175932|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
106141409|NCT02001623|366175933|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
106141410|NCT02001623|366175934|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
106141411|NCT02001623|366175920|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
106141412|NCT02001623|366175921|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
106012496|NCT03112603|365712813|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
106012497|NCT03112603|365712814|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
106012498|NCT03112603|365712812|FG000|End of Cross Over Period|Physician Decision|0|||
106012499|NCT03112603|365712813|FG001|End of Cross Over Period|Physician Decision|0|||
106012500|NCT03112603|365712814|FG002|End of Cross Over Period|Physician Decision|29|||
106012501|NCT03112603|365712812|FG000|End of Cross Over Period|Lack of Efficacy|0|||
106012502|NCT03112603|365712813|FG001|End of Cross Over Period|Lack of Efficacy|0|||
106012503|NCT03112603|365712814|FG002|End of Cross Over Period|Lack of Efficacy|8|||
106012504|NCT03112603|365712812|FG000|End of Cross Over Period|Adverse Event|0|||
106012505|NCT03112603|365712813|FG001|End of Cross Over Period|Adverse Event|0|||
106012506|NCT03112603|365712814|FG002|End of Cross Over Period|Adverse Event|6|||
106012507|NCT03112603|365712812|FG000|End of Cross Over Period|Disease Relapse|0|||
106012508|NCT03112603|365712813|FG001|End of Cross Over Period|Disease Relapse|0|||
106012509|NCT03112603|365712814|FG002|End of Cross Over Period|Disease Relapse|2|||
106012510|NCT03873116|365712815|FG000|Part 1|Study drug discontinuation due to rash|0|||
106012511|NCT03873116|365712816|FG001|Part 1|Study drug discontinuation due to rash|0|||
106012512|NCT03873116|365712817|FG002|Part 1|Study drug discontinuation due to rash|0|||
106012513|NCT03873116|365712818|FG003|Part 1|Study drug discontinuation due to rash|0|||
106012514|NCT03873116|365712819|FG004|Part 1|Study drug discontinuation due to rash|0|||
106012515|NCT03873116|365712820|FG005|Part 1|Study drug discontinuation due to rash|1|||
106012516|NCT03873116|365712815|FG000|Part 2|Withdrawal by Subject|0|||
106012517|NCT03873116|365712816|FG001|Part 2|Withdrawal by Subject|0|||
106012518|NCT03873116|365712817|FG002|Part 2|Withdrawal by Subject|1|||
106012519|NCT03873116|365712818|FG003|Part 2|Withdrawal by Subject|0|||
106012520|NCT03873116|365712819|FG004|Part 2|Withdrawal by Subject|0|||
106012521|NCT03873116|365712820|FG005|Part 2|Withdrawal by Subject|0|||
106012522|NCT03873116|365712815|FG000|Part 2|Lab abnormality or AE|0|||
106012523|NCT03873116|365712816|FG001|Part 2|Lab abnormality or AE|0|||
106012524|NCT03873116|365712817|FG002|Part 2|Lab abnormality or AE|0|||
106012525|NCT03873116|365712818|FG003|Part 2|Lab abnormality or AE|0|||
106012526|NCT03873116|365712819|FG004|Part 2|Lab abnormality or AE|1|||
106012527|NCT03873116|365712820|FG005|Part 2|Lab abnormality or AE|0|||
106012528|NCT03873116|365712815|FG000|Part 3|Withdrawal by Subject|0|||
106012529|NCT03873116|365712816|FG001|Part 3|Withdrawal by Subject|0|||
106012530|NCT03873116|365712817|FG002|Part 3|Withdrawal by Subject|0|||
106012531|NCT03873116|365712818|FG003|Part 3|Withdrawal by Subject|0|||
106012532|NCT03873116|365712819|FG004|Part 3|Withdrawal by Subject|1|||
106012533|NCT03873116|365712820|FG005|Part 3|Withdrawal by Subject|0|||
106012534|NCT00912808|365712821|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
106012535|NCT00912808|365712822|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
106012536|NCT00912808|365712821|FG000|Washout|Withdrawal by Subject|0|||
106012537|NCT00912808|365712822|FG001|Washout|Withdrawal by Subject|1|||
106012538|NCT00912808|365712821|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
106012539|NCT00912808|365712822|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
106012540|NCT00912808|365712821|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
106012541|NCT00912808|365712822|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
106012542|NCT04682366|365712823|FG000|Overall Study|Lost to Follow-up|1|||
106012543|NCT04682366|365712824|FG001|Overall Study|Lost to Follow-up|1|||
106012544|NCT00702221|365712825|FG000|Overall Study|Adverse Event|4|||
106012545|NCT00702221|365712826|FG001|Overall Study|Adverse Event|3|||
106012546|NCT00106704|365712827|FG000|Overall Study|Adverse Event|10|||
106012547|NCT00106704|365712828|FG001|Overall Study|Adverse Event|7|||
106012548|NCT00106704|365712827|FG000|Overall Study|Death|2|||
106012549|NCT00106704|365712828|FG001|Overall Study|Death|1|||
106012550|NCT00106704|365712827|FG000|Overall Study|Lack of Efficacy|67|||
106141413|NCT02001623|366175922|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
106141414|NCT02001623|366175923|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
106141415|NCT02001623|366175924|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
106141416|NCT02001623|366175925|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
106141417|NCT02001623|366175926|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
106141418|NCT02001623|366175927|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
106141419|NCT02001623|366175928|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
106141420|NCT02001623|366175929|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
106141421|NCT02001623|366175930|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
106141422|NCT02001623|366175931|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
106141423|NCT02001623|366175932|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
106141424|NCT02001623|366175933|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
106141425|NCT02001623|366175934|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
106141426|NCT01063036|366175944|FG000|Participants Treated With Study Drug|Adverse Event|1|||
106141427|NCT01063036|366175944|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
106012551|NCT00106704|365712828|FG001|Overall Study|Lack of Efficacy|69|||
106012552|NCT00106704|365712827|FG000|Overall Study|Lost to Follow-up|7|||
106141428|NCT01063036|366175944|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
106141429|NCT01063036|366175944|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
106141430|NCT01063036|366175944|FG000|Participants Treated With Study Drug|Pregnancy|1|||
105799703|NCT04380701|364924639|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
105799704|NCT04380701|364924640|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
105799705|NCT04380701|364924641|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
105799706|NCT04380701|364924642|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
105799707|NCT04380701|364924643|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
105940642|NCT05418426|365445013|FG001|Overall Study|Withdrawal by Subject|1|||
105940643|NCT05418426|365445014|FG002|Overall Study|Withdrawal by Subject|0|||
105940644|NCT05418426|365445012|FG000|Overall Study|Protocol Violation|0|||
105940645|NCT05418426|365445013|FG001|Overall Study|Protocol Violation|0|||
105940646|NCT05418426|365445014|FG002|Overall Study|Protocol Violation|1|||
106141431|NCT01063036|366175944|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
106141432|NCT01063036|366175944|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
105940647|NCT04661839|365445015|FG000|Overall Study|Not Treated|0|||
105940648|NCT04661839|365445016|FG001|Overall Study|Not Treated|0|||
105940649|NCT04661839|365445017|FG002|Overall Study|Not Treated|1|||
105940650|NCT04661839|365445018|FG003|Overall Study|Not Treated|0|||
105940651|NCT04661839|365445015|FG000|Overall Study|Lost to Follow-up|1|||
105940652|NCT04661839|365445016|FG001|Overall Study|Lost to Follow-up|0|||
105940653|NCT04661839|365445017|FG002|Overall Study|Lost to Follow-up|0|||
105940654|NCT04661839|365445018|FG003|Overall Study|Lost to Follow-up|1|||
105940655|NCT03579719|365445022|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
105940656|NCT01443026|365445023|FG000|Overall Study|Physician Decision|1|||
105940657|NCT01443026|365445024|FG001|Overall Study|Physician Decision|0|||
105940658|NCT01443026|365445023|FG000|Overall Study|Death|0|||
105940659|NCT01443026|365445024|FG001|Overall Study|Death|1|||
105940660|NCT01443026|365445023|FG000|Overall Study|Withdrawal by Subject|0|||
105940661|NCT01443026|365445024|FG001|Overall Study|Withdrawal by Subject|3|||
105940662|NCT01443026|365445023|FG000|Overall Study|Lost to Follow-up|2|||
105940663|NCT01443026|365445024|FG001|Overall Study|Lost to Follow-up|1|||
105940664|NCT00829868|365445025|FG000|Washout|Physician Decision|1|||
105940665|NCT00829868|365445026|FG001|Washout|Physician Decision|0|||
105940666|NCT03253627|365445027|FG000|Overall Study|Lost to Follow-up|1|||
105940667|NCT03253627|365445028|FG001|Overall Study|Lost to Follow-up|2|||
105940668|NCT03253627|365445027|FG000|Overall Study|Withdrawal by Subject|0|||
105940669|NCT03253627|365445028|FG001|Overall Study|Withdrawal by Subject|2|||
105940670|NCT03253627|365445027|FG000|Overall Study|Inability to complete MRI|1|||
105940671|NCT03253627|365445028|FG001|Overall Study|Inability to complete MRI|0|||
105940672|NCT06091956|365445029|FG000|Overall Study|Withdrawal by Subject|1|||
105940673|NCT06091956|365445029|FG000|Overall Study|Complicating Disease|1|||
105940674|NCT04642079|365445030|FG000|Overall Study|Lost to Follow-up|2|||
105940675|NCT04642079|365445031|FG001|Overall Study|Lost to Follow-up|5|||
105940676|NCT04642079|365445032|FG002|Overall Study|Lost to Follow-up|2|||
105940677|NCT04642079|365445033|FG003|Overall Study|Lost to Follow-up|0|||
105940678|NCT04642079|365445030|FG000|Overall Study|Withdrawal by Subject|0|||
105940679|NCT04642079|365445031|FG001|Overall Study|Withdrawal by Subject|4|||
105940680|NCT04642079|365445032|FG002|Overall Study|Withdrawal by Subject|1|||
105940681|NCT04642079|365445033|FG003|Overall Study|Withdrawal by Subject|2|||
105940682|NCT04642079|365445030|FG000|Overall Study|Other|0|||
105940683|NCT04642079|365445031|FG001|Overall Study|Other|0|||
105940684|NCT04642079|365445032|FG002|Overall Study|Other|0|||
105940685|NCT04642079|365445033|FG003|Overall Study|Other|1|||
105940686|NCT04642079|365445030|FG000|Overall Study|No longer met eligibility criteria|1|||
105940687|NCT04642079|365445031|FG001|Overall Study|No longer met eligibility criteria|0|||
105940688|NCT04642079|365445032|FG002|Overall Study|No longer met eligibility criteria|1|||
105940689|NCT04642079|365445033|FG003|Overall Study|No longer met eligibility criteria|1|||
105940690|NCT02226653|365445036|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
105940691|NCT02226653|365445037|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
105940692|NCT02226653|365445036|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
105940693|NCT02226653|365445037|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
105940694|NCT04876391|365445039|FG000|Overall Study|Withdrawal by Subject|1|||
105940695|NCT04876391|365445040|FG001|Overall Study|Withdrawal by Subject|10|||
105940696|NCT04876391|365445039|FG000|Overall Study|Lost to Follow-up|2|||
105940697|NCT04876391|365445040|FG001|Overall Study|Lost to Follow-up|4|||
105940698|NCT04876391|365445039|FG000|Overall Study|Lack of Efficacy|0|||
105940699|NCT04876391|365445040|FG001|Overall Study|Lack of Efficacy|2|||
105940700|NCT04876391|365445039|FG000|Overall Study|Adverse Event|3|||
105940701|NCT04876391|365445040|FG001|Overall Study|Adverse Event|1|||
105940702|NCT04876391|365445039|FG000|Overall Study|Patient non-compliance|0|||
105940703|NCT04876391|365445040|FG001|Overall Study|Patient non-compliance|1|||
105940704|NCT04876391|365445039|FG000|Overall Study|Personal reasons|0|||
105940705|NCT04876391|365445040|FG001|Overall Study|Personal reasons|1|||
106012553|NCT00106704|365712828|FG001|Overall Study|Lost to Follow-up|3|||
106141433|NCT01063036|366175944|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
105940706|NCT04876391|365445039|FG000|Overall Study|Withdrawn as per protocol|2|||
105940707|NCT04876391|365445040|FG001|Overall Study|Withdrawn as per protocol|2|||
105799708|NCT04380701|364924644|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
105940708|NCT00209131|365445041|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
105799709|NCT04380701|364924645|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
105799710|NCT04380701|364924646|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
105799711|NCT04380701|364924647|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
105799712|NCT04380701|364924614|FG000|Overall Study|Physician Decision|0|||
105799713|NCT04380701|364924615|FG001|Overall Study|Physician Decision|0|||
105799714|NCT04380701|364924616|FG002|Overall Study|Physician Decision|0|||
105799715|NCT04380701|364924617|FG003|Overall Study|Physician Decision|0|||
105799716|NCT04380701|364924618|FG004|Overall Study|Physician Decision|0|||
105799717|NCT04380701|364924619|FG005|Overall Study|Physician Decision|0|||
105799718|NCT04380701|364924620|FG006|Overall Study|Physician Decision|0|||
105799719|NCT04380701|364924621|FG007|Overall Study|Physician Decision|0|||
105799720|NCT04380701|364924622|FG008|Overall Study|Physician Decision|0|||
105799721|NCT04380701|364924623|FG009|Overall Study|Physician Decision|0|||
105799722|NCT04380701|364924624|FG010|Overall Study|Physician Decision|0|||
105799723|NCT04380701|364924625|FG011|Overall Study|Physician Decision|0|||
105799724|NCT04380701|364924626|FG012|Overall Study|Physician Decision|0|||
105799725|NCT04380701|364924627|FG013|Overall Study|Physician Decision|0|||
105738180|NCT00530712|364696844|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
105738181|NCT00530712|364696844|FG000|6 Month Follow-up Visit|Missed Visit|3|||
105738182|NCT00530712|364696844|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
105738183|NCT00530712|364696844|FG000|6 Month Follow-up Visit|Death|2|||
105738184|NCT00530712|364696844|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
105738185|NCT00530712|364696844|FG000|12 Month Follow-up Visit|Missed Visit|3|||
105738186|NCT00530712|364696844|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
105799726|NCT04380701|364924628|FG014|Overall Study|Physician Decision|0|||
105799727|NCT04380701|364924629|FG015|Overall Study|Physician Decision|0|||
105799728|NCT04380701|364924630|FG016|Overall Study|Physician Decision|0|||
105799729|NCT04380701|364924631|FG017|Overall Study|Physician Decision|0|||
105799730|NCT04380701|364924632|FG018|Overall Study|Physician Decision|0|||
105799731|NCT04380701|364924633|FG019|Overall Study|Physician Decision|0|||
106141434|NCT00708032|366175946|FG000|Overall Study|Adverse Event|0|||
106141435|NCT00708032|366175947|FG001|Overall Study|Adverse Event|2|||
105799732|NCT04380701|364924634|FG020|Overall Study|Physician Decision|0|||
105799733|NCT04380701|364924635|FG021|Overall Study|Physician Decision|0|||
105940709|NCT00209131|365445042|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
105940710|NCT02796651|365445043|FG000|Overall Study|Adverse Event|6|||
105940711|NCT02796651|365445043|FG000|Overall Study|Lost to Follow-up|1|||
105940712|NCT02796651|365445043|FG000|Overall Study|Withdrawal by Subject|4|||
105940713|NCT02796651|365445043|FG000|Overall Study|Protocol Violation|4|||
105940714|NCT02796651|365445043|FG000|Overall Study|Lack of Efficacy|1|||
105940715|NCT02796651|365445043|FG000|Overall Study|Other|10|||
105940716|NCT05142306|365445044|FG000|Overall Study|Withdrawal by Subject|0|||
105940717|NCT05142306|365445045|FG001|Overall Study|Withdrawal by Subject|0|||
105940718|NCT05142306|365445046|FG002|Overall Study|Withdrawal by Subject|1|||
105940719|NCT04079920|365445047|FG000|Overall Study|Adverse event, not related to study drug|2|||
105940720|NCT04079920|365445047|FG000|Overall Study|Adverse event related to study drug|10|||
105940721|NCT04079920|365445047|FG000|Overall Study|Death|2|||
105940722|NCT04079920|365445047|FG000|Overall Study|Lost to Follow-up|22|||
105940723|NCT04079920|365445047|FG000|Overall Study|Physician Decision|1|||
105940724|NCT04079920|365445047|FG000|Overall Study|Withdrawal by Subject|11|||
105940725|NCT00680914|365445050|FG000|Overall Study|Consent withdrawal|6|||
105940726|NCT00680914|365445051|FG001|Overall Study|Consent withdrawal|3|||
105940727|NCT00680914|365445050|FG000|Overall Study|Lost to Follow-up|4|||
105940728|NCT00680914|365445051|FG001|Overall Study|Lost to Follow-up|0|||
105940729|NCT00680914|365445050|FG000|Overall Study|serious adverse event (SAE)|0|||
105940730|NCT00680914|365445051|FG001|Overall Study|serious adverse event (SAE)|1|||
105940731|NCT02940223|365445052|FG000|Overall Study|Failed Requirement|2|||
106012554|NCT00106704|365712827|FG000|Overall Study|Pregnancy|1|||
106141436|NCT00708032|366175946|FG000|Overall Study|Lost to Follow-up|1|||
106141437|NCT00708032|366175947|FG001|Overall Study|Lost to Follow-up|2|||
106141438|NCT00708032|366175946|FG000|Overall Study|Pregnancy|0|||
106141439|NCT00708032|366175947|FG001|Overall Study|Pregnancy|1|||
106141440|NCT00708032|366175946|FG000|Overall Study|Poor vision|0|||
106141441|NCT00708032|366175947|FG001|Overall Study|Poor vision|6|||
106141442|NCT00708032|366175946|FG000|Overall Study|Visit out of range at month 12|4|||
105738187|NCT00530712|364696844|FG000|12 Month Follow-up Visit|Death|9|||
105799734|NCT04380701|364924636|FG022|Overall Study|Physician Decision|0|||
105799735|NCT04380701|364924637|FG023|Overall Study|Physician Decision|0|||
105799736|NCT04380701|364924638|FG024|Overall Study|Physician Decision|2|||
105799737|NCT04380701|364924639|FG025|Overall Study|Physician Decision|0|||
105799738|NCT04380701|364924640|FG026|Overall Study|Physician Decision|0|||
105940732|NCT02940223|365445053|FG001|Overall Study|Failed Requirement|0|||
105940733|NCT01299961|365445054|FG000|Overall Study|Adverse Event|3|||
105940734|NCT01299961|365445054|FG000|Overall Study|Lack of Efficacy|2|||
105940735|NCT01299961|365445054|FG000|Overall Study|Lost to Follow-up|1|||
106141443|NCT00708032|366175947|FG001|Overall Study|Visit out of range at month 12|1|||
105799739|NCT04380701|364924641|FG027|Overall Study|Physician Decision|0|||
106141444|NCT00708032|366175946|FG000|Overall Study|Did not meet protocol criteria|1|||
105799740|NCT04380701|364924642|FG028|Overall Study|Physician Decision|0|||
105738188|NCT02749370|364696845|FG000|Overall Study|Withdrawal by Subject|11|||
105738189|NCT02749370|364696845|FG000|Overall Study|Lost to Follow-up|3|||
105738190|NCT01519427|364696846|FG000|Overall Study|disease progression|2|||
105738191|NCT02260193|364696863|FG000|Overall Study|Lack of Efficacy|0|||
105738192|NCT02260193|364696864|FG001|Overall Study|Lack of Efficacy|1|||
105738193|NCT02260193|364696865|FG002|Overall Study|Lack of Efficacy|6|||
105738194|NCT02260193|364696863|FG000|Overall Study|Adverse Event|3|||
105738195|NCT02260193|364696864|FG001|Overall Study|Adverse Event|4|||
105738196|NCT02260193|364696865|FG002|Overall Study|Adverse Event|1|||
105738197|NCT02260193|364696863|FG000|Overall Study|Protocol Violation|0|||
105738198|NCT02260193|364696864|FG001|Overall Study|Protocol Violation|4|||
105738199|NCT02260193|364696865|FG002|Overall Study|Protocol Violation|0|||
105738200|NCT02260193|364696863|FG000|Overall Study|Withdrawal by Subject|3|||
105738201|NCT02260193|364696864|FG001|Overall Study|Withdrawal by Subject|0|||
105738202|NCT02260193|364696865|FG002|Overall Study|Withdrawal by Subject|2|||
105738203|NCT02260193|364696863|FG000|Overall Study|Kidney Transplantation|0|||
105738204|NCT02260193|364696864|FG001|Overall Study|Kidney Transplantation|0|||
105738205|NCT02260193|364696865|FG002|Overall Study|Kidney Transplantation|1|||
105940736|NCT02904096|365445055|FG000|Overall Study|Adverse Event|1|||
105940737|NCT02904096|365445056|FG001|Overall Study|Adverse Event|0|||
105940738|NCT02904096|365445055|FG000|Overall Study|Withdrawal by Subject|4|||
105940739|NCT02904096|365445056|FG001|Overall Study|Withdrawal by Subject|3|||
105940740|NCT02904096|365445055|FG000|Overall Study|Lost to Follow-up|10|||
105940741|NCT02904096|365445056|FG001|Overall Study|Lost to Follow-up|17|||
105940742|NCT02904096|365445055|FG000|Overall Study|Non-compliant|3|||
105940743|NCT02904096|365445056|FG001|Overall Study|Non-compliant|1|||
105940744|NCT02904096|365445055|FG000|Overall Study|Sponsor instructed|1|||
105940745|NCT02904096|365445056|FG001|Overall Study|Sponsor instructed|0|||
105940746|NCT01767857|365445057|FG000|Overall Study|Adverse Event|27|||
105940747|NCT01767857|365445058|FG001|Overall Study|Adverse Event|7|||
105940748|NCT01767857|365445057|FG000|Overall Study|Death|28|||
105940749|NCT01767857|365445058|FG001|Overall Study|Death|13|||
105940750|NCT01767857|365445057|FG000|Overall Study|Lack of Efficacy|299|||
105940751|NCT01767857|365445058|FG001|Overall Study|Lack of Efficacy|151|||
105940752|NCT01767857|365445057|FG000|Overall Study|Lost to Follow-up|1|||
105940753|NCT01767857|365445058|FG001|Overall Study|Lost to Follow-up|1|||
105940754|NCT01767857|365445057|FG000|Overall Study|Withdrawal by Subject|38|||
105940755|NCT01767857|365445058|FG001|Overall Study|Withdrawal by Subject|18|||
105940756|NCT01767857|365445057|FG000|Overall Study|Physician Decision|17|||
105940757|NCT01767857|365445058|FG001|Overall Study|Physician Decision|10|||
105940758|NCT01767857|365445057|FG000|Overall Study|Protocol Terminated|1|||
105940759|NCT01767857|365445058|FG001|Overall Study|Protocol Terminated|0|||
105940760|NCT01767857|365445057|FG000|Overall Study|Randomized But Never Treated|19|||
105940761|NCT01767857|365445058|FG001|Overall Study|Randomized But Never Treated|13|||
105940762|NCT01813357|365445061|FG000|Overall Study|Lost to Follow-up|5|||
105940763|NCT01813357|365445062|FG001|Overall Study|Lost to Follow-up|6|||
105940764|NCT02298946|365445063|FG000|Overall Study|Did not receive treatment|2|||
105940765|NCT02298946|365445064|FG001|Overall Study|Did not receive treatment|0|||
105940766|NCT02298946|365445063|FG000|Overall Study|Unevaluable|2|||
105940767|NCT02298946|365445064|FG001|Overall Study|Unevaluable|1|||
105940768|NCT02412436|365445066|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
105940769|NCT02412436|365445066|FG000|Overall Study|Lost to Follow-up|6|||
105940770|NCT02412436|365445066|FG000|Overall Study|Unable to get to clinic|3|||
105940771|NCT02412436|365445066|FG000|Overall Study|Death|1|||
105940772|NCT02412436|365445066|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
105940773|NCT04650893|365445067|FG000|Overall Study|Lost to Follow-up|11|||
105940774|NCT04650893|365445068|FG001|Overall Study|Lost to Follow-up|10|||
105940775|NCT04650893|365445069|FG002|Overall Study|Lost to Follow-up|11|||
105940776|NCT00913835|365445073|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
105940777|NCT00913835|365445074|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
105940778|NCT00913835|365445073|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
105940779|NCT00913835|365445074|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
105940780|NCT00913835|365445073|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
105940781|NCT00913835|365445074|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
105940782|NCT00913835|365445073|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
105940783|NCT00913835|365445074|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
105940784|NCT00913835|365445073|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
105940785|NCT00913835|365445074|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
105940786|NCT00773461|365445075|FG000|Overall Study|Adverse Event|1|||
105940787|NCT00773461|365445076|FG001|Overall Study|Adverse Event|3|||
105940788|NCT00773461|365445075|FG000|Overall Study|Withdrawal by Subject|4|||
106012555|NCT00106704|365712828|FG001|Overall Study|Pregnancy|0|||
105738206|NCT01108809|364696866|FG000|Overall Study|Adverse Event|3|||
105940789|NCT00773461|365445076|FG001|Overall Study|Withdrawal by Subject|1|||
105738207|NCT01108809|364696866|FG000|Overall Study|Lost to Follow-up|1|||
105738208|NCT01200511|364696868|FG000|Overall Study|Lost to Follow-up|3|||
105738209|NCT01200511|364696868|FG000|Overall Study|Withdrawal by Subject|1|||
105738210|NCT01200511|364696868|FG000|Overall Study|Adverse Event|1|||
105738211|NCT02504892|364696869|FG000|Overall Study|Adverse event-pneumonitis|2|||
105738212|NCT01415440|364696870|FG000|Overall Study|Lost to Follow-up|0|||
105738213|NCT01415440|364696871|FG001|Overall Study|Lost to Follow-up|1|||
105738214|NCT01415440|364696872|FG002|Overall Study|Lost to Follow-up|2|||
105738215|NCT01415440|364696870|FG000|Overall Study|Physician Decision|3|||
105738216|NCT01415440|364696871|FG001|Overall Study|Physician Decision|0|||
106012556|NCT00106704|365712827|FG000|Overall Study|Protocol Violation|4|||
106012557|NCT00106704|365712828|FG001|Overall Study|Protocol Violation|7|||
106012558|NCT00106704|365712827|FG000|Overall Study|Withdrawal by Subject|14|||
106012559|NCT00106704|365712828|FG001|Overall Study|Withdrawal by Subject|21|||
106012560|NCT00106704|365712827|FG000|Overall Study|Patient moved|1|||
106012561|NCT00106704|365712828|FG001|Overall Study|Patient moved|0|||
105738217|NCT01415440|364696872|FG002|Overall Study|Physician Decision|0|||
105738218|NCT01415440|364696870|FG000|Overall Study|Withdrawal by Subject|1|||
105738219|NCT01415440|364696871|FG001|Overall Study|Withdrawal by Subject|0|||
105738220|NCT01415440|364696872|FG002|Overall Study|Withdrawal by Subject|0|||
105738221|NCT04083222|364696875|FG000|Overall Study|Voluntary Withdrawal|0|||
106012562|NCT00106704|365712827|FG000|Overall Study|Site terminated|0|||
106012563|NCT00106704|365712828|FG001|Overall Study|Site terminated|1|||
106012564|NCT00106704|365712827|FG000|Overall Study|Planned major surgery|1|||
106012565|NCT00106704|365712828|FG001|Overall Study|Planned major surgery|0|||
106012566|NCT00106704|365712827|FG000|Overall Study|Patient Received Glycemic Medication|22|||
105738222|NCT04083222|364696876|FG001|Overall Study|Voluntary Withdrawal|1|||
105738223|NCT04083222|364696875|FG000|Overall Study|Reason not Specified|0|||
105738224|NCT04083222|364696876|FG001|Overall Study|Reason not Specified|1|||
105799741|NCT04380701|364924643|FG029|Overall Study|Physician Decision|0|||
105940790|NCT05487378|365445077|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
105940791|NCT05487378|365445078|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
105940792|NCT05487378|365445077|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
105940793|NCT05487378|365445078|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
105940794|NCT03249558|365445081|FG000|Overall Study|Lost to Follow-up|2|||
105940795|NCT03249558|365445082|FG001|Overall Study|Lost to Follow-up|1|||
105940796|NCT03249558|365445083|FG002|Overall Study|Lost to Follow-up|4|||
105940797|NCT03249558|365445081|FG000|Overall Study|Physician Decision|1|||
105940798|NCT03249558|365445082|FG001|Overall Study|Physician Decision|0|||
105940799|NCT03249558|365445083|FG002|Overall Study|Physician Decision|0|||
105940800|NCT03249558|365445081|FG000|Overall Study|Withdrawal by Subject|6|||
105940801|NCT03249558|365445082|FG001|Overall Study|Withdrawal by Subject|5|||
105940802|NCT03249558|365445083|FG002|Overall Study|Withdrawal by Subject|7|||
105940803|NCT03249558|365445081|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
105940804|NCT03249558|365445082|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
105940805|NCT03249558|365445083|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
105940806|NCT03249558|365445081|FG000|Overall Study|Protocol Violation|1|||
105940807|NCT03249558|365445082|FG001|Overall Study|Protocol Violation|1|||
105940808|NCT03249558|365445083|FG002|Overall Study|Protocol Violation|2|||
105940809|NCT00561821|365445084|FG000|Overall Study|Not treated|0|||
105940810|NCT00561821|365445085|FG001|Overall Study|Not treated|0|||
105940811|NCT00561821|365445086|FG002|Overall Study|Not treated|1|||
105940812|NCT00561821|365445087|FG003|Overall Study|Not treated|0|||
105940813|NCT00561821|365445084|FG000|Overall Study|Withdrawal by Subject|0|||
105940814|NCT00561821|365445085|FG001|Overall Study|Withdrawal by Subject|1|||
105940815|NCT00561821|365445086|FG002|Overall Study|Withdrawal by Subject|0|||
105940816|NCT00561821|365445087|FG003|Overall Study|Withdrawal by Subject|2|||
105940817|NCT00561821|365445084|FG000|Overall Study|Reasons not related to trial|2|||
105940818|NCT00561821|365445085|FG001|Overall Study|Reasons not related to trial|1|||
105940819|NCT00561821|365445086|FG002|Overall Study|Reasons not related to trial|0|||
105940820|NCT00561821|365445087|FG003|Overall Study|Reasons not related to trial|0|||
106012567|NCT00106704|365712828|FG001|Overall Study|Patient Received Glycemic Medication|41|||
106012568|NCT00106704|365712827|FG000|Overall Study|Unable to re-enter US|1|||
106012569|NCT00106704|365712828|FG001|Overall Study|Unable to re-enter US|0|||
105738225|NCT03103750|364696877|FG000|Overall Study|Adverse Event|1|||
105738226|NCT03103750|364696878|FG001|Overall Study|Adverse Event|0|||
105799742|NCT04380701|364924644|FG030|Overall Study|Physician Decision|0|||
105799743|NCT04380701|364924645|FG031|Overall Study|Physician Decision|0|||
105940821|NCT00561821|365445084|FG000|Overall Study|Other (reason not specified)|1|||
105940822|NCT00561821|365445085|FG001|Overall Study|Other (reason not specified)|1|||
105940823|NCT00561821|365445086|FG002|Overall Study|Other (reason not specified)|0|||
105940824|NCT00561821|365445087|FG003|Overall Study|Other (reason not specified)|0|||
105940825|NCT00561821|365445084|FG000|Overall Study|Adverse Event|2|||
105940826|NCT00561821|365445085|FG001|Overall Study|Adverse Event|3|||
106012570|NCT00106704|365712827|FG000|Overall Study|Laboratory test|1|||
105940827|NCT00561821|365445086|FG002|Overall Study|Adverse Event|1|||
105940828|NCT00561821|365445087|FG003|Overall Study|Adverse Event|1|||
105738227|NCT03103750|364696877|FG000|Overall Study|Lost to Follow-up|1|||
105738228|NCT03103750|364696878|FG001|Overall Study|Lost to Follow-up|0|||
105738229|NCT03103750|364696877|FG000|Overall Study|PET Equipment Related|2|||
105940829|NCT00908141|365445088|FG000|Overall Study|Withdrawal by Subject|0|||
105940830|NCT00908141|365445089|FG001|Overall Study|Withdrawal by Subject|1|||
105940831|NCT02520154|365445094|FG000|Overall Study|Death|1|||
105940832|NCT02520154|365445094|FG000|Overall Study|Withdrawal by Subject|2|||
105940833|NCT02520154|365445094|FG000|Overall Study|Physician Decision|2|||
105940834|NCT03648372|365445095|FG000|Overall Study|Withdrawal by Subject|2|||
105940835|NCT03648372|365445096|FG001|Overall Study|Withdrawal by Subject|0|||
105940836|NCT03648372|365445097|FG002|Overall Study|Withdrawal by Subject|0|||
106012571|NCT00106704|365712828|FG001|Overall Study|Laboratory test|1|||
106012572|NCT04798196|365712829|FG000|Overall Study|Lost to Follow-up|3|||
106012573|NCT04798196|365712830|FG001|Overall Study|Lost to Follow-up|1|||
106012574|NCT04798196|365712831|FG002|Overall Study|Lost to Follow-up|3|||
106012575|NCT01249261|365712832|FG000|Overall Study|Withdrawal by Subject|1|||
106012576|NCT01249261|365712833|FG001|Overall Study|Withdrawal by Subject|0|||
106012577|NCT00728689|365712837|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
106012578|NCT00728689|365712838|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
106012579|NCT01523366|365712839|FG000|Treatment Period 1|Withdrawal by Subject|1|||
106012580|NCT01523366|365712840|FG001|Treatment Period 1|Withdrawal by Subject|0|||
106012581|NCT01523366|365712839|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
106012582|NCT01523366|365712840|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
106012583|NCT04543279|365712845|FG000|Overall Study|Withdrawal by Subject|1|||
106012584|NCT04543279|365712846|FG001|Overall Study|Withdrawal by Subject|0|||
106012585|NCT04543279|365712845|FG000|Overall Study|Adverse Event|1|||
106012586|NCT04543279|365712846|FG001|Overall Study|Adverse Event|0|||
106012587|NCT04543279|365712845|FG000|Overall Study|Physician Decision|1|||
106012588|NCT04543279|365712846|FG001|Overall Study|Physician Decision|0|||
106012589|NCT04885998|365712849|FG000|Overall Study|Ongoing in study|3|||
106012590|NCT04885998|365712850|FG001|Overall Study|Ongoing in study|2|||
106012591|NCT04885998|365712851|FG002|Overall Study|Ongoing in study|2|||
106012592|NCT04885998|365712852|FG003|Overall Study|Ongoing in study|6|||
106012593|NCT04885998|365712849|FG000|Overall Study|Withdrawal by Subject|0|||
106012594|NCT04885998|365712850|FG001|Overall Study|Withdrawal by Subject|2|||
106012595|NCT04885998|365712851|FG002|Overall Study|Withdrawal by Subject|1|||
106012596|NCT04885998|365712852|FG003|Overall Study|Withdrawal by Subject|1|||
106012597|NCT04885998|365712849|FG000|Overall Study|Lost to Follow-up|1|||
106012598|NCT04885998|365712850|FG001|Overall Study|Lost to Follow-up|0|||
106012599|NCT04885998|365712851|FG002|Overall Study|Lost to Follow-up|0|||
106012600|NCT04885998|365712852|FG003|Overall Study|Lost to Follow-up|0|||
106012601|NCT04885998|365712849|FG000|Overall Study|Death|2|||
106012602|NCT04885998|365712850|FG001|Overall Study|Death|1|||
106012603|NCT04885998|365712851|FG002|Overall Study|Death|1|||
106012604|NCT04885998|365712852|FG003|Overall Study|Death|0|||
106012605|NCT00734539|365712855|FG000|Main Study|Death|33|||
106012606|NCT00734539|365712856|FG001|Main Study|Death|32|||
106012607|NCT00734539|365712855|FG000|Main Study|Physician Decision|2|||
106012608|NCT00734539|365712856|FG001|Main Study|Physician Decision|0|||
106012609|NCT00734539|365712855|FG000|Main Study|Withdrawal by Subject|1|||
106012610|NCT00734539|365712856|FG001|Main Study|Withdrawal by Subject|3|||
106012611|NCT00734539|365712855|FG000|Main Study|Enrolled in error; ineligible|1|||
105738230|NCT03103750|364696878|FG001|Overall Study|PET Equipment Related|2|||
105738231|NCT03607682|364696879|FG000|Overall Study|Withdrawal by Subject|1|||
105940837|NCT03648372|365445098|FG003|Overall Study|Withdrawal by Subject|0|||
105940838|NCT03648372|365445099|FG004|Overall Study|Withdrawal by Subject|0|||
105940839|NCT03648372|365445100|FG005|Overall Study|Withdrawal by Subject|1|||
105738232|NCT03607682|364696879|FG000|Overall Study|Disease progression|1|||
105738233|NCT00376688|364696880|FG000|Overall Study|Adverse Event|3|||
105738234|NCT00376688|364696880|FG000|Overall Study|Death|1|||
105738235|NCT01770353|364696881|FG000|Overall Study|Progressive disease|2|||
105738236|NCT01770353|364696882|FG001|Overall Study|Progressive disease|1|||
105738237|NCT01770353|364696881|FG000|Overall Study|Adverse Event|0|||
105738238|NCT01770353|364696882|FG001|Overall Study|Adverse Event|1|||
105738239|NCT01770353|364696881|FG000|Overall Study|Protocol Violation|1|||
105738240|NCT01770353|364696882|FG001|Overall Study|Protocol Violation|0|||
105799744|NCT04380701|364924646|FG032|Overall Study|Physician Decision|0|||
105940840|NCT03648372|365445101|FG006|Overall Study|Withdrawal by Subject|2|||
105940841|NCT03648372|365445102|FG007|Overall Study|Withdrawal by Subject|0|||
105940842|NCT03648372|365445103|FG008|Overall Study|Withdrawal by Subject|0|||
105940843|NCT03648372|365445104|FG009|Overall Study|Withdrawal by Subject|0|||
106012612|NCT00734539|365712856|FG001|Main Study|Enrolled in error; ineligible|0|||
106012613|NCT03216226|365712859|FG000|Overall Study|Adverse Event|3|||
106012614|NCT03216226|365712860|FG001|Overall Study|Adverse Event|0|||
106012615|NCT03216226|365712859|FG000|Overall Study|Protocol Violation|1|||
106012616|NCT03216226|365712860|FG001|Overall Study|Protocol Violation|3|||
106012617|NCT03216226|365712859|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
106012618|NCT03216226|365712860|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
106012619|NCT03216226|365712859|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
106016896|NCT03847896|365725905|FG000|Overall Study|A severe exacerbation event|0|||
106141445|NCT00708032|366175947|FG001|Overall Study|Did not meet protocol criteria|2|||
105799745|NCT04380701|364924647|FG033|Overall Study|Physician Decision|0|||
105799746|NCT04380701|364924614|FG000|Overall Study|Death|0|||
105799747|NCT04380701|364924615|FG001|Overall Study|Death|0|||
106141446|NCT00708032|366175946|FG000|Overall Study|Protocol Violation|4|||
106141447|NCT00708032|366175947|FG001|Overall Study|Protocol Violation|1|||
106141448|NCT00708032|366175946|FG000|Overall Study|Withdrawal by Subject|0|||
106141449|NCT00708032|366175947|FG001|Overall Study|Withdrawal by Subject|1|||
106141450|NCT01227278|366175948|FG000|Overall Study|Withdrawal by Subject|4|||
106141451|NCT01227278|366175949|FG001|Overall Study|Withdrawal by Subject|4|||
106141452|NCT01227278|366175948|FG000|Overall Study|Death|0|||
106141453|NCT01227278|366175949|FG001|Overall Study|Death|2|||
106141454|NCT01227278|366175948|FG000|Overall Study|Other|1|||
106141455|NCT01227278|366175949|FG001|Overall Study|Other|2|||
106141456|NCT02320123|366175950|FG000|Overall Study|Lost to Follow-up|4|||
106141457|NCT02320123|366175951|FG001|Overall Study|Lost to Follow-up|6|||
106141458|NCT02320123|366175950|FG000|Overall Study|Death|6|||
106141459|NCT02320123|366175951|FG001|Overall Study|Death|5|||
106141460|NCT00941655|366175956|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
106141461|NCT00941655|366175957|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
106141462|NCT00941655|366175956|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
106141463|NCT00941655|366175957|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
106141464|NCT00941655|366175956|FG000|Overall Study|progressed while on chemo|0|||
106141465|NCT00941655|366175957|FG001|Overall Study|progressed while on chemo|2|||
106141466|NCT00941655|366175956|FG000|Overall Study|refused further treatment|0|||
106141467|NCT00941655|366175957|FG001|Overall Study|refused further treatment|1|||
106141468|NCT00941655|366175956|FG000|Overall Study|withdrew consent|0|||
106141469|NCT00941655|366175957|FG001|Overall Study|withdrew consent|1|||
106141470|NCT00941655|366175956|FG000|Overall Study|non-compliant|0|||
106141471|NCT00941655|366175957|FG001|Overall Study|non-compliant|1|||
106141472|NCT02937831|366175958|FG000|Overall Study|Protocol Violation|4|||
106141473|NCT05257798|366175960|FG000|Follow-up Phase|Lost to Follow-up|1|||
106141474|NCT05257798|366175961|FG001|Follow-up Phase|Lost to Follow-up|0|||
106141475|NCT01064817|366175968|FG000|Study Completion|Physician Decision|1|||
106141476|NCT01064817|366175969|FG001|Study Completion|Physician Decision|0|||
106141477|NCT01064817|366175968|FG000|Study Completion|Withdrawal by Subject|1|||
106141478|NCT01064817|366175969|FG001|Study Completion|Withdrawal by Subject|0|||
106141479|NCT01066923|366175972|FG000|Overall Study|Withdrawal by Subject|3|||
106141480|NCT01066923|366175973|FG001|Overall Study|Withdrawal by Subject|3|||
106141481|NCT01066923|366175974|FG002|Overall Study|Withdrawal by Subject|8|||
106141482|NCT01066923|366175975|FG003|Overall Study|Withdrawal by Subject|8|||
106141483|NCT00738699|366175976|FG000|Overall Study|Withdrawal by Subject|5|||
106141484|NCT00738699|366175977|FG001|Overall Study|Withdrawal by Subject|0|||
106141485|NCT00738699|366175976|FG000|Overall Study|Lost to Follow-up|1|||
106141486|NCT00738699|366175977|FG001|Overall Study|Lost to Follow-up|0|||
106141487|NCT00738699|366175976|FG000|Overall Study|Death|144|||
106141488|NCT00738699|366175977|FG001|Overall Study|Death|68|||
106141489|NCT00738699|366175976|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
106141490|NCT00738699|366175977|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
106141491|NCT00738699|366175976|FG000|Overall Study|Other|2|||
106141492|NCT00738699|366175977|FG001|Overall Study|Other|0|||
106141493|NCT01458210|366175978|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
106141494|NCT01458210|366175978|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
106141495|NCT01458210|366175978|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
105799748|NCT04380701|364924616|FG002|Overall Study|Death|0|||
105940844|NCT03648372|365445105|FG010|Overall Study|Withdrawal by Subject|2|||
105940845|NCT03648372|365445106|FG011|Overall Study|Withdrawal by Subject|0|||
105940846|NCT03648372|365445107|FG012|Overall Study|Withdrawal by Subject|2|||
105940847|NCT03648372|365445108|FG013|Overall Study|Withdrawal by Subject|0|||
105940848|NCT03648372|365445109|FG014|Overall Study|Withdrawal by Subject|0|||
105940849|NCT03648372|365445110|FG015|Overall Study|Withdrawal by Subject|0|||
106141496|NCT01458210|366175978|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
106141497|NCT00753012|366175981|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
106141498|NCT00753012|366175982|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
106141499|NCT00753012|366175981|FG000|Overall Study|Adverse Event|2|||
106141500|NCT00753012|366175982|FG001|Overall Study|Adverse Event|0|||
106141501|NCT00753012|366175981|FG000|Overall Study|Withdrawal by Subject|0|||
106141502|NCT00753012|366175982|FG001|Overall Study|Withdrawal by Subject|1|||
106141503|NCT00753012|366175981|FG000|Overall Study|Lost to Follow-up|4|||
106141504|NCT00753012|366175982|FG001|Overall Study|Lost to Follow-up|0|||
106141505|NCT00753012|366175981|FG000|Overall Study|Confounded endpoint data|1|||
106141506|NCT00753012|366175982|FG001|Overall Study|Confounded endpoint data|0|||
105940850|NCT03648372|365445111|FG016|Overall Study|Withdrawal by Subject|1|||
106141507|NCT00344019|366175983|FG000|Overall Study|did not meet final inclusion criteria|0|||
106141508|NCT00344019|366175984|FG001|Overall Study|did not meet final inclusion criteria|0|||
105799749|NCT04380701|364924617|FG003|Overall Study|Death|0|||
106141509|NCT00344019|366175985|FG002|Overall Study|did not meet final inclusion criteria|74|||
106012620|NCT03216226|365712860|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
106012621|NCT03216226|365712859|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
106012622|NCT03216226|365712860|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
106012623|NCT00538902|365712861|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
106012624|NCT00538902|365712862|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
106012625|NCT00538902|365712863|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
106012626|NCT00538902|365712861|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
106012627|NCT00538902|365712862|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
106012628|NCT00538902|365712863|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
106012629|NCT00538902|365712861|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
106012630|NCT00538902|365712862|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
106012631|NCT00538902|365712863|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
106012632|NCT00538902|365712861|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
106012633|NCT00538902|365712862|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
106012634|NCT00538902|365712863|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
106012635|NCT00538902|365712861|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
106012636|NCT00538902|365712862|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
106012637|NCT00538902|365712863|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
106012638|NCT00538902|365712861|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
106012639|NCT00538902|365712862|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
106012640|NCT00538902|365712863|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
106012641|NCT00538902|365712861|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
106012642|NCT00538902|365712862|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
106012643|NCT00538902|365712863|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
106012644|NCT00538902|365712861|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
106012645|NCT00538902|365712862|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
106012646|NCT00538902|365712863|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
106012647|NCT04109547|365712869|FG000|Overall Study|Withdrawal by Subject|3|||
106012648|NCT04109547|365712870|FG001|Overall Study|Withdrawal by Subject|2|||
106012649|NCT04109547|365712871|FG002|Overall Study|Withdrawal by Subject|6|||
106012650|NCT04109547|365712872|FG003|Overall Study|Withdrawal by Subject|6|||
106012651|NCT04109547|365712869|FG000|Overall Study|Lost to Follow-up|0|||
106012652|NCT04109547|365712870|FG001|Overall Study|Lost to Follow-up|0|||
106012653|NCT04109547|365712871|FG002|Overall Study|Lost to Follow-up|0|||
106012654|NCT04109547|365712872|FG003|Overall Study|Lost to Follow-up|1|||
106012655|NCT04109547|365712869|FG000|Overall Study|Physician Decision|1|||
106012656|NCT04109547|365712870|FG001|Overall Study|Physician Decision|2|||
106012657|NCT04109547|365712871|FG002|Overall Study|Physician Decision|0|||
106012658|NCT04109547|365712872|FG003|Overall Study|Physician Decision|0|||
106012659|NCT03777982|365712877|FG000|Overall Study|Physician Decision|0|||
106012660|NCT03777982|365712878|FG001|Overall Study|Physician Decision|1|||
106012661|NCT00870740|365712879|FG000|Overall Study|Adverse Event|2|||
106012662|NCT00870740|365712880|FG001|Overall Study|Adverse Event|1|||
106012663|NCT00870740|365712881|FG002|Overall Study|Adverse Event|3|||
106012664|NCT00870740|365712882|FG003|Overall Study|Adverse Event|2|||
106012665|NCT00870740|365712883|FG004|Overall Study|Adverse Event|1|||
106012666|NCT00870740|365712884|FG005|Overall Study|Adverse Event|6|||
106012667|NCT00870740|365712879|FG000|Overall Study|Consent Withdrawn|6|||
106012668|NCT00870740|365712880|FG001|Overall Study|Consent Withdrawn|3|||
106012669|NCT00870740|365712881|FG002|Overall Study|Consent Withdrawn|4|||
106012670|NCT00870740|365712882|FG003|Overall Study|Consent Withdrawn|6|||
106012671|NCT00870740|365712883|FG004|Overall Study|Consent Withdrawn|6|||
106012672|NCT00870740|365712884|FG005|Overall Study|Consent Withdrawn|5|||
106012673|NCT00870740|365712879|FG000|Overall Study|Investigator Decision|2|||
106012674|NCT00870740|365712880|FG001|Overall Study|Investigator Decision|0|||
106012675|NCT00870740|365712881|FG002|Overall Study|Investigator Decision|1|||
106012676|NCT00870740|365712882|FG003|Overall Study|Investigator Decision|0|||
106012677|NCT00870740|365712883|FG004|Overall Study|Investigator Decision|0|||
106141510|NCT01988233|366175989|FG000|Overall Study|Lost to Follow-up|64|||
106141511|NCT01988233|366175990|FG001|Overall Study|Lost to Follow-up|51|||
106012678|NCT00870740|365712884|FG005|Overall Study|Investigator Decision|0|||
106141512|NCT03781336|366175995|FG000|Overall Study|Withdrawal by Subject|2|||
106012679|NCT00870740|365712879|FG000|Overall Study|Subject Non-compliance|0|||
106012680|NCT00870740|365712880|FG001|Overall Study|Subject Non-compliance|0|||
106012681|NCT00870740|365712881|FG002|Overall Study|Subject Non-compliance|0|||
106012682|NCT00870740|365712882|FG003|Overall Study|Subject Non-compliance|0|||
106012683|NCT00870740|365712883|FG004|Overall Study|Subject Non-compliance|0|||
106012684|NCT00870740|365712884|FG005|Overall Study|Subject Non-compliance|1|||
106012685|NCT00870740|365712879|FG000|Overall Study|Death|0|||
106012686|NCT00870740|365712880|FG001|Overall Study|Death|0|||
106141513|NCT03781336|366175996|FG001|Overall Study|Withdrawal by Subject|2|||
106141514|NCT00319436|366175997|FG000|Overall Study|Withdrawal by Subject|6|||
106141515|NCT00319436|366175998|FG001|Overall Study|Withdrawal by Subject|7|||
106141516|NCT00790790|366175999|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
106141517|NCT00790790|366176000|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
106141518|NCT00790790|366176001|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
106141519|NCT00790790|366175999|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
106141520|NCT00790790|366176000|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
106141521|NCT00790790|366176001|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
106141522|NCT00790790|366175999|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
106141523|NCT00790790|366176000|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
106141524|NCT00790790|366176001|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
106141525|NCT00790790|366175999|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
106141526|NCT00790790|366176000|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
106141527|NCT00790790|366176001|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
106141528|NCT00790790|366175999|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
106141529|NCT00790790|366176000|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
106141530|NCT00790790|366176001|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
106141531|NCT02194933|366176009|FG000|Overall Study|Lost to Follow-up|1|||
106141532|NCT02194933|366176010|FG001|Overall Study|Lost to Follow-up|2|||
105738241|NCT01770353|364696881|FG000|Overall Study|Physician Decision|0|||
105738242|NCT01770353|364696882|FG001|Overall Study|Physician Decision|3|||
105738243|NCT01770353|364696881|FG000|Overall Study|Clinical deterioration|3|||
105738244|NCT01770353|364696882|FG001|Overall Study|Clinical deterioration|6|||
105738245|NCT01770353|364696881|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
105738246|NCT01770353|364696882|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
105738247|NCT05270694|364698191|FG000|Overall Study|Death|1|||
105738248|NCT05270694|364698191|FG000|Overall Study|Medical issues impacted ability to participate|2|||
105738249|NCT05270694|364698191|FG000|Overall Study|Lost to Follow-up|3|||
105738250|NCT05270694|364698191|FG000|Overall Study|Withdrawal by Subject|3|||
105738251|NCT00408421|364698209|FG000|Treatment Initial Randomization|Adverse Event|5|||
105738252|NCT00408421|364698210|FG001|Treatment Initial Randomization|Adverse Event|9|||
105738253|NCT00408421|364698211|FG002|Treatment Initial Randomization|Adverse Event|0|||
105738254|NCT00408421|364698209|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
105738255|NCT00408421|364698210|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
105738256|NCT00408421|364698211|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
105940851|NCT03648372|365445112|FG017|Overall Study|Withdrawal by Subject|0|||
105940852|NCT03648372|365445113|FG018|Overall Study|Withdrawal by Subject|0|||
105940853|NCT03648372|365445114|FG019|Overall Study|Withdrawal by Subject|0|||
105940854|NCT03648372|365445115|FG020|Overall Study|Withdrawal by Subject|0|||
105940855|NCT03648372|365445095|FG000|Overall Study|Progressive Disease|2|||
105940856|NCT03648372|365445096|FG001|Overall Study|Progressive Disease|3|||
105940857|NCT03648372|365445097|FG002|Overall Study|Progressive Disease|4|||
105940858|NCT03648372|365445098|FG003|Overall Study|Progressive Disease|3|||
105940859|NCT03648372|365445099|FG004|Overall Study|Progressive Disease|2|||
105940860|NCT03648372|365445100|FG005|Overall Study|Progressive Disease|2|||
105940861|NCT03648372|365445101|FG006|Overall Study|Progressive Disease|3|||
105940862|NCT03648372|365445102|FG007|Overall Study|Progressive Disease|3|||
105940863|NCT03648372|365445103|FG008|Overall Study|Progressive Disease|5|||
105940864|NCT03648372|365445104|FG009|Overall Study|Progressive Disease|5|||
105940865|NCT03648372|365445105|FG010|Overall Study|Progressive Disease|2|||
105940866|NCT03648372|365445106|FG011|Overall Study|Progressive Disease|3|||
105940867|NCT03648372|365445107|FG012|Overall Study|Progressive Disease|3|||
105940868|NCT03648372|365445108|FG013|Overall Study|Progressive Disease|3|||
105940869|NCT03648372|365445109|FG014|Overall Study|Progressive Disease|6|||
105940870|NCT03648372|365445110|FG015|Overall Study|Progressive Disease|0|||
105940871|NCT03648372|365445111|FG016|Overall Study|Progressive Disease|0|||
105940872|NCT03648372|365445112|FG017|Overall Study|Progressive Disease|0|||
105940873|NCT03648372|365445113|FG018|Overall Study|Progressive Disease|0|||
105940874|NCT03648372|365445114|FG019|Overall Study|Progressive Disease|0|||
105940875|NCT03648372|365445115|FG020|Overall Study|Progressive Disease|0|||
105940876|NCT03648372|365445095|FG000|Overall Study|Other|0|||
105940877|NCT03648372|365445096|FG001|Overall Study|Other|0|||
105940878|NCT03648372|365445097|FG002|Overall Study|Other|0|||
105940879|NCT03648372|365445098|FG003|Overall Study|Other|0|||
105940880|NCT03648372|365445099|FG004|Overall Study|Other|1|||
105940881|NCT03648372|365445100|FG005|Overall Study|Other|0|||
106141533|NCT02194933|366176009|FG000|Overall Study|Participant met withdrawal criteria|1|||
106141534|NCT02194933|366176010|FG001|Overall Study|Participant met withdrawal criteria|3|||
105738257|NCT00408421|364698209|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
105940882|NCT03648372|365445101|FG006|Overall Study|Other|0|||
105738258|NCT00408421|364698210|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
105738259|NCT00408421|364698211|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
105940883|NCT03648372|365445102|FG007|Overall Study|Other|0|||
105738260|NCT00408421|364698209|FG000|Treatment Initial Randomization|Physician Decision|1|||
105738261|NCT00408421|364698210|FG001|Treatment Initial Randomization|Physician Decision|0|||
105738262|NCT00408421|364698211|FG002|Treatment Initial Randomization|Physician Decision|0|||
105738263|NCT00408421|364698209|FG000|Treatment Initial Randomization|Protocol Violation|0|||
105738264|NCT00408421|364698210|FG001|Treatment Initial Randomization|Protocol Violation|1|||
105738265|NCT00408421|364698211|FG002|Treatment Initial Randomization|Protocol Violation|0|||
105738266|NCT00408421|364698209|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
105738267|NCT00408421|364698210|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
105738268|NCT00408421|364698211|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
105738269|NCT00408421|364698209|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
105738270|NCT00408421|364698210|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
105738271|NCT00408421|364698211|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
105738272|NCT00408421|364698209|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
105738273|NCT00408421|364698210|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
106012687|NCT00870740|365712881|FG002|Overall Study|Death|0|||
106012688|NCT00870740|365712882|FG003|Overall Study|Death|0|||
106012689|NCT00870740|365712883|FG004|Overall Study|Death|1|||
106012690|NCT00870740|365712884|FG005|Overall Study|Death|0|||
106012691|NCT00870740|365712879|FG000|Overall Study|Other|2|||
106012692|NCT00870740|365712880|FG001|Overall Study|Other|5|||
106012693|NCT00870740|365712881|FG002|Overall Study|Other|2|||
106012694|NCT00870740|365712882|FG003|Overall Study|Other|4|||
106012695|NCT00870740|365712883|FG004|Overall Study|Other|3|||
106012696|NCT00870740|365712884|FG005|Overall Study|Other|5|||
106012697|NCT03755934|365712885|FG000|Overall Study|Adverse Event|4|||
106012698|NCT03755934|365712886|FG001|Overall Study|Adverse Event|1|||
106012699|NCT03755934|365712887|FG002|Overall Study|Adverse Event|1|||
106012700|NCT03755934|365712888|FG003|Overall Study|Adverse Event|3|||
106012701|NCT03755934|365712885|FG000|Overall Study|Physician Decision|2|||
106012702|NCT03755934|365712886|FG001|Overall Study|Physician Decision|0|||
106012703|NCT03755934|365712887|FG002|Overall Study|Physician Decision|0|||
106012704|NCT03755934|365712888|FG003|Overall Study|Physician Decision|1|||
106012705|NCT03755934|365712885|FG000|Overall Study|Withdrawal by Subject|5|||
106012706|NCT03755934|365712886|FG001|Overall Study|Withdrawal by Subject|0|||
106012707|NCT03755934|365712887|FG002|Overall Study|Withdrawal by Subject|0|||
106012708|NCT03755934|365712888|FG003|Overall Study|Withdrawal by Subject|1|||
106012709|NCT03755934|365712885|FG000|Overall Study|Other|3|||
106012710|NCT03755934|365712886|FG001|Overall Study|Other|1|||
106012711|NCT03755934|365712887|FG002|Overall Study|Other|3|||
106012712|NCT03755934|365712888|FG003|Overall Study|Other|1|||
106012713|NCT00198822|365712890|FG000|Overall Study|Lost to Follow-up|14|||
106012714|NCT00198822|365712891|FG001|Overall Study|Lost to Follow-up|20|||
106012715|NCT00198822|365712892|FG002|Overall Study|Lost to Follow-up|21|||
106012716|NCT02158442|365712893|FG000|Overall Study|Withdrawal by Subject|1|||
106012717|NCT02158442|365712894|FG001|Overall Study|Withdrawal by Subject|0|||
106012718|NCT02158442|365712893|FG000|Overall Study|Perfusion staff not available|1|||
106012719|NCT02158442|365712894|FG001|Overall Study|Perfusion staff not available|0|||
106012720|NCT00686712|365712895|FG000|Overall Study|Protocol Violation|8|||
106012721|NCT00686712|365712896|FG001|Overall Study|Protocol Violation|8|||
106012722|NCT00686712|365712897|FG002|Overall Study|Protocol Violation|10|||
106012723|NCT00686712|365712895|FG000|Overall Study|Lost to Follow-up|1|||
106012724|NCT00686712|365712896|FG001|Overall Study|Lost to Follow-up|2|||
106012725|NCT00686712|365712897|FG002|Overall Study|Lost to Follow-up|3|||
106012726|NCT00686712|365712895|FG000|Overall Study|Adverse Event|1|||
106012727|NCT00686712|365712896|FG001|Overall Study|Adverse Event|1|||
106012728|NCT00686712|365712897|FG002|Overall Study|Adverse Event|0|||
106012729|NCT04119414|365712899|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
106012730|NCT01352793|365712910|FG000|Overall Study|Lost to Follow-up|289|||
106012731|NCT01352793|365712911|FG001|Overall Study|Lost to Follow-up|125|||
106012732|NCT01352793|365712910|FG000|Overall Study|Withdrawal by Subject|120|||
105738274|NCT00408421|364698211|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
105738275|NCT00408421|364698209|FG000|Treatment Re-Randomization|Adverse Event|2|||
106012733|NCT01352793|365712911|FG001|Overall Study|Withdrawal by Subject|55|||
106012734|NCT01352793|365712910|FG000|Overall Study|Protocol Violation|44|||
106141535|NCT02194933|366176009|FG000|Overall Study|Withdrawal by Subject|0|||
106141536|NCT02194933|366176010|FG001|Overall Study|Withdrawal by Subject|2|||
105738276|NCT00408421|364698210|FG001|Treatment Re-Randomization|Adverse Event|2|||
106012735|NCT01352793|365712911|FG001|Overall Study|Protocol Violation|23|||
106012736|NCT01352793|365712910|FG000|Overall Study|Adverse Event|44|||
106012737|NCT01352793|365712911|FG001|Overall Study|Adverse Event|10|||
106012738|NCT01352793|365712910|FG000|Overall Study|Physician Decision|1|||
106012739|NCT01352793|365712911|FG001|Overall Study|Physician Decision|0|||
106141537|NCT02194933|366176009|FG000|Overall Study|Lack of Efficacy|1|||
106012740|NCT01352793|365712910|FG000|Overall Study|Pregnancy|26|||
106012741|NCT01352793|365712911|FG001|Overall Study|Pregnancy|8|||
106012742|NCT01352793|365712910|FG000|Overall Study|Other|25|||
106012743|NCT01352793|365712911|FG001|Overall Study|Other|7|||
105799750|NCT04380701|364924618|FG004|Overall Study|Death|0|||
105799751|NCT04380701|364924619|FG005|Overall Study|Death|0|||
105738277|NCT00408421|364698211|FG002|Treatment Re-Randomization|Adverse Event|4|||
105738278|NCT00408421|364698209|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
105738279|NCT00408421|364698210|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
105738280|NCT00408421|364698211|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
105738281|NCT00408421|364698209|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
105738282|NCT00408421|364698210|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
105738283|NCT00408421|364698211|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
105738284|NCT00408421|364698209|FG000|Treatment Re-Randomization|Physician Decision|1|||
105738285|NCT00408421|364698210|FG001|Treatment Re-Randomization|Physician Decision|3|||
105738286|NCT00408421|364698211|FG002|Treatment Re-Randomization|Physician Decision|0|||
105738287|NCT00408421|364698209|FG000|Treatment Re-Randomization|Protocol Violation|1|||
105738288|NCT00408421|364698210|FG001|Treatment Re-Randomization|Protocol Violation|1|||
105738289|NCT00408421|364698211|FG002|Treatment Re-Randomization|Protocol Violation|0|||
105738290|NCT00408421|364698209|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
105738291|NCT00408421|364698210|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
105738292|NCT00408421|364698211|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
105738293|NCT03314519|364698216|FG000|Overall Study|Protocol Violation|3|||
105738294|NCT03314519|364698217|FG001|Overall Study|Protocol Violation|2|||
105738295|NCT01912872|364698218|FG000|Overall Study|Lost to Follow-up|2|||
105738296|NCT01912872|364698219|FG001|Overall Study|Lost to Follow-up|3|||
105738297|NCT01912872|364698220|FG002|Overall Study|Lost to Follow-up|5|||
105738298|NCT01912872|364698221|FG003|Overall Study|Lost to Follow-up|5|||
105738299|NCT01912872|364698218|FG000|Overall Study|Other unspecified|3|||
105738300|NCT01912872|364698219|FG001|Overall Study|Other unspecified|1|||
105738301|NCT01912872|364698220|FG002|Overall Study|Other unspecified|3|||
105738302|NCT01912872|364698221|FG003|Overall Study|Other unspecified|0|||
105738303|NCT01912872|364698218|FG000|Overall Study|Informed consent withdrawn|0|||
105799752|NCT04380701|364924620|FG006|Overall Study|Death|0|||
105738304|NCT01912872|364698219|FG001|Overall Study|Informed consent withdrawn|0|||
105738305|NCT01912872|364698220|FG002|Overall Study|Informed consent withdrawn|1|||
105738306|NCT01912872|364698221|FG003|Overall Study|Informed consent withdrawn|1|||
105799753|NCT04380701|364924621|FG007|Overall Study|Death|0|||
105799754|NCT04380701|364924622|FG008|Overall Study|Death|0|||
105799755|NCT04380701|364924623|FG009|Overall Study|Death|0|||
105799756|NCT04380701|364924624|FG010|Overall Study|Death|0|||
105940884|NCT03648372|365445103|FG008|Overall Study|Other|0|||
105940885|NCT03648372|365445104|FG009|Overall Study|Other|0|||
105940886|NCT03648372|365445105|FG010|Overall Study|Other|1|||
105940887|NCT03648372|365445106|FG011|Overall Study|Other|2|||
105940888|NCT03648372|365445107|FG012|Overall Study|Other|1|||
105940889|NCT03648372|365445108|FG013|Overall Study|Other|3|||
105940890|NCT03648372|365445109|FG014|Overall Study|Other|0|||
105940891|NCT03648372|365445110|FG015|Overall Study|Other|5|||
105940892|NCT03648372|365445111|FG016|Overall Study|Other|1|||
105940893|NCT03648372|365445112|FG017|Overall Study|Other|5|||
105940894|NCT03648372|365445113|FG018|Overall Study|Other|0|||
105940895|NCT03648372|365445114|FG019|Overall Study|Other|1|||
105940896|NCT03648372|365445115|FG020|Overall Study|Other|0|||
105940897|NCT03648372|365445095|FG000|Overall Study|Lost to Follow-up|0|||
105940898|NCT03648372|365445096|FG001|Overall Study|Lost to Follow-up|0|||
105940899|NCT03648372|365445097|FG002|Overall Study|Lost to Follow-up|0|||
105940900|NCT03648372|365445098|FG003|Overall Study|Lost to Follow-up|0|||
105940901|NCT03648372|365445099|FG004|Overall Study|Lost to Follow-up|0|||
105940902|NCT03648372|365445100|FG005|Overall Study|Lost to Follow-up|0|||
105940903|NCT03648372|365445101|FG006|Overall Study|Lost to Follow-up|0|||
105940904|NCT03648372|365445102|FG007|Overall Study|Lost to Follow-up|0|||
105940905|NCT03648372|365445103|FG008|Overall Study|Lost to Follow-up|0|||
105940906|NCT03648372|365445104|FG009|Overall Study|Lost to Follow-up|0|||
105940907|NCT03648372|365445105|FG010|Overall Study|Lost to Follow-up|0|||
105940908|NCT03648372|365445106|FG011|Overall Study|Lost to Follow-up|0|||
105940909|NCT03648372|365445107|FG012|Overall Study|Lost to Follow-up|0|||
106141538|NCT02194933|366176010|FG001|Overall Study|Lack of Efficacy|2|||
105940910|NCT03648372|365445108|FG013|Overall Study|Lost to Follow-up|1|||
105940911|NCT03648372|365445109|FG014|Overall Study|Lost to Follow-up|0|||
105940912|NCT03648372|365445110|FG015|Overall Study|Lost to Follow-up|1|||
105940913|NCT03648372|365445111|FG016|Overall Study|Lost to Follow-up|0|||
105940914|NCT03648372|365445112|FG017|Overall Study|Lost to Follow-up|1|||
105940915|NCT03648372|365445113|FG018|Overall Study|Lost to Follow-up|0|||
106141539|NCT00177216|366176011|FG000|Overall Study|Withdrawal by Subject|6|||
105940916|NCT03648372|365445114|FG019|Overall Study|Lost to Follow-up|0|||
105738307|NCT01912872|364698218|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
105799757|NCT04380701|364924625|FG011|Overall Study|Death|0|||
105799758|NCT04380701|364924626|FG012|Overall Study|Death|0|||
105738308|NCT01912872|364698219|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
105940917|NCT03648372|365445115|FG020|Overall Study|Lost to Follow-up|0|||
105940918|NCT03648372|365445095|FG000|Overall Study|Start of a New Systemic Treatment|0|||
105940919|NCT03648372|365445096|FG001|Overall Study|Start of a New Systemic Treatment|0|||
106012744|NCT01352793|365712910|FG000|Overall Study|Medication error|2|||
106012745|NCT01352793|365712911|FG001|Overall Study|Medication error|2|||
106012746|NCT01352793|365712910|FG000|Overall Study|Death|1|||
106012747|NCT01352793|365712911|FG001|Overall Study|Death|0|||
106012748|NCT01352793|365712910|FG000|Overall Study|Randomized but not vaccinated|8|||
106012749|NCT01352793|365712911|FG001|Overall Study|Randomized but not vaccinated|0|||
106012750|NCT01352793|365712910|FG000|Overall Study|No longer meets eligibility criteria|25|||
106012751|NCT01352793|365712911|FG001|Overall Study|No longer meets eligibility criteria|15|||
106012752|NCT02839200|365712918|FG000|Overall Study|Withdrawal by Subject|2|||
106012753|NCT02839200|365712919|FG001|Overall Study|Withdrawal by Subject|0|||
106012754|NCT02839200|365712920|FG002|Overall Study|Withdrawal by Subject|1|||
106012755|NCT02839200|365712921|FG003|Overall Study|Withdrawal by Subject|0|||
106012756|NCT02839200|365712922|FG004|Overall Study|Withdrawal by Subject|0|||
106012757|NCT02839200|365712923|FG005|Overall Study|Withdrawal by Subject|1|||
106012758|NCT02839200|365712918|FG000|Overall Study|Lost to Follow-up|2|||
106012759|NCT02839200|365712919|FG001|Overall Study|Lost to Follow-up|0|||
106012760|NCT02839200|365712920|FG002|Overall Study|Lost to Follow-up|0|||
106012761|NCT02839200|365712921|FG003|Overall Study|Lost to Follow-up|0|||
106012762|NCT02839200|365712922|FG004|Overall Study|Lost to Follow-up|1|||
106012763|NCT02839200|365712923|FG005|Overall Study|Lost to Follow-up|0|||
106012764|NCT02839200|365712918|FG000|Overall Study|Adverse Event|0|||
106012765|NCT02839200|365712919|FG001|Overall Study|Adverse Event|0|||
106012766|NCT02839200|365712920|FG002|Overall Study|Adverse Event|0|||
106012767|NCT02839200|365712921|FG003|Overall Study|Adverse Event|0|||
106012768|NCT02839200|365712922|FG004|Overall Study|Adverse Event|1|||
106012769|NCT02839200|365712923|FG005|Overall Study|Adverse Event|0|||
106012770|NCT02839200|365712918|FG000|Overall Study|Randomized in error|0|||
106012771|NCT02839200|365712919|FG001|Overall Study|Randomized in error|1|||
106012772|NCT02839200|365712920|FG002|Overall Study|Randomized in error|0|||
106012773|NCT02839200|365712921|FG003|Overall Study|Randomized in error|0|||
106012774|NCT02839200|365712922|FG004|Overall Study|Randomized in error|0|||
106012775|NCT02839200|365712923|FG005|Overall Study|Randomized in error|0|||
106012776|NCT01929317|365712926|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
106012777|NCT01929317|365712927|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
106012778|NCT01929317|365712926|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
106012779|NCT01929317|365712927|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
106012780|NCT01929317|365712926|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
106012781|NCT01929317|365712927|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
106012782|NCT01929317|365712926|FG000|Long-term Phase|Adverse Event|5|||
106012783|NCT01929317|365712927|FG001|Long-term Phase|Adverse Event|1|||
106012784|NCT01929317|365712926|FG000|Long-term Phase|Physician Decision|3|||
106012785|NCT01929317|365712927|FG001|Long-term Phase|Physician Decision|0|||
106012786|NCT01929317|365712926|FG000|Long-term Phase|Withdrawal by Subject|4|||
106012787|NCT01929317|365712927|FG001|Long-term Phase|Withdrawal by Subject|0|||
106012788|NCT01929317|365712926|FG000|Long-term Phase|Protocol Violation|1|||
106012789|NCT01929317|365712927|FG001|Long-term Phase|Protocol Violation|0|||
106012790|NCT01929317|365712926|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
106012791|NCT01929317|365712927|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
106012792|NCT01929317|365712926|FG000|Long-term Phase|Study Closed/Terminated|5|||
106012793|NCT01929317|365712927|FG001|Long-term Phase|Study Closed/Terminated|3|||
106012794|NCT00577889|365712928|FG000|Overall Study|Withdrawal by Subject|1|||
106012795|NCT00577889|365712929|FG001|Overall Study|Withdrawal by Subject|0|||
106012796|NCT00577889|365712930|FG002|Overall Study|Withdrawal by Subject|0|||
106012797|NCT03041181|365712934|FG000|Overall Study|Disease Progression|1|||
106012798|NCT03041181|365712935|FG001|Overall Study|Disease Progression|2|||
106012799|NCT02667119|365712936|FG000|Overall Study|Lost to Follow-up|3|||
106012800|NCT02667119|365712937|FG001|Overall Study|Lost to Follow-up|0|||
106012801|NCT02760498|365712938|FG000|Overall Study|Adverse Event|3|||
106012802|NCT02760498|365712939|FG001|Overall Study|Adverse Event|3|||
106012803|NCT02760498|365712940|FG002|Overall Study|Adverse Event|1|||
106012804|NCT02760498|365712941|FG003|Overall Study|Adverse Event|1|||
106012805|NCT02760498|365712942|FG004|Overall Study|Adverse Event|0|||
106012806|NCT02760498|365712943|FG005|Overall Study|Adverse Event|6|||
106012807|NCT02760498|365712938|FG000|Overall Study|Death|7|||
106012808|NCT02760498|365712939|FG001|Overall Study|Death|5|||
106012809|NCT02760498|365712940|FG002|Overall Study|Death|5|||
106012810|NCT02760498|365712941|FG003|Overall Study|Death|7|||
106012811|NCT02760498|365712942|FG004|Overall Study|Death|0|||
106012812|NCT02760498|365712943|FG005|Overall Study|Death|23|||
106012813|NCT02760498|365712938|FG000|Overall Study|Lost to Follow-up|0|||
106012814|NCT02760498|365712939|FG001|Overall Study|Lost to Follow-up|0|||
106141540|NCT00177216|366176012|FG001|Overall Study|Withdrawal by Subject|3|||
106012815|NCT02760498|365712940|FG002|Overall Study|Lost to Follow-up|0|||
106012816|NCT02760498|365712941|FG003|Overall Study|Lost to Follow-up|0|||
106012817|NCT02760498|365712942|FG004|Overall Study|Lost to Follow-up|0|||
106012818|NCT02760498|365712943|FG005|Overall Study|Lost to Follow-up|3|||
106141541|NCT00177216|366176013|FG002|Overall Study|Withdrawal by Subject|1|||
105738309|NCT01912872|364698220|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
105738310|NCT01912872|364698221|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
105738311|NCT01912872|364698218|FG000|Overall Study|Protocol Violation|0|||
105738312|NCT01912872|364698219|FG001|Overall Study|Protocol Violation|0|||
105738313|NCT01912872|364698220|FG002|Overall Study|Protocol Violation|1|||
105738314|NCT01912872|364698221|FG003|Overall Study|Protocol Violation|0|||
105738315|NCT01912872|364698218|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105738316|NCT01912872|364698219|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105738317|NCT01912872|364698220|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105738318|NCT01912872|364698221|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
105738319|NCT01912872|364698218|FG000|Overall Study|Withdrawal of study medication|0|||
105738320|NCT01912872|364698219|FG001|Overall Study|Withdrawal of study medication|0|||
105738321|NCT01912872|364698220|FG002|Overall Study|Withdrawal of study medication|0|||
105738322|NCT01912872|364698221|FG003|Overall Study|Withdrawal of study medication|2|||
105738323|NCT01912872|364698218|FG000|Overall Study|Missing|0|||
105738324|NCT01912872|364698219|FG001|Overall Study|Missing|0|||
105738325|NCT01912872|364698220|FG002|Overall Study|Missing|0|||
105738326|NCT01912872|364698221|FG003|Overall Study|Missing|1|||
105738327|NCT02940886|364698222|FG000|Overall Study|Adverse Event|7|||
105738328|NCT02940886|364698223|FG001|Overall Study|Adverse Event|3|||
105738329|NCT02940886|364698222|FG000|Overall Study|Protocol Violation|0|||
105738330|NCT02940886|364698223|FG001|Overall Study|Protocol Violation|2|||
105738331|NCT02940886|364698222|FG000|Overall Study|Withdrawal by Subject|28|||
105738332|NCT02940886|364698223|FG001|Overall Study|Withdrawal by Subject|20|||
105738333|NCT02940886|364698222|FG000|Overall Study|Death|1|||
105738334|NCT02940886|364698223|FG001|Overall Study|Death|0|||
105738335|NCT02940886|364698222|FG000|Overall Study|Lack of Efficacy|1|||
105738336|NCT02940886|364698223|FG001|Overall Study|Lack of Efficacy|0|||
105738337|NCT02940886|364698222|FG000|Overall Study|Lost to Follow-up|49|||
105738338|NCT02940886|364698223|FG001|Overall Study|Lost to Follow-up|21|||
105738339|NCT02940886|364698222|FG000|Overall Study|Physician Decision|9|||
105738340|NCT02940886|364698223|FG001|Overall Study|Physician Decision|4|||
105738341|NCT02940886|364698222|FG000|Overall Study|Sponsor decision|0|||
105738342|NCT02940886|364698223|FG001|Overall Study|Sponsor decision|1|||
105738343|NCT02940886|364698222|FG000|Overall Study|No treatment|7|||
105738344|NCT02940886|364698223|FG001|Overall Study|No treatment|2|||
105738345|NCT02940886|364698222|FG000|Overall Study|Enrolment error|0|||
105738346|NCT02940886|364698223|FG001|Overall Study|Enrolment error|1|||
105738347|NCT01306058|364698224|FG000|Overall Study|Death|1|||
105738348|NCT01306058|364698224|FG000|Overall Study|Enrolled but did not get treatment|1|||
105738349|NCT01666444|364698225|FG000|Overall Study|Did not initiate treatment|2|||
105738350|NCT01666444|364698226|FG001|Overall Study|Did not initiate treatment|1|||
105738351|NCT03074162|364698227|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738352|NCT03074162|364698228|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738353|NCT03074162|364698229|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
105738354|NCT03074162|364698230|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738355|NCT03074162|364698231|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738356|NCT03074162|364698232|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
105738357|NCT03074162|364698227|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
105738358|NCT03074162|364698228|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
105738359|NCT03074162|364698229|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
105738360|NCT03074162|364698230|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
105940920|NCT03648372|365445097|FG002|Overall Study|Start of a New Systemic Treatment|0|||
105940921|NCT03648372|365445098|FG003|Overall Study|Start of a New Systemic Treatment|0|||
105940922|NCT03648372|365445099|FG004|Overall Study|Start of a New Systemic Treatment|0|||
105940923|NCT03648372|365445100|FG005|Overall Study|Start of a New Systemic Treatment|0|||
105940924|NCT03648372|365445101|FG006|Overall Study|Start of a New Systemic Treatment|0|||
105940925|NCT03648372|365445102|FG007|Overall Study|Start of a New Systemic Treatment|2|||
105940926|NCT03648372|365445103|FG008|Overall Study|Start of a New Systemic Treatment|0|||
105940927|NCT03648372|365445104|FG009|Overall Study|Start of a New Systemic Treatment|0|||
105940928|NCT03648372|365445105|FG010|Overall Study|Start of a New Systemic Treatment|1|||
105940929|NCT03648372|365445106|FG011|Overall Study|Start of a New Systemic Treatment|0|||
105940930|NCT03648372|365445107|FG012|Overall Study|Start of a New Systemic Treatment|0|||
105940931|NCT03648372|365445108|FG013|Overall Study|Start of a New Systemic Treatment|0|||
105940932|NCT03648372|365445109|FG014|Overall Study|Start of a New Systemic Treatment|0|||
105940933|NCT03648372|365445110|FG015|Overall Study|Start of a New Systemic Treatment|0|||
105738361|NCT03074162|364698231|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
105738362|NCT03074162|364698232|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
105738363|NCT03074162|364698227|FG000|Period 3|Withdrawal by Subject|1|||
105738364|NCT03074162|364698228|FG001|Period 3|Withdrawal by Subject|0|||
105738365|NCT03074162|364698229|FG002|Period 3|Withdrawal by Subject|0|||
105738366|NCT03074162|364698230|FG003|Period 3|Withdrawal by Subject|0|||
105940934|NCT03648372|365445111|FG016|Overall Study|Start of a New Systemic Treatment|0|||
105738367|NCT03074162|364698231|FG004|Period 3|Withdrawal by Subject|1|||
106012819|NCT02760498|365712938|FG000|Overall Study|Non-compliance with study drug|0|||
106012820|NCT02760498|365712939|FG001|Overall Study|Non-compliance with study drug|2|||
106012821|NCT02760498|365712940|FG002|Overall Study|Non-compliance with study drug|0|||
106012822|NCT02760498|365712941|FG003|Overall Study|Non-compliance with study drug|0|||
106012823|NCT02760498|365712942|FG004|Overall Study|Non-compliance with study drug|0|||
106012824|NCT02760498|365712943|FG005|Overall Study|Non-compliance with study drug|0|||
106012825|NCT02760498|365712938|FG000|Overall Study|Participant decision|1|||
106012826|NCT02760498|365712939|FG001|Overall Study|Participant decision|4|||
106012827|NCT02760498|365712940|FG002|Overall Study|Participant decision|2|||
106012828|NCT02760498|365712941|FG003|Overall Study|Participant decision|2|||
106012829|NCT02760498|365712942|FG004|Overall Study|Participant decision|1|||
106012830|NCT02760498|365712943|FG005|Overall Study|Participant decision|6|||
106012831|NCT02760498|365712938|FG000|Overall Study|Sponsor decision|0|||
106012832|NCT02760498|365712939|FG001|Overall Study|Sponsor decision|0|||
106012833|NCT02760498|365712940|FG002|Overall Study|Sponsor decision|0|||
106012834|NCT02760498|365712941|FG003|Overall Study|Sponsor decision|3|||
106012835|NCT02760498|365712942|FG004|Overall Study|Sponsor decision|0|||
106012836|NCT02760498|365712943|FG005|Overall Study|Sponsor decision|0|||
106012837|NCT02760498|365712938|FG000|Overall Study|Physician Decision|3|||
106012838|NCT02760498|365712939|FG001|Overall Study|Physician Decision|4|||
106012839|NCT02760498|365712940|FG002|Overall Study|Physician Decision|1|||
106012840|NCT02760498|365712941|FG003|Overall Study|Physician Decision|4|||
106012841|NCT02760498|365712942|FG004|Overall Study|Physician Decision|0|||
106012842|NCT02760498|365712943|FG005|Overall Study|Physician Decision|2|||
106012843|NCT02760498|365712938|FG000|Overall Study|Disease progression|21|||
106012844|NCT02760498|365712939|FG001|Overall Study|Disease progression|19|||
106012845|NCT02760498|365712940|FG002|Overall Study|Disease progression|20|||
106012846|NCT02760498|365712941|FG003|Overall Study|Disease progression|18|||
106012847|NCT02760498|365712942|FG004|Overall Study|Disease progression|4|||
106012848|NCT02760498|365712943|FG005|Overall Study|Disease progression|55|||
106012849|NCT02760498|365712938|FG000|Overall Study|Withdrawal by Subject|4|||
106012850|NCT02760498|365712939|FG001|Overall Study|Withdrawal by Subject|7|||
106012851|NCT02760498|365712940|FG002|Overall Study|Withdrawal by Subject|5|||
106012852|NCT02760498|365712941|FG003|Overall Study|Withdrawal by Subject|1|||
106012853|NCT02760498|365712942|FG004|Overall Study|Withdrawal by Subject|0|||
106012854|NCT02760498|365712943|FG005|Overall Study|Withdrawal by Subject|6|||
106012855|NCT02760498|365712938|FG000|Overall Study|Other than specified|1|||
106012856|NCT02760498|365712939|FG001|Overall Study|Other than specified|6|||
106012857|NCT02760498|365712940|FG002|Overall Study|Other than specified|0|||
106012858|NCT02760498|365712941|FG003|Overall Study|Other than specified|3|||
106012859|NCT02760498|365712942|FG004|Overall Study|Other than specified|1|||
106012860|NCT02760498|365712943|FG005|Overall Study|Other than specified|0|||
106012861|NCT02760498|365712938|FG000|Overall Study|Not treated|0|||
106012862|NCT02760498|365712939|FG001|Overall Study|Not treated|0|||
106012863|NCT02760498|365712940|FG002|Overall Study|Not treated|0|||
106012864|NCT02760498|365712941|FG003|Overall Study|Not treated|0|||
106012865|NCT02760498|365712942|FG004|Overall Study|Not treated|0|||
106012866|NCT02760498|365712943|FG005|Overall Study|Not treated|2|||
106012867|NCT02059278|365712944|FG000|Overall Study|Adverse Event|1|||
106012868|NCT02059278|365712945|FG001|Overall Study|Adverse Event|1|||
106012869|NCT02059278|365712944|FG000|Overall Study|Lost to Follow-up|1|||
106012870|NCT02059278|365712945|FG001|Overall Study|Lost to Follow-up|0|||
106012871|NCT02059278|365712944|FG000|Overall Study|Withdrawal by Subject|0|||
106012872|NCT02059278|365712945|FG001|Overall Study|Withdrawal by Subject|3|||
106012873|NCT02059278|365712944|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
106012874|NCT02059278|365712945|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
106012875|NCT04363320|365712946|FG000|Overall Study|Lost to Follow-up|43|||
106012876|NCT04363320|365712947|FG001|Overall Study|Lost to Follow-up|42|||
106012877|NCT04363320|365712948|FG002|Overall Study|Lost to Follow-up|24|||
106012878|NCT04363320|365712949|FG003|Overall Study|Lost to Follow-up|29|||
106012879|NCT04363320|365712946|FG000|Overall Study|Death|0|||
106012880|NCT04363320|365712947|FG001|Overall Study|Death|0|||
106012881|NCT04363320|365712948|FG002|Overall Study|Death|1|||
106012882|NCT04363320|365712949|FG003|Overall Study|Death|0|||
105738368|NCT03074162|364698232|FG005|Period 3|Withdrawal by Subject|0|||
105738369|NCT00950690|364698235|FG000|Overall Study|Death|4|||
105738370|NCT00950690|364698235|FG000|Overall Study|Adverse Event|15|||
105738371|NCT00950690|364698235|FG000|Overall Study|Lack of Efficacy|22|||
105738372|NCT00950690|364698235|FG000|Overall Study|Lost to Follow-up|40|||
106012883|NCT03435211|365712952|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
106012884|NCT01198977|365712953|FG000|Overall Study|Lost to Follow-up|1|||
106012885|NCT01198977|365712954|FG001|Overall Study|Lost to Follow-up|0|||
106012886|NCT03863080|365712955|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
106012887|NCT03863080|365712956|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
106012888|NCT03863080|365712957|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
106012889|NCT03863080|365712958|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
106012890|NCT03863080|365712955|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
106012891|NCT03863080|365712956|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
106012892|NCT03863080|365712957|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
106012893|NCT03863080|365712958|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
106012894|NCT03863080|365712955|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
106012895|NCT03863080|365712956|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
106012896|NCT03863080|365712957|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
106012897|NCT03863080|365712958|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
106012898|NCT01342211|365712959|FG000|Overall Study|Lost to Follow-up|0|||
106012899|NCT01342211|365712960|FG001|Overall Study|Lost to Follow-up|0|||
106012900|NCT01342211|365712961|FG002|Overall Study|Lost to Follow-up|0|||
106012901|NCT01342211|365712962|FG003|Overall Study|Lost to Follow-up|1|||
106012902|NCT01342211|365712963|FG004|Overall Study|Lost to Follow-up|0|||
106012903|NCT01342211|365712959|FG000|Overall Study|Adverse Event|0|||
106012904|NCT01342211|365712960|FG001|Overall Study|Adverse Event|0|||
106012905|NCT01342211|365712961|FG002|Overall Study|Adverse Event|0|||
106012906|NCT01342211|365712962|FG003|Overall Study|Adverse Event|0|||
106012907|NCT01342211|365712963|FG004|Overall Study|Adverse Event|1|||
106012908|NCT01342211|365712959|FG000|Overall Study|Withdrawal by Subject|0|||
106012909|NCT01342211|365712960|FG001|Overall Study|Withdrawal by Subject|0|||
106012910|NCT01342211|365712961|FG002|Overall Study|Withdrawal by Subject|0|||
106012911|NCT01342211|365712962|FG003|Overall Study|Withdrawal by Subject|1|||
106012912|NCT01342211|365712963|FG004|Overall Study|Withdrawal by Subject|0|||
106012913|NCT01342211|365712959|FG000|Overall Study|Randomized, but not Treated|0|||
106012914|NCT01342211|365712960|FG001|Overall Study|Randomized, but not Treated|2|||
106012915|NCT01342211|365712961|FG002|Overall Study|Randomized, but not Treated|0|||
106012916|NCT01342211|365712962|FG003|Overall Study|Randomized, but not Treated|0|||
106012917|NCT01342211|365712963|FG004|Overall Study|Randomized, but not Treated|1|||
106012918|NCT05660577|365714656|FG000|Overall Study|Discontinued|9|||
106012919|NCT01744977|365714657|FG000|Overall Study|Withdrawal by Subject|1|||
106012920|NCT01744977|365714658|FG001|Overall Study|Withdrawal by Subject|2|||
106012921|NCT01744977|365714657|FG000|Overall Study|Death|2|||
106012922|NCT01744977|365714658|FG001|Overall Study|Death|3|||
105940935|NCT03648372|365445112|FG017|Overall Study|Start of a New Systemic Treatment|0|||
105940936|NCT03648372|365445113|FG018|Overall Study|Start of a New Systemic Treatment|0|||
105940937|NCT03648372|365445114|FG019|Overall Study|Start of a New Systemic Treatment|0|||
105940938|NCT03648372|365445115|FG020|Overall Study|Start of a New Systemic Treatment|0|||
105940939|NCT04191135|365445116|FG000|Induction Treatment|Not Treated|2|||
105940940|NCT04191135|365445117|FG001|Induction Treatment|Not Treated|0|||
105940941|NCT04191135|365445118|FG002|Induction Treatment|Not Treated|0|||
105940942|NCT04191135|365445116|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
105940943|NCT04191135|365445117|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
105940944|NCT04191135|365445118|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
105940945|NCT04191135|365445116|FG000|Induction Treatment|Adverse Event|25|||
105940946|NCT04191135|365445117|FG001|Induction Treatment|Adverse Event|0|||
105940947|NCT04191135|365445118|FG002|Induction Treatment|Adverse Event|0|||
105940948|NCT04191135|365445116|FG000|Induction Treatment|Clinical Progression|8|||
105940949|NCT04191135|365445117|FG001|Induction Treatment|Clinical Progression|0|||
105940950|NCT04191135|365445118|FG002|Induction Treatment|Clinical Progression|0|||
105940951|NCT04191135|365445116|FG000|Induction Treatment|Excluded Medication|1|||
105940952|NCT04191135|365445117|FG001|Induction Treatment|Excluded Medication|0|||
105940953|NCT04191135|365445118|FG002|Induction Treatment|Excluded Medication|0|||
105940954|NCT04191135|365445116|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
105940955|NCT04191135|365445117|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
105940956|NCT04191135|365445118|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
105940957|NCT04191135|365445116|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
105940958|NCT04191135|365445117|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
105940959|NCT04191135|365445118|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
105940960|NCT04191135|365445116|FG000|Induction Treatment|Physician Decision|2|||
105940961|NCT04191135|365445117|FG001|Induction Treatment|Physician Decision|0|||
105940962|NCT04191135|365445118|FG002|Induction Treatment|Physician Decision|0|||
106012923|NCT01744977|365714657|FG000|Overall Study|Lost to Follow-up|2|||
106012924|NCT01744977|365714658|FG001|Overall Study|Lost to Follow-up|0|||
106012925|NCT01744977|365714657|FG000|Overall Study|No longer meets inclusion|6|||
106012926|NCT01744977|365714658|FG001|Overall Study|No longer meets inclusion|0|||
106012927|NCT02156076|365714659|FG000|Treatment Period|no longer meets study criteria|0|||
105940963|NCT04191135|365445116|FG000|Induction Treatment|Progressive Disease|135|||
105940964|NCT04191135|365445117|FG001|Induction Treatment|Progressive Disease|0|||
105940965|NCT04191135|365445118|FG002|Induction Treatment|Progressive Disease|0|||
105940966|NCT04191135|365445116|FG000|Induction Treatment|Protocol Violation|10|||
105940967|NCT04191135|365445117|FG001|Induction Treatment|Protocol Violation|0|||
105940968|NCT04191135|365445118|FG002|Induction Treatment|Protocol Violation|0|||
106012928|NCT02156076|365714660|FG001|Treatment Period|no longer meets study criteria|0|||
106141542|NCT00940992|366176014|FG000|Overall Study|Adverse Event|2|||
105940969|NCT04191135|365445116|FG000|Induction Treatment|Withdrawal by Subject|4|||
106012929|NCT02156076|365714661|FG002|Treatment Period|no longer meets study criteria|1|||
106012930|NCT02156076|365714662|FG003|Treatment Period|no longer meets study criteria|0|||
106012931|NCT02156076|365714659|FG000|Treatment Period|Poor/non-compliance|0|||
106012932|NCT02156076|365714660|FG001|Treatment Period|Poor/non-compliance|1|||
106012933|NCT02156076|365714661|FG002|Treatment Period|Poor/non-compliance|0|||
106012934|NCT02156076|365714662|FG003|Treatment Period|Poor/non-compliance|0|||
106012935|NCT02156076|365714659|FG000|Treatment Period|Lost to Follow-up|0|||
106012936|NCT02156076|365714660|FG001|Treatment Period|Lost to Follow-up|0|||
106012937|NCT02156076|365714661|FG002|Treatment Period|Lost to Follow-up|0|||
106012938|NCT02156076|365714662|FG003|Treatment Period|Lost to Follow-up|1|||
106012939|NCT02156076|365714659|FG000|Treatment Period|Withdrawal by Subject|0|||
106012940|NCT02156076|365714660|FG001|Treatment Period|Withdrawal by Subject|0|||
106012941|NCT02156076|365714661|FG002|Treatment Period|Withdrawal by Subject|1|||
106012942|NCT02156076|365714662|FG003|Treatment Period|Withdrawal by Subject|0|||
106012943|NCT02156076|365714659|FG000|Treatment Period|Subject request to discontinue treatment|0|||
106012944|NCT02156076|365714660|FG001|Treatment Period|Subject request to discontinue treatment|1|||
106012945|NCT02156076|365714661|FG002|Treatment Period|Subject request to discontinue treatment|0|||
106012946|NCT02156076|365714662|FG003|Treatment Period|Subject request to discontinue treatment|0|||
106012947|NCT02156076|365714659|FG000|Treatment Period|Adverse Event|0|||
106012948|NCT02156076|365714660|FG001|Treatment Period|Adverse Event|0|||
106012949|NCT02156076|365714661|FG002|Treatment Period|Adverse Event|0|||
106012950|NCT02156076|365714662|FG003|Treatment Period|Adverse Event|1|||
106012951|NCT02156076|365714659|FG000|Follow-up Period|Withdrawal by Subject|1|||
106012952|NCT02156076|365714660|FG001|Follow-up Period|Withdrawal by Subject|0|||
106012953|NCT02156076|365714661|FG002|Follow-up Period|Withdrawal by Subject|0|||
106012954|NCT02156076|365714662|FG003|Follow-up Period|Withdrawal by Subject|0|||
106012955|NCT00927953|365714665|FG000|Overall Study|Death|2|||
106012956|NCT00927953|365714666|FG001|Overall Study|Death|1|||
106012957|NCT02976038|365714667|FG000|Overall Study|Physician Decision|22|||
106012958|NCT02976038|365714667|FG000|Overall Study|Withdrawal by Subject|3|||
106012959|NCT02976038|365714667|FG000|Overall Study|Lost to Follow-up|2|||
106012960|NCT02976038|365714667|FG000|Overall Study|Adverse Event|1|||
106012961|NCT00346697|365714669|FG000|Overall Study|Lost to Follow-up|0|||
106012962|NCT00346697|365714670|FG001|Overall Study|Lost to Follow-up|1|||
106012963|NCT01867671|365714671|FG000|Overall Study|Adverse Event|5|||
106012964|NCT01867671|365714672|FG001|Overall Study|Adverse Event|3|||
106012965|NCT01867671|365714671|FG000|Overall Study|Anaphylaxis|0|||
106012966|NCT01867671|365714672|FG001|Overall Study|Anaphylaxis|1|||
106012967|NCT01867671|365714671|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
106012968|NCT01867671|365714672|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
106012969|NCT01867671|365714671|FG000|Overall Study|Lost to Follow-up|0|||
106012970|NCT01867671|365714672|FG001|Overall Study|Lost to Follow-up|1|||
106012971|NCT01867671|365714671|FG000|Overall Study|Non-compliance with Study Drug|1|||
106012972|NCT01867671|365714672|FG001|Overall Study|Non-compliance with Study Drug|2|||
106012973|NCT01867671|365714671|FG000|Overall Study|Withdrawal by Subject|21|||
106012974|NCT01867671|365714672|FG001|Overall Study|Withdrawal by Subject|21|||
106012975|NCT02420821|365714673|FG000|Overall Study|Lost to Follow-up|6|||
106012976|NCT02420821|365714674|FG001|Overall Study|Lost to Follow-up|6|||
106012977|NCT02420821|365714673|FG000|Overall Study|Non-compliance|0|||
106012978|NCT02420821|365714674|FG001|Overall Study|Non-compliance|2|||
106012979|NCT02420821|365714673|FG000|Overall Study|Physician Decision|6|||
106012980|NCT02420821|365714674|FG001|Overall Study|Physician Decision|2|||
106012981|NCT02420821|365714673|FG000|Overall Study|Withdrawal by Subject|32|||
106012982|NCT02420821|365714674|FG001|Overall Study|Withdrawal by Subject|25|||
106012983|NCT02420821|365714673|FG000|Overall Study|Death|270|||
106012984|NCT02420821|365714674|FG001|Overall Study|Death|263|||
106012985|NCT02420821|365714673|FG000|Overall Study|Study Terminated By Sponsor|145|||
106012986|NCT02420821|365714674|FG001|Overall Study|Study Terminated By Sponsor|149|||
106012987|NCT02420821|365714673|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
106012988|NCT02420821|365714674|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
105738373|NCT00950690|364698235|FG000|Overall Study|Other|163|||
106012989|NCT02420821|365714673|FG000|Overall Study|Adverse Event|0|||
106012990|NCT02420821|365714674|FG001|Overall Study|Adverse Event|1|||
105738374|NCT01713036|364698240|FG000|Overall Study|Death|1|||
106012991|NCT02420821|365714673|FG000|Overall Study|Protinuria|0|||
106012992|NCT02420821|365714674|FG001|Overall Study|Protinuria|1|||
106012993|NCT02420821|365714673|FG000|Overall Study|Progressive Disease|1|||
105738375|NCT00592358|364698241|FG000|Overall Study|Withdrawal by Subject|2|||
106012994|NCT02420821|365714674|FG001|Overall Study|Progressive Disease|1|||
106012995|NCT02420821|365714673|FG000|Overall Study|Disease Progression|0|||
106012996|NCT02420821|365714674|FG001|Overall Study|Disease Progression|1|||
106012997|NCT02420821|365714673|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
105738376|NCT00592358|364698241|FG000|Overall Study|Adverse Event|1|||
106012998|NCT02420821|365714674|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
106012999|NCT01409707|365714675|FG000|Overall Study|Withdrawal by Subject|5|||
105738377|NCT00592358|364698241|FG000|Overall Study|Lack of Efficacy|2|||
105738378|NCT00592358|364698241|FG000|Overall Study|Inability to swallow pills|1|||
105738379|NCT02778867|364698242|FG000|Phase 1|Withdrawal by Subject|2|||
105738380|NCT02778867|364698243|FG001|Phase 1|Withdrawal by Subject|3|||
105738381|NCT02778867|364698244|FG002|Phase 1|Withdrawal by Subject|0|||
105738382|NCT02778867|364698245|FG003|Phase 1|Withdrawal by Subject|0|||
105738383|NCT02778867|364698242|FG000|Phase 2|Withdrawal by Subject|0|||
105738384|NCT02778867|364698243|FG001|Phase 2|Withdrawal by Subject|0|||
105738385|NCT02778867|364698244|FG002|Phase 2|Withdrawal by Subject|1|||
105738386|NCT02778867|364698245|FG003|Phase 2|Withdrawal by Subject|0|||
105738387|NCT02778867|364698242|FG000|Phase 2|Physician Decision|0|||
105738388|NCT02778867|364698243|FG001|Phase 2|Physician Decision|0|||
105738389|NCT02778867|364698244|FG002|Phase 2|Physician Decision|0|||
105738390|NCT02778867|364698245|FG003|Phase 2|Physician Decision|1|||
105738391|NCT02778867|364698242|FG000|Phase 2|Adverse Event|0|||
105738392|NCT02778867|364698243|FG001|Phase 2|Adverse Event|0|||
105738393|NCT02778867|364698244|FG002|Phase 2|Adverse Event|0|||
105738394|NCT02778867|364698245|FG003|Phase 2|Adverse Event|1|||
105738395|NCT00084682|364698246|FG000|Overall Study|Withdrawal by Subject|1|||
105738396|NCT01166659|364698247|FG000|Overall Study|Subject Decision|8|||
105738397|NCT01166659|364698247|FG000|Overall Study|Investigator Decision|2|||
105738398|NCT01166659|364698247|FG000|Overall Study|Death|1|||
105738399|NCT01166659|364698247|FG000|Overall Study|Lost to Follow-up|1|||
105738400|NCT01166659|364698247|FG000|Overall Study|Study Closed at Site|1|||
105738401|NCT04760314|364698248|FG000|Induction Period|Withdrawal by Subject|0|||
105738402|NCT04760314|364698249|FG001|Induction Period|Withdrawal by Subject|1|||
105738403|NCT04760314|364698250|FG002|Induction Period|Withdrawal by Subject|1|||
105738404|NCT04760314|364698251|FG003|Induction Period|Withdrawal by Subject|0|||
105738405|NCT04760314|364698252|FG004|Induction Period|Withdrawal by Subject|0|||
105738406|NCT04760314|364698253|FG005|Induction Period|Withdrawal by Subject|0|||
105738407|NCT04760314|364698254|FG006|Induction Period|Withdrawal by Subject|0|||
105738408|NCT04760314|364698255|FG007|Induction Period|Withdrawal by Subject|0|||
105738409|NCT04760314|364698256|FG008|Induction Period|Withdrawal by Subject|0|||
105738410|NCT04760314|364698257|FG009|Induction Period|Withdrawal by Subject|0|||
105738411|NCT04760314|364698258|FG010|Induction Period|Withdrawal by Subject|0|||
105738412|NCT04760314|364698248|FG000|Induction Period|Adverse Event|0|||
105738413|NCT04760314|364698249|FG001|Induction Period|Adverse Event|0|||
105738414|NCT04760314|364698250|FG002|Induction Period|Adverse Event|2|||
105738415|NCT04760314|364698251|FG003|Induction Period|Adverse Event|0|||
105738416|NCT04760314|364698252|FG004|Induction Period|Adverse Event|0|||
105738417|NCT04760314|364698253|FG005|Induction Period|Adverse Event|0|||
105738418|NCT04760314|364698254|FG006|Induction Period|Adverse Event|0|||
105738419|NCT04760314|364698255|FG007|Induction Period|Adverse Event|0|||
105738420|NCT04760314|364698256|FG008|Induction Period|Adverse Event|0|||
105738421|NCT04760314|364698257|FG009|Induction Period|Adverse Event|0|||
105738422|NCT04760314|364698258|FG010|Induction Period|Adverse Event|0|||
105738423|NCT04760314|364698248|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738424|NCT04760314|364698249|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738425|NCT04760314|364698250|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738426|NCT04760314|364698251|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
105738427|NCT04760314|364698252|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
105738428|NCT04760314|364698253|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
105738429|NCT04760314|364698254|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
105738430|NCT04760314|364698255|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738431|NCT04760314|364698256|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
105799759|NCT04380701|364924627|FG013|Overall Study|Death|0|||
105799760|NCT04380701|364924628|FG014|Overall Study|Death|0|||
105940970|NCT04191135|365445117|FG001|Induction Treatment|Withdrawal by Subject|0|||
105940971|NCT04191135|365445118|FG002|Induction Treatment|Withdrawal by Subject|0|||
105940972|NCT04191135|365445116|FG000|Randomized Treatment|Death|0|||
105940973|NCT04191135|365445117|FG001|Randomized Treatment|Death|50|||
105940974|NCT04191135|365445118|FG002|Randomized Treatment|Death|54|||
105738432|NCT04760314|364698257|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738433|NCT04760314|364698258|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
105738434|NCT04760314|364698248|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738435|NCT04760314|364698249|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738436|NCT04760314|364698250|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105799761|NCT04380701|364924629|FG015|Overall Study|Death|0|||
105940975|NCT04191135|365445116|FG000|Randomized Treatment|Lost to Follow-up|0|||
105738437|NCT04760314|364698251|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
105738438|NCT04760314|364698252|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738439|NCT04760314|364698253|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
105738440|NCT04760314|364698254|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
105738441|NCT04760314|364698255|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738442|NCT04760314|364698256|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738443|NCT04760314|364698257|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
105738444|NCT04760314|364698258|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
106013000|NCT01409707|365714676|FG001|Overall Study|Withdrawal by Subject|17|||
106013001|NCT01409707|365714677|FG002|Overall Study|Withdrawal by Subject|16|||
106013002|NCT01294553|365714679|FG000|Overall Study|Duplicated Participants|1|||
106013003|NCT01294553|365714679|FG000|Overall Study|Protocol Violation|268|||
106013004|NCT03058146|365714680|FG000|Overall Study|Withdrawal by Subject|4|||
106013005|NCT03058146|365714681|FG001|Overall Study|Withdrawal by Subject|1|||
106013006|NCT03058146|365714680|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
106013007|NCT03058146|365714681|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
106013008|NCT04322526|365714683|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
106013009|NCT04322526|365714684|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
106013010|NCT04322526|365714683|FG000|Washout (1 Week)|Lost to Follow-up|1|||
105738445|NCT04760314|364698248|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738446|NCT04760314|364698249|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738447|NCT04760314|364698250|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738448|NCT04760314|364698251|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738449|NCT04760314|364698252|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
105738450|NCT04760314|364698253|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738451|NCT04760314|364698254|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738452|NCT04760314|364698255|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738453|NCT04760314|364698256|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738454|NCT04760314|364698257|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738455|NCT04760314|364698258|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
105738456|NCT04760314|364698248|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
105738457|NCT04760314|364698249|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
105738458|NCT04760314|364698250|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
105738459|NCT04760314|364698251|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
105738460|NCT04760314|364698252|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
105738461|NCT04760314|364698253|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
105738462|NCT04760314|364698254|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
105738463|NCT04760314|364698255|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
105738464|NCT04760314|364698256|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
105738465|NCT04760314|364698257|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
105738466|NCT04760314|364698258|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
105738467|NCT04760314|364698248|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738468|NCT04760314|364698249|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738469|NCT04760314|364698250|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738470|NCT04760314|364698251|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738471|NCT04760314|364698252|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738472|NCT04760314|364698253|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738473|NCT04760314|364698254|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738474|NCT04760314|364698255|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
105738475|NCT04760314|364698256|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105738476|NCT04760314|364698257|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
105738477|NCT04760314|364698258|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
106013011|NCT04322526|365714684|FG001|Washout (1 Week)|Lost to Follow-up|2|||
106013012|NCT03486834|365714686|FG000|Overall Study|Withdrawal by Subject|46|||
106013013|NCT03486834|365714687|FG001|Overall Study|Withdrawal by Subject|46|||
106013014|NCT03486834|365714688|FG002|Overall Study|Withdrawal by Subject|52|||
105738478|NCT04760314|364698248|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738479|NCT04760314|364698249|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738480|NCT04760314|364698250|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738481|NCT04760314|364698251|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738482|NCT04760314|364698252|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738483|NCT04760314|364698253|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738484|NCT04760314|364698254|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738485|NCT04760314|364698255|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
105738486|NCT04760314|364698256|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
105738487|NCT04760314|364698257|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
105738488|NCT04760314|364698258|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105738489|NCT04760314|364698248|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
106013015|NCT03486834|365714686|FG000|Overall Study|Adverse Event|8|||
105738490|NCT04760314|364698249|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105799762|NCT04380701|364924630|FG016|Overall Study|Death|0|||
105799763|NCT04380701|364924631|FG017|Overall Study|Death|0|||
106013016|NCT03486834|365714687|FG001|Overall Study|Adverse Event|7|||
106013017|NCT03486834|365714688|FG002|Overall Study|Adverse Event|0|||
106013018|NCT03486834|365714686|FG000|Overall Study|Lost to Follow-up|41|||
106013019|NCT03486834|365714687|FG001|Overall Study|Lost to Follow-up|24|||
106013020|NCT03486834|365714688|FG002|Overall Study|Lost to Follow-up|39|||
106013021|NCT03486834|365714686|FG000|Overall Study|Non-compliance with Study Drug|2|||
106013022|NCT03486834|365714687|FG001|Overall Study|Non-compliance with Study Drug|2|||
106013023|NCT03486834|365714688|FG002|Overall Study|Non-compliance with Study Drug|0|||
106013024|NCT03486834|365714686|FG000|Overall Study|Physician Decision|5|||
106013025|NCT03486834|365714687|FG001|Overall Study|Physician Decision|2|||
106013026|NCT03486834|365714688|FG002|Overall Study|Physician Decision|3|||
106013027|NCT03486834|365714686|FG000|Overall Study|Pregnancy|10|||
106013028|NCT03486834|365714687|FG001|Overall Study|Pregnancy|12|||
106013029|NCT03486834|365714688|FG002|Overall Study|Pregnancy|12|||
106013030|NCT03486834|365714686|FG000|Overall Study|Protocol Deviation|2|||
106013031|NCT03486834|365714687|FG001|Overall Study|Protocol Deviation|3|||
106013032|NCT03486834|365714688|FG002|Overall Study|Protocol Deviation|3|||
106013033|NCT03486834|365714686|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
106013034|NCT03486834|365714687|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
106013035|NCT03486834|365714688|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
106013036|NCT03486834|365714686|FG000|Overall Study|Randomized but not treated|4|||
106013037|NCT03486834|365714687|FG001|Overall Study|Randomized but not treated|4|||
106013038|NCT03486834|365714688|FG002|Overall Study|Randomized but not treated|1|||
106013039|NCT04476797|365714689|FG000|Overall Study|Withdrawal by Subject|1|||
106013040|NCT04476797|365714690|FG001|Overall Study|Withdrawal by Subject|0|||
106013041|NCT04476797|365714691|FG002|Overall Study|Withdrawal by Subject|0|||
106013042|NCT04476797|365714689|FG000|Overall Study|Death|0|||
106013043|NCT04476797|365714690|FG001|Overall Study|Death|1|||
106013044|NCT04476797|365714691|FG002|Overall Study|Death|2|||
106013045|NCT04476797|365714689|FG000|Overall Study|Sponsor Terminated Study|0|||
106013046|NCT04476797|365714690|FG001|Overall Study|Sponsor Terminated Study|18|||
106013047|NCT04476797|365714691|FG002|Overall Study|Sponsor Terminated Study|17|||
106013048|NCT01716234|365714694|FG000|Overall Study|Protocol Violation|0|||
106013049|NCT01716234|365714695|FG001|Overall Study|Protocol Violation|0|||
106013050|NCT01716234|365714696|FG002|Overall Study|Protocol Violation|0|||
106013051|NCT01716234|365714697|FG003|Overall Study|Protocol Violation|1|||
106013052|NCT01716234|365714698|FG004|Overall Study|Protocol Violation|1|||
106013053|NCT01716234|365714699|FG005|Overall Study|Protocol Violation|1|||
106013054|NCT01716234|365714700|FG006|Overall Study|Protocol Violation|0|||
106013055|NCT01716234|365714694|FG000|Overall Study|Lack of Efficacy|0|||
106013056|NCT01716234|365714695|FG001|Overall Study|Lack of Efficacy|0|||
106013057|NCT01716234|365714696|FG002|Overall Study|Lack of Efficacy|0|||
106013058|NCT01716234|365714697|FG003|Overall Study|Lack of Efficacy|1|||
106013059|NCT01716234|365714698|FG004|Overall Study|Lack of Efficacy|0|||
106013060|NCT01716234|365714699|FG005|Overall Study|Lack of Efficacy|0|||
106013061|NCT01716234|365714700|FG006|Overall Study|Lack of Efficacy|0|||
106013062|NCT01716234|365714694|FG000|Overall Study|Did not meet protocol eligibility|0|||
106013063|NCT01716234|365714695|FG001|Overall Study|Did not meet protocol eligibility|0|||
106013064|NCT01716234|365714696|FG002|Overall Study|Did not meet protocol eligibility|1|||
106013065|NCT01716234|365714697|FG003|Overall Study|Did not meet protocol eligibility|0|||
106013066|NCT01716234|365714698|FG004|Overall Study|Did not meet protocol eligibility|0|||
106013067|NCT01716234|365714699|FG005|Overall Study|Did not meet protocol eligibility|4|||
106013068|NCT01716234|365714700|FG006|Overall Study|Did not meet protocol eligibility|0|||
106013069|NCT01716234|365714694|FG000|Overall Study|Adverse Event|7|||
106013070|NCT01716234|365714695|FG001|Overall Study|Adverse Event|10|||
106013071|NCT01716234|365714696|FG002|Overall Study|Adverse Event|2|||
106013072|NCT01716234|365714697|FG003|Overall Study|Adverse Event|8|||
106013073|NCT01716234|365714698|FG004|Overall Study|Adverse Event|3|||
106013074|NCT01716234|365714699|FG005|Overall Study|Adverse Event|6|||
106013075|NCT01716234|365714700|FG006|Overall Study|Adverse Event|0|||
106013076|NCT01716234|365714694|FG000|Overall Study|Withdrawal by Subject|3|||
106013077|NCT01716234|365714695|FG001|Overall Study|Withdrawal by Subject|0|||
106013078|NCT01716234|365714696|FG002|Overall Study|Withdrawal by Subject|2|||
106013079|NCT01716234|365714697|FG003|Overall Study|Withdrawal by Subject|2|||
106141543|NCT00940992|366176015|FG001|Overall Study|Adverse Event|0|||
106141544|NCT00940992|366176016|FG002|Overall Study|Adverse Event|1|||
106141545|NCT00940992|366176014|FG000|Overall Study|subject request|2|||
106141546|NCT00940992|366176015|FG001|Overall Study|subject request|1|||
106013080|NCT01716234|365714698|FG004|Overall Study|Withdrawal by Subject|1|||
106013081|NCT01716234|365714699|FG005|Overall Study|Withdrawal by Subject|3|||
106013082|NCT01716234|365714700|FG006|Overall Study|Withdrawal by Subject|0|||
106013083|NCT03815929|365714704|FG000|Overall Study|Lost to Follow-up|2|||
106013084|NCT03815929|365714705|FG001|Overall Study|Lost to Follow-up|1|||
106013085|NCT03815929|365714706|FG002|Overall Study|Lost to Follow-up|0|||
106141547|NCT00940992|366176016|FG002|Overall Study|subject request|0|||
106141548|NCT00940992|366176014|FG000|Overall Study|Lost to Follow-up|0|||
106141549|NCT00940992|366176015|FG001|Overall Study|Lost to Follow-up|1|||
106013086|NCT03815929|365714704|FG000|Overall Study|Physician Decision|2|||
106013087|NCT03815929|365714705|FG001|Overall Study|Physician Decision|2|||
106013088|NCT03815929|365714706|FG002|Overall Study|Physician Decision|0|||
106013089|NCT03815929|365714704|FG000|Overall Study|Withdrawal by Subject|0|||
106013090|NCT03815929|365714705|FG001|Overall Study|Withdrawal by Subject|0|||
106141550|NCT00940992|366176016|FG002|Overall Study|Lost to Follow-up|1|||
106013091|NCT03815929|365714706|FG002|Overall Study|Withdrawal by Subject|1|||
106013092|NCT02205736|365714707|FG000|Overall Study|Lost to Follow-up|106|||
106013093|NCT01467960|365714708|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
106013094|NCT01467960|365714709|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
106013095|NCT01467960|365714710|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
106013096|NCT01467960|365714711|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
106013097|NCT01467960|365714712|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
106013098|NCT01467960|365714713|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
106013099|NCT03326713|365714714|FG000|Overall Study|Death|2|||
106013100|NCT03326713|365714715|FG001|Overall Study|Death|1|||
106013101|NCT03326713|365714716|FG002|Overall Study|Death|0|||
106013102|NCT03326713|365714714|FG000|Overall Study|Lost to Follow-up|20|||
106013103|NCT03326713|365714715|FG001|Overall Study|Lost to Follow-up|21|||
106013104|NCT03326713|365714716|FG002|Overall Study|Lost to Follow-up|33|||
106013105|NCT03326713|365714714|FG000|Overall Study|Withdrawal by Subject|1|||
106013106|NCT03326713|365714715|FG001|Overall Study|Withdrawal by Subject|2|||
106013107|NCT03326713|365714716|FG002|Overall Study|Withdrawal by Subject|11|||
106013108|NCT03326713|365714714|FG000|Overall Study|Found Ineligible|11|||
106013109|NCT03326713|365714715|FG001|Overall Study|Found Ineligible|11|||
106013110|NCT03326713|365714716|FG002|Overall Study|Found Ineligible|8|||
106013111|NCT00687193|365714719|FG000|Overall Study|Adverse Event|0|||
106013112|NCT00687193|365714720|FG001|Overall Study|Adverse Event|1|||
106013113|NCT00687193|365714721|FG002|Overall Study|Adverse Event|2|||
106013114|NCT00687193|365714722|FG003|Overall Study|Adverse Event|3|||
106013115|NCT00687193|365714723|FG004|Overall Study|Adverse Event|0|||
106013116|NCT00687193|365714724|FG005|Overall Study|Adverse Event|2|||
106013117|NCT00687193|365714719|FG000|Overall Study|Lack of Efficacy|1|||
106013118|NCT00687193|365714720|FG001|Overall Study|Lack of Efficacy|1|||
106013119|NCT00687193|365714721|FG002|Overall Study|Lack of Efficacy|0|||
106013120|NCT00687193|365714722|FG003|Overall Study|Lack of Efficacy|0|||
106013121|NCT00687193|365714723|FG004|Overall Study|Lack of Efficacy|0|||
106013122|NCT00687193|365714724|FG005|Overall Study|Lack of Efficacy|2|||
106013123|NCT00687193|365714719|FG000|Overall Study|Protocol Violation|1|||
106013124|NCT00687193|365714720|FG001|Overall Study|Protocol Violation|2|||
106013125|NCT00687193|365714721|FG002|Overall Study|Protocol Violation|0|||
106013126|NCT00687193|365714722|FG003|Overall Study|Protocol Violation|1|||
106013127|NCT00687193|365714723|FG004|Overall Study|Protocol Violation|2|||
106013128|NCT00687193|365714724|FG005|Overall Study|Protocol Violation|0|||
106013129|NCT00737672|365714731|FG000|Overall Study|Graft Abandonment|48|||
106013130|NCT00737672|365714732|FG001|Overall Study|Graft Abandonment|56|||
106013131|NCT00737672|365714731|FG000|Overall Study|Death|23|||
106013132|NCT00737672|365714732|FG001|Overall Study|Death|22|||
106013133|NCT00737672|365714731|FG000|Overall Study|Withdrawal by Subject|1|||
106013134|NCT00737672|365714732|FG001|Overall Study|Withdrawal by Subject|2|||
106013135|NCT00737672|365714731|FG000|Overall Study|Lost to Follow-up|1|||
106013136|NCT00737672|365714732|FG001|Overall Study|Lost to Follow-up|0|||
106013137|NCT00737672|365714731|FG000|Overall Study|Miscellaneous|7|||
106013138|NCT00737672|365714732|FG001|Overall Study|Miscellaneous|1|||
106013139|NCT00737672|365714731|FG000|Overall Study|Physician Decision|0|||
106013140|NCT00737672|365714732|FG001|Overall Study|Physician Decision|2|||
106013141|NCT01394016|365714734|FG000|Overall Study|Progressive Disease|2|||
106013142|NCT01394016|365714735|FG001|Overall Study|Progressive Disease|0|||
106013143|NCT01394016|365714736|FG002|Overall Study|Progressive Disease|0|||
106013144|NCT01394016|365714737|FG003|Overall Study|Progressive Disease|0|||
106013145|NCT01394016|365714738|FG004|Overall Study|Progressive Disease|0|||
106013146|NCT01394016|365714739|FG005|Overall Study|Progressive Disease|0|||
106013147|NCT01394016|365714740|FG006|Overall Study|Progressive Disease|0|||
106013148|NCT01394016|365714741|FG007|Overall Study|Progressive Disease|0|||
106013149|NCT01394016|365714742|FG008|Overall Study|Progressive Disease|0|||
105738491|NCT04760314|364698250|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738492|NCT04760314|364698251|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738493|NCT04760314|364698252|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738494|NCT04760314|364698253|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738495|NCT04760314|364698254|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738496|NCT04760314|364698255|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
106013150|NCT01394016|365714743|FG009|Overall Study|Progressive Disease|0|||
106013151|NCT01394016|365714744|FG010|Overall Study|Progressive Disease|0|||
106013152|NCT01394016|365714745|FG011|Overall Study|Progressive Disease|0|||
106013153|NCT01394016|365714746|FG012|Overall Study|Progressive Disease|0|||
106013154|NCT01394016|365714747|FG013|Overall Study|Progressive Disease|0|||
106013155|NCT01394016|365714748|FG014|Overall Study|Progressive Disease|0|||
106013156|NCT01394016|365714749|FG015|Overall Study|Progressive Disease|0|||
106013157|NCT01394016|365714750|FG016|Overall Study|Progressive Disease|0|||
106013158|NCT01394016|365714751|FG017|Overall Study|Progressive Disease|0|||
106013159|NCT01394016|365714752|FG018|Overall Study|Progressive Disease|0|||
106013160|NCT01394016|365714734|FG000|Overall Study|Withdrawal by Subject|0|||
106013161|NCT01394016|365714735|FG001|Overall Study|Withdrawal by Subject|0|||
106013162|NCT01394016|365714736|FG002|Overall Study|Withdrawal by Subject|0|||
106141551|NCT02517307|366176017|FG000|Overall Study|Withdrawal by Subject|1|||
106141552|NCT02517307|366176018|FG001|Overall Study|Withdrawal by Subject|0|||
106141553|NCT02517307|366176019|FG002|Overall Study|Withdrawal by Subject|1|||
106141554|NCT02517307|366176020|FG003|Overall Study|Withdrawal by Subject|0|||
106141555|NCT02517307|366176017|FG000|Overall Study|Protocol Violation|0|||
105738497|NCT04760314|364698256|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738498|NCT04760314|364698257|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738499|NCT04760314|364698258|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105738500|NCT04760314|364698248|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738501|NCT04760314|364698249|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738502|NCT04760314|364698250|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738503|NCT04760314|364698251|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738504|NCT04760314|364698252|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738505|NCT04760314|364698253|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738506|NCT04760314|364698254|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738507|NCT04760314|364698255|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738508|NCT04760314|364698256|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
105738509|NCT04760314|364698257|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
105738510|NCT04760314|364698258|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
105738511|NCT03504774|364698265|FG000|Overall Study|Adverse Event|2|||
105738512|NCT03504774|364698266|FG001|Overall Study|Adverse Event|0|||
105738513|NCT03504774|364698265|FG000|Overall Study|Lost to Follow-up|0|||
105738514|NCT03504774|364698266|FG001|Overall Study|Lost to Follow-up|1|||
105738515|NCT03504774|364698265|FG000|Overall Study|Protocol Violation|11|||
105738516|NCT03504774|364698266|FG001|Overall Study|Protocol Violation|3|||
105738517|NCT03504774|364698265|FG000|Overall Study|failed wk 52 DBPCFC|1|||
105738518|NCT03504774|364698266|FG001|Overall Study|failed wk 52 DBPCFC|0|||
105738519|NCT03238248|364698268|FG000|Overall Study|Death|5|||
105738520|NCT03238248|364698268|FG000|Overall Study|Withdrawal by Subject|7|||
105738521|NCT03238248|364698268|FG000|Overall Study|Participant proceeding to transplant|10|||
105738522|NCT03238248|364698268|FG000|Overall Study|Lack of Efficacy|4|||
105738523|NCT03238248|364698268|FG000|Overall Study|Physician Decision|3|||
105738524|NCT03238248|364698268|FG000|Overall Study|Transitioning to another study|1|||
105738525|NCT03238248|364698268|FG000|Overall Study|No longer benefiting|1|||
105738526|NCT03238248|364698268|FG000|Overall Study|Other complicating disease|1|||
105738527|NCT03238248|364698268|FG000|Overall Study|Adverse Event|5|||
105738528|NCT03238248|364698268|FG000|Overall Study|Disease progression|26|||
105738529|NCT03238248|364698268|FG000|Overall Study|N/A participant is still on treatment|1|||
105738530|NCT03238248|364698268|FG000|Overall Study|Decline in condition|1|||
105738531|NCT03238248|364698268|FG000|Overall Study|Alternative therapy|2|||
105738532|NCT00305006|364698273|FG000|Overall Study|Withdrawal by Subject|1|||
105738533|NCT00305006|364698274|FG001|Overall Study|Withdrawal by Subject|0|||
105738534|NCT00305006|364698273|FG000|Overall Study|Failure to complete pretest|0|||
105738535|NCT00305006|364698274|FG001|Overall Study|Failure to complete pretest|1|||
105738536|NCT00631488|364698275|FG000|Overall Study|Adverse Event|1|||
105738537|NCT00631488|364698276|FG001|Overall Study|Adverse Event|0|||
105738538|NCT00631488|364698277|FG002|Overall Study|Adverse Event|0|||
105738539|NCT00631488|364698275|FG000|Overall Study|Lost to Follow-up|2|||
105738540|NCT00631488|364698276|FG001|Overall Study|Lost to Follow-up|2|||
105738541|NCT00631488|364698277|FG002|Overall Study|Lost to Follow-up|0|||
105738542|NCT00631488|364698275|FG000|Overall Study|Physician Decision|1|||
105940976|NCT04191135|365445117|FG001|Randomized Treatment|Lost to Follow-up|0|||
105940977|NCT04191135|365445118|FG002|Randomized Treatment|Lost to Follow-up|1|||
105940978|NCT04191135|365445116|FG000|Randomized Treatment|Withdrawal by Subject|0|||
105940979|NCT04191135|365445117|FG001|Randomized Treatment|Withdrawal by Subject|2|||
105940980|NCT04191135|365445118|FG002|Randomized Treatment|Withdrawal by Subject|0|||
105940981|NCT04191135|365445116|FG000|Randomized Treatment|Ongoing in Trial|0|||
105940982|NCT04191135|365445117|FG001|Randomized Treatment|Ongoing in Trial|83|||
105940983|NCT04191135|365445118|FG002|Randomized Treatment|Ongoing in Trial|81|||
105940984|NCT03058952|365446286|FG000|Overall Study|Adverse Event|1|||
105940985|NCT03058952|365446287|FG001|Overall Study|Adverse Event|0|||
105940986|NCT03058952|365446286|FG000|Overall Study|Lost to Follow-up|15|||
105940987|NCT03058952|365446287|FG001|Overall Study|Lost to Follow-up|15|||
105940988|NCT03058952|365446286|FG000|Overall Study|Withdrawal by Subject|7|||
105940989|NCT03058952|365446287|FG001|Overall Study|Withdrawal by Subject|11|||
105940990|NCT01251965|365446288|FG000|Overall Study|Participant/physician decision|1|||
106141556|NCT02517307|366176018|FG001|Overall Study|Protocol Violation|0|||
105738543|NCT00631488|364698276|FG001|Overall Study|Physician Decision|0|||
105738544|NCT00631488|364698277|FG002|Overall Study|Physician Decision|1|||
105738545|NCT00631488|364698275|FG000|Overall Study|Protocol Violation|0|||
105738546|NCT00631488|364698276|FG001|Overall Study|Protocol Violation|0|||
105738547|NCT00631488|364698277|FG002|Overall Study|Protocol Violation|1|||
105940991|NCT01251965|365446289|FG001|Overall Study|Participant/physician decision|2|||
105940992|NCT01251965|365446290|FG002|Overall Study|Participant/physician decision|0|||
105940993|NCT01251965|365446288|FG000|Overall Study|Death|0|||
106141557|NCT02517307|366176019|FG002|Overall Study|Protocol Violation|1|||
106013163|NCT01394016|365714737|FG003|Overall Study|Withdrawal by Subject|0|||
106013164|NCT01394016|365714738|FG004|Overall Study|Withdrawal by Subject|0|||
106013165|NCT01394016|365714739|FG005|Overall Study|Withdrawal by Subject|0|||
105738548|NCT03648476|364698278|FG000|Overall Study|Withdrawal by Subject|2|||
105738549|NCT03648476|364698279|FG001|Overall Study|Withdrawal by Subject|1|||
105738550|NCT02606045|364698280|FG000|Overall Study|Study closed before treament could begin|1|||
105738551|NCT02606045|364698281|FG001|Overall Study|Study closed before treament could begin|2|||
105738552|NCT00723840|364698292|FG000|Overall Study|Lost to Follow-up|2|||
105738553|NCT00723840|364698292|FG000|Overall Study|Failure to return|18|||
105738554|NCT00723840|364698292|FG000|Overall Study|Withdrawal by Subject|55|||
105738555|NCT00723840|364698292|FG000|Overall Study|Serious Adverse Events|3|||
105738556|NCT00723840|364698292|FG000|Overall Study|Other Medical Event|2|||
105738557|NCT00723840|364698292|FG000|Overall Study|Unspecified reason|2|||
105738558|NCT00570739|364698293|FG000|Overall Study|Adverse Event|8|||
106013166|NCT01394016|365714740|FG006|Overall Study|Withdrawal by Subject|0|||
106013167|NCT01394016|365714741|FG007|Overall Study|Withdrawal by Subject|1|||
106013168|NCT01394016|365714742|FG008|Overall Study|Withdrawal by Subject|1|||
106013169|NCT01394016|365714743|FG009|Overall Study|Withdrawal by Subject|1|||
106013170|NCT01394016|365714744|FG010|Overall Study|Withdrawal by Subject|4|||
106013171|NCT01394016|365714745|FG011|Overall Study|Withdrawal by Subject|0|||
106013172|NCT01394016|365714746|FG012|Overall Study|Withdrawal by Subject|0|||
106013173|NCT01394016|365714747|FG013|Overall Study|Withdrawal by Subject|3|||
106013174|NCT01394016|365714748|FG014|Overall Study|Withdrawal by Subject|1|||
106013175|NCT01394016|365714749|FG015|Overall Study|Withdrawal by Subject|3|||
106013176|NCT01394016|365714750|FG016|Overall Study|Withdrawal by Subject|1|||
106013177|NCT01394016|365714751|FG017|Overall Study|Withdrawal by Subject|1|||
106013178|NCT01394016|365714752|FG018|Overall Study|Withdrawal by Subject|2|||
106013179|NCT01394016|365714734|FG000|Overall Study|Adverse Event|0|||
106013180|NCT01394016|365714735|FG001|Overall Study|Adverse Event|0|||
106013181|NCT01394016|365714736|FG002|Overall Study|Adverse Event|0|||
106013182|NCT01394016|365714737|FG003|Overall Study|Adverse Event|0|||
106013183|NCT01394016|365714738|FG004|Overall Study|Adverse Event|0|||
106013184|NCT01394016|365714739|FG005|Overall Study|Adverse Event|0|||
106013185|NCT01394016|365714740|FG006|Overall Study|Adverse Event|0|||
106013186|NCT01394016|365714741|FG007|Overall Study|Adverse Event|0|||
106013187|NCT01394016|365714742|FG008|Overall Study|Adverse Event|0|||
106013188|NCT01394016|365714743|FG009|Overall Study|Adverse Event|1|||
106013189|NCT01394016|365714744|FG010|Overall Study|Adverse Event|0|||
106013190|NCT01394016|365714745|FG011|Overall Study|Adverse Event|0|||
106013191|NCT01394016|365714746|FG012|Overall Study|Adverse Event|0|||
106013192|NCT01394016|365714747|FG013|Overall Study|Adverse Event|0|||
106013193|NCT01394016|365714748|FG014|Overall Study|Adverse Event|0|||
106013194|NCT01394016|365714749|FG015|Overall Study|Adverse Event|0|||
105738559|NCT00570739|364698294|FG001|Overall Study|Adverse Event|6|||
105940994|NCT01251965|365446289|FG001|Overall Study|Death|0|||
105940995|NCT01251965|365446290|FG002|Overall Study|Death|11|||
105940996|NCT02363283|365446291|FG000|Overall Study|Withdrawal by Subject|1|||
105940997|NCT02363283|365446291|FG000|Overall Study|Not eligible due to transaminitis|1|||
105940998|NCT00530257|365446297|FG000|Overall Study|Lost to Follow-up|1|||
105940999|NCT02904265|365446299|FG000|Overall Study|Physician Decision|1|||
105941000|NCT02904265|365446300|FG001|Overall Study|Physician Decision|2|||
105941001|NCT02579759|365446303|FG000|Overall Study|Protocol Violation|2|||
105941002|NCT02579759|365446304|FG001|Overall Study|Protocol Violation|0|||
105941003|NCT02579759|365446305|FG002|Overall Study|Protocol Violation|0|||
105941004|NCT02579759|365446303|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
105941005|NCT02579759|365446304|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
105941006|NCT02579759|365446305|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
105941007|NCT02579759|365446303|FG000|Overall Study|BfArM hold|13|||
105941008|NCT02579759|365446304|FG001|Overall Study|BfArM hold|12|||
105941009|NCT02579759|365446305|FG002|Overall Study|BfArM hold|12|||
105941010|NCT02579759|365446303|FG000|Overall Study|Sponsor stopped Dose 2|0|||
105941011|NCT02579759|365446304|FG001|Overall Study|Sponsor stopped Dose 2|41|||
105941012|NCT02579759|365446305|FG002|Overall Study|Sponsor stopped Dose 2|0|||
105941013|NCT02579759|365446303|FG000|Overall Study|Non compliance|0|||
105941014|NCT02579759|365446304|FG001|Overall Study|Non compliance|1|||
105941015|NCT02579759|365446305|FG002|Overall Study|Non compliance|0|||
105941016|NCT02579759|365446303|FG000|Overall Study|Pregnancy|0|||
105941017|NCT02579759|365446304|FG001|Overall Study|Pregnancy|1|||
105941018|NCT02579759|365446305|FG002|Overall Study|Pregnancy|0|||
105941019|NCT02579759|365446303|FG000|Overall Study|Inclusion/exclusion criteria|0|||
105941020|NCT02579759|365446304|FG001|Overall Study|Inclusion/exclusion criteria|0|||
105941021|NCT02579759|365446305|FG002|Overall Study|Inclusion/exclusion criteria|1|||
106013195|NCT01394016|365714750|FG016|Overall Study|Adverse Event|1|||
106013196|NCT01394016|365714751|FG017|Overall Study|Adverse Event|1|||
106013197|NCT01394016|365714752|FG018|Overall Study|Adverse Event|0|||
106013198|NCT01394016|365714734|FG000|Overall Study|Sponsor Decision|0|||
106013199|NCT01394016|365714735|FG001|Overall Study|Sponsor Decision|0|||
106013200|NCT01394016|365714736|FG002|Overall Study|Sponsor Decision|0|||
105738560|NCT00570739|364698295|FG002|Overall Study|Adverse Event|2|||
106141558|NCT02517307|366176020|FG003|Overall Study|Protocol Violation|1|||
106141559|NCT00324038|366176021|FG000|Overall Study|Adverse Event|38|||
106141560|NCT00324038|366176022|FG001|Overall Study|Adverse Event|23|||
106141561|NCT00324038|366176021|FG000|Overall Study|Lack of Efficacy|5|||
106141562|NCT00324038|366176022|FG001|Overall Study|Lack of Efficacy|13|||
106141563|NCT00324038|366176021|FG000|Overall Study|Lost to Follow-up|0|||
106141564|NCT00324038|366176022|FG001|Overall Study|Lost to Follow-up|2|||
106141565|NCT00324038|366176021|FG000|Overall Study|Other|6|||
106141566|NCT00324038|366176022|FG001|Overall Study|Other|13|||
106141567|NCT03008915|366176027|FG000|Treatment 1|Withdrawal by Subject|0|||
106141568|NCT03008915|366176028|FG001|Treatment 1|Withdrawal by Subject|1|||
106141569|NCT00290706|366176032|FG000|Overall Study|Withdrawal by Subject|2|||
106141570|NCT00290706|366176033|FG001|Overall Study|Withdrawal by Subject|0|||
106141571|NCT00290706|366176034|FG002|Overall Study|Withdrawal by Subject|0|||
106141572|NCT00290706|366176035|FG003|Overall Study|Withdrawal by Subject|0|||
106141573|NCT00290706|366176032|FG000|Overall Study|Progressive Disease|3|||
106141574|NCT00290706|366176033|FG001|Overall Study|Progressive Disease|5|||
106141575|NCT00290706|366176034|FG002|Overall Study|Progressive Disease|4|||
106141576|NCT00290706|366176035|FG003|Overall Study|Progressive Disease|10|||
106141577|NCT00290706|366176032|FG000|Overall Study|Adverse Event|0|||
106141578|NCT00290706|366176033|FG001|Overall Study|Adverse Event|1|||
106141579|NCT00290706|366176034|FG002|Overall Study|Adverse Event|2|||
106141580|NCT00290706|366176035|FG003|Overall Study|Adverse Event|0|||
106141581|NCT00290706|366176032|FG000|Overall Study|Receive auto transplant or radiation|0|||
106141582|NCT00290706|366176033|FG001|Overall Study|Receive auto transplant or radiation|0|||
106141583|NCT00290706|366176034|FG002|Overall Study|Receive auto transplant or radiation|0|||
106141584|NCT00290706|366176035|FG003|Overall Study|Receive auto transplant or radiation|1|||
106141585|NCT00290706|366176032|FG000|Overall Study|Physician Decision|0|||
106141586|NCT00290706|366176033|FG001|Overall Study|Physician Decision|0|||
106141587|NCT00290706|366176034|FG002|Overall Study|Physician Decision|0|||
106141588|NCT00290706|366176035|FG003|Overall Study|Physician Decision|1|||
106141589|NCT03395353|366176038|FG000|Overall Study|Adverse Event|20|||
106141590|NCT03395353|366176038|FG000|Overall Study|Protocol Violation|1|||
106141591|NCT03395353|366176038|FG000|Overall Study|Lack of Efficacy|3|||
106141592|NCT03395353|366176038|FG000|Overall Study|Withdrawal by Subject|24|||
105738561|NCT00570739|364698296|FG003|Overall Study|Adverse Event|2|||
105738562|NCT00570739|364698293|FG000|Overall Study|Lost to Follow-up|4|||
105738563|NCT00570739|364698294|FG001|Overall Study|Lost to Follow-up|5|||
105738564|NCT00570739|364698295|FG002|Overall Study|Lost to Follow-up|4|||
105738565|NCT00570739|364698296|FG003|Overall Study|Lost to Follow-up|1|||
105738566|NCT00570739|364698293|FG000|Overall Study|Physician Decision|1|||
105738567|NCT00570739|364698294|FG001|Overall Study|Physician Decision|1|||
105738568|NCT00570739|364698295|FG002|Overall Study|Physician Decision|0|||
105738569|NCT00570739|364698296|FG003|Overall Study|Physician Decision|0|||
105738570|NCT00570739|364698293|FG000|Overall Study|Withdrawal by Subject|7|||
105738571|NCT00570739|364698294|FG001|Overall Study|Withdrawal by Subject|7|||
105738572|NCT00570739|364698295|FG002|Overall Study|Withdrawal by Subject|3|||
105738573|NCT00570739|364698296|FG003|Overall Study|Withdrawal by Subject|5|||
105738574|NCT00570739|364698293|FG000|Overall Study|Required restricted medication|0|||
105738575|NCT00570739|364698294|FG001|Overall Study|Required restricted medication|0|||
105738576|NCT00570739|364698295|FG002|Overall Study|Required restricted medication|1|||
105738577|NCT00570739|364698296|FG003|Overall Study|Required restricted medication|0|||
105738578|NCT00570739|364698293|FG000|Overall Study|Met discontinuation criteria|1|||
105738579|NCT00570739|364698294|FG001|Overall Study|Met discontinuation criteria|0|||
105738580|NCT00570739|364698295|FG002|Overall Study|Met discontinuation criteria|1|||
105738581|NCT00570739|364698296|FG003|Overall Study|Met discontinuation criteria|1|||
105738582|NCT00570739|364698293|FG000|Overall Study|Other|0|||
105738583|NCT00570739|364698294|FG001|Overall Study|Other|2|||
105799764|NCT04380701|364924632|FG018|Overall Study|Death|0|||
105799765|NCT04380701|364924633|FG019|Overall Study|Death|0|||
105799766|NCT04380701|364924634|FG020|Overall Study|Death|0|||
105941022|NCT02579759|365446303|FG000|Overall Study|Adverse Event|4|||
106141593|NCT03395353|366176038|FG000|Overall Study|Discontinued visit|1|||
106141594|NCT03395353|366176038|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
106141595|NCT03395353|366176038|FG000|Overall Study|Physician Decision|4|||
106141596|NCT03395353|366176038|FG000|Overall Study|Early termination of overall study|33|||
106141597|NCT00605033|366176039|FG000|Overall Study|Adverse Event|2|||
106141598|NCT00605033|366176040|FG001|Overall Study|Adverse Event|2|||
106141599|NCT00605033|366176039|FG000|Overall Study|Lost to Follow-up|1|||
105738584|NCT00570739|364698295|FG002|Overall Study|Other|5|||
105738585|NCT00570739|364698296|FG003|Overall Study|Other|3|||
105941023|NCT02579759|365446304|FG001|Overall Study|Adverse Event|3|||
106141600|NCT00605033|366176040|FG001|Overall Study|Lost to Follow-up|1|||
106141601|NCT00605033|366176039|FG000|Overall Study|Withdrawal by Subject|3|||
105738586|NCT01242020|364698299|FG000|Overall Study|Withdrawal by Subject|2|||
105799767|NCT04380701|364924635|FG021|Overall Study|Death|0|||
106141602|NCT00605033|366176040|FG001|Overall Study|Withdrawal by Subject|4|||
105738587|NCT01242020|364698300|FG001|Overall Study|Withdrawal by Subject|0|||
105738588|NCT01242020|364698299|FG000|Overall Study|Failed screening|1|||
105738589|NCT01242020|364698300|FG001|Overall Study|Failed screening|0|||
105738590|NCT02179398|364698305|FG000|Overall Study|Lack of obligatory data|3|||
105738591|NCT02179398|364698306|FG001|Overall Study|Lack of obligatory data|3|||
105738592|NCT02179398|364698305|FG000|Overall Study|Lost to Follow-up|0|||
105738593|NCT02179398|364698306|FG001|Overall Study|Lost to Follow-up|1|||
105738594|NCT00772967|364698307|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738595|NCT00772967|364698308|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738596|NCT00772967|364698309|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738597|NCT00772967|364698310|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
105738598|NCT00772967|364698311|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738599|NCT00772967|364698312|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
105738600|NCT00772967|364698307|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738601|NCT00772967|364698308|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
105738602|NCT00772967|364698309|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738603|NCT00772967|364698310|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738604|NCT00772967|364698311|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738605|NCT00772967|364698312|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
105738606|NCT00772967|364698307|FG000|Crossover Treatment 3|Adverse Event|0|||
105738607|NCT00772967|364698308|FG001|Crossover Treatment 3|Adverse Event|0|||
105738608|NCT00772967|364698309|FG002|Crossover Treatment 3|Adverse Event|0|||
105738609|NCT00772967|364698310|FG003|Crossover Treatment 3|Adverse Event|0|||
105738610|NCT00772967|364698311|FG004|Crossover Treatment 3|Adverse Event|1|||
105738611|NCT00772967|364698312|FG005|Crossover Treatment 3|Adverse Event|0|||
105738612|NCT01595646|364698313|FG000|Overall Study|Withdrawal by Subject|1|||
105738613|NCT01595646|364698314|FG001|Overall Study|Withdrawal by Subject|0|||
105738614|NCT01595646|364698315|FG002|Overall Study|Withdrawal by Subject|0|||
105738615|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Adverse Event|3|||
105738616|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Adverse Event|0|||
105738617|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Adverse Event|0|||
105738618|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Other|1|||
105738619|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Other|0|||
105738620|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Other|0|||
105738621|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
105738622|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
105738623|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
105738624|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
105738625|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
105738626|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
105738627|NCT01161524|364698320|FG000|Core Study (23 Weeks)|Subject Choice|3|||
105738628|NCT01161524|364698321|FG001|Core Study (23 Weeks)|Subject Choice|2|||
105738629|NCT01161524|364698322|FG002|Core Study (23 Weeks)|Subject Choice|0|||
105738630|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
105738631|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
105738632|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
105738633|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
105738634|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
105738635|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
105738636|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
105738637|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
105738638|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
105738639|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
105738640|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
105738641|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
105738642|NCT01161524|364698320|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
105738643|NCT01161524|364698321|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
105738644|NCT01161524|364698322|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
105738645|NCT01041573|364698331|FG000|Overall Study|Withdrawal by Subject|2|||
105738646|NCT01041573|364698332|FG001|Overall Study|Withdrawal by Subject|5|||
105738647|NCT01041573|364698333|FG002|Overall Study|Withdrawal by Subject|2|||
105738648|NCT01041573|364698334|FG003|Overall Study|Withdrawal by Subject|0|||
105799768|NCT04380701|364924636|FG022|Overall Study|Death|0|||
105941024|NCT02579759|365446305|FG002|Overall Study|Adverse Event|1|||
105941025|NCT02579759|365446303|FG000|Overall Study|Withdrawal by Subject|3|||
105941026|NCT02579759|365446304|FG001|Overall Study|Withdrawal by Subject|3|||
105941027|NCT02579759|365446305|FG002|Overall Study|Withdrawal by Subject|5|||
105941028|NCT02579759|365446303|FG000|Overall Study|Lost to Follow-up|2|||
105941029|NCT02579759|365446304|FG001|Overall Study|Lost to Follow-up|2|||
105941030|NCT02579759|365446305|FG002|Overall Study|Lost to Follow-up|2|||
105941031|NCT00488293|365446307|FG000|Overall Study|Lost to Follow-up|28|||
105941032|NCT00488293|365446308|FG001|Overall Study|Lost to Follow-up|25|||
105941033|NCT00488293|365446307|FG000|Overall Study|Withdrawal by Subject|5|||
106013201|NCT01394016|365714737|FG003|Overall Study|Sponsor Decision|0|||
105738649|NCT01041573|364698331|FG000|Overall Study|Death|1|||
105738650|NCT01041573|364698332|FG001|Overall Study|Death|0|||
105738651|NCT01041573|364698333|FG002|Overall Study|Death|0|||
105738652|NCT01041573|364698334|FG003|Overall Study|Death|0|||
105738653|NCT01041573|364698331|FG000|Overall Study|Lost to Follow-up|0|||
105738654|NCT01041573|364698332|FG001|Overall Study|Lost to Follow-up|1|||
105738655|NCT01041573|364698333|FG002|Overall Study|Lost to Follow-up|2|||
105738656|NCT01041573|364698334|FG003|Overall Study|Lost to Follow-up|1|||
105738657|NCT01041573|364698331|FG000|Overall Study|Adverse Event|0|||
105738658|NCT01041573|364698332|FG001|Overall Study|Adverse Event|2|||
105738659|NCT01041573|364698333|FG002|Overall Study|Adverse Event|0|||
105738660|NCT01041573|364698334|FG003|Overall Study|Adverse Event|0|||
105738661|NCT01041573|364698331|FG000|Overall Study|relocation|1|||
105738662|NCT01041573|364698332|FG001|Overall Study|relocation|4|||
105738663|NCT01041573|364698333|FG002|Overall Study|relocation|3|||
105738664|NCT01041573|364698334|FG003|Overall Study|relocation|1|||
105738665|NCT01041573|364698331|FG000|Overall Study|further blood extraction|0|||
105738666|NCT01041573|364698332|FG001|Overall Study|further blood extraction|1|||
105738667|NCT01041573|364698333|FG002|Overall Study|further blood extraction|0|||
105738668|NCT01041573|364698334|FG003|Overall Study|further blood extraction|0|||
105738669|NCT01041573|364698331|FG000|Overall Study|positive to anti-HCV|1|||
105738670|NCT01041573|364698332|FG001|Overall Study|positive to anti-HCV|0|||
105738671|NCT01041573|364698333|FG002|Overall Study|positive to anti-HCV|0|||
105738672|NCT01041573|364698334|FG003|Overall Study|positive to anti-HCV|0|||
105738673|NCT02955186|364698335|FG000|Overall Study|Withdrawal by Subject|6|||
105738674|NCT02955186|364698336|FG001|Overall Study|Withdrawal by Subject|2|||
105738675|NCT02955186|364698335|FG000|Overall Study|Protocol Violation|1|||
105738676|NCT02955186|364698336|FG001|Overall Study|Protocol Violation|0|||
105738677|NCT01899144|364698337|FG000|Treatment Period 2|Other|1|||
105738678|NCT01899144|364698337|FG000|Treatment Period 3|Other|2|||
105738679|NCT01899144|364698337|FG000|Treatment Period 5|Other|1|||
105738680|NCT00231062|364698338|FG000|Overall Study|Physician Decision|6|||
105738681|NCT00864227|364698339|FG000|Overall Study|Withdrawal by Subject|1|||
105738682|NCT00864227|364698339|FG000|Overall Study|Disease Relapse/Progression|3|||
105738683|NCT00616239|364698340|FG000|Overall Study|Withdrawal by Subject|2|||
105738684|NCT02606877|364698341|FG000|Overall Study|Adverse Event|3|||
105738685|NCT02606877|364698342|FG001|Overall Study|Adverse Event|0|||
105738686|NCT02606877|364698341|FG000|Overall Study|Non-compliance with protocol|0|||
105738687|NCT02606877|364698342|FG001|Overall Study|Non-compliance with protocol|1|||
105738688|NCT02606877|364698341|FG000|Overall Study|Other than listed above|1|||
105738689|NCT02606877|364698342|FG001|Overall Study|Other than listed above|0|||
105738690|NCT04952389|364698346|FG000|Overall Study|Withdrawal by Subject|8|||
105738691|NCT04952389|364698347|FG001|Overall Study|Withdrawal by Subject|4|||
105738692|NCT02815397|364698350|FG000|Overall Study|Physician Decision|2|||
105738693|NCT04998851|364699870|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
105738694|NCT04998851|364699871|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
105738695|NCT04998851|364699870|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|2|||
105738696|NCT04998851|364699871|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
105738697|NCT04998851|364699870|FG000|Vaccination Period (11 Months)|Reason Not Specified|0|||
105738698|NCT04998851|364699871|FG001|Vaccination Period (11 Months)|Reason Not Specified|1|||
105738699|NCT04998851|364699870|FG000|Vaccination Period (11 Months)|Ongoing in the study|4|||
105738700|NCT04998851|364699871|FG001|Vaccination Period (11 Months)|Ongoing in the study|4|||
105738701|NCT00931892|364699872|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
105738702|NCT00931892|364699873|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
105738703|NCT00390780|364699874|FG000|Overall Study|Not completed|10|||
105738704|NCT00390780|364699875|FG001|Overall Study|Not completed|4|||
106013202|NCT01394016|365714738|FG004|Overall Study|Sponsor Decision|0|||
105738705|NCT00390780|364699874|FG000|Overall Study|Protocol Violation|6|||
105738706|NCT00390780|364699875|FG001|Overall Study|Protocol Violation|4|||
105738707|NCT00390780|364699874|FG000|Overall Study|Lost to Follow-up|3|||
105738708|NCT00390780|364699875|FG001|Overall Study|Lost to Follow-up|6|||
105738709|NCT00390780|364699874|FG000|Overall Study|Adverse Event|2|||
105738710|NCT00390780|364699875|FG001|Overall Study|Adverse Event|3|||
105738711|NCT00390780|364699874|FG000|Overall Study|Death|1|||
105738712|NCT00390780|364699875|FG001|Overall Study|Death|3|||
105738713|NCT00390780|364699874|FG000|Overall Study|Withdrawal by Subject|1|||
105738714|NCT00390780|364699875|FG001|Overall Study|Withdrawal by Subject|2|||
106013203|NCT01394016|365714739|FG005|Overall Study|Sponsor Decision|0|||
105738715|NCT00390780|364699874|FG000|Overall Study|Inclusion criteria not satisfied|0|||
105738716|NCT00390780|364699875|FG001|Overall Study|Inclusion criteria not satisfied|2|||
105738717|NCT00390780|364699874|FG000|Overall Study|Lost to follow up and other reasons|0|||
105738718|NCT00390780|364699875|FG001|Overall Study|Lost to follow up and other reasons|1|||
105738719|NCT00390780|364699874|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
105738720|NCT00390780|364699875|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
106013204|NCT01394016|365714740|FG006|Overall Study|Sponsor Decision|0|||
105799769|NCT04380701|364924637|FG023|Overall Study|Death|0|||
105799770|NCT04380701|364924638|FG024|Overall Study|Death|1|||
105799771|NCT04380701|364924639|FG025|Overall Study|Death|0|||
105799772|NCT04380701|364924640|FG026|Overall Study|Death|0|||
105799773|NCT04380701|364924641|FG027|Overall Study|Death|0|||
105799774|NCT04380701|364924642|FG028|Overall Study|Death|0|||
105799775|NCT04380701|364924643|FG029|Overall Study|Death|0|||
105799776|NCT04380701|364924644|FG030|Overall Study|Death|0|||
105799777|NCT04380701|364924645|FG031|Overall Study|Death|0|||
105799778|NCT04380701|364924646|FG032|Overall Study|Death|0|||
105799779|NCT04380701|364924647|FG033|Overall Study|Death|0|||
105799780|NCT04380701|364924614|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799781|NCT04380701|364924615|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799782|NCT04380701|364924616|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799783|NCT04380701|364924617|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799784|NCT04380701|364924618|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799785|NCT04380701|364924619|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799786|NCT04380701|364924620|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799787|NCT04380701|364924621|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799788|NCT04380701|364924622|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799789|NCT04380701|364924623|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799790|NCT04380701|364924624|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799791|NCT04380701|364924625|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799792|NCT04380701|364924626|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799793|NCT04380701|364924627|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799794|NCT04380701|364924628|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799795|NCT04380701|364924629|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799796|NCT04380701|364924630|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799797|NCT04380701|364924631|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799798|NCT04380701|364924632|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105941034|NCT00488293|365446308|FG001|Overall Study|Withdrawal by Subject|3|||
105941035|NCT00488293|365446307|FG000|Overall Study|Death|2|||
105941036|NCT00488293|365446308|FG001|Overall Study|Death|1|||
105941037|NCT00488293|365446307|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
105941038|NCT00488293|365446308|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
105941039|NCT01557569|365446310|FG000|Overall Study|Adverse Event|2|||
105941040|NCT01557569|365446311|FG001|Overall Study|Adverse Event|0|||
105941041|NCT01557569|365446310|FG000|Overall Study|high blood pressure|0|||
105941042|NCT01557569|365446311|FG001|Overall Study|high blood pressure|1|||
105941043|NCT01557569|365446310|FG000|Overall Study|Withdrawal by Subject|3|||
105941044|NCT01557569|365446311|FG001|Overall Study|Withdrawal by Subject|5|||
105941045|NCT01557569|365446310|FG000|Overall Study|noncompliance with rules of residential|0|||
105941046|NCT01557569|365446311|FG001|Overall Study|noncompliance with rules of residential|1|||
105941047|NCT01149460|365446312|FG000|Overall Study|Withdrawal by Subject|0|||
105941048|NCT01149460|365446313|FG001|Overall Study|Withdrawal by Subject|2|||
105941049|NCT02801578|365446316|FG000|Overall Study|Adverse Event|2|||
105941050|NCT00137449|365446317|FG000|Overall Study|Disease Progression|8|||
105941051|NCT00137449|365446318|FG001|Overall Study|Disease Progression|13|||
105941052|NCT00137449|365446317|FG000|Overall Study|Death|4|||
105941053|NCT00137449|365446318|FG001|Overall Study|Death|3|||
105941054|NCT00137449|365446317|FG000|Overall Study|Adverse Event|3|||
105941055|NCT00137449|365446318|FG001|Overall Study|Adverse Event|1|||
105941056|NCT00137449|365446317|FG000|Overall Study|Withdrawal by Subject|1|||
105941057|NCT00137449|365446318|FG001|Overall Study|Withdrawal by Subject|1|||
105941058|NCT01356940|365446319|FG000|First Intervention (28 Days)|Adverse Event|1|||
105941059|NCT01356940|365446320|FG001|First Intervention (28 Days)|Adverse Event|0|||
105941060|NCT01356940|365446319|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
105799799|NCT04380701|364924633|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799800|NCT04380701|364924634|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799801|NCT04380701|364924635|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
105799802|NCT04380701|364924636|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
105799803|NCT04380701|364924637|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
105941061|NCT01356940|365446320|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
105941062|NCT01537432|365446322|FG000|Overall Study|Lost to Follow-up|3|||
105941063|NCT01537432|365446323|FG001|Overall Study|Lost to Follow-up|1|||
105941064|NCT01537432|365446322|FG000|Overall Study|Withdrawal by Subject|0|||
105941065|NCT01537432|365446323|FG001|Overall Study|Withdrawal by Subject|1|||
105941066|NCT01537432|365446322|FG000|Overall Study|Administrative problems|1|||
105941067|NCT01537432|365446323|FG001|Overall Study|Administrative problems|0|||
105941068|NCT01537432|365446322|FG000|Overall Study|Adverse Event|1|||
105941069|NCT01537432|365446323|FG001|Overall Study|Adverse Event|0|||
105941070|NCT01537432|365446322|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
106013205|NCT01394016|365714741|FG007|Overall Study|Sponsor Decision|0|||
106013206|NCT01394016|365714742|FG008|Overall Study|Sponsor Decision|0|||
106013207|NCT01394016|365714743|FG009|Overall Study|Sponsor Decision|0|||
106013208|NCT01394016|365714744|FG010|Overall Study|Sponsor Decision|0|||
106013209|NCT01394016|365714745|FG011|Overall Study|Sponsor Decision|0|||
106013210|NCT01394016|365714746|FG012|Overall Study|Sponsor Decision|1|||
106013211|NCT01394016|365714747|FG013|Overall Study|Sponsor Decision|0|||
106013212|NCT01394016|365714748|FG014|Overall Study|Sponsor Decision|0|||
106013213|NCT01394016|365714749|FG015|Overall Study|Sponsor Decision|0|||
106013214|NCT01394016|365714750|FG016|Overall Study|Sponsor Decision|0|||
106013215|NCT01394016|365714751|FG017|Overall Study|Sponsor Decision|0|||
106013216|NCT01394016|365714752|FG018|Overall Study|Sponsor Decision|0|||
106013217|NCT01394016|365714734|FG000|Overall Study|Lost to Follow-up|0|||
106013218|NCT01394016|365714735|FG001|Overall Study|Lost to Follow-up|0|||
106013219|NCT01394016|365714736|FG002|Overall Study|Lost to Follow-up|0|||
106013220|NCT01394016|365714737|FG003|Overall Study|Lost to Follow-up|0|||
106013221|NCT01394016|365714738|FG004|Overall Study|Lost to Follow-up|0|||
106013222|NCT01394016|365714739|FG005|Overall Study|Lost to Follow-up|0|||
106013223|NCT01394016|365714740|FG006|Overall Study|Lost to Follow-up|0|||
106013224|NCT01394016|365714741|FG007|Overall Study|Lost to Follow-up|0|||
106013225|NCT01394016|365714742|FG008|Overall Study|Lost to Follow-up|0|||
106013226|NCT01394016|365714743|FG009|Overall Study|Lost to Follow-up|0|||
106013227|NCT01394016|365714744|FG010|Overall Study|Lost to Follow-up|0|||
106013228|NCT01394016|365714745|FG011|Overall Study|Lost to Follow-up|0|||
106013229|NCT01394016|365714746|FG012|Overall Study|Lost to Follow-up|0|||
106013230|NCT01394016|365714747|FG013|Overall Study|Lost to Follow-up|0|||
106013231|NCT01394016|365714748|FG014|Overall Study|Lost to Follow-up|0|||
106013232|NCT01394016|365714749|FG015|Overall Study|Lost to Follow-up|0|||
106013233|NCT01394016|365714750|FG016|Overall Study|Lost to Follow-up|0|||
106013234|NCT01394016|365714751|FG017|Overall Study|Lost to Follow-up|0|||
106013235|NCT01394016|365714752|FG018|Overall Study|Lost to Follow-up|1|||
106013236|NCT03534804|365714753|FG000|Overall Study|Withdrawal by Subject|1|||
106013237|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
106013238|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
106013239|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
106013240|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
106013241|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Adverse Event|2|||
106013242|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Adverse Event|5|||
106013243|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Adverse Event|1|||
106013244|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Adverse Event|2|||
106013245|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Death|13|||
106013246|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Death|17|||
106013247|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Death|1|||
106013248|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Death|0|||
106013249|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
106013250|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
106013251|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
106013252|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
106013253|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Disease Progression|2|||
106013254|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Disease Progression|0|||
106013255|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Disease Progression|0|||
106013256|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Disease Progression|0|||
106013257|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
106013258|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
106013259|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
106013260|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
106013261|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
106013262|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
106013263|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
106013264|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
106013265|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
105738721|NCT00390780|364699874|FG000|Overall Study|SAE, death|0|||
106013266|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
106013267|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
106013268|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
106013269|NCT03955146|365714754|FG000|DB Period (48 Weeks)|Participant Decision|9|||
106141603|NCT00605033|366176039|FG000|Overall Study|Protocol Violation|1|||
106141604|NCT00605033|366176040|FG001|Overall Study|Protocol Violation|1|||
105738722|NCT00390780|364699875|FG001|Overall Study|SAE, death|1|||
106013270|NCT03955146|365714755|FG001|DB Period (48 Weeks)|Participant Decision|12|||
106013271|NCT03955146|365714756|FG002|DB Period (48 Weeks)|Participant Decision|1|||
105738723|NCT01070550|364699880|FG000|Overall Study|Adverse Event|43|||
106013272|NCT03955146|365714757|FG003|DB Period (48 Weeks)|Participant Decision|1|||
106013273|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
106013274|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
106013275|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
105738724|NCT01070550|364699881|FG001|Overall Study|Adverse Event|1|||
105738725|NCT01070550|364699882|FG002|Overall Study|Adverse Event|3|||
105738726|NCT01070550|364699883|FG003|Overall Study|Adverse Event|0|||
105738727|NCT01070550|364699884|FG004|Overall Study|Adverse Event|0|||
105941071|NCT01537432|365446323|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105941072|NCT02263547|365446324|FG000|Overall Study|Adverse Event|1|||
105941073|NCT02263547|365446324|FG000|Overall Study|Lost to Follow-up|2|||
105941074|NCT03682367|365446327|FG000|Overall Study|Protocol Violation|2|||
105941075|NCT03682367|365446328|FG001|Overall Study|Protocol Violation|1|||
105941076|NCT03682367|365446327|FG000|Overall Study|Closed Study Early|0|||
105941077|NCT03682367|365446328|FG001|Overall Study|Closed Study Early|3|||
105941078|NCT01998477|365446329|FG000|Overall Study|Lost to Follow-up|4|||
105941079|NCT01998477|365446330|FG001|Overall Study|Lost to Follow-up|5|||
105941080|NCT01998477|365446329|FG000|Overall Study|Withdrawal by Subject|6|||
105941081|NCT01998477|365446330|FG001|Overall Study|Withdrawal by Subject|0|||
105941082|NCT03524157|365446332|FG000|Overall Study|cytology not readable|0|||
105941083|NCT03524157|365446333|FG001|Overall Study|cytology not readable|0|||
105941084|NCT03524157|365446334|FG002|Overall Study|cytology not readable|1|||
105941085|NCT01378195|365446335|FG000|Overall Study|Lost to Follow-up|29|||
105941086|NCT01378195|365446336|FG001|Overall Study|Lost to Follow-up|18|||
105941087|NCT01047540|365446340|FG000|Overall Study|Protocol Violation|1|||
105941088|NCT01047540|365446341|FG001|Overall Study|Protocol Violation|0|||
105941089|NCT01047540|365446342|FG002|Overall Study|Protocol Violation|0|||
105941090|NCT01047540|365446343|FG003|Overall Study|Protocol Violation|0|||
105941091|NCT01047540|365446344|FG004|Overall Study|Protocol Violation|0|||
105941092|NCT01047540|365446340|FG000|Overall Study|Lost to Follow-up|1|||
105941093|NCT01047540|365446341|FG001|Overall Study|Lost to Follow-up|0|||
105941094|NCT01047540|365446342|FG002|Overall Study|Lost to Follow-up|0|||
105941095|NCT01047540|365446343|FG003|Overall Study|Lost to Follow-up|0|||
105941096|NCT01047540|365446344|FG004|Overall Study|Lost to Follow-up|0|||
105941097|NCT01047540|365446340|FG000|Overall Study|Withdrawal by Subject|1|||
105941098|NCT01047540|365446341|FG001|Overall Study|Withdrawal by Subject|0|||
105941099|NCT01047540|365446342|FG002|Overall Study|Withdrawal by Subject|3|||
105941100|NCT01047540|365446343|FG003|Overall Study|Withdrawal by Subject|0|||
105941101|NCT01047540|365446344|FG004|Overall Study|Withdrawal by Subject|1|||
105941102|NCT01047540|365446340|FG000|Overall Study|Pregnancy|1|||
105941103|NCT01047540|365446341|FG001|Overall Study|Pregnancy|0|||
105941104|NCT01047540|365446342|FG002|Overall Study|Pregnancy|0|||
105941105|NCT01047540|365446343|FG003|Overall Study|Pregnancy|0|||
105941106|NCT01047540|365446344|FG004|Overall Study|Pregnancy|0|||
105941107|NCT01047540|365446340|FG000|Overall Study|Adverse Event|1|||
105941108|NCT01047540|365446341|FG001|Overall Study|Adverse Event|0|||
105941109|NCT01047540|365446342|FG002|Overall Study|Adverse Event|0|||
105941110|NCT01047540|365446343|FG003|Overall Study|Adverse Event|0|||
105941111|NCT01047540|365446344|FG004|Overall Study|Adverse Event|0|||
105941112|NCT01916226|365446348|FG000|Overall Study|Adverse Event|1|||
105941113|NCT01916226|365446349|FG001|Overall Study|Adverse Event|0|||
105941114|NCT01916226|365446350|FG002|Overall Study|Adverse Event|1|||
105941115|NCT01916226|365446351|FG003|Overall Study|Adverse Event|1|||
105941116|NCT01916226|365446348|FG000|Overall Study|Lack of Efficacy|0|||
105941117|NCT01916226|365446349|FG001|Overall Study|Lack of Efficacy|0|||
105738728|NCT01070550|364699885|FG005|Overall Study|Adverse Event|0|||
105738729|NCT01070550|364699880|FG000|Overall Study|Death|20|||
105738730|NCT01070550|364699881|FG001|Overall Study|Death|4|||
105738731|NCT01070550|364699882|FG002|Overall Study|Death|3|||
105738732|NCT01070550|364699883|FG003|Overall Study|Death|0|||
105738733|NCT01070550|364699884|FG004|Overall Study|Death|0|||
105738734|NCT01070550|364699885|FG005|Overall Study|Death|0|||
105738735|NCT01070550|364699880|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
105738736|NCT01070550|364699881|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105738737|NCT01070550|364699882|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105738738|NCT01070550|364699883|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105738739|NCT01070550|364699884|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105738740|NCT01070550|364699885|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105738741|NCT01070550|364699880|FG000|Overall Study|Early termination|3|||
105738742|NCT01070550|364699881|FG001|Overall Study|Early termination|0|||
105738743|NCT01070550|364699882|FG002|Overall Study|Early termination|0|||
105738744|NCT01070550|364699883|FG003|Overall Study|Early termination|0|||
105941118|NCT01916226|365446350|FG002|Overall Study|Lack of Efficacy|2|||
105941119|NCT01916226|365446351|FG003|Overall Study|Lack of Efficacy|1|||
105738745|NCT01070550|364699884|FG004|Overall Study|Early termination|0|||
105738746|NCT01070550|364699885|FG005|Overall Study|Early termination|0|||
105738747|NCT01070550|364699880|FG000|Overall Study|Failed to return|450|||
105941120|NCT01916226|365446348|FG000|Overall Study|Protocol Violation|0|||
105941121|NCT01916226|365446349|FG001|Overall Study|Protocol Violation|1|||
105738748|NCT01070550|364699881|FG001|Overall Study|Failed to return|33|||
105738749|NCT01070550|364699882|FG002|Overall Study|Failed to return|144|||
105738750|NCT01070550|364699883|FG003|Overall Study|Failed to return|40|||
105941122|NCT01916226|365446350|FG002|Overall Study|Protocol Violation|0|||
106013276|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
106013277|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
106013278|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
106013279|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
106013280|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
106013281|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
106013282|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
106013283|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
106013284|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
106013285|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
106013286|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
106013287|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
106013288|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
106013289|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
106013290|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
106013291|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
106013292|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
106013293|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
106013294|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
106013295|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
106013296|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
106013297|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
106013298|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
106013299|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
106013300|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
106013301|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
106013302|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
106013303|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
106013304|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
106013305|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
106013306|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
106013307|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
106013308|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
106013309|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
106013310|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
106013311|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
106013312|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
106013313|NCT03955146|365714754|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
106013314|NCT03955146|365714755|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
106013315|NCT03955146|365714756|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
106013316|NCT03955146|365714757|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
106013317|NCT02002598|365714760|FG000|Dose Level 1|Withdrawal by Subject|1|||
106013318|NCT02002598|365714761|FG001|Dose Level 1|Withdrawal by Subject|0|||
106013319|NCT02002598|365714762|FG002|Dose Level 1|Withdrawal by Subject|0|||
106013320|NCT02002598|365714763|FG003|Dose Level 1|Withdrawal by Subject|0|||
106013321|NCT02002598|365714764|FG004|Dose Level 1|Withdrawal by Subject|0|||
106013322|NCT05632211|365714765|FG000|Overall Study|Withdrawal by Subject|2|||
106013323|NCT05632211|365714766|FG001|Overall Study|Withdrawal by Subject|0|||
106013324|NCT05632211|365714767|FG002|Overall Study|Withdrawal by Subject|2|||
106013325|NCT05632211|365714765|FG000|Overall Study|Other reasons|1|||
106013326|NCT05632211|365714766|FG001|Overall Study|Other reasons|1|||
106013327|NCT05632211|365714767|FG002|Overall Study|Other reasons|1|||
106013328|NCT02628873|365714770|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
106013329|NCT02628873|365714771|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
106013330|NCT02628873|365714770|FG000|Second Test (1 Hour)|Physician Decision|1|||
106013331|NCT02628873|365714771|FG001|Second Test (1 Hour)|Physician Decision|0|||
106013332|NCT00630838|365714772|FG000|Overall Study|Death|0|||
106013333|NCT00630838|365714773|FG001|Overall Study|Death|1|||
106013334|NCT00630838|365714772|FG000|Overall Study|Lost to Follow-up|0|||
106013335|NCT00630838|365714773|FG001|Overall Study|Lost to Follow-up|1|||
106013336|NCT00541658|365714774|FG000|Overall Study|Adverse Event|28|||
106013337|NCT00541658|365714775|FG001|Overall Study|Adverse Event|37|||
106013338|NCT00541658|365714776|FG002|Overall Study|Adverse Event|25|||
106013339|NCT00541658|365714774|FG000|Overall Study|Physician Decision|0|||
106141605|NCT01070888|366177729|FG000|First Intervention (14 Days)|Adverse Event|0|||
106141606|NCT01070888|366177730|FG001|First Intervention (14 Days)|Adverse Event|1|||
106141607|NCT01070888|366177729|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
106141608|NCT01070888|366177730|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
106141609|NCT01070888|366177729|FG000|Washout (14 Days)|Physician Decision|1|||
106141610|NCT01070888|366177730|FG001|Washout (14 Days)|Physician Decision|0|||
105738751|NCT01070550|364699884|FG004|Overall Study|Failed to return|1|||
105738752|NCT01070550|364699885|FG005|Overall Study|Failed to return|2|||
105738753|NCT01070550|364699880|FG000|Overall Study|Incomplete treatment|2|||
105738754|NCT01070550|364699881|FG001|Overall Study|Incomplete treatment|0|||
105738755|NCT01070550|364699882|FG002|Overall Study|Incomplete treatment|0|||
105738756|NCT01070550|364699883|FG003|Overall Study|Incomplete treatment|0|||
105738757|NCT01070550|364699884|FG004|Overall Study|Incomplete treatment|0|||
105738758|NCT01070550|364699885|FG005|Overall Study|Incomplete treatment|0|||
105738759|NCT01070550|364699880|FG000|Overall Study|Lab test not done|22|||
105738760|NCT01070550|364699881|FG001|Overall Study|Lab test not done|3|||
105738761|NCT01070550|364699882|FG002|Overall Study|Lab test not done|4|||
105738762|NCT01070550|364699883|FG003|Overall Study|Lab test not done|1|||
105738763|NCT01070550|364699884|FG004|Overall Study|Lab test not done|0|||
105738764|NCT01070550|364699885|FG005|Overall Study|Lab test not done|1|||
105738765|NCT01070550|364699880|FG000|Overall Study|Lack of Efficacy|65|||
105738766|NCT01070550|364699881|FG001|Overall Study|Lack of Efficacy|1|||
105738767|NCT01070550|364699882|FG002|Overall Study|Lack of Efficacy|5|||
105738768|NCT01070550|364699883|FG003|Overall Study|Lack of Efficacy|5|||
105738769|NCT01070550|364699884|FG004|Overall Study|Lack of Efficacy|0|||
105738770|NCT01070550|364699885|FG005|Overall Study|Lack of Efficacy|1|||
105738771|NCT01070550|364699880|FG000|Overall Study|Miscellaneous|12|||
105738772|NCT01070550|364699881|FG001|Overall Study|Miscellaneous|2|||
105941123|NCT01916226|365446351|FG003|Overall Study|Protocol Violation|1|||
105941124|NCT01916226|365446348|FG000|Overall Study|Physician Decision|0|||
105941125|NCT01916226|365446349|FG001|Overall Study|Physician Decision|0|||
105941126|NCT01916226|365446350|FG002|Overall Study|Physician Decision|0|||
105941127|NCT01916226|365446351|FG003|Overall Study|Physician Decision|1|||
105941128|NCT03163667|365446352|FG000|Overall Study|Death|15|||
105941129|NCT03163667|365446353|FG001|Overall Study|Death|27|||
105941130|NCT03163667|365446352|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
105941131|NCT03163667|365446353|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
105941132|NCT02971163|365446363|FG000|Overall Study|Lost to Follow-up|4|||
105941133|NCT02971163|365446364|FG001|Overall Study|Lost to Follow-up|2|||
105941134|NCT00855166|365446365|FG000|Overall Study|Adverse Event|0|||
105941135|NCT00855166|365446366|FG001|Overall Study|Adverse Event|2|||
105941136|NCT00855166|365446365|FG000|Overall Study|Death|0|||
105941137|NCT00855166|365446366|FG001|Overall Study|Death|1|||
105941138|NCT00855166|365446365|FG000|Overall Study|Withdrawal by Subject|1|||
105941139|NCT00855166|365446366|FG001|Overall Study|Withdrawal by Subject|4|||
105941140|NCT00855166|365446365|FG000|Overall Study|Poor/non-compliance|2|||
105941141|NCT00855166|365446366|FG001|Overall Study|Poor/non-compliance|0|||
105941142|NCT00855166|365446365|FG000|Overall Study|Administrative reasons by sponsor|1|||
105941143|NCT00855166|365446366|FG001|Overall Study|Administrative reasons by sponsor|0|||
105941144|NCT00855166|365446365|FG000|Overall Study|Subject no longer meets study criteria|1|||
105941145|NCT00855166|365446366|FG001|Overall Study|Subject no longer meets study criteria|1|||
105941146|NCT00539500|365446367|FG000|Overall Study|Disease Progression|1|||
105941147|NCT00539500|365446367|FG000|Overall Study|Lost to Follow-up|2|||
105941148|NCT04126174|365446370|FG000|Overall Study|Lost to Follow-up|3|||
105941149|NCT04126174|365446371|FG001|Overall Study|Lost to Follow-up|3|||
105941150|NCT03773562|365446372|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
105941151|NCT03773562|365446372|FG000|Overall Study|Lost to Follow-up|10|||
105941152|NCT03773562|365446372|FG000|Overall Study|Withdrawal by Subject|1|||
105941153|NCT03131479|365446373|FG000|Overall Study|Adverse Event|0|||
105941154|NCT03131479|365446374|FG001|Overall Study|Adverse Event|0|||
105941155|NCT03131479|365446375|FG002|Overall Study|Adverse Event|1|||
105941156|NCT03131479|365446376|FG003|Overall Study|Adverse Event|1|||
105941157|NCT03131479|365446377|FG004|Overall Study|Adverse Event|0|||
105941158|NCT03131479|365446373|FG000|Overall Study|Subject/Guardian Decision|0|||
105941159|NCT03131479|365446374|FG001|Overall Study|Subject/Guardian Decision|0|||
105941160|NCT03131479|365446375|FG002|Overall Study|Subject/Guardian Decision|0|||
105941161|NCT03131479|365446376|FG003|Overall Study|Subject/Guardian Decision|1|||
105941162|NCT03131479|365446377|FG004|Overall Study|Subject/Guardian Decision|0|||
105941163|NCT05305651|365446378|FG000|Overall Study|Death|1|||
105941164|NCT05305651|365446378|FG000|Overall Study|Withdrawal by Subject|4|||
105941165|NCT05305651|365446378|FG000|Overall Study|Lost to Follow-up|4|||
105738773|NCT01070550|364699882|FG002|Overall Study|Miscellaneous|3|||
105941166|NCT01979185|365446379|FG000|Period 2|Other|0|||
105941167|NCT01979185|365446380|FG001|Period 2|Other|1|||
105941168|NCT02231580|365446381|FG000|Overall Study|Adverse Event|5|||
105738774|NCT01070550|364699883|FG003|Overall Study|Miscellaneous|1|||
105738775|NCT01070550|364699884|FG004|Overall Study|Miscellaneous|0|||
105738776|NCT01070550|364699885|FG005|Overall Study|Miscellaneous|0|||
105738777|NCT01070550|364699880|FG000|Overall Study|New treatment started|3|||
105738778|NCT01070550|364699881|FG001|Overall Study|New treatment started|1|||
105738779|NCT01070550|364699882|FG002|Overall Study|New treatment started|0|||
105941169|NCT02231580|365446382|FG001|Overall Study|Adverse Event|0|||
105941170|NCT04221438|365446383|FG000|Overall Study|Adverse Event|1|||
105941171|NCT04221438|365446383|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
106013340|NCT00541658|365714775|FG001|Overall Study|Physician Decision|0|||
106013341|NCT00541658|365714776|FG002|Overall Study|Physician Decision|4|||
106013342|NCT00541658|365714774|FG000|Overall Study|Lost to Follow-up|3|||
106013343|NCT00541658|365714775|FG001|Overall Study|Lost to Follow-up|3|||
106141611|NCT02962674|366177731|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
106141612|NCT02715258|366177732|FG000|Overall Study|Withdrawal by Subject|6|||
106141613|NCT02715258|366177733|FG001|Overall Study|Withdrawal by Subject|1|||
105738780|NCT01070550|364699883|FG003|Overall Study|New treatment started|2|||
106013344|NCT00541658|365714776|FG002|Overall Study|Lost to Follow-up|6|||
106013345|NCT00541658|365714774|FG000|Overall Study|Protocol Violation|0|||
106013346|NCT00541658|365714775|FG001|Overall Study|Protocol Violation|1|||
106013347|NCT00541658|365714776|FG002|Overall Study|Protocol Violation|1|||
106013348|NCT00541658|365714774|FG000|Overall Study|Withdrawal by Subject|28|||
106013349|NCT00541658|365714775|FG001|Overall Study|Withdrawal by Subject|32|||
106013350|NCT00541658|365714776|FG002|Overall Study|Withdrawal by Subject|32|||
106013351|NCT00541658|365714774|FG000|Overall Study|Took No Study Drug|1|||
106013352|NCT00541658|365714775|FG001|Overall Study|Took No Study Drug|0|||
106013353|NCT00541658|365714776|FG002|Overall Study|Took No Study Drug|0|||
106013354|NCT04986904|365714777|FG000|Overall Study|Lost to Follow-up|11|||
106013355|NCT04986904|365714777|FG000|Overall Study|Withdrawal by Subject|1|||
106013356|NCT04123470|365714778|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
106013357|NCT04123470|365714779|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
106013358|NCT04123470|365714778|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
106013359|NCT04123470|365714779|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
106013360|NCT04123470|365714778|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
106013361|NCT04123470|365714779|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
106013362|NCT04123470|365714778|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
106013363|NCT04123470|365714779|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
106013364|NCT00759941|365714780|FG000|Overall Study|Use of medication|1|||
106013365|NCT00759941|365714781|FG001|Overall Study|Use of medication|0|||
106013366|NCT00759941|365714780|FG000|Overall Study|Adverse Event|1|||
106013367|NCT00759941|365714781|FG001|Overall Study|Adverse Event|0|||
106013368|NCT00759941|365714780|FG000|Overall Study|Exited in error by site|1|||
106013369|NCT00759941|365714781|FG001|Overall Study|Exited in error by site|1|||
106013370|NCT03467750|365714793|FG000|Overall Study|Surgery canceled|1|||
106013371|NCT03467750|365714794|FG001|Overall Study|Surgery canceled|0|||
106141614|NCT02715258|366177732|FG000|Overall Study|Lost to Follow-up|7|||
105738781|NCT01070550|364699884|FG004|Overall Study|New treatment started|0|||
105738782|NCT01070550|364699885|FG005|Overall Study|New treatment started|0|||
105738783|NCT01070550|364699880|FG000|Overall Study|Non-responders|493|||
105738784|NCT01070550|364699881|FG001|Overall Study|Non-responders|4|||
105738785|NCT01070550|364699882|FG002|Overall Study|Non-responders|21|||
105738786|NCT01070550|364699883|FG003|Overall Study|Non-responders|20|||
105738787|NCT01070550|364699884|FG004|Overall Study|Non-responders|0|||
105738788|NCT01070550|364699885|FG005|Overall Study|Non-responders|2|||
105738789|NCT01070550|364699880|FG000|Overall Study|Not categorized|33|||
105738790|NCT01070550|364699881|FG001|Overall Study|Not categorized|2|||
105738791|NCT01070550|364699882|FG002|Overall Study|Not categorized|6|||
105738792|NCT01070550|364699883|FG003|Overall Study|Not categorized|1|||
105738793|NCT01070550|364699884|FG004|Overall Study|Not categorized|0|||
105738794|NCT01070550|364699885|FG005|Overall Study|Not categorized|1|||
105738795|NCT01070550|364699880|FG000|Overall Study|Protocol Violation|15|||
105738796|NCT01070550|364699881|FG001|Overall Study|Protocol Violation|1|||
105738797|NCT01070550|364699882|FG002|Overall Study|Protocol Violation|1|||
105738798|NCT01070550|364699883|FG003|Overall Study|Protocol Violation|1|||
105738799|NCT01070550|364699884|FG004|Overall Study|Protocol Violation|0|||
105738800|NCT01070550|364699885|FG005|Overall Study|Protocol Violation|0|||
105799804|NCT04380701|364924638|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
106141615|NCT02715258|366177733|FG001|Overall Study|Lost to Follow-up|1|||
106141616|NCT02715258|366177732|FG000|Overall Study|Terminated by Sponsor|0|||
106141617|NCT02715258|366177733|FG001|Overall Study|Terminated by Sponsor|1|||
106141618|NCT02715258|366177732|FG000|Overall Study|Death|0|||
106141619|NCT02715258|366177733|FG001|Overall Study|Death|1|||
105738801|NCT01070550|364699880|FG000|Overall Study|Relapse|44|||
106141620|NCT02715258|366177732|FG000|Overall Study|Subject non-compliant|1|||
105738802|NCT01070550|364699881|FG001|Overall Study|Relapse|5|||
105738803|NCT01070550|364699882|FG002|Overall Study|Relapse|14|||
105799805|NCT04380701|364924639|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
106013372|NCT03467750|365714793|FG000|Overall Study|Protocol Violation|1|||
106013373|NCT03467750|365714794|FG001|Overall Study|Protocol Violation|1|||
106013374|NCT03467750|365714793|FG000|Overall Study|Withdrawal by Subject|0|||
106013375|NCT03467750|365714794|FG001|Overall Study|Withdrawal by Subject|1|||
105738804|NCT01070550|364699883|FG003|Overall Study|Relapse|4|||
105738805|NCT01070550|364699884|FG004|Overall Study|Relapse|0|||
106013376|NCT05673876|365714795|FG000|Overall Study|Death|3|||
105738806|NCT01070550|364699885|FG005|Overall Study|Relapse|0|||
105738807|NCT01070550|364699880|FG000|Overall Study|Result not available|3|||
105738808|NCT01070550|364699881|FG001|Overall Study|Result not available|1|||
105738809|NCT01070550|364699882|FG002|Overall Study|Result not available|3|||
105738810|NCT01070550|364699883|FG003|Overall Study|Result not available|0|||
105738811|NCT01070550|364699884|FG004|Overall Study|Result not available|0|||
105738812|NCT01070550|364699885|FG005|Overall Study|Result not available|0|||
105738813|NCT01070550|364699880|FG000|Overall Study|Screen failure|1|||
105738814|NCT01070550|364699881|FG001|Overall Study|Screen failure|0|||
105738815|NCT01070550|364699882|FG002|Overall Study|Screen failure|0|||
105738816|NCT01070550|364699883|FG003|Overall Study|Screen failure|0|||
105738817|NCT01070550|364699884|FG004|Overall Study|Screen failure|0|||
106013377|NCT05673876|365714796|FG001|Overall Study|Death|1|||
106013378|NCT05673876|365714795|FG000|Overall Study|Study Terminated by Sponsor|0|||
106013379|NCT05673876|365714796|FG001|Overall Study|Study Terminated by Sponsor|1|||
106013380|NCT05673876|365714795|FG000|Overall Study|Physician Decision|0|||
106013381|NCT05673876|365714796|FG001|Overall Study|Physician Decision|1|||
106013382|NCT04500158|365714802|FG000|Overall Study|Physician Decision|17|||
106013383|NCT04500158|365714803|FG001|Overall Study|Physician Decision|11|||
106013384|NCT03205423|365714804|FG000|Overall Study|Personal|1|||
106013385|NCT03205423|365714805|FG001|Overall Study|Personal|1|||
106013386|NCT03205423|365714804|FG000|Overall Study|Physician Decision|0|||
106013387|NCT03205423|365714805|FG001|Overall Study|Physician Decision|2|||
106013388|NCT05786651|365714810|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
106013389|NCT04390763|365714811|FG000|Safety run-in Part|Adverse Event|4|||
106013390|NCT04390763|365714812|FG001|Safety run-in Part|Adverse Event|0|||
106013391|NCT04390763|365714813|FG002|Safety run-in Part|Adverse Event|0|||
106013392|NCT04390763|365714814|FG003|Safety run-in Part|Adverse Event|0|||
106013393|NCT04390763|365714811|FG000|Safety run-in Part|Physician Decision|1|||
106013394|NCT04390763|365714812|FG001|Safety run-in Part|Physician Decision|0|||
106013395|NCT04390763|365714813|FG002|Safety run-in Part|Physician Decision|0|||
106013396|NCT04390763|365714814|FG003|Safety run-in Part|Physician Decision|0|||
106013397|NCT04390763|365714811|FG000|Safety run-in Part|Progressive Disease|6|||
106013398|NCT04390763|365714812|FG001|Safety run-in Part|Progressive Disease|0|||
106013399|NCT04390763|365714813|FG002|Safety run-in Part|Progressive Disease|0|||
106013400|NCT04390763|365714814|FG003|Safety run-in Part|Progressive Disease|0|||
106013401|NCT04390763|365714811|FG000|Randomized Part|Adverse Event|0|||
106013402|NCT04390763|365714812|FG001|Randomized Part|Adverse Event|11|||
106013403|NCT04390763|365714813|FG002|Randomized Part|Adverse Event|5|||
106013404|NCT04390763|365714814|FG003|Randomized Part|Adverse Event|5|||
106013405|NCT04390763|365714811|FG000|Randomized Part|Death|0|||
106013406|NCT04390763|365714812|FG001|Randomized Part|Death|3|||
106013407|NCT04390763|365714813|FG002|Randomized Part|Death|4|||
106013408|NCT04390763|365714814|FG003|Randomized Part|Death|2|||
106013409|NCT04390763|365714811|FG000|Randomized Part|Physician Decision|0|||
106013410|NCT04390763|365714812|FG001|Randomized Part|Physician Decision|2|||
106013411|NCT04390763|365714813|FG002|Randomized Part|Physician Decision|2|||
106013412|NCT04390763|365714814|FG003|Randomized Part|Physician Decision|9|||
106013413|NCT04390763|365714811|FG000|Randomized Part|Progressive Disease|0|||
106013414|NCT04390763|365714812|FG001|Randomized Part|Progressive Disease|24|||
106013415|NCT04390763|365714813|FG002|Randomized Part|Progressive Disease|31|||
106013416|NCT04390763|365714814|FG003|Randomized Part|Progressive Disease|23|||
106013417|NCT04390763|365714811|FG000|Randomized Part|Study terminated by sponsor|0|||
106013418|NCT04390763|365714812|FG001|Randomized Part|Study terminated by sponsor|1|||
106013419|NCT04390763|365714813|FG002|Randomized Part|Study terminated by sponsor|0|||
106013420|NCT04390763|365714814|FG003|Randomized Part|Study terminated by sponsor|0|||
106013421|NCT04390763|365714811|FG000|Randomized Part|Participant Decision|0|||
106013422|NCT04390763|365714812|FG001|Randomized Part|Participant Decision|5|||
106013423|NCT04390763|365714813|FG002|Randomized Part|Participant Decision|7|||
106141621|NCT02715258|366177733|FG001|Overall Study|Subject non-compliant|1|||
106013424|NCT04390763|365714814|FG003|Randomized Part|Participant Decision|6|||
106013425|NCT04390763|365714811|FG000|Randomized Part|Not treated|0|||
106013426|NCT04390763|365714812|FG001|Randomized Part|Not treated|4|||
106141622|NCT02715258|366177732|FG000|Overall Study|GCP violation|2|||
106141623|NCT02715258|366177733|FG001|Overall Study|GCP violation|1|||
106141624|NCT02263508|366177734|FG000|Overall Study|Withdrawal by Subject|1|||
106141625|NCT02263508|366177735|FG001|Overall Study|Withdrawal by Subject|23|||
106141626|NCT02263508|366177736|FG002|Overall Study|Withdrawal by Subject|17|||
106141627|NCT02263508|366177734|FG000|Overall Study|Sponsor Decision|12|||
106141628|NCT02263508|366177735|FG001|Overall Study|Sponsor Decision|165|||
105738818|NCT01070550|364699885|FG005|Overall Study|Screen failure|0|||
105738819|NCT01070550|364699880|FG000|Overall Study|Sponsor decision|1|||
105738820|NCT01070550|364699881|FG001|Overall Study|Sponsor decision|0|||
105738821|NCT01070550|364699882|FG002|Overall Study|Sponsor decision|0|||
105738822|NCT01070550|364699883|FG003|Overall Study|Sponsor decision|0|||
106013427|NCT04390763|365714813|FG002|Randomized Part|Not treated|2|||
106013428|NCT04390763|365714814|FG003|Randomized Part|Not treated|7|||
106013429|NCT00911170|365714815|FG000|Treatment Period|Randomized in error|1|||
106013430|NCT00911170|365714816|FG001|Treatment Period|Randomized in error|1|||
106141629|NCT02263508|366177736|FG002|Overall Study|Sponsor Decision|182|||
105738823|NCT01070550|364699884|FG004|Overall Study|Sponsor decision|0|||
105738824|NCT01070550|364699885|FG005|Overall Study|Sponsor decision|0|||
105738825|NCT01070550|364699880|FG000|Overall Study|Treatment duration shortened|1|||
105738826|NCT01070550|364699881|FG001|Overall Study|Treatment duration shortened|0|||
105738827|NCT01070550|364699882|FG002|Overall Study|Treatment duration shortened|0|||
105738828|NCT01070550|364699883|FG003|Overall Study|Treatment duration shortened|0|||
105738829|NCT01070550|364699884|FG004|Overall Study|Treatment duration shortened|0|||
105738830|NCT01070550|364699885|FG005|Overall Study|Treatment duration shortened|0|||
105738831|NCT01070550|364699880|FG000|Overall Study|Treatment interrupted|7|||
105738832|NCT01070550|364699881|FG001|Overall Study|Treatment interrupted|0|||
105738833|NCT01070550|364699882|FG002|Overall Study|Treatment interrupted|1|||
105738834|NCT01070550|364699883|FG003|Overall Study|Treatment interrupted|1|||
105738835|NCT01070550|364699884|FG004|Overall Study|Treatment interrupted|0|||
105738836|NCT01070550|364699885|FG005|Overall Study|Treatment interrupted|0|||
105738837|NCT01070550|364699880|FG000|Overall Study|Treatment not started|14|||
105738838|NCT01070550|364699881|FG001|Overall Study|Treatment not started|2|||
105738839|NCT01070550|364699882|FG002|Overall Study|Treatment not started|4|||
105738840|NCT01070550|364699883|FG003|Overall Study|Treatment not started|0|||
105738841|NCT01070550|364699884|FG004|Overall Study|Treatment not started|0|||
105738842|NCT01070550|364699885|FG005|Overall Study|Treatment not started|0|||
105738843|NCT01070550|364699880|FG000|Overall Study|Treatment restarted|0|||
105738844|NCT01070550|364699881|FG001|Overall Study|Treatment restarted|1|||
105738845|NCT01070550|364699882|FG002|Overall Study|Treatment restarted|0|||
105738846|NCT01070550|364699883|FG003|Overall Study|Treatment restarted|0|||
105738847|NCT01070550|364699884|FG004|Overall Study|Treatment restarted|0|||
105738848|NCT01070550|364699885|FG005|Overall Study|Treatment restarted|0|||
105738849|NCT01070550|364699880|FG000|Overall Study|Treatment stopped|3|||
105738850|NCT01070550|364699881|FG001|Overall Study|Treatment stopped|0|||
105738851|NCT01070550|364699882|FG002|Overall Study|Treatment stopped|0|||
105738852|NCT01070550|364699883|FG003|Overall Study|Treatment stopped|0|||
105738853|NCT01070550|364699884|FG004|Overall Study|Treatment stopped|0|||
105738854|NCT01070550|364699885|FG005|Overall Study|Treatment stopped|0|||
105738855|NCT01070550|364699880|FG000|Overall Study|Treatment unavailable|1|||
105738856|NCT01070550|364699881|FG001|Overall Study|Treatment unavailable|0|||
105738857|NCT01070550|364699882|FG002|Overall Study|Treatment unavailable|0|||
105799806|NCT04380701|364924640|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105941172|NCT03620981|365446384|FG000|Overall Study|Adverse Event|14|||
105941173|NCT03620981|365446385|FG001|Overall Study|Adverse Event|38|||
105941174|NCT03620981|365446386|FG002|Overall Study|Adverse Event|25|||
105941175|NCT03620981|365446384|FG000|Overall Study|Lack of Efficacy|2|||
105941176|NCT03620981|365446385|FG001|Overall Study|Lack of Efficacy|1|||
105941177|NCT03620981|365446386|FG002|Overall Study|Lack of Efficacy|1|||
105941178|NCT03620981|365446384|FG000|Overall Study|Physician Decision|7|||
105941179|NCT03620981|365446385|FG001|Overall Study|Physician Decision|4|||
105941180|NCT03620981|365446386|FG002|Overall Study|Physician Decision|4|||
105941181|NCT03620981|365446384|FG000|Overall Study|Protocol Violation|1|||
105941182|NCT03620981|365446385|FG001|Overall Study|Protocol Violation|2|||
105941183|NCT03620981|365446386|FG002|Overall Study|Protocol Violation|1|||
105941184|NCT03620981|365446384|FG000|Overall Study|Withdrawal by Legal Representative|2|||
105941185|NCT03620981|365446385|FG001|Overall Study|Withdrawal by Legal Representative|1|||
105941186|NCT03620981|365446386|FG002|Overall Study|Withdrawal by Legal Representative|1|||
105941187|NCT03620981|365446384|FG000|Overall Study|Withdrawal by Care Giver|2|||
105941188|NCT03620981|365446385|FG001|Overall Study|Withdrawal by Care Giver|0|||
105941189|NCT03620981|365446386|FG002|Overall Study|Withdrawal by Care Giver|1|||
105941190|NCT03620981|365446384|FG000|Overall Study|Non-compliance with Study Drug|1|||
105941191|NCT03620981|365446385|FG001|Overall Study|Non-compliance with Study Drug|1|||
105941192|NCT03620981|365446386|FG002|Overall Study|Non-compliance with Study Drug|0|||
105941193|NCT04082364|365446388|FG000|Overall Study|Death|23|||
105941194|NCT04082364|365446389|FG001|Overall Study|Death|1|||
105941195|NCT04082364|365446390|FG002|Overall Study|Death|1|||
105941196|NCT04082364|365446391|FG003|Overall Study|Death|2|||
105941197|NCT04082364|365446392|FG004|Overall Study|Death|1|||
105941198|NCT04082364|365446388|FG000|Overall Study|Lost to Follow-up|1|||
105941199|NCT04082364|365446389|FG001|Overall Study|Lost to Follow-up|0|||
105941200|NCT04082364|365446390|FG002|Overall Study|Lost to Follow-up|0|||
105941201|NCT04082364|365446391|FG003|Overall Study|Lost to Follow-up|0|||
105941202|NCT04082364|365446392|FG004|Overall Study|Lost to Follow-up|1|||
106141630|NCT02263508|366177734|FG000|Overall Study|Lost to Follow-up|2|||
106141631|NCT02263508|366177735|FG001|Overall Study|Lost to Follow-up|7|||
105941203|NCT04082364|365446388|FG000|Overall Study|Physician Decision|1|||
105738858|NCT01070550|364699883|FG003|Overall Study|Treatment unavailable|0|||
105738859|NCT01070550|364699884|FG004|Overall Study|Treatment unavailable|0|||
105738860|NCT01070550|364699885|FG005|Overall Study|Treatment unavailable|0|||
105738861|NCT01070550|364699880|FG000|Overall Study|Treatment was stopped early|7|||
105738862|NCT01070550|364699881|FG001|Overall Study|Treatment was stopped early|0|||
105738863|NCT01070550|364699882|FG002|Overall Study|Treatment was stopped early|0|||
105738864|NCT01070550|364699883|FG003|Overall Study|Treatment was stopped early|0|||
105941204|NCT04082364|365446389|FG001|Overall Study|Physician Decision|1|||
105941205|NCT04082364|365446390|FG002|Overall Study|Physician Decision|0|||
105941206|NCT04082364|365446391|FG003|Overall Study|Physician Decision|2|||
105941207|NCT04082364|365446392|FG004|Overall Study|Physician Decision|1|||
105941208|NCT04082364|365446388|FG000|Overall Study|Withdrawal by Subject|1|||
105941209|NCT04082364|365446389|FG001|Overall Study|Withdrawal by Subject|1|||
105941210|NCT04082364|365446390|FG002|Overall Study|Withdrawal by Subject|0|||
105941211|NCT04082364|365446391|FG003|Overall Study|Withdrawal by Subject|0|||
105941212|NCT04082364|365446392|FG004|Overall Study|Withdrawal by Subject|1|||
105941213|NCT04082364|365446388|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
105941214|NCT04082364|365446389|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
105941215|NCT04082364|365446390|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
105941216|NCT04082364|365446391|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
105941217|NCT04082364|365446392|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
105941218|NCT04082364|365446388|FG000|Overall Study|Disease progression|0|||
105941219|NCT04082364|365446389|FG001|Overall Study|Disease progression|0|||
105941220|NCT04082364|365446390|FG002|Overall Study|Disease progression|0|||
105941221|NCT04082364|365446391|FG003|Overall Study|Disease progression|1|||
105941222|NCT04082364|365446392|FG004|Overall Study|Disease progression|0|||
105941223|NCT03934684|365446394|FG000|Overall Study|Participants continuing in study|11|||
105941224|NCT03934684|365446395|FG001|Overall Study|Participants continuing in study|4|||
105941225|NCT03934684|365446394|FG000|Overall Study|Discontinuation of carfilzomib|20|||
105941226|NCT03934684|365446395|FG001|Overall Study|Discontinuation of carfilzomib|30|||
105738865|NCT01070550|364699884|FG004|Overall Study|Treatment was stopped early|0|||
105738866|NCT01070550|364699885|FG005|Overall Study|Treatment was stopped early|0|||
105738867|NCT01070550|364699880|FG000|Overall Study|Other|5|||
105738868|NCT01070550|364699881|FG001|Overall Study|Other|0|||
105738869|NCT01070550|364699882|FG002|Overall Study|Other|0|||
105738870|NCT01070550|364699883|FG003|Overall Study|Other|1|||
105738871|NCT01070550|364699884|FG004|Overall Study|Other|0|||
105738872|NCT01070550|364699885|FG005|Overall Study|Other|0|||
105738873|NCT01070550|364699880|FG000|Overall Study|Withdrawal by Subject|35|||
105738874|NCT01070550|364699881|FG001|Overall Study|Withdrawal by Subject|0|||
105738875|NCT01070550|364699882|FG002|Overall Study|Withdrawal by Subject|3|||
105738876|NCT01070550|364699883|FG003|Overall Study|Withdrawal by Subject|0|||
105738877|NCT01070550|364699884|FG004|Overall Study|Withdrawal by Subject|0|||
105738878|NCT01070550|364699885|FG005|Overall Study|Withdrawal by Subject|0|||
105738879|NCT02869867|364699888|FG000|Overall Study|Protocol Violation|1|||
105738880|NCT02869867|364699889|FG001|Overall Study|Protocol Violation|0|||
105738881|NCT02869867|364699888|FG000|Overall Study|Lost to Follow-up|5|||
105738882|NCT02869867|364699889|FG001|Overall Study|Lost to Follow-up|5|||
105738883|NCT03554005|364699892|FG000|Overall Study|Not in participant's best interest|0|||
105738884|NCT03554005|364699893|FG001|Overall Study|Not in participant's best interest|0|||
105738885|NCT03554005|364699894|FG002|Overall Study|Not in participant's best interest|0|||
105738886|NCT03554005|364699895|FG003|Overall Study|Not in participant's best interest|0|||
105738887|NCT03554005|364699896|FG004|Overall Study|Not in participant's best interest|0|||
105738888|NCT03554005|364699897|FG005|Overall Study|Not in participant's best interest|1|||
105738889|NCT03554005|364699892|FG000|Overall Study|Disease Progression|1|||
105738890|NCT03554005|364699893|FG001|Overall Study|Disease Progression|1|||
105738891|NCT03554005|364699894|FG002|Overall Study|Disease Progression|1|||
105738892|NCT03554005|364699895|FG003|Overall Study|Disease Progression|1|||
105738893|NCT03554005|364699896|FG004|Overall Study|Disease Progression|5|||
105738894|NCT03554005|364699897|FG005|Overall Study|Disease Progression|6|||
105738895|NCT03554005|364699892|FG000|Overall Study|Adverse Event|0|||
105738896|NCT03554005|364699893|FG001|Overall Study|Adverse Event|0|||
105738897|NCT03554005|364699894|FG002|Overall Study|Adverse Event|0|||
105738898|NCT03554005|364699895|FG003|Overall Study|Adverse Event|0|||
105738899|NCT03554005|364699896|FG004|Overall Study|Adverse Event|0|||
105738900|NCT03554005|364699897|FG005|Overall Study|Adverse Event|3|||
105738901|NCT03554005|364699892|FG000|Overall Study|Physician Decision|0|||
105738902|NCT03554005|364699893|FG001|Overall Study|Physician Decision|0|||
105738903|NCT03554005|364699894|FG002|Overall Study|Physician Decision|0|||
105738904|NCT03554005|364699895|FG003|Overall Study|Physician Decision|0|||
105738905|NCT03554005|364699896|FG004|Overall Study|Physician Decision|1|||
105738906|NCT03554005|364699897|FG005|Overall Study|Physician Decision|0|||
105738907|NCT03554005|364699892|FG000|Overall Study|Other|0|||
105738908|NCT03554005|364699893|FG001|Overall Study|Other|0|||
105941227|NCT03934684|365446394|FG000|Overall Study|Death|2|||
105941228|NCT03934684|365446395|FG001|Overall Study|Death|2|||
105941229|NCT03934684|365446394|FG000|Overall Study|Lost to Follow-up|2|||
105941230|NCT03934684|365446395|FG001|Overall Study|Lost to Follow-up|5|||
105738909|NCT03554005|364699894|FG002|Overall Study|Other|0|||
105738910|NCT03554005|364699895|FG003|Overall Study|Other|0|||
105738911|NCT03554005|364699896|FG004|Overall Study|Other|0|||
105738912|NCT03554005|364699897|FG005|Overall Study|Other|1|||
105738913|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
105738914|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
105738915|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
105738916|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738917|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738918|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738919|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738920|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
105738921|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
105738922|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
105738923|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
105738924|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738925|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738926|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738927|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738928|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
105738929|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
105738930|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
105738931|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
105738932|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738933|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738934|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738935|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738936|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
105738937|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
105738938|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
105738939|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105738940|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105738941|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105799807|NCT04380701|364924641|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799808|NCT04380701|364924642|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799809|NCT04380701|364924643|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799810|NCT04380701|364924644|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105941231|NCT03934684|365446394|FG000|Overall Study|Withdrawal by Subject|7|||
105941232|NCT03934684|365446395|FG001|Overall Study|Withdrawal by Subject|8|||
105941233|NCT03633058|365446398|FG000|Overall Study|Adverse Event|0|||
105941234|NCT03633058|365446399|FG001|Overall Study|Adverse Event|0|||
105941235|NCT03633058|365446400|FG002|Overall Study|Adverse Event|1|||
105941236|NCT03633058|365446401|FG003|Overall Study|Adverse Event|0|||
105941237|NCT03034044|365446402|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
105941238|NCT04134936|365446403|FG000|Overall Study|Adverse Event|3|||
105941239|NCT04134936|365446404|FG001|Overall Study|Adverse Event|2|||
105941240|NCT04134936|365446403|FG000|Overall Study|Withdrawal by Subject|2|||
105941241|NCT04134936|365446404|FG001|Overall Study|Withdrawal by Subject|3|||
105941242|NCT04134936|365446403|FG000|Overall Study|Physician Decision|0|||
105941243|NCT04134936|365446404|FG001|Overall Study|Physician Decision|1|||
105941244|NCT04134936|365446403|FG000|Overall Study|Progressive disease, joined another trial|1|||
105941245|NCT04134936|365446404|FG001|Overall Study|Progressive disease, joined another trial|0|||
105941246|NCT04134936|365446403|FG000|Overall Study|Progressive disease|1|||
105941247|NCT04134936|365446404|FG001|Overall Study|Progressive disease|0|||
105941248|NCT01450631|365446408|FG000|Overall Study|Lost to Follow-up|2|||
105941249|NCT01450631|365446409|FG001|Overall Study|Lost to Follow-up|4|||
105941250|NCT01450631|365446408|FG000|Overall Study|Withdrawal by Subject|1|||
105941251|NCT01450631|365446409|FG001|Overall Study|Withdrawal by Subject|0|||
105941252|NCT04129398|365447631|FG000|Overall Study|Physician Decision|2|||
105941253|NCT00590317|365447634|FG000|Overall Study|Lack of Efficacy|1|||
105941254|NCT00590317|365447635|FG001|Overall Study|Lack of Efficacy|5|||
105941255|NCT02439957|365447636|FG000|Overall Study|Study Terminated|3|||
105941256|NCT02439957|365447637|FG001|Overall Study|Study Terminated|3|||
105941257|NCT02014467|365447638|FG000|Overall Study|Adverse Event|4|||
105941258|NCT02014467|365447639|FG001|Overall Study|Adverse Event|0|||
105941259|NCT02014467|365447638|FG000|Overall Study|Protocol Violation|3|||
105941260|NCT02014467|365447639|FG001|Overall Study|Protocol Violation|0|||
105941261|NCT02014467|365447638|FG000|Overall Study|Physician Decision|2|||
105941262|NCT02014467|365447639|FG001|Overall Study|Physician Decision|3|||
105941263|NCT02014467|365447638|FG000|Overall Study|Withdrawal by Subject|16|||
105941264|NCT02014467|365447639|FG001|Overall Study|Withdrawal by Subject|4|||
105941265|NCT01052779|365447641|FG000|Overall Study|Adverse Event|1|||
105941266|NCT01052779|365447642|FG001|Overall Study|Adverse Event|4|||
105941267|NCT01052779|365447641|FG000|Overall Study|Withdrawal by Subject|1|||
105941268|NCT01052779|365447642|FG001|Overall Study|Withdrawal by Subject|2|||
105941269|NCT01052779|365447641|FG000|Overall Study|Other-Protocol Violation|1|||
105952160|NCT03314935|365488196|FG012|Phase 2|Withdrawal by Subject|1|||
105952161|NCT03314935|365488197|FG013|Phase 2|Withdrawal by Subject|0|||
105799811|NCT04380701|364924645|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799812|NCT04380701|364924646|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799813|NCT04380701|364924647|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
105799814|NCT03550794|364924648|FG000|Overall Study|No longer met inclusion criteria|1|||
105799815|NCT03550794|364924649|FG001|Overall Study|No longer met inclusion criteria|2|||
105799816|NCT03550794|364924648|FG000|Overall Study|Goals of care changed|1|||
105799817|NCT03550794|364924649|FG001|Overall Study|Goals of care changed|0|||
105799818|NCT03550794|364924648|FG000|Overall Study|Withdrawal by Subject|2|||
105799819|NCT03550794|364924649|FG001|Overall Study|Withdrawal by Subject|0|||
105799820|NCT03550794|364924648|FG000|Overall Study|Death|0|||
105738942|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105799821|NCT03550794|364924649|FG001|Overall Study|Death|1|||
105799822|NCT00449930|364924650|FG000|Overall Study|Adverse Event|9|||
105799823|NCT00449930|364924651|FG001|Overall Study|Adverse Event|19|||
105799824|NCT00449930|364924650|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
105799825|NCT00449930|364924651|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
105799826|NCT00449930|364924650|FG000|Overall Study|Lack of Efficacy|10|||
105799827|NCT00449930|364924651|FG001|Overall Study|Lack of Efficacy|1|||
105799828|NCT00449930|364924650|FG000|Overall Study|Lost to Follow-up|9|||
105799829|NCT00449930|364924651|FG001|Overall Study|Lost to Follow-up|14|||
105799830|NCT00449930|364924650|FG000|Overall Study|Physician Decision|1|||
105799831|NCT00449930|364924651|FG001|Overall Study|Physician Decision|2|||
105799832|NCT00449930|364924650|FG000|Overall Study|Protocol Violation|14|||
105799833|NCT00449930|364924651|FG001|Overall Study|Protocol Violation|15|||
105799834|NCT00449930|364924650|FG000|Overall Study|Withdrawal by Subject|16|||
105799835|NCT00449930|364924651|FG001|Overall Study|Withdrawal by Subject|23|||
106013431|NCT00911170|365714815|FG000|Treatment Period|Ineligibility determined|1|||
106013432|NCT00911170|365714816|FG001|Treatment Period|Ineligibility determined|3|||
106013433|NCT00911170|365714815|FG000|Treatment Period|Protocol deviation|1|||
105738943|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105738944|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
105738945|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
105738946|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
105738947|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
105738948|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738949|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738950|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738951|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738952|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
105738953|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
105799836|NCT00449930|364924650|FG000|Overall Study|Glycemic discontinuation criteria|1|||
105799837|NCT00449930|364924651|FG001|Overall Study|Glycemic discontinuation criteria|1|||
105799838|NCT01890785|364924652|FG000|Third Intervention|Withdrawal by Subject|0|||
105941270|NCT01052779|365447642|FG001|Overall Study|Other-Protocol Violation|1|||
105941271|NCT01052779|365447641|FG000|Overall Study|Other-Surgery|0|||
105941272|NCT01052779|365447642|FG001|Overall Study|Other-Surgery|2|||
105941273|NCT01052779|365447641|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
105941274|NCT01052779|365447642|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
105941275|NCT03802916|365447643|FG000|Overall Study|Adverse Event|0|||
105941276|NCT03802916|365447644|FG001|Overall Study|Adverse Event|1|||
105941277|NCT03802916|365447643|FG000|Overall Study|Withdrawal by Subject|0|||
105941278|NCT03802916|365447644|FG001|Overall Study|Withdrawal by Subject|1|||
105941279|NCT00779909|365447645|FG000|Overall Study|Lost to Follow-up|1|||
105941280|NCT00779909|365447646|FG001|Overall Study|Lost to Follow-up|0|||
105941281|NCT00779909|365447647|FG002|Overall Study|Lost to Follow-up|0|||
105941282|NCT00779909|365447648|FG003|Overall Study|Lost to Follow-up|1|||
105941283|NCT00779909|365447645|FG000|Overall Study|Withdrawal by Subject|0|||
105941284|NCT00779909|365447646|FG001|Overall Study|Withdrawal by Subject|1|||
105941285|NCT00779909|365447647|FG002|Overall Study|Withdrawal by Subject|0|||
105941286|NCT00779909|365447648|FG003|Overall Study|Withdrawal by Subject|0|||
106013434|NCT00911170|365714816|FG001|Treatment Period|Protocol deviation|2|||
105799839|NCT01890785|364924653|FG001|Third Intervention|Withdrawal by Subject|1|||
105799840|NCT01890785|364924654|FG002|Third Intervention|Withdrawal by Subject|0|||
105941287|NCT01817777|365447649|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
105941288|NCT01817777|365447650|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
105941289|NCT01817777|365447651|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
106013435|NCT00911170|365714815|FG000|Treatment Period|Adverse Event|9|||
106013436|NCT00911170|365714816|FG001|Treatment Period|Adverse Event|10|||
105799841|NCT01890785|364924655|FG003|Third Intervention|Withdrawal by Subject|0|||
105799842|NCT01890785|364924656|FG004|Third Intervention|Withdrawal by Subject|0|||
105799843|NCT01890785|364924657|FG005|Third Intervention|Withdrawal by Subject|0|||
105941290|NCT01817777|365447649|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
106013437|NCT00911170|365714815|FG000|Treatment Period|Withdrawal by Subject|4|||
106013438|NCT00911170|365714816|FG001|Treatment Period|Withdrawal by Subject|4|||
106013439|NCT00911170|365714815|FG000|Treatment Period|Disease progression|0|||
106013440|NCT00911170|365714816|FG001|Treatment Period|Disease progression|2|||
106013441|NCT00911170|365714815|FG000|Treatment Period|Physician Decision|5|||
106013442|NCT00911170|365714816|FG001|Treatment Period|Physician Decision|5|||
106013443|NCT00911170|365714815|FG000|Treatment Period|Lost to Follow-up|0|||
106013444|NCT00911170|365714816|FG001|Treatment Period|Lost to Follow-up|1|||
106013445|NCT00911170|365714815|FG000|Treatment Period|Death|6|||
106013446|NCT00911170|365714816|FG001|Treatment Period|Death|9|||
106013447|NCT00911170|365714815|FG000|Long Term Follow-Up|Continuing in study|274|||
106013448|NCT00911170|365714816|FG001|Long Term Follow-Up|Continuing in study|269|||
106141632|NCT02263508|366177736|FG002|Overall Study|Lost to Follow-up|7|||
106141633|NCT02263508|366177734|FG000|Overall Study|Death|6|||
105738954|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
105738955|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738956|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738957|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738958|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738959|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738960|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
105738961|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
105738962|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
105738963|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738964|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738965|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738966|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738967|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738968|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
105738969|NCT01097616|364699902|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738970|NCT01097616|364699903|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738971|NCT01097616|364699904|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
105738972|NCT01097616|364699905|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738973|NCT01097616|364699906|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738974|NCT01097616|364699907|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738975|NCT01097616|364699908|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738976|NCT01097616|364699909|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
105738977|NCT01097616|364699902|FG000|Optional DB EXT Phase|Adverse Event|0|||
105738978|NCT01097616|364699903|FG001|Optional DB EXT Phase|Adverse Event|7|||
105738979|NCT01097616|364699904|FG002|Optional DB EXT Phase|Adverse Event|2|||
105738980|NCT01097616|364699905|FG003|Optional DB EXT Phase|Adverse Event|0|||
105738981|NCT01097616|364699906|FG004|Optional DB EXT Phase|Adverse Event|0|||
105738982|NCT01097616|364699907|FG005|Optional DB EXT Phase|Adverse Event|0|||
105941291|NCT01817777|365447650|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
105941292|NCT01817777|365447651|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
105941293|NCT01817777|365447649|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
105941294|NCT01817777|365447650|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
105941295|NCT01817777|365447651|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
105941296|NCT01817777|365447649|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
105941297|NCT01817777|365447650|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
105941298|NCT01817777|365447651|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
105941299|NCT01817777|365447649|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
105941300|NCT01817777|365447650|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
105941301|NCT01817777|365447651|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
105941302|NCT00129974|365447652|FG000|Overall Study|Other|1|||
105941303|NCT03242434|365447653|FG000|Overall Study|Death|0|||
105941304|NCT03242434|365447654|FG001|Overall Study|Death|2|||
105941305|NCT03729609|365447655|FG000|Overall Study|Protocol Violation|1|||
105941306|NCT00867334|365447656|FG000|Overall Study|Withdrawal by Subject|0|||
105941307|NCT00867334|365447657|FG001|Overall Study|Withdrawal by Subject|1|||
105941308|NCT00867334|365447656|FG000|Overall Study|Withdrawal by Subject|1|||
105941309|NCT00867334|365447657|FG001|Overall Study|Withdrawal by Subject|0|||
105941310|NCT00867334|365447656|FG000|Overall Study|Withdrawal by Subject|1|||
105941311|NCT00867334|365447657|FG001|Overall Study|Withdrawal by Subject|0|||
105941312|NCT01148771|365447660|FG000|Washout Period|Withdrawal by Subject|0|||
105941313|NCT01148771|365447661|FG001|Washout Period|Withdrawal by Subject|1|||
105941314|NCT03787615|365447662|FG000|Overall Study|Withdrawal by Subject|2|||
105941315|NCT03787615|365447662|FG000|Overall Study|Lost to Follow-up|2|||
105941316|NCT03766399|365447667|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941317|NCT03766399|365447668|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941318|NCT03766399|365447669|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
106013449|NCT00911170|365714815|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
106013450|NCT00911170|365714816|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
105941319|NCT03766399|365447670|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941320|NCT03766399|365447671|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105738983|NCT01097616|364699908|FG006|Optional DB EXT Phase|Adverse Event|0|||
105738984|NCT01097616|364699909|FG007|Optional DB EXT Phase|Adverse Event|0|||
105738985|NCT01097616|364699902|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
105738986|NCT01097616|364699903|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
105738987|NCT01097616|364699904|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
105738988|NCT01097616|364699905|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738989|NCT01097616|364699906|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738990|NCT01097616|364699907|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738991|NCT01097616|364699908|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738992|NCT01097616|364699909|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
105738993|NCT01097616|364699902|FG000|Optional DB EXT Phase|Protocol Violation|0|||
105738994|NCT01097616|364699903|FG001|Optional DB EXT Phase|Protocol Violation|2|||
105738995|NCT01097616|364699904|FG002|Optional DB EXT Phase|Protocol Violation|3|||
105738996|NCT01097616|364699905|FG003|Optional DB EXT Phase|Protocol Violation|0|||
105738997|NCT01097616|364699906|FG004|Optional DB EXT Phase|Protocol Violation|0|||
105738998|NCT01097616|364699907|FG005|Optional DB EXT Phase|Protocol Violation|0|||
105738999|NCT01097616|364699908|FG006|Optional DB EXT Phase|Protocol Violation|0|||
105739000|NCT01097616|364699909|FG007|Optional DB EXT Phase|Protocol Violation|0|||
105739001|NCT01097616|364699902|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
105739002|NCT01097616|364699903|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
105739003|NCT01097616|364699904|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
105739004|NCT01097616|364699905|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
105941321|NCT03766399|365447672|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941322|NCT03766399|365447673|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941323|NCT03766399|365447674|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941324|NCT03766399|365447675|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941325|NCT03766399|365447676|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941326|NCT03766399|365447677|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941327|NCT03766399|365447678|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941328|NCT03766399|365447679|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941329|NCT03766399|365447680|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
105941330|NCT03766399|365447681|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941331|NCT03766399|365447682|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941332|NCT03766399|365447683|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941333|NCT03766399|365447684|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
105941334|NCT01674062|365447689|FG000|Overall Study|Insufficient Therapeutic Response|56|||
105941335|NCT01674062|365447690|FG001|Overall Study|Insufficient Therapeutic Response|26|||
105941336|NCT01674062|365447689|FG000|Overall Study|Other|8|||
105739005|NCT01097616|364699906|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
105739006|NCT01097616|364699907|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
105739007|NCT01097616|364699908|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
105739008|NCT01097616|364699909|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
105739009|NCT01097616|364699902|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
105739010|NCT01097616|364699903|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
105739011|NCT01097616|364699904|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
105941337|NCT01674062|365447690|FG001|Overall Study|Other|1|||
105941338|NCT01674062|365447689|FG000|Overall Study|Adverse Event|1|||
105941339|NCT01674062|365447690|FG001|Overall Study|Adverse Event|1|||
105941340|NCT01674062|365447689|FG000|Overall Study|Death|0|||
105941341|NCT01674062|365447690|FG001|Overall Study|Death|1|||
105941342|NCT01674062|365447689|FG000|Overall Study|Programming Error|1|||
105941343|NCT01674062|365447690|FG001|Overall Study|Programming Error|0|||
105941344|NCT04620668|365447691|FG000|Overall Study|Withdrawal by Subject|2|||
105941345|NCT04620668|365447692|FG001|Overall Study|Withdrawal by Subject|0|||
105941346|NCT04620668|365447691|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
105941347|NCT04620668|365447692|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
105941348|NCT04620668|365447691|FG000|Overall Study|Removed before analysis: missing data|2|||
105941349|NCT04620668|365447692|FG001|Overall Study|Removed before analysis: missing data|0|||
105941350|NCT04620668|365447691|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
105941351|NCT04620668|365447692|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
105941352|NCT04620668|365447691|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
105941353|NCT04620668|365447692|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
105941354|NCT03685149|365447696|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
105941355|NCT03685149|365447697|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
105941356|NCT03685149|365447696|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
105941357|NCT03685149|365447697|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
105941358|NCT03685149|365447696|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
105952162|NCT03314935|365488198|FG014|Phase 2|Withdrawal by Subject|1|||
105952163|NCT03314935|365488184|FG000|Phase 2|Progressive Disease|0|||
105799844|NCT03001011|364924658|FG000|Overall Study|Adverse Event|9|||
105799845|NCT03001011|364924659|FG001|Overall Study|Adverse Event|3|||
105799846|NCT03001011|364924658|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
105799847|NCT03001011|364924659|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
105799848|NCT03001011|364924658|FG000|Overall Study|Other than specified above|3|||
105799849|NCT03001011|364924659|FG001|Overall Study|Other than specified above|8|||
105799850|NCT02875067|364924660|FG000|Overall Study|Withdrawal by Subject|1|||
105799851|NCT02875067|364924660|FG000|Overall Study|Withdrawal by Termination of Study|5|||
105799852|NCT02862535|364924661|FG000|Overall Study|Death|7|||
105799853|NCT02862535|364924662|FG001|Overall Study|Death|3|||
106013451|NCT00911170|365714815|FG000|Long Term Follow-Up|Physician Decision|5|||
106013452|NCT00911170|365714816|FG001|Long Term Follow-Up|Physician Decision|4|||
106013453|NCT00911170|365714815|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
106013454|NCT00911170|365714816|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
106013455|NCT00911170|365714815|FG000|Long Term Follow-Up|Death|116|||
106013456|NCT00911170|365714816|FG001|Long Term Follow-Up|Death|121|||
106013457|NCT00335777|365717149|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
105799854|NCT02862535|364924663|FG002|Overall Study|Death|2|||
105799855|NCT02862535|364924664|FG003|Overall Study|Death|5|||
105799856|NCT02862535|364924661|FG000|Overall Study|Study Terminated by Sponsor|1|||
105799857|NCT02862535|364924662|FG001|Overall Study|Study Terminated by Sponsor|3|||
105799858|NCT02862535|364924663|FG002|Overall Study|Study Terminated by Sponsor|8|||
105799859|NCT02862535|364924664|FG003|Overall Study|Study Terminated by Sponsor|5|||
105941359|NCT03685149|365447697|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
105941360|NCT00581919|365447704|FG000|Overall Study|Adverse Event|8|||
105941361|NCT00581919|365447704|FG000|Overall Study|Death|1|||
105941362|NCT00581919|365447704|FG000|Overall Study|Disease Progression|10|||
105941363|NCT00581919|365447704|FG000|Overall Study|Physician Decision|1|||
105941364|NCT00581919|365447704|FG000|Overall Study|Other Complicating Disease|1|||
105941365|NCT00581919|365447704|FG000|Overall Study|Started Non-Protocol Therapy|2|||
105941366|NCT00581919|365447704|FG000|Overall Study|Withdrawal by Subject|1|||
105941367|NCT00113373|365447705|FG000|Overall Study|Ineligible: wrong primary|1|||
105941368|NCT00113373|365447705|FG000|Overall Study|Ineligible: second primary|1|||
105941369|NCT00113373|365447705|FG000|Overall Study|Never Treated|1|||
105941370|NCT02871219|365447719|FG000|Overall Study|Adverse Event|15|||
105941371|NCT02871219|365447719|FG000|Overall Study|Death|3|||
105941372|NCT02871219|365447719|FG000|Overall Study|Progression|3|||
105941373|NCT02871219|365447719|FG000|Overall Study|Infections|7|||
105941374|NCT02871219|365447719|FG000|Overall Study|Infusion Related|4|||
105941375|NCT03312543|365447720|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
105941376|NCT03312543|365447721|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
105941377|NCT03312543|365447720|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
105941378|NCT03312543|365447721|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
105941379|NCT03312543|365447720|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
105941380|NCT03312543|365447721|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
105941381|NCT03312543|365447720|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
105941382|NCT03312543|365447721|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
105941383|NCT03312543|365447720|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
105941384|NCT03312543|365447721|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
105941385|NCT03312543|365447720|FG000|Regression (Week 12 to Week 24)|Death|0|||
105941386|NCT03312543|365447721|FG001|Regression (Week 12 to Week 24)|Death|1|||
105941387|NCT02402647|365447722|FG000|Overall Study|Lost to Follow-up|13|||
105941388|NCT02402647|365447723|FG001|Overall Study|Lost to Follow-up|7|||
105941389|NCT02402647|365447722|FG000|Overall Study|Protocol Violation|1|||
105941390|NCT02402647|365447723|FG001|Overall Study|Protocol Violation|1|||
105941391|NCT02402647|365447722|FG000|Overall Study|scheduled and timed out|2|||
105941392|NCT02402647|365447723|FG001|Overall Study|scheduled and timed out|1|||
105941393|NCT02402647|365447722|FG000|Overall Study|medical illness|2|||
105941394|NCT02402647|365447723|FG001|Overall Study|medical illness|4|||
105941395|NCT02402647|365447722|FG000|Overall Study|Moved|2|||
105941396|NCT02402647|365447723|FG001|Overall Study|Moved|0|||
106013458|NCT00335777|365717149|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
106013459|NCT00335777|365717149|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
106141634|NCT02263508|366177735|FG001|Overall Study|Death|151|||
106141635|NCT02263508|366177736|FG002|Overall Study|Death|140|||
105799860|NCT02862535|364924661|FG000|Overall Study|Enrolled, not Treated|1|||
105799861|NCT02862535|364924662|FG001|Overall Study|Enrolled, not Treated|0|||
105799862|NCT02862535|364924663|FG002|Overall Study|Enrolled, not Treated|0|||
105941397|NCT02402647|365447722|FG000|Overall Study|loved one illness|1|||
105941398|NCT02402647|365447723|FG001|Overall Study|loved one illness|0|||
105941399|NCT02402647|365447722|FG000|Overall Study|deceased preexisting condition|2|||
105941400|NCT02402647|365447723|FG001|Overall Study|deceased preexisting condition|0|||
105941401|NCT02402647|365447722|FG000|Overall Study|Other|2|||
105941402|NCT02402647|365447723|FG001|Overall Study|Other|1|||
106013460|NCT00335777|365717149|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
106013461|NCT00335777|365717149|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
105739012|NCT01097616|364699905|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
105739013|NCT01097616|364699906|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
105739014|NCT01097616|364699907|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
105739015|NCT01097616|364699908|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
105739016|NCT01097616|364699909|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
105739017|NCT01097616|364699902|FG000|Optional DB EXT Phase|Physician Decision|1|||
105739018|NCT01097616|364699903|FG001|Optional DB EXT Phase|Physician Decision|0|||
105739019|NCT01097616|364699904|FG002|Optional DB EXT Phase|Physician Decision|0|||
105739020|NCT01097616|364699905|FG003|Optional DB EXT Phase|Physician Decision|0|||
105739021|NCT01097616|364699906|FG004|Optional DB EXT Phase|Physician Decision|0|||
105739022|NCT01097616|364699907|FG005|Optional DB EXT Phase|Physician Decision|0|||
105739023|NCT01097616|364699908|FG006|Optional DB EXT Phase|Physician Decision|0|||
105739024|NCT01097616|364699909|FG007|Optional DB EXT Phase|Physician Decision|0|||
105739025|NCT01097616|364699902|FG000|DB RO Phase|Adverse Event|0|||
105739026|NCT01097616|364699903|FG001|DB RO Phase|Adverse Event|0|||
105739027|NCT01097616|364699904|FG002|DB RO Phase|Adverse Event|0|||
105739028|NCT01097616|364699905|FG003|DB RO Phase|Adverse Event|0|||
105739029|NCT01097616|364699906|FG004|DB RO Phase|Adverse Event|0|||
105739030|NCT01097616|364699907|FG005|DB RO Phase|Adverse Event|0|||
105739031|NCT01097616|364699908|FG006|DB RO Phase|Adverse Event|1|||
105739032|NCT01097616|364699909|FG007|DB RO Phase|Adverse Event|0|||
105739033|NCT01097616|364699902|FG000|DB RO Phase|Withdrawal by Subject|0|||
105739034|NCT01097616|364699903|FG001|DB RO Phase|Withdrawal by Subject|0|||
105739035|NCT01097616|364699904|FG002|DB RO Phase|Withdrawal by Subject|0|||
105739036|NCT01097616|364699905|FG003|DB RO Phase|Withdrawal by Subject|0|||
105739037|NCT01097616|364699906|FG004|DB RO Phase|Withdrawal by Subject|0|||
105739038|NCT01097616|364699907|FG005|DB RO Phase|Withdrawal by Subject|1|||
105739039|NCT01097616|364699908|FG006|DB RO Phase|Withdrawal by Subject|0|||
105739040|NCT01097616|364699909|FG007|DB RO Phase|Withdrawal by Subject|0|||
105739041|NCT01097616|364699902|FG000|DB RO Phase|Lost to Follow-up|0|||
105739042|NCT01097616|364699903|FG001|DB RO Phase|Lost to Follow-up|0|||
105739043|NCT01097616|364699904|FG002|DB RO Phase|Lost to Follow-up|0|||
105739044|NCT01097616|364699905|FG003|DB RO Phase|Lost to Follow-up|1|||
105739045|NCT01097616|364699906|FG004|DB RO Phase|Lost to Follow-up|1|||
106013462|NCT02079246|365717150|FG000|OLEX|Withdrawal before treatment|1|||
106013463|NCT02079246|365717151|FG001|OLEX|Withdrawal before treatment|0|||
106013464|NCT02079246|365717150|FG000|OLEX|Death|11|||
106013465|NCT02079246|365717151|FG001|OLEX|Death|0|||
106013466|NCT02079246|365717150|FG000|OLEX|Adverse Event|66|||
106013467|NCT02079246|365717151|FG001|OLEX|Adverse Event|0|||
106013468|NCT02079246|365717150|FG000|OLEX|Withdrawal by Subject|60|||
106013469|NCT02079246|365717151|FG001|OLEX|Withdrawal by Subject|0|||
106013470|NCT02079246|365717150|FG000|OLEX|Lost to Follow-up|6|||
106013471|NCT02079246|365717151|FG001|OLEX|Lost to Follow-up|0|||
106013472|NCT02079246|365717150|FG000|OLEX|Protocol Violation|6|||
106013473|NCT02079246|365717151|FG001|OLEX|Protocol Violation|0|||
106013474|NCT02079246|365717150|FG000|OLEX|Lack of Efficacy|3|||
106013475|NCT02079246|365717151|FG001|OLEX|Lack of Efficacy|0|||
106013476|NCT02079246|365717150|FG000|OLEX|Results of the lead-in studies|58|||
106013477|NCT02079246|365717151|FG001|OLEX|Results of the lead-in studies|0|||
106013478|NCT02079246|365717150|FG000|OLEX|Other: Disallowed medication|8|||
106013479|NCT02079246|365717151|FG001|OLEX|Other: Disallowed medication|0|||
106013480|NCT02079246|365717150|FG000|OLEX|Other: Insufficient compliance|2|||
106013481|NCT02079246|365717151|FG001|OLEX|Other: Insufficient compliance|0|||
106013482|NCT02079246|365717150|FG000|OLEX|Other: Caregiver unavailable|3|||
106013483|NCT02079246|365717151|FG001|OLEX|Other: Caregiver unavailable|0|||
106141636|NCT03265210|366177737|FG000|Overall Study|Withdrawal by Subject|7|||
105739046|NCT01097616|364699907|FG005|DB RO Phase|Lost to Follow-up|0|||
106141637|NCT03265210|366177738|FG001|Overall Study|Withdrawal by Subject|9|||
106141638|NCT03265210|366177737|FG000|Overall Study|Lost to Follow-up|2|||
105739047|NCT01097616|364699908|FG006|DB RO Phase|Lost to Follow-up|0|||
105739048|NCT01097616|364699909|FG007|DB RO Phase|Lost to Follow-up|1|||
105739049|NCT01097616|364699902|FG000|DB RO Phase|Not Treated in RO|0|||
105739050|NCT01097616|364699903|FG001|DB RO Phase|Not Treated in RO|0|||
105739051|NCT01097616|364699904|FG002|DB RO Phase|Not Treated in RO|0|||
105739052|NCT01097616|364699905|FG003|DB RO Phase|Not Treated in RO|0|||
105739053|NCT01097616|364699906|FG004|DB RO Phase|Not Treated in RO|0|||
105739054|NCT01097616|364699907|FG005|DB RO Phase|Not Treated in RO|1|||
105739055|NCT01097616|364699908|FG006|DB RO Phase|Not Treated in RO|0|||
105739056|NCT01097616|364699909|FG007|DB RO Phase|Not Treated in RO|0|||
106013484|NCT02079246|365717150|FG000|OLEX|Other: Coordinator decision|1|||
106013485|NCT02079246|365717151|FG001|OLEX|Other: Coordinator decision|0|||
106013486|NCT02079246|365717150|FG000|OLEX|Other: Worsening of condition|1|||
106013487|NCT02079246|365717151|FG001|OLEX|Other: Worsening of condition|0|||
106013488|NCT02079246|365717150|FG000|OLEX|Other: Moved to nursing home|1|||
106013489|NCT02079246|365717151|FG001|OLEX|Other: Moved to nursing home|0|||
106013490|NCT02079246|365717150|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
106013491|NCT02079246|365717151|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
106013492|NCT02079246|365717150|FG000|OLEX-MEM|Adverse Event|0|||
105739057|NCT01996319|364699910|FG000|Overall Study|Protocol Violation|1|||
105941403|NCT04197583|365447724|FG000|Overall Study|Study Stent Replacement|34|||
105739058|NCT01996319|364699911|FG001|Overall Study|Protocol Violation|0|||
105739059|NCT01996319|364699910|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
105739060|NCT01996319|364699911|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
105739061|NCT01996319|364699910|FG000|Overall Study|Adverse Event|2|||
105739062|NCT01996319|364699911|FG001|Overall Study|Adverse Event|2|||
105739063|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
105739064|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
105739065|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
105739066|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
105739067|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
105739068|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
105739069|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
105739070|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
105739071|NCT00130208|364699912|FG000|Maintenance Period (26 Weeks)|Other|1|||
105739072|NCT00130208|364699913|FG001|Maintenance Period (26 Weeks)|Other|1|||
105739073|NCT00130208|364699912|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
105739074|NCT00130208|364699913|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
105739075|NCT00130208|364699912|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
105739076|NCT00130208|364699913|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
105739077|NCT00130208|364699912|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
105739078|NCT00130208|364699913|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
105739079|NCT00130208|364699912|FG000|Washout Period (8 Weeks)|Other|1|||
105739080|NCT00130208|364699913|FG001|Washout Period (8 Weeks)|Other|1|||
105739081|NCT00771030|364699918|FG000|Overall Study|Adverse Event|0|||
105739082|NCT00771030|364699919|FG001|Overall Study|Adverse Event|1|||
105739083|NCT00771030|364699920|FG002|Overall Study|Adverse Event|0|||
105739084|NCT00771030|364699921|FG003|Overall Study|Adverse Event|0|||
105739085|NCT00771030|364699922|FG004|Overall Study|Adverse Event|0|||
105739086|NCT00771030|364699923|FG005|Overall Study|Adverse Event|0|||
105739087|NCT00771030|364699924|FG006|Overall Study|Adverse Event|0|||
105739088|NCT01839188|364699925|FG000|Overall Study|Withdrawal by Subject|1|||
105739089|NCT01327339|364699928|FG000|Overall Study|Protocol Violation|8|||
105739090|NCT00871858|364699929|FG000|Overall Study|Protocol Violation|3|||
105739091|NCT00871858|364699930|FG001|Overall Study|Protocol Violation|4|||
105739092|NCT00871858|364699929|FG000|Overall Study|Adverse Event|1|||
105739093|NCT00871858|364699930|FG001|Overall Study|Adverse Event|1|||
105739094|NCT00871858|364699929|FG000|Overall Study|Withdrawal by Subject|1|||
105739095|NCT00871858|364699930|FG001|Overall Study|Withdrawal by Subject|1|||
105739096|NCT00871858|364699929|FG000|Overall Study|Lost to Follow-up|0|||
105739097|NCT00871858|364699930|FG001|Overall Study|Lost to Follow-up|1|||
105739098|NCT03964415|364699936|FG000|Overall Study|Sponsor's decision|1563|||
105739099|NCT03964415|364699937|FG001|Overall Study|Sponsor's decision|1528|||
105739100|NCT03964415|364699936|FG000|Overall Study|Lost to Follow-up|139|||
105739101|NCT03964415|364699937|FG001|Overall Study|Lost to Follow-up|146|||
105739102|NCT03964415|364699936|FG000|Overall Study|Withdrawal by Subject|68|||
105739103|NCT03964415|364699937|FG001|Overall Study|Withdrawal by Subject|72|||
105739104|NCT03964415|364699936|FG000|Overall Study|Physician Decision|34|||
105739105|NCT03964415|364699937|FG001|Overall Study|Physician Decision|48|||
105739106|NCT03964415|364699936|FG000|Overall Study|Adverse Event|3|||
105739107|NCT03964415|364699937|FG001|Overall Study|Adverse Event|0|||
105739108|NCT03964415|364699936|FG000|Overall Study|Death|4|||
105739109|NCT03964415|364699937|FG001|Overall Study|Death|6|||
105739110|NCT03964415|364699936|FG000|Overall Study|Protocol Violation|1|||
105739111|NCT03964415|364699937|FG001|Overall Study|Protocol Violation|4|||
105739112|NCT03964415|364699936|FG000|Overall Study|Other|35|||
105739113|NCT03964415|364699937|FG001|Overall Study|Other|38|||
105739114|NCT03964415|364699936|FG000|Overall Study|Randomized but not treated|6|||
105739115|NCT03964415|364699937|FG001|Overall Study|Randomized but not treated|7|||
105739116|NCT01024465|364699938|FG000|Overall Study|Adverse Event|2|||
105739117|NCT01024465|364699938|FG000|Overall Study|Physician Decision|1|||
105739118|NCT03078608|364699940|FG000|Overall Study|Death|1|||
105739119|NCT03078608|364699941|FG001|Overall Study|Death|2|||
105739120|NCT03078608|364699942|FG002|Overall Study|Death|0|||
105739121|NCT03078608|364699943|FG003|Overall Study|Death|0|||
105739122|NCT03078608|364699940|FG000|Overall Study|Withdrawal by Subject|8|||
105739123|NCT03078608|364699941|FG001|Overall Study|Withdrawal by Subject|1|||
105739124|NCT03078608|364699942|FG002|Overall Study|Withdrawal by Subject|0|||
105739125|NCT03078608|364699943|FG003|Overall Study|Withdrawal by Subject|0|||
105739126|NCT03078608|364699940|FG000|Overall Study|Lost to Follow-up|5|||
105739127|NCT03078608|364699941|FG001|Overall Study|Lost to Follow-up|8|||
105739128|NCT03078608|364699942|FG002|Overall Study|Lost to Follow-up|4|||
105739129|NCT03078608|364699943|FG003|Overall Study|Lost to Follow-up|1|||
105739130|NCT01455428|364699944|FG000|Overall Study|Protocol Violation|2|||
105739131|NCT01455428|364699945|FG001|Overall Study|Protocol Violation|1|||
105739132|NCT01455428|364699944|FG000|Overall Study|Adverse Event|6|||
105739133|NCT01455428|364699945|FG001|Overall Study|Adverse Event|2|||
105739134|NCT01455428|364699944|FG000|Overall Study|Lost to Follow-up|1|||
105739135|NCT01455428|364699945|FG001|Overall Study|Lost to Follow-up|1|||
105739136|NCT01455428|364699944|FG000|Overall Study|Withdrawal by Subject|2|||
105739137|NCT01455428|364699945|FG001|Overall Study|Withdrawal by Subject|5|||
105739138|NCT01455428|364699944|FG000|Overall Study|Did not meet entrance criteria|0|||
105739139|NCT01455428|364699945|FG001|Overall Study|Did not meet entrance criteria|2|||
105739140|NCT01455428|364699944|FG000|Overall Study|Insufficient clinical response|0|||
105739141|NCT01455428|364699945|FG001|Overall Study|Insufficient clinical response|2|||
105739142|NCT01455428|364699944|FG000|Overall Study|Did not receive treatment|1|||
105739143|NCT01455428|364699945|FG001|Overall Study|Did not receive treatment|1|||
105739144|NCT01455428|364699944|FG000|Overall Study|Other|2|||
105739145|NCT01455428|364699945|FG001|Overall Study|Other|4|||
105739146|NCT00312377|364699956|FG000|Overall Study|Death|403|||
105739147|NCT00312377|364699957|FG001|Overall Study|Death|418|||
105941404|NCT04197583|365447725|FG001|Overall Study|Study Stent Replacement|8|||
105739148|NCT00312377|364699956|FG000|Overall Study|Withdrawal by Subject|23|||
105739149|NCT00312377|364699957|FG001|Overall Study|Withdrawal by Subject|30|||
105739150|NCT00312377|364699956|FG000|Overall Study|Lost to Follow-up|9|||
105739151|NCT00312377|364699957|FG001|Overall Study|Lost to Follow-up|12|||
105739152|NCT00312377|364699956|FG000|Overall Study|Non-compliance|0|||
105739153|NCT00312377|364699957|FG001|Overall Study|Non-compliance|2|||
105739154|NCT00312377|364699956|FG000|Overall Study|Randomised but never received treatment|6|||
105739155|NCT00312377|364699957|FG001|Overall Study|Randomised but never received treatment|6|||
105739156|NCT00312377|364699956|FG000|Overall Study|Discontinue treatment survival follow up|202|||
105739157|NCT00312377|364699957|FG001|Overall Study|Discontinue treatment survival follow up|200|||
105739158|NCT00312377|364699956|FG000|Overall Study|Site ended participation in study|1|||
105739159|NCT00312377|364699957|FG001|Overall Study|Site ended participation in study|0|||
105739160|NCT00872898|364699958|FG000|Part Two - Double Blind|Adverse Event|4|||
105739161|NCT00872898|364699959|FG001|Part Two - Double Blind|Adverse Event|3|||
105739162|NCT00872898|364699958|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
105739163|NCT00872898|364699959|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
105739164|NCT00872898|364699958|FG000|Part Two - Double Blind|Protocol Violation|1|||
105739165|NCT00872898|364699959|FG001|Part Two - Double Blind|Protocol Violation|0|||
105739166|NCT00872898|364699958|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
105739167|NCT00872898|364699959|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
105739168|NCT00872898|364699958|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
105739169|NCT00872898|364699959|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
105739170|NCT00872898|364699958|FG000|Part Two - Double Blind|Other reasons|2|||
105739171|NCT00872898|364699959|FG001|Part Two - Double Blind|Other reasons|0|||
105739172|NCT00455858|364699960|FG000|Overall Study|Lost to Follow-up|2|||
105739173|NCT00455858|364699960|FG000|Overall Study|Protocol Violation|1|||
105739174|NCT00455858|364699960|FG000|Overall Study|Lack of Efficacy|1|||
105739175|NCT00455858|364699960|FG000|Overall Study|Well controlled FPG without insulin|1|||
105739176|NCT00455858|364699960|FG000|Overall Study|Withdrawal|1|||
105941405|NCT04197583|365447724|FG000|Overall Study|Lost to Follow-up|14|||
105941406|NCT04197583|365447725|FG001|Overall Study|Lost to Follow-up|3|||
105941407|NCT04197583|365447724|FG000|Overall Study|Death|3|||
105941408|NCT04197583|365447725|FG001|Overall Study|Death|0|||
105941409|NCT04197583|365447724|FG000|Overall Study|Physician Decision|1|||
105941410|NCT04197583|365447725|FG001|Overall Study|Physician Decision|0|||
105941411|NCT04197583|365447724|FG000|Overall Study|Withdrawal by Subject|1|||
105941412|NCT04197583|365447725|FG001|Overall Study|Withdrawal by Subject|1|||
105941413|NCT04197583|365447724|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
105941414|NCT04197583|365447725|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
105941415|NCT04197583|365447724|FG000|Overall Study|Screen Failure|0|||
105941416|NCT04197583|365447725|FG001|Overall Study|Screen Failure|20|||
105941417|NCT05852470|365447726|FG000|Overall Study|Withdrawal by Subject|0|||
105941418|NCT05852470|365447727|FG001|Overall Study|Withdrawal by Subject|1|||
105941419|NCT01903863|365447728|FG000|Overall Study|Physician Decision|2|||
105941420|NCT01903863|365447729|FG001|Overall Study|Physician Decision|0|||
105941421|NCT00323622|365447734|FG000|Overall Study|Other|30|||
105941422|NCT00323622|365447735|FG001|Overall Study|Other|91|||
106141639|NCT03265210|366177738|FG001|Overall Study|Lost to Follow-up|0|||
106141640|NCT03265210|366177737|FG000|Overall Study|Physician Decision|2|||
106141641|NCT03265210|366177738|FG001|Overall Study|Physician Decision|0|||
105739177|NCT03290300|364699964|FG000|Overall Study|Lost to Follow-up|3|||
105739178|NCT04172831|364699965|FG000|Overall Study|Adverse Event|21|||
105739179|NCT04172831|364699966|FG001|Overall Study|Adverse Event|9|||
105739180|NCT04172831|364699965|FG000|Overall Study|Lack of Efficacy|2|||
105739181|NCT04172831|364699966|FG001|Overall Study|Lack of Efficacy|8|||
105739182|NCT04172831|364699965|FG000|Overall Study|Physician Decision|0|||
105739183|NCT04172831|364699966|FG001|Overall Study|Physician Decision|1|||
105739184|NCT04172831|364699965|FG000|Overall Study|Withdrawal by Subject|12|||
105739185|NCT04172831|364699966|FG001|Overall Study|Withdrawal by Subject|11|||
105941423|NCT00323622|365447736|FG002|Overall Study|Other|4|||
105941424|NCT00323622|365447737|FG003|Overall Study|Other|12|||
106141642|NCT03265210|366177737|FG000|Overall Study|Adverse Event|1|||
106141643|NCT03265210|366177738|FG001|Overall Study|Adverse Event|0|||
106141644|NCT00028769|366177739|FG000|Overall Study|Adverse Event|2|||
106141645|NCT00028769|366177739|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
106141646|NCT00028769|366177739|FG000|Overall Study|Progression or Death|31|||
105739186|NCT04172831|364699965|FG000|Overall Study|Lost to Follow-up|4|||
105739187|NCT04172831|364699966|FG001|Overall Study|Lost to Follow-up|9|||
105739188|NCT04172831|364699965|FG000|Overall Study|COVID-19 related crisis|3|||
105739189|NCT04172831|364699966|FG001|Overall Study|COVID-19 related crisis|3|||
105739190|NCT04172831|364699965|FG000|Overall Study|Subject non-compliance|1|||
105739191|NCT04172831|364699966|FG001|Overall Study|Subject non-compliance|1|||
105739192|NCT04172831|364699965|FG000|Overall Study|Family emergency|1|||
105739193|NCT04172831|364699966|FG001|Overall Study|Family emergency|0|||
105739194|NCT01558089|364699971|FG000|Overall Study|Adverse Event|1|||
105739195|NCT01558089|364699971|FG000|Overall Study|Lack of Efficacy|1|||
105739196|NCT01558089|364699971|FG000|Overall Study|Lost to Follow-up|5|||
105739197|NCT01558089|364699971|FG000|Overall Study|Withdrawal by Subject|6|||
105739198|NCT02050048|364699972|FG000|Overall Study|Lost to Follow-up|0|||
105739199|NCT02050048|364699973|FG001|Overall Study|Lost to Follow-up|1|||
105739200|NCT02050048|364699972|FG000|Overall Study|Death|1|||
105739201|NCT02050048|364699973|FG001|Overall Study|Death|0|||
105739202|NCT02050048|364699972|FG000|Overall Study|Ineligible after ERCP|4|||
105739203|NCT02050048|364699973|FG001|Overall Study|Ineligible after ERCP|1|||
105739204|NCT01469052|364699976|FG000|Overall Study|Adverse Event|2|||
105739205|NCT01469052|364699977|FG001|Overall Study|Adverse Event|3|||
105739206|NCT01469052|364699978|FG002|Overall Study|Adverse Event|0|||
105739207|NCT01469052|364699979|FG003|Overall Study|Adverse Event|2|||
105739208|NCT01469052|364699980|FG004|Overall Study|Adverse Event|0|||
105739209|NCT01469052|364699981|FG005|Overall Study|Adverse Event|1|||
105739210|NCT01469052|364699976|FG000|Overall Study|Progressive disease|3|||
105739211|NCT01469052|364699977|FG001|Overall Study|Progressive disease|0|||
105739212|NCT01469052|364699978|FG002|Overall Study|Progressive disease|5|||
105739213|NCT01469052|364699979|FG003|Overall Study|Progressive disease|3|||
105739214|NCT01469052|364699980|FG004|Overall Study|Progressive disease|7|||
105739215|NCT01469052|364699981|FG005|Overall Study|Progressive disease|2|||
105799863|NCT02862535|364924664|FG003|Overall Study|Enrolled, not Treated|1|||
105799864|NCT00964223|364924665|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
106013493|NCT02079246|365717151|FG001|OLEX-MEM|Adverse Event|6|||
106013494|NCT02079246|365717150|FG000|OLEX-MEM|Withdrawal by Subject|0|||
106013495|NCT02079246|365717151|FG001|OLEX-MEM|Withdrawal by Subject|7|||
106013496|NCT02079246|365717150|FG000|OLEX-MEM|Protocol Violation|0|||
106013497|NCT02079246|365717151|FG001|OLEX-MEM|Protocol Violation|2|||
106013498|NCT02079246|365717150|FG000|OLEX-MEM|Lost to Follow-up|0|||
106013499|NCT02079246|365717151|FG001|OLEX-MEM|Lost to Follow-up|1|||
106013500|NCT02079246|365717150|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
106013501|NCT02079246|365717151|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
106013502|NCT03714672|365717156|FG000|Overall Study|Adverse Event|0|||
106013503|NCT03714672|365717157|FG001|Overall Study|Adverse Event|0|||
106013504|NCT03714672|365717158|FG002|Overall Study|Adverse Event|3|||
106013505|NCT03714672|365717159|FG003|Overall Study|Adverse Event|0|||
106013506|NCT03714672|365717156|FG000|Overall Study|Physician Decision|0|||
106013507|NCT03714672|365717157|FG001|Overall Study|Physician Decision|1|||
106013508|NCT03714672|365717158|FG002|Overall Study|Physician Decision|0|||
106013509|NCT03714672|365717159|FG003|Overall Study|Physician Decision|0|||
106013510|NCT03714672|365717156|FG000|Overall Study|Other Reason|1|||
106013511|NCT03714672|365717157|FG001|Overall Study|Other Reason|2|||
106013512|NCT03714672|365717158|FG002|Overall Study|Other Reason|1|||
106013513|NCT03714672|365717159|FG003|Overall Study|Other Reason|1|||
106013514|NCT03714672|365717156|FG000|Overall Study|Lost to Follow-up|1|||
106013515|NCT03714672|365717157|FG001|Overall Study|Lost to Follow-up|1|||
106013516|NCT03714672|365717158|FG002|Overall Study|Lost to Follow-up|0|||
106013517|NCT03714672|365717159|FG003|Overall Study|Lost to Follow-up|0|||
106013518|NCT01671319|365717160|FG000|Overall Study|Withdrawal by Subject|1|||
106013519|NCT01432730|365717165|FG000|Period 1|Adverse Event|2|||
106141647|NCT00028769|366177739|FG000|Overall Study|Other - Not Protocol Specified|1|||
105739216|NCT01469052|364699976|FG000|Overall Study|Lack of Efficacy|0|||
105739217|NCT01469052|364699977|FG001|Overall Study|Lack of Efficacy|0|||
105739218|NCT01469052|364699978|FG002|Overall Study|Lack of Efficacy|0|||
105739219|NCT01469052|364699979|FG003|Overall Study|Lack of Efficacy|0|||
105739220|NCT01469052|364699980|FG004|Overall Study|Lack of Efficacy|0|||
105739221|NCT01469052|364699981|FG005|Overall Study|Lack of Efficacy|2|||
105739222|NCT01469052|364699976|FG000|Overall Study|Moved to rollover protocol|1|||
105739223|NCT01469052|364699977|FG001|Overall Study|Moved to rollover protocol|0|||
105739224|NCT01469052|364699978|FG002|Overall Study|Moved to rollover protocol|1|||
106013520|NCT01432730|365717166|FG001|Period 1|Adverse Event|0|||
106013521|NCT01432730|365717165|FG000|Period 2|Adverse Event|0|||
106013522|NCT01432730|365717166|FG001|Period 2|Adverse Event|4|||
106013523|NCT01298648|365717169|FG000|Overall Study|Withdrawal by Subject|2|||
106013524|NCT01298648|365717169|FG000|Overall Study|Lost to Follow-up|21|||
106013525|NCT03077412|365717170|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
106141648|NCT00028769|366177739|FG000|Overall Study|Ineligible|5|||
106141649|NCT00028769|366177739|FG000|Overall Study|Not Analyzable|1|||
106141650|NCT01134562|366177740|FG000|Overall Study|Adverse Event|0|||
106141651|NCT01134562|366177741|FG001|Overall Study|Adverse Event|1|||
106141652|NCT01134562|366177742|FG002|Overall Study|Adverse Event|0|||
106141653|NCT01134562|366177743|FG003|Overall Study|Adverse Event|0|||
106141654|NCT01134562|366177744|FG004|Overall Study|Adverse Event|0|||
106141655|NCT02496702|366177745|FG000|Overall Study|Lost to Follow-up|8|||
106141656|NCT02496702|366177746|FG001|Overall Study|Lost to Follow-up|6|||
106141657|NCT02496702|366177745|FG000|Overall Study|Only partially tested|0|||
106141658|NCT02496702|366177746|FG001|Overall Study|Only partially tested|2|||
106141659|NCT02525796|366177751|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
106141660|NCT02525796|366177752|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
106141661|NCT02525796|366177753|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
106141662|NCT02525796|366177751|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
106141663|NCT02525796|366177752|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
106141664|NCT02525796|366177753|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
106141665|NCT02525796|366177751|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
106141666|NCT02525796|366177752|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
106141667|NCT02525796|366177753|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
106141668|NCT02525796|366177751|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
106141669|NCT02525796|366177752|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
106141670|NCT02525796|366177753|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
106141671|NCT02525796|366177751|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
106141672|NCT02525796|366177752|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
106141673|NCT02525796|366177753|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
106141674|NCT02488980|366177756|FG000|Overall Study|Protocol Violation|2|||
106141675|NCT02488980|366177757|FG001|Overall Study|Protocol Violation|2|||
106141676|NCT02488980|366177758|FG002|Overall Study|Protocol Violation|2|||
106141677|NCT00391846|366177759|FG000|Overall Study|Adverse Event|4|||
106141678|NCT00391846|366177760|FG001|Overall Study|Adverse Event|1|||
106141679|NCT00391846|366177759|FG000|Overall Study|Did not meet the required elig. crit|2|||
106141680|NCT00391846|366177760|FG001|Overall Study|Did not meet the required elig. crit|2|||
106141681|NCT00391846|366177759|FG000|Overall Study|Withdrawal by Subject|2|||
106141682|NCT00391846|366177760|FG001|Overall Study|Withdrawal by Subject|3|||
106141683|NCT00391846|366177759|FG000|Overall Study|Developed study specific DC criteria|0|||
106141684|NCT00391846|366177760|FG001|Overall Study|Developed study specific DC criteria|1|||
106141685|NCT00150176|366177761|FG000|Overall Study|Adverse Event|16|||
106141686|NCT00150176|366177762|FG001|Overall Study|Adverse Event|53|||
106141687|NCT00150176|366177761|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
106141688|NCT00150176|366177762|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
106141689|NCT00150176|366177761|FG000|Overall Study|Withdrawal by Subject|19|||
106141690|NCT00150176|366177762|FG001|Overall Study|Withdrawal by Subject|12|||
106141691|NCT00150176|366177761|FG000|Overall Study|Lost to Follow-up|3|||
106141692|NCT00150176|366177762|FG001|Overall Study|Lost to Follow-up|3|||
106141693|NCT00150176|366177761|FG000|Overall Study|OTHER|11|||
106141694|NCT00150176|366177762|FG001|Overall Study|OTHER|13|||
106141695|NCT02983617|366177763|FG000|Overall Study|Adverse Event|0|||
106141696|NCT02983617|366177764|FG001|Overall Study|Adverse Event|7|||
106141697|NCT02983617|366177763|FG000|Overall Study|Death|0|||
106141698|NCT02983617|366177764|FG001|Overall Study|Death|1|||
106141699|NCT02983617|366177763|FG000|Overall Study|Investigator's Discretion|0|||
106141700|NCT02983617|366177764|FG001|Overall Study|Investigator's Discretion|1|||
106141701|NCT00393848|366177765|FG000|Overall Study|Surgical schedule|0|||
106141702|NCT00393848|366177766|FG001|Overall Study|Surgical schedule|0|||
106141703|NCT00393848|366177767|FG002|Overall Study|Surgical schedule|0|||
106141704|NCT00393848|366177768|FG003|Overall Study|Surgical schedule|1|||
105739225|NCT01469052|364699979|FG003|Overall Study|Moved to rollover protocol|0|||
105739226|NCT01469052|364699980|FG004|Overall Study|Moved to rollover protocol|0|||
105739227|NCT01469052|364699981|FG005|Overall Study|Moved to rollover protocol|1|||
105739228|NCT01469052|364699976|FG000|Overall Study|Other|0|||
105941425|NCT00323622|365447738|FG004|Overall Study|Other|32|||
106141705|NCT00393848|366177765|FG000|Overall Study|Personal reasons|0|||
106141706|NCT00393848|366177766|FG001|Overall Study|Personal reasons|0|||
106141707|NCT00393848|366177767|FG002|Overall Study|Personal reasons|2|||
106141708|NCT00393848|366177768|FG003|Overall Study|Personal reasons|0|||
106141709|NCT00549848|366177772|FG000|Overall Study|Death|1|||
106141710|NCT00549848|366177773|FG001|Overall Study|Death|4|||
106141711|NCT00549848|366177774|FG002|Overall Study|Death|13|||
106141712|NCT00549848|366177772|FG000|Overall Study|Physician Decision|0|||
106141713|NCT00549848|366177773|FG001|Overall Study|Physician Decision|0|||
106141714|NCT00549848|366177774|FG002|Overall Study|Physician Decision|4|||
106141715|NCT00549848|366177772|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
106141716|NCT00549848|366177773|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
105739229|NCT01469052|364699977|FG001|Overall Study|Other|1|||
105739230|NCT01469052|364699978|FG002|Overall Study|Other|0|||
106141717|NCT00549848|366177774|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
106141718|NCT00549848|366177772|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
106141719|NCT00549848|366177773|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
106141720|NCT00549848|366177774|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
106141721|NCT00549848|366177772|FG000|Overall Study|Participant/Family Withdraw|2|||
106141722|NCT00549848|366177773|FG001|Overall Study|Participant/Family Withdraw|3|||
106141723|NCT00549848|366177774|FG002|Overall Study|Participant/Family Withdraw|5|||
106141724|NCT00549848|366177772|FG000|Overall Study|Second Malignancy|1|||
106141725|NCT00549848|366177773|FG001|Overall Study|Second Malignancy|0|||
106141726|NCT00549848|366177774|FG002|Overall Study|Second Malignancy|0|||
106141727|NCT00549848|366177772|FG000|Overall Study|Transplant|3|||
106141728|NCT00549848|366177773|FG001|Overall Study|Transplant|3|||
106141729|NCT00549848|366177774|FG002|Overall Study|Transplant|18|||
106141730|NCT00549848|366177772|FG000|Overall Study|Unacceptable Toxicity|1|||
106141731|NCT00549848|366177773|FG001|Overall Study|Unacceptable Toxicity|6|||
106141732|NCT00549848|366177774|FG002|Overall Study|Unacceptable Toxicity|6|||
106141733|NCT01456936|366177781|FG000|Overall Study|Other reason|41|||
106141734|NCT01456936|366177782|FG001|Overall Study|Other reason|30|||
106141735|NCT01456936|366177783|FG002|Overall Study|Other reason|36|||
105739231|NCT01469052|364699979|FG003|Overall Study|Other|0|||
105739232|NCT01469052|364699980|FG004|Overall Study|Other|1|||
105739233|NCT01469052|364699981|FG005|Overall Study|Other|0|||
105739234|NCT01597193|364699982|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
105739235|NCT01597193|364699983|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
105739236|NCT01597193|364699984|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739237|NCT01597193|364699985|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739238|NCT01597193|364699986|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739239|NCT01597193|364699987|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739240|NCT01597193|364699988|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
105739241|NCT01597193|364699982|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
105739242|NCT01597193|364699983|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
105739243|NCT01597193|364699984|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
105739244|NCT01597193|364699985|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
105739245|NCT01597193|364699986|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
105739246|NCT01597193|364699987|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
105739247|NCT01597193|364699988|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
105739248|NCT01597193|364699982|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
105739249|NCT01597193|364699983|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
105739250|NCT01597193|364699984|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
105739251|NCT01597193|364699985|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
105739252|NCT01597193|364699986|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
105739253|NCT01597193|364699987|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
105739254|NCT01597193|364699988|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
105739255|NCT01597193|364699982|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739256|NCT01597193|364699983|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739257|NCT01597193|364699984|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739258|NCT01597193|364699985|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739259|NCT01597193|364699986|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739260|NCT01597193|364699987|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
105799865|NCT02278952|364924666|FG000|Overall Study|Insufficient Sample|6|||
105799866|NCT04304950|364924669|FG000|Overall Study|Lost to Follow-up|1|||
105799867|NCT04304950|364924670|FG001|Overall Study|Lost to Follow-up|1|||
105799868|NCT02418910|364924671|FG000|Overall Study|Lost to Follow-up|3|||
106013526|NCT03077412|365717171|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
106013527|NCT03077412|365717172|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
106013528|NCT03077412|365717170|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
106013529|NCT03077412|365717171|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
106013530|NCT03077412|365717172|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
106013531|NCT03077412|365717170|FG000|Overall Study|Adverse Event|1|||
106013532|NCT03077412|365717171|FG001|Overall Study|Adverse Event|2|||
106013533|NCT03077412|365717172|FG002|Overall Study|Adverse Event|2|||
106141736|NCT01456936|366177784|FG003|Overall Study|Other reason|33|||
106141737|NCT01456936|366177781|FG000|Overall Study|No longer meets eligibility criteria|4|||
106141738|NCT01456936|366177782|FG001|Overall Study|No longer meets eligibility criteria|8|||
106141739|NCT01456936|366177783|FG002|Overall Study|No longer meets eligibility criteria|6|||
106141740|NCT01456936|366177784|FG003|Overall Study|No longer meets eligibility criteria|5|||
105739261|NCT01597193|364699988|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
105739262|NCT01597193|364699982|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105739263|NCT01597193|364699983|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
106013534|NCT03077412|365717170|FG000|Overall Study|Investigator's Discretion|0|||
106013535|NCT03077412|365717171|FG001|Overall Study|Investigator's Discretion|1|||
106013536|NCT03077412|365717172|FG002|Overall Study|Investigator's Discretion|1|||
106013537|NCT03077412|365717170|FG000|Overall Study|Withdrew Consent|0|||
106013538|NCT03077412|365717171|FG001|Overall Study|Withdrew Consent|2|||
106013539|NCT03077412|365717172|FG002|Overall Study|Withdrew Consent|0|||
106013540|NCT02266888|365717173|FG000|Overall Study|Death|2|||
106013541|NCT02266888|365717174|FG001|Overall Study|Death|2|||
106013542|NCT02266888|365717175|FG002|Overall Study|Death|4|||
106141741|NCT01456936|366177781|FG000|Overall Study|Protocol Violation|4|||
106141742|NCT01456936|366177782|FG001|Overall Study|Protocol Violation|2|||
105739264|NCT01597193|364699984|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105739265|NCT01597193|364699985|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
105739266|NCT01597193|364699986|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105739267|NCT01597193|364699987|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
105739268|NCT01597193|364699988|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
105739269|NCT02508701|364699990|FG000|Overall Study|Lost to Follow-up|9|||
105739270|NCT02508701|364699991|FG001|Overall Study|Lost to Follow-up|5|||
105739271|NCT02508701|364699992|FG002|Overall Study|Lost to Follow-up|5|||
105739272|NCT02508701|364699993|FG003|Overall Study|Lost to Follow-up|3|||
105739273|NCT03648996|364699995|FG000|Overall Study|Withdrawal by Subject|0|||
105739274|NCT03648996|364699996|FG001|Overall Study|Withdrawal by Subject|2|||
105739275|NCT03648996|364699997|FG002|Overall Study|Withdrawal by Subject|2|||
105739276|NCT03648996|364699995|FG000|Overall Study|Physician Decision|2|||
105739277|NCT03648996|364699996|FG001|Overall Study|Physician Decision|0|||
105739278|NCT03648996|364699997|FG002|Overall Study|Physician Decision|0|||
105739279|NCT01259297|364700002|FG000|Double Blind Randomized Period|Death|1|||
105739280|NCT01259297|364700003|FG001|Double Blind Randomized Period|Death|1|||
105739281|NCT01259297|364700004|FG002|Double Blind Randomized Period|Death|1|||
105739282|NCT01259297|364700005|FG003|Double Blind Randomized Period|Death|2|||
105739283|NCT01259297|364700006|FG004|Double Blind Randomized Period|Death|1|||
105739284|NCT01259297|364700007|FG005|Double Blind Randomized Period|Death|5|||
105739285|NCT01259297|364700008|FG006|Double Blind Randomized Period|Death|2|||
105739286|NCT01259297|364700009|FG007|Double Blind Randomized Period|Death|1|||
105739287|NCT01259297|364700002|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739288|NCT01259297|364700003|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739289|NCT01259297|364700004|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
105739290|NCT01259297|364700005|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
105739291|NCT01259297|364700006|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
105739292|NCT01259297|364700007|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739293|NCT01259297|364700008|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739294|NCT01259297|364700009|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
105739295|NCT01259297|364700002|FG000|Double Blind Randomized Period|Other reasons|0|||
105739296|NCT01259297|364700003|FG001|Double Blind Randomized Period|Other reasons|1|||
105739297|NCT01259297|364700004|FG002|Double Blind Randomized Period|Other reasons|0|||
105739298|NCT01259297|364700005|FG003|Double Blind Randomized Period|Other reasons|0|||
105739299|NCT01259297|364700006|FG004|Double Blind Randomized Period|Other reasons|1|||
105739300|NCT01259297|364700007|FG005|Double Blind Randomized Period|Other reasons|2|||
105739301|NCT01259297|364700008|FG006|Double Blind Randomized Period|Other reasons|3|||
105739302|NCT01259297|364700009|FG007|Double Blind Randomized Period|Other reasons|1|||
105799869|NCT02418910|364924671|FG000|Overall Study|Withdrawal by Subject|4|||
105941426|NCT00323622|365447739|FG005|Overall Study|Other|74|||
105941427|NCT00323622|365447740|FG006|Overall Study|Other|5|||
105941428|NCT00323622|365447741|FG007|Overall Study|Other|13|||
105941429|NCT00323622|365447734|FG000|Overall Study|Death|1|||
105941430|NCT00323622|365447735|FG001|Overall Study|Death|1|||
105941431|NCT00323622|365447736|FG002|Overall Study|Death|0|||
105941432|NCT00323622|365447737|FG003|Overall Study|Death|0|||
105941433|NCT00323622|365447738|FG004|Overall Study|Death|7|||
105941434|NCT00323622|365447739|FG005|Overall Study|Death|0|||
105941435|NCT00323622|365447740|FG006|Overall Study|Death|0|||
105941436|NCT00323622|365447741|FG007|Overall Study|Death|2|||
105941437|NCT00835354|365447742|FG000|First Intervention|Adverse Event|0|||
105941438|NCT00835354|365447743|FG001|First Intervention|Adverse Event|1|||
106013543|NCT02266888|365717176|FG003|Overall Study|Death|2|||
105739303|NCT03242759|364700010|FG000|Overall Study|Adverse Event|5|||
105799870|NCT00345683|364924672|FG000|Overall Study|Lost to Follow-up|19|||
106141743|NCT01456936|366177783|FG002|Overall Study|Protocol Violation|5|||
105739304|NCT03242759|364700011|FG001|Overall Study|Adverse Event|1|||
105941439|NCT05021224|365447744|FG000|Overall Study|Did not complete all survey items|4|||
105941440|NCT05021224|365447745|FG001|Overall Study|Did not complete all survey items|1|||
105941441|NCT05021224|365447746|FG002|Overall Study|Did not complete all survey items|0|||
106013544|NCT02266888|365717173|FG000|Overall Study|Physician Decision|0|||
106013545|NCT02266888|365717174|FG001|Overall Study|Physician Decision|1|||
106013546|NCT02266888|365717175|FG002|Overall Study|Physician Decision|2|||
105799871|NCT00345683|364924673|FG001|Overall Study|Lost to Follow-up|7|||
105799872|NCT00345683|364924672|FG000|Overall Study|Other|6|||
105799873|NCT00345683|364924673|FG001|Overall Study|Other|2|||
105799874|NCT03634488|364924674|FG000|Overall Study|Death|1|||
105799875|NCT03634488|364924675|FG001|Overall Study|Death|0|||
105799876|NCT03634488|364924676|FG002|Overall Study|Death|0|||
105799877|NCT03634488|364924674|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
105799878|NCT03634488|364924675|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
105799879|NCT03634488|364924676|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
105799880|NCT00729365|364924677|FG000|Overall Study|Physician Decision|33|||
105799881|NCT00729365|364924678|FG001|Overall Study|Physician Decision|6|||
105799882|NCT00729365|364924679|FG002|Overall Study|Physician Decision|7|||
105799883|NCT00811070|364924680|FG000|Overall Study|Death|0|||
105799884|NCT00811070|364924681|FG001|Overall Study|Death|0|||
105799885|NCT00811070|364924682|FG002|Overall Study|Death|0|||
105799886|NCT00811070|364924683|FG003|Overall Study|Death|2|||
105799887|NCT00811070|364924684|FG004|Overall Study|Death|5|||
105799888|NCT00811070|364924685|FG005|Overall Study|Death|0|||
105799889|NCT00811070|364924680|FG000|Overall Study|Other|1|||
105799890|NCT00811070|364924681|FG001|Overall Study|Other|0|||
105799891|NCT00811070|364924682|FG002|Overall Study|Other|0|||
105799892|NCT00811070|364924683|FG003|Overall Study|Other|0|||
105799893|NCT00811070|364924684|FG004|Overall Study|Other|0|||
105799894|NCT00811070|364924685|FG005|Overall Study|Other|0|||
105799895|NCT00811070|364924680|FG000|Overall Study|Withdrawal by Subject|0|||
105799896|NCT00811070|364924681|FG001|Overall Study|Withdrawal by Subject|1|||
105799897|NCT00811070|364924682|FG002|Overall Study|Withdrawal by Subject|0|||
105799898|NCT00811070|364924683|FG003|Overall Study|Withdrawal by Subject|0|||
105799899|NCT00811070|364924684|FG004|Overall Study|Withdrawal by Subject|0|||
105799900|NCT00811070|364924685|FG005|Overall Study|Withdrawal by Subject|0|||
105799901|NCT00811070|364924680|FG000|Overall Study|Physician Decision|0|||
105799902|NCT00811070|364924681|FG001|Overall Study|Physician Decision|0|||
105799903|NCT00811070|364924682|FG002|Overall Study|Physician Decision|0|||
105799904|NCT00811070|364924683|FG003|Overall Study|Physician Decision|0|||
105799905|NCT00811070|364924684|FG004|Overall Study|Physician Decision|0|||
105799906|NCT00811070|364924685|FG005|Overall Study|Physician Decision|1|||
105799907|NCT01298596|364924687|FG000|Overall Study|Withdrawal by Subject|1|||
105799908|NCT01298596|364924688|FG001|Overall Study|Withdrawal by Subject|1|||
105799909|NCT01298596|364924687|FG000|Overall Study|Death|5|||
105799910|NCT01298596|364924688|FG001|Overall Study|Death|3|||
105799911|NCT01298596|364924687|FG000|Overall Study|Lost to Follow-up|6|||
105799912|NCT01298596|364924688|FG001|Overall Study|Lost to Follow-up|14|||
105799913|NCT01298596|364924687|FG000|Overall Study|Referred for further management|16|||
105799914|NCT01298596|364924688|FG001|Overall Study|Referred for further management|15|||
105799915|NCT01123980|364924691|FG000|Overall Study|Adverse Event|1|||
105799916|NCT01123980|364924692|FG001|Overall Study|Adverse Event|1|||
105799917|NCT01123980|364924691|FG000|Overall Study|Lack of Efficacy|1|||
105799918|NCT01123980|364924692|FG001|Overall Study|Lack of Efficacy|0|||
105799919|NCT01123980|364924691|FG000|Overall Study|Physician Decision|0|||
105799920|NCT01123980|364924692|FG001|Overall Study|Physician Decision|1|||
105799921|NCT01123980|364924691|FG000|Overall Study|Lost to Follow-up|0|||
105799922|NCT01123980|364924692|FG001|Overall Study|Lost to Follow-up|6|||
105799923|NCT01123980|364924691|FG000|Overall Study|Protocol Violation|6|||
105799924|NCT01123980|364924692|FG001|Overall Study|Protocol Violation|6|||
105799925|NCT01123980|364924691|FG000|Overall Study|Withdrawal by Subject|5|||
105799926|NCT01123980|364924692|FG001|Overall Study|Withdrawal by Subject|3|||
105799927|NCT01123980|364924691|FG000|Overall Study|Unclassified|6|||
105799928|NCT01123980|364924692|FG001|Overall Study|Unclassified|7|||
105799929|NCT04578548|364924693|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
105799930|NCT04578548|364924694|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
105799931|NCT04578548|364924693|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
105799932|NCT04578548|364924694|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
105799933|NCT04578548|364924693|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
105799934|NCT04578548|364924694|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
105799935|NCT04578548|364924693|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
105799936|NCT04578548|364924694|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
105799937|NCT04578548|364924693|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
105799938|NCT04578548|364924694|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
105799939|NCT04578548|364924693|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
105799940|NCT04578548|364924694|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
105799941|NCT00628745|364924695|FG000|Overall Study|Withdrawal by Subject|63|||
105799942|NCT00628745|364924696|FG001|Overall Study|Withdrawal by Subject|3|||
105799943|NCT00628745|364924697|FG002|Overall Study|Withdrawal by Subject|9|||
105799944|NCT00628745|364924698|FG003|Overall Study|Withdrawal by Subject|2|||
105799945|NCT00628745|364924699|FG004|Overall Study|Withdrawal by Subject|69|||
105941442|NCT05021224|365447747|FG003|Overall Study|Did not complete all survey items|2|||
105941443|NCT04551053|365447750|FG000|Overall Study|Death|9|||
105941444|NCT04551053|365447751|FG001|Overall Study|Death|9|||
105941445|NCT04551053|365447750|FG000|Overall Study|Lost to Follow-up|0|||
105941446|NCT04551053|365447751|FG001|Overall Study|Lost to Follow-up|2|||
105941447|NCT04551053|365447750|FG000|Overall Study|Study Terminated by Sponsor|53|||
106141744|NCT01456936|366177784|FG003|Overall Study|Protocol Violation|5|||
106141745|NCT01456936|366177781|FG000|Overall Study|Pregnancy|1|||
106141746|NCT01456936|366177782|FG001|Overall Study|Pregnancy|0|||
106141747|NCT01456936|366177783|FG002|Overall Study|Pregnancy|0|||
106141748|NCT01456936|366177784|FG003|Overall Study|Pregnancy|1|||
106141749|NCT01456936|366177781|FG000|Overall Study|Insufficient clinical response|4|||
106141750|NCT01456936|366177782|FG001|Overall Study|Insufficient clinical response|4|||
106141751|NCT01456936|366177783|FG002|Overall Study|Insufficient clinical response|14|||
106141752|NCT01456936|366177784|FG003|Overall Study|Insufficient clinical response|13|||
105739305|NCT03242759|364700010|FG000|Overall Study|Withdrawal by Subject|4|||
105739306|NCT03242759|364700011|FG001|Overall Study|Withdrawal by Subject|3|||
105739307|NCT03242759|364700010|FG000|Overall Study|Lost to Follow-up|3|||
105739308|NCT03242759|364700011|FG001|Overall Study|Lost to Follow-up|1|||
105739309|NCT03242759|364700010|FG000|Overall Study|Administrative problems|1|||
105739310|NCT03242759|364700011|FG001|Overall Study|Administrative problems|1|||
105739311|NCT03242759|364700010|FG000|Overall Study|Death|22|||
105739312|NCT03242759|364700011|FG001|Overall Study|Death|0|||
105739313|NCT03242759|364700010|FG000|Overall Study|Change visit schedule|0|||
105739314|NCT03242759|364700011|FG001|Overall Study|Change visit schedule|1|||
105739315|NCT00651118|364700012|FG000|Overall Study|Adverse Event|4|||
105739316|NCT00651118|364700013|FG001|Overall Study|Adverse Event|0|||
105739317|NCT00651118|364700014|FG002|Overall Study|Adverse Event|1|||
105739318|NCT00651118|364700015|FG003|Overall Study|Adverse Event|1|||
105739319|NCT00651118|364700012|FG000|Overall Study|Protocol Violation|2|||
105739320|NCT00651118|364700013|FG001|Overall Study|Protocol Violation|2|||
105739321|NCT00651118|364700014|FG002|Overall Study|Protocol Violation|6|||
105739322|NCT00651118|364700015|FG003|Overall Study|Protocol Violation|2|||
105739323|NCT00651118|364700012|FG000|Overall Study|Lost to Follow-up|2|||
105739324|NCT00651118|364700013|FG001|Overall Study|Lost to Follow-up|0|||
105739325|NCT00651118|364700014|FG002|Overall Study|Lost to Follow-up|1|||
105739326|NCT00651118|364700015|FG003|Overall Study|Lost to Follow-up|2|||
105739327|NCT00651118|364700012|FG000|Overall Study|administrative|1|||
105739328|NCT00651118|364700013|FG001|Overall Study|administrative|4|||
105739329|NCT00651118|364700014|FG002|Overall Study|administrative|2|||
105739330|NCT00651118|364700015|FG003|Overall Study|administrative|1|||
105739331|NCT00651118|364700012|FG000|Overall Study|Withdrawal by Subject|0|||
105739332|NCT00651118|364700013|FG001|Overall Study|Withdrawal by Subject|1|||
105739333|NCT00651118|364700014|FG002|Overall Study|Withdrawal by Subject|1|||
105739334|NCT00651118|364700015|FG003|Overall Study|Withdrawal by Subject|1|||
105739335|NCT00935220|364700017|FG000|Overall Study|Adverse Event|1|||
105739336|NCT00935220|364700017|FG000|Overall Study|Other reason (not specified)|1|||
105739337|NCT01000064|364700018|FG000|Overall Study|Withdrawal by Subject|1|||
105739338|NCT01000064|364700019|FG001|Overall Study|Withdrawal by Subject|1|||
105739339|NCT02518620|364700020|FG000|Overall Study|Adverse Event|23|||
105739340|NCT02518620|364700021|FG001|Overall Study|Adverse Event|11|||
105739341|NCT02518620|364700020|FG000|Overall Study|Lack of Efficacy|2|||
105739342|NCT02518620|364700021|FG001|Overall Study|Lack of Efficacy|0|||
105739343|NCT02518620|364700020|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105739344|NCT02518620|364700021|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105739345|NCT02518620|364700020|FG000|Overall Study|Physician Decision|1|||
105739346|NCT02518620|364700021|FG001|Overall Study|Physician Decision|1|||
105739347|NCT02518620|364700020|FG000|Overall Study|Sponsor's Decision|0|||
105739348|NCT02518620|364700021|FG001|Overall Study|Sponsor's Decision|3|||
105739349|NCT02518620|364700020|FG000|Overall Study|Lost to Follow-up|1|||
105941448|NCT04551053|365447751|FG001|Overall Study|Study Terminated by Sponsor|63|||
105941449|NCT04551053|365447750|FG000|Overall Study|Withdrawal by Subject|12|||
105941450|NCT04551053|365447751|FG001|Overall Study|Withdrawal by Subject|5|||
106141753|NCT01456936|366177781|FG000|Overall Study|No longer willing to participate|195|||
106141754|NCT01456936|366177782|FG001|Overall Study|No longer willing to participate|218|||
105739350|NCT02518620|364700021|FG001|Overall Study|Lost to Follow-up|1|||
105739351|NCT02518620|364700020|FG000|Overall Study|Withdrawal by Subject|17|||
105739352|NCT02518620|364700021|FG001|Overall Study|Withdrawal by Subject|9|||
105739353|NCT02518620|364700020|FG000|Overall Study|Death|1|||
105739354|NCT02518620|364700021|FG001|Overall Study|Death|0|||
105739355|NCT02518620|364700020|FG000|Overall Study|Pregnancy Wish|3|||
105739356|NCT02518620|364700021|FG001|Overall Study|Pregnancy Wish|0|||
105739357|NCT02518620|364700020|FG000|Overall Study|Pregnancy|1|||
105739358|NCT02518620|364700021|FG001|Overall Study|Pregnancy|0|||
105739359|NCT02518620|364700020|FG000|Overall Study|Relocation|2|||
105739360|NCT02518620|364700021|FG001|Overall Study|Relocation|1|||
105739361|NCT03141307|364700022|FG000|In-Hospital|Withdrawal by Subject|0|||
105739362|NCT03141307|364700023|FG001|In-Hospital|Withdrawal by Subject|2|||
105739363|NCT03141307|364700022|FG000|In-Hospital|Protocol Violation|4|||
105739364|NCT03141307|364700023|FG001|In-Hospital|Protocol Violation|0|||
105739365|NCT03141307|364700022|FG000|Follow-Up|Lost to Follow-up|97|||
105739366|NCT03141307|364700023|FG001|Follow-Up|Lost to Follow-up|54|||
105739367|NCT02658656|364700024|FG000|Screening|Failed eligibility criteria|0|||
105739368|NCT02658656|364700025|FG001|Screening|Failed eligibility criteria|0|||
105739369|NCT02658656|364700026|FG002|Screening|Failed eligibility criteria|263|||
105739370|NCT02658656|364700024|FG000|Randomization|Withdrawal by Subject|8|||
105739371|NCT02658656|364700025|FG001|Randomization|Withdrawal by Subject|7|||
105739372|NCT02658656|364700026|FG002|Randomization|Withdrawal by Subject|0|||
105739373|NCT02658656|364700024|FG000|Randomization|Lost to Follow-up|1|||
105739374|NCT02658656|364700025|FG001|Randomization|Lost to Follow-up|3|||
105739375|NCT02658656|364700026|FG002|Randomization|Lost to Follow-up|0|||
105739376|NCT02658656|364700024|FG000|Randomization|Adverse Event|4|||
105739377|NCT02658656|364700025|FG001|Randomization|Adverse Event|0|||
105739378|NCT02658656|364700026|FG002|Randomization|Adverse Event|0|||
105739379|NCT02658656|364700024|FG000|Randomization|Administrative Termination|3|||
105739380|NCT02658656|364700025|FG001|Randomization|Administrative Termination|1|||
105739381|NCT02658656|364700026|FG002|Randomization|Administrative Termination|0|||
105739382|NCT02658656|364700024|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
105739383|NCT02658656|364700025|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
105739384|NCT02658656|364700026|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
105739385|NCT02658656|364700024|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
105739386|NCT02658656|364700025|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
105739387|NCT02658656|364700026|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
105739388|NCT02658656|364700024|FG000|Randomization|Not eligible for Randomization|1|||
105739389|NCT02658656|364700025|FG001|Randomization|Not eligible for Randomization|0|||
105739390|NCT02658656|364700026|FG002|Randomization|Not eligible for Randomization|0|||
105739391|NCT02658656|364700024|FG000|Randomization|Protocol Violation|1|||
105739392|NCT02658656|364700025|FG001|Randomization|Protocol Violation|0|||
105739393|NCT02658656|364700026|FG002|Randomization|Protocol Violation|0|||
105739394|NCT05094154|364701509|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
105739395|NCT05094154|364701510|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
105739396|NCT05094154|364701509|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
105739397|NCT05094154|364701510|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
105739398|NCT01937130|364701511|FG000|Overall Study|Withdrawal by Subject|0|||
105739399|NCT01937130|364701512|FG001|Overall Study|Withdrawal by Subject|0|||
105739400|NCT01937130|364701513|FG002|Overall Study|Withdrawal by Subject|0|||
105739401|NCT01937130|364701514|FG003|Overall Study|Withdrawal by Subject|1|||
105739402|NCT01937130|364701511|FG000|Overall Study|Adverse Event|0|||
105739403|NCT01937130|364701512|FG001|Overall Study|Adverse Event|1|||
105739404|NCT01937130|364701513|FG002|Overall Study|Adverse Event|0|||
105739405|NCT01937130|364701514|FG003|Overall Study|Adverse Event|1|||
105739406|NCT01937130|364701511|FG000|Overall Study|Death|1|||
105739407|NCT01937130|364701512|FG001|Overall Study|Death|1|||
105739408|NCT01937130|364701513|FG002|Overall Study|Death|1|||
105739409|NCT01937130|364701514|FG003|Overall Study|Death|0|||
105739410|NCT01937130|364701511|FG000|Overall Study|Lost to Follow-up|2|||
105739411|NCT01937130|364701512|FG001|Overall Study|Lost to Follow-up|0|||
105739412|NCT01937130|364701513|FG002|Overall Study|Lost to Follow-up|2|||
105739413|NCT01937130|364701514|FG003|Overall Study|Lost to Follow-up|0|||
105739414|NCT01937130|364701511|FG000|Overall Study|Physician Decision|0|||
105739415|NCT01937130|364701512|FG001|Overall Study|Physician Decision|1|||
105739416|NCT01937130|364701513|FG002|Overall Study|Physician Decision|0|||
105739417|NCT01937130|364701514|FG003|Overall Study|Physician Decision|0|||
105739418|NCT01937130|364701511|FG000|Overall Study|Patients unable to swallow|0|||
105739419|NCT01937130|364701512|FG001|Overall Study|Patients unable to swallow|1|||
105739420|NCT01937130|364701513|FG002|Overall Study|Patients unable to swallow|0|||
105739421|NCT01937130|364701514|FG003|Overall Study|Patients unable to swallow|0|||
105739422|NCT01937130|364701511|FG000|Overall Study|Patient lost to FU due to death|2|||
105739423|NCT01937130|364701512|FG001|Overall Study|Patient lost to FU due to death|0|||
105739424|NCT01937130|364701513|FG002|Overall Study|Patient lost to FU due to death|0|||
105941451|NCT04551053|365447750|FG000|Overall Study|Adverse Event|1|||
105941452|NCT04551053|365447751|FG001|Overall Study|Adverse Event|0|||
105941453|NCT04551053|365447750|FG000|Overall Study|Lack of Efficacy|2|||
105941454|NCT04551053|365447751|FG001|Overall Study|Lack of Efficacy|0|||
105941455|NCT04551053|365447750|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
105941456|NCT04551053|365447751|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
105941457|NCT04551053|365447750|FG000|Overall Study|Splenapendectomi|1|||
105941458|NCT04551053|365447751|FG001|Overall Study|Splenapendectomi|0|||
105941459|NCT04551053|365447750|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
105941460|NCT04551053|365447751|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
105739425|NCT01937130|364701514|FG003|Overall Study|Patient lost to FU due to death|0|||
105739426|NCT02100657|364701515|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
105739427|NCT02100657|364701516|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
105739428|NCT02100657|364701517|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
105739429|NCT02100657|364701515|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
105739430|NCT02100657|364701516|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
105739431|NCT02100657|364701517|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
105739432|NCT02100657|364701515|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
105739433|NCT02100657|364701516|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
105739434|NCT02100657|364701517|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
105739435|NCT02100657|364701515|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
105739436|NCT02100657|364701516|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
105739437|NCT02100657|364701517|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
105739438|NCT02100657|364701515|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
105739439|NCT02100657|364701516|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
105739440|NCT02100657|364701517|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
105739441|NCT02100657|364701515|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
105739442|NCT02100657|364701516|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
105739443|NCT02100657|364701517|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
105739444|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
105739445|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
105739446|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
105739447|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Death|0|||
105739448|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Death|0|||
105739449|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Death|1|||
105739450|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
105739451|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
105739452|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
105739453|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
105739454|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
105739455|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
105739456|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
105739457|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
105739458|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
105739459|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
105739460|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
105739461|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
105739462|NCT02100657|364701515|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
105739463|NCT02100657|364701516|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
105739464|NCT02100657|364701517|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
105739465|NCT01850563|364701518|FG000|Overall Study|Not eligible|3|||
105739466|NCT01850563|364701519|FG001|Overall Study|Not eligible|0|||
105739467|NCT01790438|364701520|FG000|Overall Study|Adverse Event|3|||
105739468|NCT01790438|364701521|FG001|Overall Study|Adverse Event|2|||
105739469|NCT01790438|364701520|FG000|Overall Study|Death|4|||
105739470|NCT01790438|364701521|FG001|Overall Study|Death|0|||
105739471|NCT01790438|364701520|FG000|Overall Study|Lost to Follow-up|5|||
105739472|NCT01790438|364701521|FG001|Overall Study|Lost to Follow-up|2|||
105739473|NCT01790438|364701520|FG000|Overall Study|Withdrawal by Subject|13|||
105739474|NCT01790438|364701521|FG001|Overall Study|Withdrawal by Subject|2|||
105739475|NCT01790438|364701520|FG000|Overall Study|Physician Decision|3|||
105739476|NCT01790438|364701521|FG001|Overall Study|Physician Decision|1|||
105739477|NCT01790438|364701520|FG000|Overall Study|Sponsor Decision|0|||
105739478|NCT01790438|364701521|FG001|Overall Study|Sponsor Decision|3|||
105739479|NCT01790438|364701520|FG000|Overall Study|Protocol Required Discontinuation|7|||
105739480|NCT01790438|364701521|FG001|Overall Study|Protocol Required Discontinuation|1|||
105739481|NCT02311478|364701533|FG000|Overall Study|Withdrawal by Subject|1|||
105739482|NCT02311478|364701533|FG000|Overall Study|Lost to Follow-up|5|||
105739483|NCT02311478|364701533|FG000|Overall Study|Failed IUD Insertion|1|||
105739484|NCT03242928|364701534|FG000|Overall Study|Adverse Event|2|||
105739485|NCT03242928|364701535|FG001|Overall Study|Adverse Event|1|||
105739486|NCT03242928|364701534|FG000|Overall Study|Lost to Follow-up|2|||
105739487|NCT03242928|364701535|FG001|Overall Study|Lost to Follow-up|0|||
105739488|NCT03242928|364701534|FG000|Overall Study|Physician Decision|0|||
105739489|NCT03242928|364701535|FG001|Overall Study|Physician Decision|1|||
105739490|NCT03242928|364701534|FG000|Overall Study|Withdrawal by Subject|5|||
105739491|NCT03242928|364701535|FG001|Overall Study|Withdrawal by Subject|3|||
105739492|NCT00960440|364701536|FG000|Overall Study|Death|0|||
105739493|NCT00960440|364701537|FG001|Overall Study|Death|0|||
105739494|NCT00960440|364701538|FG002|Overall Study|Death|0|||
105739495|NCT00960440|364701539|FG003|Overall Study|Death|1|||
105739496|NCT00960440|364701536|FG000|Overall Study|Adverse Event|12|||
105739497|NCT00960440|364701537|FG001|Overall Study|Adverse Event|12|||
105739498|NCT00960440|364701538|FG002|Overall Study|Adverse Event|4|||
105739499|NCT00960440|364701539|FG003|Overall Study|Adverse Event|4|||
105739500|NCT00960440|364701536|FG000|Overall Study|Lack of Efficacy|2|||
105739501|NCT00960440|364701537|FG001|Overall Study|Lack of Efficacy|5|||
105739502|NCT00960440|364701538|FG002|Overall Study|Lack of Efficacy|3|||
105739503|NCT00960440|364701539|FG003|Overall Study|Lack of Efficacy|8|||
105739504|NCT00960440|364701536|FG000|Overall Study|Protocol Violation|2|||
105739505|NCT00960440|364701537|FG001|Overall Study|Protocol Violation|8|||
105739506|NCT00960440|364701538|FG002|Overall Study|Protocol Violation|3|||
105739507|NCT00960440|364701539|FG003|Overall Study|Protocol Violation|4|||
105739508|NCT00960440|364701536|FG000|Overall Study|Withdrawal by Subject|9|||
105739509|NCT00960440|364701537|FG001|Overall Study|Withdrawal by Subject|5|||
105739510|NCT00960440|364701538|FG002|Overall Study|Withdrawal by Subject|2|||
105739511|NCT00960440|364701539|FG003|Overall Study|Withdrawal by Subject|1|||
105739512|NCT00960440|364701536|FG000|Overall Study|Other|1|||
105739513|NCT00960440|364701537|FG001|Overall Study|Other|1|||
105739514|NCT00960440|364701538|FG002|Overall Study|Other|1|||
105739515|NCT00960440|364701539|FG003|Overall Study|Other|0|||
105739516|NCT02241512|364701544|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
105739517|NCT02241512|364701545|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
105739518|NCT00536731|364701546|FG000|Overall Study|Adverse Event|3|||
105739519|NCT00536731|364701547|FG001|Overall Study|Adverse Event|2|||
105739520|NCT00536731|364701548|FG002|Overall Study|Adverse Event|3|||
105739521|NCT00536731|364701546|FG000|Overall Study|Withdrawal by Subject|0|||
105739522|NCT00536731|364701547|FG001|Overall Study|Withdrawal by Subject|2|||
105739523|NCT00536731|364701548|FG002|Overall Study|Withdrawal by Subject|0|||
105739524|NCT00536731|364701546|FG000|Overall Study|Intake of prohibited conc. medication|0|||
105739525|NCT00536731|364701547|FG001|Overall Study|Intake of prohibited conc. medication|0|||
105739526|NCT00536731|364701548|FG002|Overall Study|Intake of prohibited conc. medication|1|||
105739527|NCT00536731|364701546|FG000|Overall Study|Safety reasons|0|||
105739528|NCT00536731|364701547|FG001|Overall Study|Safety reasons|0|||
105739529|NCT00536731|364701548|FG002|Overall Study|Safety reasons|1|||
105739530|NCT00536731|364701546|FG000|Overall Study|Other|1|||
105739531|NCT00536731|364701547|FG001|Overall Study|Other|1|||
105739532|NCT00536731|364701548|FG002|Overall Study|Other|0|||
105739533|NCT03567291|364701549|FG000|Period I|Adverse Event|14|||
105739534|NCT03567291|364701550|FG001|Period I|Adverse Event|0|||
105739535|NCT03567291|364701551|FG002|Period I|Adverse Event|0|||
105739536|NCT03567291|364701552|FG003|Period I|Adverse Event|0|||
105739537|NCT03567291|364701549|FG000|Period I|Protocol Violation|1|||
105739538|NCT03567291|364701550|FG001|Period I|Protocol Violation|0|||
105739539|NCT03567291|364701551|FG002|Period I|Protocol Violation|0|||
105739540|NCT03567291|364701552|FG003|Period I|Protocol Violation|0|||
105739541|NCT03567291|364701549|FG000|Period I|Withdrawal by Subject|23|||
105739542|NCT03567291|364701550|FG001|Period I|Withdrawal by Subject|0|||
105739543|NCT03567291|364701551|FG002|Period I|Withdrawal by Subject|0|||
105739544|NCT03567291|364701552|FG003|Period I|Withdrawal by Subject|0|||
105739545|NCT03567291|364701549|FG000|Period I|Lost to Follow-up|2|||
105739546|NCT03567291|364701550|FG001|Period I|Lost to Follow-up|0|||
105739547|NCT03567291|364701551|FG002|Period I|Lost to Follow-up|0|||
105739548|NCT03567291|364701552|FG003|Period I|Lost to Follow-up|0|||
105739549|NCT03567291|364701549|FG000|Period I|Terminated by sponsor|44|||
105739550|NCT03567291|364701550|FG001|Period I|Terminated by sponsor|0|||
105739551|NCT03567291|364701551|FG002|Period I|Terminated by sponsor|0|||
105739552|NCT03567291|364701552|FG003|Period I|Terminated by sponsor|0|||
105739553|NCT03567291|364701549|FG000|Period I|Missing or unknown|7|||
105739554|NCT03567291|364701550|FG001|Period I|Missing or unknown|0|||
105739555|NCT03567291|364701551|FG002|Period I|Missing or unknown|0|||
105739556|NCT03567291|364701552|FG003|Period I|Missing or unknown|0|||
105739557|NCT03567291|364701549|FG000|Period II|Adverse Event|0|||
105739558|NCT03567291|364701550|FG001|Period II|Adverse Event|1|||
105739559|NCT03567291|364701551|FG002|Period II|Adverse Event|0|||
105739560|NCT03567291|364701552|FG003|Period II|Adverse Event|0|||
105739561|NCT03567291|364701549|FG000|Period II|Missing or unknown|0|||
105739562|NCT03567291|364701550|FG001|Period II|Missing or unknown|2|||
105739563|NCT03567291|364701551|FG002|Period II|Missing or unknown|1|||
105739564|NCT03567291|364701552|FG003|Period II|Missing or unknown|0|||
105739565|NCT03567291|364701549|FG000|Period III|Adverse Event|0|||
105739566|NCT03567291|364701550|FG001|Period III|Adverse Event|0|||
105739567|NCT03567291|364701551|FG002|Period III|Adverse Event|0|||
105739568|NCT03567291|364701552|FG003|Period III|Adverse Event|4|||
105739569|NCT03567291|364701549|FG000|Period III|Withdrawal by Subject|0|||
105739570|NCT03567291|364701550|FG001|Period III|Withdrawal by Subject|0|||
105739571|NCT03567291|364701551|FG002|Period III|Withdrawal by Subject|0|||
105739572|NCT03567291|364701552|FG003|Period III|Withdrawal by Subject|4|||
105941461|NCT04551053|365447750|FG000|Overall Study|Medical Decision|0|||
106141755|NCT01456936|366177783|FG002|Overall Study|No longer willing to participate|224|||
105739573|NCT03567291|364701549|FG000|Period III|Lost to Follow-up|0|||
105739574|NCT03567291|364701550|FG001|Period III|Lost to Follow-up|0|||
105739575|NCT03567291|364701551|FG002|Period III|Lost to Follow-up|0|||
105739576|NCT03567291|364701552|FG003|Period III|Lost to Follow-up|1|||
105739577|NCT03567291|364701549|FG000|Period III|Terminated by sponsor|0|||
105739578|NCT03567291|364701550|FG001|Period III|Terminated by sponsor|0|||
105739579|NCT03567291|364701551|FG002|Period III|Terminated by sponsor|0|||
105739580|NCT03567291|364701552|FG003|Period III|Terminated by sponsor|68|||
105739581|NCT03567291|364701549|FG000|Period III|Missing or unknown|0|||
105739582|NCT03567291|364701550|FG001|Period III|Missing or unknown|0|||
105739583|NCT03567291|364701551|FG002|Period III|Missing or unknown|0|||
105739584|NCT03567291|364701552|FG003|Period III|Missing or unknown|8|||
105739585|NCT00637273|364701553|FG000|Overall Study|Adverse Event|11|||
105739586|NCT00637273|364701554|FG001|Overall Study|Adverse Event|5|||
105739587|NCT00637273|364701555|FG002|Overall Study|Adverse Event|7|||
105739588|NCT00637273|364701553|FG000|Overall Study|Lost to Follow-up|8|||
105739589|NCT00637273|364701554|FG001|Overall Study|Lost to Follow-up|9|||
105739590|NCT00637273|364701555|FG002|Overall Study|Lost to Follow-up|13|||
105739591|NCT00637273|364701553|FG000|Overall Study|Protocol Violation|2|||
105739592|NCT00637273|364701554|FG001|Overall Study|Protocol Violation|4|||
105739593|NCT00637273|364701555|FG002|Overall Study|Protocol Violation|1|||
105739594|NCT00637273|364701553|FG000|Overall Study|Withdrawal of Consent|18|||
105739595|NCT00637273|364701554|FG001|Overall Study|Withdrawal of Consent|6|||
105739596|NCT00637273|364701555|FG002|Overall Study|Withdrawal of Consent|18|||
105739597|NCT00637273|364701553|FG000|Overall Study|Investigator Decision|1|||
105739598|NCT00637273|364701554|FG001|Overall Study|Investigator Decision|3|||
105739599|NCT00637273|364701555|FG002|Overall Study|Investigator Decision|1|||
105739600|NCT00637273|364701553|FG000|Overall Study|Administrative|2|||
105739601|NCT00637273|364701554|FG001|Overall Study|Administrative|0|||
105739602|NCT00637273|364701555|FG002|Overall Study|Administrative|0|||
105739603|NCT00637273|364701553|FG000|Overall Study|Loss of Glucose Control|1|||
105739604|NCT00637273|364701554|FG001|Overall Study|Loss of Glucose Control|1|||
105739605|NCT00637273|364701555|FG002|Overall Study|Loss of Glucose Control|1|||
105739606|NCT00589472|364701556|FG000|Overall Study|Adverse Event|1|||
105739607|NCT05232097|364701557|FG000|Overall Study|Physician Decision|1|||
105739608|NCT01651052|364701558|FG000|Overall Study|Death|21|||
105739609|NCT01651052|364701558|FG000|Overall Study|Explant|1|||
105739610|NCT01651052|364701558|FG000|Overall Study|Withdrawal by Subject|1|||
105739611|NCT01651052|364701558|FG000|Overall Study|Lost to Follow-up|3|||
105739612|NCT01172288|364701561|FG000|Overall Study|Adverse Event|1|||
105739613|NCT01172288|364701562|FG001|Overall Study|Adverse Event|0|||
105739614|NCT01172288|364701561|FG000|Overall Study|Protocol Violation|0|||
105739615|NCT01172288|364701562|FG001|Overall Study|Protocol Violation|1|||
105739616|NCT02062151|364701567|FG000|Overall Study|screen failure|1|||
105739617|NCT00257192|364701568|FG000|Overall Study|Adverse Event|21|||
105739618|NCT00257192|364701569|FG001|Overall Study|Adverse Event|10|||
105739619|NCT00257192|364701568|FG000|Overall Study|Laboratory abnormality|1|||
105739620|NCT00257192|364701569|FG001|Overall Study|Laboratory abnormality|1|||
105739621|NCT00257192|364701568|FG000|Overall Study|Lost to Follow-up|3|||
105739622|NCT00257192|364701569|FG001|Overall Study|Lost to Follow-up|3|||
105739623|NCT00257192|364701568|FG000|Overall Study|Insufficient clinical response|18|||
105739624|NCT00257192|364701569|FG001|Overall Study|Insufficient clinical response|18|||
105739625|NCT00257192|364701568|FG000|Overall Study|Withdrawal by Subject|14|||
105739626|NCT00257192|364701569|FG001|Overall Study|Withdrawal by Subject|2|||
105739627|NCT00257192|364701568|FG000|Overall Study|Randomized but not treated|0|||
105739628|NCT00257192|364701569|FG001|Overall Study|Randomized but not treated|1|||
105739629|NCT00257192|364701568|FG000|Overall Study|Study terminated by sponsor|1|||
105739630|NCT00257192|364701569|FG001|Overall Study|Study terminated by sponsor|0|||
105739631|NCT00257192|364701568|FG000|Overall Study|Miscellaneous|0|||
105739632|NCT00257192|364701569|FG001|Overall Study|Miscellaneous|4|||
105739633|NCT02086565|364701570|FG000|Overall Study|Lost to Follow-up|9|||
105739634|NCT02086565|364701571|FG001|Overall Study|Lost to Follow-up|7|||
105739635|NCT02086565|364701570|FG000|Overall Study|Withdrawal by Subject|2|||
105739636|NCT02086565|364701571|FG001|Overall Study|Withdrawal by Subject|1|||
105739637|NCT02086565|364701570|FG000|Overall Study|Death|3|||
105739638|NCT02086565|364701571|FG001|Overall Study|Death|2|||
105739639|NCT02086565|364701570|FG000|Overall Study|withdrawn by research team|2|||
105739640|NCT02086565|364701571|FG001|Overall Study|withdrawn by research team|2|||
105739641|NCT00751101|364701572|FG000|Overall Study|Withdrawal by Subject|1|||
105739642|NCT00751101|364701573|FG001|Overall Study|Withdrawal by Subject|0|||
105739643|NCT00751101|364701572|FG000|Overall Study|No HFS / Never Started Patch/|0|||
105739644|NCT00751101|364701573|FG001|Overall Study|No HFS / Never Started Patch/|4|||
105739645|NCT00751101|364701572|FG000|Overall Study|Never began capecitabine|1|||
105739646|NCT00751101|364701573|FG001|Overall Study|Never began capecitabine|0|||
105739647|NCT00751101|364701572|FG000|Overall Study|Physician Decision|0|||
105739648|NCT00751101|364701573|FG001|Overall Study|Physician Decision|1|||
105739649|NCT00739297|364701574|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
105739650|NCT00739297|364701575|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
105739651|NCT00739297|364701576|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
105739652|NCT00739297|364701577|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
105739653|NCT00739297|364701578|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
105941462|NCT04551053|365447751|FG001|Overall Study|Medical Decision|1|||
105739654|NCT00739297|364701579|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
105739655|NCT00739297|364701580|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
105739656|NCT00739297|364701574|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739657|NCT00739297|364701575|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739658|NCT00739297|364701576|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739659|NCT00739297|364701577|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739660|NCT00739297|364701578|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
105739661|NCT00739297|364701579|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
105739662|NCT00739297|364701580|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
105739663|NCT00394914|364701581|FG000|Treatment Period|Adverse Event|0|||
105739664|NCT00394914|364701582|FG001|Treatment Period|Adverse Event|3|||
105739665|NCT00394914|364701583|FG002|Treatment Period|Adverse Event|1|||
105739666|NCT00394914|364701581|FG000|Treatment Period|Lost to Follow-up|0|||
105739667|NCT00394914|364701582|FG001|Treatment Period|Lost to Follow-up|1|||
105739668|NCT00394914|364701583|FG002|Treatment Period|Lost to Follow-up|0|||
105739669|NCT00394914|364701581|FG000|Treatment Period|Withdrawal by Subject|0|||
105739670|NCT00394914|364701582|FG001|Treatment Period|Withdrawal by Subject|2|||
105739671|NCT00394914|364701583|FG002|Treatment Period|Withdrawal by Subject|2|||
105739672|NCT00394914|364701581|FG000|Treatment Period|Noncompliance with protocol|0|||
105739673|NCT00394914|364701582|FG001|Treatment Period|Noncompliance with protocol|3|||
105739674|NCT00394914|364701583|FG002|Treatment Period|Noncompliance with protocol|2|||
105739675|NCT00394914|364701581|FG000|Treatment Period|Did not meet protocol eligibility|0|||
105739676|NCT00394914|364701582|FG001|Treatment Period|Did not meet protocol eligibility|1|||
105799946|NCT00628745|364924695|FG000|Overall Study|Does not meet inclusion criteria|0|||
105739677|NCT00394914|364701583|FG002|Treatment Period|Did not meet protocol eligibility|1|||
105739678|NCT00844428|364701585|FG000|Screening Period|Screen Failure|3|||
105739679|NCT00844428|364701585|FG000|Extension Treatment Period|Death|1|||
105739680|NCT00844428|364701585|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
105739681|NCT02749721|364701586|FG000|Screening|Withdrawal by Subject|1|||
105739682|NCT02749721|364701586|FG000|Screening|Lost to Follow-up|2|||
105739683|NCT02749721|364701586|FG000|Screening|Protocol Violation|3|||
105739684|NCT02749721|364701586|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
105739685|NCT02749721|364701586|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
105739686|NCT00863928|364701587|FG000|Overall Study|Protocol Violation|26|||
105739687|NCT00863928|364701588|FG001|Overall Study|Protocol Violation|0|||
105739688|NCT00863928|364701587|FG000|Overall Study|Withdrawal by Subject|3|||
105739689|NCT00863928|364701588|FG001|Overall Study|Withdrawal by Subject|0|||
105739690|NCT00863928|364701587|FG000|Overall Study|surgery cancellation|4|||
105739691|NCT00863928|364701588|FG001|Overall Study|surgery cancellation|0|||
105739692|NCT00863928|364701587|FG000|Overall Study|medication allergy|3|||
105739693|NCT00863928|364701588|FG001|Overall Study|medication allergy|0|||
105739694|NCT00803244|364701589|FG000|Overall Study|Adverse Event|1|||
105739695|NCT00803244|364701590|FG001|Overall Study|Adverse Event|2|||
105739696|NCT00803244|364701589|FG000|Overall Study|Withdrawal by Subject|2|||
105739697|NCT00803244|364701590|FG001|Overall Study|Withdrawal by Subject|3|||
105739698|NCT00803244|364701589|FG000|Overall Study|Any other reason not above-mentioned|4|||
105739699|NCT00803244|364701590|FG001|Overall Study|Any other reason not above-mentioned|10|||
105739700|NCT02873715|364701591|FG000|Overall Study|Lost to Follow-up|84|||
105739701|NCT02873715|364701592|FG001|Overall Study|Lost to Follow-up|94|||
105739702|NCT02873715|364701591|FG000|Overall Study|Withdrawal by Subject|7|||
105739703|NCT02873715|364701592|FG001|Overall Study|Withdrawal by Subject|26|||
105739704|NCT02021812|364701593|FG000|Overall Study|Death|8|||
105739705|NCT02021812|364701593|FG000|Overall Study|Withdrawal by Subject|3|||
105739706|NCT02021812|364701593|FG000|Overall Study|Lost to Follow-up|2|||
105739707|NCT02021812|364701593|FG000|Overall Study|Refuse to return, COVD 19|2|||
105739708|NCT03241173|364701594|FG000|Overall Study|Death|3|||
105739709|NCT03241173|364701595|FG001|Overall Study|Death|2|||
105739710|NCT03241173|364701596|FG002|Overall Study|Death|4|||
105739711|NCT03241173|364701597|FG003|Overall Study|Death|4|||
105739712|NCT03241173|364701598|FG004|Overall Study|Death|2|||
105739713|NCT03241173|364701599|FG005|Overall Study|Death|2|||
105739714|NCT03241173|364701600|FG006|Overall Study|Death|3|||
105739715|NCT03241173|364701601|FG007|Overall Study|Death|1|||
105739716|NCT03241173|364701602|FG008|Overall Study|Death|0|||
105739717|NCT03241173|364701603|FG009|Overall Study|Death|5|||
105739718|NCT03241173|364701604|FG010|Overall Study|Death|4|||
105739719|NCT03241173|364701605|FG011|Overall Study|Death|3|||
105799947|NCT00628745|364924696|FG001|Overall Study|Does not meet inclusion criteria|12|||
105941463|NCT04551053|365447750|FG000|Overall Study|Ongoing|6|||
105739720|NCT03241173|364701606|FG012|Overall Study|Death|0|||
105739721|NCT03241173|364701607|FG013|Overall Study|Death|0|||
105739722|NCT03241173|364701608|FG014|Overall Study|Death|0|||
105739723|NCT03241173|364701594|FG000|Overall Study|Withdrawal by Subject|0|||
105739724|NCT03241173|364701595|FG001|Overall Study|Withdrawal by Subject|0|||
105739725|NCT03241173|364701596|FG002|Overall Study|Withdrawal by Subject|1|||
105799948|NCT00628745|364924697|FG002|Overall Study|Does not meet inclusion criteria|0|||
105799949|NCT00628745|364924698|FG003|Overall Study|Does not meet inclusion criteria|0|||
105799950|NCT00628745|364924699|FG004|Overall Study|Does not meet inclusion criteria|18|||
105799951|NCT00628745|364924695|FG000|Overall Study|Participation in an interventional clinical trial|81|||
105799952|NCT00628745|364924696|FG001|Overall Study|Participation in an interventional clinical trial|4|||
105799953|NCT00628745|364924697|FG002|Overall Study|Participation in an interventional clinical trial|7|||
105799954|NCT00628745|364924698|FG003|Overall Study|Participation in an interventional clinical trial|0|||
105799955|NCT00628745|364924699|FG004|Overall Study|Participation in an interventional clinical trial|63|||
105799956|NCT00628745|364924695|FG000|Overall Study|Physician Decision|8|||
105799957|NCT00628745|364924696|FG001|Overall Study|Physician Decision|4|||
105799958|NCT00628745|364924697|FG002|Overall Study|Physician Decision|3|||
105799959|NCT00628745|364924698|FG003|Overall Study|Physician Decision|0|||
105799960|NCT00628745|364924699|FG004|Overall Study|Physician Decision|30|||
105799961|NCT00628745|364924695|FG000|Overall Study|Lost to Follow-up|109|||
105799962|NCT00628745|364924696|FG001|Overall Study|Lost to Follow-up|7|||
105799963|NCT00628745|364924697|FG002|Overall Study|Lost to Follow-up|7|||
105799964|NCT00628745|364924698|FG003|Overall Study|Lost to Follow-up|0|||
105799965|NCT00628745|364924699|FG004|Overall Study|Lost to Follow-up|498|||
105799966|NCT00628745|364924695|FG000|Overall Study|Death|197|||
105799967|NCT00628745|364924696|FG001|Overall Study|Death|81|||
105799968|NCT00628745|364924697|FG002|Overall Study|Death|12|||
105799969|NCT00628745|364924698|FG003|Overall Study|Death|4|||
105799970|NCT00628745|364924699|FG004|Overall Study|Death|939|||
105799971|NCT00628745|364924695|FG000|Overall Study|Participant transferred to another THAOS site|6|||
105799972|NCT00628745|364924696|FG001|Overall Study|Participant transferred to another THAOS site|0|||
105799973|NCT00628745|364924697|FG002|Overall Study|Participant transferred to another THAOS site|0|||
105799974|NCT00628745|364924698|FG003|Overall Study|Participant transferred to another THAOS site|0|||
105799975|NCT00628745|364924699|FG004|Overall Study|Participant transferred to another THAOS site|7|||
105799976|NCT00628745|364924695|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
105799977|NCT00628745|364924696|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
105799978|NCT00628745|364924697|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
105799979|NCT00628745|364924698|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
105799980|NCT00628745|364924699|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
105799981|NCT00628745|364924695|FG000|Overall Study|Site closure|152|||
105799982|NCT00628745|364924696|FG001|Overall Study|Site closure|146|||
105799983|NCT00628745|364924697|FG002|Overall Study|Site closure|6|||
105799984|NCT00628745|364924698|FG003|Overall Study|Site closure|8|||
105799985|NCT00628745|364924699|FG004|Overall Study|Site closure|691|||
105799986|NCT00628745|364924695|FG000|Overall Study|Duplicate participant|0|||
105799987|NCT00628745|364924696|FG001|Overall Study|Duplicate participant|0|||
105799988|NCT00628745|364924697|FG002|Overall Study|Duplicate participant|0|||
105799989|NCT00628745|364924698|FG003|Overall Study|Duplicate participant|0|||
105799990|NCT00628745|364924699|FG004|Overall Study|Duplicate participant|1|||
105799991|NCT00628745|364924695|FG000|Overall Study|Missing|4|||
105799992|NCT00628745|364924696|FG001|Overall Study|Missing|3|||
105799993|NCT00628745|364924697|FG002|Overall Study|Missing|0|||
105799994|NCT00628745|364924698|FG003|Overall Study|Missing|0|||
105799995|NCT00628745|364924699|FG004|Overall Study|Missing|10|||
105799996|NCT00628745|364924695|FG000|Overall Study|Othe reasons|987|||
105799997|NCT00628745|364924696|FG001|Overall Study|Othe reasons|373|||
105799998|NCT00628745|364924697|FG002|Overall Study|Othe reasons|105|||
105799999|NCT00628745|364924698|FG003|Overall Study|Othe reasons|1|||
105800000|NCT00628745|364924699|FG004|Overall Study|Othe reasons|1772|||
105800001|NCT00874757|364924700|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
105800002|NCT00766506|364926326|FG000|Overall Study|Use rescue medication after 3 hours|3|||
105800003|NCT00766506|364926327|FG001|Overall Study|Use rescue medication after 3 hours|0|||
105800004|NCT00766506|364926326|FG000|Overall Study|Other|2|||
105800005|NCT00766506|364926327|FG001|Overall Study|Other|2|||
105800006|NCT00860574|364926328|FG000|Overall Study|Death|2|||
105800007|NCT00860574|364926328|FG000|Overall Study|Relapse|1|||
105800008|NCT01246986|364926329|FG000|Overall Study|Lost to Follow-up|0|||
105800009|NCT01246986|364926330|FG001|Overall Study|Lost to Follow-up|1|||
105800010|NCT01246986|364926331|FG002|Overall Study|Lost to Follow-up|3|||
105800011|NCT01246986|364926332|FG003|Overall Study|Lost to Follow-up|0|||
105800012|NCT01246986|364926333|FG004|Overall Study|Lost to Follow-up|0|||
105800013|NCT01246986|364926334|FG005|Overall Study|Lost to Follow-up|1|||
105800014|NCT01246986|364926335|FG006|Overall Study|Lost to Follow-up|0|||
105800015|NCT01246986|364926329|FG000|Overall Study|Withdrawal by Subject|3|||
105800016|NCT01246986|364926330|FG001|Overall Study|Withdrawal by Subject|4|||
105800017|NCT01246986|364926331|FG002|Overall Study|Withdrawal by Subject|3|||
105800018|NCT01246986|364926332|FG003|Overall Study|Withdrawal by Subject|0|||
105800019|NCT01246986|364926333|FG004|Overall Study|Withdrawal by Subject|4|||
105800020|NCT01246986|364926334|FG005|Overall Study|Withdrawal by Subject|0|||
105800021|NCT01246986|364926335|FG006|Overall Study|Withdrawal by Subject|0|||
106013547|NCT02266888|365717176|FG003|Overall Study|Physician Decision|2|||
106013548|NCT02266888|365717173|FG000|Overall Study|Study Terminated|5|||
106013549|NCT02266888|365717174|FG001|Overall Study|Study Terminated|1|||
106013550|NCT02266888|365717175|FG002|Overall Study|Study Terminated|0|||
106013551|NCT02266888|365717176|FG003|Overall Study|Study Terminated|0|||
106013552|NCT02266888|365717173|FG000|Overall Study|No Longer Eligible|0|||
106013553|NCT02266888|365717174|FG001|Overall Study|No Longer Eligible|0|||
106013554|NCT02266888|365717175|FG002|Overall Study|No Longer Eligible|0|||
106013555|NCT02266888|365717176|FG003|Overall Study|No Longer Eligible|2|||
106013556|NCT02266888|365717173|FG000|Overall Study|Randomization Closed|0|||
106013557|NCT02266888|365717174|FG001|Overall Study|Randomization Closed|0|||
106013558|NCT02266888|365717175|FG002|Overall Study|Randomization Closed|4|||
106013559|NCT02266888|365717176|FG003|Overall Study|Randomization Closed|0|||
106013560|NCT02266888|365717173|FG000|Overall Study|Personnel unavailable at transplant|0|||
106013561|NCT02266888|365717174|FG001|Overall Study|Personnel unavailable at transplant|0|||
106013562|NCT02266888|365717175|FG002|Overall Study|Personnel unavailable at transplant|0|||
106013563|NCT02266888|365717176|FG003|Overall Study|Personnel unavailable at transplant|1|||
106013564|NCT02266888|365717173|FG000|Overall Study|Transfer of care|0|||
106013565|NCT02266888|365717174|FG001|Overall Study|Transfer of care|0|||
106013566|NCT02266888|365717175|FG002|Overall Study|Transfer of care|1|||
106013567|NCT02266888|365717176|FG003|Overall Study|Transfer of care|0|||
106013568|NCT04226742|365717179|FG000|Overall Study|Lost to Follow-up|16|||
106013569|NCT04226742|365717180|FG001|Overall Study|Lost to Follow-up|13|||
106013570|NCT04226742|365717179|FG000|Overall Study|Withdrawal by Subject|5|||
106013571|NCT04226742|365717180|FG001|Overall Study|Withdrawal by Subject|3|||
106013572|NCT01772316|365717183|FG000|Overall Study|Serious adverse event|1|||
106013573|NCT01772316|365717183|FG000|Overall Study|Inform consent withdrawn|1|||
106013574|NCT01772316|365717183|FG000|Overall Study|Withdrawn by sponsor decision|5|||
106013575|NCT02085161|365717185|FG000|Overall Study|Not Treated|1|||
106013576|NCT02085161|365717186|FG001|Overall Study|Not Treated|0|||
106013577|NCT02085161|365717187|FG002|Overall Study|Not Treated|0|||
106013578|NCT02085161|365717188|FG003|Overall Study|Not Treated|0|||
106013579|NCT02085161|365717185|FG000|Overall Study|Adverse Event|8|||
106013580|NCT02085161|365717186|FG001|Overall Study|Adverse Event|5|||
106013581|NCT02085161|365717187|FG002|Overall Study|Adverse Event|4|||
106013582|NCT02085161|365717188|FG003|Overall Study|Adverse Event|5|||
106013583|NCT02085161|365717185|FG000|Overall Study|Protocol Violation|0|||
106013584|NCT02085161|365717186|FG001|Overall Study|Protocol Violation|1|||
106013585|NCT02085161|365717187|FG002|Overall Study|Protocol Violation|0|||
106013586|NCT02085161|365717188|FG003|Overall Study|Protocol Violation|1|||
106013587|NCT02085161|365717185|FG000|Overall Study|Withdrawal by Subject|2|||
106013588|NCT02085161|365717186|FG001|Overall Study|Withdrawal by Subject|4|||
106013589|NCT02085161|365717187|FG002|Overall Study|Withdrawal by Subject|0|||
106013590|NCT02085161|365717188|FG003|Overall Study|Withdrawal by Subject|3|||
106013591|NCT02085161|365717185|FG000|Overall Study|Other Reason|1|||
106013592|NCT02085161|365717186|FG001|Overall Study|Other Reason|0|||
106013593|NCT02085161|365717187|FG002|Overall Study|Other Reason|1|||
106013594|NCT02085161|365717188|FG003|Overall Study|Other Reason|1|||
106013595|NCT01774721|365717189|FG000|Overall Study|Death|133|||
106013596|NCT01774721|365717190|FG001|Overall Study|Death|152|||
106013597|NCT01774721|365717189|FG000|Overall Study|Withdrawal by Subject|20|||
106013598|NCT01774721|365717190|FG001|Overall Study|Withdrawal by Subject|14|||
106013599|NCT01774721|365717189|FG000|Overall Study|Lost to Follow-up|6|||
106013600|NCT01774721|365717190|FG001|Overall Study|Lost to Follow-up|7|||
105739726|NCT03241173|364701597|FG003|Overall Study|Withdrawal by Subject|0|||
105739727|NCT03241173|364701598|FG004|Overall Study|Withdrawal by Subject|0|||
105739728|NCT03241173|364701599|FG005|Overall Study|Withdrawal by Subject|1|||
105739729|NCT03241173|364701600|FG006|Overall Study|Withdrawal by Subject|0|||
105739730|NCT03241173|364701601|FG007|Overall Study|Withdrawal by Subject|0|||
105739731|NCT03241173|364701602|FG008|Overall Study|Withdrawal by Subject|0|||
105739732|NCT03241173|364701603|FG009|Overall Study|Withdrawal by Subject|0|||
105739733|NCT03241173|364701604|FG010|Overall Study|Withdrawal by Subject|0|||
106013601|NCT01774721|365717189|FG000|Overall Study|Did not meet eligibility criteria|0|||
106013602|NCT01774721|365717190|FG001|Overall Study|Did not meet eligibility criteria|3|||
106013603|NCT01774721|365717189|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
106013604|NCT01774721|365717190|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
106013605|NCT01774721|365717189|FG000|Overall Study|Study terminated by sponsor|5|||
106013606|NCT01774721|365717190|FG001|Overall Study|Study terminated by sponsor|0|||
106013607|NCT01774721|365717189|FG000|Overall Study|Disease progression|5|||
106013608|NCT01774721|365717190|FG001|Overall Study|Disease progression|0|||
106013609|NCT03848832|365717192|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
105739734|NCT03241173|364701605|FG011|Overall Study|Withdrawal by Subject|0|||
106013610|NCT03848832|365717193|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
106141756|NCT01456936|366177784|FG003|Overall Study|No longer willing to participate|248|||
106141757|NCT01456936|366177781|FG000|Overall Study|Lost to Follow-up|135|||
106013611|NCT03848832|365717194|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
106141758|NCT01456936|366177782|FG001|Overall Study|Lost to Follow-up|126|||
106141759|NCT01456936|366177783|FG002|Overall Study|Lost to Follow-up|144|||
106141760|NCT01456936|366177784|FG003|Overall Study|Lost to Follow-up|127|||
106141761|NCT01456936|366177781|FG000|Overall Study|Medication error|0|||
106141762|NCT01456936|366177782|FG001|Overall Study|Medication error|1|||
106141763|NCT01456936|366177783|FG002|Overall Study|Medication error|0|||
106141764|NCT01456936|366177784|FG003|Overall Study|Medication error|1|||
106141765|NCT01456936|366177781|FG000|Overall Study|Adverse event (study drug)|25|||
106141766|NCT01456936|366177782|FG001|Overall Study|Adverse event (study drug)|21|||
106141767|NCT01456936|366177783|FG002|Overall Study|Adverse event (study drug)|26|||
106141768|NCT01456936|366177784|FG003|Overall Study|Adverse event (study drug)|17|||
106141769|NCT01456936|366177781|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
106141770|NCT01456936|366177782|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
106141771|NCT01456936|366177783|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
106141772|NCT01456936|366177784|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
106141773|NCT01456936|366177781|FG000|Overall Study|Death|0|||
106141774|NCT01456936|366177782|FG001|Overall Study|Death|3|||
106141775|NCT01456936|366177783|FG002|Overall Study|Death|1|||
106141776|NCT01456936|366177784|FG003|Overall Study|Death|3|||
106141777|NCT01456936|366177781|FG000|Overall Study|Randomized but not treated|21|||
106141778|NCT01456936|366177782|FG001|Overall Study|Randomized but not treated|28|||
106141779|NCT01456936|366177783|FG002|Overall Study|Randomized but not treated|16|||
106141780|NCT01456936|366177784|FG003|Overall Study|Randomized but not treated|21|||
106141781|NCT00957658|366177785|FG000|Overall Study|Death|1|||
106141782|NCT00957658|366177785|FG000|Overall Study|Lost to Follow-up|4|||
106141783|NCT00957658|366177785|FG000|Overall Study|Withdrawal by Subject|12|||
106141784|NCT00957658|366177785|FG000|Overall Study|Revision|1|||
106141785|NCT00957658|366177785|FG000|Overall Study|Incomplete 2 yr data|28|||
106141786|NCT00957658|366177785|FG000|Overall Study|Site termination|10|||
106141787|NCT00957658|366177785|FG000|Overall Study|unwilling/unable to return|2|||
106141788|NCT00957658|366177785|FG000|Overall Study|surgery cancelled|2|||
106141789|NCT00957658|366177785|FG000|Overall Study|Protocol Violation|5|||
106141790|NCT03691428|366177787|FG000|Overall Study|Withdrawal by Subject|6|||
106141791|NCT03691428|366177788|FG001|Overall Study|Withdrawal by Subject|8|||
106141792|NCT03184558|366177789|FG000|Overall Study|Withdrawal by Subject|2|||
106141793|NCT03184558|366177789|FG000|Overall Study|Death|16|||
106141794|NCT03184558|366177789|FG000|Overall Study|Lost to Follow-up|2|||
106141795|NCT03184558|366177789|FG000|Overall Study|Other|9|||
106141796|NCT02957539|366177790|FG000|Baseline to Week 16|Lost to Follow-up|8|||
106141797|NCT02957539|366177791|FG001|Baseline to Week 16|Lost to Follow-up|10|||
106141798|NCT02957539|366177792|FG002|Baseline to Week 16|Lost to Follow-up|16|||
106141799|NCT02957539|366177790|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
106141800|NCT02957539|366177791|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
106141801|NCT02957539|366177792|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
106141802|NCT02957539|366177790|FG000|Week 16 to 32|Withdrawal by Subject|3|||
106141803|NCT02957539|366177791|FG001|Week 16 to 32|Withdrawal by Subject|3|||
106141804|NCT02957539|366177792|FG002|Week 16 to 32|Withdrawal by Subject|1|||
106141805|NCT02957539|366177790|FG000|Week 16 to 32|Lost to Follow-up|8|||
106141806|NCT02957539|366177791|FG001|Week 16 to 32|Lost to Follow-up|7|||
105941464|NCT04551053|365447751|FG001|Overall Study|Ongoing|4|||
105941465|NCT03204812|365447752|FG000|Overall Study|Adverse Event|3|||
105941466|NCT04116489|365447753|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
105941467|NCT04116489|365447753|FG000|Overall Study|Withdrawal by Subject|1|||
105941468|NCT00637156|365447754|FG000|Overall Study|Withdrawal by Subject|0|||
105941469|NCT00637156|365447755|FG001|Overall Study|Withdrawal by Subject|7|||
105941470|NCT00637156|365447754|FG000|Overall Study|Death|0|||
105941471|NCT00637156|365447755|FG001|Overall Study|Death|1|||
105941472|NCT00637156|365447754|FG000|Overall Study|Lost to Follow-up|10|||
105941473|NCT00637156|365447755|FG001|Overall Study|Lost to Follow-up|16|||
105941474|NCT01385995|365447756|FG000|Period 1, 2 Months|Physician Decision|1|||
105941475|NCT01385995|365447757|FG001|Period 1, 2 Months|Physician Decision|0|||
105941476|NCT00112385|365447758|FG000|Overall Study|Lost to Follow-up|1|||
105941477|NCT00112385|365447759|FG001|Overall Study|Lost to Follow-up|0|||
105941478|NCT00112385|365447758|FG000|Overall Study|Withdrawal by Subject|0|||
105941479|NCT00112385|365447759|FG001|Overall Study|Withdrawal by Subject|1|||
105941480|NCT03345550|365448792|FG000|Overall Study|Withdrawal by Subject|1|||
105941481|NCT03345550|365448793|FG001|Overall Study|Withdrawal by Subject|0|||
106141807|NCT02957539|366177792|FG002|Week 16 to 32|Lost to Follow-up|5|||
106141808|NCT02957539|366177790|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
106141809|NCT02957539|366177791|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
106141810|NCT02957539|366177792|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
106141811|NCT02957539|366177790|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
106141812|NCT02957539|366177791|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
106141813|NCT02957539|366177792|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
106141814|NCT01565928|366177794|FG000|Overall Study|Adverse Event|3|||
106141815|NCT01565928|366177794|FG000|Overall Study|Other|3|||
105941482|NCT03345550|365448792|FG000|Overall Study|Lost to Follow-up|4|||
105941483|NCT03345550|365448793|FG001|Overall Study|Lost to Follow-up|5|||
106141816|NCT01565928|366177794|FG000|Overall Study|Progressive Disease|13|||
105739735|NCT03241173|364701606|FG012|Overall Study|Withdrawal by Subject|0|||
105739736|NCT03241173|364701607|FG013|Overall Study|Withdrawal by Subject|0|||
105739737|NCT03241173|364701608|FG014|Overall Study|Withdrawal by Subject|0|||
105739738|NCT03241173|364701594|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
105739739|NCT03241173|364701595|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
105739740|NCT03241173|364701596|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739741|NCT03241173|364701597|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
105739742|NCT03241173|364701598|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
105739743|NCT03241173|364701599|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
105739744|NCT03241173|364701600|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
105739745|NCT03241173|364701601|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
105739746|NCT03241173|364701602|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739747|NCT03241173|364701603|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105760785|NCT03627494|364776199|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
106013612|NCT03848832|365717192|FG000|Overall Study|Withdrawal by Subject|0|||
106013613|NCT03848832|365717193|FG001|Overall Study|Withdrawal by Subject|0|||
106013614|NCT03848832|365717194|FG002|Overall Study|Withdrawal by Subject|1|||
106013615|NCT03848832|365717192|FG000|Overall Study|Withdrawal (Covid-19)|0|||
106013616|NCT03848832|365717193|FG001|Overall Study|Withdrawal (Covid-19)|2|||
106013617|NCT03848832|365717194|FG002|Overall Study|Withdrawal (Covid-19)|0|||
106013618|NCT03848832|365717192|FG000|Overall Study|Physician Decision|2|||
106013619|NCT03848832|365717193|FG001|Overall Study|Physician Decision|1|||
106013620|NCT03848832|365717194|FG002|Overall Study|Physician Decision|3|||
106013621|NCT03848832|365717192|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
106013622|NCT03848832|365717193|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
106013623|NCT03848832|365717194|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
106013624|NCT03848832|365717192|FG000|Overall Study|Adverse Event|1|||
106013625|NCT03848832|365717193|FG001|Overall Study|Adverse Event|0|||
106013626|NCT03848832|365717194|FG002|Overall Study|Adverse Event|0|||
106013627|NCT01759446|365717195|FG000|Overall Study|Protocol Violation|1|||
106013628|NCT01759446|365717196|FG001|Overall Study|Protocol Violation|0|||
106013629|NCT01759446|365717197|FG002|Overall Study|Protocol Violation|1|||
106013630|NCT01759446|365717198|FG003|Overall Study|Protocol Violation|0|||
106013631|NCT01759446|365717199|FG004|Overall Study|Protocol Violation|0|||
106013632|NCT01759446|365717195|FG000|Overall Study|Withdrawal by Subject|0|||
106013633|NCT01759446|365717196|FG001|Overall Study|Withdrawal by Subject|1|||
106013634|NCT01759446|365717197|FG002|Overall Study|Withdrawal by Subject|0|||
106013635|NCT01759446|365717198|FG003|Overall Study|Withdrawal by Subject|1|||
106013636|NCT01759446|365717199|FG004|Overall Study|Withdrawal by Subject|0|||
106013637|NCT00719472|365717200|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
106013638|NCT00719472|365717200|FG000|Enrolled in Study|Subject decision to withdraw|8|||
106013639|NCT00719472|365717200|FG000|Enrolled in Study|Various Reasons|17|||
106013640|NCT00719472|365717200|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
106013641|NCT00719472|365717200|FG000|Received Cycle 1 Treatment|Death|5|||
106013642|NCT00719472|365717200|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
106013643|NCT00719472|365717200|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
106013644|NCT00719472|365717200|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
106013645|NCT00719472|365717200|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
106013646|NCT00719472|365717200|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
106013647|NCT00719472|365717200|FG000|Received Cycle 2 Treatment|Death|6|||
106013648|NCT00719472|365717200|FG000|Received Cycle 2 Treatment|Disease progression|3|||
106013649|NCT00719472|365717200|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
106013650|NCT00719472|365717200|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
106013651|NCT00719472|365717200|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
106013652|NCT00719472|365717200|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
106013653|NCT01244893|365717201|FG000|Baseline|Protocol Violation|0|||
106013654|NCT01244893|365717202|FG001|Baseline|Protocol Violation|1|||
106013655|NCT01244893|365717201|FG000|1-Week Follow Up|Lost to Follow-up|1|||
106013656|NCT01244893|365717202|FG001|1-Week Follow Up|Lost to Follow-up|0|||
106013657|NCT02399163|365717204|FG000|Overall Study|Adverse Event|2|||
106013658|NCT02399163|365717204|FG000|Overall Study|Protocol Deviation|2|||
106013659|NCT02399163|365717204|FG000|Overall Study|Withdrawal by Participant|5|||
106013660|NCT04646044|365717206|FG000|Overall Study|Lost to Follow-up|0|||
106013661|NCT04646044|365717207|FG001|Overall Study|Lost to Follow-up|0|||
106013662|NCT04646044|365717208|FG002|Overall Study|Lost to Follow-up|1|||
106013663|NCT04646044|365717209|FG003|Overall Study|Lost to Follow-up|0|||
106013664|NCT04646044|365717206|FG000|Overall Study|Withdrawal by Subject|0|||
106013665|NCT04646044|365717207|FG001|Overall Study|Withdrawal by Subject|1|||
106013666|NCT04646044|365717208|FG002|Overall Study|Withdrawal by Subject|0|||
106013667|NCT04646044|365717209|FG003|Overall Study|Withdrawal by Subject|0|||
106013668|NCT01391546|365717212|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
106013669|NCT01391546|365717213|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
106013670|NCT01524796|365717214|FG000|Overall Study|Adverse Event|13|||
106013671|NCT01524796|365717214|FG000|Overall Study|Lack of Efficacy|3|||
106013672|NCT01524796|365717214|FG000|Overall Study|Lost to Follow-up|1|||
106013673|NCT01524796|365717214|FG000|Overall Study|The price|1|||
106013674|NCT01524796|365717214|FG000|Overall Study|Withdrawal by Subject|4|||
106013675|NCT01524796|365717214|FG000|Overall Study|Move|1|||
106013676|NCT01524796|365717214|FG000|Overall Study|Deterioration of pains|1|||
106013677|NCT01524796|365717214|FG000|Overall Study|Gall stone surgery|1|||
106013678|NCT01524796|365717214|FG000|Overall Study|Nervous about confidentiality|1|||
106013679|NCT01524796|365717214|FG000|Overall Study|Switch to carbamazapine|1|||
106013680|NCT01524796|365717214|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
106013681|NCT01746901|365717217|FG000|Naloxone Challenge Phase|Adverse Event|2|||
106013682|NCT01746901|365717218|FG001|Naloxone Challenge Phase|Adverse Event|0|||
106013683|NCT01746901|365717219|FG002|Naloxone Challenge Phase|Adverse Event|0|||
106013684|NCT01746901|365717220|FG003|Naloxone Challenge Phase|Adverse Event|0|||
106013685|NCT01746901|365717221|FG004|Naloxone Challenge Phase|Adverse Event|0|||
106013686|NCT01746901|365717222|FG005|Naloxone Challenge Phase|Adverse Event|0|||
106013687|NCT01746901|365717223|FG006|Naloxone Challenge Phase|Adverse Event|0|||
106013688|NCT01746901|365717224|FG007|Naloxone Challenge Phase|Adverse Event|0|||
106013689|NCT01746901|365717225|FG008|Naloxone Challenge Phase|Adverse Event|0|||
106013690|NCT01746901|365717217|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
106013691|NCT01746901|365717218|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
106013692|NCT01746901|365717219|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
106013693|NCT01746901|365717220|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
106013694|NCT01746901|365717221|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
106013695|NCT01746901|365717222|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
106013696|NCT01746901|365717223|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
106013697|NCT01746901|365717224|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
106013698|NCT01746901|365717225|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
106013699|NCT01746901|365717217|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106013700|NCT01746901|365717218|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
106013701|NCT01746901|365717219|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106013702|NCT01746901|365717220|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106013703|NCT01746901|365717221|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106013704|NCT01746901|365717222|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106013705|NCT01746901|365717223|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105739748|NCT03241173|364701604|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
105739749|NCT03241173|364701605|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
105739750|NCT03241173|364701606|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739751|NCT03241173|364701607|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739752|NCT03241173|364701608|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
105739753|NCT03241173|364701594|FG000|Overall Study|Lost to Follow-up|0|||
105739754|NCT03241173|364701595|FG001|Overall Study|Lost to Follow-up|0|||
105739755|NCT03241173|364701596|FG002|Overall Study|Lost to Follow-up|0|||
105739756|NCT03241173|364701597|FG003|Overall Study|Lost to Follow-up|0|||
105739757|NCT03241173|364701598|FG004|Overall Study|Lost to Follow-up|1|||
105739758|NCT03241173|364701599|FG005|Overall Study|Lost to Follow-up|0|||
105739759|NCT03241173|364701600|FG006|Overall Study|Lost to Follow-up|0|||
105739760|NCT03241173|364701601|FG007|Overall Study|Lost to Follow-up|0|||
105739761|NCT03241173|364701602|FG008|Overall Study|Lost to Follow-up|0|||
105739762|NCT03241173|364701603|FG009|Overall Study|Lost to Follow-up|1|||
105739763|NCT03241173|364701604|FG010|Overall Study|Lost to Follow-up|0|||
105739764|NCT03241173|364701605|FG011|Overall Study|Lost to Follow-up|0|||
105739765|NCT03241173|364701606|FG012|Overall Study|Lost to Follow-up|0|||
105739766|NCT03241173|364701607|FG013|Overall Study|Lost to Follow-up|0|||
105739767|NCT03241173|364701608|FG014|Overall Study|Lost to Follow-up|0|||
105739768|NCT01651260|364701612|FG000|Overall Study|unable to apply product|3|||
105739769|NCT03894904|364701621|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
105739770|NCT03894904|364701622|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
105739771|NCT03894904|364701621|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
105739772|NCT03894904|364701622|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
105739773|NCT03117049|364701623|FG000|Overall Study|Continued the follow-up period|109|||
105739774|NCT03117049|364701624|FG001|Overall Study|Continued the follow-up period|129|||
105739775|NCT03117049|364701623|FG000|Overall Study|Died|82|||
105739776|NCT03117049|364701624|FG001|Overall Study|Died|93|||
105739777|NCT03117049|364701623|FG000|Overall Study|Consent withdrawal|7|||
106013706|NCT01746901|365717224|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106013707|NCT01746901|365717225|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106013708|NCT01746901|365717217|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
106013709|NCT01746901|365717218|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
106013710|NCT01746901|365717219|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
106013711|NCT01746901|365717220|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
106013712|NCT01746901|365717221|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
106013713|NCT01746901|365717222|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
106013714|NCT01746901|365717223|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
106013715|NCT01746901|365717224|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
106013716|NCT01746901|365717225|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
106013717|NCT01746901|365717217|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
106013718|NCT01746901|365717218|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
106013719|NCT01746901|365717219|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
106013720|NCT01746901|365717220|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
106013721|NCT01746901|365717221|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
106013722|NCT01746901|365717222|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
106013723|NCT01746901|365717223|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
106013724|NCT01746901|365717224|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
106013725|NCT01746901|365717225|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
106013726|NCT01746901|365717217|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106013727|NCT01746901|365717218|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
106013728|NCT01746901|365717219|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
106013729|NCT01746901|365717220|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106013730|NCT01746901|365717221|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106013731|NCT01746901|365717222|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106013732|NCT01746901|365717223|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106013733|NCT01746901|365717224|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106013734|NCT01746901|365717225|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106013735|NCT01746901|365717217|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
106013736|NCT01746901|365717218|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
106013737|NCT01746901|365717219|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
106013738|NCT01746901|365717220|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
106013739|NCT01746901|365717221|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
106013740|NCT01746901|365717222|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
106013741|NCT01746901|365717223|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
106013742|NCT01746901|365717224|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
106013743|NCT01746901|365717225|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
106013744|NCT01746901|365717217|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
106013745|NCT01746901|365717218|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
106013746|NCT01746901|365717219|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
106013747|NCT01746901|365717220|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
106013748|NCT01746901|365717221|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
106013749|NCT01746901|365717222|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
106013750|NCT01746901|365717223|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
106013751|NCT01746901|365717224|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
106013752|NCT01746901|365717225|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
106013753|NCT01746901|365717217|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
106013754|NCT01746901|365717218|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
106013755|NCT01746901|365717219|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
106013756|NCT01746901|365717220|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
106013757|NCT01746901|365717221|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
106013758|NCT01746901|365717222|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
106013759|NCT01746901|365717223|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
106013760|NCT01746901|365717224|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
106013761|NCT01746901|365717225|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
106013762|NCT01746901|365717217|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
106013763|NCT01746901|365717218|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
106013764|NCT01746901|365717219|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
106013765|NCT01746901|365717220|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
106141817|NCT01565928|366177794|FG000|Overall Study|Withdrawal by Subject|1|||
105739778|NCT03117049|364701624|FG001|Overall Study|Consent withdrawal|6|||
105739779|NCT03117049|364701623|FG000|Overall Study|Missing contact|3|||
105739780|NCT03117049|364701624|FG001|Overall Study|Missing contact|3|||
105739781|NCT01345786|364701625|FG000|Overall Study|Adverse Event|0|||
105739782|NCT01345786|364701626|FG001|Overall Study|Adverse Event|1|||
105739783|NCT01345786|364701627|FG002|Overall Study|Adverse Event|3|||
105739784|NCT01345786|364701628|FG003|Overall Study|Adverse Event|1|||
106013766|NCT01746901|365717221|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
106013767|NCT01746901|365717222|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
106013768|NCT01746901|365717223|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
106013769|NCT01746901|365717224|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
106013770|NCT01746901|365717225|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
106013771|NCT01746901|365717217|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
106013772|NCT01746901|365717218|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
106013773|NCT01746901|365717219|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
106013774|NCT01746901|365717220|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
106013775|NCT01746901|365717221|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
106013776|NCT01746901|365717222|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
106013777|NCT01746901|365717223|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
106013778|NCT01746901|365717224|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
106013779|NCT01746901|365717225|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
106013780|NCT01746901|365717217|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
106013781|NCT01746901|365717218|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
106013782|NCT01746901|365717219|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
106013783|NCT01746901|365717220|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
106013784|NCT01746901|365717221|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
106013785|NCT01746901|365717222|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
106013786|NCT01746901|365717223|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
106013787|NCT01746901|365717224|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
106013788|NCT01746901|365717225|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
106013789|NCT04225897|365717226|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013790|NCT04225897|365717227|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
106013791|NCT04225897|365717228|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013792|NCT04225897|365717229|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013793|NCT04225897|365717230|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013794|NCT04225897|365717231|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013795|NCT04225897|365717232|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013796|NCT04225897|365717233|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013797|NCT04225897|365717234|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013798|NCT04225897|365717235|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013799|NCT04225897|365717236|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013800|NCT04225897|365717237|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
106013801|NCT04225897|365717226|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013802|NCT04225897|365717227|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013803|NCT04225897|365717228|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
106013804|NCT04225897|365717229|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013805|NCT04225897|365717230|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013806|NCT04225897|365717231|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013807|NCT04225897|365717232|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013808|NCT04225897|365717233|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013809|NCT04225897|365717234|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013810|NCT04225897|365717235|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013811|NCT04225897|365717236|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013812|NCT04225897|365717237|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
106013813|NCT04225897|365717226|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013814|NCT04225897|365717227|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013815|NCT04225897|365717228|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
106013816|NCT04225897|365717229|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013817|NCT04225897|365717230|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013818|NCT04225897|365717231|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013819|NCT04225897|365717232|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
105739785|NCT01345786|364701625|FG000|Overall Study|Subject withdrew consent|2|||
105739786|NCT01345786|364701626|FG001|Overall Study|Subject withdrew consent|2|||
105739787|NCT01345786|364701627|FG002|Overall Study|Subject withdrew consent|1|||
105739788|NCT01345786|364701628|FG003|Overall Study|Subject withdrew consent|0|||
105941484|NCT02489279|365448807|FG000|Overall Study|Lost to Follow-up|12|||
105941485|NCT02489279|365448808|FG001|Overall Study|Lost to Follow-up|10|||
105941486|NCT00557440|365448811|FG000|Treatment Period 1|Adverse Event|0|||
105941487|NCT00557440|365448812|FG001|Treatment Period 1|Adverse Event|0|||
105941488|NCT00557440|365448813|FG002|Treatment Period 1|Adverse Event|1|||
105941489|NCT00124657|365448814|FG000|Overall Study|Toxicity|0|||
105941490|NCT00124657|365448815|FG001|Overall Study|Toxicity|0|||
105941491|NCT00124657|365448816|FG002|Overall Study|Toxicity|1|||
105941492|NCT00124657|365448814|FG000|Overall Study|Non-compliance|1|||
105941493|NCT00124657|365448815|FG001|Overall Study|Non-compliance|0|||
105739789|NCT01345786|364701625|FG000|Overall Study|Noncompliance with protocol|1|||
105739790|NCT01345786|364701626|FG001|Overall Study|Noncompliance with protocol|0|||
105739791|NCT01345786|364701627|FG002|Overall Study|Noncompliance with protocol|1|||
105739792|NCT01345786|364701628|FG003|Overall Study|Noncompliance with protocol|0|||
105739793|NCT01345786|364701625|FG000|Overall Study|Administrative|3|||
105739794|NCT01345786|364701626|FG001|Overall Study|Administrative|5|||
105739795|NCT01345786|364701627|FG002|Overall Study|Administrative|0|||
105739796|NCT01345786|364701628|FG003|Overall Study|Administrative|0|||
105739797|NCT01345786|364701625|FG000|Overall Study|Lost to Follow-up|0|||
105739798|NCT01345786|364701626|FG001|Overall Study|Lost to Follow-up|0|||
105739799|NCT01345786|364701627|FG002|Overall Study|Lost to Follow-up|0|||
105739800|NCT01345786|364701628|FG003|Overall Study|Lost to Follow-up|2|||
105739801|NCT02399475|364701629|FG000|Overall Study|Physician Decision|1|||
105739802|NCT02399475|364701630|FG001|Overall Study|Physician Decision|0|||
105739803|NCT02807454|364701631|FG000|Overall Study|Adverse Event|1|||
105739804|NCT02807454|364701632|FG001|Overall Study|Adverse Event|0|||
105739805|NCT02807454|364701631|FG000|Overall Study|Withdrawal by Subject|0|||
105739806|NCT02807454|364701632|FG001|Overall Study|Withdrawal by Subject|1|||
105739807|NCT02807454|364701631|FG000|Overall Study|Progressive Disease|30|||
105739808|NCT02807454|364701632|FG001|Overall Study|Progressive Disease|3|||
105739809|NCT02807454|364701631|FG000|Overall Study|Other Reasons|1|||
105739810|NCT02807454|364701632|FG001|Overall Study|Other Reasons|1|||
105739811|NCT01780389|364701633|FG000|Overall Study|Adverse Event|1|||
105739812|NCT01518192|364701634|FG000|Overall Study|Lost to Follow-up|29|||
105739813|NCT01518192|364701635|FG001|Overall Study|Lost to Follow-up|26|||
105739814|NCT01518192|364701636|FG002|Overall Study|Lost to Follow-up|35|||
105739815|NCT00085540|364701637|FG000|Overall Study|Withdrawal by Subject|0|||
105739816|NCT00085540|364701638|FG001|Overall Study|Withdrawal by Subject|1|||
105739817|NCT00085540|364701637|FG000|Overall Study|Protocol Violation|0|||
105739818|NCT00085540|364701638|FG001|Overall Study|Protocol Violation|1|||
105739819|NCT00426751|364701641|FG000|Overall Study|Adverse Event|8|||
105739820|NCT00426751|364701642|FG001|Overall Study|Adverse Event|1|||
105739821|NCT00426751|364701641|FG000|Overall Study|Lost to Follow-up|7|||
105739822|NCT00426751|364701642|FG001|Overall Study|Lost to Follow-up|6|||
105941494|NCT00124657|365448816|FG002|Overall Study|Non-compliance|4|||
105941495|NCT00124657|365448814|FG000|Overall Study|Progressive disease|14|||
105941496|NCT00124657|365448815|FG001|Overall Study|Progressive disease|5|||
105941497|NCT00124657|365448816|FG002|Overall Study|Progressive disease|27|||
105941498|NCT00124657|365448814|FG000|Overall Study|Intercurrent illness|1|||
105941499|NCT00124657|365448815|FG001|Overall Study|Intercurrent illness|0|||
105941500|NCT00124657|365448816|FG002|Overall Study|Intercurrent illness|0|||
105941501|NCT03847519|365448817|FG000|Overall Study|Death|5|||
105941502|NCT03847519|365448818|FG001|Overall Study|Death|8|||
105941503|NCT03847519|365448819|FG002|Overall Study|Death|1|||
105941504|NCT03847519|365448817|FG000|Overall Study|Lost to Follow-up|1|||
105941505|NCT03847519|365448818|FG001|Overall Study|Lost to Follow-up|2|||
105941506|NCT03847519|365448819|FG002|Overall Study|Lost to Follow-up|0|||
105941507|NCT03847519|365448817|FG000|Overall Study|Study Terminated by Sponsor|0|||
105941508|NCT03847519|365448818|FG001|Overall Study|Study Terminated by Sponsor|3|||
105941509|NCT03847519|365448819|FG002|Overall Study|Study Terminated by Sponsor|2|||
105941510|NCT00841815|365448823|FG000|Washout|Withdrawal by Subject|0|||
105941511|NCT00841815|365448824|FG001|Washout|Withdrawal by Subject|1|||
105941512|NCT00635050|365448831|FG000|Overall Study|Withdrawal by Subject|1|||
105941513|NCT03038620|365448832|FG000|Overall Study|Lost to Follow-up|18|||
105941514|NCT03038620|365448833|FG001|Overall Study|Lost to Follow-up|23|||
105941515|NCT03038620|365448832|FG000|Overall Study|Withdrawal by Subject|0|||
105941516|NCT03038620|365448833|FG001|Overall Study|Withdrawal by Subject|15|||
105941517|NCT03038620|365448832|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
105941518|NCT03038620|365448833|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
105941519|NCT01435356|365448835|FG000|Overall Study|Adverse Event|2|||
105941520|NCT01435356|365448836|FG001|Overall Study|Adverse Event|0|||
105941521|NCT01435356|365448835|FG000|Overall Study|Disease progression/recurrence|17|||
105941522|NCT01435356|365448836|FG001|Overall Study|Disease progression/recurrence|10|||
105941523|NCT01435356|365448835|FG000|Overall Study|Protocol Violation|0|||
105941524|NCT01435356|365448836|FG001|Overall Study|Protocol Violation|1|||
105941525|NCT01435356|365448835|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
105941526|NCT01435356|365448836|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
105941527|NCT01435356|365448835|FG000|Overall Study|Withdrawal by Subject|1|||
105941528|NCT01435356|365448836|FG001|Overall Study|Withdrawal by Subject|1|||
105941529|NCT01435356|365448835|FG000|Overall Study|Facial palsy|1|||
105941530|NCT01435356|365448836|FG001|Overall Study|Facial palsy|0|||
105739823|NCT00426751|364701641|FG000|Overall Study|Consent Withdrawn|0|||
105739824|NCT00426751|364701642|FG001|Overall Study|Consent Withdrawn|1|||
105739825|NCT00426751|364701641|FG000|Overall Study|Other Reasons|7|||
105739826|NCT00426751|364701642|FG001|Overall Study|Other Reasons|12|||
105941531|NCT01435356|365448835|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
105941532|NCT01435356|365448836|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
105941533|NCT01435356|365448835|FG000|Overall Study|Physician Decision|1|||
106141818|NCT01565928|366177794|FG000|Overall Study|Death|2|||
106141819|NCT01119950|366177795|FG000|Overall Study|Adverse Event|25|||
106141820|NCT01119950|366177795|FG000|Overall Study|Withdrawal by Subject|9|||
106141821|NCT01119950|366177795|FG000|Overall Study|Protocol Violation|5|||
106141822|NCT01119950|366177795|FG000|Overall Study|Lost to Follow-up|4|||
106141823|NCT01119950|366177795|FG000|Overall Study|Administrative|2|||
106141824|NCT01119950|366177795|FG000|Overall Study|Abnormal lab value|1|||
106141825|NCT01119950|366177795|FG000|Overall Study|Death|1|||
106141826|NCT00217672|366177800|FG000|Allocation|Ineligible|2|||
106141827|NCT00217672|366177801|FG001|Allocation|Ineligible|0|||
106141828|NCT00217672|366177800|FG000|Treatment|disease progression|33|||
106141829|NCT00217672|366177801|FG001|Treatment|disease progression|4|||
106141830|NCT00217672|366177800|FG000|Treatment|Adverse Event|18|||
106141831|NCT00217672|366177801|FG001|Treatment|Adverse Event|2|||
106141832|NCT00217672|366177800|FG000|Treatment|reqd treatment not permitted by protocol|6|||
106141833|NCT00217672|366177801|FG001|Treatment|reqd treatment not permitted by protocol|0|||
106141834|NCT00217672|366177800|FG000|Treatment|Physician Decision|6|||
106141835|NCT00217672|366177801|FG001|Treatment|Physician Decision|0|||
106141836|NCT00217672|366177800|FG000|Treatment|insurance issues|1|||
106141837|NCT00217672|366177801|FG001|Treatment|insurance issues|1|||
106141838|NCT00217672|366177800|FG000|Treatment|Death|2|||
106141839|NCT00217672|366177801|FG001|Treatment|Death|0|||
106141840|NCT00217672|366177800|FG000|Treatment|secondary malignancy|1|||
106141841|NCT00217672|366177801|FG001|Treatment|secondary malignancy|0|||
106141842|NCT00217672|366177800|FG000|Follow-up|Withdrawal by Subject|4|||
106141843|NCT00217672|366177801|FG001|Follow-up|Withdrawal by Subject|0|||
106141844|NCT00217672|366177800|FG000|Follow-up|Lost to Follow-up|1|||
106141845|NCT00217672|366177801|FG001|Follow-up|Lost to Follow-up|0|||
106141846|NCT01591616|366177802|FG000|Overall Study|Withdrawal by Subject|1|||
106141847|NCT01713530|366177803|FG000|Overall Study|Adverse Event|0|||
106141848|NCT01713530|366177804|FG001|Overall Study|Adverse Event|5|||
106141849|NCT01713530|366177803|FG000|Overall Study|Withdrawal criteria|21|||
106141850|NCT01713530|366177804|FG001|Overall Study|Withdrawal criteria|12|||
106141851|NCT01713530|366177803|FG000|Overall Study|Unclassified|4|||
106141852|NCT01713530|366177804|FG001|Overall Study|Unclassified|2|||
106141853|NCT00758602|366177805|FG000|Overall Study|Adverse Event|11|||
106141854|NCT00758602|366177806|FG001|Overall Study|Adverse Event|10|||
106141855|NCT00758602|366177805|FG000|Overall Study|Lost to Follow-up|4|||
106141856|NCT00758602|366177806|FG001|Overall Study|Lost to Follow-up|3|||
106141857|NCT00758602|366177805|FG000|Overall Study|Withdrawal by Subject|1|||
106141858|NCT00758602|366177806|FG001|Overall Study|Withdrawal by Subject|3|||
106141859|NCT00758602|366177805|FG000|Overall Study|Protocol Violation|0|||
106141860|NCT00758602|366177806|FG001|Overall Study|Protocol Violation|2|||
106141861|NCT00758602|366177805|FG000|Overall Study|Death|0|||
106141862|NCT00758602|366177806|FG001|Overall Study|Death|1|||
105739827|NCT00576693|364701647|FG000|Overall Study|Lost to Follow-up|7|||
105739828|NCT00576693|364701648|FG001|Overall Study|Lost to Follow-up|11|||
105739829|NCT00576693|364701647|FG000|Overall Study|Withdrawal by Subject|3|||
105739830|NCT00576693|364701648|FG001|Overall Study|Withdrawal by Subject|13|||
105739831|NCT02574312|364701651|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
105739832|NCT02574312|364701652|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
105739833|NCT01522651|364701653|FG000|Overall Study|Adverse Event|3|||
105739834|NCT01522651|364701654|FG001|Overall Study|Adverse Event|4|||
105941534|NCT01435356|365448836|FG001|Overall Study|Physician Decision|0|||
105941535|NCT01435356|365448835|FG000|Overall Study|Patient decision|3|||
105941536|NCT01435356|365448836|FG001|Overall Study|Patient decision|0|||
105941537|NCT01435356|365448835|FG000|Overall Study|Patient moved to another city|1|||
105941538|NCT01435356|365448836|FG001|Overall Study|Patient moved to another city|1|||
105941539|NCT05360784|365448837|FG000|Overall Study|Discontinued|25|||
105941540|NCT05360784|365448838|FG001|Overall Study|Discontinued|11|||
105941541|NCT04875533|365448842|FG000|Overall Study|Adverse Event|6|||
105941542|NCT04875533|365448843|FG001|Overall Study|Adverse Event|4|||
105941543|NCT04875533|365448842|FG000|Overall Study|Protocol Violation|4|||
105941544|NCT04875533|365448843|FG001|Overall Study|Protocol Violation|0|||
105941545|NCT04875533|365448842|FG000|Overall Study|Withdrawal by Subject|8|||
105941546|NCT04875533|365448843|FG001|Overall Study|Withdrawal by Subject|5|||
105941547|NCT04875533|365448842|FG000|Overall Study|No longer meets eligibility criteria|1|||
105941548|NCT04875533|365448843|FG001|Overall Study|No longer meets eligibility criteria|0|||
106141863|NCT00758602|366177805|FG000|Overall Study|Reason not specified|3|||
106141864|NCT00758602|366177806|FG001|Overall Study|Reason not specified|3|||
106141865|NCT00762606|366177808|FG000|Overall Study|Lost to Follow-up|18|||
106141866|NCT00762606|366177809|FG001|Overall Study|Lost to Follow-up|13|||
106141867|NCT01194154|366177812|FG000|Overall Study|Adverse Event|12|||
106141868|NCT01194154|366177813|FG001|Overall Study|Adverse Event|7|||
106141869|NCT01194154|366177812|FG000|Overall Study|Lost to Follow-up|2|||
106141870|NCT01194154|366177813|FG001|Overall Study|Lost to Follow-up|3|||
105941549|NCT04875533|365448842|FG000|Overall Study|Other|0|||
106013820|NCT04225897|365717233|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106141871|NCT01194154|366177812|FG000|Overall Study|Protocol Violation|0|||
106141872|NCT01194154|366177813|FG001|Overall Study|Protocol Violation|1|||
106013821|NCT04225897|365717234|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013822|NCT04225897|365717235|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013823|NCT04225897|365717236|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013824|NCT04225897|365717237|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
106013825|NCT04225897|365717226|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013826|NCT04225897|365717227|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013827|NCT04225897|365717228|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013828|NCT04225897|365717229|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013829|NCT04225897|365717230|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013830|NCT04225897|365717231|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013831|NCT04225897|365717232|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013832|NCT04225897|365717233|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
106013833|NCT04225897|365717234|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013834|NCT04225897|365717235|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013835|NCT04225897|365717236|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013836|NCT04225897|365717237|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
106013837|NCT01046396|365717238|FG000|Overall Study|Withdrawal by Subject|5|||
106013838|NCT00174187|365717239|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
106013839|NCT00174187|365717240|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
106013840|NCT00174187|365717241|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
106013841|NCT00174187|365717239|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
106013842|NCT00174187|365717240|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
106013843|NCT00174187|365717241|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
106013844|NCT00174187|365717239|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
106013845|NCT00174187|365717240|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
106013846|NCT00174187|365717241|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
106013847|NCT00174187|365717239|FG000|Period 1 (up to 3 Years)|Other|0|||
106013848|NCT00174187|365717240|FG001|Period 1 (up to 3 Years)|Other|1|||
106013849|NCT00174187|365717241|FG002|Period 1 (up to 3 Years)|Other|0|||
106013850|NCT00174187|365717239|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
106013851|NCT00174187|365717240|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
106013852|NCT00174187|365717241|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
106013853|NCT00174187|365717239|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
106013854|NCT00174187|365717240|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
106013855|NCT00174187|365717241|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
106013856|NCT00174187|365717239|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
106013857|NCT00174187|365717240|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
106013858|NCT00174187|365717241|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
106013859|NCT00174187|365717239|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
106013860|NCT00174187|365717240|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
106013861|NCT00174187|365717241|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
106013862|NCT00174187|365717239|FG000|Period 2 (After 3 Years)|Other|0|||
106013863|NCT00174187|365717240|FG001|Period 2 (After 3 Years)|Other|0|||
106013864|NCT00174187|365717241|FG002|Period 2 (After 3 Years)|Other|5|||
106013865|NCT01285557|365717242|FG000|Overall Study|Death|173|||
106013866|NCT01285557|365717243|FG001|Overall Study|Death|90|||
106013867|NCT01285557|365717242|FG000|Overall Study|Lost to Follow-up|6|||
106013868|NCT01285557|365717243|FG001|Overall Study|Lost to Follow-up|2|||
106013869|NCT01285557|365717242|FG000|Overall Study|Withdrew Consent|6|||
106013870|NCT01285557|365717243|FG001|Overall Study|Withdrew Consent|1|||
106013871|NCT01285557|365717242|FG000|Overall Study|Sponsor Study Termination|23|||
106013872|NCT01285557|365717243|FG001|Overall Study|Sponsor Study Termination|13|||
106013873|NCT01285557|365717242|FG000|Overall Study|Randomized but not treated|1|||
106013874|NCT01285557|365717243|FG001|Overall Study|Randomized but not treated|1|||
106013875|NCT01285557|365717242|FG000|Overall Study|Study follow-up ongoing|28|||
106013876|NCT01285557|365717243|FG001|Overall Study|Study follow-up ongoing|14|||
106013877|NCT01285557|365717242|FG000|Overall Study|Sponsor Decision|2|||
106013878|NCT01285557|365717243|FG001|Overall Study|Sponsor Decision|1|||
106013879|NCT03173248|365717250|FG000|Overall Study|Death|28|||
106013880|NCT03173248|365717251|FG001|Overall Study|Death|46|||
106013881|NCT03173248|365717250|FG000|Overall Study|Lost to Follow-up|0|||
106013882|NCT03173248|365717251|FG001|Overall Study|Lost to Follow-up|1|||
106013883|NCT03173248|365717250|FG000|Overall Study|Withdrawal by Subject|6|||
106013884|NCT03173248|365717251|FG001|Overall Study|Withdrawal by Subject|4|||
106013885|NCT03173248|365717250|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
106013886|NCT03173248|365717251|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
106013887|NCT01648751|365717252|FG000|Overall Study|Withdrawal by Subject|2|||
106013888|NCT01648751|365717253|FG001|Overall Study|Withdrawal by Subject|3|||
106141873|NCT01194154|366177812|FG000|Overall Study|Withdrawal by Subject|5|||
106141874|NCT01194154|366177813|FG001|Overall Study|Withdrawal by Subject|6|||
106013889|NCT01588522|365717255|FG000|Overall Study|Withdrawal by Subject|1|||
106013890|NCT01588522|365717256|FG001|Overall Study|Withdrawal by Subject|5|||
106013891|NCT01588522|365717257|FG002|Overall Study|Withdrawal by Subject|3|||
106013892|NCT01588522|365717258|FG003|Overall Study|Withdrawal by Subject|1|||
106013893|NCT01588522|365717259|FG004|Overall Study|Withdrawal by Subject|2|||
106013894|NCT01588522|365717260|FG005|Overall Study|Withdrawal by Subject|0|||
106013895|NCT01588522|365717255|FG000|Overall Study|Lack of Efficacy|0|||
106013896|NCT01588522|365717256|FG001|Overall Study|Lack of Efficacy|0|||
106013897|NCT01588522|365717257|FG002|Overall Study|Lack of Efficacy|0|||
106013898|NCT01588522|365717258|FG003|Overall Study|Lack of Efficacy|0|||
106013899|NCT01588522|365717259|FG004|Overall Study|Lack of Efficacy|1|||
106013900|NCT01588522|365717260|FG005|Overall Study|Lack of Efficacy|0|||
106013901|NCT01588522|365717255|FG000|Overall Study|Adverse Event|0|||
106013902|NCT01588522|365717256|FG001|Overall Study|Adverse Event|0|||
106013903|NCT01588522|365717257|FG002|Overall Study|Adverse Event|0|||
106013904|NCT01588522|365717258|FG003|Overall Study|Adverse Event|1|||
106013905|NCT01588522|365717259|FG004|Overall Study|Adverse Event|0|||
106013906|NCT01588522|365717260|FG005|Overall Study|Adverse Event|0|||
106013907|NCT01588522|365717255|FG000|Overall Study|Grade 2 alopecia|1|||
106013908|NCT01588522|365717256|FG001|Overall Study|Grade 2 alopecia|0|||
106013909|NCT01588522|365717257|FG002|Overall Study|Grade 2 alopecia|0|||
106013910|NCT01588522|365717258|FG003|Overall Study|Grade 2 alopecia|0|||
106013911|NCT01588522|365717259|FG004|Overall Study|Grade 2 alopecia|0|||
106013912|NCT01588522|365717260|FG005|Overall Study|Grade 2 alopecia|0|||
106013913|NCT01588522|365717255|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
106013914|NCT01588522|365717256|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
106013915|NCT01588522|365717257|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
106013916|NCT01588522|365717258|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
106013917|NCT01588522|365717259|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
106013918|NCT01588522|365717260|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
106013919|NCT01588522|365717255|FG000|Overall Study|Taken off taxane-based regimen|0|||
106013920|NCT01588522|365717256|FG001|Overall Study|Taken off taxane-based regimen|0|||
106013921|NCT01588522|365717257|FG002|Overall Study|Taken off taxane-based regimen|0|||
106013922|NCT01588522|365717258|FG003|Overall Study|Taken off taxane-based regimen|1|||
106013923|NCT01588522|365717259|FG004|Overall Study|Taken off taxane-based regimen|0|||
106013924|NCT01588522|365717260|FG005|Overall Study|Taken off taxane-based regimen|0|||
106013925|NCT01588522|365717255|FG000|Overall Study|Did not initiate chemotherapy|0|||
106013926|NCT01588522|365717256|FG001|Overall Study|Did not initiate chemotherapy|0|||
106013927|NCT01588522|365717257|FG002|Overall Study|Did not initiate chemotherapy|0|||
106013928|NCT01588522|365717258|FG003|Overall Study|Did not initiate chemotherapy|0|||
106013929|NCT01588522|365717259|FG004|Overall Study|Did not initiate chemotherapy|1|||
106013930|NCT01588522|365717260|FG005|Overall Study|Did not initiate chemotherapy|0|||
106013931|NCT02991768|365717261|FG000|Overall Study|Physician Decision|4|||
106013932|NCT02749422|365717262|FG000|Overall Study|Lost to Follow-up|0|||
106013933|NCT02749422|365717263|FG001|Overall Study|Lost to Follow-up|2|||
106013934|NCT02749422|365717262|FG000|Overall Study|Ineligible|0|||
106013935|NCT02749422|365717263|FG001|Overall Study|Ineligible|1|||
106013936|NCT02594124|365717264|FG000|Overall Study|Adverse Event|0|||
106013937|NCT02594124|365717265|FG001|Overall Study|Adverse Event|5|||
106013938|NCT02594124|365717266|FG002|Overall Study|Adverse Event|8|||
106013939|NCT02594124|365717267|FG003|Overall Study|Adverse Event|1|||
106013940|NCT02594124|365717268|FG004|Overall Study|Adverse Event|0|||
106013941|NCT02594124|365717269|FG005|Overall Study|Adverse Event|0|||
106013942|NCT02594124|365717270|FG006|Overall Study|Adverse Event|2|||
106013943|NCT02594124|365717271|FG007|Overall Study|Adverse Event|2|||
106013944|NCT02594124|365717272|FG008|Overall Study|Adverse Event|0|||
106013945|NCT02594124|365717264|FG000|Overall Study|Withdrawal by Subject|2|||
106013946|NCT02594124|365717265|FG001|Overall Study|Withdrawal by Subject|3|||
106013947|NCT02594124|365717266|FG002|Overall Study|Withdrawal by Subject|5|||
105739835|NCT01522651|364701655|FG002|Overall Study|Adverse Event|4|||
105739836|NCT01522651|364701656|FG003|Overall Study|Adverse Event|5|||
105739837|NCT01522651|364701657|FG004|Overall Study|Adverse Event|4|||
105739838|NCT01522651|364701653|FG000|Overall Study|Cardioversion|1|||
105739839|NCT01522651|364701654|FG001|Overall Study|Cardioversion|0|||
105739840|NCT01522651|364701655|FG002|Overall Study|Cardioversion|0|||
106013948|NCT02594124|365717267|FG003|Overall Study|Withdrawal by Subject|1|||
106013949|NCT02594124|365717268|FG004|Overall Study|Withdrawal by Subject|8|||
106013950|NCT02594124|365717269|FG005|Overall Study|Withdrawal by Subject|4|||
106013951|NCT02594124|365717270|FG006|Overall Study|Withdrawal by Subject|13|||
106013952|NCT02594124|365717271|FG007|Overall Study|Withdrawal by Subject|19|||
106013953|NCT02594124|365717272|FG008|Overall Study|Withdrawal by Subject|0|||
106013954|NCT02594124|365717264|FG000|Overall Study|Physician Decision|0|||
106013955|NCT02594124|365717265|FG001|Overall Study|Physician Decision|2|||
106013956|NCT02594124|365717266|FG002|Overall Study|Physician Decision|0|||
106013957|NCT02594124|365717267|FG003|Overall Study|Physician Decision|0|||
106013958|NCT02594124|365717268|FG004|Overall Study|Physician Decision|0|||
106013959|NCT02594124|365717269|FG005|Overall Study|Physician Decision|0|||
105739841|NCT01522651|364701656|FG003|Overall Study|Cardioversion|0|||
105739842|NCT01522651|364701657|FG004|Overall Study|Cardioversion|0|||
105739843|NCT01522651|364701653|FG000|Overall Study|Device Malfunction|0|||
105739844|NCT01522651|364701654|FG001|Overall Study|Device Malfunction|1|||
105739845|NCT01522651|364701655|FG002|Overall Study|Device Malfunction|0|||
105739846|NCT01522651|364701656|FG003|Overall Study|Device Malfunction|0|||
105739847|NCT01522651|364701657|FG004|Overall Study|Device Malfunction|0|||
105739848|NCT01522651|364701653|FG000|Overall Study|Investigator's Discretion|0|||
105739849|NCT01522651|364701654|FG001|Overall Study|Investigator's Discretion|1|||
105739850|NCT01522651|364701655|FG002|Overall Study|Investigator's Discretion|0|||
105739851|NCT01522651|364701656|FG003|Overall Study|Investigator's Discretion|0|||
105739852|NCT01522651|364701657|FG004|Overall Study|Investigator's Discretion|0|||
105739853|NCT01522651|364701653|FG000|Overall Study|Protocol Violation|3|||
105739854|NCT01522651|364701654|FG001|Overall Study|Protocol Violation|0|||
105739855|NCT01522651|364701655|FG002|Overall Study|Protocol Violation|0|||
105739856|NCT01522651|364701656|FG003|Overall Study|Protocol Violation|0|||
105739857|NCT01522651|364701657|FG004|Overall Study|Protocol Violation|0|||
105739858|NCT01522651|364701653|FG000|Overall Study|Reason Not Specified|0|||
105800022|NCT01335399|364926337|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
105739859|NCT01522651|364701654|FG001|Overall Study|Reason Not Specified|0|||
105739860|NCT01522651|364701655|FG002|Overall Study|Reason Not Specified|0|||
105739861|NCT01522651|364701656|FG003|Overall Study|Reason Not Specified|1|||
105739862|NCT01522651|364701657|FG004|Overall Study|Reason Not Specified|0|||
105800023|NCT01335399|364926338|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
105941550|NCT04875533|365448843|FG001|Overall Study|Other|2|||
105941551|NCT05014919|365448844|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
105941552|NCT05014919|365448845|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
105941553|NCT05014919|365448846|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
105941554|NCT05014919|365448844|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
105941555|NCT05014919|365448845|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
105941556|NCT05014919|365448846|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
105941557|NCT05014919|365448844|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
105941558|NCT05014919|365448845|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
105941559|NCT05014919|365448846|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
105941560|NCT05014919|365448844|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
105941561|NCT05014919|365448845|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
105941562|NCT05014919|365448846|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
105941563|NCT05014919|365448844|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
105941564|NCT05014919|365448845|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
105941565|NCT05014919|365448846|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
105941566|NCT05014919|365448844|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
105941567|NCT05014919|365448845|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
105941568|NCT05014919|365448846|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
105941569|NCT05014919|365448844|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
105941570|NCT05014919|365448845|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
105941571|NCT05014919|365448846|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
105941572|NCT05014919|365448844|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
105941573|NCT05014919|365448845|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
105941574|NCT05014919|365448846|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
105941575|NCT02420717|365448851|FG000|Overall Study|Did not receive all study medication|2|||
105941576|NCT02420717|365448852|FG001|Overall Study|Did not receive all study medication|0|||
105941577|NCT02420717|365448853|FG002|Overall Study|Did not receive all study medication|0|||
105941578|NCT05375929|365448858|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
105941579|NCT05375929|365448859|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
105941580|NCT05375929|365448860|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
105941581|NCT05375929|365448861|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
105941582|NCT05375929|365448858|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
105941583|NCT05375929|365448859|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
105941584|NCT05375929|365448860|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
105941585|NCT05375929|365448861|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
105941586|NCT05375929|365448858|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
105941587|NCT05375929|365448859|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
105941588|NCT05375929|365448860|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
105941589|NCT05375929|365448861|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
105739863|NCT01522651|364701653|FG000|Overall Study|Participant Non-Compliance|1|||
105739864|NCT01522651|364701654|FG001|Overall Study|Participant Non-Compliance|0|||
105739865|NCT01522651|364701655|FG002|Overall Study|Participant Non-Compliance|0|||
106141875|NCT01194154|366177812|FG000|Overall Study|Blood pressure increase|5|||
106141876|NCT01194154|366177813|FG001|Overall Study|Blood pressure increase|3|||
106141877|NCT01194154|366177812|FG000|Overall Study|Hemoglobin decrease|0|||
106141878|NCT01194154|366177813|FG001|Overall Study|Hemoglobin decrease|1|||
106141879|NCT01194154|366177812|FG000|Overall Study|Hemoglobin increase|12|||
106141880|NCT01194154|366177813|FG001|Overall Study|Hemoglobin increase|3|||
106141881|NCT01194154|366177812|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
106141882|NCT01194154|366177813|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
106141883|NCT01194154|366177812|FG000|Overall Study|Treatment with prohibited medication|4|||
106141884|NCT01194154|366177813|FG001|Overall Study|Treatment with prohibited medication|5|||
106141885|NCT01194154|366177812|FG000|Overall Study|Other|4|||
106141886|NCT01194154|366177813|FG001|Overall Study|Other|0|||
106141887|NCT01194154|366177812|FG000|Overall Study|Did not receive study medication|2|||
106141888|NCT01194154|366177813|FG001|Overall Study|Did not receive study medication|4|||
106013960|NCT02594124|365717270|FG006|Overall Study|Physician Decision|0|||
106141889|NCT00842257|366177814|FG000|Overall Study|Adverse Event|1|||
106141890|NCT01069341|366177819|FG000|Overall Study|Lost to Follow-up|1|||
106141891|NCT01802632|366177820|FG000|Overall Study|Death|28|||
106141892|NCT01802632|366177821|FG001|Overall Study|Death|1|||
106141893|NCT01802632|366177822|FG002|Overall Study|Death|38|||
106141894|NCT01802632|366177823|FG003|Overall Study|Death|0|||
106141895|NCT01802632|366177824|FG004|Overall Study|Death|2|||
106141896|NCT01802632|366177825|FG005|Overall Study|Death|0|||
106141897|NCT01802632|366177820|FG000|Overall Study|Withdrawal by Subject|4|||
106141898|NCT01802632|366177821|FG001|Overall Study|Withdrawal by Subject|2|||
106141899|NCT01802632|366177822|FG002|Overall Study|Withdrawal by Subject|7|||
106141900|NCT01802632|366177823|FG003|Overall Study|Withdrawal by Subject|3|||
106141901|NCT01802632|366177824|FG004|Overall Study|Withdrawal by Subject|0|||
106141902|NCT01802632|366177825|FG005|Overall Study|Withdrawal by Subject|1|||
106141903|NCT01802632|366177820|FG000|Overall Study|Objective Disease Progression|1|||
106013961|NCT02594124|365717271|FG007|Overall Study|Physician Decision|1|||
106013962|NCT02594124|365717272|FG008|Overall Study|Physician Decision|0|||
106013963|NCT02594124|365717264|FG000|Overall Study|Commercial drug|0|||
106013964|NCT02594124|365717265|FG001|Overall Study|Commercial drug|1|||
106013965|NCT02594124|365717266|FG002|Overall Study|Commercial drug|6|||
106013966|NCT02594124|365717267|FG003|Overall Study|Commercial drug|3|||
106013967|NCT02594124|365717268|FG004|Overall Study|Commercial drug|0|||
106013968|NCT02594124|365717269|FG005|Overall Study|Commercial drug|0|||
106013969|NCT02594124|365717270|FG006|Overall Study|Commercial drug|7|||
106013970|NCT02594124|365717271|FG007|Overall Study|Commercial drug|11|||
106013971|NCT02594124|365717272|FG008|Overall Study|Commercial drug|2|||
106013972|NCT02594124|365717264|FG000|Overall Study|Reason Not Specified|1|||
106013973|NCT02594124|365717265|FG001|Overall Study|Reason Not Specified|3|||
106013974|NCT02594124|365717266|FG002|Overall Study|Reason Not Specified|4|||
106013975|NCT02594124|365717267|FG003|Overall Study|Reason Not Specified|0|||
106013976|NCT02594124|365717268|FG004|Overall Study|Reason Not Specified|0|||
106013977|NCT02594124|365717269|FG005|Overall Study|Reason Not Specified|1|||
106013978|NCT02594124|365717270|FG006|Overall Study|Reason Not Specified|1|||
106013979|NCT02594124|365717271|FG007|Overall Study|Reason Not Specified|6|||
106013980|NCT02594124|365717272|FG008|Overall Study|Reason Not Specified|1|||
106013981|NCT02017405|365717275|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
106013982|NCT02017405|365717276|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
106013983|NCT02017405|365717277|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
106013984|NCT02017405|365717278|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
106013985|NCT02017405|365717279|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
106013986|NCT02017405|365717280|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
106013987|NCT02017405|365717275|FG000|Open-label Phase|Adverse Event|1|||
106013988|NCT02017405|365717276|FG001|Open-label Phase|Adverse Event|1|||
106013989|NCT02017405|365717277|FG002|Open-label Phase|Adverse Event|0|||
106013990|NCT02017405|365717278|FG003|Open-label Phase|Adverse Event|0|||
106141904|NCT01802632|366177821|FG001|Overall Study|Objective Disease Progression|12|||
106141905|NCT01802632|366177822|FG002|Overall Study|Objective Disease Progression|104|||
106141906|NCT01802632|366177823|FG003|Overall Study|Objective Disease Progression|6|||
106141907|NCT01802632|366177824|FG004|Overall Study|Objective Disease Progression|4|||
106141908|NCT01802632|366177825|FG005|Overall Study|Objective Disease Progression|4|||
106141909|NCT01802632|366177820|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
106141910|NCT01802632|366177821|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
106141911|NCT01802632|366177822|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
106141912|NCT01802632|366177823|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
106141913|NCT01802632|366177824|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
106141914|NCT01802632|366177825|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
106141915|NCT01802632|366177820|FG000|Overall Study|Other (not specified)|0|||
106141916|NCT01802632|366177821|FG001|Overall Study|Other (not specified)|0|||
106141917|NCT01802632|366177822|FG002|Overall Study|Other (not specified)|7|||
106141918|NCT01802632|366177823|FG003|Overall Study|Other (not specified)|1|||
105739866|NCT01522651|364701656|FG003|Overall Study|Participant Non-Compliance|0|||
105739867|NCT01522651|364701657|FG004|Overall Study|Participant Non-Compliance|0|||
105739868|NCT01522651|364701653|FG000|Overall Study|Withdrew Consent|1|||
105739869|NCT01522651|364701654|FG001|Overall Study|Withdrew Consent|1|||
105739870|NCT01522651|364701655|FG002|Overall Study|Withdrew Consent|0|||
105739871|NCT01522651|364701656|FG003|Overall Study|Withdrew Consent|1|||
105739872|NCT01522651|364701657|FG004|Overall Study|Withdrew Consent|1|||
105739873|NCT01522651|364701653|FG000|Overall Study|Randomized but Never Treated|0|||
105739874|NCT01522651|364701654|FG001|Overall Study|Randomized but Never Treated|1|||
105739875|NCT01522651|364701655|FG002|Overall Study|Randomized but Never Treated|0|||
105739876|NCT01522651|364701656|FG003|Overall Study|Randomized but Never Treated|1|||
105739877|NCT01522651|364701657|FG004|Overall Study|Randomized but Never Treated|1|||
105739878|NCT01993329|364703419|FG000|Period 2|Adverse Event|0|||
105739879|NCT01993329|364703420|FG001|Period 2|Adverse Event|0|||
105739880|NCT01993329|364703421|FG002|Period 2|Adverse Event|0|||
105739881|NCT01993329|364703422|FG003|Period 2|Adverse Event|0|||
105739882|NCT01993329|364703423|FG004|Period 2|Adverse Event|0|||
105739883|NCT01993329|364703424|FG005|Period 2|Adverse Event|1|||
106013991|NCT02017405|365717279|FG004|Open-label Phase|Adverse Event|0|||
106013992|NCT02017405|365717280|FG005|Open-label Phase|Adverse Event|0|||
105739884|NCT01993329|364703419|FG000|Wash-out|Personal reasons|0|||
105739885|NCT01993329|364703420|FG001|Wash-out|Personal reasons|1|||
105739886|NCT01993329|364703421|FG002|Wash-out|Personal reasons|0|||
105739887|NCT01993329|364703422|FG003|Wash-out|Personal reasons|0|||
106013993|NCT04774094|365717281|FG000|Overall Study|Other|2|||
106013994|NCT04774094|365717281|FG000|Overall Study|Withdrawal by Subject|9|||
106013995|NCT04774094|365717281|FG000|Overall Study|Lost to Follow-up|7|||
106013996|NCT04774094|365717281|FG000|Overall Study|Lack of Efficacy|5|||
106013997|NCT04774094|365717281|FG000|Overall Study|Death|17|||
106013998|NCT04774094|365717281|FG000|Overall Study|Adverse Event|4|||
106013999|NCT02374450|365717282|FG000|Overall Study|Protocol Violation|0|||
106014000|NCT02374450|365717283|FG001|Overall Study|Protocol Violation|1|||
106014001|NCT02374450|365717284|FG002|Overall Study|Protocol Violation|0|||
106014002|NCT02374450|365717282|FG000|Overall Study|Withdrawal by Subject|91|||
106014003|NCT02374450|365717283|FG001|Overall Study|Withdrawal by Subject|110|||
106014004|NCT02374450|365717284|FG002|Overall Study|Withdrawal by Subject|4|||
106014005|NCT02374450|365717282|FG000|Overall Study|Lost to Follow-up|168|||
106014006|NCT02374450|365717283|FG001|Overall Study|Lost to Follow-up|194|||
106014007|NCT02374450|365717284|FG002|Overall Study|Lost to Follow-up|138|||
106014008|NCT02374450|365717282|FG000|Overall Study|Death|173|||
106014009|NCT02374450|365717283|FG001|Overall Study|Death|185|||
106014010|NCT02374450|365717284|FG002|Overall Study|Death|81|||
106014011|NCT02374450|365717282|FG000|Overall Study|Migrated from the study area|538|||
106014012|NCT02374450|365717283|FG001|Overall Study|Migrated from the study area|648|||
106014013|NCT02374450|365717284|FG002|Overall Study|Migrated from the study area|181|||
106014014|NCT02374450|365717282|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
106014015|NCT02374450|365717283|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
106014016|NCT02374450|365717284|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
106014017|NCT02374450|365717282|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
106014018|NCT02374450|365717283|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
106014019|NCT02374450|365717284|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
106014020|NCT02374450|365717282|FG000|Overall Study|Other|0|||
106014021|NCT02374450|365717283|FG001|Overall Study|Other|21|||
106014022|NCT02374450|365717284|FG002|Overall Study|Other|79|||
106014023|NCT05232682|365717285|FG000|Overall Study|Lost to Follow-up|2|||
106014024|NCT04323124|365717286|FG000|Overall Study|Adverse Event|0|||
106014025|NCT04323124|365717287|FG001|Overall Study|Adverse Event|0|||
105739888|NCT01993329|364703423|FG004|Wash-out|Personal reasons|0|||
105739889|NCT01993329|364703424|FG005|Wash-out|Personal reasons|0|||
105739890|NCT02207530|364703425|FG000|Overall Study|Worsening condition under investigation|78|||
105739891|NCT02207530|364703425|FG000|Overall Study|Patient decision to stop study treatment|5|||
105739892|NCT02207530|364703425|FG000|Overall Study|Adverse Event|8|||
105739893|NCT02795988|364703426|FG000|Phase 1b|Withdrawal by Subject|0|||
105739894|NCT02795988|364703427|FG001|Phase 1b|Withdrawal by Subject|1|||
105739895|NCT02795988|364703428|FG002|Phase 1b|Withdrawal by Subject|0|||
105739896|NCT02795988|364703429|FG003|Phase 1b|Withdrawal by Subject|0|||
105739897|NCT02795988|364703430|FG004|Phase 1b|Withdrawal by Subject|0|||
105739898|NCT02795988|364703431|FG005|Phase 1b|Withdrawal by Subject|0|||
105739899|NCT02795988|364703432|FG006|Phase 1b|Withdrawal by Subject|0|||
105739900|NCT02795988|364703426|FG000|Phase 1b|Death|1|||
105739901|NCT02795988|364703427|FG001|Phase 1b|Death|2|||
105739902|NCT02795988|364703428|FG002|Phase 1b|Death|1|||
106014026|NCT04323124|365717288|FG002|Overall Study|Adverse Event|0|||
106014027|NCT04323124|365717289|FG003|Overall Study|Adverse Event|0|||
105739903|NCT02795988|364703429|FG003|Phase 1b|Death|0|||
105739904|NCT02795988|364703430|FG004|Phase 1b|Death|0|||
105739905|NCT02795988|364703431|FG005|Phase 1b|Death|0|||
106014028|NCT04323124|365717290|FG004|Overall Study|Adverse Event|0|||
106014029|NCT04323124|365717291|FG005|Overall Study|Adverse Event|1|||
106014030|NCT04323124|365717292|FG006|Overall Study|Adverse Event|0|||
106014031|NCT04323124|365717293|FG007|Overall Study|Adverse Event|1|||
106014032|NCT04323124|365717294|FG008|Overall Study|Adverse Event|1|||
106014033|NCT04323124|365717295|FG009|Overall Study|Adverse Event|0|||
106014034|NCT04323124|365717296|FG010|Overall Study|Adverse Event|0|||
106014035|NCT04323124|365717297|FG011|Overall Study|Adverse Event|0|||
106014036|NCT04323124|365717298|FG012|Overall Study|Adverse Event|0|||
105739906|NCT02795988|364703432|FG006|Phase 1b|Death|0|||
105739907|NCT02795988|364703426|FG000|Phase 1b|Physician Decision|0|||
105739908|NCT02795988|364703427|FG001|Phase 1b|Physician Decision|0|||
105739909|NCT02795988|364703428|FG002|Phase 1b|Physician Decision|1|||
105739910|NCT02795988|364703429|FG003|Phase 1b|Physician Decision|0|||
105739911|NCT02795988|364703430|FG004|Phase 1b|Physician Decision|0|||
105739912|NCT02795988|364703431|FG005|Phase 1b|Physician Decision|0|||
105739913|NCT02795988|364703432|FG006|Phase 1b|Physician Decision|0|||
105739914|NCT02795988|364703426|FG000|Phase 1b|Progressive Disease|2|||
105739915|NCT02795988|364703427|FG001|Phase 1b|Progressive Disease|2|||
105739916|NCT02795988|364703428|FG002|Phase 1b|Progressive Disease|0|||
105739917|NCT02795988|364703429|FG003|Phase 1b|Progressive Disease|0|||
105739918|NCT02795988|364703430|FG004|Phase 1b|Progressive Disease|0|||
105739919|NCT02795988|364703431|FG005|Phase 1b|Progressive Disease|0|||
105739920|NCT02795988|364703432|FG006|Phase 1b|Progressive Disease|0|||
105739921|NCT02795988|364703426|FG000|Phase 2|Withdrawal by Subject|0|||
105739922|NCT02795988|364703427|FG001|Phase 2|Withdrawal by Subject|0|||
105739923|NCT02795988|364703428|FG002|Phase 2|Withdrawal by Subject|0|||
105739924|NCT02795988|364703429|FG003|Phase 2|Withdrawal by Subject|1|||
105739925|NCT02795988|364703430|FG004|Phase 2|Withdrawal by Subject|0|||
105739926|NCT02795988|364703431|FG005|Phase 2|Withdrawal by Subject|0|||
105739927|NCT02795988|364703432|FG006|Phase 2|Withdrawal by Subject|0|||
105739928|NCT02795988|364703426|FG000|Phase 2|Death|0|||
105739929|NCT02795988|364703427|FG001|Phase 2|Death|0|||
105739930|NCT02795988|364703428|FG002|Phase 2|Death|0|||
105739931|NCT02795988|364703429|FG003|Phase 2|Death|17|||
105739932|NCT02795988|364703430|FG004|Phase 2|Death|17|||
105739933|NCT02795988|364703431|FG005|Phase 2|Death|0|||
105739934|NCT02795988|364703432|FG006|Phase 2|Death|0|||
105739935|NCT02795988|364703426|FG000|Phase 2|Other|0|||
105739936|NCT02795988|364703427|FG001|Phase 2|Other|0|||
105739937|NCT02795988|364703428|FG002|Phase 2|Other|0|||
105739938|NCT02795988|364703429|FG003|Phase 2|Other|1|||
105941590|NCT05375929|365448858|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
105941591|NCT05375929|365448859|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
105941592|NCT05375929|365448860|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
105941593|NCT05375929|365448861|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
105941594|NCT05375929|365448858|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
105941595|NCT05375929|365448859|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
105941596|NCT05375929|365448860|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
105941597|NCT05375929|365448861|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
105941598|NCT05375929|365448858|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
105941599|NCT05375929|365448859|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
105941600|NCT05375929|365448860|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
105941601|NCT05375929|365448861|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
105941602|NCT05375929|365448858|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
105941603|NCT05375929|365448859|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
105941604|NCT05375929|365448860|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
105941605|NCT05375929|365448861|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
105941606|NCT05375929|365448858|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
105941607|NCT05375929|365448859|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
105941608|NCT05375929|365448860|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
105941609|NCT05375929|365448861|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
105941610|NCT05375929|365448858|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
105941611|NCT05375929|365448859|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
105941612|NCT05375929|365448860|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
105941613|NCT05375929|365448861|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
106014037|NCT04323124|365717299|FG013|Overall Study|Adverse Event|0|||
106014038|NCT04323124|365717300|FG014|Overall Study|Adverse Event|0|||
106014039|NCT04323124|365717286|FG000|Overall Study|Other|0|||
106014040|NCT04323124|365717287|FG001|Overall Study|Other|0|||
105739939|NCT02795988|364703430|FG004|Phase 2|Other|0|||
106014041|NCT04323124|365717288|FG002|Overall Study|Other|0|||
106014042|NCT04323124|365717289|FG003|Overall Study|Other|0|||
105739940|NCT02795988|364703431|FG005|Phase 2|Other|0|||
105739941|NCT02795988|364703432|FG006|Phase 2|Other|0|||
105739942|NCT02795988|364703426|FG000|Phase 2 Extension|Death|0|||
105739943|NCT02795988|364703427|FG001|Phase 2 Extension|Death|0|||
105739944|NCT02795988|364703428|FG002|Phase 2 Extension|Death|0|||
105739945|NCT02795988|364703429|FG003|Phase 2 Extension|Death|0|||
106014043|NCT04323124|365717290|FG004|Overall Study|Other|1|||
106014044|NCT04323124|365717291|FG005|Overall Study|Other|0|||
106014045|NCT04323124|365717292|FG006|Overall Study|Other|0|||
106014046|NCT04323124|365717293|FG007|Overall Study|Other|0|||
106014047|NCT04323124|365717294|FG008|Overall Study|Other|1|||
106014048|NCT04323124|365717295|FG009|Overall Study|Other|0|||
106014049|NCT04323124|365717296|FG010|Overall Study|Other|0|||
106014050|NCT04323124|365717297|FG011|Overall Study|Other|0|||
106014051|NCT04323124|365717298|FG012|Overall Study|Other|0|||
106014052|NCT04323124|365717299|FG013|Overall Study|Other|0|||
106014053|NCT04323124|365717300|FG014|Overall Study|Other|0|||
106014054|NCT04323124|365717286|FG000|Overall Study|Coming from a red zone (COVID)|0|||
106014055|NCT04323124|365717287|FG001|Overall Study|Coming from a red zone (COVID)|0|||
106014056|NCT04323124|365717288|FG002|Overall Study|Coming from a red zone (COVID)|0|||
106014057|NCT04323124|365717289|FG003|Overall Study|Coming from a red zone (COVID)|0|||
106014058|NCT04323124|365717290|FG004|Overall Study|Coming from a red zone (COVID)|1|||
106014059|NCT04323124|365717291|FG005|Overall Study|Coming from a red zone (COVID)|1|||
106014060|NCT04323124|365717292|FG006|Overall Study|Coming from a red zone (COVID)|0|||
106014061|NCT04323124|365717293|FG007|Overall Study|Coming from a red zone (COVID)|0|||
106014062|NCT04323124|365717294|FG008|Overall Study|Coming from a red zone (COVID)|0|||
106014063|NCT04323124|365717295|FG009|Overall Study|Coming from a red zone (COVID)|0|||
106014064|NCT04323124|365717296|FG010|Overall Study|Coming from a red zone (COVID)|0|||
106014065|NCT04323124|365717297|FG011|Overall Study|Coming from a red zone (COVID)|0|||
106014066|NCT04323124|365717298|FG012|Overall Study|Coming from a red zone (COVID)|0|||
106014067|NCT04323124|365717299|FG013|Overall Study|Coming from a red zone (COVID)|0|||
106014068|NCT04323124|365717300|FG014|Overall Study|Coming from a red zone (COVID)|0|||
106014069|NCT04323124|365717286|FG000|Overall Study|No longer meets eligibility criteria|0|||
106014070|NCT04323124|365717287|FG001|Overall Study|No longer meets eligibility criteria|0|||
106014071|NCT04323124|365717288|FG002|Overall Study|No longer meets eligibility criteria|0|||
106014072|NCT04323124|365717289|FG003|Overall Study|No longer meets eligibility criteria|0|||
106014073|NCT04323124|365717290|FG004|Overall Study|No longer meets eligibility criteria|0|||
106014074|NCT04323124|365717291|FG005|Overall Study|No longer meets eligibility criteria|0|||
106014075|NCT04323124|365717292|FG006|Overall Study|No longer meets eligibility criteria|0|||
106014076|NCT04323124|365717293|FG007|Overall Study|No longer meets eligibility criteria|1|||
106014077|NCT04323124|365717294|FG008|Overall Study|No longer meets eligibility criteria|0|||
106014078|NCT04323124|365717295|FG009|Overall Study|No longer meets eligibility criteria|0|||
106014079|NCT04323124|365717296|FG010|Overall Study|No longer meets eligibility criteria|0|||
106014080|NCT04323124|365717297|FG011|Overall Study|No longer meets eligibility criteria|0|||
106014081|NCT04323124|365717298|FG012|Overall Study|No longer meets eligibility criteria|0|||
106014082|NCT04323124|365717299|FG013|Overall Study|No longer meets eligibility criteria|1|||
106014083|NCT04323124|365717300|FG014|Overall Study|No longer meets eligibility criteria|1|||
106014084|NCT04323124|365717286|FG000|Overall Study|Study terminated by sponsor|0|||
106014085|NCT04323124|365717287|FG001|Overall Study|Study terminated by sponsor|0|||
106014086|NCT04323124|365717288|FG002|Overall Study|Study terminated by sponsor|0|||
106014087|NCT04323124|365717289|FG003|Overall Study|Study terminated by sponsor|0|||
106014088|NCT04323124|365717290|FG004|Overall Study|Study terminated by sponsor|0|||
106014089|NCT04323124|365717291|FG005|Overall Study|Study terminated by sponsor|0|||
106014090|NCT04323124|365717292|FG006|Overall Study|Study terminated by sponsor|0|||
106014091|NCT04323124|365717293|FG007|Overall Study|Study terminated by sponsor|0|||
106014092|NCT04323124|365717294|FG008|Overall Study|Study terminated by sponsor|0|||
106014093|NCT04323124|365717295|FG009|Overall Study|Study terminated by sponsor|0|||
106014094|NCT04323124|365717296|FG010|Overall Study|Study terminated by sponsor|0|||
106014095|NCT04323124|365717297|FG011|Overall Study|Study terminated by sponsor|2|||
106014096|NCT04323124|365717298|FG012|Overall Study|Study terminated by sponsor|1|||
106014097|NCT04323124|365717299|FG013|Overall Study|Study terminated by sponsor|0|||
106014098|NCT04323124|365717300|FG014|Overall Study|Study terminated by sponsor|0|||
106014099|NCT00905164|365717301|FG000|Period 1|Protocol Violation|0|||
106014100|NCT00905164|365717302|FG001|Period 1|Protocol Violation|1|||
106014101|NCT02202759|365719263|FG000|Overall Study|Study Terminated by Sponsor|3|||
106014102|NCT02202759|365719264|FG001|Overall Study|Study Terminated by Sponsor|3|||
106014103|NCT02202759|365719265|FG002|Overall Study|Study Terminated by Sponsor|3|||
106014104|NCT02202759|365719263|FG000|Overall Study|Withdrawal by Subject|2|||
106014105|NCT02202759|365719264|FG001|Overall Study|Withdrawal by Subject|1|||
106014106|NCT02202759|365719265|FG002|Overall Study|Withdrawal by Subject|1|||
106014107|NCT02202759|365719263|FG000|Overall Study|Reason not Specified|4|||
106014108|NCT02202759|365719264|FG001|Overall Study|Reason not Specified|11|||
106014109|NCT02202759|365719265|FG002|Overall Study|Reason not Specified|10|||
106014110|NCT00214201|365719266|FG000|Overall Study|Withdrawal by Subject|2|||
106014111|NCT00214201|365719267|FG001|Overall Study|Withdrawal by Subject|0|||
106014112|NCT00214201|365719266|FG000|Overall Study|Death|0|||
106014113|NCT00214201|365719267|FG001|Overall Study|Death|2|||
106014114|NCT01124006|365719268|FG000|Overall Study|Withdrawal by Subject|2|||
106014115|NCT01124006|365719269|FG001|Overall Study|Withdrawal by Subject|2|||
106014116|NCT01124006|365719270|FG002|Overall Study|Withdrawal by Subject|0|||
106014117|NCT01124006|365719268|FG000|Overall Study|Lost to Follow-up|1|||
106014118|NCT01124006|365719269|FG001|Overall Study|Lost to Follow-up|0|||
106014119|NCT01124006|365719270|FG002|Overall Study|Lost to Follow-up|1|||
106014120|NCT01124006|365719268|FG000|Overall Study|Other|0|||
106014121|NCT01124006|365719269|FG001|Overall Study|Other|0|||
106014122|NCT01124006|365719270|FG002|Overall Study|Other|1|||
106014123|NCT01712399|365719272|FG000|Overall Study|Lost to Follow-up|1|||
106014124|NCT01712399|365719272|FG000|Overall Study|Withdrawal by Subject|39|||
106014125|NCT01712399|365719272|FG000|Overall Study|Death|1|||
106014126|NCT01712399|365719272|FG000|Overall Study|Adverse Event|11|||
106014127|NCT01712399|365719272|FG000|Overall Study|Study closure|345|||
106014128|NCT00706238|365719278|FG000|Overall Study|Disease progression|4|||
106014129|NCT00706238|365719278|FG000|Overall Study|Other|1|||
106014130|NCT00753506|365719279|FG000|Overall Study|Withdrawal by Subject|4|||
106014131|NCT00753506|365719280|FG001|Overall Study|Withdrawal by Subject|1|||
106014132|NCT00753506|365719279|FG000|Overall Study|Lost to Follow-up|2|||
106014133|NCT00753506|365719280|FG001|Overall Study|Lost to Follow-up|0|||
106014134|NCT00753506|365719279|FG000|Overall Study|Other reason|1|||
106014135|NCT00753506|365719280|FG001|Overall Study|Other reason|1|||
106014136|NCT01193244|365719281|FG000|Overall Study|Withdrawal by Subject|79|||
106014137|NCT01193244|365719282|FG001|Overall Study|Withdrawal by Subject|97|||
106014138|NCT01193244|365719281|FG000|Overall Study|Other|303|||
106014139|NCT01193244|365719282|FG001|Overall Study|Other|278|||
106014140|NCT01193244|365719281|FG000|Overall Study|Lost to Follow-up|6|||
106014141|NCT01193244|365719282|FG001|Overall Study|Lost to Follow-up|15|||
106014142|NCT03877510|365719283|FG000|Overall Study|Death|6|||
106014143|NCT03877510|365719283|FG000|Overall Study|Lost to Follow-up|2|||
106014144|NCT03877510|365719283|FG000|Overall Study|Non-compliance with study drug|2|||
106014145|NCT03877510|365719283|FG000|Overall Study|Lack of Efficacy|14|||
106014146|NCT03877510|365719283|FG000|Overall Study|Adverse Event|20|||
106014147|NCT03877510|365719283|FG000|Overall Study|Withdrawal by Subject|22|||
106014148|NCT03877510|365719283|FG000|Overall Study|Miscellaneous|1|||
106014149|NCT01417377|365719284|FG000|Overall Study|Lost to Follow-up|12|||
106014150|NCT01417377|365719284|FG000|Overall Study|Enrolled, but not treated|1|||
106014151|NCT03763877|365719294|FG000|Overall Study|Withdrawal by Subject|3|||
106014152|NCT03763877|365719295|FG001|Overall Study|Withdrawal by Subject|1|||
106014153|NCT03763877|365719296|FG002|Overall Study|Withdrawal by Subject|3|||
106014154|NCT03763877|365719297|FG003|Overall Study|Withdrawal by Subject|4|||
106014155|NCT03763877|365719294|FG000|Overall Study|Adverse Event|1|||
106014156|NCT03763877|365719295|FG001|Overall Study|Adverse Event|1|||
106014157|NCT03763877|365719296|FG002|Overall Study|Adverse Event|3|||
106014158|NCT03763877|365719297|FG003|Overall Study|Adverse Event|1|||
106014159|NCT03763877|365719294|FG000|Overall Study|Protocol Violation|1|||
106014160|NCT03763877|365719295|FG001|Overall Study|Protocol Violation|1|||
106014161|NCT03763877|365719296|FG002|Overall Study|Protocol Violation|0|||
106014162|NCT03763877|365719297|FG003|Overall Study|Protocol Violation|0|||
106014163|NCT03763877|365719294|FG000|Overall Study|Lost to Follow-up|0|||
106014164|NCT03763877|365719295|FG001|Overall Study|Lost to Follow-up|1|||
106014165|NCT03763877|365719296|FG002|Overall Study|Lost to Follow-up|1|||
106014166|NCT03763877|365719297|FG003|Overall Study|Lost to Follow-up|0|||
106014167|NCT03040336|365719298|FG000|Overall Study|Death|1|||
106014168|NCT03040336|365719299|FG001|Overall Study|Death|0|||
106014169|NCT03040336|365719298|FG000|Overall Study|Withdrawal by Subject|2|||
106014170|NCT03040336|365719299|FG001|Overall Study|Withdrawal by Subject|3|||
106014171|NCT00068692|365719308|FG000|Step 1: Registration|Disese progression/relapse|5|||
106014172|NCT00068692|365719309|FG001|Step 1: Registration|Disese progression/relapse|0|||
106014173|NCT00068692|365719310|FG002|Step 1: Registration|Disese progression/relapse|0|||
106014174|NCT00068692|365719311|FG003|Step 1: Registration|Disese progression/relapse|0|||
106014175|NCT00068692|365719312|FG004|Step 1: Registration|Disese progression/relapse|0|||
106014176|NCT00068692|365719313|FG005|Step 1: Registration|Disese progression/relapse|0|||
106014177|NCT00068692|365719314|FG006|Step 1: Registration|Disese progression/relapse|0|||
106141919|NCT01802632|366177824|FG004|Overall Study|Other (not specified)|0|||
106141920|NCT01802632|366177825|FG005|Overall Study|Other (not specified)|1|||
106141921|NCT02705586|366177826|FG000|Overall Study|Health Issues|2|||
106014178|NCT00068692|365719315|FG007|Step 1: Registration|Disese progression/relapse|0|||
106014179|NCT00068692|365719308|FG000|Step 1: Registration|Adverse Event|7|||
106014180|NCT00068692|365719309|FG001|Step 1: Registration|Adverse Event|0|||
106014181|NCT00068692|365719310|FG002|Step 1: Registration|Adverse Event|0|||
106014182|NCT00068692|365719311|FG003|Step 1: Registration|Adverse Event|0|||
106014183|NCT00068692|365719312|FG004|Step 1: Registration|Adverse Event|0|||
106014184|NCT00068692|365719313|FG005|Step 1: Registration|Adverse Event|0|||
106014185|NCT00068692|365719314|FG006|Step 1: Registration|Adverse Event|0|||
106014186|NCT00068692|365719315|FG007|Step 1: Registration|Adverse Event|0|||
106014187|NCT00068692|365719308|FG000|Step 1: Registration|Death|1|||
106014188|NCT00068692|365719309|FG001|Step 1: Registration|Death|0|||
106014189|NCT00068692|365719310|FG002|Step 1: Registration|Death|0|||
106014190|NCT00068692|365719311|FG003|Step 1: Registration|Death|0|||
106014191|NCT00068692|365719312|FG004|Step 1: Registration|Death|0|||
106014192|NCT00068692|365719313|FG005|Step 1: Registration|Death|0|||
105739946|NCT02795988|364703430|FG004|Phase 2 Extension|Death|0|||
105739947|NCT02795988|364703431|FG005|Phase 2 Extension|Death|5|||
105739948|NCT02795988|364703432|FG006|Phase 2 Extension|Death|6|||
105739949|NCT02795988|364703426|FG000|Phase 2 Extension|Other reasons|0|||
105739950|NCT02795988|364703427|FG001|Phase 2 Extension|Other reasons|0|||
105739951|NCT02795988|364703428|FG002|Phase 2 Extension|Other reasons|0|||
106014193|NCT00068692|365719314|FG006|Step 1: Registration|Death|0|||
106014194|NCT00068692|365719315|FG007|Step 1: Registration|Death|0|||
106014195|NCT00068692|365719308|FG000|Step 1: Registration|Withdrawal by Subject|11|||
106014196|NCT00068692|365719309|FG001|Step 1: Registration|Withdrawal by Subject|0|||
106014197|NCT00068692|365719310|FG002|Step 1: Registration|Withdrawal by Subject|0|||
106014198|NCT00068692|365719311|FG003|Step 1: Registration|Withdrawal by Subject|0|||
106014199|NCT00068692|365719312|FG004|Step 1: Registration|Withdrawal by Subject|0|||
106014200|NCT00068692|365719313|FG005|Step 1: Registration|Withdrawal by Subject|0|||
106014201|NCT00068692|365719314|FG006|Step 1: Registration|Withdrawal by Subject|0|||
106014202|NCT00068692|365719315|FG007|Step 1: Registration|Withdrawal by Subject|0|||
106014203|NCT00068692|365719308|FG000|Step 1: Registration|Alternative therapy|2|||
106014204|NCT00068692|365719309|FG001|Step 1: Registration|Alternative therapy|0|||
106014205|NCT00068692|365719310|FG002|Step 1: Registration|Alternative therapy|0|||
106014206|NCT00068692|365719311|FG003|Step 1: Registration|Alternative therapy|0|||
106014207|NCT00068692|365719312|FG004|Step 1: Registration|Alternative therapy|0|||
106014208|NCT00068692|365719313|FG005|Step 1: Registration|Alternative therapy|0|||
106014209|NCT00068692|365719314|FG006|Step 1: Registration|Alternative therapy|0|||
106014210|NCT00068692|365719315|FG007|Step 1: Registration|Alternative therapy|0|||
106014211|NCT00068692|365719308|FG000|Step 1: Registration|Complicating disease|2|||
106014212|NCT00068692|365719309|FG001|Step 1: Registration|Complicating disease|0|||
106014213|NCT00068692|365719310|FG002|Step 1: Registration|Complicating disease|0|||
106014214|NCT00068692|365719311|FG003|Step 1: Registration|Complicating disease|0|||
106014215|NCT00068692|365719312|FG004|Step 1: Registration|Complicating disease|0|||
106014216|NCT00068692|365719313|FG005|Step 1: Registration|Complicating disease|0|||
106014217|NCT00068692|365719314|FG006|Step 1: Registration|Complicating disease|0|||
106014218|NCT00068692|365719315|FG007|Step 1: Registration|Complicating disease|0|||
106014219|NCT00068692|365719308|FG000|Step 1: Registration|Protocol Violation|1|||
106014220|NCT00068692|365719309|FG001|Step 1: Registration|Protocol Violation|0|||
106014221|NCT00068692|365719310|FG002|Step 1: Registration|Protocol Violation|0|||
106014222|NCT00068692|365719311|FG003|Step 1: Registration|Protocol Violation|0|||
106014223|NCT00068692|365719312|FG004|Step 1: Registration|Protocol Violation|0|||
106014224|NCT00068692|365719313|FG005|Step 1: Registration|Protocol Violation|0|||
105739952|NCT02795988|364703429|FG003|Phase 2 Extension|Other reasons|0|||
105739953|NCT02795988|364703430|FG004|Phase 2 Extension|Other reasons|0|||
105739954|NCT02795988|364703431|FG005|Phase 2 Extension|Other reasons|2|||
105739955|NCT02795988|364703432|FG006|Phase 2 Extension|Other reasons|1|||
105739956|NCT02341014|364703433|FG000|Overall Study|Adverse Event|0|||
105739957|NCT02341014|364703434|FG001|Overall Study|Adverse Event|1|||
105739958|NCT02341014|364703435|FG002|Overall Study|Adverse Event|0|||
105739959|NCT02341014|364703436|FG003|Overall Study|Adverse Event|0|||
105739960|NCT02341014|364703437|FG004|Overall Study|Adverse Event|2|||
105739961|NCT00273858|364703444|FG000|Overall Study|Not completed 24 month observation time|334|||
105739962|NCT00273858|364703444|FG000|Overall Study|Lost to Follow-up|101|||
105739963|NCT00273858|364703444|FG000|Overall Study|Withdrawal by Subject|21|||
105739964|NCT00273858|364703444|FG000|Overall Study|Adverse Event|81|||
105739965|NCT01585961|364703445|FG000|Overall Study|Death|6|||
105739966|NCT01585961|364703445|FG000|Overall Study|Physician Decision|1|||
105739967|NCT01585961|364703445|FG000|Overall Study|Decision to use non-study catheter|1|||
105739968|NCT01585961|364703445|FG000|Overall Study|Withdrawal by Subject|1|||
105739969|NCT01585961|364703445|FG000|Overall Study|Lost to Follow-up|23|||
105739970|NCT01585961|364703445|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
105739971|NCT00109733|364703446|FG000|Overall Study|Protocol Violation|0|||
105739972|NCT00109733|364703447|FG001|Overall Study|Protocol Violation|1|||
105739973|NCT00109733|364703446|FG000|Overall Study|Stopped taking study drug|1|||
105739974|NCT00109733|364703447|FG001|Overall Study|Stopped taking study drug|1|||
106014225|NCT00068692|365719314|FG006|Step 1: Registration|Protocol Violation|0|||
106014226|NCT00068692|365719315|FG007|Step 1: Registration|Protocol Violation|0|||
106014227|NCT00068692|365719308|FG000|Step 1: Registration|Not eligible|6|||
105739975|NCT00109733|364703446|FG000|Overall Study|Non-compliant|0|||
105739976|NCT00109733|364703447|FG001|Overall Study|Non-compliant|1|||
105739977|NCT00109733|364703446|FG000|Overall Study|Could not commit time for study|1|||
105739978|NCT00109733|364703447|FG001|Overall Study|Could not commit time for study|1|||
106014228|NCT00068692|365719309|FG001|Step 1: Registration|Not eligible|0|||
106014229|NCT00068692|365719310|FG002|Step 1: Registration|Not eligible|0|||
106014230|NCT00068692|365719311|FG003|Step 1: Registration|Not eligible|0|||
105739979|NCT01671085|364703455|FG000|Overall Study|Withdrawal by Subject|1|||
105739980|NCT01671085|364703456|FG001|Overall Study|Withdrawal by Subject|0|||
105739981|NCT00553059|364703457|FG000|Overall Study|Deemed ineligible|1|||
105739982|NCT00553059|364703458|FG001|Overall Study|Deemed ineligible|1|||
105739983|NCT00553059|364703457|FG000|Overall Study|Drug supply not available|0|||
105739984|NCT00553059|364703458|FG001|Overall Study|Drug supply not available|1|||
105739985|NCT06094296|364703459|FG000|Overall Study|Progressive Disease|1|||
105739986|NCT06094296|364703460|FG001|Overall Study|Progressive Disease|0|||
105739987|NCT06094296|364703461|FG002|Overall Study|Progressive Disease|0|||
105739988|NCT06094296|364703462|FG003|Overall Study|Progressive Disease|0|||
105739989|NCT00986258|364703463|FG000|Observation Period|Not eligible to be dosed|11|||
105739990|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
105739991|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
105739992|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
105739993|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
105739994|NCT00986258|364703463|FG000|Titration and Optimal Dose Period|Other|1|||
105739995|NCT00986258|364703463|FG000|Maintenance Period|Adverse Event|5|||
105739996|NCT00986258|364703463|FG000|Maintenance Period|Lack of Efficacy|2|||
106014231|NCT00068692|365719312|FG004|Step 1: Registration|Not eligible|0|||
106014232|NCT00068692|365719313|FG005|Step 1: Registration|Not eligible|0|||
106014233|NCT00068692|365719314|FG006|Step 1: Registration|Not eligible|0|||
106014234|NCT00068692|365719315|FG007|Step 1: Registration|Not eligible|0|||
106014235|NCT00068692|365719308|FG000|Step 1: Registration|Other|2|||
106014236|NCT00068692|365719309|FG001|Step 1: Registration|Other|0|||
106014237|NCT00068692|365719310|FG002|Step 1: Registration|Other|0|||
106014238|NCT00068692|365719311|FG003|Step 1: Registration|Other|0|||
106014239|NCT00068692|365719312|FG004|Step 1: Registration|Other|0|||
106014240|NCT00068692|365719313|FG005|Step 1: Registration|Other|0|||
106014241|NCT00068692|365719314|FG006|Step 1: Registration|Other|0|||
106014242|NCT00068692|365719315|FG007|Step 1: Registration|Other|0|||
106014243|NCT00068692|365719308|FG000|Step 1: Registration|Not start protocol therapy|3|||
106014244|NCT00068692|365719309|FG001|Step 1: Registration|Not start protocol therapy|0|||
106014245|NCT00068692|365719310|FG002|Step 1: Registration|Not start protocol therapy|0|||
106014246|NCT00068692|365719311|FG003|Step 1: Registration|Not start protocol therapy|0|||
106014247|NCT00068692|365719312|FG004|Step 1: Registration|Not start protocol therapy|0|||
106014248|NCT00068692|365719313|FG005|Step 1: Registration|Not start protocol therapy|0|||
106014249|NCT00068692|365719314|FG006|Step 1: Registration|Not start protocol therapy|0|||
106014250|NCT00068692|365719315|FG007|Step 1: Registration|Not start protocol therapy|0|||
106014251|NCT00068692|365719308|FG000|Step 1: Registration|Registered but not randomized|0|||
106014252|NCT00068692|365719309|FG001|Step 1: Registration|Registered but not randomized|1|||
106014253|NCT00068692|365719310|FG002|Step 1: Registration|Registered but not randomized|0|||
106014254|NCT00068692|365719311|FG003|Step 1: Registration|Registered but not randomized|0|||
106014255|NCT00068692|365719312|FG004|Step 1: Registration|Registered but not randomized|0|||
106014256|NCT00068692|365719313|FG005|Step 1: Registration|Registered but not randomized|0|||
106014257|NCT00068692|365719314|FG006|Step 1: Registration|Registered but not randomized|0|||
106014258|NCT00068692|365719315|FG007|Step 1: Registration|Registered but not randomized|0|||
106014259|NCT00068692|365719308|FG000|Step 2: Randomization|Disesae progression/replase|0|||
106014260|NCT00068692|365719309|FG001|Step 2: Randomization|Disesae progression/replase|0|||
106014261|NCT00068692|365719310|FG002|Step 2: Randomization|Disesae progression/replase|1|||
106014262|NCT00068692|365719311|FG003|Step 2: Randomization|Disesae progression/replase|1|||
106014263|NCT00068692|365719312|FG004|Step 2: Randomization|Disesae progression/replase|0|||
106014264|NCT00068692|365719313|FG005|Step 2: Randomization|Disesae progression/replase|0|||
106014265|NCT00068692|365719314|FG006|Step 2: Randomization|Disesae progression/replase|0|||
106014266|NCT00068692|365719315|FG007|Step 2: Randomization|Disesae progression/replase|0|||
106014267|NCT00068692|365719308|FG000|Step 2: Randomization|Adverse Event|0|||
106014268|NCT00068692|365719309|FG001|Step 2: Randomization|Adverse Event|0|||
106014269|NCT00068692|365719310|FG002|Step 2: Randomization|Adverse Event|4|||
106014270|NCT00068692|365719311|FG003|Step 2: Randomization|Adverse Event|2|||
106014271|NCT00068692|365719312|FG004|Step 2: Randomization|Adverse Event|2|||
106014272|NCT00068692|365719313|FG005|Step 2: Randomization|Adverse Event|3|||
106014273|NCT00068692|365719314|FG006|Step 2: Randomization|Adverse Event|4|||
106014274|NCT00068692|365719315|FG007|Step 2: Randomization|Adverse Event|4|||
106014275|NCT00068692|365719308|FG000|Step 2: Randomization|Death|0|||
106014276|NCT00068692|365719309|FG001|Step 2: Randomization|Death|0|||
106014277|NCT00068692|365719310|FG002|Step 2: Randomization|Death|0|||
105739997|NCT00986258|364703463|FG000|Maintenance Period|Withdrawal by Subject|2|||
105739998|NCT03332667|364703464|FG000|Overall Study|Adverse Event|0|||
105739999|NCT03332667|364703465|FG001|Overall Study|Adverse Event|0|||
105740000|NCT03332667|364703466|FG002|Overall Study|Adverse Event|2|||
106014278|NCT00068692|365719311|FG003|Step 2: Randomization|Death|0|||
106014279|NCT00068692|365719312|FG004|Step 2: Randomization|Death|1|||
106014280|NCT00068692|365719313|FG005|Step 2: Randomization|Death|0|||
106014281|NCT00068692|365719314|FG006|Step 2: Randomization|Death|0|||
106014282|NCT00068692|365719315|FG007|Step 2: Randomization|Death|1|||
105740001|NCT03332667|364703467|FG003|Overall Study|Adverse Event|1|||
105740002|NCT03332667|364703464|FG000|Overall Study|Withdrawal by Subject|2|||
105740003|NCT03332667|364703465|FG001|Overall Study|Withdrawal by Subject|1|||
105740004|NCT03332667|364703466|FG002|Overall Study|Withdrawal by Subject|5|||
105740005|NCT03332667|364703467|FG003|Overall Study|Withdrawal by Subject|1|||
105740006|NCT03332667|364703464|FG000|Overall Study|Disease Progression or Relapse|2|||
105800024|NCT01335399|364926337|FG000|Pre-treatment Period|Participant request to discontinue|0|||
105941614|NCT05375929|365448858|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
105740007|NCT03332667|364703465|FG001|Overall Study|Disease Progression or Relapse|1|||
105740008|NCT03332667|364703466|FG002|Overall Study|Disease Progression or Relapse|3|||
105740009|NCT03332667|364703467|FG003|Overall Study|Disease Progression or Relapse|0|||
105740010|NCT03332667|364703464|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
105740011|NCT03332667|364703465|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
105740012|NCT03332667|364703466|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
105740013|NCT03332667|364703467|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
105740014|NCT03332667|364703464|FG000|Overall Study|No Treatment Received|0|||
105740015|NCT03332667|364703465|FG001|Overall Study|No Treatment Received|0|||
105740016|NCT03332667|364703466|FG002|Overall Study|No Treatment Received|1|||
105740017|NCT03332667|364703467|FG003|Overall Study|No Treatment Received|0|||
105740018|NCT00117338|364703468|FG000|Overall Study|Adverse Event|0|||
105740019|NCT00117338|364703469|FG001|Overall Study|Adverse Event|1|||
105740020|NCT00117338|364703468|FG000|Overall Study|Protocol Violation|3|||
105740021|NCT00117338|364703469|FG001|Overall Study|Protocol Violation|2|||
105740022|NCT00117338|364703468|FG000|Overall Study|Withdrawal by Subject|1|||
105740023|NCT00117338|364703469|FG001|Overall Study|Withdrawal by Subject|0|||
105740024|NCT00117338|364703468|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
105740025|NCT00117338|364703469|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
105740026|NCT00117338|364703468|FG000|Overall Study|Lack of Efficacy|0|||
105740027|NCT00117338|364703469|FG001|Overall Study|Lack of Efficacy|1|||
105740028|NCT02616029|364703471|FG000|Overall Study|Adverse Event|1|||
105740029|NCT02616029|364703472|FG001|Overall Study|Adverse Event|0|||
105740030|NCT02616029|364703471|FG000|Overall Study|Death|0|||
105740031|NCT02616029|364703472|FG001|Overall Study|Death|1|||
105740032|NCT02616029|364703471|FG000|Overall Study|Protocol Violation|1|||
105740033|NCT02616029|364703472|FG001|Overall Study|Protocol Violation|0|||
105740034|NCT02616029|364703471|FG000|Overall Study|Withdrew Consent|1|||
105740035|NCT02616029|364703472|FG001|Overall Study|Withdrew Consent|0|||
105740036|NCT02616029|364703471|FG000|Overall Study|Enrolled and Never Treated|1|||
105740037|NCT02616029|364703472|FG001|Overall Study|Enrolled and Never Treated|1|||
105740038|NCT04429503|364703473|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
105740039|NCT04429503|364703474|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
105740040|NCT04429503|364703475|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
105740041|NCT04429503|364703473|FG000|Overall Study|Adverse Event|1|||
105740042|NCT04429503|364703474|FG001|Overall Study|Adverse Event|9|||
105740043|NCT04429503|364703475|FG002|Overall Study|Adverse Event|2|||
105740044|NCT04429503|364703473|FG000|Overall Study|Decision by the investigator/sponsor|2|||
105740045|NCT04429503|364703474|FG001|Overall Study|Decision by the investigator/sponsor|9|||
105740046|NCT04429503|364703475|FG002|Overall Study|Decision by the investigator/sponsor|3|||
105740047|NCT04429503|364703473|FG000|Overall Study|Withdrawal by Subject|9|||
105740048|NCT04429503|364703474|FG001|Overall Study|Withdrawal by Subject|17|||
105740049|NCT04429503|364703475|FG002|Overall Study|Withdrawal by Subject|8|||
105740050|NCT04429503|364703473|FG000|Overall Study|Lost to Follow-up|5|||
105740051|NCT04429503|364703474|FG001|Overall Study|Lost to Follow-up|19|||
106141922|NCT02705586|366177826|FG000|Overall Study|Transportation Difficulties|5|||
106141923|NCT02705586|366177826|FG000|Overall Study|Vacation/Planned Absence|1|||
106141924|NCT02459899|366177829|FG000|Overall Study|Adverse Event|1|||
106141925|NCT02459899|366177830|FG001|Overall Study|Adverse Event|1|||
105740052|NCT04429503|364703475|FG002|Overall Study|Lost to Follow-up|7|||
105740053|NCT04429503|364703473|FG000|Overall Study|Death|9|||
105740054|NCT04429503|364703474|FG001|Overall Study|Death|18|||
105740055|NCT04429503|364703475|FG002|Overall Study|Death|5|||
105740056|NCT01703819|364703476|FG000|Overall Study|Adverse Event|0|||
105941615|NCT05375929|365448859|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
105941616|NCT05375929|365448860|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
105941617|NCT05375929|365448861|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
105941618|NCT02496000|365448862|FG000|Overall Study|Withdrawal by Subject|1|||
105941619|NCT02496000|365448863|FG001|Overall Study|Withdrawal by Subject|2|||
105941620|NCT02496000|365448864|FG002|Overall Study|Withdrawal by Subject|0|||
105941621|NCT02496000|365448862|FG000|Overall Study|Lost to Follow-up|1|||
105941622|NCT02496000|365448863|FG001|Overall Study|Lost to Follow-up|0|||
105941623|NCT02496000|365448864|FG002|Overall Study|Lost to Follow-up|1|||
105941624|NCT02496000|365448862|FG000|Overall Study|Protocol Violation|0|||
105941625|NCT02496000|365448863|FG001|Overall Study|Protocol Violation|0|||
105740057|NCT01703819|364703477|FG001|Overall Study|Adverse Event|1|||
105740058|NCT01703819|364703476|FG000|Overall Study|Withdrawal by Subject|0|||
105740059|NCT01703819|364703477|FG001|Overall Study|Withdrawal by Subject|1|||
105941626|NCT02496000|365448864|FG002|Overall Study|Protocol Violation|1|||
105941627|NCT02496000|365448862|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
105952164|NCT03314935|365488185|FG001|Phase 2|Progressive Disease|0|||
105740060|NCT02145156|364703479|FG000|Overall Study|No match to vaccination records|60|||
105740061|NCT02145156|364703480|FG001|Overall Study|No match to vaccination records|52|||
105941628|NCT02496000|365448863|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
105941629|NCT02496000|365448864|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
105941630|NCT02496000|365448862|FG000|Overall Study|undetermined|0|||
105941631|NCT02496000|365448863|FG001|Overall Study|undetermined|1|||
105941632|NCT02496000|365448864|FG002|Overall Study|undetermined|0|||
105941633|NCT02255656|365448865|FG000|Overall Study|Adverse Event|11|||
105941634|NCT02255656|365448865|FG000|Overall Study|Poor compliance to protocol|3|||
105941635|NCT02255656|365448865|FG000|Overall Study|Lost to Follow-up|30|||
105941636|NCT02255656|365448865|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
105941637|NCT02255656|365448865|FG000|Overall Study|Other|126|||
105941638|NCT01111552|365448866|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
105941639|NCT01111552|365448867|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105941640|NCT01111552|365448868|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105941641|NCT01111552|365448869|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105941642|NCT01111552|365448870|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105941643|NCT01111552|365448866|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
105941644|NCT01111552|365448867|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105941645|NCT01111552|365448868|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105941646|NCT01111552|365448869|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105941647|NCT01111552|365448870|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105941648|NCT01111552|365448866|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
105941649|NCT01111552|365448867|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105941650|NCT01111552|365448868|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105941651|NCT01111552|365448869|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105941652|NCT01111552|365448870|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105941653|NCT01111552|365448866|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
105941654|NCT01111552|365448867|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
105941655|NCT01111552|365448868|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
105941656|NCT01111552|365448869|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
105941657|NCT01111552|365448870|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
105941658|NCT01111552|365448866|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
105941659|NCT01111552|365448867|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
105941660|NCT01111552|365448868|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
105941661|NCT01111552|365448869|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
105941662|NCT01111552|365448870|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
105941663|NCT01111552|365448866|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
105941664|NCT01111552|365448867|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
105941665|NCT01111552|365448868|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
105941666|NCT01111552|365448869|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
105941667|NCT01111552|365448870|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
105941668|NCT01111552|365448866|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
105941669|NCT01111552|365448867|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105941670|NCT01111552|365448868|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105941671|NCT01111552|365448869|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105941672|NCT01111552|365448870|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105941673|NCT01111552|365448866|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
105941674|NCT01111552|365448867|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
105941675|NCT01111552|365448868|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
105941676|NCT01111552|365448869|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
105941677|NCT01111552|365448870|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
105941678|NCT01111552|365448866|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105941679|NCT01111552|365448867|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105941680|NCT01111552|365448868|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105941681|NCT01111552|365448869|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
105941682|NCT01111552|365448870|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105941683|NCT01111552|365448866|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
105941684|NCT01111552|365448867|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
105941685|NCT01111552|365448868|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
105952165|NCT03314935|365488186|FG002|Phase 2|Progressive Disease|0|||
105952166|NCT03314935|365488187|FG003|Phase 2|Progressive Disease|0|||
105952167|NCT03314935|365488188|FG004|Phase 2|Progressive Disease|0|||
105952168|NCT03314935|365488189|FG005|Phase 2|Progressive Disease|0|||
105952169|NCT03314935|365488190|FG006|Phase 2|Progressive Disease|0|||
105952170|NCT03314935|365488191|FG007|Phase 2|Progressive Disease|0|||
105952171|NCT03314935|365488192|FG008|Phase 2|Progressive Disease|0|||
105952172|NCT03314935|365488193|FG009|Phase 2|Progressive Disease|1|||
105952173|NCT03314935|365488194|FG010|Phase 2|Progressive Disease|1|||
105952174|NCT03314935|365488195|FG011|Phase 2|Progressive Disease|1|||
105740062|NCT02145156|364703481|FG002|Overall Study|No match to vaccination records|41|||
105740063|NCT02202031|364703484|FG000|Overall Study|Lost to Follow-up|1|||
105740064|NCT02202031|364703485|FG001|Overall Study|Lost to Follow-up|0|||
105740065|NCT02202031|364703484|FG000|Overall Study|Too Busy|1|||
105740066|NCT02202031|364703485|FG001|Overall Study|Too Busy|3|||
106014283|NCT00068692|365719308|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
106014284|NCT00068692|365719309|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
106014285|NCT00068692|365719310|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
106014286|NCT00068692|365719311|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
106014287|NCT00068692|365719312|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
106014288|NCT00068692|365719313|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
106014289|NCT00068692|365719314|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
106014290|NCT00068692|365719315|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
106014291|NCT00068692|365719308|FG000|Step 2: Randomization|alternative therapy|0|||
106014292|NCT00068692|365719309|FG001|Step 2: Randomization|alternative therapy|0|||
106014293|NCT00068692|365719310|FG002|Step 2: Randomization|alternative therapy|0|||
106014294|NCT00068692|365719311|FG003|Step 2: Randomization|alternative therapy|1|||
106014295|NCT00068692|365719312|FG004|Step 2: Randomization|alternative therapy|1|||
106014296|NCT00068692|365719313|FG005|Step 2: Randomization|alternative therapy|0|||
106014297|NCT00068692|365719314|FG006|Step 2: Randomization|alternative therapy|0|||
106014298|NCT00068692|365719315|FG007|Step 2: Randomization|alternative therapy|0|||
106014299|NCT00068692|365719308|FG000|Step 2: Randomization|Physician Decision|0|||
106014300|NCT00068692|365719309|FG001|Step 2: Randomization|Physician Decision|0|||
106014301|NCT00068692|365719310|FG002|Step 2: Randomization|Physician Decision|0|||
106014302|NCT00068692|365719311|FG003|Step 2: Randomization|Physician Decision|1|||
106014303|NCT00068692|365719312|FG004|Step 2: Randomization|Physician Decision|1|||
106014304|NCT00068692|365719313|FG005|Step 2: Randomization|Physician Decision|0|||
106014305|NCT00068692|365719314|FG006|Step 2: Randomization|Physician Decision|0|||
106014306|NCT00068692|365719315|FG007|Step 2: Randomization|Physician Decision|0|||
106014307|NCT00068692|365719308|FG000|Step 2: Randomization|Other|0|||
106014308|NCT00068692|365719309|FG001|Step 2: Randomization|Other|0|||
106014309|NCT00068692|365719310|FG002|Step 2: Randomization|Other|0|||
106014310|NCT00068692|365719311|FG003|Step 2: Randomization|Other|1|||
106014311|NCT00068692|365719312|FG004|Step 2: Randomization|Other|0|||
106014312|NCT00068692|365719313|FG005|Step 2: Randomization|Other|1|||
106014313|NCT00068692|365719314|FG006|Step 2: Randomization|Other|0|||
106014314|NCT00068692|365719315|FG007|Step 2: Randomization|Other|0|||
106014315|NCT00068692|365719308|FG000|Step 2: Randomization|never start protocol therapy|0|||
106014316|NCT00068692|365719309|FG001|Step 2: Randomization|never start protocol therapy|0|||
106014317|NCT00068692|365719310|FG002|Step 2: Randomization|never start protocol therapy|1|||
106014318|NCT00068692|365719311|FG003|Step 2: Randomization|never start protocol therapy|0|||
106014319|NCT00068692|365719312|FG004|Step 2: Randomization|never start protocol therapy|1|||
106014320|NCT00068692|365719313|FG005|Step 2: Randomization|never start protocol therapy|0|||
106014321|NCT00068692|365719314|FG006|Step 2: Randomization|never start protocol therapy|0|||
106014322|NCT00068692|365719315|FG007|Step 2: Randomization|never start protocol therapy|0|||
106014323|NCT00248040|365719317|FG000|Overall Study|transplantectomy|2|||
106014324|NCT00248040|365719318|FG001|Overall Study|transplantectomy|1|||
106014325|NCT00248040|365719319|FG002|Overall Study|transplantectomy|3|||
106014326|NCT00248040|365719317|FG000|Overall Study|transplant cancelled post treat start|1|||
106014327|NCT00248040|365719318|FG001|Overall Study|transplant cancelled post treat start|0|||
106014328|NCT00248040|365719319|FG002|Overall Study|transplant cancelled post treat start|0|||
106014329|NCT00248040|365719317|FG000|Overall Study|Death|0|||
106014330|NCT00248040|365719318|FG001|Overall Study|Death|0|||
106014331|NCT00248040|365719319|FG002|Overall Study|Death|1|||
106014332|NCT03557034|365719323|FG000|Overall Study|Withdrawal by Subject|1|||
106014333|NCT03557034|365719324|FG001|Overall Study|Withdrawal by Subject|0|||
106014334|NCT00628108|365719330|FG000|Overall Study|Adverse Event|0|||
106014335|NCT00628108|365719331|FG001|Overall Study|Adverse Event|3|||
106014336|NCT00628108|365719330|FG000|Overall Study|Withdrawal by Subject|1|||
106014337|NCT00628108|365719331|FG001|Overall Study|Withdrawal by Subject|0|||
106014338|NCT01002339|365719335|FG000|Overall Study|Withdrawal by Subject|0|||
106014339|NCT01002339|365719336|FG001|Overall Study|Withdrawal by Subject|1|||
106014340|NCT01002339|365719337|FG002|Overall Study|Withdrawal by Subject|0|||
106014341|NCT01002339|365719335|FG000|Overall Study|Incorrect treatment assignment|0|||
106014342|NCT01002339|365719336|FG001|Overall Study|Incorrect treatment assignment|0|||
106014343|NCT01002339|365719337|FG002|Overall Study|Incorrect treatment assignment|1|||
105740067|NCT02202031|364703484|FG000|Overall Study|Illness/Medical Reason|0|||
106014344|NCT01002339|365719335|FG000|Overall Study|Protocol Violation|0|||
106014345|NCT01002339|365719336|FG001|Overall Study|Protocol Violation|0|||
106014346|NCT01002339|365719337|FG002|Overall Study|Protocol Violation|2|||
106014347|NCT01002339|365719335|FG000|Overall Study|Lung cancer detected before transplant|0|||
105740068|NCT02202031|364703485|FG001|Overall Study|Illness/Medical Reason|2|||
106014348|NCT01002339|365719336|FG001|Overall Study|Lung cancer detected before transplant|0|||
105740069|NCT02202031|364703484|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
105740070|NCT02202031|364703485|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
105740071|NCT02698423|364703488|FG000|Overall Study|Lost to Follow-up|19|||
105740072|NCT02698423|364703489|FG001|Overall Study|Lost to Follow-up|24|||
105740073|NCT03634072|364703490|FG000|Overall Study|Early termination of overall study|1|||
105740074|NCT03634072|364703491|FG001|Overall Study|Early termination of overall study|0|||
105740075|NCT01952015|364703493|FG000|Induction|Protocol Violation|1|||
105740076|NCT01952015|364703493|FG000|Maintenance|Adverse Event|2|||
105941686|NCT01111552|365448869|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
105941687|NCT01111552|365448870|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
105941688|NCT01111552|365448866|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
105941689|NCT01111552|365448867|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
105941690|NCT01111552|365448868|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
105941691|NCT01111552|365448869|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
105941692|NCT01111552|365448870|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
105941693|NCT01111552|365448866|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
105941694|NCT01111552|365448867|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
105941695|NCT01111552|365448868|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
105941696|NCT01111552|365448869|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
105941697|NCT01111552|365448870|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
105941698|NCT01111552|365448866|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
105941699|NCT01111552|365448867|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
105941700|NCT01111552|365448868|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
105941701|NCT01111552|365448869|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
105941702|NCT01111552|365448870|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
105941703|NCT01111552|365448866|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105941704|NCT01111552|365448867|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105941705|NCT01111552|365448868|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
105941706|NCT01111552|365448869|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105941707|NCT01111552|365448870|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105941708|NCT03734536|365448871|FG000|Overall Study|Withdrew Consent|1|||
105941709|NCT03734536|365448872|FG001|Overall Study|Withdrew Consent|5|||
105941710|NCT03734536|365448871|FG000|Overall Study|Lost to Follow-up|10|||
105941711|NCT03734536|365448872|FG001|Overall Study|Lost to Follow-up|7|||
105941712|NCT01346592|365448875|FG000|Overall Study|Lost to Follow-up|62|||
105941713|NCT01346592|365448876|FG001|Overall Study|Lost to Follow-up|29|||
105941714|NCT01346592|365448877|FG002|Overall Study|Lost to Follow-up|29|||
105941715|NCT01346592|365448875|FG000|Overall Study|Protocol Violation|2|||
105941716|NCT01346592|365448876|FG001|Overall Study|Protocol Violation|1|||
105941717|NCT01346592|365448877|FG002|Overall Study|Protocol Violation|0|||
105941718|NCT01346592|365448875|FG000|Overall Study|Death|1|||
105941719|NCT01346592|365448876|FG001|Overall Study|Death|3|||
105941720|NCT01346592|365448877|FG002|Overall Study|Death|4|||
105941721|NCT01346592|365448875|FG000|Overall Study|Adverse Event|0|||
105941722|NCT01346592|365448876|FG001|Overall Study|Adverse Event|1|||
105941723|NCT01346592|365448877|FG002|Overall Study|Adverse Event|0|||
105941724|NCT01346592|365448875|FG000|Overall Study|Withdrawal by Subject|77|||
105941725|NCT01346592|365448876|FG001|Overall Study|Withdrawal by Subject|51|||
105941726|NCT01346592|365448877|FG002|Overall Study|Withdrawal by Subject|38|||
105941727|NCT01346592|365448875|FG000|Overall Study|Inappropriate enrollment|3|||
105941728|NCT01346592|365448876|FG001|Overall Study|Inappropriate enrollment|1|||
105941729|NCT01346592|365448877|FG002|Overall Study|Inappropriate enrollment|1|||
105941730|NCT01346592|365448875|FG000|Overall Study|Administrative reason|1|||
105941731|NCT01346592|365448876|FG001|Overall Study|Administrative reason|0|||
105941732|NCT01346592|365448877|FG002|Overall Study|Administrative reason|0|||
105941733|NCT01346592|365448875|FG000|Overall Study|Unable to Classify|7|||
105941734|NCT01346592|365448876|FG001|Overall Study|Unable to Classify|3|||
105941735|NCT01346592|365448877|FG002|Overall Study|Unable to Classify|6|||
105941736|NCT02679274|365448878|FG000|Overall Study|Withdrawal by Subject|1|||
105941737|NCT02679274|365448879|FG001|Overall Study|Withdrawal by Subject|0|||
105941738|NCT00322218|365448880|FG000|Overall Study|Death|3|||
105941739|NCT00322218|365448881|FG001|Overall Study|Death|6|||
105941740|NCT04144517|365448885|FG000|Overall Study|Physician Decision|0|||
105941741|NCT04144517|365448886|FG001|Overall Study|Physician Decision|1|||
105941742|NCT04144517|365448885|FG000|Overall Study|Other|2|||
105941743|NCT04144517|365448886|FG001|Overall Study|Other|2|||
105941744|NCT04144517|365448885|FG000|Overall Study|Death|6|||
105740077|NCT01952015|364703493|FG000|Treatment Period 3|Physician Decision|9|||
105740078|NCT02239094|364703494|FG000|Overall Study|Withdrawal by Subject|1|||
105941745|NCT04144517|365448886|FG001|Overall Study|Death|3|||
105941746|NCT00835367|365448887|FG000|Washout|Adverse Event|2|||
105740079|NCT02239094|364703494|FG000|Overall Study|Remitted before started|1|||
105740080|NCT03184701|364703495|FG000|Overall Study|Death|3|||
106141926|NCT02459899|366177831|FG002|Overall Study|Adverse Event|0|||
106141927|NCT02459899|366177832|FG003|Overall Study|Adverse Event|0|||
106141928|NCT02459899|366177829|FG000|Overall Study|Lost to Follow-up|1|||
106141929|NCT02459899|366177830|FG001|Overall Study|Lost to Follow-up|2|||
106141930|NCT02459899|366177831|FG002|Overall Study|Lost to Follow-up|0|||
106141931|NCT02459899|366177832|FG003|Overall Study|Lost to Follow-up|1|||
106141932|NCT02459899|366177829|FG000|Overall Study|Non-compliance with the treatment|0|||
106141933|NCT02459899|366177830|FG001|Overall Study|Non-compliance with the treatment|0|||
106141934|NCT02459899|366177831|FG002|Overall Study|Non-compliance with the treatment|0|||
106141935|NCT02459899|366177832|FG003|Overall Study|Non-compliance with the treatment|1|||
106141936|NCT02459899|366177829|FG000|Overall Study|Withdrawal by Subject|1|||
106141937|NCT02459899|366177830|FG001|Overall Study|Withdrawal by Subject|3|||
106141938|NCT02459899|366177831|FG002|Overall Study|Withdrawal by Subject|0|||
106141939|NCT02459899|366177832|FG003|Overall Study|Withdrawal by Subject|0|||
106141940|NCT02739035|366177835|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
106141941|NCT02739035|366177836|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
106141942|NCT02739035|366177835|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
106141943|NCT02739035|366177836|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
106014349|NCT01002339|365719337|FG002|Overall Study|Lung cancer detected before transplant|1|||
106014350|NCT01002339|365719335|FG000|Overall Study|Randomized. Not transplanted|0|||
106014351|NCT01002339|365719336|FG001|Overall Study|Randomized. Not transplanted|0|||
106014352|NCT01002339|365719337|FG002|Overall Study|Randomized. Not transplanted|1|||
106014353|NCT02215252|365719338|FG000|Overall Study|Adverse Event|1|||
106014354|NCT02215252|365719339|FG001|Overall Study|Adverse Event|5|||
106014355|NCT02215252|365719340|FG002|Overall Study|Adverse Event|2|||
106014356|NCT02215252|365719338|FG000|Overall Study|Lost to Follow-up|0|||
106014357|NCT02215252|365719339|FG001|Overall Study|Lost to Follow-up|0|||
106014358|NCT02215252|365719340|FG002|Overall Study|Lost to Follow-up|1|||
106014359|NCT02215252|365719338|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
106014360|NCT02215252|365719339|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
106014361|NCT02215252|365719340|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
106014362|NCT02215252|365719338|FG000|Overall Study|Protocol Violation|0|||
106014363|NCT02215252|365719339|FG001|Overall Study|Protocol Violation|1|||
106014364|NCT02215252|365719340|FG002|Overall Study|Protocol Violation|0|||
106014365|NCT02215252|365719338|FG000|Overall Study|Withdrawal by Subject|1|||
106014366|NCT02215252|365719339|FG001|Overall Study|Withdrawal by Subject|0|||
106014367|NCT02215252|365719340|FG002|Overall Study|Withdrawal by Subject|0|||
106014368|NCT02215252|365719338|FG000|Overall Study|Other|0|||
106014369|NCT02215252|365719339|FG001|Overall Study|Other|1|||
106014370|NCT02215252|365719340|FG002|Overall Study|Other|1|||
106014371|NCT02633306|365719341|FG000|Overall Study|Withdrawal by Subject|3|||
106014372|NCT03774576|365719342|FG000|Period 2|Adverse Event|1|||
106014373|NCT03809104|365719343|FG000|Overall Study|Withdrawal by Subject|3|||
106014374|NCT00790842|365719344|FG000|Dose Level 1|Adverse Event|1|||
106014375|NCT00790842|365719345|FG001|Dose Level 1|Adverse Event|0|||
106014376|NCT00790842|365719346|FG002|Dose Level 1|Adverse Event|0|||
106014377|NCT00790842|365719347|FG003|Dose Level 1|Adverse Event|2|||
106014378|NCT00790842|365719348|FG004|Dose Level 1|Adverse Event|0|||
106014379|NCT00790842|365719349|FG005|Dose Level 1|Adverse Event|0|||
106014380|NCT00790842|365719350|FG006|Dose Level 1|Adverse Event|0|||
106014381|NCT00790842|365719351|FG007|Dose Level 1|Adverse Event|1|||
106014382|NCT00790842|365719352|FG008|Dose Level 1|Adverse Event|0|||
106014383|NCT00790842|365719353|FG009|Dose Level 1|Adverse Event|0|||
106014384|NCT00790842|365719354|FG010|Dose Level 1|Adverse Event|0|||
106014385|NCT00790842|365719344|FG000|Dose Level 1|Physician Decision|1|||
106014386|NCT00790842|365719345|FG001|Dose Level 1|Physician Decision|0|||
106014387|NCT00790842|365719346|FG002|Dose Level 1|Physician Decision|0|||
106014388|NCT00790842|365719347|FG003|Dose Level 1|Physician Decision|0|||
106014389|NCT00790842|365719348|FG004|Dose Level 1|Physician Decision|0|||
106014390|NCT00790842|365719349|FG005|Dose Level 1|Physician Decision|0|||
106014391|NCT00790842|365719350|FG006|Dose Level 1|Physician Decision|0|||
106014392|NCT00790842|365719351|FG007|Dose Level 1|Physician Decision|1|||
106014393|NCT00790842|365719352|FG008|Dose Level 1|Physician Decision|0|||
106014394|NCT00790842|365719353|FG009|Dose Level 1|Physician Decision|0|||
106014395|NCT00790842|365719354|FG010|Dose Level 1|Physician Decision|0|||
106014396|NCT00790842|365719344|FG000|Dose Level 1|Withdrawal by Subject|1|||
106014397|NCT00790842|365719345|FG001|Dose Level 1|Withdrawal by Subject|0|||
106014398|NCT00790842|365719346|FG002|Dose Level 1|Withdrawal by Subject|0|||
106014399|NCT00790842|365719347|FG003|Dose Level 1|Withdrawal by Subject|0|||
106014400|NCT00790842|365719348|FG004|Dose Level 1|Withdrawal by Subject|0|||
106141944|NCT02739035|366177835|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
106141945|NCT02739035|366177836|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
106141946|NCT02739035|366177835|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
106014401|NCT00790842|365719349|FG005|Dose Level 1|Withdrawal by Subject|0|||
106014402|NCT00790842|365719350|FG006|Dose Level 1|Withdrawal by Subject|0|||
106014403|NCT00790842|365719351|FG007|Dose Level 1|Withdrawal by Subject|0|||
106014404|NCT00790842|365719352|FG008|Dose Level 1|Withdrawal by Subject|0|||
106014405|NCT00790842|365719353|FG009|Dose Level 1|Withdrawal by Subject|0|||
105740081|NCT03184701|364703495|FG000|Overall Study|Physician Decision|3|||
105740082|NCT03184701|364703495|FG000|Overall Study|Withdrawal by Subject|6|||
105740083|NCT03184701|364703495|FG000|Overall Study|Lost to Follow-up|5|||
105740084|NCT00590681|364703496|FG000|Overall Study|Withdrawal by Subject|7|||
105740085|NCT00590681|364703496|FG000|Overall Study|Adverse Event|8|||
105740086|NCT00590681|364703496|FG000|Overall Study|Death|3|||
105740087|NCT00590681|364703496|FG000|Overall Study|Lost to Follow-up|1|||
105740088|NCT00590681|364703496|FG000|Overall Study|disease progression|1|||
105740089|NCT02229864|364703505|FG000|Overall Study|Death|2|||
105740090|NCT02229864|364703505|FG000|Overall Study|Lost to Follow-up|1|||
105740091|NCT02084134|364703510|FG000|Overall Study|Protocol Violation|4|||
105740092|NCT02084134|364703511|FG001|Overall Study|Protocol Violation|2|||
105740093|NCT02084134|364703510|FG000|Overall Study|Death|0|||
105740094|NCT02084134|364703511|FG001|Overall Study|Death|1|||
105740095|NCT01165203|364703518|FG000|Active Phase|Serious Adverse Event|1|||
105941747|NCT00835367|365448888|FG001|Washout|Adverse Event|0|||
105941748|NCT00835367|365448887|FG000|Washout|Withdrawal by Subject|1|||
105941749|NCT00835367|365448888|FG001|Washout|Withdrawal by Subject|0|||
105941750|NCT00835367|365448887|FG000|Second Intervention|Adverse Event|1|||
105941751|NCT00835367|365448888|FG001|Second Intervention|Adverse Event|1|||
105941752|NCT03379870|365450229|FG000|Overall Study|Lost to Follow-up|1|||
105941753|NCT03379870|365450230|FG001|Overall Study|Lost to Follow-up|0|||
105941754|NCT03379870|365450229|FG000|Overall Study|Protocol Violation|1|||
105941755|NCT03379870|365450230|FG001|Overall Study|Protocol Violation|1|||
105941756|NCT03837509|365450231|FG000|Phase 1|Death|5|||
105941757|NCT03837509|365450232|FG001|Phase 1|Death|2|||
105941758|NCT03837509|365450233|FG002|Phase 1|Death|0|||
105941759|NCT03837509|365450234|FG003|Phase 1|Death|0|||
105941760|NCT03837509|365450235|FG004|Phase 1|Death|0|||
105941761|NCT03837509|365450231|FG000|Phase 2|Death|0|||
105941762|NCT03837509|365450232|FG001|Phase 2|Death|0|||
105941763|NCT03837509|365450233|FG002|Phase 2|Death|0|||
105941764|NCT03837509|365450234|FG003|Phase 2|Death|1|||
105941765|NCT03837509|365450235|FG004|Phase 2|Death|1|||
105941766|NCT04280783|365450236|FG000|Overall Study|Family issues unrelated to the study.|1|||
105941767|NCT04280783|365450237|FG001|Overall Study|Family issues unrelated to the study.|0|||
105941768|NCT04280783|365450236|FG000|Overall Study|Withdrawal by Subject|0|||
105941769|NCT04280783|365450237|FG001|Overall Study|Withdrawal by Subject|1|||
105941770|NCT04101331|365450238|FG000|Overall Study|Adverse Event|9|||
105941771|NCT04101331|365450238|FG000|Overall Study|Disease progression|82|||
105941772|NCT04101331|365450238|FG000|Overall Study|Withdrawal by Subject|1|||
105941773|NCT04101331|365450238|FG000|Overall Study|Investigator decision|6|||
105941774|NCT04101331|365450238|FG000|Overall Study|Death|6|||
105941775|NCT04101331|365450238|FG000|Overall Study|Allogenic transplant|1|||
105941776|NCT05543174|365450239|FG000|Overall Study|Ongoing|7|||
105941777|NCT03977155|365450240|FG000|Overall Study|Adverse Event|3|||
105941778|NCT03977155|365450241|FG001|Overall Study|Adverse Event|0|||
105941779|NCT03977155|365450242|FG002|Overall Study|Adverse Event|0|||
105941780|NCT03977155|365450240|FG000|Overall Study|Lost to Follow-up|0|||
105941781|NCT03977155|365450241|FG001|Overall Study|Lost to Follow-up|1|||
105941782|NCT03977155|365450242|FG002|Overall Study|Lost to Follow-up|0|||
105941783|NCT03977155|365450240|FG000|Overall Study|Withdrawal by Subject|1|||
105941784|NCT03977155|365450241|FG001|Overall Study|Withdrawal by Subject|1|||
105941785|NCT03977155|365450242|FG002|Overall Study|Withdrawal by Subject|2|||
105941786|NCT03977155|365450240|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
105941787|NCT03977155|365450241|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
105941788|NCT03977155|365450242|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
105941789|NCT01373281|365450243|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
105941790|NCT01373281|365450244|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
105941791|NCT01373281|365450243|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
105941792|NCT01373281|365450244|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
105941793|NCT01373281|365450243|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
105941794|NCT01373281|365450244|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
105941795|NCT01373281|365450243|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
105941796|NCT01373281|365450244|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
105941797|NCT01373281|365450243|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
105941798|NCT01373281|365450244|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
105941799|NCT01373281|365450243|FG000|Surveillance Expansion Period|Protocol Violation|9|||
105941800|NCT01373281|365450244|FG001|Surveillance Expansion Period|Protocol Violation|1|||
105941801|NCT01373281|365450243|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
105941802|NCT01373281|365450244|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
105941803|NCT01373281|365450243|FG000|Surveillance Expansion Period|Serious adverse event|3|||
105941804|NCT01373281|365450244|FG001|Surveillance Expansion Period|Serious adverse event|4|||
105941805|NCT04110145|365450245|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
105952175|NCT03314935|365488196|FG012|Phase 2|Progressive Disease|2|||
105740096|NCT01165203|364703519|FG001|Active Phase|Serious Adverse Event|0|||
105740097|NCT01165203|364703518|FG000|Active Phase|Withdrawal by Subject|2|||
106141947|NCT02739035|366177836|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
106141948|NCT03210402|366177837|FG000|Overall Study|Withdrawal by Subject|0|||
106141949|NCT03210402|366177838|FG001|Overall Study|Withdrawal by Subject|1|||
106141950|NCT03612804|366177853|FG000|Overall Study|Death|0|||
106141951|NCT03612804|366177854|FG001|Overall Study|Death|7|||
106141952|NCT03612804|366177855|FG002|Overall Study|Death|0|||
106141953|NCT03612804|366177856|FG003|Overall Study|Death|8|||
105740098|NCT01165203|364703519|FG001|Active Phase|Withdrawal by Subject|1|||
105740099|NCT01165203|364703518|FG000|Active Phase|Migrated/moved from study area|0|||
105740100|NCT01165203|364703519|FG001|Active Phase|Migrated/moved from study area|1|||
105740101|NCT01165203|364703518|FG000|Active Phase|Lost to Follow-up|2|||
105740102|NCT01165203|364703519|FG001|Active Phase|Lost to Follow-up|0|||
105740103|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
106141954|NCT03612804|366177853|FG000|Overall Study|Medication copay coverage issues|0|||
106141955|NCT03612804|366177854|FG001|Overall Study|Medication copay coverage issues|0|||
106141956|NCT03612804|366177855|FG002|Overall Study|Medication copay coverage issues|0|||
106141957|NCT03612804|366177856|FG003|Overall Study|Medication copay coverage issues|17|||
106141958|NCT03612804|366177853|FG000|Overall Study|Not current smoker at time of screening|0|||
106141959|NCT03612804|366177854|FG001|Overall Study|Not current smoker at time of screening|1|||
106141960|NCT03612804|366177855|FG002|Overall Study|Not current smoker at time of screening|0|||
106141961|NCT03612804|366177856|FG003|Overall Study|Not current smoker at time of screening|3|||
106141962|NCT03612804|366177853|FG000|Overall Study|Non-veteran status|0|||
106141963|NCT03612804|366177854|FG001|Overall Study|Non-veteran status|1|||
106141964|NCT03612804|366177855|FG002|Overall Study|Non-veteran status|0|||
106141965|NCT03612804|366177856|FG003|Overall Study|Non-veteran status|0|||
105740104|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
105740105|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
105740106|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
105740107|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
105740108|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
105740109|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
105740110|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
105740111|NCT01165203|364703518|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
105740112|NCT01165203|364703519|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
105941806|NCT04110145|365450246|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
105941807|NCT04110145|365450247|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
105941808|NCT04110145|365450248|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
105941809|NCT04110145|365450249|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
105941810|NCT00980044|365450250|FG000|Overall Study|Withdrawal by Subject|5|||
105941811|NCT00980044|365450251|FG001|Overall Study|Withdrawal by Subject|7|||
105941812|NCT00980044|365450252|FG002|Overall Study|Withdrawal by Subject|3|||
105941813|NCT00980044|365450250|FG000|Overall Study|Protocol Violation|0|||
105941814|NCT00980044|365450251|FG001|Overall Study|Protocol Violation|0|||
105941815|NCT00980044|365450252|FG002|Overall Study|Protocol Violation|2|||
105941816|NCT02254291|365450253|FG000|Overall Study|Withdrawal by Subject|0|||
105941817|NCT02254291|365450254|FG001|Overall Study|Withdrawal by Subject|3|||
105941818|NCT02254291|365450255|FG002|Overall Study|Withdrawal by Subject|1|||
105941819|NCT02254291|365450253|FG000|Overall Study|Missing follow-up information|0|||
105941820|NCT02254291|365450254|FG001|Overall Study|Missing follow-up information|0|||
105941821|NCT02254291|365450255|FG002|Overall Study|Missing follow-up information|1|||
105941822|NCT00500331|365450257|FG000|Overall Study|Adverse Event|0|||
105941823|NCT00500331|365450258|FG001|Overall Study|Adverse Event|2|||
105941824|NCT00500331|365450259|FG002|Overall Study|Adverse Event|0|||
105941825|NCT00500331|365450260|FG003|Overall Study|Adverse Event|1|||
105941826|NCT00500331|365450261|FG004|Overall Study|Adverse Event|2|||
105941827|NCT00500331|365450262|FG005|Overall Study|Adverse Event|2|||
105941828|NCT00500331|365450263|FG006|Overall Study|Adverse Event|0|||
106141966|NCT03612804|366177853|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
106141967|NCT03612804|366177854|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
106141968|NCT03612804|366177855|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
106141969|NCT03612804|366177856|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
106141970|NCT03612804|366177853|FG000|Overall Study|Provider retired from VA|0|||
106141971|NCT03612804|366177854|FG001|Overall Study|Provider retired from VA|0|||
106141972|NCT03612804|366177855|FG002|Overall Study|Provider retired from VA|2|||
105941829|NCT00500331|365450257|FG000|Overall Study|Lost to Follow-up|1|||
105941830|NCT00500331|365450258|FG001|Overall Study|Lost to Follow-up|1|||
105941831|NCT00500331|365450259|FG002|Overall Study|Lost to Follow-up|1|||
105941832|NCT00500331|365450260|FG003|Overall Study|Lost to Follow-up|2|||
105740113|NCT01963117|364703531|FG000|Overall Study|Death|1|||
105941833|NCT00500331|365450261|FG004|Overall Study|Lost to Follow-up|1|||
105740114|NCT01070784|364703533|FG000|Overall Study|Withdrawal by Subject|6|||
105941834|NCT00500331|365450262|FG005|Overall Study|Lost to Follow-up|0|||
105941835|NCT00500331|365450263|FG006|Overall Study|Lost to Follow-up|0|||
105941836|NCT00500331|365450257|FG000|Overall Study|Protocol Violation|3|||
105941837|NCT00500331|365450258|FG001|Overall Study|Protocol Violation|1|||
105941838|NCT00500331|365450259|FG002|Overall Study|Protocol Violation|1|||
105941839|NCT00500331|365450260|FG003|Overall Study|Protocol Violation|0|||
105941840|NCT00500331|365450261|FG004|Overall Study|Protocol Violation|1|||
105941841|NCT00500331|365450262|FG005|Overall Study|Protocol Violation|1|||
105941842|NCT00500331|365450263|FG006|Overall Study|Protocol Violation|1|||
105941843|NCT00500331|365450257|FG000|Overall Study|Withdrawal by Subject|4|||
105941844|NCT00500331|365450258|FG001|Overall Study|Withdrawal by Subject|0|||
105941845|NCT00500331|365450259|FG002|Overall Study|Withdrawal by Subject|1|||
105941846|NCT00500331|365450260|FG003|Overall Study|Withdrawal by Subject|5|||
105941847|NCT00500331|365450261|FG004|Overall Study|Withdrawal by Subject|0|||
105941848|NCT00500331|365450262|FG005|Overall Study|Withdrawal by Subject|1|||
105941849|NCT00500331|365450263|FG006|Overall Study|Withdrawal by Subject|1|||
105941850|NCT00500331|365450257|FG000|Overall Study|Lack of Efficacy|3|||
105941851|NCT00500331|365450258|FG001|Overall Study|Lack of Efficacy|1|||
105941852|NCT00500331|365450259|FG002|Overall Study|Lack of Efficacy|0|||
105941853|NCT00500331|365450260|FG003|Overall Study|Lack of Efficacy|0|||
105941854|NCT00500331|365450261|FG004|Overall Study|Lack of Efficacy|0|||
105941855|NCT00500331|365450262|FG005|Overall Study|Lack of Efficacy|0|||
105941856|NCT00500331|365450263|FG006|Overall Study|Lack of Efficacy|0|||
105941857|NCT00500331|365450257|FG000|Overall Study|Liver function test abnormality|0|||
105941858|NCT00500331|365450258|FG001|Overall Study|Liver function test abnormality|0|||
105941859|NCT00500331|365450259|FG002|Overall Study|Liver function test abnormality|1|||
105941860|NCT00500331|365450260|FG003|Overall Study|Liver function test abnormality|0|||
105941861|NCT00500331|365450261|FG004|Overall Study|Liver function test abnormality|0|||
105941862|NCT00500331|365450262|FG005|Overall Study|Liver function test abnormality|0|||
105941863|NCT00500331|365450263|FG006|Overall Study|Liver function test abnormality|0|||
105941864|NCT00500331|365450257|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
105941865|NCT00500331|365450258|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
105941866|NCT00500331|365450259|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
105941867|NCT00500331|365450260|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
105941868|NCT00500331|365450261|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
105941869|NCT00500331|365450262|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
105941870|NCT00500331|365450263|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
105941871|NCT00500331|365450257|FG000|Overall Study|Didn't return for continuation of study|1|||
105941872|NCT00500331|365450258|FG001|Overall Study|Didn't return for continuation of study|0|||
105941873|NCT00500331|365450259|FG002|Overall Study|Didn't return for continuation of study|0|||
105941874|NCT00500331|365450260|FG003|Overall Study|Didn't return for continuation of study|0|||
105941875|NCT00500331|365450261|FG004|Overall Study|Didn't return for continuation of study|0|||
105941876|NCT00500331|365450262|FG005|Overall Study|Didn't return for continuation of study|0|||
105941877|NCT00500331|365450263|FG006|Overall Study|Didn't return for continuation of study|0|||
105941878|NCT00500331|365450257|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
105941879|NCT00500331|365450258|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
105941880|NCT00500331|365450259|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
105941881|NCT00500331|365450260|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
105941882|NCT00500331|365450261|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
105941883|NCT00500331|365450262|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
105941884|NCT00500331|365450263|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
105941885|NCT00500331|365450257|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
105941886|NCT00500331|365450258|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
105941887|NCT00500331|365450259|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
105941888|NCT00500331|365450260|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
105941889|NCT00500331|365450261|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
105941890|NCT00500331|365450262|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
105941891|NCT00500331|365450263|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
105941892|NCT00500331|365450257|FG000|Overall Study|Participant was randomized by mistake|1|||
105941893|NCT00500331|365450258|FG001|Overall Study|Participant was randomized by mistake|0|||
105941894|NCT00500331|365450259|FG002|Overall Study|Participant was randomized by mistake|0|||
105941895|NCT00500331|365450260|FG003|Overall Study|Participant was randomized by mistake|0|||
105941896|NCT00500331|365450261|FG004|Overall Study|Participant was randomized by mistake|0|||
105941897|NCT00500331|365450262|FG005|Overall Study|Participant was randomized by mistake|0|||
105941898|NCT00500331|365450263|FG006|Overall Study|Participant was randomized by mistake|0|||
105941899|NCT00500331|365450257|FG000|Overall Study|Diabetologist nurse in the study|0|||
105941900|NCT00500331|365450258|FG001|Overall Study|Diabetologist nurse in the study|0|||
105941901|NCT00500331|365450259|FG002|Overall Study|Diabetologist nurse in the study|1|||
105941902|NCT00500331|365450260|FG003|Overall Study|Diabetologist nurse in the study|0|||
105941903|NCT00500331|365450261|FG004|Overall Study|Diabetologist nurse in the study|0|||
105941904|NCT00500331|365450262|FG005|Overall Study|Diabetologist nurse in the study|0|||
105941905|NCT00500331|365450263|FG006|Overall Study|Diabetologist nurse in the study|0|||
105740115|NCT01070784|364703534|FG001|Overall Study|Withdrawal by Subject|9|||
105740116|NCT01070784|364703533|FG000|Overall Study|Adverse Event|14|||
105740117|NCT01070784|364703534|FG001|Overall Study|Adverse Event|9|||
105740118|NCT00798967|364703535|FG000|Overall Study|Adverse Event|2|||
105740119|NCT00798967|364703536|FG001|Overall Study|Adverse Event|3|||
105740120|NCT00798967|364703535|FG000|Overall Study|Withdrawal by Subject|0|||
105740121|NCT00798967|364703536|FG001|Overall Study|Withdrawal by Subject|1|||
105740122|NCT00798967|364703535|FG000|Overall Study|Physician Decision|1|||
105740123|NCT00798967|364703536|FG001|Overall Study|Physician Decision|0|||
105740124|NCT00798967|364703535|FG000|Overall Study|Randomized in error by site|1|||
105740125|NCT00798967|364703536|FG001|Overall Study|Randomized in error by site|0|||
105740126|NCT01605396|364703537|FG000|Overall Study|Adverse Event|5|||
105740127|NCT01605396|364703538|FG001|Overall Study|Adverse Event|3|||
105740128|NCT01605396|364703537|FG000|Overall Study|Lost to Follow-up|1|||
105740129|NCT01605396|364703538|FG001|Overall Study|Lost to Follow-up|0|||
105740130|NCT01605396|364703537|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105740131|NCT01605396|364703538|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105740132|NCT01605396|364703537|FG000|Overall Study|Physician Decision|2|||
105740133|NCT01605396|364703538|FG001|Overall Study|Physician Decision|2|||
105740134|NCT01605396|364703537|FG000|Overall Study|Progressive Disease|23|||
105740135|NCT01605396|364703538|FG001|Overall Study|Progressive Disease|27|||
105740136|NCT01605396|364703537|FG000|Overall Study|Withdrawal by Subject|4|||
105740137|NCT01605396|364703538|FG001|Overall Study|Withdrawal by Subject|2|||
105740138|NCT01605396|364703537|FG000|Overall Study|Transfer Off Study|4|||
105740139|NCT01605396|364703538|FG001|Overall Study|Transfer Off Study|5|||
105740140|NCT01323673|364703539|FG000|Overall Study|Adverse Event|0|||
105740141|NCT01323673|364703540|FG001|Overall Study|Adverse Event|1|||
105740142|NCT01323673|364703539|FG000|Overall Study|Lost to Follow-up|0|||
105740143|NCT01323673|364703540|FG001|Overall Study|Lost to Follow-up|1|||
105740144|NCT01323673|364703539|FG000|Overall Study|Protocol Violation|1|||
105740145|NCT01323673|364703540|FG001|Overall Study|Protocol Violation|0|||
105740146|NCT01323673|364703539|FG000|Overall Study|Withdrawal by Subject|2|||
105740147|NCT01323673|364703540|FG001|Overall Study|Withdrawal by Subject|3|||
105740148|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
105740149|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
105740150|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Death|2|||
105941906|NCT00500331|365450257|FG000|Overall Study|State ban of biological samples export|0|||
105941907|NCT00500331|365450258|FG001|Overall Study|State ban of biological samples export|0|||
105941908|NCT00500331|365450259|FG002|Overall Study|State ban of biological samples export|0|||
105941909|NCT00500331|365450260|FG003|Overall Study|State ban of biological samples export|1|||
105941910|NCT00500331|365450261|FG004|Overall Study|State ban of biological samples export|0|||
105941911|NCT00500331|365450262|FG005|Overall Study|State ban of biological samples export|0|||
105941912|NCT00500331|365450263|FG006|Overall Study|State ban of biological samples export|0|||
105941913|NCT00500331|365450257|FG000|Overall Study|Protocol violated|0|||
105941914|NCT00500331|365450258|FG001|Overall Study|Protocol violated|0|||
105941915|NCT00500331|365450259|FG002|Overall Study|Protocol violated|0|||
105941916|NCT00500331|365450260|FG003|Overall Study|Protocol violated|1|||
105941917|NCT00500331|365450261|FG004|Overall Study|Protocol violated|0|||
105941918|NCT00500331|365450262|FG005|Overall Study|Protocol violated|0|||
105941919|NCT00500331|365450263|FG006|Overall Study|Protocol violated|0|||
105941920|NCT03436732|365450264|FG000|Overall Study|Not treated-enrolled in different study|1|||
105941921|NCT03436732|365450265|FG001|Overall Study|Not treated-enrolled in different study|0|||
105941922|NCT03436732|365450264|FG000|Overall Study|Off study after cycle 1|1|||
105941923|NCT03436732|365450265|FG001|Overall Study|Off study after cycle 1|0|||
105941924|NCT03436732|365450264|FG000|Overall Study|Adverse Event|2|||
105941925|NCT03436732|365450265|FG001|Overall Study|Adverse Event|0|||
105941926|NCT03436732|365450264|FG000|Overall Study|Death|0|||
105941927|NCT03436732|365450265|FG001|Overall Study|Death|1|||
105941928|NCT00939185|365450266|FG000|Overall Study|Adverse Event|3|||
105941929|NCT00939185|365450266|FG000|Overall Study|Lack of Efficacy|1|||
105941930|NCT00939185|365450266|FG000|Overall Study|Lost to Follow-up|6|||
105941931|NCT00939185|365450266|FG000|Overall Study|Other|3|||
105941932|NCT00939185|365450266|FG000|Overall Study|Withdrawal by Subject|2|||
105941933|NCT00939185|365450266|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
105941934|NCT00833703|365450267|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
105941935|NCT00833703|365450268|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
105941936|NCT05538728|365450269|FG000|Overall Study|Withdrawal by Subject|1|||
105941937|NCT05538728|365450270|FG001|Overall Study|Withdrawal by Subject|1|||
105941938|NCT03033784|365450271|FG000|Overall Study|Anxiety related to MRI scanner|0|||
105941939|NCT03033784|365450272|FG001|Overall Study|Anxiety related to MRI scanner|1|||
105941940|NCT03033784|365450273|FG002|Overall Study|Anxiety related to MRI scanner|0|||
105941941|NCT03033784|365450274|FG003|Overall Study|Anxiety related to MRI scanner|0|||
105941942|NCT03033784|365450275|FG004|Overall Study|Anxiety related to MRI scanner|0|||
105941943|NCT03033784|365450276|FG005|Overall Study|Anxiety related to MRI scanner|0|||
105941944|NCT03033784|365450277|FG006|Overall Study|Anxiety related to MRI scanner|0|||
105941945|NCT03033784|365450278|FG007|Overall Study|Anxiety related to MRI scanner|0|||
106141973|NCT03612804|366177856|FG003|Overall Study|Provider retired from VA|0|||
105740151|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Death|1|||
105740152|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
105740153|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
105740154|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Ineligible|4|||
105740155|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Ineligible|3|||
105740156|NCT04598165|364703541|FG000|Completed 6-week Follow-up|Partner refusal|0|||
105740157|NCT04598165|364703542|FG001|Completed 6-week Follow-up|Partner refusal|1|||
105740158|NCT04598165|364703541|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
105740159|NCT04598165|364703542|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
105740160|NCT00783705|364703543|FG000|Overall Study|Adverse Event|2|||
105740161|NCT00783705|364703544|FG001|Overall Study|Adverse Event|0|||
105740162|NCT00783705|364703543|FG000|Overall Study|Withdrawal by Subject|3|||
105740163|NCT00783705|364703544|FG001|Overall Study|Withdrawal by Subject|2|||
105740164|NCT00783705|364703543|FG000|Overall Study|Lost to Follow-up|1|||
105740165|NCT00783705|364703544|FG001|Overall Study|Lost to Follow-up|3|||
105740166|NCT00633139|364703548|FG000|Overall Study|Non compliance|0|||
105740167|NCT00633139|364703549|FG001|Overall Study|Non compliance|0|||
105740168|NCT00633139|364703550|FG002|Overall Study|Non compliance|1|||
105740169|NCT00633139|364703548|FG000|Overall Study|Withdrawal by Subject|0|||
105740170|NCT00633139|364703549|FG001|Overall Study|Withdrawal by Subject|1|||
105740171|NCT00633139|364703550|FG002|Overall Study|Withdrawal by Subject|0|||
105740172|NCT02160977|364703551|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
105740173|NCT02160977|364703552|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
105740174|NCT02160977|364703551|FG000|Three Months After Surgery|Lost to Follow-up|0|||
105740175|NCT02160977|364703552|FG001|Three Months After Surgery|Lost to Follow-up|2|||
105740176|NCT02160977|364703551|FG000|Six Months After Surgery|Lost to Follow-up|2|||
105740177|NCT02160977|364703552|FG001|Six Months After Surgery|Lost to Follow-up|1|||
105740178|NCT04238663|364703555|FG000|Overall Study|Lost to Follow-up|0|||
105740179|NCT04238663|364703556|FG001|Overall Study|Lost to Follow-up|1|||
105740180|NCT04238663|364703557|FG002|Overall Study|Lost to Follow-up|0|||
105941946|NCT03033784|365450279|FG008|Overall Study|Anxiety related to MRI scanner|0|||
105941947|NCT03033784|365450280|FG009|Overall Study|Anxiety related to MRI scanner|0|||
105941948|NCT03033784|365450281|FG010|Overall Study|Anxiety related to MRI scanner|0|||
105941949|NCT03033784|365450282|FG011|Overall Study|Anxiety related to MRI scanner|0|||
105941950|NCT03033784|365450283|FG012|Overall Study|Anxiety related to MRI scanner|0|||
105941951|NCT03033784|365450271|FG000|Overall Study|Withdrawal by Subject|0|||
105941952|NCT03033784|365450272|FG001|Overall Study|Withdrawal by Subject|0|||
105941953|NCT03033784|365450273|FG002|Overall Study|Withdrawal by Subject|0|||
105941954|NCT03033784|365450274|FG003|Overall Study|Withdrawal by Subject|0|||
105941955|NCT03033784|365450275|FG004|Overall Study|Withdrawal by Subject|0|||
105941956|NCT03033784|365450276|FG005|Overall Study|Withdrawal by Subject|0|||
105941957|NCT03033784|365450277|FG006|Overall Study|Withdrawal by Subject|0|||
105941958|NCT03033784|365450278|FG007|Overall Study|Withdrawal by Subject|0|||
105941959|NCT03033784|365450279|FG008|Overall Study|Withdrawal by Subject|0|||
105941960|NCT03033784|365450280|FG009|Overall Study|Withdrawal by Subject|0|||
105941961|NCT03033784|365450281|FG010|Overall Study|Withdrawal by Subject|0|||
105941962|NCT03033784|365450282|FG011|Overall Study|Withdrawal by Subject|0|||
105941963|NCT03033784|365450283|FG012|Overall Study|Withdrawal by Subject|2|||
105941964|NCT00267488|365450284|FG000|Overall Study|Sponsor Terminated Study|9|||
105941965|NCT00267488|365450284|FG000|Overall Study|Protocol Violation|1|||
105941966|NCT00267488|365450284|FG000|Overall Study|Other (Disease Progression)|1|||
105941967|NCT00505687|365450285|FG000|Overall Study|Important protocol violation|2|||
105941968|NCT00505687|365450285|FG000|Overall Study|Lack of Efficacy|15|||
105941969|NCT00505687|365450285|FG000|Overall Study|Adverse Event|48|||
105941970|NCT00505687|365450285|FG000|Overall Study|Subject withdrew consent|15|||
105941971|NCT00505687|365450285|FG000|Overall Study|Lost to Follow-up|1|||
105941972|NCT00505687|365450285|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
105941973|NCT00505687|365450285|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
105941974|NCT00505687|365450285|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
105941975|NCT00505687|365450285|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
105941976|NCT00505687|365450285|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
105941977|NCT00505687|365450285|FG000|Overall Study|Other: Disease Progression|1|||
106141974|NCT03612804|366177853|FG000|Overall Study|Withdrawal by Subject|0|||
105740181|NCT02566525|364703558|FG000|Overall Study|Protocol Violation|3|||
105740182|NCT02566525|364703559|FG001|Overall Study|Protocol Violation|5|||
105740183|NCT00337467|364703562|FG000|Overall Study|Adverse Event|3|||
105740184|NCT00337467|364703562|FG000|Overall Study|Subject Withdrew Consent|2|||
105740185|NCT00337467|364703562|FG000|Overall Study|Pregnancy|1|||
105740186|NCT00337467|364703562|FG000|Overall Study|Lost to Follow-up|2|||
105941978|NCT00505687|365450285|FG000|Overall Study|Other: As Per Sponsor|8|||
105941979|NCT00567502|365450286|FG000|Overall Study|Lost to Follow-up|91|||
105941980|NCT00567502|365450287|FG001|Overall Study|Lost to Follow-up|14|||
105941981|NCT00567502|365450288|FG002|Overall Study|Lost to Follow-up|351|||
105941982|NCT00567502|365450289|FG003|Overall Study|Lost to Follow-up|2|||
106014406|NCT00790842|365719354|FG010|Dose Level 1|Withdrawal by Subject|0|||
106014407|NCT00790842|365719344|FG000|Dose Level 2|Death|0|||
106014408|NCT00790842|365719345|FG001|Dose Level 2|Death|1|||
106014409|NCT00790842|365719346|FG002|Dose Level 2|Death|0|||
106014410|NCT00790842|365719347|FG003|Dose Level 2|Death|0|||
106014411|NCT00790842|365719348|FG004|Dose Level 2|Death|1|||
106014412|NCT00790842|365719349|FG005|Dose Level 2|Death|0|||
106014413|NCT00790842|365719350|FG006|Dose Level 2|Death|0|||
106141975|NCT03612804|366177854|FG001|Overall Study|Withdrawal by Subject|0|||
106141976|NCT03612804|366177855|FG002|Overall Study|Withdrawal by Subject|7|||
106014414|NCT00790842|365719351|FG007|Dose Level 2|Death|0|||
106014415|NCT00790842|365719352|FG008|Dose Level 2|Death|0|||
106141977|NCT03612804|366177856|FG003|Overall Study|Withdrawal by Subject|0|||
106014416|NCT00790842|365719353|FG009|Dose Level 2|Death|0|||
106141978|NCT03612804|366177853|FG000|Overall Study|Provider involved with study activities|1|||
106141979|NCT03612804|366177854|FG001|Overall Study|Provider involved with study activities|0|||
106141980|NCT03612804|366177855|FG002|Overall Study|Provider involved with study activities|0|||
106141981|NCT03612804|366177856|FG003|Overall Study|Provider involved with study activities|0|||
106141982|NCT00256243|366177857|FG000|Overall Study|Lost to Follow-up|2|||
106141983|NCT00256243|366177857|FG000|Overall Study|Death|7|||
106141984|NCT00256243|366177857|FG000|Overall Study|Not treated|1|||
106141985|NCT02248480|366177861|FG000|Overall Study|Lack of Efficacy|4|||
106141986|NCT02248480|366177862|FG001|Overall Study|Lack of Efficacy|6|||
106014417|NCT00790842|365719354|FG010|Dose Level 2|Death|0|||
106014418|NCT00790842|365719344|FG000|Dose Level 2|Physician Decision|0|||
106141987|NCT02248480|366177861|FG000|Overall Study|Adverse Event|11|||
106141988|NCT02248480|366177862|FG001|Overall Study|Adverse Event|2|||
105740187|NCT00337467|364703562|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
105740188|NCT01663740|364703564|FG000|Overall Study|Lost to Follow-up|1|||
105740189|NCT01663740|364703565|FG001|Overall Study|Lost to Follow-up|4|||
105740190|NCT01663740|364703564|FG000|Overall Study|Other|9|||
105740191|NCT01663740|364703565|FG001|Overall Study|Other|2|||
105740192|NCT01663740|364703564|FG000|Overall Study|Inclusion/Exclusion not met|1|||
105740193|NCT01663740|364703565|FG001|Overall Study|Inclusion/Exclusion not met|0|||
105740194|NCT01663740|364703564|FG000|Overall Study|Death|0|||
105740195|NCT01663740|364703565|FG001|Overall Study|Death|1|||
105740196|NCT01663740|364703564|FG000|Overall Study|Withdrawal by Subject|2|||
105740197|NCT01663740|364703565|FG001|Overall Study|Withdrawal by Subject|1|||
105740198|NCT01663740|364703564|FG000|Overall Study|No end of study status|3|||
105740199|NCT01663740|364703565|FG001|Overall Study|No end of study status|0|||
105740200|NCT02429427|364703566|FG000|Overall Study|Adverse Event|220|||
105740201|NCT02429427|364703567|FG001|Overall Study|Adverse Event|92|||
105740202|NCT02429427|364703566|FG000|Overall Study|Protocol Violation|10|||
105740203|NCT02429427|364703567|FG001|Overall Study|Protocol Violation|6|||
105740204|NCT02429427|364703566|FG000|Overall Study|Lost to Follow-up|15|||
105740205|NCT02429427|364703567|FG001|Overall Study|Lost to Follow-up|6|||
105740206|NCT02429427|364703566|FG000|Overall Study|Withdrawal by Subject|64|||
105740207|NCT02429427|364703567|FG001|Overall Study|Withdrawal by Subject|34|||
105740208|NCT02429427|364703566|FG000|Overall Study|Other|62|||
105740209|NCT02429427|364703567|FG001|Overall Study|Other|41|||
105740210|NCT02125331|364704995|FG000|Overall Study|Protocol Violation|1|||
105740211|NCT02125331|364704996|FG001|Overall Study|Protocol Violation|0|||
105740212|NCT02125331|364704995|FG000|Overall Study|technical problem|2|||
105740213|NCT02125331|364704996|FG001|Overall Study|technical problem|0|||
105740214|NCT02125331|364704995|FG000|Overall Study|screen failure|2|||
105740215|NCT02125331|364704996|FG001|Overall Study|screen failure|0|||
105740216|NCT00165646|364704997|FG000|Overall Study|Adverse Event|1|||
105740217|NCT00165646|364704998|FG001|Overall Study|Adverse Event|1|||
105740218|NCT00165646|364704999|FG002|Overall Study|Adverse Event|1|||
106014419|NCT00790842|365719345|FG001|Dose Level 2|Physician Decision|1|||
106141989|NCT02248480|366177861|FG000|Overall Study|Withdrawal by Subject|2|||
106141990|NCT02248480|366177862|FG001|Overall Study|Withdrawal by Subject|4|||
106141991|NCT02248480|366177861|FG000|Overall Study|Entry Criteria Not Met|0|||
106141992|NCT02248480|366177862|FG001|Overall Study|Entry Criteria Not Met|1|||
106141993|NCT02248480|366177861|FG000|Overall Study|Other:Physician Decision|0|||
106141994|NCT02248480|366177862|FG001|Overall Study|Other:Physician Decision|1|||
106141995|NCT02685488|366177863|FG000|Overall Study|Withdrawal by Subject|0|||
106141996|NCT02685488|366177864|FG001|Overall Study|Withdrawal by Subject|1|||
105740219|NCT00165646|364704997|FG000|Overall Study|Lack of Efficacy|1|||
105740220|NCT00165646|364704998|FG001|Overall Study|Lack of Efficacy|2|||
105740221|NCT00165646|364704999|FG002|Overall Study|Lack of Efficacy|0|||
105740222|NCT00165646|364704997|FG000|Overall Study|Withdrawal by Subject|0|||
105740223|NCT00165646|364704998|FG001|Overall Study|Withdrawal by Subject|2|||
105740224|NCT00165646|364704999|FG002|Overall Study|Withdrawal by Subject|1|||
106141997|NCT02466516|366179793|FG000|Overall Study|Adverse Event|1|||
105740225|NCT00165646|364704997|FG000|Overall Study|Physician Decision|2|||
105740226|NCT00165646|364704998|FG001|Overall Study|Physician Decision|0|||
106014420|NCT00790842|365719346|FG002|Dose Level 2|Physician Decision|0|||
106014421|NCT00790842|365719347|FG003|Dose Level 2|Physician Decision|0|||
106141998|NCT02466516|366179794|FG001|Overall Study|Adverse Event|1|||
106014422|NCT00790842|365719348|FG004|Dose Level 2|Physician Decision|0|||
106014423|NCT00790842|365719349|FG005|Dose Level 2|Physician Decision|0|||
106014424|NCT00790842|365719350|FG006|Dose Level 2|Physician Decision|0|||
106014425|NCT00790842|365719351|FG007|Dose Level 2|Physician Decision|0|||
106014426|NCT00790842|365719352|FG008|Dose Level 2|Physician Decision|0|||
106014427|NCT00790842|365719353|FG009|Dose Level 2|Physician Decision|0|||
106014428|NCT00790842|365719354|FG010|Dose Level 2|Physician Decision|0|||
106014429|NCT00790842|365719344|FG000|Dose Level 2|Withdrawal by Subject|0|||
106014430|NCT00790842|365719345|FG001|Dose Level 2|Withdrawal by Subject|1|||
106014431|NCT00790842|365719346|FG002|Dose Level 2|Withdrawal by Subject|0|||
106014432|NCT00790842|365719347|FG003|Dose Level 2|Withdrawal by Subject|0|||
106014433|NCT00790842|365719348|FG004|Dose Level 2|Withdrawal by Subject|0|||
106014434|NCT00790842|365719349|FG005|Dose Level 2|Withdrawal by Subject|0|||
106014435|NCT00790842|365719350|FG006|Dose Level 2|Withdrawal by Subject|0|||
106014436|NCT00790842|365719351|FG007|Dose Level 2|Withdrawal by Subject|0|||
106014437|NCT00790842|365719352|FG008|Dose Level 2|Withdrawal by Subject|0|||
106014438|NCT00790842|365719353|FG009|Dose Level 2|Withdrawal by Subject|0|||
106014439|NCT00790842|365719354|FG010|Dose Level 2|Withdrawal by Subject|0|||
106014440|NCT00790842|365719344|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014441|NCT00790842|365719345|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014442|NCT00790842|365719346|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014443|NCT00790842|365719347|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014444|NCT00790842|365719348|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014445|NCT00790842|365719349|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014446|NCT00790842|365719350|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014447|NCT00790842|365719351|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014448|NCT00790842|365719352|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
106014449|NCT00790842|365719353|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014450|NCT00790842|365719354|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
106014451|NCT00790842|365719344|FG000|Dose Level 3|Adverse Event|0|||
106014452|NCT00790842|365719345|FG001|Dose Level 3|Adverse Event|0|||
106014453|NCT00790842|365719346|FG002|Dose Level 3|Adverse Event|1|||
106014454|NCT00790842|365719347|FG003|Dose Level 3|Adverse Event|0|||
106014455|NCT00790842|365719348|FG004|Dose Level 3|Adverse Event|0|||
106014456|NCT00790842|365719349|FG005|Dose Level 3|Adverse Event|0|||
106014457|NCT00790842|365719350|FG006|Dose Level 3|Adverse Event|0|||
106014458|NCT00790842|365719351|FG007|Dose Level 3|Adverse Event|0|||
106014459|NCT00790842|365719352|FG008|Dose Level 3|Adverse Event|0|||
106014460|NCT00790842|365719353|FG009|Dose Level 3|Adverse Event|0|||
106141999|NCT02466516|366179795|FG002|Overall Study|Adverse Event|0|||
105740227|NCT00165646|364704999|FG002|Overall Study|Physician Decision|2|||
105740228|NCT00165646|364704997|FG000|Overall Study|Protocol Violation|1|||
105740229|NCT00165646|364704998|FG001|Overall Study|Protocol Violation|0|||
105740230|NCT00165646|364704999|FG002|Overall Study|Protocol Violation|0|||
105740231|NCT02090114|364705000|FG000|Overall Study|Withdrawal by Subject|3|||
105740232|NCT02090114|364705001|FG001|Overall Study|Withdrawal by Subject|6|||
105740233|NCT02090114|364705002|FG002|Overall Study|Withdrawal by Subject|2|||
105740234|NCT02090114|364705003|FG003|Overall Study|Withdrawal by Subject|1|||
105740235|NCT02090114|364705000|FG000|Overall Study|Physician Decision|5|||
105740236|NCT02090114|364705001|FG001|Overall Study|Physician Decision|0|||
105740237|NCT02090114|364705002|FG002|Overall Study|Physician Decision|1|||
105740238|NCT02090114|364705003|FG003|Overall Study|Physician Decision|1|||
105740239|NCT02090114|364705000|FG000|Overall Study|Adverse Event|1|||
105740240|NCT02090114|364705001|FG001|Overall Study|Adverse Event|2|||
105740241|NCT02090114|364705002|FG002|Overall Study|Adverse Event|2|||
105740242|NCT02090114|364705003|FG003|Overall Study|Adverse Event|0|||
105740243|NCT02090114|364705000|FG000|Overall Study|Progressive Disease|20|||
105740244|NCT02090114|364705001|FG001|Overall Study|Progressive Disease|21|||
105740245|NCT02090114|364705002|FG002|Overall Study|Progressive Disease|23|||
105740246|NCT02090114|364705003|FG003|Overall Study|Progressive Disease|6|||
106014461|NCT00790842|365719354|FG010|Dose Level 3|Adverse Event|0|||
106014462|NCT00790842|365719344|FG000|Dose Level 3|Withdrawal by Subject|0|||
106142000|NCT02466516|366179796|FG003|Overall Study|Adverse Event|0|||
106142001|NCT02466516|366179797|FG004|Overall Study|Adverse Event|0|||
106142002|NCT02466516|366179793|FG000|Overall Study|Withdrew Consent|1|||
105740247|NCT02090114|364705000|FG000|Overall Study|Death|1|||
105740248|NCT02090114|364705001|FG001|Overall Study|Death|0|||
105740249|NCT02090114|364705002|FG002|Overall Study|Death|1|||
105740250|NCT02090114|364705003|FG003|Overall Study|Death|0|||
106014463|NCT00790842|365719345|FG001|Dose Level 3|Withdrawal by Subject|0|||
106014464|NCT00790842|365719346|FG002|Dose Level 3|Withdrawal by Subject|3|||
105740251|NCT00500149|364705004|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
106014465|NCT00790842|365719347|FG003|Dose Level 3|Withdrawal by Subject|0|||
105740252|NCT00500149|364705005|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
105740253|NCT00500149|364705004|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
106014466|NCT00790842|365719348|FG004|Dose Level 3|Withdrawal by Subject|0|||
106014467|NCT00790842|365719349|FG005|Dose Level 3|Withdrawal by Subject|0|||
105740254|NCT00500149|364705005|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
105740255|NCT00500149|364705004|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
105740256|NCT00500149|364705005|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
105740257|NCT00500149|364705004|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
105740258|NCT00500149|364705005|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
106014468|NCT00790842|365719350|FG006|Dose Level 3|Withdrawal by Subject|0|||
106014469|NCT00790842|365719351|FG007|Dose Level 3|Withdrawal by Subject|0|||
106014470|NCT00790842|365719352|FG008|Dose Level 3|Withdrawal by Subject|0|||
106014471|NCT00790842|365719353|FG009|Dose Level 3|Withdrawal by Subject|2|||
106014472|NCT00790842|365719354|FG010|Dose Level 3|Withdrawal by Subject|0|||
106014473|NCT00790842|365719344|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106014474|NCT00790842|365719345|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106014475|NCT00790842|365719346|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106014476|NCT00790842|365719347|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106014477|NCT00790842|365719348|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
105740259|NCT00500149|364705004|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
105740260|NCT00500149|364705005|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
106014478|NCT00790842|365719349|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
105740261|NCT00500149|364705004|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
105740262|NCT00500149|364705005|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
105740263|NCT00500149|364705004|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
105740264|NCT00500149|364705005|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
105740265|NCT01158534|364705006|FG000|Overall Study|Withdrawal by Subject|1|||
105740266|NCT01158534|364705006|FG000|Overall Study|Death|1|||
105740267|NCT01158534|364705006|FG000|Overall Study|Other|1|||
105740268|NCT00521339|364705007|FG000|Treatment Phase|Adverse Event|2|||
105740269|NCT00521339|364705008|FG001|Treatment Phase|Adverse Event|0|||
105740270|NCT00521339|364705009|FG002|Treatment Phase|Adverse Event|0|||
105740271|NCT00521339|364705007|FG000|Treatment Phase|Intolerability to study drug|2|||
105740272|NCT00521339|364705008|FG001|Treatment Phase|Intolerability to study drug|0|||
105740273|NCT00521339|364705009|FG002|Treatment Phase|Intolerability to study drug|0|||
105740274|NCT00521339|364705007|FG000|Treatment Phase|Lack of Efficacy|3|||
105740275|NCT00521339|364705008|FG001|Treatment Phase|Lack of Efficacy|0|||
105740276|NCT00521339|364705009|FG002|Treatment Phase|Lack of Efficacy|0|||
105740277|NCT00521339|364705007|FG000|Treatment Phase|Withdrawal by Subject|3|||
105740278|NCT00521339|364705008|FG001|Treatment Phase|Withdrawal by Subject|0|||
105740279|NCT00521339|364705009|FG002|Treatment Phase|Withdrawal by Subject|0|||
105740280|NCT00521339|364705007|FG000|Treatment Phase|Lost to Follow-up|1|||
106014479|NCT00790842|365719350|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106014480|NCT00790842|365719351|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106014481|NCT00790842|365719352|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106014482|NCT00790842|365719353|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106014483|NCT00790842|365719354|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
106142003|NCT02466516|366179794|FG001|Overall Study|Withdrew Consent|0|||
106142004|NCT02466516|366179795|FG002|Overall Study|Withdrew Consent|0|||
106142005|NCT02466516|366179796|FG003|Overall Study|Withdrew Consent|0|||
106142006|NCT02466516|366179797|FG004|Overall Study|Withdrew Consent|0|||
106142007|NCT02466516|366179793|FG000|Overall Study|Lost to Follow-up|2|||
106142008|NCT02466516|366179794|FG001|Overall Study|Lost to Follow-up|0|||
105740281|NCT00521339|364705008|FG001|Treatment Phase|Lost to Follow-up|0|||
105740282|NCT00521339|364705009|FG002|Treatment Phase|Lost to Follow-up|0|||
105740283|NCT00521339|364705007|FG000|Treatment Phase|Protocol Violation|1|||
105740284|NCT00521339|364705008|FG001|Treatment Phase|Protocol Violation|0|||
105740285|NCT00521339|364705009|FG002|Treatment Phase|Protocol Violation|0|||
105740286|NCT00521339|364705007|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
105740287|NCT00521339|364705008|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
105740288|NCT00521339|364705009|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
105740289|NCT00521339|364705007|FG000|Treatment Extension Phase|Death|0|||
105740290|NCT00521339|364705008|FG001|Treatment Extension Phase|Death|0|||
105740291|NCT00521339|364705009|FG002|Treatment Extension Phase|Death|1|||
105740292|NCT02115815|364705010|FG000|Overall Study|Withdrawal by Subject|2|||
105740293|NCT02115815|364705011|FG001|Overall Study|Withdrawal by Subject|0|||
105740294|NCT02115815|364705012|FG002|Overall Study|Withdrawal by Subject|0|||
105740295|NCT02115815|364705013|FG003|Overall Study|Withdrawal by Subject|0|||
105740296|NCT02115815|364705014|FG004|Overall Study|Withdrawal by Subject|0|||
105740297|NCT02115815|364705015|FG005|Overall Study|Withdrawal by Subject|0|||
105740298|NCT02115815|364705016|FG006|Overall Study|Withdrawal by Subject|0|||
105740299|NCT02115815|364705010|FG000|Overall Study|Not enough drug to dose participant|0|||
105740300|NCT02115815|364705011|FG001|Overall Study|Not enough drug to dose participant|0|||
105740301|NCT02115815|364705012|FG002|Overall Study|Not enough drug to dose participant|0|||
105740302|NCT02115815|364705013|FG003|Overall Study|Not enough drug to dose participant|0|||
105740303|NCT02115815|364705014|FG004|Overall Study|Not enough drug to dose participant|0|||
105740304|NCT02115815|364705015|FG005|Overall Study|Not enough drug to dose participant|1|||
106014484|NCT00790842|365719344|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105941983|NCT00567502|365450286|FG000|Overall Study|Death|65|||
105941984|NCT00567502|365450287|FG001|Overall Study|Death|16|||
105941985|NCT00567502|365450288|FG002|Overall Study|Death|360|||
106014485|NCT00790842|365719345|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
106014486|NCT00790842|365719346|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
106014487|NCT00790842|365719347|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
106014488|NCT00790842|365719348|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
106014489|NCT00790842|365719349|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
106014490|NCT00790842|365719350|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
106014491|NCT00790842|365719351|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
106014492|NCT00790842|365719352|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
106014493|NCT00790842|365719353|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
106014494|NCT00790842|365719354|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
105740305|NCT02115815|364705016|FG006|Overall Study|Not enough drug to dose participant|0|||
105740306|NCT02115815|364705010|FG000|Overall Study|Missed appointment, randomized in error|0|||
105740307|NCT02115815|364705011|FG001|Overall Study|Missed appointment, randomized in error|0|||
105740308|NCT02115815|364705012|FG002|Overall Study|Missed appointment, randomized in error|0|||
105740309|NCT02115815|364705013|FG003|Overall Study|Missed appointment, randomized in error|0|||
105740310|NCT02115815|364705014|FG004|Overall Study|Missed appointment, randomized in error|0|||
105740311|NCT02115815|364705015|FG005|Overall Study|Missed appointment, randomized in error|1|||
105740312|NCT02115815|364705016|FG006|Overall Study|Missed appointment, randomized in error|0|||
105740313|NCT01958671|364705017|FG000|Overall Study|Adverse Event|1|||
105740314|NCT01958671|364705018|FG001|Overall Study|Adverse Event|1|||
105740315|NCT01958671|364705019|FG002|Overall Study|Adverse Event|5|||
105740316|NCT01958671|364705017|FG000|Overall Study|Death|1|||
105740317|NCT01958671|364705018|FG001|Overall Study|Death|0|||
105740318|NCT01958671|364705019|FG002|Overall Study|Death|0|||
105740319|NCT01958671|364705017|FG000|Overall Study|Excluded medication|0|||
105740320|NCT01958671|364705018|FG001|Overall Study|Excluded medication|0|||
105740321|NCT01958671|364705019|FG002|Overall Study|Excluded medication|1|||
105740322|NCT01958671|364705017|FG000|Overall Study|Hyperglycemia|0|||
105740323|NCT01958671|364705018|FG001|Overall Study|Hyperglycemia|0|||
105740324|NCT01958671|364705019|FG002|Overall Study|Hyperglycemia|2|||
105740325|NCT01958671|364705017|FG000|Overall Study|Lost to Follow-up|7|||
105740326|NCT01958671|364705018|FG001|Overall Study|Lost to Follow-up|11|||
105740327|NCT01958671|364705019|FG002|Overall Study|Lost to Follow-up|7|||
105941986|NCT00567502|365450289|FG003|Overall Study|Death|5|||
105941987|NCT00567502|365450286|FG000|Overall Study|Other|64|||
105941988|NCT00567502|365450287|FG001|Overall Study|Other|2|||
105941989|NCT00567502|365450288|FG002|Overall Study|Other|134|||
105941990|NCT00567502|365450289|FG003|Overall Study|Other|6|||
105941991|NCT00567502|365450286|FG000|Overall Study|Participant request|12|||
105941992|NCT00567502|365450287|FG001|Overall Study|Participant request|1|||
105941993|NCT00567502|365450288|FG002|Overall Study|Participant request|33|||
105941994|NCT00567502|365450289|FG003|Overall Study|Participant request|1|||
105941995|NCT00567502|365450286|FG000|Overall Study|Sponsor request|9|||
105941996|NCT00567502|365450287|FG001|Overall Study|Sponsor request|0|||
105941997|NCT00567502|365450288|FG002|Overall Study|Sponsor request|30|||
105941998|NCT00567502|365450289|FG003|Overall Study|Sponsor request|1|||
105941999|NCT00567502|365450286|FG000|Overall Study|Never Initiated Treatment|0|||
105942000|NCT00567502|365450287|FG001|Overall Study|Never Initiated Treatment|0|||
105942001|NCT00567502|365450288|FG002|Overall Study|Never Initiated Treatment|0|||
105942002|NCT00567502|365450289|FG003|Overall Study|Never Initiated Treatment|72|||
105942003|NCT00480532|365450291|FG000|Overall Study|Withdrawal by Subject|2|||
105942004|NCT00480532|365450292|FG001|Overall Study|Withdrawal by Subject|4|||
105942005|NCT00480532|365450293|FG002|Overall Study|Withdrawal by Subject|3|||
105942006|NCT00480532|365450294|FG003|Overall Study|Withdrawal by Subject|1|||
105942007|NCT00480532|365450291|FG000|Overall Study|Protocol Violation|0|||
105942008|NCT00480532|365450292|FG001|Overall Study|Protocol Violation|0|||
105942009|NCT00480532|365450293|FG002|Overall Study|Protocol Violation|1|||
106014495|NCT00790842|365719344|FG000|Dose Level 4|Adverse Event|0|||
105740328|NCT01958671|364705017|FG000|Overall Study|Non-compliance with study drug|1|||
105740329|NCT01958671|364705018|FG001|Overall Study|Non-compliance with study drug|1|||
105740330|NCT01958671|364705019|FG002|Overall Study|Non-compliance with study drug|1|||
105740331|NCT01958671|364705017|FG000|Overall Study|Pregnancy|0|||
105740332|NCT01958671|364705018|FG001|Overall Study|Pregnancy|0|||
105740333|NCT01958671|364705019|FG002|Overall Study|Pregnancy|1|||
105740334|NCT01958671|364705017|FG000|Overall Study|Protocol Violation|0|||
105942010|NCT00480532|365450294|FG003|Overall Study|Protocol Violation|0|||
105942011|NCT02367885|365450295|FG000|Overall Study|Lost to Follow-up|1|||
105942012|NCT02367885|365450296|FG001|Overall Study|Lost to Follow-up|0|||
105942013|NCT02367885|365450297|FG002|Overall Study|Lost to Follow-up|0|||
105942014|NCT02367885|365450295|FG000|Overall Study|Withdrawal by Subject|1|||
105942015|NCT02367885|365450296|FG001|Overall Study|Withdrawal by Subject|0|||
105942016|NCT02367885|365450297|FG002|Overall Study|Withdrawal by Subject|0|||
106014496|NCT00790842|365719345|FG001|Dose Level 4|Adverse Event|0|||
105740335|NCT01958671|364705018|FG001|Overall Study|Protocol Violation|1|||
105740336|NCT01958671|364705019|FG002|Overall Study|Protocol Violation|0|||
105740337|NCT01958671|364705017|FG000|Overall Study|Study site terminated by sponsor|1|||
105740338|NCT01958671|364705018|FG001|Overall Study|Study site terminated by sponsor|0|||
105740339|NCT01958671|364705019|FG002|Overall Study|Study site terminated by sponsor|1|||
105740340|NCT01958671|364705017|FG000|Overall Study|Participant moved|0|||
105740341|NCT01958671|364705018|FG001|Overall Study|Participant moved|0|||
105740342|NCT01958671|364705019|FG002|Overall Study|Participant moved|1|||
105740343|NCT01958671|364705017|FG000|Overall Study|Withdrawal by Subject|8|||
105740344|NCT01958671|364705018|FG001|Overall Study|Withdrawal by Subject|10|||
105740345|NCT01958671|364705019|FG002|Overall Study|Withdrawal by Subject|13|||
105740346|NCT01675531|364705022|FG000|Overall Study|Adverse Event|9|||
105740347|NCT01675531|364705022|FG000|Overall Study|Withdrawal by Subject|7|||
105740348|NCT01675531|364705022|FG000|Overall Study|Lack of Efficacy|1|||
105740349|NCT01675531|364705022|FG000|Overall Study|Protocol Violation|8|||
105740350|NCT04705597|364705023|FG000|Overall Study|Death|16|||
105740351|NCT04705597|364705024|FG001|Overall Study|Death|9|||
105740352|NCT04705597|364705023|FG000|Overall Study|Lost to Follow-up|1|||
105740353|NCT04705597|364705024|FG001|Overall Study|Lost to Follow-up|0|||
105740354|NCT04705597|364705023|FG000|Overall Study|Withdrawal by Subject|1|||
105740355|NCT04705597|364705024|FG001|Overall Study|Withdrawal by Subject|2|||
105740356|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
105740357|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
105740358|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
105740359|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
105740360|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
105740361|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
105740362|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
105740363|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
105740364|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
105740365|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
105740366|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
105740367|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
105740368|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
105740369|NCT02232516|364705028|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
105740370|NCT02232516|364705028|FG000|Survival Follow-up|Death|15|||
105740371|NCT02232516|364705028|FG000|Survival Follow-up|Withdrawal by Subject|3|||
105740372|NCT02232516|364705028|FG000|Survival Follow-up|Lost to Follow-up|1|||
105740373|NCT02232516|364705028|FG000|Survival Follow-up|Still in follow-up|5|||
105740374|NCT01258348|364705030|FG000|Overall Study|Adverse Event|1|||
105740375|NCT01258348|364705031|FG001|Overall Study|Adverse Event|1|||
105740376|NCT01258348|364705032|FG002|Overall Study|Adverse Event|3|||
105740377|NCT01258348|364705033|FG003|Overall Study|Adverse Event|2|||
105740378|NCT01258348|364705034|FG004|Overall Study|Adverse Event|4|||
105740379|NCT01258348|364705030|FG000|Overall Study|Progressive Disease|0|||
105740380|NCT01258348|364705031|FG001|Overall Study|Progressive Disease|3|||
105740381|NCT01258348|364705032|FG002|Overall Study|Progressive Disease|0|||
105740382|NCT01258348|364705033|FG003|Overall Study|Progressive Disease|2|||
105740383|NCT01258348|364705034|FG004|Overall Study|Progressive Disease|2|||
105740384|NCT01258348|364705030|FG000|Overall Study|Physician Decision|0|||
105740385|NCT01258348|364705031|FG001|Overall Study|Physician Decision|0|||
105740386|NCT01258348|364705032|FG002|Overall Study|Physician Decision|0|||
105740387|NCT01258348|364705033|FG003|Overall Study|Physician Decision|2|||
105740388|NCT01258348|364705034|FG004|Overall Study|Physician Decision|0|||
105740389|NCT01258348|364705030|FG000|Overall Study|Withdrawal by Subject|0|||
105740390|NCT01258348|364705031|FG001|Overall Study|Withdrawal by Subject|1|||
105740391|NCT01258348|364705032|FG002|Overall Study|Withdrawal by Subject|0|||
105740392|NCT01258348|364705033|FG003|Overall Study|Withdrawal by Subject|0|||
105740393|NCT01258348|364705034|FG004|Overall Study|Withdrawal by Subject|0|||
105740394|NCT02855411|364705035|FG000|Overall Study|Study terminated by sponsor|21|||
105740395|NCT02855411|364705035|FG000|Overall Study|Does not meet entrance criteria|14|||
105740396|NCT00907881|364705036|FG000|Overall Study|Lost to Follow-up|59|||
105740397|NCT00907881|364705036|FG000|Overall Study|Noncompliance|5|||
105740398|NCT00907881|364705036|FG000|Overall Study|Withdrawal by Subject|5|||
105740399|NCT00907881|364705036|FG000|Overall Study|Protocol Violation|1|||
105740400|NCT00907881|364705036|FG000|Overall Study|Missing discontinuation information|15|||
105740401|NCT02561000|364705037|FG000|Overall Study|Withdrawal by Subject|2|||
105740402|NCT02561000|364705038|FG001|Overall Study|Withdrawal by Subject|3|||
105740403|NCT02561000|364705039|FG002|Overall Study|Withdrawal by Subject|0|||
105740404|NCT02561000|364705037|FG000|Overall Study|Adverse Event|0|||
105740405|NCT02561000|364705038|FG001|Overall Study|Adverse Event|1|||
105740406|NCT02561000|364705039|FG002|Overall Study|Adverse Event|0|||
105740407|NCT01809262|364705040|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740408|NCT01809262|364705041|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740409|NCT01809262|364705042|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740410|NCT01809262|364705043|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
106014497|NCT00790842|365719346|FG002|Dose Level 4|Adverse Event|0|||
106014498|NCT00790842|365719347|FG003|Dose Level 4|Adverse Event|0|||
106014499|NCT00790842|365719348|FG004|Dose Level 4|Adverse Event|0|||
106014500|NCT00790842|365719349|FG005|Dose Level 4|Adverse Event|0|||
106014501|NCT00790842|365719350|FG006|Dose Level 4|Adverse Event|1|||
106014502|NCT00790842|365719351|FG007|Dose Level 4|Adverse Event|0|||
106014503|NCT00790842|365719352|FG008|Dose Level 4|Adverse Event|0|||
106014504|NCT00790842|365719353|FG009|Dose Level 4|Adverse Event|0|||
106014505|NCT00790842|365719354|FG010|Dose Level 4|Adverse Event|0|||
106014506|NCT00790842|365719344|FG000|Dose Level 4|Physician Decision|0|||
106014507|NCT00790842|365719345|FG001|Dose Level 4|Physician Decision|0|||
106014508|NCT00790842|365719346|FG002|Dose Level 4|Physician Decision|0|||
106014509|NCT00790842|365719347|FG003|Dose Level 4|Physician Decision|0|||
106014510|NCT00790842|365719348|FG004|Dose Level 4|Physician Decision|0|||
105740411|NCT01809262|364705044|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
105740412|NCT01809262|364705045|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740413|NCT01809262|364705046|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740414|NCT01809262|364705047|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740415|NCT01809262|364705048|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740416|NCT01809262|364705049|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
105740417|NCT01809262|364705040|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740418|NCT01809262|364705041|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
105740419|NCT01809262|364705042|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740420|NCT01809262|364705043|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740421|NCT01809262|364705044|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740422|NCT01809262|364705045|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740423|NCT01809262|364705046|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740424|NCT01809262|364705047|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740425|NCT01809262|364705048|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740426|NCT01809262|364705049|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
105740427|NCT04230486|364705063|FG000|Overall Study|Screen Failure|1|||
105740428|NCT03215264|364705064|FG000|Dose Level 2|Adverse Event|0|||
105740429|NCT03215264|364705065|FG001|Dose Level 2|Adverse Event|1|||
105740430|NCT03215264|364705066|FG002|Dose Level 2|Adverse Event|0|||
105740431|NCT03215264|364705064|FG000|Dose Level 3|Withdrawal by Subject|0|||
105740432|NCT03215264|364705065|FG001|Dose Level 3|Withdrawal by Subject|0|||
105740433|NCT03215264|364705066|FG002|Dose Level 3|Withdrawal by Subject|1|||
105740434|NCT02064439|364705067|FG000|Overall Study|Adverse Event|51|||
105740435|NCT02064439|364705068|FG001|Overall Study|Adverse Event|47|||
105740436|NCT02064439|364705069|FG002|Overall Study|Adverse Event|46|||
105740437|NCT02064439|364705067|FG000|Overall Study|Death|0|||
105740438|NCT02064439|364705068|FG001|Overall Study|Death|2|||
105740439|NCT02064439|364705069|FG002|Overall Study|Death|3|||
105740440|NCT02064439|364705067|FG000|Overall Study|Withdrawal by Subject|29|||
105740441|NCT02064439|364705068|FG001|Overall Study|Withdrawal by Subject|18|||
105740442|NCT02064439|364705069|FG002|Overall Study|Withdrawal by Subject|26|||
105740443|NCT02064439|364705067|FG000|Overall Study|Protocol Violation|3|||
105740444|NCT02064439|364705068|FG001|Overall Study|Protocol Violation|5|||
105740445|NCT02064439|364705069|FG002|Overall Study|Protocol Violation|3|||
105740446|NCT02064439|364705067|FG000|Overall Study|Lost to Follow-up|1|||
105740447|NCT02064439|364705068|FG001|Overall Study|Lost to Follow-up|3|||
105740448|NCT02064439|364705069|FG002|Overall Study|Lost to Follow-up|4|||
105740449|NCT02064439|364705067|FG000|Overall Study|Non-compliance with study medication|21|||
105740450|NCT02064439|364705068|FG001|Overall Study|Non-compliance with study medication|19|||
105740451|NCT02064439|364705069|FG002|Overall Study|Non-compliance with study medication|23|||
105740452|NCT02064439|364705067|FG000|Overall Study|Physician Decision|0|||
105740453|NCT02064439|364705068|FG001|Overall Study|Physician Decision|1|||
105740454|NCT02064439|364705069|FG002|Overall Study|Physician Decision|1|||
105740455|NCT02064439|364705067|FG000|Overall Study|Logistical difficulties|6|||
105740456|NCT02064439|364705068|FG001|Overall Study|Logistical difficulties|5|||
105740457|NCT02064439|364705069|FG002|Overall Study|Logistical difficulties|2|||
105740458|NCT02064439|364705067|FG000|Overall Study|Efficacy outcome reached|18|||
106014511|NCT00790842|365719349|FG005|Dose Level 4|Physician Decision|0|||
105740459|NCT02064439|364705068|FG001|Overall Study|Efficacy outcome reached|16|||
105740460|NCT02064439|364705069|FG002|Overall Study|Efficacy outcome reached|57|||
105740461|NCT02064439|364705067|FG000|Overall Study|Safety outcome reached|12|||
105740462|NCT02064439|364705068|FG001|Overall Study|Safety outcome reached|20|||
105740463|NCT02064439|364705069|FG002|Overall Study|Safety outcome reached|10|||
105740464|NCT02064439|364705067|FG000|Overall Study|Other|2|||
105740465|NCT02064439|364705068|FG001|Overall Study|Other|2|||
105740466|NCT02064439|364705069|FG002|Overall Study|Other|7|||
105740467|NCT02234583|364705072|FG000|Overall Study|Adverse Event|172|||
105740468|NCT02234583|364705073|FG001|Overall Study|Adverse Event|156|||
105740469|NCT02234583|364705072|FG000|Overall Study|Withdrawal by Subject|109|||
106014512|NCT00790842|365719350|FG006|Dose Level 4|Physician Decision|1|||
106014513|NCT00790842|365719351|FG007|Dose Level 4|Physician Decision|0|||
106014514|NCT00790842|365719352|FG008|Dose Level 4|Physician Decision|0|||
105942017|NCT03427619|365450298|FG000|Overall Study|Physician Decision|3|||
105942018|NCT03427619|365450298|FG000|Overall Study|Withdrawal by Subject|4|||
105942019|NCT03427619|365450298|FG000|Overall Study|Lost to Follow-up|5|||
105740470|NCT02234583|364705073|FG001|Overall Study|Withdrawal by Subject|157|||
105740471|NCT02234583|364705072|FG000|Overall Study|Lost to Follow-up|0|||
105740472|NCT02234583|364705073|FG001|Overall Study|Lost to Follow-up|1|||
105740473|NCT02234583|364705072|FG000|Overall Study|Lack of Efficacy|58|||
105740474|NCT02234583|364705073|FG001|Overall Study|Lack of Efficacy|103|||
105740475|NCT02234583|364705072|FG000|Overall Study|Protocol Violation|35|||
105740476|NCT02234583|364705073|FG001|Overall Study|Protocol Violation|42|||
105740477|NCT02234583|364705072|FG000|Overall Study|Other|39|||
105740478|NCT02234583|364705073|FG001|Overall Study|Other|97|||
105740479|NCT01740440|364705074|FG000|Overall Study|Lost to Follow-up|3|||
105740480|NCT01849250|364705075|FG000|Overall Study|Withdrawal by Subject|1|||
105740481|NCT01849250|364705076|FG001|Overall Study|Withdrawal by Subject|0|||
105740482|NCT01849250|364705075|FG000|Overall Study|Not Evaluable|5|||
105740483|NCT01849250|364705076|FG001|Overall Study|Not Evaluable|3|||
105740484|NCT01849250|364705075|FG000|Overall Study|Screen Failure|1|||
105740485|NCT01849250|364705076|FG001|Overall Study|Screen Failure|0|||
105740486|NCT00367640|364705077|FG000|Overall Study|Adverse Event|3|||
105740487|NCT00367640|364705078|FG001|Overall Study|Adverse Event|6|||
105740488|NCT00367640|364705079|FG002|Overall Study|Adverse Event|8|||
105740489|NCT00367640|364705080|FG003|Overall Study|Adverse Event|0|||
105740490|NCT00367640|364705077|FG000|Overall Study|Withdrawal by Subject|8|||
105740491|NCT00367640|364705078|FG001|Overall Study|Withdrawal by Subject|11|||
105740492|NCT00367640|364705079|FG002|Overall Study|Withdrawal by Subject|8|||
105740493|NCT00367640|364705080|FG003|Overall Study|Withdrawal by Subject|6|||
105740494|NCT00367640|364705077|FG000|Overall Study|Any other reason not above-mentioned|7|||
105740495|NCT00367640|364705078|FG001|Overall Study|Any other reason not above-mentioned|5|||
105740496|NCT00367640|364705079|FG002|Overall Study|Any other reason not above-mentioned|3|||
105740497|NCT00367640|364705080|FG003|Overall Study|Any other reason not above-mentioned|4|||
105740498|NCT04504032|364705082|FG000|Overall Study|Adverse Event|1|||
105740499|NCT04504032|364705083|FG001|Overall Study|Adverse Event|2|||
105740500|NCT04504032|364705082|FG000|Overall Study|Lost to Follow-up|6|||
105740501|NCT04504032|364705083|FG001|Overall Study|Lost to Follow-up|9|||
105740502|NCT04504032|364705082|FG000|Overall Study|Protocol Violation|2|||
105740503|NCT04504032|364705083|FG001|Overall Study|Protocol Violation|0|||
105740504|NCT04504032|364705082|FG000|Overall Study|Study terminated by sponsor|1|||
105740505|NCT04504032|364705083|FG001|Overall Study|Study terminated by sponsor|2|||
105740506|NCT04504032|364705082|FG000|Overall Study|Withdrawal by Subject|9|||
105740507|NCT04504032|364705083|FG001|Overall Study|Withdrawal by Subject|11|||
105740508|NCT04504032|364705082|FG000|Overall Study|Disease progression prior to dosing|15|||
105740509|NCT04504032|364705083|FG001|Overall Study|Disease progression prior to dosing|3|||
105740510|NCT04504032|364705082|FG000|Overall Study|Drug supply issues|1|||
105740511|NCT04504032|364705083|FG001|Overall Study|Drug supply issues|1|||
105740512|NCT04504032|364705082|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
105740513|NCT04504032|364705083|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
105740514|NCT02805907|364705084|FG000|Overall Study|Lost to Follow-up|3|||
105740515|NCT02805907|364705085|FG001|Overall Study|Lost to Follow-up|3|||
105740516|NCT01264965|364705086|FG000|Overall Study|Withdrawal by Subject|10|||
105740517|NCT00940342|364705088|FG000|Overall Study|Adverse Event|0|||
105740518|NCT00940342|364705089|FG001|Overall Study|Adverse Event|2|||
105740519|NCT00940342|364705090|FG002|Overall Study|Adverse Event|1|||
105740520|NCT02214186|364705093|FG000|Overall Study|Lost to Follow-up|1|||
105740521|NCT02214186|364705094|FG001|Overall Study|Lost to Follow-up|1|||
105740522|NCT02214186|364705093|FG000|Overall Study|Protocol Violation|1|||
105740523|NCT02214186|364705094|FG001|Overall Study|Protocol Violation|1|||
105740524|NCT02142894|364705095|FG000|Overall Study|Protocol Violation|8|||
105740525|NCT02116972|364705108|FG000|Overall Study|Adverse Event|4|||
105740526|NCT02116972|364705109|FG001|Overall Study|Adverse Event|4|||
105740527|NCT02116972|364705110|FG002|Overall Study|Adverse Event|1|||
105740528|NCT02116972|364705108|FG000|Overall Study|Withdrawal by Subject|1|||
105740529|NCT02116972|364705109|FG001|Overall Study|Withdrawal by Subject|1|||
105740530|NCT02116972|364705110|FG002|Overall Study|Withdrawal by Subject|5|||
105740531|NCT02116972|364705108|FG000|Overall Study|Protocol Violation|1|||
105740532|NCT02116972|364705109|FG001|Overall Study|Protocol Violation|0|||
105740533|NCT02116972|364705110|FG002|Overall Study|Protocol Violation|1|||
105740534|NCT02116972|364705108|FG000|Overall Study|Lost to Follow-up|4|||
105740535|NCT02116972|364705109|FG001|Overall Study|Lost to Follow-up|3|||
105740536|NCT02116972|364705110|FG002|Overall Study|Lost to Follow-up|1|||
105740537|NCT02116972|364705108|FG000|Overall Study|Lack of Efficacy|6|||
105740538|NCT02116972|364705109|FG001|Overall Study|Lack of Efficacy|6|||
105740539|NCT02116972|364705110|FG002|Overall Study|Lack of Efficacy|5|||
105740540|NCT02116972|364705108|FG000|Overall Study|scheduling conflicts and relocation|3|||
105740541|NCT02116972|364705109|FG001|Overall Study|scheduling conflicts and relocation|3|||
105740542|NCT02116972|364705110|FG002|Overall Study|scheduling conflicts and relocation|6|||
105740543|NCT00784784|364705111|FG000|Overall Study|Withdrawal by Subject|2|||
105942020|NCT03427619|365450298|FG000|Overall Study|Administrative|4|||
106014515|NCT00790842|365719353|FG009|Dose Level 4|Physician Decision|0|||
105740544|NCT00784784|364705112|FG001|Overall Study|Withdrawal by Subject|2|||
105740545|NCT01400971|364705113|FG000|Overall Study|Death|82|||
105740546|NCT01400971|364705113|FG000|Overall Study|Lost to Follow-up|196|||
105740547|NCT01400971|364705113|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
105740548|NCT01400971|364705113|FG000|Overall Study|Physician Decision|57|||
105740549|NCT01400971|364705113|FG000|Overall Study|Withdrawal by Subject|158|||
105740550|NCT01400971|364705113|FG000|Overall Study|Other|422|||
105740551|NCT01905397|364705114|FG000|Overall Study|Death|0|||
105740552|NCT01905397|364705115|FG001|Overall Study|Death|1|||
105740553|NCT01905397|364705114|FG000|Overall Study|Withdrawal by Subject|2|||
105740554|NCT01905397|364705115|FG001|Overall Study|Withdrawal by Subject|0|||
105740555|NCT01905397|364705114|FG000|Overall Study|Surgery canceled/aborted|9|||
105740556|NCT01905397|364705115|FG001|Overall Study|Surgery canceled/aborted|5|||
105740557|NCT01905397|364705114|FG000|Overall Study|Incision < 7 cm|2|||
105740558|NCT01905397|364705115|FG001|Overall Study|Incision < 7 cm|0|||
105740559|NCT01905397|364705114|FG000|Overall Study|Wrong treatment|1|||
105740560|NCT01905397|364705115|FG001|Overall Study|Wrong treatment|1|||
105740561|NCT01905397|364705114|FG000|Overall Study|Device not applied|3|||
105740562|NCT01905397|364705115|FG001|Overall Study|Device not applied|0|||
105740563|NCT01905397|364705114|FG000|Overall Study|Dressing not applied in operating room|1|||
105740564|NCT01905397|364705115|FG001|Overall Study|Dressing not applied in operating room|0|||
105740565|NCT01905397|364705114|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
105740566|NCT01905397|364705115|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
105740567|NCT01035255|364705119|FG000|Overall Study|Death|724|||
105740568|NCT01035255|364705120|FG001|Overall Study|Death|844|||
105740569|NCT01035255|364705119|FG000|Overall Study|Lost to Follow-up|2|||
105740570|NCT01035255|364705120|FG001|Overall Study|Lost to Follow-up|5|||
105740571|NCT01035255|364705119|FG000|Overall Study|patient's request|15|||
105740572|NCT01035255|364705120|FG001|Overall Study|patient's request|13|||
105740573|NCT01921270|364705121|FG000|Overall Study|Withdrawal by Subject|1|||
105740574|NCT00789477|364705122|FG000|Overall Study|Withdrawal by Subject|2|||
105740575|NCT00789477|364705123|FG001|Overall Study|Withdrawal by Subject|1|||
105740576|NCT00789477|364705124|FG002|Overall Study|Withdrawal by Subject|3|||
105740577|NCT00789477|364705125|FG003|Overall Study|Withdrawal by Subject|2|||
105740578|NCT00789477|364705126|FG004|Overall Study|Withdrawal by Subject|3|||
105740579|NCT00789477|364705122|FG000|Overall Study|Protocol Violation|1|||
105740580|NCT00789477|364705123|FG001|Overall Study|Protocol Violation|0|||
105740581|NCT00789477|364705124|FG002|Overall Study|Protocol Violation|0|||
105740582|NCT00789477|364705125|FG003|Overall Study|Protocol Violation|1|||
105740583|NCT00789477|364705126|FG004|Overall Study|Protocol Violation|0|||
105740584|NCT00789477|364705122|FG000|Overall Study|Adverse Event|3|||
105740585|NCT00789477|364705123|FG001|Overall Study|Adverse Event|3|||
105740586|NCT00789477|364705124|FG002|Overall Study|Adverse Event|1|||
105740587|NCT00789477|364705125|FG003|Overall Study|Adverse Event|0|||
105740588|NCT00789477|364705126|FG004|Overall Study|Adverse Event|0|||
105740589|NCT00789477|364705122|FG000|Overall Study|Death|1|||
105740590|NCT00789477|364705123|FG001|Overall Study|Death|1|||
105942021|NCT03427619|365450298|FG000|Overall Study|Other|2|||
105942022|NCT03427619|365450298|FG000|Overall Study|Unknown or Missing Completion Status|48|||
105942023|NCT02743962|365450299|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
105942024|NCT02743962|365450300|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
105942025|NCT00425555|365450304|FG000|Overall Study|Withdrawal by Subject|11|||
105942026|NCT00425555|365450305|FG001|Overall Study|Withdrawal by Subject|8|||
105942027|NCT00425555|365450304|FG000|Overall Study|Lost to Follow-up|0|||
105942028|NCT00425555|365450305|FG001|Overall Study|Lost to Follow-up|1|||
105942029|NCT00425555|365450304|FG000|Overall Study|Administrative problems|3|||
105942030|NCT00425555|365450305|FG001|Overall Study|Administrative problems|0|||
105942031|NCT00425555|365450304|FG000|Overall Study|Death|1|||
105942032|NCT00425555|365450305|FG001|Overall Study|Death|2|||
105942033|NCT00425555|365450304|FG000|Overall Study|New cancer therapy|2|||
105942034|NCT00425555|365450305|FG001|Overall Study|New cancer therapy|1|||
105942035|NCT00425555|365450304|FG000|Overall Study|Disease progression|36|||
105942036|NCT00425555|365450305|FG001|Overall Study|Disease progression|33|||
105942037|NCT00425555|365450304|FG000|Overall Study|Adverse Event|25|||
105942038|NCT00425555|365450305|FG001|Overall Study|Adverse Event|15|||
105942039|NCT00425555|365450304|FG000|Overall Study|Protocol Violation|1|||
105942040|NCT00425555|365450305|FG001|Overall Study|Protocol Violation|0|||
105942041|NCT02327169|365450307|FG000|Overall Study|Progressive Disease|1|||
105942042|NCT02327169|365450308|FG001|Overall Study|Progressive Disease|3|||
105942043|NCT02327169|365450309|FG002|Overall Study|Progressive Disease|4|||
105942044|NCT02327169|365450310|FG003|Overall Study|Progressive Disease|3|||
105740591|NCT00789477|364705124|FG002|Overall Study|Death|2|||
105740592|NCT00789477|364705125|FG003|Overall Study|Death|2|||
105740593|NCT00789477|364705126|FG004|Overall Study|Death|0|||
105740594|NCT00789477|364705122|FG000|Overall Study|Lost to Follow-up|0|||
105740595|NCT00789477|364705123|FG001|Overall Study|Lost to Follow-up|1|||
105740596|NCT00789477|364705124|FG002|Overall Study|Lost to Follow-up|4|||
105740597|NCT00789477|364705125|FG003|Overall Study|Lost to Follow-up|2|||
105740598|NCT00789477|364705126|FG004|Overall Study|Lost to Follow-up|4|||
105740599|NCT00789477|364705122|FG000|Overall Study|Lack of Efficacy|2|||
105740600|NCT00789477|364705123|FG001|Overall Study|Lack of Efficacy|0|||
105740601|NCT00789477|364705124|FG002|Overall Study|Lack of Efficacy|0|||
105740602|NCT00789477|364705125|FG003|Overall Study|Lack of Efficacy|0|||
105740603|NCT00789477|364705126|FG004|Overall Study|Lack of Efficacy|0|||
105740604|NCT00789477|364705122|FG000|Overall Study|Other|2|||
105740605|NCT00789477|364705123|FG001|Overall Study|Other|0|||
105740606|NCT00789477|364705124|FG002|Overall Study|Other|1|||
105740607|NCT00789477|364705125|FG003|Overall Study|Other|3|||
105740608|NCT00789477|364705126|FG004|Overall Study|Other|0|||
105740609|NCT02137772|364705127|FG000|Overall Study|Adverse Event|6|||
105740610|NCT02137772|364705128|FG001|Overall Study|Adverse Event|3|||
105740611|NCT02137772|364705127|FG000|Overall Study|Death|71|||
105740612|NCT02137772|364705128|FG001|Overall Study|Death|44|||
105740613|NCT02137772|364705127|FG000|Overall Study|Lost to Follow-up|8|||
105740614|NCT02137772|364705128|FG001|Overall Study|Lost to Follow-up|4|||
105740615|NCT02137772|364705127|FG000|Overall Study|Physician Decision|15|||
105740616|NCT02137772|364705128|FG001|Overall Study|Physician Decision|5|||
105740617|NCT02137772|364705127|FG000|Overall Study|Withdrawal by Subject|28|||
105740618|NCT02137772|364705128|FG001|Overall Study|Withdrawal by Subject|17|||
105740619|NCT02137772|364705127|FG000|Overall Study|Non-compliance with study drug|1|||
105740620|NCT02137772|364705128|FG001|Overall Study|Non-compliance with study drug|0|||
105740621|NCT02137772|364705127|FG000|Overall Study|Not treated|3|||
105740622|NCT02137772|364705128|FG001|Overall Study|Not treated|2|||
105740623|NCT02092389|364705129|FG000|Overall Study|Adverse Event|1|||
105740624|NCT02092389|364705129|FG000|Overall Study|Other|5|||
105740625|NCT01844700|364705130|FG000|Overall Study|Lack of Efficacy|1|||
105740626|NCT01844700|364705131|FG001|Overall Study|Lack of Efficacy|0|||
105740627|NCT01844700|364705130|FG000|Overall Study|refused medication switch|1|||
105740628|NCT01844700|364705131|FG001|Overall Study|refused medication switch|0|||
105740629|NCT01844700|364705130|FG000|Overall Study|Withdrawal by Subject|1|||
105740630|NCT01844700|364705131|FG001|Overall Study|Withdrawal by Subject|0|||
105740631|NCT01844700|364705130|FG000|Overall Study|stopped taking meds|0|||
105740632|NCT01844700|364705131|FG001|Overall Study|stopped taking meds|1|||
105740633|NCT02375698|364705132|FG000|Overall Study|Withdrawal by Subject|0|||
105740634|NCT02375698|364705133|FG001|Overall Study|Withdrawal by Subject|2|||
105740635|NCT02375698|364705132|FG000|Overall Study|Physician Decision|2|||
105740636|NCT02375698|364705133|FG001|Overall Study|Physician Decision|0|||
105740637|NCT01052012|364705137|FG000|Overall Study|Not treated|2|||
105740638|NCT01052012|364705138|FG001|Overall Study|Not treated|5|||
105740639|NCT01052012|364705139|FG002|Overall Study|Not treated|0|||
105740640|NCT01052012|364705140|FG003|Overall Study|Not treated|0|||
105740641|NCT01052012|364705141|FG004|Overall Study|Not treated|11|||
105740642|NCT01052012|364705142|FG005|Overall Study|Not treated|8|||
105740643|NCT01052012|364705137|FG000|Overall Study|Adverse Event|1|||
105740644|NCT01052012|364705138|FG001|Overall Study|Adverse Event|0|||
105740645|NCT01052012|364705139|FG002|Overall Study|Adverse Event|0|||
105740646|NCT01052012|364705140|FG003|Overall Study|Adverse Event|1|||
105740647|NCT01052012|364705141|FG004|Overall Study|Adverse Event|0|||
105740648|NCT01052012|364705142|FG005|Overall Study|Adverse Event|0|||
105740649|NCT01052012|364705137|FG000|Overall Study|Lost to Follow-up|0|||
105942045|NCT02327169|365450311|FG004|Overall Study|Progressive Disease|4|||
105942046|NCT02327169|365450312|FG005|Overall Study|Progressive Disease|3|||
105740650|NCT01052012|364705138|FG001|Overall Study|Lost to Follow-up|0|||
105740651|NCT01052012|364705139|FG002|Overall Study|Lost to Follow-up|0|||
105942047|NCT02327169|365450313|FG006|Overall Study|Progressive Disease|3|||
105942048|NCT02327169|365450314|FG007|Overall Study|Progressive Disease|3|||
105942049|NCT02327169|365450315|FG008|Overall Study|Progressive Disease|4|||
105942050|NCT02327169|365450316|FG009|Overall Study|Progressive Disease|4|||
105942051|NCT02327169|365450317|FG010|Overall Study|Progressive Disease|4|||
105942052|NCT02327169|365450318|FG011|Overall Study|Progressive Disease|3|||
105942053|NCT02327169|365450319|FG012|Overall Study|Progressive Disease|1|||
105942054|NCT02327169|365450320|FG013|Overall Study|Progressive Disease|3|||
105740652|NCT01052012|364705140|FG003|Overall Study|Lost to Follow-up|0|||
105740653|NCT01052012|364705141|FG004|Overall Study|Lost to Follow-up|1|||
105942055|NCT02327169|365450321|FG014|Overall Study|Progressive Disease|3|||
105942056|NCT02327169|365450307|FG000|Overall Study|Adverse Event|2|||
105942057|NCT02327169|365450308|FG001|Overall Study|Adverse Event|0|||
105942058|NCT02327169|365450309|FG002|Overall Study|Adverse Event|1|||
105942059|NCT02327169|365450310|FG003|Overall Study|Adverse Event|0|||
105740654|NCT01052012|364705142|FG005|Overall Study|Lost to Follow-up|0|||
105740655|NCT01052012|364705137|FG000|Overall Study|Withdrawal by Subject|1|||
105740656|NCT01052012|364705138|FG001|Overall Study|Withdrawal by Subject|1|||
105740657|NCT01052012|364705139|FG002|Overall Study|Withdrawal by Subject|0|||
105740658|NCT01052012|364705140|FG003|Overall Study|Withdrawal by Subject|0|||
105740659|NCT01052012|364705141|FG004|Overall Study|Withdrawal by Subject|3|||
105740660|NCT01052012|364705142|FG005|Overall Study|Withdrawal by Subject|1|||
105740661|NCT01052012|364705137|FG000|Overall Study|Physician Decision|0|||
105740662|NCT01052012|364705138|FG001|Overall Study|Physician Decision|0|||
105740663|NCT01052012|364705139|FG002|Overall Study|Physician Decision|0|||
106014516|NCT00790842|365719354|FG010|Dose Level 4|Physician Decision|1|||
106014517|NCT00790842|365719344|FG000|Dose Level 4|Withdrawal by Subject|0|||
106014518|NCT00790842|365719345|FG001|Dose Level 4|Withdrawal by Subject|0|||
106014519|NCT00790842|365719346|FG002|Dose Level 4|Withdrawal by Subject|0|||
106014520|NCT00790842|365719347|FG003|Dose Level 4|Withdrawal by Subject|0|||
106014521|NCT00790842|365719348|FG004|Dose Level 4|Withdrawal by Subject|0|||
105740664|NCT01052012|364705140|FG003|Overall Study|Physician Decision|0|||
105740665|NCT01052012|364705141|FG004|Overall Study|Physician Decision|0|||
105740666|NCT01052012|364705142|FG005|Overall Study|Physician Decision|1|||
105740667|NCT01052012|364705137|FG000|Overall Study|Other|0|||
105740668|NCT01052012|364705138|FG001|Overall Study|Other|0|||
105740669|NCT01052012|364705139|FG002|Overall Study|Other|0|||
105740670|NCT01052012|364705140|FG003|Overall Study|Other|0|||
105740671|NCT01052012|364705141|FG004|Overall Study|Other|1|||
105740672|NCT01052012|364705142|FG005|Overall Study|Other|0|||
105740673|NCT00564629|364705145|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
105740674|NCT00564629|364705146|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
105740675|NCT03280550|364705150|FG000|Overall Study|Withdrawal by Subject|2|||
105740676|NCT03280550|364705151|FG001|Overall Study|Withdrawal by Subject|2|||
105740677|NCT03280550|364705150|FG000|Overall Study|Physician Decision|0|||
105740678|NCT03280550|364705151|FG001|Overall Study|Physician Decision|1|||
105740679|NCT02144220|364705153|FG000|Overall Study|technology incompatibility|9|||
105740680|NCT02144220|364705153|FG000|Overall Study|Lack of Efficacy|4|||
105740681|NCT02144220|364705153|FG000|Overall Study|Physician Decision|3|||
105740682|NCT02144220|364705153|FG000|Overall Study|Withdrawal by Subject|2|||
105740683|NCT02144220|364705153|FG000|Overall Study|Protocol Violation|1|||
105740684|NCT01096446|364706914|FG000|Overall Study|Death|1|||
105740685|NCT01096446|364706915|FG001|Overall Study|Death|0|||
105740686|NCT01096446|364706914|FG000|Overall Study|Protocol Violation|2|||
105740687|NCT01096446|364706915|FG001|Overall Study|Protocol Violation|0|||
105740688|NCT01240811|364706916|FG000|Overall Study|Physician Decision|0|||
105740689|NCT01240811|364706917|FG001|Overall Study|Physician Decision|1|||
105740690|NCT01240811|364706918|FG002|Overall Study|Physician Decision|0|||
105740691|NCT01240811|364706916|FG000|Overall Study|Withdrawal by Subject|0|||
105740692|NCT01240811|364706917|FG001|Overall Study|Withdrawal by Subject|0|||
105740693|NCT01240811|364706918|FG002|Overall Study|Withdrawal by Subject|1|||
105740694|NCT02410902|364706921|FG000|Overall Study|Adverse Event|2|||
105740695|NCT02410902|364706922|FG001|Overall Study|Adverse Event|3|||
105740696|NCT02410902|364706921|FG000|Overall Study|Lost to Follow-up|4|||
105740697|NCT02410902|364706922|FG001|Overall Study|Lost to Follow-up|1|||
105740698|NCT02410902|364706921|FG000|Overall Study|Protocol Violation|1|||
105740699|NCT02410902|364706922|FG001|Overall Study|Protocol Violation|4|||
105740700|NCT02410902|364706921|FG000|Overall Study|Withdrawal by Subject|6|||
105740701|NCT02410902|364706922|FG001|Overall Study|Withdrawal by Subject|8|||
105740702|NCT02410902|364706921|FG000|Overall Study|Non-Compliance|8|||
105740703|NCT02410902|364706922|FG001|Overall Study|Non-Compliance|2|||
105740704|NCT01746732|364706923|FG000|Lead-In Period|Withdrawal by Subject|1|||
105740705|NCT01746732|364706924|FG001|Lead-In Period|Withdrawal by Subject|0|||
105740706|NCT01746732|364706925|FG002|Lead-In Period|Withdrawal by Subject|0|||
105740707|NCT01746732|364706923|FG000|Period 1|Physician Decision|0|||
105740708|NCT01746732|364706924|FG001|Period 1|Physician Decision|1|||
105740709|NCT01746732|364706925|FG002|Period 1|Physician Decision|0|||
105740710|NCT01746732|364706923|FG000|Period 2|Withdrawal by Subject|0|||
105740711|NCT01746732|364706924|FG001|Period 2|Withdrawal by Subject|0|||
105740712|NCT01746732|364706925|FG002|Period 2|Withdrawal by Subject|2|||
105740713|NCT01746732|364706923|FG000|Period 2|Adverse Event|0|||
105740714|NCT01746732|364706924|FG001|Period 2|Adverse Event|0|||
105740715|NCT01746732|364706925|FG002|Period 2|Adverse Event|1|||
105740716|NCT01746732|364706923|FG000|Period 2|Lost to Follow-up|0|||
105740717|NCT01746732|364706924|FG001|Period 2|Lost to Follow-up|0|||
106014522|NCT00790842|365719349|FG005|Dose Level 4|Withdrawal by Subject|0|||
106142009|NCT02466516|366179795|FG002|Overall Study|Lost to Follow-up|1|||
106142010|NCT02466516|366179796|FG003|Overall Study|Lost to Follow-up|0|||
106142011|NCT02466516|366179797|FG004|Overall Study|Lost to Follow-up|0|||
106142012|NCT01580293|366179805|FG000|Part A_Main Trial|Adverse Event|0|||
105740718|NCT01746732|364706925|FG002|Period 2|Lost to Follow-up|1|||
105740719|NCT02817555|364706926|FG000|Overall Study|Death|1|||
105740720|NCT02817555|364706927|FG001|Overall Study|Death|3|||
105740721|NCT02817555|364706926|FG000|Overall Study|moved away|1|||
106014523|NCT00790842|365719350|FG006|Dose Level 4|Withdrawal by Subject|0|||
106014524|NCT00790842|365719351|FG007|Dose Level 4|Withdrawal by Subject|0|||
106142013|NCT01580293|366179806|FG001|Part A_Main Trial|Adverse Event|2|||
105740722|NCT02817555|364706927|FG001|Overall Study|moved away|0|||
105740723|NCT02817555|364706926|FG000|Overall Study|transplant|1|||
105740724|NCT02817555|364706927|FG001|Overall Study|transplant|1|||
105740725|NCT02817555|364706926|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
105740726|NCT02817555|364706927|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
105740727|NCT01432262|364706928|FG000|Overall Study|Withdrawal by Subject|2|||
105740728|NCT01432262|364706929|FG001|Overall Study|Withdrawal by Subject|1|||
105740729|NCT04657016|364706930|FG000|Overall Study|Adverse Event|2|||
105740730|NCT04657016|364706931|FG001|Overall Study|Adverse Event|4|||
105740731|NCT04657016|364706930|FG000|Overall Study|Death|1|||
105740732|NCT04657016|364706931|FG001|Overall Study|Death|1|||
105740733|NCT04657016|364706930|FG000|Overall Study|Lost to Follow-up|24|||
105740734|NCT04657016|364706931|FG001|Overall Study|Lost to Follow-up|12|||
105740735|NCT04657016|364706930|FG000|Overall Study|Physician Decision|1|||
105740736|NCT04657016|364706931|FG001|Overall Study|Physician Decision|2|||
105740737|NCT04657016|364706930|FG000|Overall Study|Pregnancy|2|||
105740738|NCT04657016|364706931|FG001|Overall Study|Pregnancy|2|||
105740739|NCT04657016|364706930|FG000|Overall Study|Protocol Deviation|1|||
105740740|NCT04657016|364706931|FG001|Overall Study|Protocol Deviation|0|||
105740741|NCT04657016|364706930|FG000|Overall Study|Withdrawal by Subject|28|||
105740742|NCT04657016|364706931|FG001|Overall Study|Withdrawal by Subject|14|||
105740743|NCT04657016|364706930|FG000|Overall Study|Other - as reported by the investigator|6|||
105740744|NCT04657016|364706931|FG001|Overall Study|Other - as reported by the investigator|0|||
105740745|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
105740746|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
105740747|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
105740748|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
105740749|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Death|8|||
105740750|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Death|3|||
105740751|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
105740752|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
105740753|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
105740754|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
105740755|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
105740756|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
105740757|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
105740758|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
105740759|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
105740760|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
105740761|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
105740762|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
105740763|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
105740764|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
105740765|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
105740766|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
105740767|NCT00494871|364706932|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
105740768|NCT00494871|364706933|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
105740769|NCT00494871|364706932|FG000|Follow-up (FU) Period|Adverse Event|1|||
105740770|NCT00494871|364706933|FG001|Follow-up (FU) Period|Adverse Event|1|||
105740771|NCT00494871|364706932|FG000|Follow-up (FU) Period|Death|13|||
105740772|NCT00494871|364706933|FG001|Follow-up (FU) Period|Death|12|||
105740773|NCT00494871|364706932|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
105740774|NCT00494871|364706933|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
105740775|NCT00494871|364706932|FG000|Follow-up (FU) Period|Physician Decision|0|||
105740776|NCT00494871|364706933|FG001|Follow-up (FU) Period|Physician Decision|1|||
105740777|NCT00494871|364706932|FG000|Follow-up (FU) Period|Protocol Violation|1|||
105740778|NCT00494871|364706933|FG001|Follow-up (FU) Period|Protocol Violation|0|||
105740779|NCT00494871|364706932|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
105740780|NCT00494871|364706933|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
105740781|NCT00494871|364706932|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
105942060|NCT02327169|365450311|FG004|Overall Study|Adverse Event|1|||
105942061|NCT02327169|365450312|FG005|Overall Study|Adverse Event|0|||
105942062|NCT02327169|365450313|FG006|Overall Study|Adverse Event|0|||
105942063|NCT02327169|365450314|FG007|Overall Study|Adverse Event|0|||
105942064|NCT02327169|365450315|FG008|Overall Study|Adverse Event|0|||
105942065|NCT02327169|365450316|FG009|Overall Study|Adverse Event|2|||
105942066|NCT02327169|365450317|FG010|Overall Study|Adverse Event|0|||
105942067|NCT02327169|365450318|FG011|Overall Study|Adverse Event|3|||
105942068|NCT02327169|365450319|FG012|Overall Study|Adverse Event|0|||
105942069|NCT02327169|365450320|FG013|Overall Study|Adverse Event|2|||
106014525|NCT00790842|365719352|FG008|Dose Level 4|Withdrawal by Subject|0|||
105740782|NCT00494871|364706933|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
105740783|NCT02078713|364706936|FG000|Overall Study|Lost to Follow-up|49|||
105740784|NCT02078713|364706937|FG001|Overall Study|Lost to Follow-up|55|||
105740785|NCT02078713|364706938|FG002|Overall Study|Lost to Follow-up|0|||
105740786|NCT02078713|364706939|FG003|Overall Study|Lost to Follow-up|0|||
105942070|NCT02327169|365450321|FG014|Overall Study|Adverse Event|1|||
105942071|NCT02327169|365450307|FG000|Overall Study|Symptomatic Deterioration|0|||
106014526|NCT00790842|365719353|FG009|Dose Level 4|Withdrawal by Subject|0|||
105740787|NCT02078713|364706936|FG000|Overall Study|Pregnant at baseline|3|||
105740788|NCT02078713|364706937|FG001|Overall Study|Pregnant at baseline|5|||
105942072|NCT02327169|365450308|FG001|Overall Study|Symptomatic Deterioration|0|||
105942073|NCT02327169|365450309|FG002|Overall Study|Symptomatic Deterioration|1|||
105942074|NCT02327169|365450310|FG003|Overall Study|Symptomatic Deterioration|0|||
105942075|NCT02327169|365450311|FG004|Overall Study|Symptomatic Deterioration|1|||
105942076|NCT02327169|365450312|FG005|Overall Study|Symptomatic Deterioration|1|||
105942077|NCT02327169|365450313|FG006|Overall Study|Symptomatic Deterioration|0|||
105942078|NCT02327169|365450314|FG007|Overall Study|Symptomatic Deterioration|0|||
105942079|NCT02327169|365450315|FG008|Overall Study|Symptomatic Deterioration|2|||
105942080|NCT02327169|365450316|FG009|Overall Study|Symptomatic Deterioration|1|||
105942081|NCT02327169|365450317|FG010|Overall Study|Symptomatic Deterioration|0|||
105942082|NCT02327169|365450318|FG011|Overall Study|Symptomatic Deterioration|0|||
105942083|NCT02327169|365450319|FG012|Overall Study|Symptomatic Deterioration|0|||
105942084|NCT02327169|365450320|FG013|Overall Study|Symptomatic Deterioration|2|||
105942085|NCT02327169|365450321|FG014|Overall Study|Symptomatic Deterioration|1|||
105942086|NCT02327169|365450307|FG000|Overall Study|Reason Not Specified|0|||
105942087|NCT02327169|365450308|FG001|Overall Study|Reason Not Specified|0|||
105942088|NCT02327169|365450309|FG002|Overall Study|Reason Not Specified|1|||
105942089|NCT02327169|365450310|FG003|Overall Study|Reason Not Specified|0|||
105942090|NCT02327169|365450311|FG004|Overall Study|Reason Not Specified|0|||
105942091|NCT02327169|365450312|FG005|Overall Study|Reason Not Specified|0|||
105942092|NCT02327169|365450313|FG006|Overall Study|Reason Not Specified|0|||
105942093|NCT02327169|365450314|FG007|Overall Study|Reason Not Specified|0|||
105740789|NCT02078713|364706938|FG002|Overall Study|Pregnant at baseline|0|||
105740790|NCT02078713|364706939|FG003|Overall Study|Pregnant at baseline|0|||
105740791|NCT02078713|364706936|FG000|Overall Study|Enrolled twice|0|||
105740792|NCT02078713|364706937|FG001|Overall Study|Enrolled twice|1|||
105740793|NCT02078713|364706938|FG002|Overall Study|Enrolled twice|0|||
105740794|NCT02078713|364706939|FG003|Overall Study|Enrolled twice|0|||
105740795|NCT01104558|364706944|FG000|Overall Study|Protocol Violation|6|||
105740796|NCT01104558|364706944|FG000|Overall Study|Missing of primary efficacy assessment|10|||
105740797|NCT01104558|364706944|FG000|Overall Study|Missing of genetic analysis results|1|||
105740798|NCT04543955|364706945|FG000|Overall Study|Company cancelled study|1|||
105740799|NCT04543955|364706946|FG001|Overall Study|Company cancelled study|0|||
105740800|NCT00696657|364706947|FG000|Overall Study|Protocol Violation|0|||
105740801|NCT00696657|364706948|FG001|Overall Study|Protocol Violation|0|||
105740802|NCT00696657|364706949|FG002|Overall Study|Protocol Violation|0|||
105740803|NCT00696657|364706950|FG003|Overall Study|Protocol Violation|0|||
105740804|NCT00696657|364706951|FG004|Overall Study|Protocol Violation|0|||
105740805|NCT00696657|364706952|FG005|Overall Study|Protocol Violation|1|||
105740806|NCT00696657|364706953|FG006|Overall Study|Protocol Violation|0|||
105740807|NCT00696657|364706954|FG007|Overall Study|Protocol Violation|0|||
105740808|NCT00696657|364706955|FG008|Overall Study|Protocol Violation|1|||
105740809|NCT00696657|364706947|FG000|Overall Study|Lack of Efficacy|0|||
105740810|NCT00696657|364706948|FG001|Overall Study|Lack of Efficacy|1|||
105740811|NCT00696657|364706949|FG002|Overall Study|Lack of Efficacy|0|||
105740812|NCT00696657|364706950|FG003|Overall Study|Lack of Efficacy|0|||
105740813|NCT00696657|364706951|FG004|Overall Study|Lack of Efficacy|0|||
105740814|NCT00696657|364706952|FG005|Overall Study|Lack of Efficacy|0|||
105740815|NCT00696657|364706953|FG006|Overall Study|Lack of Efficacy|0|||
105740816|NCT00696657|364706954|FG007|Overall Study|Lack of Efficacy|0|||
105740817|NCT00696657|364706955|FG008|Overall Study|Lack of Efficacy|0|||
105740818|NCT00696657|364706947|FG000|Overall Study|Withdrawal criteria|1|||
105740819|NCT00696657|364706948|FG001|Overall Study|Withdrawal criteria|3|||
105740820|NCT00696657|364706949|FG002|Overall Study|Withdrawal criteria|2|||
105740821|NCT00696657|364706950|FG003|Overall Study|Withdrawal criteria|2|||
105740822|NCT00696657|364706951|FG004|Overall Study|Withdrawal criteria|0|||
105942094|NCT02327169|365450315|FG008|Overall Study|Reason Not Specified|0|||
105942095|NCT02327169|365450316|FG009|Overall Study|Reason Not Specified|1|||
105942096|NCT02327169|365450317|FG010|Overall Study|Reason Not Specified|2|||
105942097|NCT02327169|365450318|FG011|Overall Study|Reason Not Specified|1|||
105942098|NCT02327169|365450319|FG012|Overall Study|Reason Not Specified|0|||
105942099|NCT02327169|365450320|FG013|Overall Study|Reason Not Specified|0|||
106142014|NCT01580293|366179807|FG002|Part A_Main Trial|Adverse Event|0|||
106142015|NCT01580293|366179805|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
105740823|NCT00696657|364706952|FG005|Overall Study|Withdrawal criteria|0|||
105740824|NCT00696657|364706953|FG006|Overall Study|Withdrawal criteria|1|||
105740825|NCT00696657|364706954|FG007|Overall Study|Withdrawal criteria|1|||
105740826|NCT00696657|364706955|FG008|Overall Study|Withdrawal criteria|2|||
105740827|NCT00696657|364706947|FG000|Overall Study|Unclassified|0|||
105740828|NCT00696657|364706948|FG001|Overall Study|Unclassified|1|||
105942100|NCT02327169|365450321|FG014|Overall Study|Reason Not Specified|2|||
105740829|NCT00696657|364706949|FG002|Overall Study|Unclassified|3|||
105740830|NCT00696657|364706950|FG003|Overall Study|Unclassified|2|||
105942101|NCT02327169|365450307|FG000|Overall Study|Withdrawal by Subject|1|||
105942102|NCT02327169|365450308|FG001|Overall Study|Withdrawal by Subject|0|||
105942103|NCT02327169|365450309|FG002|Overall Study|Withdrawal by Subject|0|||
105942104|NCT02327169|365450310|FG003|Overall Study|Withdrawal by Subject|0|||
105942105|NCT02327169|365450311|FG004|Overall Study|Withdrawal by Subject|1|||
106014527|NCT00790842|365719354|FG010|Dose Level 4|Withdrawal by Subject|1|||
106014528|NCT00790842|365719344|FG000|Expansion Cohort|Adverse Event|0|||
106014529|NCT00790842|365719345|FG001|Expansion Cohort|Adverse Event|0|||
106014530|NCT00790842|365719346|FG002|Expansion Cohort|Adverse Event|0|||
106014531|NCT00790842|365719347|FG003|Expansion Cohort|Adverse Event|0|||
106014532|NCT00790842|365719348|FG004|Expansion Cohort|Adverse Event|0|||
106014533|NCT00790842|365719349|FG005|Expansion Cohort|Adverse Event|0|||
106014534|NCT00790842|365719350|FG006|Expansion Cohort|Adverse Event|1|||
106014535|NCT00790842|365719351|FG007|Expansion Cohort|Adverse Event|0|||
106014536|NCT00790842|365719352|FG008|Expansion Cohort|Adverse Event|0|||
106014537|NCT00790842|365719353|FG009|Expansion Cohort|Adverse Event|0|||
106014538|NCT00790842|365719354|FG010|Expansion Cohort|Adverse Event|0|||
106014539|NCT00790842|365719344|FG000|Expansion Cohort|Death|0|||
106014540|NCT00790842|365719345|FG001|Expansion Cohort|Death|0|||
106014541|NCT00790842|365719346|FG002|Expansion Cohort|Death|2|||
106014542|NCT00790842|365719347|FG003|Expansion Cohort|Death|0|||
106014543|NCT00790842|365719348|FG004|Expansion Cohort|Death|0|||
106142016|NCT01580293|366179806|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
105740831|NCT00696657|364706951|FG004|Overall Study|Unclassified|4|||
105740832|NCT00696657|364706952|FG005|Overall Study|Unclassified|2|||
105740833|NCT00696657|364706953|FG006|Overall Study|Unclassified|0|||
105740834|NCT00696657|364706954|FG007|Overall Study|Unclassified|0|||
105740835|NCT00696657|364706955|FG008|Overall Study|Unclassified|1|||
105740836|NCT00696657|364706947|FG000|Overall Study|Adverse Event|0|||
105740837|NCT00696657|364706948|FG001|Overall Study|Adverse Event|0|||
105740838|NCT00696657|364706949|FG002|Overall Study|Adverse Event|3|||
105740839|NCT00696657|364706950|FG003|Overall Study|Adverse Event|7|||
105740840|NCT00696657|364706951|FG004|Overall Study|Adverse Event|6|||
105740841|NCT00696657|364706952|FG005|Overall Study|Adverse Event|9|||
105740842|NCT00696657|364706953|FG006|Overall Study|Adverse Event|14|||
105740843|NCT00696657|364706954|FG007|Overall Study|Adverse Event|2|||
105740844|NCT00696657|364706955|FG008|Overall Study|Adverse Event|5|||
105740845|NCT03653507|364706958|FG000|Overall Study|Miscellaneous|26|||
105740846|NCT03653507|364706959|FG001|Overall Study|Miscellaneous|16|||
105740847|NCT03653507|364706958|FG000|Overall Study|Withdrawal by Subject|35|||
105740848|NCT03653507|364706959|FG001|Overall Study|Withdrawal by Subject|23|||
105740849|NCT03653507|364706958|FG000|Overall Study|Protocol Deviation|2|||
105740850|NCT03653507|364706959|FG001|Overall Study|Protocol Deviation|1|||
105740851|NCT03653507|364706958|FG000|Overall Study|Progressive disease|102|||
105740852|NCT03653507|364706959|FG001|Overall Study|Progressive disease|157|||
105740853|NCT03653507|364706958|FG000|Overall Study|Lost to Follow-up|1|||
105740854|NCT03653507|364706959|FG001|Overall Study|Lost to Follow-up|1|||
105740855|NCT03653507|364706958|FG000|Overall Study|Death|24|||
105740856|NCT03653507|364706959|FG001|Overall Study|Death|22|||
105740857|NCT03653507|364706958|FG000|Overall Study|Adverse Event|34|||
105740858|NCT03653507|364706959|FG001|Overall Study|Adverse Event|15|||
105740859|NCT02433210|364706960|FG000|Overall Study|Physician Decision|1|||
105740860|NCT02433210|364706961|FG001|Overall Study|Physician Decision|0|||
105740861|NCT02433210|364706962|FG002|Overall Study|Physician Decision|0|||
105740862|NCT01356602|364706963|FG000|Overall Study|Protocol Deviation|0|||
105942106|NCT02327169|365450312|FG005|Overall Study|Withdrawal by Subject|0|||
105942107|NCT02327169|365450313|FG006|Overall Study|Withdrawal by Subject|0|||
105942108|NCT02327169|365450314|FG007|Overall Study|Withdrawal by Subject|1|||
105942109|NCT02327169|365450315|FG008|Overall Study|Withdrawal by Subject|0|||
105942110|NCT02327169|365450316|FG009|Overall Study|Withdrawal by Subject|0|||
105942111|NCT02327169|365450317|FG010|Overall Study|Withdrawal by Subject|0|||
105942112|NCT02327169|365450318|FG011|Overall Study|Withdrawal by Subject|0|||
105942113|NCT02327169|365450319|FG012|Overall Study|Withdrawal by Subject|0|||
105942114|NCT02327169|365450320|FG013|Overall Study|Withdrawal by Subject|0|||
105942115|NCT02327169|365450321|FG014|Overall Study|Withdrawal by Subject|3|||
105942116|NCT02327169|365450307|FG000|Overall Study|Lost to Follow-up|0|||
105942117|NCT02327169|365450308|FG001|Overall Study|Lost to Follow-up|0|||
105942118|NCT02327169|365450309|FG002|Overall Study|Lost to Follow-up|0|||
105942119|NCT02327169|365450310|FG003|Overall Study|Lost to Follow-up|0|||
106014544|NCT00790842|365719349|FG005|Expansion Cohort|Death|0|||
105740863|NCT01356602|364706964|FG001|Overall Study|Protocol Deviation|1|||
105740864|NCT01356602|364706965|FG002|Overall Study|Protocol Deviation|1|||
105740865|NCT01356602|364706963|FG000|Overall Study|Administrative Problems|1|||
105740866|NCT01356602|364706964|FG001|Overall Study|Administrative Problems|4|||
105942120|NCT02327169|365450311|FG004|Overall Study|Lost to Follow-up|1|||
105942121|NCT02327169|365450312|FG005|Overall Study|Lost to Follow-up|0|||
106014545|NCT00790842|365719350|FG006|Expansion Cohort|Death|0|||
106014546|NCT00790842|365719351|FG007|Expansion Cohort|Death|0|||
106014547|NCT00790842|365719352|FG008|Expansion Cohort|Death|0|||
105740867|NCT01356602|364706965|FG002|Overall Study|Administrative Problems|5|||
105740868|NCT01356602|364706963|FG000|Overall Study|Lost to Follow-up|4|||
105740869|NCT01356602|364706964|FG001|Overall Study|Lost to Follow-up|5|||
105942122|NCT02327169|365450313|FG006|Overall Study|Lost to Follow-up|0|||
106014548|NCT00790842|365719353|FG009|Expansion Cohort|Death|0|||
106014549|NCT00790842|365719354|FG010|Expansion Cohort|Death|0|||
106014550|NCT00790842|365719344|FG000|Expansion Cohort|Physician Decision|0|||
105942123|NCT02327169|365450314|FG007|Overall Study|Lost to Follow-up|0|||
105942124|NCT02327169|365450315|FG008|Overall Study|Lost to Follow-up|0|||
105942125|NCT02327169|365450316|FG009|Overall Study|Lost to Follow-up|0|||
105942126|NCT02327169|365450317|FG010|Overall Study|Lost to Follow-up|0|||
105942127|NCT02327169|365450318|FG011|Overall Study|Lost to Follow-up|0|||
105942128|NCT02327169|365450319|FG012|Overall Study|Lost to Follow-up|0|||
105942129|NCT02327169|365450320|FG013|Overall Study|Lost to Follow-up|0|||
105942130|NCT02327169|365450321|FG014|Overall Study|Lost to Follow-up|0|||
105942131|NCT00478257|365450322|FG000|Overall Study|Withdrawal by Subject|8|||
105942132|NCT00478257|365450323|FG001|Overall Study|Withdrawal by Subject|3|||
105942133|NCT03931330|365450324|FG000|Overall Study|Physician Decision|1|||
105942134|NCT01381679|365450327|FG000|Overall Study|Adverse Event|3|||
105942135|NCT01381679|365450327|FG000|Overall Study|Lost to Follow-up|885|||
105942136|NCT02758626|365450328|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
105942137|NCT02758626|365450329|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
105942138|NCT02758626|365450328|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
105942139|NCT02758626|365450329|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
105942140|NCT02758626|365450328|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
105942141|NCT02758626|365450329|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
105942142|NCT02758626|365450328|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
105942143|NCT02758626|365450329|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
105942144|NCT02609503|365450330|FG000|Overall Study|Adverse Event|1|||
105942145|NCT02609503|365450330|FG000|Overall Study|Death|1|||
105942146|NCT02609503|365450330|FG000|Overall Study|Withdrawal by Subject|1|||
106014551|NCT00790842|365719345|FG001|Expansion Cohort|Physician Decision|0|||
105942147|NCT02609503|365450330|FG000|Overall Study|Disease progression|1|||
105942148|NCT02096354|365450331|FG000|Overall Study|Physician Decision|4|||
105942149|NCT02096354|365450332|FG001|Overall Study|Physician Decision|5|||
105942150|NCT02096354|365450333|FG002|Overall Study|Physician Decision|0|||
105942151|NCT02096354|365450331|FG000|Overall Study|Withdrawal by Subject|3|||
105942152|NCT02096354|365450332|FG001|Overall Study|Withdrawal by Subject|1|||
105942153|NCT02096354|365450333|FG002|Overall Study|Withdrawal by Subject|0|||
105942154|NCT02096354|365450331|FG000|Overall Study|Adverse Event|7|||
105942155|NCT02096354|365450332|FG001|Overall Study|Adverse Event|4|||
105942156|NCT02096354|365450333|FG002|Overall Study|Adverse Event|0|||
105942157|NCT02096354|365450331|FG000|Overall Study|Ineligible|0|||
105942158|NCT02096354|365450332|FG001|Overall Study|Ineligible|0|||
105942159|NCT02096354|365450333|FG002|Overall Study|Ineligible|11|||
105942160|NCT02951819|365450334|FG000|Overall Study|Death|9|||
105942161|NCT02951819|365450335|FG001|Overall Study|Death|7|||
105942162|NCT02951819|365450334|FG000|Overall Study|Withdrawal by Subject|3|||
105942163|NCT02951819|365450335|FG001|Overall Study|Withdrawal by Subject|0|||
105800025|NCT01335399|364926338|FG001|Pre-treatment Period|Participant request to discontinue|1|||
105800026|NCT01335399|364926337|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
105800027|NCT01335399|364926338|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
105800028|NCT01335399|364926337|FG000|Pre-treatment Period|Consent withdrawal|3|||
105800029|NCT01335399|364926338|FG001|Pre-treatment Period|Consent withdrawal|0|||
105800030|NCT01335399|364926337|FG000|Treatment Period|Disease progression|117|||
105800031|NCT01335399|364926338|FG001|Treatment Period|Disease progression|145|||
105800032|NCT01335399|364926337|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
105800033|NCT01335399|364926338|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
105800034|NCT01335399|364926337|FG000|Treatment Period|Study drug toxicity|52|||
105800035|NCT01335399|364926338|FG001|Treatment Period|Study drug toxicity|64|||
105800036|NCT01335399|364926337|FG000|Treatment Period|Participant request to discontinue|30|||
105800037|NCT01335399|364926338|FG001|Treatment Period|Participant request to discontinue|22|||
105800038|NCT01335399|364926337|FG000|Treatment Period|Other reasons|30|||
105800039|NCT01335399|364926338|FG001|Treatment Period|Other reasons|30|||
105800040|NCT01335399|364926337|FG000|Treatment Period|Consent withdrawal|10|||
105800041|NCT01335399|364926338|FG001|Treatment Period|Consent withdrawal|7|||
105942164|NCT02951819|365450334|FG000|Overall Study|Adverse Event|1|||
105942165|NCT02951819|365450335|FG001|Overall Study|Adverse Event|0|||
106014552|NCT00790842|365719346|FG002|Expansion Cohort|Physician Decision|1|||
106014553|NCT00790842|365719347|FG003|Expansion Cohort|Physician Decision|0|||
105800042|NCT01335399|364926337|FG000|Treatment Period|Death|7|||
105800043|NCT01335399|364926338|FG001|Treatment Period|Death|6|||
105942166|NCT02951819|365450334|FG000|Overall Study|Lack of Efficacy|4|||
105942167|NCT02951819|365450335|FG001|Overall Study|Lack of Efficacy|0|||
105800044|NCT01335399|364926337|FG000|Treatment Period|Poor/Non-compliance|3|||
105942168|NCT02951819|365450334|FG000|Overall Study|Lost to Follow-up|1|||
105942169|NCT02951819|365450335|FG001|Overall Study|Lost to Follow-up|0|||
105942170|NCT02951819|365450334|FG000|Overall Study|Progressive Disease|1|||
105942171|NCT02951819|365450335|FG001|Overall Study|Progressive Disease|0|||
105942172|NCT02951819|365450334|FG000|Overall Study|Other|9|||
105942173|NCT02951819|365450335|FG001|Overall Study|Other|0|||
106014554|NCT00790842|365719348|FG004|Expansion Cohort|Physician Decision|0|||
106142017|NCT01580293|366179807|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
106142018|NCT01580293|366179805|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
106142019|NCT01580293|366179806|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
106142020|NCT01580293|366179807|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
106142021|NCT01580293|366179805|FG000|Part A_Extension|Adverse Event|0|||
106142022|NCT01580293|366179806|FG001|Part A_Extension|Adverse Event|2|||
106142023|NCT01580293|366179807|FG002|Part A_Extension|Adverse Event|0|||
106142024|NCT01580293|366179805|FG000|Part A_Extension|Withdrawal by Subject|0|||
106142025|NCT01580293|366179806|FG001|Part A_Extension|Withdrawal by Subject|3|||
106142026|NCT01580293|366179807|FG002|Part A_Extension|Withdrawal by Subject|0|||
106142027|NCT01580293|366179805|FG000|Part A_Extension|Lost to Follow-up|0|||
106142028|NCT01580293|366179806|FG001|Part A_Extension|Lost to Follow-up|1|||
106142029|NCT01580293|366179807|FG002|Part A_Extension|Lost to Follow-up|0|||
106142030|NCT01580293|366179805|FG000|Part A_Extension|Other Reason|0|||
106142031|NCT01580293|366179806|FG001|Part A_Extension|Other Reason|1|||
106142032|NCT01580293|366179807|FG002|Part A_Extension|Other Reason|0|||
106142033|NCT01580293|366179805|FG000|Part A_Extension|Completed Japan only|0|||
106142034|NCT01580293|366179806|FG001|Part A_Extension|Completed Japan only|5|||
106142035|NCT01580293|366179807|FG002|Part A_Extension|Completed Japan only|0|||
106142036|NCT01580293|366179805|FG000|Part B|Withdrawal by Subject|0|||
106142037|NCT01580293|366179806|FG001|Part B|Withdrawal by Subject|0|||
105740870|NCT01356602|364706965|FG002|Overall Study|Lost to Follow-up|6|||
105740871|NCT01356602|364706963|FG000|Overall Study|Withdrawal by Subject|4|||
105740872|NCT01356602|364706964|FG001|Overall Study|Withdrawal by Subject|3|||
105740873|NCT01356602|364706965|FG002|Overall Study|Withdrawal by Subject|7|||
105740874|NCT01356602|364706963|FG000|Overall Study|Lack of Efficacy|0|||
105740875|NCT01356602|364706964|FG001|Overall Study|Lack of Efficacy|1|||
105740876|NCT01356602|364706965|FG002|Overall Study|Lack of Efficacy|4|||
105740877|NCT01356602|364706963|FG000|Overall Study|Adverse Event|0|||
105740878|NCT01356602|364706964|FG001|Overall Study|Adverse Event|1|||
105740879|NCT01356602|364706965|FG002|Overall Study|Adverse Event|1|||
105740880|NCT01115569|364706968|FG000|Conversion/Titration Phase|Adverse Event|59|||
106142038|NCT01580293|366179807|FG002|Part B|Withdrawal by Subject|1|||
105740881|NCT01115569|364706969|FG001|Conversion/Titration Phase|Adverse Event|0|||
105740882|NCT01115569|364706968|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
105740883|NCT01115569|364706969|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
105740884|NCT01115569|364706968|FG000|Conversion/Titration Phase|Physician Decision|5|||
105740885|NCT01115569|364706969|FG001|Conversion/Titration Phase|Physician Decision|0|||
105740886|NCT01115569|364706968|FG000|Conversion/Titration Phase|Protocol Violation|68|||
106014555|NCT00790842|365719349|FG005|Expansion Cohort|Physician Decision|0|||
106142039|NCT01580293|366179805|FG000|Part B|Other reason|0|||
106142040|NCT01580293|366179806|FG001|Part B|Other reason|0|||
106142041|NCT01580293|366179807|FG002|Part B|Other reason|1|||
106142042|NCT00423098|366179808|FG000|Overall Study|Adverse Event|1|||
106142043|NCT00423098|366179809|FG001|Overall Study|Adverse Event|2|||
106142044|NCT00423098|366179808|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105740887|NCT01115569|364706969|FG001|Conversion/Titration Phase|Protocol Violation|0|||
105740888|NCT01115569|364706968|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
105740889|NCT01115569|364706969|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
105740890|NCT01115569|364706968|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
105740891|NCT01115569|364706969|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
106142045|NCT00423098|366179809|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
106014556|NCT00790842|365719350|FG006|Expansion Cohort|Physician Decision|0|||
106014557|NCT00790842|365719351|FG007|Expansion Cohort|Physician Decision|0|||
106142046|NCT00423098|366179808|FG000|Overall Study|Administrative problems|0|||
106142047|NCT00423098|366179809|FG001|Overall Study|Administrative problems|1|||
105740892|NCT01115569|364706968|FG000|Maintenance Phase|Adverse Event|0|||
105740893|NCT01115569|364706969|FG001|Maintenance Phase|Adverse Event|43|||
105740894|NCT01115569|364706968|FG000|Maintenance Phase|Lost to Follow-up|0|||
105740895|NCT01115569|364706969|FG001|Maintenance Phase|Lost to Follow-up|8|||
105740896|NCT01115569|364706968|FG000|Maintenance Phase|Physician Decision|0|||
105740897|NCT01115569|364706969|FG001|Maintenance Phase|Physician Decision|3|||
105740898|NCT01115569|364706968|FG000|Maintenance Phase|Protocol Violation|0|||
105740899|NCT01115569|364706969|FG001|Maintenance Phase|Protocol Violation|9|||
105740900|NCT01115569|364706968|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105740901|NCT01115569|364706969|FG001|Maintenance Phase|Withdrawal by Subject|27|||
105740902|NCT01115569|364706968|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
105740903|NCT01115569|364706969|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
105740904|NCT01115569|364706968|FG000|Maintenance Phase|Administrative|0|||
105740905|NCT01115569|364706969|FG001|Maintenance Phase|Administrative|1|||
105740906|NCT01614769|364706970|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
105740907|NCT01614769|364706971|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
105740908|NCT01614769|364706972|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
105740909|NCT01614769|364706973|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
105740910|NCT01614769|364706974|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
105740911|NCT01614769|364706975|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
105740912|NCT01614769|364706970|FG000|Period 1|Protocol Violation|0|||
105740913|NCT01614769|364706971|FG001|Period 1|Protocol Violation|0|||
105740914|NCT01614769|364706972|FG002|Period 1|Protocol Violation|0|||
105740915|NCT01614769|364706973|FG003|Period 1|Protocol Violation|1|||
105740916|NCT01614769|364706974|FG004|Period 1|Protocol Violation|0|||
105740917|NCT01614769|364706975|FG005|Period 1|Protocol Violation|0|||
105740918|NCT01614769|364706970|FG000|Period 1|Withdrawal by Subject|1|||
105740919|NCT01614769|364706971|FG001|Period 1|Withdrawal by Subject|0|||
105740920|NCT01614769|364706972|FG002|Period 1|Withdrawal by Subject|0|||
105740921|NCT01614769|364706973|FG003|Period 1|Withdrawal by Subject|0|||
105800045|NCT01335399|364926338|FG001|Treatment Period|Poor/Non-compliance|4|||
105740922|NCT01614769|364706974|FG004|Period 1|Withdrawal by Subject|0|||
105740923|NCT01614769|364706975|FG005|Period 1|Withdrawal by Subject|0|||
105740924|NCT01614769|364706970|FG000|Period 3|Withdrawal by Subject|0|||
105740925|NCT01614769|364706971|FG001|Period 3|Withdrawal by Subject|0|||
105740926|NCT01614769|364706972|FG002|Period 3|Withdrawal by Subject|1|||
105740927|NCT01614769|364706973|FG003|Period 3|Withdrawal by Subject|0|||
105740928|NCT01614769|364706974|FG004|Period 3|Withdrawal by Subject|0|||
105942174|NCT03647137|365450337|FG000|Overall Study|Scan Limitation|2|||
105942175|NCT03647137|365450338|FG001|Overall Study|Scan Limitation|1|||
105942176|NCT03647137|365450339|FG002|Overall Study|Scan Limitation|1|||
105942177|NCT03647137|365450340|FG003|Overall Study|Scan Limitation|2|||
105942178|NCT03900650|365450341|FG000|Overall Study|Withdrawal by Subject|1|||
105942179|NCT03900650|365450342|FG001|Overall Study|Withdrawal by Subject|1|||
105942180|NCT03900650|365450343|FG002|Overall Study|Withdrawal by Subject|0|||
105942181|NCT03900650|365450344|FG003|Overall Study|Withdrawal by Subject|0|||
105942182|NCT03900650|365450341|FG000|Overall Study|Withdrawn by staff|1|||
105942183|NCT03900650|365450342|FG001|Overall Study|Withdrawn by staff|0|||
105942184|NCT03900650|365450343|FG002|Overall Study|Withdrawn by staff|0|||
105942185|NCT03900650|365450344|FG003|Overall Study|Withdrawn by staff|0|||
105942186|NCT01969409|365450347|FG000|Overall Study|Death|2|||
105942187|NCT01969409|365450348|FG001|Overall Study|Death|2|||
105942188|NCT01969409|365450347|FG000|Overall Study|Transplant|1|||
105942189|NCT01969409|365450348|FG001|Overall Study|Transplant|1|||
105942190|NCT01969409|365450347|FG000|Overall Study|Withdrawal by Subject|0|||
105942191|NCT01969409|365450348|FG001|Overall Study|Withdrawal by Subject|1|||
105942192|NCT02799043|365450350|FG000|Overall Study|Adverse Event|0|||
105942193|NCT02799043|365450351|FG001|Overall Study|Adverse Event|1|||
105942194|NCT02799043|365450350|FG000|Overall Study|Death|1|||
105942195|NCT02799043|365450351|FG001|Overall Study|Death|1|||
105942196|NCT02799043|365450350|FG000|Overall Study|Lost to Follow-up|3|||
105942197|NCT02799043|365450351|FG001|Overall Study|Lost to Follow-up|6|||
105942198|NCT02799043|365450350|FG000|Overall Study|Withdrawal by Subject|4|||
105942199|NCT02799043|365450351|FG001|Overall Study|Withdrawal by Subject|4|||
105942200|NCT02799043|365450350|FG000|Overall Study|Moved to different country|0|||
105942201|NCT02799043|365450351|FG001|Overall Study|Moved to different country|1|||
105942202|NCT02799043|365450350|FG000|Overall Study|Trial Screen Failure|1|||
105942203|NCT02799043|365450351|FG001|Overall Study|Trial Screen Failure|0|||
105942204|NCT02799043|365450350|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
105942205|NCT02799043|365450351|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
105942206|NCT03829683|365450352|FG000|Overall Study|Lost to Follow-up|1|||
105942207|NCT03829683|365450353|FG001|Overall Study|Lost to Follow-up|0|||
105942208|NCT03829683|365450352|FG000|Overall Study|Physician Decision|3|||
106014558|NCT00790842|365719352|FG008|Expansion Cohort|Physician Decision|0|||
106014559|NCT00790842|365719353|FG009|Expansion Cohort|Physician Decision|0|||
106014560|NCT00790842|365719354|FG010|Expansion Cohort|Physician Decision|0|||
106014561|NCT00790842|365719344|FG000|Expansion Cohort|Withdrawal by Subject|0|||
106014562|NCT00790842|365719345|FG001|Expansion Cohort|Withdrawal by Subject|0|||
106014563|NCT00790842|365719346|FG002|Expansion Cohort|Withdrawal by Subject|3|||
106014564|NCT00790842|365719347|FG003|Expansion Cohort|Withdrawal by Subject|0|||
106014565|NCT00790842|365719348|FG004|Expansion Cohort|Withdrawal by Subject|0|||
106014566|NCT00790842|365719349|FG005|Expansion Cohort|Withdrawal by Subject|0|||
106014567|NCT00790842|365719350|FG006|Expansion Cohort|Withdrawal by Subject|0|||
106014568|NCT00790842|365719351|FG007|Expansion Cohort|Withdrawal by Subject|0|||
106014569|NCT00790842|365719352|FG008|Expansion Cohort|Withdrawal by Subject|0|||
106014570|NCT00790842|365719353|FG009|Expansion Cohort|Withdrawal by Subject|0|||
106014571|NCT00790842|365719354|FG010|Expansion Cohort|Withdrawal by Subject|0|||
106014572|NCT00790842|365719344|FG000|Expansion Cohort|Study Closure|0|||
106014573|NCT00790842|365719345|FG001|Expansion Cohort|Study Closure|0|||
106014574|NCT00790842|365719346|FG002|Expansion Cohort|Study Closure|1|||
106014575|NCT00790842|365719347|FG003|Expansion Cohort|Study Closure|0|||
106014576|NCT00790842|365719348|FG004|Expansion Cohort|Study Closure|0|||
106014577|NCT00790842|365719349|FG005|Expansion Cohort|Study Closure|0|||
106014578|NCT00790842|365719350|FG006|Expansion Cohort|Study Closure|0|||
106014579|NCT00790842|365719351|FG007|Expansion Cohort|Study Closure|0|||
106014580|NCT00790842|365719352|FG008|Expansion Cohort|Study Closure|0|||
106014581|NCT00790842|365719353|FG009|Expansion Cohort|Study Closure|0|||
105740929|NCT01614769|364706975|FG005|Period 3|Withdrawal by Subject|0|||
105740930|NCT01228071|364706976|FG000|Overall Study|Protocol Violation|1|||
105740931|NCT01228071|364706976|FG000|Overall Study|Withdrawal by Subject|1|||
106014582|NCT00790842|365719354|FG010|Expansion Cohort|Study Closure|0|||
106014583|NCT00561925|365719355|FG000|14 Day Lead-In Period|Adverse Event|38|||
106014584|NCT00561925|365719356|FG001|14 Day Lead-In Period|Adverse Event|0|||
106014585|NCT00561925|365719357|FG002|14 Day Lead-In Period|Adverse Event|0|||
105740932|NCT02948777|364706986|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
105740933|NCT02750813|364706987|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
105740934|NCT02750813|364706988|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
105740935|NCT02750813|364706987|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
105740936|NCT02750813|364706988|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
105740937|NCT02043301|364706989|FG000|Overall Study|Discontinued|0|||
105740938|NCT02043301|364706990|FG001|Overall Study|Discontinued|1|||
105740939|NCT02043301|364706991|FG002|Overall Study|Discontinued|0|||
105740940|NCT03097328|364706992|FG000|Overall Study|Still on Therapy|2|||
105740941|NCT03097328|364706992|FG000|Overall Study|Progressive Disease|29|||
105740942|NCT03097328|364706992|FG000|Overall Study|Adverse Event|4|||
105740943|NCT03097328|364706992|FG000|Overall Study|Withdrawal by Subject|1|||
105740944|NCT03097328|364706992|FG000|Overall Study|Physician Decision|1|||
105740945|NCT03097328|364706992|FG000|Overall Study|Patient Decision|1|||
105740946|NCT03097328|364706992|FG000|Overall Study|Ineligible for Study Drug|1|||
105740947|NCT00883558|364706993|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
105740948|NCT00883558|364706994|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
105740949|NCT00883558|364706995|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
105740950|NCT00883558|364706993|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
105740951|NCT00883558|364706994|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
105740952|NCT00883558|364706995|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
105740953|NCT00883558|364706993|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
105740954|NCT00883558|364706994|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
105740955|NCT00883558|364706995|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
105740956|NCT00883558|364706993|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
105740957|NCT00883558|364706994|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
105740958|NCT00883558|364706995|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
105740959|NCT00883558|364706993|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
105740960|NCT00883558|364706994|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
106014586|NCT00561925|365719358|FG003|14 Day Lead-In Period|Adverse Event|0|||
106014587|NCT00561925|365719359|FG004|14 Day Lead-In Period|Adverse Event|0|||
106014588|NCT00561925|365719355|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
106014589|NCT00561925|365719356|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
106014590|NCT00561925|365719357|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
106014591|NCT00561925|365719358|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
106014592|NCT00561925|365719359|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
106014593|NCT00561925|365719355|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
106014594|NCT00561925|365719356|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
105740961|NCT00883558|364706995|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
105740962|NCT02436577|364706996|FG000|Overall Study|Protocol Deviation|0|||
105740963|NCT02436577|364706997|FG001|Overall Study|Protocol Deviation|1|||
105740964|NCT02436577|364706998|FG002|Overall Study|Protocol Deviation|0|||
105800046|NCT01335399|364926337|FG000|Treatment Period|Lost to Follow-up|2|||
105800047|NCT01335399|364926338|FG001|Treatment Period|Lost to Follow-up|2|||
105800048|NCT01335399|364926337|FG000|Treatment Period|Maximum clinical benefit|1|||
105800049|NCT01335399|364926338|FG001|Treatment Period|Maximum clinical benefit|1|||
105800050|NCT01335399|364926337|FG000|Treatment Period|No longer meet study criteria|1|||
105800051|NCT01335399|364926338|FG001|Treatment Period|No longer meet study criteria|1|||
105800052|NCT01335399|364926337|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
105800053|NCT01335399|364926338|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
105800054|NCT03262233|364926339|FG000|Overall Study|Withdrawal by Subject|12|||
105800055|NCT03262233|364926340|FG001|Overall Study|Withdrawal by Subject|8|||
105800056|NCT03262233|364926341|FG002|Overall Study|Withdrawal by Subject|21|||
105800057|NCT03262233|364926342|FG003|Overall Study|Withdrawal by Subject|13|||
105800058|NCT03262233|364926339|FG000|Overall Study|Declined due to shock|1|||
105800059|NCT03262233|364926340|FG001|Overall Study|Declined due to shock|2|||
105800060|NCT03262233|364926341|FG002|Overall Study|Declined due to shock|2|||
105800061|NCT03262233|364926342|FG003|Overall Study|Declined due to shock|3|||
105800062|NCT03262233|364926339|FG000|Overall Study|Protocol Violation|5|||
105800063|NCT03262233|364926340|FG001|Overall Study|Protocol Violation|10|||
105800064|NCT03262233|364926341|FG002|Overall Study|Protocol Violation|2|||
105800065|NCT03262233|364926342|FG003|Overall Study|Protocol Violation|13|||
105800066|NCT03262233|364926339|FG000|Overall Study|data collection artifact|0|||
105800067|NCT03262233|364926340|FG001|Overall Study|data collection artifact|1|||
105800068|NCT03262233|364926341|FG002|Overall Study|data collection artifact|0|||
105800069|NCT03262233|364926342|FG003|Overall Study|data collection artifact|0|||
105800070|NCT01120600|364926343|FG000|Overall Study|Adverse Event|7|||
105800071|NCT01120600|364926344|FG001|Overall Study|Adverse Event|7|||
105800072|NCT01120600|364926343|FG000|Overall Study|Excessive Bone Loss|0|||
105800073|NCT01120600|364926344|FG001|Overall Study|Excessive Bone Loss|4|||
105800074|NCT01120600|364926343|FG000|Overall Study|Lost to Follow-up|1|||
105800075|NCT01120600|364926344|FG001|Overall Study|Lost to Follow-up|3|||
105800076|NCT01120600|364926343|FG000|Overall Study|Physician Decision|1|||
105800077|NCT01120600|364926344|FG001|Overall Study|Physician Decision|3|||
105800078|NCT01120600|364926343|FG000|Overall Study|Protocol Violation|0|||
105800079|NCT01120600|364926344|FG001|Overall Study|Protocol Violation|4|||
105800080|NCT01120600|364926343|FG000|Overall Study|Withdrawal by Subject|10|||
105800081|NCT01120600|364926344|FG001|Overall Study|Withdrawal by Subject|11|||
105800082|NCT01011907|364926345|FG000|Overall Study|Withdrawal by Subject|13|||
105800083|NCT01011907|364926346|FG001|Overall Study|Withdrawal by Subject|11|||
105800084|NCT01011907|364926345|FG000|Overall Study|Adverse Event|1|||
105800085|NCT01011907|364926346|FG001|Overall Study|Adverse Event|4|||
105800086|NCT01406873|364926349|FG000|Overall Study|Withdrawal by Subject|1|||
105800087|NCT01406873|364926350|FG001|Overall Study|Withdrawal by Subject|1|||
105800088|NCT03990389|364926351|FG000|Overall Study|Lost to Follow-up|3|||
106014595|NCT00561925|365719357|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
106014596|NCT00561925|365719358|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
105800089|NCT03990389|364926352|FG001|Overall Study|Lost to Follow-up|0|||
105800090|NCT00207714|364926353|FG000|Overall Study|Adverse Event|6|||
105800091|NCT00207714|364926354|FG001|Overall Study|Adverse Event|2|||
105800092|NCT00207714|364926355|FG002|Overall Study|Adverse Event|4|||
105800093|NCT00207714|364926356|FG003|Overall Study|Adverse Event|3|||
105800094|NCT00207714|364926357|FG004|Overall Study|Adverse Event|1|||
105800095|NCT00207714|364926353|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
106014597|NCT00561925|365719359|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
106014598|NCT00561925|365719355|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
106014599|NCT00561925|365719356|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
106014600|NCT00561925|365719357|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
106014601|NCT00561925|365719358|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
106014602|NCT00561925|365719359|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
106014603|NCT00561925|365719355|FG000|14 Day Lead-In Period|Other|5|||
106014604|NCT00561925|365719356|FG001|14 Day Lead-In Period|Other|0|||
106142048|NCT00423098|366179808|FG000|Overall Study|Death|2|||
105800096|NCT00207714|364926354|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105800097|NCT00207714|364926355|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
105800098|NCT00207714|364926356|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
105800099|NCT00207714|364926357|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
106142049|NCT00423098|366179809|FG001|Overall Study|Death|0|||
106142050|NCT04035668|366179810|FG000|Overall Study|Adverse Event|3|||
105800100|NCT00207714|364926353|FG000|Overall Study|Other|3|||
105800101|NCT00207714|364926354|FG001|Overall Study|Other|2|||
105800102|NCT00207714|364926355|FG002|Overall Study|Other|5|||
105800103|NCT00207714|364926356|FG003|Overall Study|Other|1|||
105800104|NCT00207714|364926357|FG004|Overall Study|Other|0|||
105800105|NCT03627195|364926358|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
105800106|NCT03627195|364926359|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105800107|NCT03627195|364926360|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105800108|NCT03627195|364926361|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
106014605|NCT00561925|365719357|FG002|14 Day Lead-In Period|Other|0|||
105942209|NCT03829683|365450353|FG001|Overall Study|Physician Decision|1|||
105942210|NCT03829683|365450352|FG000|Overall Study|Withdrawal by Subject|0|||
105942211|NCT03829683|365450353|FG001|Overall Study|Withdrawal by Subject|1|||
105942212|NCT03829683|365450352|FG000|Overall Study|Discharge from hospital|1|||
105942213|NCT03829683|365450353|FG001|Overall Study|Discharge from hospital|0|||
105942214|NCT03078868|365450357|FG000|Overall Study|Physician Decision|3|||
105942215|NCT04629196|365450358|FG000|Overall Study|Subject discontinued study drug|1|||
105942216|NCT04629196|365450359|FG001|Overall Study|Subject discontinued study drug|0|||
105740965|NCT02436577|364706999|FG003|Overall Study|Protocol Deviation|0|||
105740966|NCT02436577|364707000|FG004|Overall Study|Protocol Deviation|0|||
105740967|NCT02436577|364707001|FG005|Overall Study|Protocol Deviation|0|||
105740968|NCT01675011|364707005|FG000|Overall Study|Trial terminated by Sponsor|3|||
105740969|NCT01675011|364707006|FG001|Overall Study|Trial terminated by Sponsor|1|||
105740970|NCT01252134|364707007|FG000|Period 1, 8 Hours|Personal Reasons|0|||
105740971|NCT01252134|364707008|FG001|Period 1, 8 Hours|Personal Reasons|1|||
105740972|NCT01252134|364707009|FG002|Period 1, 8 Hours|Personal Reasons|1|||
105740973|NCT01252134|364707010|FG003|Period 1, 8 Hours|Personal Reasons|0|||
105740974|NCT01252134|364707011|FG004|Period 1, 8 Hours|Personal Reasons|0|||
105740975|NCT01252134|364707012|FG005|Period 1, 8 Hours|Personal Reasons|0|||
105740976|NCT01703286|364707023|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
105740977|NCT01703286|364707024|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
105740978|NCT01703286|364707025|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
105740979|NCT01703286|364707026|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
105740980|NCT01703286|364707027|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
105740981|NCT01703286|364707028|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
105740982|NCT01703286|364707023|FG000|Period 2 Including Washout|Adverse Event|0|||
105740983|NCT01703286|364707024|FG001|Period 2 Including Washout|Adverse Event|0|||
105740984|NCT01703286|364707025|FG002|Period 2 Including Washout|Adverse Event|0|||
105740985|NCT01703286|364707026|FG003|Period 2 Including Washout|Adverse Event|1|||
105740986|NCT01703286|364707027|FG004|Period 2 Including Washout|Adverse Event|0|||
105740987|NCT01703286|364707028|FG005|Period 2 Including Washout|Adverse Event|0|||
105740988|NCT02531373|364707029|FG000|Overall Study|Lack of Efficacy|0|||
105740989|NCT02531373|364707030|FG001|Overall Study|Lack of Efficacy|0|||
105740990|NCT02531373|364707031|FG002|Overall Study|Lack of Efficacy|0|||
105740991|NCT02531373|364707032|FG003|Overall Study|Lack of Efficacy|0|||
105740992|NCT02531373|364707033|FG004|Overall Study|Lack of Efficacy|3|||
105740993|NCT02531373|364707034|FG005|Overall Study|Lack of Efficacy|2|||
105740994|NCT02531373|364707035|FG006|Overall Study|Lack of Efficacy|4|||
105740995|NCT02531373|364707036|FG007|Overall Study|Lack of Efficacy|8|||
105740996|NCT02531373|364707037|FG008|Overall Study|Lack of Efficacy|5|||
105740997|NCT02531373|364707029|FG000|Overall Study|Lost to Follow-up|0|||
105740998|NCT02531373|364707030|FG001|Overall Study|Lost to Follow-up|0|||
105740999|NCT02531373|364707031|FG002|Overall Study|Lost to Follow-up|0|||
105741000|NCT02531373|364707032|FG003|Overall Study|Lost to Follow-up|0|||
105741001|NCT02531373|364707033|FG004|Overall Study|Lost to Follow-up|0|||
105741002|NCT02531373|364707034|FG005|Overall Study|Lost to Follow-up|2|||
105741003|NCT02531373|364707035|FG006|Overall Study|Lost to Follow-up|2|||
105741004|NCT02531373|364707036|FG007|Overall Study|Lost to Follow-up|0|||
105741005|NCT02531373|364707037|FG008|Overall Study|Lost to Follow-up|0|||
105741006|NCT02531373|364707029|FG000|Overall Study|Physician Decision|0|||
105741007|NCT02531373|364707030|FG001|Overall Study|Physician Decision|0|||
105741008|NCT02531373|364707031|FG002|Overall Study|Physician Decision|0|||
105741009|NCT02531373|364707032|FG003|Overall Study|Physician Decision|0|||
105741010|NCT02531373|364707033|FG004|Overall Study|Physician Decision|2|||
105741011|NCT02531373|364707034|FG005|Overall Study|Physician Decision|1|||
105741012|NCT02531373|364707035|FG006|Overall Study|Physician Decision|0|||
105741013|NCT02531373|364707036|FG007|Overall Study|Physician Decision|0|||
105942217|NCT04629196|365450358|FG000|Overall Study|Subject study drug dosing increased|1|||
106142051|NCT04035668|366179811|FG001|Overall Study|Adverse Event|4|||
106142052|NCT04035668|366179812|FG002|Overall Study|Adverse Event|2|||
106142053|NCT04035668|366179810|FG000|Overall Study|Lost to Follow-up|0|||
105741014|NCT02531373|364707037|FG008|Overall Study|Physician Decision|0|||
105741015|NCT02531373|364707029|FG000|Overall Study|Protocol Violation|0|||
105741016|NCT02531373|364707030|FG001|Overall Study|Protocol Violation|0|||
105741017|NCT02531373|364707031|FG002|Overall Study|Protocol Violation|0|||
105741018|NCT02531373|364707032|FG003|Overall Study|Protocol Violation|0|||
105741019|NCT02531373|364707033|FG004|Overall Study|Protocol Violation|0|||
105741020|NCT02531373|364707034|FG005|Overall Study|Protocol Violation|1|||
105741021|NCT02531373|364707035|FG006|Overall Study|Protocol Violation|1|||
105942218|NCT04629196|365450359|FG001|Overall Study|Subject study drug dosing increased|1|||
105942219|NCT04629196|365450358|FG000|Overall Study|Withdrawal by Subject|1|||
105741022|NCT02531373|364707036|FG007|Overall Study|Protocol Violation|0|||
105741023|NCT02531373|364707037|FG008|Overall Study|Protocol Violation|1|||
105741024|NCT02531373|364707029|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105741025|NCT02531373|364707030|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105741026|NCT02531373|364707031|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105741027|NCT02531373|364707032|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
106014606|NCT00561925|365719358|FG003|14 Day Lead-In Period|Other|0|||
106014607|NCT00561925|365719359|FG004|14 Day Lead-In Period|Other|0|||
106014608|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
106014609|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
106014610|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
106014611|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
106014612|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
106014613|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
106014614|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
106014615|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
106014616|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
106014617|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
106014618|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
106014619|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
106014620|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
106014621|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
106014622|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
106014623|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
106014624|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
106014625|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
106014626|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
106014627|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
106014628|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
106014629|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
105741028|NCT02531373|364707033|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105741029|NCT02531373|364707034|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
105741030|NCT02531373|364707035|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
105741031|NCT02531373|364707036|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
105741032|NCT02531373|364707037|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
105741033|NCT02531373|364707029|FG000|Overall Study|Withdrawal by Subject|0|||
105741034|NCT02531373|364707030|FG001|Overall Study|Withdrawal by Subject|0|||
105741035|NCT02531373|364707031|FG002|Overall Study|Withdrawal by Subject|0|||
105741036|NCT02531373|364707032|FG003|Overall Study|Withdrawal by Subject|0|||
105741037|NCT02531373|364707033|FG004|Overall Study|Withdrawal by Subject|3|||
105741038|NCT02531373|364707034|FG005|Overall Study|Withdrawal by Subject|0|||
105741039|NCT02531373|364707035|FG006|Overall Study|Withdrawal by Subject|0|||
105741040|NCT02531373|364707036|FG007|Overall Study|Withdrawal by Subject|0|||
105741041|NCT02531373|364707037|FG008|Overall Study|Withdrawal by Subject|0|||
105741042|NCT01035606|364707043|FG000|Overall Study|change in health, job demands,family|3|||
105741043|NCT01035606|364707044|FG001|Overall Study|change in health, job demands,family|3|||
105741044|NCT01035606|364707045|FG002|Overall Study|change in health, job demands,family|4|||
105741045|NCT00592501|364707046|FG000|Overall Study|Withdrawal by Subject|1|||
105741046|NCT00592501|364707046|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
105741047|NCT03880227|364707054|FG000|First Visit|Withdrawal by Subject|1|||
105741048|NCT03880227|364707055|FG001|First Visit|Withdrawal by Subject|0|||
105741049|NCT03880227|364707056|FG002|First Visit|Withdrawal by Subject|0|||
105741050|NCT03880227|364707057|FG003|First Visit|Withdrawal by Subject|0|||
105741051|NCT03880227|364707054|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
105741052|NCT03880227|364707055|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
105741053|NCT03880227|364707056|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
105741054|NCT03880227|364707057|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
105741055|NCT03880227|364707054|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
105741056|NCT03880227|364707055|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
105741057|NCT03880227|364707056|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
105741058|NCT03880227|364707057|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
105741059|NCT03880227|364707054|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
105741060|NCT03880227|364707055|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
105741061|NCT03880227|364707056|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
105741062|NCT03880227|364707057|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
105800109|NCT03627195|364926362|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105800110|NCT03627195|364926363|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
105741063|NCT00504166|364707058|FG000|Overall Study|Adverse Event|1|||
105741064|NCT00504166|364707059|FG001|Overall Study|Adverse Event|4|||
105741065|NCT00504166|364707058|FG000|Overall Study|Withdrawal by Subject|3|||
105800111|NCT00833547|364926364|FG000|Overall Study|Withdrawal by Subject|2|||
105800112|NCT00833547|364926365|FG001|Overall Study|Withdrawal by Subject|2|||
106014630|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
106014631|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
106014632|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
106014633|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
106014634|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
106014635|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
106014636|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
106014637|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
106014638|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Death|0|||
106014639|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Death|6|||
106014640|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Death|3|||
106014641|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Death|0|||
106014642|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Death|0|||
106014643|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
106014644|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
106014645|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
106014646|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
105741066|NCT00504166|364707059|FG001|Overall Study|Withdrawal by Subject|6|||
105741067|NCT00504166|364707058|FG000|Overall Study|Physician Decision|1|||
105741068|NCT00504166|364707059|FG001|Overall Study|Physician Decision|1|||
105741069|NCT00504166|364707058|FG000|Overall Study|Lost to Follow-up|1|||
105741070|NCT00504166|364707059|FG001|Overall Study|Lost to Follow-up|3|||
105741071|NCT02650284|364707060|FG000|Overall Study|Lost to Follow-up|3|||
105741072|NCT02650284|364707061|FG001|Overall Study|Lost to Follow-up|3|||
105741073|NCT02650284|364707060|FG000|Overall Study|Consent incorrectly taken|0|||
105741074|NCT02650284|364707061|FG001|Overall Study|Consent incorrectly taken|1|||
105741075|NCT01929044|364707066|FG000|Overall Study|Adverse Event|1|||
105741076|NCT01929044|364707067|FG001|Overall Study|Adverse Event|0|||
105741077|NCT01929044|364707066|FG000|Overall Study|Protocol Violation|9|||
105741078|NCT01929044|364707067|FG001|Overall Study|Protocol Violation|14|||
105741079|NCT01929044|364707066|FG000|Overall Study|Not Treated|1|||
105741080|NCT01929044|364707067|FG001|Overall Study|Not Treated|3|||
105741081|NCT02488759|364707073|FG000|Overall Study|Disease progression|73|||
105741082|NCT02488759|364707074|FG001|Overall Study|Disease progression|111|||
105741083|NCT02488759|364707075|FG002|Overall Study|Disease progression|62|||
105741084|NCT02488759|364707076|FG003|Overall Study|Disease progression|7|||
105741085|NCT02488759|364707077|FG004|Overall Study|Disease progression|4|||
105741086|NCT02488759|364707078|FG005|Overall Study|Disease progression|2|||
105741087|NCT02488759|364707073|FG000|Overall Study|Study drug toxicity|11|||
105741088|NCT02488759|364707074|FG001|Overall Study|Study drug toxicity|33|||
105741089|NCT02488759|364707075|FG002|Overall Study|Study drug toxicity|31|||
105741090|NCT02488759|364707076|FG003|Overall Study|Study drug toxicity|0|||
105741091|NCT02488759|364707077|FG004|Overall Study|Study drug toxicity|0|||
105741092|NCT02488759|364707078|FG005|Overall Study|Study drug toxicity|2|||
105741093|NCT02488759|364707073|FG000|Overall Study|Adverse event unrelated to study drug|9|||
105741094|NCT02488759|364707074|FG001|Overall Study|Adverse event unrelated to study drug|11|||
105741095|NCT02488759|364707075|FG002|Overall Study|Adverse event unrelated to study drug|7|||
105741096|NCT02488759|364707076|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105741097|NCT02488759|364707077|FG004|Overall Study|Adverse event unrelated to study drug|1|||
105741098|NCT02488759|364707078|FG005|Overall Study|Adverse event unrelated to study drug|0|||
105741099|NCT02488759|364707073|FG000|Overall Study|Participant request to discontinue study treatment|6|||
105741100|NCT02488759|364707074|FG001|Overall Study|Participant request to discontinue study treatment|8|||
105741101|NCT02488759|364707075|FG002|Overall Study|Participant request to discontinue study treatment|4|||
105741102|NCT02488759|364707076|FG003|Overall Study|Participant request to discontinue study treatment|0|||
105741103|NCT02488759|364707077|FG004|Overall Study|Participant request to discontinue study treatment|0|||
105741104|NCT02488759|364707078|FG005|Overall Study|Participant request to discontinue study treatment|0|||
105741105|NCT02488759|364707073|FG000|Overall Study|Withdrawal by Subject|4|||
105741106|NCT02488759|364707074|FG001|Overall Study|Withdrawal by Subject|0|||
105741107|NCT02488759|364707075|FG002|Overall Study|Withdrawal by Subject|3|||
105741108|NCT02488759|364707076|FG003|Overall Study|Withdrawal by Subject|0|||
105741109|NCT02488759|364707077|FG004|Overall Study|Withdrawal by Subject|0|||
105741110|NCT02488759|364707078|FG005|Overall Study|Withdrawal by Subject|2|||
105741111|NCT02488759|364707073|FG000|Overall Study|Lost to Follow-up|0|||
105741112|NCT02488759|364707074|FG001|Overall Study|Lost to Follow-up|0|||
105741113|NCT02488759|364707075|FG002|Overall Study|Lost to Follow-up|2|||
105741114|NCT02488759|364707076|FG003|Overall Study|Lost to Follow-up|0|||
105741115|NCT02488759|364707077|FG004|Overall Study|Lost to Follow-up|0|||
106014647|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
106014648|NCT00561925|365719355|FG000|144-week Double-blind, Double-dummy|Other|0|||
105741116|NCT02488759|364707078|FG005|Overall Study|Lost to Follow-up|0|||
105741117|NCT02488759|364707073|FG000|Overall Study|Maximum clinical benefit|3|||
105741118|NCT02488759|364707074|FG001|Overall Study|Maximum clinical benefit|0|||
106014649|NCT00561925|365719356|FG001|144-week Double-blind, Double-dummy|Other|8|||
106014650|NCT00561925|365719357|FG002|144-week Double-blind, Double-dummy|Other|11|||
106014651|NCT00561925|365719358|FG003|144-week Double-blind, Double-dummy|Other|0|||
106014652|NCT00561925|365719359|FG004|144-week Double-blind, Double-dummy|Other|0|||
106014653|NCT00561925|365719355|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
106014654|NCT00561925|365719356|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
106014655|NCT00561925|365719357|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
106014656|NCT00561925|365719358|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
106014657|NCT00561925|365719359|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
106014658|NCT00891904|365719362|FG000|Overall Study|Death|1|||
106014659|NCT00891904|365719362|FG000|Overall Study|Adverse Event|1|||
106014660|NCT00907335|365719363|FG000|Overall Study|Withdrawal by Subject|2|||
106014661|NCT00907335|365719364|FG001|Overall Study|Withdrawal by Subject|0|||
106014662|NCT00907335|365719363|FG000|Overall Study|Adverse Event|4|||
106014663|NCT00907335|365719364|FG001|Overall Study|Adverse Event|1|||
106014664|NCT00907335|365719363|FG000|Overall Study|Lost to Follow-up|2|||
105741119|NCT02488759|364707075|FG002|Overall Study|Maximum clinical benefit|1|||
105741120|NCT02488759|364707076|FG003|Overall Study|Maximum clinical benefit|0|||
105741121|NCT02488759|364707077|FG004|Overall Study|Maximum clinical benefit|0|||
105741122|NCT02488759|364707078|FG005|Overall Study|Maximum clinical benefit|0|||
105741123|NCT02488759|364707073|FG000|Overall Study|Other reasons|7|||
105741124|NCT02488759|364707074|FG001|Overall Study|Other reasons|32|||
105741125|NCT02488759|364707075|FG002|Overall Study|Other reasons|23|||
105741126|NCT02488759|364707076|FG003|Overall Study|Other reasons|1|||
105741127|NCT02488759|364707077|FG004|Overall Study|Other reasons|1|||
105741128|NCT02488759|364707078|FG005|Overall Study|Other reasons|1|||
105741129|NCT04267562|364708249|FG000|Assessed for Eligibility|Screen Failure|64|||
105741130|NCT04267562|364708249|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
105741131|NCT04267562|364708249|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
105741132|NCT04267562|364708249|FG000|Assessed for Eligibility|Site closure|6|||
105741133|NCT04267562|364708249|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
105741134|NCT04267562|364708249|FG000|Assessed for Eligibility|Physician Decision|1|||
105741135|NCT04267562|364708249|FG000|Month 24|Elective hysterectomy|1|||
105741136|NCT04267562|364708249|FG000|Month 24|Lost to Follow-up|1|||
105741137|NCT04267562|364708249|FG000|Month 36|Elective hysterectomy|2|||
105741138|NCT04267562|364708249|FG000|Month 36|Lost to Follow-up|3|||
105741139|NCT00620321|364708250|FG000|Overall Study|Adverse Event|1|||
105741140|NCT00620321|364708251|FG001|Overall Study|Adverse Event|1|||
105741141|NCT00620321|364708250|FG000|Overall Study|Death|1|||
105741142|NCT00620321|364708251|FG001|Overall Study|Death|1|||
105741143|NCT00620321|364708250|FG000|Overall Study|Physician Decision|0|||
105741144|NCT00620321|364708251|FG001|Overall Study|Physician Decision|7|||
105741145|NCT00620321|364708250|FG000|Overall Study|Progressive Disease|5|||
105741146|NCT00620321|364708251|FG001|Overall Study|Progressive Disease|5|||
105741147|NCT00620321|364708250|FG000|Overall Study|Sponsor Decision|0|||
105741148|NCT00620321|364708251|FG001|Overall Study|Sponsor Decision|1|||
105741149|NCT00620321|364708250|FG000|Overall Study|Withdrawal by Subject|1|||
105741150|NCT00620321|364708251|FG001|Overall Study|Withdrawal by Subject|1|||
105741151|NCT00747617|364708253|FG000|Overall Study|Lost to Follow-up|3|||
105741152|NCT00747617|364708254|FG001|Overall Study|Lost to Follow-up|1|||
105741153|NCT01043185|364708255|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
105741154|NCT01043185|364708256|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
105741155|NCT01043185|364708257|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
105741156|NCT01043185|364708258|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
105741157|NCT01043185|364708259|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
105741158|NCT01043185|364708260|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
106014665|NCT00907335|365719364|FG001|Overall Study|Lost to Follow-up|0|||
106014666|NCT03096288|365719367|FG000|Overall Study|Withdrawal by Subject|0|||
106014667|NCT03096288|365719368|FG001|Overall Study|Withdrawal by Subject|1|||
105741159|NCT01043185|364708261|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
105741160|NCT01043185|364708262|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
105741161|NCT01043185|364708263|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
105741162|NCT01043185|364708264|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
106014668|NCT03096288|365719369|FG002|Overall Study|Withdrawal by Subject|0|||
105741163|NCT00137436|364708265|FG000|Overall Study|Adverse Event|13|||
105741164|NCT00137436|364708265|FG000|Overall Study|Death|2|||
105741165|NCT00137436|364708265|FG000|Overall Study|Lack of Efficacy|17|||
105741166|NCT00137436|364708265|FG000|Overall Study|Withdrawal by Subject|6|||
105741167|NCT00137436|364708265|FG000|Overall Study|Other|5|||
105741168|NCT03009539|364708266|FG000|Overall Study|Lost to Follow-up|132|||
105741169|NCT03009539|364708267|FG001|Overall Study|Lost to Follow-up|113|||
106014669|NCT03096288|365719370|FG003|Overall Study|Withdrawal by Subject|1|||
105741170|NCT03009539|364708268|FG002|Overall Study|Lost to Follow-up|132|||
105741171|NCT03009539|364708269|FG003|Overall Study|Lost to Follow-up|113|||
105741172|NCT03151148|364708270|FG000|Overall Study|Lost to Follow-up|1|||
106142054|NCT04035668|366179811|FG001|Overall Study|Lost to Follow-up|1|||
106142055|NCT04035668|366179812|FG002|Overall Study|Lost to Follow-up|0|||
106142056|NCT04035668|366179810|FG000|Overall Study|Physician Decision|2|||
106142057|NCT04035668|366179811|FG001|Overall Study|Physician Decision|1|||
106142058|NCT04035668|366179812|FG002|Overall Study|Physician Decision|1|||
106142059|NCT04035668|366179810|FG000|Overall Study|Subject Decision|2|||
106142060|NCT04035668|366179811|FG001|Overall Study|Subject Decision|2|||
106142061|NCT04035668|366179812|FG002|Overall Study|Subject Decision|0|||
106142062|NCT00465816|366179814|FG000|Overall Study|Lost to Follow-up|0|||
106142063|NCT00465816|366179815|FG001|Overall Study|Lost to Follow-up|0|||
106142064|NCT00465816|366179816|FG002|Overall Study|Lost to Follow-up|2|||
106142065|NCT04480827|366179817|FG000|Overall Study|Adverse Event|0|||
106142066|NCT04480827|366179818|FG001|Overall Study|Adverse Event|0|||
106142067|NCT04480827|366179819|FG002|Overall Study|Adverse Event|0|||
106142068|NCT04480827|366179820|FG003|Overall Study|Adverse Event|0|||
106142069|NCT04480827|366179821|FG004|Overall Study|Adverse Event|0|||
106142070|NCT04480827|366179822|FG005|Overall Study|Adverse Event|1|||
106142071|NCT04480827|366179823|FG006|Overall Study|Adverse Event|0|||
106142072|NCT02027558|366179829|FG000|Overall Study|Death|0|||
106142073|NCT02027558|366179830|FG001|Overall Study|Death|1|||
106142074|NCT02027558|366179829|FG000|Overall Study|Withdrawal by Subject|2|||
106142075|NCT02027558|366179830|FG001|Overall Study|Withdrawal by Subject|0|||
106142076|NCT02027558|366179829|FG000|Overall Study|Lost to Follow-up|4|||
106142077|NCT02027558|366179830|FG001|Overall Study|Lost to Follow-up|1|||
106142078|NCT02027558|366179829|FG000|Overall Study|Refused assessment|3|||
106142079|NCT02027558|366179830|FG001|Overall Study|Refused assessment|0|||
106142080|NCT03720210|366179835|FG000|Overall Study|Lost to Follow-up|1|||
106142081|NCT02698891|366179836|FG000|Overall Study|Withdrawal by Subject|2|||
106142082|NCT02698891|366179836|FG000|Overall Study|deemed ineligible|1|||
106142083|NCT02698891|366179836|FG000|Overall Study|Adverse Event|9|||
106142084|NCT00516386|366179837|FG000|Overall Study|not interested in the study|4|||
106142085|NCT00516386|366179837|FG000|Overall Study|Lost to Follow-up|2|||
106142086|NCT00703911|366179838|FG000|Overall Study|Death|1|||
106142087|NCT00703911|366179838|FG000|Overall Study|Physician Decision|6|||
106142088|NCT00703911|366179838|FG000|Overall Study|Lost to Follow-up|1|||
106142089|NCT00703911|366179838|FG000|Overall Study|Withdrawal by Subject|2|||
106142090|NCT02139046|366179839|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
106142091|NCT02139046|366179840|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
106142092|NCT02139046|366179841|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
106142093|NCT02139046|366179842|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
106142094|NCT02139046|366179843|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
106142095|NCT02139046|366179839|FG000|Overall Study|Major Protocol Deviation|9|||
106142096|NCT02139046|366179840|FG001|Overall Study|Major Protocol Deviation|10|||
106142097|NCT02139046|366179841|FG002|Overall Study|Major Protocol Deviation|16|||
105741173|NCT03151148|364708271|FG001|Overall Study|Lost to Follow-up|0|||
105741174|NCT03151148|364708270|FG000|Overall Study|Withdrawal by Subject|1|||
105741175|NCT03151148|364708271|FG001|Overall Study|Withdrawal by Subject|0|||
105741176|NCT00701727|364708272|FG000|First Treatment Period|Adverse Event|0|||
105741177|NCT00701727|364708273|FG001|First Treatment Period|Adverse Event|0|||
105741178|NCT00701727|364708272|FG000|First Treatment Period|Withdrawal by Subject|1|||
105741179|NCT00701727|364708273|FG001|First Treatment Period|Withdrawal by Subject|0|||
105741180|NCT00701727|364708272|FG000|First Treatment Period|sponsor decision|0|||
105741181|NCT00701727|364708273|FG001|First Treatment Period|sponsor decision|1|||
105741182|NCT00701727|364708272|FG000|First Treatment Period|Lost to Follow-up|0|||
105741183|NCT00701727|364708273|FG001|First Treatment Period|Lost to Follow-up|1|||
105741184|NCT00701727|364708272|FG000|Second Treatment Period|Withdrawal by Subject|2|||
105741185|NCT00701727|364708273|FG001|Second Treatment Period|Withdrawal by Subject|0|||
105741186|NCT00912015|364708275|FG000|Overall Study|Lack of Efficacy|1|||
105741187|NCT00912015|364708276|FG001|Overall Study|Lack of Efficacy|0|||
105741188|NCT00912015|364708277|FG002|Overall Study|Lack of Efficacy|0|||
105741189|NCT00912015|364708278|FG003|Overall Study|Lack of Efficacy|0|||
105741190|NCT00912015|364708275|FG000|Overall Study|Withdrawal by Subject|8|||
105741191|NCT00912015|364708276|FG001|Overall Study|Withdrawal by Subject|8|||
105741192|NCT00912015|364708277|FG002|Overall Study|Withdrawal by Subject|3|||
105741193|NCT00912015|364708278|FG003|Overall Study|Withdrawal by Subject|0|||
105741194|NCT00912015|364708275|FG000|Overall Study|Protocol Violation|1|||
105741195|NCT00912015|364708276|FG001|Overall Study|Protocol Violation|0|||
105741196|NCT00912015|364708277|FG002|Overall Study|Protocol Violation|0|||
106142098|NCT02139046|366179842|FG003|Overall Study|Major Protocol Deviation|12|||
106142099|NCT02139046|366179843|FG004|Overall Study|Major Protocol Deviation|6|||
106142100|NCT02139046|366179839|FG000|Overall Study|Lost to Follow-up|13|||
106142101|NCT02139046|366179840|FG001|Overall Study|Lost to Follow-up|16|||
105741197|NCT00912015|364708278|FG003|Overall Study|Protocol Violation|1|||
105741198|NCT00912015|364708275|FG000|Overall Study|Adverse Event|6|||
105741199|NCT00912015|364708276|FG001|Overall Study|Adverse Event|0|||
105741200|NCT00912015|364708277|FG002|Overall Study|Adverse Event|0|||
106142102|NCT02139046|366179841|FG002|Overall Study|Lost to Follow-up|16|||
106142103|NCT02139046|366179842|FG003|Overall Study|Lost to Follow-up|18|||
105741201|NCT00912015|364708278|FG003|Overall Study|Adverse Event|1|||
105741202|NCT02834403|364708281|FG000|Overall Study|Physician Decision|2|||
105741203|NCT02834403|364708282|FG001|Overall Study|Physician Decision|1|||
105741204|NCT02834403|364708283|FG002|Overall Study|Physician Decision|2|||
105741205|NCT02834403|364708284|FG003|Overall Study|Physician Decision|1|||
105741206|NCT02834403|364708285|FG004|Overall Study|Physician Decision|1|||
105741207|NCT02834403|364708286|FG005|Overall Study|Physician Decision|2|||
105741208|NCT02834403|364708287|FG006|Overall Study|Physician Decision|12|||
105741209|NCT02834403|364708281|FG000|Overall Study|Adverse Event|0|||
105741210|NCT02834403|364708282|FG001|Overall Study|Adverse Event|0|||
105741211|NCT02834403|364708283|FG002|Overall Study|Adverse Event|0|||
105741212|NCT02834403|364708284|FG003|Overall Study|Adverse Event|0|||
105741213|NCT02834403|364708285|FG004|Overall Study|Adverse Event|1|||
105741214|NCT02834403|364708286|FG005|Overall Study|Adverse Event|1|||
105741215|NCT02834403|364708287|FG006|Overall Study|Adverse Event|3|||
105741216|NCT02834403|364708281|FG000|Overall Study|Withdrawal by Subject|0|||
105741217|NCT02834403|364708282|FG001|Overall Study|Withdrawal by Subject|1|||
105741218|NCT02834403|364708283|FG002|Overall Study|Withdrawal by Subject|0|||
105741219|NCT02834403|364708284|FG003|Overall Study|Withdrawal by Subject|0|||
105741220|NCT02834403|364708285|FG004|Overall Study|Withdrawal by Subject|1|||
105741221|NCT02834403|364708286|FG005|Overall Study|Withdrawal by Subject|0|||
105741222|NCT02834403|364708287|FG006|Overall Study|Withdrawal by Subject|0|||
105741223|NCT02834403|364708281|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
105741224|NCT02834403|364708282|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
105741225|NCT02834403|364708283|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
105741226|NCT02834403|364708284|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
105741227|NCT02834403|364708285|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
105741228|NCT02834403|364708286|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
105741229|NCT02834403|364708287|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
105741230|NCT04426825|364708293|FG000|Overall Study|Death|17|||
105741231|NCT04426825|364708293|FG000|Overall Study|Lost to Follow-up|1|||
105741232|NCT04426825|364708293|FG000|Overall Study|Study terminated by sponsor|5|||
105741233|NCT01597557|364708294|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
105741234|NCT01597557|364708295|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
105741235|NCT01028651|364708299|FG000|Overall Study|Death|2|||
105741236|NCT01028651|364708299|FG000|Overall Study|Adverse Event|1|||
105741237|NCT01533935|364708300|FG000|Overall Study|Adverse Event|5|||
105741238|NCT01533935|364708301|FG001|Overall Study|Adverse Event|7|||
105741239|NCT01533935|364708302|FG002|Overall Study|Adverse Event|1|||
105741240|NCT01533935|364708303|FG003|Overall Study|Adverse Event|5|||
105741241|NCT01533935|364708304|FG004|Overall Study|Adverse Event|3|||
105741242|NCT01533935|364708300|FG000|Overall Study|Protocol Violation|0|||
105741243|NCT01533935|364708301|FG001|Overall Study|Protocol Violation|2|||
105741244|NCT01533935|364708302|FG002|Overall Study|Protocol Violation|0|||
105741245|NCT01533935|364708303|FG003|Overall Study|Protocol Violation|0|||
105741246|NCT01533935|364708304|FG004|Overall Study|Protocol Violation|0|||
105741247|NCT01533935|364708300|FG000|Overall Study|Lost to Follow-up|0|||
105741248|NCT01533935|364708301|FG001|Overall Study|Lost to Follow-up|0|||
105741249|NCT01533935|364708302|FG002|Overall Study|Lost to Follow-up|1|||
105741250|NCT01533935|364708303|FG003|Overall Study|Lost to Follow-up|0|||
105741251|NCT01533935|364708304|FG004|Overall Study|Lost to Follow-up|0|||
105741252|NCT01533935|364708300|FG000|Overall Study|Withdrawal by Subject|0|||
105741253|NCT01533935|364708301|FG001|Overall Study|Withdrawal by Subject|4|||
105741254|NCT01533935|364708302|FG002|Overall Study|Withdrawal by Subject|5|||
105741255|NCT01533935|364708303|FG003|Overall Study|Withdrawal by Subject|2|||
105741256|NCT01533935|364708304|FG004|Overall Study|Withdrawal by Subject|4|||
105741257|NCT01533935|364708300|FG000|Overall Study|Other reason not defined above|1|||
105741258|NCT01533935|364708301|FG001|Overall Study|Other reason not defined above|0|||
105741259|NCT01533935|364708302|FG002|Overall Study|Other reason not defined above|1|||
105741260|NCT01533935|364708303|FG003|Overall Study|Other reason not defined above|0|||
105741261|NCT01533935|364708304|FG004|Overall Study|Other reason not defined above|1|||
105741262|NCT03196505|364708306|FG000|Overall Study|Physician Decision|26|||
105741263|NCT03196505|364708307|FG001|Overall Study|Physician Decision|26|||
105741264|NCT01293032|364708308|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
105741265|NCT01293032|364708309|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
105741266|NCT01293032|364708310|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
105741267|NCT01293032|364708311|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
105741268|NCT01293032|364708308|FG000|Treatment|Adverse Event|0|||
105741269|NCT01293032|364708309|FG001|Treatment|Adverse Event|0|||
105741270|NCT01293032|364708310|FG002|Treatment|Adverse Event|1|||
105741271|NCT01293032|364708311|FG003|Treatment|Adverse Event|1|||
105741272|NCT01293032|364708308|FG000|Treatment|Withdrawal by Subject|2|||
105741273|NCT01293032|364708309|FG001|Treatment|Withdrawal by Subject|4|||
105741274|NCT01293032|364708310|FG002|Treatment|Withdrawal by Subject|0|||
105741275|NCT01293032|364708311|FG003|Treatment|Withdrawal by Subject|0|||
105741276|NCT01293032|364708308|FG000|Treatment|Disease Progression, relapse|0|||
105741277|NCT01293032|364708309|FG001|Treatment|Disease Progression, relapse|1|||
105741278|NCT01293032|364708310|FG002|Treatment|Disease Progression, relapse|0|||
105741279|NCT01293032|364708311|FG003|Treatment|Disease Progression, relapse|0|||
105741280|NCT01063751|364708312|FG000|Overall Study|Censored from analyses|42|||
105741281|NCT01063751|364708312|FG000|Overall Study|Withdrawal by Subject|34|||
105741282|NCT01063751|364708312|FG000|Overall Study|Lost to Follow-up|30|||
105741283|NCT01063751|364708312|FG000|Overall Study|Death|13|||
105741284|NCT01063751|364708312|FG000|Overall Study|Sponsored Terminated Study|60|||
105741285|NCT01063751|364708312|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
105741286|NCT01063751|364708312|FG000|Overall Study|Investigator site closed|10|||
105741287|NCT01063751|364708312|FG000|Overall Study|Revision|6|||
105741288|NCT01063751|364708312|FG000|Overall Study|Physician Decision|4|||
105741289|NCT02985450|364708321|FG000|Overall Study|Lost to Follow-up|7|||
105741290|NCT00431847|364708322|FG000|Overall Study|completion of less than two study visits|6|||
105741291|NCT00431847|364708323|FG001|Overall Study|completion of less than two study visits|3|||
105741292|NCT00431847|364708324|FG002|Overall Study|completion of less than two study visits|4|||
105741293|NCT00431847|364708325|FG003|Overall Study|completion of less than two study visits|14|||
105741294|NCT00431847|364708326|FG004|Overall Study|completion of less than two study visits|0|||
105741295|NCT00431847|364708322|FG000|Overall Study|Protocol Violation|0|||
105741296|NCT00431847|364708323|FG001|Overall Study|Protocol Violation|0|||
105741297|NCT00431847|364708324|FG002|Overall Study|Protocol Violation|0|||
105741298|NCT00431847|364708325|FG003|Overall Study|Protocol Violation|0|||
105741299|NCT00431847|364708326|FG004|Overall Study|Protocol Violation|1|||
105741300|NCT00339183|364708327|FG000|Overall Study|Adverse Event|5|||
105741301|NCT00339183|364708328|FG001|Overall Study|Adverse Event|3|||
105741302|NCT00339183|364708327|FG000|Overall Study|Withdrawal by Subject|16|||
105741303|NCT00339183|364708328|FG001|Overall Study|Withdrawal by Subject|19|||
105741304|NCT00339183|364708327|FG000|Overall Study|Physician Decision|2|||
105741305|NCT00339183|364708328|FG001|Overall Study|Physician Decision|4|||
105741306|NCT00339183|364708327|FG000|Overall Study|Lost to Follow-up|17|||
105741307|NCT00339183|364708328|FG001|Overall Study|Lost to Follow-up|17|||
105741308|NCT00339183|364708327|FG000|Overall Study|Protocol-specified criteria|12|||
105741309|NCT00339183|364708328|FG001|Overall Study|Protocol-specified criteria|8|||
105741310|NCT00339183|364708327|FG000|Overall Study|Missing reason|3|||
105741311|NCT00339183|364708328|FG001|Overall Study|Missing reason|1|||
105741312|NCT00339183|364708327|FG000|Overall Study|Other|46|||
105741313|NCT00339183|364708328|FG001|Overall Study|Other|40|||
105741314|NCT00339183|364708327|FG000|Overall Study|Ongoing|20|||
105741315|NCT00339183|364708328|FG001|Overall Study|Ongoing|13|||
105741316|NCT00446446|364708329|FG000|Overall Study|Death|10|||
105741317|NCT00446446|364708329|FG000|Overall Study|Withdrawal by Subject|6|||
105741318|NCT00446446|364708329|FG000|Overall Study|Other|4|||
105741319|NCT00446446|364708329|FG000|Overall Study|Disease Progession|2|||
105741320|NCT00446446|364708329|FG000|Overall Study|Adverse Event|1|||
105741321|NCT00446446|364708329|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
105741322|NCT02691247|364708335|FG000|Overall Study|Withdrawal by Subject|1|||
105741323|NCT02691247|364708336|FG001|Overall Study|Withdrawal by Subject|2|||
105741324|NCT02691247|364708337|FG002|Overall Study|Withdrawal by Subject|2|||
105741325|NCT02691247|364708335|FG000|Overall Study|Lost to Follow-up|2|||
105741326|NCT02691247|364708336|FG001|Overall Study|Lost to Follow-up|0|||
105741327|NCT02691247|364708337|FG002|Overall Study|Lost to Follow-up|1|||
105741328|NCT02399813|364708338|FG000|Overall Study|Progressive Disease-Radiographic|2|||
105741329|NCT02399813|364708338|FG000|Overall Study|Death|20|||
105741330|NCT02399813|364708338|FG000|Overall Study|Withdrawal by Subject|3|||
105741331|NCT02399813|364708338|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
106014670|NCT01411891|365719371|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
106014671|NCT01411891|365719372|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
106014672|NCT00930046|365719373|FG000|Overall Study|Wound catheter malfunctioned|1|||
105741332|NCT02399813|364708338|FG000|Overall Study|Lost to Follow-up|2|||
105741333|NCT02399813|364708338|FG000|Overall Study|Other than specified|5|||
105741334|NCT02224846|364708339|FG000|Period 1 (Month 3)|Adverse Event|2|||
105741335|NCT02224846|364708340|FG001|Period 1 (Month 3)|Adverse Event|1|||
105741336|NCT02224846|364708339|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
105741337|NCT02224846|364708340|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
105741338|NCT02224846|364708339|FG000|Period 1 (Month 3)|Protocol Violation|4|||
105741339|NCT02224846|364708340|FG001|Period 1 (Month 3)|Protocol Violation|8|||
105741340|NCT02224846|364708339|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
105741341|NCT02224846|364708340|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
105741342|NCT02224846|364708339|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
105741343|NCT02224846|364708340|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
105741344|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
105741345|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
105741346|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
106014673|NCT00930046|365719374|FG001|Overall Study|Wound catheter malfunctioned|2|||
106014674|NCT04004988|365719375|FG000|Period 1|Physician Decision|2|||
106014675|NCT04004988|365719376|FG001|Period 1|Physician Decision|0|||
106014676|NCT04004988|365719375|FG000|Period 1|Withdrawal by Subject|0|||
106014677|NCT04004988|365719376|FG001|Period 1|Withdrawal by Subject|1|||
106014678|NCT04004988|365719375|FG000|Period 1|Adverse Event|1|||
106014679|NCT04004988|365719376|FG001|Period 1|Adverse Event|2|||
105741347|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
105741348|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
105741349|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
105741350|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
105741351|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
105741352|NCT02224846|364708339|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
105741353|NCT02224846|364708340|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
105741354|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
105741355|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
105741356|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
105741357|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
105741358|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
105741359|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
105741360|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
105741361|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
105741362|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
105741363|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
105741364|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
105741365|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
105741366|NCT02224846|364708339|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
105741367|NCT02224846|364708340|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
105741368|NCT05372575|364708345|FG000|Overall Study|Protocol Violation|7|||
105741369|NCT05372575|364708346|FG001|Overall Study|Protocol Violation|16|||
105741370|NCT00053846|364708347|FG000|Overall Study|Changed mind|8|||
105741371|NCT00053846|364708348|FG001|Overall Study|Changed mind|13|||
105741372|NCT00053846|364708347|FG000|Overall Study|Became too ill|8|||
105741373|NCT00053846|364708348|FG001|Overall Study|Became too ill|7|||
105741374|NCT00053846|364708347|FG000|Overall Study|Expired|5|||
105741375|NCT00053846|364708348|FG001|Overall Study|Expired|0|||
105741376|NCT00053846|364708347|FG000|Overall Study|Became ineligible|3|||
105741377|NCT00053846|364708348|FG001|Overall Study|Became ineligible|1|||
105741378|NCT00053846|364708347|FG000|Overall Study|Did not return data|1|||
105741379|NCT00053846|364708348|FG001|Overall Study|Did not return data|2|||
105741380|NCT00053846|364708347|FG000|Overall Study|Quit due to side effects|1|||
105741381|NCT00053846|364708348|FG001|Overall Study|Quit due to side effects|3|||
105741382|NCT00053846|364708347|FG000|Overall Study|Pills too large|0|||
105741383|NCT00053846|364708348|FG001|Overall Study|Pills too large|1|||
105741384|NCT00064662|364708350|FG000|Overall Study|Death|1|||
105741385|NCT00064662|364708351|FG001|Overall Study|Death|1|||
105741386|NCT00064662|364708350|FG000|Overall Study|Lost to Follow-up|57|||
105741387|NCT00064662|364708351|FG001|Overall Study|Lost to Follow-up|44|||
105741388|NCT00064662|364708350|FG000|Overall Study|Withdrawal by Subject|14|||
105741389|NCT00064662|364708351|FG001|Overall Study|Withdrawal by Subject|14|||
105741390|NCT00064662|364708350|FG000|Overall Study|Administratively withdrawn|2|||
105741391|NCT00064662|364708351|FG001|Overall Study|Administratively withdrawn|2|||
105741392|NCT00933335|364708352|FG000|Overall Study|Lost to Follow-up|1|||
105741393|NCT00933335|364708353|FG001|Overall Study|Lost to Follow-up|3|||
105741394|NCT00933335|364708352|FG000|Overall Study|Withdrawal by Subject|0|||
105741395|NCT00933335|364708353|FG001|Overall Study|Withdrawal by Subject|1|||
105741396|NCT00933335|364708352|FG000|Overall Study|Progressive Disease|0|||
105741397|NCT00933335|364708353|FG001|Overall Study|Progressive Disease|11|||
105741398|NCT00933335|364708352|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
106014680|NCT01598532|365719377|FG000|Overall Study|Lost to Follow-up|3|||
105741399|NCT00933335|364708353|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
106014681|NCT01598532|365719377|FG000|Overall Study|Did not meet inclusion criteria|8|||
106014682|NCT00414596|365719379|FG000|Overall Study|Protocol Violation|2|||
105741400|NCT00933335|364708352|FG000|Overall Study|Co-morbid Illness|1|||
105741401|NCT00933335|364708353|FG001|Overall Study|Co-morbid Illness|0|||
105741402|NCT03196297|364708354|FG000|Main Period|Withdrawal by Subject|4|||
105741403|NCT03196297|364708354|FG000|Extension Period|Withdrawal by Subject|1|||
105741404|NCT03196297|364708354|FG000|Extension Period|Lack of Efficacy|2|||
105741405|NCT04333433|364708357|FG000|Overall Study|Withdrawal by Subject|6|||
105741406|NCT04333433|364708358|FG001|Overall Study|Withdrawal by Subject|3|||
105741407|NCT04333433|364708357|FG000|Overall Study|Death|3|||
106014683|NCT02900378|365719387|FG000|Randomization (Visit 2)|Adverse Event|14|||
106014684|NCT02900378|365719388|FG001|Randomization (Visit 2)|Adverse Event|11|||
105741408|NCT04333433|364708358|FG001|Overall Study|Death|0|||
105741409|NCT04333433|364708357|FG000|Overall Study|Lost to Follow-up|6|||
105741410|NCT04333433|364708358|FG001|Overall Study|Lost to Follow-up|1|||
105741411|NCT04333433|364708357|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
105741412|NCT04333433|364708358|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
105741413|NCT02275026|364708359|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
105741414|NCT02275026|364708359|FG000|Overall Study|Withdrawal by Subject|4|||
105741415|NCT02275026|364708359|FG000|Overall Study|Ineligible due to medical history|13|||
105741416|NCT02275026|364708359|FG000|Overall Study|MRI malfunction precluded testing|1|||
105741417|NCT02275026|364708359|FG000|Overall Study|Ineligible after MRI findings|1|||
105741418|NCT02275026|364708359|FG000|Overall Study|Lost to Follow-up|2|||
105741419|NCT02275026|364708359|FG000|Overall Study|Scanner failure|1|||
105741420|NCT05468086|364708360|FG000|Overall Study|Withdrawal by Subject|3|||
105741421|NCT05468086|364708360|FG000|Overall Study|Subject was found ineligible after consent|1|||
105741422|NCT00374907|364708361|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
105741423|NCT00374907|364708362|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
105741424|NCT00374907|364708361|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
105741425|NCT00374907|364708362|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
105741426|NCT00374907|364708361|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
105741427|NCT00374907|364708362|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
105741428|NCT00374907|364708361|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
105741429|NCT00374907|364708362|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
105741430|NCT00374907|364708361|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
105741431|NCT00374907|364708362|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
105741432|NCT02582749|364708363|FG000|Overall Study|Study terminated by funder|5|||
105741433|NCT02582749|364708364|FG001|Overall Study|Study terminated by funder|10|||
105741434|NCT02582749|364708363|FG000|Overall Study|Withdrawal by Subject|0|||
105741435|NCT02582749|364708364|FG001|Overall Study|Withdrawal by Subject|1|||
105741436|NCT04229446|364708366|FG000|Overall Study|Death|12|||
105741437|NCT04229446|364708367|FG001|Overall Study|Death|10|||
105741438|NCT04229446|364708366|FG000|Overall Study|Lost to Follow-up|5|||
105741439|NCT04229446|364708367|FG001|Overall Study|Lost to Follow-up|8|||
105741440|NCT01413178|364708368|FG000|Overall Study|Toxicity|1|||
105741441|NCT01413178|364708369|FG001|Overall Study|Toxicity|0|||
105741442|NCT01413178|364708368|FG000|Overall Study|Ineligible|0|||
105741443|NCT01413178|364708369|FG001|Overall Study|Ineligible|2|||
105741444|NCT01721408|364708370|FG000|Overall Study|Adverse Event|6|||
105741445|NCT01721408|364708371|FG001|Overall Study|Adverse Event|1|||
105741446|NCT01721408|364708370|FG000|Overall Study|Death|1|||
105741447|NCT01721408|364708371|FG001|Overall Study|Death|0|||
105741448|NCT01721408|364708370|FG000|Overall Study|Insufficient clinical response|15|||
105741449|NCT01721408|364708371|FG001|Overall Study|Insufficient clinical response|6|||
105741450|NCT01721408|364708370|FG000|Overall Study|No longer willing to participate study|9|||
105741451|NCT01721408|364708371|FG001|Overall Study|No longer willing to participate study|10|||
105741452|NCT01721408|364708370|FG000|Overall Study|Protocol Violation|0|||
105741453|NCT01721408|364708371|FG001|Overall Study|Protocol Violation|2|||
105741454|NCT01721408|364708370|FG000|Overall Study|Other|3|||
105741455|NCT01721408|364708371|FG001|Overall Study|Other|3|||
105741456|NCT01721408|364708370|FG000|Overall Study|Lost to Follow-up|1|||
105741457|NCT01721408|364708371|FG001|Overall Study|Lost to Follow-up|2|||
105741458|NCT01721408|364708370|FG000|Overall Study|Does not meet entrance criteria|1|||
105741459|NCT01721408|364708371|FG001|Overall Study|Does not meet entrance criteria|0|||
105741460|NCT01678807|364708372|FG000|Overall Study|Adverse Event|4|||
105741461|NCT01678807|364708373|FG001|Overall Study|Adverse Event|4|||
105741462|NCT01678807|364708374|FG002|Overall Study|Adverse Event|0|||
105741463|NCT01678807|364708372|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
105942220|NCT04629196|365450359|FG001|Overall Study|Withdrawal by Subject|2|||
105942221|NCT05810597|365450360|FG000|Period 1|Adverse Event|2|||
105942222|NCT05810597|365450361|FG001|Period 1|Adverse Event|0|||
105942223|NCT05810597|365450360|FG000|Period 1|Physician Decision|1|||
105942224|NCT05810597|365450361|FG001|Period 1|Physician Decision|0|||
105942225|NCT03709472|365450364|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
105942226|NCT03709472|365450365|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
105942227|NCT03709472|365450364|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
105942228|NCT03709472|365450365|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
105942229|NCT00642759|365450366|FG000|Overall Study|Protocol Violation|1|||
105942230|NCT02657356|365451638|FG000|Overall Study|Death|1|||
105942231|NCT02657356|365451639|FG001|Overall Study|Death|0|||
105942232|NCT02657356|365451638|FG000|Overall Study|Withdrawal by Subject|5|||
105741464|NCT01678807|364708373|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
105741465|NCT01678807|364708374|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
105741466|NCT00370149|364708375|FG000|Overall Study|Physician Decision|16|||
105942233|NCT02657356|365451639|FG001|Overall Study|Withdrawal by Subject|6|||
105942234|NCT02657356|365451638|FG000|Overall Study|Terminated by Sponsor|8|||
105942235|NCT02657356|365451639|FG001|Overall Study|Terminated by Sponsor|5|||
105942236|NCT02657356|365451638|FG000|Overall Study|Rolled over to EAP study|6|||
105800113|NCT00686790|364926369|FG000|Overall Study|Adverse Event|2|||
105800114|NCT00686790|364926369|FG000|Overall Study|Withdrawal by Subject|1|||
105800115|NCT00686790|364926369|FG000|Overall Study|Death|1|||
105800116|NCT00686790|364926369|FG000|Overall Study|Lost to Follow-up|12|||
105800117|NCT01690520|364926372|FG000|Overall Study|Death|25|||
105800118|NCT01690520|364926373|FG001|Overall Study|Death|21|||
105800119|NCT01690520|364926372|FG000|Overall Study|Lost to Follow-up|2|||
105800120|NCT01690520|364926373|FG001|Overall Study|Lost to Follow-up|3|||
105800121|NCT01690520|364926372|FG000|Overall Study|Withdrawal by Subject|2|||
105800122|NCT01690520|364926373|FG001|Overall Study|Withdrawal by Subject|0|||
105800123|NCT01690520|364926372|FG000|Overall Study|Relapse|0|||
105800124|NCT01690520|364926373|FG001|Overall Study|Relapse|1|||
105800125|NCT01690520|364926372|FG000|Overall Study|Other|0|||
105800126|NCT01690520|364926373|FG001|Overall Study|Other|1|||
105800127|NCT01690520|364926372|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
105800128|NCT01690520|364926373|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
106014685|NCT02900378|365719387|FG000|Randomization (Visit 2)|Death|1|||
106014686|NCT02900378|365719388|FG001|Randomization (Visit 2)|Death|4|||
106014687|NCT02900378|365719387|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
106014688|NCT02900378|365719388|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
106014689|NCT02900378|365719387|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
106014690|NCT02900378|365719388|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
106014691|NCT02900378|365719387|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
106014692|NCT02900378|365719388|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
106014693|NCT02900378|365719387|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
106014694|NCT02900378|365719388|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
106014695|NCT02900378|365719387|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
106014696|NCT02900378|365719388|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
106014697|NCT00297258|365719389|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
106014698|NCT00297258|365719389|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
106014699|NCT00297258|365719389|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
106014700|NCT00297258|365719389|FG000|Overall Study|Intercurrent Illness|3|||
106014701|NCT00297258|365719389|FG000|Overall Study|Intercurrent Death|2|||
106014702|NCT00297258|365719389|FG000|Overall Study|Deteriorization of General Condition|1|||
106014703|NCT00297258|365719389|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
106014704|NCT00297258|365719389|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
106014705|NCT00297258|365719389|FG000|Overall Study|Switch to Commercial Treatment|1|||
106014706|NCT00297258|365719389|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
106014707|NCT02819804|365719395|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
106014708|NCT00482053|365719399|FG000|Inter-treatment Period|Disease progression|1|||
106014709|NCT02557139|365719403|FG000|Overall Study|Significant liver elevation|1|||
106014710|NCT02557139|365719404|FG001|Overall Study|Significant liver elevation|0|||
106014711|NCT02557139|365719405|FG002|Overall Study|Significant liver elevation|1|||
106014712|NCT02557139|365719403|FG000|Overall Study|Withdrawal by Subject|1|||
106014713|NCT02557139|365719404|FG001|Overall Study|Withdrawal by Subject|0|||
106014714|NCT02557139|365719405|FG002|Overall Study|Withdrawal by Subject|0|||
106014715|NCT02557139|365719403|FG000|Overall Study|Illness of prohibited medication|0|||
106014716|NCT02557139|365719404|FG001|Overall Study|Illness of prohibited medication|0|||
106014717|NCT02557139|365719405|FG002|Overall Study|Illness of prohibited medication|1|||
106014718|NCT03131570|365719406|FG000|Overall Study|Adverse Event|1|||
106014719|NCT03131570|365719407|FG001|Overall Study|Adverse Event|0|||
106014720|NCT01782378|365719408|FG000|First Series|Lost to Follow-up|7|||
106014721|NCT01782378|365719409|FG001|First Series|Lost to Follow-up|8|||
106014722|NCT01782378|365719408|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
106014723|NCT01782378|365719409|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
106014724|NCT01782378|365719408|FG000|Second Series|Lost to Follow-up|8|||
106014725|NCT01782378|365719409|FG001|Second Series|Lost to Follow-up|7|||
106014726|NCT01782378|365719408|FG000|Second Series|Did not choose to complete S2 Optional|18|||
105800129|NCT00096382|364926374|FG000|Overall Study|Not treated|1|||
105800130|NCT00096382|364926375|FG001|Overall Study|Not treated|0|||
106014727|NCT01782378|365719409|FG001|Second Series|Did not choose to complete S2 Optional|0|||
106014728|NCT01352715|365719410|FG000|Overall Study|Death|3|||
106014729|NCT01352715|365719411|FG001|Overall Study|Death|3|||
106014730|NCT01352715|365719410|FG000|Overall Study|Lost to Follow-up|5|||
106014731|NCT01352715|365719411|FG001|Overall Study|Lost to Follow-up|7|||
105800131|NCT00096382|364926374|FG000|Overall Study|Death during treatment|1|||
105800132|NCT00096382|364926375|FG001|Overall Study|Death during treatment|0|||
105800133|NCT00948025|364926377|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
105800134|NCT00948025|364926378|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
105800135|NCT00948025|364926377|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
105800136|NCT00948025|364926378|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
106014732|NCT01352715|365719410|FG000|Overall Study|Withdrawal by Subject|4|||
106014733|NCT01352715|365719411|FG001|Overall Study|Withdrawal by Subject|8|||
106014734|NCT01352715|365719410|FG000|Overall Study|site closure|16|||
106014735|NCT01352715|365719411|FG001|Overall Study|site closure|15|||
106014736|NCT01352715|365719410|FG000|Overall Study|no final visit in closeout period|15|||
106014737|NCT01352715|365719411|FG001|Overall Study|no final visit in closeout period|12|||
106014738|NCT01352715|365719410|FG000|Overall Study|major ineligibility|2|||
106014739|NCT01352715|365719411|FG001|Overall Study|major ineligibility|1|||
105741467|NCT00370149|364708376|FG001|Overall Study|Physician Decision|16|||
105741468|NCT00370149|364708375|FG000|Overall Study|Protocol Violation|1|||
105741469|NCT00370149|364708376|FG001|Overall Study|Protocol Violation|0|||
105741470|NCT00370149|364708375|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
105741471|NCT00370149|364708376|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
105741472|NCT00370149|364708375|FG000|Overall Study|Pre-existing infection|0|||
105741473|NCT00370149|364708376|FG001|Overall Study|Pre-existing infection|1|||
105741474|NCT00370149|364708375|FG000|Overall Study|Antibiotic coated dressing placed|0|||
105741475|NCT00370149|364708376|FG001|Overall Study|Antibiotic coated dressing placed|1|||
105741476|NCT02322892|364709689|FG000|Overall Study|Surgery cancelled|1|||
105741477|NCT02322892|364709690|FG001|Overall Study|Surgery cancelled|2|||
105741478|NCT02322892|364709689|FG000|Overall Study|Met exclusion criteria|0|||
105741479|NCT02322892|364709690|FG001|Overall Study|Met exclusion criteria|1|||
105741480|NCT02322892|364709689|FG000|Overall Study|Protocol Violation|1|||
105741481|NCT02322892|364709690|FG001|Overall Study|Protocol Violation|0|||
105741482|NCT01755195|364709691|FG000|Overall Study|Participant noncompliance|2|||
105741483|NCT01755195|364709691|FG000|Overall Study|Switched to alternative treatment|4|||
105741484|NCT01755195|364709691|FG000|Overall Study|Withdrawal by Subject|1|||
105741485|NCT01755195|364709691|FG000|Overall Study|Participant refused to start treatment|1|||
105741486|NCT01755195|364709691|FG000|Overall Study|Participant has been consented for another trial|1|||
105741487|NCT01755195|364709691|FG000|Overall Study|Refused further treatment|3|||
105741488|NCT01755195|364709691|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
105741489|NCT01989546|364709692|FG000|Overall Study|Clinical Progression|1|||
105741490|NCT01989546|364709692|FG000|Overall Study|Disease progression on study|8|||
105741491|NCT03123354|364709693|FG000|Overall Study|Physician Decision|6|||
105741492|NCT02340819|364709694|FG000|Overall Study|Adverse Event|1|||
105741493|NCT02340819|364709694|FG000|Overall Study|Withdrawal by Subject|2|||
105741494|NCT02340819|364709694|FG000|Overall Study|Discontinued with other reason|1|||
105741495|NCT04907539|364709699|FG000|Overall Study|Consent withdrawn|1|||
105741496|NCT04907539|364709700|FG001|Overall Study|Consent withdrawn|0|||
105741497|NCT04907539|364709699|FG000|Overall Study|Death|14|||
105741498|NCT04907539|364709700|FG001|Overall Study|Death|3|||
105741499|NCT01441440|364709701|FG000|Overall Study|Death|1|||
105741500|NCT01441440|364709702|FG001|Overall Study|Death|0|||
105741501|NCT01441440|364709703|FG002|Overall Study|Death|1|||
105741502|NCT01441440|364709701|FG000|Overall Study|Adverse Event|2|||
105741503|NCT01441440|364709702|FG001|Overall Study|Adverse Event|9|||
105741504|NCT01441440|364709703|FG002|Overall Study|Adverse Event|9|||
105741505|NCT01441440|364709701|FG000|Overall Study|Lost to Follow-up|0|||
105741506|NCT01441440|364709702|FG001|Overall Study|Lost to Follow-up|2|||
105741507|NCT01441440|364709703|FG002|Overall Study|Lost to Follow-up|1|||
105741508|NCT01441440|364709701|FG000|Overall Study|Withdrawal by Subject|11|||
105741509|NCT01441440|364709702|FG001|Overall Study|Withdrawal by Subject|9|||
105741510|NCT01441440|364709703|FG002|Overall Study|Withdrawal by Subject|9|||
105741511|NCT01441440|364709701|FG000|Overall Study|Pregnancy|1|||
105741512|NCT01441440|364709702|FG001|Overall Study|Pregnancy|0|||
105741513|NCT01441440|364709703|FG002|Overall Study|Pregnancy|0|||
105741514|NCT01441440|364709701|FG000|Overall Study|Lack of Efficacy|1|||
105741515|NCT01441440|364709702|FG001|Overall Study|Lack of Efficacy|0|||
105741516|NCT01441440|364709703|FG002|Overall Study|Lack of Efficacy|1|||
105741517|NCT01441440|364709701|FG000|Overall Study|Moving|0|||
105741518|NCT01441440|364709702|FG001|Overall Study|Moving|1|||
105741519|NCT01441440|364709703|FG002|Overall Study|Moving|1|||
105741520|NCT01441440|364709701|FG000|Overall Study|Work-related matter|0|||
105741521|NCT01441440|364709702|FG001|Overall Study|Work-related matter|1|||
105741522|NCT01441440|364709703|FG002|Overall Study|Work-related matter|0|||
105741523|NCT01441440|364709701|FG000|Overall Study|Difficllty in keeping the schedule|1|||
105741524|NCT01441440|364709702|FG001|Overall Study|Difficllty in keeping the schedule|1|||
105741525|NCT01441440|364709703|FG002|Overall Study|Difficllty in keeping the schedule|0|||
105741526|NCT03276936|364709709|FG000|Overall Study|Adverse Event|4|||
105741527|NCT03276936|364709710|FG001|Overall Study|Adverse Event|2|||
105741528|NCT03276936|364709709|FG000|Overall Study|Lost to Follow-up|16|||
105741529|NCT03276936|364709710|FG001|Overall Study|Lost to Follow-up|13|||
105741530|NCT03276936|364709709|FG000|Overall Study|Withdrawal by Subject|30|||
105741531|NCT03276936|364709710|FG001|Overall Study|Withdrawal by Subject|20|||
105741532|NCT03276936|364709709|FG000|Overall Study|Not mentioned|6|||
105741533|NCT03276936|364709710|FG001|Overall Study|Not mentioned|3|||
105741534|NCT01798134|364709711|FG000|Overall Study|Lost to Follow-up|1|||
105741535|NCT01798134|364709711|FG000|Overall Study|Withdrawal by Subject|3|||
106014740|NCT03023397|365719412|FG000|Run-In|Failed screening allergen challenge|1|||
105741536|NCT01798134|364709711|FG000|Overall Study|Death|2|||
105741537|NCT01798134|364709711|FG000|Overall Study|Adverse Event|3|||
105741538|NCT01798134|364709711|FG000|Overall Study|Physician Decision|3|||
105741539|NCT01798134|364709711|FG000|Overall Study|Liver transplant/surgery|4|||
105741540|NCT02653976|364709712|FG000|Overall Study|Withdrawal by Subject|5|||
106014741|NCT03023397|365719413|FG001|Run-In|Failed screening allergen challenge|0|||
106014742|NCT03023397|365719414|FG002|Run-In|Failed screening allergen challenge|0|||
106014743|NCT03023397|365719412|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
106014744|NCT03023397|365719413|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
106014745|NCT03023397|365719414|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
106014746|NCT01656408|365719415|FG000|Overall Study|Adverse Event|0|||
106014747|NCT01656408|365719416|FG001|Overall Study|Adverse Event|0|||
106014748|NCT01656408|365719417|FG002|Overall Study|Adverse Event|1|||
106014749|NCT01656408|365719418|FG003|Overall Study|Adverse Event|0|||
106014750|NCT01656408|365719419|FG004|Overall Study|Adverse Event|0|||
106014751|NCT01656408|365719420|FG005|Overall Study|Adverse Event|1|||
106014752|NCT01656408|365719421|FG006|Overall Study|Adverse Event|1|||
106014753|NCT01656408|365719422|FG007|Overall Study|Adverse Event|0|||
106014754|NCT01656408|365719423|FG008|Overall Study|Adverse Event|1|||
105741541|NCT02653976|364709712|FG000|Overall Study|Death|4|||
105741542|NCT02023164|364709713|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
105741543|NCT02023164|364709714|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
105741544|NCT02042404|364709715|FG000|Overall Study|Death|1|||
105741545|NCT02042404|364709716|FG001|Overall Study|Death|0|||
105741546|NCT02042404|364709715|FG000|Overall Study|Unrelated Adverse Event|3|||
105741547|NCT02042404|364709716|FG001|Overall Study|Unrelated Adverse Event|0|||
105741548|NCT02042404|364709715|FG000|Overall Study|Inability to meet time requirements|1|||
105741549|NCT02042404|364709716|FG001|Overall Study|Inability to meet time requirements|0|||
105741550|NCT00726323|364709717|FG000|Overall Study|Withdrawal by Subject|3|||
105741551|NCT00726323|364709718|FG001|Overall Study|Withdrawal by Subject|1|||
105741552|NCT00726323|364709717|FG000|Overall Study|Physician Decision|1|||
105741553|NCT00726323|364709718|FG001|Overall Study|Physician Decision|0|||
105741554|NCT00726323|364709717|FG000|Overall Study|Progressive disease|23|||
105741555|NCT00726323|364709718|FG001|Overall Study|Progressive disease|16|||
105741556|NCT00726323|364709717|FG000|Overall Study|Clinical progression|0|||
105741557|NCT00726323|364709718|FG001|Overall Study|Clinical progression|3|||
105741558|NCT00726323|364709717|FG000|Overall Study|Adverse Event|9|||
105741559|NCT00726323|364709718|FG001|Overall Study|Adverse Event|9|||
105741560|NCT00726323|364709717|FG000|Overall Study|Death|1|||
105741561|NCT00726323|364709718|FG001|Overall Study|Death|0|||
105741562|NCT00726323|364709717|FG000|Overall Study|Participant wished to discontinue|0|||
105741563|NCT00726323|364709718|FG001|Overall Study|Participant wished to discontinue|1|||
105741564|NCT00726323|364709717|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
105741565|NCT00726323|364709718|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
105741566|NCT03010423|364709719|FG000|Overall Study|Study termination|8|||
105741567|NCT03430245|364709723|FG000|Overall Study|Withdrawal by Subject|6|||
105741568|NCT03430245|364709723|FG000|Overall Study|Lost to Follow-up|1|||
105741569|NCT01234402|364709724|FG000|Overall Study|Lost to Follow-up|0|||
105741570|NCT01234402|364709725|FG001|Overall Study|Lost to Follow-up|1|||
105741571|NCT01234402|364709726|FG002|Overall Study|Lost to Follow-up|3|||
105741572|NCT01234402|364709724|FG000|Overall Study|Withdrawal by Subject|1|||
105741573|NCT01234402|364709725|FG001|Overall Study|Withdrawal by Subject|3|||
105741574|NCT01234402|364709726|FG002|Overall Study|Withdrawal by Subject|4|||
105741575|NCT01234402|364709724|FG000|Overall Study|Never treated: Death|0|||
105741576|NCT01234402|364709725|FG001|Overall Study|Never treated: Death|0|||
105741577|NCT01234402|364709726|FG002|Overall Study|Never treated: Death|1|||
105741578|NCT01234402|364709724|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
105741579|NCT01234402|364709725|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
105741580|NCT01234402|364709726|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
105741581|NCT01234402|364709724|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
105741582|NCT01234402|364709725|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
105741583|NCT01234402|364709726|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
105741584|NCT04742907|364709727|FG000|Overall Study|Adverse Event|1|||
105741585|NCT04742907|364709728|FG001|Overall Study|Adverse Event|0|||
105741586|NCT04742907|364709729|FG002|Overall Study|Adverse Event|1|||
105741587|NCT04742907|364709727|FG000|Overall Study|Lost to Follow-up|3|||
105741588|NCT04742907|364709728|FG001|Overall Study|Lost to Follow-up|3|||
105741589|NCT04742907|364709729|FG002|Overall Study|Lost to Follow-up|2|||
105741590|NCT04742907|364709727|FG000|Overall Study|Physician Decision|0|||
105741591|NCT04742907|364709728|FG001|Overall Study|Physician Decision|1|||
105741592|NCT04742907|364709729|FG002|Overall Study|Physician Decision|0|||
105741593|NCT04742907|364709727|FG000|Overall Study|Protocol Violation|1|||
105741594|NCT04742907|364709728|FG001|Overall Study|Protocol Violation|1|||
105741595|NCT04742907|364709729|FG002|Overall Study|Protocol Violation|1|||
105741596|NCT04742907|364709727|FG000|Overall Study|Withdrawal by Subject|5|||
106014755|NCT01656408|365719424|FG009|Overall Study|Adverse Event|0|||
106014756|NCT01656408|365719415|FG000|Overall Study|Physician Decision|1|||
106014757|NCT01656408|365719416|FG001|Overall Study|Physician Decision|0|||
106014758|NCT01656408|365719417|FG002|Overall Study|Physician Decision|1|||
105741597|NCT04742907|364709728|FG001|Overall Study|Withdrawal by Subject|6|||
106014759|NCT01656408|365719418|FG003|Overall Study|Physician Decision|0|||
106014760|NCT01656408|365719419|FG004|Overall Study|Physician Decision|1|||
106014761|NCT01656408|365719420|FG005|Overall Study|Physician Decision|1|||
106014762|NCT01656408|365719421|FG006|Overall Study|Physician Decision|0|||
106014763|NCT01656408|365719422|FG007|Overall Study|Physician Decision|1|||
106014764|NCT01656408|365719423|FG008|Overall Study|Physician Decision|1|||
106014765|NCT01656408|365719424|FG009|Overall Study|Physician Decision|3|||
106014766|NCT05567783|365719425|FG000|Overall Study|Death|2|||
106014767|NCT05567783|365719426|FG001|Overall Study|Death|3|||
106014768|NCT05567783|365719427|FG002|Overall Study|Death|0|||
106014769|NCT05567783|365719425|FG000|Overall Study|Lost to Follow-up|25|||
106014770|NCT05567783|365719426|FG001|Overall Study|Lost to Follow-up|19|||
106014771|NCT05567783|365719427|FG002|Overall Study|Lost to Follow-up|17|||
106014772|NCT05567783|365719425|FG000|Overall Study|Physician Decision|10|||
106014773|NCT05567783|365719426|FG001|Overall Study|Physician Decision|7|||
106014774|NCT05567783|365719427|FG002|Overall Study|Physician Decision|9|||
106014775|NCT05567783|365719425|FG000|Overall Study|Study Terminated by Sponsor|924|||
106014776|NCT05567783|365719426|FG001|Overall Study|Study Terminated by Sponsor|937|||
106014777|NCT05567783|365719427|FG002|Overall Study|Study Terminated by Sponsor|941|||
106014778|NCT05567783|365719425|FG000|Overall Study|Withdrawal by Subject|23|||
106014779|NCT05567783|365719426|FG001|Overall Study|Withdrawal by Subject|27|||
105741598|NCT04742907|364709729|FG002|Overall Study|Withdrawal by Subject|4|||
105741599|NCT04742907|364709727|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
105741600|NCT04742907|364709728|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
105741601|NCT04742907|364709729|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
105741602|NCT04742907|364709727|FG000|Overall Study|Did Not Receive the Study Drug|2|||
105741603|NCT04742907|364709728|FG001|Overall Study|Did Not Receive the Study Drug|4|||
105741604|NCT04742907|364709729|FG002|Overall Study|Did Not Receive the Study Drug|4|||
105741605|NCT02280291|364709730|FG000|Overall Study|Lost to Follow-up|2|||
105741606|NCT02280291|364709731|FG001|Overall Study|Lost to Follow-up|1|||
105741607|NCT02280291|364709732|FG002|Overall Study|Lost to Follow-up|3|||
105741608|NCT02280291|364709733|FG003|Overall Study|Lost to Follow-up|8|||
105741609|NCT02280291|364709730|FG000|Overall Study|Protocol Violation|1|||
105741610|NCT02280291|364709731|FG001|Overall Study|Protocol Violation|0|||
105741611|NCT02280291|364709732|FG002|Overall Study|Protocol Violation|0|||
105741612|NCT02280291|364709733|FG003|Overall Study|Protocol Violation|0|||
105741613|NCT02280291|364709730|FG000|Overall Study|Other|1|||
105741614|NCT02280291|364709731|FG001|Overall Study|Other|1|||
105741615|NCT02280291|364709732|FG002|Overall Study|Other|0|||
105741616|NCT02280291|364709733|FG003|Overall Study|Other|0|||
105741617|NCT04964063|364709735|FG000|Overall Study|Adverse Event|4|||
105741618|NCT04964063|364709735|FG000|Overall Study|Lost to Follow-up|47|||
105741619|NCT04964063|364709735|FG000|Overall Study|Withdrawal by Subject|5|||
105741620|NCT04964063|364709735|FG000|Overall Study|Baseline Tasks Expired|41|||
105741621|NCT04964063|364709735|FG000|Overall Study|Participant withdrawn in error|1|||
105741622|NCT02284906|364709736|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105741623|NCT02284906|364709737|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105741624|NCT02284906|364709738|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105741625|NCT02284906|364709736|FG000|Overall Study|Major Protocol Deviation|0|||
105741626|NCT02284906|364709737|FG001|Overall Study|Major Protocol Deviation|1|||
105741627|NCT02284906|364709738|FG002|Overall Study|Major Protocol Deviation|0|||
105741628|NCT02284906|364709736|FG000|Overall Study|Voluntary Withdrawal|2|||
105741629|NCT02284906|364709737|FG001|Overall Study|Voluntary Withdrawal|4|||
105741630|NCT02284906|364709738|FG002|Overall Study|Voluntary Withdrawal|5|||
105741631|NCT02284906|364709736|FG000|Overall Study|Study Termination|0|||
105741632|NCT02284906|364709737|FG001|Overall Study|Study Termination|11|||
105741633|NCT02284906|364709738|FG002|Overall Study|Study Termination|14|||
105741634|NCT02284906|364709736|FG000|Overall Study|Reason not Specified|1|||
105741635|NCT02284906|364709737|FG001|Overall Study|Reason not Specified|1|||
105741636|NCT02284906|364709738|FG002|Overall Study|Reason not Specified|0|||
105741637|NCT02433288|364709740|FG000|Overall Study|Severe non-compliance to protocol|13|||
105741638|NCT02433288|364709741|FG001|Overall Study|Severe non-compliance to protocol|7|||
105741639|NCT02433288|364709740|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
105741640|NCT02433288|364709741|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
105741641|NCT02433288|364709740|FG000|Overall Study|Withdrawal by Subject|101|||
105800137|NCT00948025|364926377|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
105800138|NCT00948025|364926378|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
106014780|NCT05567783|365719427|FG002|Overall Study|Withdrawal by Subject|24|||
106014781|NCT05567783|365719425|FG000|Overall Study|Incarcerated|1|||
106014782|NCT05567783|365719426|FG001|Overall Study|Incarcerated|0|||
106014783|NCT05567783|365719427|FG002|Overall Study|Incarcerated|0|||
106014784|NCT05567783|365719425|FG000|Overall Study|Participant randomized in error|4|||
105741642|NCT02433288|364709741|FG001|Overall Study|Withdrawal by Subject|99|||
105741643|NCT02433288|364709740|FG000|Overall Study|Lost to Follow-up|2|||
105741644|NCT02433288|364709741|FG001|Overall Study|Lost to Follow-up|14|||
106142104|NCT02139046|366179843|FG004|Overall Study|Lost to Follow-up|13|||
105741645|NCT02433288|364709740|FG000|Overall Study|Death|0|||
105741646|NCT02433288|364709741|FG001|Overall Study|Death|3|||
105741647|NCT01120093|364709744|FG000|Treatment Period 1|Adverse Event|0|||
105741648|NCT01120093|364709745|FG001|Treatment Period 1|Adverse Event|0|||
105741649|NCT01120093|364709746|FG002|Treatment Period 1|Adverse Event|1|||
105741650|NCT01120093|364709747|FG003|Treatment Period 1|Adverse Event|0|||
105741651|NCT01120093|364709748|FG004|Treatment Period 1|Adverse Event|1|||
105741652|NCT01120093|364709744|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105741653|NCT01120093|364709745|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105741654|NCT01120093|364709746|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105741655|NCT01120093|364709747|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105741656|NCT01120093|364709748|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105741657|NCT01120093|364709744|FG000|Treatment Period 2|Adverse Event|0|||
105741658|NCT01120093|364709745|FG001|Treatment Period 2|Adverse Event|0|||
105741659|NCT01120093|364709746|FG002|Treatment Period 2|Adverse Event|0|||
105741660|NCT01120093|364709747|FG003|Treatment Period 2|Adverse Event|1|||
105741661|NCT01120093|364709748|FG004|Treatment Period 2|Adverse Event|0|||
105741662|NCT01120093|364709744|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105741663|NCT01120093|364709745|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105741664|NCT01120093|364709746|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105741665|NCT01120093|364709747|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105741666|NCT01120093|364709748|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105741667|NCT01120093|364709744|FG000|Treatment Period 3|Lack of Efficacy|0|||
105741668|NCT01120093|364709745|FG001|Treatment Period 3|Lack of Efficacy|0|||
105741669|NCT01120093|364709746|FG002|Treatment Period 3|Lack of Efficacy|0|||
105741670|NCT01120093|364709747|FG003|Treatment Period 3|Lack of Efficacy|1|||
105741671|NCT01120093|364709748|FG004|Treatment Period 3|Lack of Efficacy|0|||
105741672|NCT01120093|364709744|FG000|Treatment Period 3|Adverse Event|0|||
105741673|NCT01120093|364709745|FG001|Treatment Period 3|Adverse Event|0|||
105741674|NCT01120093|364709746|FG002|Treatment Period 3|Adverse Event|0|||
105741675|NCT01120093|364709747|FG003|Treatment Period 3|Adverse Event|0|||
105741676|NCT01120093|364709748|FG004|Treatment Period 3|Adverse Event|1|||
105741677|NCT01120093|364709744|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105741678|NCT01120093|364709745|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105741679|NCT01120093|364709746|FG002|Treatment Period 3|Withdrawal by Subject|1|||
105741680|NCT01120093|364709747|FG003|Treatment Period 3|Withdrawal by Subject|0|||
105741681|NCT01120093|364709748|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105741682|NCT01120093|364709744|FG000|Treatment Period 4|Adverse Event|1|||
105741683|NCT01120093|364709745|FG001|Treatment Period 4|Adverse Event|0|||
105741684|NCT01120093|364709746|FG002|Treatment Period 4|Adverse Event|0|||
105741685|NCT01120093|364709747|FG003|Treatment Period 4|Adverse Event|0|||
105741686|NCT01120093|364709748|FG004|Treatment Period 4|Adverse Event|0|||
105741687|NCT01120093|364709744|FG000|Treatment Period 5|Adverse Event|0|||
105741688|NCT01120093|364709745|FG001|Treatment Period 5|Adverse Event|1|||
105741689|NCT01120093|364709746|FG002|Treatment Period 5|Adverse Event|0|||
105741690|NCT01120093|364709747|FG003|Treatment Period 5|Adverse Event|1|||
105741691|NCT01120093|364709748|FG004|Treatment Period 5|Adverse Event|0|||
105741692|NCT00850759|364709749|FG000|Overall Study|Lost to Follow-up|7|||
105741693|NCT00850759|364709750|FG001|Overall Study|Lost to Follow-up|5|||
105741694|NCT00850759|364709751|FG002|Overall Study|Lost to Follow-up|5|||
105741695|NCT00850759|364709752|FG003|Overall Study|Lost to Follow-up|3|||
105741696|NCT01005719|364709753|FG000|Period 1|Adverse Event|0|||
105741697|NCT01005719|364709754|FG001|Period 1|Adverse Event|0|||
105741698|NCT01005719|364709755|FG002|Period 1|Adverse Event|0|||
106142105|NCT02139046|366179839|FG000|Overall Study|Voluntary Withdrawal|20|||
106142106|NCT02139046|366179840|FG001|Overall Study|Voluntary Withdrawal|8|||
105741699|NCT01005719|364709756|FG003|Period 1|Adverse Event|1|||
105741700|NCT01005719|364709757|FG004|Period 1|Adverse Event|0|||
105741701|NCT01005719|364709758|FG005|Period 1|Adverse Event|0|||
105800139|NCT04006847|364926379|FG000|Overall Study|Product issue|1|||
106142107|NCT02139046|366179841|FG002|Overall Study|Voluntary Withdrawal|10|||
106142108|NCT02139046|366179842|FG003|Overall Study|Voluntary Withdrawal|15|||
106142109|NCT02139046|366179843|FG004|Overall Study|Voluntary Withdrawal|16|||
105741702|NCT01005719|364709753|FG000|Period 1|Delay in completing study procedures|0|||
105741703|NCT01005719|364709754|FG001|Period 1|Delay in completing study procedures|0|||
105741704|NCT01005719|364709755|FG002|Period 1|Delay in completing study procedures|0|||
105741705|NCT01005719|364709756|FG003|Period 1|Delay in completing study procedures|0|||
105741706|NCT01005719|364709757|FG004|Period 1|Delay in completing study procedures|0|||
105741707|NCT01005719|364709758|FG005|Period 1|Delay in completing study procedures|1|||
105741708|NCT01005719|364709753|FG000|Period 2|Adverse Event|0|||
105741709|NCT01005719|364709754|FG001|Period 2|Adverse Event|0|||
105741710|NCT01005719|364709755|FG002|Period 2|Adverse Event|0|||
105741711|NCT01005719|364709756|FG003|Period 2|Adverse Event|0|||
105741712|NCT01005719|364709757|FG004|Period 2|Adverse Event|1|||
105741713|NCT01005719|364709758|FG005|Period 2|Adverse Event|1|||
105741714|NCT02389816|364709759|FG000|Overall Study|Randomized but Not Treated|1|||
105741715|NCT02389816|364709760|FG001|Overall Study|Randomized but Not Treated|0|||
106142110|NCT02139046|366179839|FG000|Overall Study|Lack of Efficacy|0|||
105741716|NCT02389816|364709761|FG002|Overall Study|Randomized but Not Treated|0|||
105741717|NCT02389816|364709759|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
105741718|NCT02389816|364709760|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
105741719|NCT02389816|364709761|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
105741720|NCT02389816|364709759|FG000|Overall Study|Major Protocol Deviation|1|||
105741721|NCT02389816|364709760|FG001|Overall Study|Major Protocol Deviation|0|||
105741722|NCT02389816|364709761|FG002|Overall Study|Major Protocol Deviation|0|||
105741723|NCT02389816|364709759|FG000|Overall Study|Lost to Follow-up|1|||
105741724|NCT02389816|364709760|FG001|Overall Study|Lost to Follow-up|0|||
105741725|NCT02389816|364709761|FG002|Overall Study|Lost to Follow-up|0|||
105741726|NCT02389816|364709759|FG000|Overall Study|Withdrawal of Consent|6|||
105741727|NCT02389816|364709760|FG001|Overall Study|Withdrawal of Consent|4|||
105741728|NCT02389816|364709761|FG002|Overall Study|Withdrawal of Consent|4|||
105741729|NCT02389816|364709759|FG000|Overall Study|Lack of Efficacy|1|||
105741730|NCT02389816|364709760|FG001|Overall Study|Lack of Efficacy|0|||
105741731|NCT02389816|364709761|FG002|Overall Study|Lack of Efficacy|0|||
105741732|NCT02389816|364709759|FG000|Overall Study|Non Compliance with Study Drug|1|||
105741733|NCT02389816|364709760|FG001|Overall Study|Non Compliance with Study Drug|1|||
105741734|NCT02389816|364709761|FG002|Overall Study|Non Compliance with Study Drug|1|||
105741735|NCT02389816|364709759|FG000|Overall Study|Reason not Specified|0|||
105741736|NCT02389816|364709760|FG001|Overall Study|Reason not Specified|2|||
105741737|NCT02389816|364709761|FG002|Overall Study|Reason not Specified|0|||
105741738|NCT03649321|364709762|FG000|Overall Study|Withdrawal by Subject|1|||
105741739|NCT03649321|364709763|FG001|Overall Study|Withdrawal by Subject|0|||
105741740|NCT03649321|364709762|FG000|Overall Study|Death|1|||
105800140|NCT01270841|364926383|FG000|Overall Study|Adverse Event|0|||
105800141|NCT01270841|364926384|FG001|Overall Study|Adverse Event|1|||
105800142|NCT01270841|364926385|FG002|Overall Study|Adverse Event|0|||
106014785|NCT05567783|365719426|FG001|Overall Study|Participant randomized in error|2|||
106014786|NCT05567783|365719427|FG002|Overall Study|Participant randomized in error|2|||
106014787|NCT01457703|365719428|FG000|Overall Study|Screen Failure|5|||
106014788|NCT01457703|365719429|FG001|Overall Study|Screen Failure|7|||
106014789|NCT01457703|365719428|FG000|Overall Study|Withdrawal by Subject|1|||
106014790|NCT01457703|365719429|FG001|Overall Study|Withdrawal by Subject|4|||
106014791|NCT03278249|365719430|FG000|Overall Study|Withdrawal by Subject|2|||
106014792|NCT03278249|365719430|FG000|Overall Study|Lost to Follow-up|1|||
106014793|NCT03525678|365719432|FG000|Overall Study|Withdrawal by Subject|8|||
106014794|NCT03525678|365719433|FG001|Overall Study|Withdrawal by Subject|2|||
106014795|NCT03525678|365719434|FG002|Overall Study|Withdrawal by Subject|2|||
106014796|NCT03525678|365719432|FG000|Overall Study|Physician Decision|2|||
106014797|NCT03525678|365719433|FG001|Overall Study|Physician Decision|4|||
106014798|NCT03525678|365719434|FG002|Overall Study|Physician Decision|0|||
106014799|NCT03525678|365719432|FG000|Overall Study|Lost to Follow-up|2|||
106014800|NCT03525678|365719433|FG001|Overall Study|Lost to Follow-up|1|||
106014801|NCT03525678|365719434|FG002|Overall Study|Lost to Follow-up|2|||
106014802|NCT03525678|365719432|FG000|Overall Study|Death|70|||
106014803|NCT03525678|365719433|FG001|Overall Study|Death|80|||
106014804|NCT03525678|365719434|FG002|Overall Study|Death|16|||
106014805|NCT03525678|365719432|FG000|Overall Study|other reasons|14|||
106014806|NCT03525678|365719433|FG001|Overall Study|other reasons|10|||
106014807|NCT03525678|365719434|FG002|Overall Study|other reasons|5|||
106014808|NCT03525678|365719432|FG000|Overall Study|ongoing at the time of analysis|1|||
106014809|NCT03525678|365719433|FG001|Overall Study|ongoing at the time of analysis|2|||
106014810|NCT03525678|365719434|FG002|Overall Study|ongoing at the time of analysis|0|||
106014811|NCT01177397|365720893|FG000|Overall Study|Protocol Violation|0|||
106014812|NCT01177397|365720894|FG001|Overall Study|Protocol Violation|0|||
106014813|NCT01177397|365720895|FG002|Overall Study|Protocol Violation|0|||
106014814|NCT01177397|365720896|FG003|Overall Study|Protocol Violation|0|||
105741741|NCT03649321|364709763|FG001|Overall Study|Death|0|||
105741742|NCT03408873|364709767|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
105741743|NCT03408873|364709767|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
105800143|NCT01270841|364926386|FG003|Overall Study|Adverse Event|3|||
106014815|NCT01177397|365720897|FG004|Overall Study|Protocol Violation|0|||
106014816|NCT01177397|365720898|FG005|Overall Study|Protocol Violation|1|||
106014817|NCT01177397|365720899|FG006|Overall Study|Protocol Violation|0|||
106014818|NCT01177397|365720900|FG007|Overall Study|Protocol Violation|0|||
106014819|NCT01177397|365720901|FG008|Overall Study|Protocol Violation|0|||
106014820|NCT01177397|365720902|FG009|Overall Study|Protocol Violation|0|||
106014821|NCT01177397|365720903|FG010|Overall Study|Protocol Violation|0|||
106014822|NCT01177397|365720904|FG011|Overall Study|Protocol Violation|0|||
105741744|NCT03408873|364709767|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
105741745|NCT03408873|364709767|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
105741746|NCT03408873|364709767|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
105741747|NCT03408873|364709767|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
105741748|NCT01594476|364709768|FG000|Overall Study|Protocol Violation|1|||
105741749|NCT01594476|364709769|FG001|Overall Study|Protocol Violation|3|||
105741750|NCT00406315|364709772|FG000|Overall Study|Death|1|||
106014823|NCT01177397|365720893|FG000|Overall Study|Lost to Follow-up|0|||
106014824|NCT01177397|365720894|FG001|Overall Study|Lost to Follow-up|0|||
106014825|NCT01177397|365720895|FG002|Overall Study|Lost to Follow-up|0|||
106014826|NCT01177397|365720896|FG003|Overall Study|Lost to Follow-up|0|||
106014827|NCT01177397|365720897|FG004|Overall Study|Lost to Follow-up|1|||
105741751|NCT00406315|364709772|FG000|Overall Study|Adverse Event|39|||
105741752|NCT00406315|364709772|FG000|Overall Study|Laboratory Abnormality|4|||
105741753|NCT00406315|364709772|FG000|Overall Study|Lack of Efficacy|13|||
105741754|NCT00406315|364709772|FG000|Overall Study|Other|33|||
105741755|NCT00406315|364709772|FG000|Overall Study|Lost to Follow-up|21|||
105741756|NCT00406315|364709772|FG000|Overall Study|Withdrawal by Subject|30|||
105741757|NCT01312428|364709773|FG000|Overall Study|Study Termination|3|||
105741758|NCT01312428|364709774|FG001|Overall Study|Study Termination|4|||
105741759|NCT01106534|364709775|FG000|Overall Study|Withdrawal by Subject|18|||
105741760|NCT01106534|364709775|FG000|Overall Study|Lost to Follow-up|2|||
105741761|NCT01106534|364709775|FG000|Overall Study|Death|16|||
105741762|NCT01106534|364709775|FG000|Overall Study|Physician Decision|1|||
105741763|NCT00532883|364709778|FG000|Overall Study|Adverse Event|1|||
105741764|NCT00532883|364709779|FG001|Overall Study|Adverse Event|0|||
105741765|NCT00532883|364709780|FG002|Overall Study|Adverse Event|0|||
105741766|NCT00532883|364709781|FG003|Overall Study|Adverse Event|1|||
105741767|NCT00532883|364709778|FG000|Overall Study|Lost to Follow-up|1|||
105741768|NCT00532883|364709779|FG001|Overall Study|Lost to Follow-up|1|||
105741769|NCT00532883|364709780|FG002|Overall Study|Lost to Follow-up|1|||
105741770|NCT00532883|364709781|FG003|Overall Study|Lost to Follow-up|0|||
105741771|NCT00532883|364709778|FG000|Overall Study|Withdrawal by Subject|0|||
105741772|NCT00532883|364709779|FG001|Overall Study|Withdrawal by Subject|1|||
105741773|NCT00532883|364709780|FG002|Overall Study|Withdrawal by Subject|1|||
105741774|NCT00532883|364709781|FG003|Overall Study|Withdrawal by Subject|0|||
105741775|NCT00532883|364709778|FG000|Overall Study|Subject was Nonadherent|0|||
105741776|NCT00532883|364709779|FG001|Overall Study|Subject was Nonadherent|1|||
105741777|NCT00532883|364709780|FG002|Overall Study|Subject was Nonadherent|1|||
105741778|NCT00532883|364709781|FG003|Overall Study|Subject was Nonadherent|0|||
105741779|NCT00532883|364709778|FG000|Overall Study|Early Study Termination|4|||
105741780|NCT00532883|364709779|FG001|Overall Study|Early Study Termination|4|||
105741781|NCT00532883|364709780|FG002|Overall Study|Early Study Termination|1|||
105741782|NCT00532883|364709781|FG003|Overall Study|Early Study Termination|4|||
105942237|NCT02657356|365451639|FG001|Overall Study|Rolled over to EAP study|4|||
105942238|NCT03443401|365451642|FG000|Overall Study|Lost to Follow-up|13|||
105942239|NCT03443401|365451642|FG000|Overall Study|Influential outlier|1|||
105942240|NCT00936936|365451643|FG000|Overall Study|Adverse Event|7|||
105942241|NCT00936936|365451644|FG001|Overall Study|Adverse Event|1|||
105942242|NCT00936936|365451643|FG000|Overall Study|Disease Progression|2|||
105942243|NCT00936936|365451644|FG001|Overall Study|Disease Progression|2|||
105942244|NCT00936936|365451643|FG000|Overall Study|Unrelated|3|||
105942245|NCT00936936|365451644|FG001|Overall Study|Unrelated|1|||
105942246|NCT01394185|365451645|FG000|Overall Study|Withdrawal by Subject|2|||
105942247|NCT01394185|365451646|FG001|Overall Study|Withdrawal by Subject|0|||
105942248|NCT01394185|365451647|FG002|Overall Study|Withdrawal by Subject|0|||
105942249|NCT01394185|365451648|FG003|Overall Study|Withdrawal by Subject|0|||
105942250|NCT01394185|365451649|FG004|Overall Study|Withdrawal by Subject|1|||
105942251|NCT01394185|365451650|FG005|Overall Study|Withdrawal by Subject|0|||
105942252|NCT01394185|365451645|FG000|Overall Study|Change in protocol|3|||
105942253|NCT01394185|365451646|FG001|Overall Study|Change in protocol|0|||
105942254|NCT01394185|365451647|FG002|Overall Study|Change in protocol|0|||
105942255|NCT01394185|365451648|FG003|Overall Study|Change in protocol|0|||
105942256|NCT01394185|365451649|FG004|Overall Study|Change in protocol|3|||
105942257|NCT01394185|365451650|FG005|Overall Study|Change in protocol|0|||
105942258|NCT01394185|365451645|FG000|Overall Study|Protocol Violation|1|||
105942259|NCT01394185|365451646|FG001|Overall Study|Protocol Violation|0|||
105942260|NCT01394185|365451647|FG002|Overall Study|Protocol Violation|0|||
105942261|NCT01394185|365451648|FG003|Overall Study|Protocol Violation|1|||
105942262|NCT01394185|365451649|FG004|Overall Study|Protocol Violation|0|||
106014828|NCT01177397|365720898|FG005|Overall Study|Lost to Follow-up|0|||
106014829|NCT01177397|365720899|FG006|Overall Study|Lost to Follow-up|0|||
106014830|NCT01177397|365720900|FG007|Overall Study|Lost to Follow-up|2|||
105741783|NCT03799718|364709782|FG000|Overall Study|Adverse Event|2|||
105741784|NCT02184143|364709785|FG000|Overall Study|Withdrawal by Subject|4|||
105741785|NCT02184143|364709786|FG001|Overall Study|Withdrawal by Subject|4|||
105942263|NCT01394185|365451650|FG005|Overall Study|Protocol Violation|1|||
105942264|NCT02254460|365451655|FG000|Overall Study|Adverse Event|1|||
105942265|NCT02254460|365451656|FG001|Overall Study|Adverse Event|0|||
106014831|NCT01177397|365720901|FG008|Overall Study|Lost to Follow-up|0|||
105942266|NCT02093520|365451657|FG000|Overall Study|Not treated|6|||
105942267|NCT02093520|365451658|FG001|Overall Study|Not treated|22|||
105741786|NCT02184143|364709785|FG000|Overall Study|Lost to Follow-up|5|||
105741787|NCT02184143|364709786|FG001|Overall Study|Lost to Follow-up|3|||
105741788|NCT02184143|364709785|FG000|Overall Study|Death|1|||
105942268|NCT00321932|365451659|FG000|Overall Study|Death|3|||
105942269|NCT00321932|365451660|FG001|Overall Study|Death|6|||
106014832|NCT01177397|365720902|FG009|Overall Study|Lost to Follow-up|0|||
105741789|NCT02184143|364709786|FG001|Overall Study|Death|0|||
105741790|NCT00321984|364709790|FG000|Overall Study|Adverse Event|9|||
105741791|NCT00321984|364709791|FG001|Overall Study|Adverse Event|6|||
105741792|NCT00321984|364709792|FG002|Overall Study|Adverse Event|8|||
105741793|NCT00321984|364709790|FG000|Overall Study|Protocol Violation|0|||
105741794|NCT00321984|364709791|FG001|Overall Study|Protocol Violation|1|||
105741795|NCT00321984|364709792|FG002|Overall Study|Protocol Violation|1|||
105741796|NCT00321984|364709790|FG000|Overall Study|Lost to Follow-up|2|||
105741797|NCT00321984|364709791|FG001|Overall Study|Lost to Follow-up|4|||
105741798|NCT00321984|364709792|FG002|Overall Study|Lost to Follow-up|2|||
105741799|NCT00321984|364709790|FG000|Overall Study|Withdrawal by Subject|8|||
105741800|NCT00321984|364709791|FG001|Overall Study|Withdrawal by Subject|6|||
105741801|NCT00321984|364709792|FG002|Overall Study|Withdrawal by Subject|5|||
105741802|NCT00321984|364709790|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
105741803|NCT00321984|364709791|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
105741804|NCT00321984|364709792|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
105741805|NCT00321984|364709790|FG000|Overall Study|Lack of Efficacy|3|||
105741806|NCT00321984|364709791|FG001|Overall Study|Lack of Efficacy|1|||
105741807|NCT00321984|364709792|FG002|Overall Study|Lack of Efficacy|3|||
105741808|NCT00321984|364709790|FG000|Overall Study|Noncompliant|0|||
105741809|NCT00321984|364709791|FG001|Overall Study|Noncompliant|0|||
105741810|NCT00321984|364709792|FG002|Overall Study|Noncompliant|2|||
105741811|NCT00321984|364709790|FG000|Overall Study|Pregnancy|0|||
105741812|NCT00321984|364709791|FG001|Overall Study|Pregnancy|1|||
105741813|NCT00321984|364709792|FG002|Overall Study|Pregnancy|0|||
105942270|NCT00321932|365451659|FG000|Overall Study|Withdrawal by Subject|3|||
105942271|NCT00321932|365451660|FG001|Overall Study|Withdrawal by Subject|6|||
105942272|NCT00321932|365451659|FG000|Overall Study|Early relapse|2|||
105942273|NCT00321932|365451660|FG001|Overall Study|Early relapse|8|||
105942274|NCT00321932|365451659|FG000|Overall Study|Missing data|2|||
105942275|NCT00321932|365451660|FG001|Overall Study|Missing data|1|||
105942276|NCT01904279|365451662|FG000|Overall Study|Lack of Efficacy|2|||
105942277|NCT01904279|365451663|FG001|Overall Study|Lack of Efficacy|3|||
105942278|NCT01904279|365451662|FG000|Overall Study|Withdrawal by Subject|1|||
105942279|NCT01904279|365451663|FG001|Overall Study|Withdrawal by Subject|0|||
105942280|NCT04992273|365451672|FG000|Overall Study|Lost to Follow-up|0|||
105942281|NCT04992273|365451673|FG001|Overall Study|Lost to Follow-up|1|||
105942282|NCT01344356|365451674|FG000|Overall Study|Physician Decision|0|||
105942283|NCT01344356|365451675|FG001|Overall Study|Physician Decision|3|||
105942284|NCT01344356|365451674|FG000|Overall Study|Lost to Follow-up|0|||
105942285|NCT01344356|365451675|FG001|Overall Study|Lost to Follow-up|6|||
105942286|NCT00856557|365451678|FG000|Overall Study|No patients with contextual flags|12|||
105942287|NCT00856557|365451679|FG001|Overall Study|No patients with contextual flags|16|||
105942288|NCT03673176|365451680|FG000|Overall Study|Death prior to intervention|1|||
105942289|NCT03673176|365451680|FG000|Overall Study|Death following intervention|3|||
105942290|NCT03673176|365451680|FG000|Overall Study|Withdrawal by Subject|1|||
105942291|NCT00337168|365451681|FG000|Overall Study|Death|5|||
105942292|NCT00337168|365451681|FG000|Overall Study|Not protocol specified|2|||
105942293|NCT00337168|365451681|FG000|Overall Study|Did not start therapy|1|||
105942294|NCT03283241|365451682|FG000|Overall Study|Adverse Event|4|||
105942295|NCT03283241|365451683|FG001|Overall Study|Adverse Event|1|||
105942296|NCT03283241|365451682|FG000|Overall Study|Withdrawal by Subject|0|||
105942297|NCT03283241|365451683|FG001|Overall Study|Withdrawal by Subject|1|||
105942298|NCT03283241|365451682|FG000|Overall Study|Subject relocated to Finland|0|||
105942299|NCT03283241|365451683|FG001|Overall Study|Subject relocated to Finland|1|||
105942300|NCT00666263|365451686|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
105942301|NCT00666263|365451687|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
105942302|NCT00666263|365451686|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
105942303|NCT00666263|365451687|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
105942304|NCT00666263|365451686|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
105942305|NCT00666263|365451687|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
105942306|NCT00586157|365451693|FG000|First Intervention|Worsening behavior|1|||
105942307|NCT00586157|365451694|FG001|First Intervention|Worsening behavior|0|||
105942308|NCT00586157|365451693|FG000|Second Intervention|Withdrawal by Subject|1|||
105741814|NCT00321984|364709790|FG000|Overall Study|Per Subject Request|1|||
105741815|NCT00321984|364709791|FG001|Overall Study|Per Subject Request|0|||
105741816|NCT00321984|364709792|FG002|Overall Study|Per Subject Request|0|||
105741817|NCT00321984|364709790|FG000|Overall Study|Per Investigator Request|1|||
105942309|NCT00586157|365451694|FG001|Second Intervention|Withdrawal by Subject|0|||
105942310|NCT00586157|365451693|FG000|Second Intervention|Worsening behavior|1|||
105942311|NCT00586157|365451694|FG001|Second Intervention|Worsening behavior|0|||
106142111|NCT02139046|366179840|FG001|Overall Study|Lack of Efficacy|1|||
106142112|NCT02139046|366179841|FG002|Overall Study|Lack of Efficacy|2|||
105942312|NCT00586157|365451693|FG000|Second Intervention|Adverse Event|0|||
105942313|NCT00586157|365451694|FG001|Second Intervention|Adverse Event|1|||
105942314|NCT04484857|365451695|FG000|Overall Study|Adverse Event|2|||
105942315|NCT04484857|365451695|FG000|Overall Study|Death|10|||
105942316|NCT04484857|365451695|FG000|Overall Study|Withdrawal by Subject|3|||
105942317|NCT04484857|365451695|FG000|Overall Study|Transferred/Relocation|5|||
105942318|NCT04484857|365451695|FG000|Overall Study|Kidney Transplant|7|||
105942319|NCT04484857|365451695|FG000|Overall Study|Other than specified|4|||
105942320|NCT04484857|365451695|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
105942321|NCT01225952|365451696|FG000|Overall Study|Lost to Follow-up|1|||
105942322|NCT01225952|365451697|FG001|Overall Study|Lost to Follow-up|0|||
105942323|NCT01225952|365451698|FG002|Overall Study|Lost to Follow-up|0|||
105942324|NCT01225952|365451696|FG000|Overall Study|Study Eye Explanted|0|||
105942325|NCT01225952|365451697|FG001|Overall Study|Study Eye Explanted|0|||
105942326|NCT01225952|365451698|FG002|Overall Study|Study Eye Explanted|1|||
105741818|NCT00321984|364709791|FG001|Overall Study|Per Investigator Request|0|||
105741819|NCT00321984|364709792|FG002|Overall Study|Per Investigator Request|0|||
105741820|NCT00321984|364709790|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
105741821|NCT00321984|364709791|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
105741822|NCT00321984|364709792|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
105741823|NCT01525849|364709796|FG000|Overall Study|Lost to Follow-up|3|||
105942327|NCT01225952|365451696|FG000|Overall Study|Withdrawal by Subject|4|||
105942328|NCT01225952|365451697|FG001|Overall Study|Withdrawal by Subject|4|||
105942329|NCT01225952|365451698|FG002|Overall Study|Withdrawal by Subject|5|||
106014833|NCT01177397|365720903|FG010|Overall Study|Lost to Follow-up|0|||
106014834|NCT01177397|365720904|FG011|Overall Study|Lost to Follow-up|0|||
106014835|NCT01177397|365720893|FG000|Overall Study|Death|0|||
106014836|NCT01177397|365720894|FG001|Overall Study|Death|0|||
106014837|NCT01177397|365720895|FG002|Overall Study|Death|1|||
106014838|NCT01177397|365720896|FG003|Overall Study|Death|1|||
106014839|NCT01177397|365720897|FG004|Overall Study|Death|0|||
106014840|NCT01177397|365720898|FG005|Overall Study|Death|0|||
106014841|NCT01177397|365720899|FG006|Overall Study|Death|0|||
106014842|NCT01177397|365720900|FG007|Overall Study|Death|5|||
106014843|NCT01177397|365720901|FG008|Overall Study|Death|2|||
106014844|NCT01177397|365720902|FG009|Overall Study|Death|1|||
106014845|NCT01177397|365720903|FG010|Overall Study|Death|0|||
106014846|NCT01177397|365720904|FG011|Overall Study|Death|0|||
106014847|NCT01177397|365720893|FG000|Overall Study|Withdrawal by Subject|0|||
106014848|NCT01177397|365720894|FG001|Overall Study|Withdrawal by Subject|0|||
106014849|NCT01177397|365720895|FG002|Overall Study|Withdrawal by Subject|1|||
106014850|NCT01177397|365720896|FG003|Overall Study|Withdrawal by Subject|1|||
106014851|NCT01177397|365720897|FG004|Overall Study|Withdrawal by Subject|1|||
106014852|NCT01177397|365720898|FG005|Overall Study|Withdrawal by Subject|2|||
106014853|NCT01177397|365720899|FG006|Overall Study|Withdrawal by Subject|0|||
106014854|NCT01177397|365720900|FG007|Overall Study|Withdrawal by Subject|5|||
106014855|NCT01177397|365720901|FG008|Overall Study|Withdrawal by Subject|9|||
106014856|NCT01177397|365720902|FG009|Overall Study|Withdrawal by Subject|1|||
106014857|NCT01177397|365720903|FG010|Overall Study|Withdrawal by Subject|1|||
106014858|NCT01177397|365720904|FG011|Overall Study|Withdrawal by Subject|0|||
106014859|NCT01177397|365720893|FG000|Overall Study|Adverse Event|0|||
106014860|NCT01177397|365720894|FG001|Overall Study|Adverse Event|0|||
106014861|NCT01177397|365720895|FG002|Overall Study|Adverse Event|1|||
106014862|NCT01177397|365720896|FG003|Overall Study|Adverse Event|2|||
106142113|NCT02139046|366179842|FG003|Overall Study|Lack of Efficacy|1|||
106142114|NCT02139046|366179843|FG004|Overall Study|Lack of Efficacy|2|||
106142115|NCT02139046|366179839|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
105942330|NCT01225952|365451696|FG000|Overall Study|Surgical complications|1|||
105942331|NCT01225952|365451697|FG001|Overall Study|Surgical complications|0|||
105942332|NCT01225952|365451698|FG002|Overall Study|Surgical complications|0|||
105942333|NCT02378480|365451699|FG000|Overall Study|Physician Decision|1|||
105942334|NCT02378480|365451700|FG001|Overall Study|Physician Decision|1|||
105942335|NCT02378480|365451699|FG000|Overall Study|Death|1|||
105942336|NCT02378480|365451700|FG001|Overall Study|Death|2|||
105942337|NCT02378480|365451699|FG000|Overall Study|Randomized, but Not Treated|6|||
105942338|NCT02378480|365451700|FG001|Overall Study|Randomized, but Not Treated|4|||
105942339|NCT02378480|365451699|FG000|Overall Study|Adverse Event|0|||
105942340|NCT02378480|365451700|FG001|Overall Study|Adverse Event|1|||
105741824|NCT01525849|364709797|FG001|Overall Study|Lost to Follow-up|2|||
105741825|NCT01525849|364709796|FG000|Overall Study|Withdrawal by Subject|1|||
106014863|NCT01177397|365720897|FG004|Overall Study|Adverse Event|0|||
106014864|NCT01177397|365720898|FG005|Overall Study|Adverse Event|12|||
106014865|NCT01177397|365720899|FG006|Overall Study|Adverse Event|1|||
106014866|NCT01177397|365720900|FG007|Overall Study|Adverse Event|14|||
106014867|NCT01177397|365720901|FG008|Overall Study|Adverse Event|8|||
106014868|NCT01177397|365720902|FG009|Overall Study|Adverse Event|6|||
105942341|NCT02378480|365451699|FG000|Overall Study|Missed EOT/PTE Visit|1|||
105942342|NCT02378480|365451700|FG001|Overall Study|Missed EOT/PTE Visit|2|||
106014869|NCT01177397|365720903|FG010|Overall Study|Adverse Event|3|||
105942343|NCT02378480|365451699|FG000|Overall Study|Withdrawal by Subject|9|||
106014870|NCT01177397|365720904|FG011|Overall Study|Adverse Event|7|||
106014871|NCT01177397|365720893|FG000|Overall Study|Disease progression|1|||
105800144|NCT01270841|364926383|FG000|Overall Study|Withdrawal by Subject|3|||
105800145|NCT01270841|364926384|FG001|Overall Study|Withdrawal by Subject|2|||
105800146|NCT01270841|364926385|FG002|Overall Study|Withdrawal by Subject|3|||
105800147|NCT01270841|364926386|FG003|Overall Study|Withdrawal by Subject|3|||
105800148|NCT01270841|364926383|FG000|Overall Study|Lost to Follow-up|3|||
105800149|NCT01270841|364926384|FG001|Overall Study|Lost to Follow-up|1|||
105800150|NCT01270841|364926385|FG002|Overall Study|Lost to Follow-up|4|||
105800151|NCT01270841|364926386|FG003|Overall Study|Lost to Follow-up|2|||
105800152|NCT01270841|364926383|FG000|Overall Study|Physician Decision|0|||
105800153|NCT01270841|364926384|FG001|Overall Study|Physician Decision|1|||
105800154|NCT01270841|364926385|FG002|Overall Study|Physician Decision|0|||
106014872|NCT01177397|365720894|FG001|Overall Study|Disease progression|2|||
106014873|NCT01177397|365720895|FG002|Overall Study|Disease progression|5|||
106014874|NCT01177397|365720896|FG003|Overall Study|Disease progression|5|||
106014875|NCT01177397|365720897|FG004|Overall Study|Disease progression|4|||
106014876|NCT01177397|365720898|FG005|Overall Study|Disease progression|10|||
106014877|NCT01177397|365720899|FG006|Overall Study|Disease progression|10|||
106014878|NCT01177397|365720900|FG007|Overall Study|Disease progression|21|||
106014879|NCT01177397|365720901|FG008|Overall Study|Disease progression|18|||
106014880|NCT01177397|365720902|FG009|Overall Study|Disease progression|12|||
106014881|NCT01177397|365720903|FG010|Overall Study|Disease progression|10|||
105800155|NCT01270841|364926386|FG003|Overall Study|Physician Decision|0|||
105800156|NCT01270841|364926383|FG000|Overall Study|Did not qualify|6|||
105942344|NCT02378480|365451700|FG001|Overall Study|Withdrawal by Subject|4|||
105942345|NCT02378480|365451699|FG000|Overall Study|Lost to Follow-up|10|||
105942346|NCT02378480|365451700|FG001|Overall Study|Lost to Follow-up|18|||
105942347|NCT01230060|365451706|FG000|Overall Study|Withdrawal by Subject|1|||
105942348|NCT01217892|365451707|FG000|Overall Study|Adverse Event|1|||
105942349|NCT01217892|365451708|FG001|Overall Study|Adverse Event|1|||
105942350|NCT01217892|365451709|FG002|Overall Study|Adverse Event|1|||
105942351|NCT01217892|365451710|FG003|Overall Study|Adverse Event|0|||
105942352|NCT01217892|365451707|FG000|Overall Study|Withdrawal by Subject|0|||
105942353|NCT01217892|365451708|FG001|Overall Study|Withdrawal by Subject|2|||
105942354|NCT01217892|365451709|FG002|Overall Study|Withdrawal by Subject|1|||
105942355|NCT01217892|365451710|FG003|Overall Study|Withdrawal by Subject|0|||
105942356|NCT01217892|365451707|FG000|Overall Study|Lab value|1|||
105942357|NCT01217892|365451708|FG001|Overall Study|Lab value|0|||
105942358|NCT01217892|365451709|FG002|Overall Study|Lab value|1|||
105942359|NCT01217892|365451710|FG003|Overall Study|Lab value|0|||
105942360|NCT01217892|365451707|FG000|Overall Study|Subject no longer meets study criteria|5|||
105942361|NCT01217892|365451708|FG001|Overall Study|Subject no longer meets study criteria|2|||
105942362|NCT01217892|365451709|FG002|Overall Study|Subject no longer meets study criteria|4|||
105942363|NCT01217892|365451710|FG003|Overall Study|Subject no longer meets study criteria|8|||
105942364|NCT01217892|365451707|FG000|Overall Study|Incorrect enrollment|0|||
105942365|NCT01217892|365451708|FG001|Overall Study|Incorrect enrollment|1|||
105942366|NCT01217892|365451709|FG002|Overall Study|Incorrect enrollment|1|||
105942367|NCT01217892|365451710|FG003|Overall Study|Incorrect enrollment|0|||
105942368|NCT01217892|365451707|FG000|Overall Study|Poor/Non-Compliance|0|||
105942369|NCT01217892|365451708|FG001|Overall Study|Poor/Non-Compliance|0|||
105942370|NCT01217892|365451709|FG002|Overall Study|Poor/Non-Compliance|1|||
105942371|NCT01217892|365451710|FG003|Overall Study|Poor/Non-Compliance|0|||
105942372|NCT01285102|365451711|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
105942373|NCT02157610|365451712|FG000|Overall Study|Death|4|||
105942374|NCT02157610|365451713|FG001|Overall Study|Death|4|||
105942375|NCT05763381|365451720|FG000|Overall Study|Lost to Follow-up|2|||
105942376|NCT05763381|365451721|FG001|Overall Study|Lost to Follow-up|3|||
105942377|NCT05763381|365451720|FG000|Overall Study|Withdrawal by Subject|1|||
105942378|NCT05763381|365451721|FG001|Overall Study|Withdrawal by Subject|2|||
105942379|NCT02853136|365451724|FG000|Wash-out|Adverse Event|0|||
105942380|NCT02853136|365451725|FG001|Wash-out|Adverse Event|0|||
105942381|NCT02853136|365451726|FG002|Wash-out|Adverse Event|0|||
105942382|NCT02853136|365451727|FG003|Wash-out|Adverse Event|1|||
105942383|NCT00863304|365451730|FG000|Overall Study|Adverse Event|10|||
106014882|NCT01177397|365720904|FG011|Overall Study|Disease progression|8|||
106014883|NCT01177397|365720893|FG000|Overall Study|Other reasons|0|||
105800157|NCT01270841|364926384|FG001|Overall Study|Did not qualify|3|||
105942384|NCT00863304|365451731|FG001|Overall Study|Adverse Event|4|||
106014884|NCT01177397|365720894|FG001|Overall Study|Other reasons|0|||
106014885|NCT01177397|365720895|FG002|Overall Study|Other reasons|1|||
106014886|NCT01177397|365720896|FG003|Overall Study|Other reasons|0|||
105800158|NCT01270841|364926385|FG002|Overall Study|Did not qualify|4|||
105942385|NCT00863304|365451732|FG002|Overall Study|Adverse Event|14|||
105942386|NCT00863304|365451733|FG003|Overall Study|Adverse Event|16|||
105942387|NCT00863304|365451730|FG000|Overall Study|Lost to Follow-up|1|||
105942388|NCT00863304|365451731|FG001|Overall Study|Lost to Follow-up|5|||
105942389|NCT00863304|365451732|FG002|Overall Study|Lost to Follow-up|4|||
105942390|NCT00863304|365451733|FG003|Overall Study|Lost to Follow-up|2|||
105942391|NCT00863304|365451730|FG000|Overall Study|Lack of Efficacy|57|||
106142116|NCT02139046|366179840|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
106142117|NCT02139046|366179841|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
106142118|NCT02139046|366179842|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
106142119|NCT02139046|366179843|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
106142120|NCT02139046|366179839|FG000|Overall Study|Other Miscellaneous Reasons|10|||
106142121|NCT02139046|366179840|FG001|Overall Study|Other Miscellaneous Reasons|9|||
106142122|NCT02139046|366179841|FG002|Overall Study|Other Miscellaneous Reasons|4|||
105741826|NCT01525849|364709797|FG001|Overall Study|Withdrawal by Subject|9|||
105741827|NCT01525849|364709796|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
105741828|NCT01525849|364709797|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
105741829|NCT01525849|364709796|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
105741830|NCT01525849|364709797|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
105741831|NCT01469013|364709803|FG000|Part A (Treatment Period)|Adverse Event|1|||
105741832|NCT01469013|364709804|FG001|Part A (Treatment Period)|Adverse Event|0|||
105741833|NCT01469013|364709805|FG002|Part A (Treatment Period)|Adverse Event|0|||
105741834|NCT01469013|364709806|FG003|Part A (Treatment Period)|Adverse Event|0|||
105741835|NCT01469013|364709807|FG004|Part A (Treatment Period)|Adverse Event|1|||
105741836|NCT01469013|364709808|FG005|Part A (Treatment Period)|Adverse Event|0|||
105741837|NCT01469013|364709809|FG006|Part A (Treatment Period)|Adverse Event|0|||
105741838|NCT01469013|364709810|FG007|Part A (Treatment Period)|Adverse Event|0|||
105741839|NCT01469013|364709811|FG008|Part A (Treatment Period)|Adverse Event|0|||
105741840|NCT01469013|364709812|FG009|Part A (Treatment Period)|Adverse Event|0|||
105741841|NCT01469013|364709813|FG010|Part A (Treatment Period)|Adverse Event|0|||
105741842|NCT01469013|364709814|FG011|Part A (Treatment Period)|Adverse Event|0|||
105741843|NCT01469013|364709815|FG012|Part A (Treatment Period)|Adverse Event|0|||
105741844|NCT01469013|364709803|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741845|NCT01469013|364709804|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741846|NCT01469013|364709805|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
105741847|NCT01469013|364709806|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741848|NCT01469013|364709807|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741849|NCT01469013|364709808|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741850|NCT01469013|364709809|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741851|NCT01469013|364709810|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741852|NCT01469013|364709811|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741853|NCT01469013|364709812|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741854|NCT01469013|364709813|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741855|NCT01469013|364709814|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741856|NCT01469013|364709815|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
105741857|NCT01469013|364709803|FG000|Part B (Extension Period)|Adverse Event|0|||
105741858|NCT01469013|364709804|FG001|Part B (Extension Period)|Adverse Event|0|||
105741859|NCT01469013|364709805|FG002|Part B (Extension Period)|Adverse Event|0|||
105741860|NCT01469013|364709806|FG003|Part B (Extension Period)|Adverse Event|0|||
105741861|NCT01469013|364709807|FG004|Part B (Extension Period)|Adverse Event|0|||
105741862|NCT01469013|364709808|FG005|Part B (Extension Period)|Adverse Event|2|||
105741863|NCT01469013|364709809|FG006|Part B (Extension Period)|Adverse Event|5|||
105741864|NCT01469013|364709810|FG007|Part B (Extension Period)|Adverse Event|5|||
105741865|NCT01469013|364709811|FG008|Part B (Extension Period)|Adverse Event|3|||
105741866|NCT01469013|364709812|FG009|Part B (Extension Period)|Adverse Event|3|||
105741867|NCT01469013|364709813|FG010|Part B (Extension Period)|Adverse Event|1|||
105741868|NCT01469013|364709814|FG011|Part B (Extension Period)|Adverse Event|6|||
105741869|NCT01469013|364709815|FG012|Part B (Extension Period)|Adverse Event|3|||
105741870|NCT01469013|364709803|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
105741871|NCT01469013|364709804|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
105741872|NCT01469013|364709805|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
105741873|NCT01469013|364709806|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
105741874|NCT01469013|364709807|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
105741875|NCT01469013|364709808|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
105741876|NCT01469013|364709809|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
105741877|NCT01469013|364709810|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
105741878|NCT01469013|364709811|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
105741879|NCT01469013|364709812|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
105741880|NCT01469013|364709813|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
105741881|NCT01469013|364709814|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
105741882|NCT01469013|364709815|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
105741883|NCT00793819|364709816|FG000|Overall Study|Adverse Event|8|||
105741884|NCT00793819|364709817|FG001|Overall Study|Adverse Event|4|||
105741885|NCT00793819|364709816|FG000|Overall Study|Lack of Efficacy|1|||
105741886|NCT00793819|364709817|FG001|Overall Study|Lack of Efficacy|1|||
105741887|NCT00793819|364709816|FG000|Overall Study|Withdrawal by Subject|4|||
105741888|NCT00793819|364709817|FG001|Overall Study|Withdrawal by Subject|3|||
105741889|NCT00793819|364709816|FG000|Overall Study|Lost to Follow-up|1|||
106142123|NCT02139046|366179842|FG003|Overall Study|Other Miscellaneous Reasons|9|||
106142124|NCT02139046|366179843|FG004|Overall Study|Other Miscellaneous Reasons|12|||
105741890|NCT00793819|364709817|FG001|Overall Study|Lost to Follow-up|1|||
105741891|NCT00002663|364709818|FG000|Overall Study|Death|4|||
105741892|NCT00002663|364709819|FG001|Overall Study|Death|1|||
105741893|NCT00002663|364709820|FG002|Overall Study|Death|1|||
105741894|NCT00002663|364709821|FG003|Overall Study|Death|0|||
105741895|NCT00002663|364709822|FG004|Overall Study|Death|0|||
105741896|NCT00002663|364709823|FG005|Overall Study|Death|13|||
105741897|NCT00002663|364709824|FG006|Overall Study|Death|0|||
105741898|NCT00002663|364709825|FG007|Overall Study|Death|1|||
105741899|NCT00002663|364709826|FG008|Overall Study|Death|1|||
105741900|NCT00002663|364709827|FG009|Overall Study|Death|1|||
105741901|NCT00002663|364709818|FG000|Overall Study|Lost to Follow-up|3|||
105741902|NCT00002663|364709819|FG001|Overall Study|Lost to Follow-up|0|||
105741903|NCT00002663|364709820|FG002|Overall Study|Lost to Follow-up|0|||
105741904|NCT00002663|364709821|FG003|Overall Study|Lost to Follow-up|1|||
105741905|NCT00002663|364709822|FG004|Overall Study|Lost to Follow-up|0|||
105741906|NCT00002663|364709823|FG005|Overall Study|Lost to Follow-up|1|||
105741907|NCT00002663|364709824|FG006|Overall Study|Lost to Follow-up|0|||
105741908|NCT00002663|364709825|FG007|Overall Study|Lost to Follow-up|0|||
105741909|NCT00002663|364709826|FG008|Overall Study|Lost to Follow-up|0|||
105741910|NCT00002663|364709827|FG009|Overall Study|Lost to Follow-up|0|||
105741911|NCT00002663|364709818|FG000|Overall Study|Other|0|||
105741912|NCT00002663|364709819|FG001|Overall Study|Other|1|||
105741913|NCT00002663|364709820|FG002|Overall Study|Other|0|||
105741914|NCT00002663|364709821|FG003|Overall Study|Other|0|||
105741915|NCT00002663|364709822|FG004|Overall Study|Other|0|||
105741916|NCT00002663|364709823|FG005|Overall Study|Other|1|||
105741917|NCT00002663|364709824|FG006|Overall Study|Other|1|||
105741918|NCT00002663|364709825|FG007|Overall Study|Other|0|||
105741919|NCT00002663|364709826|FG008|Overall Study|Other|0|||
105741920|NCT00002663|364709827|FG009|Overall Study|Other|0|||
105741921|NCT00002663|364709818|FG000|Overall Study|Physician Decision|0|||
105741922|NCT00002663|364709819|FG001|Overall Study|Physician Decision|0|||
105741923|NCT00002663|364709820|FG002|Overall Study|Physician Decision|0|||
105741924|NCT00002663|364709821|FG003|Overall Study|Physician Decision|0|||
105741925|NCT00002663|364709822|FG004|Overall Study|Physician Decision|1|||
105741926|NCT00002663|364709823|FG005|Overall Study|Physician Decision|0|||
105741927|NCT00002663|364709824|FG006|Overall Study|Physician Decision|0|||
105741928|NCT00002663|364709825|FG007|Overall Study|Physician Decision|0|||
105741929|NCT00002663|364709826|FG008|Overall Study|Physician Decision|1|||
105741930|NCT00002663|364709827|FG009|Overall Study|Physician Decision|1|||
105741931|NCT00002663|364709818|FG000|Overall Study|Adverse Event|0|||
105741932|NCT00002663|364709819|FG001|Overall Study|Adverse Event|0|||
105741933|NCT00002663|364709820|FG002|Overall Study|Adverse Event|0|||
105741934|NCT00002663|364709821|FG003|Overall Study|Adverse Event|1|||
105741935|NCT00002663|364709822|FG004|Overall Study|Adverse Event|0|||
105741936|NCT00002663|364709823|FG005|Overall Study|Adverse Event|0|||
105741937|NCT00002663|364709824|FG006|Overall Study|Adverse Event|0|||
105741938|NCT00002663|364709825|FG007|Overall Study|Adverse Event|1|||
105741939|NCT00002663|364709826|FG008|Overall Study|Adverse Event|0|||
105741940|NCT00002663|364709827|FG009|Overall Study|Adverse Event|0|||
105741941|NCT02868216|364709831|FG000|Overall Study|Death|0|||
105741942|NCT02868216|364709832|FG001|Overall Study|Death|1|||
105741943|NCT02868216|364709831|FG000|Overall Study|coronary artery bypass|1|||
105741944|NCT02868216|364709832|FG001|Overall Study|coronary artery bypass|0|||
105741945|NCT02868216|364709831|FG000|Overall Study|Withdrawal by Subject|7|||
105741946|NCT02868216|364709832|FG001|Overall Study|Withdrawal by Subject|5|||
105800159|NCT01270841|364926386|FG003|Overall Study|Did not qualify|5|||
105800160|NCT01270841|364926383|FG000|Overall Study|Protocol Violation|1|||
105800161|NCT01270841|364926384|FG001|Overall Study|Protocol Violation|5|||
105741947|NCT03161678|364709835|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
105741948|NCT03161678|364709836|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
105741949|NCT03161678|364709837|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
105741950|NCT03161678|364709838|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
105741951|NCT03161678|364709839|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
105741952|NCT03161678|364709840|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
105741953|NCT03161678|364709835|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
105741954|NCT03161678|364709836|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
105741955|NCT03161678|364709837|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
105741956|NCT03161678|364709838|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
105741957|NCT03161678|364709839|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
105741958|NCT03161678|364709840|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
105741959|NCT03161678|364709835|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
105741960|NCT03161678|364709836|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
105741961|NCT03161678|364709837|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
105942392|NCT00863304|365451731|FG001|Overall Study|Lack of Efficacy|26|||
105942393|NCT00863304|365451732|FG002|Overall Study|Lack of Efficacy|30|||
105741962|NCT03161678|364709838|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
105741963|NCT03161678|364709839|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
105741964|NCT03161678|364709840|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
105741965|NCT03161678|364709835|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105942394|NCT00863304|365451733|FG003|Overall Study|Lack of Efficacy|28|||
105942395|NCT00863304|365451730|FG000|Overall Study|Withdrawal by Subject|19|||
105741966|NCT03161678|364709836|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741967|NCT03161678|364709837|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741968|NCT03161678|364709838|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
105741969|NCT03161678|364709839|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741970|NCT03161678|364709840|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
105741971|NCT03609359|364709841|FG000|Overall Study|Progression of primary disease (PD)|25|||
105741972|NCT03609359|364709841|FG000|Overall Study|Patient's refusal|1|||
105741973|NCT03609359|364709841|FG000|Overall Study|Physician Decision|1|||
105741974|NCT03609359|364709841|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
105741975|NCT01757704|364709842|FG000|Overall Study|Protocol Violation|1|||
105741976|NCT01757704|364709843|FG001|Overall Study|Protocol Violation|3|||
105741977|NCT01879618|364709844|FG000|Overall Study|Does not meet entrance criteria|1|||
105741978|NCT01879618|364709844|FG000|Overall Study|Withdrawal by Subject|1|||
105741979|NCT01879618|364709844|FG000|Overall Study|Surgery;changed schedule; not available|8|||
105741980|NCT01879618|364709844|FG000|Overall Study|Protocol Violation|6|||
105741981|NCT01879618|364709844|FG000|Overall Study|Adverse Event|5|||
105741982|NCT02552355|364709845|FG000|Overall Study|Adverse Event|0|||
105741983|NCT02552355|364709846|FG001|Overall Study|Adverse Event|2|||
105741984|NCT02552355|364709847|FG002|Overall Study|Adverse Event|2|||
105741985|NCT02552355|364709848|FG003|Overall Study|Adverse Event|0|||
105741986|NCT02552355|364709845|FG000|Overall Study|Withdrawal by Subject|0|||
105741987|NCT02552355|364709846|FG001|Overall Study|Withdrawal by Subject|0|||
105741988|NCT02552355|364709847|FG002|Overall Study|Withdrawal by Subject|0|||
105741989|NCT02552355|364709848|FG003|Overall Study|Withdrawal by Subject|1|||
105741990|NCT00443430|364709849|FG000|Overall Study|Lack of Efficacy|3|||
105741991|NCT00443430|364709850|FG001|Overall Study|Lack of Efficacy|3|||
105741992|NCT00443430|364709849|FG000|Overall Study|Adverse Event|1|||
105741993|NCT00443430|364709850|FG001|Overall Study|Adverse Event|1|||
105741994|NCT04743635|364709851|FG000|Overall Study|Lost to Follow-up|2|||
105741995|NCT04743635|364709852|FG001|Overall Study|Lost to Follow-up|0|||
105741996|NCT03141086|364709855|FG000|Overall Study|Study Terminated By Sponsor|1|||
105741997|NCT03141086|364709856|FG001|Overall Study|Study Terminated By Sponsor|1|||
105741998|NCT03141086|364709855|FG000|Overall Study|Withdrawal by Subject|0|||
105741999|NCT03141086|364709856|FG001|Overall Study|Withdrawal by Subject|1|||
105742000|NCT03141086|364709855|FG000|Overall Study|Protocol Violation|0|||
105742001|NCT03141086|364709856|FG001|Overall Study|Protocol Violation|1|||
105742002|NCT03141086|364709855|FG000|Overall Study|Adverse Event|0|||
105742003|NCT03141086|364709856|FG001|Overall Study|Adverse Event|2|||
105742004|NCT04439838|364711049|FG000|Overall Study|Withdrawal by Subject|0|||
105742005|NCT04439838|364711050|FG001|Overall Study|Withdrawal by Subject|0|||
105742006|NCT04439838|364711051|FG002|Overall Study|Withdrawal by Subject|0|||
105742007|NCT04439838|364711052|FG003|Overall Study|Withdrawal by Subject|0|||
105742008|NCT04439838|364711053|FG004|Overall Study|Withdrawal by Subject|0|||
105742009|NCT04439838|364711054|FG005|Overall Study|Withdrawal by Subject|0|||
105742010|NCT04439838|364711055|FG006|Overall Study|Withdrawal by Subject|0|||
105742011|NCT04439838|364711056|FG007|Overall Study|Withdrawal by Subject|0|||
105742012|NCT04439838|364711057|FG008|Overall Study|Withdrawal by Subject|1|||
105742013|NCT04494633|364711058|FG000|Overall Study|Lost to Follow-up|5|||
105742014|NCT04494633|364711059|FG001|Overall Study|Lost to Follow-up|3|||
105742015|NCT04494633|364711058|FG000|Overall Study|Protocol Violation|1|||
105742016|NCT04494633|364711059|FG001|Overall Study|Protocol Violation|1|||
105942396|NCT00863304|365451731|FG001|Overall Study|Withdrawal by Subject|14|||
105942397|NCT00863304|365451732|FG002|Overall Study|Withdrawal by Subject|20|||
105942398|NCT00863304|365451733|FG003|Overall Study|Withdrawal by Subject|18|||
105942399|NCT00863304|365451730|FG000|Overall Study|Other|1|||
105942400|NCT00863304|365451731|FG001|Overall Study|Other|0|||
105942401|NCT00863304|365451732|FG002|Overall Study|Other|0|||
106142125|NCT02082158|366179845|FG000|Overall Study|Withdrawal by Subject|0|||
105742017|NCT04467164|364711063|FG000|Washout (1 Week)|Lost to Follow-up|2|||
105742018|NCT04467164|364711064|FG001|Washout (1 Week)|Lost to Follow-up|0|||
105742019|NCT01254604|364711065|FG000|Overall Study|Lost to Follow-up|1|||
105742020|NCT01254604|364711066|FG001|Overall Study|Lost to Follow-up|1|||
105742021|NCT01254604|364711065|FG000|Overall Study|Protocol Violation|2|||
105742022|NCT01254604|364711066|FG001|Overall Study|Protocol Violation|2|||
105742023|NCT01254604|364711065|FG000|Overall Study|Withdrawal by Subject|2|||
105742024|NCT01254604|364711066|FG001|Overall Study|Withdrawal by Subject|4|||
105742025|NCT01254604|364711065|FG000|Overall Study|Adverse Event|3|||
105742026|NCT01254604|364711066|FG001|Overall Study|Adverse Event|2|||
105742027|NCT01701583|364711067|FG000|Overall Study|Withdrawal by Subject|2|||
105742028|NCT01701583|364711068|FG001|Overall Study|Withdrawal by Subject|0|||
105742029|NCT00943319|364711069|FG000|Overall Study|Death|1|||
105742030|NCT03650452|364711073|FG000|Overall Study|Physician Decision|1|||
105942402|NCT00863304|365451733|FG003|Overall Study|Other|1|||
105942403|NCT00863304|365451730|FG000|Overall Study|Protocol Violation|2|||
105942404|NCT00863304|365451731|FG001|Overall Study|Protocol Violation|6|||
105742031|NCT03650452|364711074|FG001|Overall Study|Physician Decision|0|||
105742032|NCT03650452|364711073|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
105742033|NCT03650452|364711074|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105742034|NCT03650452|364711073|FG000|Overall Study|Adverse Event|3|||
105742035|NCT03650452|364711074|FG001|Overall Study|Adverse Event|4|||
105742036|NCT03650452|364711073|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
105742037|NCT03650452|364711074|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
105742038|NCT02273050|364711075|FG000|Overall Study|Adverse Event|4|||
105742039|NCT02273050|364711076|FG001|Overall Study|Adverse Event|3|||
105742040|NCT02273050|364711077|FG002|Overall Study|Adverse Event|3|||
105742041|NCT02273050|364711075|FG000|Overall Study|Death|0|||
105742042|NCT02273050|364711076|FG001|Overall Study|Death|0|||
105742043|NCT02273050|364711077|FG002|Overall Study|Death|1|||
105742044|NCT02273050|364711075|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
105742045|NCT02273050|364711076|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
105742046|NCT02273050|364711077|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
105742047|NCT02273050|364711075|FG000|Overall Study|Lack of Efficacy|0|||
105742048|NCT02273050|364711076|FG001|Overall Study|Lack of Efficacy|1|||
105742049|NCT02273050|364711077|FG002|Overall Study|Lack of Efficacy|1|||
105742050|NCT02273050|364711075|FG000|Overall Study|Withdrawal by Subject|17|||
105742051|NCT02273050|364711076|FG001|Overall Study|Withdrawal by Subject|14|||
105742052|NCT02273050|364711077|FG002|Overall Study|Withdrawal by Subject|16|||
105742053|NCT02273050|364711075|FG000|Overall Study|Lost to Follow-up|0|||
105742054|NCT02273050|364711076|FG001|Overall Study|Lost to Follow-up|2|||
105742055|NCT02273050|364711077|FG002|Overall Study|Lost to Follow-up|3|||
105742056|NCT02273050|364711075|FG000|Overall Study|Protocol Violation|3|||
105742057|NCT02273050|364711076|FG001|Overall Study|Protocol Violation|1|||
105742058|NCT02273050|364711077|FG002|Overall Study|Protocol Violation|4|||
105742059|NCT01795898|364711078|FG000|Overall Study|Adverse Event|27|||
105742060|NCT01795898|364711078|FG000|Overall Study|Lost to Follow-up|20|||
105742061|NCT01795898|364711078|FG000|Overall Study|Withdrawal of consent|6|||
105742062|NCT01795898|364711078|FG000|Overall Study|Diagnosed with metastasis|1|||
105742063|NCT01795898|364711078|FG000|Overall Study|No pain|1|||
105742064|NCT01795898|364711078|FG000|Overall Study|Death|1|||
105742065|NCT01795898|364711078|FG000|Overall Study|Withdrew consent & had adverse events|3|||
105742066|NCT01795898|364711078|FG000|Overall Study|Physician Decision|1|||
105742067|NCT03628417|364711079|FG000|Overall Study|Death|1|||
105742068|NCT03628417|364711080|FG001|Overall Study|Death|1|||
105742069|NCT00769704|364711081|FG000|Overall Study|Lost to Follow-up|3|||
105742070|NCT00769704|364711082|FG001|Overall Study|Lost to Follow-up|2|||
105742071|NCT00769704|364711081|FG000|Overall Study|Death|95|||
105742072|NCT00769704|364711082|FG001|Overall Study|Death|190|||
105742073|NCT00769704|364711081|FG000|Overall Study|Withdrawal by Subject|12|||
105742074|NCT00769704|364711082|FG001|Overall Study|Withdrawal by Subject|5|||
105742075|NCT00769704|364711081|FG000|Overall Study|Other|1|||
105742076|NCT00769704|364711082|FG001|Overall Study|Other|2|||
105742077|NCT04346628|364711083|FG000|Overall Study|Lost to Follow-up|4|||
105742078|NCT04346628|364711084|FG001|Overall Study|Lost to Follow-up|4|||
105742079|NCT04346628|364711083|FG000|Overall Study|Withdrew (had personal reasons)|2|||
105942405|NCT00863304|365451732|FG002|Overall Study|Protocol Violation|2|||
105942406|NCT00863304|365451733|FG003|Overall Study|Protocol Violation|0|||
105942407|NCT00863304|365451730|FG000|Overall Study|Randomized, but not Treated|3|||
105942408|NCT00863304|365451731|FG001|Overall Study|Randomized, but not Treated|1|||
105942409|NCT00863304|365451732|FG002|Overall Study|Randomized, but not Treated|4|||
105942410|NCT00863304|365451733|FG003|Overall Study|Randomized, but not Treated|1|||
105942411|NCT00863304|365451730|FG000|Overall Study|Entered extension study|101|||
105742080|NCT04346628|364711084|FG001|Overall Study|Withdrew (had personal reasons)|5|||
105742081|NCT04346628|364711083|FG000|Overall Study|Withdrew (medication intolerant)|0|||
105742082|NCT04346628|364711084|FG001|Overall Study|Withdrew (medication intolerant)|3|||
105742083|NCT04346628|364711083|FG000|Overall Study|Withdrew (declined intervention)|0|||
105742084|NCT04346628|364711084|FG001|Overall Study|Withdrew (declined intervention)|1|||
105742085|NCT03350750|364711085|FG000|Overall Study|Death|1|||
105742086|NCT03350750|364711086|FG001|Overall Study|Death|1|||
105742087|NCT02417233|364711089|FG000|Overall Study|Death|4|||
105742088|NCT02417233|364711090|FG001|Overall Study|Death|10|||
105742089|NCT02417233|364711091|FG002|Overall Study|Death|14|||
105942412|NCT00863304|365451731|FG001|Overall Study|Entered extension study|129|||
105942413|NCT00863304|365451732|FG002|Overall Study|Entered extension study|113|||
105952176|NCT03314935|365488197|FG013|Phase 2|Progressive Disease|0|||
105952177|NCT03314935|365488198|FG014|Phase 2|Progressive Disease|1|||
105952178|NCT03314935|365488184|FG000|Phase 2|Study Terminated by Sponsor|0|||
105952179|NCT03314935|365488185|FG001|Phase 2|Study Terminated by Sponsor|0|||
105952180|NCT03314935|365488186|FG002|Phase 2|Study Terminated by Sponsor|0|||
105952181|NCT03314935|365488187|FG003|Phase 2|Study Terminated by Sponsor|0|||
105952182|NCT03314935|365488188|FG004|Phase 2|Study Terminated by Sponsor|0|||
105952183|NCT03314935|365488189|FG005|Phase 2|Study Terminated by Sponsor|0|||
105952184|NCT03314935|365488190|FG006|Phase 2|Study Terminated by Sponsor|0|||
105952185|NCT03314935|365488191|FG007|Phase 2|Study Terminated by Sponsor|0|||
105800162|NCT01270841|364926385|FG002|Overall Study|Protocol Violation|0|||
105800163|NCT01270841|364926386|FG003|Overall Study|Protocol Violation|0|||
105800164|NCT01270841|364926383|FG000|Overall Study|Enrolled in error|0|||
105800165|NCT01270841|364926384|FG001|Overall Study|Enrolled in error|1|||
105800166|NCT01270841|364926385|FG002|Overall Study|Enrolled in error|0|||
105800167|NCT01270841|364926386|FG003|Overall Study|Enrolled in error|0|||
105800168|NCT01326702|364926387|FG000|Overall Study|Other|1|||
105800169|NCT01326702|364926388|FG001|Overall Study|Other|0|||
105800170|NCT01326702|364926389|FG002|Overall Study|Other|0|||
105800171|NCT01326702|364926390|FG003|Overall Study|Other|0|||
105800172|NCT01326702|364926391|FG004|Overall Study|Other|0|||
105800173|NCT01326702|364926392|FG005|Overall Study|Other|1|||
105800174|NCT01326702|364926393|FG006|Overall Study|Other|0|||
105800175|NCT01326702|364926387|FG000|Overall Study|progressive disease|1|||
105800176|NCT01326702|364926388|FG001|Overall Study|progressive disease|1|||
105800177|NCT01326702|364926389|FG002|Overall Study|progressive disease|3|||
105800178|NCT01326702|364926390|FG003|Overall Study|progressive disease|1|||
105800179|NCT01326702|364926391|FG004|Overall Study|progressive disease|3|||
105800180|NCT01326702|364926392|FG005|Overall Study|progressive disease|2|||
105800181|NCT01326702|364926393|FG006|Overall Study|progressive disease|3|||
105800182|NCT01326702|364926387|FG000|Overall Study|Death|0|||
105800183|NCT01326702|364926388|FG001|Overall Study|Death|1|||
105800184|NCT01326702|364926389|FG002|Overall Study|Death|0|||
105800185|NCT01326702|364926390|FG003|Overall Study|Death|0|||
105800186|NCT01326702|364926391|FG004|Overall Study|Death|0|||
105800187|NCT01326702|364926392|FG005|Overall Study|Death|0|||
105800188|NCT01326702|364926393|FG006|Overall Study|Death|0|||
105800189|NCT01326702|364926387|FG000|Overall Study|Adverse Event|0|||
105800190|NCT01326702|364926388|FG001|Overall Study|Adverse Event|0|||
105800191|NCT01326702|364926389|FG002|Overall Study|Adverse Event|1|||
105800192|NCT01326702|364926390|FG003|Overall Study|Adverse Event|1|||
105800193|NCT01326702|364926391|FG004|Overall Study|Adverse Event|0|||
105800194|NCT01326702|364926392|FG005|Overall Study|Adverse Event|3|||
105800195|NCT01326702|364926393|FG006|Overall Study|Adverse Event|1|||
105800196|NCT01326702|364926387|FG000|Overall Study|Withdrawal by Subject|0|||
105800197|NCT01326702|364926388|FG001|Overall Study|Withdrawal by Subject|0|||
106142126|NCT02082158|366179846|FG001|Overall Study|Withdrawal by Subject|0|||
106142127|NCT02082158|366179847|FG002|Overall Study|Withdrawal by Subject|0|||
105800198|NCT01326702|364926389|FG002|Overall Study|Withdrawal by Subject|1|||
105800199|NCT01326702|364926390|FG003|Overall Study|Withdrawal by Subject|0|||
105800200|NCT01326702|364926391|FG004|Overall Study|Withdrawal by Subject|1|||
105800201|NCT01326702|364926392|FG005|Overall Study|Withdrawal by Subject|1|||
105800202|NCT01326702|364926393|FG006|Overall Study|Withdrawal by Subject|3|||
105800203|NCT01326702|364926387|FG000|Overall Study|Not Treated|0|||
105800204|NCT01326702|364926388|FG001|Overall Study|Not Treated|0|||
105800205|NCT01326702|364926389|FG002|Overall Study|Not Treated|0|||
105800206|NCT01326702|364926390|FG003|Overall Study|Not Treated|1|||
105800207|NCT01326702|364926391|FG004|Overall Study|Not Treated|0|||
105800208|NCT01326702|364926392|FG005|Overall Study|Not Treated|1|||
105800209|NCT01326702|364926393|FG006|Overall Study|Not Treated|0|||
105800210|NCT02402933|364926395|FG000|Overall Study|Withdrawal by Subject|4|||
105800211|NCT02402933|364926395|FG000|Overall Study|Discontinued; Site Termination|10|||
105800212|NCT00265083|364926401|FG000|Overall Study|Adverse Event|5|||
105800213|NCT00265083|364926402|FG001|Overall Study|Adverse Event|13|||
105800214|NCT00265083|364926403|FG002|Overall Study|Adverse Event|15|||
106142128|NCT02082158|366179848|FG003|Overall Study|Withdrawal by Subject|0|||
106142129|NCT02082158|366179849|FG004|Overall Study|Withdrawal by Subject|1|||
106142130|NCT02082158|366179850|FG005|Overall Study|Withdrawal by Subject|0|||
106142131|NCT02082158|366179845|FG000|Overall Study|Failed Fit-testing|8|||
106142132|NCT02082158|366179846|FG001|Overall Study|Failed Fit-testing|8|||
106142133|NCT02082158|366179847|FG002|Overall Study|Failed Fit-testing|14|||
106142134|NCT02082158|366179848|FG003|Overall Study|Failed Fit-testing|4|||
106142135|NCT02082158|366179849|FG004|Overall Study|Failed Fit-testing|3|||
106142136|NCT02082158|366179850|FG005|Overall Study|Failed Fit-testing|7|||
106142137|NCT02057692|366179862|FG000|Overall Study|Adverse Event|1|||
106142138|NCT02057692|366179863|FG001|Overall Study|Adverse Event|0|||
105800215|NCT00265083|364926401|FG000|Overall Study|Lost to Follow-up|3|||
105800216|NCT00265083|364926402|FG001|Overall Study|Lost to Follow-up|4|||
105800217|NCT00265083|364926403|FG002|Overall Study|Lost to Follow-up|4|||
105800218|NCT00265083|364926401|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
105800219|NCT00265083|364926402|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
105800220|NCT00265083|364926403|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
105800221|NCT00265083|364926401|FG000|Overall Study|Other|1|||
105800222|NCT00265083|364926402|FG001|Overall Study|Other|12|||
105800223|NCT00265083|364926403|FG002|Overall Study|Other|9|||
106142139|NCT02057692|366179864|FG002|Overall Study|Adverse Event|0|||
106142140|NCT02057692|366179865|FG003|Overall Study|Adverse Event|0|||
105800224|NCT00534092|364926409|FG000|Overall Study|Lost to Follow-up|1|||
105800225|NCT00534092|364926410|FG001|Overall Study|Lost to Follow-up|0|||
106142141|NCT02057692|366179862|FG000|Overall Study|Lost to Follow-up|0|||
105800226|NCT00534092|364926409|FG000|Overall Study|personal reasons/family concerns|1|||
105942414|NCT00863304|365451733|FG003|Overall Study|Entered extension study|125|||
105742090|NCT02417233|364711089|FG000|Overall Study|Lost to Follow-up|27|||
105742091|NCT02417233|364711090|FG001|Overall Study|Lost to Follow-up|39|||
105742092|NCT02417233|364711091|FG002|Overall Study|Lost to Follow-up|34|||
105742093|NCT02417233|364711089|FG000|Overall Study|Protocol Violation|2|||
105742094|NCT02417233|364711090|FG001|Overall Study|Protocol Violation|0|||
105742095|NCT02417233|364711091|FG002|Overall Study|Protocol Violation|2|||
105742096|NCT02417233|364711089|FG000|Overall Study|Withdrawal by Subject|2|||
105742097|NCT02417233|364711090|FG001|Overall Study|Withdrawal by Subject|1|||
105742098|NCT02417233|364711091|FG002|Overall Study|Withdrawal by Subject|8|||
105742099|NCT02417233|364711089|FG000|Overall Study|Relocation out of study area|1|||
105742100|NCT02417233|364711090|FG001|Overall Study|Relocation out of study area|0|||
105742101|NCT02417233|364711091|FG002|Overall Study|Relocation out of study area|1|||
105742102|NCT02417233|364711089|FG000|Overall Study|Mentally unstable|0|||
105742103|NCT02417233|364711090|FG001|Overall Study|Mentally unstable|1|||
105742104|NCT02417233|364711091|FG002|Overall Study|Mentally unstable|0|||
105742105|NCT01096550|364711097|FG000|Overall Study|discontinued site|10|||
105742106|NCT01096550|364711098|FG001|Overall Study|discontinued site|11|||
105742107|NCT01096550|364711097|FG000|Overall Study|non-regular treatment track at clinic|1|||
105742108|NCT01096550|364711098|FG001|Overall Study|non-regular treatment track at clinic|1|||
105742109|NCT01096550|364711097|FG000|Overall Study|clinic readmission|1|||
105742110|NCT01096550|364711098|FG001|Overall Study|clinic readmission|1|||
105742111|NCT01096550|364711097|FG000|Overall Study|Withdrawal by Subject|0|||
105742112|NCT01096550|364711098|FG001|Overall Study|Withdrawal by Subject|1|||
105742113|NCT01096550|364711097|FG000|Overall Study|non-African American participant|13|||
105742114|NCT01096550|364711098|FG001|Overall Study|non-African American participant|6|||
105742115|NCT01096550|364711097|FG000|Overall Study|Lost to Follow-up|12|||
105742116|NCT01096550|364711098|FG001|Overall Study|Lost to Follow-up|9|||
105742117|NCT03510663|364711101|FG000|Overall Study|Withdrawal by Subject|0|||
105742118|NCT03510663|364711102|FG001|Overall Study|Withdrawal by Subject|1|||
105742119|NCT03510663|364711103|FG002|Overall Study|Withdrawal by Subject|0|||
105742120|NCT03510663|364711104|FG003|Overall Study|Withdrawal by Subject|0|||
105742121|NCT03510663|364711105|FG004|Overall Study|Withdrawal by Subject|0|||
105742122|NCT03510663|364711106|FG005|Overall Study|Withdrawal by Subject|0|||
105742123|NCT03510663|364711107|FG006|Overall Study|Withdrawal by Subject|0|||
105742124|NCT03510663|364711108|FG007|Overall Study|Withdrawal by Subject|0|||
105742125|NCT02026271|364711111|FG000|Overall Study|Adverse Event|2|||
105742126|NCT02026271|364711112|FG001|Overall Study|Adverse Event|3|||
105742127|NCT02026271|364711113|FG002|Overall Study|Adverse Event|2|||
105742128|NCT02026271|364711114|FG003|Overall Study|Adverse Event|3|||
105742129|NCT02026271|364711115|FG004|Overall Study|Adverse Event|0|||
105742130|NCT02026271|364711111|FG000|Overall Study|Withdrawal by Subject|0|||
105742131|NCT02026271|364711112|FG001|Overall Study|Withdrawal by Subject|0|||
105742132|NCT02026271|364711113|FG002|Overall Study|Withdrawal by Subject|0|||
105742133|NCT02026271|364711114|FG003|Overall Study|Withdrawal by Subject|0|||
105742134|NCT02026271|364711115|FG004|Overall Study|Withdrawal by Subject|1|||
105742135|NCT01095250|364711116|FG000|Overall Study|administrative reasons|8|||
105742136|NCT01095250|364711117|FG001|Overall Study|administrative reasons|10|||
105742137|NCT01095250|364711118|FG002|Overall Study|administrative reasons|7|||
105742138|NCT01095250|364711119|FG003|Overall Study|administrative reasons|5|||
105742139|NCT01095250|364711116|FG000|Overall Study|Withdrawal by Subject|0|||
105742140|NCT01095250|364711117|FG001|Overall Study|Withdrawal by Subject|0|||
105742141|NCT01095250|364711118|FG002|Overall Study|Withdrawal by Subject|1|||
105742142|NCT01095250|364711119|FG003|Overall Study|Withdrawal by Subject|0|||
105942415|NCT01055028|365451737|FG000|Screening|Screen Failure|1|||
105942416|NCT01055028|365451738|FG001|Screening|Screen Failure|1|||
105942417|NCT01055028|365451737|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
105942418|NCT01055028|365451738|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
105942419|NCT01055028|365451737|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
105942420|NCT01055028|365451738|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
105942421|NCT01055028|365451737|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
105942422|NCT01055028|365451738|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
105942423|NCT06582732|365451741|FG000|Initial Study Period|Adverse Event|0|||
105942424|NCT06582732|365451742|FG001|Initial Study Period|Adverse Event|0|||
105742143|NCT01915849|364711120|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
105742144|NCT01915849|364711121|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
105742145|NCT01915849|364711122|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
105742146|NCT01915849|364711123|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
105742147|NCT01915849|364711120|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
105742148|NCT01915849|364711121|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105742149|NCT01915849|364711122|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105742150|NCT01915849|364711123|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105742151|NCT00001262|364711126|FG000|Overall Study|Death|10|||
105942425|NCT06582732|365451743|FG002|Initial Study Period|Adverse Event|0|||
105942426|NCT06582732|365451744|FG003|Initial Study Period|Adverse Event|2|||
105742152|NCT00001262|364711127|FG001|Overall Study|Death|11|||
105742153|NCT00001262|364711128|FG002|Overall Study|Death|0|||
105742154|NCT00001262|364711126|FG000|Overall Study|Withdrawal by Subject|0|||
105742155|NCT00001262|364711127|FG001|Overall Study|Withdrawal by Subject|3|||
105742156|NCT00001262|364711128|FG002|Overall Study|Withdrawal by Subject|0|||
105742157|NCT00878072|364711129|FG000|Overall Study|Withdrew consent|2|||
105742158|NCT01954121|364711136|FG000|Overall Study|Lack of Efficacy|94|||
105742159|NCT01954121|364711137|FG001|Overall Study|Lack of Efficacy|41|||
105742160|NCT01954121|364711136|FG000|Overall Study|Protocol Violation|0|||
105742161|NCT01954121|364711137|FG001|Overall Study|Protocol Violation|2|||
105942427|NCT06582732|365451745|FG004|Initial Study Period|Adverse Event|0|||
105942428|NCT06582732|365451746|FG005|Initial Study Period|Adverse Event|0|||
105942429|NCT06582732|365451747|FG006|Initial Study Period|Adverse Event|0|||
105942430|NCT06582732|365451741|FG000|Initial Study Period|Death|1|||
105942431|NCT06582732|365451742|FG001|Initial Study Period|Death|0|||
105942432|NCT06582732|365451743|FG002|Initial Study Period|Death|0|||
105942433|NCT06582732|365451744|FG003|Initial Study Period|Death|0|||
105942434|NCT06582732|365451745|FG004|Initial Study Period|Death|1|||
105942435|NCT06582732|365451746|FG005|Initial Study Period|Death|0|||
105942436|NCT06582732|365451747|FG006|Initial Study Period|Death|0|||
105942437|NCT06582732|365451741|FG000|Initial Study Period|Lost to Follow-up|0|||
105942438|NCT06582732|365451742|FG001|Initial Study Period|Lost to Follow-up|0|||
105942439|NCT06582732|365451743|FG002|Initial Study Period|Lost to Follow-up|2|||
105942440|NCT06582732|365451744|FG003|Initial Study Period|Lost to Follow-up|0|||
105942441|NCT06582732|365451745|FG004|Initial Study Period|Lost to Follow-up|0|||
105942442|NCT06582732|365451746|FG005|Initial Study Period|Lost to Follow-up|0|||
105942443|NCT06582732|365451747|FG006|Initial Study Period|Lost to Follow-up|0|||
105942444|NCT06582732|365451741|FG000|Initial Study Period|Withdrawal by Subject|0|||
105942445|NCT06582732|365451742|FG001|Initial Study Period|Withdrawal by Subject|1|||
105942446|NCT06582732|365451743|FG002|Initial Study Period|Withdrawal by Subject|0|||
105942447|NCT06582732|365451744|FG003|Initial Study Period|Withdrawal by Subject|1|||
105942448|NCT06582732|365451745|FG004|Initial Study Period|Withdrawal by Subject|3|||
105942449|NCT06582732|365451746|FG005|Initial Study Period|Withdrawal by Subject|1|||
105942450|NCT06582732|365451747|FG006|Initial Study Period|Withdrawal by Subject|2|||
105942451|NCT06582732|365451741|FG000|Initial Study Period|Moved Away|0|||
105942452|NCT06582732|365451742|FG001|Initial Study Period|Moved Away|0|||
105942453|NCT06582732|365451743|FG002|Initial Study Period|Moved Away|0|||
105942454|NCT06582732|365451744|FG003|Initial Study Period|Moved Away|0|||
105942455|NCT06582732|365451745|FG004|Initial Study Period|Moved Away|1|||
105942456|NCT06582732|365451746|FG005|Initial Study Period|Moved Away|0|||
105942457|NCT06582732|365451747|FG006|Initial Study Period|Moved Away|0|||
105942458|NCT04023487|365451750|FG000|Overall Study|Lost to Follow-up|5|||
105942459|NCT04023487|365451751|FG001|Overall Study|Lost to Follow-up|4|||
105942460|NCT04023487|365451750|FG000|Overall Study|Pregnancy|1|||
105942461|NCT04023487|365451751|FG001|Overall Study|Pregnancy|2|||
105942462|NCT04023487|365451750|FG000|Overall Study|Withdrawal by Subject|4|||
105942463|NCT04023487|365451751|FG001|Overall Study|Withdrawal by Subject|5|||
105942464|NCT04023487|365451750|FG000|Overall Study|Partially completed testing|8|||
105942465|NCT04023487|365451751|FG001|Overall Study|Partially completed testing|4|||
105942466|NCT02919618|365451752|FG000|Overall Study|Death|1|||
105942467|NCT02592863|365451753|FG000|Overall Study|Withdrawal by Subject|2|||
105942468|NCT02592863|365451754|FG001|Overall Study|Withdrawal by Subject|2|||
105942469|NCT02592863|365451753|FG000|Overall Study|Lost to Follow-up|1|||
105942470|NCT02592863|365451754|FG001|Overall Study|Lost to Follow-up|1|||
105942471|NCT02743221|365451755|FG000|Overall Study|Progressive disease|29|||
105942472|NCT02743221|365451756|FG001|Overall Study|Progressive disease|38|||
105942473|NCT02743221|365451755|FG000|Overall Study|Adverse Event|17|||
105942474|NCT02743221|365451756|FG001|Overall Study|Adverse Event|14|||
105942475|NCT02743221|365451755|FG000|Overall Study|non medical reason|8|||
105742162|NCT01954121|364711136|FG000|Overall Study|Lost to Follow-up|5|||
106014887|NCT01177397|365720897|FG004|Overall Study|Other reasons|1|||
106014888|NCT01177397|365720898|FG005|Overall Study|Other reasons|1|||
105742163|NCT01954121|364711137|FG001|Overall Study|Lost to Follow-up|6|||
105742164|NCT01954121|364711136|FG000|Overall Study|Withdrawal by Subject|18|||
105742165|NCT01954121|364711137|FG001|Overall Study|Withdrawal by Subject|12|||
105942476|NCT02743221|365451756|FG001|Overall Study|non medical reason|2|||
105942477|NCT02743221|365451755|FG000|Overall Study|Physician Decision|2|||
105942478|NCT02743221|365451756|FG001|Overall Study|Physician Decision|5|||
105942479|NCT02743221|365451755|FG000|Overall Study|Patient not eligible, not treated|0|||
105942480|NCT02743221|365451756|FG001|Overall Study|Patient not eligible, not treated|1|||
105942481|NCT04770285|365451758|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
105942482|NCT04770285|365451759|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
105942483|NCT04770285|365451758|FG000|Overall Study|Lack of Efficacy|0|||
105942484|NCT04770285|365451759|FG001|Overall Study|Lack of Efficacy|1|||
105942485|NCT04770285|365451758|FG000|Overall Study|Lost to Follow-up|11|||
105942486|NCT04770285|365451759|FG001|Overall Study|Lost to Follow-up|8|||
105942487|NCT04770285|365451758|FG000|Overall Study|Protocol Deviation|6|||
105742166|NCT01954121|364711136|FG000|Overall Study|Pregnancy|1|||
105742167|NCT01954121|364711137|FG001|Overall Study|Pregnancy|1|||
105742168|NCT01954121|364711136|FG000|Overall Study|AE, serious fatal|1|||
105742169|NCT01954121|364711137|FG001|Overall Study|AE, serious fatal|0|||
105742170|NCT01954121|364711136|FG000|Overall Study|AE, non-serious non-fatal|5|||
105742171|NCT01954121|364711137|FG001|Overall Study|AE, non-serious non-fatal|22|||
105742172|NCT01954121|364711136|FG000|Overall Study|SAE, non-fatal|1|||
105742173|NCT01954121|364711137|FG001|Overall Study|SAE, non-fatal|4|||
105742174|NCT01954121|364711136|FG000|Overall Study|Non-compliant with study procedures|1|||
105742175|NCT01954121|364711137|FG001|Overall Study|Non-compliant with study procedures|0|||
105742176|NCT01954121|364711136|FG000|Overall Study|Non-compliant patient|1|||
105742177|NCT01954121|364711137|FG001|Overall Study|Non-compliant patient|1|||
105742178|NCT01954121|364711136|FG000|Overall Study|Subject did not follow instructions|0|||
105742179|NCT01954121|364711137|FG001|Overall Study|Subject did not follow instructions|2|||
105742180|NCT03382899|364711141|FG000|Overall Study|Ineligibility Determined|0|||
105742181|NCT03382899|364711142|FG001|Overall Study|Ineligibility Determined|1|||
105742182|NCT03382899|364711141|FG000|Overall Study|Lost to Follow-up|0|||
105742183|NCT03382899|364711142|FG001|Overall Study|Lost to Follow-up|1|||
105742184|NCT03382899|364711141|FG000|Overall Study|Sponsor's decision|31|||
105742185|NCT03382899|364711142|FG001|Overall Study|Sponsor's decision|28|||
105742186|NCT03382899|364711141|FG000|Overall Study|Withdrawal by Subject|0|||
105742187|NCT03382899|364711142|FG001|Overall Study|Withdrawal by Subject|5|||
105742188|NCT02588248|364711143|FG000|Overall Study|Physician Decision|4|||
105742189|NCT02588248|364711144|FG001|Overall Study|Physician Decision|3|||
105742190|NCT00872170|364711148|FG000|Overall Study|Adverse Event|1|||
105742191|NCT00872170|364711149|FG001|Overall Study|Adverse Event|0|||
105742192|NCT00804193|364711150|FG000|Overall Study|Lack of baseline fungus|32|||
105742193|NCT00804193|364711151|FG001|Overall Study|Lack of baseline fungus|31|||
105742194|NCT00804193|364711152|FG002|Overall Study|Lack of baseline fungus|19|||
105742195|NCT00804193|364711150|FG000|Overall Study|Adverse Event|0|||
105742196|NCT00804193|364711151|FG001|Overall Study|Adverse Event|0|||
105742197|NCT00804193|364711152|FG002|Overall Study|Adverse Event|2|||
105742198|NCT00804193|364711150|FG000|Overall Study|Lack of Efficacy|1|||
105742199|NCT00804193|364711151|FG001|Overall Study|Lack of Efficacy|1|||
105942488|NCT04770285|365451759|FG001|Overall Study|Protocol Deviation|6|||
105942489|NCT04770285|365451758|FG000|Overall Study|Technical Problem|0|||
105942490|NCT04770285|365451759|FG001|Overall Study|Technical Problem|1|||
105942491|NCT04770285|365451758|FG000|Overall Study|Withdrawal by Subject|9|||
105942492|NCT04770285|365451759|FG001|Overall Study|Withdrawal by Subject|8|||
105942493|NCT04770285|365451758|FG000|Overall Study|Reason Not Specified|0|||
105942494|NCT04770285|365451759|FG001|Overall Study|Reason Not Specified|1|||
105942495|NCT03464461|365451760|FG000|Overall Study|exclusionary medication given ,|1|||
105942496|NCT03464461|365451761|FG001|Overall Study|exclusionary medication given ,|2|||
105942497|NCT03464461|365451762|FG002|Overall Study|exclusionary medication given ,|0|||
105942498|NCT03464461|365451760|FG000|Overall Study|Physician Decision|0|||
105942499|NCT03464461|365451761|FG001|Overall Study|Physician Decision|1|||
105942500|NCT03464461|365451762|FG002|Overall Study|Physician Decision|0|||
105942501|NCT00133705|365452767|FG000|Overall Study|Withdrawal by Subject|2|||
105942502|NCT00133705|365452768|FG001|Overall Study|Withdrawal by Subject|3|||
105942503|NCT00959049|365452769|FG000|Overall Study|Adverse Event|1|||
105942504|NCT00959049|365452770|FG001|Overall Study|Adverse Event|0|||
105942505|NCT00959049|365452771|FG002|Overall Study|Adverse Event|0|||
105942506|NCT00959049|365452772|FG003|Overall Study|Adverse Event|0|||
105942507|NCT00959049|365452773|FG004|Overall Study|Adverse Event|0|||
105942508|NCT00959049|365452774|FG005|Overall Study|Adverse Event|0|||
105942509|NCT00959049|365452769|FG000|Overall Study|Lost to Follow-up|17|||
105942510|NCT00959049|365452770|FG001|Overall Study|Lost to Follow-up|5|||
105942511|NCT00959049|365452771|FG002|Overall Study|Lost to Follow-up|1|||
105942512|NCT00959049|365452772|FG003|Overall Study|Lost to Follow-up|10|||
105942513|NCT00959049|365452773|FG004|Overall Study|Lost to Follow-up|9|||
105942514|NCT00959049|365452774|FG005|Overall Study|Lost to Follow-up|1|||
105942515|NCT00959049|365452769|FG000|Overall Study|Contraindicated medication|0|||
105742200|NCT00804193|364711152|FG002|Overall Study|Lack of Efficacy|3|||
105742201|NCT00804193|364711150|FG000|Overall Study|Protocol Violation|0|||
105742202|NCT00804193|364711151|FG001|Overall Study|Protocol Violation|8|||
105742203|NCT00804193|364711152|FG002|Overall Study|Protocol Violation|2|||
105742204|NCT00804193|364711150|FG000|Overall Study|Lost to Follow-up|3|||
105742205|NCT00804193|364711151|FG001|Overall Study|Lost to Follow-up|3|||
105742206|NCT00804193|364711152|FG002|Overall Study|Lost to Follow-up|4|||
105942516|NCT00959049|365452770|FG001|Overall Study|Contraindicated medication|0|||
105942517|NCT00959049|365452771|FG002|Overall Study|Contraindicated medication|0|||
105942518|NCT00959049|365452772|FG003|Overall Study|Contraindicated medication|1|||
105942519|NCT00959049|365452773|FG004|Overall Study|Contraindicated medication|0|||
105942520|NCT00959049|365452774|FG005|Overall Study|Contraindicated medication|0|||
105942521|NCT00959049|365452769|FG000|Overall Study|Withdrawal by Subject|0|||
105742207|NCT00804193|364711150|FG000|Overall Study|Withdrawal by Subject|3|||
105742208|NCT00804193|364711151|FG001|Overall Study|Withdrawal by Subject|1|||
105742209|NCT00804193|364711152|FG002|Overall Study|Withdrawal by Subject|2|||
105742210|NCT00527111|364711153|FG000|Overall Study|Adverse Event|14|||
105742211|NCT00527111|364711154|FG001|Overall Study|Adverse Event|13|||
105742212|NCT00527111|364711153|FG000|Overall Study|Death|0|||
105742213|NCT00527111|364711154|FG001|Overall Study|Death|1|||
105742214|NCT00527111|364711153|FG000|Overall Study|Investigator Request|2|||
105742215|NCT00527111|364711154|FG001|Overall Study|Investigator Request|1|||
105742216|NCT00527111|364711153|FG000|Overall Study|Patient Request|2|||
105742217|NCT00527111|364711154|FG001|Overall Study|Patient Request|5|||
105742218|NCT00527111|364711153|FG000|Overall Study|Other|2|||
105742219|NCT00527111|364711154|FG001|Overall Study|Other|2|||
105742220|NCT00705224|364711155|FG000|Overall Study|Adverse Event|1|||
105742221|NCT00705224|364711155|FG000|Overall Study|Lack of Efficacy|2|||
105742222|NCT00705224|364711155|FG000|Overall Study|Withdrawal by Subject|3|||
105742223|NCT00705224|364711155|FG000|Overall Study|Lost to Follow-up|5|||
105742224|NCT03283163|364711156|FG000|Overall Study|Lost to Follow-up|1|||
105742225|NCT03283163|364711156|FG000|Overall Study|other life commitments|6|||
105742226|NCT03283163|364711156|FG000|Overall Study|COVID-19 institution wide halting|1|||
105742227|NCT03283163|364711156|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
105742228|NCT03283163|364711156|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
105742229|NCT00237796|364711159|FG000|Overall Study|Baseline and one other ILSS required|10|||
105742230|NCT00237796|364711160|FG001|Overall Study|Baseline and one other ILSS required|5|||
105742231|NCT01193348|364711164|FG000|Screening Period|Screen Failure|5|||
105742232|NCT01193348|364711164|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
105742233|NCT01193348|364711164|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
105742234|NCT01193348|364711164|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
105742235|NCT01193348|364711164|FG000|Extension Treatment Period|Physician Decision|1|||
105742236|NCT01193348|364711164|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
105742237|NCT04070378|364711165|FG000|Overall Study|Withdrawal by Subject|2|||
105742238|NCT04070378|364711165|FG000|Overall Study|Screen Failure|6|||
105742239|NCT04070378|364711165|FG000|Overall Study|Physician Decision|1|||
105742240|NCT04070378|364711165|FG000|Overall Study|Adverse Event|1|||
105742241|NCT03596177|364711167|FG000|Single Blind Period|Withdrawal by Subject|1|||
105742242|NCT03596177|364711168|FG001|Single Blind Period|Withdrawal by Subject|1|||
105742243|NCT03596177|364711167|FG000|Single Blind Period|Other|1|||
105742244|NCT03596177|364711168|FG001|Single Blind Period|Other|0|||
105742245|NCT03596177|364711167|FG000|Double Blind Period|Withdrawal by Subject|0|||
105742246|NCT03596177|364711168|FG001|Double Blind Period|Withdrawal by Subject|1|||
105942522|NCT00959049|365452770|FG001|Overall Study|Withdrawal by Subject|2|||
105942523|NCT00959049|365452771|FG002|Overall Study|Withdrawal by Subject|0|||
105942524|NCT00959049|365452772|FG003|Overall Study|Withdrawal by Subject|0|||
105942525|NCT00959049|365452773|FG004|Overall Study|Withdrawal by Subject|0|||
105942526|NCT00959049|365452774|FG005|Overall Study|Withdrawal by Subject|0|||
105942527|NCT01892189|365452776|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
105942528|NCT01892189|365452777|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
105942529|NCT01892189|365452778|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
105942530|NCT01892189|365452779|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
105942531|NCT01892189|365452780|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
105942532|NCT01892189|365452781|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
105942533|NCT01892189|365452782|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
105942534|NCT01892189|365452783|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
105942535|NCT01892189|365452784|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
105942536|NCT01892189|365452776|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105942537|NCT01892189|365452777|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105942538|NCT01892189|365452778|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
105942539|NCT01892189|365452779|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105942540|NCT01892189|365452780|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105942541|NCT01892189|365452781|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105942542|NCT01892189|365452782|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105942543|NCT01892189|365452783|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105942544|NCT01892189|365452784|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105942545|NCT01892189|365452776|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105942546|NCT01892189|365452777|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
106014889|NCT01177397|365720899|FG006|Overall Study|Other reasons|2|||
105742247|NCT03596177|364711167|FG000|Double Blind Period|Other|0|||
105742248|NCT03596177|364711168|FG001|Double Blind Period|Other|4|||
105742249|NCT03596177|364711167|FG000|Double Blind Period|Death during safety follow-up|0|||
105742250|NCT03596177|364711168|FG001|Double Blind Period|Death during safety follow-up|1|||
105742251|NCT00968253|364711169|FG000|Overall Study|Death|0|||
105742252|NCT00968253|364711170|FG001|Overall Study|Death|0|||
105742253|NCT00968253|364711171|FG002|Overall Study|Death|2|||
105742254|NCT00968253|364711169|FG000|Overall Study|Withdrawal by Subject|0|||
105942547|NCT01892189|365452778|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105942548|NCT01892189|365452779|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105942549|NCT01892189|365452780|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105800227|NCT00534092|364926410|FG001|Overall Study|personal reasons/family concerns|0|||
105800228|NCT02323295|364926414|FG000|Overall Study|Adverse Event|0|||
105800229|NCT02323295|364926415|FG001|Overall Study|Adverse Event|1|||
105800230|NCT02323295|364926414|FG000|Overall Study|Withdrawal by Subject|0|||
105800231|NCT02323295|364926415|FG001|Overall Study|Withdrawal by Subject|1|||
105800232|NCT02323295|364926414|FG000|Overall Study|Patient did not have surgery as planned.|0|||
105800233|NCT02323295|364926415|FG001|Overall Study|Patient did not have surgery as planned.|1|||
105800234|NCT00830063|364926416|FG000|Overall Study|Adverse Event|7|||
105800235|NCT00830063|364926417|FG001|Overall Study|Adverse Event|13|||
105800236|NCT00830063|364926418|FG002|Overall Study|Adverse Event|16|||
106014890|NCT01177397|365720900|FG007|Overall Study|Other reasons|6|||
106014891|NCT01177397|365720901|FG008|Overall Study|Other reasons|10|||
106014892|NCT01177397|365720902|FG009|Overall Study|Other reasons|8|||
106014893|NCT01177397|365720903|FG010|Overall Study|Other reasons|0|||
106014894|NCT01177397|365720904|FG011|Overall Study|Other reasons|2|||
106014895|NCT01760733|365720906|FG000|Waiting List|Death|18|||
106014896|NCT01760733|365720906|FG000|Waiting List|Removed from waiting list|41|||
106014897|NCT01760733|365720906|FG000|Waiting List|Not received a transplant yet|13|||
106014898|NCT01760733|365720906|FG000|Transplanted|Not reached 10 years post transplant|184|||
106014899|NCT01760733|365720906|FG000|Transplanted|Death|26|||
106014900|NCT01760733|365720906|FG000|Transplanted|Graft loss|7|||
106014901|NCT00882557|365720909|FG000|Overall Study|Withdrawal by Subject|1|||
106014902|NCT00882557|365720910|FG001|Overall Study|Withdrawal by Subject|0|||
106014903|NCT00882557|365720909|FG000|Overall Study|Trouble with Vein Access|1|||
106014904|NCT00882557|365720910|FG001|Overall Study|Trouble with Vein Access|0|||
106014905|NCT00882557|365720909|FG000|Overall Study|Randomized Not Treated|0|||
106014906|NCT00882557|365720910|FG001|Overall Study|Randomized Not Treated|1|||
106014907|NCT02282605|365720911|FG000|Overall Study|negative SA result on Day -1|3|||
106014908|NCT02282605|365720912|FG001|Overall Study|negative SA result on Day -1|0|||
106014909|NCT02282605|365720913|FG002|Overall Study|negative SA result on Day -1|0|||
106014910|NCT01383356|365720914|FG000|Period 1|Adverse Event|5|||
106014911|NCT01383356|365720915|FG001|Period 1|Adverse Event|3|||
106014912|NCT01383356|365720914|FG000|Period 1|Non-compliance|3|||
106014913|NCT01383356|365720915|FG001|Period 1|Non-compliance|0|||
106014914|NCT01383356|365720914|FG000|Period 1|Out of Range Mid-study-Test|0|||
106014915|NCT01383356|365720915|FG001|Period 1|Out of Range Mid-study-Test|1|||
106014916|NCT01383356|365720914|FG000|Period 1|Personal|0|||
106014917|NCT01383356|365720915|FG001|Period 1|Personal|2|||
106014918|NCT03938259|365720919|FG000|Overall Study|unable to establish baseline for ventilation|1|||
106014919|NCT03938259|365720920|FG001|Overall Study|unable to establish baseline for ventilation|1|||
106014920|NCT02158546|365720922|FG000|Overall Study|Physician Decision|0|||
106014921|NCT02158546|365720923|FG001|Overall Study|Physician Decision|1|||
106014922|NCT02158546|365720924|FG002|Overall Study|Physician Decision|0|||
106014923|NCT02158546|365720925|FG003|Overall Study|Physician Decision|0|||
106014924|NCT02158546|365720922|FG000|Overall Study|Non-compliance|0|||
106014925|NCT02158546|365720923|FG001|Overall Study|Non-compliance|1|||
106014926|NCT02158546|365720924|FG002|Overall Study|Non-compliance|0|||
106014927|NCT02158546|365720925|FG003|Overall Study|Non-compliance|1|||
106014928|NCT02158546|365720922|FG000|Overall Study|Failure to meet eligibility criteria|0|||
106014929|NCT02158546|365720923|FG001|Overall Study|Failure to meet eligibility criteria|1|||
106014930|NCT02158546|365720924|FG002|Overall Study|Failure to meet eligibility criteria|0|||
106014931|NCT02158546|365720925|FG003|Overall Study|Failure to meet eligibility criteria|0|||
106014932|NCT02158546|365720922|FG000|Overall Study|Lack of Efficacy|1|||
106014933|NCT02158546|365720923|FG001|Overall Study|Lack of Efficacy|1|||
106014934|NCT02158546|365720924|FG002|Overall Study|Lack of Efficacy|0|||
106014935|NCT02158546|365720925|FG003|Overall Study|Lack of Efficacy|0|||
106014936|NCT02158546|365720922|FG000|Overall Study|Adverse Event|2|||
106014937|NCT02158546|365720923|FG001|Overall Study|Adverse Event|2|||
106014938|NCT02158546|365720924|FG002|Overall Study|Adverse Event|0|||
106014939|NCT02158546|365720925|FG003|Overall Study|Adverse Event|0|||
106014940|NCT02158546|365720922|FG000|Overall Study|Withdrawal by Subject|6|||
106014941|NCT02158546|365720923|FG001|Overall Study|Withdrawal by Subject|2|||
106014942|NCT02158546|365720924|FG002|Overall Study|Withdrawal by Subject|1|||
106014943|NCT02158546|365720925|FG003|Overall Study|Withdrawal by Subject|0|||
106014944|NCT02158546|365720922|FG000|Overall Study|Lost to Follow-up|5|||
106014945|NCT02158546|365720923|FG001|Overall Study|Lost to Follow-up|4|||
106014946|NCT02158546|365720924|FG002|Overall Study|Lost to Follow-up|0|||
106014947|NCT02158546|365720925|FG003|Overall Study|Lost to Follow-up|1|||
106014948|NCT02158546|365720922|FG000|Overall Study|Site Excluded|5|||
106014949|NCT02158546|365720923|FG001|Overall Study|Site Excluded|5|||
106014950|NCT02158546|365720924|FG002|Overall Study|Site Excluded|3|||
106014951|NCT02158546|365720925|FG003|Overall Study|Site Excluded|4|||
106014952|NCT00803569|365720926|FG000|Overall Study|Progressive Disease|3|||
105800237|NCT00830063|364926419|FG003|Overall Study|Adverse Event|13|||
105800238|NCT00830063|364926416|FG000|Overall Study|Death|1|||
106142142|NCT02057692|366179863|FG001|Overall Study|Lost to Follow-up|0|||
106142143|NCT02057692|366179864|FG002|Overall Study|Lost to Follow-up|0|||
106142144|NCT02057692|366179865|FG003|Overall Study|Lost to Follow-up|1|||
106142145|NCT00943735|366179868|FG000|Overall Study|Adverse Event|12|||
106142146|NCT00943735|366179868|FG000|Overall Study|Withdrawal by Subject|8|||
106142147|NCT00943735|366179868|FG000|Overall Study|Death|1|||
106142148|NCT00943735|366179868|FG000|Overall Study|Other|8|||
106142149|NCT00943735|366179868|FG000|Overall Study|Other|3|||
106142150|NCT01405924|366179869|FG000|Overall Study|Protocol Violation|8|||
106142151|NCT01405924|366179869|FG000|Overall Study|Missing/Incomplete Data|2|||
106142152|NCT01329328|366179870|FG000|Overall Study|Withdrawal by Subject|2|||
106142153|NCT01329328|366179871|FG001|Overall Study|Withdrawal by Subject|4|||
106142154|NCT01329328|366179872|FG002|Overall Study|Withdrawal by Subject|3|||
106142155|NCT01924767|366179873|FG000|Overall Study|Adverse Event|1|||
106142156|NCT01924767|366179874|FG001|Overall Study|Adverse Event|0|||
106142157|NCT01924767|366179875|FG002|Overall Study|Adverse Event|1|||
106142158|NCT01924767|366179876|FG003|Overall Study|Adverse Event|0|||
106142159|NCT01924767|366179877|FG004|Overall Study|Adverse Event|0|||
106142160|NCT01505881|366179882|FG000|Overall Study|Adverse Event|0|||
106142161|NCT01505881|366179883|FG001|Overall Study|Adverse Event|1|||
106142162|NCT01505881|366179882|FG000|Overall Study|Lost to Follow-up|2|||
106142163|NCT01505881|366179883|FG001|Overall Study|Lost to Follow-up|0|||
106142164|NCT01505881|366179882|FG000|Overall Study|Withdrawal by Subject|2|||
106142165|NCT01505881|366179883|FG001|Overall Study|Withdrawal by Subject|0|||
106142166|NCT00922207|366179884|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
106142167|NCT00922207|366179885|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
106142168|NCT00922207|366179886|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
106142169|NCT00922207|366179884|FG000|Overall Study|Insufficient Therapeutic Response|0|||
106142170|NCT00922207|366179885|FG001|Overall Study|Insufficient Therapeutic Response|0|||
106142171|NCT00922207|366179886|FG002|Overall Study|Insufficient Therapeutic Response|1|||
106142172|NCT00922207|366179884|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
106142173|NCT00922207|366179885|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
106142174|NCT00922207|366179886|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
106142175|NCT00922207|366179884|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
106142176|NCT00922207|366179885|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
106142177|NCT00922207|366179886|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
106142178|NCT00922207|366179884|FG000|Overall Study|Withdrew Consent|2|||
106142179|NCT00922207|366179885|FG001|Overall Study|Withdrew Consent|5|||
106142180|NCT00922207|366179886|FG002|Overall Study|Withdrew Consent|2|||
106142181|NCT00922207|366179884|FG000|Overall Study|Abnormality of Laboratory Test|0|||
106142182|NCT00922207|366179885|FG001|Overall Study|Abnormality of Laboratory Test|1|||
106142183|NCT00922207|366179886|FG002|Overall Study|Abnormality of Laboratory Test|1|||
105742255|NCT00968253|364711170|FG001|Overall Study|Withdrawal by Subject|0|||
105742256|NCT00968253|364711171|FG002|Overall Study|Withdrawal by Subject|1|||
105742257|NCT00968253|364711169|FG000|Overall Study|Disease Progression|0|||
105742258|NCT00968253|364711170|FG001|Overall Study|Disease Progression|3|||
105742259|NCT00968253|364711171|FG002|Overall Study|Disease Progression|3|||
105742260|NCT00968253|364711169|FG000|Overall Study|Adverse Event|0|||
105742261|NCT00968253|364711170|FG001|Overall Study|Adverse Event|0|||
105742262|NCT00968253|364711171|FG002|Overall Study|Adverse Event|1|||
105742263|NCT03259334|364711172|FG000|Overall Study|Adverse Event|3|||
105742264|NCT03259334|364711173|FG001|Overall Study|Adverse Event|8|||
105742265|NCT03259334|364711174|FG002|Overall Study|Adverse Event|5|||
105742266|NCT03259334|364711172|FG000|Overall Study|Withdrawal by Subject|4|||
105742267|NCT03259334|364711173|FG001|Overall Study|Withdrawal by Subject|2|||
105742268|NCT03259334|364711174|FG002|Overall Study|Withdrawal by Subject|4|||
105742269|NCT03259334|364711172|FG000|Overall Study|Physician Decision|1|||
106142184|NCT02880241|366179889|FG000|Overall Study|Lack of Efficacy|1|||
106142185|NCT02880241|366179890|FG001|Overall Study|Lack of Efficacy|0|||
106142186|NCT02880241|366179891|FG002|Overall Study|Lack of Efficacy|0|||
106142187|NCT02880241|366179892|FG003|Overall Study|Lack of Efficacy|0|||
106142188|NCT02880241|366179893|FG004|Overall Study|Lack of Efficacy|0|||
106142189|NCT02880241|366179894|FG005|Overall Study|Lack of Efficacy|0|||
106142190|NCT01104415|366179895|FG000|Core Phase|Consent withdrawn by subjects|1|||
106142191|NCT01104415|366179896|FG001|Core Phase|Consent withdrawn by subjects|0|||
106142192|NCT01104415|366179895|FG000|Extension Period|Progressive disease|0|||
106142193|NCT01104415|366179896|FG001|Extension Period|Progressive disease|4|||
105742270|NCT03259334|364711173|FG001|Overall Study|Physician Decision|0|||
105742271|NCT03259334|364711174|FG002|Overall Study|Physician Decision|0|||
105742272|NCT03259334|364711172|FG000|Overall Study|Lost to Follow-up|0|||
105742273|NCT03259334|364711173|FG001|Overall Study|Lost to Follow-up|2|||
105742274|NCT03259334|364711174|FG002|Overall Study|Lost to Follow-up|1|||
106142194|NCT01104415|366179895|FG000|Extension Period|Death|0|||
106142195|NCT01104415|366179896|FG001|Extension Period|Death|1|||
106142196|NCT01104415|366179895|FG000|Extension Period|Physician Decision|0|||
105742275|NCT03259334|364711172|FG000|Overall Study|Protocol Deviation|0|||
105742276|NCT03259334|364711173|FG001|Overall Study|Protocol Deviation|3|||
105742277|NCT03259334|364711174|FG002|Overall Study|Protocol Deviation|2|||
105742278|NCT03259334|364711172|FG000|Overall Study|Lack of Efficacy|2|||
105742279|NCT03259334|364711173|FG001|Overall Study|Lack of Efficacy|0|||
105742280|NCT03259334|364711174|FG002|Overall Study|Lack of Efficacy|1|||
105742281|NCT03259334|364711172|FG000|Overall Study|Randomized but never treated|0|||
105742282|NCT03259334|364711173|FG001|Overall Study|Randomized but never treated|2|||
105742283|NCT03259334|364711174|FG002|Overall Study|Randomized but never treated|0|||
105742284|NCT01921257|364711175|FG000|Overall Study|Adverse Event|1|||
105742285|NCT01921257|364711175|FG000|Overall Study|Protocol Violation|1|||
105742286|NCT01921257|364711175|FG000|Overall Study|Withdrawal by Subject|1|||
105742287|NCT02149836|364711178|FG000|Overall Study|Withdrawal by Subject|1|||
105742288|NCT04594239|364711181|FG000|Overall Study|Withdrawal by Subject|3|||
105742289|NCT04594239|364711182|FG001|Overall Study|Withdrawal by Subject|4|||
105742290|NCT04594239|364711183|FG002|Overall Study|Withdrawal by Subject|2|||
105742291|NCT04594239|364711184|FG003|Overall Study|Withdrawal by Subject|4|||
105742292|NCT04594239|364711181|FG000|Overall Study|Lost to Follow-up|8|||
105742293|NCT04594239|364711182|FG001|Overall Study|Lost to Follow-up|5|||
105742294|NCT04594239|364711183|FG002|Overall Study|Lost to Follow-up|4|||
105742295|NCT04594239|364711184|FG003|Overall Study|Lost to Follow-up|6|||
105742296|NCT04594239|364711181|FG000|Overall Study|Subject relocated|0|||
105742297|NCT04594239|364711182|FG001|Overall Study|Subject relocated|0|||
105742298|NCT04594239|364711183|FG002|Overall Study|Subject relocated|0|||
105742299|NCT04594239|364711184|FG003|Overall Study|Subject relocated|1|||
105742300|NCT03229759|364711189|FG000|Overall Study|Screen Failure|30|||
105742301|NCT05128162|364711190|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
105742302|NCT05128162|364711190|FG000|Overall Study|Physician Decision|1|||
105742303|NCT00719732|364711191|FG000|Overall Study|Lost to Follow-up|20|||
105742304|NCT00719732|364711191|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
105742305|NCT00719732|364711191|FG000|Overall Study|Illness not associated with device|1|||
105742306|NCT00436215|364711192|FG000|Overall Study|Refused further treatment|3|||
105742307|NCT00436215|364711192|FG000|Overall Study|Small bowel obstruction|1|||
105742308|NCT00309777|364711197|FG000|Overall Study|Adverse Event|13|||
105742309|NCT00309777|364711198|FG001|Overall Study|Adverse Event|2|||
105742310|NCT00309777|364711199|FG002|Overall Study|Adverse Event|8|||
105942550|NCT01892189|365452781|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
105942551|NCT01892189|365452782|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105942552|NCT01892189|365452783|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105942553|NCT01892189|365452784|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
105942554|NCT00095576|365452785|FG000|Overall Study|Adverse Event|5|||
105942555|NCT00095576|365452786|FG001|Overall Study|Adverse Event|3|||
105942556|NCT00095576|365452785|FG000|Overall Study|Lost to Follow-up|233|||
105942557|NCT00095576|365452786|FG001|Overall Study|Lost to Follow-up|229|||
105942558|NCT00095576|365452785|FG000|Overall Study|Protocol Violation|1|||
105942559|NCT00095576|365452786|FG001|Overall Study|Protocol Violation|0|||
105942560|NCT00095576|365452785|FG000|Overall Study|Withdrawal by Subject|34|||
105942561|NCT00095576|365452786|FG001|Overall Study|Withdrawal by Subject|47|||
105942562|NCT00095576|365452785|FG000|Overall Study|Option to switch to a rollover study|1097|||
105942563|NCT00095576|365452786|FG001|Overall Study|Option to switch to a rollover study|1099|||
105942564|NCT00095576|365452785|FG000|Overall Study|Site terminated|75|||
105942565|NCT00095576|365452786|FG001|Overall Study|Site terminated|67|||
105942566|NCT00095576|365452785|FG000|Overall Study|Subject moved|30|||
105942567|NCT00095576|365452786|FG001|Overall Study|Subject moved|36|||
105942568|NCT00443456|365452787|FG000|Overall Study|Adverse Event|16|||
105942569|NCT00443456|365452787|FG000|Overall Study|Move|1|||
105942570|NCT00443456|365452787|FG000|Overall Study|Withdrawal by Subject|1|||
105742311|NCT00309777|364711200|FG003|Overall Study|Adverse Event|1|||
105742312|NCT00309777|364711197|FG000|Overall Study|Protocol Violation|4|||
105742313|NCT00309777|364711198|FG001|Overall Study|Protocol Violation|1|||
105742314|NCT00309777|364711199|FG002|Overall Study|Protocol Violation|3|||
105742315|NCT00309777|364711200|FG003|Overall Study|Protocol Violation|1|||
105942571|NCT01472185|365452797|FG000|Overall Study|Randomized but Not Treated|0|||
105942572|NCT01472185|365452798|FG001|Overall Study|Randomized but Not Treated|1|||
105942573|NCT01472185|365452797|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
105742316|NCT00309777|364711197|FG000|Overall Study|Withdrawal by Subject|6|||
105742317|NCT00309777|364711198|FG001|Overall Study|Withdrawal by Subject|5|||
105742318|NCT00309777|364711199|FG002|Overall Study|Withdrawal by Subject|7|||
105742319|NCT00309777|364711200|FG003|Overall Study|Withdrawal by Subject|2|||
105742320|NCT00309777|364711197|FG000|Overall Study|Lost to Follow-up|0|||
105742321|NCT00309777|364711198|FG001|Overall Study|Lost to Follow-up|0|||
105742322|NCT00309777|364711199|FG002|Overall Study|Lost to Follow-up|1|||
105742323|NCT00309777|364711200|FG003|Overall Study|Lost to Follow-up|0|||
105742324|NCT00309777|364711197|FG000|Overall Study|Death|0|||
105742325|NCT00309777|364711198|FG001|Overall Study|Death|1|||
105742326|NCT00309777|364711199|FG002|Overall Study|Death|0|||
105742327|NCT00309777|364711200|FG003|Overall Study|Death|0|||
105742328|NCT03625986|364712697|FG000|Randomization Period|Lost to Follow-up|7|||
105742329|NCT03625986|364712698|FG001|Randomization Period|Lost to Follow-up|12|||
105742330|NCT03625986|364712697|FG000|Randomization Period|Withdrawal by Subject|10|||
105742331|NCT03625986|364712698|FG001|Randomization Period|Withdrawal by Subject|6|||
105742332|NCT01605071|364712699|FG000|Overall Study|Withdrawal by Subject|3|||
105742333|NCT01605071|364712700|FG001|Overall Study|Withdrawal by Subject|2|||
105742334|NCT00392171|364712701|FG000|Overall Study|Did not meet inclusion criteria|4|||
105742335|NCT00392171|364712701|FG000|Overall Study|Disease progression|101|||
105742336|NCT01931462|364712702|FG000|Overall Study|Withdrawal by Subject|1|||
105742337|NCT02361762|364712703|FG000|Overall Study|Withdrawal by Subject|0|||
105742338|NCT02361762|364712704|FG001|Overall Study|Withdrawal by Subject|1|||
105742339|NCT02361762|364712703|FG000|Overall Study|Lost to Follow-up|0|||
105742340|NCT02361762|364712704|FG001|Overall Study|Lost to Follow-up|1|||
105742341|NCT00059215|364712706|FG000|Overall Study|Adverse Event|5|||
105742342|NCT00059215|364712707|FG001|Overall Study|Adverse Event|5|||
105742343|NCT00059215|364712708|FG002|Overall Study|Adverse Event|9|||
105742344|NCT00059215|364712709|FG003|Overall Study|Adverse Event|9|||
105742345|NCT00059215|364712706|FG000|Overall Study|Death|0|||
105742346|NCT00059215|364712707|FG001|Overall Study|Death|0|||
105742347|NCT00059215|364712708|FG002|Overall Study|Death|3|||
105742348|NCT00059215|364712709|FG003|Overall Study|Death|0|||
105742349|NCT00059215|364712706|FG000|Overall Study|Lost to Follow-up|1|||
105742350|NCT00059215|364712707|FG001|Overall Study|Lost to Follow-up|2|||
105742351|NCT00059215|364712708|FG002|Overall Study|Lost to Follow-up|0|||
105742352|NCT00059215|364712709|FG003|Overall Study|Lost to Follow-up|0|||
105742353|NCT00059215|364712706|FG000|Overall Study|Withdrawal by Subject|4|||
105742354|NCT00059215|364712707|FG001|Overall Study|Withdrawal by Subject|4|||
105742355|NCT00059215|364712708|FG002|Overall Study|Withdrawal by Subject|1|||
105742356|NCT00059215|364712709|FG003|Overall Study|Withdrawal by Subject|3|||
105742357|NCT00059215|364712706|FG000|Overall Study|Protocol Violation|1|||
105742358|NCT00059215|364712707|FG001|Overall Study|Protocol Violation|0|||
105742359|NCT00059215|364712708|FG002|Overall Study|Protocol Violation|1|||
105742360|NCT00059215|364712709|FG003|Overall Study|Protocol Violation|0|||
105742361|NCT00059215|364712706|FG000|Overall Study|Protocol entry criteria not met|1|||
105742362|NCT00059215|364712707|FG001|Overall Study|Protocol entry criteria not met|1|||
105742363|NCT00059215|364712708|FG002|Overall Study|Protocol entry criteria not met|0|||
105742364|NCT00059215|364712709|FG003|Overall Study|Protocol entry criteria not met|2|||
105742365|NCT00059215|364712706|FG000|Overall Study|Physician Decision|1|||
105742366|NCT00059215|364712707|FG001|Overall Study|Physician Decision|2|||
105742367|NCT00059215|364712708|FG002|Overall Study|Physician Decision|1|||
105942574|NCT01472185|365452798|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
105942575|NCT01472185|365452797|FG000|Overall Study|Hyperglycemia|5|||
105942576|NCT01472185|365452798|FG001|Overall Study|Hyperglycemia|2|||
105942577|NCT01472185|365452797|FG000|Overall Study|Investigator's Discretion|3|||
105942578|NCT01472185|365452798|FG001|Overall Study|Investigator's Discretion|1|||
105942579|NCT01472185|365452797|FG000|Overall Study|Lost to Follow-up|4|||
105942580|NCT01472185|365452798|FG001|Overall Study|Lost to Follow-up|1|||
105942581|NCT01472185|365452797|FG000|Overall Study|Protocol Violation|5|||
105942582|NCT01472185|365452798|FG001|Overall Study|Protocol Violation|1|||
105942583|NCT01472185|365452797|FG000|Overall Study|Subject Noncompliance|8|||
105942584|NCT01472185|365452798|FG001|Overall Study|Subject Noncompliance|15|||
106014953|NCT00803569|365720926|FG000|Overall Study|Noncompliance|1|||
106142197|NCT01104415|366179896|FG001|Extension Period|Physician Decision|1|||
105742368|NCT00059215|364712709|FG003|Overall Study|Physician Decision|1|||
105942585|NCT01472185|365452797|FG000|Overall Study|Subject Withdrew Consent|6|||
105942586|NCT01472185|365452798|FG001|Overall Study|Subject Withdrew Consent|3|||
105742369|NCT00502307|364712712|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
105742370|NCT00502307|364712713|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
105800239|NCT00830063|364926417|FG001|Overall Study|Death|0|||
105942587|NCT01309230|365452799|FG000|Overall Study|Withdrawal by Subject|0|||
105942588|NCT01309230|365452800|FG001|Overall Study|Withdrawal by Subject|2|||
106142198|NCT01104415|366179895|FG000|Extension Period|Transition to Study LX1606.302|0|||
105742371|NCT00502307|364712714|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
105742372|NCT00502307|364712712|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
105742373|NCT00502307|364712713|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
105742374|NCT00502307|364712714|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
105742375|NCT00502307|364712712|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
105742376|NCT00502307|364712713|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
105742377|NCT00502307|364712714|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
105742378|NCT00502307|364712712|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
105742379|NCT00502307|364712713|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
105742380|NCT00502307|364712714|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
105742381|NCT00502307|364712712|FG000|Maintenance Period|Progressive disease|80|||
105742382|NCT00502307|364712713|FG001|Maintenance Period|Progressive disease|0|||
105742383|NCT00502307|364712714|FG002|Maintenance Period|Progressive disease|0|||
105742384|NCT00502307|364712712|FG000|Maintenance Period|Discontinued due to other reasons|68|||
105742385|NCT00502307|364712713|FG001|Maintenance Period|Discontinued due to other reasons|0|||
105742386|NCT00502307|364712714|FG002|Maintenance Period|Discontinued due to other reasons|0|||
105742387|NCT00414310|364712715|FG000|Overall Study|Not treated|1|||
105742388|NCT00414310|364712716|FG001|Overall Study|Not treated|0|||
105742389|NCT03041116|364712717|FG000|Double-blind|Death|0|||
105742390|NCT03041116|364712718|FG001|Double-blind|Death|2|||
105742391|NCT03041116|364712717|FG000|Double-blind|Withdrawal by Subject|0|||
105742392|NCT03041116|364712718|FG001|Double-blind|Withdrawal by Subject|4|||
105742393|NCT03041116|364712717|FG000|Open-label|Death|1|||
105742394|NCT03041116|364712718|FG001|Open-label|Death|0|||
105742395|NCT03041116|364712717|FG000|Open-label|Termination of the study by Sponsor|39|||
105742396|NCT03041116|364712718|FG001|Open-label|Termination of the study by Sponsor|37|||
105742397|NCT03041116|364712717|FG000|Open-label|Withdrawal by Subject|1|||
105742398|NCT03041116|364712718|FG001|Open-label|Withdrawal by Subject|0|||
105742399|NCT00833248|364712719|FG000|Overall Study|Adverse Event|3|||
105742400|NCT00833248|364712720|FG001|Overall Study|Adverse Event|0|||
105742401|NCT00833248|364712719|FG000|Overall Study|Protocol Violation|1|||
105742402|NCT00833248|364712720|FG001|Overall Study|Protocol Violation|2|||
105742403|NCT00833248|364712719|FG000|Overall Study|Withdrawal by Subject|0|||
105742404|NCT00833248|364712720|FG001|Overall Study|Withdrawal by Subject|1|||
105742405|NCT01781429|364712722|FG000|Overall Study|Death|0|||
105742406|NCT01781429|364712723|FG001|Overall Study|Death|0|||
105742407|NCT01781429|364712724|FG002|Overall Study|Death|0|||
105742408|NCT01781429|364712725|FG003|Overall Study|Death|0|||
105742409|NCT01781429|364712726|FG004|Overall Study|Death|0|||
105742410|NCT01781429|364712727|FG005|Overall Study|Death|0|||
105742411|NCT01781429|364712728|FG006|Overall Study|Death|0|||
105742412|NCT01781429|364712729|FG007|Overall Study|Death|0|||
105742413|NCT01781429|364712730|FG008|Overall Study|Death|0|||
105742414|NCT01781429|364712731|FG009|Overall Study|Death|1|||
105742415|NCT01781429|364712732|FG010|Overall Study|Death|0|||
105742416|NCT01781429|364712733|FG011|Overall Study|Death|0|||
105742417|NCT01781429|364712734|FG012|Overall Study|Death|1|||
105742418|NCT01781429|364712735|FG013|Overall Study|Death|0|||
105742419|NCT01781429|364712736|FG014|Overall Study|Death|1|||
105742420|NCT01781429|364712737|FG015|Overall Study|Death|0|||
105742421|NCT01781429|364712722|FG000|Overall Study|Withdrawal by Subject|0|||
105742422|NCT01781429|364712723|FG001|Overall Study|Withdrawal by Subject|0|||
105742423|NCT01781429|364712724|FG002|Overall Study|Withdrawal by Subject|0|||
105742424|NCT01781429|364712725|FG003|Overall Study|Withdrawal by Subject|0|||
105742425|NCT01781429|364712726|FG004|Overall Study|Withdrawal by Subject|0|||
105742426|NCT01781429|364712727|FG005|Overall Study|Withdrawal by Subject|0|||
105742427|NCT01781429|364712728|FG006|Overall Study|Withdrawal by Subject|0|||
105742428|NCT01781429|364712729|FG007|Overall Study|Withdrawal by Subject|0|||
105742429|NCT01781429|364712730|FG008|Overall Study|Withdrawal by Subject|1|||
105742430|NCT01781429|364712731|FG009|Overall Study|Withdrawal by Subject|3|||
105742431|NCT01781429|364712732|FG010|Overall Study|Withdrawal by Subject|1|||
105742432|NCT01781429|364712733|FG011|Overall Study|Withdrawal by Subject|1|||
105742433|NCT01781429|364712734|FG012|Overall Study|Withdrawal by Subject|5|||
105742434|NCT01781429|364712735|FG013|Overall Study|Withdrawal by Subject|2|||
106142199|NCT01104415|366179896|FG001|Extension Period|Transition to Study LX1606.302|4|||
106142200|NCT01104415|366179895|FG000|Extension Period|Heart surgery/feeling miserable|0|||
105742435|NCT01781429|364712736|FG014|Overall Study|Withdrawal by Subject|3|||
105742436|NCT01781429|364712737|FG015|Overall Study|Withdrawal by Subject|0|||
105742437|NCT01781429|364712722|FG000|Overall Study|Disease Progression|1|||
105742438|NCT01781429|364712723|FG001|Overall Study|Disease Progression|0|||
105742439|NCT01781429|364712724|FG002|Overall Study|Disease Progression|1|||
105742440|NCT01781429|364712725|FG003|Overall Study|Disease Progression|1|||
105742441|NCT01781429|364712726|FG004|Overall Study|Disease Progression|1|||
105742442|NCT01781429|364712727|FG005|Overall Study|Disease Progression|4|||
105742443|NCT01781429|364712728|FG006|Overall Study|Disease Progression|7|||
105742444|NCT01781429|364712729|FG007|Overall Study|Disease Progression|4|||
105742445|NCT01781429|364712730|FG008|Overall Study|Disease Progression|6|||
105742446|NCT01781429|364712731|FG009|Overall Study|Disease Progression|15|||
105742447|NCT01781429|364712732|FG010|Overall Study|Disease Progression|15|||
105742448|NCT01781429|364712733|FG011|Overall Study|Disease Progression|15|||
105742449|NCT01781429|364712734|FG012|Overall Study|Disease Progression|15|||
105742450|NCT01781429|364712735|FG013|Overall Study|Disease Progression|4|||
105742451|NCT01781429|364712736|FG014|Overall Study|Disease Progression|11|||
106014954|NCT01208207|365720929|FG000|Part I|Adverse Event|19|||
106014955|NCT01208207|365720930|FG001|Part I|Adverse Event|2|||
106014956|NCT01208207|365720931|FG002|Part I|Adverse Event|6|||
106014957|NCT01208207|365720932|FG003|Part I|Adverse Event|0|||
106014958|NCT01208207|365720933|FG004|Part I|Adverse Event|0|||
106014959|NCT01208207|365720934|FG005|Part I|Adverse Event|0|||
106014960|NCT01208207|365720935|FG006|Part I|Adverse Event|0|||
106014961|NCT01208207|365720929|FG000|Part I|Lack of Efficacy|21|||
106014962|NCT01208207|365720930|FG001|Part I|Lack of Efficacy|3|||
106014963|NCT01208207|365720931|FG002|Part I|Lack of Efficacy|2|||
106014964|NCT01208207|365720932|FG003|Part I|Lack of Efficacy|0|||
106014965|NCT01208207|365720933|FG004|Part I|Lack of Efficacy|0|||
106014966|NCT01208207|365720934|FG005|Part I|Lack of Efficacy|0|||
106014967|NCT01208207|365720935|FG006|Part I|Lack of Efficacy|0|||
106014968|NCT01208207|365720929|FG000|Part I|Lost to Follow-up|6|||
106014969|NCT01208207|365720930|FG001|Part I|Lost to Follow-up|1|||
106014970|NCT01208207|365720931|FG002|Part I|Lost to Follow-up|0|||
106014971|NCT01208207|365720932|FG003|Part I|Lost to Follow-up|0|||
106014972|NCT01208207|365720933|FG004|Part I|Lost to Follow-up|0|||
106014973|NCT01208207|365720934|FG005|Part I|Lost to Follow-up|0|||
106014974|NCT01208207|365720935|FG006|Part I|Lost to Follow-up|0|||
106014975|NCT01208207|365720929|FG000|Part I|Non-Compliance With Study Drug|1|||
106014976|NCT01208207|365720930|FG001|Part I|Non-Compliance With Study Drug|0|||
106014977|NCT01208207|365720931|FG002|Part I|Non-Compliance With Study Drug|1|||
106014978|NCT01208207|365720932|FG003|Part I|Non-Compliance With Study Drug|0|||
106014979|NCT01208207|365720933|FG004|Part I|Non-Compliance With Study Drug|0|||
106014980|NCT01208207|365720934|FG005|Part I|Non-Compliance With Study Drug|0|||
106014981|NCT01208207|365720935|FG006|Part I|Non-Compliance With Study Drug|0|||
106014982|NCT01208207|365720929|FG000|Part I|Physician Decision|0|||
106014983|NCT01208207|365720930|FG001|Part I|Physician Decision|1|||
106014984|NCT01208207|365720931|FG002|Part I|Physician Decision|0|||
106014985|NCT01208207|365720932|FG003|Part I|Physician Decision|0|||
106014986|NCT01208207|365720933|FG004|Part I|Physician Decision|0|||
106014987|NCT01208207|365720934|FG005|Part I|Physician Decision|0|||
106014988|NCT01208207|365720935|FG006|Part I|Physician Decision|0|||
106014989|NCT01208207|365720929|FG000|Part I|Progressive Disease|1|||
106014990|NCT01208207|365720930|FG001|Part I|Progressive Disease|0|||
106014991|NCT01208207|365720931|FG002|Part I|Progressive Disease|0|||
106014992|NCT01208207|365720932|FG003|Part I|Progressive Disease|0|||
106014993|NCT01208207|365720933|FG004|Part I|Progressive Disease|0|||
106014994|NCT01208207|365720934|FG005|Part I|Progressive Disease|0|||
106014995|NCT01208207|365720935|FG006|Part I|Progressive Disease|0|||
106014996|NCT01208207|365720929|FG000|Part I|Protocol Violation|8|||
106014997|NCT01208207|365720930|FG001|Part I|Protocol Violation|0|||
106014998|NCT01208207|365720931|FG002|Part I|Protocol Violation|2|||
106014999|NCT01208207|365720932|FG003|Part I|Protocol Violation|0|||
106015000|NCT01208207|365720933|FG004|Part I|Protocol Violation|0|||
106015001|NCT01208207|365720934|FG005|Part I|Protocol Violation|0|||
106015002|NCT01208207|365720935|FG006|Part I|Protocol Violation|0|||
106015003|NCT01208207|365720929|FG000|Part I|Withdrawal by Subject|14|||
106015004|NCT01208207|365720930|FG001|Part I|Withdrawal by Subject|4|||
106015005|NCT01208207|365720931|FG002|Part I|Withdrawal by Subject|4|||
106015006|NCT01208207|365720932|FG003|Part I|Withdrawal by Subject|0|||
106015007|NCT01208207|365720933|FG004|Part I|Withdrawal by Subject|0|||
106015008|NCT01208207|365720934|FG005|Part I|Withdrawal by Subject|0|||
106015009|NCT01208207|365720935|FG006|Part I|Withdrawal by Subject|0|||
106015010|NCT01208207|365720929|FG000|Part II|Withdrawal by Subject|0|||
106015011|NCT01208207|365720930|FG001|Part II|Withdrawal by Subject|0|||
106015012|NCT01208207|365720931|FG002|Part II|Withdrawal by Subject|0|||
106142201|NCT01104415|366179896|FG001|Extension Period|Heart surgery/feeling miserable|1|||
106015013|NCT01208207|365720932|FG003|Part II|Withdrawal by Subject|10|||
106142202|NCT02000817|366179902|FG000|Overall Study|Withdrawal by Subject|2|||
106142203|NCT02000817|366179903|FG001|Overall Study|Withdrawal by Subject|0|||
105742452|NCT01781429|364712737|FG015|Overall Study|Disease Progression|0|||
105742453|NCT01781429|364712722|FG000|Overall Study|Unacceptable Toxicity|0|||
105742454|NCT01781429|364712723|FG001|Overall Study|Unacceptable Toxicity|0|||
105742455|NCT01781429|364712724|FG002|Overall Study|Unacceptable Toxicity|0|||
105742456|NCT01781429|364712725|FG003|Overall Study|Unacceptable Toxicity|0|||
105742457|NCT01781429|364712726|FG004|Overall Study|Unacceptable Toxicity|0|||
105742458|NCT01781429|364712727|FG005|Overall Study|Unacceptable Toxicity|0|||
105742459|NCT01781429|364712728|FG006|Overall Study|Unacceptable Toxicity|0|||
105742460|NCT01781429|364712729|FG007|Overall Study|Unacceptable Toxicity|0|||
105742461|NCT01781429|364712730|FG008|Overall Study|Unacceptable Toxicity|0|||
105742462|NCT01781429|364712731|FG009|Overall Study|Unacceptable Toxicity|0|||
105742463|NCT01781429|364712732|FG010|Overall Study|Unacceptable Toxicity|0|||
105742464|NCT01781429|364712733|FG011|Overall Study|Unacceptable Toxicity|2|||
105742465|NCT01781429|364712734|FG012|Overall Study|Unacceptable Toxicity|0|||
105742466|NCT01781429|364712735|FG013|Overall Study|Unacceptable Toxicity|0|||
105742467|NCT01781429|364712736|FG014|Overall Study|Unacceptable Toxicity|0|||
105742468|NCT01781429|364712737|FG015|Overall Study|Unacceptable Toxicity|0|||
105742469|NCT01781429|364712722|FG000|Overall Study|Patient Condition Changed|0|||
105742470|NCT01781429|364712723|FG001|Overall Study|Patient Condition Changed|0|||
105742471|NCT01781429|364712724|FG002|Overall Study|Patient Condition Changed|0|||
105742472|NCT01781429|364712725|FG003|Overall Study|Patient Condition Changed|0|||
105742473|NCT01781429|364712726|FG004|Overall Study|Patient Condition Changed|0|||
105742474|NCT01781429|364712727|FG005|Overall Study|Patient Condition Changed|0|||
105742475|NCT01781429|364712728|FG006|Overall Study|Patient Condition Changed|0|||
105742476|NCT01781429|364712729|FG007|Overall Study|Patient Condition Changed|0|||
105742477|NCT01781429|364712730|FG008|Overall Study|Patient Condition Changed|0|||
105742478|NCT01781429|364712731|FG009|Overall Study|Patient Condition Changed|4|||
105742479|NCT01781429|364712732|FG010|Overall Study|Patient Condition Changed|0|||
105742480|NCT01781429|364712733|FG011|Overall Study|Patient Condition Changed|1|||
105742481|NCT01781429|364712734|FG012|Overall Study|Patient Condition Changed|0|||
105742482|NCT01781429|364712735|FG013|Overall Study|Patient Condition Changed|1|||
105742483|NCT01781429|364712736|FG014|Overall Study|Patient Condition Changed|0|||
105742484|NCT01781429|364712737|FG015|Overall Study|Patient Condition Changed|0|||
105742485|NCT01781429|364712722|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
105742486|NCT01781429|364712723|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
105742487|NCT01781429|364712724|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
105742488|NCT01781429|364712725|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
105742489|NCT01781429|364712726|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
105742490|NCT01781429|364712727|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
105742491|NCT01781429|364712728|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
105742492|NCT01781429|364712729|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
105742493|NCT01781429|364712730|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
105742494|NCT01781429|364712731|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
105742495|NCT01781429|364712732|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
105742496|NCT01781429|364712733|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
105742497|NCT01781429|364712734|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
105742498|NCT01781429|364712735|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
105742499|NCT01781429|364712736|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
105742500|NCT01781429|364712737|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
105742501|NCT01781429|364712722|FG000|Overall Study|Enrolled, but not treated|0|||
105742502|NCT01781429|364712723|FG001|Overall Study|Enrolled, but not treated|0|||
105742503|NCT01781429|364712724|FG002|Overall Study|Enrolled, but not treated|0|||
105742504|NCT01781429|364712725|FG003|Overall Study|Enrolled, but not treated|0|||
105742505|NCT01781429|364712726|FG004|Overall Study|Enrolled, but not treated|0|||
105742506|NCT01781429|364712727|FG005|Overall Study|Enrolled, but not treated|0|||
105742507|NCT01781429|364712728|FG006|Overall Study|Enrolled, but not treated|0|||
105742508|NCT01781429|364712729|FG007|Overall Study|Enrolled, but not treated|0|||
105742509|NCT01781429|364712730|FG008|Overall Study|Enrolled, but not treated|0|||
105742510|NCT01781429|364712731|FG009|Overall Study|Enrolled, but not treated|0|||
105742511|NCT01781429|364712732|FG010|Overall Study|Enrolled, but not treated|1|||
105742512|NCT01781429|364712733|FG011|Overall Study|Enrolled, but not treated|0|||
105742513|NCT01781429|364712734|FG012|Overall Study|Enrolled, but not treated|0|||
105800240|NCT00830063|364926418|FG002|Overall Study|Death|0|||
105800241|NCT00830063|364926419|FG003|Overall Study|Death|0|||
105942589|NCT01309230|365452799|FG000|Overall Study|Observation arm closed|0|||
105942590|NCT01309230|365452800|FG001|Overall Study|Observation arm closed|2|||
105942591|NCT00427700|365452803|FG000|Overall Study|Lost to Follow-up|2|||
105942592|NCT00427700|365452804|FG001|Overall Study|Lost to Follow-up|5|||
105942593|NCT00427700|365452803|FG000|Overall Study|no induction of menses|1|||
105942594|NCT00427700|365452804|FG001|Overall Study|no induction of menses|4|||
105942595|NCT00427700|365452803|FG000|Overall Study|Pregnancy|0|||
105942596|NCT00427700|365452804|FG001|Overall Study|Pregnancy|2|||
105942597|NCT04581395|365452805|FG000|Overall Study|Protocol Violation|4|||
105942598|NCT04581395|365452806|FG001|Overall Study|Protocol Violation|3|||
105942599|NCT04581395|365452807|FG002|Overall Study|Protocol Violation|2|||
105942600|NCT04581395|365452805|FG000|Overall Study|Physician Decision|0|||
105942601|NCT04581395|365452806|FG001|Overall Study|Physician Decision|1|||
105942602|NCT04581395|365452807|FG002|Overall Study|Physician Decision|0|||
105942603|NCT00721110|365452808|FG000|Overall Study|Ultram use|1|||
105942604|NCT00721110|365452809|FG001|Overall Study|Ultram use|0|||
105942605|NCT00721110|365452810|FG002|Overall Study|Ultram use|0|||
105942606|NCT00721110|365452811|FG003|Overall Study|Ultram use|0|||
105942607|NCT00721110|365452808|FG000|Overall Study|vertical incision|0|||
105942608|NCT00721110|365452809|FG001|Overall Study|vertical incision|0|||
105742514|NCT01781429|364712735|FG013|Overall Study|Enrolled, but not treated|0|||
105742515|NCT01781429|364712736|FG014|Overall Study|Enrolled, but not treated|0|||
105742516|NCT01781429|364712737|FG015|Overall Study|Enrolled, but not treated|0|||
105742517|NCT02678741|364712738|FG000|Overall Study|Death|4|||
105742518|NCT02678741|364712738|FG000|Overall Study|Withdrawal by Subject|1|||
105942609|NCT00721110|365452810|FG002|Overall Study|vertical incision|1|||
105942610|NCT00721110|365452811|FG003|Overall Study|vertical incision|0|||
105942611|NCT01554904|365452812|FG000|Overall Study|Withdrawal by Subject|3|||
105942612|NCT01554904|365452812|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
105942613|NCT02038647|365452815|FG000|Overall Study|Progressive Disease|50|||
105742519|NCT02678741|364712738|FG000|Overall Study|ineligible|3|||
105742520|NCT02678741|364712738|FG000|Overall Study|Not RECIST Measurable|2|||
105742521|NCT02678741|364712738|FG000|Overall Study|Lack of Efficacy|10|||
105742522|NCT01725152|364712739|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
105742523|NCT01725152|364712740|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
105742524|NCT01725152|364712739|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
105742525|NCT01725152|364712740|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
105742526|NCT01725152|364712739|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
105742527|NCT01725152|364712740|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
105742528|NCT01725152|364712739|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
105742529|NCT01725152|364712740|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
105742530|NCT03539458|364712744|FG000|Overall Study|Death|1|||
105742531|NCT01202227|364712751|FG000|Overall Study|Adverse Event|16|||
105742532|NCT01202227|364712751|FG000|Overall Study|Withdrawal by Subject|2|||
105742533|NCT01202227|364712751|FG000|Overall Study|Lack of Efficacy|1|||
105742534|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
105742535|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
105742536|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742537|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742538|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742539|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742540|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
105742541|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742542|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
105742543|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742544|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742545|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
105742546|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742547|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
105742548|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
105742549|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
105742550|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
105742551|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
105742552|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
105742553|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
105742554|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
105742555|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Other|0|||
105742556|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Other|1|||
105742557|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Other|0|||
105742558|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Other|0|||
105742559|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Other|0|||
105742560|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Other|0|||
105742561|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Other|0|||
105742562|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
105742563|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
105742564|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
105742565|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
105742566|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
105742567|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
105742568|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
105742569|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
105742570|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
105742571|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
105742572|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
105742573|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
105742574|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
105742575|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
105742576|NCT00365716|364712754|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
105742577|NCT00365716|364712755|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
105742578|NCT00365716|364712756|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
105742579|NCT00365716|364712757|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
105742580|NCT00365716|364712758|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
105742581|NCT00365716|364712759|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
105742582|NCT00365716|364712760|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
105742583|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
105742584|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
105742585|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
105742586|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
105742587|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
105742588|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
105742589|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
105742590|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
105742591|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
105742592|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
105742593|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
105742594|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
105742595|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
105742596|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
105742597|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
105742598|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
105742599|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
105742600|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
105742601|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
105742602|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
105742603|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
105742604|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
105742605|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742606|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742607|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742608|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
105742609|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742610|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
105742611|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742612|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
105742613|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
105742614|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742615|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742616|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742617|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
105742618|NCT00365716|364712754|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
105742619|NCT00365716|364712755|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
105742620|NCT00365716|364712756|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
105742621|NCT00365716|364712757|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
105742622|NCT00365716|364712758|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
105742623|NCT00365716|364712759|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
105742624|NCT00365716|364712760|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
105742625|NCT00365716|364712754|FG000|Extension 1|Lost to Follow-up|0|||
105742626|NCT00365716|364712755|FG001|Extension 1|Lost to Follow-up|0|||
105742627|NCT00365716|364712756|FG002|Extension 1|Lost to Follow-up|0|||
105742628|NCT00365716|364712757|FG003|Extension 1|Lost to Follow-up|0|||
105742629|NCT00365716|364712758|FG004|Extension 1|Lost to Follow-up|0|||
105742630|NCT00365716|364712759|FG005|Extension 1|Lost to Follow-up|1|||
105742631|NCT00365716|364712760|FG006|Extension 1|Lost to Follow-up|0|||
105742632|NCT00365716|364712754|FG000|Extension 1|Other|0|||
105742633|NCT00365716|364712755|FG001|Extension 1|Other|0|||
105742634|NCT00365716|364712756|FG002|Extension 1|Other|0|||
105742635|NCT00365716|364712757|FG003|Extension 1|Other|0|||
105742636|NCT00365716|364712758|FG004|Extension 1|Other|0|||
105942614|NCT02038647|365452816|FG001|Overall Study|Progressive Disease|59|||
105942615|NCT02038647|365452815|FG000|Overall Study|Adverse Event|18|||
105942616|NCT02038647|365452816|FG001|Overall Study|Adverse Event|10|||
105942617|NCT02038647|365452815|FG000|Overall Study|Symptomatic Deterioration|7|||
105942618|NCT02038647|365452816|FG001|Overall Study|Symptomatic Deterioration|7|||
105942619|NCT02038647|365452815|FG000|Overall Study|Withdrawal by Subject|5|||
105942620|NCT02038647|365452816|FG001|Overall Study|Withdrawal by Subject|2|||
105942621|NCT02038647|365452815|FG000|Overall Study|Not Reported|0|||
105942622|NCT02038647|365452816|FG001|Overall Study|Not Reported|1|||
105942623|NCT02038647|365452815|FG000|Overall Study|Ongoing at Datacut|9|||
105942624|NCT02038647|365452816|FG001|Overall Study|Ongoing at Datacut|10|||
105742637|NCT00365716|364712759|FG005|Extension 1|Other|9|||
105742638|NCT00365716|364712760|FG006|Extension 1|Other|0|||
105742639|NCT00365716|364712754|FG000|Extension 1|Moved|0|||
105742640|NCT00365716|364712755|FG001|Extension 1|Moved|0|||
105742641|NCT00365716|364712756|FG002|Extension 1|Moved|0|||
105742642|NCT00365716|364712757|FG003|Extension 1|Moved|0|||
105742643|NCT00365716|364712758|FG004|Extension 1|Moved|0|||
105742644|NCT00365716|364712759|FG005|Extension 1|Moved|4|||
105742645|NCT00365716|364712760|FG006|Extension 1|Moved|0|||
105942625|NCT05805150|365452817|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
105952186|NCT03314935|365488192|FG008|Phase 2|Study Terminated by Sponsor|0|||
105952187|NCT03314935|365488193|FG009|Phase 2|Study Terminated by Sponsor|0|||
105952188|NCT03314935|365488194|FG010|Phase 2|Study Terminated by Sponsor|7|||
106015014|NCT01208207|365720933|FG004|Part II|Withdrawal by Subject|9|||
106015015|NCT01208207|365720934|FG005|Part II|Withdrawal by Subject|3|||
106015016|NCT01208207|365720935|FG006|Part II|Withdrawal by Subject|5|||
106015017|NCT01208207|365720929|FG000|Part II|Adverse Event|0|||
106015018|NCT01208207|365720930|FG001|Part II|Adverse Event|0|||
106015019|NCT01208207|365720931|FG002|Part II|Adverse Event|0|||
106015020|NCT01208207|365720932|FG003|Part II|Adverse Event|5|||
106015021|NCT01208207|365720933|FG004|Part II|Adverse Event|9|||
106015022|NCT01208207|365720934|FG005|Part II|Adverse Event|4|||
106015023|NCT01208207|365720935|FG006|Part II|Adverse Event|2|||
106015024|NCT01208207|365720929|FG000|Part II|Lack of Efficacy|0|||
106015025|NCT01208207|365720930|FG001|Part II|Lack of Efficacy|0|||
106015026|NCT01208207|365720931|FG002|Part II|Lack of Efficacy|0|||
106015027|NCT01208207|365720932|FG003|Part II|Lack of Efficacy|6|||
106015028|NCT01208207|365720933|FG004|Part II|Lack of Efficacy|4|||
106015029|NCT01208207|365720934|FG005|Part II|Lack of Efficacy|3|||
106015030|NCT01208207|365720935|FG006|Part II|Lack of Efficacy|3|||
106015031|NCT01208207|365720929|FG000|Part II|Lost to Follow-up|0|||
106015032|NCT01208207|365720930|FG001|Part II|Lost to Follow-up|0|||
106015033|NCT01208207|365720931|FG002|Part II|Lost to Follow-up|0|||
106015034|NCT01208207|365720932|FG003|Part II|Lost to Follow-up|4|||
106015035|NCT01208207|365720933|FG004|Part II|Lost to Follow-up|0|||
106015036|NCT01208207|365720934|FG005|Part II|Lost to Follow-up|2|||
106015037|NCT01208207|365720935|FG006|Part II|Lost to Follow-up|1|||
106015038|NCT01208207|365720929|FG000|Part II|Non-Compliance With Study Drug|0|||
106015039|NCT01208207|365720930|FG001|Part II|Non-Compliance With Study Drug|0|||
106142204|NCT02000817|366179904|FG002|Overall Study|Withdrawal by Subject|0|||
105742646|NCT00365716|364712754|FG000|Extension 1|Withdrawal by Subject|0|||
105742647|NCT00365716|364712755|FG001|Extension 1|Withdrawal by Subject|0|||
105742648|NCT00365716|364712756|FG002|Extension 1|Withdrawal by Subject|0|||
105742649|NCT00365716|364712757|FG003|Extension 1|Withdrawal by Subject|0|||
105742650|NCT00365716|364712758|FG004|Extension 1|Withdrawal by Subject|0|||
105742651|NCT00365716|364712759|FG005|Extension 1|Withdrawal by Subject|3|||
105742652|NCT00365716|364712760|FG006|Extension 1|Withdrawal by Subject|0|||
105742653|NCT00365716|364712754|FG000|Extension 1|Pregnancy|0|||
105742654|NCT00365716|364712755|FG001|Extension 1|Pregnancy|0|||
105742655|NCT00365716|364712756|FG002|Extension 1|Pregnancy|0|||
105742656|NCT00365716|364712757|FG003|Extension 1|Pregnancy|0|||
105742657|NCT00365716|364712758|FG004|Extension 1|Pregnancy|0|||
105742658|NCT00365716|364712759|FG005|Extension 1|Pregnancy|4|||
105742659|NCT00365716|364712760|FG006|Extension 1|Pregnancy|0|||
105742660|NCT00365716|364712754|FG000|Extension 1|Protocol Violation|0|||
105742661|NCT00365716|364712755|FG001|Extension 1|Protocol Violation|0|||
105742662|NCT00365716|364712756|FG002|Extension 1|Protocol Violation|0|||
105742663|NCT00365716|364712757|FG003|Extension 1|Protocol Violation|0|||
105742664|NCT00365716|364712758|FG004|Extension 1|Protocol Violation|0|||
105742665|NCT00365716|364712759|FG005|Extension 1|Protocol Violation|1|||
105742666|NCT00365716|364712760|FG006|Extension 1|Protocol Violation|0|||
105742667|NCT00365716|364712754|FG000|Extension 2|Lost to Follow-up|0|||
105742668|NCT00365716|364712755|FG001|Extension 2|Lost to Follow-up|0|||
105742669|NCT00365716|364712756|FG002|Extension 2|Lost to Follow-up|0|||
105742670|NCT00365716|364712757|FG003|Extension 2|Lost to Follow-up|0|||
105742671|NCT00365716|364712758|FG004|Extension 2|Lost to Follow-up|0|||
105742672|NCT00365716|364712759|FG005|Extension 2|Lost to Follow-up|0|||
105742673|NCT00365716|364712760|FG006|Extension 2|Lost to Follow-up|2|||
105742674|NCT00365716|364712754|FG000|Extension 2|Other|0|||
105742675|NCT00365716|364712755|FG001|Extension 2|Other|0|||
105742676|NCT00365716|364712756|FG002|Extension 2|Other|0|||
105742677|NCT00365716|364712757|FG003|Extension 2|Other|0|||
105742678|NCT00365716|364712758|FG004|Extension 2|Other|0|||
105742679|NCT00365716|364712759|FG005|Extension 2|Other|0|||
105742680|NCT00365716|364712760|FG006|Extension 2|Other|3|||
105742681|NCT00365716|364712754|FG000|Extension 2|Withdrawal by Subject|0|||
106015040|NCT01208207|365720931|FG002|Part II|Non-Compliance With Study Drug|0|||
106015041|NCT01208207|365720932|FG003|Part II|Non-Compliance With Study Drug|4|||
106142205|NCT02000817|366179905|FG003|Overall Study|Withdrawal by Subject|0|||
106015042|NCT01208207|365720933|FG004|Part II|Non-Compliance With Study Drug|1|||
106015043|NCT01208207|365720934|FG005|Part II|Non-Compliance With Study Drug|1|||
106015044|NCT01208207|365720935|FG006|Part II|Non-Compliance With Study Drug|0|||
106015045|NCT01208207|365720929|FG000|Part II|Physician Decision|0|||
106015046|NCT01208207|365720930|FG001|Part II|Physician Decision|0|||
105742682|NCT00365716|364712755|FG001|Extension 2|Withdrawal by Subject|0|||
105742683|NCT00365716|364712756|FG002|Extension 2|Withdrawal by Subject|0|||
105742684|NCT00365716|364712757|FG003|Extension 2|Withdrawal by Subject|0|||
105742685|NCT00365716|364712758|FG004|Extension 2|Withdrawal by Subject|0|||
105742686|NCT00365716|364712759|FG005|Extension 2|Withdrawal by Subject|0|||
105742687|NCT00365716|364712760|FG006|Extension 2|Withdrawal by Subject|5|||
105742688|NCT00913978|364712761|FG000|Overall Study|Surgeon choice|1|||
105742689|NCT00913978|364712762|FG001|Overall Study|Surgeon choice|3|||
105742690|NCT00316303|364712763|FG000|Overall Study|Lost to Follow-up|11|||
106015047|NCT01208207|365720931|FG002|Part II|Physician Decision|0|||
106015048|NCT01208207|365720932|FG003|Part II|Physician Decision|1|||
106015049|NCT01208207|365720933|FG004|Part II|Physician Decision|0|||
106142206|NCT02000817|366179902|FG000|Overall Study|Adverse Event|0|||
106142207|NCT02000817|366179903|FG001|Overall Study|Adverse Event|1|||
105742691|NCT00316303|364712764|FG001|Overall Study|Lost to Follow-up|16|||
105742692|NCT01753076|364712767|FG000|Overall Study|Adverse Event|17|||
105742693|NCT01753076|364712768|FG001|Overall Study|Adverse Event|18|||
105742694|NCT01753076|364712767|FG000|Overall Study|Lack of Efficacy|3|||
105742695|NCT01753076|364712768|FG001|Overall Study|Lack of Efficacy|1|||
105742696|NCT01753076|364712767|FG000|Overall Study|Lost to Follow-up|2|||
105742697|NCT01753076|364712768|FG001|Overall Study|Lost to Follow-up|1|||
105742698|NCT01753076|364712767|FG000|Overall Study|Physician Decision|4|||
105742699|NCT01753076|364712768|FG001|Overall Study|Physician Decision|2|||
105742700|NCT01753076|364712767|FG000|Overall Study|Withdrawal by Subject|14|||
105742701|NCT01753076|364712768|FG001|Overall Study|Withdrawal by Subject|24|||
105742702|NCT01753076|364712767|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
105742703|NCT01753076|364712768|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
105742704|NCT02575079|364712769|FG000|Overall Study|Death|3|||
105742705|NCT02575079|364712770|FG001|Overall Study|Death|0|||
105742706|NCT02575079|364712769|FG000|Overall Study|Withdrawal by Subject|3|||
105742707|NCT02575079|364712770|FG001|Overall Study|Withdrawal by Subject|0|||
105742708|NCT02918266|364712771|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
105742709|NCT02918266|364712772|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742710|NCT02918266|364712773|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742711|NCT02918266|364712774|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742712|NCT02918266|364712775|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742713|NCT02918266|364712776|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742714|NCT02918266|364712777|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
105742715|NCT02918266|364712778|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742716|NCT02918266|364712779|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
105942626|NCT05805150|365452818|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
105942627|NCT02284893|365452821|FG000|26 Week (Short Term)|Adverse Event|1|||
105942628|NCT02284893|365452822|FG001|26 Week (Short Term)|Adverse Event|9|||
105942629|NCT02284893|365452821|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
105942630|NCT02284893|365452822|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
105942631|NCT02284893|365452821|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
105942632|NCT02284893|365452822|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
105942633|NCT02284893|365452821|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
105942634|NCT02284893|365452822|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
105942635|NCT02284893|365452821|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
105942636|NCT02284893|365452822|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
105942637|NCT02284893|365452821|FG000|26 Week (Short Term)|Other|1|||
105942638|NCT02284893|365452822|FG001|26 Week (Short Term)|Other|1|||
105942639|NCT02284893|365452821|FG000|52 Week (Long Term)|Adverse Event|3|||
105942640|NCT02284893|365452822|FG001|52 Week (Long Term)|Adverse Event|1|||
105942641|NCT02284893|365452821|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
105942642|NCT02284893|365452822|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
105942643|NCT02284893|365452821|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
105942644|NCT02284893|365452822|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
105942645|NCT02284893|365452821|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
105942646|NCT02284893|365452822|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
105942647|NCT02284893|365452821|FG000|52 Week (Long Term)|Non-Compliance|2|||
105942648|NCT02284893|365452822|FG001|52 Week (Long Term)|Non-Compliance|3|||
105942649|NCT02757430|365452823|FG000|Overall Study|Physician Decision|6|||
105942650|NCT02757430|365452823|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
105942651|NCT02757430|365452823|FG000|Overall Study|No informed consent|1|||
105942652|NCT02757430|365452823|FG000|Overall Study|No procedure performed|2|||
105942653|NCT00265122|365452826|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
105942654|NCT00265122|365452827|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
105942655|NCT00265122|365452828|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
105942656|NCT00265122|365452829|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
105942657|NCT00265122|365452830|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
105942658|NCT00265122|365452831|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
105942659|NCT00265122|365452826|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
105942660|NCT00265122|365452827|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
105942661|NCT00265122|365452828|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
105942662|NCT00265122|365452829|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
105942663|NCT00265122|365452830|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
105942664|NCT00265122|365452831|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
105942665|NCT00265122|365452826|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
105942666|NCT00265122|365452827|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
105942667|NCT00265122|365452828|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
105942668|NCT00265122|365452829|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
105742717|NCT02918266|364712780|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742718|NCT02918266|364712781|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
105742719|NCT00471536|364712782|FG000|Overall Study|Withdrawal by Subject|1|||
105742720|NCT01259856|364712789|FG000|Overall Study|Adverse Event|12|||
105742721|NCT01259856|364712790|FG001|Overall Study|Adverse Event|9|||
105742722|NCT01259856|364712789|FG000|Overall Study|Death|0|||
105742723|NCT01259856|364712790|FG001|Overall Study|Death|1|||
105742724|NCT01259856|364712789|FG000|Overall Study|Lack of Efficacy|3|||
105742725|NCT01259856|364712790|FG001|Overall Study|Lack of Efficacy|1|||
105742726|NCT01259856|364712789|FG000|Overall Study|Lost to Follow-up|1|||
105742727|NCT01259856|364712790|FG001|Overall Study|Lost to Follow-up|1|||
105742728|NCT01259856|364712789|FG000|Overall Study|Physician Decision|2|||
105742729|NCT01259856|364712790|FG001|Overall Study|Physician Decision|1|||
105742730|NCT01259856|364712789|FG000|Overall Study|Withdrawal by Subject|9|||
105742731|NCT01259856|364712790|FG001|Overall Study|Withdrawal by Subject|10|||
105742732|NCT01259856|364712789|FG000|Overall Study|Treatment never started|0|||
105742733|NCT01259856|364712790|FG001|Overall Study|Treatment never started|6|||
105742734|NCT01259856|364712789|FG000|Overall Study|Study closure by sponsor|40|||
105742735|NCT01259856|364712790|FG001|Overall Study|Study closure by sponsor|41|||
105742736|NCT01259856|364712789|FG000|Overall Study|Patient developed other disease|0|||
105742737|NCT01259856|364712790|FG001|Overall Study|Patient developed other disease|1|||
105742738|NCT01259856|364712789|FG000|Overall Study|Transfer to another study|0|||
105742739|NCT01259856|364712790|FG001|Overall Study|Transfer to another study|1|||
105742740|NCT01259856|364712789|FG000|Overall Study|Unknown/missing|2|||
105742741|NCT01259856|364712790|FG001|Overall Study|Unknown/missing|2|||
105742742|NCT01860534|364712793|FG000|ROP #1|Needed treatment for ROP|0|||
105742743|NCT01860534|364712794|FG001|ROP #1|Needed treatment for ROP|1|||
105742744|NCT01860534|364712793|FG000|ROP #2|discharged prior to ROP #2|1|||
105742745|NCT01860534|364712794|FG001|ROP #2|discharged prior to ROP #2|0|||
105742746|NCT00788775|364712795|FG000|Overall Study|Progressive Disease|8|||
105742747|NCT00788775|364712796|FG001|Overall Study|Progressive Disease|6|||
105742748|NCT00788775|364712795|FG000|Overall Study|Withdrawal by Subject|0|||
105742749|NCT00788775|364712796|FG001|Overall Study|Withdrawal by Subject|2|||
105742750|NCT00788775|364712795|FG000|Overall Study|Patient Non-Compliance|1|||
105742751|NCT00788775|364712796|FG001|Overall Study|Patient Non-Compliance|0|||
105742752|NCT00788775|364712795|FG000|Overall Study|Patient's measurable disease resected.|1|||
105742753|NCT00788775|364712796|FG001|Overall Study|Patient's measurable disease resected.|0|||
105742754|NCT00578864|364712797|FG000|Overall Study|Death|1|||
105742755|NCT00578864|364712798|FG001|Overall Study|Death|0|||
105742756|NCT01702363|364712799|FG000|Overall Study|Adverse Event|14|||
105742757|NCT01702363|364712799|FG000|Overall Study|Lack of Efficacy|4|||
105742758|NCT01702363|364712799|FG000|Overall Study|Withdrawal by Subject|2|||
105742759|NCT00905307|364712800|FG000|Overall Study|Switched to Open Label Rescue|7|||
105742760|NCT00905307|364712801|FG001|Overall Study|Switched to Open Label Rescue|17|||
105742761|NCT00905307|364712802|FG002|Overall Study|Switched to Open Label Rescue|11|||
105742762|NCT00905307|364712803|FG003|Overall Study|Switched to Open Label Rescue|11|||
105742763|NCT00905307|364712804|FG004|Overall Study|Switched to Open Label Rescue|4|||
105742764|NCT00905307|364712805|FG005|Overall Study|Switched to Open Label Rescue|15|||
105742765|NCT00905307|364712800|FG000|Overall Study|Lost to Follow-up|0|||
105742766|NCT00905307|364712801|FG001|Overall Study|Lost to Follow-up|0|||
105742767|NCT00905307|364712802|FG002|Overall Study|Lost to Follow-up|0|||
105742768|NCT00905307|364712803|FG003|Overall Study|Lost to Follow-up|0|||
105742769|NCT00905307|364712804|FG004|Overall Study|Lost to Follow-up|1|||
105742770|NCT00905307|364712805|FG005|Overall Study|Lost to Follow-up|1|||
105742771|NCT00905307|364712800|FG000|Overall Study|Adverse Event|3|||
105742772|NCT00905307|364712801|FG001|Overall Study|Adverse Event|4|||
105742773|NCT00905307|364712802|FG002|Overall Study|Adverse Event|5|||
105742774|NCT00905307|364712803|FG003|Overall Study|Adverse Event|11|||
105742775|NCT00905307|364712804|FG004|Overall Study|Adverse Event|3|||
105742776|NCT00905307|364712805|FG005|Overall Study|Adverse Event|5|||
105742777|NCT00905307|364712800|FG000|Overall Study|Withdrawal by Subject|5|||
106015050|NCT01208207|365720934|FG005|Part II|Physician Decision|2|||
105742778|NCT00905307|364712801|FG001|Overall Study|Withdrawal by Subject|13|||
105742779|NCT00905307|364712802|FG002|Overall Study|Withdrawal by Subject|15|||
105742780|NCT00905307|364712803|FG003|Overall Study|Withdrawal by Subject|11|||
105742781|NCT00905307|364712804|FG004|Overall Study|Withdrawal by Subject|4|||
105742782|NCT00905307|364712805|FG005|Overall Study|Withdrawal by Subject|13|||
105742783|NCT00905307|364712800|FG000|Overall Study|Protocol Violation|1|||
105742784|NCT00905307|364712801|FG001|Overall Study|Protocol Violation|0|||
105742785|NCT00905307|364712802|FG002|Overall Study|Protocol Violation|1|||
105742786|NCT00905307|364712803|FG003|Overall Study|Protocol Violation|0|||
105742787|NCT00905307|364712804|FG004|Overall Study|Protocol Violation|0|||
105742788|NCT00905307|364712805|FG005|Overall Study|Protocol Violation|0|||
105742789|NCT00905307|364712800|FG000|Overall Study|Lack of Efficacy|6|||
105742790|NCT00905307|364712801|FG001|Overall Study|Lack of Efficacy|3|||
105742791|NCT00905307|364712802|FG002|Overall Study|Lack of Efficacy|5|||
105742792|NCT00905307|364712803|FG003|Overall Study|Lack of Efficacy|4|||
106015051|NCT01208207|365720935|FG006|Part II|Physician Decision|0|||
106015052|NCT01208207|365720929|FG000|Part II|Protocol Violation|0|||
106015053|NCT01208207|365720930|FG001|Part II|Protocol Violation|0|||
106015054|NCT01208207|365720931|FG002|Part II|Protocol Violation|0|||
106015055|NCT01208207|365720932|FG003|Part II|Protocol Violation|1|||
106015056|NCT01208207|365720933|FG004|Part II|Protocol Violation|0|||
106015057|NCT01208207|365720934|FG005|Part II|Protocol Violation|0|||
106015058|NCT01208207|365720935|FG006|Part II|Protocol Violation|0|||
106015059|NCT01208207|365720929|FG000|Part II|Technical Problems|0|||
106015060|NCT01208207|365720930|FG001|Part II|Technical Problems|0|||
106015061|NCT01208207|365720931|FG002|Part II|Technical Problems|0|||
106015062|NCT01208207|365720932|FG003|Part II|Technical Problems|1|||
106015063|NCT01208207|365720933|FG004|Part II|Technical Problems|0|||
106015064|NCT01208207|365720934|FG005|Part II|Technical Problems|1|||
106015065|NCT01208207|365720935|FG006|Part II|Technical Problems|0|||
106015066|NCT05021978|365720936|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
106015067|NCT05021978|365720937|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
106015068|NCT05021978|365720938|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
105742793|NCT00905307|364712804|FG004|Overall Study|Lack of Efficacy|4|||
105742794|NCT00905307|364712805|FG005|Overall Study|Lack of Efficacy|8|||
105742795|NCT01201798|364712809|FG000|Overall Study|Adverse Event|2|||
105742796|NCT01201798|364712810|FG001|Overall Study|Adverse Event|0|||
105742797|NCT01201798|364712809|FG000|Overall Study|Lost to Follow-up|3|||
105742798|NCT01201798|364712810|FG001|Overall Study|Lost to Follow-up|5|||
105742799|NCT01201798|364712809|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
106015069|NCT05021978|365720939|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
106015070|NCT05021978|365720936|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
106015071|NCT05021978|365720937|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
106015072|NCT05021978|365720938|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
106015073|NCT05021978|365720939|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
106015074|NCT02177032|365720942|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
106015075|NCT02177032|365720943|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
106015076|NCT02177032|365720944|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
106015077|NCT02177032|365720945|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
106015078|NCT02177032|365720942|FG000|Overall Study|Lost to Follow-up|0|||
106015079|NCT02177032|365720943|FG001|Overall Study|Lost to Follow-up|2|||
106015080|NCT02177032|365720944|FG002|Overall Study|Lost to Follow-up|0|||
106015081|NCT02177032|365720945|FG003|Overall Study|Lost to Follow-up|0|||
106015082|NCT02177032|365720942|FG000|Overall Study|OTHER|2|||
106015083|NCT02177032|365720943|FG001|Overall Study|OTHER|0|||
106015084|NCT02177032|365720944|FG002|Overall Study|OTHER|1|||
106015085|NCT02177032|365720945|FG003|Overall Study|OTHER|0|||
106015086|NCT02177032|365720942|FG000|Overall Study|Withdrawal by Subject|1|||
106015087|NCT02177032|365720943|FG001|Overall Study|Withdrawal by Subject|0|||
106015088|NCT02177032|365720944|FG002|Overall Study|Withdrawal by Subject|1|||
106015089|NCT02177032|365720945|FG003|Overall Study|Withdrawal by Subject|0|||
106015090|NCT00665652|365720946|FG000|Overall Study|Adverse Event|4|||
105742800|NCT01201798|364712810|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
105742801|NCT01201798|364712809|FG000|Overall Study|Noncompliance|1|||
105742802|NCT01201798|364712810|FG001|Overall Study|Noncompliance|0|||
105742803|NCT01201798|364712809|FG000|Overall Study|Protocol Violation|1|||
105742804|NCT01201798|364712810|FG001|Overall Study|Protocol Violation|1|||
105742805|NCT01201798|364712809|FG000|Overall Study|Treatment Failure|1|||
105742806|NCT01201798|364712810|FG001|Overall Study|Treatment Failure|8|||
105742807|NCT00525148|364712811|FG000|Overall Study|Other Adverse Event|3|||
105742808|NCT00525148|364712812|FG001|Overall Study|Other Adverse Event|5|||
105742809|NCT00525148|364712813|FG002|Overall Study|Other Adverse Event|1|||
105742810|NCT00525148|364712814|FG003|Overall Study|Other Adverse Event|8|||
105742811|NCT00525148|364712811|FG000|Overall Study|Progressive disease|18|||
105742812|NCT00525148|364712812|FG001|Overall Study|Progressive disease|30|||
105742813|NCT00525148|364712813|FG002|Overall Study|Progressive disease|6|||
105742814|NCT00525148|364712814|FG003|Overall Study|Progressive disease|49|||
105742815|NCT00525148|364712811|FG000|Overall Study|Refused continuation of study medication|0|||
105742816|NCT00525148|364712812|FG001|Overall Study|Refused continuation of study medication|2|||
105742817|NCT00525148|364712813|FG002|Overall Study|Refused continuation of study medication|0|||
105742818|NCT00525148|364712814|FG003|Overall Study|Refused continuation of study medication|1|||
105742819|NCT00525148|364712811|FG000|Overall Study|Other than stated|2|||
105742820|NCT00525148|364712812|FG001|Overall Study|Other than stated|1|||
105742821|NCT00525148|364712813|FG002|Overall Study|Other than stated|0|||
105742822|NCT00525148|364712814|FG003|Overall Study|Other than stated|3|||
106015091|NCT00665652|365720946|FG000|Overall Study|Death|1|||
106015092|NCT00665652|365720946|FG000|Overall Study|No longer met inclusion criteria.|1|||
106015093|NCT02004093|365720950|FG000|Overall Study|Death|2|||
106015094|NCT02004093|365720951|FG001|Overall Study|Death|1|||
106015095|NCT02004093|365720950|FG000|Overall Study|Lack of Efficacy|66|||
106015096|NCT02004093|365720951|FG001|Overall Study|Lack of Efficacy|62|||
106015097|NCT02004093|365720950|FG000|Overall Study|Protocol Violation|0|||
106015098|NCT02004093|365720951|FG001|Overall Study|Protocol Violation|1|||
106015099|NCT02004093|365720950|FG000|Overall Study|Lost to Follow-up|0|||
106142208|NCT02000817|366179904|FG002|Overall Study|Adverse Event|0|||
105742823|NCT01603641|364712815|FG000|Overall Study|Did not Receive Treatment|3|||
105742824|NCT01603641|364712815|FG000|Overall Study|Adverse Event|1|||
105742825|NCT01603641|364712815|FG000|Overall Study|Lack of Efficacy|1|||
105742826|NCT01603641|364712815|FG000|Overall Study|Lost to Follow-up|6|||
105742827|NCT01603641|364712815|FG000|Overall Study|Personal Reasons|18|||
105742828|NCT01603641|364712815|FG000|Overall Study|Other Miscellaneous Reasons|6|||
105742829|NCT00114972|364712822|FG000|Overall Study|Withdrawal by Subject|40|||
105742830|NCT00114972|364712823|FG001|Overall Study|Withdrawal by Subject|7|||
105742831|NCT00114972|364712822|FG000|Overall Study|Lost to Follow-up|8|||
105742832|NCT00114972|364712823|FG001|Overall Study|Lost to Follow-up|5|||
105742833|NCT00830037|364712824|FG000|Overall Study|Withdrawal by Subject|2|||
105742834|NCT00830037|364712825|FG001|Overall Study|Withdrawal by Subject|3|||
105742835|NCT00830037|364712824|FG000|Overall Study|Lost to Follow-up|1|||
105742836|NCT00830037|364712825|FG001|Overall Study|Lost to Follow-up|2|||
105742837|NCT00830037|364712824|FG000|Overall Study|Active when terminated by DSMB|15|||
105742838|NCT00830037|364712825|FG001|Overall Study|Active when terminated by DSMB|14|||
105742839|NCT00752609|364712826|FG000|Overall Study|Adverse Event|2|||
105742840|NCT00752609|364712827|FG001|Overall Study|Adverse Event|2|||
105742841|NCT00752609|364712826|FG000|Overall Study|Withdrawal by Subject|3|||
105742842|NCT00752609|364712827|FG001|Overall Study|Withdrawal by Subject|0|||
105742843|NCT00752609|364712826|FG000|Overall Study|Physician Decision|1|||
105742844|NCT00752609|364712827|FG001|Overall Study|Physician Decision|0|||
105742845|NCT00752609|364712826|FG000|Overall Study|Death|1|||
105742846|NCT00752609|364712827|FG001|Overall Study|Death|0|||
105742847|NCT00752609|364712826|FG000|Overall Study|Met exclusion criteria|1|||
105742848|NCT00752609|364712827|FG001|Overall Study|Met exclusion criteria|0|||
105742849|NCT00752609|364712826|FG000|Overall Study|Received Aranesp in error|1|||
105742850|NCT00752609|364712827|FG001|Overall Study|Received Aranesp in error|0|||
105742851|NCT00938327|364712830|FG000|Overall Study|Adverse Event|2|||
105742852|NCT00938327|364712830|FG000|Overall Study|Protocol Violation|1|||
105742853|NCT00938327|364712830|FG000|Overall Study|Withdrawal by Subject|4|||
105742854|NCT00938327|364712830|FG000|Overall Study|Lost to Follow-up|37|||
105742855|NCT00938327|364712830|FG000|Overall Study|2nd dose received outside of the study|7|||
105742856|NCT00938327|364712830|FG000|Overall Study|Vaccine not received as out of stock|9|||
105742857|NCT01379534|364712831|FG000|Treatment Phase|Withdrawal by Subject|2|||
105742858|NCT01379534|364712832|FG001|Treatment Phase|Withdrawal by Subject|2|||
105742859|NCT01379534|364712831|FG000|Treatment Phase|Progressive disease|13|||
105742860|NCT01379534|364712832|FG001|Treatment Phase|Progressive disease|22|||
105742861|NCT01379534|364712831|FG000|Treatment Phase|Adverse Event|7|||
105942669|NCT00265122|365452830|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
105942670|NCT00265122|365452831|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
105942671|NCT00265122|365452826|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
105942672|NCT00265122|365452827|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
105942673|NCT00265122|365452828|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
105942674|NCT00265122|365452829|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
105942675|NCT00265122|365452830|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
105942676|NCT00265122|365452831|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
105942677|NCT00265122|365452826|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
105942678|NCT00265122|365452827|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
105942679|NCT00265122|365452828|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
105942680|NCT00265122|365452829|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
105942681|NCT00265122|365452830|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
105942682|NCT00265122|365452831|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
105942683|NCT00265122|365452826|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
105942684|NCT00265122|365452827|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
105942685|NCT00265122|365452828|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
105942686|NCT00265122|365452829|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
105942687|NCT00265122|365452830|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
105942688|NCT00265122|365452831|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
105942689|NCT02657343|365452832|FG000|Overall Study|Death|0|||
105942690|NCT02657343|365452833|FG001|Overall Study|Death|2|||
105942691|NCT02657343|365452834|FG002|Overall Study|Death|0|||
105942692|NCT02657343|365452835|FG003|Overall Study|Death|0|||
105942693|NCT02657343|365452836|FG004|Overall Study|Death|0|||
105942694|NCT02657343|365452837|FG005|Overall Study|Death|0|||
105942695|NCT02657343|365452832|FG000|Overall Study|Patient went to hospice|1|||
105942696|NCT02657343|365452833|FG001|Overall Study|Patient went to hospice|0|||
106015100|NCT02004093|365720951|FG001|Overall Study|Lost to Follow-up|1|||
106142209|NCT02000817|366179905|FG003|Overall Study|Adverse Event|0|||
106142210|NCT02000817|366179902|FG000|Overall Study|Lost to Follow-up|0|||
105742862|NCT01379534|364712832|FG001|Treatment Phase|Adverse Event|7|||
105742863|NCT01379534|364712831|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
105742864|NCT01379534|364712832|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
105800242|NCT00830063|364926416|FG000|Overall Study|Lost to Follow-up|0|||
105742865|NCT01379534|364712831|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
105742866|NCT01379534|364712832|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
105742867|NCT01379534|364712831|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
105742868|NCT01379534|364712832|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
105742869|NCT01379534|364712831|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
105942697|NCT02657343|365452834|FG002|Overall Study|Patient went to hospice|0|||
105942698|NCT02657343|365452835|FG003|Overall Study|Patient went to hospice|0|||
105742870|NCT01379534|364712832|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
105742871|NCT02680847|364712833|FG000|Overall Study|Other|2|||
105742872|NCT02680847|364712834|FG001|Overall Study|Other|0|||
105742873|NCT02680847|364712835|FG002|Overall Study|Other|0|||
105742874|NCT02680847|364712833|FG000|Overall Study|No longer met eligibility criteria|2|||
105742875|NCT02680847|364712834|FG001|Overall Study|No longer met eligibility criteria|2|||
105742876|NCT02680847|364712835|FG002|Overall Study|No longer met eligibility criteria|0|||
105742877|NCT02680847|364712833|FG000|Overall Study|Unwilling to participate in study|1|||
105742878|NCT02680847|364712834|FG001|Overall Study|Unwilling to participate in study|1|||
105742879|NCT02680847|364712835|FG002|Overall Study|Unwilling to participate in study|0|||
105742880|NCT02680847|364712833|FG000|Overall Study|Lack of Efficacy|0|||
105742881|NCT02680847|364712834|FG001|Overall Study|Lack of Efficacy|0|||
105742882|NCT02680847|364712835|FG002|Overall Study|Lack of Efficacy|2|||
105742883|NCT02680847|364712833|FG000|Overall Study|Adverse Event|0|||
105742884|NCT02680847|364712834|FG001|Overall Study|Adverse Event|0|||
105742885|NCT02680847|364712835|FG002|Overall Study|Adverse Event|1|||
105742886|NCT00829166|364712836|FG000|Overall Study|Death|305|||
105742887|NCT00829166|364712837|FG001|Overall Study|Death|333|||
105742888|NCT00829166|364712836|FG000|Overall Study|Lost to Follow-up|5|||
105742889|NCT00829166|364712837|FG001|Overall Study|Lost to Follow-up|4|||
105742890|NCT00829166|364712836|FG000|Overall Study|Physician's Decision|4|||
105742891|NCT00829166|364712837|FG001|Overall Study|Physician's Decision|3|||
105742892|NCT00829166|364712836|FG000|Overall Study|Subject's Decision|41|||
105742893|NCT00829166|364712837|FG001|Overall Study|Subject's Decision|55|||
105742894|NCT00829166|364712836|FG000|Overall Study|Sponsor's Decision|137|||
105742895|NCT00829166|364712837|FG001|Overall Study|Sponsor's Decision|98|||
105742896|NCT00829166|364712836|FG000|Overall Study|Reason Not Specified|3|||
105742897|NCT00829166|364712837|FG001|Overall Study|Reason Not Specified|3|||
105742898|NCT02538666|364712838|FG000|Pre-Treatment|Disease progression|1|||
105742899|NCT02538666|364712839|FG001|Pre-Treatment|Disease progression|0|||
105742900|NCT02538666|364712840|FG002|Pre-Treatment|Disease progression|0|||
105742901|NCT02538666|364712838|FG000|Pre-Treatment|no longer meets study criteria|1|||
105742902|NCT02538666|364712839|FG001|Pre-Treatment|no longer meets study criteria|0|||
105742903|NCT02538666|364712840|FG002|Pre-Treatment|no longer meets study criteria|0|||
105742904|NCT02538666|364712838|FG000|Pre-Treatment|Withdrew Consent|0|||
105742905|NCT02538666|364712839|FG001|Pre-Treatment|Withdrew Consent|1|||
105742906|NCT02538666|364712840|FG002|Pre-Treatment|Withdrew Consent|1|||
105742907|NCT02538666|364712838|FG000|Treatment|Disease progression|270|||
105742908|NCT02538666|364712839|FG001|Treatment|Disease progression|227|||
105742909|NCT02538666|364712840|FG002|Treatment|Disease progression|165|||
105742910|NCT02538666|364712838|FG000|Treatment|Study drug toxicity|1|||
105742911|NCT02538666|364712839|FG001|Treatment|Study drug toxicity|29|||
105742912|NCT02538666|364712840|FG002|Treatment|Study drug toxicity|92|||
105742913|NCT02538666|364712838|FG000|Treatment|Death|0|||
105742914|NCT02538666|364712839|FG001|Treatment|Death|2|||
105742915|NCT02538666|364712840|FG002|Treatment|Death|3|||
105742916|NCT02538666|364712838|FG000|Treatment|Adverse event unrelated to study drug|8|||
105742917|NCT02538666|364712839|FG001|Treatment|Adverse event unrelated to study drug|10|||
105742918|NCT02538666|364712840|FG002|Treatment|Adverse event unrelated to study drug|15|||
105742919|NCT02538666|364712838|FG000|Treatment|Participant request to discontinue study treatment|3|||
105742920|NCT02538666|364712839|FG001|Treatment|Participant request to discontinue study treatment|6|||
105742921|NCT02538666|364712840|FG002|Treatment|Participant request to discontinue study treatment|11|||
105742922|NCT02538666|364712838|FG000|Treatment|Participant withdrew consent|2|||
105742923|NCT02538666|364712839|FG001|Treatment|Participant withdrew consent|5|||
105742924|NCT02538666|364712840|FG002|Treatment|Participant withdrew consent|3|||
105742925|NCT02538666|364712838|FG000|Treatment|Lost to Follow-up|0|||
105742926|NCT02538666|364712839|FG001|Treatment|Lost to Follow-up|1|||
105742927|NCT02538666|364712840|FG002|Treatment|Lost to Follow-up|1|||
105742928|NCT02538666|364712838|FG000|Treatment|Maximum clinical benefit|4|||
105742929|NCT02538666|364712839|FG001|Treatment|Maximum clinical benefit|3|||
105742930|NCT02538666|364712840|FG002|Treatment|Maximum clinical benefit|4|||
105742931|NCT02538666|364712838|FG000|Treatment|Poor/non-compliance|0|||
105942699|NCT02657343|365452836|FG004|Overall Study|Patient went to hospice|0|||
105800243|NCT00830063|364926417|FG001|Overall Study|Lost to Follow-up|0|||
105742932|NCT02538666|364712839|FG001|Treatment|Poor/non-compliance|1|||
105742933|NCT02538666|364712840|FG002|Treatment|Poor/non-compliance|0|||
105742934|NCT02538666|364712838|FG000|Treatment|Participant no longer meets study criteria|0|||
105742935|NCT02538666|364712839|FG001|Treatment|Participant no longer meets study criteria|2|||
105742936|NCT02538666|364712840|FG002|Treatment|Participant no longer meets study criteria|0|||
106015101|NCT02004093|365720950|FG000|Overall Study|Withdrawal by Subject|3|||
106015102|NCT02004093|365720951|FG001|Overall Study|Withdrawal by Subject|7|||
106015103|NCT02004093|365720950|FG000|Overall Study|Other|3|||
106015104|NCT02004093|365720951|FG001|Overall Study|Other|1|||
106015105|NCT01055197|365720954|FG000|Overall Study|Protocol Violation|7|||
106015106|NCT01055197|365720955|FG001|Overall Study|Protocol Violation|2|||
106015107|NCT01055197|365720954|FG000|Overall Study|Withdrawal by Subject|2|||
106015108|NCT01055197|365720955|FG001|Overall Study|Withdrawal by Subject|0|||
106015109|NCT02504151|365720956|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
106015110|NCT02504151|365720957|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
106015111|NCT02504151|365720956|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
106015112|NCT02504151|365720957|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
106015113|NCT02504151|365720956|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
106015114|NCT02504151|365720957|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
106015115|NCT02504151|365720956|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
106015116|NCT02504151|365720957|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
106015117|NCT05038982|365720958|FG000|Overall Study|Withdrawal by Subject|0|||
106015118|NCT05038982|365720959|FG001|Overall Study|Withdrawal by Subject|2|||
106015119|NCT02691507|365720960|FG000|Overall Study|Missed Visit 3|0|||
106015120|NCT02691507|365720961|FG001|Overall Study|Missed Visit 3|1|||
105742937|NCT02538666|364712838|FG000|Treatment|Administrative reason by sponsor|0|||
105742938|NCT02538666|364712839|FG001|Treatment|Administrative reason by sponsor|0|||
105742939|NCT02538666|364712840|FG002|Treatment|Administrative reason by sponsor|1|||
105742940|NCT02538666|364712838|FG000|Treatment|Other reasons|8|||
105742941|NCT02538666|364712839|FG001|Treatment|Other reasons|15|||
105742942|NCT02538666|364712840|FG002|Treatment|Other reasons|5|||
105742943|NCT02538666|364712838|FG000|Treatment|Not reported|2|||
105742944|NCT02538666|364712839|FG001|Treatment|Not reported|2|||
105742945|NCT02538666|364712840|FG002|Treatment|Not reported|2|||
105742946|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
105742947|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
105742948|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
105742949|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
105742950|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
105742951|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
105742952|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
105742953|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
105742954|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
105742955|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
105742956|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
105742957|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
105742958|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742959|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
105742960|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742961|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742962|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742963|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
105742964|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
105742965|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
105742966|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
105742967|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
105742968|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
105742969|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
105742970|NCT03345836|364712843|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
105742971|NCT03345836|364712844|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
106142211|NCT02000817|366179903|FG001|Overall Study|Lost to Follow-up|0|||
106142212|NCT02000817|366179904|FG002|Overall Study|Lost to Follow-up|1|||
106142213|NCT02000817|366179905|FG003|Overall Study|Lost to Follow-up|0|||
105742972|NCT03345836|364712845|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
105742973|NCT03345836|364712846|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
105742974|NCT03345836|364712847|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
105742975|NCT03345836|364712848|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
105742976|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
105742977|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
105800244|NCT00830063|364926418|FG002|Overall Study|Lost to Follow-up|3|||
106015121|NCT01663103|365720965|FG000|Overall Study|Withdrawal by Subject|1|||
106015122|NCT01663103|365720966|FG001|Overall Study|Withdrawal by Subject|2|||
106015123|NCT01663103|365720965|FG000|Overall Study|Adverse Event|1|||
106015124|NCT01663103|365720966|FG001|Overall Study|Adverse Event|0|||
106015125|NCT01663103|365720965|FG000|Overall Study|dog bite|1|||
106015126|NCT01663103|365720966|FG001|Overall Study|dog bite|0|||
106015127|NCT03944577|365720967|FG000|Overall Study|Adverse Event|3|||
106015128|NCT00391586|365720968|FG000|Overall Study|Progressive disease|13|||
106015129|NCT00391586|365720968|FG000|Overall Study|Adverse Event|5|||
105742978|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
105742979|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
105742980|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
105742981|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
105742982|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
105742983|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
105742984|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
105742985|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
105742986|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
105742987|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
105742988|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742989|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742990|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742991|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742992|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
105742993|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
105742994|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
105742995|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
105742996|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
105742997|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
105742998|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
105742999|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
105743000|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743001|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743002|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743003|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743004|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
105743005|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
105743006|NCT03345836|364712843|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
105743007|NCT03345836|364712844|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
105743008|NCT03345836|364712845|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
105743009|NCT03345836|364712846|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
105743010|NCT03345836|364712847|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
105743011|NCT03345836|364712848|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
105743012|NCT01544595|364712849|FG000|Status at Week 68|Adverse Event|3|||
105743013|NCT01544595|364712850|FG001|Status at Week 68|Adverse Event|2|||
105743014|NCT01544595|364712851|FG002|Status at Week 68|Adverse Event|1|||
105743015|NCT01544595|364712852|FG003|Status at Week 68|Adverse Event|0|||
105743016|NCT01544595|364712853|FG004|Status at Week 68|Adverse Event|0|||
105743017|NCT01544595|364712854|FG005|Status at Week 68|Adverse Event|0|||
105743018|NCT01544595|364712849|FG000|Status at Week 68|Lack of Efficacy|1|||
105743019|NCT01544595|364712850|FG001|Status at Week 68|Lack of Efficacy|0|||
105743020|NCT01544595|364712851|FG002|Status at Week 68|Lack of Efficacy|0|||
105743021|NCT01544595|364712852|FG003|Status at Week 68|Lack of Efficacy|0|||
105743022|NCT01544595|364712853|FG004|Status at Week 68|Lack of Efficacy|0|||
105743023|NCT01544595|364712854|FG005|Status at Week 68|Lack of Efficacy|0|||
105743024|NCT01544595|364712849|FG000|Status at Week 68|Lost to Follow-up|1|||
105743025|NCT01544595|364712850|FG001|Status at Week 68|Lost to Follow-up|1|||
105743026|NCT01544595|364712851|FG002|Status at Week 68|Lost to Follow-up|0|||
105743027|NCT01544595|364712852|FG003|Status at Week 68|Lost to Follow-up|0|||
105743028|NCT01544595|364712853|FG004|Status at Week 68|Lost to Follow-up|0|||
105743029|NCT01544595|364712854|FG005|Status at Week 68|Lost to Follow-up|0|||
105743030|NCT01544595|364712849|FG000|Status at Week 68|Non-compliance with study treatment|1|||
105743031|NCT01544595|364712850|FG001|Status at Week 68|Non-compliance with study treatment|0|||
105743032|NCT01544595|364712851|FG002|Status at Week 68|Non-compliance with study treatment|0|||
106015130|NCT00391586|365720968|FG000|Overall Study|Physician Decision|2|||
106015131|NCT00391586|365720968|FG000|Overall Study|Death|4|||
106015132|NCT01658436|365720977|FG000|Overall Study|Adverse Event|6|||
106015133|NCT01658436|365720978|FG001|Overall Study|Adverse Event|5|||
105743033|NCT01544595|364712852|FG003|Status at Week 68|Non-compliance with study treatment|1|||
105743034|NCT01544595|364712853|FG004|Status at Week 68|Non-compliance with study treatment|0|||
106015134|NCT01658436|365720977|FG000|Overall Study|Physician Decision|1|||
106015135|NCT01658436|365720978|FG001|Overall Study|Physician Decision|0|||
106015136|NCT01658436|365720977|FG000|Overall Study|Progressive disease|12|||
106015137|NCT01658436|365720978|FG001|Overall Study|Progressive disease|4|||
106015138|NCT01658436|365720977|FG000|Overall Study|Study terminated by sponsor|0|||
106015139|NCT01658436|365720978|FG001|Overall Study|Study terminated by sponsor|1|||
106015140|NCT01658436|365720977|FG000|Overall Study|Subject/guardian decision|0|||
106015141|NCT01658436|365720978|FG001|Overall Study|Subject/guardian decision|1|||
106015142|NCT01658436|365720977|FG000|Overall Study|Death|1|||
106015143|NCT01658436|365720978|FG001|Overall Study|Death|0|||
106015144|NCT00949702|365720979|FG000|Overall Study|Death|40|||
106015145|NCT00949702|365720979|FG000|Overall Study|Disease progression|7|||
106015146|NCT00949702|365720979|FG000|Overall Study|Withdrawal of consent|1|||
106015147|NCT01654302|365720980|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
106015148|NCT01654302|365720981|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
106015149|NCT03133793|365720982|FG000|Overall Study|Withdrawal by Subject|0|||
105743035|NCT01544595|364712854|FG005|Status at Week 68|Non-compliance with study treatment|0|||
105743036|NCT01544595|364712849|FG000|Status at Week 68|Protocol Violation|2|||
105743037|NCT01544595|364712850|FG001|Status at Week 68|Protocol Violation|0|||
105743038|NCT01544595|364712851|FG002|Status at Week 68|Protocol Violation|1|||
105743039|NCT01544595|364712852|FG003|Status at Week 68|Protocol Violation|1|||
105743040|NCT01544595|364712853|FG004|Status at Week 68|Protocol Violation|0|||
105743041|NCT01544595|364712854|FG005|Status at Week 68|Protocol Violation|0|||
105743042|NCT01544595|364712849|FG000|Status at Week 68|Technical problems|1|||
105743043|NCT01544595|364712850|FG001|Status at Week 68|Technical problems|0|||
105743044|NCT01544595|364712851|FG002|Status at Week 68|Technical problems|0|||
105743045|NCT01544595|364712852|FG003|Status at Week 68|Technical problems|1|||
105743046|NCT01544595|364712853|FG004|Status at Week 68|Technical problems|0|||
105743047|NCT01544595|364712854|FG005|Status at Week 68|Technical problems|0|||
105743048|NCT01544595|364712849|FG000|Status at Week 68|Withdrawal by Subject|0|||
105743049|NCT01544595|364712850|FG001|Status at Week 68|Withdrawal by Subject|1|||
105743050|NCT01544595|364712851|FG002|Status at Week 68|Withdrawal by Subject|1|||
105743051|NCT01544595|364712852|FG003|Status at Week 68|Withdrawal by Subject|2|||
105743052|NCT01544595|364712853|FG004|Status at Week 68|Withdrawal by Subject|0|||
105743053|NCT01544595|364712854|FG005|Status at Week 68|Withdrawal by Subject|0|||
105743054|NCT01544595|364712849|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
105743055|NCT01544595|364712850|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
105743056|NCT01544595|364712851|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
105743057|NCT01544595|364712852|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
105743058|NCT01544595|364712853|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
105743059|NCT01544595|364712854|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
105743060|NCT01544595|364712849|FG000|Status at Week 156|Withdrawal by Subject|9|||
105743061|NCT01544595|364712850|FG001|Status at Week 156|Withdrawal by Subject|10|||
105743062|NCT01544595|364712851|FG002|Status at Week 156|Withdrawal by Subject|4|||
105743063|NCT01544595|364712852|FG003|Status at Week 156|Withdrawal by Subject|9|||
105743064|NCT01544595|364712853|FG004|Status at Week 156|Withdrawal by Subject|20|||
105743065|NCT01544595|364712854|FG005|Status at Week 156|Withdrawal by Subject|6|||
105743066|NCT01544595|364712849|FG000|Status at Week 156|Adverse Event|9|||
105743067|NCT01544595|364712850|FG001|Status at Week 156|Adverse Event|11|||
105743068|NCT01544595|364712851|FG002|Status at Week 156|Adverse Event|1|||
105743069|NCT01544595|364712852|FG003|Status at Week 156|Adverse Event|3|||
105743070|NCT01544595|364712853|FG004|Status at Week 156|Adverse Event|4|||
105743071|NCT01544595|364712854|FG005|Status at Week 156|Adverse Event|2|||
105743072|NCT01544595|364712849|FG000|Status at Week 156|Lost to Follow-up|4|||
105743073|NCT01544595|364712850|FG001|Status at Week 156|Lost to Follow-up|4|||
105743074|NCT01544595|364712851|FG002|Status at Week 156|Lost to Follow-up|0|||
105743075|NCT01544595|364712852|FG003|Status at Week 156|Lost to Follow-up|1|||
105743076|NCT01544595|364712853|FG004|Status at Week 156|Lost to Follow-up|4|||
105743077|NCT01544595|364712854|FG005|Status at Week 156|Lost to Follow-up|1|||
105743078|NCT01544595|364712849|FG000|Status at Week 156|Non-compliance with study treatement|0|||
105743079|NCT01544595|364712850|FG001|Status at Week 156|Non-compliance with study treatement|1|||
105743080|NCT01544595|364712851|FG002|Status at Week 156|Non-compliance with study treatement|0|||
105743081|NCT01544595|364712852|FG003|Status at Week 156|Non-compliance with study treatement|1|||
105743082|NCT01544595|364712853|FG004|Status at Week 156|Non-compliance with study treatement|0|||
105743083|NCT01544595|364712854|FG005|Status at Week 156|Non-compliance with study treatement|1|||
105743084|NCT01544595|364712849|FG000|Status at Week 156|Physician Decision|0|||
105743085|NCT01544595|364712850|FG001|Status at Week 156|Physician Decision|3|||
105743086|NCT01544595|364712851|FG002|Status at Week 156|Physician Decision|1|||
105743087|NCT01544595|364712852|FG003|Status at Week 156|Physician Decision|0|||
105743088|NCT01544595|364712853|FG004|Status at Week 156|Physician Decision|0|||
105743089|NCT01544595|364712854|FG005|Status at Week 156|Physician Decision|0|||
105743090|NCT01544595|364712849|FG000|Status at Week 156|Pregnancy|2|||
105743091|NCT01544595|364712850|FG001|Status at Week 156|Pregnancy|3|||
106015150|NCT03133793|365720983|FG001|Overall Study|Withdrawal by Subject|4|||
106015151|NCT03133793|365720984|FG002|Overall Study|Withdrawal by Subject|2|||
106015152|NCT03133793|365720985|FG003|Overall Study|Withdrawal by Subject|4|||
105743092|NCT01544595|364712851|FG002|Status at Week 156|Pregnancy|0|||
105743093|NCT01544595|364712852|FG003|Status at Week 156|Pregnancy|0|||
105743094|NCT01544595|364712853|FG004|Status at Week 156|Pregnancy|0|||
105743095|NCT01544595|364712854|FG005|Status at Week 156|Pregnancy|0|||
105743096|NCT01544595|364712849|FG000|Status at Week 156|Protocol Violation|3|||
105743097|NCT01544595|364712850|FG001|Status at Week 156|Protocol Violation|1|||
105743098|NCT01544595|364712851|FG002|Status at Week 156|Protocol Violation|2|||
105743099|NCT01544595|364712852|FG003|Status at Week 156|Protocol Violation|2|||
105743100|NCT01544595|364712853|FG004|Status at Week 156|Protocol Violation|0|||
105743101|NCT01544595|364712854|FG005|Status at Week 156|Protocol Violation|0|||
105743102|NCT01544595|364712849|FG000|Status at Week 156|Technical problems|3|||
105743103|NCT01544595|364712850|FG001|Status at Week 156|Technical problems|1|||
105743104|NCT01544595|364712851|FG002|Status at Week 156|Technical problems|0|||
105743105|NCT01544595|364712852|FG003|Status at Week 156|Technical problems|1|||
105743106|NCT01544595|364712853|FG004|Status at Week 156|Technical problems|0|||
105743107|NCT01544595|364712854|FG005|Status at Week 156|Technical problems|0|||
105743108|NCT01544595|364712849|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
105743109|NCT01544595|364712850|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
105743110|NCT01544595|364712851|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
105743111|NCT01544595|364712852|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
105743112|NCT01544595|364712853|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
105743113|NCT01544595|364712854|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
105743114|NCT01544595|364712849|FG000|Status at Week 156|Lack of Efficacy|1|||
105743115|NCT01544595|364712850|FG001|Status at Week 156|Lack of Efficacy|0|||
105743116|NCT01544595|364712851|FG002|Status at Week 156|Lack of Efficacy|1|||
105743117|NCT01544595|364712852|FG003|Status at Week 156|Lack of Efficacy|4|||
105743118|NCT01544595|364712853|FG004|Status at Week 156|Lack of Efficacy|10|||
105743119|NCT01544595|364712854|FG005|Status at Week 156|Lack of Efficacy|5|||
105743120|NCT01465178|364712858|FG000|Overall Study|Withdrawal by Subject|1|||
105743121|NCT01465178|364712859|FG001|Overall Study|Withdrawal by Subject|0|||
105743122|NCT04072146|364712864|FG000|Overall Study|Adverse Event|0|||
105743123|NCT04072146|364712865|FG001|Overall Study|Adverse Event|1|||
105743124|NCT01987986|364712866|FG000|Overall Study|Lost to Follow-up|1|||
105743125|NCT01987986|364712867|FG001|Overall Study|Lost to Follow-up|0|||
105743126|NCT01987986|364712868|FG002|Overall Study|Lost to Follow-up|0|||
105743127|NCT01987986|364712869|FG003|Overall Study|Lost to Follow-up|0|||
105743128|NCT01987986|364712866|FG000|Overall Study|Adverse Event|1|||
105743129|NCT01987986|364712867|FG001|Overall Study|Adverse Event|0|||
105743130|NCT01987986|364712868|FG002|Overall Study|Adverse Event|2|||
105743131|NCT01987986|364712869|FG003|Overall Study|Adverse Event|0|||
105743132|NCT01617434|364712870|FG000|Overall Study|Adverse Event|12|||
105743133|NCT01617434|364712871|FG001|Overall Study|Adverse Event|3|||
105743134|NCT01617434|364712870|FG000|Overall Study|Protocol Violation|8|||
105743135|NCT01617434|364712871|FG001|Overall Study|Protocol Violation|7|||
105743136|NCT01617434|364712870|FG000|Overall Study|Withdrawal Criteria|12|||
105942700|NCT02657343|365452837|FG005|Overall Study|Patient went to hospice|0|||
105942701|NCT02657343|365452832|FG000|Overall Study|Withdrawal by Subject|0|||
105942702|NCT02657343|365452833|FG001|Overall Study|Withdrawal by Subject|0|||
105942703|NCT02657343|365452834|FG002|Overall Study|Withdrawal by Subject|0|||
105942704|NCT02657343|365452835|FG003|Overall Study|Withdrawal by Subject|0|||
105942705|NCT02657343|365452836|FG004|Overall Study|Withdrawal by Subject|1|||
105942706|NCT02657343|365452837|FG005|Overall Study|Withdrawal by Subject|0|||
105942707|NCT02011542|365452838|FG000|Overall Study|Physician Decision|1|||
105942708|NCT00663260|365452840|FG000|Overall Study|Lack of Efficacy|2|||
105942709|NCT00663260|365452841|FG001|Overall Study|Lack of Efficacy|0|||
105942710|NCT00663260|365452842|FG002|Overall Study|Lack of Efficacy|0|||
105942711|NCT00663260|365452840|FG000|Overall Study|Adverse Event|12|||
105942712|NCT00663260|365452841|FG001|Overall Study|Adverse Event|7|||
105942713|NCT00663260|365452842|FG002|Overall Study|Adverse Event|6|||
105942714|NCT00663260|365452840|FG000|Overall Study|Withdrawal by Subject|3|||
105942715|NCT00663260|365452841|FG001|Overall Study|Withdrawal by Subject|1|||
105942716|NCT00663260|365452842|FG002|Overall Study|Withdrawal by Subject|6|||
105942717|NCT00663260|365452840|FG000|Overall Study|Death|1|||
105942718|NCT00663260|365452841|FG001|Overall Study|Death|0|||
105942719|NCT00663260|365452842|FG002|Overall Study|Death|1|||
105942720|NCT00663260|365452840|FG000|Overall Study|Lost to Follow-up|0|||
105942721|NCT00663260|365452841|FG001|Overall Study|Lost to Follow-up|1|||
105942722|NCT00663260|365452842|FG002|Overall Study|Lost to Follow-up|0|||
105942723|NCT00663260|365452840|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
105942724|NCT00663260|365452841|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
105942725|NCT00663260|365452842|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
105942726|NCT00980798|365452850|FG000|Overall Study|Adverse Event|7|||
105743137|NCT01617434|364712871|FG001|Overall Study|Withdrawal Criteria|37|||
105743138|NCT01617434|364712870|FG000|Overall Study|Unclassified|3|||
105743139|NCT01617434|364712871|FG001|Overall Study|Unclassified|4|||
105942727|NCT00980798|365452851|FG001|Overall Study|Adverse Event|36|||
106142214|NCT03383146|366179909|FG000|Overall Study|Screen Failure|1|||
106142215|NCT03383146|366179910|FG001|Overall Study|Screen Failure|0|||
105800245|NCT00830063|364926419|FG003|Overall Study|Lost to Follow-up|1|||
106142216|NCT03383146|366179909|FG000|Overall Study|Adverse Event|6|||
106142217|NCT03383146|366179910|FG001|Overall Study|Adverse Event|18|||
106142218|NCT03383146|366179909|FG000|Overall Study|Lack of Efficacy|0|||
106142219|NCT03383146|366179910|FG001|Overall Study|Lack of Efficacy|3|||
106142220|NCT03383146|366179909|FG000|Overall Study|Withdrawal by Subject|20|||
106142221|NCT03383146|366179910|FG001|Overall Study|Withdrawal by Subject|36|||
106142222|NCT03383146|366179909|FG000|Overall Study|Lost to Follow-up|5|||
105743140|NCT01431144|364714859|FG000|Overall Study|Implant mobility and removal|2|||
105743141|NCT01431144|364714860|FG001|Overall Study|Implant mobility and removal|0|||
105743142|NCT02279524|364714861|FG000|Overall Study|Withdrawal by Subject|3|||
105743143|NCT02279524|364714862|FG001|Overall Study|Withdrawal by Subject|6|||
105743144|NCT02279524|364714863|FG002|Overall Study|Withdrawal by Subject|3|||
105743145|NCT02279524|364714861|FG000|Overall Study|Adverse Event|4|||
105743146|NCT02279524|364714862|FG001|Overall Study|Adverse Event|3|||
105743147|NCT02279524|364714863|FG002|Overall Study|Adverse Event|2|||
105743148|NCT02279524|364714861|FG000|Overall Study|Lost to Follow-up|1|||
105743149|NCT02279524|364714862|FG001|Overall Study|Lost to Follow-up|1|||
105743150|NCT02279524|364714863|FG002|Overall Study|Lost to Follow-up|0|||
105743151|NCT02279524|364714861|FG000|Overall Study|Disallowed medication|1|||
105743152|NCT02279524|364714862|FG001|Overall Study|Disallowed medication|1|||
105743153|NCT02279524|364714863|FG002|Overall Study|Disallowed medication|2|||
105743154|NCT02279524|364714861|FG000|Overall Study|Bariatric surgery|1|||
105743155|NCT02279524|364714862|FG001|Overall Study|Bariatric surgery|0|||
105743156|NCT02279524|364714863|FG002|Overall Study|Bariatric surgery|0|||
105743157|NCT00074412|364714864|FG000|Overall Study|Death|30|||
105743158|NCT00074412|364714865|FG001|Overall Study|Death|26|||
105743159|NCT00074412|364714864|FG000|Overall Study|Lost to Follow-up|52|||
105743160|NCT00074412|364714865|FG001|Overall Study|Lost to Follow-up|58|||
105743161|NCT03509207|364714866|FG000|Overall Study|Death|2|||
105743162|NCT00418834|364714869|FG000|Overall Study|Adverse Event|16|||
105743163|NCT00418834|364714870|FG001|Overall Study|Adverse Event|9|||
105743164|NCT00418834|364714869|FG000|Overall Study|Lost to Follow-up|0|||
105743165|NCT00418834|364714870|FG001|Overall Study|Lost to Follow-up|1|||
105743166|NCT00418834|364714869|FG000|Overall Study|Protocol Violation|4|||
105743167|NCT00418834|364714870|FG001|Overall Study|Protocol Violation|3|||
105743168|NCT00418834|364714869|FG000|Overall Study|Withdrawal by Subject|3|||
105743169|NCT00418834|364714870|FG001|Overall Study|Withdrawal by Subject|7|||
105743170|NCT01953328|364714871|FG000|Overall Study|Withdrawal by Subject|0|||
105743171|NCT01953328|364714872|FG001|Overall Study|Withdrawal by Subject|0|||
105743172|NCT01953328|364714873|FG002|Overall Study|Withdrawal by Subject|0|||
105743173|NCT01953328|364714874|FG003|Overall Study|Withdrawal by Subject|0|||
105743174|NCT01953328|364714875|FG004|Overall Study|Withdrawal by Subject|1|||
105743175|NCT01953328|364714876|FG005|Overall Study|Withdrawal by Subject|0|||
105743176|NCT01953328|364714877|FG006|Overall Study|Withdrawal by Subject|0|||
105743177|NCT01953328|364714878|FG007|Overall Study|Withdrawal by Subject|0|||
105743178|NCT01953328|364714871|FG000|Overall Study|Lost to Follow-up|0|||
105743179|NCT01953328|364714872|FG001|Overall Study|Lost to Follow-up|0|||
105743180|NCT01953328|364714873|FG002|Overall Study|Lost to Follow-up|0|||
105743181|NCT01953328|364714874|FG003|Overall Study|Lost to Follow-up|0|||
105743182|NCT01953328|364714875|FG004|Overall Study|Lost to Follow-up|1|||
105743183|NCT01953328|364714876|FG005|Overall Study|Lost to Follow-up|0|||
105743184|NCT01953328|364714877|FG006|Overall Study|Lost to Follow-up|0|||
105743185|NCT01953328|364714878|FG007|Overall Study|Lost to Follow-up|0|||
105743186|NCT00492856|364714882|FG000|Induction|Adverse Event|2|||
105743187|NCT00492856|364714883|FG001|Induction|Adverse Event|0|||
105743188|NCT00492856|364714884|FG002|Induction|Adverse Event|0|||
105743189|NCT00492856|364714885|FG003|Induction|Adverse Event|0|||
105743190|NCT00492856|364714882|FG000|Induction|Withdrawal by Subject|1|||
105743191|NCT00492856|364714883|FG001|Induction|Withdrawal by Subject|0|||
105743192|NCT00492856|364714884|FG002|Induction|Withdrawal by Subject|0|||
105743193|NCT00492856|364714885|FG003|Induction|Withdrawal by Subject|0|||
105743194|NCT00492856|364714882|FG000|Induction|Death|3|||
105743195|NCT00492856|364714883|FG001|Induction|Death|0|||
105743196|NCT00492856|364714884|FG002|Induction|Death|0|||
105743197|NCT00492856|364714885|FG003|Induction|Death|0|||
105743198|NCT00492856|364714882|FG000|Consolidation|Adverse Event|6|||
105743199|NCT00492856|364714883|FG001|Consolidation|Adverse Event|0|||
105743200|NCT00492856|364714884|FG002|Consolidation|Adverse Event|0|||
105743201|NCT00492856|364714885|FG003|Consolidation|Adverse Event|0|||
105743202|NCT00492856|364714882|FG000|Consolidation|Not protocol specified|2|||
105743203|NCT00492856|364714883|FG001|Consolidation|Not protocol specified|0|||
106142223|NCT03383146|366179910|FG001|Overall Study|Lost to Follow-up|15|||
106142224|NCT03383146|366179909|FG000|Overall Study|Death|0|||
106142225|NCT03383146|366179910|FG001|Overall Study|Death|2|||
105743204|NCT00492856|364714884|FG002|Consolidation|Not protocol specified|0|||
106142226|NCT03383146|366179909|FG000|Overall Study|Physician Decision|0|||
105800246|NCT00830063|364926416|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
105743205|NCT00492856|364714885|FG003|Consolidation|Not protocol specified|0|||
105743206|NCT00492856|364714882|FG000|Consolidation|Lost to Follow-up|1|||
105743207|NCT00492856|364714883|FG001|Consolidation|Lost to Follow-up|0|||
105743208|NCT00492856|364714884|FG002|Consolidation|Lost to Follow-up|0|||
105743209|NCT00492856|364714885|FG003|Consolidation|Lost to Follow-up|0|||
105743210|NCT00492856|364714882|FG000|Post-consolidation|Adverse Event|0|||
105743211|NCT00492856|364714883|FG001|Post-consolidation|Adverse Event|4|||
105743212|NCT00492856|364714884|FG002|Post-consolidation|Adverse Event|0|||
105743213|NCT00492856|364714885|FG003|Post-consolidation|Adverse Event|1|||
105743214|NCT00492856|364714882|FG000|Post-consolidation|Withdrawal by Subject|0|||
105743215|NCT00492856|364714883|FG001|Post-consolidation|Withdrawal by Subject|4|||
105743216|NCT00492856|364714884|FG002|Post-consolidation|Withdrawal by Subject|0|||
105743217|NCT00492856|364714885|FG003|Post-consolidation|Withdrawal by Subject|0|||
105743218|NCT00492856|364714882|FG000|Post-consolidation|Death|0|||
105743219|NCT00492856|364714883|FG001|Post-consolidation|Death|1|||
105743220|NCT00492856|364714884|FG002|Post-consolidation|Death|0|||
105743221|NCT00492856|364714885|FG003|Post-consolidation|Death|0|||
105743222|NCT00492856|364714882|FG000|Post-consolidation|Not protocol specified|0|||
105743223|NCT00492856|364714883|FG001|Post-consolidation|Not protocol specified|1|||
105743224|NCT00492856|364714884|FG002|Post-consolidation|Not protocol specified|0|||
105743225|NCT00492856|364714885|FG003|Post-consolidation|Not protocol specified|0|||
105743226|NCT00492856|364714882|FG000|Post-consolidation|Lost to Follow-up|0|||
105743227|NCT00492856|364714883|FG001|Post-consolidation|Lost to Follow-up|2|||
105743228|NCT00492856|364714884|FG002|Post-consolidation|Lost to Follow-up|0|||
105743229|NCT00492856|364714885|FG003|Post-consolidation|Lost to Follow-up|0|||
105743230|NCT00492856|364714882|FG000|Post-consolidation|Observation Arm|0|||
105743231|NCT00492856|364714883|FG001|Post-consolidation|Observation Arm|0|||
105743232|NCT00492856|364714884|FG002|Post-consolidation|Observation Arm|27|||
105743233|NCT00492856|364714885|FG003|Post-consolidation|Observation Arm|0|||
105743234|NCT01520324|364714886|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
105743235|NCT02626819|364714887|FG000|Overall Study|Lost to Follow-up|3|||
105743236|NCT02626819|364714888|FG001|Overall Study|Lost to Follow-up|2|||
105743237|NCT02626819|364714887|FG000|Overall Study|Withdrawal by Subject|1|||
105743238|NCT02626819|364714888|FG001|Overall Study|Withdrawal by Subject|0|||
105743239|NCT02626819|364714887|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
105743240|NCT02626819|364714888|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
105743241|NCT02819310|364714889|FG000|Overall Study|Withdrawal by Subject|37|||
105743242|NCT02819310|364714889|FG000|Overall Study|Lost to Follow-up|16|||
105743243|NCT02819310|364714889|FG000|Overall Study|Adverse Event|13|||
105743244|NCT02819310|364714889|FG000|Overall Study|Lack of Efficacy|5|||
105743245|NCT02819310|364714889|FG000|Overall Study|Physician Decision|8|||
105743246|NCT02819310|364714889|FG000|Overall Study|Protocol Violation|30|||
105743247|NCT03488472|364714890|FG000|Overall Study|disease progression additional mets|1|||
105743248|NCT00028002|364714895|FG000|Overall Study|Withdrawal by Subject|3|||
105743249|NCT00028002|364714895|FG000|Overall Study|Ineligible|8|||
105743250|NCT01793051|364714896|FG000|Overall Study|Withdrawal by Subject|6|||
105743251|NCT01793051|364714897|FG001|Overall Study|Withdrawal by Subject|4|||
105743252|NCT01793051|364714896|FG000|Overall Study|Adverse Event|0|||
105743253|NCT01793051|364714897|FG001|Overall Study|Adverse Event|2|||
105743254|NCT01793051|364714896|FG000|Overall Study|Too ill to continue|1|||
105743255|NCT01793051|364714897|FG001|Overall Study|Too ill to continue|0|||
105743256|NCT01793051|364714896|FG000|Overall Study|Switched chemo|1|||
105743257|NCT01793051|364714897|FG001|Overall Study|Switched chemo|1|||
105743258|NCT01793051|364714896|FG000|Overall Study|Lack of compliance|1|||
105743259|NCT01793051|364714897|FG001|Overall Study|Lack of compliance|0|||
105743260|NCT01793051|364714896|FG000|Overall Study|Requested to be removed from the study|1|||
105743261|NCT01793051|364714897|FG001|Overall Study|Requested to be removed from the study|1|||
105743262|NCT01881620|364714898|FG000|Overall Study|Protocol Violation|4|||
105743263|NCT01808118|364714899|FG000|Period 1|Adverse Event|15|||
105743264|NCT01808118|364714900|FG001|Period 1|Adverse Event|0|||
105743265|NCT01808118|364714901|FG002|Period 1|Adverse Event|0|||
105743266|NCT01808118|364714899|FG000|Period 1|Withdrew consent|24|||
105743267|NCT01808118|364714900|FG001|Period 1|Withdrew consent|0|||
105743268|NCT01808118|364714901|FG002|Period 1|Withdrew consent|0|||
105743269|NCT01808118|364714899|FG000|Period 1|Lost to Follow-up|9|||
105743270|NCT01808118|364714900|FG001|Period 1|Lost to Follow-up|0|||
105800247|NCT00830063|364926417|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
105800248|NCT00830063|364926418|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
105800249|NCT00830063|364926419|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
105743271|NCT01808118|364714901|FG002|Period 1|Lost to Follow-up|0|||
105743272|NCT01808118|364714899|FG000|Period 1|Did not meet criteria for remission|303|||
105743273|NCT01808118|364714900|FG001|Period 1|Did not meet criteria for remission|0|||
105743274|NCT01808118|364714901|FG002|Period 1|Did not meet criteria for remission|0|||
105743275|NCT01808118|364714899|FG000|Period 1|Enrolled in error|7|||
105800250|NCT00830063|364926416|FG000|Overall Study|Lack of Efficacy|51|||
105743276|NCT01808118|364714900|FG001|Period 1|Enrolled in error|0|||
105743277|NCT01808118|364714901|FG002|Period 1|Enrolled in error|0|||
105743278|NCT01808118|364714899|FG000|Period 1|Did not meet inclusion criteria|3|||
105743279|NCT01808118|364714900|FG001|Period 1|Did not meet inclusion criteria|0|||
105743280|NCT01808118|364714901|FG002|Period 1|Did not meet inclusion criteria|0|||
105743281|NCT01808118|364714899|FG000|Period 1|Non-conformance with inclusion criteria|3|||
105743282|NCT01808118|364714900|FG001|Period 1|Non-conformance with inclusion criteria|0|||
105743283|NCT01808118|364714901|FG002|Period 1|Non-conformance with inclusion criteria|0|||
105743284|NCT01808118|364714899|FG000|Period 1|Investigator decision: site closure|2|||
105743285|NCT01808118|364714900|FG001|Period 1|Investigator decision: site closure|0|||
106015153|NCT03133793|365720982|FG000|Overall Study|Lost to Follow-up|1|||
106015154|NCT03133793|365720983|FG001|Overall Study|Lost to Follow-up|0|||
105743286|NCT01808118|364714901|FG002|Period 1|Investigator decision: site closure|0|||
106015155|NCT03133793|365720984|FG002|Overall Study|Lost to Follow-up|2|||
106015156|NCT03133793|365720985|FG003|Overall Study|Lost to Follow-up|0|||
106015157|NCT03133793|365720982|FG000|Overall Study|Death|0|||
105743287|NCT01808118|364714899|FG000|Period 1|Non-compliance per sponsor|1|||
105743288|NCT01808118|364714900|FG001|Period 1|Non-compliance per sponsor|0|||
105743289|NCT01808118|364714901|FG002|Period 1|Non-compliance per sponsor|0|||
105743290|NCT01808118|364714899|FG000|Period 1|Lack of Efficacy|1|||
105743291|NCT01808118|364714900|FG001|Period 1|Lack of Efficacy|0|||
105743292|NCT01808118|364714901|FG002|Period 1|Lack of Efficacy|0|||
105743293|NCT01808118|364714899|FG000|Period 2|Adverse Event|0|||
105743294|NCT01808118|364714900|FG001|Period 2|Adverse Event|4|||
105743295|NCT01808118|364714901|FG002|Period 2|Adverse Event|0|||
105743296|NCT01808118|364714899|FG000|Period 2|Withdrew consent|0|||
105743297|NCT01808118|364714900|FG001|Period 2|Withdrew consent|7|||
105743298|NCT01808118|364714901|FG002|Period 2|Withdrew consent|6|||
105743299|NCT01808118|364714899|FG000|Period 2|Lost to Follow-up|0|||
105743300|NCT01808118|364714900|FG001|Period 2|Lost to Follow-up|0|||
105743301|NCT01808118|364714901|FG002|Period 2|Lost to Follow-up|2|||
105743302|NCT01808118|364714899|FG000|Period 2|Investigator no longer conducting trials|0|||
105743303|NCT01808118|364714900|FG001|Period 2|Investigator no longer conducting trials|1|||
105743304|NCT01808118|364714901|FG002|Period 2|Investigator no longer conducting trials|0|||
105743305|NCT01808118|364714899|FG000|Period 2|Switched to other therapy|0|||
105743306|NCT01808118|364714900|FG001|Period 2|Switched to other therapy|1|||
105743307|NCT01808118|364714901|FG002|Period 2|Switched to other therapy|0|||
105743308|NCT01998581|364714903|FG000|Overall Study|Refused repeat treatment|20|||
105743309|NCT01998581|364714904|FG001|Overall Study|Refused repeat treatment|4|||
105743310|NCT01998581|364714903|FG000|Overall Study|Protocol Violation|1|||
105743311|NCT01998581|364714904|FG001|Overall Study|Protocol Violation|0|||
105743312|NCT01998581|364714903|FG000|Overall Study|Withdrawal by Subject|8|||
105743313|NCT01998581|364714904|FG001|Overall Study|Withdrawal by Subject|1|||
105743314|NCT01998581|364714903|FG000|Overall Study|Lost to Follow-up|12|||
105743315|NCT01998581|364714904|FG001|Overall Study|Lost to Follow-up|4|||
105743316|NCT01998581|364714903|FG000|Overall Study|Adverse Event|1|||
105743317|NCT01998581|364714904|FG001|Overall Study|Adverse Event|1|||
105743318|NCT01998581|364714903|FG000|Overall Study|Other reasons|3|||
105743319|NCT01998581|364714904|FG001|Overall Study|Other reasons|2|||
105743320|NCT01998581|364714903|FG000|Overall Study|Randomized but withdrew before treatment|1|||
105743321|NCT01998581|364714904|FG001|Overall Study|Randomized but withdrew before treatment|0|||
105743322|NCT02245568|364714905|FG000|Overall Study|Study terminated by Sponsor|346|||
105743323|NCT02245568|364714905|FG000|Overall Study|Adverse Event|144|||
105743324|NCT02245568|364714905|FG000|Overall Study|Lack of Efficacy|98|||
105743325|NCT02245568|364714905|FG000|Overall Study|Withdrawal by Caregiver|85|||
105743326|NCT02245568|364714905|FG000|Overall Study|Withdrawal by Subject|77|||
105743327|NCT02245568|364714905|FG000|Overall Study|Withdrawal by Legal Representative|31|||
105743328|NCT02245568|364714905|FG000|Overall Study|Missing (Site closure)|16|||
105743329|NCT02245568|364714905|FG000|Overall Study|Physician Decision|14|||
105743330|NCT02245568|364714905|FG000|Overall Study|Non-compliance with study drug|11|||
105743331|NCT02245568|364714905|FG000|Overall Study|Death|9|||
105743332|NCT02245568|364714905|FG000|Overall Study|Blue staining|6|||
105743333|NCT02245568|364714905|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
105743334|NCT02245568|364714905|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
105743335|NCT02245568|364714905|FG000|Overall Study|Lost to Follow-up|5|||
105743336|NCT02044159|364714907|FG000|Overall Study|Consent declined (deferred consent)|2|||
105743337|NCT02044159|364714908|FG001|Overall Study|Consent declined (deferred consent)|4|||
105743338|NCT02044159|364714907|FG000|Overall Study|No longer eligible, drug not given|1|||
105743339|NCT02044159|364714908|FG001|Overall Study|No longer eligible, drug not given|0|||
105743340|NCT02044159|364714907|FG000|Overall Study|Nurse declined to give study drug|1|||
105743341|NCT02044159|364714908|FG001|Overall Study|Nurse declined to give study drug|0|||
105743342|NCT00903032|364714909|FG000|Overall Study|Withdrawal by Subject|5|||
105743343|NCT00903032|364714910|FG001|Overall Study|Withdrawal by Subject|3|||
105743344|NCT00903032|364714909|FG000|Overall Study|Lost to Follow-up|2|||
105743345|NCT00903032|364714910|FG001|Overall Study|Lost to Follow-up|2|||
105743346|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
105800251|NCT00830063|364926417|FG001|Overall Study|Lack of Efficacy|23|||
106015158|NCT03133793|365720983|FG001|Overall Study|Death|0|||
106015159|NCT03133793|365720984|FG002|Overall Study|Death|0|||
105743347|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105743348|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105743349|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105743350|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
105743351|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
105743352|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105743353|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105743354|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105743355|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
105743356|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
105743357|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105743358|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105743359|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105743360|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
105743361|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
105743362|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
105743363|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
105743364|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
105743365|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
105743366|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
105743367|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
105743368|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
105743369|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
105743370|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
105743371|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
105743372|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
106015160|NCT03133793|365720985|FG003|Overall Study|Death|1|||
106015161|NCT02952820|365720986|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
106015162|NCT02952820|365720987|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
106015163|NCT02952820|365720988|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
106015164|NCT02952820|365720986|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
106015165|NCT02952820|365720987|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
106015166|NCT02952820|365720988|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
106015167|NCT02952820|365720986|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
106015168|NCT02952820|365720987|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
106015169|NCT02952820|365720988|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
106015170|NCT02952820|365720986|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
106015171|NCT02952820|365720987|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
106015172|NCT02952820|365720988|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
106015173|NCT02952820|365720986|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
106015174|NCT02952820|365720987|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
106015175|NCT02952820|365720988|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
106015176|NCT02952820|365720986|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
106015177|NCT02952820|365720987|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
106142227|NCT03383146|366179910|FG001|Overall Study|Physician Decision|1|||
106142228|NCT03383146|366179909|FG000|Overall Study|Protocol Deviation|1|||
106142229|NCT03383146|366179910|FG001|Overall Study|Protocol Deviation|8|||
106142230|NCT03383146|366179909|FG000|Overall Study|Study Terminated by the Sponsor|48|||
106142231|NCT03383146|366179910|FG001|Overall Study|Study Terminated by the Sponsor|95|||
106142232|NCT03383146|366179909|FG000|Overall Study|Reason not Specified|4|||
106142233|NCT03383146|366179910|FG001|Overall Study|Reason not Specified|6|||
105743373|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105743374|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
106142234|NCT03024606|366179911|FG000|Overall Study|Withdrawal by Subject|9|||
106142235|NCT03024606|366179912|FG001|Overall Study|Withdrawal by Subject|10|||
106142236|NCT00639002|366179919|FG000|Overall Study|Death|1|||
106142237|NCT00639002|366179919|FG000|Overall Study|Adverse Event|1|||
106142238|NCT00639002|366179919|FG000|Overall Study|Protocol Violation|1|||
106142239|NCT00639002|366179919|FG000|Overall Study|Disease progression|3|||
106142240|NCT00639002|366179919|FG000|Overall Study|Physician Decision|6|||
105743375|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
105743376|NCT01111539|364714911|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
105743377|NCT01111539|364714912|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
105743378|NCT01111539|364714913|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
105743379|NCT01111539|364714914|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
106015178|NCT02952820|365720988|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
106142241|NCT00639002|366179919|FG000|Overall Study|Lack of Efficacy|1|||
106142242|NCT05686421|366179923|FG000|Overall Study|Screen failure|22|||
105800252|NCT00830063|364926418|FG002|Overall Study|Lack of Efficacy|25|||
105800253|NCT00830063|364926419|FG003|Overall Study|Lack of Efficacy|32|||
105800254|NCT00830063|364926416|FG000|Overall Study|Other|5|||
105800255|NCT00830063|364926417|FG001|Overall Study|Other|5|||
105800256|NCT00830063|364926418|FG002|Overall Study|Other|8|||
105800257|NCT00830063|364926419|FG003|Overall Study|Other|6|||
105743380|NCT01111539|364714915|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
105743381|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105800258|NCT00830063|364926416|FG000|Overall Study|Withdrawal by Subject|16|||
105800259|NCT00830063|364926417|FG001|Overall Study|Withdrawal by Subject|10|||
105800260|NCT00830063|364926418|FG002|Overall Study|Withdrawal by Subject|16|||
105800261|NCT00830063|364926419|FG003|Overall Study|Withdrawal by Subject|13|||
105800262|NCT00830063|364926416|FG000|Overall Study|Protocol Violation|1|||
105800263|NCT00830063|364926417|FG001|Overall Study|Protocol Violation|0|||
105743382|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105743383|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
105743384|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
105743385|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
105743386|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105743387|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105743388|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
105743389|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
105743390|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
105743391|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
105800264|NCT00830063|364926418|FG002|Overall Study|Protocol Violation|3|||
105800265|NCT00830063|364926419|FG003|Overall Study|Protocol Violation|2|||
105800266|NCT00830063|364926416|FG000|Overall Study|Randomized But Not Treated|0|||
105800267|NCT00830063|364926417|FG001|Overall Study|Randomized But Not Treated|2|||
105800268|NCT00830063|364926418|FG002|Overall Study|Randomized But Not Treated|0|||
105800269|NCT00830063|364926419|FG003|Overall Study|Randomized But Not Treated|2|||
105743392|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
105743393|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
105743394|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
105743395|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
105743396|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
105743397|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
105800270|NCT00787566|364926420|FG000|Overall Study|AE related to chemotherapy|0|||
105800271|NCT00787566|364926421|FG001|Overall Study|AE related to chemotherapy|1|||
105800272|NCT00787566|364926422|FG002|Overall Study|AE related to chemotherapy|0|||
105800273|NCT02140164|364926423|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
105800274|NCT00686374|364926428|FG000|Overall Study|Lack of Efficacy|10|||
105800275|NCT00686374|364926428|FG000|Overall Study|Adverse Event|8|||
105800276|NCT00686374|364926428|FG000|Overall Study|Withdrew consent|5|||
105800277|NCT00686374|364926428|FG000|Overall Study|Lost to Follow-up|1|||
105800278|NCT00686374|364926428|FG000|Overall Study|Missing reason|33|||
105800279|NCT00686374|364926428|FG000|Overall Study|Other, not specified|4|||
105800280|NCT02853929|364926429|FG000|Overall Study|Lost to Follow-up|3|||
105800281|NCT02853929|364926430|FG001|Overall Study|Lost to Follow-up|0|||
105800282|NCT02853929|364926429|FG000|Overall Study|Withdrawal by Subject|1|||
105942728|NCT00980798|365452850|FG000|Overall Study|Lack of Efficacy|16|||
105942729|NCT00980798|365452851|FG001|Overall Study|Lack of Efficacy|5|||
105942730|NCT00980798|365452850|FG000|Overall Study|Lost to Follow-up|0|||
105942731|NCT00980798|365452851|FG001|Overall Study|Lost to Follow-up|1|||
105942732|NCT00980798|365452850|FG000|Overall Study|Physician Decision|2|||
105942733|NCT00980798|365452851|FG001|Overall Study|Physician Decision|1|||
105942734|NCT00980798|365452850|FG000|Overall Study|Withdrawal by Subject|8|||
105942735|NCT00980798|365452851|FG001|Overall Study|Withdrawal by Subject|11|||
105942736|NCT00980798|365452850|FG000|Overall Study|Other|0|||
105942737|NCT00980798|365452851|FG001|Overall Study|Other|1|||
105942738|NCT01491919|365452852|FG000|Overall Study|Insufficient PK sampling|1|||
105942739|NCT01491919|365452853|FG001|Overall Study|Insufficient PK sampling|2|||
105942740|NCT01491919|365452854|FG002|Overall Study|Insufficient PK sampling|1|||
105942741|NCT04724837|365452855|FG000|Overall Study|Other|4|||
105942742|NCT04724837|365452856|FG001|Overall Study|Other|16|||
105942743|NCT04724837|365452857|FG002|Overall Study|Other|0|||
105942744|NCT04724837|365452855|FG000|Overall Study|Withdrawal by Subject|2|||
105942745|NCT04724837|365452856|FG001|Overall Study|Withdrawal by Subject|9|||
105942746|NCT04724837|365452857|FG002|Overall Study|Withdrawal by Subject|9|||
105942747|NCT04724837|365452855|FG000|Overall Study|Adverse Event|2|||
105942748|NCT04724837|365452856|FG001|Overall Study|Adverse Event|7|||
105942749|NCT04724837|365452857|FG002|Overall Study|Adverse Event|4|||
105942750|NCT04724837|365452855|FG000|Overall Study|Lost to Follow-up|0|||
105942751|NCT04724837|365452856|FG001|Overall Study|Lost to Follow-up|1|||
105942752|NCT04724837|365452857|FG002|Overall Study|Lost to Follow-up|3|||
105942753|NCT04724837|365452855|FG000|Overall Study|Physician Decision|1|||
106015179|NCT02952820|365720986|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
106015180|NCT02952820|365720987|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
106015181|NCT02952820|365720988|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
106015182|NCT02952820|365720986|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
106015183|NCT02952820|365720987|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
106015184|NCT02952820|365720988|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
106015185|NCT02952820|365720986|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
106015186|NCT02952820|365720987|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
106015187|NCT02952820|365720988|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
106015188|NCT02952820|365720986|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
106015189|NCT02952820|365720987|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
106015190|NCT02952820|365720988|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
106015191|NCT02952820|365720986|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
106015192|NCT02952820|365720987|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
106015193|NCT02952820|365720988|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
106015194|NCT02952820|365720986|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
106015195|NCT02952820|365720987|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
106015196|NCT02952820|365720988|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
106015197|NCT02952820|365720986|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
106015198|NCT02952820|365720987|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
106015199|NCT02952820|365720988|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
106015200|NCT02952820|365720986|FG000|Active Treatment Period (6 Months)|Not treated|0|||
106015201|NCT02952820|365720987|FG001|Active Treatment Period (6 Months)|Not treated|0|||
106015202|NCT02952820|365720988|FG002|Active Treatment Period (6 Months)|Not treated|1|||
106015203|NCT01599637|365720989|FG000|Overall Study|administrative problems|0|||
105743398|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
105743399|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
105743400|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
105743401|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
105743402|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
105743403|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
105743404|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
105800283|NCT02853929|364926430|FG001|Overall Study|Withdrawal by Subject|0|||
105800284|NCT02853929|364926429|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
105800285|NCT02853929|364926430|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
105800286|NCT02770716|364926431|FG000|Overall Study|Death|101|||
105800287|NCT02770716|364926432|FG001|Overall Study|Death|45|||
105800288|NCT02770716|364926431|FG000|Overall Study|Withdrawal by Subject|4|||
105800289|NCT02770716|364926432|FG001|Overall Study|Withdrawal by Subject|2|||
105800290|NCT02770716|364926431|FG000|Overall Study|Lost to Follow-up|1|||
105800291|NCT02770716|364926432|FG001|Overall Study|Lost to Follow-up|0|||
105743405|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
105743406|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
105743407|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
105743408|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
105743409|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
105743410|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
105743411|NCT01111539|364714911|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105743412|NCT01111539|364714912|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105800292|NCT02770716|364926431|FG000|Overall Study|Various reasons|6|||
105800293|NCT02770716|364926432|FG001|Overall Study|Various reasons|2|||
105800294|NCT03568500|364926433|FG000|Overall Study|Lost to Follow-up|1|||
105800295|NCT03568500|364926434|FG001|Overall Study|Lost to Follow-up|1|||
105800296|NCT03568500|364926435|FG002|Overall Study|Lost to Follow-up|2|||
105800297|NCT03568500|364926433|FG000|Overall Study|Adverse Event|1|||
106015204|NCT01599637|365720990|FG001|Overall Study|administrative problems|2|||
106015205|NCT01599637|365720991|FG002|Overall Study|administrative problems|0|||
106015206|NCT01599637|365720989|FG000|Overall Study|Adverse Event|1|||
105800298|NCT03568500|364926434|FG001|Overall Study|Adverse Event|1|||
105800299|NCT03568500|364926435|FG002|Overall Study|Adverse Event|2|||
105800300|NCT03568500|364926433|FG000|Overall Study|Physician Decision|1|||
105800301|NCT03568500|364926434|FG001|Overall Study|Physician Decision|0|||
105800302|NCT03568500|364926435|FG002|Overall Study|Physician Decision|0|||
105800303|NCT03568500|364926433|FG000|Overall Study|Withdrawal by Subject|4|||
105800304|NCT03568500|364926434|FG001|Overall Study|Withdrawal by Subject|2|||
105800305|NCT03568500|364926435|FG002|Overall Study|Withdrawal by Subject|0|||
105800306|NCT03568500|364926433|FG000|Overall Study|Technical Problems|2|||
105800307|NCT03568500|364926434|FG001|Overall Study|Technical Problems|1|||
105800308|NCT03568500|364926435|FG002|Overall Study|Technical Problems|0|||
105800309|NCT03568500|364926433|FG000|Overall Study|Participant Noncompliance|1|||
105800310|NCT03568500|364926434|FG001|Overall Study|Participant Noncompliance|1|||
105800311|NCT03568500|364926435|FG002|Overall Study|Participant Noncompliance|0|||
105800312|NCT00827359|364926447|FG000|Overall Study|Progressive Diseas|19|||
105800313|NCT00827359|364926447|FG000|Overall Study|Unacceptable Toxicity|5|||
105800314|NCT00827359|364926447|FG000|Overall Study|Ineligible|1|||
105800315|NCT02059187|364926448|FG000|Overall Study|Adverse Event|0|||
105800316|NCT02059187|364926449|FG001|Overall Study|Adverse Event|3|||
105800317|NCT02059187|364926448|FG000|Overall Study|Death|1|||
105800318|NCT02059187|364926449|FG001|Overall Study|Death|1|||
105800319|NCT02059187|364926448|FG000|Overall Study|Lost to Follow-up|9|||
105800320|NCT02059187|364926449|FG001|Overall Study|Lost to Follow-up|8|||
105800321|NCT02059187|364926448|FG000|Overall Study|Non-compliance with study drug|1|||
105800322|NCT02059187|364926449|FG001|Overall Study|Non-compliance with study drug|0|||
105800323|NCT02059187|364926448|FG000|Overall Study|Physician Decision|1|||
105800324|NCT02059187|364926449|FG001|Overall Study|Physician Decision|2|||
105800325|NCT02059187|364926448|FG000|Overall Study|Protocol Violation|1|||
105800326|NCT02059187|364926449|FG001|Overall Study|Protocol Violation|0|||
105800327|NCT02059187|364926448|FG000|Overall Study|Withdrawal by Subject|12|||
105800328|NCT02059187|364926449|FG001|Overall Study|Withdrawal by Subject|8|||
105800329|NCT01889862|364926450|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
105800330|NCT01889862|364926451|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
105800331|NCT01889862|364926452|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
105800332|NCT01889862|364926453|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
105800333|NCT01889862|364926454|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
105800334|NCT01889862|364926450|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
105800335|NCT01889862|364926451|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
105800336|NCT01889862|364926452|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
105800337|NCT01889862|364926453|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
105800338|NCT01889862|364926454|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
105800339|NCT01889862|364926450|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
105800340|NCT01889862|364926451|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
105800341|NCT01889862|364926452|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
105800342|NCT01889862|364926453|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
105800343|NCT01889862|364926454|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
105800344|NCT01889862|364926450|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
105800345|NCT01889862|364926451|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
105800346|NCT01889862|364926452|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
105800347|NCT01889862|364926453|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
105800348|NCT01889862|364926454|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
105942754|NCT04724837|365452856|FG001|Overall Study|Physician Decision|2|||
105942755|NCT04724837|365452857|FG002|Overall Study|Physician Decision|0|||
105942756|NCT04724837|365452855|FG000|Overall Study|Death|0|||
105942757|NCT04724837|365452856|FG001|Overall Study|Death|0|||
105942758|NCT04724837|365452857|FG002|Overall Study|Death|1|||
105942759|NCT04724837|365452855|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
105942760|NCT04724837|365452856|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
105942761|NCT04724837|365452857|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
105942762|NCT04724837|365452855|FG000|Overall Study|Study Terminated by Sponsor|0|||
105942763|NCT04724837|365452856|FG001|Overall Study|Study Terminated by Sponsor|1|||
105942764|NCT04724837|365452857|FG002|Overall Study|Study Terminated by Sponsor|0|||
105942765|NCT00522379|365452858|FG000|Overall Study|Adverse Event|12|||
105942766|NCT00522379|365452859|FG001|Overall Study|Adverse Event|15|||
105942767|NCT00522379|365452860|FG002|Overall Study|Adverse Event|12|||
105942768|NCT00522379|365452861|FG003|Overall Study|Adverse Event|5|||
105800349|NCT01889862|364926450|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
105800350|NCT01889862|364926451|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
105800351|NCT01889862|364926452|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
105800352|NCT01889862|364926453|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
105800353|NCT01889862|364926454|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
105800354|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
105800355|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
105800356|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
105942769|NCT00522379|365452862|FG004|Overall Study|Adverse Event|17|||
105942770|NCT00522379|365452858|FG000|Overall Study|Lack of Efficacy|3|||
106015207|NCT01599637|365720990|FG001|Overall Study|Adverse Event|0|||
106015208|NCT01599637|365720991|FG002|Overall Study|Adverse Event|0|||
106015209|NCT00993967|365720993|FG000|Overall Study|Adverse Event|8|||
106015210|NCT00993967|365720993|FG000|Overall Study|Death|1|||
106015211|NCT00993967|365720993|FG000|Overall Study|Lost to Follow-up|14|||
106015212|NCT00993967|365720993|FG000|Overall Study|Withdrawal by Subject|36|||
106015213|NCT00993967|365720993|FG000|Overall Study|Protocol Violation|2|||
106015214|NCT00515619|365720994|FG000|Overall Study|Adverse Event|34|||
106015215|NCT00515619|365720994|FG000|Overall Study|Lack of Efficacy|92|||
106015216|NCT00515619|365720994|FG000|Overall Study|Withdrawal by Subject|66|||
106015217|NCT00515619|365720994|FG000|Overall Study|Protocol Violation|3|||
106015218|NCT00515619|365720994|FG000|Overall Study|Lost to Follow-up|4|||
106015219|NCT00515619|365720994|FG000|Overall Study|Unsatisfactory compliance|6|||
106015220|NCT00515619|365720994|FG000|Overall Study|Other: Site discontinuing trials|2|||
106015221|NCT00515619|365720994|FG000|Overall Study|Other: Subject cannot attend visits|2|||
106142243|NCT05686421|366179924|FG001|Overall Study|Screen failure|0|||
106142244|NCT05686421|366179925|FG002|Overall Study|Screen failure|0|||
106142245|NCT05686421|366179926|FG003|Overall Study|Screen failure|0|||
106142246|NCT00547118|366179934|FG000|Overall Study|Did not qualify prior to starting drug|1|||
106142247|NCT00547118|366179935|FG001|Overall Study|Did not qualify prior to starting drug|1|||
106142248|NCT00547118|366179934|FG000|Overall Study|Study suspended|7|||
106142249|NCT00547118|366179935|FG001|Overall Study|Study suspended|8|||
106142250|NCT03863834|366179936|FG000|Overall Study|Lost to Follow-up|3|||
106142251|NCT00361283|366179938|FG000|Overall Study|Lost to Follow-up|27|||
106142252|NCT00094575|366179939|FG000|Overall Study|Death|146|||
106142253|NCT00094575|366179940|FG001|Overall Study|Death|146|||
106142254|NCT02551055|366179947|FG000|Overall Study|Death|2|||
106142255|NCT02551055|366179948|FG001|Overall Study|Death|4|||
106142256|NCT02551055|366179949|FG002|Overall Study|Death|2|||
106142257|NCT02551055|366179950|FG003|Overall Study|Death|2|||
106142258|NCT02551055|366179951|FG004|Overall Study|Death|2|||
105942771|NCT00522379|365452859|FG001|Overall Study|Lack of Efficacy|0|||
105942772|NCT00522379|365452860|FG002|Overall Study|Lack of Efficacy|2|||
105942773|NCT00522379|365452861|FG003|Overall Study|Lack of Efficacy|2|||
105942774|NCT00522379|365452862|FG004|Overall Study|Lack of Efficacy|7|||
105942775|NCT00522379|365452858|FG000|Overall Study|Withdrawal by Subject|2|||
105942776|NCT00522379|365452859|FG001|Overall Study|Withdrawal by Subject|3|||
105942777|NCT00522379|365452860|FG002|Overall Study|Withdrawal by Subject|1|||
106015222|NCT00515619|365720994|FG000|Overall Study|Other: Subject required surgery|1|||
106015223|NCT00515619|365720994|FG000|Overall Study|Other: Subject moved to another country|1|||
106015224|NCT00515619|365720994|FG000|Overall Study|Other: Investigator decision|1|||
106142259|NCT02551055|366179952|FG005|Overall Study|Death|1|||
105942778|NCT00522379|365452861|FG003|Overall Study|Withdrawal by Subject|2|||
105942779|NCT00522379|365452862|FG004|Overall Study|Withdrawal by Subject|0|||
105942780|NCT00522379|365452858|FG000|Overall Study|Protocol Violation|1|||
106015225|NCT00515619|365720994|FG000|Overall Study|Other: Subject became pregnant|1|||
106015226|NCT00515619|365720994|FG000|Overall Study|Other: Request from sponsor|1|||
106015227|NCT00515619|365720994|FG000|Overall Study|Other: Drug available on license|1|||
106015228|NCT00515619|365720994|FG000|Overall Study|Other: Subject interested in other AED|1|||
106142260|NCT02551055|366179953|FG006|Overall Study|Death|2|||
106142261|NCT02551055|366179954|FG007|Overall Study|Death|0|||
106142262|NCT02551055|366179947|FG000|Overall Study|Study Terminated by Sponsor|1|||
106142263|NCT02551055|366179948|FG001|Overall Study|Study Terminated by Sponsor|1|||
106142264|NCT02551055|366179949|FG002|Overall Study|Study Terminated by Sponsor|0|||
106142265|NCT02551055|366179950|FG003|Overall Study|Study Terminated by Sponsor|2|||
106142266|NCT02551055|366179951|FG004|Overall Study|Study Terminated by Sponsor|2|||
106142267|NCT02551055|366179952|FG005|Overall Study|Study Terminated by Sponsor|0|||
106142268|NCT02551055|366179953|FG006|Overall Study|Study Terminated by Sponsor|0|||
106142269|NCT02551055|366179954|FG007|Overall Study|Study Terminated by Sponsor|0|||
106142270|NCT02551055|366179947|FG000|Overall Study|Withdrawal by Subject|1|||
106142271|NCT02551055|366179948|FG001|Overall Study|Withdrawal by Subject|1|||
106142272|NCT02551055|366179949|FG002|Overall Study|Withdrawal by Subject|0|||
106142273|NCT02551055|366179950|FG003|Overall Study|Withdrawal by Subject|1|||
106142274|NCT02551055|366179951|FG004|Overall Study|Withdrawal by Subject|2|||
106142275|NCT02551055|366179952|FG005|Overall Study|Withdrawal by Subject|0|||
106142276|NCT02551055|366179953|FG006|Overall Study|Withdrawal by Subject|0|||
106142277|NCT02551055|366179954|FG007|Overall Study|Withdrawal by Subject|0|||
106142278|NCT02551055|366179947|FG000|Overall Study|Reason not specified|0|||
105743413|NCT01111539|364714913|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105743414|NCT01111539|364714914|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
105743415|NCT01111539|364714915|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
105743416|NCT01984346|364714916|FG000|Overall Study|Physician Decision|4|||
105743417|NCT01984346|364714917|FG001|Overall Study|Physician Decision|2|||
105743418|NCT01984346|364714916|FG000|Overall Study|Withdrawal by Subject|2|||
105743419|NCT01984346|364714917|FG001|Overall Study|Withdrawal by Subject|2|||
105743420|NCT01984346|364714916|FG000|Overall Study|Enrollment Closed|8|||
105743421|NCT01984346|364714917|FG001|Overall Study|Enrollment Closed|1|||
105743422|NCT01984346|364714916|FG000|Overall Study|Insurance Coverage|1|||
105743423|NCT01984346|364714917|FG001|Overall Study|Insurance Coverage|0|||
105743424|NCT01984346|364714916|FG000|Overall Study|Intra-operative Exclusion|2|||
105743425|NCT01984346|364714917|FG001|Overall Study|Intra-operative Exclusion|0|||
105743426|NCT01876732|364714922|FG000|Overall Study|MMA was not over 800mg/dL|75|||
105743427|NCT00372190|364714923|FG000|Overall Study|Lost to Follow-up|3|||
105743428|NCT00372190|364714924|FG001|Overall Study|Lost to Follow-up|1|||
105743429|NCT05058664|364714929|FG000|Overall Study|No follow-up data provided|4|||
105743430|NCT05058664|364714930|FG001|Overall Study|No follow-up data provided|0|||
105743431|NCT05058664|364714931|FG002|Overall Study|No follow-up data provided|2|||
105743432|NCT05058664|364714929|FG000|Overall Study|Withdrawal by Subject|0|||
105743433|NCT05058664|364714930|FG001|Overall Study|Withdrawal by Subject|0|||
105743434|NCT05058664|364714931|FG002|Overall Study|Withdrawal by Subject|1|||
105743435|NCT01617681|364714932|FG000|Period 1 Double Blind|Adverse Event|2|||
105743436|NCT01617681|364714933|FG001|Period 1 Double Blind|Adverse Event|0|||
105743437|NCT01617681|364714934|FG002|Period 1 Double Blind|Adverse Event|0|||
105743438|NCT01617681|364714935|FG003|Period 1 Double Blind|Adverse Event|2|||
105743439|NCT01617681|364714936|FG004|Period 1 Double Blind|Adverse Event|0|||
105743440|NCT01617681|364714932|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
105743441|NCT01617681|364714933|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
105743442|NCT01617681|364714934|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
105743443|NCT01617681|364714935|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
105743444|NCT01617681|364714936|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
105743445|NCT01617681|364714932|FG000|Period 2 Open Label|Adverse Event|0|||
105743446|NCT01617681|364714933|FG001|Period 2 Open Label|Adverse Event|0|||
105743447|NCT01617681|364714934|FG002|Period 2 Open Label|Adverse Event|0|||
105743448|NCT01617681|364714935|FG003|Period 2 Open Label|Adverse Event|0|||
105743449|NCT01617681|364714936|FG004|Period 2 Open Label|Adverse Event|3|||
105743450|NCT01617681|364714932|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
105743451|NCT01617681|364714933|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
105743452|NCT01617681|364714934|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
105743453|NCT01617681|364714935|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
105743454|NCT01617681|364714936|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
105743455|NCT05131451|364714937|FG000|Overall Study|Protocol Violation|1|||
105743456|NCT05131451|364714938|FG001|Overall Study|Protocol Violation|0|||
105743457|NCT00972244|364714939|FG000|Overall Study|Incorrect Enrolment|1|||
105743458|NCT00972244|364714940|FG001|Overall Study|Incorrect Enrolment|0|||
105743459|NCT00972244|364714941|FG002|Overall Study|Incorrect Enrolment|0|||
105743460|NCT00972244|364714942|FG003|Overall Study|Incorrect Enrolment|0|||
106142279|NCT02551055|366179948|FG001|Overall Study|Reason not specified|0|||
105743461|NCT00972244|364714943|FG004|Overall Study|Incorrect Enrolment|0|||
105743462|NCT00972244|364714939|FG000|Overall Study|Adverse Event|0|||
105743463|NCT00972244|364714940|FG001|Overall Study|Adverse Event|1|||
105743464|NCT00972244|364714941|FG002|Overall Study|Adverse Event|1|||
105942781|NCT00522379|365452859|FG001|Overall Study|Protocol Violation|1|||
105743465|NCT00972244|364714942|FG003|Overall Study|Adverse Event|0|||
105743466|NCT00972244|364714943|FG004|Overall Study|Adverse Event|0|||
105743467|NCT00972244|364714939|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
105743468|NCT00972244|364714940|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
105743469|NCT00972244|364714941|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
106142280|NCT02551055|366179949|FG002|Overall Study|Reason not specified|0|||
106142281|NCT02551055|366179950|FG003|Overall Study|Reason not specified|0|||
106142282|NCT02551055|366179951|FG004|Overall Study|Reason not specified|1|||
105800357|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
105800358|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
105800359|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
105800360|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
105800361|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
105800362|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
105800363|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
105800364|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
105800365|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
105800366|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
105800367|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
105800368|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
105743470|NCT00972244|364714942|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
105743471|NCT00972244|364714943|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
105743472|NCT00972244|364714939|FG000|Overall Study|Withdrawal by Subject|1|||
105743473|NCT00972244|364714940|FG001|Overall Study|Withdrawal by Subject|2|||
105743474|NCT00972244|364714941|FG002|Overall Study|Withdrawal by Subject|1|||
105743475|NCT00972244|364714942|FG003|Overall Study|Withdrawal by Subject|0|||
105743476|NCT00972244|364714943|FG004|Overall Study|Withdrawal by Subject|1|||
105743477|NCT00972244|364714939|FG000|Overall Study|Safety|0|||
105743478|NCT00972244|364714940|FG001|Overall Study|Safety|0|||
105743479|NCT00972244|364714941|FG002|Overall Study|Safety|0|||
105743480|NCT00972244|364714942|FG003|Overall Study|Safety|0|||
105743481|NCT00972244|364714943|FG004|Overall Study|Safety|1|||
105743482|NCT00972244|364714939|FG000|Overall Study|Death|1|||
105743483|NCT00972244|364714940|FG001|Overall Study|Death|0|||
105743484|NCT00972244|364714941|FG002|Overall Study|Death|0|||
105743485|NCT00972244|364714942|FG003|Overall Study|Death|0|||
105743486|NCT00972244|364714943|FG004|Overall Study|Death|0|||
105743487|NCT00972244|364714939|FG000|Overall Study|Various|0|||
105743488|NCT00972244|364714940|FG001|Overall Study|Various|0|||
105743489|NCT00972244|364714941|FG002|Overall Study|Various|0|||
105743490|NCT00972244|364714942|FG003|Overall Study|Various|0|||
105743491|NCT00972244|364714943|FG004|Overall Study|Various|2|||
105942782|NCT00522379|365452860|FG002|Overall Study|Protocol Violation|2|||
105743492|NCT01856595|364714950|FG000|Overall Study|Withdrawal by Subject|0|||
105743493|NCT01856595|364714951|FG001|Overall Study|Withdrawal by Subject|1|||
105743494|NCT01856595|364714952|FG002|Overall Study|Withdrawal by Subject|0|||
105743495|NCT01856595|364714953|FG003|Overall Study|Withdrawal by Subject|0|||
105743496|NCT01856595|364714954|FG004|Overall Study|Withdrawal by Subject|0|||
105743497|NCT01856595|364714955|FG005|Overall Study|Withdrawal by Subject|0|||
105942783|NCT00522379|365452861|FG003|Overall Study|Protocol Violation|0|||
105942784|NCT00522379|365452862|FG004|Overall Study|Protocol Violation|0|||
105942785|NCT00522379|365452858|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
105942786|NCT00522379|365452859|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
105942787|NCT00522379|365452860|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
105942788|NCT00522379|365452861|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
105942789|NCT00522379|365452862|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
105942790|NCT00522379|365452858|FG000|Overall Study|Lost to Follow-up|1|||
105942791|NCT00522379|365452859|FG001|Overall Study|Lost to Follow-up|0|||
105942792|NCT00522379|365452860|FG002|Overall Study|Lost to Follow-up|4|||
105942793|NCT00522379|365452861|FG003|Overall Study|Lost to Follow-up|2|||
105942794|NCT00522379|365452862|FG004|Overall Study|Lost to Follow-up|2|||
105942795|NCT00522379|365452858|FG000|Overall Study|Randomization error|0|||
105942796|NCT00522379|365452859|FG001|Overall Study|Randomization error|0|||
105942797|NCT00522379|365452860|FG002|Overall Study|Randomization error|0|||
105942798|NCT00522379|365452861|FG003|Overall Study|Randomization error|0|||
105942799|NCT00522379|365452862|FG004|Overall Study|Randomization error|1|||
105942800|NCT00522379|365452858|FG000|Overall Study|Dispensing error|1|||
105942801|NCT00522379|365452859|FG001|Overall Study|Dispensing error|0|||
105942802|NCT00522379|365452860|FG002|Overall Study|Dispensing error|0|||
105942803|NCT00522379|365452861|FG003|Overall Study|Dispensing error|1|||
105942804|NCT00522379|365452862|FG004|Overall Study|Dispensing error|0|||
105942805|NCT00522379|365452858|FG000|Overall Study|Subject Moved|1|||
105942806|NCT00522379|365452859|FG001|Overall Study|Subject Moved|1|||
105942807|NCT00522379|365452860|FG002|Overall Study|Subject Moved|0|||
105942808|NCT00522379|365452861|FG003|Overall Study|Subject Moved|0|||
105942809|NCT00522379|365452862|FG004|Overall Study|Subject Moved|0|||
105942810|NCT00522379|365452858|FG000|Overall Study|Sponsor Request|0|||
105942811|NCT00522379|365452859|FG001|Overall Study|Sponsor Request|1|||
105942812|NCT00522379|365452860|FG002|Overall Study|Sponsor Request|0|||
105942813|NCT00522379|365452861|FG003|Overall Study|Sponsor Request|0|||
105942814|NCT00522379|365452862|FG004|Overall Study|Sponsor Request|0|||
105942815|NCT00522379|365452858|FG000|Overall Study|Family Problem|0|||
105942816|NCT00522379|365452859|FG001|Overall Study|Family Problem|0|||
105942817|NCT00522379|365452860|FG002|Overall Study|Family Problem|1|||
105942818|NCT00522379|365452861|FG003|Overall Study|Family Problem|0|||
105743498|NCT01856595|364714956|FG006|Overall Study|Withdrawal by Subject|1|||
105743499|NCT01856595|364714957|FG007|Overall Study|Withdrawal by Subject|0|||
105743500|NCT01856595|364714958|FG008|Overall Study|Withdrawal by Subject|0|||
105743501|NCT01763905|364714966|FG000|Overall Study|Withdrawal by Subject|1|||
105743502|NCT01763905|364714967|FG001|Overall Study|Withdrawal by Subject|1|||
105743503|NCT01763905|364714968|FG002|Overall Study|Withdrawal by Subject|0|||
105743504|NCT01763905|364714969|FG003|Overall Study|Withdrawal by Subject|1|||
105743505|NCT01763905|364714966|FG000|Overall Study|Decision by sponsor|5|||
105743506|NCT01763905|364714967|FG001|Overall Study|Decision by sponsor|0|||
105743507|NCT01763905|364714968|FG002|Overall Study|Decision by sponsor|8|||
105743508|NCT01763905|364714969|FG003|Overall Study|Decision by sponsor|0|||
105743509|NCT01763905|364714966|FG000|Overall Study|Lost to Follow-up|0|||
105743510|NCT01763905|364714967|FG001|Overall Study|Lost to Follow-up|0|||
105743511|NCT01763905|364714968|FG002|Overall Study|Lost to Follow-up|1|||
105743512|NCT01763905|364714969|FG003|Overall Study|Lost to Follow-up|0|||
105743513|NCT01327651|364714971|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
105743514|NCT01327651|364714972|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
105743515|NCT01327651|364714973|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
105743516|NCT01327651|364714974|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
105743517|NCT01327651|364714975|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
105743518|NCT01327651|364714976|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
105743519|NCT01327651|364714977|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
105743520|NCT01327651|364714978|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
105743521|NCT01327651|364714979|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
105743522|NCT01327651|364714971|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
105743523|NCT01327651|364714972|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743524|NCT01327651|364714973|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743525|NCT01327651|364714974|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743526|NCT01327651|364714975|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743527|NCT01327651|364714976|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743528|NCT01327651|364714977|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743529|NCT01327651|364714978|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743530|NCT01327651|364714979|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
105743531|NCT01327651|364714971|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
105743532|NCT01327651|364714972|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
105743533|NCT01327651|364714973|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
105743534|NCT01327651|364714974|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
105743535|NCT01327651|364714975|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
105743536|NCT01327651|364714976|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
105743537|NCT01327651|364714977|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
105743538|NCT01327651|364714978|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
105743539|NCT01327651|364714979|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
105743540|NCT01327651|364714971|FG000|Post Study Follow-up|Lost to Follow-up|0|||
105743541|NCT01327651|364714972|FG001|Post Study Follow-up|Lost to Follow-up|1|||
105743542|NCT01327651|364714973|FG002|Post Study Follow-up|Lost to Follow-up|1|||
105743543|NCT01327651|364714974|FG003|Post Study Follow-up|Lost to Follow-up|0|||
105743544|NCT01327651|364714975|FG004|Post Study Follow-up|Lost to Follow-up|0|||
105743545|NCT01327651|364714976|FG005|Post Study Follow-up|Lost to Follow-up|0|||
105743546|NCT01327651|364714977|FG006|Post Study Follow-up|Lost to Follow-up|4|||
105743547|NCT01327651|364714978|FG007|Post Study Follow-up|Lost to Follow-up|1|||
105743548|NCT01327651|364714979|FG008|Post Study Follow-up|Lost to Follow-up|2|||
105743549|NCT00995345|364714982|FG000|Overall Study|Withdrawal by Subject|4|||
105743550|NCT00995345|364714983|FG001|Overall Study|Withdrawal by Subject|2|||
105743551|NCT00995345|364714984|FG002|Overall Study|Withdrawal by Subject|1|||
105743552|NCT00995345|364714985|FG003|Overall Study|Withdrawal by Subject|3|||
105743553|NCT00995345|364714986|FG004|Overall Study|Withdrawal by Subject|1|||
105743554|NCT00995345|364714982|FG000|Overall Study|Adverse Event|3|||
105743555|NCT00995345|364714983|FG001|Overall Study|Adverse Event|1|||
105743556|NCT00995345|364714984|FG002|Overall Study|Adverse Event|2|||
105942819|NCT00522379|365452862|FG004|Overall Study|Family Problem|0|||
105942820|NCT00522379|365452858|FG000|Overall Study|Site Closed|0|||
105942821|NCT00522379|365452859|FG001|Overall Study|Site Closed|0|||
105743557|NCT00995345|364714985|FG003|Overall Study|Adverse Event|0|||
105743558|NCT00995345|364714986|FG004|Overall Study|Adverse Event|1|||
105743559|NCT00995345|364714982|FG000|Overall Study|Lost to Follow-up|2|||
105942822|NCT00522379|365452860|FG002|Overall Study|Site Closed|0|||
106142283|NCT02551055|366179952|FG005|Overall Study|Reason not specified|0|||
105743560|NCT00995345|364714983|FG001|Overall Study|Lost to Follow-up|2|||
105743561|NCT00995345|364714984|FG002|Overall Study|Lost to Follow-up|2|||
105743562|NCT00995345|364714985|FG003|Overall Study|Lost to Follow-up|1|||
105743563|NCT00995345|364714986|FG004|Overall Study|Lost to Follow-up|0|||
105743564|NCT00995345|364714982|FG000|Overall Study|all other reasons combined|2|||
105942823|NCT00522379|365452861|FG003|Overall Study|Site Closed|1|||
106015229|NCT03067077|365720995|FG000|Overall Study|Did not receive surgery|4|||
106015230|NCT03067077|365720996|FG001|Overall Study|Did not receive surgery|5|||
106015231|NCT03067077|365720995|FG000|Overall Study|Lost to Follow-up|3|||
106015232|NCT03067077|365720996|FG001|Overall Study|Lost to Follow-up|2|||
106015233|NCT02170077|365720997|FG000|Overall Study|Withdrawal by Subject|3|||
106015234|NCT02170077|365720998|FG001|Overall Study|Withdrawal by Subject|4|||
105743565|NCT00995345|364714983|FG001|Overall Study|all other reasons combined|2|||
105743566|NCT00995345|364714984|FG002|Overall Study|all other reasons combined|2|||
105743567|NCT00995345|364714985|FG003|Overall Study|all other reasons combined|1|||
105743568|NCT00995345|364714986|FG004|Overall Study|all other reasons combined|3|||
105743569|NCT01425190|364714989|FG000|Overall Study|Full dose not consumed.|1|||
105743570|NCT01425190|364714990|FG001|Overall Study|Full dose not consumed.|0|||
105743571|NCT01425190|364714991|FG002|Overall Study|Full dose not consumed.|0|||
105743572|NCT04285346|364714992|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
105743573|NCT04285346|364714993|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
105743574|NCT04285346|364714992|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
105743575|NCT04285346|364714993|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
105743576|NCT04285346|364714992|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
105743577|NCT04285346|364714993|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
105743578|NCT01975272|364714996|FG000|Overall Study|Excluded after protocol amendment|1|||
105743579|NCT01975272|364714997|FG001|Overall Study|Excluded after protocol amendment|1|||
105743580|NCT01975272|364714998|FG002|Overall Study|Excluded after protocol amendment|2|||
105743581|NCT00610935|364714999|FG000|Overall Study|Lost to Follow-up|0|||
105743582|NCT00610935|364715000|FG001|Overall Study|Lost to Follow-up|1|||
105743583|NCT00610935|364714999|FG000|Overall Study|Withdrawal by Subject|0|||
105743584|NCT00610935|364715000|FG001|Overall Study|Withdrawal by Subject|2|||
105743585|NCT00610935|364714999|FG000|Overall Study|Sponsor Discontinuation|1|||
105743586|NCT00610935|364715000|FG001|Overall Study|Sponsor Discontinuation|0|||
105743587|NCT01519245|364715001|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
105743588|NCT01519245|364715002|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
105743589|NCT00740779|364715003|FG000|Overall Study|Adverse Event|4|||
105743590|NCT00740779|364715004|FG001|Overall Study|Adverse Event|6|||
105743591|NCT00740779|364715005|FG002|Overall Study|Adverse Event|3|||
105743592|NCT00740779|364715003|FG000|Overall Study|Protocol Violation|1|||
105743593|NCT00740779|364715004|FG001|Overall Study|Protocol Violation|1|||
105743594|NCT00740779|364715005|FG002|Overall Study|Protocol Violation|1|||
105743595|NCT00740779|364715003|FG000|Overall Study|Lack of Efficacy|0|||
105743596|NCT00740779|364715004|FG001|Overall Study|Lack of Efficacy|0|||
105743597|NCT00740779|364715005|FG002|Overall Study|Lack of Efficacy|2|||
105743598|NCT00740779|364715003|FG000|Overall Study|Withdrawal by Subject|2|||
105743599|NCT00740779|364715004|FG001|Overall Study|Withdrawal by Subject|4|||
105743600|NCT00740779|364715005|FG002|Overall Study|Withdrawal by Subject|2|||
105743601|NCT00740779|364715003|FG000|Overall Study|Lost to Follow-up|2|||
105743602|NCT00740779|364715004|FG001|Overall Study|Lost to Follow-up|3|||
105743603|NCT00740779|364715005|FG002|Overall Study|Lost to Follow-up|5|||
105743604|NCT00850460|364715006|FG000|Overall Study|Lost to Follow-up|4|||
105743605|NCT00850460|364715007|FG001|Overall Study|Lost to Follow-up|4|||
105743606|NCT02203838|364715010|FG000|Overall Study|Lack of Efficacy|7|||
105743607|NCT02203838|364715011|FG001|Overall Study|Lack of Efficacy|0|||
105743608|NCT02203838|364715012|FG002|Overall Study|Lack of Efficacy|1|||
105743609|NCT02203838|364715013|FG003|Overall Study|Lack of Efficacy|1|||
105743610|NCT02203838|364715010|FG000|Overall Study|Adverse Event|46|||
105743611|NCT02203838|364715011|FG001|Overall Study|Adverse Event|6|||
105743612|NCT02203838|364715012|FG002|Overall Study|Adverse Event|3|||
105743613|NCT02203838|364715013|FG003|Overall Study|Adverse Event|2|||
105743614|NCT02203838|364715010|FG000|Overall Study|Lost to Follow-up|39|||
105743615|NCT02203838|364715011|FG001|Overall Study|Lost to Follow-up|3|||
105743616|NCT02203838|364715012|FG002|Overall Study|Lost to Follow-up|2|||
105743617|NCT02203838|364715013|FG003|Overall Study|Lost to Follow-up|1|||
105743618|NCT02203838|364715010|FG000|Overall Study|Protocol Violation|7|||
106015235|NCT02170077|365720999|FG002|Overall Study|Withdrawal by Subject|2|||
106015236|NCT02170077|365720997|FG000|Overall Study|Adverse Event|4|||
105800369|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
105800370|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
105800371|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
106015237|NCT02170077|365720998|FG001|Overall Study|Adverse Event|4|||
105743619|NCT02203838|364715011|FG001|Overall Study|Protocol Violation|3|||
105743620|NCT02203838|364715012|FG002|Overall Study|Protocol Violation|0|||
105743621|NCT02203838|364715013|FG003|Overall Study|Protocol Violation|0|||
105743622|NCT02203838|364715010|FG000|Overall Study|Withdrawal by Subject|83|||
105743623|NCT02203838|364715011|FG001|Overall Study|Withdrawal by Subject|10|||
105743624|NCT02203838|364715012|FG002|Overall Study|Withdrawal by Subject|8|||
105743625|NCT02203838|364715013|FG003|Overall Study|Withdrawal by Subject|11|||
105743626|NCT02203838|364715010|FG000|Overall Study|Physician Decision|27|||
106015238|NCT02170077|365720999|FG002|Overall Study|Adverse Event|4|||
106015239|NCT02170077|365720997|FG000|Overall Study|Lost to Follow-up|0|||
106015240|NCT02170077|365720998|FG001|Overall Study|Lost to Follow-up|1|||
105743627|NCT02203838|364715011|FG001|Overall Study|Physician Decision|0|||
106015241|NCT02170077|365720999|FG002|Overall Study|Lost to Follow-up|0|||
105743628|NCT02203838|364715012|FG002|Overall Study|Physician Decision|2|||
105743629|NCT02203838|364715013|FG003|Overall Study|Physician Decision|3|||
105743630|NCT02203838|364715010|FG000|Overall Study|Other|1|||
105743631|NCT02203838|364715011|FG001|Overall Study|Other|0|||
105743632|NCT02203838|364715012|FG002|Overall Study|Other|0|||
105743633|NCT02203838|364715013|FG003|Overall Study|Other|0|||
105743634|NCT04590937|364715014|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
105743635|NCT01635933|364715015|FG000|Overall Study|Adverse Event|1|||
105743636|NCT01635933|364715016|FG001|Overall Study|Adverse Event|0|||
105743637|NCT01635933|364715015|FG000|Overall Study|Lost to Follow-up|0|||
105743638|NCT01635933|364715016|FG001|Overall Study|Lost to Follow-up|5|||
105743639|NCT01635933|364715015|FG000|Overall Study|Subject decision|1|||
105743640|NCT01635933|364715016|FG001|Overall Study|Subject decision|1|||
105743641|NCT01635933|364715015|FG000|Overall Study|Noncompliance|0|||
105743642|NCT01635933|364715016|FG001|Overall Study|Noncompliance|1|||
105743643|NCT01635933|364715015|FG000|Overall Study|No longer had transportation|0|||
105743644|NCT01635933|364715016|FG001|Overall Study|No longer had transportation|1|||
105743645|NCT01555463|364715021|FG000|Treatment|Adverse Event|6|||
105743646|NCT01555463|364715022|FG001|Treatment|Adverse Event|12|||
105743647|NCT01555463|364715021|FG000|Treatment|Withdrawal by Subject|24|||
105743648|NCT01555463|364715022|FG001|Treatment|Withdrawal by Subject|36|||
105743649|NCT01555463|364715021|FG000|Treatment|Lost to Follow-up|28|||
105743650|NCT01555463|364715022|FG001|Treatment|Lost to Follow-up|23|||
105743651|NCT01555463|364715021|FG000|Treatment|Protocol Violation|4|||
105743652|NCT01555463|364715022|FG001|Treatment|Protocol Violation|5|||
105743653|NCT01555463|364715021|FG000|Treatment|Other reason|2|||
105743654|NCT01555463|364715022|FG001|Treatment|Other reason|3|||
105743655|NCT01555463|364715021|FG000|Follow up|Adverse Event|2|||
105743656|NCT01555463|364715022|FG001|Follow up|Adverse Event|5|||
105743657|NCT01555463|364715021|FG000|Follow up|Death|0|||
105743658|NCT01555463|364715022|FG001|Follow up|Death|1|||
105743659|NCT01555463|364715021|FG000|Follow up|Withdrawal by Subject|22|||
105743660|NCT01555463|364715022|FG001|Follow up|Withdrawal by Subject|22|||
105743661|NCT01555463|364715021|FG000|Follow up|Lost to Follow-up|9|||
105743662|NCT01555463|364715022|FG001|Follow up|Lost to Follow-up|10|||
105743663|NCT01555463|364715021|FG000|Follow up|Protocol Violation|2|||
105743664|NCT01555463|364715022|FG001|Follow up|Protocol Violation|4|||
105743665|NCT01555463|364715021|FG000|Follow up|Other reason|3|||
105743666|NCT01555463|364715022|FG001|Follow up|Other reason|3|||
105743667|NCT00320385|364715024|FG000|Overall Study|Lost to Follow-up|7|||
105743668|NCT00320385|364715025|FG001|Overall Study|Lost to Follow-up|10|||
105743669|NCT00320385|364715024|FG000|Overall Study|Withdrawal by Subject|6|||
105743670|NCT00320385|364715025|FG001|Overall Study|Withdrawal by Subject|7|||
105743671|NCT00320385|364715024|FG000|Overall Study|Sponsor Terminated Study|2|||
105743672|NCT00320385|364715025|FG001|Overall Study|Sponsor Terminated Study|1|||
105743673|NCT00320385|364715024|FG000|Overall Study|Investigator Decision|0|||
105743674|NCT00320385|364715025|FG001|Overall Study|Investigator Decision|1|||
105743675|NCT00320385|364715024|FG000|Overall Study|Death|1|||
105743676|NCT00320385|364715025|FG001|Overall Study|Death|2|||
105743677|NCT00320385|364715024|FG000|Overall Study|Serious Adverse Event|1|||
105743678|NCT00320385|364715025|FG001|Overall Study|Serious Adverse Event|0|||
105743679|NCT00320385|364715024|FG000|Overall Study|Withdrew Consent|1|||
105743680|NCT00320385|364715025|FG001|Overall Study|Withdrew Consent|0|||
105743681|NCT00320385|364715024|FG000|Overall Study|Adverse Event|0|||
105743682|NCT00320385|364715025|FG001|Overall Study|Adverse Event|1|||
105743683|NCT04370028|364715026|FG000|Overall Study|Withdrawal by Subject|695|||
105743684|NCT04370028|364715026|FG000|Overall Study|Protocol Violation|9|||
105743685|NCT04370028|364715026|FG000|Overall Study|Adverse Event|3|||
105743686|NCT00222729|364715027|FG000|Overall Study|Adverse Event|3|||
105743687|NCT02213198|364715032|FG000|Baseline|No show for intake|7|||
105743688|NCT02213198|364715033|FG001|Baseline|No show for intake|9|||
105743689|NCT02213198|364715032|FG000|Baseline|Withdrawal by Subject|34|||
105743690|NCT02213198|364715033|FG001|Baseline|Withdrawal by Subject|11|||
105743691|NCT02213198|364715032|FG000|Baseline|transferred out of clinic|7|||
105743692|NCT02213198|364715033|FG001|Baseline|transferred out of clinic|9|||
105743693|NCT02213198|364715032|FG000|Baseline|Lost to Follow-up|40|||
105743694|NCT02213198|364715033|FG001|Baseline|Lost to Follow-up|21|||
105743695|NCT02213198|364715032|FG000|Baseline|incarcerated,violent|0|||
105743696|NCT02213198|364715033|FG001|Baseline|incarcerated,violent|1|||
105743697|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
105743698|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
105743699|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
105743700|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
105743701|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
105743702|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
105743703|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
105743704|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
105743705|NCT02213198|364715032|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
105743706|NCT02213198|364715033|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
105743707|NCT02213198|364715032|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
105743708|NCT02213198|364715033|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
105743709|NCT03135028|364715034|FG000|Overall Study|Death|6|||
105743710|NCT03135028|364715034|FG000|Overall Study|Study Terminated by Sponsor|2|||
105743711|NCT03135028|364715034|FG000|Overall Study|Withdrew Consent|1|||
105743712|NCT02379923|364715038|FG000|Overall Study|Death|5|||
105743713|NCT03844633|364715039|FG000|1 Week FU|Lost to Follow-up|0|||
105743714|NCT03844633|364715040|FG001|1 Week FU|Lost to Follow-up|1|||
105743715|NCT03844633|364715041|FG002|1 Week FU|Lost to Follow-up|4|||
105743716|NCT03844633|364715039|FG000|12-month Follow-up|Lost to Follow-up|7|||
105743717|NCT03844633|364715040|FG001|12-month Follow-up|Lost to Follow-up|5|||
105743718|NCT03844633|364715041|FG002|12-month Follow-up|Lost to Follow-up|8|||
105743719|NCT05896761|364715042|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
105743720|NCT05896761|364715043|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
105743721|NCT05896761|364715042|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
105743722|NCT05896761|364715043|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
105743723|NCT03552549|364715044|FG000|Overall Study|Disease progression|25|||
105743724|NCT03552549|364715045|FG001|Overall Study|Disease progression|17|||
105743725|NCT03552549|364715044|FG000|Overall Study|Adverse event in first 12 months|12|||
105743726|NCT03552549|364715045|FG001|Overall Study|Adverse event in first 12 months|8|||
105743727|NCT03552549|364715044|FG000|Overall Study|Withdrawal by Subject|7|||
105743728|NCT03552549|364715045|FG001|Overall Study|Withdrawal by Subject|7|||
105743729|NCT03552549|364715044|FG000|Overall Study|Unknown (no reason provided)|4|||
105743730|NCT03552549|364715045|FG001|Overall Study|Unknown (no reason provided)|2|||
105743731|NCT03552549|364715044|FG000|Overall Study|Not in participant's best interest|2|||
105743732|NCT03552549|364715045|FG001|Overall Study|Not in participant's best interest|1|||
105743733|NCT03552549|364715044|FG000|Overall Study|Did not complete study treatment|2|||
105743734|NCT03552549|364715045|FG001|Overall Study|Did not complete study treatment|3|||
105743735|NCT03552549|364715044|FG000|Overall Study|Did not meet eligibility criteria|1|||
105743736|NCT03552549|364715045|FG001|Overall Study|Did not meet eligibility criteria|0|||
105743737|NCT03552549|364715044|FG000|Overall Study|Administrative|0|||
105743738|NCT03552549|364715045|FG001|Overall Study|Administrative|14|||
105743739|NCT03288779|364715046|FG000|Overall Study|Withdrawal by Subject|3|||
105743740|NCT01355068|364715047|FG000|First Intervention Period|Adverse Event|0|||
105743741|NCT01355068|364715048|FG001|First Intervention Period|Adverse Event|1|||
105743742|NCT01355068|364715047|FG000|First Intervention Period|Withdrawal by Subject|0|||
105743743|NCT01355068|364715048|FG001|First Intervention Period|Withdrawal by Subject|1|||
105743744|NCT00524745|364715049|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
105743745|NCT00524745|364715050|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
105743746|NCT00524745|364715051|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
105743747|NCT00524745|364715052|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
105743748|NCT00540449|364715053|FG000|Overall Study|Adverse Event|12|||
105743749|NCT00540449|364715054|FG001|Overall Study|Adverse Event|32|||
105743750|NCT00540449|364715053|FG000|Overall Study|Sponsor's Decision|1|||
105743751|NCT00540449|364715054|FG001|Overall Study|Sponsor's Decision|1|||
105743752|NCT00540449|364715053|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
105743753|NCT00540449|364715054|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
105743754|NCT00540449|364715053|FG000|Overall Study|Lost to Follow-up|19|||
105743755|NCT00540449|364715054|FG001|Overall Study|Lost to Follow-up|17|||
105743756|NCT00540449|364715053|FG000|Overall Study|Subject Non-Compliant|7|||
105743757|NCT00540449|364715054|FG001|Overall Study|Subject Non-Compliant|5|||
105743758|NCT00540449|364715053|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
105743759|NCT00540449|364715054|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
105743760|NCT00540449|364715053|FG000|Overall Study|Withdrawal by Subject|10|||
105743761|NCT00540449|364715054|FG001|Overall Study|Withdrawal by Subject|10|||
105743762|NCT00540449|364715053|FG000|Overall Study|Other|1|||
105743763|NCT00540449|364715054|FG001|Overall Study|Other|4|||
105743764|NCT00601523|364715055|FG000|Overall Study|Adverse Event|42|||
105743765|NCT00601523|364715056|FG001|Overall Study|Adverse Event|14|||
105743766|NCT00601523|364715055|FG000|Overall Study|Lack of Efficacy|3|||
105743767|NCT00601523|364715056|FG001|Overall Study|Lack of Efficacy|0|||
105743768|NCT00601523|364715055|FG000|Overall Study|Protocol Violation|5|||
105743769|NCT00601523|364715056|FG001|Overall Study|Protocol Violation|1|||
105743770|NCT00601523|364715055|FG000|Overall Study|Lost to Follow-up|0|||
105743771|NCT00601523|364715056|FG001|Overall Study|Lost to Follow-up|1|||
105743772|NCT00601523|364715055|FG000|Overall Study|Withdrawal by Subject|18|||
105743773|NCT00601523|364715056|FG001|Overall Study|Withdrawal by Subject|9|||
105743774|NCT00601523|364715055|FG000|Overall Study|Other|9|||
105743775|NCT00601523|364715056|FG001|Overall Study|Other|1|||
105743776|NCT03643432|364715057|FG000|Overall Study|Lost to Follow-up|1|||
105743777|NCT03643432|364715058|FG001|Overall Study|Lost to Follow-up|0|||
106015242|NCT02170077|365720997|FG000|Overall Study|Exclusion criteria|2|||
106015243|NCT02170077|365720998|FG001|Overall Study|Exclusion criteria|2|||
106015244|NCT02170077|365720999|FG002|Overall Study|Exclusion criteria|5|||
106015245|NCT02170077|365720997|FG000|Overall Study|Exacerbation of seizures|0|||
106015246|NCT02170077|365720998|FG001|Overall Study|Exacerbation of seizures|2|||
106015247|NCT02170077|365720999|FG002|Overall Study|Exacerbation of seizures|1|||
106015248|NCT01958164|365721000|FG000|Overall Study|Adverse Event|0|||
106015249|NCT01958164|365721001|FG001|Overall Study|Adverse Event|2|||
106015250|NCT01958164|365721000|FG000|Overall Study|Lost to Follow-up|2|||
106015251|NCT01958164|365721001|FG001|Overall Study|Lost to Follow-up|3|||
106015252|NCT02963506|365721007|FG000|Double-Blind Period|Adverse Event|0|||
106015253|NCT02963506|365721008|FG001|Double-Blind Period|Adverse Event|0|||
106015254|NCT02963506|365721009|FG002|Double-Blind Period|Adverse Event|1|||
106015255|NCT02963506|365721010|FG003|Double-Blind Period|Adverse Event|0|||
106015256|NCT02963506|365721011|FG004|Double-Blind Period|Adverse Event|0|||
106015257|NCT02963506|365721012|FG005|Double-Blind Period|Adverse Event|0|||
105743778|NCT00953043|364716786|FG000|Overall Study|Withdrawal by Subject|4|||
105743779|NCT00953043|364716787|FG001|Overall Study|Withdrawal by Subject|0|||
105743780|NCT00953043|364716786|FG000|Overall Study|Physician Decision|0|||
105743781|NCT00953043|364716787|FG001|Overall Study|Physician Decision|2|||
105743782|NCT01251276|364716791|FG000|Overall Study|Protocol Violation|1|||
105743783|NCT01251276|364716792|FG001|Overall Study|Protocol Violation|0|||
105743784|NCT01251276|364716791|FG000|Overall Study|Lost to Follow-up|0|||
105743785|NCT01251276|364716792|FG001|Overall Study|Lost to Follow-up|1|||
105743786|NCT01345123|364716793|FG000|Overall Study|participants no longer with health plan|79|||
105743787|NCT01345123|364716794|FG001|Overall Study|participants no longer with health plan|85|||
105743788|NCT01345123|364716795|FG002|Overall Study|participants no longer with health plan|88|||
105743789|NCT03703375|364716796|FG000|Randomization Period|Withdrawal by Subject|0|||
105743790|NCT03703375|364716797|FG001|Randomization Period|Withdrawal by Subject|0|||
105743791|NCT03703375|364716798|FG002|Randomization Period|Withdrawal by Subject|0|||
105743792|NCT03703375|364716799|FG003|Randomization Period|Withdrawal by Subject|1|||
105743793|NCT03703375|364716796|FG000|Randomization Period|Completed safety run-in treatment|7|||
105743794|NCT03703375|364716797|FG001|Randomization Period|Completed safety run-in treatment|0|||
105743795|NCT03703375|364716798|FG002|Randomization Period|Completed safety run-in treatment|0|||
105743796|NCT03703375|364716799|FG003|Randomization Period|Completed safety run-in treatment|0|||
105743797|NCT03703375|364716796|FG000|Treatment Period|Other Reasons|0|||
105743798|NCT03703375|364716797|FG001|Treatment Period|Other Reasons|1|||
105743799|NCT03703375|364716798|FG002|Treatment Period|Other Reasons|0|||
105743800|NCT03703375|364716799|FG003|Treatment Period|Other Reasons|3|||
105743801|NCT03703375|364716796|FG000|Treatment Period|Consent Withdrawal|0|||
105743802|NCT03703375|364716797|FG001|Treatment Period|Consent Withdrawal|0|||
105743803|NCT03703375|364716798|FG002|Treatment Period|Consent Withdrawal|0|||
105743804|NCT03703375|364716799|FG003|Treatment Period|Consent Withdrawal|1|||
105743805|NCT03703375|364716796|FG000|Treatment Period|Death|1|||
105743806|NCT03703375|364716797|FG001|Treatment Period|Death|0|||
105743807|NCT03703375|364716798|FG002|Treatment Period|Death|1|||
105743808|NCT03703375|364716799|FG003|Treatment Period|Death|2|||
105743809|NCT03703375|364716796|FG000|Treatment Period|Toxicity of Study Treatment|2|||
105743810|NCT03703375|364716797|FG001|Treatment Period|Toxicity of Study Treatment|0|||
105743811|NCT03703375|364716798|FG002|Treatment Period|Toxicity of Study Treatment|4|||
105743812|NCT03703375|364716799|FG003|Treatment Period|Toxicity of Study Treatment|1|||
105743813|NCT03703375|364716796|FG000|Treatment Period|Progression|32|||
105743814|NCT03703375|364716797|FG001|Treatment Period|Progression|1|||
105743815|NCT03703375|364716798|FG002|Treatment Period|Progression|7|||
105743816|NCT03703375|364716799|FG003|Treatment Period|Progression|11|||
105743817|NCT03703375|364716796|FG000|Treatment Period|Completed treatment|7|||
105743818|NCT03703375|364716797|FG001|Treatment Period|Completed treatment|2|||
105743819|NCT03703375|364716798|FG002|Treatment Period|Completed treatment|0|||
105743820|NCT03703375|364716799|FG003|Treatment Period|Completed treatment|0|||
105743821|NCT00625365|364716801|FG000|Overall Study|Withdrawal by Subject|1|||
105743822|NCT00625365|364716801|FG000|Overall Study|No IV access|5|||
105743823|NCT00625365|364716801|FG000|Overall Study|VSD|1|||
106015258|NCT02963506|365721013|FG006|Double-Blind Period|Adverse Event|0|||
105800372|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
105800373|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
106015259|NCT02963506|365721014|FG007|Double-Blind Period|Adverse Event|0|||
106142284|NCT02551055|366179953|FG006|Overall Study|Reason not specified|1|||
105743824|NCT00366548|364716802|FG000|Infant Series|Adverse Event|1|||
105743825|NCT00366548|364716803|FG001|Infant Series|Adverse Event|3|||
105743826|NCT00366548|364716802|FG000|Infant Series|Protocol Violation|0|||
105743827|NCT00366548|364716803|FG001|Infant Series|Protocol Violation|1|||
105743828|NCT00366548|364716802|FG000|Infant Series|Withdrawal by Subject|3|||
105743829|NCT00366548|364716803|FG001|Infant Series|Withdrawal by Subject|1|||
106015260|NCT02963506|365721015|FG008|Double-Blind Period|Adverse Event|0|||
106015261|NCT02963506|365721016|FG009|Double-Blind Period|Adverse Event|0|||
106015262|NCT02963506|365721017|FG010|Double-Blind Period|Adverse Event|0|||
106015263|NCT02963506|365721018|FG011|Double-Blind Period|Adverse Event|0|||
106142285|NCT02551055|366179954|FG007|Overall Study|Reason not specified|0|||
106015264|NCT02963506|365721019|FG012|Double-Blind Period|Adverse Event|0|||
106015265|NCT02963506|365721007|FG000|Double-Blind Period|Death|0|||
106015266|NCT02963506|365721008|FG001|Double-Blind Period|Death|0|||
106015267|NCT02963506|365721009|FG002|Double-Blind Period|Death|0|||
106015268|NCT02963506|365721010|FG003|Double-Blind Period|Death|1|||
106015269|NCT02963506|365721011|FG004|Double-Blind Period|Death|0|||
106015270|NCT02963506|365721012|FG005|Double-Blind Period|Death|0|||
106015271|NCT02963506|365721013|FG006|Double-Blind Period|Death|0|||
105743830|NCT00366548|364716802|FG000|After Infant Series|Withdrawal by Subject|3|||
105743831|NCT00366548|364716803|FG001|After Infant Series|Withdrawal by Subject|1|||
105743832|NCT00366548|364716802|FG000|After Infant Series|Adverse Event|2|||
105743833|NCT00366548|364716803|FG001|After Infant Series|Adverse Event|0|||
105743834|NCT00366548|364716802|FG000|After Infant Series|Lost to Follow-up|1|||
105743835|NCT00366548|364716803|FG001|After Infant Series|Lost to Follow-up|0|||
105743836|NCT02849990|364716804|FG000|Overall Study|Adverse Event|1|||
105743837|NCT02849990|364716804|FG000|Overall Study|Withdrawal by Subject|1|||
105743838|NCT01051986|364716805|FG000|Overall Study|Death|1|||
105743839|NCT01051986|364716806|FG001|Overall Study|Death|0|||
105743840|NCT01051986|364716805|FG000|Overall Study|Withdrawal by Subject|2|||
105743841|NCT01051986|364716806|FG001|Overall Study|Withdrawal by Subject|1|||
105743842|NCT01051986|364716805|FG000|Overall Study|Protocol Violation|2|||
105743843|NCT01051986|364716806|FG001|Overall Study|Protocol Violation|3|||
105743844|NCT00623467|364716807|FG000|Overall Study|Lost to Follow-up|1|||
105743845|NCT00623467|364716807|FG000|Overall Study|Protocol Violation|4|||
105743846|NCT00623467|364716807|FG000|Overall Study|Withdrawal by Subject|2|||
105743847|NCT02179515|364716808|FG000|Overall Study|switched to alternative treatment|0|||
105743848|NCT02179515|364716809|FG001|Overall Study|switched to alternative treatment|1|||
105743849|NCT02179515|364716810|FG002|Overall Study|switched to alternative treatment|1|||
105743850|NCT02179515|364716808|FG000|Overall Study|Death|0|||
105743851|NCT02179515|364716809|FG001|Overall Study|Death|1|||
105743852|NCT02179515|364716810|FG002|Overall Study|Death|1|||
105743853|NCT02179515|364716808|FG000|Overall Study|refused further treatment|0|||
105743854|NCT02179515|364716809|FG001|Overall Study|refused further treatment|3|||
105743855|NCT02179515|364716810|FG002|Overall Study|refused further treatment|4|||
105743856|NCT02179515|364716808|FG000|Overall Study|Disease progression on study|2|||
105743857|NCT02179515|364716809|FG001|Overall Study|Disease progression on study|11|||
105743858|NCT02179515|364716810|FG002|Overall Study|Disease progression on study|8|||
105743859|NCT00411788|364716812|FG000|Overall Study|Protocol Violation|1|||
105743860|NCT00411788|364716812|FG000|Overall Study|Adverse Event|1|||
105743861|NCT00879814|364716813|FG000|Overall Study|Adverse Event|0|||
105743862|NCT00879814|364716814|FG001|Overall Study|Adverse Event|1|||
105743863|NCT00879814|364716815|FG002|Overall Study|Adverse Event|0|||
105743864|NCT00879814|364716816|FG003|Overall Study|Adverse Event|0|||
105743865|NCT00879814|364716813|FG000|Overall Study|Lost to Follow-up|1|||
105743866|NCT00879814|364716814|FG001|Overall Study|Lost to Follow-up|0|||
105743867|NCT00879814|364716815|FG002|Overall Study|Lost to Follow-up|0|||
105743868|NCT00879814|364716816|FG003|Overall Study|Lost to Follow-up|2|||
105743869|NCT00879814|364716813|FG000|Overall Study|Participant Failed to Return|0|||
105743870|NCT00879814|364716814|FG001|Overall Study|Participant Failed to Return|0|||
105743871|NCT00879814|364716815|FG002|Overall Study|Participant Failed to Return|0|||
105743872|NCT00879814|364716816|FG003|Overall Study|Participant Failed to Return|1|||
105743873|NCT00879814|364716813|FG000|Overall Study|Withdrawal by Subject|3|||
106015272|NCT02963506|365721014|FG007|Double-Blind Period|Death|0|||
106015273|NCT02963506|365721015|FG008|Double-Blind Period|Death|0|||
106015274|NCT02963506|365721016|FG009|Double-Blind Period|Death|0|||
106015275|NCT02963506|365721017|FG010|Double-Blind Period|Death|0|||
106015276|NCT02963506|365721018|FG011|Double-Blind Period|Death|0|||
106015277|NCT02963506|365721019|FG012|Double-Blind Period|Death|0|||
106015278|NCT02963506|365721007|FG000|Double-Blind Period|Lost to Follow-up|0|||
106015279|NCT02963506|365721008|FG001|Double-Blind Period|Lost to Follow-up|1|||
105743874|NCT00879814|364716814|FG001|Overall Study|Withdrawal by Subject|1|||
105743875|NCT00879814|364716815|FG002|Overall Study|Withdrawal by Subject|1|||
105743876|NCT00879814|364716816|FG003|Overall Study|Withdrawal by Subject|2|||
105743877|NCT00879814|364716813|FG000|Overall Study|Physician Decision|0|||
105743878|NCT00879814|364716814|FG001|Overall Study|Physician Decision|0|||
105743879|NCT00879814|364716815|FG002|Overall Study|Physician Decision|1|||
105743880|NCT00879814|364716816|FG003|Overall Study|Physician Decision|0|||
105743881|NCT00879814|364716813|FG000|Overall Study|Other|0|||
105743882|NCT00879814|364716814|FG001|Overall Study|Other|0|||
105743883|NCT00879814|364716815|FG002|Overall Study|Other|1|||
105743884|NCT00879814|364716816|FG003|Overall Study|Other|0|||
106015280|NCT02963506|365721009|FG002|Double-Blind Period|Lost to Follow-up|0|||
106015281|NCT02963506|365721010|FG003|Double-Blind Period|Lost to Follow-up|0|||
105743885|NCT01554956|364716819|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
105800374|NCT01889862|364926450|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
105800375|NCT01889862|364926451|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
106015282|NCT02963506|365721011|FG004|Double-Blind Period|Lost to Follow-up|0|||
106015283|NCT02963506|365721012|FG005|Double-Blind Period|Lost to Follow-up|0|||
106015284|NCT02963506|365721013|FG006|Double-Blind Period|Lost to Follow-up|0|||
105743886|NCT01554956|364716820|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
105743887|NCT01554956|364716821|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
105743888|NCT01554956|364716819|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
105743889|NCT01554956|364716820|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
105743890|NCT01554956|364716821|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
105743891|NCT01554956|364716819|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
105743892|NCT01554956|364716820|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
105743893|NCT01554956|364716821|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
105743894|NCT01428063|364716822|FG000|Overall Study|Lack of Efficacy|8|||
105743895|NCT01428063|364716823|FG001|Overall Study|Lack of Efficacy|4|||
105743896|NCT01428063|364716824|FG002|Overall Study|Lack of Efficacy|1|||
105743897|NCT01428063|364716822|FG000|Overall Study|Adverse Event|2|||
105743898|NCT01428063|364716823|FG001|Overall Study|Adverse Event|3|||
105743899|NCT01428063|364716824|FG002|Overall Study|Adverse Event|0|||
105743900|NCT01428063|364716822|FG000|Overall Study|Lost to Follow-up|0|||
105743901|NCT01428063|364716823|FG001|Overall Study|Lost to Follow-up|2|||
105743902|NCT01428063|364716824|FG002|Overall Study|Lost to Follow-up|0|||
105743903|NCT01428063|364716822|FG000|Overall Study|No longer meets study criteria|0|||
105743904|NCT01428063|364716823|FG001|Overall Study|No longer meets study criteria|1|||
105743905|NCT01428063|364716824|FG002|Overall Study|No longer meets study criteria|0|||
105743906|NCT00069095|364716825|FG000|Primary Treatment Phase|Ongoing|0|||
105743907|NCT00069095|364716826|FG001|Primary Treatment Phase|Ongoing|0|||
105743908|NCT00069095|364716827|FG002|Primary Treatment Phase|Ongoing|5|||
105743909|NCT00069095|364716828|FG003|Primary Treatment Phase|Ongoing|7|||
105743910|NCT00069095|364716829|FG004|Primary Treatment Phase|Ongoing|7|||
105743911|NCT00069095|364716830|FG005|Primary Treatment Phase|Ongoing|4|||
105743912|NCT00069095|364716825|FG000|Primary Treatment Phase|Admin/Other|29|||
105743913|NCT00069095|364716826|FG001|Primary Treatment Phase|Admin/Other|38|||
105743914|NCT00069095|364716827|FG002|Primary Treatment Phase|Admin/Other|31|||
105743915|NCT00069095|364716828|FG003|Primary Treatment Phase|Admin/Other|45|||
105743916|NCT00069095|364716829|FG004|Primary Treatment Phase|Admin/Other|48|||
105743917|NCT00069095|364716830|FG005|Primary Treatment Phase|Admin/Other|42|||
105743918|NCT00069095|364716825|FG000|Primary Treatment Phase|Adverse Event|99|||
105743919|NCT00069095|364716826|FG001|Primary Treatment Phase|Adverse Event|92|||
105743920|NCT00069095|364716827|FG002|Primary Treatment Phase|Adverse Event|71|||
105743921|NCT00069095|364716828|FG003|Primary Treatment Phase|Adverse Event|72|||
105743922|NCT00069095|364716829|FG004|Primary Treatment Phase|Adverse Event|109|||
105743923|NCT00069095|364716830|FG005|Primary Treatment Phase|Adverse Event|101|||
105743924|NCT00069095|364716825|FG000|Primary Treatment Phase|Death|14|||
105743925|NCT00069095|364716826|FG001|Primary Treatment Phase|Death|8|||
105743926|NCT00069095|364716827|FG002|Primary Treatment Phase|Death|2|||
105743927|NCT00069095|364716828|FG003|Primary Treatment Phase|Death|5|||
105743928|NCT00069095|364716829|FG004|Primary Treatment Phase|Death|8|||
105743929|NCT00069095|364716830|FG005|Primary Treatment Phase|Death|8|||
105743930|NCT00069095|364716825|FG000|Primary Treatment Phase|Failure to return|5|||
105743931|NCT00069095|364716826|FG001|Primary Treatment Phase|Failure to return|5|||
105743932|NCT00069095|364716827|FG002|Primary Treatment Phase|Failure to return|0|||
105743933|NCT00069095|364716828|FG003|Primary Treatment Phase|Failure to return|0|||
105743934|NCT00069095|364716829|FG004|Primary Treatment Phase|Failure to return|0|||
105743935|NCT00069095|364716830|FG005|Primary Treatment Phase|Failure to return|2|||
105743936|NCT00069095|364716825|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
105743937|NCT00069095|364716826|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
105743938|NCT00069095|364716827|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
105743939|NCT00069095|364716828|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
105743940|NCT00069095|364716829|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
105743941|NCT00069095|364716830|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
105743942|NCT00069095|364716825|FG000|Primary Treatment Phase|Refused treatment|15|||
105743943|NCT00069095|364716826|FG001|Primary Treatment Phase|Refused treatment|26|||
105743944|NCT00069095|364716827|FG002|Primary Treatment Phase|Refused treatment|17|||
105743945|NCT00069095|364716828|FG003|Primary Treatment Phase|Refused treatment|31|||
105743946|NCT00069095|364716829|FG004|Primary Treatment Phase|Refused treatment|24|||
105743947|NCT00069095|364716830|FG005|Primary Treatment Phase|Refused treatment|27|||
105800376|NCT01889862|364926452|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
105743948|NCT00069095|364716825|FG000|Primary Treatment Phase|Withdrew|2|||
105743949|NCT00069095|364716826|FG001|Primary Treatment Phase|Withdrew|3|||
105743950|NCT00069095|364716827|FG002|Primary Treatment Phase|Withdrew|8|||
105942824|NCT00522379|365452862|FG004|Overall Study|Site Closed|0|||
105942825|NCT00522379|365452858|FG000|Overall Study|Subject Withdrawal|0|||
105942826|NCT00522379|365452859|FG001|Overall Study|Subject Withdrawal|0|||
105942827|NCT00522379|365452860|FG002|Overall Study|Subject Withdrawal|0|||
105942828|NCT00522379|365452861|FG003|Overall Study|Subject Withdrawal|1|||
105942829|NCT00522379|365452862|FG004|Overall Study|Subject Withdrawal|0|||
105942830|NCT00967499|365452867|FG000|Overall Study|Adverse Event|0|||
105942831|NCT00967499|365452868|FG001|Overall Study|Adverse Event|1|||
105743951|NCT00069095|364716828|FG003|Primary Treatment Phase|Withdrew|2|||
105743952|NCT00069095|364716829|FG004|Primary Treatment Phase|Withdrew|4|||
105743953|NCT00069095|364716830|FG005|Primary Treatment Phase|Withdrew|9|||
105743954|NCT00069095|364716825|FG000|Primary Treatment Phase|Other Violation|0|||
105743955|NCT00069095|364716826|FG001|Primary Treatment Phase|Other Violation|1|||
105743956|NCT00069095|364716827|FG002|Primary Treatment Phase|Other Violation|1|||
105743957|NCT00069095|364716828|FG003|Primary Treatment Phase|Other Violation|1|||
105743958|NCT00069095|364716829|FG004|Primary Treatment Phase|Other Violation|0|||
105743959|NCT00069095|364716830|FG005|Primary Treatment Phase|Other Violation|1|||
105743960|NCT00069095|364716825|FG000|Primary Treatment Phase|Violation criteria|0|||
105743961|NCT00069095|364716826|FG001|Primary Treatment Phase|Violation criteria|2|||
105743962|NCT00069095|364716827|FG002|Primary Treatment Phase|Violation criteria|4|||
105743963|NCT00069095|364716828|FG003|Primary Treatment Phase|Violation criteria|3|||
105743964|NCT00069095|364716829|FG004|Primary Treatment Phase|Violation criteria|1|||
105743965|NCT00069095|364716830|FG005|Primary Treatment Phase|Violation criteria|5|||
105743966|NCT00069095|364716825|FG000|Post-study Treatment Phase|Missing reason|1|||
105743967|NCT00069095|364716826|FG001|Post-study Treatment Phase|Missing reason|3|||
105743968|NCT00069095|364716827|FG002|Post-study Treatment Phase|Missing reason|12|||
105743969|NCT00069095|364716828|FG003|Post-study Treatment Phase|Missing reason|8|||
105743970|NCT00069095|364716829|FG004|Post-study Treatment Phase|Missing reason|18|||
105743971|NCT00069095|364716830|FG005|Post-study Treatment Phase|Missing reason|17|||
105743972|NCT00069095|364716825|FG000|Post-study Treatment Phase|Adverse Event|2|||
105743973|NCT00069095|364716826|FG001|Post-study Treatment Phase|Adverse Event|3|||
105743974|NCT00069095|364716827|FG002|Post-study Treatment Phase|Adverse Event|1|||
105743975|NCT00069095|364716828|FG003|Post-study Treatment Phase|Adverse Event|0|||
105743976|NCT00069095|364716829|FG004|Post-study Treatment Phase|Adverse Event|5|||
105743977|NCT00069095|364716830|FG005|Post-study Treatment Phase|Adverse Event|1|||
105743978|NCT00069095|364716825|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
105743979|NCT00069095|364716826|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
105743980|NCT00069095|364716827|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
105743981|NCT00069095|364716828|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
105743982|NCT00069095|364716829|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
105743983|NCT00069095|364716830|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
105743984|NCT00069095|364716825|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
105743985|NCT00069095|364716826|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
105743986|NCT00069095|364716827|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
105743987|NCT00069095|364716828|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
105743988|NCT00069095|364716829|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
105743989|NCT00069095|364716830|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
105743990|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
105743991|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
105743992|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
105743993|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
105743994|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
105743995|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
105743996|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant had complete response|1|||
105743997|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant had complete response|1|||
105743998|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant had complete response|0|||
105743999|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant had complete response|0|||
105744000|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant had complete response|0|||
105744001|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant had complete response|0|||
105744002|NCT00069095|364716825|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744003|NCT00069095|364716826|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
105744004|NCT00069095|364716827|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744005|NCT00069095|364716828|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744006|NCT00069095|364716829|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744007|NCT00069095|364716830|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
105744008|NCT00069095|364716825|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
105744009|NCT00069095|364716826|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
105744010|NCT00069095|364716827|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
105744011|NCT00069095|364716828|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
105744012|NCT00069095|364716829|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
105942832|NCT00967499|365452867|FG000|Overall Study|Protocol Violation|1|||
105942833|NCT00967499|365452868|FG001|Overall Study|Protocol Violation|0|||
105942834|NCT00967499|365452867|FG000|Overall Study|Sponsor Decision|1|||
105942835|NCT00967499|365452868|FG001|Overall Study|Sponsor Decision|0|||
105942836|NCT00967499|365452867|FG000|Overall Study|Randomized but not treated|63|||
105942837|NCT00967499|365452868|FG001|Overall Study|Randomized but not treated|59|||
106015285|NCT02963506|365721014|FG007|Double-Blind Period|Lost to Follow-up|0|||
105744013|NCT00069095|364716830|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
105744014|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
105744015|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
105744016|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
105744017|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
105744018|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
105744019|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
105744020|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
105744021|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
105744022|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
105744023|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
105744024|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
105744025|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
105744026|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744027|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744028|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744029|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
105744030|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744031|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
105744032|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
105744033|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
105744034|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
105744035|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
105744036|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
105744037|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
105744038|NCT00069095|364716825|FG000|Post-study Treatment Phase|Surgery|0|||
105744039|NCT00069095|364716826|FG001|Post-study Treatment Phase|Surgery|0|||
105744040|NCT00069095|364716827|FG002|Post-study Treatment Phase|Surgery|0|||
105744041|NCT00069095|364716828|FG003|Post-study Treatment Phase|Surgery|1|||
105744042|NCT00069095|364716829|FG004|Post-study Treatment Phase|Surgery|1|||
105744043|NCT00069095|364716830|FG005|Post-study Treatment Phase|Surgery|0|||
105744044|NCT00069095|364716825|FG000|Post-study Treatment Phase|Death|0|||
105744045|NCT00069095|364716826|FG001|Post-study Treatment Phase|Death|0|||
105744046|NCT00069095|364716827|FG002|Post-study Treatment Phase|Death|0|||
105744047|NCT00069095|364716828|FG003|Post-study Treatment Phase|Death|0|||
105744048|NCT00069095|364716829|FG004|Post-study Treatment Phase|Death|1|||
105744049|NCT00069095|364716830|FG005|Post-study Treatment Phase|Death|0|||
105744050|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
105744051|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
105744052|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
105744053|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
105744054|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
105744055|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
105744056|NCT00069095|364716825|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744057|NCT00069095|364716826|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744058|NCT00069095|364716827|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744059|NCT00069095|364716828|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744060|NCT00069095|364716829|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
105744061|NCT00069095|364716830|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
105744062|NCT00069095|364716825|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744063|NCT00069095|364716826|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744064|NCT00069095|364716827|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744065|NCT00069095|364716828|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744066|NCT00069095|364716829|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
105744067|NCT00069095|364716830|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
105744068|NCT00069095|364716825|FG000|Post-study Treatment Phase|Investigator decision|0|||
105800377|NCT01889862|364926453|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
105800378|NCT01889862|364926454|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
105800379|NCT00971204|364926455|FG000|Overall Study|Did not meet all criteria-not treated|14|||
105800380|NCT00971204|364926455|FG000|Overall Study|Lost to Follow-up|10|||
105800381|NCT00879970|364926459|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
106015286|NCT02963506|365721015|FG008|Double-Blind Period|Lost to Follow-up|0|||
105744069|NCT00069095|364716826|FG001|Post-study Treatment Phase|Investigator decision|0|||
105744070|NCT00069095|364716827|FG002|Post-study Treatment Phase|Investigator decision|0|||
105744071|NCT00069095|364716828|FG003|Post-study Treatment Phase|Investigator decision|0|||
105744072|NCT00069095|364716829|FG004|Post-study Treatment Phase|Investigator decision|0|||
105744073|NCT00069095|364716830|FG005|Post-study Treatment Phase|Investigator decision|1|||
105744074|NCT00069095|364716825|FG000|Follow-up Phase|Death|174|||
106015287|NCT02963506|365721016|FG009|Double-Blind Period|Lost to Follow-up|0|||
106015288|NCT02963506|365721017|FG010|Double-Blind Period|Lost to Follow-up|0|||
106015289|NCT02963506|365721018|FG011|Double-Blind Period|Lost to Follow-up|0|||
105744075|NCT00069095|364716826|FG001|Follow-up Phase|Death|206|||
105744076|NCT00069095|364716827|FG002|Follow-up Phase|Death|120|||
105744077|NCT00069095|364716828|FG003|Follow-up Phase|Death|112|||
105744078|NCT00069095|364716829|FG004|Follow-up Phase|Death|92|||
105744079|NCT00069095|364716830|FG005|Follow-up Phase|Death|101|||
105744080|NCT00506077|364716831|FG000|Treatment Period 1|Adverse Event|2|||
105744081|NCT00506077|364716832|FG001|Treatment Period 1|Adverse Event|1|||
105744082|NCT00506077|364716831|FG000|Treatment Period 1|Lost to Follow-up|0|||
105744083|NCT00506077|364716832|FG001|Treatment Period 1|Lost to Follow-up|2|||
105744084|NCT00506077|364716831|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105744085|NCT00506077|364716832|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105744086|NCT00506077|364716831|FG000|Treatment Period 2|Adverse Event|0|||
105744087|NCT00506077|364716832|FG001|Treatment Period 2|Adverse Event|1|||
105744088|NCT00506077|364716831|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105744089|NCT00506077|364716832|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105744090|NCT00532948|364716835|FG000|Overall Study|Protocol Violation|1|||
105744091|NCT00532948|364716836|FG001|Overall Study|Protocol Violation|0|||
105744092|NCT00532948|364716837|FG002|Overall Study|Protocol Violation|0|||
105744093|NCT00532948|364716835|FG000|Overall Study|Death|3|||
105744094|NCT00532948|364716836|FG001|Overall Study|Death|3|||
105744095|NCT00532948|364716837|FG002|Overall Study|Death|4|||
105744096|NCT00532948|364716835|FG000|Overall Study|Violation of selection criteria at entry|0|||
105744097|NCT00532948|364716836|FG001|Overall Study|Violation of selection criteria at entry|1|||
105744098|NCT00532948|364716837|FG002|Overall Study|Violation of selection criteria at entry|0|||
105744099|NCT00532948|364716835|FG000|Overall Study|Failure to return|0|||
105744100|NCT00532948|364716836|FG001|Overall Study|Failure to return|1|||
105744101|NCT00532948|364716837|FG002|Overall Study|Failure to return|0|||
105744102|NCT01087528|364716843|FG000|Overall Study|Withdrawal by Subject|1|||
105744103|NCT01087528|364716843|FG000|Overall Study|Incomplete CE procedure|6|||
105744104|NCT03116399|364716848|FG000|Overall Study|Death|8|||
105744105|NCT03116399|364716849|FG001|Overall Study|Death|3|||
105744106|NCT03116399|364716848|FG000|Overall Study|Lost to Follow-up|7|||
105744107|NCT03116399|364716849|FG001|Overall Study|Lost to Follow-up|11|||
105744108|NCT03116399|364716848|FG000|Overall Study|Investigator Decision|1|||
105744109|NCT03116399|364716849|FG001|Overall Study|Investigator Decision|1|||
105744110|NCT03116399|364716848|FG000|Overall Study|Withdrawal by Subject|24|||
105744111|NCT03116399|364716849|FG001|Overall Study|Withdrawal by Subject|9|||
105744112|NCT00069576|364716852|FG000|Original Trial|Lost to Follow-up|25|||
105744113|NCT00069576|364716853|FG001|Original Trial|Lost to Follow-up|33|||
105744114|NCT00069576|364716852|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
105744115|NCT00069576|364716853|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
105744116|NCT02496585|364716854|FG000|Overall Study|Death|3|||
105744117|NCT02496585|364716855|FG001|Overall Study|Death|0|||
105744118|NCT02496585|364716854|FG000|Overall Study|Lost to Follow-up|2|||
105744119|NCT02496585|364716855|FG001|Overall Study|Lost to Follow-up|0|||
105744120|NCT02496585|364716854|FG000|Overall Study|Withdrawal by Subject|1|||
105744121|NCT02496585|364716855|FG001|Overall Study|Withdrawal by Subject|2|||
105744122|NCT02496585|364716854|FG000|Overall Study|Progression of Malignancy|4|||
105744123|NCT02496585|364716855|FG001|Overall Study|Progression of Malignancy|1|||
106015290|NCT02963506|365721019|FG012|Double-Blind Period|Lost to Follow-up|0|||
106015291|NCT02963506|365721007|FG000|Double-Blind Period|Withdrawal by Subject|0|||
106015292|NCT02963506|365721008|FG001|Double-Blind Period|Withdrawal by Subject|0|||
106015293|NCT02963506|365721009|FG002|Double-Blind Period|Withdrawal by Subject|1|||
106015294|NCT02963506|365721010|FG003|Double-Blind Period|Withdrawal by Subject|1|||
106015295|NCT02963506|365721011|FG004|Double-Blind Period|Withdrawal by Subject|0|||
106015296|NCT02963506|365721012|FG005|Double-Blind Period|Withdrawal by Subject|0|||
106015297|NCT02963506|365721013|FG006|Double-Blind Period|Withdrawal by Subject|0|||
106015298|NCT02963506|365721014|FG007|Double-Blind Period|Withdrawal by Subject|0|||
106015299|NCT02963506|365721015|FG008|Double-Blind Period|Withdrawal by Subject|0|||
106015300|NCT02963506|365721016|FG009|Double-Blind Period|Withdrawal by Subject|0|||
105744124|NCT02702193|364716856|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
105744125|NCT02702193|364716857|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
105744126|NCT02702193|364716856|FG000|4 Month Follow up|Withdrawal by Subject|1|||
105744127|NCT02702193|364716857|FG001|4 Month Follow up|Withdrawal by Subject|0|||
105744128|NCT02702193|364716856|FG000|4 Month Follow up|Lost to Follow-up|17|||
105744129|NCT02702193|364716857|FG001|4 Month Follow up|Lost to Follow-up|18|||
105744130|NCT02702193|364716856|FG000|8 Month Follow up|Withdrawal by Subject|1|||
105744131|NCT02702193|364716857|FG001|8 Month Follow up|Withdrawal by Subject|0|||
105800382|NCT00879970|364926460|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
105800383|NCT00879970|364926461|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
105800384|NCT00879970|364926462|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
105800385|NCT00879970|364926463|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
105800386|NCT00879970|364926459|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
105800387|NCT00879970|364926460|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
105800388|NCT00879970|364926461|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
105800389|NCT00879970|364926462|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
105800390|NCT00879970|364926463|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
105800391|NCT00879970|364926459|FG000|Period 1 TZD Randomization|Death|2|||
105800392|NCT00879970|364926460|FG001|Period 1 TZD Randomization|Death|1|||
105800393|NCT00879970|364926461|FG002|Period 1 TZD Randomization|Death|0|||
105800394|NCT00879970|364926462|FG003|Period 1 TZD Randomization|Death|0|||
105800395|NCT00879970|364926463|FG004|Period 1 TZD Randomization|Death|0|||
105800396|NCT00879970|364926459|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
105800397|NCT00879970|364926460|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
105800398|NCT00879970|364926461|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
105800399|NCT00879970|364926462|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
105800400|NCT00879970|364926463|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
105800401|NCT00879970|364926459|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
105800402|NCT00879970|364926460|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
105800403|NCT00879970|364926461|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
105800404|NCT00879970|364926462|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
105800405|NCT00879970|364926463|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
105800406|NCT00879970|364926459|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
105800407|NCT00879970|364926460|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
105800408|NCT00879970|364926461|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
105800409|NCT00879970|364926462|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
105800410|NCT00879970|364926463|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
105800411|NCT00879970|364926459|FG000|Period 2 Vitamin D Randomization|Death|0|||
105800412|NCT00879970|364926460|FG001|Period 2 Vitamin D Randomization|Death|0|||
105800413|NCT00879970|364926461|FG002|Period 2 Vitamin D Randomization|Death|0|||
106015301|NCT02963506|365721017|FG010|Double-Blind Period|Withdrawal by Subject|0|||
106015302|NCT02963506|365721018|FG011|Double-Blind Period|Withdrawal by Subject|0|||
106015303|NCT02963506|365721019|FG012|Double-Blind Period|Withdrawal by Subject|0|||
106015304|NCT02963506|365721007|FG000|Double-Blind Period|No compliance|0|||
106015305|NCT02963506|365721008|FG001|Double-Blind Period|No compliance|1|||
106015306|NCT02963506|365721009|FG002|Double-Blind Period|No compliance|0|||
106015307|NCT02963506|365721010|FG003|Double-Blind Period|No compliance|0|||
106015308|NCT02963506|365721011|FG004|Double-Blind Period|No compliance|0|||
106015309|NCT02963506|365721012|FG005|Double-Blind Period|No compliance|0|||
106015310|NCT02963506|365721013|FG006|Double-Blind Period|No compliance|0|||
106015311|NCT02963506|365721014|FG007|Double-Blind Period|No compliance|0|||
106015312|NCT02963506|365721015|FG008|Double-Blind Period|No compliance|0|||
106015313|NCT02963506|365721016|FG009|Double-Blind Period|No compliance|0|||
106015314|NCT02963506|365721017|FG010|Double-Blind Period|No compliance|0|||
106015315|NCT02963506|365721018|FG011|Double-Blind Period|No compliance|0|||
106015316|NCT02963506|365721019|FG012|Double-Blind Period|No compliance|0|||
106015317|NCT02963506|365721007|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015318|NCT02963506|365721008|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
106015319|NCT02963506|365721009|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015320|NCT02963506|365721010|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015321|NCT02963506|365721011|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015322|NCT02963506|365721012|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015323|NCT02963506|365721013|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015324|NCT02963506|365721014|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015325|NCT02963506|365721015|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015326|NCT02963506|365721016|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015327|NCT02963506|365721017|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015328|NCT02963506|365721018|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015329|NCT02963506|365721019|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
106015330|NCT02963506|365721007|FG000|Dose-Blind Period|Adverse Event|0|||
106015331|NCT02963506|365721008|FG001|Dose-Blind Period|Adverse Event|0|||
106015332|NCT02963506|365721009|FG002|Dose-Blind Period|Adverse Event|0|||
106015333|NCT02963506|365721010|FG003|Dose-Blind Period|Adverse Event|0|||
106015334|NCT02963506|365721011|FG004|Dose-Blind Period|Adverse Event|0|||
106015335|NCT02963506|365721012|FG005|Dose-Blind Period|Adverse Event|1|||
106015336|NCT02963506|365721013|FG006|Dose-Blind Period|Adverse Event|3|||
106015337|NCT02963506|365721014|FG007|Dose-Blind Period|Adverse Event|2|||
106015338|NCT02963506|365721015|FG008|Dose-Blind Period|Adverse Event|2|||
106142286|NCT02754479|366179955|FG000|Overall Study|Lost to Follow-up|1|||
105744132|NCT02702193|364716856|FG000|8 Month Follow up|Lost to Follow-up|14|||
105744133|NCT02702193|364716857|FG001|8 Month Follow up|Lost to Follow-up|18|||
105744134|NCT02702193|364716856|FG000|12 Month Follow up|Withdrawal by Subject|1|||
105744135|NCT02702193|364716857|FG001|12 Month Follow up|Withdrawal by Subject|0|||
105744136|NCT02702193|364716856|FG000|12 Month Follow up|Lost to Follow-up|16|||
105744137|NCT02702193|364716857|FG001|12 Month Follow up|Lost to Follow-up|18|||
105744138|NCT00358917|364716858|FG000|Overall Study|Adverse Event|14|||
105744139|NCT00358917|364716859|FG001|Overall Study|Adverse Event|21|||
105744140|NCT00358917|364716858|FG000|Overall Study|Withdrawal by Subject|5|||
105744141|NCT00358917|364716859|FG001|Overall Study|Withdrawal by Subject|7|||
105744142|NCT00358917|364716858|FG000|Overall Study|Lost to Follow-up|20|||
105744143|NCT00358917|364716859|FG001|Overall Study|Lost to Follow-up|17|||
105744144|NCT00358917|364716858|FG000|Overall Study|Noncompliance|12|||
105744145|NCT00358917|364716859|FG001|Overall Study|Noncompliance|11|||
105744146|NCT00358917|364716858|FG000|Overall Study|Death|2|||
105744147|NCT00358917|364716859|FG001|Overall Study|Death|3|||
105744148|NCT00358917|364716858|FG000|Overall Study|Virologic failure|11|||
105744149|NCT00358917|364716859|FG001|Overall Study|Virologic failure|8|||
105744150|NCT00358917|364716858|FG000|Overall Study|Unable to Continue Participation|2|||
105744151|NCT00358917|364716859|FG001|Overall Study|Unable to Continue Participation|2|||
105744152|NCT05091060|364716868|FG000|Overall Study|Lost to Follow-up|1|||
105744153|NCT01798706|364716869|FG000|Overall Study|Adverse Event|15|||
105744154|NCT01798706|364716870|FG001|Overall Study|Adverse Event|10|||
105744155|NCT01798706|364716869|FG000|Overall Study|Lack of Efficacy|0|||
105744156|NCT01798706|364716870|FG001|Overall Study|Lack of Efficacy|2|||
105744157|NCT01798706|364716869|FG000|Overall Study|Poor compliance to protocol|1|||
105744158|NCT01798706|364716870|FG001|Overall Study|Poor compliance to protocol|0|||
105744159|NCT01798706|364716869|FG000|Overall Study|Other than specified above|5|||
105744160|NCT01798706|364716870|FG001|Overall Study|Other than specified above|9|||
105744161|NCT00496873|364716871|FG000|Overall Study|Ineligible|2|||
105744162|NCT00496873|364716871|FG000|Overall Study|Death|2|||
105744163|NCT00496873|364716871|FG000|Overall Study|Withdrawal by Subject|3|||
105744164|NCT02775864|364716872|FG000|Overall Study|Data ended end of 2010|1764|||
105744165|NCT02775864|364716873|FG001|Overall Study|Data ended end of 2010|2880|||
105744166|NCT02775864|364716874|FG002|Overall Study|Data ended end of 2010|1140|||
105744167|NCT02775864|364716875|FG003|Overall Study|Data ended end of 2010|1194|||
105744168|NCT02775864|364716872|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
105744169|NCT02775864|364716873|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
105744170|NCT02775864|364716874|FG002|Overall Study|Medicaid eligibility discontinued|720|||
105744171|NCT02775864|364716875|FG003|Overall Study|Medicaid eligibility discontinued|890|||
105744172|NCT03238235|364716876|FG000|Overall Study|Adverse Event|2|||
105744173|NCT03238235|364716877|FG001|Overall Study|Adverse Event|0|||
105744174|NCT03238235|364716876|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
105744175|NCT03238235|364716877|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
105744176|NCT01318083|364716878|FG000|Overall Study|Adverse Event|4|||
105744177|NCT01318083|364716879|FG001|Overall Study|Adverse Event|1|||
105744178|NCT01318083|364716880|FG002|Overall Study|Adverse Event|2|||
105744179|NCT01318083|364716878|FG000|Overall Study|Withdrawal by Subject|1|||
105744180|NCT01318083|364716879|FG001|Overall Study|Withdrawal by Subject|0|||
105744181|NCT01318083|364716880|FG002|Overall Study|Withdrawal by Subject|2|||
105744182|NCT01318083|364716878|FG000|Overall Study|Lack of Efficacy|0|||
105744183|NCT01318083|364716879|FG001|Overall Study|Lack of Efficacy|0|||
105744184|NCT01318083|364716880|FG002|Overall Study|Lack of Efficacy|1|||
105744185|NCT01318083|364716878|FG000|Overall Study|Treatment Complications|1|||
105744186|NCT01318083|364716879|FG001|Overall Study|Treatment Complications|0|||
105744187|NCT01318083|364716880|FG002|Overall Study|Treatment Complications|0|||
105744188|NCT01318083|364716878|FG000|Overall Study|Lack of Study Medication Compliance|0|||
105744189|NCT01318083|364716879|FG001|Overall Study|Lack of Study Medication Compliance|1|||
105744190|NCT01318083|364716880|FG002|Overall Study|Lack of Study Medication Compliance|0|||
105744191|NCT02028338|364716881|FG000|Overall Study|Withdrawal by Subject|3|||
105744192|NCT02028338|364716882|FG001|Overall Study|Withdrawal by Subject|1|||
105744193|NCT02028338|364716881|FG000|Overall Study|Unable to contact participant|1|||
105744194|NCT02028338|364716882|FG001|Overall Study|Unable to contact participant|0|||
105744195|NCT00256867|364716890|FG000|Overall Study|Adverse Event|0|||
105744196|NCT00256867|364716891|FG001|Overall Study|Adverse Event|1|||
105744197|NCT00256867|364716892|FG002|Overall Study|Adverse Event|1|||
105744198|NCT00256867|364716893|FG003|Overall Study|Adverse Event|1|||
105744199|NCT00256867|364716894|FG004|Overall Study|Adverse Event|2|||
106015339|NCT02963506|365721016|FG009|Dose-Blind Period|Adverse Event|2|||
105744200|NCT00256867|364716895|FG005|Overall Study|Adverse Event|2|||
105744201|NCT00256867|364716896|FG006|Overall Study|Adverse Event|1|||
105744202|NCT00256867|364716897|FG007|Overall Study|Adverse Event|4|||
105744203|NCT00256867|364716890|FG000|Overall Study|Lost to Follow-up|2|||
105744204|NCT00256867|364716891|FG001|Overall Study|Lost to Follow-up|2|||
105744205|NCT00256867|364716892|FG002|Overall Study|Lost to Follow-up|2|||
105744206|NCT00256867|364716893|FG003|Overall Study|Lost to Follow-up|3|||
105744207|NCT00256867|364716894|FG004|Overall Study|Lost to Follow-up|2|||
105744208|NCT00256867|364716895|FG005|Overall Study|Lost to Follow-up|0|||
105744209|NCT00256867|364716896|FG006|Overall Study|Lost to Follow-up|1|||
105744210|NCT00256867|364716897|FG007|Overall Study|Lost to Follow-up|2|||
105744211|NCT00256867|364716890|FG000|Overall Study|Protocol Violation|0|||
105744212|NCT00256867|364716891|FG001|Overall Study|Protocol Violation|0|||
105744213|NCT00256867|364716892|FG002|Overall Study|Protocol Violation|0|||
105744214|NCT00256867|364716893|FG003|Overall Study|Protocol Violation|1|||
105744215|NCT00256867|364716894|FG004|Overall Study|Protocol Violation|0|||
105744216|NCT00256867|364716895|FG005|Overall Study|Protocol Violation|1|||
105744217|NCT00256867|364716896|FG006|Overall Study|Protocol Violation|0|||
105744218|NCT00256867|364716897|FG007|Overall Study|Protocol Violation|1|||
105744219|NCT00256867|364716890|FG000|Overall Study|Withdrawal by Subject|0|||
105744220|NCT00256867|364716891|FG001|Overall Study|Withdrawal by Subject|0|||
105744221|NCT00256867|364716892|FG002|Overall Study|Withdrawal by Subject|1|||
105744222|NCT00256867|364716893|FG003|Overall Study|Withdrawal by Subject|1|||
105744223|NCT00256867|364716894|FG004|Overall Study|Withdrawal by Subject|2|||
105744224|NCT00256867|364716895|FG005|Overall Study|Withdrawal by Subject|2|||
105744225|NCT00256867|364716896|FG006|Overall Study|Withdrawal by Subject|3|||
105744226|NCT00256867|364716897|FG007|Overall Study|Withdrawal by Subject|2|||
105744227|NCT00256867|364716890|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744228|NCT00256867|364716891|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
105744229|NCT00256867|364716892|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744230|NCT00256867|364716893|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744231|NCT00256867|364716894|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744232|NCT00256867|364716895|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744233|NCT00256867|364716896|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744234|NCT00256867|364716897|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
105744235|NCT00256867|364716890|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744236|NCT00256867|364716891|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744237|NCT00256867|364716892|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744238|NCT00256867|364716893|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744239|NCT00256867|364716894|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744240|NCT00256867|364716895|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744241|NCT00256867|364716896|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
105744242|NCT00256867|364716897|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
105744243|NCT00256867|364716890|FG000|Overall Study|Investigator's Decision|0|||
105744244|NCT00256867|364716891|FG001|Overall Study|Investigator's Decision|0|||
105744245|NCT00256867|364716892|FG002|Overall Study|Investigator's Decision|0|||
105744246|NCT00256867|364716893|FG003|Overall Study|Investigator's Decision|0|||
105744247|NCT00256867|364716894|FG004|Overall Study|Investigator's Decision|1|||
105744248|NCT00256867|364716895|FG005|Overall Study|Investigator's Decision|0|||
105744249|NCT00256867|364716896|FG006|Overall Study|Investigator's Decision|0|||
105744250|NCT00256867|364716897|FG007|Overall Study|Investigator's Decision|0|||
105744251|NCT00256867|364716890|FG000|Overall Study|Non-compliance with study medication|0|||
105744252|NCT00256867|364716891|FG001|Overall Study|Non-compliance with study medication|0|||
105744253|NCT00256867|364716892|FG002|Overall Study|Non-compliance with study medication|0|||
105744254|NCT00256867|364716893|FG003|Overall Study|Non-compliance with study medication|0|||
105744255|NCT00256867|364716894|FG004|Overall Study|Non-compliance with study medication|0|||
105744256|NCT00256867|364716895|FG005|Overall Study|Non-compliance with study medication|0|||
105744257|NCT00256867|364716896|FG006|Overall Study|Non-compliance with study medication|0|||
105744258|NCT00256867|364716897|FG007|Overall Study|Non-compliance with study medication|1|||
105744259|NCT00256867|364716890|FG000|Overall Study|Participant travelled Overseas|0|||
105744260|NCT00256867|364716891|FG001|Overall Study|Participant travelled Overseas|1|||
105744261|NCT00256867|364716892|FG002|Overall Study|Participant travelled Overseas|0|||
105744262|NCT00256867|364716893|FG003|Overall Study|Participant travelled Overseas|0|||
105744263|NCT00256867|364716894|FG004|Overall Study|Participant travelled Overseas|0|||
105744264|NCT00256867|364716895|FG005|Overall Study|Participant travelled Overseas|0|||
105744265|NCT00256867|364716896|FG006|Overall Study|Participant travelled Overseas|0|||
105744266|NCT00256867|364716897|FG007|Overall Study|Participant travelled Overseas|0|||
105744267|NCT00256867|364716890|FG000|Overall Study|Participant out of assessment window|0|||
105744268|NCT00256867|364716891|FG001|Overall Study|Participant out of assessment window|0|||
105744269|NCT00256867|364716892|FG002|Overall Study|Participant out of assessment window|1|||
105744270|NCT00256867|364716893|FG003|Overall Study|Participant out of assessment window|0|||
105744271|NCT00256867|364716894|FG004|Overall Study|Participant out of assessment window|0|||
105744272|NCT00256867|364716895|FG005|Overall Study|Participant out of assessment window|0|||
105744273|NCT00256867|364716896|FG006|Overall Study|Participant out of assessment window|0|||
105744274|NCT00256867|364716897|FG007|Overall Study|Participant out of assessment window|0|||
105800414|NCT00879970|364926462|FG003|Period 2 Vitamin D Randomization|Death|2|||
105744275|NCT00256867|364716890|FG000|Overall Study|Withdrawal by participant|0|||
105744276|NCT00256867|364716891|FG001|Overall Study|Withdrawal by participant|0|||
105800415|NCT00879970|364926463|FG004|Period 2 Vitamin D Randomization|Death|0|||
105744277|NCT00256867|364716892|FG002|Overall Study|Withdrawal by participant|0|||
105744278|NCT00256867|364716893|FG003|Overall Study|Withdrawal by participant|0|||
105744279|NCT00256867|364716894|FG004|Overall Study|Withdrawal by participant|0|||
105744280|NCT00256867|364716895|FG005|Overall Study|Withdrawal by participant|1|||
105744281|NCT00256867|364716896|FG006|Overall Study|Withdrawal by participant|0|||
105744282|NCT00256867|364716897|FG007|Overall Study|Withdrawal by participant|0|||
105744283|NCT03827473|364716901|FG000|Overall Study|Withdrawal by Subject|1|||
105744284|NCT03827473|364716902|FG001|Overall Study|Withdrawal by Subject|0|||
105744285|NCT03342469|364716903|FG000|Overall Study|Withdrawal by Subject|0|||
105744286|NCT03342469|364716904|FG001|Overall Study|Withdrawal by Subject|1|||
105744287|NCT03342469|364716905|FG002|Overall Study|Withdrawal by Subject|0|||
105744288|NCT03342469|364716906|FG003|Overall Study|Withdrawal by Subject|0|||
105744289|NCT00243230|364716907|FG000|Double-Blind Period|Adverse Event|0|||
105744290|NCT00243230|364716908|FG001|Double-Blind Period|Adverse Event|2|||
105744291|NCT00243230|364716909|FG002|Double-Blind Period|Adverse Event|2|||
105744292|NCT00243230|364716910|FG003|Double-Blind Period|Adverse Event|0|||
105744293|NCT00243230|364716907|FG000|Double-Blind Period|Withdrawal by Subject|1|||
105744294|NCT00243230|364716908|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105744295|NCT00243230|364716909|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105744296|NCT00243230|364716910|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105744297|NCT00243230|364716907|FG000|Double-Blind Period|Protocol Violation|0|||
105744298|NCT00243230|364716908|FG001|Double-Blind Period|Protocol Violation|0|||
105744299|NCT00243230|364716909|FG002|Double-Blind Period|Protocol Violation|1|||
105744300|NCT00243230|364716910|FG003|Double-Blind Period|Protocol Violation|0|||
105744301|NCT00243230|364716907|FG000|Double-Blind Period|Randomized but Not Treated|0|||
105744302|NCT00243230|364716908|FG001|Double-Blind Period|Randomized but Not Treated|0|||
105744303|NCT00243230|364716909|FG002|Double-Blind Period|Randomized but Not Treated|2|||
105744304|NCT00243230|364716910|FG003|Double-Blind Period|Randomized but Not Treated|0|||
105744305|NCT00243230|364716907|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
105744306|NCT00243230|364716908|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
105744307|NCT00243230|364716909|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
105744308|NCT00243230|364716910|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
105744309|NCT00243230|364716907|FG000|Open Label Period|Adverse Event|0|||
105744310|NCT00243230|364716908|FG001|Open Label Period|Adverse Event|0|||
105744311|NCT00243230|364716909|FG002|Open Label Period|Adverse Event|0|||
105744312|NCT00243230|364716910|FG003|Open Label Period|Adverse Event|2|||
105744313|NCT00243230|364716907|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
105744314|NCT00243230|364716908|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
105744315|NCT00243230|364716909|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
105744316|NCT00243230|364716910|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
105744317|NCT00243230|364716907|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
105744318|NCT00243230|364716908|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
105744319|NCT00243230|364716909|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
105744320|NCT00243230|364716910|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
105744321|NCT00243230|364716907|FG000|Open Label Period|Lost to Follow-up|0|||
105744322|NCT00243230|364716908|FG001|Open Label Period|Lost to Follow-up|0|||
105744323|NCT00243230|364716909|FG002|Open Label Period|Lost to Follow-up|0|||
105744324|NCT00243230|364716910|FG003|Open Label Period|Lost to Follow-up|2|||
105744325|NCT00243230|364716907|FG000|Open Label Period|Withdrawal by Subject|0|||
105744326|NCT00243230|364716908|FG001|Open Label Period|Withdrawal by Subject|0|||
105744327|NCT00243230|364716909|FG002|Open Label Period|Withdrawal by Subject|0|||
105744328|NCT00243230|364716910|FG003|Open Label Period|Withdrawal by Subject|2|||
105744329|NCT00243230|364716907|FG000|Open Label Period|Protocol Violation|0|||
105744330|NCT00243230|364716908|FG001|Open Label Period|Protocol Violation|0|||
105744331|NCT00243230|364716909|FG002|Open Label Period|Protocol Violation|0|||
105744332|NCT00243230|364716910|FG003|Open Label Period|Protocol Violation|2|||
105744333|NCT00243230|364716907|FG000|Open Label Period|Administrative Reason|0|||
105744334|NCT00243230|364716908|FG001|Open Label Period|Administrative Reason|0|||
105744335|NCT00243230|364716909|FG002|Open Label Period|Administrative Reason|0|||
105744336|NCT00243230|364716910|FG003|Open Label Period|Administrative Reason|63|||
105744337|NCT04160468|364716914|FG000|Overall Study|Lost to Follow-up|19|||
105744338|NCT04160468|364716915|FG001|Overall Study|Lost to Follow-up|4|||
105744339|NCT04160468|364716914|FG000|Overall Study|Randomized but not dosed|6|||
105744340|NCT04160468|364716915|FG001|Overall Study|Randomized but not dosed|0|||
105744341|NCT04160468|364716914|FG000|Overall Study|Withdrawal by Subject|4|||
105744342|NCT04160468|364716915|FG001|Overall Study|Withdrawal by Subject|1|||
105744343|NCT04160468|364716914|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
105744344|NCT04160468|364716915|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
105744345|NCT04160468|364716914|FG000|Overall Study|Participant incarcerated|1|||
105744346|NCT04160468|364716915|FG001|Overall Study|Participant incarcerated|0|||
105744347|NCT01912768|364716916|FG000|Overall Study|Adverse Event|2|||
105744348|NCT01912768|364716917|FG001|Overall Study|Adverse Event|0|||
105744349|NCT01912768|364716916|FG000|Overall Study|Lost to Follow-up|2|||
106142287|NCT01121549|366179956|FG000|Overall Study|Adverse Event|10|||
105744350|NCT01912768|364716917|FG001|Overall Study|Lost to Follow-up|1|||
105744351|NCT01912768|364716916|FG000|Overall Study|Withdrawal by Subject|5|||
105744352|NCT01912768|364716917|FG001|Overall Study|Withdrawal by Subject|3|||
105744353|NCT01912768|364716916|FG000|Overall Study|Randomized in error|1|||
105744354|NCT01912768|364716917|FG001|Overall Study|Randomized in error|0|||
105744355|NCT01402284|364716918|FG000|Overall Study|Withdrawal consent|2|||
105744356|NCT01402284|364716918|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
105744357|NCT01402284|364716918|FG000|Overall Study|Physician Decision|1|||
105744358|NCT01402284|364716918|FG000|Overall Study|Disease progression on study|10|||
105744359|NCT01199263|364716919|FG000|Overall Study|Ineligible|0|||
105744360|NCT01199263|364716920|FG001|Overall Study|Ineligible|2|||
105744361|NCT01199263|364716919|FG000|Overall Study|Never Treated|6|||
105744362|NCT01199263|364716920|FG001|Overall Study|Never Treated|0|||
105744363|NCT00540436|364716921|FG000|First 12-Week Treatment Period|Adverse Event|1|||
105744364|NCT00540436|364716921|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
105744365|NCT00540436|364716921|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
105744366|NCT00540436|364716921|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
105744367|NCT03255291|364716922|FG000|Overall Study|Determined to be ineligible|10|||
105744368|NCT03255291|364716923|FG001|Overall Study|Determined to be ineligible|12|||
105744369|NCT03255291|364716924|FG002|Overall Study|Determined to be ineligible|6|||
105744370|NCT03255291|364716925|FG003|Overall Study|Determined to be ineligible|6|||
105744371|NCT03255291|364716926|FG004|Overall Study|Determined to be ineligible|5|||
105744372|NCT03255291|364716927|FG005|Overall Study|Determined to be ineligible|10|||
105744373|NCT03255291|364716922|FG000|Overall Study|Baseline data collection issues|3|||
105744374|NCT03255291|364716923|FG001|Overall Study|Baseline data collection issues|0|||
105744375|NCT03255291|364716924|FG002|Overall Study|Baseline data collection issues|0|||
105744376|NCT03255291|364716925|FG003|Overall Study|Baseline data collection issues|0|||
105744377|NCT03255291|364716926|FG004|Overall Study|Baseline data collection issues|2|||
105744378|NCT03255291|364716927|FG005|Overall Study|Baseline data collection issues|0|||
105744379|NCT03987620|364716928|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
105744380|NCT03987620|364716929|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
105744381|NCT03987620|364716928|FG000|Overall Study|Adverse Event|3|||
105744382|NCT03987620|364716929|FG001|Overall Study|Adverse Event|0|||
105744383|NCT03987620|364716928|FG000|Overall Study|Lost to Follow-up|1|||
105744384|NCT03987620|364716929|FG001|Overall Study|Lost to Follow-up|2|||
105744385|NCT03987620|364716928|FG000|Overall Study|Physician Decision|0|||
105744386|NCT03987620|364716929|FG001|Overall Study|Physician Decision|1|||
105744387|NCT03987620|364716928|FG000|Overall Study|Pregnancy|1|||
105744388|NCT03987620|364716929|FG001|Overall Study|Pregnancy|0|||
105744389|NCT03987620|364716928|FG000|Overall Study|Withdrawal by Subject|7|||
105744390|NCT03987620|364716929|FG001|Overall Study|Withdrawal by Subject|1|||
105744391|NCT03987620|364716928|FG000|Overall Study|Other|2|||
105744392|NCT03987620|364716929|FG001|Overall Study|Other|5|||
105744393|NCT01204658|364716930|FG000|Primary Phase|Adverse Event|0|||
105744394|NCT01204658|364716931|FG001|Primary Phase|Adverse Event|0|||
105942838|NCT05252702|365452869|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
105942839|NCT05252702|365452869|FG000|Overall Study|Death|16|||
105942840|NCT05252702|365452869|FG000|Overall Study|System explant|5|||
105942841|NCT05252702|365452869|FG000|Overall Study|Lost to Follow-up|1|||
105942842|NCT05252702|365452869|FG000|Overall Study|Withdrawn by investigator|1|||
105942843|NCT05252702|365452869|FG000|Overall Study|Visit not due|306|||
105942844|NCT05252702|365452869|FG000|Overall Study|Visit within window but not completed|92|||
105942845|NCT05252702|365452869|FG000|Overall Study|Unsuccessful implant|1|||
105942846|NCT02607722|365452870|FG000|Overall Study|No data reliability|1|||
105942847|NCT02607722|365452870|FG000|Overall Study|no patient visit|18|||
105942848|NCT02607722|365452870|FG000|Overall Study|missing info in CRF|13|||
105942849|NCT02607722|365452870|FG000|Overall Study|Withdrawal by Subject|616|||
105942850|NCT02607722|365452870|FG000|Overall Study|Lost to Follow-up|312|||
105942851|NCT02607722|365452870|FG000|Overall Study|Improved|22|||
105942852|NCT02607722|365452870|FG000|Overall Study|Lack of Efficacy|316|||
105942853|NCT02607722|365452870|FG000|Overall Study|Adverse Event|2553|||
105942854|NCT02607722|365452870|FG000|Overall Study|Not treated|1|||
105942855|NCT02607722|365452870|FG000|Overall Study|No CRF collected|138|||
105942856|NCT02607722|365452870|FG000|Overall Study|without CRF|4225|||
105942857|NCT02607722|365452870|FG000|Overall Study|Physician Decision|367|||
105942858|NCT03238196|365452871|FG000|Overall Study|Adverse Event|3|||
106142288|NCT01121549|366179956|FG000|Overall Study|Lack of Efficacy|11|||
105744395|NCT01204658|364716932|FG002|Primary Phase|Adverse Event|1|||
105942859|NCT03238196|365452872|FG001|Overall Study|Adverse Event|0|||
105942860|NCT03238196|365452873|FG002|Overall Study|Adverse Event|2|||
105942861|NCT03238196|365452874|FG003|Overall Study|Adverse Event|2|||
105942862|NCT03238196|365452871|FG000|Overall Study|Withdrawal by Subject|4|||
105942863|NCT03238196|365452872|FG001|Overall Study|Withdrawal by Subject|1|||
105942864|NCT03238196|365452873|FG002|Overall Study|Withdrawal by Subject|1|||
105744396|NCT01204658|364716933|FG003|Primary Phase|Adverse Event|0|||
105744397|NCT04937816|364716934|FG000|Overall Study|Study drug stopped, reason missing|5|||
105800416|NCT00863057|364926464|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
105800417|NCT00863057|364926465|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
105800418|NCT00863057|364926466|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
105800419|NCT00863057|364926467|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
105800420|NCT00863057|364926464|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
105800421|NCT00863057|364926465|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
105800422|NCT00863057|364926466|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
105800423|NCT00863057|364926467|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
105800424|NCT00863057|364926464|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
105800425|NCT00863057|364926465|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
105800426|NCT00863057|364926466|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
105800427|NCT00863057|364926467|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
105800428|NCT00863057|364926464|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
105800429|NCT00863057|364926465|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
105800430|NCT00863057|364926466|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
105800431|NCT00863057|364926467|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
105800432|NCT01789281|364926472|FG000|Overall Study|Disease progression|15|||
105800433|NCT01789281|364926473|FG001|Overall Study|Disease progression|4|||
105800434|NCT01789281|364926472|FG000|Overall Study|Adverse Event|5|||
105800435|NCT01789281|364926473|FG001|Overall Study|Adverse Event|5|||
105800436|NCT01789281|364926472|FG000|Overall Study|Withdrawal by Subject|1|||
105800437|NCT01789281|364926473|FG001|Overall Study|Withdrawal by Subject|0|||
105800438|NCT01789281|364926472|FG000|Overall Study|Lost to Follow-up|1|||
105800439|NCT01789281|364926473|FG001|Overall Study|Lost to Follow-up|0|||
105800440|NCT01789281|364926472|FG000|Overall Study|Administrative problems|0|||
105800441|NCT01789281|364926473|FG001|Overall Study|Administrative problems|1|||
105800442|NCT00106028|364926474|FG000|Overall Study|Adverse Event|3|||
105800443|NCT00106028|364926475|FG001|Overall Study|Adverse Event|2|||
105800444|NCT00106028|364926474|FG000|Overall Study|Protocol Violation|1|||
105800445|NCT00106028|364926475|FG001|Overall Study|Protocol Violation|1|||
105800446|NCT00106028|364926474|FG000|Overall Study|Withdrawal by Subject|2|||
105800447|NCT00106028|364926475|FG001|Overall Study|Withdrawal by Subject|8|||
105800448|NCT00106028|364926474|FG000|Overall Study|Lost to Follow-up|0|||
105800449|NCT00106028|364926475|FG001|Overall Study|Lost to Follow-up|1|||
105800450|NCT00814658|364926476|FG000|Overall Study|Lost to Follow-up|0|||
105800451|NCT00814658|364926477|FG001|Overall Study|Lost to Follow-up|1|||
105800452|NCT00814658|364926476|FG000|Overall Study|Physician Decision|1|||
105800453|NCT00814658|364926477|FG001|Overall Study|Physician Decision|0|||
105800454|NCT00814658|364926476|FG000|Overall Study|Adverse Event|3|||
105800455|NCT00814658|364926477|FG001|Overall Study|Adverse Event|3|||
105800456|NCT00738920|364926484|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
105800457|NCT00738920|364926485|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
105800458|NCT00738920|364926486|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
106015340|NCT02963506|365721017|FG010|Dose-Blind Period|Adverse Event|1|||
105744398|NCT04937816|364716935|FG001|Overall Study|Study drug stopped, reason missing|3|||
105744399|NCT04937816|364716936|FG002|Overall Study|Study drug stopped, reason missing|4|||
105744400|NCT04937816|364716937|FG003|Overall Study|Study drug stopped, reason missing|6|||
105744401|NCT04937816|364716938|FG004|Overall Study|Study drug stopped, reason missing|1|||
105744402|NCT04937816|364716939|FG005|Overall Study|Study drug stopped, reason missing|0|||
105744403|NCT04937816|364716940|FG006|Overall Study|Study drug stopped, reason missing|0|||
105744404|NCT04937816|364716934|FG000|Overall Study|Other than stated below|173|||
105744405|NCT04937816|364716935|FG001|Overall Study|Other than stated below|143|||
105744406|NCT04937816|364716936|FG002|Overall Study|Other than stated below|125|||
105744407|NCT04937816|364716937|FG003|Overall Study|Other than stated below|44|||
105744408|NCT04937816|364716938|FG004|Overall Study|Other than stated below|45|||
105744409|NCT04937816|364716939|FG005|Overall Study|Other than stated below|28|||
106015341|NCT02963506|365721018|FG011|Dose-Blind Period|Adverse Event|1|||
105744410|NCT04937816|364716940|FG006|Overall Study|Other than stated below|31|||
105744411|NCT04937816|364716934|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
105744412|NCT04937816|364716935|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
105744413|NCT04937816|364716936|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
105744414|NCT04937816|364716937|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
105800459|NCT00738920|364926484|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
105800460|NCT00738920|364926485|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
105800461|NCT00738920|364926486|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
105800462|NCT00738920|364926484|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
105800463|NCT00738920|364926485|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
105800464|NCT00738920|364926486|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
105800465|NCT00738920|364926484|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
105800466|NCT00738920|364926485|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
106142289|NCT01121549|366179956|FG000|Overall Study|Lost to Follow-up|12|||
105800467|NCT00738920|364926486|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
105800468|NCT00738920|364926484|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
106015342|NCT02963506|365721019|FG012|Dose-Blind Period|Adverse Event|6|||
106015343|NCT02963506|365721007|FG000|Dose-Blind Period|Lack of Efficacy|0|||
106015344|NCT02963506|365721008|FG001|Dose-Blind Period|Lack of Efficacy|0|||
106015345|NCT02963506|365721009|FG002|Dose-Blind Period|Lack of Efficacy|0|||
106015346|NCT02963506|365721010|FG003|Dose-Blind Period|Lack of Efficacy|0|||
106015347|NCT02963506|365721011|FG004|Dose-Blind Period|Lack of Efficacy|0|||
106015348|NCT02963506|365721012|FG005|Dose-Blind Period|Lack of Efficacy|0|||
106015349|NCT02963506|365721013|FG006|Dose-Blind Period|Lack of Efficacy|0|||
106015350|NCT02963506|365721014|FG007|Dose-Blind Period|Lack of Efficacy|1|||
106015351|NCT02963506|365721015|FG008|Dose-Blind Period|Lack of Efficacy|0|||
106015352|NCT02963506|365721016|FG009|Dose-Blind Period|Lack of Efficacy|1|||
106015353|NCT02963506|365721017|FG010|Dose-Blind Period|Lack of Efficacy|0|||
106015354|NCT02963506|365721018|FG011|Dose-Blind Period|Lack of Efficacy|0|||
106015355|NCT02963506|365721019|FG012|Dose-Blind Period|Lack of Efficacy|0|||
106015356|NCT02963506|365721007|FG000|Dose-Blind Period|Lost to Follow-up|0|||
106015357|NCT02963506|365721008|FG001|Dose-Blind Period|Lost to Follow-up|0|||
106015358|NCT02963506|365721009|FG002|Dose-Blind Period|Lost to Follow-up|0|||
106015359|NCT02963506|365721010|FG003|Dose-Blind Period|Lost to Follow-up|0|||
106015360|NCT02963506|365721011|FG004|Dose-Blind Period|Lost to Follow-up|0|||
106015361|NCT02963506|365721012|FG005|Dose-Blind Period|Lost to Follow-up|1|||
106015362|NCT02963506|365721013|FG006|Dose-Blind Period|Lost to Follow-up|0|||
106015363|NCT02963506|365721014|FG007|Dose-Blind Period|Lost to Follow-up|0|||
106015364|NCT02963506|365721015|FG008|Dose-Blind Period|Lost to Follow-up|1|||
106015365|NCT02963506|365721016|FG009|Dose-Blind Period|Lost to Follow-up|0|||
106015366|NCT02963506|365721017|FG010|Dose-Blind Period|Lost to Follow-up|0|||
106015367|NCT02963506|365721018|FG011|Dose-Blind Period|Lost to Follow-up|1|||
106015368|NCT02963506|365721019|FG012|Dose-Blind Period|Lost to Follow-up|0|||
106015369|NCT02963506|365721007|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
106015370|NCT02963506|365721008|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
106015371|NCT02963506|365721009|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
106015372|NCT02963506|365721010|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
106015373|NCT02963506|365721011|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
106015374|NCT02963506|365721012|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
106015375|NCT02963506|365721013|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
106015376|NCT02963506|365721014|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
106015377|NCT02963506|365721015|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
106015378|NCT02963506|365721016|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
106015379|NCT02963506|365721017|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
106142290|NCT01121549|366179956|FG000|Overall Study|Did not meet entrance criteria|9|||
106142291|NCT01121549|366179956|FG000|Overall Study|Study terminated by sponsor|197|||
105744415|NCT04937816|364716938|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
105744416|NCT04937816|364716939|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
105744417|NCT04937816|364716940|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
105744418|NCT04937816|364716934|FG000|Overall Study|Lost to Follow-up|15|||
105744419|NCT04937816|364716935|FG001|Overall Study|Lost to Follow-up|9|||
105744420|NCT04937816|364716936|FG002|Overall Study|Lost to Follow-up|6|||
105744421|NCT04937816|364716937|FG003|Overall Study|Lost to Follow-up|6|||
105744422|NCT04937816|364716938|FG004|Overall Study|Lost to Follow-up|16|||
105744423|NCT04937816|364716939|FG005|Overall Study|Lost to Follow-up|11|||
105744424|NCT04937816|364716940|FG006|Overall Study|Lost to Follow-up|17|||
105744425|NCT04937816|364716934|FG000|Overall Study|Protocol Violation|15|||
105744426|NCT04937816|364716935|FG001|Overall Study|Protocol Violation|15|||
105744427|NCT04937816|364716936|FG002|Overall Study|Protocol Violation|12|||
105744428|NCT04937816|364716937|FG003|Overall Study|Protocol Violation|30|||
105744429|NCT04937816|364716938|FG004|Overall Study|Protocol Violation|24|||
105744430|NCT04937816|364716939|FG005|Overall Study|Protocol Violation|5|||
105744431|NCT04937816|364716940|FG006|Overall Study|Protocol Violation|5|||
105744432|NCT04937816|364716934|FG000|Overall Study|Adverse Event|303|||
105744433|NCT04937816|364716935|FG001|Overall Study|Adverse Event|267|||
105744434|NCT04937816|364716936|FG002|Overall Study|Adverse Event|273|||
105744435|NCT04937816|364716937|FG003|Overall Study|Adverse Event|553|||
105744436|NCT04937816|364716938|FG004|Overall Study|Adverse Event|575|||
105744437|NCT04937816|364716939|FG005|Overall Study|Adverse Event|343|||
105744438|NCT04937816|364716940|FG006|Overall Study|Adverse Event|337|||
105744439|NCT04937816|364716934|FG000|Overall Study|Not treated|4|||
105744440|NCT04937816|364716935|FG001|Overall Study|Not treated|2|||
105744441|NCT04937816|364716936|FG002|Overall Study|Not treated|2|||
105744442|NCT04937816|364716937|FG003|Overall Study|Not treated|2|||
105744443|NCT04937816|364716938|FG004|Overall Study|Not treated|1|||
106015380|NCT02963506|365721018|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
106015381|NCT02963506|365721019|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
106015382|NCT02963506|365721007|FG000|Dose-Blind Period|Sponsor decision|0|||
106015383|NCT02963506|365721008|FG001|Dose-Blind Period|Sponsor decision|0|||
106015384|NCT02963506|365721009|FG002|Dose-Blind Period|Sponsor decision|0|||
106015385|NCT02963506|365721010|FG003|Dose-Blind Period|Sponsor decision|0|||
106015386|NCT02963506|365721011|FG004|Dose-Blind Period|Sponsor decision|0|||
105744444|NCT04937816|364716939|FG005|Overall Study|Not treated|4|||
106015387|NCT02963506|365721012|FG005|Dose-Blind Period|Sponsor decision|1|||
106015388|NCT02963506|365721013|FG006|Dose-Blind Period|Sponsor decision|0|||
106015389|NCT02963506|365721014|FG007|Dose-Blind Period|Sponsor decision|0|||
106015390|NCT02963506|365721015|FG008|Dose-Blind Period|Sponsor decision|0|||
106015391|NCT02963506|365721016|FG009|Dose-Blind Period|Sponsor decision|0|||
106015392|NCT02963506|365721017|FG010|Dose-Blind Period|Sponsor decision|0|||
106015393|NCT02963506|365721018|FG011|Dose-Blind Period|Sponsor decision|0|||
106015394|NCT02963506|365721019|FG012|Dose-Blind Period|Sponsor decision|0|||
106015395|NCT02963506|365721007|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015396|NCT02963506|365721008|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015397|NCT02963506|365721009|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015398|NCT02963506|365721010|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015399|NCT02963506|365721011|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015400|NCT02963506|365721012|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015401|NCT02963506|365721013|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015402|NCT02963506|365721014|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015403|NCT02963506|365721015|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015404|NCT02963506|365721016|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015405|NCT02963506|365721017|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
106015406|NCT02963506|365721018|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
105744445|NCT04937816|364716940|FG006|Overall Study|Not treated|0|||
105744446|NCT02364947|364719177|FG000|Overall Study|Withdrawal by Subject|10|||
105744447|NCT02364947|364719178|FG001|Overall Study|Withdrawal by Subject|8|||
105744448|NCT02364947|364719179|FG002|Overall Study|Withdrawal by Subject|9|||
105744449|NCT02364947|364719177|FG000|Overall Study|Adverse Event|45|||
105744450|NCT02364947|364719178|FG001|Overall Study|Adverse Event|33|||
105744451|NCT02364947|364719179|FG002|Overall Study|Adverse Event|11|||
105744452|NCT02364947|364719177|FG000|Overall Study|Protocol Violation|1|||
105744453|NCT02364947|364719178|FG001|Overall Study|Protocol Violation|1|||
105744454|NCT02364947|364719179|FG002|Overall Study|Protocol Violation|1|||
105744455|NCT02364947|364719177|FG000|Overall Study|Physician Decision|3|||
105744456|NCT02364947|364719178|FG001|Overall Study|Physician Decision|2|||
105744457|NCT02364947|364719179|FG002|Overall Study|Physician Decision|5|||
105744458|NCT02364947|364719177|FG000|Overall Study|Death|0|||
105744459|NCT02364947|364719178|FG001|Overall Study|Death|1|||
105744460|NCT02364947|364719179|FG002|Overall Study|Death|0|||
105744461|NCT05525975|364719180|FG000|Overall Study|Surgery cancellation|4|||
105744462|NCT05525975|364719181|FG001|Overall Study|Surgery cancellation|5|||
105744463|NCT05525975|364719180|FG000|Overall Study|didn't fill prescription|1|||
105744464|NCT05525975|364719181|FG001|Overall Study|didn't fill prescription|0|||
105744465|NCT05525975|364719180|FG000|Overall Study|Withdrawal by Subject|0|||
105744466|NCT05525975|364719181|FG001|Overall Study|Withdrawal by Subject|3|||
105744467|NCT00615290|364719182|FG000|Overall Study|Adverse Event|2|||
105744468|NCT00615290|364719182|FG000|Overall Study|Lost to Follow-up|3|||
105744469|NCT00615290|364719182|FG000|Overall Study|Withdrawal by Subject|1|||
105744470|NCT00615290|364719182|FG000|Overall Study|Other|2|||
105744471|NCT00441441|364719186|FG000|Overall Study|Adverse Event|2|||
105744472|NCT00441441|364719187|FG001|Overall Study|Adverse Event|1|||
105744473|NCT00441441|364719186|FG000|Overall Study|Protocol Violation|4|||
105744474|NCT00441441|364719187|FG001|Overall Study|Protocol Violation|6|||
105744475|NCT00441441|364719186|FG000|Overall Study|Exacerbation of asthma|1|||
105744476|NCT00441441|364719187|FG001|Overall Study|Exacerbation of asthma|2|||
105744477|NCT00441441|364719186|FG000|Overall Study|Withdrawal by Subject|1|||
105744478|NCT00441441|364719187|FG001|Overall Study|Withdrawal by Subject|2|||
105744479|NCT00441441|364719186|FG000|Overall Study|Other|3|||
105744480|NCT00441441|364719187|FG001|Overall Study|Other|3|||
105744481|NCT00262080|364719188|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
105744482|NCT00262080|364719189|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105744483|NCT00262080|364719190|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
105744484|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
105744485|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
105744486|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
105744487|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
105744488|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
105744489|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
105800469|NCT00738920|364926485|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
105800470|NCT00738920|364926486|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
106015407|NCT02963506|365721019|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
106015408|NCT02129699|365721020|FG000|Overall Study|Did not start treatment|3|||
106015409|NCT02129699|365721021|FG001|Overall Study|Did not start treatment|2|||
106015410|NCT00750438|365721025|FG000|Overall Study|Protocol Violation|4|||
105744490|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
105744491|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
105744492|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
106015411|NCT00750438|365721026|FG001|Overall Study|Protocol Violation|1|||
105800471|NCT00738920|364926484|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
105800472|NCT00738920|364926485|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
105800473|NCT00738920|364926486|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
105800474|NCT00738920|364926484|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
105800475|NCT00738920|364926485|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
105744493|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
105800476|NCT00738920|364926486|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
105800477|NCT00738920|364926484|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
105800478|NCT00738920|364926485|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
105800479|NCT00738920|364926486|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
105800480|NCT00738920|364926484|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
105800481|NCT00738920|364926485|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
105800482|NCT00738920|364926486|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
105800483|NCT00738920|364926484|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
105800484|NCT00738920|364926485|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
105800485|NCT00738920|364926486|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
105800486|NCT02133352|364926487|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
105800487|NCT03016078|364926488|FG000|Overall Study|Protocol Violation|1|||
105800488|NCT03016078|364926488|FG000|Overall Study|Protocol Violation|1|||
105800489|NCT02378506|364926489|FG000|Overall Study|Lack of Efficacy|3|||
105800490|NCT02378506|364926489|FG000|Overall Study|Withdrawal by Subject|4|||
105800491|NCT02378506|364926489|FG000|Overall Study|Protocol Violation|2|||
105800492|NCT02378506|364926489|FG000|Overall Study|Death|1|||
105800493|NCT02378506|364926489|FG000|Overall Study|Adverse Event|14|||
105800494|NCT02378506|364926489|FG000|Overall Study|Randomized But Not Treated|1|||
105800495|NCT02557672|364926490|FG000|Overall Study|Withdrawal by Subject|4|||
105800496|NCT02557672|364926491|FG001|Overall Study|Withdrawal by Subject|2|||
105800497|NCT01355523|364928467|FG000|Overall Study|Withdrawal by Subject|1|||
105800498|NCT01355523|364928468|FG001|Overall Study|Withdrawal by Subject|4|||
105800499|NCT01355523|364928467|FG000|Overall Study|Lost to Follow-up|0|||
105800500|NCT01355523|364928468|FG001|Overall Study|Lost to Follow-up|2|||
105800501|NCT01355523|364928467|FG000|Overall Study|Protocol Violation|0|||
105800502|NCT01355523|364928468|FG001|Overall Study|Protocol Violation|2|||
105800503|NCT01355523|364928467|FG000|Overall Study|Adverse Event|0|||
105800504|NCT01355523|364928468|FG001|Overall Study|Adverse Event|2|||
105800505|NCT00566098|364928472|FG000|Collection of MILs|Withdrawal by Subject|1|||
105800506|NCT00566098|364928472|FG000|Collection of MILs|Relapsed|1|||
105800507|NCT00566098|364928472|FG000|Generation of MILs Product|Relapsed|1|||
105800508|NCT00566098|364928472|FG000|Administration of ASCT+MILs|Death|10|||
105800509|NCT00566098|364928472|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
105800510|NCT03836729|364928473|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
105800511|NCT02544633|364928476|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
105800512|NCT02544633|364928477|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
105800513|NCT02544633|364928478|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
105800514|NCT02544633|364928479|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
105744494|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
105744495|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
105800515|NCT02544633|364928476|FG000|Treatment Period|Adverse Event|7|||
105800516|NCT02544633|364928477|FG001|Treatment Period|Adverse Event|4|||
105800517|NCT02544633|364928478|FG002|Treatment Period|Adverse Event|0|||
105800518|NCT02544633|364928479|FG003|Treatment Period|Adverse Event|5|||
105744496|NCT00262080|364719188|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
105744497|NCT00262080|364719189|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
105744498|NCT00262080|364719190|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
105744499|NCT02273752|364719191|FG000|Overall Study|Trial was terminated early|2|||
105744500|NCT03580382|364719192|FG000|Overall Study|Early Termination of Study|0|||
105744501|NCT03580382|364719193|FG001|Overall Study|Early Termination of Study|3|||
105744502|NCT02808312|364719194|FG000|Overall Study|Enrolled but Never Treated|0|||
105744503|NCT02808312|364719195|FG001|Overall Study|Enrolled but Never Treated|0|||
105800519|NCT02544633|364928476|FG000|Treatment Period|Lack of Efficacy|17|||
105800520|NCT02544633|364928477|FG001|Treatment Period|Lack of Efficacy|11|||
106015412|NCT00750438|365721025|FG000|Overall Study|Physician Decision|2|||
106015413|NCT00750438|365721026|FG001|Overall Study|Physician Decision|2|||
105800521|NCT02544633|364928478|FG002|Treatment Period|Lack of Efficacy|5|||
105800522|NCT02544633|364928479|FG003|Treatment Period|Lack of Efficacy|5|||
105800523|NCT02544633|364928476|FG000|Treatment Period|Global Deterioration of Health|3|||
106015414|NCT00750438|365721025|FG000|Overall Study|Withdrawal by Subject|1|||
105800524|NCT02544633|364928477|FG001|Treatment Period|Global Deterioration of Health|3|||
105800525|NCT02544633|364928478|FG002|Treatment Period|Global Deterioration of Health|0|||
105800526|NCT02544633|364928479|FG003|Treatment Period|Global Deterioration of Health|1|||
105800527|NCT02544633|364928476|FG000|Treatment Period|Withdrawal by Subject|1|||
105800528|NCT02544633|364928477|FG001|Treatment Period|Withdrawal by Subject|0|||
106015415|NCT00750438|365721026|FG001|Overall Study|Withdrawal by Subject|1|||
106015416|NCT01108185|365721030|FG000|Overall Study|Non-compliance|15|||
106015417|NCT01108185|365721030|FG000|Overall Study|Lost to Follow-up|12|||
106015418|NCT02581410|365721031|FG000|Vaccination Phase|Adverse Event|2|||
106015419|NCT02581410|365721032|FG001|Vaccination Phase|Adverse Event|1|||
106015420|NCT02581410|365721031|FG000|Vaccination Phase|Withdrawal by Subject|0|||
106015421|NCT02581410|365721032|FG001|Vaccination Phase|Withdrawal by Subject|1|||
106015422|NCT02581410|365721031|FG000|Vaccination Phase|Migrated/moved from study area|0|||
106015423|NCT02581410|365721032|FG001|Vaccination Phase|Migrated/moved from study area|1|||
106015424|NCT02581410|365721031|FG000|End of Study Phase|Adverse Event|4|||
106015425|NCT02581410|365721032|FG001|End of Study Phase|Adverse Event|3|||
106015426|NCT02581410|365721031|FG000|End of Study Phase|Withdrawal by Subject|1|||
106015427|NCT02581410|365721032|FG001|End of Study Phase|Withdrawal by Subject|2|||
106015428|NCT02581410|365721031|FG000|End of Study Phase|Migrated/moved from study area|0|||
106015429|NCT02581410|365721032|FG001|End of Study Phase|Migrated/moved from study area|3|||
106015430|NCT02581410|365721031|FG000|End of Study Phase|Lost to Follow-up|0|||
106015431|NCT02581410|365721032|FG001|End of Study Phase|Lost to Follow-up|2|||
106015432|NCT02581410|365721031|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
106015433|NCT02581410|365721032|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
106015434|NCT00670748|365721037|FG000|Overall Study|Death during treatment|1|||
106015435|NCT00670748|365721038|FG001|Overall Study|Death during treatment|1|||
106015436|NCT00670748|365721039|FG002|Overall Study|Death during treatment|1|||
106015437|NCT00670748|365721040|FG003|Overall Study|Death during treatment|0|||
106015438|NCT00670748|365721037|FG000|Overall Study|Not off study|2|||
106015439|NCT00670748|365721038|FG001|Overall Study|Not off study|1|||
106015440|NCT00670748|365721039|FG002|Overall Study|Not off study|1|||
106015441|NCT00670748|365721040|FG003|Overall Study|Not off study|1|||
106015442|NCT03493464|365721057|FG000|Overall Study|Surgery not performed|1|||
106015443|NCT02807402|365721058|FG000|Overall Study|Failure to Return|1|||
105744504|NCT02808312|364719196|FG002|Overall Study|Enrolled but Never Treated|1|||
105744505|NCT02808312|364719197|FG003|Overall Study|Enrolled but Never Treated|0|||
105744506|NCT02808312|364719198|FG004|Overall Study|Enrolled but Never Treated|0|||
105744507|NCT01826422|364719204|FG000|Overall Study|Withdrawal by Subject|1|||
105744508|NCT01826422|364719205|FG001|Overall Study|Withdrawal by Subject|3|||
105744509|NCT04009096|364719206|FG000|Overall Study|Withdrawal by Subject|0|||
105744510|NCT04009096|364719207|FG001|Overall Study|Withdrawal by Subject|7|||
105744511|NCT04009096|364719208|FG002|Overall Study|Withdrawal by Subject|0|||
105744512|NCT04009096|364719206|FG000|Overall Study|Physician Decision|0|||
105744513|NCT04009096|364719207|FG001|Overall Study|Physician Decision|1|||
105744514|NCT04009096|364719208|FG002|Overall Study|Physician Decision|0|||
105744515|NCT05151471|364719209|FG000|Overall Study|Adverse Event|21|||
105744516|NCT05151471|364719210|FG001|Overall Study|Adverse Event|16|||
105744517|NCT05151471|364719209|FG000|Overall Study|Death|1|||
105744518|NCT05151471|364719210|FG001|Overall Study|Death|0|||
105744519|NCT05151471|364719209|FG000|Overall Study|Lost to Follow-up|0|||
105744520|NCT05151471|364719210|FG001|Overall Study|Lost to Follow-up|1|||
105744521|NCT05151471|364719209|FG000|Overall Study|Withdrawal by Subject|7|||
105744522|NCT05151471|364719210|FG001|Overall Study|Withdrawal by Subject|9|||
105744523|NCT05151471|364719209|FG000|Overall Study|Study terminated by sponsor|49|||
105744524|NCT05151471|364719210|FG001|Overall Study|Study terminated by sponsor|47|||
105744525|NCT05151471|364719209|FG000|Overall Study|Other|2|||
105744526|NCT05151471|364719210|FG001|Overall Study|Other|1|||
105744527|NCT04263142|364719211|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
105744528|NCT04263142|364719212|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
105744529|NCT04263142|364719213|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
105744530|NCT04263142|364719214|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
105744531|NCT04263142|364719215|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
105744532|NCT04263142|364719211|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
105744533|NCT04263142|364719212|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
105744534|NCT04263142|364719213|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
105744535|NCT04263142|364719214|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
105744536|NCT04263142|364719215|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
105744537|NCT00718419|364719216|FG000|Overall Study|Adverse Event|2|||
105744538|NCT00718419|364719217|FG001|Overall Study|Adverse Event|1|||
105744539|NCT00718419|364719216|FG000|Overall Study|Physician Decision|1|||
105744540|NCT00718419|364719217|FG001|Overall Study|Physician Decision|6|||
105744541|NCT00718419|364719216|FG000|Overall Study|Sponsor decision|0|||
106015444|NCT02807402|365721058|FG000|Overall Study|Death|3|||
106015445|NCT02807402|365721058|FG000|Overall Study|Other|2|||
106015446|NCT03910244|365723187|FG000|Overall Study|Adverse Event|14|||
106015447|NCT03910244|365723188|FG001|Overall Study|Adverse Event|0|||
106015448|NCT03910244|365723187|FG000|Overall Study|Death|1|||
106015449|NCT03910244|365723188|FG001|Overall Study|Death|0|||
106015450|NCT03910244|365723187|FG000|Overall Study|Lost to Follow-up|0|||
105744542|NCT00718419|364719217|FG001|Overall Study|Sponsor decision|1|||
106015451|NCT03910244|365723188|FG001|Overall Study|Lost to Follow-up|2|||
106015452|NCT03910244|365723187|FG000|Overall Study|Joint withdrawal decision|1|||
106015453|NCT03910244|365723188|FG001|Overall Study|Joint withdrawal decision|0|||
106015454|NCT03910244|365723187|FG000|Overall Study|Study Terminated by Sponsor|7|||
106015455|NCT03910244|365723188|FG001|Overall Study|Study Terminated by Sponsor|4|||
106015456|NCT03910244|365723187|FG000|Overall Study|Physician Decision|1|||
106015457|NCT03910244|365723188|FG001|Overall Study|Physician Decision|0|||
106015458|NCT03910244|365723187|FG000|Overall Study|Protocol Violation|1|||
106015459|NCT03910244|365723188|FG001|Overall Study|Protocol Violation|0|||
105744543|NCT00718419|364719216|FG000|Overall Study|Withdrawal by Subject|0|||
105744544|NCT00718419|364719217|FG001|Overall Study|Withdrawal by Subject|5|||
105744545|NCT00718419|364719216|FG000|Overall Study|Progressive Disease|7|||
105744546|NCT00718419|364719217|FG001|Overall Study|Progressive Disease|25|||
105744547|NCT00718419|364719216|FG000|Overall Study|Death Due to Progressive Disease|2|||
105744548|NCT00718419|364719217|FG001|Overall Study|Death Due to Progressive Disease|0|||
105744549|NCT00718419|364719216|FG000|Overall Study|Death Due to Study Drug Related|0|||
105744550|NCT00718419|364719217|FG001|Overall Study|Death Due to Study Drug Related|1|||
105744551|NCT00718419|364719216|FG000|Overall Study|Death Due to Adverse Events|1|||
105744552|NCT00718419|364719217|FG001|Overall Study|Death Due to Adverse Events|0|||
105744553|NCT01623531|364719220|FG000|Overall Study|Death|1|||
105744554|NCT01623531|364719221|FG001|Overall Study|Death|0|||
105744555|NCT01623531|364719220|FG000|Overall Study|Protocol Violation|2|||
105744556|NCT01623531|364719221|FG001|Overall Study|Protocol Violation|1|||
105744557|NCT01623531|364719220|FG000|Overall Study|Missing data at primary outcome time poi|1|||
105744558|NCT01623531|364719221|FG001|Overall Study|Missing data at primary outcome time poi|1|||
105744559|NCT01429792|364719222|FG000|Overall Study|Other Reasons|67|||
105744560|NCT01429792|364719222|FG000|Overall Study|Unknown Disposition|94|||
105744561|NCT01429792|364719222|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
105744562|NCT01429792|364719222|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
105744563|NCT01429792|364719222|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
105744564|NCT01429792|364719222|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
105744565|NCT01429792|364719222|FG000|Overall Study|Withdrawal by Subject|70|||
105744566|NCT01429792|364719222|FG000|Overall Study|Lost to Follow-up|88|||
105744567|NCT00450372|364719224|FG000|Overall Study|Physician Decision|1|||
105744568|NCT00520676|364719226|FG000|Overall Study|Death|84|||
105744569|NCT00520676|364719227|FG001|Overall Study|Death|81|||
105744570|NCT00520676|364719226|FG000|Overall Study|Lost to Follow-up|6|||
105744571|NCT00520676|364719227|FG001|Overall Study|Lost to Follow-up|10|||
105744572|NCT00520676|364719226|FG000|Overall Study|Physician Decision|4|||
105744573|NCT00520676|364719227|FG001|Overall Study|Physician Decision|1|||
106015460|NCT03910244|365723187|FG000|Overall Study|Withdrawal by Subject|7|||
106015461|NCT03910244|365723188|FG001|Overall Study|Withdrawal by Subject|2|||
106015462|NCT02489318|365723189|FG000|Randomized|Withdrawal by Subject|0|||
106142292|NCT01121549|366179956|FG000|Overall Study|Pregnancy|1|||
106142293|NCT01121549|366179956|FG000|Overall Study|Protocol Violation|33|||
106142294|NCT01121549|366179956|FG000|Overall Study|Withdrawal by Subject|16|||
106142295|NCT01121549|366179956|FG000|Overall Study|Other|58|||
106142296|NCT02041104|366179957|FG000|Overall Study|Lost to Follow-up|1|||
106142297|NCT02041104|366179958|FG001|Overall Study|Lost to Follow-up|4|||
106142298|NCT02041104|366179957|FG000|Overall Study|discomfort during OGTT|0|||
106142299|NCT02041104|366179958|FG001|Overall Study|discomfort during OGTT|3|||
106142300|NCT01063517|366179959|FG000|Overall Study|Consent withdrawal|1|||
106142301|NCT01063517|366179960|FG001|Overall Study|Consent withdrawal|0|||
106142302|NCT01063517|366179959|FG000|Overall Study|Study reached data cut-off|19|||
106142303|NCT01063517|366179960|FG001|Overall Study|Study reached data cut-off|7|||
106142304|NCT01063517|366179959|FG000|Overall Study|Lost to Follow-up|4|||
106142305|NCT01063517|366179960|FG001|Overall Study|Lost to Follow-up|3|||
106142306|NCT01063517|366179959|FG000|Overall Study|Withdrawal by Subject|1|||
106142307|NCT01063517|366179960|FG001|Overall Study|Withdrawal by Subject|2|||
105744574|NCT00520676|364719226|FG000|Overall Study|Withdrawal by Subject|7|||
105744575|NCT00520676|364719227|FG001|Overall Study|Withdrawal by Subject|11|||
105744576|NCT03484923|364719230|FG000|Overall Study|Adverse Event|3|||
105744577|NCT03484923|364719231|FG001|Overall Study|Adverse Event|3|||
105744578|NCT03484923|364719232|FG002|Overall Study|Adverse Event|5|||
105744579|NCT03484923|364719233|FG003|Overall Study|Adverse Event|11|||
105744580|NCT03484923|364719234|FG004|Overall Study|Adverse Event|1|||
105744581|NCT03484923|364719230|FG000|Overall Study|Death|2|||
105744582|NCT03484923|364719231|FG001|Overall Study|Death|2|||
105744583|NCT03484923|364719232|FG002|Overall Study|Death|3|||
105744584|NCT03484923|364719233|FG003|Overall Study|Death|0|||
105744585|NCT03484923|364719234|FG004|Overall Study|Death|1|||
105744586|NCT03484923|364719230|FG000|Overall Study|Physician Decision|6|||
106015463|NCT02489318|365723190|FG001|Randomized|Withdrawal by Subject|1|||
106015464|NCT02489318|365723189|FG000|Treated|Adverse Event|19|||
106015465|NCT02489318|365723190|FG001|Treated|Adverse Event|62|||
106142308|NCT01063517|366179959|FG000|Overall Study|Death|33|||
106142309|NCT01063517|366179960|FG001|Overall Study|Death|48|||
106142310|NCT00617201|366179963|FG000|Overall Study|Lost to Follow-up|9|||
106142311|NCT00617201|366179964|FG001|Overall Study|Lost to Follow-up|13|||
106142312|NCT00546871|366179965|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
105744587|NCT03484923|364719231|FG001|Overall Study|Physician Decision|7|||
105744588|NCT03484923|364719232|FG002|Overall Study|Physician Decision|6|||
105744589|NCT03484923|364719233|FG003|Overall Study|Physician Decision|3|||
105744590|NCT03484923|364719234|FG004|Overall Study|Physician Decision|2|||
105744591|NCT03484923|364719230|FG000|Overall Study|Progressive disease|33|||
105744592|NCT03484923|364719231|FG001|Overall Study|Progressive disease|28|||
105744593|NCT03484923|364719232|FG002|Overall Study|Progressive disease|26|||
105744594|NCT03484923|364719233|FG003|Overall Study|Progressive disease|30|||
105744595|NCT03484923|364719234|FG004|Overall Study|Progressive disease|16|||
105744596|NCT03484923|364719230|FG000|Overall Study|Subject Decision|1|||
105744597|NCT03484923|364719231|FG001|Overall Study|Subject Decision|3|||
105744598|NCT03484923|364719232|FG002|Overall Study|Subject Decision|3|||
105744599|NCT03484923|364719233|FG003|Overall Study|Subject Decision|0|||
105744600|NCT03484923|364719234|FG004|Overall Study|Subject Decision|1|||
105744601|NCT03439748|364719236|FG000|Overall Study|Withdrawal by Subject|11|||
105744602|NCT03439748|364719237|FG001|Overall Study|Withdrawal by Subject|17|||
105744603|NCT03165721|364719242|FG000|Overall Study|Refused further treatment|3|||
105744604|NCT03165721|364719243|FG001|Overall Study|Refused further treatment|0|||
105744605|NCT03165721|364719244|FG002|Overall Study|Refused further treatment|0|||
105744606|NCT03165721|364719242|FG000|Overall Study|Physician Decision|1|||
105744607|NCT03165721|364719243|FG001|Overall Study|Physician Decision|0|||
105744608|NCT03165721|364719244|FG002|Overall Study|Physician Decision|0|||
105744609|NCT01863849|364719245|FG000|Overall Study|Lost to Follow-up|1|||
105744610|NCT01863849|364719246|FG001|Overall Study|Lost to Follow-up|0|||
105744611|NCT01718509|364719249|FG000|Overall Study|Lost to Follow-up|18|||
105744612|NCT01718509|364719250|FG001|Overall Study|Lost to Follow-up|15|||
105744613|NCT01718509|364719249|FG000|Overall Study|Withdrawal by Subject|7|||
105744614|NCT01718509|364719250|FG001|Overall Study|Withdrawal by Subject|13|||
105744615|NCT01718509|364719249|FG000|Overall Study|Adverse Event|5|||
105744616|NCT01718509|364719250|FG001|Overall Study|Adverse Event|7|||
105942865|NCT03238196|365452874|FG003|Overall Study|Withdrawal by Subject|0|||
105942866|NCT03238196|365452871|FG000|Overall Study|Disease progression|14|||
105942867|NCT03238196|365452872|FG001|Overall Study|Disease progression|2|||
105942868|NCT03238196|365452873|FG002|Overall Study|Disease progression|3|||
105942869|NCT03238196|365452874|FG003|Overall Study|Disease progression|2|||
105942870|NCT03238196|365452871|FG000|Overall Study|Still on treatment|1|||
105942871|NCT03238196|365452872|FG001|Overall Study|Still on treatment|0|||
105942872|NCT03238196|365452873|FG002|Overall Study|Still on treatment|0|||
105942873|NCT03238196|365452874|FG003|Overall Study|Still on treatment|0|||
105942874|NCT04562090|365452875|FG000|Overall Study|Withdrawal by Subject|3|||
105942875|NCT04562090|365452876|FG001|Overall Study|Withdrawal by Subject|4|||
105942876|NCT04562090|365452875|FG000|Overall Study|Protocol Violation|2|||
105942877|NCT04562090|365452876|FG001|Overall Study|Protocol Violation|0|||
105942878|NCT04562090|365452875|FG000|Overall Study|Lack of Efficacy|0|||
105942879|NCT04562090|365452876|FG001|Overall Study|Lack of Efficacy|1|||
105942880|NCT04562090|365452875|FG000|Overall Study|Adverse Event|1|||
105942881|NCT04562090|365452876|FG001|Overall Study|Adverse Event|4|||
105942882|NCT04562090|365452875|FG000|Overall Study|Miscellaneous|0|||
105942883|NCT04562090|365452876|FG001|Overall Study|Miscellaneous|3|||
105942884|NCT00847730|365452877|FG000|Overall Study|Multiple interruptions in therapy|8|||
105942885|NCT04938427|365452880|FG000|Overall Study|Adverse Event|5|||
105942886|NCT04938427|365452881|FG001|Overall Study|Adverse Event|19|||
105942887|NCT04938427|365452880|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105942888|NCT04938427|365452881|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105942889|NCT04938427|365452880|FG000|Overall Study|Withdrawal by Subject|1|||
105942890|NCT04938427|365452881|FG001|Overall Study|Withdrawal by Subject|0|||
105942891|NCT04938427|365452880|FG000|Overall Study|Reason Not Specified|2|||
105942892|NCT04938427|365452881|FG001|Overall Study|Reason Not Specified|1|||
105942893|NCT02495883|365452882|FG000|Overall Study|Excessive head motion|1|||
105744617|NCT01718509|364719249|FG000|Overall Study|Other|13|||
105744618|NCT01718509|364719250|FG001|Overall Study|Other|11|||
105744619|NCT01718509|364719249|FG000|Overall Study|Protocol Violation|4|||
105744620|NCT01718509|364719250|FG001|Overall Study|Protocol Violation|2|||
105744621|NCT01718509|364719249|FG000|Overall Study|Lack of Efficacy|1|||
105744622|NCT01718509|364719250|FG001|Overall Study|Lack of Efficacy|0|||
105744623|NCT03456713|364719252|FG000|Overall Study|Lost to Follow-up|1|||
105942894|NCT02495883|365452883|FG001|Overall Study|Excessive head motion|0|||
105942895|NCT00618787|365452884|FG000|Overall Study|Adverse Event|0|||
105744624|NCT03456713|364719253|FG001|Overall Study|Lost to Follow-up|0|||
105744625|NCT03456713|364719254|FG002|Overall Study|Lost to Follow-up|0|||
105744626|NCT03456713|364719255|FG003|Overall Study|Lost to Follow-up|0|||
105744627|NCT01263691|364719256|FG000|Overall Study|Lost to Follow-up|1|||
105744628|NCT01263691|364719257|FG001|Overall Study|Lost to Follow-up|0|||
105942896|NCT00618787|365452885|FG001|Overall Study|Adverse Event|1|||
105744629|NCT01263691|364719258|FG002|Overall Study|Lost to Follow-up|1|||
105744630|NCT01263691|364719259|FG003|Overall Study|Lost to Follow-up|1|||
105744631|NCT01263691|364719260|FG004|Overall Study|Lost to Follow-up|0|||
105942897|NCT00618787|365452884|FG000|Overall Study|Withdrawal by Subject|2|||
105942898|NCT00618787|365452885|FG001|Overall Study|Withdrawal by Subject|1|||
106015466|NCT02489318|365723189|FG000|Treated|Death|13|||
106015467|NCT02489318|365723190|FG001|Treated|Death|11|||
106015468|NCT02489318|365723189|FG000|Treated|Physician Decision|4|||
106015469|NCT02489318|365723190|FG001|Treated|Physician Decision|6|||
106015470|NCT02489318|365723189|FG000|Treated|Protocol Violation|1|||
105744632|NCT01263691|364719261|FG005|Overall Study|Lost to Follow-up|0|||
105744633|NCT01263691|364719256|FG000|Overall Study|Withdrawal by Subject|1|||
105744634|NCT01263691|364719257|FG001|Overall Study|Withdrawal by Subject|0|||
105744635|NCT01263691|364719258|FG002|Overall Study|Withdrawal by Subject|0|||
105744636|NCT01263691|364719259|FG003|Overall Study|Withdrawal by Subject|0|||
105744637|NCT01263691|364719260|FG004|Overall Study|Withdrawal by Subject|0|||
105744638|NCT01263691|364719261|FG005|Overall Study|Withdrawal by Subject|0|||
105744639|NCT01263691|364719256|FG000|Overall Study|Adverse Event|1|||
105744640|NCT01263691|364719257|FG001|Overall Study|Adverse Event|0|||
105744641|NCT01263691|364719258|FG002|Overall Study|Adverse Event|0|||
105744642|NCT01263691|364719259|FG003|Overall Study|Adverse Event|0|||
105744643|NCT01263691|364719260|FG004|Overall Study|Adverse Event|0|||
105744644|NCT01263691|364719261|FG005|Overall Study|Adverse Event|0|||
105744645|NCT01728584|364719265|FG000|Overall Study|Adverse Event|1|||
105744646|NCT01728584|364719266|FG001|Overall Study|Adverse Event|0|||
105744647|NCT01728584|364719267|FG002|Overall Study|Adverse Event|0|||
105744648|NCT01728584|364719268|FG003|Overall Study|Adverse Event|0|||
105744649|NCT01728584|364719265|FG000|Overall Study|Physician Decision|4|||
105744650|NCT01728584|364719266|FG001|Overall Study|Physician Decision|0|||
105744651|NCT01728584|364719267|FG002|Overall Study|Physician Decision|1|||
105744652|NCT01728584|364719268|FG003|Overall Study|Physician Decision|0|||
105744653|NCT01728584|364719265|FG000|Overall Study|Withdrawal by Subject|1|||
105744654|NCT01728584|364719266|FG001|Overall Study|Withdrawal by Subject|0|||
105744655|NCT01728584|364719267|FG002|Overall Study|Withdrawal by Subject|0|||
105744656|NCT01728584|364719268|FG003|Overall Study|Withdrawal by Subject|0|||
105744657|NCT01728584|364719265|FG000|Overall Study|Screen failure|1|||
105744658|NCT01728584|364719266|FG001|Overall Study|Screen failure|0|||
105744659|NCT01728584|364719267|FG002|Overall Study|Screen failure|0|||
105744660|NCT01728584|364719268|FG003|Overall Study|Screen failure|0|||
105744661|NCT01728584|364719265|FG000|Overall Study|Other reason (not specified)|1|||
105744662|NCT01728584|364719266|FG001|Overall Study|Other reason (not specified)|0|||
105744663|NCT01728584|364719267|FG002|Overall Study|Other reason (not specified)|0|||
105744664|NCT01728584|364719268|FG003|Overall Study|Other reason (not specified)|1|||
105744665|NCT02935634|364719269|FG000|Randomization|Participant withdrew consent|0|||
105744666|NCT02935634|364719270|FG001|Randomization|Participant withdrew consent|1|||
105744667|NCT02935634|364719271|FG002|Randomization|Participant withdrew consent|0|||
105744668|NCT02935634|364719272|FG003|Randomization|Participant withdrew consent|0|||
105744669|NCT02935634|364719273|FG004|Randomization|Participant withdrew consent|0|||
105744670|NCT02935634|364719274|FG005|Randomization|Participant withdrew consent|0|||
105744671|NCT02935634|364719269|FG000|Randomization|Death|2|||
105744672|NCT02935634|364719270|FG001|Randomization|Death|1|||
105744673|NCT02935634|364719271|FG002|Randomization|Death|1|||
105744674|NCT02935634|364719272|FG003|Randomization|Death|0|||
105744675|NCT02935634|364719273|FG004|Randomization|Death|0|||
105744676|NCT02935634|364719274|FG005|Randomization|Death|0|||
105744677|NCT02935634|364719269|FG000|Randomization|Other reasons|0|||
105744678|NCT02935634|364719270|FG001|Randomization|Other reasons|2|||
105744679|NCT02935634|364719271|FG002|Randomization|Other reasons|2|||
105744680|NCT02935634|364719272|FG003|Randomization|Other reasons|0|||
105744681|NCT02935634|364719273|FG004|Randomization|Other reasons|0|||
105744682|NCT02935634|364719274|FG005|Randomization|Other reasons|0|||
105744683|NCT02935634|364719269|FG000|Treatment: Track 1|Disease progression|15|||
105744684|NCT02935634|364719270|FG001|Treatment: Track 1|Disease progression|17|||
105744685|NCT02935634|364719271|FG002|Treatment: Track 1|Disease progression|28|||
105744686|NCT02935634|364719272|FG003|Treatment: Track 1|Disease progression|4|||
106015471|NCT02489318|365723190|FG001|Treated|Protocol Violation|2|||
106015472|NCT02489318|365723189|FG000|Treated|Withdrawal by Subject|37|||
106015473|NCT02489318|365723190|FG001|Treated|Withdrawal by Subject|36|||
105744687|NCT02935634|364719273|FG004|Treatment: Track 1|Disease progression|6|||
105744688|NCT02935634|364719274|FG005|Treatment: Track 1|Disease progression|2|||
105744689|NCT02935634|364719269|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
105744690|NCT02935634|364719270|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
105744691|NCT02935634|364719271|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
105744692|NCT02935634|364719272|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
105744693|NCT02935634|364719273|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
106015474|NCT02489318|365723189|FG000|Treated|Other: Progressive Disease|245|||
106015475|NCT02489318|365723190|FG001|Treated|Other: Progressive Disease|138|||
105744694|NCT02935634|364719274|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
105744695|NCT02935634|364719269|FG000|Treatment: Track 1|Lost to Follow-up|1|||
105744696|NCT02935634|364719270|FG001|Treatment: Track 1|Lost to Follow-up|0|||
106015476|NCT02489318|365723189|FG000|Treated|Other|0|||
106015477|NCT02489318|365723190|FG001|Treated|Other|2|||
105744697|NCT02935634|364719271|FG002|Treatment: Track 1|Lost to Follow-up|0|||
105744698|NCT02935634|364719272|FG003|Treatment: Track 1|Lost to Follow-up|0|||
105744699|NCT02935634|364719273|FG004|Treatment: Track 1|Lost to Follow-up|0|||
105744700|NCT02935634|364719274|FG005|Treatment: Track 1|Lost to Follow-up|0|||
105744701|NCT02935634|364719269|FG000|Treatment: Track 1|Study drug toxicity|2|||
105744702|NCT02935634|364719270|FG001|Treatment: Track 1|Study drug toxicity|1|||
105744703|NCT02935634|364719271|FG002|Treatment: Track 1|Study drug toxicity|3|||
105744704|NCT02935634|364719272|FG003|Treatment: Track 1|Study drug toxicity|0|||
105744705|NCT02935634|364719273|FG004|Treatment: Track 1|Study drug toxicity|0|||
105744706|NCT02935634|364719274|FG005|Treatment: Track 1|Study drug toxicity|1|||
105744707|NCT02935634|364719269|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
106142313|NCT00546871|366179966|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
106142314|NCT00546871|366179965|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
105744708|NCT02935634|364719270|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
105744709|NCT02935634|364719271|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
105744710|NCT02935634|364719272|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
105744711|NCT02935634|364719273|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
105744712|NCT02935634|364719274|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
105744713|NCT02935634|364719269|FG000|Treatment: Track 1|Participant withdrew consent|2|||
105744714|NCT02935634|364719270|FG001|Treatment: Track 1|Participant withdrew consent|0|||
105744715|NCT02935634|364719271|FG002|Treatment: Track 1|Participant withdrew consent|1|||
105744716|NCT02935634|364719272|FG003|Treatment: Track 1|Participant withdrew consent|0|||
105744717|NCT02935634|364719273|FG004|Treatment: Track 1|Participant withdrew consent|1|||
105744718|NCT02935634|364719274|FG005|Treatment: Track 1|Participant withdrew consent|0|||
105744719|NCT02935634|364719269|FG000|Treatment: Track 1|Other reasons|0|||
105744720|NCT02935634|364719270|FG001|Treatment: Track 1|Other reasons|0|||
105744721|NCT02935634|364719271|FG002|Treatment: Track 1|Other reasons|2|||
105744722|NCT02935634|364719272|FG003|Treatment: Track 1|Other reasons|0|||
105744723|NCT02935634|364719273|FG004|Treatment: Track 1|Other reasons|0|||
105744724|NCT02935634|364719274|FG005|Treatment: Track 1|Other reasons|0|||
105744725|NCT02935634|364719269|FG000|Treatment: Track 2|Disease progression|13|||
105744726|NCT02935634|364719270|FG001|Treatment: Track 2|Disease progression|26|||
105744727|NCT02935634|364719271|FG002|Treatment: Track 2|Disease progression|20|||
105744728|NCT02935634|364719272|FG003|Treatment: Track 2|Disease progression|5|||
105744729|NCT02935634|364719273|FG004|Treatment: Track 2|Disease progression|1|||
105744730|NCT02935634|364719274|FG005|Treatment: Track 2|Disease progression|4|||
105744731|NCT02935634|364719269|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
105744732|NCT02935634|364719270|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
105744733|NCT02935634|364719271|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
105744734|NCT02935634|364719272|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
105744735|NCT02935634|364719273|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
105744736|NCT02935634|364719274|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
105744737|NCT02935634|364719269|FG000|Treatment: Track 2|Study drug toxicity|7|||
105744738|NCT02935634|364719270|FG001|Treatment: Track 2|Study drug toxicity|3|||
105744739|NCT02935634|364719271|FG002|Treatment: Track 2|Study drug toxicity|0|||
105744740|NCT02935634|364719272|FG003|Treatment: Track 2|Study drug toxicity|0|||
105744741|NCT02935634|364719273|FG004|Treatment: Track 2|Study drug toxicity|0|||
105744742|NCT02935634|364719274|FG005|Treatment: Track 2|Study drug toxicity|0|||
105744743|NCT02935634|364719269|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
105942899|NCT00618787|365452884|FG000|Overall Study|Lost to Follow-up|1|||
105942900|NCT00618787|365452885|FG001|Overall Study|Lost to Follow-up|0|||
105942901|NCT03556891|365452886|FG000|Overall Study|Adverse Event|4|||
105942902|NCT03556891|365452886|FG000|Overall Study|MRI Need|3|||
105942903|NCT03556891|365452886|FG000|Overall Study|Device Failure|1|||
105942904|NCT03556891|365452886|FG000|Overall Study|Death|1|||
105942905|NCT03556891|365452886|FG000|Overall Study|Lost to Follow-up|1|||
105942906|NCT03556891|365452886|FG000|Overall Study|Missing at random|1|||
105942907|NCT03556891|365452886|FG000|Overall Study|Missing due to COVID|1|||
105942908|NCT03556891|365452886|FG000|Overall Study|Protocol Violation|1|||
105744744|NCT02935634|364719270|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
105744745|NCT02935634|364719271|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
105744746|NCT02935634|364719272|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
105744747|NCT02935634|364719273|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
105744748|NCT02935634|364719274|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
105744749|NCT02935634|364719269|FG000|Treatment: Track 2|Participant withdrew consent|0|||
105744750|NCT02935634|364719270|FG001|Treatment: Track 2|Participant withdrew consent|1|||
105942909|NCT05654181|365454923|FG000|Overall Study|Adverse Event|1|||
105942910|NCT05654181|365454924|FG001|Overall Study|Adverse Event|0|||
106142315|NCT00546871|366179966|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
105942911|NCT05654181|365454925|FG002|Overall Study|Adverse Event|0|||
105942912|NCT05654181|365454926|FG003|Overall Study|Adverse Event|0|||
105942913|NCT05654181|365454927|FG004|Overall Study|Adverse Event|0|||
105800529|NCT02544633|364928478|FG002|Treatment Period|Withdrawal by Subject|0|||
105800530|NCT02544633|364928479|FG003|Treatment Period|Withdrawal by Subject|0|||
105800531|NCT02544633|364928476|FG000|Treatment Period|Lost to Follow-up|0|||
105800532|NCT02544633|364928477|FG001|Treatment Period|Lost to Follow-up|1|||
105800533|NCT02544633|364928478|FG002|Treatment Period|Lost to Follow-up|0|||
105800534|NCT02544633|364928479|FG003|Treatment Period|Lost to Follow-up|0|||
105800535|NCT02544633|364928476|FG000|Treatment Period|Death|0|||
105800536|NCT02544633|364928477|FG001|Treatment Period|Death|0|||
106015478|NCT02489318|365723189|FG000|Treated|Ongoing|0|||
105744751|NCT02935634|364719271|FG002|Treatment: Track 2|Participant withdrew consent|1|||
105744752|NCT02935634|364719272|FG003|Treatment: Track 2|Participant withdrew consent|0|||
105744753|NCT02935634|364719273|FG004|Treatment: Track 2|Participant withdrew consent|1|||
105744754|NCT02935634|364719274|FG005|Treatment: Track 2|Participant withdrew consent|0|||
105744755|NCT01727713|364719291|FG000|Overall Study|Lost to Follow-up|5|||
105744756|NCT01727713|364719291|FG000|Overall Study|Adverse Event|10|||
105744757|NCT01727713|364719291|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
105744758|NCT01727713|364719291|FG000|Overall Study|Withdrawal by Subject|13|||
105744759|NCT01727713|364719291|FG000|Overall Study|Protocol Deviation|2|||
105744760|NCT02651194|364719292|FG000|Overall Study|Lost to Follow-up|3|||
105744761|NCT02651194|364719292|FG000|Overall Study|Other|2|||
105744762|NCT01253044|364719296|FG000|Overall Study|Lost to Follow-up|38|||
105744763|NCT01253044|364719297|FG001|Overall Study|Lost to Follow-up|29|||
105744764|NCT03885726|364719298|FG000|Overall Study|Staffing issues/lost interest|1|||
105744765|NCT03885726|364719298|FG000|Overall Study|Early discharge from hospital|3|||
105744766|NCT02065869|364719301|FG000|Overall Study|Death|7|||
105744767|NCT02065869|364719301|FG000|Overall Study|Disease relapse|16|||
105744768|NCT02065869|364719301|FG000|Overall Study|Lost to Follow-up|4|||
105744769|NCT02065869|364719301|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
105744770|NCT02065869|364719301|FG000|Overall Study|Withdrawal by Subject|1|||
105744771|NCT02761993|364719304|FG000|Overall Study|Adverse Event|0|||
105744772|NCT02761993|364719305|FG001|Overall Study|Adverse Event|2|||
105744773|NCT02761993|364719306|FG002|Overall Study|Adverse Event|0|||
105744774|NCT02761993|364719304|FG000|Overall Study|Lost to Follow-up|1|||
105744775|NCT02761993|364719305|FG001|Overall Study|Lost to Follow-up|3|||
105744776|NCT02761993|364719306|FG002|Overall Study|Lost to Follow-up|2|||
105744777|NCT02761993|364719304|FG000|Overall Study|Withdrawal by Subject|1|||
105744778|NCT02761993|364719305|FG001|Overall Study|Withdrawal by Subject|1|||
105744779|NCT02761993|364719306|FG002|Overall Study|Withdrawal by Subject|2|||
105744780|NCT01842620|364719307|FG000|Period 1|Withdrawal by Subject|1|||
105744781|NCT01842620|364719308|FG001|Period 1|Withdrawal by Subject|0|||
105744782|NCT02739594|364719309|FG000|Overall Study|Undesired Event|3|||
105744783|NCT02739594|364719310|FG001|Overall Study|Undesired Event|4|||
105744784|NCT02739594|364719309|FG000|Overall Study|Violation of Eligibility Criteria|1|||
105744785|NCT02739594|364719310|FG001|Overall Study|Violation of Eligibility Criteria|2|||
105744786|NCT02739594|364719309|FG000|Overall Study|Protocol Violation|5|||
105744787|NCT02739594|364719310|FG001|Overall Study|Protocol Violation|6|||
105744788|NCT02739594|364719309|FG000|Overall Study|Death|4|||
105744789|NCT02739594|364719310|FG001|Overall Study|Death|2|||
105744790|NCT02739594|364719309|FG000|Overall Study|Renal Insufficiency|4|||
105744791|NCT02739594|364719310|FG001|Overall Study|Renal Insufficiency|6|||
105744792|NCT02739594|364719309|FG000|Overall Study|Administrative Reasons|1|||
105744793|NCT02739594|364719310|FG001|Overall Study|Administrative Reasons|3|||
105800537|NCT02544633|364928478|FG002|Treatment Period|Death|1|||
106015479|NCT02489318|365723190|FG001|Treated|Ongoing|267|||
106015480|NCT00956007|365723191|FG000|Overall Study|Protocol Violation|27|||
106015481|NCT00956007|365723192|FG001|Overall Study|Protocol Violation|23|||
106015482|NCT02968004|365723193|FG000|Main Study Phase|Adverse Event|1|||
106015483|NCT02968004|365723194|FG001|Main Study Phase|Adverse Event|0|||
106015484|NCT02968004|365723193|FG000|Main Study Phase|Withdrawal by Subject|0|||
106015485|NCT02968004|365723194|FG001|Main Study Phase|Withdrawal by Subject|1|||
106015486|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
106015487|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
106015488|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
105744794|NCT02739594|364719309|FG000|Overall Study|Withdrawal by Subject|1|||
105744795|NCT02739594|364719310|FG001|Overall Study|Withdrawal by Subject|1|||
105744796|NCT02739594|364719309|FG000|Overall Study|Lost to Follow-up|0|||
105744797|NCT02739594|364719310|FG001|Overall Study|Lost to Follow-up|1|||
105744798|NCT02739594|364719309|FG000|Overall Study|Elevated Serum Creatinine|0|||
105744799|NCT02739594|364719310|FG001|Overall Study|Elevated Serum Creatinine|1|||
105800538|NCT02544633|364928479|FG003|Treatment Period|Death|0|||
106015489|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
106015490|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
105744800|NCT02739594|364719309|FG000|Overall Study|Other|6|||
105744801|NCT02739594|364719310|FG001|Overall Study|Other|2|||
105744802|NCT00952289|364719316|FG000|All Participants|Death|9|||
105744803|NCT00952289|364719317|FG001|All Participants|Death|9|||
105744804|NCT00952289|364719316|FG000|All Participants|Adverse Event|8|||
105800539|NCT02544633|364928476|FG000|Treatment Period|Non-compliance|0|||
106015491|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
106015492|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
106015493|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
106015494|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
106015495|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
106015496|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
106015497|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
106015498|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
106142316|NCT00546871|366179965|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
105744805|NCT00952289|364719317|FG001|All Participants|Adverse Event|8|||
106015499|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
106015500|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
106015501|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
106015502|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
106015503|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
106015504|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
106015505|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
106015506|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
106015507|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
106015508|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
106015509|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
106015510|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
106015511|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
106015512|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
106015513|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
106015514|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
106015515|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
106015516|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
106015517|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
106015518|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
106142317|NCT00546871|366179966|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
106142318|NCT00546871|366179965|FG000|Study Extension Period|Protocol Violation|1|||
106142319|NCT00546871|366179966|FG001|Study Extension Period|Protocol Violation|0|||
106142320|NCT00546871|366179965|FG000|Study Extension Period|Withdrawal by Subject|0|||
105744806|NCT00952289|364719316|FG000|All Participants|Disease progression|3|||
105744807|NCT00952289|364719317|FG001|All Participants|Disease progression|12|||
105744808|NCT00952289|364719316|FG000|All Participants|Withdrawal by Subject|1|||
105744809|NCT00952289|364719317|FG001|All Participants|Withdrawal by Subject|10|||
105744810|NCT00952289|364719316|FG000|All Participants|Data lost during site relocation|0|||
105744811|NCT00952289|364719317|FG001|All Participants|Data lost during site relocation|1|||
105744812|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
105744813|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
105744814|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
105744815|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
105744816|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
105744817|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
105744818|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
105942914|NCT05654181|365454928|FG005|Overall Study|Adverse Event|0|||
105942915|NCT05654181|365454929|FG006|Overall Study|Adverse Event|0|||
105942916|NCT05654181|365454930|FG007|Overall Study|Adverse Event|1|||
105942917|NCT05654181|365454931|FG008|Overall Study|Adverse Event|0|||
105942918|NCT05654181|365454932|FG009|Overall Study|Adverse Event|0|||
105942919|NCT05654181|365454923|FG000|Overall Study|Withdrawal by Subject|0|||
105942920|NCT05654181|365454924|FG001|Overall Study|Withdrawal by Subject|0|||
105942921|NCT05654181|365454925|FG002|Overall Study|Withdrawal by Subject|0|||
105942922|NCT05654181|365454926|FG003|Overall Study|Withdrawal by Subject|0|||
105942923|NCT05654181|365454927|FG004|Overall Study|Withdrawal by Subject|0|||
105942924|NCT05654181|365454928|FG005|Overall Study|Withdrawal by Subject|0|||
105942925|NCT05654181|365454929|FG006|Overall Study|Withdrawal by Subject|0|||
105942926|NCT05654181|365454930|FG007|Overall Study|Withdrawal by Subject|1|||
105942927|NCT05654181|365454931|FG008|Overall Study|Withdrawal by Subject|0|||
105942928|NCT05654181|365454932|FG009|Overall Study|Withdrawal by Subject|0|||
105942929|NCT05654181|365454923|FG000|Overall Study|Other|0|||
106015519|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
106015520|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
106142321|NCT00546871|366179966|FG001|Study Extension Period|Withdrawal by Subject|1|||
105942930|NCT05654181|365454924|FG001|Overall Study|Other|0|||
105942931|NCT05654181|365454925|FG002|Overall Study|Other|0|||
105942932|NCT05654181|365454926|FG003|Overall Study|Other|0|||
105942933|NCT05654181|365454927|FG004|Overall Study|Other|1|||
105744819|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
105744820|NCT00952289|364719316|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
105744821|NCT00952289|364719317|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
105744822|NCT00875017|364719318|FG000|First Intervention|Withdrawal by Subject|1|||
105744823|NCT00875017|364719319|FG001|First Intervention|Withdrawal by Subject|0|||
105744824|NCT00875017|364719320|FG002|First Intervention|Withdrawal by Subject|1|||
105744825|NCT00875017|364719321|FG003|First Intervention|Withdrawal by Subject|0|||
105744826|NCT00875017|364719322|FG004|First Intervention|Withdrawal by Subject|0|||
105744827|NCT00875017|364719323|FG005|First Intervention|Withdrawal by Subject|0|||
105744828|NCT00875017|364719318|FG000|First Intervention|Adverse Event|0|||
105744829|NCT00875017|364719319|FG001|First Intervention|Adverse Event|0|||
105744830|NCT00875017|364719320|FG002|First Intervention|Adverse Event|0|||
105744831|NCT00875017|364719321|FG003|First Intervention|Adverse Event|1|||
105744832|NCT00875017|364719322|FG004|First Intervention|Adverse Event|0|||
105744833|NCT00875017|364719323|FG005|First Intervention|Adverse Event|0|||
105744834|NCT00875017|364719318|FG000|First Intervention|Problems collecting rectal effluent|1|||
105744835|NCT00875017|364719319|FG001|First Intervention|Problems collecting rectal effluent|0|||
105744836|NCT00875017|364719320|FG002|First Intervention|Problems collecting rectal effluent|0|||
105744837|NCT00875017|364719321|FG003|First Intervention|Problems collecting rectal effluent|0|||
105744838|NCT00875017|364719322|FG004|First Intervention|Problems collecting rectal effluent|0|||
105744839|NCT00875017|364719323|FG005|First Intervention|Problems collecting rectal effluent|0|||
105744840|NCT00875017|364719318|FG000|First Intervention|Intolerance to nasogastric tube|0|||
105744841|NCT00875017|364719319|FG001|First Intervention|Intolerance to nasogastric tube|0|||
105744842|NCT00875017|364719320|FG002|First Intervention|Intolerance to nasogastric tube|0|||
105744843|NCT00875017|364719321|FG003|First Intervention|Intolerance to nasogastric tube|0|||
105744844|NCT00875017|364719322|FG004|First Intervention|Intolerance to nasogastric tube|1|||
105744845|NCT00875017|364719323|FG005|First Intervention|Intolerance to nasogastric tube|0|||
105942934|NCT05654181|365454928|FG005|Overall Study|Other|1|||
105942935|NCT05654181|365454929|FG006|Overall Study|Other|0|||
105942936|NCT05654181|365454930|FG007|Overall Study|Other|0|||
105942937|NCT05654181|365454931|FG008|Overall Study|Other|0|||
105942938|NCT05654181|365454932|FG009|Overall Study|Other|0|||
105942939|NCT03440385|365454939|FG000|Overall Study|Other Reason|4|||
105942940|NCT03440385|365454940|FG001|Overall Study|Other Reason|1|||
105942941|NCT03440385|365454939|FG000|Overall Study|Site Closed|1|||
105942942|NCT03440385|365454940|FG001|Overall Study|Site Closed|0|||
105942943|NCT03440385|365454939|FG000|Overall Study|Lost to Follow-up|2|||
105942944|NCT03440385|365454940|FG001|Overall Study|Lost to Follow-up|0|||
105942945|NCT03440385|365454939|FG000|Overall Study|Withdrawal by Subject|12|||
105942946|NCT03440385|365454940|FG001|Overall Study|Withdrawal by Subject|6|||
105942947|NCT03440385|365454939|FG000|Overall Study|Lack of Efficacy|9|||
105942948|NCT03440385|365454940|FG001|Overall Study|Lack of Efficacy|2|||
105942949|NCT03440385|365454939|FG000|Overall Study|Adverse Event|15|||
105942950|NCT03440385|365454940|FG001|Overall Study|Adverse Event|11|||
105942951|NCT02475681|365454941|FG000|Overall Study|Death|16|||
105942952|NCT02475681|365454942|FG001|Overall Study|Death|6|||
105942953|NCT02475681|365454943|FG002|Overall Study|Death|9|||
105942954|NCT02475681|365454941|FG000|Overall Study|Physician Decision|0|||
105942955|NCT02475681|365454942|FG001|Overall Study|Physician Decision|3|||
105942956|NCT02475681|365454943|FG002|Overall Study|Physician Decision|1|||
105942957|NCT02475681|365454941|FG000|Overall Study|Withdrawal by Subject|12|||
105942958|NCT02475681|365454942|FG001|Overall Study|Withdrawal by Subject|6|||
105942959|NCT02475681|365454943|FG002|Overall Study|Withdrawal by Subject|9|||
105942960|NCT02475681|365454941|FG000|Overall Study|Lost to Follow-up|2|||
105942961|NCT02475681|365454942|FG001|Overall Study|Lost to Follow-up|1|||
105942962|NCT02475681|365454943|FG002|Overall Study|Lost to Follow-up|3|||
105942963|NCT02475681|365454941|FG000|Overall Study|Ongoing in Study|0|||
105942964|NCT02475681|365454942|FG001|Overall Study|Ongoing in Study|163|||
106015521|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
106015522|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
106142322|NCT01350804|366179967|FG000|Core Study|Withdrawal by Subject|11|||
105744846|NCT00875017|364719318|FG000|Washout|Problem collecting rectal effluent|0|||
105744847|NCT00875017|364719319|FG001|Washout|Problem collecting rectal effluent|0|||
105744848|NCT00875017|364719320|FG002|Washout|Problem collecting rectal effluent|1|||
105744849|NCT00875017|364719321|FG003|Washout|Problem collecting rectal effluent|0|||
105744850|NCT00875017|364719322|FG004|Washout|Problem collecting rectal effluent|0|||
105744851|NCT00875017|364719323|FG005|Washout|Problem collecting rectal effluent|0|||
105942965|NCT02475681|365454943|FG002|Overall Study|Ongoing in Study|157|||
105942966|NCT02475681|365454941|FG000|Overall Study|Reasons other than above listed|2|||
105942967|NCT02475681|365454942|FG001|Overall Study|Reasons other than above listed|0|||
105942968|NCT02475681|365454943|FG002|Overall Study|Reasons other than above listed|0|||
105942969|NCT00363298|365454947|FG000|First Study Week|Lack of Efficacy|6|||
105942970|NCT00363298|365454948|FG001|First Study Week|Lack of Efficacy|5|||
105942971|NCT00363298|365454947|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
105942972|NCT00363298|365454948|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
105744852|NCT00875017|364719318|FG000|Second Intervention|Adverse Event|0|||
105744853|NCT00875017|364719319|FG001|Second Intervention|Adverse Event|0|||
105744854|NCT00875017|364719320|FG002|Second Intervention|Adverse Event|0|||
105744855|NCT00875017|364719321|FG003|Second Intervention|Adverse Event|1|||
105744856|NCT00875017|364719322|FG004|Second Intervention|Adverse Event|0|||
105744857|NCT00875017|364719323|FG005|Second Intervention|Adverse Event|0|||
105744858|NCT00875017|364719318|FG000|Washout|Problems collecting rectal effluent|0|||
105744859|NCT00875017|364719319|FG001|Washout|Problems collecting rectal effluent|1|||
105744860|NCT00875017|364719320|FG002|Washout|Problems collecting rectal effluent|0|||
105744861|NCT00875017|364719321|FG003|Washout|Problems collecting rectal effluent|0|||
105744862|NCT00875017|364719322|FG004|Washout|Problems collecting rectal effluent|0|||
105744863|NCT00875017|364719323|FG005|Washout|Problems collecting rectal effluent|0|||
105744864|NCT00875017|364719318|FG000|Third Intervention|Adverse Event|0|||
105744865|NCT00875017|364719319|FG001|Third Intervention|Adverse Event|1|||
105744866|NCT00875017|364719320|FG002|Third Intervention|Adverse Event|1|||
105744867|NCT00875017|364719321|FG003|Third Intervention|Adverse Event|0|||
105744868|NCT00875017|364719322|FG004|Third Intervention|Adverse Event|0|||
105744869|NCT00875017|364719323|FG005|Third Intervention|Adverse Event|0|||
105744870|NCT00875017|364719318|FG000|Washout|Withdrawal by Subject|0|||
105744871|NCT00875017|364719319|FG001|Washout|Withdrawal by Subject|0|||
105744872|NCT00875017|364719320|FG002|Washout|Withdrawal by Subject|0|||
105744873|NCT00875017|364719321|FG003|Washout|Withdrawal by Subject|0|||
105744874|NCT00875017|364719322|FG004|Washout|Withdrawal by Subject|1|||
105744875|NCT00875017|364719323|FG005|Washout|Withdrawal by Subject|0|||
105744876|NCT00875017|364719318|FG000|Fourth Intervention|Inability to comply with fasting|0|||
105744877|NCT00875017|364719319|FG001|Fourth Intervention|Inability to comply with fasting|0|||
105744878|NCT00875017|364719320|FG002|Fourth Intervention|Inability to comply with fasting|0|||
105744879|NCT00875017|364719321|FG003|Fourth Intervention|Inability to comply with fasting|0|||
105744880|NCT00875017|364719322|FG004|Fourth Intervention|Inability to comply with fasting|0|||
105744881|NCT00875017|364719323|FG005|Fourth Intervention|Inability to comply with fasting|1|||
105744882|NCT02689219|364719324|FG000|Overall Study|Death|1|||
105744883|NCT02689219|364719325|FG001|Overall Study|Death|1|||
105744884|NCT02689219|364719324|FG000|Overall Study|Disease Progression|10|||
105744885|NCT02689219|364719325|FG001|Overall Study|Disease Progression|6|||
105744886|NCT01477892|364719326|FG000|Overall Study|Withdrawal by Subject|0|||
105744887|NCT01477892|364719327|FG001|Overall Study|Withdrawal by Subject|2|||
105744888|NCT03375112|364719331|FG000|Overall Study|Withdrawal by Subject|3|||
105744889|NCT03375112|364719332|FG001|Overall Study|Withdrawal by Subject|0|||
105744890|NCT05515601|364719336|FG000|Overall Study|Withdrawal by Subject|1|||
105744891|NCT05515601|364719337|FG001|Overall Study|Withdrawal by Subject|3|||
105744892|NCT05515601|364719338|FG002|Overall Study|Withdrawal by Subject|2|||
105744893|NCT05515601|364719339|FG003|Overall Study|Withdrawal by Subject|1|||
105744894|NCT05515601|364719340|FG004|Overall Study|Withdrawal by Subject|1|||
105744895|NCT05515601|364719341|FG005|Overall Study|Withdrawal by Subject|1|||
105744896|NCT05515601|364719336|FG000|Overall Study|Lost to Follow-up|0|||
105744897|NCT05515601|364719337|FG001|Overall Study|Lost to Follow-up|0|||
105744898|NCT05515601|364719338|FG002|Overall Study|Lost to Follow-up|0|||
105744899|NCT05515601|364719339|FG003|Overall Study|Lost to Follow-up|0|||
105744900|NCT05515601|364719340|FG004|Overall Study|Lost to Follow-up|1|||
105744901|NCT05515601|364719341|FG005|Overall Study|Lost to Follow-up|0|||
105744902|NCT00777491|364719342|FG000|Overall Study|Protocol Violation|0|||
105744903|NCT00777491|364719343|FG001|Overall Study|Protocol Violation|2|||
105744904|NCT00777491|364719342|FG000|Overall Study|Did not receive any protocol treatment|2|||
105744905|NCT00777491|364719343|FG001|Overall Study|Did not receive any protocol treatment|0|||
105744906|NCT00364845|364719346|FG000|Overall Study|Adverse Event|1|||
105744907|NCT00364845|364719347|FG001|Overall Study|Adverse Event|0|||
105744908|NCT00364845|364719346|FG000|Overall Study|Withdrawal by Subject|2|||
105744909|NCT00364845|364719347|FG001|Overall Study|Withdrawal by Subject|1|||
105744910|NCT00364845|364719346|FG000|Overall Study|Physician Decision|8|||
105744911|NCT00364845|364719347|FG001|Overall Study|Physician Decision|8|||
105744912|NCT00364845|364719346|FG000|Overall Study|Lost to Follow-up|0|||
106015523|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
105744913|NCT00364845|364719347|FG001|Overall Study|Lost to Follow-up|1|||
105744914|NCT00364845|364719346|FG000|Overall Study|Death|0|||
105744915|NCT00364845|364719347|FG001|Overall Study|Death|1|||
105744916|NCT01187901|364719348|FG000|Overall Study|Protocol Violation|1|||
105744917|NCT01187901|364719349|FG001|Overall Study|Protocol Violation|0|||
105744918|NCT01187901|364719348|FG000|Overall Study|Lost to Follow-up|1|||
105744919|NCT01187901|364719349|FG001|Overall Study|Lost to Follow-up|2|||
105744920|NCT01187901|364719348|FG000|Overall Study|Unrelated Health Reasons|1|||
106015524|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
105744921|NCT01187901|364719349|FG001|Overall Study|Unrelated Health Reasons|2|||
105744922|NCT01187901|364719348|FG000|Overall Study|Suspected Allergic Reaction|1|||
105744923|NCT01187901|364719349|FG001|Overall Study|Suspected Allergic Reaction|1|||
105744924|NCT01187901|364719348|FG000|Overall Study|Adverse Event|3|||
105744925|NCT01187901|364719349|FG001|Overall Study|Adverse Event|0|||
106142323|NCT01350804|366179968|FG001|Core Study|Withdrawal by Subject|17|||
105744926|NCT01187901|364719348|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
105744927|NCT01187901|364719349|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
105744928|NCT01187901|364719348|FG000|Overall Study|Pregnancy|0|||
105744929|NCT01187901|364719349|FG001|Overall Study|Pregnancy|2|||
105744930|NCT00524316|364719352|FG000|Overall Study|Withdrawal by Subject|2|||
105744931|NCT00524316|364719352|FG000|Overall Study|Adverse Event|7|||
105744932|NCT00524316|364719352|FG000|Overall Study|Disease Progression|7|||
105744933|NCT02426658|364719353|FG000|Overall Study|Withdrawal by Subject|1|||
105744934|NCT02426658|364719353|FG000|Overall Study|Patient expired before treatment|2|||
105744935|NCT02928406|364719356|FG000|Overall Study|Death|780|||
105744936|NCT02928406|364719356|FG000|Overall Study|Progressive disease|3|||
105744937|NCT02928406|364719356|FG000|Overall Study|Lost to Follow-up|49|||
105744938|NCT02928406|364719356|FG000|Overall Study|Non-compliance|2|||
105744939|NCT02928406|364719356|FG000|Overall Study|Withdrawal by Subject|40|||
105744940|NCT02928406|364719356|FG000|Overall Study|Study terminated by sponsor|57|||
105744941|NCT02928406|364719356|FG000|Overall Study|Physician Decision|1|||
105744942|NCT02928406|364719356|FG000|Overall Study|Various reasons|72|||
105744943|NCT00786838|364719357|FG000|Overall Study|Physician Decision|4|||
105744944|NCT00786838|364719357|FG000|Overall Study|Death|4|||
105744945|NCT00786838|364719357|FG000|Overall Study|Adverse Event|6|||
105744946|NCT00786838|364719357|FG000|Overall Study|Progressive disease|31|||
105744947|NCT00786838|364719357|FG000|Overall Study|Withdrawal by Subject|4|||
105744948|NCT02065622|364719358|FG000|Induction Study|Adverse Event|13|||
105744949|NCT02065622|364719359|FG001|Induction Study|Adverse Event|19|||
105744950|NCT02065622|364719360|FG002|Induction Study|Adverse Event|0|||
105744951|NCT02065622|364719361|FG003|Induction Study|Adverse Event|0|||
105744952|NCT02065622|364719362|FG004|Induction Study|Adverse Event|0|||
105744953|NCT02065622|364719358|FG000|Induction Study|Withdrawal by Subject|3|||
105744954|NCT02065622|364719359|FG001|Induction Study|Withdrawal by Subject|5|||
105744955|NCT02065622|364719360|FG002|Induction Study|Withdrawal by Subject|0|||
105744956|NCT02065622|364719361|FG003|Induction Study|Withdrawal by Subject|0|||
105744957|NCT02065622|364719362|FG004|Induction Study|Withdrawal by Subject|0|||
105744958|NCT02065622|364719358|FG000|Induction Study|Lost to Follow-up|1|||
105744959|NCT02065622|364719359|FG001|Induction Study|Lost to Follow-up|0|||
105744960|NCT02065622|364719360|FG002|Induction Study|Lost to Follow-up|0|||
105744961|NCT02065622|364719361|FG003|Induction Study|Lost to Follow-up|0|||
105744962|NCT02065622|364719362|FG004|Induction Study|Lost to Follow-up|0|||
105744963|NCT02065622|364719358|FG000|Induction Study|Lack of Efficacy|22|||
105744964|NCT02065622|364719359|FG001|Induction Study|Lack of Efficacy|27|||
105744965|NCT02065622|364719360|FG002|Induction Study|Lack of Efficacy|0|||
105744966|NCT02065622|364719361|FG003|Induction Study|Lack of Efficacy|0|||
105744967|NCT02065622|364719362|FG004|Induction Study|Lack of Efficacy|0|||
105744968|NCT02065622|364719358|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
105744969|NCT02065622|364719359|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
105744970|NCT02065622|364719360|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
105744971|NCT02065622|364719361|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
105744972|NCT02065622|364719362|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
105744973|NCT02065622|364719358|FG000|Induction Study|Subject Noncompliance|1|||
105744974|NCT02065622|364719359|FG001|Induction Study|Subject Noncompliance|1|||
105744975|NCT02065622|364719360|FG002|Induction Study|Subject Noncompliance|0|||
105744976|NCT02065622|364719361|FG003|Induction Study|Subject Noncompliance|0|||
105744977|NCT02065622|364719362|FG004|Induction Study|Subject Noncompliance|0|||
105744978|NCT02065622|364719358|FG000|Induction Study|Other, Not Specified|3|||
105744979|NCT02065622|364719359|FG001|Induction Study|Other, Not Specified|2|||
105744980|NCT02065622|364719360|FG002|Induction Study|Other, Not Specified|0|||
105744981|NCT02065622|364719361|FG003|Induction Study|Other, Not Specified|0|||
105744982|NCT02065622|364719362|FG004|Induction Study|Other, Not Specified|0|||
105744983|NCT02065622|364719358|FG000|Maintenance Study|Adverse Event|0|||
105744984|NCT02065622|364719359|FG001|Maintenance Study|Adverse Event|0|||
105744985|NCT02065622|364719360|FG002|Maintenance Study|Adverse Event|25|||
105942973|NCT03552029|365454950|FG000|Overall Study|Death|3|||
105942974|NCT03552029|365454951|FG001|Overall Study|Death|0|||
105942975|NCT03552029|365454950|FG000|Overall Study|Adverse Event|1|||
105744986|NCT02065622|364719361|FG003|Maintenance Study|Adverse Event|22|||
105744987|NCT02065622|364719362|FG004|Maintenance Study|Adverse Event|11|||
105744988|NCT02065622|364719358|FG000|Maintenance Study|Withdrawal by Subject|0|||
105744989|NCT02065622|364719359|FG001|Maintenance Study|Withdrawal by Subject|0|||
105744990|NCT02065622|364719360|FG002|Maintenance Study|Withdrawal by Subject|11|||
105744991|NCT02065622|364719361|FG003|Maintenance Study|Withdrawal by Subject|5|||
105744992|NCT02065622|364719362|FG004|Maintenance Study|Withdrawal by Subject|7|||
105744993|NCT02065622|364719358|FG000|Maintenance Study|Lost to Follow-up|0|||
105744994|NCT02065622|364719359|FG001|Maintenance Study|Lost to Follow-up|0|||
105744995|NCT02065622|364719360|FG002|Maintenance Study|Lost to Follow-up|4|||
105744996|NCT02065622|364719361|FG003|Maintenance Study|Lost to Follow-up|1|||
105744997|NCT02065622|364719362|FG004|Maintenance Study|Lost to Follow-up|1|||
105942976|NCT03552029|365454951|FG001|Overall Study|Adverse Event|0|||
105942977|NCT03552029|365454950|FG000|Overall Study|Lack of Efficacy|0|||
105942978|NCT03552029|365454951|FG001|Overall Study|Lack of Efficacy|2|||
105744998|NCT02065622|364719358|FG000|Maintenance Study|Lack of Efficacy|0|||
105744999|NCT02065622|364719359|FG001|Maintenance Study|Lack of Efficacy|0|||
105745000|NCT02065622|364719360|FG002|Maintenance Study|Lack of Efficacy|70|||
105745001|NCT02065622|364719361|FG003|Maintenance Study|Lack of Efficacy|55|||
105745002|NCT02065622|364719362|FG004|Maintenance Study|Lack of Efficacy|19|||
105745003|NCT02065622|364719358|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
105745004|NCT02065622|364719359|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
105745005|NCT02065622|364719360|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
105745006|NCT02065622|364719361|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
105745007|NCT02065622|364719362|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
105745008|NCT02065622|364719358|FG000|Maintenance Study|Subject Non-Compliance|0|||
105745009|NCT02065622|364719359|FG001|Maintenance Study|Subject Non-Compliance|0|||
105745010|NCT02065622|364719360|FG002|Maintenance Study|Subject Non-Compliance|1|||
105745011|NCT02065622|364719361|FG003|Maintenance Study|Subject Non-Compliance|3|||
105745012|NCT02065622|364719362|FG004|Maintenance Study|Subject Non-Compliance|2|||
105745013|NCT02065622|364719358|FG000|Maintenance Study|Other, Not Specified|0|||
105745014|NCT02065622|364719359|FG001|Maintenance Study|Other, Not Specified|0|||
105745015|NCT02065622|364719360|FG002|Maintenance Study|Other, Not Specified|6|||
105745016|NCT02065622|364719361|FG003|Maintenance Study|Other, Not Specified|14|||
105745017|NCT02065622|364719362|FG004|Maintenance Study|Other, Not Specified|2|||
105745018|NCT02065622|364719358|FG000|Maintenance Study|Unknown Reason|0|||
105745019|NCT02065622|364719359|FG001|Maintenance Study|Unknown Reason|0|||
105745020|NCT02065622|364719360|FG002|Maintenance Study|Unknown Reason|0|||
105745021|NCT02065622|364719361|FG003|Maintenance Study|Unknown Reason|1|||
105745022|NCT02065622|364719362|FG004|Maintenance Study|Unknown Reason|0|||
105745023|NCT00091390|364719363|FG000|Overall Study|Protocol Violation|1|||
105745024|NCT00091390|364719363|FG000|Overall Study|No protocol treatment|3|||
105745025|NCT04920084|364721049|FG000|Overall Study|Adverse Event|1|||
105745026|NCT04920084|364721049|FG000|Overall Study|Lost to Follow-up|2|||
105745027|NCT04920084|364721049|FG000|Overall Study|Withdrawal by Subject|2|||
105745028|NCT04191967|364721050|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
105745029|NCT04191967|364721050|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
105745030|NCT00523341|364721060|FG000|Overall Study|Withdrawal by Subject|399|||
105745031|NCT00523341|364721061|FG001|Overall Study|Withdrawal by Subject|427|||
105745032|NCT00523341|364721060|FG000|Overall Study|Other|181|||
105745033|NCT00523341|364721061|FG001|Overall Study|Other|198|||
105745034|NCT00523341|364721060|FG000|Overall Study|Adverse Event|122|||
105745035|NCT00523341|364721061|FG001|Overall Study|Adverse Event|155|||
105745036|NCT00523341|364721060|FG000|Overall Study|Death|101|||
105745037|NCT00523341|364721061|FG001|Overall Study|Death|110|||
105745038|NCT00523341|364721060|FG000|Overall Study|Lost to Follow-up|73|||
105745039|NCT00523341|364721061|FG001|Overall Study|Lost to Follow-up|61|||
105745040|NCT00523341|364721060|FG000|Overall Study|Non-compliance|20|||
105745041|NCT00523341|364721061|FG001|Overall Study|Non-compliance|13|||
105745042|NCT00523341|364721060|FG000|Overall Study|Physician Decision|14|||
105745043|NCT00523341|364721061|FG001|Overall Study|Physician Decision|13|||
105745044|NCT00523341|364721060|FG000|Overall Study|Requirement for Alternative Therapy|4|||
105745045|NCT00523341|364721061|FG001|Overall Study|Requirement for Alternative Therapy|14|||
105745046|NCT00523341|364721060|FG000|Overall Study|Protocol Deviation|6|||
105745047|NCT00523341|364721061|FG001|Overall Study|Protocol Deviation|5|||
105745048|NCT00523341|364721060|FG000|Overall Study|Ineligibility Determined|3|||
105745049|NCT00523341|364721061|FG001|Overall Study|Ineligibility Determined|4|||
105745050|NCT00523341|364721060|FG000|Overall Study|Disease Progression|1|||
105745051|NCT00523341|364721061|FG001|Overall Study|Disease Progression|0|||
105745052|NCT00051558|364721064|FG000|Overall Study|Adverse Event|30|||
105745053|NCT00051558|364721065|FG001|Overall Study|Adverse Event|18|||
105745054|NCT00051558|364721064|FG000|Overall Study|Withdrawal by Subject|29|||
105745055|NCT00051558|364721065|FG001|Overall Study|Withdrawal by Subject|42|||
105745056|NCT00051558|364721064|FG000|Overall Study|Death|9|||
105745057|NCT00051558|364721065|FG001|Overall Study|Death|15|||
105745058|NCT00051558|364721064|FG000|Overall Study|Lost to Follow-up|4|||
105745059|NCT00051558|364721065|FG001|Overall Study|Lost to Follow-up|13|||
105745060|NCT00051558|364721064|FG000|Overall Study|Protocol Violation|3|||
105745061|NCT00051558|364721065|FG001|Overall Study|Protocol Violation|4|||
105745062|NCT00051558|364721064|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
105800540|NCT02544633|364928477|FG001|Treatment Period|Non-compliance|0|||
105745063|NCT00051558|364721065|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
105745064|NCT00051558|364721064|FG000|Overall Study|Sponsor Decision|6|||
105745065|NCT00051558|364721065|FG001|Overall Study|Sponsor Decision|1|||
105745066|NCT00051558|364721064|FG000|Overall Study|Other|2|||
105745067|NCT00051558|364721065|FG001|Overall Study|Other|1|||
105745068|NCT00051558|364721064|FG000|Overall Study|Significant Lab Value|2|||
105745069|NCT00051558|364721065|FG001|Overall Study|Significant Lab Value|0|||
105745070|NCT00051558|364721064|FG000|Overall Study|Physician Decision|5|||
105745071|NCT00051558|364721065|FG001|Overall Study|Physician Decision|0|||
105800541|NCT02544633|364928478|FG002|Treatment Period|Non-compliance|1|||
105745072|NCT00716417|364721069|FG000|Overall Study|Adverse Event|0|||
105745073|NCT00716417|364721070|FG001|Overall Study|Adverse Event|0|||
105745074|NCT00716417|364721071|FG002|Overall Study|Adverse Event|2|||
105745075|NCT00716417|364721072|FG003|Overall Study|Adverse Event|1|||
105745076|NCT00716417|364721073|FG004|Overall Study|Adverse Event|0|||
105745077|NCT00716417|364721074|FG005|Overall Study|Adverse Event|0|||
105745078|NCT00716417|364721075|FG006|Overall Study|Adverse Event|3|||
105745079|NCT00716417|364721076|FG007|Overall Study|Adverse Event|1|||
105745080|NCT00716417|364721077|FG008|Overall Study|Adverse Event|0|||
105745081|NCT00716417|364721078|FG009|Overall Study|Adverse Event|3|||
105745082|NCT00716417|364721069|FG000|Overall Study|Withdrawal by Subject|0|||
105745083|NCT00716417|364721070|FG001|Overall Study|Withdrawal by Subject|1|||
105745084|NCT00716417|364721071|FG002|Overall Study|Withdrawal by Subject|0|||
105745085|NCT00716417|364721072|FG003|Overall Study|Withdrawal by Subject|2|||
105745086|NCT00716417|364721073|FG004|Overall Study|Withdrawal by Subject|0|||
105745087|NCT00716417|364721074|FG005|Overall Study|Withdrawal by Subject|0|||
105745088|NCT00716417|364721075|FG006|Overall Study|Withdrawal by Subject|1|||
105745089|NCT00716417|364721076|FG007|Overall Study|Withdrawal by Subject|0|||
105745090|NCT00716417|364721077|FG008|Overall Study|Withdrawal by Subject|0|||
105745091|NCT00716417|364721078|FG009|Overall Study|Withdrawal by Subject|0|||
105745092|NCT00716417|364721069|FG000|Overall Study|Progressive disease|3|||
105745093|NCT00716417|364721070|FG001|Overall Study|Progressive disease|5|||
105745094|NCT00716417|364721071|FG002|Overall Study|Progressive disease|3|||
105745095|NCT00716417|364721072|FG003|Overall Study|Progressive disease|8|||
105745096|NCT00716417|364721073|FG004|Overall Study|Progressive disease|0|||
105745097|NCT00716417|364721074|FG005|Overall Study|Progressive disease|3|||
105745098|NCT00716417|364721075|FG006|Overall Study|Progressive disease|3|||
105745099|NCT00716417|364721076|FG007|Overall Study|Progressive disease|1|||
105745100|NCT00716417|364721077|FG008|Overall Study|Progressive disease|5|||
105745101|NCT00716417|364721078|FG009|Overall Study|Progressive disease|0|||
105745102|NCT00716417|364721069|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
105745103|NCT00716417|364721070|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
105745104|NCT00716417|364721071|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
105745105|NCT00716417|364721072|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
105745106|NCT00716417|364721073|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
105745107|NCT00716417|364721074|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
105745108|NCT00716417|364721075|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
105745109|NCT00716417|364721076|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
105745110|NCT00716417|364721077|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
105745111|NCT00716417|364721078|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
105745112|NCT00716417|364721069|FG000|Overall Study|On patient request due to toxicities|0|||
105745113|NCT00716417|364721070|FG001|Overall Study|On patient request due to toxicities|0|||
105745114|NCT00716417|364721071|FG002|Overall Study|On patient request due to toxicities|0|||
105745115|NCT00716417|364721072|FG003|Overall Study|On patient request due to toxicities|0|||
105745116|NCT00716417|364721073|FG004|Overall Study|On patient request due to toxicities|0|||
105745117|NCT00716417|364721074|FG005|Overall Study|On patient request due to toxicities|0|||
105745118|NCT00716417|364721075|FG006|Overall Study|On patient request due to toxicities|0|||
105745119|NCT00716417|364721076|FG007|Overall Study|On patient request due to toxicities|1|||
105745120|NCT00716417|364721077|FG008|Overall Study|On patient request due to toxicities|0|||
105745121|NCT00716417|364721078|FG009|Overall Study|On patient request due to toxicities|0|||
105745122|NCT01830543|364721083|FG000|Overall Study|Subject Decision|19|||
105745123|NCT01830543|364721084|FG001|Overall Study|Subject Decision|21|||
105745124|NCT01830543|364721085|FG002|Overall Study|Subject Decision|57|||
105745125|NCT01830543|364721083|FG000|Overall Study|Adverse Event|91|||
105745126|NCT01830543|364721084|FG001|Overall Study|Adverse Event|77|||
105745127|NCT01830543|364721085|FG002|Overall Study|Adverse Event|76|||
105745128|NCT01830543|364721083|FG000|Overall Study|Death|20|||
105745129|NCT01830543|364721084|FG001|Overall Study|Death|22|||
105745130|NCT01830543|364721085|FG002|Overall Study|Death|22|||
105745131|NCT01830543|364721083|FG000|Overall Study|Protocol Violation|3|||
105745132|NCT01830543|364721084|FG001|Overall Study|Protocol Violation|7|||
105745133|NCT01830543|364721085|FG002|Overall Study|Protocol Violation|7|||
105745134|NCT01830543|364721083|FG000|Overall Study|Physician Decision|11|||
105745135|NCT01830543|364721084|FG001|Overall Study|Physician Decision|5|||
105745136|NCT01830543|364721085|FG002|Overall Study|Physician Decision|12|||
106015525|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
105745137|NCT01830543|364721083|FG000|Overall Study|Withdrawal by consent|3|||
105745138|NCT01830543|364721084|FG001|Overall Study|Withdrawal by consent|3|||
105745139|NCT01830543|364721085|FG002|Overall Study|Withdrawal by consent|3|||
105745140|NCT01830543|364721083|FG000|Overall Study|Other|12|||
106015526|NCT02968004|365723193|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
105745141|NCT01830543|364721084|FG001|Overall Study|Other|17|||
105745142|NCT01830543|364721085|FG002|Overall Study|Other|37|||
105745143|NCT04281030|364721087|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
105745144|NCT04281030|364721088|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
105800542|NCT02544633|364928479|FG003|Treatment Period|Non-compliance|0|||
105745145|NCT04281030|364721087|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
105745146|NCT04281030|364721088|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
105745147|NCT05619172|364721091|FG000|Safety Cohort 1|Death|7|||
105745148|NCT05619172|364721092|FG001|Safety Cohort 1|Death|0|||
105745149|NCT05619172|364721091|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
105745150|NCT05619172|364721092|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
105745151|NCT05619172|364721091|FG000|Safety Cohort 2|Death|0|||
105745152|NCT05619172|364721092|FG001|Safety Cohort 2|Death|1|||
105800543|NCT02544633|364928476|FG000|Treatment Period|Clinical Disease Progression|0|||
105800544|NCT02544633|364928477|FG001|Treatment Period|Clinical Disease Progression|0|||
105800545|NCT02544633|364928478|FG002|Treatment Period|Clinical Disease Progression|0|||
105800546|NCT02544633|364928479|FG003|Treatment Period|Clinical Disease Progression|1|||
105800547|NCT02544633|364928476|FG000|Survival Follow-up Period|Death|12|||
105800548|NCT02544633|364928477|FG001|Survival Follow-up Period|Death|14|||
105800549|NCT02544633|364928478|FG002|Survival Follow-up Period|Death|3|||
105800550|NCT02544633|364928479|FG003|Survival Follow-up Period|Death|9|||
105800551|NCT02544633|364928476|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
105800552|NCT02544633|364928477|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
105800553|NCT02544633|364928478|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
105800554|NCT02544633|364928479|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
105800555|NCT02544633|364928476|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
105800556|NCT02544633|364928477|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
105800557|NCT02544633|364928478|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
105800558|NCT02544633|364928479|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
105800559|NCT02544633|364928476|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
105800560|NCT02544633|364928477|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
105800561|NCT02544633|364928478|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
105800562|NCT02544633|364928479|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
105942979|NCT03552029|365454950|FG000|Overall Study|Physician Decision|0|||
105942980|NCT03552029|365454951|FG001|Overall Study|Physician Decision|1|||
105942981|NCT03552029|365454950|FG000|Overall Study|Study terminated by Sponsor|0|||
105942982|NCT03552029|365454951|FG001|Overall Study|Study terminated by Sponsor|1|||
105942983|NCT03552029|365454950|FG000|Overall Study|Other|0|||
105942984|NCT03552029|365454951|FG001|Overall Study|Other|2|||
105942985|NCT02374255|365454957|FG000|Overall Study|Withdrawal by Subject|2|||
105942986|NCT02374255|365454958|FG001|Overall Study|Withdrawal by Subject|0|||
105942987|NCT02374255|365454959|FG002|Overall Study|Withdrawal by Subject|0|||
105942988|NCT02374255|365454960|FG003|Overall Study|Withdrawal by Subject|0|||
105942989|NCT00851084|365454961|FG000|Overall Study|Randomized but not treated|1|||
105942990|NCT00851084|365454962|FG001|Overall Study|Randomized but not treated|0|||
105942991|NCT00851084|365454961|FG000|Overall Study|Adverse Event|26|||
105942992|NCT00851084|365454962|FG001|Overall Study|Adverse Event|36|||
105942993|NCT00851084|365454961|FG000|Overall Study|Disease progression|52|||
105800578|NCT00775983|364928487|FG000|Overall Study|Protocol Violation|1|||
105800579|NCT00775983|364928488|FG001|Overall Study|Protocol Violation|2|||
105800580|NCT03763331|364928489|FG000|Overall Study|Lost to Follow-up|1|||
105800581|NCT03763331|364928490|FG001|Overall Study|Lost to Follow-up|0|||
105800582|NCT03763331|364928489|FG000|Overall Study|Withdrawal by Subject|1|||
105800583|NCT03763331|364928490|FG001|Overall Study|Withdrawal by Subject|0|||
105800584|NCT03763331|364928489|FG000|Overall Study|Non-compliance|0|||
105800585|NCT03763331|364928490|FG001|Overall Study|Non-compliance|3|||
105745153|NCT05619172|364721091|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
105745154|NCT05619172|364721092|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
105800586|NCT01155063|364928491|FG000|Overall Study|Adverse Event|1|||
105942994|NCT00851084|365454962|FG001|Overall Study|Disease progression|47|||
105942995|NCT00851084|365454961|FG000|Overall Study|Poor compliance to protocol|1|||
105942996|NCT00851084|365454962|FG001|Overall Study|Poor compliance to protocol|1|||
105942997|NCT00851084|365454961|FG000|Overall Study|Physician Decision|13|||
105942998|NCT00851084|365454962|FG001|Overall Study|Physician Decision|14|||
105942999|NCT00851084|365454961|FG000|Overall Study|Consent withdrawn|0|||
105943000|NCT00851084|365454962|FG001|Overall Study|Consent withdrawn|2|||
105943001|NCT00851084|365454961|FG000|Overall Study|Withdrawal by Subject|11|||
106015527|NCT02968004|365723194|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
106015528|NCT05029362|365723195|FG000|Overall Study|Lost to Follow-up|9|||
105800587|NCT01155063|364928491|FG000|Overall Study|Withdrawal by Subject|1|||
105800588|NCT01155063|364928491|FG000|Overall Study|Study terminated by sponsor|87|||
105745155|NCT04184622|364721093|FG000|Primary Treatment Period|Adverse Event|6|||
105745156|NCT04184622|364721094|FG001|Primary Treatment Period|Adverse Event|4|||
105745157|NCT04184622|364721095|FG002|Primary Treatment Period|Adverse Event|8|||
105800589|NCT00936884|364928492|FG000|Double-blind|Withdrawal by Subject|6|||
105800590|NCT00936884|364928493|FG001|Double-blind|Withdrawal by Subject|4|||
105800591|NCT00936884|364928494|FG002|Double-blind|Withdrawal by Subject|0|||
105943002|NCT00851084|365454962|FG001|Overall Study|Withdrawal by Subject|12|||
105943003|NCT00851084|365454961|FG000|Overall Study|Metastatic surgery|6|||
105943004|NCT00851084|365454962|FG001|Overall Study|Metastatic surgery|6|||
106015529|NCT03771664|365723205|FG000|Overall Study|Adverse Event|1|||
105745158|NCT04184622|364721096|FG003|Primary Treatment Period|Adverse Event|6|||
105745159|NCT04184622|364721093|FG000|Primary Treatment Period|Death|4|||
105745160|NCT04184622|364721094|FG001|Primary Treatment Period|Death|4|||
105745161|NCT04184622|364721095|FG002|Primary Treatment Period|Death|2|||
105745162|NCT04184622|364721096|FG003|Primary Treatment Period|Death|1|||
105745163|NCT04184622|364721093|FG000|Primary Treatment Period|Lost to Follow-up|41|||
105745164|NCT04184622|364721094|FG001|Primary Treatment Period|Lost to Follow-up|17|||
105745165|NCT04184622|364721095|FG002|Primary Treatment Period|Lost to Follow-up|15|||
105745166|NCT04184622|364721096|FG003|Primary Treatment Period|Lost to Follow-up|13|||
105745167|NCT04184622|364721093|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
105745168|NCT04184622|364721094|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
105745169|NCT04184622|364721095|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
105745170|NCT04184622|364721096|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
105745171|NCT04184622|364721093|FG000|Primary Treatment Period|Physician Decision|0|||
105745172|NCT04184622|364721094|FG001|Primary Treatment Period|Physician Decision|0|||
105745173|NCT04184622|364721095|FG002|Primary Treatment Period|Physician Decision|3|||
105745174|NCT04184622|364721096|FG003|Primary Treatment Period|Physician Decision|1|||
105745175|NCT04184622|364721093|FG000|Primary Treatment Period|Pregnancy|4|||
105745176|NCT04184622|364721094|FG001|Primary Treatment Period|Pregnancy|3|||
105745177|NCT04184622|364721095|FG002|Primary Treatment Period|Pregnancy|4|||
105745178|NCT04184622|364721096|FG003|Primary Treatment Period|Pregnancy|1|||
105745179|NCT04184622|364721093|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
105745180|NCT04184622|364721094|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
105745181|NCT04184622|364721095|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
105745182|NCT04184622|364721096|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
105745183|NCT04184622|364721093|FG000|Additional Treatment Period|Adverse Event|1|||
105745184|NCT04184622|364721094|FG001|Additional Treatment Period|Adverse Event|2|||
105745185|NCT04184622|364721095|FG002|Additional Treatment Period|Adverse Event|1|||
105745186|NCT04184622|364721096|FG003|Additional Treatment Period|Adverse Event|0|||
105745187|NCT04184622|364721093|FG000|Additional Treatment Period|Death|0|||
105745188|NCT04184622|364721094|FG001|Additional Treatment Period|Death|0|||
105745189|NCT04184622|364721095|FG002|Additional Treatment Period|Death|1|||
105745190|NCT04184622|364721096|FG003|Additional Treatment Period|Death|1|||
105745191|NCT04184622|364721093|FG000|Additional Treatment Period|Lost to Follow-up|6|||
105745192|NCT04184622|364721094|FG001|Additional Treatment Period|Lost to Follow-up|4|||
105745193|NCT04184622|364721095|FG002|Additional Treatment Period|Lost to Follow-up|8|||
105745194|NCT04184622|364721096|FG003|Additional Treatment Period|Lost to Follow-up|6|||
105745195|NCT04184622|364721093|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
105745196|NCT04184622|364721094|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
105745197|NCT04184622|364721095|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
105745198|NCT04184622|364721096|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
105745199|NCT04184622|364721093|FG000|Additional Treatment Period|Physician Decision|0|||
105745200|NCT04184622|364721094|FG001|Additional Treatment Period|Physician Decision|0|||
105745201|NCT04184622|364721095|FG002|Additional Treatment Period|Physician Decision|1|||
105745202|NCT04184622|364721096|FG003|Additional Treatment Period|Physician Decision|0|||
105745203|NCT04184622|364721093|FG000|Additional Treatment Period|Pregnancy|0|||
105745204|NCT04184622|364721094|FG001|Additional Treatment Period|Pregnancy|0|||
105745205|NCT04184622|364721095|FG002|Additional Treatment Period|Pregnancy|0|||
105745206|NCT04184622|364721096|FG003|Additional Treatment Period|Pregnancy|1|||
105745207|NCT04184622|364721093|FG000|Additional Treatment Period|Protocol deviation|0|||
105745208|NCT04184622|364721094|FG001|Additional Treatment Period|Protocol deviation|0|||
105745209|NCT04184622|364721095|FG002|Additional Treatment Period|Protocol deviation|1|||
105745210|NCT04184622|364721096|FG003|Additional Treatment Period|Protocol deviation|0|||
105745211|NCT04184622|364721093|FG000|Additional Treatment Period|Site closed|1|||
105745212|NCT04184622|364721094|FG001|Additional Treatment Period|Site closed|0|||
105745213|NCT04184622|364721095|FG002|Additional Treatment Period|Site closed|1|||
105745214|NCT04184622|364721096|FG003|Additional Treatment Period|Site closed|0|||
105745215|NCT04184622|364721093|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
105745216|NCT04184622|364721094|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
106015530|NCT03771664|365723206|FG001|Overall Study|Adverse Event|0|||
105745217|NCT04184622|364721095|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
105745218|NCT04184622|364721096|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
105745219|NCT04184622|364721093|FG000|Safety Follow-up Period|Adverse Event|6|||
105745220|NCT04184622|364721094|FG001|Safety Follow-up Period|Adverse Event|8|||
105745221|NCT04184622|364721095|FG002|Safety Follow-up Period|Adverse Event|9|||
105745222|NCT04184622|364721096|FG003|Safety Follow-up Period|Adverse Event|16|||
105745223|NCT04184622|364721093|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
105745224|NCT04184622|364721094|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
105745225|NCT04184622|364721095|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
105745226|NCT04184622|364721096|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
105800592|NCT00936884|364928492|FG000|Double-blind|Death|2|||
105800593|NCT00936884|364928493|FG001|Double-blind|Death|1|||
105800594|NCT00936884|364928494|FG002|Double-blind|Death|0|||
105800595|NCT00936884|364928492|FG000|Double-blind|Lack of Efficacy|1|||
105800596|NCT00936884|364928493|FG001|Double-blind|Lack of Efficacy|1|||
105800597|NCT00936884|364928494|FG002|Double-blind|Lack of Efficacy|0|||
105800598|NCT00936884|364928492|FG000|Double-blind|Adverse Event|1|||
105800599|NCT00936884|364928493|FG001|Double-blind|Adverse Event|0|||
105800600|NCT00936884|364928494|FG002|Double-blind|Adverse Event|0|||
105800601|NCT00936884|364928492|FG000|Double-blind|Physician Decision|1|||
105800602|NCT00936884|364928493|FG001|Double-blind|Physician Decision|0|||
105800603|NCT00936884|364928494|FG002|Double-blind|Physician Decision|0|||
105800604|NCT00936884|364928492|FG000|Double-blind|No post baseline diary entry|1|||
105800605|NCT00936884|364928493|FG001|Double-blind|No post baseline diary entry|0|||
105800606|NCT00936884|364928494|FG002|Double-blind|No post baseline diary entry|0|||
105800607|NCT00936884|364928492|FG000|Double-blind|Did not receive study drug|0|||
105800608|NCT00936884|364928493|FG001|Double-blind|Did not receive study drug|1|||
105800609|NCT00936884|364928494|FG002|Double-blind|Did not receive study drug|0|||
105800610|NCT01312779|364928495|FG000|Overall Study|Withdrawal by Subject|2|||
105800611|NCT01312779|364928495|FG000|Overall Study|Death|3|||
105800612|NCT01312779|364928495|FG000|Overall Study|Not Implanted with Device|27|||
105800613|NCT04741503|364928496|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
105800614|NCT04741503|364928497|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
105800615|NCT04741503|364928498|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
105800616|NCT04741503|364928496|FG000|Initial Enrollment|Overquotas removed|0|||
105800617|NCT04741503|364928497|FG001|Initial Enrollment|Overquotas removed|0|||
105800618|NCT04741503|364928498|FG002|Initial Enrollment|Overquotas removed|186|||
105800619|NCT04741503|364928496|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
105800620|NCT04741503|364928497|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
105800621|NCT04741503|364928498|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
105800622|NCT01314703|364928499|FG000|Overall Study|screen failure and closed enrollment|8|||
105800623|NCT00597584|364928500|FG000|Overall Study|Adverse Event|4|||
105800624|NCT00597584|364928501|FG001|Overall Study|Adverse Event|2|||
105800625|NCT00597584|364928500|FG000|Overall Study|Death|53|||
105800626|NCT00597584|364928501|FG001|Overall Study|Death|30|||
105800627|NCT00597584|364928500|FG000|Overall Study|Lack of Efficacy|1|||
105800628|NCT00597584|364928501|FG001|Overall Study|Lack of Efficacy|0|||
105800629|NCT00597584|364928500|FG000|Overall Study|Lost to Follow-up|2|||
105800630|NCT00597584|364928501|FG001|Overall Study|Lost to Follow-up|4|||
105800631|NCT00597584|364928500|FG000|Overall Study|Physician Decision|3|||
105800632|NCT00597584|364928501|FG001|Overall Study|Physician Decision|0|||
105800633|NCT00597584|364928500|FG000|Overall Study|Pregnancy|2|||
105800634|NCT00597584|364928501|FG001|Overall Study|Pregnancy|0|||
105800635|NCT00597584|364928500|FG000|Overall Study|Withdrawal by Subject|44|||
105800636|NCT00597584|364928501|FG001|Overall Study|Withdrawal by Subject|12|||
105800637|NCT00597584|364928500|FG000|Overall Study|Discontinued Dialysis|0|||
105800638|NCT00597584|364928501|FG001|Overall Study|Discontinued Dialysis|1|||
105800639|NCT00597584|364928500|FG000|Overall Study|Lost ability to consent|1|||
105800640|NCT00597584|364928501|FG001|Overall Study|Lost ability to consent|1|||
105745227|NCT04184622|364721093|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
105745228|NCT04184622|364721094|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
105745229|NCT04184622|364721095|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
105745230|NCT04184622|364721096|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
105745231|NCT04184622|364721093|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
105745232|NCT04184622|364721094|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
105745233|NCT04184622|364721095|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
105745234|NCT04184622|364721096|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
105745235|NCT04184622|364721093|FG000|Safety Follow-up Period|Physician Decision|1|||
105745236|NCT04184622|364721094|FG001|Safety Follow-up Period|Physician Decision|0|||
105745237|NCT04184622|364721095|FG002|Safety Follow-up Period|Physician Decision|0|||
105745238|NCT04184622|364721096|FG003|Safety Follow-up Period|Physician Decision|1|||
105745239|NCT04184622|364721093|FG000|Safety Follow-up Period|Pregnancy|1|||
105800641|NCT00597584|364928500|FG000|Overall Study|Never dosed|1|||
105800642|NCT00597584|364928501|FG001|Overall Study|Never dosed|0|||
105800643|NCT00597584|364928500|FG000|Overall Study|Relocation|8|||
105800644|NCT00597584|364928501|FG001|Overall Study|Relocation|6|||
105800645|NCT00597584|364928500|FG000|Overall Study|Renal transplant|9|||
105800646|NCT00597584|364928501|FG001|Overall Study|Renal transplant|7|||
105800647|NCT01859390|364928502|FG000|Overall Study|Insufficient Sputum Collected|1|||
105800648|NCT01859390|364928503|FG001|Overall Study|Insufficient Sputum Collected|3|||
105800649|NCT01859390|364928502|FG000|Overall Study|Sample Missing Collection Date|0|||
105745240|NCT04184622|364721094|FG001|Safety Follow-up Period|Pregnancy|3|||
105745241|NCT04184622|364721095|FG002|Safety Follow-up Period|Pregnancy|0|||
105800650|NCT01859390|364928503|FG001|Overall Study|Sample Missing Collection Date|1|||
105745242|NCT04184622|364721096|FG003|Safety Follow-up Period|Pregnancy|6|||
105745243|NCT04184622|364721093|FG000|Safety Follow-up Period|Protocol deviation|1|||
105745244|NCT04184622|364721094|FG001|Safety Follow-up Period|Protocol deviation|0|||
105745245|NCT04184622|364721095|FG002|Safety Follow-up Period|Protocol deviation|0|||
105745246|NCT04184622|364721096|FG003|Safety Follow-up Period|Protocol deviation|0|||
105745247|NCT04184622|364721093|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
105745248|NCT04184622|364721094|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
105745249|NCT04184622|364721095|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
105745250|NCT04184622|364721096|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
105745251|NCT01219959|364721107|FG000|Overall Study|Adverse Event|6|||
105745252|NCT01219959|364721108|FG001|Overall Study|Adverse Event|14|||
105745253|NCT01219959|364721107|FG000|Overall Study|Physician Decision|0|||
105745254|NCT01219959|364721108|FG001|Overall Study|Physician Decision|4|||
105745255|NCT01219959|364721107|FG000|Overall Study|Withdrawal by Subject|0|||
105745256|NCT01219959|364721108|FG001|Overall Study|Withdrawal by Subject|2|||
105745257|NCT01219959|364721107|FG000|Overall Study|Renal Transplantation|0|||
105745258|NCT01219959|364721108|FG001|Overall Study|Renal Transplantation|3|||
105745259|NCT01219959|364721107|FG000|Overall Study|Other|1|||
105745260|NCT01219959|364721108|FG001|Overall Study|Other|0|||
105745261|NCT05906732|364721109|FG000|Overall Study|Withdrawal by Subject|1|||
105745262|NCT05906732|364721110|FG001|Overall Study|Withdrawal by Subject|0|||
105745263|NCT05906732|364721111|FG002|Overall Study|Withdrawal by Subject|0|||
105745264|NCT05906732|364721112|FG003|Overall Study|Withdrawal by Subject|0|||
105745265|NCT05906732|364721109|FG000|Overall Study|Physician Decision|2|||
105745266|NCT05906732|364721110|FG001|Overall Study|Physician Decision|4|||
105745267|NCT05906732|364721111|FG002|Overall Study|Physician Decision|0|||
105745268|NCT05906732|364721112|FG003|Overall Study|Physician Decision|0|||
105745269|NCT05628181|364721113|FG000|Overall Study|Death|2|||
105745270|NCT05628181|364721114|FG001|Overall Study|Death|4|||
105745271|NCT05628181|364721115|FG002|Overall Study|Death|0|||
105745272|NCT01358877|364721117|FG000|Overall Study|Death|80|||
105745273|NCT01358877|364721118|FG001|Overall Study|Death|89|||
105745274|NCT01358877|364721117|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
105745275|NCT01358877|364721118|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
105745276|NCT01358877|364721117|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
105745277|NCT01358877|364721118|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
105745278|NCT01358877|364721117|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
105745279|NCT01358877|364721118|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
105745280|NCT01358877|364721117|FG000|Overall Study|Other|142|||
105745281|NCT01358877|364721118|FG001|Overall Study|Other|129|||
105745282|NCT03656926|364721119|FG000|Overall Study|Adverse Event|5|||
105745283|NCT03656926|364721120|FG001|Overall Study|Adverse Event|4|||
105745284|NCT03656926|364721119|FG000|Overall Study|Withdrawal by Subject|7|||
105745285|NCT03656926|364721120|FG001|Overall Study|Withdrawal by Subject|2|||
105745286|NCT03656926|364721119|FG000|Overall Study|Screen fail after randomization|1|||
105745287|NCT03656926|364721120|FG001|Overall Study|Screen fail after randomization|0|||
105745288|NCT03656926|364721119|FG000|Overall Study|PI decision due to patient condition|1|||
105745289|NCT03656926|364721120|FG001|Overall Study|PI decision due to patient condition|0|||
105745290|NCT03656926|364721119|FG000|Overall Study|Patient unresponsiveness|1|||
105745291|NCT03656926|364721120|FG001|Overall Study|Patient unresponsiveness|0|||
105745292|NCT06150573|364721121|FG000|Overall Study|Did not meet study criteria|1|||
105745293|NCT06150573|364721122|FG001|Overall Study|Did not meet study criteria|0|||
105745294|NCT06150573|364721121|FG000|Overall Study|Adverse Event|1|||
105745295|NCT06150573|364721122|FG001|Overall Study|Adverse Event|0|||
105745296|NCT06150573|364721121|FG000|Overall Study|Lost to Follow-up|0|||
105745297|NCT06150573|364721122|FG001|Overall Study|Lost to Follow-up|1|||
105745298|NCT06150573|364721121|FG000|Overall Study|Protocol Violation|0|||
105745299|NCT06150573|364721122|FG001|Overall Study|Protocol Violation|1|||
105745300|NCT06150573|364721121|FG000|Overall Study|Withdrawal by Subject|2|||
105745301|NCT06150573|364721122|FG001|Overall Study|Withdrawal by Subject|0|||
105745302|NCT01698905|364721123|FG000|Overall Study|Adverse Event|4|||
105745303|NCT01698905|364721123|FG000|Overall Study|Physician Decision|2|||
105745304|NCT01698905|364721123|FG000|Overall Study|Pregnancy|1|||
105745305|NCT01698905|364721123|FG000|Overall Study|Protocol Violation|1|||
105745306|NCT01698905|364721123|FG000|Overall Study|Subject/guardian decision|2|||
105745307|NCT01698905|364721123|FG000|Overall Study|Death|1|||
105745308|NCT05610176|364721124|FG000|Overall Study|Death|6|||
105745309|NCT04948333|364721125|FG000|Overall Study|Adverse Event|6|||
105745310|NCT04948333|364721126|FG001|Overall Study|Adverse Event|4|||
105745311|NCT04948333|364721127|FG002|Overall Study|Adverse Event|0|||
105745312|NCT04948333|364721128|FG003|Overall Study|Adverse Event|2|||
105745313|NCT04948333|364721125|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
105745314|NCT04948333|364721126|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105745315|NCT04948333|364721127|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105745316|NCT04948333|364721128|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105745317|NCT04948333|364721125|FG000|Overall Study|Progressive Disease|1|||
105745318|NCT04948333|364721126|FG001|Overall Study|Progressive Disease|5|||
105745319|NCT04948333|364721127|FG002|Overall Study|Progressive Disease|0|||
105745320|NCT04948333|364721128|FG003|Overall Study|Progressive Disease|0|||
105745321|NCT04948333|364721125|FG000|Overall Study|Physician Decision|2|||
105745322|NCT04948333|364721126|FG001|Overall Study|Physician Decision|2|||
105745323|NCT04948333|364721127|FG002|Overall Study|Physician Decision|0|||
105745324|NCT04948333|364721128|FG003|Overall Study|Physician Decision|0|||
105745325|NCT04948333|364721125|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
105745326|NCT04948333|364721126|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
105745327|NCT04948333|364721127|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
105745328|NCT04948333|364721128|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
105745329|NCT04948333|364721125|FG000|Overall Study|Withdrawal by Subject|2|||
105745330|NCT04948333|364721126|FG001|Overall Study|Withdrawal by Subject|0|||
105745331|NCT04948333|364721127|FG002|Overall Study|Withdrawal by Subject|0|||
105745332|NCT04948333|364721128|FG003|Overall Study|Withdrawal by Subject|1|||
105745333|NCT04948333|364721125|FG000|Overall Study|Protocol Violation|0|||
105745334|NCT04948333|364721126|FG001|Overall Study|Protocol Violation|1|||
105745335|NCT04948333|364721127|FG002|Overall Study|Protocol Violation|0|||
105745336|NCT04948333|364721128|FG003|Overall Study|Protocol Violation|0|||
105745337|NCT04948333|364721125|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
105745338|NCT04948333|364721126|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
105745339|NCT04948333|364721127|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
105745340|NCT04948333|364721128|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
105745341|NCT03607838|364721129|FG000|Overall Study|Lack of Efficacy|14|||
105745342|NCT03607838|364721130|FG001|Overall Study|Lack of Efficacy|20|||
105745343|NCT03607838|364721129|FG000|Overall Study|Withdrawal by Subject|13|||
105745344|NCT03607838|364721130|FG001|Overall Study|Withdrawal by Subject|8|||
105745345|NCT03607838|364721129|FG000|Overall Study|Lost to Follow-up|6|||
105745346|NCT03607838|364721130|FG001|Overall Study|Lost to Follow-up|11|||
105745347|NCT03607838|364721129|FG000|Overall Study|Adverse Event|2|||
105745348|NCT03607838|364721130|FG001|Overall Study|Adverse Event|2|||
105745349|NCT03607838|364721129|FG000|Overall Study|Physician Decision|2|||
105745350|NCT03607838|364721130|FG001|Overall Study|Physician Decision|0|||
105745351|NCT03607838|364721129|FG000|Overall Study|Failure to meet randomization criteria|1|||
105745352|NCT03607838|364721130|FG001|Overall Study|Failure to meet randomization criteria|2|||
105745353|NCT03607838|364721129|FG000|Overall Study|Pregnancy|1|||
105745354|NCT03607838|364721130|FG001|Overall Study|Pregnancy|0|||
105745355|NCT03607838|364721129|FG000|Overall Study|Protocol Violation|1|||
105745356|NCT03607838|364721130|FG001|Overall Study|Protocol Violation|0|||
105745357|NCT03607838|364721129|FG000|Overall Study|Due to work|1|||
105745358|NCT03607838|364721130|FG001|Overall Study|Due to work|0|||
105745359|NCT03607838|364721129|FG000|Overall Study|Litigation|0|||
105745360|NCT03607838|364721130|FG001|Overall Study|Litigation|1|||
105745361|NCT03607838|364721129|FG000|Overall Study|Temperature excursion for study drug|0|||
105745362|NCT03607838|364721130|FG001|Overall Study|Temperature excursion for study drug|1|||
105745363|NCT03607838|364721129|FG000|Overall Study|Change of mind|0|||
105745364|NCT03607838|364721130|FG001|Overall Study|Change of mind|1|||
105745365|NCT03249792|364721131|FG000|Arms 1, 2, and 4|Death|1|||
105745366|NCT03249792|364721132|FG001|Arms 1, 2, and 4|Death|1|||
105745367|NCT03249792|364721133|FG002|Arms 1, 2, and 4|Death|0|||
105745368|NCT03249792|364721134|FG003|Arms 1, 2, and 4|Death|2|||
105745369|NCT03249792|364721135|FG004|Arms 1, 2, and 4|Death|3|||
105745370|NCT03249792|364721136|FG005|Arms 1, 2, and 4|Death|2|||
105745371|NCT03249792|364721137|FG006|Arms 1, 2, and 4|Death|2|||
105745372|NCT03249792|364721138|FG007|Arms 1, 2, and 4|Death|4|||
105745373|NCT03249792|364721139|FG008|Arms 1, 2, and 4|Death|2|||
105745374|NCT03249792|364721140|FG009|Arms 1, 2, and 4|Death|1|||
105745375|NCT03249792|364721141|FG010|Arms 1, 2, and 4|Death|7|||
105745376|NCT03249792|364721142|FG011|Arms 1, 2, and 4|Death|7|||
105745377|NCT03249792|364721143|FG012|Arms 1, 2, and 4|Death|12|||
105745378|NCT03249792|364721144|FG013|Arms 1, 2, and 4|Death|7|||
105745379|NCT03249792|364721145|FG014|Arms 1, 2, and 4|Death|0|||
105745380|NCT03249792|364721146|FG015|Arms 1, 2, and 4|Death|4|||
105745381|NCT03249792|364721147|FG016|Arms 1, 2, and 4|Death|4|||
105745382|NCT03249792|364721148|FG017|Arms 1, 2, and 4|Death|12|||
105745383|NCT03249792|364721149|FG018|Arms 1, 2, and 4|Death|6|||
105943005|NCT00851084|365454961|FG000|Overall Study|Other|7|||
105745384|NCT03249792|364721150|FG019|Arms 1, 2, and 4|Death|4|||
105745385|NCT03249792|364721151|FG020|Arms 1, 2, and 4|Death|2|||
105745386|NCT03249792|364721152|FG021|Arms 1, 2, and 4|Death|3|||
105745387|NCT03249792|364721153|FG022|Arms 1, 2, and 4|Death|1|||
105745388|NCT03249792|364721154|FG023|Arms 1, 2, and 4|Death|1|||
105745389|NCT03249792|364721155|FG024|Arms 1, 2, and 4|Death|4|||
105745390|NCT03249792|364721156|FG025|Arms 1, 2, and 4|Death|0|||
105745391|NCT03249792|364721157|FG026|Arms 1, 2, and 4|Death|0|||
105745392|NCT03249792|364721158|FG027|Arms 1, 2, and 4|Death|0|||
105745393|NCT03249792|364721159|FG028|Arms 1, 2, and 4|Death|0|||
105745394|NCT03249792|364721160|FG029|Arms 1, 2, and 4|Death|0|||
105745395|NCT03249792|364721161|FG030|Arms 1, 2, and 4|Death|0|||
105745396|NCT03249792|364721162|FG031|Arms 1, 2, and 4|Death|0|||
105745397|NCT03249792|364721163|FG032|Arms 1, 2, and 4|Death|0|||
105800651|NCT01859390|364928502|FG000|Overall Study|Tube Cracked|0|||
105800652|NCT01859390|364928503|FG001|Overall Study|Tube Cracked|2|||
105800653|NCT01859390|364928502|FG000|Overall Study|Shipment Error|0|||
105800654|NCT01859390|364928503|FG001|Overall Study|Shipment Error|1|||
105800655|NCT01020305|364928511|FG000|Overall Study|Adverse Event|2|||
105800656|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
105800657|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
105800658|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
105800659|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
105800660|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
105800661|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
105800662|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
105800663|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
105800664|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
105800665|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
105800666|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
105800667|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
105800668|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
105800669|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
105800670|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
105800671|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
105800672|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
105800673|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
105800674|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
105800675|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
105800676|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
105800677|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
105800678|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
105800679|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
105800680|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
105800681|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
105800682|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
105800683|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
105800684|NCT01872689|364928521|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
105800685|NCT01872689|364928522|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
105745398|NCT03249792|364721131|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745399|NCT03249792|364721132|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745400|NCT03249792|364721133|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745401|NCT03249792|364721134|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745402|NCT03249792|364721135|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745403|NCT03249792|364721136|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745404|NCT03249792|364721137|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
105745405|NCT03249792|364721138|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745406|NCT03249792|364721139|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
105745407|NCT03249792|364721140|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745408|NCT03249792|364721141|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
105745409|NCT03249792|364721142|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
105745410|NCT03249792|364721143|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
105745411|NCT03249792|364721144|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
105745412|NCT03249792|364721145|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105800686|NCT01872689|364928523|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
105745413|NCT03249792|364721146|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745414|NCT03249792|364721147|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
105745415|NCT03249792|364721148|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105800687|NCT01872689|364928524|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
105943006|NCT00851084|365454962|FG001|Overall Study|Other|1|||
105943007|NCT00734032|365454963|FG000|Overall Study|Adverse Event|0|||
105943008|NCT00734032|365454964|FG001|Overall Study|Adverse Event|1|||
105943009|NCT00734032|365454965|FG002|Overall Study|Adverse Event|0|||
105943010|NCT00734032|365454966|FG003|Overall Study|Adverse Event|0|||
105943011|NCT03360344|365454967|FG000|Overall Study|Withdrawal by Subject|0|||
105943012|NCT03360344|365454968|FG001|Overall Study|Withdrawal by Subject|1|||
105943013|NCT03360344|365454969|FG002|Overall Study|Withdrawal by Subject|1|||
105943014|NCT02301897|365454970|FG000|Treatment Course 1|Non-Compliance|0|||
105943015|NCT02301897|365454971|FG001|Treatment Course 1|Non-Compliance|0|||
105943016|NCT02301897|365454972|FG002|Treatment Course 1|Non-Compliance|1|||
105943017|NCT02301897|365454970|FG000|Treatment Course 1|Adverse Event|1|||
105943018|NCT02301897|365454971|FG001|Treatment Course 1|Adverse Event|1|||
105943019|NCT02301897|365454972|FG002|Treatment Course 1|Adverse Event|0|||
105943020|NCT02301897|365454970|FG000|Treatment Course 1|Lost to Follow-up|1|||
105943021|NCT02301897|365454971|FG001|Treatment Course 1|Lost to Follow-up|2|||
105745416|NCT03249792|364721149|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745417|NCT03249792|364721150|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745418|NCT03249792|364721151|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745419|NCT03249792|364721152|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745420|NCT03249792|364721153|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
106015531|NCT03771664|365723205|FG000|Overall Study|Lost to Follow-up|1|||
106015532|NCT03771664|365723206|FG001|Overall Study|Lost to Follow-up|0|||
106015533|NCT03771664|365723205|FG000|Overall Study|Withdrawal by Participant|1|||
106015534|NCT03771664|365723206|FG001|Overall Study|Withdrawal by Participant|4|||
106015535|NCT03771664|365723205|FG000|Overall Study|Randomized but not Treated|0|||
106015536|NCT03771664|365723206|FG001|Overall Study|Randomized but not Treated|1|||
106015537|NCT01662102|365723207|FG000|Overall Study|Sponsor's decision|1|||
106015538|NCT01662102|365723208|FG001|Overall Study|Sponsor's decision|0|||
106015539|NCT00724698|365723209|FG000|Overall Study|Adverse Event|9|||
106015540|NCT00724698|365723209|FG000|Overall Study|Failure of Therapy|4|||
106015541|NCT00724698|365723209|FG000|Overall Study|Poor Compliance|16|||
105745421|NCT03249792|364721154|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
105745422|NCT03249792|364721155|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745423|NCT03249792|364721156|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745424|NCT03249792|364721157|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745425|NCT03249792|364721158|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745426|NCT03249792|364721159|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745427|NCT03249792|364721160|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745428|NCT03249792|364721161|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745429|NCT03249792|364721162|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745430|NCT03249792|364721163|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
105745431|NCT03249792|364721131|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
105745432|NCT03249792|364721132|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
105745433|NCT03249792|364721133|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
105745434|NCT03249792|364721134|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
105745435|NCT03249792|364721135|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
105745436|NCT03249792|364721136|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
105745437|NCT03249792|364721137|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
105745438|NCT03249792|364721138|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
105745439|NCT03249792|364721139|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
105745440|NCT03249792|364721140|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
105745441|NCT03249792|364721141|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
105745442|NCT03249792|364721142|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
105745443|NCT03249792|364721143|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
105745444|NCT03249792|364721144|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
105745445|NCT03249792|364721145|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
105745446|NCT03249792|364721146|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
105745447|NCT03249792|364721147|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
105745448|NCT03249792|364721148|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
105745449|NCT03249792|364721149|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
105745450|NCT03249792|364721150|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
105745451|NCT03249792|364721151|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
105745452|NCT03249792|364721152|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
106015542|NCT00724698|365723209|FG000|Overall Study|Lost to Follow-up|36|||
106015543|NCT00724698|365723209|FG000|Overall Study|No Info|25|||
106015544|NCT00043979|365723210|FG000|Period 1|recipient with progressive disease|7|||
106015545|NCT00043979|365723211|FG001|Period 1|recipient with progressive disease|4|||
106015546|NCT00043979|365723212|FG002|Period 1|recipient with progressive disease|3|||
106015547|NCT04041414|365723213|FG000|Overall Study|Lost to Follow-up|1|||
106015548|NCT04041414|365723214|FG001|Overall Study|Lost to Follow-up|2|||
106015549|NCT04639258|365723220|FG000|Overall Study|Screen failure|5|||
106015550|NCT04639258|365723220|FG000|Overall Study|Physician Decision|2|||
106015551|NCT04639258|365723220|FG000|Overall Study|Early study termination|3|||
106015552|NCT04639258|365723220|FG000|Overall Study|Withdrawal by Subject|1|||
106015553|NCT02556177|365723223|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
106015554|NCT02556177|365723224|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
106142324|NCT01350804|366179969|FG002|Core Study|Withdrawal by Subject|16|||
106142325|NCT01350804|366179970|FG003|Core Study|Withdrawal by Subject|7|||
105745453|NCT03249792|364721153|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
106015555|NCT00658359|365723225|FG000|Overall Study|Death|3|||
106015556|NCT00658359|365723226|FG001|Overall Study|Death|1|||
105745454|NCT03249792|364721154|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
105745455|NCT03249792|364721155|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
105745456|NCT03249792|364721156|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
105745457|NCT03249792|364721157|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
105745458|NCT03249792|364721158|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
106015557|NCT00658359|365723227|FG002|Overall Study|Death|2|||
106015558|NCT00658359|365723225|FG000|Overall Study|Adverse Event|13|||
106015559|NCT00658359|365723226|FG001|Overall Study|Adverse Event|6|||
106015560|NCT00658359|365723227|FG002|Overall Study|Adverse Event|9|||
105745459|NCT03249792|364721159|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
105745460|NCT03249792|364721160|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
105745461|NCT03249792|364721161|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
106142326|NCT01350804|366179967|FG000|Core Study|Study terminated by Sponsor|0|||
106015561|NCT00658359|365723225|FG000|Overall Study|Protocol Violation|1|||
106015562|NCT00658359|365723226|FG001|Overall Study|Protocol Violation|0|||
106015563|NCT00658359|365723227|FG002|Overall Study|Protocol Violation|0|||
106015564|NCT00658359|365723225|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
106015565|NCT00658359|365723226|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
106015566|NCT00658359|365723227|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
106015567|NCT00658359|365723225|FG000|Overall Study|Withdrawal by Subject|7|||
105745462|NCT03249792|364721162|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
105745463|NCT03249792|364721163|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
105745464|NCT03249792|364721131|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745465|NCT03249792|364721132|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745466|NCT03249792|364721133|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745467|NCT03249792|364721134|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745468|NCT03249792|364721135|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745469|NCT03249792|364721136|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745470|NCT03249792|364721137|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745471|NCT03249792|364721138|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745472|NCT03249792|364721139|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
105745473|NCT03249792|364721140|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745474|NCT03249792|364721141|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
105943022|NCT02301897|365454972|FG002|Treatment Course 1|Lost to Follow-up|1|||
106015568|NCT00658359|365723226|FG001|Overall Study|Withdrawal by Subject|4|||
106015569|NCT00658359|365723227|FG002|Overall Study|Withdrawal by Subject|2|||
105745475|NCT03249792|364721142|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745476|NCT03249792|364721143|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
105943023|NCT02301897|365454970|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
105943024|NCT02301897|365454971|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
105943025|NCT02301897|365454972|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
105943026|NCT02301897|365454970|FG000|Treatment Course 1|Withdrawal by Subject|0|||
105943027|NCT02301897|365454971|FG001|Treatment Course 1|Withdrawal by Subject|0|||
105943028|NCT02301897|365454972|FG002|Treatment Course 1|Withdrawal by Subject|2|||
105943029|NCT02301897|365454970|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
105943030|NCT02301897|365454971|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
105943031|NCT02301897|365454972|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
105745477|NCT03249792|364721144|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745478|NCT03249792|364721145|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745479|NCT03249792|364721146|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745480|NCT03249792|364721147|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
105745481|NCT03249792|364721148|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
105745482|NCT03249792|364721149|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
105800688|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
105800689|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
105943032|NCT02301897|365454970|FG000|Treatment Course 2|Lost to Follow-up|0|||
105943033|NCT02301897|365454971|FG001|Treatment Course 2|Lost to Follow-up|2|||
105943034|NCT02301897|365454972|FG002|Treatment Course 2|Lost to Follow-up|0|||
105943035|NCT02301897|365454970|FG000|Treatment Course 2|Pregnancy|0|||
105943036|NCT02301897|365454971|FG001|Treatment Course 2|Pregnancy|1|||
105943037|NCT02301897|365454972|FG002|Treatment Course 2|Pregnancy|1|||
105943038|NCT02301897|365454970|FG000|Treatment Course 2|Withdrawal by Subject|0|||
105943039|NCT02301897|365454971|FG001|Treatment Course 2|Withdrawal by Subject|2|||
105943040|NCT02301897|365454972|FG002|Treatment Course 2|Withdrawal by Subject|0|||
105943041|NCT02301897|365454970|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
105943042|NCT02301897|365454971|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
105943043|NCT02301897|365454972|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
105943044|NCT00278161|365454973|FG000|Overall Study|Death|11|||
106015570|NCT00658359|365723225|FG000|Overall Study|Lost to Follow-up|2|||
106015571|NCT00658359|365723226|FG001|Overall Study|Lost to Follow-up|2|||
106015572|NCT00658359|365723227|FG002|Overall Study|Lost to Follow-up|4|||
106015573|NCT00658359|365723225|FG000|Overall Study|Lack of Efficacy|0|||
106015574|NCT00658359|365723226|FG001|Overall Study|Lack of Efficacy|1|||
106015575|NCT00658359|365723227|FG002|Overall Study|Lack of Efficacy|0|||
105745483|NCT03249792|364721150|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
105745484|NCT03249792|364721151|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745485|NCT03249792|364721152|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745486|NCT03249792|364721153|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745487|NCT03249792|364721154|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
105800690|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
105943045|NCT04507763|365454975|FG000|Overall Study|Participants did not meet entrance criteria|201|||
105943046|NCT01602484|365454976|FG000|Overall Study|Airway issues unrelated to study|0|||
105943047|NCT01602484|365454977|FG001|Overall Study|Airway issues unrelated to study|1|||
105943048|NCT00754572|365454978|FG000|Overall Study|Adverse Event|19|||
105943049|NCT00754572|365454978|FG000|Overall Study|Other|39|||
105943050|NCT00754572|365454978|FG000|Overall Study|Protocol Violation|3|||
105943051|NCT00754572|365454978|FG000|Overall Study|Withdrawal by Subject|3|||
105943052|NCT00754572|365454978|FG000|Overall Study|Lack of Efficacy|2|||
106015576|NCT02558296|365723228|FG000|Completed the Study Through Week 24|Adverse Event|9|||
106015577|NCT02558296|365723229|FG001|Completed the Study Through Week 24|Adverse Event|3|||
106015578|NCT02558296|365723228|FG000|Completed the Study Through Week 24|Death|7|||
106015579|NCT02558296|365723229|FG001|Completed the Study Through Week 24|Death|7|||
106015580|NCT02558296|365723228|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
106015581|NCT02558296|365723229|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
106015582|NCT02558296|365723228|FG000|Completed the Study Through Week 24|Physician Decision|1|||
106015583|NCT02558296|365723229|FG001|Completed the Study Through Week 24|Physician Decision|0|||
106015584|NCT02558296|365723228|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
106015585|NCT02558296|365723229|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
106015586|NCT02558296|365723228|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
106015587|NCT02558296|365723229|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
106015588|NCT02558296|365723228|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
105800691|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
105800692|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
105800693|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
105800694|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
105800695|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
105800696|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
105800697|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
105800698|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
105800699|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
105800700|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
105800701|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
105800702|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
105800703|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
105800704|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
105800705|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
105800706|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
105800707|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
105800708|NCT01872689|364928521|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
105800709|NCT01872689|364928522|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
105800710|NCT01872689|364928523|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
105800711|NCT01872689|364928524|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
105800712|NCT03989115|364928525|FG000|Overall Study|Withdrawal by Subject|2|||
105800713|NCT03989115|364928526|FG001|Overall Study|Withdrawal by Subject|1|||
105800714|NCT03989115|364928527|FG002|Overall Study|Withdrawal by Subject|3|||
105800715|NCT03989115|364928528|FG003|Overall Study|Withdrawal by Subject|0|||
105800716|NCT03989115|364928529|FG004|Overall Study|Withdrawal by Subject|17|||
105800717|NCT03989115|364928530|FG005|Overall Study|Withdrawal by Subject|1|||
105800718|NCT03989115|364928531|FG006|Overall Study|Withdrawal by Subject|0|||
105800719|NCT03989115|364928532|FG007|Overall Study|Withdrawal by Subject|0|||
105800720|NCT03989115|364928525|FG000|Overall Study|Sponsor decision to terminate the study|1|||
105800721|NCT03989115|364928526|FG001|Overall Study|Sponsor decision to terminate the study|1|||
105800722|NCT03989115|364928527|FG002|Overall Study|Sponsor decision to terminate the study|0|||
105800723|NCT03989115|364928528|FG003|Overall Study|Sponsor decision to terminate the study|1|||
105800724|NCT03989115|364928529|FG004|Overall Study|Sponsor decision to terminate the study|11|||
105800725|NCT03989115|364928530|FG005|Overall Study|Sponsor decision to terminate the study|0|||
105800726|NCT03989115|364928531|FG006|Overall Study|Sponsor decision to terminate the study|2|||
105800727|NCT03989115|364928532|FG007|Overall Study|Sponsor decision to terminate the study|1|||
105800728|NCT03989115|364928525|FG000|Overall Study|Lost to Follow-up|2|||
105800729|NCT03989115|364928526|FG001|Overall Study|Lost to Follow-up|0|||
105800730|NCT03989115|364928527|FG002|Overall Study|Lost to Follow-up|0|||
105800731|NCT03989115|364928528|FG003|Overall Study|Lost to Follow-up|0|||
105800732|NCT03989115|364928529|FG004|Overall Study|Lost to Follow-up|1|||
105943053|NCT00754572|365454978|FG000|Overall Study|Death|1|||
105943054|NCT00754572|365454978|FG000|Overall Study|Administrative Reason|3|||
105943055|NCT00754572|365454978|FG000|Overall Study|Lost to Follow-up|1|||
105943056|NCT04617860|365454979|FG000|Overall Study|Adverse Event|0|||
105943057|NCT04617860|365454980|FG001|Overall Study|Adverse Event|2|||
105943058|NCT04617860|365454981|FG002|Overall Study|Adverse Event|2|||
105943059|NCT04617860|365454979|FG000|Overall Study|Withdrawal by Subject|0|||
106015589|NCT02558296|365723229|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
106015590|NCT02558296|365723228|FG000|Completed the Study|Adverse Event|14|||
106015591|NCT02558296|365723229|FG001|Completed the Study|Adverse Event|5|||
105943060|NCT04617860|365454980|FG001|Overall Study|Withdrawal by Subject|0|||
105943061|NCT04617860|365454981|FG002|Overall Study|Withdrawal by Subject|2|||
105943062|NCT04617860|365454979|FG000|Overall Study|Physician Decision|0|||
105943063|NCT04617860|365454980|FG001|Overall Study|Physician Decision|1|||
106015592|NCT02558296|365723228|FG000|Completed the Study|Death|39|||
106015593|NCT02558296|365723229|FG001|Completed the Study|Death|25|||
106015594|NCT02558296|365723228|FG000|Completed the Study|Lost to Follow-up|31|||
106015595|NCT02558296|365723229|FG001|Completed the Study|Lost to Follow-up|23|||
106015596|NCT02558296|365723228|FG000|Completed the Study|Physician Decision|6|||
106015597|NCT02558296|365723229|FG001|Completed the Study|Physician Decision|0|||
106015598|NCT02558296|365723228|FG000|Completed the Study|Protocol Violation|2|||
106015599|NCT02558296|365723229|FG001|Completed the Study|Protocol Violation|1|||
106015600|NCT02558296|365723228|FG000|Completed the Study|Withdrawal by Subject|53|||
106015601|NCT02558296|365723229|FG001|Completed the Study|Withdrawal by Subject|31|||
106015602|NCT02558296|365723228|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
106015603|NCT02558296|365723229|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
106015604|NCT02919995|365723230|FG000|Overall Study|Adverse Event|0|||
106015605|NCT02919995|365723231|FG001|Overall Study|Adverse Event|0|||
106015606|NCT02919995|365723232|FG002|Overall Study|Adverse Event|0|||
106015607|NCT02919995|365723233|FG003|Overall Study|Adverse Event|0|||
106015608|NCT02919995|365723234|FG004|Overall Study|Adverse Event|0|||
106015609|NCT02919995|365723235|FG005|Overall Study|Adverse Event|1|||
106015610|NCT02531802|365723238|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
106015611|NCT02531802|365723239|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
106015612|NCT02531802|365723240|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
106015613|NCT02531802|365723241|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
106015614|NCT02531802|365723242|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
106015615|NCT02531802|365723243|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
106015616|NCT02531802|365723244|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
106015617|NCT02531802|365723245|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
106015618|NCT02531802|365723246|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
106015619|NCT02531802|365723247|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
106015620|NCT02531802|365723248|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
106015621|NCT02531802|365723249|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
106015622|NCT02531802|365723250|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
105745488|NCT03249792|364721155|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745489|NCT03249792|364721156|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745490|NCT03249792|364721157|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745491|NCT03249792|364721158|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745492|NCT03249792|364721159|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745493|NCT03249792|364721160|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745494|NCT03249792|364721161|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745495|NCT03249792|364721162|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745496|NCT03249792|364721163|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
105745497|NCT03249792|364721131|FG000|Switch Over Period|Withdrawal by Subject|0|||
105745498|NCT03249792|364721132|FG001|Switch Over Period|Withdrawal by Subject|0|||
105745499|NCT03249792|364721133|FG002|Switch Over Period|Withdrawal by Subject|0|||
105745500|NCT03249792|364721134|FG003|Switch Over Period|Withdrawal by Subject|0|||
105745501|NCT03249792|364721135|FG004|Switch Over Period|Withdrawal by Subject|0|||
105745502|NCT03249792|364721136|FG005|Switch Over Period|Withdrawal by Subject|0|||
105745503|NCT03249792|364721137|FG006|Switch Over Period|Withdrawal by Subject|0|||
105745504|NCT03249792|364721138|FG007|Switch Over Period|Withdrawal by Subject|0|||
105745505|NCT03249792|364721139|FG008|Switch Over Period|Withdrawal by Subject|0|||
105745506|NCT03249792|364721140|FG009|Switch Over Period|Withdrawal by Subject|0|||
105745507|NCT03249792|364721141|FG010|Switch Over Period|Withdrawal by Subject|0|||
105745508|NCT03249792|364721142|FG011|Switch Over Period|Withdrawal by Subject|0|||
105745509|NCT03249792|364721143|FG012|Switch Over Period|Withdrawal by Subject|0|||
105745510|NCT03249792|364721144|FG013|Switch Over Period|Withdrawal by Subject|0|||
105745511|NCT03249792|364721145|FG014|Switch Over Period|Withdrawal by Subject|0|||
105745512|NCT03249792|364721146|FG015|Switch Over Period|Withdrawal by Subject|0|||
105745513|NCT03249792|364721147|FG016|Switch Over Period|Withdrawal by Subject|0|||
105745514|NCT03249792|364721148|FG017|Switch Over Period|Withdrawal by Subject|0|||
105745515|NCT03249792|364721149|FG018|Switch Over Period|Withdrawal by Subject|0|||
105745516|NCT03249792|364721150|FG019|Switch Over Period|Withdrawal by Subject|0|||
105745517|NCT03249792|364721151|FG020|Switch Over Period|Withdrawal by Subject|0|||
105745518|NCT03249792|364721152|FG021|Switch Over Period|Withdrawal by Subject|0|||
105745519|NCT03249792|364721153|FG022|Switch Over Period|Withdrawal by Subject|0|||
105745520|NCT03249792|364721154|FG023|Switch Over Period|Withdrawal by Subject|0|||
105745521|NCT03249792|364721155|FG024|Switch Over Period|Withdrawal by Subject|0|||
105745522|NCT03249792|364721156|FG025|Switch Over Period|Withdrawal by Subject|0|||
106015623|NCT02531802|365723251|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
105745523|NCT03249792|364721157|FG026|Switch Over Period|Withdrawal by Subject|0|||
105745524|NCT03249792|364721158|FG027|Switch Over Period|Withdrawal by Subject|0|||
105745525|NCT03249792|364721159|FG028|Switch Over Period|Withdrawal by Subject|0|||
105745526|NCT03249792|364721160|FG029|Switch Over Period|Withdrawal by Subject|0|||
105745527|NCT03249792|364721161|FG030|Switch Over Period|Withdrawal by Subject|0|||
105745528|NCT03249792|364721162|FG031|Switch Over Period|Withdrawal by Subject|1|||
105745529|NCT03249792|364721163|FG032|Switch Over Period|Withdrawal by Subject|0|||
105745530|NCT03249792|364721131|FG000|Switch Over Period|Progressive Disease|0|||
105745531|NCT03249792|364721132|FG001|Switch Over Period|Progressive Disease|0|||
105745532|NCT03249792|364721133|FG002|Switch Over Period|Progressive Disease|0|||
105745533|NCT03249792|364721134|FG003|Switch Over Period|Progressive Disease|0|||
105745534|NCT03249792|364721135|FG004|Switch Over Period|Progressive Disease|0|||
105745535|NCT03249792|364721136|FG005|Switch Over Period|Progressive Disease|0|||
105745536|NCT03249792|364721137|FG006|Switch Over Period|Progressive Disease|0|||
105745537|NCT03249792|364721138|FG007|Switch Over Period|Progressive Disease|0|||
105745538|NCT03249792|364721139|FG008|Switch Over Period|Progressive Disease|0|||
105745539|NCT03249792|364721140|FG009|Switch Over Period|Progressive Disease|0|||
105745540|NCT03249792|364721141|FG010|Switch Over Period|Progressive Disease|0|||
105745541|NCT03249792|364721142|FG011|Switch Over Period|Progressive Disease|0|||
105745542|NCT03249792|364721143|FG012|Switch Over Period|Progressive Disease|0|||
105745543|NCT03249792|364721144|FG013|Switch Over Period|Progressive Disease|0|||
105745544|NCT03249792|364721145|FG014|Switch Over Period|Progressive Disease|0|||
105745545|NCT03249792|364721146|FG015|Switch Over Period|Progressive Disease|0|||
105745546|NCT03249792|364721147|FG016|Switch Over Period|Progressive Disease|0|||
105745547|NCT03249792|364721148|FG017|Switch Over Period|Progressive Disease|0|||
105745548|NCT03249792|364721149|FG018|Switch Over Period|Progressive Disease|0|||
105745549|NCT03249792|364721150|FG019|Switch Over Period|Progressive Disease|0|||
105745550|NCT03249792|364721151|FG020|Switch Over Period|Progressive Disease|0|||
105745551|NCT03249792|364721152|FG021|Switch Over Period|Progressive Disease|0|||
105745552|NCT03249792|364721153|FG022|Switch Over Period|Progressive Disease|0|||
105745553|NCT03249792|364721154|FG023|Switch Over Period|Progressive Disease|0|||
105745554|NCT03249792|364721155|FG024|Switch Over Period|Progressive Disease|0|||
105745555|NCT03249792|364721156|FG025|Switch Over Period|Progressive Disease|0|||
105745556|NCT03249792|364721157|FG026|Switch Over Period|Progressive Disease|1|||
105745557|NCT03249792|364721158|FG027|Switch Over Period|Progressive Disease|0|||
105745558|NCT03249792|364721159|FG028|Switch Over Period|Progressive Disease|1|||
105745559|NCT03249792|364721160|FG029|Switch Over Period|Progressive Disease|2|||
105745560|NCT03249792|364721161|FG030|Switch Over Period|Progressive Disease|1|||
105745561|NCT03249792|364721162|FG031|Switch Over Period|Progressive Disease|0|||
105745562|NCT03249792|364721163|FG032|Switch Over Period|Progressive Disease|1|||
105745563|NCT03249792|364721131|FG000|Switch Over Period|Adverse Event|0|||
105745564|NCT03249792|364721132|FG001|Switch Over Period|Adverse Event|0|||
105745565|NCT03249792|364721133|FG002|Switch Over Period|Adverse Event|0|||
105745566|NCT03249792|364721134|FG003|Switch Over Period|Adverse Event|0|||
105745567|NCT03249792|364721135|FG004|Switch Over Period|Adverse Event|0|||
105745568|NCT03249792|364721136|FG005|Switch Over Period|Adverse Event|0|||
105745569|NCT03249792|364721137|FG006|Switch Over Period|Adverse Event|0|||
105745570|NCT03249792|364721138|FG007|Switch Over Period|Adverse Event|0|||
105745571|NCT03249792|364721139|FG008|Switch Over Period|Adverse Event|0|||
105745572|NCT03249792|364721140|FG009|Switch Over Period|Adverse Event|0|||
105745573|NCT03249792|364721141|FG010|Switch Over Period|Adverse Event|0|||
105745574|NCT03249792|364721142|FG011|Switch Over Period|Adverse Event|0|||
105745575|NCT03249792|364721143|FG012|Switch Over Period|Adverse Event|0|||
105745576|NCT03249792|364721144|FG013|Switch Over Period|Adverse Event|0|||
105745577|NCT03249792|364721145|FG014|Switch Over Period|Adverse Event|0|||
105745578|NCT03249792|364721146|FG015|Switch Over Period|Adverse Event|0|||
105745579|NCT03249792|364721147|FG016|Switch Over Period|Adverse Event|0|||
105745580|NCT03249792|364721148|FG017|Switch Over Period|Adverse Event|0|||
105745581|NCT03249792|364721149|FG018|Switch Over Period|Adverse Event|0|||
105745582|NCT03249792|364721150|FG019|Switch Over Period|Adverse Event|0|||
105745583|NCT03249792|364721151|FG020|Switch Over Period|Adverse Event|0|||
105745584|NCT03249792|364721152|FG021|Switch Over Period|Adverse Event|0|||
105745585|NCT03249792|364721153|FG022|Switch Over Period|Adverse Event|0|||
105745586|NCT03249792|364721154|FG023|Switch Over Period|Adverse Event|0|||
105745587|NCT03249792|364721155|FG024|Switch Over Period|Adverse Event|0|||
105745588|NCT03249792|364721156|FG025|Switch Over Period|Adverse Event|1|||
105745589|NCT03249792|364721157|FG026|Switch Over Period|Adverse Event|0|||
105745590|NCT03249792|364721158|FG027|Switch Over Period|Adverse Event|1|||
105745591|NCT03249792|364721159|FG028|Switch Over Period|Adverse Event|0|||
105745592|NCT03249792|364721160|FG029|Switch Over Period|Adverse Event|0|||
105745593|NCT03249792|364721161|FG030|Switch Over Period|Adverse Event|0|||
105745594|NCT03249792|364721162|FG031|Switch Over Period|Adverse Event|0|||
105745595|NCT03249792|364721163|FG032|Switch Over Period|Adverse Event|0|||
105745596|NCT03745313|364721164|FG000|At 30 Days Follow-up|Death|2|||
105745597|NCT03745313|364721164|FG000|At 6 Months Follow-up|Death|1|||
105745598|NCT03745313|364721164|FG000|At 6 Months Follow-up|Missed Visit|1|||
105745599|NCT03745313|364721164|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
105745600|NCT03745313|364721164|FG000|At 1 Year Follow-up|Death|2|||
105745601|NCT03745313|364721164|FG000|At 1 Year Follow-up|Missed Visit|2|||
105745602|NCT03745313|364721164|FG000|At 2 Year Follow-up|Missed Visit|1|||
106142327|NCT01350804|366179968|FG001|Core Study|Study terminated by Sponsor|0|||
105745603|NCT04171037|364721165|FG000|Overall Study|Lost to Follow-up|1|||
105745604|NCT04171037|364721166|FG001|Overall Study|Lost to Follow-up|0|||
105745605|NCT04171037|364721165|FG000|Overall Study|Physician Decision|3|||
105745606|NCT04171037|364721166|FG001|Overall Study|Physician Decision|3|||
105745607|NCT01864018|364721169|FG000|Overall Study|Ineligible|3|||
105745608|NCT01864018|364721170|FG001|Overall Study|Ineligible|1|||
105745609|NCT05122650|364721173|FG000|Overall Study|Adverse Event|4|||
105745610|NCT05122650|364721174|FG001|Overall Study|Adverse Event|16|||
105745611|NCT05122650|364721175|FG002|Overall Study|Adverse Event|11|||
105745612|NCT05122650|364721176|FG003|Overall Study|Adverse Event|12|||
105745613|NCT05122650|364721173|FG000|Overall Study|Lack of Efficacy|0|||
105745614|NCT05122650|364721174|FG001|Overall Study|Lack of Efficacy|1|||
105745615|NCT05122650|364721175|FG002|Overall Study|Lack of Efficacy|1|||
105745616|NCT05122650|364721176|FG003|Overall Study|Lack of Efficacy|2|||
105745617|NCT05122650|364721173|FG000|Overall Study|Lost to Follow-up|1|||
105745618|NCT05122650|364721174|FG001|Overall Study|Lost to Follow-up|1|||
105745619|NCT05122650|364721175|FG002|Overall Study|Lost to Follow-up|3|||
105745620|NCT05122650|364721176|FG003|Overall Study|Lost to Follow-up|0|||
105745621|NCT05122650|364721173|FG000|Overall Study|Non-compliance with study intervention|0|||
105745622|NCT05122650|364721174|FG001|Overall Study|Non-compliance with study intervention|0|||
105745623|NCT05122650|364721175|FG002|Overall Study|Non-compliance with study intervention|0|||
105745624|NCT05122650|364721176|FG003|Overall Study|Non-compliance with study intervention|2|||
105745625|NCT05122650|364721173|FG000|Overall Study|Protocol Violation|0|||
105745626|NCT05122650|364721174|FG001|Overall Study|Protocol Violation|1|||
105745627|NCT05122650|364721175|FG002|Overall Study|Protocol Violation|0|||
105745628|NCT05122650|364721176|FG003|Overall Study|Protocol Violation|1|||
105745629|NCT05122650|364721173|FG000|Overall Study|Randomized by mistake|0|||
105745630|NCT05122650|364721174|FG001|Overall Study|Randomized by mistake|0|||
105745631|NCT05122650|364721175|FG002|Overall Study|Randomized by mistake|3|||
105745632|NCT05122650|364721176|FG003|Overall Study|Randomized by mistake|2|||
105745633|NCT05122650|364721173|FG000|Overall Study|Sponsor request|0|||
105745634|NCT05122650|364721174|FG001|Overall Study|Sponsor request|1|||
105745635|NCT05122650|364721175|FG002|Overall Study|Sponsor request|1|||
105745636|NCT05122650|364721176|FG003|Overall Study|Sponsor request|2|||
105745637|NCT05122650|364721173|FG000|Overall Study|Withdrawal by Subject|3|||
105745638|NCT05122650|364721174|FG001|Overall Study|Withdrawal by Subject|7|||
105745639|NCT05122650|364721175|FG002|Overall Study|Withdrawal by Subject|4|||
105943064|NCT04617860|365454981|FG002|Overall Study|Physician Decision|0|||
105943065|NCT04617860|365454979|FG000|Overall Study|Sponsor Decision|0|||
105943066|NCT04617860|365454980|FG001|Overall Study|Sponsor Decision|3|||
105943067|NCT04617860|365454981|FG002|Overall Study|Sponsor Decision|1|||
105943068|NCT04617860|365454979|FG000|Overall Study|Termination of Study by Sponsor|8|||
105943069|NCT04617860|365454980|FG001|Overall Study|Termination of Study by Sponsor|4|||
105943070|NCT04617860|365454981|FG002|Overall Study|Termination of Study by Sponsor|13|||
105943071|NCT00605189|365454982|FG000|Overall Study|Adverse Event|1|||
105943072|NCT00605189|365454983|FG001|Overall Study|Adverse Event|0|||
105943073|NCT00605189|365454984|FG002|Overall Study|Adverse Event|0|||
105943074|NCT00605189|365454982|FG000|Overall Study|Other|2|||
105943075|NCT00605189|365454983|FG001|Overall Study|Other|2|||
105943076|NCT00605189|365454984|FG002|Overall Study|Other|0|||
105943077|NCT02697448|365454985|FG000|Overall Study|Protocol Violation|2|||
105943078|NCT02697448|365454986|FG001|Overall Study|Protocol Violation|4|||
105943079|NCT02697448|365454985|FG000|Overall Study|Clinical concerns during ablation|1|||
105943080|NCT02697448|365454986|FG001|Overall Study|Clinical concerns during ablation|1|||
105943081|NCT02697448|365454985|FG000|Overall Study|No data collected|2|||
105943082|NCT02697448|365454986|FG001|Overall Study|No data collected|0|||
105943083|NCT02507934|365454987|FG000|Overall Study|Lost to Follow-up|2|||
105943084|NCT02507934|365454988|FG001|Overall Study|Lost to Follow-up|0|||
105943085|NCT02507934|365454987|FG000|Overall Study|Withdrawal by Subject|2|||
105943086|NCT02507934|365454988|FG001|Overall Study|Withdrawal by Subject|0|||
105943087|NCT00654355|365454989|FG000|Overall Study|Lost to Follow-up|2|||
105943088|NCT00654355|365454990|FG001|Overall Study|Lost to Follow-up|2|||
105943089|NCT01051661|365454991|FG000|Overall Study|Adverse Event|1|||
105943090|NCT01051661|365454992|FG001|Overall Study|Adverse Event|1|||
105943091|NCT01051661|365454993|FG002|Overall Study|Adverse Event|1|||
105943092|NCT01051661|365454994|FG003|Overall Study|Adverse Event|1|||
105745640|NCT05122650|364721176|FG003|Overall Study|Withdrawal by Subject|8|||
105745641|NCT05122650|364721173|FG000|Overall Study|Other|5|||
105745642|NCT05122650|364721174|FG001|Overall Study|Other|0|||
105745643|NCT05122650|364721175|FG002|Overall Study|Other|0|||
105745644|NCT05122650|364721176|FG003|Overall Study|Other|0|||
105943093|NCT01051661|365454995|FG004|Overall Study|Adverse Event|0|||
105943094|NCT01051661|365454996|FG005|Overall Study|Adverse Event|0|||
105745645|NCT00488033|364721181|FG000|Overall Study|Withdrawal by Subject|1|||
105943095|NCT01051661|365454991|FG000|Overall Study|Lost to Follow-up|13|||
105943096|NCT01051661|365454992|FG001|Overall Study|Lost to Follow-up|22|||
105943097|NCT01051661|365454993|FG002|Overall Study|Lost to Follow-up|15|||
105943098|NCT01051661|365454994|FG003|Overall Study|Lost to Follow-up|17|||
106142328|NCT01350804|366179969|FG002|Core Study|Study terminated by Sponsor|0|||
106142329|NCT01350804|366179970|FG003|Core Study|Study terminated by Sponsor|2|||
106142330|NCT01350804|366179967|FG000|Core Study|Protocol deviation|1|||
106142331|NCT01350804|366179968|FG001|Core Study|Protocol deviation|0|||
105745646|NCT00488033|364721182|FG001|Overall Study|Withdrawal by Subject|0|||
105745647|NCT00992446|364721184|FG000|Overall Study|Disease Progression|1|||
105745648|NCT00992446|364721184|FG000|Overall Study|Withdrawal by Subject|2|||
105745649|NCT00992446|364721184|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
105745650|NCT04891770|364721617|FG000|Overall Study|Withdrew consent|1|||
105745651|NCT04891770|364721618|FG001|Overall Study|Withdrew consent|3|||
105745652|NCT04891770|364721619|FG002|Overall Study|Withdrew consent|0|||
105745653|NCT04891770|364721617|FG000|Overall Study|Enrolled but never treated|0|||
105745654|NCT04891770|364721618|FG001|Overall Study|Enrolled but never treated|0|||
105745655|NCT04891770|364721619|FG002|Overall Study|Enrolled but never treated|1|||
105745656|NCT04891770|364721617|FG000|Overall Study|Investigator's discretion|0|||
105745657|NCT04891770|364721618|FG001|Overall Study|Investigator's discretion|1|||
105745658|NCT04891770|364721619|FG002|Overall Study|Investigator's discretion|0|||
105745659|NCT06239610|364721620|FG000|Overall Study|no usable migration data for minimum of one day|11|||
105745660|NCT02678780|364721631|FG000|Overall Study|Adverse Event|11|||
105745661|NCT02678780|364721632|FG001|Overall Study|Adverse Event|14|||
105745662|NCT02678780|364721631|FG000|Overall Study|Withdrawal by Subject|2|||
105745663|NCT02678780|364721632|FG001|Overall Study|Withdrawal by Subject|1|||
105745664|NCT02678780|364721631|FG000|Overall Study|Sponsor discontinuation|7|||
105745665|NCT02678780|364721632|FG001|Overall Study|Sponsor discontinuation|4|||
105745666|NCT02678780|364721631|FG000|Overall Study|Death|1|||
105745667|NCT02678780|364721632|FG001|Overall Study|Death|1|||
105745668|NCT02678780|364721631|FG000|Overall Study|Other|6|||
105745669|NCT02678780|364721632|FG001|Overall Study|Other|8|||
105745670|NCT03675737|364721636|FG000|Overall Study|Death|593|||
105745671|NCT03675737|364721637|FG001|Overall Study|Death|660|||
105745672|NCT03675737|364721636|FG000|Overall Study|Lost to Follow-up|1|||
105745673|NCT03675737|364721637|FG001|Overall Study|Lost to Follow-up|5|||
105745674|NCT03675737|364721636|FG000|Overall Study|Physician Decision|1|||
105745675|NCT03675737|364721637|FG001|Overall Study|Physician Decision|0|||
105745676|NCT03675737|364721636|FG000|Overall Study|Withdrawal by Subject|14|||
105745677|NCT03675737|364721637|FG001|Overall Study|Withdrawal by Subject|12|||
105745678|NCT03675737|364721636|FG000|Overall Study|Ongoing in Study|181|||
105745679|NCT03675737|364721637|FG001|Overall Study|Ongoing in Study|112|||
105943099|NCT01051661|365454995|FG004|Overall Study|Lost to Follow-up|10|||
105943100|NCT01051661|365454996|FG005|Overall Study|Lost to Follow-up|24|||
105943101|NCT01051661|365454991|FG000|Overall Study|Migrated/moved from study area|1|||
105943102|NCT01051661|365454992|FG001|Overall Study|Migrated/moved from study area|6|||
105943103|NCT01051661|365454993|FG002|Overall Study|Migrated/moved from study area|6|||
105943104|NCT01051661|365454994|FG003|Overall Study|Migrated/moved from study area|8|||
105943105|NCT01051661|365454995|FG004|Overall Study|Migrated/moved from study area|7|||
105943106|NCT01051661|365454996|FG005|Overall Study|Migrated/moved from study area|3|||
105943107|NCT01051661|365454991|FG000|Overall Study|Refused blood sampling|0|||
105943108|NCT01051661|365454992|FG001|Overall Study|Refused blood sampling|0|||
105943109|NCT01051661|365454993|FG002|Overall Study|Refused blood sampling|0|||
105943110|NCT01051661|365454994|FG003|Overall Study|Refused blood sampling|0|||
105943111|NCT01051661|365454995|FG004|Overall Study|Refused blood sampling|0|||
105943112|NCT01051661|365454996|FG005|Overall Study|Refused blood sampling|1|||
105943113|NCT01051661|365454991|FG000|Overall Study|Data not reliable|1|||
105943114|NCT01051661|365454992|FG001|Overall Study|Data not reliable|0|||
105943115|NCT01051661|365454993|FG002|Overall Study|Data not reliable|0|||
105943116|NCT01051661|365454994|FG003|Overall Study|Data not reliable|0|||
105943117|NCT01051661|365454995|FG004|Overall Study|Data not reliable|0|||
105943118|NCT01051661|365454996|FG005|Overall Study|Data not reliable|1|||
105943119|NCT01051661|365454991|FG000|Overall Study|Unable to attend visit(s)|2|||
105943120|NCT01051661|365454992|FG001|Overall Study|Unable to attend visit(s)|4|||
105943121|NCT01051661|365454993|FG002|Overall Study|Unable to attend visit(s)|2|||
105943122|NCT01051661|365454994|FG003|Overall Study|Unable to attend visit(s)|1|||
105943123|NCT01051661|365454995|FG004|Overall Study|Unable to attend visit(s)|3|||
105943124|NCT01051661|365454996|FG005|Overall Study|Unable to attend visit(s)|2|||
105943125|NCT01051661|365454991|FG000|Overall Study|Consent not received from both parents|0|||
105943126|NCT01051661|365454992|FG001|Overall Study|Consent not received from both parents|0|||
105745680|NCT05315297|364721638|FG000|Overall Study|Lost to Follow-up|6|||
105745681|NCT05315297|364721639|FG001|Overall Study|Lost to Follow-up|4|||
105943127|NCT01051661|365454993|FG002|Overall Study|Consent not received from both parents|0|||
105943128|NCT01051661|365454994|FG003|Overall Study|Consent not received from both parents|0|||
105943129|NCT01051661|365454995|FG004|Overall Study|Consent not received from both parents|0|||
105943130|NCT01051661|365454996|FG005|Overall Study|Consent not received from both parents|1|||
106142332|NCT01350804|366179969|FG002|Core Study|Protocol deviation|1|||
105745682|NCT05315297|364721638|FG000|Overall Study|Withdrawal by Subject|0|||
105745683|NCT05315297|364721639|FG001|Overall Study|Withdrawal by Subject|1|||
105745684|NCT03050359|364722950|FG000|Overall Study|Randomized But Not Treated|2|||
105800733|NCT03989115|364928530|FG005|Overall Study|Lost to Follow-up|0|||
105800734|NCT03989115|364928531|FG006|Overall Study|Lost to Follow-up|0|||
105800735|NCT03989115|364928532|FG007|Overall Study|Lost to Follow-up|0|||
105800736|NCT03989115|364928525|FG000|Overall Study|Death|2|||
105800737|NCT03989115|364928526|FG001|Overall Study|Death|2|||
105800738|NCT03989115|364928527|FG002|Overall Study|Death|9|||
105800739|NCT03989115|364928528|FG003|Overall Study|Death|6|||
105800740|NCT03989115|364928529|FG004|Overall Study|Death|31|||
105800741|NCT03989115|364928530|FG005|Overall Study|Death|6|||
105800742|NCT03989115|364928531|FG006|Overall Study|Death|2|||
105800743|NCT03989115|364928532|FG007|Overall Study|Death|3|||
105800744|NCT03989115|364928525|FG000|Overall Study|Other|1|||
105800745|NCT03989115|364928526|FG001|Overall Study|Other|2|||
105800746|NCT03989115|364928527|FG002|Overall Study|Other|0|||
105800747|NCT03989115|364928528|FG003|Overall Study|Other|0|||
105800748|NCT03989115|364928529|FG004|Overall Study|Other|5|||
105800749|NCT03989115|364928530|FG005|Overall Study|Other|0|||
105800750|NCT03989115|364928531|FG006|Overall Study|Other|0|||
105800751|NCT03989115|364928532|FG007|Overall Study|Other|0|||
105800752|NCT00326885|364928533|FG000|Overall Study|Adverse Event|1|||
105800753|NCT00326885|364928533|FG000|Overall Study|Withdrawal by Subject|3|||
105800754|NCT00326885|364928533|FG000|Overall Study|Physician Decision|1|||
105800755|NCT00326885|364928533|FG000|Overall Study|Hospice withdrew consent|2|||
105800756|NCT01706198|364928534|FG000|Overall Study|Adverse Event|12|||
105800757|NCT01706198|364928535|FG001|Overall Study|Adverse Event|15|||
105800758|NCT01706198|364928534|FG000|Overall Study|Protocol Violation|7|||
105800759|NCT01706198|364928535|FG001|Overall Study|Protocol Violation|5|||
105800760|NCT01706198|364928534|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
105800761|NCT01706198|364928535|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
105800762|NCT01706198|364928534|FG000|Overall Study|Lost to Follow-up|97|||
105800763|NCT01706198|364928535|FG001|Overall Study|Lost to Follow-up|93|||
105800764|NCT01706198|364928534|FG000|Overall Study|Physician Decision|23|||
105800765|NCT01706198|364928535|FG001|Overall Study|Physician Decision|37|||
105800766|NCT01706198|364928534|FG000|Overall Study|Withdrawal by Subject|23|||
105800767|NCT01706198|364928535|FG001|Overall Study|Withdrawal by Subject|31|||
105800768|NCT02499354|364928536|FG000|Overall Study|Withdrawal by Subject|1|||
105800769|NCT02499354|364928537|FG001|Overall Study|Withdrawal by Subject|0|||
105800770|NCT04356573|364928538|FG000|Overall Study|Didn't Qualify|1|||
105800771|NCT04356573|364928539|FG001|Overall Study|Didn't Qualify|0|||
105800772|NCT02424565|364928540|FG000|Period 1 (D0)|Protocol Violation|0|||
105800773|NCT02424565|364928541|FG001|Period 1 (D0)|Protocol Violation|1|||
105800774|NCT01415921|364928543|FG000|Overall Study|Adverse Event|0|||
105800775|NCT01415921|364928544|FG001|Overall Study|Adverse Event|1|||
105800776|NCT01415921|364928543|FG000|Overall Study|Physician Decision|1|||
105800777|NCT01415921|364928544|FG001|Overall Study|Physician Decision|1|||
105800778|NCT01415921|364928543|FG000|Overall Study|Withdrawal by Subject|0|||
105800779|NCT01415921|364928544|FG001|Overall Study|Withdrawal by Subject|1|||
105800780|NCT01415921|364928543|FG000|Overall Study|Other|2|||
105800781|NCT01415921|364928544|FG001|Overall Study|Other|0|||
105800782|NCT02143947|364928547|FG000|Overall Study|Lost to Follow-up|4|||
105800783|NCT02143947|364928548|FG001|Overall Study|Lost to Follow-up|2|||
105800784|NCT01244815|364928549|FG000|Overall Study|Not Treated|0|||
105800785|NCT01244815|364928550|FG001|Overall Study|Not Treated|1|||
105800786|NCT01244815|364928551|FG002|Overall Study|Not Treated|0|||
105800787|NCT01244815|364928552|FG003|Overall Study|Not Treated|0|||
106015624|NCT02531802|365723252|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
106015625|NCT02531802|365723253|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
106015626|NCT02531802|365723254|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
106015627|NCT02531802|365723255|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
106015628|NCT02531802|365723256|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
106142333|NCT01350804|366179970|FG003|Core Study|Protocol deviation|0|||
106142334|NCT01350804|366179967|FG000|Core Study|Physician Decision|1|||
105800788|NCT01244815|364928549|FG000|Overall Study|Adverse Event|4|||
105800789|NCT01244815|364928550|FG001|Overall Study|Adverse Event|7|||
105800790|NCT01244815|364928551|FG002|Overall Study|Adverse Event|5|||
105800791|NCT01244815|364928552|FG003|Overall Study|Adverse Event|5|||
105800792|NCT01244815|364928549|FG000|Overall Study|Treatment Failure|0|||
105800793|NCT01244815|364928550|FG001|Overall Study|Treatment Failure|0|||
105800794|NCT01244815|364928551|FG002|Overall Study|Treatment Failure|0|||
105800795|NCT01244815|364928552|FG003|Overall Study|Treatment Failure|1|||
105800796|NCT01244815|364928549|FG000|Overall Study|Lost to Follow-up|3|||
106015629|NCT02531802|365723257|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
105800797|NCT01244815|364928550|FG001|Overall Study|Lost to Follow-up|2|||
105800798|NCT01244815|364928551|FG002|Overall Study|Lost to Follow-up|3|||
105800799|NCT01244815|364928552|FG003|Overall Study|Lost to Follow-up|2|||
106142335|NCT01350804|366179968|FG001|Core Study|Physician Decision|0|||
105800800|NCT01244815|364928549|FG000|Overall Study|Withdrawal by Subject|0|||
105800801|NCT01244815|364928550|FG001|Overall Study|Withdrawal by Subject|2|||
105800802|NCT01244815|364928551|FG002|Overall Study|Withdrawal by Subject|0|||
105800803|NCT01244815|364928552|FG003|Overall Study|Withdrawal by Subject|3|||
105943131|NCT01051661|365454991|FG000|Overall Study|Failure to comply with protocol|0|||
105943132|NCT01051661|365454992|FG001|Overall Study|Failure to comply with protocol|0|||
105943133|NCT01051661|365454993|FG002|Overall Study|Failure to comply with protocol|2|||
105745685|NCT03050359|364722951|FG001|Overall Study|Randomized But Not Treated|0|||
105745686|NCT03050359|364722950|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
105745687|NCT03050359|364722951|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
105745688|NCT03050359|364722950|FG000|Overall Study|Significant Protocol Deviation|2|||
105745689|NCT03050359|364722951|FG001|Overall Study|Significant Protocol Deviation|3|||
105745690|NCT03050359|364722950|FG000|Overall Study|Lost to Follow-up|2|||
105745691|NCT03050359|364722951|FG001|Overall Study|Lost to Follow-up|1|||
105745692|NCT03050359|364722950|FG000|Overall Study|Voluntary Withdrawal|4|||
105745693|NCT03050359|364722951|FG001|Overall Study|Voluntary Withdrawal|6|||
105745694|NCT03050359|364722950|FG000|Overall Study|Pregnancy|1|||
105745695|NCT03050359|364722951|FG001|Overall Study|Pregnancy|0|||
105745696|NCT03050359|364722950|FG000|Overall Study|Reason Not Specified|1|||
105745697|NCT03050359|364722951|FG001|Overall Study|Reason Not Specified|0|||
105745698|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
105745699|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
105745700|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
105745701|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
105745702|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
105745703|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
105745704|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
105745705|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
105745706|NCT02614287|364722954|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
105745707|NCT02614287|364722955|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
105745708|NCT02614287|364722954|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
105745709|NCT02614287|364722955|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
105745710|NCT02614287|364722954|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
105745711|NCT02614287|364722955|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
105745712|NCT02614287|364722954|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
105745713|NCT02614287|364722955|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
105745714|NCT00683475|364722957|FG000|Overall Study|Withdrawal by Subject|1|||
105745715|NCT00683475|364722958|FG001|Overall Study|Withdrawal by Subject|0|||
105745716|NCT00683475|364722957|FG000|Overall Study|Never Treated: Adverse Event|2|||
105745717|NCT00683475|364722958|FG001|Overall Study|Never Treated: Adverse Event|3|||
105745718|NCT00683475|364722957|FG000|Overall Study|Never Treated: Progressive Disease|1|||
105745719|NCT00683475|364722958|FG001|Overall Study|Never Treated: Progressive Disease|0|||
105745720|NCT02922634|364722959|FG000|Overall Study|Withdrawal by Subject|5|||
105745721|NCT02922634|364722959|FG000|Overall Study|Did not have their surgery|5|||
105745722|NCT00352755|364722960|FG000|Overall Study|Physician Decision|1|||
105745723|NCT00352755|364722960|FG000|Overall Study|Adverse Event|1|||
105745724|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
105745725|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
105745726|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
105745727|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
105745728|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
105745729|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
105745730|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
105800804|NCT01244815|364928549|FG000|Overall Study|Protocol Violation|7|||
105943134|NCT01051661|365454994|FG003|Overall Study|Failure to comply with protocol|0|||
105943135|NCT01051661|365454995|FG004|Overall Study|Failure to comply with protocol|0|||
105943136|NCT01051661|365454996|FG005|Overall Study|Failure to comply with protocol|0|||
105943137|NCT01051661|365454991|FG000|Overall Study|Subject lost legal representation|0|||
105943138|NCT01051661|365454992|FG001|Overall Study|Subject lost legal representation|0|||
105943139|NCT01051661|365454993|FG002|Overall Study|Subject lost legal representation|0|||
105943140|NCT01051661|365454994|FG003|Overall Study|Subject lost legal representation|0|||
105943141|NCT01051661|365454995|FG004|Overall Study|Subject lost legal representation|1|||
105943142|NCT01051661|365454996|FG005|Overall Study|Subject lost legal representation|0|||
105943143|NCT01051661|365454991|FG000|Overall Study|Protocol Violation|0|||
105943144|NCT01051661|365454992|FG001|Overall Study|Protocol Violation|0|||
105943145|NCT01051661|365454993|FG002|Overall Study|Protocol Violation|0|||
105943146|NCT01051661|365454994|FG003|Overall Study|Protocol Violation|1|||
105943147|NCT01051661|365454995|FG004|Overall Study|Protocol Violation|2|||
105943148|NCT01051661|365454996|FG005|Overall Study|Protocol Violation|1|||
105943149|NCT01051661|365454991|FG000|Overall Study|Withdrawal by Subject|16|||
105943150|NCT01051661|365454992|FG001|Overall Study|Withdrawal by Subject|30|||
106142336|NCT01350804|366179969|FG002|Core Study|Physician Decision|1|||
105800805|NCT01244815|364928550|FG001|Overall Study|Protocol Violation|4|||
105943151|NCT01051661|365454993|FG002|Overall Study|Withdrawal by Subject|13|||
105943152|NCT01051661|365454994|FG003|Overall Study|Withdrawal by Subject|28|||
105943153|NCT01051661|365454995|FG004|Overall Study|Withdrawal by Subject|12|||
105745731|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105745732|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
105745733|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
105745734|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
105745735|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
105745736|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
105745737|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
105745738|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
105745739|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
105745740|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
105745741|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
105745742|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
106015630|NCT02531802|365723258|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
106015631|NCT02531802|365723238|FG000|Received Vaccination 2|Physician Decision|0|||
106015632|NCT02531802|365723239|FG001|Received Vaccination 2|Physician Decision|0|||
106015633|NCT02531802|365723240|FG002|Received Vaccination 2|Physician Decision|0|||
106015634|NCT02531802|365723241|FG003|Received Vaccination 2|Physician Decision|0|||
106015635|NCT02531802|365723242|FG004|Received Vaccination 2|Physician Decision|0|||
106015636|NCT02531802|365723243|FG005|Received Vaccination 2|Physician Decision|1|||
106015637|NCT02531802|365723244|FG006|Received Vaccination 2|Physician Decision|0|||
106015638|NCT02531802|365723245|FG007|Received Vaccination 2|Physician Decision|0|||
106015639|NCT02531802|365723246|FG008|Received Vaccination 2|Physician Decision|0|||
106015640|NCT02531802|365723247|FG009|Received Vaccination 2|Physician Decision|2|||
105745743|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
105745744|NCT00423085|364722961|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
105745745|NCT00423085|364722962|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
105745746|NCT00423085|364722963|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
105745747|NCT00423085|364722964|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
105745748|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
105745749|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
105745750|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
105745751|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
105745752|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
105745753|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
105745754|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
105745755|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
105745756|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
105745757|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
105745758|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
105745759|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
105745760|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
105745761|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
105745762|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
105800806|NCT01244815|364928551|FG002|Overall Study|Protocol Violation|3|||
106015641|NCT02531802|365723248|FG010|Received Vaccination 2|Physician Decision|0|||
106015642|NCT02531802|365723249|FG011|Received Vaccination 2|Physician Decision|0|||
106015643|NCT02531802|365723250|FG012|Received Vaccination 2|Physician Decision|0|||
106015644|NCT02531802|365723251|FG013|Received Vaccination 2|Physician Decision|1|||
106015645|NCT02531802|365723252|FG014|Received Vaccination 2|Physician Decision|0|||
106015646|NCT02531802|365723253|FG015|Received Vaccination 2|Physician Decision|0|||
106015647|NCT02531802|365723254|FG016|Received Vaccination 2|Physician Decision|0|||
106015648|NCT02531802|365723255|FG017|Received Vaccination 2|Physician Decision|1|||
106015649|NCT02531802|365723256|FG018|Received Vaccination 2|Physician Decision|0|||
106015650|NCT02531802|365723257|FG019|Received Vaccination 2|Physician Decision|0|||
106015651|NCT02531802|365723258|FG020|Received Vaccination 2|Physician Decision|0|||
106015652|NCT02531802|365723238|FG000|Received Vaccination 2|Adverse Event|0|||
106015653|NCT02531802|365723239|FG001|Received Vaccination 2|Adverse Event|0|||
106015654|NCT02531802|365723240|FG002|Received Vaccination 2|Adverse Event|0|||
106015655|NCT02531802|365723241|FG003|Received Vaccination 2|Adverse Event|0|||
106015656|NCT02531802|365723242|FG004|Received Vaccination 2|Adverse Event|0|||
106015657|NCT02531802|365723243|FG005|Received Vaccination 2|Adverse Event|2|||
106015658|NCT02531802|365723244|FG006|Received Vaccination 2|Adverse Event|0|||
106142337|NCT01350804|366179970|FG003|Core Study|Physician Decision|3|||
106142338|NCT01350804|366179967|FG000|Core Study|Lost to Follow-up|3|||
106142339|NCT01350804|366179968|FG001|Core Study|Lost to Follow-up|0|||
106142340|NCT01350804|366179969|FG002|Core Study|Lost to Follow-up|2|||
106142341|NCT01350804|366179970|FG003|Core Study|Lost to Follow-up|1|||
106015659|NCT02531802|365723245|FG007|Received Vaccination 2|Adverse Event|0|||
106015660|NCT02531802|365723246|FG008|Received Vaccination 2|Adverse Event|0|||
106142342|NCT01350804|366179967|FG000|Core Study|Lack of Efficacy|16|||
106142343|NCT01350804|366179968|FG001|Core Study|Lack of Efficacy|19|||
106142344|NCT01350804|366179969|FG002|Core Study|Lack of Efficacy|18|||
106142345|NCT01350804|366179970|FG003|Core Study|Lack of Efficacy|5|||
106142346|NCT01350804|366179967|FG000|Core Study|Death|1|||
106142347|NCT01350804|366179968|FG001|Core Study|Death|1|||
105745763|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
105745764|NCT00423085|364722961|FG000|52-Week Open-Label Extension Phase|Death|0|||
105745765|NCT00423085|364722962|FG001|52-Week Open-Label Extension Phase|Death|0|||
105745766|NCT00423085|364722963|FG002|52-Week Open-Label Extension Phase|Death|0|||
105745767|NCT00423085|364722964|FG003|52-Week Open-Label Extension Phase|Death|2|||
105745768|NCT03331666|364722965|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
105745769|NCT03331666|364722966|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
105745770|NCT02939937|364722967|FG000|Overall Study|Adverse Event|5|||
105745771|NCT02939937|364722968|FG001|Overall Study|Adverse Event|0|||
105745772|NCT02939937|364722967|FG000|Overall Study|Lost to Follow-up|1|||
105745773|NCT02939937|364722968|FG001|Overall Study|Lost to Follow-up|3|||
105745774|NCT01361009|364722972|FG000|Overall Study|Protocol Violation|116|||
105745775|NCT03100942|364722976|FG000|Randomized Treatment Period|Withdrew Consent|4|||
105745776|NCT03100942|364722977|FG001|Randomized Treatment Period|Withdrew Consent|5|||
105745777|NCT03100942|364722978|FG002|Randomized Treatment Period|Withdrew Consent|3|||
105745778|NCT03100942|364722979|FG003|Randomized Treatment Period|Withdrew Consent|3|||
105745779|NCT03100942|364722980|FG004|Randomized Treatment Period|Withdrew Consent|0|||
105745780|NCT03100942|364722981|FG005|Randomized Treatment Period|Withdrew Consent|0|||
105745781|NCT03100942|364722982|FG006|Randomized Treatment Period|Withdrew Consent|0|||
105745782|NCT03100942|364722976|FG000|Randomized Treatment Period|Adverse Event|5|||
105745783|NCT03100942|364722977|FG001|Randomized Treatment Period|Adverse Event|2|||
105745784|NCT03100942|364722978|FG002|Randomized Treatment Period|Adverse Event|1|||
105745785|NCT03100942|364722979|FG003|Randomized Treatment Period|Adverse Event|0|||
105745786|NCT03100942|364722980|FG004|Randomized Treatment Period|Adverse Event|0|||
105745787|NCT03100942|364722981|FG005|Randomized Treatment Period|Adverse Event|0|||
105745788|NCT03100942|364722982|FG006|Randomized Treatment Period|Adverse Event|0|||
105745789|NCT03100942|364722976|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
105745790|NCT03100942|364722977|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
105745791|NCT03100942|364722978|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
105745792|NCT03100942|364722979|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
105745793|NCT03100942|364722980|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
105745794|NCT03100942|364722981|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
105745795|NCT03100942|364722982|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
105745796|NCT03100942|364722976|FG000|Randomized Treatment Period|Protocol Violation|0|||
105745797|NCT03100942|364722977|FG001|Randomized Treatment Period|Protocol Violation|1|||
105745798|NCT03100942|364722978|FG002|Randomized Treatment Period|Protocol Violation|1|||
105745799|NCT03100942|364722979|FG003|Randomized Treatment Period|Protocol Violation|1|||
105745800|NCT03100942|364722980|FG004|Randomized Treatment Period|Protocol Violation|0|||
105745801|NCT03100942|364722981|FG005|Randomized Treatment Period|Protocol Violation|0|||
105745802|NCT03100942|364722982|FG006|Randomized Treatment Period|Protocol Violation|0|||
105745803|NCT03100942|364722976|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
105745804|NCT03100942|364722977|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
105745805|NCT03100942|364722978|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
105745806|NCT03100942|364722979|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
105745807|NCT03100942|364722980|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
105745808|NCT03100942|364722981|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
105745809|NCT03100942|364722982|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
105745810|NCT03100942|364722976|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
105745811|NCT03100942|364722977|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105745812|NCT03100942|364722978|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105800807|NCT01244815|364928552|FG003|Overall Study|Protocol Violation|1|||
105943154|NCT01051661|365454996|FG005|Overall Study|Withdrawal by Subject|34|||
105943155|NCT00759395|365454999|FG000|Overall Study|Adverse Event|1|||
105943156|NCT00759395|365455000|FG001|Overall Study|Adverse Event|0|||
105943157|NCT00759395|365454999|FG000|Overall Study|Withdrawal by Subject|1|||
105943158|NCT00759395|365455000|FG001|Overall Study|Withdrawal by Subject|0|||
105943159|NCT00759395|365454999|FG000|Overall Study|Lack of Efficacy|0|||
105943160|NCT00759395|365455000|FG001|Overall Study|Lack of Efficacy|2|||
105943161|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
105943162|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
105943163|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
105943164|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
105943165|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
105943166|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
105943167|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
105943168|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
105943169|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
105800808|NCT01244815|364928549|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
105800809|NCT01244815|364928550|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
105800810|NCT01244815|364928551|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
105800811|NCT01244815|364928552|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
105800812|NCT01808209|364928555|FG000|Overall Study|Lost to Follow-up|0|||
105800813|NCT01808209|364928556|FG001|Overall Study|Lost to Follow-up|1|||
105800814|NCT00910858|364928557|FG000|Pharmacokinetic Phase|Adverse Event|1|||
105800815|NCT00910858|364928558|FG001|Pharmacokinetic Phase|Adverse Event|0|||
105800816|NCT00910858|364928559|FG002|Pharmacokinetic Phase|Adverse Event|0|||
105800817|NCT00910858|364928557|FG000|Monotherapy Phase|Adverse Event|3|||
105800818|NCT00910858|364928558|FG001|Monotherapy Phase|Adverse Event|2|||
105800819|NCT00910858|364928559|FG002|Monotherapy Phase|Adverse Event|0|||
105800820|NCT00910858|364928557|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
105800821|NCT00910858|364928558|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
105800822|NCT00910858|364928559|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
105800823|NCT00910858|364928557|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
105800824|NCT00910858|364928558|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
105800825|NCT00910858|364928559|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
105800826|NCT00910858|364928557|FG000|Monotherapy Phase|Protocol Violation|1|||
105800827|NCT00910858|364928558|FG001|Monotherapy Phase|Protocol Violation|0|||
105800828|NCT00910858|364928559|FG002|Monotherapy Phase|Protocol Violation|0|||
105800829|NCT00910858|364928557|FG000|Monotherapy Phase|Other|3|||
105800830|NCT00910858|364928558|FG001|Monotherapy Phase|Other|4|||
105800831|NCT00910858|364928559|FG002|Monotherapy Phase|Other|2|||
105800832|NCT00910858|364928557|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
105800833|NCT00910858|364928558|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
105800834|NCT00910858|364928559|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
105800835|NCT00910858|364928557|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
105800836|NCT00910858|364928558|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
105800837|NCT00910858|364928559|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
105800838|NCT00910858|364928557|FG000|Combined Treatment Phase|Protocol Violation|1|||
105800839|NCT00910858|364928558|FG001|Combined Treatment Phase|Protocol Violation|0|||
105800840|NCT00910858|364928559|FG002|Combined Treatment Phase|Protocol Violation|0|||
105800841|NCT00910858|364928557|FG000|Combined Treatment Phase|Other|0|||
105800842|NCT00910858|364928558|FG001|Combined Treatment Phase|Other|2|||
105800843|NCT00910858|364928559|FG002|Combined Treatment Phase|Other|1|||
105800844|NCT00697112|364928560|FG000|Overall Study|Adverse Event|8|||
105800845|NCT00697112|364928560|FG000|Overall Study|Lost to Follow-up|1|||
105800846|NCT00697112|364928560|FG000|Overall Study|Did not meet inclusion criteria|1|||
105800847|NCT02041494|364928561|FG000|Overall Study|Death|1|||
105800848|NCT02041494|364928562|FG001|Overall Study|Death|3|||
105800849|NCT02041494|364928561|FG000|Overall Study|Lost to Follow-up|2|||
105800850|NCT02041494|364928562|FG001|Overall Study|Lost to Follow-up|6|||
105800851|NCT02041494|364928561|FG000|Overall Study|study terminated|16|||
105800852|NCT02041494|364928562|FG001|Overall Study|study terminated|11|||
105800853|NCT03066440|364928563|FG000|Overall Study|Physician Decision|1|||
105800854|NCT03066440|364928564|FG001|Overall Study|Physician Decision|1|||
105800855|NCT03066440|364928563|FG000|Overall Study|Protocol Violation|0|||
105800856|NCT03066440|364928564|FG001|Overall Study|Protocol Violation|2|||
105800857|NCT01965535|364928566|FG000|Overall Study|Lack of Efficacy|2|||
105800858|NCT01965535|364928567|FG001|Overall Study|Lack of Efficacy|1|||
105800859|NCT01418352|364928568|FG000|Overall Study|Lost to Follow-up|2|||
105800860|NCT01418352|364928569|FG001|Overall Study|Lost to Follow-up|0|||
105800861|NCT01418352|364928570|FG002|Overall Study|Lost to Follow-up|0|||
105800862|NCT01418352|364928571|FG003|Overall Study|Lost to Follow-up|0|||
105800863|NCT01418352|364928568|FG000|Overall Study|Adverse Event|0|||
105800864|NCT01418352|364928569|FG001|Overall Study|Adverse Event|1|||
105800865|NCT01418352|364928570|FG002|Overall Study|Adverse Event|0|||
106015661|NCT02531802|365723247|FG009|Received Vaccination 2|Adverse Event|0|||
106015662|NCT02531802|365723248|FG010|Received Vaccination 2|Adverse Event|0|||
106015663|NCT02531802|365723249|FG011|Received Vaccination 2|Adverse Event|0|||
106015664|NCT02531802|365723250|FG012|Received Vaccination 2|Adverse Event|0|||
106015665|NCT02531802|365723251|FG013|Received Vaccination 2|Adverse Event|0|||
106015666|NCT02531802|365723252|FG014|Received Vaccination 2|Adverse Event|0|||
106142348|NCT01350804|366179969|FG002|Core Study|Death|1|||
105800866|NCT01418352|364928571|FG003|Overall Study|Adverse Event|0|||
105800867|NCT01418352|364928568|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
105800868|NCT01418352|364928569|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
105800869|NCT01418352|364928570|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
105800870|NCT01418352|364928571|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
106015667|NCT02531802|365723253|FG015|Received Vaccination 2|Adverse Event|0|||
105800871|NCT01418352|364928568|FG000|Overall Study|Subject Withdrew Consent|0|||
105800872|NCT01418352|364928569|FG001|Overall Study|Subject Withdrew Consent|1|||
105800873|NCT01418352|364928570|FG002|Overall Study|Subject Withdrew Consent|2|||
106015668|NCT02531802|365723254|FG016|Received Vaccination 2|Adverse Event|0|||
106142349|NCT01350804|366179970|FG003|Core Study|Death|0|||
105800874|NCT01418352|364928571|FG003|Overall Study|Subject Withdrew Consent|1|||
105800875|NCT01418352|364928568|FG000|Overall Study|Protocol Deviation|0|||
105800876|NCT01418352|364928569|FG001|Overall Study|Protocol Deviation|0|||
105800877|NCT01418352|364928570|FG002|Overall Study|Protocol Deviation|1|||
105800878|NCT01418352|364928571|FG003|Overall Study|Protocol Deviation|0|||
105800879|NCT01418352|364928568|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
105800880|NCT01418352|364928569|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
105800881|NCT01418352|364928570|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
105800882|NCT01418352|364928571|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
105745813|NCT03100942|364722979|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
105745814|NCT03100942|364722980|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105745815|NCT03100942|364722981|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105745816|NCT03100942|364722982|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
105745817|NCT03100942|364722976|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745818|NCT03100942|364722977|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745819|NCT03100942|364722978|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745820|NCT03100942|364722979|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745821|NCT03100942|364722980|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745822|NCT03100942|364722981|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
105745823|NCT03100942|364722982|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
105745824|NCT04402008|364722986|FG000|Overall Study|Adverse Event|0|||
105745825|NCT04402008|364722987|FG001|Overall Study|Adverse Event|0|||
105745826|NCT04402008|364722988|FG002|Overall Study|Adverse Event|0|||
105745827|NCT04402008|364722989|FG003|Overall Study|Adverse Event|1|||
105745828|NCT04402008|364722990|FG004|Overall Study|Adverse Event|0|||
105745829|NCT04402008|364722991|FG005|Overall Study|Adverse Event|0|||
105745830|NCT04402008|364722992|FG006|Overall Study|Adverse Event|0|||
105745831|NCT04402008|364722986|FG000|Overall Study|Disease Progression|3|||
105745832|NCT04402008|364722987|FG001|Overall Study|Disease Progression|2|||
105745833|NCT04402008|364722988|FG002|Overall Study|Disease Progression|3|||
105745834|NCT04402008|364722989|FG003|Overall Study|Disease Progression|3|||
105745835|NCT04402008|364722990|FG004|Overall Study|Disease Progression|4|||
105745836|NCT04402008|364722991|FG005|Overall Study|Disease Progression|3|||
105800883|NCT03670537|364928572|FG000|Overall Study|Protocol Violation|1|||
105800884|NCT03751020|364928573|FG000|Overall Study|Withdrawal by Subject|2|||
105800885|NCT03751020|364928574|FG001|Overall Study|Withdrawal by Subject|0|||
105943170|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
105943171|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
105943172|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
105943173|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
105943174|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
105943175|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
105943176|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
105943177|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
105943178|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
105943179|NCT00086515|365455003|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
105943180|NCT00086515|365455004|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
105943181|NCT00086515|365455003|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
105943182|NCT00086515|365455004|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
105943183|NCT00086515|365455003|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
105943184|NCT00086515|365455004|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
105943185|NCT00086515|365455003|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
105943186|NCT00086515|365455004|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
105943187|NCT00086515|365455003|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
105943188|NCT00086515|365455004|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
105943189|NCT00086515|365455003|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
105943190|NCT00086515|365455004|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
105943191|NCT00086515|365455003|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
105943192|NCT00086515|365455004|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
105943193|NCT00086515|365455003|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
105943194|NCT00086515|365455004|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
105943195|NCT00086515|365455003|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
106142350|NCT01350804|366179967|FG000|Core Study|Adverse Event|8|||
105745837|NCT04402008|364722992|FG006|Overall Study|Disease Progression|10|||
105745838|NCT04402008|364722986|FG000|Overall Study|Withdrawal by Subject|0|||
105745839|NCT04402008|364722987|FG001|Overall Study|Withdrawal by Subject|1|||
105745840|NCT04402008|364722988|FG002|Overall Study|Withdrawal by Subject|0|||
105745841|NCT04402008|364722989|FG003|Overall Study|Withdrawal by Subject|0|||
105943196|NCT00086515|365455004|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
105943197|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
105943198|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
105800886|NCT03751020|364928575|FG002|Overall Study|Withdrawal by Subject|0|||
105800887|NCT03751020|364928573|FG000|Overall Study|Lost to Follow-up|7|||
105800888|NCT03751020|364928574|FG001|Overall Study|Lost to Follow-up|4|||
105800889|NCT03751020|364928575|FG002|Overall Study|Lost to Follow-up|10|||
105800890|NCT00033631|364928576|FG000|Overall Study|Protocol Violation|14|||
105800891|NCT00033631|364928577|FG001|Overall Study|Protocol Violation|11|||
105800892|NCT00033631|364928576|FG000|Overall Study|Withdrawal by Subject|4|||
105800893|NCT00033631|364928577|FG001|Overall Study|Withdrawal by Subject|4|||
105800894|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
105800895|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
105800896|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
105800897|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
105800898|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
105800899|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
105800900|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
105800901|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
105800902|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
105800903|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
105800904|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
105800905|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
105800906|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
105800907|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
105800908|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
105800909|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
105800910|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
105800911|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
105800912|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
105800913|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
105800914|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
105800915|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
105800916|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
105800917|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
105800918|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
105800919|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
105800920|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
105800921|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
105800922|NCT00528879|364928578|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
105800923|NCT00528879|364928579|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
105800924|NCT00528879|364928580|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
105800925|NCT00528879|364928581|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
105800926|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
105800927|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
105800928|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
105800929|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
105800930|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
105800931|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
105800932|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
105800933|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
105800934|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
105800935|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
105800936|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
105800937|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
105800938|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
105800939|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
105800940|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
105800941|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
105800942|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
105800943|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
105800944|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
105800945|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
105800946|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
105943199|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
105943200|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
105943201|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
105943202|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
105943203|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
105943204|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
106015669|NCT02531802|365723255|FG017|Received Vaccination 2|Adverse Event|2|||
106015670|NCT02531802|365723256|FG018|Received Vaccination 2|Adverse Event|1|||
106015671|NCT02531802|365723257|FG019|Received Vaccination 2|Adverse Event|0|||
106015672|NCT02531802|365723258|FG020|Received Vaccination 2|Adverse Event|1|||
106015673|NCT02531802|365723238|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
106015674|NCT02531802|365723239|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
105745842|NCT04402008|364722990|FG004|Overall Study|Withdrawal by Subject|1|||
105745843|NCT04402008|364722991|FG005|Overall Study|Withdrawal by Subject|0|||
105745844|NCT04402008|364722992|FG006|Overall Study|Withdrawal by Subject|0|||
105745845|NCT04402008|364722986|FG000|Overall Study|Sponsor Decision|0|||
105745846|NCT04402008|364722987|FG001|Overall Study|Sponsor Decision|0|||
105745847|NCT04402008|364722988|FG002|Overall Study|Sponsor Decision|0|||
105745848|NCT04402008|364722989|FG003|Overall Study|Sponsor Decision|0|||
105745849|NCT04402008|364722990|FG004|Overall Study|Sponsor Decision|0|||
105745850|NCT04402008|364722991|FG005|Overall Study|Sponsor Decision|0|||
105745851|NCT04402008|364722992|FG006|Overall Study|Sponsor Decision|3|||
105745852|NCT04402008|364722986|FG000|Overall Study|Death|0|||
105745853|NCT04402008|364722987|FG001|Overall Study|Death|0|||
105745854|NCT04402008|364722988|FG002|Overall Study|Death|0|||
105745855|NCT04402008|364722989|FG003|Overall Study|Death|0|||
105745856|NCT04402008|364722990|FG004|Overall Study|Death|1|||
105745857|NCT04402008|364722991|FG005|Overall Study|Death|0|||
105745858|NCT04402008|364722992|FG006|Overall Study|Death|2|||
105745859|NCT04402008|364722986|FG000|Overall Study|Other|0|||
105745860|NCT04402008|364722987|FG001|Overall Study|Other|0|||
105745861|NCT04402008|364722988|FG002|Overall Study|Other|0|||
105745862|NCT04402008|364722989|FG003|Overall Study|Other|0|||
105745863|NCT04402008|364722990|FG004|Overall Study|Other|0|||
105745864|NCT04402008|364722991|FG005|Overall Study|Other|0|||
105745865|NCT04402008|364722992|FG006|Overall Study|Other|5|||
105745866|NCT01401010|364722997|FG000|Overall Study|Could not interpret assay results|1|||
105745867|NCT01401010|364722998|FG001|Overall Study|Could not interpret assay results|0|||
105745868|NCT01912729|364722999|FG000|Overall Study|Withdrawal by Subject|0|||
105745869|NCT01912729|364723000|FG001|Overall Study|Withdrawal by Subject|1|||
105745870|NCT01952834|364723001|FG000|Overall Study|Adverse Event|1|||
105745871|NCT04360187|364723008|FG000|Double-Blind Treatment|Adverse Event|9|||
105745872|NCT04360187|364723009|FG001|Double-Blind Treatment|Adverse Event|11|||
105745873|NCT04360187|364723008|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
105745874|NCT04360187|364723009|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
105745875|NCT04360187|364723008|FG000|Double-Blind Treatment|Physician Decision|1|||
105745876|NCT04360187|364723009|FG001|Double-Blind Treatment|Physician Decision|0|||
105745877|NCT04360187|364723008|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
105745878|NCT04360187|364723009|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
105745879|NCT04360187|364723008|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
105745880|NCT04360187|364723009|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
105745881|NCT04360187|364723008|FG000|Follow-Up|Lost to Follow-up|1|||
105745882|NCT04360187|364723009|FG001|Follow-Up|Lost to Follow-up|0|||
105745883|NCT00988559|364723015|FG000|Overall Study|Withdrawal by Subject|1|||
105745884|NCT00988559|364723016|FG001|Overall Study|Withdrawal by Subject|1|||
105943205|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
105943206|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
105943207|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
105943208|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
105943209|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
105943210|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
105943211|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
105943212|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
105943213|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
105943214|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
105943215|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
105943216|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
105943217|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
105943218|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
105943219|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
105943220|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
105943221|NCT00086515|365455003|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
105943222|NCT00086515|365455004|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
105943223|NCT02082977|365455005|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
105943224|NCT02082977|365455006|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
105745885|NCT00988559|364723017|FG002|Overall Study|Withdrawal by Subject|0|||
105745886|NCT00988559|364723018|FG003|Overall Study|Withdrawal by Subject|1|||
105745887|NCT00988559|364723015|FG000|Overall Study|Pregnancy|0|||
105745888|NCT00988559|364723016|FG001|Overall Study|Pregnancy|1|||
105745889|NCT00988559|364723017|FG002|Overall Study|Pregnancy|1|||
105745890|NCT00988559|364723018|FG003|Overall Study|Pregnancy|0|||
106015675|NCT02531802|365723240|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
105745891|NCT00988559|364723015|FG000|Overall Study|Lost to Follow-up|0|||
105745892|NCT00988559|364723016|FG001|Overall Study|Lost to Follow-up|0|||
105745893|NCT00988559|364723017|FG002|Overall Study|Lost to Follow-up|1|||
105745894|NCT00988559|364723018|FG003|Overall Study|Lost to Follow-up|0|||
105745895|NCT03007953|364723019|FG000|Overall Study|Withdrawal by Subject|5|||
105745896|NCT03007953|364723020|FG001|Overall Study|Withdrawal by Subject|2|||
105745897|NCT03007953|364723019|FG000|Overall Study|Death|5|||
105745898|NCT03007953|364723020|FG001|Overall Study|Death|7|||
105745899|NCT03007953|364723019|FG000|Overall Study|Lost to Follow-up|3|||
105745900|NCT03007953|364723020|FG001|Overall Study|Lost to Follow-up|2|||
105745901|NCT03007953|364723019|FG000|Overall Study|Enrolled in Hospice|3|||
105745902|NCT03007953|364723020|FG001|Overall Study|Enrolled in Hospice|2|||
105745903|NCT00515008|364723021|FG000|Overall Study|Lost to Follow-up|1|||
105745904|NCT00515008|364723022|FG001|Overall Study|Lost to Follow-up|0|||
105745905|NCT00515008|364723021|FG000|Overall Study|Declined|0|||
105745906|NCT00515008|364723022|FG001|Overall Study|Declined|3|||
105745907|NCT00515008|364723021|FG000|Overall Study|Left the Boston Area|1|||
105745908|NCT00515008|364723022|FG001|Overall Study|Left the Boston Area|1|||
105745909|NCT00515008|364723021|FG000|Overall Study|Scheduling conflict|1|||
105745910|NCT00515008|364723022|FG001|Overall Study|Scheduling conflict|0|||
105745911|NCT00748540|364723023|FG000|Overall Study|Physician Decision|1|||
105745912|NCT01930799|364723027|FG000|Overall Study|Withdrawal by Subject|3|||
105745913|NCT01930799|364723027|FG000|Overall Study|Lost to Follow-up|5|||
105745914|NCT02402218|364723028|FG000|Overall Study|Did not pickup study medication|12|||
105745915|NCT02402218|364723029|FG001|Overall Study|Did not pickup study medication|9|||
105745916|NCT02402218|364723030|FG002|Overall Study|Did not pickup study medication|13|||
105745917|NCT02402218|364723028|FG000|Overall Study|Lack of Efficacy|0|||
105745918|NCT02402218|364723029|FG001|Overall Study|Lack of Efficacy|1|||
105745919|NCT02402218|364723030|FG002|Overall Study|Lack of Efficacy|1|||
105745920|NCT02402218|364723028|FG000|Overall Study|Death|1|||
105745921|NCT02402218|364723029|FG001|Overall Study|Death|0|||
105745922|NCT02402218|364723030|FG002|Overall Study|Death|0|||
105745923|NCT02402218|364723028|FG000|Overall Study|Reinfection|0|||
105745924|NCT02402218|364723029|FG001|Overall Study|Reinfection|0|||
105745925|NCT02402218|364723030|FG002|Overall Study|Reinfection|1|||
105745926|NCT02402218|364723028|FG000|Overall Study|Adverse Event|0|||
105745927|NCT02402218|364723029|FG001|Overall Study|Adverse Event|2|||
105745928|NCT02402218|364723030|FG002|Overall Study|Adverse Event|1|||
105745929|NCT02402218|364723028|FG000|Overall Study|Withdrawal by Subject|1|||
105745930|NCT02402218|364723029|FG001|Overall Study|Withdrawal by Subject|1|||
105943225|NCT02082977|365455007|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
105943226|NCT02082977|365455008|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
105943227|NCT02082977|365455009|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
105943228|NCT02082977|365455010|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
105943229|NCT02082977|365455011|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
105943230|NCT02082977|365455012|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
105943231|NCT02082977|365455013|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
105943232|NCT02082977|365455014|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
105943233|NCT02082977|365455005|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943234|NCT02082977|365455006|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943235|NCT02082977|365455007|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943236|NCT02082977|365455008|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943237|NCT02082977|365455009|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943238|NCT02082977|365455010|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943239|NCT02082977|365455011|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943240|NCT02082977|365455012|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
105943241|NCT02082977|365455013|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943242|NCT02082977|365455014|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
105943243|NCT02082977|365455005|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943244|NCT02082977|365455006|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943245|NCT02082977|365455007|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943246|NCT02082977|365455008|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943247|NCT02082977|365455009|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943248|NCT02082977|365455010|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
105943249|NCT02082977|365455011|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943250|NCT02082977|365455012|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943251|NCT02082977|365455013|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943252|NCT02082977|365455014|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
105943253|NCT02082977|365455005|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105943254|NCT02082977|365455006|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105943255|NCT02082977|365455007|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105943256|NCT02082977|365455008|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105943257|NCT02082977|365455009|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
105943258|NCT02082977|365455010|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
105943259|NCT02082977|365455011|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
106015676|NCT02531802|365723241|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
106015677|NCT02531802|365723242|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
106015678|NCT02531802|365723243|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
106015679|NCT02531802|365723244|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
106015680|NCT02531802|365723245|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
106015681|NCT02531802|365723246|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
106015682|NCT02531802|365723247|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
106015683|NCT02531802|365723248|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
106015684|NCT02531802|365723249|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
106015685|NCT02531802|365723250|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
106015686|NCT02531802|365723251|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
106015687|NCT02531802|365723252|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
106015688|NCT02531802|365723253|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
106015689|NCT02531802|365723254|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
106015690|NCT02531802|365723255|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
106015691|NCT02531802|365723256|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
106015692|NCT02531802|365723257|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
106015693|NCT02531802|365723258|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
106015694|NCT01263197|365723263|FG000|First Intervention (Period 1)|Adverse Event|0|||
106015695|NCT01263197|365723264|FG001|First Intervention (Period 1)|Adverse Event|0|||
106015696|NCT01263197|365723265|FG002|First Intervention (Period 1)|Adverse Event|0|||
106015697|NCT01263197|365723266|FG003|First Intervention (Period 1)|Adverse Event|0|||
106015698|NCT01263197|365723267|FG004|First Intervention (Period 1)|Adverse Event|0|||
106015699|NCT01263197|365723268|FG005|First Intervention (Period 1)|Adverse Event|1|||
105745931|NCT02402218|364723030|FG002|Overall Study|Withdrawal by Subject|1|||
106142351|NCT01350804|366179968|FG001|Core Study|Adverse Event|10|||
106142352|NCT01350804|366179969|FG002|Core Study|Adverse Event|8|||
106142353|NCT01350804|366179970|FG003|Core Study|Adverse Event|8|||
106142354|NCT01350804|366179967|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
105745932|NCT04436822|364723031|FG000|Overall Study|Physician Decision|2|||
105745933|NCT04436822|364723032|FG001|Overall Study|Physician Decision|0|||
105745934|NCT04436822|364723031|FG000|Overall Study|Sponsor request|1|||
105745935|NCT04436822|364723032|FG001|Overall Study|Sponsor request|0|||
105745936|NCT04436822|364723031|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105745937|NCT04436822|364723032|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105745938|NCT04436822|364723031|FG000|Overall Study|Unsuccessful procedure|0|||
105745939|NCT04436822|364723032|FG001|Overall Study|Unsuccessful procedure|1|||
105745940|NCT04436822|364723031|FG000|Overall Study|Withdrawal due to Covid-19|8|||
105745941|NCT04436822|364723032|FG001|Overall Study|Withdrawal due to Covid-19|1|||
105745942|NCT04436822|364723031|FG000|Overall Study|Withdrawal by Subject|1|||
105745943|NCT04436822|364723032|FG001|Overall Study|Withdrawal by Subject|0|||
105745944|NCT04436822|364723031|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
105745945|NCT04436822|364723032|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
105745946|NCT02371759|364723035|FG000|Overall Study|Protocol Violation|3|||
105745947|NCT02371759|364723036|FG001|Overall Study|Protocol Violation|1|||
105745948|NCT02371759|364723037|FG002|Overall Study|Protocol Violation|1|||
105745949|NCT02371759|364723038|FG003|Overall Study|Protocol Violation|0|||
105745950|NCT02371759|364723039|FG004|Overall Study|Protocol Violation|3|||
105745951|NCT02371759|364723040|FG005|Overall Study|Protocol Violation|1|||
105745952|NCT02371759|364723041|FG006|Overall Study|Protocol Violation|0|||
105745953|NCT02371759|364723042|FG007|Overall Study|Protocol Violation|3|||
105745954|NCT02371759|364723035|FG000|Overall Study|Withdrawal by Subject|0|||
105745955|NCT02371759|364723036|FG001|Overall Study|Withdrawal by Subject|0|||
105745956|NCT02371759|364723037|FG002|Overall Study|Withdrawal by Subject|0|||
105745957|NCT02371759|364723038|FG003|Overall Study|Withdrawal by Subject|0|||
105745958|NCT02371759|364723039|FG004|Overall Study|Withdrawal by Subject|0|||
105745959|NCT02371759|364723040|FG005|Overall Study|Withdrawal by Subject|0|||
105745960|NCT02371759|364723041|FG006|Overall Study|Withdrawal by Subject|0|||
105745961|NCT02371759|364723042|FG007|Overall Study|Withdrawal by Subject|1|||
105745962|NCT01423617|364723048|FG000|Overall Study|Lost to Follow-up|0|||
105745963|NCT01423617|364723049|FG001|Overall Study|Lost to Follow-up|1|||
105745964|NCT01515306|364723050|FG000|Overall Study|Adverse Event|3|||
105745965|NCT01515306|364723051|FG001|Overall Study|Adverse Event|2|||
105745966|NCT01515306|364723050|FG000|Overall Study|Progressive Disease|19|||
105745967|NCT01515306|364723051|FG001|Overall Study|Progressive Disease|9|||
105745968|NCT01515306|364723050|FG000|Overall Study|Withdrawal by Subject|1|||
106015700|NCT01263197|365723263|FG000|Washout Period 1|Protocol Violation|0|||
106142355|NCT01350804|366179968|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
105745969|NCT01515306|364723051|FG001|Overall Study|Withdrawal by Subject|2|||
105745970|NCT01515306|364723050|FG000|Overall Study|Physician Decision|1|||
105745971|NCT01515306|364723051|FG001|Overall Study|Physician Decision|1|||
105745972|NCT00369668|364723055|FG000|Overall Study|Lack of Efficacy|4|||
105745973|NCT00369668|364723056|FG001|Overall Study|Lack of Efficacy|5|||
105745974|NCT00369668|364723057|FG002|Overall Study|Lack of Efficacy|7|||
105745975|NCT03201198|364723065|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
105745976|NCT03201198|364723066|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
105745977|NCT03201198|364723065|FG000|Overall Study|Withdrawal by Subject|2|||
105745978|NCT03201198|364723066|FG001|Overall Study|Withdrawal by Subject|3|||
105745979|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
105745980|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
105745981|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
105745982|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
105745983|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
105745984|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
105745985|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
105745986|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
105745987|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
105745988|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
105745989|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
105745990|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
105745991|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
105745992|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
105745993|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
105745994|NCT03855137|364723068|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
105745995|NCT03855137|364723069|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
105745996|NCT03855137|364723070|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
105745997|NCT03855137|364723068|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
105745998|NCT03855137|364723069|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
105745999|NCT03855137|364723070|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
105746000|NCT03855137|364723068|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
105746001|NCT03855137|364723069|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
105746002|NCT03855137|364723070|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
105746003|NCT03855137|364723068|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
105746004|NCT03855137|364723069|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
105746005|NCT03855137|364723070|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
105746006|NCT03855137|364723068|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
105746007|NCT03855137|364723069|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
105746008|NCT03855137|364723070|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
105746009|NCT01745393|364723071|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
105746010|NCT01745393|364723072|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
105746011|NCT01745393|364723071|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
105746012|NCT01745393|364723072|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
105746013|NCT01745393|364723071|FG000|12-month Follow-up|Lost to Follow-up|6|||
105746014|NCT01745393|364723072|FG001|12-month Follow-up|Lost to Follow-up|5|||
105746015|NCT02427477|364723077|FG000|Period 1|Adverse Event|1|||
105746016|NCT02427477|364723078|FG001|Period 1|Adverse Event|0|||
105746017|NCT00471445|364723079|FG000|Overall Study|Withdrawal by Subject|1|||
105746018|NCT00471445|364723080|FG001|Overall Study|Withdrawal by Subject|1|||
105746019|NCT00471445|364723079|FG000|Overall Study|Ineligible|1|||
105746020|NCT00471445|364723080|FG001|Overall Study|Ineligible|0|||
105746021|NCT00471445|364723079|FG000|Overall Study|Protocol Violation|0|||
105746022|NCT00471445|364723080|FG001|Overall Study|Protocol Violation|1|||
105746023|NCT03591146|364723084|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
105746024|NCT03591146|364723085|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
105746025|NCT03591146|364723086|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
105746026|NCT03591146|364723087|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
105746027|NCT03591146|364723088|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
105746028|NCT03591146|364723084|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
105746029|NCT03591146|364723085|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
105746030|NCT03591146|364723086|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
105746031|NCT03591146|364723087|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
105746032|NCT03591146|364723088|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
105746033|NCT03591146|364723084|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
105943260|NCT02082977|365455012|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
105943261|NCT02082977|365455013|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
105943262|NCT02082977|365455014|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
105943263|NCT02082977|365455005|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105943264|NCT02082977|365455006|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105943265|NCT02082977|365455007|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105943266|NCT02082977|365455008|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105943267|NCT02082977|365455009|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105746034|NCT03591146|364723085|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
105746035|NCT03591146|364723086|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
105746036|NCT03591146|364723087|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
105746037|NCT03591146|364723088|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
105746038|NCT03591146|364723084|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
105746039|NCT03591146|364723085|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
105746040|NCT03591146|364723086|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
105746041|NCT03591146|364723087|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
105746042|NCT03591146|364723088|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
105746043|NCT04737031|364723091|FG000|Overall Study|Patients who did not have a treatment visit|0|||
105746044|NCT04737031|364723092|FG001|Overall Study|Patients who did not have a treatment visit|31|||
105746045|NCT04737031|364723093|FG002|Overall Study|Patients who did not have a treatment visit|93|||
105746046|NCT04737031|364723094|FG003|Overall Study|Patients who did not have a treatment visit|227|||
105746047|NCT04369430|364723095|FG000|Overall Study|Adverse Event|2|||
105746048|NCT04369430|364723096|FG001|Overall Study|Adverse Event|3|||
105746049|NCT04369430|364723095|FG000|Overall Study|Death|1|||
105746050|NCT04369430|364723096|FG001|Overall Study|Death|0|||
105746051|NCT04369430|364723095|FG000|Overall Study|Withdrawal by Subject|4|||
105746052|NCT04369430|364723096|FG001|Overall Study|Withdrawal by Subject|3|||
105746053|NCT04369430|364723095|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
105746054|NCT04369430|364723096|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
105746055|NCT04369430|364723095|FG000|Overall Study|Lost to Follow-up|0|||
105746056|NCT04369430|364723096|FG001|Overall Study|Lost to Follow-up|1|||
105746057|NCT02435277|364723099|FG000|Overall Study|Adverse Event|1|||
105746058|NCT02435277|364723100|FG001|Overall Study|Adverse Event|1|||
105746059|NCT02435277|364723101|FG002|Overall Study|Adverse Event|0|||
105746060|NCT02435277|364723102|FG003|Overall Study|Adverse Event|0|||
105746061|NCT02435277|364723099|FG000|Overall Study|Withdrawal by Subject|1|||
105746062|NCT02435277|364723100|FG001|Overall Study|Withdrawal by Subject|0|||
105746063|NCT02435277|364723101|FG002|Overall Study|Withdrawal by Subject|0|||
105746064|NCT02435277|364723102|FG003|Overall Study|Withdrawal by Subject|0|||
105746065|NCT01067508|364723103|FG000|Overall Study|Physician Decision|0|||
105746066|NCT01067508|364723104|FG001|Overall Study|Physician Decision|1|||
105746067|NCT01067508|364723103|FG000|Overall Study|Withdrawal by Subject|0|||
105746068|NCT01067508|364723104|FG001|Overall Study|Withdrawal by Subject|1|||
105746069|NCT00444626|364723107|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
105746070|NCT00444626|364723107|FG000|Initial Treatment Period|Adverse Event|1|||
105746071|NCT00444626|364723107|FG000|Initial Treatment Period|Lost to Follow-up|9|||
105746072|NCT04715230|364723110|FG000|Overall Study|Withdrawal by Subject|1|||
105746073|NCT04715230|364723111|FG001|Overall Study|Withdrawal by Subject|0|||
105746074|NCT04715230|364723112|FG002|Overall Study|Withdrawal by Subject|0|||
105746075|NCT04715230|364723110|FG000|Overall Study|Lost to Follow-up|0|||
105746076|NCT04715230|364723111|FG001|Overall Study|Lost to Follow-up|5|||
105746077|NCT04715230|364723112|FG002|Overall Study|Lost to Follow-up|1|||
105746078|NCT03352414|364723113|FG000|Overall Study|Ineligible by operative criteria|12|||
105746079|NCT03352414|364723114|FG001|Overall Study|Ineligible by operative criteria|10|||
105746080|NCT03453151|364723115|FG000|Overall Study|Withdrawal by Subject|1|||
105746081|NCT03453151|364723115|FG000|Overall Study|Physician Decision|3|||
105746082|NCT00142519|364723116|FG000|Overall Study|Not Treated|7|||
105746083|NCT00142519|364723117|FG001|Overall Study|Not Treated|9|||
105746084|NCT00142519|364723116|FG000|Overall Study|Protocol Violation|1|||
105746085|NCT00142519|364723117|FG001|Overall Study|Protocol Violation|0|||
105746086|NCT00142519|364723116|FG000|Overall Study|Withdrawal by Subject|10|||
105746087|NCT00142519|364723117|FG001|Overall Study|Withdrawal by Subject|7|||
105746088|NCT01687413|364723118|FG000|Overall Study|Withdrawal by Subject|0|||
105746089|NCT01687413|364723119|FG001|Overall Study|Withdrawal by Subject|2|||
105746090|NCT01687413|364723118|FG000|Overall Study|Not eligible|0|||
105746091|NCT01687413|364723119|FG001|Overall Study|Not eligible|2|||
105746092|NCT01687413|364723118|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
105746093|NCT01687413|364723119|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
105746094|NCT01767194|364723120|FG000|Overall Study|Adverse Event|1|||
105746095|NCT01767194|364723121|FG001|Overall Study|Adverse Event|1|||
105746096|NCT01767194|364723120|FG000|Overall Study|Death|0|||
105746097|NCT01767194|364723121|FG001|Overall Study|Death|1|||
105746098|NCT01767194|364723120|FG000|Overall Study|Lack of Efficacy|12|||
105746099|NCT01767194|364723121|FG001|Overall Study|Lack of Efficacy|11|||
105746100|NCT01767194|364723120|FG000|Overall Study|Physician Decision|2|||
105746101|NCT01767194|364723121|FG001|Overall Study|Physician Decision|23|||
105746102|NCT01767194|364723120|FG000|Overall Study|Withdrawal by Subject|0|||
105746103|NCT01767194|364723121|FG001|Overall Study|Withdrawal by Subject|1|||
105746104|NCT01767194|364723120|FG000|Overall Study|Ineligible|1|||
105746105|NCT01767194|364723121|FG001|Overall Study|Ineligible|1|||
105746106|NCT01767194|364723120|FG000|Overall Study|Refusal by patient/parent|2|||
105746107|NCT01767194|364723121|FG001|Overall Study|Refusal by patient/parent|4|||
105746108|NCT01767194|364723120|FG000|Overall Study|Criteria not met on time for next cycle|0|||
105746109|NCT01767194|364723121|FG001|Overall Study|Criteria not met on time for next cycle|1|||
105746110|NCT04973228|364723122|FG000|Overall Study|Adverse Event|2|||
105746111|NCT04973228|364723123|FG001|Overall Study|Adverse Event|3|||
105746112|NCT04973228|364723122|FG000|Overall Study|Lack of Efficacy|1|||
105746113|NCT04973228|364723123|FG001|Overall Study|Lack of Efficacy|3|||
105746114|NCT04973228|364723122|FG000|Overall Study|Lost to Follow-up|12|||
105746115|NCT04973228|364723123|FG001|Overall Study|Lost to Follow-up|4|||
105746116|NCT04973228|364723122|FG000|Overall Study|Withdrawal by Subject|11|||
105746117|NCT04973228|364723123|FG001|Overall Study|Withdrawal by Subject|4|||
105746118|NCT04973228|364723122|FG000|Overall Study|Did not tolerate application|1|||
105746119|NCT04973228|364723123|FG001|Overall Study|Did not tolerate application|0|||
105746120|NCT04973228|364723122|FG000|Overall Study|Wanted to early terminate and use own product|0|||
105746121|NCT04973228|364723123|FG001|Overall Study|Wanted to early terminate and use own product|1|||
105746122|NCT04973228|364723122|FG000|Overall Study|Missed visits due to new work schedule|1|||
105746123|NCT04973228|364723123|FG001|Overall Study|Missed visits due to new work schedule|0|||
105746124|NCT02349789|364725122|FG000|Overall Study|Withdrawal by Subject|2|||
105746125|NCT00786032|364725125|FG000|Overall Study|Death|4|||
105746126|NCT00786032|364725125|FG000|Overall Study|Withdrawal by Subject|14|||
105746127|NCT00786032|364725125|FG000|Overall Study|Did not complete in the timeframe|6|||
105746128|NCT02723604|364725126|FG000|Overall Study|ineligible|1|||
105746129|NCT02723604|364725126|FG000|Overall Study|never received treatment|1|||
105746130|NCT02457182|364725127|FG000|Overall Study|Lost to Follow-up|1|||
105746131|NCT02457182|364725128|FG001|Overall Study|Lost to Follow-up|0|||
105746132|NCT00311181|364725132|FG000|Overall Study|Final DFTs were not obtained|96|||
105746133|NCT02397694|364725133|FG000|Double-Blinded Phase|Adverse Event|1|||
105746134|NCT02397694|364725134|FG001|Double-Blinded Phase|Adverse Event|0|||
105746135|NCT02397694|364725133|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
105746136|NCT02397694|364725134|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
105746137|NCT02397694|364725133|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
105746138|NCT02397694|364725134|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
105746139|NCT02397694|364725133|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
105746140|NCT02397694|364725134|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
105746141|NCT02397694|364725133|FG000|Open Label Extension Phase|Protocol Violation|1|||
105746142|NCT02397694|364725134|FG001|Open Label Extension Phase|Protocol Violation|0|||
105746143|NCT02397694|364725133|FG000|Open Label Extension Phase|Withdrew Consent|3|||
105746144|NCT02397694|364725134|FG001|Open Label Extension Phase|Withdrew Consent|1|||
105746145|NCT02397694|364725133|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
105746146|NCT02397694|364725134|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
105746147|NCT03497429|364725136|FG000|Overall Study|Progressive disease|3|||
105746148|NCT03497429|364725137|FG001|Overall Study|Progressive disease|4|||
105746149|NCT03497429|364725136|FG000|Overall Study|Adverse Event|0|||
105746150|NCT03497429|364725137|FG001|Overall Study|Adverse Event|2|||
105746151|NCT03987919|364725138|FG000|Overall Study|Adverse Event|1|||
105746152|NCT03987919|364725139|FG001|Overall Study|Adverse Event|4|||
105746153|NCT03987919|364725140|FG002|Overall Study|Adverse Event|1|||
105746154|NCT03987919|364725141|FG003|Overall Study|Adverse Event|3|||
105746155|NCT03987919|364725138|FG000|Overall Study|Death|4|||
105746156|NCT03987919|364725139|FG001|Overall Study|Death|4|||
105746157|NCT03987919|364725140|FG002|Overall Study|Death|4|||
105746158|NCT03987919|364725141|FG003|Overall Study|Death|1|||
105746159|NCT03987919|364725138|FG000|Overall Study|Lost to Follow-up|5|||
105746160|NCT03987919|364725139|FG001|Overall Study|Lost to Follow-up|6|||
105746161|NCT03987919|364725140|FG002|Overall Study|Lost to Follow-up|8|||
105746162|NCT03987919|364725141|FG003|Overall Study|Lost to Follow-up|12|||
105746163|NCT03987919|364725138|FG000|Overall Study|Physician Decision|0|||
105746164|NCT03987919|364725139|FG001|Overall Study|Physician Decision|2|||
105943268|NCT02082977|365455010|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105943269|NCT02082977|365455011|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105943270|NCT02082977|365455012|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
105943271|NCT02082977|365455013|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105943272|NCT02082977|365455014|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
105943273|NCT02106832|365455015|FG000|Overall Study|Adverse Event|1|||
106142356|NCT01350804|366179969|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
106142357|NCT01350804|366179970|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
105746165|NCT03987919|364725140|FG002|Overall Study|Physician Decision|0|||
105746166|NCT03987919|364725141|FG003|Overall Study|Physician Decision|4|||
105746167|NCT03987919|364725138|FG000|Overall Study|Pregnancy|1|||
105746168|NCT03987919|364725139|FG001|Overall Study|Pregnancy|0|||
105746169|NCT03987919|364725140|FG002|Overall Study|Pregnancy|1|||
105746170|NCT03987919|364725141|FG003|Overall Study|Pregnancy|1|||
105746171|NCT03987919|364725138|FG000|Overall Study|Protocol Violation|0|||
105746172|NCT03987919|364725139|FG001|Overall Study|Protocol Violation|1|||
105746173|NCT03987919|364725140|FG002|Overall Study|Protocol Violation|0|||
105746174|NCT03987919|364725141|FG003|Overall Study|Protocol Violation|0|||
105943274|NCT02106832|365455016|FG001|Overall Study|Adverse Event|2|||
105746175|NCT03987919|364725138|FG000|Overall Study|Site terminated by Sponsor|0|||
106015701|NCT01263197|365723264|FG001|Washout Period 1|Protocol Violation|0|||
106015702|NCT01263197|365723265|FG002|Washout Period 1|Protocol Violation|0|||
106015703|NCT01263197|365723266|FG003|Washout Period 1|Protocol Violation|0|||
106015704|NCT01263197|365723267|FG004|Washout Period 1|Protocol Violation|1|||
106015705|NCT01263197|365723268|FG005|Washout Period 1|Protocol Violation|0|||
106015706|NCT01263197|365723263|FG000|Washout Period 2|Physician Decision|0|||
106015707|NCT01263197|365723264|FG001|Washout Period 2|Physician Decision|0|||
106015708|NCT01263197|365723265|FG002|Washout Period 2|Physician Decision|0|||
106015709|NCT01263197|365723266|FG003|Washout Period 2|Physician Decision|0|||
106015710|NCT01263197|365723267|FG004|Washout Period 2|Physician Decision|0|||
106015711|NCT01263197|365723268|FG005|Washout Period 2|Physician Decision|1|||
106142358|NCT01350804|366179967|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
106142359|NCT01350804|366179968|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
106142360|NCT01350804|366179969|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
106142361|NCT01350804|366179970|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
106142362|NCT01350804|366179967|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
106142363|NCT01350804|366179968|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
106142364|NCT01350804|366179969|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
106142365|NCT01350804|366179970|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
106142366|NCT01350804|366179967|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
106142367|NCT01350804|366179968|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
106142368|NCT01350804|366179969|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
106142369|NCT01350804|366179970|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
106142370|NCT01350804|366179967|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
106142371|NCT01350804|366179968|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
106142372|NCT01350804|366179969|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
106142373|NCT01350804|366179970|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
106142374|NCT01350804|366179967|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
106142375|NCT01350804|366179968|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
106142376|NCT01350804|366179969|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
106142377|NCT01350804|366179970|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
106142378|NCT03183518|366179971|FG000|Overall Study|Other (Not specified)|2|||
106142379|NCT03183518|366179971|FG000|Overall Study|Other (Withdrawal of consent)|1|||
106142380|NCT02106442|366179976|FG000|Overall Study|Case Report Forms Uncollected|7|||
106142381|NCT02106442|366179976|FG000|Overall Study|Protocol Deviation|30|||
106142382|NCT04493242|366179977|FG000|Overall Study|Death|10|||
106142383|NCT04493242|366179978|FG001|Overall Study|Death|14|||
106142384|NCT04493242|366179979|FG002|Overall Study|Death|16|||
105746176|NCT03987919|364725139|FG001|Overall Study|Site terminated by Sponsor|0|||
105746177|NCT03987919|364725140|FG002|Overall Study|Site terminated by Sponsor|0|||
105746178|NCT03987919|364725141|FG003|Overall Study|Site terminated by Sponsor|1|||
105746179|NCT03987919|364725138|FG000|Overall Study|Withdrawal by Subject|7|||
105746180|NCT03987919|364725139|FG001|Overall Study|Withdrawal by Subject|7|||
105746181|NCT03987919|364725140|FG002|Overall Study|Withdrawal by Subject|8|||
105746182|NCT03987919|364725141|FG003|Overall Study|Withdrawal by Subject|4|||
105746183|NCT03987919|364725138|FG000|Overall Study|Other - as reported by the investigator|1|||
105746184|NCT03987919|364725139|FG001|Overall Study|Other - as reported by the investigator|3|||
105746185|NCT03987919|364725140|FG002|Overall Study|Other - as reported by the investigator|2|||
105746186|NCT03987919|364725141|FG003|Overall Study|Other - as reported by the investigator|0|||
105746187|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
105746188|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
105746189|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
105746190|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105746191|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105746192|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105746193|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
106015712|NCT01263197|365723263|FG000|Washout Period 2|Protocol Violation|0|||
106015713|NCT01263197|365723264|FG001|Washout Period 2|Protocol Violation|0|||
106142385|NCT04493242|366179977|FG000|Overall Study|Lost to Follow-up|1|||
106142386|NCT04493242|366179978|FG001|Overall Study|Lost to Follow-up|1|||
106142387|NCT04493242|366179979|FG002|Overall Study|Lost to Follow-up|0|||
105746194|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
105746195|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
105746196|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
105746197|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
106142388|NCT04493242|366179977|FG000|Overall Study|Withdrawal by Subject|1|||
105746198|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105746199|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105746200|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105746201|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
106015714|NCT01263197|365723265|FG002|Washout Period 2|Protocol Violation|0|||
106015715|NCT01263197|365723266|FG003|Washout Period 2|Protocol Violation|1|||
106142389|NCT04493242|366179978|FG001|Overall Study|Withdrawal by Subject|0|||
105746202|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
105746203|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
105746204|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746205|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746206|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746207|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746208|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746209|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746210|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
105746211|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
105746212|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746213|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746214|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746215|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746216|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746217|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746218|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
105746219|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
105746220|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
105746221|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
105746222|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746223|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746224|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746225|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746226|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
105746227|NCT03725202|364725142|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746228|NCT03725202|364725143|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746229|NCT03725202|364725144|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
105746230|NCT03725202|364725145|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746231|NCT03725202|364725146|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746232|NCT03725202|364725147|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746233|NCT03725202|364725148|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746234|NCT03725202|364725149|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
105746235|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
105746236|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
105746237|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
105746238|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
105746239|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
105746240|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
105746241|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
105746242|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
105746243|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
105746244|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
105746245|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
105746246|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
105746247|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
105746248|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
105746249|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
105746250|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
105746251|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746252|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746253|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746254|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
105746255|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746256|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
105746257|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
105746258|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
105746259|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746260|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746261|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105800947|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
106142390|NCT04493242|366179979|FG002|Overall Study|Withdrawal by Subject|0|||
106142391|NCT04493242|366179977|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
106142392|NCT04493242|366179978|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
106015716|NCT01263197|365723267|FG004|Washout Period 2|Protocol Violation|0|||
106015717|NCT01263197|365723268|FG005|Washout Period 2|Protocol Violation|0|||
106015718|NCT01263197|365723263|FG000|Third Intervention (Period 3)|Adverse Event|0|||
106015719|NCT01263197|365723264|FG001|Third Intervention (Period 3)|Adverse Event|1|||
106015720|NCT01263197|365723265|FG002|Third Intervention (Period 3)|Adverse Event|0|||
106015721|NCT01263197|365723266|FG003|Third Intervention (Period 3)|Adverse Event|0|||
106015722|NCT01263197|365723267|FG004|Third Intervention (Period 3)|Adverse Event|0|||
106015723|NCT01263197|365723268|FG005|Third Intervention (Period 3)|Adverse Event|0|||
106015724|NCT03967444|365723269|FG000|Overall Study|Lost to Follow-up|1|||
106015725|NCT03967444|365723270|FG001|Overall Study|Lost to Follow-up|2|||
106015726|NCT05197049|365723271|FG000|Overall Study|Death|0|||
106015727|NCT05197049|365723272|FG001|Overall Study|Death|1|||
106015728|NCT05197049|365723273|FG002|Overall Study|Death|0|||
106015729|NCT05197049|365723271|FG000|Overall Study|Lost to Follow-up|3|||
106015730|NCT05197049|365723272|FG001|Overall Study|Lost to Follow-up|1|||
106015731|NCT05197049|365723273|FG002|Overall Study|Lost to Follow-up|0|||
106015732|NCT05197049|365723271|FG000|Overall Study|Withdrawal by Subject|15|||
106015733|NCT05197049|365723272|FG001|Overall Study|Withdrawal by Subject|3|||
106015734|NCT05197049|365723273|FG002|Overall Study|Withdrawal by Subject|1|||
106015735|NCT05197049|365723271|FG000|Overall Study|GCP non-compliance|1|||
106015736|NCT05197049|365723272|FG001|Overall Study|GCP non-compliance|2|||
106015737|NCT05197049|365723273|FG002|Overall Study|GCP non-compliance|0|||
105746262|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746263|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746264|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746265|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
105746266|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
105746267|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746268|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746269|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746270|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746271|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746272|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
105746273|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746274|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
105746275|NCT03725202|364725142|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746276|NCT03725202|364725143|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746277|NCT03725202|364725144|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746278|NCT03725202|364725145|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
105746279|NCT03725202|364725146|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746280|NCT03725202|364725147|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
105746281|NCT03725202|364725148|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
105746282|NCT03725202|364725149|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
105746283|NCT01328249|364725150|FG000|Overall Study|Adverse Event|3|||
105746284|NCT01328249|364725151|FG001|Overall Study|Adverse Event|0|||
105746285|NCT01328249|364725150|FG000|Overall Study|Disease progression|1|||
105746286|NCT01328249|364725151|FG001|Overall Study|Disease progression|0|||
105746287|NCT01328249|364725150|FG000|Overall Study|Withdrawal by Subject|1|||
105746288|NCT01328249|364725151|FG001|Overall Study|Withdrawal by Subject|1|||
105746289|NCT01328249|364725150|FG000|Overall Study|Moved before end of treatment visit|1|||
105746290|NCT01328249|364725151|FG001|Overall Study|Moved before end of treatment visit|0|||
105746291|NCT01328249|364725150|FG000|Overall Study|Subject choice|1|||
105746292|NCT01328249|364725151|FG001|Overall Study|Subject choice|1|||
105746293|NCT01328249|364725150|FG000|Overall Study|Protocol Violation|0|||
105746294|NCT01328249|364725151|FG001|Overall Study|Protocol Violation|1|||
105746295|NCT01215734|364725152|FG000|Overall Study|Death|0|||
105746296|NCT01215734|364725153|FG001|Overall Study|Death|1|||
105746297|NCT02330549|364725158|FG000|Overall Study|Adverse Event|1|||
105746298|NCT02330549|364725159|FG001|Overall Study|Adverse Event|0|||
105746299|NCT02330549|364725158|FG000|Overall Study|Subject withdrew consent|2|||
105746300|NCT02330549|364725159|FG001|Overall Study|Subject withdrew consent|1|||
106015738|NCT01454102|365723274|FG000|Overall Study|Continuing in the treatment period|0|||
106015739|NCT01454102|365723275|FG001|Overall Study|Continuing in the treatment period|0|||
106015740|NCT01454102|365723276|FG002|Overall Study|Continuing in the treatment period|0|||
106015741|NCT01454102|365723277|FG003|Overall Study|Continuing in the treatment period|0|||
105746301|NCT02330549|364725158|FG000|Overall Study|Failure to meet randomization criteria|1|||
105746302|NCT02330549|364725159|FG001|Overall Study|Failure to meet randomization criteria|0|||
106015742|NCT01454102|365723278|FG004|Overall Study|Continuing in the treatment period|3|||
106015743|NCT01454102|365723279|FG005|Overall Study|Continuing in the treatment period|3|||
106015744|NCT01454102|365723280|FG006|Overall Study|Continuing in the treatment period|2|||
106015745|NCT01454102|365723281|FG007|Overall Study|Continuing in the treatment period|0|||
106015746|NCT01454102|365723282|FG008|Overall Study|Continuing in the treatment period|1|||
105943275|NCT02106832|365455017|FG002|Overall Study|Adverse Event|3|||
105943276|NCT02106832|365455018|FG003|Overall Study|Adverse Event|0|||
105943277|NCT02106832|365455015|FG000|Overall Study|Death|4|||
105943278|NCT02106832|365455016|FG001|Overall Study|Death|4|||
105943279|NCT02106832|365455017|FG002|Overall Study|Death|1|||
105943280|NCT02106832|365455018|FG003|Overall Study|Death|4|||
105943281|NCT02106832|365455015|FG000|Overall Study|Deterioration of general conditions|0|||
105943282|NCT02106832|365455016|FG001|Overall Study|Deterioration of general conditions|0|||
105943283|NCT02106832|365455017|FG002|Overall Study|Deterioration of general conditions|1|||
105943284|NCT02106832|365455018|FG003|Overall Study|Deterioration of general conditions|0|||
105943285|NCT02106832|365455015|FG000|Overall Study|Lost to Follow-up|0|||
105943286|NCT02106832|365455016|FG001|Overall Study|Lost to Follow-up|1|||
105943287|NCT02106832|365455017|FG002|Overall Study|Lost to Follow-up|1|||
105943288|NCT02106832|365455018|FG003|Overall Study|Lost to Follow-up|3|||
105943289|NCT02106832|365455015|FG000|Overall Study|Physician Decision|1|||
105943290|NCT02106832|365455016|FG001|Overall Study|Physician Decision|0|||
105943291|NCT02106832|365455017|FG002|Overall Study|Physician Decision|0|||
105943292|NCT02106832|365455018|FG003|Overall Study|Physician Decision|0|||
105943293|NCT02106832|365455015|FG000|Overall Study|Protocol Violation|0|||
105943294|NCT02106832|365455016|FG001|Overall Study|Protocol Violation|0|||
105943295|NCT02106832|365455017|FG002|Overall Study|Protocol Violation|0|||
105943296|NCT02106832|365455018|FG003|Overall Study|Protocol Violation|1|||
105943297|NCT02106832|365455015|FG000|Overall Study|Withdrawal by Subject|17|||
105943298|NCT02106832|365455016|FG001|Overall Study|Withdrawal by Subject|17|||
105943299|NCT02106832|365455017|FG002|Overall Study|Withdrawal by Subject|10|||
105943300|NCT02106832|365455018|FG003|Overall Study|Withdrawal by Subject|7|||
105943301|NCT02106832|365455015|FG000|Overall Study|Technical problems|0|||
105943302|NCT02106832|365455016|FG001|Overall Study|Technical problems|1|||
105943303|NCT02106832|365455017|FG002|Overall Study|Technical problems|0|||
105943304|NCT02106832|365455018|FG003|Overall Study|Technical problems|0|||
105943305|NCT03485157|365455019|FG000|Double Blind Phase|Lost to Follow-up|4|||
105943306|NCT03485157|365455020|FG001|Double Blind Phase|Lost to Follow-up|4|||
105943307|NCT03485157|365455019|FG000|Double Blind Phase|Adverse Event|2|||
105943308|NCT03485157|365455020|FG001|Double Blind Phase|Adverse Event|1|||
105943309|NCT03485157|365455019|FG000|Double Blind Phase|Withdrawal by Subject|6|||
105943310|NCT03485157|365455020|FG001|Double Blind Phase|Withdrawal by Subject|9|||
105943311|NCT03485157|365455019|FG000|Double Blind Phase|Removal by PI|3|||
105943312|NCT03485157|365455020|FG001|Double Blind Phase|Removal by PI|7|||
105943313|NCT03485157|365455019|FG000|Open Label Phase|Lost to Follow-up|1|||
105746303|NCT00495495|364725163|FG000|Overall Study|Protocol Violation|99|||
105746304|NCT00745368|364725164|FG000|Overall Study|Unable to provide sample|3|||
105746305|NCT02163993|364725168|FG000|Treatment Period|Adverse Event|0|||
105746306|NCT02163993|364725169|FG001|Treatment Period|Adverse Event|1|||
105746307|NCT02163993|364725170|FG002|Treatment Period|Adverse Event|0|||
105746308|NCT02163993|364725171|FG003|Treatment Period|Adverse Event|0|||
105746309|NCT02163993|364725172|FG004|Treatment Period|Adverse Event|1|||
105746310|NCT02163993|364725168|FG000|Treatment Period|Lost to Follow-up|2|||
105746311|NCT02163993|364725169|FG001|Treatment Period|Lost to Follow-up|3|||
105746312|NCT02163993|364725170|FG002|Treatment Period|Lost to Follow-up|1|||
105746313|NCT02163993|364725171|FG003|Treatment Period|Lost to Follow-up|3|||
105746314|NCT02163993|364725172|FG004|Treatment Period|Lost to Follow-up|1|||
105746315|NCT02163993|364725168|FG000|Treatment Period|Physician Decision|1|||
105746316|NCT02163993|364725169|FG001|Treatment Period|Physician Decision|0|||
105746317|NCT02163993|364725170|FG002|Treatment Period|Physician Decision|0|||
105746318|NCT02163993|364725171|FG003|Treatment Period|Physician Decision|0|||
105746319|NCT02163993|364725172|FG004|Treatment Period|Physician Decision|0|||
105746320|NCT02163993|364725168|FG000|Treatment Period|Protocol Violation|2|||
105746321|NCT02163993|364725169|FG001|Treatment Period|Protocol Violation|1|||
105746322|NCT02163993|364725170|FG002|Treatment Period|Protocol Violation|0|||
105746323|NCT02163993|364725171|FG003|Treatment Period|Protocol Violation|1|||
105746324|NCT02163993|364725172|FG004|Treatment Period|Protocol Violation|2|||
105746325|NCT02163993|364725168|FG000|Treatment Period|Withdrawal by Subject|6|||
105746326|NCT02163993|364725169|FG001|Treatment Period|Withdrawal by Subject|4|||
105746327|NCT02163993|364725170|FG002|Treatment Period|Withdrawal by Subject|1|||
105746328|NCT02163993|364725171|FG003|Treatment Period|Withdrawal by Subject|4|||
105746329|NCT02163993|364725172|FG004|Treatment Period|Withdrawal by Subject|1|||
105746330|NCT02163993|364725168|FG000|Treatment Period|Not treated|1|||
105746331|NCT02163993|364725169|FG001|Treatment Period|Not treated|0|||
105746332|NCT02163993|364725170|FG002|Treatment Period|Not treated|0|||
105746333|NCT02163993|364725171|FG003|Treatment Period|Not treated|1|||
105746334|NCT02163993|364725172|FG004|Treatment Period|Not treated|2|||
105746335|NCT02163993|364725168|FG000|Post-treatment Period|Adverse Event|0|||
105746336|NCT02163993|364725169|FG001|Post-treatment Period|Adverse Event|0|||
105746337|NCT02163993|364725170|FG002|Post-treatment Period|Adverse Event|1|||
105943314|NCT03485157|365455020|FG001|Open Label Phase|Lost to Follow-up|2|||
106015747|NCT01454102|365723283|FG009|Overall Study|Continuing in the treatment period|0|||
105943315|NCT03485157|365455019|FG000|Open Label Phase|Adverse Event|0|||
105943316|NCT03485157|365455020|FG001|Open Label Phase|Adverse Event|1|||
105746338|NCT02163993|364725171|FG003|Post-treatment Period|Adverse Event|0|||
105746339|NCT02163993|364725172|FG004|Post-treatment Period|Adverse Event|0|||
105746340|NCT02163993|364725168|FG000|Post-treatment Period|Lost to Follow-up|2|||
105746341|NCT02163993|364725169|FG001|Post-treatment Period|Lost to Follow-up|2|||
105746342|NCT02163993|364725170|FG002|Post-treatment Period|Lost to Follow-up|3|||
105746343|NCT02163993|364725171|FG003|Post-treatment Period|Lost to Follow-up|1|||
105746344|NCT02163993|364725172|FG004|Post-treatment Period|Lost to Follow-up|0|||
105746345|NCT02163993|364725168|FG000|Post-treatment Period|Protocol Violation|0|||
105746346|NCT02163993|364725169|FG001|Post-treatment Period|Protocol Violation|0|||
105746347|NCT02163993|364725170|FG002|Post-treatment Period|Protocol Violation|0|||
105746348|NCT02163993|364725171|FG003|Post-treatment Period|Protocol Violation|0|||
105746349|NCT02163993|364725172|FG004|Post-treatment Period|Protocol Violation|1|||
105746350|NCT02163993|364725168|FG000|Post-treatment Period|Withdrawal by Subject|2|||
105746351|NCT02163993|364725169|FG001|Post-treatment Period|Withdrawal by Subject|4|||
105746352|NCT02163993|364725170|FG002|Post-treatment Period|Withdrawal by Subject|0|||
105746353|NCT02163993|364725171|FG003|Post-treatment Period|Withdrawal by Subject|1|||
105746354|NCT02163993|364725172|FG004|Post-treatment Period|Withdrawal by Subject|2|||
105746355|NCT00853489|364725173|FG000|Overall Study|Lost to Follow-up|5|||
105746356|NCT00853489|364725174|FG001|Overall Study|Lost to Follow-up|2|||
105746357|NCT00434512|364725175|FG000|Overall Study|Migrated/moved from study area|0|||
105746358|NCT00434512|364725176|FG001|Overall Study|Migrated/moved from study area|0|||
105746359|NCT00434512|364725177|FG002|Overall Study|Migrated/moved from study area|0|||
105746360|NCT00434512|364725178|FG003|Overall Study|Migrated/moved from study area|1|||
105746361|NCT00434512|364725179|FG004|Overall Study|Migrated/moved from study area|1|||
105746362|NCT00434512|364725180|FG005|Overall Study|Migrated/moved from study area|1|||
105746363|NCT00434512|364725175|FG000|Overall Study|Other|0|||
105746364|NCT00434512|364725176|FG001|Overall Study|Other|1|||
105746365|NCT00434512|364725177|FG002|Overall Study|Other|0|||
105746366|NCT00434512|364725178|FG003|Overall Study|Other|0|||
105746367|NCT00434512|364725179|FG004|Overall Study|Other|0|||
105746368|NCT00434512|364725180|FG005|Overall Study|Other|0|||
105746369|NCT02006667|364725181|FG000|Overall Study|Adverse Event|3|||
105746370|NCT02006667|364725181|FG000|Overall Study|Death|2|||
105746371|NCT02006667|364725181|FG000|Overall Study|Withdrawal by Subject|1|||
105746372|NCT00782418|364725184|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
105746373|NCT00782418|364725185|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746374|NCT00782418|364725186|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746375|NCT00782418|364725187|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746376|NCT00782418|364725188|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746377|NCT00782418|364725189|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746378|NCT00782418|364725190|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
105746379|NCT00782418|364725184|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
105746380|NCT00782418|364725185|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
105746381|NCT00782418|364725186|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
105746382|NCT00782418|364725187|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
105746383|NCT00782418|364725188|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
105943317|NCT03485157|365455019|FG000|Open Label Phase|Withdrawal by Subject|1|||
105943318|NCT03485157|365455020|FG001|Open Label Phase|Withdrawal by Subject|2|||
105943319|NCT03485157|365455019|FG000|Open Label Phase|Removal by PI|2|||
105943320|NCT03485157|365455020|FG001|Open Label Phase|Removal by PI|0|||
105943321|NCT02302222|365455032|FG000|Overall Study|Physician Decision|0|||
105943322|NCT02302222|365455033|FG001|Overall Study|Physician Decision|4|||
105943323|NCT02302222|365455032|FG000|Overall Study|Lost to Follow-up|1|||
105943324|NCT02302222|365455033|FG001|Overall Study|Lost to Follow-up|0|||
105943325|NCT02302222|365455032|FG000|Overall Study|Treatment discontinued before day 5|0|||
105943326|NCT02302222|365455033|FG001|Overall Study|Treatment discontinued before day 5|1|||
105943327|NCT02302222|365455032|FG000|Overall Study|Withdrawn prior to any treatment|0|||
105943328|NCT02302222|365455033|FG001|Overall Study|Withdrawn prior to any treatment|1|||
105943329|NCT03559556|365455036|FG000|Overall Study|Withdrawal by Subject|1|||
105943330|NCT03110562|365455037|FG000|Initial Treatment Period|Disease Progression|1|||
105943331|NCT03110562|365455038|FG001|Initial Treatment Period|Disease Progression|1|||
105943332|NCT03110562|365455039|FG002|Initial Treatment Period|Disease Progression|0|||
105943333|NCT03110562|365455040|FG003|Initial Treatment Period|Disease Progression|0|||
105943334|NCT03110562|365455037|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
105943335|NCT03110562|365455038|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
106142393|NCT04493242|366179979|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
106142394|NCT04493242|366179977|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
106142395|NCT04493242|366179978|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
106142396|NCT04493242|366179979|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
105746384|NCT00782418|364725189|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
106142397|NCT04722003|366181838|FG000|Overall Study|Lost to Follow-up|2|||
105943336|NCT03110562|365455039|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
106015748|NCT01454102|365723284|FG010|Overall Study|Continuing in the treatment period|0|||
106015749|NCT01454102|365723285|FG011|Overall Study|Continuing in the treatment period|4|||
106015750|NCT01454102|365723286|FG012|Overall Study|Continuing in the treatment period|7|||
106015751|NCT01454102|365723287|FG013|Overall Study|Continuing in the treatment period|4|||
106015752|NCT01454102|365723288|FG014|Overall Study|Continuing in the treatment period|3|||
106015753|NCT01454102|365723289|FG015|Overall Study|Continuing in the treatment period|1|||
106015754|NCT03739203|365723293|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
106015755|NCT03739203|365723294|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
106015756|NCT03739203|365723295|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
106015757|NCT03739203|365723293|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
106015758|NCT03739203|365723294|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
106015759|NCT03739203|365723295|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
106015760|NCT03739203|365723293|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
106015761|NCT03739203|365723294|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
106015762|NCT03739203|365723295|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
106015763|NCT03739203|365723293|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
106015764|NCT03739203|365723294|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
106015765|NCT03739203|365723295|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
106015766|NCT03739203|365723293|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
106015767|NCT03739203|365723294|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
106015768|NCT03739203|365723295|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
106015769|NCT03739203|365723293|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
106015770|NCT03739203|365723294|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
106015771|NCT03739203|365723295|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
106015772|NCT03739203|365723293|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
106015773|NCT03739203|365723294|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
106015774|NCT03739203|365723295|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
106015775|NCT03739203|365723293|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
105746385|NCT00782418|364725190|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
105746386|NCT03298412|364725191|FG000|Run-in Period|Other, Not Specified|1|||
105746387|NCT03298412|364725191|FG000|Run-in Period|Disease Progression|1|||
105746388|NCT03298412|364725191|FG000|Run-in Period|Ineligibility Determined|1|||
105746389|NCT03298412|364725191|FG000|Run-in Period|Decision by Sponsor|6|||
105746390|NCT01104584|364725194|FG000|Overall Study|Study drug never administered|21|||
105746391|NCT01104584|364725194|FG000|Overall Study|Study prematurely discontinued|2|||
105746392|NCT02345252|364725207|FG000|Double-Blind Phase|Adverse Event|2|||
105746393|NCT02345252|364725208|FG001|Double-Blind Phase|Adverse Event|3|||
105746394|NCT02345252|364725207|FG000|Double-Blind Phase|Death|1|||
105746395|NCT02345252|364725208|FG001|Double-Blind Phase|Death|2|||
105746396|NCT02345252|364725207|FG000|Double-Blind Phase|Lack of Efficacy|1|||
105746397|NCT02345252|364725208|FG001|Double-Blind Phase|Lack of Efficacy|0|||
105746398|NCT02345252|364725207|FG000|Double-Blind Phase|Investigator's Discretion|4|||
105746399|NCT02345252|364725208|FG001|Double-Blind Phase|Investigator's Discretion|6|||
105746400|NCT02345252|364725207|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
105746401|NCT02345252|364725208|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
105746402|NCT02345252|364725207|FG000|Double-Blind Phase|Protocol Violation|2|||
105746403|NCT02345252|364725208|FG001|Double-Blind Phase|Protocol Violation|1|||
105746404|NCT02345252|364725207|FG000|Double-Blind Phase|Withdrew Consent|21|||
105746405|NCT02345252|364725208|FG001|Double-Blind Phase|Withdrew Consent|23|||
105746406|NCT02345252|364725207|FG000|Double-Blind Phase|Lost to Follow-up|8|||
105746407|NCT02345252|364725208|FG001|Double-Blind Phase|Lost to Follow-up|10|||
105746408|NCT02345252|364725207|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
105746409|NCT02345252|364725208|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
105746410|NCT00436566|364725209|FG000|Overall Study|Withdrawal by Subject|2|||
105746411|NCT00436566|364725209|FG000|Overall Study|Protocol Violation|1|||
105746412|NCT01934894|364725210|FG000|Overall Study|Adverse Event|1|||
105746413|NCT01934894|364725211|FG001|Overall Study|Adverse Event|2|||
105746414|NCT01934894|364725210|FG000|Overall Study|Death|2|||
105746415|NCT01934894|364725211|FG001|Overall Study|Death|0|||
105746416|NCT01934894|364725210|FG000|Overall Study|Withdrawal by Subject|0|||
105746417|NCT01934894|364725211|FG001|Overall Study|Withdrawal by Subject|1|||
105746418|NCT01934894|364725210|FG000|Overall Study|Progressive Disease|3|||
105746419|NCT01934894|364725211|FG001|Overall Study|Progressive Disease|2|||
105746420|NCT01689207|364725212|FG000|Overall Study|Adverse Event|0|||
105746421|NCT01689207|364725213|FG001|Overall Study|Adverse Event|1|||
105746422|NCT01689207|364725214|FG002|Overall Study|Adverse Event|0|||
105746423|NCT01689207|364725215|FG003|Overall Study|Adverse Event|0|||
105746424|NCT01689207|364725216|FG004|Overall Study|Adverse Event|2|||
105746425|NCT01689207|364725217|FG005|Overall Study|Adverse Event|1|||
105746426|NCT01689207|364725218|FG006|Overall Study|Adverse Event|0|||
105746427|NCT01689207|364725219|FG007|Overall Study|Adverse Event|0|||
106015776|NCT03739203|365723294|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
106015777|NCT03739203|365723295|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
106015778|NCT03739203|365723293|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
106015779|NCT03739203|365723294|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
106015780|NCT03739203|365723295|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
106015781|NCT03739203|365723293|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
106015782|NCT03739203|365723294|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
106015783|NCT03739203|365723295|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
106015784|NCT03739203|365723293|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
106015785|NCT03739203|365723294|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
106015786|NCT03739203|365723295|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
106015787|NCT00830440|365723298|FG000|Overall Study|Protocol Violation|1|||
106015788|NCT00830440|365723299|FG001|Overall Study|Protocol Violation|0|||
106015789|NCT00830440|365723298|FG000|Overall Study|Withdrawal by Subject|1|||
106142398|NCT04722003|366181839|FG001|Overall Study|Lost to Follow-up|0|||
106142399|NCT04722003|366181838|FG000|Overall Study|Physician Decision|1|||
106142400|NCT04722003|366181839|FG001|Overall Study|Physician Decision|0|||
106142401|NCT00364286|366181840|FG000|Overall Study|Withdrawal by Subject|1|||
106142402|NCT00364286|366181840|FG000|Overall Study|Adverse Event|2|||
106142403|NCT00768664|366181842|FG000|Overall Study|Death|57|||
106142404|NCT00768664|366181842|FG000|Overall Study|Lost to Follow-up|2|||
106142405|NCT00768664|366181842|FG000|Overall Study|Other|9|||
106142406|NCT00768664|366181842|FG000|Overall Study|Participant refused|1|||
106142407|NCT01400776|366181843|FG000|Overall Study|Adverse Event|7|||
105800948|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
105800949|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
105800950|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
105800951|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
105800952|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
105800953|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
106142408|NCT01400776|366181844|FG001|Overall Study|Adverse Event|2|||
105800954|NCT00528879|364928578|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
105800955|NCT00528879|364928579|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
105800956|NCT00528879|364928580|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
105800957|NCT00528879|364928581|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
105800958|NCT04130919|364928587|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
105800959|NCT04130919|364928588|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
105800960|NCT04130919|364928589|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
105800961|NCT04130919|364928590|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
105800962|NCT04130919|364928591|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
105800963|NCT04130919|364928592|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
105800964|NCT04130919|364928587|FG000|Blinded Treatment Phase|Adverse Event|0|||
105800965|NCT04130919|364928588|FG001|Blinded Treatment Phase|Adverse Event|0|||
105800966|NCT04130919|364928589|FG002|Blinded Treatment Phase|Adverse Event|1|||
105800967|NCT04130919|364928590|FG003|Blinded Treatment Phase|Adverse Event|0|||
105800968|NCT04130919|364928591|FG004|Blinded Treatment Phase|Adverse Event|0|||
105800969|NCT04130919|364928592|FG005|Blinded Treatment Phase|Adverse Event|0|||
105800970|NCT04130919|364928587|FG000|Blinded Treatment Phase|Disease worsening|0|||
106142409|NCT01400776|366181845|FG002|Overall Study|Adverse Event|9|||
106142410|NCT01400776|366181846|FG003|Overall Study|Adverse Event|2|||
106142411|NCT01400776|366181843|FG000|Overall Study|Lost to Follow-up|1|||
106142412|NCT01400776|366181844|FG001|Overall Study|Lost to Follow-up|0|||
105800971|NCT04130919|364928588|FG001|Blinded Treatment Phase|Disease worsening|0|||
105800972|NCT04130919|364928589|FG002|Blinded Treatment Phase|Disease worsening|1|||
106015790|NCT00830440|365723299|FG001|Overall Study|Withdrawal by Subject|0|||
106142413|NCT01400776|366181845|FG002|Overall Study|Lost to Follow-up|4|||
106142414|NCT01400776|366181846|FG003|Overall Study|Lost to Follow-up|1|||
106142415|NCT01400776|366181843|FG000|Overall Study|Withdrew Consent|4|||
106142416|NCT01400776|366181844|FG001|Overall Study|Withdrew Consent|2|||
106142417|NCT01400776|366181845|FG002|Overall Study|Withdrew Consent|6|||
105800973|NCT04130919|364928590|FG003|Blinded Treatment Phase|Disease worsening|0|||
105800974|NCT04130919|364928591|FG004|Blinded Treatment Phase|Disease worsening|0|||
105800975|NCT04130919|364928592|FG005|Blinded Treatment Phase|Disease worsening|0|||
106142418|NCT01400776|366181846|FG003|Overall Study|Withdrew Consent|1|||
106142419|NCT01400776|366181843|FG000|Overall Study|Protocol Deviation|6|||
106142420|NCT01400776|366181844|FG001|Overall Study|Protocol Deviation|1|||
105800976|NCT04130919|364928587|FG000|Blinded Treatment Phase|Investigator's decision|0|||
105800977|NCT04130919|364928588|FG001|Blinded Treatment Phase|Investigator's decision|1|||
106015791|NCT00830440|365723298|FG000|Overall Study|unsuccessful procedure|4|||
106015792|NCT00830440|365723299|FG001|Overall Study|unsuccessful procedure|0|||
106142421|NCT01400776|366181845|FG002|Overall Study|Protocol Deviation|5|||
106142422|NCT01400776|366181846|FG003|Overall Study|Protocol Deviation|2|||
106142423|NCT01400776|366181843|FG000|Overall Study|Reason not Specified|3|||
106015793|NCT00830440|365723298|FG000|Overall Study|Adverse Event|2|||
106015794|NCT00830440|365723299|FG001|Overall Study|Adverse Event|0|||
106015795|NCT02592798|365723300|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
106015796|NCT02592798|365723301|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
106015797|NCT02592798|365723300|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
106015798|NCT02592798|365723301|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
106015799|NCT02592798|365723300|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
106015800|NCT02592798|365723301|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
106015801|NCT02592798|365723300|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
106015802|NCT02592798|365723301|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
106015803|NCT02592798|365723300|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
105746428|NCT01689207|364725220|FG008|Overall Study|Adverse Event|1|||
105746429|NCT01689207|364725221|FG009|Overall Study|Adverse Event|0|||
105746430|NCT01689207|364725222|FG010|Overall Study|Adverse Event|0|||
105746431|NCT00303108|364725225|FG000|Overall Study|Adverse Event|5|||
105746432|NCT00303108|364725226|FG001|Overall Study|Adverse Event|6|||
105746433|NCT00303108|364725227|FG002|Overall Study|Adverse Event|7|||
105746434|NCT00303108|364725225|FG000|Overall Study|Patient Request|4|||
105746435|NCT00303108|364725226|FG001|Overall Study|Patient Request|2|||
105746436|NCT00303108|364725227|FG002|Overall Study|Patient Request|8|||
105746437|NCT00303108|364725225|FG000|Overall Study|Failed Entry|1|||
105746438|NCT00303108|364725226|FG001|Overall Study|Failed Entry|0|||
105746439|NCT00303108|364725227|FG002|Overall Study|Failed Entry|1|||
105746440|NCT00303108|364725225|FG000|Overall Study|ineligible|2|||
105746441|NCT00303108|364725226|FG001|Overall Study|ineligible|1|||
105746442|NCT00303108|364725227|FG002|Overall Study|ineligible|0|||
105746443|NCT01655823|364725230|FG000|Overall Study|Lost to Follow-up|0|||
105746444|NCT01655823|364725231|FG001|Overall Study|Lost to Follow-up|1|||
105746445|NCT01655823|364725232|FG002|Overall Study|Lost to Follow-up|0|||
105746446|NCT01655823|364725233|FG003|Overall Study|Lost to Follow-up|0|||
105746447|NCT01655823|364725234|FG004|Overall Study|Lost to Follow-up|1|||
105746448|NCT01655823|364725230|FG000|Overall Study|Withdrawal by Subject|0|||
105746449|NCT01655823|364725231|FG001|Overall Study|Withdrawal by Subject|1|||
105746450|NCT01655823|364725232|FG002|Overall Study|Withdrawal by Subject|0|||
105746451|NCT01655823|364725233|FG003|Overall Study|Withdrawal by Subject|1|||
105746452|NCT01655823|364725234|FG004|Overall Study|Withdrawal by Subject|0|||
105746453|NCT00894413|364725235|FG000|Overall Study|Physician Decision|0|||
105746454|NCT00894413|364725236|FG001|Overall Study|Physician Decision|2|||
105746455|NCT00894413|364725235|FG000|Overall Study|Adverse Event|0|||
105746456|NCT00894413|364725236|FG001|Overall Study|Adverse Event|2|||
105746457|NCT00894413|364725235|FG000|Overall Study|Withdrawal by Subject|0|||
105746458|NCT00894413|364725236|FG001|Overall Study|Withdrawal by Subject|4|||
105746459|NCT03126539|364725244|FG000|Overall Study|Lost to Follow-up|1|||
105746460|NCT03126539|364725245|FG001|Overall Study|Lost to Follow-up|1|||
105746461|NCT03126539|364725246|FG002|Overall Study|Lost to Follow-up|1|||
105746462|NCT03126539|364725247|FG003|Overall Study|Lost to Follow-up|0|||
105746463|NCT03126539|364725248|FG004|Overall Study|Lost to Follow-up|0|||
105746464|NCT02632110|364725249|FG000|Overall Study|Withdrawal by Subject|1|||
105746465|NCT02632110|364725250|FG001|Overall Study|Withdrawal by Subject|1|||
105746466|NCT02632110|364725251|FG002|Overall Study|Withdrawal by Subject|0|||
105746467|NCT02632110|364725252|FG003|Overall Study|Withdrawal by Subject|0|||
105746468|NCT02632110|364725253|FG004|Overall Study|Withdrawal by Subject|1|||
105746469|NCT02632110|364725254|FG005|Overall Study|Withdrawal by Subject|1|||
105746470|NCT02632110|364725255|FG006|Overall Study|Withdrawal by Subject|3|||
105746471|NCT02632110|364725256|FG007|Overall Study|Withdrawal by Subject|3|||
105746472|NCT02632110|364725257|FG008|Overall Study|Withdrawal by Subject|1|||
105746473|NCT02632110|364725258|FG009|Overall Study|Withdrawal by Subject|1|||
105746474|NCT00008138|364725259|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
105746475|NCT00008138|364725259|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
105746476|NCT00008138|364725259|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
105746477|NCT00008138|364725259|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
105746478|NCT00008138|364725259|FG000|Interval Debulking|Withdrawal by Subject|2|||
105746479|NCT00008138|364725259|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
105746480|NCT00008138|364725259|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
105746481|NCT00008138|364725259|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
105746482|NCT00516269|364725260|FG000|Overall Study|Adverse Event|2|||
105746483|NCT00516269|364725261|FG001|Overall Study|Adverse Event|1|||
105746484|NCT00516269|364725260|FG000|Overall Study|Lost to Follow-up|0|||
105746485|NCT00516269|364725261|FG001|Overall Study|Lost to Follow-up|1|||
105746486|NCT00516269|364725260|FG000|Overall Study|Protocol Violation|0|||
105746487|NCT00516269|364725261|FG001|Overall Study|Protocol Violation|1|||
105746488|NCT03213626|364725262|FG000|Overall Study|Adverse Event|1|||
105746489|NCT03213626|364725262|FG000|Overall Study|Progressive Disease|6|||
105746490|NCT00905021|364725263|FG000|Overall Study|Adverse Event|2|||
105746491|NCT02635737|364725264|FG000|Overall Study|Protocol Violation|1|||
105800978|NCT04130919|364928589|FG002|Blinded Treatment Phase|Investigator's decision|0|||
105800979|NCT04130919|364928590|FG003|Blinded Treatment Phase|Investigator's decision|0|||
105800980|NCT04130919|364928591|FG004|Blinded Treatment Phase|Investigator's decision|0|||
105800981|NCT04130919|364928592|FG005|Blinded Treatment Phase|Investigator's decision|0|||
105800982|NCT04130919|364928587|FG000|Blinded Treatment Phase|Withdrew consent|1|||
105800983|NCT04130919|364928588|FG001|Blinded Treatment Phase|Withdrew consent|0|||
105800984|NCT04130919|364928589|FG002|Blinded Treatment Phase|Withdrew consent|0|||
105800985|NCT04130919|364928590|FG003|Blinded Treatment Phase|Withdrew consent|0|||
105800986|NCT04130919|364928591|FG004|Blinded Treatment Phase|Withdrew consent|0|||
105800987|NCT04130919|364928592|FG005|Blinded Treatment Phase|Withdrew consent|0|||
105800988|NCT04130919|364928587|FG000|Open-label Treatment Phase|Withdrew consent|0|||
105800989|NCT04130919|364928588|FG001|Open-label Treatment Phase|Withdrew consent|0|||
105800990|NCT04130919|364928589|FG002|Open-label Treatment Phase|Withdrew consent|0|||
105800991|NCT04130919|364928590|FG003|Open-label Treatment Phase|Withdrew consent|1|||
105800992|NCT04130919|364928591|FG004|Open-label Treatment Phase|Withdrew consent|1|||
105800993|NCT04130919|364928592|FG005|Open-label Treatment Phase|Withdrew consent|1|||
105800994|NCT04130919|364928587|FG000|Open-label Treatment Phase|Disease worsening|0|||
105800995|NCT04130919|364928588|FG001|Open-label Treatment Phase|Disease worsening|0|||
105800996|NCT04130919|364928589|FG002|Open-label Treatment Phase|Disease worsening|0|||
105800997|NCT04130919|364928590|FG003|Open-label Treatment Phase|Disease worsening|1|||
105800998|NCT04130919|364928591|FG004|Open-label Treatment Phase|Disease worsening|0|||
105800999|NCT04130919|364928592|FG005|Open-label Treatment Phase|Disease worsening|1|||
105801000|NCT04130919|364928587|FG000|Open-label Treatment Phase|Investigator's decision|0|||
105801001|NCT04130919|364928588|FG001|Open-label Treatment Phase|Investigator's decision|0|||
105801002|NCT04130919|364928589|FG002|Open-label Treatment Phase|Investigator's decision|0|||
105801003|NCT04130919|364928590|FG003|Open-label Treatment Phase|Investigator's decision|1|||
105801004|NCT04130919|364928591|FG004|Open-label Treatment Phase|Investigator's decision|0|||
105801005|NCT04130919|364928592|FG005|Open-label Treatment Phase|Investigator's decision|0|||
105801006|NCT04130919|364928587|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
105801007|NCT04130919|364928588|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
105801008|NCT04130919|364928589|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
105801009|NCT04130919|364928590|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
105801010|NCT04130919|364928591|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
105801011|NCT04130919|364928592|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
105801012|NCT04130919|364928587|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105801013|NCT04130919|364928588|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105801014|NCT04130919|364928589|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105801015|NCT04130919|364928590|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105801016|NCT04130919|364928591|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
105801017|NCT04130919|364928592|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
105943337|NCT03110562|365455040|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
105943338|NCT03110562|365455037|FG000|Initial Treatment Period|Adverse Event|1|||
105943339|NCT03110562|365455038|FG001|Initial Treatment Period|Adverse Event|0|||
105943340|NCT03110562|365455039|FG002|Initial Treatment Period|Adverse Event|0|||
105943341|NCT03110562|365455040|FG003|Initial Treatment Period|Adverse Event|0|||
105943342|NCT03110562|365455037|FG000|Initial Treatment Period|Death|74|||
105943343|NCT03110562|365455038|FG001|Initial Treatment Period|Death|82|||
105943344|NCT03110562|365455039|FG002|Initial Treatment Period|Death|0|||
105943345|NCT03110562|365455040|FG003|Initial Treatment Period|Death|0|||
105943346|NCT03110562|365455037|FG000|Initial Treatment Period|Lost to Follow-up|13|||
105943347|NCT03110562|365455038|FG001|Initial Treatment Period|Lost to Follow-up|8|||
105943348|NCT03110562|365455039|FG002|Initial Treatment Period|Lost to Follow-up|0|||
105943349|NCT03110562|365455040|FG003|Initial Treatment Period|Lost to Follow-up|0|||
105943350|NCT03110562|365455037|FG000|Initial Treatment Period|Protocol Deviation|1|||
105943351|NCT03110562|365455038|FG001|Initial Treatment Period|Protocol Deviation|0|||
105943352|NCT03110562|365455039|FG002|Initial Treatment Period|Protocol Deviation|0|||
105943353|NCT03110562|365455040|FG003|Initial Treatment Period|Protocol Deviation|0|||
105943354|NCT03110562|365455037|FG000|Initial Treatment Period|Physician Decision|2|||
105943355|NCT03110562|365455038|FG001|Initial Treatment Period|Physician Decision|1|||
105746492|NCT01511419|364725265|FG000|Dose 2|Physician Decision|1|||
105746493|NCT01511419|364725266|FG001|Dose 2|Physician Decision|0|||
105746494|NCT04570657|364725267|FG000|Overall Study|Adverse Event|0|||
105746495|NCT04570657|364725268|FG001|Overall Study|Adverse Event|0|||
105746496|NCT04570657|364725269|FG002|Overall Study|Adverse Event|1|||
105746497|NCT04570657|364725267|FG000|Overall Study|Lost to Follow-up|0|||
105746498|NCT04570657|364725268|FG001|Overall Study|Lost to Follow-up|0|||
105746499|NCT04570657|364725269|FG002|Overall Study|Lost to Follow-up|1|||
105746500|NCT04570657|364725267|FG000|Overall Study|Physician Decision|0|||
105746501|NCT04570657|364725268|FG001|Overall Study|Physician Decision|1|||
105746502|NCT04570657|364725269|FG002|Overall Study|Physician Decision|0|||
105746503|NCT04570657|364725267|FG000|Overall Study|Withdrawal by Subject|1|||
105943356|NCT03110562|365455039|FG002|Initial Treatment Period|Physician Decision|0|||
105943357|NCT03110562|365455040|FG003|Initial Treatment Period|Physician Decision|0|||
105943358|NCT03110562|365455037|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
105943359|NCT03110562|365455038|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
105943360|NCT03110562|365455039|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
105943361|NCT03110562|365455040|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
105943362|NCT03110562|365455037|FG000|Initial Treatment Period|Other|5|||
105746504|NCT04570657|364725268|FG001|Overall Study|Withdrawal by Subject|2|||
105746505|NCT04570657|364725269|FG002|Overall Study|Withdrawal by Subject|2|||
105746506|NCT01752842|364725276|FG000|Overall Study|Adverse Event|3|||
105746507|NCT01752842|364725277|FG001|Overall Study|Adverse Event|0|||
105746508|NCT01752842|364725276|FG000|Overall Study|Withdrawal by Subject|0|||
105746509|NCT01752842|364725277|FG001|Overall Study|Withdrawal by Subject|2|||
105746510|NCT00488618|364725278|FG000|Overall Study|Adverse Event|13|||
105746511|NCT00488618|364725279|FG001|Overall Study|Adverse Event|17|||
105746512|NCT00488618|364725278|FG000|Overall Study|Insufficient Therapeutic Response|18|||
105746513|NCT00488618|364725279|FG001|Overall Study|Insufficient Therapeutic Response|11|||
105746514|NCT00488618|364725278|FG000|Overall Study|Protocol Violation|0|||
105746515|NCT00488618|364725279|FG001|Overall Study|Protocol Violation|2|||
105746516|NCT00488618|364725278|FG000|Overall Study|Withdrawal of Consent|15|||
105746517|NCT00488618|364725279|FG001|Overall Study|Withdrawal of Consent|13|||
105746518|NCT00488618|364725278|FG000|Overall Study|Lost to Follow-up|1|||
105746519|NCT00488618|364725279|FG001|Overall Study|Lost to Follow-up|0|||
105746520|NCT00506948|364726867|FG000|Overall Study|Death|4|||
105746521|NCT00506948|364726867|FG000|Overall Study|Adverse Event|5|||
105746522|NCT00506948|364726867|FG000|Overall Study|Physician Decision|1|||
105746523|NCT03364335|364726868|FG000|Overall Study|Adverse Event|3|||
105746524|NCT03364335|364726869|FG001|Overall Study|Adverse Event|4|||
105746525|NCT03364335|364726870|FG002|Overall Study|Adverse Event|1|||
105746526|NCT03364335|364726871|FG003|Overall Study|Adverse Event|2|||
105746527|NCT03364335|364726872|FG004|Overall Study|Adverse Event|0|||
105746528|NCT03364335|364726868|FG000|Overall Study|Lost to Follow-up|7|||
105746529|NCT03364335|364726869|FG001|Overall Study|Lost to Follow-up|7|||
105746530|NCT03364335|364726870|FG002|Overall Study|Lost to Follow-up|10|||
105746531|NCT03364335|364726871|FG003|Overall Study|Lost to Follow-up|11|||
105746532|NCT03364335|364726872|FG004|Overall Study|Lost to Follow-up|11|||
105746533|NCT01194804|364726873|FG000|Overall Study|Withdrawal by Subject|1|||
105746534|NCT01303380|364726874|FG000|Overall Study|Lack of compliance to study procedures|1|||
105746535|NCT02326467|364726877|FG000|Overall Study|Withdrawal by Subject|1|||
105746536|NCT02709083|364726886|FG000|Overall Study|Original PI left institution|7|||
105746537|NCT00111475|364726887|FG000|Overall Study|Lost to Follow-up|0|||
105746538|NCT00111475|364726888|FG001|Overall Study|Lost to Follow-up|0|||
105746539|NCT00111475|364726889|FG002|Overall Study|Lost to Follow-up|0|||
105746540|NCT00111475|364726890|FG003|Overall Study|Lost to Follow-up|0|||
105746541|NCT00111475|364726891|FG004|Overall Study|Lost to Follow-up|0|||
105746542|NCT00111475|364726892|FG005|Overall Study|Lost to Follow-up|1|||
105746543|NCT00111475|364726893|FG006|Overall Study|Lost to Follow-up|0|||
105746544|NCT00111475|364726894|FG007|Overall Study|Lost to Follow-up|0|||
105746545|NCT00111475|364726895|FG008|Overall Study|Lost to Follow-up|0|||
105746546|NCT00111475|364726896|FG009|Overall Study|Lost to Follow-up|0|||
105746547|NCT01026389|364726897|FG000|Overall Study|Withdrawal by Subject|1|||
105746548|NCT01026389|364726898|FG001|Overall Study|Withdrawal by Subject|3|||
105746549|NCT01026389|364726897|FG000|Overall Study|change of treatment, patient moved|4|||
105746550|NCT01026389|364726898|FG001|Overall Study|change of treatment, patient moved|2|||
105746551|NCT00836277|364726899|FG000|Overall Study|Not evaluable for response|6|||
105746552|NCT01457118|364726912|FG000|Overall Study|Adverse Event|1|||
105746553|NCT01457118|364726913|FG001|Overall Study|Adverse Event|0|||
105746554|NCT01457118|364726914|FG002|Overall Study|Adverse Event|0|||
105746555|NCT01457118|364726915|FG003|Overall Study|Adverse Event|1|||
105746556|NCT01457118|364726912|FG000|Overall Study|Clinical Progression|0|||
105746557|NCT01457118|364726913|FG001|Overall Study|Clinical Progression|1|||
105746558|NCT01457118|364726914|FG002|Overall Study|Clinical Progression|0|||
105746559|NCT01457118|364726915|FG003|Overall Study|Clinical Progression|1|||
105746560|NCT01457118|364726912|FG000|Overall Study|Physician Decision|2|||
105746561|NCT01457118|364726913|FG001|Overall Study|Physician Decision|0|||
105746562|NCT01457118|364726914|FG002|Overall Study|Physician Decision|0|||
105746563|NCT01457118|364726915|FG003|Overall Study|Physician Decision|0|||
105746564|NCT01457118|364726912|FG000|Overall Study|Progressive Disease by RECIST|12|||
105746565|NCT01457118|364726913|FG001|Overall Study|Progressive Disease by RECIST|3|||
105746566|NCT01457118|364726914|FG002|Overall Study|Progressive Disease by RECIST|1|||
105746567|NCT01457118|364726915|FG003|Overall Study|Progressive Disease by RECIST|0|||
105746568|NCT01457118|364726912|FG000|Overall Study|Withdrawal by Subject|5|||
105746569|NCT01457118|364726913|FG001|Overall Study|Withdrawal by Subject|0|||
105746570|NCT01457118|364726914|FG002|Overall Study|Withdrawal by Subject|0|||
105746571|NCT01457118|364726915|FG003|Overall Study|Withdrawal by Subject|0|||
105746572|NCT02324842|364726916|FG000|Overall Study|Lost to Follow-up|1|||
105943363|NCT03110562|365455038|FG001|Initial Treatment Period|Other|4|||
105943364|NCT03110562|365455039|FG002|Initial Treatment Period|Other|0|||
105943365|NCT03110562|365455040|FG003|Initial Treatment Period|Other|0|||
105943366|NCT03110562|365455037|FG000|Initial Treatment Period|Randomized but never treated|0|||
105943367|NCT03110562|365455038|FG001|Initial Treatment Period|Randomized but never treated|3|||
105943368|NCT03110562|365455039|FG002|Initial Treatment Period|Randomized but never treated|0|||
105943369|NCT03110562|365455040|FG003|Initial Treatment Period|Randomized but never treated|0|||
105746573|NCT02324842|364726917|FG001|Overall Study|Lost to Follow-up|1|||
105746574|NCT02324842|364726918|FG002|Overall Study|Lost to Follow-up|2|||
105746575|NCT00115349|364726919|FG000|Overall Study|Study closed due to low enrollment.|11|||
105746576|NCT00115349|364726920|FG001|Overall Study|Study closed due to low enrollment.|9|||
105746577|NCT05142332|364726921|FG000|Overall Study|Withdrawal by Subject|0|||
105746578|NCT05142332|364726922|FG001|Overall Study|Withdrawal by Subject|1|||
105746579|NCT05142332|364726923|FG002|Overall Study|Withdrawal by Subject|2|||
105746580|NCT05142332|364726924|FG003|Overall Study|Withdrawal by Subject|0|||
105746581|NCT05142332|364726925|FG004|Overall Study|Withdrawal by Subject|0|||
105746582|NCT05142332|364726926|FG005|Overall Study|Withdrawal by Subject|2|||
105746583|NCT05142332|364726927|FG006|Overall Study|Withdrawal by Subject|6|||
105746584|NCT05142332|364726921|FG000|Overall Study|Left ED|3|||
105746585|NCT05142332|364726922|FG001|Overall Study|Left ED|0|||
105746586|NCT05142332|364726923|FG002|Overall Study|Left ED|4|||
105746587|NCT05142332|364726924|FG003|Overall Study|Left ED|6|||
105746588|NCT05142332|364726925|FG004|Overall Study|Left ED|1|||
105746589|NCT05142332|364726926|FG005|Overall Study|Left ED|2|||
105746590|NCT05142332|364726927|FG006|Overall Study|Left ED|6|||
105746591|NCT05142332|364726921|FG000|Overall Study|Physician Decision|0|||
105746592|NCT05142332|364726922|FG001|Overall Study|Physician Decision|0|||
105746593|NCT05142332|364726923|FG002|Overall Study|Physician Decision|2|||
105746594|NCT05142332|364726924|FG003|Overall Study|Physician Decision|1|||
105746595|NCT05142332|364726925|FG004|Overall Study|Physician Decision|0|||
105746596|NCT05142332|364726926|FG005|Overall Study|Physician Decision|0|||
105746597|NCT05142332|364726927|FG006|Overall Study|Physician Decision|3|||
105746598|NCT05142332|364726921|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
105746599|NCT05142332|364726922|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
105746600|NCT05142332|364726923|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
105746601|NCT05142332|364726924|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
105746602|NCT05142332|364726925|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
105746603|NCT05142332|364726926|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
105746604|NCT05142332|364726927|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
105746605|NCT02116660|364726928|FG000|Overall Study|Deteriorating renal function|0|||
105746606|NCT02116660|364726929|FG001|Overall Study|Deteriorating renal function|1|||
105746607|NCT02116660|364726928|FG000|Overall Study|Adverse Event|1|||
105746608|NCT02116660|364726929|FG001|Overall Study|Adverse Event|1|||
105746609|NCT02116660|364726928|FG000|Overall Study|Withdrawal by Subject|0|||
105746610|NCT02116660|364726929|FG001|Overall Study|Withdrawal by Subject|2|||
105746611|NCT02116660|364726928|FG000|Overall Study|Organization reason|1|||
105746612|NCT02116660|364726929|FG001|Overall Study|Organization reason|0|||
105746613|NCT02750800|364726930|FG000|Overall Study|Adverse Event|18|||
105746614|NCT02750800|364726930|FG000|Overall Study|Lost to Follow-up|12|||
105746615|NCT02750800|364726930|FG000|Overall Study|Investigator decision|53|||
105746616|NCT02750800|364726930|FG000|Overall Study|Patient request|12|||
105746617|NCT02750800|364726930|FG000|Overall Study|Other, not specified|3|||
105746618|NCT00643487|364726937|FG000|Overall Study|Technical difficulty|3|||
105746619|NCT00390416|364726938|FG000|Overall Study|Withdrawal by Subject|1|||
105746620|NCT00390416|364726938|FG000|Overall Study|Not treated|3|||
105746621|NCT05631548|364726939|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
105746622|NCT05631548|364726940|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
105746623|NCT00630812|364726941|FG000|Randomisation to First Dose|Adverse Event|1|||
105746624|NCT00630812|364726942|FG001|Randomisation to First Dose|Adverse Event|1|||
105746625|NCT00630812|364726941|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
105746626|NCT00630812|364726942|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
105746627|NCT00630812|364726941|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
105746628|NCT00630812|364726942|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
105801018|NCT00845026|364928595|FG000|Study Period III|Adverse Event|23|||
105801019|NCT00845026|364928596|FG001|Study Period III|Adverse Event|19|||
105943370|NCT03110562|365455037|FG000|Crossover Period|Disease Progression|0|||
105746629|NCT00630812|364726941|FG000|Randomisation to First Dose|Protocol Violation|4|||
105746630|NCT00630812|364726942|FG001|Randomisation to First Dose|Protocol Violation|1|||
105746631|NCT00630812|364726941|FG000|Double Blind Treatment Period|Adverse Event|13|||
105746632|NCT00630812|364726942|FG001|Double Blind Treatment Period|Adverse Event|5|||
105746633|NCT00630812|364726941|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
105801020|NCT00845026|364928595|FG000|Study Period III|Perceived lack of efficacy|27|||
105801021|NCT00845026|364928596|FG001|Study Period III|Perceived lack of efficacy|15|||
105801022|NCT00845026|364928595|FG000|Study Period III|Withdrawal by Subject|19|||
105801023|NCT00845026|364928596|FG001|Study Period III|Withdrawal by Subject|15|||
105801024|NCT00845026|364928595|FG000|Study Period III|Entry Criteria not met|8|||
105801025|NCT00845026|364928596|FG001|Study Period III|Entry Criteria not met|11|||
105801026|NCT00845026|364928595|FG000|Study Period III|Lost to Follow-up|4|||
105801027|NCT00845026|364928596|FG001|Study Period III|Lost to Follow-up|5|||
105801028|NCT00845026|364928595|FG000|Study Period III|Protocol Violation|8|||
105801029|NCT00845026|364928596|FG001|Study Period III|Protocol Violation|1|||
105801030|NCT00845026|364928595|FG000|Study Period III|Scheduled conflict|3|||
105801031|NCT00845026|364928596|FG001|Study Period III|Scheduled conflict|1|||
105801032|NCT00845026|364928595|FG000|Study Period III|Subject is moving or has moved|2|||
105801033|NCT00845026|364928596|FG001|Study Period III|Subject is moving or has moved|4|||
105801034|NCT00845026|364928595|FG000|Study Period III|Transportation issues|1|||
105801035|NCT00845026|364928596|FG001|Study Period III|Transportation issues|1|||
105801036|NCT00845026|364928595|FG000|Study Period IV|Adverse Event|4|||
105801037|NCT00845026|364928596|FG001|Study Period IV|Adverse Event|0|||
105801038|NCT00845026|364928595|FG000|Study Period IV|Perceived lack of efficacy|2|||
105801039|NCT00845026|364928596|FG001|Study Period IV|Perceived lack of efficacy|1|||
105801040|NCT00845026|364928595|FG000|Study Period IV|Protocol Violation|3|||
105801041|NCT00845026|364928596|FG001|Study Period IV|Protocol Violation|1|||
105801042|NCT00845026|364928595|FG000|Study Period IV|Lost to Follow-up|1|||
105801043|NCT00845026|364928596|FG001|Study Period IV|Lost to Follow-up|0|||
105801044|NCT00845026|364928595|FG000|Study Period IV|Withdrawal by Subject|4|||
105801045|NCT00845026|364928596|FG001|Study Period IV|Withdrawal by Subject|1|||
105801046|NCT00845026|364928595|FG000|Study Period IV|Entry Criteria Not Met|1|||
105801047|NCT00845026|364928596|FG001|Study Period IV|Entry Criteria Not Met|0|||
105801048|NCT00845026|364928595|FG000|Study Period IV|Subject is moving or has moved|0|||
105801049|NCT00845026|364928596|FG001|Study Period IV|Subject is moving or has moved|1|||
105801050|NCT00845026|364928595|FG000|Study Period IV|Scheduling conflict|1|||
105801051|NCT00845026|364928596|FG001|Study Period IV|Scheduling conflict|0|||
105801052|NCT02065791|364928597|FG000|Overall Study|Closed Site|1|||
105801053|NCT02065791|364928598|FG001|Overall Study|Closed Site|1|||
105801054|NCT02065791|364928597|FG000|Overall Study|Withdrawal by Subject|11|||
105801055|NCT02065791|364928598|FG001|Overall Study|Withdrawal by Subject|5|||
105801056|NCT02065791|364928597|FG000|Overall Study|Lost to Follow-up|13|||
105801057|NCT02065791|364928598|FG001|Overall Study|Lost to Follow-up|9|||
105801058|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
105801059|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
105801060|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
105801061|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
105801062|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
105801063|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
105801064|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
105801065|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
105943371|NCT03110562|365455038|FG001|Crossover Period|Disease Progression|0|||
105943372|NCT03110562|365455039|FG002|Crossover Period|Disease Progression|1|||
105943373|NCT03110562|365455040|FG003|Crossover Period|Disease Progression|0|||
105746634|NCT00630812|364726942|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105746635|NCT00630812|364726941|FG000|Double Blind Treatment Period|Physician Decision|2|||
105746636|NCT00630812|364726942|FG001|Double Blind Treatment Period|Physician Decision|1|||
105746637|NCT00630812|364726941|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105746638|NCT00630812|364726942|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105746639|NCT00630812|364726941|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
105746640|NCT00630812|364726942|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
105746641|NCT00630812|364726941|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
105746642|NCT00630812|364726942|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
105746643|NCT00630812|364726941|FG000|Double Blind Treatment Period|Non-compliance|0|||
105746644|NCT00630812|364726942|FG001|Double Blind Treatment Period|Non-compliance|1|||
105746645|NCT01248130|364726943|FG000|Overall Study|Protocol Violation|1|||
105746646|NCT01248130|364726944|FG001|Overall Study|Protocol Violation|0|||
105801066|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
105801067|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
105801068|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
105801069|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
105801070|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
105801071|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
105943374|NCT03110562|365455037|FG000|Crossover Period|Withdrawal by Subject|0|||
105943375|NCT03110562|365455038|FG001|Crossover Period|Withdrawal by Subject|0|||
105746647|NCT01248130|364726943|FG000|Overall Study|Ineligible|1|||
105746648|NCT01248130|364726944|FG001|Overall Study|Ineligible|0|||
105943376|NCT03110562|365455039|FG002|Crossover Period|Withdrawal by Subject|8|||
105943377|NCT03110562|365455040|FG003|Crossover Period|Withdrawal by Subject|6|||
105801072|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
105801073|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
105801074|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
105801075|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
105801076|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
105801077|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
105801078|NCT00272961|364928599|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
105801079|NCT00272961|364928600|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
105801080|NCT00272961|364928601|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
105801081|NCT00272961|364928602|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
105801082|NCT00272961|364928603|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
105801083|NCT00272961|364928599|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
105801084|NCT00272961|364928600|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
105801085|NCT00272961|364928601|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
105801086|NCT00272961|364928602|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
105801087|NCT00272961|364928603|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
105801088|NCT00272961|364928599|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
105801089|NCT00272961|364928600|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
105801090|NCT00272961|364928601|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
105801091|NCT00272961|364928602|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
105801092|NCT00272961|364928603|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
105801093|NCT00272961|364928599|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
105801094|NCT00272961|364928600|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
105801095|NCT00272961|364928601|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
105801096|NCT00272961|364928602|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
105943378|NCT03110562|365455037|FG000|Crossover Period|Death|0|||
105943379|NCT03110562|365455038|FG001|Crossover Period|Death|0|||
105943380|NCT03110562|365455039|FG002|Crossover Period|Death|37|||
105943381|NCT03110562|365455040|FG003|Crossover Period|Death|3|||
105943382|NCT03110562|365455037|FG000|Crossover Period|Lost to Follow-up|0|||
105943383|NCT03110562|365455038|FG001|Crossover Period|Lost to Follow-up|0|||
105943384|NCT03110562|365455039|FG002|Crossover Period|Lost to Follow-up|0|||
105943385|NCT03110562|365455040|FG003|Crossover Period|Lost to Follow-up|1|||
105943386|NCT03110562|365455037|FG000|Crossover Period|Other|0|||
105943387|NCT03110562|365455038|FG001|Crossover Period|Other|0|||
105943388|NCT03110562|365455039|FG002|Crossover Period|Other|1|||
105943389|NCT03110562|365455040|FG003|Crossover Period|Other|1|||
105943390|NCT03110562|365455037|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
105943391|NCT03110562|365455038|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
105943392|NCT03110562|365455039|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
105943393|NCT03110562|365455040|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
105943394|NCT01877278|365455043|FG000|Overall Study|Lost to Follow-up|3|||
105943395|NCT01877278|365455044|FG001|Overall Study|Lost to Follow-up|3|||
105801097|NCT00272961|364928603|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
105801098|NCT02746705|364928606|FG000|Overall Study|Physician Decision|1|||
105801099|NCT02746705|364928607|FG001|Overall Study|Physician Decision|1|||
105801100|NCT02746705|364928606|FG000|Overall Study|Lost to Follow-up|1|||
105801101|NCT02746705|364928607|FG001|Overall Study|Lost to Follow-up|0|||
105801102|NCT02746705|364928606|FG000|Overall Study|outlier scores deemed not valid|0|||
105943396|NCT04727151|365455045|FG000|Overall Study|Death|0|||
105943397|NCT04727151|365455046|FG001|Overall Study|Death|0|||
105943398|NCT04727151|365455047|FG002|Overall Study|Death|0|||
105943399|NCT04727151|365455048|FG003|Overall Study|Death|0|||
105943400|NCT04727151|365455049|FG004|Overall Study|Death|3|||
105943401|NCT04727151|365455045|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
105943402|NCT04727151|365455046|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
105801103|NCT02746705|364928607|FG001|Overall Study|outlier scores deemed not valid|1|||
105943403|NCT04727151|365455047|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
105943404|NCT04727151|365455048|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
105943405|NCT04727151|365455049|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
106142424|NCT01400776|366181844|FG001|Overall Study|Reason not Specified|0|||
105801104|NCT01964105|364928608|FG000|Overall Study|Lost to Follow-up|2|||
105801105|NCT01964105|364928609|FG001|Overall Study|Lost to Follow-up|13|||
105801106|NCT01964105|364928610|FG002|Overall Study|Lost to Follow-up|0|||
105801107|NCT01571635|364928612|FG000|Overall Study|Adverse Event|3|||
105801108|NCT01571635|364928613|FG001|Overall Study|Adverse Event|0|||
105943406|NCT02769481|365455050|FG000|Overall Study|Protocol Violation|1|||
105943407|NCT02769481|365455051|FG001|Overall Study|Protocol Violation|0|||
105943408|NCT02769481|365455050|FG000|Overall Study|Adverse Event|3|||
105943409|NCT02769481|365455051|FG001|Overall Study|Adverse Event|6|||
105746649|NCT01911845|364726945|FG000|Overall Study|Adverse Event|2|||
105746650|NCT01911845|364726945|FG000|Overall Study|Lost to Follow-up|1|||
105746651|NCT01911845|364726945|FG000|Overall Study|Other (not specified)|3|||
105746652|NCT01980706|364726946|FG000|Overall Study|Withdrawal by Subject|9|||
105746653|NCT01980706|364726947|FG001|Overall Study|Withdrawal by Subject|6|||
105746654|NCT01980706|364726948|FG002|Overall Study|Withdrawal by Subject|2|||
105746655|NCT01980706|364726946|FG000|Overall Study|Adverse Event|1|||
105746656|NCT01980706|364726947|FG001|Overall Study|Adverse Event|2|||
106142425|NCT01400776|366181845|FG002|Overall Study|Reason not Specified|4|||
106142426|NCT01400776|366181846|FG003|Overall Study|Reason not Specified|3|||
106142427|NCT01198275|366181847|FG000|Overall Study|Adverse Event|2|||
106142428|NCT01198275|366181848|FG001|Overall Study|Adverse Event|3|||
105746657|NCT01980706|364726948|FG002|Overall Study|Adverse Event|5|||
105746658|NCT01980706|364726946|FG000|Overall Study|Lost to Follow-up|3|||
105746659|NCT01980706|364726947|FG001|Overall Study|Lost to Follow-up|4|||
105746660|NCT01980706|364726948|FG002|Overall Study|Lost to Follow-up|3|||
105746661|NCT01980706|364726946|FG000|Overall Study|miscellaneous|4|||
105746662|NCT01980706|364726947|FG001|Overall Study|miscellaneous|5|||
105746663|NCT01980706|364726948|FG002|Overall Study|miscellaneous|3|||
105746664|NCT01163253|364726949|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
105746665|NCT01163253|364726950|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
106142429|NCT01198275|366181847|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
106142430|NCT01198275|366181848|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
106142431|NCT00004124|366181853|FG000|Overall Study|Received no protocol therapy|12|||
106142432|NCT00004124|366181854|FG001|Overall Study|Received no protocol therapy|20|||
106142433|NCT00446550|366181855|FG000|Overall Study|Adverse Event|1|||
106142434|NCT00446550|366181856|FG001|Overall Study|Adverse Event|0|||
106142435|NCT02613871|366181859|FG000|Overall Study|Death|2|||
105746666|NCT01163253|364726949|FG000|Overall Study|Study Terminated by Sponsor|978|||
105746667|NCT01163253|364726950|FG001|Overall Study|Study Terminated by Sponsor|349|||
105746668|NCT01163253|364726949|FG000|Overall Study|Protocol Violation|43|||
105746669|NCT01163253|364726950|FG001|Overall Study|Protocol Violation|12|||
105746670|NCT01163253|364726949|FG000|Overall Study|Withdrawal by Subject|199|||
105746671|NCT01163253|364726950|FG001|Overall Study|Withdrawal by Subject|50|||
105746672|NCT01163253|364726949|FG000|Overall Study|Medication Error|1|||
105746673|NCT01163253|364726950|FG001|Overall Study|Medication Error|0|||
105746674|NCT01163253|364726949|FG000|Overall Study|Lost to Follow-up|125|||
105746675|NCT01163253|364726950|FG001|Overall Study|Lost to Follow-up|23|||
105746676|NCT01163253|364726949|FG000|Overall Study|Insufficient Clinical Response|423|||
105746677|NCT01163253|364726950|FG001|Overall Study|Insufficient Clinical Response|29|||
105746678|NCT01163253|364726949|FG000|Overall Study|Adverse Event|300|||
105746679|NCT01163253|364726950|FG001|Overall Study|Adverse Event|78|||
105746680|NCT01163253|364726949|FG000|Overall Study|Death|17|||
105746681|NCT01163253|364726950|FG001|Overall Study|Death|5|||
105746682|NCT01163253|364726949|FG000|Overall Study|Ongoing|13|||
105746683|NCT01163253|364726950|FG001|Overall Study|Ongoing|4|||
105746684|NCT01163253|364726949|FG000|Overall Study|Other Unspecified|170|||
105746685|NCT01163253|364726950|FG001|Overall Study|Other Unspecified|34|||
105746686|NCT05118386|364726956|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746687|NCT05118386|364726957|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746688|NCT05118386|364726958|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746689|NCT05118386|364726959|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
105746690|NCT05118386|364726960|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746691|NCT05118386|364726961|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
105746692|NCT05118386|364726956|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746693|NCT05118386|364726957|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746694|NCT05118386|364726958|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746695|NCT05118386|364726959|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746696|NCT05118386|364726960|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
105746697|NCT05118386|364726961|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
105746698|NCT02683525|364726962|FG000|Overall Study|Lost to Follow-up|1|||
105746699|NCT02683525|364726962|FG000|Overall Study|Physician Decision|1|||
105746700|NCT02683525|364726962|FG000|Overall Study|Disease Progression|6|||
105746701|NCT01468909|364726972|FG000|Overall Study|Never Treated|2|||
105746702|NCT01468909|364726973|FG001|Overall Study|Never Treated|2|||
105746703|NCT01005732|364726979|FG000|Overall Study|Lost to Follow-up|10|||
105746704|NCT01005732|364726979|FG000|Overall Study|Death|1|||
105746705|NCT00937768|364726980|FG000|Overall Study|Refused Further Treatment|3|||
106142436|NCT02613871|366181859|FG000|Overall Study|Withdrew Consent|1|||
105746706|NCT00937768|364726981|FG001|Overall Study|Refused Further Treatment|2|||
105746707|NCT00937768|364726980|FG000|Overall Study|Disease Progression|1|||
105746708|NCT00937768|364726981|FG001|Overall Study|Disease Progression|1|||
105746709|NCT00937768|364726980|FG000|Overall Study|Alternate Treatment|0|||
105746710|NCT00937768|364726981|FG001|Overall Study|Alternate Treatment|1|||
105746711|NCT00937768|364726980|FG000|Overall Study|No Further Funding|4|||
106142437|NCT01930045|366181860|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
106142438|NCT01930045|366181861|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
106142439|NCT01930045|366181862|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
106142440|NCT01930045|366181863|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
106142441|NCT01930045|366181864|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
106142442|NCT01930045|366181865|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
106142443|NCT01930045|366181860|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
106142444|NCT01930045|366181861|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
106142445|NCT01930045|366181862|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
106142446|NCT01930045|366181863|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
106142447|NCT01930045|366181864|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
106142448|NCT01930045|366181865|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
106142449|NCT01786564|366181866|FG000|Overall Study|Lost to Follow-up|47|||
106142450|NCT01786564|366181866|FG000|Overall Study|Ineligible|17|||
106142451|NCT00494442|366181867|FG000|Overall Study|Death|1|||
106142452|NCT00494442|366181868|FG001|Overall Study|Death|1|||
106142453|NCT00494442|366181867|FG000|Overall Study|Lack of Efficacy|16|||
105746712|NCT00937768|364726981|FG001|Overall Study|No Further Funding|4|||
105746713|NCT02998554|364726988|FG000|Overall Study|Adverse Event|8|||
105746714|NCT02998554|364726989|FG001|Overall Study|Adverse Event|3|||
105746715|NCT02998554|364726988|FG000|Overall Study|Protocol deviation|1|||
105746716|NCT02998554|364726989|FG001|Overall Study|Protocol deviation|0|||
105746717|NCT02998554|364726988|FG000|Overall Study|Withdrawal by Subject|2|||
105746718|NCT02998554|364726989|FG001|Overall Study|Withdrawal by Subject|6|||
105746719|NCT02998554|364726988|FG000|Overall Study|Lost to Follow-up|0|||
105746720|NCT02998554|364726989|FG001|Overall Study|Lost to Follow-up|1|||
105746721|NCT02998554|364726988|FG000|Overall Study|Lack of Efficacy|0|||
105746722|NCT02998554|364726989|FG001|Overall Study|Lack of Efficacy|1|||
105746723|NCT01079962|364726994|FG000|Overall Study|Adverse Event|2|||
105746724|NCT01079962|364726995|FG001|Overall Study|Adverse Event|2|||
105746725|NCT01079962|364726994|FG000|Overall Study|Withdrawal by Subject|5|||
105746726|NCT01079962|364726995|FG001|Overall Study|Withdrawal by Subject|7|||
105746727|NCT01079962|364726994|FG000|Overall Study|Protocol Violation|2|||
105746728|NCT01079962|364726995|FG001|Overall Study|Protocol Violation|2|||
105746729|NCT01079962|364726994|FG000|Overall Study|No blood pressure (BP) control|3|||
105746730|NCT01079962|364726995|FG001|Overall Study|No blood pressure (BP) control|0|||
105746731|NCT01079962|364726994|FG000|Overall Study|Inclusion/exclusion criteria|1|||
105746732|NCT01079962|364726995|FG001|Overall Study|Inclusion/exclusion criteria|3|||
105746733|NCT01079962|364726994|FG000|Overall Study|Participant not returning for next visit|1|||
105746734|NCT01079962|364726995|FG001|Overall Study|Participant not returning for next visit|0|||
105746735|NCT01079962|364726994|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
105746736|NCT01079962|364726995|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
105746737|NCT01331239|364726996|FG000|Part II: Core Study|Adverse Event|0|||
105746738|NCT01331239|364726997|FG001|Part II: Core Study|Adverse Event|3|||
105746739|NCT01331239|364726998|FG002|Part II: Core Study|Adverse Event|0|||
105746740|NCT01331239|364726996|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
105746741|NCT01331239|364726997|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
105746742|NCT01331239|364726998|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
105746743|NCT01331239|364726996|FG000|Part II: Core Study|Withdrawal by Subject|0|||
105746744|NCT01331239|364726997|FG001|Part II: Core Study|Withdrawal by Subject|2|||
105746745|NCT01331239|364726998|FG002|Part II: Core Study|Withdrawal by Subject|0|||
105746746|NCT01331239|364726996|FG000|Part II: Core Study|Administrative problems|0|||
105746747|NCT01331239|364726997|FG001|Part II: Core Study|Administrative problems|1|||
105746748|NCT01331239|364726998|FG002|Part II: Core Study|Administrative problems|0|||
105746749|NCT01072539|364726999|FG000|Overall Study|Treated prior to the Site Initiation|1|||
105746750|NCT01072539|364726999|FG000|Overall Study|Protocol Violation|2|||
105746751|NCT00946530|364727000|FG000|Overall Study|Withdrawal by Subject|0|||
105746752|NCT00946530|364727001|FG001|Overall Study|Withdrawal by Subject|3|||
105746753|NCT00946530|364727002|FG002|Overall Study|Withdrawal by Subject|0|||
105746754|NCT00946530|364727003|FG003|Overall Study|Withdrawal by Subject|3|||
105746755|NCT00946530|364727000|FG000|Overall Study|Physician Decision|1|||
105746756|NCT00946530|364727001|FG001|Overall Study|Physician Decision|1|||
106142454|NCT00494442|366181868|FG001|Overall Study|Lack of Efficacy|10|||
106142455|NCT00494442|366181867|FG000|Overall Study|Adverse Event|0|||
105746757|NCT00946530|364727002|FG002|Overall Study|Physician Decision|1|||
105746758|NCT00946530|364727003|FG003|Overall Study|Physician Decision|1|||
105746759|NCT01008995|364727006|FG000|Controlled Period|Adverse Event|1|||
105746760|NCT01008995|364727007|FG001|Controlled Period|Adverse Event|2|||
105746761|NCT01008995|364727008|FG002|Controlled Period|Adverse Event|0|||
105746762|NCT01008995|364727009|FG003|Controlled Period|Adverse Event|0|||
106142456|NCT00494442|366181868|FG001|Overall Study|Adverse Event|2|||
106142457|NCT00494442|366181867|FG000|Overall Study|Physician Decision|0|||
106142458|NCT00494442|366181868|FG001|Overall Study|Physician Decision|1|||
106142459|NCT00494442|366181867|FG000|Overall Study|Non-compliance|0|||
106142460|NCT00494442|366181868|FG001|Overall Study|Non-compliance|1|||
106142461|NCT00494442|366181867|FG000|Overall Study|Intercurrent illness|0|||
105746763|NCT01008995|364727006|FG000|Controlled Period|Other|2|||
105746764|NCT01008995|364727007|FG001|Controlled Period|Other|1|||
105746765|NCT01008995|364727008|FG002|Controlled Period|Other|0|||
105746766|NCT01008995|364727009|FG003|Controlled Period|Other|0|||
105746767|NCT01008995|364727006|FG000|After Controlled Period|Adverse Event|0|||
105746768|NCT01008995|364727007|FG001|After Controlled Period|Adverse Event|0|||
105746769|NCT01008995|364727008|FG002|After Controlled Period|Adverse Event|1|||
105746770|NCT01008995|364727009|FG003|After Controlled Period|Adverse Event|1|||
105746771|NCT01008995|364727006|FG000|After Controlled Period|Other|0|||
105746772|NCT01008995|364727007|FG001|After Controlled Period|Other|0|||
105746773|NCT01008995|364727008|FG002|After Controlled Period|Other|1|||
105746774|NCT01008995|364727009|FG003|After Controlled Period|Other|0|||
105746775|NCT00115804|364727010|FG000|Overall Study|Adverse Event|2|||
105746776|NCT03422133|364727013|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
106142462|NCT00494442|366181868|FG001|Overall Study|Intercurrent illness|1|||
106142463|NCT03804918|366181869|FG000|Overall Study|Participant did not use the app|1|||
105746777|NCT03422133|364727014|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
105746778|NCT00755846|364729097|FG000|Overall Study|Adverse Event|0|||
105746779|NCT00755846|364729098|FG001|Overall Study|Adverse Event|0|||
105746780|NCT00755846|364729099|FG002|Overall Study|Adverse Event|0|||
105746781|NCT00755846|364729100|FG003|Overall Study|Adverse Event|1|||
105746782|NCT00755846|364729101|FG004|Overall Study|Adverse Event|3|||
105746783|NCT00755846|364729102|FG005|Overall Study|Adverse Event|2|||
105746784|NCT00755846|364729097|FG000|Overall Study|Protocol Violation|1|||
105746785|NCT00755846|364729098|FG001|Overall Study|Protocol Violation|1|||
105746786|NCT00755846|364729099|FG002|Overall Study|Protocol Violation|1|||
105746787|NCT00755846|364729100|FG003|Overall Study|Protocol Violation|1|||
105746788|NCT00755846|364729101|FG004|Overall Study|Protocol Violation|1|||
105746789|NCT00755846|364729102|FG005|Overall Study|Protocol Violation|1|||
105746790|NCT00755846|364729097|FG000|Overall Study|Lost to Follow-up|0|||
105746791|NCT00755846|364729098|FG001|Overall Study|Lost to Follow-up|2|||
105746792|NCT00755846|364729099|FG002|Overall Study|Lost to Follow-up|1|||
105746793|NCT00755846|364729100|FG003|Overall Study|Lost to Follow-up|0|||
105746794|NCT00755846|364729101|FG004|Overall Study|Lost to Follow-up|4|||
105746795|NCT00755846|364729102|FG005|Overall Study|Lost to Follow-up|2|||
105746796|NCT00755846|364729097|FG000|Overall Study|Withdrawal by Subject|2|||
105746797|NCT00755846|364729098|FG001|Overall Study|Withdrawal by Subject|3|||
105746798|NCT00755846|364729099|FG002|Overall Study|Withdrawal by Subject|5|||
105746799|NCT00755846|364729100|FG003|Overall Study|Withdrawal by Subject|2|||
105746800|NCT00755846|364729101|FG004|Overall Study|Withdrawal by Subject|0|||
105746801|NCT00755846|364729102|FG005|Overall Study|Withdrawal by Subject|1|||
105746802|NCT00755846|364729097|FG000|Overall Study|Hyperglycemic Rescue|21|||
106142464|NCT00813904|366181874|FG000|Overall Study|Death|1|||
106142465|NCT00964366|366181875|FG000|Overall Study|Did not qualify at Day 1|1|||
106142466|NCT00964366|366181876|FG001|Overall Study|Did not qualify at Day 1|0|||
106142467|NCT00964366|366181875|FG000|Overall Study|Withdrawal by Subject|0|||
106142468|NCT00964366|366181876|FG001|Overall Study|Withdrawal by Subject|1|||
106142469|NCT04842604|366181877|FG000|Overall Study|Death|1|||
106142470|NCT04842604|366181878|FG001|Overall Study|Death|0|||
106142471|NCT04842604|366181877|FG000|Overall Study|Other|4|||
106142472|NCT04842604|366181878|FG001|Overall Study|Other|4|||
106142473|NCT04842604|366181877|FG000|Overall Study|Randomized but not treated|1|||
106142474|NCT04842604|366181878|FG001|Overall Study|Randomized but not treated|0|||
106142475|NCT01563354|366181879|FG000|Core Phase|Adverse Event|5|||
106142476|NCT01563354|366181880|FG001|Core Phase|Adverse Event|15|||
106142477|NCT01563354|366181881|FG002|Core Phase|Adverse Event|13|||
106142478|NCT01563354|366181879|FG000|Core Phase|Withdrawal by Subject|1|||
105746803|NCT00755846|364729098|FG001|Overall Study|Hyperglycemic Rescue|7|||
105746804|NCT00755846|364729099|FG002|Overall Study|Hyperglycemic Rescue|5|||
105746805|NCT00755846|364729100|FG003|Overall Study|Hyperglycemic Rescue|8|||
105746806|NCT00755846|364729101|FG004|Overall Study|Hyperglycemic Rescue|8|||
105746807|NCT00755846|364729102|FG005|Overall Study|Hyperglycemic Rescue|7|||
105746808|NCT00755846|364729097|FG000|Overall Study|Physician Decision|1|||
105746809|NCT00755846|364729098|FG001|Overall Study|Physician Decision|3|||
105746810|NCT00755846|364729099|FG002|Overall Study|Physician Decision|0|||
105746811|NCT00755846|364729100|FG003|Overall Study|Physician Decision|1|||
106142479|NCT01563354|366181880|FG001|Core Phase|Withdrawal by Subject|0|||
106142480|NCT01563354|366181881|FG002|Core Phase|Withdrawal by Subject|3|||
106142481|NCT01563354|366181879|FG000|Core Phase|Lost to Follow-up|1|||
106142482|NCT01563354|366181880|FG001|Core Phase|Lost to Follow-up|0|||
105746812|NCT00755846|364729101|FG004|Overall Study|Physician Decision|0|||
105746813|NCT00755846|364729102|FG005|Overall Study|Physician Decision|1|||
105746814|NCT00755846|364729097|FG000|Overall Study|Administrative Error|0|||
105746815|NCT00755846|364729098|FG001|Overall Study|Administrative Error|1|||
105746816|NCT00755846|364729099|FG002|Overall Study|Administrative Error|0|||
105746817|NCT00755846|364729100|FG003|Overall Study|Administrative Error|0|||
105746818|NCT00755846|364729101|FG004|Overall Study|Administrative Error|0|||
105746819|NCT00755846|364729102|FG005|Overall Study|Administrative Error|0|||
105943410|NCT02769481|365455050|FG000|Overall Study|Entry Criteria Not Met|1|||
105943411|NCT02769481|365455051|FG001|Overall Study|Entry Criteria Not Met|2|||
105943412|NCT02769481|365455050|FG000|Overall Study|Withdrawal by Subject|14|||
105943413|NCT02769481|365455051|FG001|Overall Study|Withdrawal by Subject|16|||
105943414|NCT02769481|365455050|FG000|Overall Study|Lost to Follow-up|9|||
105943415|NCT02769481|365455051|FG001|Overall Study|Lost to Follow-up|9|||
105943416|NCT02769481|365455050|FG000|Overall Study|Physician Decision|0|||
105943417|NCT02769481|365455051|FG001|Overall Study|Physician Decision|1|||
105943418|NCT02769481|365455050|FG000|Overall Study|Terminated by Sponsor|1|||
105943419|NCT02769481|365455051|FG001|Overall Study|Terminated by Sponsor|0|||
105943420|NCT02769481|365455050|FG000|Overall Study|Death|0|||
105943421|NCT02769481|365455051|FG001|Overall Study|Death|1|||
105943422|NCT02769481|365455050|FG000|Overall Study|Undefined|4|||
105943423|NCT02769481|365455051|FG001|Overall Study|Undefined|1|||
105943424|NCT03510715|365455052|FG000|Overall Study|Adverse Event|1|||
105943425|NCT03510715|365455053|FG001|Overall Study|Adverse Event|0|||
105943426|NCT04976855|365455054|FG000|Part I|Withdrawal by Subject|0|||
105943427|NCT04976855|365455055|FG001|Part I|Withdrawal by Subject|1|||
105943428|NCT04976855|365455056|FG002|Part I|Withdrawal by Subject|0|||
105943429|NCT04976855|365455057|FG003|Part I|Withdrawal by Subject|0|||
105943430|NCT04976855|365455058|FG004|Part I|Withdrawal by Subject|0|||
105943431|NCT04976855|365455059|FG005|Part I|Withdrawal by Subject|0|||
105943432|NCT04976855|365455060|FG006|Part I|Withdrawal by Subject|0|||
105943433|NCT04976855|365455054|FG000|Part II|Adverse Event|0|||
105943434|NCT04976855|365455055|FG001|Part II|Adverse Event|0|||
106015804|NCT02592798|365723301|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
106015805|NCT02592798|365723300|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
106015806|NCT02592798|365723301|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
106015807|NCT02592798|365723300|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
106015808|NCT02592798|365723301|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
106015809|NCT02592798|365723300|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
106015810|NCT02592798|365723301|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
105746820|NCT00755846|364729097|FG000|Overall Study|Participant Non-compliance|0|||
105746821|NCT00755846|364729098|FG001|Overall Study|Participant Non-compliance|0|||
105746822|NCT00755846|364729099|FG002|Overall Study|Participant Non-compliance|0|||
105746823|NCT00755846|364729100|FG003|Overall Study|Participant Non-compliance|0|||
105746824|NCT00755846|364729101|FG004|Overall Study|Participant Non-compliance|1|||
105746825|NCT00755846|364729102|FG005|Overall Study|Participant Non-compliance|0|||
105746826|NCT02669862|364729103|FG000|Overall Study|Lost to Follow-up|0|||
105746827|NCT02669862|364729104|FG001|Overall Study|Lost to Follow-up|2|||
105746828|NCT02669862|364729105|FG002|Overall Study|Lost to Follow-up|1|||
105746829|NCT02669862|364729103|FG000|Overall Study|Withdrawal by Subject|2|||
105746830|NCT02669862|364729104|FG001|Overall Study|Withdrawal by Subject|2|||
105746831|NCT02669862|364729105|FG002|Overall Study|Withdrawal by Subject|3|||
105746832|NCT02669862|364729103|FG000|Overall Study|moved|0|||
105746833|NCT02669862|364729104|FG001|Overall Study|moved|1|||
105746834|NCT02669862|364729105|FG002|Overall Study|moved|0|||
105746835|NCT02669862|364729103|FG000|Overall Study|Protocol Violation|0|||
105746836|NCT02669862|364729104|FG001|Overall Study|Protocol Violation|0|||
105746837|NCT02669862|364729105|FG002|Overall Study|Protocol Violation|1|||
105746838|NCT00288860|364729106|FG000|Overall Study|Did not complete intake|4|||
105746839|NCT00288860|364729107|FG001|Overall Study|Did not complete intake|8|||
105746840|NCT00288860|364729106|FG000|Overall Study|Death|4|||
105746841|NCT00288860|364729107|FG001|Overall Study|Death|3|||
105746842|NCT00288860|364729106|FG000|Overall Study|Withdrawal by Subject|20|||
105746843|NCT00288860|364729107|FG001|Overall Study|Withdrawal by Subject|15|||
105746844|NCT00288860|364729106|FG000|Overall Study|Lost to Follow-up|74|||
105746845|NCT00288860|364729107|FG001|Overall Study|Lost to Follow-up|71|||
105943435|NCT04976855|365455056|FG002|Part II|Adverse Event|0|||
105943436|NCT04976855|365455057|FG003|Part II|Adverse Event|1|||
105943437|NCT04976855|365455058|FG004|Part II|Adverse Event|0|||
105943438|NCT04976855|365455059|FG005|Part II|Adverse Event|0|||
105943439|NCT04976855|365455060|FG006|Part II|Adverse Event|0|||
105943440|NCT04976855|365455054|FG000|Part II|Withdrawal by Subject|0|||
105943441|NCT04976855|365455055|FG001|Part II|Withdrawal by Subject|0|||
105943442|NCT04976855|365455056|FG002|Part II|Withdrawal by Subject|0|||
105943443|NCT04976855|365455057|FG003|Part II|Withdrawal by Subject|0|||
105943444|NCT04976855|365455058|FG004|Part II|Withdrawal by Subject|1|||
105943445|NCT04976855|365455059|FG005|Part II|Withdrawal by Subject|0|||
105746846|NCT00882999|364729108|FG000|Overall Study|Adverse Event|0|||
105746847|NCT00882999|364729109|FG001|Overall Study|Adverse Event|0|||
105746848|NCT00882999|364729110|FG002|Overall Study|Adverse Event|0|||
105746849|NCT00882999|364729111|FG003|Overall Study|Adverse Event|0|||
105943446|NCT04976855|365455060|FG006|Part II|Withdrawal by Subject|0|||
105943447|NCT04976855|365455054|FG000|Part II|Lost to Follow-up|0|||
105746850|NCT00882999|364729112|FG004|Overall Study|Adverse Event|1|||
105746851|NCT00882999|364729113|FG005|Overall Study|Adverse Event|0|||
105746852|NCT00882999|364729114|FG006|Overall Study|Adverse Event|0|||
105943448|NCT04976855|365455055|FG001|Part II|Lost to Follow-up|0|||
105943449|NCT04976855|365455056|FG002|Part II|Lost to Follow-up|0|||
105943450|NCT04976855|365455057|FG003|Part II|Lost to Follow-up|0|||
105943451|NCT04976855|365455058|FG004|Part II|Lost to Follow-up|0|||
105943452|NCT04976855|365455059|FG005|Part II|Lost to Follow-up|1|||
105943453|NCT04976855|365455060|FG006|Part II|Lost to Follow-up|0|||
105943454|NCT05185453|365455063|FG000|Overall Study|Lost to Follow-up|13|||
105943455|NCT05185453|365455064|FG001|Overall Study|Lost to Follow-up|3|||
105943456|NCT01972659|365455077|FG000|Overall Study|Protocol Violation|2|||
105943457|NCT01972659|365455078|FG001|Overall Study|Protocol Violation|2|||
105943458|NCT01972659|365455077|FG000|Overall Study|problems realted to acceleromyograph|2|||
105943459|NCT01972659|365455078|FG001|Overall Study|problems realted to acceleromyograph|1|||
105943460|NCT03274466|365455096|FG000|Overall Study|Withdrawal by Subject|7|||
105943461|NCT03274466|365455097|FG001|Overall Study|Withdrawal by Subject|3|||
105943462|NCT03274466|365455096|FG000|Overall Study|Protocol Specified Withdrawal|5|||
105943463|NCT03274466|365455097|FG001|Overall Study|Protocol Specified Withdrawal|11|||
105943464|NCT03274466|365455096|FG000|Overall Study|Lost to Follow-up|5|||
105943465|NCT03274466|365455097|FG001|Overall Study|Lost to Follow-up|7|||
105943466|NCT03274466|365455096|FG000|Overall Study|Subject Non-compliance|0|||
106015811|NCT02592798|365723300|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
106015812|NCT02592798|365723301|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
106015813|NCT02592798|365723300|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
105746853|NCT00882999|364729108|FG000|Overall Study|Death|0|||
105746854|NCT00882999|364729109|FG001|Overall Study|Death|1|||
105746855|NCT00882999|364729110|FG002|Overall Study|Death|0|||
105746856|NCT00882999|364729111|FG003|Overall Study|Death|0|||
105746857|NCT00882999|364729112|FG004|Overall Study|Death|0|||
105746858|NCT00882999|364729113|FG005|Overall Study|Death|0|||
105746859|NCT00882999|364729114|FG006|Overall Study|Death|0|||
105746860|NCT00882999|364729108|FG000|Overall Study|Withdrawal by Subject|7|||
105746861|NCT00882999|364729109|FG001|Overall Study|Withdrawal by Subject|6|||
105746862|NCT00882999|364729110|FG002|Overall Study|Withdrawal by Subject|3|||
105746863|NCT00882999|364729111|FG003|Overall Study|Withdrawal by Subject|3|||
105746864|NCT00882999|364729112|FG004|Overall Study|Withdrawal by Subject|6|||
105746865|NCT00882999|364729113|FG005|Overall Study|Withdrawal by Subject|5|||
105746866|NCT00882999|364729114|FG006|Overall Study|Withdrawal by Subject|5|||
105746867|NCT00882999|364729108|FG000|Overall Study|Lost to Follow-up|0|||
105746868|NCT00882999|364729109|FG001|Overall Study|Lost to Follow-up|1|||
105746869|NCT00882999|364729110|FG002|Overall Study|Lost to Follow-up|1|||
105746870|NCT00882999|364729111|FG003|Overall Study|Lost to Follow-up|2|||
105746871|NCT00882999|364729112|FG004|Overall Study|Lost to Follow-up|1|||
105746872|NCT00882999|364729113|FG005|Overall Study|Lost to Follow-up|1|||
105746873|NCT00882999|364729114|FG006|Overall Study|Lost to Follow-up|2|||
105746874|NCT00882999|364729108|FG000|Overall Study|Physician Decision|1|||
105746875|NCT00882999|364729109|FG001|Overall Study|Physician Decision|0|||
105746876|NCT00882999|364729110|FG002|Overall Study|Physician Decision|0|||
105746877|NCT00882999|364729111|FG003|Overall Study|Physician Decision|0|||
105746878|NCT00882999|364729112|FG004|Overall Study|Physician Decision|0|||
105746879|NCT00882999|364729113|FG005|Overall Study|Physician Decision|1|||
105746880|NCT00882999|364729114|FG006|Overall Study|Physician Decision|1|||
105746881|NCT02586233|364729115|FG000|Overall Study|Randomized but did not receive treatment|0|||
105746882|NCT02586233|364729116|FG001|Overall Study|Randomized but did not receive treatment|1|||
105746883|NCT02586233|364729117|FG002|Overall Study|Randomized but did not receive treatment|0|||
105746884|NCT02586233|364729118|FG003|Overall Study|Randomized but did not receive treatment|0|||
105746885|NCT02586233|364729119|FG004|Overall Study|Randomized but did not receive treatment|0|||
105746886|NCT02586233|364729120|FG005|Overall Study|Randomized but did not receive treatment|2|||
105746887|NCT02586233|364729121|FG006|Overall Study|Randomized but did not receive treatment|2|||
105746888|NCT02586233|364729115|FG000|Overall Study|Death|0|||
105746889|NCT02586233|364729116|FG001|Overall Study|Death|1|||
105746890|NCT02586233|364729117|FG002|Overall Study|Death|0|||
105746891|NCT02586233|364729118|FG003|Overall Study|Death|0|||
105746892|NCT02586233|364729119|FG004|Overall Study|Death|2|||
105746893|NCT02586233|364729120|FG005|Overall Study|Death|0|||
105746894|NCT02586233|364729121|FG006|Overall Study|Death|0|||
105943467|NCT03274466|365455097|FG001|Overall Study|Subject Non-compliance|1|||
106015814|NCT02592798|365723301|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
105746895|NCT01894477|364729124|FG000|Overall Study|Protocol Violation|0|||
105943468|NCT03274466|365455096|FG000|Overall Study|Adverse Event|3|||
106015815|NCT02592798|365723300|FG000|Transition From DB2 to OLE|Other reasons|1|||
105746896|NCT01894477|364729125|FG001|Overall Study|Protocol Violation|1|||
105746897|NCT01894477|364729124|FG000|Overall Study|protocol changed due SC changed to cord|0|||
105943469|NCT03274466|365455097|FG001|Overall Study|Adverse Event|3|||
105746898|NCT01894477|364729125|FG001|Overall Study|protocol changed due SC changed to cord|1|||
105746899|NCT01757405|364729126|FG000|Overall Study|Lost to Follow-up|1|||
105746900|NCT01757405|364729127|FG001|Overall Study|Lost to Follow-up|1|||
105746901|NCT01757405|364729126|FG000|Overall Study|Withdrawal by Subject|0|||
105746902|NCT01757405|364729127|FG001|Overall Study|Withdrawal by Subject|1|||
105746903|NCT00238303|364729128|FG000|Overall Study|Withdrawal by Subject|11|||
106015816|NCT02592798|365723301|FG001|Transition From DB2 to OLE|Other reasons|0|||
105801109|NCT01571635|364928614|FG002|Overall Study|Adverse Event|2|||
105801110|NCT01571635|364928615|FG003|Overall Study|Adverse Event|3|||
105801111|NCT01571635|364928616|FG004|Overall Study|Adverse Event|5|||
105801112|NCT01571635|364928612|FG000|Overall Study|Other reasons|2|||
105801113|NCT01571635|364928613|FG001|Overall Study|Other reasons|1|||
105801114|NCT01571635|364928614|FG002|Overall Study|Other reasons|2|||
105801115|NCT01571635|364928615|FG003|Overall Study|Other reasons|2|||
105801116|NCT01571635|364928616|FG004|Overall Study|Other reasons|1|||
105801117|NCT01571635|364928612|FG000|Overall Study|Study terminated by sponsor|0|||
105801118|NCT01571635|364928613|FG001|Overall Study|Study terminated by sponsor|4|||
105801119|NCT01571635|364928614|FG002|Overall Study|Study terminated by sponsor|1|||
105801120|NCT01571635|364928615|FG003|Overall Study|Study terminated by sponsor|3|||
105801121|NCT01571635|364928616|FG004|Overall Study|Study terminated by sponsor|1|||
105801122|NCT01571635|364928612|FG000|Overall Study|Withdrew consent|1|||
105801123|NCT01571635|364928613|FG001|Overall Study|Withdrew consent|1|||
105801124|NCT01571635|364928614|FG002|Overall Study|Withdrew consent|2|||
105801125|NCT01571635|364928615|FG003|Overall Study|Withdrew consent|3|||
105801126|NCT01571635|364928616|FG004|Overall Study|Withdrew consent|0|||
105801127|NCT01571635|364928612|FG000|Overall Study|Lack of Efficacy|0|||
105801128|NCT01571635|364928613|FG001|Overall Study|Lack of Efficacy|2|||
105801129|NCT01571635|364928614|FG002|Overall Study|Lack of Efficacy|0|||
105801130|NCT01571635|364928615|FG003|Overall Study|Lack of Efficacy|1|||
105801131|NCT01571635|364928616|FG004|Overall Study|Lack of Efficacy|2|||
105801132|NCT02868281|364928617|FG000|Overall Study|Adverse Event|2|||
105801133|NCT02868281|364928618|FG001|Overall Study|Adverse Event|2|||
105801134|NCT02868281|364928617|FG000|Overall Study|Protocol Violation|13|||
105801135|NCT02868281|364928618|FG001|Overall Study|Protocol Violation|10|||
105801136|NCT02868281|364928617|FG000|Overall Study|Lost to Follow-up|3|||
105801137|NCT02868281|364928618|FG001|Overall Study|Lost to Follow-up|6|||
105801138|NCT02868281|364928617|FG000|Overall Study|Withdrawal by Subject|11|||
105801139|NCT02868281|364928618|FG001|Overall Study|Withdrawal by Subject|15|||
105801140|NCT02868281|364928617|FG000|Overall Study|Physician Decision|2|||
105801141|NCT02868281|364928618|FG001|Overall Study|Physician Decision|0|||
105801142|NCT02868281|364928617|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
105801143|NCT02868281|364928618|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
105801144|NCT02868281|364928617|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
105801145|NCT02868281|364928618|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
105801146|NCT02868281|364928617|FG000|Overall Study|Long journey/moving away|1|||
105801147|NCT02868281|364928618|FG001|Overall Study|Long journey/moving away|1|||
105801148|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
105801149|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
105801150|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
105801151|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
105801152|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
105801153|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
105801154|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
105801155|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801156|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
105943470|NCT03274466|365455096|FG000|Overall Study|Physician Decision|0|||
105746904|NCT00238303|364729129|FG001|Overall Study|Withdrawal by Subject|1|||
105746905|NCT00238303|364729130|FG002|Overall Study|Withdrawal by Subject|2|||
105746906|NCT00238303|364729128|FG000|Overall Study|Death|1|||
105746907|NCT00238303|364729129|FG001|Overall Study|Death|0|||
105746908|NCT00238303|364729130|FG002|Overall Study|Death|1|||
105746909|NCT00238303|364729128|FG000|Overall Study|Other Medical Problems|2|||
105746910|NCT00238303|364729129|FG001|Overall Study|Other Medical Problems|0|||
105746911|NCT00238303|364729130|FG002|Overall Study|Other Medical Problems|2|||
105746912|NCT00238303|364729128|FG000|Overall Study|Poor tolerance of study treatment|1|||
105746913|NCT00238303|364729129|FG001|Overall Study|Poor tolerance of study treatment|0|||
105746914|NCT00238303|364729130|FG002|Overall Study|Poor tolerance of study treatment|1|||
105943471|NCT03274466|365455097|FG001|Overall Study|Physician Decision|1|||
105746915|NCT00238303|364729128|FG000|Overall Study|Adverse Event|0|||
105746916|NCT00238303|364729129|FG001|Overall Study|Adverse Event|1|||
105801157|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
105801158|NCT00124449|364928619|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
105801159|NCT00124449|364928620|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
105801160|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
105801161|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
105801162|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
105801163|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
105801164|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
105801165|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
105943472|NCT03274466|365455096|FG000|Overall Study|Protocol Violation|3|||
105746917|NCT00238303|364729130|FG002|Overall Study|Adverse Event|3|||
105746918|NCT02561299|364729131|FG000|Overall Study|Death|2|||
105746919|NCT02561299|364729132|FG001|Overall Study|Death|4|||
105746920|NCT02561299|364729131|FG000|Overall Study|Lost to Follow-up|1|||
105746921|NCT02561299|364729132|FG001|Overall Study|Lost to Follow-up|0|||
105746922|NCT02561299|364729131|FG000|Overall Study|Withdrawal by Subject|2|||
105746923|NCT02561299|364729132|FG001|Overall Study|Withdrawal by Subject|2|||
105746924|NCT01592409|364729133|FG000|Overall Study|Withdrawal by Subject|0|||
105746925|NCT01592409|364729134|FG001|Overall Study|Withdrawal by Subject|1|||
105746926|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
105746927|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
105746928|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
105746929|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
105746930|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
105746931|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
105746932|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746933|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
105746934|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
105746935|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
105746936|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
105746937|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
105746938|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
105746939|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
105746940|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746941|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746942|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746943|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746944|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746945|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746946|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746947|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746948|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
105746949|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746950|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746951|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746952|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746953|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746954|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746955|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
105746956|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746957|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
105746958|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746959|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746960|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746961|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
105746962|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
105746963|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746964|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746965|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746966|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746967|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746968|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746969|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746970|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746971|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
105746972|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746973|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746974|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746975|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746976|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746977|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746978|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746979|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105943473|NCT03274466|365455097|FG001|Overall Study|Protocol Violation|3|||
105746980|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746981|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746982|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746983|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746984|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746985|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
105746986|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746987|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746988|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746989|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746990|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746991|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746992|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746993|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746994|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
105746995|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
105746996|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
105746997|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
105746998|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
105746999|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
105747000|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
105747001|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
105747002|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
105747003|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
105747004|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
105747005|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
105747006|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
105747007|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
105747008|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
105747009|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
105747010|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
105747011|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
105747012|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
105747013|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
105747014|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
105747015|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
105747016|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
105747017|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
105747018|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747019|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747020|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747021|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747022|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747023|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747024|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747025|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747026|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
105747027|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747028|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747029|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747030|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747031|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
105747032|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747033|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747034|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747035|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747036|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747037|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747038|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747039|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
105747040|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
106142483|NCT01563354|366181881|FG002|Core Phase|Lost to Follow-up|0|||
106142484|NCT01563354|366181879|FG000|Core Phase|Death|1|||
106142485|NCT01563354|366181880|FG001|Core Phase|Death|5|||
106142486|NCT01563354|366181881|FG002|Core Phase|Death|2|||
105801166|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
105801167|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
105801168|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
105801169|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
105801170|NCT00124449|364928619|FG000|18-Month Untreated Observation Period|Relocated|1|||
105801171|NCT00124449|364928620|FG001|18-Month Untreated Observation Period|Relocated|0|||
105801172|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
105801173|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
105801174|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
105801175|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
105801176|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
105801177|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
105801178|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
105801179|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
105801180|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
105801181|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
105801182|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
105801183|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
105801184|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
105801185|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
105801186|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
105801187|NCT00529568|364928621|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
105801188|NCT00529568|364928622|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
105801189|NCT00529568|364928623|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
105801190|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
105801191|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
105801192|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
105801193|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
105801194|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
105801195|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
105801196|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
105801197|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
105801198|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
105801199|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
105801200|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
105801201|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
105801202|NCT00529568|364928621|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
105801203|NCT00529568|364928622|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
105801204|NCT00529568|364928623|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
105801205|NCT00931385|364928624|FG000|Overall Study|Adverse Event|2|||
105801206|NCT00931385|364928625|FG001|Overall Study|Adverse Event|1|||
105801207|NCT00931385|364928626|FG002|Overall Study|Adverse Event|0|||
105801208|NCT00931385|364928627|FG003|Overall Study|Adverse Event|3|||
105801209|NCT00931385|364928624|FG000|Overall Study|Protocol Violation|0|||
105801210|NCT00931385|364928625|FG001|Overall Study|Protocol Violation|0|||
105801211|NCT00931385|364928626|FG002|Overall Study|Protocol Violation|1|||
105801212|NCT00931385|364928627|FG003|Overall Study|Protocol Violation|0|||
105801213|NCT00931385|364928624|FG000|Overall Study|Withdrawal by Subject|0|||
105801214|NCT00931385|364928625|FG001|Overall Study|Withdrawal by Subject|1|||
105943474|NCT01107886|365455101|FG000|Overall Study|Lost to Follow-up|15|||
105943475|NCT01107886|365455102|FG001|Overall Study|Lost to Follow-up|13|||
105943476|NCT01107886|365455101|FG000|Overall Study|Withdrawal by Subject|180|||
105943477|NCT01107886|365455102|FG001|Overall Study|Withdrawal by Subject|196|||
105943478|NCT01107886|365455101|FG000|Overall Study|Administrative withdrawal of consent|7|||
105943479|NCT01107886|365455102|FG001|Overall Study|Administrative withdrawal of consent|5|||
105943480|NCT01649869|365455107|FG000|Overall Study|Family member illness|1|||
105943481|NCT01649869|365455108|FG001|Overall Study|Family member illness|0|||
106142487|NCT01563354|366181879|FG000|Core Phase|Diseasse progression|18|||
106142488|NCT01563354|366181880|FG001|Core Phase|Diseasse progression|7|||
106142489|NCT01563354|366181881|FG002|Core Phase|Diseasse progression|8|||
106142490|NCT01563354|366181879|FG000|Core Phase|Protocol deviation|2|||
106142491|NCT01563354|366181880|FG001|Core Phase|Protocol deviation|0|||
105801215|NCT00931385|364928626|FG002|Overall Study|Withdrawal by Subject|0|||
105943482|NCT01649869|365455107|FG000|Overall Study|Required treatment outside protocol|1|||
105943483|NCT01649869|365455108|FG001|Overall Study|Required treatment outside protocol|0|||
105943484|NCT01649869|365455107|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
105943485|NCT01649869|365455108|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
105943486|NCT02776735|365455109|FG000|Overall Study|Adverse Event|0|||
106142492|NCT01563354|366181881|FG002|Core Phase|Protocol deviation|0|||
105747041|NCT02052778|364729137|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747042|NCT02052778|364729138|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747043|NCT02052778|364729139|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747044|NCT02052778|364729140|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747045|NCT02052778|364729141|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747046|NCT02052778|364729142|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
105747047|NCT02052778|364729143|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747048|NCT02052778|364729144|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747049|NCT02052778|364729145|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747050|NCT02052778|364729146|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747051|NCT02052778|364729147|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747052|NCT02052778|364729148|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747053|NCT02052778|364729149|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
105747054|NCT02052778|364729150|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747055|NCT02052778|364729151|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747056|NCT02052778|364729152|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747057|NCT02052778|364729153|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747058|NCT02052778|364729154|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747059|NCT02052778|364729155|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747060|NCT02052778|364729156|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747061|NCT02052778|364729157|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747062|NCT02052778|364729158|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747063|NCT02052778|364729159|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
105747064|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747065|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747066|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747067|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747068|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747069|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747070|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747071|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747072|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747073|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747074|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747075|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747076|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747077|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747078|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
105747079|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
105747080|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
105747081|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
105747082|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
105747083|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
105747084|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
105747085|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
105747086|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
105747087|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747088|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747089|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747090|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747091|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747092|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747093|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747094|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747095|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747096|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747097|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747098|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747099|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747100|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105760786|NCT03627494|364776200|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
105943487|NCT02776735|365455110|FG001|Overall Study|Adverse Event|0|||
105943488|NCT02776735|365455111|FG002|Overall Study|Adverse Event|0|||
105943489|NCT02776735|365455112|FG003|Overall Study|Adverse Event|1|||
105943490|NCT02776735|365455113|FG004|Overall Study|Adverse Event|0|||
105943491|NCT02776735|365455114|FG005|Overall Study|Adverse Event|1|||
105943492|NCT02776735|365455109|FG000|Overall Study|Lost to Follow-up|0|||
105943493|NCT02776735|365455110|FG001|Overall Study|Lost to Follow-up|0|||
105943494|NCT02776735|365455111|FG002|Overall Study|Lost to Follow-up|0|||
105943495|NCT02776735|365455112|FG003|Overall Study|Lost to Follow-up|1|||
105943496|NCT02776735|365455113|FG004|Overall Study|Lost to Follow-up|0|||
105943497|NCT02776735|365455114|FG005|Overall Study|Lost to Follow-up|0|||
105943498|NCT02776735|365455109|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105943499|NCT02776735|365455110|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105943500|NCT02776735|365455111|FG002|Overall Study|Withdrawal by parent/guardian|2|||
105943501|NCT02776735|365455112|FG003|Overall Study|Withdrawal by parent/guardian|2|||
105943502|NCT02776735|365455113|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105943503|NCT02776735|365455114|FG005|Overall Study|Withdrawal by parent/guardian|0|||
105943504|NCT02776735|365455109|FG000|Overall Study|Withdrawal by Subject|1|||
105943505|NCT02776735|365455110|FG001|Overall Study|Withdrawal by Subject|0|||
105943506|NCT02776735|365455111|FG002|Overall Study|Withdrawal by Subject|0|||
105943507|NCT02776735|365455112|FG003|Overall Study|Withdrawal by Subject|0|||
105943508|NCT02776735|365455113|FG004|Overall Study|Withdrawal by Subject|0|||
105943509|NCT02776735|365455114|FG005|Overall Study|Withdrawal by Subject|1|||
105943510|NCT02776735|365455109|FG000|Overall Study|Other|0|||
105943511|NCT02776735|365455110|FG001|Overall Study|Other|0|||
105943512|NCT02776735|365455111|FG002|Overall Study|Other|3|||
105943513|NCT02776735|365455112|FG003|Overall Study|Other|0|||
105943514|NCT02776735|365455113|FG004|Overall Study|Other|0|||
105943515|NCT02776735|365455114|FG005|Overall Study|Other|0|||
105943516|NCT03332056|365456648|FG000|Overall Study|Incomplete questionnaires|8|||
105943517|NCT03332056|365456649|FG001|Overall Study|Incomplete questionnaires|9|||
105943518|NCT03332056|365456648|FG000|Overall Study|Passed stone prior to surgery date|1|||
105943519|NCT03332056|365456649|FG001|Overall Study|Passed stone prior to surgery date|0|||
105943520|NCT03332056|365456648|FG000|Overall Study|Did not require a ureteral stent|0|||
105943521|NCT03332056|365456649|FG001|Overall Study|Did not require a ureteral stent|1|||
106015817|NCT02592798|365723300|FG000|Open Label Period (OLE)|Other reasons|0|||
106015818|NCT02592798|365723301|FG001|Open Label Period (OLE)|Other reasons|2|||
105747101|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
105747102|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
105747103|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747104|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
105747105|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
105747106|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
105747107|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
105747108|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
105747109|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
105747110|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747111|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747112|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747113|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747114|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747115|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747116|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747117|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747118|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747119|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747120|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747121|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747122|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747123|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747124|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
105943522|NCT01935947|365456652|FG000|Overall Study|Adverse Event|0|||
105943523|NCT01935947|365456653|FG001|Overall Study|Adverse Event|2|||
105943524|NCT01935947|365456654|FG002|Overall Study|Adverse Event|0|||
105943525|NCT01935947|365456652|FG000|Overall Study|Diease Progression|2|||
105943526|NCT01935947|365456653|FG001|Overall Study|Diease Progression|2|||
105943527|NCT01935947|365456654|FG002|Overall Study|Diease Progression|2|||
105943528|NCT01935947|365456652|FG000|Overall Study|Death|1|||
105943529|NCT01935947|365456653|FG001|Overall Study|Death|0|||
105943530|NCT01935947|365456654|FG002|Overall Study|Death|0|||
105943531|NCT00573768|365456656|FG000|Overall Study|Adverse Event|1|||
105943532|NCT00573768|365456657|FG001|Overall Study|Adverse Event|1|||
105943533|NCT00573768|365456658|FG002|Overall Study|Adverse Event|2|||
105943534|NCT00573768|365456656|FG000|Overall Study|Protocol Violation|1|||
105943535|NCT00573768|365456657|FG001|Overall Study|Protocol Violation|0|||
105943536|NCT00573768|365456658|FG002|Overall Study|Protocol Violation|1|||
105943537|NCT00573768|365456656|FG000|Overall Study|Withdrawal by Subject|0|||
105943538|NCT00573768|365456657|FG001|Overall Study|Withdrawal by Subject|1|||
105943539|NCT00573768|365456658|FG002|Overall Study|Withdrawal by Subject|0|||
105943540|NCT00573768|365456656|FG000|Overall Study|Lost to Follow-up|0|||
105943541|NCT00573768|365456657|FG001|Overall Study|Lost to Follow-up|0|||
105943542|NCT00573768|365456658|FG002|Overall Study|Lost to Follow-up|1|||
105943543|NCT03243084|365456659|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
105943544|NCT03243084|365456660|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
105943545|NCT03322566|365456663|FG000|Overall Study|Death|34|||
105943546|NCT03322566|365456664|FG001|Overall Study|Death|35|||
105943547|NCT03322566|365456665|FG002|Overall Study|Death|23|||
105943548|NCT03322566|365456663|FG000|Overall Study|Physician Decision|6|||
105943549|NCT03322566|365456664|FG001|Overall Study|Physician Decision|7|||
105943550|NCT03322566|365456665|FG002|Overall Study|Physician Decision|2|||
105943551|NCT03322566|365456663|FG000|Overall Study|Withdrawal by Subject|4|||
105943552|NCT03322566|365456664|FG001|Overall Study|Withdrawal by Subject|3|||
105943553|NCT03322566|365456665|FG002|Overall Study|Withdrawal by Subject|6|||
105943554|NCT03322566|365456663|FG000|Overall Study|Lost to Follow-up|0|||
105943555|NCT03322566|365456664|FG001|Overall Study|Lost to Follow-up|0|||
105943556|NCT03322566|365456665|FG002|Overall Study|Lost to Follow-up|1|||
105943557|NCT03322566|365456663|FG000|Overall Study|Study terminated by sponsor|1|||
105747125|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
105747126|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
105747127|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747128|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
105747129|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
105747130|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747131|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747132|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
105747133|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747134|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747135|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747136|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747137|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747138|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747139|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747140|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747141|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747142|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747143|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747144|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747145|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747146|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747147|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
105747148|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
105747149|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747150|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747151|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747152|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747153|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747154|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747155|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
105747156|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747157|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747158|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747159|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105943558|NCT03322566|365456664|FG001|Overall Study|Study terminated by sponsor|0|||
105943559|NCT03322566|365456665|FG002|Overall Study|Study terminated by sponsor|1|||
105943560|NCT02314923|365456666|FG000|Overall Study|Death|0|||
105943561|NCT02314923|365456667|FG001|Overall Study|Death|0|||
105943562|NCT02314923|365456668|FG002|Overall Study|Death|0|||
105943563|NCT02314923|365456669|FG003|Overall Study|Death|1|||
105943564|NCT02314923|365456670|FG004|Overall Study|Death|0|||
105943565|NCT02314923|365456671|FG005|Overall Study|Death|0|||
105943566|NCT02314923|365456672|FG006|Overall Study|Death|0|||
105943567|NCT02314923|365456673|FG007|Overall Study|Death|0|||
105943568|NCT02314923|365456674|FG008|Overall Study|Death|0|||
105943569|NCT02314923|365456675|FG009|Overall Study|Death|0|||
105943570|NCT02314923|365456666|FG000|Overall Study|Lost to Follow-up|2|||
105943571|NCT02314923|365456667|FG001|Overall Study|Lost to Follow-up|3|||
105943572|NCT02314923|365456668|FG002|Overall Study|Lost to Follow-up|1|||
105943573|NCT02314923|365456669|FG003|Overall Study|Lost to Follow-up|0|||
105943574|NCT02314923|365456670|FG004|Overall Study|Lost to Follow-up|0|||
105943575|NCT02314923|365456671|FG005|Overall Study|Lost to Follow-up|0|||
105943576|NCT02314923|365456672|FG006|Overall Study|Lost to Follow-up|3|||
105943577|NCT02314923|365456673|FG007|Overall Study|Lost to Follow-up|4|||
105943578|NCT02314923|365456674|FG008|Overall Study|Lost to Follow-up|2|||
105943579|NCT02314923|365456675|FG009|Overall Study|Lost to Follow-up|0|||
105943580|NCT02314923|365456666|FG000|Overall Study|Withdrawal by Subject|0|||
105943581|NCT02314923|365456667|FG001|Overall Study|Withdrawal by Subject|0|||
105943582|NCT02314923|365456668|FG002|Overall Study|Withdrawal by Subject|1|||
105943583|NCT02314923|365456669|FG003|Overall Study|Withdrawal by Subject|0|||
105943584|NCT02314923|365456670|FG004|Overall Study|Withdrawal by Subject|1|||
105943585|NCT02314923|365456671|FG005|Overall Study|Withdrawal by Subject|0|||
105943586|NCT02314923|365456672|FG006|Overall Study|Withdrawal by Subject|1|||
105943587|NCT02314923|365456673|FG007|Overall Study|Withdrawal by Subject|0|||
105943588|NCT02314923|365456674|FG008|Overall Study|Withdrawal by Subject|0|||
105943589|NCT02314923|365456675|FG009|Overall Study|Withdrawal by Subject|0|||
105943590|NCT02314923|365456666|FG000|Overall Study|Physician Decision|0|||
105943591|NCT02314923|365456667|FG001|Overall Study|Physician Decision|1|||
105943592|NCT02314923|365456668|FG002|Overall Study|Physician Decision|0|||
105943593|NCT02314923|365456669|FG003|Overall Study|Physician Decision|0|||
105943594|NCT02314923|365456670|FG004|Overall Study|Physician Decision|0|||
105943595|NCT02314923|365456671|FG005|Overall Study|Physician Decision|0|||
105943596|NCT02314923|365456672|FG006|Overall Study|Physician Decision|0|||
105943597|NCT02314923|365456673|FG007|Overall Study|Physician Decision|0|||
105943598|NCT02314923|365456674|FG008|Overall Study|Physician Decision|0|||
105943599|NCT02314923|365456675|FG009|Overall Study|Physician Decision|0|||
105943600|NCT02314923|365456666|FG000|Overall Study|Participant unavailable|0|||
105943601|NCT02314923|365456667|FG001|Overall Study|Participant unavailable|0|||
105943602|NCT02314923|365456668|FG002|Overall Study|Participant unavailable|0|||
105943603|NCT02314923|365456669|FG003|Overall Study|Participant unavailable|0|||
105943604|NCT02314923|365456670|FG004|Overall Study|Participant unavailable|0|||
105943605|NCT02314923|365456671|FG005|Overall Study|Participant unavailable|1|||
105943606|NCT02314923|365456672|FG006|Overall Study|Participant unavailable|0|||
105943607|NCT02314923|365456673|FG007|Overall Study|Participant unavailable|0|||
105943608|NCT02314923|365456674|FG008|Overall Study|Participant unavailable|0|||
105943609|NCT02314923|365456675|FG009|Overall Study|Participant unavailable|0|||
105943610|NCT02314923|365456666|FG000|Overall Study|Screen failure|0|||
105943611|NCT02314923|365456667|FG001|Overall Study|Screen failure|0|||
105943612|NCT02314923|365456668|FG002|Overall Study|Screen failure|0|||
105943613|NCT02314923|365456669|FG003|Overall Study|Screen failure|0|||
105943614|NCT02314923|365456670|FG004|Overall Study|Screen failure|0|||
105943615|NCT02314923|365456671|FG005|Overall Study|Screen failure|0|||
105943616|NCT02314923|365456672|FG006|Overall Study|Screen failure|1|||
105943617|NCT02314923|365456673|FG007|Overall Study|Screen failure|0|||
105943618|NCT02314923|365456674|FG008|Overall Study|Screen failure|0|||
105943619|NCT02314923|365456675|FG009|Overall Study|Screen failure|0|||
105943620|NCT02314923|365456666|FG000|Overall Study|Participant relocation|1|||
105943621|NCT02314923|365456667|FG001|Overall Study|Participant relocation|0|||
105943622|NCT02314923|365456668|FG002|Overall Study|Participant relocation|0|||
105943623|NCT02314923|365456669|FG003|Overall Study|Participant relocation|0|||
105943624|NCT02314923|365456670|FG004|Overall Study|Participant relocation|0|||
105943625|NCT02314923|365456671|FG005|Overall Study|Participant relocation|0|||
105943626|NCT02314923|365456672|FG006|Overall Study|Participant relocation|0|||
105943627|NCT02314923|365456673|FG007|Overall Study|Participant relocation|1|||
106015819|NCT02592798|365723300|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
105747160|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747161|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105943628|NCT02314923|365456674|FG008|Overall Study|Participant relocation|0|||
105943629|NCT02314923|365456675|FG009|Overall Study|Participant relocation|0|||
105943630|NCT00725985|365456676|FG000|ITP- Treatment Disposition|Adverse Event|20|||
105943631|NCT00725985|365456677|FG001|ITP- Treatment Disposition|Adverse Event|10|||
105943632|NCT00725985|365456678|FG002|ITP- Treatment Disposition|Adverse Event|5|||
105943633|NCT00725985|365456679|FG003|ITP- Treatment Disposition|Adverse Event|0|||
105943634|NCT00725985|365456680|FG004|ITP- Treatment Disposition|Adverse Event|0|||
105943635|NCT00725985|365456681|FG005|ITP- Treatment Disposition|Adverse Event|0|||
105943636|NCT00725985|365456682|FG006|ITP- Treatment Disposition|Adverse Event|0|||
105943637|NCT00725985|365456683|FG007|ITP- Treatment Disposition|Adverse Event|0|||
105943638|NCT00725985|365456684|FG008|ITP- Treatment Disposition|Adverse Event|0|||
105943639|NCT00725985|365456685|FG009|ITP- Treatment Disposition|Adverse Event|0|||
105943640|NCT00725985|365456686|FG010|ITP- Treatment Disposition|Adverse Event|0|||
105943641|NCT00725985|365456687|FG011|ITP- Treatment Disposition|Adverse Event|0|||
105943642|NCT00725985|365456676|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943643|NCT00725985|365456677|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943644|NCT00725985|365456678|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
105943645|NCT00725985|365456679|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943646|NCT00725985|365456680|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943647|NCT00725985|365456681|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943648|NCT00725985|365456682|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943649|NCT00725985|365456683|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943650|NCT00725985|365456684|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943651|NCT00725985|365456685|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943652|NCT00725985|365456686|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943653|NCT00725985|365456687|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
105943654|NCT00725985|365456676|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
105943655|NCT00725985|365456677|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
105943656|NCT00725985|365456678|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
105943657|NCT00725985|365456679|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
105943658|NCT00725985|365456680|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
105943659|NCT00725985|365456681|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
105943660|NCT00725985|365456682|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
105943661|NCT00725985|365456683|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
105943662|NCT00725985|365456684|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
105943663|NCT00725985|365456685|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
105943664|NCT00725985|365456686|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
105943665|NCT00725985|365456687|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
105943666|NCT00725985|365456676|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
105943667|NCT00725985|365456677|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
105943668|NCT00725985|365456678|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
105943669|NCT00725985|365456679|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
105943670|NCT00725985|365456680|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
105943671|NCT00725985|365456681|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
105943672|NCT00725985|365456682|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
105943673|NCT00725985|365456683|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
105943674|NCT00725985|365456684|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
105943675|NCT00725985|365456685|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
105943676|NCT00725985|365456686|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
105943677|NCT00725985|365456687|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
105943678|NCT00725985|365456676|FG000|ITP- Treatment Disposition|Other|50|||
105943679|NCT00725985|365456677|FG001|ITP- Treatment Disposition|Other|38|||
105943680|NCT00725985|365456678|FG002|ITP- Treatment Disposition|Other|24|||
105943681|NCT00725985|365456679|FG003|ITP- Treatment Disposition|Other|0|||
105943682|NCT00725985|365456680|FG004|ITP- Treatment Disposition|Other|0|||
105943683|NCT00725985|365456681|FG005|ITP- Treatment Disposition|Other|0|||
105943684|NCT00725985|365456682|FG006|ITP- Treatment Disposition|Other|0|||
105943685|NCT00725985|365456683|FG007|ITP- Treatment Disposition|Other|0|||
105943686|NCT00725985|365456684|FG008|ITP- Treatment Disposition|Other|0|||
105943687|NCT00725985|365456685|FG009|ITP- Treatment Disposition|Other|0|||
105943688|NCT00725985|365456686|FG010|ITP- Treatment Disposition|Other|0|||
105943689|NCT00725985|365456687|FG011|ITP- Treatment Disposition|Other|0|||
105943690|NCT00725985|365456676|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943691|NCT00725985|365456677|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943692|NCT00725985|365456678|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943693|NCT00725985|365456679|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
105943694|NCT00725985|365456680|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
105943695|NCT00725985|365456681|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
105943696|NCT00725985|365456682|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943697|NCT00725985|365456683|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943698|NCT00725985|365456684|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943699|NCT00725985|365456685|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943700|NCT00725985|365456686|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943701|NCT00725985|365456687|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
105943702|NCT00725985|365456676|FG000|OLMP (Up to 96 Weeks)|Death|0|||
105943703|NCT00725985|365456677|FG001|OLMP (Up to 96 Weeks)|Death|0|||
105943704|NCT00725985|365456678|FG002|OLMP (Up to 96 Weeks)|Death|0|||
105943705|NCT00725985|365456679|FG003|OLMP (Up to 96 Weeks)|Death|0|||
105943706|NCT00725985|365456680|FG004|OLMP (Up to 96 Weeks)|Death|1|||
105943707|NCT00725985|365456681|FG005|OLMP (Up to 96 Weeks)|Death|0|||
105943708|NCT00725985|365456682|FG006|OLMP (Up to 96 Weeks)|Death|0|||
105943709|NCT00725985|365456683|FG007|OLMP (Up to 96 Weeks)|Death|0|||
105943710|NCT00725985|365456684|FG008|OLMP (Up to 96 Weeks)|Death|0|||
106015820|NCT02592798|365723301|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
105943711|NCT00725985|365456685|FG009|OLMP (Up to 96 Weeks)|Death|0|||
106142493|NCT01563354|366181879|FG000|Core Phase|PI decision - did not enter extension|0|||
106142494|NCT01563354|366181880|FG001|Core Phase|PI decision - did not enter extension|1|||
106142495|NCT01563354|366181881|FG002|Core Phase|PI decision - did not enter extension|0|||
106142496|NCT01563354|366181879|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
106142497|NCT01563354|366181880|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
106142498|NCT01563354|366181881|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
106142499|NCT01563354|366181879|FG000|Extension Phase|Adverse Event|0|||
106142500|NCT01563354|366181880|FG001|Extension Phase|Adverse Event|3|||
106142501|NCT01563354|366181881|FG002|Extension Phase|Adverse Event|2|||
106142502|NCT01563354|366181879|FG000|Extension Phase|Withdrawal by Subject|0|||
105747162|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747163|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747164|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747165|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747166|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747167|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747168|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747169|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747170|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
105747171|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
105747172|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747173|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747174|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747175|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
105747176|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747177|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747178|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
105747179|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
105747180|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
105747181|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
105747182|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
105747183|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
105747184|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
105747185|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
105747186|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
105747187|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
105747188|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
105747189|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
105747190|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
105747191|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
105747192|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
105747193|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
105747194|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
105747195|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
105747196|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
105747197|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
105747198|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
105747199|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
105747200|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
105747201|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
105747202|NCT02052778|364729137|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747203|NCT02052778|364729138|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747204|NCT02052778|364729139|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747205|NCT02052778|364729140|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747206|NCT02052778|364729141|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747207|NCT02052778|364729142|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747208|NCT02052778|364729143|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747209|NCT02052778|364729144|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747210|NCT02052778|364729145|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747211|NCT02052778|364729146|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747212|NCT02052778|364729147|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747213|NCT02052778|364729148|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105943712|NCT00725985|365456686|FG010|OLMP (Up to 96 Weeks)|Death|0|||
105943713|NCT00725985|365456687|FG011|OLMP (Up to 96 Weeks)|Death|0|||
106142503|NCT01563354|366181880|FG001|Extension Phase|Withdrawal by Subject|1|||
106142504|NCT01563354|366181881|FG002|Extension Phase|Withdrawal by Subject|0|||
106142505|NCT01563354|366181879|FG000|Extension Phase|Administration problems|3|||
105747214|NCT02052778|364729149|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747215|NCT02052778|364729150|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747216|NCT02052778|364729151|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
105747217|NCT02052778|364729152|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
105747218|NCT02052778|364729153|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
105747219|NCT02052778|364729154|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747220|NCT02052778|364729155|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
105747221|NCT02052778|364729156|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747222|NCT02052778|364729157|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747223|NCT02052778|364729158|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747224|NCT02052778|364729159|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
105747225|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747226|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747227|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747228|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747229|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747230|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747231|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747232|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747233|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747234|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747235|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747236|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747237|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747238|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747239|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747240|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747241|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747242|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747243|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105943714|NCT00725985|365456676|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943715|NCT00725985|365456677|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105747244|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747245|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747246|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
105747247|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
105747248|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747249|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747250|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747251|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747252|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747253|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747254|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747255|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747256|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747257|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747258|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105943716|NCT00725985|365456678|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943717|NCT00725985|365456679|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
105943718|NCT00725985|365456680|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943719|NCT00725985|365456681|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943720|NCT00725985|365456682|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943721|NCT00725985|365456683|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943722|NCT00725985|365456684|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943723|NCT00725985|365456685|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943724|NCT00725985|365456686|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943725|NCT00725985|365456687|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
105943726|NCT00725985|365456676|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943727|NCT00725985|365456677|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943728|NCT00725985|365456678|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943729|NCT00725985|365456679|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943730|NCT00725985|365456680|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943731|NCT00725985|365456681|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
105943732|NCT00725985|365456682|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943733|NCT00725985|365456683|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
105747259|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747260|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747261|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747262|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105943734|NCT00725985|365456684|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
105747263|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747264|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747265|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747266|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747267|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747268|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747269|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
105747270|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
105747271|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747272|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747273|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747274|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747275|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747276|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747277|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747278|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747279|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747280|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747281|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747282|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747283|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747284|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747285|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747286|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747287|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747288|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747289|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747290|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747291|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747292|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
105747293|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
105747294|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747295|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747296|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747297|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747298|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747299|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747300|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747301|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747302|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747303|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747304|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747305|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747306|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747307|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747308|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747309|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747310|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747311|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747312|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747313|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747314|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747315|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
105747316|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
105747317|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747318|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747319|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747320|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747321|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747322|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747323|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747324|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
106142506|NCT01563354|366181880|FG001|Extension Phase|Administration problems|2|||
106142507|NCT01563354|366181881|FG002|Extension Phase|Administration problems|3|||
106142508|NCT01563354|366181879|FG000|Extension Phase|Disease progression|9|||
106142509|NCT01563354|366181880|FG001|Extension Phase|Disease progression|8|||
106142510|NCT01563354|366181881|FG002|Extension Phase|Disease progression|10|||
106142511|NCT00139737|366181884|FG000|Overall Study|Withdrawal by Subject|190|||
106142512|NCT00139737|366181884|FG000|Overall Study|Adverse Event|58|||
106142513|NCT00139737|366181884|FG000|Overall Study|Lack of Efficacy|40|||
106142514|NCT00139737|366181884|FG000|Overall Study|Lost to Follow-up|8|||
106142515|NCT00139737|366181884|FG000|Overall Study|Death|3|||
106142516|NCT00139737|366181884|FG000|Overall Study|Laboratory Abnormality|2|||
106142517|NCT00139737|366181884|FG000|Overall Study|Protocol Violation|18|||
106142518|NCT00139737|366181884|FG000|Overall Study|Withdrew During Screening Phase|8|||
106142519|NCT00139737|366181884|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
106142520|NCT00139737|366181884|FG000|Overall Study|Screened, Not Treated|13|||
105747325|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747326|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747327|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747328|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747329|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747330|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747331|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747332|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747333|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747334|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747335|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747336|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747337|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747338|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
105747339|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
105747340|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
105747341|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
105747342|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
105747343|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
105747344|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
105747345|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
105747346|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
105747347|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
105747348|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
105747349|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
105747350|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
105747351|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
105747352|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
105747353|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
105747354|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
105747355|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
105747356|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
105747357|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
105747358|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
105747359|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
105747360|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
105747361|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
105747362|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
105747363|NCT02052778|364729137|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747364|NCT02052778|364729138|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747365|NCT02052778|364729139|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747366|NCT02052778|364729140|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747367|NCT02052778|364729141|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747368|NCT02052778|364729142|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747369|NCT02052778|364729143|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747370|NCT02052778|364729144|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747371|NCT02052778|364729145|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747372|NCT02052778|364729146|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747373|NCT02052778|364729147|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747374|NCT02052778|364729148|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747375|NCT02052778|364729149|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747376|NCT02052778|364729150|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
106142521|NCT01460342|366181887|FG000|Overall Study|Adverse Event|5|||
106142522|NCT01460342|366181888|FG001|Overall Study|Adverse Event|4|||
106142523|NCT01460342|366181887|FG000|Overall Study|Lost to Follow-up|1|||
106142524|NCT01460342|366181888|FG001|Overall Study|Lost to Follow-up|2|||
106142525|NCT01460342|366181887|FG000|Overall Study|Protocol Violation|0|||
106142526|NCT01460342|366181888|FG001|Overall Study|Protocol Violation|1|||
106142527|NCT01460342|366181887|FG000|Overall Study|Withdrawal by Subject|3|||
106142528|NCT01460342|366181888|FG001|Overall Study|Withdrawal by Subject|4|||
106142529|NCT01460342|366181887|FG000|Overall Study|Physician Decision|1|||
105747377|NCT02052778|364729151|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747378|NCT02052778|364729152|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747379|NCT02052778|364729153|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747380|NCT02052778|364729154|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747381|NCT02052778|364729155|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747382|NCT02052778|364729156|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747383|NCT02052778|364729157|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747384|NCT02052778|364729158|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
105747385|NCT02052778|364729159|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
105747386|NCT01994226|364729162|FG000|Overall Study|Protocol Violation|13|||
105747387|NCT01994226|364729163|FG001|Overall Study|Protocol Violation|10|||
105747388|NCT01994226|364729162|FG000|Overall Study|Early Cessation of treatment|6|||
105747389|NCT01994226|364729163|FG001|Overall Study|Early Cessation of treatment|11|||
105747390|NCT01576016|364729168|FG000|Lead Safety|Death|132|||
105747391|NCT01576016|364729169|FG001|Lead Safety|Death|0|||
105747392|NCT01576016|364729168|FG000|Lead Safety|Withdrawal by Subject|81|||
105747393|NCT01576016|364729169|FG001|Lead Safety|Withdrawal by Subject|0|||
105747394|NCT01576016|364729168|FG000|Lead Safety|System Explanted without Replacement|24|||
105747395|NCT01576016|364729169|FG001|Lead Safety|System Explanted without Replacement|0|||
105747396|NCT01576016|364729168|FG000|Lead Safety|Physician Decision|14|||
105747397|NCT01576016|364729169|FG001|Lead Safety|Physician Decision|0|||
105747398|NCT01576016|364729168|FG000|Lead Safety|Lost to Follow-up|13|||
105747399|NCT01576016|364729169|FG001|Lead Safety|Lost to Follow-up|0|||
105747400|NCT01576016|364729168|FG000|Lead Safety|Unsuccessful implant|2|||
105747401|NCT01576016|364729169|FG001|Lead Safety|Unsuccessful implant|0|||
105747402|NCT01576016|364729168|FG000|Lead Safety|Sponsor request|1|||
105747403|NCT01576016|364729169|FG001|Lead Safety|Sponsor request|0|||
105747404|NCT01576016|364729168|FG000|Lead Safety|Device replaced with CRT-D|1|||
105747405|NCT01576016|364729169|FG001|Lead Safety|Device replaced with CRT-D|0|||
105747406|NCT01576016|364729168|FG000|Lead Safety|Patient on Palliative Care|1|||
105747407|NCT01576016|364729169|FG001|Lead Safety|Patient on Palliative Care|0|||
105747408|NCT01576016|364729168|FG000|Lead Safety|Patient noncompliance|1|||
105747409|NCT01576016|364729169|FG001|Lead Safety|Patient noncompliance|0|||
105747410|NCT01576016|364729168|FG000|Lead Safety|Too far from study site|1|||
105747411|NCT01576016|364729169|FG001|Lead Safety|Too far from study site|0|||
105747412|NCT01576016|364729168|FG000|Lead Safety|System deactivated|1|||
105747413|NCT01576016|364729169|FG001|Lead Safety|System deactivated|0|||
105747414|NCT01576016|364729168|FG000|Lead Safety|Patient no longer followed by study PI|1|||
105747415|NCT01576016|364729169|FG001|Lead Safety|Patient no longer followed by study PI|0|||
105747416|NCT01576016|364729168|FG000|MRI Safety|Withdrawal by Subject|0|||
105747417|NCT01576016|364729169|FG001|MRI Safety|Withdrawal by Subject|10|||
105747418|NCT01576016|364729168|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
105747419|NCT01576016|364729169|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
105747420|NCT01576016|364729168|FG000|MRI Safety|Has not yet completed MRI scan|0|||
105747421|NCT01576016|364729169|FG001|MRI Safety|Has not yet completed MRI scan|56|||
105747422|NCT01576016|364729168|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
105747423|NCT01576016|364729169|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
105747424|NCT02411201|364729170|FG000|Overall Study|Adverse Event|2|||
105747425|NCT02411201|364729170|FG000|Overall Study|Withdrawal by Subject|2|||
105747426|NCT02411201|364729170|FG000|Overall Study|Age group completed|2|||
105747427|NCT01260467|364729171|FG000|Overall Study|Withdrawal by Subject|2|||
105747428|NCT02488551|364729172|FG000|Overall Study|Lost to Follow-up|4|||
105747429|NCT02488551|364729173|FG001|Overall Study|Lost to Follow-up|7|||
105747430|NCT02488551|364729174|FG002|Overall Study|Lost to Follow-up|0|||
105747431|NCT02488551|364729175|FG003|Overall Study|Lost to Follow-up|0|||
105747432|NCT02488551|364729172|FG000|Overall Study|Military Deployment|1|||
105747433|NCT02488551|364729173|FG001|Overall Study|Military Deployment|1|||
105747434|NCT02488551|364729174|FG002|Overall Study|Military Deployment|0|||
105747435|NCT02488551|364729175|FG003|Overall Study|Military Deployment|0|||
105747436|NCT00798694|364729176|FG000|Overall Study|Lost to Follow-up|1|||
105747437|NCT00798694|364729177|FG001|Overall Study|Lost to Follow-up|1|||
105747438|NCT00798694|364729176|FG000|Overall Study|Physician Decision|1|||
105801216|NCT00931385|364928627|FG003|Overall Study|Withdrawal by Subject|1|||
106142530|NCT01460342|366181888|FG001|Overall Study|Physician Decision|3|||
106142531|NCT01460342|366181887|FG000|Overall Study|Lack of Efficacy|1|||
106142532|NCT01460342|366181888|FG001|Overall Study|Lack of Efficacy|0|||
105747439|NCT00798694|364729177|FG001|Overall Study|Physician Decision|0|||
105747440|NCT01409031|364729180|FG000|Overall Study|transferred to other hosp|1|||
105747441|NCT01409031|364729181|FG001|Overall Study|transferred to other hosp|0|||
105747442|NCT04507867|364729193|FG000|Overall Study|Death|7|||
105747443|NCT04507867|364729194|FG001|Overall Study|Death|1|||
105747444|NCT01188564|364729197|FG000|Double-blind Phase|randomized not treated|1|||
106142533|NCT05046132|366181891|FG000|Overall Study|Adverse Event|4|||
106142534|NCT05046132|366181892|FG001|Overall Study|Adverse Event|0|||
105747445|NCT01188564|364729198|FG001|Double-blind Phase|randomized not treated|0|||
105747446|NCT01094730|364729199|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
105747447|NCT01094730|364729200|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
105747448|NCT01094730|364729199|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
105747449|NCT01094730|364729200|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
105747450|NCT01094730|364729199|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
105747451|NCT01094730|364729200|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
105747452|NCT01094730|364729199|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
105747453|NCT01094730|364729200|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
105747454|NCT01094730|364729199|FG000|Period 2 (14 Days)|Protocol Violation|2|||
105747455|NCT01094730|364729200|FG001|Period 2 (14 Days)|Protocol Violation|0|||
105747456|NCT01094730|364729199|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
105747457|NCT01094730|364729200|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
105747458|NCT01094730|364729199|FG000|Period 2 (14 Days)|Adverse Event|0|||
105747459|NCT01094730|364729200|FG001|Period 2 (14 Days)|Adverse Event|1|||
105747460|NCT01094730|364729199|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
105747461|NCT01094730|364729200|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
105747462|NCT00779324|364729201|FG000|Overall Study|Lost to Follow-up|2|||
105747463|NCT00779324|364729202|FG001|Overall Study|Lost to Follow-up|1|||
105747464|NCT00779324|364729201|FG000|Overall Study|Withdrawal by Subject|4|||
105747465|NCT00779324|364729202|FG001|Overall Study|Withdrawal by Subject|2|||
105747466|NCT00779324|364729201|FG000|Overall Study|Missed visit|1|||
105747467|NCT00779324|364729202|FG001|Overall Study|Missed visit|1|||
105747468|NCT01217190|364729203|FG000|Second Dosing|Withdrawal by Subject|0|||
105747469|NCT01217190|364729204|FG001|Second Dosing|Withdrawal by Subject|2|||
105747470|NCT00543569|364729205|FG000|Overall Study|Death|2|||
105747471|NCT00543569|364729206|FG001|Overall Study|Death|2|||
105747472|NCT00543569|364729207|FG002|Overall Study|Death|3|||
105747473|NCT00543569|364729208|FG003|Overall Study|Death|1|||
105747474|NCT00543569|364729205|FG000|Overall Study|Lost to Follow-up|0|||
105747475|NCT00543569|364729206|FG001|Overall Study|Lost to Follow-up|0|||
105747476|NCT00543569|364729207|FG002|Overall Study|Lost to Follow-up|1|||
105747477|NCT00543569|364729208|FG003|Overall Study|Lost to Follow-up|1|||
105747478|NCT00543569|364729205|FG000|Overall Study|Miscellaneous Reasons|7|||
105747479|NCT00543569|364729206|FG001|Overall Study|Miscellaneous Reasons|3|||
105747480|NCT00543569|364729207|FG002|Overall Study|Miscellaneous Reasons|11|||
105747481|NCT00543569|364729208|FG003|Overall Study|Miscellaneous Reasons|4|||
105747482|NCT00543569|364729205|FG000|Overall Study|Randomized but never received study drug|3|||
105747483|NCT00543569|364729206|FG001|Overall Study|Randomized but never received study drug|3|||
105747484|NCT00543569|364729207|FG002|Overall Study|Randomized but never received study drug|5|||
105747485|NCT00543569|364729208|FG003|Overall Study|Randomized but never received study drug|3|||
106142535|NCT05046132|366181893|FG002|Overall Study|Adverse Event|0|||
106142536|NCT05046132|366181891|FG000|Overall Study|Withdrawal by Subject|3|||
106142537|NCT05046132|366181892|FG001|Overall Study|Withdrawal by Subject|0|||
105747486|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Adverse Event|0|||
105747487|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Adverse Event|1|||
105747488|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Adverse Event|0|||
105747489|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Adverse Event|1|||
105747490|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Adverse Event|1|||
105943735|NCT00725985|365456685|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943736|NCT00725985|365456686|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943737|NCT00725985|365456687|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
105943738|NCT00725985|365456676|FG000|OLMP (Up to 96 Weeks)|Other|0|||
105943739|NCT00725985|365456677|FG001|OLMP (Up to 96 Weeks)|Other|0|||
105943740|NCT00725985|365456678|FG002|OLMP (Up to 96 Weeks)|Other|0|||
105943741|NCT00725985|365456679|FG003|OLMP (Up to 96 Weeks)|Other|15|||
105747491|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Adverse Event|0|||
105747492|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Adverse Event|3|||
105747493|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Adverse Event|0|||
105747494|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Adverse Event|0|||
105747495|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Adverse Event|0|||
105747496|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Adverse Event|0|||
105747497|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747498|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747499|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747500|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747501|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
105747502|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747503|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747504|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
105943742|NCT00725985|365456680|FG004|OLMP (Up to 96 Weeks)|Other|20|||
105943743|NCT00725985|365456681|FG005|OLMP (Up to 96 Weeks)|Other|44|||
105747505|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105801217|NCT00931385|364928624|FG000|Overall Study|Lost to Follow-up|0|||
106142538|NCT05046132|366181893|FG002|Overall Study|Withdrawal by Subject|0|||
105943744|NCT00725985|365456682|FG006|OLMP (Up to 96 Weeks)|Other|0|||
105943745|NCT00725985|365456683|FG007|OLMP (Up to 96 Weeks)|Other|0|||
105943746|NCT00725985|365456684|FG008|OLMP (Up to 96 Weeks)|Other|0|||
105747506|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747507|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105747508|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Death|0|||
105747509|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Death|0|||
105747510|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Death|0|||
105747511|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Death|0|||
105747512|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Death|0|||
105747513|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Death|0|||
105747514|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Death|0|||
105747515|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Death|1|||
105747516|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Death|0|||
105747517|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Death|0|||
105747518|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Death|0|||
105747519|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Disease Progression|3|||
105747520|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Disease Progression|2|||
105747521|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Disease Progression|5|||
105747522|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Disease Progression|6|||
105747523|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Disease Progression|4|||
105747524|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Disease Progression|6|||
105747525|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Disease Progression|7|||
105747526|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Disease Progression|4|||
105747527|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Disease Progression|0|||
105747528|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Disease Progression|0|||
105747529|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Disease Progression|0|||
105747530|NCT00195260|364729212|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
105747531|NCT00195260|364729213|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
105747532|NCT00195260|364729214|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
105747533|NCT00195260|364729215|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747534|NCT00195260|364729216|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747535|NCT00195260|364729217|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
105747536|NCT00195260|364729218|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747537|NCT00195260|364729219|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747538|NCT00195260|364729220|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747539|NCT00195260|364729221|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747540|NCT00195260|364729222|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
105747541|NCT00195260|364729212|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747542|NCT00195260|364729213|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747543|NCT00195260|364729214|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747544|NCT00195260|364729215|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747545|NCT00195260|364729216|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747546|NCT00195260|364729217|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747547|NCT00195260|364729218|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747548|NCT00195260|364729219|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
105747549|NCT00195260|364729220|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
105747550|NCT00195260|364729221|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
105747551|NCT00195260|364729222|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
105747552|NCT00195260|364729212|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747553|NCT00195260|364729213|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747554|NCT00195260|364729214|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747555|NCT00195260|364729215|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747556|NCT00195260|364729216|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747557|NCT00195260|364729217|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747558|NCT00195260|364729218|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747559|NCT00195260|364729219|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
105747560|NCT00195260|364729220|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
105747561|NCT00195260|364729221|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
105747562|NCT00195260|364729222|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
105747563|NCT00195260|364729212|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105943747|NCT00725985|365456685|FG009|OLMP (Up to 96 Weeks)|Other|0|||
106142539|NCT05046132|366181891|FG000|Overall Study|Positive Covid19 Result.|0|||
106142540|NCT05046132|366181892|FG001|Overall Study|Positive Covid19 Result.|1|||
105747564|NCT00195260|364729213|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747565|NCT00195260|364729214|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105943748|NCT00725985|365456686|FG010|OLMP (Up to 96 Weeks)|Other|0|||
105943749|NCT00725985|365456687|FG011|OLMP (Up to 96 Weeks)|Other|0|||
105943750|NCT00725985|365456676|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943751|NCT00725985|365456677|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
106142541|NCT05046132|366181893|FG002|Overall Study|Positive Covid19 Result.|0|||
105943752|NCT00725985|365456678|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943753|NCT00725985|365456679|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943754|NCT00725985|365456680|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105801218|NCT00931385|364928625|FG001|Overall Study|Lost to Follow-up|0|||
105801219|NCT00931385|364928626|FG002|Overall Study|Lost to Follow-up|0|||
105801220|NCT00931385|364928627|FG003|Overall Study|Lost to Follow-up|1|||
105801221|NCT02230085|364928628|FG000|Overall Study|Physician Decision|1|||
105801222|NCT02230085|364928628|FG000|Overall Study|Withdrawal by Subject|3|||
105801223|NCT00580983|364928632|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
105801224|NCT02173301|364928633|FG000|Overall Study|Adverse Event|7|||
105801225|NCT02173301|364928634|FG001|Overall Study|Adverse Event|8|||
105801226|NCT02173301|364928635|FG002|Overall Study|Adverse Event|13|||
105801227|NCT02173301|364928636|FG003|Overall Study|Adverse Event|5|||
105801228|NCT02173301|364928633|FG000|Overall Study|Withdrawal by Subject|8|||
105801229|NCT02173301|364928634|FG001|Overall Study|Withdrawal by Subject|10|||
105801230|NCT02173301|364928635|FG002|Overall Study|Withdrawal by Subject|4|||
105801231|NCT02173301|364928636|FG003|Overall Study|Withdrawal by Subject|8|||
105801232|NCT02173301|364928633|FG000|Overall Study|Lost to Follow-up|4|||
105801233|NCT02173301|364928634|FG001|Overall Study|Lost to Follow-up|4|||
105801234|NCT02173301|364928635|FG002|Overall Study|Lost to Follow-up|2|||
105801235|NCT02173301|364928636|FG003|Overall Study|Lost to Follow-up|2|||
105801236|NCT02173301|364928633|FG000|Overall Study|Protocol Violation|0|||
105801237|NCT02173301|364928634|FG001|Overall Study|Protocol Violation|1|||
105801238|NCT02173301|364928635|FG002|Overall Study|Protocol Violation|0|||
105801239|NCT02173301|364928636|FG003|Overall Study|Protocol Violation|0|||
105801240|NCT02173301|364928633|FG000|Overall Study|Physician Decision|0|||
105801241|NCT02173301|364928634|FG001|Overall Study|Physician Decision|0|||
105801242|NCT02173301|364928635|FG002|Overall Study|Physician Decision|1|||
105801243|NCT02173301|364928636|FG003|Overall Study|Physician Decision|0|||
105801244|NCT02173301|364928633|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
105801245|NCT02173301|364928634|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
105801246|NCT02173301|364928635|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
105801247|NCT02173301|364928636|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
105801248|NCT01025193|364928637|FG000|Overall Study|Protocol Violation|1|||
105801249|NCT01025193|364928637|FG000|Overall Study|Adverse Event|3|||
105801250|NCT01098240|364928638|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
105801251|NCT01098240|364928639|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
105801252|NCT01098240|364928640|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
105801253|NCT01098240|364928638|FG000|Open-Label Phase|Protocol Violation|4|||
105801254|NCT01098240|364928639|FG001|Open-Label Phase|Protocol Violation|0|||
105801255|NCT01098240|364928640|FG002|Open-Label Phase|Protocol Violation|0|||
105801256|NCT01098240|364928638|FG000|Open-Label Phase|Lost to Follow-up|13|||
105801257|NCT01098240|364928639|FG001|Open-Label Phase|Lost to Follow-up|0|||
105801258|NCT01098240|364928640|FG002|Open-Label Phase|Lost to Follow-up|0|||
105801259|NCT01098240|364928638|FG000|Open-Label Phase|Other|19|||
105801260|NCT01098240|364928639|FG001|Open-Label Phase|Other|0|||
105801261|NCT01098240|364928640|FG002|Open-Label Phase|Other|0|||
105801262|NCT01098240|364928638|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
105801263|NCT01098240|364928639|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105801264|NCT01098240|364928640|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
105801265|NCT01098240|364928638|FG000|Open-Label Phase|Pregnancy|1|||
105801266|NCT01098240|364928639|FG001|Open-Label Phase|Pregnancy|0|||
105801267|NCT01098240|364928640|FG002|Open-Label Phase|Pregnancy|0|||
105801268|NCT01098240|364928638|FG000|Open-Label Phase|Withdrawal by Subject|9|||
105943755|NCT00725985|365456681|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943756|NCT00725985|365456682|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943757|NCT00725985|365456683|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
105943758|NCT00725985|365456684|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943759|NCT00725985|365456685|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943760|NCT00725985|365456686|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943761|NCT00725985|365456687|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
105943762|NCT00725985|365456676|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105801269|NCT01098240|364928639|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105801270|NCT01098240|364928640|FG002|Open-Label Phase|Withdrawal by Subject|0|||
105801271|NCT01098240|364928638|FG000|Open-Label Phase|Adverse Event|12|||
105801272|NCT01098240|364928639|FG001|Open-Label Phase|Adverse Event|0|||
105801273|NCT01098240|364928640|FG002|Open-Label Phase|Adverse Event|0|||
105801274|NCT01098240|364928638|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
105801275|NCT01098240|364928639|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
105801276|NCT01098240|364928640|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
105801277|NCT01098240|364928638|FG000|Double-Blind Phase|Protocol Violation|0|||
105801278|NCT01098240|364928639|FG001|Double-Blind Phase|Protocol Violation|2|||
106142542|NCT01831791|366181894|FG000|Overall Study|Withdrawal by Subject|10|||
106142543|NCT03460756|366181895|FG000|Overall Study|Adverse Event|0|||
106142544|NCT03460756|366181896|FG001|Overall Study|Adverse Event|0|||
105747566|NCT00195260|364729215|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747567|NCT00195260|364729216|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747568|NCT00195260|364729217|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747569|NCT00195260|364729218|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747570|NCT00195260|364729219|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
105747571|NCT00195260|364729220|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
105747572|NCT00195260|364729221|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
105747573|NCT00195260|364729222|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
105747574|NCT00195260|364729212|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747575|NCT00195260|364729213|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747576|NCT00195260|364729214|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747577|NCT00195260|364729215|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747578|NCT00195260|364729216|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747579|NCT00195260|364729217|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747580|NCT00195260|364729218|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747581|NCT00195260|364729219|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
105747582|NCT00195260|364729220|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
105747583|NCT00195260|364729221|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
105747584|NCT00195260|364729222|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
105747585|NCT04544709|364729223|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
105747586|NCT02993224|364729224|FG000|Core Phase - Period 1|Adverse Event|4|||
105747587|NCT02993224|364729224|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
105747588|NCT02993224|364729224|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
105747589|NCT02993224|364729224|FG000|Core Phase- Period 2|Adverse Event|1|||
105747590|NCT02993224|364729224|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
105747591|NCT02993224|364729224|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
105747592|NCT02993224|364729224|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
105747593|NCT02993224|364729224|FG000|Extension Phase|Adverse Event|3|||
105747594|NCT02993224|364729224|FG000|Extension Phase|Withdrawal by Subject|3|||
105747595|NCT02993224|364729224|FG000|Extension Phase|Lost to Follow-up|2|||
105747596|NCT02993224|364729224|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
105747597|NCT01814800|364729225|FG000|Overall Study|Adverse Event|2|||
105747598|NCT01814800|364729225|FG000|Overall Study|Pregnancy|1|||
105747599|NCT01814800|364729225|FG000|Overall Study|Sponsor decision|1|||
105747600|NCT01814800|364729225|FG000|Overall Study|Subject relocation|1|||
105747601|NCT03136185|364729226|FG000|Overall Study|Adverse Event|0|||
105747602|NCT03136185|364729227|FG001|Overall Study|Adverse Event|1|||
105747603|NCT03136185|364729228|FG002|Overall Study|Adverse Event|3|||
105747604|NCT03136185|364729229|FG003|Overall Study|Adverse Event|1|||
105747605|NCT03136185|364729230|FG004|Overall Study|Adverse Event|2|||
105747606|NCT03136185|364729231|FG005|Overall Study|Adverse Event|2|||
105747607|NCT03136185|364729232|FG006|Overall Study|Adverse Event|5|||
105747608|NCT03136185|364729233|FG007|Overall Study|Adverse Event|1|||
105747609|NCT03136185|364729234|FG008|Overall Study|Adverse Event|1|||
105747610|NCT03136185|364729226|FG000|Overall Study|Death|0|||
105747611|NCT03136185|364729227|FG001|Overall Study|Death|0|||
105747612|NCT03136185|364729228|FG002|Overall Study|Death|0|||
105747613|NCT03136185|364729229|FG003|Overall Study|Death|1|||
105747614|NCT03136185|364729230|FG004|Overall Study|Death|1|||
105747615|NCT03136185|364729231|FG005|Overall Study|Death|0|||
105747616|NCT03136185|364729232|FG006|Overall Study|Death|1|||
105747617|NCT03136185|364729233|FG007|Overall Study|Death|0|||
105747618|NCT03136185|364729234|FG008|Overall Study|Death|0|||
105747619|NCT03136185|364729226|FG000|Overall Study|Physician Decision|3|||
105747620|NCT03136185|364729227|FG001|Overall Study|Physician Decision|1|||
105747621|NCT03136185|364729228|FG002|Overall Study|Physician Decision|1|||
105747622|NCT03136185|364729229|FG003|Overall Study|Physician Decision|2|||
105747623|NCT03136185|364729230|FG004|Overall Study|Physician Decision|1|||
105747624|NCT03136185|364729231|FG005|Overall Study|Physician Decision|2|||
105747625|NCT03136185|364729232|FG006|Overall Study|Physician Decision|1|||
105747626|NCT03136185|364729233|FG007|Overall Study|Physician Decision|0|||
105747627|NCT03136185|364729234|FG008|Overall Study|Physician Decision|1|||
105747628|NCT03136185|364729226|FG000|Overall Study|Protocol Defined Disease Progression|0|||
105747629|NCT03136185|364729227|FG001|Overall Study|Protocol Defined Disease Progression|0|||
105747630|NCT03136185|364729228|FG002|Overall Study|Protocol Defined Disease Progression|1|||
105747631|NCT03136185|364729229|FG003|Overall Study|Protocol Defined Disease Progression|0|||
105747632|NCT03136185|364729230|FG004|Overall Study|Protocol Defined Disease Progression|0|||
105747633|NCT03136185|364729231|FG005|Overall Study|Protocol Defined Disease Progression|1|||
105747634|NCT03136185|364729232|FG006|Overall Study|Protocol Defined Disease Progression|0|||
105801279|NCT01098240|364928640|FG002|Double-Blind Phase|Protocol Violation|4|||
106142545|NCT03460756|366181897|FG002|Overall Study|Adverse Event|0|||
105943763|NCT00725985|365456677|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105943764|NCT00725985|365456678|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105747635|NCT03136185|364729233|FG007|Overall Study|Protocol Defined Disease Progression|1|||
105747636|NCT03136185|364729234|FG008|Overall Study|Protocol Defined Disease Progression|1|||
105747637|NCT03136185|364729226|FG000|Overall Study|Withdrawal by Subject|1|||
105747638|NCT03136185|364729227|FG001|Overall Study|Withdrawal by Subject|0|||
105747639|NCT03136185|364729228|FG002|Overall Study|Withdrawal by Subject|1|||
105747640|NCT03136185|364729229|FG003|Overall Study|Withdrawal by Subject|1|||
105747641|NCT03136185|364729230|FG004|Overall Study|Withdrawal by Subject|1|||
105747642|NCT03136185|364729231|FG005|Overall Study|Withdrawal by Subject|1|||
105747643|NCT03136185|364729232|FG006|Overall Study|Withdrawal by Subject|2|||
105747644|NCT03136185|364729233|FG007|Overall Study|Withdrawal by Subject|3|||
105747645|NCT03136185|364729234|FG008|Overall Study|Withdrawal by Subject|3|||
105747646|NCT03136185|364729226|FG000|Overall Study|Not Reported|4|||
105747647|NCT03136185|364729227|FG001|Overall Study|Not Reported|1|||
105747648|NCT03136185|364729228|FG002|Overall Study|Not Reported|0|||
105747649|NCT03136185|364729229|FG003|Overall Study|Not Reported|1|||
105747650|NCT03136185|364729230|FG004|Overall Study|Not Reported|0|||
105747651|NCT03136185|364729231|FG005|Overall Study|Not Reported|2|||
105747652|NCT03136185|364729232|FG006|Overall Study|Not Reported|1|||
105747653|NCT03136185|364729233|FG007|Overall Study|Not Reported|1|||
105747654|NCT03136185|364729234|FG008|Overall Study|Not Reported|0|||
105747655|NCT02491073|364729236|FG000|Overall Study|screen failure|1|||
105747656|NCT02491073|364729237|FG001|Overall Study|screen failure|0|||
105747657|NCT03738566|364729238|FG000|Initial Study Phase|Withdrawal by Subject|1|||
105747658|NCT03738566|364729239|FG001|Initial Study Phase|Withdrawal by Subject|1|||
105747659|NCT03738566|364729240|FG002|Initial Study Phase|Withdrawal by Subject|2|||
105747660|NCT03738566|364729241|FG003|Initial Study Phase|Withdrawal by Subject|0|||
105747661|NCT03738566|364729238|FG000|Initial Study Phase|Death|0|||
105747662|NCT03738566|364729239|FG001|Initial Study Phase|Death|1|||
105747663|NCT03738566|364729240|FG002|Initial Study Phase|Death|0|||
105747664|NCT03738566|364729241|FG003|Initial Study Phase|Death|0|||
105747665|NCT03738566|364729238|FG000|Initial Study Phase|Treatment failure|5|||
105747666|NCT03738566|364729239|FG001|Initial Study Phase|Treatment failure|0|||
105747667|NCT03738566|364729240|FG002|Initial Study Phase|Treatment failure|0|||
105747668|NCT03738566|364729241|FG003|Initial Study Phase|Treatment failure|0|||
105747669|NCT03738566|364729238|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
105747670|NCT03738566|364729239|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
105747671|NCT03738566|364729240|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
105747672|NCT03738566|364729241|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
105747673|NCT00634244|364729242|FG000|Overall Study|Never started treatment|0|||
105747674|NCT00634244|364729243|FG001|Overall Study|Never started treatment|1|||
105747675|NCT00634244|364729244|FG002|Overall Study|Never started treatment|0|||
105747676|NCT00634244|364729242|FG000|Overall Study|Death|1|||
105747677|NCT00634244|364729243|FG001|Overall Study|Death|6|||
105747678|NCT00634244|364729244|FG002|Overall Study|Death|0|||
105747679|NCT00634244|364729242|FG000|Overall Study|Adverse Event|0|||
105747680|NCT00634244|364729243|FG001|Overall Study|Adverse Event|2|||
105747681|NCT00634244|364729244|FG002|Overall Study|Adverse Event|0|||
105747682|NCT00634244|364729242|FG000|Overall Study|Withdrawal by Subject|0|||
105747683|NCT00634244|364729243|FG001|Overall Study|Withdrawal by Subject|1|||
105747684|NCT00634244|364729244|FG002|Overall Study|Withdrawal by Subject|0|||
105747685|NCT00634244|364729242|FG000|Overall Study|Physician Decision|0|||
105747686|NCT00634244|364729243|FG001|Overall Study|Physician Decision|1|||
105747687|NCT00634244|364729244|FG002|Overall Study|Physician Decision|0|||
105747688|NCT00634244|364729242|FG000|Overall Study|Disease progression/relapse|0|||
105747689|NCT00634244|364729243|FG001|Overall Study|Disease progression/relapse|1|||
105747690|NCT00634244|364729244|FG002|Overall Study|Disease progression/relapse|0|||
105747691|NCT00634244|364729242|FG000|Overall Study|Other complicating disease|0|||
105747692|NCT00634244|364729243|FG001|Overall Study|Other complicating disease|1|||
105747693|NCT00634244|364729244|FG002|Overall Study|Other complicating disease|0|||
105747694|NCT01683071|364729245|FG000|Part 1|Lack of Efficacy|1|||
105747695|NCT01683071|364729246|FG001|Part 1|Lack of Efficacy|0|||
105747696|NCT01683071|364729247|FG002|Part 1|Lack of Efficacy|0|||
105747697|NCT01683071|364729248|FG003|Part 1|Lack of Efficacy|3|||
105747698|NCT01683071|364729249|FG004|Part 1|Lack of Efficacy|0|||
105747699|NCT01683071|364729250|FG005|Part 1|Lack of Efficacy|0|||
105747700|NCT01683071|364729245|FG000|Part 1|Withdrawal by Subject|1|||
105747701|NCT01683071|364729246|FG001|Part 1|Withdrawal by Subject|2|||
105747702|NCT01683071|364729247|FG002|Part 1|Withdrawal by Subject|2|||
105747703|NCT01683071|364729248|FG003|Part 1|Withdrawal by Subject|1|||
105747704|NCT01683071|364729249|FG004|Part 1|Withdrawal by Subject|0|||
105747705|NCT01683071|364729250|FG005|Part 1|Withdrawal by Subject|0|||
105747706|NCT01683071|364729245|FG000|Part 1|Surgery Cancelled|1|||
105747707|NCT01683071|364729246|FG001|Part 1|Surgery Cancelled|0|||
105747708|NCT01683071|364729247|FG002|Part 1|Surgery Cancelled|0|||
105747709|NCT01683071|364729248|FG003|Part 1|Surgery Cancelled|0|||
105747710|NCT01683071|364729249|FG004|Part 1|Surgery Cancelled|0|||
105801280|NCT01098240|364928638|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105801281|NCT01098240|364928639|FG001|Double-Blind Phase|Lost to Follow-up|2|||
105801282|NCT01098240|364928640|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105801283|NCT01098240|364928638|FG000|Double-Blind Phase|Other|0|||
105801284|NCT01098240|364928639|FG001|Double-Blind Phase|Other|2|||
105801285|NCT01098240|364928640|FG002|Double-Blind Phase|Other|2|||
105801286|NCT01098240|364928638|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
105801287|NCT01098240|364928639|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
105801288|NCT01098240|364928640|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
105801289|NCT01098240|364928638|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
105801290|NCT01098240|364928639|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
105801291|NCT01098240|364928640|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
105801292|NCT01098240|364928638|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105801293|NCT01098240|364928639|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
105801294|NCT01098240|364928640|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
105801295|NCT01098240|364928638|FG000|Double-Blind Phase|Adverse Event|0|||
105801296|NCT01098240|364928639|FG001|Double-Blind Phase|Adverse Event|3|||
105801297|NCT01098240|364928640|FG002|Double-Blind Phase|Adverse Event|3|||
105801298|NCT01715415|364928644|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
105801299|NCT01715415|364928645|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
105801300|NCT01715415|364928644|FG000|Double-blind Treatment|Adverse Event|3|||
105801301|NCT01715415|364928645|FG001|Double-blind Treatment|Adverse Event|0|||
105801302|NCT01715415|364928644|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
105801303|NCT01715415|364928645|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
105801304|NCT01715415|364928644|FG000|Double-blind Treatment|Other|1|||
105801305|NCT01715415|364928645|FG001|Double-blind Treatment|Other|0|||
105801306|NCT01715415|364928644|FG000|Open-label Treatment|Adverse Event|0|||
105801307|NCT01715415|364928645|FG001|Open-label Treatment|Adverse Event|1|||
105801308|NCT01715415|364928644|FG000|Open-label Treatment|Subject Noncompliant|0|||
105801309|NCT01715415|364928645|FG001|Open-label Treatment|Subject Noncompliant|1|||
105801310|NCT01015612|364928646|FG000|Overall Study|Death|113|||
105801311|NCT01015612|364928646|FG000|Overall Study|Withdrawal by Subject|40|||
105801312|NCT04136626|364928647|FG000|Treatment Phase|Withdrawal by Subject|1|||
105801313|NCT04136626|364928648|FG001|Treatment Phase|Withdrawal by Subject|9|||
105801314|NCT04136626|364928647|FG000|Treatment Phase|Adverse Event|1|||
105801315|NCT04136626|364928648|FG001|Treatment Phase|Adverse Event|0|||
105801316|NCT04136626|364928647|FG000|Treatment Phase|Lost to Follow-up|1|||
105801317|NCT04136626|364928648|FG001|Treatment Phase|Lost to Follow-up|5|||
105801318|NCT04136626|364928647|FG000|12-month Follow-up|Lost to Follow-up|8|||
105801319|NCT04136626|364928648|FG001|12-month Follow-up|Lost to Follow-up|7|||
105801320|NCT01416142|364930533|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
105801321|NCT01416142|364930534|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
105801322|NCT01416142|364930535|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
105801323|NCT01165242|364930537|FG000|Overall Study|Unreachable Subjects|1|||
105801324|NCT01165242|364930538|FG001|Overall Study|Unreachable Subjects|0|||
105801325|NCT01165242|364930539|FG002|Overall Study|Unreachable Subjects|0|||
105801326|NCT01165242|364930537|FG000|Overall Study|Incarcerated Subjects|0|||
105801327|NCT01165242|364930538|FG001|Overall Study|Incarcerated Subjects|1|||
105801328|NCT01165242|364930539|FG002|Overall Study|Incarcerated Subjects|0|||
105801329|NCT01165242|364930537|FG000|Overall Study|Visit 2 Declined by Subject|0|||
105801330|NCT01165242|364930538|FG001|Overall Study|Visit 2 Declined by Subject|0|||
105801331|NCT01165242|364930539|FG002|Overall Study|Visit 2 Declined by Subject|1|||
105801332|NCT01165242|364930537|FG000|Overall Study|Withdrawal by Subject|0|||
105801333|NCT01165242|364930538|FG001|Overall Study|Withdrawal by Subject|2|||
105801334|NCT01165242|364930539|FG002|Overall Study|Withdrawal by Subject|2|||
105801335|NCT01165242|364930537|FG000|Overall Study|Extended Holiday|0|||
105801336|NCT01165242|364930538|FG001|Overall Study|Extended Holiday|0|||
105801337|NCT01165242|364930539|FG002|Overall Study|Extended Holiday|1|||
105801338|NCT01165242|364930537|FG000|Overall Study|Lost to Follow-up|9|||
105801339|NCT01165242|364930538|FG001|Overall Study|Lost to Follow-up|7|||
105801340|NCT01165242|364930539|FG002|Overall Study|Lost to Follow-up|10|||
105801341|NCT03770000|364930540|FG000|Overall Study|Premature discontinuation due to PD|0|||
105801342|NCT03770000|364930541|FG001|Overall Study|Premature discontinuation due to PD|0|||
105801343|NCT03770000|364930542|FG002|Overall Study|Premature discontinuation due to PD|1|||
106015821|NCT02592798|365723300|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
105801344|NCT03770000|364930543|FG003|Overall Study|Premature discontinuation due to PD|3|||
105801345|NCT03770000|364930544|FG004|Overall Study|Premature discontinuation due to PD|2|||
105801346|NCT03877237|364930545|FG000|Overall Study|Adverse Event|1|||
105801347|NCT03877237|364930546|FG001|Overall Study|Adverse Event|2|||
105801348|NCT03877237|364930545|FG000|Overall Study|Death|3|||
105801349|NCT03877237|364930546|FG001|Overall Study|Death|2|||
105801350|NCT03877237|364930545|FG000|Overall Study|Physician Decision|1|||
105801351|NCT03877237|364930546|FG001|Overall Study|Physician Decision|0|||
105801352|NCT03877237|364930545|FG000|Overall Study|Withdrawal by Subject|0|||
106015822|NCT02592798|365723301|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
105801353|NCT03877237|364930546|FG001|Overall Study|Withdrawal by Subject|2|||
105747711|NCT01683071|364729250|FG005|Part 1|Surgery Cancelled|0|||
105747712|NCT01683071|364729245|FG000|Part 1|Did not receive study drug|1|||
105747713|NCT01683071|364729246|FG001|Part 1|Did not receive study drug|0|||
105747714|NCT01683071|364729247|FG002|Part 1|Did not receive study drug|0|||
105747715|NCT01683071|364729248|FG003|Part 1|Did not receive study drug|1|||
105747716|NCT01683071|364729249|FG004|Part 1|Did not receive study drug|0|||
105747717|NCT01683071|364729250|FG005|Part 1|Did not receive study drug|0|||
105747718|NCT01683071|364729245|FG000|Part 1|Early termination; met exclusion criteria|0|||
105747719|NCT01683071|364729246|FG001|Part 1|Early termination; met exclusion criteria|2|||
105747720|NCT01683071|364729247|FG002|Part 1|Early termination; met exclusion criteria|1|||
105747721|NCT01683071|364729248|FG003|Part 1|Early termination; met exclusion criteria|0|||
105747722|NCT01683071|364729249|FG004|Part 1|Early termination; met exclusion criteria|0|||
105747723|NCT01683071|364729250|FG005|Part 1|Early termination; met exclusion criteria|0|||
105747724|NCT01683071|364729245|FG000|Part 2|Lack of Efficacy|0|||
105747725|NCT01683071|364729246|FG001|Part 2|Lack of Efficacy|0|||
105747726|NCT01683071|364729247|FG002|Part 2|Lack of Efficacy|0|||
105747727|NCT01683071|364729248|FG003|Part 2|Lack of Efficacy|0|||
105747728|NCT01683071|364729249|FG004|Part 2|Lack of Efficacy|3|||
105747729|NCT01683071|364729250|FG005|Part 2|Lack of Efficacy|4|||
105747730|NCT01683071|364729245|FG000|Part 2|Lost to Follow-up|0|||
105747731|NCT01683071|364729246|FG001|Part 2|Lost to Follow-up|0|||
105747732|NCT01683071|364729247|FG002|Part 2|Lost to Follow-up|0|||
105747733|NCT01683071|364729248|FG003|Part 2|Lost to Follow-up|0|||
105747734|NCT01683071|364729249|FG004|Part 2|Lost to Follow-up|2|||
105747735|NCT01683071|364729250|FG005|Part 2|Lost to Follow-up|0|||
105747736|NCT01683071|364729245|FG000|Part 2|Withdrawal by Subject|0|||
105747737|NCT01683071|364729246|FG001|Part 2|Withdrawal by Subject|0|||
105747738|NCT01683071|364729247|FG002|Part 2|Withdrawal by Subject|0|||
105747739|NCT01683071|364729248|FG003|Part 2|Withdrawal by Subject|0|||
105747740|NCT01683071|364729249|FG004|Part 2|Withdrawal by Subject|3|||
105747741|NCT01683071|364729250|FG005|Part 2|Withdrawal by Subject|3|||
105747742|NCT01683071|364729245|FG000|Part 2|Surgery cancelled|0|||
105747743|NCT01683071|364729246|FG001|Part 2|Surgery cancelled|0|||
105747744|NCT01683071|364729247|FG002|Part 2|Surgery cancelled|0|||
105747745|NCT01683071|364729248|FG003|Part 2|Surgery cancelled|0|||
105747746|NCT01683071|364729249|FG004|Part 2|Surgery cancelled|4|||
105747747|NCT01683071|364729250|FG005|Part 2|Surgery cancelled|2|||
105747748|NCT01683071|364729245|FG000|Part 2|Did not receive study drug|0|||
105747749|NCT01683071|364729246|FG001|Part 2|Did not receive study drug|0|||
105747750|NCT01683071|364729247|FG002|Part 2|Did not receive study drug|0|||
105747751|NCT01683071|364729248|FG003|Part 2|Did not receive study drug|0|||
105747752|NCT01683071|364729249|FG004|Part 2|Did not receive study drug|2|||
105747753|NCT01683071|364729250|FG005|Part 2|Did not receive study drug|1|||
105747754|NCT01683071|364729245|FG000|Part 2|Met exclusion criterion|0|||
105747755|NCT01683071|364729246|FG001|Part 2|Met exclusion criterion|0|||
105747756|NCT01683071|364729247|FG002|Part 2|Met exclusion criterion|0|||
105747757|NCT01683071|364729248|FG003|Part 2|Met exclusion criterion|0|||
105747758|NCT01683071|364729249|FG004|Part 2|Met exclusion criterion|1|||
105747759|NCT01683071|364729250|FG005|Part 2|Met exclusion criterion|1|||
105747760|NCT01683071|364729245|FG000|Part 2|Protocol deviation|0|||
105747761|NCT01683071|364729246|FG001|Part 2|Protocol deviation|0|||
105747762|NCT01683071|364729247|FG002|Part 2|Protocol deviation|0|||
105747763|NCT01683071|364729248|FG003|Part 2|Protocol deviation|0|||
105747764|NCT01683071|364729249|FG004|Part 2|Protocol deviation|1|||
105747765|NCT01683071|364729250|FG005|Part 2|Protocol deviation|2|||
105747766|NCT01683071|364729245|FG000|Part 2|Withdrawal by investigator decision|0|||
105747767|NCT01683071|364729246|FG001|Part 2|Withdrawal by investigator decision|0|||
105747768|NCT01683071|364729247|FG002|Part 2|Withdrawal by investigator decision|0|||
105747769|NCT01683071|364729248|FG003|Part 2|Withdrawal by investigator decision|0|||
105747770|NCT01683071|364729249|FG004|Part 2|Withdrawal by investigator decision|1|||
105747771|NCT01683071|364729250|FG005|Part 2|Withdrawal by investigator decision|2|||
105747772|NCT00406640|364729258|FG000|Acute Phase|Adverse Event|18|||
106015823|NCT02592798|365723300|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
106015824|NCT02592798|365723301|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
105747773|NCT00406640|364729259|FG001|Acute Phase|Adverse Event|13|||
105747774|NCT00406640|364729258|FG000|Acute Phase|Failed to Return|5|||
105747775|NCT00406640|364729259|FG001|Acute Phase|Failed to Return|1|||
105747776|NCT00406640|364729258|FG000|Acute Phase|Physician Decision|0|||
105747777|NCT00406640|364729259|FG001|Acute Phase|Physician Decision|1|||
105747778|NCT00406640|364729258|FG000|Acute Phase|Lost to Follow-up|7|||
105747779|NCT00406640|364729259|FG001|Acute Phase|Lost to Follow-up|4|||
105747780|NCT00406640|364729258|FG000|Acute Phase|Protocol deviation|4|||
105747781|NCT00406640|364729259|FG001|Acute Phase|Protocol deviation|10|||
105747782|NCT00406640|364729258|FG000|Acute Phase|Protocol Violation|3|||
105747783|NCT00406640|364729259|FG001|Acute Phase|Protocol Violation|2|||
105747784|NCT00406640|364729258|FG000|Acute Phase|Withdrawal by Subject|11|||
105747785|NCT00406640|364729259|FG001|Acute Phase|Withdrawal by Subject|9|||
105747786|NCT00406640|364729258|FG000|Acute Phase|Lack of Efficacy|3|||
105747787|NCT00406640|364729259|FG001|Acute Phase|Lack of Efficacy|3|||
105747788|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
105747789|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
105943765|NCT00725985|365456679|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105943766|NCT00725985|365456680|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105943767|NCT00725985|365456681|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105943768|NCT00725985|365456682|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105943769|NCT00725985|365456683|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105943770|NCT00725985|365456684|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
106015825|NCT02592798|365723300|FG000|Open Label Period (OLE)|Adverse Event|0|||
106015826|NCT02592798|365723301|FG001|Open Label Period (OLE)|Adverse Event|1|||
106015827|NCT01967940|365723307|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
106015828|NCT01967940|365723308|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
106015829|NCT01967940|365723309|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
106015830|NCT01967940|365723310|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
105747790|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Death|1|||
105747791|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Death|0|||
105747792|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
105747793|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
105747794|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
105747795|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
105747796|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
105747797|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
105747798|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|non-compliance|7|||
105747799|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|non-compliance|5|||
105747800|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
105747801|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
105747802|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
105747803|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
105747804|NCT00406640|364729258|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
105747805|NCT00406640|364729259|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
105747806|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
105747807|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
105747808|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
105747809|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
105747810|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
105747811|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
105747812|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
105747813|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
105747814|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
105747815|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
105747816|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
105747817|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
105747818|NCT00406640|364729258|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
105747819|NCT00406640|364729259|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
105747820|NCT05301322|364729267|FG000|Overall Study|Adverse Event|7|||
105747821|NCT05301322|364729268|FG001|Overall Study|Adverse Event|3|||
105747822|NCT05301322|364729267|FG000|Overall Study|Death|0|||
105747823|NCT05301322|364729268|FG001|Overall Study|Death|1|||
105747824|NCT05301322|364729267|FG000|Overall Study|Lost to Follow-up|2|||
105747825|NCT05301322|364729268|FG001|Overall Study|Lost to Follow-up|1|||
105747826|NCT05301322|364729267|FG000|Overall Study|Protocol Violation|3|||
105747827|NCT05301322|364729268|FG001|Overall Study|Protocol Violation|1|||
105747828|NCT05301322|364729267|FG000|Overall Study|Withdrawal by Subject|3|||
105747829|NCT05301322|364729268|FG001|Overall Study|Withdrawal by Subject|0|||
105747830|NCT05301322|364729267|FG000|Overall Study|Other|4|||
105747831|NCT05301322|364729268|FG001|Overall Study|Other|0|||
105747832|NCT01968187|364729272|FG000|Overall Study|Adverse Event|0|||
105747833|NCT01968187|364729273|FG001|Overall Study|Adverse Event|1|||
105747834|NCT01968187|364729272|FG000|Overall Study|Randomized but not treated|1|||
105747835|NCT01968187|364729273|FG001|Overall Study|Randomized but not treated|0|||
105747836|NCT03829332|364729276|FG000|Overall Study|Death|225|||
105747837|NCT03829332|364729277|FG001|Overall Study|Death|230|||
105747838|NCT03829332|364729276|FG000|Overall Study|Lost to Follow-up|1|||
105747839|NCT03829332|364729277|FG001|Overall Study|Lost to Follow-up|3|||
105747840|NCT03829332|364729276|FG000|Overall Study|Physician Decision|1|||
105747841|NCT03829332|364729277|FG001|Overall Study|Physician Decision|0|||
105747842|NCT03829332|364729276|FG000|Overall Study|Sponsor Decision|71|||
105747843|NCT03829332|364729277|FG001|Overall Study|Sponsor Decision|72|||
105747844|NCT03829332|364729276|FG000|Overall Study|Withdrawal by Subject|11|||
105747845|NCT03829332|364729277|FG001|Overall Study|Withdrawal by Subject|9|||
105747846|NCT00430521|364729278|FG000|Overall Study|Adverse Event|0|||
105747847|NCT00430521|364729279|FG001|Overall Study|Adverse Event|0|||
105747848|NCT00430521|364729280|FG002|Overall Study|Adverse Event|0|||
106015831|NCT01967940|365723307|FG000|Part 2|Adverse Event|0|||
105747849|NCT00430521|364729281|FG003|Overall Study|Adverse Event|0|||
105747850|NCT00430521|364729282|FG004|Overall Study|Adverse Event|0|||
105747851|NCT00430521|364729283|FG005|Overall Study|Adverse Event|2|||
105747852|NCT00430521|364729284|FG006|Overall Study|Adverse Event|1|||
105747853|NCT00430521|364729285|FG007|Overall Study|Adverse Event|0|||
105747854|NCT00430521|364729278|FG000|Overall Study|Lost to Follow-up|7|||
105747855|NCT00430521|364729279|FG001|Overall Study|Lost to Follow-up|8|||
105747856|NCT00430521|364729280|FG002|Overall Study|Lost to Follow-up|3|||
105747857|NCT00430521|364729281|FG003|Overall Study|Lost to Follow-up|5|||
105747858|NCT00430521|364729282|FG004|Overall Study|Lost to Follow-up|5|||
105747859|NCT00430521|364729283|FG005|Overall Study|Lost to Follow-up|2|||
105747860|NCT00430521|364729284|FG006|Overall Study|Lost to Follow-up|8|||
105747861|NCT00430521|364729285|FG007|Overall Study|Lost to Follow-up|10|||
105747862|NCT00430521|364729278|FG000|Overall Study|Pregnancy|0|||
105747863|NCT00430521|364729279|FG001|Overall Study|Pregnancy|0|||
105747864|NCT00430521|364729280|FG002|Overall Study|Pregnancy|0|||
105747865|NCT00430521|364729281|FG003|Overall Study|Pregnancy|0|||
105747866|NCT00430521|364729282|FG004|Overall Study|Pregnancy|0|||
105747867|NCT00430521|364729283|FG005|Overall Study|Pregnancy|0|||
105747868|NCT00430521|364729284|FG006|Overall Study|Pregnancy|1|||
105747869|NCT00430521|364729285|FG007|Overall Study|Pregnancy|0|||
105747870|NCT00430521|364729278|FG000|Overall Study|Vaccine Expired|0|||
105747871|NCT00430521|364729279|FG001|Overall Study|Vaccine Expired|0|||
105747872|NCT00430521|364729280|FG002|Overall Study|Vaccine Expired|0|||
105747873|NCT00430521|364729281|FG003|Overall Study|Vaccine Expired|0|||
105747874|NCT00430521|364729282|FG004|Overall Study|Vaccine Expired|0|||
105747875|NCT00430521|364729283|FG005|Overall Study|Vaccine Expired|1|||
105747876|NCT00430521|364729284|FG006|Overall Study|Vaccine Expired|0|||
105747877|NCT00430521|364729285|FG007|Overall Study|Vaccine Expired|0|||
105747878|NCT00430521|364729278|FG000|Overall Study|Protocol Violation|1|||
105747879|NCT00430521|364729279|FG001|Overall Study|Protocol Violation|0|||
105747880|NCT00430521|364729280|FG002|Overall Study|Protocol Violation|0|||
105747881|NCT00430521|364729281|FG003|Overall Study|Protocol Violation|0|||
105747882|NCT00430521|364729282|FG004|Overall Study|Protocol Violation|0|||
105747883|NCT00430521|364729283|FG005|Overall Study|Protocol Violation|0|||
105747884|NCT00430521|364729284|FG006|Overall Study|Protocol Violation|0|||
105747885|NCT00430521|364729285|FG007|Overall Study|Protocol Violation|0|||
105747886|NCT00430521|364729278|FG000|Overall Study|Withdrawal by Subject|3|||
105747887|NCT00430521|364729279|FG001|Overall Study|Withdrawal by Subject|1|||
105747888|NCT00430521|364729280|FG002|Overall Study|Withdrawal by Subject|0|||
105747889|NCT00430521|364729281|FG003|Overall Study|Withdrawal by Subject|3|||
105747890|NCT00430521|364729282|FG004|Overall Study|Withdrawal by Subject|0|||
105747891|NCT00430521|364729283|FG005|Overall Study|Withdrawal by Subject|0|||
105747892|NCT00430521|364729284|FG006|Overall Study|Withdrawal by Subject|0|||
105747893|NCT00430521|364729285|FG007|Overall Study|Withdrawal by Subject|2|||
105747894|NCT04095286|364729286|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747895|NCT04095286|364729287|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
105747896|NCT04095286|364729288|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747897|NCT04095286|364729289|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747898|NCT04095286|364729290|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747899|NCT04095286|364729291|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747900|NCT04095286|364729286|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
105747901|NCT04095286|364729287|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747902|NCT04095286|364729288|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747903|NCT04095286|364729289|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747904|NCT04095286|364729290|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747905|NCT04095286|364729291|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
105747906|NCT04095286|364729286|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105747907|NCT04095286|364729287|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105747908|NCT04095286|364729288|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
105747909|NCT04095286|364729289|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105801354|NCT02236754|364930547|FG000|Overall Study|Withdrawal by Subject|1|||
105747910|NCT04095286|364729290|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105801355|NCT02236754|364930548|FG001|Overall Study|Withdrawal by Subject|0|||
105801356|NCT02082912|364930549|FG000|Overall Study|Physician Decision|0|||
105801357|NCT02082912|364930550|FG001|Overall Study|Physician Decision|1|||
105801358|NCT01835132|364930551|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
105801359|NCT00856778|364930552|FG000|Overall Study|Adverse Event|7|||
106142546|NCT03460756|366181898|FG003|Overall Study|Adverse Event|1|||
106142547|NCT03460756|366181895|FG000|Overall Study|Lack of Efficacy|0|||
106142548|NCT03460756|366181896|FG001|Overall Study|Lack of Efficacy|0|||
105747911|NCT04095286|364729291|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
105801360|NCT00856778|364930552|FG000|Overall Study|Withdrawal by Subject|10|||
105801361|NCT00856778|364930552|FG000|Overall Study|Study deviation|2|||
105801362|NCT00856778|364930552|FG000|Overall Study|Lost to Follow-up|5|||
106142549|NCT03460756|366181897|FG002|Overall Study|Lack of Efficacy|0|||
105747912|NCT04095286|364729286|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747913|NCT04095286|364729287|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747914|NCT04095286|364729288|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
105747915|NCT04095286|364729289|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747916|NCT04095286|364729290|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747917|NCT04095286|364729291|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
105747918|NCT04095286|364729286|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747919|NCT04095286|364729287|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747920|NCT04095286|364729288|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747921|NCT04095286|364729289|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747922|NCT04095286|364729290|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
105747923|NCT04095286|364729291|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
105747924|NCT03003403|364729292|FG000|Overall Study|Ineligible|8|||
105747925|NCT03003403|364729293|FG001|Overall Study|Ineligible|7|||
105747926|NCT03003403|364729292|FG000|Overall Study|Withdrawal by Subject|3|||
105747927|NCT03003403|364729293|FG001|Overall Study|Withdrawal by Subject|1|||
105760787|NCT03627494|364776201|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760788|NCT03627494|364776202|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760789|NCT03627494|364776203|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760790|NCT03627494|364776204|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760791|NCT03627494|364776205|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760792|NCT03627494|364776206|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760793|NCT03627494|364776207|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760794|NCT03627494|364776208|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
105760795|NCT03627494|364776197|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760796|NCT03627494|364776198|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760797|NCT03627494|364776199|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760798|NCT03627494|364776200|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760799|NCT03627494|364776201|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760800|NCT03627494|364776202|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760801|NCT03627494|364776203|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760802|NCT03627494|364776204|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760803|NCT03627494|364776205|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
105760804|NCT03627494|364776206|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760805|NCT03627494|364776207|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760806|NCT03627494|364776208|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
105760807|NCT03627494|364776197|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760808|NCT03627494|364776198|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760809|NCT03627494|364776199|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760810|NCT03627494|364776200|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760811|NCT03627494|364776201|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760812|NCT03627494|364776202|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760813|NCT03627494|364776203|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760814|NCT03627494|364776204|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760815|NCT03627494|364776205|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760816|NCT03627494|364776206|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
105760817|NCT03627494|364776207|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
105760818|NCT03627494|364776208|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
105760819|NCT00191386|364778025|FG000|Overall Study|Adverse Event|16|||
105760820|NCT00191386|364778025|FG000|Overall Study|Lost to Follow-up|1|||
105760821|NCT00191386|364778025|FG000|Overall Study|Entry Criteria Exclusion|3|||
105760822|NCT00191386|364778025|FG000|Overall Study|Protocol Violation|18|||
105760823|NCT00191386|364778025|FG000|Overall Study|Withdrawal by Subject|96|||
105760824|NCT00191386|364778025|FG000|Overall Study|Physician Decision|11|||
105760825|NCT00191386|364778025|FG000|Overall Study|Lack of Efficacy|15|||
105760826|NCT02009930|364778029|FG000|Overall Study|withdrawn|5|||
105760827|NCT02707601|364778030|FG000|Overall Study|Death|0|||
105760828|NCT02707601|364778031|FG001|Overall Study|Death|1|||
105760829|NCT02707601|364778030|FG000|Overall Study|Lack of Efficacy|0|||
105760830|NCT02707601|364778031|FG001|Overall Study|Lack of Efficacy|1|||
105760831|NCT02707601|364778030|FG000|Overall Study|Investigator's Discretion|1|||
105760832|NCT02707601|364778031|FG001|Overall Study|Investigator's Discretion|0|||
105760833|NCT02707601|364778030|FG000|Overall Study|Withdrew Consent|0|||
105760834|NCT02707601|364778031|FG001|Overall Study|Withdrew Consent|1|||
105760835|NCT02707601|364778030|FG000|Overall Study|Lost to Follow-up|1|||
105760836|NCT02707601|364778031|FG001|Overall Study|Lost to Follow-up|1|||
105760837|NCT02707601|364778030|FG000|Overall Study|Participants Randomized but Not Treated|2|||
105760838|NCT02707601|364778031|FG001|Overall Study|Participants Randomized but Not Treated|0|||
105760839|NCT01444898|364778032|FG000|Overall Study|Withdrawal by Subject|1|||
105943771|NCT00725985|365456685|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105943772|NCT00725985|365456686|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
106015832|NCT01967940|365723308|FG001|Part 2|Adverse Event|0|||
105760840|NCT00493467|364778035|FG000|Overall Study|Death|1|||
105760841|NCT01831804|364778036|FG000|Overall Study|Adverse Event|0|||
105747928|NCT02294318|364731028|FG000|Overall Study|Worsening of drinking|3|||
105747929|NCT02294318|364731029|FG001|Overall Study|Worsening of drinking|0|||
105747930|NCT02294318|364731028|FG000|Overall Study|Not exposed to intervention|0|||
105747931|NCT02294318|364731029|FG001|Overall Study|Not exposed to intervention|2|||
105747932|NCT01694420|364731031|FG000|Overall Study|Lost to Follow-up|3|||
105747933|NCT03621943|364731032|FG000|First Randomized Intervention|Lost to Follow-up|51|||
105747934|NCT03621943|364731033|FG001|First Randomized Intervention|Lost to Follow-up|54|||
105747935|NCT03621943|364731032|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
105747936|NCT03621943|364731033|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
105747937|NCT03621943|364731032|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
105747938|NCT03621943|364731033|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
105747939|NCT03621943|364731032|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
105747940|NCT03621943|364731033|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
105747941|NCT00315705|364731034|FG000|Phase 1|Refused further treatment|1|||
105747942|NCT00315705|364731034|FG000|Phase 1|Failure to achieve response|8|||
105747943|NCT00315705|364731034|FG000|Phase 1|Disease relapse|4|||
105747944|NCT00315705|364731034|FG000|Phase 1|Scheduled for transplant|9|||
105747945|NCT00315705|364731034|FG000|Phase 1|Death|3|||
105747946|NCT00315705|364731034|FG000|Phase 2|Physician Decision|4|||
105747947|NCT00315705|364731034|FG000|Phase 2|Adverse Event|1|||
105747948|NCT00315705|364731034|FG000|Phase 2|Failure to achieve response|3|||
105747949|NCT00315705|364731034|FG000|Phase 2|Disease relapse|1|||
105747950|NCT00315705|364731034|FG000|Phase 2|Scheduled for transplant|8|||
105747951|NCT00315705|364731034|FG000|Phase 2|Other|1|||
105747952|NCT00315705|364731034|FG000|Phase 2|Death|7|||
105747953|NCT00748553|364731035|FG000|Overall Study|Adverse Event|0|||
105747954|NCT00748553|364731036|FG001|Overall Study|Adverse Event|1|||
105747955|NCT00748553|364731035|FG000|Overall Study|disease progression|2|||
105747956|NCT00748553|364731036|FG001|Overall Study|disease progression|0|||
105747957|NCT00748553|364731035|FG000|Overall Study|noncompliance|1|||
105747958|NCT00748553|364731036|FG001|Overall Study|noncompliance|0|||
105747959|NCT00948818|364731037|FG000|Overall Study|Adverse Event|10|||
105747960|NCT00948818|364731038|FG001|Overall Study|Adverse Event|32|||
105747961|NCT00948818|364731037|FG000|Overall Study|Protocol Violation|9|||
105747962|NCT00948818|364731038|FG001|Overall Study|Protocol Violation|10|||
105747963|NCT00948818|364731037|FG000|Overall Study|Withdrawal by Subject|25|||
105747964|NCT00948818|364731038|FG001|Overall Study|Withdrawal by Subject|25|||
105747965|NCT00948818|364731037|FG000|Overall Study|Lost to Follow-up|10|||
105747966|NCT00948818|364731038|FG001|Overall Study|Lost to Follow-up|17|||
105747967|NCT00948818|364731037|FG000|Overall Study|Lack of Efficacy|4|||
105747968|NCT00948818|364731038|FG001|Overall Study|Lack of Efficacy|5|||
105747969|NCT00948818|364731037|FG000|Overall Study|Other Reason|4|||
105747970|NCT00948818|364731038|FG001|Overall Study|Other Reason|5|||
105801363|NCT01681771|364930553|FG000|Overall Study|Lost to Follow-up|4|||
105747971|NCT01716533|364731039|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
105801364|NCT01681771|364930554|FG001|Overall Study|Lost to Follow-up|2|||
105801365|NCT03208933|364930555|FG000|Overall Study|Death|3|||
105801366|NCT03208933|364930555|FG000|Overall Study|Withdrawal by Subject|3|||
105801367|NCT03208933|364930555|FG000|Overall Study|Adverse Event|1|||
105801368|NCT03208933|364930555|FG000|Overall Study|Lost to Follow-up|2|||
105801369|NCT03208933|364930555|FG000|Overall Study|Physician Decision|3|||
105801370|NCT03208933|364930555|FG000|Overall Study|Protocol Violation|1|||
105801371|NCT02024698|364930558|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
105801372|NCT02024698|364930559|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
105801373|NCT00525031|364930561|FG000|Overall Study|Disease Progression|1|||
105801374|NCT00525031|364930562|FG001|Overall Study|Disease Progression|1|||
105801375|NCT00881959|364930563|FG000|Overall Study|Lost to Follow-up|2|||
105801376|NCT00881959|364930564|FG001|Overall Study|Lost to Follow-up|4|||
105801377|NCT02791659|364930565|FG000|Overall Study|Protocol Violation|0|||
105801378|NCT02791659|364930566|FG001|Overall Study|Protocol Violation|1|||
105801379|NCT01456052|364930567|FG000|Overall Study|Adverse Event|1|||
105801380|NCT01456052|364930568|FG001|Overall Study|Adverse Event|1|||
105801381|NCT01456052|364930569|FG002|Overall Study|Adverse Event|2|||
105801382|NCT01456052|364930567|FG000|Overall Study|Consent withdrawn|0|||
105801383|NCT01456052|364930568|FG001|Overall Study|Consent withdrawn|2|||
105801384|NCT01456052|364930569|FG002|Overall Study|Consent withdrawn|1|||
105801385|NCT01456052|364930567|FG000|Overall Study|Protocol Violation|0|||
105801386|NCT01456052|364930568|FG001|Overall Study|Protocol Violation|1|||
105801387|NCT01456052|364930569|FG002|Overall Study|Protocol Violation|0|||
105801388|NCT01456052|364930567|FG000|Overall Study|Physician Decision|1|||
105801389|NCT01456052|364930568|FG001|Overall Study|Physician Decision|0|||
105801390|NCT01456052|364930569|FG002|Overall Study|Physician Decision|1|||
105801391|NCT01456052|364930567|FG000|Overall Study|Treatment Failure|0|||
105801392|NCT01456052|364930568|FG001|Overall Study|Treatment Failure|1|||
105801393|NCT01456052|364930569|FG002|Overall Study|Treatment Failure|1|||
105801394|NCT01625845|364930572|FG000|Overall Study|Adverse Event|1|||
105801395|NCT01625845|364930573|FG001|Overall Study|Adverse Event|2|||
105801396|NCT01625845|364930572|FG000|Overall Study|Lost to Follow-up|2|||
105801397|NCT01625845|364930573|FG001|Overall Study|Lost to Follow-up|1|||
105801398|NCT01625845|364930572|FG000|Overall Study|Withdrawal by Subject|2|||
105801399|NCT01625845|364930573|FG001|Overall Study|Withdrawal by Subject|0|||
105801400|NCT01070966|364930575|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
105801401|NCT01070966|364930575|FG000|Participants for Safety Evaluation|Off-label use|9|||
105801402|NCT01070966|364930575|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
105801403|NCT01070966|364930575|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
105801404|NCT01070966|364930575|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
105801405|NCT01070966|364930575|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
105801406|NCT01070966|364930575|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
105801407|NCT01070966|364930575|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
105747972|NCT01716533|364731040|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
105747973|NCT01716533|364731041|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
105747974|NCT01716533|364731042|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
105747975|NCT01716533|364731039|FG000|Overall Study|Withdrawal by Subject|0|||
105747976|NCT01716533|364731040|FG001|Overall Study|Withdrawal by Subject|0|||
105747977|NCT01716533|364731041|FG002|Overall Study|Withdrawal by Subject|0|||
105747978|NCT01716533|364731042|FG003|Overall Study|Withdrawal by Subject|5|||
105747979|NCT01716533|364731039|FG000|Overall Study|Death|0|||
105747980|NCT01716533|364731040|FG001|Overall Study|Death|0|||
105801408|NCT02762565|364930576|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
105801409|NCT01113710|364930577|FG000|Overall Study|Adverse Event|64|||
105801410|NCT01113710|364930577|FG000|Overall Study|Lack of Efficacy|41|||
105801411|NCT01113710|364930577|FG000|Overall Study|No Information Available|40|||
105801412|NCT01113710|364930577|FG000|Overall Study|Withdrawal by Subject|28|||
105801413|NCT01113710|364930577|FG000|Overall Study|Lost to Follow-up|20|||
105801414|NCT01113710|364930577|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
105801415|NCT01113710|364930577|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
105801416|NCT01113710|364930577|FG000|Overall Study|Lack of Patient's Compliance|8|||
105801417|NCT01113710|364930577|FG000|Overall Study|Other|7|||
105801418|NCT01113710|364930577|FG000|Overall Study|Adverse Event/Other|5|||
105801419|NCT01113710|364930577|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
105801420|NCT01113710|364930577|FG000|Overall Study|Lack of Efficacy/Other|4|||
106015833|NCT01967940|365723309|FG002|Part 2|Adverse Event|0|||
105747981|NCT01716533|364731041|FG002|Overall Study|Death|0|||
105747982|NCT01716533|364731042|FG003|Overall Study|Death|2|||
105747983|NCT01716533|364731039|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
105801421|NCT01113710|364930577|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
105801422|NCT01113710|364930577|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
105801423|NCT01113710|364930577|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
105801424|NCT01113710|364930577|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
105943773|NCT00725985|365456687|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
105943774|NCT00725985|365456676|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105943775|NCT00725985|365456677|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105943776|NCT00725985|365456678|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105943777|NCT00725985|365456679|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105943778|NCT00725985|365456680|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105943779|NCT00725985|365456681|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105747984|NCT01716533|364731040|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
105747985|NCT01716533|364731041|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
105747986|NCT01716533|364731042|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
105943780|NCT00725985|365456682|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
105943781|NCT00725985|365456683|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
105943782|NCT00725985|365456684|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
105943783|NCT00725985|365456685|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105943784|NCT00725985|365456686|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105943785|NCT00725985|365456687|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
105747987|NCT01670656|364731046|FG000|Overall Study|Non-compliance with study drug|0|||
105747988|NCT01670656|364731047|FG001|Overall Study|Non-compliance with study drug|0|||
105747989|NCT01670656|364731048|FG002|Overall Study|Non-compliance with study drug|3|||
105747990|NCT01670656|364731049|FG003|Overall Study|Non-compliance with study drug|0|||
105747991|NCT01670656|364731050|FG004|Overall Study|Non-compliance with study drug|1|||
105747992|NCT01670656|364731046|FG000|Overall Study|Pregnancy|0|||
105747993|NCT01670656|364731047|FG001|Overall Study|Pregnancy|0|||
105747994|NCT01670656|364731048|FG002|Overall Study|Pregnancy|0|||
105747995|NCT01670656|364731049|FG003|Overall Study|Pregnancy|0|||
105747996|NCT01670656|364731050|FG004|Overall Study|Pregnancy|1|||
105747997|NCT01670656|364731046|FG000|Overall Study|Withdrawal by Subject|1|||
105747998|NCT01670656|364731047|FG001|Overall Study|Withdrawal by Subject|1|||
105747999|NCT01670656|364731048|FG002|Overall Study|Withdrawal by Subject|0|||
105748000|NCT01670656|364731049|FG003|Overall Study|Withdrawal by Subject|0|||
105748001|NCT01670656|364731050|FG004|Overall Study|Withdrawal by Subject|0|||
105748002|NCT01670656|364731046|FG000|Overall Study|Non-compliance with protocol|0|||
105748003|NCT01670656|364731047|FG001|Overall Study|Non-compliance with protocol|3|||
105748004|NCT01670656|364731048|FG002|Overall Study|Non-compliance with protocol|1|||
105748005|NCT01670656|364731049|FG003|Overall Study|Non-compliance with protocol|1|||
105748006|NCT01670656|364731050|FG004|Overall Study|Non-compliance with protocol|2|||
105748007|NCT01670656|364731046|FG000|Overall Study|Adverse Event|2|||
105748008|NCT01670656|364731047|FG001|Overall Study|Adverse Event|2|||
105748009|NCT01670656|364731048|FG002|Overall Study|Adverse Event|2|||
105748010|NCT01670656|364731049|FG003|Overall Study|Adverse Event|3|||
105748011|NCT01670656|364731050|FG004|Overall Study|Adverse Event|3|||
105748012|NCT01670656|364731046|FG000|Overall Study|Subject withdrew consent|0|||
105748013|NCT01670656|364731047|FG001|Overall Study|Subject withdrew consent|1|||
105748014|NCT01670656|364731048|FG002|Overall Study|Subject withdrew consent|2|||
105748015|NCT01670656|364731049|FG003|Overall Study|Subject withdrew consent|1|||
105748016|NCT01670656|364731050|FG004|Overall Study|Subject withdrew consent|1|||
105748017|NCT01670656|364731046|FG000|Overall Study|Lost to Follow-up|0|||
105748018|NCT01670656|364731047|FG001|Overall Study|Lost to Follow-up|0|||
105748019|NCT01670656|364731048|FG002|Overall Study|Lost to Follow-up|0|||
105748020|NCT01670656|364731049|FG003|Overall Study|Lost to Follow-up|0|||
105748021|NCT01670656|364731050|FG004|Overall Study|Lost to Follow-up|3|||
105748022|NCT01670656|364731046|FG000|Overall Study|Subject moved|0|||
105748023|NCT01670656|364731047|FG001|Overall Study|Subject moved|0|||
105748024|NCT01670656|364731048|FG002|Overall Study|Subject moved|0|||
105748025|NCT01670656|364731049|FG003|Overall Study|Subject moved|1|||
105748026|NCT01670656|364731050|FG004|Overall Study|Subject moved|0|||
105748027|NCT00165841|364731051|FG000|Overall Study|Adverse Event|2|||
105748028|NCT00165841|364731052|FG001|Overall Study|Adverse Event|3|||
105748029|NCT00165841|364731051|FG000|Overall Study|Lack of Efficacy|6|||
105748030|NCT00165841|364731052|FG001|Overall Study|Lack of Efficacy|33|||
105748031|NCT00165841|364731051|FG000|Overall Study|Lost to Follow-up|4|||
105748032|NCT00165841|364731052|FG001|Overall Study|Lost to Follow-up|4|||
105748033|NCT00165841|364731051|FG000|Overall Study|Withdrawal by Subject|7|||
105748034|NCT00165841|364731052|FG001|Overall Study|Withdrawal by Subject|8|||
105748035|NCT00165841|364731051|FG000|Overall Study|Physician Decision|1|||
105748036|NCT00165841|364731052|FG001|Overall Study|Physician Decision|0|||
105748037|NCT00165841|364731051|FG000|Overall Study|Protocol Violation|6|||
105748038|NCT00165841|364731052|FG001|Overall Study|Protocol Violation|8|||
105943786|NCT00725985|365456676|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105943787|NCT00725985|365456677|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105748039|NCT00165841|364731051|FG000|Overall Study|Other|3|||
105748040|NCT00165841|364731052|FG001|Overall Study|Other|5|||
105748041|NCT00165841|364731051|FG000|Overall Study|Medication Noncompliance|1|||
105748042|NCT00165841|364731052|FG001|Overall Study|Medication Noncompliance|1|||
105943788|NCT00725985|365456678|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105943789|NCT00725985|365456679|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105943790|NCT00725985|365456680|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105748043|NCT00789958|364731053|FG000|Overall Study|Adverse Event|3|||
105748044|NCT00789958|364731053|FG000|Overall Study|Withdrawal by Subject|4|||
105748045|NCT00789958|364731053|FG000|Overall Study|Progression|3|||
105748046|NCT00789958|364731053|FG000|Overall Study|not protocol specified|1|||
105801425|NCT01113710|364930577|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
105801426|NCT01113710|364930577|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
105748047|NCT00789958|364731053|FG000|Overall Study|Not eligible/not analyzable|26|||
105748048|NCT00254293|364731054|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748049|NCT00254293|364731055|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
105748050|NCT00254293|364731056|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748051|NCT00254293|364731057|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
105748052|NCT00254293|364731058|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748053|NCT00254293|364731059|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748054|NCT00254293|364731060|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
105748055|NCT00254293|364731054|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748056|NCT00254293|364731055|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748057|NCT00254293|364731056|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
105748058|NCT00254293|364731057|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748059|NCT00254293|364731058|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748060|NCT00254293|364731059|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748061|NCT00254293|364731060|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
105748062|NCT00254293|364731054|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748063|NCT00254293|364731055|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748064|NCT00254293|364731056|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
105748065|NCT00254293|364731057|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748066|NCT00254293|364731058|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748067|NCT00254293|364731059|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748068|NCT00254293|364731060|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
105748069|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Death|0|||
105748070|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Death|0|||
105748071|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Death|1|||
105748072|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Death|0|||
105748073|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Death|0|||
105748074|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Death|0|||
105748075|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Death|0|||
105748076|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
105748077|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
105748078|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
105748079|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
105748080|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
105748081|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
105748082|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
105748083|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
105748084|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
105748085|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
105748086|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
105748087|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
105748088|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
105748089|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
105748090|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748091|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748092|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
105748093|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748094|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748095|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748096|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
105748097|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748098|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748099|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
105801427|NCT01113710|364930577|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
105748100|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748101|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748102|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105748103|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
105943791|NCT00725985|365456681|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105943792|NCT00725985|365456682|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105748104|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748105|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748106|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
105748107|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748108|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748109|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748110|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
105748111|NCT00254293|364731054|FG000|LTE Open Label Variable SC Dosing|Other|0|||
105748112|NCT00254293|364731055|FG001|LTE Open Label Variable SC Dosing|Other|0|||
105748113|NCT00254293|364731056|FG002|LTE Open Label Variable SC Dosing|Other|2|||
105748114|NCT00254293|364731057|FG003|LTE Open Label Variable SC Dosing|Other|0|||
105748115|NCT00254293|364731058|FG004|LTE Open Label Variable SC Dosing|Other|0|||
105748116|NCT00254293|364731059|FG005|LTE Open Label Variable SC Dosing|Other|0|||
105748117|NCT00254293|364731060|FG006|LTE Open Label Variable SC Dosing|Other|0|||
105748118|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Death|0|||
105748119|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Death|0|||
105748120|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Death|0|||
105748121|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Death|0|||
105748122|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Death|0|||
105748123|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Death|0|||
105748124|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Death|3|||
105748125|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748126|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748127|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748128|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748129|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748130|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
105748131|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
105748132|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748133|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748134|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748135|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748136|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748137|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
105748138|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
105748139|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748140|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748141|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748142|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748143|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748144|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
105748145|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
105748146|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748147|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748148|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748149|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748150|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748151|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
105748152|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
105748153|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748154|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748155|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748156|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748157|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748158|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
105748159|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
105748160|NCT00254293|364731054|FG000|LTE Open Label Fixed Dosing|Other|0|||
105748161|NCT00254293|364731055|FG001|LTE Open Label Fixed Dosing|Other|0|||
105748162|NCT00254293|364731056|FG002|LTE Open Label Fixed Dosing|Other|0|||
105748163|NCT00254293|364731057|FG003|LTE Open Label Fixed Dosing|Other|0|||
105748164|NCT00254293|364731058|FG004|LTE Open Label Fixed Dosing|Other|0|||
105748165|NCT00254293|364731059|FG005|LTE Open Label Fixed Dosing|Other|0|||
105748166|NCT00254293|364731060|FG006|LTE Open Label Fixed Dosing|Other|1|||
105748167|NCT01575197|364731061|FG000|Overall Study|Migration out of study area|1|||
105748168|NCT01575197|364731062|FG001|Overall Study|Migration out of study area|5|||
105748169|NCT01575197|364731063|FG002|Overall Study|Migration out of study area|4|||
105748170|NCT01575197|364731061|FG000|Overall Study|SAE|0|||
105748171|NCT01575197|364731062|FG001|Overall Study|SAE|1|||
105748172|NCT01575197|364731063|FG002|Overall Study|SAE|0|||
105748173|NCT01575197|364731061|FG000|Overall Study|Lost to Follow-up|0|||
105748174|NCT01575197|364731062|FG001|Overall Study|Lost to Follow-up|1|||
105748175|NCT01575197|364731063|FG002|Overall Study|Lost to Follow-up|0|||
105748176|NCT01575197|364731061|FG000|Overall Study|Withdrawal by Subject|0|||
105760842|NCT01831804|364778037|FG001|Overall Study|Adverse Event|0|||
105748177|NCT01575197|364731062|FG001|Overall Study|Withdrawal by Subject|1|||
105748178|NCT01575197|364731063|FG002|Overall Study|Withdrawal by Subject|1|||
105748179|NCT01575197|364731061|FG000|Overall Study|Protocol Violation|2|||
105748180|NCT01575197|364731062|FG001|Overall Study|Protocol Violation|1|||
105748181|NCT01575197|364731063|FG002|Overall Study|Protocol Violation|1|||
105748182|NCT03137121|364731064|FG000|Overall Study|Withdrawal by Subject|0|||
105748183|NCT03137121|364731065|FG001|Overall Study|Withdrawal by Subject|1|||
105748184|NCT03196193|364731066|FG000|Overall Study|Adverse Event|1|||
105748185|NCT03196193|364731067|FG001|Overall Study|Adverse Event|0|||
105748186|NCT03196193|364731066|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
105748187|NCT03196193|364731067|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
105748188|NCT01995136|364731070|FG000|Overall Study|Change in residence|1|||
105748189|NCT04410198|364731071|FG000|Overall Study|Death|10|||
105748190|NCT04410198|364731071|FG000|Overall Study|Withdrawal by Subject|7|||
105748191|NCT04410198|364731071|FG000|Overall Study|Transferred/Relocation|4|||
105748192|NCT04410198|364731071|FG000|Overall Study|Kidney Transplant|9|||
105748193|NCT04410198|364731071|FG000|Overall Study|Adverse Event|4|||
105748194|NCT04410198|364731071|FG000|Overall Study|Physician Decision|2|||
105748195|NCT04410198|364731071|FG000|Overall Study|Other than specified|1|||
105748196|NCT01354353|364731078|FG000|Overall Study|Adverse Event|1|||
105748197|NCT01354353|364731079|FG001|Overall Study|Adverse Event|0|||
105748198|NCT01354353|364731080|FG002|Overall Study|Adverse Event|0|||
105748199|NCT01354353|364731081|FG003|Overall Study|Adverse Event|4|||
105748200|NCT01354353|364731082|FG004|Overall Study|Adverse Event|0|||
105748201|NCT01354353|364731083|FG005|Overall Study|Adverse Event|5|||
105748202|NCT01354353|364731078|FG000|Overall Study|Entry Criteria Not Met|0|||
105748203|NCT01354353|364731079|FG001|Overall Study|Entry Criteria Not Met|0|||
105748204|NCT01354353|364731080|FG002|Overall Study|Entry Criteria Not Met|0|||
105748205|NCT01354353|364731081|FG003|Overall Study|Entry Criteria Not Met|1|||
105748206|NCT01354353|364731082|FG004|Overall Study|Entry Criteria Not Met|1|||
105748207|NCT01354353|364731083|FG005|Overall Study|Entry Criteria Not Met|0|||
105748208|NCT01354353|364731078|FG000|Overall Study|Physician Decision|0|||
105748209|NCT01354353|364731079|FG001|Overall Study|Physician Decision|1|||
105748210|NCT01354353|364731080|FG002|Overall Study|Physician Decision|1|||
105748211|NCT01354353|364731081|FG003|Overall Study|Physician Decision|0|||
105748212|NCT01354353|364731082|FG004|Overall Study|Physician Decision|0|||
105748213|NCT01354353|364731083|FG005|Overall Study|Physician Decision|0|||
105748214|NCT01354353|364731078|FG000|Overall Study|Withdrawal by Subject|2|||
105748215|NCT01354353|364731079|FG001|Overall Study|Withdrawal by Subject|0|||
105748216|NCT01354353|364731080|FG002|Overall Study|Withdrawal by Subject|1|||
105748217|NCT01354353|364731081|FG003|Overall Study|Withdrawal by Subject|0|||
105748218|NCT01354353|364731082|FG004|Overall Study|Withdrawal by Subject|0|||
105748219|NCT01354353|364731083|FG005|Overall Study|Withdrawal by Subject|1|||
105748220|NCT03583372|364731084|FG000|Overall Study|Withdrawal by Subject|6|||
105748221|NCT03583372|364731085|FG001|Overall Study|Withdrawal by Subject|11|||
105748222|NCT03583372|364731086|FG002|Overall Study|Withdrawal by Subject|7|||
105748223|NCT03583372|364731087|FG003|Overall Study|Withdrawal by Subject|8|||
105748224|NCT03583372|364731084|FG000|Overall Study|Lost to Follow-up|4|||
105748225|NCT03583372|364731085|FG001|Overall Study|Lost to Follow-up|6|||
105748226|NCT03583372|364731086|FG002|Overall Study|Lost to Follow-up|3|||
105748227|NCT03583372|364731087|FG003|Overall Study|Lost to Follow-up|2|||
105748228|NCT03583372|364731084|FG000|Overall Study|Adverse Event|1|||
105748229|NCT03583372|364731085|FG001|Overall Study|Adverse Event|3|||
105748230|NCT03583372|364731086|FG002|Overall Study|Adverse Event|4|||
105748231|NCT03583372|364731087|FG003|Overall Study|Adverse Event|4|||
105748232|NCT03583372|364731084|FG000|Overall Study|Physician Decision|0|||
105748233|NCT03583372|364731085|FG001|Overall Study|Physician Decision|1|||
105748234|NCT03583372|364731086|FG002|Overall Study|Physician Decision|1|||
105748235|NCT03583372|364731087|FG003|Overall Study|Physician Decision|1|||
105748236|NCT03583372|364731084|FG000|Overall Study|Lack of Efficacy|0|||
105748237|NCT03583372|364731085|FG001|Overall Study|Lack of Efficacy|1|||
105748238|NCT03583372|364731086|FG002|Overall Study|Lack of Efficacy|0|||
105748239|NCT03583372|364731087|FG003|Overall Study|Lack of Efficacy|1|||
105748240|NCT03583372|364731084|FG000|Overall Study|Death|1|||
105748241|NCT03583372|364731085|FG001|Overall Study|Death|0|||
105748242|NCT03583372|364731086|FG002|Overall Study|Death|0|||
105748243|NCT03583372|364731087|FG003|Overall Study|Death|0|||
105748244|NCT03583372|364731084|FG000|Overall Study|Protocol Violation|0|||
105748245|NCT03583372|364731085|FG001|Overall Study|Protocol Violation|1|||
105801428|NCT01113710|364930577|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
105748246|NCT03583372|364731086|FG002|Overall Study|Protocol Violation|0|||
105748247|NCT03583372|364731087|FG003|Overall Study|Protocol Violation|0|||
105748248|NCT03583372|364731084|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
105748249|NCT03583372|364731085|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
105748250|NCT03583372|364731086|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
105748251|NCT03583372|364731087|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
105748252|NCT03583372|364731084|FG000|Overall Study|Did Not Receive Study Drug|0|||
105748253|NCT03583372|364731085|FG001|Overall Study|Did Not Receive Study Drug|1|||
105801429|NCT01113710|364930577|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
105801430|NCT01113710|364930577|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
105801431|NCT01113710|364930577|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
105801432|NCT01113710|364930577|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
105801433|NCT01113710|364930577|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
105801434|NCT01078623|364930578|FG000|Treatment Period 1|Adverse Event|1|||
105801435|NCT01078623|364930579|FG001|Treatment Period 1|Adverse Event|1|||
105801436|NCT01078623|364930580|FG002|Treatment Period 1|Adverse Event|1|||
105801437|NCT01078623|364930581|FG003|Treatment Period 1|Adverse Event|0|||
105801438|NCT01078623|364930582|FG004|Treatment Period 1|Adverse Event|0|||
105801439|NCT01078623|364930583|FG005|Treatment Period 1|Adverse Event|0|||
105801440|NCT01078623|364930584|FG006|Treatment Period 1|Adverse Event|1|||
105801441|NCT01078623|364930585|FG007|Treatment Period 1|Adverse Event|0|||
105801442|NCT01078623|364930586|FG008|Treatment Period 1|Adverse Event|1|||
105801443|NCT01078623|364930587|FG009|Treatment Period 1|Adverse Event|1|||
105801444|NCT01078623|364930588|FG010|Treatment Period 1|Adverse Event|0|||
105801445|NCT01078623|364930589|FG011|Treatment Period 1|Adverse Event|0|||
105801446|NCT01078623|364930590|FG012|Treatment Period 1|Adverse Event|0|||
105801447|NCT01078623|364930591|FG013|Treatment Period 1|Adverse Event|0|||
105801448|NCT01078623|364930592|FG014|Treatment Period 1|Adverse Event|0|||
105801449|NCT01078623|364930593|FG015|Treatment Period 1|Adverse Event|0|||
105801450|NCT01078623|364930594|FG016|Treatment Period 1|Adverse Event|0|||
105801451|NCT01078623|364930595|FG017|Treatment Period 1|Adverse Event|0|||
105801452|NCT01078623|364930596|FG018|Treatment Period 1|Adverse Event|0|||
105801453|NCT01078623|364930597|FG019|Treatment Period 1|Adverse Event|0|||
105801454|NCT01078623|364930578|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105801455|NCT01078623|364930579|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105801456|NCT01078623|364930580|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105801457|NCT01078623|364930581|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105801458|NCT01078623|364930582|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105801459|NCT01078623|364930583|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105801460|NCT01078623|364930584|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105801461|NCT01078623|364930585|FG007|Treatment Period 1|Withdrawal by Subject|1|||
105801462|NCT01078623|364930586|FG008|Treatment Period 1|Withdrawal by Subject|0|||
105801463|NCT01078623|364930587|FG009|Treatment Period 1|Withdrawal by Subject|0|||
105801464|NCT01078623|364930588|FG010|Treatment Period 1|Withdrawal by Subject|1|||
105801465|NCT01078623|364930589|FG011|Treatment Period 1|Withdrawal by Subject|0|||
105801466|NCT01078623|364930590|FG012|Treatment Period 1|Withdrawal by Subject|0|||
105801467|NCT01078623|364930591|FG013|Treatment Period 1|Withdrawal by Subject|0|||
105801468|NCT01078623|364930592|FG014|Treatment Period 1|Withdrawal by Subject|0|||
105801469|NCT01078623|364930593|FG015|Treatment Period 1|Withdrawal by Subject|0|||
105801470|NCT01078623|364930594|FG016|Treatment Period 1|Withdrawal by Subject|0|||
105801471|NCT01078623|364930595|FG017|Treatment Period 1|Withdrawal by Subject|0|||
105801472|NCT01078623|364930596|FG018|Treatment Period 1|Withdrawal by Subject|0|||
105801473|NCT01078623|364930597|FG019|Treatment Period 1|Withdrawal by Subject|0|||
105801474|NCT01078623|364930578|FG000|Treatment Period 1|Protocol Violation|0|||
105801475|NCT01078623|364930579|FG001|Treatment Period 1|Protocol Violation|0|||
105801476|NCT01078623|364930580|FG002|Treatment Period 1|Protocol Violation|0|||
105801477|NCT01078623|364930581|FG003|Treatment Period 1|Protocol Violation|0|||
105801478|NCT01078623|364930582|FG004|Treatment Period 1|Protocol Violation|0|||
105801479|NCT01078623|364930583|FG005|Treatment Period 1|Protocol Violation|1|||
105801480|NCT01078623|364930584|FG006|Treatment Period 1|Protocol Violation|0|||
105801481|NCT01078623|364930585|FG007|Treatment Period 1|Protocol Violation|0|||
105801482|NCT01078623|364930586|FG008|Treatment Period 1|Protocol Violation|0|||
105801483|NCT01078623|364930587|FG009|Treatment Period 1|Protocol Violation|0|||
105801484|NCT01078623|364930588|FG010|Treatment Period 1|Protocol Violation|0|||
105801485|NCT01078623|364930589|FG011|Treatment Period 1|Protocol Violation|0|||
105801486|NCT01078623|364930590|FG012|Treatment Period 1|Protocol Violation|0|||
105801487|NCT01078623|364930591|FG013|Treatment Period 1|Protocol Violation|0|||
105801488|NCT01078623|364930592|FG014|Treatment Period 1|Protocol Violation|0|||
106142550|NCT03460756|366181898|FG003|Overall Study|Lack of Efficacy|2|||
106142551|NCT03460756|366181895|FG000|Overall Study|Lost to Follow-up|0|||
106142552|NCT03460756|366181896|FG001|Overall Study|Lost to Follow-up|1|||
106142553|NCT03460756|366181897|FG002|Overall Study|Lost to Follow-up|2|||
106142554|NCT03460756|366181898|FG003|Overall Study|Lost to Follow-up|1|||
106142555|NCT03460756|366181895|FG000|Overall Study|Pregnancy|0|||
105801489|NCT01078623|364930593|FG015|Treatment Period 1|Protocol Violation|0|||
105801490|NCT01078623|364930594|FG016|Treatment Period 1|Protocol Violation|0|||
105801491|NCT01078623|364930595|FG017|Treatment Period 1|Protocol Violation|0|||
105801492|NCT01078623|364930596|FG018|Treatment Period 1|Protocol Violation|0|||
105801493|NCT01078623|364930597|FG019|Treatment Period 1|Protocol Violation|0|||
105801494|NCT01078623|364930578|FG000|Treatment Period 2|Adverse Event|0|||
105801495|NCT01078623|364930579|FG001|Treatment Period 2|Adverse Event|0|||
105943793|NCT00725985|365456683|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105801496|NCT01078623|364930580|FG002|Treatment Period 2|Adverse Event|0|||
105801497|NCT01078623|364930581|FG003|Treatment Period 2|Adverse Event|0|||
106142556|NCT03460756|366181896|FG001|Overall Study|Pregnancy|0|||
105748254|NCT03583372|364731086|FG002|Overall Study|Did Not Receive Study Drug|0|||
105748255|NCT03583372|364731087|FG003|Overall Study|Did Not Receive Study Drug|0|||
105748256|NCT03583372|364731084|FG000|Overall Study|Captured as Other in the Database|1|||
105748257|NCT03583372|364731085|FG001|Overall Study|Captured as Other in the Database|2|||
105748258|NCT03583372|364731086|FG002|Overall Study|Captured as Other in the Database|4|||
105748259|NCT03583372|364731087|FG003|Overall Study|Captured as Other in the Database|1|||
105748260|NCT02796391|364731088|FG000|Overall Study|Lost to Follow-up|2|||
105748261|NCT02796391|364731089|FG001|Overall Study|Lost to Follow-up|2|||
105748262|NCT02796391|364731090|FG002|Overall Study|Lost to Follow-up|13|||
105748263|NCT02796391|364731091|FG003|Overall Study|Lost to Follow-up|8|||
105748264|NCT02796391|364731092|FG004|Overall Study|Lost to Follow-up|14|||
105748265|NCT02796391|364731093|FG005|Overall Study|Lost to Follow-up|13|||
105748266|NCT02796391|364731088|FG000|Overall Study|COVID|0|||
105748267|NCT02796391|364731089|FG001|Overall Study|COVID|0|||
105748268|NCT02796391|364731090|FG002|Overall Study|COVID|5|||
105748269|NCT02796391|364731091|FG003|Overall Study|COVID|5|||
105748270|NCT02796391|364731092|FG004|Overall Study|COVID|2|||
105748271|NCT02796391|364731093|FG005|Overall Study|COVID|4|||
105748272|NCT02796391|364731088|FG000|Overall Study|Participant did not like study cigarettes|0|||
105748273|NCT02796391|364731089|FG001|Overall Study|Participant did not like study cigarettes|0|||
105748274|NCT02796391|364731090|FG002|Overall Study|Participant did not like study cigarettes|3|||
105748275|NCT02796391|364731091|FG003|Overall Study|Participant did not like study cigarettes|0|||
105748276|NCT02796391|364731092|FG004|Overall Study|Participant did not like study cigarettes|0|||
105748277|NCT02796391|364731093|FG005|Overall Study|Participant did not like study cigarettes|0|||
105748278|NCT02796391|364731088|FG000|Overall Study|Withdrawal by Subject|1|||
105748279|NCT02796391|364731089|FG001|Overall Study|Withdrawal by Subject|1|||
105748280|NCT02796391|364731090|FG002|Overall Study|Withdrawal by Subject|4|||
105748281|NCT02796391|364731091|FG003|Overall Study|Withdrawal by Subject|3|||
105748282|NCT02796391|364731092|FG004|Overall Study|Withdrawal by Subject|4|||
105748283|NCT02796391|364731093|FG005|Overall Study|Withdrawal by Subject|3|||
105748284|NCT02796391|364731088|FG000|Overall Study|Adverse Event|0|||
105748285|NCT02796391|364731089|FG001|Overall Study|Adverse Event|0|||
105748286|NCT02796391|364731090|FG002|Overall Study|Adverse Event|0|||
105748287|NCT02796391|364731091|FG003|Overall Study|Adverse Event|1|||
105748288|NCT02796391|364731092|FG004|Overall Study|Adverse Event|0|||
105748289|NCT02796391|364731093|FG005|Overall Study|Adverse Event|0|||
105748290|NCT02796391|364731088|FG000|Overall Study|Protocol Violation|0|||
105748291|NCT02796391|364731089|FG001|Overall Study|Protocol Violation|0|||
105748292|NCT02796391|364731090|FG002|Overall Study|Protocol Violation|0|||
105748293|NCT02796391|364731091|FG003|Overall Study|Protocol Violation|1|||
105748294|NCT02796391|364731092|FG004|Overall Study|Protocol Violation|0|||
105748295|NCT02796391|364731093|FG005|Overall Study|Protocol Violation|0|||
105748296|NCT02681055|364731096|FG000|Weeks 5-12|Adverse Event|1|||
105748297|NCT02695524|364731097|FG000|Overall Study|Lost to Follow-up|3|||
105748298|NCT02695524|364731098|FG001|Overall Study|Lost to Follow-up|2|||
105748299|NCT02695524|364731097|FG000|Overall Study|Death|0|||
105748300|NCT02695524|364731098|FG001|Overall Study|Death|1|||
105748301|NCT00377611|364731101|FG000|Overall Study|Adverse Event|2|||
105748302|NCT00377611|364731102|FG001|Overall Study|Adverse Event|9|||
105748303|NCT00377611|364731101|FG000|Overall Study|Protocol Violation|2|||
105748304|NCT00377611|364731102|FG001|Overall Study|Protocol Violation|0|||
105748305|NCT00377611|364731101|FG000|Overall Study|Withdrawal by Subject|0|||
105748306|NCT00377611|364731102|FG001|Overall Study|Withdrawal by Subject|5|||
105748307|NCT00377611|364731101|FG000|Overall Study|Lost to Follow-up|18|||
105748308|NCT00377611|364731102|FG001|Overall Study|Lost to Follow-up|16|||
105748309|NCT00377611|364731101|FG000|Overall Study|Other|0|||
105748310|NCT00377611|364731102|FG001|Overall Study|Other|3|||
105748311|NCT00831441|364731103|FG000|Randomized|Death|82|||
105748312|NCT00831441|364731104|FG001|Randomized|Death|81|||
105748313|NCT00831441|364731103|FG000|Randomized|Adverse Event|248|||
105748314|NCT00831441|364731104|FG001|Randomized|Adverse Event|321|||
105748315|NCT00831441|364731103|FG000|Randomized|Emergency procedure|2|||
105748316|NCT00831441|364731104|FG001|Randomized|Emergency procedure|2|||
105748317|NCT00831441|364731103|FG000|Randomized|Elective procedure|26|||
105748318|NCT00831441|364731104|FG001|Randomized|Elective procedure|25|||
105748319|NCT00831441|364731103|FG000|Randomized|Physician Decision|26|||
105748320|NCT00831441|364731104|FG001|Randomized|Physician Decision|35|||
105748321|NCT00831441|364731103|FG000|Randomized|No longer met criteria|13|||
105748322|NCT00831441|364731104|FG001|Randomized|No longer met criteria|19|||
105748323|NCT00831441|364731103|FG000|Randomized|Withdrawal by Subject|178|||
105748324|NCT00831441|364731104|FG001|Randomized|Withdrawal by Subject|212|||
105748325|NCT00831441|364731103|FG000|Randomized|Lost to Follow-up|26|||
105748326|NCT00831441|364731104|FG001|Randomized|Lost to Follow-up|35|||
105748327|NCT00831441|364731103|FG000|Randomized|Administrative reason by sponsor|2780|||
105748328|NCT00831441|364731104|FG001|Randomized|Administrative reason by sponsor|2671|||
105748329|NCT00831441|364731103|FG000|Randomized|poor/non-compliance|30|||
105748330|NCT00831441|364731104|FG001|Randomized|poor/non-compliance|38|||
105748331|NCT00831441|364731103|FG000|Randomized|non-specified|276|||
105748332|NCT00831441|364731104|FG001|Randomized|non-specified|266|||
105760843|NCT01831804|364778038|FG002|Overall Study|Adverse Event|0|||
105748333|NCT00831441|364731103|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
105748334|NCT00831441|364731104|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
105748335|NCT00831441|364731103|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
105748336|NCT00831441|364731104|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
105748337|NCT00831441|364731103|FG000|Follow Up (30 Days)|Death|63|||
105748338|NCT00831441|364731104|FG001|Follow Up (30 Days)|Death|86|||
105748339|NCT00831441|364731103|FG000|Follow Up (30 Days)|non-specified|16|||
105748340|NCT00831441|364731104|FG001|Follow Up (30 Days)|non-specified|26|||
105748341|NCT00831441|364731103|FG000|Follow Up (30 Days)|missing end of study status|0|||
105748342|NCT00831441|364731104|FG001|Follow Up (30 Days)|missing end of study status|1|||
105748343|NCT05674344|364731105|FG000|Overall Study|Screen Fail|21|||
105748344|NCT05674344|364731105|FG000|Overall Study|Incomplete study procedures|3|||
105748345|NCT00111917|364731106|FG000|Overall Study|Withdrawal by Subject|1|||
105748346|NCT00111917|364731107|FG001|Overall Study|Withdrawal by Subject|1|||
105748347|NCT00798655|364731111|FG000|Overall Study|Did not receive at least one dose of pan|2|||
105748348|NCT00960934|364731112|FG000|Overall Study|Adverse Event|2|||
105748349|NCT00960934|364731113|FG001|Overall Study|Adverse Event|3|||
105748350|NCT00960934|364731114|FG002|Overall Study|Adverse Event|3|||
105748351|NCT00960934|364731115|FG003|Overall Study|Adverse Event|2|||
105748352|NCT00960934|364731116|FG004|Overall Study|Adverse Event|4|||
105748353|NCT00960934|364731117|FG005|Overall Study|Adverse Event|3|||
105748354|NCT00960934|364731112|FG000|Overall Study|Lack of Efficacy|1|||
105748355|NCT00960934|364731113|FG001|Overall Study|Lack of Efficacy|0|||
105748356|NCT00960934|364731114|FG002|Overall Study|Lack of Efficacy|0|||
105748357|NCT00960934|364731115|FG003|Overall Study|Lack of Efficacy|0|||
105748358|NCT00960934|364731116|FG004|Overall Study|Lack of Efficacy|0|||
105748359|NCT00960934|364731117|FG005|Overall Study|Lack of Efficacy|0|||
105748360|NCT00960934|364731112|FG000|Overall Study|Lost to Follow-up|0|||
105748361|NCT00960934|364731113|FG001|Overall Study|Lost to Follow-up|1|||
105748362|NCT00960934|364731114|FG002|Overall Study|Lost to Follow-up|0|||
105748363|NCT00960934|364731115|FG003|Overall Study|Lost to Follow-up|0|||
105748364|NCT00960934|364731116|FG004|Overall Study|Lost to Follow-up|0|||
105748365|NCT00960934|364731117|FG005|Overall Study|Lost to Follow-up|0|||
105748366|NCT00960934|364731112|FG000|Overall Study|Other|2|||
105748367|NCT00960934|364731113|FG001|Overall Study|Other|1|||
105748368|NCT00960934|364731114|FG002|Overall Study|Other|5|||
105748369|NCT00960934|364731115|FG003|Overall Study|Other|4|||
105748370|NCT00960934|364731116|FG004|Overall Study|Other|2|||
105748371|NCT00960934|364731117|FG005|Overall Study|Other|2|||
105748372|NCT00960934|364731112|FG000|Overall Study|Physician Decision|0|||
105748373|NCT00960934|364731113|FG001|Overall Study|Physician Decision|1|||
105748374|NCT00960934|364731114|FG002|Overall Study|Physician Decision|0|||
105748375|NCT00960934|364731115|FG003|Overall Study|Physician Decision|0|||
105748376|NCT00960934|364731116|FG004|Overall Study|Physician Decision|0|||
105748377|NCT00960934|364731117|FG005|Overall Study|Physician Decision|0|||
105748378|NCT00960934|364731112|FG000|Overall Study|Progressive Disease|1|||
105748379|NCT00960934|364731113|FG001|Overall Study|Progressive Disease|1|||
105748380|NCT00960934|364731114|FG002|Overall Study|Progressive Disease|0|||
105748381|NCT00960934|364731115|FG003|Overall Study|Progressive Disease|0|||
105748382|NCT00960934|364731116|FG004|Overall Study|Progressive Disease|1|||
105748383|NCT00960934|364731117|FG005|Overall Study|Progressive Disease|1|||
105748384|NCT00960934|364731112|FG000|Overall Study|Protocol Violation|3|||
105748385|NCT00960934|364731113|FG001|Overall Study|Protocol Violation|4|||
105748386|NCT00960934|364731114|FG002|Overall Study|Protocol Violation|0|||
105748387|NCT00960934|364731115|FG003|Overall Study|Protocol Violation|3|||
105748388|NCT00960934|364731116|FG004|Overall Study|Protocol Violation|3|||
105748389|NCT00960934|364731117|FG005|Overall Study|Protocol Violation|2|||
105748390|NCT00960934|364731112|FG000|Overall Study|Withdrawal by Subject|5|||
105748391|NCT00960934|364731113|FG001|Overall Study|Withdrawal by Subject|6|||
105748392|NCT00960934|364731114|FG002|Overall Study|Withdrawal by Subject|4|||
105748393|NCT00960934|364731115|FG003|Overall Study|Withdrawal by Subject|5|||
105748394|NCT00960934|364731116|FG004|Overall Study|Withdrawal by Subject|5|||
105748395|NCT00960934|364731117|FG005|Overall Study|Withdrawal by Subject|7|||
105748396|NCT00960934|364731112|FG000|Overall Study|Study Terminated by Sponsor|50|||
105748397|NCT00960934|364731113|FG001|Overall Study|Study Terminated by Sponsor|46|||
105748398|NCT00960934|364731114|FG002|Overall Study|Study Terminated by Sponsor|52|||
105748399|NCT00960934|364731115|FG003|Overall Study|Study Terminated by Sponsor|50|||
105748400|NCT00960934|364731116|FG004|Overall Study|Study Terminated by Sponsor|49|||
105748401|NCT00960934|364731117|FG005|Overall Study|Study Terminated by Sponsor|49|||
105748402|NCT01640925|364731120|FG000|Overall Study|Withdrawal by Subject|1|||
105748403|NCT01640925|364731121|FG001|Overall Study|Withdrawal by Subject|0|||
105748404|NCT01640925|364731120|FG000|Overall Study|Previously enrolled in this trial|13|||
105748405|NCT01640925|364731121|FG001|Overall Study|Previously enrolled in this trial|11|||
105748406|NCT01030458|364731132|FG000|Overall Study|Lost to Follow-up|9|||
105748407|NCT01030458|364731133|FG001|Overall Study|Lost to Follow-up|10|||
105748408|NCT01030458|364731132|FG000|Overall Study|Withdrawal by Subject|2|||
105748409|NCT01030458|364731133|FG001|Overall Study|Withdrawal by Subject|3|||
105748410|NCT01030458|364731132|FG000|Overall Study|Logistical reasons|9|||
105748411|NCT01030458|364731133|FG001|Overall Study|Logistical reasons|5|||
105801498|NCT01078623|364930582|FG004|Treatment Period 2|Adverse Event|0|||
105801499|NCT01078623|364930583|FG005|Treatment Period 2|Adverse Event|0|||
105801500|NCT01078623|364930584|FG006|Treatment Period 2|Adverse Event|1|||
105801501|NCT01078623|364930585|FG007|Treatment Period 2|Adverse Event|0|||
105801502|NCT01078623|364930586|FG008|Treatment Period 2|Adverse Event|0|||
105801503|NCT01078623|364930587|FG009|Treatment Period 2|Adverse Event|0|||
105801504|NCT01078623|364930588|FG010|Treatment Period 2|Adverse Event|0|||
105801505|NCT01078623|364930589|FG011|Treatment Period 2|Adverse Event|0|||
105801506|NCT01078623|364930590|FG012|Treatment Period 2|Adverse Event|0|||
105801507|NCT01078623|364930591|FG013|Treatment Period 2|Adverse Event|0|||
105748412|NCT01030458|364731132|FG000|Overall Study|Moved or changed job|6|||
105748413|NCT01030458|364731133|FG001|Overall Study|Moved or changed job|13|||
105748414|NCT01030458|364731132|FG000|Overall Study|Side effect of medication|1|||
105748415|NCT01030458|364731133|FG001|Overall Study|Side effect of medication|1|||
105748416|NCT02338492|364731134|FG000|Overall Study|Death|32|||
105748417|NCT02338492|364731134|FG000|Overall Study|Adverse Event|3|||
105748418|NCT02338492|364731134|FG000|Overall Study|Lost to Follow-up|4|||
105748419|NCT02338492|364731134|FG000|Overall Study|Reason not captured above|6|||
105748420|NCT02492997|364731140|FG000|Overall Study|Withdrawal by Subject|1|||
105748421|NCT02492997|364731141|FG001|Overall Study|Withdrawal by Subject|0|||
105748422|NCT02492997|364731140|FG000|Overall Study|Gained Weight|1|||
105748423|NCT02492997|364731141|FG001|Overall Study|Gained Weight|0|||
105748424|NCT02492997|364731140|FG000|Overall Study|Lost to Follow-up|0|||
105748425|NCT02492997|364731141|FG001|Overall Study|Lost to Follow-up|1|||
105748426|NCT01842308|364731146|FG000|Overall Study|Withdrawal by Subject|0|||
105748427|NCT01842308|364731147|FG001|Overall Study|Withdrawal by Subject|0|||
105748428|NCT01842308|364731148|FG002|Overall Study|Withdrawal by Subject|0|||
105748429|NCT01842308|364731149|FG003|Overall Study|Withdrawal by Subject|0|||
105748430|NCT01842308|364731150|FG004|Overall Study|Withdrawal by Subject|1|||
105748431|NCT03888391|364731151|FG000|Overall Study|Lost to Follow-up|15|||
105748432|NCT02130427|364731157|FG000|Overall Study|Imaging results not interpretable|30|||
105748433|NCT01100307|364731166|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
105748434|NCT01100307|364731167|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
105748435|NCT01100307|364731166|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
105748436|NCT01100307|364731167|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
105748437|NCT01100307|364731166|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
105748438|NCT01100307|364731167|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
105748439|NCT01100307|364731166|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
105748440|NCT01100307|364731167|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
105748441|NCT01100307|364731166|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
105748442|NCT01100307|364731167|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
105748443|NCT01100307|364731166|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
105748444|NCT01100307|364731167|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
105748445|NCT01496430|364731168|FG000|Overall Study|Adverse Event|0|||
105748446|NCT01496430|364731169|FG001|Overall Study|Adverse Event|0|||
105748447|NCT01496430|364731170|FG002|Overall Study|Adverse Event|1|||
105748448|NCT01496430|364731168|FG000|Overall Study|Major Protocol Deviation|0|||
105748449|NCT01496430|364731169|FG001|Overall Study|Major Protocol Deviation|0|||
105748450|NCT01496430|364731170|FG002|Overall Study|Major Protocol Deviation|1|||
105748451|NCT01496430|364731168|FG000|Overall Study|Lost to Follow-up|2|||
105748452|NCT01496430|364731169|FG001|Overall Study|Lost to Follow-up|3|||
105748453|NCT01496430|364731170|FG002|Overall Study|Lost to Follow-up|1|||
105748454|NCT01496430|364731168|FG000|Overall Study|Voluntary Withdrawal|2|||
105748455|NCT01496430|364731169|FG001|Overall Study|Voluntary Withdrawal|1|||
105748456|NCT01496430|364731170|FG002|Overall Study|Voluntary Withdrawal|6|||
105748457|NCT01496430|364731168|FG000|Overall Study|Principal Investigator Discretion|0|||
105801508|NCT01078623|364930592|FG014|Treatment Period 2|Adverse Event|0|||
105748458|NCT01496430|364731169|FG001|Overall Study|Principal Investigator Discretion|1|||
105748459|NCT01496430|364731170|FG002|Overall Study|Principal Investigator Discretion|1|||
105748460|NCT01496430|364731168|FG000|Overall Study|Other|2|||
105748461|NCT01496430|364731169|FG001|Overall Study|Other|0|||
105748462|NCT01496430|364731170|FG002|Overall Study|Other|0|||
105748463|NCT04056455|364731171|FG000|Overall Study|Adverse Event|1|||
105748464|NCT04056455|364731172|FG001|Overall Study|Adverse Event|0|||
105748465|NCT01474746|364731176|FG000|Overall Study|Lost to Follow-up|1|||
105748466|NCT01474746|364731177|FG001|Overall Study|Lost to Follow-up|1|||
105748467|NCT01474746|364731176|FG000|Overall Study|Withdrawal by Subject|2|||
105748468|NCT01474746|364731177|FG001|Overall Study|Withdrawal by Subject|1|||
105748469|NCT01766336|364731178|FG000|Overall Study|Adverse Event|11|||
105748470|NCT01766336|364731179|FG001|Overall Study|Adverse Event|8|||
105748471|NCT01766336|364731178|FG000|Overall Study|Death|4|||
105801509|NCT01078623|364930593|FG015|Treatment Period 2|Adverse Event|0|||
105748472|NCT01766336|364731179|FG001|Overall Study|Death|3|||
105943794|NCT00725985|365456684|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
105943795|NCT00725985|365456685|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
105801510|NCT01078623|364930594|FG016|Treatment Period 2|Adverse Event|0|||
105801511|NCT01078623|364930595|FG017|Treatment Period 2|Adverse Event|0|||
105748473|NCT01766336|364731178|FG000|Overall Study|Lost to Follow-up|1|||
105748474|NCT01766336|364731179|FG001|Overall Study|Lost to Follow-up|3|||
105748475|NCT01766336|364731178|FG000|Overall Study|Physician Decision|4|||
105748476|NCT01766336|364731179|FG001|Overall Study|Physician Decision|2|||
105748477|NCT01766336|364731178|FG000|Overall Study|Protocol Violation|0|||
105748478|NCT01766336|364731179|FG001|Overall Study|Protocol Violation|1|||
105748479|NCT01766336|364731178|FG000|Overall Study|Sponsor Decision|52|||
105748480|NCT01766336|364731179|FG001|Overall Study|Sponsor Decision|43|||
105748481|NCT01766336|364731178|FG000|Overall Study|Withdrawal by Subject|18|||
105748482|NCT01766336|364731179|FG001|Overall Study|Withdrawal by Subject|15|||
105748483|NCT03807739|364731180|FG000|Overall Study|Adverse Event|1|||
105748484|NCT03807739|364731181|FG001|Overall Study|Adverse Event|0|||
105748485|NCT03807739|364731182|FG002|Overall Study|Adverse Event|0|||
105748486|NCT03807739|364731183|FG003|Overall Study|Adverse Event|0|||
105748487|NCT03807739|364731180|FG000|Overall Study|Withdrawal by Subject|1|||
105748488|NCT03807739|364731181|FG001|Overall Study|Withdrawal by Subject|0|||
105748489|NCT03807739|364731182|FG002|Overall Study|Withdrawal by Subject|0|||
105748490|NCT03807739|364731183|FG003|Overall Study|Withdrawal by Subject|0|||
105748491|NCT03599141|364731187|FG000|Overall Study|Lost to Follow-up|3|||
105748492|NCT03599141|364731188|FG001|Overall Study|Lost to Follow-up|1|||
105748493|NCT00807846|364731189|FG000|Overall Study|Adverse Event|5|||
105748494|NCT00807846|364731190|FG001|Overall Study|Adverse Event|0|||
105748495|NCT00807846|364731189|FG000|Overall Study|Lack of Efficacy|2|||
105748496|NCT00807846|364731190|FG001|Overall Study|Lack of Efficacy|0|||
105748497|NCT00807846|364731189|FG000|Overall Study|Protocol Violation|2|||
105748498|NCT00807846|364731190|FG001|Overall Study|Protocol Violation|1|||
105748499|NCT00807846|364731189|FG000|Overall Study|Withdrawal by Subject|2|||
105748500|NCT00807846|364731190|FG001|Overall Study|Withdrawal by Subject|1|||
105748501|NCT00807846|364731189|FG000|Overall Study|Other|1|||
105748502|NCT00807846|364731190|FG001|Overall Study|Other|2|||
105748503|NCT01081873|364731191|FG000|Overall Study|Death|86|||
105748504|NCT01081873|364731191|FG000|Overall Study|Withdrawal by Subject|10|||
105748505|NCT01081873|364731191|FG000|Overall Study|Lost to Follow-up|142|||
105748506|NCT01081873|364731191|FG000|Overall Study|Progression of prostate cancer|13|||
105748507|NCT01081873|364731191|FG000|Overall Study|Other|47|||
105748508|NCT01165021|364731192|FG000|Overall Study|Death|1|||
105748509|NCT03977727|364731193|FG000|Second Treatment|Lost to Follow-up|0|||
105748510|NCT03977727|364731194|FG001|Second Treatment|Lost to Follow-up|3|||
105748511|NCT01419665|364731195|FG000|Combination Treatment|Adverse Event|7|||
105748512|NCT01419665|364731196|FG001|Combination Treatment|Adverse Event|10|||
105748513|NCT01419665|364731195|FG000|Combination Treatment|Physician Decision|5|||
105748514|NCT01419665|364731196|FG001|Combination Treatment|Physician Decision|8|||
105748515|NCT01419665|364731195|FG000|Combination Treatment|Protocol Violation|6|||
105748516|NCT01419665|364731196|FG001|Combination Treatment|Protocol Violation|2|||
105748517|NCT01419665|364731195|FG000|Combination Treatment|disease progression|10|||
105748518|NCT01419665|364731196|FG001|Combination Treatment|disease progression|9|||
105748519|NCT01419665|364731195|FG000|Combination Treatment|Death|5|||
105748520|NCT01419665|364731196|FG001|Combination Treatment|Death|7|||
105748521|NCT01419665|364731195|FG000|Combination Treatment|administrative problems|0|||
105748522|NCT01419665|364731196|FG001|Combination Treatment|administrative problems|1|||
105748523|NCT01419665|364731195|FG000|Combination Treatment|Withdrawal by Subject|5|||
105748524|NCT01419665|364731196|FG001|Combination Treatment|Withdrawal by Subject|4|||
105748525|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
105748526|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
105748527|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
105748528|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
105748529|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
105748530|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
105748531|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
105748532|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
105748533|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
105748534|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
105748535|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
105748536|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
105748537|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Death|1|||
105748538|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Death|2|||
105748539|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
105748540|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
105748541|NCT01419665|364731195|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
105748542|NCT01419665|364731196|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
105748543|NCT01419665|364731195|FG000|Open Label Phase|Death|1|||
105748544|NCT01419665|364731196|FG001|Open Label Phase|Death|0|||
105760844|NCT01831804|364778039|FG003|Overall Study|Adverse Event|0|||
105943796|NCT00725985|365456686|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
106015834|NCT01967940|365723310|FG003|Part 2|Adverse Event|1|||
105943797|NCT00725985|365456687|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
106142557|NCT03460756|366181897|FG002|Overall Study|Pregnancy|0|||
105748545|NCT01419665|364731195|FG000|Open Label Phase|disease progression|0|||
105748546|NCT01419665|364731196|FG001|Open Label Phase|disease progression|1|||
105748547|NCT02596711|364731197|FG000|Overall Study|Lost to Follow-up|1|||
105748548|NCT02596711|364731198|FG001|Overall Study|Lost to Follow-up|2|||
105748549|NCT02596711|364731199|FG002|Overall Study|Lost to Follow-up|3|||
105748550|NCT05108805|364731202|FG000|Overall Study|T-cell expansion was not successful.|5|||
105748551|NCT04752189|364731203|FG000|Overall Study|Withdrawal by Subject|0|||
105748552|NCT04752189|364731204|FG001|Overall Study|Withdrawal by Subject|150|||
105748553|NCT04752189|364731203|FG000|Overall Study|Lost to Follow-up|261|||
105748554|NCT04752189|364731204|FG001|Overall Study|Lost to Follow-up|126|||
105748555|NCT02020031|364732499|FG000|Overall Study|Physician Decision|1|||
105748556|NCT02020031|364732500|FG001|Overall Study|Physician Decision|1|||
105748557|NCT02625324|364732504|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
105748558|NCT02625324|364732504|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
105748559|NCT02625324|364732504|FG000|6-Month Follow-up Subject Accountability|Death|5|||
105748560|NCT02625324|364732504|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
105748561|NCT02625324|364732504|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
105748562|NCT02625324|364732504|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
105748563|NCT02625324|364732504|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
105748564|NCT02625324|364732504|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
105748565|NCT02625324|364732504|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
105748566|NCT02625324|364732504|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
105748567|NCT02625324|364732504|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
105748568|NCT02625324|364732504|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
105748569|NCT02625324|364732504|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
105748570|NCT02625324|364732504|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
105748571|NCT02625324|364732504|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
105748572|NCT02625324|364732504|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
105748573|NCT02625324|364732504|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
105748574|NCT02702518|364732505|FG000|Overall Study|Lost to Follow-up|3|||
105748575|NCT02702518|364732506|FG001|Overall Study|Lost to Follow-up|4|||
105748576|NCT01000727|364732509|FG000|Overall Study|Lost to Follow-up|41|||
105748577|NCT01000727|364732510|FG001|Overall Study|Lost to Follow-up|43|||
105748578|NCT01000727|364732509|FG000|Overall Study|Withdrawal by Subject|111|||
105748579|NCT01000727|364732510|FG001|Overall Study|Withdrawal by Subject|109|||
105748580|NCT01000727|364732509|FG000|Overall Study|Study closed/terminated|23|||
105748581|NCT01000727|364732510|FG001|Overall Study|Study closed/terminated|24|||
105748582|NCT03303092|364732514|FG000|Overall Study|Adverse Event|1|||
105748583|NCT03303092|364732515|FG001|Overall Study|Adverse Event|0|||
105748584|NCT03303092|364732516|FG002|Overall Study|Adverse Event|1|||
105748585|NCT03303092|364732514|FG000|Overall Study|Protocol Violation|1|||
105748586|NCT03303092|364732515|FG001|Overall Study|Protocol Violation|5|||
105748587|NCT03303092|364732516|FG002|Overall Study|Protocol Violation|1|||
105748588|NCT03303092|364732514|FG000|Overall Study|Withdrawal by Subject|1|||
105748589|NCT03303092|364732515|FG001|Overall Study|Withdrawal by Subject|1|||
105748590|NCT03303092|364732516|FG002|Overall Study|Withdrawal by Subject|3|||
105748591|NCT03544268|364732518|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
105748592|NCT03544268|364732519|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
105748593|NCT01697267|364732520|FG000|Overall Study|Death|3|||
105748594|NCT01697267|364732521|FG001|Overall Study|Death|1|||
105748595|NCT01697267|364732520|FG000|Overall Study|Withdrawal by Subject|5|||
105748596|NCT01697267|364732521|FG001|Overall Study|Withdrawal by Subject|5|||
105748597|NCT01697267|364732520|FG000|Overall Study|Adverse Event|2|||
105748598|NCT01697267|364732521|FG001|Overall Study|Adverse Event|1|||
105748599|NCT01697267|364732520|FG000|Overall Study|Lost to Follow-up|2|||
105748600|NCT01697267|364732521|FG001|Overall Study|Lost to Follow-up|4|||
105748601|NCT01697267|364732520|FG000|Overall Study|Physician Decision|2|||
105748602|NCT01697267|364732521|FG001|Overall Study|Physician Decision|4|||
105748603|NCT00568958|364732526|FG000|Allocation|Withdrawal by Subject|7|||
105748604|NCT00568958|364732527|FG001|Allocation|Withdrawal by Subject|3|||
105748605|NCT00568958|364732526|FG000|Allocation|Physician Decision|2|||
105748606|NCT00568958|364732527|FG001|Allocation|Physician Decision|0|||
105748607|NCT00568958|364732526|FG000|Follow-Up|Withdrawal by Subject|6|||
105748608|NCT00568958|364732527|FG001|Follow-Up|Withdrawal by Subject|6|||
105748609|NCT00568958|364732526|FG000|Follow-Up|Physician Decision|1|||
105748610|NCT00568958|364732527|FG001|Follow-Up|Physician Decision|1|||
105748611|NCT00568958|364732526|FG000|Follow-Up|Family Emergency|1|||
105748612|NCT00568958|364732527|FG001|Follow-Up|Family Emergency|0|||
105748613|NCT00568958|364732526|FG000|Follow-Up|Adverse Event|1|||
105748614|NCT00568958|364732527|FG001|Follow-Up|Adverse Event|0|||
105748615|NCT00756886|364732534|FG000|Overall Study|Lost to Follow-up|1|||
105748616|NCT00756886|364732535|FG001|Overall Study|Lost to Follow-up|0|||
105748617|NCT00756886|364732534|FG000|Overall Study|Adverse Event|0|||
105748618|NCT00756886|364732535|FG001|Overall Study|Adverse Event|3|||
105748619|NCT00756886|364732534|FG000|Overall Study|Lack of Efficacy|1|||
105748620|NCT00756886|364732535|FG001|Overall Study|Lack of Efficacy|0|||
105748621|NCT00756886|364732534|FG000|Overall Study|Ineligible|9|||
105748622|NCT00756886|364732535|FG001|Overall Study|Ineligible|4|||
105748623|NCT04348656|364732536|FG000|Overall Study|Withdrawal by Subject|2|||
105748624|NCT04348656|364732537|FG001|Overall Study|Withdrawal by Subject|0|||
105748625|NCT04348656|364732536|FG000|Overall Study|Lost to Follow-up|11|||
105748626|NCT04348656|364732537|FG001|Overall Study|Lost to Follow-up|6|||
105748627|NCT01395368|364732538|FG000|Overall Study|Physician Decision|14|||
105748628|NCT01395368|364732538|FG000|Overall Study|Withdrawal by Subject|2|||
105748629|NCT03072719|364732542|FG000|Overall Study|Adverse Event|1|||
105748630|NCT03072719|364732543|FG001|Overall Study|Adverse Event|1|||
105748631|NCT02387372|364732546|FG000|Overall Study|Not Treated|1|||
105748632|NCT02387372|364732547|FG001|Overall Study|Not Treated|0|||
105748633|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
105748634|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
105748635|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
105748636|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
105748637|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
105748638|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
105748639|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
105748640|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
105748641|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
105748642|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
105748643|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
105748644|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
105748645|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
105748646|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
105748647|NCT00848549|364732549|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
105748648|NCT00848549|364732550|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
105748649|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
105748650|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
105748651|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
105748652|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
105748653|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
105748654|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
105748655|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
105801512|NCT01078623|364930596|FG018|Treatment Period 2|Adverse Event|1|||
105801513|NCT01078623|364930597|FG019|Treatment Period 2|Adverse Event|0|||
105801514|NCT01078623|364930578|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105801515|NCT01078623|364930579|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105801516|NCT01078623|364930580|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105801517|NCT01078623|364930581|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105801518|NCT01078623|364930582|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105801519|NCT01078623|364930583|FG005|Treatment Period 2|Withdrawal by Subject|1|||
105801520|NCT01078623|364930584|FG006|Treatment Period 2|Withdrawal by Subject|0|||
105801521|NCT01078623|364930585|FG007|Treatment Period 2|Withdrawal by Subject|0|||
105801522|NCT01078623|364930586|FG008|Treatment Period 2|Withdrawal by Subject|0|||
105801523|NCT01078623|364930587|FG009|Treatment Period 2|Withdrawal by Subject|0|||
105801524|NCT01078623|364930588|FG010|Treatment Period 2|Withdrawal by Subject|0|||
105801525|NCT01078623|364930589|FG011|Treatment Period 2|Withdrawal by Subject|0|||
105801526|NCT01078623|364930590|FG012|Treatment Period 2|Withdrawal by Subject|0|||
105801527|NCT01078623|364930591|FG013|Treatment Period 2|Withdrawal by Subject|0|||
105801528|NCT01078623|364930592|FG014|Treatment Period 2|Withdrawal by Subject|0|||
105801529|NCT01078623|364930593|FG015|Treatment Period 2|Withdrawal by Subject|0|||
106015835|NCT01967940|365723307|FG000|Part 2|Unknown Reason|0|||
106015836|NCT01967940|365723308|FG001|Part 2|Unknown Reason|0|||
106015837|NCT01967940|365723309|FG002|Part 2|Unknown Reason|0|||
105801530|NCT01078623|364930594|FG016|Treatment Period 2|Withdrawal by Subject|0|||
106015838|NCT01967940|365723310|FG003|Part 2|Unknown Reason|1|||
105748656|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
105748657|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
105748658|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
105748659|NCT00848549|364732549|FG000|E2090-E044-314 (Extension Study)|Other|5|||
105801531|NCT01078623|364930595|FG017|Treatment Period 2|Withdrawal by Subject|0|||
106015839|NCT00942604|365723312|FG000|Overall Study|Protocol Violation|1|||
106015840|NCT00942604|365723313|FG001|Overall Study|Protocol Violation|1|||
105748660|NCT00848549|364732550|FG001|E2090-E044-314 (Extension Study)|Other|6|||
105748661|NCT02546674|364732562|FG000|Overall Study|Adverse Event|19|||
105748662|NCT02546674|364732562|FG000|Overall Study|Death|1|||
105801532|NCT01078623|364930596|FG018|Treatment Period 2|Withdrawal by Subject|0|||
106015841|NCT00942604|365723312|FG000|Overall Study|Adverse Event|0|||
105748663|NCT02546674|364732562|FG000|Overall Study|Lost to Follow-up|1|||
105748664|NCT02546674|364732562|FG000|Overall Study|Physician Decision|13|||
105748665|NCT02546674|364732562|FG000|Overall Study|Pregnancy|1|||
105748666|NCT02546674|364732562|FG000|Overall Study|Progressive Disease|2|||
105748667|NCT02546674|364732562|FG000|Overall Study|Protocol Deviation|2|||
105748668|NCT02546674|364732562|FG000|Overall Study|Subject/Guardian Decision|6|||
105748669|NCT02546674|364732562|FG000|Overall Study|Withdrawal of Informed Consent|3|||
105748670|NCT02864940|364732564|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
105748671|NCT02864940|364732565|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
105748672|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
105748673|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748674|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748675|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748676|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748677|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748678|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748679|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748680|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
105748681|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
105748682|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748683|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748684|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748685|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748686|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748687|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748688|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748689|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
105748690|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
105748691|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748692|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748693|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748694|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748695|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748696|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748697|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748698|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
105748699|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
105748700|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748701|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748702|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748703|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748704|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748705|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748706|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748707|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
105748708|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
105748709|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748710|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748711|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748712|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748713|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748714|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748715|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748716|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
105748717|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
105748718|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748719|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748720|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748721|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748722|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
106015842|NCT00942604|365723313|FG001|Overall Study|Adverse Event|1|||
106015843|NCT00942604|365723312|FG000|Overall Study|Withdrawal by Subject|0|||
106015844|NCT00942604|365723313|FG001|Overall Study|Withdrawal by Subject|1|||
105748723|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748724|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748725|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
105748726|NCT02175771|364732566|FG000|Run-In Period (Pre-assignment)|Other|8|||
105748727|NCT02175771|364732567|FG001|Run-In Period (Pre-assignment)|Other|0|||
105748728|NCT02175771|364732568|FG002|Run-In Period (Pre-assignment)|Other|0|||
105748729|NCT02175771|364732569|FG003|Run-In Period (Pre-assignment)|Other|0|||
105943798|NCT00833690|365456691|FG000|Overall Study|Withdrawal by Subject|1|||
105801533|NCT01078623|364930597|FG019|Treatment Period 2|Withdrawal by Subject|0|||
105801534|NCT01078623|364930578|FG000|Treatment Period 3|Adverse Event|0|||
105801535|NCT01078623|364930579|FG001|Treatment Period 3|Adverse Event|0|||
105801536|NCT01078623|364930580|FG002|Treatment Period 3|Adverse Event|0|||
105801537|NCT01078623|364930581|FG003|Treatment Period 3|Adverse Event|0|||
105801538|NCT01078623|364930582|FG004|Treatment Period 3|Adverse Event|1|||
105801539|NCT01078623|364930583|FG005|Treatment Period 3|Adverse Event|0|||
105801540|NCT01078623|364930584|FG006|Treatment Period 3|Adverse Event|0|||
105801541|NCT01078623|364930585|FG007|Treatment Period 3|Adverse Event|0|||
105748730|NCT02175771|364732570|FG004|Run-In Period (Pre-assignment)|Other|0|||
105748731|NCT02175771|364732571|FG005|Run-In Period (Pre-assignment)|Other|0|||
105748732|NCT02175771|364732572|FG006|Run-In Period (Pre-assignment)|Other|0|||
105748733|NCT02175771|364732573|FG007|Run-In Period (Pre-assignment)|Other|0|||
105748734|NCT02175771|364732574|FG008|Run-In Period (Pre-assignment)|Other|0|||
105748735|NCT02175771|364732566|FG000|Treatment Period|Adverse Event|0|||
105748736|NCT02175771|364732567|FG001|Treatment Period|Adverse Event|2|||
105748737|NCT02175771|364732568|FG002|Treatment Period|Adverse Event|1|||
105748738|NCT02175771|364732569|FG003|Treatment Period|Adverse Event|1|||
105748739|NCT02175771|364732570|FG004|Treatment Period|Adverse Event|1|||
105943799|NCT00833690|365456692|FG001|Overall Study|Withdrawal by Subject|0|||
105943800|NCT00833690|365456693|FG002|Overall Study|Withdrawal by Subject|0|||
105801542|NCT01078623|364930586|FG008|Treatment Period 3|Adverse Event|0|||
105801543|NCT01078623|364930587|FG009|Treatment Period 3|Adverse Event|0|||
105801544|NCT01078623|364930588|FG010|Treatment Period 3|Adverse Event|0|||
105801545|NCT01078623|364930589|FG011|Treatment Period 3|Adverse Event|0|||
105801546|NCT01078623|364930590|FG012|Treatment Period 3|Adverse Event|0|||
105801547|NCT01078623|364930591|FG013|Treatment Period 3|Adverse Event|1|||
105801548|NCT01078623|364930592|FG014|Treatment Period 3|Adverse Event|0|||
105801549|NCT01078623|364930593|FG015|Treatment Period 3|Adverse Event|0|||
105801550|NCT01078623|364930594|FG016|Treatment Period 3|Adverse Event|0|||
105801551|NCT01078623|364930595|FG017|Treatment Period 3|Adverse Event|0|||
105801552|NCT01078623|364930596|FG018|Treatment Period 3|Adverse Event|0|||
105801553|NCT01078623|364930597|FG019|Treatment Period 3|Adverse Event|0|||
105801554|NCT01078623|364930578|FG000|Treatment Period 4|Adverse Event|0|||
105801555|NCT01078623|364930579|FG001|Treatment Period 4|Adverse Event|0|||
105801556|NCT01078623|364930580|FG002|Treatment Period 4|Adverse Event|1|||
105801557|NCT01078623|364930581|FG003|Treatment Period 4|Adverse Event|0|||
105801558|NCT01078623|364930582|FG004|Treatment Period 4|Adverse Event|0|||
105801559|NCT01078623|364930583|FG005|Treatment Period 4|Adverse Event|0|||
105801560|NCT01078623|364930584|FG006|Treatment Period 4|Adverse Event|0|||
105801561|NCT01078623|364930585|FG007|Treatment Period 4|Adverse Event|0|||
105801562|NCT01078623|364930586|FG008|Treatment Period 4|Adverse Event|0|||
105801563|NCT01078623|364930587|FG009|Treatment Period 4|Adverse Event|0|||
105801564|NCT01078623|364930588|FG010|Treatment Period 4|Adverse Event|0|||
105801565|NCT01078623|364930589|FG011|Treatment Period 4|Adverse Event|0|||
105801566|NCT01078623|364930590|FG012|Treatment Period 4|Adverse Event|0|||
105801567|NCT01078623|364930591|FG013|Treatment Period 4|Adverse Event|0|||
105801568|NCT01078623|364930592|FG014|Treatment Period 4|Adverse Event|0|||
106142558|NCT03460756|366181898|FG003|Overall Study|Pregnancy|1|||
105748740|NCT02175771|364732571|FG005|Treatment Period|Adverse Event|3|||
105801569|NCT01078623|364930593|FG015|Treatment Period 4|Adverse Event|0|||
105801570|NCT01078623|364930594|FG016|Treatment Period 4|Adverse Event|0|||
105801571|NCT01078623|364930595|FG017|Treatment Period 4|Adverse Event|0|||
105801572|NCT01078623|364930596|FG018|Treatment Period 4|Adverse Event|0|||
105801573|NCT01078623|364930597|FG019|Treatment Period 4|Adverse Event|0|||
105943801|NCT00833690|365456691|FG000|Overall Study|Discontinued study drug|3|||
105943802|NCT00833690|365456692|FG001|Overall Study|Discontinued study drug|2|||
106142559|NCT03460756|366181895|FG000|Overall Study|Protocol Violation|0|||
105748741|NCT02175771|364732572|FG006|Treatment Period|Adverse Event|2|||
105748742|NCT02175771|364732573|FG007|Treatment Period|Adverse Event|0|||
105801574|NCT01078623|364930578|FG000|Treatment Period 4|Withdrawal by Subject|0|||
105943803|NCT00833690|365456693|FG002|Overall Study|Discontinued study drug|0|||
106142560|NCT03460756|366181896|FG001|Overall Study|Protocol Violation|0|||
105748743|NCT02175771|364732574|FG008|Treatment Period|Adverse Event|1|||
105748744|NCT02175771|364732566|FG000|Treatment Period|Withdrawal by Subject|0|||
105748745|NCT02175771|364732567|FG001|Treatment Period|Withdrawal by Subject|9|||
105748746|NCT02175771|364732568|FG002|Treatment Period|Withdrawal by Subject|3|||
105801575|NCT01078623|364930579|FG001|Treatment Period 4|Withdrawal by Subject|0|||
105801576|NCT01078623|364930580|FG002|Treatment Period 4|Withdrawal by Subject|0|||
105801577|NCT01078623|364930581|FG003|Treatment Period 4|Withdrawal by Subject|0|||
105801578|NCT01078623|364930582|FG004|Treatment Period 4|Withdrawal by Subject|0|||
105801579|NCT01078623|364930583|FG005|Treatment Period 4|Withdrawal by Subject|0|||
105801580|NCT01078623|364930584|FG006|Treatment Period 4|Withdrawal by Subject|0|||
105801581|NCT01078623|364930585|FG007|Treatment Period 4|Withdrawal by Subject|0|||
105943804|NCT03898180|365456694|FG000|Overall Study|Death|178|||
105748747|NCT02175771|364732569|FG003|Treatment Period|Withdrawal by Subject|6|||
105748748|NCT02175771|364732570|FG004|Treatment Period|Withdrawal by Subject|2|||
105748749|NCT02175771|364732571|FG005|Treatment Period|Withdrawal by Subject|4|||
105748750|NCT02175771|364732572|FG006|Treatment Period|Withdrawal by Subject|2|||
105748751|NCT02175771|364732573|FG007|Treatment Period|Withdrawal by Subject|9|||
105748752|NCT02175771|364732574|FG008|Treatment Period|Withdrawal by Subject|2|||
105748753|NCT02175771|364732566|FG000|Treatment Period|Noncompliance|0|||
105748754|NCT02175771|364732567|FG001|Treatment Period|Noncompliance|1|||
105748755|NCT02175771|364732568|FG002|Treatment Period|Noncompliance|2|||
105748756|NCT02175771|364732569|FG003|Treatment Period|Noncompliance|0|||
105748757|NCT02175771|364732570|FG004|Treatment Period|Noncompliance|0|||
105748758|NCT02175771|364732571|FG005|Treatment Period|Noncompliance|0|||
105748759|NCT02175771|364732572|FG006|Treatment Period|Noncompliance|0|||
105748760|NCT02175771|364732573|FG007|Treatment Period|Noncompliance|0|||
105748761|NCT02175771|364732574|FG008|Treatment Period|Noncompliance|1|||
105748762|NCT02175771|364732566|FG000|Treatment Period|Protocol Violation|0|||
105748763|NCT02175771|364732567|FG001|Treatment Period|Protocol Violation|0|||
105748764|NCT02175771|364732568|FG002|Treatment Period|Protocol Violation|0|||
105748765|NCT02175771|364732569|FG003|Treatment Period|Protocol Violation|0|||
105748766|NCT02175771|364732570|FG004|Treatment Period|Protocol Violation|0|||
105748767|NCT02175771|364732571|FG005|Treatment Period|Protocol Violation|0|||
105748768|NCT02175771|364732572|FG006|Treatment Period|Protocol Violation|0|||
105748769|NCT02175771|364732573|FG007|Treatment Period|Protocol Violation|1|||
105748770|NCT02175771|364732574|FG008|Treatment Period|Protocol Violation|0|||
105748771|NCT02175771|364732566|FG000|Treatment Period|Disease progression|0|||
105748772|NCT02175771|364732567|FG001|Treatment Period|Disease progression|0|||
105748773|NCT02175771|364732568|FG002|Treatment Period|Disease progression|0|||
105748774|NCT02175771|364732569|FG003|Treatment Period|Disease progression|0|||
105748775|NCT02175771|364732570|FG004|Treatment Period|Disease progression|0|||
105748776|NCT02175771|364732571|FG005|Treatment Period|Disease progression|0|||
105748777|NCT02175771|364732572|FG006|Treatment Period|Disease progression|0|||
105748778|NCT02175771|364732573|FG007|Treatment Period|Disease progression|2|||
105748779|NCT02175771|364732574|FG008|Treatment Period|Disease progression|0|||
105748780|NCT02175771|364732566|FG000|Treatment Period|Lost to Follow-up|0|||
105748781|NCT02175771|364732567|FG001|Treatment Period|Lost to Follow-up|3|||
105748782|NCT02175771|364732568|FG002|Treatment Period|Lost to Follow-up|1|||
105748783|NCT02175771|364732569|FG003|Treatment Period|Lost to Follow-up|3|||
105748784|NCT02175771|364732570|FG004|Treatment Period|Lost to Follow-up|1|||
105748785|NCT02175771|364732571|FG005|Treatment Period|Lost to Follow-up|2|||
105748786|NCT02175771|364732572|FG006|Treatment Period|Lost to Follow-up|1|||
105748787|NCT02175771|364732573|FG007|Treatment Period|Lost to Follow-up|2|||
105748788|NCT02175771|364732574|FG008|Treatment Period|Lost to Follow-up|2|||
105748789|NCT02175771|364732566|FG000|Treatment Period|Lack of Efficacy|0|||
105748790|NCT02175771|364732567|FG001|Treatment Period|Lack of Efficacy|0|||
105748791|NCT02175771|364732568|FG002|Treatment Period|Lack of Efficacy|0|||
105748792|NCT02175771|364732569|FG003|Treatment Period|Lack of Efficacy|0|||
105748793|NCT02175771|364732570|FG004|Treatment Period|Lack of Efficacy|0|||
105748794|NCT02175771|364732571|FG005|Treatment Period|Lack of Efficacy|1|||
105748795|NCT02175771|364732572|FG006|Treatment Period|Lack of Efficacy|0|||
105748796|NCT02175771|364732573|FG007|Treatment Period|Lack of Efficacy|1|||
105748797|NCT02175771|364732574|FG008|Treatment Period|Lack of Efficacy|0|||
105748798|NCT02175771|364732566|FG000|Treatment Period|Other|0|||
105748799|NCT02175771|364732567|FG001|Treatment Period|Other|1|||
105748800|NCT02175771|364732568|FG002|Treatment Period|Other|0|||
105748801|NCT02175771|364732569|FG003|Treatment Period|Other|3|||
105748802|NCT02175771|364732570|FG004|Treatment Period|Other|1|||
105748803|NCT02175771|364732571|FG005|Treatment Period|Other|0|||
105748804|NCT02175771|364732572|FG006|Treatment Period|Other|0|||
105943805|NCT03898180|365456695|FG001|Overall Study|Death|173|||
105748805|NCT02175771|364732573|FG007|Treatment Period|Other|2|||
105748806|NCT02175771|364732574|FG008|Treatment Period|Other|0|||
105748807|NCT03364673|364732575|FG000|Overall Study|Withdrawal by Subject|2|||
105748808|NCT03364673|364732575|FG000|Overall Study|Injury unrelated to study|3|||
105748809|NCT02232087|364732576|FG000|Overall Study|Withdrawal by Subject|2|||
105748810|NCT02232087|364732577|FG001|Overall Study|Withdrawal by Subject|0|||
105748811|NCT02232087|364732578|FG002|Overall Study|Withdrawal by Subject|0|||
105748812|NCT02232087|364732579|FG003|Overall Study|Withdrawal by Subject|0|||
105748813|NCT02232087|364732580|FG004|Overall Study|Withdrawal by Subject|0|||
105748814|NCT02232087|364732581|FG005|Overall Study|Withdrawal by Subject|1|||
105748815|NCT02232087|364732576|FG000|Overall Study|poor inhalation technique|0|||
105748816|NCT02232087|364732577|FG001|Overall Study|poor inhalation technique|1|||
105748817|NCT02232087|364732578|FG002|Overall Study|poor inhalation technique|0|||
105748818|NCT02232087|364732579|FG003|Overall Study|poor inhalation technique|0|||
105748819|NCT02232087|364732580|FG004|Overall Study|poor inhalation technique|0|||
105748820|NCT02232087|364732581|FG005|Overall Study|poor inhalation technique|2|||
105748821|NCT02232087|364732576|FG000|Overall Study|protocol stop criteria|0|||
105943806|NCT03898180|365456694|FG000|Overall Study|Physician Decision|1|||
105748822|NCT02232087|364732577|FG001|Overall Study|protocol stop criteria|1|||
105943807|NCT03898180|365456695|FG001|Overall Study|Physician Decision|0|||
105943808|NCT03898180|365456694|FG000|Overall Study|Sponsor Decision|3|||
105943809|NCT03898180|365456695|FG001|Overall Study|Sponsor Decision|0|||
105943810|NCT03898180|365456694|FG000|Overall Study|Lost to Follow-up|1|||
105943811|NCT03898180|365456695|FG001|Overall Study|Lost to Follow-up|0|||
105943812|NCT03898180|365456694|FG000|Overall Study|Withdrawal by Subject|5|||
105943813|NCT03898180|365456695|FG001|Overall Study|Withdrawal by Subject|4|||
105943814|NCT04924114|365456698|FG000|Overall Study|Withdrawal by Subject|0|||
105943815|NCT04924114|365456699|FG001|Overall Study|Withdrawal by Subject|2|||
105943816|NCT04924114|365456700|FG002|Overall Study|Withdrawal by Subject|2|||
105943817|NCT04924114|365456701|FG003|Overall Study|Withdrawal by Subject|0|||
105943818|NCT04924114|365456702|FG004|Overall Study|Withdrawal by Subject|1|||
105943819|NCT05473715|365456703|FG000|Overall Study|Trial terminate|2|||
105943820|NCT05473715|365456704|FG001|Overall Study|Trial terminate|1|||
106015845|NCT00942604|365723312|FG000|Overall Study|Patient relocation|1|||
105748823|NCT02232087|364732578|FG002|Overall Study|protocol stop criteria|0|||
105748824|NCT02232087|364732579|FG003|Overall Study|protocol stop criteria|1|||
105748825|NCT02232087|364732580|FG004|Overall Study|protocol stop criteria|0|||
105748826|NCT02232087|364732581|FG005|Overall Study|protocol stop criteria|0|||
105748827|NCT02232087|364732576|FG000|Overall Study|Adverse Event|0|||
105748828|NCT02232087|364732577|FG001|Overall Study|Adverse Event|0|||
105748829|NCT02232087|364732578|FG002|Overall Study|Adverse Event|0|||
105748830|NCT02232087|364732579|FG003|Overall Study|Adverse Event|0|||
105748831|NCT02232087|364732580|FG004|Overall Study|Adverse Event|1|||
105748832|NCT02232087|364732581|FG005|Overall Study|Adverse Event|0|||
105748833|NCT02504268|364732583|FG000|Overall Study|Adverse Event|18|||
105748834|NCT02504268|364732584|FG001|Overall Study|Adverse Event|8|||
105748835|NCT02504268|364732585|FG002|Overall Study|Adverse Event|14|||
105748836|NCT02504268|364732586|FG003|Overall Study|Adverse Event|0|||
105748837|NCT02504268|364732587|FG004|Overall Study|Adverse Event|0|||
105748838|NCT02504268|364732588|FG005|Overall Study|Adverse Event|0|||
105748839|NCT02504268|364732589|FG006|Overall Study|Adverse Event|0|||
105748840|NCT02504268|364732590|FG007|Overall Study|Adverse Event|0|||
105748841|NCT02504268|364732591|FG008|Overall Study|Adverse Event|0|||
105748842|NCT02504268|364732583|FG000|Overall Study|Withdrawal of Consent|11|||
105748843|NCT02504268|364732584|FG001|Overall Study|Withdrawal of Consent|10|||
105748844|NCT02504268|364732585|FG002|Overall Study|Withdrawal of Consent|3|||
105748845|NCT02504268|364732586|FG003|Overall Study|Withdrawal of Consent|0|||
105748846|NCT02504268|364732587|FG004|Overall Study|Withdrawal of Consent|0|||
105748847|NCT02504268|364732588|FG005|Overall Study|Withdrawal of Consent|0|||
105748848|NCT02504268|364732589|FG006|Overall Study|Withdrawal of Consent|0|||
105748849|NCT02504268|364732590|FG007|Overall Study|Withdrawal of Consent|0|||
105748850|NCT02504268|364732591|FG008|Overall Study|Withdrawal of Consent|0|||
105748851|NCT02504268|364732583|FG000|Overall Study|Pregnancy|2|||
105748852|NCT02504268|364732584|FG001|Overall Study|Pregnancy|0|||
105748853|NCT02504268|364732585|FG002|Overall Study|Pregnancy|0|||
105748854|NCT02504268|364732586|FG003|Overall Study|Pregnancy|0|||
105748855|NCT02504268|364732587|FG004|Overall Study|Pregnancy|0|||
105748856|NCT02504268|364732588|FG005|Overall Study|Pregnancy|0|||
105748857|NCT02504268|364732589|FG006|Overall Study|Pregnancy|0|||
105748858|NCT02504268|364732590|FG007|Overall Study|Pregnancy|0|||
105748859|NCT02504268|364732591|FG008|Overall Study|Pregnancy|0|||
105748860|NCT02504268|364732583|FG000|Overall Study|Lost to Follow-up|3|||
105748861|NCT02504268|364732584|FG001|Overall Study|Lost to Follow-up|6|||
105748862|NCT02504268|364732585|FG002|Overall Study|Lost to Follow-up|4|||
105748863|NCT02504268|364732586|FG003|Overall Study|Lost to Follow-up|0|||
106015846|NCT00942604|365723313|FG001|Overall Study|Patient relocation|1|||
106015847|NCT01146795|365723314|FG000|Overall Study|Withdrawal by Subject|4|||
106015848|NCT01146795|365723314|FG000|Overall Study|Adverse Event|6|||
105748864|NCT02504268|364732587|FG004|Overall Study|Lost to Follow-up|0|||
105748865|NCT02504268|364732588|FG005|Overall Study|Lost to Follow-up|0|||
105748866|NCT02504268|364732589|FG006|Overall Study|Lost to Follow-up|0|||
105748867|NCT02504268|364732590|FG007|Overall Study|Lost to Follow-up|0|||
105748868|NCT02504268|364732591|FG008|Overall Study|Lost to Follow-up|0|||
105748869|NCT02504268|364732583|FG000|Overall Study|Death|1|||
105748870|NCT02504268|364732584|FG001|Overall Study|Death|1|||
105748871|NCT02504268|364732585|FG002|Overall Study|Death|0|||
105748872|NCT02504268|364732586|FG003|Overall Study|Death|0|||
105748873|NCT02504268|364732587|FG004|Overall Study|Death|0|||
105943821|NCT03528902|365456710|FG000|Overall Study|Adverse Event|1|||
105943822|NCT03528902|365456711|FG001|Overall Study|Adverse Event|0|||
105943823|NCT05030766|365456712|FG000|Phase 1 Participants|Lost to Follow-up|12|||
105748874|NCT02504268|364732588|FG005|Overall Study|Death|0|||
105748875|NCT02504268|364732589|FG006|Overall Study|Death|0|||
105943824|NCT05030766|365456713|FG001|Phase 1 Participants|Lost to Follow-up|22|||
105943825|NCT05030766|365456714|FG002|Phase 1 Participants|Lost to Follow-up|0|||
105748876|NCT02504268|364732590|FG007|Overall Study|Death|0|||
105748877|NCT02504268|364732591|FG008|Overall Study|Death|0|||
105748878|NCT02504268|364732583|FG000|Overall Study|Subject Request to Discontinue|11|||
105943826|NCT05030766|365456715|FG003|Phase 1 Participants|Lost to Follow-up|0|||
105943827|NCT05030766|365456712|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
105943828|NCT05030766|365456713|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
105943829|NCT05030766|365456714|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
105943830|NCT05030766|365456715|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
105943831|NCT05030766|365456712|FG000|Phase 2 Participants|Lost to Follow-up|0|||
105748879|NCT02504268|364732584|FG001|Overall Study|Subject Request to Discontinue|3|||
105748880|NCT02504268|364732585|FG002|Overall Study|Subject Request to Discontinue|6|||
105748881|NCT02504268|364732586|FG003|Overall Study|Subject Request to Discontinue|0|||
105748882|NCT02504268|364732587|FG004|Overall Study|Subject Request to Discontinue|0|||
105748883|NCT02504268|364732588|FG005|Overall Study|Subject Request to Discontinue|0|||
105748884|NCT02504268|364732589|FG006|Overall Study|Subject Request to Discontinue|0|||
105748885|NCT02504268|364732590|FG007|Overall Study|Subject Request to Discontinue|0|||
105748886|NCT02504268|364732591|FG008|Overall Study|Subject Request to Discontinue|0|||
105748887|NCT02504268|364732583|FG000|Overall Study|No Longer Meets Study Criteria|2|||
105748888|NCT02504268|364732584|FG001|Overall Study|No Longer Meets Study Criteria|3|||
105748889|NCT02504268|364732585|FG002|Overall Study|No Longer Meets Study Criteria|0|||
105748890|NCT02504268|364732586|FG003|Overall Study|No Longer Meets Study Criteria|0|||
105748891|NCT02504268|364732587|FG004|Overall Study|No Longer Meets Study Criteria|0|||
105748892|NCT02504268|364732588|FG005|Overall Study|No Longer Meets Study Criteria|0|||
105748893|NCT02504268|364732589|FG006|Overall Study|No Longer Meets Study Criteria|0|||
105748894|NCT02504268|364732590|FG007|Overall Study|No Longer Meets Study Criteria|0|||
105748895|NCT02504268|364732591|FG008|Overall Study|No Longer Meets Study Criteria|0|||
105748896|NCT02504268|364732583|FG000|Overall Study|Lack of Efficacy|11|||
105748897|NCT02504268|364732584|FG001|Overall Study|Lack of Efficacy|35|||
105748898|NCT02504268|364732585|FG002|Overall Study|Lack of Efficacy|9|||
105748899|NCT02504268|364732586|FG003|Overall Study|Lack of Efficacy|0|||
105748900|NCT02504268|364732587|FG004|Overall Study|Lack of Efficacy|0|||
105748901|NCT02504268|364732588|FG005|Overall Study|Lack of Efficacy|0|||
105748902|NCT02504268|364732589|FG006|Overall Study|Lack of Efficacy|0|||
105748903|NCT02504268|364732590|FG007|Overall Study|Lack of Efficacy|0|||
105748904|NCT02504268|364732591|FG008|Overall Study|Lack of Efficacy|0|||
105748905|NCT02504268|364732583|FG000|Overall Study|Poor/Non-Compliance|3|||
105748906|NCT02504268|364732584|FG001|Overall Study|Poor/Non-Compliance|2|||
105748907|NCT02504268|364732585|FG002|Overall Study|Poor/Non-Compliance|3|||
105748908|NCT02504268|364732586|FG003|Overall Study|Poor/Non-Compliance|0|||
105748909|NCT02504268|364732587|FG004|Overall Study|Poor/Non-Compliance|0|||
105748910|NCT02504268|364732588|FG005|Overall Study|Poor/Non-Compliance|0|||
105748911|NCT02504268|364732589|FG006|Overall Study|Poor/Non-Compliance|0|||
105748912|NCT02504268|364732590|FG007|Overall Study|Poor/Non-Compliance|0|||
105748913|NCT02504268|364732591|FG008|Overall Study|Poor/Non-Compliance|0|||
105748914|NCT02504268|364732583|FG000|Overall Study|Not Disclosed|1|||
105748915|NCT02504268|364732584|FG001|Overall Study|Not Disclosed|0|||
105748916|NCT02504268|364732585|FG002|Overall Study|Not Disclosed|2|||
105748917|NCT02504268|364732586|FG003|Overall Study|Not Disclosed|0|||
105748918|NCT02504268|364732587|FG004|Overall Study|Not Disclosed|0|||
105748919|NCT02504268|364732588|FG005|Overall Study|Not Disclosed|0|||
105748920|NCT02504268|364732589|FG006|Overall Study|Not Disclosed|0|||
105748921|NCT02504268|364732590|FG007|Overall Study|Not Disclosed|0|||
105748922|NCT02504268|364732591|FG008|Overall Study|Not Disclosed|0|||
105748923|NCT03025217|364732592|FG000|Overall Study|Pregnancy|1|||
105748924|NCT03025217|364732592|FG000|Overall Study|Lost to Follow-up|1|||
105748925|NCT03025217|364732592|FG000|Overall Study|Not eligible, poor English|2|||
105748926|NCT04069156|364732593|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
105748927|NCT04069156|364732594|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
105748928|NCT04069156|364732593|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
105748929|NCT04069156|364732594|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
105943832|NCT05030766|365456713|FG001|Phase 2 Participants|Lost to Follow-up|0|||
105748930|NCT04069156|364732593|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
105748931|NCT04069156|364732594|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
105748932|NCT04069156|364732593|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
105748933|NCT04069156|364732594|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
105748934|NCT02208024|364732595|FG000|Overall Study|Withdrawal by Subject|1|||
105748935|NCT01958125|364732596|FG000|Overall Study|Missing diary data|2|||
105748936|NCT01958125|364732597|FG001|Overall Study|Missing diary data|6|||
105748937|NCT01958125|364732596|FG000|Overall Study|No headache attacks|0|||
105748938|NCT01958125|364732597|FG001|Overall Study|No headache attacks|2|||
105748939|NCT04804033|364732599|FG000|Period 1: DBT Phase|Adverse Event|1|||
105748940|NCT04804033|364732600|FG001|Period 1: DBT Phase|Adverse Event|5|||
105748941|NCT04804033|364732601|FG002|Period 1: DBT Phase|Adverse Event|3|||
105943833|NCT05030766|365456714|FG002|Phase 2 Participants|Lost to Follow-up|6|||
105943834|NCT05030766|365456715|FG003|Phase 2 Participants|Lost to Follow-up|2|||
105748942|NCT04804033|364732602|FG003|Period 1: DBT Phase|Adverse Event|4|||
105943835|NCT00645658|365456716|FG000|Overall Study|Withdrawal by Subject|1|||
105943836|NCT00645658|365456717|FG001|Overall Study|Withdrawal by Subject|0|||
105748943|NCT04804033|364732599|FG000|Period 1: DBT Phase|Death|1|||
105748944|NCT04804033|364732600|FG001|Period 1: DBT Phase|Death|0|||
105748945|NCT04804033|364732601|FG002|Period 1: DBT Phase|Death|0|||
105748946|NCT04804033|364732602|FG003|Period 1: DBT Phase|Death|0|||
105748947|NCT04804033|364732599|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
105748948|NCT04804033|364732600|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
105748949|NCT04804033|364732601|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
105748950|NCT04804033|364732602|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
105748951|NCT04804033|364732599|FG000|Period 1: DBT Phase|Non-compliance|1|||
105748952|NCT04804033|364732600|FG001|Period 1: DBT Phase|Non-compliance|0|||
105748953|NCT04804033|364732601|FG002|Period 1: DBT Phase|Non-compliance|1|||
105748954|NCT04804033|364732602|FG003|Period 1: DBT Phase|Non-compliance|2|||
105748955|NCT04804033|364732599|FG000|Period 1: DBT Phase|Other|0|||
105748956|NCT04804033|364732600|FG001|Period 1: DBT Phase|Other|1|||
105748957|NCT04804033|364732601|FG002|Period 1: DBT Phase|Other|0|||
105748958|NCT04804033|364732602|FG003|Period 1: DBT Phase|Other|0|||
105748959|NCT04804033|364732599|FG000|Period 1: DBT Phase|Pregnancy|2|||
105748960|NCT04804033|364732600|FG001|Period 1: DBT Phase|Pregnancy|0|||
105748961|NCT04804033|364732601|FG002|Period 1: DBT Phase|Pregnancy|0|||
105748962|NCT04804033|364732602|FG003|Period 1: DBT Phase|Pregnancy|0|||
105748963|NCT04804033|364732599|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
105748964|NCT04804033|364732600|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
105748965|NCT04804033|364732601|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
105748966|NCT04804033|364732602|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
105748967|NCT04804033|364732599|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
105748968|NCT04804033|364732600|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
105748969|NCT04804033|364732601|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
105748970|NCT04804033|364732602|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
105748971|NCT04804033|364732599|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
105748972|NCT04804033|364732600|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
105748973|NCT04804033|364732601|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
105748974|NCT04804033|364732602|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
105748975|NCT04804033|364732599|FG000|Period 2: OLE Phase|Adverse Event|3|||
105748976|NCT04804033|364732600|FG001|Period 2: OLE Phase|Adverse Event|4|||
105748977|NCT04804033|364732601|FG002|Period 2: OLE Phase|Adverse Event|2|||
105748978|NCT04804033|364732602|FG003|Period 2: OLE Phase|Adverse Event|0|||
105748979|NCT04804033|364732599|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
105748980|NCT04804033|364732600|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
105748981|NCT04804033|364732601|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
105748982|NCT04804033|364732602|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
105748983|NCT04804033|364732599|FG000|Period 2: OLE Phase|Non-compliance|2|||
105748984|NCT04804033|364732600|FG001|Period 2: OLE Phase|Non-compliance|2|||
105748985|NCT04804033|364732601|FG002|Period 2: OLE Phase|Non-compliance|0|||
105748986|NCT04804033|364732602|FG003|Period 2: OLE Phase|Non-compliance|1|||
105748987|NCT04804033|364732599|FG000|Period 2: OLE Phase|Other|0|||
105748988|NCT04804033|364732600|FG001|Period 2: OLE Phase|Other|2|||
105748989|NCT04804033|364732601|FG002|Period 2: OLE Phase|Other|0|||
105748990|NCT04804033|364732602|FG003|Period 2: OLE Phase|Other|0|||
105748991|NCT04804033|364732599|FG000|Period 2: OLE Phase|Physician Decision|1|||
105748992|NCT04804033|364732600|FG001|Period 2: OLE Phase|Physician Decision|1|||
105748993|NCT04804033|364732601|FG002|Period 2: OLE Phase|Physician Decision|0|||
105748994|NCT04804033|364732602|FG003|Period 2: OLE Phase|Physician Decision|0|||
105943837|NCT00645658|365456716|FG000|Overall Study|Did not complete all assesments|0|||
105943838|NCT00645658|365456717|FG001|Overall Study|Did not complete all assesments|2|||
105943839|NCT03331354|365456726|FG000|Overall Study|Withdrawal by Subject|1|||
105943840|NCT03331354|365456727|FG001|Overall Study|Withdrawal by Subject|3|||
105943841|NCT03331354|365456726|FG000|Overall Study|Lost to Follow-up|3|||
105943842|NCT03331354|365456727|FG001|Overall Study|Lost to Follow-up|3|||
105748995|NCT04804033|364732599|FG000|Period 2: OLE Phase|Pregnancy|0|||
105748996|NCT04804033|364732600|FG001|Period 2: OLE Phase|Pregnancy|0|||
105748997|NCT04804033|364732601|FG002|Period 2: OLE Phase|Pregnancy|2|||
105748998|NCT04804033|364732602|FG003|Period 2: OLE Phase|Pregnancy|0|||
105748999|NCT04804033|364732599|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
105749000|NCT04804033|364732600|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
105749001|NCT04804033|364732601|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
105749002|NCT04804033|364732602|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
105749003|NCT04804033|364732599|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
105749004|NCT04804033|364732600|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
105749005|NCT04804033|364732601|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
105749006|NCT04804033|364732602|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
105749007|NCT04804033|364732599|FG000|Period 2: OLE Phase|Not reported|0|||
105943843|NCT03331354|365456726|FG000|Overall Study|Found employment before initiated active intervention|0|||
105749008|NCT04804033|364732600|FG001|Period 2: OLE Phase|Not reported|2|||
105749009|NCT04804033|364732601|FG002|Period 2: OLE Phase|Not reported|0|||
105749010|NCT04804033|364732602|FG003|Period 2: OLE Phase|Not reported|0|||
105943844|NCT03331354|365456727|FG001|Overall Study|Found employment before initiated active intervention|4|||
105943845|NCT00928668|365456730|FG000|Overall Study|Adverse Event|1|||
105943846|NCT00928668|365456731|FG001|Overall Study|Adverse Event|0|||
105943847|NCT00928668|365456732|FG002|Overall Study|Adverse Event|0|||
105943848|NCT00928668|365456733|FG003|Overall Study|Adverse Event|0|||
105943849|NCT00928668|365456734|FG004|Overall Study|Adverse Event|0|||
105943850|NCT00928668|365456730|FG000|Overall Study|Protocol Violation|0|||
105943851|NCT00928668|365456731|FG001|Overall Study|Protocol Violation|0|||
105943852|NCT00928668|365456732|FG002|Overall Study|Protocol Violation|0|||
105943853|NCT00928668|365456733|FG003|Overall Study|Protocol Violation|0|||
105943854|NCT00928668|365456734|FG004|Overall Study|Protocol Violation|1|||
105943855|NCT00928668|365456730|FG000|Overall Study|Withdrawal by Subject|0|||
105943856|NCT00928668|365456731|FG001|Overall Study|Withdrawal by Subject|1|||
105943857|NCT00928668|365456732|FG002|Overall Study|Withdrawal by Subject|1|||
105943858|NCT00928668|365456733|FG003|Overall Study|Withdrawal by Subject|0|||
105943859|NCT00928668|365456734|FG004|Overall Study|Withdrawal by Subject|0|||
105943860|NCT00928668|365456730|FG000|Overall Study|Other reasons not listed above|0|||
105943861|NCT00928668|365456731|FG001|Overall Study|Other reasons not listed above|0|||
105943862|NCT00928668|365456732|FG002|Overall Study|Other reasons not listed above|0|||
105943863|NCT00928668|365456733|FG003|Overall Study|Other reasons not listed above|1|||
105749011|NCT04804033|364732599|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
105749012|NCT04804033|364732600|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
105749013|NCT04804033|364732601|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
105749014|NCT04804033|364732602|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
105749015|NCT04804033|364732599|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
105749016|NCT04804033|364732600|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
105749017|NCT04804033|364732601|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
105749018|NCT04804033|364732602|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
105749019|NCT04804033|364732599|FG000|Period 3: Follow-up Phase|Other|0|||
105749020|NCT04804033|364732600|FG001|Period 3: Follow-up Phase|Other|1|||
105749021|NCT04804033|364732601|FG002|Period 3: Follow-up Phase|Other|2|||
105749022|NCT04804033|364732602|FG003|Period 3: Follow-up Phase|Other|1|||
105749023|NCT04804033|364732599|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
105749024|NCT04804033|364732600|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
105749025|NCT04804033|364732601|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
105749026|NCT04804033|364732602|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
105749027|NCT04804033|364732599|FG000|Period 3: Follow-up Phase|Not reported|18|||
105749028|NCT04804033|364732600|FG001|Period 3: Follow-up Phase|Not reported|15|||
105749029|NCT04804033|364732601|FG002|Period 3: Follow-up Phase|Not reported|1|||
105749030|NCT04804033|364732602|FG003|Period 3: Follow-up Phase|Not reported|4|||
105749031|NCT00862849|364732607|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749032|NCT00862849|364732608|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
105749033|NCT00862849|364732609|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749034|NCT00862849|364732610|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749035|NCT00862849|364732611|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749036|NCT00862849|364732612|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
105749037|NCT00862849|364732607|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749038|NCT00862849|364732608|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
105749039|NCT00862849|364732609|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749040|NCT00862849|364732610|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749041|NCT00862849|364732611|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749042|NCT00862849|364732612|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
105749043|NCT01153763|364732623|FG000|Overall Study|Study Closed|16|||
105749044|NCT01153763|364732623|FG000|Overall Study|Lost to Follow-up|1|||
105749045|NCT01153763|364732623|FG000|Overall Study|Physician Decision|2|||
105749046|NCT01153763|364732623|FG000|Overall Study|Withdrawal by Subject|2|||
105749047|NCT01019486|364732624|FG000|Overall Study|Withdrawal by Subject|1|||
105749048|NCT01019486|364732625|FG001|Overall Study|Withdrawal by Subject|1|||
105749049|NCT01019486|364732626|FG002|Overall Study|Withdrawal by Subject|1|||
105943864|NCT00928668|365456734|FG004|Overall Study|Other reasons not listed above|0|||
105943865|NCT02661815|365456741|FG000|Overall Study|Withdrawal by Subject|1|||
105943866|NCT02661815|365456742|FG001|Overall Study|Withdrawal by Subject|0|||
105943867|NCT02661815|365456743|FG002|Overall Study|Withdrawal by Subject|0|||
105943868|NCT02661815|365456744|FG003|Overall Study|Withdrawal by Subject|0|||
105943869|NCT05837481|365456747|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
105943870|NCT05837481|365456748|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
105943871|NCT02014376|365456749|FG000|Overall Study|Adverse Event|1|||
105943872|NCT02014376|365456750|FG001|Overall Study|Adverse Event|1|||
105749050|NCT03029650|364732628|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
105760845|NCT01831804|364778040|FG004|Overall Study|Adverse Event|0|||
105943873|NCT02014376|365456751|FG002|Overall Study|Adverse Event|0|||
105943874|NCT02014376|365456749|FG000|Overall Study|Lost to Follow-up|2|||
105943875|NCT02014376|365456750|FG001|Overall Study|Lost to Follow-up|0|||
105749051|NCT03029650|364732629|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
105749052|NCT03029650|364732628|FG000|Washout (1 Week)|Physician Decision|0|||
105749053|NCT03029650|364732629|FG001|Washout (1 Week)|Physician Decision|1|||
105749054|NCT02605447|364732631|FG000|Overall Study|Death|66|||
105749055|NCT02605447|364732631|FG000|Overall Study|Physician Decision|1|||
105749056|NCT02605447|364732631|FG000|Overall Study|Lost to Follow-up|24|||
105749057|NCT02605447|364732631|FG000|Overall Study|Withdrawal by Subject|10|||
105749058|NCT02605447|364732631|FG000|Overall Study|Not disclosed|1|||
105749059|NCT03628508|364732635|FG000|Overall Study|Lost to Follow-up|1|||
105749060|NCT05836818|364732638|FG000|Overall Study|Physician Decision|1|||
105749061|NCT05836818|364732639|FG001|Overall Study|Physician Decision|1|||
105749062|NCT05836818|364732640|FG002|Overall Study|Physician Decision|0|||
105749063|NCT05836818|364732638|FG000|Overall Study|Withdrawal by Subject|0|||
105749064|NCT05836818|364732639|FG001|Overall Study|Withdrawal by Subject|0|||
105749065|NCT05836818|364732640|FG002|Overall Study|Withdrawal by Subject|1|||
105749066|NCT05836818|364732638|FG000|Overall Study|Later found to be previously vaccinated|0|||
105749067|NCT05836818|364732639|FG001|Overall Study|Later found to be previously vaccinated|1|||
105749068|NCT05836818|364732640|FG002|Overall Study|Later found to be previously vaccinated|3|||
105749069|NCT05836818|364732638|FG000|Overall Study|Pregnancy|0|||
105749070|NCT05836818|364732639|FG001|Overall Study|Pregnancy|1|||
105749071|NCT05836818|364732640|FG002|Overall Study|Pregnancy|0|||
105749072|NCT05836818|364732638|FG000|Overall Study|Allergic to vaccines|0|||
105749073|NCT05836818|364732639|FG001|Overall Study|Allergic to vaccines|1|||
105749074|NCT05836818|364732640|FG002|Overall Study|Allergic to vaccines|0|||
105749075|NCT03011840|364732641|FG000|Overall Study|Not received PIL in post PIL phase|0|||
105749076|NCT03011840|364732642|FG001|Overall Study|Not received PIL in post PIL phase|21|||
105749077|NCT01552928|364732643|FG000|Period 3|Adverse Event|0|||
105749078|NCT01552928|364732644|FG001|Period 3|Adverse Event|0|||
105749079|NCT01552928|364732645|FG002|Period 3|Adverse Event|1|||
105749080|NCT01552928|364732646|FG003|Period 3|Adverse Event|0|||
105749081|NCT01454401|364732650|FG000|Overall Study|Death|1|||
105749082|NCT01454401|364732650|FG000|Overall Study|hospitalised|1|||
105749083|NCT01454401|364732650|FG000|Overall Study|osteomyelitis|2|||
105749084|NCT01454401|364732650|FG000|Overall Study|non-adherence|1|||
105749085|NCT03260205|364732653|FG000|Overall Study|Adverse Event|2|||
105749086|NCT03260205|364732654|FG001|Overall Study|Adverse Event|0|||
105749087|NCT03260205|364732655|FG002|Overall Study|Adverse Event|2|||
105749088|NCT03260205|364732656|FG003|Overall Study|Adverse Event|2|||
105749089|NCT03260205|364732657|FG004|Overall Study|Adverse Event|4|||
105749090|NCT03260205|364732653|FG000|Overall Study|Lost to Follow-up|2|||
105749091|NCT03260205|364732654|FG001|Overall Study|Lost to Follow-up|2|||
105749092|NCT03260205|364732655|FG002|Overall Study|Lost to Follow-up|1|||
105749093|NCT03260205|364732656|FG003|Overall Study|Lost to Follow-up|1|||
105749094|NCT03260205|364732657|FG004|Overall Study|Lost to Follow-up|5|||
105749095|NCT03260205|364732653|FG000|Overall Study|Protocol Violation|0|||
105749096|NCT03260205|364732654|FG001|Overall Study|Protocol Violation|0|||
105749097|NCT03260205|364732655|FG002|Overall Study|Protocol Violation|2|||
105749098|NCT03260205|364732656|FG003|Overall Study|Protocol Violation|0|||
105749099|NCT03260205|364732657|FG004|Overall Study|Protocol Violation|1|||
105749100|NCT03260205|364732653|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
105749101|NCT03260205|364732654|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
105749102|NCT03260205|364732655|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
105749103|NCT03260205|364732656|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
105749104|NCT03260205|364732657|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
105749105|NCT03260205|364732653|FG000|Overall Study|Other: Unspecified|0|||
105749106|NCT03260205|364732654|FG001|Overall Study|Other: Unspecified|0|||
105749107|NCT03260205|364732655|FG002|Overall Study|Other: Unspecified|3|||
105749108|NCT03260205|364732656|FG003|Overall Study|Other: Unspecified|1|||
105749109|NCT03260205|364732657|FG004|Overall Study|Other: Unspecified|1|||
105749110|NCT03260205|364732653|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
105749111|NCT03260205|364732654|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
105749112|NCT03260205|364732655|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
105749113|NCT03260205|364732656|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
105749114|NCT03260205|364732657|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
105749115|NCT01116687|364734273|FG000|Overall Study|Withdrawal by Subject|4|||
105749116|NCT00424528|364734274|FG000|Overall Study|Adverse Event|2|||
105749117|NCT00424528|364734275|FG001|Overall Study|Adverse Event|1|||
105749118|NCT00424528|364734276|FG002|Overall Study|Adverse Event|2|||
105749119|NCT00424528|364734274|FG000|Overall Study|Protocol Violation|1|||
105749120|NCT00424528|364734275|FG001|Overall Study|Protocol Violation|1|||
105749121|NCT00424528|364734276|FG002|Overall Study|Protocol Violation|0|||
105749122|NCT00424528|364734274|FG000|Overall Study|Lost to Follow-up|0|||
105749123|NCT00424528|364734275|FG001|Overall Study|Lost to Follow-up|1|||
105749124|NCT00424528|364734276|FG002|Overall Study|Lost to Follow-up|0|||
105749125|NCT00424528|364734274|FG000|Overall Study|noncompliance with study requirements|2|||
105749126|NCT00424528|364734275|FG001|Overall Study|noncompliance with study requirements|1|||
105749127|NCT00424528|364734276|FG002|Overall Study|noncompliance with study requirements|2|||
105749128|NCT02115113|364734277|FG000|Participants in Run-in Period|Death|0|||
105749129|NCT02115113|364734278|FG001|Participants in Run-in Period|Death|0|||
105749130|NCT02115113|364734279|FG002|Participants in Run-in Period|Death|1|||
105749131|NCT02115113|364734277|FG000|Participants in Run-in Period|Administrative problems|0|||
105749132|NCT02115113|364734278|FG001|Participants in Run-in Period|Administrative problems|0|||
105749133|NCT02115113|364734279|FG002|Participants in Run-in Period|Administrative problems|1|||
105749134|NCT02115113|364734277|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
105749135|NCT02115113|364734278|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
105749136|NCT02115113|364734279|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
105749137|NCT02115113|364734277|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
105749138|NCT02115113|364734278|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
105749139|NCT02115113|364734279|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
105749140|NCT02115113|364734277|FG000|Participants Randomized|Lost to Follow-up|1|||
105749141|NCT02115113|364734278|FG001|Participants Randomized|Lost to Follow-up|0|||
105749142|NCT02115113|364734279|FG002|Participants Randomized|Lost to Follow-up|0|||
105749143|NCT02115113|364734277|FG000|Participants Randomized|Death|1|||
105749144|NCT02115113|364734278|FG001|Participants Randomized|Death|0|||
105749145|NCT02115113|364734279|FG002|Participants Randomized|Death|0|||
105749146|NCT00789191|364734283|FG000|Overall Study|Adverse Event|2|||
105749147|NCT00789191|364734284|FG001|Overall Study|Adverse Event|4|||
105749148|NCT00789191|364734283|FG000|Overall Study|Lack of Efficacy|0|||
105749149|NCT00789191|364734284|FG001|Overall Study|Lack of Efficacy|5|||
105749150|NCT00789191|364734283|FG000|Overall Study|Protocol Violation|5|||
105749151|NCT00789191|364734284|FG001|Overall Study|Protocol Violation|3|||
105749152|NCT00789191|364734283|FG000|Overall Study|Withdrawal Criteria|2|||
105749153|NCT00789191|364734284|FG001|Overall Study|Withdrawal Criteria|4|||
105749154|NCT00789191|364734283|FG000|Overall Study|Unclassified|5|||
105749155|NCT00789191|364734284|FG001|Overall Study|Unclassified|3|||
105749156|NCT01009983|364734285|FG000|Overall Study|necessary scans not completed|1|||
105749157|NCT00762372|364734286|FG000|Overall Study|Adverse Event|1|||
105749158|NCT00762372|364734287|FG001|Overall Study|Adverse Event|0|||
105749159|NCT00762372|364734288|FG002|Overall Study|Adverse Event|0|||
105749160|NCT02395653|364734289|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
105749161|NCT02395653|364734289|FG000|Overall Study|Consent Withdrawn at Screening|1|||
105749162|NCT02395653|364734289|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
105749163|NCT02395653|364734289|FG000|Overall Study|Investigator Decision at Screening|1|||
105749164|NCT02395653|364734289|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
105749165|NCT02395653|364734289|FG000|Overall Study|Withdrawal by Subject|1|||
105749166|NCT02395653|364734289|FG000|Overall Study|Lost to Follow-up|1|||
105749167|NCT02616185|364734290|FG000|Overall Study|Death|0|||
105749168|NCT02616185|364734291|FG001|Overall Study|Death|0|||
105749169|NCT02616185|364734292|FG002|Overall Study|Death|0|||
105749170|NCT02616185|364734293|FG003|Overall Study|Death|1|||
105749171|NCT02616185|364734294|FG004|Overall Study|Death|2|||
105749172|NCT02616185|364734295|FG005|Overall Study|Death|0|||
105749173|NCT02616185|364734296|FG006|Overall Study|Death|0|||
105749174|NCT02616185|364734297|FG007|Overall Study|Death|2|||
105749175|NCT02616185|364734298|FG008|Overall Study|Death|1|||
105749176|NCT02616185|364734290|FG000|Overall Study|Study terminated by sponsor|0|||
105749177|NCT02616185|364734291|FG001|Overall Study|Study terminated by sponsor|0|||
105749178|NCT02616185|364734292|FG002|Overall Study|Study terminated by sponsor|1|||
105749179|NCT02616185|364734293|FG003|Overall Study|Study terminated by sponsor|0|||
105749180|NCT02616185|364734294|FG004|Overall Study|Study terminated by sponsor|0|||
105749181|NCT02616185|364734295|FG005|Overall Study|Study terminated by sponsor|0|||
105749182|NCT02616185|364734296|FG006|Overall Study|Study terminated by sponsor|5|||
105749183|NCT02616185|364734297|FG007|Overall Study|Study terminated by sponsor|2|||
105749184|NCT02616185|364734298|FG008|Overall Study|Study terminated by sponsor|0|||
105749185|NCT02616185|364734290|FG000|Overall Study|Participant refused further follow-up|1|||
105749186|NCT02616185|364734291|FG001|Overall Study|Participant refused further follow-up|1|||
105749187|NCT02616185|364734292|FG002|Overall Study|Participant refused further follow-up|2|||
105749188|NCT02616185|364734293|FG003|Overall Study|Participant refused further follow-up|3|||
105749189|NCT02616185|364734294|FG004|Overall Study|Participant refused further follow-up|4|||
105749190|NCT02616185|364734295|FG005|Overall Study|Participant refused further follow-up|0|||
105749191|NCT02616185|364734296|FG006|Overall Study|Participant refused further follow-up|3|||
105749192|NCT02616185|364734297|FG007|Overall Study|Participant refused further follow-up|4|||
105749193|NCT02616185|364734298|FG008|Overall Study|Participant refused further follow-up|3|||
105749194|NCT02616185|364734290|FG000|Overall Study|Not reported|0|||
105749195|NCT02616185|364734291|FG001|Overall Study|Not reported|0|||
105749196|NCT02616185|364734292|FG002|Overall Study|Not reported|0|||
105749197|NCT02616185|364734293|FG003|Overall Study|Not reported|1|||
105749198|NCT02616185|364734294|FG004|Overall Study|Not reported|3|||
105749199|NCT02616185|364734295|FG005|Overall Study|Not reported|1|||
105749200|NCT02616185|364734296|FG006|Overall Study|Not reported|0|||
105749201|NCT02616185|364734297|FG007|Overall Study|Not reported|5|||
105749202|NCT02616185|364734298|FG008|Overall Study|Not reported|2|||
105749203|NCT01346371|364734299|FG000|Overall Study|Lost to Follow-up|2|||
105943876|NCT02014376|365456751|FG002|Overall Study|Lost to Follow-up|0|||
105943877|NCT00815633|365456752|FG000|Overall Study|study terminated|1|||
105943878|NCT01983111|365456755|FG000|Overall Study|Withdrawal by Subject|8|||
105749204|NCT01346371|364734300|FG001|Overall Study|Lost to Follow-up|0|||
105749205|NCT00487084|364734305|FG000|Overall Study|Did not receive intervention|4|||
105749206|NCT00487084|364734306|FG001|Overall Study|Did not receive intervention|3|||
105749207|NCT00487084|364734307|FG002|Overall Study|Did not receive intervention|5|||
105749208|NCT01626352|364734310|FG000|Overall Study|Disease Progression|3|||
105749209|NCT01626352|364734310|FG000|Overall Study|Intercurrent Illness|2|||
105749210|NCT01626352|364734310|FG000|Overall Study|Death|2|||
105749211|NCT01626352|364734310|FG000|Overall Study|Withdrawal by Subject|1|||
105749212|NCT01626352|364734310|FG000|Overall Study|Non-Compliance|1|||
105749213|NCT01626352|364734310|FG000|Overall Study|Never Treated|1|||
105749214|NCT03446651|364734313|FG000|Overall Study|Lost to Follow-up|4|||
105749215|NCT03446651|364734314|FG001|Overall Study|Lost to Follow-up|0|||
105749216|NCT03446651|364734313|FG000|Overall Study|Open Label Participants|5|||
105749217|NCT03446651|364734314|FG001|Overall Study|Open Label Participants|0|||
105749218|NCT00343291|364734315|FG000|Overall Study|Adverse Event|13|||
105749219|NCT00343291|364734316|FG001|Overall Study|Adverse Event|13|||
105749220|NCT00343291|364734315|FG000|Overall Study|Death|3|||
105749221|NCT00343291|364734316|FG001|Overall Study|Death|2|||
105749222|NCT00343291|364734315|FG000|Overall Study|Progressive disease|33|||
105749223|NCT00343291|364734316|FG001|Overall Study|Progressive disease|34|||
105749224|NCT00343291|364734315|FG000|Overall Study|Withdrawal by Subject|0|||
105749225|NCT00343291|364734316|FG001|Overall Study|Withdrawal by Subject|2|||
105749226|NCT00343291|364734315|FG000|Overall Study|Other|8|||
105749227|NCT00343291|364734316|FG001|Overall Study|Other|5|||
105749228|NCT04831515|364734317|FG000|First Intervention|Adverse Event|0|||
105749229|NCT04831515|364734318|FG001|First Intervention|Adverse Event|1|||
105749230|NCT02156492|364734321|FG000|Period 1|No Reason Given|0|||
105749231|NCT02156492|364734322|FG001|Period 1|No Reason Given|1|||
105749232|NCT02156492|364734323|FG002|Period 1|No Reason Given|0|||
105749233|NCT02156492|364734321|FG000|Period 3|Adverse Event|0|||
105749234|NCT02156492|364734322|FG001|Period 3|Adverse Event|1|||
105749235|NCT02156492|364734323|FG002|Period 3|Adverse Event|0|||
105749236|NCT02420223|364734331|FG000|Overall Study|Adverse Event|1|||
105749237|NCT02420223|364734332|FG001|Overall Study|Adverse Event|0|||
105749238|NCT02420223|364734331|FG000|Overall Study|Physician Decision|0|||
105749239|NCT02420223|364734332|FG001|Overall Study|Physician Decision|2|||
105749240|NCT01332019|364734333|FG000|Overall Study|Was Not Dosed|1|||
105749241|NCT01332019|364734334|FG001|Overall Study|Was Not Dosed|0|||
105749242|NCT01332019|364734333|FG000|Overall Study|Other|16|||
105749243|NCT01332019|364734334|FG001|Overall Study|Other|18|||
105749244|NCT01332019|364734333|FG000|Overall Study|Death|2|||
105749245|NCT01332019|364734334|FG001|Overall Study|Death|1|||
105749246|NCT01332019|364734333|FG000|Overall Study|Physician Decision|4|||
105749247|NCT01332019|364734334|FG001|Overall Study|Physician Decision|3|||
105749248|NCT01332019|364734333|FG000|Overall Study|Withdrawal by Subject|73|||
105749249|NCT01332019|364734334|FG001|Overall Study|Withdrawal by Subject|71|||
105749250|NCT01332019|364734333|FG000|Overall Study|Lost to Follow-up|4|||
105749251|NCT01332019|364734334|FG001|Overall Study|Lost to Follow-up|7|||
105749252|NCT01332019|364734333|FG000|Overall Study|Adverse Event|13|||
105749253|NCT01332019|364734334|FG001|Overall Study|Adverse Event|22|||
105749254|NCT00871377|364734337|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749255|NCT00871377|364734338|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749256|NCT00871377|364734339|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
105749257|NCT00871377|364734340|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749258|NCT00871377|364734341|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749259|NCT00871377|364734342|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
105749260|NCT00871377|364734337|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749261|NCT00871377|364734338|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749262|NCT00871377|364734339|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749263|NCT00871377|364734340|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749264|NCT00871377|364734341|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
105749265|NCT00871377|364734342|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
105943879|NCT01983111|365456756|FG001|Overall Study|Withdrawal by Subject|6|||
105943880|NCT01983111|365456755|FG000|Overall Study|Adverse Event|4|||
105749266|NCT00871377|364734337|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
105943881|NCT01983111|365456756|FG001|Overall Study|Adverse Event|0|||
105943882|NCT01983111|365456755|FG000|Overall Study|Protocol Violation|0|||
105749267|NCT00871377|364734338|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
105943883|NCT01983111|365456756|FG001|Overall Study|Protocol Violation|1|||
105749268|NCT00871377|364734339|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749269|NCT00871377|364734340|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749270|NCT00871377|364734341|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749271|NCT00871377|364734342|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749272|NCT00871377|364734337|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749273|NCT00871377|364734338|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
105943884|NCT03502200|365456757|FG000|Overall Study|Adverse Event|1|||
105943885|NCT03502200|365456758|FG001|Overall Study|Adverse Event|0|||
105943886|NCT03502200|365456757|FG000|Overall Study|Lost to Follow-up|36|||
105943887|NCT03502200|365456758|FG001|Overall Study|Lost to Follow-up|38|||
105749274|NCT00871377|364734339|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749275|NCT00871377|364734340|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749276|NCT00871377|364734341|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
105749277|NCT00871377|364734342|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
105749278|NCT00871377|364734337|FG000|Third Intervention (10 Weeks)|Death|0|||
105749279|NCT00871377|364734338|FG001|Third Intervention (10 Weeks)|Death|0|||
105749280|NCT00871377|364734339|FG002|Third Intervention (10 Weeks)|Death|0|||
105749281|NCT00871377|364734340|FG003|Third Intervention (10 Weeks)|Death|1|||
105749282|NCT00871377|364734341|FG004|Third Intervention (10 Weeks)|Death|0|||
105749283|NCT00871377|364734342|FG005|Third Intervention (10 Weeks)|Death|0|||
105749284|NCT01944969|364734344|FG000|Overall Study|Adverse Event|1|||
105749285|NCT01944969|364734344|FG000|Overall Study|Lack of Efficacy|1|||
105749286|NCT01944969|364734344|FG000|Overall Study|Non-compliance with IMP|1|||
105749287|NCT01944969|364734344|FG000|Overall Study|Administrative or other reasons|23|||
105749288|NCT00310388|364734345|FG000|Primary Reporting Phase|Adverse Event|101|||
105749289|NCT00310388|364734346|FG001|Primary Reporting Phase|Adverse Event|0|||
105749290|NCT00310388|364734345|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
105749291|NCT00310388|364734346|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
105749292|NCT00310388|364734345|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
105749293|NCT00310388|364734346|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
105749294|NCT00310388|364734345|FG000|Primary Reporting Phase|Protocol Violation|10|||
105749295|NCT00310388|364734346|FG001|Primary Reporting Phase|Protocol Violation|0|||
105749296|NCT00310388|364734345|FG000|Primary Reporting Phase|Pregnancy|3|||
105749297|NCT00310388|364734346|FG001|Primary Reporting Phase|Pregnancy|0|||
105749298|NCT00310388|364734345|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
105749299|NCT00310388|364734346|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
105749300|NCT00310388|364734345|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
105749301|NCT00310388|364734346|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
105749302|NCT00310388|364734345|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
105749303|NCT00310388|364734346|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
105749304|NCT00310388|364734345|FG000|Primary Reporting Phase|Physician Decision|2|||
105749305|NCT00310388|364734346|FG001|Primary Reporting Phase|Physician Decision|0|||
105749306|NCT00310388|364734345|FG000|Primary Reporting Phase|Request of the sponsor|19|||
105749307|NCT00310388|364734346|FG001|Primary Reporting Phase|Request of the sponsor|0|||
105749308|NCT00310388|364734345|FG000|Primary Reporting Phase|Failed to return|8|||
105749309|NCT00310388|364734346|FG001|Primary Reporting Phase|Failed to return|0|||
105749310|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
105749311|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
105749312|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant request|2|||
105749313|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant request|0|||
105749314|NCT00310388|364734345|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
105749315|NCT00310388|364734346|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
105749316|NCT00310388|364734345|FG000|Primary Reporting Phase|Discontinuation of study|1|||
105749317|NCT00310388|364734346|FG001|Primary Reporting Phase|Discontinuation of study|0|||
105749318|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
105749319|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
105749320|NCT00310388|364734345|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
105749321|NCT00310388|364734346|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
105749322|NCT00310388|364734345|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
105749323|NCT00310388|364734346|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
105749324|NCT00310388|364734345|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
105749325|NCT00310388|364734346|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
105749326|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant passed away|1|||
105943888|NCT03502200|365456757|FG000|Overall Study|Study Team Decision|1|||
105943889|NCT03502200|365456758|FG001|Overall Study|Study Team Decision|1|||
105943890|NCT03502200|365456757|FG000|Overall Study|Withdrawal by Subject|5|||
105943891|NCT03502200|365456758|FG001|Overall Study|Withdrawal by Subject|7|||
105749327|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant passed away|0|||
105943892|NCT03502200|365456757|FG000|Overall Study|Death|0|||
105943893|NCT03502200|365456758|FG001|Overall Study|Death|2|||
106142561|NCT03460756|366181897|FG002|Overall Study|Protocol Violation|0|||
105749328|NCT00310388|364734345|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
105749329|NCT00310388|364734346|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
105749330|NCT00310388|364734345|FG000|Primary Reporting Phase|Missing|1|||
105749331|NCT00310388|364734346|FG001|Primary Reporting Phase|Missing|0|||
105749332|NCT00310388|364734345|FG000|Primary Reporting Phase|Other|1|||
106142562|NCT03460756|366181898|FG003|Overall Study|Protocol Violation|1|||
105749333|NCT00310388|364734346|FG001|Primary Reporting Phase|Other|0|||
105749334|NCT00310388|364734345|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
105749335|NCT00310388|364734346|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
105749336|NCT00310388|364734345|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
105749337|NCT00310388|364734346|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
105749338|NCT00310388|364734345|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
105749339|NCT00310388|364734346|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
105749340|NCT00310388|364734345|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
105749341|NCT00310388|364734346|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
105749342|NCT01610076|364734349|FG000|Overall Study|Technical issue with video|0|||
105749343|NCT01610076|364734350|FG001|Overall Study|Technical issue with video|1|||
105749344|NCT01610076|364734349|FG000|Overall Study|Lost to Follow-up|3|||
105749345|NCT01610076|364734350|FG001|Overall Study|Lost to Follow-up|4|||
105749346|NCT04017442|364734352|FG000|Overall Study|Withdrawal by Subject|0|||
105749347|NCT04017442|364734353|FG001|Overall Study|Withdrawal by Subject|3|||
105749348|NCT04017442|364734352|FG000|Overall Study|Lost to Follow-up|21|||
105749349|NCT04017442|364734353|FG001|Overall Study|Lost to Follow-up|19|||
105749350|NCT00082758|364734358|FG000|Overall Study|Adverse Event|0|||
105749351|NCT00082758|364734359|FG001|Overall Study|Adverse Event|2|||
105749352|NCT00082758|364734360|FG002|Overall Study|Adverse Event|0|||
105749353|NCT00082758|364734358|FG000|Overall Study|Lack of Efficacy|12|||
105749354|NCT00082758|364734359|FG001|Overall Study|Lack of Efficacy|13|||
105749355|NCT00082758|364734360|FG002|Overall Study|Lack of Efficacy|0|||
105749356|NCT00082758|364734358|FG000|Overall Study|Physician Decision|0|||
105749357|NCT00082758|364734359|FG001|Overall Study|Physician Decision|1|||
105749358|NCT00082758|364734360|FG002|Overall Study|Physician Decision|0|||
105749359|NCT00082758|364734358|FG000|Overall Study|Withdrawal by Subject|3|||
105749360|NCT00082758|364734359|FG001|Overall Study|Withdrawal by Subject|0|||
105749361|NCT00082758|364734360|FG002|Overall Study|Withdrawal by Subject|0|||
105749362|NCT00082758|364734358|FG000|Overall Study|Protocol Violation|0|||
105749363|NCT00082758|364734359|FG001|Overall Study|Protocol Violation|1|||
105749364|NCT00082758|364734360|FG002|Overall Study|Protocol Violation|0|||
105749365|NCT00937560|364734361|FG000|Initial Treatment|Death|6|||
105749366|NCT00937560|364734361|FG000|Initial Treatment|Withdraw consent|3|||
105749367|NCT00937560|364734361|FG000|Initial Treatment|Adverse Event|1|||
105749368|NCT00937560|364734361|FG000|Initial Treatment|Lost to Follow-up|1|||
105749369|NCT00937560|364734361|FG000|Initial Treatment|No end of study page|10|||
105749370|NCT00937560|364734361|FG000|Maintenance Treatment|Death|12|||
105749371|NCT00937560|364734361|FG000|Maintenance Treatment|Withdraw consent|5|||
105749372|NCT00937560|364734361|FG000|Maintenance Treatment|According to protocol|1|||
105749373|NCT03421964|364734362|FG000|Overall Study|Lost to Follow-up|11|||
105749374|NCT03421964|364734363|FG001|Overall Study|Lost to Follow-up|21|||
105749375|NCT03421964|364734362|FG000|Overall Study|Withdrawal by Subject|9|||
105749376|NCT03421964|364734363|FG001|Overall Study|Withdrawal by Subject|3|||
105749377|NCT03421964|364734362|FG000|Overall Study|Incarcerated|1|||
105749378|NCT03421964|364734363|FG001|Overall Study|Incarcerated|0|||
105749379|NCT03421964|364734362|FG000|Overall Study|Inpt Treatment Facility|1|||
105749380|NCT03421964|364734363|FG001|Overall Study|Inpt Treatment Facility|1|||
105749381|NCT03421964|364734362|FG000|Overall Study|Virtual Platform Issues|1|||
105749382|NCT03421964|364734363|FG001|Overall Study|Virtual Platform Issues|1|||
105749383|NCT02938585|364734364|FG000|Overall Study|Withdrawal by parent or guardian|0|||
105749384|NCT02938585|364734365|FG001|Overall Study|Withdrawal by parent or guardian|1|||
105749385|NCT02938585|364734366|FG002|Overall Study|Withdrawal by parent or guardian|0|||
105749386|NCT02938585|364734367|FG003|Overall Study|Withdrawal by parent or guardian|0|||
105749387|NCT02938585|364734364|FG000|Overall Study|Withdrawal by Subject|0|||
105749388|NCT02938585|364734365|FG001|Overall Study|Withdrawal by Subject|0|||
105749389|NCT02938585|364734366|FG002|Overall Study|Withdrawal by Subject|0|||
105749390|NCT02938585|364734367|FG003|Overall Study|Withdrawal by Subject|5|||
105749391|NCT01774344|364734368|FG000|Overall Study|Withdrawal by Subject|3|||
105749392|NCT01774344|364734369|FG001|Overall Study|Withdrawal by Subject|10|||
105749393|NCT01774344|364734368|FG000|Overall Study|Protocol Violation|0|||
105749394|NCT01774344|364734369|FG001|Overall Study|Protocol Violation|1|||
105749395|NCT01774344|364734368|FG000|Overall Study|Lost to Follow-up|4|||
105749396|NCT01774344|364734369|FG001|Overall Study|Lost to Follow-up|10|||
105749397|NCT01774344|364734368|FG000|Overall Study|End of survival follow-up not available|2|||
105749398|NCT01774344|364734369|FG001|Overall Study|End of survival follow-up not available|2|||
105749399|NCT01774344|364734368|FG000|Overall Study|Data collection finished|4|||
105749400|NCT01774344|364734369|FG001|Overall Study|Data collection finished|14|||
105749401|NCT01774344|364734368|FG000|Overall Study|Other|0|||
105749402|NCT01774344|364734369|FG001|Overall Study|Other|1|||
105749403|NCT01774344|364734368|FG000|Overall Study|Did not enter Survival Follow up|49|||
105749404|NCT01774344|364734369|FG001|Overall Study|Did not enter Survival Follow up|83|||
105749405|NCT03364608|364734370|FG000|Overall Study|Withdrawal by Subject|4|||
105749406|NCT03364608|364734370|FG000|Overall Study|Protocol Violation|2|||
105749407|NCT03364608|364734370|FG000|Overall Study|Lost to Follow-up|2|||
105749408|NCT04096326|364734371|FG000|Overall Study|Withdrawal by Subject|0|||
105749409|NCT04096326|364734372|FG001|Overall Study|Withdrawal by Subject|0|||
105749410|NCT04096326|364734373|FG002|Overall Study|Withdrawal by Subject|0|||
105749411|NCT04096326|364734374|FG003|Overall Study|Withdrawal by Subject|0|||
105749412|NCT04096326|364734375|FG004|Overall Study|Withdrawal by Subject|0|||
105749413|NCT04096326|364734376|FG005|Overall Study|Withdrawal by Subject|0|||
105749414|NCT04096326|364734377|FG006|Overall Study|Withdrawal by Subject|1|||
105749415|NCT04096326|364734378|FG007|Overall Study|Withdrawal by Subject|0|||
105749416|NCT04096326|364734379|FG008|Overall Study|Withdrawal by Subject|0|||
105749417|NCT04096326|364734380|FG009|Overall Study|Withdrawal by Subject|0|||
105749418|NCT04096326|364734371|FG000|Overall Study|Lost to Follow-up|0|||
105749419|NCT04096326|364734372|FG001|Overall Study|Lost to Follow-up|1|||
105749420|NCT04096326|364734373|FG002|Overall Study|Lost to Follow-up|0|||
105749421|NCT04096326|364734374|FG003|Overall Study|Lost to Follow-up|0|||
105749422|NCT04096326|364734375|FG004|Overall Study|Lost to Follow-up|0|||
105749423|NCT04096326|364734376|FG005|Overall Study|Lost to Follow-up|0|||
105749424|NCT04096326|364734377|FG006|Overall Study|Lost to Follow-up|0|||
105749425|NCT04096326|364734378|FG007|Overall Study|Lost to Follow-up|0|||
105749426|NCT04096326|364734379|FG008|Overall Study|Lost to Follow-up|0|||
105749427|NCT04096326|364734380|FG009|Overall Study|Lost to Follow-up|0|||
105749428|NCT04096326|364734371|FG000|Overall Study|COVID-19-related reasons|0|||
105749429|NCT04096326|364734372|FG001|Overall Study|COVID-19-related reasons|0|||
105749430|NCT04096326|364734373|FG002|Overall Study|COVID-19-related reasons|0|||
105749431|NCT04096326|364734374|FG003|Overall Study|COVID-19-related reasons|0|||
105749432|NCT04096326|364734375|FG004|Overall Study|COVID-19-related reasons|1|||
105749433|NCT04096326|364734376|FG005|Overall Study|COVID-19-related reasons|5|||
105749434|NCT04096326|364734377|FG006|Overall Study|COVID-19-related reasons|0|||
105749435|NCT04096326|364734378|FG007|Overall Study|COVID-19-related reasons|0|||
105749436|NCT04096326|364734379|FG008|Overall Study|COVID-19-related reasons|0|||
105749437|NCT04096326|364734380|FG009|Overall Study|COVID-19-related reasons|0|||
105749438|NCT02108600|364734381|FG000|Overall Study|Withdrawal by Subject|2|||
105749439|NCT02108600|364734382|FG001|Overall Study|Withdrawal by Subject|0|||
105749440|NCT02108600|364734381|FG000|Overall Study|Lost to Follow-up|1|||
105749441|NCT02108600|364734382|FG001|Overall Study|Lost to Follow-up|1|||
105749442|NCT03150095|364734385|FG000|Overall Study|Death|0|||
105749443|NCT03150095|364734386|FG001|Overall Study|Death|1|||
105749444|NCT03150095|364734385|FG000|Overall Study|Lost to Follow-up|1|||
105749445|NCT03150095|364734386|FG001|Overall Study|Lost to Follow-up|1|||
105749446|NCT03150095|364734385|FG000|Overall Study|Withdrawal by Subject|4|||
105749447|NCT03150095|364734386|FG001|Overall Study|Withdrawal by Subject|0|||
105749448|NCT03150095|364734385|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
105749449|NCT03150095|364734386|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
105749450|NCT00617409|364734388|FG000|Overall Study|Withdrawal by Subject|4|||
105749451|NCT00617409|364734389|FG001|Overall Study|Withdrawal by Subject|1|||
105749452|NCT00617409|364734390|FG002|Overall Study|Withdrawal by Subject|2|||
105749453|NCT00617409|364734388|FG000|Overall Study|Adverse Event|0|||
105749454|NCT00617409|364734389|FG001|Overall Study|Adverse Event|2|||
105749455|NCT00617409|364734390|FG002|Overall Study|Adverse Event|3|||
105749456|NCT00617409|364734388|FG000|Overall Study|Disease Progression|8|||
105749457|NCT00617409|364734389|FG001|Overall Study|Disease Progression|8|||
105749458|NCT00617409|364734390|FG002|Overall Study|Disease Progression|18|||
105749459|NCT00617409|364734388|FG000|Overall Study|Death|3|||
105749460|NCT00617409|364734389|FG001|Overall Study|Death|5|||
105749461|NCT00617409|364734390|FG002|Overall Study|Death|4|||
105749462|NCT00617409|364734388|FG000|Overall Study|Alternative Therapy|1|||
105749463|NCT00617409|364734389|FG001|Overall Study|Alternative Therapy|2|||
105749464|NCT00617409|364734390|FG002|Overall Study|Alternative Therapy|0|||
105749465|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
105749466|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
105749467|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
106142563|NCT03460756|366181895|FG000|Overall Study|Withdrawal by Subject|0|||
106142564|NCT03460756|366181896|FG001|Overall Study|Withdrawal by Subject|4|||
106142565|NCT03460756|366181897|FG002|Overall Study|Withdrawal by Subject|7|||
106142566|NCT03460756|366181898|FG003|Overall Study|Withdrawal by Subject|3|||
105749468|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
105749469|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
105749470|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
105749471|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
105749472|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
105749473|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
105749474|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
106142567|NCT02441036|366181903|FG000|Overall Study|No tissue resected|0|||
105749475|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
105749476|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
105749477|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
106142568|NCT02441036|366181904|FG001|Overall Study|No tissue resected|1|||
105943894|NCT00855335|365456759|FG000|Overall Study|Lost to Follow-up|0|||
105943895|NCT00855335|365456760|FG001|Overall Study|Lost to Follow-up|0|||
105943896|NCT00855335|365456761|FG002|Overall Study|Lost to Follow-up|3|||
105943897|NCT00855335|365456762|FG003|Overall Study|Lost to Follow-up|1|||
105749478|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
105749479|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
105749480|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
105749481|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
105749482|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105749483|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
105749484|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
105749485|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
105749486|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105749487|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
105749488|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105749489|NCT01106625|364734406|FG000|Core Period: Baseline to Week 26|Other|8|||
105749490|NCT01106625|364734407|FG001|Core Period: Baseline to Week 26|Other|7|||
105943898|NCT00855335|365456763|FG004|Overall Study|Lost to Follow-up|0|||
105943899|NCT00855335|365456759|FG000|Overall Study|Withdrawal by Subject|0|||
105943900|NCT00855335|365456760|FG001|Overall Study|Withdrawal by Subject|0|||
105749491|NCT01106625|364734408|FG002|Core Period: Baseline to Week 26|Other|4|||
105749492|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
105749493|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
105749494|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
105749495|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
105749496|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
105749497|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
105749498|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
105749499|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105749500|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
105749501|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105749502|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105749503|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105749504|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
105749505|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105749506|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
105749507|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
105749508|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
105749509|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
105749510|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
105749511|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
105749512|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
105749513|NCT01106625|364734406|FG000|Extension Period: Week 26 to Week 52|Other|5|||
105749514|NCT01106625|364734407|FG001|Extension Period: Week 26 to Week 52|Other|5|||
105749515|NCT01106625|364734408|FG002|Extension Period: Week 26 to Week 52|Other|4|||
105749516|NCT01363713|364734409|FG000|Overall Study|Adverse Event|1|||
105749517|NCT01363713|364734409|FG000|Overall Study|Protocol Violation|3|||
105749518|NCT01363713|364734409|FG000|Overall Study|Withdrawal by Subject|2|||
105749519|NCT03943953|364734410|FG000|Trial of ITG 1|Lost to Follow-up|19|||
105749520|NCT03943953|364734411|FG001|Trial of ITG 1|Lost to Follow-up|1|||
105749521|NCT03943953|364734410|FG000|Trial of ITG 2|Lost to Follow-up|8|||
105749522|NCT03943953|364734411|FG001|Trial of ITG 2|Lost to Follow-up|0|||
105749523|NCT03943953|364734410|FG000|Trial of ITG 3|Lost to Follow-up|2|||
105749524|NCT03943953|364734411|FG001|Trial of ITG 3|Lost to Follow-up|0|||
105749525|NCT03943953|364734410|FG000|Trial of ITG 4|Lost to Follow-up|2|||
105749526|NCT03943953|364734411|FG001|Trial of ITG 4|Lost to Follow-up|0|||
105749527|NCT00511342|364734412|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
105749528|NCT00511342|364734413|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
105749529|NCT00511342|364734412|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
105749530|NCT00511342|364734413|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
105749531|NCT00511342|364734412|FG000|Overall Study|Pregnancy|0|||
105749532|NCT00511342|364734413|FG001|Overall Study|Pregnancy|1|||
105749533|NCT00511342|364734412|FG000|Overall Study|Pregnancy wish|0|||
105749534|NCT00511342|364734413|FG001|Overall Study|Pregnancy wish|1|||
105943901|NCT00855335|365456761|FG002|Overall Study|Withdrawal by Subject|0|||
105943902|NCT00855335|365456762|FG003|Overall Study|Withdrawal by Subject|1|||
105943903|NCT00855335|365456763|FG004|Overall Study|Withdrawal by Subject|0|||
105943904|NCT00855335|365456759|FG000|Overall Study|Adverse Event|2|||
105749535|NCT00511342|364734412|FG000|Overall Study|Lost to Follow-up|1|||
105749536|NCT00511342|364734413|FG001|Overall Study|Lost to Follow-up|5|||
105749537|NCT00511342|364734412|FG000|Overall Study|Other Reason|2|||
105749538|NCT00511342|364734413|FG001|Overall Study|Other Reason|2|||
105749539|NCT00668200|364734423|FG000|Overall Study|Withdrawal by Subject|2|||
105943905|NCT00855335|365456760|FG001|Overall Study|Adverse Event|0|||
105943906|NCT00855335|365456761|FG002|Overall Study|Adverse Event|0|||
105943907|NCT00855335|365456762|FG003|Overall Study|Adverse Event|0|||
105943908|NCT00855335|365456763|FG004|Overall Study|Adverse Event|0|||
105943909|NCT00855335|365456759|FG000|Overall Study|Physician Decision|1|||
105943910|NCT00855335|365456760|FG001|Overall Study|Physician Decision|1|||
105943911|NCT00855335|365456761|FG002|Overall Study|Physician Decision|0|||
105943912|NCT00855335|365456762|FG003|Overall Study|Physician Decision|0|||
105943913|NCT00855335|365456763|FG004|Overall Study|Physician Decision|0|||
105943914|NCT00855335|365456759|FG000|Overall Study|Other|2|||
105943915|NCT00855335|365456760|FG001|Overall Study|Other|1|||
105943916|NCT00855335|365456761|FG002|Overall Study|Other|2|||
105943917|NCT00855335|365456762|FG003|Overall Study|Other|5|||
105943918|NCT00855335|365456763|FG004|Overall Study|Other|1|||
105943919|NCT02526290|365456766|FG000|Overall Study|Adverse Event|3|||
105943920|NCT02526290|365456766|FG000|Overall Study|Withdrawal by Subject|4|||
105749540|NCT00668200|364734423|FG000|Overall Study|Lost to Follow-up|1|||
105749541|NCT00718666|364734424|FG000|Booster Phase Year 5|No active participation request|0|||
105749542|NCT00718666|364734425|FG001|Booster Phase Year 5|No active participation request|0|||
105749543|NCT00718666|364734426|FG002|Booster Phase Year 5|No active participation request|1|||
105749544|NCT00718666|364734424|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
105749545|NCT00718666|364734425|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
105749546|NCT00718666|364734426|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
105749547|NCT00718666|364734424|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
105749548|NCT00718666|364734425|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
105749549|NCT00718666|364734426|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
105749550|NCT00718666|364734424|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
105749551|NCT00718666|364734425|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
105749552|NCT00718666|364734426|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
105749553|NCT00997321|364734427|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
105749554|NCT00997321|364734428|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
105749555|NCT02509598|364734429|FG000|Overall Study|Withdrawal by Subject|1|||
105749556|NCT02196038|364734430|FG000|Overall Study|Death|16|||
105749557|NCT02196038|364734431|FG001|Overall Study|Death|21|||
105749558|NCT02196038|364734430|FG000|Overall Study|Withdrawal by Subject|0|||
105749559|NCT02196038|364734431|FG001|Overall Study|Withdrawal by Subject|1|||
105749560|NCT02196038|364734430|FG000|Overall Study|Lost to Follow-up|1|||
105749561|NCT02196038|364734431|FG001|Overall Study|Lost to Follow-up|0|||
105749562|NCT00421343|364734432|FG000|Overall Study|Death|1|||
105749563|NCT00421343|364734432|FG000|Overall Study|Withdrawal by Subject|2|||
105749564|NCT00421343|364734432|FG000|Overall Study|Lost to Follow-up|3|||
105749565|NCT01276457|364734440|FG000|Core Study|Adverse Event|6|||
105749566|NCT01276457|364734441|FG001|Core Study|Adverse Event|3|||
105749567|NCT01276457|364734440|FG000|Core Study|Lost to Follow-up|1|||
105749568|NCT01276457|364734441|FG001|Core Study|Lost to Follow-up|2|||
105749569|NCT01276457|364734440|FG000|Core Study|Administrative problems|1|||
105749570|NCT01276457|364734441|FG001|Core Study|Administrative problems|1|||
105749571|NCT01276457|364734440|FG000|Core Study|Death|2|||
105749572|NCT01276457|364734441|FG001|Core Study|Death|2|||
105749573|NCT01276457|364734440|FG000|Core Study|Lack of Efficacy|3|||
105749574|NCT01276457|364734441|FG001|Core Study|Lack of Efficacy|12|||
105749575|NCT01276457|364734440|FG000|Extension Study|Lost to Follow-up|3|||
105749576|NCT01276457|364734441|FG001|Extension Study|Lost to Follow-up|0|||
105749577|NCT01276457|364734440|FG000|Extension Study|Death|0|||
105749578|NCT01276457|364734441|FG001|Extension Study|Death|1|||
105749579|NCT01276457|364734440|FG000|Extension Study|Lack of Efficacy|3|||
105749580|NCT01276457|364734441|FG001|Extension Study|Lack of Efficacy|1|||
105749581|NCT02993146|364734444|FG000|Overall Study|Withdrawal by Subject|0|||
105749582|NCT02993146|364734445|FG001|Overall Study|Withdrawal by Subject|0|||
105749583|NCT02993146|364734446|FG002|Overall Study|Withdrawal by Subject|1|||
105749584|NCT02993146|364734447|FG003|Overall Study|Withdrawal by Subject|1|||
105749585|NCT01599754|364734448|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
105749586|NCT01599754|364734449|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
105749587|NCT01599754|364734448|FG000|Overall Study|Participant noncompliance|4|||
105943921|NCT02526290|365456766|FG000|Overall Study|Physician Decision|1|||
105943922|NCT00105066|365456767|FG000|Overall Study|Adverse Event|2|||
105749588|NCT01599754|364734449|FG001|Overall Study|Participant noncompliance|4|||
105749589|NCT01599754|364734448|FG000|Overall Study|Lost to Follow-up|13|||
105943923|NCT00105066|365456768|FG001|Overall Study|Adverse Event|5|||
105943924|NCT00437073|365456769|FG000|Overall Study|Sponsor Terminated Study|1|||
105943925|NCT00437073|365456770|FG001|Overall Study|Sponsor Terminated Study|0|||
105749590|NCT01599754|364734449|FG001|Overall Study|Lost to Follow-up|6|||
105749591|NCT01599754|364734448|FG000|Overall Study|Death|31|||
105943926|NCT00437073|365456769|FG000|Overall Study|Physician Decision|0|||
105943927|NCT00437073|365456770|FG001|Overall Study|Physician Decision|1|||
105943928|NCT00982280|365456772|FG000|Observation Period|Not eligible to be dosed|19|||
105749592|NCT01599754|364734449|FG001|Overall Study|Death|33|||
105749593|NCT01599754|364734448|FG000|Overall Study|Adverse Event|3|||
105749594|NCT01599754|364734449|FG001|Overall Study|Adverse Event|2|||
105749595|NCT01599754|364734448|FG000|Overall Study|Investigator decision|1|||
105749596|NCT01599754|364734449|FG001|Overall Study|Investigator decision|3|||
105749597|NCT01599754|364734448|FG000|Overall Study|Withdrawal by Subject|24|||
105749598|NCT01599754|364734449|FG001|Overall Study|Withdrawal by Subject|25|||
105749599|NCT01599754|364734448|FG000|Overall Study|Study terminated by sponsor|282|||
105749600|NCT01599754|364734449|FG001|Overall Study|Study terminated by sponsor|285|||
105749601|NCT02429258|364736591|FG000|Overall Study|Withdrawal by Subject|2|||
105749602|NCT02429258|364736592|FG001|Overall Study|Withdrawal by Subject|0|||
105749603|NCT02429258|364736591|FG000|Overall Study|Protocol Violation|0|||
105749604|NCT02429258|364736592|FG001|Overall Study|Protocol Violation|1|||
105749605|NCT02670915|364736593|FG000|Overall Study|Withdrawal by Subject|0|||
105749606|NCT02670915|364736594|FG001|Overall Study|Withdrawal by Subject|1|||
105749607|NCT02670915|364736595|FG002|Overall Study|Withdrawal by Subject|4|||
105749608|NCT02670915|364736593|FG000|Overall Study|Withdrawal by parent/guardian|4|||
105749609|NCT02670915|364736594|FG001|Overall Study|Withdrawal by parent/guardian|4|||
105749610|NCT02670915|364736595|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105749611|NCT02670915|364736593|FG000|Overall Study|Unclassified|0|||
105749612|NCT02670915|364736594|FG001|Overall Study|Unclassified|3|||
105749613|NCT02670915|364736595|FG002|Overall Study|Unclassified|0|||
105749614|NCT00818207|364736599|FG000|Overall Study|Adverse Event|6|||
105749615|NCT00818207|364736600|FG001|Overall Study|Adverse Event|0|||
105749616|NCT00818207|364736599|FG000|Overall Study|Lost to Follow-up|160|||
105749617|NCT00818207|364736600|FG001|Overall Study|Lost to Follow-up|146|||
105749618|NCT00818207|364736599|FG000|Overall Study|Multiple reasons|11|||
105749619|NCT00818207|364736600|FG001|Overall Study|Multiple reasons|12|||
105749620|NCT00818207|364736599|FG000|Overall Study|Withdrawal by Subject|42|||
105749621|NCT00818207|364736600|FG001|Overall Study|Withdrawal by Subject|104|||
105749622|NCT00818207|364736599|FG000|Overall Study|Death|3|||
105749623|NCT00818207|364736600|FG001|Overall Study|Death|5|||
105749624|NCT02494778|364736601|FG000|Overall Study|Death|3|||
105749625|NCT02494778|364736601|FG000|Overall Study|Other|173|||
105749626|NCT02494778|364736601|FG000|Overall Study|Lack of Efficacy|4|||
105749627|NCT02494778|364736601|FG000|Overall Study|Adverse Event|18|||
105749628|NCT02494778|364736601|FG000|Overall Study|Withdrawal by Subject|20|||
105749629|NCT02494778|364736601|FG000|Overall Study|Lost to Follow-up|2|||
105749630|NCT02494778|364736601|FG000|Overall Study|Noncompliant with study drug admin.|1|||
105749631|NCT00967226|364736602|FG000|Overall Study|Adverse Event|0|||
105749632|NCT00967226|364736603|FG001|Overall Study|Adverse Event|5|||
105749633|NCT00967226|364736602|FG000|Overall Study|Protocol Violation|2|||
105749634|NCT00967226|364736603|FG001|Overall Study|Protocol Violation|0|||
105749635|NCT00967226|364736602|FG000|Overall Study|Physician Decision|0|||
105749636|NCT00967226|364736603|FG001|Overall Study|Physician Decision|1|||
105749637|NCT02174861|364736608|FG000|Overall Study|Decision by sponsor|8|||
105749638|NCT02174861|364736608|FG000|Overall Study|Withdrawal by Subject|124|||
105749639|NCT02174861|364736608|FG000|Overall Study|Lost to Follow-up|26|||
105749640|NCT00605722|364736609|FG000|Overall Study|Adverse Event|6|||
105749641|NCT00605722|364736609|FG000|Overall Study|Insufficient therapeutic response|44|||
105749642|NCT00605722|364736609|FG000|Overall Study|Failure to return|1|||
105749643|NCT02622724|364736610|FG000|Overall Study|Death|51|||
105749644|NCT02622724|364736611|FG001|Overall Study|Death|53|||
105749645|NCT02622724|364736610|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
105749646|NCT02622724|364736611|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
105749647|NCT02622724|364736610|FG000|Overall Study|Early termination of study|38|||
105749648|NCT02622724|364736611|FG001|Overall Study|Early termination of study|43|||
105749649|NCT00296725|364736612|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
105749650|NCT00296725|364736612|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
105749651|NCT00296725|364736612|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
106142569|NCT02441036|366181905|FG002|Overall Study|No tissue resected|0|||
105749652|NCT00356863|364736613|FG000|Overall Study|Death|16|||
105749653|NCT00356863|364736614|FG001|Overall Study|Death|32|||
105749654|NCT00356863|364736613|FG000|Overall Study|Lost to Follow-up|76|||
105749655|NCT00356863|364736614|FG001|Overall Study|Lost to Follow-up|43|||
106142570|NCT02441036|366181906|FG003|Overall Study|No tissue resected|1|||
105749656|NCT04032171|364736621|FG000|Overall Study|Study Termination|1|||
105749657|NCT04032171|364736622|FG001|Overall Study|Study Termination|0|||
105749658|NCT02124707|364736627|FG000|Overall Study|Adverse Event|5|||
105749659|NCT02124707|364736627|FG000|Overall Study|Physician Decision|1|||
105749660|NCT02124707|364736627|FG000|Overall Study|Death|1|||
105749661|NCT00781599|364736628|FG000|Overall Study|Lost to Follow-up|7|||
105749662|NCT00781599|364736629|FG001|Overall Study|Lost to Follow-up|4|||
106142571|NCT02441036|366181907|FG004|Overall Study|No tissue resected|0|||
105749663|NCT00987623|364736630|FG000|Overall Study|Lost to Follow-up|2|||
105749664|NCT00987623|364736631|FG001|Overall Study|Lost to Follow-up|1|||
105749665|NCT00987623|364736630|FG000|Overall Study|Time/job conflict|2|||
105749666|NCT00987623|364736631|FG001|Overall Study|Time/job conflict|0|||
105749667|NCT00987623|364736630|FG000|Overall Study|Discomfort|1|||
105749668|NCT00987623|364736631|FG001|Overall Study|Discomfort|0|||
105749669|NCT00987623|364736630|FG000|Overall Study|Biomicroscopy|0|||
105749670|NCT00987623|364736631|FG001|Overall Study|Biomicroscopy|1|||
105749671|NCT00987623|364736630|FG000|Overall Study|Influenza|0|||
105749672|NCT00987623|364736631|FG001|Overall Study|Influenza|1|||
105749673|NCT02512068|364736632|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
105749674|NCT02512068|364736633|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
105749675|NCT02512068|364736632|FG000|Overall Study|Major Protocol Deviation|1|||
105749676|NCT02512068|364736633|FG001|Overall Study|Major Protocol Deviation|0|||
105749677|NCT02512068|364736632|FG000|Overall Study|Voluntary Withdrawal|0|||
105749678|NCT02512068|364736633|FG001|Overall Study|Voluntary Withdrawal|1|||
105749679|NCT02512068|364736632|FG000|Overall Study|Lack of Efficacy|0|||
105749680|NCT02512068|364736633|FG001|Overall Study|Lack of Efficacy|1|||
105749681|NCT02512068|364736632|FG000|Overall Study|Reason Not Specified|3|||
105749682|NCT02512068|364736633|FG001|Overall Study|Reason Not Specified|5|||
105749683|NCT03471767|364736636|FG000|Overall Study|Withdrawal by Subject|3|||
105749684|NCT03471767|364736637|FG001|Overall Study|Withdrawal by Subject|1|||
105749685|NCT03471767|364736636|FG000|Overall Study|Adverse Event|1|||
105749686|NCT03471767|364736637|FG001|Overall Study|Adverse Event|0|||
105749687|NCT03471767|364736636|FG000|Overall Study|Lost to Follow-up|1|||
105749688|NCT03471767|364736637|FG001|Overall Study|Lost to Follow-up|0|||
105749689|NCT03471767|364736636|FG000|Overall Study|PI Withdrawal|1|||
105749690|NCT03471767|364736637|FG001|Overall Study|PI Withdrawal|3|||
105749691|NCT00678587|364736643|FG000|Overall Study|Adverse Event|3|||
105749692|NCT00678587|364736644|FG001|Overall Study|Adverse Event|3|||
105749693|NCT00678587|364736643|FG000|Overall Study|Lack of Efficacy|1|||
105749694|NCT00678587|364736644|FG001|Overall Study|Lack of Efficacy|0|||
105749695|NCT00678587|364736643|FG000|Overall Study|Protocol Violation|2|||
105749696|NCT00678587|364736644|FG001|Overall Study|Protocol Violation|1|||
105749697|NCT00678587|364736643|FG000|Overall Study|Study Closed/Terminated|1|||
105749698|NCT00678587|364736644|FG001|Overall Study|Study Closed/Terminated|0|||
105749699|NCT00678587|364736643|FG000|Overall Study|Lost to Follow-up|3|||
105749700|NCT00678587|364736644|FG001|Overall Study|Lost to Follow-up|5|||
105749701|NCT00678587|364736643|FG000|Overall Study|Investigator Discretion|2|||
105749702|NCT00678587|364736644|FG001|Overall Study|Investigator Discretion|6|||
105749703|NCT00678587|364736643|FG000|Overall Study|Withdrew Consent|8|||
105749704|NCT00678587|364736644|FG001|Overall Study|Withdrew Consent|3|||
105749705|NCT03806179|364736647|FG000|Overall Study|Progressive disease|0|||
105749706|NCT03806179|364736648|FG001|Overall Study|Progressive disease|2|||
105749707|NCT01151579|364736649|FG000|Overall Study|Physician Decision|3|||
105749708|NCT01151579|364736650|FG001|Overall Study|Physician Decision|1|||
105749709|NCT01151579|364736649|FG000|Overall Study|Withdrawal by Subject|3|||
105749710|NCT01151579|364736650|FG001|Overall Study|Withdrawal by Subject|2|||
105749711|NCT01151579|364736649|FG000|Overall Study|Not meet inclusion criteria|6|||
105749712|NCT01151579|364736650|FG001|Overall Study|Not meet inclusion criteria|4|||
105749713|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
105749714|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
105749715|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Death|2|||
105749716|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Death|1|||
105749717|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
105749718|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
105749719|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
105749720|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
105749721|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
105749722|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
105749723|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
105749724|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
105749725|NCT03633227|364736653|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
105749726|NCT03633227|364736654|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
105749727|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
105749728|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
105749729|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
105749730|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
105749731|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
105749732|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
105749733|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
105749734|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
105749735|NCT03633227|364736653|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
105749736|NCT03633227|364736654|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
105801582|NCT01078623|364930586|FG008|Treatment Period 4|Withdrawal by Subject|0|||
105749737|NCT01606761|364736655|FG000|Prior to Week 24|Lost to Follow-up|0|||
105749738|NCT01606761|364736656|FG001|Prior to Week 24|Lost to Follow-up|3|||
105749739|NCT01606761|364736657|FG002|Prior to Week 24|Lost to Follow-up|2|||
105749740|NCT01606761|364736658|FG003|Prior to Week 24|Lost to Follow-up|0|||
105749741|NCT01606761|364736659|FG004|Prior to Week 24|Lost to Follow-up|0|||
105749742|NCT01606761|364736655|FG000|Prior to Week 24|Withdrawal by Subject|12|||
105749743|NCT01606761|364736656|FG001|Prior to Week 24|Withdrawal by Subject|10|||
105943929|NCT00982280|365456772|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
105943930|NCT00982280|365456772|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
105749744|NCT01606761|364736657|FG002|Prior to Week 24|Withdrawal by Subject|9|||
105749745|NCT01606761|364736658|FG003|Prior to Week 24|Withdrawal by Subject|0|||
105749746|NCT01606761|364736659|FG004|Prior to Week 24|Withdrawal by Subject|0|||
105749747|NCT01606761|364736655|FG000|Prior to Week 24|Adverse Event|11|||
105749748|NCT01606761|364736656|FG001|Prior to Week 24|Adverse Event|18|||
105749749|NCT01606761|364736657|FG002|Prior to Week 24|Adverse Event|22|||
105749750|NCT01606761|364736658|FG003|Prior to Week 24|Adverse Event|0|||
105749751|NCT01606761|364736659|FG004|Prior to Week 24|Adverse Event|0|||
105749752|NCT01606761|364736655|FG000|Prior to Week 24|Lack of Efficacy|15|||
105749753|NCT01606761|364736656|FG001|Prior to Week 24|Lack of Efficacy|14|||
105749754|NCT01606761|364736657|FG002|Prior to Week 24|Lack of Efficacy|8|||
105749755|NCT01606761|364736658|FG003|Prior to Week 24|Lack of Efficacy|0|||
105749756|NCT01606761|364736659|FG004|Prior to Week 24|Lack of Efficacy|0|||
105749757|NCT01606761|364736655|FG000|Prior to Week 24|Physician Decision|0|||
105749758|NCT01606761|364736656|FG001|Prior to Week 24|Physician Decision|3|||
105749759|NCT01606761|364736657|FG002|Prior to Week 24|Physician Decision|1|||
105749760|NCT01606761|364736658|FG003|Prior to Week 24|Physician Decision|0|||
105749761|NCT01606761|364736659|FG004|Prior to Week 24|Physician Decision|0|||
105749762|NCT01606761|364736655|FG000|Prior to Week 24|Other|4|||
105749763|NCT01606761|364736656|FG001|Prior to Week 24|Other|7|||
105749764|NCT01606761|364736657|FG002|Prior to Week 24|Other|5|||
105749765|NCT01606761|364736658|FG003|Prior to Week 24|Other|0|||
105749766|NCT01606761|364736659|FG004|Prior to Week 24|Other|0|||
105749767|NCT01606761|364736655|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
105749768|NCT01606761|364736656|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
105749769|NCT01606761|364736657|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
105749770|NCT01606761|364736658|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
105943931|NCT00982280|365456772|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
105943932|NCT00982280|365456772|FG000|Maintenance Period|Adverse Event|1|||
105943933|NCT01506726|365456773|FG000|Overall Study|Adverse Event|1|||
105943934|NCT01506726|365456774|FG001|Overall Study|Adverse Event|2|||
105943935|NCT03773484|365456775|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
105943936|NCT05852340|365456780|FG000|Period 5|Not completing the meal|0|||
105943937|NCT05852340|365456781|FG001|Period 5|Not completing the meal|1|||
105943938|NCT05852340|365456782|FG002|Period 5|Not completing the meal|0|||
105943939|NCT05852340|365456783|FG003|Period 5|Not completing the meal|0|||
105943940|NCT05852340|365456780|FG000|Period 5|Adverse Event|0|||
105943941|NCT05852340|365456781|FG001|Period 5|Adverse Event|0|||
106015849|NCT01146795|365723314|FG000|Overall Study|Still in treatment at study closure|10|||
106015850|NCT05375760|365723315|FG000|Overall Study|Adverse Event|1|||
106015851|NCT05375760|365723316|FG001|Overall Study|Adverse Event|0|||
106015852|NCT05375760|365723315|FG000|Overall Study|Death|0|||
106015853|NCT05375760|365723316|FG001|Overall Study|Death|1|||
106015854|NCT05375760|365723315|FG000|Overall Study|Lost to Follow-up|6|||
106015855|NCT05375760|365723316|FG001|Overall Study|Lost to Follow-up|6|||
106015856|NCT05375760|365723315|FG000|Overall Study|Withdrawal by Subject|17|||
106015857|NCT05375760|365723316|FG001|Overall Study|Withdrawal by Subject|19|||
106015858|NCT05375760|365723315|FG000|Overall Study|Dosing halted by FDA|96|||
106015859|NCT05375760|365723316|FG001|Overall Study|Dosing halted by FDA|100|||
106015860|NCT05375760|365723315|FG000|Overall Study|Not compliant with study visit|2|||
106015861|NCT05375760|365723316|FG001|Overall Study|Not compliant with study visit|0|||
106015862|NCT05375760|365723315|FG000|Overall Study|Physician Decision|1|||
106015863|NCT05375760|365723316|FG001|Overall Study|Physician Decision|0|||
106015864|NCT05375760|365723315|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
106015865|NCT05375760|365723316|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
106015866|NCT05375760|365723315|FG000|Overall Study|Participant moved|1|||
106015867|NCT05375760|365723316|FG001|Overall Study|Participant moved|0|||
105749771|NCT01606761|364736659|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
105749772|NCT01606761|364736655|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
105749773|NCT01606761|364736656|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
106015868|NCT00363480|365723317|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
106015869|NCT00363480|365723317|FG000|Overall Study|Adverse Event|4|||
105943942|NCT05852340|365456782|FG002|Period 5|Adverse Event|0|||
105943943|NCT05852340|365456783|FG003|Period 5|Adverse Event|1|||
105749774|NCT01606761|364736657|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
105749775|NCT01606761|364736658|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
105749776|NCT01606761|364736659|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
106142572|NCT00723450|366181909|FG000|Open-Label Phase|Adverse Event|26|||
106142573|NCT00723450|366181910|FG001|Open-Label Phase|Adverse Event|0|||
106142574|NCT00723450|366181911|FG002|Open-Label Phase|Adverse Event|0|||
106142575|NCT00723450|366181909|FG000|Open-Label Phase|Lack of Efficacy|18|||
106142576|NCT00723450|366181910|FG001|Open-Label Phase|Lack of Efficacy|0|||
106142577|NCT00723450|366181911|FG002|Open-Label Phase|Lack of Efficacy|0|||
106142578|NCT00723450|366181909|FG000|Open-Label Phase|Protocol Violation|35|||
106142579|NCT00723450|366181910|FG001|Open-Label Phase|Protocol Violation|0|||
106142580|NCT00723450|366181911|FG002|Open-Label Phase|Protocol Violation|0|||
106142581|NCT00723450|366181909|FG000|Open-Label Phase|Lost to Follow-up|7|||
106142582|NCT00723450|366181910|FG001|Open-Label Phase|Lost to Follow-up|0|||
106142583|NCT00723450|366181911|FG002|Open-Label Phase|Lost to Follow-up|0|||
105943944|NCT00071032|365456786|FG000|Overall Study|Lost to Follow-up|1|||
105943945|NCT00071032|365456787|FG001|Overall Study|Lost to Follow-up|1|||
105943946|NCT00071032|365456786|FG000|Overall Study|Withdrawal by Subject|8|||
105943947|NCT00071032|365456787|FG001|Overall Study|Withdrawal by Subject|6|||
106142584|NCT00723450|366181909|FG000|Open-Label Phase|Physician Decision|2|||
106142585|NCT00723450|366181910|FG001|Open-Label Phase|Physician Decision|0|||
106142586|NCT00723450|366181911|FG002|Open-Label Phase|Physician Decision|0|||
106142587|NCT00723450|366181909|FG000|Open-Label Phase|Withdrawal by Subject|37|||
106142588|NCT00723450|366181910|FG001|Open-Label Phase|Withdrawal by Subject|0|||
106142589|NCT00723450|366181911|FG002|Open-Label Phase|Withdrawal by Subject|0|||
106142590|NCT00723450|366181909|FG000|Randomized Phase|Adverse Event|0|||
106142591|NCT00723450|366181910|FG001|Randomized Phase|Adverse Event|26|||
106142592|NCT00723450|366181911|FG002|Randomized Phase|Adverse Event|17|||
106142593|NCT00723450|366181909|FG000|Randomized Phase|Lack of Efficacy|0|||
106142594|NCT00723450|366181910|FG001|Randomized Phase|Lack of Efficacy|11|||
105943948|NCT00071032|365456786|FG000|Overall Study|Missing Primary Outcome|0|||
106142595|NCT00723450|366181911|FG002|Randomized Phase|Lack of Efficacy|11|||
106142596|NCT00723450|366181909|FG000|Randomized Phase|Protocol Violation|0|||
106142597|NCT00723450|366181910|FG001|Randomized Phase|Protocol Violation|9|||
106142598|NCT00723450|366181911|FG002|Randomized Phase|Protocol Violation|13|||
106142599|NCT00723450|366181909|FG000|Randomized Phase|Lost to Follow-up|0|||
106142600|NCT00723450|366181910|FG001|Randomized Phase|Lost to Follow-up|2|||
106142601|NCT00723450|366181911|FG002|Randomized Phase|Lost to Follow-up|3|||
106142602|NCT00723450|366181909|FG000|Randomized Phase|Physician Decision|0|||
106142603|NCT00723450|366181910|FG001|Randomized Phase|Physician Decision|3|||
106142604|NCT00723450|366181911|FG002|Randomized Phase|Physician Decision|1|||
106142605|NCT00723450|366181909|FG000|Randomized Phase|Withdrawal by Subject|0|||
106142606|NCT00723450|366181910|FG001|Randomized Phase|Withdrawal by Subject|14|||
106142607|NCT00723450|366181911|FG002|Randomized Phase|Withdrawal by Subject|22|||
105749777|NCT01606761|364736655|FG000|Week 24 to Week 52|Adverse Event|0|||
105749778|NCT01606761|364736656|FG001|Week 24 to Week 52|Adverse Event|11|||
105943949|NCT00071032|365456787|FG001|Overall Study|Missing Primary Outcome|1|||
105943950|NCT01889251|365456789|FG000|Overall Study|Adverse Event|1|||
105943951|NCT01889251|365456790|FG001|Overall Study|Adverse Event|0|||
106142608|NCT03192046|366181912|FG000|Overall Study|Withdrawal by Subject|1|||
105749779|NCT01606761|364736657|FG002|Week 24 to Week 52|Adverse Event|14|||
105749780|NCT01606761|364736658|FG003|Week 24 to Week 52|Adverse Event|3|||
105749781|NCT01606761|364736659|FG004|Week 24 to Week 52|Adverse Event|15|||
105749782|NCT01606761|364736655|FG000|Week 24 to Week 52|Death|0|||
105749783|NCT01606761|364736656|FG001|Week 24 to Week 52|Death|0|||
105749784|NCT01606761|364736657|FG002|Week 24 to Week 52|Death|2|||
105749785|NCT01606761|364736658|FG003|Week 24 to Week 52|Death|1|||
105749786|NCT01606761|364736659|FG004|Week 24 to Week 52|Death|0|||
105749787|NCT01606761|364736655|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
105749788|NCT01606761|364736656|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
105749789|NCT01606761|364736657|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
105749790|NCT01606761|364736658|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
105749791|NCT01606761|364736659|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
105749792|NCT01606761|364736655|FG000|Week 24 to Week 52|Physician Decision|0|||
106142609|NCT03192046|366181913|FG001|Overall Study|Withdrawal by Subject|1|||
106142610|NCT01909336|366181914|FG000|Overall Study|Lost to Follow-up|4|||
106142611|NCT01909336|366181915|FG001|Overall Study|Lost to Follow-up|2|||
105943952|NCT03781570|365456793|FG000|Overall Study|Technical Issues (equipment failure)|31|||
106142612|NCT01909336|366181916|FG002|Overall Study|Lost to Follow-up|2|||
106142613|NCT01909336|366181914|FG000|Overall Study|Physician Decision|0|||
105943953|NCT03781570|365456793|FG000|Overall Study|Withdrawal by Subject|7|||
106142614|NCT01909336|366181915|FG001|Overall Study|Physician Decision|1|||
106142615|NCT01909336|366181916|FG002|Overall Study|Physician Decision|1|||
106142616|NCT01901276|366181921|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
106142617|NCT01901276|366181922|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
106142618|NCT01596504|366181923|FG000|Overall Study|Participant's Private Reason|0|||
105749793|NCT01606761|364736656|FG001|Week 24 to Week 52|Physician Decision|1|||
105749794|NCT01606761|364736657|FG002|Week 24 to Week 52|Physician Decision|1|||
105749795|NCT01606761|364736658|FG003|Week 24 to Week 52|Physician Decision|0|||
105749796|NCT01606761|364736659|FG004|Week 24 to Week 52|Physician Decision|0|||
105801583|NCT01078623|364930587|FG009|Treatment Period 4|Withdrawal by Subject|0|||
105801584|NCT01078623|364930588|FG010|Treatment Period 4|Withdrawal by Subject|0|||
105801585|NCT01078623|364930589|FG011|Treatment Period 4|Withdrawal by Subject|0|||
105801586|NCT01078623|364930590|FG012|Treatment Period 4|Withdrawal by Subject|0|||
105801587|NCT01078623|364930591|FG013|Treatment Period 4|Withdrawal by Subject|0|||
105801588|NCT01078623|364930592|FG014|Treatment Period 4|Withdrawal by Subject|0|||
105801589|NCT01078623|364930593|FG015|Treatment Period 4|Withdrawal by Subject|1|||
105801590|NCT01078623|364930594|FG016|Treatment Period 4|Withdrawal by Subject|0|||
105801591|NCT01078623|364930595|FG017|Treatment Period 4|Withdrawal by Subject|0|||
105801592|NCT01078623|364930596|FG018|Treatment Period 4|Withdrawal by Subject|0|||
105801593|NCT01078623|364930597|FG019|Treatment Period 4|Withdrawal by Subject|0|||
105801594|NCT01725113|364930598|FG000|Overall Study|Kidney Transplant|1|||
105801595|NCT01725113|364930599|FG001|Overall Study|Kidney Transplant|1|||
105801596|NCT01725113|364930598|FG000|Overall Study|Withdrawal by Subject|0|||
105801597|NCT01725113|364930599|FG001|Overall Study|Withdrawal by Subject|1|||
105801598|NCT02480010|364930601|FG000|Overall Study|Adverse Event|3|||
105801599|NCT02480010|364930602|FG001|Overall Study|Adverse Event|1|||
105943954|NCT03781570|365456793|FG000|Overall Study|Physical Constraints|11|||
105943955|NCT01107496|365456794|FG000|Overall Study|Adverse Event|1|||
105943956|NCT01107496|365456795|FG001|Overall Study|Adverse Event|0|||
105943957|NCT01107496|365456794|FG000|Overall Study|Lack of Efficacy|1|||
105943958|NCT01107496|365456795|FG001|Overall Study|Lack of Efficacy|0|||
105943959|NCT01107496|365456794|FG000|Overall Study|Protocol Violation|0|||
105943960|NCT01107496|365456795|FG001|Overall Study|Protocol Violation|1|||
105943961|NCT01107496|365456794|FG000|Overall Study|Lost to Follow-up|0|||
105943962|NCT01107496|365456795|FG001|Overall Study|Lost to Follow-up|1|||
105943963|NCT02757768|365456801|FG000|Overall Study|Randomized Never Received Study Drug|3|||
105943964|NCT02757768|365456802|FG001|Overall Study|Randomized Never Received Study Drug|4|||
105943965|NCT02757768|365456801|FG000|Overall Study|Adverse Event|5|||
105943966|NCT02757768|365456802|FG001|Overall Study|Adverse Event|3|||
105943967|NCT02757768|365456801|FG000|Overall Study|Lack of Efficacy|2|||
106015870|NCT00363480|365723317|FG000|Overall Study|Lost to Follow-up|5|||
106015871|NCT00363480|365723317|FG000|Overall Study|Withdrawal by Subject|5|||
106015872|NCT00363480|365723317|FG000|Overall Study|Non-compliance of subject|1|||
106015873|NCT00363480|365723317|FG000|Overall Study|Participant discontinued on its own|1|||
106015874|NCT03853109|365723318|FG000|Overall Study|Withdrawal by Subject|0|||
106015875|NCT03853109|365723319|FG001|Overall Study|Withdrawal by Subject|0|||
106015876|NCT03853109|365723320|FG002|Overall Study|Withdrawal by Subject|1|||
106015877|NCT03853109|365723321|FG003|Overall Study|Withdrawal by Subject|2|||
106015878|NCT03853109|365723322|FG004|Overall Study|Withdrawal by Subject|1|||
106015879|NCT03853109|365723323|FG005|Overall Study|Withdrawal by Subject|4|||
106015880|NCT03853109|365723324|FG006|Overall Study|Withdrawal by Subject|5|||
106015881|NCT03853109|365723325|FG007|Overall Study|Withdrawal by Subject|3|||
106015882|NCT03853109|365723318|FG000|Overall Study|Decision by Sponsor|0|||
106015883|NCT03853109|365723319|FG001|Overall Study|Decision by Sponsor|0|||
106015884|NCT03853109|365723320|FG002|Overall Study|Decision by Sponsor|1|||
106015885|NCT03853109|365723321|FG003|Overall Study|Decision by Sponsor|0|||
106015886|NCT03853109|365723322|FG004|Overall Study|Decision by Sponsor|1|||
106015887|NCT03853109|365723323|FG005|Overall Study|Decision by Sponsor|1|||
106015888|NCT03853109|365723324|FG006|Overall Study|Decision by Sponsor|10|||
106015889|NCT03853109|365723325|FG007|Overall Study|Decision by Sponsor|2|||
106015890|NCT03853109|365723318|FG000|Overall Study|Lost to Follow-up|0|||
106015891|NCT03853109|365723319|FG001|Overall Study|Lost to Follow-up|0|||
106015892|NCT03853109|365723320|FG002|Overall Study|Lost to Follow-up|0|||
106015893|NCT03853109|365723321|FG003|Overall Study|Lost to Follow-up|0|||
106015894|NCT03853109|365723322|FG004|Overall Study|Lost to Follow-up|1|||
106015895|NCT03853109|365723323|FG005|Overall Study|Lost to Follow-up|3|||
106015896|NCT03853109|365723324|FG006|Overall Study|Lost to Follow-up|0|||
106015897|NCT03853109|365723325|FG007|Overall Study|Lost to Follow-up|0|||
106015898|NCT03853109|365723318|FG000|Overall Study|Death|2|||
106015899|NCT03853109|365723319|FG001|Overall Study|Death|5|||
106015900|NCT03853109|365723320|FG002|Overall Study|Death|8|||
106015901|NCT03853109|365723321|FG003|Overall Study|Death|10|||
106015902|NCT03853109|365723322|FG004|Overall Study|Death|3|||
105801600|NCT02480010|364930601|FG000|Overall Study|Death|1|||
105943968|NCT02757768|365456802|FG001|Overall Study|Lack of Efficacy|1|||
105943969|NCT02757768|365456801|FG000|Overall Study|Lost to Follow-up|1|||
105943970|NCT02757768|365456802|FG001|Overall Study|Lost to Follow-up|0|||
106015903|NCT03853109|365723323|FG005|Overall Study|Death|20|||
106015904|NCT03853109|365723324|FG006|Overall Study|Death|10|||
106015905|NCT03853109|365723325|FG007|Overall Study|Death|5|||
105801601|NCT02480010|364930602|FG001|Overall Study|Death|0|||
105943971|NCT02757768|365456801|FG000|Overall Study|Protocol Deviation|2|||
105943972|NCT02757768|365456802|FG001|Overall Study|Protocol Deviation|9|||
106015906|NCT02731638|365723326|FG000|Overall Study|Lost to Follow-up|6|||
106015907|NCT02731638|365723327|FG001|Overall Study|Lost to Follow-up|9|||
106015908|NCT00361296|365723328|FG000|Overall Study|Physician Decision|1|||
106015909|NCT00361296|365723328|FG000|Overall Study|Lack of Efficacy|2|||
106015910|NCT01217229|365723329|FG000|Overall Study|Adverse Event|1|||
105749797|NCT01606761|364736655|FG000|Week 24 to Week 52|Other|0|||
105749798|NCT01606761|364736656|FG001|Week 24 to Week 52|Other|1|||
105749799|NCT01606761|364736657|FG002|Week 24 to Week 52|Other|5|||
105749800|NCT01606761|364736658|FG003|Week 24 to Week 52|Other|2|||
105749801|NCT01606761|364736659|FG004|Week 24 to Week 52|Other|2|||
105749802|NCT01606761|364736655|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
105749803|NCT01606761|364736656|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
105749804|NCT01606761|364736657|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
105749805|NCT01606761|364736658|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
105749806|NCT01606761|364736659|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
105749807|NCT01606761|364736655|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
105749808|NCT01606761|364736656|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
105749809|NCT01606761|364736657|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
105749810|NCT01606761|364736658|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
105749811|NCT01606761|364736659|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
105749812|NCT01606761|364736655|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
105749813|NCT01606761|364736656|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
105749814|NCT01606761|364736657|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
105749815|NCT01606761|364736658|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
105749816|NCT01606761|364736659|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
105749817|NCT01606761|364736655|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
105749818|NCT01606761|364736656|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
105749819|NCT01606761|364736657|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
105749820|NCT01606761|364736658|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
105749821|NCT01606761|364736659|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
105749822|NCT02951988|364736675|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
105749823|NCT02951988|364736676|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
105749824|NCT02951988|364736677|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
105749825|NCT02951988|364736678|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
105749826|NCT02951988|364736675|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
105749827|NCT02951988|364736676|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
105749828|NCT02951988|364736677|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
105749829|NCT02951988|364736678|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
105749830|NCT02951988|364736675|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
105749831|NCT02951988|364736676|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
105749832|NCT02951988|364736677|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
105749833|NCT02951988|364736678|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
105749834|NCT02951988|364736675|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
105749835|NCT02951988|364736676|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
105749836|NCT02951988|364736677|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
105749837|NCT02951988|364736678|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
105749838|NCT02951988|364736675|FG000|Open-Label Treatment Period|Protocol Violation|22|||
105749839|NCT02951988|364736676|FG001|Open-Label Treatment Period|Protocol Violation|0|||
105749840|NCT02951988|364736677|FG002|Open-Label Treatment Period|Protocol Violation|0|||
105749841|NCT02951988|364736678|FG003|Open-Label Treatment Period|Protocol Violation|0|||
105749842|NCT02951988|364736675|FG000|Open-Label Treatment Period|Pregnancy|2|||
105749843|NCT02951988|364736676|FG001|Open-Label Treatment Period|Pregnancy|0|||
105749844|NCT02951988|364736677|FG002|Open-Label Treatment Period|Pregnancy|0|||
105749845|NCT02951988|364736678|FG003|Open-Label Treatment Period|Pregnancy|0|||
105749846|NCT02951988|364736675|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
105749847|NCT02951988|364736676|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
105749848|NCT02951988|364736677|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
105749849|NCT02951988|364736678|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
105749850|NCT02951988|364736675|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
105749851|NCT02951988|364736676|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
105749852|NCT02951988|364736677|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
105749853|NCT02951988|364736678|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
105749854|NCT02951988|364736675|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
105749855|NCT02951988|364736676|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
105749856|NCT02951988|364736677|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
105749857|NCT02951988|364736678|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
105801602|NCT02480010|364930601|FG000|Overall Study|Insufficient therapeutic response|31|||
106142619|NCT01596504|366181924|FG001|Overall Study|Participant's Private Reason|1|||
105801603|NCT02480010|364930602|FG001|Overall Study|Insufficient therapeutic response|29|||
106142620|NCT01596504|366181925|FG002|Overall Study|Participant's Private Reason|0|||
106142621|NCT01596504|366181923|FG000|Overall Study|Adverse Event|1|||
106142622|NCT01596504|366181924|FG001|Overall Study|Adverse Event|2|||
106142623|NCT01596504|366181925|FG002|Overall Study|Adverse Event|1|||
106142624|NCT01596504|366181923|FG000|Overall Study|Withdrawal by Subject|1|||
105749858|NCT02951988|364736675|FG000|Open-Label Treatment Period|Adverse Event|45|||
105749859|NCT02951988|364736676|FG001|Open-Label Treatment Period|Adverse Event|0|||
105749860|NCT02951988|364736677|FG002|Open-Label Treatment Period|Adverse Event|0|||
105749861|NCT02951988|364736678|FG003|Open-Label Treatment Period|Adverse Event|0|||
105749862|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
105749863|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
105749864|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
105749865|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
105749866|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
105749867|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
105749868|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
105749869|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
105943973|NCT02757768|365456801|FG000|Overall Study|Withdrawal by Subject|16|||
105943974|NCT02757768|365456802|FG001|Overall Study|Withdrawal by Subject|9|||
105943975|NCT02757768|365456801|FG000|Overall Study|Miscellaneous|4|||
105749870|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
105749871|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
105749872|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
105749873|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
105749874|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105749875|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
105749876|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
105749877|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
105749878|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Pregnancy|0|||
105749879|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Pregnancy|1|||
105749880|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Pregnancy|1|||
105749881|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Pregnancy|0|||
105749882|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105749883|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
105749884|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
105749885|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
105749886|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105749887|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
105749888|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
105749889|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
105749890|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105749891|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Adverse Event|8|||
105749892|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Adverse Event|3|||
105749893|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Adverse Event|6|||
105749894|NCT02951988|364736675|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
105749895|NCT02951988|364736676|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
105749896|NCT02951988|364736677|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
105749897|NCT02951988|364736678|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
105749898|NCT01341652|364736685|FG000|Overall Study|Incorrect Random Assignment|0|||
105749899|NCT01341652|364736686|FG001|Overall Study|Incorrect Random Assignment|1|||
105749900|NCT01341652|364736685|FG000|Overall Study|ineligible; presence metastatic disease|0|||
105749901|NCT01341652|364736686|FG001|Overall Study|ineligible; presence metastatic disease|1|||
105749902|NCT00632463|364736688|FG000|Overall Study|Adverse Event|0|||
105749903|NCT00632463|364736689|FG001|Overall Study|Adverse Event|1|||
105749904|NCT00632463|364736690|FG002|Overall Study|Adverse Event|0|||
105749905|NCT04146467|364736695|FG000|Overall Study|Adverse Event|0|||
105749906|NCT04146467|364736696|FG001|Overall Study|Adverse Event|1|||
105749907|NCT04146467|364736695|FG000|Overall Study|Lost to Follow-up|0|||
105749908|NCT04146467|364736696|FG001|Overall Study|Lost to Follow-up|2|||
105749909|NCT00621855|364736698|FG000|Overall Study|Adverse Event|32|||
105749910|NCT00621855|364736699|FG001|Overall Study|Adverse Event|31|||
105749911|NCT00621855|364736700|FG002|Overall Study|Adverse Event|48|||
105749912|NCT00621855|364736701|FG003|Overall Study|Adverse Event|34|||
105943976|NCT02757768|365456802|FG001|Overall Study|Miscellaneous|2|||
105943977|NCT03514134|365459347|FG000|Overall Study|Lost to Follow-up|0|||
105943978|NCT03514134|365459348|FG001|Overall Study|Lost to Follow-up|1|||
105943979|NCT03768336|365459351|FG000|Overall Study|Lost to Follow-up|3|||
105943980|NCT03768336|365459352|FG001|Overall Study|Lost to Follow-up|2|||
105943981|NCT03768336|365459351|FG000|Overall Study|Became Ineligible|2|||
105943982|NCT03768336|365459352|FG001|Overall Study|Became Ineligible|0|||
105943983|NCT03768336|365459351|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
105943984|NCT03768336|365459352|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
105943985|NCT03768336|365459351|FG000|Overall Study|Missed final survey (post-treatment|0|||
105943986|NCT03768336|365459352|FG001|Overall Study|Missed final survey (post-treatment|1|||
106015911|NCT01217229|365723329|FG000|Overall Study|Disease progression, deterioration|2|||
105943987|NCT03502681|365459355|FG000|Overall Study|Adverse Event|1|||
105749913|NCT00621855|364736702|FG004|Overall Study|Adverse Event|31|||
105749914|NCT00621855|364736698|FG000|Overall Study|Lost to Follow-up|0|||
105749915|NCT00621855|364736699|FG001|Overall Study|Lost to Follow-up|1|||
105749916|NCT00621855|364736700|FG002|Overall Study|Lost to Follow-up|3|||
105943988|NCT03502681|365459356|FG001|Overall Study|Adverse Event|1|||
105943989|NCT03502681|365459355|FG000|Overall Study|Disease Progression|2|||
105943990|NCT03502681|365459356|FG001|Overall Study|Disease Progression|1|||
105943991|NCT01444781|365459357|FG000|Overall Study|Lost to Follow-up|0|||
105943992|NCT01444781|365459358|FG001|Overall Study|Lost to Follow-up|3|||
105943993|NCT01444781|365459359|FG002|Overall Study|Lost to Follow-up|1|||
105943994|NCT01444781|365459357|FG000|Overall Study|Withdrawal by Subject|3|||
105943995|NCT01444781|365459358|FG001|Overall Study|Withdrawal by Subject|1|||
105943996|NCT01444781|365459359|FG002|Overall Study|Withdrawal by Subject|2|||
105943997|NCT06790303|365459370|FG000|Overall Study|Study Terminated by sponsor|4|||
105749917|NCT00621855|364736701|FG003|Overall Study|Lost to Follow-up|4|||
105749918|NCT00621855|364736702|FG004|Overall Study|Lost to Follow-up|1|||
105749919|NCT00621855|364736698|FG000|Overall Study|Protocol Violation|16|||
105749920|NCT00621855|364736699|FG001|Overall Study|Protocol Violation|8|||
105749921|NCT00621855|364736700|FG002|Overall Study|Protocol Violation|6|||
105749922|NCT00621855|364736701|FG003|Overall Study|Protocol Violation|7|||
105749923|NCT00621855|364736702|FG004|Overall Study|Protocol Violation|8|||
105749924|NCT00621855|364736698|FG000|Overall Study|Withdrawal by Subject|16|||
105749925|NCT00621855|364736699|FG001|Overall Study|Withdrawal by Subject|11|||
105749926|NCT00621855|364736700|FG002|Overall Study|Withdrawal by Subject|13|||
105749927|NCT00621855|364736701|FG003|Overall Study|Withdrawal by Subject|13|||
105749928|NCT00621855|364736702|FG004|Overall Study|Withdrawal by Subject|9|||
105749929|NCT00621855|364736698|FG000|Overall Study|Other|9|||
105749930|NCT00621855|364736699|FG001|Overall Study|Other|7|||
105749931|NCT00621855|364736700|FG002|Overall Study|Other|6|||
105749932|NCT00621855|364736701|FG003|Overall Study|Other|5|||
105749933|NCT00621855|364736702|FG004|Overall Study|Other|4|||
105749934|NCT00621855|364736698|FG000|Overall Study|Patients did not receive study drug|3|||
105749935|NCT00621855|364736699|FG001|Overall Study|Patients did not receive study drug|3|||
105749936|NCT00621855|364736700|FG002|Overall Study|Patients did not receive study drug|5|||
105749937|NCT00621855|364736701|FG003|Overall Study|Patients did not receive study drug|4|||
105749938|NCT00621855|364736702|FG004|Overall Study|Patients did not receive study drug|2|||
105749939|NCT03731364|364736703|FG000|Overall Study|Adverse Event|0|||
105749940|NCT03731364|364736704|FG001|Overall Study|Adverse Event|0|||
105749941|NCT03731364|364736705|FG002|Overall Study|Adverse Event|1|||
105749942|NCT03731364|364736706|FG003|Overall Study|Adverse Event|2|||
105749943|NCT03731364|364736707|FG004|Overall Study|Adverse Event|1|||
105749944|NCT02953782|364736708|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
105749945|NCT02953782|364736709|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
105749946|NCT02953782|364736710|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
105749947|NCT02953782|364736711|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
105749948|NCT02953782|364736712|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
105749949|NCT02953782|364736713|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
105749950|NCT02953782|364736714|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
105749951|NCT02953782|364736715|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
105749952|NCT02953782|364736708|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
105749953|NCT02953782|364736709|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749954|NCT02953782|364736710|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
105749955|NCT02953782|364736711|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749956|NCT02953782|364736712|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
105749957|NCT02953782|364736713|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749958|NCT02953782|364736714|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749959|NCT02953782|364736715|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
105749960|NCT02953782|364736708|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105749961|NCT02953782|364736709|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
105749962|NCT02953782|364736710|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105749963|NCT02953782|364736711|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
105749964|NCT02953782|364736712|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
105749965|NCT02953782|364736713|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105749966|NCT02953782|364736714|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
105749967|NCT02953782|364736715|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
106142625|NCT01596504|366181924|FG001|Overall Study|Withdrawal by Subject|0|||
105749968|NCT02953782|364736708|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749969|NCT02953782|364736709|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749970|NCT02953782|364736710|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
105801604|NCT02480010|364930601|FG000|Overall Study|Refused Treatment|0|||
105943998|NCT06790303|365459370|FG000|Overall Study|Death|4|||
105943999|NCT04123704|365459372|FG000|Overall Study|Disease progression|2|||
106142626|NCT01596504|366181925|FG002|Overall Study|Withdrawal by Subject|0|||
106142627|NCT01490580|366181926|FG000|Overall Study|Parents withdrew consent|0|||
106142628|NCT01490580|366181927|FG001|Overall Study|Parents withdrew consent|2|||
106142629|NCT02026258|366181928|FG000|Randomized|Did not start treatment|2|||
106142630|NCT02026258|366181929|FG001|Randomized|Did not start treatment|1|||
106142631|NCT02026258|366181928|FG000|Randomized|Change in treatment plan|1|||
106142632|NCT02026258|366181929|FG001|Randomized|Change in treatment plan|0|||
106142633|NCT02026258|366181928|FG000|Randomized|Presence of periodontal disease|1|||
106142634|NCT02026258|366181929|FG001|Randomized|Presence of periodontal disease|1|||
106142635|NCT02026258|366181928|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
106142636|NCT02026258|366181929|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
106142637|NCT02026258|366181928|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
106142638|NCT02026258|366181929|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
106142639|NCT00878722|366181933|FG000|Overall Study|Progressive disease|3|||
106142640|NCT00878722|366181934|FG001|Overall Study|Progressive disease|3|||
106142641|NCT00878722|366181935|FG002|Overall Study|Progressive disease|3|||
106142642|NCT00878722|366181936|FG003|Overall Study|Progressive disease|7|||
106142643|NCT00878722|366181937|FG004|Overall Study|Progressive disease|7|||
106142644|NCT00878722|366181938|FG005|Overall Study|Progressive disease|1|||
106142645|NCT00878722|366181939|FG006|Overall Study|Progressive disease|4|||
106142646|NCT00878722|366181940|FG007|Overall Study|Progressive disease|3|||
106142647|NCT00878722|366181933|FG000|Overall Study|Death|0|||
106142648|NCT00878722|366181934|FG001|Overall Study|Death|0|||
106142649|NCT00878722|366181935|FG002|Overall Study|Death|0|||
106142650|NCT00878722|366181936|FG003|Overall Study|Death|1|||
106142651|NCT00878722|366181937|FG004|Overall Study|Death|0|||
106142652|NCT00878722|366181938|FG005|Overall Study|Death|1|||
106142653|NCT00878722|366181939|FG006|Overall Study|Death|0|||
106142654|NCT00878722|366181940|FG007|Overall Study|Death|2|||
106142655|NCT00878722|366181933|FG000|Overall Study|Adverse Event|0|||
106142656|NCT00878722|366181934|FG001|Overall Study|Adverse Event|0|||
106142657|NCT00878722|366181935|FG002|Overall Study|Adverse Event|0|||
106142658|NCT00878722|366181936|FG003|Overall Study|Adverse Event|0|||
106142659|NCT00878722|366181937|FG004|Overall Study|Adverse Event|0|||
106142660|NCT00878722|366181938|FG005|Overall Study|Adverse Event|0|||
106142661|NCT00878722|366181939|FG006|Overall Study|Adverse Event|2|||
106142662|NCT00878722|366181940|FG007|Overall Study|Adverse Event|0|||
106142663|NCT00878722|366181933|FG000|Overall Study|Withdrawal by Subject|0|||
106142664|NCT00878722|366181934|FG001|Overall Study|Withdrawal by Subject|0|||
106142665|NCT00878722|366181935|FG002|Overall Study|Withdrawal by Subject|0|||
106142666|NCT00878722|366181936|FG003|Overall Study|Withdrawal by Subject|0|||
106142667|NCT00878722|366181937|FG004|Overall Study|Withdrawal by Subject|0|||
106142668|NCT00878722|366181938|FG005|Overall Study|Withdrawal by Subject|0|||
106142669|NCT00878722|366181939|FG006|Overall Study|Withdrawal by Subject|0|||
106142670|NCT00878722|366181940|FG007|Overall Study|Withdrawal by Subject|2|||
106142671|NCT00878722|366181933|FG000|Overall Study|Relapse|0|||
106142672|NCT00878722|366181934|FG001|Overall Study|Relapse|0|||
106142673|NCT00878722|366181935|FG002|Overall Study|Relapse|0|||
106142674|NCT00878722|366181936|FG003|Overall Study|Relapse|1|||
106142675|NCT00878722|366181937|FG004|Overall Study|Relapse|0|||
106142676|NCT00878722|366181938|FG005|Overall Study|Relapse|0|||
106142677|NCT00878722|366181939|FG006|Overall Study|Relapse|0|||
106142678|NCT00878722|366181940|FG007|Overall Study|Relapse|0|||
106142679|NCT00530842|366181943|FG000|Overall Study|Adverse Event|10|||
106142680|NCT00530842|366181944|FG001|Overall Study|Adverse Event|6|||
106142681|NCT00530842|366181943|FG000|Overall Study|Lack of Efficacy|2|||
106142682|NCT00530842|366181944|FG001|Overall Study|Lack of Efficacy|1|||
106142683|NCT00530842|366181943|FG000|Overall Study|Lost to Follow-up|0|||
106142684|NCT00530842|366181944|FG001|Overall Study|Lost to Follow-up|4|||
106142685|NCT00530842|366181943|FG000|Overall Study|Protocol Violation|3|||
106142686|NCT00530842|366181944|FG001|Overall Study|Protocol Violation|2|||
106142687|NCT00530842|366181943|FG000|Overall Study|Withdrawal by Subject|4|||
106142688|NCT00530842|366181944|FG001|Overall Study|Withdrawal by Subject|5|||
106142689|NCT00530842|366181943|FG000|Overall Study|Individual different reasons|4|||
106142690|NCT00530842|366181944|FG001|Overall Study|Individual different reasons|3|||
106142691|NCT00530842|366181943|FG000|Period 1|Adverse Event|7|||
106142692|NCT00530842|366181944|FG001|Period 1|Adverse Event|3|||
106142693|NCT00530842|366181943|FG000|Period 1|Lack of Efficacy|1|||
106142694|NCT00530842|366181944|FG001|Period 1|Lack of Efficacy|1|||
106142695|NCT00530842|366181943|FG000|Period 1|Protocol Violation|2|||
106142696|NCT00530842|366181944|FG001|Period 1|Protocol Violation|1|||
106142697|NCT00530842|366181943|FG000|Period 1|Withdrawal by Subject|2|||
106142698|NCT00530842|366181944|FG001|Period 1|Withdrawal by Subject|3|||
105749971|NCT02953782|364736711|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
105749972|NCT02953782|364736712|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749973|NCT02953782|364736713|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749974|NCT02953782|364736714|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
106142699|NCT00530842|366181943|FG000|Period 1|Individual different reasons|2|||
105944000|NCT03014089|365459374|FG000|Overall Study|Withdrawal by Subject|0|||
105944001|NCT03014089|365459375|FG001|Overall Study|Withdrawal by Subject|1|||
105944002|NCT03014089|365459376|FG002|Overall Study|Withdrawal by Subject|1|||
105944003|NCT03014089|365459377|FG003|Overall Study|Withdrawal by Subject|1|||
105944004|NCT03014089|365459374|FG000|Overall Study|Lost to Follow-up|1|||
105944005|NCT03014089|365459375|FG001|Overall Study|Lost to Follow-up|0|||
105944006|NCT03014089|365459376|FG002|Overall Study|Lost to Follow-up|0|||
105944007|NCT03014089|365459377|FG003|Overall Study|Lost to Follow-up|0|||
105944008|NCT03014089|365459374|FG000|Overall Study|Adverse Event|1|||
105944009|NCT03014089|365459375|FG001|Overall Study|Adverse Event|0|||
105944010|NCT03014089|365459376|FG002|Overall Study|Adverse Event|1|||
105944011|NCT03014089|365459377|FG003|Overall Study|Adverse Event|0|||
105944012|NCT03468998|365459378|FG000|Overall Study|Withdrawal by Subject|1|||
105944013|NCT03468998|365459379|FG001|Overall Study|Withdrawal by Subject|1|||
105944014|NCT03468998|365459380|FG002|Overall Study|Withdrawal by Subject|0|||
105944015|NCT03468998|365459381|FG003|Overall Study|Withdrawal by Subject|4|||
105944016|NCT03468998|365459382|FG004|Overall Study|Withdrawal by Subject|1|||
105944017|NCT03468998|365459383|FG005|Overall Study|Withdrawal by Subject|0|||
105944018|NCT03257657|365459387|FG000|Overall Study|Lost to Follow-up|0|||
105944019|NCT03257657|365459388|FG001|Overall Study|Lost to Follow-up|3|||
105944020|NCT03257657|365459387|FG000|Overall Study|Withdrawn|0|||
105944021|NCT03257657|365459388|FG001|Overall Study|Withdrawn|1|||
105944022|NCT03257657|365459387|FG000|Overall Study|Noted not eligible right after enrolled|0|||
105944023|NCT03257657|365459388|FG001|Overall Study|Noted not eligible right after enrolled|1|||
105944024|NCT00836706|365459396|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
105944025|NCT00836706|365459397|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
105944026|NCT02989857|365459398|FG000|Randomization Phase|Not Treated|3|||
105944027|NCT02989857|365459399|FG001|Randomization Phase|Not Treated|2|||
105944028|NCT02989857|365459400|FG002|Randomization Phase|Not Treated|0|||
105944029|NCT03122184|365459403|FG000|Overall Study|Lost to Follow-up|4|||
105944030|NCT03122184|365459404|FG001|Overall Study|Lost to Follow-up|6|||
105944031|NCT03122184|365459403|FG000|Overall Study|Withdrawal by Subject|3|||
105944032|NCT03122184|365459404|FG001|Overall Study|Withdrawal by Subject|0|||
105944033|NCT03122184|365459403|FG000|Overall Study|Terminated due to cognitive problem|1|||
105944034|NCT03122184|365459404|FG001|Overall Study|Terminated due to cognitive problem|0|||
105944035|NCT03440411|365459411|FG000|Overall Study|Adverse Event|0|||
105944036|NCT03440411|365459412|FG001|Overall Study|Adverse Event|0|||
105944037|NCT03440411|365459413|FG002|Overall Study|Adverse Event|1|||
105944038|NCT03440411|365459414|FG003|Overall Study|Adverse Event|0|||
105944039|NCT03440411|365459411|FG000|Overall Study|PD|2|||
105944040|NCT03440411|365459412|FG001|Overall Study|PD|1|||
105944041|NCT03440411|365459413|FG002|Overall Study|PD|1|||
106142700|NCT00530842|366181944|FG001|Period 1|Individual different reasons|3|||
106142701|NCT00530842|366181943|FG000|Period 2|Adverse Event|3|||
105944042|NCT03440411|365459414|FG003|Overall Study|PD|1|||
105944043|NCT03440411|365459411|FG000|Overall Study|Withdrawal by Subject|1|||
105944044|NCT03440411|365459412|FG001|Overall Study|Withdrawal by Subject|0|||
105944045|NCT03440411|365459413|FG002|Overall Study|Withdrawal by Subject|0|||
105944046|NCT03440411|365459414|FG003|Overall Study|Withdrawal by Subject|0|||
105944047|NCT03440411|365459411|FG000|Overall Study|Closed study by sponsor|0|||
105944048|NCT03440411|365459412|FG001|Overall Study|Closed study by sponsor|0|||
105944049|NCT03440411|365459413|FG002|Overall Study|Closed study by sponsor|0|||
105944050|NCT03440411|365459414|FG003|Overall Study|Closed study by sponsor|1|||
105944051|NCT00688740|365459415|FG000|Overall Study|Adverse Event|45|||
105944052|NCT00688740|365459416|FG001|Overall Study|Adverse Event|8|||
105944053|NCT00688740|365459415|FG000|Overall Study|Death|2|||
105944054|NCT00688740|365459416|FG001|Overall Study|Death|2|||
105944055|NCT00688740|365459415|FG000|Overall Study|Lost to Follow-up|0|||
105944056|NCT00688740|365459416|FG001|Overall Study|Lost to Follow-up|1|||
105944057|NCT00688740|365459415|FG000|Overall Study|Consent Withdrawn|17|||
105944058|NCT00688740|365459416|FG001|Overall Study|Consent Withdrawn|17|||
105944059|NCT00688740|365459415|FG000|Overall Study|Breast Cancer Relapse|1|||
105944060|NCT00688740|365459416|FG001|Overall Study|Breast Cancer Relapse|4|||
105944061|NCT00688740|365459415|FG000|Overall Study|Violation of Inclusion Criteria|1|||
105944062|NCT00688740|365459416|FG001|Overall Study|Violation of Inclusion Criteria|3|||
105944063|NCT00189423|365459417|FG000|Overall Study|Death|746|||
105944064|NCT00189423|365459418|FG001|Overall Study|Death|747|||
105944065|NCT00189423|365459417|FG000|Overall Study|Withdrawal by Subject|9|||
105944066|NCT00189423|365459418|FG001|Overall Study|Withdrawal by Subject|9|||
105944067|NCT00189423|365459417|FG000|Overall Study|Lost to Follow-up|10|||
105944068|NCT00189423|365459418|FG001|Overall Study|Lost to Follow-up|10|||
105944069|NCT04622592|365459419|FG000|Overall Study|Death|0|||
105944070|NCT04622592|365459420|FG001|Overall Study|Death|0|||
105944071|NCT04622592|365459421|FG002|Overall Study|Death|1|||
105944072|NCT04622592|365459422|FG003|Overall Study|Death|0|||
105944073|NCT04622592|365459423|FG004|Overall Study|Death|0|||
105944074|NCT04622592|365459424|FG005|Overall Study|Death|0|||
105944075|NCT04622592|365459425|FG006|Overall Study|Death|0|||
105944076|NCT04622592|365459426|FG007|Overall Study|Death|1|||
105944077|NCT04622592|365459419|FG000|Overall Study|Lost to Follow-up|0|||
105944078|NCT04622592|365459420|FG001|Overall Study|Lost to Follow-up|0|||
105944079|NCT04622592|365459421|FG002|Overall Study|Lost to Follow-up|0|||
105944080|NCT04622592|365459422|FG003|Overall Study|Lost to Follow-up|3|||
105944081|NCT04622592|365459423|FG004|Overall Study|Lost to Follow-up|1|||
105944082|NCT04622592|365459424|FG005|Overall Study|Lost to Follow-up|0|||
105944083|NCT04622592|365459425|FG006|Overall Study|Lost to Follow-up|2|||
105944084|NCT04622592|365459426|FG007|Overall Study|Lost to Follow-up|2|||
105944085|NCT04622592|365459419|FG000|Overall Study|Physician Decision|0|||
105944086|NCT04622592|365459420|FG001|Overall Study|Physician Decision|0|||
105944087|NCT04622592|365459421|FG002|Overall Study|Physician Decision|0|||
105944088|NCT04622592|365459422|FG003|Overall Study|Physician Decision|0|||
105944089|NCT04622592|365459423|FG004|Overall Study|Physician Decision|1|||
105944090|NCT04622592|365459424|FG005|Overall Study|Physician Decision|0|||
106015912|NCT01217229|365723329|FG000|Overall Study|Disease progression, Cheson criteria|14|||
106015913|NCT01217229|365723329|FG000|Overall Study|Protocol Violation|1|||
106015914|NCT01217229|365723329|FG000|Overall Study|Disease progression not confirmed|2|||
106015915|NCT01094119|365723346|FG000|Overall Study|Lack of Efficacy|2|||
106015916|NCT01094119|365723347|FG001|Overall Study|Lack of Efficacy|4|||
106015917|NCT01523756|365723348|FG000|Baseline Period|Adverse Event|0|||
105749975|NCT02953782|364736715|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
105749976|NCT02953782|364736708|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749977|NCT02953782|364736709|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749978|NCT02953782|364736710|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749979|NCT02953782|364736711|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749980|NCT02953782|364736712|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
105749981|NCT02953782|364736713|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
105749982|NCT02953782|364736714|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
105749983|NCT02953782|364736715|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
105749984|NCT02953782|364736708|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105749985|NCT02953782|364736709|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105749986|NCT02953782|364736710|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105749987|NCT02953782|364736711|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105749988|NCT02953782|364736712|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
105760846|NCT01831804|364778041|FG005|Overall Study|Adverse Event|0|||
105760847|NCT01831804|364778042|FG006|Overall Study|Adverse Event|1|||
105760848|NCT01831804|364778043|FG007|Overall Study|Adverse Event|0|||
105760849|NCT01831804|364778044|FG008|Overall Study|Adverse Event|1|||
105760850|NCT01831804|364778036|FG000|Overall Study|Protocol Violation|0|||
105760851|NCT01831804|364778037|FG001|Overall Study|Protocol Violation|0|||
105760852|NCT01831804|364778038|FG002|Overall Study|Protocol Violation|2|||
105760853|NCT01831804|364778039|FG003|Overall Study|Protocol Violation|0|||
105760854|NCT01831804|364778040|FG004|Overall Study|Protocol Violation|0|||
105760855|NCT01831804|364778041|FG005|Overall Study|Protocol Violation|0|||
105760856|NCT01831804|364778042|FG006|Overall Study|Protocol Violation|0|||
105760857|NCT01831804|364778043|FG007|Overall Study|Protocol Violation|0|||
105760858|NCT01831804|364778044|FG008|Overall Study|Protocol Violation|0|||
105760859|NCT01831804|364778036|FG000|Overall Study|Protocol defined stopping criteria|1|||
105760860|NCT01831804|364778037|FG001|Overall Study|Protocol defined stopping criteria|1|||
105760861|NCT01831804|364778038|FG002|Overall Study|Protocol defined stopping criteria|3|||
105760862|NCT01831804|364778039|FG003|Overall Study|Protocol defined stopping criteria|0|||
105760863|NCT01831804|364778040|FG004|Overall Study|Protocol defined stopping criteria|1|||
105760864|NCT01831804|364778041|FG005|Overall Study|Protocol defined stopping criteria|0|||
105760865|NCT01831804|364778042|FG006|Overall Study|Protocol defined stopping criteria|0|||
105760866|NCT01831804|364778043|FG007|Overall Study|Protocol defined stopping criteria|0|||
105760867|NCT01831804|364778044|FG008|Overall Study|Protocol defined stopping criteria|0|||
105760868|NCT01831804|364778036|FG000|Overall Study|Lost to Follow-up|0|||
105760869|NCT01831804|364778037|FG001|Overall Study|Lost to Follow-up|0|||
105760870|NCT01831804|364778038|FG002|Overall Study|Lost to Follow-up|1|||
105760871|NCT01831804|364778039|FG003|Overall Study|Lost to Follow-up|0|||
105760872|NCT01831804|364778040|FG004|Overall Study|Lost to Follow-up|0|||
105760873|NCT01831804|364778041|FG005|Overall Study|Lost to Follow-up|0|||
105760874|NCT01831804|364778042|FG006|Overall Study|Lost to Follow-up|0|||
105760875|NCT01831804|364778043|FG007|Overall Study|Lost to Follow-up|0|||
105760876|NCT01831804|364778044|FG008|Overall Study|Lost to Follow-up|1|||
105760877|NCT01831804|364778036|FG000|Overall Study|Investigator discretion|0|||
105760878|NCT01831804|364778037|FG001|Overall Study|Investigator discretion|0|||
105760879|NCT01831804|364778038|FG002|Overall Study|Investigator discretion|0|||
105760880|NCT01831804|364778039|FG003|Overall Study|Investigator discretion|0|||
105760881|NCT01831804|364778040|FG004|Overall Study|Investigator discretion|1|||
105760882|NCT01831804|364778041|FG005|Overall Study|Investigator discretion|0|||
105760883|NCT01831804|364778042|FG006|Overall Study|Investigator discretion|0|||
105760884|NCT01831804|364778043|FG007|Overall Study|Investigator discretion|1|||
105760885|NCT01831804|364778044|FG008|Overall Study|Investigator discretion|0|||
105760886|NCT01831804|364778036|FG000|Overall Study|Withdrew Consent|0|||
105944091|NCT04622592|365459425|FG006|Overall Study|Physician Decision|0|||
105944092|NCT04622592|365459426|FG007|Overall Study|Physician Decision|0|||
105944093|NCT04622592|365459419|FG000|Overall Study|Withdrawal by Subject|1|||
105944094|NCT04622592|365459420|FG001|Overall Study|Withdrawal by Subject|0|||
105944095|NCT04622592|365459421|FG002|Overall Study|Withdrawal by Subject|2|||
105944096|NCT04622592|365459422|FG003|Overall Study|Withdrawal by Subject|0|||
105944097|NCT04622592|365459423|FG004|Overall Study|Withdrawal by Subject|0|||
105944098|NCT04622592|365459424|FG005|Overall Study|Withdrawal by Subject|0|||
105944099|NCT04622592|365459425|FG006|Overall Study|Withdrawal by Subject|1|||
105944100|NCT04622592|365459426|FG007|Overall Study|Withdrawal by Subject|4|||
105944101|NCT04622592|365459419|FG000|Overall Study|Other than specified above|0|||
105944102|NCT04622592|365459420|FG001|Overall Study|Other than specified above|0|||
105944103|NCT04622592|365459421|FG002|Overall Study|Other than specified above|1|||
105944104|NCT04622592|365459422|FG003|Overall Study|Other than specified above|0|||
105944105|NCT04622592|365459423|FG004|Overall Study|Other than specified above|0|||
105749989|NCT02953782|364736713|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
105749990|NCT02953782|364736714|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
105749991|NCT02953782|364736715|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
105749992|NCT02953782|364736708|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749993|NCT02953782|364736709|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749994|NCT02953782|364736710|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749995|NCT02953782|364736711|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749996|NCT02953782|364736712|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
105749997|NCT02953782|364736713|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
105749998|NCT02953782|364736714|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
105749999|NCT02953782|364736715|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
105750000|NCT02953782|364736708|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750001|NCT02953782|364736709|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750002|NCT02953782|364736710|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750003|NCT02953782|364736711|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750004|NCT02953782|364736712|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750005|NCT02953782|364736713|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750006|NCT02953782|364736714|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
105750007|NCT02953782|364736715|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
105750008|NCT01934192|364736716|FG000|Overall Study|Protocol Violation|0|||
105750009|NCT01934192|364736717|FG001|Overall Study|Protocol Violation|0|||
105750010|NCT01934192|364736718|FG002|Overall Study|Protocol Violation|0|||
105750011|NCT01934192|364736719|FG003|Overall Study|Protocol Violation|1|||
105750012|NCT01934192|364736716|FG000|Overall Study|Other: reached stopping criteria|6|||
105750013|NCT01934192|364736717|FG001|Overall Study|Other: reached stopping criteria|5|||
105944106|NCT04622592|365459424|FG005|Overall Study|Other than specified above|0|||
105944107|NCT04622592|365459425|FG006|Overall Study|Other than specified above|0|||
105944108|NCT04622592|365459426|FG007|Overall Study|Other than specified above|0|||
106142702|NCT00530842|366181944|FG001|Period 2|Adverse Event|3|||
105750014|NCT01934192|364736718|FG002|Overall Study|Other: reached stopping criteria|1|||
105750015|NCT01934192|364736719|FG003|Overall Study|Other: reached stopping criteria|0|||
105944109|NCT04734210|365459428|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
105944110|NCT04734210|365459429|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
105944111|NCT04734210|365459430|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
105944112|NCT04734210|365459428|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
105944113|NCT04734210|365459429|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
105944114|NCT04734210|365459430|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
105944115|NCT04734210|365459428|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
105944116|NCT04734210|365459429|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
105944117|NCT04734210|365459430|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
105944118|NCT04734210|365459428|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
105944119|NCT04734210|365459429|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
105944120|NCT04734210|365459430|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
105944121|NCT01209767|365459434|FG000|Overall Study|Withdrawal by Subject|1|||
105944122|NCT01209767|365459434|FG000|Overall Study|Lost to Follow-up|3|||
106015918|NCT01523756|365723349|FG001|Baseline Period|Adverse Event|1|||
106015919|NCT01523756|365723348|FG000|Test Period 1|Adverse Event|1|||
106142703|NCT00530842|366181943|FG000|Period 2|Lack of Efficacy|1|||
105944123|NCT03580044|365459435|FG000|Overall Study|Death|2|||
105944124|NCT03580044|365459436|FG001|Overall Study|Death|1|||
105944125|NCT03580044|365459435|FG000|Overall Study|Withdrawal by Subject|1|||
105944126|NCT03580044|365459436|FG001|Overall Study|Withdrawal by Subject|1|||
105944127|NCT01822925|365459437|FG000|Overall Study|Adverse Event|1|||
105944128|NCT01822925|365459438|FG001|Overall Study|Adverse Event|1|||
105944129|NCT01822925|365459439|FG002|Overall Study|Adverse Event|1|||
105944130|NCT01822925|365459440|FG003|Overall Study|Adverse Event|1|||
105944131|NCT01822925|365459437|FG000|Overall Study|Lost to Follow-up|0|||
105944132|NCT01822925|365459438|FG001|Overall Study|Lost to Follow-up|1|||
105944133|NCT01822925|365459439|FG002|Overall Study|Lost to Follow-up|0|||
105944134|NCT01822925|365459440|FG003|Overall Study|Lost to Follow-up|0|||
106142704|NCT00530842|366181944|FG001|Period 2|Lack of Efficacy|0|||
106142705|NCT00530842|366181943|FG000|Period 2|Lost to Follow-up|0|||
106142706|NCT00530842|366181944|FG001|Period 2|Lost to Follow-up|4|||
106142707|NCT00530842|366181943|FG000|Period 2|Protocol Violation|1|||
106142708|NCT00530842|366181944|FG001|Period 2|Protocol Violation|0|||
106142709|NCT00530842|366181943|FG000|Period 2|Withdrawal by Subject|1|||
106142710|NCT00530842|366181944|FG001|Period 2|Withdrawal by Subject|2|||
106142711|NCT00530842|366181943|FG000|Period 2|Individual different reasons|2|||
106142712|NCT00530842|366181944|FG001|Period 2|Individual different reasons|0|||
106142713|NCT04347954|366181945|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
106142714|NCT04347954|366181946|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
106142715|NCT04347954|366181947|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
106142716|NCT04347954|366181945|FG000|Overall Study|Lost to Follow-up|0|||
105750016|NCT01934192|364736716|FG000|Overall Study|Physician Decision|3|||
105750017|NCT01934192|364736717|FG001|Overall Study|Physician Decision|2|||
105750018|NCT01934192|364736718|FG002|Overall Study|Physician Decision|0|||
105750019|NCT01934192|364736719|FG003|Overall Study|Physician Decision|0|||
105750020|NCT02357849|364736720|FG000|Overall Study|Withdrawal by Subject|2|||
105750021|NCT02357849|364736721|FG001|Overall Study|Withdrawal by Subject|3|||
105750022|NCT04105244|364736722|FG000|Overall Study|Withdrawal by Subject|10|||
105750023|NCT04105244|364736723|FG001|Overall Study|Withdrawal by Subject|12|||
105750024|NCT04105244|364736722|FG000|Overall Study|Lost to Follow-up|20|||
105750025|NCT04105244|364736723|FG001|Overall Study|Lost to Follow-up|15|||
105750026|NCT04105244|364736722|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
105750027|NCT04105244|364736723|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
105750028|NCT04105244|364736722|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
105750029|NCT04105244|364736723|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
105750030|NCT02756650|364736724|FG000|Overall Study|Physician Decision|1|||
105750031|NCT02756650|364736724|FG000|Overall Study|Adverse Event|1|||
105750032|NCT04031404|364738710|FG000|Baseline|Lost to Follow-up|0|||
105750033|NCT04031404|364738711|FG001|Baseline|Lost to Follow-up|1|||
105750034|NCT04031404|364738710|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
105750035|NCT04031404|364738711|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
105750036|NCT04031404|364738710|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
105750037|NCT04031404|364738711|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
105750038|NCT04031404|364738710|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
105750039|NCT04031404|364738711|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
105750040|NCT04031404|364738710|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
105750041|NCT04031404|364738711|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
105801605|NCT02480010|364930602|FG001|Overall Study|Refused Treatment|3|||
105944135|NCT01822925|365459437|FG000|Overall Study|Protocol Violation|1|||
105944136|NCT01822925|365459438|FG001|Overall Study|Protocol Violation|0|||
106142717|NCT04347954|366181946|FG001|Overall Study|Lost to Follow-up|1|||
106142718|NCT04347954|366181947|FG002|Overall Study|Lost to Follow-up|0|||
106142719|NCT02534350|366181948|FG000|Overall Study|Randomized But Not Treated|1|||
106142720|NCT02534350|366181949|FG001|Overall Study|Randomized But Not Treated|0|||
106142721|NCT02534350|366181948|FG000|Overall Study|Protocol Violation|1|||
106142722|NCT02534350|366181949|FG001|Overall Study|Protocol Violation|0|||
106142723|NCT02534350|366181948|FG000|Overall Study|Withdrew Consent|2|||
106142724|NCT02534350|366181949|FG001|Overall Study|Withdrew Consent|0|||
106142725|NCT03478696|366181953|FG000|Overall Study|Adverse Event|1|||
106142726|NCT03478696|366181954|FG001|Overall Study|Adverse Event|5|||
106142727|NCT03478696|366181953|FG000|Overall Study|Lost to Follow-up|1|||
106142728|NCT03478696|366181954|FG001|Overall Study|Lost to Follow-up|0|||
106142729|NCT03478696|366181953|FG000|Overall Study|Physician Decision|6|||
105750042|NCT03712345|364738716|FG000|Overall Study|Failure to meet randomization criteria|0|||
105750043|NCT03712345|364738717|FG001|Overall Study|Failure to meet randomization criteria|0|||
105750044|NCT03712345|364738718|FG002|Overall Study|Failure to meet randomization criteria|1|||
105750045|NCT05254613|364738719|FG000|Overall Study|Lost to Follow-up|0|||
105750046|NCT05254613|364738720|FG001|Overall Study|Lost to Follow-up|0|||
105750047|NCT05254613|364738721|FG002|Overall Study|Lost to Follow-up|1|||
105750048|NCT02924688|364738722|FG000|Overall Study|Adverse Event|9|||
105801606|NCT01830920|364930604|FG000|Overall Study|Adverse Event|1|||
105944137|NCT01822925|365459439|FG002|Overall Study|Protocol Violation|0|||
105944138|NCT01822925|365459440|FG003|Overall Study|Protocol Violation|1|||
106142730|NCT03478696|366181954|FG001|Overall Study|Physician Decision|3|||
106142731|NCT03478696|366181953|FG000|Overall Study|Withdrawal by Subject|9|||
105750049|NCT02924688|364738723|FG001|Overall Study|Adverse Event|3|||
105750050|NCT02924688|364738724|FG002|Overall Study|Adverse Event|2|||
105750051|NCT02924688|364738725|FG003|Overall Study|Adverse Event|2|||
105750052|NCT02924688|364738726|FG004|Overall Study|Adverse Event|3|||
105750053|NCT02924688|364738727|FG005|Overall Study|Adverse Event|2|||
105750054|NCT02924688|364738722|FG000|Overall Study|Lack of Efficacy|2|||
105750055|NCT02924688|364738723|FG001|Overall Study|Lack of Efficacy|3|||
105750056|NCT02924688|364738724|FG002|Overall Study|Lack of Efficacy|4|||
105750057|NCT02924688|364738725|FG003|Overall Study|Lack of Efficacy|2|||
105750058|NCT02924688|364738726|FG004|Overall Study|Lack of Efficacy|1|||
105750059|NCT02924688|364738727|FG005|Overall Study|Lack of Efficacy|1|||
105750060|NCT02924688|364738722|FG000|Overall Study|Protocol Violation|3|||
105750061|NCT02924688|364738723|FG001|Overall Study|Protocol Violation|7|||
105750062|NCT02924688|364738724|FG002|Overall Study|Protocol Violation|5|||
105750063|NCT02924688|364738725|FG003|Overall Study|Protocol Violation|6|||
105750064|NCT02924688|364738726|FG004|Overall Study|Protocol Violation|2|||
105750065|NCT02924688|364738727|FG005|Overall Study|Protocol Violation|2|||
105750066|NCT02924688|364738722|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
105750067|NCT02924688|364738723|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
105750068|NCT02924688|364738724|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
105750069|NCT02924688|364738725|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
105750070|NCT02924688|364738726|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
105750071|NCT02924688|364738727|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
105750072|NCT02924688|364738722|FG000|Overall Study|Lost to Follow-up|2|||
105750073|NCT02924688|364738723|FG001|Overall Study|Lost to Follow-up|4|||
105750074|NCT02924688|364738724|FG002|Overall Study|Lost to Follow-up|2|||
105750075|NCT02924688|364738725|FG003|Overall Study|Lost to Follow-up|4|||
105750076|NCT02924688|364738726|FG004|Overall Study|Lost to Follow-up|2|||
105750077|NCT02924688|364738727|FG005|Overall Study|Lost to Follow-up|4|||
105750078|NCT02924688|364738722|FG000|Overall Study|Physician Decision|2|||
105750079|NCT02924688|364738723|FG001|Overall Study|Physician Decision|1|||
105750080|NCT02924688|364738724|FG002|Overall Study|Physician Decision|0|||
105750081|NCT02924688|364738725|FG003|Overall Study|Physician Decision|1|||
105750082|NCT02924688|364738726|FG004|Overall Study|Physician Decision|1|||
105750083|NCT02924688|364738727|FG005|Overall Study|Physician Decision|1|||
105750084|NCT02924688|364738722|FG000|Overall Study|Withdrawal by Subject|14|||
105750085|NCT02924688|364738723|FG001|Overall Study|Withdrawal by Subject|13|||
105750086|NCT02924688|364738724|FG002|Overall Study|Withdrawal by Subject|9|||
105750087|NCT02924688|364738725|FG003|Overall Study|Withdrawal by Subject|12|||
105750088|NCT02924688|364738726|FG004|Overall Study|Withdrawal by Subject|13|||
105750089|NCT02924688|364738727|FG005|Overall Study|Withdrawal by Subject|14|||
105750090|NCT02370498|364738731|FG000|Overall Study|Adverse Event|10|||
105750091|NCT02370498|364738732|FG001|Overall Study|Adverse Event|8|||
105750092|NCT02370498|364738731|FG000|Overall Study|Death|263|||
105750093|NCT02370498|364738732|FG001|Overall Study|Death|265|||
105750094|NCT02370498|364738731|FG000|Overall Study|Protocol Violation|1|||
105750095|NCT02370498|364738732|FG001|Overall Study|Protocol Violation|2|||
105750096|NCT02370498|364738731|FG000|Overall Study|Withdrawal by Subject|7|||
105750097|NCT02370498|364738732|FG001|Overall Study|Withdrawal by Subject|12|||
105750098|NCT02370498|364738731|FG000|Overall Study|Sponsor's decision|15|||
105750099|NCT02370498|364738732|FG001|Overall Study|Sponsor's decision|9|||
105750100|NCT03225716|364738733|FG000|Overall Study|Withdrawal by Subject|2|||
105750101|NCT03225716|364738734|FG001|Overall Study|Withdrawal by Subject|2|||
105801607|NCT01830920|364930605|FG001|Overall Study|Adverse Event|0|||
105944139|NCT01822925|365459437|FG000|Overall Study|Withdrawal by Subject|2|||
105944140|NCT01822925|365459438|FG001|Overall Study|Withdrawal by Subject|0|||
105944141|NCT01822925|365459439|FG002|Overall Study|Withdrawal by Subject|2|||
105944142|NCT01822925|365459440|FG003|Overall Study|Withdrawal by Subject|2|||
105944143|NCT01822925|365459437|FG000|Overall Study|Taking prohibited medication|2|||
105944144|NCT01822925|365459438|FG001|Overall Study|Taking prohibited medication|0|||
105944145|NCT01822925|365459439|FG002|Overall Study|Taking prohibited medication|0|||
105944146|NCT01822925|365459440|FG003|Overall Study|Taking prohibited medication|1|||
105944147|NCT00023595|365459445|FG000|5 Year Follow up|Lost to Follow-up|2|||
105944148|NCT00023595|365459446|FG001|5 Year Follow up|Lost to Follow-up|2|||
105944149|NCT00023595|365459447|FG002|5 Year Follow up|Lost to Follow-up|1|||
105944150|NCT00023595|365459448|FG003|5 Year Follow up|Lost to Follow-up|7|||
105944151|NCT00023595|365459449|FG004|5 Year Follow up|Lost to Follow-up|3|||
105944152|NCT00023595|365459445|FG000|10 Year Follow up|Lost to Follow-up|12|||
105944153|NCT00023595|365459446|FG001|10 Year Follow up|Lost to Follow-up|10|||
105944154|NCT00023595|365459447|FG002|10 Year Follow up|Lost to Follow-up|3|||
105944155|NCT00023595|365459448|FG003|10 Year Follow up|Lost to Follow-up|0|||
105944156|NCT00023595|365459449|FG004|10 Year Follow up|Lost to Follow-up|0|||
105944157|NCT05889468|365459451|FG000|Overall Study|Lost to Follow-up|9|||
105944158|NCT05889468|365459452|FG001|Overall Study|Lost to Follow-up|2|||
105944159|NCT05889468|365459451|FG000|Overall Study|Withdrawal by Subject|2|||
105944160|NCT05889468|365459452|FG001|Overall Study|Withdrawal by Subject|2|||
105944161|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944162|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
105944163|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944164|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
105944165|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
105944166|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
105944167|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
105944168|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944169|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944170|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944171|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944172|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944173|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944174|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944175|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944176|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
105944177|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
105944178|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
105944179|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
105944180|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
105944181|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
105944182|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
105944183|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
105944184|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
105944185|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
105944186|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
105944187|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
105944188|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
105944189|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
105944190|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
106142732|NCT03478696|366181954|FG001|Overall Study|Withdrawal by Subject|4|||
106142733|NCT03299816|366181955|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
106142734|NCT03299816|366181956|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
106142735|NCT03299816|366181955|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
106142736|NCT03299816|366181956|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
105944191|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
106142737|NCT03299816|366181955|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
106142738|NCT03299816|366181956|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
106142739|NCT00367991|366181957|FG000|Overall Study|Withdrawal by Subject|1|||
106142740|NCT00367991|366181958|FG001|Overall Study|Withdrawal by Subject|1|||
106142741|NCT00367991|366181957|FG000|Overall Study|Adverse Event|1|||
106142742|NCT00367991|366181958|FG001|Overall Study|Adverse Event|1|||
106142743|NCT01968226|366181974|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
106142744|NCT01585558|366181975|FG000|Overall Study|Withdrawal by Subject|4|||
106142745|NCT01585558|366181976|FG001|Overall Study|Withdrawal by Subject|5|||
106142746|NCT01585558|366181977|FG002|Overall Study|Withdrawal by Subject|8|||
106142747|NCT01585558|366181975|FG000|Overall Study|Lost to Follow-up|2|||
106142748|NCT01585558|366181976|FG001|Overall Study|Lost to Follow-up|0|||
106142749|NCT01585558|366181977|FG002|Overall Study|Lost to Follow-up|3|||
106142750|NCT01585558|366181975|FG000|Overall Study|Adverse Event|3|||
106142751|NCT01585558|366181976|FG001|Overall Study|Adverse Event|4|||
106142752|NCT01585558|366181977|FG002|Overall Study|Adverse Event|1|||
106142753|NCT01585558|366181975|FG000|Overall Study|Protocol Violation|4|||
106142754|NCT01585558|366181976|FG001|Overall Study|Protocol Violation|3|||
106142755|NCT01585558|366181977|FG002|Overall Study|Protocol Violation|2|||
106142756|NCT01585558|366181975|FG000|Overall Study|Lack of Efficacy|0|||
105944192|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
105944193|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
105944194|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
105944195|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105750102|NCT03225716|364738735|FG002|Overall Study|Withdrawal by Subject|0|||
105750103|NCT03225716|364738733|FG000|Overall Study|Lack of Efficacy|1|||
105750104|NCT03225716|364738734|FG001|Overall Study|Lack of Efficacy|0|||
105750105|NCT03225716|364738735|FG002|Overall Study|Lack of Efficacy|0|||
105944196|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944197|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944198|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944199|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944200|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944201|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
106142757|NCT01585558|366181976|FG001|Overall Study|Lack of Efficacy|0|||
105944202|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944203|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944204|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944205|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944206|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944207|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944208|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
105944209|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
105944210|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
106015920|NCT01523756|365723349|FG001|Test Period 1|Adverse Event|0|||
106015921|NCT01523756|365723348|FG000|Test Period 2|Withdrawal by Subject|0|||
106015922|NCT01523756|365723349|FG001|Test Period 2|Withdrawal by Subject|1|||
106015923|NCT06042855|365723352|FG000|Overall Study|No Receipt of Study Drug|48|||
106015924|NCT06042855|365723353|FG001|Overall Study|No Receipt of Study Drug|57|||
106015925|NCT06042855|365723352|FG000|Overall Study|Administratively Withdrawn|59|||
106015926|NCT06042855|365723353|FG001|Overall Study|Administratively Withdrawn|59|||
105944211|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
105944212|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
105944213|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
105944214|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
105944215|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
105944216|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944217|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944218|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944219|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944220|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944221|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944222|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944223|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944224|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105944225|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944226|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944227|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944228|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
105944229|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944230|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944231|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
105944232|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944233|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944234|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944235|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105750106|NCT03225716|364738733|FG000|Overall Study|Adverse Event|2|||
105750107|NCT03225716|364738734|FG001|Overall Study|Adverse Event|0|||
105750108|NCT03225716|364738735|FG002|Overall Study|Adverse Event|1|||
105750109|NCT03225716|364738733|FG000|Overall Study|Study early termination by Sponsor|0|||
105750110|NCT03225716|364738734|FG001|Overall Study|Study early termination by Sponsor|0|||
105750111|NCT03225716|364738735|FG002|Overall Study|Study early termination by Sponsor|2|||
105750112|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
105750113|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
105750114|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
105750115|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
105750116|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
105750117|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
105750118|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
105750119|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
105750120|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
105750121|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
105750122|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
105944236|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944237|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944238|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944239|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
106015927|NCT02379091|365723354|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105750123|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
105750124|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
105944240|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
105944241|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944242|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944243|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
105944244|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944245|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944246|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944247|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944248|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944249|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944250|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944251|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944252|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944253|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944254|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944255|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944256|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
105944257|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
105944258|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
105944259|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
105944260|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944261|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944262|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944263|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944264|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944265|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944266|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944267|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944268|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944269|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944270|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944271|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944272|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105944273|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
105944274|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
105944275|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
105944276|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
105944277|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
105944278|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
105944279|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
105944280|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
105944281|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
105944282|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
105944283|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
105944284|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
105944285|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
105944286|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
105944287|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
105944288|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
105944289|NCT02958865|365459453|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944290|NCT02958865|365459454|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944291|NCT02958865|365459455|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105750125|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
105750126|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
105750127|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105750128|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105750129|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
105750130|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
105750131|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
105750132|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
105750133|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
105944292|NCT02958865|365459456|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944293|NCT02958865|365459457|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
105944294|NCT02958865|365459458|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944295|NCT02958865|365459459|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944296|NCT02958865|365459460|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
106015928|NCT02379091|365723355|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
106142758|NCT01585558|366181977|FG002|Overall Study|Lack of Efficacy|1|||
105944297|NCT02958865|365459461|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944298|NCT02958865|365459462|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944299|NCT02958865|365459463|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944300|NCT02958865|365459464|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944301|NCT02958865|365459465|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944302|NCT02958865|365459466|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944303|NCT02958865|365459467|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944304|NCT02958865|365459468|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105944305|NCT02958865|365459453|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105944306|NCT02958865|365459454|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105944307|NCT02958865|365459455|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105944308|NCT02958865|365459456|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105944309|NCT02958865|365459457|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105944310|NCT02958865|365459458|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105944311|NCT02958865|365459459|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105944312|NCT02958865|365459460|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105944313|NCT02958865|365459461|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105944314|NCT02958865|365459462|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
105944315|NCT02958865|365459463|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
105944316|NCT02958865|365459464|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105944317|NCT02958865|365459465|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
105944318|NCT02958865|365459466|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105944319|NCT02958865|365459467|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
105944320|NCT02958865|365459468|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
105944321|NCT02958865|365459453|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944322|NCT02958865|365459454|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944323|NCT02958865|365459455|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944324|NCT02958865|365459456|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944325|NCT02958865|365459457|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944326|NCT02958865|365459458|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944327|NCT02958865|365459459|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944328|NCT02958865|365459460|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944329|NCT02958865|365459461|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
105944330|NCT02958865|365459462|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
105944331|NCT02958865|365459463|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944332|NCT02958865|365459464|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
105944333|NCT02958865|365459465|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944334|NCT02958865|365459466|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
105944335|NCT02958865|365459467|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
105944336|NCT02958865|365459468|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
105944337|NCT02958865|365459453|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944338|NCT02958865|365459454|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944339|NCT02958865|365459455|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944340|NCT02958865|365459456|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944341|NCT02958865|365459457|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944342|NCT02958865|365459458|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944343|NCT02958865|365459459|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944344|NCT02958865|365459460|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944345|NCT02958865|365459461|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944346|NCT02958865|365459462|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
105944347|NCT02958865|365459463|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944348|NCT02958865|365459464|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944349|NCT02958865|365459465|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944350|NCT02958865|365459466|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944351|NCT02958865|365459467|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
105944352|NCT02958865|365459468|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
105944353|NCT02958865|365459453|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944354|NCT02958865|365459454|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944355|NCT02958865|365459455|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944356|NCT02958865|365459456|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105750134|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
105750135|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
105750136|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
105750137|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
105750138|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
105750139|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
105750140|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
105801608|NCT01830920|364930606|FG002|Overall Study|Adverse Event|1|||
105801609|NCT01830920|364930607|FG003|Overall Study|Adverse Event|0|||
105801610|NCT01830920|364930608|FG004|Overall Study|Adverse Event|0|||
105944357|NCT02958865|365459457|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944358|NCT02958865|365459458|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944359|NCT02958865|365459459|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944360|NCT02958865|365459460|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944361|NCT02958865|365459461|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944362|NCT02958865|365459462|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944363|NCT02958865|365459463|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
105944364|NCT02958865|365459464|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
105944365|NCT02958865|365459465|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
105944366|NCT02958865|365459466|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
105944367|NCT02958865|365459467|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
105944368|NCT02958865|365459468|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
105944369|NCT02958865|365459453|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
105944370|NCT02958865|365459454|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
105944371|NCT02958865|365459455|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
105944372|NCT02958865|365459456|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
105944373|NCT02958865|365459457|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
105944374|NCT02958865|365459458|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
105944375|NCT02958865|365459459|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
105944376|NCT02958865|365459460|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
105944377|NCT02958865|365459461|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
105944378|NCT02958865|365459462|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
105944379|NCT02958865|365459463|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
105944380|NCT02958865|365459464|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
105944381|NCT02958865|365459465|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
105944382|NCT02958865|365459466|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
105944383|NCT02958865|365459467|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
105944384|NCT02958865|365459468|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
106015929|NCT02379091|365723356|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
106015930|NCT02379091|365723357|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
106015931|NCT02379091|365723354|FG000|Overall Study|Principal Investigator Discretion|0|||
106015932|NCT02379091|365723355|FG001|Overall Study|Principal Investigator Discretion|1|||
106015933|NCT02379091|365723356|FG002|Overall Study|Principal Investigator Discretion|0|||
106015934|NCT02379091|365723357|FG003|Overall Study|Principal Investigator Discretion|0|||
106015935|NCT02379091|365723354|FG000|Overall Study|Lost to Follow-up|0|||
106015936|NCT02379091|365723355|FG001|Overall Study|Lost to Follow-up|0|||
106015937|NCT02379091|365723356|FG002|Overall Study|Lost to Follow-up|0|||
106015938|NCT02379091|365723357|FG003|Overall Study|Lost to Follow-up|1|||
106015939|NCT02379091|365723354|FG000|Overall Study|Voluntary Withdrawal|2|||
106015940|NCT02379091|365723355|FG001|Overall Study|Voluntary Withdrawal|5|||
106015941|NCT02379091|365723356|FG002|Overall Study|Voluntary Withdrawal|2|||
106015942|NCT02379091|365723357|FG003|Overall Study|Voluntary Withdrawal|4|||
106015943|NCT02379091|365723354|FG000|Overall Study|Study Termination|7|||
106015944|NCT02379091|365723355|FG001|Overall Study|Study Termination|2|||
106015945|NCT02379091|365723356|FG002|Overall Study|Study Termination|5|||
106015946|NCT02379091|365723357|FG003|Overall Study|Study Termination|8|||
106015947|NCT02379091|365723354|FG000|Overall Study|Lack of Efficacy|3|||
106015948|NCT02379091|365723355|FG001|Overall Study|Lack of Efficacy|0|||
106015949|NCT02379091|365723356|FG002|Overall Study|Lack of Efficacy|0|||
106015950|NCT02379091|365723357|FG003|Overall Study|Lack of Efficacy|0|||
106015951|NCT01780974|365723358|FG000|Overall Study|Death|1|||
106015952|NCT01780974|365723359|FG001|Overall Study|Death|0|||
106015953|NCT01780974|365723358|FG000|Overall Study|Adverse Event|1|||
106015954|NCT01780974|365723359|FG001|Overall Study|Adverse Event|3|||
106015955|NCT01724346|365723360|FG000|Overall Study|Death|42|||
106015956|NCT01724346|365723361|FG001|Overall Study|Death|42|||
106015957|NCT01724346|365723360|FG000|Overall Study|Lost to Follow-up|5|||
105750141|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
106015958|NCT01724346|365723361|FG001|Overall Study|Lost to Follow-up|1|||
106015959|NCT01724346|365723360|FG000|Overall Study|Withdrawal by Subject|27|||
106015960|NCT01724346|365723361|FG001|Overall Study|Withdrawal by Subject|19|||
106015961|NCT01724346|365723360|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
106015962|NCT01724346|365723361|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
106015963|NCT00525161|365723364|FG000|Overall Study|Adverse Event|1|||
105750142|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
105750143|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105944385|NCT02958865|365459453|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944386|NCT02958865|365459454|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944387|NCT02958865|365459455|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944388|NCT02958865|365459456|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944389|NCT02958865|365459457|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944390|NCT02958865|365459458|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944391|NCT02958865|365459459|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944392|NCT02958865|365459460|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944393|NCT02958865|365459461|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944394|NCT02958865|365459462|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105750144|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750145|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750146|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750147|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
105750148|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
105750149|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
105750150|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
105750151|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
105750152|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
105750153|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
105750154|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
105750155|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
105750156|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
105750157|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
105750158|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
105944395|NCT02958865|365459463|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944396|NCT02958865|365459464|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944397|NCT02958865|365459465|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105750159|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
105750160|NCT03444870|364738736|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
105750161|NCT03444870|364738737|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750162|NCT03444870|364738738|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750163|NCT03444870|364738739|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750164|NCT03444870|364738740|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750165|NCT03444870|364738741|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
105750166|NCT03444870|364738736|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105750167|NCT03444870|364738737|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105750168|NCT03444870|364738738|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105750169|NCT03444870|364738739|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
105750170|NCT03444870|364738740|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
105750171|NCT03444870|364738741|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
105750172|NCT03444870|364738736|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750173|NCT03444870|364738737|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750174|NCT03444870|364738738|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750175|NCT03444870|364738739|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750176|NCT03444870|364738740|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
105750177|NCT03444870|364738741|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
105750178|NCT03444870|364738736|FG000|Open-Label Extension (OLE) Period|Death|0|||
105750179|NCT03444870|364738737|FG001|Open-Label Extension (OLE) Period|Death|0|||
105750180|NCT03444870|364738738|FG002|Open-Label Extension (OLE) Period|Death|0|||
105750181|NCT03444870|364738739|FG003|Open-Label Extension (OLE) Period|Death|0|||
105750182|NCT03444870|364738740|FG004|Open-Label Extension (OLE) Period|Death|1|||
105750183|NCT03444870|364738741|FG005|Open-Label Extension (OLE) Period|Death|0|||
105750184|NCT00501046|364738756|FG000|Overall Study|Adverse Event|21|||
105750185|NCT00501046|364738757|FG001|Overall Study|Adverse Event|25|||
105750186|NCT00501046|364738756|FG000|Overall Study|Death|23|||
105944398|NCT02958865|365459466|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
105944399|NCT02958865|365459467|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105944400|NCT02958865|365459468|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
105750187|NCT00501046|364738757|FG001|Overall Study|Death|30|||
105750188|NCT00501046|364738756|FG000|Overall Study|Lost to Follow-up|14|||
105750189|NCT00501046|364738757|FG001|Overall Study|Lost to Follow-up|13|||
105750190|NCT00501046|364738756|FG000|Overall Study|Physician Decision|7|||
105801611|NCT01830920|364930604|FG000|Overall Study|Withdrawal by Subject|2|||
105750191|NCT00501046|364738757|FG001|Overall Study|Physician Decision|2|||
105750192|NCT00501046|364738756|FG000|Overall Study|Pregnancy|0|||
105944401|NCT02958865|365459453|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944402|NCT02958865|365459454|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944403|NCT02958865|365459455|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944404|NCT02958865|365459456|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944405|NCT02958865|365459457|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944406|NCT02958865|365459458|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944407|NCT02958865|365459459|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944408|NCT02958865|365459460|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944409|NCT02958865|365459461|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944410|NCT02958865|365459462|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944411|NCT02958865|365459463|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944412|NCT02958865|365459464|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944413|NCT02958865|365459465|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944414|NCT02958865|365459466|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
105944415|NCT02958865|365459467|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944416|NCT02958865|365459468|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
105944417|NCT02958865|365459453|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944418|NCT02958865|365459454|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944419|NCT02958865|365459455|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944420|NCT02958865|365459456|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944421|NCT02958865|365459457|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944422|NCT02958865|365459458|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944423|NCT02958865|365459459|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944424|NCT02958865|365459460|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944425|NCT02958865|365459461|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944426|NCT02958865|365459462|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
105944427|NCT02958865|365459463|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944428|NCT02958865|365459464|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944429|NCT02958865|365459465|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944430|NCT02958865|365459466|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105750193|NCT00501046|364738757|FG001|Overall Study|Pregnancy|3|||
105944431|NCT02958865|365459467|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944432|NCT02958865|365459468|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
105944433|NCT01767987|365459471|FG000|Overall Study|Physician Decision|4|||
105944434|NCT01767987|365459472|FG001|Overall Study|Physician Decision|1|||
105944435|NCT01153516|365459473|FG000|Overall Study|Both subjects refused surgery|2|||
105944436|NCT01153516|365459474|FG001|Overall Study|Both subjects refused surgery|0|||
105944437|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
105944438|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105944439|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105944440|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105944441|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105944442|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105944443|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
105944444|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
105944445|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
105944446|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
105944447|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
105944448|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
105944449|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
105944450|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
105944451|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
105944452|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
105944453|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
105944454|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
105944455|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
105944456|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
105944457|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
105944458|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
105944459|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
105944460|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
105944461|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
105944462|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
105944463|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
105944464|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
105944465|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
105944466|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
105944467|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
105944468|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
105944469|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
105944470|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
105944471|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
105944472|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
105944473|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
105944474|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
105944475|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
105944476|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
105944477|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
105944478|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
105944479|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
105944480|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105944481|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105944482|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105944483|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105944484|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105944485|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
105944486|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105750194|NCT00501046|364738756|FG000|Overall Study|Protocol Violation|2|||
105750195|NCT00501046|364738757|FG001|Overall Study|Protocol Violation|1|||
105750196|NCT00501046|364738756|FG000|Overall Study|Withdrawal by Subject|84|||
105750197|NCT00501046|364738757|FG001|Overall Study|Withdrawal by Subject|83|||
105750198|NCT00501046|364738756|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
105750199|NCT00501046|364738757|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
105944487|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
105944488|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105944489|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105944490|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
106015964|NCT01076361|365723365|FG000|Overall Study|22 leads were excluded from analysis|21|||
106015965|NCT03848728|365723366|FG000|Overall Study|Death|16|||
105750200|NCT01397552|364738758|FG000|Overall Study|Adverse Event|1|||
105750201|NCT01397552|364738759|FG001|Overall Study|Adverse Event|0|||
105944491|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105944492|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
105944493|NCT01362790|365459480|FG000|Pilot Phase & Phase 2|Death on study|0|||
105944494|NCT01362790|365459481|FG001|Pilot Phase & Phase 2|Death on study|0|||
105944495|NCT01362790|365459482|FG002|Pilot Phase & Phase 2|Death on study|0|||
105944496|NCT01362790|365459483|FG003|Pilot Phase & Phase 2|Death on study|1|||
105944497|NCT01362790|365459484|FG004|Pilot Phase & Phase 2|Death on study|0|||
105944498|NCT01362790|365459485|FG005|Pilot Phase & Phase 2|Death on study|0|||
105944499|NCT01362790|365459486|FG006|Pilot Phase & Phase 2|Death on study|0|||
105944500|NCT01362790|365459480|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
105944501|NCT01362790|365459481|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
105944502|NCT01362790|365459482|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
105944503|NCT01362790|365459483|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
105944504|NCT01362790|365459484|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
105944505|NCT01362790|365459485|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
105944506|NCT01362790|365459486|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
105944507|NCT01362790|365459480|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105944508|NCT01362790|365459481|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105944509|NCT01362790|365459482|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105944510|NCT01362790|365459483|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105944511|NCT01362790|365459484|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
105944512|NCT01362790|365459485|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105944513|NCT01362790|365459486|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
105944514|NCT01362790|365459480|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
105944515|NCT01362790|365459481|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
105944516|NCT01362790|365459482|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
105944517|NCT01362790|365459483|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
105944518|NCT01362790|365459484|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
105944519|NCT01362790|365459485|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
105944520|NCT01362790|365459486|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
105944521|NCT00049543|365459489|FG000|Overall Study|still on treatment|2|||
105750202|NCT01397552|364738758|FG000|Overall Study|Withdrawal by Subject|2|||
105750203|NCT01397552|364738759|FG001|Overall Study|Withdrawal by Subject|1|||
105750204|NCT00423735|364738760|FG000|Overall Study|Ineligible / No protocol treatment|8|||
105750205|NCT00423735|364738761|FG001|Overall Study|Ineligible / No protocol treatment|6|||
105750206|NCT00423735|364738762|FG002|Overall Study|Ineligible / No protocol treatment|0|||
105944522|NCT00049543|365459490|FG001|Overall Study|still on treatment|9|||
105944523|NCT04507269|365459520|FG000|Overall Study|Withdrawal by Subject|1|||
105944524|NCT04507269|365459521|FG001|Overall Study|Withdrawal by Subject|1|||
105944525|NCT04507269|365459522|FG002|Overall Study|Withdrawal by Subject|0|||
105750207|NCT00992784|364738763|FG000|Overall Study|Adverse Event|2|||
105944526|NCT04507269|365459523|FG003|Overall Study|Withdrawal by Subject|0|||
105944527|NCT04507269|365459524|FG004|Overall Study|Withdrawal by Subject|0|||
105944528|NCT04507269|365459525|FG005|Overall Study|Withdrawal by Subject|0|||
105944529|NCT04507269|365459520|FG000|Overall Study|Lost to Follow-up|0|||
105944530|NCT04507269|365459521|FG001|Overall Study|Lost to Follow-up|0|||
105944531|NCT04507269|365459522|FG002|Overall Study|Lost to Follow-up|0|||
105944532|NCT04507269|365459523|FG003|Overall Study|Lost to Follow-up|0|||
105944533|NCT04507269|365459524|FG004|Overall Study|Lost to Follow-up|1|||
105750208|NCT00992784|364738764|FG001|Overall Study|Adverse Event|1|||
105750209|NCT00992784|364738765|FG002|Overall Study|Adverse Event|0|||
105750210|NCT00992784|364738763|FG000|Overall Study|Withdrawal by Subject|1|||
105750211|NCT00992784|364738764|FG001|Overall Study|Withdrawal by Subject|1|||
105750212|NCT00992784|364738765|FG002|Overall Study|Withdrawal by Subject|1|||
105750213|NCT01088438|364738769|FG000|Overall Study|Withdrawal by Subject|11|||
105750214|NCT01088438|364738770|FG001|Overall Study|Withdrawal by Subject|6|||
105750215|NCT01088438|364738769|FG000|Overall Study|Lost to Follow-up|18|||
105750216|NCT01088438|364738770|FG001|Overall Study|Lost to Follow-up|30|||
105750217|NCT03521687|364738774|FG000|Overall Study|Adverse Event|4|||
105750218|NCT03521687|364738774|FG000|Overall Study|Physician Decision|1|||
105750219|NCT00608530|364738775|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
105750220|NCT00608530|364738776|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
105750221|NCT00608530|364738777|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
105750222|NCT00608530|364738778|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
105750223|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
105944534|NCT04507269|365459525|FG005|Overall Study|Lost to Follow-up|0|||
105944535|NCT05715827|365459535|FG000|Overall Study|Physician Decision|0|||
105750224|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
105944536|NCT05715827|365459536|FG001|Overall Study|Physician Decision|1|||
105944537|NCT05715827|365459535|FG000|Overall Study|console communication error|0|||
105944538|NCT05715827|365459536|FG001|Overall Study|console communication error|1|||
105944539|NCT03663582|365460549|FG000|Overall Study|Physician Decision|1|||
105944540|NCT02390076|365460550|FG000|Overall Study|Lost to Follow-up|2|||
105944541|NCT02390076|365460551|FG001|Overall Study|Lost to Follow-up|1|||
105944542|NCT02390076|365460552|FG002|Overall Study|Lost to Follow-up|4|||
105944543|NCT01905540|365460556|FG000|Period 3|Other|1|||
105944544|NCT01905540|365460557|FG001|Period 3|Other|0|||
105944545|NCT01905540|365460558|FG002|Period 3|Other|1|||
105944546|NCT01905540|365460559|FG003|Period 3|Other|1|||
105944547|NCT02546323|365460560|FG000|Overall Study|Withdrawal by Subject|36|||
105944548|NCT02546323|365460561|FG001|Overall Study|Withdrawal by Subject|33|||
105944549|NCT02546323|365460560|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
105944550|NCT02546323|365460561|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
105944551|NCT02546323|365460560|FG000|Overall Study|Adverse Event|17|||
105944552|NCT02546323|365460561|FG001|Overall Study|Adverse Event|11|||
105944553|NCT02546323|365460560|FG000|Overall Study|Patient Specific Reasons|1|||
105944554|NCT02546323|365460561|FG001|Overall Study|Patient Specific Reasons|2|||
105944555|NCT02546323|365460560|FG000|Overall Study|Lost to Follow-up|2|||
105944556|NCT02546323|365460561|FG001|Overall Study|Lost to Follow-up|3|||
105944557|NCT02546323|365460560|FG000|Overall Study|Non-compliance with Study Drug|2|||
105944558|NCT02546323|365460561|FG001|Overall Study|Non-compliance with Study Drug|2|||
105944559|NCT02546323|365460560|FG000|Overall Study|Met Withdrawal Criteria|2|||
105944560|NCT02546323|365460561|FG001|Overall Study|Met Withdrawal Criteria|14|||
105944561|NCT02090764|365460562|FG000|Overall Study|Adverse Event|1|||
105944562|NCT02090764|365460563|FG001|Overall Study|Adverse Event|3|||
105944563|NCT02090764|365460562|FG000|Overall Study|Lack of Efficacy|0|||
105944564|NCT02090764|365460563|FG001|Overall Study|Lack of Efficacy|13|||
105944565|NCT02090764|365460562|FG000|Overall Study|Withdrawal by Subject|2|||
105944566|NCT02090764|365460563|FG001|Overall Study|Withdrawal by Subject|1|||
105944567|NCT02090764|365460562|FG000|Overall Study|Intercurrent illness and other|1|||
105944568|NCT02090764|365460563|FG001|Overall Study|Intercurrent illness and other|1|||
105944569|NCT02090764|365460562|FG000|Overall Study|Lost to Follow-up|2|||
105944570|NCT02090764|365460563|FG001|Overall Study|Lost to Follow-up|2|||
105944571|NCT03412929|365460564|FG000|Overall Study|Protocol Violation|3|||
105944572|NCT01182350|365460565|FG000|Overall Study|Adverse Event|5|||
105944573|NCT01182350|365460566|FG001|Overall Study|Adverse Event|0|||
105944574|NCT01182350|365460567|FG002|Overall Study|Adverse Event|0|||
105944575|NCT01182350|365460568|FG003|Overall Study|Adverse Event|0|||
105944576|NCT01182350|365460569|FG004|Overall Study|Adverse Event|0|||
105944577|NCT01182350|365460565|FG000|Overall Study|Disease Progression|15|||
105944578|NCT01182350|365460566|FG001|Overall Study|Disease Progression|12|||
105944579|NCT01182350|365460567|FG002|Overall Study|Disease Progression|0|||
105944580|NCT01182350|365460568|FG003|Overall Study|Disease Progression|1|||
105944581|NCT01182350|365460569|FG004|Overall Study|Disease Progression|0|||
105944582|NCT01182350|365460565|FG000|Overall Study|Death|0|||
105944583|NCT01182350|365460566|FG001|Overall Study|Death|1|||
105944584|NCT01182350|365460567|FG002|Overall Study|Death|1|||
105944585|NCT01182350|365460568|FG003|Overall Study|Death|0|||
105944586|NCT01182350|365460569|FG004|Overall Study|Death|0|||
105944587|NCT01182350|365460565|FG000|Overall Study|Withdrawal by Subject|3|||
105944588|NCT01182350|365460566|FG001|Overall Study|Withdrawal by Subject|1|||
105944589|NCT01182350|365460567|FG002|Overall Study|Withdrawal by Subject|0|||
105944590|NCT01182350|365460568|FG003|Overall Study|Withdrawal by Subject|1|||
105944591|NCT01182350|365460569|FG004|Overall Study|Withdrawal by Subject|0|||
105944592|NCT01182350|365460565|FG000|Overall Study|Alternative Therapy|2|||
105944593|NCT01182350|365460566|FG001|Overall Study|Alternative Therapy|0|||
105944594|NCT01182350|365460567|FG002|Overall Study|Alternative Therapy|1|||
105944595|NCT01182350|365460568|FG003|Overall Study|Alternative Therapy|0|||
105944596|NCT01182350|365460569|FG004|Overall Study|Alternative Therapy|0|||
105944597|NCT01182350|365460565|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
105944598|NCT01182350|365460566|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
105944599|NCT01182350|365460567|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
105944600|NCT01182350|365460568|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
105944601|NCT01182350|365460569|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
105944602|NCT01182350|365460565|FG000|Overall Study|Unevaluable for Biopsy|0|||
105944603|NCT01182350|365460566|FG001|Overall Study|Unevaluable for Biopsy|0|||
105944604|NCT01182350|365460567|FG002|Overall Study|Unevaluable for Biopsy|0|||
105944605|NCT01182350|365460568|FG003|Overall Study|Unevaluable for Biopsy|0|||
105944606|NCT01182350|365460569|FG004|Overall Study|Unevaluable for Biopsy|3|||
105944607|NCT03232567|365460570|FG000|Overall Study|Withdrawal by Subject|0|||
105944608|NCT03232567|365460571|FG001|Overall Study|Withdrawal by Subject|1|||
105944609|NCT03232567|365460572|FG002|Overall Study|Withdrawal by Subject|0|||
105944610|NCT03232567|365460573|FG003|Overall Study|Withdrawal by Subject|0|||
105944611|NCT02457065|365460578|FG000|Overall Study|Lost to Follow-up|9|||
105944612|NCT02457065|365460579|FG001|Overall Study|Lost to Follow-up|11|||
105944613|NCT03038087|365460580|FG000|Overall Study|lost data|1|||
105944614|NCT01605097|365460582|FG000|Overall Study|Protocol Violation|1|||
105944615|NCT01728246|365460583|FG000|Overall Study|Participant needed rescue medication|1|||
105944616|NCT01728246|365460584|FG001|Overall Study|Participant needed rescue medication|5|||
105944617|NCT01728246|365460583|FG000|Overall Study|Protocol Violation|1|||
105944618|NCT01728246|365460584|FG001|Overall Study|Protocol Violation|0|||
106015966|NCT03848728|365723367|FG001|Overall Study|Death|13|||
105944619|NCT01728246|365460583|FG000|Overall Study|Withdrawal by Subject|2|||
105944620|NCT01728246|365460584|FG001|Overall Study|Withdrawal by Subject|3|||
105944621|NCT01728246|365460583|FG000|Overall Study|Lost to Follow-up|23|||
105944622|NCT01728246|365460584|FG001|Overall Study|Lost to Follow-up|22|||
105944623|NCT01728246|365460583|FG000|Overall Study|Lack of Efficacy|1|||
105944624|NCT01728246|365460584|FG001|Overall Study|Lack of Efficacy|1|||
105944625|NCT01728246|365460583|FG000|Overall Study|Adverse Event|8|||
105944626|NCT01728246|365460584|FG001|Overall Study|Adverse Event|5|||
105944627|NCT01038323|365460585|FG000|Overall Study|Withdrawal by Subject|3|||
105944628|NCT01038323|365460586|FG001|Overall Study|Withdrawal by Subject|2|||
105944629|NCT01038323|365460587|FG002|Overall Study|Withdrawal by Subject|4|||
105944630|NCT04380142|365460593|FG000|LD/CD Stabilization Period|Adverse Event|3|||
105944631|NCT04380142|365460594|FG001|LD/CD Stabilization Period|Adverse Event|0|||
105750225|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
105750226|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
105750227|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
105750228|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
105750229|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
105750230|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
105750231|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
105944632|NCT04380142|365460595|FG002|LD/CD Stabilization Period|Adverse Event|0|||
105944633|NCT04380142|365460593|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
105944634|NCT04380142|365460594|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
105944635|NCT04380142|365460595|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
105944636|NCT04380142|365460593|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
105944637|NCT04380142|365460594|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
105944638|NCT04380142|365460595|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
105944639|NCT04380142|365460593|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
105944640|NCT04380142|365460594|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
105944641|NCT04380142|365460595|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
105944642|NCT04380142|365460593|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
105944643|NCT04380142|365460594|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
105944644|NCT04380142|365460595|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
105944645|NCT04380142|365460593|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
105944646|NCT04380142|365460594|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
105944647|NCT04380142|365460595|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
105944648|NCT04380142|365460593|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105944649|NCT04380142|365460594|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105944650|NCT04380142|365460595|FG002|Double-Blind Treatment Period|Adverse Event|14|||
105944651|NCT04380142|365460593|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
105944652|NCT04380142|365460594|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
105944653|NCT04380142|365460595|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
105944654|NCT04380142|365460593|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
105944655|NCT04380142|365460594|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
105944656|NCT04380142|365460595|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
105944657|NCT04380142|365460593|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
105944658|NCT04380142|365460594|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
105944659|NCT04380142|365460595|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
105944660|NCT04380142|365460593|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
105944661|NCT04380142|365460594|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
105944662|NCT04380142|365460595|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
105944663|NCT04380142|365460593|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
105944664|NCT04380142|365460594|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
105944665|NCT04380142|365460595|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
105944666|NCT00787150|365460607|FG000|Overall Study|Adverse Event|4|||
105944667|NCT00787150|365460608|FG001|Overall Study|Adverse Event|4|||
105944668|NCT00787150|365460609|FG002|Overall Study|Adverse Event|4|||
105944669|NCT00787150|365460607|FG000|Overall Study|Physician Decision|1|||
105944670|NCT00787150|365460608|FG001|Overall Study|Physician Decision|2|||
105944671|NCT00787150|365460609|FG002|Overall Study|Physician Decision|1|||
105944672|NCT00787150|365460607|FG000|Overall Study|Withdrawal by Subject|2|||
105944673|NCT00787150|365460608|FG001|Overall Study|Withdrawal by Subject|1|||
105944674|NCT00787150|365460609|FG002|Overall Study|Withdrawal by Subject|0|||
105944675|NCT00787150|365460607|FG000|Overall Study|Dosing incorrect study durg|2|||
105944676|NCT00787150|365460608|FG001|Overall Study|Dosing incorrect study durg|0|||
105944677|NCT00787150|365460609|FG002|Overall Study|Dosing incorrect study durg|0|||
105944678|NCT00526799|365460611|FG000|Overall Study|Withdrawal by Subject|1|||
105944679|NCT00526799|365460612|FG001|Overall Study|Withdrawal by Subject|0|||
105944680|NCT00526799|365460611|FG000|Overall Study|Intercurrent Complicating Disease|0|||
105944681|NCT00526799|365460612|FG001|Overall Study|Intercurrent Complicating Disease|1|||
105944682|NCT04347538|365460613|FG000|Overall Study|Lost to Follow-up|4|||
105944683|NCT04347538|365460614|FG001|Overall Study|Lost to Follow-up|5|||
105944684|NCT04347538|365460615|FG002|Overall Study|Lost to Follow-up|7|||
105944685|NCT02259231|365460616|FG000|Overall Study|Adverse Event|1|||
105944686|NCT02259231|365460617|FG001|Overall Study|Adverse Event|1|||
105944687|NCT02259231|365460618|FG002|Overall Study|Adverse Event|2|||
105944688|NCT02259231|365460619|FG003|Overall Study|Adverse Event|0|||
105944689|NCT02259231|365460620|FG004|Overall Study|Adverse Event|0|||
105944690|NCT02259231|365460621|FG005|Overall Study|Adverse Event|0|||
105944691|NCT02259231|365460622|FG006|Overall Study|Adverse Event|0|||
105944692|NCT02259231|365460616|FG000|Overall Study|Progressive Disease|4|||
105944693|NCT02259231|365460617|FG001|Overall Study|Progressive Disease|5|||
105944694|NCT02259231|365460618|FG002|Overall Study|Progressive Disease|4|||
105944695|NCT02259231|365460619|FG003|Overall Study|Progressive Disease|5|||
105944696|NCT02259231|365460620|FG004|Overall Study|Progressive Disease|4|||
105944697|NCT02259231|365460621|FG005|Overall Study|Progressive Disease|5|||
105944698|NCT02259231|365460622|FG006|Overall Study|Progressive Disease|4|||
105944699|NCT02259231|365460616|FG000|Overall Study|Sponsor termination of study|1|||
105944700|NCT02259231|365460617|FG001|Overall Study|Sponsor termination of study|0|||
105944701|NCT02259231|365460618|FG002|Overall Study|Sponsor termination of study|0|||
105944702|NCT02259231|365460619|FG003|Overall Study|Sponsor termination of study|1|||
105944703|NCT02259231|365460620|FG004|Overall Study|Sponsor termination of study|2|||
105944704|NCT02259231|365460621|FG005|Overall Study|Sponsor termination of study|1|||
105944705|NCT02259231|365460622|FG006|Overall Study|Sponsor termination of study|1|||
105944706|NCT05535972|365460635|FG000|Overall Study|Withdrawal by Subject|31|||
105944707|NCT05535972|365460635|FG000|Overall Study|Lost to Follow-up|5|||
105944708|NCT05535972|365460635|FG000|Overall Study|Adverse Event|6|||
105944709|NCT05535972|365460635|FG000|Overall Study|Protocol Deviation|2|||
105944710|NCT00432965|365460636|FG000|Overall Study|Lost to Follow-up|22|||
105944711|NCT00432965|365460637|FG001|Overall Study|Lost to Follow-up|19|||
105944712|NCT00432965|365460636|FG000|Overall Study|Withdrawal by Subject|13|||
105944713|NCT00432965|365460637|FG001|Overall Study|Withdrawal by Subject|13|||
105944714|NCT00432965|365460636|FG000|Overall Study|Physician Decision|14|||
105944715|NCT00432965|365460637|FG001|Overall Study|Physician Decision|13|||
105944716|NCT00432965|365460636|FG000|Overall Study|Lack of Efficacy|8|||
105944717|NCT00432965|365460637|FG001|Overall Study|Lack of Efficacy|13|||
105944718|NCT00432965|365460636|FG000|Overall Study|Non-compliance|7|||
105944719|NCT00432965|365460637|FG001|Overall Study|Non-compliance|0|||
105944720|NCT00432965|365460636|FG000|Overall Study|Adverse Event|22|||
105944721|NCT00432965|365460637|FG001|Overall Study|Adverse Event|19|||
105944722|NCT00432965|365460636|FG000|Overall Study|Death|3|||
105944723|NCT00432965|365460637|FG001|Overall Study|Death|4|||
105944724|NCT00432965|365460636|FG000|Overall Study|Exclusionary Methods|1|||
105944725|NCT00432965|365460637|FG001|Overall Study|Exclusionary Methods|2|||
105944726|NCT00432965|365460636|FG000|Overall Study|Incomplete Data|4|||
105944727|NCT00432965|365460637|FG001|Overall Study|Incomplete Data|3|||
105944728|NCT06071104|365460638|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
105944729|NCT03518060|365460639|FG000|Overall Study|Death|1|||
105944730|NCT03518060|365460639|FG000|Overall Study|Poor adherence|1|||
105944731|NCT03518060|365460639|FG000|Overall Study|Withdrawal of informed consent|2|||
105944732|NCT03518060|365460639|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
105944733|NCT03518060|365460639|FG000|Overall Study|Physician Decision|7|||
105944734|NCT03518060|365460639|FG000|Overall Study|Adverse drug reactions|23|||
105944735|NCT03518060|365460639|FG000|Overall Study|Withdrawal by Subject|25|||
105944736|NCT03518060|365460639|FG000|Overall Study|Lost to Follow-up|13|||
105944737|NCT01344226|365460643|FG000|Overall Study|Protocol Violation|2|||
105944738|NCT01344226|365460643|FG000|Overall Study|Withdrawal by Subject|3|||
105944739|NCT01344226|365460643|FG000|Overall Study|Lack of Efficacy|3|||
105944740|NCT03636022|365460648|FG000|Overall Study|Withdrawal by Subject|1|||
105944741|NCT03636022|365460649|FG001|Overall Study|Withdrawal by Subject|3|||
105944742|NCT01969058|365460650|FG000|Overall Study|Withdrawal by Subject|2|||
105944743|NCT01969058|365460651|FG001|Overall Study|Withdrawal by Subject|0|||
105944744|NCT01969058|365460650|FG000|Overall Study|Adverse Event|1|||
105944745|NCT01969058|365460651|FG001|Overall Study|Adverse Event|0|||
105944746|NCT03012880|365460652|FG000|Overall Study|Withdrawal by Subject|1|||
105944747|NCT03012880|365460653|FG001|Overall Study|Withdrawal by Subject|0|||
105944748|NCT03012880|365460652|FG000|Overall Study|Ineligible|1|||
105944749|NCT03012880|365460653|FG001|Overall Study|Ineligible|0|||
105944750|NCT01587196|365460654|FG000|Overall Study|Lost to Follow-up|50|||
105944751|NCT01587196|365460654|FG000|Overall Study|Withdrawal by Subject|4|||
105944752|NCT01355627|365460655|FG000|Overall Study|Request By the Patient to Discontinue|5|||
105944753|NCT01355627|365460656|FG001|Overall Study|Request By the Patient to Discontinue|7|||
105944754|NCT01355627|365460655|FG000|Overall Study|Lost to Follow-up|8|||
105944755|NCT01355627|365460656|FG001|Overall Study|Lost to Follow-up|7|||
105944756|NCT01355627|365460655|FG000|Overall Study|Fatal Adverse Event|19|||
105944757|NCT01355627|365460656|FG001|Overall Study|Fatal Adverse Event|23|||
105944758|NCT01355627|365460655|FG000|Overall Study|Other|1|||
105944759|NCT01355627|365460656|FG001|Overall Study|Other|1|||
105944760|NCT02022202|365460657|FG000|Overall Study|Withdrawal by Subject|2|||
105944761|NCT02022202|365460657|FG000|Overall Study|Disease Progression|3|||
105944762|NCT02022202|365460657|FG000|Overall Study|Desire go to immediately to surgery|3|||
105944763|NCT02038036|365460660|FG000|Core Study|Adverse Event|7|||
105944764|NCT02038036|365460661|FG001|Core Study|Adverse Event|7|||
105944765|NCT02038036|365460660|FG000|Core Study|Death|1|||
105944766|NCT02038036|365460661|FG001|Core Study|Death|1|||
105944767|NCT02038036|365460660|FG000|Core Study|Disease progression|2|||
106015967|NCT03848728|365723366|FG000|Overall Study|Outmigrated to non-study community|98|||
106015968|NCT03848728|365723367|FG001|Overall Study|Outmigrated to non-study community|106|||
106015969|NCT03848728|365723366|FG000|Overall Study|Transfered to non-study clinic|32|||
106015970|NCT03848728|365723367|FG001|Overall Study|Transfered to non-study clinic|48|||
106015971|NCT03848728|365723366|FG000|Overall Study|Withdrawal by Subject|1|||
106015972|NCT03848728|365723367|FG001|Overall Study|Withdrawal by Subject|0|||
106015973|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
106015974|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
106015975|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|Death|1|||
106015976|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|Death|1|||
106015977|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
106015978|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
106015979|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
106015980|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
106015981|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
106015982|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
106015983|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
106015984|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
106015985|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
106015986|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
106015987|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
106015988|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
106015989|NCT03728881|365723368|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
106015990|NCT03728881|365723369|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
106015991|NCT03728881|365723368|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
106015992|NCT03728881|365723369|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
106015993|NCT03728881|365723368|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
106015994|NCT03728881|365723369|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
106015995|NCT00787644|365723372|FG000|Overall Study|Lost to Follow-up|1|||
106015996|NCT00787644|365723373|FG001|Overall Study|Lost to Follow-up|1|||
105944768|NCT02038036|365460661|FG001|Core Study|Disease progression|2|||
105750232|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
105750233|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
105750234|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
105750235|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
105750236|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
105750237|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
105750238|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
105750239|NCT00608530|364738775|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
105750240|NCT00608530|364738776|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
105944769|NCT02038036|365460660|FG000|Core Study|Lost to Follow-up|0|||
105944770|NCT02038036|365460661|FG001|Core Study|Lost to Follow-up|1|||
105944771|NCT02038036|365460660|FG000|Core Study|Physician Decision|2|||
105944772|NCT02038036|365460661|FG001|Core Study|Physician Decision|1|||
105944773|NCT02038036|365460660|FG000|Core Study|Subject/guardian decision|0|||
105944774|NCT02038036|365460661|FG001|Core Study|Subject/guardian decision|1|||
105944775|NCT02038036|365460660|FG000|Core Study|Withdrawal by Subject|3|||
105750241|NCT00608530|364738777|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
105750242|NCT00608530|364738778|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
105750243|NCT01952730|364738779|FG000|Overall Study|FDA shut down core lab used by study|1|||
105750244|NCT01357915|364738783|FG000|Overall Study|Lost to Follow-up|3|||
105750245|NCT01357915|364738784|FG001|Overall Study|Lost to Follow-up|0|||
105750246|NCT00973921|364738789|FG000|Overall Study|IVUS results were not available|9|||
105750247|NCT05086289|364738790|FG000|Overall Study|Adverse Event|4|||
105750248|NCT05086289|364738791|FG001|Overall Study|Adverse Event|2|||
105944776|NCT02038036|365460661|FG001|Core Study|Withdrawal by Subject|1|||
105944777|NCT02038036|365460660|FG000|Crossover Period|Withdrawal by Subject|0|||
105944778|NCT02038036|365460661|FG001|Crossover Period|Withdrawal by Subject|3|||
105944779|NCT02038036|365460660|FG000|Crossover Period|Adverse Event|0|||
105944780|NCT02038036|365460661|FG001|Crossover Period|Adverse Event|9|||
105944781|NCT02038036|365460660|FG000|Crossover Period|Death|0|||
105944782|NCT02038036|365460661|FG001|Crossover Period|Death|2|||
105944783|NCT02038036|365460660|FG000|Crossover Period|Disease progression|0|||
105944784|NCT02038036|365460661|FG001|Crossover Period|Disease progression|3|||
105944785|NCT02038036|365460660|FG000|Crossover Period|Lost to Follow-up|0|||
105944786|NCT02038036|365460661|FG001|Crossover Period|Lost to Follow-up|1|||
105944787|NCT02038036|365460660|FG000|Crossover Period|Physician Decision|0|||
105944788|NCT02038036|365460661|FG001|Crossover Period|Physician Decision|2|||
105944789|NCT03814044|365460666|FG000|Overall Study|Protocol deviation|1|||
105944790|NCT03423979|365460667|FG000|Overall Study|Death|1|||
105944791|NCT01992757|365462699|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
105944792|NCT00633126|365462700|FG000|Overall Study|Did not receive full dose|1|||
105944793|NCT01432444|365462706|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
105944794|NCT01432444|365462707|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
105944795|NCT01432444|365462708|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
105944796|NCT01432444|365462706|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
105944797|NCT01432444|365462707|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
105944798|NCT01432444|365462708|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
105944799|NCT01432444|365462706|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
105944800|NCT01432444|365462707|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
105944801|NCT01432444|365462708|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
105944802|NCT01432444|365462706|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
105944803|NCT01432444|365462707|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
105944804|NCT01432444|365462708|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
105944805|NCT01432444|365462706|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
105944806|NCT01432444|365462707|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
105944807|NCT01432444|365462708|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
105944808|NCT01432444|365462706|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
105944809|NCT01432444|365462707|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
105944810|NCT01432444|365462708|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
105944811|NCT01432444|365462706|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
105944812|NCT01432444|365462707|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
105944813|NCT01432444|365462708|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
105944814|NCT01432444|365462706|FG000|Treatment Phase|Lost to Follow-up|0|||
105944815|NCT01432444|365462707|FG001|Treatment Phase|Lost to Follow-up|33|||
105944816|NCT01432444|365462708|FG002|Treatment Phase|Lost to Follow-up|0|||
105944817|NCT01432444|365462706|FG000|Treatment Phase|Adverse Event|0|||
105944818|NCT01432444|365462707|FG001|Treatment Phase|Adverse Event|37|||
105944819|NCT01432444|365462708|FG002|Treatment Phase|Adverse Event|0|||
105944820|NCT01432444|365462706|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
105944821|NCT01432444|365462707|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
105944822|NCT01432444|365462708|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
105944823|NCT01432444|365462706|FG000|Treatment Phase|Physician Decision|0|||
105944824|NCT01432444|365462707|FG001|Treatment Phase|Physician Decision|5|||
105944825|NCT01432444|365462708|FG002|Treatment Phase|Physician Decision|0|||
105944826|NCT01432444|365462706|FG000|Treatment Phase|Withdrawal by Subject|0|||
105944827|NCT01432444|365462707|FG001|Treatment Phase|Withdrawal by Subject|41|||
105944828|NCT01432444|365462708|FG002|Treatment Phase|Withdrawal by Subject|0|||
105944829|NCT01432444|365462706|FG000|Treatment Phase|Protocol Deviation|0|||
105944830|NCT01432444|365462707|FG001|Treatment Phase|Protocol Deviation|3|||
105944831|NCT01432444|365462708|FG002|Treatment Phase|Protocol Deviation|0|||
105944832|NCT01432444|365462706|FG000|Treatment Phase|Lack of Efficacy|0|||
105944833|NCT01432444|365462707|FG001|Treatment Phase|Lack of Efficacy|10|||
105944834|NCT01432444|365462708|FG002|Treatment Phase|Lack of Efficacy|0|||
105944835|NCT01432444|365462706|FG000|Extension Phase|Lost to Follow-up|0|||
105944836|NCT01432444|365462707|FG001|Extension Phase|Lost to Follow-up|0|||
105944837|NCT01432444|365462708|FG002|Extension Phase|Lost to Follow-up|17|||
105944838|NCT01432444|365462706|FG000|Extension Phase|Adverse Event|0|||
105944839|NCT01432444|365462707|FG001|Extension Phase|Adverse Event|0|||
105944840|NCT01432444|365462708|FG002|Extension Phase|Adverse Event|10|||
105944841|NCT01432444|365462706|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
105944842|NCT01432444|365462707|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
105750249|NCT05086289|364738790|FG000|Overall Study|Lost to Follow-up|2|||
105944843|NCT01432444|365462708|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
105944844|NCT01432444|365462706|FG000|Extension Phase|Met Withdrawal Criteria|0|||
105944845|NCT01432444|365462707|FG001|Extension Phase|Met Withdrawal Criteria|0|||
105944846|NCT01432444|365462708|FG002|Extension Phase|Met Withdrawal Criteria|144|||
105944847|NCT01432444|365462706|FG000|Extension Phase|Physician Decision|0|||
105944848|NCT01432444|365462707|FG001|Extension Phase|Physician Decision|0|||
105944849|NCT01432444|365462708|FG002|Extension Phase|Physician Decision|1|||
105944850|NCT01432444|365462706|FG000|Extension Phase|Withdrawal by Subject|0|||
105944851|NCT01432444|365462707|FG001|Extension Phase|Withdrawal by Subject|0|||
105944852|NCT01432444|365462708|FG002|Extension Phase|Withdrawal by Subject|13|||
105944853|NCT02538614|365462709|FG000|Overall Study|Progressive Disease|2|||
105944854|NCT00183248|365462710|FG000|Overall Study|Lost to Follow-up|0|||
105944855|NCT00183248|365462711|FG001|Overall Study|Lost to Follow-up|1|||
105944856|NCT00183248|365462710|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
105944857|NCT00183248|365462711|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
105944858|NCT03309202|365462712|FG000|Overall Study|Lost to Follow-up|1|||
105944859|NCT03309202|365462713|FG001|Overall Study|Lost to Follow-up|0|||
105944860|NCT03309202|365462714|FG002|Overall Study|Lost to Follow-up|0|||
105944861|NCT03309202|365462715|FG003|Overall Study|Lost to Follow-up|0|||
105944862|NCT05201807|365462716|FG000|Overall Study|Adverse Event|1|||
105944863|NCT05201807|365462716|FG000|Overall Study|COVID-19 Related|1|||
105944864|NCT00831389|365462719|FG000|Overall Study|Withdrawal by Subject|0|||
105801612|NCT01830920|364930605|FG001|Overall Study|Withdrawal by Subject|2|||
105801613|NCT01830920|364930606|FG002|Overall Study|Withdrawal by Subject|1|||
105801614|NCT01830920|364930607|FG003|Overall Study|Withdrawal by Subject|7|||
105801615|NCT01830920|364930608|FG004|Overall Study|Withdrawal by Subject|1|||
105801616|NCT01830920|364930604|FG000|Overall Study|Death|3|||
105801617|NCT01830920|364930605|FG001|Overall Study|Death|3|||
105801618|NCT01830920|364930606|FG002|Overall Study|Death|5|||
105801619|NCT01830920|364930607|FG003|Overall Study|Death|4|||
105801620|NCT01830920|364930608|FG004|Overall Study|Death|4|||
105801621|NCT01830920|364930604|FG000|Overall Study|Other|15|||
105801622|NCT01830920|364930605|FG001|Overall Study|Other|1|||
105801623|NCT01830920|364930606|FG002|Overall Study|Other|1|||
105801624|NCT01830920|364930607|FG003|Overall Study|Other|5|||
105801625|NCT01830920|364930608|FG004|Overall Study|Other|3|||
105801626|NCT02217345|364930609|FG000|Overall Study|Lost to Follow-up|2|||
105801627|NCT02217345|364930610|FG001|Overall Study|Lost to Follow-up|1|||
105801628|NCT02217345|364930609|FG000|Overall Study|Withdrawal by Subject|3|||
105801629|NCT02217345|364930610|FG001|Overall Study|Withdrawal by Subject|2|||
105801630|NCT02217345|364930609|FG000|Overall Study|Adverse Event|2|||
105801631|NCT02217345|364930610|FG001|Overall Study|Adverse Event|1|||
105801632|NCT02217345|364930609|FG000|Overall Study|Physician Decision|0|||
105801633|NCT02217345|364930610|FG001|Overall Study|Physician Decision|1|||
105944865|NCT00831389|365462720|FG001|Overall Study|Withdrawal by Subject|1|||
105944866|NCT01358734|365462727|FG000|Overall Study|Adverse Event|4|||
105944867|NCT01358734|365462728|FG001|Overall Study|Adverse Event|7|||
105944868|NCT01358734|365462729|FG002|Overall Study|Adverse Event|3|||
105944869|NCT01358734|365462727|FG000|Overall Study|Lack of Efficacy|0|||
105944870|NCT01358734|365462728|FG001|Overall Study|Lack of Efficacy|1|||
105944871|NCT01358734|365462729|FG002|Overall Study|Lack of Efficacy|3|||
105944872|NCT01358734|365462727|FG000|Overall Study|Withdrawal by Subject|1|||
105944873|NCT01358734|365462728|FG001|Overall Study|Withdrawal by Subject|6|||
105944874|NCT01358734|365462729|FG002|Overall Study|Withdrawal by Subject|3|||
105944875|NCT01358734|365462727|FG000|Overall Study|Death|3|||
105944876|NCT01358734|365462728|FG001|Overall Study|Death|7|||
105944877|NCT01358734|365462729|FG002|Overall Study|Death|2|||
105944878|NCT01358734|365462727|FG000|Overall Study|Progressive Disease|5|||
105944879|NCT01358734|365462728|FG001|Overall Study|Progressive Disease|13|||
105944880|NCT01358734|365462729|FG002|Overall Study|Progressive Disease|16|||
105944881|NCT01358734|365462727|FG000|Overall Study|Non-compliance with study drug|0|||
105944882|NCT01358734|365462728|FG001|Overall Study|Non-compliance with study drug|0|||
105944883|NCT01358734|365462729|FG002|Overall Study|Non-compliance with study drug|1|||
105944884|NCT01358734|365462727|FG000|Overall Study|Other|2|||
105944885|NCT01358734|365462728|FG001|Overall Study|Other|5|||
105944886|NCT01358734|365462729|FG002|Overall Study|Other|4|||
105944887|NCT01358734|365462727|FG000|Overall Study|Protocol Violation|0|||
105944888|NCT01358734|365462728|FG001|Overall Study|Protocol Violation|0|||
105944889|NCT01358734|365462729|FG002|Overall Study|Protocol Violation|2|||
105944890|NCT03610048|365462730|FG000|Overall Study|Study terminated by sponsor|84|||
105944891|NCT03610048|365462730|FG000|Overall Study|Adverse Event|32|||
105944892|NCT03610048|365462730|FG000|Overall Study|Withdrawal by Subject|31|||
105944893|NCT03610048|365462730|FG000|Overall Study|Lost to Follow-up|8|||
105944894|NCT03610048|365462730|FG000|Overall Study|Other|4|||
105944895|NCT03610048|365462730|FG000|Overall Study|Physician Decision|1|||
105944896|NCT03610048|365462730|FG000|Overall Study|Pregnancy|1|||
105944897|NCT01198587|365462732|FG000|Overall Study|Lost to Follow-up|8|||
105801634|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801635|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801636|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801637|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
105944898|NCT01198587|365462733|FG001|Overall Study|Lost to Follow-up|0|||
105944899|NCT01198587|365462734|FG002|Overall Study|Lost to Follow-up|9|||
105944900|NCT01198587|365462735|FG003|Overall Study|Lost to Follow-up|0|||
105944901|NCT00320606|365462737|FG000|Overall Study|Adverse Event|1|||
105944902|NCT00320606|365462737|FG000|Overall Study|Protocol Violation|1|||
105944903|NCT00320606|365462737|FG000|Overall Study|Withdrawal by Subject|1|||
105944904|NCT03605693|365462742|FG000|Overall Study|Lost to Follow-up|4|||
105944905|NCT03605693|365462743|FG001|Overall Study|Lost to Follow-up|0|||
105944906|NCT03605693|365462742|FG000|Overall Study|Physician Decision|1|||
105944907|NCT03605693|365462743|FG001|Overall Study|Physician Decision|0|||
105944908|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
105944909|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
105944910|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
105944911|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
105944912|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
105944913|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
105750250|NCT05086289|364738791|FG001|Overall Study|Lost to Follow-up|0|||
105750251|NCT05086289|364738790|FG000|Overall Study|Non-compliance with study drug|2|||
105750252|NCT05086289|364738791|FG001|Overall Study|Non-compliance with study drug|1|||
105750253|NCT05086289|364738790|FG000|Overall Study|Physician Decision|2|||
105750254|NCT05086289|364738791|FG001|Overall Study|Physician Decision|0|||
105750255|NCT05086289|364738790|FG000|Overall Study|Withdrawal by Subject|5|||
105750256|NCT05086289|364738791|FG001|Overall Study|Withdrawal by Subject|2|||
105750257|NCT02045212|364738792|FG000|Overall Study|Adverse Event|0|||
105750258|NCT02045212|364738793|FG001|Overall Study|Adverse Event|1|||
105750259|NCT02045212|364738792|FG000|Overall Study|Withdrawal by Subject|1|||
105750260|NCT02045212|364738793|FG001|Overall Study|Withdrawal by Subject|0|||
105750261|NCT02045212|364738792|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
105750262|NCT02045212|364738793|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
105750263|NCT04799405|364738794|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
105750264|NCT01029002|364738795|FG000|Overall Study|Lost to Follow-up|2|||
105750265|NCT01029002|364738796|FG001|Overall Study|Lost to Follow-up|4|||
105750266|NCT00926796|364738797|FG000|Overall Study|Did not receive randomized treatment|4|||
105750267|NCT00926796|364738798|FG001|Overall Study|Did not receive randomized treatment|7|||
105750268|NCT00926796|364738797|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
105750269|NCT00926796|364738798|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
105750270|NCT00926796|364738797|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
105750271|NCT00926796|364738798|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
105750272|NCT00926796|364738797|FG000|Overall Study|Adverse Event|7|||
105750273|NCT00926796|364738798|FG001|Overall Study|Adverse Event|14|||
105750274|NCT00926796|364738797|FG000|Overall Study|Lost to Follow-up|22|||
105750275|NCT00926796|364738798|FG001|Overall Study|Lost to Follow-up|13|||
105750276|NCT00926796|364738797|FG000|Overall Study|Protocol Violation|15|||
105750277|NCT00926796|364738798|FG001|Overall Study|Protocol Violation|11|||
105750278|NCT00926796|364738797|FG000|Overall Study|Withdrawal by Subject|1|||
105750279|NCT00926796|364738798|FG001|Overall Study|Withdrawal by Subject|0|||
105750280|NCT00101192|364738802|FG000|Overall Study|Ineligible|6|||
105944914|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
105944915|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
105944916|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
105944917|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
105944918|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
105944919|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
105944920|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
105944921|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
105944922|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
105944923|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
105944924|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
105944925|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
105944926|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
105944927|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
105944928|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
105944929|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
105944930|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
105944931|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
105944932|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
105944933|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
105944934|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
105944935|NCT03093415|365462744|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
105944936|NCT03093415|365462745|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
105944937|NCT03093415|365462746|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
105750281|NCT00101192|364738802|FG000|Overall Study|Inevaluable|1|||
105750282|NCT02618928|364738805|FG000|Overall Study|Failure to Return|28|||
105760887|NCT01831804|364778037|FG001|Overall Study|Withdrew Consent|1|||
105801638|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801639|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801640|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801641|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801642|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801643|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
105801644|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105801645|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105801646|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Adverse Event|1|||
105801647|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Adverse Event|1|||
105801648|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Adverse Event|1|||
105801649|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Adverse Event|1|||
105801650|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Adverse Event|0|||
105801651|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Adverse Event|0|||
105801652|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Adverse Event|0|||
105801653|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Adverse Event|0|||
105801654|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
105801655|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
105801656|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
105801657|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
105801658|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
105801659|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
105801660|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
105944938|NCT03093415|365462744|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
105944939|NCT03093415|365462745|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
105944940|NCT03093415|365462746|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
105944941|NCT03895372|365462747|FG000|Investigational Treatment Period|Adverse Event|1|||
105944942|NCT03895372|365462748|FG001|Investigational Treatment Period|Adverse Event|0|||
105944943|NCT03895372|365462749|FG002|Investigational Treatment Period|Adverse Event|0|||
105944944|NCT03895372|365462750|FG003|Investigational Treatment Period|Adverse Event|0|||
105944945|NCT03895372|365462751|FG004|Investigational Treatment Period|Adverse Event|0|||
105944946|NCT03895372|365462752|FG005|Investigational Treatment Period|Adverse Event|0|||
105944947|NCT03895372|365462753|FG006|Investigational Treatment Period|Adverse Event|4|||
105944948|NCT03895372|365462754|FG007|Investigational Treatment Period|Adverse Event|3|||
105944949|NCT03895372|365462747|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
105944950|NCT03895372|365462748|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
105944951|NCT03895372|365462749|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
105801661|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
105801662|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
105801663|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
105944952|NCT03895372|365462750|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
105944953|NCT03895372|365462751|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
106015997|NCT00787644|365723372|FG000|Overall Study|Withdrawal by Subject|1|||
105944954|NCT03895372|365462752|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
105944955|NCT03895372|365462753|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
105944956|NCT03895372|365462754|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
105944957|NCT03895372|365462747|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
105944958|NCT03895372|365462748|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
105944959|NCT03895372|365462749|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
105944960|NCT03895372|365462750|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
105944961|NCT03895372|365462751|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
105944962|NCT03895372|365462752|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
105944963|NCT03895372|365462753|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
105944964|NCT03895372|365462754|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
105944965|NCT03895372|365462747|FG000|Investigational Treatment Period|Other|0|||
105944966|NCT03895372|365462748|FG001|Investigational Treatment Period|Other|0|||
105944967|NCT03895372|365462749|FG002|Investigational Treatment Period|Other|0|||
105944968|NCT03895372|365462750|FG003|Investigational Treatment Period|Other|0|||
105944969|NCT03895372|365462751|FG004|Investigational Treatment Period|Other|0|||
105944970|NCT03895372|365462752|FG005|Investigational Treatment Period|Other|1|||
105944971|NCT03895372|365462753|FG006|Investigational Treatment Period|Other|0|||
105944972|NCT03895372|365462754|FG007|Investigational Treatment Period|Other|2|||
105944973|NCT03895372|365462747|FG000|Investigational Treatment Period|Protocol Violation|0|||
105944974|NCT03895372|365462748|FG001|Investigational Treatment Period|Protocol Violation|0|||
105944975|NCT03895372|365462749|FG002|Investigational Treatment Period|Protocol Violation|0|||
105944976|NCT03895372|365462750|FG003|Investigational Treatment Period|Protocol Violation|1|||
105944977|NCT03895372|365462751|FG004|Investigational Treatment Period|Protocol Violation|0|||
106015998|NCT00787644|365723373|FG001|Overall Study|Withdrawal by Subject|1|||
106015999|NCT00536744|365723374|FG000|Overall Study|Adverse Event|13|||
105944978|NCT03895372|365462752|FG005|Investigational Treatment Period|Protocol Violation|0|||
105944979|NCT03895372|365462753|FG006|Investigational Treatment Period|Protocol Violation|0|||
105944980|NCT03895372|365462754|FG007|Investigational Treatment Period|Protocol Violation|0|||
105944981|NCT03895372|365462747|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
105944982|NCT03895372|365462748|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
105944983|NCT03895372|365462749|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
105944984|NCT03895372|365462750|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
105944985|NCT03895372|365462751|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
105944986|NCT03895372|365462752|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
105944987|NCT03895372|365462753|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
105944988|NCT03895372|365462754|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
105944989|NCT03895372|365462747|FG000|Extension Treatment Period|Adverse Event|0|||
105944990|NCT03895372|365462748|FG001|Extension Treatment Period|Adverse Event|1|||
105944991|NCT03895372|365462749|FG002|Extension Treatment Period|Adverse Event|0|||
105944992|NCT03895372|365462750|FG003|Extension Treatment Period|Adverse Event|1|||
105944993|NCT03895372|365462751|FG004|Extension Treatment Period|Adverse Event|0|||
105944994|NCT03895372|365462752|FG005|Extension Treatment Period|Adverse Event|0|||
105944995|NCT03895372|365462753|FG006|Extension Treatment Period|Adverse Event|3|||
105944996|NCT03895372|365462754|FG007|Extension Treatment Period|Adverse Event|3|||
105944997|NCT03895372|365462747|FG000|Extension Treatment Period|Other|1|||
105944998|NCT03895372|365462748|FG001|Extension Treatment Period|Other|3|||
105944999|NCT03895372|365462749|FG002|Extension Treatment Period|Other|0|||
105945000|NCT03895372|365462750|FG003|Extension Treatment Period|Other|0|||
105945001|NCT03895372|365462751|FG004|Extension Treatment Period|Other|1|||
105945002|NCT03895372|365462752|FG005|Extension Treatment Period|Other|0|||
105945003|NCT03895372|365462753|FG006|Extension Treatment Period|Other|0|||
105945004|NCT03895372|365462754|FG007|Extension Treatment Period|Other|2|||
105945005|NCT03895372|365462747|FG000|Extension Treatment Period|Pregnancy|0|||
105945006|NCT03895372|365462748|FG001|Extension Treatment Period|Pregnancy|0|||
105945007|NCT03895372|365462749|FG002|Extension Treatment Period|Pregnancy|0|||
105945008|NCT03895372|365462750|FG003|Extension Treatment Period|Pregnancy|0|||
105945009|NCT03895372|365462751|FG004|Extension Treatment Period|Pregnancy|1|||
105945010|NCT03895372|365462752|FG005|Extension Treatment Period|Pregnancy|0|||
105945011|NCT03895372|365462753|FG006|Extension Treatment Period|Pregnancy|0|||
105945012|NCT03895372|365462754|FG007|Extension Treatment Period|Pregnancy|0|||
105945013|NCT03895372|365462747|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
105945014|NCT03895372|365462748|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
105945015|NCT03895372|365462749|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
105945016|NCT03895372|365462750|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
105945017|NCT03895372|365462751|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
105945018|NCT03895372|365462752|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
105945019|NCT03895372|365462753|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
105945020|NCT03895372|365462754|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
105945021|NCT03559530|365462755|FG000|Overall Study|non-location of medical records|44|||
105945022|NCT03559530|365462756|FG001|Overall Study|non-location of medical records|0|||
105945023|NCT03559530|365462755|FG000|Overall Study|culture results not considered for treat|29|||
105945024|NCT03559530|365462756|FG001|Overall Study|culture results not considered for treat|0|||
105945025|NCT03559530|365462755|FG000|Overall Study|duplicate cases|8|||
105945026|NCT03559530|365462756|FG001|Overall Study|duplicate cases|0|||
105945027|NCT03559530|365462755|FG000|Overall Study|other species of Acinetobacte|7|||
105945028|NCT03559530|365462756|FG001|Overall Study|other species of Acinetobacte|0|||
105801664|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
105945029|NCT03559530|365462755|FG000|Overall Study|contamination / colonization|3|||
105945030|NCT03559530|365462756|FG001|Overall Study|contamination / colonization|0|||
105945031|NCT01646827|365462757|FG000|Overall Study|Lost to Follow-up|0|||
105945032|NCT01646827|365462758|FG001|Overall Study|Lost to Follow-up|3|||
105945033|NCT01646827|365462757|FG000|Overall Study|Physician Decision|1|||
105945034|NCT01646827|365462758|FG001|Overall Study|Physician Decision|2|||
105945035|NCT01646827|365462757|FG000|Overall Study|Withdrawal by Subject|1|||
105945036|NCT01646827|365462758|FG001|Overall Study|Withdrawal by Subject|0|||
105945037|NCT02303262|365462759|FG000|Overall Study|Withdrawal by Subject|2|||
105945038|NCT02706392|365462769|FG000|Overall Study|Death|1|||
105945039|NCT02706392|365462770|FG001|Overall Study|Death|0|||
105945040|NCT02706392|365462771|FG002|Overall Study|Death|2|||
105945041|NCT02706392|365462772|FG003|Overall Study|Death|2|||
105945042|NCT02706392|365462773|FG004|Overall Study|Death|5|||
105945043|NCT02706392|365462774|FG005|Overall Study|Death|2|||
105945044|NCT00619866|365462777|FG000|Weeks 1 - 12|Adverse Event|0|||
105945045|NCT00619866|365462778|FG001|Weeks 1 - 12|Adverse Event|1|||
105945046|NCT00619866|365462779|FG002|Weeks 1 - 12|Adverse Event|2|||
105945047|NCT00619866|365462780|FG003|Weeks 1 - 12|Adverse Event|0|||
105945048|NCT00619866|365462781|FG004|Weeks 1 - 12|Adverse Event|0|||
105945049|NCT00619866|365462777|FG000|Weeks 1 - 12|Non-compliance|0|||
105945050|NCT00619866|365462778|FG001|Weeks 1 - 12|Non-compliance|0|||
105945051|NCT00619866|365462779|FG002|Weeks 1 - 12|Non-compliance|1|||
105945052|NCT00619866|365462780|FG003|Weeks 1 - 12|Non-compliance|0|||
105945053|NCT00619866|365462781|FG004|Weeks 1 - 12|Non-compliance|0|||
105945054|NCT00619866|365462777|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
105945055|NCT00619866|365462778|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
105945056|NCT00619866|365462779|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
105945057|NCT00619866|365462780|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
105945058|NCT00619866|365462781|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
105945059|NCT00619866|365462777|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
105945060|NCT00619866|365462778|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
105945061|NCT00619866|365462779|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
105945062|NCT00619866|365462780|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
105945063|NCT00619866|365462781|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
105945064|NCT00619866|365462777|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
105945065|NCT00619866|365462778|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
105945066|NCT00619866|365462779|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
105945067|NCT00619866|365462780|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
105945068|NCT00619866|365462781|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
105945069|NCT00619866|365462777|FG000|Weeks 1 - 12|Sponsor Decision|0|||
105945070|NCT00619866|365462778|FG001|Weeks 1 - 12|Sponsor Decision|1|||
105945071|NCT00619866|365462779|FG002|Weeks 1 - 12|Sponsor Decision|0|||
105945072|NCT00619866|365462780|FG003|Weeks 1 - 12|Sponsor Decision|0|||
105945073|NCT00619866|365462781|FG004|Weeks 1 - 12|Sponsor Decision|0|||
105945074|NCT00619866|365462777|FG000|Weeks 13 - 24|Adverse Event|0|||
105945075|NCT00619866|365462778|FG001|Weeks 13 - 24|Adverse Event|0|||
105945076|NCT00619866|365462779|FG002|Weeks 13 - 24|Adverse Event|2|||
105945077|NCT00619866|365462780|FG003|Weeks 13 - 24|Adverse Event|1|||
105945078|NCT00619866|365462781|FG004|Weeks 13 - 24|Adverse Event|0|||
105945079|NCT00619866|365462777|FG000|Weeks 13 - 24|Protocol Deviation|0|||
105945080|NCT00619866|365462778|FG001|Weeks 13 - 24|Protocol Deviation|0|||
105945081|NCT00619866|365462779|FG002|Weeks 13 - 24|Protocol Deviation|0|||
105945082|NCT00619866|365462780|FG003|Weeks 13 - 24|Protocol Deviation|1|||
105945083|NCT00619866|365462781|FG004|Weeks 13 - 24|Protocol Deviation|0|||
105945084|NCT00619866|365462777|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
105945085|NCT00619866|365462778|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
105945086|NCT00619866|365462779|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
105945087|NCT00619866|365462780|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
105945088|NCT00619866|365462781|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
105945089|NCT00619866|365462777|FG000|Weeks 13 - 24|Non-compliance|0|||
105945090|NCT00619866|365462778|FG001|Weeks 13 - 24|Non-compliance|1|||
105945091|NCT00619866|365462779|FG002|Weeks 13 - 24|Non-compliance|1|||
105945092|NCT00619866|365462780|FG003|Weeks 13 - 24|Non-compliance|0|||
105945093|NCT00619866|365462781|FG004|Weeks 13 - 24|Non-compliance|0|||
105945094|NCT00619866|365462777|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
105945095|NCT00619866|365462778|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
105945096|NCT00619866|365462779|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
105945097|NCT00619866|365462780|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
105945098|NCT00619866|365462781|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
105945099|NCT04716894|365462784|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
105945100|NCT04716894|365462784|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
105945101|NCT05205616|365462785|FG000|Overall Study|Lost to Follow-up|4|||
105945102|NCT05205616|365462786|FG001|Overall Study|Lost to Follow-up|4|||
105945103|NCT01121757|365462787|FG000|First Drug|Death|1|||
105945104|NCT01121757|365462788|FG001|First Drug|Death|0|||
105945105|NCT01121757|365462787|FG000|First Drug|Disease Progression|0|||
105945106|NCT01121757|365462788|FG001|First Drug|Disease Progression|2|||
105945107|NCT01121757|365462787|FG000|Combination|Physician Decision|0|||
105945108|NCT01121757|365462788|FG001|Combination|Physician Decision|1|||
105945109|NCT01121757|365462787|FG000|Combination|Disease Progression|2|||
105945110|NCT01121757|365462788|FG001|Combination|Disease Progression|0|||
105945111|NCT04079738|365462789|FG000|Study Treatment|Death|1|||
105945112|NCT04079738|365462790|FG001|Study Treatment|Death|0|||
105945113|NCT04079738|365462791|FG002|Study Treatment|Death|0|||
105945114|NCT04079738|365462792|FG003|Study Treatment|Death|0|||
105945115|NCT04079738|365462789|FG000|Study Treatment|Adverse Event|2|||
105945116|NCT04079738|365462790|FG001|Study Treatment|Adverse Event|0|||
105945117|NCT04079738|365462791|FG002|Study Treatment|Adverse Event|0|||
105945118|NCT04079738|365462792|FG003|Study Treatment|Adverse Event|0|||
105945119|NCT04079738|365462789|FG000|Study Treatment|withdrawal before treatment|1|||
105945120|NCT04079738|365462790|FG001|Study Treatment|withdrawal before treatment|0|||
105945121|NCT04079738|365462791|FG002|Study Treatment|withdrawal before treatment|0|||
105945122|NCT04079738|365462792|FG003|Study Treatment|withdrawal before treatment|0|||
105945123|NCT04079738|365462789|FG000|Study Treatment|symptomatic deterioration|2|||
105945124|NCT04079738|365462790|FG001|Study Treatment|symptomatic deterioration|0|||
106016000|NCT00536744|365723375|FG001|Overall Study|Adverse Event|10|||
106016001|NCT00536744|365723374|FG000|Overall Study|Death|2|||
106016002|NCT00536744|365723375|FG001|Overall Study|Death|1|||
106016003|NCT00536744|365723374|FG000|Overall Study|Physician Decision|3|||
106016004|NCT00536744|365723375|FG001|Overall Study|Physician Decision|1|||
106016005|NCT00536744|365723374|FG000|Overall Study|Lost to Follow-up|3|||
106016006|NCT00536744|365723375|FG001|Overall Study|Lost to Follow-up|5|||
106016007|NCT00536744|365723374|FG000|Overall Study|Withdrawal by Subject|7|||
106016008|NCT00536744|365723375|FG001|Overall Study|Withdrawal by Subject|8|||
106016009|NCT00536744|365723374|FG000|Overall Study|PI tried alternative treatment|1|||
106016010|NCT00536744|365723375|FG001|Overall Study|PI tried alternative treatment|3|||
106016011|NCT04498832|365723376|FG000|Overall Study|Adverse Event|1|||
106016012|NCT04498832|365723377|FG001|Overall Study|Adverse Event|3|||
106016013|NCT04498832|365723376|FG000|Overall Study|Withdrawal by Subject|0|||
106016014|NCT04498832|365723377|FG001|Overall Study|Withdrawal by Subject|1|||
106016015|NCT04161157|365723378|FG000|Overall Study|Lost to Follow-up|4|||
106016016|NCT04161157|365723378|FG000|Overall Study|Death|3|||
106016017|NCT04161157|365723378|FG000|Overall Study|Ineligible|2|||
106016018|NCT04161157|365723378|FG000|Overall Study|Withdrawal by Subject|4|||
106016019|NCT04108208|365723379|FG000|Overall Study|Withdrawal by Subject|2|||
106016020|NCT04108208|365723380|FG001|Overall Study|Withdrawal by Subject|6|||
106016021|NCT04108208|365723379|FG000|Overall Study|other-ongoing|20|||
106016022|NCT04108208|365723380|FG001|Overall Study|other-ongoing|40|||
106016023|NCT04108208|365723379|FG000|Overall Study|Death|1|||
106016024|NCT04108208|365723380|FG001|Overall Study|Death|4|||
106016025|NCT04108208|365723379|FG000|Overall Study|Lost to Follow-up|2|||
106016026|NCT04108208|365723380|FG001|Overall Study|Lost to Follow-up|0|||
106016027|NCT06078124|365723384|FG000|Overall Study|Lost to Follow-up|14|||
106016028|NCT06078124|365723385|FG001|Overall Study|Lost to Follow-up|14|||
106016029|NCT04145349|365724376|FG000|Overall Study|Withdrawal by Subject|3|||
106016030|NCT04145349|365724377|FG001|Overall Study|Withdrawal by Subject|0|||
106016031|NCT04145349|365724376|FG000|Overall Study|Lost to Follow-up|0|||
106016032|NCT04145349|365724377|FG001|Overall Study|Lost to Follow-up|1|||
106016033|NCT04145349|365724376|FG000|Overall Study|On study treatment (Ongoing)|0|||
106016034|NCT04145349|365724377|FG001|Overall Study|On study treatment (Ongoing)|1|||
106016035|NCT04579380|365724379|FG000|Overall Study|Death|9|||
106016036|NCT04579380|365724380|FG001|Overall Study|Death|22|||
106016037|NCT04579380|365724381|FG002|Overall Study|Death|22|||
106016038|NCT04579380|365724382|FG003|Overall Study|Death|17|||
106016039|NCT04579380|365724383|FG004|Overall Study|Death|6|||
106016040|NCT04579380|365724384|FG005|Overall Study|Death|21|||
106016041|NCT04579380|365724385|FG006|Overall Study|Death|10|||
106016042|NCT04579380|365724386|FG007|Overall Study|Death|11|||
106016043|NCT04579380|365724387|FG008|Overall Study|Death|25|||
106016044|NCT04579380|365724379|FG000|Overall Study|Withdrawal by Subject|0|||
106016045|NCT04579380|365724380|FG001|Overall Study|Withdrawal by Subject|3|||
106016046|NCT04579380|365724381|FG002|Overall Study|Withdrawal by Subject|4|||
106016047|NCT04579380|365724382|FG003|Overall Study|Withdrawal by Subject|0|||
106016048|NCT04579380|365724383|FG004|Overall Study|Withdrawal by Subject|1|||
105945125|NCT04079738|365462791|FG002|Study Treatment|symptomatic deterioration|0|||
105945126|NCT04079738|365462792|FG003|Study Treatment|symptomatic deterioration|0|||
105945127|NCT04079738|365462789|FG000|Study Treatment|Disease Progression|1|||
105945128|NCT04079738|365462790|FG001|Study Treatment|Disease Progression|0|||
105945129|NCT04079738|365462791|FG002|Study Treatment|Disease Progression|0|||
105945130|NCT04079738|365462792|FG003|Study Treatment|Disease Progression|0|||
105945131|NCT04079738|365462789|FG000|Study Treatment|withdrawal after treatment|1|||
105945132|NCT04079738|365462790|FG001|Study Treatment|withdrawal after treatment|0|||
105945133|NCT04079738|365462791|FG002|Study Treatment|withdrawal after treatment|0|||
105945134|NCT04079738|365462792|FG003|Study Treatment|withdrawal after treatment|0|||
105945135|NCT04079738|365462789|FG000|Follow up|Withdrawal by Subject|3|||
105945136|NCT04079738|365462790|FG001|Follow up|Withdrawal by Subject|0|||
105945137|NCT04079738|365462791|FG002|Follow up|Withdrawal by Subject|0|||
105945138|NCT04079738|365462792|FG003|Follow up|Withdrawal by Subject|0|||
105945139|NCT04079738|365462789|FG000|Follow up|Death|5|||
106016049|NCT04579380|365724384|FG005|Overall Study|Withdrawal by Subject|2|||
106016050|NCT04579380|365724385|FG006|Overall Study|Withdrawal by Subject|0|||
106016051|NCT04579380|365724386|FG007|Overall Study|Withdrawal by Subject|1|||
105945140|NCT04079738|365462790|FG001|Follow up|Death|0|||
105945141|NCT04079738|365462791|FG002|Follow up|Death|0|||
106016052|NCT04579380|365724387|FG008|Overall Study|Withdrawal by Subject|2|||
106016053|NCT04579380|365724379|FG000|Overall Study|Ongoing|2|||
106016054|NCT04579380|365724380|FG001|Overall Study|Ongoing|6|||
106016055|NCT04579380|365724381|FG002|Overall Study|Ongoing|4|||
106016056|NCT04579380|365724382|FG003|Overall Study|Ongoing|8|||
106016057|NCT04579380|365724383|FG004|Overall Study|Ongoing|5|||
106016058|NCT04579380|365724384|FG005|Overall Study|Ongoing|8|||
106016059|NCT04579380|365724385|FG006|Overall Study|Ongoing|3|||
106016060|NCT04579380|365724386|FG007|Overall Study|Ongoing|19|||
106016061|NCT04579380|365724387|FG008|Overall Study|Ongoing|6|||
106016062|NCT04770753|365724389|FG000|Overall Study|Randomized, never treated|1|||
105945142|NCT04079738|365462792|FG003|Follow up|Death|0|||
105945143|NCT01380080|365462796|FG000|Overall Study|Death|36|||
105945144|NCT01380080|365462797|FG001|Overall Study|Death|44|||
105945145|NCT01380080|365462796|FG000|Overall Study|Site is closing|28|||
105945146|NCT01380080|365462797|FG001|Overall Study|Site is closing|31|||
105945147|NCT01380080|365462796|FG000|Overall Study|Not able to get to clinic|7|||
105945148|NCT01380080|365462797|FG001|Overall Study|Not able to get to clinic|1|||
105945149|NCT01380080|365462796|FG000|Overall Study|Not willing to adhere to requirements|6|||
105945150|NCT01380080|365462797|FG001|Overall Study|Not willing to adhere to requirements|2|||
105945151|NCT01380080|365462796|FG000|Overall Study|Withdrawal by Subject|5|||
105945152|NCT01380080|365462797|FG001|Overall Study|Withdrawal by Subject|2|||
105945153|NCT01380080|365462796|FG000|Overall Study|Lost to Follow-up|3|||
105945154|NCT01380080|365462797|FG001|Overall Study|Lost to Follow-up|3|||
105945155|NCT02135133|365462798|FG000|Overall Study|Adverse Event|10|||
105945156|NCT02135133|365462798|FG000|Overall Study|regulatory mandate|5|||
105945157|NCT05081843|365462799|FG000|Overall Study|Lost to Follow-up|135|||
105945158|NCT05081843|365462800|FG001|Overall Study|Lost to Follow-up|145|||
105945159|NCT02303821|365462801|FG000|Overall Study|Withdrawal by Subject|0|||
105945160|NCT02303821|365462802|FG001|Overall Study|Withdrawal by Subject|0|||
105945161|NCT02303821|365462803|FG002|Overall Study|Withdrawal by Subject|0|||
105945162|NCT02303821|365462804|FG003|Overall Study|Withdrawal by Subject|0|||
105945163|NCT02303821|365462805|FG004|Overall Study|Withdrawal by Subject|0|||
105945164|NCT02303821|365462806|FG005|Overall Study|Withdrawal by Subject|0|||
105945165|NCT02303821|365462807|FG006|Overall Study|Withdrawal by Subject|0|||
105945166|NCT02303821|365462808|FG007|Overall Study|Withdrawal by Subject|2|||
105945167|NCT02303821|365462801|FG000|Overall Study|Death|0|||
105945168|NCT02303821|365462802|FG001|Overall Study|Death|2|||
105945169|NCT02303821|365462803|FG002|Overall Study|Death|0|||
105945170|NCT02303821|365462804|FG003|Overall Study|Death|0|||
105945171|NCT02303821|365462805|FG004|Overall Study|Death|0|||
105945172|NCT02303821|365462806|FG005|Overall Study|Death|3|||
105945173|NCT02303821|365462807|FG006|Overall Study|Death|41|||
105945174|NCT02303821|365462808|FG007|Overall Study|Death|29|||
105945175|NCT02303821|365462801|FG000|Overall Study|Lost to Follow-up|0|||
106016063|NCT04770753|365724390|FG001|Overall Study|Randomized, never treated|1|||
106016064|NCT04770753|365724389|FG000|Overall Study|Withdrawal by Subject|3|||
106016065|NCT04770753|365724390|FG001|Overall Study|Withdrawal by Subject|1|||
106016066|NCT04770753|365724389|FG000|Overall Study|Adverse Event|2|||
106016067|NCT04770753|365724390|FG001|Overall Study|Adverse Event|0|||
106016068|NCT04770753|365724389|FG000|Overall Study|Pregnancy|1|||
106016069|NCT04770753|365724390|FG001|Overall Study|Pregnancy|0|||
106016070|NCT04770753|365724389|FG000|Overall Study|Other un-specified|1|||
105945176|NCT02303821|365462802|FG001|Overall Study|Lost to Follow-up|0|||
105945177|NCT02303821|365462803|FG002|Overall Study|Lost to Follow-up|0|||
106016071|NCT04770753|365724390|FG001|Overall Study|Other un-specified|0|||
106016072|NCT00775190|365724391|FG000|Overall Study|Lost to Follow-up|2|||
106016073|NCT00775190|365724392|FG001|Overall Study|Lost to Follow-up|3|||
106016074|NCT00775190|365724391|FG000|Overall Study|Withdrawal by Subject|1|||
106016075|NCT00775190|365724392|FG001|Overall Study|Withdrawal by Subject|2|||
106016076|NCT00775190|365724391|FG000|Overall Study|Protocol Violation|1|||
106016077|NCT00775190|365724392|FG001|Overall Study|Protocol Violation|0|||
106016078|NCT00463567|365724393|FG000|Overall Study|Adverse Event|29|||
106016079|NCT00463567|365724394|FG001|Overall Study|Adverse Event|26|||
106016080|NCT00463567|365724395|FG002|Overall Study|Adverse Event|17|||
106016081|NCT00463567|365724396|FG003|Overall Study|Adverse Event|46|||
106016082|NCT00463567|365724397|FG004|Overall Study|Adverse Event|10|||
105945178|NCT02303821|365462804|FG003|Overall Study|Lost to Follow-up|0|||
105945179|NCT02303821|365462805|FG004|Overall Study|Lost to Follow-up|0|||
105945180|NCT02303821|365462806|FG005|Overall Study|Lost to Follow-up|0|||
105945181|NCT02303821|365462807|FG006|Overall Study|Lost to Follow-up|1|||
105945182|NCT02303821|365462808|FG007|Overall Study|Lost to Follow-up|0|||
105945183|NCT02303821|365462801|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105945184|NCT02303821|365462802|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105945185|NCT02303821|365462803|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105945186|NCT02303821|365462804|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105945187|NCT02303821|365462805|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105945188|NCT02303821|365462806|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105945189|NCT02303821|365462807|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
106016083|NCT00463567|365724398|FG005|Overall Study|Adverse Event|10|||
106016084|NCT00463567|365724399|FG006|Overall Study|Adverse Event|4|||
106016085|NCT00463567|365724393|FG000|Overall Study|Withdrawal by Subject|29|||
105945190|NCT02303821|365462808|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
105945191|NCT02303821|365462801|FG000|Overall Study|Decision by sponsor|0|||
105945192|NCT02303821|365462802|FG001|Overall Study|Decision by sponsor|0|||
106016086|NCT00463567|365724394|FG001|Overall Study|Withdrawal by Subject|22|||
105945193|NCT02303821|365462803|FG002|Overall Study|Decision by sponsor|0|||
105945194|NCT02303821|365462804|FG003|Overall Study|Decision by sponsor|0|||
105945195|NCT02303821|365462805|FG004|Overall Study|Decision by sponsor|0|||
105945196|NCT02303821|365462806|FG005|Overall Study|Decision by sponsor|1|||
105945197|NCT02303821|365462807|FG006|Overall Study|Decision by sponsor|0|||
105945198|NCT02303821|365462808|FG007|Overall Study|Decision by sponsor|0|||
105945199|NCT02303821|365462801|FG000|Overall Study|Protocol-specified criteria|0|||
105945200|NCT02303821|365462802|FG001|Overall Study|Protocol-specified criteria|1|||
105945201|NCT02303821|365462803|FG002|Overall Study|Protocol-specified criteria|0|||
105945202|NCT02303821|365462804|FG003|Overall Study|Protocol-specified criteria|0|||
105945203|NCT02303821|365462805|FG004|Overall Study|Protocol-specified criteria|0|||
105945204|NCT02303821|365462806|FG005|Overall Study|Protocol-specified criteria|1|||
105945205|NCT02303821|365462807|FG006|Overall Study|Protocol-specified criteria|0|||
105945206|NCT02303821|365462808|FG007|Overall Study|Protocol-specified criteria|0|||
105945207|NCT02711202|365462809|FG000|Overall Study|Adverse Event|3|||
105945208|NCT02711202|365462810|FG001|Overall Study|Adverse Event|0|||
105945209|NCT02711202|365462809|FG000|Overall Study|graft loss|1|||
105945210|NCT02711202|365462810|FG001|Overall Study|graft loss|0|||
105945211|NCT01722669|365462813|FG000|Overall Study|Withdrawal by Subject|0|||
105945212|NCT01722669|365462814|FG001|Overall Study|Withdrawal by Subject|0|||
105945213|NCT01722669|365462815|FG002|Overall Study|Withdrawal by Subject|0|||
105945214|NCT01722669|365462816|FG003|Overall Study|Withdrawal by Subject|0|||
105945215|NCT01722669|365462817|FG004|Overall Study|Withdrawal by Subject|0|||
105945216|NCT01722669|365462818|FG005|Overall Study|Withdrawal by Subject|2|||
105945217|NCT03211416|365462825|FG000|Overall Study|Adverse Event|7|||
105945218|NCT03211416|365462825|FG000|Overall Study|Lack of Efficacy|2|||
105945219|NCT03211416|365462825|FG000|Overall Study|Physician Decision|1|||
105945220|NCT03448393|365462836|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105945221|NCT03448393|365462837|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105945222|NCT03448393|365462838|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
105945223|NCT03448393|365462839|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105945224|NCT03448393|365462840|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105945225|NCT03448393|365462841|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105945226|NCT03448393|365462842|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105945227|NCT03448393|365462843|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
105945228|NCT03448393|365462844|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
105945229|NCT03448393|365462836|FG000|Dose Expansion|Not treated - screen failure|0|||
105945230|NCT03448393|365462837|FG001|Dose Expansion|Not treated - screen failure|0|||
105945231|NCT03448393|365462838|FG002|Dose Expansion|Not treated - screen failure|0|||
105945232|NCT03448393|365462839|FG003|Dose Expansion|Not treated - screen failure|0|||
105945233|NCT03448393|365462840|FG004|Dose Expansion|Not treated - screen failure|0|||
105945234|NCT03448393|365462841|FG005|Dose Expansion|Not treated - screen failure|0|||
105945235|NCT03448393|365462842|FG006|Dose Expansion|Not treated - screen failure|0|||
105945236|NCT03448393|365462843|FG007|Dose Expansion|Not treated - screen failure|0|||
105945237|NCT03448393|365462844|FG008|Dose Expansion|Not treated - screen failure|7|||
105945238|NCT04756531|365462847|FG000|Overall Study|Adverse Event|0|||
105945239|NCT04756531|365462848|FG001|Overall Study|Adverse Event|0|||
105945240|NCT04756531|365462849|FG002|Overall Study|Adverse Event|0|||
105945241|NCT04756531|365462850|FG003|Overall Study|Adverse Event|0|||
105945242|NCT04756531|365462851|FG004|Overall Study|Adverse Event|1|||
105945243|NCT04756531|365462852|FG005|Overall Study|Adverse Event|0|||
105945244|NCT04756531|365462853|FG006|Overall Study|Adverse Event|0|||
105945245|NCT04756531|365462854|FG007|Overall Study|Adverse Event|0|||
105945246|NCT04756531|365462855|FG008|Overall Study|Adverse Event|0|||
105945247|NCT04756531|365462856|FG009|Overall Study|Adverse Event|0|||
105945248|NCT04756531|365462857|FG010|Overall Study|Adverse Event|0|||
105945249|NCT04756531|365462858|FG011|Overall Study|Adverse Event|0|||
105945250|NCT04756531|365462859|FG012|Overall Study|Adverse Event|0|||
105945251|NCT04756531|365462860|FG013|Overall Study|Adverse Event|0|||
105945252|NCT04756531|365462861|FG014|Overall Study|Adverse Event|0|||
105945253|NCT04756531|365462862|FG015|Overall Study|Adverse Event|0|||
105945254|NCT04756531|365462863|FG016|Overall Study|Adverse Event|0|||
105945255|NCT04756531|365462864|FG017|Overall Study|Adverse Event|0|||
105945256|NCT04756531|365462847|FG000|Overall Study|Withdrawal by Subject|0|||
105945257|NCT04756531|365462848|FG001|Overall Study|Withdrawal by Subject|0|||
105945258|NCT04756531|365462849|FG002|Overall Study|Withdrawal by Subject|0|||
105945259|NCT04756531|365462850|FG003|Overall Study|Withdrawal by Subject|0|||
105945260|NCT04756531|365462851|FG004|Overall Study|Withdrawal by Subject|0|||
105945261|NCT04756531|365462852|FG005|Overall Study|Withdrawal by Subject|0|||
105945262|NCT04756531|365462853|FG006|Overall Study|Withdrawal by Subject|1|||
105945263|NCT04756531|365462854|FG007|Overall Study|Withdrawal by Subject|0|||
105945264|NCT04756531|365462855|FG008|Overall Study|Withdrawal by Subject|0|||
105945265|NCT04756531|365462856|FG009|Overall Study|Withdrawal by Subject|0|||
106016087|NCT00463567|365724395|FG002|Overall Study|Withdrawal by Subject|20|||
105945266|NCT04756531|365462857|FG010|Overall Study|Withdrawal by Subject|0|||
105945267|NCT04756531|365462858|FG011|Overall Study|Withdrawal by Subject|0|||
105945268|NCT04756531|365462859|FG012|Overall Study|Withdrawal by Subject|0|||
105945269|NCT04756531|365462860|FG013|Overall Study|Withdrawal by Subject|0|||
105945270|NCT04756531|365462861|FG014|Overall Study|Withdrawal by Subject|0|||
105945271|NCT04756531|365462862|FG015|Overall Study|Withdrawal by Subject|0|||
105945272|NCT04756531|365462863|FG016|Overall Study|Withdrawal by Subject|0|||
105945273|NCT04756531|365462864|FG017|Overall Study|Withdrawal by Subject|0|||
105945274|NCT05318287|365462865|FG000|Overall Study|Lost to Follow-up|8|||
105945275|NCT03537508|365462868|FG000|Overall Study|Adverse Event|2|||
105945276|NCT03537508|365462869|FG001|Overall Study|Adverse Event|1|||
105945277|NCT03537508|365462868|FG000|Overall Study|Protocol Violation|65|||
105945278|NCT03537508|365462869|FG001|Overall Study|Protocol Violation|48|||
105945279|NCT03537508|365462868|FG000|Overall Study|Lost to Follow-up|86|||
106016088|NCT00463567|365724396|FG003|Overall Study|Withdrawal by Subject|37|||
106016089|NCT00463567|365724397|FG004|Overall Study|Withdrawal by Subject|6|||
106016090|NCT00463567|365724398|FG005|Overall Study|Withdrawal by Subject|5|||
106016091|NCT00463567|365724399|FG006|Overall Study|Withdrawal by Subject|1|||
106016092|NCT00463567|365724393|FG000|Overall Study|Protocol Deviation|13|||
106016093|NCT00463567|365724394|FG001|Overall Study|Protocol Deviation|9|||
106016094|NCT00463567|365724395|FG002|Overall Study|Protocol Deviation|14|||
106016095|NCT00463567|365724396|FG003|Overall Study|Protocol Deviation|11|||
106016096|NCT00463567|365724397|FG004|Overall Study|Protocol Deviation|1|||
106016097|NCT00463567|365724398|FG005|Overall Study|Protocol Deviation|1|||
106016098|NCT00463567|365724399|FG006|Overall Study|Protocol Deviation|2|||
106016099|NCT00463567|365724393|FG000|Overall Study|Lost to Follow-up|12|||
106016100|NCT00463567|365724394|FG001|Overall Study|Lost to Follow-up|6|||
106016101|NCT00463567|365724395|FG002|Overall Study|Lost to Follow-up|13|||
106016102|NCT00463567|365724396|FG003|Overall Study|Lost to Follow-up|8|||
106016103|NCT00463567|365724397|FG004|Overall Study|Lost to Follow-up|1|||
106016104|NCT00463567|365724398|FG005|Overall Study|Lost to Follow-up|1|||
106016105|NCT00463567|365724399|FG006|Overall Study|Lost to Follow-up|1|||
106016106|NCT00463567|365724393|FG000|Overall Study|Administrative problems|5|||
106016107|NCT00463567|365724394|FG001|Overall Study|Administrative problems|3|||
106016108|NCT00463567|365724395|FG002|Overall Study|Administrative problems|6|||
106016109|NCT00463567|365724396|FG003|Overall Study|Administrative problems|9|||
106016110|NCT00463567|365724397|FG004|Overall Study|Administrative problems|3|||
106016111|NCT00463567|365724398|FG005|Overall Study|Administrative problems|2|||
106016112|NCT00463567|365724399|FG006|Overall Study|Administrative problems|2|||
106016113|NCT00463567|365724393|FG000|Overall Study|Lack of Efficacy|4|||
106016114|NCT00463567|365724394|FG001|Overall Study|Lack of Efficacy|9|||
106016115|NCT00463567|365724395|FG002|Overall Study|Lack of Efficacy|9|||
106016116|NCT00463567|365724396|FG003|Overall Study|Lack of Efficacy|17|||
106016117|NCT00463567|365724397|FG004|Overall Study|Lack of Efficacy|1|||
106016118|NCT00463567|365724398|FG005|Overall Study|Lack of Efficacy|0|||
106016119|NCT00463567|365724399|FG006|Overall Study|Lack of Efficacy|1|||
106016120|NCT00463567|365724393|FG000|Overall Study|Abnormal lab value(s)|1|||
106016121|NCT00463567|365724394|FG001|Overall Study|Abnormal lab value(s)|1|||
106016122|NCT00463567|365724395|FG002|Overall Study|Abnormal lab value(s)|2|||
106016123|NCT00463567|365724396|FG003|Overall Study|Abnormal lab value(s)|1|||
106016124|NCT00463567|365724397|FG004|Overall Study|Abnormal lab value(s)|1|||
106016125|NCT00463567|365724398|FG005|Overall Study|Abnormal lab value(s)|0|||
106016126|NCT00463567|365724399|FG006|Overall Study|Abnormal lab value(s)|0|||
106016127|NCT00463567|365724393|FG000|Overall Study|Abnormal test procedure result(s)|1|||
106016128|NCT00463567|365724394|FG001|Overall Study|Abnormal test procedure result(s)|1|||
106016129|NCT00463567|365724395|FG002|Overall Study|Abnormal test procedure result(s)|6|||
106016130|NCT00463567|365724396|FG003|Overall Study|Abnormal test procedure result(s)|2|||
106016131|NCT00463567|365724397|FG004|Overall Study|Abnormal test procedure result(s)|0|||
106016132|NCT00463567|365724398|FG005|Overall Study|Abnormal test procedure result(s)|2|||
106016133|NCT00463567|365724399|FG006|Overall Study|Abnormal test procedure result(s)|0|||
106016134|NCT00463567|365724393|FG000|Overall Study|Death|1|||
106016135|NCT00463567|365724394|FG001|Overall Study|Death|0|||
106016136|NCT00463567|365724395|FG002|Overall Study|Death|2|||
106016137|NCT00463567|365724396|FG003|Overall Study|Death|0|||
105945280|NCT03537508|365462869|FG001|Overall Study|Lost to Follow-up|60|||
105760888|NCT01831804|364778038|FG002|Overall Study|Withdrew Consent|0|||
105945281|NCT03537508|365462868|FG000|Overall Study|Withdrawal by parent/guardian|263|||
106016138|NCT00463567|365724397|FG004|Overall Study|Death|0|||
106016139|NCT00463567|365724398|FG005|Overall Study|Death|0|||
106016140|NCT00463567|365724399|FG006|Overall Study|Death|0|||
106016141|NCT01458392|365724402|FG000|Overall Study|Death|2|||
105945282|NCT03537508|365462869|FG001|Overall Study|Withdrawal by parent/guardian|149|||
105945283|NCT04466891|365462873|FG000|Overall Study|Death|52|||
105945284|NCT04466891|365462874|FG001|Overall Study|Death|5|||
105945285|NCT04466891|365462873|FG000|Overall Study|Withdrawal by Subject|8|||
105945286|NCT04466891|365462874|FG001|Overall Study|Withdrawal by Subject|1|||
105945287|NCT02457793|365462878|FG000|Overall Study|Reason not specified|0|||
105945288|NCT02457793|365462879|FG001|Overall Study|Reason not specified|0|||
105945289|NCT02457793|365462880|FG002|Overall Study|Reason not specified|0|||
105945290|NCT02457793|365462881|FG003|Overall Study|Reason not specified|1|||
105945291|NCT02457793|365462882|FG004|Overall Study|Reason not specified|1|||
105945292|NCT02457793|365462883|FG005|Overall Study|Reason not specified|1|||
105945293|NCT02457793|365462878|FG000|Overall Study|Withdrawal by Subject|0|||
105945294|NCT02457793|365462879|FG001|Overall Study|Withdrawal by Subject|4|||
105945295|NCT02457793|365462880|FG002|Overall Study|Withdrawal by Subject|2|||
105945296|NCT02457793|365462881|FG003|Overall Study|Withdrawal by Subject|2|||
105945297|NCT02457793|365462882|FG004|Overall Study|Withdrawal by Subject|2|||
105945298|NCT02457793|365462883|FG005|Overall Study|Withdrawal by Subject|2|||
105945299|NCT02457793|365462878|FG000|Overall Study|Adverse Event|0|||
105945300|NCT02457793|365462879|FG001|Overall Study|Adverse Event|0|||
105945301|NCT02457793|365462880|FG002|Overall Study|Adverse Event|0|||
105945302|NCT02457793|365462881|FG003|Overall Study|Adverse Event|1|||
105945303|NCT02457793|365462882|FG004|Overall Study|Adverse Event|0|||
105945304|NCT02457793|365462883|FG005|Overall Study|Adverse Event|0|||
105945305|NCT02457793|365462878|FG000|Overall Study|Physician Decision|1|||
105945306|NCT02457793|365462879|FG001|Overall Study|Physician Decision|0|||
105945307|NCT02457793|365462880|FG002|Overall Study|Physician Decision|1|||
105945308|NCT02457793|365462881|FG003|Overall Study|Physician Decision|1|||
105945309|NCT02457793|365462882|FG004|Overall Study|Physician Decision|1|||
105945310|NCT02457793|365462883|FG005|Overall Study|Physician Decision|3|||
105945311|NCT00835172|365462886|FG000|Washout|Protocol Violation|0|||
105945312|NCT00835172|365462887|FG001|Washout|Protocol Violation|1|||
105945313|NCT04890509|365462888|FG000|Overall Study|Death|4|||
105945314|NCT04890509|365462889|FG001|Overall Study|Death|4|||
105945315|NCT00003645|365463860|FG000|Overall Study|Death|4|||
105945316|NCT00003645|365463861|FG001|Overall Study|Death|1|||
105945317|NCT00003645|365463860|FG000|Overall Study|Lost to Follow-up|7|||
105945318|NCT00003645|365463861|FG001|Overall Study|Lost to Follow-up|8|||
105945319|NCT00003645|365463860|FG000|Overall Study|Withdrawal by Subject|1|||
105945320|NCT00003645|365463861|FG001|Overall Study|Withdrawal by Subject|3|||
105945321|NCT04490278|365463864|FG000|Overall Study|Lost to Follow-up|6|||
105945322|NCT00565747|365463874|FG000|Overall Study|No embryo transfer|67|||
105945323|NCT00565747|365463875|FG001|Overall Study|No embryo transfer|73|||
105945324|NCT00415636|365463876|FG000|Overall Study|Symptomatic deterioration|1|||
105945325|NCT00415636|365463877|FG001|Overall Study|Symptomatic deterioration|0|||
105945326|NCT00415636|365463878|FG002|Overall Study|Symptomatic deterioration|1|||
105945327|NCT00415636|365463879|FG003|Overall Study|Symptomatic deterioration|2|||
105945328|NCT00415636|365463880|FG004|Overall Study|Symptomatic deterioration|0|||
105945329|NCT00415636|365463881|FG005|Overall Study|Symptomatic deterioration|1|||
105945330|NCT00415636|365463876|FG000|Overall Study|Adverse Event|0|||
105945331|NCT00415636|365463877|FG001|Overall Study|Adverse Event|0|||
105945332|NCT00415636|365463878|FG002|Overall Study|Adverse Event|0|||
105945333|NCT00415636|365463879|FG003|Overall Study|Adverse Event|1|||
105945334|NCT00415636|365463880|FG004|Overall Study|Adverse Event|1|||
105945335|NCT00415636|365463881|FG005|Overall Study|Adverse Event|0|||
105945336|NCT00415636|365463876|FG000|Overall Study|Withdrawal by Subject|0|||
105945337|NCT00415636|365463877|FG001|Overall Study|Withdrawal by Subject|0|||
105945338|NCT00415636|365463878|FG002|Overall Study|Withdrawal by Subject|0|||
105945339|NCT00415636|365463879|FG003|Overall Study|Withdrawal by Subject|0|||
105945340|NCT00415636|365463880|FG004|Overall Study|Withdrawal by Subject|1|||
105945341|NCT00415636|365463881|FG005|Overall Study|Withdrawal by Subject|0|||
105945342|NCT00415636|365463876|FG000|Overall Study|Disease progression|0|||
105945343|NCT00415636|365463877|FG001|Overall Study|Disease progression|0|||
105945344|NCT00415636|365463878|FG002|Overall Study|Disease progression|0|||
105945345|NCT00415636|365463879|FG003|Overall Study|Disease progression|3|||
105945346|NCT00415636|365463880|FG004|Overall Study|Disease progression|0|||
105945347|NCT00415636|365463881|FG005|Overall Study|Disease progression|1|||
105945348|NCT02138825|365463882|FG000|Main Study Treatment|Adverse Event|11|||
105945349|NCT02138825|365463883|FG001|Main Study Treatment|Adverse Event|3|||
105945350|NCT02138825|365463882|FG000|Main Study Treatment|Death|1|||
105945351|NCT02138825|365463883|FG001|Main Study Treatment|Death|2|||
105945352|NCT02138825|365463882|FG000|Main Study Treatment|Protocol Violation|2|||
105945353|NCT02138825|365463883|FG001|Main Study Treatment|Protocol Violation|2|||
105945354|NCT02138825|365463882|FG000|Main Study Treatment|Sponsor decision|12|||
105945355|NCT02138825|365463883|FG001|Main Study Treatment|Sponsor decision|18|||
105945356|NCT02138825|365463882|FG000|Main Study Treatment|Study terminated by sponsor|10|||
105945357|NCT02138825|365463883|FG001|Main Study Treatment|Study terminated by sponsor|9|||
105945358|NCT02138825|365463882|FG000|Main Study Treatment|Withdrawal by Subject|3|||
105945359|NCT02138825|365463883|FG001|Main Study Treatment|Withdrawal by Subject|1|||
105945360|NCT02138825|365463882|FG000|Main Study Treatment|Medical decision|1|||
105945361|NCT02138825|365463883|FG001|Main Study Treatment|Medical decision|0|||
105945362|NCT02138825|365463882|FG000|Long-term Extension|Study termination by sponsor|32|||
105945363|NCT02138825|365463883|FG001|Long-term Extension|Study termination by sponsor|38|||
105945364|NCT02138825|365463882|FG000|Safety Follow-up|Adverse Event|4|||
105945365|NCT02138825|365463883|FG001|Safety Follow-up|Adverse Event|3|||
105945366|NCT02138825|365463882|FG000|Safety Follow-up|Death|11|||
105945367|NCT02138825|365463883|FG001|Safety Follow-up|Death|5|||
105945368|NCT02138825|365463882|FG000|Safety Follow-up|Withdrawal by Subject|5|||
105945369|NCT02138825|365463883|FG001|Safety Follow-up|Withdrawal by Subject|3|||
105945370|NCT02138825|365463882|FG000|Safety Follow-up|clinic worsening|1|||
105945371|NCT02138825|365463883|FG001|Safety Follow-up|clinic worsening|0|||
105945372|NCT02138825|365463882|FG000|Safety Follow-up|withdrawal by PI|1|||
105945373|NCT02138825|365463883|FG001|Safety Follow-up|withdrawal by PI|0|||
105945374|NCT02138825|365463882|FG000|Safety Follow-up|logistical difficulties|0|||
105945375|NCT02138825|365463883|FG001|Safety Follow-up|logistical difficulties|1|||
105945376|NCT02138825|365463882|FG000|Safety Follow-up|progressive disease|0|||
105945377|NCT02138825|365463883|FG001|Safety Follow-up|progressive disease|2|||
105945378|NCT02138825|365463882|FG000|Safety Follow-up|too unwell to attend the visit|0|||
105945379|NCT02138825|365463883|FG001|Safety Follow-up|too unwell to attend the visit|1|||
105945380|NCT02138825|365463882|FG000|Safety Follow-up|treatment unblinded|0|||
105945381|NCT02138825|365463883|FG001|Safety Follow-up|treatment unblinded|1|||
105945382|NCT02138825|365463882|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
105945383|NCT02138825|365463883|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
105945384|NCT01517984|365463885|FG000|Overall Study|Lost to Follow-up|0|||
105945385|NCT01517984|365463886|FG001|Overall Study|Lost to Follow-up|1|||
105945386|NCT01517984|365463887|FG002|Overall Study|Lost to Follow-up|0|||
105945387|NCT01517984|365463888|FG003|Overall Study|Lost to Follow-up|0|||
105945388|NCT01517984|365463885|FG000|Overall Study|Withdrawal by Subject|1|||
105945389|NCT01517984|365463886|FG001|Overall Study|Withdrawal by Subject|8|||
105945390|NCT01517984|365463887|FG002|Overall Study|Withdrawal by Subject|4|||
105945391|NCT01517984|365463888|FG003|Overall Study|Withdrawal by Subject|1|||
105945392|NCT01517984|365463885|FG000|Overall Study|Screen Failure|4|||
105945393|NCT01517984|365463886|FG001|Overall Study|Screen Failure|0|||
105945394|NCT01517984|365463887|FG002|Overall Study|Screen Failure|0|||
105945395|NCT01517984|365463888|FG003|Overall Study|Screen Failure|0|||
105945396|NCT01517984|365463885|FG000|Overall Study|Ineligible for randomization|0|||
105945397|NCT01517984|365463886|FG001|Overall Study|Ineligible for randomization|14|||
105945398|NCT01517984|365463887|FG002|Overall Study|Ineligible for randomization|0|||
105945399|NCT01517984|365463888|FG003|Overall Study|Ineligible for randomization|0|||
105945400|NCT05067335|365463889|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
105945401|NCT05067335|365463890|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
105945402|NCT05067335|365463891|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
105945403|NCT05067335|365463892|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
105945404|NCT05067335|365463889|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
105945405|NCT05067335|365463890|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
105945406|NCT05067335|365463891|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
105945407|NCT05067335|365463892|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
105945408|NCT05067335|365463889|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
105945409|NCT05067335|365463890|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
105945410|NCT05067335|365463891|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
105945411|NCT05067335|365463892|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
105945412|NCT05067335|365463889|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
105945413|NCT05067335|365463890|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
105945414|NCT05067335|365463891|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
105945415|NCT05067335|365463892|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
105945416|NCT05067335|365463889|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
105945417|NCT05067335|365463890|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
105945418|NCT05067335|365463891|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
105945419|NCT05067335|365463892|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
105945420|NCT05067335|365463889|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
105945421|NCT05067335|365463890|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
105945422|NCT05067335|365463891|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
106016142|NCT01458392|365724403|FG001|Overall Study|Death|11|||
106142759|NCT00841035|366181978|FG000|Phase 1 Overall Study|Physician Decision|13|||
106142760|NCT03603717|366181989|FG000|Overall Study|Lost to Follow-up|20|||
106142761|NCT03603717|366181990|FG001|Overall Study|Lost to Follow-up|20|||
106142762|NCT03603717|366181989|FG000|Overall Study|Withdrawal by Subject|16|||
106142763|NCT03603717|366181990|FG001|Overall Study|Withdrawal by Subject|10|||
106142764|NCT00430300|366181996|FG000|Overall Study|Adverse Event|0|||
106142765|NCT00430300|366181997|FG001|Overall Study|Adverse Event|2|||
105801665|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801666|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801667|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
105801668|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
105801669|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
105801670|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801671|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
105801672|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801673|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
105801674|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
105801675|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
105801676|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801677|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801678|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801679|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801680|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801681|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
105801682|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801683|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
105801684|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105801685|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105801686|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105945423|NCT05067335|365463892|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
105945424|NCT05067335|365463889|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
106016143|NCT01458392|365724404|FG002|Overall Study|Death|22|||
106016144|NCT01458392|365724402|FG000|Overall Study|At the discretion of the sponsor|0|||
106016145|NCT01458392|365724403|FG001|Overall Study|At the discretion of the sponsor|2|||
106016146|NCT01458392|365724404|FG002|Overall Study|At the discretion of the sponsor|7|||
105945425|NCT05067335|365463890|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
105945426|NCT05067335|365463891|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
105945427|NCT05067335|365463892|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
105945428|NCT05067335|365463889|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
106016147|NCT01458392|365724402|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
106016148|NCT01458392|365724403|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
106016149|NCT01458392|365724404|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
106016150|NCT03841604|365724407|FG000|Overall Study|Withdrawal by Subject|3|||
106016151|NCT03841604|365724408|FG001|Overall Study|Withdrawal by Subject|1|||
106016152|NCT03841604|365724407|FG000|Overall Study|Adverse Event|4|||
105945429|NCT05067335|365463890|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
105945430|NCT05067335|365463891|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
105945431|NCT05067335|365463892|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
105750283|NCT02618928|364738805|FG000|Overall Study|Insufficient Virological Response|1|||
105750284|NCT02618928|364738805|FG000|Overall Study|Withdrawal by Subject|2|||
105750285|NCT02618928|364738805|FG000|Overall Study|Death|3|||
106016153|NCT03841604|365724408|FG001|Overall Study|Adverse Event|2|||
106016154|NCT03841604|365724407|FG000|Overall Study|Physician Decision|1|||
106016155|NCT03841604|365724408|FG001|Overall Study|Physician Decision|0|||
106016156|NCT02395471|365724412|FG000|Overall Study|Lost to Follow-up|2|||
106016157|NCT02395471|365724413|FG001|Overall Study|Lost to Follow-up|0|||
106016158|NCT02395471|365724412|FG000|Overall Study|Withdrawal by Subject|2|||
106016159|NCT02395471|365724413|FG001|Overall Study|Withdrawal by Subject|1|||
106016160|NCT02395471|365724412|FG000|Overall Study|Physician Decision|1|||
106016161|NCT02395471|365724413|FG001|Overall Study|Physician Decision|0|||
106016162|NCT02395471|365724412|FG000|Overall Study|Protocol Violation|0|||
106016163|NCT02395471|365724413|FG001|Overall Study|Protocol Violation|1|||
106016164|NCT02395471|365724412|FG000|Overall Study|Failure to swollow sponge twice|1|||
106016165|NCT02395471|365724413|FG001|Overall Study|Failure to swollow sponge twice|0|||
106016166|NCT02395471|365724412|FG000|Overall Study|Patient did not return for procedure|0|||
106016167|NCT02395471|365724413|FG001|Overall Study|Patient did not return for procedure|1|||
106016168|NCT02395471|365724412|FG000|Overall Study|Subject not eligible|1|||
106016169|NCT02395471|365724413|FG001|Overall Study|Subject not eligible|0|||
105750286|NCT02618928|364738805|FG000|Overall Study|Other|11|||
105750287|NCT02618928|364738805|FG000|Overall Study|Missing|6|||
105750288|NCT02618928|364738805|FG000|Overall Study|Treatment Never Started|7|||
105750289|NCT00264849|364738812|FG000|Overall Study|Adverse Event|7|||
105750290|NCT00264849|364738813|FG001|Overall Study|Adverse Event|2|||
105750291|NCT00264849|364738812|FG000|Overall Study|Withdrawal by Subject|7|||
105750292|NCT00264849|364738813|FG001|Overall Study|Withdrawal by Subject|11|||
105801687|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
106016170|NCT00711191|365724414|FG000|Overall Study|Adverse Event|1|||
106016171|NCT00711191|365724415|FG001|Overall Study|Adverse Event|1|||
105750293|NCT00264849|364738812|FG000|Overall Study|Protocol Violation|5|||
105945432|NCT05067335|365463889|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
105945433|NCT05067335|365463890|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
105945434|NCT05067335|365463891|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
105945435|NCT05067335|365463892|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
105945436|NCT05067335|365463889|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
105945437|NCT05067335|365463890|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
105945438|NCT05067335|365463891|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
105945439|NCT05067335|365463892|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
105945440|NCT02164864|365463893|FG000|Overall Study|Trial disease worsening|7|||
105945441|NCT02164864|365463894|FG001|Overall Study|Trial disease worsening|5|||
105945442|NCT02164864|365463895|FG002|Overall Study|Trial disease worsening|1|||
105945443|NCT02164864|365463893|FG000|Overall Study|Other pre-existing disease worsening|6|||
105945444|NCT02164864|365463894|FG001|Overall Study|Other pre-existing disease worsening|4|||
105945445|NCT02164864|365463895|FG002|Overall Study|Other pre-existing disease worsening|9|||
105945446|NCT02164864|365463893|FG000|Overall Study|Other Adverse Event (AE)|52|||
105945447|NCT02164864|365463894|FG001|Overall Study|Other Adverse Event (AE)|32|||
105945448|NCT02164864|365463895|FG002|Overall Study|Other Adverse Event (AE)|49|||
105945449|NCT02164864|365463893|FG000|Overall Study|Protocol Violation|2|||
105945450|NCT02164864|365463894|FG001|Overall Study|Protocol Violation|4|||
105945451|NCT02164864|365463895|FG002|Overall Study|Protocol Violation|1|||
105945452|NCT02164864|365463893|FG000|Overall Study|Lost to Follow-up|4|||
105945453|NCT02164864|365463894|FG001|Overall Study|Lost to Follow-up|3|||
105945454|NCT02164864|365463895|FG002|Overall Study|Lost to Follow-up|2|||
105945455|NCT02164864|365463893|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
105945456|NCT02164864|365463894|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
105945457|NCT02164864|365463895|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
105750294|NCT00264849|364738813|FG001|Overall Study|Protocol Violation|3|||
105750295|NCT00264849|364738812|FG000|Overall Study|Lack of Efficacy|1|||
105750296|NCT00264849|364738813|FG001|Overall Study|Lack of Efficacy|6|||
105750297|NCT00264849|364738812|FG000|Overall Study|Lost to Follow-up|0|||
105750298|NCT00264849|364738813|FG001|Overall Study|Lost to Follow-up|2|||
105750299|NCT00264849|364738812|FG000|Overall Study|Death|0|||
105750300|NCT00264849|364738813|FG001|Overall Study|Death|1|||
105750301|NCT00264849|364738812|FG000|Overall Study|Administrative Problems|2|||
105750302|NCT00264849|364738813|FG001|Overall Study|Administrative Problems|0|||
105750303|NCT00099359|364738814|FG000|Overall Study|Death|11|||
105750304|NCT00099359|364738815|FG001|Overall Study|Death|15|||
105750305|NCT00099359|364738816|FG002|Overall Study|Death|17|||
105750306|NCT00099359|364738814|FG000|Overall Study|Withdrawal by Subject|19|||
105750307|NCT00099359|364738815|FG001|Overall Study|Withdrawal by Subject|19|||
105750308|NCT00099359|364738816|FG002|Overall Study|Withdrawal by Subject|23|||
105750309|NCT00099359|364738814|FG000|Overall Study|Lost to Follow-up|15|||
105750310|NCT00099359|364738815|FG001|Overall Study|Lost to Follow-up|24|||
105750311|NCT00099359|364738816|FG002|Overall Study|Lost to Follow-up|24|||
105750312|NCT00099359|364738814|FG000|Overall Study|moved out of area|9|||
105750313|NCT00099359|364738815|FG001|Overall Study|moved out of area|7|||
105750314|NCT00099359|364738816|FG002|Overall Study|moved out of area|4|||
105750315|NCT01982773|364738817|FG000|Overall Study|Withdrawal by Subject|1|||
105945458|NCT02164864|365463893|FG000|Overall Study|Other than stated|3|||
105945459|NCT02164864|365463894|FG001|Overall Study|Other than stated|4|||
105945460|NCT02164864|365463895|FG002|Overall Study|Other than stated|14|||
105945461|NCT00652834|365463896|FG000|Overall Study|Withdrawal by Subject|3|||
105945462|NCT00652834|365463896|FG000|Overall Study|Lost to Follow-up|2|||
105945463|NCT02434081|365463897|FG000|Overall Study|Death (never started treatment)|2|||
105945464|NCT02434081|365463897|FG000|Overall Study|Death|2|||
105945465|NCT02434081|365463897|FG000|Overall Study|Progression|20|||
105945466|NCT02434081|365463897|FG000|Overall Study|Adverse Event|20|||
105945467|NCT02434081|365463897|FG000|Overall Study|Physician Decision|2|||
105945468|NCT02434081|365463897|FG000|Overall Study|Withdrawal by Subject|1|||
105945469|NCT02434081|365463897|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
105945470|NCT00419744|365463898|FG000|Overall Study|Adverse Event|39|||
105945471|NCT00419744|365463899|FG001|Overall Study|Adverse Event|40|||
105945472|NCT00419744|365463900|FG002|Overall Study|Adverse Event|50|||
105945473|NCT00419744|365463898|FG000|Overall Study|Withdrawal by Subject|45|||
105945474|NCT00419744|365463899|FG001|Overall Study|Withdrawal by Subject|49|||
105945475|NCT00419744|365463900|FG002|Overall Study|Withdrawal by Subject|52|||
105945476|NCT00419744|365463898|FG000|Overall Study|Lost to Follow-up|8|||
105945477|NCT00419744|365463899|FG001|Overall Study|Lost to Follow-up|10|||
105945478|NCT00419744|365463900|FG002|Overall Study|Lost to Follow-up|6|||
105750316|NCT01982773|364738818|FG001|Overall Study|Withdrawal by Subject|3|||
105750317|NCT01982773|364738817|FG000|Overall Study|Lost to Follow-up|7|||
105750318|NCT01982773|364738818|FG001|Overall Study|Lost to Follow-up|1|||
105945479|NCT00419744|365463898|FG000|Overall Study|Protocol Violation|4|||
105945480|NCT00419744|365463899|FG001|Overall Study|Protocol Violation|7|||
105945481|NCT00419744|365463900|FG002|Overall Study|Protocol Violation|8|||
105945482|NCT00419744|365463898|FG000|Overall Study|Randomized in error|9|||
105945483|NCT00419744|365463899|FG001|Overall Study|Randomized in error|6|||
105945484|NCT00419744|365463900|FG002|Overall Study|Randomized in error|7|||
105945485|NCT00419744|365463898|FG000|Overall Study|Moving out of state|2|||
105945486|NCT00419744|365463899|FG001|Overall Study|Moving out of state|0|||
105945487|NCT00419744|365463900|FG002|Overall Study|Moving out of state|1|||
105945488|NCT00419744|365463898|FG000|Overall Study|Physician Decision|10|||
105945489|NCT00419744|365463899|FG001|Overall Study|Physician Decision|5|||
105945490|NCT00419744|365463900|FG002|Overall Study|Physician Decision|6|||
105945491|NCT00419744|365463898|FG000|Overall Study|Spirometry mouthpiece issues|0|||
105945492|NCT00419744|365463899|FG001|Overall Study|Spirometry mouthpiece issues|1|||
105945493|NCT00419744|365463900|FG002|Overall Study|Spirometry mouthpiece issues|2|||
105945494|NCT00419744|365463898|FG000|Overall Study|Incorrect medication kit dispensed|0|||
105945495|NCT00419744|365463899|FG001|Overall Study|Incorrect medication kit dispensed|0|||
105945496|NCT00419744|365463900|FG002|Overall Study|Incorrect medication kit dispensed|1|||
105945497|NCT05448950|365463902|FG000|Overall Study|Death|2|||
105945498|NCT05448950|365463902|FG000|Overall Study|Withdrawal by Subject|1|||
105945499|NCT05448950|365463902|FG000|Overall Study|AVG abandoned|4|||
105945500|NCT00879398|365463903|FG000|Overall Study|Visit Stop|399|||
105945501|NCT00879398|365463903|FG000|Overall Study|Lack of Efficacy|64|||
105945502|NCT00879398|365463903|FG000|Overall Study|Adverse Event|41|||
105945503|NCT00879398|365463903|FG000|Overall Study|Other Reasons|171|||
106016172|NCT00711191|365724416|FG002|Overall Study|Adverse Event|2|||
106016173|NCT00711191|365724414|FG000|Overall Study|Objective progression or relapse|2|||
106016174|NCT00711191|365724415|FG001|Overall Study|Objective progression or relapse|3|||
106016175|NCT00711191|365724416|FG002|Overall Study|Objective progression or relapse|7|||
106016176|NCT00711191|365724414|FG000|Overall Study|Withdrawal by Subject|0|||
106016177|NCT00711191|365724415|FG001|Overall Study|Withdrawal by Subject|1|||
106016178|NCT00711191|365724416|FG002|Overall Study|Withdrawal by Subject|3|||
106016179|NCT02035267|365724417|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
106016180|NCT02035267|365724418|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
106016181|NCT02035267|365724419|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
106016182|NCT02035267|365724420|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
106016183|NCT02035267|365724417|FG000|Overall Study|Adverse Event|0|||
106016184|NCT02035267|365724418|FG001|Overall Study|Adverse Event|0|||
106016185|NCT02035267|365724419|FG002|Overall Study|Adverse Event|1|||
106016186|NCT02035267|365724420|FG003|Overall Study|Adverse Event|0|||
106016187|NCT02035267|365724417|FG000|Overall Study|Lost to Follow-up|0|||
106016188|NCT02035267|365724418|FG001|Overall Study|Lost to Follow-up|0|||
106016189|NCT02035267|365724419|FG002|Overall Study|Lost to Follow-up|0|||
106016190|NCT02035267|365724420|FG003|Overall Study|Lost to Follow-up|1|||
106016191|NCT02035267|365724417|FG000|Overall Study|Other unspecified|0|||
106016192|NCT02035267|365724418|FG001|Overall Study|Other unspecified|1|||
106016193|NCT02035267|365724419|FG002|Overall Study|Other unspecified|0|||
106016194|NCT02035267|365724420|FG003|Overall Study|Other unspecified|0|||
106016195|NCT00836693|365724421|FG000|Overall Study|Adverse Event|4|||
106016196|NCT00836693|365724422|FG001|Overall Study|Adverse Event|1|||
106016197|NCT00836693|365724421|FG000|Overall Study|Sponsor Decision|0|||
106016198|NCT00836693|365724422|FG001|Overall Study|Sponsor Decision|1|||
106016199|NCT00836693|365724421|FG000|Overall Study|Physician Decision|2|||
106016200|NCT00836693|365724422|FG001|Overall Study|Physician Decision|0|||
106016201|NCT00836693|365724421|FG000|Overall Study|Withdrawal by Subject|9|||
106016202|NCT00836693|365724422|FG001|Overall Study|Withdrawal by Subject|4|||
106016203|NCT00836693|365724421|FG000|Overall Study|Protocol Violation|1|||
105945504|NCT03189719|365463909|FG000|Overall Study|Death|325|||
105945505|NCT03189719|365463910|FG001|Overall Study|Death|361|||
105750319|NCT02509494|364738819|FG000|Overall Study|Lost to Follow-up|8|||
105750320|NCT02509494|364738820|FG001|Overall Study|Lost to Follow-up|47|||
105945506|NCT03189719|365463909|FG000|Overall Study|Physician Decision|1|||
105945507|NCT03189719|365463910|FG001|Overall Study|Physician Decision|0|||
105945508|NCT03189719|365463909|FG000|Overall Study|Sponsor Decision|40|||
106016204|NCT00836693|365724422|FG001|Overall Study|Protocol Violation|0|||
105750321|NCT02509494|364738821|FG002|Overall Study|Lost to Follow-up|19|||
105945509|NCT03189719|365463910|FG001|Overall Study|Sponsor Decision|12|||
105945510|NCT03189719|365463909|FG000|Overall Study|Withdrawal by Subject|7|||
105945511|NCT03189719|365463910|FG001|Overall Study|Withdrawal by Subject|3|||
105945512|NCT04532749|365463913|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
105945513|NCT04532749|365463914|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
106016205|NCT00836693|365724421|FG000|Overall Study|Lost to Follow-up|1|||
106016206|NCT00836693|365724422|FG001|Overall Study|Lost to Follow-up|0|||
106016207|NCT02612779|365724423|FG000|Overall Study|Administrative reason by sponsor|4|||
106016208|NCT02612779|365724424|FG001|Overall Study|Administrative reason by sponsor|1|||
106016209|NCT02612779|365724423|FG000|Overall Study|No longer meet study criteria|0|||
106142766|NCT00430300|366181998|FG002|Overall Study|Adverse Event|1|||
105945514|NCT04532749|365463913|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
105945515|NCT04532749|365463914|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
105945516|NCT04532749|365463913|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
105945517|NCT04532749|365463914|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
105945518|NCT04532749|365463913|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
105945519|NCT04532749|365463914|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
105945520|NCT04532749|365463913|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
105945521|NCT04532749|365463914|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
105945522|NCT04532749|365463913|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
105945523|NCT04532749|365463914|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
105945524|NCT04532749|365463913|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
105945525|NCT04532749|365463914|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
105750322|NCT02509494|364738822|FG003|Overall Study|Lost to Follow-up|6|||
105750323|NCT02509494|364738823|FG004|Overall Study|Lost to Follow-up|3|||
105750324|NCT02509494|364738824|FG005|Overall Study|Lost to Follow-up|3|||
105750325|NCT02509494|364738825|FG006|Overall Study|Lost to Follow-up|1|||
105750326|NCT02509494|364738826|FG007|Overall Study|Lost to Follow-up|3|||
105750327|NCT02509494|364738827|FG008|Overall Study|Lost to Follow-up|1|||
105750328|NCT02509494|364738819|FG000|Overall Study|Physician Decision|2|||
105750329|NCT02509494|364738820|FG001|Overall Study|Physician Decision|1|||
106016210|NCT02612779|365724424|FG001|Overall Study|No longer meet study criteria|1|||
106016211|NCT02612779|365724423|FG000|Overall Study|Disease progression|29|||
106016212|NCT02612779|365724424|FG001|Overall Study|Disease progression|2|||
105750330|NCT02509494|364738821|FG002|Overall Study|Physician Decision|0|||
105750331|NCT02509494|364738822|FG003|Overall Study|Physician Decision|0|||
105750332|NCT02509494|364738823|FG004|Overall Study|Physician Decision|0|||
105750333|NCT02509494|364738824|FG005|Overall Study|Physician Decision|0|||
105750334|NCT02509494|364738825|FG006|Overall Study|Physician Decision|0|||
105750335|NCT02509494|364738826|FG007|Overall Study|Physician Decision|0|||
105750336|NCT02509494|364738827|FG008|Overall Study|Physician Decision|0|||
105750337|NCT02509494|364738819|FG000|Overall Study|Withdrawal by Subject|4|||
105750338|NCT02509494|364738820|FG001|Overall Study|Withdrawal by Subject|17|||
105750339|NCT02509494|364738821|FG002|Overall Study|Withdrawal by Subject|7|||
105750340|NCT02509494|364738822|FG003|Overall Study|Withdrawal by Subject|5|||
105750341|NCT02509494|364738823|FG004|Overall Study|Withdrawal by Subject|0|||
105750342|NCT02509494|364738824|FG005|Overall Study|Withdrawal by Subject|6|||
105750343|NCT02509494|364738825|FG006|Overall Study|Withdrawal by Subject|1|||
105750344|NCT02509494|364738826|FG007|Overall Study|Withdrawal by Subject|2|||
105750345|NCT02509494|364738827|FG008|Overall Study|Withdrawal by Subject|1|||
105750346|NCT02509494|364738819|FG000|Overall Study|Death|0|||
105750347|NCT02509494|364738820|FG001|Overall Study|Death|1|||
105750348|NCT02509494|364738821|FG002|Overall Study|Death|0|||
105750349|NCT02509494|364738822|FG003|Overall Study|Death|0|||
105750350|NCT02509494|364738823|FG004|Overall Study|Death|1|||
105750351|NCT02509494|364738824|FG005|Overall Study|Death|0|||
105750352|NCT02509494|364738825|FG006|Overall Study|Death|0|||
105750353|NCT02509494|364738826|FG007|Overall Study|Death|1|||
105750354|NCT02509494|364738827|FG008|Overall Study|Death|0|||
105801688|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
105945526|NCT04532749|365463913|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
105945527|NCT04532749|365463914|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
105945528|NCT04532749|365463913|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
106016213|NCT02612779|365724423|FG000|Overall Study|Study drug toxicity|10|||
106016214|NCT02612779|365724424|FG001|Overall Study|Study drug toxicity|1|||
106016215|NCT02612779|365724423|FG000|Overall Study|Death|1|||
106016216|NCT02612779|365724424|FG001|Overall Study|Death|0|||
106016217|NCT02612779|365724423|FG000|Overall Study|Adverse event unrelated to study drug|5|||
106016218|NCT02612779|365724424|FG001|Overall Study|Adverse event unrelated to study drug|0|||
106016219|NCT02612779|365724423|FG000|Overall Study|Participant withdrew consent|4|||
106016220|NCT02612779|365724424|FG001|Overall Study|Participant withdrew consent|0|||
106016221|NCT02612779|365724423|FG000|Overall Study|Lost to Follow-up|1|||
106016222|NCT02612779|365724424|FG001|Overall Study|Lost to Follow-up|0|||
106016223|NCT02612779|365724423|FG000|Overall Study|Maximum clinical benefit|10|||
106016224|NCT02612779|365724424|FG001|Overall Study|Maximum clinical benefit|1|||
106016225|NCT02612779|365724423|FG000|Overall Study|Other reasons|4|||
106016226|NCT02612779|365724424|FG001|Overall Study|Other reasons|0|||
106016227|NCT03594110|365724428|FG000|Interventional Part|Participant concerned about study treatment|23|||
106016228|NCT03594110|365724429|FG001|Interventional Part|Participant concerned about study treatment|28|||
105750355|NCT02509494|364738819|FG000|Overall Study|Other|0|||
105750356|NCT02509494|364738820|FG001|Overall Study|Other|4|||
105750357|NCT02509494|364738821|FG002|Overall Study|Other|5|||
105750358|NCT02509494|364738822|FG003|Overall Study|Other|0|||
105750359|NCT02509494|364738823|FG004|Overall Study|Other|0|||
105750360|NCT02509494|364738824|FG005|Overall Study|Other|0|||
105945529|NCT04532749|365463914|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
105945530|NCT04532749|365463913|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
105945531|NCT04532749|365463914|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
105945532|NCT02936323|365463915|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105945533|NCT02936323|365463916|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
105945534|NCT02936323|365463917|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105945535|NCT02936323|365463918|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
105945536|NCT02936323|365463919|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
105945537|NCT02936323|365463920|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
105945538|NCT02936323|365463921|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105945539|NCT02936323|365463922|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105945540|NCT02936323|365463923|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105750361|NCT02509494|364738825|FG006|Overall Study|Other|0|||
105750362|NCT02509494|364738826|FG007|Overall Study|Other|0|||
105750363|NCT02509494|364738827|FG008|Overall Study|Other|0|||
105750364|NCT02509494|364738819|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105750365|NCT02509494|364738820|FG001|Overall Study|Non-Compliance With Study Drug|11|||
105945541|NCT02936323|365463924|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
105945542|NCT02936323|365463915|FG000|Phase 1 Dose Escalation|Death|2|||
105945543|NCT02936323|365463916|FG001|Phase 1 Dose Escalation|Death|1|||
105945544|NCT02936323|365463917|FG002|Phase 1 Dose Escalation|Death|3|||
105945545|NCT02936323|365463918|FG003|Phase 1 Dose Escalation|Death|1|||
105945546|NCT02936323|365463919|FG004|Phase 1 Dose Escalation|Death|2|||
105945547|NCT02936323|365463920|FG005|Phase 1 Dose Escalation|Death|3|||
105945548|NCT02936323|365463921|FG006|Phase 1 Dose Escalation|Death|3|||
105945549|NCT02936323|365463922|FG007|Phase 1 Dose Escalation|Death|0|||
105945550|NCT02936323|365463923|FG008|Phase 1 Dose Escalation|Death|0|||
105945551|NCT02936323|365463924|FG009|Phase 1 Dose Escalation|Death|0|||
106016229|NCT03594110|365724428|FG000|Interventional Part|Doctor advice|38|||
106016230|NCT03594110|365724429|FG001|Interventional Part|Doctor advice|40|||
106016231|NCT03594110|365724428|FG000|Interventional Part|Participants' wish|89|||
106016232|NCT03594110|365724429|FG001|Interventional Part|Participants' wish|68|||
106016233|NCT03594110|365724428|FG000|Interventional Part|Adverse event-non-fatal events|119|||
106016234|NCT03594110|365724429|FG001|Interventional Part|Adverse event-non-fatal events|116|||
106016235|NCT03594110|365724428|FG000|Interventional Part|Study drug stopped, reason missing|336|||
106142767|NCT00430300|366181999|FG003|Overall Study|Adverse Event|1|||
105750366|NCT02509494|364738821|FG002|Overall Study|Non-Compliance With Study Drug|7|||
105945552|NCT02936323|365463915|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945553|NCT02936323|365463916|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945554|NCT02936323|365463917|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945555|NCT02936323|365463918|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945556|NCT02936323|365463919|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945557|NCT02936323|365463920|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
105945558|NCT02936323|365463921|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945559|NCT02936323|365463922|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945560|NCT02936323|365463923|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945561|NCT02936323|365463924|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
105945562|NCT02936323|365463915|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105945563|NCT02936323|365463916|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105945564|NCT02936323|365463917|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105945565|NCT02936323|365463918|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105945566|NCT02936323|365463919|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105945567|NCT02936323|365463920|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105945568|NCT02936323|365463921|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
105945569|NCT02936323|365463922|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
105945570|NCT02936323|365463923|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
105945571|NCT02936323|365463924|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
105945572|NCT02936323|365463915|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
105945573|NCT02936323|365463916|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
105945574|NCT02936323|365463917|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
105945575|NCT02936323|365463918|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
105945576|NCT02936323|365463919|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
105945577|NCT02936323|365463920|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
105945578|NCT02936323|365463921|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
105945579|NCT02936323|365463922|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
105945580|NCT02936323|365463923|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
105945581|NCT02936323|365463924|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
105750367|NCT02509494|364738822|FG003|Overall Study|Non-Compliance With Study Drug|0|||
105945582|NCT02936323|365463915|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105945583|NCT02936323|365463916|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105945584|NCT02936323|365463917|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105945585|NCT02936323|365463918|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105945586|NCT02936323|365463919|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105945587|NCT02936323|365463920|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105945588|NCT02936323|365463921|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105945589|NCT02936323|365463922|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
105945590|NCT02936323|365463923|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
105945591|NCT02936323|365463924|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
105945592|NCT02936323|365463915|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945593|NCT02936323|365463916|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945594|NCT02936323|365463917|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945595|NCT02936323|365463918|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945596|NCT02936323|365463919|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945597|NCT02936323|365463920|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945598|NCT02936323|365463921|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945599|NCT02936323|365463922|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945600|NCT02936323|365463923|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
105945601|NCT02936323|365463924|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
105945602|NCT02936323|365463915|FG000|Phase 2a Dose Expansion|Death|0|||
105945603|NCT02936323|365463916|FG001|Phase 2a Dose Expansion|Death|0|||
105945604|NCT02936323|365463917|FG002|Phase 2a Dose Expansion|Death|0|||
105945605|NCT02936323|365463918|FG003|Phase 2a Dose Expansion|Death|0|||
105945606|NCT02936323|365463919|FG004|Phase 2a Dose Expansion|Death|0|||
105945607|NCT02936323|365463920|FG005|Phase 2a Dose Expansion|Death|0|||
105945608|NCT02936323|365463921|FG006|Phase 2a Dose Expansion|Death|0|||
105945609|NCT02936323|365463922|FG007|Phase 2a Dose Expansion|Death|4|||
105945610|NCT02936323|365463923|FG008|Phase 2a Dose Expansion|Death|8|||
105945611|NCT02936323|365463924|FG009|Phase 2a Dose Expansion|Death|10|||
105945612|NCT02781558|365463925|FG000|Overall Study|Lost to Follow-up|2|||
105945613|NCT02781558|365463926|FG001|Overall Study|Lost to Follow-up|2|||
105945614|NCT02781558|365463925|FG000|Overall Study|Adverse Event|1|||
105945615|NCT02781558|365463926|FG001|Overall Study|Adverse Event|0|||
105945616|NCT00643279|365463933|FG000|Overall Study|Death|13|||
105945617|NCT00643279|365463934|FG001|Overall Study|Death|11|||
105945618|NCT00643279|365463933|FG000|Overall Study|Withdrawal by Subject|3|||
105945619|NCT00643279|365463934|FG001|Overall Study|Withdrawal by Subject|0|||
105945620|NCT00643279|365463933|FG000|Overall Study|Lost to Follow-up|0|||
105945621|NCT00643279|365463934|FG001|Overall Study|Lost to Follow-up|1|||
105945622|NCT00643279|365463933|FG000|Overall Study|Physician Decision|0|||
105945623|NCT00643279|365463934|FG001|Overall Study|Physician Decision|1|||
105945624|NCT00545779|365463936|FG000|Overall Study|Violation of selection criteria at entry|8|||
105945625|NCT00545779|365463936|FG000|Overall Study|Other protocol violation|1|||
105945626|NCT00545779|365463936|FG000|Overall Study|Did not cooperate|7|||
105945627|NCT00545779|365463936|FG000|Overall Study|Withdrawal by Subject|20|||
105945628|NCT00545779|365463936|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
105945629|NCT00545779|365463936|FG000|Overall Study|Failure to return|3|||
105945630|NCT03612570|365463937|FG000|Overall Study|Lost to Follow-up|1|||
105945631|NCT05929326|365463940|FG000|Overall Study|unqualified sample|2|||
105945632|NCT05929326|365463941|FG001|Overall Study|unqualified sample|3|||
105945633|NCT05929326|365463942|FG002|Overall Study|unqualified sample|7|||
105945634|NCT01994876|365463945|FG000|Test Period 1|Withdrawal by Subject|0|||
105945635|NCT01994876|365463946|FG001|Test Period 1|Withdrawal by Subject|1|||
105945636|NCT01994876|365463945|FG000|Test Period 1|Adverse Event|0|||
105945637|NCT01994876|365463946|FG001|Test Period 1|Adverse Event|1|||
105945638|NCT01994876|365463945|FG000|Test Period 2|Adverse Event|1|||
105945639|NCT01994876|365463946|FG001|Test Period 2|Adverse Event|0|||
105945640|NCT01994876|365463945|FG000|Test Period 2|Protocol Violation|0|||
105945641|NCT01994876|365463946|FG001|Test Period 2|Protocol Violation|1|||
105945642|NCT03586973|365463947|FG000|Overall Study|Death|15|||
105750368|NCT02509494|364738823|FG004|Overall Study|Non-Compliance With Study Drug|1|||
105750369|NCT02509494|364738824|FG005|Overall Study|Non-Compliance With Study Drug|2|||
105750370|NCT02509494|364738825|FG006|Overall Study|Non-Compliance With Study Drug|1|||
105945643|NCT03586973|365463948|FG001|Overall Study|Death|8|||
105945644|NCT03586973|365463947|FG000|Overall Study|Site Terminated by Sponsor|3|||
105945645|NCT03586973|365463948|FG001|Overall Study|Site Terminated by Sponsor|6|||
105945646|NCT03586973|365463947|FG000|Overall Study|Withdrawal by Subject|1|||
105945647|NCT03586973|365463948|FG001|Overall Study|Withdrawal by Subject|0|||
105945648|NCT03586973|365463947|FG000|Overall Study|Lost to Follow-up|1|||
105945649|NCT03586973|365463948|FG001|Overall Study|Lost to Follow-up|0|||
105945650|NCT02661672|365463952|FG000|Overall Study|Lost to Follow-up|1|||
105750371|NCT02509494|364738826|FG007|Overall Study|Non-Compliance With Study Drug|1|||
105945651|NCT02661672|365463952|FG000|Overall Study|Death|4|||
105945652|NCT03984188|365463953|FG000|Overall Study|Death|2|||
105945653|NCT03984188|365463954|FG001|Overall Study|Death|4|||
105945654|NCT03984188|365463953|FG000|Overall Study|Physician Decision|0|||
105945655|NCT03984188|365463954|FG001|Overall Study|Physician Decision|2|||
105945656|NCT03984188|365463953|FG000|Overall Study|Lost to Follow-up|3|||
105945657|NCT03984188|365463954|FG001|Overall Study|Lost to Follow-up|2|||
105945658|NCT03984188|365463953|FG000|Overall Study|Withdrawal by Subject|6|||
105945659|NCT03984188|365463954|FG001|Overall Study|Withdrawal by Subject|0|||
105750372|NCT02509494|364738827|FG008|Overall Study|Non-Compliance With Study Drug|0|||
105750373|NCT02104804|364738828|FG000|Overall Study|Did not take study medication|0|||
105750374|NCT02104804|364738829|FG001|Overall Study|Did not take study medication|1|||
105750375|NCT02104804|364738828|FG000|Overall Study|Study specific discontinuation criteria|6|||
105750376|NCT02104804|364738829|FG001|Overall Study|Study specific discontinuation criteria|1|||
105750377|NCT02104804|364738828|FG000|Overall Study|Other listed|2|||
105750378|NCT02104804|364738829|FG001|Overall Study|Other listed|1|||
105750379|NCT02104804|364738828|FG000|Overall Study|Protocol Violation|0|||
105750380|NCT02104804|364738829|FG001|Overall Study|Protocol Violation|1|||
105750381|NCT02104804|364738828|FG000|Overall Study|Adverse Event|4|||
105750382|NCT02104804|364738829|FG001|Overall Study|Adverse Event|3|||
105945660|NCT01397253|365465189|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
105945661|NCT01397253|365465190|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
105945662|NCT00442702|365465193|FG000|Titration Period|Adverse Event|2|||
105945663|NCT00442702|365465194|FG001|Titration Period|Adverse Event|0|||
105945664|NCT00442702|365465193|FG000|Titration Period|Death|3|||
105945665|NCT00442702|365465194|FG001|Titration Period|Death|2|||
105945666|NCT00442702|365465193|FG000|Titration Period|Insufficient Therapeutic Response|1|||
105945667|NCT00442702|365465194|FG001|Titration Period|Insufficient Therapeutic Response|0|||
105945668|NCT00442702|365465193|FG000|Titration Period|Refused Treatment|4|||
105945669|NCT00442702|365465194|FG001|Titration Period|Refused Treatment|1|||
105945670|NCT00442702|365465193|FG000|Titration Period|Failure to return|1|||
105945671|NCT00442702|365465194|FG001|Titration Period|Failure to return|0|||
105945672|NCT00442702|365465193|FG000|Titration Period|Hospitalized in another hospital|1|||
105945673|NCT00442702|365465194|FG001|Titration Period|Hospitalized in another hospital|0|||
105945674|NCT00442702|365465193|FG000|Evaluation Period|Adverse Event|1|||
105945675|NCT00442702|365465194|FG001|Evaluation Period|Adverse Event|0|||
105945676|NCT00442702|365465193|FG000|Evaluation Period|Death|1|||
105945677|NCT00442702|365465194|FG001|Evaluation Period|Death|1|||
105945678|NCT00442702|365465193|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
105945679|NCT00442702|365465194|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
105945680|NCT00442702|365465193|FG000|Evaluation Period|Refused treatment|1|||
105945681|NCT00442702|365465194|FG001|Evaluation Period|Refused treatment|1|||
105945682|NCT00442702|365465193|FG000|Evaluation Period|Renal transplant|0|||
105945683|NCT00442702|365465194|FG001|Evaluation Period|Renal transplant|1|||
105945684|NCT00442702|365465193|FG000|Evaluation Period|Failure to return|1|||
105945685|NCT00442702|365465194|FG001|Evaluation Period|Failure to return|0|||
105945686|NCT00442702|365465193|FG000|Evaluation Period|Site closure|0|||
105945687|NCT00442702|365465194|FG001|Evaluation Period|Site closure|1|||
105945688|NCT00730327|365465195|FG000|Overall Study|Lost to Follow-up|14|||
105945689|NCT00730327|365465196|FG001|Overall Study|Lost to Follow-up|16|||
105945690|NCT00730327|365465195|FG000|Overall Study|Adverse Event|8|||
105945691|NCT00730327|365465196|FG001|Overall Study|Adverse Event|1|||
105945692|NCT00730327|365465195|FG000|Overall Study|Withdrawal by Subject|3|||
105945693|NCT00730327|365465196|FG001|Overall Study|Withdrawal by Subject|13|||
105945694|NCT00730327|365465195|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
105945695|NCT00730327|365465196|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
105945696|NCT02552225|365465197|FG000|Overall Study|Withdrawal by Subject|1|||
105945697|NCT02552225|365465198|FG001|Overall Study|Withdrawal by Subject|0|||
105945698|NCT01168596|365465202|FG000|Overall Study|Withdrawal by Subject|3|||
105945699|NCT01168596|365465203|FG001|Overall Study|Withdrawal by Subject|1|||
105945700|NCT02297516|365465206|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
105945701|NCT02297516|365465207|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
105750383|NCT02104804|364738828|FG000|Overall Study|Withdrawal by Subject|4|||
105945702|NCT02297516|365465206|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
105945703|NCT02297516|365465207|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
105945704|NCT02297516|365465206|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
105945705|NCT02297516|365465207|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
105945706|NCT04507204|365465208|FG000|Overall Study|Adverse Event|8|||
105945707|NCT04507204|365465209|FG001|Overall Study|Adverse Event|13|||
105945708|NCT04507204|365465208|FG000|Overall Study|Death|0|||
105750384|NCT02104804|364738829|FG001|Overall Study|Withdrawal by Subject|12|||
105750385|NCT05319080|364738831|FG000|Overall Study|Withdrawal by Subject|2|||
105750386|NCT05319080|364738831|FG000|Overall Study|Physician Decision|4|||
105750387|NCT00751114|364738832|FG000|Overall Study|Adverse Event|2|||
105750388|NCT00751114|364738833|FG001|Overall Study|Adverse Event|4|||
105750389|NCT00751114|364738832|FG000|Overall Study|Protocol Violation|8|||
105750390|NCT00751114|364738833|FG001|Overall Study|Protocol Violation|9|||
105750391|NCT00751114|364738832|FG000|Overall Study|Withdrawal by Subject|9|||
105945709|NCT04507204|365465209|FG001|Overall Study|Death|1|||
105945710|NCT04507204|365465208|FG000|Overall Study|Lost to Follow-up|15|||
105945711|NCT04507204|365465209|FG001|Overall Study|Lost to Follow-up|14|||
105945712|NCT04507204|365465208|FG000|Overall Study|Poor Compliance with Protocol|2|||
105945713|NCT04507204|365465209|FG001|Overall Study|Poor Compliance with Protocol|4|||
105945714|NCT04507204|365465208|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
105945715|NCT04507204|365465209|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
105945716|NCT04507204|365465208|FG000|Overall Study|Withdrawal of Patient Consent|21|||
105945717|NCT04507204|365465209|FG001|Overall Study|Withdrawal of Patient Consent|13|||
105945718|NCT01664624|365465210|FG000|Overall Study|Adverse Event|0|||
105945719|NCT01664624|365465211|FG001|Overall Study|Adverse Event|1|||
105945720|NCT01664624|365465212|FG002|Overall Study|Adverse Event|0|||
105945721|NCT01664624|365465213|FG003|Overall Study|Adverse Event|0|||
105945722|NCT03386773|365465217|FG000|Overall Study|Lost to Follow-up|24|||
105945723|NCT03386773|365465218|FG001|Overall Study|Lost to Follow-up|33|||
105945724|NCT03386773|365465217|FG000|Overall Study|Withdrawal by Subject|3|||
105945725|NCT03386773|365465218|FG001|Overall Study|Withdrawal by Subject|2|||
105945726|NCT03983421|365465219|FG000|Overall Study|Lost to Follow-up|1|||
105945727|NCT04573972|365465224|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
105945728|NCT04573972|365465225|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
105945729|NCT02724839|365465226|FG000|Overall Study|Withdrawal by Subject|1|||
105945730|NCT02724839|365465227|FG001|Overall Study|Withdrawal by Subject|1|||
105945731|NCT02724839|365465228|FG002|Overall Study|Withdrawal by Subject|0|||
105945732|NCT02724839|365465226|FG000|Overall Study|Lost to Follow-up|0|||
105945733|NCT02724839|365465227|FG001|Overall Study|Lost to Follow-up|3|||
105945734|NCT02724839|365465228|FG002|Overall Study|Lost to Follow-up|2|||
105945735|NCT02724839|365465226|FG000|Overall Study|Physician Decision|0|||
105945736|NCT02724839|365465227|FG001|Overall Study|Physician Decision|0|||
105945737|NCT02724839|365465228|FG002|Overall Study|Physician Decision|3|||
105945738|NCT01155050|365465230|FG000|Overall Study|Lost to Follow-up|15|||
105945739|NCT01155050|365465231|FG001|Overall Study|Lost to Follow-up|20|||
105945740|NCT01155050|365465232|FG002|Overall Study|Lost to Follow-up|19|||
105945741|NCT01155050|365465233|FG003|Overall Study|Lost to Follow-up|22|||
105945742|NCT01645176|365465234|FG000|Overall Study|Lack of Efficacy|4|||
105945743|NCT01645176|365465234|FG000|Overall Study|did not complete final MRI|1|||
105945744|NCT05878067|365465235|FG000|Overall Study|Lost to Follow-up|2|||
105945745|NCT02234362|365465236|FG000|Overall Study|Not eligible after first screening visit|17|||
105945746|NCT02234362|365465236|FG000|Overall Study|Lost to Follow-up|6|||
105945747|NCT02234362|365465236|FG000|Overall Study|Withdrawal by Subject|3|||
105945748|NCT00560417|365465237|FG000|Overall Study|Adverse Event|3|||
105945749|NCT00560417|365465238|FG001|Overall Study|Adverse Event|2|||
105750392|NCT00751114|364738833|FG001|Overall Study|Withdrawal by Subject|4|||
105750393|NCT00751114|364738832|FG000|Overall Study|Lost to Follow-up|4|||
105750394|NCT00751114|364738833|FG001|Overall Study|Lost to Follow-up|7|||
105750395|NCT00751114|364738832|FG000|Overall Study|Lack of Efficacy|0|||
105750396|NCT00751114|364738833|FG001|Overall Study|Lack of Efficacy|7|||
105750397|NCT00751114|364738832|FG000|Overall Study|Not Treated|13|||
105750398|NCT00751114|364738833|FG001|Overall Study|Not Treated|1|||
105750399|NCT00751114|364738832|FG000|Overall Study|Out of country for 2 months|1|||
105945750|NCT00560417|365465237|FG000|Overall Study|Entry Criteria Not Met|1|||
105945751|NCT00560417|365465238|FG001|Overall Study|Entry Criteria Not Met|0|||
105945752|NCT00560417|365465237|FG000|Overall Study|Lost to Follow-up|0|||
105945753|NCT00560417|365465238|FG001|Overall Study|Lost to Follow-up|1|||
106016236|NCT03594110|365724429|FG001|Interventional Part|Study drug stopped, reason missing|294|||
106016237|NCT03594110|365724428|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
106016238|NCT03594110|365724429|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
106016239|NCT03594110|365724428|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
106016240|NCT03594110|365724429|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
106016241|NCT03594110|365724428|FG000|Interventional Part|Contraindicated drug started|32|||
105750400|NCT00751114|364738833|FG001|Overall Study|Out of country for 2 months|0|||
105750401|NCT00751114|364738832|FG000|Overall Study|Move to another city|1|||
105750402|NCT00751114|364738833|FG001|Overall Study|Move to another city|0|||
105750403|NCT02358369|364738838|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
105750404|NCT02358369|364738839|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
105750405|NCT02358369|364738840|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
105750406|NCT02358369|364738841|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
105750407|NCT02358369|364738842|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
105750408|NCT02358369|364738838|FG000|Treatment Period A/B|Adverse Event|0|||
105750409|NCT02358369|364738839|FG001|Treatment Period A/B|Adverse Event|0|||
105945754|NCT00560417|365465237|FG000|Overall Study|Physician Decision|2|||
105945755|NCT00560417|365465238|FG001|Overall Study|Physician Decision|6|||
106016242|NCT03594110|365724429|FG001|Interventional Part|Contraindicated drug started|18|||
106016897|NCT03847896|365725906|FG001|Overall Study|A severe exacerbation event|0|||
105750410|NCT02358369|364738840|FG002|Treatment Period A/B|Adverse Event|1|||
105750411|NCT02358369|364738841|FG003|Treatment Period A/B|Adverse Event|2|||
105945756|NCT00560417|365465237|FG000|Overall Study|Protocol Violation|6|||
105945757|NCT00560417|365465238|FG001|Overall Study|Protocol Violation|5|||
105945758|NCT00560417|365465237|FG000|Overall Study|Sponsor Decision|2|||
105945759|NCT00560417|365465238|FG001|Overall Study|Sponsor Decision|0|||
105945760|NCT00560417|365465237|FG000|Overall Study|Withdrawal by Subject|3|||
105945761|NCT00560417|365465238|FG001|Overall Study|Withdrawal by Subject|3|||
105945762|NCT00904371|365465241|FG000|Overall Study|Adverse Event|2|||
105945763|NCT00904371|365465241|FG000|Overall Study|Lost to Follow-up|4|||
105945764|NCT00904371|365465241|FG000|Overall Study|Discontinued at target blood pressure|2|||
105945765|NCT00904371|365465241|FG000|Overall Study|Continued with Tritace|1|||
105945766|NCT00261833|365465242|FG000|Overall Study|Death|1|||
105945767|NCT00261833|365465243|FG001|Overall Study|Death|3|||
105945768|NCT00261833|365465242|FG000|Overall Study|Adverse Event|1|||
105945769|NCT00261833|365465243|FG001|Overall Study|Adverse Event|4|||
105945770|NCT00261833|365465242|FG000|Overall Study|Withdrawal by Subject|5|||
105945771|NCT00261833|365465243|FG001|Overall Study|Withdrawal by Subject|7|||
105945772|NCT00261833|365465242|FG000|Overall Study|Protocol Violation|0|||
105945773|NCT00261833|365465243|FG001|Overall Study|Protocol Violation|1|||
105945774|NCT00261833|365465242|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
105945775|NCT00261833|365465243|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
105945776|NCT00261833|365465242|FG000|Overall Study|Lung transplantation|1|||
105945777|NCT00261833|365465243|FG001|Overall Study|Lung transplantation|1|||
105945778|NCT00261833|365465242|FG000|Overall Study|Missing reason|1|||
105945779|NCT00261833|365465243|FG001|Overall Study|Missing reason|0|||
105750412|NCT02358369|364738842|FG004|Treatment Period A/B|Adverse Event|0|||
105750413|NCT02358369|364738838|FG000|Treatment Period A/B|Death|0|||
105750414|NCT02358369|364738839|FG001|Treatment Period A/B|Death|0|||
105750415|NCT02358369|364738840|FG002|Treatment Period A/B|Death|1|||
105750416|NCT02358369|364738841|FG003|Treatment Period A/B|Death|0|||
105750417|NCT02358369|364738842|FG004|Treatment Period A/B|Death|0|||
105750418|NCT02358369|364738838|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
105750419|NCT02358369|364738839|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
105750420|NCT02358369|364738840|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
105750421|NCT02358369|364738841|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
105750422|NCT02358369|364738842|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
105750423|NCT02358369|364738838|FG000|Treatment Period C|Adverse Event|0|||
105750424|NCT02358369|364738839|FG001|Treatment Period C|Adverse Event|0|||
105750425|NCT02358369|364738840|FG002|Treatment Period C|Adverse Event|0|||
105750426|NCT02358369|364738841|FG003|Treatment Period C|Adverse Event|0|||
105750427|NCT02358369|364738842|FG004|Treatment Period C|Adverse Event|7|||
105750428|NCT04465396|364738843|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
105750429|NCT04465396|364738844|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
105750430|NCT04465396|364738845|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
105750431|NCT04465396|364738846|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
105750432|NCT03095521|364738850|FG000|Overall Study|Withdrawal by Subject|0|||
105750433|NCT03095521|364738851|FG001|Overall Study|Withdrawal by Subject|1|||
105750434|NCT03095521|364738850|FG000|Overall Study|Lost to Follow-up|0|||
105750435|NCT03095521|364738851|FG001|Overall Study|Lost to Follow-up|1|||
105750436|NCT03076190|364738852|FG000|Overall Study|Lost to Follow-up|9|||
105750437|NCT03076190|364738853|FG001|Overall Study|Lost to Follow-up|34|||
105750438|NCT03076190|364738852|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
105750439|NCT03076190|364738853|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
105750440|NCT03259490|364738854|FG000|Period 1|Withdrawal by Subject|0|||
105750441|NCT03259490|364738855|FG001|Period 1|Withdrawal by Subject|1|||
105750442|NCT03259490|364738854|FG000|Period 2|Protocol Violation|1|||
105750443|NCT03259490|364738855|FG001|Period 2|Protocol Violation|0|||
105750444|NCT00434122|364738856|FG000|Overall Study|Non-compliance with protocol|0|||
105750445|NCT00434122|364738857|FG001|Overall Study|Non-compliance with protocol|1|||
105750446|NCT00434122|364738856|FG000|Overall Study|loss of subject contact|1|||
105750447|NCT00434122|364738857|FG001|Overall Study|loss of subject contact|1|||
105750448|NCT00434122|364738856|FG000|Overall Study|Personal reasons|1|||
105750449|NCT00434122|364738857|FG001|Overall Study|Personal reasons|1|||
105750450|NCT00434122|364738856|FG000|Overall Study|Large follicle size|2|||
105750451|NCT00434122|364738857|FG001|Overall Study|Large follicle size|2|||
105750452|NCT00434122|364738856|FG000|Overall Study|Low follicular response.|1|||
105750453|NCT00434122|364738857|FG001|Overall Study|Low follicular response.|2|||
105750454|NCT00434122|364738856|FG000|Overall Study|Travelling of subject.|1|||
105750455|NCT00434122|364738857|FG001|Overall Study|Travelling of subject.|0|||
105945780|NCT00261833|365465242|FG000|Overall Study|Not interested in being participant|0|||
105945781|NCT00261833|365465243|FG001|Overall Study|Not interested in being participant|1|||
105750456|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
105750457|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
105750458|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
105750459|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
105750460|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
105945782|NCT00622726|365465244|FG000|March, 2008 to August, 2010|Death|5|||
105945783|NCT00622726|365465245|FG001|March, 2008 to August, 2010|Death|2|||
106016898|NCT03847896|365725907|FG002|Overall Study|A severe exacerbation event|0|||
105750461|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
105945784|NCT00622726|365465244|FG000|August, 2010 to April, 2013|Death|1|||
105945785|NCT00622726|365465245|FG001|August, 2010 to April, 2013|Death|5|||
105945786|NCT00553254|365465248|FG000|Overall Study|Death|3|||
105945787|NCT00553254|365465249|FG001|Overall Study|Death|6|||
105945788|NCT00553254|365465250|FG002|Overall Study|Death|25|||
105945789|NCT00553254|365465248|FG000|Overall Study|Lost to Follow-up|0|||
105945790|NCT00553254|365465249|FG001|Overall Study|Lost to Follow-up|0|||
105945791|NCT00553254|365465250|FG002|Overall Study|Lost to Follow-up|2|||
106016243|NCT03594110|365724428|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
106016244|NCT03594110|365724429|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
105750462|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
105750463|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
105750464|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
105750465|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
105750466|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
105750467|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
105750468|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105750469|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105750470|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
105750471|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105945792|NCT00553254|365465248|FG000|Overall Study|Withdrawal by Subject|2|||
106016245|NCT03594110|365724428|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
106016246|NCT03594110|365724429|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
106016247|NCT03594110|365724428|FG000|Non-interventional Part|Withdrawal by Subject|3|||
106016248|NCT03594110|365724429|FG001|Non-interventional Part|Withdrawal by Subject|4|||
106016249|NCT03594110|365724428|FG000|Non-interventional Part|Lost to Follow-up|45|||
106016250|NCT03594110|365724429|FG001|Non-interventional Part|Lost to Follow-up|41|||
106016251|NCT04614974|365724438|FG000|Overall Study|Lost to Follow-up|14|||
106016252|NCT04614974|365724439|FG001|Overall Study|Lost to Follow-up|11|||
106016253|NCT03901963|365724440|FG000|Overall Study|Lost to Follow-up|1|||
106016254|NCT03901963|365724441|FG001|Overall Study|Lost to Follow-up|1|||
106016255|NCT03901963|365724440|FG000|Overall Study|Physician Decision|1|||
106016256|NCT03901963|365724441|FG001|Overall Study|Physician Decision|2|||
106016257|NCT03901963|365724440|FG000|Overall Study|Protocol Violation|1|||
106016258|NCT03901963|365724441|FG001|Overall Study|Protocol Violation|1|||
106016259|NCT03901963|365724440|FG000|Overall Study|Withdrawal by Subject|4|||
106016260|NCT03901963|365724441|FG001|Overall Study|Withdrawal by Subject|11|||
106016261|NCT03901963|365724440|FG000|Overall Study|Ongoing|84|||
106016262|NCT03901963|365724441|FG001|Overall Study|Ongoing|73|||
106016263|NCT03901963|365724440|FG000|Overall Study|Randomized but not treated|3|||
106016264|NCT03901963|365724441|FG001|Overall Study|Randomized but not treated|3|||
106016265|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
106016266|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
106016267|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016268|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016269|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016270|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
106016271|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
106016272|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016273|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016274|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016275|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016276|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016277|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016278|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
106016279|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105945793|NCT00553254|365465249|FG001|Overall Study|Withdrawal by Subject|0|||
105945794|NCT00553254|365465250|FG002|Overall Study|Withdrawal by Subject|2|||
106016280|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016281|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
105945795|NCT00553254|365465248|FG000|Overall Study|Study terminated by Sponsor|0|||
105945796|NCT00553254|365465249|FG001|Overall Study|Study terminated by Sponsor|0|||
105945797|NCT00553254|365465250|FG002|Overall Study|Study terminated by Sponsor|1|||
105945798|NCT00553254|365465248|FG000|Overall Study|Other|1|||
105945799|NCT00553254|365465249|FG001|Overall Study|Other|0|||
105945800|NCT00553254|365465250|FG002|Overall Study|Other|13|||
105945801|NCT04476784|365465251|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
105945802|NCT04476784|365465252|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
105945803|NCT00335829|365465253|FG000|Overall Study|Withdrawal by Subject|1|||
105945804|NCT00335829|365465253|FG000|Overall Study|Lost to Follow-up|1|||
105945805|NCT00335829|365465253|FG000|Overall Study|Adverse Event|1|||
105945806|NCT02735200|365465254|FG000|Overall Study|Lost to Follow-up|0|||
105945807|NCT02735200|365465255|FG001|Overall Study|Lost to Follow-up|5|||
105945808|NCT02735200|365465254|FG000|Overall Study|Withdrawal by Subject|8|||
105945809|NCT02735200|365465255|FG001|Overall Study|Withdrawal by Subject|0|||
105945810|NCT00673920|365465258|FG000|Baseline up to Week 48|Withdrew consent|1|||
105945811|NCT00673920|365465259|FG001|Baseline up to Week 48|Withdrew consent|0|||
105945812|NCT00673920|365465260|FG002|Baseline up to Week 48|Withdrew consent|2|||
105945813|NCT00673920|365465261|FG003|Baseline up to Week 48|Withdrew consent|0|||
105945814|NCT00673920|365465262|FG004|Baseline up to Week 48|Withdrew consent|0|||
105945815|NCT00673920|365465263|FG005|Baseline up to Week 48|Withdrew consent|0|||
105945816|NCT00673920|365465264|FG006|Baseline up to Week 48|Withdrew consent|0|||
105945817|NCT00673920|365465265|FG007|Baseline up to Week 48|Withdrew consent|0|||
105945818|NCT00673920|365465258|FG000|Baseline up to Week 48|Refused treatment|1|||
105945819|NCT00673920|365465259|FG001|Baseline up to Week 48|Refused treatment|0|||
105945820|NCT00673920|365465260|FG002|Baseline up to Week 48|Refused treatment|0|||
105945821|NCT00673920|365465261|FG003|Baseline up to Week 48|Refused treatment|0|||
105945822|NCT00673920|365465262|FG004|Baseline up to Week 48|Refused treatment|0|||
105945823|NCT00673920|365465263|FG005|Baseline up to Week 48|Refused treatment|0|||
105945824|NCT00673920|365465264|FG006|Baseline up to Week 48|Refused treatment|0|||
105945825|NCT00673920|365465265|FG007|Baseline up to Week 48|Refused treatment|0|||
105945826|NCT00673920|365465258|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
105945827|NCT00673920|365465259|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
105945828|NCT00673920|365465260|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
105945829|NCT00673920|365465261|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
105945830|NCT00673920|365465262|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
105945831|NCT00673920|365465263|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
105945832|NCT00673920|365465264|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
105945833|NCT00673920|365465265|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
105945834|NCT00673920|365465258|FG000|Baseline up to Week 48|Protocol Violation|0|||
105945835|NCT00673920|365465259|FG001|Baseline up to Week 48|Protocol Violation|0|||
105945836|NCT00673920|365465260|FG002|Baseline up to Week 48|Protocol Violation|1|||
105945837|NCT00673920|365465261|FG003|Baseline up to Week 48|Protocol Violation|0|||
105945838|NCT00673920|365465262|FG004|Baseline up to Week 48|Protocol Violation|0|||
105945839|NCT00673920|365465263|FG005|Baseline up to Week 48|Protocol Violation|0|||
105945840|NCT00673920|365465264|FG006|Baseline up to Week 48|Protocol Violation|0|||
105945841|NCT00673920|365465265|FG007|Baseline up to Week 48|Protocol Violation|0|||
105945842|NCT00673920|365465258|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105945843|NCT00673920|365465259|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105945844|NCT00673920|365465260|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
105945845|NCT00673920|365465261|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105945846|NCT00673920|365465262|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105945847|NCT00673920|365465263|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105945848|NCT00673920|365465264|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105945849|NCT00673920|365465265|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
105945850|NCT00673920|365465258|FG000|Baseline up to Week 48|Administrative/Other|0|||
105945851|NCT00673920|365465259|FG001|Baseline up to Week 48|Administrative/Other|1|||
105945852|NCT00673920|365465260|FG002|Baseline up to Week 48|Administrative/Other|2|||
105945853|NCT00673920|365465261|FG003|Baseline up to Week 48|Administrative/Other|0|||
105945854|NCT00673920|365465262|FG004|Baseline up to Week 48|Administrative/Other|0|||
105945855|NCT00673920|365465263|FG005|Baseline up to Week 48|Administrative/Other|0|||
105945856|NCT00673920|365465264|FG006|Baseline up to Week 48|Administrative/Other|0|||
105945857|NCT00673920|365465265|FG007|Baseline up to Week 48|Administrative/Other|0|||
105945858|NCT00673920|365465258|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105945859|NCT00673920|365465259|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
105945860|NCT00673920|365465260|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
105945861|NCT00673920|365465261|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105945862|NCT00673920|365465262|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105945863|NCT00673920|365465263|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105945864|NCT00673920|365465264|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105945865|NCT00673920|365465265|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
105945866|NCT00673920|365465258|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105945867|NCT00673920|365465259|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105945868|NCT00673920|365465260|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105945869|NCT00673920|365465261|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105945870|NCT00673920|365465262|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105945871|NCT00673920|365465263|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105945872|NCT00673920|365465264|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
105945873|NCT00673920|365465265|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
105945874|NCT00673920|365465258|FG000|Week 24 to Week 48|Failure to return|0|||
105945875|NCT00673920|365465259|FG001|Week 24 to Week 48|Failure to return|0|||
105945876|NCT00673920|365465260|FG002|Week 24 to Week 48|Failure to return|0|||
105945877|NCT00673920|365465261|FG003|Week 24 to Week 48|Failure to return|0|||
105945878|NCT00673920|365465262|FG004|Week 24 to Week 48|Failure to return|0|||
105945879|NCT00673920|365465263|FG005|Week 24 to Week 48|Failure to return|1|||
105945880|NCT00673920|365465264|FG006|Week 24 to Week 48|Failure to return|0|||
105945881|NCT00673920|365465265|FG007|Week 24 to Week 48|Failure to return|0|||
105945882|NCT00673920|365465258|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
105945883|NCT00673920|365465259|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
105945884|NCT00673920|365465260|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
105945885|NCT00673920|365465261|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
105945886|NCT00673920|365465262|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
105945887|NCT00673920|365465263|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
105945888|NCT00673920|365465264|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
105945889|NCT00673920|365465265|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
105945890|NCT00673920|365465258|FG000|Week 24 to Week 48|Death|0|||
105945891|NCT00673920|365465259|FG001|Week 24 to Week 48|Death|0|||
105945892|NCT00673920|365465260|FG002|Week 24 to Week 48|Death|0|||
105945893|NCT00673920|365465261|FG003|Week 24 to Week 48|Death|0|||
105945894|NCT00673920|365465262|FG004|Week 24 to Week 48|Death|0|||
105945895|NCT00673920|365465263|FG005|Week 24 to Week 48|Death|1|||
105945896|NCT00673920|365465264|FG006|Week 24 to Week 48|Death|0|||
105945897|NCT00673920|365465265|FG007|Week 24 to Week 48|Death|0|||
105945898|NCT00673920|365465258|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
105945899|NCT00673920|365465259|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
105945900|NCT00673920|365465260|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
105945901|NCT00673920|365465261|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
105945902|NCT00673920|365465262|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
105945903|NCT00673920|365465263|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
105945904|NCT00673920|365465264|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
105945905|NCT00673920|365465265|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
105945906|NCT04856527|365465266|FG000|Overall Study|Unable to complete experimental task|2|||
105945907|NCT04856527|365465267|FG001|Overall Study|Unable to complete experimental task|0|||
105945908|NCT01493414|365465268|FG000|Overall Study|Adverse Event|405|||
105945909|NCT01493414|365465268|FG000|Overall Study|Disease progression|204|||
105945910|NCT01493414|365465268|FG000|Overall Study|Death|101|||
105945911|NCT01493414|365465268|FG000|Overall Study|Physician Decision|93|||
105945912|NCT01493414|365465268|FG000|Overall Study|Withdrawal by Subject|79|||
105945913|NCT01493414|365465268|FG000|Overall Study|Protocol deviation|27|||
105945914|NCT01493414|365465268|FG000|Overall Study|Administrative problems|25|||
105945915|NCT01493414|365465268|FG000|Overall Study|Lost to Follow-up|16|||
105945916|NCT01816295|365465269|FG000|Double Blind Phase|Adverse Event|11|||
105945917|NCT01816295|365465270|FG001|Double Blind Phase|Adverse Event|8|||
105945918|NCT01816295|365465269|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
105945919|NCT01816295|365465270|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
105945920|NCT01816295|365465269|FG000|Double Blind Phase|Lost to Follow-up|3|||
105945921|NCT01816295|365465270|FG001|Double Blind Phase|Lost to Follow-up|5|||
105945922|NCT01816295|365465269|FG000|Double Blind Phase|Physician Decision|2|||
105750472|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105750473|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
105750474|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
105750475|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
105750476|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
105750477|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
105750478|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
105750479|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
105750480|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
105750481|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
105750482|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
105750483|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
105760889|NCT01831804|364778039|FG003|Overall Study|Withdrew Consent|0|||
105945923|NCT01816295|365465270|FG001|Double Blind Phase|Physician Decision|2|||
105945924|NCT01816295|365465269|FG000|Double Blind Phase|Protocol Violation|17|||
105945925|NCT01816295|365465270|FG001|Double Blind Phase|Protocol Violation|11|||
105945926|NCT01816295|365465269|FG000|Double Blind Phase|Sponsor Decision|8|||
105945927|NCT01816295|365465270|FG001|Double Blind Phase|Sponsor Decision|8|||
105945928|NCT01816295|365465269|FG000|Double Blind Phase|Withdrawal by Subject|22|||
105945929|NCT01816295|365465270|FG001|Double Blind Phase|Withdrawal by Subject|20|||
105945930|NCT01816295|365465269|FG000|OLE Phase|Adverse Event|17|||
105945931|NCT01816295|365465270|FG001|OLE Phase|Adverse Event|15|||
105945932|NCT01816295|365465269|FG000|OLE Phase|Death|1|||
105945933|NCT01816295|365465270|FG001|OLE Phase|Death|0|||
105945934|NCT01816295|365465269|FG000|OLE Phase|Entry Criteria Not Met|3|||
105945935|NCT01816295|365465270|FG001|OLE Phase|Entry Criteria Not Met|5|||
105945936|NCT01816295|365465269|FG000|OLE Phase|Lost to Follow-up|5|||
105945937|NCT01816295|365465270|FG001|OLE Phase|Lost to Follow-up|5|||
105945938|NCT01816295|365465269|FG000|OLE Phase|Physician Decision|3|||
105945939|NCT01816295|365465270|FG001|OLE Phase|Physician Decision|1|||
105945940|NCT01816295|365465269|FG000|OLE Phase|Protocol Violation|4|||
105945941|NCT01816295|365465270|FG001|OLE Phase|Protocol Violation|4|||
105945942|NCT01816295|365465269|FG000|OLE Phase|Sponsor Decision|7|||
105945943|NCT01816295|365465270|FG001|OLE Phase|Sponsor Decision|9|||
105945944|NCT01816295|365465269|FG000|OLE Phase|Withdrawal by Subject|10|||
105945945|NCT01816295|365465270|FG001|OLE Phase|Withdrawal by Subject|10|||
105945946|NCT01816295|365465269|FG000|OLE Phase|Lack of Efficacy|3|||
105945947|NCT01816295|365465270|FG001|OLE Phase|Lack of Efficacy|7|||
105945948|NCT01968980|365465278|FG000|Overall Study|Death|0|||
105945949|NCT01968980|365465279|FG001|Overall Study|Death|1|||
105945950|NCT01968980|365465278|FG000|Overall Study|Adverse Event|1|||
105945951|NCT01968980|365465279|FG001|Overall Study|Adverse Event|3|||
105945952|NCT01968980|365465278|FG000|Overall Study|Does not meet entry criteria|1|||
105945953|NCT01968980|365465279|FG001|Overall Study|Does not meet entry criteria|3|||
105945954|NCT01968980|365465278|FG000|Overall Study|Withdrawal by Subject|13|||
106016282|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016283|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016284|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
106016285|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
106016286|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016287|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016288|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016289|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016290|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016291|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016292|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
106016293|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
106016294|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016295|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016296|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016297|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016298|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016299|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
106016300|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016301|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016302|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016303|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016304|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016305|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016306|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
106016307|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016308|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016309|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016310|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016311|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016312|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
106016313|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
106016314|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016315|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016316|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105945955|NCT01968980|365465279|FG001|Overall Study|Withdrawal by Subject|5|||
105945956|NCT01968980|365465278|FG000|Overall Study|Other unspecified|1|||
105945957|NCT01968980|365465279|FG001|Overall Study|Other unspecified|2|||
105945958|NCT01242514|365465283|FG000|Overall Study|e.g., project closure|1042|||
105945959|NCT01242514|365465284|FG001|Overall Study|e.g., project closure|305|||
105945960|NCT01242514|365465285|FG002|Overall Study|e.g., project closure|171|||
105945961|NCT01242514|365465283|FG000|Overall Study|Subject decision|33|||
105945962|NCT01242514|365465284|FG001|Overall Study|Subject decision|8|||
105945963|NCT01242514|365465285|FG002|Overall Study|Subject decision|2|||
105945964|NCT01242514|365465283|FG000|Overall Study|Severe non-compliance to protocol|5|||
105945965|NCT01242514|365465284|FG001|Overall Study|Severe non-compliance to protocol|2|||
105945966|NCT01242514|365465285|FG002|Overall Study|Severe non-compliance to protocol|1|||
105945967|NCT01242514|365465283|FG000|Overall Study|Lack of therapeutic response|99|||
105945968|NCT01242514|365465284|FG001|Overall Study|Lack of therapeutic response|16|||
105945969|NCT01242514|365465285|FG002|Overall Study|Lack of therapeutic response|10|||
105945970|NCT01242514|365465283|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
105945971|NCT01242514|365465284|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
105945972|NCT01242514|365465285|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
105945973|NCT01242514|365465283|FG000|Overall Study|Lost to Follow-up|14|||
105945974|NCT01242514|365465284|FG001|Overall Study|Lost to Follow-up|5|||
105945975|NCT01242514|365465285|FG002|Overall Study|Lost to Follow-up|4|||
105945976|NCT01242514|365465283|FG000|Overall Study|Adverse Event|129|||
105945977|NCT01242514|365465284|FG001|Overall Study|Adverse Event|18|||
105945978|NCT01242514|365465285|FG002|Overall Study|Adverse Event|19|||
105945979|NCT00862940|365465287|FG000|Overall Study|Adverse Event|15|||
105945980|NCT00862940|365465288|FG001|Overall Study|Adverse Event|12|||
105945981|NCT00862940|365465287|FG000|Overall Study|Lack of Efficacy|1|||
105945982|NCT00862940|365465288|FG001|Overall Study|Lack of Efficacy|3|||
105945983|NCT00862940|365465287|FG000|Overall Study|Protocol Violation|2|||
105945984|NCT00862940|365465288|FG001|Overall Study|Protocol Violation|5|||
105945985|NCT00862940|365465287|FG000|Overall Study|Withdrawal by Subject|4|||
105945986|NCT00862940|365465288|FG001|Overall Study|Withdrawal by Subject|6|||
105945987|NCT00862940|365465287|FG000|Overall Study|Non-compliance|4|||
105945988|NCT00862940|365465288|FG001|Overall Study|Non-compliance|0|||
105945989|NCT00862940|365465287|FG000|Overall Study|Lost to Follow-up|0|||
105945990|NCT00862940|365465288|FG001|Overall Study|Lost to Follow-up|1|||
105945991|NCT00862940|365465287|FG000|Overall Study|Administrative or other reason(s)|4|||
105945992|NCT00862940|365465288|FG001|Overall Study|Administrative or other reason(s)|3|||
105945993|NCT04803214|365465297|FG000|Overall Study|Adverse Event|1|||
105945994|NCT04803214|365465298|FG001|Overall Study|Adverse Event|0|||
105945995|NCT04803214|365465297|FG000|Overall Study|Withdrawal by Subject|1|||
105945996|NCT04803214|365465298|FG001|Overall Study|Withdrawal by Subject|2|||
105945997|NCT04803214|365465297|FG000|Overall Study|Lost to Follow-up|2|||
105945998|NCT04803214|365465298|FG001|Overall Study|Lost to Follow-up|4|||
105945999|NCT04803214|365465297|FG000|Overall Study|Physician Decision|1|||
105946000|NCT04803214|365465298|FG001|Overall Study|Physician Decision|1|||
105946001|NCT04803214|365465297|FG000|Overall Study|Missed 12 month visit|0|||
105946002|NCT04803214|365465298|FG001|Overall Study|Missed 12 month visit|3|||
105946003|NCT00404248|365465312|FG000|Overall Study|pts declining status|0|||
105946004|NCT00404248|365465313|FG001|Overall Study|pts declining status|1|||
105946005|NCT00404248|365465314|FG002|Overall Study|pts declining status|0|||
105946006|NCT00404248|365465315|FG003|Overall Study|pts declining status|0|||
105946007|NCT00404248|365465316|FG004|Overall Study|pts declining status|0|||
105946008|NCT00404248|365465317|FG005|Overall Study|pts declining status|0|||
105946009|NCT00404248|365465318|FG006|Overall Study|pts declining status|0|||
105946010|NCT00404248|365465319|FG007|Overall Study|pts declining status|0|||
105946011|NCT00404248|365465320|FG008|Overall Study|pts declining status|0|||
105946012|NCT00789555|365465321|FG000|Overall Study|Protocol Amendment|78|||
105946013|NCT00789555|365465322|FG001|Overall Study|Protocol Amendment|76|||
105946014|NCT00789555|365465323|FG002|Overall Study|Protocol Amendment|80|||
105946015|NCT00789555|365465321|FG000|Overall Study|Adverse Event|17|||
105946016|NCT00789555|365465322|FG001|Overall Study|Adverse Event|7|||
105946017|NCT00789555|365465323|FG002|Overall Study|Adverse Event|10|||
105946018|NCT00789555|365465321|FG000|Overall Study|Lost to Follow-up|9|||
105946019|NCT00789555|365465322|FG001|Overall Study|Lost to Follow-up|10|||
105946020|NCT00789555|365465323|FG002|Overall Study|Lost to Follow-up|18|||
105946021|NCT00789555|365465321|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
105946022|NCT00789555|365465322|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
105946023|NCT00789555|365465323|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
105946024|NCT00789555|365465321|FG000|Overall Study|Treatment failure|11|||
105946025|NCT00789555|365465322|FG001|Overall Study|Treatment failure|8|||
105946026|NCT00789555|365465323|FG002|Overall Study|Treatment failure|12|||
105946027|NCT00789555|365465321|FG000|Overall Study|Protocol Violation|6|||
105946028|NCT00789555|365465322|FG001|Overall Study|Protocol Violation|9|||
105946029|NCT00789555|365465323|FG002|Overall Study|Protocol Violation|13|||
105760890|NCT01831804|364778040|FG004|Overall Study|Withdrew Consent|0|||
105946030|NCT01405196|365465326|FG000|Overall Study|Study Terminated by Sponsor|0|||
105946031|NCT01405196|365465327|FG001|Overall Study|Study Terminated by Sponsor|0|||
105946032|NCT01405196|365465328|FG002|Overall Study|Study Terminated by Sponsor|9|||
105946033|NCT01405196|365465329|FG003|Overall Study|Study Terminated by Sponsor|0|||
105946034|NCT01405196|365465326|FG000|Overall Study|Other|2|||
105946035|NCT01405196|365465327|FG001|Overall Study|Other|2|||
105946036|NCT01405196|365465328|FG002|Overall Study|Other|5|||
105946037|NCT01405196|365465329|FG003|Overall Study|Other|0|||
105946038|NCT01405196|365465326|FG000|Overall Study|Withdrawal by Subject|4|||
105946039|NCT01405196|365465327|FG001|Overall Study|Withdrawal by Subject|6|||
105946040|NCT01405196|365465328|FG002|Overall Study|Withdrawal by Subject|3|||
105946041|NCT01405196|365465329|FG003|Overall Study|Withdrawal by Subject|6|||
105946042|NCT01405196|365465326|FG000|Overall Study|Adverse Event|2|||
105946043|NCT01405196|365465327|FG001|Overall Study|Adverse Event|2|||
105946044|NCT01405196|365465328|FG002|Overall Study|Adverse Event|0|||
105946045|NCT01405196|365465329|FG003|Overall Study|Adverse Event|2|||
105946046|NCT01405196|365465326|FG000|Overall Study|Death|1|||
105946047|NCT01405196|365465327|FG001|Overall Study|Death|0|||
105946048|NCT01405196|365465328|FG002|Overall Study|Death|3|||
105946049|NCT01405196|365465329|FG003|Overall Study|Death|0|||
105946050|NCT01405196|365465326|FG000|Overall Study|Lost to Follow-up|2|||
105946051|NCT01405196|365465327|FG001|Overall Study|Lost to Follow-up|2|||
105946052|NCT01405196|365465328|FG002|Overall Study|Lost to Follow-up|3|||
105946053|NCT01405196|365465329|FG003|Overall Study|Lost to Follow-up|1|||
105946054|NCT00698841|365465330|FG000|Overall Study|Withdrawal by Subject|2|||
105946055|NCT00698841|365465330|FG000|Overall Study|Adverse Event|3|||
105946056|NCT00698841|365465330|FG000|Overall Study|Disease progression|7|||
105946057|NCT00698841|365465330|FG000|Overall Study|Failure to meet eligibility criteria|2|||
105946058|NCT00698841|365465330|FG000|Overall Study|Study drug toxicity|2|||
105946059|NCT00698841|365465330|FG000|Overall Study|Other|2|||
105946060|NCT00791648|365466764|FG000|Overall Study|Physician Decision|0|||
105946061|NCT00791648|365466765|FG001|Overall Study|Physician Decision|1|||
105946062|NCT00791648|365466764|FG000|Overall Study|Withdrawal by Subject|0|||
105946063|NCT00791648|365466765|FG001|Overall Study|Withdrawal by Subject|1|||
105946064|NCT04976777|365466766|FG000|Overall Study|COVID-19 Infection|1|||
105946065|NCT04976777|365466767|FG001|Overall Study|COVID-19 Infection|0|||
105946066|NCT00462826|365466768|FG000|Overall Study|Ineligible - second primary|1|||
105946067|NCT00462826|365466768|FG000|Overall Study|Ineligible - wrong cell type|1|||
105946068|NCT00462826|365466768|FG000|Overall Study|Ineligible - wrong primary|2|||
105946069|NCT00462826|365466768|FG000|Overall Study|Never treated|1|||
105946070|NCT01657370|365466769|FG000|Overall Study|Withdrawal by Subject|0|||
105946071|NCT01657370|365466770|FG001|Overall Study|Withdrawal by Subject|0|||
105946072|NCT01657370|365466771|FG002|Overall Study|Withdrawal by Subject|1|||
105946073|NCT01657370|365466772|FG003|Overall Study|Withdrawal by Subject|0|||
105946074|NCT01657370|365466773|FG004|Overall Study|Withdrawal by Subject|0|||
105946075|NCT01657370|365466774|FG005|Overall Study|Withdrawal by Subject|1|||
105946076|NCT01657370|365466769|FG000|Overall Study|Physician Decision|2|||
105946077|NCT01657370|365466770|FG001|Overall Study|Physician Decision|3|||
105946078|NCT01657370|365466771|FG002|Overall Study|Physician Decision|1|||
105946079|NCT01657370|365466772|FG003|Overall Study|Physician Decision|2|||
105946080|NCT01657370|365466773|FG004|Overall Study|Physician Decision|5|||
105946081|NCT01657370|365466774|FG005|Overall Study|Physician Decision|0|||
105946082|NCT01657370|365466769|FG000|Overall Study|Lack of Qualifying Event|1|||
105946083|NCT01657370|365466770|FG001|Overall Study|Lack of Qualifying Event|0|||
105946084|NCT01657370|365466771|FG002|Overall Study|Lack of Qualifying Event|3|||
105946085|NCT01657370|365466772|FG003|Overall Study|Lack of Qualifying Event|2|||
105946086|NCT01657370|365466773|FG004|Overall Study|Lack of Qualifying Event|1|||
105946087|NCT01657370|365466774|FG005|Overall Study|Lack of Qualifying Event|2|||
105946088|NCT01657370|365466769|FG000|Overall Study|Adverse Event|0|||
105946089|NCT01657370|365466770|FG001|Overall Study|Adverse Event|0|||
105946090|NCT01657370|365466771|FG002|Overall Study|Adverse Event|0|||
105946091|NCT01657370|365466772|FG003|Overall Study|Adverse Event|0|||
105946092|NCT01657370|365466773|FG004|Overall Study|Adverse Event|1|||
105946093|NCT01657370|365466774|FG005|Overall Study|Adverse Event|0|||
105946094|NCT01657370|365466769|FG000|Overall Study|Protocol Violation|1|||
105946095|NCT01657370|365466770|FG001|Overall Study|Protocol Violation|1|||
105946096|NCT01657370|365466771|FG002|Overall Study|Protocol Violation|1|||
105946097|NCT01657370|365466772|FG003|Overall Study|Protocol Violation|1|||
105946098|NCT01657370|365466773|FG004|Overall Study|Protocol Violation|0|||
105946099|NCT01657370|365466774|FG005|Overall Study|Protocol Violation|0|||
105946100|NCT01657370|365466769|FG000|Overall Study|Lost to Follow-up|2|||
105946101|NCT01657370|365466770|FG001|Overall Study|Lost to Follow-up|0|||
105946102|NCT01657370|365466771|FG002|Overall Study|Lost to Follow-up|1|||
105946103|NCT01657370|365466772|FG003|Overall Study|Lost to Follow-up|0|||
105946104|NCT01657370|365466773|FG004|Overall Study|Lost to Follow-up|0|||
105946105|NCT01657370|365466774|FG005|Overall Study|Lost to Follow-up|1|||
105946106|NCT04795531|365466775|FG000|Overall Study|Withdrawal by Subject|4|||
105946107|NCT04795531|365466776|FG001|Overall Study|Withdrawal by Subject|4|||
105946108|NCT04795531|365466775|FG000|Overall Study|Lost to Follow-up|0|||
105946109|NCT04795531|365466776|FG001|Overall Study|Lost to Follow-up|1|||
105946110|NCT04795531|365466775|FG000|Overall Study|Physician Decision|0|||
105946111|NCT04795531|365466776|FG001|Overall Study|Physician Decision|2|||
105946112|NCT04795531|365466775|FG000|Overall Study|Death|2|||
105946113|NCT04795531|365466776|FG001|Overall Study|Death|1|||
105946114|NCT04043286|365466777|FG000|Overall Study|Withdrawal by Subject|2|||
105946115|NCT04043286|365466778|FG001|Overall Study|Withdrawal by Subject|2|||
105750484|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
105750485|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
105750486|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105946116|NCT01164007|365466785|FG000|Overall Study|Adverse Event|5|||
105750487|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750488|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750489|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
105750490|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750491|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
105750492|NCT01963208|364738858|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750493|NCT01963208|364738859|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750494|NCT01963208|364738860|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750495|NCT01963208|364738861|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
105750496|NCT01963208|364738862|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750497|NCT01963208|364738863|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
105750498|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
105750499|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
105946117|NCT01164007|365466785|FG000|Overall Study|Progression of Disease|30|||
105946118|NCT01164007|365466785|FG000|Overall Study|Protocol Violation|1|||
105946119|NCT01164007|365466785|FG000|Overall Study|Withdrawal by Subject|1|||
105946120|NCT01164007|365466785|FG000|Overall Study|Medical Decision|3|||
105946121|NCT02519842|365466786|FG000|Base Study: Cycle 1|Screening Failure|1|||
105946122|NCT02519842|365466787|FG001|Base Study: Cycle 1|Screening Failure|1|||
105946123|NCT02519842|365466788|FG002|Base Study: Cycle 1|Screening Failure|0|||
105946124|NCT02519842|365466786|FG000|Base Study: Cycle 1|Adverse Event|1|||
105946125|NCT02519842|365466787|FG001|Base Study: Cycle 1|Adverse Event|0|||
105946126|NCT02519842|365466788|FG002|Base Study: Cycle 1|Adverse Event|0|||
105946127|NCT02519842|365466786|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
105946128|NCT02519842|365466787|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
105946129|NCT02519842|365466788|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
105946130|NCT02519842|365466786|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
105946131|NCT02519842|365466787|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
105946132|NCT02519842|365466788|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
105946133|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
105946134|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
105946135|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
105946136|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
105946137|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
105946138|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
105946139|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105946140|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
105946141|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
105946142|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
105946143|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
105946144|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
105946145|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Death|0|||
105946146|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Death|0|||
105946147|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Death|1|||
105946148|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
105946149|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
105946150|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
105946151|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
105946152|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
105946153|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
105946154|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
105946155|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
105946156|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
105946157|NCT02519842|365466786|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
105750500|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
105750501|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
105750502|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
105750503|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
105750504|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
105946158|NCT02519842|365466787|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
105946159|NCT02519842|365466788|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
105946160|NCT02300233|365466789|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
105946161|NCT02300233|365466790|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
105946162|NCT02300233|365466791|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
105946163|NCT02300233|365466789|FG000|Overall Study|Withdrawal by Subject|1|||
105946164|NCT02300233|365466790|FG001|Overall Study|Withdrawal by Subject|0|||
105946165|NCT02300233|365466791|FG002|Overall Study|Withdrawal by Subject|3|||
105946166|NCT02300233|365466789|FG000|Overall Study|Investigator Judgement|0|||
105946167|NCT02300233|365466790|FG001|Overall Study|Investigator Judgement|0|||
105946168|NCT02300233|365466791|FG002|Overall Study|Investigator Judgement|1|||
105946169|NCT02300233|365466789|FG000|Overall Study|Reason Not Specified|0|||
105946170|NCT02300233|365466790|FG001|Overall Study|Reason Not Specified|0|||
105946171|NCT02300233|365466791|FG002|Overall Study|Reason Not Specified|5|||
105946172|NCT02921256|365466794|FG000|Arm 1a v. Arm II|Adverse Event|6|||
105946173|NCT02921256|365466795|FG001|Arm 1a v. Arm II|Adverse Event|15|||
105946174|NCT02921256|365466796|FG002|Arm 1a v. Arm II|Adverse Event|0|||
105946175|NCT02921256|365466794|FG000|Arm 1a v. Arm II|Death|0|||
105946176|NCT02921256|365466795|FG001|Arm 1a v. Arm II|Death|2|||
105946177|NCT02921256|365466796|FG002|Arm 1a v. Arm II|Death|0|||
105946178|NCT02921256|365466794|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
105946179|NCT02921256|365466795|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
105946180|NCT02921256|365466796|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
105946181|NCT02921256|365466794|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
105946182|NCT02921256|365466795|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
105946183|NCT02921256|365466796|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
105946184|NCT02921256|365466794|FG000|Arm 1a v. Arm II|Physician Decision|1|||
105946185|NCT02921256|365466795|FG001|Arm 1a v. Arm II|Physician Decision|1|||
105946186|NCT02921256|365466796|FG002|Arm 1a v. Arm II|Physician Decision|0|||
105946187|NCT02921256|365466794|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
105946188|NCT02921256|365466795|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
105946189|NCT02921256|365466796|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
105946190|NCT02921256|365466794|FG000|Arm Ib v Arm III|Adverse Event|9|||
105946191|NCT02921256|365466795|FG001|Arm Ib v Arm III|Adverse Event|0|||
105946192|NCT02921256|365466796|FG002|Arm Ib v Arm III|Adverse Event|4|||
105946193|NCT02921256|365466794|FG000|Arm Ib v Arm III|Death|1|||
105946194|NCT02921256|365466795|FG001|Arm Ib v Arm III|Death|0|||
105946195|NCT02921256|365466796|FG002|Arm Ib v Arm III|Death|1|||
105946196|NCT02921256|365466794|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
105946197|NCT02921256|365466795|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
105946198|NCT02921256|365466796|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
105946199|NCT02921256|365466794|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
105946200|NCT02921256|365466795|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
105946201|NCT02921256|365466796|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
105946202|NCT02921256|365466794|FG000|Arm Ib v Arm III|Physician Decision|4|||
105946203|NCT02921256|365466795|FG001|Arm Ib v Arm III|Physician Decision|0|||
105946204|NCT02921256|365466796|FG002|Arm Ib v Arm III|Physician Decision|1|||
105946205|NCT02921256|365466794|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
105946206|NCT02921256|365466795|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
106016317|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016318|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105760891|NCT01831804|364778041|FG005|Overall Study|Withdrew Consent|0|||
105946207|NCT02921256|365466796|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
105946208|NCT01143402|365466797|FG000|Overall Study|Rapid clinical decline|1|||
106016319|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
105946209|NCT01143402|365466798|FG001|Overall Study|Rapid clinical decline|1|||
105946210|NCT01143402|365466799|FG002|Overall Study|Rapid clinical decline|0|||
105946211|NCT01143402|365466797|FG000|Overall Study|Not Treated|0|||
105946212|NCT01143402|365466798|FG001|Overall Study|Not Treated|0|||
105946213|NCT01143402|365466799|FG002|Overall Study|Not Treated|1|||
105946214|NCT00431964|365466800|FG000|Overall Study|Adverse Event|1|||
105946215|NCT00431964|365466801|FG001|Overall Study|Adverse Event|0|||
105946216|NCT00431964|365466800|FG000|Overall Study|Lost to Follow-up|1|||
105946217|NCT00431964|365466801|FG001|Overall Study|Lost to Follow-up|2|||
105946218|NCT00431964|365466800|FG000|Overall Study|Physician Decision|2|||
105946219|NCT00431964|365466801|FG001|Overall Study|Physician Decision|2|||
105946220|NCT00431964|365466800|FG000|Overall Study|Withdrawal by Subject|2|||
105946221|NCT00431964|365466801|FG001|Overall Study|Withdrawal by Subject|1|||
105946222|NCT00431964|365466800|FG000|Overall Study|Parental Consent Withdrawn|0|||
105946223|NCT00431964|365466801|FG001|Overall Study|Parental Consent Withdrawn|2|||
105946224|NCT00431964|365466800|FG000|Overall Study|Due to Unstable Health|0|||
105946225|NCT00431964|365466801|FG001|Overall Study|Due to Unstable Health|1|||
105946226|NCT01696643|365466806|FG000|Overall Study|Adverse Event|15|||
105946227|NCT01696643|365466807|FG001|Overall Study|Adverse Event|7|||
105946228|NCT01696643|365466806|FG000|Overall Study|Death|1|||
105946229|NCT01696643|365466807|FG001|Overall Study|Death|2|||
105946230|NCT01696643|365466806|FG000|Overall Study|Lack of Efficacy|3|||
105946231|NCT01696643|365466807|FG001|Overall Study|Lack of Efficacy|0|||
105946232|NCT01696643|365466806|FG000|Overall Study|Lost to Follow-up|67|||
105946233|NCT01696643|365466807|FG001|Overall Study|Lost to Follow-up|67|||
105946234|NCT01696643|365466806|FG000|Overall Study|Physician Decision|3|||
105946235|NCT01696643|365466807|FG001|Overall Study|Physician Decision|2|||
105946236|NCT01696643|365466806|FG000|Overall Study|Pregnancy|0|||
105946237|NCT01696643|365466807|FG001|Overall Study|Pregnancy|1|||
105946238|NCT01696643|365466806|FG000|Overall Study|Protocol Violation|7|||
105946239|NCT01696643|365466807|FG001|Overall Study|Protocol Violation|7|||
105946240|NCT01696643|365466806|FG000|Overall Study|Study Terminated by Sponsor|286|||
105946241|NCT01696643|365466807|FG001|Overall Study|Study Terminated by Sponsor|294|||
105946242|NCT01696643|365466806|FG000|Overall Study|Withdrawal by Subject|142|||
105946243|NCT01696643|365466807|FG001|Overall Study|Withdrawal by Subject|149|||
105946244|NCT01696643|365466806|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
105946245|NCT01696643|365466807|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
105946246|NCT01696643|365466806|FG000|Overall Study|Site Error|2|||
105946247|NCT01696643|365466807|FG001|Overall Study|Site Error|1|||
105946248|NCT01696643|365466806|FG000|Overall Study|Participant Incarcerated|0|||
105946249|NCT01696643|365466807|FG001|Overall Study|Participant Incarcerated|1|||
105946250|NCT01696643|365466806|FG000|Overall Study|Medical Monitor Decision|0|||
105946251|NCT01696643|365466807|FG001|Overall Study|Medical Monitor Decision|2|||
105946252|NCT01696643|365466806|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
105946253|NCT01696643|365466807|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
105946254|NCT00485173|365466814|FG000|Overall Study|Death|4|||
105946255|NCT00485173|365466815|FG001|Overall Study|Death|3|||
105946256|NCT00485173|365466814|FG000|Overall Study|Lost to Follow-up|32|||
105946257|NCT00485173|365466815|FG001|Overall Study|Lost to Follow-up|61|||
105946258|NCT01849276|365466816|FG000|Followed for Survival for 5 Years|Death|1|||
105946259|NCT01849276|365466816|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
105946260|NCT02031302|365466831|FG000|Overall Study|Death|115|||
105946261|NCT02031302|365466832|FG001|Overall Study|Death|0|||
105946262|NCT02031302|365466831|FG000|Overall Study|Not treated with study valve system|18|||
105946263|NCT02031302|365466832|FG001|Overall Study|Not treated with study valve system|0|||
105946264|NCT02031302|365466831|FG000|Overall Study|Missed Follow Up|27|||
105946265|NCT02031302|365466832|FG001|Overall Study|Missed Follow Up|0|||
105750505|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
105750506|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
105750507|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
105946266|NCT02031302|365466831|FG000|Overall Study|Lost to Follow-up|4|||
105946267|NCT02031302|365466832|FG001|Overall Study|Lost to Follow-up|0|||
105946268|NCT03950856|365466842|FG000|Overall Study|Death|1|||
105946269|NCT03950856|365466843|FG001|Overall Study|Death|2|||
105946270|NCT03950856|365466844|FG002|Overall Study|Death|0|||
105946271|NCT03950856|365466845|FG003|Overall Study|Death|0|||
105750508|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
105750509|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
105946272|NCT03950856|365466842|FG000|Overall Study|Lost to Follow-up|5|||
105946273|NCT03950856|365466843|FG001|Overall Study|Lost to Follow-up|6|||
105946274|NCT03950856|365466844|FG002|Overall Study|Lost to Follow-up|8|||
105946275|NCT03950856|365466845|FG003|Overall Study|Lost to Follow-up|2|||
105946276|NCT03950856|365466842|FG000|Overall Study|Protocol Violation|2|||
105946277|NCT03950856|365466843|FG001|Overall Study|Protocol Violation|0|||
105750510|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105946278|NCT03950856|365466844|FG002|Overall Study|Protocol Violation|0|||
105946279|NCT03950856|365466845|FG003|Overall Study|Protocol Violation|1|||
105946280|NCT03950856|365466842|FG000|Overall Study|Withdrawal by Subject|4|||
105946281|NCT03950856|365466843|FG001|Overall Study|Withdrawal by Subject|1|||
105946282|NCT03950856|365466844|FG002|Overall Study|Withdrawal by Subject|3|||
105946283|NCT03950856|365466845|FG003|Overall Study|Withdrawal by Subject|1|||
105946284|NCT03950856|365466842|FG000|Overall Study|Unable to phone|7|||
105946285|NCT03950856|365466843|FG001|Overall Study|Unable to phone|6|||
105946286|NCT03950856|365466844|FG002|Overall Study|Unable to phone|7|||
105946287|NCT03950856|365466845|FG003|Overall Study|Unable to phone|2|||
105946288|NCT05899829|365466848|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
105946289|NCT05899829|365466849|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
105946290|NCT05899829|365466848|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
105946291|NCT05899829|365466849|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
105946292|NCT04549454|365466857|FG000|T1 to T2|Lost to Follow-up|22|||
105946293|NCT04549454|365466858|FG001|T1 to T2|Lost to Follow-up|26|||
105946294|NCT04549454|365466857|FG000|T1 to T3|Lost to Follow-up|31|||
105946295|NCT04549454|365466858|FG001|T1 to T3|Lost to Follow-up|36|||
105946296|NCT00867035|365466859|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
105946297|NCT00867035|365466860|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
105946298|NCT00867035|365466859|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
105750511|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105946299|NCT00867035|365466860|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
105946300|NCT00016354|365466861|FG000|Overall Study|Lack of Efficacy|0|||
105760892|NCT01831804|364778042|FG006|Overall Study|Withdrew Consent|0|||
105946301|NCT00016354|365466862|FG001|Overall Study|Lack of Efficacy|0|||
105946302|NCT00016354|365466863|FG002|Overall Study|Lack of Efficacy|0|||
105946303|NCT00016354|365466864|FG003|Overall Study|Lack of Efficacy|0|||
105946304|NCT00016354|365466865|FG004|Overall Study|Lack of Efficacy|0|||
105946305|NCT00016354|365466866|FG005|Overall Study|Lack of Efficacy|0|||
105946306|NCT00016354|365466867|FG006|Overall Study|Lack of Efficacy|0|||
105946307|NCT00016354|365466868|FG007|Overall Study|Lack of Efficacy|1|||
105946308|NCT02993263|365466869|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
105946309|NCT04704193|365466870|FG000|Overall Study|Withdrawal by Subject|1|||
105946310|NCT00829998|365466871|FG000|Washout|Adverse Event|0|||
105946311|NCT00829998|365466872|FG001|Washout|Adverse Event|1|||
105946312|NCT05788991|365466875|FG000|Overall Study|Not treated with study medication|1|||
105946313|NCT05788991|365466876|FG001|Overall Study|Not treated with study medication|3|||
105946314|NCT05788991|365466875|FG000|Overall Study|Withdrawal by Subject|1|||
105946315|NCT05788991|365466876|FG001|Overall Study|Withdrawal by Subject|0|||
105946316|NCT05788991|365466875|FG000|Overall Study|Lack of Efficacy|0|||
105946317|NCT05788991|365466876|FG001|Overall Study|Lack of Efficacy|1|||
105946318|NCT05788991|365466875|FG000|Overall Study|Protocol Violation|1|||
105946319|NCT05788991|365466876|FG001|Overall Study|Protocol Violation|2|||
105946320|NCT05270863|365466877|FG000|Visit 2 First Intervention|Randomization error|0|||
105946321|NCT05270863|365466878|FG001|Visit 2 First Intervention|Randomization error|0|||
105946322|NCT05270863|365466879|FG002|Visit 2 First Intervention|Randomization error|0|||
105946323|NCT05270863|365466880|FG003|Visit 2 First Intervention|Randomization error|1|||
105946324|NCT05270863|365466881|FG004|Visit 2 First Intervention|Randomization error|0|||
105946325|NCT05270863|365466882|FG005|Visit 2 First Intervention|Randomization error|0|||
105946326|NCT05270863|365466877|FG000|First Washout|Withdrawal by Subject|0|||
105946327|NCT05270863|365466878|FG001|First Washout|Withdrawal by Subject|0|||
105946328|NCT05270863|365466879|FG002|First Washout|Withdrawal by Subject|0|||
105946329|NCT05270863|365466880|FG003|First Washout|Withdrawal by Subject|0|||
105946330|NCT05270863|365466881|FG004|First Washout|Withdrawal by Subject|1|||
105946331|NCT05270863|365466882|FG005|First Washout|Withdrawal by Subject|1|||
105946332|NCT05270863|365466877|FG000|First Washout|Lost to Follow-up|0|||
105946333|NCT05270863|365466878|FG001|First Washout|Lost to Follow-up|0|||
105946334|NCT05270863|365466879|FG002|First Washout|Lost to Follow-up|0|||
105946335|NCT05270863|365466880|FG003|First Washout|Lost to Follow-up|0|||
105946336|NCT05270863|365466881|FG004|First Washout|Lost to Follow-up|0|||
105946337|NCT05270863|365466882|FG005|First Washout|Lost to Follow-up|1|||
105946338|NCT05270863|365466877|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
105946339|NCT05270863|365466878|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
105946340|NCT05270863|365466879|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
105946341|NCT05270863|365466880|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
105946342|NCT05270863|365466881|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
105946343|NCT05270863|365466882|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
105946344|NCT05270863|365466877|FG000|Second Washout|Withdrawal by Subject|1|||
105946345|NCT05270863|365466878|FG001|Second Washout|Withdrawal by Subject|1|||
105946346|NCT05270863|365466879|FG002|Second Washout|Withdrawal by Subject|0|||
105946347|NCT05270863|365466880|FG003|Second Washout|Withdrawal by Subject|0|||
105946348|NCT05270863|365466881|FG004|Second Washout|Withdrawal by Subject|0|||
105946349|NCT05270863|365466882|FG005|Second Washout|Withdrawal by Subject|0|||
105946350|NCT05270863|365466877|FG000|Second Washout|Lost to Follow-up|0|||
105946351|NCT05270863|365466878|FG001|Second Washout|Lost to Follow-up|0|||
105946352|NCT05270863|365466879|FG002|Second Washout|Lost to Follow-up|0|||
105946353|NCT05270863|365466880|FG003|Second Washout|Lost to Follow-up|1|||
105946354|NCT05270863|365466881|FG004|Second Washout|Lost to Follow-up|0|||
105946355|NCT05270863|365466882|FG005|Second Washout|Lost to Follow-up|0|||
105946356|NCT04712669|365466883|FG000|Double Blind Phase|Adverse Event|4|||
105946357|NCT04712669|365466884|FG001|Double Blind Phase|Adverse Event|4|||
105750512|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105750513|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105750514|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
105750515|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
105750516|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105801689|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
105750517|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105750518|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105801690|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105946358|NCT04712669|365466885|FG002|Double Blind Phase|Adverse Event|3|||
105946359|NCT04712669|365466886|FG003|Double Blind Phase|Adverse Event|0|||
105946360|NCT04712669|365466887|FG004|Double Blind Phase|Adverse Event|0|||
105946361|NCT04712669|365466888|FG005|Double Blind Phase|Adverse Event|0|||
105946362|NCT04712669|365466889|FG006|Double Blind Phase|Adverse Event|0|||
105946363|NCT04712669|365466890|FG007|Double Blind Phase|Adverse Event|0|||
105946364|NCT04712669|365466883|FG000|Double Blind Phase|Physician Decision|1|||
105946365|NCT04712669|365466884|FG001|Double Blind Phase|Physician Decision|0|||
105946366|NCT04712669|365466885|FG002|Double Blind Phase|Physician Decision|0|||
105946367|NCT04712669|365466886|FG003|Double Blind Phase|Physician Decision|0|||
105946368|NCT04712669|365466887|FG004|Double Blind Phase|Physician Decision|0|||
105946369|NCT04712669|365466888|FG005|Double Blind Phase|Physician Decision|0|||
105946370|NCT04712669|365466889|FG006|Double Blind Phase|Physician Decision|0|||
105750519|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105946371|NCT04712669|365466890|FG007|Double Blind Phase|Physician Decision|0|||
105946372|NCT04712669|365466883|FG000|Double Blind Phase|Withdrawal by Subject|3|||
105946373|NCT04712669|365466884|FG001|Double Blind Phase|Withdrawal by Subject|6|||
105946374|NCT04712669|365466885|FG002|Double Blind Phase|Withdrawal by Subject|0|||
105946375|NCT04712669|365466886|FG003|Double Blind Phase|Withdrawal by Subject|0|||
105946376|NCT04712669|365466887|FG004|Double Blind Phase|Withdrawal by Subject|0|||
105946377|NCT04712669|365466888|FG005|Double Blind Phase|Withdrawal by Subject|0|||
105946378|NCT04712669|365466889|FG006|Double Blind Phase|Withdrawal by Subject|0|||
105946379|NCT04712669|365466890|FG007|Double Blind Phase|Withdrawal by Subject|0|||
105946380|NCT04712669|365466883|FG000|Double Blind Phase|Termination by Sponsor|0|||
105946381|NCT04712669|365466884|FG001|Double Blind Phase|Termination by Sponsor|0|||
105946382|NCT04712669|365466885|FG002|Double Blind Phase|Termination by Sponsor|1|||
105946383|NCT04712669|365466886|FG003|Double Blind Phase|Termination by Sponsor|0|||
105946384|NCT04712669|365466887|FG004|Double Blind Phase|Termination by Sponsor|0|||
105946385|NCT04712669|365466888|FG005|Double Blind Phase|Termination by Sponsor|0|||
105946386|NCT04712669|365466889|FG006|Double Blind Phase|Termination by Sponsor|0|||
105946387|NCT04712669|365466890|FG007|Double Blind Phase|Termination by Sponsor|0|||
105946388|NCT04712669|365466883|FG000|Open Label Phase|Adverse Event|0|||
105946389|NCT04712669|365466884|FG001|Open Label Phase|Adverse Event|0|||
105946390|NCT04712669|365466885|FG002|Open Label Phase|Adverse Event|0|||
105946391|NCT04712669|365466886|FG003|Open Label Phase|Adverse Event|1|||
105946392|NCT04712669|365466887|FG004|Open Label Phase|Adverse Event|1|||
105946393|NCT04712669|365466888|FG005|Open Label Phase|Adverse Event|3|||
105946394|NCT04712669|365466889|FG006|Open Label Phase|Adverse Event|1|||
105946395|NCT04712669|365466890|FG007|Open Label Phase|Adverse Event|2|||
105946396|NCT04712669|365466883|FG000|Open Label Phase|Death|0|||
105946397|NCT04712669|365466884|FG001|Open Label Phase|Death|0|||
105946398|NCT04712669|365466885|FG002|Open Label Phase|Death|0|||
105946399|NCT04712669|365466886|FG003|Open Label Phase|Death|1|||
105946400|NCT04712669|365466887|FG004|Open Label Phase|Death|0|||
105946401|NCT04712669|365466888|FG005|Open Label Phase|Death|0|||
105946402|NCT04712669|365466889|FG006|Open Label Phase|Death|0|||
105946403|NCT04712669|365466890|FG007|Open Label Phase|Death|0|||
105946404|NCT04712669|365466883|FG000|Open Label Phase|Lack of Efficacy|0|||
105946405|NCT04712669|365466884|FG001|Open Label Phase|Lack of Efficacy|0|||
105946406|NCT04712669|365466885|FG002|Open Label Phase|Lack of Efficacy|0|||
105946407|NCT04712669|365466886|FG003|Open Label Phase|Lack of Efficacy|0|||
105946408|NCT04712669|365466887|FG004|Open Label Phase|Lack of Efficacy|1|||
105750520|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
105750521|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
105946409|NCT04712669|365466888|FG005|Open Label Phase|Lack of Efficacy|0|||
105946410|NCT04712669|365466889|FG006|Open Label Phase|Lack of Efficacy|0|||
105946411|NCT04712669|365466890|FG007|Open Label Phase|Lack of Efficacy|0|||
105946412|NCT04712669|365466883|FG000|Open Label Phase|Lost to Follow-up|0|||
105946413|NCT04712669|365466884|FG001|Open Label Phase|Lost to Follow-up|0|||
105946414|NCT04712669|365466885|FG002|Open Label Phase|Lost to Follow-up|0|||
105946415|NCT04712669|365466886|FG003|Open Label Phase|Lost to Follow-up|0|||
105946416|NCT04712669|365466887|FG004|Open Label Phase|Lost to Follow-up|0|||
105946417|NCT04712669|365466888|FG005|Open Label Phase|Lost to Follow-up|0|||
105946418|NCT04712669|365466889|FG006|Open Label Phase|Lost to Follow-up|1|||
105946419|NCT04712669|365466890|FG007|Open Label Phase|Lost to Follow-up|1|||
105946420|NCT04712669|365466883|FG000|Open Label Phase|Physician Decision|0|||
105946421|NCT04712669|365466884|FG001|Open Label Phase|Physician Decision|0|||
105946422|NCT04712669|365466885|FG002|Open Label Phase|Physician Decision|0|||
105946423|NCT04712669|365466886|FG003|Open Label Phase|Physician Decision|1|||
105946424|NCT04712669|365466887|FG004|Open Label Phase|Physician Decision|0|||
105946425|NCT04712669|365466888|FG005|Open Label Phase|Physician Decision|0|||
105750522|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
105946426|NCT04712669|365466889|FG006|Open Label Phase|Physician Decision|0|||
105946427|NCT04712669|365466890|FG007|Open Label Phase|Physician Decision|0|||
105946428|NCT04712669|365466883|FG000|Open Label Phase|Withdrawal by Subject|0|||
105946429|NCT04712669|365466884|FG001|Open Label Phase|Withdrawal by Subject|0|||
105946430|NCT04712669|365466885|FG002|Open Label Phase|Withdrawal by Subject|0|||
105946431|NCT04712669|365466886|FG003|Open Label Phase|Withdrawal by Subject|1|||
105946432|NCT04712669|365466887|FG004|Open Label Phase|Withdrawal by Subject|5|||
105946433|NCT04712669|365466888|FG005|Open Label Phase|Withdrawal by Subject|5|||
105946434|NCT04712669|365466889|FG006|Open Label Phase|Withdrawal by Subject|0|||
105946435|NCT04712669|365466890|FG007|Open Label Phase|Withdrawal by Subject|4|||
105946436|NCT04712669|365466883|FG000|Open Label Phase|Termination by Sponsor|0|||
105946437|NCT04712669|365466884|FG001|Open Label Phase|Termination by Sponsor|0|||
105946438|NCT04712669|365466885|FG002|Open Label Phase|Termination by Sponsor|0|||
105946439|NCT04712669|365466886|FG003|Open Label Phase|Termination by Sponsor|11|||
105946440|NCT04712669|365466887|FG004|Open Label Phase|Termination by Sponsor|9|||
105946441|NCT04712669|365466888|FG005|Open Label Phase|Termination by Sponsor|14|||
105946442|NCT04712669|365466889|FG006|Open Label Phase|Termination by Sponsor|0|||
105946443|NCT04712669|365466890|FG007|Open Label Phase|Termination by Sponsor|14|||
105946444|NCT04464473|365466891|FG000|Overall Study|New piercing could not be removed for scanning|0|||
105946445|NCT04464473|365466892|FG001|Overall Study|New piercing could not be removed for scanning|0|||
105946446|NCT04464473|365466893|FG002|Overall Study|New piercing could not be removed for scanning|0|||
105946447|NCT04464473|365466894|FG003|Overall Study|New piercing could not be removed for scanning|1|||
105946448|NCT04464473|365466895|FG004|Overall Study|New piercing could not be removed for scanning|0|||
105946449|NCT04464473|365466896|FG005|Overall Study|New piercing could not be removed for scanning|0|||
105946450|NCT04464473|365466891|FG000|Overall Study|Adverse Event|0|||
105946451|NCT04464473|365466892|FG001|Overall Study|Adverse Event|0|||
105946452|NCT04464473|365466893|FG002|Overall Study|Adverse Event|0|||
105946453|NCT04464473|365466894|FG003|Overall Study|Adverse Event|1|||
105946454|NCT04464473|365466895|FG004|Overall Study|Adverse Event|0|||
105946455|NCT04464473|365466896|FG005|Overall Study|Adverse Event|0|||
105946456|NCT04464473|365466891|FG000|Overall Study|Lost to Follow-up|0|||
105946457|NCT04464473|365466892|FG001|Overall Study|Lost to Follow-up|0|||
105946458|NCT04464473|365466893|FG002|Overall Study|Lost to Follow-up|0|||
105946459|NCT04464473|365466894|FG003|Overall Study|Lost to Follow-up|1|||
105946460|NCT04464473|365466895|FG004|Overall Study|Lost to Follow-up|0|||
105946461|NCT04464473|365466896|FG005|Overall Study|Lost to Follow-up|0|||
105946462|NCT03802396|365466897|FG000|Overall Study|Withdrawal by Subject|2|||
105946463|NCT03802396|365466898|FG001|Overall Study|Withdrawal by Subject|0|||
105946464|NCT03802396|365466897|FG000|Overall Study|Surgery Cancelled|1|||
105946465|NCT03802396|365466898|FG001|Overall Study|Surgery Cancelled|0|||
105946466|NCT03557502|365466899|FG000|Protocol 2|Withdrawal by Subject|1|||
105946467|NCT03557502|365466900|FG001|Protocol 2|Withdrawal by Subject|1|||
105946468|NCT03557502|365466899|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
105946469|NCT03557502|365466900|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
105946470|NCT02561962|365466905|FG000|Overall Study|Withdrawal by Subject|1|||
105946471|NCT02561962|365466906|FG001|Overall Study|Withdrawal by Subject|0|||
105946472|NCT02561962|365466907|FG002|Overall Study|Withdrawal by Subject|0|||
105946473|NCT02561962|365466908|FG003|Overall Study|Withdrawal by Subject|0|||
105946474|NCT02561962|365466909|FG004|Overall Study|Withdrawal by Subject|1|||
105946475|NCT02561962|365466910|FG005|Overall Study|Withdrawal by Subject|1|||
105946476|NCT02561962|365466911|FG006|Overall Study|Withdrawal by Subject|2|||
105946477|NCT02561962|365466912|FG007|Overall Study|Withdrawal by Subject|1|||
105946478|NCT02561962|365466913|FG008|Overall Study|Withdrawal by Subject|0|||
105946479|NCT02561962|365466905|FG000|Overall Study|Decision by sponsor|0|||
105946480|NCT02561962|365466906|FG001|Overall Study|Decision by sponsor|0|||
105946481|NCT02561962|365466907|FG002|Overall Study|Decision by sponsor|0|||
105946482|NCT02561962|365466908|FG003|Overall Study|Decision by sponsor|0|||
105946483|NCT02561962|365466909|FG004|Overall Study|Decision by sponsor|1|||
105946484|NCT02561962|365466910|FG005|Overall Study|Decision by sponsor|1|||
105946485|NCT02561962|365466911|FG006|Overall Study|Decision by sponsor|0|||
105946486|NCT02561962|365466912|FG007|Overall Study|Decision by sponsor|3|||
105946487|NCT02561962|365466913|FG008|Overall Study|Decision by sponsor|0|||
105946488|NCT02561962|365466905|FG000|Overall Study|Lost to Follow-up|0|||
105946489|NCT02561962|365466906|FG001|Overall Study|Lost to Follow-up|0|||
105946490|NCT02561962|365466907|FG002|Overall Study|Lost to Follow-up|0|||
105946491|NCT02561962|365466908|FG003|Overall Study|Lost to Follow-up|0|||
105946492|NCT02561962|365466909|FG004|Overall Study|Lost to Follow-up|0|||
105946493|NCT02561962|365466910|FG005|Overall Study|Lost to Follow-up|1|||
105750523|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
105750524|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
105750525|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
105750526|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
105750527|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
105750528|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
105750529|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
105750530|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
105750531|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
105750532|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
105750533|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
105750534|NCT01963208|364738858|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750535|NCT01963208|364738859|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750536|NCT01963208|364738860|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750537|NCT01963208|364738861|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750538|NCT01963208|364738862|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
105750539|NCT01963208|364738863|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
105750540|NCT01536119|364738866|FG000|Overall Study|Lost to Follow-up|17|||
105750541|NCT01536119|364738867|FG001|Overall Study|Lost to Follow-up|14|||
105750542|NCT00448916|364738868|FG000|Overall Study|Adverse Event|2|||
105750543|NCT00448916|364738869|FG001|Overall Study|Adverse Event|2|||
105750544|NCT00448916|364738870|FG002|Overall Study|Adverse Event|3|||
105750545|NCT00448916|364738871|FG003|Overall Study|Adverse Event|2|||
105750546|NCT00448916|364738868|FG000|Overall Study|Lack of Efficacy|1|||
105750547|NCT00448916|364738869|FG001|Overall Study|Lack of Efficacy|0|||
105750548|NCT00448916|364738870|FG002|Overall Study|Lack of Efficacy|2|||
105750549|NCT00448916|364738871|FG003|Overall Study|Lack of Efficacy|1|||
105750550|NCT00448916|364738868|FG000|Overall Study|Withdrawal by Subject|3|||
105750551|NCT00448916|364738869|FG001|Overall Study|Withdrawal by Subject|3|||
105750552|NCT00448916|364738870|FG002|Overall Study|Withdrawal by Subject|1|||
105750553|NCT00448916|364738871|FG003|Overall Study|Withdrawal by Subject|1|||
105750554|NCT00448916|364738868|FG000|Overall Study|Other|1|||
105750555|NCT00448916|364738869|FG001|Overall Study|Other|0|||
105750556|NCT00448916|364738870|FG002|Overall Study|Other|0|||
105750557|NCT00448916|364738871|FG003|Overall Study|Other|0|||
105750558|NCT00448916|364738868|FG000|Overall Study|Lost to Follow-up|0|||
105750559|NCT00448916|364738869|FG001|Overall Study|Lost to Follow-up|1|||
105946494|NCT02561962|365466911|FG006|Overall Study|Lost to Follow-up|0|||
105946495|NCT02561962|365466912|FG007|Overall Study|Lost to Follow-up|0|||
105946496|NCT02561962|365466913|FG008|Overall Study|Lost to Follow-up|0|||
105946497|NCT01346176|365466914|FG000|Recruited|Protocol Violation|1|||
105946498|NCT01346176|365466915|FG001|Recruited|Protocol Violation|0|||
105946499|NCT01346176|365466916|FG002|Recruited|Protocol Violation|0|||
105946500|NCT01346176|365466914|FG000|Completed Advance Directive|Death|3|||
105946501|NCT01346176|365466915|FG001|Completed Advance Directive|Death|2|||
105946502|NCT01346176|365466916|FG002|Completed Advance Directive|Death|2|||
105946503|NCT01346176|365466914|FG000|Completed Advance Directive|Became Ineligible|3|||
105946504|NCT01346176|365466915|FG001|Completed Advance Directive|Became Ineligible|0|||
105946505|NCT01346176|365466916|FG002|Completed Advance Directive|Became Ineligible|1|||
105946506|NCT01346176|365466914|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
105946507|NCT01346176|365466915|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
105946508|NCT01346176|365466916|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
105946509|NCT01346176|365466914|FG000|Completed Satisfaction Survey|Death|3|||
105946510|NCT01346176|365466915|FG001|Completed Satisfaction Survey|Death|0|||
105946511|NCT01346176|365466916|FG002|Completed Satisfaction Survey|Death|2|||
105946512|NCT01346176|365466914|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
105946513|NCT01346176|365466915|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
105946514|NCT01346176|365466916|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
105946515|NCT04237584|365466917|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
105946516|NCT04237584|365466918|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
105946517|NCT04237584|365466919|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
105946518|NCT04237584|365466920|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
105946519|NCT04237584|365466917|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
105946520|NCT04237584|365466918|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
105750560|NCT00448916|364738870|FG002|Overall Study|Lost to Follow-up|0|||
105750561|NCT00448916|364738871|FG003|Overall Study|Lost to Follow-up|1|||
105750562|NCT00448916|364738868|FG000|Overall Study|Protocol Violation|0|||
105750563|NCT00448916|364738869|FG001|Overall Study|Protocol Violation|0|||
105750564|NCT00448916|364738870|FG002|Overall Study|Protocol Violation|0|||
105750565|NCT00448916|364738871|FG003|Overall Study|Protocol Violation|1|||
105750566|NCT01185249|364738872|FG000|Overall Study|Patients discharged or change in status|42|||
105750567|NCT01810042|364738877|FG000|Overall Study|Lost to Follow-up|10|||
105946521|NCT04237584|365466919|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
105946522|NCT04237584|365466920|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
105750568|NCT02164513|364738878|FG000|Overall Study|Adverse Event|162|||
105750569|NCT02164513|364738879|FG001|Overall Study|Adverse Event|180|||
105750570|NCT02164513|364738880|FG002|Overall Study|Adverse Event|111|||
105750571|NCT02164513|364738878|FG000|Overall Study|Other: Study Closed or terminated|5|||
105750572|NCT02164513|364738879|FG001|Overall Study|Other: Study Closed or terminated|2|||
105750573|NCT02164513|364738880|FG002|Overall Study|Other: Study Closed or terminated|4|||
105750574|NCT02164513|364738878|FG000|Overall Study|Lost to Follow-up|30|||
105750575|NCT02164513|364738879|FG001|Overall Study|Lost to Follow-up|36|||
105750576|NCT02164513|364738880|FG002|Overall Study|Lost to Follow-up|22|||
105750577|NCT02164513|364738878|FG000|Overall Study|Physician Decision|47|||
105750578|NCT02164513|364738879|FG001|Overall Study|Physician Decision|57|||
105750579|NCT02164513|364738880|FG002|Overall Study|Physician Decision|28|||
105750580|NCT02164513|364738878|FG000|Overall Study|Withdrawal by Subject|192|||
105750581|NCT02164513|364738879|FG001|Overall Study|Withdrawal by Subject|261|||
105750582|NCT02164513|364738880|FG002|Overall Study|Withdrawal by Subject|130|||
105750583|NCT02164513|364738878|FG000|Overall Study|Other: Reason not provided by site|1|||
105750584|NCT02164513|364738879|FG001|Overall Study|Other: Reason not provided by site|0|||
105750585|NCT02164513|364738880|FG002|Overall Study|Other: Reason not provided by site|0|||
105750586|NCT03707158|364738881|FG000|Midtreatment|Lost to Follow-up|16|||
105750587|NCT03707158|364738882|FG001|Midtreatment|Lost to Follow-up|7|||
105750588|NCT03707158|364738881|FG000|Midtreatment|Withdrawal by Subject|28|||
105750589|NCT03707158|364738882|FG001|Midtreatment|Withdrawal by Subject|19|||
105750590|NCT03707158|364738881|FG000|Posttreatment|Lost to Follow-up|0|||
105750591|NCT03707158|364738882|FG001|Posttreatment|Lost to Follow-up|5|||
105750592|NCT03707158|364738881|FG000|Follow-up|Lost to Follow-up|19|||
105750593|NCT03707158|364738882|FG001|Follow-up|Lost to Follow-up|18|||
105750594|NCT03707158|364738881|FG000|Follow-up|Withdrawal by Subject|13|||
105750595|NCT03707158|364738882|FG001|Follow-up|Withdrawal by Subject|6|||
105750596|NCT04569084|364738883|FG000|Overall Study|Adverse Event|10|||
105750597|NCT04569084|364738884|FG001|Overall Study|Adverse Event|14|||
105750598|NCT04569084|364738883|FG000|Overall Study|Death|2|||
105750599|NCT04569084|364738884|FG001|Overall Study|Death|3|||
105750600|NCT04569084|364738883|FG000|Overall Study|Lost to Follow-up|1|||
105750601|NCT04569084|364738884|FG001|Overall Study|Lost to Follow-up|1|||
105750602|NCT04569084|364738883|FG000|Overall Study|Physician Decision|3|||
105750603|NCT04569084|364738884|FG001|Overall Study|Physician Decision|3|||
105750604|NCT04569084|364738883|FG000|Overall Study|Protocol Violation|2|||
105750605|NCT04569084|364738884|FG001|Overall Study|Protocol Violation|1|||
105750606|NCT04569084|364738883|FG000|Overall Study|Withdrawal by Subject|20|||
105750607|NCT04569084|364738884|FG001|Overall Study|Withdrawal by Subject|21|||
105750608|NCT04569084|364738883|FG000|Overall Study|Study terminated by sponsor|26|||
105750609|NCT04569084|364738884|FG001|Overall Study|Study terminated by sponsor|23|||
105750610|NCT04569084|364738883|FG000|Overall Study|Other|3|||
105750611|NCT04569084|364738884|FG001|Overall Study|Other|5|||
105750612|NCT02773238|364738885|FG000|Overall Study|Lack of Efficacy|4|||
105750613|NCT01208038|364738886|FG000|Overall Study|Withdrawal by Subject|1|||
105750614|NCT01877382|364738889|FG000|Dose Escalation|Progressive disease|2|||
105750615|NCT01877382|364738890|FG001|Dose Escalation|Progressive disease|0|||
105750616|NCT01877382|364738891|FG002|Dose Escalation|Progressive disease|1|||
105750617|NCT01877382|364738892|FG003|Dose Escalation|Progressive disease|6|||
105750618|NCT01877382|364738893|FG004|Dose Escalation|Progressive disease|1|||
105750619|NCT01877382|364738894|FG005|Dose Escalation|Progressive disease|0|||
105750620|NCT01877382|364738895|FG006|Dose Escalation|Progressive disease|3|||
105750621|NCT01877382|364738896|FG007|Dose Escalation|Progressive disease|10|||
105750622|NCT01877382|364738897|FG008|Dose Escalation|Progressive disease|4|||
105750623|NCT01877382|364738898|FG009|Dose Escalation|Progressive disease|2|||
105750624|NCT01877382|364738899|FG010|Dose Escalation|Progressive disease|3|||
105750625|NCT01877382|364738900|FG011|Dose Escalation|Progressive disease|3|||
105750626|NCT01877382|364738901|FG012|Dose Escalation|Progressive disease|13|||
105750627|NCT01877382|364738902|FG013|Dose Escalation|Progressive disease|1|||
105750628|NCT01877382|364738903|FG014|Dose Escalation|Progressive disease|0|||
105750629|NCT01877382|364738889|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
105750630|NCT01877382|364738890|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750631|NCT01877382|364738891|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750632|NCT01877382|364738892|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
105750633|NCT01877382|364738893|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750634|NCT01877382|364738894|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750635|NCT01877382|364738895|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
105750636|NCT01877382|364738896|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750637|NCT01877382|364738897|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750638|NCT01877382|364738898|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105946523|NCT04237584|365466917|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
105946524|NCT04237584|365466918|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
105946525|NCT04237584|365466919|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
105946526|NCT04237584|365466920|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
105946527|NCT04237584|365466917|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
105946528|NCT04237584|365466918|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
105750639|NCT01877382|364738899|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750640|NCT01877382|364738900|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750641|NCT01877382|364738901|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750642|NCT01877382|364738902|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750643|NCT01877382|364738903|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750644|NCT01877382|364738889|FG000|Dose Escalation|Clinical progression|0|||
105750645|NCT01877382|364738890|FG001|Dose Escalation|Clinical progression|1|||
105750646|NCT01877382|364738891|FG002|Dose Escalation|Clinical progression|0|||
105750647|NCT01877382|364738892|FG003|Dose Escalation|Clinical progression|2|||
105750648|NCT01877382|364738893|FG004|Dose Escalation|Clinical progression|0|||
105750649|NCT01877382|364738894|FG005|Dose Escalation|Clinical progression|0|||
105750650|NCT01877382|364738895|FG006|Dose Escalation|Clinical progression|1|||
105750651|NCT01877382|364738896|FG007|Dose Escalation|Clinical progression|0|||
105750652|NCT01877382|364738897|FG008|Dose Escalation|Clinical progression|0|||
105750653|NCT01877382|364738898|FG009|Dose Escalation|Clinical progression|1|||
105750654|NCT01877382|364738899|FG010|Dose Escalation|Clinical progression|0|||
105750655|NCT01877382|364738900|FG011|Dose Escalation|Clinical progression|0|||
105750656|NCT01877382|364738901|FG012|Dose Escalation|Clinical progression|2|||
105750657|NCT01877382|364738902|FG013|Dose Escalation|Clinical progression|1|||
105750658|NCT01877382|364738903|FG014|Dose Escalation|Clinical progression|0|||
105946529|NCT04237584|365466919|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
105946530|NCT04237584|365466920|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
105946531|NCT04237584|365466917|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
105750659|NCT01877382|364738889|FG000|Dose Escalation|Adverse Event|0|||
105946532|NCT04237584|365466918|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
105946533|NCT04237584|365466919|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
105946534|NCT04237584|365466920|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
105946535|NCT01400412|365466921|FG000|Overall Study|Lost to Follow-up|4|||
105946536|NCT01400412|365466922|FG001|Overall Study|Lost to Follow-up|7|||
105946537|NCT01400412|365466921|FG000|Overall Study|Withdrawal by Subject|3|||
105946538|NCT01400412|365466922|FG001|Overall Study|Withdrawal by Subject|4|||
105946539|NCT01400412|365466921|FG000|Overall Study|Unable to complete|3|||
105946540|NCT01400412|365466922|FG001|Overall Study|Unable to complete|3|||
105946541|NCT01400412|365466921|FG000|Overall Study|Never started study treatment|0|||
105946542|NCT01400412|365466922|FG001|Overall Study|Never started study treatment|3|||
105946543|NCT02471144|365469166|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
105946544|NCT02471144|365469167|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
105946545|NCT02471144|365469168|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
105946546|NCT02471144|365469169|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
105946547|NCT02471144|365469170|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
105946548|NCT02471144|365469171|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
105946549|NCT02471144|365469172|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
105946550|NCT02471144|365469173|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
105946551|NCT02471144|365469174|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
105946552|NCT02471144|365469175|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
105946553|NCT02471144|365469176|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
105946554|NCT02471144|365469166|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946555|NCT02471144|365469167|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946556|NCT02471144|365469168|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946557|NCT02471144|365469169|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
105946558|NCT02471144|365469170|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946559|NCT02471144|365469171|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946560|NCT02471144|365469172|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946561|NCT02471144|365469173|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946562|NCT02471144|365469174|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946563|NCT02471144|365469175|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946564|NCT02471144|365469176|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
105946565|NCT02471144|365469166|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105750660|NCT01877382|364738890|FG001|Dose Escalation|Adverse Event|0|||
105946566|NCT02471144|365469167|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946567|NCT02471144|365469168|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
105946568|NCT02471144|365469169|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946569|NCT02471144|365469170|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946570|NCT02471144|365469171|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946571|NCT02471144|365469172|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946572|NCT02471144|365469173|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946573|NCT02471144|365469174|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946574|NCT02471144|365469175|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946575|NCT02471144|365469176|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
105946576|NCT02471144|365469166|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
105946577|NCT02471144|365469167|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
105946578|NCT02471144|365469168|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946579|NCT02471144|365469169|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946580|NCT02471144|365469170|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946581|NCT02471144|365469171|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946582|NCT02471144|365469172|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946583|NCT02471144|365469173|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946584|NCT02471144|365469174|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946585|NCT02471144|365469175|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946586|NCT02471144|365469176|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
105946587|NCT02471144|365469166|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105946588|NCT02471144|365469167|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105946589|NCT02471144|365469168|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105946590|NCT02471144|365469169|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105946591|NCT02471144|365469170|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
105946592|NCT02471144|365469171|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105946593|NCT02471144|365469172|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
105946594|NCT02471144|365469173|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105946595|NCT02471144|365469174|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
105946596|NCT02471144|365469175|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105946597|NCT02471144|365469176|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
105946598|NCT02471144|365469166|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946599|NCT02471144|365469167|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946600|NCT02471144|365469168|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946601|NCT02471144|365469169|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946602|NCT02471144|365469170|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946603|NCT02471144|365469171|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
105946604|NCT02471144|365469172|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946605|NCT02471144|365469173|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946606|NCT02471144|365469174|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
105946607|NCT02471144|365469175|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946608|NCT02471144|365469176|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
105946609|NCT02471144|365469166|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946610|NCT02471144|365469167|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946611|NCT02471144|365469168|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946612|NCT02471144|365469169|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946613|NCT02471144|365469170|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946614|NCT02471144|365469171|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946615|NCT02471144|365469172|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946616|NCT02471144|365469173|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946617|NCT02471144|365469174|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
105946618|NCT02471144|365469175|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105946619|NCT02471144|365469176|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
105750661|NCT01877382|364738891|FG002|Dose Escalation|Adverse Event|0|||
105750662|NCT01877382|364738892|FG003|Dose Escalation|Adverse Event|4|||
105750663|NCT01877382|364738893|FG004|Dose Escalation|Adverse Event|1|||
105750664|NCT01877382|364738894|FG005|Dose Escalation|Adverse Event|2|||
105750665|NCT01877382|364738895|FG006|Dose Escalation|Adverse Event|1|||
105750666|NCT01877382|364738896|FG007|Dose Escalation|Adverse Event|2|||
105750667|NCT01877382|364738897|FG008|Dose Escalation|Adverse Event|0|||
105750668|NCT01877382|364738898|FG009|Dose Escalation|Adverse Event|0|||
105750669|NCT01877382|364738899|FG010|Dose Escalation|Adverse Event|0|||
105750670|NCT01877382|364738900|FG011|Dose Escalation|Adverse Event|0|||
105750671|NCT01877382|364738901|FG012|Dose Escalation|Adverse Event|1|||
105750672|NCT01877382|364738902|FG013|Dose Escalation|Adverse Event|0|||
105750673|NCT01877382|364738903|FG014|Dose Escalation|Adverse Event|0|||
105750674|NCT01877382|364738889|FG000|Dose Escalation|Withdrawal by Subject|0|||
105750675|NCT01877382|364738890|FG001|Dose Escalation|Withdrawal by Subject|0|||
105750676|NCT01877382|364738891|FG002|Dose Escalation|Withdrawal by Subject|0|||
105946620|NCT02471144|365469166|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946621|NCT02471144|365469167|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946622|NCT02471144|365469168|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946623|NCT02471144|365469169|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946624|NCT02471144|365469170|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946625|NCT02471144|365469171|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946626|NCT02471144|365469172|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946627|NCT02471144|365469173|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
105946628|NCT02471144|365469174|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
105946629|NCT02471144|365469175|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946630|NCT02471144|365469176|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
105946631|NCT02471144|365469166|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946632|NCT02471144|365469167|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946633|NCT02471144|365469168|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946634|NCT02471144|365469169|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946635|NCT02471144|365469170|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946636|NCT02471144|365469171|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946637|NCT02471144|365469172|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946638|NCT02471144|365469173|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946639|NCT02471144|365469174|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
105946640|NCT02471144|365469175|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
105946641|NCT02471144|365469176|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
105946642|NCT02471144|365469166|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946643|NCT02471144|365469167|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946644|NCT02471144|365469168|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946645|NCT02471144|365469169|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946646|NCT02471144|365469170|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946647|NCT02471144|365469171|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946648|NCT02471144|365469172|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946649|NCT02471144|365469173|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946650|NCT02471144|365469174|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946651|NCT02471144|365469175|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
105946652|NCT02471144|365469176|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
105946653|NCT02471144|365469166|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946654|NCT02471144|365469167|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946655|NCT02471144|365469168|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946656|NCT02471144|365469169|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946657|NCT02471144|365469170|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946658|NCT02471144|365469171|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946659|NCT02471144|365469172|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946660|NCT02471144|365469173|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946661|NCT02471144|365469174|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946662|NCT02471144|365469175|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
105946663|NCT02471144|365469176|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
105946664|NCT02471144|365469166|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946665|NCT02471144|365469167|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946666|NCT02471144|365469168|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946667|NCT02471144|365469169|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946668|NCT02471144|365469170|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946669|NCT02471144|365469171|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946670|NCT02471144|365469172|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946671|NCT02471144|365469173|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946672|NCT02471144|365469174|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
105946673|NCT02471144|365469175|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
105946674|NCT02471144|365469176|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
105946675|NCT02471144|365469166|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105946676|NCT02471144|365469167|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105946677|NCT02471144|365469168|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105946678|NCT02471144|365469169|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105946679|NCT02471144|365469170|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105946680|NCT02471144|365469171|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105946681|NCT02471144|365469172|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105750677|NCT01877382|364738892|FG003|Dose Escalation|Withdrawal by Subject|0|||
105750678|NCT01877382|364738893|FG004|Dose Escalation|Withdrawal by Subject|0|||
105750679|NCT01877382|364738894|FG005|Dose Escalation|Withdrawal by Subject|3|||
105750680|NCT01877382|364738895|FG006|Dose Escalation|Withdrawal by Subject|2|||
105750681|NCT01877382|364738896|FG007|Dose Escalation|Withdrawal by Subject|1|||
105750682|NCT01877382|364738897|FG008|Dose Escalation|Withdrawal by Subject|1|||
105946682|NCT02471144|365469173|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105946683|NCT02471144|365469174|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105946684|NCT02471144|365469175|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
105946685|NCT02471144|365469176|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
105750683|NCT01877382|364738898|FG009|Dose Escalation|Withdrawal by Subject|0|||
105750684|NCT01877382|364738899|FG010|Dose Escalation|Withdrawal by Subject|0|||
105750685|NCT01877382|364738900|FG011|Dose Escalation|Withdrawal by Subject|0|||
105750686|NCT01877382|364738901|FG012|Dose Escalation|Withdrawal by Subject|0|||
105750687|NCT01877382|364738902|FG013|Dose Escalation|Withdrawal by Subject|0|||
105750688|NCT01877382|364738903|FG014|Dose Escalation|Withdrawal by Subject|0|||
105750689|NCT01877382|364738889|FG000|Dose Escalation|Protocol Violation|0|||
105750690|NCT01877382|364738890|FG001|Dose Escalation|Protocol Violation|0|||
105946686|NCT02471144|365469166|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105946687|NCT02471144|365469167|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105946688|NCT02471144|365469168|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105946689|NCT02471144|365469169|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105750691|NCT01877382|364738891|FG002|Dose Escalation|Protocol Violation|0|||
105750692|NCT01877382|364738892|FG003|Dose Escalation|Protocol Violation|0|||
105750693|NCT01877382|364738893|FG004|Dose Escalation|Protocol Violation|0|||
105750694|NCT01877382|364738894|FG005|Dose Escalation|Protocol Violation|0|||
105750695|NCT01877382|364738895|FG006|Dose Escalation|Protocol Violation|1|||
105750696|NCT01877382|364738896|FG007|Dose Escalation|Protocol Violation|0|||
105750697|NCT01877382|364738897|FG008|Dose Escalation|Protocol Violation|0|||
105750698|NCT01877382|364738898|FG009|Dose Escalation|Protocol Violation|0|||
105750699|NCT01877382|364738899|FG010|Dose Escalation|Protocol Violation|0|||
105750700|NCT01877382|364738900|FG011|Dose Escalation|Protocol Violation|0|||
105750701|NCT01877382|364738901|FG012|Dose Escalation|Protocol Violation|0|||
105750702|NCT01877382|364738902|FG013|Dose Escalation|Protocol Violation|0|||
105750703|NCT01877382|364738903|FG014|Dose Escalation|Protocol Violation|0|||
105750704|NCT01877382|364738889|FG000|Dose Escalation|Study terminated by sponsor|0|||
105750705|NCT01877382|364738890|FG001|Dose Escalation|Study terminated by sponsor|0|||
105750706|NCT01877382|364738891|FG002|Dose Escalation|Study terminated by sponsor|0|||
105750707|NCT01877382|364738892|FG003|Dose Escalation|Study terminated by sponsor|0|||
105750708|NCT01877382|364738893|FG004|Dose Escalation|Study terminated by sponsor|0|||
105750709|NCT01877382|364738894|FG005|Dose Escalation|Study terminated by sponsor|0|||
105750710|NCT01877382|364738895|FG006|Dose Escalation|Study terminated by sponsor|0|||
105750711|NCT01877382|364738896|FG007|Dose Escalation|Study terminated by sponsor|1|||
105946690|NCT02471144|365469170|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105946691|NCT02471144|365469171|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105946692|NCT02471144|365469172|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105946693|NCT02471144|365469173|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105946694|NCT02471144|365469174|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
105946695|NCT02471144|365469175|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
105946696|NCT02471144|365469176|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
105946697|NCT02278003|365469177|FG000|Overall Study|Withdrawal by Subject|11|||
105946698|NCT02278003|365469178|FG001|Overall Study|Withdrawal by Subject|0|||
105946699|NCT02278003|365469177|FG000|Overall Study|Not Treated|1|||
105946700|NCT02278003|365469178|FG001|Overall Study|Not Treated|0|||
105946701|NCT02278003|365469177|FG000|Overall Study|Recognition task improperly completed|7|||
105946702|NCT02278003|365469178|FG001|Overall Study|Recognition task improperly completed|0|||
105946703|NCT00876447|365469181|FG000|Overall Study|Other miscellaneous reasons|3|||
105946704|NCT00876447|365469182|FG001|Overall Study|Other miscellaneous reasons|8|||
105946705|NCT00876447|365469181|FG000|Overall Study|Site closure|19|||
105946706|NCT00876447|365469182|FG001|Overall Study|Site closure|14|||
105946707|NCT00876447|365469181|FG000|Overall Study|Protocol Violation|9|||
105946708|NCT00876447|365469182|FG001|Overall Study|Protocol Violation|3|||
105946709|NCT00876447|365469181|FG000|Overall Study|Personal reasons|30|||
105946710|NCT00876447|365469182|FG001|Overall Study|Personal reasons|28|||
105946711|NCT00876447|365469181|FG000|Overall Study|Lost to Follow-up|6|||
105946712|NCT00876447|365469182|FG001|Overall Study|Lost to Follow-up|15|||
105946713|NCT00876447|365469181|FG000|Overall Study|Pregnancy|4|||
105946714|NCT00876447|365469182|FG001|Overall Study|Pregnancy|2|||
105946715|NCT00876447|365469181|FG000|Overall Study|Lack of Efficacy|5|||
105946716|NCT00876447|365469182|FG001|Overall Study|Lack of Efficacy|3|||
105946717|NCT00876447|365469181|FG000|Overall Study|Adverse Event|4|||
105946718|NCT00876447|365469182|FG001|Overall Study|Adverse Event|8|||
105946719|NCT03674281|365469183|FG000|Overall Study|screen failure|2|||
105946720|NCT03674281|365469184|FG001|Overall Study|screen failure|0|||
105946721|NCT03674281|365469185|FG002|Overall Study|screen failure|0|||
105946722|NCT03674281|365469183|FG000|Overall Study|Withdrawal by Subject|1|||
105946723|NCT03674281|365469184|FG001|Overall Study|Withdrawal by Subject|3|||
105946724|NCT03674281|365469185|FG002|Overall Study|Withdrawal by Subject|3|||
105946725|NCT00366457|365469186|FG000|Overall Study|never began study therapy|2|||
105946726|NCT01497197|365469187|FG000|Overall Study|Lost to Follow-up|1|||
105946727|NCT01497197|365469188|FG001|Overall Study|Lost to Follow-up|0|||
105946728|NCT01497197|365469187|FG000|Overall Study|Protocol Violation|0|||
105946729|NCT01497197|365469188|FG001|Overall Study|Protocol Violation|2|||
105946730|NCT01497197|365469187|FG000|Overall Study|Withdrawal by Subject|2|||
105946731|NCT01497197|365469188|FG001|Overall Study|Withdrawal by Subject|1|||
105946732|NCT01497197|365469187|FG000|Overall Study|Excessive/lack of response to treatment|1|||
105946733|NCT01497197|365469188|FG001|Overall Study|Excessive/lack of response to treatment|0|||
105946734|NCT01497197|365469187|FG000|Overall Study|Risk of OHSS|1|||
105946735|NCT01497197|365469188|FG001|Overall Study|Risk of OHSS|0|||
105946736|NCT01497197|365469187|FG000|Overall Study|No oocytes retrieved|3|||
105946737|NCT01497197|365469188|FG001|Overall Study|No oocytes retrieved|2|||
105946738|NCT01497197|365469187|FG000|Overall Study|No fertilisation|6|||
105946739|NCT01497197|365469188|FG001|Overall Study|No fertilisation|5|||
105946740|NCT01497197|365469187|FG000|Overall Study|Intention to freeze all embryos|0|||
105946741|NCT01497197|365469188|FG001|Overall Study|Intention to freeze all embryos|1|||
105946742|NCT01497197|365469187|FG000|Overall Study|All embryos discarded|0|||
105946743|NCT01497197|365469188|FG001|Overall Study|All embryos discarded|3|||
105946744|NCT01497197|365469187|FG000|Overall Study|Other|3|||
105946745|NCT01497197|365469188|FG001|Overall Study|Other|1|||
105946746|NCT01425814|365469190|FG000|Period 1|Stability criteria not fulfilled|0|||
105946747|NCT01425814|365469191|FG001|Period 1|Stability criteria not fulfilled|1|||
105946748|NCT01425814|365469192|FG002|Period 1|Stability criteria not fulfilled|0|||
105946749|NCT01425814|365469193|FG003|Period 1|Stability criteria not fulfilled|0|||
105946750|NCT01425814|365469194|FG004|Period 1|Stability criteria not fulfilled|0|||
105946751|NCT01425814|365469195|FG005|Period 1|Stability criteria not fulfilled|0|||
105946752|NCT01425814|365469190|FG000|Period 2|Stability criteria not fulfilled|0|||
105946753|NCT01425814|365469191|FG001|Period 2|Stability criteria not fulfilled|1|||
105946754|NCT01425814|365469192|FG002|Period 2|Stability criteria not fulfilled|0|||
105946755|NCT01425814|365469193|FG003|Period 2|Stability criteria not fulfilled|0|||
105946756|NCT01425814|365469194|FG004|Period 2|Stability criteria not fulfilled|0|||
105946757|NCT01425814|365469195|FG005|Period 2|Stability criteria not fulfilled|0|||
105946758|NCT01425814|365469190|FG000|Period 3|Adverse Event|0|||
105946759|NCT01425814|365469191|FG001|Period 3|Adverse Event|0|||
105946760|NCT01425814|365469192|FG002|Period 3|Adverse Event|0|||
105946761|NCT01425814|365469193|FG003|Period 3|Adverse Event|0|||
105946762|NCT01425814|365469194|FG004|Period 3|Adverse Event|0|||
105946763|NCT01425814|365469195|FG005|Period 3|Adverse Event|1|||
105946764|NCT01425814|365469190|FG000|Period 4|Adverse Event|1|||
105946765|NCT01425814|365469191|FG001|Period 4|Adverse Event|0|||
105946766|NCT01425814|365469192|FG002|Period 4|Adverse Event|1|||
105946767|NCT01425814|365469193|FG003|Period 4|Adverse Event|0|||
105946768|NCT01425814|365469194|FG004|Period 4|Adverse Event|0|||
105946769|NCT01425814|365469195|FG005|Period 4|Adverse Event|0|||
105946770|NCT01425814|365469190|FG000|Period 5|Stability criteria not fulfilled|0|||
105946771|NCT01425814|365469191|FG001|Period 5|Stability criteria not fulfilled|0|||
105946772|NCT01425814|365469192|FG002|Period 5|Stability criteria not fulfilled|1|||
105946773|NCT01425814|365469193|FG003|Period 5|Stability criteria not fulfilled|0|||
105946774|NCT01425814|365469194|FG004|Period 5|Stability criteria not fulfilled|0|||
105946775|NCT01425814|365469195|FG005|Period 5|Stability criteria not fulfilled|1|||
105946776|NCT03186638|365469196|FG000|Overall Study|Withdrawal by Subject|4|||
105946777|NCT03186638|365469197|FG001|Overall Study|Withdrawal by Subject|4|||
105946778|NCT03186638|365469196|FG000|Overall Study|Withdrawn due to medical problem|3|||
105946779|NCT03186638|365469197|FG001|Overall Study|Withdrawn due to medical problem|2|||
105946780|NCT03186638|365469196|FG000|Overall Study|Lost to Follow-up|1|||
105946781|NCT03186638|365469197|FG001|Overall Study|Lost to Follow-up|0|||
105946782|NCT03801525|365469201|FG000|Overall Study|Adverse Event|17|||
105946783|NCT03801525|365469202|FG001|Overall Study|Adverse Event|1|||
105946784|NCT03801525|365469203|FG002|Overall Study|Adverse Event|0|||
105946785|NCT03801525|365469201|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
105750712|NCT01877382|364738897|FG008|Dose Escalation|Study terminated by sponsor|1|||
105946786|NCT03801525|365469202|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
105946787|NCT03801525|365469203|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
105946788|NCT03801525|365469201|FG000|Overall Study|Death|29|||
105946789|NCT03801525|365469202|FG001|Overall Study|Death|1|||
105946790|NCT03801525|365469203|FG002|Overall Study|Death|4|||
105946791|NCT03801525|365469201|FG000|Overall Study|Disease Progression|6|||
105946792|NCT03801525|365469202|FG001|Overall Study|Disease Progression|0|||
105946793|NCT03801525|365469203|FG002|Overall Study|Disease Progression|1|||
105946794|NCT03801525|365469201|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
105946795|NCT03801525|365469202|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
105946796|NCT03801525|365469203|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
105946797|NCT03801525|365469201|FG000|Overall Study|Investigator Decision|18|||
105946798|NCT03801525|365469202|FG001|Overall Study|Investigator Decision|1|||
105946799|NCT03801525|365469203|FG002|Overall Study|Investigator Decision|0|||
105946800|NCT03801525|365469201|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
105946801|NCT03801525|365469202|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
105946802|NCT03801525|365469203|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
105946803|NCT03801525|365469201|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
105946804|NCT03801525|365469202|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
105946805|NCT03801525|365469203|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
105946806|NCT03801525|365469201|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
105946807|NCT03801525|365469202|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
105946808|NCT03801525|365469203|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
105946809|NCT03801525|365469201|FG000|Overall Study|Withdrawal of Subject Consent|38|||
105946810|NCT03801525|365469202|FG001|Overall Study|Withdrawal of Subject Consent|2|||
105946811|NCT03801525|365469203|FG002|Overall Study|Withdrawal of Subject Consent|1|||
105946812|NCT03801525|365469201|FG000|Overall Study|Reason not Specified|4|||
105946813|NCT03801525|365469202|FG001|Overall Study|Reason not Specified|0|||
105946814|NCT03801525|365469203|FG002|Overall Study|Reason not Specified|4|||
105946815|NCT01263119|365469206|FG000|Period 1|Protocol Violation|2|||
105946816|NCT01263119|365469206|FG000|Period 2|Adverse Event|2|||
105946817|NCT02684461|365469207|FG000|Overall Study|Adverse Event|1|||
105946818|NCT02684461|365469208|FG001|Overall Study|Adverse Event|0|||
105946819|NCT02684461|365469209|FG002|Overall Study|Adverse Event|0|||
105946820|NCT02684461|365469207|FG000|Overall Study|Lack of Efficacy|1|||
105946821|NCT02684461|365469208|FG001|Overall Study|Lack of Efficacy|2|||
105946822|NCT02684461|365469209|FG002|Overall Study|Lack of Efficacy|0|||
105946823|NCT01206517|365469214|FG000|Overall Study|Withdrawal by Subject|0|||
105946824|NCT01206517|365469215|FG001|Overall Study|Withdrawal by Subject|0|||
105946825|NCT01206517|365469216|FG002|Overall Study|Withdrawal by Subject|2|||
105946826|NCT01206517|365469217|FG003|Overall Study|Withdrawal by Subject|0|||
105946827|NCT01206517|365469218|FG004|Overall Study|Withdrawal by Subject|1|||
105946828|NCT01206517|365469219|FG005|Overall Study|Withdrawal by Subject|0|||
105946829|NCT01029535|365469220|FG000|Overall Study|Lost to Follow-up|24|||
105946830|NCT01029535|365469220|FG000|Overall Study|Protocol Violation|2|||
105946831|NCT01029535|365469220|FG000|Overall Study|Participant Withdrew Consent|2|||
105946832|NCT01029535|365469220|FG000|Overall Study|Adverse Event|1|||
105946833|NCT01029535|365469220|FG000|Overall Study|Use of Another Treatment|1|||
105946834|NCT01029535|365469220|FG000|Overall Study|Death|1|||
105946835|NCT04047446|365469221|FG000|Overall Study|Physician Decision|1|||
105946836|NCT04047446|365469222|FG001|Overall Study|Physician Decision|0|||
105946837|NCT02367456|365469223|FG000|Overall Study|Death|8|||
105946838|NCT02367456|365469224|FG001|Overall Study|Death|24|||
105946839|NCT02367456|365469225|FG002|Overall Study|Death|17|||
105946840|NCT02367456|365469223|FG000|Overall Study|Lost to Follow-up|1|||
105946841|NCT02367456|365469224|FG001|Overall Study|Lost to Follow-up|3|||
105946842|NCT02367456|365469225|FG002|Overall Study|Lost to Follow-up|1|||
105946843|NCT02367456|365469223|FG000|Overall Study|Other reason|3|||
105946844|NCT02367456|365469224|FG001|Overall Study|Other reason|3|||
105946845|NCT02367456|365469225|FG002|Overall Study|Other reason|9|||
105946846|NCT02367456|365469223|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
105946847|NCT02367456|365469224|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
105946848|NCT02367456|365469225|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
105946849|NCT00329420|365469226|FG000|Re-induction Phase|Lack of Efficacy|0|||
105946850|NCT00329420|365469227|FG001|Re-induction Phase|Lack of Efficacy|1|||
105946851|NCT00329420|365469228|FG002|Re-induction Phase|Lack of Efficacy|0|||
105946852|NCT00329420|365469226|FG000|Re-induction Phase|Withdrawal of Consent|0|||
105946853|NCT00329420|365469227|FG001|Re-induction Phase|Withdrawal of Consent|0|||
105946854|NCT00329420|365469228|FG002|Re-induction Phase|Withdrawal of Consent|1|||
105946855|NCT00329420|365469226|FG000|Re-induction Phase|Did not respond to re-induction|6|||
105946856|NCT00329420|365469227|FG001|Re-induction Phase|Did not respond to re-induction|5|||
105946857|NCT00329420|365469228|FG002|Re-induction Phase|Did not respond to re-induction|7|||
105946858|NCT00329420|365469226|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
105946859|NCT00329420|365469227|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
105946860|NCT00329420|365469228|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
105946861|NCT00329420|365469226|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
105946862|NCT00329420|365469227|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
105946863|NCT00329420|365469228|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
105946864|NCT00329420|365469226|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
105946865|NCT00329420|365469227|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
105946866|NCT00329420|365469228|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
105946867|NCT03639610|365469229|FG000|Overall Study|Adverse Event|7|||
105946868|NCT03639610|365469230|FG001|Overall Study|Adverse Event|1|||
105946869|NCT03639610|365469231|FG002|Overall Study|Adverse Event|0|||
105946870|NCT03639610|365469229|FG000|Overall Study|Physician Decision|3|||
105946871|NCT03639610|365469230|FG001|Overall Study|Physician Decision|1|||
105946872|NCT03639610|365469231|FG002|Overall Study|Physician Decision|0|||
105946873|NCT03639610|365469229|FG000|Overall Study|Disease progression|8|||
105946874|NCT03639610|365469230|FG001|Overall Study|Disease progression|5|||
105946875|NCT03639610|365469231|FG002|Overall Study|Disease progression|3|||
105946876|NCT03639610|365469229|FG000|Overall Study|Study terminated by sponsor|2|||
105946877|NCT03639610|365469230|FG001|Overall Study|Study terminated by sponsor|1|||
105946878|NCT03639610|365469231|FG002|Overall Study|Study terminated by sponsor|1|||
105946879|NCT03639610|365469229|FG000|Overall Study|Patient request to stop treatment|1|||
105946880|NCT03639610|365469230|FG001|Overall Study|Patient request to stop treatment|2|||
105946881|NCT03639610|365469231|FG002|Overall Study|Patient request to stop treatment|0|||
105946882|NCT01959529|365469234|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
105946883|NCT01959529|365469235|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
105946884|NCT01959529|365469234|FG000|Overall Study|Lost to Follow-up|4|||
105946885|NCT01959529|365469235|FG001|Overall Study|Lost to Follow-up|1|||
105946886|NCT01959529|365469234|FG000|Overall Study|Other|70|||
105946887|NCT01959529|365469235|FG001|Overall Study|Other|68|||
105946888|NCT01959529|365469234|FG000|Overall Study|Hypoglycaemia|1|||
105946889|NCT01959529|365469235|FG001|Overall Study|Hypoglycaemia|1|||
105946890|NCT01959529|365469234|FG000|Overall Study|Lack of glycaemic control|1|||
105946891|NCT01959529|365469235|FG001|Overall Study|Lack of glycaemic control|1|||
105946892|NCT00557193|365469236|FG000|Induction|Adverse Event|2|||
105946893|NCT00557193|365469237|FG001|Induction|Adverse Event|0|||
105946894|NCT00557193|365469238|FG002|Induction|Adverse Event|0|||
105946895|NCT00557193|365469239|FG003|Induction|Adverse Event|0|||
105946896|NCT00557193|365469240|FG004|Induction|Adverse Event|0|||
105946897|NCT00557193|365469241|FG005|Induction|Adverse Event|0|||
105750713|NCT01877382|364738898|FG009|Dose Escalation|Study terminated by sponsor|0|||
105760893|NCT01831804|364778043|FG007|Overall Study|Withdrew Consent|2|||
105946898|NCT00557193|365469236|FG000|Induction|Death|6|||
105946899|NCT00557193|365469237|FG001|Induction|Death|0|||
105946900|NCT00557193|365469238|FG002|Induction|Death|0|||
105946901|NCT00557193|365469239|FG003|Induction|Death|0|||
105946902|NCT00557193|365469240|FG004|Induction|Death|0|||
105946903|NCT00557193|365469241|FG005|Induction|Death|0|||
105946904|NCT00557193|365469236|FG000|Induction|Physician Decision|3|||
105750714|NCT01877382|364738899|FG010|Dose Escalation|Study terminated by sponsor|0|||
105750715|NCT01877382|364738900|FG011|Dose Escalation|Study terminated by sponsor|0|||
105750716|NCT01877382|364738901|FG012|Dose Escalation|Study terminated by sponsor|3|||
105750717|NCT01877382|364738902|FG013|Dose Escalation|Study terminated by sponsor|0|||
105750718|NCT01877382|364738903|FG014|Dose Escalation|Study terminated by sponsor|0|||
105750719|NCT01877382|364738889|FG000|Dose Escalation|Death|0|||
105946905|NCT00557193|365469237|FG001|Induction|Physician Decision|0|||
105946906|NCT00557193|365469238|FG002|Induction|Physician Decision|0|||
105946907|NCT00557193|365469239|FG003|Induction|Physician Decision|0|||
105946908|NCT00557193|365469240|FG004|Induction|Physician Decision|0|||
105946909|NCT00557193|365469241|FG005|Induction|Physician Decision|0|||
105946910|NCT00557193|365469236|FG000|Induction|Withdrawal by Subject|1|||
105946911|NCT00557193|365469237|FG001|Induction|Withdrawal by Subject|0|||
105946912|NCT00557193|365469238|FG002|Induction|Withdrawal by Subject|0|||
105946913|NCT00557193|365469239|FG003|Induction|Withdrawal by Subject|0|||
105946914|NCT00557193|365469240|FG004|Induction|Withdrawal by Subject|0|||
105946915|NCT00557193|365469241|FG005|Induction|Withdrawal by Subject|0|||
105946916|NCT00557193|365469236|FG000|Induction|Refusal of Further Protocol Therapy|2|||
105946917|NCT00557193|365469237|FG001|Induction|Refusal of Further Protocol Therapy|0|||
105946918|NCT00557193|365469238|FG002|Induction|Refusal of Further Protocol Therapy|0|||
105946919|NCT00557193|365469239|FG003|Induction|Refusal of Further Protocol Therapy|0|||
105946920|NCT00557193|365469240|FG004|Induction|Refusal of Further Protocol Therapy|0|||
105946921|NCT00557193|365469241|FG005|Induction|Refusal of Further Protocol Therapy|0|||
105946922|NCT00557193|365469236|FG000|Induction|Ineligible|8|||
105946923|NCT00557193|365469237|FG001|Induction|Ineligible|0|||
105946924|NCT00557193|365469238|FG002|Induction|Ineligible|0|||
105946925|NCT00557193|365469239|FG003|Induction|Ineligible|0|||
105946926|NCT00557193|365469240|FG004|Induction|Ineligible|0|||
105946927|NCT00557193|365469241|FG005|Induction|Ineligible|0|||
105946928|NCT00557193|365469236|FG000|Induction|Inevaluable for post Induction|2|||
105946929|NCT00557193|365469237|FG001|Induction|Inevaluable for post Induction|0|||
105946930|NCT00557193|365469238|FG002|Induction|Inevaluable for post Induction|0|||
105946931|NCT00557193|365469239|FG003|Induction|Inevaluable for post Induction|0|||
105946932|NCT00557193|365469240|FG004|Induction|Inevaluable for post Induction|0|||
105946933|NCT00557193|365469241|FG005|Induction|Inevaluable for post Induction|0|||
105946934|NCT00557193|365469236|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
105946935|NCT00557193|365469237|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105946936|NCT00557193|365469238|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105946937|NCT00557193|365469239|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105946938|NCT00557193|365469240|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105946939|NCT00557193|365469241|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
105946940|NCT00557193|365469236|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105946941|NCT00557193|365469237|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
105946942|NCT00557193|365469238|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
105946943|NCT00557193|365469239|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
105946944|NCT00557193|365469240|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
105946945|NCT00557193|365469241|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
105946946|NCT00557193|365469236|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
105946947|NCT00557193|365469237|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
105946948|NCT00557193|365469238|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
105946949|NCT00557193|365469239|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
105946950|NCT00557193|365469240|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
105946951|NCT00557193|365469241|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
105946952|NCT00557193|365469236|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
105946953|NCT00557193|365469237|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
105946954|NCT00557193|365469238|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
105946955|NCT00557193|365469239|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
105946956|NCT00557193|365469240|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
105946957|NCT00557193|365469241|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
105946958|NCT00557193|365469236|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
105946959|NCT00557193|365469237|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
105946960|NCT00557193|365469238|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
105946961|NCT00557193|365469239|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
105946962|NCT00557193|365469240|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
105946963|NCT00557193|365469241|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
105750720|NCT01877382|364738890|FG001|Dose Escalation|Death|0|||
105750721|NCT01877382|364738891|FG002|Dose Escalation|Death|0|||
105750722|NCT01877382|364738892|FG003|Dose Escalation|Death|0|||
105946964|NCT00557193|365469236|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
105946965|NCT00557193|365469237|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
105946966|NCT00557193|365469238|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
105946967|NCT00557193|365469239|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
105946968|NCT00557193|365469240|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
105946969|NCT00557193|365469241|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
105946970|NCT00557193|365469236|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105946971|NCT00557193|365469237|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105946972|NCT00557193|365469238|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
105946973|NCT00557193|365469239|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105946974|NCT00557193|365469240|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105946975|NCT00557193|365469241|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
105946976|NCT00557193|365469236|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105946977|NCT00557193|365469237|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105946978|NCT00557193|365469238|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
105946979|NCT00557193|365469239|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105946980|NCT00557193|365469240|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105946981|NCT00557193|365469241|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
105946982|NCT00557193|365469236|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
105946983|NCT00557193|365469237|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
105946984|NCT00557193|365469238|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
105946985|NCT00557193|365469239|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
105946986|NCT00557193|365469240|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
105946987|NCT00557193|365469241|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
105946988|NCT03984825|365469242|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
105946989|NCT03984825|365469242|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
105946990|NCT03984825|365469242|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
105946991|NCT02569853|365469243|FG000|Overall Study|Adverse Event|2|||
105946992|NCT02569853|365469244|FG001|Overall Study|Adverse Event|0|||
105750723|NCT01877382|364738893|FG004|Dose Escalation|Death|0|||
105750724|NCT01877382|364738894|FG005|Dose Escalation|Death|0|||
105750725|NCT01877382|364738895|FG006|Dose Escalation|Death|0|||
105750726|NCT01877382|364738896|FG007|Dose Escalation|Death|1|||
105750727|NCT01877382|364738897|FG008|Dose Escalation|Death|0|||
105750728|NCT01877382|364738898|FG009|Dose Escalation|Death|0|||
105750729|NCT01877382|364738899|FG010|Dose Escalation|Death|0|||
105750730|NCT01877382|364738900|FG011|Dose Escalation|Death|0|||
105750731|NCT01877382|364738901|FG012|Dose Escalation|Death|1|||
105750732|NCT01877382|364738902|FG013|Dose Escalation|Death|1|||
105750733|NCT01877382|364738903|FG014|Dose Escalation|Death|0|||
105750734|NCT01877382|364738889|FG000|Dose Expansion|Progressive disease|0|||
105750735|NCT01877382|364738890|FG001|Dose Expansion|Progressive disease|0|||
105750736|NCT01877382|364738891|FG002|Dose Expansion|Progressive disease|0|||
105750737|NCT01877382|364738892|FG003|Dose Expansion|Progressive disease|0|||
105750738|NCT01877382|364738893|FG004|Dose Expansion|Progressive disease|0|||
105750739|NCT01877382|364738894|FG005|Dose Expansion|Progressive disease|0|||
105750740|NCT01877382|364738895|FG006|Dose Expansion|Progressive disease|0|||
105750741|NCT01877382|364738896|FG007|Dose Expansion|Progressive disease|0|||
105750742|NCT01877382|364738897|FG008|Dose Expansion|Progressive disease|0|||
105750743|NCT01877382|364738898|FG009|Dose Expansion|Progressive disease|0|||
105750744|NCT01877382|364738899|FG010|Dose Expansion|Progressive disease|0|||
105750745|NCT01877382|364738900|FG011|Dose Expansion|Progressive disease|0|||
105750746|NCT01877382|364738901|FG012|Dose Expansion|Progressive disease|0|||
105750747|NCT01877382|364738902|FG013|Dose Expansion|Progressive disease|0|||
105750748|NCT01877382|364738903|FG014|Dose Expansion|Progressive disease|11|||
105750749|NCT01877382|364738889|FG000|Dose Expansion|Clinical progression|0|||
105750750|NCT01877382|364738890|FG001|Dose Expansion|Clinical progression|0|||
105801691|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105801692|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105946993|NCT02569853|365469243|FG000|Overall Study|Withdrawal by Subject|3|||
105946994|NCT02569853|365469244|FG001|Overall Study|Withdrawal by Subject|2|||
105750751|NCT01877382|364738891|FG002|Dose Expansion|Clinical progression|0|||
105750752|NCT01877382|364738892|FG003|Dose Expansion|Clinical progression|0|||
105750753|NCT01877382|364738893|FG004|Dose Expansion|Clinical progression|0|||
105750754|NCT01877382|364738894|FG005|Dose Expansion|Clinical progression|0|||
105946995|NCT02569853|365469243|FG000|Overall Study|Lost to Follow-up|3|||
105946996|NCT02569853|365469244|FG001|Overall Study|Lost to Follow-up|3|||
105946997|NCT02569853|365469243|FG000|Overall Study|Protocol Violation|1|||
105946998|NCT02569853|365469244|FG001|Overall Study|Protocol Violation|1|||
105946999|NCT02569853|365469243|FG000|Overall Study|Did not experience migraine attack|10|||
105947000|NCT02569853|365469244|FG001|Overall Study|Did not experience migraine attack|7|||
105750755|NCT01877382|364738895|FG006|Dose Expansion|Clinical progression|0|||
105750756|NCT01877382|364738896|FG007|Dose Expansion|Clinical progression|0|||
105947001|NCT02569853|365469243|FG000|Overall Study|Physician Decision|1|||
105750757|NCT01877382|364738897|FG008|Dose Expansion|Clinical progression|0|||
105750758|NCT01877382|364738898|FG009|Dose Expansion|Clinical progression|0|||
105750759|NCT01877382|364738899|FG010|Dose Expansion|Clinical progression|0|||
105750760|NCT01877382|364738900|FG011|Dose Expansion|Clinical progression|0|||
105750761|NCT01877382|364738901|FG012|Dose Expansion|Clinical progression|0|||
105750762|NCT01877382|364738902|FG013|Dose Expansion|Clinical progression|0|||
105750763|NCT01877382|364738903|FG014|Dose Expansion|Clinical progression|6|||
105750764|NCT01877382|364738889|FG000|Dose Expansion|Adverse Event|0|||
105750765|NCT01877382|364738890|FG001|Dose Expansion|Adverse Event|0|||
105750766|NCT01877382|364738891|FG002|Dose Expansion|Adverse Event|0|||
105750767|NCT01877382|364738892|FG003|Dose Expansion|Adverse Event|0|||
105750768|NCT01877382|364738893|FG004|Dose Expansion|Adverse Event|0|||
105750769|NCT01877382|364738894|FG005|Dose Expansion|Adverse Event|0|||
105750770|NCT01877382|364738895|FG006|Dose Expansion|Adverse Event|0|||
105750771|NCT01877382|364738896|FG007|Dose Expansion|Adverse Event|0|||
105750772|NCT01877382|364738897|FG008|Dose Expansion|Adverse Event|0|||
105750773|NCT01877382|364738898|FG009|Dose Expansion|Adverse Event|0|||
105750774|NCT01877382|364738899|FG010|Dose Expansion|Adverse Event|0|||
105750775|NCT01877382|364738900|FG011|Dose Expansion|Adverse Event|0|||
105750776|NCT01877382|364738901|FG012|Dose Expansion|Adverse Event|0|||
105750777|NCT01877382|364738902|FG013|Dose Expansion|Adverse Event|0|||
105750778|NCT01877382|364738903|FG014|Dose Expansion|Adverse Event|1|||
105750779|NCT01877382|364738889|FG000|Dose Expansion|Death|0|||
105750780|NCT01877382|364738890|FG001|Dose Expansion|Death|0|||
105750781|NCT01877382|364738891|FG002|Dose Expansion|Death|0|||
105750782|NCT01877382|364738892|FG003|Dose Expansion|Death|0|||
105750783|NCT01877382|364738893|FG004|Dose Expansion|Death|0|||
105750784|NCT01877382|364738894|FG005|Dose Expansion|Death|0|||
105750785|NCT01877382|364738895|FG006|Dose Expansion|Death|0|||
105750786|NCT01877382|364738896|FG007|Dose Expansion|Death|0|||
105750787|NCT01877382|364738897|FG008|Dose Expansion|Death|0|||
105750788|NCT01877382|364738898|FG009|Dose Expansion|Death|0|||
105750789|NCT01877382|364738899|FG010|Dose Expansion|Death|0|||
105750790|NCT01877382|364738900|FG011|Dose Expansion|Death|0|||
105750791|NCT01877382|364738901|FG012|Dose Expansion|Death|0|||
105750792|NCT01877382|364738902|FG013|Dose Expansion|Death|0|||
105750793|NCT01877382|364738903|FG014|Dose Expansion|Death|1|||
105750794|NCT01877382|364738889|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750795|NCT01877382|364738890|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750796|NCT01877382|364738891|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750797|NCT01877382|364738892|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750798|NCT01877382|364738893|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750799|NCT01877382|364738894|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750800|NCT01877382|364738895|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750801|NCT01877382|364738896|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750802|NCT01877382|364738897|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750803|NCT01877382|364738898|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750804|NCT01877382|364738899|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750805|NCT01877382|364738900|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750806|NCT01877382|364738901|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750807|NCT01877382|364738902|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
105750808|NCT01877382|364738903|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
105947002|NCT02569853|365469244|FG001|Overall Study|Physician Decision|1|||
105947003|NCT01948427|365469247|FG000|Overall Study|Serious Adverse Event|3|||
105947004|NCT01948427|365469248|FG001|Overall Study|Serious Adverse Event|0|||
105947005|NCT01948427|365469249|FG002|Overall Study|Serious Adverse Event|0|||
105947006|NCT01948427|365469250|FG003|Overall Study|Serious Adverse Event|0|||
105947007|NCT01948427|365469251|FG004|Overall Study|Serious Adverse Event|1|||
105947008|NCT01948427|365469247|FG000|Overall Study|Investigator Request|0|||
105947009|NCT01948427|365469248|FG001|Overall Study|Investigator Request|8|||
105750809|NCT00808249|364738906|FG000|Overall Study|Adverse Event|4|||
105750810|NCT00808249|364738907|FG001|Overall Study|Adverse Event|7|||
105750811|NCT00808249|364738908|FG002|Overall Study|Adverse Event|10|||
105750812|NCT00808249|364738909|FG003|Overall Study|Adverse Event|6|||
105750813|NCT00808249|364738906|FG000|Overall Study|Lost to Follow-up|2|||
105750814|NCT00808249|364738907|FG001|Overall Study|Lost to Follow-up|3|||
105750815|NCT00808249|364738908|FG002|Overall Study|Lost to Follow-up|3|||
105750816|NCT00808249|364738909|FG003|Overall Study|Lost to Follow-up|5|||
105750817|NCT00808249|364738906|FG000|Overall Study|Withdrawal by Subject|4|||
105750818|NCT00808249|364738907|FG001|Overall Study|Withdrawal by Subject|0|||
105947010|NCT01948427|365469249|FG002|Overall Study|Investigator Request|0|||
105750819|NCT00808249|364738908|FG002|Overall Study|Withdrawal by Subject|2|||
105947011|NCT01948427|365469250|FG003|Overall Study|Investigator Request|0|||
105750820|NCT00808249|364738909|FG003|Overall Study|Withdrawal by Subject|4|||
105750821|NCT00808249|364738906|FG000|Overall Study|Protocol Violation|3|||
105750822|NCT00808249|364738907|FG001|Overall Study|Protocol Violation|3|||
105750823|NCT00808249|364738908|FG002|Overall Study|Protocol Violation|3|||
105750824|NCT00808249|364738909|FG003|Overall Study|Protocol Violation|0|||
105750825|NCT00808249|364738906|FG000|Overall Study|Lack of Efficacy|1|||
105750826|NCT00808249|364738907|FG001|Overall Study|Lack of Efficacy|1|||
105750827|NCT00808249|364738908|FG002|Overall Study|Lack of Efficacy|0|||
105750828|NCT00808249|364738909|FG003|Overall Study|Lack of Efficacy|0|||
105947012|NCT01948427|365469251|FG004|Overall Study|Investigator Request|6|||
105947013|NCT01948427|365469247|FG000|Overall Study|Lost to Follow-up|1|||
105947014|NCT01948427|365469248|FG001|Overall Study|Lost to Follow-up|0|||
105947015|NCT01948427|365469249|FG002|Overall Study|Lost to Follow-up|0|||
105947016|NCT01948427|365469250|FG003|Overall Study|Lost to Follow-up|0|||
105947017|NCT01948427|365469251|FG004|Overall Study|Lost to Follow-up|4|||
105947018|NCT01948427|365469247|FG000|Overall Study|Withdrawal by Subject|2|||
105947019|NCT01948427|365469248|FG001|Overall Study|Withdrawal by Subject|0|||
105947020|NCT01948427|365469249|FG002|Overall Study|Withdrawal by Subject|0|||
105947021|NCT01948427|365469250|FG003|Overall Study|Withdrawal by Subject|0|||
105947022|NCT01948427|365469251|FG004|Overall Study|Withdrawal by Subject|1|||
105947023|NCT01948427|365469247|FG000|Overall Study|Other, Not Specified|1|||
105947024|NCT01948427|365469248|FG001|Overall Study|Other, Not Specified|9|||
105947025|NCT01948427|365469249|FG002|Overall Study|Other, Not Specified|0|||
105947026|NCT01948427|365469250|FG003|Overall Study|Other, Not Specified|0|||
105947027|NCT01948427|365469251|FG004|Overall Study|Other, Not Specified|2|||
105947028|NCT02095106|365469254|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
105947029|NCT02095106|365469255|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
105947030|NCT01500317|365469260|FG000|Overall Study|Withdrawal by Subject|3|||
105947031|NCT01500317|365469261|FG001|Overall Study|Withdrawal by Subject|2|||
105947032|NCT01500317|365469262|FG002|Overall Study|Withdrawal by Subject|0|||
105947033|NCT00583219|365469263|FG000|Phase 2|Withdrawal by Subject|1|||
105750829|NCT00808249|364738906|FG000|Overall Study|study specific discontinuation criteria|1|||
105750830|NCT00808249|364738907|FG001|Overall Study|study specific discontinuation criteria|0|||
105750831|NCT00808249|364738908|FG002|Overall Study|study specific discontinuation criteria|1|||
105750832|NCT00808249|364738909|FG003|Overall Study|study specific discontinuation criteria|0|||
105750833|NCT00808249|364738906|FG000|Overall Study|All other reasons|2|||
105750834|NCT00808249|364738907|FG001|Overall Study|All other reasons|1|||
105750835|NCT00808249|364738908|FG002|Overall Study|All other reasons|3|||
105750836|NCT00808249|364738909|FG003|Overall Study|All other reasons|1|||
105750837|NCT00479557|364738910|FG000|Overall Study|Death|0|||
105750838|NCT00479557|364738911|FG001|Overall Study|Death|0|||
105750839|NCT00479557|364738912|FG002|Overall Study|Death|0|||
105750840|NCT00479557|364738913|FG003|Overall Study|Death|0|||
105750841|NCT00479557|364738914|FG004|Overall Study|Death|0|||
105750842|NCT00479557|364738915|FG005|Overall Study|Death|1|||
105750843|NCT00479557|364738916|FG006|Overall Study|Death|0|||
105750844|NCT00479557|364738910|FG000|Overall Study|Lack of Efficacy|1|||
105750845|NCT00479557|364738911|FG001|Overall Study|Lack of Efficacy|0|||
105750846|NCT00479557|364738912|FG002|Overall Study|Lack of Efficacy|0|||
105750847|NCT00479557|364738913|FG003|Overall Study|Lack of Efficacy|0|||
105750848|NCT00479557|364738914|FG004|Overall Study|Lack of Efficacy|0|||
105750849|NCT00479557|364738915|FG005|Overall Study|Lack of Efficacy|0|||
105750850|NCT00479557|364738916|FG006|Overall Study|Lack of Efficacy|0|||
105750851|NCT00479557|364738910|FG000|Overall Study|Lost to Follow-up|0|||
105750852|NCT00479557|364738911|FG001|Overall Study|Lost to Follow-up|2|||
105750853|NCT00479557|364738912|FG002|Overall Study|Lost to Follow-up|0|||
105750854|NCT00479557|364738913|FG003|Overall Study|Lost to Follow-up|2|||
105947034|NCT01541371|365469264|FG000|Overall Study|Withdrawal by Subject|14|||
105947035|NCT01541371|365469264|FG000|Overall Study|Lost to Follow-up|21|||
105947036|NCT01541371|365469264|FG000|Overall Study|Adverse Event|15|||
105947037|NCT01541371|365469264|FG000|Overall Study|Lack of Efficacy|12|||
105947038|NCT01541371|365469264|FG000|Overall Study|Protocol Violation|6|||
105947039|NCT01541371|365469264|FG000|Overall Study|Study medication non-compliance|3|||
105947040|NCT01541371|365469264|FG000|Overall Study|Other|6|||
105947041|NCT02006927|365469267|FG000|Overall Study|Adverse Event|2|||
105947042|NCT02006927|365469267|FG000|Overall Study|Withdrawal by Subject|1|||
105750855|NCT00479557|364738914|FG004|Overall Study|Lost to Follow-up|0|||
105947043|NCT02493764|365469273|FG000|Overall Study|Adverse Event|2|||
105947044|NCT02493764|365469274|FG001|Overall Study|Adverse Event|2|||
105750856|NCT00479557|364738915|FG005|Overall Study|Lost to Follow-up|0|||
105750857|NCT00479557|364738916|FG006|Overall Study|Lost to Follow-up|0|||
105750858|NCT00479557|364738910|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
105750859|NCT00479557|364738911|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105750860|NCT00479557|364738912|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
105947045|NCT02493764|365469273|FG000|Overall Study|Death|44|||
105947046|NCT02493764|365469274|FG001|Overall Study|Death|58|||
105750861|NCT00479557|364738913|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
105750862|NCT00479557|364738914|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105750863|NCT00479557|364738915|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
105750864|NCT00479557|364738916|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
105750865|NCT00479557|364738910|FG000|Overall Study|AE not related to Study Drug|1|||
105750866|NCT00479557|364738911|FG001|Overall Study|AE not related to Study Drug|3|||
105750867|NCT00479557|364738912|FG002|Overall Study|AE not related to Study Drug|0|||
105750868|NCT00479557|364738913|FG003|Overall Study|AE not related to Study Drug|0|||
105750869|NCT00479557|364738914|FG004|Overall Study|AE not related to Study Drug|2|||
105947047|NCT02493764|365469273|FG000|Overall Study|Lost to Follow-up|2|||
105947048|NCT02493764|365469274|FG001|Overall Study|Lost to Follow-up|1|||
105947049|NCT02493764|365469273|FG000|Overall Study|Protocol Violation|6|||
105947050|NCT02493764|365469274|FG001|Overall Study|Protocol Violation|7|||
105947051|NCT02493764|365469273|FG000|Overall Study|Physician Decision|1|||
105947052|NCT02493764|365469274|FG001|Overall Study|Physician Decision|1|||
105947053|NCT02493764|365469273|FG000|Overall Study|Participant moved|17|||
105947054|NCT02493764|365469274|FG001|Overall Study|Participant moved|5|||
105947055|NCT02493764|365469273|FG000|Overall Study|Withdrawal parent/guardian|0|||
105947056|NCT02493764|365469274|FG001|Overall Study|Withdrawal parent/guardian|1|||
105947057|NCT02493764|365469273|FG000|Overall Study|Withdrawal by Subject|11|||
105750870|NCT00479557|364738915|FG005|Overall Study|AE not related to Study Drug|2|||
105750871|NCT00479557|364738916|FG006|Overall Study|AE not related to Study Drug|1|||
105750872|NCT00479557|364738910|FG000|Overall Study|Caregiver Request|2|||
105750873|NCT00479557|364738911|FG001|Overall Study|Caregiver Request|2|||
105750874|NCT00479557|364738912|FG002|Overall Study|Caregiver Request|2|||
105750875|NCT00479557|364738913|FG003|Overall Study|Caregiver Request|0|||
105947058|NCT02493764|365469274|FG001|Overall Study|Withdrawal by Subject|7|||
105947059|NCT01561976|365469275|FG000|Period 1|Adverse Event|0|||
105947060|NCT01561976|365469276|FG001|Period 1|Adverse Event|0|||
105947061|NCT01561976|365469277|FG002|Period 1|Adverse Event|1|||
105947062|NCT01561976|365469278|FG003|Period 1|Adverse Event|0|||
105947063|NCT01561976|365469279|FG004|Period 1|Adverse Event|0|||
105947064|NCT01561976|365469280|FG005|Period 1|Adverse Event|0|||
105947065|NCT01561976|365469275|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
105947066|NCT01561976|365469276|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
105947067|NCT01561976|365469277|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
105750876|NCT00479557|364738914|FG004|Overall Study|Caregiver Request|1|||
105750877|NCT00479557|364738915|FG005|Overall Study|Caregiver Request|2|||
105750878|NCT00479557|364738916|FG006|Overall Study|Caregiver Request|0|||
105750879|NCT00479557|364738910|FG000|Overall Study|Investigator Request|0|||
105750880|NCT00479557|364738911|FG001|Overall Study|Investigator Request|0|||
105750881|NCT00479557|364738912|FG002|Overall Study|Investigator Request|1|||
105750882|NCT00479557|364738913|FG003|Overall Study|Investigator Request|0|||
105750883|NCT00479557|364738914|FG004|Overall Study|Investigator Request|0|||
105750884|NCT00479557|364738915|FG005|Overall Study|Investigator Request|0|||
105750885|NCT00479557|364738916|FG006|Overall Study|Investigator Request|0|||
105947068|NCT01561976|365469278|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
105947069|NCT01561976|365469279|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
105947070|NCT01561976|365469280|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
105750886|NCT00479557|364738910|FG000|Overall Study|Subject Request|3|||
105750887|NCT00479557|364738911|FG001|Overall Study|Subject Request|0|||
105750888|NCT00479557|364738912|FG002|Overall Study|Subject Request|1|||
105750889|NCT00479557|364738913|FG003|Overall Study|Subject Request|1|||
105750890|NCT00479557|364738914|FG004|Overall Study|Subject Request|1|||
105750891|NCT00479557|364738915|FG005|Overall Study|Subject Request|4|||
105947071|NCT01561976|365469275|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105947072|NCT01561976|365469276|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105947073|NCT01561976|365469277|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105947074|NCT01561976|365469278|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105947075|NCT01561976|365469279|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
105947076|NCT01561976|365469280|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
105947077|NCT01561976|365469275|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
105947078|NCT01561976|365469276|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
105947079|NCT01561976|365469277|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
105750892|NCT00479557|364738916|FG006|Overall Study|Subject Request|1|||
105750893|NCT00479557|364738910|FG000|Overall Study|Other|2|||
105750894|NCT00479557|364738911|FG001|Overall Study|Other|3|||
105750895|NCT00479557|364738912|FG002|Overall Study|Other|1|||
105750896|NCT00479557|364738913|FG003|Overall Study|Other|0|||
105801693|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
105947080|NCT01561976|365469278|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
105947081|NCT01561976|365469279|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
105947082|NCT01561976|365469280|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
105947083|NCT05136170|365469283|FG000|Overall Study|Withdrawal by Subject|2|||
105750897|NCT00479557|364738914|FG004|Overall Study|Other|0|||
105750898|NCT00479557|364738915|FG005|Overall Study|Other|3|||
105947084|NCT05136170|365469284|FG001|Overall Study|Withdrawal by Subject|2|||
105750899|NCT00479557|364738916|FG006|Overall Study|Other|0|||
105750900|NCT00333619|364740741|FG000|Overall Study|Death|12|||
105750901|NCT00333619|364740742|FG001|Overall Study|Death|6|||
105947085|NCT05136170|365469283|FG000|Overall Study|Can no longer make office visits|1|||
105947086|NCT05136170|365469284|FG001|Overall Study|Can no longer make office visits|0|||
105947087|NCT01088503|365469290|FG000|Overall Study|Withdrawal by Subject|118|||
105947088|NCT01088503|365469291|FG001|Overall Study|Withdrawal by Subject|327|||
105947089|NCT01088503|365469292|FG002|Overall Study|Withdrawal by Subject|10|||
105750902|NCT00333619|364740741|FG000|Overall Study|Withdrawal by Subject|6|||
105750903|NCT00333619|364740742|FG001|Overall Study|Withdrawal by Subject|1|||
105750904|NCT00333619|364740741|FG000|Overall Study|Lost to Follow-up|3|||
105750905|NCT00333619|364740742|FG001|Overall Study|Lost to Follow-up|3|||
105750906|NCT02690207|364740749|FG000|Overall Study|Lost to Follow-up|48|||
105750907|NCT02690207|364740749|FG000|Overall Study|Withdrawal by Subject|46|||
105947090|NCT01088503|365469290|FG000|Overall Study|Death|64|||
105947091|NCT01088503|365469291|FG001|Overall Study|Death|358|||
105947092|NCT01088503|365469292|FG002|Overall Study|Death|7|||
105947093|NCT02836249|365469293|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105947094|NCT02836249|365469294|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
105947095|NCT02836249|365469295|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105750908|NCT02690207|364740749|FG000|Overall Study|Protocol Violation|2|||
105750909|NCT02690207|364740749|FG000|Overall Study|Serious adverse event|110|||
105750910|NCT02690207|364740749|FG000|Overall Study|Non-serious Adverse Event|18|||
105750911|NCT02690207|364740749|FG000|Overall Study|Migrated/moved from study area|5|||
105750912|NCT02690207|364740749|FG000|Overall Study|Suspected HZ Episode|1|||
105750913|NCT02690207|364740749|FG000|Overall Study|Other reasons for withdrawal|23|||
105750914|NCT01369849|364740750|FG000|Overall Study|Ineligible prior to treatment|0|||
105750915|NCT01369849|364740751|FG001|Overall Study|Ineligible prior to treatment|0|||
105750916|NCT01369849|364740752|FG002|Overall Study|Ineligible prior to treatment|1|||
105750917|NCT01369849|364740750|FG000|Overall Study|Ineligible after receiving treatment|0|||
105750918|NCT01369849|364740751|FG001|Overall Study|Ineligible after receiving treatment|1|||
105750919|NCT01369849|364740752|FG002|Overall Study|Ineligible after receiving treatment|0|||
105750920|NCT00174785|364740753|FG000|Overall Study|Adverse Event|293|||
105750921|NCT00174785|364740754|FG001|Overall Study|Adverse Event|191|||
105750922|NCT00174785|364740753|FG000|Overall Study|Protocol Violation|14|||
105750923|NCT00174785|364740754|FG001|Overall Study|Protocol Violation|14|||
105750924|NCT00174785|364740753|FG000|Overall Study|Withdrawal by Subject|173|||
105750925|NCT00174785|364740754|FG001|Overall Study|Withdrawal by Subject|175|||
105947096|NCT02836249|365469296|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
105947097|NCT02836249|365469293|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
105947098|NCT02836249|365469294|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
105947099|NCT02836249|365469295|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
105750926|NCT00174785|364740753|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
105750927|NCT00174785|364740754|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
105750928|NCT00174785|364740753|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
105947100|NCT02836249|365469296|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
105750929|NCT00174785|364740754|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
105750930|NCT00174785|364740753|FG000|Overall Study|Other prohibited medication|5|||
105750931|NCT00174785|364740754|FG001|Overall Study|Other prohibited medication|3|||
105947101|NCT02836249|365469293|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
105947102|NCT02836249|365469294|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
105750932|NCT00174785|364740753|FG000|Overall Study|Family request|6|||
105750933|NCT00174785|364740754|FG001|Overall Study|Family request|8|||
105947103|NCT02836249|365469295|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
105947104|NCT02836249|365469296|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
105947105|NCT02836249|365469293|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105947106|NCT02836249|365469294|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105947107|NCT02836249|365469295|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105947108|NCT02836249|365469296|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105947109|NCT02836249|365469293|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
105947110|NCT02836249|365469294|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
105947111|NCT02836249|365469295|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
105947112|NCT02836249|365469296|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
105947113|NCT02836249|365469293|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
105947114|NCT02836249|365469294|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
105947115|NCT02836249|365469295|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
105947116|NCT02836249|365469296|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
105947117|NCT02836249|365469293|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
105947118|NCT02836249|365469294|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
105947119|NCT02836249|365469295|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
105947120|NCT02836249|365469296|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
105947121|NCT02836249|365469293|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
105947122|NCT02836249|365469294|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
105947123|NCT02836249|365469295|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
105947124|NCT02836249|365469296|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
105947125|NCT02836249|365469293|FG000|Open-Label TAF Treatment Phase|Death|0|||
105947126|NCT02836249|365469294|FG001|Open-Label TAF Treatment Phase|Death|0|||
105947127|NCT02836249|365469295|FG002|Open-Label TAF Treatment Phase|Death|1|||
105947128|NCT02836249|365469296|FG003|Open-Label TAF Treatment Phase|Death|0|||
105947129|NCT02836249|365469293|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
105947130|NCT02836249|365469294|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
105947131|NCT02836249|365469295|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
105947132|NCT02836249|365469296|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
105947133|NCT02836249|365469293|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
105947134|NCT02836249|365469294|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
105947135|NCT02836249|365469295|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
105947136|NCT02836249|365469296|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
105947137|NCT05134649|365469299|FG000|Overall Study|Lost to Follow-up|12|||
105947138|NCT05134649|365469299|FG000|Overall Study|Withdrawal by Subject|14|||
105947139|NCT05134649|365469299|FG000|Overall Study|Pregnancy|1|||
105947140|NCT05134649|365469299|FG000|Overall Study|Other, not specified|3|||
105947141|NCT02412670|365469302|FG000|Overall Study|Adverse Event|4|||
105947142|NCT02412670|365469303|FG001|Overall Study|Adverse Event|1|||
105750934|NCT00174785|364740753|FG000|Overall Study|Not pre-specified/Not coded|56|||
105947143|NCT02412670|365469302|FG000|Overall Study|Physician Decision|1|||
105947144|NCT02412670|365469303|FG001|Overall Study|Physician Decision|0|||
105947145|NCT02412670|365469302|FG000|Overall Study|Withdrawal by Subject|1|||
105947146|NCT02412670|365469303|FG001|Overall Study|Withdrawal by Subject|0|||
105947147|NCT02412670|365469302|FG000|Overall Study|Ineligible|1|||
105947148|NCT02412670|365469303|FG001|Overall Study|Ineligible|0|||
105947149|NCT01448616|365469314|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
105947150|NCT01448616|365469315|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
105947151|NCT01448616|365469316|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
105947152|NCT01448616|365469317|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
105947153|NCT01448616|365469314|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
105947154|NCT01448616|365469315|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
105947155|NCT01448616|365469316|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
105947156|NCT01448616|365469317|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
105947157|NCT01448616|365469314|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
105947158|NCT01448616|365469315|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
105947159|NCT01448616|365469316|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
105750935|NCT00174785|364740754|FG001|Overall Study|Not pre-specified/Not coded|70|||
105750936|NCT01754922|364740755|FG000|Overall Study|Adverse Event|0|||
105750937|NCT01754922|364740756|FG001|Overall Study|Adverse Event|1|||
105750938|NCT01093755|364740757|FG000|Overall Study|Withdrawal by Subject|3|||
105750939|NCT01093755|364740758|FG001|Overall Study|Withdrawal by Subject|4|||
105750940|NCT02106455|364740761|FG000|Overall Study|Case Report Form Uncollected|6|||
105750941|NCT02106455|364740761|FG000|Overall Study|Protocol Deviation|2|||
105750942|NCT03558555|364740766|FG000|Overall Study|Lost to Follow-up|2|||
105750943|NCT03558555|364740767|FG001|Overall Study|Lost to Follow-up|1|||
105750944|NCT00194025|364740768|FG000|Overall Study|Adverse Event|1|||
105750945|NCT00194025|364740768|FG000|Overall Study|non-adherence with study medication|4|||
105750946|NCT00289185|364740780|FG000|Overall Study|Withdrawal by Subject|4|||
105750947|NCT00289185|364740781|FG001|Overall Study|Withdrawal by Subject|8|||
105750948|NCT00289185|364740780|FG000|Overall Study|Lost to Follow-up|23|||
105801694|NCT00950599|364930612|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
105801695|NCT00950599|364930613|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
105801696|NCT00950599|364930614|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
105801697|NCT00950599|364930615|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
105801698|NCT00950599|364930616|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
105801699|NCT00950599|364930617|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
105801700|NCT00950599|364930618|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
105801701|NCT00950599|364930619|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
105801702|NCT00950599|364930620|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
105801703|NCT00950599|364930621|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
105801704|NCT00950599|364930612|FG000|Follow-Up Period|Adverse Event|0|||
105801705|NCT00950599|364930613|FG001|Follow-Up Period|Adverse Event|0|||
105801706|NCT00950599|364930614|FG002|Follow-Up Period|Adverse Event|0|||
105801707|NCT00950599|364930615|FG003|Follow-Up Period|Adverse Event|0|||
105801708|NCT00950599|364930616|FG004|Follow-Up Period|Adverse Event|0|||
105801709|NCT00950599|364930617|FG005|Follow-Up Period|Adverse Event|0|||
105801710|NCT00950599|364930618|FG006|Follow-Up Period|Adverse Event|0|||
105801711|NCT00950599|364930619|FG007|Follow-Up Period|Adverse Event|0|||
105801712|NCT00950599|364930620|FG008|Follow-Up Period|Adverse Event|1|||
105801713|NCT00950599|364930621|FG009|Follow-Up Period|Adverse Event|0|||
105801714|NCT00950599|364930612|FG000|Follow-Up Period|Lack of Efficacy|0|||
105801715|NCT00950599|364930613|FG001|Follow-Up Period|Lack of Efficacy|0|||
105801716|NCT00950599|364930614|FG002|Follow-Up Period|Lack of Efficacy|0|||
105801717|NCT00950599|364930615|FG003|Follow-Up Period|Lack of Efficacy|0|||
105801718|NCT00950599|364930616|FG004|Follow-Up Period|Lack of Efficacy|0|||
105801719|NCT00950599|364930617|FG005|Follow-Up Period|Lack of Efficacy|0|||
105801720|NCT00950599|364930618|FG006|Follow-Up Period|Lack of Efficacy|0|||
105801721|NCT00950599|364930619|FG007|Follow-Up Period|Lack of Efficacy|0|||
105801722|NCT00950599|364930620|FG008|Follow-Up Period|Lack of Efficacy|3|||
105801723|NCT00950599|364930621|FG009|Follow-Up Period|Lack of Efficacy|0|||
105801724|NCT00950599|364930612|FG000|Follow-Up Period|Lost to Follow-up|0|||
105801725|NCT00950599|364930613|FG001|Follow-Up Period|Lost to Follow-up|0|||
105801726|NCT00950599|364930614|FG002|Follow-Up Period|Lost to Follow-up|0|||
105801727|NCT00950599|364930615|FG003|Follow-Up Period|Lost to Follow-up|0|||
105947160|NCT01448616|365469317|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
105947161|NCT01448616|365469314|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
105947162|NCT01448616|365469315|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
105947163|NCT01448616|365469316|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
105947164|NCT01448616|365469317|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
105947165|NCT01448616|365469314|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
105947166|NCT01448616|365469315|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
105947167|NCT01448616|365469316|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
105947168|NCT01448616|365469317|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
105947169|NCT00760552|365469324|FG000|Overall Study|Death|2|||
105947170|NCT00760552|365469325|FG001|Overall Study|Death|0|||
105947171|NCT00760552|365469324|FG000|Overall Study|Lost to Follow-up|11|||
105947172|NCT00760552|365469325|FG001|Overall Study|Lost to Follow-up|10|||
105947173|NCT02943473|365469326|FG000|Overall Study|enrolled but not dosed|1|||
105801728|NCT00950599|364930616|FG004|Follow-Up Period|Lost to Follow-up|0|||
105947174|NCT02943473|365469326|FG000|Overall Study|screen failure|1|||
105947175|NCT02943473|365469326|FG000|Overall Study|Physician Decision|4|||
105801729|NCT00950599|364930617|FG005|Follow-Up Period|Lost to Follow-up|0|||
105801730|NCT00950599|364930618|FG006|Follow-Up Period|Lost to Follow-up|0|||
105801731|NCT00950599|364930619|FG007|Follow-Up Period|Lost to Follow-up|0|||
105801732|NCT00950599|364930620|FG008|Follow-Up Period|Lost to Follow-up|5|||
105801733|NCT00950599|364930621|FG009|Follow-Up Period|Lost to Follow-up|1|||
105801734|NCT00950599|364930612|FG000|Follow-Up Period|Physician Decision|0|||
105801735|NCT00950599|364930613|FG001|Follow-Up Period|Physician Decision|0|||
105801736|NCT00950599|364930614|FG002|Follow-Up Period|Physician Decision|0|||
105801737|NCT00950599|364930615|FG003|Follow-Up Period|Physician Decision|0|||
105801738|NCT00950599|364930616|FG004|Follow-Up Period|Physician Decision|0|||
105801739|NCT00950599|364930617|FG005|Follow-Up Period|Physician Decision|0|||
105801740|NCT00950599|364930618|FG006|Follow-Up Period|Physician Decision|0|||
105801741|NCT00950599|364930619|FG007|Follow-Up Period|Physician Decision|0|||
105801742|NCT00950599|364930620|FG008|Follow-Up Period|Physician Decision|1|||
105801743|NCT00950599|364930621|FG009|Follow-Up Period|Physician Decision|0|||
105801744|NCT00950599|364930612|FG000|Follow-Up Period|Poor/Noncompliance|0|||
105801745|NCT00950599|364930613|FG001|Follow-Up Period|Poor/Noncompliance|0|||
105801746|NCT00950599|364930614|FG002|Follow-Up Period|Poor/Noncompliance|0|||
105801747|NCT00950599|364930615|FG003|Follow-Up Period|Poor/Noncompliance|0|||
105801748|NCT00950599|364930616|FG004|Follow-Up Period|Poor/Noncompliance|0|||
105801749|NCT00950599|364930617|FG005|Follow-Up Period|Poor/Noncompliance|0|||
105801750|NCT00950599|364930618|FG006|Follow-Up Period|Poor/Noncompliance|0|||
105801751|NCT00950599|364930619|FG007|Follow-Up Period|Poor/Noncompliance|0|||
105801752|NCT00950599|364930620|FG008|Follow-Up Period|Poor/Noncompliance|1|||
105801753|NCT00950599|364930621|FG009|Follow-Up Period|Poor/Noncompliance|0|||
105801754|NCT00950599|364930612|FG000|Follow-Up Period|Subject withdrew Consent|0|||
105801755|NCT00950599|364930613|FG001|Follow-Up Period|Subject withdrew Consent|0|||
105801756|NCT00950599|364930614|FG002|Follow-Up Period|Subject withdrew Consent|0|||
105801757|NCT00950599|364930615|FG003|Follow-Up Period|Subject withdrew Consent|0|||
105801758|NCT00950599|364930616|FG004|Follow-Up Period|Subject withdrew Consent|0|||
105801759|NCT00950599|364930617|FG005|Follow-Up Period|Subject withdrew Consent|0|||
105801760|NCT00950599|364930618|FG006|Follow-Up Period|Subject withdrew Consent|0|||
105801761|NCT00950599|364930619|FG007|Follow-Up Period|Subject withdrew Consent|0|||
105801762|NCT00950599|364930620|FG008|Follow-Up Period|Subject withdrew Consent|2|||
105801763|NCT00950599|364930621|FG009|Follow-Up Period|Subject withdrew Consent|1|||
105801764|NCT02436135|364930622|FG000|Overall Study|Progressive Disease|3|||
105801765|NCT02436135|364930623|FG001|Overall Study|Progressive Disease|1|||
105801766|NCT02436135|364930622|FG000|Overall Study|Investigator Discretion|1|||
105801767|NCT02436135|364930623|FG001|Overall Study|Investigator Discretion|2|||
105801768|NCT02436135|364930622|FG000|Overall Study|Adverse Event|1|||
105801769|NCT02436135|364930623|FG001|Overall Study|Adverse Event|0|||
105801770|NCT02436135|364930622|FG000|Overall Study|Withdrawal by Participant|1|||
105801771|NCT02436135|364930623|FG001|Overall Study|Withdrawal by Participant|0|||
105801772|NCT02436135|364930622|FG000|Overall Study|Study Terminated By Sponsor|0|||
105801773|NCT02436135|364930623|FG001|Overall Study|Study Terminated By Sponsor|1|||
105801774|NCT02729194|364930624|FG000|Overall Study|Withdrawal by Subject|3|||
105947176|NCT04211363|365469327|FG000|Overall Study|Adverse Event|5|||
105947177|NCT04211363|365469328|FG001|Overall Study|Adverse Event|2|||
105801775|NCT01361607|364930626|FG000|Overall Study|Adverse Event|38|||
105801776|NCT01361607|364930627|FG001|Overall Study|Adverse Event|29|||
105947178|NCT04211363|365469327|FG000|Overall Study|Physician Decision|0|||
105947179|NCT04211363|365469328|FG001|Overall Study|Physician Decision|1|||
105947180|NCT04211363|365469327|FG000|Overall Study|Protocol Violation|1|||
105947181|NCT04211363|365469328|FG001|Overall Study|Protocol Violation|0|||
105947182|NCT04211363|365469327|FG000|Overall Study|Pregnancy|1|||
105947183|NCT04211363|365469328|FG001|Overall Study|Pregnancy|0|||
105947184|NCT04211363|365469327|FG000|Overall Study|Lost to Follow-up|12|||
105947185|NCT04211363|365469328|FG001|Overall Study|Lost to Follow-up|4|||
105947186|NCT04211363|365469327|FG000|Overall Study|Withdrawal by Subject|11|||
105947187|NCT04211363|365469328|FG001|Overall Study|Withdrawal by Subject|11|||
105947188|NCT04211363|365469327|FG000|Overall Study|Other|1|||
105947189|NCT04211363|365469328|FG001|Overall Study|Other|2|||
105947190|NCT03434834|365469329|FG000|Overall Study|unable to swallow OCT probe|16|||
105947191|NCT01736917|365469330|FG000|Overall Study|Adverse Event|1|||
105947192|NCT01736917|365469330|FG000|Overall Study|Protocol Violation|10|||
105947193|NCT01911260|365469331|FG000|Supplementation Period|transference or evasion of school|7|||
105947194|NCT01911260|365469332|FG001|Supplementation Period|transference or evasion of school|9|||
105947195|NCT01911260|365469333|FG002|Supplementation Period|transference or evasion of school|7|||
105947196|NCT01911260|365469334|FG003|Supplementation Period|transference or evasion of school|6|||
105801777|NCT01361607|364930626|FG000|Overall Study|Withdrawal by Subject|19|||
105801778|NCT01361607|364930627|FG001|Overall Study|Withdrawal by Subject|8|||
105947197|NCT01911260|365469331|FG000|Supplementation Period|Adverse Event|2|||
105801779|NCT01361607|364930626|FG000|Overall Study|Withdrawal by Investigator|5|||
105801780|NCT01361607|364930627|FG001|Overall Study|Withdrawal by Investigator|3|||
105801781|NCT01361607|364930626|FG000|Overall Study|Lost to Follow-up|1|||
105801782|NCT01361607|364930627|FG001|Overall Study|Lost to Follow-up|0|||
105750949|NCT00289185|364740781|FG001|Overall Study|Lost to Follow-up|17|||
105750950|NCT00289185|364740780|FG000|Overall Study|Death|1|||
105750951|NCT00289185|364740781|FG001|Overall Study|Death|1|||
105750952|NCT01658579|364740782|FG000|Treatment Period A|Other|0|||
105750953|NCT01658579|364740783|FG001|Treatment Period A|Other|0|||
105750954|NCT01658579|364740784|FG002|Treatment Period A|Other|1|||
105750955|NCT01658579|364740785|FG003|Treatment Period A|Other|1|||
105750956|NCT01658579|364740782|FG000|Treatment Period A|Adverse Event|1|||
105750957|NCT01658579|364740783|FG001|Treatment Period A|Adverse Event|0|||
105750958|NCT01658579|364740784|FG002|Treatment Period A|Adverse Event|0|||
105750959|NCT01658579|364740785|FG003|Treatment Period A|Adverse Event|0|||
105750960|NCT01658579|364740782|FG000|Treatment Period B|Other|0|||
105750961|NCT01658579|364740783|FG001|Treatment Period B|Other|0|||
105750962|NCT01658579|364740784|FG002|Treatment Period B|Other|0|||
105750963|NCT01658579|364740785|FG003|Treatment Period B|Other|1|||
105750964|NCT01124448|364740786|FG000|Overall Study|Lost to Follow-up|0|||
105750965|NCT01124448|364740787|FG001|Overall Study|Lost to Follow-up|3|||
105801783|NCT01361607|364930626|FG000|Overall Study|Met Withdrawal Criteria|1|||
105801784|NCT01361607|364930627|FG001|Overall Study|Met Withdrawal Criteria|1|||
105801785|NCT01809314|364930628|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
105801786|NCT01809314|364930628|FG000|Overall Study|Adverse Event|6|||
105801787|NCT01809314|364930628|FG000|Overall Study|Insufficient Therapeutic Response|14|||
105801788|NCT01809314|364930628|FG000|Overall Study|Lost to Follow-up|724|||
105801789|NCT01684722|364930629|FG000|Overall Study|Lost to Follow-up|78|||
105801790|NCT01684722|364930630|FG001|Overall Study|Lost to Follow-up|56|||
105801791|NCT01684722|364930631|FG002|Overall Study|Lost to Follow-up|75|||
105801792|NCT01684722|364930632|FG003|Overall Study|Lost to Follow-up|89|||
105801793|NCT01684722|364930629|FG000|Overall Study|Death|19|||
105801794|NCT01684722|364930630|FG001|Overall Study|Death|21|||
105801795|NCT01684722|364930631|FG002|Overall Study|Death|19|||
105801796|NCT01684722|364930632|FG003|Overall Study|Death|21|||
105947198|NCT01911260|365469332|FG001|Supplementation Period|Adverse Event|0|||
105947199|NCT01911260|365469333|FG002|Supplementation Period|Adverse Event|1|||
105947200|NCT01911260|365469334|FG003|Supplementation Period|Adverse Event|0|||
105947201|NCT01911260|365469331|FG000|Supplementation Period|refused to receive supplement|1|||
105947202|NCT01911260|365469332|FG001|Supplementation Period|refused to receive supplement|0|||
105947203|NCT01911260|365469333|FG002|Supplementation Period|refused to receive supplement|1|||
105947204|NCT01911260|365469334|FG003|Supplementation Period|refused to receive supplement|0|||
105947205|NCT01911260|365469331|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
105947206|NCT01911260|365469332|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
105947207|NCT01911260|365469333|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
105947208|NCT01911260|365469334|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
105947209|NCT01911260|365469331|FG000|Follow-up Period|transference or evasion of school|13|||
105947210|NCT01911260|365469332|FG001|Follow-up Period|transference or evasion of school|20|||
105947211|NCT01911260|365469333|FG002|Follow-up Period|transference or evasion of school|15|||
105947212|NCT01911260|365469334|FG003|Follow-up Period|transference or evasion of school|12|||
105947213|NCT01656161|365469342|FG000|Overall Study|Death|3|||
105947214|NCT01656161|365469342|FG000|Overall Study|Adverse Event|2|||
105947215|NCT01656161|365469342|FG000|Overall Study|Protocol Violation|1|||
105947216|NCT01656161|365469342|FG000|Overall Study|Withdrawal by Subject|1|||
105947217|NCT01215851|365469347|FG000|Treatment Period|Adverse Event|1|||
105947218|NCT01215851|365469348|FG001|Treatment Period|Adverse Event|1|||
105947219|NCT01215851|365469349|FG002|Treatment Period|Adverse Event|1|||
105947220|NCT01215851|365469350|FG003|Treatment Period|Adverse Event|3|||
105947221|NCT01215851|365469351|FG004|Treatment Period|Adverse Event|0|||
105947222|NCT01215851|365469352|FG005|Treatment Period|Adverse Event|1|||
105947223|NCT01215851|365469347|FG000|Follow up Period|Lost to Follow-up|0|||
105750966|NCT01124448|364740786|FG000|Overall Study|Protocol Violation|2|||
105750967|NCT01124448|364740787|FG001|Overall Study|Protocol Violation|0|||
105750968|NCT02432040|364740788|FG000|Overall Study|Lack of Efficacy|3|||
105750969|NCT02432040|364740789|FG001|Overall Study|Lack of Efficacy|0|||
105750970|NCT02432040|364740788|FG000|Overall Study|Lost to Follow-up|4|||
105750971|NCT02432040|364740789|FG001|Overall Study|Lost to Follow-up|5|||
105750972|NCT02432040|364740788|FG000|Overall Study|Physician Decision|1|||
105750973|NCT02432040|364740789|FG001|Overall Study|Physician Decision|1|||
105947224|NCT01215851|365469348|FG001|Follow up Period|Lost to Follow-up|0|||
106142768|NCT00430300|366181996|FG000|Overall Study|Withdrawal by Subject|1|||
105750974|NCT03198754|364740790|FG000|Overall Study|Withdrawal by Subject|5|||
105750975|NCT03198754|364740791|FG001|Overall Study|Withdrawal by Subject|4|||
106142769|NCT00430300|366181997|FG001|Overall Study|Withdrawal by Subject|0|||
106142770|NCT00430300|366181998|FG002|Overall Study|Withdrawal by Subject|5|||
106142771|NCT00430300|366181999|FG003|Overall Study|Withdrawal by Subject|0|||
105750976|NCT03198754|364740790|FG000|Overall Study|Lost to Follow-up|4|||
105750977|NCT03198754|364740791|FG001|Overall Study|Lost to Follow-up|3|||
105750978|NCT03198754|364740790|FG000|Overall Study|Ineligible|2|||
105801797|NCT00219557|364930634|FG000|Phase 1|Lack of Efficacy|3|||
105801798|NCT00219557|364930635|FG001|Phase 1|Lack of Efficacy|0|||
105801799|NCT00219557|364930636|FG002|Phase 1|Lack of Efficacy|0|||
105750979|NCT03198754|364740791|FG001|Overall Study|Ineligible|1|||
105750980|NCT02108951|364740792|FG000|Overall Study|Lost to Follow-up|1|||
105750981|NCT02108951|364740792|FG000|Overall Study|Patient's/guardian's decision|1|||
105750982|NCT02108951|364740792|FG000|Overall Study|Study Terminated by Sponsor|14|||
105750983|NCT00305253|364740795|FG000|Overall Study|Withdrawal by Subject|0|||
105750984|NCT00305253|364740796|FG001|Overall Study|Withdrawal by Subject|1|||
105750985|NCT01098461|364740797|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
105750986|NCT01098461|364740798|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
105750987|NCT01098461|364740799|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
105750988|NCT01098461|364740800|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
105750989|NCT01098461|364740797|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
105750990|NCT01098461|364740798|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
105750991|NCT01098461|364740799|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
105750992|NCT01098461|364740800|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
105750993|NCT01098461|364740797|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
105750994|NCT01098461|364740798|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
105750995|NCT01098461|364740799|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
105750996|NCT01098461|364740800|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
105750997|NCT01098461|364740797|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
105750998|NCT01098461|364740798|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
105750999|NCT01098461|364740799|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
105751000|NCT01098461|364740800|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
105751001|NCT01098461|364740797|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
105751002|NCT01098461|364740798|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
105751003|NCT01098461|364740799|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
105751004|NCT01098461|364740800|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
105751005|NCT01098461|364740797|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
105751006|NCT01098461|364740798|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
105751007|NCT01098461|364740799|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
105751008|NCT01098461|364740800|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
105751009|NCT01098461|364740797|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
105751010|NCT01098461|364740798|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
105751011|NCT01098461|364740799|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
105751012|NCT01098461|364740800|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
105751013|NCT01514188|364740801|FG000|Overall Study|Adverse Event|3|||
105751014|NCT01514188|364740802|FG001|Overall Study|Adverse Event|5|||
105751015|NCT01514188|364740801|FG000|Overall Study|Withdrawal by Subject|2|||
105751016|NCT01514188|364740802|FG001|Overall Study|Withdrawal by Subject|4|||
105751017|NCT01514188|364740801|FG000|Overall Study|Protocol Violation|2|||
105751018|NCT01514188|364740802|FG001|Overall Study|Protocol Violation|4|||
105751019|NCT01514188|364740801|FG000|Overall Study|Physician Decision|0|||
105751020|NCT01514188|364740802|FG001|Overall Study|Physician Decision|2|||
105751021|NCT01514188|364740801|FG000|Overall Study|Disease Progression|13|||
105751022|NCT01514188|364740802|FG001|Overall Study|Disease Progression|14|||
105751023|NCT01514188|364740801|FG000|Overall Study|Death|1|||
105751024|NCT01514188|364740802|FG001|Overall Study|Death|3|||
105751025|NCT01514188|364740801|FG000|Overall Study|Other|2|||
105751026|NCT01514188|364740802|FG001|Overall Study|Other|1|||
105751027|NCT02932332|364740803|FG000|Overall Study|Withdrawal by Subject|1|||
105751028|NCT02932332|364740804|FG001|Overall Study|Withdrawal by Subject|1|||
105751029|NCT02932332|364740805|FG002|Overall Study|Withdrawal by Subject|0|||
105751030|NCT02932332|364740806|FG003|Overall Study|Withdrawal by Subject|1|||
105751031|NCT02932332|364740803|FG000|Overall Study|Chest pain|0|||
105751032|NCT02932332|364740804|FG001|Overall Study|Chest pain|0|||
105751033|NCT02932332|364740805|FG002|Overall Study|Chest pain|0|||
105751034|NCT02932332|364740806|FG003|Overall Study|Chest pain|1|||
105751035|NCT02932332|364740803|FG000|Overall Study|Not Dyspneic cough|1|||
105751036|NCT02932332|364740804|FG001|Overall Study|Not Dyspneic cough|2|||
105751037|NCT02932332|364740805|FG002|Overall Study|Not Dyspneic cough|1|||
105751038|NCT02932332|364740806|FG003|Overall Study|Not Dyspneic cough|0|||
105751039|NCT05373706|364740807|FG000|Overall Study|Lost to Follow-up|2|||
105751040|NCT05373706|364740808|FG001|Overall Study|Lost to Follow-up|2|||
106142772|NCT00430300|366181996|FG000|Overall Study|Laboratory abnormality|1|||
106142773|NCT00430300|366181997|FG001|Overall Study|Laboratory abnormality|0|||
106142774|NCT00430300|366181998|FG002|Overall Study|Laboratory abnormality|0|||
106142775|NCT00430300|366181999|FG003|Overall Study|Laboratory abnormality|0|||
106142776|NCT00430300|366181996|FG000|Overall Study|Other|0|||
106142777|NCT00430300|366181997|FG001|Overall Study|Other|0|||
106142778|NCT00430300|366181998|FG002|Overall Study|Other|0|||
106142779|NCT00430300|366181999|FG003|Overall Study|Other|1|||
106142780|NCT01713946|366182004|FG000|Overall Study|Death|0|||
106142781|NCT01713946|366182005|FG001|Overall Study|Death|2|||
106142782|NCT01713946|366182006|FG002|Overall Study|Death|2|||
106142783|NCT01713946|366182004|FG000|Overall Study|Adverse Event|19|||
105751041|NCT01486784|364740809|FG000|Overall Study|Withdrawal by Subject|0|||
105751042|NCT01486784|364740810|FG001|Overall Study|Withdrawal by Subject|0|||
105751043|NCT01486784|364740811|FG002|Overall Study|Withdrawal by Subject|1|||
105751044|NCT01486784|364740812|FG003|Overall Study|Withdrawal by Subject|0|||
105751045|NCT01486784|364740813|FG004|Overall Study|Withdrawal by Subject|1|||
105751046|NCT01486784|364740814|FG005|Overall Study|Withdrawal by Subject|2|||
105751047|NCT01486784|364740809|FG000|Overall Study|Subject did not meet entry criteria|0|||
105947225|NCT01215851|365469349|FG002|Follow up Period|Lost to Follow-up|0|||
105947226|NCT01215851|365469350|FG003|Follow up Period|Lost to Follow-up|0|||
105751048|NCT01486784|364740810|FG001|Overall Study|Subject did not meet entry criteria|0|||
105751049|NCT01486784|364740811|FG002|Overall Study|Subject did not meet entry criteria|0|||
105751050|NCT01486784|364740812|FG003|Overall Study|Subject did not meet entry criteria|0|||
105751051|NCT01486784|364740813|FG004|Overall Study|Subject did not meet entry criteria|1|||
105751052|NCT01486784|364740814|FG005|Overall Study|Subject did not meet entry criteria|0|||
105751053|NCT01486784|364740809|FG000|Overall Study|Death|0|||
105751054|NCT01486784|364740810|FG001|Overall Study|Death|0|||
105751055|NCT01486784|364740811|FG002|Overall Study|Death|0|||
105751056|NCT01486784|364740812|FG003|Overall Study|Death|0|||
105751057|NCT01486784|364740813|FG004|Overall Study|Death|0|||
105751058|NCT01486784|364740814|FG005|Overall Study|Death|1|||
105751059|NCT01021852|364740815|FG000|Treatment Period 1|Adverse Event|3|||
105947227|NCT01215851|365469351|FG004|Follow up Period|Lost to Follow-up|0|||
105947228|NCT01215851|365469352|FG005|Follow up Period|Lost to Follow-up|1|||
105947229|NCT00746811|365469355|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
105947230|NCT00746811|365469356|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
105947231|NCT04881760|365469357|FG000|Overall Study|Adverse Event|0|||
105947232|NCT04881760|365469358|FG001|Overall Study|Adverse Event|1|||
105947233|NCT04881760|365469359|FG002|Overall Study|Adverse Event|1|||
105947234|NCT04881760|365469360|FG003|Overall Study|Adverse Event|0|||
105751060|NCT01021852|364740816|FG001|Treatment Period 1|Adverse Event|1|||
105751061|NCT01021852|364740817|FG002|Treatment Period 1|Adverse Event|1|||
105751062|NCT01021852|364740818|FG003|Treatment Period 1|Adverse Event|0|||
105751063|NCT01021852|364740819|FG004|Treatment Period 1|Adverse Event|2|||
105751064|NCT01021852|364740820|FG005|Treatment Period 1|Adverse Event|2|||
105751065|NCT01021852|364740821|FG006|Treatment Period 1|Adverse Event|0|||
105751066|NCT01021852|364740822|FG007|Treatment Period 1|Adverse Event|0|||
105947235|NCT04881760|365469361|FG004|Overall Study|Adverse Event|1|||
105947236|NCT04881760|365469362|FG005|Overall Study|Adverse Event|1|||
105947237|NCT04881760|365469363|FG006|Overall Study|Adverse Event|2|||
105947238|NCT04881760|365469357|FG000|Overall Study|Death|0|||
105947239|NCT04881760|365469358|FG001|Overall Study|Death|0|||
105947240|NCT04881760|365469359|FG002|Overall Study|Death|0|||
105947241|NCT04881760|365469360|FG003|Overall Study|Death|1|||
105947242|NCT04881760|365469361|FG004|Overall Study|Death|0|||
105751067|NCT01021852|364740815|FG000|Treatment Period 1|Pregnancy|0|||
105751068|NCT01021852|364740816|FG001|Treatment Period 1|Pregnancy|0|||
105751069|NCT01021852|364740817|FG002|Treatment Period 1|Pregnancy|1|||
105751070|NCT01021852|364740818|FG003|Treatment Period 1|Pregnancy|0|||
105751071|NCT01021852|364740819|FG004|Treatment Period 1|Pregnancy|0|||
105751072|NCT01021852|364740820|FG005|Treatment Period 1|Pregnancy|0|||
105751073|NCT01021852|364740821|FG006|Treatment Period 1|Pregnancy|0|||
105751074|NCT01021852|364740822|FG007|Treatment Period 1|Pregnancy|0|||
105751075|NCT01021852|364740815|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105751076|NCT01021852|364740816|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105751077|NCT01021852|364740817|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105947243|NCT04881760|365469362|FG005|Overall Study|Death|0|||
105947244|NCT04881760|365469363|FG006|Overall Study|Death|0|||
105751078|NCT01021852|364740818|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105751079|NCT01021852|364740819|FG004|Treatment Period 1|Withdrawal by Subject|1|||
105751080|NCT01021852|364740820|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105751081|NCT01021852|364740821|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105751082|NCT01021852|364740822|FG007|Treatment Period 1|Withdrawal by Subject|1|||
105751083|NCT01021852|364740815|FG000|Treatment Period 1|Not Treated|0|||
105751084|NCT01021852|364740816|FG001|Treatment Period 1|Not Treated|0|||
105751085|NCT01021852|364740817|FG002|Treatment Period 1|Not Treated|0|||
105751086|NCT01021852|364740818|FG003|Treatment Period 1|Not Treated|2|||
105751087|NCT01021852|364740819|FG004|Treatment Period 1|Not Treated|0|||
105751088|NCT01021852|364740820|FG005|Treatment Period 1|Not Treated|0|||
105751089|NCT01021852|364740821|FG006|Treatment Period 1|Not Treated|0|||
105751090|NCT01021852|364740822|FG007|Treatment Period 1|Not Treated|0|||
105751091|NCT01021852|364740815|FG000|Washout Period-Placebo|Adverse Event|0|||
105751092|NCT01021852|364740816|FG001|Washout Period-Placebo|Adverse Event|0|||
105751093|NCT01021852|364740817|FG002|Washout Period-Placebo|Adverse Event|0|||
105947245|NCT04881760|365469357|FG000|Overall Study|Lost to Follow-up|5|||
105751094|NCT01021852|364740818|FG003|Washout Period-Placebo|Adverse Event|1|||
105947246|NCT04881760|365469358|FG001|Overall Study|Lost to Follow-up|7|||
105751095|NCT01021852|364740819|FG004|Washout Period-Placebo|Adverse Event|0|||
105751096|NCT01021852|364740820|FG005|Washout Period-Placebo|Adverse Event|1|||
105947247|NCT04881760|365469359|FG002|Overall Study|Lost to Follow-up|5|||
105947248|NCT04881760|365469360|FG003|Overall Study|Lost to Follow-up|1|||
105947249|NCT04881760|365469361|FG004|Overall Study|Lost to Follow-up|2|||
105947250|NCT04881760|365469362|FG005|Overall Study|Lost to Follow-up|4|||
105947251|NCT04881760|365469363|FG006|Overall Study|Lost to Follow-up|4|||
105947252|NCT04881760|365469357|FG000|Overall Study|Withdrawal by Subject|13|||
105947253|NCT04881760|365469358|FG001|Overall Study|Withdrawal by Subject|1|||
105947254|NCT04881760|365469359|FG002|Overall Study|Withdrawal by Subject|1|||
105947255|NCT04881760|365469360|FG003|Overall Study|Withdrawal by Subject|4|||
105947256|NCT04881760|365469361|FG004|Overall Study|Withdrawal by Subject|2|||
105947257|NCT04881760|365469362|FG005|Overall Study|Withdrawal by Subject|1|||
105947258|NCT04881760|365469363|FG006|Overall Study|Withdrawal by Subject|2|||
105947259|NCT04881760|365469357|FG000|Overall Study|Randomized but Never Treated|0|||
105947260|NCT04881760|365469358|FG001|Overall Study|Randomized but Never Treated|0|||
105751097|NCT01021852|364740821|FG006|Washout Period-Placebo|Adverse Event|0|||
105751098|NCT01021852|364740822|FG007|Washout Period-Placebo|Adverse Event|0|||
105751099|NCT01021852|364740815|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
105751100|NCT01021852|364740816|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
105751101|NCT01021852|364740817|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
105751102|NCT01021852|364740818|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
105751103|NCT01021852|364740819|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
105751104|NCT01021852|364740820|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
105751105|NCT01021852|364740821|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
105751106|NCT01021852|364740822|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
105751107|NCT01021852|364740815|FG000|Washout Period-Placebo|Protocol Violation|0|||
105751108|NCT01021852|364740816|FG001|Washout Period-Placebo|Protocol Violation|0|||
105751109|NCT01021852|364740817|FG002|Washout Period-Placebo|Protocol Violation|0|||
105751110|NCT01021852|364740818|FG003|Washout Period-Placebo|Protocol Violation|0|||
105751111|NCT01021852|364740819|FG004|Washout Period-Placebo|Protocol Violation|0|||
105751112|NCT01021852|364740820|FG005|Washout Period-Placebo|Protocol Violation|0|||
105751113|NCT01021852|364740821|FG006|Washout Period-Placebo|Protocol Violation|1|||
105751114|NCT01021852|364740822|FG007|Washout Period-Placebo|Protocol Violation|0|||
105751115|NCT01021852|364740815|FG000|Washout Period-No Drug|Adverse Event|1|||
105751116|NCT01021852|364740816|FG001|Washout Period-No Drug|Adverse Event|0|||
105751117|NCT01021852|364740817|FG002|Washout Period-No Drug|Adverse Event|0|||
105751118|NCT01021852|364740818|FG003|Washout Period-No Drug|Adverse Event|0|||
105751119|NCT01021852|364740819|FG004|Washout Period-No Drug|Adverse Event|0|||
105751120|NCT01021852|364740820|FG005|Washout Period-No Drug|Adverse Event|1|||
105751121|NCT01021852|364740821|FG006|Washout Period-No Drug|Adverse Event|0|||
105751122|NCT01021852|364740822|FG007|Washout Period-No Drug|Adverse Event|0|||
105751123|NCT01021852|364740815|FG000|Treatment Period 2|Adverse Event|0|||
105751124|NCT01021852|364740816|FG001|Treatment Period 2|Adverse Event|1|||
105751125|NCT01021852|364740817|FG002|Treatment Period 2|Adverse Event|0|||
105751126|NCT01021852|364740818|FG003|Treatment Period 2|Adverse Event|0|||
105751127|NCT01021852|364740819|FG004|Treatment Period 2|Adverse Event|1|||
105751128|NCT01021852|364740820|FG005|Treatment Period 2|Adverse Event|0|||
105751129|NCT01021852|364740821|FG006|Treatment Period 2|Adverse Event|1|||
105751130|NCT01021852|364740822|FG007|Treatment Period 2|Adverse Event|0|||
105751131|NCT01021852|364740815|FG000|Treatment Period 2|Lack of Efficacy|0|||
105751132|NCT01021852|364740816|FG001|Treatment Period 2|Lack of Efficacy|0|||
105751133|NCT01021852|364740817|FG002|Treatment Period 2|Lack of Efficacy|0|||
105801800|NCT00219557|364930634|FG000|Phase 1|Adverse Event|2|||
105947261|NCT04881760|365469359|FG002|Overall Study|Randomized but Never Treated|0|||
105947262|NCT04881760|365469360|FG003|Overall Study|Randomized but Never Treated|1|||
105947263|NCT04881760|365469361|FG004|Overall Study|Randomized but Never Treated|0|||
105947264|NCT04881760|365469362|FG005|Overall Study|Randomized but Never Treated|0|||
105947265|NCT04881760|365469363|FG006|Overall Study|Randomized but Never Treated|0|||
105947266|NCT04881760|365469357|FG000|Overall Study|Inadvertent Enrollment|2|||
105947267|NCT04881760|365469358|FG001|Overall Study|Inadvertent Enrollment|0|||
105947268|NCT04881760|365469359|FG002|Overall Study|Inadvertent Enrollment|0|||
105751134|NCT01021852|364740818|FG003|Treatment Period 2|Lack of Efficacy|0|||
105751135|NCT01021852|364740819|FG004|Treatment Period 2|Lack of Efficacy|0|||
105751136|NCT01021852|364740820|FG005|Treatment Period 2|Lack of Efficacy|1|||
105751137|NCT01021852|364740821|FG006|Treatment Period 2|Lack of Efficacy|0|||
105751138|NCT01021852|364740822|FG007|Treatment Period 2|Lack of Efficacy|0|||
105751139|NCT01021852|364740815|FG000|Treatment Period 2|Physician Decision|0|||
105751140|NCT01021852|364740816|FG001|Treatment Period 2|Physician Decision|0|||
105751141|NCT01021852|364740817|FG002|Treatment Period 2|Physician Decision|1|||
105751142|NCT01021852|364740818|FG003|Treatment Period 2|Physician Decision|0|||
105751143|NCT01021852|364740819|FG004|Treatment Period 2|Physician Decision|0|||
105751144|NCT01021852|364740820|FG005|Treatment Period 2|Physician Decision|0|||
105751145|NCT01021852|364740821|FG006|Treatment Period 2|Physician Decision|0|||
105751146|NCT01021852|364740822|FG007|Treatment Period 2|Physician Decision|0|||
105751147|NCT01021852|364740815|FG000|Treatment Period 2|Protocol Violation|0|||
105801801|NCT00219557|364930635|FG001|Phase 1|Adverse Event|0|||
105947269|NCT04881760|365469360|FG003|Overall Study|Inadvertent Enrollment|0|||
105947270|NCT04881760|365469361|FG004|Overall Study|Inadvertent Enrollment|0|||
105751148|NCT01021852|364740816|FG001|Treatment Period 2|Protocol Violation|0|||
105751149|NCT01021852|364740817|FG002|Treatment Period 2|Protocol Violation|0|||
105751150|NCT01021852|364740818|FG003|Treatment Period 2|Protocol Violation|0|||
105751151|NCT01021852|364740819|FG004|Treatment Period 2|Protocol Violation|1|||
105751152|NCT01021852|364740820|FG005|Treatment Period 2|Protocol Violation|0|||
105751153|NCT01021852|364740821|FG006|Treatment Period 2|Protocol Violation|1|||
105751154|NCT01021852|364740822|FG007|Treatment Period 2|Protocol Violation|0|||
105751155|NCT01021852|364740815|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105751156|NCT01021852|364740816|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105751157|NCT01021852|364740817|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105751158|NCT01021852|364740818|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105751159|NCT01021852|364740819|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105947271|NCT04881760|365469362|FG005|Overall Study|Inadvertent Enrollment|0|||
105947272|NCT04881760|365469363|FG006|Overall Study|Inadvertent Enrollment|0|||
105947273|NCT04881760|365469357|FG000|Overall Study|Site Closure|0|||
105947274|NCT04881760|365469358|FG001|Overall Study|Site Closure|0|||
105947275|NCT04881760|365469359|FG002|Overall Study|Site Closure|0|||
105947276|NCT04881760|365469360|FG003|Overall Study|Site Closure|1|||
105947277|NCT04881760|365469361|FG004|Overall Study|Site Closure|0|||
105947278|NCT04881760|365469362|FG005|Overall Study|Site Closure|0|||
105947279|NCT04881760|365469363|FG006|Overall Study|Site Closure|0|||
105947280|NCT01538199|365469364|FG000|Overall Study|Lost to Follow-up|1|||
105947281|NCT01538199|365469365|FG001|Overall Study|Lost to Follow-up|2|||
105947282|NCT01538199|365469366|FG002|Overall Study|Lost to Follow-up|1|||
105947283|NCT01538199|365469367|FG003|Overall Study|Lost to Follow-up|0|||
105947284|NCT01538199|365469364|FG000|Overall Study|participant did not have time|1|||
105947285|NCT01538199|365469365|FG001|Overall Study|participant did not have time|0|||
105947286|NCT01538199|365469366|FG002|Overall Study|participant did not have time|0|||
105947287|NCT01538199|365469367|FG003|Overall Study|participant did not have time|2|||
105947288|NCT01538199|365469364|FG000|Overall Study|Lack of Efficacy|0|||
105947289|NCT01538199|365469365|FG001|Overall Study|Lack of Efficacy|1|||
105947290|NCT01538199|365469366|FG002|Overall Study|Lack of Efficacy|0|||
105947291|NCT01538199|365469367|FG003|Overall Study|Lack of Efficacy|0|||
105947292|NCT02081586|365469368|FG000|Overall Study|Lost to Follow-up|0|||
105947293|NCT02081586|365469369|FG001|Overall Study|Lost to Follow-up|1|||
105947294|NCT02081586|365469370|FG002|Overall Study|Lost to Follow-up|0|||
105947295|NCT02081586|365469371|FG003|Overall Study|Lost to Follow-up|1|||
105947296|NCT02081586|365469368|FG000|Overall Study|Head injury not related to study|0|||
105947297|NCT02081586|365469369|FG001|Overall Study|Head injury not related to study|0|||
106016320|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
106016321|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105751160|NCT01021852|364740820|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105751161|NCT01021852|364740821|FG006|Treatment Period 2|Withdrawal by Subject|1|||
105751162|NCT01021852|364740822|FG007|Treatment Period 2|Withdrawal by Subject|2|||
105751163|NCT02841787|364740823|FG000|Overall Study|Lost to Follow-up|1|||
105751164|NCT02841787|364740824|FG001|Overall Study|Lost to Follow-up|0|||
105751165|NCT02841787|364740825|FG002|Overall Study|Lost to Follow-up|0|||
105751166|NCT02841787|364740823|FG000|Overall Study|Symptoms dropped below threshold|1|||
105751167|NCT02841787|364740824|FG001|Overall Study|Symptoms dropped below threshold|0|||
105751168|NCT02841787|364740825|FG002|Overall Study|Symptoms dropped below threshold|0|||
105751169|NCT02841787|364740823|FG000|Overall Study|Withdrawal by Subject|1|||
105751170|NCT02841787|364740824|FG001|Overall Study|Withdrawal by Subject|4|||
105751171|NCT02841787|364740825|FG002|Overall Study|Withdrawal by Subject|0|||
105751172|NCT00712322|364740831|FG000|Overall Study|Protocol deviation|0|||
105751173|NCT00712322|364740832|FG001|Overall Study|Protocol deviation|1|||
105751174|NCT00712322|364740833|FG002|Overall Study|Protocol deviation|0|||
105751175|NCT01025817|364740835|FG000|Completed Study Medication|Adverse Event|66|||
105751176|NCT01025817|364740836|FG001|Completed Study Medication|Adverse Event|39|||
105751177|NCT01025817|364740835|FG000|Completed Study Medication|Protocol Deviation|9|||
105751178|NCT01025817|364740836|FG001|Completed Study Medication|Protocol Deviation|8|||
105751179|NCT01025817|364740835|FG000|Completed Study Medication|Withdrawal by Subject|8|||
105751180|NCT01025817|364740836|FG001|Completed Study Medication|Withdrawal by Subject|9|||
106016322|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016323|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105751181|NCT01025817|364740835|FG000|Completed Study Medication|Administrative problems|7|||
105751182|NCT01025817|364740836|FG001|Completed Study Medication|Administrative problems|5|||
105751183|NCT01025817|364740835|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
105751184|NCT01025817|364740836|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
105947298|NCT02081586|365469370|FG002|Overall Study|Head injury not related to study|1|||
105947299|NCT02081586|365469371|FG003|Overall Study|Head injury not related to study|0|||
105947300|NCT03770286|365469372|FG000|Overall Study|Lost to Follow-up|6|||
105947301|NCT03770286|365469373|FG001|Overall Study|Lost to Follow-up|4|||
105947302|NCT03770286|365469374|FG002|Overall Study|Lost to Follow-up|3|||
106142784|NCT01713946|366182005|FG001|Overall Study|Adverse Event|14|||
105751185|NCT01025817|364740835|FG000|Completed Study Medication|Abnormal test procedure|4|||
105947303|NCT03770286|365469372|FG000|Overall Study|Protocol Violation|1|||
105947304|NCT03770286|365469373|FG001|Overall Study|Protocol Violation|0|||
105947305|NCT03770286|365469374|FG002|Overall Study|Protocol Violation|2|||
105947306|NCT02297412|365469375|FG000|Overall Study|Canceled|1|||
105947307|NCT02297412|365469376|FG001|Overall Study|Canceled|1|||
105947308|NCT00656370|365469377|FG000|Overall Study|Screen Failures|7|||
105947309|NCT00656370|365469377|FG000|Overall Study|Alternates|3|||
105947310|NCT01542788|365469378|FG000|Overall Study|Randomized but Not Treated|2|||
105947311|NCT01542788|365469379|FG001|Overall Study|Randomized but Not Treated|0|||
105947312|NCT01542788|365469378|FG000|Overall Study|Lack of Efficacy|41|||
105947313|NCT01542788|365469379|FG001|Overall Study|Lack of Efficacy|71|||
105947314|NCT01542788|365469378|FG000|Overall Study|Lost to Follow-up|5|||
105947315|NCT01542788|365469379|FG001|Overall Study|Lost to Follow-up|0|||
106016324|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105751186|NCT01025817|364740836|FG001|Completed Study Medication|Abnormal test procedure|0|||
105751187|NCT01025817|364740835|FG000|Completed Study Medication|Graft loss|2|||
105751188|NCT01025817|364740836|FG001|Completed Study Medication|Graft loss|5|||
105751189|NCT01025817|364740835|FG000|Completed Study Medication|Death|2|||
105751190|NCT01025817|364740836|FG001|Completed Study Medication|Death|2|||
105751191|NCT01025817|364740835|FG000|Completed Study Medication|Abnormal lab values|0|||
105751192|NCT01025817|364740836|FG001|Completed Study Medication|Abnormal lab values|2|||
105751193|NCT01025817|364740835|FG000|Completed Study Medication|Subject no longer required study drug|0|||
105751194|NCT01025817|364740836|FG001|Completed Study Medication|Subject no longer required study drug|1|||
105751195|NCT01025817|364740835|FG000|Completed Study Medication|Lost to Follow-up|0|||
105751196|NCT01025817|364740836|FG001|Completed Study Medication|Lost to Follow-up|1|||
105751197|NCT01025817|364740835|FG000|Completed Study|Withdrawal by Subject|8|||
105751198|NCT01025817|364740836|FG001|Completed Study|Withdrawal by Subject|16|||
105751199|NCT01025817|364740835|FG000|Completed Study|Death|6|||
105751200|NCT01025817|364740836|FG001|Completed Study|Death|5|||
105751201|NCT01025817|364740835|FG000|Completed Study|Missing|2|||
105751202|NCT01025817|364740836|FG001|Completed Study|Missing|0|||
105751203|NCT01025817|364740835|FG000|Completed Study|Lost to Follow-up|0|||
105751204|NCT01025817|364740836|FG001|Completed Study|Lost to Follow-up|1|||
105751205|NCT02237157|364740837|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
105751206|NCT02237157|364740838|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
105751207|NCT02237157|364740839|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
105751208|NCT02237157|364740840|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
105751209|NCT02237157|364740837|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
105751210|NCT02237157|364740838|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
105751211|NCT02237157|364740839|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
105751212|NCT02237157|364740840|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
105751213|NCT01996748|364740841|FG000|Overall Study|Personal reason|1|||
105751214|NCT01996748|364740842|FG001|Overall Study|Personal reason|0|||
105751215|NCT01996748|364740841|FG000|Overall Study|Physician Decision|2|||
105751216|NCT01996748|364740842|FG001|Overall Study|Physician Decision|0|||
105751217|NCT01996748|364740841|FG000|Overall Study|Adverse Event|1|||
105751218|NCT01996748|364740842|FG001|Overall Study|Adverse Event|4|||
105751219|NCT01996748|364740841|FG000|Overall Study|Withdrawal by Subject|0|||
105751220|NCT01996748|364740842|FG001|Overall Study|Withdrawal by Subject|1|||
105751221|NCT01996748|364740841|FG000|Overall Study|Lost to Follow-up|4|||
105751222|NCT01996748|364740842|FG001|Overall Study|Lost to Follow-up|1|||
105751223|NCT00488592|364740845|FG000|Overall Study|Withdrawal by Subject|1|||
105751224|NCT00488592|364740845|FG000|Overall Study|Disease progression|1|||
105751225|NCT00488592|364740845|FG000|Overall Study|Enrolled but not treated|1|||
105751226|NCT00603980|364740847|FG000|Study Qualification|Protocol Violation|3|||
105751227|NCT00603980|364740847|FG000|Study Qualification|Inconsistent data reporting|13|||
105751228|NCT00603980|364740847|FG000|Main Study|14th subject completed trial|1|||
105751229|NCT00702052|364740848|FG000|Overall Study|Adverse Event|23|||
105751230|NCT00702052|364740848|FG000|Overall Study|Disease Progression|30|||
106016325|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016326|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016327|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
106016328|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
105751231|NCT00702052|364740848|FG000|Overall Study|Withdrawal by Subject|5|||
105751232|NCT01627067|364740849|FG000|Overall Study|Screen Failure|1|||
105751233|NCT01096849|364740853|FG000|Overall Study|Consent Withdrawn|1|||
105751234|NCT01096849|364740854|FG001|Overall Study|Consent Withdrawn|4|||
105751235|NCT01096849|364740855|FG002|Overall Study|Consent Withdrawn|2|||
105751236|NCT01096849|364740853|FG000|Overall Study|Lack of Efficacy|0|||
105947316|NCT01542788|365469378|FG000|Overall Study|Death|3|||
105751237|NCT01096849|364740854|FG001|Overall Study|Lack of Efficacy|2|||
105751238|NCT01096849|364740855|FG002|Overall Study|Lack of Efficacy|0|||
105947317|NCT01542788|365469379|FG001|Overall Study|Death|0|||
105801802|NCT00219557|364930636|FG002|Phase 1|Adverse Event|0|||
105801803|NCT00219557|364930634|FG000|Phase 1|Withdrawal by Subject|1|||
105801804|NCT00219557|364930635|FG001|Phase 1|Withdrawal by Subject|0|||
105801805|NCT00219557|364930636|FG002|Phase 1|Withdrawal by Subject|0|||
105801806|NCT00219557|364930634|FG000|Phase 1|Started chemotherapy at other institute|1|||
105801807|NCT00219557|364930635|FG001|Phase 1|Started chemotherapy at other institute|0|||
105801808|NCT00219557|364930636|FG002|Phase 1|Started chemotherapy at other institute|0|||
105801809|NCT00219557|364930634|FG000|Phase 2|Lack of Efficacy|0|||
105947318|NCT01542788|365469378|FG000|Overall Study|Protocol Violation|2|||
105947319|NCT01542788|365469379|FG001|Overall Study|Protocol Violation|0|||
105947320|NCT01542788|365469378|FG000|Overall Study|Physician Decision|1|||
105947321|NCT01542788|365469379|FG001|Overall Study|Physician Decision|0|||
105947322|NCT01542788|365469378|FG000|Overall Study|Withdrawal by Subject|1|||
105947323|NCT01542788|365469379|FG001|Overall Study|Withdrawal by Subject|0|||
105947324|NCT00529633|365471128|FG000|Overall Study|Withdrawal by Subject|1|||
105947325|NCT00529633|365471129|FG001|Overall Study|Withdrawal by Subject|1|||
105947326|NCT01323192|365471137|FG000|Overall Study|Adverse Event|6|||
105947327|NCT01323192|365471138|FG001|Overall Study|Adverse Event|1|||
105947328|NCT01323192|365471137|FG000|Overall Study|Withdrawal by Subject|3|||
105801810|NCT00219557|364930635|FG001|Phase 2|Lack of Efficacy|21|||
105947329|NCT01323192|365471138|FG001|Overall Study|Withdrawal by Subject|1|||
105947330|NCT01323192|365471137|FG000|Overall Study|Noncompliance with study medication|0|||
105947331|NCT01323192|365471138|FG001|Overall Study|Noncompliance with study medication|3|||
105947332|NCT01323192|365471137|FG000|Overall Study|Nonmedical reasons|0|||
105947333|NCT01323192|365471138|FG001|Overall Study|Nonmedical reasons|1|||
105947334|NCT05246514|365471147|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
105947335|NCT05246514|365471147|FG000|Overall Study|Withdrawal by Subject|1|||
105947336|NCT05246514|365471147|FG000|Overall Study|Death|13|||
105947337|NCT00140140|365471151|FG000|Overall Study|Unacceptable toxicity|1|||
105947338|NCT00140140|365471152|FG001|Overall Study|Unacceptable toxicity|1|||
105947339|NCT00140140|365471153|FG002|Overall Study|Unacceptable toxicity|2|||
105947340|NCT00140140|365471151|FG000|Overall Study|Physician Decision|1|||
105947341|NCT00140140|365471152|FG001|Overall Study|Physician Decision|1|||
105801811|NCT00219557|364930636|FG002|Phase 2|Lack of Efficacy|15|||
105801812|NCT00219557|364930634|FG000|Phase 2|Adverse Event|0|||
105801813|NCT00219557|364930635|FG001|Phase 2|Adverse Event|22|||
105801814|NCT00219557|364930636|FG002|Phase 2|Adverse Event|2|||
105801815|NCT00219557|364930634|FG000|Phase 2|Death|0|||
105801816|NCT00219557|364930635|FG001|Phase 2|Death|8|||
105801817|NCT00219557|364930636|FG002|Phase 2|Death|2|||
105801818|NCT00219557|364930634|FG000|Phase 2|Other|0|||
105801819|NCT00219557|364930635|FG001|Phase 2|Other|8|||
105801820|NCT00219557|364930636|FG002|Phase 2|Other|6|||
105801821|NCT00219557|364930634|FG000|Phase 2|Withdrawal by Subject|0|||
105801822|NCT00219557|364930635|FG001|Phase 2|Withdrawal by Subject|9|||
105801823|NCT00219557|364930636|FG002|Phase 2|Withdrawal by Subject|5|||
105801824|NCT00219557|364930634|FG000|Phase 2|Treatment not received|0|||
105947342|NCT00140140|365471153|FG002|Overall Study|Physician Decision|0|||
105947343|NCT02835690|365471154|FG000|Overall Study|Death|12|||
105947344|NCT02835690|365471155|FG001|Overall Study|Death|11|||
105947345|NCT02835690|365471156|FG002|Overall Study|Death|13|||
105947346|NCT02835690|365471154|FG000|Overall Study|Transferred to Extension Study|2|||
105947347|NCT02835690|365471155|FG001|Overall Study|Transferred to Extension Study|2|||
105947348|NCT02835690|365471156|FG002|Overall Study|Transferred to Extension Study|1|||
105947349|NCT02835690|365471154|FG000|Overall Study|Did Not Continue on Extension Study|0|||
105947350|NCT02835690|365471155|FG001|Overall Study|Did Not Continue on Extension Study|0|||
105947351|NCT02835690|365471156|FG002|Overall Study|Did Not Continue on Extension Study|1|||
105947352|NCT02835690|365471154|FG000|Overall Study|Not Treated|0|||
105947353|NCT02835690|365471155|FG001|Overall Study|Not Treated|2|||
105947354|NCT02835690|365471156|FG002|Overall Study|Not Treated|0|||
105947355|NCT02704208|365471160|FG000|Overall Study|Lost to Follow-up|42|||
105947356|NCT02704208|365471161|FG001|Overall Study|Lost to Follow-up|37|||
105947357|NCT03493958|365471163|FG000|Overall Study|Withdrawal by Subject|6|||
105947358|NCT03493958|365471163|FG000|Overall Study|Lost to Follow-up|7|||
105947359|NCT03493958|365471163|FG000|Overall Study|Did not complete all required study procedures|2|||
105947360|NCT04388826|365471164|FG000|Overall Study|Lost to Follow-up|3|||
105947361|NCT04388826|365471165|FG001|Overall Study|Lost to Follow-up|2|||
105801825|NCT00219557|364930635|FG001|Phase 2|Treatment not received|1|||
105947362|NCT04388826|365471164|FG000|Overall Study|Adverse Event|1|||
105801826|NCT00219557|364930636|FG002|Phase 2|Treatment not received|3|||
105801827|NCT01427803|364930639|FG000|Overall Study|Lost to Follow-up|32|||
105801828|NCT01427803|364930640|FG001|Overall Study|Lost to Follow-up|26|||
105801829|NCT01427803|364930639|FG000|Overall Study|Withdrawal by Subject|20|||
105801830|NCT01427803|364930640|FG001|Overall Study|Withdrawal by Subject|0|||
105801831|NCT01427803|364930639|FG000|Overall Study|Unable to complete full treatment period|6|||
105801832|NCT01427803|364930640|FG001|Overall Study|Unable to complete full treatment period|0|||
105801833|NCT01427803|364930639|FG000|Overall Study|Protocol Violation|1|||
105801834|NCT01427803|364930640|FG001|Overall Study|Protocol Violation|0|||
105801835|NCT01427803|364930639|FG000|Overall Study|Physician Decision|3|||
105801836|NCT01427803|364930640|FG001|Overall Study|Physician Decision|0|||
105801837|NCT01427803|364930639|FG000|Overall Study|did not take product|1|||
105801838|NCT01427803|364930640|FG001|Overall Study|did not take product|0|||
105801839|NCT01612156|364930644|FG000|Overall Study|Protocol Violation|2|||
105801840|NCT01612156|364930645|FG001|Overall Study|Protocol Violation|0|||
105801841|NCT00373685|364930646|FG000|Overall Study|Death|2|||
105801842|NCT00373685|364930647|FG001|Overall Study|Death|1|||
105801843|NCT00373685|364930646|FG000|Overall Study|Adverse Event|278|||
105801844|NCT00373685|364930647|FG001|Overall Study|Adverse Event|253|||
105801845|NCT00373685|364930646|FG000|Overall Study|Insufficient clinical response|169|||
105801846|NCT00373685|364930647|FG001|Overall Study|Insufficient clinical response|119|||
105801847|NCT00373685|364930646|FG000|Overall Study|Did not meet entrance criteria|167|||
105801848|NCT00373685|364930647|FG001|Overall Study|Did not meet entrance criteria|184|||
105801849|NCT00373685|364930646|FG000|Overall Study|Lost to follow up|83|||
105801850|NCT00373685|364930647|FG001|Overall Study|Lost to follow up|103|||
105947363|NCT04388826|365471165|FG001|Overall Study|Adverse Event|0|||
105947364|NCT02410772|365471168|FG000|Overall Study|Death|3|||
105947365|NCT02410772|365471169|FG001|Overall Study|Death|4|||
105947366|NCT02410772|365471170|FG002|Overall Study|Death|8|||
105947367|NCT02410772|365471168|FG000|Overall Study|Lost to Follow-up|31|||
105801851|NCT00373685|364930646|FG000|Overall Study|No longer willing to participate|337|||
105801852|NCT00373685|364930647|FG001|Overall Study|No longer willing to participate|352|||
105801853|NCT00373685|364930646|FG000|Overall Study|Other|149|||
105801854|NCT00373685|364930647|FG001|Overall Study|Other|146|||
105801855|NCT00373685|364930646|FG000|Overall Study|Protocol Violation|191|||
105801856|NCT00373685|364930647|FG001|Overall Study|Protocol Violation|182|||
105801857|NCT00373685|364930646|FG000|Overall Study|Final Status Unknown|12|||
105801858|NCT00373685|364930647|FG001|Overall Study|Final Status Unknown|4|||
105801859|NCT00373685|364930646|FG000|Overall Study|Randomized, not treated|51|||
105801860|NCT00373685|364930647|FG001|Overall Study|Randomized, not treated|77|||
105801861|NCT02570165|364930648|FG000|Overall Study|Adverse Event|1|||
105801862|NCT02570165|364930649|FG001|Overall Study|Adverse Event|0|||
105801863|NCT02570165|364930650|FG002|Overall Study|Adverse Event|2|||
105801864|NCT02570165|364930651|FG003|Overall Study|Adverse Event|0|||
105801865|NCT02570165|364930652|FG004|Overall Study|Adverse Event|0|||
105801866|NCT02570165|364930653|FG005|Overall Study|Adverse Event|0|||
105801867|NCT02570165|364930654|FG006|Overall Study|Adverse Event|0|||
105801868|NCT02570165|364930648|FG000|Overall Study|Lack of Efficacy|0|||
105801869|NCT02570165|364930649|FG001|Overall Study|Lack of Efficacy|1|||
105801870|NCT02570165|364930650|FG002|Overall Study|Lack of Efficacy|0|||
105801871|NCT02570165|364930651|FG003|Overall Study|Lack of Efficacy|0|||
105801872|NCT02570165|364930652|FG004|Overall Study|Lack of Efficacy|4|||
105801873|NCT02570165|364930653|FG005|Overall Study|Lack of Efficacy|0|||
105801874|NCT02570165|364930654|FG006|Overall Study|Lack of Efficacy|0|||
105801875|NCT02570165|364930648|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
105801876|NCT02570165|364930649|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
105801877|NCT02570165|364930650|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
105801878|NCT02570165|364930651|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
105801879|NCT02570165|364930652|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
105801880|NCT02570165|364930653|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
105801881|NCT02570165|364930654|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
105801882|NCT02570165|364930648|FG000|Overall Study|Lost to Follow-up|0|||
105801883|NCT02570165|364930649|FG001|Overall Study|Lost to Follow-up|0|||
105801884|NCT02570165|364930650|FG002|Overall Study|Lost to Follow-up|1|||
105801885|NCT02570165|364930651|FG003|Overall Study|Lost to Follow-up|1|||
105801886|NCT02570165|364930652|FG004|Overall Study|Lost to Follow-up|0|||
105801887|NCT02570165|364930653|FG005|Overall Study|Lost to Follow-up|0|||
105801888|NCT02570165|364930654|FG006|Overall Study|Lost to Follow-up|0|||
105801889|NCT02570165|364930648|FG000|Overall Study|Physician Decision|0|||
105801890|NCT02570165|364930649|FG001|Overall Study|Physician Decision|1|||
105801891|NCT02570165|364930650|FG002|Overall Study|Physician Decision|0|||
105801892|NCT02570165|364930651|FG003|Overall Study|Physician Decision|0|||
105801893|NCT02570165|364930652|FG004|Overall Study|Physician Decision|0|||
105801894|NCT02570165|364930653|FG005|Overall Study|Physician Decision|0|||
105801895|NCT02570165|364930654|FG006|Overall Study|Physician Decision|0|||
105947368|NCT02410772|365471169|FG001|Overall Study|Lost to Follow-up|23|||
106142785|NCT01713946|366182006|FG002|Overall Study|Adverse Event|13|||
105801896|NCT02570165|364930648|FG000|Overall Study|Withdrawal by Subject|0|||
105801897|NCT02570165|364930649|FG001|Overall Study|Withdrawal by Subject|0|||
105801898|NCT02570165|364930650|FG002|Overall Study|Withdrawal by Subject|0|||
105801899|NCT02570165|364930651|FG003|Overall Study|Withdrawal by Subject|2|||
105801900|NCT02570165|364930652|FG004|Overall Study|Withdrawal by Subject|1|||
105801901|NCT02570165|364930653|FG005|Overall Study|Withdrawal by Subject|0|||
105801902|NCT02570165|364930654|FG006|Overall Study|Withdrawal by Subject|0|||
105801903|NCT02570165|364930648|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801904|NCT02570165|364930649|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801905|NCT02570165|364930650|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801906|NCT02570165|364930651|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801907|NCT02570165|364930652|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801908|NCT02570165|364930653|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
105801909|NCT02570165|364930654|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
105801910|NCT02570165|364930648|FG000|Overall Study|Withdrawal Request by GSK|0|||
105801911|NCT02570165|364930649|FG001|Overall Study|Withdrawal Request by GSK|0|||
105801912|NCT02570165|364930650|FG002|Overall Study|Withdrawal Request by GSK|2|||
105801913|NCT02570165|364930651|FG003|Overall Study|Withdrawal Request by GSK|0|||
105801914|NCT02570165|364930652|FG004|Overall Study|Withdrawal Request by GSK|0|||
105801915|NCT02570165|364930653|FG005|Overall Study|Withdrawal Request by GSK|0|||
105801916|NCT02570165|364930654|FG006|Overall Study|Withdrawal Request by GSK|0|||
105801917|NCT01208402|364930655|FG000|Overall Study|Withdrawal by Subject|1|||
105801918|NCT01208402|364930656|FG001|Overall Study|Withdrawal by Subject|0|||
105801919|NCT05288673|364930657|FG000|Overall Study|Consent withdrawn by subject|0|||
105801920|NCT05288673|364930658|FG001|Overall Study|Consent withdrawn by subject|0|||
105801921|NCT05288673|364930659|FG002|Overall Study|Consent withdrawn by subject|1|||
105801922|NCT01335464|364930660|FG000|Overall Study|Adverse Event|15|||
105801923|NCT01335464|364930661|FG001|Overall Study|Adverse Event|25|||
105801924|NCT01335464|364930660|FG000|Overall Study|Non compliant with protocol|2|||
105801925|NCT01335464|364930661|FG001|Overall Study|Non compliant with protocol|0|||
105801926|NCT01335464|364930660|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
105801927|NCT01335464|364930661|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
105801928|NCT01335464|364930660|FG000|Overall Study|Not treated|2|||
105801929|NCT01335464|364930661|FG001|Overall Study|Not treated|0|||
105801930|NCT01335464|364930660|FG000|Overall Study|Reason other than those stated above|1|||
105801931|NCT01335464|364930661|FG001|Overall Study|Reason other than those stated above|1|||
105801932|NCT03156270|364930662|FG000|Overall Study|Failed pre-treatment screening|1|||
105947369|NCT02410772|365471170|FG002|Overall Study|Lost to Follow-up|22|||
105801933|NCT03156270|364930662|FG000|Overall Study|Lost to Follow-up|1|||
105801934|NCT00591253|364930663|FG000|Overall Study|Adverse Event|3|||
105801935|NCT00591253|364930664|FG001|Overall Study|Adverse Event|3|||
105801936|NCT00591253|364930665|FG002|Overall Study|Adverse Event|1|||
105801937|NCT00591253|364930663|FG000|Overall Study|Protocol Violation|2|||
105801938|NCT00591253|364930664|FG001|Overall Study|Protocol Violation|2|||
105801939|NCT00591253|364930665|FG002|Overall Study|Protocol Violation|2|||
105801940|NCT00591253|364930663|FG000|Overall Study|Lost to Follow-up|2|||
105801941|NCT00591253|364930664|FG001|Overall Study|Lost to Follow-up|4|||
105801942|NCT00591253|364930665|FG002|Overall Study|Lost to Follow-up|0|||
105801943|NCT00591253|364930663|FG000|Overall Study|Withdrawal by Subject|1|||
105801944|NCT00591253|364930664|FG001|Overall Study|Withdrawal by Subject|7|||
105801945|NCT00591253|364930665|FG002|Overall Study|Withdrawal by Subject|6|||
105801946|NCT00591253|364930663|FG000|Overall Study|Lack of Efficacy|1|||
105801947|NCT00591253|364930664|FG001|Overall Study|Lack of Efficacy|0|||
105801948|NCT00591253|364930665|FG002|Overall Study|Lack of Efficacy|3|||
105801949|NCT00591253|364930663|FG000|Overall Study|Other|5|||
105801950|NCT00591253|364930664|FG001|Overall Study|Other|5|||
105801951|NCT00591253|364930665|FG002|Overall Study|Other|3|||
105801952|NCT01504867|364930666|FG000|Overall Study|Inclusion criteria not met|2|||
105801953|NCT01504867|364930667|FG001|Overall Study|Inclusion criteria not met|2|||
105801954|NCT01504867|364930666|FG000|Overall Study|Consent revoked|5|||
105801955|NCT01504867|364930667|FG001|Overall Study|Consent revoked|1|||
105801956|NCT00571922|364930668|FG000|Overall Study|Completion unknown|36|||
105801957|NCT00571922|364930669|FG001|Overall Study|Completion unknown|36|||
105947370|NCT02410772|365471168|FG000|Overall Study|Pregnancy|8|||
105801958|NCT01254045|364930680|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
105801959|NCT01254045|364930681|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801960|NCT01254045|364930682|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801961|NCT01254045|364930683|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801962|NCT01254045|364930684|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801963|NCT01254045|364930685|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
105801964|NCT02971605|364930686|FG000|Overall Study|Withdrawal by Subject|1|||
105801965|NCT02110706|364930687|FG000|Overall Study|Adverse Event|2|||
105801966|NCT02110706|364930688|FG001|Overall Study|Adverse Event|3|||
105801967|NCT02110706|364930687|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
105801968|NCT02110706|364930688|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
105801969|NCT02533999|364930689|FG000|Overall Study|Lost to Follow-up|3|||
105947371|NCT02410772|365471169|FG001|Overall Study|Pregnancy|4|||
105801970|NCT02533999|364930690|FG001|Overall Study|Lost to Follow-up|5|||
105801971|NCT02533999|364930689|FG000|Overall Study|Protocol Violation|3|||
105801972|NCT02533999|364930690|FG001|Overall Study|Protocol Violation|0|||
105801973|NCT02533999|364930689|FG000|Overall Study|Adverse Event|0|||
105801974|NCT02533999|364930690|FG001|Overall Study|Adverse Event|1|||
105801975|NCT02533999|364930689|FG000|Overall Study|Randomized but intervention not received|0|||
105801976|NCT02533999|364930690|FG001|Overall Study|Randomized but intervention not received|1|||
105801977|NCT00597207|364930693|FG000|Overall Study|Lost to Follow-up|5|||
105801978|NCT00597207|364930694|FG001|Overall Study|Lost to Follow-up|7|||
105801979|NCT00520351|364930695|FG000|First Intervention|Withdrawal by Subject|1|||
105801980|NCT00520351|364930696|FG001|First Intervention|Withdrawal by Subject|1|||
105801981|NCT01261325|364930699|FG000|Overall Study|Lack of Efficacy|1|||
105801982|NCT01261325|364930700|FG001|Overall Study|Lack of Efficacy|1|||
105801983|NCT01261325|364930701|FG002|Overall Study|Lack of Efficacy|0|||
105801984|NCT01261325|364930699|FG000|Overall Study|Withdrawal by Subject|2|||
105801985|NCT01261325|364930700|FG001|Overall Study|Withdrawal by Subject|2|||
105801986|NCT01261325|364930701|FG002|Overall Study|Withdrawal by Subject|4|||
105801987|NCT01261325|364930699|FG000|Overall Study|SAE, non-fatal|1|||
105801988|NCT01261325|364930700|FG001|Overall Study|SAE, non-fatal|5|||
105801989|NCT01261325|364930701|FG002|Overall Study|SAE, non-fatal|1|||
105801990|NCT01261325|364930699|FG000|Overall Study|AE, non-serious non-fatal|9|||
105801991|NCT01261325|364930700|FG001|Overall Study|AE, non-serious non-fatal|15|||
105801992|NCT01261325|364930701|FG002|Overall Study|AE, non-serious non-fatal|13|||
105801993|NCT01261325|364930699|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105801994|NCT01261325|364930700|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105801995|NCT01261325|364930701|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105801996|NCT01261325|364930699|FG000|Overall Study|Non Compliance|2|||
105801997|NCT01261325|364930700|FG001|Overall Study|Non Compliance|0|||
105801998|NCT01261325|364930701|FG002|Overall Study|Non Compliance|0|||
105801999|NCT01261325|364930699|FG000|Overall Study|Patient Randomized by Mistake|0|||
105802000|NCT01261325|364930700|FG001|Overall Study|Patient Randomized by Mistake|1|||
105802001|NCT01261325|364930701|FG002|Overall Study|Patient Randomized by Mistake|0|||
105802002|NCT01261325|364930699|FG000|Overall Study|Erroneously Randomized|1|||
105802003|NCT01261325|364930700|FG001|Overall Study|Erroneously Randomized|0|||
105802004|NCT01261325|364930701|FG002|Overall Study|Erroneously Randomized|0|||
105802005|NCT01261325|364930699|FG000|Overall Study|Screen Failure|1|||
105802006|NCT01261325|364930700|FG001|Overall Study|Screen Failure|0|||
105802007|NCT01261325|364930701|FG002|Overall Study|Screen Failure|0|||
105802008|NCT01261325|364930699|FG000|Overall Study|Randomized in Error|0|||
105802009|NCT01261325|364930700|FG001|Overall Study|Randomized in Error|0|||
105802010|NCT01261325|364930701|FG002|Overall Study|Randomized in Error|1|||
105802011|NCT01261325|364930699|FG000|Overall Study|Protocol Violation|0|||
105802012|NCT01261325|364930700|FG001|Overall Study|Protocol Violation|3|||
105802013|NCT01261325|364930701|FG002|Overall Study|Protocol Violation|1|||
105802014|NCT01261325|364930699|FG000|Overall Study|Lost to Follow-up|0|||
105802015|NCT01261325|364930700|FG001|Overall Study|Lost to Follow-up|1|||
105802016|NCT01261325|364930701|FG002|Overall Study|Lost to Follow-up|3|||
105802017|NCT01261325|364930699|FG000|Overall Study|AE, serious fatal|0|||
105802018|NCT01261325|364930700|FG001|Overall Study|AE, serious fatal|0|||
105802019|NCT01261325|364930701|FG002|Overall Study|AE, serious fatal|2|||
105802020|NCT03077828|364930702|FG000|Treatment Cycles|Death|1|||
105802021|NCT03077828|364930702|FG000|Treatment Cycles|Withdrawal by Subject|1|||
105802022|NCT03077828|364930702|FG000|Treatment Cycles|Screen Fail|2|||
105802023|NCT03077828|364930702|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
105802024|NCT03077828|364930702|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
105802025|NCT03077828|364930702|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
105802026|NCT03077828|364930702|FG000|Follow-up|Patients still in follow-up|15|||
105802027|NCT03443869|364930705|FG000|Overall Study|Death|3|||
105947372|NCT02410772|365471170|FG002|Overall Study|Pregnancy|5|||
105947373|NCT02410772|365471168|FG000|Overall Study|Protocol Violation|8|||
105802028|NCT03443869|364930706|FG001|Overall Study|Death|3|||
105802029|NCT03443869|364930705|FG000|Overall Study|Withdrawal by Subject|34|||
105802030|NCT03443869|364930706|FG001|Overall Study|Withdrawal by Subject|22|||
105802031|NCT03443869|364930705|FG000|Overall Study|Lost to Follow-up|1|||
105802032|NCT03443869|364930706|FG001|Overall Study|Lost to Follow-up|2|||
105802033|NCT03443869|364930705|FG000|Overall Study|Physician Decision|3|||
105802034|NCT03443869|364930706|FG001|Overall Study|Physician Decision|3|||
105802035|NCT03443869|364930705|FG000|Overall Study|Other|4|||
105802036|NCT03443869|364930706|FG001|Overall Study|Other|4|||
105802037|NCT00096486|364930707|FG000|Overall Study|Withdrawal by Subject|0|||
105802038|NCT00096486|364930708|FG001|Overall Study|Withdrawal by Subject|0|||
105802039|NCT00096486|364930709|FG002|Overall Study|Withdrawal by Subject|1|||
105802040|NCT00096486|364930710|FG003|Overall Study|Withdrawal by Subject|1|||
105802041|NCT00096486|364930707|FG000|Overall Study|Not Treated|0|||
105802042|NCT00096486|364930708|FG001|Overall Study|Not Treated|0|||
105802043|NCT00096486|364930709|FG002|Overall Study|Not Treated|1|||
105802044|NCT00096486|364930710|FG003|Overall Study|Not Treated|1|||
105802045|NCT01559818|364930711|FG000|Overall Study|Physician Decision|1|||
105947374|NCT02410772|365471169|FG001|Overall Study|Protocol Violation|8|||
105947375|NCT02410772|365471170|FG002|Overall Study|Protocol Violation|4|||
105947376|NCT02410772|365471168|FG000|Overall Study|Baseline Drug Resistance|49|||
105947377|NCT02410772|365471169|FG001|Overall Study|Baseline Drug Resistance|40|||
105947378|NCT02410772|365471170|FG002|Overall Study|Baseline Drug Resistance|51|||
105947379|NCT02410772|365471168|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
105947380|NCT02410772|365471169|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
105947381|NCT02410772|365471170|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
105947382|NCT02410772|365471168|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
105947383|NCT02410772|365471169|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
105947384|NCT02410772|365471170|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
105947385|NCT00949533|365471171|FG000|Overall Study|Lost to Follow-up|0|||
106016329|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016330|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016331|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016332|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016333|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016334|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
106016335|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
106016336|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
106016337|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
106016338|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
106016339|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
106016340|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
106016341|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
106016342|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
106016343|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
106016344|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105751239|NCT01096849|364740853|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
105751240|NCT01096849|364740854|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
105751241|NCT01096849|364740855|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
105751242|NCT01096849|364740853|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
105751243|NCT01096849|364740854|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
105751244|NCT01096849|364740855|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
105751245|NCT01096849|364740853|FG000|Overall Study|Administrative Reasons|0|||
105751246|NCT01096849|364740854|FG001|Overall Study|Administrative Reasons|1|||
105751247|NCT01096849|364740855|FG002|Overall Study|Administrative Reasons|2|||
105751248|NCT01096849|364740853|FG000|Overall Study|Lost to Follow-up|1|||
105751249|NCT01096849|364740854|FG001|Overall Study|Lost to Follow-up|3|||
105751250|NCT01096849|364740855|FG002|Overall Study|Lost to Follow-up|1|||
105751251|NCT04167306|364740856|FG000|Overall Study|Lost to Follow-up|2|||
105751252|NCT04167306|364740857|FG001|Overall Study|Lost to Follow-up|2|||
105751253|NCT04167306|364740858|FG002|Overall Study|Lost to Follow-up|5|||
105751254|NCT04167306|364740859|FG003|Overall Study|Lost to Follow-up|5|||
105751255|NCT04167306|364740856|FG000|Overall Study|Adverse Event|13|||
105751256|NCT04167306|364740857|FG001|Overall Study|Adverse Event|14|||
105751257|NCT04167306|364740858|FG002|Overall Study|Adverse Event|5|||
105751258|NCT04167306|364740859|FG003|Overall Study|Adverse Event|4|||
105751259|NCT04167306|364740856|FG000|Overall Study|Withdrawal by Subject|4|||
105751260|NCT04167306|364740857|FG001|Overall Study|Withdrawal by Subject|6|||
105751261|NCT04167306|364740858|FG002|Overall Study|Withdrawal by Subject|8|||
105751262|NCT04167306|364740859|FG003|Overall Study|Withdrawal by Subject|3|||
105751263|NCT04167306|364740856|FG000|Overall Study|covid|1|||
105751264|NCT04167306|364740857|FG001|Overall Study|covid|1|||
105751265|NCT04167306|364740858|FG002|Overall Study|covid|2|||
105751266|NCT04167306|364740859|FG003|Overall Study|covid|1|||
105802046|NCT01559818|364930711|FG000|Overall Study|Pregnancy|1|||
105802047|NCT01559818|364930711|FG000|Overall Study|Study terminated by Sponsor|4|||
105751267|NCT04167306|364740856|FG000|Overall Study|concomitant medication|0|||
105751268|NCT04167306|364740857|FG001|Overall Study|concomitant medication|0|||
105751269|NCT04167306|364740858|FG002|Overall Study|concomitant medication|0|||
105751270|NCT04167306|364740859|FG003|Overall Study|concomitant medication|1|||
105751271|NCT04167306|364740856|FG000|Overall Study|Alcohol treatment|0|||
105751272|NCT04167306|364740857|FG001|Overall Study|Alcohol treatment|4|||
105751273|NCT04167306|364740858|FG002|Overall Study|Alcohol treatment|3|||
105751274|NCT04167306|364740859|FG003|Overall Study|Alcohol treatment|2|||
105751275|NCT04167306|364740856|FG000|Overall Study|non-compliance|0|||
105751276|NCT04167306|364740857|FG001|Overall Study|non-compliance|0|||
105751277|NCT04167306|364740858|FG002|Overall Study|non-compliance|1|||
105751278|NCT04167306|364740859|FG003|Overall Study|non-compliance|0|||
105947386|NCT00949533|365471172|FG001|Overall Study|Lost to Follow-up|1|||
105947387|NCT01170663|365471177|FG000|Overall Study|Lost to Follow-up|3|||
105947388|NCT01170663|365471178|FG001|Overall Study|Lost to Follow-up|9|||
105947389|NCT01170663|365471177|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
105947390|NCT01170663|365471178|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
105947391|NCT00744861|365471184|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
105947392|NCT00744861|365471185|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
105947393|NCT00744861|365471186|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
105751279|NCT04167306|364740856|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
105947394|NCT00744861|365471187|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
105947395|NCT00744861|365471184|FG000|Feasibility Stage 1|Pregnancy|0|||
105947396|NCT00744861|365471185|FG001|Feasibility Stage 1|Pregnancy|1|||
105947397|NCT00744861|365471186|FG002|Feasibility Stage 1|Pregnancy|0|||
105751280|NCT04167306|364740857|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
105751281|NCT04167306|364740858|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
105751282|NCT04167306|364740859|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
105751283|NCT01232894|364740860|FG000|Overall Study|Lost to Follow-up|0|||
105751284|NCT01232894|364740861|FG001|Overall Study|Lost to Follow-up|1|||
105751285|NCT01232894|364740860|FG000|Overall Study|Death|1|||
105751286|NCT01232894|364740861|FG001|Overall Study|Death|0|||
105751287|NCT01232894|364740860|FG000|Overall Study|Protocol Violation|1|||
105751288|NCT01232894|364740861|FG001|Overall Study|Protocol Violation|1|||
105751289|NCT01232894|364740860|FG000|Overall Study|Withdrawal by Subject|8|||
105751290|NCT01232894|364740861|FG001|Overall Study|Withdrawal by Subject|5|||
105751291|NCT01232894|364740860|FG000|Overall Study|Physician Decision|2|||
105751292|NCT01232894|364740861|FG001|Overall Study|Physician Decision|1|||
105751293|NCT03970395|364740862|FG000|Overall Study|Withdrawal by Subject|3|||
105751294|NCT03970395|364740863|FG001|Overall Study|Withdrawal by Subject|4|||
105751295|NCT03970395|364740862|FG000|Overall Study|Lost to Follow-up|4|||
105751296|NCT03970395|364740863|FG001|Overall Study|Lost to Follow-up|8|||
105751297|NCT00403559|364740864|FG000|Overall Study|Adverse Event|0|||
105751298|NCT00403559|364740865|FG001|Overall Study|Adverse Event|1|||
105751299|NCT00403559|364740864|FG000|Overall Study|Lost to Follow-up|3|||
105751300|NCT00403559|364740865|FG001|Overall Study|Lost to Follow-up|3|||
105751301|NCT00403559|364740864|FG000|Overall Study|Withdrawal by Subject|1|||
105751302|NCT00403559|364740865|FG001|Overall Study|Withdrawal by Subject|0|||
105751303|NCT00929734|364740866|FG000|Overall Study|Lost to Follow-up|2|||
105751304|NCT00929734|364740867|FG001|Overall Study|Lost to Follow-up|1|||
105751305|NCT00929734|364740866|FG000|Overall Study|Withdrawal by Subject|0|||
105751306|NCT00929734|364740867|FG001|Overall Study|Withdrawal by Subject|2|||
105751307|NCT02921919|364740868|FG000|Overall Study|Other|5|||
105751308|NCT02921919|364740869|FG001|Overall Study|Other|6|||
105751309|NCT02921919|364740868|FG000|Overall Study|Lost to Follow-up|0|||
105751310|NCT02921919|364740869|FG001|Overall Study|Lost to Follow-up|1|||
105751311|NCT02921919|364740868|FG000|Overall Study|Withdrawal by Subject|5|||
105751312|NCT02921919|364740869|FG001|Overall Study|Withdrawal by Subject|1|||
105751313|NCT02921919|364740868|FG000|Overall Study|Disease Progression|47|||
105751314|NCT02921919|364740869|FG001|Overall Study|Disease Progression|38|||
105751315|NCT02921919|364740868|FG000|Overall Study|Physician Decision|3|||
105751316|NCT02921919|364740869|FG001|Overall Study|Physician Decision|2|||
105751317|NCT02921919|364740868|FG000|Overall Study|Adverse Event|6|||
105751318|NCT02921919|364740869|FG001|Overall Study|Adverse Event|4|||
105751319|NCT01449682|364740870|FG000|Overall Study|Death|0|||
105751320|NCT01449682|364740871|FG001|Overall Study|Death|1|||
105751321|NCT01449682|364740870|FG000|Overall Study|Adverse Event|1|||
105947398|NCT00744861|365471187|FG003|Feasibility Stage 1|Pregnancy|0|||
106016345|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
106016346|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
106142786|NCT01713946|366182004|FG000|Overall Study|Withdrawal by Subject|12|||
105751322|NCT01449682|364740871|FG001|Overall Study|Adverse Event|0|||
105751323|NCT03550131|364740873|FG000|Overall Study|Lost to Follow-up|16|||
105751324|NCT03550131|364740874|FG001|Overall Study|Lost to Follow-up|24|||
105751325|NCT03550131|364740873|FG000|Overall Study|Withdrawal by Subject|36|||
105751326|NCT03550131|364740874|FG001|Overall Study|Withdrawal by Subject|28|||
105751327|NCT03550131|364740873|FG000|Overall Study|Illness of dyad member|10|||
105751328|NCT03550131|364740874|FG001|Overall Study|Illness of dyad member|2|||
105751329|NCT03550131|364740873|FG000|Overall Study|Death of person with dementia|4|||
105751330|NCT03550131|364740874|FG001|Overall Study|Death of person with dementia|8|||
105751331|NCT02112994|364740875|FG000|Overall Study|Progressive Disease|0|||
105751332|NCT02112994|364740876|FG001|Overall Study|Progressive Disease|0|||
105751333|NCT02112994|364740877|FG002|Overall Study|Progressive Disease|1|||
105751334|NCT02112994|364740875|FG000|Overall Study|Pregnancy|0|||
105751335|NCT02112994|364740876|FG001|Overall Study|Pregnancy|1|||
105751336|NCT02112994|364740877|FG002|Overall Study|Pregnancy|1|||
105751337|NCT02112994|364740875|FG000|Overall Study|Liver Transplant|0|||
105751338|NCT02112994|364740876|FG001|Overall Study|Liver Transplant|1|||
105751339|NCT02112994|364740877|FG002|Overall Study|Liver Transplant|0|||
105751340|NCT02112994|364740875|FG000|Overall Study|Withdrawal by Subject|0|||
105947399|NCT00744861|365471184|FG000|Pivotal Stage 2|Adverse Event|0|||
105947400|NCT00744861|365471185|FG001|Pivotal Stage 2|Adverse Event|0|||
105947401|NCT00744861|365471186|FG002|Pivotal Stage 2|Adverse Event|6|||
105947402|NCT00744861|365471187|FG003|Pivotal Stage 2|Adverse Event|11|||
105947403|NCT00744861|365471184|FG000|Pivotal Stage 2|Death|0|||
105947404|NCT00744861|365471185|FG001|Pivotal Stage 2|Death|0|||
105947405|NCT00744861|365471186|FG002|Pivotal Stage 2|Death|0|||
105947406|NCT00744861|365471187|FG003|Pivotal Stage 2|Death|1|||
105947407|NCT00744861|365471184|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
105947408|NCT00744861|365471185|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
105947409|NCT00744861|365471186|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
105947410|NCT00744861|365471187|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
105947411|NCT00744861|365471184|FG000|Pivotal Stage 2|Physician Decision|0|||
105947412|NCT00744861|365471185|FG001|Pivotal Stage 2|Physician Decision|0|||
105947413|NCT00744861|365471186|FG002|Pivotal Stage 2|Physician Decision|3|||
105947414|NCT00744861|365471187|FG003|Pivotal Stage 2|Physician Decision|1|||
105947415|NCT00744861|365471184|FG000|Pivotal Stage 2|Protocol Violation|0|||
105947416|NCT00744861|365471185|FG001|Pivotal Stage 2|Protocol Violation|0|||
105947417|NCT00744861|365471186|FG002|Pivotal Stage 2|Protocol Violation|0|||
105947418|NCT00744861|365471187|FG003|Pivotal Stage 2|Protocol Violation|1|||
105947419|NCT00744861|365471184|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
105947420|NCT00744861|365471185|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
105947421|NCT00744861|365471186|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
105947422|NCT00744861|365471187|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
105947423|NCT00744861|365471184|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
105947424|NCT00744861|365471185|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
105947425|NCT00744861|365471186|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
105947426|NCT00744861|365471187|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
105947427|NCT03218917|365471188|FG000|Overall Study|Adverse Event|3|||
105947428|NCT03218917|365471189|FG001|Overall Study|Adverse Event|3|||
105947429|NCT03218917|365471190|FG002|Overall Study|Adverse Event|2|||
106016347|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105751341|NCT02112994|364740876|FG001|Overall Study|Withdrawal by Subject|0|||
105751342|NCT02112994|364740877|FG002|Overall Study|Withdrawal by Subject|1|||
105751343|NCT00414960|364740878|FG000|Overall Study|Adverse Event|4|||
105751344|NCT00414960|364740879|FG001|Overall Study|Adverse Event|0|||
105751345|NCT00414960|364740878|FG000|Overall Study|Withdrawal by Subject|3|||
105751346|NCT00414960|364740879|FG001|Overall Study|Withdrawal by Subject|0|||
105751347|NCT00414960|364740878|FG000|Overall Study|Physician Decision|0|||
105751348|NCT00414960|364740879|FG001|Overall Study|Physician Decision|1|||
105751349|NCT04633473|364740880|FG000|Overall Study|Withdrawal by Subject|6|||
105751350|NCT04387136|364740882|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
105751351|NCT04387136|364740883|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
105751352|NCT03294681|364740886|FG000|Overall Study|Withdrawal by Subject|1|||
105751353|NCT03089216|364740887|FG000|Overall Study|Adverse Event|0|||
105751354|NCT03089216|364740888|FG001|Overall Study|Adverse Event|0|||
105751355|NCT03089216|364740889|FG002|Overall Study|Adverse Event|0|||
105751356|NCT03089216|364740890|FG003|Overall Study|Adverse Event|1|||
105751357|NCT01348425|364740893|FG000|Overall Study|Imaging was not taken.|1|||
105751358|NCT01348425|364740894|FG001|Overall Study|Imaging was not taken.|1|||
105751359|NCT02720016|364740895|FG000|Overall Study|Separation of couple|6|||
105751360|NCT02720016|364740896|FG001|Overall Study|Separation of couple|8|||
105751361|NCT02720016|364740897|FG002|Overall Study|Separation of couple|2|||
105751362|NCT02720016|364740895|FG000|Overall Study|Withdrawal by Subject|6|||
105751363|NCT02720016|364740896|FG001|Overall Study|Withdrawal by Subject|6|||
105947430|NCT03218917|365471188|FG000|Overall Study|Subject withdrew consent|2|||
105947431|NCT03218917|365471189|FG001|Overall Study|Subject withdrew consent|4|||
105947432|NCT03218917|365471190|FG002|Overall Study|Subject withdrew consent|10|||
105947433|NCT03218917|365471188|FG000|Overall Study|Physician Decision|0|||
105947434|NCT03218917|365471189|FG001|Overall Study|Physician Decision|1|||
106016348|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
105751364|NCT02720016|364740897|FG002|Overall Study|Withdrawal by Subject|4|||
105751365|NCT02720016|364740895|FG000|Overall Study|Scheduling issues|2|||
105751366|NCT02720016|364740896|FG001|Overall Study|Scheduling issues|4|||
105751367|NCT02720016|364740897|FG002|Overall Study|Scheduling issues|7|||
105751368|NCT02720016|364740895|FG000|Overall Study|Childcare|2|||
105751369|NCT02720016|364740896|FG001|Overall Study|Childcare|0|||
105751370|NCT02720016|364740897|FG002|Overall Study|Childcare|2|||
105947435|NCT03218917|365471190|FG002|Overall Study|Physician Decision|1|||
105947436|NCT03218917|365471188|FG000|Overall Study|Lost to Follow-up|1|||
105947437|NCT03218917|365471189|FG001|Overall Study|Lost to Follow-up|0|||
105947438|NCT03218917|365471190|FG002|Overall Study|Lost to Follow-up|0|||
105751371|NCT02720016|364740895|FG000|Overall Study|Withdrawal by PI|2|||
105751372|NCT02720016|364740896|FG001|Overall Study|Withdrawal by PI|2|||
105751373|NCT02720016|364740897|FG002|Overall Study|Withdrawal by PI|0|||
105751374|NCT02720016|364740895|FG000|Overall Study|Moved away|2|||
105751375|NCT02720016|364740896|FG001|Overall Study|Moved away|0|||
105751376|NCT02720016|364740897|FG002|Overall Study|Moved away|0|||
105751377|NCT02720016|364740895|FG000|Overall Study|Not Primary Health Concern|0|||
105751378|NCT02720016|364740896|FG001|Overall Study|Not Primary Health Concern|0|||
105751379|NCT02720016|364740897|FG002|Overall Study|Not Primary Health Concern|2|||
105751380|NCT02720016|364740895|FG000|Overall Study|Transportation issues|0|||
105751381|NCT02720016|364740896|FG001|Overall Study|Transportation issues|0|||
105751382|NCT02720016|364740897|FG002|Overall Study|Transportation issues|1|||
105751383|NCT02720016|364740895|FG000|Overall Study|Other|0|||
105751384|NCT02720016|364740896|FG001|Overall Study|Other|0|||
105751385|NCT02720016|364740897|FG002|Overall Study|Other|2|||
105751386|NCT04501679|364740900|FG000|Overall Study|Pregnancy|0|||
105751387|NCT04501679|364740901|FG001|Overall Study|Pregnancy|1|||
105751388|NCT04501679|364740900|FG000|Overall Study|Adverse Event|4|||
105751389|NCT04501679|364740901|FG001|Overall Study|Adverse Event|2|||
105751390|NCT04501679|364740900|FG000|Overall Study|Withdrawal by Subject|2|||
105751391|NCT04501679|364740901|FG001|Overall Study|Withdrawal by Subject|0|||
105751392|NCT04501679|364740900|FG000|Overall Study|Physician Decision|1|||
105751393|NCT04501679|364740901|FG001|Overall Study|Physician Decision|0|||
105751394|NCT04501679|364740900|FG000|Overall Study|Lost to Follow-up|2|||
105751395|NCT04501679|364740901|FG001|Overall Study|Lost to Follow-up|0|||
105751396|NCT00205699|364742418|FG000|Overall Study|Lost to Follow-up|1|||
105751397|NCT00205699|364742419|FG001|Overall Study|Lost to Follow-up|3|||
105751398|NCT00205699|364742420|FG002|Overall Study|Lost to Follow-up|5|||
105751399|NCT00205699|364742418|FG000|Overall Study|Adverse Event|1|||
105751400|NCT00205699|364742419|FG001|Overall Study|Adverse Event|0|||
105751401|NCT00205699|364742420|FG002|Overall Study|Adverse Event|0|||
105751402|NCT00205699|364742418|FG000|Overall Study|Withdrawal by Subject|1|||
105751403|NCT00205699|364742419|FG001|Overall Study|Withdrawal by Subject|2|||
105751404|NCT00205699|364742420|FG002|Overall Study|Withdrawal by Subject|1|||
105751405|NCT00205699|364742418|FG000|Overall Study|Lack of Efficacy|0|||
105751406|NCT00205699|364742419|FG001|Overall Study|Lack of Efficacy|1|||
105751407|NCT00205699|364742420|FG002|Overall Study|Lack of Efficacy|0|||
105751408|NCT01114373|364742421|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
105751409|NCT01114373|364742422|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
105751410|NCT01114373|364742421|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
105751411|NCT01114373|364742422|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
105751412|NCT01114373|364742421|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
105751413|NCT01114373|364742422|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
105751414|NCT01114373|364742421|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
105751415|NCT01114373|364742422|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
105751416|NCT01170702|364742430|FG000|Overall Study|Exclusion criteria met after consent|1|||
105751417|NCT01170702|364742431|FG001|Overall Study|Exclusion criteria met after consent|2|||
105751418|NCT01170702|364742432|FG002|Overall Study|Exclusion criteria met after consent|0|||
105751419|NCT01170702|364742433|FG003|Overall Study|Exclusion criteria met after consent|2|||
105751420|NCT00229203|364742434|FG000|Overall Study|Progressive disease|18|||
105751421|NCT00229203|364742435|FG001|Overall Study|Progressive disease|9|||
105751422|NCT00229203|364742434|FG000|Overall Study|Toxicity|6|||
105751423|NCT00229203|364742435|FG001|Overall Study|Toxicity|1|||
105751424|NCT00229203|364742434|FG000|Overall Study|Death|4|||
105802048|NCT01559818|364930711|FG000|Overall Study|Withdrawal by Subject|1|||
105802049|NCT03705169|364930713|FG000|Overall Study|Lost to Follow-up|0|||
105802050|NCT03705169|364930714|FG001|Overall Study|Lost to Follow-up|0|||
105802051|NCT03705169|364930715|FG002|Overall Study|Lost to Follow-up|0|||
105751425|NCT00229203|364742435|FG001|Overall Study|Death|2|||
105751426|NCT00229203|364742434|FG000|Overall Study|Other|3|||
105751427|NCT00229203|364742435|FG001|Overall Study|Other|3|||
105751428|NCT00229203|364742434|FG000|Overall Study|Withdrawal by Subject|1|||
105802052|NCT03705169|364930716|FG003|Overall Study|Lost to Follow-up|2|||
105802053|NCT03705169|364930717|FG004|Overall Study|Lost to Follow-up|0|||
105802054|NCT03705169|364930718|FG005|Overall Study|Lost to Follow-up|2|||
105802055|NCT03705169|364930719|FG006|Overall Study|Lost to Follow-up|1|||
105802056|NCT03705169|364930720|FG007|Overall Study|Lost to Follow-up|0|||
106016349|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106142787|NCT01713946|366182005|FG001|Overall Study|Withdrawal by Subject|12|||
105751429|NCT00229203|364742435|FG001|Overall Study|Withdrawal by Subject|4|||
105751430|NCT04321252|364742436|FG000|Overall Study|Withdrawal by Subject|0|||
105751431|NCT04321252|364742437|FG001|Overall Study|Withdrawal by Subject|0|||
105751432|NCT04321252|364742438|FG002|Overall Study|Withdrawal by Subject|0|||
105751433|NCT04321252|364742439|FG003|Overall Study|Withdrawal by Subject|0|||
105751434|NCT04321252|364742440|FG004|Overall Study|Withdrawal by Subject|0|||
105751435|NCT04321252|364742441|FG005|Overall Study|Withdrawal by Subject|1|||
105802057|NCT03705169|364930721|FG008|Overall Study|Lost to Follow-up|0|||
105751436|NCT04321252|364742442|FG006|Overall Study|Withdrawal by Subject|0|||
105802058|NCT03705169|364930722|FG009|Overall Study|Lost to Follow-up|1|||
106142788|NCT01713946|366182006|FG002|Overall Study|Withdrawal by Subject|8|||
105751437|NCT04321252|364742443|FG007|Overall Study|Withdrawal by Subject|0|||
105751438|NCT04321252|364742444|FG008|Overall Study|Withdrawal by Subject|0|||
105802059|NCT03705169|364930713|FG000|Overall Study|Adverse Event|0|||
105947439|NCT03218917|365471188|FG000|Overall Study|Reason Missing|0|||
105947440|NCT03218917|365471189|FG001|Overall Study|Reason Missing|2|||
105947441|NCT03218917|365471190|FG002|Overall Study|Reason Missing|0|||
105947442|NCT03218917|365471188|FG000|Overall Study|Death|0|||
105947443|NCT03218917|365471189|FG001|Overall Study|Death|1|||
105947444|NCT03218917|365471190|FG002|Overall Study|Death|0|||
105947445|NCT03218917|365471188|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105947446|NCT03218917|365471189|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105947447|NCT03218917|365471190|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105947448|NCT01307449|365471191|FG000|Overall Study|Adverse Event|1|||
105947449|NCT01307449|365471192|FG001|Overall Study|Adverse Event|0|||
105947450|NCT01307449|365471193|FG002|Overall Study|Adverse Event|0|||
105947451|NCT01307449|365471194|FG003|Overall Study|Adverse Event|0|||
105947452|NCT01463527|365471197|FG000|Overall Study|Protocol Violation|1|||
105947453|NCT01463527|365471198|FG001|Overall Study|Protocol Violation|1|||
105947454|NCT01463527|365471197|FG000|Overall Study|Crying >20% of sedation|5|||
105947455|NCT01463527|365471198|FG001|Overall Study|Crying >20% of sedation|6|||
105947456|NCT01977222|365471199|FG000|Overall Study|Withdrawal by Subject|1|||
105947457|NCT01531998|365471200|FG000|Overall Study|Withdrawal by Subject|3|||
105947458|NCT01076010|365471201|FG000|Overall Study|Death|15|||
105947459|NCT01076010|365471202|FG001|Overall Study|Death|1|||
105947460|NCT01076010|365471203|FG002|Overall Study|Death|0|||
105947461|NCT01076010|365471201|FG000|Overall Study|Adverse Event|7|||
105947462|NCT01076010|365471202|FG001|Overall Study|Adverse Event|2|||
105947463|NCT01076010|365471203|FG002|Overall Study|Adverse Event|0|||
105947464|NCT01076010|365471201|FG000|Overall Study|Progressive disease|90|||
105947465|NCT01076010|365471202|FG001|Overall Study|Progressive disease|30|||
105947466|NCT01076010|365471203|FG002|Overall Study|Progressive disease|1|||
105947467|NCT01076010|365471201|FG000|Overall Study|Lack of Efficacy|4|||
105947468|NCT01076010|365471202|FG001|Overall Study|Lack of Efficacy|0|||
105947469|NCT01076010|365471203|FG002|Overall Study|Lack of Efficacy|0|||
105947470|NCT01076010|365471201|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
105947471|NCT01076010|365471202|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
105947472|NCT01076010|365471203|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
105947473|NCT01076010|365471201|FG000|Overall Study|Significant Surgical Procedure|0|||
105947474|NCT01076010|365471202|FG001|Overall Study|Significant Surgical Procedure|1|||
105947475|NCT01076010|365471203|FG002|Overall Study|Significant Surgical Procedure|0|||
105947476|NCT01076010|365471201|FG000|Overall Study|Protocol Violation|0|||
105947477|NCT01076010|365471202|FG001|Overall Study|Protocol Violation|1|||
105947478|NCT01076010|365471203|FG002|Overall Study|Protocol Violation|0|||
105947479|NCT01076010|365471201|FG000|Overall Study|Noncompliance|1|||
105947480|NCT01076010|365471202|FG001|Overall Study|Noncompliance|1|||
105947481|NCT01076010|365471203|FG002|Overall Study|Noncompliance|0|||
105947482|NCT01076010|365471201|FG000|Overall Study|Withdrawal by Subject|3|||
105947483|NCT01076010|365471202|FG001|Overall Study|Withdrawal by Subject|0|||
105947484|NCT01076010|365471203|FG002|Overall Study|Withdrawal by Subject|1|||
105947485|NCT01076010|365471201|FG000|Overall Study|Other|5|||
105947486|NCT01076010|365471202|FG001|Overall Study|Other|2|||
105947487|NCT01076010|365471203|FG002|Overall Study|Other|0|||
105947488|NCT01156844|365471206|FG000|Overall Study|Adverse Event|0|||
105947489|NCT01156844|365471207|FG001|Overall Study|Adverse Event|0|||
105947490|NCT01156844|365471208|FG002|Overall Study|Adverse Event|1|||
105947491|NCT01156844|365471209|FG003|Overall Study|Adverse Event|1|||
105947492|NCT01156844|365471206|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105947493|NCT01156844|365471207|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105947494|NCT01156844|365471208|FG002|Overall Study|Abnormal test procedure result(s)|2|||
105947495|NCT01156844|365471209|FG003|Overall Study|Abnormal test procedure result(s)|2|||
105947496|NCT01156844|365471206|FG000|Overall Study|Withdrawal by Subject|0|||
105947497|NCT01156844|365471207|FG001|Overall Study|Withdrawal by Subject|0|||
105947498|NCT01156844|365471208|FG002|Overall Study|Withdrawal by Subject|2|||
105751439|NCT00579501|364742445|FG000|Overall Study|Death|1|||
105751440|NCT00579501|364742445|FG000|Overall Study|End of neoadjuvant therapy|25|||
105751441|NCT00579501|364742445|FG000|Overall Study|toxicity|1|||
105751442|NCT00579501|364742445|FG000|Overall Study|Secondary lesion|1|||
105751443|NCT00579501|364742445|FG000|Overall Study|Radiation therapy before surgery|1|||
105751444|NCT01089582|364742446|FG000|Overall Study|Death|2|||
105751445|NCT01089582|364742446|FG000|Overall Study|Adverse Event|15|||
105751446|NCT01089582|364742446|FG000|Overall Study|Lost to Follow-up|8|||
105751447|NCT01089582|364742446|FG000|Overall Study|Other|4|||
105751448|NCT01089582|364742446|FG000|Overall Study|Withdrawal by Subject|1|||
105751449|NCT01199055|364742451|FG000|Overall Study|Death|0|||
105751450|NCT01199055|364742452|FG001|Overall Study|Death|1|||
105751451|NCT01199055|364742453|FG002|Overall Study|Death|0|||
105751452|NCT01199055|364742451|FG000|Overall Study|Physician Decision|0|||
105751453|NCT01199055|364742452|FG001|Overall Study|Physician Decision|1|||
105751454|NCT01199055|364742453|FG002|Overall Study|Physician Decision|1|||
105947499|NCT01156844|365471209|FG003|Overall Study|Withdrawal by Subject|2|||
105947500|NCT01156844|365471206|FG000|Overall Study|Lost to Follow-up|0|||
105947501|NCT01156844|365471207|FG001|Overall Study|Lost to Follow-up|0|||
105947502|NCT01156844|365471208|FG002|Overall Study|Lost to Follow-up|1|||
105947503|NCT01156844|365471209|FG003|Overall Study|Lost to Follow-up|0|||
105947504|NCT01156844|365471206|FG000|Overall Study|Administrative problems|0|||
105947505|NCT01156844|365471207|FG001|Overall Study|Administrative problems|1|||
105947506|NCT01156844|365471208|FG002|Overall Study|Administrative problems|0|||
105947507|NCT01156844|365471209|FG003|Overall Study|Administrative problems|1|||
105947508|NCT01156844|365471206|FG000|Overall Study|Protocol deviation|2|||
105947509|NCT01156844|365471207|FG001|Overall Study|Protocol deviation|0|||
105947510|NCT01156844|365471208|FG002|Overall Study|Protocol deviation|0|||
105947511|NCT01156844|365471209|FG003|Overall Study|Protocol deviation|0|||
105947512|NCT00565409|365471210|FG000|Period 1 Open Label|Adverse Event|17|||
105947513|NCT00565409|365471211|FG001|Period 1 Open Label|Adverse Event|0|||
105751455|NCT01199055|364742451|FG000|Overall Study|Progressive disease|2|||
105751456|NCT01199055|364742452|FG001|Overall Study|Progressive disease|1|||
105751457|NCT01199055|364742453|FG002|Overall Study|Progressive disease|2|||
105751458|NCT01199055|364742451|FG000|Overall Study|Withdrawal by Subject|0|||
105751459|NCT01199055|364742452|FG001|Overall Study|Withdrawal by Subject|0|||
105947514|NCT00565409|365471212|FG002|Period 1 Open Label|Adverse Event|0|||
105947515|NCT00565409|365471213|FG003|Period 1 Open Label|Adverse Event|0|||
105947516|NCT00565409|365471210|FG000|Period 1 Open Label|Death|2|||
105947517|NCT00565409|365471211|FG001|Period 1 Open Label|Death|0|||
105947518|NCT00565409|365471212|FG002|Period 1 Open Label|Death|0|||
105947519|NCT00565409|365471213|FG003|Period 1 Open Label|Death|0|||
105947520|NCT00565409|365471210|FG000|Period 1 Open Label|Lost to Follow-up|1|||
105760894|NCT01831804|364778044|FG008|Overall Study|Withdrew Consent|0|||
105751460|NCT01199055|364742453|FG002|Overall Study|Withdrawal by Subject|1|||
105751461|NCT03341923|364742454|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
105751462|NCT03341923|364742455|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
105751463|NCT00084929|364742456|FG000|Overall Study|ineligible - medical contraindication|1|||
105751464|NCT00084929|364742456|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
105751465|NCT00084929|364742456|FG000|Overall Study|Ineligible - Medical history|6|||
105751466|NCT00084929|364742456|FG000|Overall Study|Withdrawal by Subject|10|||
105751467|NCT00084929|364742456|FG000|Overall Study|Missing/incomplete CTC exam|9|||
105751468|NCT00084929|364742456|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
105751469|NCT00844649|364742457|FG000|Overall Study|Progressive Disease|196|||
105751470|NCT00844649|364742458|FG001|Overall Study|Progressive Disease|245|||
105751471|NCT00844649|364742457|FG000|Overall Study|Adverse Event|128|||
105751472|NCT00844649|364742458|FG001|Overall Study|Adverse Event|73|||
105751473|NCT00844649|364742457|FG000|Overall Study|Physician Decision|25|||
105751474|NCT00844649|364742458|FG001|Overall Study|Physician Decision|18|||
105751475|NCT00844649|364742457|FG000|Overall Study|Protocol Violation|10|||
105751476|NCT00844649|364742458|FG001|Overall Study|Protocol Violation|6|||
105751477|NCT00844649|364742457|FG000|Overall Study|Withdrawal by Subject|28|||
105751478|NCT00844649|364742458|FG001|Overall Study|Withdrawal by Subject|39|||
105751479|NCT00844649|364742457|FG000|Overall Study|Other|7|||
105751480|NCT00844649|364742458|FG001|Overall Study|Other|10|||
105751481|NCT00844649|364742457|FG000|Overall Study|Withdrew prior to starting treatment|11|||
105751482|NCT00844649|364742458|FG001|Overall Study|Withdrew prior to starting treatment|27|||
105751483|NCT03337152|364742460|FG000|Overall Study|Physician Decision|1|||
105751484|NCT03337152|364742461|FG001|Overall Study|Physician Decision|0|||
105751485|NCT03337152|364742460|FG000|Overall Study|Lost to Follow-up|1|||
105751486|NCT03337152|364742461|FG001|Overall Study|Lost to Follow-up|3|||
105751487|NCT03337152|364742460|FG000|Overall Study|Adverse Event|3|||
105751488|NCT03337152|364742461|FG001|Overall Study|Adverse Event|1|||
105751489|NCT03337152|364742460|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
105751490|NCT03337152|364742461|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
105751491|NCT04397718|364742462|FG000|Overall Study|Death|7|||
105751492|NCT04397718|364742463|FG001|Overall Study|Death|11|||
105751493|NCT04397718|364742462|FG000|Overall Study|Lost to Follow-up|0|||
105751494|NCT04397718|364742463|FG001|Overall Study|Lost to Follow-up|4|||
105751495|NCT00077610|364742464|FG000|Overall Study|Adverse Event|9|||
105751496|NCT00077610|364742465|FG001|Overall Study|Adverse Event|7|||
105751497|NCT00077610|364742466|FG002|Overall Study|Adverse Event|1|||
105751498|NCT00077610|364742464|FG000|Overall Study|Lost to Follow-up|0|||
105751499|NCT00077610|364742465|FG001|Overall Study|Lost to Follow-up|1|||
105751500|NCT00077610|364742466|FG002|Overall Study|Lost to Follow-up|2|||
105751501|NCT00077610|364742464|FG000|Overall Study|Withdrawal by Subject|4|||
105751502|NCT00077610|364742465|FG001|Overall Study|Withdrawal by Subject|10|||
105751503|NCT00077610|364742466|FG002|Overall Study|Withdrawal by Subject|6|||
105751504|NCT00077610|364742464|FG000|Overall Study|Death|17|||
105751505|NCT00077610|364742465|FG001|Overall Study|Death|13|||
105751506|NCT00077610|364742466|FG002|Overall Study|Death|13|||
105751507|NCT00077610|364742464|FG000|Overall Study|Renal transplant|12|||
105751508|NCT00077610|364742465|FG001|Overall Study|Renal transplant|15|||
105751509|NCT00077610|364742466|FG002|Overall Study|Renal transplant|11|||
105751510|NCT00077610|364742464|FG000|Overall Study|Withdrew from dialysis care|5|||
105751511|NCT00077610|364742465|FG001|Overall Study|Withdrew from dialysis care|0|||
105751512|NCT00077610|364742466|FG002|Overall Study|Withdrew from dialysis care|3|||
105751513|NCT00077610|364742464|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105751514|NCT00077610|364742465|FG001|Overall Study|Insufficient Therapeutic Response|0|||
105751515|NCT00077610|364742466|FG002|Overall Study|Insufficient Therapeutic Response|0|||
105751516|NCT00077610|364742464|FG000|Overall Study|Multiple blood transfusions|0|||
105751517|NCT00077610|364742465|FG001|Overall Study|Multiple blood transfusions|0|||
105751518|NCT00077610|364742466|FG002|Overall Study|Multiple blood transfusions|1|||
105751519|NCT00077610|364742464|FG000|Overall Study|Principal Investigator's decision|1|||
105751520|NCT00077610|364742465|FG001|Overall Study|Principal Investigator's decision|0|||
105751521|NCT00077610|364742466|FG002|Overall Study|Principal Investigator's decision|1|||
105751522|NCT00077610|364742464|FG000|Overall Study|Worsening of health condition|1|||
105751523|NCT00077610|364742465|FG001|Overall Study|Worsening of health condition|1|||
105751524|NCT00077610|364742466|FG002|Overall Study|Worsening of health condition|0|||
105751525|NCT00077610|364742464|FG000|Overall Study|Given Epogen in hospital|1|||
105751526|NCT00077610|364742465|FG001|Overall Study|Given Epogen in hospital|0|||
105751527|NCT00077610|364742466|FG002|Overall Study|Given Epogen in hospital|0|||
105751528|NCT00077610|364742464|FG000|Overall Study|Transferred to other unit|0|||
105751529|NCT00077610|364742465|FG001|Overall Study|Transferred to other unit|0|||
105751530|NCT00077610|364742466|FG002|Overall Study|Transferred to other unit|1|||
105751531|NCT00077610|364742464|FG000|Overall Study|Transferred to nursing home|0|||
105751532|NCT00077610|364742465|FG001|Overall Study|Transferred to nursing home|0|||
105751533|NCT00077610|364742466|FG002|Overall Study|Transferred to nursing home|1|||
105751534|NCT00077610|364742464|FG000|Overall Study|Transfer to satellite unit|1|||
105751535|NCT00077610|364742465|FG001|Overall Study|Transfer to satellite unit|0|||
105751536|NCT00077610|364742466|FG002|Overall Study|Transfer to satellite unit|0|||
105751537|NCT00077610|364742464|FG000|Overall Study|Transfer to other center for surgery|1|||
105751538|NCT00077610|364742465|FG001|Overall Study|Transfer to other center for surgery|0|||
105751539|NCT00077610|364742466|FG002|Overall Study|Transfer to other center for surgery|0|||
105947521|NCT00565409|365471211|FG001|Period 1 Open Label|Lost to Follow-up|0|||
105947522|NCT00565409|365471212|FG002|Period 1 Open Label|Lost to Follow-up|0|||
105947523|NCT00565409|365471213|FG003|Period 1 Open Label|Lost to Follow-up|0|||
105947524|NCT00565409|365471210|FG000|Period 1 Open Label|Other|21|||
105947525|NCT00565409|365471211|FG001|Period 1 Open Label|Other|0|||
105947526|NCT00565409|365471212|FG002|Period 1 Open Label|Other|0|||
105947527|NCT00565409|365471213|FG003|Period 1 Open Label|Other|0|||
105947528|NCT00565409|365471210|FG000|Period 1 Open Label|Protocol Violation|14|||
105947529|NCT00565409|365471211|FG001|Period 1 Open Label|Protocol Violation|0|||
105947530|NCT00565409|365471212|FG002|Period 1 Open Label|Protocol Violation|0|||
105751540|NCT00077610|364742464|FG000|Overall Study|Change in dialysis modality|1|||
105751541|NCT00077610|364742465|FG001|Overall Study|Change in dialysis modality|0|||
105751542|NCT00077610|364742466|FG002|Overall Study|Change in dialysis modality|0|||
105751543|NCT00077610|364742464|FG000|Overall Study|Relocation|0|||
105751544|NCT00077610|364742465|FG001|Overall Study|Relocation|8|||
105751545|NCT00077610|364742466|FG002|Overall Study|Relocation|5|||
105751546|NCT00077610|364742464|FG000|Overall Study|Financial issues|0|||
105751547|NCT00077610|364742465|FG001|Overall Study|Financial issues|1|||
105947531|NCT00565409|365471213|FG003|Period 1 Open Label|Protocol Violation|0|||
105947532|NCT00565409|365471210|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
105947533|NCT00565409|365471211|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
105947534|NCT00565409|365471212|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
105947535|NCT00565409|365471213|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
105947536|NCT00565409|365471210|FG000|Period 1 Open Label|no conclusion of participation record|1|||
105947537|NCT00565409|365471211|FG001|Period 1 Open Label|no conclusion of participation record|0|||
105947538|NCT00565409|365471212|FG002|Period 1 Open Label|no conclusion of participation record|0|||
105947539|NCT00565409|365471213|FG003|Period 1 Open Label|no conclusion of participation record|0|||
105947540|NCT00565409|365471210|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
105947541|NCT00565409|365471211|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
105947542|NCT00565409|365471212|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
105947543|NCT00565409|365471213|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
105947544|NCT00565409|365471210|FG000|Period 2 Double-Blind|Adverse Event|0|||
105947545|NCT00565409|365471211|FG001|Period 2 Double-Blind|Adverse Event|7|||
105947546|NCT00565409|365471212|FG002|Period 2 Double-Blind|Adverse Event|4|||
105947547|NCT00565409|365471213|FG003|Period 2 Double-Blind|Adverse Event|5|||
105947548|NCT00565409|365471210|FG000|Period 2 Double-Blind|Death|0|||
105947549|NCT00565409|365471211|FG001|Period 2 Double-Blind|Death|2|||
105947550|NCT00565409|365471212|FG002|Period 2 Double-Blind|Death|0|||
105947551|NCT00565409|365471213|FG003|Period 2 Double-Blind|Death|0|||
105947552|NCT00565409|365471210|FG000|Period 2 Double-Blind|Protocol Violation|0|||
105947553|NCT00565409|365471211|FG001|Period 2 Double-Blind|Protocol Violation|4|||
105947554|NCT00565409|365471212|FG002|Period 2 Double-Blind|Protocol Violation|6|||
105947555|NCT00565409|365471213|FG003|Period 2 Double-Blind|Protocol Violation|2|||
105947556|NCT00565409|365471210|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
105947557|NCT00565409|365471211|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
105947558|NCT00565409|365471212|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
105947559|NCT00565409|365471213|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
105947560|NCT00565409|365471210|FG000|Period 2 Double-Blind|Other|0|||
105947561|NCT00565409|365471211|FG001|Period 2 Double-Blind|Other|4|||
105947562|NCT00565409|365471212|FG002|Period 2 Double-Blind|Other|5|||
105751548|NCT00077610|364742466|FG002|Overall Study|Financial issues|0|||
105751549|NCT00077610|364742464|FG000|Overall Study|Sponsors decision to withdraw|0|||
105751550|NCT00077610|364742465|FG001|Overall Study|Sponsors decision to withdraw|0|||
105751551|NCT00077610|364742466|FG002|Overall Study|Sponsors decision to withdraw|1|||
105751552|NCT02493426|364742481|FG000|Overall Study|Withdrawal by Subject|0|||
105751553|NCT02493426|364742482|FG001|Overall Study|Withdrawal by Subject|1|||
105751554|NCT01069523|364742483|FG000|Overall Study|Withdrawal by Subject|4|||
105751555|NCT01069523|364742484|FG001|Overall Study|Withdrawal by Subject|7|||
105751556|NCT01875367|364742486|FG000|Overall Study|Not complete at least 2 questionaries|4|||
105751557|NCT01875367|364742487|FG001|Overall Study|Not complete at least 2 questionaries|2|||
105947563|NCT00565409|365471213|FG003|Period 2 Double-Blind|Other|9|||
105947564|NCT00565409|365471210|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
105947565|NCT00565409|365471211|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
105947566|NCT00565409|365471212|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
105947567|NCT00565409|365471213|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
106142789|NCT01713946|366182004|FG000|Overall Study|Lack of Efficacy|8|||
106142790|NCT01713946|366182005|FG001|Overall Study|Lack of Efficacy|8|||
105751558|NCT01875367|364742486|FG000|Overall Study|Not receive study treatment|1|||
105751559|NCT01875367|364742487|FG001|Overall Study|Not receive study treatment|0|||
106142791|NCT01713946|366182006|FG002|Overall Study|Lack of Efficacy|14|||
105751560|NCT01479374|364742491|FG000|Overall Study|Adverse Event|2|||
105751561|NCT01479374|364742492|FG001|Overall Study|Adverse Event|1|||
105751562|NCT01479374|364742493|FG002|Overall Study|Adverse Event|0|||
105751563|NCT01479374|364742491|FG000|Overall Study|Lost to Follow-up|1|||
105751564|NCT01479374|364742492|FG001|Overall Study|Lost to Follow-up|2|||
105751565|NCT01479374|364742493|FG002|Overall Study|Lost to Follow-up|0|||
105751566|NCT01479374|364742491|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
105751567|NCT01479374|364742492|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
105751568|NCT01479374|364742493|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
105751569|NCT01479374|364742491|FG000|Overall Study|Other|0|||
105751570|NCT01479374|364742492|FG001|Overall Study|Other|4|||
105751571|NCT01479374|364742493|FG002|Overall Study|Other|5|||
105751572|NCT04533815|364742494|FG000|Overall Study|Adverse Event|2|||
105751573|NCT04533815|364742494|FG000|Overall Study|Site withdrew|5|||
105751574|NCT01551758|364742495|FG000|Overall Study|Adverse Event|29|||
105751575|NCT01551758|364742496|FG001|Overall Study|Adverse Event|43|||
105751576|NCT01551758|364742495|FG000|Overall Study|Lack of Efficacy|0|||
105751577|NCT01551758|364742496|FG001|Overall Study|Lack of Efficacy|1|||
105751578|NCT01551758|364742495|FG000|Overall Study|Protocol Violation|5|||
105751579|NCT01551758|364742496|FG001|Overall Study|Protocol Violation|6|||
105751580|NCT01551758|364742495|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
105751581|NCT01551758|364742496|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
105751582|NCT01551758|364742495|FG000|Overall Study|Lost to Follow-up|29|||
105751583|NCT01551758|364742496|FG001|Overall Study|Lost to Follow-up|25|||
105751584|NCT01551758|364742495|FG000|Overall Study|Physician Decision|9|||
105751585|NCT01551758|364742496|FG001|Overall Study|Physician Decision|3|||
105751586|NCT01551758|364742495|FG000|Overall Study|Withdrawal by Subject|14|||
105751587|NCT01551758|364742496|FG001|Overall Study|Withdrawal by Subject|17|||
105751588|NCT03670641|364742497|FG000|Overall Study|Lost to Follow-up|3|||
105751589|NCT00242580|364742500|FG000|Overall Study|Adverse Event|3|||
105751590|NCT00242580|364742501|FG001|Overall Study|Adverse Event|0|||
105751591|NCT00242580|364742502|FG002|Overall Study|Adverse Event|2|||
105751592|NCT00242580|364742500|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105751593|NCT00242580|364742501|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
105751594|NCT00242580|364742502|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
105751595|NCT00242580|364742500|FG000|Overall Study|Protocol Violation|0|||
105751596|NCT00242580|364742501|FG001|Overall Study|Protocol Violation|0|||
105751597|NCT00242580|364742502|FG002|Overall Study|Protocol Violation|1|||
105751598|NCT00242580|364742500|FG000|Overall Study|Subject withdrew consent|2|||
105751599|NCT00242580|364742501|FG001|Overall Study|Subject withdrew consent|2|||
105751600|NCT00242580|364742502|FG002|Overall Study|Subject withdrew consent|5|||
105751601|NCT00242580|364742500|FG000|Overall Study|Lost to Follow-up|0|||
105751602|NCT00242580|364742501|FG001|Overall Study|Lost to Follow-up|3|||
105751603|NCT00242580|364742502|FG002|Overall Study|Lost to Follow-up|0|||
105751604|NCT00242580|364742500|FG000|Overall Study|Death|1|||
105751605|NCT00242580|364742501|FG001|Overall Study|Death|2|||
105751606|NCT00242580|364742502|FG002|Overall Study|Death|1|||
105751607|NCT01737840|364742510|FG000|Overall Study|Diagnosed with an other pathology|2|||
105751608|NCT01737840|364742511|FG001|Overall Study|Diagnosed with an other pathology|2|||
105751609|NCT01189435|364742512|FG000|Overall Study|Withdrawal by Subject|1|||
105751610|NCT01189435|364742512|FG000|Overall Study|Physician Decision|1|||
105751611|NCT01253421|364742513|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
105751612|NCT01253421|364742514|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
105751613|NCT01253421|364742515|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
105751614|NCT01253421|364742516|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
105751615|NCT01253421|364742517|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
105751616|NCT01253421|364742513|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
105751617|NCT01253421|364742514|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
105751618|NCT01253421|364742515|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
105751619|NCT01253421|364742516|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
105751620|NCT01253421|364742517|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
105751621|NCT01253421|364742513|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
105751622|NCT01253421|364742514|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
105751623|NCT01253421|364742515|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
105751624|NCT01253421|364742516|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
105751625|NCT01253421|364742517|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
105751626|NCT01253421|364742513|FG000|Assessment and Scheduling|Physician Decision|1|||
105947568|NCT03440008|365471217|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
105947569|NCT03440008|365471218|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
105947570|NCT03440008|365471217|FG000|Overall Study|Withdrawal by Subject|1|||
105947571|NCT03440008|365471218|FG001|Overall Study|Withdrawal by Subject|0|||
105947572|NCT00382174|365471227|FG000|Overall Study|Lost to Follow-up|1|||
105947573|NCT00382174|365471228|FG001|Overall Study|Lost to Follow-up|4|||
105947574|NCT00382174|365471229|FG002|Overall Study|Lost to Follow-up|5|||
105947575|NCT00382174|365471227|FG000|Overall Study|Adverse Event|1|||
105947576|NCT00382174|365471228|FG001|Overall Study|Adverse Event|4|||
105947577|NCT00382174|365471229|FG002|Overall Study|Adverse Event|5|||
105947578|NCT00382174|365471227|FG000|Overall Study|Withdrawal by Subject|1|||
105947579|NCT00382174|365471228|FG001|Overall Study|Withdrawal by Subject|4|||
105947580|NCT00382174|365471229|FG002|Overall Study|Withdrawal by Subject|5|||
105947581|NCT00382174|365471227|FG000|Overall Study|Non compliance|1|||
105947582|NCT00382174|365471228|FG001|Overall Study|Non compliance|0|||
105947583|NCT00382174|365471229|FG002|Overall Study|Non compliance|1|||
105947584|NCT00382174|365471227|FG000|Overall Study|Physician Decision|0|||
105947585|NCT00382174|365471228|FG001|Overall Study|Physician Decision|2|||
105947586|NCT00382174|365471229|FG002|Overall Study|Physician Decision|2|||
105947587|NCT00382174|365471227|FG000|Overall Study|Failed to meet criteria|0|||
105947588|NCT00382174|365471228|FG001|Overall Study|Failed to meet criteria|1|||
105947589|NCT00382174|365471229|FG002|Overall Study|Failed to meet criteria|1|||
105947590|NCT00382174|365471227|FG000|Overall Study|Wounds merged|0|||
105947591|NCT00382174|365471228|FG001|Overall Study|Wounds merged|2|||
105947592|NCT00382174|365471229|FG002|Overall Study|Wounds merged|2|||
105947593|NCT03097289|365471232|FG000|Overall Study|Adverse Event|1|||
105947594|NCT03097289|365471232|FG000|Overall Study|Equipment failure|2|||
105947595|NCT03097289|365471232|FG000|Overall Study|Collected platelet product unusable|3|||
105947596|NCT00654732|365471233|FG000|Overall Study|Adverse Event|4|||
105947597|NCT00654732|365471234|FG001|Overall Study|Adverse Event|6|||
105947598|NCT04138056|365471235|FG000|Primary Study|Lost to Follow-up|3|||
105947599|NCT04138056|365471236|FG001|Primary Study|Lost to Follow-up|4|||
105947600|NCT04138056|365471237|FG002|Primary Study|Lost to Follow-up|1|||
105947601|NCT04138056|365471238|FG003|Primary Study|Lost to Follow-up|1|||
105947602|NCT04138056|365471239|FG004|Primary Study|Lost to Follow-up|4|||
105947603|NCT04138056|365471235|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
105947604|NCT04138056|365471236|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
105947605|NCT04138056|365471237|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
105947606|NCT04138056|365471238|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
105947607|NCT04138056|365471239|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
105947608|NCT04138056|365471235|FG000|Extension Study|Lost to Follow-up|1|||
105947609|NCT04138056|365471236|FG001|Extension Study|Lost to Follow-up|2|||
105947610|NCT04138056|365471237|FG002|Extension Study|Lost to Follow-up|1|||
105947611|NCT04138056|365471238|FG003|Extension Study|Lost to Follow-up|0|||
105947612|NCT04138056|365471239|FG004|Extension Study|Lost to Follow-up|1|||
105947613|NCT01734902|365471240|FG000|Overall Study|Other than listed|0|||
105947614|NCT01734902|365471241|FG001|Overall Study|Other than listed|2|||
105947615|NCT00060944|365471242|FG000|Overall Study|Adverse Event|12|||
105947616|NCT00060944|365471243|FG001|Overall Study|Adverse Event|10|||
105947617|NCT00060944|365471242|FG000|Overall Study|Death|2|||
105947618|NCT00060944|365471243|FG001|Overall Study|Death|3|||
105947619|NCT00060944|365471242|FG000|Overall Study|Withdrawal by Subject|18|||
105947620|NCT00060944|365471243|FG001|Overall Study|Withdrawal by Subject|5|||
105947621|NCT00060944|365471242|FG000|Overall Study|Disease Progression|93|||
105947622|NCT00060944|365471243|FG001|Overall Study|Disease Progression|94|||
105947623|NCT00060944|365471242|FG000|Overall Study|Lost to Follow-up|1|||
105947624|NCT00060944|365471243|FG001|Overall Study|Lost to Follow-up|0|||
105947625|NCT00060944|365471242|FG000|Overall Study|Subject Ineligible To Continue|2|||
105947626|NCT00060944|365471243|FG001|Overall Study|Subject Ineligible To Continue|1|||
105947627|NCT00060944|365471242|FG000|Overall Study|Treatment Switch|0|||
105947628|NCT00060944|365471243|FG001|Overall Study|Treatment Switch|13|||
105947629|NCT00060944|365471242|FG000|Overall Study|Other|2|||
105947630|NCT00060944|365471243|FG001|Overall Study|Other|4|||
105947631|NCT00060944|365471242|FG000|Overall Study|randomized but not treated|6|||
105947632|NCT00060944|365471243|FG001|Overall Study|randomized but not treated|4|||
105947633|NCT00776230|365471244|FG000|Overall Study|Lost to Follow-up|2|||
105947634|NCT00776230|365471245|FG001|Overall Study|Lost to Follow-up|1|||
105947635|NCT00776230|365471246|FG002|Overall Study|Lost to Follow-up|5|||
105947636|NCT00776230|365471244|FG000|Overall Study|Not vaccinated at Day 0|1|||
105751627|NCT01253421|364742514|FG001|Assessment and Scheduling|Physician Decision|0|||
105751628|NCT01253421|364742515|FG002|Assessment and Scheduling|Physician Decision|0|||
105751629|NCT01253421|364742516|FG003|Assessment and Scheduling|Physician Decision|0|||
105751630|NCT01253421|364742517|FG004|Assessment and Scheduling|Physician Decision|0|||
105751631|NCT01253421|364742513|FG000|Drug+Scanning Visit|Physician Decision|0|||
105751632|NCT01253421|364742514|FG001|Drug+Scanning Visit|Physician Decision|0|||
105751633|NCT01253421|364742515|FG002|Drug+Scanning Visit|Physician Decision|0|||
105751634|NCT01253421|364742516|FG003|Drug+Scanning Visit|Physician Decision|0|||
105751635|NCT01253421|364742517|FG004|Drug+Scanning Visit|Physician Decision|1|||
105751636|NCT00980980|364742518|FG000|Overall Study|Withdrawal by Hospital|0|||
105751637|NCT00980980|364742519|FG001|Overall Study|Withdrawal by Hospital|1|||
105751638|NCT00980980|364742520|FG002|Overall Study|Withdrawal by Hospital|0|||
105751639|NCT03666858|364742522|FG000|Cohort 1|Adverse Event|1|||
105751640|NCT03666858|364742523|FG001|Cohort 1|Adverse Event|0|||
105751641|NCT03666858|364742522|FG000|Cohort 2|Adverse Event|0|||
105751642|NCT03666858|364742523|FG001|Cohort 2|Adverse Event|1|||
105751643|NCT00121992|364742524|FG000|Overall Study|Treatment not received|2|||
105751644|NCT00121992|364742525|FG001|Overall Study|Treatment not received|11|||
105751645|NCT03282357|364742526|FG000|Overall Study|Lost to Follow-up|3|||
105751646|NCT03282357|364742526|FG000|Overall Study|Withdrawal by Subject|4|||
105751647|NCT03282357|364742526|FG000|Overall Study|Adverse Event|1|||
105751648|NCT03282357|364742526|FG000|Overall Study|Other|9|||
105751649|NCT03722784|364742533|FG000|Overall Study|Withdrawal by Subject|1|||
105751650|NCT03722784|364742534|FG001|Overall Study|Withdrawal by Subject|0|||
105751651|NCT03722784|364742533|FG000|Overall Study|Physician Decision|1|||
105751652|NCT03722784|364742534|FG001|Overall Study|Physician Decision|1|||
105751653|NCT03722784|364742533|FG000|Overall Study|Protocol Violation|0|||
105751654|NCT03722784|364742534|FG001|Overall Study|Protocol Violation|1|||
105751655|NCT00910429|364742535|FG000|Overall Study|Death|18|||
105751656|NCT00910429|364742536|FG001|Overall Study|Death|12|||
105751657|NCT00910429|364742535|FG000|Overall Study|Withdrawal by Subject|3|||
105751658|NCT00910429|364742536|FG001|Overall Study|Withdrawal by Subject|2|||
105751659|NCT00910429|364742535|FG000|Overall Study|Protocol Violation|1|||
105751660|NCT00910429|364742536|FG001|Overall Study|Protocol Violation|0|||
105751661|NCT00910429|364742535|FG000|Overall Study|Lost to Follow-up|2|||
105751662|NCT00910429|364742536|FG001|Overall Study|Lost to Follow-up|1|||
105751663|NCT00910429|364742535|FG000|Overall Study|Adverse Event|10|||
105751664|NCT00910429|364742536|FG001|Overall Study|Adverse Event|5|||
105751665|NCT00910429|364742535|FG000|Overall Study|Drug non-compliance|1|||
105751666|NCT00910429|364742536|FG001|Overall Study|Drug non-compliance|0|||
105751667|NCT00910429|364742535|FG000|Overall Study|Lack of Efficacy|4|||
105751668|NCT00910429|364742536|FG001|Overall Study|Lack of Efficacy|1|||
105751669|NCT01317615|364742537|FG000|Overall Study|Disease progression|25|||
105751670|NCT01317615|364742537|FG000|Overall Study|New cancer therapy|5|||
105751671|NCT01317615|364742537|FG000|Overall Study|Death|6|||
105751672|NCT01317615|364742537|FG000|Overall Study|Withdrawal by Subject|5|||
105751673|NCT01317615|364742537|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105751674|NCT01317615|364742537|FG000|Overall Study|Adverse Event|7|||
105751675|NCT04191577|364742539|FG000|Overall Study|Withdrawal by Subject|2|||
105751676|NCT04191577|364742540|FG001|Overall Study|Withdrawal by Subject|2|||
105751677|NCT04191577|364742541|FG002|Overall Study|Withdrawal by Subject|1|||
105751678|NCT04191577|364742539|FG000|Overall Study|Physician Decision|1|||
105751679|NCT04191577|364742540|FG001|Overall Study|Physician Decision|1|||
105751680|NCT04191577|364742541|FG002|Overall Study|Physician Decision|0|||
105751681|NCT04191577|364742539|FG000|Overall Study|Adverse Event|0|||
105751682|NCT04191577|364742540|FG001|Overall Study|Adverse Event|0|||
105751683|NCT04191577|364742541|FG002|Overall Study|Adverse Event|1|||
105751684|NCT04191577|364742539|FG000|Overall Study|Death|0|||
105751685|NCT04191577|364742540|FG001|Overall Study|Death|0|||
105751686|NCT04191577|364742541|FG002|Overall Study|Death|1|||
106142792|NCT01713946|366182004|FG000|Overall Study|Protocol Violation|2|||
105751687|NCT00349752|364742542|FG000|Overall Study|Adverse Event|8|||
105751688|NCT00349752|364742543|FG001|Overall Study|Adverse Event|12|||
105751689|NCT00349752|364742542|FG000|Overall Study|Lack of Efficacy|37|||
105751690|NCT00349752|364742543|FG001|Overall Study|Lack of Efficacy|42|||
105751691|NCT00349752|364742542|FG000|Overall Study|Lost to Follow-up|4|||
105751692|NCT00349752|364742543|FG001|Overall Study|Lost to Follow-up|2|||
105751693|NCT00349752|364742542|FG000|Overall Study|Personal reasons|6|||
105751694|NCT00349752|364742543|FG001|Overall Study|Personal reasons|5|||
105751695|NCT00349752|364742542|FG000|Overall Study|Other: Required exclusionary medication|0|||
105751696|NCT00349752|364742543|FG001|Overall Study|Other: Required exclusionary medication|1|||
105751697|NCT00349752|364742542|FG000|Overall Study|Other: Non compliance|0|||
105751698|NCT00349752|364742543|FG001|Overall Study|Other: Non compliance|1|||
105751699|NCT00349752|364742542|FG000|Overall Study|Other: Patient stopped steroids|0|||
105760895|NCT01342952|364778052|FG000|Overall Study|Adverse Event|0|||
106142793|NCT01713946|366182005|FG001|Overall Study|Protocol Violation|4|||
106142794|NCT01713946|366182006|FG002|Overall Study|Protocol Violation|1|||
106142795|NCT01713946|366182004|FG000|Overall Study|Lost to Follow-up|0|||
106142796|NCT01713946|366182005|FG001|Overall Study|Lost to Follow-up|0|||
105751700|NCT00349752|364742543|FG001|Overall Study|Other: Patient stopped steroids|1|||
105751701|NCT00349752|364742542|FG000|Overall Study|Other: Patient's steroid use|1|||
105751702|NCT00349752|364742543|FG001|Overall Study|Other: Patient's steroid use|0|||
105947637|NCT00776230|365471245|FG001|Overall Study|Not vaccinated at Day 0|0|||
105947638|NCT00776230|365471246|FG002|Overall Study|Not vaccinated at Day 0|0|||
105947639|NCT00776230|365471244|FG000|Overall Study|Withdrawal by Subject|0|||
105947640|NCT00776230|365471245|FG001|Overall Study|Withdrawal by Subject|1|||
105947641|NCT00776230|365471246|FG002|Overall Study|Withdrawal by Subject|0|||
105947642|NCT00776230|365471244|FG000|Overall Study|Subject missed Visit 4|0|||
105947643|NCT00776230|365471245|FG001|Overall Study|Subject missed Visit 4|1|||
105947644|NCT00776230|365471246|FG002|Overall Study|Subject missed Visit 4|0|||
105947645|NCT00518180|365471247|FG000|Overall Study|Withdrawal by Subject|29|||
105751703|NCT00349752|364742542|FG000|Overall Study|Other: Ineligible|1|||
105751704|NCT00349752|364742543|FG001|Overall Study|Other: Ineligible|0|||
105751705|NCT00349752|364742542|FG000|Overall Study|Other: Inadvertently unblinded|1|||
105751706|NCT00349752|364742543|FG001|Overall Study|Other: Inadvertently unblinded|0|||
105751707|NCT00349752|364742542|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
105751708|NCT00349752|364742543|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
105751709|NCT03521193|364742545|FG000|Overall Study|Withdrawal by Subject|8|||
105751710|NCT03521193|364742546|FG001|Overall Study|Withdrawal by Subject|0|||
105751711|NCT03521193|364742545|FG000|Overall Study|non compliant to ASA treatment|8|||
105751712|NCT03521193|364742546|FG001|Overall Study|non compliant to ASA treatment|0|||
105751713|NCT00738374|364742547|FG000|Induction Treatment Phase|Adverse Event|14|||
105751714|NCT00738374|364742548|FG001|Induction Treatment Phase|Adverse Event|0|||
105751715|NCT00738374|364742549|FG002|Induction Treatment Phase|Adverse Event|0|||
105751716|NCT00738374|364742550|FG003|Induction Treatment Phase|Adverse Event|0|||
105751717|NCT00738374|364742547|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
105751718|NCT00738374|364742548|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
105751719|NCT00738374|364742549|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
105751720|NCT00738374|364742550|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
105751721|NCT00738374|364742547|FG000|Induction Treatment Phase|Physician Decision|2|||
105751722|NCT00738374|364742548|FG001|Induction Treatment Phase|Physician Decision|0|||
105751723|NCT00738374|364742549|FG002|Induction Treatment Phase|Physician Decision|0|||
105751724|NCT00738374|364742550|FG003|Induction Treatment Phase|Physician Decision|0|||
105751725|NCT00738374|364742547|FG000|Induction Treatment Phase|Protocol Violation|2|||
105751726|NCT00738374|364742548|FG001|Induction Treatment Phase|Protocol Violation|0|||
105751727|NCT00738374|364742549|FG002|Induction Treatment Phase|Protocol Violation|0|||
105751728|NCT00738374|364742550|FG003|Induction Treatment Phase|Protocol Violation|0|||
105751729|NCT00738374|364742547|FG000|Induction Treatment Phase|Non-compliance|1|||
105751730|NCT00738374|364742548|FG001|Induction Treatment Phase|Non-compliance|0|||
105751731|NCT00738374|364742549|FG002|Induction Treatment Phase|Non-compliance|0|||
105751732|NCT00738374|364742550|FG003|Induction Treatment Phase|Non-compliance|0|||
105751733|NCT00738374|364742547|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
105751734|NCT00738374|364742548|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
105751735|NCT00738374|364742549|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
105751736|NCT00738374|364742550|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
105751737|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
105751738|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
105751739|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
106016350|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
106016351|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016352|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016353|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016354|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
106016355|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016356|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016357|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016358|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
105751740|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
105751741|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
105751742|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
105751743|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
105751744|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
105947646|NCT00518180|365471248|FG001|Overall Study|Withdrawal by Subject|30|||
105947647|NCT00518180|365471249|FG002|Overall Study|Withdrawal by Subject|42|||
105751745|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
105751746|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
105751747|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
105760896|NCT01342952|364778053|FG001|Overall Study|Adverse Event|5|||
105751748|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
105751749|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
105751750|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
105751751|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
105751752|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
105751753|NCT00738374|364742547|FG000|Maintenance Treatment/Observation Phase|Other|0|||
105751754|NCT00738374|364742548|FG001|Maintenance Treatment/Observation Phase|Other|1|||
105751755|NCT00738374|364742549|FG002|Maintenance Treatment/Observation Phase|Other|0|||
105751756|NCT00738374|364742550|FG003|Maintenance Treatment/Observation Phase|Other|0|||
105751757|NCT00064350|364742553|FG000|Induction Treatment|Disease Progression|5|||
105751758|NCT00064350|364742554|FG001|Induction Treatment|Disease Progression|1|||
105751759|NCT00064350|364742555|FG002|Induction Treatment|Disease Progression|110|||
105751760|NCT00064350|364742553|FG000|Induction Treatment|Adverse Event|0|||
105751761|NCT00064350|364742554|FG001|Induction Treatment|Adverse Event|2|||
105751762|NCT00064350|364742555|FG002|Induction Treatment|Adverse Event|49|||
105751763|NCT00064350|364742553|FG000|Induction Treatment|Death|0|||
105751764|NCT00064350|364742554|FG001|Induction Treatment|Death|0|||
105751765|NCT00064350|364742555|FG002|Induction Treatment|Death|9|||
105751766|NCT00064350|364742553|FG000|Induction Treatment|Withdrawal by Subject|0|||
105751767|NCT00064350|364742554|FG001|Induction Treatment|Withdrawal by Subject|0|||
105751768|NCT00064350|364742555|FG002|Induction Treatment|Withdrawal by Subject|21|||
105751769|NCT00064350|364742553|FG000|Induction Treatment|Ineligible or never started treatment|3|||
105751770|NCT00064350|364742554|FG001|Induction Treatment|Ineligible or never started treatment|6|||
105751771|NCT00064350|364742555|FG002|Induction Treatment|Ineligible or never started treatment|34|||
105751772|NCT00064350|364742553|FG000|Induction Treatment|Other|0|||
105751773|NCT00064350|364742554|FG001|Induction Treatment|Other|0|||
105751774|NCT00064350|364742555|FG002|Induction Treatment|Other|13|||
105751775|NCT00064350|364742553|FG000|Randomization|Adverse Event|8|||
105751776|NCT00064350|364742554|FG001|Randomization|Adverse Event|3|||
105751777|NCT00064350|364742555|FG002|Randomization|Adverse Event|0|||
105751778|NCT00064350|364742553|FG000|Randomization|Death|3|||
105751779|NCT00064350|364742554|FG001|Randomization|Death|0|||
105751780|NCT00064350|364742555|FG002|Randomization|Death|0|||
105751781|NCT00064350|364742553|FG000|Randomization|Withdrawal by Subject|1|||
105751782|NCT00064350|364742554|FG001|Randomization|Withdrawal by Subject|0|||
105751783|NCT00064350|364742555|FG002|Randomization|Withdrawal by Subject|0|||
105751784|NCT00064350|364742553|FG000|Randomization|Ineligible or never started treatment|9|||
105751785|NCT00064350|364742554|FG001|Randomization|Ineligible or never started treatment|15|||
105751786|NCT00064350|364742555|FG002|Randomization|Ineligible or never started treatment|0|||
105751787|NCT00064350|364742553|FG000|Randomization|Other|5|||
105751788|NCT00064350|364742554|FG001|Randomization|Other|0|||
105751789|NCT00064350|364742555|FG002|Randomization|Other|0|||
105751790|NCT00064350|364742553|FG000|Cross-Over|Adverse Event|0|||
105751791|NCT00064350|364742554|FG001|Cross-Over|Adverse Event|1|||
105947648|NCT00518180|365471247|FG000|Overall Study|Lost to Follow-up|30|||
105947649|NCT00518180|365471248|FG001|Overall Study|Lost to Follow-up|28|||
105947650|NCT00518180|365471249|FG002|Overall Study|Lost to Follow-up|34|||
105947651|NCT00518180|365471247|FG000|Overall Study|Administrative reason|0|||
105751792|NCT00064350|364742555|FG002|Cross-Over|Adverse Event|0|||
105751793|NCT00064350|364742553|FG000|Cross-Over|Death|1|||
105751794|NCT00064350|364742554|FG001|Cross-Over|Death|3|||
105947652|NCT00518180|365471248|FG001|Overall Study|Administrative reason|2|||
105947653|NCT00518180|365471249|FG002|Overall Study|Administrative reason|2|||
105947654|NCT00518180|365471247|FG000|Overall Study|Protocol Violation|5|||
105947655|NCT00518180|365471248|FG001|Overall Study|Protocol Violation|7|||
105751795|NCT00064350|364742555|FG002|Cross-Over|Death|0|||
105751796|NCT00064350|364742553|FG000|Cross-Over|Withdrawal by Subject|2|||
105751797|NCT00064350|364742554|FG001|Cross-Over|Withdrawal by Subject|2|||
105751798|NCT00064350|364742555|FG002|Cross-Over|Withdrawal by Subject|0|||
105751799|NCT00064350|364742553|FG000|Cross-Over|Ineligible or never started treatment|3|||
105751800|NCT00064350|364742554|FG001|Cross-Over|Ineligible or never started treatment|6|||
105751801|NCT00064350|364742555|FG002|Cross-Over|Ineligible or never started treatment|0|||
105751802|NCT00064350|364742553|FG000|Cross-Over|Other|0|||
105751803|NCT00064350|364742554|FG001|Cross-Over|Other|2|||
105751804|NCT00064350|364742555|FG002|Cross-Over|Other|0|||
105751805|NCT03600714|364742558|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
105751806|NCT03784027|364742561|FG000|Period 1|Withdrawal by Subject|0|||
105751807|NCT03784027|364742562|FG001|Period 1|Withdrawal by Subject|1|||
105751808|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
105751809|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
105751810|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
105751811|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
105751812|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
105751813|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
105751814|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
105751815|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
105751816|NCT01179347|364744558|FG000|Double-blind Period (12 Weeks)|Other|2|||
105751817|NCT01179347|364744559|FG001|Double-blind Period (12 Weeks)|Other|4|||
105751818|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
105751819|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
105751820|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
105751821|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
105751822|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
105751823|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
105751824|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
105751825|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
105751826|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
105751827|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
105751828|NCT01179347|364744558|FG000|Open-label Period (12 Weeks)|Other|7|||
105751829|NCT01179347|364744559|FG001|Open-label Period (12 Weeks)|Other|4|||
105751830|NCT01283997|364744560|FG000|Overall Study|Physician Decision|8|||
105751831|NCT01283997|364744561|FG001|Overall Study|Physician Decision|10|||
105751832|NCT01283997|364744560|FG000|Overall Study|Withdrawal by Subject|3|||
105751833|NCT01283997|364744561|FG001|Overall Study|Withdrawal by Subject|2|||
105751834|NCT01283997|364744560|FG000|Overall Study|Physically unable to continue|0|||
105751835|NCT01283997|364744561|FG001|Overall Study|Physically unable to continue|1|||
105751836|NCT01283997|364744560|FG000|Overall Study|Progressive disease|1|||
105751837|NCT01283997|364744561|FG001|Overall Study|Progressive disease|0|||
105751838|NCT01283997|364744560|FG000|Overall Study|Other|4|||
105751839|NCT01283997|364744561|FG001|Overall Study|Other|4|||
105751840|NCT01677624|364744562|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
105751841|NCT00839423|364744568|FG000|Overall Study|Adverse Event|4|||
105751842|NCT00839423|364744569|FG001|Overall Study|Adverse Event|3|||
105751843|NCT00839423|364744570|FG002|Overall Study|Adverse Event|7|||
105751844|NCT00839423|364744571|FG003|Overall Study|Adverse Event|16|||
105751845|NCT00839423|364744568|FG000|Overall Study|Lack of Efficacy|6|||
105751846|NCT00839423|364744569|FG001|Overall Study|Lack of Efficacy|6|||
105751847|NCT00839423|364744570|FG002|Overall Study|Lack of Efficacy|3|||
105751848|NCT00839423|364744571|FG003|Overall Study|Lack of Efficacy|2|||
105751849|NCT00839423|364744568|FG000|Overall Study|Non-compliance|0|||
105751850|NCT00839423|364744569|FG001|Overall Study|Non-compliance|0|||
105751851|NCT00839423|364744570|FG002|Overall Study|Non-compliance|0|||
105751852|NCT00839423|364744571|FG003|Overall Study|Non-compliance|1|||
105751853|NCT00839423|364744568|FG000|Overall Study|Protocol Violation|0|||
105751854|NCT00839423|364744569|FG001|Overall Study|Protocol Violation|1|||
105751855|NCT00839423|364744570|FG002|Overall Study|Protocol Violation|2|||
105751856|NCT00839423|364744571|FG003|Overall Study|Protocol Violation|0|||
105751857|NCT00839423|364744568|FG000|Overall Study|Withdrawal of consent|4|||
105751858|NCT00839423|364744569|FG001|Overall Study|Withdrawal of consent|0|||
105751859|NCT00839423|364744570|FG002|Overall Study|Withdrawal of consent|4|||
105751860|NCT00839423|364744571|FG003|Overall Study|Withdrawal of consent|1|||
105751861|NCT00839423|364744568|FG000|Overall Study|Lost to Follow-up|1|||
105751862|NCT00839423|364744569|FG001|Overall Study|Lost to Follow-up|0|||
105751863|NCT00839423|364744570|FG002|Overall Study|Lost to Follow-up|1|||
105751864|NCT00839423|364744571|FG003|Overall Study|Lost to Follow-up|0|||
105751865|NCT00839423|364744568|FG000|Overall Study|Administrative or other reasons|3|||
105751866|NCT00839423|364744569|FG001|Overall Study|Administrative or other reasons|0|||
105751867|NCT00839423|364744570|FG002|Overall Study|Administrative or other reasons|1|||
105751868|NCT00839423|364744571|FG003|Overall Study|Administrative or other reasons|0|||
105751869|NCT01071096|364744572|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
105751870|NCT01071096|364744573|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
105751871|NCT01885078|364744576|FG000|Treatment Period|Adverse Event|52|||
105751872|NCT01885078|364744577|FG001|Treatment Period|Adverse Event|136|||
105751873|NCT01885078|364744578|FG002|Treatment Period|Adverse Event|30|||
105751874|NCT01885078|364744579|FG003|Treatment Period|Adverse Event|73|||
105751875|NCT01885078|364744580|FG004|Treatment Period|Adverse Event|17|||
105751876|NCT01885078|364744581|FG005|Treatment Period|Adverse Event|72|||
105751877|NCT01885078|364744582|FG006|Treatment Period|Adverse Event|24|||
105751878|NCT01885078|364744583|FG007|Treatment Period|Adverse Event|5|||
105751879|NCT01885078|364744584|FG008|Treatment Period|Adverse Event|0|||
105751880|NCT01885078|364744585|FG009|Treatment Period|Adverse Event|0|||
105751881|NCT01885078|364744576|FG000|Treatment Period|Death|13|||
105751882|NCT01885078|364744577|FG001|Treatment Period|Death|33|||
105751883|NCT01885078|364744578|FG002|Treatment Period|Death|5|||
105751884|NCT01885078|364744579|FG003|Treatment Period|Death|9|||
105751885|NCT01885078|364744580|FG004|Treatment Period|Death|2|||
105751886|NCT01885078|364744581|FG005|Treatment Period|Death|10|||
105751887|NCT01885078|364744582|FG006|Treatment Period|Death|3|||
105751888|NCT01885078|364744583|FG007|Treatment Period|Death|2|||
105751889|NCT01885078|364744584|FG008|Treatment Period|Death|0|||
105751890|NCT01885078|364744585|FG009|Treatment Period|Death|0|||
105751891|NCT01885078|364744576|FG000|Treatment Period|Lack of Efficacy|12|||
105751892|NCT01885078|364744577|FG001|Treatment Period|Lack of Efficacy|33|||
105751893|NCT01885078|364744578|FG002|Treatment Period|Lack of Efficacy|10|||
105751894|NCT01885078|364744579|FG003|Treatment Period|Lack of Efficacy|23|||
105751895|NCT01885078|364744580|FG004|Treatment Period|Lack of Efficacy|24|||
105751896|NCT01885078|364744581|FG005|Treatment Period|Lack of Efficacy|58|||
105751897|NCT01885078|364744582|FG006|Treatment Period|Lack of Efficacy|9|||
105751898|NCT01885078|364744583|FG007|Treatment Period|Lack of Efficacy|5|||
105751899|NCT01885078|364744584|FG008|Treatment Period|Lack of Efficacy|0|||
105751900|NCT01885078|364744585|FG009|Treatment Period|Lack of Efficacy|0|||
105751901|NCT01885078|364744576|FG000|Treatment Period|Lost to Follow-up|16|||
105751902|NCT01885078|364744577|FG001|Treatment Period|Lost to Follow-up|19|||
105751903|NCT01885078|364744578|FG002|Treatment Period|Lost to Follow-up|7|||
105751904|NCT01885078|364744579|FG003|Treatment Period|Lost to Follow-up|9|||
105947656|NCT00518180|365471249|FG002|Overall Study|Protocol Violation|4|||
105947657|NCT00518180|365471247|FG000|Overall Study|Unable to classify|0|||
105947658|NCT00518180|365471248|FG001|Overall Study|Unable to classify|2|||
105947659|NCT00518180|365471249|FG002|Overall Study|Unable to classify|0|||
105947660|NCT00518180|365471247|FG000|Overall Study|Adverse Event|1|||
105947661|NCT00518180|365471248|FG001|Overall Study|Adverse Event|0|||
105947662|NCT00518180|365471249|FG002|Overall Study|Adverse Event|0|||
105947663|NCT03510273|365471250|FG000|Overall Study|Withdrawal by Subject|2|||
105947664|NCT03510273|365471250|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
105947665|NCT03510273|365471250|FG000|Overall Study|Moved away from study area|4|||
105947666|NCT01374425|365471253|FG000|Overall Study|Radiographic Disease Progression|86|||
105947667|NCT01374425|365471254|FG001|Overall Study|Radiographic Disease Progression|81|||
105947668|NCT01374425|365471253|FG000|Overall Study|Clinical Disease Progression|9|||
105947669|NCT01374425|365471254|FG001|Overall Study|Clinical Disease Progression|6|||
105947670|NCT01374425|365471253|FG000|Overall Study|Adverse Event|29|||
105947671|NCT01374425|365471254|FG001|Overall Study|Adverse Event|18|||
105947672|NCT01374425|365471253|FG000|Overall Study|Death (Progression of Disease)|1|||
105947673|NCT01374425|365471254|FG001|Overall Study|Death (Progression of Disease)|0|||
105947674|NCT01374425|365471253|FG000|Overall Study|Death (Adverse Event)|2|||
105947675|NCT01374425|365471254|FG001|Overall Study|Death (Adverse Event)|4|||
105947676|NCT01374425|365471253|FG000|Overall Study|Withdrawal by Subject|6|||
105947677|NCT01374425|365471254|FG001|Overall Study|Withdrawal by Subject|7|||
105947678|NCT01374425|365471253|FG000|Overall Study|Refused Treatment|10|||
105947679|NCT01374425|365471254|FG001|Overall Study|Refused Treatment|24|||
106016359|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016360|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016361|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016362|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
106016363|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
106016364|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
105751905|NCT01885078|364744580|FG004|Treatment Period|Lost to Follow-up|2|||
105751906|NCT01885078|364744581|FG005|Treatment Period|Lost to Follow-up|8|||
105751907|NCT01885078|364744582|FG006|Treatment Period|Lost to Follow-up|2|||
105751908|NCT01885078|364744583|FG007|Treatment Period|Lost to Follow-up|0|||
105947680|NCT01374425|365471253|FG000|Overall Study|Protocol Violation|2|||
105947681|NCT01374425|365471254|FG001|Overall Study|Protocol Violation|3|||
105947682|NCT01374425|365471253|FG000|Overall Study|Sponsor Decision|0|||
105947683|NCT01374425|365471254|FG001|Overall Study|Sponsor Decision|1|||
105947684|NCT01374425|365471253|FG000|Overall Study|Lost to Follow-up|2|||
105751909|NCT01885078|364744584|FG008|Treatment Period|Lost to Follow-up|0|||
105751910|NCT01885078|364744585|FG009|Treatment Period|Lost to Follow-up|0|||
105751911|NCT01885078|364744576|FG000|Treatment Period|Physician Decision|19|||
105751912|NCT01885078|364744577|FG001|Treatment Period|Physician Decision|21|||
105751913|NCT01885078|364744578|FG002|Treatment Period|Physician Decision|5|||
105751914|NCT01885078|364744579|FG003|Treatment Period|Physician Decision|12|||
105751915|NCT01885078|364744580|FG004|Treatment Period|Physician Decision|9|||
105947685|NCT01374425|365471254|FG001|Overall Study|Lost to Follow-up|1|||
105947686|NCT01374425|365471253|FG000|Overall Study|Other|41|||
105947687|NCT01374425|365471254|FG001|Overall Study|Other|43|||
105947688|NCT01276106|365471257|FG000|Overall Study|Adverse Event|3|||
105947689|NCT01276106|365471258|FG001|Overall Study|Adverse Event|3|||
105947690|NCT01276106|365471259|FG002|Overall Study|Adverse Event|11|||
105947691|NCT01276106|365471260|FG003|Overall Study|Adverse Event|3|||
105947692|NCT01276106|365471257|FG000|Overall Study|Withdrawal by Subject|6|||
105947693|NCT01276106|365471258|FG001|Overall Study|Withdrawal by Subject|3|||
105947694|NCT01276106|365471259|FG002|Overall Study|Withdrawal by Subject|1|||
105947695|NCT01276106|365471260|FG003|Overall Study|Withdrawal by Subject|6|||
105947696|NCT01276106|365471257|FG000|Overall Study|Lack of Efficacy|0|||
105947697|NCT01276106|365471258|FG001|Overall Study|Lack of Efficacy|1|||
105947698|NCT01276106|365471259|FG002|Overall Study|Lack of Efficacy|0|||
106142797|NCT01713946|366182006|FG002|Overall Study|Lost to Follow-up|1|||
105751916|NCT01885078|364744581|FG005|Treatment Period|Physician Decision|24|||
105751917|NCT01885078|364744582|FG006|Treatment Period|Physician Decision|4|||
105751918|NCT01885078|364744583|FG007|Treatment Period|Physician Decision|3|||
105751919|NCT01885078|364744584|FG008|Treatment Period|Physician Decision|0|||
105751920|NCT01885078|364744585|FG009|Treatment Period|Physician Decision|0|||
105751921|NCT01885078|364744576|FG000|Treatment Period|Protocol Violation|3|||
105751922|NCT01885078|364744577|FG001|Treatment Period|Protocol Violation|5|||
105751923|NCT01885078|364744578|FG002|Treatment Period|Protocol Violation|0|||
105751924|NCT01885078|364744579|FG003|Treatment Period|Protocol Violation|3|||
105751925|NCT01885078|364744580|FG004|Treatment Period|Protocol Violation|1|||
105751926|NCT01885078|364744581|FG005|Treatment Period|Protocol Violation|6|||
105751927|NCT01885078|364744582|FG006|Treatment Period|Protocol Violation|0|||
105751928|NCT01885078|364744583|FG007|Treatment Period|Protocol Violation|0|||
105751929|NCT01885078|364744584|FG008|Treatment Period|Protocol Violation|0|||
105751930|NCT01885078|364744585|FG009|Treatment Period|Protocol Violation|0|||
105751931|NCT01885078|364744576|FG000|Treatment Period|Sponsor Decision|245|||
105751932|NCT01885078|364744577|FG001|Treatment Period|Sponsor Decision|648|||
105751933|NCT01885078|364744578|FG002|Treatment Period|Sponsor Decision|49|||
105751934|NCT01885078|364744579|FG003|Treatment Period|Sponsor Decision|90|||
105751935|NCT01885078|364744580|FG004|Treatment Period|Sponsor Decision|20|||
105751936|NCT01885078|364744581|FG005|Treatment Period|Sponsor Decision|38|||
105751937|NCT01885078|364744582|FG006|Treatment Period|Sponsor Decision|162|||
105751938|NCT01885078|364744583|FG007|Treatment Period|Sponsor Decision|3|||
105751939|NCT01885078|364744584|FG008|Treatment Period|Sponsor Decision|0|||
105751940|NCT01885078|364744585|FG009|Treatment Period|Sponsor Decision|0|||
105751941|NCT01885078|364744576|FG000|Treatment Period|Withdrawal by Subject|72|||
105751942|NCT01885078|364744577|FG001|Treatment Period|Withdrawal by Subject|132|||
105751943|NCT01885078|364744578|FG002|Treatment Period|Withdrawal by Subject|25|||
105751944|NCT01885078|364744579|FG003|Treatment Period|Withdrawal by Subject|63|||
105751945|NCT01885078|364744580|FG004|Treatment Period|Withdrawal by Subject|15|||
105751946|NCT01885078|364744581|FG005|Treatment Period|Withdrawal by Subject|34|||
105751947|NCT01885078|364744582|FG006|Treatment Period|Withdrawal by Subject|17|||
105751948|NCT01885078|364744583|FG007|Treatment Period|Withdrawal by Subject|10|||
105751949|NCT01885078|364744584|FG008|Treatment Period|Withdrawal by Subject|0|||
105751950|NCT01885078|364744585|FG009|Treatment Period|Withdrawal by Subject|0|||
105751951|NCT01885078|364744576|FG000|Treatment Period|Other|0|||
105751952|NCT01885078|364744577|FG001|Treatment Period|Other|0|||
105751953|NCT01885078|364744578|FG002|Treatment Period|Other|0|||
105751954|NCT01885078|364744579|FG003|Treatment Period|Other|1|||
105751955|NCT01885078|364744580|FG004|Treatment Period|Other|0|||
105751956|NCT01885078|364744581|FG005|Treatment Period|Other|0|||
105751957|NCT01885078|364744582|FG006|Treatment Period|Other|0|||
105751958|NCT01885078|364744583|FG007|Treatment Period|Other|0|||
105751959|NCT01885078|364744584|FG008|Treatment Period|Other|0|||
105751960|NCT01885078|364744585|FG009|Treatment Period|Other|0|||
105751961|NCT01885078|364744576|FG000|Step-down Period|Sponsor Decision|0|||
105751962|NCT01885078|364744577|FG001|Step-down Period|Sponsor Decision|0|||
105751963|NCT01885078|364744578|FG002|Step-down Period|Sponsor Decision|0|||
105751964|NCT01885078|364744579|FG003|Step-down Period|Sponsor Decision|0|||
105751965|NCT01885078|364744580|FG004|Step-down Period|Sponsor Decision|0|||
105751966|NCT01885078|364744581|FG005|Step-down Period|Sponsor Decision|0|||
105751967|NCT01885078|364744582|FG006|Step-down Period|Sponsor Decision|0|||
105947699|NCT01276106|365471260|FG003|Overall Study|Lack of Efficacy|1|||
105947700|NCT01276106|365471257|FG000|Overall Study|Lost to Follow-up|2|||
105751968|NCT01885078|364744583|FG007|Step-down Period|Sponsor Decision|0|||
105751969|NCT01885078|364744584|FG008|Step-down Period|Sponsor Decision|1|||
105751970|NCT01885078|364744585|FG009|Step-down Period|Sponsor Decision|1|||
105751971|NCT01885078|364744576|FG000|Step-down Period|Adverse Event|0|||
105751972|NCT01885078|364744577|FG001|Step-down Period|Adverse Event|0|||
105751973|NCT01885078|364744578|FG002|Step-down Period|Adverse Event|0|||
105751974|NCT01885078|364744579|FG003|Step-down Period|Adverse Event|0|||
105751975|NCT01885078|364744580|FG004|Step-down Period|Adverse Event|0|||
105751976|NCT01885078|364744581|FG005|Step-down Period|Adverse Event|0|||
105947701|NCT01276106|365471258|FG001|Overall Study|Lost to Follow-up|1|||
105947702|NCT01276106|365471259|FG002|Overall Study|Lost to Follow-up|1|||
105947703|NCT01276106|365471260|FG003|Overall Study|Lost to Follow-up|0|||
105947704|NCT01276106|365471257|FG000|Overall Study|Physician Decision|0|||
105947705|NCT01276106|365471258|FG001|Overall Study|Physician Decision|0|||
105947706|NCT01276106|365471259|FG002|Overall Study|Physician Decision|1|||
105947707|NCT01276106|365471260|FG003|Overall Study|Physician Decision|1|||
105947708|NCT01276106|365471257|FG000|Overall Study|Protocol Violation|1|||
105947709|NCT01276106|365471258|FG001|Overall Study|Protocol Violation|1|||
105947710|NCT01276106|365471259|FG002|Overall Study|Protocol Violation|0|||
105947711|NCT01276106|365471260|FG003|Overall Study|Protocol Violation|2|||
105947712|NCT01276106|365471257|FG000|Overall Study|Insufficient therapeutic effects|0|||
105947713|NCT01276106|365471258|FG001|Overall Study|Insufficient therapeutic effects|0|||
105947714|NCT01276106|365471259|FG002|Overall Study|Insufficient therapeutic effects|2|||
105947715|NCT01276106|365471260|FG003|Overall Study|Insufficient therapeutic effects|0|||
105947716|NCT03913130|365471267|FG000|Overall Study|Sponsor Decision|1|||
105947717|NCT01634152|365471268|FG000|Overall Study|Adverse Event|2|||
105947718|NCT01634152|365471269|FG001|Overall Study|Adverse Event|0|||
105947719|NCT01634152|365471270|FG002|Overall Study|Adverse Event|2|||
105947720|NCT01634152|365471268|FG000|Overall Study|Consent withdrawn not due to AE|1|||
105947721|NCT01634152|365471269|FG001|Overall Study|Consent withdrawn not due to AE|0|||
105947722|NCT01634152|365471270|FG002|Overall Study|Consent withdrawn not due to AE|1|||
105947723|NCT01634152|365471268|FG000|Overall Study|Not treated|0|||
105947724|NCT01634152|365471269|FG001|Overall Study|Not treated|1|||
105947725|NCT01634152|365471270|FG002|Overall Study|Not treated|0|||
105947726|NCT01634152|365471268|FG000|Overall Study|Other reason not defined above|1|||
105947727|NCT01634152|365471269|FG001|Overall Study|Other reason not defined above|0|||
105947728|NCT01634152|365471270|FG002|Overall Study|Other reason not defined above|1|||
105947729|NCT05489328|365473407|FG000|Overall Study|Lost to Follow-up|0|||
105947730|NCT05489328|365473408|FG001|Overall Study|Lost to Follow-up|0|||
105947731|NCT05489328|365473409|FG002|Overall Study|Lost to Follow-up|1|||
105947732|NCT05489328|365473410|FG003|Overall Study|Lost to Follow-up|0|||
105947733|NCT05489328|365473411|FG004|Overall Study|Lost to Follow-up|2|||
105947734|NCT05489328|365473412|FG005|Overall Study|Lost to Follow-up|0|||
105947735|NCT05489328|365473413|FG006|Overall Study|Lost to Follow-up|0|||
105947736|NCT05489328|365473414|FG007|Overall Study|Lost to Follow-up|1|||
105947737|NCT05489328|365473415|FG008|Overall Study|Lost to Follow-up|0|||
105947738|NCT05489328|365473407|FG000|Overall Study|Withdrawal by Subject|0|||
105947739|NCT05489328|365473408|FG001|Overall Study|Withdrawal by Subject|0|||
105947740|NCT05489328|365473409|FG002|Overall Study|Withdrawal by Subject|0|||
105947741|NCT05489328|365473410|FG003|Overall Study|Withdrawal by Subject|0|||
105947742|NCT05489328|365473411|FG004|Overall Study|Withdrawal by Subject|0|||
105947743|NCT05489328|365473412|FG005|Overall Study|Withdrawal by Subject|0|||
105947744|NCT05489328|365473413|FG006|Overall Study|Withdrawal by Subject|1|||
105947745|NCT05489328|365473414|FG007|Overall Study|Withdrawal by Subject|1|||
105947746|NCT05489328|365473415|FG008|Overall Study|Withdrawal by Subject|0|||
105947747|NCT05489328|365473407|FG000|Overall Study|Other|0|||
105947748|NCT05489328|365473408|FG001|Overall Study|Other|0|||
105751977|NCT01885078|364744582|FG006|Step-down Period|Adverse Event|0|||
105751978|NCT01885078|364744583|FG007|Step-down Period|Adverse Event|0|||
105751979|NCT01885078|364744584|FG008|Step-down Period|Adverse Event|29|||
105751980|NCT01885078|364744585|FG009|Step-down Period|Adverse Event|38|||
105751981|NCT01885078|364744576|FG000|Step-down Period|Withdrawal by Subject|0|||
105751982|NCT01885078|364744577|FG001|Step-down Period|Withdrawal by Subject|0|||
105751983|NCT01885078|364744578|FG002|Step-down Period|Withdrawal by Subject|0|||
105751984|NCT01885078|364744579|FG003|Step-down Period|Withdrawal by Subject|0|||
105751985|NCT01885078|364744580|FG004|Step-down Period|Withdrawal by Subject|0|||
105751986|NCT01885078|364744581|FG005|Step-down Period|Withdrawal by Subject|0|||
105751987|NCT01885078|364744582|FG006|Step-down Period|Withdrawal by Subject|0|||
105751988|NCT01885078|364744583|FG007|Step-down Period|Withdrawal by Subject|0|||
105751989|NCT01885078|364744584|FG008|Step-down Period|Withdrawal by Subject|25|||
105947749|NCT05489328|365473409|FG002|Overall Study|Other|0|||
105751990|NCT01885078|364744585|FG009|Step-down Period|Withdrawal by Subject|15|||
105751991|NCT01885078|364744576|FG000|Step-down Period|Physician Decision|0|||
105947750|NCT05489328|365473410|FG003|Overall Study|Other|0|||
105947751|NCT05489328|365473411|FG004|Overall Study|Other|0|||
105947752|NCT05489328|365473412|FG005|Overall Study|Other|0|||
105947753|NCT05489328|365473413|FG006|Overall Study|Other|0|||
105947754|NCT05489328|365473414|FG007|Overall Study|Other|1|||
105751992|NCT01885078|364744577|FG001|Step-down Period|Physician Decision|0|||
105751993|NCT01885078|364744578|FG002|Step-down Period|Physician Decision|0|||
105751994|NCT01885078|364744579|FG003|Step-down Period|Physician Decision|0|||
105751995|NCT01885078|364744580|FG004|Step-down Period|Physician Decision|0|||
105751996|NCT01885078|364744581|FG005|Step-down Period|Physician Decision|0|||
105947755|NCT05489328|365473415|FG008|Overall Study|Other|1|||
105947756|NCT01083602|365473416|FG000|Overall Study|Adverse Event|11|||
105947757|NCT01083602|365473416|FG000|Overall Study|New Cancer Therapy|2|||
105947758|NCT01083602|365473416|FG000|Overall Study|Death|1|||
105947759|NCT01083602|365473416|FG000|Overall Study|Withdrawal by Subject|5|||
105947760|NCT01083602|365473416|FG000|Overall Study|Lack of Efficacy|36|||
105947761|NCT01585025|365473418|FG000|Overall Study|Withdrawal by Subject|0|||
105947762|NCT01585025|365473419|FG001|Overall Study|Withdrawal by Subject|3|||
105947763|NCT01585025|365473420|FG002|Overall Study|Withdrawal by Subject|4|||
105947764|NCT03698279|365473421|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105947765|NCT03698279|365473422|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105947766|NCT03698279|365473423|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105947767|NCT03698279|365473424|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105947768|NCT03698279|365473425|FG004|Overall Study|Withdrawal by parent/guardian|0|||
105947769|NCT03698279|365473426|FG005|Overall Study|Withdrawal by parent/guardian|0|||
105947770|NCT03698279|365473421|FG000|Overall Study|Protocol deviation|1|||
105947771|NCT03698279|365473422|FG001|Overall Study|Protocol deviation|0|||
105947772|NCT03698279|365473423|FG002|Overall Study|Protocol deviation|1|||
105947773|NCT03698279|365473424|FG003|Overall Study|Protocol deviation|0|||
105947774|NCT03698279|365473425|FG004|Overall Study|Protocol deviation|0|||
105947775|NCT03698279|365473426|FG005|Overall Study|Protocol deviation|0|||
105947776|NCT03698279|365473421|FG000|Overall Study|Withdrawal by Subject|0|||
105947777|NCT03698279|365473422|FG001|Overall Study|Withdrawal by Subject|0|||
105947778|NCT03698279|365473423|FG002|Overall Study|Withdrawal by Subject|1|||
105947779|NCT03698279|365473424|FG003|Overall Study|Withdrawal by Subject|0|||
105947780|NCT03698279|365473425|FG004|Overall Study|Withdrawal by Subject|0|||
105947781|NCT03698279|365473426|FG005|Overall Study|Withdrawal by Subject|0|||
105947782|NCT03698279|365473421|FG000|Overall Study|Lost to Follow-up|3|||
105947783|NCT03698279|365473422|FG001|Overall Study|Lost to Follow-up|1|||
105947784|NCT03698279|365473423|FG002|Overall Study|Lost to Follow-up|4|||
105947785|NCT03698279|365473424|FG003|Overall Study|Lost to Follow-up|5|||
105947786|NCT03698279|365473425|FG004|Overall Study|Lost to Follow-up|0|||
105947787|NCT03698279|365473426|FG005|Overall Study|Lost to Follow-up|0|||
105947788|NCT00402987|365473434|FG000|Overall Study|Lack of Efficacy|0|||
105947789|NCT00402987|365473435|FG001|Overall Study|Lack of Efficacy|0|||
105947790|NCT00402987|365473436|FG002|Overall Study|Lack of Efficacy|1|||
105947791|NCT00402987|365473437|FG003|Overall Study|Lack of Efficacy|0|||
105947792|NCT01668004|365473438|FG000|Overall Study|Adverse Event|7|||
105947793|NCT01668004|365473438|FG000|Overall Study|Withdrawal by Subject|2|||
105947794|NCT01668004|365473438|FG000|Overall Study|Lost to Follow-up|5|||
105947795|NCT01668004|365473438|FG000|Overall Study|Lack of Efficacy|9|||
105947796|NCT01668004|365473438|FG000|Overall Study|Non-compliance with treatment|2|||
105947797|NCT02448381|365473439|FG000|Overall Study|Adverse Event|2|||
105947798|NCT02448381|365473440|FG001|Overall Study|Adverse Event|0|||
105947799|NCT02448381|365473439|FG000|Overall Study|Lost to Follow-up|16|||
105947800|NCT02448381|365473440|FG001|Overall Study|Lost to Follow-up|9|||
105947801|NCT02448381|365473439|FG000|Overall Study|Physician Decision|1|||
105947802|NCT02448381|365473440|FG001|Overall Study|Physician Decision|1|||
105947803|NCT02448381|365473439|FG000|Overall Study|Pregnancy|1|||
105947804|NCT02448381|365473440|FG001|Overall Study|Pregnancy|0|||
105947805|NCT02448381|365473439|FG000|Overall Study|Withdrawal by Subject|13|||
105947806|NCT02448381|365473440|FG001|Overall Study|Withdrawal by Subject|9|||
105947807|NCT02448381|365473439|FG000|Overall Study|Noncompliance with Study Procedures|2|||
105947808|NCT02448381|365473440|FG001|Overall Study|Noncompliance with Study Procedures|0|||
105947809|NCT00399035|365473441|FG000|Overall Study|Death|289|||
105947810|NCT00399035|365473442|FG001|Overall Study|Death|141|||
105947811|NCT00399035|365473443|FG002|Overall Study|Death|234|||
105947812|NCT00399035|365473441|FG000|Overall Study|Lost to Follow-up|2|||
105947813|NCT00399035|365473442|FG001|Overall Study|Lost to Follow-up|1|||
105947814|NCT00399035|365473443|FG002|Overall Study|Lost to Follow-up|5|||
105947815|NCT00399035|365473441|FG000|Overall Study|Withdrawal by Subject|19|||
105751997|NCT01885078|364744582|FG006|Step-down Period|Physician Decision|0|||
105751998|NCT01885078|364744583|FG007|Step-down Period|Physician Decision|0|||
105751999|NCT01885078|364744584|FG008|Step-down Period|Physician Decision|7|||
105752000|NCT01885078|364744585|FG009|Step-down Period|Physician Decision|2|||
105752001|NCT01885078|364744576|FG000|Step-down Period|Death|0|||
105752002|NCT01885078|364744577|FG001|Step-down Period|Death|0|||
105752003|NCT01885078|364744578|FG002|Step-down Period|Death|0|||
105752004|NCT01885078|364744579|FG003|Step-down Period|Death|0|||
105752005|NCT01885078|364744580|FG004|Step-down Period|Death|0|||
105752006|NCT01885078|364744581|FG005|Step-down Period|Death|0|||
105752007|NCT01885078|364744582|FG006|Step-down Period|Death|0|||
105752008|NCT01885078|364744583|FG007|Step-down Period|Death|0|||
105752009|NCT01885078|364744584|FG008|Step-down Period|Death|4|||
105947816|NCT00399035|365473442|FG001|Overall Study|Withdrawal by Subject|15|||
105947817|NCT00399035|365473443|FG002|Overall Study|Withdrawal by Subject|12|||
105947818|NCT00399035|365473441|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
105947819|NCT00399035|365473442|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
105947820|NCT00399035|365473443|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
105947821|NCT00399035|365473441|FG000|Overall Study|Severe non-compliance with protocol|2|||
105947822|NCT00399035|365473442|FG001|Overall Study|Severe non-compliance with protocol|1|||
105752010|NCT01885078|364744585|FG009|Step-down Period|Death|3|||
105752011|NCT01885078|364744576|FG000|Step-down Period|Lost to Follow-up|0|||
105752012|NCT01885078|364744577|FG001|Step-down Period|Lost to Follow-up|0|||
105752013|NCT01885078|364744578|FG002|Step-down Period|Lost to Follow-up|0|||
105752014|NCT01885078|364744579|FG003|Step-down Period|Lost to Follow-up|0|||
105752015|NCT01885078|364744580|FG004|Step-down Period|Lost to Follow-up|0|||
105752016|NCT01885078|364744581|FG005|Step-down Period|Lost to Follow-up|0|||
105752017|NCT01885078|364744582|FG006|Step-down Period|Lost to Follow-up|0|||
105752018|NCT01885078|364744583|FG007|Step-down Period|Lost to Follow-up|0|||
105752019|NCT01885078|364744584|FG008|Step-down Period|Lost to Follow-up|1|||
105752020|NCT01885078|364744585|FG009|Step-down Period|Lost to Follow-up|1|||
105752021|NCT01885078|364744576|FG000|Step-down Period|Lack of Efficacy|0|||
105752022|NCT01885078|364744577|FG001|Step-down Period|Lack of Efficacy|0|||
105752023|NCT01885078|364744578|FG002|Step-down Period|Lack of Efficacy|0|||
105752024|NCT01885078|364744579|FG003|Step-down Period|Lack of Efficacy|0|||
105947823|NCT00399035|365473443|FG002|Overall Study|Severe non-compliance with protocol|0|||
105947824|NCT00854360|365473454|FG000|Overall Study|Adverse Event|0|||
105947825|NCT00854360|365473455|FG001|Overall Study|Adverse Event|1|||
105947826|NCT00854360|365473456|FG002|Overall Study|Adverse Event|2|||
105947827|NCT00854360|365473457|FG003|Overall Study|Adverse Event|6|||
105947828|NCT00854360|365473454|FG000|Overall Study|Withdrawal by Subject|0|||
105947829|NCT00854360|365473455|FG001|Overall Study|Withdrawal by Subject|0|||
105947830|NCT00854360|365473456|FG002|Overall Study|Withdrawal by Subject|0|||
105947831|NCT00854360|365473457|FG003|Overall Study|Withdrawal by Subject|1|||
105947832|NCT00854360|365473454|FG000|Overall Study|Pregnancy|0|||
105947833|NCT00854360|365473455|FG001|Overall Study|Pregnancy|1|||
105947834|NCT00854360|365473456|FG002|Overall Study|Pregnancy|0|||
105947835|NCT00854360|365473457|FG003|Overall Study|Pregnancy|0|||
105947836|NCT00854360|365473454|FG000|Overall Study|Lack of Efficacy|2|||
105947837|NCT00854360|365473455|FG001|Overall Study|Lack of Efficacy|1|||
105947838|NCT00854360|365473456|FG002|Overall Study|Lack of Efficacy|0|||
105947839|NCT00854360|365473457|FG003|Overall Study|Lack of Efficacy|0|||
105947840|NCT00854360|365473454|FG000|Overall Study|Other|0|||
105947841|NCT00854360|365473455|FG001|Overall Study|Other|0|||
105947842|NCT00854360|365473456|FG002|Overall Study|Other|0|||
105947843|NCT00854360|365473457|FG003|Overall Study|Other|3|||
105947844|NCT02949011|365473458|FG000|Overall Study|Adverse Event|6|||
105947845|NCT02949011|365473459|FG001|Overall Study|Adverse Event|7|||
105947846|NCT02949011|365473460|FG002|Overall Study|Adverse Event|3|||
105947847|NCT02949011|365473458|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
105947848|NCT02949011|365473459|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
105947849|NCT02949011|365473460|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
105947850|NCT02949011|365473458|FG000|Overall Study|Protocol Deviation|5|||
105947851|NCT02949011|365473459|FG001|Overall Study|Protocol Deviation|3|||
105947852|NCT02949011|365473460|FG002|Overall Study|Protocol Deviation|3|||
105947853|NCT02949011|365473458|FG000|Overall Study|Lack of Efficacy|0|||
105947854|NCT02949011|365473459|FG001|Overall Study|Lack of Efficacy|2|||
105947855|NCT02949011|365473460|FG002|Overall Study|Lack of Efficacy|0|||
105947856|NCT02949011|365473458|FG000|Overall Study|Withdrawal by Subject|13|||
105947857|NCT02949011|365473459|FG001|Overall Study|Withdrawal by Subject|13|||
105947858|NCT02949011|365473460|FG002|Overall Study|Withdrawal by Subject|21|||
105947859|NCT02949011|365473458|FG000|Overall Study|Lost to Follow-up|7|||
105947860|NCT02949011|365473459|FG001|Overall Study|Lost to Follow-up|5|||
105947861|NCT02949011|365473460|FG002|Overall Study|Lost to Follow-up|5|||
105947862|NCT02949011|365473458|FG000|Overall Study|Death|0|||
105947863|NCT02949011|365473459|FG001|Overall Study|Death|0|||
105947864|NCT02949011|365473460|FG002|Overall Study|Death|1|||
105947865|NCT02949011|365473458|FG000|Overall Study|Miscellaneous|2|||
105947866|NCT02949011|365473459|FG001|Overall Study|Miscellaneous|4|||
105947867|NCT02949011|365473460|FG002|Overall Study|Miscellaneous|6|||
105947868|NCT02037529|365473463|FG000|Overall Study|Withdrawal by Subject|1|||
105947869|NCT02037529|365473464|FG001|Overall Study|Withdrawal by Subject|3|||
105947870|NCT02037529|365473463|FG000|Overall Study|Adverse Event|0|||
105947871|NCT02037529|365473464|FG001|Overall Study|Adverse Event|1|||
105947872|NCT02441218|365473465|FG000|Overall Study|Death|503|||
105947873|NCT02441218|365473466|FG001|Overall Study|Death|553|||
105947874|NCT02441218|365473465|FG000|Overall Study|Withdrawal by Subject|73|||
105947875|NCT02441218|365473466|FG001|Overall Study|Withdrawal by Subject|58|||
105947876|NCT02441218|365473465|FG000|Overall Study|Lost to Follow-up|2|||
105947877|NCT02441218|365473466|FG001|Overall Study|Lost to Follow-up|1|||
105947878|NCT00718315|365473467|FG000|Overall Study|Adverse Event|1|||
105947879|NCT00718315|365473468|FG001|Overall Study|Adverse Event|2|||
105752025|NCT01885078|364744580|FG004|Step-down Period|Lack of Efficacy|0|||
105752026|NCT01885078|364744581|FG005|Step-down Period|Lack of Efficacy|0|||
105752027|NCT01885078|364744582|FG006|Step-down Period|Lack of Efficacy|0|||
105947880|NCT00718315|365473469|FG002|Overall Study|Adverse Event|3|||
105947881|NCT00718315|365473467|FG000|Overall Study|Death|6|||
105947882|NCT00718315|365473468|FG001|Overall Study|Death|6|||
105947883|NCT00718315|365473469|FG002|Overall Study|Death|5|||
105947884|NCT00718315|365473467|FG000|Overall Study|Lost to Follow-up|2|||
105947885|NCT00718315|365473468|FG001|Overall Study|Lost to Follow-up|3|||
105947886|NCT00718315|365473469|FG002|Overall Study|Lost to Follow-up|4|||
105947887|NCT00718315|365473467|FG000|Overall Study|Protocol Violation|5|||
105752028|NCT01885078|364744583|FG007|Step-down Period|Lack of Efficacy|0|||
105752029|NCT01885078|364744584|FG008|Step-down Period|Lack of Efficacy|1|||
105752030|NCT01885078|364744585|FG009|Step-down Period|Lack of Efficacy|0|||
105752031|NCT01885078|364744576|FG000|Step-down Period|Protocol Violation|0|||
105752032|NCT01885078|364744577|FG001|Step-down Period|Protocol Violation|0|||
105752033|NCT01885078|364744578|FG002|Step-down Period|Protocol Violation|0|||
105752034|NCT01885078|364744579|FG003|Step-down Period|Protocol Violation|0|||
105752035|NCT01885078|364744580|FG004|Step-down Period|Protocol Violation|0|||
105752036|NCT01885078|364744581|FG005|Step-down Period|Protocol Violation|0|||
105752037|NCT01885078|364744582|FG006|Step-down Period|Protocol Violation|0|||
105752038|NCT01885078|364744583|FG007|Step-down Period|Protocol Violation|0|||
105752039|NCT01885078|364744584|FG008|Step-down Period|Protocol Violation|1|||
105752040|NCT01885078|364744585|FG009|Step-down Period|Protocol Violation|1|||
105752041|NCT03115112|364744586|FG000|Overall Study|Adverse Event|5|||
105752042|NCT03115112|364744587|FG001|Overall Study|Adverse Event|1|||
105752043|NCT03115112|364744586|FG000|Overall Study|Withdrawal by Subject|4|||
105752044|NCT03115112|364744587|FG001|Overall Study|Withdrawal by Subject|2|||
105752045|NCT03115112|364744586|FG000|Overall Study|Lost to Follow-up|0|||
105752046|NCT03115112|364744587|FG001|Overall Study|Lost to Follow-up|1|||
105752047|NCT03115112|364744586|FG000|Overall Study|Death|1|||
105752048|NCT03115112|364744587|FG001|Overall Study|Death|0|||
105752049|NCT03115112|364744586|FG000|Overall Study|Pregnancy|1|||
105752050|NCT03115112|364744587|FG001|Overall Study|Pregnancy|0|||
105752051|NCT03115112|364744586|FG000|Overall Study|Site closure|1|||
105752052|NCT03115112|364744587|FG001|Overall Study|Site closure|1|||
105752053|NCT02168803|364744588|FG000|Overall Study|Lost to Follow-up|1|||
105752054|NCT02168803|364744589|FG001|Overall Study|Lost to Follow-up|0|||
105752055|NCT02168803|364744590|FG002|Overall Study|Lost to Follow-up|1|||
105752056|NCT02168803|364744588|FG000|Overall Study|Withdrawal by Subject|1|||
105752057|NCT02168803|364744589|FG001|Overall Study|Withdrawal by Subject|1|||
105947888|NCT00718315|365473468|FG001|Overall Study|Protocol Violation|5|||
105947889|NCT00718315|365473469|FG002|Overall Study|Protocol Violation|3|||
105947890|NCT00718315|365473467|FG000|Overall Study|Erlotinib dose decreased|4|||
105947891|NCT00718315|365473468|FG001|Overall Study|Erlotinib dose decreased|3|||
105947892|NCT00718315|365473469|FG002|Overall Study|Erlotinib dose decreased|1|||
105947893|NCT00718315|365473467|FG000|Overall Study|Use of Minocyclin|1|||
105947894|NCT00718315|365473468|FG001|Overall Study|Use of Minocyclin|1|||
105947895|NCT00718315|365473469|FG002|Overall Study|Use of Minocyclin|1|||
105947896|NCT00718315|365473467|FG000|Overall Study|Disease progression|0|||
105947897|NCT00718315|365473468|FG001|Overall Study|Disease progression|1|||
105947898|NCT00718315|365473469|FG002|Overall Study|Disease progression|1|||
105947899|NCT00718315|365473467|FG000|Overall Study|Other|0|||
105947900|NCT00718315|365473468|FG001|Overall Study|Other|0|||
105947901|NCT00718315|365473469|FG002|Overall Study|Other|1|||
105947902|NCT00718315|365473467|FG000|Overall Study|Use of ATB and Corticoids|0|||
105947903|NCT00718315|365473468|FG001|Overall Study|Use of ATB and Corticoids|1|||
105947904|NCT00718315|365473469|FG002|Overall Study|Use of ATB and Corticoids|2|||
105947905|NCT00163189|365473470|FG000|Overall Study|Other|6|||
105947906|NCT00163189|365473470|FG000|Overall Study|Lost to Follow-up|1|||
105947907|NCT00163189|365473470|FG000|Overall Study|Protocol Violation|2|||
105947908|NCT00163189|365473470|FG000|Overall Study|Death|3|||
105947909|NCT00163189|365473470|FG000|Overall Study|Adverse Event|6|||
105947910|NCT00163189|365473470|FG000|Overall Study|Lack of Efficacy|7|||
105947911|NCT00163189|365473470|FG000|Overall Study|Study terminated by sponsor|11|||
105947912|NCT00163189|365473470|FG000|Overall Study|Withdrawal by Subject|11|||
105947913|NCT00163189|365473470|FG000|Overall Study|Did not meet continuation criterion|16|||
105947914|NCT02271880|365473472|FG000|Overall Study|Premature discontinuation of study|3|||
105947915|NCT02271880|365473473|FG001|Overall Study|Premature discontinuation of study|4|||
105947916|NCT00806585|365473475|FG000|Overall Study|Study terminated by Sponsor|0|||
105947917|NCT00806585|365473476|FG001|Overall Study|Study terminated by Sponsor|0|||
105947918|NCT00806585|365473477|FG002|Overall Study|Study terminated by Sponsor|1|||
105947919|NCT00806585|365473478|FG003|Overall Study|Study terminated by Sponsor|2|||
105947920|NCT00806585|365473479|FG004|Overall Study|Study terminated by Sponsor|0|||
105947921|NCT00806585|365473475|FG000|Overall Study|Protocol Violation|3|||
105947922|NCT00806585|365473476|FG001|Overall Study|Protocol Violation|1|||
105947923|NCT00806585|365473477|FG002|Overall Study|Protocol Violation|2|||
105947924|NCT00806585|365473478|FG003|Overall Study|Protocol Violation|0|||
105947925|NCT00806585|365473479|FG004|Overall Study|Protocol Violation|0|||
105947926|NCT00806585|365473475|FG000|Overall Study|Physician Decision|0|||
105947927|NCT00806585|365473476|FG001|Overall Study|Physician Decision|2|||
105947928|NCT00806585|365473477|FG002|Overall Study|Physician Decision|3|||
105947929|NCT00806585|365473478|FG003|Overall Study|Physician Decision|0|||
105947930|NCT00806585|365473479|FG004|Overall Study|Physician Decision|1|||
105752058|NCT02168803|364744590|FG002|Overall Study|Withdrawal by Subject|2|||
105752059|NCT02168803|364744588|FG000|Overall Study|Physician Decision|0|||
105752060|NCT02168803|364744589|FG001|Overall Study|Physician Decision|1|||
105752061|NCT02168803|364744590|FG002|Overall Study|Physician Decision|0|||
105752062|NCT02168803|364744588|FG000|Overall Study|Adverse Event|0|||
105947931|NCT00806585|365473475|FG000|Overall Study|Lost to Follow-up|2|||
105752063|NCT02168803|364744589|FG001|Overall Study|Adverse Event|1|||
105752064|NCT02168803|364744590|FG002|Overall Study|Adverse Event|1|||
105752065|NCT02168803|364744588|FG000|Overall Study|Death|0|||
105752066|NCT02168803|364744589|FG001|Overall Study|Death|0|||
105752067|NCT02168803|364744590|FG002|Overall Study|Death|1|||
105752068|NCT02168803|364744588|FG000|Overall Study|Sponsor Decision|0|||
105752069|NCT02168803|364744589|FG001|Overall Study|Sponsor Decision|0|||
105752070|NCT02168803|364744590|FG002|Overall Study|Sponsor Decision|1|||
105752071|NCT01107405|364744591|FG000|Overall Study|Adverse Event|1|||
105752072|NCT01107405|364744592|FG001|Overall Study|Adverse Event|1|||
105752073|NCT01107405|364744593|FG002|Overall Study|Adverse Event|0|||
105752074|NCT01107405|364744594|FG003|Overall Study|Adverse Event|0|||
105752075|NCT01107405|364744595|FG004|Overall Study|Adverse Event|2|||
105752076|NCT01107405|364744591|FG000|Overall Study|Withdrawal by Subject|1|||
105752077|NCT01107405|364744592|FG001|Overall Study|Withdrawal by Subject|0|||
105752078|NCT01107405|364744593|FG002|Overall Study|Withdrawal by Subject|1|||
105752079|NCT01107405|364744594|FG003|Overall Study|Withdrawal by Subject|2|||
105752080|NCT01107405|364744595|FG004|Overall Study|Withdrawal by Subject|1|||
105752081|NCT01107405|364744591|FG000|Overall Study|Protocol Violation|0|||
105752082|NCT01107405|364744592|FG001|Overall Study|Protocol Violation|0|||
105752083|NCT01107405|364744593|FG002|Overall Study|Protocol Violation|1|||
105752084|NCT01107405|364744594|FG003|Overall Study|Protocol Violation|1|||
105752085|NCT01107405|364744595|FG004|Overall Study|Protocol Violation|0|||
105752086|NCT01653158|364744596|FG000|Overall Study|Death|0|||
105752087|NCT01653158|364744597|FG001|Overall Study|Death|0|||
105752088|NCT01653158|364744598|FG002|Overall Study|Death|0|||
105752089|NCT01653158|364744599|FG003|Overall Study|Death|1|||
105752090|NCT01653158|364744600|FG004|Overall Study|Death|0|||
105752091|NCT01653158|364744601|FG005|Overall Study|Death|0|||
105752092|NCT01653158|364744602|FG006|Overall Study|Death|0|||
105752093|NCT01653158|364744603|FG007|Overall Study|Death|2|||
105752094|NCT01653158|364744596|FG000|Overall Study|Adverse Event|0|||
105752095|NCT01653158|364744597|FG001|Overall Study|Adverse Event|0|||
106016365|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016366|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016367|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016368|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
106016369|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016370|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016371|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016372|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016373|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016374|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016375|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016376|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
106016377|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016378|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016379|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016380|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
106016381|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
106016382|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016383|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016384|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
106016385|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
106016386|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016387|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016388|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016389|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016390|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
106016391|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016392|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016393|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016394|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016395|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105752096|NCT01653158|364744598|FG002|Overall Study|Adverse Event|0|||
105752097|NCT01653158|364744599|FG003|Overall Study|Adverse Event|1|||
105752098|NCT01653158|364744600|FG004|Overall Study|Adverse Event|0|||
105752099|NCT01653158|364744601|FG005|Overall Study|Adverse Event|0|||
105752100|NCT01653158|364744602|FG006|Overall Study|Adverse Event|0|||
105752101|NCT01653158|364744603|FG007|Overall Study|Adverse Event|3|||
105752102|NCT01653158|364744596|FG000|Overall Study|Other|0|||
105752103|NCT01653158|364744597|FG001|Overall Study|Other|0|||
105752104|NCT01653158|364744598|FG002|Overall Study|Other|0|||
105947932|NCT00806585|365473476|FG001|Overall Study|Lost to Follow-up|1|||
105947933|NCT00806585|365473477|FG002|Overall Study|Lost to Follow-up|2|||
105947934|NCT00806585|365473478|FG003|Overall Study|Lost to Follow-up|2|||
105947935|NCT00806585|365473479|FG004|Overall Study|Lost to Follow-up|5|||
105947936|NCT00806585|365473475|FG000|Overall Study|Lack of Efficacy|1|||
105947937|NCT00806585|365473476|FG001|Overall Study|Lack of Efficacy|0|||
105947938|NCT00806585|365473477|FG002|Overall Study|Lack of Efficacy|0|||
105947939|NCT00806585|365473478|FG003|Overall Study|Lack of Efficacy|0|||
105947940|NCT00806585|365473479|FG004|Overall Study|Lack of Efficacy|0|||
105947941|NCT00806585|365473475|FG000|Overall Study|Adverse Event|1|||
105752105|NCT01653158|364744599|FG003|Overall Study|Other|0|||
105752106|NCT01653158|364744600|FG004|Overall Study|Other|0|||
105752107|NCT01653158|364744601|FG005|Overall Study|Other|0|||
105752108|NCT01653158|364744602|FG006|Overall Study|Other|0|||
105752109|NCT01653158|364744603|FG007|Overall Study|Other|1|||
105752110|NCT01653158|364744596|FG000|Overall Study|Progressive disease|0|||
105752111|NCT01653158|364744597|FG001|Overall Study|Progressive disease|0|||
105752112|NCT01653158|364744598|FG002|Overall Study|Progressive disease|0|||
105752113|NCT01653158|364744599|FG003|Overall Study|Progressive disease|0|||
105752114|NCT01653158|364744600|FG004|Overall Study|Progressive disease|1|||
105752115|NCT01653158|364744601|FG005|Overall Study|Progressive disease|1|||
105752116|NCT01653158|364744602|FG006|Overall Study|Progressive disease|2|||
105752117|NCT01653158|364744603|FG007|Overall Study|Progressive disease|9|||
105752118|NCT01653158|364744596|FG000|Overall Study|Withdrawal by Subject|1|||
105752119|NCT01653158|364744597|FG001|Overall Study|Withdrawal by Subject|0|||
105752120|NCT01653158|364744598|FG002|Overall Study|Withdrawal by Subject|0|||
105752121|NCT01653158|364744599|FG003|Overall Study|Withdrawal by Subject|0|||
105752122|NCT01653158|364744600|FG004|Overall Study|Withdrawal by Subject|0|||
105752123|NCT01653158|364744601|FG005|Overall Study|Withdrawal by Subject|0|||
105752124|NCT01653158|364744602|FG006|Overall Study|Withdrawal by Subject|0|||
105752125|NCT01653158|364744603|FG007|Overall Study|Withdrawal by Subject|0|||
105752126|NCT00980343|364744606|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
105752127|NCT00980343|364744607|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
105752128|NCT00848250|364744613|FG000|Overall Study|surgery was completed without cardiopulm|0|||
105752129|NCT00848250|364744614|FG001|Overall Study|surgery was completed without cardiopulm|1|||
105752130|NCT01205451|364744615|FG000|Overall Study|Lost to Follow-up|1|||
105752131|NCT01205451|364744616|FG001|Overall Study|Lost to Follow-up|1|||
105752132|NCT01205451|364744615|FG000|Overall Study|Withdrawal by Subject|5|||
105752133|NCT01205451|364744616|FG001|Overall Study|Withdrawal by Subject|9|||
105752134|NCT03457103|364744617|FG000|Overall Study|illness/hospitalization|4|||
105752135|NCT03457103|364744618|FG001|Overall Study|illness/hospitalization|2|||
105752136|NCT03457103|364744617|FG000|Overall Study|Lost to Follow-up|2|||
105752137|NCT03457103|364744618|FG001|Overall Study|Lost to Follow-up|1|||
105752138|NCT03457103|364744617|FG000|Overall Study|Withdrawal by Subject|1|||
105752139|NCT03457103|364744618|FG001|Overall Study|Withdrawal by Subject|2|||
105752140|NCT03457103|364744617|FG000|Overall Study|financial/ insurance issues|1|||
105752141|NCT03457103|364744618|FG001|Overall Study|financial/ insurance issues|1|||
105752142|NCT03004469|364744619|FG000|Overall Study|Adverse Event|6|||
105752143|NCT03004469|364744620|FG001|Overall Study|Adverse Event|4|||
105752144|NCT03004469|364744621|FG002|Overall Study|Adverse Event|6|||
105752145|NCT03004469|364744619|FG000|Overall Study|Lack of Efficacy|1|||
105752146|NCT03004469|364744620|FG001|Overall Study|Lack of Efficacy|0|||
105752147|NCT03004469|364744621|FG002|Overall Study|Lack of Efficacy|1|||
105752148|NCT03004469|364744619|FG000|Overall Study|Lost to Follow-up|23|||
105752149|NCT03004469|364744620|FG001|Overall Study|Lost to Follow-up|14|||
105752150|NCT03004469|364744621|FG002|Overall Study|Lost to Follow-up|6|||
105752151|NCT03004469|364744619|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105752152|NCT03004469|364744620|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105752153|NCT03004469|364744621|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105752154|NCT03004469|364744619|FG000|Overall Study|Protocol Violation|0|||
105947942|NCT00806585|365473476|FG001|Overall Study|Adverse Event|5|||
105752155|NCT03004469|364744620|FG001|Overall Study|Protocol Violation|0|||
105752156|NCT03004469|364744621|FG002|Overall Study|Protocol Violation|1|||
105752157|NCT03004469|364744619|FG000|Overall Study|Withdrawal by Subject|29|||
105752158|NCT03004469|364744620|FG001|Overall Study|Withdrawal by Subject|27|||
105752159|NCT03004469|364744621|FG002|Overall Study|Withdrawal by Subject|10|||
105752160|NCT03004469|364744619|FG000|Overall Study|Other unspecified reason|0|||
105752161|NCT03004469|364744620|FG001|Overall Study|Other unspecified reason|4|||
105752162|NCT03004469|364744621|FG002|Overall Study|Other unspecified reason|1|||
105752163|NCT00259740|364744622|FG000|Overall Study|Physician Decision|1|||
105752164|NCT00259740|364744623|FG001|Overall Study|Physician Decision|1|||
105752165|NCT00259740|364744622|FG000|Overall Study|Adverse Event|0|||
105947943|NCT00806585|365473477|FG002|Overall Study|Adverse Event|3|||
105752166|NCT00259740|364744623|FG001|Overall Study|Adverse Event|2|||
105752167|NCT00259740|364744622|FG000|Overall Study|Withdrawal by Subject|2|||
105752168|NCT00259740|364744623|FG001|Overall Study|Withdrawal by Subject|6|||
105752169|NCT00259740|364744622|FG000|Overall Study|Death|1|||
105752170|NCT00259740|364744623|FG001|Overall Study|Death|1|||
105752171|NCT00259740|364744622|FG000|Overall Study|Disease progression|19|||
105752172|NCT00259740|364744623|FG001|Overall Study|Disease progression|36|||
105752173|NCT00259740|364744622|FG000|Overall Study|Ongoing|17|||
105752174|NCT00259740|364744623|FG001|Overall Study|Ongoing|3|||
105752175|NCT00259740|364744622|FG000|Overall Study|Other|3|||
105752176|NCT00259740|364744623|FG001|Overall Study|Other|0|||
105752177|NCT00259740|364744622|FG000|Overall Study|Requirement for alternative therapy|0|||
105752178|NCT00259740|364744623|FG001|Overall Study|Requirement for alternative therapy|4|||
105752179|NCT00502320|364744624|FG000|Overall Study|Lost to Follow-up|1|||
105752180|NCT00502320|364744625|FG001|Overall Study|Lost to Follow-up|1|||
105752181|NCT00502320|364744624|FG000|Overall Study|Withdrew Consent|1|||
105752182|NCT00502320|364744625|FG001|Overall Study|Withdrew Consent|0|||
105752183|NCT00502320|364744624|FG000|Overall Study|No longer met criteria|1|||
105752184|NCT00502320|364744625|FG001|Overall Study|No longer met criteria|0|||
105752185|NCT00502320|364744624|FG000|Overall Study|Screen Failure|0|||
105752186|NCT00502320|364744625|FG001|Overall Study|Screen Failure|1|||
105752187|NCT00502320|364744624|FG000|Overall Study|Adverse Event|3|||
105752188|NCT00502320|364744625|FG001|Overall Study|Adverse Event|5|||
105752189|NCT02394808|364744626|FG000|Period 1|Unsatisfactory lens fitting|0|||
105752190|NCT02394808|364744627|FG001|Period 1|Unsatisfactory lens fitting|1|||
105752191|NCT02394808|364744626|FG000|Period 2|Lost to Follow-up|1|||
105752192|NCT02394808|364744627|FG001|Period 2|Lost to Follow-up|0|||
105752193|NCT00125190|364744628|FG000|Overall Study|Subject/Parent Decision|7|||
105752194|NCT00125190|364744628|FG000|Overall Study|Non-compliance|2|||
105752195|NCT00125190|364744628|FG000|Overall Study|Adverse Event|1|||
105752196|NCT00125190|364744628|FG000|Overall Study|Other|1|||
105752197|NCT00125190|364744628|FG000|Overall Study|Lost to Follow-up|4|||
105752198|NCT00916370|364744632|FG000|Overall Study|Death|3|||
105752199|NCT00916370|364744633|FG001|Overall Study|Death|1|||
105752200|NCT00916370|364744632|FG000|Overall Study|Withdrawal by Subject|2|||
105752201|NCT00916370|364744633|FG001|Overall Study|Withdrawal by Subject|0|||
105752202|NCT00916370|364744632|FG000|Overall Study|Physician Decision|0|||
105752203|NCT00916370|364744633|FG001|Overall Study|Physician Decision|1|||
105752204|NCT03105700|364744638|FG000|Overall Study|screen fail|3|||
105752205|NCT03105700|364744638|FG000|Overall Study|Lost to Follow-up|4|||
105752206|NCT01586156|364744639|FG000|Overall Study|Pregnancy|0|||
105752207|NCT01586156|364744640|FG001|Overall Study|Pregnancy|1|||
105752208|NCT01586156|364744641|FG002|Overall Study|Pregnancy|0|||
105752209|NCT00547378|364744642|FG000|Randomized Cohort|Withdrawal by Subject|7|||
105752210|NCT00547378|364744643|FG001|Randomized Cohort|Withdrawal by Subject|5|||
105752211|NCT00547378|364744644|FG002|Randomized Cohort|Withdrawal by Subject|0|||
105752212|NCT00547378|364744642|FG000|Randomized Cohort|Death|0|||
105752213|NCT00547378|364744643|FG001|Randomized Cohort|Death|1|||
105752214|NCT00547378|364744644|FG002|Randomized Cohort|Death|0|||
105752215|NCT00547378|364744642|FG000|Randomized Cohort|Lost to Follow-up|1|||
105752216|NCT00547378|364744643|FG001|Randomized Cohort|Lost to Follow-up|0|||
105752217|NCT00547378|364744644|FG002|Randomized Cohort|Lost to Follow-up|0|||
105752218|NCT00547378|364744642|FG000|Randomized Cohort|Adverse Event|1|||
105752219|NCT00547378|364744643|FG001|Randomized Cohort|Adverse Event|0|||
105752220|NCT00547378|364744644|FG002|Randomized Cohort|Adverse Event|0|||
105752221|NCT00547378|364744642|FG000|Randomized Cohort|Other reasons|2|||
105752222|NCT00547378|364744643|FG001|Randomized Cohort|Other reasons|0|||
105752223|NCT00547378|364744644|FG002|Randomized Cohort|Other reasons|0|||
105752224|NCT00547378|364744642|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
105752225|NCT00547378|364744643|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
105752226|NCT00547378|364744644|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
105752227|NCT00547378|364744642|FG000|All Implanted Cohort|Adverse Event|4|||
105752228|NCT00547378|364744643|FG001|All Implanted Cohort|Adverse Event|10|||
105752229|NCT00547378|364744644|FG002|All Implanted Cohort|Adverse Event|17|||
105752230|NCT00547378|364744642|FG000|All Implanted Cohort|Lost to Follow-up|0|||
105752231|NCT00547378|364744643|FG001|All Implanted Cohort|Lost to Follow-up|1|||
105752232|NCT00547378|364744644|FG002|All Implanted Cohort|Lost to Follow-up|14|||
105752233|NCT00547378|364744642|FG000|All Implanted Cohort|Death|3|||
105752234|NCT00547378|364744643|FG001|All Implanted Cohort|Death|1|||
105752235|NCT00547378|364744644|FG002|All Implanted Cohort|Death|4|||
105752236|NCT00547378|364744642|FG000|All Implanted Cohort|Physician Decision|0|||
105752237|NCT00547378|364744643|FG001|All Implanted Cohort|Physician Decision|2|||
105752238|NCT00547378|364744644|FG002|All Implanted Cohort|Physician Decision|6|||
105752239|NCT00547378|364744642|FG000|All Implanted Cohort|Site closure|2|||
105752240|NCT00547378|364744643|FG001|All Implanted Cohort|Site closure|0|||
105752241|NCT00547378|364744644|FG002|All Implanted Cohort|Site closure|1|||
105752242|NCT00547378|364744642|FG000|All Implanted Cohort|Other reasons|1|||
105752243|NCT00547378|364744643|FG001|All Implanted Cohort|Other reasons|0|||
105752244|NCT00547378|364744644|FG002|All Implanted Cohort|Other reasons|1|||
105752245|NCT02768194|364744645|FG000|Period 1|Adverse Event|0|||
105752246|NCT02768194|364744646|FG001|Period 1|Adverse Event|0|||
105752247|NCT02768194|364744647|FG002|Period 1|Adverse Event|0|||
105752248|NCT02768194|364744648|FG003|Period 1|Adverse Event|1|||
105752249|NCT02768194|364744649|FG004|Period 1|Adverse Event|0|||
105752250|NCT02768194|364744650|FG005|Period 1|Adverse Event|0|||
105752251|NCT02768194|364744645|FG000|Period 2|Other (Reason not specified)|1|||
105752252|NCT02768194|364744646|FG001|Period 2|Other (Reason not specified)|0|||
105752253|NCT02768194|364744647|FG002|Period 2|Other (Reason not specified)|0|||
105752254|NCT02768194|364744648|FG003|Period 2|Other (Reason not specified)|0|||
105752255|NCT02768194|364744649|FG004|Period 2|Other (Reason not specified)|0|||
105752256|NCT02768194|364744650|FG005|Period 2|Other (Reason not specified)|0|||
105752257|NCT02768194|364744645|FG000|Period 3|Other (Reason not specified)|0|||
105752258|NCT02768194|364744646|FG001|Period 3|Other (Reason not specified)|1|||
105752259|NCT02768194|364744647|FG002|Period 3|Other (Reason not specified)|0|||
105752260|NCT02768194|364744648|FG003|Period 3|Other (Reason not specified)|0|||
105752261|NCT02768194|364744649|FG004|Period 3|Other (Reason not specified)|0|||
105752262|NCT02768194|364744650|FG005|Period 3|Other (Reason not specified)|0|||
105752263|NCT01318512|364744651|FG000|Maintenance Period (6 Months)|Death|2|||
105752264|NCT01318512|364744651|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
105752265|NCT04863014|364744652|FG000|Overall Study|Lost to Follow-up|3|||
105752266|NCT04863014|364744653|FG001|Overall Study|Lost to Follow-up|2|||
105752267|NCT04863014|364744652|FG000|Overall Study|Subject Decision|0|||
105752268|NCT04863014|364744653|FG001|Overall Study|Subject Decision|4|||
105752269|NCT00975195|364744657|FG000|Overall Study|Adverse Event|108|||
105752270|NCT00975195|364744658|FG001|Overall Study|Adverse Event|101|||
105752271|NCT00975195|364744657|FG000|Overall Study|Lack of Efficacy|6|||
105752272|NCT00975195|364744658|FG001|Overall Study|Lack of Efficacy|6|||
105947944|NCT00806585|365473478|FG003|Overall Study|Adverse Event|4|||
105947945|NCT00806585|365473479|FG004|Overall Study|Adverse Event|2|||
105947946|NCT00806585|365473475|FG000|Overall Study|Withdrawal by Subject|10|||
105947947|NCT00806585|365473476|FG001|Overall Study|Withdrawal by Subject|8|||
105947948|NCT00806585|365473477|FG002|Overall Study|Withdrawal by Subject|9|||
105752273|NCT00975195|364744657|FG000|Overall Study|Protocol Violation|27|||
105752274|NCT00975195|364744658|FG001|Overall Study|Protocol Violation|23|||
105752275|NCT00975195|364744657|FG000|Overall Study|Lost to Follow-up|9|||
105752276|NCT00975195|364744658|FG001|Overall Study|Lost to Follow-up|7|||
105752277|NCT00975195|364744657|FG000|Overall Study|Withdrawal by Subject|48|||
105752278|NCT00975195|364744658|FG001|Overall Study|Withdrawal by Subject|61|||
105752279|NCT00975195|364744657|FG000|Overall Study|Other reason not defined above|29|||
105752280|NCT00975195|364744658|FG001|Overall Study|Other reason not defined above|33|||
105752281|NCT00975195|364744657|FG000|Overall Study|Not treated|1|||
105752282|NCT00975195|364744658|FG001|Overall Study|Not treated|2|||
105752283|NCT00363246|364744659|FG000|Overall Study|Death|40|||
105752284|NCT00363246|364744659|FG000|Overall Study|Withdrawal by Subject|19|||
105752285|NCT00363246|364744659|FG000|Overall Study|Lost to Follow-up|14|||
105752286|NCT00363246|364744659|FG000|Overall Study|Bad health|6|||
105752287|NCT00363246|364744659|FG000|Overall Study|Stopped using wheelchair|11|||
105752288|NCT00363246|364744659|FG000|Overall Study|Subject expressed security concerns|2|||
105752289|NCT00363246|364744659|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
105752290|NCT01822691|364744660|FG000|Overall Study|Withdrawal by Subject|2|||
105752291|NCT01553916|364744661|FG000|Overall Study|Withdrawal by Subject|2|||
105752292|NCT01553916|364744661|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
105947949|NCT00806585|365473478|FG003|Overall Study|Withdrawal by Subject|3|||
105947950|NCT00806585|365473479|FG004|Overall Study|Withdrawal by Subject|11|||
105752293|NCT04348591|364744666|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
105752294|NCT04348591|364744667|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
105752295|NCT04348591|364744666|FG000|Imaging Session (120 Min)|Physician Decision|0|||
105752296|NCT04348591|364744667|FG001|Imaging Session (120 Min)|Physician Decision|1|||
105752297|NCT04348591|364744666|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
105752298|NCT04348591|364744667|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
105752299|NCT01778127|364744668|FG000|Overall Study|Lost to Follow-up|5|||
105752300|NCT01778127|364744669|FG001|Overall Study|Lost to Follow-up|1|||
105752301|NCT01778127|364744670|FG002|Overall Study|Lost to Follow-up|2|||
105752302|NCT01778127|364744668|FG000|Overall Study|Withdrawal by Subject|3|||
105752303|NCT01778127|364744669|FG001|Overall Study|Withdrawal by Subject|1|||
105752304|NCT01778127|364744670|FG002|Overall Study|Withdrawal by Subject|4|||
105752305|NCT01968954|364744671|FG000|Overall Study|Adverse Event|6|||
105752306|NCT01968954|364744672|FG001|Overall Study|Adverse Event|3|||
105752307|NCT01968954|364744671|FG000|Overall Study|Death|1|||
105752308|NCT01968954|364744672|FG001|Overall Study|Death|2|||
105752309|NCT01968954|364744671|FG000|Overall Study|Lost to Follow-up|6|||
105752310|NCT01968954|364744672|FG001|Overall Study|Lost to Follow-up|4|||
105752311|NCT01968954|364744671|FG000|Overall Study|Withdrawal by Subject|20|||
105947951|NCT00806585|365473475|FG000|Overall Study|Completion status unknown|15|||
105947952|NCT00806585|365473476|FG001|Overall Study|Completion status unknown|14|||
105752312|NCT01968954|364744672|FG001|Overall Study|Withdrawal by Subject|23|||
105752313|NCT01968954|364744671|FG000|Overall Study|Other|7|||
105752314|NCT01968954|364744672|FG001|Overall Study|Other|8|||
105752315|NCT01968954|364744671|FG000|Overall Study|Protocol Violation|0|||
105752316|NCT01968954|364744672|FG001|Overall Study|Protocol Violation|1|||
105752317|NCT01968954|364744671|FG000|Overall Study|Did not met inclusion criteria|0|||
105752318|NCT01968954|364744672|FG001|Overall Study|Did not met inclusion criteria|2|||
105752319|NCT02648724|364744673|FG000|Overall Study|Withdrawal by Subject|0|||
105752320|NCT02648724|364744674|FG001|Overall Study|Withdrawal by Subject|1|||
105752321|NCT02648724|364744675|FG002|Overall Study|Withdrawal by Subject|1|||
105752322|NCT02648724|364744676|FG003|Overall Study|Withdrawal by Subject|0|||
105752323|NCT02648724|364744677|FG004|Overall Study|Withdrawal by Subject|1|||
105752324|NCT02648724|364744678|FG005|Overall Study|Withdrawal by Subject|0|||
105752325|NCT02648724|364744679|FG006|Overall Study|Withdrawal by Subject|0|||
105752326|NCT02648724|364744673|FG000|Overall Study|Progressive disease|2|||
105752327|NCT02648724|364744674|FG001|Overall Study|Progressive disease|2|||
105752328|NCT02648724|364744675|FG002|Overall Study|Progressive disease|2|||
105752329|NCT02648724|364744676|FG003|Overall Study|Progressive disease|3|||
105752330|NCT02648724|364744677|FG004|Overall Study|Progressive disease|22|||
105752331|NCT02648724|364744678|FG005|Overall Study|Progressive disease|7|||
105752332|NCT02648724|364744679|FG006|Overall Study|Progressive disease|8|||
105752333|NCT02648724|364744673|FG000|Overall Study|Other reason (unknown)|1|||
105752334|NCT02648724|364744674|FG001|Overall Study|Other reason (unknown)|0|||
105752335|NCT02648724|364744675|FG002|Overall Study|Other reason (unknown)|0|||
105752336|NCT02648724|364744676|FG003|Overall Study|Other reason (unknown)|0|||
105752337|NCT02648724|364744677|FG004|Overall Study|Other reason (unknown)|0|||
105752338|NCT02648724|364744678|FG005|Overall Study|Other reason (unknown)|0|||
105752339|NCT02648724|364744679|FG006|Overall Study|Other reason (unknown)|0|||
105752340|NCT02648724|364744673|FG000|Overall Study|Protocol Violation|0|||
105752341|NCT02648724|364744674|FG001|Overall Study|Protocol Violation|0|||
105752342|NCT02648724|364744675|FG002|Overall Study|Protocol Violation|0|||
105752343|NCT02648724|364744676|FG003|Overall Study|Protocol Violation|0|||
105752344|NCT02648724|364744677|FG004|Overall Study|Protocol Violation|1|||
105752345|NCT02648724|364744678|FG005|Overall Study|Protocol Violation|0|||
105752346|NCT02648724|364744679|FG006|Overall Study|Protocol Violation|0|||
105752347|NCT02648724|364744673|FG000|Overall Study|Death|0|||
105752348|NCT02648724|364744674|FG001|Overall Study|Death|0|||
105752349|NCT02648724|364744675|FG002|Overall Study|Death|0|||
105752350|NCT02648724|364744676|FG003|Overall Study|Death|0|||
105947953|NCT00806585|365473477|FG002|Overall Study|Completion status unknown|12|||
105947954|NCT00806585|365473478|FG003|Overall Study|Completion status unknown|4|||
105947955|NCT00806585|365473479|FG004|Overall Study|Completion status unknown|12|||
105947956|NCT00506142|365473480|FG000|Overall Study|Adverse Event|8|||
105947957|NCT00506142|365473481|FG001|Overall Study|Adverse Event|7|||
105947958|NCT00506142|365473480|FG000|Overall Study|Lack of Efficacy|21|||
105947959|NCT00506142|365473481|FG001|Overall Study|Lack of Efficacy|7|||
105947960|NCT00506142|365473480|FG000|Overall Study|Withdrawal by Subject|4|||
105947961|NCT00506142|365473481|FG001|Overall Study|Withdrawal by Subject|5|||
105947962|NCT00506142|365473480|FG000|Overall Study|Physician Decision|1|||
105947963|NCT00506142|365473481|FG001|Overall Study|Physician Decision|0|||
105947964|NCT00506142|365473480|FG000|Overall Study|New health condition|1|||
105947965|NCT00506142|365473481|FG001|Overall Study|New health condition|0|||
105947966|NCT00474903|365473482|FG000|Overall Study|Protocol Violation|1|||
105947967|NCT00474903|365473483|FG001|Overall Study|Protocol Violation|5|||
105947968|NCT00474903|365473484|FG002|Overall Study|Protocol Violation|2|||
105947969|NCT00399529|365473485|FG000|Overall Study|Off Study Prior to Treatment|2|||
105947970|NCT03435380|365473486|FG000|Overall Study|Death|1|||
105947971|NCT03435380|365473487|FG001|Overall Study|Death|2|||
105947972|NCT03435380|365473488|FG002|Overall Study|Death|1|||
105947973|NCT03435380|365473486|FG000|Overall Study|Lost to Follow-up|12|||
105947974|NCT03435380|365473487|FG001|Overall Study|Lost to Follow-up|8|||
105947975|NCT03435380|365473488|FG002|Overall Study|Lost to Follow-up|6|||
105752351|NCT02648724|364744677|FG004|Overall Study|Death|0|||
105752352|NCT02648724|364744678|FG005|Overall Study|Death|0|||
105752353|NCT02648724|364744679|FG006|Overall Study|Death|3|||
105752354|NCT02648724|364744673|FG000|Overall Study|Physician Decision|0|||
105752355|NCT02648724|364744674|FG001|Overall Study|Physician Decision|0|||
105752356|NCT02648724|364744675|FG002|Overall Study|Physician Decision|0|||
105752357|NCT02648724|364744676|FG003|Overall Study|Physician Decision|0|||
105752358|NCT02648724|364744677|FG004|Overall Study|Physician Decision|1|||
105752359|NCT02648724|364744678|FG005|Overall Study|Physician Decision|0|||
105752360|NCT02648724|364744679|FG006|Overall Study|Physician Decision|1|||
105752361|NCT02648724|364744673|FG000|Overall Study|Transferred to named patient program|0|||
105947976|NCT03435380|365473486|FG000|Overall Study|Physician Decision|1|||
105947977|NCT03435380|365473487|FG001|Overall Study|Physician Decision|0|||
105947978|NCT03435380|365473488|FG002|Overall Study|Physician Decision|0|||
105947979|NCT03435380|365473486|FG000|Overall Study|Withdrawal by Subject|0|||
105752362|NCT02648724|364744674|FG001|Overall Study|Transferred to named patient program|0|||
105752363|NCT02648724|364744675|FG002|Overall Study|Transferred to named patient program|0|||
105947980|NCT03435380|365473487|FG001|Overall Study|Withdrawal by Subject|1|||
105947981|NCT03435380|365473488|FG002|Overall Study|Withdrawal by Subject|1|||
105947982|NCT03435380|365473486|FG000|Overall Study|Ineligible|0|||
105947983|NCT03435380|365473487|FG001|Overall Study|Ineligible|1|||
105947984|NCT03435380|365473488|FG002|Overall Study|Ineligible|1|||
105947985|NCT01936831|365473489|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105947986|NCT01936831|365473490|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105752364|NCT02648724|364744676|FG003|Overall Study|Transferred to named patient program|0|||
105752365|NCT02648724|364744677|FG004|Overall Study|Transferred to named patient program|0|||
105947987|NCT01936831|365473491|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105947988|NCT01936831|365473492|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105947989|NCT01936831|365473493|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105947990|NCT01936831|365473494|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
105947991|NCT01936831|365473495|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105947992|NCT01936831|365473496|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105947993|NCT01936831|365473497|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
105947994|NCT02133573|365473503|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
105947995|NCT02133573|365473504|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
105947996|NCT02133573|365473503|FG000|Overall Study|Child Deaths|3|||
105947997|NCT02133573|365473504|FG001|Overall Study|Child Deaths|5|||
105947998|NCT02133573|365473503|FG000|Overall Study|Child Declined Follow Ups|2|||
105752366|NCT02648724|364744678|FG005|Overall Study|Transferred to named patient program|1|||
105752367|NCT02648724|364744679|FG006|Overall Study|Transferred to named patient program|0|||
105752368|NCT03655717|364744682|FG000|Overall Study|Withdrawal by Subject|4|||
105752369|NCT03655717|364744683|FG001|Overall Study|Withdrawal by Subject|8|||
105752370|NCT03655717|364744684|FG002|Overall Study|Withdrawal by Subject|1|||
105752371|NCT03655717|364744685|FG003|Overall Study|Withdrawal by Subject|0|||
105752372|NCT03655717|364744686|FG004|Overall Study|Withdrawal by Subject|0|||
105752373|NCT03655717|364744687|FG005|Overall Study|Withdrawal by Subject|1|||
105752374|NCT03655717|364744688|FG006|Overall Study|Withdrawal by Subject|3|||
105752375|NCT03655717|364744689|FG007|Overall Study|Withdrawal by Subject|1|||
105752376|NCT03655717|364744690|FG008|Overall Study|Withdrawal by Subject|2|||
105752377|NCT03655717|364744691|FG009|Overall Study|Withdrawal by Subject|0|||
105752378|NCT03655717|364744692|FG010|Overall Study|Withdrawal by Subject|0|||
105752379|NCT03655717|364744693|FG011|Overall Study|Withdrawal by Subject|1|||
105752380|NCT03655717|364744694|FG012|Overall Study|Withdrawal by Subject|0|||
105752381|NCT03655717|364744695|FG013|Overall Study|Withdrawal by Subject|3|||
105752382|NCT03655717|364744696|FG014|Overall Study|Withdrawal by Subject|0|||
105752383|NCT03655717|364744697|FG015|Overall Study|Withdrawal by Subject|1|||
105752384|NCT03655717|364744698|FG016|Overall Study|Withdrawal by Subject|0|||
105752385|NCT03655717|364744699|FG017|Overall Study|Withdrawal by Subject|0|||
105752386|NCT03655717|364744700|FG018|Overall Study|Withdrawal by Subject|1|||
105752387|NCT03655717|364744701|FG019|Overall Study|Withdrawal by Subject|0|||
105752388|NCT03655717|364744702|FG020|Overall Study|Withdrawal by Subject|0|||
105752389|NCT03655717|364744703|FG021|Overall Study|Withdrawal by Subject|1|||
105752390|NCT03655717|364744704|FG022|Overall Study|Withdrawal by Subject|2|||
105752391|NCT03655717|364744705|FG023|Overall Study|Withdrawal by Subject|1|||
105752392|NCT03655717|364744706|FG024|Overall Study|Withdrawal by Subject|1|||
105752393|NCT03655717|364744707|FG025|Overall Study|Withdrawal by Subject|0|||
105752394|NCT03655717|364744682|FG000|Overall Study|Physician Decision|3|||
105752395|NCT03655717|364744683|FG001|Overall Study|Physician Decision|3|||
105752396|NCT03655717|364744684|FG002|Overall Study|Physician Decision|0|||
105752397|NCT03655717|364744685|FG003|Overall Study|Physician Decision|0|||
105752398|NCT03655717|364744686|FG004|Overall Study|Physician Decision|0|||
105752399|NCT03655717|364744687|FG005|Overall Study|Physician Decision|0|||
105752400|NCT03655717|364744688|FG006|Overall Study|Physician Decision|0|||
105947999|NCT02133573|365473504|FG001|Overall Study|Child Declined Follow Ups|1|||
105948000|NCT02133573|365473503|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
106016396|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016397|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
105752401|NCT03655717|364744689|FG007|Overall Study|Physician Decision|0|||
105752402|NCT03655717|364744690|FG008|Overall Study|Physician Decision|0|||
105752403|NCT03655717|364744691|FG009|Overall Study|Physician Decision|1|||
105752404|NCT03655717|364744692|FG010|Overall Study|Physician Decision|0|||
105752405|NCT03655717|364744693|FG011|Overall Study|Physician Decision|0|||
105752406|NCT03655717|364744694|FG012|Overall Study|Physician Decision|0|||
105752407|NCT03655717|364744695|FG013|Overall Study|Physician Decision|0|||
105752408|NCT03655717|364744696|FG014|Overall Study|Physician Decision|0|||
105948001|NCT02133573|365473504|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
105948002|NCT02746809|365473509|FG000|Enrollment|Inclusion Exclusion not met|9|||
105752409|NCT03655717|364744697|FG015|Overall Study|Physician Decision|0|||
105752410|NCT03655717|364744698|FG016|Overall Study|Physician Decision|0|||
105752411|NCT03655717|364744699|FG017|Overall Study|Physician Decision|0|||
105752412|NCT03655717|364744700|FG018|Overall Study|Physician Decision|0|||
105752413|NCT03655717|364744701|FG019|Overall Study|Physician Decision|1|||
105752414|NCT03655717|364744702|FG020|Overall Study|Physician Decision|0|||
105752415|NCT03655717|364744703|FG021|Overall Study|Physician Decision|0|||
105752416|NCT03655717|364744704|FG022|Overall Study|Physician Decision|0|||
106016398|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
106016399|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
106016400|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016401|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016402|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016403|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016404|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
106016405|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016406|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016407|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016408|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016409|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016410|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016411|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016412|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
105752417|NCT03655717|364744705|FG023|Overall Study|Physician Decision|1|||
105752418|NCT03655717|364744706|FG024|Overall Study|Physician Decision|0|||
105752419|NCT03655717|364744707|FG025|Overall Study|Physician Decision|0|||
105752420|NCT03655717|364744682|FG000|Overall Study|Lost to Follow-up|3|||
105752421|NCT03655717|364744683|FG001|Overall Study|Lost to Follow-up|1|||
105752422|NCT03655717|364744684|FG002|Overall Study|Lost to Follow-up|0|||
105752423|NCT03655717|364744685|FG003|Overall Study|Lost to Follow-up|1|||
105752424|NCT03655717|364744686|FG004|Overall Study|Lost to Follow-up|0|||
105752425|NCT03655717|364744687|FG005|Overall Study|Lost to Follow-up|1|||
105752426|NCT03655717|364744688|FG006|Overall Study|Lost to Follow-up|0|||
105752427|NCT03655717|364744689|FG007|Overall Study|Lost to Follow-up|0|||
106016413|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
106016414|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016415|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016416|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016417|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016418|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
106016419|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016420|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016421|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016422|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
106016423|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016424|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105752428|NCT03655717|364744690|FG008|Overall Study|Lost to Follow-up|0|||
105752429|NCT03655717|364744691|FG009|Overall Study|Lost to Follow-up|0|||
105752430|NCT03655717|364744692|FG010|Overall Study|Lost to Follow-up|0|||
105752431|NCT03655717|364744693|FG011|Overall Study|Lost to Follow-up|1|||
105752432|NCT03655717|364744694|FG012|Overall Study|Lost to Follow-up|0|||
105752433|NCT03655717|364744695|FG013|Overall Study|Lost to Follow-up|0|||
105752434|NCT03655717|364744696|FG014|Overall Study|Lost to Follow-up|0|||
106016425|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105752435|NCT03655717|364744697|FG015|Overall Study|Lost to Follow-up|0|||
105752436|NCT03655717|364744698|FG016|Overall Study|Lost to Follow-up|0|||
105752437|NCT03655717|364744699|FG017|Overall Study|Lost to Follow-up|0|||
105752438|NCT03655717|364744700|FG018|Overall Study|Lost to Follow-up|0|||
105752439|NCT03655717|364744701|FG019|Overall Study|Lost to Follow-up|0|||
105752440|NCT03655717|364744702|FG020|Overall Study|Lost to Follow-up|0|||
105752441|NCT03655717|364744703|FG021|Overall Study|Lost to Follow-up|0|||
105752442|NCT03655717|364744704|FG022|Overall Study|Lost to Follow-up|0|||
105752443|NCT03655717|364744705|FG023|Overall Study|Lost to Follow-up|0|||
105752444|NCT03655717|364744706|FG024|Overall Study|Lost to Follow-up|0|||
105752445|NCT03655717|364744707|FG025|Overall Study|Lost to Follow-up|0|||
105752446|NCT00675103|364744708|FG000|Overall Study|Lack of Efficacy|2|||
105752447|NCT00675103|364744708|FG000|Overall Study|Adverse Event|1|||
105752448|NCT03288493|364744712|FG000|Overall Study|Withdrawal by Subject|4|||
106016426|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105752449|NCT03288493|364744713|FG001|Overall Study|Withdrawal by Subject|0|||
105752450|NCT03288493|364744714|FG002|Overall Study|Withdrawal by Subject|0|||
105752451|NCT03288493|364744715|FG003|Overall Study|Withdrawal by Subject|0|||
105752452|NCT03288493|364744716|FG004|Overall Study|Withdrawal by Subject|0|||
105752453|NCT03288493|364744717|FG005|Overall Study|Withdrawal by Subject|2|||
105752454|NCT03288493|364744718|FG006|Overall Study|Withdrawal by Subject|0|||
105752455|NCT03288493|364744712|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
105752456|NCT03288493|364744713|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
105752457|NCT03288493|364744714|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
105752458|NCT03288493|364744715|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
105752459|NCT03288493|364744716|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
105752460|NCT03288493|364744717|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
105752461|NCT03288493|364744718|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
105752462|NCT03288493|364744712|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
105752463|NCT03288493|364744713|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
105752464|NCT03288493|364744714|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
105752465|NCT03288493|364744715|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
105752466|NCT03288493|364744716|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
105752467|NCT03288493|364744717|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
105752468|NCT03288493|364744718|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
105752469|NCT03288493|364744712|FG000|Overall Study|Death|2|||
105752470|NCT03288493|364744713|FG001|Overall Study|Death|0|||
105752471|NCT03288493|364744714|FG002|Overall Study|Death|0|||
105752472|NCT03288493|364744715|FG003|Overall Study|Death|0|||
105752473|NCT03288493|364744716|FG004|Overall Study|Death|0|||
105752474|NCT03288493|364744717|FG005|Overall Study|Death|0|||
105752475|NCT03288493|364744718|FG006|Overall Study|Death|0|||
105752476|NCT03288493|364744712|FG000|Overall Study|other reason not listed above|2|||
105752477|NCT03288493|364744713|FG001|Overall Study|other reason not listed above|0|||
105752478|NCT03288493|364744714|FG002|Overall Study|other reason not listed above|0|||
105752479|NCT03288493|364744715|FG003|Overall Study|other reason not listed above|0|||
105752480|NCT03288493|364744716|FG004|Overall Study|other reason not listed above|0|||
105752481|NCT03288493|364744717|FG005|Overall Study|other reason not listed above|0|||
105752482|NCT03288493|364744718|FG006|Overall Study|other reason not listed above|0|||
105752483|NCT04092816|364746378|FG000|Overall Study|Lost to Follow-up|1|||
105752484|NCT04092816|364746379|FG001|Overall Study|Lost to Follow-up|2|||
105752485|NCT00369967|364746381|FG000|Overall Study|Lost to Follow-up|23|||
105752486|NCT00369967|364746382|FG001|Overall Study|Lost to Follow-up|12|||
105752487|NCT01747811|364746383|FG000|Overall Study|Lack of Efficacy|2|||
105752488|NCT01747811|364746384|FG001|Overall Study|Lack of Efficacy|4|||
105752489|NCT01263093|364746385|FG000|Washout|Physician Decision|1|||
105752490|NCT01263093|364746386|FG001|Washout|Physician Decision|0|||
105752491|NCT01263093|364746385|FG000|Period 2|Adverse Event|1|||
105752492|NCT01263093|364746386|FG001|Period 2|Adverse Event|0|||
105752493|NCT00280150|364746387|FG000|Overall Study|Adverse Event|0|||
105752494|NCT00280150|364746388|FG001|Overall Study|Adverse Event|1|||
105752495|NCT00280150|364746389|FG002|Overall Study|Adverse Event|2|||
105752496|NCT00280150|364746390|FG003|Overall Study|Adverse Event|3|||
105752497|NCT00280150|364746387|FG000|Overall Study|Lack of Efficacy|0|||
105752498|NCT00280150|364746388|FG001|Overall Study|Lack of Efficacy|0|||
105752499|NCT00280150|364746389|FG002|Overall Study|Lack of Efficacy|0|||
105752500|NCT00280150|364746390|FG003|Overall Study|Lack of Efficacy|3|||
105752501|NCT00280150|364746387|FG000|Overall Study|Physician Decision|0|||
105752502|NCT00280150|364746388|FG001|Overall Study|Physician Decision|0|||
105752503|NCT00280150|364746389|FG002|Overall Study|Physician Decision|0|||
105752504|NCT00280150|364746390|FG003|Overall Study|Physician Decision|1|||
105752505|NCT00280150|364746387|FG000|Overall Study|Protocol Violation|0|||
105752506|NCT00280150|364746388|FG001|Overall Study|Protocol Violation|0|||
105752507|NCT00280150|364746389|FG002|Overall Study|Protocol Violation|0|||
105752508|NCT00280150|364746390|FG003|Overall Study|Protocol Violation|1|||
105752509|NCT00280150|364746387|FG000|Overall Study|Withdrawal by Subject|0|||
105752510|NCT00280150|364746388|FG001|Overall Study|Withdrawal by Subject|0|||
105752511|NCT00280150|364746389|FG002|Overall Study|Withdrawal by Subject|0|||
105752512|NCT00280150|364746390|FG003|Overall Study|Withdrawal by Subject|1|||
105752513|NCT00280150|364746387|FG000|Overall Study|Did not get consolidation therapy|3|||
105752514|NCT00280150|364746388|FG001|Overall Study|Did not get consolidation therapy|0|||
105752515|NCT00280150|364746389|FG002|Overall Study|Did not get consolidation therapy|3|||
105752516|NCT00280150|364746390|FG003|Overall Study|Did not get consolidation therapy|0|||
105752517|NCT00280150|364746387|FG000|Overall Study|Declining Performance Status|0|||
105752518|NCT00280150|364746388|FG001|Overall Study|Declining Performance Status|0|||
105752519|NCT00280150|364746389|FG002|Overall Study|Declining Performance Status|0|||
105752520|NCT00280150|364746390|FG003|Overall Study|Declining Performance Status|1|||
105752521|NCT02871401|364746399|FG000|Overall Study|Adverse Event|1|||
105752522|NCT02871401|364746400|FG001|Overall Study|Adverse Event|0|||
105752523|NCT01120379|364746401|FG000|One Year Timepoint|Withdrawal by Subject|41|||
105752524|NCT01120379|364746401|FG000|One Year Timepoint|Lost to Follow-up|115|||
105752525|NCT01120379|364746401|FG000|One Year Timepoint|Death|108|||
105752526|NCT01120379|364746401|FG000|One Year Timepoint|Physician Decision|9|||
105752527|NCT01120379|364746401|FG000|One Year Timepoint|Any other reason for early termination|5|||
105802060|NCT03705169|364930714|FG001|Overall Study|Adverse Event|0|||
105802061|NCT03705169|364930715|FG002|Overall Study|Adverse Event|0|||
105802062|NCT03705169|364930716|FG003|Overall Study|Adverse Event|1|||
105802063|NCT03705169|364930717|FG004|Overall Study|Adverse Event|0|||
105802064|NCT03705169|364930718|FG005|Overall Study|Adverse Event|0|||
105948003|NCT02746809|365473509|FG000|Enrollment|Withdrawal by Subject|1|||
105948004|NCT02746809|365473509|FG000|Enrollment|Expected Enrollment Met|2|||
105948005|NCT02746809|365473509|FG000|Procedure|Death|1|||
105948006|NCT02746809|365473509|FG000|1-Month|Death|5|||
105948007|NCT02746809|365473509|FG000|6-Month|Death|2|||
105948008|NCT02746809|365473509|FG000|6-Month|Withdrawal by Subject|1|||
105948009|NCT02746809|365473509|FG000|12-Month|Death|3|||
105948010|NCT02746809|365473509|FG000|12-Month|Withdrawal by Subject|2|||
105948011|NCT02746809|365473509|FG000|24-Month|Death|1|||
105948012|NCT02746809|365473509|FG000|24-Month|Withdrawal by Subject|1|||
105948013|NCT02746809|365473509|FG000|36-Month|Death|8|||
105948014|NCT02746809|365473509|FG000|36-Month|Withdrawal by Subject|1|||
105948015|NCT02746809|365473509|FG000|48-Month|Death|7|||
105948016|NCT02746809|365473509|FG000|48-Month|Withdrawal by Subject|1|||
105948017|NCT02746809|365473509|FG000|60-Month|Death|1|||
105948018|NCT02746809|365473509|FG000|60-Month|Lost to Follow-up|2|||
105948019|NCT02431325|365473512|FG000|Overall Study|Adverse Event|3|||
105948020|NCT02431325|365473513|FG001|Overall Study|Adverse Event|0|||
105948021|NCT02431325|365473512|FG000|Overall Study|Lost to Follow-up|0|||
105948022|NCT02431325|365473513|FG001|Overall Study|Lost to Follow-up|1|||
105948023|NCT02431325|365473512|FG000|Overall Study|Withdrawal by Subject|1|||
105948024|NCT02431325|365473513|FG001|Overall Study|Withdrawal by Subject|2|||
105948025|NCT02431325|365473512|FG000|Overall Study|Declined to take study medication|1|||
105948026|NCT02431325|365473513|FG001|Overall Study|Declined to take study medication|0|||
105948027|NCT02431325|365473512|FG000|Overall Study|Withdrew before starting study medication|1|||
105948028|NCT02431325|365473513|FG001|Overall Study|Withdrew before starting study medication|0|||
105948029|NCT02431325|365473512|FG000|Overall Study|Placebo shortage|2|||
105948030|NCT02431325|365473513|FG001|Overall Study|Placebo shortage|0|||
105948031|NCT01128569|365473514|FG000|Washout Period 1|Adverse Event|0|||
105948032|NCT01128569|365473515|FG001|Washout Period 1|Adverse Event|0|||
105948033|NCT01128569|365473516|FG002|Washout Period 1|Adverse Event|1|||
105948034|NCT01128569|365473517|FG003|Washout Period 1|Adverse Event|0|||
105948035|NCT01128569|365473518|FG004|Washout Period 1|Adverse Event|0|||
105948036|NCT01128569|365473519|FG005|Washout Period 1|Adverse Event|0|||
105948037|NCT01128569|365473514|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105948038|NCT01128569|365473515|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105948039|NCT01128569|365473516|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105948040|NCT01128569|365473517|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105948041|NCT01128569|365473518|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105948042|NCT01128569|365473519|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105948043|NCT00894387|365473520|FG000|Overall Study|Adverse Event|44|||
105948044|NCT00894387|365473521|FG001|Overall Study|Adverse Event|45|||
105948045|NCT00894387|365473520|FG000|Overall Study|Abnormal Laboratory values|2|||
105948046|NCT00894387|365473521|FG001|Overall Study|Abnormal Laboratory values|2|||
105948047|NCT00894387|365473520|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105948048|NCT00894387|365473521|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105948049|NCT00894387|365473520|FG000|Overall Study|Lost to Follow-up|3|||
105948050|NCT00894387|365473521|FG001|Overall Study|Lost to Follow-up|5|||
105948051|NCT00894387|365473520|FG000|Overall Study|Administrative problems|2|||
105948052|NCT00894387|365473521|FG001|Overall Study|Administrative problems|2|||
105948053|NCT00894387|365473520|FG000|Overall Study|Death|77|||
105948054|NCT00894387|365473521|FG001|Overall Study|Death|76|||
105948055|NCT00894387|365473520|FG000|Overall Study|Protocol Deviation|4|||
105752528|NCT01120379|364746401|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
105802065|NCT03705169|364930719|FG006|Overall Study|Adverse Event|0|||
105802066|NCT03705169|364930720|FG007|Overall Study|Adverse Event|0|||
105948056|NCT00894387|365473521|FG001|Overall Study|Protocol Deviation|0|||
105948057|NCT00894387|365473520|FG000|Overall Study|Patient's request|25|||
105948058|NCT00894387|365473521|FG001|Overall Study|Patient's request|30|||
105948059|NCT00894387|365473520|FG000|Overall Study|Other (Missing)|5|||
105948060|NCT00894387|365473521|FG001|Overall Study|Other (Missing)|3|||
105948061|NCT00894387|365473520|FG000|Overall Study|Mis-randomized|13|||
105948062|NCT00894387|365473521|FG001|Overall Study|Mis-randomized|9|||
105752529|NCT01120379|364746401|FG000|Two Year Timepoint|Lost to Follow-up|87|||
105752530|NCT01120379|364746401|FG000|Two Year Timepoint|Death|123|||
105948063|NCT00894387|365473520|FG000|Overall Study|GCP non-compliance|0|||
105948064|NCT00894387|365473521|FG001|Overall Study|GCP non-compliance|2|||
105948065|NCT02115321|365473522|FG000|Overall Study|Death|1|||
105948066|NCT02115321|365473523|FG001|Overall Study|Death|0|||
105948067|NCT04403919|365473530|FG000|Overall Study|Lost to Follow-up|0|||
105948068|NCT04403919|365473531|FG001|Overall Study|Lost to Follow-up|0|||
105948069|NCT04403919|365473532|FG002|Overall Study|Lost to Follow-up|0|||
105752531|NCT01120379|364746401|FG000|Two Year Timepoint|Physician Decision|12|||
105752532|NCT01120379|364746401|FG000|Two Year Timepoint|Any other reason for early termination|4|||
105752533|NCT01120379|364746401|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
105752534|NCT01120379|364746401|FG000|Three Year Timepoint|Lost to Follow-up|43|||
105752535|NCT01120379|364746401|FG000|Three Year Timepoint|Death|120|||
105752536|NCT01120379|364746401|FG000|Three Year Timepoint|Physician Decision|9|||
105752537|NCT01120379|364746401|FG000|Three Year Timepoint|Any other reason for early termination|17|||
105752538|NCT01120379|364746401|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
105752539|NCT01120379|364746401|FG000|Four Year Timepoint|Lost to Follow-up|10|||
105752540|NCT01120379|364746401|FG000|Four Year Timepoint|Death|131|||
105752541|NCT01120379|364746401|FG000|Four Year Timepoint|Physician Decision|5|||
105752542|NCT01120379|364746401|FG000|Four Year Timepoint|Any other reason for early termination|217|||
105752543|NCT04656418|364746402|FG000|Overall Study|Withdrawal by Subject|1|||
105752544|NCT04656418|364746403|FG001|Overall Study|Withdrawal by Subject|3|||
105752545|NCT03162055|364746404|FG000|Overall Study|Adverse Event|6|||
105752546|NCT03162055|364746405|FG001|Overall Study|Adverse Event|5|||
105752547|NCT03162055|364746404|FG000|Overall Study|Death|3|||
105752548|NCT03162055|364746405|FG001|Overall Study|Death|3|||
105752549|NCT03162055|364746404|FG000|Overall Study|Lost to Follow-up|0|||
105752550|NCT03162055|364746405|FG001|Overall Study|Lost to Follow-up|1|||
105752551|NCT03162055|364746404|FG000|Overall Study|Study-specific withdrawal criteria|22|||
105752552|NCT03162055|364746405|FG001|Overall Study|Study-specific withdrawal criteria|14|||
105752553|NCT03162055|364746404|FG000|Overall Study|Withdrawal by Subject|17|||
105752554|NCT03162055|364746405|FG001|Overall Study|Withdrawal by Subject|2|||
105752555|NCT03162055|364746404|FG000|Overall Study|Did not receive treatment|2|||
105752556|NCT03162055|364746405|FG001|Overall Study|Did not receive treatment|0|||
105752557|NCT03162055|364746404|FG000|Overall Study|Incorrect randomization|4|||
105752558|NCT03162055|364746405|FG001|Overall Study|Incorrect randomization|3|||
105752559|NCT03162055|364746404|FG000|Overall Study|Other|8|||
105752560|NCT03162055|364746405|FG001|Overall Study|Other|15|||
105752561|NCT01617655|364746406|FG000|Overall Study|Adverse Event|2|||
105752562|NCT01617655|364746407|FG001|Overall Study|Adverse Event|3|||
105752563|NCT01617655|364746406|FG000|Overall Study|Poor compliance to protocol|1|||
105752564|NCT01617655|364746407|FG001|Overall Study|Poor compliance to protocol|4|||
105752565|NCT01617655|364746406|FG000|Overall Study|Participants moved|0|||
105752566|NCT01617655|364746407|FG001|Overall Study|Participants moved|4|||
105752567|NCT01617655|364746406|FG000|Overall Study|Consent withdrawn by participant|1|||
105752568|NCT01617655|364746407|FG001|Overall Study|Consent withdrawn by participant|1|||
105752569|NCT01617655|364746406|FG000|Overall Study|Last visit outside protocol visit window|1|||
105752570|NCT01617655|364746407|FG001|Overall Study|Last visit outside protocol visit window|10|||
105752571|NCT01617655|364746406|FG000|Overall Study|Site closure|3|||
105752572|NCT01617655|364746407|FG001|Overall Study|Site closure|5|||
105752573|NCT01617655|364746406|FG000|Overall Study|Other than specified above|1|||
105752574|NCT01617655|364746407|FG001|Overall Study|Other than specified above|2|||
105752575|NCT00485589|364746408|FG000|Overall Study|Death|2|||
105752576|NCT00485589|364746409|FG001|Overall Study|Death|2|||
105752577|NCT00485589|364746410|FG002|Overall Study|Death|0|||
105752578|NCT00485589|364746408|FG000|Overall Study|Failure to return|6|||
105752579|NCT00485589|364746409|FG001|Overall Study|Failure to return|5|||
105752580|NCT00485589|364746410|FG002|Overall Study|Failure to return|1|||
105752581|NCT00485589|364746408|FG000|Overall Study|Protocol Violation|1|||
105752582|NCT00485589|364746409|FG001|Overall Study|Protocol Violation|0|||
105752583|NCT00485589|364746410|FG002|Overall Study|Protocol Violation|0|||
105948070|NCT04403919|365473533|FG003|Overall Study|Lost to Follow-up|1|||
105948071|NCT01612676|365473534|FG000|Overall Study|Adverse Event|2|||
105752584|NCT00485589|364746408|FG000|Overall Study|Violation of selection criteria at entry|0|||
105752585|NCT00485589|364746409|FG001|Overall Study|Violation of selection criteria at entry|3|||
105752586|NCT00485589|364746410|FG002|Overall Study|Violation of selection criteria at entry|1|||
105752587|NCT00485589|364746408|FG000|Overall Study|Administrative/Other|1|||
105752588|NCT00485589|364746409|FG001|Overall Study|Administrative/Other|2|||
105752589|NCT00485589|364746410|FG002|Overall Study|Administrative/Other|1|||
105752590|NCT00485589|364746408|FG000|Overall Study|Insufficient therapeutic response|10|||
105752591|NCT00485589|364746409|FG001|Overall Study|Insufficient therapeutic response|3|||
105752592|NCT00485589|364746410|FG002|Overall Study|Insufficient therapeutic response|1|||
105752593|NCT00485589|364746408|FG000|Overall Study|Refused treatment/did not cooperate|1|||
105752594|NCT00485589|364746409|FG001|Overall Study|Refused treatment/did not cooperate|0|||
105948072|NCT01612676|365473535|FG001|Overall Study|Adverse Event|3|||
105948073|NCT01612676|365473536|FG002|Overall Study|Adverse Event|1|||
105752595|NCT00485589|364746410|FG002|Overall Study|Refused treatment/did not cooperate|2|||
105752596|NCT00485589|364746408|FG000|Overall Study|Withdrawal by Subject|3|||
105752597|NCT00485589|364746409|FG001|Overall Study|Withdrawal by Subject|2|||
105752598|NCT00485589|364746410|FG002|Overall Study|Withdrawal by Subject|2|||
105752599|NCT00485589|364746408|FG000|Overall Study|Adverse Event|3|||
105752600|NCT00485589|364746409|FG001|Overall Study|Adverse Event|3|||
105752601|NCT00485589|364746410|FG002|Overall Study|Adverse Event|10|||
105752602|NCT02585999|364746411|FG000|Overall Study|Lost to Follow-up|1|||
105752603|NCT02585999|364746411|FG000|Overall Study|Protocol Violation|1|||
105752604|NCT00120289|364746412|FG000|Overall Study|Death|96|||
105752605|NCT00120289|364746413|FG001|Overall Study|Death|82|||
105752606|NCT00120289|364746412|FG000|Overall Study|Lost to Follow-up|11|||
105752607|NCT00120289|364746413|FG001|Overall Study|Lost to Follow-up|14|||
105752608|NCT00120289|364746412|FG000|Overall Study|Withdrawal by Subject|14|||
105752609|NCT00120289|364746413|FG001|Overall Study|Withdrawal by Subject|13|||
105752610|NCT01061736|364746415|FG000|Overall Study|Dose regimen not selected|0|||
105752611|NCT01061736|364746416|FG001|Overall Study|Dose regimen not selected|0|||
105752612|NCT01061736|364746417|FG002|Overall Study|Dose regimen not selected|0|||
105752613|NCT01061736|364746418|FG003|Overall Study|Dose regimen not selected|0|||
105752614|NCT01061736|364746419|FG004|Overall Study|Dose regimen not selected|0|||
105752615|NCT01061736|364746420|FG005|Overall Study|Dose regimen not selected|0|||
105752616|NCT01061736|364746421|FG006|Overall Study|Dose regimen not selected|79|||
105752617|NCT01061736|364746422|FG007|Overall Study|Dose regimen not selected|0|||
105752618|NCT01061736|364746423|FG008|Overall Study|Dose regimen not selected|0|||
105752619|NCT01061736|364746424|FG009|Overall Study|Dose regimen not selected|0|||
105752620|NCT01061736|364746415|FG000|Overall Study|Adverse Event|13|||
105752621|NCT01061736|364746416|FG001|Overall Study|Adverse Event|1|||
105752622|NCT01061736|364746417|FG002|Overall Study|Adverse Event|3|||
105752623|NCT01061736|364746418|FG003|Overall Study|Adverse Event|2|||
105752624|NCT01061736|364746419|FG004|Overall Study|Adverse Event|4|||
105752625|NCT01061736|364746420|FG005|Overall Study|Adverse Event|1|||
105752626|NCT01061736|364746421|FG006|Overall Study|Adverse Event|4|||
105752627|NCT01061736|364746422|FG007|Overall Study|Adverse Event|63|||
105752628|NCT01061736|364746423|FG008|Overall Study|Adverse Event|67|||
105752629|NCT01061736|364746424|FG009|Overall Study|Adverse Event|34|||
105752630|NCT01061736|364746415|FG000|Overall Study|Lack of Efficacy|0|||
105752631|NCT01061736|364746416|FG001|Overall Study|Lack of Efficacy|2|||
105752632|NCT01061736|364746417|FG002|Overall Study|Lack of Efficacy|1|||
105752633|NCT01061736|364746418|FG003|Overall Study|Lack of Efficacy|1|||
105752634|NCT01061736|364746419|FG004|Overall Study|Lack of Efficacy|1|||
105752635|NCT01061736|364746420|FG005|Overall Study|Lack of Efficacy|2|||
105752636|NCT01061736|364746421|FG006|Overall Study|Lack of Efficacy|1|||
105752637|NCT01061736|364746422|FG007|Overall Study|Lack of Efficacy|9|||
105752638|NCT01061736|364746423|FG008|Overall Study|Lack of Efficacy|9|||
105752639|NCT01061736|364746424|FG009|Overall Study|Lack of Efficacy|10|||
105752640|NCT01061736|364746415|FG000|Overall Study|Poor compliance to protocol|0|||
105752641|NCT01061736|364746416|FG001|Overall Study|Poor compliance to protocol|0|||
105752642|NCT01061736|364746417|FG002|Overall Study|Poor compliance to protocol|0|||
105752643|NCT01061736|364746418|FG003|Overall Study|Poor compliance to protocol|0|||
105752644|NCT01061736|364746419|FG004|Overall Study|Poor compliance to protocol|0|||
105752645|NCT01061736|364746420|FG005|Overall Study|Poor compliance to protocol|0|||
105752646|NCT01061736|364746421|FG006|Overall Study|Poor compliance to protocol|0|||
105752647|NCT01061736|364746422|FG007|Overall Study|Poor compliance to protocol|2|||
105752648|NCT01061736|364746423|FG008|Overall Study|Poor compliance to protocol|5|||
105752649|NCT01061736|364746424|FG009|Overall Study|Poor compliance to protocol|9|||
105752650|NCT01061736|364746415|FG000|Overall Study|Not treated|0|||
105948074|NCT01612676|365473537|FG003|Overall Study|Adverse Event|3|||
105948075|NCT01612676|365473534|FG000|Overall Study|Protocol Violation|0|||
105948076|NCT01612676|365473535|FG001|Overall Study|Protocol Violation|1|||
105948077|NCT01612676|365473536|FG002|Overall Study|Protocol Violation|0|||
105948078|NCT01612676|365473537|FG003|Overall Study|Protocol Violation|0|||
105752651|NCT01061736|364746416|FG001|Overall Study|Not treated|0|||
105752652|NCT01061736|364746417|FG002|Overall Study|Not treated|0|||
105752653|NCT01061736|364746418|FG003|Overall Study|Not treated|0|||
105948079|NCT00181844|365473547|FG000|Signed Consent|Withdrawal by Subject|5|||
105948080|NCT00181844|365473547|FG000|Signed Consent|Did not meet entrance criteria|7|||
105752654|NCT01061736|364746419|FG004|Overall Study|Not treated|1|||
105752655|NCT01061736|364746420|FG005|Overall Study|Not treated|0|||
105752656|NCT01061736|364746421|FG006|Overall Study|Not treated|0|||
105752657|NCT01061736|364746422|FG007|Overall Study|Not treated|2|||
105752658|NCT01061736|364746423|FG008|Overall Study|Not treated|1|||
105752659|NCT01061736|364746424|FG009|Overall Study|Not treated|0|||
105752660|NCT01061736|364746415|FG000|Overall Study|Other than specified above|0|||
105752661|NCT01061736|364746416|FG001|Overall Study|Other than specified above|1|||
105752662|NCT01061736|364746417|FG002|Overall Study|Other than specified above|2|||
105752663|NCT01061736|364746418|FG003|Overall Study|Other than specified above|0|||
105752664|NCT01061736|364746419|FG004|Overall Study|Other than specified above|1|||
105752665|NCT01061736|364746420|FG005|Overall Study|Other than specified above|0|||
105752666|NCT01061736|364746421|FG006|Overall Study|Other than specified above|0|||
105948081|NCT00181844|365473547|FG000|Exposed to Study Medication|Adverse Event|10|||
105948082|NCT00181844|365473547|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
105948083|NCT00181844|365473547|FG000|Exposed to Study Medication|Non-compliance|2|||
105948084|NCT00181844|365473547|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
105948085|NCT00181844|365473547|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
105948086|NCT01987557|365473558|FG000|Overall Study|Protocol Violation|1|||
105948087|NCT01987557|365473559|FG001|Overall Study|Protocol Violation|0|||
105948088|NCT01987557|365473560|FG002|Overall Study|Protocol Violation|1|||
105948089|NCT01987557|365473558|FG000|Overall Study|Withdrawal by Subject|2|||
105948090|NCT01987557|365473559|FG001|Overall Study|Withdrawal by Subject|1|||
105948091|NCT01987557|365473560|FG002|Overall Study|Withdrawal by Subject|2|||
105948092|NCT01987557|365473558|FG000|Overall Study|Adverse Event|0|||
105948093|NCT01987557|365473559|FG001|Overall Study|Adverse Event|2|||
105948094|NCT01987557|365473560|FG002|Overall Study|Adverse Event|0|||
105948095|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
105948096|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
105948097|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
105948098|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Death|0|||
105948099|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Death|0|||
105948100|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Death|1|||
105948101|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
105948102|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
105948103|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
105948104|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
105948105|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
105948106|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
105948107|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
105948108|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
105948109|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
105948110|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Graft loss|0|||
105948111|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Graft loss|0|||
105948112|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Graft loss|7|||
105948113|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
105752667|NCT01061736|364746422|FG007|Overall Study|Other than specified above|18|||
105752668|NCT01061736|364746423|FG008|Overall Study|Other than specified above|15|||
105752669|NCT01061736|364746424|FG009|Overall Study|Other than specified above|21|||
105752670|NCT01207388|364746425|FG000|Overall Study|Death|67|||
105752671|NCT01207388|364746425|FG000|Overall Study|Withdrawal by Subject|1|||
105752672|NCT01895452|364746434|FG000|Overall Study|Adverse Event|1|||
105752673|NCT01895452|364746435|FG001|Overall Study|Adverse Event|4|||
105752674|NCT01895452|364746434|FG000|Overall Study|Lost to Follow-up|1|||
105752675|NCT01895452|364746435|FG001|Overall Study|Lost to Follow-up|5|||
105752676|NCT01895452|364746434|FG000|Overall Study|Pregnancy|0|||
105752677|NCT01895452|364746435|FG001|Overall Study|Pregnancy|1|||
105752678|NCT01895452|364746434|FG000|Overall Study|Withdrawal by Subject|2|||
105752679|NCT01895452|364746435|FG001|Overall Study|Withdrawal by Subject|14|||
105752680|NCT01895452|364746434|FG000|Overall Study|Underlying disease|0|||
105752681|NCT01895452|364746435|FG001|Overall Study|Underlying disease|3|||
105752682|NCT01895452|364746434|FG000|Overall Study|Noncompliance with study drug|0|||
105752683|NCT01895452|364746435|FG001|Overall Study|Noncompliance with study drug|1|||
105752684|NCT01954251|364746436|FG000|Overall Study|Adverse Event|5|||
105752685|NCT01954251|364746437|FG001|Overall Study|Adverse Event|7|||
105752686|NCT01954251|364746436|FG000|Overall Study|Lost to Follow-up|6|||
105752687|NCT01954251|364746437|FG001|Overall Study|Lost to Follow-up|6|||
105752688|NCT01954251|364746436|FG000|Overall Study|Withdrawal by Subject|2|||
105752689|NCT01954251|364746437|FG001|Overall Study|Withdrawal by Subject|6|||
105752690|NCT00190983|364746440|FG000|Overall Study|Inevaluable (never treated)|2|||
105752691|NCT02287402|364746441|FG000|Treatment Period|Adverse Event|17|||
105752692|NCT02287402|364746441|FG000|Treatment Period|Voluntary Withdrawal|10|||
105752693|NCT02287402|364746441|FG000|Follow-up|Lost to Follow-up|1|||
105752694|NCT02287402|364746441|FG000|Follow-up|Voluntary Withdrawal|2|||
105752695|NCT01844830|364746442|FG000|Overall Study|Withdrawal by Subject|1|||
105752696|NCT01844830|364746443|FG001|Overall Study|Withdrawal by Subject|0|||
105752697|NCT04247815|364746444|FG000|Overall Study|Adverse Event|1|||
105752698|NCT04247815|364746445|FG001|Overall Study|Adverse Event|0|||
105752699|NCT04247815|364746444|FG000|Overall Study|Withdrawal by Subject|1|||
105752700|NCT04247815|364746445|FG001|Overall Study|Withdrawal by Subject|0|||
105752701|NCT04247815|364746444|FG000|Overall Study|Protocol Violation|0|||
105752702|NCT04247815|364746445|FG001|Overall Study|Protocol Violation|1|||
105752703|NCT02207556|364746446|FG000|Overall Study|Physician Decision|1|||
105752704|NCT02207556|364746447|FG001|Overall Study|Physician Decision|0|||
105752705|NCT02207556|364746446|FG000|Overall Study|Withdrawal by Subject|1|||
105752706|NCT02207556|364746447|FG001|Overall Study|Withdrawal by Subject|0|||
105752707|NCT02207556|364746446|FG000|Overall Study|Death|0|||
105948114|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
105948115|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
105948116|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
105752708|NCT02207556|364746447|FG001|Overall Study|Death|5|||
105752709|NCT00089479|364746453|FG000|Overall Study|Death|108|||
105752710|NCT00089479|364746454|FG001|Overall Study|Death|75|||
105752711|NCT00089479|364746453|FG000|Overall Study|Withdrawal by Subject|86|||
105752712|NCT00089479|364746454|FG001|Overall Study|Withdrawal by Subject|107|||
105752713|NCT00089479|364746453|FG000|Overall Study|Lost to Follow-up|137|||
105752714|NCT00089479|364746454|FG001|Overall Study|Lost to Follow-up|107|||
105752715|NCT04724733|364746455|FG000|Overall Study|Lost to Follow-up|1|||
105802067|NCT03705169|364930721|FG008|Overall Study|Adverse Event|0|||
105802068|NCT03705169|364930722|FG009|Overall Study|Adverse Event|0|||
105802069|NCT03705169|364930713|FG000|Overall Study|Site Closure|0|||
105802070|NCT03705169|364930714|FG001|Overall Study|Site Closure|0|||
105802071|NCT03705169|364930715|FG002|Overall Study|Site Closure|0|||
105802072|NCT03705169|364930716|FG003|Overall Study|Site Closure|1|||
105802073|NCT03705169|364930717|FG004|Overall Study|Site Closure|0|||
105802074|NCT03705169|364930718|FG005|Overall Study|Site Closure|0|||
105802075|NCT03705169|364930719|FG006|Overall Study|Site Closure|0|||
105802076|NCT03705169|364930720|FG007|Overall Study|Site Closure|0|||
105802077|NCT03705169|364930721|FG008|Overall Study|Site Closure|0|||
105802078|NCT03705169|364930722|FG009|Overall Study|Site Closure|0|||
105802079|NCT03705169|364930713|FG000|Overall Study|Did not receive study treatment|0|||
105802080|NCT03705169|364930714|FG001|Overall Study|Did not receive study treatment|0|||
105802081|NCT03705169|364930715|FG002|Overall Study|Did not receive study treatment|0|||
105802082|NCT03705169|364930716|FG003|Overall Study|Did not receive study treatment|1|||
105802083|NCT03705169|364930717|FG004|Overall Study|Did not receive study treatment|0|||
105802084|NCT03705169|364930718|FG005|Overall Study|Did not receive study treatment|0|||
105802085|NCT03705169|364930719|FG006|Overall Study|Did not receive study treatment|0|||
105802086|NCT03705169|364930720|FG007|Overall Study|Did not receive study treatment|0|||
105802087|NCT03705169|364930721|FG008|Overall Study|Did not receive study treatment|0|||
105802088|NCT03705169|364930722|FG009|Overall Study|Did not receive study treatment|0|||
105802089|NCT03705169|364930713|FG000|Overall Study|Concerns about study visit compliance|0|||
105948117|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
105948118|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
105948119|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
105948120|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
105948121|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
105948122|NCT00956293|365473561|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
105948123|NCT00956293|365473562|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
105948124|NCT00956293|365473563|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
105948125|NCT00956293|365473561|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
105948126|NCT00956293|365473562|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
105948127|NCT00956293|365473563|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
105948128|NCT00956293|365473561|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
105948129|NCT00956293|365473562|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
105948130|NCT00956293|365473563|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
105948131|NCT00956293|365473561|FG000|Main Period (Randomization)|Adverse Event|0|||
105948132|NCT00956293|365473562|FG001|Main Period (Randomization)|Adverse Event|15|||
105948133|NCT00956293|365473563|FG002|Main Period (Randomization)|Adverse Event|0|||
105948134|NCT00956293|365473561|FG000|Follow-up Period|Follow-up period was terminated.|20|||
105948135|NCT00956293|365473562|FG001|Follow-up Period|Follow-up period was terminated.|32|||
105948136|NCT00956293|365473563|FG002|Follow-up Period|Follow-up period was terminated.|0|||
105948137|NCT03383666|365473564|FG000|Overall Study|Withdrawal by Subject|2|||
105948138|NCT03383666|365473564|FG000|Overall Study|Lost to Follow-up|2|||
105948139|NCT03507127|365473567|FG000|Overall Study|Withdrawal by Subject|1|||
105948140|NCT03507127|365473568|FG001|Overall Study|Withdrawal by Subject|0|||
105948141|NCT03507127|365473567|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
105948142|NCT03507127|365473568|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
105948143|NCT03508050|365473569|FG000|Overall Study|Pleural adhesions|1|||
105948144|NCT03508050|365473570|FG001|Overall Study|Pleural adhesions|0|||
105948145|NCT03508050|365473569|FG000|Overall Study|Mucus plug|1|||
105948146|NCT03508050|365473570|FG001|Overall Study|Mucus plug|0|||
105948147|NCT03508050|365473569|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
105948148|NCT03508050|365473570|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
105948149|NCT03508050|365473569|FG000|Overall Study|Sustained desaturation|0|||
105948150|NCT03508050|365473570|FG001|Overall Study|Sustained desaturation|1|||
105948151|NCT03961308|365473571|FG000|Overall Study|Withdrawal by Subject|1|||
105948152|NCT03961308|365473572|FG001|Overall Study|Withdrawal by Subject|0|||
105948153|NCT03961308|365473571|FG000|Overall Study|Other|1|||
105752716|NCT04724733|364746456|FG001|Overall Study|Lost to Follow-up|1|||
105752717|NCT04724733|364746457|FG002|Overall Study|Lost to Follow-up|1|||
105752718|NCT04511819|364746458|FG000|Overall Study|Non-compliance with study drug|5|||
105948154|NCT03961308|365473572|FG001|Overall Study|Other|0|||
105752719|NCT04511819|364746459|FG001|Overall Study|Non-compliance with study drug|1|||
105752720|NCT04511819|364746458|FG000|Overall Study|Withdrawal by Subject|0|||
105752721|NCT04511819|364746459|FG001|Overall Study|Withdrawal by Subject|3|||
105752722|NCT04511819|364746458|FG000|Overall Study|Adverse Event|0|||
105752723|NCT04511819|364746459|FG001|Overall Study|Adverse Event|1|||
105752724|NCT04511819|364746458|FG000|Overall Study|Protocol deviation|1|||
105752725|NCT04511819|364746459|FG001|Overall Study|Protocol deviation|0|||
105752726|NCT01742078|364746460|FG000|Overall Study|Withdrawal by Subject|0|||
105752727|NCT01742078|364746461|FG001|Overall Study|Withdrawal by Subject|0|||
105752728|NCT01742078|364746462|FG002|Overall Study|Withdrawal by Subject|0|||
105752729|NCT01742078|364746463|FG003|Overall Study|Withdrawal by Subject|1|||
105752730|NCT01742078|364746464|FG004|Overall Study|Withdrawal by Subject|0|||
105752731|NCT01742078|364746465|FG005|Overall Study|Withdrawal by Subject|0|||
105752732|NCT01742078|364746466|FG006|Overall Study|Withdrawal by Subject|0|||
105752733|NCT01742078|364746467|FG007|Overall Study|Withdrawal by Subject|0|||
105752734|NCT01742078|364746468|FG008|Overall Study|Withdrawal by Subject|0|||
105752735|NCT04580394|364746469|FG000|First Intervention|Incorrectly Randomized|1|||
105752736|NCT04580394|364746469|FG000|First Intervention|Physician Decision|1|||
105752737|NCT04580394|364746469|FG000|First Intervention|Lost to Follow-up|1|||
105752738|NCT04580394|364746469|FG000|Washout (One Week)|Withdrawal by Subject|1|||
105752739|NCT04580394|364746469|FG000|Washout (One Week)|Adverse Event|1|||
105752740|NCT04580394|364746469|FG000|Washout (One Week)|Withdrawal by Subject|2|||
105752741|NCT04580394|364746469|FG000|Third Intervention|Adverse Event|1|||
105752742|NCT04580394|364746469|FG000|Third Intervention|Withdrawal by Subject|1|||
105752743|NCT04580394|364746469|FG000|Washout (One Week)|Withdrawal by Subject|2|||
105752744|NCT00642746|364746472|FG000|Overall Study|Patient unevaluable|1|||
105752745|NCT00642746|364746473|FG001|Overall Study|Patient unevaluable|0|||
105752746|NCT00424294|364746477|FG000|Overall Study|Adverse Event|4|||
105752747|NCT00424294|364746478|FG001|Overall Study|Adverse Event|10|||
105752748|NCT00424294|364746477|FG000|Overall Study|Lack of Efficacy|2|||
105752749|NCT00424294|364746478|FG001|Overall Study|Lack of Efficacy|1|||
105752750|NCT00424294|364746477|FG000|Overall Study|Withdrawal by Subject|1|||
105752751|NCT00424294|364746478|FG001|Overall Study|Withdrawal by Subject|2|||
105752752|NCT00424294|364746477|FG000|Overall Study|Other|0|||
105752753|NCT00424294|364746478|FG001|Overall Study|Other|2|||
105752754|NCT00424294|364746477|FG000|Overall Study|Randomized but not Treated|1|||
105752755|NCT00424294|364746478|FG001|Overall Study|Randomized but not Treated|0|||
105752756|NCT01797965|364746481|FG000|Overall Study|Adverse Event|104|||
105752757|NCT01797965|364746482|FG001|Overall Study|Adverse Event|129|||
105752758|NCT01797965|364746483|FG002|Overall Study|Adverse Event|4|||
105752759|NCT01797965|364746484|FG003|Overall Study|Adverse Event|21|||
105752760|NCT01797965|364746481|FG000|Overall Study|Lost to Follow-up|9|||
105752761|NCT01797965|364746482|FG001|Overall Study|Lost to Follow-up|8|||
105752762|NCT01797965|364746483|FG002|Overall Study|Lost to Follow-up|1|||
105752763|NCT01797965|364746484|FG003|Overall Study|Lost to Follow-up|2|||
105752764|NCT01797965|364746481|FG000|Overall Study|Consent withdrawn|130|||
105752765|NCT01797965|364746482|FG001|Overall Study|Consent withdrawn|117|||
105752766|NCT01797965|364746483|FG002|Overall Study|Consent withdrawn|3|||
105752767|NCT01797965|364746484|FG003|Overall Study|Consent withdrawn|35|||
105752768|NCT01797965|364746481|FG000|Overall Study|Investigator decision|21|||
105752769|NCT01797965|364746482|FG001|Overall Study|Investigator decision|15|||
105752770|NCT01797965|364746483|FG002|Overall Study|Investigator decision|0|||
105752771|NCT01797965|364746484|FG003|Overall Study|Investigator decision|0|||
105752772|NCT01797965|364746481|FG000|Overall Study|Death|2|||
105752773|NCT01797965|364746482|FG001|Overall Study|Death|4|||
105752774|NCT01797965|364746483|FG002|Overall Study|Death|0|||
105752775|NCT01797965|364746484|FG003|Overall Study|Death|0|||
105948155|NCT03961308|365473571|FG000|Overall Study|Lost to Follow-up|0|||
105948156|NCT03961308|365473572|FG001|Overall Study|Lost to Follow-up|1|||
105948157|NCT03961308|365473571|FG000|Overall Study|Adverse Event|0|||
105948158|NCT03961308|365473572|FG001|Overall Study|Adverse Event|1|||
105752776|NCT01797965|364746481|FG000|Overall Study|Disease progression, defined by protocol|3|||
105752777|NCT01797965|364746482|FG001|Overall Study|Disease progression, defined by protocol|1|||
105752778|NCT01797965|364746483|FG002|Overall Study|Disease progression, defined by protocol|0|||
105752779|NCT01797965|364746484|FG003|Overall Study|Disease progression, defined by protocol|0|||
105752780|NCT01797965|364746481|FG000|Overall Study|Reason Not Specified|280|||
105752781|NCT01797965|364746482|FG001|Overall Study|Reason Not Specified|295|||
105752782|NCT01797965|364746483|FG002|Overall Study|Reason Not Specified|0|||
105752783|NCT01797965|364746484|FG003|Overall Study|Reason Not Specified|15|||
105752784|NCT00304915|364746485|FG000|Overall Study|Lost to Follow-up|11|||
105752785|NCT00304915|364746486|FG001|Overall Study|Lost to Follow-up|11|||
105752786|NCT00304915|364746485|FG000|Overall Study|Death|4|||
105752787|NCT00304915|364746486|FG001|Overall Study|Death|5|||
105752788|NCT00304915|364746485|FG000|Overall Study|Withdrawal by Subject|3|||
105752789|NCT00304915|364746486|FG001|Overall Study|Withdrawal by Subject|0|||
105752790|NCT03442829|364746489|FG000|Overall Study|Scheduling clash|3|||
105752791|NCT03442829|364746490|FG001|Overall Study|Scheduling clash|1|||
105948159|NCT01677988|365473573|FG000|Overall Study|Lack of Efficacy|2|||
105948160|NCT00659425|365473574|FG000|Overall Study|Disease progression|1|||
105948161|NCT00659425|365473575|FG001|Overall Study|Disease progression|0|||
105948162|NCT00659425|365473576|FG002|Overall Study|Disease progression|0|||
105948163|NCT00659425|365473577|FG003|Overall Study|Disease progression|1|||
105948164|NCT00659425|365473578|FG004|Overall Study|Disease progression|0|||
105948165|NCT00659425|365473579|FG005|Overall Study|Disease progression|2|||
105948166|NCT00659425|365473580|FG006|Overall Study|Disease progression|4|||
105948167|NCT00659425|365473581|FG007|Overall Study|Disease progression|3|||
105948168|NCT00659425|365473582|FG008|Overall Study|Disease progression|5|||
105948169|NCT00659425|365473583|FG009|Overall Study|Disease progression|3|||
105752792|NCT03442829|364746489|FG000|Overall Study|Illness unrelated to study|1|||
105752793|NCT03442829|364746490|FG001|Overall Study|Illness unrelated to study|1|||
105752794|NCT03491553|364746493|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
105752795|NCT03491553|364746494|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
105752796|NCT03491553|364746495|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
105752797|NCT03491553|364746496|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
105752798|NCT03491553|364746497|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
105752799|NCT03491553|364746498|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
105752800|NCT03491553|364746493|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
105752801|NCT03491553|364746494|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
105752802|NCT03491553|364746495|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
105752803|NCT03491553|364746496|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
105752804|NCT03491553|364746497|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
105752805|NCT03491553|364746498|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
105752806|NCT04404010|364746505|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
105752807|NCT04404010|364746506|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
105752808|NCT00586924|364746507|FG000|Overall Study|Adverse event/serious adverse event|0|||
105752809|NCT00586924|364746508|FG001|Overall Study|Adverse event/serious adverse event|0|||
105752810|NCT00586924|364746509|FG002|Overall Study|Adverse event/serious adverse event|0|||
105752811|NCT00586924|364746510|FG003|Overall Study|Adverse event/serious adverse event|1|||
105752812|NCT00586924|364746511|FG004|Overall Study|Adverse event/serious adverse event|0|||
105752813|NCT00586924|364746512|FG005|Overall Study|Adverse event/serious adverse event|2|||
105752814|NCT00586924|364746507|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
105752815|NCT00586924|364746508|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
105760897|NCT01342952|364778054|FG002|Overall Study|Adverse Event|1|||
106016427|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016428|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
105752816|NCT00586924|364746509|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
105752817|NCT00586924|364746510|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
105752818|NCT00586924|364746511|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
105752819|NCT00586924|364746512|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
105752820|NCT00586924|364746507|FG000|Overall Study|Disease progression|0|||
105752821|NCT00586924|364746508|FG001|Overall Study|Disease progression|0|||
105752822|NCT00586924|364746509|FG002|Overall Study|Disease progression|0|||
105752823|NCT00586924|364746510|FG003|Overall Study|Disease progression|1|||
105752824|NCT00586924|364746511|FG004|Overall Study|Disease progression|1|||
105752825|NCT00586924|364746512|FG005|Overall Study|Disease progression|0|||
105752826|NCT00586924|364746507|FG000|Overall Study|Development of neutralizing antibodies|2|||
105760898|NCT01342952|364778055|FG003|Overall Study|Adverse Event|0|||
105948170|NCT00659425|365473574|FG000|Overall Study|Death|0|||
105948171|NCT00659425|365473575|FG001|Overall Study|Death|0|||
105948172|NCT00659425|365473576|FG002|Overall Study|Death|0|||
105948173|NCT00659425|365473577|FG003|Overall Study|Death|1|||
105948174|NCT00659425|365473578|FG004|Overall Study|Death|0|||
105752827|NCT00586924|364746508|FG001|Overall Study|Development of neutralizing antibodies|2|||
105752828|NCT00586924|364746509|FG002|Overall Study|Development of neutralizing antibodies|2|||
105752829|NCT00586924|364746510|FG003|Overall Study|Development of neutralizing antibodies|0|||
105752830|NCT00586924|364746511|FG004|Overall Study|Development of neutralizing antibodies|0|||
105752831|NCT00586924|364746512|FG005|Overall Study|Development of neutralizing antibodies|22|||
105752832|NCT00586924|364746507|FG000|Overall Study|Complete response|0|||
105752833|NCT00586924|364746508|FG001|Overall Study|Complete response|1|||
105752834|NCT00586924|364746509|FG002|Overall Study|Complete response|0|||
105752835|NCT00586924|364746510|FG003|Overall Study|Complete response|0|||
105752836|NCT00586924|364746511|FG004|Overall Study|Complete response|2|||
105948175|NCT00659425|365473579|FG005|Overall Study|Death|0|||
105948176|NCT00659425|365473580|FG006|Overall Study|Death|1|||
105948177|NCT00659425|365473581|FG007|Overall Study|Death|0|||
105948178|NCT00659425|365473582|FG008|Overall Study|Death|0|||
105948179|NCT00659425|365473583|FG009|Overall Study|Death|0|||
105752837|NCT00586924|364746512|FG005|Overall Study|Complete response|2|||
105752838|NCT00586924|364746507|FG000|Overall Study|Other|1|||
105752839|NCT00586924|364746508|FG001|Overall Study|Other|0|||
105752840|NCT00586924|364746509|FG002|Overall Study|Other|1|||
105948180|NCT00659425|365473574|FG000|Overall Study|Adverse Event|0|||
105948181|NCT00659425|365473575|FG001|Overall Study|Adverse Event|0|||
105752841|NCT00586924|364746510|FG003|Overall Study|Other|1|||
105752842|NCT00586924|364746511|FG004|Overall Study|Other|1|||
105752843|NCT00586924|364746512|FG005|Overall Study|Other|6|||
105752844|NCT00536978|364746513|FG000|Overall Study|Not eligible for Adback Infusion|22|||
105752845|NCT00118482|364746514|FG000|Overall Study|Lost to Follow-up|7|||
105752846|NCT00118482|364746515|FG001|Overall Study|Lost to Follow-up|7|||
105752847|NCT00118482|364746514|FG000|Overall Study|Withdrawal by Subject|23|||
105752848|NCT00118482|364746515|FG001|Overall Study|Withdrawal by Subject|22|||
105752849|NCT02128763|364746519|FG000|Overall Study|Death|1|||
105752850|NCT02128763|364746520|FG001|Overall Study|Death|0|||
105752851|NCT02128763|364746519|FG000|Overall Study|Lost to Follow-up|19|||
105752852|NCT02128763|364746520|FG001|Overall Study|Lost to Follow-up|16|||
105752853|NCT00819585|364746521|FG000|Core Study|Adverse Event|2|||
105752854|NCT00819585|364746522|FG001|Core Study|Adverse Event|1|||
105752855|NCT00819585|364746523|FG002|Core Study|Adverse Event|1|||
105752856|NCT00819585|364746524|FG003|Core Study|Adverse Event|4|||
105752857|NCT00819585|364746525|FG004|Core Study|Adverse Event|1|||
105752858|NCT00819585|364746526|FG005|Core Study|Adverse Event|0|||
105752859|NCT00819585|364746527|FG006|Core Study|Adverse Event|2|||
105752860|NCT00819585|364746528|FG007|Core Study|Adverse Event|0|||
105752861|NCT00819585|364746529|FG008|Core Study|Adverse Event|0|||
105752862|NCT00819585|364746530|FG009|Core Study|Adverse Event|0|||
105752863|NCT00819585|364746531|FG010|Core Study|Adverse Event|0|||
105752864|NCT00819585|364746521|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
105752865|NCT00819585|364746522|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
105752866|NCT00819585|364746523|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
105752867|NCT00819585|364746524|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
105752868|NCT00819585|364746525|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
105752869|NCT00819585|364746526|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
105752870|NCT00819585|364746527|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
105752871|NCT00819585|364746528|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
105752872|NCT00819585|364746529|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
105752873|NCT00819585|364746530|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
105752874|NCT00819585|364746531|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
105752875|NCT00819585|364746521|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752876|NCT00819585|364746522|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
105752877|NCT00819585|364746523|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752878|NCT00819585|364746524|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752879|NCT00819585|364746525|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752880|NCT00819585|364746526|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752881|NCT00819585|364746527|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
105752882|NCT00819585|364746528|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752883|NCT00819585|364746529|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752884|NCT00819585|364746530|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
105948182|NCT00659425|365473576|FG002|Overall Study|Adverse Event|0|||
105948183|NCT00659425|365473577|FG003|Overall Study|Adverse Event|0|||
105948184|NCT00659425|365473578|FG004|Overall Study|Adverse Event|0|||
105948185|NCT00659425|365473579|FG005|Overall Study|Adverse Event|1|||
105948186|NCT00659425|365473580|FG006|Overall Study|Adverse Event|0|||
105948187|NCT00659425|365473581|FG007|Overall Study|Adverse Event|3|||
105948188|NCT00659425|365473582|FG008|Overall Study|Adverse Event|1|||
105948189|NCT00659425|365473583|FG009|Overall Study|Adverse Event|4|||
105948190|NCT00659425|365473574|FG000|Overall Study|Investigator Discretion|0|||
105948191|NCT00659425|365473575|FG001|Overall Study|Investigator Discretion|0|||
105948192|NCT00659425|365473576|FG002|Overall Study|Investigator Discretion|0|||
105948193|NCT00659425|365473577|FG003|Overall Study|Investigator Discretion|0|||
105948194|NCT00659425|365473578|FG004|Overall Study|Investigator Discretion|0|||
105948195|NCT00659425|365473579|FG005|Overall Study|Investigator Discretion|1|||
105948196|NCT00659425|365473580|FG006|Overall Study|Investigator Discretion|0|||
105948197|NCT00659425|365473581|FG007|Overall Study|Investigator Discretion|3|||
105948198|NCT00659425|365473582|FG008|Overall Study|Investigator Discretion|0|||
105752885|NCT00819585|364746531|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
105752886|NCT00819585|364746521|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
105752887|NCT00819585|364746522|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
105752888|NCT00819585|364746523|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
105752889|NCT00819585|364746524|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
105752890|NCT00819585|364746525|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
105752891|NCT00819585|364746526|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
105752892|NCT00819585|364746527|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
105752893|NCT00819585|364746528|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
105752894|NCT00819585|364746529|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
105752895|NCT00819585|364746530|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
105752896|NCT00819585|364746531|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
105752897|NCT00819585|364746521|FG000|Core Study|Subject Withdrew Consent|0|||
105752898|NCT00819585|364746522|FG001|Core Study|Subject Withdrew Consent|3|||
105948199|NCT00659425|365473583|FG009|Overall Study|Investigator Discretion|0|||
105948200|NCT00659425|365473574|FG000|Overall Study|Other|0|||
105752899|NCT00819585|364746523|FG002|Core Study|Subject Withdrew Consent|2|||
105752900|NCT00819585|364746524|FG003|Core Study|Subject Withdrew Consent|1|||
105752901|NCT00819585|364746525|FG004|Core Study|Subject Withdrew Consent|0|||
105752902|NCT00819585|364746526|FG005|Core Study|Subject Withdrew Consent|0|||
105752903|NCT00819585|364746527|FG006|Core Study|Subject Withdrew Consent|3|||
105752904|NCT00819585|364746528|FG007|Core Study|Subject Withdrew Consent|0|||
105752905|NCT00819585|364746529|FG008|Core Study|Subject Withdrew Consent|0|||
105752906|NCT00819585|364746530|FG009|Core Study|Subject Withdrew Consent|0|||
105752907|NCT00819585|364746531|FG010|Core Study|Subject Withdrew Consent|0|||
105752908|NCT00819585|364746521|FG000|Core Study|Lost to Follow-up|2|||
105752909|NCT00819585|364746522|FG001|Core Study|Lost to Follow-up|1|||
105752910|NCT00819585|364746523|FG002|Core Study|Lost to Follow-up|2|||
105752911|NCT00819585|364746524|FG003|Core Study|Lost to Follow-up|0|||
105752912|NCT00819585|364746525|FG004|Core Study|Lost to Follow-up|1|||
105752913|NCT00819585|364746526|FG005|Core Study|Lost to Follow-up|1|||
105752914|NCT00819585|364746527|FG006|Core Study|Lost to Follow-up|1|||
105752915|NCT00819585|364746528|FG007|Core Study|Lost to Follow-up|0|||
105752916|NCT00819585|364746529|FG008|Core Study|Lost to Follow-up|0|||
105752917|NCT00819585|364746530|FG009|Core Study|Lost to Follow-up|0|||
105752918|NCT00819585|364746531|FG010|Core Study|Lost to Follow-up|0|||
105752919|NCT00819585|364746521|FG000|Core Study|Administrative Problems|0|||
105752920|NCT00819585|364746522|FG001|Core Study|Administrative Problems|0|||
105752921|NCT00819585|364746523|FG002|Core Study|Administrative Problems|0|||
105752922|NCT00819585|364746524|FG003|Core Study|Administrative Problems|0|||
105752923|NCT00819585|364746525|FG004|Core Study|Administrative Problems|0|||
105752924|NCT00819585|364746526|FG005|Core Study|Administrative Problems|0|||
105752925|NCT00819585|364746527|FG006|Core Study|Administrative Problems|2|||
105752926|NCT00819585|364746528|FG007|Core Study|Administrative Problems|0|||
105752927|NCT00819585|364746529|FG008|Core Study|Administrative Problems|0|||
105752928|NCT00819585|364746530|FG009|Core Study|Administrative Problems|0|||
105752929|NCT00819585|364746531|FG010|Core Study|Administrative Problems|0|||
105752930|NCT00819585|364746521|FG000|Core Study|Death|0|||
105752931|NCT00819585|364746522|FG001|Core Study|Death|0|||
105752932|NCT00819585|364746523|FG002|Core Study|Death|0|||
105752933|NCT00819585|364746524|FG003|Core Study|Death|0|||
105752934|NCT00819585|364746525|FG004|Core Study|Death|0|||
105752935|NCT00819585|364746526|FG005|Core Study|Death|0|||
105752936|NCT00819585|364746527|FG006|Core Study|Death|1|||
105752937|NCT00819585|364746528|FG007|Core Study|Death|0|||
105752938|NCT00819585|364746529|FG008|Core Study|Death|0|||
105752939|NCT00819585|364746530|FG009|Core Study|Death|0|||
105752940|NCT00819585|364746531|FG010|Core Study|Death|0|||
105752941|NCT00819585|364746521|FG000|Core Study|Protocol Violation|0|||
105752942|NCT00819585|364746522|FG001|Core Study|Protocol Violation|0|||
105752943|NCT00819585|364746523|FG002|Core Study|Protocol Violation|1|||
105752944|NCT00819585|364746524|FG003|Core Study|Protocol Violation|0|||
105752945|NCT00819585|364746525|FG004|Core Study|Protocol Violation|0|||
105752946|NCT00819585|364746526|FG005|Core Study|Protocol Violation|1|||
105948201|NCT00659425|365473575|FG001|Overall Study|Other|1|||
105752947|NCT00819585|364746527|FG006|Core Study|Protocol Violation|3|||
105752948|NCT00819585|364746528|FG007|Core Study|Protocol Violation|0|||
105752949|NCT00819585|364746529|FG008|Core Study|Protocol Violation|0|||
105752950|NCT00819585|364746530|FG009|Core Study|Protocol Violation|0|||
105752951|NCT00819585|364746531|FG010|Core Study|Protocol Violation|0|||
105752952|NCT00819585|364746521|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
105752953|NCT00819585|364746522|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
105752954|NCT00819585|364746523|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
105752955|NCT00819585|364746524|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
105752956|NCT00819585|364746525|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
105752957|NCT00819585|364746526|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
105752958|NCT00819585|364746527|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
105752959|NCT00819585|364746528|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
105752960|NCT00819585|364746529|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
105752961|NCT00819585|364746530|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
105752962|NCT00819585|364746531|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
105752963|NCT00819585|364746521|FG000|Extension Study|Subject Withdrew Consent|0|||
105752964|NCT00819585|364746522|FG001|Extension Study|Subject Withdrew Consent|0|||
105752965|NCT00819585|364746523|FG002|Extension Study|Subject Withdrew Consent|0|||
105752966|NCT00819585|364746524|FG003|Extension Study|Subject Withdrew Consent|0|||
105752967|NCT00819585|364746525|FG004|Extension Study|Subject Withdrew Consent|0|||
105752968|NCT00819585|364746526|FG005|Extension Study|Subject Withdrew Consent|0|||
105752969|NCT00819585|364746527|FG006|Extension Study|Subject Withdrew Consent|0|||
105752970|NCT00819585|364746528|FG007|Extension Study|Subject Withdrew Consent|0|||
105752971|NCT00819585|364746529|FG008|Extension Study|Subject Withdrew Consent|3|||
105752972|NCT00819585|364746530|FG009|Extension Study|Subject Withdrew Consent|0|||
105752973|NCT00819585|364746531|FG010|Extension Study|Subject Withdrew Consent|1|||
105752974|NCT00819585|364746521|FG000|Extension Study|Lost to Follow-up|0|||
105752975|NCT00819585|364746522|FG001|Extension Study|Lost to Follow-up|0|||
105948202|NCT00659425|365473576|FG002|Overall Study|Other|1|||
105752976|NCT00819585|364746523|FG002|Extension Study|Lost to Follow-up|0|||
105752977|NCT00819585|364746524|FG003|Extension Study|Lost to Follow-up|0|||
105752978|NCT00819585|364746525|FG004|Extension Study|Lost to Follow-up|0|||
105752979|NCT00819585|364746526|FG005|Extension Study|Lost to Follow-up|0|||
105752980|NCT00819585|364746527|FG006|Extension Study|Lost to Follow-up|0|||
105752981|NCT00819585|364746528|FG007|Extension Study|Lost to Follow-up|0|||
105752982|NCT00819585|364746529|FG008|Extension Study|Lost to Follow-up|2|||
105752983|NCT00819585|364746530|FG009|Extension Study|Lost to Follow-up|1|||
105752984|NCT00819585|364746531|FG010|Extension Study|Lost to Follow-up|1|||
105752985|NCT00819585|364746521|FG000|Extension Study|Death|0|||
105752986|NCT00819585|364746522|FG001|Extension Study|Death|0|||
105752987|NCT00819585|364746523|FG002|Extension Study|Death|0|||
105752988|NCT00819585|364746524|FG003|Extension Study|Death|0|||
105948203|NCT00659425|365473577|FG003|Overall Study|Other|2|||
105948204|NCT00659425|365473578|FG004|Overall Study|Other|4|||
105948205|NCT00659425|365473579|FG005|Overall Study|Other|0|||
105948206|NCT00659425|365473580|FG006|Overall Study|Other|3|||
105948207|NCT00659425|365473581|FG007|Overall Study|Other|2|||
105948208|NCT00659425|365473582|FG008|Overall Study|Other|0|||
105948209|NCT00659425|365473583|FG009|Overall Study|Other|6|||
105948210|NCT01174563|365473584|FG000|Overall Study|Progressive Disease|45|||
105948211|NCT01174563|365473584|FG000|Overall Study|Death|5|||
105948212|NCT01174563|365473584|FG000|Overall Study|Investigator's Discretion|5|||
105948213|NCT01174563|365473584|FG000|Overall Study|Participant Withdrew Consent|3|||
105948214|NCT01174563|365473584|FG000|Overall Study|Rash Adverse Event|1|||
105948215|NCT01174563|365473584|FG000|Overall Study|Sponsor's decision|1|||
105948216|NCT00279214|365473602|FG000|Overall Study|Physician Decision|3|||
106016429|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016430|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016431|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016432|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
106016433|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016434|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016435|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016436|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016437|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016438|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016439|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016440|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
106016441|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
106016442|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016443|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016444|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016445|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016446|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
106016447|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016448|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016449|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016450|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016451|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016452|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016453|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016454|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
106016455|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016456|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016457|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016458|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016459|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016460|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
106016461|NCT04033445|365724447|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016462|NCT04033445|365724448|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016463|NCT04033445|365724449|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105752989|NCT00819585|364746525|FG004|Extension Study|Death|0|||
105752990|NCT00819585|364746526|FG005|Extension Study|Death|0|||
105752991|NCT00819585|364746527|FG006|Extension Study|Death|0|||
105752992|NCT00819585|364746528|FG007|Extension Study|Death|0|||
105752993|NCT00819585|364746529|FG008|Extension Study|Death|2|||
105752994|NCT00819585|364746530|FG009|Extension Study|Death|0|||
105752995|NCT00819585|364746531|FG010|Extension Study|Death|0|||
105948217|NCT00279214|365473603|FG001|Overall Study|Physician Decision|2|||
105948218|NCT04046939|365473604|FG000|Primary Assessment Period|Adverse Event|1|||
105948219|NCT04046939|365473605|FG001|Primary Assessment Period|Adverse Event|0|||
105948220|NCT04046939|365473606|FG002|Primary Assessment Period|Adverse Event|0|||
105752996|NCT01973452|364746532|FG000|Overall Study|Lack of Efficacy|0|||
105752997|NCT01973452|364746533|FG001|Overall Study|Lack of Efficacy|1|||
105752998|NCT01973452|364746532|FG000|Overall Study|Lost to Follow-up|1|||
105752999|NCT01973452|364746533|FG001|Overall Study|Lost to Follow-up|0|||
105753000|NCT01973452|364746532|FG000|Overall Study|Withdrawal by Subject|10|||
105753001|NCT01973452|364746533|FG001|Overall Study|Withdrawal by Subject|9|||
105753002|NCT01973452|364746532|FG000|Overall Study|Ineligible|1|||
105753003|NCT01973452|364746533|FG001|Overall Study|Ineligible|1|||
105753004|NCT01973452|364746532|FG000|Overall Study|Surgery canceled by participant|5|||
105753005|NCT01973452|364746533|FG001|Overall Study|Surgery canceled by participant|3|||
105753006|NCT02198651|364748014|FG000|Lead-in Period|Withdrew consent|13|||
105753007|NCT02198651|364748015|FG001|Lead-in Period|Withdrew consent|0|||
105753008|NCT02198651|364748016|FG002|Lead-in Period|Withdrew consent|0|||
105753009|NCT02198651|364748017|FG003|Lead-in Period|Withdrew consent|0|||
105753010|NCT02198651|364748018|FG004|Lead-in Period|Withdrew consent|0|||
105753011|NCT02198651|364748014|FG000|Lead-in Period|Adverse Event|2|||
105753012|NCT02198651|364748015|FG001|Lead-in Period|Adverse Event|0|||
105753013|NCT02198651|364748016|FG002|Lead-in Period|Adverse Event|0|||
105753014|NCT02198651|364748017|FG003|Lead-in Period|Adverse Event|0|||
105753015|NCT02198651|364748018|FG004|Lead-in Period|Adverse Event|0|||
105753016|NCT02198651|364748014|FG000|Lead-in Period|Other, not specified|22|||
105753017|NCT02198651|364748015|FG001|Lead-in Period|Other, not specified|0|||
105753018|NCT02198651|364748016|FG002|Lead-in Period|Other, not specified|0|||
105753019|NCT02198651|364748017|FG003|Lead-in Period|Other, not specified|0|||
105753020|NCT02198651|364748018|FG004|Lead-in Period|Other, not specified|0|||
105753021|NCT02198651|364748014|FG000|Double-blind Period|Withdrew consent|0|||
105753022|NCT02198651|364748015|FG001|Double-blind Period|Withdrew consent|4|||
105753023|NCT02198651|364748016|FG002|Double-blind Period|Withdrew consent|0|||
105753024|NCT02198651|364748017|FG003|Double-blind Period|Withdrew consent|0|||
105753025|NCT02198651|364748018|FG004|Double-blind Period|Withdrew consent|0|||
105753026|NCT02198651|364748014|FG000|Double-blind Period|Adverse Event|0|||
105753027|NCT02198651|364748015|FG001|Double-blind Period|Adverse Event|1|||
105753028|NCT02198651|364748016|FG002|Double-blind Period|Adverse Event|0|||
105753029|NCT02198651|364748017|FG003|Double-blind Period|Adverse Event|0|||
105753030|NCT02198651|364748018|FG004|Double-blind Period|Adverse Event|0|||
105753031|NCT02198651|364748014|FG000|Double-blind Period|Other, not specified|0|||
105753032|NCT02198651|364748015|FG001|Double-blind Period|Other, not specified|4|||
105753033|NCT02198651|364748016|FG002|Double-blind Period|Other, not specified|1|||
105753034|NCT02198651|364748017|FG003|Double-blind Period|Other, not specified|0|||
105753035|NCT02198651|364748018|FG004|Double-blind Period|Other, not specified|0|||
105753036|NCT02198651|364748014|FG000|Open-label Rescue Period|Withdrew consent|0|||
105753037|NCT02198651|364748015|FG001|Open-label Rescue Period|Withdrew consent|0|||
105753038|NCT02198651|364748016|FG002|Open-label Rescue Period|Withdrew consent|0|||
105753039|NCT02198651|364748017|FG003|Open-label Rescue Period|Withdrew consent|2|||
105753040|NCT02198651|364748018|FG004|Open-label Rescue Period|Withdrew consent|0|||
105753041|NCT02198651|364748014|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
105753042|NCT02198651|364748015|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
105753043|NCT02198651|364748016|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
105753044|NCT02198651|364748017|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
105753045|NCT02198651|364748018|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
105753046|NCT04095442|364748022|FG000|Overall Study|Lost to Follow-up|0|||
105753047|NCT04095442|364748023|FG001|Overall Study|Lost to Follow-up|1|||
105753048|NCT04095442|364748022|FG000|Overall Study|Screen failure|1|||
105753049|NCT04095442|364748023|FG001|Overall Study|Screen failure|0|||
105753050|NCT00255034|364748027|FG000|Overall Study|Withdrawal by Subject|15|||
105753051|NCT00255034|364748028|FG001|Overall Study|Withdrawal by Subject|38|||
105753052|NCT00574119|364748032|FG000|Overall Study|Adverse Event|1|||
105753053|NCT00574119|364748032|FG000|Overall Study|Protocol Violation|1|||
105753054|NCT00574119|364748032|FG000|Overall Study|Withdrawal by Subject|1|||
105753055|NCT00574119|364748032|FG000|Overall Study|Physician Decision|1|||
105753056|NCT04124692|364748036|FG000|Overall Study|Medical reason|0|||
105753057|NCT04124692|364748037|FG001|Overall Study|Medical reason|1|||
105753058|NCT04124692|364748036|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
105948221|NCT04046939|365473607|FG003|Primary Assessment Period|Adverse Event|0|||
105948222|NCT04046939|365473604|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
105753059|NCT04124692|364748037|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
105753060|NCT04124692|364748036|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
105753061|NCT04124692|364748037|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
105753062|NCT04124692|364748036|FG000|Overall Study|Lost to Follow-up|2|||
105753063|NCT04124692|364748037|FG001|Overall Study|Lost to Follow-up|4|||
105753064|NCT04124692|364748036|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
105753065|NCT04124692|364748037|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
105753066|NCT00363051|364748038|FG000|Overall Study|Adminstrative problems|1|||
105948223|NCT04046939|365473605|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
105948224|NCT04046939|365473606|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
105948225|NCT04046939|365473607|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
105948226|NCT04046939|365473604|FG000|Primary Assessment Period|Physician Decision|0|||
105948227|NCT04046939|365473605|FG001|Primary Assessment Period|Physician Decision|0|||
105948228|NCT04046939|365473606|FG002|Primary Assessment Period|Physician Decision|1|||
105948229|NCT04046939|365473607|FG003|Primary Assessment Period|Physician Decision|0|||
105948230|NCT04046939|365473604|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
105948231|NCT04046939|365473605|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
105948232|NCT04046939|365473606|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
105948233|NCT04046939|365473607|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
105948234|NCT01280968|365473608|FG000|Overall Study|Lost to Follow-up|8|||
105948235|NCT01280968|365473609|FG001|Overall Study|Lost to Follow-up|2|||
105948236|NCT01280968|365473608|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
105948237|NCT01280968|365473609|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
105948238|NCT01280968|365473608|FG000|Overall Study|Commuting Problems|2|||
105948239|NCT01280968|365473609|FG001|Overall Study|Commuting Problems|0|||
105948240|NCT01280968|365473608|FG000|Overall Study|Anxiety|2|||
105948241|NCT01280968|365473609|FG001|Overall Study|Anxiety|0|||
105948242|NCT01280968|365473608|FG000|Overall Study|Adverse Event|1|||
105948243|NCT01280968|365473609|FG001|Overall Study|Adverse Event|0|||
105948244|NCT01280968|365473608|FG000|Overall Study|Scheduling Conflicts|1|||
105948245|NCT01280968|365473609|FG001|Overall Study|Scheduling Conflicts|1|||
105948246|NCT01280968|365473608|FG000|Overall Study|Pre-existing Neurological Condition|1|||
105948247|NCT01280968|365473609|FG001|Overall Study|Pre-existing Neurological Condition|0|||
105948248|NCT01280968|365473608|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
105948249|NCT01280968|365473609|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
105948250|NCT01729039|365473610|FG000|Overall Study|disqualified|2|||
105948251|NCT01729039|365473611|FG001|Overall Study|disqualified|5|||
105948252|NCT01729039|365473610|FG000|Overall Study|Withdrawal by Subject|8|||
105948253|NCT01729039|365473611|FG001|Overall Study|Withdrawal by Subject|7|||
105948254|NCT01214837|365473612|FG000|Overall Study|Death|0|||
105948255|NCT01214837|365473613|FG001|Overall Study|Death|0|||
105948256|NCT01214837|365473614|FG002|Overall Study|Death|1|||
105948257|NCT01214837|365473612|FG000|Overall Study|Adverse Event|1|||
105753067|NCT00363051|364748039|FG001|Overall Study|Adminstrative problems|1|||
105753068|NCT00363051|364748038|FG000|Overall Study|Adverse Event|21|||
105753069|NCT00363051|364748039|FG001|Overall Study|Adverse Event|12|||
105753070|NCT00363051|364748038|FG000|Overall Study|New Cancer Therapy|2|||
105753071|NCT00363051|364748039|FG001|Overall Study|New Cancer Therapy|1|||
105753072|NCT00363051|364748038|FG000|Overall Study|Withdrawal by Subject|11|||
105753073|NCT00363051|364748039|FG001|Overall Study|Withdrawal by Subject|3|||
105753074|NCT00363051|364748038|FG000|Overall Study|Lost to Follow-up|0|||
105948258|NCT01214837|365473613|FG001|Overall Study|Adverse Event|2|||
105948259|NCT01214837|365473614|FG002|Overall Study|Adverse Event|1|||
105948260|NCT01214837|365473612|FG000|Overall Study|Withdrawal by Subject|27|||
105948261|NCT01214837|365473613|FG001|Overall Study|Withdrawal by Subject|36|||
105948262|NCT01214837|365473614|FG002|Overall Study|Withdrawal by Subject|28|||
105948263|NCT01214837|365473612|FG000|Overall Study|Lost to Follow-up|20|||
105948264|NCT01214837|365473613|FG001|Overall Study|Lost to Follow-up|15|||
105948265|NCT01214837|365473614|FG002|Overall Study|Lost to Follow-up|21|||
105948266|NCT01214837|365473612|FG000|Overall Study|Inappropriate Enrolment|0|||
105948267|NCT01214837|365473613|FG001|Overall Study|Inappropriate Enrolment|1|||
105948268|NCT01214837|365473614|FG002|Overall Study|Inappropriate Enrolment|2|||
105753075|NCT00363051|364748039|FG001|Overall Study|Lost to Follow-up|1|||
105753076|NCT00363051|364748038|FG000|Overall Study|Protocol Violation|0|||
105753077|NCT00363051|364748039|FG001|Overall Study|Protocol Violation|2|||
105753078|NCT00363051|364748038|FG000|Overall Study|Death|3|||
105753079|NCT00363051|364748039|FG001|Overall Study|Death|2|||
105753080|NCT01957709|364748040|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
105753081|NCT00650091|364748054|FG000|Amended Study Design|Withdrawal by Subject|12|||
105753082|NCT00650091|364748055|FG001|Amended Study Design|Withdrawal by Subject|11|||
105753083|NCT00650091|364748056|FG002|Amended Study Design|Withdrawal by Subject|0|||
105753084|NCT00650091|364748054|FG000|Amended Study Design|Physician Decision|5|||
105753085|NCT00650091|364748055|FG001|Amended Study Design|Physician Decision|0|||
105753086|NCT00650091|364748056|FG002|Amended Study Design|Physician Decision|0|||
105753087|NCT00650091|364748054|FG000|Amended Study Design|Adverse Event|1|||
105753088|NCT00650091|364748055|FG001|Amended Study Design|Adverse Event|4|||
105753089|NCT00650091|364748056|FG002|Amended Study Design|Adverse Event|0|||
105753090|NCT00650091|364748054|FG000|Amended Study Design|Lung transplantation|4|||
105948269|NCT01214837|365473612|FG000|Overall Study|Administrative Reason|2|||
105948270|NCT01214837|365473613|FG001|Overall Study|Administrative Reason|6|||
105948271|NCT01214837|365473614|FG002|Overall Study|Administrative Reason|4|||
105948272|NCT01214837|365473612|FG000|Overall Study|Protocol Violation|3|||
105948273|NCT01214837|365473613|FG001|Overall Study|Protocol Violation|1|||
105948274|NCT01214837|365473614|FG002|Overall Study|Protocol Violation|5|||
105948275|NCT01214837|365473612|FG000|Overall Study|Unable to Classify|1|||
105948276|NCT01214837|365473613|FG001|Overall Study|Unable to Classify|3|||
105948277|NCT01214837|365473614|FG002|Overall Study|Unable to Classify|0|||
105948278|NCT04696146|365474993|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
105948279|NCT04696146|365474994|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
105948280|NCT04696146|365474993|FG000|Overall Study|Off hours issue with product|1|||
105753091|NCT00650091|364748055|FG001|Amended Study Design|Lung transplantation|2|||
105753092|NCT00650091|364748056|FG002|Amended Study Design|Lung transplantation|0|||
105753093|NCT00650091|364748054|FG000|Amended Study Design|Other|1|||
105753094|NCT00650091|364748055|FG001|Amended Study Design|Other|3|||
105753095|NCT00650091|364748056|FG002|Amended Study Design|Other|0|||
105753096|NCT01204697|364748057|FG000|Overall Study|Death|26|||
105753097|NCT01204697|364748058|FG001|Overall Study|Death|27|||
105753098|NCT01204697|364748057|FG000|Overall Study|Lost to Follow-up|3|||
105753099|NCT01204697|364748058|FG001|Overall Study|Lost to Follow-up|4|||
105753100|NCT01204697|364748057|FG000|Overall Study|Withdrawal by Subject|2|||
105753101|NCT01204697|364748058|FG001|Overall Study|Withdrawal by Subject|4|||
105753102|NCT01204697|364748057|FG000|Overall Study|Randomized, but not treated|0|||
105753103|NCT01204697|364748058|FG001|Overall Study|Randomized, but not treated|1|||
105753104|NCT01677507|364748060|FG000|Initial Assignment|Adverse Event|0|||
105753105|NCT01677507|364748061|FG001|Initial Assignment|Adverse Event|1|||
105753106|NCT01677507|364748060|FG000|Initial Assignment|Protocol Violation|0|||
105753107|NCT01677507|364748061|FG001|Initial Assignment|Protocol Violation|1|||
105753108|NCT01677507|364748060|FG000|Second Assigment|Withdrawal by Subject|2|||
105753109|NCT01677507|364748061|FG001|Second Assigment|Withdrawal by Subject|2|||
105753110|NCT01677507|364748060|FG000|Second Assigment|Adverse Event|1|||
105753111|NCT01677507|364748061|FG001|Second Assigment|Adverse Event|3|||
105753112|NCT01194869|364748062|FG000|Overall Study|Disease Progression|2|||
105753113|NCT01194869|364748062|FG000|Overall Study|Toxicity|2|||
105753114|NCT00213980|364748063|FG000|Overall Study|Withdrawal by Subject|3|||
105753115|NCT00213980|364748064|FG001|Overall Study|Withdrawal by Subject|1|||
105753116|NCT00213980|364748063|FG000|Overall Study|Adverse Event|1|||
105753117|NCT00213980|364748064|FG001|Overall Study|Adverse Event|1|||
105753118|NCT00213980|364748063|FG000|Overall Study|Disease progression|0|||
105753119|NCT00213980|364748064|FG001|Overall Study|Disease progression|2|||
105753120|NCT00213980|364748063|FG000|Overall Study|Developed ovarian cancer|1|||
105753121|NCT00213980|364748064|FG001|Overall Study|Developed ovarian cancer|0|||
105753122|NCT00213980|364748063|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
105753123|NCT00213980|364748064|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
105948281|NCT04696146|365474994|FG001|Overall Study|Off hours issue with product|0|||
105753124|NCT00098020|364748074|FG000|Overall Study|Adverse Event|2|||
105753125|NCT00098020|364748074|FG000|Overall Study|Lost to Follow-up|1|||
105753126|NCT00098020|364748074|FG000|Overall Study|elevated liver enzymes|1|||
105753127|NCT00098020|364748074|FG000|Overall Study|Low urine PCR|1|||
105753128|NCT00098020|364748074|FG000|Overall Study|Low epidermal growth factor receptor|1|||
105753129|NCT01453998|364748076|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
105753130|NCT01453998|364748077|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
105753131|NCT01453998|364748078|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
105753132|NCT03495453|364748079|FG000|Overall Study|Withdrawal by Subject|0|||
105753133|NCT03495453|364748080|FG001|Overall Study|Withdrawal by Subject|1|||
105753134|NCT00085917|364748081|FG000|Overall Study|Adverse Event|4|||
105948282|NCT01334918|365474995|FG000|Overall Study|Did not receive study drug|6|||
105948283|NCT01334918|365474996|FG001|Overall Study|Did not receive study drug|0|||
105948284|NCT01334918|365474995|FG000|Overall Study|Adverse Event|2|||
105948285|NCT01334918|365474996|FG001|Overall Study|Adverse Event|0|||
105753135|NCT00085917|364748082|FG001|Overall Study|Adverse Event|3|||
105753136|NCT00209170|364748083|FG000|Overall Study|Adverse Event|0|||
105753137|NCT00209170|364748084|FG001|Overall Study|Adverse Event|1|||
105753138|NCT00209170|364748083|FG000|Overall Study|Withdrawal by Subject|2|||
105753139|NCT00209170|364748084|FG001|Overall Study|Withdrawal by Subject|1|||
105753140|NCT00209170|364748083|FG000|Overall Study|Lack of Efficacy|0|||
105753141|NCT00209170|364748084|FG001|Overall Study|Lack of Efficacy|1|||
105753142|NCT01879319|364748088|FG000|Overall Study|Withdrawal by Subject|1|||
105753143|NCT01879319|364748089|FG001|Overall Study|Withdrawal by Subject|0|||
105753144|NCT01879319|364748088|FG000|Overall Study|Lost to Follow-up|1|||
105753145|NCT01879319|364748089|FG001|Overall Study|Lost to Follow-up|5|||
105753146|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
105753147|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Death|5|||
105753148|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
105753149|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
105753150|NCT01360762|364748090|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
105753151|NCT01360762|364748090|FG000|Whole Study Period|Lost to Follow-up|10|||
105753152|NCT01360762|364748090|FG000|Whole Study Period|Death|7|||
105753153|NCT01360762|364748090|FG000|Whole Study Period|Patient relapsed|18|||
105753154|NCT01360762|364748090|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
105753155|NCT02767856|364748091|FG000|Overall Study|Lost to Follow-up|9|||
105753156|NCT02767856|364748092|FG001|Overall Study|Lost to Follow-up|1|||
105753157|NCT02767856|364748091|FG000|Overall Study|Withdrawal by Subject|2|||
105753158|NCT02767856|364748092|FG001|Overall Study|Withdrawal by Subject|1|||
105753159|NCT00843843|364748095|FG000|Overall Study|Physician Decision|1|||
105753160|NCT00843843|364748096|FG001|Overall Study|Physician Decision|1|||
105753161|NCT00843843|364748095|FG000|Overall Study|Protocol Violation|1|||
105753162|NCT00843843|364748096|FG001|Overall Study|Protocol Violation|1|||
105753163|NCT00589979|364748097|FG000|Run-In Period|Adverse Event|5|||
105753164|NCT00589979|364748098|FG001|Run-In Period|Adverse Event|0|||
105948286|NCT01334918|365474995|FG000|Overall Study|Withdrawal by Subject|0|||
105948287|NCT01334918|365474996|FG001|Overall Study|Withdrawal by Subject|1|||
105948288|NCT02239926|365474999|FG000|Overall Study|Withdrawal by Subject|0|||
105948289|NCT02239926|365475000|FG001|Overall Study|Withdrawal by Subject|1|||
106016464|NCT04033445|365724450|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016465|NCT04033445|365724451|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016466|NCT04033445|365724452|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016467|NCT04033445|365724453|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016468|NCT04033445|365724454|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
106016469|NCT04033445|365724455|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016470|NCT04033445|365724456|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105753165|NCT00589979|364748099|FG002|Run-In Period|Adverse Event|0|||
105948290|NCT01702298|365475001|FG000|Overall Study|Withdrawal by Subject|1|||
105948291|NCT01917318|365475008|FG000|First Treatment|Withdrawal by Subject|0|||
105948292|NCT01917318|365475009|FG001|First Treatment|Withdrawal by Subject|1|||
105948293|NCT00487981|365475010|FG000|Overall Study|Hypothyroidism diagnosis|1|||
105948294|NCT03498716|365475012|FG000|Overall Study|Withdrawal by Subject|88|||
105948295|NCT03498716|365475013|FG001|Overall Study|Withdrawal by Subject|73|||
105948296|NCT03498716|365475012|FG000|Overall Study|Study Terminated By Sponsor|933|||
105948297|NCT03498716|365475013|FG001|Overall Study|Study Terminated By Sponsor|927|||
105948298|NCT03498716|365475012|FG000|Overall Study|Lost to Follow-up|15|||
105948299|NCT03498716|365475013|FG001|Overall Study|Lost to Follow-up|26|||
105948300|NCT03498716|365475012|FG000|Overall Study|Disease Relapse|0|||
105948301|NCT03498716|365475013|FG001|Overall Study|Disease Relapse|1|||
105948302|NCT03498716|365475012|FG000|Overall Study|Death|58|||
105948303|NCT03498716|365475013|FG001|Overall Study|Death|72|||
105948304|NCT03498716|365475012|FG000|Overall Study|Physician Decision|4|||
105948305|NCT03498716|365475013|FG001|Overall Study|Physician Decision|2|||
105948306|NCT01570387|365475014|FG000|Overall Study|Adverse Event|1|||
105753166|NCT00589979|364748097|FG000|Run-In Period|Protocol Violation|3|||
105753167|NCT00589979|364748098|FG001|Run-In Period|Protocol Violation|0|||
106016471|NCT04033445|365724457|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105753168|NCT00589979|364748099|FG002|Run-In Period|Protocol Violation|0|||
105753169|NCT00589979|364748097|FG000|Run-In Period|Did not qualify for randomization|54|||
105753170|NCT00589979|364748098|FG001|Run-In Period|Did not qualify for randomization|0|||
105753171|NCT00589979|364748099|FG002|Run-In Period|Did not qualify for randomization|0|||
105753172|NCT00589979|364748097|FG000|Run-In Period|Withdrawal by Subject|10|||
105753173|NCT00589979|364748098|FG001|Run-In Period|Withdrawal by Subject|0|||
105753174|NCT00589979|364748099|FG002|Run-In Period|Withdrawal by Subject|0|||
105753175|NCT00589979|364748097|FG000|Run-In Period|Informed Consent Withdrawn|4|||
105948307|NCT01570387|365475015|FG001|Overall Study|Adverse Event|0|||
105948308|NCT01570387|365475016|FG002|Overall Study|Adverse Event|0|||
105948309|NCT01570387|365475017|FG003|Overall Study|Adverse Event|0|||
105948310|NCT01570387|365475014|FG000|Overall Study|Death|0|||
105753176|NCT00589979|364748098|FG001|Run-In Period|Informed Consent Withdrawn|0|||
105753177|NCT00589979|364748099|FG002|Run-In Period|Informed Consent Withdrawn|0|||
105753178|NCT00589979|364748097|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
105753179|NCT00589979|364748098|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
105753180|NCT00589979|364748099|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
105753181|NCT00589979|364748097|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
105753182|NCT00589979|364748098|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
105753183|NCT00589979|364748099|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
105753184|NCT00589979|364748097|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
105753185|NCT00589979|364748098|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
105753186|NCT00589979|364748099|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
105753187|NCT00589979|364748097|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
105753188|NCT00589979|364748098|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
105753189|NCT00589979|364748099|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
105753190|NCT00589979|364748097|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
105753191|NCT00589979|364748098|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
105753192|NCT00589979|364748099|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
105753193|NCT00589979|364748097|FG000|Double-Blind Treatment Period 2|Other|0|||
105753194|NCT00589979|364748098|FG001|Double-Blind Treatment Period 2|Other|0|||
105753195|NCT00589979|364748099|FG002|Double-Blind Treatment Period 2|Other|1|||
105753196|NCT00589979|364748097|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
105753197|NCT00589979|364748098|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
105753198|NCT00589979|364748099|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
105753199|NCT00589979|364748097|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
105753200|NCT00589979|364748098|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
105753201|NCT00589979|364748099|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
105753202|NCT00976950|364748100|FG000|Overall Study|Adverse Event|3|||
105753203|NCT00976950|364748100|FG000|Overall Study|Events with no relationship to Aptivus|3|||
105753204|NCT02662985|364748101|FG000|Treatment Period 1|Adverse Event|0|||
105753205|NCT02662985|364748102|FG001|Treatment Period 1|Adverse Event|2|||
105753206|NCT02662985|364748101|FG000|Treatment Period 1|Protocol Violation|0|||
105753207|NCT02662985|364748102|FG001|Treatment Period 1|Protocol Violation|1|||
105753208|NCT02662985|364748101|FG000|Treatment Period 1|Physician Decision|1|||
105753209|NCT02662985|364748102|FG001|Treatment Period 1|Physician Decision|0|||
105753210|NCT02662985|364748101|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105753211|NCT02662985|364748102|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105753212|NCT02662985|364748101|FG000|Treatment Period 2|Lack of Efficacy|0|||
105753213|NCT02662985|364748102|FG001|Treatment Period 2|Lack of Efficacy|1|||
105753214|NCT02662985|364748101|FG000|Treatment Period 2|Lost to Follow-up|1|||
105753215|NCT02662985|364748102|FG001|Treatment Period 2|Lost to Follow-up|0|||
105753216|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
105753217|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
105753218|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
105753219|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
105753220|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
105753221|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
105753222|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
105753223|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
105753224|NCT02662985|364748101|FG000|Treatment Period 3 (Extension Period)|Death|0|||
105753225|NCT02662985|364748102|FG001|Treatment Period 3 (Extension Period)|Death|1|||
105753226|NCT01397448|364748103|FG000|Overall Study|Adverse Event|4|||
105753227|NCT01397448|364748104|FG001|Overall Study|Adverse Event|4|||
105753228|NCT01397448|364748105|FG002|Overall Study|Adverse Event|6|||
105753229|NCT01397448|364748103|FG000|Overall Study|Withdrawal by Subject|4|||
105753230|NCT01397448|364748104|FG001|Overall Study|Withdrawal by Subject|4|||
105753231|NCT01397448|364748105|FG002|Overall Study|Withdrawal by Subject|3|||
105753232|NCT01397448|364748103|FG000|Overall Study|Lack of Efficacy|2|||
105753233|NCT01397448|364748104|FG001|Overall Study|Lack of Efficacy|0|||
105753234|NCT01397448|364748105|FG002|Overall Study|Lack of Efficacy|5|||
105753235|NCT01397448|364748103|FG000|Overall Study|Other|8|||
105753236|NCT01397448|364748104|FG001|Overall Study|Other|7|||
105753237|NCT01397448|364748105|FG002|Overall Study|Other|4|||
105753238|NCT01511107|364748106|FG000|Overall Study|Ineligible|3|||
105753239|NCT01511107|364748107|FG001|Overall Study|Ineligible|2|||
105753240|NCT01511107|364748106|FG000|Overall Study|Lost to Follow-up|10|||
105753241|NCT01511107|364748107|FG001|Overall Study|Lost to Follow-up|19|||
105753242|NCT01511107|364748106|FG000|Overall Study|Withdrawal by Subject|9|||
105753243|NCT01511107|364748107|FG001|Overall Study|Withdrawal by Subject|20|||
105753244|NCT02120157|364748110|FG000|Overall Study|Death|8|||
105753245|NCT00441103|364748114|FG000|Overall Study|Adverse Event|2|||
105753246|NCT00441103|364748115|FG001|Overall Study|Adverse Event|1|||
105753247|NCT00441103|364748114|FG000|Overall Study|Death|1|||
105753248|NCT00441103|364748115|FG001|Overall Study|Death|0|||
105948311|NCT01570387|365475015|FG001|Overall Study|Death|0|||
105948312|NCT01570387|365475016|FG002|Overall Study|Death|0|||
105948313|NCT01570387|365475017|FG003|Overall Study|Death|1|||
105948314|NCT01570387|365475014|FG000|Overall Study|Withdrawal by Subject|0|||
105948315|NCT01570387|365475015|FG001|Overall Study|Withdrawal by Subject|0|||
105948316|NCT01570387|365475016|FG002|Overall Study|Withdrawal by Subject|0|||
105948317|NCT01570387|365475017|FG003|Overall Study|Withdrawal by Subject|1|||
105948318|NCT01567722|365475020|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
105948319|NCT01567722|365475021|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
105948320|NCT01567722|365475022|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
105948321|NCT01567722|365475020|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
105948322|NCT01567722|365475021|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
105948323|NCT01567722|365475022|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
105948324|NCT01567722|365475020|FG000|Overall Study|Protocol closure by the OCG|2|||
105948325|NCT01567722|365475021|FG001|Overall Study|Protocol closure by the OCG|0|||
105948326|NCT01567722|365475022|FG002|Overall Study|Protocol closure by the OCG|0|||
105948327|NCT01567722|365475020|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
105948328|NCT01567722|365475021|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
105948329|NCT01567722|365475022|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
105948330|NCT01832727|365475027|FG000|Overall Study|Adverse Event|4|||
105948331|NCT01832727|365475028|FG001|Overall Study|Adverse Event|6|||
105948332|NCT01832727|365475029|FG002|Overall Study|Adverse Event|1|||
105948333|NCT01832727|365475030|FG003|Overall Study|Adverse Event|0|||
105948334|NCT01832727|365475031|FG004|Overall Study|Adverse Event|1|||
105948335|NCT01832727|365475032|FG005|Overall Study|Adverse Event|1|||
105753249|NCT00441103|364748114|FG000|Overall Study|Disease Progression|2|||
105753250|NCT00441103|364748115|FG001|Overall Study|Disease Progression|0|||
105753251|NCT00441103|364748114|FG000|Overall Study|Lost to Follow-up|1|||
105753252|NCT00441103|364748115|FG001|Overall Study|Lost to Follow-up|0|||
105948336|NCT01832727|365475033|FG006|Overall Study|Adverse Event|2|||
105753253|NCT00441103|364748114|FG000|Overall Study|Protocol Violation|1|||
105753254|NCT00441103|364748115|FG001|Overall Study|Protocol Violation|0|||
105753255|NCT00441103|364748114|FG000|Overall Study|Participant unable to use Rebiject II|1|||
105753256|NCT00441103|364748115|FG001|Overall Study|Participant unable to use Rebiject II|0|||
105753257|NCT00441103|364748114|FG000|Overall Study|Participant refused MRI|1|||
105753258|NCT00441103|364748115|FG001|Overall Study|Participant refused MRI|0|||
105753259|NCT00441103|364748114|FG000|Overall Study|Inclusion criteria absent|1|||
105753260|NCT00441103|364748115|FG001|Overall Study|Inclusion criteria absent|0|||
105753261|NCT00441103|364748114|FG000|Overall Study|Non-compliant|0|||
105753262|NCT00441103|364748115|FG001|Overall Study|Non-compliant|1|||
105753263|NCT00441103|364748114|FG000|Overall Study|Participant decided to withdraw|1|||
105753264|NCT00441103|364748115|FG001|Overall Study|Participant decided to withdraw|0|||
105753265|NCT00441103|364748114|FG000|Overall Study|Participant's reason|0|||
105753266|NCT00441103|364748115|FG001|Overall Study|Participant's reason|1|||
105753267|NCT00441103|364748114|FG000|Overall Study|Participant decided to stop|0|||
105753268|NCT00441103|364748115|FG001|Overall Study|Participant decided to stop|1|||
105753269|NCT01577160|364748116|FG000|Overall Study|Adverse Event|9|||
105753270|NCT01577160|364748116|FG000|Overall Study|Lack of Efficacy|15|||
105753271|NCT01577160|364748116|FG000|Overall Study|Lost to Follow-up|40|||
105753272|NCT01577160|364748116|FG000|Overall Study|Withdrawal by Subject|18|||
105753273|NCT01577160|364748116|FG000|Overall Study|Subject Uncooperative|7|||
105753274|NCT01577160|364748116|FG000|Overall Study|Other|9|||
105753275|NCT01029886|364748120|FG000|Overall Study|Adverse Event|12|||
105753276|NCT01029886|364748121|FG001|Overall Study|Adverse Event|25|||
105753277|NCT01029886|364748120|FG000|Overall Study|Lost to Follow-up|1|||
105948337|NCT01832727|365475034|FG007|Overall Study|Adverse Event|1|||
105948338|NCT01832727|365475035|FG008|Overall Study|Adverse Event|9|||
105948339|NCT01832727|365475027|FG000|Overall Study|Disease progression|3|||
105948340|NCT01832727|365475028|FG001|Overall Study|Disease progression|0|||
105948341|NCT01832727|365475029|FG002|Overall Study|Disease progression|2|||
105948342|NCT01832727|365475030|FG003|Overall Study|Disease progression|1|||
105948343|NCT01832727|365475031|FG004|Overall Study|Disease progression|3|||
105948344|NCT01832727|365475032|FG005|Overall Study|Disease progression|3|||
105948345|NCT01832727|365475033|FG006|Overall Study|Disease progression|6|||
105948346|NCT01832727|365475034|FG007|Overall Study|Disease progression|2|||
105948347|NCT01832727|365475035|FG008|Overall Study|Disease progression|7|||
105948348|NCT01832727|365475027|FG000|Overall Study|Lost to Follow-up|0|||
105948349|NCT01832727|365475028|FG001|Overall Study|Lost to Follow-up|0|||
105948350|NCT01832727|365475029|FG002|Overall Study|Lost to Follow-up|0|||
105948351|NCT01832727|365475030|FG003|Overall Study|Lost to Follow-up|1|||
105948352|NCT01832727|365475031|FG004|Overall Study|Lost to Follow-up|0|||
105948353|NCT01832727|365475032|FG005|Overall Study|Lost to Follow-up|0|||
105948354|NCT01832727|365475033|FG006|Overall Study|Lost to Follow-up|0|||
105948355|NCT01832727|365475034|FG007|Overall Study|Lost to Follow-up|0|||
105948356|NCT01832727|365475035|FG008|Overall Study|Lost to Follow-up|0|||
106016472|NCT04033445|365724458|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016473|NCT04033445|365724459|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
106016474|NCT04033445|365724460|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
105948357|NCT01832727|365475027|FG000|Overall Study|Physician Decision|1|||
105948358|NCT01832727|365475028|FG001|Overall Study|Physician Decision|0|||
105948359|NCT01832727|365475029|FG002|Overall Study|Physician Decision|0|||
105948360|NCT01832727|365475030|FG003|Overall Study|Physician Decision|1|||
105948361|NCT01832727|365475031|FG004|Overall Study|Physician Decision|0|||
105948362|NCT01832727|365475032|FG005|Overall Study|Physician Decision|1|||
105948363|NCT01832727|365475033|FG006|Overall Study|Physician Decision|0|||
105948364|NCT01832727|365475034|FG007|Overall Study|Physician Decision|0|||
105948365|NCT01832727|365475035|FG008|Overall Study|Physician Decision|0|||
105948366|NCT01832727|365475027|FG000|Overall Study|Withdrawal by Subject|1|||
105948367|NCT01832727|365475028|FG001|Overall Study|Withdrawal by Subject|1|||
105948368|NCT01832727|365475029|FG002|Overall Study|Withdrawal by Subject|0|||
105753278|NCT01029886|364748121|FG001|Overall Study|Lost to Follow-up|0|||
105753279|NCT01029886|364748120|FG000|Overall Study|Physician Decision|2|||
105753280|NCT01029886|364748121|FG001|Overall Study|Physician Decision|6|||
105753281|NCT01029886|364748120|FG000|Overall Study|Protocol Violation|17|||
105753282|NCT01029886|364748121|FG001|Overall Study|Protocol Violation|5|||
105753283|NCT01029886|364748120|FG000|Overall Study|Withdrawal by Subject|8|||
105753284|NCT01029886|364748121|FG001|Overall Study|Withdrawal by Subject|18|||
105753285|NCT01029886|364748120|FG000|Overall Study|Entry Criteria Not Met|13|||
105753286|NCT01029886|364748121|FG001|Overall Study|Entry Criteria Not Met|5|||
105753287|NCT01029886|364748120|FG000|Overall Study|Sponsor Decision|1|||
105753288|NCT01029886|364748121|FG001|Overall Study|Sponsor Decision|0|||
105753289|NCT01029886|364748120|FG000|Overall Study|Loss Glucose Control|7|||
105753290|NCT01029886|364748121|FG001|Overall Study|Loss Glucose Control|1|||
105753291|NCT00417976|364748124|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
105753292|NCT00417976|364748124|FG000|Overall Study|Treatment -related toxicity|2|||
105753293|NCT00645567|364748129|FG000|Overall Study|Adverse Event|1|||
105753294|NCT04664855|364748130|FG000|Overall Study|Withdrawal by Subject|0|||
105753295|NCT04664855|364748131|FG001|Overall Study|Withdrawal by Subject|2|||
105753296|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
105753297|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
105753298|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
105753299|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
105753300|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Physician Decision|1|||
105753301|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Physician Decision|0|||
105753302|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Physician Decision|0|||
105753303|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Physician Decision|0|||
105753304|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
105753305|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
105753306|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
105753307|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
105753308|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
105753309|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
105753310|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
105753311|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
105753312|NCT05127421|364748132|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
105753313|NCT05127421|364748133|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
105753314|NCT05127421|364748134|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
105753315|NCT05127421|364748135|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
105753316|NCT05127421|364748132|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
105753317|NCT05127421|364748133|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
105753318|NCT05127421|364748134|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
105753319|NCT05127421|364748135|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
105753320|NCT05127421|364748132|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
105753321|NCT05127421|364748133|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
105753322|NCT05127421|364748134|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
105753323|NCT05127421|364748135|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
105753324|NCT05127421|364748132|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
105753325|NCT05127421|364748133|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
105948369|NCT01832727|365475030|FG003|Overall Study|Withdrawal by Subject|1|||
105753326|NCT05127421|364748134|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
105753327|NCT05127421|364748135|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
105753328|NCT02219087|364748136|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
105753329|NCT02219087|364748137|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
105753330|NCT00255086|364748138|FG000|Overall Study|Adverse Event|1|||
105753331|NCT00255086|364748139|FG001|Overall Study|Adverse Event|1|||
105753332|NCT00255086|364748138|FG000|Overall Study|Protocol Violation|1|||
105753333|NCT00255086|364748139|FG001|Overall Study|Protocol Violation|1|||
105753334|NCT02365584|364748148|FG000|Overall Study|Adverse Event|2|||
105753335|NCT02365584|364748149|FG001|Overall Study|Adverse Event|2|||
105948370|NCT01832727|365475031|FG004|Overall Study|Withdrawal by Subject|0|||
105948371|NCT01832727|365475032|FG005|Overall Study|Withdrawal by Subject|1|||
105948372|NCT01832727|365475033|FG006|Overall Study|Withdrawal by Subject|0|||
105948373|NCT01832727|365475034|FG007|Overall Study|Withdrawal by Subject|2|||
105948374|NCT01832727|365475035|FG008|Overall Study|Withdrawal by Subject|1|||
105948375|NCT01832727|365475027|FG000|Overall Study|Study terminated by sponsor|0|||
105948376|NCT01832727|365475028|FG001|Overall Study|Study terminated by sponsor|0|||
105948377|NCT01832727|365475029|FG002|Overall Study|Study terminated by sponsor|0|||
105948378|NCT01832727|365475030|FG003|Overall Study|Study terminated by sponsor|0|||
105948379|NCT01832727|365475031|FG004|Overall Study|Study terminated by sponsor|0|||
105948380|NCT01832727|365475032|FG005|Overall Study|Study terminated by sponsor|0|||
105948381|NCT01832727|365475033|FG006|Overall Study|Study terminated by sponsor|0|||
105948382|NCT01832727|365475034|FG007|Overall Study|Study terminated by sponsor|1|||
105948383|NCT01832727|365475035|FG008|Overall Study|Study terminated by sponsor|1|||
105948384|NCT03323164|365475038|FG000|Overall Study|Poor quality imaging/scans|2|||
105948385|NCT03323164|365475039|FG001|Overall Study|Poor quality imaging/scans|2|||
105948386|NCT01823289|365475040|FG000|Overall Study|Lost to Follow-up|5|||
105948387|NCT01823289|365475040|FG000|Overall Study|Adverse Event|5|||
105948388|NCT01823289|365475040|FG000|Overall Study|Lack of Efficacy|1|||
105948389|NCT01823289|365475040|FG000|Overall Study|Physician Decision|9|||
105948390|NCT01823289|365475040|FG000|Overall Study|Administered contraindicated medicine|1|||
105948391|NCT01823289|365475040|FG000|Overall Study|Transaminase increased more than 3 times|1|||
105948392|NCT01823289|365475040|FG000|Overall Study|Drug affected efficacy and safety|1|||
105948393|NCT01823289|365475040|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
105948394|NCT01657305|365475045|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
105948395|NCT01657305|365475045|FG000|Overall Study|Withdrawal by Subject|4|||
105948396|NCT01657305|365475045|FG000|Overall Study|Adverse Event|1|||
105948397|NCT01657305|365475045|FG000|Overall Study|Lost to Follow-up|1|||
105948398|NCT01657305|365475045|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
105948399|NCT04103450|365475048|FG000|Overall Study|Adverse Event|4|||
105753336|NCT02365584|364748148|FG000|Overall Study|Withdrawal by Subject|1|||
105753337|NCT02365584|364748149|FG001|Overall Study|Withdrawal by Subject|0|||
105753338|NCT02365584|364748148|FG000|Overall Study|Disease Progression|9|||
105753339|NCT02365584|364748149|FG001|Overall Study|Disease Progression|12|||
105753340|NCT00632541|364748150|FG000|Overall Study|Adverse Event|7|||
105753341|NCT01842607|364748152|FG000|Overall Study|Adverse Event|11|||
105753342|NCT01842607|364748152|FG000|Overall Study|Lack of Efficacy|19|||
105753343|NCT01842607|364748152|FG000|Overall Study|Protocol Violation|8|||
105753344|NCT01842607|364748152|FG000|Overall Study|Protocol defined stopping criteria|2|||
105753345|NCT01842607|364748152|FG000|Overall Study|Lost to Follow-up|3|||
105753346|NCT01842607|364748152|FG000|Overall Study|Physician Decision|9|||
105753347|NCT01842607|364748152|FG000|Overall Study|Withdrawal by Subject|14|||
105753348|NCT00012012|364748153|FG000|Overall Study|Protocol Violation|1|||
105753349|NCT00012012|364748154|FG001|Overall Study|Protocol Violation|1|||
105753350|NCT00012012|364748153|FG000|Overall Study|Withdrawal by Subject|0|||
105753351|NCT00012012|364748154|FG001|Overall Study|Withdrawal by Subject|2|||
105753352|NCT03519516|364748155|FG000|Overall Study|Adverse Event|0|||
105753353|NCT03519516|364748156|FG001|Overall Study|Adverse Event|1|||
105753354|NCT00964158|364748157|FG000|Overall Study|Lost to Follow-up|0|||
105753355|NCT00964158|364748158|FG001|Overall Study|Lost to Follow-up|1|||
105753356|NCT00964158|364748159|FG002|Overall Study|Lost to Follow-up|2|||
105753357|NCT00964158|364748157|FG000|Overall Study|Withdrawal by Subject|0|||
105753358|NCT00964158|364748158|FG001|Overall Study|Withdrawal by Subject|0|||
105753359|NCT00964158|364748159|FG002|Overall Study|Withdrawal by Subject|6|||
105753360|NCT02721251|364748160|FG000|Overall Study|Withdrawal by Subject|8|||
105753361|NCT02721251|364748161|FG001|Overall Study|Withdrawal by Subject|7|||
105753362|NCT02721251|364748162|FG002|Overall Study|Withdrawal by Subject|9|||
105753363|NCT02721251|364748160|FG000|Overall Study|poor adherence|2|||
105753364|NCT02721251|364748161|FG001|Overall Study|poor adherence|2|||
105753365|NCT02721251|364748162|FG002|Overall Study|poor adherence|2|||
105753366|NCT02017899|364750141|FG000|Overall Study|Withdrawal by Subject|0|||
105753367|NCT02017899|364750142|FG001|Overall Study|Withdrawal by Subject|0|||
105753368|NCT02017899|364750143|FG002|Overall Study|Withdrawal by Subject|0|||
105753369|NCT02017899|364750144|FG003|Overall Study|Withdrawal by Subject|1|||
105753370|NCT02017899|364750145|FG004|Overall Study|Withdrawal by Subject|1|||
105753371|NCT02017899|364750146|FG005|Overall Study|Withdrawal by Subject|0|||
105753372|NCT01146951|364750147|FG000|Overall Study|Adverse Event|4|||
105753373|NCT01146951|364750148|FG001|Overall Study|Adverse Event|1|||
105753374|NCT02126670|364750149|FG000|Overall Study|Withdrawal by Subject|1|||
105753375|NCT02126670|364750150|FG001|Overall Study|Withdrawal by Subject|0|||
105753376|NCT02126670|364750151|FG002|Overall Study|Withdrawal by Subject|0|||
105753377|NCT02126670|364750152|FG003|Overall Study|Withdrawal by Subject|1|||
105753378|NCT03363919|364750153|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
105753379|NCT03363919|364750154|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
105948400|NCT04103450|365475049|FG001|Overall Study|Adverse Event|2|||
105948401|NCT04103450|365475048|FG000|Overall Study|Lack of Efficacy|3|||
105948402|NCT04103450|365475049|FG001|Overall Study|Lack of Efficacy|0|||
105948403|NCT04103450|365475048|FG000|Overall Study|Withdrawal by Subject|5|||
105753380|NCT03363919|364750153|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
105753381|NCT03363919|364750154|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
105753382|NCT00424346|364750155|FG000|Core Study|Adverse Event|5|||
105753383|NCT00424346|364750156|FG001|Core Study|Adverse Event|3|||
105753384|NCT00424346|364750157|FG002|Core Study|Adverse Event|1|||
105753385|NCT00424346|364750158|FG003|Core Study|Adverse Event|1|||
105948404|NCT04103450|365475049|FG001|Overall Study|Withdrawal by Subject|3|||
105948405|NCT04103450|365475048|FG000|Overall Study|Lost to Follow-up|1|||
105948406|NCT04103450|365475049|FG001|Overall Study|Lost to Follow-up|2|||
105948407|NCT04103450|365475048|FG000|Overall Study|Physician Decision|1|||
105948408|NCT04103450|365475049|FG001|Overall Study|Physician Decision|2|||
105948409|NCT04103450|365475048|FG000|Overall Study|Protocol Violation|1|||
105948410|NCT04103450|365475049|FG001|Overall Study|Protocol Violation|0|||
105753386|NCT00424346|364750155|FG000|Core Study|Abnormal Laboratory Values|0|||
105753387|NCT00424346|364750156|FG001|Core Study|Abnormal Laboratory Values|1|||
105753388|NCT00424346|364750157|FG002|Core Study|Abnormal Laboratory Values|0|||
105753389|NCT00424346|364750158|FG003|Core Study|Abnormal Laboratory Values|0|||
105948411|NCT04103450|365475048|FG000|Overall Study|Other|1|||
105753390|NCT00424346|364750155|FG000|Core Study|Lack of Efficacy|1|||
105753391|NCT00424346|364750156|FG001|Core Study|Lack of Efficacy|3|||
105753392|NCT00424346|364750157|FG002|Core Study|Lack of Efficacy|0|||
105753393|NCT00424346|364750158|FG003|Core Study|Lack of Efficacy|4|||
105753394|NCT00424346|364750155|FG000|Core Study|Withdrawal by Subject|1|||
105753395|NCT00424346|364750156|FG001|Core Study|Withdrawal by Subject|0|||
105753396|NCT00424346|364750157|FG002|Core Study|Withdrawal by Subject|0|||
105753397|NCT00424346|364750158|FG003|Core Study|Withdrawal by Subject|2|||
105948412|NCT04103450|365475049|FG001|Overall Study|Other|1|||
105948413|NCT01959932|365475055|FG000|Overall Study|Withdrawal by Subject|1|||
105948414|NCT01959932|365475056|FG001|Overall Study|Withdrawal by Subject|0|||
105948415|NCT01959932|365475057|FG002|Overall Study|Withdrawal by Subject|0|||
105948416|NCT00397540|365475058|FG000|Overall Study|short follow-up duration < 12 months|1|||
105948417|NCT00397540|365475059|FG001|Overall Study|short follow-up duration < 12 months|0|||
105753398|NCT00424346|364750155|FG000|Core Study|Lost to Follow-up|1|||
105753399|NCT00424346|364750156|FG001|Core Study|Lost to Follow-up|1|||
105753400|NCT00424346|364750157|FG002|Core Study|Lost to Follow-up|0|||
105753401|NCT00424346|364750158|FG003|Core Study|Lost to Follow-up|0|||
105948418|NCT01133847|365475060|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
105753402|NCT00424346|364750155|FG000|Core Study|Administrative Problems|1|||
105948419|NCT01133847|365475061|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
105948420|NCT01133847|365475062|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
105948421|NCT01133847|365475060|FG000|Follow-Up Phase|Lost to Follow-up|1|||
105948422|NCT01133847|365475061|FG001|Follow-Up Phase|Lost to Follow-up|3|||
105753403|NCT00424346|364750156|FG001|Core Study|Administrative Problems|0|||
105753404|NCT00424346|364750157|FG002|Core Study|Administrative Problems|1|||
105753405|NCT00424346|364750158|FG003|Core Study|Administrative Problems|0|||
105753406|NCT00424346|364750155|FG000|Core Study|Protocol Violation|0|||
105753407|NCT00424346|364750156|FG001|Core Study|Protocol Violation|0|||
105753408|NCT00424346|364750157|FG002|Core Study|Protocol Violation|2|||
105753409|NCT00424346|364750158|FG003|Core Study|Protocol Violation|0|||
105753410|NCT00424346|364750155|FG000|Extension Phase|Adverse Event|0|||
105948423|NCT01133847|365475062|FG002|Follow-Up Phase|Lost to Follow-up|7|||
105948424|NCT02536664|365475063|FG000|Overall Study|Inadequate completion of documentation|2|||
105948425|NCT02536664|365475064|FG001|Overall Study|Inadequate completion of documentation|4|||
105753411|NCT00424346|364750156|FG001|Extension Phase|Adverse Event|9|||
105753412|NCT00424346|364750157|FG002|Extension Phase|Adverse Event|5|||
105753413|NCT00424346|364750158|FG003|Extension Phase|Adverse Event|4|||
105753414|NCT00424346|364750155|FG000|Extension Phase|Lack of Efficacy|0|||
105753415|NCT00424346|364750156|FG001|Extension Phase|Lack of Efficacy|16|||
105753416|NCT00424346|364750157|FG002|Extension Phase|Lack of Efficacy|14|||
105753417|NCT00424346|364750158|FG003|Extension Phase|Lack of Efficacy|11|||
105753418|NCT00424346|364750155|FG000|Extension Phase|Withdrawal by Subject|0|||
105753419|NCT00424346|364750156|FG001|Extension Phase|Withdrawal by Subject|5|||
105753420|NCT00424346|364750157|FG002|Extension Phase|Withdrawal by Subject|3|||
105753421|NCT00424346|364750158|FG003|Extension Phase|Withdrawal by Subject|4|||
105753422|NCT00424346|364750155|FG000|Extension Phase|Lost to Follow-up|0|||
105753423|NCT00424346|364750156|FG001|Extension Phase|Lost to Follow-up|2|||
105753424|NCT00424346|364750157|FG002|Extension Phase|Lost to Follow-up|0|||
105753425|NCT00424346|364750158|FG003|Extension Phase|Lost to Follow-up|0|||
105753426|NCT00424346|364750155|FG000|Extension Phase|Administrative Problems|0|||
105753427|NCT00424346|364750156|FG001|Extension Phase|Administrative Problems|69|||
105753428|NCT00424346|364750157|FG002|Extension Phase|Administrative Problems|32|||
105753429|NCT00424346|364750158|FG003|Extension Phase|Administrative Problems|35|||
105753430|NCT00424346|364750155|FG000|Extension Phase|Death|0|||
105753431|NCT00424346|364750156|FG001|Extension Phase|Death|0|||
105753432|NCT00424346|364750157|FG002|Extension Phase|Death|0|||
105753433|NCT00424346|364750158|FG003|Extension Phase|Death|1|||
105753434|NCT00424346|364750155|FG000|Extension Phase|Protocol Violation|0|||
105753435|NCT00424346|364750156|FG001|Extension Phase|Protocol Violation|1|||
105753436|NCT00424346|364750157|FG002|Extension Phase|Protocol Violation|1|||
105753437|NCT00424346|364750158|FG003|Extension Phase|Protocol Violation|0|||
105753438|NCT00781963|364750161|FG000|Overall Study|Death|3|||
105753439|NCT00781963|364750162|FG001|Overall Study|Death|0|||
105753440|NCT00781963|364750161|FG000|Overall Study|Lost to Follow-up|2|||
105753441|NCT00781963|364750162|FG001|Overall Study|Lost to Follow-up|1|||
105753442|NCT00781963|364750161|FG000|Overall Study|Withdrawal by Subject|3|||
105753443|NCT00781963|364750162|FG001|Overall Study|Withdrawal by Subject|1|||
105753444|NCT00781963|364750161|FG000|Overall Study|Refused follow-up|9|||
105753445|NCT00781963|364750162|FG001|Overall Study|Refused follow-up|0|||
105753446|NCT02064205|364750163|FG000|Overall Study|Withdrawal by Subject|1|||
105753447|NCT01149343|364750170|FG000|Overall Study|Withdrawal by Subject|1|||
105753448|NCT01149343|364750171|FG001|Overall Study|Withdrawal by Subject|1|||
105753449|NCT01149343|364750172|FG002|Overall Study|Withdrawal by Subject|1|||
105753450|NCT01149343|364750173|FG003|Overall Study|Withdrawal by Subject|5|||
105753451|NCT01149343|364750170|FG000|Overall Study|Death|10|||
105753452|NCT01149343|364750171|FG001|Overall Study|Death|13|||
105753453|NCT01149343|364750172|FG002|Overall Study|Death|18|||
105753454|NCT01149343|364750173|FG003|Overall Study|Death|18|||
105753455|NCT01149343|364750170|FG000|Overall Study|Lost to Follow-up|1|||
105753456|NCT01149343|364750171|FG001|Overall Study|Lost to Follow-up|0|||
105753457|NCT01149343|364750172|FG002|Overall Study|Lost to Follow-up|0|||
105753458|NCT01149343|364750173|FG003|Overall Study|Lost to Follow-up|1|||
105753459|NCT01149343|364750170|FG000|Overall Study|Other|8|||
105753460|NCT01149343|364750171|FG001|Overall Study|Other|10|||
105753461|NCT01149343|364750172|FG002|Overall Study|Other|2|||
105753462|NCT01149343|364750173|FG003|Overall Study|Other|14|||
105753463|NCT01149343|364750170|FG000|Overall Study|Sponsor study termination|0|||
105948426|NCT02536664|365475063|FG000|Overall Study|Progression|13|||
105948427|NCT02536664|365475064|FG001|Overall Study|Progression|18|||
105948428|NCT02536664|365475063|FG000|Overall Study|Death due to lymphoma|2|||
105948429|NCT02536664|365475064|FG001|Overall Study|Death due to lymphoma|1|||
105753464|NCT01149343|364750171|FG001|Overall Study|Sponsor study termination|0|||
105753465|NCT01149343|364750172|FG002|Overall Study|Sponsor study termination|0|||
105753466|NCT01149343|364750173|FG003|Overall Study|Sponsor study termination|2|||
105753467|NCT01149343|364750170|FG000|Overall Study|Recurrence / Progressive disease|0|||
105753468|NCT01149343|364750171|FG001|Overall Study|Recurrence / Progressive disease|0|||
105753469|NCT01149343|364750172|FG002|Overall Study|Recurrence / Progressive disease|1|||
105753470|NCT01149343|364750173|FG003|Overall Study|Recurrence / Progressive disease|0|||
105753471|NCT02505542|364750192|FG000|Part A: Open-Label Period|Adverse Event|31|||
105753472|NCT02505542|364750193|FG001|Part A: Open-Label Period|Adverse Event|0|||
105753473|NCT02505542|364750194|FG002|Part A: Open-Label Period|Adverse Event|0|||
105753474|NCT02505542|364750195|FG003|Part A: Open-Label Period|Adverse Event|0|||
105753475|NCT02505542|364750192|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
105753476|NCT02505542|364750193|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
105760899|NCT01342952|364778052|FG000|Overall Study|Lost to Follow-up|0|||
105948430|NCT02536664|365475063|FG000|Overall Study|Death due to other reason|3|||
105948431|NCT02536664|365475064|FG001|Overall Study|Death due to other reason|2|||
105948432|NCT02536664|365475063|FG000|Overall Study|Intolerability|8|||
105948433|NCT02536664|365475064|FG001|Overall Study|Intolerability|6|||
105948434|NCT02536664|365475063|FG000|Overall Study|Withdrawal by Subject|8|||
105948435|NCT02536664|365475064|FG001|Overall Study|Withdrawal by Subject|5|||
105948436|NCT02536664|365475063|FG000|Overall Study|Other|18|||
105948437|NCT02536664|365475064|FG001|Overall Study|Other|24|||
105948438|NCT02536664|365475063|FG000|Overall Study|Missing|53|||
105948439|NCT02536664|365475064|FG001|Overall Study|Missing|20|||
105948440|NCT00271544|365475082|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
105948441|NCT00271544|365475082|FG000|Overall Study|Model 4196 lead not attempted|9|||
105948442|NCT00271544|365475082|FG000|Overall Study|Implant not attempted|4|||
105948443|NCT03358030|365475083|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
105948444|NCT03358030|365475084|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
105753477|NCT02505542|364750194|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
105753478|NCT02505542|364750195|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
105753479|NCT02505542|364750192|FG000|Part A: Open-Label Period|Protocol Violation|1|||
105753480|NCT02505542|364750193|FG001|Part A: Open-Label Period|Protocol Violation|0|||
105753481|NCT02505542|364750194|FG002|Part A: Open-Label Period|Protocol Violation|0|||
105753482|NCT02505542|364750195|FG003|Part A: Open-Label Period|Protocol Violation|0|||
105753483|NCT02505542|364750192|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
105753484|NCT02505542|364750193|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
105753485|NCT02505542|364750194|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
105753486|NCT02505542|364750195|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
105753487|NCT02505542|364750192|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
105753488|NCT02505542|364750193|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
105753489|NCT02505542|364750194|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
105753490|NCT02505542|364750195|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
105753491|NCT02505542|364750192|FG000|Part A: Open-Label Period|New medical history available|1|||
105753492|NCT02505542|364750193|FG001|Part A: Open-Label Period|New medical history available|0|||
105753493|NCT02505542|364750194|FG002|Part A: Open-Label Period|New medical history available|0|||
105753494|NCT02505542|364750195|FG003|Part A: Open-Label Period|New medical history available|0|||
105753495|NCT02505542|364750192|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
105753496|NCT02505542|364750193|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
105753497|NCT02505542|364750194|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
105753498|NCT02505542|364750195|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
105753499|NCT02505542|364750192|FG000|Part A: Open-Label Period|Pregnancy|2|||
105753500|NCT02505542|364750193|FG001|Part A: Open-Label Period|Pregnancy|0|||
105753501|NCT02505542|364750194|FG002|Part A: Open-Label Period|Pregnancy|0|||
105753502|NCT02505542|364750195|FG003|Part A: Open-Label Period|Pregnancy|0|||
105753503|NCT02505542|364750192|FG000|Part A: Open-Label Period|Sponsor directive|1|||
105753504|NCT02505542|364750193|FG001|Part A: Open-Label Period|Sponsor directive|0|||
105753505|NCT02505542|364750194|FG002|Part A: Open-Label Period|Sponsor directive|0|||
105753506|NCT02505542|364750195|FG003|Part A: Open-Label Period|Sponsor directive|0|||
105948445|NCT03358030|365475085|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
105948446|NCT03358030|365475086|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
105948447|NCT03358030|365475083|FG000|Overall Study|Ineligibility|0|||
105948448|NCT03358030|365475084|FG001|Overall Study|Ineligibility|0|||
105948449|NCT03358030|365475085|FG002|Overall Study|Ineligibility|0|||
105948450|NCT03358030|365475086|FG003|Overall Study|Ineligibility|2|||
105948451|NCT03358030|365475083|FG000|Overall Study|Voluntary Withdrawal|1|||
105948452|NCT03358030|365475084|FG001|Overall Study|Voluntary Withdrawal|1|||
105948453|NCT03358030|365475085|FG002|Overall Study|Voluntary Withdrawal|3|||
105948454|NCT03358030|365475086|FG003|Overall Study|Voluntary Withdrawal|1|||
105948455|NCT03358030|365475083|FG000|Overall Study|Other|0|||
105948456|NCT03358030|365475084|FG001|Overall Study|Other|0|||
105948457|NCT03358030|365475085|FG002|Overall Study|Other|1|||
105948458|NCT03358030|365475086|FG003|Overall Study|Other|0|||
105948459|NCT04540367|365475087|FG000|Overall Study|Withdrawal by Subject|0|||
105948460|NCT04540367|365475088|FG001|Overall Study|Withdrawal by Subject|0|||
105948461|NCT04540367|365475089|FG002|Overall Study|Withdrawal by Subject|0|||
105948462|NCT04540367|365475090|FG003|Overall Study|Withdrawal by Subject|2|||
105948463|NCT04540367|365475087|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
105948464|NCT04540367|365475088|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
105948465|NCT04540367|365475089|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
105948466|NCT04540367|365475090|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
105948467|NCT04540367|365475087|FG000|Overall Study|Adverse Event|0|||
105753507|NCT02505542|364750192|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
105753508|NCT02505542|364750193|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
105948468|NCT04540367|365475088|FG001|Overall Study|Adverse Event|0|||
105948469|NCT04540367|365475089|FG002|Overall Study|Adverse Event|1|||
105948470|NCT04540367|365475090|FG003|Overall Study|Adverse Event|1|||
105948471|NCT00829244|365475091|FG000|Overall Study|Adverse Event|1|||
105948472|NCT00829244|365475092|FG001|Overall Study|Adverse Event|3|||
105948473|NCT00829244|365475091|FG000|Overall Study|Protocol Violation|1|||
105948474|NCT00829244|365475092|FG001|Overall Study|Protocol Violation|0|||
105948475|NCT00829244|365475091|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
105948476|NCT00829244|365475092|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
105948477|NCT00829244|365475091|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
105948478|NCT00829244|365475092|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
105948479|NCT00829244|365475091|FG000|Overall Study|No fertilization|2|||
105948480|NCT00829244|365475092|FG001|Overall Study|No fertilization|2|||
105948481|NCT00829244|365475091|FG000|Overall Study|All embryos discarded|0|||
105948482|NCT00829244|365475092|FG001|Overall Study|All embryos discarded|3|||
105948483|NCT00829244|365475091|FG000|Overall Study|No embryo cleavage|0|||
105948484|NCT00829244|365475092|FG001|Overall Study|No embryo cleavage|2|||
105948485|NCT00907621|365475096|FG000|Overall Study|Lost to Follow-up|6|||
105948486|NCT00907621|365475097|FG001|Overall Study|Lost to Follow-up|3|||
105948487|NCT00907621|365475096|FG000|Overall Study|intercurrent febrile illness|1|||
105948488|NCT00907621|365475097|FG001|Overall Study|intercurrent febrile illness|1|||
105753509|NCT02505542|364750194|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
105753510|NCT02505542|364750195|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
105753511|NCT02505542|364750192|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
105753512|NCT02505542|364750193|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
105753513|NCT02505542|364750194|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
105753514|NCT02505542|364750195|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
105753515|NCT02505542|364750192|FG000|Part A: Open-Label Period|Non-compliance|1|||
105753516|NCT02505542|364750193|FG001|Part A: Open-Label Period|Non-compliance|0|||
105753517|NCT02505542|364750194|FG002|Part A: Open-Label Period|Non-compliance|0|||
105753518|NCT02505542|364750195|FG003|Part A: Open-Label Period|Non-compliance|0|||
105753519|NCT02505542|364750192|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
105753520|NCT02505542|364750193|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
105753521|NCT02505542|364750194|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
105753522|NCT02505542|364750195|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
105753523|NCT02505542|364750192|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
105753524|NCT02505542|364750193|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
105753525|NCT02505542|364750194|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
105753526|NCT02505542|364750195|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
105753527|NCT02505542|364750192|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
105753528|NCT02505542|364750193|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
105753529|NCT02505542|364750194|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
105753530|NCT02505542|364750195|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
105948489|NCT00902330|365475100|FG000|Overall Study|Too overwhelmed by treatment|2|||
105948490|NCT00902330|365475101|FG001|Overall Study|Too overwhelmed by treatment|5|||
105948491|NCT00902330|365475100|FG000|Overall Study|Adverse Event|1|||
105948492|NCT00902330|365475101|FG001|Overall Study|Adverse Event|0|||
105948493|NCT00902330|365475100|FG000|Overall Study|No post baseline data|1|||
105948494|NCT00902330|365475101|FG001|Overall Study|No post baseline data|0|||
105753531|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Adverse Event|0|||
105760900|NCT01342952|364778053|FG001|Overall Study|Lost to Follow-up|2|||
105948495|NCT03342560|365475102|FG000|Overall Study|Lost to Follow-up|2|||
105948496|NCT03213509|365475103|FG000|Overall Study|Did not consent for verbal autopsy|4|||
105948497|NCT03213509|365475104|FG001|Overall Study|Did not consent for verbal autopsy|5|||
105948498|NCT02604511|365475105|FG000|Overall Study|Adverse Event|3|||
105948499|NCT02604511|365475105|FG000|Overall Study|Disease Progression|4|||
105948500|NCT02604511|365475105|FG000|Overall Study|Withdrawal by Subject|3|||
105948501|NCT02604511|365475105|FG000|Overall Study|Participant ineligible|1|||
105948502|NCT02604511|365475105|FG000|Overall Study|Intercurrent illness|1|||
105948503|NCT04290624|365475106|FG000|Overall Study|Adverse Event|1|||
105948504|NCT04290624|365475107|FG001|Overall Study|Adverse Event|0|||
105948505|NCT01342094|365475113|FG000|Overall Study|Adverse Event|5|||
105948506|NCT01342094|365475114|FG001|Overall Study|Adverse Event|0|||
105948507|NCT01342094|365475113|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105948508|NCT01342094|365475114|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105948509|NCT01342094|365475113|FG000|Overall Study|Withdrawal by Subject|0|||
105948510|NCT01342094|365475114|FG001|Overall Study|Withdrawal by Subject|2|||
105948511|NCT02121509|365475115|FG000|Washout Period (35 Days)|Adverse Event|1|||
105948512|NCT02121509|365475116|FG001|Washout Period (35 Days)|Adverse Event|1|||
105948513|NCT02121509|365475117|FG002|Washout Period (35 Days)|Adverse Event|0|||
105948514|NCT02121509|365475118|FG003|Washout Period (35 Days)|Adverse Event|0|||
105948515|NCT02121509|365475115|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
105948516|NCT02121509|365475116|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
105948517|NCT02121509|365475117|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
105948518|NCT02121509|365475118|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
105948519|NCT02121509|365475115|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
105948520|NCT02121509|365475116|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
105948521|NCT02121509|365475117|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
105948522|NCT02121509|365475118|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
105948523|NCT03069716|365475123|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
105948524|NCT03069716|365475124|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
105948525|NCT03069716|365475125|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
105948526|NCT03069716|365475123|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
105948527|NCT03069716|365475124|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
105948528|NCT03069716|365475125|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
105948529|NCT03069716|365475123|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
105948530|NCT03069716|365475124|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
105948531|NCT03069716|365475125|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
105948532|NCT03069716|365475123|FG000|Randomized Treatment|Withdrawal by Subject|0|||
105948533|NCT03069716|365475124|FG001|Randomized Treatment|Withdrawal by Subject|2|||
105948534|NCT03069716|365475125|FG002|Randomized Treatment|Withdrawal by Subject|0|||
105948535|NCT03402841|365475131|FG000|Overall Study|Withdrawal by Subject|3|||
105948536|NCT03402841|365475131|FG000|Overall Study|Lost to Follow-up|2|||
105948537|NCT03402841|365475131|FG000|Overall Study|Death|146|||
105948538|NCT01085214|365475134|FG000|Overall Study|Alternate treatment required|1|||
105948539|NCT00542178|365475137|FG000|Overall Study|did not complete year 4 follow-up|75|||
105948540|NCT00542178|365475138|FG001|Overall Study|did not complete year 4 follow-up|80|||
105948541|NCT00542178|365475139|FG002|Overall Study|did not complete year 4 follow-up|74|||
105948542|NCT00542178|365475140|FG003|Overall Study|did not complete year 4 follow-up|62|||
105948543|NCT00542178|365475141|FG004|Overall Study|did not complete year 4 follow-up|64|||
105948544|NCT00542178|365475142|FG005|Overall Study|did not complete year 4 follow-up|89|||
105948545|NCT00542178|365475143|FG006|Overall Study|did not complete year 4 follow-up|87|||
105948546|NCT00542178|365475144|FG007|Overall Study|did not complete year 4 follow-up|85|||
105948547|NCT01150357|365475147|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
105948548|NCT01150357|365475148|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
105948549|NCT01150357|365475149|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
105948550|NCT01150357|365475147|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
105948551|NCT01150357|365475148|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
105948552|NCT01150357|365475149|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
105948553|NCT01150357|365475147|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
105948554|NCT01150357|365475148|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
105948555|NCT01150357|365475149|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
105948556|NCT01150357|365475147|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
105948557|NCT01150357|365475148|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
105948558|NCT01150357|365475149|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
105948559|NCT01150357|365475147|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
105948560|NCT01150357|365475148|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
105948561|NCT01150357|365475149|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
106016475|NCT04033445|365724447|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
106016476|NCT04033445|365724448|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
106016477|NCT04033445|365724449|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105948562|NCT01150357|365475147|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
105948563|NCT01150357|365475148|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
105948564|NCT01150357|365475149|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
105948565|NCT01150357|365475147|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
105948566|NCT01150357|365475148|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
105948567|NCT01150357|365475149|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
105948568|NCT01576783|365476860|FG000|Overall Study|Change in Medical Care|1|||
105948569|NCT01576783|365476861|FG001|Overall Study|Change in Medical Care|0|||
105948570|NCT01576783|365476860|FG000|Overall Study|Lost to Follow-up|14|||
105948571|NCT01576783|365476861|FG001|Overall Study|Lost to Follow-up|16|||
105948572|NCT01576783|365476860|FG000|Overall Study|Withdrawal by Subject|5|||
105948573|NCT01576783|365476861|FG001|Overall Study|Withdrawal by Subject|1|||
105948574|NCT02114177|365476862|FG000|Overall Study|Lost to Follow-up|1|||
105948575|NCT02114177|365476863|FG001|Overall Study|Lost to Follow-up|2|||
105948576|NCT02114177|365476862|FG000|Overall Study|Withdrawal by Subject|6|||
105948577|NCT02114177|365476863|FG001|Overall Study|Withdrawal by Subject|1|||
105948578|NCT02114177|365476862|FG000|Overall Study|Other|2|||
105948579|NCT02114177|365476863|FG001|Overall Study|Other|1|||
105948580|NCT01819272|365476865|FG000|Overall Study|Adverse Event|1|||
105948581|NCT01819272|365476866|FG001|Overall Study|Adverse Event|0|||
105948582|NCT01819272|365476867|FG002|Overall Study|Adverse Event|0|||
105948583|NCT01819272|365476868|FG003|Overall Study|Adverse Event|2|||
105948584|NCT01819272|365476869|FG004|Overall Study|Adverse Event|0|||
105948585|NCT01819272|365476870|FG005|Overall Study|Adverse Event|0|||
105948586|NCT01819272|365476865|FG000|Overall Study|Lost to Follow-up|3|||
105948587|NCT01819272|365476866|FG001|Overall Study|Lost to Follow-up|0|||
105948588|NCT01819272|365476867|FG002|Overall Study|Lost to Follow-up|1|||
105948589|NCT01819272|365476868|FG003|Overall Study|Lost to Follow-up|0|||
105948590|NCT01819272|365476869|FG004|Overall Study|Lost to Follow-up|0|||
105948591|NCT01819272|365476870|FG005|Overall Study|Lost to Follow-up|3|||
105753532|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Adverse Event|0|||
105948592|NCT01819272|365476865|FG000|Overall Study|Protocol Violation|0|||
106016478|NCT04033445|365724450|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
106016479|NCT04033445|365724451|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105948593|NCT01819272|365476866|FG001|Overall Study|Protocol Violation|0|||
105948594|NCT01819272|365476867|FG002|Overall Study|Protocol Violation|0|||
105948595|NCT01819272|365476868|FG003|Overall Study|Protocol Violation|1|||
105948596|NCT01819272|365476869|FG004|Overall Study|Protocol Violation|2|||
105753533|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Adverse Event|1|||
105753534|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Adverse Event|3|||
105753535|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
105753536|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
105753537|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
105753538|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
105753539|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
105753540|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
105753541|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
105753542|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
105753543|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
105753544|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
105753545|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
105753546|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
105753547|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
105753548|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
105753549|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
105753550|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
105753551|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
105753552|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
105753553|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
105753554|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
105753555|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
105753556|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
105753557|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
105753558|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
105753559|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Miscalculation|0|||
105753560|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Miscalculation|1|||
105753561|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Miscalculation|0|||
105753562|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Miscalculation|0|||
105753563|NCT02505542|364750192|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
105753564|NCT02505542|364750193|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
105753565|NCT02505542|364750194|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
105753566|NCT02505542|364750195|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
105948597|NCT01819272|365476870|FG005|Overall Study|Protocol Violation|3|||
105948598|NCT01819272|365476865|FG000|Overall Study|Physician Decision|0|||
105948599|NCT01819272|365476866|FG001|Overall Study|Physician Decision|1|||
105948600|NCT01819272|365476867|FG002|Overall Study|Physician Decision|0|||
105948601|NCT01819272|365476868|FG003|Overall Study|Physician Decision|0|||
105948602|NCT01819272|365476869|FG004|Overall Study|Physician Decision|0|||
105948603|NCT01819272|365476870|FG005|Overall Study|Physician Decision|0|||
105948604|NCT01819272|365476865|FG000|Overall Study|Withdrawal of Consent|0|||
105948605|NCT01819272|365476866|FG001|Overall Study|Withdrawal of Consent|1|||
105948606|NCT01819272|365476867|FG002|Overall Study|Withdrawal of Consent|2|||
105948607|NCT01819272|365476868|FG003|Overall Study|Withdrawal of Consent|1|||
105948608|NCT01819272|365476869|FG004|Overall Study|Withdrawal of Consent|0|||
105753567|NCT01464788|364750196|FG000|Overall Study|Lost to Follow-up|0|||
105753568|NCT01464788|364750197|FG001|Overall Study|Lost to Follow-up|1|||
105753569|NCT01464788|364750198|FG002|Overall Study|Lost to Follow-up|0|||
105753570|NCT01464788|364750196|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
105753571|NCT01464788|364750197|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
105753572|NCT01464788|364750198|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
105753573|NCT01594333|364750201|FG000|Overall Study|Death|96|||
105753574|NCT01594333|364750202|FG001|Overall Study|Death|83|||
105753575|NCT01594333|364750201|FG000|Overall Study|Lost to Follow-up|5|||
105753576|NCT01594333|364750202|FG001|Overall Study|Lost to Follow-up|5|||
105753577|NCT01594333|364750201|FG000|Overall Study|Withdrawal by Subject|60|||
105753578|NCT01594333|364750202|FG001|Overall Study|Withdrawal by Subject|63|||
105948609|NCT01819272|365476870|FG005|Overall Study|Withdrawal of Consent|1|||
105753579|NCT00400712|364750203|FG000|Overall Study|Death|1|||
105753580|NCT00400712|364750204|FG001|Overall Study|Death|0|||
105753581|NCT00400712|364750203|FG000|Overall Study|Withdrawal by Subject|11|||
105753582|NCT00400712|364750204|FG001|Overall Study|Withdrawal by Subject|12|||
105753583|NCT00400712|364750203|FG000|Overall Study|Physician Decision|5|||
105753584|NCT00400712|364750204|FG001|Overall Study|Physician Decision|4|||
105753585|NCT02670330|364750205|FG000|Overall Study|Protocol Deviation|1|||
105753586|NCT02670330|364750206|FG001|Overall Study|Protocol Deviation|0|||
105753587|NCT02670330|364750205|FG000|Overall Study|Study Terminated By Sponsor|36|||
105753588|NCT02670330|364750206|FG001|Overall Study|Study Terminated By Sponsor|43|||
105753589|NCT02670330|364750205|FG000|Overall Study|Adverse Event|1|||
105753590|NCT02670330|364750206|FG001|Overall Study|Adverse Event|3|||
105753591|NCT02670330|364750205|FG000|Overall Study|Withdrawal by Subject|34|||
105753592|NCT02670330|364750206|FG001|Overall Study|Withdrawal by Subject|29|||
105753593|NCT02670330|364750205|FG000|Overall Study|Lost to Follow-up|3|||
105753594|NCT02670330|364750206|FG001|Overall Study|Lost to Follow-up|2|||
105753595|NCT03691610|364750212|FG000|Overall Study|Adverse Event|0|||
105948610|NCT01819272|365476865|FG000|Overall Study|Loss of Glucose Control|2|||
105948611|NCT01819272|365476866|FG001|Overall Study|Loss of Glucose Control|1|||
105948612|NCT01819272|365476867|FG002|Overall Study|Loss of Glucose Control|0|||
105948613|NCT01819272|365476868|FG003|Overall Study|Loss of Glucose Control|1|||
105948614|NCT01819272|365476869|FG004|Overall Study|Loss of Glucose Control|2|||
105948615|NCT01819272|365476870|FG005|Overall Study|Loss of Glucose Control|0|||
105948616|NCT01897493|365476871|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
105948617|NCT01173679|365476874|FG000|Overall Study|Death|1|||
105948618|NCT01250054|365476875|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
105948619|NCT01250054|365476876|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
105753596|NCT03691610|364750213|FG001|Overall Study|Adverse Event|1|||
105753597|NCT03691610|364750214|FG002|Overall Study|Adverse Event|0|||
105753598|NCT03691610|364750215|FG003|Overall Study|Adverse Event|0|||
105753599|NCT03691610|364750212|FG000|Overall Study|Protocol Deviation|15|||
105753600|NCT03691610|364750213|FG001|Overall Study|Protocol Deviation|8|||
105753601|NCT03691610|364750214|FG002|Overall Study|Protocol Deviation|1|||
105753602|NCT03691610|364750215|FG003|Overall Study|Protocol Deviation|2|||
105753603|NCT03691610|364750212|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
105753604|NCT03691610|364750213|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
105753605|NCT03691610|364750214|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
105753606|NCT03691610|364750215|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
105753607|NCT03691610|364750212|FG000|Overall Study|Lost to Follow-up|20|||
105753608|NCT03691610|364750213|FG001|Overall Study|Lost to Follow-up|11|||
105753609|NCT03691610|364750214|FG002|Overall Study|Lost to Follow-up|5|||
105753610|NCT03691610|364750215|FG003|Overall Study|Lost to Follow-up|2|||
105753611|NCT00878215|364750217|FG000|Overall Study|Determined to be ineligible|0|||
105753612|NCT00878215|364750218|FG001|Overall Study|Determined to be ineligible|10|||
105753613|NCT00878215|364750219|FG002|Overall Study|Determined to be ineligible|0|||
105753614|NCT00878215|364750220|FG003|Overall Study|Determined to be ineligible|0|||
105753615|NCT05294211|364750222|FG000|Overall Study|Withdrawal by Subject|3|||
105753616|NCT05294211|364750222|FG000|Overall Study|Physician Decision|2|||
105753617|NCT05294211|364750222|FG000|Overall Study|Progressed to active labor|1|||
105753618|NCT05294211|364750222|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
105753619|NCT05294211|364750222|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
105948620|NCT01732536|365476879|FG000|Overall Study|Withdrawal by Subject|1|||
105948621|NCT01732536|365476880|FG001|Overall Study|Withdrawal by Subject|1|||
105948622|NCT00805389|365476881|FG000|Overall Study|Adverse Event|0|||
105948623|NCT00805389|365476882|FG001|Overall Study|Adverse Event|0|||
105948624|NCT00805389|365476883|FG002|Overall Study|Adverse Event|1|||
105948625|NCT00805389|365476884|FG003|Overall Study|Adverse Event|2|||
105948626|NCT00805389|365476885|FG004|Overall Study|Adverse Event|0|||
105948627|NCT00805389|365476881|FG000|Overall Study|Lost to Follow-up|4|||
105948628|NCT00805389|365476882|FG001|Overall Study|Lost to Follow-up|3|||
105948629|NCT00805389|365476883|FG002|Overall Study|Lost to Follow-up|6|||
105948630|NCT00805389|365476884|FG003|Overall Study|Lost to Follow-up|10|||
105948631|NCT00805389|365476885|FG004|Overall Study|Lost to Follow-up|9|||
105948632|NCT00805389|365476881|FG000|Overall Study|Protocol Violation|0|||
105948633|NCT00805389|365476882|FG001|Overall Study|Protocol Violation|0|||
105948634|NCT00805389|365476883|FG002|Overall Study|Protocol Violation|1|||
105948635|NCT00805389|365476884|FG003|Overall Study|Protocol Violation|0|||
105948636|NCT00805389|365476885|FG004|Overall Study|Protocol Violation|0|||
105948637|NCT00805389|365476881|FG000|Overall Study|Withdrawal by Subject|3|||
105948638|NCT00805389|365476882|FG001|Overall Study|Withdrawal by Subject|2|||
105948639|NCT00805389|365476883|FG002|Overall Study|Withdrawal by Subject|4|||
105948640|NCT00805389|365476884|FG003|Overall Study|Withdrawal by Subject|5|||
105948641|NCT00805389|365476885|FG004|Overall Study|Withdrawal by Subject|4|||
105948642|NCT00503984|365476886|FG000|Overall Study|Protocol Violation|0|||
105948643|NCT00503984|365476887|FG001|Overall Study|Protocol Violation|1|||
105948644|NCT00503984|365476888|FG002|Overall Study|Protocol Violation|0|||
105948645|NCT00503984|365476889|FG003|Overall Study|Protocol Violation|0|||
105948646|NCT00503984|365476890|FG004|Overall Study|Protocol Violation|0|||
105948647|NCT00503984|365476891|FG005|Overall Study|Protocol Violation|0|||
105948648|NCT00503984|365476886|FG000|Overall Study|Adverse Event|0|||
105948649|NCT00503984|365476887|FG001|Overall Study|Adverse Event|1|||
105948650|NCT00503984|365476888|FG002|Overall Study|Adverse Event|0|||
105948651|NCT00503984|365476889|FG003|Overall Study|Adverse Event|0|||
105948652|NCT00503984|365476890|FG004|Overall Study|Adverse Event|0|||
105753620|NCT00406783|364750223|FG000|Overall Study|Adverse Event|4|||
105753621|NCT00406783|364750224|FG001|Overall Study|Adverse Event|4|||
105753622|NCT00406783|364750223|FG000|Overall Study|Treatment Failure|2|||
105753623|NCT00406783|364750224|FG001|Overall Study|Treatment Failure|3|||
105948653|NCT00503984|365476891|FG005|Overall Study|Adverse Event|0|||
105948654|NCT00503984|365476886|FG000|Overall Study|Death|0|||
105948655|NCT00503984|365476887|FG001|Overall Study|Death|0|||
105753624|NCT00406783|364750223|FG000|Overall Study|Lost to Follow-up|3|||
105948656|NCT00503984|365476888|FG002|Overall Study|Death|0|||
105753625|NCT00406783|364750224|FG001|Overall Study|Lost to Follow-up|0|||
105948657|NCT00503984|365476889|FG003|Overall Study|Death|0|||
105948658|NCT00503984|365476890|FG004|Overall Study|Death|1|||
105948659|NCT00503984|365476891|FG005|Overall Study|Death|0|||
105948660|NCT01246960|365476894|FG000|Overall Study|Lost to Follow-up|3|||
105948661|NCT01246960|365476895|FG001|Overall Study|Lost to Follow-up|1|||
105948662|NCT01246960|365476894|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
105948663|NCT01246960|365476895|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
105948664|NCT02296476|365476897|FG000|Overall Study|Disease Progression|6|||
105948665|NCT02296476|365476898|FG001|Overall Study|Disease Progression|4|||
105948666|NCT02296476|365476899|FG002|Overall Study|Disease Progression|2|||
105948667|NCT00272792|365476900|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
105948668|NCT00272792|365476901|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
105948669|NCT00272792|365476900|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
105948670|NCT00272792|365476901|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
105948671|NCT00272792|365476900|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
105948672|NCT00272792|365476901|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
105948673|NCT00272792|365476900|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
105948674|NCT00272792|365476901|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
105948675|NCT01276704|365476906|FG000|Overall Study|Lost to Follow-up|2|||
105948676|NCT01276704|365476907|FG001|Overall Study|Lost to Follow-up|3|||
105948677|NCT01276704|365476906|FG000|Overall Study|Non-compliant|2|||
105948678|NCT01276704|365476907|FG001|Overall Study|Non-compliant|2|||
105948679|NCT01276704|365476906|FG000|Overall Study|Withdrawal by Subject|7|||
105753626|NCT00406783|364750223|FG000|Overall Study|Withdrawal by Subject|1|||
105753627|NCT00406783|364750224|FG001|Overall Study|Withdrawal by Subject|4|||
105753628|NCT00406783|364750223|FG000|Overall Study|Protocol Violation|4|||
105753629|NCT00406783|364750224|FG001|Overall Study|Protocol Violation|4|||
105753630|NCT03334396|364750225|FG000|Overall Study|Adverse Event|1|||
105753631|NCT03334396|364750226|FG001|Overall Study|Adverse Event|0|||
105753632|NCT03334396|364750227|FG002|Overall Study|Adverse Event|1|||
105753633|NCT03334396|364750228|FG003|Overall Study|Adverse Event|0|||
105948680|NCT01276704|365476907|FG001|Overall Study|Withdrawal by Subject|1|||
105948681|NCT01276704|365476906|FG000|Overall Study|Physician Decision|3|||
105948682|NCT01276704|365476907|FG001|Overall Study|Physician Decision|5|||
105948683|NCT03376516|365476908|FG000|Overall Study|Not treated|1|||
105948684|NCT03376516|365476908|FG000|Overall Study|Consent withdrawn|1|||
105948685|NCT01359956|365476909|FG000|Overall Study|Death|58|||
105753634|NCT03334396|364750229|FG004|Overall Study|Adverse Event|0|||
105948686|NCT01359956|365476910|FG001|Overall Study|Death|60|||
105948687|NCT01359956|365476911|FG002|Overall Study|Death|66|||
105948688|NCT01359956|365476912|FG003|Overall Study|Death|57|||
105948689|NCT01359956|365476909|FG000|Overall Study|Lost to Follow-up|3|||
105948690|NCT01359956|365476910|FG001|Overall Study|Lost to Follow-up|4|||
105948691|NCT01359956|365476911|FG002|Overall Study|Lost to Follow-up|1|||
105948692|NCT01359956|365476912|FG003|Overall Study|Lost to Follow-up|1|||
105948693|NCT00710593|365476913|FG000|Overall Study|Incarceration|1|||
105948694|NCT00710593|365476914|FG001|Overall Study|Incarceration|0|||
105948695|NCT00710593|365476913|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
105948696|NCT00710593|365476914|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
105948697|NCT00710593|365476913|FG000|Overall Study|Lost to Follow-up|3|||
105948698|NCT00710593|365476914|FG001|Overall Study|Lost to Follow-up|1|||
105948699|NCT00710593|365476913|FG000|Overall Study|Moved out of area|1|||
105948700|NCT00710593|365476914|FG001|Overall Study|Moved out of area|0|||
105948701|NCT00710593|365476913|FG000|Overall Study|Failure to adhere or complete study eval|1|||
105948702|NCT00710593|365476914|FG001|Overall Study|Failure to adhere or complete study eval|1|||
105948703|NCT00710593|365476913|FG000|Overall Study|Protocol Violation|1|||
105948704|NCT00710593|365476914|FG001|Overall Study|Protocol Violation|1|||
105948705|NCT00710593|365476913|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
105948706|NCT00710593|365476914|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
105948707|NCT01784029|365476915|FG000|Overall Study|Lost to Follow-up|19|||
105948708|NCT01784029|365476916|FG001|Overall Study|Lost to Follow-up|20|||
105948709|NCT01784029|365476917|FG002|Overall Study|Lost to Follow-up|22|||
105948710|NCT02829996|365476918|FG000|Overall Study|Withdrawal by Subject|1|||
105753635|NCT03334396|364750230|FG005|Overall Study|Adverse Event|0|||
105753636|NCT03334396|364750231|FG006|Overall Study|Adverse Event|0|||
105753637|NCT03334396|364750232|FG007|Overall Study|Adverse Event|0|||
105753638|NCT03334396|364750225|FG000|Overall Study|Lack of Efficacy|10|||
105753639|NCT03334396|364750226|FG001|Overall Study|Lack of Efficacy|4|||
105753640|NCT03334396|364750227|FG002|Overall Study|Lack of Efficacy|1|||
105753641|NCT03334396|364750228|FG003|Overall Study|Lack of Efficacy|3|||
105753642|NCT03334396|364750229|FG004|Overall Study|Lack of Efficacy|1|||
105753643|NCT03334396|364750230|FG005|Overall Study|Lack of Efficacy|0|||
105753644|NCT03334396|364750231|FG006|Overall Study|Lack of Efficacy|0|||
105753645|NCT03334396|364750232|FG007|Overall Study|Lack of Efficacy|1|||
105753646|NCT03334396|364750225|FG000|Overall Study|Lost to Follow-up|0|||
105753647|NCT03334396|364750226|FG001|Overall Study|Lost to Follow-up|0|||
105753648|NCT03334396|364750227|FG002|Overall Study|Lost to Follow-up|1|||
105948711|NCT02829996|365476919|FG001|Overall Study|Withdrawal by Subject|0|||
105948712|NCT02829996|365476920|FG002|Overall Study|Withdrawal by Subject|0|||
105948713|NCT02829996|365476921|FG003|Overall Study|Withdrawal by Subject|0|||
105948714|NCT02829996|365476922|FG004|Overall Study|Withdrawal by Subject|0|||
105948715|NCT00582907|365476923|FG000|1st Course|Withdrawal by Subject|1|||
105948716|NCT00582907|365476924|FG001|1st Course|Withdrawal by Subject|0|||
105948717|NCT00582907|365476925|FG002|1st Course|Withdrawal by Subject|0|||
105948718|NCT00582907|365476926|FG003|1st Course|Withdrawal by Subject|0|||
105948719|NCT00582907|365476923|FG000|1st Course|Lost to Follow-up|0|||
105948720|NCT00582907|365476924|FG001|1st Course|Lost to Follow-up|0|||
105948721|NCT00582907|365476925|FG002|1st Course|Lost to Follow-up|0|||
105948722|NCT00582907|365476926|FG003|1st Course|Lost to Follow-up|1|||
105948723|NCT00582907|365476923|FG000|2nd Course|Lack of Efficacy|1|||
105948724|NCT00582907|365476924|FG001|2nd Course|Lack of Efficacy|0|||
105948725|NCT00582907|365476925|FG002|2nd Course|Lack of Efficacy|0|||
105948726|NCT00582907|365476926|FG003|2nd Course|Lack of Efficacy|0|||
105948727|NCT02332928|365476928|FG000|Overall Study|Withdrawal by Subject|0|||
105948728|NCT02332928|365476929|FG001|Overall Study|Withdrawal by Subject|2|||
105948729|NCT02332928|365476928|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
105948730|NCT02332928|365476929|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
105948731|NCT01441960|365476930|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
105948732|NCT01441960|365476931|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
105948733|NCT01441960|365476930|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
105948734|NCT01441960|365476931|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
105948735|NCT01441960|365476930|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
105948736|NCT01441960|365476931|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
105948737|NCT00370292|365476932|FG000|Overall Study|Disease Progression|4|||
105753649|NCT03334396|364750228|FG003|Overall Study|Lost to Follow-up|0|||
105753650|NCT03334396|364750229|FG004|Overall Study|Lost to Follow-up|0|||
105753651|NCT03334396|364750230|FG005|Overall Study|Lost to Follow-up|0|||
105753652|NCT03334396|364750231|FG006|Overall Study|Lost to Follow-up|1|||
105753653|NCT03334396|364750232|FG007|Overall Study|Lost to Follow-up|0|||
105753654|NCT03334396|364750225|FG000|Overall Study|Physician Decision|1|||
105948738|NCT00370292|365476932|FG000|Overall Study|Adverse Event|7|||
105948739|NCT00370292|365476932|FG000|Overall Study|Physician Decision|2|||
105948740|NCT02986074|365476933|FG000|First Trial Period|Adverse Event|1|||
105948741|NCT02986074|365476934|FG001|First Trial Period|Adverse Event|0|||
105948742|NCT02986074|365476935|FG002|First Trial Period|Adverse Event|0|||
105948743|NCT02986074|365476936|FG003|First Trial Period|Adverse Event|0|||
105948744|NCT02986074|365476933|FG000|Follow up Period|system explant|0|||
105948745|NCT02986074|365476934|FG001|Follow up Period|system explant|0|||
105948746|NCT02986074|365476935|FG002|Follow up Period|system explant|1|||
105948747|NCT02986074|365476936|FG003|Follow up Period|system explant|2|||
105948748|NCT02986074|365476933|FG000|Follow up Period|Physician Decision|0|||
105948749|NCT02986074|365476934|FG001|Follow up Period|Physician Decision|0|||
105948750|NCT02986074|365476935|FG002|Follow up Period|Physician Decision|0|||
105948751|NCT02986074|365476936|FG003|Follow up Period|Physician Decision|1|||
105948752|NCT00069641|365476937|FG000|Overall Study|Death|1|||
105948753|NCT00069641|365476938|FG001|Overall Study|Death|0|||
105948754|NCT00069641|365476939|FG002|Overall Study|Death|1|||
105948755|NCT00688597|365476940|FG000|Overall Study|Adverse Event|2|||
105948756|NCT00688597|365476941|FG001|Overall Study|Adverse Event|0|||
105948757|NCT00688597|365476942|FG002|Overall Study|Adverse Event|0|||
105948758|NCT00688597|365476940|FG000|Overall Study|Physician Decision|1|||
105948759|NCT00688597|365476941|FG001|Overall Study|Physician Decision|0|||
105948760|NCT00688597|365476942|FG002|Overall Study|Physician Decision|0|||
105948761|NCT00598650|365476945|FG000|Overall Study|Withdrawal by Subject|3|||
105948762|NCT00598650|365476945|FG000|Overall Study|Adverse Event|18|||
105948763|NCT00598650|365476945|FG000|Overall Study|No treatment for 3 weeks|1|||
105948764|NCT00598650|365476945|FG000|Overall Study|Not eligible|1|||
105948765|NCT00598650|365476945|FG000|Overall Study|Prohibited Concomitant Medication|2|||
105948766|NCT00598650|365476945|FG000|Overall Study|Physician Decision|2|||
105948767|NCT00492557|365476946|FG000|Overall Study|Subject request|12|||
105948768|NCT00492557|365476947|FG001|Overall Study|Subject request|11|||
105948769|NCT00492557|365476946|FG000|Overall Study|Protocol Violation|7|||
105948770|NCT00492557|365476947|FG001|Overall Study|Protocol Violation|8|||
105948771|NCT00492557|365476946|FG000|Overall Study|Other|2|||
105948772|NCT00492557|365476947|FG001|Overall Study|Other|2|||
105948773|NCT00492557|365476946|FG000|Overall Study|Death|1|||
105948774|NCT00492557|365476947|FG001|Overall Study|Death|1|||
105948775|NCT00492557|365476946|FG000|Overall Study|Adverse Event|1|||
105948776|NCT00492557|365476947|FG001|Overall Study|Adverse Event|0|||
105948777|NCT00492557|365476946|FG000|Overall Study|Failed to return|1|||
105948778|NCT00492557|365476947|FG001|Overall Study|Failed to return|0|||
105948779|NCT00492557|365476946|FG000|Overall Study|Lost to Follow-up|0|||
105948780|NCT00492557|365476947|FG001|Overall Study|Lost to Follow-up|1|||
105948781|NCT04778592|365476948|FG000|Overall Study|Adverse Event|1|||
105948782|NCT04778592|365476949|FG001|Overall Study|Adverse Event|2|||
105948783|NCT04778592|365476948|FG000|Overall Study|Withdrawal by Subject|1|||
105948784|NCT04778592|365476949|FG001|Overall Study|Withdrawal by Subject|2|||
105948785|NCT02862574|365476954|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105948786|NCT02862574|365476955|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105948787|NCT02862574|365476956|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105948788|NCT02862574|365476954|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
105948789|NCT02862574|365476955|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
105948790|NCT02862574|365476956|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
105948791|NCT02862574|365476954|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
105948792|NCT02862574|365476955|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
105948793|NCT02862574|365476956|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
105948794|NCT02660229|365476958|FG000|Overall Study|Adverse Event|2|||
105948795|NCT02660229|365476959|FG001|Overall Study|Adverse Event|0|||
105948796|NCT02660229|365476958|FG000|Overall Study|Withdrawal by Subject|0|||
105948797|NCT02660229|365476959|FG001|Overall Study|Withdrawal by Subject|1|||
105948798|NCT01049373|365476964|FG000|Overall Study|Protocol Violation|9|||
105948799|NCT01049373|365476965|FG001|Overall Study|Protocol Violation|9|||
105948800|NCT01049373|365476964|FG000|Overall Study|Withdrawal by Subject|8|||
105948801|NCT01049373|365476965|FG001|Overall Study|Withdrawal by Subject|5|||
105948802|NCT01049373|365476964|FG000|Overall Study|Adverse Event|3|||
105948803|NCT01049373|365476965|FG001|Overall Study|Adverse Event|3|||
105948804|NCT01049373|365476964|FG000|Overall Study|Lost to Follow-up|9|||
105948805|NCT01049373|365476965|FG001|Overall Study|Lost to Follow-up|4|||
105948806|NCT01049373|365476964|FG000|Overall Study|no evaluable study values|9|||
105948807|NCT01049373|365476965|FG001|Overall Study|no evaluable study values|21|||
105948808|NCT01049373|365476964|FG000|Overall Study|Other|1|||
105948809|NCT01049373|365476965|FG001|Overall Study|Other|1|||
105948810|NCT01049373|365476964|FG000|Overall Study|Non-cooperation|0|||
105948811|NCT01049373|365476965|FG001|Overall Study|Non-cooperation|1|||
105948812|NCT01693367|365476970|FG000|Overall Study|Withdrawal by Subject|1|||
105948813|NCT01693367|365476971|FG001|Overall Study|Withdrawal by Subject|1|||
105948814|NCT01693367|365476970|FG000|Overall Study|Physician Decision|0|||
105948815|NCT01693367|365476971|FG001|Overall Study|Physician Decision|1|||
105948816|NCT02136914|365476972|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
105948817|NCT02136914|365476973|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
105948818|NCT02136914|365476972|FG000|Overall Study|Withdrawal by Subject|3|||
105948819|NCT02136914|365476973|FG001|Overall Study|Withdrawal by Subject|10|||
105948820|NCT02136914|365476972|FG000|Overall Study|Subject Unwilling to Proceed|7|||
105948821|NCT02136914|365476973|FG001|Overall Study|Subject Unwilling to Proceed|2|||
105948822|NCT02136914|365476972|FG000|Overall Study|Lost to Follow-up|1|||
105948823|NCT02136914|365476973|FG001|Overall Study|Lost to Follow-up|1|||
105948824|NCT02136914|365476972|FG000|Overall Study|Did Not Receive Study Drug|2|||
105948825|NCT02136914|365476973|FG001|Overall Study|Did Not Receive Study Drug|0|||
105948826|NCT02136914|365476972|FG000|Overall Study|Lack of Efficacy|1|||
105948827|NCT02136914|365476973|FG001|Overall Study|Lack of Efficacy|0|||
105948828|NCT02136914|365476972|FG000|Overall Study|Death|0|||
105948829|NCT02136914|365476973|FG001|Overall Study|Death|1|||
105948830|NCT00328172|365476974|FG000|Overall Study|Adverse Event|3|||
105948831|NCT00328172|365476975|FG001|Overall Study|Adverse Event|2|||
105948832|NCT00328172|365476976|FG002|Overall Study|Adverse Event|1|||
105753655|NCT03334396|364750226|FG001|Overall Study|Physician Decision|0|||
105948833|NCT00328172|365476977|FG003|Overall Study|Adverse Event|2|||
105948834|NCT00328172|365476978|FG004|Overall Study|Adverse Event|1|||
105948835|NCT00328172|365476974|FG000|Overall Study|Protocol Violation|0|||
105753656|NCT03334396|364750227|FG002|Overall Study|Physician Decision|0|||
105753657|NCT03334396|364750228|FG003|Overall Study|Physician Decision|0|||
105753658|NCT03334396|364750229|FG004|Overall Study|Physician Decision|0|||
105753659|NCT03334396|364750230|FG005|Overall Study|Physician Decision|0|||
105753660|NCT03334396|364750231|FG006|Overall Study|Physician Decision|0|||
105753661|NCT03334396|364750232|FG007|Overall Study|Physician Decision|0|||
105948836|NCT00328172|365476975|FG001|Overall Study|Protocol Violation|1|||
105948837|NCT00328172|365476976|FG002|Overall Study|Protocol Violation|1|||
105948838|NCT00328172|365476977|FG003|Overall Study|Protocol Violation|0|||
105948839|NCT00328172|365476978|FG004|Overall Study|Protocol Violation|0|||
105948840|NCT00328172|365476974|FG000|Overall Study|Lost to Follow-up|1|||
105948841|NCT00328172|365476975|FG001|Overall Study|Lost to Follow-up|1|||
105948842|NCT00328172|365476976|FG002|Overall Study|Lost to Follow-up|2|||
105948843|NCT00328172|365476977|FG003|Overall Study|Lost to Follow-up|1|||
105948844|NCT00328172|365476978|FG004|Overall Study|Lost to Follow-up|1|||
105948845|NCT00328172|365476974|FG000|Overall Study|Withdrawal by Subject|1|||
105948846|NCT00328172|365476975|FG001|Overall Study|Withdrawal by Subject|1|||
105948847|NCT00328172|365476976|FG002|Overall Study|Withdrawal by Subject|1|||
105948848|NCT00328172|365476977|FG003|Overall Study|Withdrawal by Subject|6|||
105948849|NCT00328172|365476978|FG004|Overall Study|Withdrawal by Subject|0|||
105948850|NCT00328172|365476974|FG000|Overall Study|Lack of Efficacy|14|||
105948851|NCT00328172|365476975|FG001|Overall Study|Lack of Efficacy|9|||
105948852|NCT00328172|365476976|FG002|Overall Study|Lack of Efficacy|4|||
105948853|NCT00328172|365476977|FG003|Overall Study|Lack of Efficacy|4|||
105948854|NCT00328172|365476978|FG004|Overall Study|Lack of Efficacy|3|||
105948855|NCT00328172|365476974|FG000|Overall Study|Other reason (not specified)|3|||
105948856|NCT00328172|365476975|FG001|Overall Study|Other reason (not specified)|0|||
105948857|NCT00328172|365476976|FG002|Overall Study|Other reason (not specified)|1|||
105948858|NCT00328172|365476977|FG003|Overall Study|Other reason (not specified)|0|||
105948859|NCT00328172|365476978|FG004|Overall Study|Other reason (not specified)|0|||
105948860|NCT00077974|365476979|FG000|Overall Study|Adverse Event|22|||
105948861|NCT00077974|365476979|FG000|Overall Study|Protocol Violation|1|||
105948862|NCT00077974|365476979|FG000|Overall Study|Withdrawal by Subject|3|||
105948863|NCT00077974|365476979|FG000|Overall Study|Lack of Efficacy|76|||
105948864|NCT00077974|365476979|FG000|Overall Study|Decision of Sponsor|2|||
105753662|NCT03334396|364750225|FG000|Overall Study|Withdrawal by Subject|10|||
105753663|NCT03334396|364750226|FG001|Overall Study|Withdrawal by Subject|5|||
105948865|NCT00256126|365476980|FG000|Overall Study|Adverse Event|1|||
105948866|NCT00256126|365476981|FG001|Overall Study|Adverse Event|0|||
105948867|NCT00256126|365476980|FG000|Overall Study|Other|1|||
105948868|NCT00256126|365476981|FG001|Overall Study|Other|2|||
105948869|NCT01990742|365476993|FG000|Overall Study|Withdrawal by facility|407|||
105948870|NCT01990742|365476994|FG001|Overall Study|Withdrawal by facility|1083|||
105948871|NCT01990742|365476993|FG000|Overall Study|Facility closed|0|||
105948872|NCT01990742|365476994|FG001|Overall Study|Facility closed|270|||
105948873|NCT00976456|365476995|FG000|Overall Study|Adverse Event|17|||
105948874|NCT00976456|365476996|FG001|Overall Study|Adverse Event|22|||
105753664|NCT03334396|364750227|FG002|Overall Study|Withdrawal by Subject|7|||
105948875|NCT00976456|365476995|FG000|Overall Study|Death|7|||
105948876|NCT00976456|365476996|FG001|Overall Study|Death|9|||
105948877|NCT00976456|365476995|FG000|Overall Study|Lack of Efficacy|5|||
105948878|NCT00976456|365476996|FG001|Overall Study|Lack of Efficacy|2|||
105948879|NCT00976456|365476995|FG000|Overall Study|Withdrawal by Subject|3|||
105948880|NCT00976456|365476996|FG001|Overall Study|Withdrawal by Subject|1|||
105948881|NCT00976456|365476995|FG000|Overall Study|screening failure, unknown|11|||
105948882|NCT00976456|365476996|FG001|Overall Study|screening failure, unknown|4|||
105948883|NCT02131766|365476997|FG000|Overall Study|Withdrawal by Subject|4|||
105948884|NCT00454116|365476999|FG000|Overall Study|Adverse Event|5|||
105948885|NCT00454116|365477000|FG001|Overall Study|Adverse Event|11|||
105948886|NCT00454116|365477001|FG002|Overall Study|Adverse Event|9|||
105948887|NCT00454116|365476999|FG000|Overall Study|Condition under investigation worsened|17|||
105948888|NCT00454116|365477000|FG001|Overall Study|Condition under investigation worsened|13|||
105948889|NCT00454116|365477001|FG002|Overall Study|Condition under investigation worsened|18|||
105948890|NCT00454116|365476999|FG000|Overall Study|Withdrawal by Subject|3|||
105948891|NCT00454116|365477000|FG001|Overall Study|Withdrawal by Subject|3|||
105948892|NCT00454116|365477001|FG002|Overall Study|Withdrawal by Subject|1|||
105948893|NCT00454116|365476999|FG000|Overall Study|Other|2|||
105948894|NCT00454116|365477000|FG001|Overall Study|Other|2|||
105948895|NCT00454116|365477001|FG002|Overall Study|Other|0|||
105948896|NCT02980107|365477008|FG000|Overall Study|Withdrawal by Subject|51|||
105948897|NCT02980107|365477009|FG001|Overall Study|Withdrawal by Subject|62|||
105948898|NCT03179761|365477010|FG000|Overall Study|Death|2|||
105948899|NCT03179761|365477011|FG001|Overall Study|Death|5|||
105948900|NCT03179761|365477010|FG000|Overall Study|Lost to Follow-up|2|||
105948901|NCT03179761|365477011|FG001|Overall Study|Lost to Follow-up|2|||
105948902|NCT03179761|365477010|FG000|Overall Study|Protocol Violation|1|||
105948903|NCT03179761|365477011|FG001|Overall Study|Protocol Violation|0|||
105948904|NCT03179761|365477010|FG000|Overall Study|Withdrawal by Subject|1|||
105948905|NCT03179761|365477011|FG001|Overall Study|Withdrawal by Subject|4|||
105948906|NCT03179761|365477010|FG000|Overall Study|Investigator Request|0|||
105948907|NCT03179761|365477011|FG001|Overall Study|Investigator Request|2|||
105948908|NCT04562116|365477012|FG000|Overall Study|Lost to Follow-up|1|||
105948909|NCT04562116|365477012|FG000|Overall Study|Withdrawal by Subject|3|||
105948910|NCT04064905|365477013|FG000|Overall Study|Lost to Follow-up|0|||
105948911|NCT04064905|365477014|FG001|Overall Study|Lost to Follow-up|3|||
105948912|NCT04064905|365477015|FG002|Overall Study|Lost to Follow-up|1|||
105948913|NCT04064905|365477016|FG003|Overall Study|Lost to Follow-up|4|||
105948914|NCT04064905|365477017|FG004|Overall Study|Lost to Follow-up|2|||
105948915|NCT01378117|365477022|FG000|Overall Study|withdrawal|2|||
105948916|NCT01378117|365477023|FG001|Overall Study|withdrawal|1|||
105948917|NCT01378117|365477024|FG002|Overall Study|withdrawal|2|||
105948918|NCT01378117|365477022|FG000|Overall Study|discharged before med given|2|||
105948919|NCT01378117|365477023|FG001|Overall Study|discharged before med given|0|||
105948920|NCT01378117|365477024|FG002|Overall Study|discharged before med given|1|||
105948921|NCT00967616|365477025|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
105948922|NCT00967616|365477026|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
105948923|NCT00967616|365477025|FG000|Overall Study|Death|0|||
105948924|NCT00967616|365477026|FG001|Overall Study|Death|3|||
105948925|NCT00967616|365477025|FG000|Overall Study|Withdrawal by Subject|8|||
105948926|NCT00967616|365477026|FG001|Overall Study|Withdrawal by Subject|4|||
105948927|NCT00967616|365477025|FG000|Overall Study|Progressive Disease|31|||
105948928|NCT00967616|365477026|FG001|Overall Study|Progressive Disease|18|||
105948929|NCT00967616|365477025|FG000|Overall Study|Other|8|||
105948930|NCT00967616|365477026|FG001|Overall Study|Other|8|||
105948931|NCT00967616|365477025|FG000|Overall Study|Protocol Violation|1|||
105948932|NCT00967616|365477026|FG001|Overall Study|Protocol Violation|0|||
105948933|NCT00952705|365478747|FG000|Overall Study|Lost to Follow-up|24|||
105948934|NCT00952705|365478748|FG001|Overall Study|Lost to Follow-up|8|||
105948935|NCT00952705|365478749|FG002|Overall Study|Lost to Follow-up|9|||
105948936|NCT00952705|365478747|FG000|Overall Study|Withdrawal by Subject|2|||
105948937|NCT00952705|365478748|FG001|Overall Study|Withdrawal by Subject|1|||
105948938|NCT00952705|365478749|FG002|Overall Study|Withdrawal by Subject|1|||
105948939|NCT00952705|365478747|FG000|Overall Study|Death|2|||
105948940|NCT00952705|365478748|FG001|Overall Study|Death|0|||
105948941|NCT00952705|365478749|FG002|Overall Study|Death|0|||
105948942|NCT00952705|365478747|FG000|Overall Study|Incarcerated post dose|5|||
105948943|NCT00952705|365478748|FG001|Overall Study|Incarcerated post dose|0|||
105948944|NCT00952705|365478749|FG002|Overall Study|Incarcerated post dose|0|||
105948945|NCT00952705|365478747|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
105948946|NCT00952705|365478748|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
105948947|NCT00952705|365478749|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
105948948|NCT02276040|365478751|FG000|Overall Study|Physician Decision|15|||
105948949|NCT03545672|365478759|FG000|Overall Study|Uncertain diagnosis|2|||
105948950|NCT03545672|365478760|FG001|Overall Study|Uncertain diagnosis|1|||
105948951|NCT03545672|365478759|FG000|Overall Study|Protocol Violation|2|||
105948952|NCT03545672|365478760|FG001|Overall Study|Protocol Violation|2|||
105948953|NCT01628913|365478761|FG000|Overall Study|Adverse Event|12|||
105948954|NCT01628913|365478762|FG001|Overall Study|Adverse Event|5|||
105948955|NCT01628913|365478761|FG000|Overall Study|Disease Progression|11|||
105948956|NCT01628913|365478762|FG001|Overall Study|Disease Progression|14|||
105948957|NCT01628913|365478761|FG000|Overall Study|Protocol Violation|1|||
105948958|NCT01628913|365478762|FG001|Overall Study|Protocol Violation|0|||
105948959|NCT01628913|365478761|FG000|Overall Study|Death|1|||
105948960|NCT01628913|365478762|FG001|Overall Study|Death|0|||
105948961|NCT01628913|365478761|FG000|Overall Study|study terminated by Sponsor|4|||
105948962|NCT01628913|365478762|FG001|Overall Study|study terminated by Sponsor|9|||
105948963|NCT01628913|365478761|FG000|Overall Study|Withdrawal by Subject|1|||
105948964|NCT01628913|365478762|FG001|Overall Study|Withdrawal by Subject|0|||
105948965|NCT01628913|365478761|FG000|Overall Study|Physician Decision|1|||
105948966|NCT01628913|365478762|FG001|Overall Study|Physician Decision|3|||
105948967|NCT02415556|365478766|FG000|Overall Study|Adverse Event|3|||
105948968|NCT02415556|365478767|FG001|Overall Study|Adverse Event|4|||
105948969|NCT02415556|365478768|FG002|Overall Study|Adverse Event|2|||
105948970|NCT02415556|365478769|FG003|Overall Study|Adverse Event|4|||
105802090|NCT03705169|364930714|FG001|Overall Study|Concerns about study visit compliance|0|||
105802091|NCT03705169|364930715|FG002|Overall Study|Concerns about study visit compliance|0|||
105802092|NCT03705169|364930716|FG003|Overall Study|Concerns about study visit compliance|1|||
105802093|NCT03705169|364930717|FG004|Overall Study|Concerns about study visit compliance|0|||
105802094|NCT03705169|364930718|FG005|Overall Study|Concerns about study visit compliance|0|||
105802095|NCT03705169|364930719|FG006|Overall Study|Concerns about study visit compliance|0|||
105802096|NCT03705169|364930720|FG007|Overall Study|Concerns about study visit compliance|0|||
105802097|NCT03705169|364930721|FG008|Overall Study|Concerns about study visit compliance|0|||
105802098|NCT03705169|364930722|FG009|Overall Study|Concerns about study visit compliance|0|||
105802099|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
105802100|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
105802101|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
105802102|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
105802103|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
105802104|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
105948971|NCT02415556|365478766|FG000|Overall Study|Lost to Follow-up|4|||
105948972|NCT02415556|365478767|FG001|Overall Study|Lost to Follow-up|5|||
105948973|NCT02415556|365478768|FG002|Overall Study|Lost to Follow-up|4|||
105948974|NCT02415556|365478769|FG003|Overall Study|Lost to Follow-up|1|||
106016480|NCT04033445|365724452|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
106016481|NCT04033445|365724453|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105948975|NCT02415556|365478766|FG000|Overall Study|Withdrawal by Subject|13|||
105948976|NCT02415556|365478767|FG001|Overall Study|Withdrawal by Subject|4|||
105753665|NCT03334396|364750228|FG003|Overall Study|Withdrawal by Subject|2|||
105753666|NCT03334396|364750229|FG004|Overall Study|Withdrawal by Subject|2|||
105753667|NCT03334396|364750230|FG005|Overall Study|Withdrawal by Subject|1|||
105753668|NCT03334396|364750231|FG006|Overall Study|Withdrawal by Subject|2|||
105948977|NCT02415556|365478768|FG002|Overall Study|Withdrawal by Subject|14|||
105948978|NCT02415556|365478769|FG003|Overall Study|Withdrawal by Subject|12|||
105948979|NCT02415556|365478766|FG000|Overall Study|Physician Decision|1|||
105948980|NCT02415556|365478767|FG001|Overall Study|Physician Decision|3|||
105948981|NCT02415556|365478768|FG002|Overall Study|Physician Decision|1|||
105948982|NCT02415556|365478769|FG003|Overall Study|Physician Decision|2|||
105948983|NCT02415556|365478766|FG000|Overall Study|Censored - study completion|4|||
105753669|NCT03334396|364750232|FG007|Overall Study|Withdrawal by Subject|0|||
105753670|NCT03334396|364750225|FG000|Overall Study|Pregnancy|0|||
105753671|NCT03334396|364750226|FG001|Overall Study|Pregnancy|1|||
105753672|NCT03334396|364750227|FG002|Overall Study|Pregnancy|0|||
105753673|NCT03334396|364750228|FG003|Overall Study|Pregnancy|0|||
105753674|NCT03334396|364750229|FG004|Overall Study|Pregnancy|0|||
105753675|NCT03334396|364750230|FG005|Overall Study|Pregnancy|0|||
105753676|NCT03334396|364750231|FG006|Overall Study|Pregnancy|0|||
105753677|NCT03334396|364750232|FG007|Overall Study|Pregnancy|0|||
105948984|NCT02415556|365478767|FG001|Overall Study|Censored - study completion|5|||
105948985|NCT02415556|365478768|FG002|Overall Study|Censored - study completion|1|||
105948986|NCT02415556|365478769|FG003|Overall Study|Censored - study completion|0|||
105948987|NCT02415556|365478766|FG000|Overall Study|Family-related issues|0|||
105948988|NCT02415556|365478767|FG001|Overall Study|Family-related issues|0|||
105948989|NCT02415556|365478768|FG002|Overall Study|Family-related issues|0|||
105948990|NCT02415556|365478769|FG003|Overall Study|Family-related issues|1|||
105948991|NCT00105534|365478770|FG000|Overall Study|Adverse Event|2|||
105948992|NCT00105534|365478771|FG001|Overall Study|Adverse Event|5|||
105948993|NCT00105534|365478770|FG000|Overall Study|Protocol Violation|1|||
105948994|NCT00105534|365478771|FG001|Overall Study|Protocol Violation|4|||
105948995|NCT00105534|365478770|FG000|Overall Study|Withdrawal by Subject|6|||
105948996|NCT00105534|365478771|FG001|Overall Study|Withdrawal by Subject|6|||
105948997|NCT00105534|365478770|FG000|Overall Study|Lost to Follow-up|5|||
105948998|NCT00105534|365478771|FG001|Overall Study|Lost to Follow-up|1|||
105948999|NCT00105534|365478770|FG000|Overall Study|Lack of Efficacy|7|||
105949000|NCT00105534|365478771|FG001|Overall Study|Lack of Efficacy|15|||
105949001|NCT00105534|365478770|FG000|Overall Study|Treatment unmasked|1|||
105949002|NCT00105534|365478771|FG001|Overall Study|Treatment unmasked|0|||
105949003|NCT00105534|365478770|FG000|Overall Study|Other Reason|0|||
105949004|NCT00105534|365478771|FG001|Overall Study|Other Reason|2|||
105949005|NCT01944020|365478772|FG000|Overall Study|Withdrawal by Subject|5|||
105949006|NCT01944020|365478773|FG001|Overall Study|Withdrawal by Subject|0|||
105949007|NCT03423602|365478778|FG000|Overall Study|Death|1|||
105949008|NCT03423602|365478778|FG000|Overall Study|Lost to Follow-up|6|||
105949009|NCT03423602|365478778|FG000|Overall Study|Protocol Violation|1|||
105949010|NCT03423602|365478778|FG000|Overall Study|Withdrawal by Subject|4|||
105949011|NCT00560508|365478779|FG000|12 Week Double-blind Period|Adverse Event|3|||
105753678|NCT03334396|364750225|FG000|Overall Study|Ineligible|0|||
105753679|NCT03334396|364750226|FG001|Overall Study|Ineligible|1|||
105753680|NCT03334396|364750227|FG002|Overall Study|Ineligible|0|||
105753681|NCT03334396|364750228|FG003|Overall Study|Ineligible|0|||
105753682|NCT03334396|364750229|FG004|Overall Study|Ineligible|0|||
105753683|NCT03334396|364750230|FG005|Overall Study|Ineligible|0|||
105753684|NCT03334396|364750231|FG006|Overall Study|Ineligible|0|||
105753685|NCT03334396|364750232|FG007|Overall Study|Ineligible|0|||
105753686|NCT03334396|364750225|FG000|Overall Study|Started New Job|1|||
105753687|NCT03334396|364750226|FG001|Overall Study|Started New Job|0|||
105753688|NCT03334396|364750227|FG002|Overall Study|Started New Job|0|||
105753689|NCT03334396|364750228|FG003|Overall Study|Started New Job|0|||
105753690|NCT03334396|364750229|FG004|Overall Study|Started New Job|0|||
105753691|NCT03334396|364750230|FG005|Overall Study|Started New Job|0|||
105753692|NCT03334396|364750231|FG006|Overall Study|Started New Job|0|||
105753693|NCT03334396|364750232|FG007|Overall Study|Started New Job|0|||
105753694|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
105753695|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
105753696|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
105753697|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
105753698|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
105753699|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
105753700|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
105753701|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
105753702|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
105753703|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
105753704|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
105753705|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
105753706|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
105753707|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
105949012|NCT00560508|365478780|FG001|12 Week Double-blind Period|Adverse Event|2|||
105949013|NCT00560508|365478779|FG000|12 Week Double-blind Period|Protocol Violation|1|||
105949014|NCT00560508|365478780|FG001|12 Week Double-blind Period|Protocol Violation|0|||
105949015|NCT00560508|365478779|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
105949016|NCT00560508|365478780|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
105949017|NCT00560508|365478779|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
105753708|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
105753709|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
105753710|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Missing|3|||
105753711|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Missing|1|||
105753712|NCT00838916|364750233|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
105753713|NCT00838916|364750234|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
105753714|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
105753715|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
105753716|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
105753717|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
105753718|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
105753719|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
105753720|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
105753721|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
105753722|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
105753723|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
105753724|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
105753725|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
105753726|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
105753727|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
105753728|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
105753729|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
105753730|NCT00838916|364750233|FG000|Follow-up Period (8 Weeks)|Missing|3|||
105753731|NCT00838916|364750234|FG001|Follow-up Period (8 Weeks)|Missing|0|||
105753732|NCT01969799|364750235|FG000|Overall Study|Adverse Event|0|||
105753733|NCT01969799|364750236|FG001|Overall Study|Adverse Event|1|||
105753734|NCT01969799|364750235|FG000|Overall Study|Death|16|||
105753735|NCT01969799|364750236|FG001|Overall Study|Death|11|||
105753736|NCT01969799|364750235|FG000|Overall Study|Lost to Follow-up|0|||
105753737|NCT01969799|364750236|FG001|Overall Study|Lost to Follow-up|2|||
105753738|NCT01969799|364750235|FG000|Overall Study|Physician Decision|1|||
105753739|NCT01969799|364750236|FG001|Overall Study|Physician Decision|0|||
105753740|NCT02927873|364750237|FG000|Overall Study|Lost to Follow-up|0|||
105753741|NCT02927873|364750238|FG001|Overall Study|Lost to Follow-up|1|||
105753742|NCT02927873|364750239|FG002|Overall Study|Lost to Follow-up|0|||
105753743|NCT02927873|364750240|FG003|Overall Study|Lost to Follow-up|0|||
105753744|NCT02927873|364750241|FG004|Overall Study|Lost to Follow-up|0|||
105753745|NCT02927873|364750242|FG005|Overall Study|Lost to Follow-up|0|||
105753746|NCT02927873|364750237|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753747|NCT02927873|364750238|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
105753748|NCT02927873|364750239|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753749|NCT02927873|364750240|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753750|NCT02927873|364750241|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753751|NCT02927873|364750242|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105753752|NCT02927873|364750237|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753753|NCT02927873|364750238|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753754|NCT02927873|364750239|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753755|NCT02927873|364750240|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753756|NCT02927873|364750241|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753757|NCT02927873|364750242|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105753758|NCT02927873|364750237|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753759|NCT02927873|364750238|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
105753760|NCT02927873|364750239|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753761|NCT02927873|364750240|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753762|NCT02927873|364750241|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753763|NCT02927873|364750242|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
105753764|NCT02927873|364750237|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
105753765|NCT02927873|364750238|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753766|NCT02927873|364750239|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753767|NCT02927873|364750240|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753768|NCT02927873|364750241|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753769|NCT02927873|364750242|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
105753770|NCT02927873|364750237|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
105753771|NCT02927873|364750238|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105753772|NCT02927873|364750239|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105753773|NCT02927873|364750240|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105753774|NCT02927873|364750241|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105753775|NCT02927873|364750242|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
105802105|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
105802106|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
105802107|NCT00185211|364930723|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
105802108|NCT00185211|364930724|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
105802109|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
105802110|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
105802111|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
105949018|NCT00560508|365478780|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
105802112|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
105802113|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
105802114|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
105802115|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
105802116|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
105949019|NCT00560508|365478779|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
105949020|NCT00560508|365478780|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
105802117|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
105802118|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
105753776|NCT02034474|364750243|FG000|Overall Study|Adverse Event|3|||
105949021|NCT00560508|365478779|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
105949022|NCT00560508|365478780|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
105949023|NCT00560508|365478779|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
105949024|NCT00560508|365478780|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
105949025|NCT01192126|365478781|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
105949026|NCT01192126|365478782|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
105949027|NCT01192126|365478781|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
105949028|NCT01192126|365478782|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
105753777|NCT02034474|364750244|FG001|Overall Study|Adverse Event|2|||
105753778|NCT02034474|364750243|FG000|Overall Study|Withdrawal by Subject|1|||
105753779|NCT02034474|364750244|FG001|Overall Study|Withdrawal by Subject|2|||
105753780|NCT01391819|364750250|FG000|Overall Study|Withdrawal by Subject|56|||
105753781|NCT01391819|364750250|FG000|Overall Study|Migrated/moved from study area|82|||
105753782|NCT01391819|364750250|FG000|Overall Study|Lost to Follow-up|252|||
105753783|NCT01391819|364750250|FG000|Overall Study|Death|3|||
105753784|NCT01391819|364750250|FG000|Overall Study|Other|9|||
105753785|NCT03629041|364750251|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
105753786|NCT03629041|364750252|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
105753787|NCT03629041|364750253|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
105753788|NCT03629041|364750254|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
105753789|NCT00393913|364750256|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
105753790|NCT00393913|364750256|FG000|Initial Assessment|Withdrawal by Subject|16|||
105753791|NCT00393913|364750256|FG000|CPAP|Withdrawal by Subject|3|||
105753792|NCT00393913|364750256|FG000|CPAP|Physician Decision|1|||
105753793|NCT00393913|364750256|FG000|CPAP|TEchnical problem with CPAP|3|||
105753794|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
105753795|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
105753796|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
105753797|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
105753798|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
105753799|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
105753800|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
105753801|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
105753802|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
105753803|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
105753804|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
105753805|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
105802119|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
105949029|NCT03257358|365478783|FG000|Overall Study|Adverse Event|25|||
105949030|NCT03257358|365478784|FG001|Overall Study|Adverse Event|12|||
105949031|NCT03257358|365478783|FG000|Overall Study|Lack of Efficacy|1|||
105949032|NCT03257358|365478784|FG001|Overall Study|Lack of Efficacy|1|||
105949033|NCT03257358|365478783|FG000|Overall Study|Lost to Follow-up|12|||
105949034|NCT03257358|365478784|FG001|Overall Study|Lost to Follow-up|4|||
105949035|NCT03257358|365478783|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
105949036|NCT03257358|365478784|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
105949037|NCT03257358|365478783|FG000|Overall Study|Physician Decision|2|||
105949038|NCT03257358|365478784|FG001|Overall Study|Physician Decision|2|||
105949039|NCT03257358|365478783|FG000|Overall Study|Protocol Violation|5|||
105949040|NCT03257358|365478784|FG001|Overall Study|Protocol Violation|3|||
105949041|NCT03257358|365478783|FG000|Overall Study|Technical problems|4|||
105949042|NCT03257358|365478784|FG001|Overall Study|Technical problems|1|||
105949043|NCT03257358|365478783|FG000|Overall Study|Withdrawal by Subject|8|||
105949044|NCT03257358|365478784|FG001|Overall Study|Withdrawal by Subject|3|||
105949045|NCT03257358|365478783|FG000|Overall Study|Withdrawal of informed consent|9|||
105949046|NCT03257358|365478784|FG001|Overall Study|Withdrawal of informed consent|5|||
105949047|NCT03257358|365478783|FG000|Overall Study|New therapy for study indication|1|||
105949048|NCT03257358|365478784|FG001|Overall Study|New therapy for study indication|0|||
105949049|NCT03257358|365478783|FG000|Overall Study|No longer requires treatment|0|||
105949050|NCT03257358|365478784|FG001|Overall Study|No longer requires treatment|1|||
105949051|NCT01114737|365478785|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
105753806|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
105753807|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
105753808|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
105753809|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
105753810|NCT03488251|364750257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
105753811|NCT03488251|364750258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
105753812|NCT03488251|364750259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
105753813|NCT03488251|364750260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
105753814|NCT00178464|364750263|FG000|Overall Study|Withdrawal by Subject|1|||
105753815|NCT00178464|364750263|FG000|Overall Study|Physician Decision|1|||
105753816|NCT00870818|364750264|FG000|Overall Study|Lost to Follow-up|3|||
105753817|NCT00870818|364750265|FG001|Overall Study|Lost to Follow-up|2|||
105753818|NCT00870818|364750266|FG002|Overall Study|Lost to Follow-up|1|||
105753819|NCT00870818|364750267|FG003|Overall Study|Lost to Follow-up|0|||
105753820|NCT00870818|364750268|FG004|Overall Study|Lost to Follow-up|0|||
105753821|NCT00870818|364750264|FG000|Overall Study|Withdrawal by Subject|0|||
105753822|NCT00870818|364750265|FG001|Overall Study|Withdrawal by Subject|0|||
105753823|NCT00870818|364750266|FG002|Overall Study|Withdrawal by Subject|1|||
105753824|NCT00870818|364750267|FG003|Overall Study|Withdrawal by Subject|2|||
105753825|NCT00870818|364750268|FG004|Overall Study|Withdrawal by Subject|0|||
105753826|NCT00870818|364750264|FG000|Overall Study|Terminated by sponsor|29|||
105753827|NCT00870818|364750265|FG001|Overall Study|Terminated by sponsor|70|||
105753828|NCT00870818|364750266|FG002|Overall Study|Terminated by sponsor|36|||
105753829|NCT00870818|364750267|FG003|Overall Study|Terminated by sponsor|36|||
105753830|NCT00870818|364750268|FG004|Overall Study|Terminated by sponsor|38|||
105753831|NCT00870818|364750264|FG000|Overall Study|Other|0|||
105753832|NCT00870818|364750265|FG001|Overall Study|Other|1|||
105753833|NCT00870818|364750266|FG002|Overall Study|Other|0|||
105753834|NCT00870818|364750267|FG003|Overall Study|Other|0|||
105753835|NCT00870818|364750268|FG004|Overall Study|Other|0|||
105753836|NCT00995670|364750269|FG000|Overall Study|Failed arterial cannulation|1|||
105753837|NCT00995670|364750270|FG001|Overall Study|Failed arterial cannulation|0|||
105753838|NCT00995670|364750271|FG002|Overall Study|Failed arterial cannulation|3|||
105753839|NCT02227108|364750272|FG000|Overall Study|Did not receive treatment|2|||
105753840|NCT02227108|364750272|FG000|Overall Study|Other|3|||
105753841|NCT02227108|364750272|FG000|Overall Study|Progressive disease|17|||
105753842|NCT02227108|364750272|FG000|Overall Study|Initiation of alternative therapy|2|||
105753843|NCT02227108|364750272|FG000|Overall Study|Investigator discretion|1|||
105753844|NCT02227108|364750272|FG000|Overall Study|Adverse Event|6|||
105753845|NCT02486952|364750273|FG000|Overall Study|Not Started Induction Therapy|3|||
105753846|NCT02486952|364750273|FG000|Overall Study|Adverse Event|1|||
105753847|NCT02486952|364750273|FG000|Overall Study|Death|15|||
105753848|NCT02486952|364750273|FG000|Overall Study|Lack of Efficacy|3|||
105753849|NCT02486952|364750273|FG000|Overall Study|Lost to Follow-up|26|||
105753850|NCT02486952|364750273|FG000|Overall Study|Other|2|||
105753851|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
105753852|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
105753853|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
105753854|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
105949052|NCT01114737|365478786|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
105949053|NCT01114737|365478785|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
105949054|NCT01114737|365478786|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
105802120|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
105802121|NCT00185211|364930723|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
105949055|NCT01114737|365478785|FG000|Randomized Treatment Period|Pregnancy|1|||
105949056|NCT01114737|365478786|FG001|Randomized Treatment Period|Pregnancy|0|||
105949057|NCT01114737|365478785|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
105949058|NCT01114737|365478786|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
105949059|NCT01114737|365478785|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
105949060|NCT01114737|365478786|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
105802122|NCT00185211|364930724|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
105802123|NCT00382291|364932520|FG000|Overall Study|Adverse Event|1|||
105802124|NCT00382291|364932521|FG001|Overall Study|Adverse Event|2|||
105802125|NCT00382291|364932522|FG002|Overall Study|Adverse Event|2|||
105949061|NCT01114737|365478785|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
105802126|NCT00382291|364932520|FG000|Overall Study|Protocol Violation|1|||
105949062|NCT01114737|365478786|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
105949063|NCT00329030|365478787|FG000|Overall Study|Withdrawal by Subject|1|||
105753855|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
105753856|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
105753857|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
105753858|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
105753859|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
105753860|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
105753861|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
105753862|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
105753863|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
105753864|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
105753865|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
105753866|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
105753867|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
105753868|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
105753869|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
105753870|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
105753871|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
105753872|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
105753873|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
105753874|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
105753875|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
105753876|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
105753877|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
105753878|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
105753879|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
105753880|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
105753881|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
105753882|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
105753883|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
105753884|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
105753885|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
105753886|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
105753887|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
105753888|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
105753889|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
105753890|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
105753891|NCT00383721|364750274|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
105753892|NCT00383721|364750275|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
105753893|NCT00383721|364750276|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
105753894|NCT00383721|364750277|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
105753895|NCT00383721|364750278|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
105753896|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
105753897|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
105753898|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
105753899|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
105753900|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
105753901|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
105753902|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
105753903|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
105753904|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
105753905|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
105753906|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
105753907|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
105949064|NCT00329030|365478788|FG001|Overall Study|Withdrawal by Subject|3|||
105753908|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
105753909|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
105753910|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
105753911|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
105753912|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
105802127|NCT00382291|364932521|FG001|Overall Study|Protocol Violation|0|||
105949065|NCT00329030|365478787|FG000|Overall Study|Progressive Disease|6|||
105949066|NCT00329030|365478788|FG001|Overall Study|Progressive Disease|2|||
105802128|NCT00382291|364932522|FG002|Overall Study|Protocol Violation|0|||
105802129|NCT00382291|364932520|FG000|Overall Study|Temporary study suspension|2|||
105949067|NCT00329030|365478787|FG000|Overall Study|Ineligible Pathology|1|||
105949068|NCT00329030|365478788|FG001|Overall Study|Ineligible Pathology|1|||
105949069|NCT02286895|365478789|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
105949070|NCT02286895|365478790|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
105949071|NCT02286895|365478789|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
105949072|NCT02286895|365478790|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
105949073|NCT02286895|365478789|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
105949074|NCT02286895|365478790|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
105949075|NCT00305448|365478791|FG000|Overall Study|Protocol Violation|0|||
105949076|NCT00305448|365478792|FG001|Overall Study|Protocol Violation|1|||
105949077|NCT00305448|365478793|FG002|Overall Study|Protocol Violation|0|||
105949078|NCT00305448|365478791|FG000|Overall Study|Withdrawal by Subject|2|||
105949079|NCT00305448|365478792|FG001|Overall Study|Withdrawal by Subject|0|||
105949080|NCT00305448|365478793|FG002|Overall Study|Withdrawal by Subject|1|||
105949081|NCT00305448|365478791|FG000|Overall Study|Adverse Event|1|||
105949082|NCT00305448|365478792|FG001|Overall Study|Adverse Event|0|||
105949083|NCT00305448|365478793|FG002|Overall Study|Adverse Event|1|||
105949084|NCT00305448|365478791|FG000|Overall Study|Disease Progression|27|||
105949085|NCT00305448|365478792|FG001|Overall Study|Disease Progression|31|||
105949086|NCT00305448|365478793|FG002|Overall Study|Disease Progression|28|||
105949087|NCT00305448|365478791|FG000|Overall Study|Subjective Disease Progression|1|||
105949088|NCT00305448|365478792|FG001|Overall Study|Subjective Disease Progression|2|||
105949089|NCT00305448|365478793|FG002|Overall Study|Subjective Disease Progression|2|||
105949090|NCT00305448|365478791|FG000|Overall Study|Tumor Marker Elevation|0|||
105949091|NCT00305448|365478792|FG001|Overall Study|Tumor Marker Elevation|0|||
105949092|NCT00305448|365478793|FG002|Overall Study|Tumor Marker Elevation|1|||
105949093|NCT00002766|365478794|FG000|Overall Study|Withdrawal by Subject|0|||
105949094|NCT00002766|365478795|FG001|Overall Study|Withdrawal by Subject|1|||
105949095|NCT00002766|365478794|FG000|Overall Study|Patient Not Treated|1|||
105949096|NCT00002766|365478795|FG001|Overall Study|Patient Not Treated|2|||
105949097|NCT00002766|365478794|FG000|Overall Study|Adverse Event|1|||
105949098|NCT00002766|365478795|FG001|Overall Study|Adverse Event|1|||
105949099|NCT00002766|365478794|FG000|Overall Study|Protocol Violation|1|||
105949100|NCT00002766|365478795|FG001|Overall Study|Protocol Violation|0|||
105949101|NCT00783432|365478796|FG000|Overall Study|Adverse Event|22|||
105949102|NCT00783432|365478797|FG001|Overall Study|Adverse Event|17|||
105949103|NCT00783432|365478796|FG000|Overall Study|Lack of Efficacy|20|||
105949104|NCT00783432|365478797|FG001|Overall Study|Lack of Efficacy|21|||
105949105|NCT00783432|365478796|FG000|Overall Study|Lost to Follow-up|11|||
105949106|NCT00783432|365478797|FG001|Overall Study|Lost to Follow-up|6|||
105949107|NCT00783432|365478796|FG000|Overall Study|Withdrawal by Subject|23|||
105949108|NCT00783432|365478797|FG001|Overall Study|Withdrawal by Subject|20|||
105949109|NCT00783432|365478796|FG000|Overall Study|subject moved|3|||
106016482|NCT04033445|365724454|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
105802130|NCT00382291|364932521|FG001|Overall Study|Temporary study suspension|2|||
105802131|NCT00382291|364932522|FG002|Overall Study|Temporary study suspension|5|||
105802132|NCT00382291|364932520|FG000|Overall Study|Withdrawal by Subject|0|||
105802133|NCT00382291|364932521|FG001|Overall Study|Withdrawal by Subject|2|||
105802134|NCT00382291|364932522|FG002|Overall Study|Withdrawal by Subject|0|||
105802135|NCT00382291|364932520|FG000|Overall Study|Physician Decision|0|||
105802136|NCT00382291|364932521|FG001|Overall Study|Physician Decision|1|||
105802137|NCT00382291|364932522|FG002|Overall Study|Physician Decision|0|||
105802138|NCT00382291|364932520|FG000|Overall Study|Lack of Efficacy|0|||
105802139|NCT00382291|364932521|FG001|Overall Study|Lack of Efficacy|0|||
105802140|NCT00382291|364932522|FG002|Overall Study|Lack of Efficacy|1|||
105802141|NCT01375010|364932523|FG000|Overall Study|Lost to Follow-up|8|||
105802142|NCT01375010|364932524|FG001|Overall Study|Lost to Follow-up|2|||
105802143|NCT01375010|364932523|FG000|Overall Study|Withdrawal by Subject|4|||
105802144|NCT01375010|364932524|FG001|Overall Study|Withdrawal by Subject|2|||
105802145|NCT02266706|364932525|FG000|Overall Study|Withdrawal by Subject|0|||
105949110|NCT00783432|365478797|FG001|Overall Study|subject moved|5|||
105949111|NCT00783432|365478796|FG000|Overall Study|Protocol Violation|6|||
105949112|NCT00783432|365478797|FG001|Overall Study|Protocol Violation|9|||
105949113|NCT01119287|365478798|FG000|Overall Study|Patient Decision, not related to AE|0|||
105802146|NCT02266706|364932526|FG001|Overall Study|Withdrawal by Subject|1|||
105802147|NCT02266706|364932527|FG002|Overall Study|Withdrawal by Subject|1|||
105802148|NCT02266706|364932528|FG003|Overall Study|Withdrawal by Subject|0|||
105802149|NCT02266706|364932529|FG004|Overall Study|Withdrawal by Subject|0|||
105949114|NCT01119287|365478799|FG001|Overall Study|Patient Decision, not related to AE|0|||
105949115|NCT01119287|365478800|FG002|Overall Study|Patient Decision, not related to AE|2|||
105949116|NCT01119287|365478801|FG003|Overall Study|Patient Decision, not related to AE|2|||
105753913|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
105753914|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
105753915|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
105753916|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105753917|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105753918|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105753919|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
105753920|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
105753921|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
105753922|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
105753923|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
105753924|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
105753925|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
105753926|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
105753927|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
105753928|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
105753929|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
105753930|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
105753931|NCT00383721|364750274|FG000|26-Week Treatment Safety Extension|Administrative|1|||
105753932|NCT00383721|364750275|FG001|26-Week Treatment Safety Extension|Administrative|2|||
105753933|NCT00383721|364750276|FG002|26-Week Treatment Safety Extension|Administrative|3|||
105753934|NCT00383721|364750277|FG003|26-Week Treatment Safety Extension|Administrative|1|||
105753935|NCT00383721|364750278|FG004|26-Week Treatment Safety Extension|Administrative|0|||
105753936|NCT03814590|364750279|FG000|Overall Study|Adverse Event|0|||
105753937|NCT03814590|364750280|FG001|Overall Study|Adverse Event|0|||
105753938|NCT03814590|364750281|FG002|Overall Study|Adverse Event|0|||
105753939|NCT03814590|364750282|FG003|Overall Study|Adverse Event|0|||
105753940|NCT03814590|364750283|FG004|Overall Study|Adverse Event|0|||
105753941|NCT03814590|364750284|FG005|Overall Study|Adverse Event|1|||
105753942|NCT03814590|364750285|FG006|Overall Study|Adverse Event|1|||
105753943|NCT03814590|364750286|FG007|Overall Study|Adverse Event|1|||
105753944|NCT03814590|364750287|FG008|Overall Study|Adverse Event|0|||
105753945|NCT03814590|364750288|FG009|Overall Study|Adverse Event|0|||
105753946|NCT03814590|364750289|FG010|Overall Study|Adverse Event|1|||
105753947|NCT03814590|364750290|FG011|Overall Study|Adverse Event|0|||
105753948|NCT03814590|364750291|FG012|Overall Study|Adverse Event|3|||
105753949|NCT03814590|364750292|FG013|Overall Study|Adverse Event|0|||
105753950|NCT03814590|364750279|FG000|Overall Study|Lost to Follow-up|0|||
105753951|NCT03814590|364750280|FG001|Overall Study|Lost to Follow-up|2|||
105753952|NCT03814590|364750281|FG002|Overall Study|Lost to Follow-up|1|||
105753953|NCT03814590|364750282|FG003|Overall Study|Lost to Follow-up|0|||
105753954|NCT03814590|364750283|FG004|Overall Study|Lost to Follow-up|1|||
105753955|NCT03814590|364750284|FG005|Overall Study|Lost to Follow-up|1|||
105753956|NCT03814590|364750285|FG006|Overall Study|Lost to Follow-up|1|||
105753957|NCT03814590|364750286|FG007|Overall Study|Lost to Follow-up|1|||
105753958|NCT03814590|364750287|FG008|Overall Study|Lost to Follow-up|0|||
105753959|NCT03814590|364750288|FG009|Overall Study|Lost to Follow-up|0|||
105753960|NCT03814590|364750289|FG010|Overall Study|Lost to Follow-up|1|||
105753961|NCT03814590|364750290|FG011|Overall Study|Lost to Follow-up|0|||
105753962|NCT03814590|364750291|FG012|Overall Study|Lost to Follow-up|0|||
105753963|NCT03814590|364750292|FG013|Overall Study|Lost to Follow-up|1|||
105753964|NCT03814590|364750279|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753965|NCT03814590|364750280|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753966|NCT03814590|364750281|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753967|NCT03814590|364750282|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753968|NCT03814590|364750283|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753969|NCT03814590|364750284|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753970|NCT03814590|364750285|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753971|NCT03814590|364750286|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753972|NCT03814590|364750287|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753973|NCT03814590|364750288|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
105753974|NCT03814590|364750289|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753975|NCT03814590|364750290|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753976|NCT03814590|364750291|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753977|NCT03814590|364750292|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
105753978|NCT03814590|364750279|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105760901|NCT01342952|364778054|FG002|Overall Study|Lost to Follow-up|0|||
105802150|NCT02266706|364932530|FG005|Overall Study|Withdrawal by Subject|1|||
105802151|NCT02266706|364932531|FG006|Overall Study|Withdrawal by Subject|0|||
105802152|NCT02266706|364932532|FG007|Overall Study|Withdrawal by Subject|0|||
105802153|NCT02266706|364932533|FG008|Overall Study|Withdrawal by Subject|0|||
105802154|NCT02266706|364932525|FG000|Overall Study|Screen failure|0|||
105802155|NCT02266706|364932526|FG001|Overall Study|Screen failure|0|||
105802156|NCT02266706|364932527|FG002|Overall Study|Screen failure|0|||
105802157|NCT02266706|364932528|FG003|Overall Study|Screen failure|0|||
105802158|NCT02266706|364932529|FG004|Overall Study|Screen failure|0|||
105802159|NCT02266706|364932530|FG005|Overall Study|Screen failure|1|||
105802160|NCT02266706|364932531|FG006|Overall Study|Screen failure|1|||
105802161|NCT02266706|364932532|FG007|Overall Study|Screen failure|0|||
105802162|NCT02266706|364932533|FG008|Overall Study|Screen failure|0|||
105802163|NCT02266706|364932525|FG000|Overall Study|Enrollment in another study|0|||
105802164|NCT02266706|364932526|FG001|Overall Study|Enrollment in another study|0|||
105802165|NCT02266706|364932527|FG002|Overall Study|Enrollment in another study|0|||
105802166|NCT02266706|364932528|FG003|Overall Study|Enrollment in another study|1|||
105949117|NCT01119287|365478802|FG004|Overall Study|Patient Decision, not related to AE|1|||
105949118|NCT01119287|365478803|FG005|Overall Study|Patient Decision, not related to AE|0|||
105949119|NCT00945659|365478806|FG000|Overall Study|Lost to Follow-up|7|||
105949120|NCT00945659|365478807|FG001|Overall Study|Lost to Follow-up|20|||
105949121|NCT00945659|365478808|FG002|Overall Study|Lost to Follow-up|17|||
105949122|NCT04661033|365478809|FG000|Overall Study|Adverse Event|0|||
105949123|NCT04661033|365478810|FG001|Overall Study|Adverse Event|0|||
105949124|NCT04661033|365478811|FG002|Overall Study|Adverse Event|1|||
105949125|NCT04661033|365478812|FG003|Overall Study|Adverse Event|0|||
105949126|NCT04661033|365478809|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
105949127|NCT04661033|365478810|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
105949128|NCT04661033|365478811|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
105949129|NCT04661033|365478812|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
105949130|NCT04661033|365478809|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
105949131|NCT04661033|365478810|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
105949132|NCT04661033|365478811|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
105949133|NCT04661033|365478812|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
105949134|NCT04661033|365478809|FG000|Overall Study|Early discontinuation as per PI|1|||
105949135|NCT04661033|365478810|FG001|Overall Study|Early discontinuation as per PI|0|||
105949136|NCT04661033|365478811|FG002|Overall Study|Early discontinuation as per PI|0|||
105949137|NCT04661033|365478812|FG003|Overall Study|Early discontinuation as per PI|0|||
105949138|NCT00448448|365478813|FG000|Overall Study|Withdrawal by Subject|13|||
105949139|NCT00448448|365478814|FG001|Overall Study|Withdrawal by Subject|2|||
105949140|NCT00448448|365478813|FG000|Overall Study|On protocol when study ended|83|||
105949141|NCT00448448|365478814|FG001|Overall Study|On protocol when study ended|36|||
105949142|NCT00448448|365478813|FG000|Overall Study|Lost to Follow-up|2|||
105949143|NCT00448448|365478814|FG001|Overall Study|Lost to Follow-up|1|||
105949144|NCT00448448|365478813|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
105949145|NCT00448448|365478814|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
105949146|NCT00448448|365478813|FG000|Overall Study|Signed consent lost|0|||
105949147|NCT00448448|365478814|FG001|Overall Study|Signed consent lost|1|||
105949148|NCT02284191|365478815|FG000|Overall Study|Withdrawal by Subject|1|||
105949149|NCT02284191|365478816|FG001|Overall Study|Withdrawal by Subject|3|||
105949150|NCT02284191|365478815|FG000|Overall Study|Lost to Follow-up|1|||
105949151|NCT02284191|365478816|FG001|Overall Study|Lost to Follow-up|0|||
105949152|NCT02257684|365478817|FG000|Overall Study|Adverse Event|2|||
105949153|NCT02257684|365478817|FG000|Overall Study|Lack of Efficacy|1|||
105949154|NCT02257684|365478817|FG000|Overall Study|Sponsor's Decision|1|||
105949155|NCT01876381|365478821|FG000|Overall Study|Lack of Efficacy|5|||
105760902|NCT01342952|364778055|FG003|Overall Study|Lost to Follow-up|0|||
105760903|NCT01342952|364778052|FG000|Overall Study|Withdrawal by Subject|1|||
105760904|NCT01342952|364778053|FG001|Overall Study|Withdrawal by Subject|1|||
105760905|NCT01342952|364778054|FG002|Overall Study|Withdrawal by Subject|0|||
105760906|NCT01342952|364778055|FG003|Overall Study|Withdrawal by Subject|0|||
105760907|NCT01342952|364778052|FG000|Overall Study|Physician Decision|3|||
105760908|NCT01342952|364778053|FG001|Overall Study|Physician Decision|3|||
105760909|NCT01342952|364778054|FG002|Overall Study|Physician Decision|1|||
105760910|NCT01342952|364778055|FG003|Overall Study|Physician Decision|0|||
105760911|NCT02156804|364778056|FG000|Overall Study|Withdrawal by Subject|1|||
105760912|NCT00294684|364778061|FG000|Overall Study|Lost to Follow-up|5|||
105760913|NCT00294684|364778062|FG001|Overall Study|Lost to Follow-up|8|||
105760914|NCT04362813|364778063|FG000|Overall Study|Death|12|||
105760915|NCT04362813|364778064|FG001|Overall Study|Death|16|||
105760916|NCT04362813|364778063|FG000|Overall Study|Withdrawal by Subject|3|||
105760917|NCT04362813|364778064|FG001|Overall Study|Withdrawal by Subject|1|||
105760918|NCT04362813|364778063|FG000|Overall Study|Protocol Violation|0|||
105760919|NCT04362813|364778064|FG001|Overall Study|Protocol Violation|3|||
105949156|NCT01876381|365478821|FG000|Overall Study|Physician Decision|1|||
105949157|NCT01876381|365478821|FG000|Overall Study|Withdrawal by Subject|1|||
105949158|NCT03139448|365478822|FG000|Overall Study|Lack of Efficacy|6|||
105949159|NCT03139448|365478823|FG001|Overall Study|Lack of Efficacy|7|||
105949160|NCT03139448|365478822|FG000|Overall Study|Location of procedure changed|2|||
105949161|NCT03139448|365478823|FG001|Overall Study|Location of procedure changed|8|||
105753979|NCT03814590|364750280|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753980|NCT03814590|364750281|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753981|NCT03814590|364750282|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753982|NCT03814590|364750283|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753983|NCT03814590|364750284|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
105753984|NCT03814590|364750285|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
105753985|NCT03814590|364750286|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
105753986|NCT03814590|364750287|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753987|NCT03814590|364750288|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
105753988|NCT03814590|364750289|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
105753989|NCT03814590|364750290|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
105753990|NCT03814590|364750291|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
105753991|NCT03814590|364750292|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
105753992|NCT03814590|364750279|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753993|NCT03814590|364750280|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753994|NCT03814590|364750281|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753995|NCT03814590|364750282|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753996|NCT03814590|364750283|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753997|NCT03814590|364750284|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753998|NCT03814590|364750285|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105753999|NCT03814590|364750286|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105754000|NCT03814590|364750287|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754001|NCT03814590|364750288|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105754002|NCT03814590|364750289|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754003|NCT03814590|364750290|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754004|NCT03814590|364750291|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754005|NCT03814590|364750292|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105754006|NCT03814590|364750279|FG000|Overall Study|UNKNOWN REASON|0|||
105754007|NCT03814590|364750280|FG001|Overall Study|UNKNOWN REASON|0|||
105754008|NCT03814590|364750281|FG002|Overall Study|UNKNOWN REASON|0|||
105754009|NCT03814590|364750282|FG003|Overall Study|UNKNOWN REASON|0|||
105754010|NCT03814590|364750283|FG004|Overall Study|UNKNOWN REASON|0|||
105754011|NCT03814590|364750284|FG005|Overall Study|UNKNOWN REASON|0|||
105754012|NCT03814590|364750285|FG006|Overall Study|UNKNOWN REASON|0|||
105754013|NCT03814590|364750286|FG007|Overall Study|UNKNOWN REASON|1|||
105754014|NCT03814590|364750287|FG008|Overall Study|UNKNOWN REASON|0|||
105754015|NCT03814590|364750288|FG009|Overall Study|UNKNOWN REASON|0|||
105754016|NCT03814590|364750289|FG010|Overall Study|UNKNOWN REASON|0|||
105754017|NCT03814590|364750290|FG011|Overall Study|UNKNOWN REASON|0|||
105754018|NCT03814590|364750291|FG012|Overall Study|UNKNOWN REASON|0|||
105754019|NCT03814590|364750292|FG013|Overall Study|UNKNOWN REASON|0|||
105754020|NCT01935336|364750293|FG000|Overall Study|Adverse Event|1|||
105754021|NCT01935336|364750294|FG001|Overall Study|Adverse Event|0|||
105754022|NCT01935336|364750295|FG002|Overall Study|Adverse Event|0|||
105754023|NCT01935336|364750296|FG003|Overall Study|Adverse Event|0|||
105754024|NCT01935336|364750293|FG000|Overall Study|Progressive disease|5|||
105754025|NCT01935336|364750294|FG001|Overall Study|Progressive disease|3|||
105754026|NCT01935336|364750295|FG002|Overall Study|Progressive disease|47|||
105754027|NCT01935336|364750296|FG003|Overall Study|Progressive disease|66|||
105754028|NCT01401465|364750297|FG000|Treatment Period 1|Adverse Event|4|||
105754029|NCT01401465|364750298|FG001|Treatment Period 1|Adverse Event|1|||
105754030|NCT01401465|364750297|FG000|Treatment Period 1|Pregnancy|0|||
105754031|NCT01401465|364750298|FG001|Treatment Period 1|Pregnancy|1|||
105754032|NCT01401465|364750297|FG000|Treatment Period 1|Protocol Violation|5|||
105754033|NCT01401465|364750298|FG001|Treatment Period 1|Protocol Violation|0|||
105754034|NCT01401465|364750297|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105754035|NCT01401465|364750298|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105754036|NCT01401465|364750297|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
105754037|NCT01401465|364750298|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
105754038|NCT01401465|364750297|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
105754039|NCT01401465|364750298|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
105949162|NCT03139448|365478822|FG000|Overall Study|Withdrawal by Subject|3|||
105949163|NCT03139448|365478823|FG001|Overall Study|Withdrawal by Subject|6|||
105802167|NCT02266706|364932529|FG004|Overall Study|Enrollment in another study|0|||
105949164|NCT03139448|365478822|FG000|Overall Study|Screen fail|1|||
105949165|NCT03139448|365478823|FG001|Overall Study|Screen fail|3|||
105949166|NCT03139448|365478822|FG000|Overall Study|Physician Decision|0|||
105949167|NCT03139448|365478823|FG001|Overall Study|Physician Decision|2|||
105949168|NCT00523978|365478826|FG000|Overall Study|Withdrawal by Subject|3|||
105949169|NCT00523978|365478827|FG001|Overall Study|Withdrawal by Subject|7|||
105949170|NCT00523978|365478826|FG000|Overall Study|Screen Failures|5|||
105949171|NCT00523978|365478827|FG001|Overall Study|Screen Failures|1|||
105949172|NCT00523978|365478826|FG000|Overall Study|Death|1|||
105949173|NCT00523978|365478827|FG001|Overall Study|Death|0|||
105949174|NCT02216526|365478828|FG000|Overall Study|Adverse Event|1|||
105949175|NCT02216526|365478829|FG001|Overall Study|Adverse Event|1|||
105949176|NCT02216526|365478830|FG002|Overall Study|Adverse Event|0|||
105949177|NCT02216526|365478828|FG000|Overall Study|Death|0|||
105949178|NCT02216526|365478829|FG001|Overall Study|Death|1|||
105949179|NCT02216526|365478830|FG002|Overall Study|Death|3|||
105949180|NCT02216526|365478828|FG000|Overall Study|Protocol Violation|2|||
105949181|NCT02216526|365478829|FG001|Overall Study|Protocol Violation|0|||
105949182|NCT02216526|365478830|FG002|Overall Study|Protocol Violation|2|||
105949183|NCT02216526|365478828|FG000|Overall Study|Hospitalization|2|||
105949184|NCT02216526|365478829|FG001|Overall Study|Hospitalization|1|||
105949185|NCT02216526|365478830|FG002|Overall Study|Hospitalization|3|||
105949186|NCT02170064|365478831|FG000|Overall Study|Withdrawal by Subject|5|||
105949187|NCT02170064|365478832|FG001|Overall Study|Withdrawal by Subject|1|||
105949188|NCT02170064|365478833|FG002|Overall Study|Withdrawal by Subject|1|||
105949189|NCT02170064|365478831|FG000|Overall Study|Physician Decision|1|||
105949190|NCT02170064|365478832|FG001|Overall Study|Physician Decision|1|||
105949191|NCT02170064|365478833|FG002|Overall Study|Physician Decision|0|||
105949192|NCT04436744|365478839|FG000|Overall Study|Adverse Event|1|||
105949193|NCT04436744|365478840|FG001|Overall Study|Adverse Event|1|||
105949194|NCT04436744|365478839|FG000|Overall Study|Death|1|||
105949195|NCT04436744|365478840|FG001|Overall Study|Death|0|||
105949196|NCT04436744|365478839|FG000|Overall Study|Lost to Follow-up|0|||
105949197|NCT04436744|365478840|FG001|Overall Study|Lost to Follow-up|2|||
105949198|NCT04436744|365478839|FG000|Overall Study|Physician Decision|0|||
105949199|NCT04436744|365478840|FG001|Overall Study|Physician Decision|1|||
105949200|NCT04436744|365478839|FG000|Overall Study|Progressive Disease|0|||
105949201|NCT04436744|365478840|FG001|Overall Study|Progressive Disease|4|||
105949202|NCT04436744|365478839|FG000|Overall Study|Protocol Deviation|1|||
105949203|NCT04436744|365478840|FG001|Overall Study|Protocol Deviation|1|||
105949204|NCT04436744|365478839|FG000|Overall Study|Withdrawal by Subject|1|||
105949205|NCT04436744|365478840|FG001|Overall Study|Withdrawal by Subject|2|||
105949206|NCT00940602|365478841|FG000|Overall Study|Administrative problems|1|||
105949207|NCT00940602|365478842|FG001|Overall Study|Administrative problems|1|||
105949208|NCT00940602|365478841|FG000|Overall Study|Patient/guardian decision|13|||
105949209|NCT00940602|365478842|FG001|Overall Study|Patient/guardian decision|28|||
105949210|NCT00940602|365478841|FG000|Overall Study|Physician Decision|8|||
105949211|NCT00940602|365478842|FG001|Overall Study|Physician Decision|5|||
105949212|NCT00940602|365478841|FG000|Overall Study|Pregnancy|1|||
105949213|NCT00940602|365478842|FG001|Overall Study|Pregnancy|0|||
105949214|NCT00940602|365478841|FG000|Overall Study|Protocol Deviation (untreated)|1|||
105949215|NCT00940602|365478842|FG001|Overall Study|Protocol Deviation (untreated)|0|||
105949216|NCT00940602|365478841|FG000|Overall Study|Disease progression|8|||
105949217|NCT00940602|365478842|FG001|Overall Study|Disease progression|2|||
105949218|NCT00940602|365478841|FG000|Overall Study|Death|38|||
105949219|NCT00940602|365478842|FG001|Overall Study|Death|19|||
105949220|NCT00940602|365478841|FG000|Overall Study|Lost to Follow-up|3|||
105949221|NCT00940602|365478842|FG001|Overall Study|Lost to Follow-up|1|||
105949222|NCT00940602|365478841|FG000|Overall Study|Patient withdrew consent|26|||
105949223|NCT00940602|365478842|FG001|Overall Study|Patient withdrew consent|13|||
105949224|NCT00940602|365478841|FG000|Overall Study|Adverse Event|7|||
105949225|NCT00940602|365478842|FG001|Overall Study|Adverse Event|2|||
105949226|NCT00940602|365478841|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
105949227|NCT00940602|365478842|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
105949228|NCT01880957|365478843|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
105949229|NCT01880957|365478844|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
105949230|NCT01880957|365478843|FG000|Overall Study|Lost to Follow-up|11|||
105949231|NCT01880957|365478844|FG001|Overall Study|Lost to Follow-up|0|||
105949232|NCT01880957|365478843|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
105949233|NCT01880957|365478844|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
105949234|NCT01463033|365478845|FG000|Overall Study|Lost to Follow-up|4|||
105949235|NCT01463033|365478846|FG001|Overall Study|Lost to Follow-up|4|||
105949236|NCT01463033|365478845|FG000|Overall Study|Death|3|||
105949237|NCT01463033|365478846|FG001|Overall Study|Death|2|||
105949238|NCT02961244|365478849|FG000|Overall Study|Protocol Violation|0|||
105949239|NCT02961244|365478850|FG001|Overall Study|Protocol Violation|1|||
105949240|NCT02961244|365478849|FG000|Overall Study|Withdrawal by Subject|1|||
105949241|NCT02961244|365478850|FG001|Overall Study|Withdrawal by Subject|2|||
105949242|NCT02961244|365478849|FG000|Overall Study|Surgery plan change after study approval|0|||
105949243|NCT02961244|365478850|FG001|Overall Study|Surgery plan change after study approval|2|||
105949244|NCT02961244|365478849|FG000|Overall Study|Lost to Follow-up|0|||
105949245|NCT02961244|365478850|FG001|Overall Study|Lost to Follow-up|2|||
105949246|NCT02961244|365478849|FG000|Overall Study|İnadequate data|0|||
105949247|NCT02961244|365478850|FG001|Overall Study|İnadequate data|2|||
105949248|NCT01854528|365478851|FG000|Overall Study|Adverse Event|0|||
105949249|NCT01854528|365478852|FG001|Overall Study|Adverse Event|4|||
105949250|NCT01854528|365478851|FG000|Overall Study|Withdrawal by Subject|0|||
105949251|NCT01854528|365478852|FG001|Overall Study|Withdrawal by Subject|2|||
105949252|NCT01854528|365478851|FG000|Overall Study|Virologic Failure|0|||
105949253|NCT01854528|365478852|FG001|Overall Study|Virologic Failure|9|||
105949254|NCT02761642|365478858|FG000|Overall Study|Did not Receive Study Treatment|3|||
105949255|NCT02761642|365478858|FG000|Overall Study|Adverse Event|13|||
105949256|NCT02761642|365478858|FG000|Overall Study|Withdrawal by Subject|2|||
105754040|NCT01401465|364750297|FG000|Treatment Period 1|Scheduling Difficulties|1|||
105754041|NCT01401465|364750298|FG001|Treatment Period 1|Scheduling Difficulties|1|||
105754042|NCT01401465|364750297|FG000|Treatment Period 2|Lost to Follow-up|0|||
105754043|NCT01401465|364750298|FG001|Treatment Period 2|Lost to Follow-up|1|||
105754044|NCT01401465|364750297|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105754045|NCT01401465|364750298|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105754046|NCT00986427|364750299|FG000|Overall Study|Lost to Follow-up|2|||
105754047|NCT00986427|364750300|FG001|Overall Study|Lost to Follow-up|0|||
105949257|NCT02761642|365478858|FG000|Overall Study|Non-compliant|7|||
105949258|NCT02761642|365478858|FG000|Overall Study|Death|3|||
105949259|NCT02761642|365478858|FG000|Overall Study|Lack of Efficacy|20|||
105949260|NCT02761642|365478858|FG000|Overall Study|Physician Decision|1|||
105949261|NCT02761642|365478858|FG000|Overall Study|Reason Unspecified|21|||
105949262|NCT03768427|365478859|FG000|Overall Study|Death|0|||
105949263|NCT03768427|365478860|FG001|Overall Study|Death|0|||
105949264|NCT03768427|365478861|FG002|Overall Study|Death|1|||
105949265|NCT03768427|365478862|FG003|Overall Study|Death|0|||
105949266|NCT03768427|365478859|FG000|Overall Study|Lost to Follow-up|2|||
105949267|NCT03768427|365478860|FG001|Overall Study|Lost to Follow-up|0|||
105949268|NCT03768427|365478861|FG002|Overall Study|Lost to Follow-up|0|||
105949269|NCT03768427|365478862|FG003|Overall Study|Lost to Follow-up|0|||
105949270|NCT03768427|365478859|FG000|Overall Study|Physician Decision|3|||
105949271|NCT03768427|365478860|FG001|Overall Study|Physician Decision|2|||
105949272|NCT03768427|365478861|FG002|Overall Study|Physician Decision|4|||
105949273|NCT03768427|365478862|FG003|Overall Study|Physician Decision|4|||
105949274|NCT03768427|365478859|FG000|Overall Study|Withdrawal by Subject|7|||
105949275|NCT03768427|365478860|FG001|Overall Study|Withdrawal by Subject|2|||
105949276|NCT03768427|365478861|FG002|Overall Study|Withdrawal by Subject|6|||
105949277|NCT03768427|365478862|FG003|Overall Study|Withdrawal by Subject|7|||
105949278|NCT00570713|365478863|FG000|Overall Study|Adverse Event|16|||
105949279|NCT00570713|365478864|FG001|Overall Study|Adverse Event|9|||
105949280|NCT00570713|365478863|FG000|Overall Study|Death|7|||
105949281|NCT00570713|365478864|FG001|Overall Study|Death|7|||
105949282|NCT00570713|365478863|FG000|Overall Study|Lack of Efficacy|40|||
105949283|NCT00570713|365478864|FG001|Overall Study|Lack of Efficacy|49|||
105949284|NCT00570713|365478863|FG000|Overall Study|Physician Decision|2|||
105949285|NCT00570713|365478864|FG001|Overall Study|Physician Decision|2|||
105949286|NCT00570713|365478863|FG000|Overall Study|Withdrawal by Subject|3|||
105949287|NCT00570713|365478864|FG001|Overall Study|Withdrawal by Subject|3|||
105949288|NCT00570713|365478863|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
105949289|NCT00570713|365478864|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
105949290|NCT03958331|365478867|FG000|Overall Study|Withdrawal by Subject|3|||
105949291|NCT03958331|365478868|FG001|Overall Study|Withdrawal by Subject|1|||
105949292|NCT03958331|365478869|FG002|Overall Study|Withdrawal by Subject|5|||
105949293|NCT03958331|365478867|FG000|Overall Study|Weaned from medicine|2|||
105949294|NCT03958331|365478868|FG001|Overall Study|Weaned from medicine|0|||
105949295|NCT03958331|365478869|FG002|Overall Study|Weaned from medicine|0|||
105949296|NCT03958331|365478867|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
105949297|NCT03958331|365478868|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
105949298|NCT03958331|365478869|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
105949299|NCT00730886|365478870|FG000|Overall Study|Lost to Follow-up|1|||
105949300|NCT00730886|365478871|FG001|Overall Study|Lost to Follow-up|0|||
105949301|NCT00730886|365478870|FG000|Overall Study|Physician Decision|1|||
105949302|NCT00730886|365478871|FG001|Overall Study|Physician Decision|0|||
105949303|NCT02505425|365478872|FG000|Overall Study|Lost to Follow-up|41|||
105949304|NCT02505425|365478873|FG001|Overall Study|Lost to Follow-up|61|||
105949305|NCT02505425|365478874|FG002|Overall Study|Lost to Follow-up|31|||
105949306|NCT02505425|365478875|FG003|Overall Study|Lost to Follow-up|19|||
105802168|NCT02266706|364932530|FG005|Overall Study|Enrollment in another study|0|||
105802169|NCT02266706|364932531|FG006|Overall Study|Enrollment in another study|0|||
105949307|NCT02505425|365478872|FG000|Overall Study|Withdrawal by Subject|39|||
105949308|NCT02505425|365478873|FG001|Overall Study|Withdrawal by Subject|9|||
105949309|NCT02505425|365478874|FG002|Overall Study|Withdrawal by Subject|19|||
105949310|NCT02505425|365478875|FG003|Overall Study|Withdrawal by Subject|7|||
105949311|NCT02505425|365478872|FG000|Overall Study|Death|8|||
105949312|NCT02505425|365478873|FG001|Overall Study|Death|12|||
105949313|NCT02505425|365478874|FG002|Overall Study|Death|0|||
105949314|NCT02505425|365478875|FG003|Overall Study|Death|0|||
105802170|NCT02266706|364932532|FG007|Overall Study|Enrollment in another study|0|||
105949315|NCT01152437|365478883|FG000|Overall Study|Other Adverse Event|8|||
105802171|NCT02266706|364932533|FG008|Overall Study|Enrollment in another study|0|||
105802172|NCT02614703|364932534|FG000|Overall Study|Withdrawal by Subject|7|||
105802173|NCT02614703|364932535|FG001|Overall Study|Withdrawal by Subject|1|||
105802174|NCT01977352|364932536|FG000|Overall Study|Lost to Follow-up|1|||
105802175|NCT01977352|364932537|FG001|Overall Study|Lost to Follow-up|2|||
105802176|NCT02092961|364932538|FG000|Overall Study|Not reported|1|||
105802177|NCT02092961|364932539|FG001|Overall Study|Not reported|0|||
105802178|NCT02092961|364932540|FG002|Overall Study|Not reported|1|||
105802179|NCT02092961|364932538|FG000|Overall Study|Study stopped|13|||
105802180|NCT02092961|364932539|FG001|Overall Study|Study stopped|9|||
105802181|NCT02092961|364932540|FG002|Overall Study|Study stopped|12|||
105802182|NCT02092961|364932538|FG000|Overall Study|Lack of therapeutic response|2|||
105802183|NCT02092961|364932539|FG001|Overall Study|Lack of therapeutic response|1|||
105802184|NCT02092961|364932540|FG002|Overall Study|Lack of therapeutic response|3|||
105802185|NCT02092961|364932538|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
105802186|NCT02092961|364932539|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
105802187|NCT02092961|364932540|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
105802188|NCT02092961|364932538|FG000|Overall Study|Adverse Event|2|||
105802189|NCT02092961|364932539|FG001|Overall Study|Adverse Event|4|||
105802190|NCT02092961|364932540|FG002|Overall Study|Adverse Event|0|||
105802191|NCT02270983|364932541|FG000|Overall Study|Adverse Event|3|||
105949316|NCT01152437|365478884|FG001|Overall Study|Other Adverse Event|1|||
105949317|NCT01152437|365478885|FG002|Overall Study|Other Adverse Event|7|||
105949318|NCT01152437|365478883|FG000|Overall Study|Not treated|0|||
105949319|NCT01152437|365478884|FG001|Overall Study|Not treated|1|||
105949320|NCT01152437|365478885|FG002|Overall Study|Not treated|2|||
105949321|NCT01152437|365478883|FG000|Overall Study|Progressive disease|27|||
105949322|NCT01152437|365478884|FG001|Overall Study|Progressive disease|13|||
105949323|NCT01152437|365478885|FG002|Overall Study|Progressive disease|32|||
105949324|NCT01152437|365478883|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
105949325|NCT01152437|365478884|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
105949326|NCT01152437|365478885|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
105949327|NCT02317627|365478889|FG000|Overall Study|Withdrawal by Subject|0|||
105949328|NCT02317627|365478890|FG001|Overall Study|Withdrawal by Subject|1|||
105949329|NCT02317627|365478891|FG002|Overall Study|Withdrawal by Subject|1|||
105949330|NCT02317627|365478889|FG000|Overall Study|Lost to Follow-up|2|||
105949331|NCT02317627|365478890|FG001|Overall Study|Lost to Follow-up|0|||
105949332|NCT02317627|365478891|FG002|Overall Study|Lost to Follow-up|0|||
105949333|NCT02317627|365478889|FG000|Overall Study|Stopped by Investigator|0|||
105949334|NCT02317627|365478890|FG001|Overall Study|Stopped by Investigator|1|||
105949335|NCT02317627|365478891|FG002|Overall Study|Stopped by Investigator|0|||
105949336|NCT02317627|365478889|FG000|Overall Study|Adverse Event|0|||
105949337|NCT02317627|365478890|FG001|Overall Study|Adverse Event|2|||
105949338|NCT02317627|365478891|FG002|Overall Study|Adverse Event|3|||
105949339|NCT02317627|365478889|FG000|Overall Study|Non-compliance with study drug|0|||
105949340|NCT02317627|365478890|FG001|Overall Study|Non-compliance with study drug|1|||
105949341|NCT02317627|365478891|FG002|Overall Study|Non-compliance with study drug|0|||
105949342|NCT01581684|365480416|FG000|Overall Study|Other reason not defined|0|||
105949343|NCT01581684|365480417|FG001|Overall Study|Other reason not defined|0|||
105949344|NCT01581684|365480418|FG002|Overall Study|Other reason not defined|0|||
105949345|NCT01581684|365480419|FG003|Overall Study|Other reason not defined|0|||
105949346|NCT01581684|365480420|FG004|Overall Study|Other reason not defined|0|||
105949347|NCT01581684|365480421|FG005|Overall Study|Other reason not defined|0|||
105949348|NCT01581684|365480422|FG006|Overall Study|Other reason not defined|0|||
105949349|NCT01581684|365480423|FG007|Overall Study|Other reason not defined|0|||
105949350|NCT01581684|365480424|FG008|Overall Study|Other reason not defined|1|||
105949351|NCT01581684|365480425|FG009|Overall Study|Other reason not defined|0|||
105949352|NCT03728933|365480426|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105949353|NCT03728933|365480427|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105949354|NCT03728933|365480428|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105949355|NCT03728933|365480426|FG000|Overall Study|Withdrawal by Subject|0|||
105949356|NCT03728933|365480427|FG001|Overall Study|Withdrawal by Subject|0|||
105949357|NCT03728933|365480428|FG002|Overall Study|Withdrawal by Subject|1|||
105949358|NCT03728933|365480426|FG000|Overall Study|Lost to Follow-up|0|||
105949359|NCT03728933|365480427|FG001|Overall Study|Lost to Follow-up|1|||
105949360|NCT03728933|365480428|FG002|Overall Study|Lost to Follow-up|0|||
105949361|NCT03728933|365480426|FG000|Overall Study|Adverse Event|1|||
105949362|NCT03728933|365480427|FG001|Overall Study|Adverse Event|0|||
105949363|NCT03728933|365480428|FG002|Overall Study|Adverse Event|0|||
105949364|NCT00639457|365480429|FG000|Overall Study|Withdrawal by Subject|2|||
105949365|NCT00639457|365480430|FG001|Overall Study|Withdrawal by Subject|3|||
105949366|NCT03235050|365480431|FG000|Overall Study|Adverse Event|0|||
105949367|NCT03235050|365480432|FG001|Overall Study|Adverse Event|0|||
105949368|NCT03235050|365480433|FG002|Overall Study|Adverse Event|1|||
105949369|NCT03235050|365480434|FG003|Overall Study|Adverse Event|4|||
105949370|NCT03235050|365480435|FG004|Overall Study|Adverse Event|1|||
105949371|NCT03235050|365480431|FG000|Overall Study|Death|0|||
105949372|NCT03235050|365480432|FG001|Overall Study|Death|0|||
105949373|NCT03235050|365480433|FG002|Overall Study|Death|0|||
105949374|NCT03235050|365480434|FG003|Overall Study|Death|2|||
105949375|NCT03235050|365480435|FG004|Overall Study|Death|1|||
105949376|NCT03235050|365480431|FG000|Overall Study|Lost to Follow-up|1|||
105949377|NCT03235050|365480432|FG001|Overall Study|Lost to Follow-up|2|||
105949378|NCT03235050|365480433|FG002|Overall Study|Lost to Follow-up|1|||
105949379|NCT03235050|365480434|FG003|Overall Study|Lost to Follow-up|2|||
105949380|NCT03235050|365480435|FG004|Overall Study|Lost to Follow-up|0|||
105949381|NCT03235050|365480431|FG000|Overall Study|Withdrawal by Subject|3|||
105949382|NCT03235050|365480432|FG001|Overall Study|Withdrawal by Subject|2|||
105949383|NCT03235050|365480433|FG002|Overall Study|Withdrawal by Subject|2|||
105949384|NCT03235050|365480434|FG003|Overall Study|Withdrawal by Subject|5|||
105949385|NCT03235050|365480435|FG004|Overall Study|Withdrawal by Subject|7|||
105949386|NCT03235050|365480431|FG000|Overall Study|Other reasons|0|||
105949387|NCT03235050|365480432|FG001|Overall Study|Other reasons|1|||
105949388|NCT03235050|365480433|FG002|Overall Study|Other reasons|0|||
105949389|NCT03235050|365480434|FG003|Overall Study|Other reasons|1|||
105949390|NCT03235050|365480435|FG004|Overall Study|Other reasons|2|||
105949391|NCT01621178|365480436|FG000|Overall Study|Adverse Event|5|||
105949392|NCT01621178|365480437|FG001|Overall Study|Adverse Event|2|||
105949393|NCT01621178|365480438|FG002|Overall Study|Adverse Event|8|||
105949394|NCT01621178|365480436|FG000|Overall Study|Death|6|||
105949395|NCT01621178|365480437|FG001|Overall Study|Death|7|||
105949396|NCT01621178|365480438|FG002|Overall Study|Death|2|||
105802192|NCT02270983|364932542|FG001|Overall Study|Adverse Event|2|||
105802193|NCT02270983|364932543|FG002|Overall Study|Adverse Event|6|||
105802194|NCT02270983|364932541|FG000|Overall Study|Lack of Efficacy|2|||
105802195|NCT02270983|364932542|FG001|Overall Study|Lack of Efficacy|1|||
105802196|NCT02270983|364932543|FG002|Overall Study|Lack of Efficacy|1|||
105802197|NCT02270983|364932541|FG000|Overall Study|Withdrawal by Subject|1|||
105802198|NCT02270983|364932542|FG001|Overall Study|Withdrawal by Subject|0|||
105802199|NCT02270983|364932543|FG002|Overall Study|Withdrawal by Subject|2|||
105802200|NCT02270983|364932541|FG000|Overall Study|Lost to Follow-up|1|||
105802201|NCT02270983|364932542|FG001|Overall Study|Lost to Follow-up|1|||
105802202|NCT02270983|364932543|FG002|Overall Study|Lost to Follow-up|2|||
105802203|NCT02270983|364932541|FG000|Overall Study|Protocol Violation|1|||
105802204|NCT02270983|364932542|FG001|Overall Study|Protocol Violation|1|||
105802205|NCT02270983|364932543|FG002|Overall Study|Protocol Violation|1|||
105802206|NCT02270983|364932541|FG000|Overall Study|family emergency|0|||
105802207|NCT02270983|364932542|FG001|Overall Study|family emergency|1|||
105949397|NCT01621178|365480436|FG000|Overall Study|Lost to Follow-up|1|||
105949398|NCT01621178|365480437|FG001|Overall Study|Lost to Follow-up|2|||
105949399|NCT01621178|365480438|FG002|Overall Study|Lost to Follow-up|1|||
105802208|NCT02270983|364932543|FG002|Overall Study|family emergency|0|||
105802209|NCT02270983|364932541|FG000|Overall Study|study procedure non-compliance|1|||
105949400|NCT01621178|365480436|FG000|Overall Study|Withdrawal by Subject|14|||
105949401|NCT01621178|365480437|FG001|Overall Study|Withdrawal by Subject|17|||
105949402|NCT01621178|365480438|FG002|Overall Study|Withdrawal by Subject|18|||
105949403|NCT01621178|365480436|FG000|Overall Study|Physician Decision|5|||
105949404|NCT01621178|365480437|FG001|Overall Study|Physician Decision|2|||
105802210|NCT02270983|364932542|FG001|Overall Study|study procedure non-compliance|0|||
105802211|NCT02270983|364932543|FG002|Overall Study|study procedure non-compliance|0|||
105949405|NCT01621178|365480438|FG002|Overall Study|Physician Decision|7|||
105949406|NCT02935192|365480439|FG000|Overall Study|Withdrawal by Subject|8|||
105949407|NCT02935192|365480440|FG001|Overall Study|Withdrawal by Subject|4|||
105949408|NCT02465931|365480441|FG000|Overall Study|Lost to Follow-up|9|||
105949409|NCT02465931|365480442|FG001|Overall Study|Lost to Follow-up|11|||
105949410|NCT02465931|365480441|FG000|Overall Study|Protocol Violation|1|||
105949411|NCT02465931|365480442|FG001|Overall Study|Protocol Violation|0|||
105802212|NCT02270983|364932541|FG000|Overall Study|moved away from study site|0|||
105802213|NCT02270983|364932542|FG001|Overall Study|moved away from study site|1|||
105802214|NCT02270983|364932543|FG002|Overall Study|moved away from study site|0|||
105802215|NCT00854620|364932544|FG000|Overall Study|Adverse Event|1|||
105949412|NCT02465931|365480441|FG000|Overall Study|Withdrawal by Subject|1|||
105949413|NCT02465931|365480442|FG001|Overall Study|Withdrawal by Subject|0|||
105949414|NCT03423121|365480446|FG000|Overall Study|Lost to Follow-up|2|||
105949415|NCT03423121|365480447|FG001|Overall Study|Lost to Follow-up|6|||
105949416|NCT03423121|365480446|FG000|Overall Study|Adverse Event|1|||
105949417|NCT03423121|365480447|FG001|Overall Study|Adverse Event|0|||
105949418|NCT01354223|365480448|FG000|Overall Study|Withdrawal by Subject|3|||
105949419|NCT01354223|365480449|FG001|Overall Study|Withdrawal by Subject|1|||
105949420|NCT04102007|365480453|FG000|Overall Study|Adverse Event|4|||
105949421|NCT04102007|365480453|FG000|Overall Study|Lost to Follow-up|3|||
105949422|NCT04102007|365480453|FG000|Overall Study|Withdrawal by Subject|12|||
105949423|NCT04102007|365480453|FG000|Overall Study|Eligibility Violation|5|||
105949424|NCT04102007|365480453|FG000|Overall Study|Lack of Efficacy|6|||
105949425|NCT04102007|365480453|FG000|Overall Study|Protocol Deviation|5|||
105949426|NCT04102007|365480453|FG000|Overall Study|Protocol Compliance|1|||
105949427|NCT04102007|365480453|FG000|Overall Study|Withdrew Treatment|2|||
105949428|NCT04102007|365480453|FG000|Overall Study|Pregnancy|1|||
105949429|NCT00305877|365480454|FG000|Overall Study|Lack of Efficacy|6|||
105949430|NCT00305877|365480455|FG001|Overall Study|Lack of Efficacy|9|||
105949431|NCT00305877|365480454|FG000|Overall Study|Adverse Event|9|||
105949432|NCT00305877|365480455|FG001|Overall Study|Adverse Event|14|||
105949433|NCT00305877|365480454|FG000|Overall Study|Death|0|||
105949434|NCT00305877|365480455|FG001|Overall Study|Death|1|||
105949435|NCT00305877|365480454|FG000|Overall Study|Withdrawal by Subject|4|||
105949436|NCT00305877|365480455|FG001|Overall Study|Withdrawal by Subject|2|||
105949437|NCT00305877|365480454|FG000|Overall Study|Physician Decision|1|||
105949438|NCT00305877|365480455|FG001|Overall Study|Physician Decision|1|||
105949439|NCT00305877|365480454|FG000|Overall Study|Never start treatment|2|||
105949440|NCT00305877|365480455|FG001|Overall Study|Never start treatment|5|||
105949441|NCT00305877|365480454|FG000|Overall Study|Ineligible|2|||
105949442|NCT00305877|365480455|FG001|Overall Study|Ineligible|1|||
105949443|NCT00305877|365480454|FG000|Overall Study|Transportation issue with daily RT|0|||
105949444|NCT00305877|365480455|FG001|Overall Study|Transportation issue with daily RT|1|||
105949445|NCT00457392|365480456|FG000|Overall Study|Objective Progression or Relapse|229|||
105949446|NCT00457392|365480457|FG001|Overall Study|Objective Progression or Relapse|296|||
105949447|NCT00457392|365480456|FG000|Overall Study|Death|106|||
105949448|NCT00457392|365480457|FG001|Overall Study|Death|106|||
105949449|NCT00457392|365480456|FG000|Overall Study|Adverse Event|84|||
105754048|NCT00986427|364750299|FG000|Overall Study|Lack of Efficacy|1|||
105754049|NCT00986427|364750300|FG001|Overall Study|Lack of Efficacy|0|||
105754050|NCT00986427|364750299|FG000|Overall Study|Withdrawal by Subject|1|||
105754051|NCT00986427|364750300|FG001|Overall Study|Withdrawal by Subject|0|||
105754052|NCT01115738|364750301|FG000|Overall Study|Death|1|||
105754053|NCT01115738|364750302|FG001|Overall Study|Death|0|||
105754054|NCT01115738|364750303|FG002|Overall Study|Death|0|||
105754055|NCT01115738|364750301|FG000|Overall Study|Lost to Follow-up|0|||
105754056|NCT01115738|364750302|FG001|Overall Study|Lost to Follow-up|0|||
105754057|NCT01115738|364750303|FG002|Overall Study|Lost to Follow-up|1|||
105754058|NCT01115738|364750301|FG000|Overall Study|Physician Decision|18|||
105754059|NCT01115738|364750302|FG001|Overall Study|Physician Decision|15|||
105754060|NCT01115738|364750303|FG002|Overall Study|Physician Decision|17|||
105754061|NCT01115738|364750301|FG000|Overall Study|Withdrawal by Subject|6|||
105754062|NCT01115738|364750302|FG001|Overall Study|Withdrawal by Subject|6|||
105754063|NCT01115738|364750303|FG002|Overall Study|Withdrawal by Subject|9|||
105754064|NCT03245723|364750304|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
105754065|NCT03245723|364750305|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
105754066|NCT03245723|364750304|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
105754067|NCT03245723|364750305|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
105754068|NCT03245723|364750304|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
105754069|NCT03245723|364750305|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
105754070|NCT03245723|364750304|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
105754071|NCT03245723|364750305|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
105754072|NCT03337139|364750307|FG000|Phase I|Withdrawal by Subject|10|||
105754073|NCT03337139|364750308|FG001|Phase I|Withdrawal by Subject|0|||
105754074|NCT00077376|364750309|FG000|Overall Study|Adverse Event|8|||
105754075|NCT00077376|364750309|FG000|Overall Study|Withdrawal by Subject|2|||
105754076|NCT00077376|364750309|FG000|Overall Study|Death|1|||
105949450|NCT00457392|365480457|FG001|Overall Study|Adverse Event|41|||
105754077|NCT00077376|364750309|FG000|Overall Study|Physician Decision|1|||
105754078|NCT00077376|364750309|FG000|Overall Study|Alternative therapy|5|||
105754079|NCT00077376|364750309|FG000|Overall Study|Complicating disease|1|||
105754080|NCT00077376|364750309|FG000|Overall Study|Still on treatment|1|||
105754081|NCT00077376|364750309|FG000|Overall Study|Symptomatic deterioration|1|||
105949451|NCT00457392|365480456|FG000|Overall Study|Global Deterioration of Health Status|22|||
105949452|NCT00457392|365480457|FG001|Overall Study|Global Deterioration of Health Status|8|||
105949453|NCT00457392|365480456|FG000|Overall Study|Withdrawal by Subject|14|||
105949454|NCT00457392|365480457|FG001|Overall Study|Withdrawal by Subject|8|||
105949455|NCT00457392|365480456|FG000|Overall Study|Lost to Follow-up|6|||
105949456|NCT00457392|365480457|FG001|Overall Study|Lost to Follow-up|7|||
105949457|NCT00457392|365480456|FG000|Overall Study|Protocol Violation|4|||
105949458|NCT00457392|365480457|FG001|Overall Study|Protocol Violation|3|||
105949459|NCT00457392|365480456|FG000|Overall Study|Other|7|||
105949460|NCT00457392|365480457|FG001|Overall Study|Other|4|||
105949461|NCT00457392|365480456|FG000|Overall Study|Study Terminated by Sponsor|1|||
105754082|NCT00077376|364750309|FG000|Overall Study|Surgery|1|||
105754083|NCT00077376|364750309|FG000|Overall Study|Insurance ran out|1|||
105754084|NCT01736254|364750310|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
105754085|NCT01736254|364750310|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
105754086|NCT01255306|364751615|FG000|Overall Study|Physician Decision|1|||
105754087|NCT01255306|364751616|FG001|Overall Study|Physician Decision|1|||
105754088|NCT00453180|364751621|FG000|Overall Study|Lost to Follow-up|2|||
105754089|NCT00453180|364751622|FG001|Overall Study|Lost to Follow-up|1|||
105754090|NCT00453180|364751621|FG000|Overall Study|Adverse Event|1|||
105754091|NCT00453180|364751622|FG001|Overall Study|Adverse Event|2|||
105754092|NCT00804843|364751626|FG000|Overall Study|Protocol Violation|1|||
105754093|NCT00804843|364751627|FG001|Overall Study|Protocol Violation|0|||
105754094|NCT00804843|364751626|FG000|Overall Study|Adverse Event|8|||
105754095|NCT00804843|364751627|FG001|Overall Study|Adverse Event|5|||
105754096|NCT00804843|364751626|FG000|Overall Study|Withdrawal by Subject|1|||
105754097|NCT00804843|364751627|FG001|Overall Study|Withdrawal by Subject|2|||
105754098|NCT01975246|364751634|FG000|Overall Study|Adverse Event|2|||
105754099|NCT01975246|364751635|FG001|Overall Study|Adverse Event|1|||
105754100|NCT01975246|364751634|FG000|Overall Study|Lack of Efficacy|1|||
105754101|NCT01975246|364751635|FG001|Overall Study|Lack of Efficacy|0|||
105754102|NCT01975246|364751634|FG000|Overall Study|Protocol Violation|1|||
105754103|NCT01975246|364751635|FG001|Overall Study|Protocol Violation|0|||
105754104|NCT01975246|364751634|FG000|Overall Study|Other than stated|0|||
105754105|NCT01975246|364751635|FG001|Overall Study|Other than stated|1|||
105754106|NCT01646398|364751642|FG000|Overall Study|Withdrawal by Subject|1|||
105754107|NCT01646398|364751643|FG001|Overall Study|Withdrawal by Subject|0|||
105754108|NCT02499575|364751644|FG000|Overall Study|Protocol Violation|0|||
105754109|NCT02499575|364751645|FG001|Overall Study|Protocol Violation|1|||
105754110|NCT02586077|364751646|FG000|Overall Study|Withdrawal by Subject|1|||
105754111|NCT02586077|364751646|FG000|Overall Study|Physician Decision|4|||
105754112|NCT02586077|364751646|FG000|Overall Study|Lost to Follow-up|3|||
105754113|NCT03287245|364751647|FG000|Overall Study|Study terminated by sponsor|3|||
105754114|NCT03287245|364751648|FG001|Overall Study|Study terminated by sponsor|0|||
105754115|NCT03287245|364751649|FG002|Overall Study|Study terminated by sponsor|3|||
105754116|NCT03287245|364751650|FG003|Overall Study|Study terminated by sponsor|1|||
105754117|NCT03287245|364751647|FG000|Overall Study|Adverse Event|1|||
105754118|NCT03287245|364751648|FG001|Overall Study|Adverse Event|0|||
105754119|NCT03287245|364751649|FG002|Overall Study|Adverse Event|0|||
105754120|NCT03287245|364751650|FG003|Overall Study|Adverse Event|0|||
105754121|NCT03287245|364751647|FG000|Overall Study|Withdrawal by Subject|8|||
105754122|NCT03287245|364751648|FG001|Overall Study|Withdrawal by Subject|3|||
105754123|NCT03287245|364751649|FG002|Overall Study|Withdrawal by Subject|3|||
105754124|NCT03287245|364751650|FG003|Overall Study|Withdrawal by Subject|0|||
105754125|NCT03287245|364751647|FG000|Overall Study|Physician Decision|3|||
105754126|NCT03287245|364751648|FG001|Overall Study|Physician Decision|2|||
105754127|NCT03287245|364751649|FG002|Overall Study|Physician Decision|0|||
105754128|NCT03287245|364751650|FG003|Overall Study|Physician Decision|0|||
105754129|NCT00949910|364751651|FG000|Overall Study|Progressive Disease|3750|||
105754130|NCT00949910|364751651|FG000|Overall Study|Symptomatic Deterioration|1088|||
105754131|NCT00949910|364751651|FG000|Overall Study|Lost to Follow-up|100|||
105754132|NCT00949910|364751651|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
105754133|NCT00949910|364751651|FG000|Overall Study|Participant Refusal|390|||
105754134|NCT00949910|364751651|FG000|Overall Study|Death Due to Malignant Disease|456|||
105754135|NCT00949910|364751651|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
105754136|NCT00949910|364751651|FG000|Overall Study|Death Due to Adverse Event|115|||
105754137|NCT00949910|364751651|FG000|Overall Study|Death Due to Toxicity|3|||
105754138|NCT00949910|364751651|FG000|Overall Study|Death from Unknown Cause|5|||
105754139|NCT00949910|364751651|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
105754140|NCT00949910|364751651|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
105754141|NCT00949910|364751651|FG000|Overall Study|Switched to Commercial Treatment|4|||
105754142|NCT00949910|364751651|FG000|Overall Study|Violation of Eligibility|23|||
105754143|NCT00949910|364751651|FG000|Overall Study|Logistical Reasons|13|||
105754144|NCT00949910|364751651|FG000|Overall Study|Non-Compliance|10|||
105754145|NCT00949910|364751651|FG000|Overall Study|Prolonged Dosing Interruption|4|||
105754146|NCT00949910|364751651|FG000|Overall Study|Adverse Event|83|||
105754147|NCT00949910|364751651|FG000|Overall Study|Serious Adverse Event|6|||
105802216|NCT01623830|364932547|FG000|Overall Study|Withdrawal by Subject|6|||
105754148|NCT00949910|364751651|FG000|Overall Study|Physician/Participant Decision|7|||
105754149|NCT00949910|364751651|FG000|Overall Study|Other|4|||
105754150|NCT00949910|364751651|FG000|Overall Study|No Data|9|||
105754151|NCT03297216|364751660|FG000|Overall Study|Death|0|||
105754152|NCT03297216|364751661|FG001|Overall Study|Death|1|||
105754153|NCT03297216|364751660|FG000|Overall Study|Miscarriage|0|||
105754154|NCT03297216|364751661|FG001|Overall Study|Miscarriage|2|||
105949462|NCT00457392|365480457|FG001|Overall Study|Study Terminated by Sponsor|4|||
105949463|NCT00457392|365480456|FG000|Overall Study|Randomized, Not Treated|7|||
105949464|NCT00457392|365480457|FG001|Overall Study|Randomized, Not Treated|3|||
105949465|NCT01135992|365480458|FG000|Overall Study|Adverse Event|1|||
105949466|NCT01135992|365480458|FG000|Overall Study|Lack of Efficacy|1|||
105949467|NCT01135992|365480458|FG000|Overall Study|Protocol Violation|2|||
105949468|NCT01135992|365480458|FG000|Overall Study|Withdrawal criteria|10|||
105949469|NCT01135992|365480458|FG000|Overall Study|Unclassified|7|||
105949470|NCT02973997|365480459|FG000|Overall Study|Withdrawal by Subject|4|||
105949471|NCT02973997|365480460|FG001|Overall Study|Withdrawal by Subject|0|||
105949472|NCT02973997|365480459|FG000|Overall Study|Adverse Event|4|||
105949473|NCT02973997|365480460|FG001|Overall Study|Adverse Event|1|||
105949474|NCT02973997|365480459|FG000|Overall Study|Disease Progression|11|||
105949475|NCT02973997|365480460|FG001|Overall Study|Disease Progression|20|||
105949476|NCT02973997|365480459|FG000|Overall Study|Alternative Therapy|3|||
105949477|NCT02973997|365480460|FG001|Overall Study|Alternative Therapy|0|||
105949478|NCT02973997|365480459|FG000|Overall Study|Other complicating disease|0|||
105949479|NCT02973997|365480460|FG001|Overall Study|Other complicating disease|1|||
105949480|NCT02973997|365480459|FG000|Overall Study|Death|0|||
105949481|NCT02973997|365480460|FG001|Overall Study|Death|1|||
105949482|NCT00892008|365480461|FG000|Overall Study|Death|5|||
105949483|NCT00892008|365480461|FG000|Overall Study|Lack of Efficacy|3|||
105949484|NCT00892008|365480461|FG000|Overall Study|Lost to Follow-up|142|||
105949485|NCT00892008|365480461|FG000|Overall Study|Other|378|||
105949486|NCT00892008|365480461|FG000|Overall Study|Adverse Event|37|||
105949487|NCT02727322|365480462|FG000|Overall Study|Withdrawal by Subject|1|||
105949488|NCT02727322|365480463|FG001|Overall Study|Withdrawal by Subject|1|||
105949489|NCT02727322|365480462|FG000|Overall Study|Protocol Violation|1|||
105949490|NCT02727322|365480463|FG001|Overall Study|Protocol Violation|0|||
105949491|NCT00355030|365480464|FG000|Study Period 1 Treatment|Adverse Event|1|||
105949492|NCT00355030|365480465|FG001|Study Period 1 Treatment|Adverse Event|1|||
105949493|NCT00355030|365480464|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
105754155|NCT03297216|364751660|FG000|Overall Study|Lost to Follow-up|3|||
105754156|NCT03297216|364751661|FG001|Overall Study|Lost to Follow-up|2|||
105754157|NCT03434418|364751662|FG000|Overall Study|Disease Progression|11|||
105754158|NCT03434418|364751662|FG000|Overall Study|Adverse Event|2|||
105754159|NCT03434418|364751662|FG000|Overall Study|Physician Decision|1|||
105754160|NCT03434418|364751662|FG000|Overall Study|Decline in Performance Status (PS)|1|||
105754161|NCT02062463|364751663|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
105754162|NCT02062463|364751664|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
105754163|NCT02062463|364751665|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
105754164|NCT02062463|364751666|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
105754165|NCT02062463|364751663|FG000|Stage 2|Adverse Event|0|||
105754166|NCT02062463|364751664|FG001|Stage 2|Adverse Event|0|||
105754167|NCT02062463|364751665|FG002|Stage 2|Adverse Event|12|||
105754168|NCT02062463|364751666|FG003|Stage 2|Adverse Event|20|||
105754169|NCT02062463|364751663|FG000|Stage 2|Lack of Efficacy|0|||
105754170|NCT02062463|364751664|FG001|Stage 2|Lack of Efficacy|0|||
105754171|NCT02062463|364751665|FG002|Stage 2|Lack of Efficacy|3|||
105754172|NCT02062463|364751666|FG003|Stage 2|Lack of Efficacy|4|||
105754173|NCT02062463|364751663|FG000|Stage 2|Lost to Follow-up|0|||
105754174|NCT02062463|364751664|FG001|Stage 2|Lost to Follow-up|0|||
105754175|NCT02062463|364751665|FG002|Stage 2|Lost to Follow-up|20|||
105754176|NCT02062463|364751666|FG003|Stage 2|Lost to Follow-up|20|||
105754177|NCT02062463|364751663|FG000|Stage 2|Non-Compliance|0|||
105754178|NCT02062463|364751664|FG001|Stage 2|Non-Compliance|0|||
105754179|NCT02062463|364751665|FG002|Stage 2|Non-Compliance|0|||
105754180|NCT02062463|364751666|FG003|Stage 2|Non-Compliance|1|||
105754181|NCT02062463|364751663|FG000|Stage 2|Other than specified|0|||
105754182|NCT02062463|364751664|FG001|Stage 2|Other than specified|0|||
105754183|NCT02062463|364751665|FG002|Stage 2|Other than specified|3|||
105754184|NCT02062463|364751666|FG003|Stage 2|Other than specified|1|||
105754185|NCT02062463|364751663|FG000|Stage 2|Withdrawal by Subject|0|||
105754186|NCT02062463|364751664|FG001|Stage 2|Withdrawal by Subject|0|||
105754187|NCT02062463|364751665|FG002|Stage 2|Withdrawal by Subject|15|||
105754188|NCT02062463|364751666|FG003|Stage 2|Withdrawal by Subject|10|||
105754189|NCT01956240|364751671|FG000|Overall Study|Lost to Follow-up|6|||
105754190|NCT01956240|364751672|FG001|Overall Study|Lost to Follow-up|20|||
105754191|NCT01956240|364751671|FG000|Overall Study|Adverse Event|17|||
105754192|NCT01956240|364751672|FG001|Overall Study|Adverse Event|4|||
105754193|NCT00600028|364751675|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105754194|NCT00600028|364751676|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
105949494|NCT00355030|365480465|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
105754195|NCT00600028|364751675|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
105754196|NCT00600028|364751676|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
105949495|NCT00355030|365480464|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
105949496|NCT00355030|365480465|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
105949497|NCT00355030|365480464|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
105949498|NCT00355030|365480465|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
105802217|NCT01623830|364932548|FG001|Overall Study|Withdrawal by Subject|7|||
105802218|NCT01623830|364932547|FG000|Overall Study|Exclusion from Study|1|||
105802219|NCT01623830|364932548|FG001|Overall Study|Exclusion from Study|2|||
105802220|NCT04242186|364932549|FG000|Overall Study|Death|5|||
105802221|NCT01792284|364932550|FG000|Lead-in Period|Adverse Event|15|||
105802222|NCT01792284|364932551|FG001|Lead-in Period|Adverse Event|0|||
105802223|NCT01792284|364932552|FG002|Lead-in Period|Adverse Event|0|||
105802224|NCT01792284|364932550|FG000|Lead-in Period|Lost to Follow-up|2|||
105802225|NCT01792284|364932551|FG001|Lead-in Period|Lost to Follow-up|0|||
105802226|NCT01792284|364932552|FG002|Lead-in Period|Lost to Follow-up|0|||
105802227|NCT01792284|364932550|FG000|Lead-in Period|Protocol Violation|1|||
105802228|NCT01792284|364932551|FG001|Lead-in Period|Protocol Violation|0|||
105802229|NCT01792284|364932552|FG002|Lead-in Period|Protocol Violation|0|||
105802230|NCT01792284|364932550|FG000|Lead-in Period|Withdrawal by Subject|10|||
105802231|NCT01792284|364932551|FG001|Lead-in Period|Withdrawal by Subject|0|||
105802232|NCT01792284|364932552|FG002|Lead-in Period|Withdrawal by Subject|0|||
105802233|NCT01792284|364932550|FG000|Lead-in Period|Physician Decision|1|||
105802234|NCT01792284|364932551|FG001|Lead-in Period|Physician Decision|0|||
105802235|NCT01792284|364932552|FG002|Lead-in Period|Physician Decision|0|||
105802236|NCT01792284|364932550|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
105949499|NCT00355030|365480464|FG000|Study Period 1 Treatment|Physician Decision|0|||
105949500|NCT00355030|365480465|FG001|Study Period 1 Treatment|Physician Decision|1|||
105802237|NCT01792284|364932551|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
105802238|NCT01792284|364932552|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
105802239|NCT01792284|364932550|FG000|Randomization Period 1|Withdrawal by Subject|0|||
105802240|NCT01792284|364932551|FG001|Randomization Period 1|Withdrawal by Subject|1|||
105802241|NCT01792284|364932552|FG002|Randomization Period 1|Withdrawal by Subject|1|||
105802242|NCT01792284|364932550|FG000|Randomization Period 1|Physician Decision|0|||
105802243|NCT01792284|364932551|FG001|Randomization Period 1|Physician Decision|1|||
105802244|NCT01792284|364932552|FG002|Randomization Period 1|Physician Decision|1|||
105802245|NCT01792284|364932550|FG000|Randomization Period 1|Adverse Event|0|||
105802246|NCT01792284|364932551|FG001|Randomization Period 1|Adverse Event|0|||
105949501|NCT00355030|365480464|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
105949502|NCT00355030|365480465|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
105949503|NCT00355030|365480464|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
105949504|NCT00355030|365480465|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
105949505|NCT00355030|365480464|FG000|Study Period 1 Treatment|Other|2|||
105949506|NCT00355030|365480465|FG001|Study Period 1 Treatment|Other|6|||
105949507|NCT00355030|365480464|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
105949508|NCT00355030|365480465|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
105949509|NCT00355030|365480464|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
105949510|NCT00355030|365480465|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
105949511|NCT03046446|365480466|FG000|Overall Study|Lack of Efficacy|7|||
105949512|NCT03046446|365480466|FG000|Overall Study|Adverse Event|6|||
105754197|NCT00600028|364751675|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
105754198|NCT00600028|364751676|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
105754199|NCT01830816|364751679|FG000|Overall Study|Progressive Disease|12|||
105754200|NCT01830816|364751680|FG001|Overall Study|Progressive Disease|7|||
105754201|NCT01830816|364751681|FG002|Overall Study|Progressive Disease|7|||
105754202|NCT01830816|364751679|FG000|Overall Study|Adverse Event|3|||
105754203|NCT01830816|364751680|FG001|Overall Study|Adverse Event|4|||
105754204|NCT01830816|364751681|FG002|Overall Study|Adverse Event|0|||
105754205|NCT01830816|364751679|FG000|Overall Study|Study Terminated by Sponsor|1|||
105754206|NCT01830816|364751680|FG001|Overall Study|Study Terminated by Sponsor|1|||
105754207|NCT01830816|364751681|FG002|Overall Study|Study Terminated by Sponsor|0|||
105754208|NCT01830816|364751679|FG000|Overall Study|Withdrawal by Subject|1|||
105754209|NCT01830816|364751680|FG001|Overall Study|Withdrawal by Subject|1|||
105754210|NCT01830816|364751681|FG002|Overall Study|Withdrawal by Subject|0|||
105754211|NCT01830816|364751679|FG000|Overall Study|Lost to Follow-up|0|||
105754212|NCT01830816|364751680|FG001|Overall Study|Lost to Follow-up|1|||
105754213|NCT01830816|364751681|FG002|Overall Study|Lost to Follow-up|0|||
105754214|NCT01830816|364751679|FG000|Overall Study|Symptomatic Deterioration|1|||
105754215|NCT01830816|364751680|FG001|Overall Study|Symptomatic Deterioration|0|||
105754216|NCT01830816|364751681|FG002|Overall Study|Symptomatic Deterioration|0|||
105754217|NCT01830816|364751679|FG000|Overall Study|Reason not Specified|2|||
105754218|NCT01830816|364751680|FG001|Overall Study|Reason not Specified|0|||
105754219|NCT01830816|364751681|FG002|Overall Study|Reason not Specified|0|||
105754220|NCT03587584|364751682|FG000|Overall Study|SOC deviations|4|||
105802247|NCT01792284|364932552|FG002|Randomization Period 1|Adverse Event|2|||
105802248|NCT01792284|364932550|FG000|Randomization Period 1|Lost to Follow-up|0|||
105802249|NCT01792284|364932551|FG001|Randomization Period 1|Lost to Follow-up|0|||
105802250|NCT01792284|364932552|FG002|Randomization Period 1|Lost to Follow-up|1|||
105802251|NCT01792284|364932550|FG000|Randomization Period 2|Protocol Violation|0|||
105802252|NCT01792284|364932551|FG001|Randomization Period 2|Protocol Violation|1|||
105802253|NCT01792284|364932552|FG002|Randomization Period 2|Protocol Violation|0|||
105802254|NCT01792284|364932550|FG000|Randomization Period 2|Withdrawal by Subject|0|||
105802255|NCT01792284|364932551|FG001|Randomization Period 2|Withdrawal by Subject|2|||
105802256|NCT01792284|364932552|FG002|Randomization Period 2|Withdrawal by Subject|0|||
105802257|NCT02257632|364932553|FG000|Overall Study|Withdrawal by Subject|0|||
105802258|NCT02257632|364932554|FG001|Overall Study|Withdrawal by Subject|1|||
105802259|NCT02257632|364932553|FG000|Overall Study|Adverse Event|1|||
105802260|NCT02257632|364932554|FG001|Overall Study|Adverse Event|2|||
105802261|NCT01605461|364932555|FG000|Overall Study|Lost to Follow-up|3|||
105802262|NCT01605461|364932555|FG000|Overall Study|Withdrawal by Subject|1|||
105802263|NCT01169649|364932556|FG000|Overall Study|Patient Not Treated|3|||
105802264|NCT01847313|364932557|FG000|Overall Study|Death|0|||
105802265|NCT01847313|364932558|FG001|Overall Study|Death|1|||
105802266|NCT01847313|364932557|FG000|Overall Study|Withdrawal by Subject|0|||
105802267|NCT01847313|364932558|FG001|Overall Study|Withdrawal by Subject|1|||
105802268|NCT02370784|364932559|FG000|Overall Study|Patient started prohibited medication|0|||
105802269|NCT02370784|364932560|FG001|Overall Study|Patient started prohibited medication|1|||
105802270|NCT02962882|364932562|FG000|Overall Study|Adverse Event|2|||
105802271|NCT02962882|364932562|FG000|Overall Study|Withdrawal by Subject|2|||
105802272|NCT02962882|364932562|FG000|Overall Study|Transfer from ICU|32|||
105802273|NCT01663714|364932563|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
105802274|NCT01663714|364932563|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
105802275|NCT01663714|364932563|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
105802276|NCT01663714|364932563|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
105802277|NCT01663714|364932563|FG000|Long-Term Follow-Up|Death|4|||
105802278|NCT01663714|364932563|FG000|Long-Term Follow-Up|Non-compliance|1|||
105802279|NCT02280421|364932564|FG000|Washout (2 Weeks)|Adverse Event|0|||
105802280|NCT02280421|364932565|FG001|Washout (2 Weeks)|Adverse Event|1|||
105802281|NCT02280421|364932564|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
105802282|NCT02280421|364932565|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
105802283|NCT00515073|364932570|FG000|Overall Study|Withdrawal by Subject|1|||
105802284|NCT00515073|364932570|FG000|Overall Study|Physician Decision|1|||
105802285|NCT02764489|364932571|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
105802286|NCT02764489|364932572|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
105802287|NCT02764489|364932571|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
105802288|NCT02764489|364932572|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
105802289|NCT02764489|364932571|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
105802290|NCT02764489|364932572|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
105802291|NCT02764489|364932571|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
105802292|NCT02764489|364932572|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
105802293|NCT00660790|364932575|FG000|Baseline to 3 Months|Death|1|||
105802294|NCT00660790|364932575|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
105802295|NCT00660790|364932575|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
105802296|NCT03549130|364932576|FG000|Overall Study|Adverse Event|0|||
105802297|NCT03549130|364932577|FG001|Overall Study|Adverse Event|1|||
105802298|NCT03549130|364932576|FG000|Overall Study|Lost to Follow-up|0|||
105802299|NCT03549130|364932577|FG001|Overall Study|Lost to Follow-up|1|||
105802300|NCT02038634|364932578|FG000|Overall Study|Lost to Follow-up|0|||
105802301|NCT02038634|364932579|FG001|Overall Study|Lost to Follow-up|1|||
105802302|NCT00463866|364932580|FG000|Overall Study|Adverse Event|70|||
105802303|NCT00463866|364932581|FG001|Overall Study|Adverse Event|93|||
105802304|NCT00463866|364932580|FG000|Overall Study|Withdrawal by Subject|81|||
105802305|NCT00463866|364932581|FG001|Overall Study|Withdrawal by Subject|79|||
106016483|NCT04033445|365724455|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
106016484|NCT04033445|365724456|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
106016485|NCT04033445|365724457|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
106016486|NCT04033445|365724458|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
106016487|NCT04033445|365724459|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
106016488|NCT04033445|365724460|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
106016489|NCT04033445|365724447|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
106016490|NCT04033445|365724448|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
106016491|NCT04033445|365724449|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105802306|NCT00463866|364932580|FG000|Overall Study|Lost to Follow-up|46|||
105802307|NCT00463866|364932581|FG001|Overall Study|Lost to Follow-up|55|||
105802308|NCT00463866|364932580|FG000|Overall Study|Incorrect Enrolment|64|||
106016492|NCT04033445|365724450|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105802309|NCT00463866|364932581|FG001|Overall Study|Incorrect Enrolment|66|||
105802310|NCT00463866|364932580|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
105802311|NCT00463866|364932581|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
105802312|NCT00463866|364932580|FG000|Overall Study|Safety Reason|1|||
105802313|NCT00463866|364932581|FG001|Overall Study|Safety Reason|3|||
105949513|NCT03046446|365480466|FG000|Overall Study|Lost to Follow-up|3|||
105949514|NCT03046446|365480466|FG000|Overall Study|Withdrawal by Subject|14|||
105949515|NCT03046446|365480466|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
105949516|NCT03046446|365480466|FG000|Overall Study|Disease Progression (see caveats)|25|||
105949517|NCT03046446|365480466|FG000|Overall Study|Non OA related knee surgery|1|||
105949518|NCT01493089|365480467|FG000|Overall Study|Protocol Violation|2|||
105949519|NCT01493089|365480468|FG001|Overall Study|Protocol Violation|2|||
105949520|NCT01493089|365480467|FG000|Overall Study|Withdrawal by Subject|1|||
105949521|NCT01493089|365480468|FG001|Overall Study|Withdrawal by Subject|0|||
105754221|NCT03587584|364751683|FG001|Overall Study|SOC deviations|6|||
105754222|NCT03587584|364751682|FG000|Overall Study|Incomplete data|0|||
105754223|NCT03587584|364751683|FG001|Overall Study|Incomplete data|3|||
105754224|NCT00387348|364751684|FG000|Overall Study|Death|1|||
105754225|NCT00387348|364751685|FG001|Overall Study|Death|1|||
105754226|NCT00387348|364751686|FG002|Overall Study|Death|0|||
105754227|NCT00387348|364751684|FG000|Overall Study|Physician Decision|1|||
105754228|NCT00387348|364751685|FG001|Overall Study|Physician Decision|0|||
105754229|NCT00387348|364751686|FG002|Overall Study|Physician Decision|1|||
105754230|NCT00387348|364751684|FG000|Overall Study|Withdrawal by Subject|0|||
105754231|NCT00387348|364751685|FG001|Overall Study|Withdrawal by Subject|2|||
105754232|NCT00387348|364751686|FG002|Overall Study|Withdrawal by Subject|2|||
105754233|NCT00387348|364751684|FG000|Overall Study|Adverse Event|1|||
105754234|NCT00387348|364751685|FG001|Overall Study|Adverse Event|0|||
105754235|NCT00387348|364751686|FG002|Overall Study|Adverse Event|1|||
105754236|NCT00830115|364751687|FG000|Overall Study|Adverse Event|2|||
105754237|NCT00830115|364751687|FG000|Overall Study|Improvement/recovery|1|||
105754238|NCT00571688|364751691|FG000|Overall Study|Lost to Follow-up|3|||
105754239|NCT00571688|364751692|FG001|Overall Study|Lost to Follow-up|6|||
105754240|NCT00571688|364751691|FG000|Overall Study|subject did not tolerate Consta|1|||
105754241|NCT00571688|364751692|FG001|Overall Study|subject did not tolerate Consta|0|||
105754242|NCT00571688|364751691|FG000|Overall Study|subject moved out of the area|1|||
105754243|NCT00571688|364751692|FG001|Overall Study|subject moved out of the area|0|||
105754244|NCT02022033|364751693|FG000|Overall Study|Physician Decision|1|||
105754245|NCT01103778|364751694|FG000|Overall Study|Lost to Follow-up|1|||
105754246|NCT01103778|364751694|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
105754247|NCT01103778|364751694|FG000|Overall Study|Screen failure|1|||
105754248|NCT03067129|364751695|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
105754249|NCT03067129|364751696|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
105754250|NCT03067129|364751697|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
105754251|NCT03067129|364751698|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
105754252|NCT03067129|364751695|FG000|Overall Study|Withdrawal by Subject|0|||
105754253|NCT03067129|364751696|FG001|Overall Study|Withdrawal by Subject|0|||
105754254|NCT03067129|364751697|FG002|Overall Study|Withdrawal by Subject|1|||
105754255|NCT03067129|364751698|FG003|Overall Study|Withdrawal by Subject|2|||
105754256|NCT03067129|364751695|FG000|Overall Study|Lost to Follow-up|5|||
105754257|NCT03067129|364751696|FG001|Overall Study|Lost to Follow-up|5|||
105754258|NCT03067129|364751697|FG002|Overall Study|Lost to Follow-up|4|||
105754259|NCT03067129|364751698|FG003|Overall Study|Lost to Follow-up|3|||
105754260|NCT03247413|364751699|FG000|Overall Study|Lost to Follow-up|28|||
105754261|NCT00565058|364751700|FG000|Overall Study|Adverse Event|1|||
105754262|NCT00565058|364751701|FG001|Overall Study|Adverse Event|0|||
105754263|NCT01838590|364751702|FG000|Overall Study|Lack of Efficacy|12|||
105754264|NCT01838590|364751703|FG001|Overall Study|Lack of Efficacy|4|||
105754265|NCT01838590|364751702|FG000|Overall Study|Lost to Follow-up|0|||
105754266|NCT01838590|364751703|FG001|Overall Study|Lost to Follow-up|1|||
105754267|NCT02802878|364751704|FG000|Overall Study|Withdrawal by Subject|3|||
105754268|NCT02802878|364751705|FG001|Overall Study|Withdrawal by Subject|3|||
105754269|NCT02802878|364751704|FG000|Overall Study|Protocol Violation|1|||
105754270|NCT02802878|364751705|FG001|Overall Study|Protocol Violation|0|||
105754271|NCT01996904|364751706|FG000|Overall Study|Lost to Follow-up|38|||
105754272|NCT01996904|364751707|FG001|Overall Study|Lost to Follow-up|27|||
105949522|NCT01493089|365480467|FG000|Overall Study|Physician Decision|0|||
105949523|NCT01493089|365480468|FG001|Overall Study|Physician Decision|1|||
105754273|NCT01608724|364751708|FG000|Overall Study|Withdrawal by Subject|131|||
105754274|NCT01608724|364751708|FG000|Overall Study|Lost to Follow-up|41|||
105754275|NCT01608724|364751708|FG000|Overall Study|Study-specific discontinuation criteria|32|||
105754276|NCT01608724|364751708|FG000|Overall Study|Adverse Event|29|||
105754277|NCT01608724|364751708|FG000|Overall Study|Protocol Violation|6|||
105754278|NCT01608724|364751708|FG000|Overall Study|bood sugar too high, etc.|3|||
105949524|NCT01870869|365480469|FG000|Overall Study|Implanted with nonstudy device|1|||
105949525|NCT01870869|365480470|FG001|Overall Study|Implanted with nonstudy device|3|||
105754279|NCT01608724|364751708|FG000|Overall Study|Safety reasons|1|||
105754280|NCT00717366|364751709|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
105754281|NCT00717366|364751710|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
105754282|NCT00717366|364751709|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
105754283|NCT00717366|364751710|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
105949526|NCT01870869|365480471|FG002|Overall Study|Implanted with nonstudy device|14|||
105949527|NCT01870869|365480472|FG003|Overall Study|Implanted with nonstudy device|4|||
105949528|NCT01870869|365480469|FG000|Overall Study|Death|0|||
105949529|NCT01870869|365480470|FG001|Overall Study|Death|0|||
105949530|NCT01870869|365480471|FG002|Overall Study|Death|7|||
105949531|NCT01870869|365480472|FG003|Overall Study|Death|1|||
105949532|NCT01870869|365480469|FG000|Overall Study|Subject choice|6|||
105949533|NCT01870869|365480470|FG001|Overall Study|Subject choice|2|||
105949534|NCT01870869|365480471|FG002|Overall Study|Subject choice|22|||
105949535|NCT01870869|365480472|FG003|Overall Study|Subject choice|8|||
105949536|NCT01870869|365480469|FG000|Overall Study|Lost to Follow-up|10|||
105949537|NCT01870869|365480470|FG001|Overall Study|Lost to Follow-up|2|||
105949538|NCT01870869|365480471|FG002|Overall Study|Lost to Follow-up|25|||
105949539|NCT01870869|365480472|FG003|Overall Study|Lost to Follow-up|3|||
105949540|NCT01870869|365480469|FG000|Overall Study|Reason not Specified|1|||
105949541|NCT01870869|365480470|FG001|Overall Study|Reason not Specified|2|||
105949542|NCT01870869|365480471|FG002|Overall Study|Reason not Specified|20|||
105754284|NCT00717366|364751709|FG000|Core Study Period (20 Weeks)|Death|0|||
105754285|NCT00717366|364751710|FG001|Core Study Period (20 Weeks)|Death|1|||
105754286|NCT00717366|364751709|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
105754287|NCT00717366|364751710|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
105754288|NCT00717366|364751709|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
105754289|NCT00717366|364751710|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
105754290|NCT00717366|364751709|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
105754291|NCT00717366|364751710|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
105754292|NCT00717366|364751709|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
105754293|NCT00717366|364751710|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
105754294|NCT00622869|364751711|FG000|Overall Study|Subject Withdrew Consent|13|||
105754295|NCT00622869|364751712|FG001|Overall Study|Subject Withdrew Consent|17|||
105754296|NCT00622869|364751713|FG002|Overall Study|Subject Withdrew Consent|11|||
105754297|NCT00622869|364751711|FG000|Overall Study|Administrative Problems|11|||
105754298|NCT00622869|364751712|FG001|Overall Study|Administrative Problems|17|||
105754299|NCT00622869|364751713|FG002|Overall Study|Administrative Problems|13|||
105754300|NCT00622869|364751711|FG000|Overall Study|Death|12|||
105754301|NCT00622869|364751712|FG001|Overall Study|Death|15|||
105754302|NCT00622869|364751713|FG002|Overall Study|Death|10|||
105754303|NCT00622869|364751711|FG000|Overall Study|Lost to Follow-up|2|||
105754304|NCT00622869|364751712|FG001|Overall Study|Lost to Follow-up|4|||
105754305|NCT00622869|364751713|FG002|Overall Study|Lost to Follow-up|2|||
105754306|NCT00622869|364751711|FG000|Overall Study|Graft Loss|5|||
105754307|NCT00622869|364751712|FG001|Overall Study|Graft Loss|3|||
105754308|NCT00622869|364751713|FG002|Overall Study|Graft Loss|2|||
105754309|NCT00622869|364751711|FG000|Overall Study|Missing|0|||
105754310|NCT00622869|364751712|FG001|Overall Study|Missing|1|||
105754311|NCT00622869|364751713|FG002|Overall Study|Missing|1|||
105754312|NCT00438399|364751717|FG000|Overall Study|Lost to Follow-up|2|||
105754313|NCT00438399|364751718|FG001|Overall Study|Lost to Follow-up|2|||
105754314|NCT00438399|364751719|FG002|Overall Study|Lost to Follow-up|1|||
105754315|NCT00438399|364751720|FG003|Overall Study|Lost to Follow-up|1|||
105754316|NCT00438399|364751721|FG004|Overall Study|Lost to Follow-up|1|||
105754317|NCT00438399|364751722|FG005|Overall Study|Lost to Follow-up|1|||
105754318|NCT00438399|364751717|FG000|Overall Study|Adverse Event|0|||
105754319|NCT00438399|364751718|FG001|Overall Study|Adverse Event|0|||
105754320|NCT00438399|364751719|FG002|Overall Study|Adverse Event|1|||
105754321|NCT00438399|364751720|FG003|Overall Study|Adverse Event|1|||
105754322|NCT00438399|364751721|FG004|Overall Study|Adverse Event|0|||
105754323|NCT00438399|364751722|FG005|Overall Study|Adverse Event|1|||
105754324|NCT00438399|364751717|FG000|Overall Study|Withdrawal by Subject|5|||
105754325|NCT00438399|364751718|FG001|Overall Study|Withdrawal by Subject|6|||
105754326|NCT00438399|364751719|FG002|Overall Study|Withdrawal by Subject|3|||
105754327|NCT00438399|364751720|FG003|Overall Study|Withdrawal by Subject|2|||
105754328|NCT00438399|364751721|FG004|Overall Study|Withdrawal by Subject|2|||
105754329|NCT00438399|364751722|FG005|Overall Study|Withdrawal by Subject|2|||
105754330|NCT00438399|364751717|FG000|Overall Study|Protocol Violation|0|||
105754331|NCT00438399|364751718|FG001|Overall Study|Protocol Violation|0|||
105949543|NCT01870869|365480472|FG003|Overall Study|Reason not Specified|4|||
105754332|NCT00438399|364751719|FG002|Overall Study|Protocol Violation|1|||
105754333|NCT00438399|364751720|FG003|Overall Study|Protocol Violation|0|||
105754334|NCT00438399|364751721|FG004|Overall Study|Protocol Violation|0|||
105754335|NCT00438399|364751722|FG005|Overall Study|Protocol Violation|1|||
105754336|NCT00438399|364751717|FG000|Overall Study|Subje stopped study|0|||
105754337|NCT00438399|364751718|FG001|Overall Study|Subje stopped study|0|||
105754338|NCT00438399|364751719|FG002|Overall Study|Subje stopped study|1|||
105949544|NCT01870869|365480469|FG000|Overall Study|Not evaluable|10|||
105754339|NCT00438399|364751720|FG003|Overall Study|Subje stopped study|0|||
105949545|NCT01870869|365480470|FG001|Overall Study|Not evaluable|5|||
105949546|NCT01870869|365480471|FG002|Overall Study|Not evaluable|42|||
105754340|NCT00438399|364751721|FG004|Overall Study|Subje stopped study|0|||
105949547|NCT01870869|365480472|FG003|Overall Study|Not evaluable|10|||
105754341|NCT00438399|364751722|FG005|Overall Study|Subje stopped study|0|||
105754342|NCT00438399|364751717|FG000|Overall Study|Pregnancy|0|||
105754343|NCT00438399|364751718|FG001|Overall Study|Pregnancy|0|||
105754344|NCT00438399|364751719|FG002|Overall Study|Pregnancy|0|||
105754345|NCT00438399|364751720|FG003|Overall Study|Pregnancy|0|||
105754346|NCT00438399|364751721|FG004|Overall Study|Pregnancy|0|||
105754347|NCT00438399|364751722|FG005|Overall Study|Pregnancy|1|||
105754348|NCT00438399|364751717|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
105754349|NCT00438399|364751718|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
105754350|NCT00438399|364751719|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
105754351|NCT00438399|364751720|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
105760920|NCT04362813|364778063|FG000|Overall Study|Lost to Follow-up|1|||
105760921|NCT04362813|364778064|FG001|Overall Study|Lost to Follow-up|1|||
105760922|NCT04362813|364778063|FG000|Overall Study|Enrolled but did not receive treatment|2|||
105760923|NCT04362813|364778064|FG001|Overall Study|Enrolled but did not receive treatment|4|||
105760924|NCT00961116|364778065|FG000|Washout Period of 7 Days|Adverse Event|1|||
105760925|NCT00961116|364778066|FG001|Washout Period of 7 Days|Adverse Event|1|||
105760926|NCT00961116|364778065|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
105760927|NCT00961116|364778066|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105760928|NCT00961116|364778065|FG000|Washout Period of 7 Days|Protocol Violation|0|||
105760929|NCT00961116|364778066|FG001|Washout Period of 7 Days|Protocol Violation|1|||
105760930|NCT03407170|364778070|FG000|Overall Study|Adverse Event|1|||
105760931|NCT00425100|364778076|FG000|Overall Study|Adverse Event|36|||
105760932|NCT00425100|364778076|FG000|Overall Study|Lack of Efficacy|4|||
105760933|NCT00425100|364778076|FG000|Overall Study|Lost to Follow-up|2|||
105760934|NCT00425100|364778076|FG000|Overall Study|Protocol Violation|4|||
105760935|NCT00425100|364778076|FG000|Overall Study|Withdrawal by Subject|7|||
105760936|NCT01235728|364778078|FG000|Overall Study|Protocol Violation|0|||
105760937|NCT01235728|364778079|FG001|Overall Study|Protocol Violation|0|||
105760938|NCT01235728|364778080|FG002|Overall Study|Protocol Violation|0|||
105760939|NCT01235728|364778081|FG003|Overall Study|Protocol Violation|1|||
105760940|NCT01235728|364778082|FG004|Overall Study|Protocol Violation|0|||
105760941|NCT01235728|364778083|FG005|Overall Study|Protocol Violation|0|||
105760942|NCT01235728|364778084|FG006|Overall Study|Protocol Violation|0|||
105760943|NCT01235728|364778085|FG007|Overall Study|Protocol Violation|0|||
105760944|NCT02565615|364778086|FG000|Overall Study|Death|0|||
105760945|NCT02565615|364778087|FG001|Overall Study|Death|1|||
105760946|NCT02565615|364778088|FG002|Overall Study|Death|0|||
105760947|NCT02565615|364778089|FG003|Overall Study|Death|0|||
105760948|NCT02565615|364778090|FG004|Overall Study|Death|4|||
105760949|NCT02565615|364778086|FG000|Overall Study|Not willing to participate in study|2|||
105760950|NCT02565615|364778087|FG001|Overall Study|Not willing to participate in study|21|||
105760951|NCT02565615|364778088|FG002|Overall Study|Not willing to participate in study|0|||
105760952|NCT02565615|364778089|FG003|Overall Study|Not willing to participate in study|1|||
105760953|NCT02565615|364778090|FG004|Overall Study|Not willing to participate in study|169|||
105760954|NCT02565615|364778086|FG000|Overall Study|Lost to Follow-up|0|||
105760955|NCT02565615|364778087|FG001|Overall Study|Lost to Follow-up|4|||
105760956|NCT02565615|364778088|FG002|Overall Study|Lost to Follow-up|0|||
105760957|NCT02565615|364778089|FG003|Overall Study|Lost to Follow-up|1|||
105760958|NCT02565615|364778090|FG004|Overall Study|Lost to Follow-up|765|||
105760959|NCT02565615|364778086|FG000|Overall Study|Not meeting eligibility criteria|0|||
105760960|NCT02565615|364778087|FG001|Overall Study|Not meeting eligibility criteria|7|||
105760961|NCT02565615|364778088|FG002|Overall Study|Not meeting eligibility criteria|0|||
105760962|NCT02565615|364778089|FG003|Overall Study|Not meeting eligibility criteria|0|||
105760963|NCT02565615|364778090|FG004|Overall Study|Not meeting eligibility criteria|25|||
105760964|NCT02565615|364778086|FG000|Overall Study|Reason not defined|0|||
105760965|NCT02565615|364778087|FG001|Overall Study|Reason not defined|2|||
105760966|NCT02565615|364778088|FG002|Overall Study|Reason not defined|0|||
105760967|NCT02565615|364778089|FG003|Overall Study|Reason not defined|1|||
105760968|NCT02565615|364778090|FG004|Overall Study|Reason not defined|62|||
105760969|NCT02565615|364778086|FG000|Overall Study|Adverse Event|1|||
105760970|NCT02565615|364778087|FG001|Overall Study|Adverse Event|1|||
105760971|NCT02565615|364778088|FG002|Overall Study|Adverse Event|0|||
105760972|NCT02565615|364778089|FG003|Overall Study|Adverse Event|0|||
105760973|NCT02565615|364778090|FG004|Overall Study|Adverse Event|9|||
105760974|NCT02565615|364778086|FG000|Overall Study|Untreated|0|||
105760975|NCT02565615|364778087|FG001|Overall Study|Untreated|0|||
105760976|NCT02565615|364778088|FG002|Overall Study|Untreated|0|||
105760977|NCT02565615|364778089|FG003|Overall Study|Untreated|0|||
105760978|NCT02565615|364778090|FG004|Overall Study|Untreated|567|||
105760979|NCT00861380|364778093|FG000|Overall Study|Withdrawal Information not recorded|8427|||
105760980|NCT00861380|364778094|FG001|Overall Study|Withdrawal Information not recorded|9112|||
105760981|NCT00861380|364778095|FG002|Overall Study|Withdrawal Information not recorded|8872|||
105760982|NCT00861380|364778096|FG003|Overall Study|Withdrawal Information not recorded|3689|||
105760983|NCT00861380|364778097|FG004|Overall Study|Withdrawal Information not recorded|1812|||
105802314|NCT00463866|364932580|FG000|Overall Study|Mis-Randomization of subject|0|||
105802315|NCT00463866|364932581|FG001|Overall Study|Mis-Randomization of subject|1|||
105802316|NCT00463866|364932580|FG000|Overall Study|Other|22|||
105802317|NCT00463866|364932581|FG001|Overall Study|Other|22|||
105802318|NCT02265952|364932582|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
105802319|NCT02265952|364932583|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
105802320|NCT02265952|364932582|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
105802321|NCT02265952|364932583|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
105802322|NCT04313283|364932587|FG000|Overall Study|did not complete intervention|4|||
105802323|NCT01170364|364932609|FG000|Overall Study|Protocol Violation|4|||
105802324|NCT01170364|364932610|FG001|Overall Study|Protocol Violation|1|||
105802325|NCT04132232|364932611|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
105802326|NCT04132232|364932612|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
105802327|NCT04132232|364932611|FG000|Overall Study|Lost to Follow-up|6|||
105802328|NCT04132232|364932612|FG001|Overall Study|Lost to Follow-up|7|||
105802329|NCT00368537|364932618|FG000|Randomization|No study drug dosed|13|||
105802330|NCT00368537|364932619|FG001|Randomization|No study drug dosed|6|||
105802331|NCT00368537|364932618|FG000|Baseline Participants|Lost to Follow-up|16|||
105802332|NCT00368537|364932619|FG001|Baseline Participants|Lost to Follow-up|17|||
105802333|NCT00368537|364932618|FG000|Baseline Participants|Withdrawal by Subject|6|||
105802334|NCT00368537|364932619|FG001|Baseline Participants|Withdrawal by Subject|4|||
105802335|NCT00368537|364932618|FG000|Baseline Participants|Death|1|||
105802336|NCT00368537|364932619|FG001|Baseline Participants|Death|2|||
105802337|NCT00368537|364932618|FG000|Baseline Participants|No susceptibility|1|||
105802338|NCT00368537|364932619|FG001|Baseline Participants|No susceptibility|0|||
105802339|NCT00368537|364932618|FG000|Baseline Participants|Patient uncompliant|0|||
105802340|NCT00368537|364932619|FG001|Baseline Participants|Patient uncompliant|1|||
105802341|NCT01368276|364932631|FG000|Overall Study|Death|1|||
105802342|NCT01368276|364932632|FG001|Overall Study|Death|10|||
105802343|NCT01427920|364932633|FG000|Overall Study|Adverse Event|1|||
105802344|NCT01427920|364932634|FG001|Overall Study|Adverse Event|2|||
105802345|NCT01427920|364932633|FG000|Overall Study|Lack of Efficacy|1|||
105802346|NCT01427920|364932634|FG001|Overall Study|Lack of Efficacy|0|||
105802347|NCT01427920|364932633|FG000|Overall Study|Protocol Violation|1|||
105802348|NCT01427920|364932634|FG001|Overall Study|Protocol Violation|3|||
105802349|NCT01427920|364932633|FG000|Overall Study|Withdrawal Criteria|4|||
105802350|NCT01427920|364932634|FG001|Overall Study|Withdrawal Criteria|4|||
105802351|NCT01427920|364932633|FG000|Overall Study|Unclassified|2|||
105802352|NCT01427920|364932634|FG001|Overall Study|Unclassified|8|||
105802353|NCT01717456|364932636|FG000|End of Treatment|Physician Decision|0|||
105802354|NCT01717456|364932637|FG001|End of Treatment|Physician Decision|1|||
105802355|NCT01717456|364932636|FG000|End of Treatment|Lost to Follow-up|0|||
105802356|NCT01717456|364932637|FG001|End of Treatment|Lost to Follow-up|1|||
105802357|NCT01717456|364932636|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
105802358|NCT01717456|364932637|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
105802359|NCT01967888|364932644|FG000|Overall Study|Lost to Follow-up|6|||
105802360|NCT01967888|364932645|FG001|Overall Study|Lost to Follow-up|4|||
105802361|NCT01967888|364932644|FG000|Overall Study|Withdrawal by Subject|1|||
105802362|NCT01967888|364932645|FG001|Overall Study|Withdrawal by Subject|1|||
105802363|NCT01967888|364932644|FG000|Overall Study|Did Not Have Transplant|1|||
105802364|NCT01967888|364932645|FG001|Overall Study|Did Not Have Transplant|0|||
105802365|NCT01967888|364932644|FG000|Overall Study|Research visit not done, data recorded|1|||
105802366|NCT01967888|364932645|FG001|Overall Study|Research visit not done, data recorded|0|||
105802367|NCT01967888|364932644|FG000|Overall Study|Subject excluded after randomization|1|||
105802368|NCT01967888|364932645|FG001|Overall Study|Subject excluded after randomization|0|||
105802369|NCT01967888|364932644|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
105802370|NCT01967888|364932645|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
105802371|NCT01967888|364932644|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
105802372|NCT01967888|364932645|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
105802373|NCT01401478|364932648|FG000|Overall Study|Study drug not available|6|||
105802374|NCT01401478|364932648|FG000|Overall Study|Adverse Event|5|||
105802375|NCT01401478|364932648|FG000|Overall Study|Hyperphosphatemia|5|||
105802376|NCT01401478|364932648|FG000|Overall Study|Lost to Follow-up|5|||
105949548|NCT01073293|365480473|FG000|Overall Study|Lost to Follow-up|0|||
105949549|NCT01073293|365480474|FG001|Overall Study|Lost to Follow-up|1|||
105802377|NCT01401478|364932648|FG000|Overall Study|Kidney transplantation|3|||
105802378|NCT01401478|364932648|FG000|Overall Study|Withdrawal by Subject|3|||
105802379|NCT01401478|364932648|FG000|Overall Study|Blood samples not available|1|||
105802380|NCT01401478|364932648|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
105802381|NCT01401478|364932648|FG000|Overall Study|Low intact parathyroid hormone|1|||
105802382|NCT01401478|364932648|FG000|Overall Study|Serious adverse event|1|||
105802383|NCT03255031|364932649|FG000|Overall Study|Adverse Event|5|||
105802384|NCT03255031|364932650|FG001|Overall Study|Adverse Event|3|||
105802385|NCT03255031|364932649|FG000|Overall Study|Physician Decision|2|||
105802386|NCT03255031|364932650|FG001|Overall Study|Physician Decision|1|||
105802387|NCT03255031|364932649|FG000|Overall Study|Withdrawal by Subject|9|||
105802388|NCT03255031|364932650|FG001|Overall Study|Withdrawal by Subject|3|||
105802389|NCT01664494|364932653|FG000|Overall Study|Withdrawal by Subject|27|||
105802390|NCT01664494|364932653|FG000|Overall Study|Death|18|||
105802391|NCT01664494|364932653|FG000|Overall Study|Other|49|||
105802392|NCT01664494|364932653|FG000|Overall Study|Lost to Follow-up|99|||
105802393|NCT01138150|364932656|FG000|Overall Study|blood unable to be processed|0|||
105802394|NCT01138150|364932657|FG001|Overall Study|blood unable to be processed|1|||
105802395|NCT01138150|364932656|FG000|Overall Study|Physician Decision|1|||
105802396|NCT01138150|364932657|FG001|Overall Study|Physician Decision|0|||
105802397|NCT01328054|364932659|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
105802398|NCT01328054|364932660|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
105802399|NCT01328054|364932659|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
105802400|NCT01328054|364932660|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
105802401|NCT01328054|364932659|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
105802402|NCT01328054|364932660|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
105802403|NCT02390219|364932669|FG000|Overall Study|Death|1|||
105802404|NCT02390219|364932669|FG000|Overall Study|Physician Decision|1|||
105802405|NCT02390219|364932669|FG000|Overall Study|Adverse Event|6|||
105802406|NCT02390219|364932669|FG000|Overall Study|Withdrawal by Subject|1|||
105802407|NCT02390219|364932669|FG000|Overall Study|Lost to Follow-up|2|||
105802408|NCT02390219|364932669|FG000|Overall Study|Other|2|||
105802409|NCT01337050|364932670|FG000|Overall Study|Death|0|||
105802410|NCT01337050|364932671|FG001|Overall Study|Death|0|||
105802411|NCT01337050|364932672|FG002|Overall Study|Death|4|||
105802412|NCT01337050|364932670|FG000|Overall Study|Other|4|||
105802413|NCT01337050|364932671|FG001|Overall Study|Other|6|||
105802414|NCT01337050|364932672|FG002|Overall Study|Other|8|||
105802415|NCT01337050|364932670|FG000|Overall Study|Participants refused further follow-up|0|||
105802416|NCT01337050|364932671|FG001|Overall Study|Participants refused further follow-up|7|||
105802417|NCT01337050|364932672|FG002|Overall Study|Participants refused further follow-up|7|||
105802418|NCT00656019|364932673|FG000|Overall Study|Not Eligible|10|||
105802419|NCT00656019|364932674|FG001|Overall Study|Not Eligible|0|||
105802420|NCT00656019|364932675|FG002|Overall Study|Not Eligible|0|||
105802421|NCT00656019|364932676|FG003|Overall Study|Not Eligible|0|||
105802422|NCT00656019|364932673|FG000|Overall Study|Withdrawal by Subject|2|||
105802423|NCT00656019|364932674|FG001|Overall Study|Withdrawal by Subject|0|||
105802424|NCT00656019|364932675|FG002|Overall Study|Withdrawal by Subject|0|||
105802425|NCT00656019|364932676|FG003|Overall Study|Withdrawal by Subject|0|||
105802426|NCT00656019|364932673|FG000|Overall Study|Lost to Follow-up|2|||
105754352|NCT00438399|364751721|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
105754353|NCT00438399|364751722|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
105754354|NCT01364233|364751723|FG000|Overall Study|Lost to Follow-up|1|||
105754355|NCT00302718|364751724|FG000|Overall Study|Participant left the hospital|1|||
105754356|NCT00302718|364751725|FG001|Overall Study|Participant left the hospital|0|||
105754357|NCT00302718|364751726|FG002|Overall Study|Participant left the hospital|0|||
105754358|NCT00302718|364751727|FG003|Overall Study|Participant left the hospital|1|||
105754359|NCT00302718|364751724|FG000|Overall Study|Withdrawal by Subject|0|||
105754360|NCT00302718|364751725|FG001|Overall Study|Withdrawal by Subject|1|||
105754361|NCT00302718|364751726|FG002|Overall Study|Withdrawal by Subject|0|||
105754362|NCT00302718|364751727|FG003|Overall Study|Withdrawal by Subject|0|||
105754363|NCT00302718|364751724|FG000|Overall Study|Participant left primary care setting|0|||
105754364|NCT00302718|364751725|FG001|Overall Study|Participant left primary care setting|0|||
105754365|NCT00302718|364751726|FG002|Overall Study|Participant left primary care setting|2|||
105754366|NCT00302718|364751727|FG003|Overall Study|Participant left primary care setting|1|||
105754367|NCT04900038|364751728|FG000|Overall Study|Adverse Event|1|||
105754368|NCT04900038|364751729|FG001|Overall Study|Adverse Event|0|||
105754369|NCT04900038|364751730|FG002|Overall Study|Adverse Event|1|||
105754370|NCT04900038|364751731|FG003|Overall Study|Adverse Event|1|||
105754371|NCT04900038|364751728|FG000|Overall Study|Withdrawal by Subject|0|||
105754372|NCT04900038|364751729|FG001|Overall Study|Withdrawal by Subject|1|||
105754373|NCT04900038|364751730|FG002|Overall Study|Withdrawal by Subject|0|||
105754374|NCT04900038|364751731|FG003|Overall Study|Withdrawal by Subject|0|||
106016493|NCT04033445|365724451|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105754375|NCT04900038|364751728|FG000|Overall Study|Study terminated by sponsor|18|||
105754376|NCT04900038|364751729|FG001|Overall Study|Study terminated by sponsor|15|||
106016494|NCT04033445|365724452|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105802427|NCT00656019|364932674|FG001|Overall Study|Lost to Follow-up|1|||
105802428|NCT00656019|364932675|FG002|Overall Study|Lost to Follow-up|0|||
105802429|NCT00656019|364932676|FG003|Overall Study|Lost to Follow-up|0|||
105802430|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
105802431|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
105802432|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
105802433|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
106016495|NCT04033445|365724453|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105754377|NCT04900038|364751730|FG002|Overall Study|Study terminated by sponsor|17|||
105754378|NCT04900038|364751731|FG003|Overall Study|Study terminated by sponsor|14|||
105754379|NCT04900038|364751728|FG000|Overall Study|Protocol Deviation|1|||
105754380|NCT04900038|364751729|FG001|Overall Study|Protocol Deviation|1|||
105754381|NCT04900038|364751730|FG002|Overall Study|Protocol Deviation|0|||
105754382|NCT04900038|364751731|FG003|Overall Study|Protocol Deviation|0|||
105754383|NCT04900038|364751728|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
105754384|NCT04900038|364751729|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
105754385|NCT04900038|364751730|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
105754386|NCT04900038|364751731|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
105754387|NCT04900038|364751728|FG000|Overall Study|Lost to Follow-up|0|||
105754388|NCT04900038|364751729|FG001|Overall Study|Lost to Follow-up|0|||
105754389|NCT04900038|364751730|FG002|Overall Study|Lost to Follow-up|0|||
105754390|NCT04900038|364751731|FG003|Overall Study|Lost to Follow-up|1|||
105754391|NCT04111107|364751732|FG000|Overall Study|Withdrawal by Subject|6|||
105754392|NCT04111107|364751732|FG000|Overall Study|Declining Health|5|||
105754393|NCT01714817|364751733|FG000|Year 1 Period|Lack of Efficacy|11|||
105754394|NCT01714817|364751734|FG001|Year 1 Period|Lack of Efficacy|9|||
105754395|NCT01714817|364751733|FG000|Year 1 Period|Adverse Event|20|||
105754396|NCT01714817|364751734|FG001|Year 1 Period|Adverse Event|17|||
105754397|NCT01714817|364751733|FG000|Year 1 Period|Withdrawal by Subject|6|||
105754398|NCT01714817|364751734|FG001|Year 1 Period|Withdrawal by Subject|7|||
105754399|NCT01714817|364751733|FG000|Year 1 Period|Death|1|||
105754400|NCT01714817|364751734|FG001|Year 1 Period|Death|1|||
105754401|NCT01714817|364751733|FG000|Year 1 Period|Lost to Follow-up|0|||
105754402|NCT01714817|364751734|FG001|Year 1 Period|Lost to Follow-up|2|||
105754403|NCT01714817|364751733|FG000|Year 1 Period|Poor / non-compliance|0|||
105754404|NCT01714817|364751734|FG001|Year 1 Period|Poor / non-compliance|1|||
105754405|NCT01714817|364751733|FG000|Year 1 Period|Pregnancy|2|||
105754406|NCT01714817|364751734|FG001|Year 1 Period|Pregnancy|0|||
105754407|NCT01714817|364751733|FG000|Year 1 Period|Participant no longer meets criteria|6|||
105754408|NCT01714817|364751734|FG001|Year 1 Period|Participant no longer meets criteria|2|||
105754409|NCT01714817|364751733|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
105754410|NCT01714817|364751734|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
105754411|NCT01714817|364751733|FG000|Year 1 Period|Change in Concomitant Medication|0|||
105754412|NCT01714817|364751734|FG001|Year 1 Period|Change in Concomitant Medication|1|||
105754413|NCT01714817|364751733|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
105754414|NCT01714817|364751734|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
105754415|NCT01714817|364751733|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
105754416|NCT01714817|364751734|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
105754417|NCT01714817|364751733|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
105754418|NCT01714817|364751734|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
105754419|NCT01714817|364751733|FG000|Year 2 Period|Lack of Efficacy|4|||
105754420|NCT01714817|364751734|FG001|Year 2 Period|Lack of Efficacy|12|||
105754421|NCT01714817|364751733|FG000|Year 2 Period|Adverse Event|7|||
105754422|NCT01714817|364751734|FG001|Year 2 Period|Adverse Event|6|||
105754423|NCT01714817|364751733|FG000|Year 2 Period|Participant request to stop treatment|4|||
105754424|NCT01714817|364751734|FG001|Year 2 Period|Participant request to stop treatment|4|||
105754425|NCT01714817|364751733|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
105754426|NCT01714817|364751734|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
105754427|NCT01714817|364751733|FG000|Year 2 Period|Participant withdrew consent|1|||
105754428|NCT01714817|364751734|FG001|Year 2 Period|Participant withdrew consent|5|||
105754429|NCT01714817|364751733|FG000|Year 2 Period|Participant no longer meets criteria|1|||
105754430|NCT01714817|364751734|FG001|Year 2 Period|Participant no longer meets criteria|4|||
105754431|NCT01714817|364751733|FG000|Year 2 Period|Lost to Follow-up|2|||
105754432|NCT01714817|364751734|FG001|Year 2 Period|Lost to Follow-up|0|||
105754433|NCT01714817|364751733|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
105754434|NCT01714817|364751734|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
106016496|NCT04033445|365724454|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105754435|NCT01714817|364751733|FG000|Year 2 Period|Pregnancy|1|||
105754436|NCT01714817|364751734|FG001|Year 2 Period|Pregnancy|1|||
105754437|NCT01714817|364751733|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
105754438|NCT01714817|364751734|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
105754439|NCT01714817|364751733|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
105754440|NCT01714817|364751734|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
105754441|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
105754442|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
105754443|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
105754444|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
105754445|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
105754446|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
105754447|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
105802434|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
105802435|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Adverse Event|60|||
105802436|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Adverse Event|0|||
105802437|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Adverse Event|0|||
105802438|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Adverse Event|0|||
105802439|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Adverse Event|0|||
105802440|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
105802441|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
105802442|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
105802443|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
105802444|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
105802445|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Physician Decision|10|||
105802446|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Physician Decision|0|||
105802447|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Physician Decision|0|||
105802448|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Physician Decision|0|||
105802449|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Physician Decision|0|||
105802450|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
105802451|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
105802452|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
105802453|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
105802454|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
105802455|NCT01360632|364932679|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
105802456|NCT01360632|364932680|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
105802457|NCT01360632|364932681|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
105802458|NCT01360632|364932682|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
105802459|NCT01360632|364932683|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
105802460|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
105802461|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
105802462|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
105802463|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
105802464|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
105802465|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Adverse Event|0|||
105802466|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Adverse Event|3|||
105802467|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Adverse Event|9|||
105802468|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Adverse Event|3|||
105802469|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Adverse Event|0|||
105802470|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105802471|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105802472|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
105802473|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
105802474|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
105802475|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Physician Decision|0|||
105802476|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Physician Decision|0|||
105802477|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Physician Decision|0|||
105802478|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Physician Decision|1|||
105802479|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Physician Decision|0|||
105802480|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
105802481|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
105802482|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
105802483|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
105802484|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
105802485|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
105802486|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
105802487|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
105802488|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
105802489|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
105802490|NCT01360632|364932679|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
105802491|NCT01360632|364932680|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
105802492|NCT01360632|364932681|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
105802493|NCT01360632|364932682|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
105802494|NCT01360632|364932683|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
105802495|NCT01360632|364932679|FG000|Phase A+|Lost to Follow-up|0|||
105802496|NCT01360632|364932680|FG001|Phase A+|Lost to Follow-up|0|||
105802497|NCT01360632|364932681|FG002|Phase A+|Lost to Follow-up|0|||
105802498|NCT01360632|364932682|FG003|Phase A+|Lost to Follow-up|0|||
105802499|NCT01360632|364932683|FG004|Phase A+|Lost to Follow-up|2|||
105802500|NCT01360632|364932679|FG000|Phase A+|Adverse Event|0|||
105802501|NCT01360632|364932680|FG001|Phase A+|Adverse Event|0|||
105802502|NCT01360632|364932681|FG002|Phase A+|Adverse Event|0|||
105802503|NCT01360632|364932682|FG003|Phase A+|Adverse Event|0|||
105802504|NCT01360632|364932683|FG004|Phase A+|Adverse Event|2|||
105802505|NCT01360632|364932679|FG000|Phase A+|Met Withdrawal Criteria|0|||
105802506|NCT01360632|364932680|FG001|Phase A+|Met Withdrawal Criteria|0|||
105802507|NCT01360632|364932681|FG002|Phase A+|Met Withdrawal Criteria|0|||
105802508|NCT01360632|364932682|FG003|Phase A+|Met Withdrawal Criteria|0|||
105802509|NCT01360632|364932683|FG004|Phase A+|Met Withdrawal Criteria|7|||
105802510|NCT01360632|364932679|FG000|Phase A+|Physician Decision|0|||
105802511|NCT01360632|364932680|FG001|Phase A+|Physician Decision|0|||
105949550|NCT01073293|365480473|FG000|Overall Study|Withdrawal by Subject|5|||
105949551|NCT01073293|365480474|FG001|Overall Study|Withdrawal by Subject|10|||
105754448|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
105754449|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
105754450|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
105754451|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
105754452|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
105754453|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105754454|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
105754455|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
105754456|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
105754457|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
105754458|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
105754459|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
105754460|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
105754461|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
105754462|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
105754463|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
105754464|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
105754465|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
105754466|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
105754467|NCT01714817|364751733|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
105754468|NCT01714817|364751734|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
105754469|NCT01244191|364751735|FG000|Overall Study|Progressive disease|295|||
105754470|NCT01244191|364751736|FG001|Overall Study|Progressive disease|350|||
105754471|NCT01244191|364751735|FG000|Overall Study|Clinical disease progression|54|||
105754472|NCT01244191|364751736|FG001|Overall Study|Clinical disease progression|36|||
105754473|NCT01244191|364751735|FG000|Overall Study|Adverse Event|65|||
105754474|NCT01244191|364751736|FG001|Overall Study|Adverse Event|48|||
105754475|NCT01244191|364751735|FG000|Overall Study|Death|22|||
105754476|NCT01244191|364751736|FG001|Overall Study|Death|29|||
105754477|NCT01244191|364751735|FG000|Overall Study|Lost to Follow-up|0|||
105754478|NCT01244191|364751736|FG001|Overall Study|Lost to Follow-up|2|||
105754479|NCT01244191|364751735|FG000|Overall Study|Protocol Violation|1|||
105754480|NCT01244191|364751736|FG001|Overall Study|Protocol Violation|2|||
105754481|NCT01244191|364751735|FG000|Overall Study|Withdrawal by Subject|31|||
105754482|NCT01244191|364751736|FG001|Overall Study|Withdrawal by Subject|23|||
105754483|NCT01244191|364751735|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
105754484|NCT01244191|364751736|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
105754485|NCT00646113|364753641|FG000|Overall Study|Lost to Follow-up|5|||
105754486|NCT00646113|364753641|FG000|Overall Study|Adverse Event|3|||
105754487|NCT01337167|364753642|FG000|Infant Series|Adverse Event|1|||
105754488|NCT01337167|364753643|FG001|Infant Series|Adverse Event|1|||
105754489|NCT01337167|364753642|FG000|Infant Series|Death|1|||
105754490|NCT01337167|364753643|FG001|Infant Series|Death|1|||
105754491|NCT01337167|364753642|FG000|Infant Series|Lost to Follow-up|13|||
105754492|NCT01337167|364753643|FG001|Infant Series|Lost to Follow-up|7|||
105754493|NCT01337167|364753642|FG000|Infant Series|Non-compliance with study drug|2|||
105754494|NCT01337167|364753643|FG001|Infant Series|Non-compliance with study drug|1|||
105754495|NCT01337167|364753642|FG000|Infant Series|Physician Decision|3|||
105754496|NCT01337167|364753643|FG001|Infant Series|Physician Decision|1|||
105754497|NCT01337167|364753642|FG000|Infant Series|Protocol Violation|22|||
105754498|NCT01337167|364753643|FG001|Infant Series|Protocol Violation|9|||
105754499|NCT01337167|364753642|FG000|Infant Series|Withdrawal by Subject|15|||
105754500|NCT01337167|364753643|FG001|Infant Series|Withdrawal by Subject|4|||
105754501|NCT01337167|364753642|FG000|Infant Series|Randomized but not vaccinated|5|||
105754502|NCT01337167|364753643|FG001|Infant Series|Randomized but not vaccinated|3|||
105754503|NCT01337167|364753642|FG000|Interim Period|Lost to Follow-up|51|||
105754504|NCT01337167|364753643|FG001|Interim Period|Lost to Follow-up|23|||
105949552|NCT00698828|365480479|FG000|Overall Study|Adverse Event|3|||
105754505|NCT01337167|364753642|FG000|Interim Period|Non-compliance with study drug|1|||
105754506|NCT01337167|364753643|FG001|Interim Period|Non-compliance with study drug|0|||
105754507|NCT01337167|364753642|FG000|Interim Period|Physician Decision|6|||
105754508|NCT01337167|364753643|FG001|Interim Period|Physician Decision|3|||
105754509|NCT01337167|364753642|FG000|Interim Period|Protocol Violation|5|||
105754510|NCT01337167|364753643|FG001|Interim Period|Protocol Violation|3|||
105754511|NCT01337167|364753642|FG000|Interim Period|Withdrawal by Subject|18|||
105754512|NCT01337167|364753643|FG001|Interim Period|Withdrawal by Subject|10|||
105754513|NCT01337167|364753642|FG000|Interim Period|Other protocol criterion not met|0|||
105754514|NCT01337167|364753643|FG001|Interim Period|Other protocol criterion not met|1|||
105754515|NCT01337167|364753642|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
105949553|NCT00698828|365480480|FG001|Overall Study|Adverse Event|4|||
105949554|NCT00698828|365480481|FG002|Overall Study|Adverse Event|4|||
105949555|NCT00698828|365480479|FG000|Overall Study|Death|0|||
105949556|NCT00698828|365480480|FG001|Overall Study|Death|0|||
105949557|NCT00698828|365480481|FG002|Overall Study|Death|1|||
105949558|NCT00698828|365480479|FG000|Overall Study|Exacerbation of COPD|1|||
105949559|NCT00698828|365480480|FG001|Overall Study|Exacerbation of COPD|3|||
106016497|NCT04033445|365724455|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
105754516|NCT01337167|364753643|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
105754517|NCT01337167|364753642|FG000|Toddler Vaccinations|Protocol Violation|0|||
105754518|NCT01337167|364753643|FG001|Toddler Vaccinations|Protocol Violation|1|||
105754519|NCT01337167|364753642|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
105754520|NCT01337167|364753643|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
105754521|NCT03833817|364753644|FG000|Overall Study|Withdrawal by Subject|3|||
105754522|NCT03833817|364753645|FG001|Overall Study|Withdrawal by Subject|3|||
105754523|NCT03833817|364753644|FG000|Overall Study|Lost to Follow-up|3|||
105754524|NCT03833817|364753645|FG001|Overall Study|Lost to Follow-up|3|||
105754525|NCT00884221|364753646|FG000|Overall Study|Withdrawal by Subject|0|||
105754526|NCT00884221|364753647|FG001|Overall Study|Withdrawal by Subject|3|||
105754527|NCT00884221|364753646|FG000|Overall Study|Adverse Event|6|||
105754528|NCT00884221|364753647|FG001|Overall Study|Adverse Event|3|||
105754529|NCT00884221|364753646|FG000|Overall Study|Protocol Violation|16|||
105754530|NCT00884221|364753647|FG001|Overall Study|Protocol Violation|13|||
105754531|NCT00884221|364753646|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
105754532|NCT00884221|364753647|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
105754533|NCT03073213|364753650|FG000|Multiple Dose Period|Protocol Violation|0|||
105754534|NCT03073213|364753651|FG001|Multiple Dose Period|Protocol Violation|0|||
105754535|NCT03073213|364753652|FG002|Multiple Dose Period|Protocol Violation|1|||
105754536|NCT01993615|364753661|FG000|Overall Study|Death|1|||
105754537|NCT01993615|364753662|FG001|Overall Study|Death|0|||
105754538|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
105754539|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
105754540|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|Death|1|||
105754541|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|Death|0|||
105754542|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
105754543|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
105754544|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
105754545|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
105754546|NCT01175213|364753665|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
105754547|NCT01175213|364753666|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
105754548|NCT01175213|364753665|FG000|Safety Follow-up|Adverse Event|1|||
105754549|NCT01175213|364753666|FG001|Safety Follow-up|Adverse Event|0|||
105754550|NCT01245764|364753667|FG000|Study Phase A|Other|3|||
105754551|NCT01245764|364753668|FG001|Study Phase A|Other|2|||
105754552|NCT01245764|364753669|FG002|Study Phase A|Other|3|||
105754553|NCT01245764|364753670|FG003|Study Phase A|Other|1|||
105754554|NCT01245764|364753667|FG000|Study Phase A|Protocol Violation|6|||
105754555|NCT01245764|364753668|FG001|Study Phase A|Protocol Violation|3|||
105754556|NCT01245764|364753669|FG002|Study Phase A|Protocol Violation|2|||
105754557|NCT01245764|364753670|FG003|Study Phase A|Protocol Violation|2|||
105754558|NCT01245764|364753667|FG000|Study Phase A|Lost to Follow-up|0|||
105754559|NCT01245764|364753668|FG001|Study Phase A|Lost to Follow-up|0|||
105754560|NCT01245764|364753669|FG002|Study Phase A|Lost to Follow-up|5|||
105754561|NCT01245764|364753670|FG003|Study Phase A|Lost to Follow-up|0|||
105754562|NCT00003476|364753671|FG000|Overall Study|Not evaluable|1|||
105754563|NCT03097614|364753677|FG000|Overall Study|Adverse Event|3|||
105754564|NCT03057951|364753678|FG000|Overall Study|Adverse Event|553|||
105754565|NCT03057951|364753679|FG001|Overall Study|Adverse Event|575|||
105754566|NCT03057951|364753678|FG000|Overall Study|Protocol Violation|30|||
105754567|NCT03057951|364753679|FG001|Overall Study|Protocol Violation|24|||
105754568|NCT03057951|364753678|FG000|Overall Study|Lost to Follow-up|6|||
105754569|NCT03057951|364753679|FG001|Overall Study|Lost to Follow-up|16|||
105754570|NCT03057951|364753678|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
105754571|NCT03057951|364753679|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
105754572|NCT03057951|364753678|FG000|Overall Study|Study drug stopped, reason missing|6|||
105754573|NCT03057951|364753679|FG001|Overall Study|Study drug stopped, reason missing|1|||
105754574|NCT03057951|364753678|FG000|Overall Study|Medical advice|6|||
105754575|NCT03057951|364753679|FG001|Overall Study|Medical advice|2|||
105754576|NCT03057951|364753678|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
105949560|NCT00698828|365480481|FG002|Overall Study|Exacerbation of COPD|0|||
105949561|NCT00698828|365480479|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
105949562|NCT00698828|365480480|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
105949563|NCT00698828|365480481|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
105949564|NCT00698828|365480479|FG000|Overall Study|Investigator/Sponsor decision|1|||
105949565|NCT00698828|365480480|FG001|Overall Study|Investigator/Sponsor decision|0|||
105949566|NCT00698828|365480481|FG002|Overall Study|Investigator/Sponsor decision|2|||
105754577|NCT03057951|364753679|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
105802512|NCT01360632|364932681|FG002|Phase A+|Physician Decision|0|||
105802513|NCT01360632|364932682|FG003|Phase A+|Physician Decision|0|||
105802514|NCT01360632|364932683|FG004|Phase A+|Physician Decision|3|||
105802515|NCT01360632|364932679|FG000|Phase A+|Withdrawal by Subject|0|||
105802516|NCT01360632|364932680|FG001|Phase A+|Withdrawal by Subject|0|||
105802517|NCT01360632|364932681|FG002|Phase A+|Withdrawal by Subject|0|||
105802518|NCT01360632|364932682|FG003|Phase A+|Withdrawal by Subject|0|||
105802519|NCT01360632|364932683|FG004|Phase A+|Withdrawal by Subject|8|||
105802520|NCT01360632|364932679|FG000|Phase A+|Protocol Deviation|0|||
105802521|NCT01360632|364932680|FG001|Phase A+|Protocol Deviation|0|||
105802522|NCT01360632|364932681|FG002|Phase A+|Protocol Deviation|0|||
105802523|NCT01360632|364932682|FG003|Phase A+|Protocol Deviation|0|||
105802524|NCT01360632|364932683|FG004|Phase A+|Protocol Deviation|3|||
105802525|NCT02123459|364932685|FG000|Washout Period (1 Day)|Adverse Event|1|||
105802526|NCT02123459|364932686|FG001|Washout Period (1 Day)|Adverse Event|0|||
105802527|NCT02196506|364932691|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
105802528|NCT02196506|364932692|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
105802529|NCT02196506|364932693|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
105802530|NCT02196506|364932694|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
105802531|NCT02196506|364932691|FG000|Phase A|Withdrawal by Subject|34|||
105802532|NCT02196506|364932692|FG001|Phase A|Withdrawal by Subject|0|||
105802533|NCT02196506|364932693|FG002|Phase A|Withdrawal by Subject|0|||
105802534|NCT02196506|364932694|FG003|Phase A|Withdrawal by Subject|0|||
105802535|NCT02196506|364932691|FG000|Phase A|Adverse Event|22|||
105802536|NCT02196506|364932692|FG001|Phase A|Adverse Event|0|||
105802537|NCT02196506|364932693|FG002|Phase A|Adverse Event|0|||
105802538|NCT02196506|364932694|FG003|Phase A|Adverse Event|0|||
105802539|NCT02196506|364932691|FG000|Phase A|Lost to Follow-up|9|||
105802540|NCT02196506|364932692|FG001|Phase A|Lost to Follow-up|0|||
105802541|NCT02196506|364932693|FG002|Phase A|Lost to Follow-up|0|||
105802542|NCT02196506|364932694|FG003|Phase A|Lost to Follow-up|0|||
105802543|NCT02196506|364932691|FG000|Phase A|Protocol deviation|12|||
105802544|NCT02196506|364932692|FG001|Phase A|Protocol deviation|0|||
105802545|NCT02196506|364932693|FG002|Phase A|Protocol deviation|0|||
105802546|NCT02196506|364932694|FG003|Phase A|Protocol deviation|0|||
105802547|NCT02196506|364932691|FG000|Phase A|Participant withdrawn by investigator|10|||
105802548|NCT02196506|364932692|FG001|Phase A|Participant withdrawn by investigator|0|||
105802549|NCT02196506|364932693|FG002|Phase A|Participant withdrawn by investigator|0|||
105802550|NCT02196506|364932694|FG003|Phase A|Participant withdrawn by investigator|0|||
105802551|NCT02196506|364932691|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
105802552|NCT02196506|364932692|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
105949567|NCT00698828|365480479|FG000|Overall Study|Lost to Follow-up|1|||
105949568|NCT00698828|365480480|FG001|Overall Study|Lost to Follow-up|1|||
105949569|NCT00698828|365480481|FG002|Overall Study|Lost to Follow-up|0|||
105949570|NCT00698828|365480479|FG000|Overall Study|Withdrew consent|0|||
105949571|NCT00698828|365480480|FG001|Overall Study|Withdrew consent|7|||
105949572|NCT00698828|365480481|FG002|Overall Study|Withdrew consent|4|||
105949573|NCT00698828|365480479|FG000|Overall Study|Withdrew consent (not treated)|2|||
105949574|NCT00698828|365480480|FG001|Overall Study|Withdrew consent (not treated)|0|||
105949575|NCT00698828|365480481|FG002|Overall Study|Withdrew consent (not treated)|0|||
105949576|NCT02013609|365480482|FG000|Overall Study|Withdrawal by Subject|9|||
105754578|NCT03057951|364753678|FG000|Overall Study|Investigator decision|2|||
105754579|NCT03057951|364753679|FG001|Overall Study|Investigator decision|0|||
105949577|NCT02013609|365480482|FG000|Overall Study|Lost to Follow-up|3|||
105949578|NCT02013609|365480482|FG000|Overall Study|Adverse Event|3|||
105949579|NCT02013609|365480482|FG000|Overall Study|Met Withdrawal Criteria|3|||
106016498|NCT04033445|365724456|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
106016499|NCT04033445|365724457|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
106016500|NCT04033445|365724458|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
106016501|NCT04033445|365724459|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
106016502|NCT04033445|365724460|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
106016503|NCT04033445|365724447|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
106016504|NCT04033445|365724448|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105754580|NCT03057951|364753678|FG000|Overall Study|Patient decision|5|||
105754581|NCT03057951|364753679|FG001|Overall Study|Patient decision|2|||
105754582|NCT03057951|364753678|FG000|Overall Study|Not attending study visits|3|||
105754583|NCT03057951|364753679|FG001|Overall Study|Not attending study visits|0|||
105754584|NCT03057951|364753678|FG000|Overall Study|Patient moved away|3|||
105754585|NCT03057951|364753679|FG001|Overall Study|Patient moved away|4|||
105754586|NCT03057951|364753678|FG000|Overall Study|Other reason than stated above|23|||
105754587|NCT03057951|364753679|FG001|Overall Study|Other reason than stated above|29|||
105754588|NCT03057951|364753678|FG000|Overall Study|Not treated|2|||
105754589|NCT03057951|364753679|FG001|Overall Study|Not treated|1|||
105754590|NCT00696436|364753681|FG000|Overall Study|Adverse Event|7|||
105754591|NCT00696436|364753682|FG001|Overall Study|Adverse Event|9|||
105754592|NCT00696436|364753683|FG002|Overall Study|Adverse Event|8|||
105754593|NCT00696436|364753684|FG003|Overall Study|Adverse Event|6|||
105754594|NCT00696436|364753685|FG004|Overall Study|Adverse Event|4|||
105754595|NCT00696436|364753681|FG000|Overall Study|Protocol Violation|3|||
105754596|NCT00696436|364753682|FG001|Overall Study|Protocol Violation|2|||
105754597|NCT00696436|364753683|FG002|Overall Study|Protocol Violation|2|||
105949580|NCT01788943|365480483|FG000|Overall Study|Withdrawal by Subject|1|||
105949581|NCT01788943|365480484|FG001|Overall Study|Withdrawal by Subject|0|||
105949582|NCT00186628|365480487|FG000|Overall Study|Death|2|||
105754598|NCT00696436|364753684|FG003|Overall Study|Protocol Violation|0|||
105754599|NCT00696436|364753685|FG004|Overall Study|Protocol Violation|1|||
105754600|NCT00696436|364753681|FG000|Overall Study|Lost to Follow-up|1|||
105754601|NCT00696436|364753682|FG001|Overall Study|Lost to Follow-up|6|||
105754602|NCT00696436|364753683|FG002|Overall Study|Lost to Follow-up|2|||
105754603|NCT00696436|364753684|FG003|Overall Study|Lost to Follow-up|4|||
105949583|NCT00186628|365480487|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
105754604|NCT00696436|364753685|FG004|Overall Study|Lost to Follow-up|3|||
105949584|NCT02581891|365480488|FG000|Overall Study|Adverse Event|4|||
105949585|NCT02581891|365480489|FG001|Overall Study|Adverse Event|6|||
105949586|NCT02581891|365480488|FG000|Overall Study|Death|3|||
105949587|NCT02581891|365480489|FG001|Overall Study|Death|4|||
105949588|NCT02581891|365480488|FG000|Overall Study|Lost to Follow-up|1|||
105949589|NCT02581891|365480489|FG001|Overall Study|Lost to Follow-up|2|||
105949590|NCT02581891|365480488|FG000|Overall Study|Physician Decision|0|||
105949591|NCT02581891|365480489|FG001|Overall Study|Physician Decision|1|||
105949592|NCT02581891|365480488|FG000|Overall Study|Withdrawal by Subject|4|||
105949593|NCT02581891|365480489|FG001|Overall Study|Withdrawal by Subject|5|||
105949594|NCT02581891|365480488|FG000|Overall Study|Other Reasons|3|||
105949595|NCT02581891|365480489|FG001|Overall Study|Other Reasons|1|||
105949596|NCT02581891|365480488|FG000|Overall Study|Discontinued during followup|1|||
105949597|NCT02581891|365480489|FG001|Overall Study|Discontinued during followup|0|||
105949598|NCT02927795|365480490|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
105949599|NCT02927795|365480490|FG000|Overall Study|Not Treated|4|||
105949600|NCT01130337|365480491|FG000|Overall Study|Withdrawal by Subject|3|||
105949601|NCT01130337|365480491|FG000|Overall Study|Principal investigator decision|1|||
105949602|NCT01130337|365480491|FG000|Overall Study|Death|1|||
105949603|NCT01130337|365480491|FG000|Overall Study|Disease progression|1|||
105949604|NCT01130337|365480491|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
105949605|NCT01130337|365480491|FG000|Overall Study|Surgical resection (R2)|1|||
105949606|NCT00107276|365480492|FG000|Overall Study|Progression|46|||
105949607|NCT00107276|365480492|FG000|Overall Study|Adverse Event|6|||
105949608|NCT00107276|365480492|FG000|Overall Study|M.D. decision|2|||
105949609|NCT00107276|365480492|FG000|Overall Study|Patient refusal|1|||
105949610|NCT00107276|365480492|FG000|Overall Study|Death|1|||
105949611|NCT00107276|365480492|FG000|Overall Study|Ineligible|16|||
105949612|NCT04846231|365480493|FG000|Overall Study|Lost to Follow-up|1|||
105949613|NCT04846231|365480494|FG001|Overall Study|Lost to Follow-up|0|||
105949614|NCT04846231|365480495|FG002|Overall Study|Lost to Follow-up|0|||
105949615|NCT04846231|365480496|FG003|Overall Study|Lost to Follow-up|0|||
105949616|NCT04846231|365480497|FG004|Overall Study|Lost to Follow-up|0|||
105949617|NCT04846231|365480498|FG005|Overall Study|Lost to Follow-up|0|||
105949618|NCT04846231|365480499|FG006|Overall Study|Lost to Follow-up|0|||
105949619|NCT04846231|365480500|FG007|Overall Study|Lost to Follow-up|1|||
105949620|NCT04846231|365480493|FG000|Overall Study|Withdrawal by Subject|0|||
105949621|NCT04846231|365480494|FG001|Overall Study|Withdrawal by Subject|1|||
105949622|NCT04846231|365480495|FG002|Overall Study|Withdrawal by Subject|2|||
105949623|NCT04846231|365480496|FG003|Overall Study|Withdrawal by Subject|1|||
105949624|NCT04846231|365480497|FG004|Overall Study|Withdrawal by Subject|0|||
105802553|NCT02196506|364932693|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
105802554|NCT02196506|364932694|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
105802555|NCT02196506|364932691|FG000|Phase B|Lack of Efficacy|0|||
105802556|NCT02196506|364932692|FG001|Phase B|Lack of Efficacy|1|||
105802557|NCT02196506|364932693|FG002|Phase B|Lack of Efficacy|2|||
105802558|NCT02196506|364932694|FG003|Phase B|Lack of Efficacy|0|||
105802559|NCT02196506|364932691|FG000|Phase B|Withdrawal by Participant|0|||
105802560|NCT02196506|364932692|FG001|Phase B|Withdrawal by Participant|8|||
105802561|NCT02196506|364932693|FG002|Phase B|Withdrawal by Participant|1|||
105802562|NCT02196506|364932694|FG003|Phase B|Withdrawal by Participant|0|||
105802563|NCT02196506|364932691|FG000|Phase B|Adverse Event|0|||
105802564|NCT02196506|364932692|FG001|Phase B|Adverse Event|4|||
105802565|NCT02196506|364932693|FG002|Phase B|Adverse Event|1|||
105949625|NCT04846231|365480498|FG005|Overall Study|Withdrawal by Subject|0|||
105949626|NCT04846231|365480499|FG006|Overall Study|Withdrawal by Subject|0|||
105949627|NCT04846231|365480500|FG007|Overall Study|Withdrawal by Subject|0|||
105949628|NCT04846231|365480493|FG000|Overall Study|Protocol Violation|0|||
105949629|NCT04846231|365480494|FG001|Overall Study|Protocol Violation|1|||
105949630|NCT04846231|365480495|FG002|Overall Study|Protocol Violation|0|||
105949631|NCT04846231|365480496|FG003|Overall Study|Protocol Violation|0|||
105949632|NCT04846231|365480497|FG004|Overall Study|Protocol Violation|0|||
105949633|NCT04846231|365480498|FG005|Overall Study|Protocol Violation|0|||
105949634|NCT04846231|365480499|FG006|Overall Study|Protocol Violation|0|||
105949635|NCT04846231|365480500|FG007|Overall Study|Protocol Violation|0|||
105949636|NCT04846231|365480493|FG000|Overall Study|Adverse Event|0|||
105949637|NCT04846231|365480494|FG001|Overall Study|Adverse Event|0|||
105949638|NCT04846231|365480495|FG002|Overall Study|Adverse Event|0|||
105949639|NCT04846231|365480496|FG003|Overall Study|Adverse Event|0|||
105949640|NCT04846231|365480497|FG004|Overall Study|Adverse Event|0|||
105949641|NCT04846231|365480498|FG005|Overall Study|Adverse Event|0|||
105949642|NCT04846231|365480499|FG006|Overall Study|Adverse Event|1|||
105949643|NCT04846231|365480500|FG007|Overall Study|Adverse Event|1|||
105949644|NCT02504372|365480501|FG000|Overall Study|Death|136|||
105949645|NCT02504372|365480502|FG001|Overall Study|Death|154|||
105949646|NCT02504372|365480501|FG000|Overall Study|Lost to Follow-up|0|||
105949647|NCT02504372|365480502|FG001|Overall Study|Lost to Follow-up|2|||
105949648|NCT02504372|365480501|FG000|Overall Study|Withdrawal of consent|25|||
105949649|NCT02504372|365480502|FG001|Overall Study|Withdrawal of consent|16|||
105949650|NCT02504372|365480501|FG000|Overall Study|Participants ongoing|429|||
105949651|NCT02504372|365480502|FG001|Overall Study|Participants ongoing|415|||
105949652|NCT01188967|365480503|FG000|Overall Study|Withdrawal by Subject|1|||
105949653|NCT01188967|365480504|FG001|Overall Study|Withdrawal by Subject|1|||
105949654|NCT01188967|365480503|FG000|Overall Study|Physician Decision|1|||
105949655|NCT01188967|365480504|FG001|Overall Study|Physician Decision|1|||
105949656|NCT01188967|365480503|FG000|Overall Study|Lost to Follow-up|3|||
105949657|NCT01188967|365480504|FG001|Overall Study|Lost to Follow-up|2|||
105949658|NCT00332696|365480505|FG000|Overall Study|Death|24|||
105949659|NCT00332696|365480506|FG001|Overall Study|Death|14|||
105949660|NCT00332696|365480505|FG000|Overall Study|Insufficient therapeutic effect|4|||
105949661|NCT00332696|365480506|FG001|Overall Study|Insufficient therapeutic effect|11|||
105949662|NCT00332696|365480505|FG000|Overall Study|Adverse Event|1|||
105949663|NCT00332696|365480506|FG001|Overall Study|Adverse Event|2|||
105949664|NCT00332696|365480505|FG000|Overall Study|Condition does not justify treatment|0|||
105802566|NCT02196506|364932694|FG003|Phase B|Adverse Event|0|||
105802567|NCT02196506|364932691|FG000|Phase B|Lost to Follow-up|0|||
105802568|NCT02196506|364932692|FG001|Phase B|Lost to Follow-up|2|||
105949665|NCT00332696|365480506|FG001|Overall Study|Condition does not justify treatment|2|||
105949666|NCT00332696|365480505|FG000|Overall Study|Lost to Follow-up|0|||
105949667|NCT00332696|365480506|FG001|Overall Study|Lost to Follow-up|1|||
105949668|NCT00332696|365480505|FG000|Overall Study|Withdrawal by Subject|1|||
105949669|NCT00332696|365480506|FG001|Overall Study|Withdrawal by Subject|0|||
105949670|NCT00461708|365480507|FG000|Overall Study|Adverse Event|17|||
105949671|NCT00461708|365480508|FG001|Overall Study|Adverse Event|7|||
105949672|NCT00461708|365480507|FG000|Overall Study|Lack of Efficacy|68|||
105802569|NCT02196506|364932693|FG002|Phase B|Lost to Follow-up|1|||
105802570|NCT02196506|364932694|FG003|Phase B|Lost to Follow-up|0|||
105949673|NCT00461708|365480508|FG001|Overall Study|Lack of Efficacy|20|||
105949674|NCT00461708|365480507|FG000|Overall Study|Physician Decision|10|||
105949675|NCT00461708|365480508|FG001|Overall Study|Physician Decision|4|||
105949676|NCT00461708|365480507|FG000|Overall Study|Withdrawal by Subject|8|||
105949677|NCT00461708|365480508|FG001|Overall Study|Withdrawal by Subject|2|||
105802571|NCT02196506|364932691|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
105949678|NCT00461708|365480507|FG000|Overall Study|Other|4|||
105949679|NCT00461708|365480508|FG001|Overall Study|Other|4|||
105949680|NCT00461708|365480507|FG000|Overall Study|Death|8|||
105949681|NCT00461708|365480508|FG001|Overall Study|Death|1|||
105949682|NCT02259114|365480509|FG000|Overall Study|Progressive Disease|14|||
105949683|NCT02259114|365480510|FG001|Overall Study|Progressive Disease|2|||
105949684|NCT02259114|365480511|FG002|Overall Study|Progressive Disease|10|||
105949685|NCT02259114|365480512|FG003|Overall Study|Progressive Disease|2|||
105949686|NCT02259114|365480513|FG004|Overall Study|Progressive Disease|5|||
105949687|NCT02259114|365480509|FG000|Overall Study|Adverse Event|2|||
105949688|NCT02259114|365480510|FG001|Overall Study|Adverse Event|1|||
105949689|NCT02259114|365480511|FG002|Overall Study|Adverse Event|0|||
105754605|NCT00696436|364753681|FG000|Overall Study|Withdrawal by Subject|4|||
105754606|NCT00696436|364753682|FG001|Overall Study|Withdrawal by Subject|11|||
105754607|NCT00696436|364753683|FG002|Overall Study|Withdrawal by Subject|5|||
105754608|NCT00696436|364753684|FG003|Overall Study|Withdrawal by Subject|7|||
105754609|NCT00696436|364753685|FG004|Overall Study|Withdrawal by Subject|1|||
105754610|NCT00696436|364753681|FG000|Overall Study|Lack of Efficacy|3|||
105754611|NCT00696436|364753682|FG001|Overall Study|Lack of Efficacy|1|||
105754612|NCT00696436|364753683|FG002|Overall Study|Lack of Efficacy|5|||
105754613|NCT00696436|364753684|FG003|Overall Study|Lack of Efficacy|2|||
105754614|NCT00696436|364753685|FG004|Overall Study|Lack of Efficacy|4|||
105754615|NCT00696436|364753681|FG000|Overall Study|Participant Unavailability|2|||
105754616|NCT00696436|364753682|FG001|Overall Study|Participant Unavailability|0|||
105754617|NCT00696436|364753683|FG002|Overall Study|Participant Unavailability|2|||
105754618|NCT00696436|364753684|FG003|Overall Study|Participant Unavailability|1|||
105754619|NCT00696436|364753685|FG004|Overall Study|Participant Unavailability|0|||
105754620|NCT00696436|364753681|FG000|Overall Study|Administrative Error|2|||
105754621|NCT00696436|364753682|FG001|Overall Study|Administrative Error|0|||
105754622|NCT00696436|364753683|FG002|Overall Study|Administrative Error|2|||
105754623|NCT00696436|364753684|FG003|Overall Study|Administrative Error|0|||
105754624|NCT00696436|364753685|FG004|Overall Study|Administrative Error|0|||
105754625|NCT00696436|364753681|FG000|Overall Study|Participant Non-compliance|0|||
105754626|NCT00696436|364753682|FG001|Overall Study|Participant Non-compliance|0|||
105754627|NCT00696436|364753683|FG002|Overall Study|Participant Non-compliance|1|||
105754628|NCT00696436|364753684|FG003|Overall Study|Participant Non-compliance|2|||
105754629|NCT00696436|364753685|FG004|Overall Study|Participant Non-compliance|0|||
105754630|NCT00696436|364753681|FG000|Overall Study|Administrative Decision|1|||
105754631|NCT00696436|364753682|FG001|Overall Study|Administrative Decision|0|||
105754632|NCT00696436|364753683|FG002|Overall Study|Administrative Decision|0|||
105754633|NCT00696436|364753684|FG003|Overall Study|Administrative Decision|0|||
105754634|NCT00696436|364753685|FG004|Overall Study|Administrative Decision|0|||
105754635|NCT00696436|364753681|FG000|Overall Study|Missing|0|||
105754636|NCT00696436|364753682|FG001|Overall Study|Missing|1|||
105754637|NCT00696436|364753683|FG002|Overall Study|Missing|1|||
105754638|NCT00696436|364753684|FG003|Overall Study|Missing|0|||
105754639|NCT00696436|364753685|FG004|Overall Study|Missing|0|||
105754640|NCT02282982|364753686|FG000|Overall Study|Lost to Follow-up|15|||
105754641|NCT02282982|364753686|FG000|Overall Study|Withdrew consent|2|||
105754642|NCT02282982|364753686|FG000|Overall Study|Death|4|||
105754643|NCT02282982|364753686|FG000|Overall Study|Lack of product|156|||
105754644|NCT02282982|364753686|FG000|Overall Study|Palivizumab is ended|11|||
105754645|NCT02282982|364753686|FG000|Overall Study|Other, not specified|18|||
105754646|NCT03172481|364753690|FG000|Double-blind|Withdrawal by Subject|1|||
105754647|NCT03172481|364753691|FG001|Double-blind|Withdrawal by Subject|0|||
105754648|NCT02716194|364753692|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
105754649|NCT02716194|364753693|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
105754650|NCT02716194|364753694|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
105754651|NCT00971425|364753695|FG000|Overall Study|Adverse Event|1|||
105754652|NCT00971425|364753696|FG001|Overall Study|Adverse Event|1|||
105754653|NCT00971425|364753695|FG000|Overall Study|Withdrawal by Subject|0|||
105754654|NCT00971425|364753696|FG001|Overall Study|Withdrawal by Subject|1|||
105754655|NCT01925612|364753707|FG000|Overall Study|Progressive Disease|1|||
105754656|NCT01925612|364753708|FG001|Overall Study|Progressive Disease|1|||
105754657|NCT01925612|364753709|FG002|Overall Study|Progressive Disease|1|||
105754658|NCT01925612|364753710|FG003|Overall Study|Progressive Disease|0|||
105754659|NCT01925612|364753711|FG004|Overall Study|Progressive Disease|0|||
105754660|NCT01925612|364753707|FG000|Overall Study|Adverse Event|3|||
105754661|NCT01925612|364753708|FG001|Overall Study|Adverse Event|3|||
105754662|NCT01925612|364753709|FG002|Overall Study|Adverse Event|0|||
105754663|NCT01925612|364753710|FG003|Overall Study|Adverse Event|1|||
105754664|NCT01925612|364753711|FG004|Overall Study|Adverse Event|2|||
105754665|NCT00225147|364753714|FG000|Open-label Phase|Lost to Follow-up|0|||
105754666|NCT00225147|364753715|FG001|Open-label Phase|Lost to Follow-up|0|||
105754667|NCT00225147|364753716|FG002|Open-label Phase|Lost to Follow-up|0|||
105754668|NCT00225147|364753717|FG003|Open-label Phase|Lost to Follow-up|4|||
105754669|NCT00225147|364753714|FG000|Open-label Phase|Withdrawal by Subject|0|||
105949690|NCT02259114|365480512|FG003|Overall Study|Adverse Event|0|||
105949691|NCT02259114|365480513|FG004|Overall Study|Adverse Event|1|||
105949692|NCT02259114|365480509|FG000|Overall Study|Death|3|||
105949693|NCT02259114|365480510|FG001|Overall Study|Death|0|||
105949694|NCT02259114|365480511|FG002|Overall Study|Death|1|||
105754670|NCT00225147|364753715|FG001|Open-label Phase|Withdrawal by Subject|0|||
105754671|NCT00225147|364753716|FG002|Open-label Phase|Withdrawal by Subject|0|||
105754672|NCT00225147|364753717|FG003|Open-label Phase|Withdrawal by Subject|6|||
105754673|NCT04019795|364753718|FG000|Overall Study|Withdrawal by Subject|1|||
105754674|NCT04019795|364753719|FG001|Overall Study|Withdrawal by Subject|2|||
105754675|NCT04019795|364753720|FG002|Overall Study|Withdrawal by Subject|2|||
105754676|NCT04019795|364753721|FG003|Overall Study|Withdrawal by Subject|1|||
105754677|NCT04019795|364753718|FG000|Overall Study|Lost to Follow-up|0|||
105754678|NCT04019795|364753719|FG001|Overall Study|Lost to Follow-up|1|||
105754679|NCT04019795|364753720|FG002|Overall Study|Lost to Follow-up|1|||
105754680|NCT04019795|364753721|FG003|Overall Study|Lost to Follow-up|2|||
105754681|NCT04019795|364753718|FG000|Overall Study|Treatment non-compliance|3|||
105754682|NCT04019795|364753719|FG001|Overall Study|Treatment non-compliance|1|||
105754683|NCT04019795|364753720|FG002|Overall Study|Treatment non-compliance|2|||
105754684|NCT04019795|364753721|FG003|Overall Study|Treatment non-compliance|0|||
105754685|NCT04019795|364753718|FG000|Overall Study|Physician Decision|0|||
105754686|NCT04019795|364753719|FG001|Overall Study|Physician Decision|0|||
105754687|NCT04019795|364753720|FG002|Overall Study|Physician Decision|1|||
105754688|NCT04019795|364753721|FG003|Overall Study|Physician Decision|0|||
105754689|NCT04019795|364753718|FG000|Overall Study|Adverse Event|1|||
105754690|NCT04019795|364753719|FG001|Overall Study|Adverse Event|0|||
105754691|NCT04019795|364753720|FG002|Overall Study|Adverse Event|0|||
105754692|NCT04019795|364753721|FG003|Overall Study|Adverse Event|0|||
105754693|NCT02899377|364753727|FG000|Overall Study|Adverse Event|1|||
105754694|NCT02899377|364753728|FG001|Overall Study|Adverse Event|0|||
105754695|NCT00340834|364753731|FG000|Core Phase of Study|Adverse Event|26|||
105754696|NCT00340834|364753732|FG001|Core Phase of Study|Adverse Event|9|||
105754697|NCT00340834|364753733|FG002|Core Phase of Study|Adverse Event|9|||
105754698|NCT00340834|364753734|FG003|Core Phase of Study|Adverse Event|0|||
105754699|NCT00340834|364753735|FG004|Core Phase of Study|Adverse Event|0|||
105754700|NCT00340834|364753731|FG000|Core Phase of Study|Withdrawal by Subject|11|||
105754701|NCT00340834|364753732|FG001|Core Phase of Study|Withdrawal by Subject|9|||
105754702|NCT00340834|364753733|FG002|Core Phase of Study|Withdrawal by Subject|16|||
105754703|NCT00340834|364753734|FG003|Core Phase of Study|Withdrawal by Subject|0|||
105754704|NCT00340834|364753735|FG004|Core Phase of Study|Withdrawal by Subject|0|||
105754705|NCT00340834|364753731|FG000|Core Phase of Study|Administrative Problems|6|||
105754706|NCT00340834|364753732|FG001|Core Phase of Study|Administrative Problems|2|||
105754707|NCT00340834|364753733|FG002|Core Phase of Study|Administrative Problems|7|||
105754708|NCT00340834|364753734|FG003|Core Phase of Study|Administrative Problems|0|||
105754709|NCT00340834|364753735|FG004|Core Phase of Study|Administrative Problems|0|||
105754710|NCT00340834|364753731|FG000|Core Phase of Study|Lack of Efficacy|3|||
105754711|NCT00340834|364753732|FG001|Core Phase of Study|Lack of Efficacy|3|||
105754712|NCT00340834|364753733|FG002|Core Phase of Study|Lack of Efficacy|7|||
105754713|NCT00340834|364753734|FG003|Core Phase of Study|Lack of Efficacy|0|||
105754714|NCT00340834|364753735|FG004|Core Phase of Study|Lack of Efficacy|0|||
105754715|NCT00340834|364753731|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
105754716|NCT00340834|364753732|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
105754717|NCT00340834|364753733|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
105754718|NCT00340834|364753734|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
105754719|NCT00340834|364753735|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
105754720|NCT00340834|364753731|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
105754721|NCT00340834|364753732|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
105754722|NCT00340834|364753733|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
105754723|NCT00340834|364753734|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
105754724|NCT00340834|364753735|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
105802572|NCT02196506|364932692|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
105802573|NCT02196506|364932693|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
105754725|NCT00340834|364753731|FG000|Core Phase of Study|Lost to Follow-up|1|||
105754726|NCT00340834|364753732|FG001|Core Phase of Study|Lost to Follow-up|1|||
105754727|NCT00340834|364753733|FG002|Core Phase of Study|Lost to Follow-up|4|||
105754728|NCT00340834|364753734|FG003|Core Phase of Study|Lost to Follow-up|0|||
105754729|NCT00340834|364753735|FG004|Core Phase of Study|Lost to Follow-up|0|||
105754730|NCT00340834|364753731|FG000|Core Phase of Study|Death|2|||
105802574|NCT02196506|364932694|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
105949695|NCT02259114|365480512|FG003|Overall Study|Death|0|||
105754731|NCT00340834|364753732|FG001|Core Phase of Study|Death|0|||
105754732|NCT00340834|364753733|FG002|Core Phase of Study|Death|0|||
105754733|NCT00340834|364753734|FG003|Core Phase of Study|Death|0|||
105754734|NCT00340834|364753735|FG004|Core Phase of Study|Death|0|||
105754735|NCT00340834|364753731|FG000|Core Phase of Study|Protocol Violation|0|||
105754736|NCT00340834|364753732|FG001|Core Phase of Study|Protocol Violation|0|||
105754737|NCT00340834|364753733|FG002|Core Phase of Study|Protocol Violation|2|||
105754738|NCT00340834|364753734|FG003|Core Phase of Study|Protocol Violation|0|||
105754739|NCT00340834|364753735|FG004|Core Phase of Study|Protocol Violation|0|||
105949696|NCT02259114|365480513|FG004|Overall Study|Death|0|||
105802575|NCT02196506|364932691|FG000|Phase A+|Withdrawal by Participant|0|||
105802576|NCT02196506|364932692|FG001|Phase A+|Withdrawal by Participant|0|||
105802577|NCT02196506|364932693|FG002|Phase A+|Withdrawal by Participant|0|||
105802578|NCT02196506|364932694|FG003|Phase A+|Withdrawal by Participant|5|||
105802579|NCT02196506|364932691|FG000|Phase A+|Adverse Event|0|||
105802580|NCT02196506|364932692|FG001|Phase A+|Adverse Event|0|||
105802581|NCT02196506|364932693|FG002|Phase A+|Adverse Event|0|||
105802582|NCT02196506|364932694|FG003|Phase A+|Adverse Event|1|||
105802583|NCT02196506|364932691|FG000|Phase A+|Lost to Follow-up|0|||
105802584|NCT02196506|364932692|FG001|Phase A+|Lost to Follow-up|0|||
105802585|NCT02196506|364932693|FG002|Phase A+|Lost to Follow-up|0|||
105802586|NCT02196506|364932694|FG003|Phase A+|Lost to Follow-up|6|||
105802587|NCT02196506|364932691|FG000|Phase A+|Participant withdrawn by investigator|0|||
105802588|NCT02196506|364932692|FG001|Phase A+|Participant withdrawn by investigator|0|||
105802589|NCT02196506|364932693|FG002|Phase A+|Participant withdrawn by investigator|0|||
105802590|NCT02196506|364932694|FG003|Phase A+|Participant withdrawn by investigator|1|||
105949697|NCT02259114|365480509|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
105949698|NCT02259114|365480510|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
105949699|NCT02259114|365480511|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
105949700|NCT02259114|365480512|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
105949701|NCT02259114|365480513|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
105802591|NCT00254397|364932695|FG000|Overall Study|Disease Progression|4|||
105802592|NCT00254397|364932696|FG001|Overall Study|Disease Progression|1|||
105949702|NCT02259114|365480509|FG000|Overall Study|Withdrawal by Subject|0|||
105949703|NCT02259114|365480510|FG001|Overall Study|Withdrawal by Subject|0|||
105949704|NCT02259114|365480511|FG002|Overall Study|Withdrawal by Subject|1|||
105949705|NCT02259114|365480512|FG003|Overall Study|Withdrawal by Subject|1|||
105949706|NCT02259114|365480513|FG004|Overall Study|Withdrawal by Subject|0|||
105802593|NCT00254397|364932697|FG002|Overall Study|Disease Progression|16|||
105802594|NCT00254397|364932698|FG003|Overall Study|Disease Progression|23|||
105802595|NCT00254397|364932695|FG000|Overall Study|Non-Compliant|0|||
105802596|NCT00254397|364932696|FG001|Overall Study|Non-Compliant|0|||
105802597|NCT00254397|364932697|FG002|Overall Study|Non-Compliant|0|||
105802598|NCT00254397|364932698|FG003|Overall Study|Non-Compliant|1|||
105802599|NCT00254397|364932695|FG000|Overall Study|Adverse Event|2|||
105802600|NCT00254397|364932696|FG001|Overall Study|Adverse Event|0|||
105802601|NCT00254397|364932697|FG002|Overall Study|Adverse Event|3|||
105802602|NCT00254397|364932698|FG003|Overall Study|Adverse Event|1|||
105949707|NCT02259114|365480509|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
105949708|NCT02259114|365480510|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
105949709|NCT02259114|365480511|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
105949710|NCT02259114|365480512|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
105949711|NCT02259114|365480513|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
105802603|NCT01070394|364932699|FG000|Overall Study|Adverse Event|6|||
105949712|NCT02259114|365480509|FG000|Overall Study|Not Treated|1|||
105949713|NCT02259114|365480510|FG001|Overall Study|Not Treated|0|||
105754740|NCT00340834|364753731|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
105754741|NCT00340834|364753732|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
105754742|NCT00340834|364753733|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
105754743|NCT00340834|364753734|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
105754744|NCT00340834|364753735|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
105754745|NCT00340834|364753731|FG000|Extension Phase of Study|Subject withdrew consent|26|||
105754746|NCT00340834|364753732|FG001|Extension Phase of Study|Subject withdrew consent|31|||
105754747|NCT00340834|364753733|FG002|Extension Phase of Study|Subject withdrew consent|0|||
105754748|NCT00340834|364753734|FG003|Extension Phase of Study|Subject withdrew consent|12|||
105754749|NCT00340834|364753735|FG004|Extension Phase of Study|Subject withdrew consent|15|||
105754750|NCT00340834|364753731|FG000|Extension Phase of Study|Adverse Event|21|||
105754751|NCT00340834|364753732|FG001|Extension Phase of Study|Adverse Event|22|||
105754752|NCT00340834|364753733|FG002|Extension Phase of Study|Adverse Event|0|||
105754753|NCT00340834|364753734|FG003|Extension Phase of Study|Adverse Event|19|||
105754754|NCT00340834|364753735|FG004|Extension Phase of Study|Adverse Event|7|||
105754755|NCT00340834|364753731|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
105754756|NCT00340834|364753732|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
105754757|NCT00340834|364753733|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
105754758|NCT00340834|364753734|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
105754759|NCT00340834|364753735|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
105754760|NCT00340834|364753731|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
105754761|NCT00340834|364753732|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
105754762|NCT00340834|364753733|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
105754763|NCT00340834|364753734|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
105754764|NCT00340834|364753735|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
105754765|NCT00340834|364753731|FG000|Extension Phase of Study|Lost to Follow-up|1|||
105754766|NCT00340834|364753732|FG001|Extension Phase of Study|Lost to Follow-up|1|||
105754767|NCT00340834|364753733|FG002|Extension Phase of Study|Lost to Follow-up|0|||
105754768|NCT00340834|364753734|FG003|Extension Phase of Study|Lost to Follow-up|2|||
105754769|NCT00340834|364753735|FG004|Extension Phase of Study|Lost to Follow-up|3|||
105754770|NCT00340834|364753731|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
105754771|NCT00340834|364753732|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
105754772|NCT00340834|364753733|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
105754773|NCT00340834|364753734|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
105754774|NCT00340834|364753735|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
105754775|NCT00340834|364753731|FG000|Extension Phase of Study|Administrative problems|3|||
105754776|NCT00340834|364753732|FG001|Extension Phase of Study|Administrative problems|0|||
105754777|NCT00340834|364753733|FG002|Extension Phase of Study|Administrative problems|0|||
105754778|NCT00340834|364753734|FG003|Extension Phase of Study|Administrative problems|1|||
105754779|NCT00340834|364753735|FG004|Extension Phase of Study|Administrative problems|1|||
105754780|NCT00340834|364753731|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
105754781|NCT00340834|364753732|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
105754782|NCT00340834|364753733|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
105754783|NCT00340834|364753734|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
105754784|NCT00340834|364753735|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
105754785|NCT00340834|364753731|FG000|Extension Phase of Study|Protocol Violation|3|||
105754786|NCT00340834|364753732|FG001|Extension Phase of Study|Protocol Violation|0|||
105754787|NCT00340834|364753733|FG002|Extension Phase of Study|Protocol Violation|0|||
105754788|NCT00340834|364753734|FG003|Extension Phase of Study|Protocol Violation|0|||
105754789|NCT00340834|364753735|FG004|Extension Phase of Study|Protocol Violation|0|||
105754790|NCT00340834|364753731|FG000|Extension Phase of Study|Death|0|||
105754791|NCT00340834|364753732|FG001|Extension Phase of Study|Death|0|||
105754792|NCT00340834|364753733|FG002|Extension Phase of Study|Death|0|||
105754793|NCT00340834|364753734|FG003|Extension Phase of Study|Death|0|||
105754794|NCT00340834|364753735|FG004|Extension Phase of Study|Death|1|||
105754795|NCT03372603|364753736|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
105754796|NCT03372603|364753737|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
105754797|NCT03372603|364753736|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
105754798|NCT03372603|364753737|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
105754799|NCT03084718|364753738|FG000|Overall Study|Withdrawal by Subject|4|||
105754800|NCT03084718|364753739|FG001|Overall Study|Withdrawal by Subject|3|||
105754801|NCT03084718|364753740|FG002|Overall Study|Withdrawal by Subject|4|||
105754802|NCT03084718|364753741|FG003|Overall Study|Withdrawal by Subject|0|||
105754803|NCT03084718|364753742|FG004|Overall Study|Withdrawal by Subject|0|||
106016505|NCT04033445|365724449|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
106016506|NCT04033445|365724450|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
106016507|NCT04033445|365724451|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
106016508|NCT04033445|365724452|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105754804|NCT03084718|364753738|FG000|Overall Study|Physician Decision|1|||
105754805|NCT03084718|364753739|FG001|Overall Study|Physician Decision|0|||
105754806|NCT03084718|364753740|FG002|Overall Study|Physician Decision|0|||
105754807|NCT03084718|364753741|FG003|Overall Study|Physician Decision|0|||
105754808|NCT03084718|364753742|FG004|Overall Study|Physician Decision|0|||
105754809|NCT03084718|364753738|FG000|Overall Study|Adverse Event|3|||
105754810|NCT03084718|364753739|FG001|Overall Study|Adverse Event|5|||
105754811|NCT03084718|364753740|FG002|Overall Study|Adverse Event|5|||
105754812|NCT03084718|364753741|FG003|Overall Study|Adverse Event|8|||
105754813|NCT03084718|364753742|FG004|Overall Study|Adverse Event|2|||
105754814|NCT03084718|364753738|FG000|Overall Study|Lack of Efficacy|2|||
105754815|NCT03084718|364753739|FG001|Overall Study|Lack of Efficacy|0|||
105754816|NCT03084718|364753740|FG002|Overall Study|Lack of Efficacy|1|||
105754817|NCT03084718|364753741|FG003|Overall Study|Lack of Efficacy|4|||
105754818|NCT03084718|364753742|FG004|Overall Study|Lack of Efficacy|0|||
105754819|NCT03084718|364753738|FG000|Overall Study|Lost to Follow-up|0|||
105754820|NCT03084718|364753739|FG001|Overall Study|Lost to Follow-up|1|||
105754821|NCT03084718|364753740|FG002|Overall Study|Lost to Follow-up|0|||
105754822|NCT03084718|364753741|FG003|Overall Study|Lost to Follow-up|0|||
105754823|NCT03084718|364753742|FG004|Overall Study|Lost to Follow-up|2|||
105754824|NCT03084718|364753738|FG000|Overall Study|Protocol Violation|0|||
105754825|NCT03084718|364753739|FG001|Overall Study|Protocol Violation|0|||
105754826|NCT03084718|364753740|FG002|Overall Study|Protocol Violation|1|||
105754827|NCT03084718|364753741|FG003|Overall Study|Protocol Violation|0|||
105754828|NCT03084718|364753742|FG004|Overall Study|Protocol Violation|0|||
105754829|NCT03084718|364753738|FG000|Overall Study|Death|0|||
105754830|NCT03084718|364753739|FG001|Overall Study|Death|1|||
105754831|NCT03084718|364753740|FG002|Overall Study|Death|0|||
105754832|NCT03084718|364753741|FG003|Overall Study|Death|0|||
105754833|NCT03084718|364753742|FG004|Overall Study|Death|0|||
105754834|NCT03084718|364753738|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
105754835|NCT03084718|364753739|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
105754836|NCT03084718|364753740|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
105754837|NCT03084718|364753741|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
105754838|NCT03084718|364753742|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
105754839|NCT03986190|364753743|FG000|Overall Study|Withdrawal by Subject|12|||
105754840|NCT03986190|364753744|FG001|Overall Study|Withdrawal by Subject|0|||
105754841|NCT02806947|364753745|FG000|Overall Study|Withdrawal by Subject|5|||
105754842|NCT02806947|364753746|FG001|Overall Study|Withdrawal by Subject|1|||
105754843|NCT04929613|364753747|FG000|Overall Study|Withdrawal by Subject|12|||
105754844|NCT00865189|364753751|FG000|Overall Study|Other|1|||
105754845|NCT00865189|364753752|FG001|Overall Study|Other|2|||
105754846|NCT00865189|364753751|FG000|Overall Study|Death|4|||
105754847|NCT00865189|364753752|FG001|Overall Study|Death|11|||
105754848|NCT00865189|364753751|FG000|Overall Study|Lost to Follow-up|6|||
105754849|NCT00865189|364753752|FG001|Overall Study|Lost to Follow-up|6|||
105754850|NCT00865189|364753751|FG000|Overall Study|Withdrawal by Subject|1|||
105754851|NCT00865189|364753752|FG001|Overall Study|Withdrawal by Subject|0|||
105754852|NCT00664209|364753756|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
105754853|NCT00664209|364753756|FG000|Study Treatment Period|Physician Decision|4|||
105754854|NCT00664209|364753756|FG000|Study Treatment Period|Withdrawal by Subject|2|||
105754855|NCT00091026|364753767|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
105754856|NCT00091026|364753768|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
105754857|NCT00091026|364753767|FG000|Overall Study|Patient withdrew and never received trea|0|||
105754858|NCT00091026|364753768|FG001|Overall Study|Patient withdrew and never received trea|2|||
105754859|NCT00091026|364753767|FG000|Overall Study|Unknown-never received treatment|0|||
105754860|NCT00091026|364753768|FG001|Overall Study|Unknown-never received treatment|1|||
105754861|NCT00418379|364753769|FG000|Year 1|Adverse Event|9|||
105754862|NCT00418379|364753770|FG001|Year 1|Adverse Event|15|||
105754863|NCT00418379|364753771|FG002|Year 1|Adverse Event|3|||
105754864|NCT00418379|364753769|FG000|Year 1|Withdrawal by Subject|7|||
105754865|NCT00418379|364753770|FG001|Year 1|Withdrawal by Subject|8|||
105754866|NCT00418379|364753771|FG002|Year 1|Withdrawal by Subject|5|||
105754867|NCT00418379|364753769|FG000|Year 1|Any other reason not above-mentioned|2|||
105754868|NCT00418379|364753770|FG001|Year 1|Any other reason not above-mentioned|5|||
105754869|NCT00418379|364753771|FG002|Year 1|Any other reason not above-mentioned|7|||
105754870|NCT00418379|364753769|FG000|Year 2|Adverse Event|5|||
105754871|NCT00418379|364753770|FG001|Year 2|Adverse Event|2|||
105754872|NCT00418379|364753771|FG002|Year 2|Adverse Event|1|||
105754873|NCT00418379|364753769|FG000|Year 2|Withdrawal by Subject|1|||
105754874|NCT00418379|364753770|FG001|Year 2|Withdrawal by Subject|1|||
105754875|NCT00418379|364753771|FG002|Year 2|Withdrawal by Subject|3|||
105754876|NCT00418379|364753769|FG000|Year 2|Any other reason not above-mentioned|2|||
105754877|NCT00418379|364753770|FG001|Year 2|Any other reason not above-mentioned|1|||
105754878|NCT00418379|364753771|FG002|Year 2|Any other reason not above-mentioned|6|||
105754879|NCT00418379|364753769|FG000|Year 3|Withdrawal by Subject|1|||
105949714|NCT02259114|365480511|FG002|Overall Study|Not Treated|0|||
105949715|NCT02259114|365480512|FG003|Overall Study|Not Treated|0|||
105949716|NCT02259114|365480513|FG004|Overall Study|Not Treated|0|||
105949717|NCT03789292|365480517|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
105949718|NCT03789292|365480518|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
105949719|NCT03789292|365480519|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
105949720|NCT03789292|365480517|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
105949721|NCT03789292|365480518|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
105949722|NCT03789292|365480519|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
105949723|NCT03789292|365480517|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
105949724|NCT03789292|365480518|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
105949725|NCT03789292|365480519|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
105949726|NCT03789292|365480517|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
105949727|NCT03789292|365480518|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
105949728|NCT03789292|365480519|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
105949729|NCT03789292|365480517|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
105949730|NCT03789292|365480518|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
105949731|NCT03789292|365480519|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
105949732|NCT03789292|365480517|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
105949733|NCT03789292|365480518|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
105949734|NCT03789292|365480519|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
105949735|NCT03789292|365480517|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
105949736|NCT03789292|365480518|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
105754880|NCT00418379|364753770|FG001|Year 3|Withdrawal by Subject|1|||
105949737|NCT03789292|365480519|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
105949738|NCT03789292|365480517|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
105949739|NCT03789292|365480518|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
105949740|NCT03789292|365480519|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
105949741|NCT03789292|365480517|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
105754881|NCT00418379|364753771|FG002|Year 3|Withdrawal by Subject|2|||
105754882|NCT00418379|364753769|FG000|Year 3|Any other reason not above-mentioned|2|||
105754883|NCT00418379|364753770|FG001|Year 3|Any other reason not above-mentioned|1|||
105754884|NCT00418379|364753771|FG002|Year 3|Any other reason not above-mentioned|1|||
105754885|NCT00418379|364753769|FG000|Year 4|Adverse Event|0|||
105754886|NCT00418379|364753770|FG001|Year 4|Adverse Event|1|||
105754887|NCT00418379|364753771|FG002|Year 4|Adverse Event|0|||
105754888|NCT00418379|364753769|FG000|Year 4|Withdrawal by Subject|2|||
105754889|NCT00418379|364753770|FG001|Year 4|Withdrawal by Subject|3|||
105754890|NCT00418379|364753771|FG002|Year 4|Withdrawal by Subject|2|||
105754891|NCT00418379|364753769|FG000|Year 4|Any other reason not above-mentioned|1|||
105754892|NCT00418379|364753770|FG001|Year 4|Any other reason not above-mentioned|1|||
105754893|NCT00418379|364753771|FG002|Year 4|Any other reason not above-mentioned|0|||
105754894|NCT00418379|364753769|FG000|Year 5|Adverse Event|0|||
105754895|NCT00418379|364753770|FG001|Year 5|Adverse Event|1|||
105754896|NCT00418379|364753771|FG002|Year 5|Adverse Event|0|||
105754897|NCT00418379|364753769|FG000|Year 5|Any other reason not above-mentioned|2|||
105754898|NCT00418379|364753770|FG001|Year 5|Any other reason not above-mentioned|4|||
105754899|NCT00418379|364753771|FG002|Year 5|Any other reason not above-mentioned|3|||
105754900|NCT01764256|364753772|FG000|Received All Vaccinations|Adverse Event|1|||
105754901|NCT01764256|364753773|FG001|Received All Vaccinations|Adverse Event|1|||
105754902|NCT01764256|364753774|FG002|Received All Vaccinations|Adverse Event|0|||
105754903|NCT01764256|364753775|FG003|Received All Vaccinations|Adverse Event|0|||
105754904|NCT01764256|364753772|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
105754905|NCT01764256|364753773|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
105754906|NCT01764256|364753774|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
105754907|NCT01764256|364753775|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
105754908|NCT01764256|364753772|FG000|Received All Vaccinations|Lost to Follow-up|1|||
105754909|NCT01764256|364753773|FG001|Received All Vaccinations|Lost to Follow-up|0|||
105754910|NCT01764256|364753774|FG002|Received All Vaccinations|Lost to Follow-up|0|||
105754911|NCT01764256|364753775|FG003|Received All Vaccinations|Lost to Follow-up|0|||
105754912|NCT01764256|364753772|FG000|Completed Study|Lost to Follow-up|0|||
105754913|NCT01764256|364753773|FG001|Completed Study|Lost to Follow-up|0|||
105754914|NCT01764256|364753774|FG002|Completed Study|Lost to Follow-up|0|||
105754915|NCT01764256|364753775|FG003|Completed Study|Lost to Follow-up|1|||
105754916|NCT01354431|364753779|FG000|Pre-Treatment Period|Not reported|1|||
106016509|NCT04033445|365724453|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105754917|NCT01354431|364753780|FG001|Pre-Treatment Period|Not reported|0|||
105754918|NCT01354431|364753781|FG002|Pre-Treatment Period|Not reported|0|||
105754919|NCT01354431|364753779|FG000|Treatment Period|Disease Progression|50|||
105754920|NCT01354431|364753780|FG001|Treatment Period|Disease Progression|40|||
105754921|NCT01354431|364753781|FG002|Treatment Period|Disease Progression|44|||
105949742|NCT03789292|365480518|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
105949743|NCT03789292|365480519|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
105754922|NCT01354431|364753779|FG000|Treatment Period|Study Drug Toxicity|5|||
105754923|NCT01354431|364753780|FG001|Treatment Period|Study Drug Toxicity|8|||
105754924|NCT01354431|364753781|FG002|Treatment Period|Study Drug Toxicity|4|||
105754925|NCT01354431|364753779|FG000|Treatment Period|Death|0|||
105754926|NCT01354431|364753780|FG001|Treatment Period|Death|1|||
105754927|NCT01354431|364753781|FG002|Treatment Period|Death|0|||
105754928|NCT01354431|364753779|FG000|Treatment Period|AE unrelated to study drug|1|||
105754929|NCT01354431|364753780|FG001|Treatment Period|AE unrelated to study drug|2|||
105754930|NCT01354431|364753781|FG002|Treatment Period|AE unrelated to study drug|5|||
105754931|NCT01354431|364753779|FG000|Treatment Period|Participant request to discontinue|2|||
105754932|NCT01354431|364753780|FG001|Treatment Period|Participant request to discontinue|2|||
105754933|NCT01354431|364753781|FG002|Treatment Period|Participant request to discontinue|1|||
105754934|NCT01354431|364753779|FG000|Treatment Period|Participant withdrew consent|0|||
105754935|NCT01354431|364753780|FG001|Treatment Period|Participant withdrew consent|1|||
105754936|NCT01354431|364753781|FG002|Treatment Period|Participant withdrew consent|0|||
105754937|NCT01354431|364753779|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
105754938|NCT01354431|364753780|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
105754939|NCT01354431|364753781|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
105754940|NCT00634114|364753782|FG000|Overall Study|Adverse Event|6|||
105754941|NCT00634114|364753783|FG001|Overall Study|Adverse Event|8|||
105754942|NCT00634114|364753784|FG002|Overall Study|Adverse Event|3|||
105754943|NCT00634114|364753782|FG000|Overall Study|Withdrawal by Subject|9|||
105754944|NCT00634114|364753783|FG001|Overall Study|Withdrawal by Subject|6|||
105754945|NCT00634114|364753784|FG002|Overall Study|Withdrawal by Subject|11|||
105754946|NCT00634114|364753782|FG000|Overall Study|Lost to Follow-up|0|||
105754947|NCT00634114|364753783|FG001|Overall Study|Lost to Follow-up|0|||
105754948|NCT00634114|364753784|FG002|Overall Study|Lost to Follow-up|1|||
105754949|NCT00634114|364753782|FG000|Overall Study|Protocol Violation|3|||
105754950|NCT00634114|364753783|FG001|Overall Study|Protocol Violation|3|||
105754951|NCT00634114|364753784|FG002|Overall Study|Protocol Violation|1|||
105754952|NCT00634114|364753782|FG000|Overall Study|Pregnancy|1|||
105754953|NCT00634114|364753783|FG001|Overall Study|Pregnancy|0|||
105754954|NCT00634114|364753784|FG002|Overall Study|Pregnancy|0|||
105754955|NCT00634114|364753782|FG000|Overall Study|Incorrect enrolment|0|||
105754956|NCT00634114|364753783|FG001|Overall Study|Incorrect enrolment|1|||
105754957|NCT00634114|364753784|FG002|Overall Study|Incorrect enrolment|0|||
105754958|NCT00634114|364753782|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
105754959|NCT00634114|364753783|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
105754960|NCT00634114|364753784|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
105754961|NCT00634114|364753782|FG000|Overall Study|Difficult to continue|3|||
105754962|NCT00634114|364753783|FG001|Overall Study|Difficult to continue|1|||
105754963|NCT00634114|364753784|FG002|Overall Study|Difficult to continue|1|||
105754964|NCT00634114|364753782|FG000|Overall Study|Other reason|1|||
105754965|NCT00634114|364753783|FG001|Overall Study|Other reason|1|||
105754966|NCT00634114|364753784|FG002|Overall Study|Other reason|1|||
105754967|NCT03699631|364753787|FG000|Overall Study|Adverse Event|3|||
105754968|NCT00585923|364753788|FG000|Overall Study|Physician decided not to continue|31|||
105754969|NCT00585923|364753789|FG001|Overall Study|Physician decided not to continue|33|||
105754970|NCT02121756|364753790|FG000|Overall Study|Adverse Event|3|||
105754971|NCT02121756|364753791|FG001|Overall Study|Adverse Event|0|||
105754972|NCT02121756|364753790|FG000|Overall Study|Protocol Violation|1|||
105754973|NCT02121756|364753791|FG001|Overall Study|Protocol Violation|1|||
105754974|NCT02121756|364753790|FG000|Overall Study|Physician Decision|2|||
105754975|NCT02121756|364753791|FG001|Overall Study|Physician Decision|1|||
105754976|NCT00138424|364753794|FG000|Overall Study|Physician Decision|0|||
105754977|NCT00138424|364753795|FG001|Overall Study|Physician Decision|1|||
105754978|NCT00138424|364753796|FG002|Overall Study|Physician Decision|0|||
105754979|NCT00138424|364753797|FG003|Overall Study|Physician Decision|0|||
105754980|NCT04311177|364753798|FG000|Overall Study|Adverse Event|3|||
105754981|NCT04311177|364753799|FG001|Overall Study|Adverse Event|1|||
105754982|NCT04311177|364753798|FG000|Overall Study|Physician Decision|4|||
105754983|NCT04311177|364753799|FG001|Overall Study|Physician Decision|3|||
105754984|NCT04311177|364753798|FG000|Overall Study|Withdrawal by Subject|1|||
105949744|NCT03789292|365480517|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
105949745|NCT03789292|365480518|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
105949746|NCT03789292|365480519|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
105949747|NCT03789292|365480517|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
105949748|NCT03789292|365480518|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
106016510|NCT04033445|365724454|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
105754985|NCT04311177|364753799|FG001|Overall Study|Withdrawal by Subject|0|||
105754986|NCT02176291|364753800|FG000|Overall Study|Death|1|||
105754987|NCT02176291|364753801|FG001|Overall Study|Death|0|||
105754988|NCT02176291|364753800|FG000|Overall Study|non compliance with protocol|2|||
105949749|NCT03789292|365480519|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
105949750|NCT03789292|365480517|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
105949751|NCT03789292|365480518|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
105949752|NCT03789292|365480519|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
105949753|NCT03789292|365480517|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
105949754|NCT03789292|365480518|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
105949755|NCT03789292|365480519|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
105949756|NCT02230189|365480520|FG000|Overall Study|Withdrawal by Subject|3|||
105949757|NCT02230189|365480521|FG001|Overall Study|Withdrawal by Subject|0|||
105949758|NCT02230189|365480522|FG002|Overall Study|Withdrawal by Subject|1|||
105949759|NCT02230189|365480520|FG000|Overall Study|Lost to Follow-up|1|||
105949760|NCT02230189|365480521|FG001|Overall Study|Lost to Follow-up|0|||
105949761|NCT02230189|365480522|FG002|Overall Study|Lost to Follow-up|0|||
105949762|NCT02230189|365480520|FG000|Overall Study|Physician Decision|1|||
105949763|NCT02230189|365480521|FG001|Overall Study|Physician Decision|0|||
105949764|NCT02230189|365480522|FG002|Overall Study|Physician Decision|0|||
105949765|NCT00575666|365480526|FG000|Overall Study|Withdrawal by Subject|3|||
105949766|NCT00575666|365480527|FG001|Overall Study|Withdrawal by Subject|2|||
105949767|NCT00575666|365480526|FG000|Overall Study|Physician Decision|1|||
105949768|NCT00575666|365480527|FG001|Overall Study|Physician Decision|1|||
105949769|NCT01368614|365480528|FG000|Screening Period|Screen Failure|58|||
105949770|NCT01368614|365480529|FG001|Screening Period|Screen Failure|0|||
105949771|NCT01368614|365480530|FG002|Screening Period|Screen Failure|0|||
105949772|NCT01368614|365480531|FG003|Screening Period|Screen Failure|0|||
105949773|NCT01368614|365480528|FG000|Study Period|Withdrawal by Subject|0|||
105949774|NCT01368614|365480529|FG001|Study Period|Withdrawal by Subject|1|||
105949775|NCT01368614|365480530|FG002|Study Period|Withdrawal by Subject|1|||
105949776|NCT01368614|365480531|FG003|Study Period|Withdrawal by Subject|3|||
105949777|NCT01368614|365480528|FG000|Study Period|Lost to Follow-up|0|||
105949778|NCT01368614|365480529|FG001|Study Period|Lost to Follow-up|0|||
105949779|NCT01368614|365480530|FG002|Study Period|Lost to Follow-up|1|||
105949780|NCT01368614|365480531|FG003|Study Period|Lost to Follow-up|0|||
105949781|NCT02951780|365480532|FG000|Period 1|Adverse Event|0|||
105949782|NCT02951780|365480533|FG001|Period 1|Adverse Event|0|||
105949783|NCT02951780|365480534|FG002|Period 1|Adverse Event|0|||
105949784|NCT02951780|365480535|FG003|Period 1|Adverse Event|1|||
105949785|NCT02951780|365480536|FG004|Period 1|Adverse Event|0|||
105949786|NCT02951780|365480537|FG005|Period 1|Adverse Event|0|||
105949787|NCT02951780|365480538|FG006|Period 1|Adverse Event|0|||
105949788|NCT02951780|365480539|FG007|Period 1|Adverse Event|0|||
105949789|NCT02951780|365480540|FG008|Period 1|Adverse Event|0|||
105949790|NCT02951780|365480532|FG000|Period 1|Scheduling Conflicts|0|||
105949791|NCT02951780|365480533|FG001|Period 1|Scheduling Conflicts|0|||
105949792|NCT02951780|365480534|FG002|Period 1|Scheduling Conflicts|0|||
105949793|NCT02951780|365480535|FG003|Period 1|Scheduling Conflicts|0|||
105949794|NCT02951780|365480536|FG004|Period 1|Scheduling Conflicts|0|||
105949795|NCT02951780|365480537|FG005|Period 1|Scheduling Conflicts|0|||
105949796|NCT02951780|365480538|FG006|Period 1|Scheduling Conflicts|0|||
105949797|NCT02951780|365480539|FG007|Period 1|Scheduling Conflicts|1|||
105949798|NCT02951780|365480540|FG008|Period 1|Scheduling Conflicts|0|||
105949799|NCT02951780|365480532|FG000|Period 2|Scheduling Conflicts|0|||
105949800|NCT02951780|365480533|FG001|Period 2|Scheduling Conflicts|0|||
105949801|NCT02951780|365480534|FG002|Period 2|Scheduling Conflicts|0|||
106016511|NCT04033445|365724455|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
106016512|NCT04033445|365724456|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
106016513|NCT04033445|365724457|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
106016514|NCT04033445|365724458|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
106142798|NCT01713946|366182004|FG000|Overall Study|Administrative problems|1|||
106142799|NCT01713946|366182005|FG001|Overall Study|Administrative problems|0|||
106142800|NCT01713946|366182006|FG002|Overall Study|Administrative problems|0|||
105949802|NCT02951780|365480535|FG003|Period 2|Scheduling Conflicts|0|||
105949803|NCT02951780|365480536|FG004|Period 2|Scheduling Conflicts|0|||
105949804|NCT02951780|365480537|FG005|Period 2|Scheduling Conflicts|0|||
105949805|NCT02951780|365480538|FG006|Period 2|Scheduling Conflicts|0|||
105949806|NCT02951780|365480539|FG007|Period 2|Scheduling Conflicts|1|||
105949807|NCT02951780|365480540|FG008|Period 2|Scheduling Conflicts|0|||
105949808|NCT02359903|365480544|FG000|Overall Study|Adverse Event|0|||
105949809|NCT02359903|365480545|FG001|Overall Study|Adverse Event|2|||
105949810|NCT00546481|365480546|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
105949811|NCT00546481|365480547|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
105949812|NCT00546481|365480548|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
105949813|NCT00546481|365480546|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
105949814|NCT00546481|365480547|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
105949815|NCT00546481|365480548|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
105949816|NCT00546481|365480546|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
105802604|NCT01070394|364932699|FG000|Overall Study|Withdrawal by Subject|1|||
105806515|NCT03038113|364949009|FG009|Overall Study|Withdrawal by Subject|0|||
105806516|NCT03038113|364949010|FG010|Overall Study|Withdrawal by Subject|0|||
105806517|NCT03038113|364949011|FG011|Overall Study|Withdrawal by Subject|0|||
105806518|NCT03038113|364949012|FG012|Overall Study|Withdrawal by Subject|0|||
105806519|NCT03038113|364949013|FG013|Overall Study|Withdrawal by Subject|1|||
105806520|NCT03038113|364949000|FG000|Overall Study|Lost to Follow-up|0|||
105806521|NCT03038113|364949001|FG001|Overall Study|Lost to Follow-up|0|||
105806522|NCT03038113|364949002|FG002|Overall Study|Lost to Follow-up|0|||
105806523|NCT03038113|364949003|FG003|Overall Study|Lost to Follow-up|0|||
105806524|NCT03038113|364949004|FG004|Overall Study|Lost to Follow-up|0|||
105806525|NCT03038113|364949005|FG005|Overall Study|Lost to Follow-up|0|||
105806526|NCT03038113|364949006|FG006|Overall Study|Lost to Follow-up|1|||
105806527|NCT03038113|364949007|FG007|Overall Study|Lost to Follow-up|0|||
105806528|NCT03038113|364949008|FG008|Overall Study|Lost to Follow-up|0|||
105806529|NCT03038113|364949009|FG009|Overall Study|Lost to Follow-up|0|||
105806530|NCT03038113|364949010|FG010|Overall Study|Lost to Follow-up|0|||
105806531|NCT03038113|364949011|FG011|Overall Study|Lost to Follow-up|0|||
105806532|NCT03038113|364949012|FG012|Overall Study|Lost to Follow-up|0|||
105806533|NCT03038113|364949013|FG013|Overall Study|Lost to Follow-up|0|||
105806534|NCT03209570|364949015|FG000|Overall Study|Death|1|||
105806535|NCT03209570|364949016|FG001|Overall Study|Death|0|||
105806536|NCT03209570|364949015|FG000|Overall Study|Incomplete Data|8|||
105949817|NCT00546481|365480547|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
105949818|NCT00546481|365480548|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
105949819|NCT00546481|365480546|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
105754989|NCT02176291|364753801|FG001|Overall Study|non compliance with protocol|0|||
105754990|NCT02176291|364753800|FG000|Overall Study|Withdrawal by Subject|2|||
105754991|NCT02176291|364753801|FG001|Overall Study|Withdrawal by Subject|0|||
105754992|NCT02815293|364753802|FG000|Overall Study|Study termination by sponsor|10|||
105754993|NCT02815293|364753803|FG001|Overall Study|Study termination by sponsor|7|||
105754994|NCT02815293|364753804|FG002|Overall Study|Study termination by sponsor|0|||
105754995|NCT02815293|364753802|FG000|Overall Study|Participants not randomized|0|||
105754996|NCT02815293|364753803|FG001|Overall Study|Participants not randomized|0|||
105754997|NCT02815293|364753804|FG002|Overall Study|Participants not randomized|18|||
105754998|NCT02815293|364753802|FG000|Overall Study|Adverse Event|0|||
105754999|NCT02815293|364753803|FG001|Overall Study|Adverse Event|1|||
105755000|NCT02815293|364753804|FG002|Overall Study|Adverse Event|0|||
105755001|NCT02159469|364753805|FG000|Overall Study|Missing Completion status|1|||
105755002|NCT02159469|364753805|FG000|Overall Study|Adverse Event|5|||
105755003|NCT02159469|364753805|FG000|Overall Study|Non-compliance|2|||
105755004|NCT02159469|364753805|FG000|Overall Study|Withdrawal by Subject|9|||
105755005|NCT02159469|364753805|FG000|Overall Study|Lost to Follow-up|1|||
105755006|NCT02159469|364753805|FG000|Overall Study|Sponsor's request|2|||
105755007|NCT02159469|364753805|FG000|Overall Study|Met Stopping Criteria|3|||
105755008|NCT02159469|364753805|FG000|Overall Study|Other|1|||
105755009|NCT02159469|364753805|FG000|Overall Study|Multiple|29|||
105755010|NCT00592553|364753808|FG000|Overall Study|Protocol Noncompliance|1|||
105755011|NCT00592553|364753809|FG001|Overall Study|Protocol Noncompliance|0|||
105755012|NCT00592553|364753810|FG002|Overall Study|Protocol Noncompliance|0|||
105755013|NCT01669811|364753815|FG000|Overall Study|Investigator decision|0|||
105755014|NCT01669811|364753816|FG001|Overall Study|Investigator decision|1|||
105755015|NCT01669811|364753815|FG000|Overall Study|Withdrawal by Subject|1|||
105755016|NCT01669811|364753816|FG001|Overall Study|Withdrawal by Subject|2|||
105755017|NCT01669811|364753815|FG000|Overall Study|Adverse Event|2|||
105755018|NCT01669811|364753816|FG001|Overall Study|Adverse Event|6|||
105755019|NCT01669811|364753815|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105755020|NCT01669811|364753816|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
105755021|NCT02554253|364753819|FG000|Overall Study|ineligible after enrollment|1|||
105755022|NCT02554253|364753820|FG001|Overall Study|ineligible after enrollment|0|||
105755023|NCT02554253|364753819|FG000|Overall Study|converted to transcatheter procedure|0|||
105755024|NCT02554253|364753820|FG001|Overall Study|converted to transcatheter procedure|1|||
105755025|NCT02554253|364753819|FG000|Overall Study|received both drugs|0|||
105755026|NCT02554253|364753820|FG001|Overall Study|received both drugs|1|||
105755027|NCT01561560|364753821|FG000|First Two Weeks of Wear|Time/job conflict|0|||
105755028|NCT01561560|364753822|FG001|First Two Weeks of Wear|Time/job conflict|1|||
105755029|NCT01561560|364753821|FG000|First Two Weeks of Wear|Adverse Event|0|||
105755030|NCT01561560|364753822|FG001|First Two Weeks of Wear|Adverse Event|1|||
105755031|NCT01561560|364753821|FG000|Second Two Weeks of Wear|Adverse Event|0|||
105755032|NCT01561560|364753822|FG001|Second Two Weeks of Wear|Adverse Event|1|||
105755033|NCT01871896|364753823|FG000|Overall Study|Lost to Follow-up|1|||
105755034|NCT02310906|364755705|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
105755035|NCT02310906|364755706|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
105755036|NCT02310906|364755707|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
105755037|NCT02310906|364755708|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
105755038|NCT02310906|364755705|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
105755039|NCT02310906|364755706|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
105755040|NCT02310906|364755707|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
105949820|NCT00546481|365480547|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
105949821|NCT00546481|365480548|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
105949822|NCT00546481|365480546|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
105949823|NCT00546481|365480547|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
105949824|NCT00546481|365480548|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
105949825|NCT00546481|365480546|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
105949826|NCT00546481|365480547|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
105949827|NCT00546481|365480548|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
105949828|NCT00546481|365480546|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
105949829|NCT00546481|365480547|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
105949830|NCT00546481|365480548|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
105949831|NCT00546481|365480546|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
105949832|NCT00546481|365480547|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
105949833|NCT00546481|365480548|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
105949834|NCT00546481|365480546|FG000|Maintenance Phase (CERA)|Other Reason|0|||
106016515|NCT04033445|365724459|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
106016516|NCT04033445|365724460|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
106016517|NCT04033445|365724447|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105802605|NCT03372083|364934487|FG000|Overall Study|Adverse Event|3|||
105949835|NCT00546481|365480547|FG001|Maintenance Phase (CERA)|Other Reason|0|||
105949836|NCT00546481|365480548|FG002|Maintenance Phase (CERA)|Other Reason|1|||
105949837|NCT02271529|365480553|FG000|Overall Study|Withdrawal by Subject|1|||
105949838|NCT03783780|365480558|FG000|Overall Study|Withdrawn prior to completion|1|||
105949839|NCT02629861|365480562|FG000|Overall Study|Adverse Event|7|||
105949840|NCT02629861|365480563|FG001|Overall Study|Adverse Event|5|||
105949841|NCT02629861|365480564|FG002|Overall Study|Adverse Event|4|||
105949842|NCT02629861|365480562|FG000|Overall Study|Withdrawal by Subject|5|||
105949843|NCT02629861|365480563|FG001|Overall Study|Withdrawal by Subject|8|||
105949844|NCT02629861|365480564|FG002|Overall Study|Withdrawal by Subject|13|||
105949845|NCT02629861|365480562|FG000|Overall Study|Protocol Violation|2|||
105949846|NCT02629861|365480563|FG001|Overall Study|Protocol Violation|3|||
105949847|NCT02629861|365480564|FG002|Overall Study|Protocol Violation|7|||
105949848|NCT02629861|365480562|FG000|Overall Study|Lost to Follow-up|12|||
105949849|NCT02629861|365480563|FG001|Overall Study|Lost to Follow-up|9|||
105949850|NCT02629861|365480564|FG002|Overall Study|Lost to Follow-up|4|||
105949851|NCT02629861|365480562|FG000|Overall Study|Other|1|||
105949852|NCT02629861|365480563|FG001|Overall Study|Other|1|||
105949853|NCT02629861|365480564|FG002|Overall Study|Other|0|||
105802606|NCT03372083|364934487|FG000|Overall Study|Physician Decision|1|||
105802607|NCT03372083|364934487|FG000|Overall Study|Withdrawal by Subject|1|||
105802608|NCT03769181|364934490|FG000|Overall Study|Adverse Event|1|||
105802609|NCT03769181|364934491|FG001|Overall Study|Adverse Event|0|||
105802610|NCT03769181|364934492|FG002|Overall Study|Adverse Event|2|||
105802611|NCT03769181|364934493|FG003|Overall Study|Adverse Event|4|||
105802612|NCT03769181|364934490|FG000|Overall Study|Withdrawal by Subject|1|||
105802613|NCT03769181|364934491|FG001|Overall Study|Withdrawal by Subject|0|||
105802614|NCT03769181|364934492|FG002|Overall Study|Withdrawal by Subject|2|||
105949854|NCT02629861|365480562|FG000|Overall Study|Pregnancy|2|||
105949855|NCT02629861|365480563|FG001|Overall Study|Pregnancy|1|||
105949856|NCT02629861|365480564|FG002|Overall Study|Pregnancy|0|||
105949857|NCT00165789|365480565|FG000|Overall Study|Adverse Event|0|||
105949858|NCT00165789|365480566|FG001|Overall Study|Adverse Event|3|||
105949859|NCT00165789|365480567|FG002|Overall Study|Adverse Event|0|||
105949860|NCT00165789|365480568|FG003|Overall Study|Adverse Event|12|||
105949861|NCT00165789|365480565|FG000|Overall Study|Withdrawal by Subject|0|||
105949862|NCT00165789|365480566|FG001|Overall Study|Withdrawal by Subject|1|||
105802615|NCT03769181|364934493|FG003|Overall Study|Withdrawal by Subject|1|||
105949863|NCT00165789|365480567|FG002|Overall Study|Withdrawal by Subject|1|||
105949864|NCT00165789|365480568|FG003|Overall Study|Withdrawal by Subject|2|||
105949865|NCT01847443|365480573|FG000|Study Period 1|Withdrawal by Subject|0|||
105949866|NCT01847443|365480574|FG001|Study Period 1|Withdrawal by Subject|1|||
105949867|NCT01847443|365480575|FG002|Study Period 1|Withdrawal by Subject|0|||
105949868|NCT01847443|365480576|FG003|Study Period 1|Withdrawal by Subject|0|||
105755041|NCT02310906|364755708|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
105949869|NCT01847443|365480573|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
105949870|NCT01847443|365480574|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
105755042|NCT02310906|364755705|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
105755043|NCT02310906|364755706|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
105755044|NCT02310906|364755707|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
105755045|NCT02310906|364755708|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
105755046|NCT02310906|364755705|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
105755047|NCT02310906|364755706|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
105755048|NCT02310906|364755707|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
105755049|NCT02310906|364755708|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
105755050|NCT01840228|364755717|FG000|Overall Study|Lost to Follow-up|1|||
105755051|NCT01840228|364755718|FG001|Overall Study|Lost to Follow-up|1|||
105755052|NCT03654755|364755719|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
105755053|NCT03654755|364755720|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
105755054|NCT03654755|364755721|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
105755055|NCT03654755|364755719|FG000|Overall Study|Withdrawal by Subject|2|||
105755056|NCT03654755|364755720|FG001|Overall Study|Withdrawal by Subject|4|||
105755057|NCT03654755|364755721|FG002|Overall Study|Withdrawal by Subject|8|||
105755058|NCT03654755|364755719|FG000|Overall Study|Lost to Follow-up|1|||
105755059|NCT03654755|364755720|FG001|Overall Study|Lost to Follow-up|3|||
105755060|NCT03654755|364755721|FG002|Overall Study|Lost to Follow-up|7|||
105755061|NCT03654755|364755719|FG000|Overall Study|Physician Decision|0|||
105755062|NCT03654755|364755720|FG001|Overall Study|Physician Decision|1|||
105755063|NCT03654755|364755721|FG002|Overall Study|Physician Decision|0|||
105755064|NCT03654755|364755719|FG000|Overall Study|Adverse Event|0|||
105755065|NCT03654755|364755720|FG001|Overall Study|Adverse Event|0|||
105755066|NCT03654755|364755721|FG002|Overall Study|Adverse Event|4|||
105755067|NCT03654755|364755719|FG000|Overall Study|Lack of Efficacy|0|||
105755068|NCT03654755|364755720|FG001|Overall Study|Lack of Efficacy|0|||
105755069|NCT03654755|364755721|FG002|Overall Study|Lack of Efficacy|1|||
105755070|NCT01429077|364755724|FG000|Overall Study|Lost to Follow-up|0|||
105755071|NCT01429077|364755725|FG001|Overall Study|Lost to Follow-up|3|||
105755072|NCT01413542|364755727|FG000|Overall Study|Physician Decision|1|||
105755073|NCT01413542|364755728|FG001|Overall Study|Physician Decision|0|||
105755074|NCT01413542|364755729|FG002|Overall Study|Physician Decision|3|||
105755075|NCT01413542|364755730|FG003|Overall Study|Physician Decision|0|||
105755076|NCT01413542|364755727|FG000|Overall Study|Adverse Event|0|||
105755077|NCT01413542|364755728|FG001|Overall Study|Adverse Event|0|||
105755078|NCT01413542|364755729|FG002|Overall Study|Adverse Event|0|||
105755079|NCT01413542|364755730|FG003|Overall Study|Adverse Event|1|||
105755080|NCT00830804|364755731|FG000|Overall Study|Lost to Follow-up|4|||
105755081|NCT00830804|364755731|FG000|Overall Study|Death|1|||
105755082|NCT00830804|364755731|FG000|Overall Study|Unable to get to clinic|7|||
105755083|NCT00830804|364755731|FG000|Overall Study|Consent withdrawn|2|||
105755084|NCT00830804|364755731|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
105755085|NCT00510068|364755734|FG000|Double-blind Period|Disease progression|98|||
105755086|NCT00510068|364755735|FG001|Double-blind Period|Disease progression|169|||
105755087|NCT00510068|364755734|FG000|Double-blind Period|Final primary analysis|52|||
105755088|NCT00510068|364755735|FG001|Double-blind Period|Final primary analysis|18|||
105755089|NCT00510068|364755734|FG000|Double-blind Period|Adverse Event|37|||
105755090|NCT00510068|364755735|FG001|Double-blind Period|Adverse Event|7|||
105755091|NCT00510068|364755734|FG000|Double-blind Period|Withdrawal by Subject|8|||
105755092|NCT00510068|364755735|FG001|Double-blind Period|Withdrawal by Subject|6|||
105755093|NCT00510068|364755734|FG000|Double-blind Period|Death|4|||
105755094|NCT00510068|364755735|FG001|Double-blind Period|Death|3|||
105755095|NCT00510068|364755734|FG000|Double-blind Period|Abnormal test result (s)|1|||
105755096|NCT00510068|364755735|FG001|Double-blind Period|Abnormal test result (s)|0|||
105755097|NCT00510068|364755734|FG000|Double-blind Period|Lost to Follow-up|1|||
105755098|NCT00510068|364755735|FG001|Double-blind Period|Lost to Follow-up|0|||
105755099|NCT00510068|364755734|FG000|Double-blind Period|Protocol Violation|6|||
105755100|NCT00510068|364755735|FG001|Double-blind Period|Protocol Violation|0|||
105755101|NCT00510068|364755734|FG000|Open-label Period|Disease Progression|124|||
105755102|NCT00510068|364755735|FG001|Open-label Period|Disease Progression|0|||
105755103|NCT00510068|364755734|FG000|Open-label Period|Adverse Event|46|||
105755104|NCT00510068|364755735|FG001|Open-label Period|Adverse Event|0|||
105755105|NCT00510068|364755734|FG000|Open-label Period|Withdrawal by Subject|21|||
105755106|NCT00510068|364755735|FG001|Open-label Period|Withdrawal by Subject|0|||
105755107|NCT00510068|364755734|FG000|Open-label Period|Administrative problems|17|||
105755108|NCT00510068|364755735|FG001|Open-label Period|Administrative problems|0|||
105755109|NCT00510068|364755734|FG000|Open-label Period|Death|7|||
105755110|NCT00510068|364755735|FG001|Open-label Period|Death|0|||
105755111|NCT00510068|364755734|FG000|Open-label Period|New cancer therapy|7|||
105755112|NCT00510068|364755735|FG001|Open-label Period|New cancer therapy|0|||
105949871|NCT01847443|365480575|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
105949872|NCT01847443|365480576|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
105949873|NCT01847443|365480573|FG000|Washout Period Before Study Period 2|Other reason|1|||
105949874|NCT01847443|365480574|FG001|Washout Period Before Study Period 2|Other reason|0|||
105949875|NCT01847443|365480575|FG002|Washout Period Before Study Period 2|Other reason|0|||
105949876|NCT01847443|365480576|FG003|Washout Period Before Study Period 2|Other reason|0|||
105949877|NCT01847443|365480573|FG000|Washout Period Before Study Period 3|Other reason|1|||
105949878|NCT01847443|365480574|FG001|Washout Period Before Study Period 3|Other reason|0|||
105949879|NCT01847443|365480575|FG002|Washout Period Before Study Period 3|Other reason|0|||
105949880|NCT01847443|365480576|FG003|Washout Period Before Study Period 3|Other reason|0|||
105949881|NCT01847443|365480573|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
105755113|NCT00510068|364755734|FG000|Open-label Period|Protocol Violation|2|||
105755114|NCT00510068|364755735|FG001|Open-label Period|Protocol Violation|0|||
105755115|NCT00510068|364755734|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
105755116|NCT00510068|364755735|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
105755117|NCT02180217|364755738|FG000|Overall Study|Adverse Event|3|||
105949882|NCT01847443|365480574|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
105949883|NCT01847443|365480575|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
106016518|NCT04033445|365724448|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105755118|NCT02180217|364755739|FG001|Overall Study|Adverse Event|2|||
105755119|NCT02180217|364755740|FG002|Overall Study|Adverse Event|22|||
105755120|NCT02180217|364755738|FG000|Overall Study|Death|1|||
105755121|NCT02180217|364755739|FG001|Overall Study|Death|1|||
105755122|NCT02180217|364755740|FG002|Overall Study|Death|0|||
105755123|NCT02180217|364755738|FG000|Overall Study|Withdrawal by Subject|1|||
105755124|NCT02180217|364755739|FG001|Overall Study|Withdrawal by Subject|1|||
105755125|NCT02180217|364755740|FG002|Overall Study|Withdrawal by Subject|4|||
105755126|NCT02180217|364755738|FG000|Overall Study|Subject/Guardian decision|5|||
105755127|NCT02180217|364755739|FG001|Overall Study|Subject/Guardian decision|3|||
105755128|NCT02180217|364755740|FG002|Overall Study|Subject/Guardian decision|6|||
105755129|NCT02180217|364755738|FG000|Overall Study|Physician Decision|1|||
105755130|NCT02180217|364755739|FG001|Overall Study|Physician Decision|1|||
105755131|NCT02180217|364755740|FG002|Overall Study|Physician Decision|6|||
105755132|NCT02180217|364755738|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105755133|NCT02180217|364755739|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105755134|NCT02180217|364755740|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105755135|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
105755136|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
105755137|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
105755138|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
105755139|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
105755140|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
105755141|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Death|1|||
105755142|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Death|3|||
105755143|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
105755144|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
105755145|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
105755146|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
105755147|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
105755148|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
105755149|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
105755150|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
105755151|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
105755152|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
105755153|NCT02553317|364755741|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
105755154|NCT02553317|364755742|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
105755155|NCT01181102|364755743|FG000|Overall Study|Adverse Event|28|||
105755156|NCT01181102|364755744|FG001|Overall Study|Adverse Event|26|||
105755157|NCT01181102|364755743|FG000|Overall Study|Lack of Efficacy|3|||
105755158|NCT01181102|364755744|FG001|Overall Study|Lack of Efficacy|1|||
105755159|NCT01181102|364755743|FG000|Overall Study|Lost to Follow-up|2|||
105755160|NCT01181102|364755744|FG001|Overall Study|Lost to Follow-up|0|||
105755161|NCT01181102|364755743|FG000|Overall Study|Physician Decision|3|||
105755162|NCT01181102|364755744|FG001|Overall Study|Physician Decision|1|||
105755163|NCT01181102|364755743|FG000|Overall Study|Protocol Violation|5|||
105755164|NCT01181102|364755744|FG001|Overall Study|Protocol Violation|6|||
105755165|NCT01181102|364755743|FG000|Overall Study|Withdrawal by Subject|10|||
105755166|NCT01181102|364755744|FG001|Overall Study|Withdrawal by Subject|12|||
105755167|NCT00239837|364755755|FG000|Overall Study|Lost to Follow-up|3|||
105755168|NCT00239837|364755756|FG001|Overall Study|Lost to Follow-up|7|||
106016519|NCT04033445|365724449|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105949884|NCT01847443|365480576|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
105949885|NCT01847443|365480573|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
105949886|NCT01847443|365480574|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
105949887|NCT01847443|365480575|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
105949888|NCT01847443|365480576|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
105949889|NCT05076045|365480580|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
105755169|NCT01153893|364755757|FG000|Overall Study|Adverse Event|1|||
105949890|NCT05076045|365480581|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
105755170|NCT01153893|364755758|FG001|Overall Study|Adverse Event|0|||
105755171|NCT03176277|364755759|FG000|Part A Dose Escalation Study|Adverse Event|1|||
105755172|NCT03176277|364755760|FG001|Part A Dose Escalation Study|Adverse Event|0|||
105755173|NCT03176277|364755761|FG002|Part A Dose Escalation Study|Adverse Event|1|||
105755174|NCT03176277|364755762|FG003|Part A Dose Escalation Study|Adverse Event|0|||
105755175|NCT03176277|364755759|FG000|Part A Dose Escalation Study|Physician Decision|1|||
105755176|NCT03176277|364755760|FG001|Part A Dose Escalation Study|Physician Decision|1|||
105755177|NCT03176277|364755761|FG002|Part A Dose Escalation Study|Physician Decision|2|||
105755178|NCT03176277|364755762|FG003|Part A Dose Escalation Study|Physician Decision|0|||
105755179|NCT03176277|364755759|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
105755180|NCT03176277|364755760|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
105755181|NCT03176277|364755761|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
105755182|NCT03176277|364755762|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
105755183|NCT03176277|364755759|FG000|Part A Dose Escalation Study|Progressive disease|3|||
105755184|NCT03176277|364755760|FG001|Part A Dose Escalation Study|Progressive disease|1|||
105755185|NCT03176277|364755761|FG002|Part A Dose Escalation Study|Progressive disease|3|||
105755186|NCT03176277|364755762|FG003|Part A Dose Escalation Study|Progressive disease|0|||
105755187|NCT02940626|364755764|FG000|Overall Study|Death|40|||
105755188|NCT02940626|364755765|FG001|Overall Study|Death|32|||
105755189|NCT02940626|364755764|FG000|Overall Study|Lost to Follow-up|5|||
105755190|NCT02940626|364755765|FG001|Overall Study|Lost to Follow-up|2|||
105755191|NCT02940626|364755764|FG000|Overall Study|Withdrawal by Subject|1|||
105755192|NCT02940626|364755765|FG001|Overall Study|Withdrawal by Subject|0|||
105755193|NCT02940626|364755764|FG000|Overall Study|Transfer to Hospice Care|1|||
105755194|NCT02940626|364755765|FG001|Overall Study|Transfer to Hospice Care|0|||
105755195|NCT02940626|364755764|FG000|Overall Study|Prohibited Concomitant Medication|0|||
105755196|NCT02940626|364755765|FG001|Overall Study|Prohibited Concomitant Medication|1|||
105755197|NCT01324622|364755768|FG000|Overall Study|Lost to Follow-up|7|||
105755198|NCT01324622|364755769|FG001|Overall Study|Lost to Follow-up|7|||
105949891|NCT03391882|365480582|FG000|Study Overall|Adverse Event|3|||
105949892|NCT03391882|365480583|FG001|Study Overall|Adverse Event|6|||
105949893|NCT03391882|365480584|FG002|Study Overall|Adverse Event|1|||
105949894|NCT03391882|365480585|FG003|Study Overall|Adverse Event|1|||
105949895|NCT03391882|365480586|FG004|Study Overall|Adverse Event|3|||
105949896|NCT03391882|365480587|FG005|Study Overall|Adverse Event|1|||
105949897|NCT03391882|365480582|FG000|Study Overall|Lack of Efficacy|13|||
105949898|NCT03391882|365480583|FG001|Study Overall|Lack of Efficacy|9|||
105949899|NCT03391882|365480584|FG002|Study Overall|Lack of Efficacy|0|||
105949900|NCT03391882|365480585|FG003|Study Overall|Lack of Efficacy|0|||
105949901|NCT03391882|365480586|FG004|Study Overall|Lack of Efficacy|0|||
105949902|NCT03391882|365480587|FG005|Study Overall|Lack of Efficacy|0|||
105949903|NCT03391882|365480582|FG000|Study Overall|Withdrawal by Subject|3|||
105949904|NCT03391882|365480583|FG001|Study Overall|Withdrawal by Subject|3|||
105949905|NCT03391882|365480584|FG002|Study Overall|Withdrawal by Subject|2|||
105949906|NCT03391882|365480585|FG003|Study Overall|Withdrawal by Subject|2|||
105949907|NCT03391882|365480586|FG004|Study Overall|Withdrawal by Subject|1|||
105949908|NCT03391882|365480587|FG005|Study Overall|Withdrawal by Subject|3|||
105949909|NCT03391882|365480582|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105949910|NCT03391882|365480583|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
105949911|NCT03391882|365480584|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105949912|NCT03391882|365480585|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105949913|NCT03391882|365480586|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105949914|NCT03391882|365480587|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
105949915|NCT03391882|365480582|FG000|Study Overall|Protocol Violation|1|||
105949916|NCT03391882|365480583|FG001|Study Overall|Protocol Violation|0|||
105949917|NCT03391882|365480584|FG002|Study Overall|Protocol Violation|0|||
105949918|NCT03391882|365480585|FG003|Study Overall|Protocol Violation|0|||
105949919|NCT03391882|365480586|FG004|Study Overall|Protocol Violation|0|||
105949920|NCT03391882|365480587|FG005|Study Overall|Protocol Violation|0|||
105949921|NCT03391882|365480582|FG000|Part A - Titration Phase|Adverse Event|3|||
105949922|NCT03391882|365480583|FG001|Part A - Titration Phase|Adverse Event|6|||
105949923|NCT03391882|365480584|FG002|Part A - Titration Phase|Adverse Event|0|||
105949924|NCT03391882|365480585|FG003|Part A - Titration Phase|Adverse Event|0|||
105949925|NCT03391882|365480586|FG004|Part A - Titration Phase|Adverse Event|0|||
105949926|NCT03391882|365480587|FG005|Part A - Titration Phase|Adverse Event|0|||
105949927|NCT03391882|365480582|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
105949928|NCT03391882|365480583|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
105949929|NCT03391882|365480584|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
105755199|NCT01324622|364755768|FG000|Overall Study|Death|1|||
105755200|NCT01324622|364755769|FG001|Overall Study|Death|0|||
105755201|NCT01324622|364755768|FG000|Overall Study|Lack of Efficacy|1|||
105755202|NCT01324622|364755769|FG001|Overall Study|Lack of Efficacy|0|||
105755203|NCT00618449|364755770|FG000|Overall Study|Lost to Follow-up|98|||
105755204|NCT00618449|364755771|FG001|Overall Study|Lost to Follow-up|110|||
105755205|NCT01441115|364755772|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
105755206|NCT00574496|364755777|FG000|Overall Study|Withdrawal by Subject|1|||
105755207|NCT00413062|364755778|FG000|Overall Study|Adverse event/serious adverse event|289|||
105755208|NCT00413062|364755779|FG001|Overall Study|Adverse event/serious adverse event|56|||
105755209|NCT00413062|364755778|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
105755210|NCT00413062|364755779|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
105755211|NCT00413062|364755778|FG000|Overall Study|Withdrawal of informed consent|111|||
105755212|NCT00413062|364755779|FG001|Overall Study|Withdrawal of informed consent|36|||
105755213|NCT00413062|364755778|FG000|Overall Study|Pregnancy|15|||
105755214|NCT00413062|364755779|FG001|Overall Study|Pregnancy|5|||
105755215|NCT00413062|364755778|FG000|Overall Study|Pregnancy wish|17|||
105755216|NCT00413062|364755779|FG001|Overall Study|Pregnancy wish|6|||
105755217|NCT00413062|364755778|FG000|Overall Study|Lost to Follow-up|175|||
105755218|NCT00413062|364755779|FG001|Overall Study|Lost to Follow-up|73|||
105755219|NCT00413062|364755778|FG000|Overall Study|Other reason|70|||
105755220|NCT00413062|364755779|FG001|Overall Study|Other reason|34|||
105755221|NCT03454412|364755781|FG000|Baseline Assesment|Physician Decision|12|||
105755222|NCT02475395|364755782|FG000|Overall Study|Protocol Violation|30|||
105755223|NCT02475395|364755783|FG001|Overall Study|Protocol Violation|3|||
105755224|NCT01927419|364755784|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105755225|NCT01927419|364755785|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
105755226|NCT01927419|364755784|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
105755227|NCT01927419|364755785|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
105755228|NCT01927419|364755784|FG000|Treatment Period|Disease progression|17|||
105755229|NCT01927419|364755785|FG001|Treatment Period|Disease progression|20|||
105755230|NCT01927419|364755784|FG000|Treatment Period|Study drug toxicity|48|||
105755231|NCT01927419|364755785|FG001|Treatment Period|Study drug toxicity|10|||
105949930|NCT03391882|365480585|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
105949931|NCT03391882|365480586|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
105755232|NCT01927419|364755784|FG000|Treatment Period|Death|0|||
105755233|NCT01927419|364755785|FG001|Treatment Period|Death|1|||
105755234|NCT01927419|364755784|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
105755235|NCT01927419|364755785|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
105949932|NCT03391882|365480587|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
105949933|NCT03391882|365480582|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
105949934|NCT03391882|365480583|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
105949935|NCT03391882|365480584|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
105802616|NCT03769181|364934490|FG000|Overall Study|Progressive disease|9|||
106016520|NCT04033445|365724450|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105949936|NCT03391882|365480585|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
105949937|NCT03391882|365480586|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
105949938|NCT03391882|365480587|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
105949939|NCT03391882|365480582|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105949940|NCT03391882|365480583|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
105949941|NCT03391882|365480584|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105949942|NCT03391882|365480585|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105949943|NCT03391882|365480586|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105949944|NCT03391882|365480587|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
105949945|NCT03391882|365480582|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
105949946|NCT03391882|365480583|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
105949947|NCT03391882|365480584|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
105949948|NCT03391882|365480585|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
105949949|NCT03391882|365480586|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
105949950|NCT03391882|365480587|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
105949951|NCT03391882|365480582|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
105949952|NCT03391882|365480583|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
105949953|NCT03391882|365480584|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
105949954|NCT03391882|365480585|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
105949955|NCT03391882|365480586|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
105949956|NCT03391882|365480587|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
105949957|NCT03391882|365480582|FG000|Part B - Treatment Phase|Adverse Event|0|||
105949958|NCT03391882|365480583|FG001|Part B - Treatment Phase|Adverse Event|0|||
105949959|NCT03391882|365480584|FG002|Part B - Treatment Phase|Adverse Event|1|||
105949960|NCT03391882|365480585|FG003|Part B - Treatment Phase|Adverse Event|1|||
105949961|NCT03391882|365480586|FG004|Part B - Treatment Phase|Adverse Event|3|||
105949962|NCT03391882|365480587|FG005|Part B - Treatment Phase|Adverse Event|1|||
105949963|NCT03391882|365480582|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
105949964|NCT03391882|365480583|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
105949965|NCT03391882|365480584|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
105755236|NCT01927419|364755784|FG000|Treatment Period|Participant request to discontinue|12|||
105755237|NCT01927419|364755785|FG001|Treatment Period|Participant request to discontinue|4|||
105755238|NCT01927419|364755784|FG000|Treatment Period|Withdrawal by Subject|1|||
105755239|NCT01927419|364755785|FG001|Treatment Period|Withdrawal by Subject|1|||
105755240|NCT01927419|364755784|FG000|Treatment Period|Maximum Clinical Benefit|6|||
105755241|NCT01927419|364755785|FG001|Treatment Period|Maximum Clinical Benefit|2|||
105755242|NCT01927419|364755784|FG000|Treatment Period|Other reasons|3|||
105755243|NCT01927419|364755785|FG001|Treatment Period|Other reasons|4|||
105755244|NCT01927419|364755784|FG000|Treatment Period|Not Reported|1|||
105755245|NCT01927419|364755785|FG001|Treatment Period|Not Reported|1|||
105755246|NCT03730194|364755788|FG000|First Stage Treatment|Withdrawal by Subject|1|||
105755247|NCT03730194|364755789|FG001|First Stage Treatment|Withdrawal by Subject|1|||
105755248|NCT03730194|364755790|FG002|First Stage Treatment|Withdrawal by Subject|0|||
105755249|NCT03730194|364755791|FG003|First Stage Treatment|Withdrawal by Subject|0|||
105755250|NCT03730194|364755792|FG004|First Stage Treatment|Withdrawal by Subject|0|||
105755251|NCT03730194|364755793|FG005|First Stage Treatment|Withdrawal by Subject|0|||
105755252|NCT03730194|364755788|FG000|First Stage Treatment|Protocol Violation|3|||
105755253|NCT03730194|364755789|FG001|First Stage Treatment|Protocol Violation|3|||
105755254|NCT03730194|364755790|FG002|First Stage Treatment|Protocol Violation|0|||
105755255|NCT03730194|364755791|FG003|First Stage Treatment|Protocol Violation|0|||
105755256|NCT03730194|364755792|FG004|First Stage Treatment|Protocol Violation|0|||
105755257|NCT03730194|364755793|FG005|First Stage Treatment|Protocol Violation|0|||
105755258|NCT01681576|364755794|FG000|Period 1|Adverse Event|1|||
105755259|NCT01681576|364755795|FG001|Period 1|Adverse Event|0|||
105755260|NCT01681576|364755794|FG000|Period 1|Protocol Deviation|1|||
105755261|NCT01681576|364755795|FG001|Period 1|Protocol Deviation|0|||
105755262|NCT01681576|364755794|FG000|Period 2|subject/guardian decision|3|||
105755263|NCT01681576|364755795|FG001|Period 2|subject/guardian decision|1|||
105755264|NCT01681576|364755794|FG000|Period 2|Non-compliance with study treatment|1|||
105755265|NCT01681576|364755795|FG001|Period 2|Non-compliance with study treatment|0|||
105755266|NCT00115765|364755796|FG000|Overall Study|Withdrawal by Subject|22|||
105755267|NCT00115765|364755797|FG001|Overall Study|Withdrawal by Subject|53|||
105755268|NCT00115765|364755798|FG002|Overall Study|Withdrawal by Subject|76|||
105755269|NCT00115765|364755799|FG003|Overall Study|Withdrawal by Subject|15|||
105755270|NCT00115765|364755796|FG000|Overall Study|Physician Decision|4|||
105755271|NCT00115765|364755797|FG001|Overall Study|Physician Decision|15|||
105755272|NCT00115765|364755798|FG002|Overall Study|Physician Decision|18|||
105755273|NCT00115765|364755799|FG003|Overall Study|Physician Decision|13|||
105949966|NCT03391882|365480585|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
105949967|NCT03391882|365480586|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
105949968|NCT03391882|365480587|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
105949969|NCT02112656|365480588|FG000|Overall Study|Death|78|||
105949970|NCT02112656|365480589|FG001|Overall Study|Death|82|||
105755274|NCT00115765|364755796|FG000|Overall Study|Lost to Follow-up|3|||
105755275|NCT00115765|364755797|FG001|Overall Study|Lost to Follow-up|20|||
105755276|NCT00115765|364755798|FG002|Overall Study|Lost to Follow-up|18|||
105755277|NCT00115765|364755799|FG003|Overall Study|Lost to Follow-up|1|||
105755278|NCT00115765|364755796|FG000|Overall Study|Other|6|||
105755279|NCT00115765|364755797|FG001|Overall Study|Other|12|||
106016521|NCT04033445|365724451|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
106016522|NCT04033445|365724452|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105949971|NCT02112656|365480588|FG000|Overall Study|Withdrawal by Subject|9|||
105949972|NCT02112656|365480589|FG001|Overall Study|Withdrawal by Subject|11|||
105949973|NCT02112656|365480588|FG000|Overall Study|Lost to Follow-up|2|||
105949974|NCT02112656|365480589|FG001|Overall Study|Lost to Follow-up|4|||
105949975|NCT02112656|365480588|FG000|Overall Study|Noncompliance|1|||
105949976|NCT02112656|365480589|FG001|Overall Study|Noncompliance|2|||
105949977|NCT00027560|365480590|FG000|Overall Study|Withdrawal by Subject|1|||
105949978|NCT00755807|365482277|FG000|Acute Phase|Adverse Event|16|||
105949979|NCT00755807|365482278|FG001|Acute Phase|Adverse Event|5|||
105949980|NCT00755807|365482277|FG000|Acute Phase|Protocol Violation|1|||
105949981|NCT00755807|365482278|FG001|Acute Phase|Protocol Violation|3|||
105949982|NCT00755807|365482277|FG000|Acute Phase|Withdrawal by Subject|1|||
105949983|NCT00755807|365482278|FG001|Acute Phase|Withdrawal by Subject|2|||
105949984|NCT00755807|365482277|FG000|Acute Phase|Lack of Efficacy|0|||
105949985|NCT00755807|365482278|FG001|Acute Phase|Lack of Efficacy|1|||
105949986|NCT00755807|365482277|FG000|Acute Phase|Physician Decision|0|||
105949987|NCT00755807|365482278|FG001|Acute Phase|Physician Decision|1|||
105949988|NCT00755807|365482277|FG000|Open-label Extension Phase|Adverse Event|7|||
105949989|NCT00755807|365482278|FG001|Open-label Extension Phase|Adverse Event|7|||
105949990|NCT00755807|365482277|FG000|Open-label Extension Phase|Protocol Violation|5|||
105949991|NCT00755807|365482278|FG001|Open-label Extension Phase|Protocol Violation|2|||
105755280|NCT00115765|364755798|FG002|Overall Study|Other|9|||
105755281|NCT00115765|364755799|FG003|Overall Study|Other|2|||
105755282|NCT01518244|364755802|FG000|Overall Study|Adverse Event|3|||
105755283|NCT03543358|364755803|FG000|Overall Study|Death|1|||
105755284|NCT03543358|364755804|FG001|Overall Study|Death|0|||
105755285|NCT03543358|364755803|FG000|Overall Study|Disease Progression|1|||
105755286|NCT03543358|364755804|FG001|Overall Study|Disease Progression|0|||
105755287|NCT03543358|364755803|FG000|Overall Study|Parent Study Closure|1|||
105755288|NCT03543358|364755804|FG001|Overall Study|Parent Study Closure|0|||
105755289|NCT01766817|364755807|FG000|Overall Study|Drug-related adverse event|1|||
105755290|NCT01766817|364755808|FG001|Overall Study|Drug-related adverse event|2|||
105755291|NCT01766817|364755809|FG002|Overall Study|Drug-related adverse event|1|||
105755292|NCT01766817|364755807|FG000|Overall Study|Drug-unrelated adverse event|3|||
105755293|NCT01766817|364755808|FG001|Overall Study|Drug-unrelated adverse event|3|||
105755294|NCT01766817|364755809|FG002|Overall Study|Drug-unrelated adverse event|3|||
105755295|NCT01766817|364755807|FG000|Overall Study|Death|1|||
105755296|NCT01766817|364755808|FG001|Overall Study|Death|1|||
105755297|NCT01766817|364755809|FG002|Overall Study|Death|0|||
105755298|NCT01766817|364755807|FG000|Overall Study|Unable to take study drug|0|||
105755299|NCT01766817|364755808|FG001|Overall Study|Unable to take study drug|1|||
105755300|NCT01766817|364755809|FG002|Overall Study|Unable to take study drug|0|||
105755301|NCT01766817|364755807|FG000|Overall Study|Withdrawal by Subject|2|||
105755302|NCT01766817|364755808|FG001|Overall Study|Withdrawal by Subject|0|||
105755303|NCT01766817|364755809|FG002|Overall Study|Withdrawal by Subject|3|||
105755304|NCT01766817|364755807|FG000|Overall Study|Subject non-compliance|0|||
105755305|NCT01766817|364755808|FG001|Overall Study|Subject non-compliance|1|||
105755306|NCT01766817|364755809|FG002|Overall Study|Subject non-compliance|2|||
105755307|NCT01766817|364755807|FG000|Overall Study|Physician Decision|3|||
105755308|NCT01766817|364755808|FG001|Overall Study|Physician Decision|3|||
105755309|NCT01766817|364755809|FG002|Overall Study|Physician Decision|4|||
105755310|NCT01766817|364755807|FG000|Overall Study|Other|1|||
105755311|NCT01766817|364755808|FG001|Overall Study|Other|0|||
105755312|NCT01766817|364755809|FG002|Overall Study|Other|0|||
105755313|NCT01928485|364755812|FG000|Overall Study|Physician Decision|0|||
105755314|NCT01928485|364755813|FG001|Overall Study|Physician Decision|1|||
105755315|NCT03589885|364755814|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
105755316|NCT03589885|364755815|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
105755317|NCT03589885|364755816|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
105755318|NCT03589885|364755817|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
105755319|NCT03589885|364755818|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
105755320|NCT03589885|364755814|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
105755321|NCT03589885|364755815|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
105755322|NCT03589885|364755816|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
105755323|NCT03589885|364755817|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
105755324|NCT03589885|364755818|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
105755325|NCT03589885|364755814|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
105755326|NCT03589885|364755815|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
105755327|NCT03589885|364755816|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
105755328|NCT03589885|364755817|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
105755329|NCT03589885|364755818|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
105755330|NCT03589885|364755814|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
105949992|NCT00755807|365482277|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
105949993|NCT00755807|365482278|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
105949994|NCT00755807|365482277|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
105949995|NCT00755807|365482278|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
105802617|NCT03769181|364934491|FG001|Overall Study|Progressive disease|7|||
105802618|NCT03769181|364934492|FG002|Overall Study|Progressive disease|13|||
105802619|NCT03769181|364934493|FG003|Overall Study|Progressive disease|6|||
105802620|NCT03769181|364934490|FG000|Overall Study|Other - Unspecified|2|||
105802621|NCT03769181|364934491|FG001|Overall Study|Other - Unspecified|1|||
105802622|NCT03769181|364934492|FG002|Overall Study|Other - Unspecified|0|||
105802623|NCT03769181|364934493|FG003|Overall Study|Other - Unspecified|0|||
105802624|NCT00928252|364934494|FG000|Overall Study|Physician Decision|3|||
105802625|NCT03341273|364934497|FG000|Overall Study|Lost to Follow-up|7|||
105802626|NCT03341273|364934498|FG001|Overall Study|Lost to Follow-up|7|||
105802627|NCT03341273|364934497|FG000|Overall Study|Withdrawal by Subject|4|||
105802628|NCT03341273|364934498|FG001|Overall Study|Withdrawal by Subject|2|||
105802629|NCT03341273|364934497|FG000|Overall Study|Physician Decision|1|||
105802630|NCT03341273|364934498|FG001|Overall Study|Physician Decision|0|||
105802631|NCT03341273|364934497|FG000|Overall Study|Protocol Violation|0|||
105802632|NCT03341273|364934498|FG001|Overall Study|Protocol Violation|1|||
105802633|NCT03341273|364934497|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
106016523|NCT04033445|365724453|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
106016524|NCT04033445|365724454|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
106016525|NCT04033445|365724455|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
105802634|NCT03341273|364934498|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
105802635|NCT03341273|364934497|FG000|Overall Study|Became ineligible after enrollment|1|||
105802636|NCT03341273|364934498|FG001|Overall Study|Became ineligible after enrollment|0|||
105802637|NCT03341273|364934497|FG000|Overall Study|Not Eligible at Enrollment|0|||
105802638|NCT03341273|364934498|FG001|Overall Study|Not Eligible at Enrollment|1|||
105802639|NCT03341273|364934497|FG000|Overall Study|Participant incarcerated|1|||
105802640|NCT03341273|364934498|FG001|Overall Study|Participant incarcerated|0|||
105802641|NCT04228302|364934499|FG000|Overall Study|Adverse Event|0|||
105802642|NCT04228302|364934500|FG001|Overall Study|Adverse Event|0|||
105802643|NCT04228302|364934501|FG002|Overall Study|Adverse Event|0|||
105802644|NCT04228302|364934502|FG003|Overall Study|Adverse Event|0|||
105802645|NCT04228302|364934503|FG004|Overall Study|Adverse Event|1|||
105802646|NCT04228302|364934504|FG005|Overall Study|Adverse Event|0|||
105802647|NCT00667719|364934516|FG000|Overall Study|Adverse Event|39|||
105802648|NCT00667719|364934516|FG000|Overall Study|Abnormal Test Procedure|1|||
105802649|NCT00667719|364934516|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105802650|NCT00667719|364934516|FG000|Overall Study|Protocol Violation|3|||
105802651|NCT00667719|364934516|FG000|Overall Study|Withdrawal by Subject|17|||
105802652|NCT00667719|364934516|FG000|Overall Study|Lost to Follow-up|8|||
105802653|NCT00078819|364934517|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
105802654|NCT00078819|364934518|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
105802655|NCT00078819|364934519|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
105802656|NCT00078819|364934520|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
105802657|NCT00078819|364934517|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
105802658|NCT00078819|364934518|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
105802659|NCT00078819|364934519|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
105802660|NCT00078819|364934520|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
105802661|NCT00078819|364934517|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
105802662|NCT00078819|364934518|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
105949996|NCT00755807|365482277|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
105949997|NCT00755807|365482278|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
105949998|NCT00755807|365482277|FG000|Open-label Extension Phase|Sponsor Decision|0|||
105949999|NCT00755807|365482278|FG001|Open-label Extension Phase|Sponsor Decision|1|||
105950000|NCT01133665|365482279|FG000|Overall Study|Physician Decision|2|||
105802663|NCT00078819|364934519|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
105950001|NCT02122380|365482280|FG000|First Intervention (30 Days)|Adverse Event|1|||
105755331|NCT03589885|364755815|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
105755332|NCT03589885|364755816|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
105755333|NCT03589885|364755817|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
105755334|NCT03589885|364755818|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
105755335|NCT03589885|364755814|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
105755336|NCT03589885|364755815|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
105755337|NCT03589885|364755816|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
105950002|NCT02122380|365482281|FG001|First Intervention (30 Days)|Adverse Event|0|||
105950003|NCT02122380|365482280|FG000|First Intervention (30 Days)|Physician Decision|0|||
105950004|NCT02122380|365482281|FG001|First Intervention (30 Days)|Physician Decision|1|||
105950005|NCT02122380|365482280|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
105950006|NCT02122380|365482281|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
105950007|NCT02122380|365482280|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
105950008|NCT02122380|365482281|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
105950009|NCT02122380|365482280|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
105950010|NCT02122380|365482281|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
105755338|NCT03589885|364755817|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
105755339|NCT03589885|364755818|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
105755340|NCT03589885|364755814|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
105755341|NCT03589885|364755815|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
105755342|NCT03589885|364755816|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
105755343|NCT03589885|364755817|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
105755344|NCT03589885|364755818|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
105755345|NCT03589885|364755814|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
105755346|NCT03589885|364755815|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
105755347|NCT03589885|364755816|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
105755348|NCT03589885|364755817|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
105755349|NCT03589885|364755818|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
105755350|NCT03589885|364755814|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
105755351|NCT03589885|364755815|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
105950011|NCT02921789|365482282|FG000|Overall Study|Adverse Event|0|||
105950012|NCT02921789|365482283|FG001|Overall Study|Adverse Event|1|||
105950013|NCT02921789|365482282|FG000|Overall Study|Lost to Follow-up|1|||
105950014|NCT02921789|365482283|FG001|Overall Study|Lost to Follow-up|0|||
105950015|NCT02921789|365482282|FG000|Overall Study|Protocol Deviation|2|||
105950016|NCT02921789|365482283|FG001|Overall Study|Protocol Deviation|0|||
105950017|NCT02921789|365482282|FG000|Overall Study|Withdrawal by Subject|2|||
106016526|NCT04033445|365724456|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
106016527|NCT04033445|365724457|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
105950018|NCT02921789|365482283|FG001|Overall Study|Withdrawal by Subject|1|||
105950019|NCT02921789|365482282|FG000|Overall Study|Miscellaneous|3|||
106016528|NCT04033445|365724458|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
105755352|NCT03589885|364755816|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
105755353|NCT03589885|364755817|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
105755354|NCT03589885|364755818|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
105755355|NCT02260648|364755824|FG000|Overall Study|Adverse Event|3|||
105755356|NCT02260648|364755825|FG001|Overall Study|Adverse Event|0|||
105755357|NCT02260648|364755826|FG002|Overall Study|Adverse Event|1|||
105755358|NCT02260648|364755824|FG000|Overall Study|Withdrawal by Subject|1|||
105755359|NCT02260648|364755825|FG001|Overall Study|Withdrawal by Subject|1|||
105755360|NCT02260648|364755826|FG002|Overall Study|Withdrawal by Subject|0|||
105755361|NCT02260648|364755824|FG000|Overall Study|Protocol Violation|1|||
105755362|NCT02260648|364755825|FG001|Overall Study|Protocol Violation|0|||
105755363|NCT02260648|364755826|FG002|Overall Study|Protocol Violation|0|||
105755364|NCT02260648|364755824|FG000|Overall Study|Discontinue Due to Study Termination|13|||
105755365|NCT02260648|364755825|FG001|Overall Study|Discontinue Due to Study Termination|12|||
105755366|NCT02260648|364755826|FG002|Overall Study|Discontinue Due to Study Termination|7|||
105755367|NCT04093258|364755827|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
105950020|NCT02921789|365482283|FG001|Overall Study|Miscellaneous|2|||
106016529|NCT04033445|365724459|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
106016530|NCT04033445|365724460|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
106016531|NCT04033445|365724447|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
106016532|NCT04033445|365724448|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
106016533|NCT04033445|365724449|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
106016534|NCT04033445|365724450|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
106016535|NCT04033445|365724451|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
105755368|NCT04093258|364755828|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
105755369|NCT00594204|364755830|FG000|Overall Study|Adverse Event|15|||
105755370|NCT00594204|364755831|FG001|Overall Study|Adverse Event|3|||
105755371|NCT00594204|364755830|FG000|Overall Study|Lost to Follow-up|9|||
105755372|NCT00594204|364755831|FG001|Overall Study|Lost to Follow-up|5|||
105950021|NCT04099277|365482284|FG000|Overall Study|Physician Decision|1|||
105950022|NCT04099277|365482284|FG000|Overall Study|Withdrawal by Subject|1|||
106016536|NCT04033445|365724452|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
106016537|NCT04033445|365724453|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
106016538|NCT04033445|365724454|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
106016539|NCT04033445|365724455|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
106016540|NCT04033445|365724456|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
106016541|NCT04033445|365724457|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
106016542|NCT04033445|365724458|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
106016543|NCT04033445|365724459|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
106016544|NCT04033445|365724460|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
106016545|NCT04033445|365724447|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016546|NCT04033445|365724448|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
105755373|NCT00594204|364755830|FG000|Overall Study|Withdrawal by Subject|23|||
105755374|NCT00594204|364755831|FG001|Overall Study|Withdrawal by Subject|29|||
105755375|NCT00594204|364755830|FG000|Overall Study|Other|4|||
105755376|NCT00594204|364755831|FG001|Overall Study|Other|3|||
105755377|NCT00594204|364755830|FG000|Overall Study|Lack of Efficacy|3|||
105755378|NCT00594204|364755831|FG001|Overall Study|Lack of Efficacy|4|||
105755379|NCT00594204|364755830|FG000|Overall Study|Randomized but not treated|4|||
105755380|NCT00594204|364755831|FG001|Overall Study|Randomized but not treated|1|||
105755381|NCT00567541|364755832|FG000|Overall Study|Adverse Event|0|||
105755382|NCT00567541|364755833|FG001|Overall Study|Adverse Event|1|||
105755383|NCT00805545|364755834|FG000|Overall Study|Protocol Violation|3|||
105755384|NCT00805545|364755835|FG001|Overall Study|Protocol Violation|2|||
105755385|NCT00805545|364755834|FG000|Overall Study|Protocol Violation|3|||
105755386|NCT00805545|364755835|FG001|Overall Study|Protocol Violation|1|||
105755387|NCT00507416|364755836|FG000|Overall Study|Adverse Event|58|||
105755388|NCT00507416|364755837|FG001|Overall Study|Adverse Event|67|||
105755389|NCT00507416|364755838|FG002|Overall Study|Adverse Event|65|||
105755390|NCT00507416|364755836|FG000|Overall Study|Protocol Violation|1|||
105755391|NCT00507416|364755837|FG001|Overall Study|Protocol Violation|2|||
105755392|NCT00507416|364755838|FG002|Overall Study|Protocol Violation|0|||
105755393|NCT00507416|364755836|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
105755394|NCT00507416|364755837|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
105755395|NCT00507416|364755838|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
105755396|NCT00507416|364755836|FG000|Overall Study|Progressive Disease|20|||
105755397|NCT00507416|364755837|FG001|Overall Study|Progressive Disease|10|||
105755398|NCT00507416|364755838|FG002|Overall Study|Progressive Disease|13|||
105755399|NCT00507416|364755836|FG000|Overall Study|Patient declined further treatment|18|||
105755400|NCT00507416|364755837|FG001|Overall Study|Patient declined further treatment|14|||
105755401|NCT00507416|364755838|FG002|Overall Study|Patient declined further treatment|11|||
105755402|NCT00507416|364755836|FG000|Overall Study|Other|11|||
105755403|NCT00507416|364755837|FG001|Overall Study|Other|16|||
105755404|NCT00507416|364755838|FG002|Overall Study|Other|13|||
105755405|NCT00507416|364755836|FG000|Overall Study|Did not Receive Study Treatment|3|||
105755406|NCT00507416|364755837|FG001|Overall Study|Did not Receive Study Treatment|9|||
105755407|NCT00507416|364755838|FG002|Overall Study|Did not Receive Study Treatment|4|||
105755408|NCT03101514|364755841|FG000|Overall Study|Withdrawal by Subject|4|||
105755409|NCT03101514|364755841|FG000|Overall Study|Protocol Violation|2|||
105755410|NCT03101514|364755841|FG000|Overall Study|patient's information was incomplete|1|||
105755411|NCT02379390|364755844|FG000|Overall Study|Adverse Event|1|||
105755412|NCT02379390|364755845|FG001|Overall Study|Adverse Event|1|||
105755413|NCT02379390|364755844|FG000|Overall Study|Investigator's decision|1|||
105755414|NCT02379390|364755845|FG001|Overall Study|Investigator's decision|0|||
105755415|NCT02379390|364755844|FG000|Overall Study|Study Termination|0|||
105755416|NCT02379390|364755845|FG001|Overall Study|Study Termination|1|||
105755417|NCT04142216|364755848|FG000|Overall Study|Hospitalization|0|||
105755418|NCT04142216|364755849|FG001|Overall Study|Hospitalization|2|||
105755419|NCT04142216|364755848|FG000|Overall Study|Death|3|||
105755420|NCT04142216|364755849|FG001|Overall Study|Death|1|||
105755421|NCT04142216|364755848|FG000|Overall Study|Referral to another hemodialysis unit|3|||
105755422|NCT04142216|364755849|FG001|Overall Study|Referral to another hemodialysis unit|2|||
105755423|NCT04142216|364755848|FG000|Overall Study|Use of clove|0|||
105755424|NCT04142216|364755849|FG001|Overall Study|Use of clove|1|||
105755425|NCT01054976|364755852|FG000|Overall Study|Adverse Event|16|||
105755426|NCT01054976|364755852|FG000|Overall Study|Uncooperative participations to study|7|||
105755427|NCT01054976|364755852|FG000|Overall Study|Withdrawal by Subject|4|||
105755428|NCT01054976|364755852|FG000|Overall Study|Other|8|||
105755429|NCT02555657|364755853|FG000|Overall Study|Death|274|||
105755430|NCT02555657|364755854|FG001|Overall Study|Death|262|||
105755431|NCT02555657|364755853|FG000|Overall Study|Physician Decision|0|||
105755432|NCT02555657|364755854|FG001|Overall Study|Physician Decision|1|||
105755433|NCT02555657|364755853|FG000|Overall Study|Sponsor Decision|27|||
105755434|NCT02555657|364755854|FG001|Overall Study|Sponsor Decision|15|||
105755435|NCT02555657|364755853|FG000|Overall Study|Withdrawal by Subject|11|||
105755436|NCT02555657|364755854|FG001|Overall Study|Withdrawal by Subject|32|||
105755437|NCT00493974|364755855|FG000|Overall Study|Death|1|||
105755438|NCT00493974|364755856|FG001|Overall Study|Death|2|||
105755439|NCT00493974|364755855|FG000|Overall Study|Withdrawal by Subject|8|||
105755440|NCT00493974|364755856|FG001|Overall Study|Withdrawal by Subject|6|||
105755441|NCT00493974|364755855|FG000|Overall Study|Lost to Follow-up|4|||
105755442|NCT00493974|364755856|FG001|Overall Study|Lost to Follow-up|6|||
105755443|NCT01578785|364755858|FG000|Overall Study|Withdrawal by Subject|0|||
105755444|NCT01578785|364755859|FG001|Overall Study|Withdrawal by Subject|1|||
105755445|NCT01578785|364755858|FG000|Overall Study|Study terminated by sponsor|59|||
105755446|NCT01578785|364755859|FG001|Overall Study|Study terminated by sponsor|118|||
105950023|NCT02896257|365482285|FG000|Providers|Without eligible patients|21|||
105950024|NCT02896257|365482286|FG001|Providers|Without eligible patients|28|||
105950025|NCT02896257|365482285|FG000|Patients|PFT entry criteria not met|43|||
105950026|NCT02896257|365482286|FG001|Patients|PFT entry criteria not met|50|||
105950027|NCT02896257|365482285|FG000|Patients|No capacity to review|8|||
105950028|NCT02896257|365482286|FG001|Patients|No capacity to review|11|||
105950029|NCT02896257|365482285|FG000|Patients|Appointment rescheduled/cancelled|5|||
105950030|NCT02896257|365482286|FG001|Patients|Appointment rescheduled/cancelled|7|||
105950031|NCT02896257|365482285|FG000|Patients|PCP not assigned a clinic|4|||
105950032|NCT02896257|365482286|FG001|Patients|PCP not assigned a clinic|0|||
105950033|NCT02896257|365482285|FG000|Patients|No history of COPD|0|||
105950034|NCT02896257|365482286|FG001|Patients|No history of COPD|1|||
105950035|NCT02896257|365482285|FG000|Patients|Deceased between review and index date|0|||
105755447|NCT00475540|364755861|FG000|36 Months|Lost to Follow-up|4|||
105950036|NCT02896257|365482286|FG001|Patients|Deceased between review and index date|1|||
105950037|NCT02896257|365482285|FG000|Patients|No ICS Rx upon review|1|||
105950038|NCT02896257|365482286|FG001|Patients|No ICS Rx upon review|1|||
105950039|NCT02896257|365482285|FG000|Patients|Protocol Violation|2|||
105950040|NCT02896257|365482286|FG001|Patients|Protocol Violation|1|||
105950041|NCT02896257|365482285|FG000|Patients|Hospice care|0|||
105950042|NCT02896257|365482286|FG001|Patients|Hospice care|1|||
105950043|NCT01126190|365482290|FG000|Double-Blind Phase|Death|0|||
105950044|NCT01126190|365482291|FG001|Double-Blind Phase|Death|1|||
105950045|NCT01126190|365482292|FG002|Double-Blind Phase|Death|0|||
105950046|NCT01126190|365482290|FG000|Double-Blind Phase|Adverse Event|1|||
105950047|NCT01126190|365482291|FG001|Double-Blind Phase|Adverse Event|2|||
105950048|NCT01126190|365482292|FG002|Double-Blind Phase|Adverse Event|0|||
105950049|NCT01126190|365482290|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
105950050|NCT01126190|365482291|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
105950051|NCT01126190|365482292|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105950052|NCT01126190|365482290|FG000|Double-Blind Phase|Request of Investigator|1|||
105950053|NCT01126190|365482291|FG001|Double-Blind Phase|Request of Investigator|0|||
105950054|NCT01126190|365482292|FG002|Double-Blind Phase|Request of Investigator|0|||
105950055|NCT01126190|365482290|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
105950056|NCT01126190|365482291|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
106016547|NCT04033445|365724449|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016548|NCT04033445|365724450|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016549|NCT04033445|365724451|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016550|NCT04033445|365724452|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016551|NCT04033445|365724453|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016552|NCT04033445|365724454|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016553|NCT04033445|365724455|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016554|NCT04033445|365724456|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016555|NCT04033445|365724457|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016556|NCT04033445|365724458|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016557|NCT04033445|365724459|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
106016558|NCT04033445|365724460|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
106016559|NCT04033445|365724447|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
105755448|NCT00475540|364755862|FG001|36 Months|Lost to Follow-up|4|||
105755449|NCT00475540|364755861|FG000|36 Months|Death|1|||
105755450|NCT00475540|364755862|FG001|36 Months|Death|2|||
105755451|NCT00475540|364755861|FG000|36 Months|Censored due to reoperation|3|||
105755452|NCT00475540|364755862|FG001|36 Months|Censored due to reoperation|0|||
105755453|NCT00377429|364755863|FG000|Overall Study|Withdrawal by Subject|5|||
105755454|NCT00377429|364755863|FG000|Overall Study|Adverse Event|8|||
105755455|NCT00377429|364755863|FG000|Overall Study|Physician Decision|1|||
105755456|NCT00377429|364755863|FG000|Overall Study|Patient non-compliance|1|||
105950057|NCT01126190|365482292|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
105950058|NCT01126190|365482290|FG000|Double-Blind Phase|Non-compliance|1|||
105950059|NCT01126190|365482291|FG001|Double-Blind Phase|Non-compliance|0|||
105950060|NCT01126190|365482292|FG002|Double-Blind Phase|Non-compliance|0|||
105950061|NCT01126190|365482290|FG000|Double-Blind Phase|Lost to Follow-up|1|||
105950062|NCT01126190|365482291|FG001|Double-Blind Phase|Lost to Follow-up|3|||
105755457|NCT02559206|364755869|FG000|Overall Study|Adverse Event|0|||
105755458|NCT02559206|364755870|FG001|Overall Study|Adverse Event|4|||
105755459|NCT02559206|364755871|FG002|Overall Study|Adverse Event|1|||
105755460|NCT02559206|364755872|FG003|Overall Study|Adverse Event|5|||
105755461|NCT02559206|364755873|FG004|Overall Study|Adverse Event|3|||
105755462|NCT02559206|364755874|FG005|Overall Study|Adverse Event|0|||
105755463|NCT02559206|364755875|FG006|Overall Study|Adverse Event|1|||
105755464|NCT02559206|364755876|FG007|Overall Study|Adverse Event|0|||
105755465|NCT02559206|364755869|FG000|Overall Study|Protocol Violation|1|||
105755466|NCT02559206|364755870|FG001|Overall Study|Protocol Violation|0|||
105755467|NCT02559206|364755871|FG002|Overall Study|Protocol Violation|1|||
105755468|NCT02559206|364755872|FG003|Overall Study|Protocol Violation|0|||
105755469|NCT02559206|364755873|FG004|Overall Study|Protocol Violation|0|||
105755470|NCT02559206|364755874|FG005|Overall Study|Protocol Violation|2|||
105755471|NCT02559206|364755875|FG006|Overall Study|Protocol Violation|0|||
105755472|NCT02559206|364755876|FG007|Overall Study|Protocol Violation|0|||
105755473|NCT02559206|364755869|FG000|Overall Study|Withdrawal by Subject|3|||
105755474|NCT02559206|364755870|FG001|Overall Study|Withdrawal by Subject|3|||
105950063|NCT01126190|365482292|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105950064|NCT01126190|365482290|FG000|Open-Label Phase|Death|0|||
105950065|NCT01126190|365482291|FG001|Open-Label Phase|Death|0|||
105950066|NCT01126190|365482292|FG002|Open-Label Phase|Death|1|||
105950067|NCT01126190|365482290|FG000|Open-Label Phase|Adverse Event|0|||
105950068|NCT01126190|365482291|FG001|Open-Label Phase|Adverse Event|0|||
105950069|NCT01126190|365482292|FG002|Open-Label Phase|Adverse Event|4|||
105950070|NCT01126190|365482290|FG000|Open-Label Phase|Withdrawal by Subject|0|||
105950071|NCT01126190|365482291|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105950072|NCT01126190|365482292|FG002|Open-Label Phase|Withdrawal by Subject|6|||
105950073|NCT01123148|365482301|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
105950074|NCT01123148|365482301|FG000|Overall Study|Didn't meet milestone criteria|1|||
105950075|NCT00925002|365482305|FG000|Overall Study|Other|1|||
105950076|NCT00925002|365482306|FG001|Overall Study|Other|4|||
105950077|NCT00925002|365482307|FG002|Overall Study|Other|0|||
105950078|NCT00925002|365482305|FG000|Overall Study|Death|1|||
105950079|NCT00925002|365482306|FG001|Overall Study|Death|1|||
105950080|NCT00925002|365482307|FG002|Overall Study|Death|5|||
105950081|NCT00925002|365482305|FG000|Overall Study|Adverse Event|3|||
105950082|NCT00925002|365482306|FG001|Overall Study|Adverse Event|1|||
105950083|NCT00925002|365482307|FG002|Overall Study|Adverse Event|2|||
105950084|NCT00925002|365482305|FG000|Overall Study|Participant withdrew consent|1|||
105755475|NCT02559206|364755871|FG002|Overall Study|Withdrawal by Subject|1|||
105755476|NCT02559206|364755872|FG003|Overall Study|Withdrawal by Subject|3|||
105950085|NCT00925002|365482306|FG001|Overall Study|Participant withdrew consent|3|||
105950086|NCT00925002|365482307|FG002|Overall Study|Participant withdrew consent|3|||
105755477|NCT02559206|364755873|FG004|Overall Study|Withdrawal by Subject|5|||
105950087|NCT02154061|365482308|FG000|Overall Study|Pregnancy|1|||
105950088|NCT02154061|365482309|FG001|Overall Study|Pregnancy|0|||
105950089|NCT02154061|365482308|FG000|Overall Study|enrolled but not vaccinated|1|||
105755478|NCT02559206|364755874|FG005|Overall Study|Withdrawal by Subject|4|||
105755479|NCT02559206|364755875|FG006|Overall Study|Withdrawal by Subject|1|||
105950090|NCT02154061|365482309|FG001|Overall Study|enrolled but not vaccinated|0|||
105950091|NCT03338400|365482310|FG000|Overall Study|Lost to Follow-up|1|||
105950092|NCT03338400|365482311|FG001|Overall Study|Lost to Follow-up|2|||
105950093|NCT01534481|365482320|FG000|Overall Study|Lost to Follow-up|29|||
105950094|NCT01534481|365482321|FG001|Overall Study|Lost to Follow-up|24|||
105950095|NCT01534481|365482320|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
105950096|NCT01534481|365482321|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
105950097|NCT05525910|365482322|FG000|Period 4|Per sponsor due to study timelines|0|||
105950098|NCT05525910|365482323|FG001|Period 4|Per sponsor due to study timelines|0|||
105950099|NCT05525910|365482324|FG002|Period 4|Per sponsor due to study timelines|1|||
105950100|NCT05525910|365482325|FG003|Period 4|Per sponsor due to study timelines|1|||
105950101|NCT05525910|365482326|FG004|Period 4|Per sponsor due to study timelines|1|||
105950102|NCT02750514|365482327|FG000|Track 1|Disease progression|20|||
105950103|NCT02750514|365482328|FG001|Track 1|Disease progression|1|||
105950104|NCT02750514|365482329|FG002|Track 1|Disease progression|0|||
105950105|NCT02750514|365482330|FG003|Track 1|Disease progression|1|||
105950106|NCT02750514|365482331|FG004|Track 1|Disease progression|0|||
105950107|NCT02750514|365482327|FG000|Track 1|Adverse event unrelated to study drug|1|||
105950108|NCT02750514|365482328|FG001|Track 1|Adverse event unrelated to study drug|0|||
105950109|NCT02750514|365482329|FG002|Track 1|Adverse event unrelated to study drug|0|||
105950110|NCT02750514|365482330|FG003|Track 1|Adverse event unrelated to study drug|0|||
105950111|NCT02750514|365482331|FG004|Track 1|Adverse event unrelated to study drug|0|||
105755480|NCT02559206|364755876|FG007|Overall Study|Withdrawal by Subject|2|||
105755481|NCT02559206|364755869|FG000|Overall Study|Lost to Follow-up|3|||
105950112|NCT02750514|365482327|FG000|Track 1|Study drug toxicity|4|||
105755482|NCT02559206|364755870|FG001|Overall Study|Lost to Follow-up|5|||
105755483|NCT02559206|364755871|FG002|Overall Study|Lost to Follow-up|3|||
105755484|NCT02559206|364755872|FG003|Overall Study|Lost to Follow-up|3|||
105755485|NCT02559206|364755873|FG004|Overall Study|Lost to Follow-up|2|||
105755486|NCT02559206|364755874|FG005|Overall Study|Lost to Follow-up|5|||
105755487|NCT02559206|364755875|FG006|Overall Study|Lost to Follow-up|1|||
105755488|NCT02559206|364755876|FG007|Overall Study|Lost to Follow-up|4|||
105755489|NCT02559206|364755869|FG000|Overall Study|Lack of Efficacy|1|||
105755490|NCT02559206|364755870|FG001|Overall Study|Lack of Efficacy|0|||
105755491|NCT02559206|364755871|FG002|Overall Study|Lack of Efficacy|3|||
105755492|NCT02559206|364755872|FG003|Overall Study|Lack of Efficacy|2|||
105755493|NCT02559206|364755873|FG004|Overall Study|Lack of Efficacy|2|||
105755494|NCT02559206|364755874|FG005|Overall Study|Lack of Efficacy|3|||
105755495|NCT02559206|364755875|FG006|Overall Study|Lack of Efficacy|3|||
105755496|NCT02559206|364755876|FG007|Overall Study|Lack of Efficacy|3|||
105755497|NCT02559206|364755869|FG000|Overall Study|Other Not Specified|0|||
105755498|NCT02559206|364755870|FG001|Overall Study|Other Not Specified|0|||
105755499|NCT02559206|364755871|FG002|Overall Study|Other Not Specified|0|||
105755500|NCT02559206|364755872|FG003|Overall Study|Other Not Specified|1|||
105755501|NCT02559206|364755873|FG004|Overall Study|Other Not Specified|0|||
105755502|NCT02559206|364755874|FG005|Overall Study|Other Not Specified|0|||
105755503|NCT02559206|364755875|FG006|Overall Study|Other Not Specified|0|||
105755504|NCT02559206|364755876|FG007|Overall Study|Other Not Specified|0|||
105755505|NCT02947022|364755877|FG000|Overall Study|Study Stopped|1|||
105755506|NCT00571519|364758193|FG000|Overall Study|Subject withdrew consent|0|||
105755507|NCT00571519|364758194|FG001|Overall Study|Subject withdrew consent|1|||
105755508|NCT00571519|364758195|FG002|Overall Study|Subject withdrew consent|0|||
105755509|NCT00571519|364758196|FG003|Overall Study|Subject withdrew consent|2|||
105755510|NCT00571519|364758197|FG004|Overall Study|Subject withdrew consent|1|||
105755511|NCT00571519|364758198|FG005|Overall Study|Subject withdrew consent|1|||
105755512|NCT00571519|364758199|FG006|Overall Study|Subject withdrew consent|2|||
105755513|NCT00571519|364758193|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
105755514|NCT00571519|364758194|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
105755515|NCT00571519|364758195|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
105755516|NCT00571519|364758196|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
105755517|NCT00571519|364758197|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
105755518|NCT00571519|364758198|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
105755519|NCT00571519|364758199|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
105755520|NCT00571519|364758193|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755521|NCT00571519|364758194|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
105755522|NCT00571519|364758195|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755523|NCT00571519|364758196|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755524|NCT00571519|364758197|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755525|NCT00571519|364758198|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755526|NCT00571519|364758199|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
105755527|NCT00571519|364758193|FG000|Overall Study|Termination of study by Sponsor|2|||
105755528|NCT00571519|364758194|FG001|Overall Study|Termination of study by Sponsor|7|||
105755529|NCT00571519|364758195|FG002|Overall Study|Termination of study by Sponsor|10|||
105755530|NCT00571519|364758196|FG003|Overall Study|Termination of study by Sponsor|24|||
105755531|NCT00571519|364758197|FG004|Overall Study|Termination of study by Sponsor|8|||
105755532|NCT00571519|364758198|FG005|Overall Study|Termination of study by Sponsor|9|||
105755533|NCT00571519|364758199|FG006|Overall Study|Termination of study by Sponsor|22|||
105755534|NCT00571519|364758193|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755535|NCT00571519|364758194|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755536|NCT00571519|364758195|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
105755537|NCT00571519|364758196|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755538|NCT00571519|364758197|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755539|NCT00571519|364758198|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755540|NCT00571519|364758199|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
105755541|NCT05263921|364758201|FG000|Overall Study|Other: family emergency.|0|||
105755542|NCT05263921|364758202|FG001|Overall Study|Other: family emergency.|0|||
105755543|NCT05263921|364758203|FG002|Overall Study|Other: family emergency.|1|||
105755544|NCT05263921|364758204|FG003|Overall Study|Other: family emergency.|0|||
105755545|NCT02701192|364758207|FG000|Overall Study|Protocol Violation|2|||
105755546|NCT02701192|364758207|FG000|Overall Study|Lost to Follow-up|4|||
105755547|NCT02862548|364758208|FG000|Randomized Phase (Up to Week 48)|Death|0|||
105755548|NCT02862548|364758209|FG001|Randomized Phase (Up to Week 48)|Death|1|||
105755549|NCT02862548|364758208|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
105755550|NCT02862548|364758209|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
105755551|NCT02862548|364758208|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
105755552|NCT02862548|364758209|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
105755553|NCT02862548|364758208|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
105755554|NCT02862548|364758209|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
106142801|NCT01713946|366182004|FG000|Overall Study|Did not continue in Ext|0|||
106142802|NCT01713946|366182005|FG001|Overall Study|Did not continue in Ext|3|||
105755555|NCT00880763|364758210|FG000|Extension Period (Part 2)|Adverse Event|0|||
105755556|NCT00880763|364758211|FG001|Extension Period (Part 2)|Adverse Event|0|||
105755557|NCT00880763|364758212|FG002|Extension Period (Part 2)|Adverse Event|1|||
105755558|NCT00880763|364758213|FG003|Extension Period (Part 2)|Adverse Event|1|||
105755559|NCT00880763|364758210|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
105755560|NCT00880763|364758211|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
105755561|NCT00880763|364758212|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
105755562|NCT00880763|364758213|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
105755563|NCT00880763|364758210|FG000|Extension Period (Part 2)|Physician Decision|0|||
105755564|NCT00880763|364758211|FG001|Extension Period (Part 2)|Physician Decision|1|||
105755565|NCT00880763|364758212|FG002|Extension Period (Part 2)|Physician Decision|1|||
105755566|NCT00880763|364758213|FG003|Extension Period (Part 2)|Physician Decision|0|||
105755567|NCT00880763|364758210|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
105755568|NCT00880763|364758211|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
105755569|NCT00880763|364758212|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
105755570|NCT00880763|364758213|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
105755571|NCT02667457|364758215|FG000|Overall Study|Withdrawal by Subject|1|||
105755572|NCT02667457|364758216|FG001|Overall Study|Withdrawal by Subject|0|||
105755573|NCT02667457|364758215|FG000|Overall Study|Other Reason|0|||
106142803|NCT01713946|366182006|FG002|Overall Study|Did not continue in Ext|0|||
106142804|NCT01713946|366182004|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
106142805|NCT01713946|366182005|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
106142806|NCT01713946|366182006|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
106142807|NCT01713946|366182004|FG000|Overall Study|Patients never switched to everolimus|0|||
106142808|NCT01713946|366182005|FG001|Overall Study|Patients never switched to everolimus|0|||
106142809|NCT01713946|366182006|FG002|Overall Study|Patients never switched to everolimus|5|||
106142810|NCT02299336|366182007|FG000|Overall Study|Withdrawal by Subject|11|||
106142811|NCT02299336|366182007|FG000|Overall Study|Adverse Event|1|||
106142812|NCT02299336|366182007|FG000|Overall Study|Death|1|||
106142813|NCT02299336|366182007|FG000|Overall Study|Lost to Follow-up|1|||
106142814|NCT00482729|366183514|FG000|Overall Study|Adverse Event|29|||
106142815|NCT00482729|366183515|FG001|Overall Study|Adverse Event|33|||
106142816|NCT00482729|366183514|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
106142817|NCT00482729|366183515|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
106142818|NCT00482729|366183514|FG000|Overall Study|Hyperglycemia Criteria|7|||
106142819|NCT00482729|366183515|FG001|Overall Study|Hyperglycemia Criteria|5|||
106142820|NCT00482729|366183514|FG000|Overall Study|Lack of Efficacy|4|||
106142821|NCT00482729|366183515|FG001|Overall Study|Lack of Efficacy|16|||
106142822|NCT00482729|366183514|FG000|Overall Study|Lost to Follow-up|86|||
106142823|NCT00482729|366183515|FG001|Overall Study|Lost to Follow-up|66|||
106142824|NCT00482729|366183514|FG000|Overall Study|Physician Decision|10|||
106142825|NCT00482729|366183515|FG001|Overall Study|Physician Decision|7|||
106142826|NCT00482729|366183514|FG000|Overall Study|Pregnancy|4|||
106142827|NCT00482729|366183515|FG001|Overall Study|Pregnancy|2|||
106142828|NCT00482729|366183514|FG000|Overall Study|Protocol Violation|10|||
106142829|NCT00482729|366183515|FG001|Overall Study|Protocol Violation|18|||
106142830|NCT00482729|366183514|FG000|Overall Study|Withdrawal by Subject|67|||
106142831|NCT00482729|366183515|FG001|Overall Study|Withdrawal by Subject|69|||
106142832|NCT01062126|366183519|FG000|Overall Study|Death|209|||
106142833|NCT01062126|366183519|FG000|Overall Study|All Withdrawals|324|||
106142834|NCT00661778|366183529|FG000|Overall Study|Disease Progression|23|||
106142835|NCT00661778|366183529|FG000|Overall Study|Adverse Event|18|||
106142836|NCT00661778|366183529|FG000|Overall Study|Reason not Specified|6|||
106142837|NCT00661778|366183529|FG000|Overall Study|Protocol Violation|2|||
106142838|NCT00661778|366183529|FG000|Overall Study|Withdrawal of Consent|1|||
106142839|NCT00628862|366183530|FG000|Overall Study|Adverse Event|6|||
106142840|NCT00628862|366183531|FG001|Overall Study|Adverse Event|8|||
106142841|NCT00628862|366183532|FG002|Overall Study|Adverse Event|10|||
106142842|NCT00628862|366183530|FG000|Overall Study|Withdrawal by Subject|4|||
106142843|NCT00628862|366183531|FG001|Overall Study|Withdrawal by Subject|6|||
106142844|NCT00628862|366183532|FG002|Overall Study|Withdrawal by Subject|11|||
106142845|NCT00628862|366183530|FG000|Overall Study|Lost to Follow-up|0|||
106142846|NCT00628862|366183531|FG001|Overall Study|Lost to Follow-up|2|||
106142847|NCT00628862|366183532|FG002|Overall Study|Lost to Follow-up|1|||
106142848|NCT00628862|366183530|FG000|Overall Study|Protocol Violation|1|||
106142849|NCT00628862|366183531|FG001|Overall Study|Protocol Violation|0|||
106142850|NCT00628862|366183532|FG002|Overall Study|Protocol Violation|0|||
106142851|NCT00628862|366183530|FG000|Overall Study|COPD Exacerbation|0|||
106142852|NCT00628862|366183531|FG001|Overall Study|COPD Exacerbation|1|||
106142853|NCT00628862|366183532|FG002|Overall Study|COPD Exacerbation|0|||
106142854|NCT02814643|366183533|FG000|Overall Study|Lost to Follow-up|0|||
105950113|NCT02750514|365482328|FG001|Track 1|Study drug toxicity|1|||
105802664|NCT00078819|364934520|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
105802665|NCT00078819|364934517|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
105802666|NCT00078819|364934518|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
105802667|NCT00078819|364934519|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
105802668|NCT00078819|364934520|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
105802669|NCT00078819|364934517|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
105802670|NCT00078819|364934518|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
105802671|NCT00078819|364934519|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
105802672|NCT00078819|364934520|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
105802673|NCT00078819|364934517|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
105802674|NCT00078819|364934518|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
105802675|NCT00078819|364934519|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
105802676|NCT00078819|364934520|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
105802677|NCT00078819|364934517|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
105802678|NCT00078819|364934518|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
105802679|NCT00078819|364934519|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
105950114|NCT02750514|365482329|FG002|Track 1|Study drug toxicity|0|||
105950115|NCT02750514|365482330|FG003|Track 1|Study drug toxicity|1|||
106016560|NCT04033445|365724448|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
106016561|NCT04033445|365724449|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
106016562|NCT04033445|365724450|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
105755574|NCT02667457|364758216|FG001|Overall Study|Other Reason|2|||
105755575|NCT02475850|364758217|FG000|Overall Study|Death|155|||
105755576|NCT02475850|364758218|FG001|Overall Study|Death|141|||
105755577|NCT02475850|364758217|FG000|Overall Study|Lost to Follow-up|217|||
105755578|NCT02475850|364758218|FG001|Overall Study|Lost to Follow-up|188|||
105755579|NCT02475850|364758217|FG000|Overall Study|Withdrawal by Subject|221|||
105755580|NCT02475850|364758218|FG001|Overall Study|Withdrawal by Subject|155|||
105755581|NCT01253187|364758221|FG000|Period 2|Withdrawal by Subject|0|||
105755582|NCT01253187|364758222|FG001|Period 2|Withdrawal by Subject|0|||
105755583|NCT01253187|364758223|FG002|Period 2|Withdrawal by Subject|0|||
105755584|NCT01253187|364758224|FG003|Period 2|Withdrawal by Subject|0|||
105755585|NCT01253187|364758225|FG004|Period 2|Withdrawal by Subject|1|||
105755586|NCT01253187|364758226|FG005|Period 2|Withdrawal by Subject|0|||
105755587|NCT01253187|364758221|FG000|Period 3|Pregnancy|1|||
105755588|NCT01253187|364758222|FG001|Period 3|Pregnancy|0|||
105755589|NCT01253187|364758223|FG002|Period 3|Pregnancy|0|||
105755590|NCT01253187|364758224|FG003|Period 3|Pregnancy|0|||
105755591|NCT01253187|364758225|FG004|Period 3|Pregnancy|0|||
105755592|NCT01253187|364758226|FG005|Period 3|Pregnancy|0|||
105755593|NCT01253187|364758221|FG000|Period 3|difficulty with blood sampling|0|||
105755594|NCT01253187|364758222|FG001|Period 3|difficulty with blood sampling|1|||
105755595|NCT01253187|364758223|FG002|Period 3|difficulty with blood sampling|0|||
105755596|NCT01253187|364758224|FG003|Period 3|difficulty with blood sampling|0|||
105755597|NCT01253187|364758225|FG004|Period 3|difficulty with blood sampling|0|||
105755598|NCT01253187|364758226|FG005|Period 3|difficulty with blood sampling|0|||
105755599|NCT01253187|364758221|FG000|Period 3|non-compliance|0|||
105755600|NCT01253187|364758222|FG001|Period 3|non-compliance|0|||
105755601|NCT01253187|364758223|FG002|Period 3|non-compliance|0|||
105755602|NCT01253187|364758224|FG003|Period 3|non-compliance|0|||
105755603|NCT01253187|364758225|FG004|Period 3|non-compliance|1|||
105755604|NCT01253187|364758226|FG005|Period 3|non-compliance|0|||
105755605|NCT02759562|364758229|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
105950116|NCT02750514|365482331|FG004|Track 1|Study drug toxicity|0|||
105950117|NCT02750514|365482327|FG000|Track 1|Participant request to discontinue|1|||
105755606|NCT02759562|364758230|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
105755607|NCT02759562|364758229|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
105755608|NCT02759562|364758230|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
105755609|NCT00505752|364758234|FG000|Overall Study|Adverse Event|1|||
105755610|NCT00505752|364758235|FG001|Overall Study|Adverse Event|0|||
105755611|NCT00505752|364758236|FG002|Overall Study|Adverse Event|1|||
105755612|NCT00505752|364758237|FG003|Overall Study|Adverse Event|0|||
105755613|NCT00505752|364758234|FG000|Overall Study|Lost to Follow-up|1|||
105755614|NCT00505752|364758235|FG001|Overall Study|Lost to Follow-up|0|||
105755615|NCT00505752|364758236|FG002|Overall Study|Lost to Follow-up|0|||
105755616|NCT00505752|364758237|FG003|Overall Study|Lost to Follow-up|0|||
105755617|NCT00505752|364758234|FG000|Overall Study|Lack of ovarian response|1|||
105755618|NCT00505752|364758235|FG001|Overall Study|Lack of ovarian response|3|||
105755619|NCT00505752|364758236|FG002|Overall Study|Lack of ovarian response|0|||
105755620|NCT00505752|364758237|FG003|Overall Study|Lack of ovarian response|0|||
105755621|NCT00505752|364758234|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105755622|NCT00505752|364758235|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105755623|NCT00505752|364758236|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
105755624|NCT00505752|364758237|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105755625|NCT00505752|364758234|FG000|Overall Study|No oocytes retrieved|0|||
105755626|NCT00505752|364758235|FG001|Overall Study|No oocytes retrieved|2|||
105755627|NCT00505752|364758236|FG002|Overall Study|No oocytes retrieved|0|||
105755628|NCT00505752|364758237|FG003|Overall Study|No oocytes retrieved|1|||
105755629|NCT00505752|364758234|FG000|Overall Study|No Fertilization|1|||
105755630|NCT00505752|364758235|FG001|Overall Study|No Fertilization|1|||
105755631|NCT00505752|364758236|FG002|Overall Study|No Fertilization|2|||
105755632|NCT00505752|364758237|FG003|Overall Study|No Fertilization|1|||
105755633|NCT00505752|364758234|FG000|Overall Study|All embryos/blastocysts discarded|0|||
105755634|NCT00505752|364758235|FG001|Overall Study|All embryos/blastocysts discarded|0|||
105755635|NCT00505752|364758236|FG002|Overall Study|All embryos/blastocysts discarded|1|||
105755636|NCT00505752|364758237|FG003|Overall Study|All embryos/blastocysts discarded|1|||
105755637|NCT00505752|364758234|FG000|Overall Study|Other|1|||
105755638|NCT00505752|364758235|FG001|Overall Study|Other|2|||
105755639|NCT00505752|364758236|FG002|Overall Study|Other|1|||
105755640|NCT00505752|364758237|FG003|Overall Study|Other|2|||
105755641|NCT03024255|364758240|FG000|Overall Study|Adverse Event|1|||
105755642|NCT03024255|364758241|FG001|Overall Study|Adverse Event|4|||
105755643|NCT03024255|364758242|FG002|Overall Study|Adverse Event|8|||
105755644|NCT03024255|364758243|FG003|Overall Study|Adverse Event|0|||
105755645|NCT03024255|364758240|FG000|Overall Study|Withdrawal by Subject|3|||
105755646|NCT03024255|364758241|FG001|Overall Study|Withdrawal by Subject|1|||
105755647|NCT03024255|364758242|FG002|Overall Study|Withdrawal by Subject|0|||
105755648|NCT03024255|364758243|FG003|Overall Study|Withdrawal by Subject|3|||
105755649|NCT03024255|364758240|FG000|Overall Study|Protocol Violation|0|||
105755650|NCT03024255|364758241|FG001|Overall Study|Protocol Violation|0|||
105755651|NCT03024255|364758242|FG002|Overall Study|Protocol Violation|2|||
105755652|NCT03024255|364758243|FG003|Overall Study|Protocol Violation|0|||
105755653|NCT03024255|364758240|FG000|Overall Study|Lost to Follow-up|1|||
105755654|NCT03024255|364758241|FG001|Overall Study|Lost to Follow-up|2|||
105755655|NCT03024255|364758242|FG002|Overall Study|Lost to Follow-up|1|||
105755656|NCT03024255|364758243|FG003|Overall Study|Lost to Follow-up|1|||
105755657|NCT03024255|364758240|FG000|Overall Study|Lack of Efficacy|1|||
105755658|NCT03024255|364758241|FG001|Overall Study|Lack of Efficacy|0|||
105755659|NCT03024255|364758242|FG002|Overall Study|Lack of Efficacy|0|||
105755660|NCT03024255|364758243|FG003|Overall Study|Lack of Efficacy|0|||
105755661|NCT03024255|364758240|FG000|Overall Study|Protocol Noncompliance|1|||
105755662|NCT03024255|364758241|FG001|Overall Study|Protocol Noncompliance|1|||
105755663|NCT03024255|364758242|FG002|Overall Study|Protocol Noncompliance|0|||
105755664|NCT03024255|364758243|FG003|Overall Study|Protocol Noncompliance|1|||
105755665|NCT03625141|364758244|FG000|Overall Study|Adverse Event|0|||
105755666|NCT03625141|364758245|FG001|Overall Study|Adverse Event|2|||
105755667|NCT03625141|364758244|FG000|Overall Study|Study Terminated By Sponsor|1|||
105755668|NCT03625141|364758245|FG001|Overall Study|Study Terminated By Sponsor|13|||
105755669|NCT03625141|364758244|FG000|Overall Study|Withdrawal by Subject|3|||
105755670|NCT03625141|364758245|FG001|Overall Study|Withdrawal by Subject|0|||
105755671|NCT03625141|364758244|FG000|Overall Study|Withdrawal Of Consent|0|||
105755672|NCT03625141|364758245|FG001|Overall Study|Withdrawal Of Consent|1|||
105755673|NCT03625141|364758244|FG000|Overall Study|Death|11|||
105755674|NCT03625141|364758245|FG001|Overall Study|Death|47|||
105755675|NCT03625141|364758244|FG000|Overall Study|Progressive Disease|0|||
105755676|NCT03625141|364758245|FG001|Overall Study|Progressive Disease|2|||
105755677|NCT00433446|364758252|FG000|Overall Study|Adverse Event|4|||
105802680|NCT00078819|364934520|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
106142855|NCT02814643|366183534|FG001|Overall Study|Lost to Follow-up|1|||
105802681|NCT00078819|364934517|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
105802682|NCT00078819|364934518|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
105802683|NCT00078819|364934519|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
105802684|NCT00078819|364934520|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
105802685|NCT00619619|364934521|FG000|Overall Study|Physician Decision|0|||
105802686|NCT00619619|364934522|FG001|Overall Study|Physician Decision|0|||
105802687|NCT00619619|364934523|FG002|Overall Study|Physician Decision|1|||
105802688|NCT00619619|364934524|FG003|Overall Study|Physician Decision|0|||
106142856|NCT02814643|366183533|FG000|Overall Study|Withdrawal by Subject|1|||
106142857|NCT02814643|366183534|FG001|Overall Study|Withdrawal by Subject|2|||
106142858|NCT02631148|366183537|FG000|Overall Study|8 were ineligible|8|||
106142859|NCT02631148|366183538|FG001|Overall Study|8 were ineligible|0|||
106142860|NCT02631148|366183537|FG000|Overall Study|Withdrawal by Subject|1|||
106142861|NCT02631148|366183538|FG001|Overall Study|Withdrawal by Subject|0|||
106142862|NCT02631148|366183537|FG000|Overall Study|PAH not available to study participant|1|||
106142863|NCT02631148|366183538|FG001|Overall Study|PAH not available to study participant|0|||
106142864|NCT00726999|366183543|FG000|Overall Study|Physician Decision|0|||
106142865|NCT00726999|366183544|FG001|Overall Study|Physician Decision|1|||
106142866|NCT00726999|366183543|FG000|Overall Study|Withdrawal by Subject|2|||
106142867|NCT00726999|366183544|FG001|Overall Study|Withdrawal by Subject|0|||
106142868|NCT00726999|366183543|FG000|Overall Study|Protocol Violation|1|||
106142869|NCT00726999|366183544|FG001|Overall Study|Protocol Violation|0|||
106142870|NCT00807144|366183549|FG000|Overall Study|Lost to Follow-up|0|||
106142871|NCT00807144|366183550|FG001|Overall Study|Lost to Follow-up|1|||
106142872|NCT01337635|366183551|FG000|Overall Study|Lost to Follow-up|0|||
106142873|NCT01337635|366183552|FG001|Overall Study|Lost to Follow-up|1|||
106142874|NCT04956575|366183553|FG000|Overall Study|Death|1|||
106142875|NCT04956575|366183554|FG001|Overall Study|Death|0|||
106142876|NCT04956575|366183555|FG002|Overall Study|Death|0|||
106142877|NCT04956575|366183556|FG003|Overall Study|Death|0|||
106142878|NCT04956575|366183557|FG004|Overall Study|Death|0|||
106142879|NCT04956575|366183558|FG005|Overall Study|Death|0|||
106142880|NCT04956575|366183559|FG006|Overall Study|Death|0|||
106142881|NCT04956575|366183560|FG007|Overall Study|Death|1|||
106142882|NCT04956575|366183561|FG008|Overall Study|Death|0|||
106142883|NCT04956575|366183562|FG009|Overall Study|Death|1|||
106142884|NCT04956575|366183563|FG010|Overall Study|Death|0|||
106142885|NCT04956575|366183564|FG011|Overall Study|Death|0|||
106142886|NCT04956575|366183553|FG000|Overall Study|Lost to Follow-up|3|||
106142887|NCT04956575|366183554|FG001|Overall Study|Lost to Follow-up|4|||
106142888|NCT04956575|366183555|FG002|Overall Study|Lost to Follow-up|2|||
106142889|NCT04956575|366183556|FG003|Overall Study|Lost to Follow-up|3|||
106142890|NCT04956575|366183557|FG004|Overall Study|Lost to Follow-up|1|||
106142891|NCT04956575|366183558|FG005|Overall Study|Lost to Follow-up|10|||
106142892|NCT04956575|366183559|FG006|Overall Study|Lost to Follow-up|11|||
106142893|NCT04956575|366183560|FG007|Overall Study|Lost to Follow-up|7|||
106142894|NCT04956575|366183561|FG008|Overall Study|Lost to Follow-up|4|||
106142895|NCT04956575|366183562|FG009|Overall Study|Lost to Follow-up|2|||
106142896|NCT04956575|366183563|FG010|Overall Study|Lost to Follow-up|3|||
106142897|NCT04956575|366183564|FG011|Overall Study|Lost to Follow-up|8|||
106142898|NCT04956575|366183553|FG000|Overall Study|Withdrawal by Subject|1|||
106142899|NCT04956575|366183554|FG001|Overall Study|Withdrawal by Subject|2|||
105802689|NCT00619619|364934525|FG004|Overall Study|Physician Decision|0|||
105802690|NCT00619619|364934526|FG005|Overall Study|Physician Decision|0|||
105802691|NCT00619619|364934527|FG006|Overall Study|Physician Decision|0|||
105802692|NCT00619619|364934528|FG007|Overall Study|Physician Decision|0|||
105802693|NCT00619619|364934521|FG000|Overall Study|Protocol Violation|0|||
105802694|NCT00619619|364934522|FG001|Overall Study|Protocol Violation|0|||
105802695|NCT00619619|364934523|FG002|Overall Study|Protocol Violation|0|||
105802696|NCT00619619|364934524|FG003|Overall Study|Protocol Violation|1|||
105802697|NCT00619619|364934525|FG004|Overall Study|Protocol Violation|0|||
105802698|NCT00619619|364934526|FG005|Overall Study|Protocol Violation|0|||
105802699|NCT00619619|364934527|FG006|Overall Study|Protocol Violation|1|||
105802700|NCT00619619|364934528|FG007|Overall Study|Protocol Violation|1|||
105802701|NCT00619619|364934521|FG000|Overall Study|Adverse Event|0|||
105802702|NCT00619619|364934522|FG001|Overall Study|Adverse Event|0|||
105802703|NCT00619619|364934523|FG002|Overall Study|Adverse Event|0|||
105802704|NCT00619619|364934524|FG003|Overall Study|Adverse Event|0|||
105802705|NCT00619619|364934525|FG004|Overall Study|Adverse Event|2|||
105802706|NCT00619619|364934526|FG005|Overall Study|Adverse Event|0|||
105802707|NCT00619619|364934527|FG006|Overall Study|Adverse Event|0|||
105802708|NCT00619619|364934528|FG007|Overall Study|Adverse Event|2|||
105802709|NCT01159769|364934529|FG000|Overall Study|Adverse Event|1|||
105802710|NCT00323609|364934530|FG000|Overall Study|Death|16|||
105802711|NCT00323609|364934531|FG001|Overall Study|Death|21|||
105802712|NCT00323609|364934532|FG002|Overall Study|Death|0|||
105802713|NCT00323609|364934533|FG003|Overall Study|Death|0|||
105802714|NCT00323609|364934530|FG000|Overall Study|Lost to Follow-up|9|||
105802715|NCT00323609|364934531|FG001|Overall Study|Lost to Follow-up|10|||
105802716|NCT00323609|364934532|FG002|Overall Study|Lost to Follow-up|0|||
105802717|NCT00323609|364934533|FG003|Overall Study|Lost to Follow-up|0|||
105802718|NCT00323609|364934530|FG000|Overall Study|Physician Decision|2|||
105802719|NCT00323609|364934531|FG001|Overall Study|Physician Decision|0|||
105802720|NCT00323609|364934532|FG002|Overall Study|Physician Decision|0|||
105802721|NCT00323609|364934533|FG003|Overall Study|Physician Decision|1|||
105802722|NCT00323609|364934530|FG000|Overall Study|Withdrawal by Subject|11|||
105802723|NCT00323609|364934531|FG001|Overall Study|Withdrawal by Subject|23|||
105802724|NCT00323609|364934532|FG002|Overall Study|Withdrawal by Subject|4|||
105802725|NCT00323609|364934533|FG003|Overall Study|Withdrawal by Subject|4|||
105802726|NCT00323609|364934530|FG000|Overall Study|Other non-VCF-related medical condition|3|||
105802727|NCT00323609|364934531|FG001|Overall Study|Other non-VCF-related medical condition|2|||
105802728|NCT00323609|364934532|FG002|Overall Study|Other non-VCF-related medical condition|0|||
105802729|NCT00323609|364934533|FG003|Overall Study|Other non-VCF-related medical condition|0|||
105802730|NCT00323609|364934530|FG000|Overall Study|Sponsor discontinued trial|29|||
105802731|NCT00323609|364934531|FG001|Overall Study|Sponsor discontinued trial|29|||
105802732|NCT00323609|364934532|FG002|Overall Study|Sponsor discontinued trial|0|||
105802733|NCT00323609|364934533|FG003|Overall Study|Sponsor discontinued trial|0|||
105806537|NCT03209570|364949016|FG001|Overall Study|Incomplete Data|10|||
105802734|NCT00323609|364934530|FG000|Overall Study|Unrelenting or severe back pain|1|||
105802735|NCT00323609|364934531|FG001|Overall Study|Unrelenting or severe back pain|1|||
105802736|NCT00323609|364934532|FG002|Overall Study|Unrelenting or severe back pain|0|||
105802737|NCT00323609|364934533|FG003|Overall Study|Unrelenting or severe back pain|0|||
105802738|NCT00323609|364934530|FG000|Overall Study|Logistical withdrawal|9|||
105802739|NCT00323609|364934531|FG001|Overall Study|Logistical withdrawal|5|||
105802740|NCT00323609|364934532|FG002|Overall Study|Logistical withdrawal|0|||
105802741|NCT00323609|364934533|FG003|Overall Study|Logistical withdrawal|1|||
105802742|NCT00323609|364934530|FG000|Overall Study|Other reason|11|||
105802743|NCT00323609|364934531|FG001|Overall Study|Other reason|8|||
105802744|NCT00323609|364934532|FG002|Overall Study|Other reason|4|||
105802745|NCT00323609|364934533|FG003|Overall Study|Other reason|9|||
105802746|NCT01827371|364934535|FG000|Overall Study|Adverse Event|0|||
105802747|NCT01827371|364934536|FG001|Overall Study|Adverse Event|0|||
106016563|NCT04033445|365724451|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
106016564|NCT04033445|365724452|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
106016565|NCT04033445|365724453|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
106016566|NCT04033445|365724454|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
106016567|NCT04033445|365724455|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
106016568|NCT04033445|365724456|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
106016569|NCT04033445|365724457|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
105802748|NCT01827371|364934537|FG002|Overall Study|Adverse Event|4|||
105802749|NCT01827371|364934538|FG003|Overall Study|Adverse Event|2|||
105802750|NCT01827371|364934535|FG000|Overall Study|Lost to Follow-up|0|||
105802751|NCT01827371|364934536|FG001|Overall Study|Lost to Follow-up|2|||
105802752|NCT01827371|364934537|FG002|Overall Study|Lost to Follow-up|0|||
105802753|NCT01827371|364934538|FG003|Overall Study|Lost to Follow-up|4|||
105802754|NCT01827371|364934535|FG000|Overall Study|Protocol Violation|1|||
106016570|NCT04033445|365724458|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
106016571|NCT04033445|365724459|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
105802755|NCT01827371|364934536|FG001|Overall Study|Protocol Violation|0|||
105755678|NCT00433446|364758252|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
105755679|NCT00433446|364758252|FG000|Overall Study|Progression|44|||
105755680|NCT00433446|364758252|FG000|Overall Study|Other - Not Protocol specified|3|||
105755681|NCT00433446|364758252|FG000|Overall Study|Ineligible|9|||
105755682|NCT03819218|364758253|FG000|Overall Study|Protocol Violation|1|||
105755683|NCT02680587|364758254|FG000|Overall Study|Withdrawal by Subject|1|||
105755684|NCT02680587|364758255|FG001|Overall Study|Withdrawal by Subject|0|||
105755685|NCT01231607|364758259|FG000|Overall Study|Adverse Event|0|||
105755686|NCT01231607|364758260|FG001|Overall Study|Adverse Event|8|||
105755687|NCT01231607|364758261|FG002|Overall Study|Adverse Event|4|||
105755688|NCT01231607|364758262|FG003|Overall Study|Adverse Event|4|||
105755689|NCT01231607|364758263|FG004|Overall Study|Adverse Event|5|||
105755690|NCT01231607|364758259|FG000|Overall Study|Lost to Follow-up|13|||
105755691|NCT01231607|364758260|FG001|Overall Study|Lost to Follow-up|11|||
105755692|NCT01231607|364758261|FG002|Overall Study|Lost to Follow-up|10|||
105755693|NCT01231607|364758262|FG003|Overall Study|Lost to Follow-up|10|||
105755694|NCT01231607|364758263|FG004|Overall Study|Lost to Follow-up|4|||
105755695|NCT01231607|364758259|FG000|Overall Study|Physician Decision|4|||
105755696|NCT01231607|364758260|FG001|Overall Study|Physician Decision|4|||
105755697|NCT01231607|364758261|FG002|Overall Study|Physician Decision|3|||
105755698|NCT01231607|364758262|FG003|Overall Study|Physician Decision|5|||
105755699|NCT01231607|364758263|FG004|Overall Study|Physician Decision|4|||
105755700|NCT01231607|364758259|FG000|Overall Study|Protocol Violation|3|||
105755701|NCT01231607|364758260|FG001|Overall Study|Protocol Violation|2|||
105755702|NCT01231607|364758261|FG002|Overall Study|Protocol Violation|0|||
105755703|NCT01231607|364758262|FG003|Overall Study|Protocol Violation|2|||
105755704|NCT01231607|364758263|FG004|Overall Study|Protocol Violation|2|||
105755705|NCT01231607|364758259|FG000|Overall Study|Withdrawal by Subject|9|||
105755706|NCT01231607|364758260|FG001|Overall Study|Withdrawal by Subject|9|||
105755707|NCT01231607|364758261|FG002|Overall Study|Withdrawal by Subject|14|||
105755708|NCT01231607|364758262|FG003|Overall Study|Withdrawal by Subject|17|||
105755709|NCT01231607|364758263|FG004|Overall Study|Withdrawal by Subject|9|||
105755710|NCT02501902|364758264|FG000|Overall Study|Subject Refused Further Follow-up|0|||
105755711|NCT02501902|364758265|FG001|Overall Study|Subject Refused Further Follow-up|0|||
105755712|NCT02501902|364758266|FG002|Overall Study|Subject Refused Further Follow-up|0|||
105755713|NCT02501902|364758267|FG003|Overall Study|Subject Refused Further Follow-up|0|||
105755714|NCT02501902|364758268|FG004|Overall Study|Subject Refused Further Follow-up|0|||
105755715|NCT02501902|364758269|FG005|Overall Study|Subject Refused Further Follow-up|0|||
105755716|NCT02501902|364758270|FG006|Overall Study|Subject Refused Further Follow-up|0|||
105755717|NCT02501902|364758271|FG007|Overall Study|Subject Refused Further Follow-up|1|||
105755718|NCT02501902|364758264|FG000|Overall Study|Study Terminated by Sponsor|0|||
105755719|NCT02501902|364758265|FG001|Overall Study|Study Terminated by Sponsor|3|||
105755720|NCT02501902|364758266|FG002|Overall Study|Study Terminated by Sponsor|0|||
105755721|NCT02501902|364758267|FG003|Overall Study|Study Terminated by Sponsor|1|||
105755722|NCT02501902|364758268|FG004|Overall Study|Study Terminated by Sponsor|1|||
105755723|NCT02501902|364758269|FG005|Overall Study|Study Terminated by Sponsor|0|||
105755724|NCT02501902|364758270|FG006|Overall Study|Study Terminated by Sponsor|2|||
105755725|NCT02501902|364758271|FG007|Overall Study|Study Terminated by Sponsor|4|||
105755726|NCT02501902|364758264|FG000|Overall Study|Death|3|||
105755727|NCT02501902|364758265|FG001|Overall Study|Death|4|||
105755728|NCT02501902|364758266|FG002|Overall Study|Death|4|||
105755729|NCT02501902|364758267|FG003|Overall Study|Death|10|||
105755730|NCT02501902|364758268|FG004|Overall Study|Death|10|||
105755731|NCT02501902|364758269|FG005|Overall Study|Death|11|||
105755732|NCT02501902|364758270|FG006|Overall Study|Death|7|||
105755733|NCT02501902|364758271|FG007|Overall Study|Death|15|||
105950118|NCT02750514|365482328|FG001|Track 1|Participant request to discontinue|0|||
105755734|NCT03325556|364758272|FG000|Open-label Period|Lack of Response in OL period|70|||
105755735|NCT03325556|364758273|FG001|Open-label Period|Lack of Response in OL period|0|||
105755736|NCT03325556|364758274|FG002|Open-label Period|Lack of Response in OL period|0|||
105755737|NCT03325556|364758272|FG000|Open-label Period|Adverse Event|27|||
105755738|NCT03325556|364758273|FG001|Open-label Period|Adverse Event|0|||
105755739|NCT03325556|364758274|FG002|Open-label Period|Adverse Event|0|||
105755740|NCT03325556|364758272|FG000|Open-label Period|Death|1|||
105755741|NCT03325556|364758273|FG001|Open-label Period|Death|0|||
105755742|NCT03325556|364758274|FG002|Open-label Period|Death|0|||
105950119|NCT02750514|365482329|FG002|Track 1|Participant request to discontinue|0|||
105950120|NCT02750514|365482330|FG003|Track 1|Participant request to discontinue|0|||
105755743|NCT03325556|364758272|FG000|Open-label Period|Lost to Follow-up|1|||
105755744|NCT03325556|364758273|FG001|Open-label Period|Lost to Follow-up|0|||
105755745|NCT03325556|364758274|FG002|Open-label Period|Lost to Follow-up|0|||
105755746|NCT03325556|364758272|FG000|Open-label Period|Non-compliance with study drug|5|||
105755747|NCT03325556|364758273|FG001|Open-label Period|Non-compliance with study drug|0|||
105755748|NCT03325556|364758274|FG002|Open-label Period|Non-compliance with study drug|0|||
105755749|NCT03325556|364758272|FG000|Open-label Period|Use of prohibited medication|1|||
105755750|NCT03325556|364758273|FG001|Open-label Period|Use of prohibited medication|0|||
105755751|NCT03325556|364758274|FG002|Open-label Period|Use of prohibited medication|0|||
105950121|NCT02750514|365482331|FG004|Track 1|Participant request to discontinue|0|||
105950122|NCT02750514|365482327|FG000|Track 1|Other reasons|1|||
105950123|NCT02750514|365482328|FG001|Track 1|Other reasons|0|||
105755752|NCT03325556|364758272|FG000|Open-label Period|Protocol Violation|4|||
105755753|NCT03325556|364758273|FG001|Open-label Period|Protocol Violation|0|||
105755754|NCT03325556|364758274|FG002|Open-label Period|Protocol Violation|0|||
105755755|NCT03325556|364758272|FG000|Open-label Period|Withdrawal by Subject|17|||
105755756|NCT03325556|364758273|FG001|Open-label Period|Withdrawal by Subject|0|||
105755757|NCT03325556|364758274|FG002|Open-label Period|Withdrawal by Subject|0|||
105755758|NCT03325556|364758272|FG000|Open-label Period|Not otherwise specified|8|||
105755759|NCT03325556|364758273|FG001|Open-label Period|Not otherwise specified|0|||
105755760|NCT03325556|364758274|FG002|Open-label Period|Not otherwise specified|0|||
105755761|NCT03325556|364758272|FG000|Open-label Period|Administrative discont. at study termination|41|||
105755762|NCT03325556|364758273|FG001|Open-label Period|Administrative discont. at study termination|0|||
105755763|NCT03325556|364758274|FG002|Open-label Period|Administrative discont. at study termination|0|||
105755764|NCT03325556|364758272|FG000|Double-blind Period|Relapse|0|||
105755765|NCT03325556|364758273|FG001|Double-blind Period|Relapse|15|||
105755766|NCT03325556|364758274|FG002|Double-blind Period|Relapse|34|||
105755767|NCT03325556|364758272|FG000|Double-blind Period|Adverse Event|0|||
105755768|NCT03325556|364758273|FG001|Double-blind Period|Adverse Event|3|||
105755769|NCT03325556|364758274|FG002|Double-blind Period|Adverse Event|1|||
105755770|NCT03325556|364758272|FG000|Double-blind Period|Noncompliance with study drug|0|||
105755771|NCT03325556|364758273|FG001|Double-blind Period|Noncompliance with study drug|0|||
105755772|NCT03325556|364758274|FG002|Double-blind Period|Noncompliance with study drug|1|||
105755773|NCT03325556|364758272|FG000|Double-blind Period|Use of prohibited medication|0|||
105755774|NCT03325556|364758273|FG001|Double-blind Period|Use of prohibited medication|1|||
105755775|NCT03325556|364758274|FG002|Double-blind Period|Use of prohibited medication|0|||
105755776|NCT03325556|364758272|FG000|Double-blind Period|Physician Decision|0|||
105755777|NCT03325556|364758273|FG001|Double-blind Period|Physician Decision|0|||
105755778|NCT03325556|364758274|FG002|Double-blind Period|Physician Decision|1|||
105755779|NCT03325556|364758272|FG000|Double-blind Period|Withdrawal by Subject|0|||
105755780|NCT03325556|364758273|FG001|Double-blind Period|Withdrawal by Subject|6|||
105755781|NCT03325556|364758274|FG002|Double-blind Period|Withdrawal by Subject|4|||
105755782|NCT03325556|364758272|FG000|Double-blind Period|Not otherwise specified|0|||
105755783|NCT03325556|364758273|FG001|Double-blind Period|Not otherwise specified|1|||
105755784|NCT03325556|364758274|FG002|Double-blind Period|Not otherwise specified|5|||
105755785|NCT03325556|364758272|FG000|Double-blind Period|Administrative discont. at study termination|0|||
105755786|NCT03325556|364758273|FG001|Double-blind Period|Administrative discont. at study termination|35|||
105755787|NCT03325556|364758274|FG002|Double-blind Period|Administrative discont. at study termination|31|||
105755788|NCT01767519|364758285|FG000|Overall Study|Other Reasons|4|||
105755789|NCT01767519|364758286|FG001|Overall Study|Other Reasons|4|||
105755790|NCT01767519|364758287|FG002|Overall Study|Other Reasons|2|||
105755791|NCT01767519|364758285|FG000|Overall Study|Protocol Violation|0|||
105755792|NCT01767519|364758286|FG001|Overall Study|Protocol Violation|3|||
105755793|NCT01767519|364758287|FG002|Overall Study|Protocol Violation|0|||
105755794|NCT01767519|364758285|FG000|Overall Study|Personal Reasons|1|||
105755795|NCT01767519|364758286|FG001|Overall Study|Personal Reasons|0|||
105755796|NCT01767519|364758287|FG002|Overall Study|Personal Reasons|0|||
105755797|NCT01767519|364758285|FG000|Overall Study|Lost to Follow-up|3|||
105755798|NCT01767519|364758286|FG001|Overall Study|Lost to Follow-up|1|||
105755799|NCT01767519|364758287|FG002|Overall Study|Lost to Follow-up|2|||
105755800|NCT01767519|364758285|FG000|Overall Study|Lack of Efficacy|1|||
105755801|NCT01767519|364758286|FG001|Overall Study|Lack of Efficacy|0|||
105755802|NCT01767519|364758287|FG002|Overall Study|Lack of Efficacy|0|||
105755803|NCT01767519|364758285|FG000|Overall Study|Adverse Event|5|||
105755804|NCT01767519|364758286|FG001|Overall Study|Adverse Event|5|||
105755805|NCT01767519|364758287|FG002|Overall Study|Adverse Event|1|||
105755806|NCT01890512|364758290|FG000|Overall Study|Physician Decision|1|||
105755807|NCT01890512|364758290|FG000|Overall Study|Withdrawal by Subject|1|||
105755808|NCT01890512|364758290|FG000|Overall Study|Protocol Violation|1|||
105755809|NCT00946881|364758291|FG000|First Treatment|Withdrawal by Subject|1|||
105755810|NCT00946881|364758291|FG000|First Treatment|Patient relocated to another state|1|||
105755811|NCT00946881|364758291|FG000|Retreatment|Withdrawal by Subject|1|||
105755812|NCT02157506|364758296|FG000|Overall Study|Adverse Event|0|||
105755813|NCT02157506|364758297|FG001|Overall Study|Adverse Event|1|||
105755814|NCT02157506|364758298|FG002|Overall Study|Adverse Event|0|||
105755815|NCT02157506|364758299|FG003|Overall Study|Adverse Event|0|||
105755816|NCT02157506|364758300|FG004|Overall Study|Adverse Event|0|||
105755817|NCT02157506|364758296|FG000|Overall Study|Lost to Follow-up|0|||
105755818|NCT02157506|364758297|FG001|Overall Study|Lost to Follow-up|0|||
105755819|NCT02157506|364758298|FG002|Overall Study|Lost to Follow-up|1|||
105755820|NCT02157506|364758299|FG003|Overall Study|Lost to Follow-up|0|||
105755821|NCT02157506|364758300|FG004|Overall Study|Lost to Follow-up|0|||
105755822|NCT00764478|364758303|FG000|Overall Study|Adverse Event|1|||
105755823|NCT00764478|364758304|FG001|Overall Study|Adverse Event|1|||
105950124|NCT02750514|365482329|FG002|Track 1|Other reasons|0|||
105755824|NCT00764478|364758305|FG002|Overall Study|Adverse Event|1|||
105755825|NCT00764478|364758303|FG000|Overall Study|Withdrawal by Subject|7|||
105755826|NCT00764478|364758304|FG001|Overall Study|Withdrawal by Subject|12|||
105755827|NCT00764478|364758305|FG002|Overall Study|Withdrawal by Subject|1|||
105755828|NCT00764478|364758303|FG000|Overall Study|Lost to Follow-up|7|||
105755829|NCT00764478|364758304|FG001|Overall Study|Lost to Follow-up|8|||
105755830|NCT00764478|364758305|FG002|Overall Study|Lost to Follow-up|5|||
105755831|NCT00764478|364758303|FG000|Overall Study|Protocol Violation|0|||
105755832|NCT00764478|364758304|FG001|Overall Study|Protocol Violation|1|||
105755833|NCT00764478|364758305|FG002|Overall Study|Protocol Violation|1|||
105755834|NCT02270684|364758306|FG000|Overall Study|Lost to Follow-up|0|||
105755835|NCT02270684|364758307|FG001|Overall Study|Lost to Follow-up|3|||
105755836|NCT02270684|364758306|FG000|Overall Study|Study terminated|1|||
105755837|NCT02270684|364758307|FG001|Overall Study|Study terminated|0|||
105755838|NCT00643604|364758311|FG000|Overall Study|Death|1|||
105755839|NCT02702011|364758315|FG000|Overall Study|Withdrawal by Subject|0|||
105755840|NCT02702011|364758316|FG001|Overall Study|Withdrawal by Subject|1|||
105755841|NCT02702011|364758317|FG002|Overall Study|Withdrawal by Subject|0|||
105755842|NCT02702011|364758318|FG003|Overall Study|Withdrawal by Subject|0|||
105755843|NCT01740388|364758322|FG000|Overall Study|Withdrawal by Subject|1|||
105755844|NCT01740388|364758323|FG001|Overall Study|Withdrawal by Subject|2|||
105755845|NCT01740388|364758322|FG000|Overall Study|Lost to Follow-up|2|||
105755846|NCT01740388|364758323|FG001|Overall Study|Lost to Follow-up|0|||
105755847|NCT01740388|364758322|FG000|Overall Study|Physician Decision|2|||
105755848|NCT01740388|364758323|FG001|Overall Study|Physician Decision|6|||
105755849|NCT01740388|364758322|FG000|Overall Study|Subjects missing data, completed|41|||
105755850|NCT01740388|364758323|FG001|Overall Study|Subjects missing data, completed|36|||
105755851|NCT00862121|364758326|FG000|Overall Study|Adverse Event|1|||
105755852|NCT00862121|364758327|FG001|Overall Study|Adverse Event|2|||
105755853|NCT00862121|364758326|FG000|Overall Study|Lack of Efficacy|0|||
105755854|NCT00862121|364758327|FG001|Overall Study|Lack of Efficacy|3|||
105755855|NCT00862121|364758326|FG000|Overall Study|Protocol Violation|0|||
105755856|NCT00862121|364758327|FG001|Overall Study|Protocol Violation|1|||
105755857|NCT00862121|364758326|FG000|Overall Study|Exclusion criterion violation|0|||
105755858|NCT00862121|364758327|FG001|Overall Study|Exclusion criterion violation|1|||
105755859|NCT00862121|364758326|FG000|Overall Study|Incorrect randomisation|0|||
105755860|NCT00862121|364758327|FG001|Overall Study|Incorrect randomisation|1|||
105755861|NCT01582971|364758328|FG000|Overall Study|Death|2|||
105755862|NCT01582971|364758329|FG001|Overall Study|Death|1|||
105755863|NCT01582971|364758328|FG000|Overall Study|Lost to Follow-up|18|||
105755864|NCT01582971|364758329|FG001|Overall Study|Lost to Follow-up|21|||
105755865|NCT01582971|364758328|FG000|Overall Study|Withdrawal by Subject|4|||
105755866|NCT01582971|364758329|FG001|Overall Study|Withdrawal by Subject|2|||
105755867|NCT01582971|364758328|FG000|Overall Study|Other|15|||
105755868|NCT01582971|364758329|FG001|Overall Study|Other|13|||
105755869|NCT02007954|364758332|FG000|Overall Study|Received liver transplant|3|||
105755870|NCT02007954|364758332|FG000|Overall Study|Switch in treatment modality|2|||
105755871|NCT02007954|364758332|FG000|Overall Study|Disease progression and unrelated AE|1|||
105755872|NCT02007954|364758332|FG000|Overall Study|Death|1|||
105755873|NCT01195363|364758334|FG000|Overall Study|Lost to Follow-up|7|||
105755874|NCT01195363|364758335|FG001|Overall Study|Lost to Follow-up|4|||
105755875|NCT01195363|364758334|FG000|Overall Study|Adverse Event|3|||
105755876|NCT01195363|364758335|FG001|Overall Study|Adverse Event|1|||
105755877|NCT01195363|364758334|FG000|Overall Study|Lack of Efficacy|0|||
105755878|NCT01195363|364758335|FG001|Overall Study|Lack of Efficacy|4|||
105755879|NCT01195363|364758334|FG000|Overall Study|incarceration|1|||
105755880|NCT01195363|364758335|FG001|Overall Study|incarceration|0|||
105755881|NCT02188719|364758336|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
105755882|NCT02188719|364758337|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
105755883|NCT02188719|364758338|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
105755884|NCT02188719|364758339|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
105755885|NCT01763866|364758340|FG000|Overall Study|Withdrawal by Subject|2|||
105755886|NCT01763866|364758341|FG001|Overall Study|Withdrawal by Subject|1|||
105755887|NCT01763866|364758342|FG002|Overall Study|Withdrawal by Subject|4|||
105755888|NCT01763866|364758343|FG003|Overall Study|Withdrawal by Subject|0|||
105755889|NCT01763866|364758344|FG004|Overall Study|Withdrawal by Subject|0|||
105755890|NCT01763866|364758345|FG005|Overall Study|Withdrawal by Subject|3|||
105755891|NCT01763866|364758346|FG006|Overall Study|Withdrawal by Subject|4|||
105755892|NCT01763866|364758347|FG007|Overall Study|Withdrawal by Subject|0|||
105755893|NCT01763866|364758348|FG008|Overall Study|Withdrawal by Subject|1|||
105755894|NCT01763866|364758349|FG009|Overall Study|Withdrawal by Subject|1|||
105755895|NCT01763866|364758350|FG010|Overall Study|Withdrawal by Subject|2|||
105755896|NCT01763866|364758351|FG011|Overall Study|Withdrawal by Subject|2|||
105755897|NCT01763866|364758352|FG012|Overall Study|Withdrawal by Subject|2|||
105755898|NCT01763866|364758353|FG013|Overall Study|Withdrawal by Subject|0|||
105755899|NCT01763866|364758354|FG014|Overall Study|Withdrawal by Subject|6|||
105755900|NCT01763866|364758355|FG015|Overall Study|Withdrawal by Subject|3|||
105802756|NCT01827371|364934537|FG002|Overall Study|Protocol Violation|0|||
105802757|NCT01827371|364934538|FG003|Overall Study|Protocol Violation|0|||
105802758|NCT01827371|364934535|FG000|Overall Study|Withdrawal by Subject|1|||
105802759|NCT01827371|364934536|FG001|Overall Study|Withdrawal by Subject|2|||
105802760|NCT01827371|364934537|FG002|Overall Study|Withdrawal by Subject|2|||
105802761|NCT01827371|364934538|FG003|Overall Study|Withdrawal by Subject|3|||
105802762|NCT01827371|364934535|FG000|Overall Study|Physician Decision|0|||
105802763|NCT01827371|364934536|FG001|Overall Study|Physician Decision|1|||
105802764|NCT01827371|364934537|FG002|Overall Study|Physician Decision|0|||
105802765|NCT01827371|364934538|FG003|Overall Study|Physician Decision|1|||
105802766|NCT01827371|364934535|FG000|Overall Study|Temporary study halt to vaccinations|11|||
105802767|NCT01827371|364934536|FG001|Overall Study|Temporary study halt to vaccinations|2|||
105802768|NCT01827371|364934537|FG002|Overall Study|Temporary study halt to vaccinations|5|||
105802769|NCT01827371|364934538|FG003|Overall Study|Temporary study halt to vaccinations|13|||
105802770|NCT00475852|364934542|FG000|Overall Study|Death|444|||
105802771|NCT00475852|364934543|FG001|Overall Study|Death|456|||
105802772|NCT00475852|364934542|FG000|Overall Study|Withdrawal by Subject|19|||
105802773|NCT00475852|364934543|FG001|Overall Study|Withdrawal by Subject|24|||
105802774|NCT00475852|364934542|FG000|Overall Study|Lost to Follow-up|54|||
105802775|NCT00475852|364934543|FG001|Overall Study|Lost to Follow-up|68|||
105802776|NCT00297479|364934544|FG000|Overall Study|Lost to Follow-up|37|||
105802777|NCT00297479|364934545|FG001|Overall Study|Lost to Follow-up|54|||
105802778|NCT00297479|364934546|FG002|Overall Study|Lost to Follow-up|51|||
105802779|NCT03196791|364934547|FG000|Overall Study|Protocol Violation|7|||
105802780|NCT03196791|364934548|FG001|Overall Study|Protocol Violation|3|||
105802781|NCT03196791|364934547|FG000|Overall Study|Withdrawal by Subject|3|||
105802782|NCT03196791|364934548|FG001|Overall Study|Withdrawal by Subject|2|||
105802783|NCT03063632|364934552|FG000|Overall Study|Death|4|||
105802784|NCT03063632|364934553|FG001|Overall Study|Death|6|||
105802785|NCT03063632|364934552|FG000|Overall Study|Lost to Follow-up|0|||
105802786|NCT03063632|364934553|FG001|Overall Study|Lost to Follow-up|1|||
105802787|NCT03063632|364934552|FG000|Overall Study|Withdrawal by Subject|0|||
105802788|NCT03063632|364934553|FG001|Overall Study|Withdrawal by Subject|2|||
105802789|NCT03063632|364934552|FG000|Overall Study|Physician Decision|2|||
105802790|NCT03063632|364934553|FG001|Overall Study|Physician Decision|0|||
105802791|NCT03063632|364934552|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
105802792|NCT03063632|364934553|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
105802793|NCT01698320|364934558|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
105802794|NCT01698320|364934559|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
105802795|NCT01698320|364934560|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
105802796|NCT01698320|364934558|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
105802797|NCT01698320|364934559|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
105802798|NCT01698320|364934560|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
105802799|NCT01698320|364934558|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
105802800|NCT01698320|364934559|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
105802801|NCT01698320|364934560|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
105802802|NCT01698320|364934558|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
105802803|NCT01698320|364934559|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
105802804|NCT01698320|364934560|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
105802805|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Adverse Event|0|||
105802806|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Adverse Event|1|||
105802807|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Adverse Event|1|||
105802808|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
105802809|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
105802810|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
105802811|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
105802812|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
105802813|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
105802814|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Pregnancy|0|||
105802815|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Pregnancy|1|||
105802816|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Pregnancy|1|||
105802817|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
105802818|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
105802819|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
105802820|NCT01698320|364934558|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
105802821|NCT01698320|364934559|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
105802822|NCT01698320|364934560|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
105802823|NCT01698320|364934558|FG000|40-Week Open-Label Period|Adverse Event|0|||
105802824|NCT01698320|364934559|FG001|40-Week Open-Label Period|Adverse Event|3|||
105802825|NCT01698320|364934560|FG002|40-Week Open-Label Period|Adverse Event|2|||
105802826|NCT01698320|364934558|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
105802827|NCT01698320|364934559|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
105802828|NCT01698320|364934560|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
105802829|NCT01698320|364934558|FG000|40-Week Open-Label Period|Pregnancy|0|||
105802830|NCT01698320|364934559|FG001|40-Week Open-Label Period|Pregnancy|2|||
105802831|NCT01698320|364934560|FG002|40-Week Open-Label Period|Pregnancy|1|||
105802832|NCT01698320|364934558|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
105802833|NCT01698320|364934559|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
105802834|NCT01698320|364934560|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
105802835|NCT01698320|364934558|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
105802836|NCT01698320|364934559|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
105802837|NCT01698320|364934560|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
105802838|NCT01783496|364934561|FG000|Overall Study|Lost to Follow-up|0|||
105802839|NCT01783496|364934562|FG001|Overall Study|Lost to Follow-up|0|||
105802840|NCT01783496|364934563|FG002|Overall Study|Lost to Follow-up|0|||
105802841|NCT01783496|364934564|FG003|Overall Study|Lost to Follow-up|2|||
105802842|NCT01783496|364934565|FG004|Overall Study|Lost to Follow-up|0|||
105802843|NCT01783496|364934566|FG005|Overall Study|Lost to Follow-up|1|||
105802844|NCT01783496|364934561|FG000|Overall Study|Withdrawal by Subject|1|||
105802845|NCT01783496|364934562|FG001|Overall Study|Withdrawal by Subject|0|||
105802846|NCT01783496|364934563|FG002|Overall Study|Withdrawal by Subject|0|||
105802847|NCT01783496|364934564|FG003|Overall Study|Withdrawal by Subject|0|||
105802848|NCT01783496|364934565|FG004|Overall Study|Withdrawal by Subject|0|||
105950125|NCT02750514|365482330|FG003|Track 1|Other reasons|0|||
105950126|NCT02750514|365482331|FG004|Track 1|Other reasons|0|||
105950127|NCT02750514|365482327|FG000|Track 2|Disease progression|4|||
105806538|NCT03209570|364949015|FG000|Overall Study|Protocol Violation|1|||
105802849|NCT01783496|364934566|FG005|Overall Study|Withdrawal by Subject|0|||
105802850|NCT01280981|364934573|FG000|Overall Study|Withdrawal by Subject|11|||
105802851|NCT01280981|364934573|FG000|Overall Study|Protocol Violation|2|||
105802852|NCT01280981|364934573|FG000|Overall Study|Lack of Efficacy|13|||
105802853|NCT01280981|364934573|FG000|Overall Study|Lost to Follow-up|3|||
105802854|NCT01280981|364934573|FG000|Overall Study|Adverse Event|6|||
105802855|NCT01280981|364934573|FG000|Overall Study|Irregular or discontinued menses|3|||
105802856|NCT01280981|364934573|FG000|Overall Study|Failed to return|45|||
105802857|NCT01280981|364934573|FG000|Overall Study|Non-compliance with protocol|3|||
105802858|NCT01280981|364934573|FG000|Overall Study|Withdrawal of consent|3|||
105802859|NCT01280981|364934573|FG000|Overall Study|Elective surgery|2|||
105802860|NCT01280981|364934573|FG000|Overall Study|Study site closure|1|||
105802861|NCT05085964|364934574|FG000|Overall Study|Premature termination of study|21|||
105802862|NCT05085964|364934575|FG001|Overall Study|Premature termination of study|0|||
105802863|NCT00545233|364934576|FG000|Overall Study|Adverse Event|10|||
105802864|NCT00545233|364934577|FG001|Overall Study|Adverse Event|5|||
105802865|NCT00545233|364934576|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
105802866|NCT00545233|364934577|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
105802867|NCT00545233|364934576|FG000|Overall Study|Protocol Violation|2|||
105802868|NCT00545233|364934577|FG001|Overall Study|Protocol Violation|0|||
105802869|NCT00545233|364934576|FG000|Overall Study|Refused Treatment|9|||
105802870|NCT00545233|364934577|FG001|Overall Study|Refused Treatment|7|||
105802871|NCT00545233|364934576|FG000|Overall Study|Failure to Return|4|||
105802872|NCT00545233|364934577|FG001|Overall Study|Failure to Return|6|||
105802873|NCT00545233|364934576|FG000|Overall Study|Insufficient response|14|||
105802874|NCT00545233|364934577|FG001|Overall Study|Insufficient response|15|||
105802875|NCT00545233|364934576|FG000|Overall Study|Physician Decision|2|||
105802876|NCT00545233|364934577|FG001|Overall Study|Physician Decision|1|||
105802877|NCT01783730|364934578|FG000|Overall Study|Failed to meet inclusion criteria|6|||
105802878|NCT00252187|364934579|FG000|Overall Study|Adverse Event|3|||
105802879|NCT00252187|364934580|FG001|Overall Study|Adverse Event|1|||
105802880|NCT00252187|364934579|FG000|Overall Study|Withdrawal by Subject|1|||
105802881|NCT00252187|364934580|FG001|Overall Study|Withdrawal by Subject|0|||
105802882|NCT01086215|364934585|FG000|Overall Study|Death|14|||
105802883|NCT01086215|364934586|FG001|Overall Study|Death|8|||
105802884|NCT01086215|364934587|FG002|Overall Study|Death|8|||
105802885|NCT01086215|364934588|FG003|Overall Study|Death|1|||
105802886|NCT01086215|364934585|FG000|Overall Study|Lost to Follow-up|22|||
105802887|NCT01086215|364934586|FG001|Overall Study|Lost to Follow-up|39|||
105802888|NCT01086215|364934587|FG002|Overall Study|Lost to Follow-up|18|||
105802889|NCT01086215|364934588|FG003|Overall Study|Lost to Follow-up|2|||
105802890|NCT03469271|364934591|FG000|Overall Study|Withdrawal by Subject|2|||
105802891|NCT03469271|364934592|FG001|Overall Study|Withdrawal by Subject|0|||
105802892|NCT03469271|364934593|FG002|Overall Study|Withdrawal by Subject|0|||
105802893|NCT03469271|364934594|FG003|Overall Study|Withdrawal by Subject|1|||
105802894|NCT03264066|364934595|FG000|Overall Study|Adverse Event|1|||
105802895|NCT03264066|364934596|FG001|Overall Study|Adverse Event|1|||
105802896|NCT03264066|364934597|FG002|Overall Study|Adverse Event|0|||
105802897|NCT03264066|364934598|FG003|Overall Study|Adverse Event|0|||
105802898|NCT03264066|364934599|FG004|Overall Study|Adverse Event|0|||
105802899|NCT03264066|364934600|FG005|Overall Study|Adverse Event|0|||
105802900|NCT03264066|364934595|FG000|Overall Study|Death|12|||
105802901|NCT03264066|364934596|FG001|Overall Study|Death|12|||
105802902|NCT03264066|364934597|FG002|Overall Study|Death|8|||
105802903|NCT03264066|364934598|FG003|Overall Study|Death|10|||
105802904|NCT03264066|364934599|FG004|Overall Study|Death|6|||
105802905|NCT03264066|364934600|FG005|Overall Study|Death|1|||
105802906|NCT03264066|364934595|FG000|Overall Study|Lost to Follow-up|1|||
105802907|NCT03264066|364934596|FG001|Overall Study|Lost to Follow-up|0|||
105802908|NCT03264066|364934597|FG002|Overall Study|Lost to Follow-up|0|||
105802909|NCT03264066|364934598|FG003|Overall Study|Lost to Follow-up|0|||
105802910|NCT03264066|364934599|FG004|Overall Study|Lost to Follow-up|0|||
105802911|NCT03264066|364934600|FG005|Overall Study|Lost to Follow-up|0|||
105802912|NCT03264066|364934595|FG000|Overall Study|Progressive Disease|0|||
105950128|NCT02750514|365482328|FG001|Track 2|Disease progression|5|||
105802913|NCT03264066|364934596|FG001|Overall Study|Progressive Disease|2|||
105802914|NCT03264066|364934597|FG002|Overall Study|Progressive Disease|1|||
105802915|NCT03264066|364934598|FG003|Overall Study|Progressive Disease|0|||
105802916|NCT03264066|364934599|FG004|Overall Study|Progressive Disease|0|||
105802917|NCT03264066|364934600|FG005|Overall Study|Progressive Disease|0|||
105802918|NCT03264066|364934595|FG000|Overall Study|Study Terminated by Sponsor|5|||
105802919|NCT03264066|364934596|FG001|Overall Study|Study Terminated by Sponsor|5|||
105802920|NCT03264066|364934597|FG002|Overall Study|Study Terminated by Sponsor|8|||
105802921|NCT03264066|364934598|FG003|Overall Study|Study Terminated by Sponsor|5|||
105802922|NCT03264066|364934599|FG004|Overall Study|Study Terminated by Sponsor|1|||
105802923|NCT03264066|364934600|FG005|Overall Study|Study Terminated by Sponsor|2|||
105802924|NCT03264066|364934595|FG000|Overall Study|Withdrawal by Subject|1|||
105802925|NCT03264066|364934596|FG001|Overall Study|Withdrawal by Subject|0|||
105950129|NCT02750514|365482329|FG002|Track 2|Disease progression|2|||
105950130|NCT02750514|365482330|FG003|Track 2|Disease progression|5|||
105950131|NCT02750514|365482331|FG004|Track 2|Disease progression|0|||
105755901|NCT01763866|364758356|FG016|Overall Study|Withdrawal by Subject|0|||
105755902|NCT01763866|364758357|FG017|Overall Study|Withdrawal by Subject|1|||
105755903|NCT01763866|364758358|FG018|Overall Study|Withdrawal by Subject|1|||
105755904|NCT01763866|364758359|FG019|Overall Study|Withdrawal by Subject|1|||
105755905|NCT01763866|364758360|FG020|Overall Study|Withdrawal by Subject|2|||
105755906|NCT01763866|364758361|FG021|Overall Study|Withdrawal by Subject|1|||
105755907|NCT01763866|364758362|FG022|Overall Study|Withdrawal by Subject|2|||
105755908|NCT01763866|364758363|FG023|Overall Study|Withdrawal by Subject|1|||
105755909|NCT01763866|364758340|FG000|Overall Study|Decision by sponsor|0|||
105755910|NCT01763866|364758341|FG001|Overall Study|Decision by sponsor|0|||
105755911|NCT01763866|364758342|FG002|Overall Study|Decision by sponsor|1|||
105755912|NCT01763866|364758343|FG003|Overall Study|Decision by sponsor|0|||
105755913|NCT01763866|364758344|FG004|Overall Study|Decision by sponsor|2|||
105755914|NCT01763866|364758345|FG005|Overall Study|Decision by sponsor|0|||
105755915|NCT01763866|364758346|FG006|Overall Study|Decision by sponsor|2|||
105755916|NCT01763866|364758347|FG007|Overall Study|Decision by sponsor|0|||
105755917|NCT01763866|364758348|FG008|Overall Study|Decision by sponsor|2|||
105755918|NCT01763866|364758349|FG009|Overall Study|Decision by sponsor|0|||
105755919|NCT01763866|364758350|FG010|Overall Study|Decision by sponsor|6|||
105755920|NCT01763866|364758351|FG011|Overall Study|Decision by sponsor|0|||
105755921|NCT01763866|364758352|FG012|Overall Study|Decision by sponsor|1|||
105755922|NCT01763866|364758353|FG013|Overall Study|Decision by sponsor|0|||
105755923|NCT01763866|364758354|FG014|Overall Study|Decision by sponsor|5|||
105755924|NCT01763866|364758355|FG015|Overall Study|Decision by sponsor|0|||
105755925|NCT01763866|364758356|FG016|Overall Study|Decision by sponsor|0|||
105755926|NCT01763866|364758357|FG017|Overall Study|Decision by sponsor|0|||
105755927|NCT01763866|364758358|FG018|Overall Study|Decision by sponsor|4|||
105755928|NCT01763866|364758359|FG019|Overall Study|Decision by sponsor|0|||
105755929|NCT01763866|364758360|FG020|Overall Study|Decision by sponsor|2|||
105755930|NCT01763866|364758361|FG021|Overall Study|Decision by sponsor|0|||
105755931|NCT01763866|364758362|FG022|Overall Study|Decision by sponsor|1|||
105755932|NCT01763866|364758363|FG023|Overall Study|Decision by sponsor|0|||
105755933|NCT01763866|364758340|FG000|Overall Study|Lost to Follow-up|0|||
105755934|NCT01763866|364758341|FG001|Overall Study|Lost to Follow-up|0|||
105755935|NCT01763866|364758342|FG002|Overall Study|Lost to Follow-up|0|||
105755936|NCT01763866|364758343|FG003|Overall Study|Lost to Follow-up|0|||
105755937|NCT01763866|364758344|FG004|Overall Study|Lost to Follow-up|0|||
105755938|NCT01763866|364758345|FG005|Overall Study|Lost to Follow-up|0|||
105755939|NCT01763866|364758346|FG006|Overall Study|Lost to Follow-up|1|||
105755940|NCT01763866|364758347|FG007|Overall Study|Lost to Follow-up|0|||
105755941|NCT01763866|364758348|FG008|Overall Study|Lost to Follow-up|0|||
105755942|NCT01763866|364758349|FG009|Overall Study|Lost to Follow-up|0|||
105755943|NCT01763866|364758350|FG010|Overall Study|Lost to Follow-up|0|||
105755944|NCT01763866|364758351|FG011|Overall Study|Lost to Follow-up|0|||
105755945|NCT01763866|364758352|FG012|Overall Study|Lost to Follow-up|1|||
105755946|NCT01763866|364758353|FG013|Overall Study|Lost to Follow-up|0|||
105755947|NCT01763866|364758354|FG014|Overall Study|Lost to Follow-up|1|||
105755948|NCT01763866|364758355|FG015|Overall Study|Lost to Follow-up|0|||
105755949|NCT01763866|364758356|FG016|Overall Study|Lost to Follow-up|0|||
105755950|NCT01763866|364758357|FG017|Overall Study|Lost to Follow-up|0|||
105755951|NCT01763866|364758358|FG018|Overall Study|Lost to Follow-up|1|||
105755952|NCT01763866|364758359|FG019|Overall Study|Lost to Follow-up|1|||
105755953|NCT01763866|364758360|FG020|Overall Study|Lost to Follow-up|0|||
105755954|NCT01763866|364758361|FG021|Overall Study|Lost to Follow-up|0|||
105755955|NCT01763866|364758362|FG022|Overall Study|Lost to Follow-up|0|||
105755956|NCT01763866|364758363|FG023|Overall Study|Lost to Follow-up|1|||
105755957|NCT01763866|364758340|FG000|Overall Study|Death|0|||
105755958|NCT01763866|364758341|FG001|Overall Study|Death|0|||
105755959|NCT01763866|364758342|FG002|Overall Study|Death|0|||
105755960|NCT01763866|364758343|FG003|Overall Study|Death|0|||
105755961|NCT01763866|364758344|FG004|Overall Study|Death|0|||
105755962|NCT01763866|364758345|FG005|Overall Study|Death|0|||
105755963|NCT01763866|364758346|FG006|Overall Study|Death|0|||
105755964|NCT01763866|364758347|FG007|Overall Study|Death|0|||
105755965|NCT01763866|364758348|FG008|Overall Study|Death|0|||
105755966|NCT01763866|364758349|FG009|Overall Study|Death|0|||
105755967|NCT01763866|364758350|FG010|Overall Study|Death|0|||
105755968|NCT01763866|364758351|FG011|Overall Study|Death|0|||
105755969|NCT01763866|364758352|FG012|Overall Study|Death|0|||
105755970|NCT01763866|364758353|FG013|Overall Study|Death|0|||
105755971|NCT01763866|364758354|FG014|Overall Study|Death|0|||
105755972|NCT01763866|364758355|FG015|Overall Study|Death|0|||
105755973|NCT01763866|364758356|FG016|Overall Study|Death|1|||
105755974|NCT01763866|364758357|FG017|Overall Study|Death|0|||
105755975|NCT01763866|364758358|FG018|Overall Study|Death|0|||
105755976|NCT01763866|364758359|FG019|Overall Study|Death|0|||
105950132|NCT02750514|365482327|FG000|Track 2|Adverse event unrelated to study drug|1|||
105755977|NCT01763866|364758360|FG020|Overall Study|Death|0|||
105755978|NCT01763866|364758361|FG021|Overall Study|Death|0|||
105755979|NCT01763866|364758362|FG022|Overall Study|Death|0|||
105802926|NCT03264066|364934597|FG002|Overall Study|Withdrawal by Subject|0|||
105802927|NCT03264066|364934598|FG003|Overall Study|Withdrawal by Subject|5|||
105802928|NCT03264066|364934599|FG004|Overall Study|Withdrawal by Subject|0|||
105802929|NCT03264066|364934600|FG005|Overall Study|Withdrawal by Subject|0|||
105802930|NCT03361956|364934601|FG000|Overall Study|Adverse Event|1|||
105802931|NCT03361956|364934602|FG001|Overall Study|Adverse Event|0|||
105802932|NCT03361956|364934603|FG002|Overall Study|Adverse Event|1|||
105802933|NCT03361956|364934604|FG003|Overall Study|Adverse Event|1|||
105802934|NCT03361956|364934605|FG004|Overall Study|Adverse Event|0|||
105802935|NCT03361956|364934601|FG000|Overall Study|Other|0|||
105802936|NCT03361956|364934602|FG001|Overall Study|Other|0|||
105802937|NCT03361956|364934603|FG002|Overall Study|Other|0|||
105802938|NCT03361956|364934604|FG003|Overall Study|Other|1|||
105802939|NCT03361956|364934605|FG004|Overall Study|Other|0|||
105802940|NCT03361956|364934601|FG000|Overall Study|Withdrawal by Subject|2|||
105802941|NCT03361956|364934602|FG001|Overall Study|Withdrawal by Subject|2|||
105802942|NCT03361956|364934603|FG002|Overall Study|Withdrawal by Subject|2|||
105802943|NCT03361956|364934604|FG003|Overall Study|Withdrawal by Subject|0|||
105802944|NCT03361956|364934605|FG004|Overall Study|Withdrawal by Subject|3|||
105802945|NCT03361956|364934601|FG000|Overall Study|Disease Relapse|0|||
105802946|NCT03361956|364934602|FG001|Overall Study|Disease Relapse|0|||
105802947|NCT03361956|364934603|FG002|Overall Study|Disease Relapse|1|||
105802948|NCT03361956|364934604|FG003|Overall Study|Disease Relapse|0|||
105802949|NCT03361956|364934605|FG004|Overall Study|Disease Relapse|0|||
105802950|NCT03361956|364934601|FG000|Overall Study|Physician Decision|0|||
105802951|NCT03361956|364934602|FG001|Overall Study|Physician Decision|2|||
105802952|NCT03361956|364934603|FG002|Overall Study|Physician Decision|0|||
105802953|NCT03361956|364934604|FG003|Overall Study|Physician Decision|1|||
105802954|NCT03361956|364934605|FG004|Overall Study|Physician Decision|0|||
105802955|NCT03361956|364934601|FG000|Overall Study|Lost to Follow-up|0|||
105802956|NCT03361956|364934602|FG001|Overall Study|Lost to Follow-up|0|||
105802957|NCT03361956|364934603|FG002|Overall Study|Lost to Follow-up|1|||
105802958|NCT03361956|364934604|FG003|Overall Study|Lost to Follow-up|1|||
105802959|NCT03361956|364934605|FG004|Overall Study|Lost to Follow-up|2|||
105802960|NCT00871728|364934611|FG000|Overall Study|Adverse Event|1|||
105802961|NCT00871728|364934611|FG000|Overall Study|Protocol Violation|7|||
105802962|NCT00871728|364934611|FG000|Overall Study|Lost to Follow-up|2|||
105802963|NCT00871728|364934611|FG000|Overall Study|Failed to Visit Hospital|4|||
105802964|NCT00871728|364934611|FG000|Overall Study|Participant Non-compliance|1|||
105802965|NCT00871728|364934611|FG000|Overall Study|Withdrawal of Informed Consent|5|||
105802966|NCT03404206|364934614|FG000|Overall Study|Withdrawal by Subject|1|||
105802967|NCT03404206|364934615|FG001|Overall Study|Withdrawal by Subject|1|||
105802968|NCT03404206|364934616|FG002|Overall Study|Withdrawal by Subject|0|||
105802969|NCT03404206|364934614|FG000|Overall Study|Lost to Follow-up|3|||
105802970|NCT03404206|364934615|FG001|Overall Study|Lost to Follow-up|1|||
105802971|NCT03404206|364934616|FG002|Overall Study|Lost to Follow-up|0|||
105802972|NCT00146770|364934624|FG000|Overall Study|Adverse Event|2|||
105802973|NCT00146770|364934625|FG001|Overall Study|Adverse Event|0|||
105802974|NCT00146770|364934624|FG000|Overall Study|Pregnancy|1|||
105802975|NCT00146770|364934625|FG001|Overall Study|Pregnancy|0|||
105802976|NCT00146770|364934624|FG000|Overall Study|Withdrawal by Subject|2|||
105802977|NCT00146770|364934625|FG001|Overall Study|Withdrawal by Subject|0|||
105802978|NCT02826603|364934632|FG000|Overall Study|Adverse Event|17|||
105802979|NCT02826603|364934633|FG001|Overall Study|Adverse Event|9|||
105802980|NCT02826603|364934632|FG000|Overall Study|Lack of Efficacy|4|||
105802981|NCT02826603|364934633|FG001|Overall Study|Lack of Efficacy|9|||
105802982|NCT02826603|364934632|FG000|Overall Study|Lost to Follow-up|13|||
105802983|NCT02826603|364934633|FG001|Overall Study|Lost to Follow-up|12|||
105802984|NCT02826603|364934632|FG000|Overall Study|Noncompliance with treatment|0|||
105802985|NCT02826603|364934633|FG001|Overall Study|Noncompliance with treatment|2|||
105802986|NCT02826603|364934632|FG000|Overall Study|Physician Decision|1|||
105802987|NCT02826603|364934633|FG001|Overall Study|Physician Decision|7|||
105802988|NCT02826603|364934632|FG000|Overall Study|Pregnancy|1|||
105802989|NCT02826603|364934633|FG001|Overall Study|Pregnancy|2|||
105755980|NCT01763866|364758363|FG023|Overall Study|Death|0|||
105755981|NCT00966693|364758374|FG000|Overall Study|Adverse Event|0|||
105755982|NCT00966693|364758375|FG001|Overall Study|Adverse Event|0|||
105755983|NCT00966693|364758376|FG002|Overall Study|Adverse Event|1|||
105755984|NCT00966693|364758377|FG003|Overall Study|Adverse Event|2|||
105755985|NCT00966693|364758374|FG000|Overall Study|Death|0|||
105755986|NCT00966693|364758375|FG001|Overall Study|Death|0|||
105755987|NCT00966693|364758376|FG002|Overall Study|Death|1|||
105755988|NCT00966693|364758377|FG003|Overall Study|Death|0|||
105755989|NCT00966693|364758374|FG000|Overall Study|Withdrawal by Subject|1|||
105755990|NCT00966693|364758375|FG001|Overall Study|Withdrawal by Subject|0|||
105755991|NCT00966693|364758376|FG002|Overall Study|Withdrawal by Subject|0|||
105755992|NCT00966693|364758377|FG003|Overall Study|Withdrawal by Subject|5|||
105755993|NCT00966693|364758374|FG000|Overall Study|Disease Progression|0|||
105755994|NCT00966693|364758375|FG001|Overall Study|Disease Progression|0|||
105755995|NCT00966693|364758376|FG002|Overall Study|Disease Progression|1|||
105755996|NCT00966693|364758377|FG003|Overall Study|Disease Progression|16|||
105755997|NCT00171314|364758378|FG000|Overall Study|Adverse Event|44|||
105755998|NCT00171314|364758379|FG001|Overall Study|Adverse Event|41|||
105755999|NCT00171314|364758378|FG000|Overall Study|Lack of Efficacy|19|||
105756000|NCT00171314|364758379|FG001|Overall Study|Lack of Efficacy|14|||
105756001|NCT00171314|364758378|FG000|Overall Study|Withdrawal by Subject|9|||
105756002|NCT00171314|364758379|FG001|Overall Study|Withdrawal by Subject|6|||
105756003|NCT00171314|364758378|FG000|Overall Study|Abnormal Test Procedure Results|9|||
105802990|NCT02826603|364934632|FG000|Overall Study|Protocol Violation|3|||
105802991|NCT02826603|364934633|FG001|Overall Study|Protocol Violation|3|||
105802992|NCT02826603|364934632|FG000|Overall Study|Withdrawal by Subject|20|||
105802993|NCT02826603|364934633|FG001|Overall Study|Withdrawal by Subject|19|||
105756004|NCT00171314|364758379|FG001|Overall Study|Abnormal Test Procedure Results|3|||
105756005|NCT00171314|364758378|FG000|Overall Study|Protocol Violation|3|||
105756006|NCT00171314|364758379|FG001|Overall Study|Protocol Violation|7|||
105756007|NCT00171314|364758378|FG000|Overall Study|Administrative Problems|4|||
105756008|NCT00171314|364758379|FG001|Overall Study|Administrative Problems|3|||
105756009|NCT00171314|364758378|FG000|Overall Study|Lost to Follow-up|1|||
105756010|NCT00171314|364758379|FG001|Overall Study|Lost to Follow-up|3|||
105802994|NCT02826603|364934632|FG000|Overall Study|Death|2|||
105802995|NCT02826603|364934633|FG001|Overall Study|Death|0|||
105802996|NCT02826603|364934632|FG000|Overall Study|New therapy for study indication|0|||
105756011|NCT00171314|364758378|FG000|Overall Study|Death|2|||
105756012|NCT00171314|364758379|FG001|Overall Study|Death|1|||
105756013|NCT02293902|364758383|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
105756014|NCT02293902|364758384|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
105756015|NCT02293902|364758385|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
105756016|NCT02293902|364758386|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
105756017|NCT02293902|364758387|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
105756018|NCT02293902|364758383|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
105756019|NCT02293902|364758384|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
105756020|NCT02293902|364758385|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
105756021|NCT02293902|364758386|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
105756022|NCT02293902|364758387|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
105756023|NCT02293902|364758383|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
105756024|NCT02293902|364758384|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
105756025|NCT02293902|364758385|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
105756026|NCT02293902|364758386|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
105756027|NCT02293902|364758387|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
105756028|NCT02293902|364758383|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
105756029|NCT02293902|364758384|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
105756030|NCT02293902|364758385|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
105756031|NCT02293902|364758386|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
105756032|NCT02293902|364758387|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
105756033|NCT02293902|364758383|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
105756034|NCT02293902|364758384|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
105756035|NCT02293902|364758385|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
105756036|NCT02293902|364758386|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
105756037|NCT02293902|364758387|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
105756038|NCT00562640|364760083|FG000|Overall Study|Death|0|||
105756039|NCT00562640|364760084|FG001|Overall Study|Death|1|||
105756040|NCT00562640|364760085|FG002|Overall Study|Death|1|||
105756041|NCT00562640|364760086|FG003|Overall Study|Death|0|||
105756042|NCT02658968|364760087|FG000|Received Rituximab|Adverse Event|0|||
105756043|NCT02658968|364760088|FG001|Received Rituximab|Adverse Event|0|||
105756044|NCT02658968|364760089|FG002|Received Rituximab|Adverse Event|0|||
105756045|NCT02658968|364760090|FG003|Received Rituximab|Adverse Event|0|||
105756046|NCT02658968|364760091|FG004|Received Rituximab|Adverse Event|1|||
105756047|NCT02658968|364760087|FG000|Received Rituximab|Progressive disease|0|||
105756048|NCT02658968|364760088|FG001|Received Rituximab|Progressive disease|0|||
105756049|NCT02658968|364760089|FG002|Received Rituximab|Progressive disease|0|||
105756050|NCT02658968|364760090|FG003|Received Rituximab|Progressive disease|0|||
105756051|NCT02658968|364760091|FG004|Received Rituximab|Progressive disease|1|||
105756052|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
105756053|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
105756054|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
105756055|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
105756056|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
105756057|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
105756058|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
105756059|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
105756060|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
105756061|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
105756062|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
105756063|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
105756064|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
105756065|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
105756066|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
105756067|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
105756068|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
105756069|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
105756070|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
105756071|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
105756072|NCT02658968|364760087|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
105756073|NCT02658968|364760088|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
105756074|NCT02658968|364760089|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
105756075|NCT02658968|364760090|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
105756076|NCT02658968|364760091|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
105756077|NCT00603733|364760096|FG000|Active Phase ITT|Adverse Event|8|||
105756078|NCT00603733|364760097|FG001|Active Phase ITT|Adverse Event|7|||
105756079|NCT00603733|364760096|FG000|Active Phase ITT|Withdrawal by Subject|0|||
105756080|NCT00603733|364760097|FG001|Active Phase ITT|Withdrawal by Subject|3|||
105756081|NCT00603733|364760096|FG000|Active Phase ITT|Lost to Follow-up|0|||
105756082|NCT00603733|364760097|FG001|Active Phase ITT|Lost to Follow-up|1|||
105756083|NCT00603733|364760096|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
105756084|NCT00603733|364760097|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
105756085|NCT00603733|364760096|FG000|Active Phase ITT|Lack of Efficacy|1|||
105756086|NCT00603733|364760097|FG001|Active Phase ITT|Lack of Efficacy|2|||
105756087|NCT00603733|364760096|FG000|Active Phase ITT|Subject moved, site closed|1|||
105756088|NCT00603733|364760097|FG001|Active Phase ITT|Subject moved, site closed|1|||
105756089|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
105756090|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
105756091|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
105756092|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
105756093|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
105756094|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
105756095|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
105756096|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
105756097|NCT00603733|364760096|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
105756098|NCT00603733|364760097|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
105756099|NCT00603733|364760096|FG000|Maintenance Phase ITT|Adverse Event|3|||
105756100|NCT00603733|364760097|FG001|Maintenance Phase ITT|Adverse Event|6|||
105756101|NCT00603733|364760096|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
105756102|NCT00603733|364760097|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
105756103|NCT00603733|364760096|FG000|Maintenance Phase ITT|Protocol Violation|1|||
105756104|NCT00603733|364760097|FG001|Maintenance Phase ITT|Protocol Violation|1|||
105756105|NCT00603733|364760096|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
105756106|NCT00603733|364760097|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
105756107|NCT00603733|364760096|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
105756108|NCT00603733|364760097|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
105756109|NCT00603733|364760096|FG000|Maintenance Phase ITT|Physician Decision|0|||
105756110|NCT00603733|364760097|FG001|Maintenance Phase ITT|Physician Decision|1|||
105756111|NCT00603733|364760096|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
105756112|NCT00603733|364760097|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
105756113|NCT02700919|364760098|FG000|Overall Study|Physician Decision|1|||
105756114|NCT02700919|364760099|FG001|Overall Study|Physician Decision|0|||
105756115|NCT02700919|364760100|FG002|Overall Study|Physician Decision|0|||
105756116|NCT02700919|364760098|FG000|Overall Study|Protocol Violation|1|||
105756117|NCT02700919|364760099|FG001|Overall Study|Protocol Violation|0|||
105756118|NCT02700919|364760100|FG002|Overall Study|Protocol Violation|0|||
105756119|NCT02700919|364760098|FG000|Overall Study|Adverse Event|1|||
105756120|NCT02700919|364760099|FG001|Overall Study|Adverse Event|3|||
105756121|NCT02700919|364760100|FG002|Overall Study|Adverse Event|1|||
105756122|NCT02700919|364760098|FG000|Overall Study|Withdrawal by Subject|5|||
105756123|NCT02700919|364760099|FG001|Overall Study|Withdrawal by Subject|8|||
105756124|NCT02700919|364760100|FG002|Overall Study|Withdrawal by Subject|2|||
105756125|NCT02700919|364760098|FG000|Overall Study|Lost to Follow-up|2|||
105756126|NCT02700919|364760099|FG001|Overall Study|Lost to Follow-up|0|||
105756127|NCT02700919|364760100|FG002|Overall Study|Lost to Follow-up|0|||
105756128|NCT02700919|364760098|FG000|Overall Study|Other|2|||
105756129|NCT02700919|364760099|FG001|Overall Study|Other|1|||
105756130|NCT02700919|364760100|FG002|Overall Study|Other|1|||
105756131|NCT02150213|364760106|FG000|Overall Study|Lost to Follow-up|1|||
105756132|NCT02150213|364760106|FG000|Overall Study|Withdrawal by Subject|1|||
105756133|NCT01297309|364760110|FG000|Overall Study|Eligibility failure|2|||
105756134|NCT01297309|364760110|FG000|Overall Study|Screen failure|2|||
105756135|NCT01297309|364760110|FG000|Overall Study|Withdrawal by Subject|5|||
105756136|NCT01297309|364760110|FG000|Overall Study|Adverse Event|1|||
105756137|NCT01297309|364760110|FG000|Overall Study|Investigator Decision|2|||
105756138|NCT01297309|364760110|FG000|Overall Study|Death|1|||
105756139|NCT01297309|364760110|FG000|Overall Study|Participant not entering extensionperiod|1|||
105756140|NCT03039738|364760111|FG000|Overall Study|Incomplete data sets|54|||
105756141|NCT03039738|364760112|FG001|Overall Study|Incomplete data sets|0|||
105756142|NCT02670928|364760114|FG000|Overall Study|Adverse Event|3|||
105756143|NCT02670928|364760115|FG001|Overall Study|Adverse Event|1|||
105756144|NCT02670928|364760114|FG000|Overall Study|Withdrawal by Subject|4|||
105802997|NCT02826603|364934633|FG001|Overall Study|New therapy for study indication|1|||
105802998|NCT00003102|364934636|FG000|Overall Study|Physician Decision|1|||
105756145|NCT02670928|364760115|FG001|Overall Study|Withdrawal by Subject|0|||
105756146|NCT02670928|364760114|FG000|Overall Study|Lost to Follow-up|1|||
105756147|NCT02670928|364760115|FG001|Overall Study|Lost to Follow-up|0|||
105756148|NCT02670928|364760114|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
105756149|NCT02670928|364760115|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
105756150|NCT04681729|364760116|FG000|Overall Study|Lack of Efficacy|2|||
105756151|NCT04681729|364760117|FG001|Overall Study|Lack of Efficacy|2|||
105756152|NCT04681729|364760116|FG000|Overall Study|Withdrawal by Subject|8|||
105756153|NCT04681729|364760117|FG001|Overall Study|Withdrawal by Subject|9|||
105756154|NCT02678312|364760118|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
105756155|NCT02678312|364760119|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
105756156|NCT02678312|364760120|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
105756157|NCT02678312|364760121|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
105756158|NCT02678312|364760122|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
105756159|NCT02678312|364760118|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
105756160|NCT02678312|364760119|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
105756161|NCT02678312|364760120|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
105756162|NCT02678312|364760121|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
105756163|NCT02678312|364760122|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
105756164|NCT02678312|364760118|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
105756165|NCT02678312|364760119|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
105756166|NCT02678312|364760120|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
105756167|NCT02678312|364760121|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
105756168|NCT02678312|364760122|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
105756169|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
105756170|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
105756171|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
105756172|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
105756173|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
105756174|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Death|0|||
105756175|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Death|0|||
105756176|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Death|0|||
105756177|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Death|8|||
105756178|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Death|12|||
105756179|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
105756180|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
105756181|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
105756182|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
105756183|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
105756184|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
105756185|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
105756186|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
105756187|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
105756188|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
105756189|NCT02678312|364760118|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
105756190|NCT02678312|364760119|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
105756191|NCT02678312|364760120|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
105756192|NCT02678312|364760121|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
105756193|NCT02678312|364760122|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
105756194|NCT00912340|364760125|FG000|Overall Study|Adverse Event|2|||
105756195|NCT00912340|364760126|FG001|Overall Study|Adverse Event|4|||
105756196|NCT00912340|364760127|FG002|Overall Study|Adverse Event|0|||
105756197|NCT00912340|364760125|FG000|Overall Study|Protocol revised to remove arm|0|||
105756198|NCT00912340|364760126|FG001|Overall Study|Protocol revised to remove arm|0|||
105756199|NCT00912340|364760127|FG002|Overall Study|Protocol revised to remove arm|4|||
105756200|NCT01517412|364760130|FG000|Overall Study|Adverse Event|10|||
105756201|NCT01517412|364760131|FG001|Overall Study|Adverse Event|11|||
105756202|NCT01517412|364760130|FG000|Overall Study|Lack of Efficacy|10|||
105756203|NCT01517412|364760131|FG001|Overall Study|Lack of Efficacy|5|||
105756204|NCT01517412|364760130|FG000|Overall Study|Poor compliance to protocol|8|||
105756205|NCT01517412|364760131|FG001|Overall Study|Poor compliance to protocol|3|||
105756206|NCT01517412|364760130|FG000|Overall Study|Other than specified above|8|||
105950133|NCT02750514|365482328|FG001|Track 2|Adverse event unrelated to study drug|0|||
105950134|NCT02750514|365482329|FG002|Track 2|Adverse event unrelated to study drug|0|||
105756207|NCT01517412|364760131|FG001|Overall Study|Other than specified above|5|||
105756208|NCT02215616|364760139|FG000|Overall Study|Sponsor requested to stop study drug|0|||
105756209|NCT02215616|364760140|FG001|Overall Study|Sponsor requested to stop study drug|0|||
105756210|NCT02215616|364760141|FG002|Overall Study|Sponsor requested to stop study drug|1|||
105756211|NCT02215616|364760142|FG003|Overall Study|Sponsor requested to stop study drug|4|||
105756212|NCT02215616|364760139|FG000|Overall Study|Death|1|||
105756213|NCT02215616|364760140|FG001|Overall Study|Death|0|||
105756214|NCT02215616|364760141|FG002|Overall Study|Death|0|||
105756215|NCT02215616|364760142|FG003|Overall Study|Death|0|||
105756216|NCT02215616|364760139|FG000|Overall Study|Adverse Event|7|||
105756217|NCT02215616|364760140|FG001|Overall Study|Adverse Event|4|||
105756218|NCT02215616|364760141|FG002|Overall Study|Adverse Event|9|||
105950135|NCT02750514|365482330|FG003|Track 2|Adverse event unrelated to study drug|0|||
105756219|NCT02215616|364760142|FG003|Overall Study|Adverse Event|2|||
105756220|NCT02215616|364760139|FG000|Overall Study|Withdrawal by Subject|1|||
105756221|NCT02215616|364760140|FG001|Overall Study|Withdrawal by Subject|8|||
105802999|NCT00003102|364934637|FG001|Overall Study|Physician Decision|1|||
105803000|NCT00003102|364934638|FG002|Overall Study|Physician Decision|0|||
105803001|NCT00003102|364934636|FG000|Overall Study|Progressive Disease|0|||
105803002|NCT00003102|364934637|FG001|Overall Study|Progressive Disease|1|||
105803003|NCT00003102|364934638|FG002|Overall Study|Progressive Disease|0|||
105803004|NCT00003102|364934636|FG000|Overall Study|Adverse Event|0|||
105803005|NCT00003102|364934637|FG001|Overall Study|Adverse Event|1|||
105803006|NCT00003102|364934638|FG002|Overall Study|Adverse Event|1|||
105950136|NCT02750514|365482331|FG004|Track 2|Adverse event unrelated to study drug|0|||
105950137|NCT02750514|365482327|FG000|Track 2|Study drug toxicity|1|||
105950138|NCT02750514|365482328|FG001|Track 2|Study drug toxicity|2|||
105950139|NCT02750514|365482329|FG002|Track 2|Study drug toxicity|0|||
105950140|NCT02750514|365482330|FG003|Track 2|Study drug toxicity|2|||
105756222|NCT02215616|364760141|FG002|Overall Study|Withdrawal by Subject|2|||
105756223|NCT02215616|364760142|FG003|Overall Study|Withdrawal by Subject|5|||
105756224|NCT02215616|364760139|FG000|Overall Study|Non-compliance|0|||
105756225|NCT02215616|364760140|FG001|Overall Study|Non-compliance|2|||
105756226|NCT02215616|364760141|FG002|Overall Study|Non-compliance|1|||
105756227|NCT02215616|364760142|FG003|Overall Study|Non-compliance|0|||
105756228|NCT02215616|364760139|FG000|Overall Study|Protocol Violation|0|||
105756229|NCT02215616|364760140|FG001|Overall Study|Protocol Violation|2|||
105756230|NCT02215616|364760141|FG002|Overall Study|Protocol Violation|0|||
105756231|NCT02215616|364760142|FG003|Overall Study|Protocol Violation|0|||
105756232|NCT02215616|364760139|FG000|Overall Study|Lost to Follow-up|1|||
105756233|NCT02215616|364760140|FG001|Overall Study|Lost to Follow-up|1|||
105756234|NCT02215616|364760141|FG002|Overall Study|Lost to Follow-up|0|||
105756235|NCT02215616|364760142|FG003|Overall Study|Lost to Follow-up|1|||
105756236|NCT02215616|364760139|FG000|Overall Study|Other than specified|1|||
105756237|NCT02215616|364760140|FG001|Overall Study|Other than specified|0|||
105756238|NCT02215616|364760141|FG002|Overall Study|Other than specified|1|||
105756239|NCT02215616|364760142|FG003|Overall Study|Other than specified|1|||
105756240|NCT04624672|364760148|FG000|Overall Study|Early Study Closure|2|||
105756241|NCT04624672|364760149|FG001|Overall Study|Early Study Closure|1|||
105756242|NCT03472040|364760150|FG000|Overall Study|Physician Decision|0|||
105756243|NCT03472040|364760151|FG001|Overall Study|Physician Decision|3|||
105756244|NCT03472040|364760150|FG000|Overall Study|Withdrawal by Subject|10|||
105756245|NCT03472040|364760151|FG001|Overall Study|Withdrawal by Subject|23|||
105756246|NCT03472040|364760150|FG000|Overall Study|Perceived Lack of Efficacy|29|||
105756247|NCT03472040|364760151|FG001|Overall Study|Perceived Lack of Efficacy|30|||
105756248|NCT03472040|364760150|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
105756249|NCT03472040|364760151|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
105756250|NCT03472040|364760150|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
105756251|NCT03472040|364760151|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
105756252|NCT03472040|364760150|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
105756253|NCT03472040|364760151|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
105756254|NCT03472040|364760150|FG000|Overall Study|Subject Non-compliance|2|||
105756255|NCT03472040|364760151|FG001|Overall Study|Subject Non-compliance|5|||
105756256|NCT03472040|364760150|FG000|Overall Study|Discontinuation due to Rash|0|||
105756257|NCT03472040|364760151|FG001|Overall Study|Discontinuation due to Rash|1|||
105756258|NCT03472040|364760150|FG000|Overall Study|Subsequent Ineligibility|0|||
105756259|NCT03472040|364760151|FG001|Overall Study|Subsequent Ineligibility|2|||
105950141|NCT02750514|365482331|FG004|Track 2|Study drug toxicity|0|||
105950142|NCT02750514|365482327|FG000|Track 2|Participant withdrew consent|0|||
105756260|NCT03472040|364760150|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
105803007|NCT00003102|364934636|FG000|Overall Study|Death|0|||
105803008|NCT00003102|364934637|FG001|Overall Study|Death|0|||
105950143|NCT02750514|365482328|FG001|Track 2|Participant withdrew consent|1|||
105756261|NCT03472040|364760151|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
105756262|NCT02685995|364760158|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
105803009|NCT00003102|364934638|FG002|Overall Study|Death|1|||
105803010|NCT00583596|364934639|FG000|Overall Study|Lost to Follow-up|110|||
105950144|NCT02750514|365482329|FG002|Track 2|Participant withdrew consent|0|||
105803011|NCT00583596|364934639|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
105803012|NCT00583596|364934639|FG000|Overall Study|Death|2|||
105803013|NCT00583596|364934639|FG000|Overall Study|Withdrawal by Subject|6|||
105803014|NCT00583596|364934639|FG000|Overall Study|Lost to Follow-up|94|||
105803015|NCT00583596|364934639|FG000|Overall Study|Data not complete|1|||
105803016|NCT00583596|364934639|FG000|Overall Study|Not consented|15|||
105803017|NCT00583596|364934639|FG000|Overall Study|Outside f-up window|26|||
105803018|NCT03558997|364934644|FG000|Overall Study|Adverse Event|0|||
105803019|NCT03558997|364934645|FG001|Overall Study|Adverse Event|2|||
105803020|NCT03558997|364934646|FG002|Overall Study|Adverse Event|5|||
105803021|NCT03558997|364934647|FG003|Overall Study|Adverse Event|1|||
105803022|NCT03558997|364934644|FG000|Overall Study|Physician Decision|0|||
105803023|NCT03558997|364934645|FG001|Overall Study|Physician Decision|0|||
105803024|NCT03558997|364934646|FG002|Overall Study|Physician Decision|1|||
105803025|NCT03558997|364934647|FG003|Overall Study|Physician Decision|0|||
105803026|NCT03558997|364934644|FG000|Overall Study|Withdrawal by Subject|1|||
105803027|NCT03558997|364934645|FG001|Overall Study|Withdrawal by Subject|0|||
105803028|NCT03558997|364934646|FG002|Overall Study|Withdrawal by Subject|1|||
105803029|NCT03558997|364934647|FG003|Overall Study|Withdrawal by Subject|1|||
105803030|NCT03558997|364934644|FG000|Overall Study|Lost to Follow-up|0|||
105803031|NCT03558997|364934645|FG001|Overall Study|Lost to Follow-up|0|||
105803032|NCT03558997|364934646|FG002|Overall Study|Lost to Follow-up|1|||
105803033|NCT03558997|364934647|FG003|Overall Study|Lost to Follow-up|0|||
105803034|NCT00616928|364934648|FG000|Overall Study|Adverse Event|6|||
105803035|NCT00616928|364934649|FG001|Overall Study|Adverse Event|3|||
105803036|NCT00616928|364934650|FG002|Overall Study|Adverse Event|2|||
105803037|NCT00616928|364934651|FG003|Overall Study|Adverse Event|2|||
105803038|NCT00616928|364934648|FG000|Overall Study|Other|51|||
105803039|NCT00616928|364934649|FG001|Overall Study|Other|8|||
105803040|NCT00616928|364934650|FG002|Overall Study|Other|15|||
105803041|NCT00616928|364934651|FG003|Overall Study|Other|5|||
105803042|NCT00616928|364934648|FG000|Overall Study|Lost to Follow-up|5|||
105803043|NCT00616928|364934649|FG001|Overall Study|Lost to Follow-up|7|||
105803044|NCT00616928|364934650|FG002|Overall Study|Lost to Follow-up|0|||
105803045|NCT00616928|364934651|FG003|Overall Study|Lost to Follow-up|0|||
105803046|NCT04049552|364934654|FG000|Overall Study|Lost to Follow-up|1|||
105803047|NCT04409002|364934655|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
105803048|NCT03740100|364934658|FG000|Overall Study|Adverse Event|1|||
105803049|NCT03740100|364934658|FG000|Overall Study|Death|1|||
105803050|NCT03083132|364934660|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
105803051|NCT03083132|364934661|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
105803052|NCT03083132|364934660|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
105803053|NCT03083132|364934661|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
105803054|NCT03083132|364934660|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
105803055|NCT03083132|364934661|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
105803056|NCT01588106|364934662|FG000|Overall Study|Withdrawal by Subject|5|||
105803057|NCT01588106|364934663|FG001|Overall Study|Withdrawal by Subject|4|||
105803058|NCT00066807|364934671|FG000|Overall Study|Study was terminated early|14|||
105803059|NCT00066807|364934672|FG001|Overall Study|Study was terminated early|15|||
105803060|NCT05028751|364934673|FG000|Overall Study|Study Terminated by Sponsor|3|||
105803061|NCT05028751|364934674|FG001|Overall Study|Study Terminated by Sponsor|0|||
105803062|NCT05028751|364934675|FG002|Overall Study|Study Terminated by Sponsor|0|||
105803063|NCT05028751|364934676|FG003|Overall Study|Study Terminated by Sponsor|0|||
105803064|NCT05028751|364934673|FG000|Overall Study|Death|9|||
105803065|NCT05028751|364934674|FG001|Overall Study|Death|3|||
105803066|NCT05028751|364934675|FG002|Overall Study|Death|2|||
106016572|NCT04033445|365724460|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
106016573|NCT04033445|365724447|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016574|NCT04033445|365724448|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016575|NCT04033445|365724449|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
105803067|NCT05028751|364934676|FG003|Overall Study|Death|4|||
105803068|NCT05028751|364934673|FG000|Overall Study|Withdrawal by Subject|0|||
105803069|NCT05028751|364934674|FG001|Overall Study|Withdrawal by Subject|0|||
105803070|NCT05028751|364934675|FG002|Overall Study|Withdrawal by Subject|1|||
105803071|NCT05028751|364934676|FG003|Overall Study|Withdrawal by Subject|0|||
105803072|NCT05028751|364934673|FG000|Overall Study|Miscellaneous|2|||
105803073|NCT05028751|364934674|FG001|Overall Study|Miscellaneous|0|||
105803074|NCT05028751|364934675|FG002|Overall Study|Miscellaneous|0|||
105803075|NCT05028751|364934676|FG003|Overall Study|Miscellaneous|0|||
105803076|NCT00972153|364934680|FG000|Overall Study|Equipment malfunction during case|0|||
105803077|NCT00972153|364934681|FG001|Overall Study|Equipment malfunction during case|1|||
105803078|NCT00972153|364934682|FG002|Overall Study|Equipment malfunction during case|0|||
105803079|NCT02919475|364936487|FG000|Overall Study|Adverse Event|3|||
105803080|NCT02919475|364936488|FG001|Overall Study|Adverse Event|3|||
105803081|NCT02919475|364936489|FG002|Overall Study|Adverse Event|3|||
105803082|NCT02919475|364936490|FG003|Overall Study|Adverse Event|9|||
105803083|NCT02919475|364936491|FG004|Overall Study|Adverse Event|2|||
105803084|NCT02919475|364936487|FG000|Overall Study|Death|0|||
105803085|NCT02919475|364936488|FG001|Overall Study|Death|1|||
105803086|NCT02919475|364936489|FG002|Overall Study|Death|0|||
105803087|NCT02919475|364936490|FG003|Overall Study|Death|0|||
105803088|NCT02919475|364936491|FG004|Overall Study|Death|0|||
105803089|NCT02919475|364936487|FG000|Overall Study|Lost to Follow-up|0|||
105803090|NCT02919475|364936488|FG001|Overall Study|Lost to Follow-up|0|||
105803091|NCT02919475|364936489|FG002|Overall Study|Lost to Follow-up|0|||
105803092|NCT02919475|364936490|FG003|Overall Study|Lost to Follow-up|1|||
105803093|NCT02919475|364936491|FG004|Overall Study|Lost to Follow-up|0|||
105803094|NCT02919475|364936487|FG000|Overall Study|Withdrawal by Subject|2|||
105803095|NCT02919475|364936488|FG001|Overall Study|Withdrawal by Subject|3|||
105803096|NCT02919475|364936489|FG002|Overall Study|Withdrawal by Subject|1|||
105803097|NCT02919475|364936490|FG003|Overall Study|Withdrawal by Subject|2|||
105803098|NCT02919475|364936491|FG004|Overall Study|Withdrawal by Subject|2|||
105803099|NCT02919475|364936487|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105803100|NCT02919475|364936488|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105803101|NCT02919475|364936489|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105803102|NCT02919475|364936490|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
105803103|NCT02919475|364936491|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
105803104|NCT00693784|364936493|FG000|Overall Study|Lost to Follow-up|2|||
105803105|NCT00693784|364936493|FG000|Overall Study|Withdrawal by Subject|2|||
105803106|NCT01664052|364936495|FG000|Phase 1|No device placement|6|||
105803107|NCT01664052|364936496|FG001|Phase 1|No device placement|0|||
105803108|NCT01664052|364936495|FG000|Phase 1|No HSG 1 hr post placement|1|||
105803109|NCT01664052|364936496|FG001|Phase 1|No HSG 1 hr post placement|0|||
105803110|NCT01664052|364936495|FG000|Phase 2|No device placement|0|||
105803111|NCT01664052|364936496|FG001|Phase 2|No device placement|4|||
105803112|NCT01042977|364936497|FG000|Overall Study|Adverse Event|4|||
105803113|NCT01042977|364936498|FG001|Overall Study|Adverse Event|12|||
105803114|NCT01042977|364936497|FG000|Overall Study|Death|2|||
105803115|NCT01042977|364936498|FG001|Overall Study|Death|1|||
105803116|NCT01042977|364936497|FG000|Overall Study|Withdrawal by Subject|8|||
105803117|NCT01042977|364936498|FG001|Overall Study|Withdrawal by Subject|16|||
105803118|NCT01042977|364936497|FG000|Overall Study|Lost to Follow-up|0|||
105803119|NCT01042977|364936498|FG001|Overall Study|Lost to Follow-up|2|||
105803120|NCT01042977|364936497|FG000|Overall Study|Poor/non-compliance|3|||
105803121|NCT01042977|364936498|FG001|Overall Study|Poor/non-compliance|4|||
105803122|NCT01042977|364936497|FG000|Overall Study|Subject no longer meets study criteria|15|||
105803123|NCT01042977|364936498|FG001|Overall Study|Subject no longer meets study criteria|13|||
105803124|NCT01042977|364936497|FG000|Overall Study|Incorrect enrollment|6|||
105803125|NCT01042977|364936498|FG001|Overall Study|Incorrect enrollment|4|||
105803126|NCT01042977|364936497|FG000|Overall Study|Safety|0|||
105803127|NCT01042977|364936498|FG001|Overall Study|Safety|2|||
105803128|NCT01042977|364936497|FG000|Overall Study|Administrative reason by sponsor|0|||
105803129|NCT01042977|364936498|FG001|Overall Study|Administrative reason by sponsor|1|||
105803130|NCT01042977|364936497|FG000|Overall Study|Various|3|||
105803131|NCT01042977|364936498|FG001|Overall Study|Various|0|||
105803132|NCT01677910|364936503|FG000|Double-Blind Treatment Period|Adverse Event|6|||
105803133|NCT01677910|364936504|FG001|Double-Blind Treatment Period|Adverse Event|2|||
105803134|NCT01677910|364936505|FG002|Double-Blind Treatment Period|Adverse Event|3|||
105803135|NCT01677910|364936506|FG003|Double-Blind Treatment Period|Adverse Event|0|||
105803136|NCT01677910|364936503|FG000|Double-Blind Treatment Period|Physician Decision|0|||
105803137|NCT01677910|364936504|FG001|Double-Blind Treatment Period|Physician Decision|0|||
105803138|NCT01677910|364936505|FG002|Double-Blind Treatment Period|Physician Decision|1|||
105803139|NCT01677910|364936506|FG003|Double-Blind Treatment Period|Physician Decision|0|||
105803140|NCT01677910|364936503|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
105803141|NCT01677910|364936504|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
105803142|NCT01677910|364936505|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
105803143|NCT01677910|364936506|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
105803144|NCT01677910|364936503|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
105803145|NCT01677910|364936504|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
105803146|NCT01677910|364936505|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
105803147|NCT01677910|364936506|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
105803148|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
105803149|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
105803150|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
105803151|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
105803152|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105803153|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105803154|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105803155|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
105803156|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105950145|NCT02750514|365482330|FG003|Track 2|Participant withdrew consent|0|||
105950146|NCT02750514|365482331|FG004|Track 2|Participant withdrew consent|0|||
105950147|NCT02750514|365482327|FG000|Track 3|Disease progression|0|||
105950148|NCT02750514|365482328|FG001|Track 3|Disease progression|24|||
105756263|NCT02685995|364760159|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
105756264|NCT00868166|364760160|FG000|Overall Study|Death|58|||
105756265|NCT00868166|364760161|FG001|Overall Study|Death|65|||
105756266|NCT00868166|364760160|FG000|Overall Study|Withdrawal by Subject|33|||
105756267|NCT00868166|364760161|FG001|Overall Study|Withdrawal by Subject|25|||
105756268|NCT00868166|364760160|FG000|Overall Study|Protocol Violation|1|||
105756269|NCT00868166|364760161|FG001|Overall Study|Protocol Violation|0|||
105756270|NCT00868166|364760160|FG000|Overall Study|Lost to Follow-up|1|||
105756271|NCT00868166|364760161|FG001|Overall Study|Lost to Follow-up|3|||
105756272|NCT00868166|364760160|FG000|Overall Study|Adverse Event|9|||
105756273|NCT00868166|364760161|FG001|Overall Study|Adverse Event|10|||
105756274|NCT00868166|364760160|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
105756275|NCT00868166|364760161|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
105756276|NCT00868166|364760160|FG000|Overall Study|Non-compliance with IMP|1|||
105756277|NCT00868166|364760161|FG001|Overall Study|Non-compliance with IMP|1|||
105756278|NCT00126581|364760164|FG000|Overall Study|Adverse Event|3|||
105756279|NCT00126581|364760165|FG001|Overall Study|Adverse Event|7|||
105756280|NCT00126581|364760164|FG000|Overall Study|Death|3|||
105756281|NCT00126581|364760165|FG001|Overall Study|Death|2|||
105756282|NCT00126581|364760164|FG000|Overall Study|Withdrawal by Subject|1|||
105756283|NCT00126581|364760165|FG001|Overall Study|Withdrawal by Subject|4|||
105756284|NCT00126581|364760164|FG000|Overall Study|Alternative therapy|3|||
105756285|NCT00126581|364760165|FG001|Overall Study|Alternative therapy|3|||
105756286|NCT00126581|364760164|FG000|Overall Study|Other illness/MD discretion|3|||
105756287|NCT00126581|364760165|FG001|Overall Study|Other illness/MD discretion|4|||
105756288|NCT00793182|364760166|FG000|Overall Study|Adverse Event|0|||
105756289|NCT00793182|364760167|FG001|Overall Study|Adverse Event|1|||
105756290|NCT01188538|364760170|FG000|Overall Study|Lost to Follow-up|0|||
105756291|NCT01188538|364760171|FG001|Overall Study|Lost to Follow-up|1|||
105756292|NCT01797445|364760174|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
105756293|NCT01797445|364760175|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
105756294|NCT01797445|364760174|FG000|Double-Blind Phase|Adverse Event|3|||
105756295|NCT01797445|364760175|FG001|Double-Blind Phase|Adverse Event|0|||
105756296|NCT01797445|364760174|FG000|Double-Blind Phase|Death|5|||
105756297|NCT01797445|364760175|FG001|Double-Blind Phase|Death|4|||
105756298|NCT01797445|364760174|FG000|Double-Blind Phase|Pregnancy|0|||
105756299|NCT01797445|364760175|FG001|Double-Blind Phase|Pregnancy|1|||
105756300|NCT01797445|364760174|FG000|Double-Blind Phase|Lack of Efficacy|1|||
105756301|NCT01797445|364760175|FG001|Double-Blind Phase|Lack of Efficacy|2|||
105756302|NCT01797445|364760174|FG000|Double-Blind Phase|Investigator's Discretion|15|||
105756303|NCT01797445|364760175|FG001|Double-Blind Phase|Investigator's Discretion|17|||
105756304|NCT01797445|364760174|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
105756305|NCT01797445|364760175|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
105756306|NCT01797445|364760174|FG000|Double-Blind Phase|Protocol Violation|0|||
105756307|NCT01797445|364760175|FG001|Double-Blind Phase|Protocol Violation|1|||
105756308|NCT01797445|364760174|FG000|Double-Blind Phase|Withdrew Consent|20|||
105756309|NCT01797445|364760175|FG001|Double-Blind Phase|Withdrew Consent|35|||
105756310|NCT01797445|364760174|FG000|Double-Blind Phase|Lost to Follow-up|34|||
105756311|NCT01797445|364760175|FG001|Double-Blind Phase|Lost to Follow-up|26|||
105756312|NCT01797445|364760174|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
105756313|NCT01797445|364760175|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
105756314|NCT01595438|364760178|FG000|Overall Study|Lost to Follow-up|20|||
105756315|NCT01595438|364760179|FG001|Overall Study|Lost to Follow-up|20|||
105756316|NCT01595438|364760178|FG000|Overall Study|Withdrawal by Subject|12|||
105756317|NCT01595438|364760179|FG001|Overall Study|Withdrawal by Subject|12|||
105756318|NCT01595438|364760178|FG000|Overall Study|Other Eligibility criteria|11|||
105756319|NCT01595438|364760179|FG001|Overall Study|Other Eligibility criteria|9|||
105756320|NCT01280266|364760180|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
105756321|NCT01280266|364760181|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
105756322|NCT01280266|364760180|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
105756323|NCT01280266|364760181|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
105756324|NCT01381718|364760182|FG000|Overall Study|Withdrawal by Subject|2|||
105756325|NCT01381718|364760183|FG001|Overall Study|Withdrawal by Subject|5|||
105950149|NCT02750514|365482329|FG002|Track 3|Disease progression|13|||
105950150|NCT02750514|365482330|FG003|Track 3|Disease progression|14|||
105756326|NCT01381718|364760182|FG000|Overall Study|Lost to Follow-up|3|||
105756327|NCT01381718|364760183|FG001|Overall Study|Lost to Follow-up|5|||
105756328|NCT01381718|364760182|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
105756329|NCT01381718|364760183|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
105756330|NCT00618995|364760188|FG000|Period 1|Adverse Event|0|||
105756331|NCT00618995|364760189|FG001|Period 1|Adverse Event|0|||
105950151|NCT02750514|365482331|FG004|Track 3|Disease progression|0|||
105803157|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105803158|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105803159|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
105803160|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105803161|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105803162|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105803163|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
105803164|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
105803165|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
105803166|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
105803167|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
105803168|NCT01677910|364936503|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
105803169|NCT01677910|364936504|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
105803170|NCT01677910|364936505|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
105803171|NCT01677910|364936506|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
105803172|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
105803173|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803174|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803175|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803176|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803177|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803178|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
105803179|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
105803180|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803181|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803182|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803183|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803184|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803185|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
105803186|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
105803187|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803188|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803189|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803190|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803191|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803192|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
105803193|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
105803194|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803195|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803196|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803197|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803198|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803199|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
105803200|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
105803201|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803202|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803203|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803204|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803205|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803206|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
105803207|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
105803208|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803209|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803210|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803211|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803212|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803213|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
105803214|NCT00606684|364936507|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
105803215|NCT00606684|364936508|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105950152|NCT02750514|365482327|FG000|Track 3|Adverse event unrelated to study drug|0|||
105950153|NCT02750514|365482328|FG001|Track 3|Adverse event unrelated to study drug|1|||
105950154|NCT02750514|365482329|FG002|Track 3|Adverse event unrelated to study drug|1|||
105950155|NCT02750514|365482330|FG003|Track 3|Adverse event unrelated to study drug|1|||
105950156|NCT02750514|365482331|FG004|Track 3|Adverse event unrelated to study drug|0|||
105950157|NCT02750514|365482327|FG000|Track 3|Study drug toxicity|0|||
105950158|NCT02750514|365482328|FG001|Track 3|Study drug toxicity|3|||
105756332|NCT00618995|364760190|FG002|Period 1|Adverse Event|1|||
105756333|NCT00618995|364760191|FG003|Period 1|Adverse Event|0|||
105756334|NCT00618995|364760188|FG000|Period 1|Protocol Violation|0|||
105756335|NCT00618995|364760189|FG001|Period 1|Protocol Violation|1|||
105756336|NCT00618995|364760190|FG002|Period 1|Protocol Violation|1|||
105756337|NCT00618995|364760191|FG003|Period 1|Protocol Violation|0|||
105756338|NCT00618995|364760188|FG000|Period 2|Protocol Violation|0|||
105756339|NCT00618995|364760189|FG001|Period 2|Protocol Violation|0|||
105756340|NCT00618995|364760190|FG002|Period 2|Protocol Violation|1|||
105756341|NCT00618995|364760191|FG003|Period 2|Protocol Violation|0|||
105756342|NCT00618995|364760188|FG000|Period 4|Adverse Event|1|||
105756343|NCT00618995|364760189|FG001|Period 4|Adverse Event|0|||
105756344|NCT00618995|364760190|FG002|Period 4|Adverse Event|0|||
105756345|NCT00618995|364760191|FG003|Period 4|Adverse Event|0|||
105756346|NCT00065442|364760195|FG000|Overall Study|Lost to Follow-up|1|||
105756347|NCT00065442|364760196|FG001|Overall Study|Lost to Follow-up|1|||
105756348|NCT00065442|364760195|FG000|Overall Study|Death|121|||
105756349|NCT00065442|364760196|FG001|Overall Study|Death|210|||
105756350|NCT00065442|364760195|FG000|Overall Study|Withdrawal by Subject|3|||
105756351|NCT00065442|364760196|FG001|Overall Study|Withdrawal by Subject|9|||
105756352|NCT02029638|364760197|FG000|Overall Study|Death|0|||
105756353|NCT02029638|364760198|FG001|Overall Study|Death|0|||
105756354|NCT02029638|364760199|FG002|Overall Study|Death|1|||
105756355|NCT02029638|364760197|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
105756356|NCT02029638|364760198|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
105756357|NCT02029638|364760199|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
105756358|NCT01153841|364760202|FG000|Overall Study|Adverse Event|1|||
105756359|NCT01153841|364760203|FG001|Overall Study|Adverse Event|0|||
105756360|NCT01153841|364760202|FG000|Overall Study|Withdrawal by Subject|1|||
105756361|NCT01153841|364760203|FG001|Overall Study|Withdrawal by Subject|0|||
105756362|NCT01153841|364760202|FG000|Overall Study|Protocol Violation|2|||
105756363|NCT01153841|364760203|FG001|Overall Study|Protocol Violation|0|||
105756364|NCT01153841|364760202|FG000|Overall Study|Lost to Follow-up|2|||
105756365|NCT01153841|364760203|FG001|Overall Study|Lost to Follow-up|0|||
105756366|NCT03428997|364760216|FG000|Overall Study|Sponsor decision.|1|||
105756367|NCT03428997|364760216|FG000|Overall Study|Withdrawal by Subject|3|||
105756368|NCT03428997|364760216|FG000|Overall Study|Lost to Follow-up|4|||
105756369|NCT00965146|364760218|FG000|Overall Study|Death|7|||
105756370|NCT00965146|364760218|FG000|Overall Study|Lost to Follow-up|22|||
105756371|NCT00965146|364760218|FG000|Overall Study|Withdrawal by Subject|17|||
105756372|NCT00965146|364760218|FG000|Overall Study|Unable to return|1|||
105756373|NCT00965146|364760218|FG000|Overall Study|Unwilling to return|11|||
105756374|NCT00965146|364760218|FG000|Overall Study|Intercurrent illness|1|||
105756375|NCT00965146|364760218|FG000|Overall Study|Revision / Removal of Study Implant|6|||
105756376|NCT00965146|364760218|FG000|Overall Study|Overall Study Termination|145|||
105756377|NCT00425113|364760219|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
105756378|NCT00425113|364760220|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
105756379|NCT00425113|364760219|FG000|Overall Study|diagnosis of abdominal TB|0|||
105756380|NCT00425113|364760220|FG001|Overall Study|diagnosis of abdominal TB|1|||
105756381|NCT00425113|364760219|FG000|Overall Study|missing study drug more than 14 days|0|||
105756382|NCT00425113|364760220|FG001|Overall Study|missing study drug more than 14 days|1|||
105756383|NCT00425113|364760219|FG000|Overall Study|Withdrawal by Subject|1|||
105756384|NCT00425113|364760220|FG001|Overall Study|Withdrawal by Subject|0|||
105756385|NCT00936117|364760221|FG000|Overall Study|Adverse Event|7|||
105756386|NCT00936117|364760221|FG000|Overall Study|Unable to continue oral medication|3|||
105756387|NCT01309841|364760224|FG000|Overall Study|Other|0|||
105756388|NCT01309841|364760225|FG001|Overall Study|Other|1|||
105756389|NCT01309841|364760226|FG002|Overall Study|Other|1|||
105756390|NCT01309841|364760224|FG000|Overall Study|Lost to Follow-up|7|||
105756391|NCT01309841|364760225|FG001|Overall Study|Lost to Follow-up|6|||
105756392|NCT01309841|364760226|FG002|Overall Study|Lost to Follow-up|4|||
105756393|NCT01309841|364760224|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
105756394|NCT01309841|364760225|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
105756395|NCT01309841|364760226|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
105756396|NCT01309841|364760224|FG000|Overall Study|Lack of Efficacy|0|||
105756397|NCT01309841|364760225|FG001|Overall Study|Lack of Efficacy|0|||
105756398|NCT01309841|364760226|FG002|Overall Study|Lack of Efficacy|2|||
105756399|NCT01309841|364760224|FG000|Overall Study|Adverse Event|9|||
105756400|NCT01309841|364760225|FG001|Overall Study|Adverse Event|22|||
105756401|NCT01309841|364760226|FG002|Overall Study|Adverse Event|11|||
105756402|NCT01309841|364760224|FG000|Overall Study|Death|1|||
105756403|NCT01309841|364760225|FG001|Overall Study|Death|0|||
105756404|NCT01309841|364760226|FG002|Overall Study|Death|0|||
105756405|NCT01309841|364760224|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105756406|NCT01309841|364760225|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105756407|NCT01309841|364760226|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
105756408|NCT01309841|364760224|FG000|Overall Study|Withdrawal by Subject|17|||
105756409|NCT01309841|364760225|FG001|Overall Study|Withdrawal by Subject|6|||
105950159|NCT02750514|365482329|FG002|Track 3|Study drug toxicity|0|||
105950160|NCT02750514|365482330|FG003|Track 3|Study drug toxicity|1|||
105950161|NCT02750514|365482331|FG004|Track 3|Study drug toxicity|0|||
105950162|NCT02750514|365482327|FG000|Track 3|Participant request to discontinue|0|||
105950163|NCT02750514|365482328|FG001|Track 3|Participant request to discontinue|2|||
105950164|NCT02750514|365482329|FG002|Track 3|Participant request to discontinue|0|||
105950165|NCT02750514|365482330|FG003|Track 3|Participant request to discontinue|0|||
105950166|NCT02750514|365482331|FG004|Track 3|Participant request to discontinue|0|||
105950167|NCT02750514|365482327|FG000|Track 3|Participant withdrew consent|0|||
105950168|NCT02750514|365482328|FG001|Track 3|Participant withdrew consent|3|||
105950169|NCT02750514|365482329|FG002|Track 3|Participant withdrew consent|1|||
105950170|NCT02750514|365482330|FG003|Track 3|Participant withdrew consent|0|||
105950171|NCT02750514|365482331|FG004|Track 3|Participant withdrew consent|0|||
105950172|NCT02750514|365482327|FG000|Track 3|Other reasons|0|||
105950173|NCT02750514|365482328|FG001|Track 3|Other reasons|3|||
105950174|NCT02750514|365482329|FG002|Track 3|Other reasons|0|||
105950175|NCT02750514|365482330|FG003|Track 3|Other reasons|0|||
105950176|NCT02750514|365482331|FG004|Track 3|Other reasons|0|||
105950177|NCT02750514|365482327|FG000|Track 4|Study drug toxicity|0|||
105950178|NCT02750514|365482328|FG001|Track 4|Study drug toxicity|6|||
105756410|NCT01309841|364760226|FG002|Overall Study|Withdrawal by Subject|13|||
105756411|NCT01309841|364760224|FG000|Overall Study|Did Not Receive Treatment|2|||
105756412|NCT01309841|364760225|FG001|Overall Study|Did Not Receive Treatment|0|||
105756413|NCT01309841|364760226|FG002|Overall Study|Did Not Receive Treatment|1|||
105756414|NCT01309841|364760224|FG000|Overall Study|Severe non-compliance with protocol|0|||
105756415|NCT01309841|364760225|FG001|Overall Study|Severe non-compliance with protocol|5|||
105756416|NCT01309841|364760226|FG002|Overall Study|Severe non-compliance with protocol|2|||
105756417|NCT00050960|364760227|FG000|Overall Study|Progressive Disease|137|||
105756418|NCT00050960|364760228|FG001|Overall Study|Progressive Disease|93|||
105756419|NCT00050960|364760227|FG000|Overall Study|Stable Disease|19|||
105756420|NCT00050960|364760228|FG001|Overall Study|Stable Disease|48|||
105756421|NCT00050960|364760227|FG000|Overall Study|Partial Response|14|||
105756422|NCT00050960|364760228|FG001|Overall Study|Partial Response|19|||
105756423|NCT00050960|364760227|FG000|Overall Study|Complete Response|0|||
105756424|NCT00050960|364760228|FG001|Overall Study|Complete Response|2|||
105756425|NCT00050960|364760227|FG000|Overall Study|Adverse Event|62|||
105756426|NCT00050960|364760228|FG001|Overall Study|Adverse Event|61|||
105756427|NCT00050960|364760227|FG000|Overall Study|Lost to Follow-up|0|||
105756428|NCT00050960|364760228|FG001|Overall Study|Lost to Follow-up|1|||
105756429|NCT00050960|364760227|FG000|Overall Study|Withdrawal by Subject|23|||
105756430|NCT00050960|364760228|FG001|Overall Study|Withdrawal by Subject|18|||
105756431|NCT00050960|364760227|FG000|Overall Study|Administrative|31|||
105756432|NCT00050960|364760228|FG001|Overall Study|Administrative|46|||
105756433|NCT00050960|364760227|FG000|Overall Study|Non-compliance|3|||
105756434|NCT00050960|364760228|FG001|Overall Study|Non-compliance|1|||
105756435|NCT00050960|364760227|FG000|Overall Study|Death|13|||
105756436|NCT00050960|364760228|FG001|Overall Study|Death|15|||
105756437|NCT00305604|364760229|FG000|Overall Study|Adverse Event|6|||
105756438|NCT00305604|364760230|FG001|Overall Study|Adverse Event|3|||
105756439|NCT00305604|364760229|FG000|Overall Study|Lack of Efficacy|11|||
105756440|NCT00305604|364760230|FG001|Overall Study|Lack of Efficacy|18|||
105756441|NCT00305604|364760229|FG000|Overall Study|Lost to Follow-up|0|||
105756442|NCT00305604|364760230|FG001|Overall Study|Lost to Follow-up|4|||
105756443|NCT00305604|364760229|FG000|Overall Study|Protocol Violation|2|||
105756444|NCT00305604|364760230|FG001|Overall Study|Protocol Violation|1|||
105756445|NCT00305604|364760229|FG000|Overall Study|Withdrawal by Subject|12|||
105756446|NCT00305604|364760230|FG001|Overall Study|Withdrawal by Subject|21|||
105756447|NCT00305604|364760229|FG000|Overall Study|Patient moved|1|||
105756448|NCT00305604|364760230|FG001|Overall Study|Patient moved|0|||
105756449|NCT00764946|364760231|FG000|Overall Study|Lack of Efficacy|1|||
105756450|NCT00764946|364760232|FG001|Overall Study|Lack of Efficacy|0|||
105756451|NCT00764946|364760233|FG002|Overall Study|Lack of Efficacy|0|||
105756452|NCT00764946|364760231|FG000|Overall Study|Lost to Follow-up|3|||
105756453|NCT00764946|364760232|FG001|Overall Study|Lost to Follow-up|4|||
105756454|NCT00764946|364760233|FG002|Overall Study|Lost to Follow-up|0|||
105756455|NCT00764946|364760231|FG000|Overall Study|Physician Decision|2|||
105803216|NCT00606684|364936509|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105950179|NCT02750514|365482329|FG002|Track 4|Study drug toxicity|0|||
105950180|NCT02750514|365482330|FG003|Track 4|Study drug toxicity|5|||
105756456|NCT00764946|364760232|FG001|Overall Study|Physician Decision|4|||
105756457|NCT00764946|364760233|FG002|Overall Study|Physician Decision|0|||
105950181|NCT02750514|365482331|FG004|Track 4|Study drug toxicity|0|||
105803217|NCT00606684|364936510|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105950182|NCT02750514|365482327|FG000|Track 4|Participant request to discontinue|0|||
105756458|NCT00764946|364760231|FG000|Overall Study|Adverse Event|3|||
105756459|NCT00764946|364760232|FG001|Overall Study|Adverse Event|2|||
105756460|NCT00764946|364760233|FG002|Overall Study|Adverse Event|1|||
105756461|NCT00764946|364760231|FG000|Overall Study|Withdrawal by Subject|3|||
105803218|NCT00606684|364936511|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105803219|NCT00606684|364936512|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105803220|NCT00606684|364936513|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
105803221|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105803222|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Adverse Event|3|||
105803223|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Adverse Event|2|||
105803224|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Adverse Event|4|||
105803225|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Adverse Event|2|||
105803226|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Adverse Event|0|||
105803227|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Adverse Event|1|||
105803228|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803229|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
105803230|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803231|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803232|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
105803233|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803234|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
105803235|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
105803236|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
105803237|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
105803238|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
105803239|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
105803240|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
105803241|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
105803242|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
105803243|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
105803244|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
105803245|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
105803246|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
105803247|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
105803248|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
105803249|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Physician Decision|0|||
105803250|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Physician Decision|5|||
105803251|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Physician Decision|1|||
105803252|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Physician Decision|0|||
105803253|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Physician Decision|3|||
105803254|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Physician Decision|1|||
105803255|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Physician Decision|2|||
105803256|NCT00606684|364936507|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105803257|NCT00606684|364936508|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105803258|NCT00606684|364936509|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105803259|NCT00606684|364936510|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105803260|NCT00606684|364936511|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105803261|NCT00606684|364936512|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
105803262|NCT00606684|364936513|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105803263|NCT02763579|364936514|FG000|Global Period|Death|167|||
105803264|NCT02763579|364936515|FG001|Global Period|Death|151|||
105803265|NCT02763579|364936516|FG002|Global Period|Death|0|||
105803266|NCT02763579|364936517|FG003|Global Period|Death|0|||
105803267|NCT02763579|364936514|FG000|Global Period|Lost to Follow-up|2|||
105803268|NCT02763579|364936515|FG001|Global Period|Lost to Follow-up|4|||
105803269|NCT02763579|364936516|FG002|Global Period|Lost to Follow-up|0|||
105803270|NCT02763579|364936517|FG003|Global Period|Lost to Follow-up|0|||
105803271|NCT02763579|364936514|FG000|Global Period|Physician Decision|0|||
105803272|NCT02763579|364936515|FG001|Global Period|Physician Decision|2|||
105803273|NCT02763579|364936516|FG002|Global Period|Physician Decision|0|||
105803274|NCT02763579|364936517|FG003|Global Period|Physician Decision|0|||
105803275|NCT02763579|364936514|FG000|Global Period|Study Terminated By Sponsor|21|||
105803276|NCT02763579|364936515|FG001|Global Period|Study Terminated By Sponsor|26|||
105803277|NCT02763579|364936516|FG002|Global Period|Study Terminated By Sponsor|0|||
105803278|NCT02763579|364936517|FG003|Global Period|Study Terminated By Sponsor|0|||
105803279|NCT02763579|364936514|FG000|Global Period|Withdrawal by Subject|12|||
105803280|NCT02763579|364936515|FG001|Global Period|Withdrawal by Subject|18|||
105803281|NCT02763579|364936516|FG002|Global Period|Withdrawal by Subject|0|||
105803282|NCT02763579|364936517|FG003|Global Period|Withdrawal by Subject|0|||
105803283|NCT02763579|364936514|FG000|China Period|Death|0|||
105803284|NCT02763579|364936515|FG001|China Period|Death|0|||
105950183|NCT02750514|365482328|FG001|Track 4|Participant request to discontinue|1|||
105950184|NCT02750514|365482329|FG002|Track 4|Participant request to discontinue|0|||
105950185|NCT02750514|365482330|FG003|Track 4|Participant request to discontinue|1|||
105803285|NCT02763579|364936516|FG002|China Period|Death|46|||
105803286|NCT02763579|364936517|FG003|China Period|Death|48|||
105803287|NCT02763579|364936514|FG000|China Period|Lost to Follow-up|0|||
105803288|NCT02763579|364936515|FG001|China Period|Lost to Follow-up|0|||
105803289|NCT02763579|364936516|FG002|China Period|Lost to Follow-up|1|||
105803290|NCT02763579|364936517|FG003|China Period|Lost to Follow-up|1|||
105803291|NCT02763579|364936514|FG000|China Period|Physician Decision|0|||
105803292|NCT02763579|364936515|FG001|China Period|Physician Decision|0|||
105803293|NCT02763579|364936516|FG002|China Period|Physician Decision|0|||
105803294|NCT02763579|364936517|FG003|China Period|Physician Decision|1|||
105803295|NCT02763579|364936514|FG000|China Period|Study Terminated By Sponsor|0|||
105803296|NCT02763579|364936515|FG001|China Period|Study Terminated By Sponsor|0|||
105803297|NCT02763579|364936516|FG002|China Period|Study Terminated By Sponsor|3|||
105803298|NCT02763579|364936517|FG003|China Period|Study Terminated By Sponsor|4|||
105803299|NCT02763579|364936514|FG000|China Period|Withdrawal by Subject|0|||
105803300|NCT02763579|364936515|FG001|China Period|Withdrawal by Subject|0|||
105803301|NCT02763579|364936516|FG002|China Period|Withdrawal by Subject|3|||
105803302|NCT02763579|364936517|FG003|China Period|Withdrawal by Subject|3|||
105803303|NCT01034137|364936527|FG000|Overall Study|Adverse Event|9|||
105803304|NCT01034137|364936528|FG001|Overall Study|Adverse Event|10|||
105803305|NCT01034137|364936529|FG002|Overall Study|Adverse Event|8|||
105803306|NCT01034137|364936527|FG000|Overall Study|Withdrawal by Subject|4|||
105803307|NCT01034137|364936528|FG001|Overall Study|Withdrawal by Subject|3|||
105803308|NCT01034137|364936529|FG002|Overall Study|Withdrawal by Subject|3|||
105803309|NCT01034137|364936527|FG000|Overall Study|Lack of Efficacy|9|||
105803310|NCT01034137|364936528|FG001|Overall Study|Lack of Efficacy|4|||
105803311|NCT01034137|364936529|FG002|Overall Study|Lack of Efficacy|13|||
105803312|NCT01034137|364936527|FG000|Overall Study|Protocol Violation|2|||
105803313|NCT01034137|364936528|FG001|Overall Study|Protocol Violation|2|||
105803314|NCT01034137|364936529|FG002|Overall Study|Protocol Violation|1|||
105803315|NCT01034137|364936527|FG000|Overall Study|Refused treatment or did not cooperate|2|||
105803316|NCT01034137|364936528|FG001|Overall Study|Refused treatment or did not cooperate|0|||
105803317|NCT01034137|364936529|FG002|Overall Study|Refused treatment or did not cooperate|1|||
105950186|NCT02750514|365482331|FG004|Track 4|Participant request to discontinue|0|||
105950187|NCT02750514|365482327|FG000|Track 4|Participant withdrew consent|0|||
105950188|NCT02750514|365482328|FG001|Track 4|Participant withdrew consent|1|||
105950189|NCT02750514|365482329|FG002|Track 4|Participant withdrew consent|0|||
105950190|NCT02750514|365482330|FG003|Track 4|Participant withdrew consent|0|||
105950191|NCT02750514|365482331|FG004|Track 4|Participant withdrew consent|0|||
105950192|NCT02750514|365482327|FG000|Track 4|Other reasons|0|||
105950193|NCT02750514|365482328|FG001|Track 4|Other reasons|5|||
105950194|NCT02750514|365482329|FG002|Track 4|Other reasons|0|||
105950195|NCT02750514|365482330|FG003|Track 4|Other reasons|3|||
105950196|NCT02750514|365482331|FG004|Track 4|Other reasons|0|||
105950197|NCT02750514|365482327|FG000|Track 4|Disease progression|0|||
105950198|NCT02750514|365482328|FG001|Track 4|Disease progression|33|||
105950199|NCT02750514|365482329|FG002|Track 4|Disease progression|0|||
105950200|NCT02750514|365482330|FG003|Track 4|Disease progression|32|||
105803318|NCT01034137|364936527|FG000|Overall Study|Administrative or other|2|||
105803319|NCT01034137|364936528|FG001|Overall Study|Administrative or other|3|||
105803320|NCT01034137|364936529|FG002|Overall Study|Administrative or other|4|||
105803321|NCT01764854|364936535|FG000|Overall Study|Adverse Event|0|||
105803322|NCT01764854|364936536|FG001|Overall Study|Adverse Event|0|||
105950201|NCT02750514|365482331|FG004|Track 4|Disease progression|0|||
105950202|NCT02750514|365482327|FG000|Track 4|Adverse event unrelated to study drug|0|||
105950203|NCT02750514|365482328|FG001|Track 4|Adverse event unrelated to study drug|5|||
105950204|NCT02750514|365482329|FG002|Track 4|Adverse event unrelated to study drug|0|||
105950205|NCT02750514|365482330|FG003|Track 4|Adverse event unrelated to study drug|0|||
105803323|NCT01764854|364936537|FG002|Overall Study|Adverse Event|2|||
105803324|NCT01764854|364936538|FG003|Overall Study|Adverse Event|0|||
105803325|NCT01764854|364936535|FG000|Overall Study|Withdrawal by Subject|0|||
105803326|NCT01764854|364936536|FG001|Overall Study|Withdrawal by Subject|0|||
105803327|NCT01764854|364936537|FG002|Overall Study|Withdrawal by Subject|1|||
105803328|NCT01764854|364936538|FG003|Overall Study|Withdrawal by Subject|0|||
105803329|NCT01764854|364936535|FG000|Overall Study|relocation|0|||
105803330|NCT01764854|364936536|FG001|Overall Study|relocation|0|||
105803331|NCT01764854|364936537|FG002|Overall Study|relocation|2|||
105803332|NCT01764854|364936538|FG003|Overall Study|relocation|0|||
105803333|NCT01764854|364936535|FG000|Overall Study|Protocol Violation|0|||
105803334|NCT01764854|364936536|FG001|Overall Study|Protocol Violation|0|||
105803335|NCT01764854|364936537|FG002|Overall Study|Protocol Violation|1|||
105950206|NCT02750514|365482331|FG004|Track 4|Adverse event unrelated to study drug|0|||
105950207|NCT02750514|365482327|FG000|Track 4|Death|0|||
105950208|NCT02750514|365482328|FG001|Track 4|Death|0|||
105803336|NCT01764854|364936538|FG003|Overall Study|Protocol Violation|2|||
105803337|NCT01703741|364936540|FG000|Overall Study|Withdrawal by Subject|6|||
105803338|NCT01703741|364936540|FG000|Overall Study|Adverse Event|2|||
105950209|NCT02750514|365482329|FG002|Track 4|Death|0|||
105950210|NCT02750514|365482330|FG003|Track 4|Death|1|||
105756462|NCT00764946|364760232|FG001|Overall Study|Withdrawal by Subject|6|||
105756463|NCT00764946|364760233|FG002|Overall Study|Withdrawal by Subject|2|||
105756464|NCT00764946|364760231|FG000|Overall Study|Never Treated|1|||
105756465|NCT00764946|364760232|FG001|Overall Study|Never Treated|1|||
105756466|NCT00764946|364760233|FG002|Overall Study|Never Treated|1|||
105756467|NCT04685499|364760235|FG000|Overall Study|Study Terminated Early|1|||
105756468|NCT00006604|364760236|FG000|Overall Study|Met study objective - no further FU|1|||
105756469|NCT00006604|364760237|FG001|Overall Study|Met study objective - no further FU|0|||
105756470|NCT00006604|364760238|FG002|Overall Study|Met study objective - no further FU|0|||
105756471|NCT00006604|364760239|FG003|Overall Study|Met study objective - no further FU|0|||
105756472|NCT00006604|364760240|FG004|Overall Study|Met study objective - no further FU|0|||
105756473|NCT00006604|364760241|FG005|Overall Study|Met study objective - no further FU|0|||
105756474|NCT00006604|364760242|FG006|Overall Study|Met study objective - no further FU|0|||
105756475|NCT00006604|364760243|FG007|Overall Study|Met study objective - no further FU|0|||
105756476|NCT00006604|364760244|FG008|Overall Study|Met study objective - no further FU|0|||
105756477|NCT00006604|364760245|FG009|Overall Study|Met study objective - no further FU|0|||
105756478|NCT00006604|364760246|FG010|Overall Study|Met study objective - no further FU|0|||
105756479|NCT00006604|364760247|FG011|Overall Study|Met study objective - no further FU|0|||
105756480|NCT00006604|364760248|FG012|Overall Study|Met study objective - no further FU|0|||
105756481|NCT00006604|364760249|FG013|Overall Study|Met study objective - no further FU|0|||
105756482|NCT00006604|364760250|FG014|Overall Study|Met study objective - no further FU|1|||
105756483|NCT00006604|364760251|FG015|Overall Study|Met study objective - no further FU|1|||
105756484|NCT00006604|364760252|FG016|Overall Study|Met study objective - no further FU|0|||
105756485|NCT00006604|364760236|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
105756486|NCT00006604|364760237|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
105756487|NCT00006604|364760238|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
105756488|NCT00006604|364760239|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
105756489|NCT00006604|364760240|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
105756490|NCT00006604|364760241|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
105756491|NCT00006604|364760242|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
105756492|NCT00006604|364760243|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
105756493|NCT00006604|364760244|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
105756494|NCT00006604|364760245|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
105756495|NCT00006604|364760246|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
105756496|NCT00006604|364760247|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
105756497|NCT00006604|364760248|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
105756498|NCT00006604|364760249|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
105756499|NCT00006604|364760250|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
105756500|NCT00006604|364760251|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
105756501|NCT00006604|364760252|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
105756502|NCT00006604|364760236|FG000|Overall Study|Death|0|||
105756503|NCT00006604|364760237|FG001|Overall Study|Death|0|||
105756504|NCT00006604|364760238|FG002|Overall Study|Death|0|||
105756505|NCT00006604|364760239|FG003|Overall Study|Death|0|||
105756506|NCT00006604|364760240|FG004|Overall Study|Death|0|||
105756507|NCT00006604|364760241|FG005|Overall Study|Death|0|||
105756508|NCT00006604|364760242|FG006|Overall Study|Death|0|||
105756509|NCT00006604|364760243|FG007|Overall Study|Death|0|||
105756510|NCT00006604|364760244|FG008|Overall Study|Death|0|||
105756511|NCT00006604|364760245|FG009|Overall Study|Death|1|||
105756512|NCT00006604|364760246|FG010|Overall Study|Death|1|||
105756513|NCT00006604|364760247|FG011|Overall Study|Death|1|||
105756514|NCT00006604|364760248|FG012|Overall Study|Death|0|||
105756515|NCT00006604|364760249|FG013|Overall Study|Death|0|||
105756516|NCT00006604|364760250|FG014|Overall Study|Death|0|||
105756517|NCT00006604|364760251|FG015|Overall Study|Death|0|||
105756518|NCT00006604|364760252|FG016|Overall Study|Death|0|||
105756519|NCT00006604|364760236|FG000|Overall Study|Severe debilitation, unable to continue|0|||
105756520|NCT00006604|364760237|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105756521|NCT00006604|364760238|FG002|Overall Study|Severe debilitation, unable to continue|0|||
105756522|NCT00006604|364760239|FG003|Overall Study|Severe debilitation, unable to continue|0|||
105756523|NCT00006604|364760240|FG004|Overall Study|Severe debilitation, unable to continue|0|||
105756524|NCT00006604|364760241|FG005|Overall Study|Severe debilitation, unable to continue|0|||
105756525|NCT00006604|364760242|FG006|Overall Study|Severe debilitation, unable to continue|3|||
105756526|NCT00006604|364760243|FG007|Overall Study|Severe debilitation, unable to continue|0|||
105756527|NCT00006604|364760244|FG008|Overall Study|Severe debilitation, unable to continue|0|||
105756528|NCT00006604|364760245|FG009|Overall Study|Severe debilitation, unable to continue|5|||
105756529|NCT00006604|364760246|FG010|Overall Study|Severe debilitation, unable to continue|0|||
105756530|NCT00006604|364760247|FG011|Overall Study|Severe debilitation, unable to continue|2|||
105756531|NCT00006604|364760248|FG012|Overall Study|Severe debilitation, unable to continue|1|||
105756532|NCT00006604|364760249|FG013|Overall Study|Severe debilitation, unable to continue|0|||
105756533|NCT00006604|364760250|FG014|Overall Study|Severe debilitation, unable to continue|2|||
105950211|NCT02750514|365482331|FG004|Track 4|Death|0|||
105950212|NCT02750514|365482327|FG000|Track 5|Disease progression|0|||
105950213|NCT02750514|365482328|FG001|Track 5|Disease progression|0|||
105756534|NCT00006604|364760251|FG015|Overall Study|Severe debilitation, unable to continue|0|||
105756535|NCT00006604|364760252|FG016|Overall Study|Severe debilitation, unable to continue|0|||
105756536|NCT00006604|364760236|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
105756537|NCT00006604|364760237|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
105756538|NCT00006604|364760238|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
105756539|NCT00006604|364760239|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
105756540|NCT00006604|364760240|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
105756541|NCT00006604|364760241|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
105756542|NCT00006604|364760242|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
105756543|NCT00006604|364760243|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
105756544|NCT00006604|364760244|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
105756545|NCT00006604|364760245|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
105756546|NCT00006604|364760246|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
105756547|NCT00006604|364760247|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
105756548|NCT00006604|364760248|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
105756549|NCT00006604|364760249|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
105756550|NCT00006604|364760250|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
105756551|NCT00006604|364760251|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
105756552|NCT00006604|364760252|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
105756553|NCT00006604|364760236|FG000|Overall Study|Site closing|0|||
105756554|NCT00006604|364760237|FG001|Overall Study|Site closing|0|||
105756555|NCT00006604|364760238|FG002|Overall Study|Site closing|1|||
105756556|NCT00006604|364760239|FG003|Overall Study|Site closing|1|||
105756557|NCT00006604|364760240|FG004|Overall Study|Site closing|0|||
105756558|NCT00006604|364760241|FG005|Overall Study|Site closing|0|||
105756559|NCT00006604|364760242|FG006|Overall Study|Site closing|0|||
105756560|NCT00006604|364760243|FG007|Overall Study|Site closing|1|||
105756561|NCT00006604|364760244|FG008|Overall Study|Site closing|0|||
105756562|NCT00006604|364760245|FG009|Overall Study|Site closing|0|||
105756563|NCT00006604|364760246|FG010|Overall Study|Site closing|0|||
105756564|NCT00006604|364760247|FG011|Overall Study|Site closing|1|||
105756565|NCT00006604|364760248|FG012|Overall Study|Site closing|1|||
105756566|NCT00006604|364760249|FG013|Overall Study|Site closing|1|||
105756567|NCT00006604|364760250|FG014|Overall Study|Site closing|0|||
105756568|NCT00006604|364760251|FG015|Overall Study|Site closing|0|||
105756569|NCT00006604|364760252|FG016|Overall Study|Site closing|1|||
105756570|NCT00006604|364760236|FG000|Overall Study|Withdrawal by Subject|1|||
105756571|NCT00006604|364760237|FG001|Overall Study|Withdrawal by Subject|0|||
105756572|NCT00006604|364760238|FG002|Overall Study|Withdrawal by Subject|2|||
105756573|NCT00006604|364760239|FG003|Overall Study|Withdrawal by Subject|0|||
105756574|NCT00006604|364760240|FG004|Overall Study|Withdrawal by Subject|1|||
105756575|NCT00006604|364760241|FG005|Overall Study|Withdrawal by Subject|2|||
105756576|NCT00006604|364760242|FG006|Overall Study|Withdrawal by Subject|2|||
105756577|NCT00006604|364760243|FG007|Overall Study|Withdrawal by Subject|0|||
105756578|NCT00006604|364760244|FG008|Overall Study|Withdrawal by Subject|1|||
105756579|NCT00006604|364760245|FG009|Overall Study|Withdrawal by Subject|3|||
105756580|NCT00006604|364760246|FG010|Overall Study|Withdrawal by Subject|2|||
105756581|NCT00006604|364760247|FG011|Overall Study|Withdrawal by Subject|0|||
105756582|NCT00006604|364760248|FG012|Overall Study|Withdrawal by Subject|1|||
105756583|NCT00006604|364760249|FG013|Overall Study|Withdrawal by Subject|2|||
105756584|NCT00006604|364760250|FG014|Overall Study|Withdrawal by Subject|1|||
105756585|NCT00006604|364760251|FG015|Overall Study|Withdrawal by Subject|0|||
105756586|NCT00006604|364760252|FG016|Overall Study|Withdrawal by Subject|1|||
105756587|NCT00006604|364760236|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
105756588|NCT00006604|364760237|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
105756589|NCT00006604|364760238|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
105756590|NCT00006604|364760239|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
105756591|NCT00006604|364760240|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
105756592|NCT00006604|364760241|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
105756593|NCT00006604|364760242|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
105756594|NCT00006604|364760243|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
105756595|NCT00006604|364760244|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
105756596|NCT00006604|364760245|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
105756597|NCT00006604|364760246|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
105756598|NCT00006604|364760247|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
105756599|NCT00006604|364760248|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
105756600|NCT00006604|364760249|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
105756601|NCT00006604|364760250|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
105950214|NCT02750514|365482329|FG002|Track 5|Disease progression|0|||
106016576|NCT04033445|365724450|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016577|NCT04033445|365724451|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016578|NCT04033445|365724452|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016579|NCT04033445|365724453|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016580|NCT04033445|365724454|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016581|NCT04033445|365724455|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016582|NCT04033445|365724456|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
106016583|NCT04033445|365724457|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016584|NCT04033445|365724458|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
106016585|NCT04033445|365724459|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
106016586|NCT04033445|365724460|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
106016587|NCT03748641|365724461|FG000|Overall Study|Ongoing|155|||
106016588|NCT03748641|365724462|FG001|Overall Study|Ongoing|148|||
105756602|NCT00006604|364760251|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
105756603|NCT00006604|364760252|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
105756604|NCT00006604|364760236|FG000|Overall Study|Lost to Follow-up|0|||
105756605|NCT00006604|364760237|FG001|Overall Study|Lost to Follow-up|0|||
105756606|NCT00006604|364760238|FG002|Overall Study|Lost to Follow-up|0|||
105756607|NCT00006604|364760239|FG003|Overall Study|Lost to Follow-up|0|||
105756608|NCT00006604|364760240|FG004|Overall Study|Lost to Follow-up|0|||
105756609|NCT00006604|364760241|FG005|Overall Study|Lost to Follow-up|0|||
105756610|NCT00006604|364760242|FG006|Overall Study|Lost to Follow-up|0|||
105756611|NCT00006604|364760243|FG007|Overall Study|Lost to Follow-up|1|||
105756612|NCT00006604|364760244|FG008|Overall Study|Lost to Follow-up|0|||
105756613|NCT00006604|364760245|FG009|Overall Study|Lost to Follow-up|2|||
105756614|NCT00006604|364760246|FG010|Overall Study|Lost to Follow-up|0|||
105756615|NCT00006604|364760247|FG011|Overall Study|Lost to Follow-up|0|||
105756616|NCT00006604|364760248|FG012|Overall Study|Lost to Follow-up|0|||
105756617|NCT00006604|364760249|FG013|Overall Study|Lost to Follow-up|0|||
105756618|NCT00006604|364760250|FG014|Overall Study|Lost to Follow-up|0|||
105756619|NCT00006604|364760251|FG015|Overall Study|Lost to Follow-up|1|||
105756620|NCT00006604|364760252|FG016|Overall Study|Lost to Follow-up|3|||
105756621|NCT00006604|364760236|FG000|Overall Study|Other Reason|0|||
105756622|NCT00006604|364760237|FG001|Overall Study|Other Reason|0|||
105756623|NCT00006604|364760238|FG002|Overall Study|Other Reason|0|||
105756624|NCT00006604|364760239|FG003|Overall Study|Other Reason|0|||
105756625|NCT00006604|364760240|FG004|Overall Study|Other Reason|0|||
105756626|NCT00006604|364760241|FG005|Overall Study|Other Reason|1|||
105756627|NCT00006604|364760242|FG006|Overall Study|Other Reason|0|||
105756628|NCT00006604|364760243|FG007|Overall Study|Other Reason|0|||
105756629|NCT00006604|364760244|FG008|Overall Study|Other Reason|0|||
105756630|NCT00006604|364760245|FG009|Overall Study|Other Reason|1|||
105756631|NCT00006604|364760246|FG010|Overall Study|Other Reason|0|||
105756632|NCT00006604|364760247|FG011|Overall Study|Other Reason|0|||
105756633|NCT00006604|364760248|FG012|Overall Study|Other Reason|0|||
105756634|NCT00006604|364760249|FG013|Overall Study|Other Reason|0|||
105756635|NCT00006604|364760250|FG014|Overall Study|Other Reason|0|||
105756636|NCT00006604|364760251|FG015|Overall Study|Other Reason|0|||
105756637|NCT00006604|364760252|FG016|Overall Study|Other Reason|0|||
105756638|NCT02431468|364760253|FG000|Overall Study|Adverse Event|2|||
105756639|NCT02431468|364760254|FG001|Overall Study|Adverse Event|4|||
105756640|NCT02431468|364760255|FG002|Overall Study|Adverse Event|5|||
105756641|NCT02431468|364760253|FG000|Overall Study|Withdrawal by Subject|4|||
105756642|NCT02431468|364760254|FG001|Overall Study|Withdrawal by Subject|12|||
105756643|NCT02431468|364760255|FG002|Overall Study|Withdrawal by Subject|2|||
105756644|NCT02431468|364760253|FG000|Overall Study|noncompliance, investigator termination,|2|||
105756645|NCT02431468|364760254|FG001|Overall Study|noncompliance, investigator termination,|2|||
105756646|NCT02431468|364760255|FG002|Overall Study|noncompliance, investigator termination,|2|||
105756647|NCT01361919|364760256|FG000|Overall Study|technical issues|10|||
105756648|NCT01361919|364760257|FG001|Overall Study|technical issues|12|||
105756649|NCT01361919|364760258|FG002|Overall Study|technical issues|10|||
105756650|NCT01056341|364760259|FG000|Overall Study|Treatment Intolerance|0|||
105756651|NCT01056341|364760260|FG001|Overall Study|Treatment Intolerance|2|||
105756652|NCT01056341|364760261|FG002|Overall Study|Treatment Intolerance|0|||
105756653|NCT01056341|364760262|FG003|Overall Study|Treatment Intolerance|2|||
105756654|NCT01056341|364760263|FG004|Overall Study|Treatment Intolerance|0|||
105756655|NCT01056341|364760259|FG000|Overall Study|Lack of Efficacy|32|||
105756656|NCT01056341|364760260|FG001|Overall Study|Lack of Efficacy|30|||
105756657|NCT01056341|364760261|FG002|Overall Study|Lack of Efficacy|7|||
105756658|NCT01056341|364760262|FG003|Overall Study|Lack of Efficacy|25|||
105756659|NCT01056341|364760263|FG004|Overall Study|Lack of Efficacy|9|||
105756660|NCT01056341|364760259|FG000|Overall Study|Other reasons|4|||
105756661|NCT01056341|364760260|FG001|Overall Study|Other reasons|4|||
105756662|NCT01056341|364760261|FG002|Overall Study|Other reasons|8|||
105756663|NCT01056341|364760262|FG003|Overall Study|Other reasons|9|||
105756664|NCT01056341|364760263|FG004|Overall Study|Other reasons|5|||
105803339|NCT01703741|364936540|FG000|Overall Study|Physician Decision|2|||
105803340|NCT01703741|364936540|FG000|Overall Study|Protocol Violation|1|||
105803341|NCT01703741|364936540|FG000|Overall Study|Lost to Follow-up|3|||
105803342|NCT01703741|364936540|FG000|Overall Study|Subject did not want to continue|2|||
105803343|NCT01703741|364936540|FG000|Overall Study|Subject cannot comply with study visits|1|||
105803344|NCT01703741|364936540|FG000|Overall Study|Subject started testosterone injections|1|||
105803345|NCT00672620|364936542|FG000|Overall Study|Adverse Event|7|||
105803346|NCT00672620|364936543|FG001|Overall Study|Adverse Event|7|||
105803347|NCT00672620|364936544|FG002|Overall Study|Adverse Event|12|||
105803348|NCT00672620|364936545|FG003|Overall Study|Adverse Event|17|||
105803349|NCT00672620|364936542|FG000|Overall Study|Lack of Efficacy|1|||
105803350|NCT00672620|364936543|FG001|Overall Study|Lack of Efficacy|2|||
105803351|NCT00672620|364936544|FG002|Overall Study|Lack of Efficacy|2|||
105803352|NCT00672620|364936545|FG003|Overall Study|Lack of Efficacy|0|||
105803353|NCT00672620|364936542|FG000|Overall Study|Noncompliance with Study Drug|3|||
105803354|NCT00672620|364936543|FG001|Overall Study|Noncompliance with Study Drug|4|||
105803355|NCT00672620|364936544|FG002|Overall Study|Noncompliance with Study Drug|0|||
105803356|NCT00672620|364936545|FG003|Overall Study|Noncompliance with Study Drug|2|||
105950215|NCT02750514|365482330|FG003|Track 5|Disease progression|0|||
105756665|NCT01086150|364760264|FG000|Overall Study|Withdrawal by Subject|0|||
105756666|NCT01086150|364760265|FG001|Overall Study|Withdrawal by Subject|4|||
105756667|NCT01086150|364760266|FG002|Overall Study|Withdrawal by Subject|1|||
105756668|NCT01086150|364760264|FG000|Overall Study|Lost to Follow-up|0|||
105756669|NCT01086150|364760265|FG001|Overall Study|Lost to Follow-up|1|||
105756670|NCT01086150|364760266|FG002|Overall Study|Lost to Follow-up|0|||
105756671|NCT01086150|364760264|FG000|Overall Study|Screen Failure|0|||
105756672|NCT01086150|364760265|FG001|Overall Study|Screen Failure|1|||
105756673|NCT01086150|364760266|FG002|Overall Study|Screen Failure|0|||
105756674|NCT03956225|364760270|FG000|Overall Study|Lack of Efficacy|1|||
105756675|NCT03956225|364760271|FG001|Overall Study|Lack of Efficacy|1|||
105756676|NCT03956225|364760270|FG000|Overall Study|Lost to Follow-up|0|||
105756677|NCT03956225|364760271|FG001|Overall Study|Lost to Follow-up|1|||
105756678|NCT03956225|364760270|FG000|Overall Study|Withdrawal by Subject|2|||
105756679|NCT03956225|364760271|FG001|Overall Study|Withdrawal by Subject|1|||
105756680|NCT03956225|364760270|FG000|Overall Study|Other Reasons|2|||
105756681|NCT03956225|364760271|FG001|Overall Study|Other Reasons|1|||
105756682|NCT00039741|364760272|FG000|Overall Study|Death|0|||
105756683|NCT00039741|364760273|FG001|Overall Study|Death|1|||
105756684|NCT00039741|364760274|FG002|Overall Study|Death|0|||
105756685|NCT00039741|364760275|FG003|Overall Study|Death|0|||
105756686|NCT00039741|364760272|FG000|Overall Study|Lost to Follow-up|3|||
105756687|NCT00039741|364760273|FG001|Overall Study|Lost to Follow-up|1|||
105756688|NCT00039741|364760274|FG002|Overall Study|Lost to Follow-up|5|||
105756689|NCT00039741|364760275|FG003|Overall Study|Lost to Follow-up|2|||
105756690|NCT00039741|364760272|FG000|Overall Study|Confounding medical condition|1|||
105756691|NCT00039741|364760273|FG001|Overall Study|Confounding medical condition|0|||
105756692|NCT00039741|364760274|FG002|Overall Study|Confounding medical condition|0|||
105756693|NCT00039741|364760275|FG003|Overall Study|Confounding medical condition|0|||
105756694|NCT00039741|364760272|FG000|Overall Study|Not able to get to clinic|5|||
105756695|NCT00039741|364760273|FG001|Overall Study|Not able to get to clinic|2|||
105756696|NCT00039741|364760274|FG002|Overall Study|Not able to get to clinic|0|||
105756697|NCT00039741|364760275|FG003|Overall Study|Not able to get to clinic|3|||
105756698|NCT00039741|364760272|FG000|Overall Study|Moved|3|||
105756699|NCT00039741|364760273|FG001|Overall Study|Moved|2|||
105756700|NCT00039741|364760274|FG002|Overall Study|Moved|3|||
105756701|NCT00039741|364760275|FG003|Overall Study|Moved|6|||
105756702|NCT00039741|364760272|FG000|Overall Study|Non-compliance with protocol|1|||
105756703|NCT00039741|364760273|FG001|Overall Study|Non-compliance with protocol|0|||
105756704|NCT00039741|364760274|FG002|Overall Study|Non-compliance with protocol|1|||
105756705|NCT00039741|364760275|FG003|Overall Study|Non-compliance with protocol|0|||
105756706|NCT00039741|364760272|FG000|Overall Study|Withdrew consent|0|||
105756707|NCT00039741|364760273|FG001|Overall Study|Withdrew consent|5|||
105756708|NCT00039741|364760274|FG002|Overall Study|Withdrew consent|0|||
105756709|NCT00039741|364760275|FG003|Overall Study|Withdrew consent|1|||
105756710|NCT00039741|364760272|FG000|Overall Study|Missed final visit|2|||
105756711|NCT00039741|364760273|FG001|Overall Study|Missed final visit|1|||
105756712|NCT00039741|364760274|FG002|Overall Study|Missed final visit|2|||
105756713|NCT00039741|364760275|FG003|Overall Study|Missed final visit|2|||
105756714|NCT00293423|364760276|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
105756715|NCT00293423|364760277|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
105756716|NCT00293423|364760276|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
105756717|NCT00293423|364760277|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
105803357|NCT00672620|364936542|FG000|Overall Study|Protocol Deviations|5|||
105803358|NCT00672620|364936543|FG001|Overall Study|Protocol Deviations|7|||
105803359|NCT00672620|364936544|FG002|Overall Study|Protocol Deviations|2|||
105803360|NCT00672620|364936545|FG003|Overall Study|Protocol Deviations|5|||
105803361|NCT00672620|364936542|FG000|Overall Study|Withdrawal of Consent|6|||
105803362|NCT00672620|364936543|FG001|Overall Study|Withdrawal of Consent|12|||
105803363|NCT00672620|364936544|FG002|Overall Study|Withdrawal of Consent|5|||
105803364|NCT00672620|364936545|FG003|Overall Study|Withdrawal of Consent|6|||
105803365|NCT00672620|364936542|FG000|Overall Study|Lost to Follow-up|8|||
105803366|NCT00672620|364936543|FG001|Overall Study|Lost to Follow-up|19|||
105803367|NCT00672620|364936544|FG002|Overall Study|Lost to Follow-up|8|||
105803368|NCT00672620|364936545|FG003|Overall Study|Lost to Follow-up|11|||
105803369|NCT00672620|364936542|FG000|Overall Study|Reason not Specified|3|||
105803370|NCT00672620|364936543|FG001|Overall Study|Reason not Specified|3|||
105803371|NCT00672620|364936544|FG002|Overall Study|Reason not Specified|2|||
105803372|NCT00672620|364936545|FG003|Overall Study|Reason not Specified|1|||
105803373|NCT02965820|364936546|FG000|Period 2, Second 30 Days|Adverse Event|1|||
105803374|NCT02965820|364936547|FG001|Period 2, Second 30 Days|Adverse Event|1|||
105803375|NCT02741271|364936550|FG000|Overall Study|Lost to Follow-up|2|||
105803376|NCT02741271|364936551|FG001|Overall Study|Lost to Follow-up|0|||
105803377|NCT02741271|364936550|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105803378|NCT02741271|364936551|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105803379|NCT03652961|364936552|FG000|Overall Study|Lost to Follow-up|3|||
105803380|NCT03652961|364936552|FG000|Overall Study|Screen Failure|1|||
105803381|NCT00410410|364936553|FG000|Induction Period (IP)|Death|1|||
105803382|NCT00410410|364936554|FG001|Induction Period (IP)|Death|0|||
105803383|NCT00410410|364936555|FG002|Induction Period (IP)|Death|0|||
105803384|NCT00410410|364936556|FG003|Induction Period (IP)|Death|0|||
105803385|NCT00410410|364936557|FG004|Induction Period (IP)|Death|0|||
105803386|NCT00410410|364936558|FG005|Induction Period (IP)|Death|0|||
105803387|NCT00410410|364936559|FG006|Induction Period (IP)|Death|0|||
105803388|NCT00410410|364936560|FG007|Induction Period (IP)|Death|0|||
105950216|NCT02750514|365482331|FG004|Track 5|Disease progression|34|||
105950217|NCT02750514|365482327|FG000|Track 5|Adverse event unrelated to study drug|0|||
105950218|NCT02750514|365482328|FG001|Track 5|Adverse event unrelated to study drug|0|||
105950219|NCT02750514|365482329|FG002|Track 5|Adverse event unrelated to study drug|0|||
105950220|NCT02750514|365482330|FG003|Track 5|Adverse event unrelated to study drug|0|||
105950221|NCT02750514|365482331|FG004|Track 5|Adverse event unrelated to study drug|2|||
105950222|NCT02750514|365482327|FG000|Track 5|Study drug toxicity|0|||
105950223|NCT02750514|365482328|FG001|Track 5|Study drug toxicity|0|||
105950224|NCT02750514|365482329|FG002|Track 5|Study drug toxicity|0|||
105950225|NCT02750514|365482330|FG003|Track 5|Study drug toxicity|0|||
105950226|NCT02750514|365482331|FG004|Track 5|Study drug toxicity|2|||
105950227|NCT02750514|365482327|FG000|Track 5|Participant request to discontinue|0|||
105950228|NCT02750514|365482328|FG001|Track 5|Participant request to discontinue|0|||
105950229|NCT02750514|365482329|FG002|Track 5|Participant request to discontinue|0|||
105950230|NCT02750514|365482330|FG003|Track 5|Participant request to discontinue|0|||
105950231|NCT02750514|365482331|FG004|Track 5|Participant request to discontinue|3|||
105950232|NCT02750514|365482327|FG000|Track 5|Other reasons|0|||
105950233|NCT02750514|365482328|FG001|Track 5|Other reasons|0|||
105950234|NCT02750514|365482329|FG002|Track 5|Other reasons|0|||
105950235|NCT02750514|365482330|FG003|Track 5|Other reasons|0|||
105950236|NCT02750514|365482331|FG004|Track 5|Other reasons|2|||
105950237|NCT01812057|365482332|FG000|Overall Study|Protocol Violation|1|||
105950238|NCT01812057|365482333|FG001|Overall Study|Protocol Violation|0|||
105950239|NCT01812057|365482332|FG000|Overall Study|Physician Decision|1|||
105950240|NCT01812057|365482333|FG001|Overall Study|Physician Decision|0|||
105950241|NCT01882465|365482336|FG000|Period 1|Lens Discomfort|0|||
105950242|NCT01882465|365482337|FG001|Period 1|Lens Discomfort|0|||
105950243|NCT01882465|365482338|FG002|Period 1|Lens Discomfort|0|||
105950244|NCT01882465|365482339|FG003|Period 1|Lens Discomfort|1|||
105950245|NCT01882465|365482340|FG004|Period 1|Lens Discomfort|0|||
105950246|NCT01882465|365482341|FG005|Period 1|Lens Discomfort|0|||
105950247|NCT01882465|365482342|FG006|Period 1|Lens Discomfort|0|||
105950248|NCT01882465|365482336|FG000|Period 1|Withdrawal by Subject|0|||
105803389|NCT00410410|364936561|FG008|Induction Period (IP)|Death|0|||
105803390|NCT00410410|364936553|FG000|Induction Period (IP)|Adverse Event|3|||
105803391|NCT00410410|364936554|FG001|Induction Period (IP)|Adverse Event|4|||
105803392|NCT00410410|364936555|FG002|Induction Period (IP)|Adverse Event|2|||
105950249|NCT01882465|365482337|FG001|Period 1|Withdrawal by Subject|0|||
105950250|NCT01882465|365482338|FG002|Period 1|Withdrawal by Subject|0|||
105950251|NCT01882465|365482339|FG003|Period 1|Withdrawal by Subject|0|||
105950252|NCT01882465|365482340|FG004|Period 1|Withdrawal by Subject|0|||
105803393|NCT00410410|364936556|FG003|Induction Period (IP)|Adverse Event|4|||
105803394|NCT00410410|364936557|FG004|Induction Period (IP)|Adverse Event|1|||
105803395|NCT00410410|364936558|FG005|Induction Period (IP)|Adverse Event|0|||
105803396|NCT00410410|364936559|FG006|Induction Period (IP)|Adverse Event|0|||
105803397|NCT00410410|364936560|FG007|Induction Period (IP)|Adverse Event|0|||
105803398|NCT00410410|364936561|FG008|Induction Period (IP)|Adverse Event|0|||
105803399|NCT00410410|364936553|FG000|Induction Period (IP)|Lack of Efficacy|26|||
105950253|NCT01882465|365482341|FG005|Period 1|Withdrawal by Subject|0|||
105950254|NCT01882465|365482342|FG006|Period 1|Withdrawal by Subject|1|||
105950255|NCT01882465|365482336|FG000|Period 2|Protocol Violation|0|||
105756718|NCT00293423|364760276|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
105756719|NCT00293423|364760277|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
105756720|NCT00293423|364760276|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
105756721|NCT00293423|364760277|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
105756722|NCT00293423|364760276|FG000|Surgical Resection|processing error during surgical resection|1|||
105756723|NCT00293423|364760277|FG001|Surgical Resection|processing error during surgical resection|0|||
105756724|NCT00293423|364760276|FG000|Surgical Resection|Withdrawal by Subject|4|||
105756725|NCT00293423|364760277|FG001|Surgical Resection|Withdrawal by Subject|0|||
105756726|NCT00293423|364760276|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
105756727|NCT00293423|364760277|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
105756728|NCT01529385|364760278|FG000|Overall Study|Lost to Follow-up|2|||
105756729|NCT01529385|364760279|FG001|Overall Study|Lost to Follow-up|1|||
105756730|NCT01021813|364760283|FG000|DB Treatment Phase|Adverse Event|60|||
105756731|NCT01021813|364760284|FG001|DB Treatment Phase|Adverse Event|22|||
105756732|NCT01021813|364760285|FG002|DB Treatment Phase|Adverse Event|0|||
105756733|NCT01021813|364760286|FG003|DB Treatment Phase|Adverse Event|0|||
105756734|NCT01021813|364760287|FG004|DB Treatment Phase|Adverse Event|0|||
105756735|NCT01021813|364760283|FG000|DB Treatment Phase|Lack of Efficacy|44|||
105756736|NCT01021813|364760284|FG001|DB Treatment Phase|Lack of Efficacy|28|||
105756737|NCT01021813|364760285|FG002|DB Treatment Phase|Lack of Efficacy|0|||
105756738|NCT01021813|364760286|FG003|DB Treatment Phase|Lack of Efficacy|0|||
105756739|NCT01021813|364760287|FG004|DB Treatment Phase|Lack of Efficacy|0|||
105756740|NCT01021813|364760283|FG000|DB Treatment Phase|Lost to Follow-up|14|||
105756741|NCT01021813|364760284|FG001|DB Treatment Phase|Lost to Follow-up|12|||
105756742|NCT01021813|364760285|FG002|DB Treatment Phase|Lost to Follow-up|0|||
105756743|NCT01021813|364760286|FG003|DB Treatment Phase|Lost to Follow-up|0|||
105756744|NCT01021813|364760287|FG004|DB Treatment Phase|Lost to Follow-up|0|||
105756745|NCT01021813|364760283|FG000|DB Treatment Phase|Physician Decision|17|||
105756746|NCT01021813|364760284|FG001|DB Treatment Phase|Physician Decision|8|||
105756747|NCT01021813|364760285|FG002|DB Treatment Phase|Physician Decision|0|||
105756748|NCT01021813|364760286|FG003|DB Treatment Phase|Physician Decision|0|||
105756749|NCT01021813|364760287|FG004|DB Treatment Phase|Physician Decision|0|||
105756750|NCT01021813|364760283|FG000|DB Treatment Phase|Pregnancy|1|||
105756751|NCT01021813|364760284|FG001|DB Treatment Phase|Pregnancy|0|||
105756752|NCT01021813|364760285|FG002|DB Treatment Phase|Pregnancy|0|||
105756753|NCT01021813|364760286|FG003|DB Treatment Phase|Pregnancy|0|||
105756754|NCT01021813|364760287|FG004|DB Treatment Phase|Pregnancy|0|||
105756755|NCT01021813|364760283|FG000|DB Treatment Phase|Protocol Violation|4|||
105756756|NCT01021813|364760284|FG001|DB Treatment Phase|Protocol Violation|3|||
105756757|NCT01021813|364760285|FG002|DB Treatment Phase|Protocol Violation|0|||
105756758|NCT01021813|364760286|FG003|DB Treatment Phase|Protocol Violation|0|||
105756759|NCT01021813|364760287|FG004|DB Treatment Phase|Protocol Violation|0|||
105756760|NCT01021813|364760283|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
105756761|NCT01021813|364760284|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
105756762|NCT01021813|364760285|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
105756763|NCT01021813|364760286|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
105756764|NCT01021813|364760287|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
105756765|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
105756766|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
105756767|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
105756768|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
105756769|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
105756770|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
105756771|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
105756772|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
105756773|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
105756774|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
105756775|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
105756776|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
105756777|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
105756778|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
105756779|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
105756780|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
105756781|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
105756782|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
105756783|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
105756784|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
105803400|NCT00410410|364936554|FG001|Induction Period (IP)|Lack of Efficacy|24|||
105803401|NCT00410410|364936555|FG002|Induction Period (IP)|Lack of Efficacy|8|||
105803402|NCT00410410|364936556|FG003|Induction Period (IP)|Lack of Efficacy|8|||
105803403|NCT00410410|364936557|FG004|Induction Period (IP)|Lack of Efficacy|7|||
105803404|NCT00410410|364936558|FG005|Induction Period (IP)|Lack of Efficacy|7|||
105803405|NCT00410410|364936559|FG006|Induction Period (IP)|Lack of Efficacy|0|||
105803406|NCT00410410|364936560|FG007|Induction Period (IP)|Lack of Efficacy|0|||
105803407|NCT00410410|364936561|FG008|Induction Period (IP)|Lack of Efficacy|0|||
105803408|NCT00410410|364936553|FG000|Induction Period (IP)|Lost to Follow-up|2|||
105803409|NCT00410410|364936554|FG001|Induction Period (IP)|Lost to Follow-up|2|||
105803410|NCT00410410|364936555|FG002|Induction Period (IP)|Lost to Follow-up|2|||
105803411|NCT00410410|364936556|FG003|Induction Period (IP)|Lost to Follow-up|3|||
105803412|NCT00410410|364936557|FG004|Induction Period (IP)|Lost to Follow-up|0|||
105803413|NCT00410410|364936558|FG005|Induction Period (IP)|Lost to Follow-up|1|||
105803414|NCT00410410|364936559|FG006|Induction Period (IP)|Lost to Follow-up|0|||
105803415|NCT00410410|364936560|FG007|Induction Period (IP)|Lost to Follow-up|0|||
105803416|NCT00410410|364936561|FG008|Induction Period (IP)|Lost to Follow-up|0|||
105803417|NCT00410410|364936553|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
105803418|NCT00410410|364936554|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
105803419|NCT00410410|364936555|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
105803420|NCT00410410|364936556|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
105803421|NCT00410410|364936557|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
105803422|NCT00410410|364936558|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
105803423|NCT00410410|364936559|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
105803424|NCT00410410|364936560|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
105803425|NCT00410410|364936561|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
105803426|NCT00410410|364936553|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803427|NCT00410410|364936554|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803428|NCT00410410|364936555|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
105803429|NCT00410410|364936556|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803430|NCT00410410|364936557|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803431|NCT00410410|364936558|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803432|NCT00410410|364936559|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803433|NCT00410410|364936560|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803434|NCT00410410|364936561|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
105803435|NCT00410410|364936553|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803436|NCT00410410|364936554|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803437|NCT00410410|364936555|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803438|NCT00410410|364936556|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803439|NCT00410410|364936557|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
105803440|NCT00410410|364936558|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
105803441|NCT00410410|364936559|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803442|NCT00410410|364936560|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803443|NCT00410410|364936561|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
105803444|NCT00410410|364936553|FG000|Induction Period (IP)|Other|0|||
105803445|NCT00410410|364936554|FG001|Induction Period (IP)|Other|0|||
105803446|NCT00410410|364936555|FG002|Induction Period (IP)|Other|1|||
105803447|NCT00410410|364936556|FG003|Induction Period (IP)|Other|0|||
105803448|NCT00410410|364936557|FG004|Induction Period (IP)|Other|0|||
105803449|NCT00410410|364936558|FG005|Induction Period (IP)|Other|0|||
105803450|NCT00410410|364936559|FG006|Induction Period (IP)|Other|0|||
105803451|NCT00410410|364936560|FG007|Induction Period (IP)|Other|0|||
105803452|NCT00410410|364936561|FG008|Induction Period (IP)|Other|0|||
105803453|NCT00410410|364936553|FG000|Maintenance Period (MP)|Death|0|||
105803454|NCT00410410|364936554|FG001|Maintenance Period (MP)|Death|0|||
105803455|NCT00410410|364936555|FG002|Maintenance Period (MP)|Death|0|||
105803456|NCT00410410|364936556|FG003|Maintenance Period (MP)|Death|0|||
105803457|NCT00410410|364936557|FG004|Maintenance Period (MP)|Death|0|||
105803458|NCT00410410|364936558|FG005|Maintenance Period (MP)|Death|0|||
105803459|NCT00410410|364936559|FG006|Maintenance Period (MP)|Death|1|||
105803460|NCT00410410|364936560|FG007|Maintenance Period (MP)|Death|0|||
105803461|NCT00410410|364936561|FG008|Maintenance Period (MP)|Death|0|||
105803462|NCT00410410|364936553|FG000|Maintenance Period (MP)|Adverse Event|0|||
105803463|NCT00410410|364936554|FG001|Maintenance Period (MP)|Adverse Event|0|||
105803464|NCT00410410|364936555|FG002|Maintenance Period (MP)|Adverse Event|0|||
105803465|NCT00410410|364936556|FG003|Maintenance Period (MP)|Adverse Event|0|||
105803466|NCT00410410|364936557|FG004|Maintenance Period (MP)|Adverse Event|0|||
105803467|NCT00410410|364936558|FG005|Maintenance Period (MP)|Adverse Event|0|||
105803468|NCT00410410|364936559|FG006|Maintenance Period (MP)|Adverse Event|1|||
105803469|NCT00410410|364936560|FG007|Maintenance Period (MP)|Adverse Event|3|||
105803470|NCT00410410|364936561|FG008|Maintenance Period (MP)|Adverse Event|0|||
105803471|NCT00410410|364936553|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
105803472|NCT00410410|364936554|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
105803473|NCT00410410|364936555|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
105803474|NCT00410410|364936556|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
105806539|NCT03209570|364949016|FG001|Overall Study|Protocol Violation|0|||
105803475|NCT00410410|364936557|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
105803476|NCT00410410|364936558|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
105803477|NCT00410410|364936559|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
105803478|NCT00410410|364936560|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
105803479|NCT00410410|364936561|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
105803480|NCT00410410|364936553|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
105803481|NCT00410410|364936554|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
105803482|NCT00410410|364936555|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
105803483|NCT00410410|364936556|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
105803484|NCT00410410|364936557|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
105803485|NCT00410410|364936558|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
105803486|NCT00410410|364936559|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
105803487|NCT00410410|364936560|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
105803488|NCT00410410|364936561|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
105803489|NCT00410410|364936553|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803490|NCT00410410|364936554|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803491|NCT00410410|364936555|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803492|NCT00410410|364936556|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803493|NCT00410410|364936557|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803494|NCT00410410|364936558|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803495|NCT00410410|364936559|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
105803496|NCT00410410|364936560|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
105803497|NCT00410410|364936561|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
105803498|NCT00410410|364936553|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803499|NCT00410410|364936554|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803500|NCT00410410|364936555|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803501|NCT00410410|364936556|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803502|NCT00410410|364936557|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803503|NCT00410410|364936558|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803504|NCT00410410|364936559|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
105803505|NCT00410410|364936560|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
105803506|NCT00410410|364936561|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
105803507|NCT00410410|364936553|FG000|Open-Label Period (OL)|Death|0|||
105803508|NCT00410410|364936554|FG001|Open-Label Period (OL)|Death|0|||
105803509|NCT00410410|364936555|FG002|Open-Label Period (OL)|Death|0|||
105803510|NCT00410410|364936556|FG003|Open-Label Period (OL)|Death|0|||
105803511|NCT00410410|364936557|FG004|Open-Label Period (OL)|Death|0|||
105803512|NCT00410410|364936558|FG005|Open-Label Period (OL)|Death|0|||
105803513|NCT00410410|364936559|FG006|Open-Label Period (OL)|Death|0|||
105803514|NCT00410410|364936560|FG007|Open-Label Period (OL)|Death|0|||
105803515|NCT00410410|364936561|FG008|Open-Label Period (OL)|Death|1|||
105803516|NCT00410410|364936553|FG000|Open-Label Period (OL)|Adverse Event|0|||
105803517|NCT00410410|364936554|FG001|Open-Label Period (OL)|Adverse Event|0|||
105803518|NCT00410410|364936555|FG002|Open-Label Period (OL)|Adverse Event|0|||
105803519|NCT00410410|364936556|FG003|Open-Label Period (OL)|Adverse Event|0|||
105803520|NCT00410410|364936557|FG004|Open-Label Period (OL)|Adverse Event|0|||
105803521|NCT00410410|364936558|FG005|Open-Label Period (OL)|Adverse Event|0|||
105803522|NCT00410410|364936559|FG006|Open-Label Period (OL)|Adverse Event|0|||
105803523|NCT00410410|364936560|FG007|Open-Label Period (OL)|Adverse Event|0|||
105803524|NCT00410410|364936561|FG008|Open-Label Period (OL)|Adverse Event|10|||
105803525|NCT00410410|364936553|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
105803526|NCT00410410|364936554|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
105803527|NCT00410410|364936555|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
105803528|NCT00410410|364936556|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
105803529|NCT00410410|364936557|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
105803530|NCT00410410|364936558|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
105803531|NCT00410410|364936559|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
105803532|NCT00410410|364936560|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
105803533|NCT00410410|364936561|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
105803534|NCT00410410|364936553|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
105803535|NCT00410410|364936554|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
105803536|NCT00410410|364936555|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
105803537|NCT00410410|364936556|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
105803538|NCT00410410|364936557|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
105803539|NCT00410410|364936558|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
105950256|NCT01882465|365482337|FG001|Period 2|Protocol Violation|0|||
105803540|NCT00410410|364936559|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
105803541|NCT00410410|364936560|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
105803542|NCT00410410|364936561|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
105803543|NCT00410410|364936553|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803544|NCT00410410|364936554|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803545|NCT00410410|364936555|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803546|NCT00410410|364936556|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803547|NCT00410410|364936557|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803548|NCT00410410|364936558|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803549|NCT00410410|364936559|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803550|NCT00410410|364936560|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
105803551|NCT00410410|364936561|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
105803552|NCT00410410|364936553|FG000|Open-Label Period (OL)|Pregnancy|0|||
105803553|NCT00410410|364936554|FG001|Open-Label Period (OL)|Pregnancy|0|||
105803554|NCT00410410|364936555|FG002|Open-Label Period (OL)|Pregnancy|0|||
105803555|NCT00410410|364936556|FG003|Open-Label Period (OL)|Pregnancy|0|||
105803556|NCT00410410|364936557|FG004|Open-Label Period (OL)|Pregnancy|0|||
105803557|NCT00410410|364936558|FG005|Open-Label Period (OL)|Pregnancy|0|||
105803558|NCT00410410|364936559|FG006|Open-Label Period (OL)|Pregnancy|0|||
105803559|NCT00410410|364936560|FG007|Open-Label Period (OL)|Pregnancy|0|||
105803560|NCT00410410|364936561|FG008|Open-Label Period (OL)|Pregnancy|1|||
105803561|NCT00410410|364936553|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803562|NCT00410410|364936554|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803563|NCT00410410|364936555|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803564|NCT00410410|364936556|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803565|NCT00410410|364936557|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803566|NCT00410410|364936558|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803567|NCT00410410|364936559|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803568|NCT00410410|364936560|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
105803569|NCT00410410|364936561|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
105803570|NCT00410410|364936553|FG000|Open-Label Period (OL)|Other|0|||
105803571|NCT00410410|364936554|FG001|Open-Label Period (OL)|Other|0|||
105803572|NCT00410410|364936555|FG002|Open-Label Period (OL)|Other|0|||
105803573|NCT00410410|364936556|FG003|Open-Label Period (OL)|Other|0|||
105803574|NCT00410410|364936557|FG004|Open-Label Period (OL)|Other|0|||
105803575|NCT00410410|364936558|FG005|Open-Label Period (OL)|Other|0|||
105803576|NCT00410410|364936559|FG006|Open-Label Period (OL)|Other|0|||
105803577|NCT00410410|364936560|FG007|Open-Label Period (OL)|Other|0|||
105803578|NCT00410410|364936561|FG008|Open-Label Period (OL)|Other|7|||
105803579|NCT01023269|364936562|FG000|Overall Study|early termination of the study|2|||
105803580|NCT01023269|364936563|FG001|Overall Study|early termination of the study|0|||
105803581|NCT01953783|364936564|FG000|Overall Study|Progressive disease|2|||
105803582|NCT00903383|364936566|FG000|Overall Study|Adverse Event|1|||
105803583|NCT00903383|364936567|FG001|Overall Study|Adverse Event|2|||
105803584|NCT00903383|364936568|FG002|Overall Study|Adverse Event|3|||
105803585|NCT00903383|364936569|FG003|Overall Study|Adverse Event|1|||
105803586|NCT00903383|364936566|FG000|Overall Study|Physician Decision|1|||
105803587|NCT00903383|364936567|FG001|Overall Study|Physician Decision|2|||
105803588|NCT00903383|364936568|FG002|Overall Study|Physician Decision|0|||
105803589|NCT00903383|364936569|FG003|Overall Study|Physician Decision|0|||
105803590|NCT00903383|364936566|FG000|Overall Study|Lost to Follow-up|0|||
105803591|NCT00903383|364936567|FG001|Overall Study|Lost to Follow-up|0|||
105803592|NCT00903383|364936568|FG002|Overall Study|Lost to Follow-up|0|||
105803593|NCT00903383|364936569|FG003|Overall Study|Lost to Follow-up|1|||
105803594|NCT00903383|364936566|FG000|Overall Study|Decision of Sponsor|1|||
105803595|NCT00903383|364936567|FG001|Overall Study|Decision of Sponsor|0|||
105803596|NCT00903383|364936568|FG002|Overall Study|Decision of Sponsor|0|||
105803597|NCT00903383|364936569|FG003|Overall Study|Decision of Sponsor|0|||
105803598|NCT00903383|364936566|FG000|Overall Study|Withdrawal by Subject|4|||
105803599|NCT00903383|364936567|FG001|Overall Study|Withdrawal by Subject|1|||
105803600|NCT00903383|364936568|FG002|Overall Study|Withdrawal by Subject|0|||
105803601|NCT00903383|364936569|FG003|Overall Study|Withdrawal by Subject|2|||
105803602|NCT00903383|364936566|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
105803603|NCT00903383|364936567|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
105803604|NCT00903383|364936568|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
105803605|NCT00903383|364936569|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
105803606|NCT00903383|364936566|FG000|Overall Study|Patient Decision|0|||
105803607|NCT00903383|364936567|FG001|Overall Study|Patient Decision|0|||
105803608|NCT00903383|364936568|FG002|Overall Study|Patient Decision|0|||
105950257|NCT01882465|365482338|FG002|Period 2|Protocol Violation|0|||
105950258|NCT01882465|365482339|FG003|Period 2|Protocol Violation|0|||
105803609|NCT00903383|364936569|FG003|Overall Study|Patient Decision|1|||
105803610|NCT00479401|364936570|FG000|Overall Study|Adverse Event|24|||
105803611|NCT00479401|364936571|FG001|Overall Study|Adverse Event|20|||
105803612|NCT00479401|364936572|FG002|Overall Study|Adverse Event|4|||
105803613|NCT00479401|364936570|FG000|Overall Study|Lack of Efficacy|2|||
105803614|NCT00479401|364936571|FG001|Overall Study|Lack of Efficacy|2|||
105803615|NCT00479401|364936572|FG002|Overall Study|Lack of Efficacy|4|||
105803616|NCT00479401|364936570|FG000|Overall Study|Protocol Violation|2|||
105803617|NCT00479401|364936571|FG001|Overall Study|Protocol Violation|1|||
105803618|NCT00479401|364936572|FG002|Overall Study|Protocol Violation|1|||
105803619|NCT00479401|364936570|FG000|Overall Study|Lost to Follow-up|1|||
105950259|NCT01882465|365482340|FG004|Period 2|Protocol Violation|1|||
105756785|NCT01021813|364760283|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
105756786|NCT01021813|364760284|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
105756787|NCT01021813|364760285|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
105756788|NCT01021813|364760286|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
105756789|NCT01021813|364760287|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
105756790|NCT01512108|364761522|FG000|Overall Study|Adverse Event|9|||
105756791|NCT01512108|364761523|FG001|Overall Study|Adverse Event|4|||
105756792|NCT01512108|364761522|FG000|Overall Study|Protocol Violation|1|||
105756793|NCT01512108|364761523|FG001|Overall Study|Protocol Violation|2|||
105756794|NCT01512108|364761522|FG000|Overall Study|Withdrawal Criteria|1|||
105756795|NCT01512108|364761523|FG001|Overall Study|Withdrawal Criteria|0|||
105756796|NCT01512108|364761522|FG000|Overall Study|Unclassified|11|||
105756797|NCT01512108|364761523|FG001|Overall Study|Unclassified|3|||
105756798|NCT02109744|364761527|FG000|Overall Study|Death|1|||
105756799|NCT02109744|364761528|FG001|Overall Study|Death|1|||
105756800|NCT02109744|364761527|FG000|Overall Study|no marrow exam|1|||
105756801|NCT02109744|364761528|FG001|Overall Study|no marrow exam|0|||
105756802|NCT01827319|364761533|FG000|Overall Study|Lost to Follow-up|3|||
105756803|NCT03927911|364761536|FG000|Overall Study|problems with eDiary|0|||
105756804|NCT03927911|364761537|FG001|Overall Study|problems with eDiary|1|||
105756805|NCT03927911|364761538|FG002|Overall Study|problems with eDiary|0|||
105756806|NCT03927911|364761539|FG003|Overall Study|problems with eDiary|1|||
105756807|NCT03927911|364761540|FG004|Overall Study|problems with eDiary|0|||
105756808|NCT03927911|364761541|FG005|Overall Study|problems with eDiary|4|||
105756809|NCT03927911|364761536|FG000|Overall Study|Adverse Event|0|||
105756810|NCT03927911|364761537|FG001|Overall Study|Adverse Event|0|||
105756811|NCT03927911|364761538|FG002|Overall Study|Adverse Event|0|||
105756812|NCT03927911|364761539|FG003|Overall Study|Adverse Event|0|||
105756813|NCT03927911|364761540|FG004|Overall Study|Adverse Event|0|||
105756814|NCT03927911|364761541|FG005|Overall Study|Adverse Event|1|||
105756815|NCT03927911|364761536|FG000|Overall Study|not treated -study terminated by sponsor|0|||
105756816|NCT03927911|364761537|FG001|Overall Study|not treated -study terminated by sponsor|1|||
105756817|NCT03927911|364761538|FG002|Overall Study|not treated -study terminated by sponsor|0|||
105756818|NCT03927911|364761539|FG003|Overall Study|not treated -study terminated by sponsor|0|||
105756819|NCT03927911|364761540|FG004|Overall Study|not treated -study terminated by sponsor|0|||
105756820|NCT03927911|364761541|FG005|Overall Study|not treated -study terminated by sponsor|0|||
105756821|NCT03927911|364761536|FG000|Overall Study|Surgery cancelled|0|||
105756822|NCT03927911|364761537|FG001|Overall Study|Surgery cancelled|0|||
105756823|NCT03927911|364761538|FG002|Overall Study|Surgery cancelled|0|||
105756824|NCT03927911|364761539|FG003|Overall Study|Surgery cancelled|1|||
105756825|NCT03927911|364761540|FG004|Overall Study|Surgery cancelled|0|||
105756826|NCT03927911|364761541|FG005|Overall Study|Surgery cancelled|1|||
105756827|NCT03927911|364761536|FG000|Overall Study|Protocol Violation|0|||
105756828|NCT03927911|364761537|FG001|Overall Study|Protocol Violation|0|||
105756829|NCT03927911|364761538|FG002|Overall Study|Protocol Violation|0|||
105756830|NCT03927911|364761539|FG003|Overall Study|Protocol Violation|0|||
105756831|NCT03927911|364761540|FG004|Overall Study|Protocol Violation|0|||
105756832|NCT03927911|364761541|FG005|Overall Study|Protocol Violation|1|||
105756833|NCT03728140|364761548|FG000|Overall Study|Abnormal embryo transfer operation|10|||
105756834|NCT03728140|364761549|FG001|Overall Study|Abnormal embryo transfer operation|7|||
105756835|NCT02384395|364761550|FG000|Overall Study|Physician Decision|4|||
105756836|NCT02384395|364761550|FG000|Overall Study|Withdrawal by Subject|3|||
105756837|NCT02384395|364761550|FG000|Overall Study|Lost to Follow-up|3|||
105756838|NCT02267278|364761551|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
105756839|NCT02267278|364761551|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
105756840|NCT02267278|364761551|FG000|Overall Study|Developed new cancer diagnoses|2|||
105756841|NCT02267278|364761551|FG000|Overall Study|prescribed prohibited medication|1|||
105756842|NCT00415519|364761552|FG000|Overall Study|Adverse Event|1|||
105756843|NCT00415519|364761553|FG001|Overall Study|Adverse Event|0|||
105756844|NCT00415519|364761552|FG000|Overall Study|Withdrawal by Subject|2|||
105756845|NCT00415519|364761553|FG001|Overall Study|Withdrawal by Subject|0|||
105756846|NCT00415519|364761552|FG000|Overall Study|Patient's convenience|1|||
105756847|NCT00415519|364761553|FG001|Overall Study|Patient's convenience|0|||
105756848|NCT00367341|364761555|FG000|Overall Study|Physician Decision|1|||
105756849|NCT00367341|364761556|FG001|Overall Study|Physician Decision|0|||
105756850|NCT00367341|364761555|FG000|Overall Study|Protocol Violation|1|||
105950260|NCT01882465|365482341|FG005|Period 2|Protocol Violation|0|||
105756851|NCT00367341|364761556|FG001|Overall Study|Protocol Violation|0|||
105756852|NCT01705587|364761557|FG000|Overall Study|Withdrawal by Subject|0|||
105756853|NCT01705587|364761558|FG001|Overall Study|Withdrawal by Subject|1|||
105756854|NCT02119026|364761561|FG000|1st-line Treatment|Adverse Event|9|||
105756855|NCT02119026|364761562|FG001|1st-line Treatment|Adverse Event|14|||
105756856|NCT02119026|364761561|FG000|1st-line Treatment|Physician Decision|3|||
105756857|NCT02119026|364761562|FG001|1st-line Treatment|Physician Decision|8|||
105756858|NCT02119026|364761561|FG000|1st-line Treatment|Withdrawal by Subject|4|||
105756859|NCT02119026|364761562|FG001|1st-line Treatment|Withdrawal by Subject|10|||
105803620|NCT00479401|364936571|FG001|Overall Study|Lost to Follow-up|1|||
105803621|NCT00479401|364936572|FG002|Overall Study|Lost to Follow-up|1|||
105803622|NCT00479401|364936570|FG000|Overall Study|Withdrawal by Subject|16|||
105803623|NCT00479401|364936571|FG001|Overall Study|Withdrawal by Subject|10|||
105803624|NCT00479401|364936572|FG002|Overall Study|Withdrawal by Subject|2|||
105803625|NCT00479401|364936570|FG000|Overall Study|Exclusion criteria, relocation|4|||
105803626|NCT00479401|364936571|FG001|Overall Study|Exclusion criteria, relocation|3|||
105803627|NCT00479401|364936572|FG002|Overall Study|Exclusion criteria, relocation|0|||
105803628|NCT01430104|364936575|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
105803629|NCT01076166|364936576|FG000|Overall Study|Adverse Event|3|||
105803630|NCT01076166|364936576|FG000|Overall Study|Symptoms improved/resolved|6|||
105803631|NCT00481247|364936580|FG000|Overall Study|Death|0|||
105803632|NCT00481247|364936581|FG001|Overall Study|Death|1|||
105803633|NCT00481247|364936580|FG000|Overall Study|Disease progression|18|||
105803634|NCT00481247|364936581|FG001|Overall Study|Disease progression|22|||
105803635|NCT00481247|364936580|FG000|Overall Study|Intolerance|42|||
105803636|NCT00481247|364936581|FG001|Overall Study|Intolerance|17|||
105803637|NCT00481247|364936580|FG000|Overall Study|Treatment failure|10|||
105803638|NCT00481247|364936581|FG001|Overall Study|Treatment failure|14|||
105803639|NCT00481247|364936580|FG000|Overall Study|AE unrelated to study drug|13|||
105803640|NCT00481247|364936581|FG001|Overall Study|AE unrelated to study drug|4|||
105803641|NCT00481247|364936580|FG000|Overall Study|Withdrawal by Subject|8|||
105803642|NCT00481247|364936581|FG001|Overall Study|Withdrawal by Subject|13|||
105803643|NCT00481247|364936580|FG000|Overall Study|Pregnancy|2|||
105803644|NCT00481247|364936581|FG001|Overall Study|Pregnancy|1|||
105803645|NCT00481247|364936580|FG000|Overall Study|Lost to Follow-up|1|||
105803646|NCT00481247|364936581|FG001|Overall Study|Lost to Follow-up|2|||
105803647|NCT00481247|364936580|FG000|Overall Study|Poor compliance/noncompliance|1|||
105803648|NCT00481247|364936581|FG001|Overall Study|Poor compliance/noncompliance|7|||
105803649|NCT00481247|364936580|FG000|Overall Study|Administrative reason by sponsor|157|||
105803650|NCT00481247|364936581|FG001|Overall Study|Administrative reason by sponsor|162|||
105803651|NCT00481247|364936580|FG000|Overall Study|Varied|6|||
105803652|NCT00481247|364936581|FG001|Overall Study|Varied|15|||
105803653|NCT00481247|364936580|FG000|Overall Study|Did not receive treatment|1|||
105803654|NCT00481247|364936581|FG001|Overall Study|Did not receive treatment|2|||
105803655|NCT00446654|364936582|FG000|Overall Study|Withdrawal by Subject|1|||
105803656|NCT00446654|364936583|FG001|Overall Study|Withdrawal by Subject|0|||
105803657|NCT00446654|364936582|FG000|Overall Study|Adverse Event|1|||
105803658|NCT00446654|364936583|FG001|Overall Study|Adverse Event|0|||
105803659|NCT01841359|364936590|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
105803660|NCT01841359|364936590|FG000|Overall Study|Concommitant medical issues|2|||
105803661|NCT01841359|364936590|FG000|Overall Study|Adverse Event|3|||
105803662|NCT01841359|364936590|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
105803663|NCT04896385|364936593|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
105803664|NCT04896385|364936594|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
105803665|NCT04896385|364936595|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
105803666|NCT04896385|364936596|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
105803667|NCT04896385|364936593|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
105803668|NCT04896385|364936594|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
105803669|NCT04896385|364936595|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
105803670|NCT04896385|364936596|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
105803671|NCT04896385|364936593|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
105803672|NCT04896385|364936594|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
105803673|NCT04896385|364936595|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
105803674|NCT04896385|364936596|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
105803675|NCT04896385|364936593|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
105803676|NCT04896385|364936594|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
105803677|NCT04896385|364936595|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
105803678|NCT04896385|364936596|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
105803679|NCT04896385|364936593|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
105803680|NCT04896385|364936594|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
105803681|NCT04896385|364936595|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
105803682|NCT04896385|364936596|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
105803683|NCT04896385|364936593|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
105803684|NCT04896385|364936594|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
105803685|NCT04896385|364936595|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
105803686|NCT04896385|364936596|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
105803687|NCT01875445|364936597|FG000|Overall Study|Lost to Follow-up|5|||
105803688|NCT01875445|364936598|FG001|Overall Study|Lost to Follow-up|0|||
105803689|NCT01875445|364936597|FG000|Overall Study|Withdrawal by Subject|2|||
105803690|NCT01875445|364936598|FG001|Overall Study|Withdrawal by Subject|0|||
105803691|NCT05017493|364936599|FG000|Overall Study|Withdrawal by Subject|26|||
105803692|NCT05017493|364936600|FG001|Overall Study|Withdrawal by Subject|0|||
105803693|NCT05017493|364936599|FG000|Overall Study|Physician Decision|15|||
105803694|NCT05017493|364936600|FG001|Overall Study|Physician Decision|0|||
105803695|NCT05017493|364936599|FG000|Overall Study|Protocol Violation|81|||
105803696|NCT05017493|364936600|FG001|Overall Study|Protocol Violation|0|||
105803697|NCT02280356|364936609|FG000|Overall Study|Not Treated|2|||
105803698|NCT02280356|364936609|FG000|Overall Study|Withdrawal by Subject|1|||
105803699|NCT02280356|364936609|FG000|Overall Study|Not evaluable|2|||
105803700|NCT01484028|364936610|FG000|Period 1|Lost to Follow-up|0|||
105803701|NCT01484028|364936611|FG001|Period 1|Lost to Follow-up|1|||
105803702|NCT01484028|364936612|FG002|Period 1|Lost to Follow-up|0|||
105803703|NCT01484028|364936613|FG003|Period 1|Lost to Follow-up|0|||
105803704|NCT01484028|364936610|FG000|Period 1|Non-Compliance to Protocol|0|||
105803705|NCT01484028|364936611|FG001|Period 1|Non-Compliance to Protocol|1|||
105803706|NCT01484028|364936612|FG002|Period 1|Non-Compliance to Protocol|0|||
105803707|NCT01484028|364936613|FG003|Period 1|Non-Compliance to Protocol|1|||
105803708|NCT01484028|364936610|FG000|Period 1|Lens Discomfort|0|||
105803709|NCT01484028|364936611|FG001|Period 1|Lens Discomfort|1|||
105803710|NCT01484028|364936612|FG002|Period 1|Lens Discomfort|0|||
105803711|NCT01484028|364936613|FG003|Period 1|Lens Discomfort|0|||
105803712|NCT03493698|364936614|FG000|Treatment Period C|Adverse Event|1|||
105803713|NCT03493698|364936614|FG000|Treatment Period C|Withdrawal by Subject|1|||
105803714|NCT00395083|364936615|FG000|Overall Study|Withdrawal by Subject|6|||
105803715|NCT00395083|364936616|FG001|Overall Study|Withdrawal by Subject|5|||
105803716|NCT00395083|364936615|FG000|Overall Study|Developed another disease|4|||
105803717|NCT00395083|364936616|FG001|Overall Study|Developed another disease|3|||
105803718|NCT03760510|364936617|FG000|Overall Study|Not ventilated for 24 hours|105|||
105803719|NCT03760510|364936618|FG001|Overall Study|Not ventilated for 24 hours|97|||
105803720|NCT04147715|364936623|FG000|Overall Study|Adverse Event|0|||
105803721|NCT04147715|364936624|FG001|Overall Study|Adverse Event|0|||
105803722|NCT04147715|364936625|FG002|Overall Study|Adverse Event|0|||
105803723|NCT04147715|364936626|FG003|Overall Study|Adverse Event|0|||
105803724|NCT04147715|364936627|FG004|Overall Study|Adverse Event|0|||
105803725|NCT04147715|364936628|FG005|Overall Study|Adverse Event|0|||
105803726|NCT04147715|364936629|FG006|Overall Study|Adverse Event|0|||
105803727|NCT04147715|364936630|FG007|Overall Study|Adverse Event|2|||
105803728|NCT04147715|364936631|FG008|Overall Study|Adverse Event|1|||
105803729|NCT04147715|364936632|FG009|Overall Study|Adverse Event|0|||
105803730|NCT04147715|364936633|FG010|Overall Study|Adverse Event|0|||
105803731|NCT04147715|364936634|FG011|Overall Study|Adverse Event|0|||
105803732|NCT00926289|364936636|FG000|Overall Study|Adverse Event|9|||
105803733|NCT00926289|364936637|FG001|Overall Study|Adverse Event|11|||
105803734|NCT00926289|364936636|FG000|Overall Study|Protocol Violation|8|||
105803735|NCT00926289|364936637|FG001|Overall Study|Protocol Violation|12|||
105803736|NCT00926289|364936636|FG000|Overall Study|Lost to Follow-up|3|||
105803737|NCT00926289|364936637|FG001|Overall Study|Lost to Follow-up|6|||
105803738|NCT00926289|364936636|FG000|Overall Study|Withdrawal by Subject|4|||
105803739|NCT00926289|364936637|FG001|Overall Study|Withdrawal by Subject|4|||
105803740|NCT00926289|364936636|FG000|Overall Study|Other|1|||
105803741|NCT00926289|364936637|FG001|Overall Study|Other|3|||
105803742|NCT01199601|364936640|FG000|Overall Study|Lost to Follow-up|47|||
105803743|NCT01199601|364936641|FG001|Overall Study|Lost to Follow-up|66|||
105803744|NCT01199601|364936640|FG000|Overall Study|Withdrawal by Subject|15|||
105803745|NCT01199601|364936641|FG001|Overall Study|Withdrawal by Subject|3|||
105803746|NCT01199601|364936640|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
105803747|NCT01199601|364936641|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
105803748|NCT02629965|364936643|FG000|Period 1|Adverse Event|1|||
105803749|NCT02629965|364936644|FG001|Period 1|Adverse Event|0|||
105950261|NCT01882465|365482342|FG006|Period 2|Protocol Violation|0|||
105950262|NCT00696878|365482347|FG000|Overall Study|Adverse Event|8|||
105950263|NCT00696878|365482347|FG000|Overall Study|Withdrawal by Subject|87|||
105950264|NCT00696878|365482347|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
105950265|NCT00696878|365482347|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
105803750|NCT02629965|364936643|FG000|Period 1|Unexpected worsening of disease|2|||
105803751|NCT02629965|364936644|FG001|Period 1|Unexpected worsening of disease|0|||
105803752|NCT02629965|364936643|FG000|Period 1|Other than listed above|1|||
105950266|NCT00696878|365482347|FG000|Overall Study|Trial stopped|32|||
105950267|NCT00696878|365482347|FG000|Overall Study|Other reason (not specified)|55|||
105803753|NCT02629965|364936644|FG001|Period 1|Other than listed above|2|||
105803754|NCT02629965|364936643|FG000|Period 2|Adverse Event|1|||
105803755|NCT02629965|364936644|FG001|Period 2|Adverse Event|0|||
105803756|NCT00299728|364936647|FG000|Overall Study|Lost to Follow-up|0|||
105803757|NCT00299728|364936648|FG001|Overall Study|Lost to Follow-up|1|||
105803758|NCT00299728|364936647|FG000|Overall Study|Withdrawal by Subject|0|||
105803759|NCT00299728|364936648|FG001|Overall Study|Withdrawal by Subject|1|||
105803760|NCT00299728|364936647|FG000|Overall Study|Progressive disease|0|||
105803761|NCT00299728|364936648|FG001|Overall Study|Progressive disease|1|||
105803762|NCT03387059|364936651|FG000|Overall Study|Study termination|5|||
105803763|NCT03387059|364936652|FG001|Overall Study|Study termination|4|||
105950268|NCT03937479|365482349|FG000|Overall Study|Adverse Event|2|||
105950269|NCT03937479|365482350|FG001|Overall Study|Adverse Event|3|||
105950270|NCT03937479|365482351|FG002|Overall Study|Adverse Event|0|||
105950271|NCT03937479|365482352|FG003|Overall Study|Adverse Event|0|||
105950272|NCT03937479|365482353|FG004|Overall Study|Adverse Event|1|||
105950273|NCT03937479|365482349|FG000|Overall Study|Withdrawal by Subject|3|||
105950274|NCT03937479|365482350|FG001|Overall Study|Withdrawal by Subject|5|||
105950275|NCT03937479|365482351|FG002|Overall Study|Withdrawal by Subject|2|||
105950276|NCT03937479|365482352|FG003|Overall Study|Withdrawal by Subject|2|||
105950277|NCT03937479|365482353|FG004|Overall Study|Withdrawal by Subject|1|||
105950278|NCT03937479|365482349|FG000|Overall Study|Protocol Violation|5|||
105950279|NCT03937479|365482350|FG001|Overall Study|Protocol Violation|6|||
105950280|NCT03937479|365482351|FG002|Overall Study|Protocol Violation|4|||
105950281|NCT03937479|365482352|FG003|Overall Study|Protocol Violation|3|||
105950282|NCT03937479|365482353|FG004|Overall Study|Protocol Violation|2|||
105950283|NCT03937479|365482349|FG000|Overall Study|Lost to Follow-up|0|||
105950284|NCT03937479|365482350|FG001|Overall Study|Lost to Follow-up|1|||
105950285|NCT03937479|365482351|FG002|Overall Study|Lost to Follow-up|0|||
105950286|NCT03937479|365482352|FG003|Overall Study|Lost to Follow-up|1|||
105756860|NCT02119026|364761561|FG000|1st-line Treatment|Patient condition or compliance|6|||
105756861|NCT02119026|364761562|FG001|1st-line Treatment|Patient condition or compliance|4|||
105756862|NCT02119026|364761561|FG000|1st-line Treatment|Surgery of metastases|2|||
105756863|NCT02119026|364761562|FG001|1st-line Treatment|Surgery of metastases|1|||
105950287|NCT03937479|365482353|FG004|Overall Study|Lost to Follow-up|0|||
105950288|NCT03937479|365482349|FG000|Overall Study|Physician Decision|0|||
105950289|NCT03937479|365482350|FG001|Overall Study|Physician Decision|0|||
105950290|NCT03937479|365482351|FG002|Overall Study|Physician Decision|1|||
105950291|NCT03937479|365482352|FG003|Overall Study|Physician Decision|0|||
105950292|NCT03937479|365482353|FG004|Overall Study|Physician Decision|1|||
105756864|NCT02119026|364761561|FG000|1st-line Treatment|Death|2|||
105756865|NCT02119026|364761562|FG001|1st-line Treatment|Death|1|||
105756866|NCT02119026|364761561|FG000|2nd-line Treatment|Lost to Follow-up|2|||
105756867|NCT02119026|364761562|FG001|2nd-line Treatment|Lost to Follow-up|0|||
105756868|NCT02119026|364761561|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
105756869|NCT02119026|364761562|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
105756870|NCT02119026|364761561|FG000|2nd-line Treatment|Adverse Event|4|||
105756871|NCT02119026|364761562|FG001|2nd-line Treatment|Adverse Event|1|||
105756872|NCT04295356|364761563|FG000|Overall Study|Physician Decision|1|||
105756873|NCT04295356|364761564|FG001|Overall Study|Physician Decision|0|||
105756874|NCT04295356|364761563|FG000|Overall Study|Lost to Follow-up|0|||
105756875|NCT04295356|364761564|FG001|Overall Study|Lost to Follow-up|3|||
105756876|NCT04295356|364761563|FG000|Overall Study|Protocol Violation|0|||
105756877|NCT04295356|364761564|FG001|Overall Study|Protocol Violation|1|||
105756878|NCT00469209|364761571|FG000|Overall Study|Adverse Event|1|||
105756879|NCT00469209|364761572|FG001|Overall Study|Adverse Event|0|||
105756880|NCT00469209|364761573|FG002|Overall Study|Adverse Event|1|||
105756881|NCT00712933|364761574|FG000|Overall Study|Adverse Event|69|||
105756882|NCT00712933|364761574|FG000|Overall Study|Lack of Efficacy|6|||
105756883|NCT00712933|364761574|FG000|Overall Study|Lost to Follow-up|22|||
105756884|NCT00712933|364761574|FG000|Overall Study|Non-compliance with study drug|13|||
105756885|NCT00712933|364761574|FG000|Overall Study|Other Pregnancy|37|||
105756886|NCT00712933|364761574|FG000|Overall Study|Sponsor decision|14|||
105756887|NCT00712933|364761574|FG000|Overall Study|Withdrew consent|4|||
105756888|NCT00712933|364761574|FG000|Overall Study|Hip replacement surgery|1|||
105756889|NCT00712933|364761574|FG000|Overall Study|Involved in Clinical research|3|||
105756890|NCT00712933|364761574|FG000|Overall Study|Participant hospitalized|1|||
105756891|NCT00712933|364761574|FG000|Overall Study|Participant travelled overseas|2|||
105756892|NCT00712933|364761574|FG000|Overall Study|Death of patient|1|||
105756893|NCT00712933|364761574|FG000|Overall Study|Other Physician decision|1|||
105756894|NCT00712933|364761574|FG000|Overall Study|Not committed to contraception|1|||
105756895|NCT00712933|364761574|FG000|Overall Study|Participant received medication|1|||
105756896|NCT00712933|364761574|FG000|Overall Study|Physician Decision|36|||
105756897|NCT00712933|364761574|FG000|Overall Study|Protocol Violation|4|||
105756898|NCT00712933|364761574|FG000|Overall Study|Withdrawal by Subject|151|||
105756899|NCT01329341|364761575|FG000|Overall Study|Withdrawal by Subject|44|||
105756900|NCT00448760|364761578|FG000|Overall Study|Death|3|||
105756901|NCT01295580|364761579|FG000|Overall Study|Protocol Violation|4|||
105756902|NCT01295580|364761580|FG001|Overall Study|Protocol Violation|2|||
105756903|NCT01295580|364761579|FG000|Overall Study|Withdrawal by Subject|1|||
105756904|NCT01295580|364761580|FG001|Overall Study|Withdrawal by Subject|4|||
105950293|NCT01193101|365482356|FG000|Overall Study|Adverse Event|0|||
105950294|NCT01193101|365482357|FG001|Overall Study|Adverse Event|1|||
105950295|NCT01193101|365482358|FG002|Overall Study|Adverse Event|1|||
105756905|NCT01295580|364761579|FG000|Overall Study|Adverse Event|2|||
105950296|NCT01193101|365482359|FG003|Overall Study|Adverse Event|3|||
105756906|NCT01295580|364761580|FG001|Overall Study|Adverse Event|1|||
105756907|NCT01295580|364761579|FG000|Overall Study|Lost to Follow-up|1|||
105756908|NCT01295580|364761580|FG001|Overall Study|Lost to Follow-up|0|||
105950297|NCT01193101|365482356|FG000|Overall Study|Lack of Efficacy|3|||
105950298|NCT01193101|365482357|FG001|Overall Study|Lack of Efficacy|1|||
105803764|NCT03586830|364936653|FG000|Overall Study|Site terminated by Sponsor|1|||
105803765|NCT03586830|364936654|FG001|Overall Study|Site terminated by Sponsor|4|||
105803766|NCT03586830|364936655|FG002|Overall Study|Site terminated by Sponsor|3|||
105803767|NCT03586830|364936656|FG003|Overall Study|Site terminated by Sponsor|3|||
105803768|NCT03586830|364936653|FG000|Overall Study|Lost to Follow-up|0|||
105803769|NCT03586830|364936654|FG001|Overall Study|Lost to Follow-up|2|||
105803770|NCT03586830|364936655|FG002|Overall Study|Lost to Follow-up|2|||
105803771|NCT03586830|364936656|FG003|Overall Study|Lost to Follow-up|1|||
105803772|NCT03586830|364936653|FG000|Overall Study|Withdrawal by Subject|1|||
105803773|NCT03586830|364936654|FG001|Overall Study|Withdrawal by Subject|0|||
105803774|NCT03586830|364936655|FG002|Overall Study|Withdrawal by Subject|3|||
105803775|NCT03586830|364936656|FG003|Overall Study|Withdrawal by Subject|1|||
105803776|NCT00275028|364938588|FG000|Overall Study|Withdrew consent before treatment began|1|||
105803777|NCT00275028|364938588|FG000|Overall Study|Withdrawal by Subject|5|||
105803778|NCT00275028|364938588|FG000|Overall Study|Adverse Event|9|||
105803779|NCT00275028|364938588|FG000|Overall Study|Progressive Disease|30|||
105803780|NCT00275028|364938588|FG000|Overall Study|Physician Decision|2|||
105803781|NCT01059071|364938591|FG000|Overall Study|Lack of Efficacy|1|||
105803782|NCT01059071|364938592|FG001|Overall Study|Lack of Efficacy|4|||
105803783|NCT01059071|364938593|FG002|Overall Study|Lack of Efficacy|2|||
105803784|NCT01059071|364938594|FG003|Overall Study|Lack of Efficacy|3|||
105803785|NCT01059071|364938591|FG000|Overall Study|Withdrawal by Subject|1|||
105803786|NCT01059071|364938592|FG001|Overall Study|Withdrawal by Subject|0|||
105803787|NCT01059071|364938593|FG002|Overall Study|Withdrawal by Subject|0|||
105803788|NCT01059071|364938594|FG003|Overall Study|Withdrawal by Subject|2|||
105803789|NCT01059071|364938591|FG000|Overall Study|Physician Decision|0|||
105803790|NCT01059071|364938592|FG001|Overall Study|Physician Decision|0|||
105803791|NCT01059071|364938593|FG002|Overall Study|Physician Decision|0|||
105803792|NCT01059071|364938594|FG003|Overall Study|Physician Decision|1|||
105803793|NCT03840811|364938603|FG000|Overall Study|Lost to Follow-up|0|||
105803794|NCT03840811|364938604|FG001|Overall Study|Lost to Follow-up|0|||
105803795|NCT03840811|364938605|FG002|Overall Study|Lost to Follow-up|1|||
105950299|NCT01193101|365482358|FG002|Overall Study|Lack of Efficacy|0|||
105950300|NCT01193101|365482359|FG003|Overall Study|Lack of Efficacy|8|||
105803796|NCT01904383|364938606|FG000|Overall Study|CRF not collected|117|||
105803797|NCT01904383|364938606|FG000|Overall Study|Reason not listed|147|||
105803798|NCT01904383|364938606|FG000|Overall Study|Lost to Follow-up|674|||
105803799|NCT01904383|364938606|FG000|Overall Study|Lack of Efficacy|370|||
105803800|NCT01904383|364938606|FG000|Overall Study|Improvement|141|||
105803801|NCT01904383|364938606|FG000|Overall Study|Adverse Event|271|||
105803802|NCT01904383|364938606|FG000|Overall Study|No patient visit after entry|54|||
105803803|NCT01294592|364938607|FG000|Overall Study|Adverse Event|28|||
105803804|NCT01294592|364938608|FG001|Overall Study|Adverse Event|13|||
105803805|NCT01294592|364938607|FG000|Overall Study|Lack of Efficacy|7|||
105803806|NCT01294592|364938608|FG001|Overall Study|Lack of Efficacy|5|||
105803807|NCT01294592|364938607|FG000|Overall Study|Protocol Violation|1|||
105803808|NCT01294592|364938608|FG001|Overall Study|Protocol Violation|7|||
105803809|NCT01294592|364938607|FG000|Overall Study|Lost to Follow-up|7|||
105950301|NCT01193101|365482356|FG000|Overall Study|Withdrawal by Subject|2|||
105950302|NCT01193101|365482357|FG001|Overall Study|Withdrawal by Subject|4|||
105950303|NCT01193101|365482358|FG002|Overall Study|Withdrawal by Subject|1|||
105950304|NCT01193101|365482359|FG003|Overall Study|Withdrawal by Subject|1|||
105950305|NCT01193101|365482356|FG000|Overall Study|Administrative problems|0|||
105803810|NCT01294592|364938608|FG001|Overall Study|Lost to Follow-up|9|||
105803811|NCT01294592|364938607|FG000|Overall Study|Physician Decision|6|||
105803812|NCT01294592|364938608|FG001|Overall Study|Physician Decision|11|||
105803813|NCT01294592|364938607|FG000|Overall Study|Withdrawal by Subject|28|||
105803814|NCT01294592|364938608|FG001|Overall Study|Withdrawal by Subject|28|||
105803815|NCT01084005|364938609|FG000|Overall Study|Adverse Event|1|||
105803816|NCT01084005|364938610|FG001|Overall Study|Adverse Event|8|||
105803817|NCT01084005|364938609|FG000|Overall Study|Protocol Violation|3|||
105803818|NCT01084005|364938610|FG001|Overall Study|Protocol Violation|7|||
105803819|NCT01084005|364938609|FG000|Overall Study|Withdrawal by Subject|1|||
105803820|NCT01084005|364938610|FG001|Overall Study|Withdrawal by Subject|1|||
105803821|NCT00549198|364938611|FG000|Overall Study|Adverse Event|28|||
105803822|NCT00549198|364938612|FG001|Overall Study|Adverse Event|26|||
105803823|NCT00549198|364938611|FG000|Overall Study|Insufficient Viral Load Response|4|||
105950306|NCT01193101|365482357|FG001|Overall Study|Administrative problems|0|||
105950307|NCT01193101|365482358|FG002|Overall Study|Administrative problems|1|||
105950308|NCT01193101|365482359|FG003|Overall Study|Administrative problems|0|||
105803824|NCT00549198|364938612|FG001|Overall Study|Insufficient Viral Load Response|2|||
105803825|NCT00549198|364938611|FG000|Overall Study|Protocol-defined Virological Failure|7|||
105803826|NCT00549198|364938612|FG001|Overall Study|Protocol-defined Virological Failure|0|||
105803827|NCT00549198|364938611|FG000|Overall Study|Non-compliance|2|||
105803828|NCT00549198|364938612|FG001|Overall Study|Non-compliance|4|||
105803829|NCT00549198|364938611|FG000|Overall Study|Lost to Follow-up|7|||
105803830|NCT00549198|364938612|FG001|Overall Study|Lost to Follow-up|8|||
105950309|NCT01193101|365482356|FG000|Overall Study|Abnormal test procedure results|0|||
105950310|NCT01193101|365482357|FG001|Overall Study|Abnormal test procedure results|1|||
105950311|NCT01193101|365482358|FG002|Overall Study|Abnormal test procedure results|0|||
105756909|NCT01295580|364761579|FG000|Overall Study|Lack of Efficacy|1|||
105756910|NCT01295580|364761580|FG001|Overall Study|Lack of Efficacy|0|||
105756911|NCT01295580|364761579|FG000|Overall Study|Other: inconvenience|1|||
105756912|NCT01295580|364761580|FG001|Overall Study|Other: inconvenience|0|||
105756913|NCT01295580|364761579|FG000|Overall Study|Other: family objection|0|||
105756914|NCT01295580|364761580|FG001|Overall Study|Other: family objection|1|||
105756915|NCT04603391|364761583|FG000|First Intervention (4 Days)|Adverse Event|1|||
105756916|NCT04603391|364761584|FG001|First Intervention (4 Days)|Adverse Event|0|||
105756917|NCT04603391|364761583|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
105756918|NCT04603391|364761584|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
105756919|NCT02759861|364761585|FG000|Overall Study|Death|1|||
105756920|NCT05590767|364761589|FG000|Overall Study|Protocol Violation|1|||
105756921|NCT05590767|364761589|FG000|Overall Study|surgery canceled|1|||
105756922|NCT05590767|364761589|FG000|Overall Study|interscalene brachial block not performed|1|||
105756923|NCT00992186|364761590|FG000|Overall Study|Withdrawal by Subject|2|||
105756924|NCT00992186|364761590|FG000|Overall Study|Protocol Violation|1|||
105756925|NCT00992186|364761590|FG000|Overall Study|Physician Decision|1|||
105756926|NCT00992186|364761590|FG000|Overall Study|Adverse Event|9|||
105756927|NCT00992186|364761590|FG000|Overall Study|Progressive Disease|30|||
105756928|NCT00992186|364761590|FG000|Overall Study|Refusal To Receive Study Agent|3|||
105756929|NCT02378883|364761592|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
105756930|NCT02378883|364761592|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
105756931|NCT02378883|364761592|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
105756932|NCT02378883|364761592|FG000|30 Day Follow-Up|Physician Decision|2|||
105756933|NCT02378883|364761592|FG000|30 Day Follow-Up|Missed Visit|2|||
105756934|NCT02378883|364761592|FG000|30 Day Follow-Up|Death|1|||
105756935|NCT02378883|364761592|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
105756936|NCT02378883|364761592|FG000|12 Months Follow-Up|Death|2|||
105756937|NCT00318565|364761593|FG000|Overall Study|Excluded per protocol|24|||
105756938|NCT03037307|364761594|FG000|Period 1|Did Not Meet Study Criteria|0|||
105756939|NCT03037307|364761595|FG001|Period 1|Did Not Meet Study Criteria|0|||
105756940|NCT03037307|364761596|FG002|Period 1|Did Not Meet Study Criteria|0|||
105756941|NCT03037307|364761597|FG003|Period 1|Did Not Meet Study Criteria|1|||
105756942|NCT03037307|364761598|FG004|Period 1|Did Not Meet Study Criteria|0|||
105756943|NCT03037307|364761599|FG005|Period 1|Did Not Meet Study Criteria|0|||
105756944|NCT00691093|364761601|FG000|Overall Study|Adverse Event|1|||
105756945|NCT00691093|364761601|FG000|Overall Study|Lost to Follow-up|1|||
105756946|NCT00691093|364761601|FG000|Overall Study|Lack of Efficacy|1|||
105756947|NCT00691093|364761601|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
105756948|NCT00270998|364761602|FG000|3 Month Follow-up|Adverse Event|1|||
105756949|NCT00270998|364761603|FG001|3 Month Follow-up|Adverse Event|0|||
105756950|NCT00270998|364761604|FG002|3 Month Follow-up|Adverse Event|0|||
105756951|NCT00270998|364761602|FG000|3 Month Follow-up|Lack of Efficacy|1|||
105756952|NCT00270998|364761603|FG001|3 Month Follow-up|Lack of Efficacy|2|||
105756953|NCT00270998|364761604|FG002|3 Month Follow-up|Lack of Efficacy|1|||
105756954|NCT00270998|364761602|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
105756955|NCT00270998|364761603|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
105756956|NCT00270998|364761604|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
105756957|NCT00270998|364761602|FG000|3 Month Follow-up|Pessary did not fit|12|||
105756958|NCT00270998|364761603|FG001|3 Month Follow-up|Pessary did not fit|0|||
105756959|NCT00270998|364761604|FG002|3 Month Follow-up|Pessary did not fit|0|||
105756960|NCT00270998|364761602|FG000|3 Month Follow-up|Personal/family health|1|||
105756961|NCT00270998|364761603|FG001|3 Month Follow-up|Personal/family health|1|||
105756962|NCT00270998|364761604|FG002|3 Month Follow-up|Personal/family health|0|||
105756963|NCT00270998|364761602|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
105756964|NCT00270998|364761603|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
105756965|NCT00270998|364761604|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
105756966|NCT00270998|364761602|FG000|12 Month Follow-up|Lack of Efficacy|5|||
105756967|NCT00270998|364761603|FG001|12 Month Follow-up|Lack of Efficacy|4|||
105756968|NCT00270998|364761604|FG002|12 Month Follow-up|Lack of Efficacy|3|||
105756969|NCT00270998|364761602|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
105756970|NCT00270998|364761603|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
105756971|NCT00270998|364761604|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
105756972|NCT00270998|364761602|FG000|12 Month Follow-up|Pessary did not fit|1|||
105756973|NCT00270998|364761603|FG001|12 Month Follow-up|Pessary did not fit|0|||
105756974|NCT00270998|364761604|FG002|12 Month Follow-up|Pessary did not fit|0|||
105756975|NCT00270998|364761602|FG000|12 Month Follow-up|Personal/family health|0|||
105756976|NCT00270998|364761603|FG001|12 Month Follow-up|Personal/family health|5|||
105756977|NCT00270998|364761604|FG002|12 Month Follow-up|Personal/family health|1|||
105756978|NCT00270998|364761602|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
105950312|NCT01193101|365482359|FG003|Overall Study|Abnormal test procedure results|0|||
105756979|NCT00270998|364761603|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
105756980|NCT00270998|364761604|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
105950313|NCT00950651|365482362|FG000|Overall Study|Adverse Event|17|||
105950314|NCT00950651|365482363|FG001|Overall Study|Adverse Event|20|||
105803831|NCT00549198|364938611|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
105803832|NCT00549198|364938612|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
105803833|NCT00549198|364938611|FG000|Overall Study|Protocol Violation|7|||
105803834|NCT00549198|364938612|FG001|Overall Study|Protocol Violation|2|||
105803835|NCT00549198|364938611|FG000|Overall Study|Investigator Decision|4|||
105803836|NCT00549198|364938612|FG001|Overall Study|Investigator Decision|3|||
105803837|NCT00549198|364938611|FG000|Overall Study|Withdrawal by Subject|7|||
105803838|NCT00549198|364938612|FG001|Overall Study|Withdrawal by Subject|7|||
105803839|NCT00549198|364938611|FG000|Overall Study|Disease Progression|1|||
105803840|NCT00549198|364938612|FG001|Overall Study|Disease Progression|0|||
105803841|NCT00549198|364938611|FG000|Overall Study|Participant Moved|2|||
105803842|NCT00549198|364938612|FG001|Overall Study|Participant Moved|0|||
105803843|NCT00549198|364938611|FG000|Overall Study|Participant not able to perform Week 96|1|||
105803844|NCT00549198|364938612|FG001|Overall Study|Participant not able to perform Week 96|0|||
105803845|NCT00549198|364938611|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
105803846|NCT00549198|364938612|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
105803847|NCT00549198|364938611|FG000|Overall Study|Prohibited Medication|1|||
105803848|NCT00549198|364938612|FG001|Overall Study|Prohibited Medication|2|||
105803849|NCT00549198|364938611|FG000|Overall Study|Participant planning pregnancy|1|||
105803850|NCT00549198|364938612|FG001|Overall Study|Participant planning pregnancy|0|||
105803851|NCT00549198|364938611|FG000|Overall Study|Participant overweight, no scan possible|1|||
105803852|NCT00549198|364938612|FG001|Overall Study|Participant overweight, no scan possible|0|||
105803853|NCT00549198|364938611|FG000|Overall Study|No scan facilities|0|||
105803854|NCT00549198|364938612|FG001|Overall Study|No scan facilities|2|||
105803855|NCT00549198|364938611|FG000|Overall Study|Pregnancy|0|||
105803856|NCT00549198|364938612|FG001|Overall Study|Pregnancy|3|||
105803857|NCT00549198|364938611|FG000|Overall Study|Not Exposed to Study Drug|3|||
105803858|NCT00549198|364938612|FG001|Overall Study|Not Exposed to Study Drug|4|||
105803859|NCT01473758|364938614|FG000|Cycle 1|Adverse Event|10|||
105803860|NCT01473758|364938615|FG001|Cycle 1|Adverse Event|2|||
105803861|NCT01473758|364938616|FG002|Cycle 1|Adverse Event|0|||
105803862|NCT01473758|364938617|FG003|Cycle 1|Adverse Event|0|||
105803863|NCT01473758|364938614|FG000|Cycle 1|Withdrawal by Subject|1|||
105803864|NCT01473758|364938615|FG001|Cycle 1|Withdrawal by Subject|1|||
105803865|NCT01473758|364938616|FG002|Cycle 1|Withdrawal by Subject|0|||
105803866|NCT01473758|364938617|FG003|Cycle 1|Withdrawal by Subject|0|||
105803867|NCT01473758|364938614|FG000|Cycle 2|Adverse Event|0|||
105803868|NCT01473758|364938615|FG001|Cycle 2|Adverse Event|0|||
105803869|NCT01473758|364938616|FG002|Cycle 2|Adverse Event|5|||
105803870|NCT01473758|364938617|FG003|Cycle 2|Adverse Event|0|||
105803871|NCT03650400|364938619|FG000|Overall Study|Study terminated by sponsor|0|||
105803872|NCT03650400|364938620|FG001|Overall Study|Study terminated by sponsor|5|||
105803873|NCT03572933|364938623|FG000|Overall Study|Adverse Event|4|||
105803874|NCT03572933|364938624|FG001|Overall Study|Adverse Event|1|||
105803875|NCT03572933|364938623|FG000|Overall Study|Withdrawal by Subject|0|||
105803876|NCT03572933|364938624|FG001|Overall Study|Withdrawal by Subject|1|||
105803877|NCT02049359|364938629|FG000|Overall Study|Lost to Follow-up|26|||
105803878|NCT02049359|364938630|FG001|Overall Study|Lost to Follow-up|19|||
105803879|NCT03377556|364938631|FG000|Overall Study|Adverse Event|5|||
105803880|NCT03377556|364938631|FG000|Overall Study|Refusal unrelated to adverse events|1|||
105803881|NCT03377556|364938631|FG000|Overall Study|Progression/relapse|38|||
105803882|NCT03377556|364938631|FG000|Overall Study|Death|3|||
105803883|NCT00112489|364938657|FG000|Overall Study|Refused further treatment|8|||
105803884|NCT00112489|364938657|FG000|Overall Study|Adverse Event|12|||
105950315|NCT00950651|365482362|FG000|Overall Study|Death|1|||
105950316|NCT00950651|365482363|FG001|Overall Study|Death|0|||
105950317|NCT00950651|365482362|FG000|Overall Study|Lack of Efficacy|2|||
105950318|NCT00950651|365482363|FG001|Overall Study|Lack of Efficacy|2|||
105950319|NCT00950651|365482362|FG000|Overall Study|Protocol Violation|3|||
105950320|NCT00950651|365482363|FG001|Overall Study|Protocol Violation|4|||
105950321|NCT00950651|365482362|FG000|Overall Study|Withdrawal by Subject|8|||
105950322|NCT00950651|365482363|FG001|Overall Study|Withdrawal by Subject|9|||
105803885|NCT00112489|364938657|FG000|Overall Study|Death|2|||
105803886|NCT00112489|364938657|FG000|Overall Study|Other, Not Specified|9|||
105950323|NCT00776789|365482364|FG000|Overall Study|Consent refusal|2|||
105950324|NCT00776789|365482365|FG001|Overall Study|Consent refusal|2|||
105950325|NCT00776789|365482364|FG000|Overall Study|Poor quality video|1|||
105803887|NCT00112489|364938657|FG000|Overall Study|Patient never treated|2|||
105803888|NCT00112489|364938657|FG000|Overall Study|Ineligible|7|||
105803889|NCT01797120|364938658|FG000|Overall Study|Disesae progression|37|||
105803890|NCT01797120|364938659|FG001|Overall Study|Disesae progression|49|||
105803891|NCT01797120|364938658|FG000|Overall Study|Adverse Event|13|||
105803892|NCT01797120|364938659|FG001|Overall Study|Adverse Event|5|||
105803893|NCT01797120|364938658|FG000|Overall Study|Withdrawal by Subject|6|||
105803894|NCT01797120|364938659|FG001|Overall Study|Withdrawal by Subject|6|||
105803895|NCT01797120|364938658|FG000|Overall Study|Symptomatic progression|2|||
105803896|NCT01797120|364938659|FG001|Overall Study|Symptomatic progression|1|||
105803897|NCT01797120|364938658|FG000|Overall Study|Non-compliance|1|||
105803898|NCT01797120|364938659|FG001|Overall Study|Non-compliance|0|||
105803899|NCT01797120|364938658|FG000|Overall Study|Physician Decision|3|||
105803900|NCT01797120|364938659|FG001|Overall Study|Physician Decision|0|||
105803901|NCT01797120|364938658|FG000|Overall Study|still on treatment|2|||
105803902|NCT01797120|364938659|FG001|Overall Study|still on treatment|4|||
105803903|NCT01797120|364938658|FG000|Overall Study|never start protocol therapy|2|||
105803904|NCT01797120|364938659|FG001|Overall Study|never start protocol therapy|0|||
105803905|NCT01567306|364938660|FG000|Overall Study|Protocol Violation|2|||
105803906|NCT01567306|364938661|FG001|Overall Study|Protocol Violation|2|||
105803907|NCT01567306|364938662|FG002|Overall Study|Protocol Violation|0|||
105803908|NCT01567306|364938663|FG003|Overall Study|Protocol Violation|3|||
105803909|NCT01567306|364938664|FG004|Overall Study|Protocol Violation|1|||
105803910|NCT01567306|364938665|FG005|Overall Study|Protocol Violation|1|||
105803911|NCT01567306|364938660|FG000|Overall Study|Change site living|1|||
105803912|NCT01567306|364938661|FG001|Overall Study|Change site living|0|||
105803913|NCT01567306|364938662|FG002|Overall Study|Change site living|0|||
105803914|NCT01567306|364938663|FG003|Overall Study|Change site living|0|||
105803915|NCT01567306|364938664|FG004|Overall Study|Change site living|0|||
105803916|NCT01567306|364938665|FG005|Overall Study|Change site living|0|||
105803917|NCT01567306|364938660|FG000|Overall Study|Adverse Event|0|||
105803918|NCT01567306|364938661|FG001|Overall Study|Adverse Event|0|||
105803919|NCT01567306|364938662|FG002|Overall Study|Adverse Event|0|||
105803920|NCT01567306|364938663|FG003|Overall Study|Adverse Event|2|||
105803921|NCT01567306|364938664|FG004|Overall Study|Adverse Event|4|||
105803922|NCT01567306|364938665|FG005|Overall Study|Adverse Event|1|||
105803923|NCT01567306|364938660|FG000|Overall Study|Lost to Follow-up|0|||
105803924|NCT01567306|364938661|FG001|Overall Study|Lost to Follow-up|0|||
105803925|NCT01567306|364938662|FG002|Overall Study|Lost to Follow-up|0|||
105803926|NCT01567306|364938663|FG003|Overall Study|Lost to Follow-up|0|||
105803927|NCT01567306|364938664|FG004|Overall Study|Lost to Follow-up|2|||
105803928|NCT01567306|364938665|FG005|Overall Study|Lost to Follow-up|0|||
105803929|NCT01567306|364938660|FG000|Overall Study|Withdrawal by Subject|0|||
105803930|NCT01567306|364938661|FG001|Overall Study|Withdrawal by Subject|0|||
105803931|NCT01567306|364938662|FG002|Overall Study|Withdrawal by Subject|0|||
105803932|NCT01567306|364938663|FG003|Overall Study|Withdrawal by Subject|0|||
105803933|NCT01567306|364938664|FG004|Overall Study|Withdrawal by Subject|0|||
105803934|NCT01567306|364938665|FG005|Overall Study|Withdrawal by Subject|1|||
105803935|NCT01489956|364938666|FG000|Overall Study|Lost to Follow-up|1|||
105803936|NCT01489956|364938667|FG001|Overall Study|Lost to Follow-up|0|||
105803937|NCT01489956|364938668|FG002|Overall Study|Lost to Follow-up|0|||
105803938|NCT01489956|364938666|FG000|Overall Study|Withdrawal by Subject|0|||
105803939|NCT01489956|364938667|FG001|Overall Study|Withdrawal by Subject|0|||
105803940|NCT01489956|364938668|FG002|Overall Study|Withdrawal by Subject|1|||
105803941|NCT02114931|364938669|FG000|Overall Study|Withdrawal by Subject|15|||
105803942|NCT02114931|364938670|FG001|Overall Study|Withdrawal by Subject|18|||
105803943|NCT02114931|364938669|FG000|Overall Study|Adverse Event|4|||
105803944|NCT02114931|364938670|FG001|Overall Study|Adverse Event|6|||
105803945|NCT02114931|364938669|FG000|Overall Study|Lost to Follow-up|3|||
105803946|NCT02114931|364938670|FG001|Overall Study|Lost to Follow-up|3|||
105950326|NCT00776789|365482365|FG001|Overall Study|Poor quality video|1|||
105950327|NCT02850978|365482369|FG000|Overall Study|Uncollectable CRF|27|||
105950328|NCT02850978|365482369|FG000|Overall Study|No visit since the first visit|35|||
105950329|NCT02850978|365482369|FG000|Overall Study|Adverse Event|81|||
105803947|NCT02114931|364938669|FG000|Overall Study|Physician Decision|1|||
105950330|NCT02850978|365482369|FG000|Overall Study|Lack of Efficacy|40|||
105950331|NCT02850978|365482369|FG000|Overall Study|Improvement in condition|34|||
105950332|NCT02850978|365482369|FG000|Overall Study|Lost to Follow-up|121|||
105950333|NCT02850978|365482369|FG000|Overall Study|Reason not listed|88|||
105950334|NCT00114127|365482372|FG000|Overall Study|Adverse Event|2|||
105950335|NCT00114127|365482373|FG001|Overall Study|Adverse Event|1|||
105803948|NCT02114931|364938670|FG001|Overall Study|Physician Decision|2|||
105803949|NCT02114931|364938669|FG000|Overall Study|Other|2|||
105803950|NCT02114931|364938670|FG001|Overall Study|Other|1|||
105803951|NCT03565211|364938671|FG000|Overall Study|Withdrawal by Subject|2|||
105803952|NCT03565211|364938671|FG000|Overall Study|Lost to Follow-up|1|||
105803953|NCT03565211|364938671|FG000|Overall Study|Adverse Event|44|||
105803954|NCT03565211|364938671|FG000|Overall Study|Personal issues|1|||
105803955|NCT04133519|364938676|FG000|Overall Study|Withdrawal by Subject|5|||
105803956|NCT04133519|364938677|FG001|Overall Study|Withdrawal by Subject|4|||
105803957|NCT04133519|364938676|FG000|Overall Study|Protocol Violation|0|||
105950336|NCT00114127|365482372|FG000|Overall Study|Lost to Follow-up|1|||
105950337|NCT00114127|365482373|FG001|Overall Study|Lost to Follow-up|0|||
105950338|NCT00114127|365482372|FG000|Overall Study|Withdrawal by Subject|1|||
105950339|NCT00114127|365482373|FG001|Overall Study|Withdrawal by Subject|3|||
105950340|NCT00881894|365482374|FG000|Overall Study|Consent withdrawn|0|||
105803958|NCT04133519|364938677|FG001|Overall Study|Protocol Violation|1|||
105803959|NCT04133519|364938676|FG000|Overall Study|Never started treatment|1|||
105756981|NCT01896856|364761605|FG000|Overall Study|Transportation issues / Non-compliance|0|||
105756982|NCT01896856|364761606|FG001|Overall Study|Transportation issues / Non-compliance|0|||
105756983|NCT01896856|364761607|FG002|Overall Study|Transportation issues / Non-compliance|1|||
105756984|NCT01896856|364761608|FG003|Overall Study|Transportation issues / Non-compliance|0|||
105756985|NCT01896856|364761609|FG004|Overall Study|Transportation issues / Non-compliance|0|||
105756986|NCT01896856|364761610|FG005|Overall Study|Transportation issues / Non-compliance|0|||
105756987|NCT00282867|364761611|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
105756988|NCT00282867|364761612|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
105756989|NCT00282867|364761613|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
105756990|NCT01700985|364761616|FG000|Overall Study|Incarcerated|0|||
105756991|NCT01700985|364761617|FG001|Overall Study|Incarcerated|1|||
105756992|NCT02677220|364761618|FG000|Overall Study|Adverse Event|1|||
105756993|NCT01504971|364761620|FG000|Overall Study|Physician Decision|13|||
105756994|NCT01357889|364761621|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
105756995|NCT01357889|364761622|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
105756996|NCT01357889|364761621|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
105756997|NCT01357889|364761622|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
105756998|NCT01357889|364761621|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
105756999|NCT01357889|364761622|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
105757000|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
105757001|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
105757002|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
105757003|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
105757004|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
105757005|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
105757006|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
105757007|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
105757008|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
105757009|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
105757010|NCT01357889|364761621|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
105757011|NCT01357889|364761622|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
105757012|NCT01357889|364761621|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
105757013|NCT01357889|364761622|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
105757014|NCT01357889|364761621|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
105757015|NCT01357889|364761622|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
105757016|NCT01357889|364761621|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
105757017|NCT01357889|364761622|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
105757018|NCT01357889|364761621|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
105757019|NCT01357889|364761622|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
105757020|NCT03970824|364761623|FG000|Overall Study|Withdrawal by Subject|1|||
105757021|NCT03970824|364761624|FG001|Overall Study|Withdrawal by Subject|1|||
105757022|NCT03970824|364761625|FG002|Overall Study|Withdrawal by Subject|3|||
105757023|NCT03970824|364761623|FG000|Overall Study|Lost to Follow-up|0|||
105757024|NCT03970824|364761624|FG001|Overall Study|Lost to Follow-up|2|||
105757025|NCT03970824|364761625|FG002|Overall Study|Lost to Follow-up|1|||
105757026|NCT03970824|364761623|FG000|Overall Study|Adverse Event|1|||
105757027|NCT03970824|364761624|FG001|Overall Study|Adverse Event|0|||
105757028|NCT03970824|364761625|FG002|Overall Study|Adverse Event|0|||
105757029|NCT01248364|364761626|FG000|Overall Study|Adverse Event|0|||
105757030|NCT01248364|364761627|FG001|Overall Study|Adverse Event|1|||
105757031|NCT01248364|364761628|FG002|Overall Study|Adverse Event|0|||
105757032|NCT01248364|364761629|FG003|Overall Study|Adverse Event|0|||
105757033|NCT02146248|364761630|FG000|Overall Study|Withdrawal by Subject|2|||
105757034|NCT01167582|364761631|FG000|Overall Study|Lost to Follow-up|0|||
105757035|NCT01167582|364761632|FG001|Overall Study|Lost to Follow-up|1|||
105757036|NCT00575094|364761633|FG000|Overall Study|Adverse Event|2|||
105757037|NCT00575094|364761633|FG000|Overall Study|Withdrawal by Subject|1|||
105757038|NCT03498287|364761636|FG000|Overall Study|Withdrawal by Subject|3|||
105757039|NCT03498287|364761637|FG001|Overall Study|Withdrawal by Subject|0|||
105757040|NCT03498287|364761636|FG000|Overall Study|Protocol Violation|0|||
105757041|NCT03498287|364761637|FG001|Overall Study|Protocol Violation|4|||
105757042|NCT03498287|364761636|FG000|Overall Study|Adverse Event|0|||
105757043|NCT03498287|364761637|FG001|Overall Study|Adverse Event|1|||
105757044|NCT02921763|364761638|FG000|Overall Study|Adverse Event|4|||
105757045|NCT02921763|364761638|FG000|Overall Study|Lost to Follow-up|4|||
105757046|NCT02921763|364761638|FG000|Overall Study|Lack of Efficacy|3|||
105757047|NCT02921763|364761638|FG000|Overall Study|Protocol Violation|2|||
105757048|NCT02921763|364761638|FG000|Overall Study|Withdrawal by Subject|2|||
105757049|NCT02921763|364761638|FG000|Overall Study|Physician Decision|1|||
105757050|NCT02921763|364761638|FG000|Overall Study|No data obtained|2|||
105757051|NCT01374217|364761639|FG000|Overall Study|Lack of Efficacy|13|||
105757052|NCT03371732|364761640|FG000|Overall Study|Withdrawal by Subject|9|||
105803960|NCT04133519|364938677|FG001|Overall Study|Never started treatment|1|||
105803961|NCT03840135|364938678|FG000|Overall Study|Protocol Violation|6|||
105803962|NCT03840135|364938679|FG001|Overall Study|Protocol Violation|1|||
105803963|NCT03840135|364938678|FG000|Overall Study|Withdrawal by Subject|1|||
105803964|NCT03840135|364938679|FG001|Overall Study|Withdrawal by Subject|0|||
105803965|NCT02063698|364938680|FG000|Overall Study|did not complete booklet for days 2-8|1|||
105803966|NCT02063698|364938681|FG001|Overall Study|did not complete booklet for days 2-8|2|||
105803967|NCT01092702|364938682|FG000|Overall Study|Withdrawal by Subject|7|||
105803968|NCT01092702|364938682|FG000|Overall Study|Lost to Follow-up|2|||
105803969|NCT03412019|364938685|FG000|Overall Study|Withdrawal by Subject|1|||
105803970|NCT03412019|364938686|FG001|Overall Study|Withdrawal by Subject|1|||
105803971|NCT00415532|364938687|FG000|Treatment Period|Adverse Event|2|||
105803972|NCT00415532|364938688|FG001|Treatment Period|Adverse Event|3|||
105803973|NCT00415532|364938687|FG000|Treatment Period|Death|2|||
105803974|NCT00415532|364938688|FG001|Treatment Period|Death|1|||
105803975|NCT00415532|364938687|FG000|Treatment Period|Lost to Follow-up|1|||
105950341|NCT00881894|365482375|FG001|Overall Study|Consent withdrawn|1|||
105950342|NCT00881894|365482374|FG000|Overall Study|Other reasons for premature termination|1|||
105803976|NCT00415532|364938688|FG001|Treatment Period|Lost to Follow-up|1|||
105803977|NCT00415532|364938687|FG000|Treatment Period|Protocol Violation|1|||
105803978|NCT00415532|364938688|FG001|Treatment Period|Protocol Violation|0|||
105803979|NCT00415532|364938687|FG000|Treatment Period|Withdrawal by Subject|6|||
105803980|NCT00415532|364938688|FG001|Treatment Period|Withdrawal by Subject|6|||
105803981|NCT00415532|364938687|FG000|Treatment Period|Other|2|||
105803982|NCT00415532|364938688|FG001|Treatment Period|Other|2|||
105803983|NCT00415532|364938687|FG000|Treatment Period|Ineligibility determined|1|||
105803984|NCT00415532|364938688|FG001|Treatment Period|Ineligibility determined|1|||
105803985|NCT00415532|364938687|FG000|Treatment Period|Noncompliance|1|||
105803986|NCT00415532|364938688|FG001|Treatment Period|Noncompliance|1|||
105803987|NCT00415532|364938687|FG000|Treatment Period|Requirement for alternative therapy|1|||
105803988|NCT00415532|364938688|FG001|Treatment Period|Requirement for alternative therapy|0|||
105803989|NCT00415532|364938687|FG000|Safety Follow Up Period|Adverse Event|1|||
105803990|NCT00415532|364938688|FG001|Safety Follow Up Period|Adverse Event|3|||
105803991|NCT00415532|364938687|FG000|Safety Follow Up Period|Death|3|||
105803992|NCT00415532|364938688|FG001|Safety Follow Up Period|Death|0|||
105803993|NCT00415532|364938687|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
105803994|NCT00415532|364938688|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
105803995|NCT00415532|364938687|FG000|Safety Follow Up Period|Other|1|||
105803996|NCT00415532|364938688|FG001|Safety Follow Up Period|Other|4|||
105803997|NCT00415532|364938687|FG000|Safety Follow Up Period|Ineligibility determined|1|||
105803998|NCT00415532|364938688|FG001|Safety Follow Up Period|Ineligibility determined|1|||
105803999|NCT00415532|364938687|FG000|Safety Follow Up Period|Noncompliance|1|||
105804000|NCT00415532|364938688|FG001|Safety Follow Up Period|Noncompliance|0|||
105804001|NCT00415532|364938687|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
105804002|NCT00415532|364938688|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
105804003|NCT00686920|364938690|FG000|Overall Study|Death|45|||
105804004|NCT00686920|364938691|FG001|Overall Study|Death|14|||
105804005|NCT00686920|364938690|FG000|Overall Study|Liver Transplant|23|||
105804006|NCT00686920|364938691|FG001|Overall Study|Liver Transplant|8|||
105804007|NCT00686920|364938690|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
105804008|NCT00686920|364938691|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
105804009|NCT00686920|364938690|FG000|Overall Study|Withdrawal by Subject|23|||
105804010|NCT00686920|364938691|FG001|Overall Study|Withdrawal by Subject|5|||
105804011|NCT00686920|364938690|FG000|Overall Study|Protocol Violation|2|||
105804012|NCT00686920|364938691|FG001|Overall Study|Protocol Violation|1|||
105804013|NCT00686920|364938690|FG000|Overall Study|Adverse Event|10|||
105804014|NCT00686920|364938691|FG001|Overall Study|Adverse Event|2|||
105804015|NCT00686920|364938690|FG000|Overall Study|Personal Reason|0|||
105804016|NCT00686920|364938691|FG001|Overall Study|Personal Reason|1|||
105804017|NCT00686920|364938690|FG000|Overall Study|Lost to Follow-up|15|||
105804018|NCT00686920|364938691|FG001|Overall Study|Lost to Follow-up|3|||
105950343|NCT00881894|365482375|FG001|Overall Study|Other reasons for premature termination|2|||
105950344|NCT00421148|365482376|FG000|Overall Study|Lost to Follow-up|0|||
105950345|NCT00421148|365482377|FG001|Overall Study|Lost to Follow-up|0|||
105804019|NCT00686920|364938690|FG000|Overall Study|Moved to Another State|1|||
105804020|NCT00686920|364938691|FG001|Overall Study|Moved to Another State|0|||
105804021|NCT00686920|364938690|FG000|Overall Study|Transferred to Nursing Home|1|||
105804022|NCT00686920|364938691|FG001|Overall Study|Transferred to Nursing Home|0|||
105804023|NCT00686920|364938690|FG000|Overall Study|Noncompliance|9|||
105804024|NCT00686920|364938691|FG001|Overall Study|Noncompliance|0|||
105804025|NCT00686920|364938690|FG000|Overall Study|Principal Investigator Decision|2|||
105804026|NCT00686920|364938691|FG001|Overall Study|Principal Investigator Decision|0|||
105950346|NCT00421148|365482378|FG002|Overall Study|Lost to Follow-up|0|||
105804027|NCT00947011|364938698|FG000|Overall Study|Study was terminated,PI left institution|12|||
105804028|NCT01141283|364938699|FG000|Overall Study|Adverse Event|56|||
105804029|NCT01141283|364938699|FG000|Overall Study|Lost to Follow-up|4|||
105757053|NCT03371732|364761641|FG001|Overall Study|Withdrawal by Subject|3|||
105757054|NCT03371732|364761640|FG000|Overall Study|Refusal to continue|3|||
105757055|NCT03371732|364761641|FG001|Overall Study|Refusal to continue|4|||
105757056|NCT02581982|364761642|FG000|Overall Study|Lack of Efficacy|12|||
105757057|NCT02581982|364761642|FG000|Overall Study|Adverse Event|3|||
105757058|NCT02581982|364761642|FG000|Overall Study|Physician Decision|1|||
105757059|NCT00599027|364761643|FG000|Overall Study|Withdrawal by Subject|1|||
105757060|NCT00599027|364761644|FG001|Overall Study|Withdrawal by Subject|1|||
105757061|NCT00599027|364761643|FG000|Overall Study|Adverse Event|0|||
105757062|NCT00599027|364761644|FG001|Overall Study|Adverse Event|1|||
105757063|NCT00599027|364761643|FG000|Overall Study|Treatment Failure|0|||
105757064|NCT00599027|364761644|FG001|Overall Study|Treatment Failure|1|||
105757065|NCT01586806|364761645|FG000|Overall Study|Protocol Violation|0|||
105757066|NCT01586806|364761646|FG001|Overall Study|Protocol Violation|1|||
105757067|NCT01586806|364761647|FG002|Overall Study|Protocol Violation|0|||
105757068|NCT01586806|364761645|FG000|Overall Study|Withdrawal by Subject|1|||
105757069|NCT01586806|364761646|FG001|Overall Study|Withdrawal by Subject|0|||
105757070|NCT01586806|364761647|FG002|Overall Study|Withdrawal by Subject|0|||
105757071|NCT01586806|364761645|FG000|Overall Study|Lost to Follow-up|2|||
105757072|NCT01586806|364761646|FG001|Overall Study|Lost to Follow-up|3|||
105757073|NCT01586806|364761647|FG002|Overall Study|Lost to Follow-up|2|||
105757074|NCT01033487|364761648|FG000|Fourth Intervention Period|Adverse Event|0|||
105757075|NCT01033487|364761649|FG001|Fourth Intervention Period|Adverse Event|0|||
105757076|NCT01033487|364761650|FG002|Fourth Intervention Period|Adverse Event|0|||
105757077|NCT01033487|364761651|FG003|Fourth Intervention Period|Adverse Event|0|||
105757078|NCT01033487|364761652|FG004|Fourth Intervention Period|Adverse Event|0|||
105757079|NCT01033487|364761653|FG005|Fourth Intervention Period|Adverse Event|0|||
105757080|NCT01033487|364761654|FG006|Fourth Intervention Period|Adverse Event|0|||
105757081|NCT01033487|364761655|FG007|Fourth Intervention Period|Adverse Event|0|||
105757082|NCT01033487|364761656|FG008|Fourth Intervention Period|Adverse Event|1|||
105757083|NCT01033487|364761657|FG009|Fourth Intervention Period|Adverse Event|0|||
105757084|NCT02031432|364761659|FG000|Overall Study|Protocol Violation|1|||
105757085|NCT02031432|364761659|FG000|Overall Study|Lack of Efficacy|5|||
105757086|NCT02031432|364761659|FG000|Overall Study|Cancer Progression|2|||
105757087|NCT02031432|364761659|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
105757088|NCT02031432|364761659|FG000|Overall Study|Adverse Event|8|||
105757089|NCT02031432|364761659|FG000|Overall Study|Withdrawal by Subject|5|||
105757090|NCT02031432|364761659|FG000|Overall Study|Lost to Follow-up|1|||
105757091|NCT02031432|364761659|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
105757092|NCT02031432|364761659|FG000|Overall Study|Death|10|||
105757093|NCT01688635|364761660|FG000|Washout 1|Withdrawal by Subject|1|||
105757094|NCT01688635|364761661|FG001|Washout 1|Withdrawal by Subject|0|||
105757095|NCT01688635|364761660|FG000|Washout 1|Adverse Event|0|||
105757096|NCT01688635|364761661|FG001|Washout 1|Adverse Event|1|||
105757097|NCT01688635|364761660|FG000|Washout 1|Physician Decision|0|||
105757098|NCT01688635|364761661|FG001|Washout 1|Physician Decision|1|||
105757099|NCT01688635|364761660|FG000|Washout 2|Physician Decision|1|||
105757100|NCT01688635|364761661|FG001|Washout 2|Physician Decision|0|||
105757101|NCT01688635|364761660|FG000|Washout 2|Withdrawal by Subject|1|||
105757102|NCT01688635|364761661|FG001|Washout 2|Withdrawal by Subject|0|||
105757103|NCT01688635|364761660|FG000|Washout 2|Sponsor Decision|1|||
105757104|NCT01688635|364761661|FG001|Washout 2|Sponsor Decision|2|||
105757105|NCT01688635|364761660|FG000|Washout 3|Withdrawal by Subject|1|||
105757106|NCT01688635|364761661|FG001|Washout 3|Withdrawal by Subject|0|||
105757107|NCT01265420|364761663|FG000|Overall Study|Lost to Follow-up|1|||
105757108|NCT03947255|364762915|FG000|Overall Study|Study Closure by Sponsor|2|||
105757109|NCT03947255|364762916|FG001|Overall Study|Study Closure by Sponsor|2|||
105757110|NCT03947255|364762915|FG000|Overall Study|Withdrawal by Subject|2|||
105757111|NCT03947255|364762916|FG001|Overall Study|Withdrawal by Subject|2|||
105757112|NCT03947255|364762915|FG000|Overall Study|Lost to Follow-up|2|||
105757113|NCT03947255|364762916|FG001|Overall Study|Lost to Follow-up|0|||
105757114|NCT03947255|364762915|FG000|Overall Study|Death|0|||
105757115|NCT03947255|364762916|FG001|Overall Study|Death|2|||
105757116|NCT03287869|364762917|FG000|Overall Study|Adverse Event|14|||
105757117|NCT03287869|364762918|FG001|Overall Study|Adverse Event|12|||
105757118|NCT03287869|364762917|FG000|Overall Study|Lack of Efficacy|1|||
105757119|NCT03287869|364762918|FG001|Overall Study|Lack of Efficacy|0|||
105757120|NCT03287869|364762917|FG000|Overall Study|Lost to Follow-up|13|||
105757121|NCT03287869|364762918|FG001|Overall Study|Lost to Follow-up|19|||
105757122|NCT03287869|364762917|FG000|Overall Study|Non-Compliance With Study Drug|5|||
105757123|NCT03287869|364762918|FG001|Overall Study|Non-Compliance With Study Drug|9|||
105757124|NCT03287869|364762917|FG000|Overall Study|Progressive Disease|1|||
105757125|NCT03287869|364762918|FG001|Overall Study|Progressive Disease|0|||
105757126|NCT03287869|364762917|FG000|Overall Study|Protocol Deviation|2|||
105757127|NCT03287869|364762918|FG001|Overall Study|Protocol Deviation|1|||
105757128|NCT03287869|364762917|FG000|Overall Study|Withdrawal by Subject|36|||
105757129|NCT03287869|364762918|FG001|Overall Study|Withdrawal by Subject|43|||
105757130|NCT03287869|364762917|FG000|Overall Study|Early Closure of the Site|0|||
105757131|NCT03287869|364762918|FG001|Overall Study|Early Closure of the Site|1|||
105757132|NCT03287869|364762917|FG000|Overall Study|Physician Decision|5|||
105757133|NCT03287869|364762918|FG001|Overall Study|Physician Decision|5|||
105757134|NCT03287869|364762917|FG000|Overall Study|Reason not Specified|6|||
105757135|NCT03287869|364762918|FG001|Overall Study|Reason not Specified|3|||
105757136|NCT03488238|364762919|FG000|Overall Study|Equipment malfunction|1|||
105757137|NCT03488238|364762919|FG000|Overall Study|Adverse Event|1|||
105757138|NCT01293006|364762920|FG000|Period 2|Lost to Follow-up|1|||
105757139|NCT01293006|364762921|FG001|Period 2|Lost to Follow-up|0|||
105757140|NCT01293006|364762922|FG002|Period 2|Lost to Follow-up|0|||
105757141|NCT01293006|364762923|FG003|Period 2|Lost to Follow-up|0|||
105757142|NCT00525785|364762927|FG000|Overall Study|Withdrawal by Subject|1|||
105757143|NCT00525785|364762927|FG000|Overall Study|Lack of Efficacy|1|||
105757144|NCT00525785|364762927|FG000|Overall Study|Physician Decision|1|||
105757145|NCT01357980|364762932|FG000|Overall Study|Lack of Efficacy|0|||
105757146|NCT01357980|364762933|FG001|Overall Study|Lack of Efficacy|1|||
105757147|NCT01357980|364762934|FG002|Overall Study|Lack of Efficacy|0|||
105757148|NCT01357980|364762935|FG003|Overall Study|Lack of Efficacy|0|||
105757149|NCT01357980|364762932|FG000|Overall Study|Consent withdrawn|0|||
105757150|NCT01357980|364762933|FG001|Overall Study|Consent withdrawn|0|||
105757151|NCT01357980|364762934|FG002|Overall Study|Consent withdrawn|1|||
105757152|NCT01357980|364762935|FG003|Overall Study|Consent withdrawn|0|||
105757153|NCT04507776|364762936|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
105757154|NCT01624506|364762937|FG000|Overall Study|Lost to Follow-up|29|||
105757155|NCT01624506|364762938|FG001|Overall Study|Lost to Follow-up|15|||
105757156|NCT01624506|364762937|FG000|Overall Study|Withdrawal by Subject|9|||
105757157|NCT01624506|364762938|FG001|Overall Study|Withdrawal by Subject|2|||
105757158|NCT01624506|364762937|FG000|Overall Study|Death|1|||
105757159|NCT01624506|364762938|FG001|Overall Study|Death|0|||
105757160|NCT01624506|364762937|FG000|Overall Study|LINX explants|23|||
105757161|NCT01624506|364762938|FG001|Overall Study|LINX explants|0|||
105757162|NCT01624506|364762937|FG000|Overall Study|Adverse Event|3|||
105757163|NCT01624506|364762938|FG001|Overall Study|Adverse Event|0|||
105757164|NCT01281189|364762941|FG000|Overall Study|Adverse Event|7|||
105757165|NCT01281189|364762942|FG001|Overall Study|Adverse Event|9|||
105757166|NCT01281189|364762941|FG000|Overall Study|Lost to Follow-up|6|||
105757167|NCT01281189|364762942|FG001|Overall Study|Lost to Follow-up|4|||
105757168|NCT01281189|364762941|FG000|Overall Study|Withdrawal by Subject|21|||
105757169|NCT01281189|364762942|FG001|Overall Study|Withdrawal by Subject|24|||
105757170|NCT01281189|364762941|FG000|Overall Study|Physician Decision|2|||
105757171|NCT01281189|364762942|FG001|Overall Study|Physician Decision|3|||
105757172|NCT01281189|364762941|FG000|Overall Study|Death|103|||
105757173|NCT01281189|364762942|FG001|Overall Study|Death|91|||
105757174|NCT01281189|364762941|FG000|Overall Study|Other|8|||
105757175|NCT01281189|364762942|FG001|Overall Study|Other|12|||
105757176|NCT00877006|364762946|FG000|Treatment Period|Death|2|||
105757177|NCT00877006|364762947|FG001|Treatment Period|Death|1|||
105757178|NCT00877006|364762946|FG000|Treatment Period|Adverse Event|10|||
105757179|NCT00877006|364762947|FG001|Treatment Period|Adverse Event|3|||
105757180|NCT00877006|364762946|FG000|Treatment Period|Withdrawal by Subject|2|||
105757181|NCT00877006|364762947|FG001|Treatment Period|Withdrawal by Subject|3|||
105757182|NCT00877006|364762946|FG000|Treatment Period|Protocol Violation|1|||
105757183|NCT00877006|364762947|FG001|Treatment Period|Protocol Violation|0|||
105757184|NCT00877006|364762946|FG000|Treatment Period|Lost to Follow-up|0|||
105757185|NCT00877006|364762947|FG001|Treatment Period|Lost to Follow-up|1|||
105757186|NCT00877006|364762946|FG000|Treatment Period|Disease Progression|1|||
105757187|NCT00877006|364762947|FG001|Treatment Period|Disease Progression|2|||
105757188|NCT00877006|364762946|FG000|Treatment Period|Started New Treatment Regimen|2|||
105757189|NCT00877006|364762947|FG001|Treatment Period|Started New Treatment Regimen|5|||
105757190|NCT00877006|364762946|FG000|Treatment Period|Other|4|||
105757191|NCT00877006|364762947|FG001|Treatment Period|Other|4|||
105757192|NCT00877006|364762946|FG000|Treatment Period|Randomized but Not Treated|3|||
105757193|NCT00877006|364762947|FG001|Treatment Period|Randomized but Not Treated|8|||
105757194|NCT00877006|364762946|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
105757195|NCT00877006|364762947|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
105757196|NCT00877006|364762946|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
105757197|NCT00877006|364762947|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
105757198|NCT00877006|364762946|FG000|Long-Term Follow-up Period|Death|26|||
105757199|NCT00877006|364762947|FG001|Long-Term Follow-up Period|Death|18|||
105757200|NCT00877006|364762946|FG000|Long-Term Follow-up Period|Other|7|||
105757201|NCT00877006|364762947|FG001|Long-Term Follow-up Period|Other|9|||
105757202|NCT00817206|364762948|FG000|Overall Study|Adverse Event|10|||
105757203|NCT00817206|364762949|FG001|Overall Study|Adverse Event|3|||
105757204|NCT00817206|364762948|FG000|Overall Study|Protocol Violation|0|||
105757205|NCT00817206|364762949|FG001|Overall Study|Protocol Violation|2|||
105757206|NCT00817206|364762948|FG000|Overall Study|Lost to Follow-up|0|||
105757207|NCT00817206|364762949|FG001|Overall Study|Lost to Follow-up|1|||
105757208|NCT00817206|364762948|FG000|Overall Study|Death|2|||
105757209|NCT00817206|364762949|FG001|Overall Study|Death|0|||
105757210|NCT00817206|364762948|FG000|Overall Study|Withdrawal by Subject|7|||
105804030|NCT01141283|364938699|FG000|Overall Study|Withdrawal by Subject|14|||
105804031|NCT01141283|364938699|FG000|Overall Study|Administrative|4|||
105804032|NCT01141283|364938699|FG000|Overall Study|Lack of Efficacy|10|||
105804033|NCT02974114|364938702|FG000|Overall Study|Other (Not specified)|0|||
105804034|NCT02974114|364938703|FG001|Overall Study|Other (Not specified)|1|||
105804035|NCT02974114|364938704|FG002|Overall Study|Other (Not specified)|2|||
105804036|NCT01620983|364938705|FG000|Overall Study|Lost to Follow-up|8|||
105804037|NCT01620983|364938706|FG001|Overall Study|Lost to Follow-up|4|||
105804038|NCT01620983|364938707|FG002|Overall Study|Lost to Follow-up|9|||
105804039|NCT01620983|364938705|FG000|Overall Study|Withdrawal by Subject|6|||
105804040|NCT01620983|364938706|FG001|Overall Study|Withdrawal by Subject|8|||
105804041|NCT01620983|364938707|FG002|Overall Study|Withdrawal by Subject|1|||
105804042|NCT01620983|364938705|FG000|Overall Study|Death|2|||
105804043|NCT01620983|364938706|FG001|Overall Study|Death|0|||
105804044|NCT01620983|364938707|FG002|Overall Study|Death|0|||
105804045|NCT01620983|364938705|FG000|Overall Study|Physician Decision|3|||
105804046|NCT01620983|364938706|FG001|Overall Study|Physician Decision|10|||
105804047|NCT01620983|364938707|FG002|Overall Study|Physician Decision|5|||
105804048|NCT01580020|364938708|FG000|Overall Study|Lack of Efficacy|0|||
105950347|NCT00421148|365482379|FG003|Overall Study|Lost to Follow-up|0|||
105950348|NCT00421148|365482380|FG004|Overall Study|Lost to Follow-up|0|||
105757211|NCT00817206|364762949|FG001|Overall Study|Withdrawal by Subject|3|||
105757212|NCT00817206|364762948|FG000|Overall Study|Physician Decision|2|||
105757213|NCT00817206|364762949|FG001|Overall Study|Physician Decision|0|||
105757214|NCT02273037|364762951|FG000|Overall Study|Lost to Follow-up|1|||
105757215|NCT02273037|364762952|FG001|Overall Study|Lost to Follow-up|0|||
105757216|NCT02273037|364762951|FG000|Overall Study|Delivered before monitoring initiated|1|||
105757217|NCT02273037|364762952|FG001|Overall Study|Delivered before monitoring initiated|3|||
105757218|NCT02273037|364762951|FG000|Overall Study|Breech delivery|2|||
105757219|NCT02273037|364762952|FG001|Overall Study|Breech delivery|3|||
105757220|NCT02273037|364762951|FG000|Overall Study|Multiple delivery|2|||
105757221|NCT02273037|364762952|FG001|Overall Study|Multiple delivery|2|||
105757222|NCT02273037|364762951|FG000|Overall Study|Other complication|2|||
105757223|NCT02273037|364762952|FG001|Overall Study|Other complication|0|||
105757224|NCT00851253|364762953|FG000|Overall Study|Disease Progression|1|||
105757225|NCT00851253|364762954|FG001|Overall Study|Disease Progression|0|||
105757226|NCT02062398|364762955|FG000|Overall Study|Implant removal|1|||
105757227|NCT01779648|364762956|FG000|Overall Study|Protocol Violation|1|||
105757228|NCT01779648|364762957|FG001|Overall Study|Protocol Violation|0|||
105757229|NCT02786836|364762960|FG000|Overall Study|Death|1|||
105757230|NCT02786836|364762960|FG000|Overall Study|Lack of Efficacy|2|||
105757231|NCT02786836|364762960|FG000|Overall Study|Protocol Violation|3|||
105757232|NCT02786836|364762960|FG000|Overall Study|Withdrawal by Subject|3|||
105757233|NCT02786836|364762960|FG000|Overall Study|Liver Transplantation|2|||
105757234|NCT02786836|364762960|FG000|Overall Study|Device or Pharmacy Issues|3|||
105757235|NCT01106391|364762961|FG000|Overall Study|Death|12|||
105757236|NCT01106391|364762961|FG000|Overall Study|Withdrawal by Subject|7|||
105757237|NCT00881361|364762962|FG000|Overall Study|Terminated prior to surgery|27|||
105757238|NCT00881361|364762963|FG001|Overall Study|Terminated prior to surgery|7|||
105757239|NCT00881361|364762964|FG002|Overall Study|Terminated prior to surgery|0|||
105757240|NCT00881361|364762962|FG000|Overall Study|Ineligible|17|||
105950349|NCT00421148|365482381|FG005|Overall Study|Lost to Follow-up|0|||
105950350|NCT00421148|365482382|FG006|Overall Study|Lost to Follow-up|0|||
105950351|NCT00421148|365482383|FG007|Overall Study|Lost to Follow-up|0|||
105950352|NCT00421148|365482384|FG008|Overall Study|Lost to Follow-up|0|||
105950353|NCT00421148|365482385|FG009|Overall Study|Lost to Follow-up|0|||
105950354|NCT00421148|365482386|FG010|Overall Study|Lost to Follow-up|0|||
105950355|NCT00421148|365482387|FG011|Overall Study|Lost to Follow-up|0|||
105950356|NCT00421148|365482388|FG012|Overall Study|Lost to Follow-up|0|||
105950357|NCT00421148|365482389|FG013|Overall Study|Lost to Follow-up|0|||
105950358|NCT00421148|365482390|FG014|Overall Study|Lost to Follow-up|0|||
105950359|NCT00421148|365482391|FG015|Overall Study|Lost to Follow-up|0|||
105950360|NCT00421148|365482392|FG016|Overall Study|Lost to Follow-up|0|||
105950361|NCT00421148|365482393|FG017|Overall Study|Lost to Follow-up|1|||
105950362|NCT00421148|365482394|FG018|Overall Study|Lost to Follow-up|0|||
105950363|NCT00421148|365482395|FG019|Overall Study|Lost to Follow-up|0|||
105950364|NCT00421148|365482376|FG000|Overall Study|Withdrawal by Subject|0|||
105950365|NCT00421148|365482377|FG001|Overall Study|Withdrawal by Subject|0|||
105950366|NCT00421148|365482378|FG002|Overall Study|Withdrawal by Subject|0|||
105757241|NCT00881361|364762963|FG001|Overall Study|Ineligible|2|||
105804049|NCT01580020|364938709|FG001|Overall Study|Lack of Efficacy|5|||
105757242|NCT00881361|364762964|FG002|Overall Study|Ineligible|2|||
105804050|NCT01580020|364938710|FG002|Overall Study|Lack of Efficacy|0|||
105804051|NCT01580020|364938711|FG003|Overall Study|Lack of Efficacy|1|||
105804052|NCT01580020|364938708|FG000|Overall Study|Withdrawal by Subject|0|||
105804053|NCT01580020|364938709|FG001|Overall Study|Withdrawal by Subject|1|||
105950367|NCT00421148|365482379|FG003|Overall Study|Withdrawal by Subject|0|||
105757243|NCT03017846|364762965|FG000|Overall Study|Lost to Follow-up|3|||
105950368|NCT00421148|365482380|FG004|Overall Study|Withdrawal by Subject|0|||
105950369|NCT00421148|365482381|FG005|Overall Study|Withdrawal by Subject|0|||
105950370|NCT00421148|365482382|FG006|Overall Study|Withdrawal by Subject|0|||
105950371|NCT00421148|365482383|FG007|Overall Study|Withdrawal by Subject|0|||
105950372|NCT00421148|365482384|FG008|Overall Study|Withdrawal by Subject|0|||
105950373|NCT00421148|365482385|FG009|Overall Study|Withdrawal by Subject|0|||
105950374|NCT00421148|365482386|FG010|Overall Study|Withdrawal by Subject|0|||
105950375|NCT00421148|365482387|FG011|Overall Study|Withdrawal by Subject|0|||
105950376|NCT00421148|365482388|FG012|Overall Study|Withdrawal by Subject|0|||
105757244|NCT03017846|364762965|FG000|Overall Study|Adverse Event|2|||
105757245|NCT02988219|364762967|FG000|Overall Study|Lack of Efficacy|1|||
105757246|NCT02988219|364762968|FG001|Overall Study|Lack of Efficacy|1|||
105757247|NCT02988219|364762967|FG000|Overall Study|Withdrawal by Subject|0|||
105757248|NCT02988219|364762968|FG001|Overall Study|Withdrawal by Subject|2|||
105757249|NCT01522443|364762969|FG000|Overall Study|No longer receiving clinical benefit|36|||
105757250|NCT01522443|364762970|FG001|Overall Study|No longer receiving clinical benefit|28|||
105757251|NCT01522443|364762969|FG000|Overall Study|Adverse Event|10|||
105757252|NCT01522443|364762970|FG001|Overall Study|Adverse Event|15|||
105757253|NCT01522443|364762969|FG000|Overall Study|Withdrawal by Subject|5|||
105757254|NCT01522443|364762970|FG001|Overall Study|Withdrawal by Subject|8|||
105757255|NCT01522443|364762969|FG000|Overall Study|No study treatment given|1|||
105757256|NCT01522443|364762970|FG001|Overall Study|No study treatment given|1|||
105757257|NCT01522443|364762969|FG000|Overall Study|Other|1|||
105757258|NCT01522443|364762970|FG001|Overall Study|Other|3|||
105757259|NCT00118911|364762971|FG000|Overall Study|Withdrawal by Subject|2|||
105757260|NCT00118911|364762972|FG001|Overall Study|Withdrawal by Subject|5|||
105757261|NCT00830960|364762973|FG000|Overall Study|Death|5|||
105757262|NCT00830960|364762974|FG001|Overall Study|Death|4|||
105757263|NCT00830960|364762975|FG002|Overall Study|Death|3|||
105757264|NCT00830960|364762976|FG003|Overall Study|Death|2|||
105757265|NCT00830960|364762977|FG004|Overall Study|Death|6|||
105757266|NCT00830960|364762978|FG005|Overall Study|Death|1|||
105757267|NCT00830960|364762973|FG000|Overall Study|Lost to Follow-up|1|||
105757268|NCT00830960|364762974|FG001|Overall Study|Lost to Follow-up|1|||
105757269|NCT00830960|364762975|FG002|Overall Study|Lost to Follow-up|1|||
105757270|NCT00830960|364762976|FG003|Overall Study|Lost to Follow-up|0|||
105757271|NCT00830960|364762977|FG004|Overall Study|Lost to Follow-up|0|||
105757272|NCT00830960|364762978|FG005|Overall Study|Lost to Follow-up|1|||
105757273|NCT00830960|364762973|FG000|Overall Study|Withdrawal by Subject|19|||
105757274|NCT00830960|364762974|FG001|Overall Study|Withdrawal by Subject|19|||
105757275|NCT00830960|364762975|FG002|Overall Study|Withdrawal by Subject|18|||
105757276|NCT00830960|364762976|FG003|Overall Study|Withdrawal by Subject|23|||
105757277|NCT00830960|364762977|FG004|Overall Study|Withdrawal by Subject|16|||
105757278|NCT00830960|364762978|FG005|Overall Study|Withdrawal by Subject|21|||
105757279|NCT00830960|364762973|FG000|Overall Study|Sponsor Decision|1|||
105757280|NCT00830960|364762974|FG001|Overall Study|Sponsor Decision|2|||
105757281|NCT00830960|364762975|FG002|Overall Study|Sponsor Decision|3|||
105757282|NCT00830960|364762976|FG003|Overall Study|Sponsor Decision|4|||
105757283|NCT00830960|364762977|FG004|Overall Study|Sponsor Decision|5|||
105757284|NCT00830960|364762978|FG005|Overall Study|Sponsor Decision|7|||
105757285|NCT00830960|364762973|FG000|Overall Study|No study drug received|7|||
105757286|NCT00830960|364762974|FG001|Overall Study|No study drug received|2|||
105757287|NCT00830960|364762975|FG002|Overall Study|No study drug received|4|||
105757288|NCT00830960|364762976|FG003|Overall Study|No study drug received|3|||
105757289|NCT00830960|364762977|FG004|Overall Study|No study drug received|5|||
105757290|NCT00830960|364762978|FG005|Overall Study|No study drug received|7|||
105757291|NCT00776555|364762979|FG000|Overall Study|Study terminated|3|||
105757292|NCT00776555|364762980|FG001|Overall Study|Study terminated|0|||
105757293|NCT02855450|364762981|FG000|Overall Study|Adverse Event|1|||
105757294|NCT02855450|364762982|FG001|Overall Study|Adverse Event|0|||
105757295|NCT02855450|364762981|FG000|Overall Study|Lost to Follow-up|4|||
105757296|NCT02855450|364762982|FG001|Overall Study|Lost to Follow-up|0|||
105757297|NCT03483116|364762983|FG000|Overall Study|Adverse Event|0|||
105757298|NCT03483116|364762984|FG001|Overall Study|Adverse Event|1|||
105757299|NCT03483116|364762985|FG002|Overall Study|Adverse Event|0|||
105757300|NCT03483116|364762986|FG003|Overall Study|Adverse Event|1|||
105757301|NCT03483116|364762983|FG000|Overall Study|Protocol Violation|1|||
105757302|NCT03483116|364762984|FG001|Overall Study|Protocol Violation|0|||
105757303|NCT03483116|364762985|FG002|Overall Study|Protocol Violation|0|||
105757304|NCT03483116|364762986|FG003|Overall Study|Protocol Violation|7|||
105757305|NCT03483116|364762983|FG000|Overall Study|Lost to Follow-up|9|||
105757306|NCT03483116|364762984|FG001|Overall Study|Lost to Follow-up|4|||
105757307|NCT03483116|364762985|FG002|Overall Study|Lost to Follow-up|9|||
105757308|NCT03483116|364762986|FG003|Overall Study|Lost to Follow-up|5|||
105757309|NCT03483116|364762983|FG000|Overall Study|Death|1|||
105757310|NCT03483116|364762984|FG001|Overall Study|Death|0|||
105950377|NCT00421148|365482389|FG013|Overall Study|Withdrawal by Subject|0|||
105950378|NCT00421148|365482390|FG014|Overall Study|Withdrawal by Subject|0|||
105757311|NCT03483116|364762985|FG002|Overall Study|Death|2|||
105757312|NCT03483116|364762986|FG003|Overall Study|Death|1|||
105757313|NCT03483116|364762983|FG000|Overall Study|Withdrawal by Subject|14|||
105804054|NCT01580020|364938710|FG002|Overall Study|Withdrawal by Subject|1|||
105804055|NCT01580020|364938711|FG003|Overall Study|Withdrawal by Subject|0|||
105804056|NCT01580020|364938708|FG000|Overall Study|Adverse Event|1|||
105804057|NCT01580020|364938709|FG001|Overall Study|Adverse Event|1|||
105804058|NCT01580020|364938710|FG002|Overall Study|Adverse Event|1|||
105804059|NCT01580020|364938711|FG003|Overall Study|Adverse Event|1|||
105804060|NCT01580020|364938708|FG000|Overall Study|Administrative Problems|0|||
105804061|NCT01580020|364938709|FG001|Overall Study|Administrative Problems|0|||
105804062|NCT01580020|364938710|FG002|Overall Study|Administrative Problems|1|||
105804063|NCT01580020|364938711|FG003|Overall Study|Administrative Problems|0|||
105804064|NCT01580020|364938708|FG000|Overall Study|Lost to Follow-up|0|||
105804065|NCT01580020|364938709|FG001|Overall Study|Lost to Follow-up|0|||
105804066|NCT01580020|364938710|FG002|Overall Study|Lost to Follow-up|1|||
105804067|NCT01580020|364938711|FG003|Overall Study|Lost to Follow-up|0|||
105804068|NCT03124381|364938718|FG000|Overall Study|Lost to Follow-up|1|||
105804069|NCT03124381|364938719|FG001|Overall Study|Lost to Follow-up|1|||
105804070|NCT03124381|364938718|FG000|Overall Study|Withdrawal by Subject|6|||
105804071|NCT03124381|364938719|FG001|Overall Study|Withdrawal by Subject|3|||
105804072|NCT03124381|364938718|FG000|Overall Study|Protocol Violation|0|||
105804073|NCT03124381|364938719|FG001|Overall Study|Protocol Violation|1|||
105804074|NCT03124381|364938718|FG000|Overall Study|Adverse Event|1|||
105804075|NCT03124381|364938719|FG001|Overall Study|Adverse Event|1|||
105804076|NCT03124381|364938718|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
105804077|NCT03124381|364938719|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
105804078|NCT03210259|364938720|FG000|12-Week Run-in Period|Adverse Event|1|||
105804079|NCT03210259|364938721|FG001|12-Week Run-in Period|Adverse Event|0|||
105804080|NCT03210259|364938722|FG002|12-Week Run-in Period|Adverse Event|0|||
105804081|NCT03210259|364938720|FG000|12-Week Run-in Period|Death|1|||
105804082|NCT03210259|364938721|FG001|12-Week Run-in Period|Death|0|||
105804083|NCT03210259|364938722|FG002|12-Week Run-in Period|Death|0|||
105804084|NCT03210259|364938720|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
105804085|NCT03210259|364938721|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
105804086|NCT03210259|364938722|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
105804087|NCT03210259|364938720|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
105804088|NCT03210259|364938721|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
105804089|NCT03210259|364938722|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
105804090|NCT03210259|364938720|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
105804091|NCT03210259|364938721|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
105804092|NCT03210259|364938722|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
105804093|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
105804094|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
105804095|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
105804096|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
105804097|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
105804098|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
105804099|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
105804100|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
105804101|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
105804102|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
105804103|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
105804104|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
105804105|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
105804106|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
105804107|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
105804108|NCT03210259|364938720|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
105804109|NCT03210259|364938721|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
105804110|NCT03210259|364938722|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
105804111|NCT02087059|364938723|FG000|Overall Study|Disease Progression|1|||
105804112|NCT02087059|364938723|FG000|Overall Study|Adverse Event|5|||
105804113|NCT02087059|364938723|FG000|Overall Study|Lost to Follow-up|1|||
105804114|NCT01102777|364938726|FG000|Overall Study|Death|2|||
105804115|NCT01102777|364938727|FG001|Overall Study|Death|6|||
105804116|NCT01102777|364938726|FG000|Overall Study|Lost to Follow-up|7|||
105804117|NCT01102777|364938727|FG001|Overall Study|Lost to Follow-up|10|||
105804118|NCT00706706|364938728|FG000|Overall Study|Death|53|||
105804119|NCT00706706|364938728|FG000|Overall Study|Lost to Follow-up|7|||
105804120|NCT00706706|364938728|FG000|Overall Study|Study endpoint had reached|45|||
105804121|NCT01306253|364938729|FG000|Overall Study|Lost to Follow-up|1|||
105804122|NCT01306253|364938730|FG001|Overall Study|Lost to Follow-up|1|||
105804123|NCT00771901|364938731|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
105804124|NCT00771901|364938732|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
105804125|NCT00771901|364938733|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
105804126|NCT00408876|364938734|FG000|Overall Study|Adverse Event|9|||
105804127|NCT00408876|364938735|FG001|Overall Study|Adverse Event|17|||
105757314|NCT03483116|364762984|FG001|Overall Study|Withdrawal by Subject|16|||
105757315|NCT03483116|364762985|FG002|Overall Study|Withdrawal by Subject|14|||
105757316|NCT03483116|364762986|FG003|Overall Study|Withdrawal by Subject|16|||
105757317|NCT03483116|364762983|FG000|Overall Study|Unknown other reason|3|||
105757318|NCT03483116|364762984|FG001|Overall Study|Unknown other reason|2|||
105757319|NCT03483116|364762985|FG002|Overall Study|Unknown other reason|1|||
105757320|NCT03483116|364762986|FG003|Overall Study|Unknown other reason|1|||
105757321|NCT00426556|364762987|FG000|Phase I - Core Phase|Disease Progression|0|||
105757322|NCT00426556|364762988|FG001|Phase I - Core Phase|Disease Progression|6|||
105757323|NCT00426556|364762989|FG002|Phase I - Core Phase|Disease Progression|2|||
105757324|NCT00426556|364762990|FG003|Phase I - Core Phase|Disease Progression|0|||
105757325|NCT00426556|364762987|FG000|Phase I - Core Phase|Adverse Event|1|||
105757326|NCT00426556|364762988|FG001|Phase I - Core Phase|Adverse Event|3|||
105757327|NCT00426556|364762989|FG002|Phase I - Core Phase|Adverse Event|1|||
105757328|NCT00426556|364762990|FG003|Phase I - Core Phase|Adverse Event|0|||
105757329|NCT00426556|364762987|FG000|Phase I - Core Phase|Death|0|||
105757330|NCT00426556|364762988|FG001|Phase I - Core Phase|Death|1|||
105757331|NCT00426556|364762989|FG002|Phase I - Core Phase|Death|0|||
105757332|NCT00426556|364762990|FG003|Phase I - Core Phase|Death|0|||
105757333|NCT00426556|364762987|FG000|Phase I - Extension Phase|Adverse Event|0|||
105757334|NCT00426556|364762988|FG001|Phase I - Extension Phase|Adverse Event|1|||
105757335|NCT00426556|364762989|FG002|Phase I - Extension Phase|Adverse Event|1|||
105757336|NCT00426556|364762990|FG003|Phase I - Extension Phase|Adverse Event|0|||
105757337|NCT00426556|364762987|FG000|Phase I - Extension Phase|Disease Progression|5|||
105757338|NCT00426556|364762988|FG001|Phase I - Extension Phase|Disease Progression|5|||
105757339|NCT00426556|364762989|FG002|Phase I - Extension Phase|Disease Progression|6|||
105757340|NCT00426556|364762990|FG003|Phase I - Extension Phase|Disease Progression|0|||
105757341|NCT00426556|364762987|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
105757342|NCT00426556|364762988|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
105757343|NCT00426556|364762989|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
105757344|NCT00426556|364762990|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
105757345|NCT00426556|364762987|FG000|Phase II - Core Phase|Disease Progression|0|||
105757346|NCT00426556|364762988|FG001|Phase II - Core Phase|Disease Progression|0|||
105757347|NCT00426556|364762989|FG002|Phase II - Core Phase|Disease Progression|0|||
105757348|NCT00426556|364762990|FG003|Phase II - Core Phase|Disease Progression|16|||
105757349|NCT00426556|364762987|FG000|Phase II - Core Phase|Adverse Event|0|||
105757350|NCT00426556|364762988|FG001|Phase II - Core Phase|Adverse Event|0|||
105757351|NCT00426556|364762989|FG002|Phase II - Core Phase|Adverse Event|0|||
105757352|NCT00426556|364762990|FG003|Phase II - Core Phase|Adverse Event|8|||
105757353|NCT00426556|364762987|FG000|Phase II - Extension Phase|Disease Progression|0|||
105757354|NCT00426556|364762988|FG001|Phase II - Extension Phase|Disease Progression|0|||
105757355|NCT00426556|364762989|FG002|Phase II - Extension Phase|Disease Progression|0|||
105757356|NCT00426556|364762990|FG003|Phase II - Extension Phase|Disease Progression|21|||
105757357|NCT00426556|364762987|FG000|Phase II - Extension Phase|Adverse Event|0|||
105757358|NCT00426556|364762988|FG001|Phase II - Extension Phase|Adverse Event|0|||
105757359|NCT00426556|364762989|FG002|Phase II - Extension Phase|Adverse Event|0|||
105757360|NCT00426556|364762990|FG003|Phase II - Extension Phase|Adverse Event|2|||
105757361|NCT05159362|364762993|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
105757362|NCT05159362|364762994|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
105757363|NCT05159362|364762995|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
105757364|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
105757365|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
105757366|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
105757367|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
105757368|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
105757369|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
105757370|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
105757371|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
105757372|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
105757373|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
105757374|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
105757375|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
105757376|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
105757377|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
105757378|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
105804128|NCT00408876|364938736|FG002|Overall Study|Adverse Event|27|||
105804129|NCT00408876|364938737|FG003|Overall Study|Adverse Event|10|||
105757379|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
105804130|NCT00408876|364938734|FG000|Overall Study|Withdrawal by Subject|3|||
105804131|NCT00408876|364938735|FG001|Overall Study|Withdrawal by Subject|6|||
106016589|NCT03748641|365724463|FG002|Overall Study|Ongoing|66|||
105804132|NCT00408876|364938736|FG002|Overall Study|Withdrawal by Subject|6|||
105804133|NCT00408876|364938737|FG003|Overall Study|Withdrawal by Subject|14|||
105804134|NCT00408876|364938734|FG000|Overall Study|Lack of Efficacy|2|||
105804135|NCT00408876|364938735|FG001|Overall Study|Lack of Efficacy|4|||
105804136|NCT00408876|364938736|FG002|Overall Study|Lack of Efficacy|5|||
105804137|NCT00408876|364938737|FG003|Overall Study|Lack of Efficacy|6|||
105804138|NCT00408876|364938734|FG000|Overall Study|Lost to Follow-up|1|||
105804139|NCT00408876|364938735|FG001|Overall Study|Lost to Follow-up|6|||
105804140|NCT00408876|364938736|FG002|Overall Study|Lost to Follow-up|5|||
105804141|NCT00408876|364938737|FG003|Overall Study|Lost to Follow-up|2|||
105804142|NCT00408876|364938734|FG000|Overall Study|Protocol Violation|0|||
105804143|NCT00408876|364938735|FG001|Overall Study|Protocol Violation|3|||
105804144|NCT00408876|364938736|FG002|Overall Study|Protocol Violation|4|||
105804145|NCT00408876|364938737|FG003|Overall Study|Protocol Violation|3|||
105804146|NCT00408876|364938734|FG000|Overall Study|Physician Decision|1|||
105804147|NCT00408876|364938735|FG001|Overall Study|Physician Decision|0|||
105804148|NCT00408876|364938736|FG002|Overall Study|Physician Decision|3|||
105804149|NCT00408876|364938737|FG003|Overall Study|Physician Decision|0|||
105804150|NCT02006147|364938738|FG000|Overall Study|Protocol Violation|1|||
105804151|NCT02006147|364938739|FG001|Overall Study|Protocol Violation|1|||
105804152|NCT02006147|364938740|FG002|Overall Study|Protocol Violation|0|||
105804153|NCT02006147|364938741|FG003|Overall Study|Protocol Violation|0|||
105804154|NCT02006147|364938738|FG000|Overall Study|Withdrawal by Subject|0|||
105804155|NCT02006147|364938739|FG001|Overall Study|Withdrawal by Subject|1|||
105804156|NCT02006147|364938740|FG002|Overall Study|Withdrawal by Subject|0|||
105804157|NCT02006147|364938741|FG003|Overall Study|Withdrawal by Subject|0|||
105804158|NCT02006147|364938738|FG000|Overall Study|Withdrawal by Sponsor|1|||
105804159|NCT02006147|364938739|FG001|Overall Study|Withdrawal by Sponsor|0|||
105804160|NCT02006147|364938740|FG002|Overall Study|Withdrawal by Sponsor|0|||
105804161|NCT02006147|364938741|FG003|Overall Study|Withdrawal by Sponsor|0|||
105804162|NCT02668302|364938748|FG000|Overall Study|Withdrawal by Subject|1|||
105804163|NCT02668302|364938749|FG001|Overall Study|Withdrawal by Subject|0|||
105804164|NCT00895583|364938750|FG000|Overall Study|Adverse Event|28|||
105804165|NCT00895583|364938751|FG001|Overall Study|Adverse Event|4|||
105804166|NCT00895583|364938750|FG000|Overall Study|Death|2|||
105804167|NCT00895583|364938751|FG001|Overall Study|Death|1|||
105804168|NCT00895583|364938750|FG000|Overall Study|Physician Decision|3|||
105804169|NCT00895583|364938751|FG001|Overall Study|Physician Decision|1|||
105804170|NCT00895583|364938750|FG000|Overall Study|Lost to Follow-up|1|||
105804171|NCT00895583|364938751|FG001|Overall Study|Lost to Follow-up|3|||
105804172|NCT00895583|364938750|FG000|Overall Study|Protocol Violation|1|||
105804173|NCT00895583|364938751|FG001|Overall Study|Protocol Violation|0|||
105804174|NCT00895583|364938750|FG000|Overall Study|Withdrawal by Subject|4|||
105804175|NCT00895583|364938751|FG001|Overall Study|Withdrawal by Subject|2|||
105804176|NCT00895583|364938750|FG000|Overall Study|Lack of Efficacy|5|||
105804177|NCT00895583|364938751|FG001|Overall Study|Lack of Efficacy|0|||
105804178|NCT00895583|364938750|FG000|Overall Study|Other|0|||
105804179|NCT00895583|364938751|FG001|Overall Study|Other|1|||
105804180|NCT00526890|364938752|FG000|Overall Study|Adverse Event|2|||
105804181|NCT00095199|364938753|FG000|Overall Study|Adverse Event|40|||
105804182|NCT00095199|364938754|FG001|Overall Study|Adverse Event|22|||
105804183|NCT00095199|364938755|FG002|Overall Study|Adverse Event|26|||
105804184|NCT00095199|364938756|FG003|Overall Study|Adverse Event|11|||
105804185|NCT00095199|364938753|FG000|Overall Study|Progressive disease|213|||
105804186|NCT00095199|364938754|FG001|Overall Study|Progressive disease|179|||
105804187|NCT00095199|364938755|FG002|Overall Study|Progressive disease|105|||
105804188|NCT00095199|364938756|FG003|Overall Study|Progressive disease|98|||
105804189|NCT00095199|364938753|FG000|Overall Study|Death|10|||
105804190|NCT00095199|364938754|FG001|Overall Study|Death|6|||
105804191|NCT00095199|364938755|FG002|Overall Study|Death|11|||
105804192|NCT00095199|364938756|FG003|Overall Study|Death|9|||
105804193|NCT00095199|364938753|FG000|Overall Study|Withdrawal by Subject|21|||
105804194|NCT00095199|364938754|FG001|Overall Study|Withdrawal by Subject|16|||
105804195|NCT00095199|364938755|FG002|Overall Study|Withdrawal by Subject|13|||
105804196|NCT00095199|364938756|FG003|Overall Study|Withdrawal by Subject|22|||
105804197|NCT00095199|364938753|FG000|Overall Study|Protocol Violation|4|||
105804198|NCT00095199|364938754|FG001|Overall Study|Protocol Violation|4|||
105804199|NCT00095199|364938755|FG002|Overall Study|Protocol Violation|2|||
105950379|NCT00421148|365482391|FG015|Overall Study|Withdrawal by Subject|0|||
105804200|NCT00095199|364938756|FG003|Overall Study|Protocol Violation|0|||
105804201|NCT00095199|364938753|FG000|Overall Study|Liver function test results elevated|0|||
105804202|NCT00095199|364938754|FG001|Overall Study|Liver function test results elevated|0|||
105804203|NCT00095199|364938755|FG002|Overall Study|Liver function test results elevated|1|||
105804204|NCT00095199|364938756|FG003|Overall Study|Liver function test results elevated|1|||
105950380|NCT00421148|365482392|FG016|Overall Study|Withdrawal by Subject|0|||
105950381|NCT00421148|365482393|FG017|Overall Study|Withdrawal by Subject|1|||
105804205|NCT00095199|364938753|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
105804206|NCT00095199|364938754|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
105950382|NCT00421148|365482394|FG018|Overall Study|Withdrawal by Subject|0|||
105950383|NCT00421148|365482395|FG019|Overall Study|Withdrawal by Subject|0|||
105950384|NCT00421148|365482376|FG000|Overall Study|Protocol Violation|0|||
105950385|NCT00421148|365482377|FG001|Overall Study|Protocol Violation|0|||
105950386|NCT00421148|365482378|FG002|Overall Study|Protocol Violation|0|||
105757380|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
105757381|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
105757382|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
105757383|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
105757384|NCT01376245|364762996|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
105757385|NCT01376245|364762997|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
105757386|NCT01376245|364762998|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
105757387|NCT01376245|364762999|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
105757388|NCT01376245|364763000|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
105757389|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
105757390|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
105757391|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
105757392|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
105757393|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
105757394|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
105757395|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
105757396|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
105757397|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
105757398|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
105757399|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105757400|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
105757401|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
105757402|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
105757403|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
105757404|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105757405|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
105757406|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
105757407|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
105757408|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
105757409|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105757410|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
105757411|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
105757412|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105757413|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
105757414|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
105757415|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
105757416|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
105757417|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
105757418|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
105757419|NCT01376245|364762996|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
105757420|NCT01376245|364762997|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
105757421|NCT01376245|364762998|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
105757422|NCT01376245|364762999|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
105757423|NCT01376245|364763000|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
105757424|NCT01335698|364763001|FG000|Treatment Stage 1|Lack of Efficacy|3|||
105757425|NCT01335698|364763002|FG001|Treatment Stage 1|Lack of Efficacy|1|||
105757426|NCT01335698|364763003|FG002|Treatment Stage 1|Lack of Efficacy|3|||
105757427|NCT01335698|364763004|FG003|Treatment Stage 1|Lack of Efficacy|3|||
105757428|NCT01335698|364763005|FG004|Treatment Stage 1|Lack of Efficacy|1|||
105757429|NCT01335698|364763001|FG000|Treatment Stage 1|Adverse Event|1|||
105757430|NCT01335698|364763002|FG001|Treatment Stage 1|Adverse Event|2|||
105757431|NCT01335698|364763003|FG002|Treatment Stage 1|Adverse Event|2|||
105757432|NCT01335698|364763004|FG003|Treatment Stage 1|Adverse Event|1|||
105950387|NCT00421148|365482379|FG003|Overall Study|Protocol Violation|0|||
105950388|NCT00421148|365482380|FG004|Overall Study|Protocol Violation|0|||
105757433|NCT01335698|364763005|FG004|Treatment Stage 1|Adverse Event|1|||
105757434|NCT01335698|364763001|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
105757435|NCT01335698|364763002|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
105757436|NCT01335698|364763003|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
105757437|NCT01335698|364763004|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
105757438|NCT01335698|364763005|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
105950389|NCT00421148|365482381|FG005|Overall Study|Protocol Violation|1|||
105950390|NCT00421148|365482382|FG006|Overall Study|Protocol Violation|0|||
105950391|NCT00421148|365482383|FG007|Overall Study|Protocol Violation|0|||
105950392|NCT00421148|365482384|FG008|Overall Study|Protocol Violation|0|||
105950393|NCT00421148|365482385|FG009|Overall Study|Protocol Violation|0|||
105950394|NCT00421148|365482386|FG010|Overall Study|Protocol Violation|0|||
105757439|NCT01335698|364763001|FG000|Treatment Stage 1|Lost to Follow-up|1|||
105757440|NCT01335698|364763002|FG001|Treatment Stage 1|Lost to Follow-up|1|||
105757441|NCT01335698|364763003|FG002|Treatment Stage 1|Lost to Follow-up|0|||
105757442|NCT01335698|364763004|FG003|Treatment Stage 1|Lost to Follow-up|0|||
105757443|NCT01335698|364763005|FG004|Treatment Stage 1|Lost to Follow-up|0|||
105757444|NCT01335698|364763001|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
105757445|NCT01335698|364763002|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
105757446|NCT01335698|364763003|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
105757447|NCT01335698|364763004|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
105757448|NCT01335698|364763005|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
105757449|NCT01335698|364763001|FG000|Treatment Stage 1|No longer meets study criteria|1|||
105757450|NCT01335698|364763002|FG001|Treatment Stage 1|No longer meets study criteria|1|||
105757451|NCT01335698|364763003|FG002|Treatment Stage 1|No longer meets study criteria|0|||
105757452|NCT01335698|364763004|FG003|Treatment Stage 1|No longer meets study criteria|1|||
105757453|NCT01335698|364763005|FG004|Treatment Stage 1|No longer meets study criteria|0|||
105757454|NCT01335698|364763001|FG000|Treatment Stage 1|Other|1|||
105757455|NCT01335698|364763002|FG001|Treatment Stage 1|Other|0|||
105757456|NCT01335698|364763003|FG002|Treatment Stage 1|Other|0|||
105757457|NCT01335698|364763004|FG003|Treatment Stage 1|Other|1|||
105757458|NCT01335698|364763005|FG004|Treatment Stage 1|Other|0|||
105757459|NCT01335698|364763001|FG000|Treatment Stage 2|Lack of Efficacy|2|||
105757460|NCT01335698|364763002|FG001|Treatment Stage 2|Lack of Efficacy|1|||
105757461|NCT01335698|364763003|FG002|Treatment Stage 2|Lack of Efficacy|3|||
105757462|NCT01335698|364763004|FG003|Treatment Stage 2|Lack of Efficacy|1|||
105757463|NCT01335698|364763005|FG004|Treatment Stage 2|Lack of Efficacy|0|||
105757464|NCT01335698|364763001|FG000|Treatment Stage 2|Adverse Event|2|||
105757465|NCT01335698|364763002|FG001|Treatment Stage 2|Adverse Event|0|||
105757466|NCT01335698|364763003|FG002|Treatment Stage 2|Adverse Event|0|||
105757467|NCT01335698|364763004|FG003|Treatment Stage 2|Adverse Event|3|||
105757468|NCT01335698|364763005|FG004|Treatment Stage 2|Adverse Event|0|||
105757469|NCT01335698|364763001|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
105757470|NCT01335698|364763002|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
105757471|NCT01335698|364763003|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
105757472|NCT01335698|364763004|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
105757473|NCT01335698|364763005|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
105757474|NCT01335698|364763001|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
105757475|NCT01335698|364763002|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
105757476|NCT01335698|364763003|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
105757477|NCT01335698|364763004|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
105757478|NCT01335698|364763005|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
105757479|NCT01335698|364763001|FG000|Treatment Stage 2|Lost to Follow-up|1|||
105757480|NCT01335698|364763002|FG001|Treatment Stage 2|Lost to Follow-up|0|||
105757481|NCT01335698|364763003|FG002|Treatment Stage 2|Lost to Follow-up|0|||
105757482|NCT01335698|364763004|FG003|Treatment Stage 2|Lost to Follow-up|0|||
105757483|NCT01335698|364763005|FG004|Treatment Stage 2|Lost to Follow-up|0|||
105757484|NCT01335698|364763001|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
105757485|NCT01335698|364763002|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
105757486|NCT01335698|364763003|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
105757487|NCT01335698|364763004|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
105757488|NCT01335698|364763005|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
105757489|NCT01335698|364763001|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
105757490|NCT01335698|364763002|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
105757491|NCT01335698|364763003|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
105757492|NCT01335698|364763004|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
105757493|NCT01335698|364763005|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
105757494|NCT01335698|364763001|FG000|Treatment Stage 2|Switched to another formulation|1|||
105757495|NCT01335698|364763002|FG001|Treatment Stage 2|Switched to another formulation|1|||
105757496|NCT01335698|364763003|FG002|Treatment Stage 2|Switched to another formulation|0|||
105757497|NCT01335698|364763004|FG003|Treatment Stage 2|Switched to another formulation|0|||
105757498|NCT01335698|364763005|FG004|Treatment Stage 2|Switched to another formulation|0|||
105757499|NCT00416312|364763006|FG000|Overall Study|tumors not visible on imaging|2|||
105950395|NCT00421148|365482387|FG011|Overall Study|Protocol Violation|0|||
105950396|NCT00421148|365482388|FG012|Overall Study|Protocol Violation|0|||
105950397|NCT00421148|365482389|FG013|Overall Study|Protocol Violation|0|||
105950398|NCT00421148|365482390|FG014|Overall Study|Protocol Violation|0|||
105757500|NCT02727660|364763009|FG000|Overall Study|Lack of Efficacy|40|||
105757501|NCT02727660|364763010|FG001|Overall Study|Lack of Efficacy|40|||
105757502|NCT02727660|364763011|FG002|Overall Study|Lack of Efficacy|70|||
105950399|NCT00421148|365482391|FG015|Overall Study|Protocol Violation|0|||
105950400|NCT00421148|365482392|FG016|Overall Study|Protocol Violation|0|||
105950401|NCT00421148|365482393|FG017|Overall Study|Protocol Violation|0|||
105950402|NCT00421148|365482394|FG018|Overall Study|Protocol Violation|1|||
105950403|NCT00421148|365482395|FG019|Overall Study|Protocol Violation|0|||
105757503|NCT02727660|364763009|FG000|Overall Study|Adverse Event|28|||
105757504|NCT02727660|364763010|FG001|Overall Study|Adverse Event|21|||
105757505|NCT02727660|364763011|FG002|Overall Study|Adverse Event|32|||
105757506|NCT02727660|364763009|FG000|Overall Study|Withdrawal by Subject|26|||
105757507|NCT02727660|364763010|FG001|Overall Study|Withdrawal by Subject|25|||
105757508|NCT02727660|364763011|FG002|Overall Study|Withdrawal by Subject|30|||
105757509|NCT02727660|364763009|FG000|Overall Study|Physician Decision|3|||
105757510|NCT02727660|364763010|FG001|Overall Study|Physician Decision|8|||
105757511|NCT02727660|364763011|FG002|Overall Study|Physician Decision|14|||
105757512|NCT02727660|364763009|FG000|Overall Study|Lost to Follow-up|5|||
105757513|NCT02727660|364763010|FG001|Overall Study|Lost to Follow-up|9|||
105757514|NCT02727660|364763011|FG002|Overall Study|Lost to Follow-up|8|||
105757515|NCT02727660|364763009|FG000|Overall Study|Protocol Violation|7|||
105757516|NCT02727660|364763010|FG001|Overall Study|Protocol Violation|5|||
105757517|NCT02727660|364763011|FG002|Overall Study|Protocol Violation|5|||
105757518|NCT02727660|364763009|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
105757519|NCT02727660|364763010|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
105757520|NCT02727660|364763011|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
105757521|NCT02727660|364763009|FG000|Overall Study|Administrative Reasons|2|||
105757522|NCT02727660|364763010|FG001|Overall Study|Administrative Reasons|3|||
105757523|NCT02727660|364763011|FG002|Overall Study|Administrative Reasons|4|||
105757524|NCT00105560|364763012|FG000|Overall Study|Lost to Follow-up|1|||
105757525|NCT01182337|364763018|FG000|Overall Study|Withdrawal by Subject|3|||
105757526|NCT01182337|364763019|FG001|Overall Study|Withdrawal by Subject|1|||
105757527|NCT01182337|364763018|FG000|Overall Study|Lost to Follow-up|0|||
105757528|NCT01182337|364763019|FG001|Overall Study|Lost to Follow-up|1|||
105757529|NCT03103906|364763020|FG000|Overall Study|Adverse Event|2|||
105757530|NCT03103906|364763021|FG001|Overall Study|Adverse Event|3|||
105757531|NCT03103906|364763020|FG000|Overall Study|Other|2|||
105757532|NCT03103906|364763021|FG001|Overall Study|Other|0|||
105757533|NCT03571256|364763022|FG000|Overall Study|Adverse Event|3|||
105757534|NCT03571256|364763023|FG001|Overall Study|Adverse Event|0|||
105757535|NCT03571256|364763024|FG002|Overall Study|Adverse Event|1|||
105757536|NCT03571256|364763022|FG000|Overall Study|Withdrawal by Subject|3|||
105757537|NCT03571256|364763023|FG001|Overall Study|Withdrawal by Subject|1|||
105757538|NCT03571256|364763024|FG002|Overall Study|Withdrawal by Subject|1|||
105757539|NCT03571256|364763022|FG000|Overall Study|Other than specified|0|||
105757540|NCT03571256|364763023|FG001|Overall Study|Other than specified|1|||
105757541|NCT03571256|364763024|FG002|Overall Study|Other than specified|1|||
105757542|NCT03571256|364763022|FG000|Overall Study|Protocol Violation|0|||
105757543|NCT03571256|364763023|FG001|Overall Study|Protocol Violation|1|||
105757544|NCT03571256|364763024|FG002|Overall Study|Protocol Violation|1|||
105757545|NCT00772382|364763027|FG000|Overall Study|Adverse Event|19|||
105757546|NCT00772382|364763027|FG000|Overall Study|Death|6|||
105757547|NCT00772382|364763027|FG000|Overall Study|Lack of Efficacy|4|||
105757548|NCT00772382|364763027|FG000|Overall Study|Physician Decision|5|||
105757549|NCT00772382|364763027|FG000|Overall Study|Protocol Violation|1|||
105757550|NCT00772382|364763027|FG000|Overall Study|Withdrawal by Subject|10|||
105757551|NCT00772382|364763027|FG000|Overall Study|Other Reasons|10|||
105757552|NCT01641991|364763031|FG000|Overall Study|Physician Decision|0|||
105757553|NCT01641991|364763032|FG001|Overall Study|Physician Decision|1|||
105757554|NCT01641991|364763033|FG002|Overall Study|Physician Decision|7|||
105757555|NCT01641991|364763034|FG003|Overall Study|Physician Decision|5|||
105757556|NCT01641991|364763031|FG000|Overall Study|Withdrawal by Subject|4|||
105757557|NCT01641991|364763032|FG001|Overall Study|Withdrawal by Subject|2|||
105757558|NCT01641991|364763033|FG002|Overall Study|Withdrawal by Subject|1|||
105757559|NCT01641991|364763034|FG003|Overall Study|Withdrawal by Subject|5|||
105757560|NCT01641991|364763031|FG000|Overall Study|Adverse Event|2|||
105757561|NCT01641991|364763032|FG001|Overall Study|Adverse Event|1|||
105757562|NCT01641991|364763033|FG002|Overall Study|Adverse Event|2|||
105757563|NCT01641991|364763034|FG003|Overall Study|Adverse Event|1|||
105757564|NCT01641991|364763031|FG000|Overall Study|Lost to Follow-up|0|||
105757565|NCT01641991|364763032|FG001|Overall Study|Lost to Follow-up|2|||
105757566|NCT01641991|364763033|FG002|Overall Study|Lost to Follow-up|3|||
105757567|NCT01641991|364763034|FG003|Overall Study|Lost to Follow-up|1|||
105757568|NCT01641991|364763031|FG000|Overall Study|Protocol Violation|1|||
105757569|NCT01641991|364763032|FG001|Overall Study|Protocol Violation|1|||
105757570|NCT01641991|364763033|FG002|Overall Study|Protocol Violation|3|||
105757571|NCT01641991|364763034|FG003|Overall Study|Protocol Violation|0|||
105757572|NCT01641991|364763031|FG000|Overall Study|Pregnancy|0|||
105757573|NCT01641991|364763032|FG001|Overall Study|Pregnancy|0|||
105757574|NCT01641991|364763033|FG002|Overall Study|Pregnancy|1|||
105757575|NCT01641991|364763034|FG003|Overall Study|Pregnancy|0|||
105950404|NCT03289533|365482396|FG000|Overall Study|Death|12|||
105757576|NCT01641991|364763031|FG000|Overall Study|no longer eligible|2|||
105757577|NCT01641991|364763032|FG001|Overall Study|no longer eligible|1|||
105950405|NCT03289533|365482396|FG000|Overall Study|Terminated from study by sponsor|10|||
105950406|NCT01030822|365482397|FG000|Overall Study|Moved/migrated from study area|6|||
105950407|NCT01030822|365482398|FG001|Overall Study|Moved/migrated from study area|7|||
105950408|NCT01030822|365482399|FG002|Overall Study|Moved/migrated from study area|3|||
105757578|NCT01641991|364763033|FG002|Overall Study|no longer eligible|0|||
105757579|NCT01641991|364763034|FG003|Overall Study|no longer eligible|4|||
105757580|NCT02807363|364763035|FG000|Dosing Period|Adverse Event|0|||
105757581|NCT02807363|364763036|FG001|Dosing Period|Adverse Event|1|||
105757582|NCT02807363|364763037|FG002|Dosing Period|Adverse Event|0|||
105757583|NCT02807363|364763038|FG003|Dosing Period|Adverse Event|0|||
105757584|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
105757585|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
105757586|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
105757587|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
105757588|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
105757589|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
105757590|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
105757591|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
105757592|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
105757593|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
105757594|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
105757595|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
105757596|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
105757597|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
105757598|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
105757599|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
105757600|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
105757601|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
105757602|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
105757603|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
105757604|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
105757605|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
105757606|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
105757607|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
105757608|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
105757609|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
105757610|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
105757611|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
105757612|NCT00476996|364763039|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
105757613|NCT00476996|364763040|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
105757614|NCT00476996|364763041|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
105757615|NCT00476996|364763042|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
105757616|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
105757617|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
105757618|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
105757619|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
105757620|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
105757621|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
105757622|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
105757623|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
105757624|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Death|0|||
105757625|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Death|0|||
105757626|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Death|0|||
105757627|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Death|7|||
105757628|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
105757629|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
105757630|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
105757631|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
105757632|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
105757633|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
105757634|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
105757635|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
105757636|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
105757637|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
105757638|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
105757639|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
105757640|NCT00476996|364763039|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
105757641|NCT00476996|364763040|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
106016590|NCT03748641|365724464|FG003|Overall Study|Ongoing|79|||
105757642|NCT00476996|364763041|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
105757643|NCT00476996|364763042|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
105757644|NCT03219567|364763043|FG000|Overall Study|Withdrawal by Subject|0|||
105757645|NCT03219567|364763044|FG001|Overall Study|Withdrawal by Subject|1|||
105757646|NCT02939599|364763046|FG000|Overall Study|Adverse Event|1|||
105757647|NCT02939599|364763047|FG001|Overall Study|Adverse Event|0|||
105757648|NCT02939599|364763046|FG000|Overall Study|Study Terminated By Sponsor|2|||
105757649|NCT02939599|364763047|FG001|Overall Study|Study Terminated By Sponsor|2|||
105757650|NCT02148211|364763054|FG000|Overall Study|Lost to Follow-up|352|||
105757651|NCT02726113|364763058|FG000|Total Enrollment|Physician Decision|0|||
105757652|NCT02726113|364763059|FG001|Total Enrollment|Physician Decision|1|||
105757653|NCT02726113|364763058|FG000|Total Enrollment|Protocol Violation|1|||
105757654|NCT02726113|364763059|FG001|Total Enrollment|Protocol Violation|0|||
105757655|NCT02726113|364763058|FG000|Total Enrollment|Withdrawal by Subject|2|||
105757656|NCT02726113|364763059|FG001|Total Enrollment|Withdrawal by Subject|1|||
105757657|NCT02726113|364763058|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
105757658|NCT02726113|364763059|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
105757659|NCT02726113|364763058|FG000|Genomic Analysis|Protocol Violation|1|||
105757660|NCT02726113|364763059|FG001|Genomic Analysis|Protocol Violation|0|||
105757661|NCT02726113|364763058|FG000|Genomic Analysis|Withdrawal by Subject|2|||
105757662|NCT02726113|364763059|FG001|Genomic Analysis|Withdrawal by Subject|1|||
105757663|NCT02726113|364763058|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
105757664|NCT02726113|364763059|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
105757665|NCT01617187|364763062|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
105757666|NCT01617187|364763063|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
105757667|NCT01617187|364763064|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
105757668|NCT01617187|364763065|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
105757669|NCT01617187|364763062|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
105757670|NCT01617187|364763063|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
105757671|NCT01617187|364763064|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
105757672|NCT01617187|364763065|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
105757673|NCT01617187|364763062|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
105757674|NCT01617187|364763063|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
105757675|NCT01617187|364763064|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
105757676|NCT01617187|364763065|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
105757677|NCT01617187|364763062|FG000|Treatment Through Study Completion|Adverse Event|1|||
105757678|NCT01617187|364763063|FG001|Treatment Through Study Completion|Adverse Event|1|||
105757679|NCT01617187|364763064|FG002|Treatment Through Study Completion|Adverse Event|0|||
105757680|NCT01617187|364763065|FG003|Treatment Through Study Completion|Adverse Event|1|||
105757681|NCT01617187|364763062|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
105757682|NCT01617187|364763063|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
105757683|NCT01617187|364763064|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
105757684|NCT01617187|364763065|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
105757685|NCT01617187|364763062|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
105757686|NCT01617187|364763063|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
105757687|NCT01617187|364763064|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
105757688|NCT01617187|364763065|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
105757689|NCT01617187|364763062|FG000|Treatment Through Study Completion|Protocol Violation|1|||
105757690|NCT01617187|364763063|FG001|Treatment Through Study Completion|Protocol Violation|0|||
105757691|NCT01617187|364763064|FG002|Treatment Through Study Completion|Protocol Violation|0|||
105757692|NCT01617187|364763065|FG003|Treatment Through Study Completion|Protocol Violation|1|||
105757693|NCT02843178|364765350|FG000|Overall Study|Lost to Follow-up|8|||
105757694|NCT02843178|364765351|FG001|Overall Study|Lost to Follow-up|8|||
105757695|NCT02843178|364765352|FG002|Overall Study|Lost to Follow-up|6|||
105757696|NCT02843178|364765353|FG003|Overall Study|Lost to Follow-up|3|||
105757697|NCT02843178|364765350|FG000|Overall Study|Withdrawal by Subject|0|||
105757698|NCT02843178|364765351|FG001|Overall Study|Withdrawal by Subject|0|||
105757699|NCT02843178|364765352|FG002|Overall Study|Withdrawal by Subject|1|||
105757700|NCT02843178|364765353|FG003|Overall Study|Withdrawal by Subject|1|||
105757701|NCT02420795|364765354|FG000|Overall Study|Withdrawal by Subject|1|||
105757702|NCT02420795|364765355|FG001|Overall Study|Withdrawal by Subject|0|||
105757703|NCT02420795|364765356|FG002|Overall Study|Withdrawal by Subject|0|||
105757704|NCT02420795|364765354|FG000|Overall Study|Adverse Event|1|||
105757705|NCT02420795|364765355|FG001|Overall Study|Adverse Event|0|||
105757706|NCT02420795|364765356|FG002|Overall Study|Adverse Event|0|||
105757707|NCT02420795|364765354|FG000|Overall Study|Progressive disease|2|||
105757708|NCT02420795|364765355|FG001|Overall Study|Progressive disease|2|||
105757709|NCT02420795|364765356|FG002|Overall Study|Progressive disease|4|||
105757710|NCT02420795|364765354|FG000|Overall Study|Death|0|||
105757711|NCT02420795|364765355|FG001|Overall Study|Death|0|||
105804207|NCT00095199|364938755|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
105804208|NCT00095199|364938756|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
105804209|NCT00095199|364938753|FG000|Overall Study|Physician Decision|5|||
105804210|NCT00095199|364938754|FG001|Overall Study|Physician Decision|6|||
105804211|NCT00095199|364938755|FG002|Overall Study|Physician Decision|1|||
105804212|NCT00095199|364938756|FG003|Overall Study|Physician Decision|1|||
105804213|NCT00095199|364938753|FG000|Overall Study|Not eligible|1|||
105804214|NCT00095199|364938754|FG001|Overall Study|Not eligible|7|||
105804215|NCT00095199|364938755|FG002|Overall Study|Not eligible|0|||
105804216|NCT00095199|364938756|FG003|Overall Study|Not eligible|1|||
105804217|NCT00095199|364938753|FG000|Overall Study|Started Palliative Radiotherapy|1|||
105804218|NCT00095199|364938754|FG001|Overall Study|Started Palliative Radiotherapy|0|||
105804219|NCT00095199|364938755|FG002|Overall Study|Started Palliative Radiotherapy|0|||
105804220|NCT00095199|364938756|FG003|Overall Study|Started Palliative Radiotherapy|0|||
105804221|NCT00095199|364938753|FG000|Overall Study|Started radiotherapy regimen|0|||
105804222|NCT00095199|364938754|FG001|Overall Study|Started radiotherapy regimen|1|||
105804223|NCT00095199|364938755|FG002|Overall Study|Started radiotherapy regimen|0|||
105804224|NCT00095199|364938756|FG003|Overall Study|Started radiotherapy regimen|0|||
105804225|NCT00095199|364938753|FG000|Overall Study|Primary tumor removed in other surgery|0|||
105804226|NCT00095199|364938754|FG001|Overall Study|Primary tumor removed in other surgery|1|||
105804227|NCT00095199|364938755|FG002|Overall Study|Primary tumor removed in other surgery|0|||
105804228|NCT00095199|364938756|FG003|Overall Study|Primary tumor removed in other surgery|0|||
105804229|NCT00095199|364938753|FG000|Overall Study|Data inadvertently lost by site|1|||
105804230|NCT00095199|364938754|FG001|Overall Study|Data inadvertently lost by site|0|||
105804231|NCT00095199|364938755|FG002|Overall Study|Data inadvertently lost by site|0|||
105950409|NCT01030822|365482397|FG000|Overall Study|Withdrawal by Subject|16|||
105950410|NCT01030822|365482398|FG001|Overall Study|Withdrawal by Subject|13|||
105950411|NCT01030822|365482399|FG002|Overall Study|Withdrawal by Subject|16|||
105950412|NCT01030822|365482397|FG000|Overall Study|Lost to Follow-up|9|||
105950413|NCT01030822|365482398|FG001|Overall Study|Lost to Follow-up|4|||
105950414|NCT01030822|365482399|FG002|Overall Study|Lost to Follow-up|7|||
105950415|NCT00363311|365482400|FG000|Overall Study|Adverse Event|6|||
105804232|NCT00095199|364938756|FG003|Overall Study|Data inadvertently lost by site|0|||
105950416|NCT00363311|365482401|FG001|Overall Study|Adverse Event|4|||
105950417|NCT00363311|365482400|FG000|Overall Study|Lost to Follow-up|3|||
105804233|NCT02995837|364938758|FG000|Overall Study|Lost to Follow-up|9|||
105804234|NCT02995837|364938759|FG001|Overall Study|Lost to Follow-up|8|||
105804235|NCT00633152|364940280|FG000|Overall Study|Adverse Event|1|||
105804236|NCT00633152|364940281|FG001|Overall Study|Adverse Event|0|||
105804237|NCT00633152|364940280|FG000|Overall Study|Randomized, did not receive study drug|5|||
105950418|NCT00363311|365482401|FG001|Overall Study|Lost to Follow-up|0|||
105950419|NCT00363311|365482400|FG000|Overall Study|Protocol Violation|1|||
105950420|NCT00363311|365482401|FG001|Overall Study|Protocol Violation|2|||
105804238|NCT00633152|364940281|FG001|Overall Study|Randomized, did not receive study drug|2|||
105804239|NCT00633152|364940280|FG000|Overall Study|Withdrawal by Subject|1|||
105804240|NCT00633152|364940281|FG001|Overall Study|Withdrawal by Subject|1|||
105804241|NCT00633152|364940280|FG000|Overall Study|Lost to Follow-up|4|||
105804242|NCT00633152|364940281|FG001|Overall Study|Lost to Follow-up|1|||
105950421|NCT00363311|365482400|FG000|Overall Study|Withdrawal by Subject|12|||
105950422|NCT00363311|365482401|FG001|Overall Study|Withdrawal by Subject|6|||
105757712|NCT02420795|364765356|FG002|Overall Study|Death|1|||
105757713|NCT01002742|364765357|FG000|Overall Study|Determined to be ineligible|0|||
105757714|NCT01002742|364765358|FG001|Overall Study|Determined to be ineligible|1|||
105757715|NCT00656084|364765361|FG000|Overall Study|Adverse Event|4|||
105757716|NCT00656084|364765361|FG000|Overall Study|Withdrawal by Subject|1|||
105757717|NCT00656084|364765361|FG000|Overall Study|Patient Request|1|||
105757718|NCT00656084|364765361|FG000|Overall Study|Investigator Request|1|||
105757719|NCT01494987|364765362|FG000|Overall Study|Adverse Event|6|||
105757720|NCT01494987|364765363|FG001|Overall Study|Adverse Event|5|||
105757721|NCT01494987|364765362|FG000|Overall Study|Hyperglycemia|6|||
105757722|NCT01494987|364765363|FG001|Overall Study|Hyperglycemia|4|||
105757723|NCT01494987|364765362|FG000|Overall Study|Investigator's Discretion|1|||
105757724|NCT01494987|364765363|FG001|Overall Study|Investigator's Discretion|2|||
105804243|NCT00633152|364940280|FG000|Overall Study|Miscellaneous Other|3|||
105950423|NCT00363311|365482400|FG000|Overall Study|Physician Decision|1|||
105950424|NCT00363311|365482401|FG001|Overall Study|Physician Decision|1|||
105804244|NCT00633152|364940281|FG001|Overall Study|Miscellaneous Other|2|||
105804245|NCT00472446|364940282|FG000|Overall Study|Protocol Violation|0|||
105804246|NCT00472446|364940283|FG001|Overall Study|Protocol Violation|0|||
105950425|NCT00363311|365482400|FG000|Overall Study|Sponsor Terminated Study|2|||
105950426|NCT00363311|365482401|FG001|Overall Study|Sponsor Terminated Study|2|||
105950427|NCT00363311|365482400|FG000|Overall Study|Disease Progression|46|||
105804247|NCT00472446|364940284|FG002|Overall Study|Protocol Violation|0|||
105950428|NCT00363311|365482401|FG001|Overall Study|Disease Progression|26|||
105757725|NCT01494987|364765362|FG000|Overall Study|Lost to Follow-up|1|||
105757726|NCT01494987|364765363|FG001|Overall Study|Lost to Follow-up|1|||
105757727|NCT01494987|364765362|FG000|Overall Study|Protocol Violation|3|||
105757728|NCT01494987|364765363|FG001|Overall Study|Protocol Violation|3|||
105757729|NCT01494987|364765362|FG000|Overall Study|Subject Non-Compliance|9|||
105757730|NCT01494987|364765363|FG001|Overall Study|Subject Non-Compliance|10|||
105757731|NCT01494987|364765362|FG000|Overall Study|Subject Withdrew Consent|2|||
105757732|NCT01494987|364765363|FG001|Overall Study|Subject Withdrew Consent|3|||
105757733|NCT00436982|364765364|FG000|Overall Study|Withdrawal by Subject|3|||
105757734|NCT00436982|364765365|FG001|Overall Study|Withdrawal by Subject|1|||
105757735|NCT00436982|364765364|FG000|Overall Study|Did not receive allocated intervention|0|||
105757736|NCT00436982|364765365|FG001|Overall Study|Did not receive allocated intervention|1|||
105757737|NCT00436982|364765364|FG000|Overall Study|no RSA data|1|||
105757738|NCT00436982|364765365|FG001|Overall Study|no RSA data|2|||
105757739|NCT00953225|364765369|FG000|Overall Study|Withdrawal by Subject|2|||
105757740|NCT00953225|364765370|FG001|Overall Study|Withdrawal by Subject|0|||
105757741|NCT00640146|364765371|FG000|Overall Study|Adverse Event|2|||
105757742|NCT00640146|364765372|FG001|Overall Study|Adverse Event|0|||
105757743|NCT00640146|364765371|FG000|Overall Study|Lost to Follow-up|0|||
105757744|NCT00640146|364765372|FG001|Overall Study|Lost to Follow-up|1|||
105757745|NCT00640146|364765371|FG000|Overall Study|Lack of Efficacy|0|||
105757746|NCT00640146|364765372|FG001|Overall Study|Lack of Efficacy|1|||
105757747|NCT00640146|364765371|FG000|Overall Study|Withdrawal by Subject|1|||
105757748|NCT00640146|364765372|FG001|Overall Study|Withdrawal by Subject|1|||
105757749|NCT00640146|364765371|FG000|Overall Study|Randomized but not treated|1|||
105757750|NCT00640146|364765372|FG001|Overall Study|Randomized but not treated|3|||
105757751|NCT05742841|364765374|FG000|Overall Study|Withdrawal by Subject|1|||
105757752|NCT05742841|364765374|FG000|Overall Study|Lost to Follow-up|1|||
105757753|NCT02455388|364765375|FG000|Overall Study|Protocol Violation|1|||
105757754|NCT02455388|364765376|FG001|Overall Study|Protocol Violation|0|||
105757755|NCT02455388|364765377|FG002|Overall Study|Protocol Violation|4|||
105757756|NCT02455388|364765375|FG000|Overall Study|Withdrawal by Subject|0|||
105757757|NCT02455388|364765376|FG001|Overall Study|Withdrawal by Subject|0|||
105757758|NCT02455388|364765377|FG002|Overall Study|Withdrawal by Subject|7|||
105757759|NCT01316939|364765378|FG000|Overall Study|Study closed/terminated|26|||
105757760|NCT01316939|364765379|FG001|Overall Study|Study closed/terminated|25|||
105757761|NCT01316939|364765380|FG002|Overall Study|Study closed/terminated|23|||
105757762|NCT01316939|364765378|FG000|Overall Study|Lack of Efficacy|24|||
105757763|NCT01316939|364765379|FG001|Overall Study|Lack of Efficacy|25|||
105757764|NCT01316939|364765380|FG002|Overall Study|Lack of Efficacy|25|||
105757765|NCT01316939|364765378|FG000|Overall Study|Adverse Event|9|||
105757766|NCT01316939|364765379|FG001|Overall Study|Adverse Event|12|||
105757767|NCT01316939|364765380|FG002|Overall Study|Adverse Event|11|||
105757768|NCT01316939|364765378|FG000|Overall Study|Withdrawal by Subject|1|||
105757769|NCT01316939|364765379|FG001|Overall Study|Withdrawal by Subject|3|||
105757770|NCT01316939|364765380|FG002|Overall Study|Withdrawal by Subject|6|||
105757771|NCT01316939|364765378|FG000|Overall Study|Physician Decision|2|||
105757772|NCT01316939|364765379|FG001|Overall Study|Physician Decision|2|||
105757773|NCT01316939|364765380|FG002|Overall Study|Physician Decision|1|||
105757774|NCT01316939|364765378|FG000|Overall Study|Lost to Follow-up|0|||
105757775|NCT01316939|364765379|FG001|Overall Study|Lost to Follow-up|0|||
105757776|NCT01316939|364765380|FG002|Overall Study|Lost to Follow-up|2|||
105757777|NCT01316939|364765378|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
105757778|NCT01316939|364765379|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
105757779|NCT01316939|364765380|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
105757780|NCT01316939|364765378|FG000|Overall Study|Protocol Violation|0|||
105757781|NCT01316939|364765379|FG001|Overall Study|Protocol Violation|1|||
105757782|NCT01316939|364765380|FG002|Overall Study|Protocol Violation|0|||
105757783|NCT02254551|364765381|FG000|Dose Escalation|Physician Decision|1|||
105757784|NCT02254551|364765381|FG000|Dose Escalation|Dose-limiting toxicity|2|||
105757785|NCT04847141|364765382|FG000|Overall Study|Adverse Event|1|||
105757786|NCT04847141|364765383|FG001|Overall Study|Adverse Event|0|||
105757787|NCT04847141|364765384|FG002|Overall Study|Adverse Event|1|||
105757788|NCT04847141|364765382|FG000|Overall Study|Withdrawal by Subject|2|||
105757789|NCT04847141|364765383|FG001|Overall Study|Withdrawal by Subject|4|||
105757790|NCT04847141|364765384|FG002|Overall Study|Withdrawal by Subject|3|||
105757791|NCT04847141|364765382|FG000|Overall Study|Lost to Follow-up|7|||
105757792|NCT04847141|364765383|FG001|Overall Study|Lost to Follow-up|5|||
105757793|NCT04847141|364765384|FG002|Overall Study|Lost to Follow-up|7|||
105757794|NCT04847141|364765382|FG000|Overall Study|Reason not Specified|0|||
105804248|NCT00472446|364940285|FG003|Overall Study|Protocol Violation|1|||
105757795|NCT04847141|364765383|FG001|Overall Study|Reason not Specified|1|||
105757796|NCT04847141|364765384|FG002|Overall Study|Reason not Specified|0|||
105757797|NCT04058158|364765385|FG000|Period 1|Death|1|||
105757798|NCT04058158|364765386|FG001|Period 1|Death|0|||
105804249|NCT00472446|364940282|FG000|Overall Study|Reintervention|0|||
105804250|NCT00472446|364940283|FG001|Overall Study|Reintervention|0|||
105757799|NCT04058158|364765385|FG000|Period 1|Adverse Event|1|||
105757800|NCT04058158|364765386|FG001|Period 1|Adverse Event|1|||
105757801|NCT04058158|364765385|FG000|Period 1|Pregnancy|0|||
105757802|NCT04058158|364765386|FG001|Period 1|Pregnancy|1|||
105757803|NCT01634113|364765387|FG000|Overall Study|Not treated|0|||
105757804|NCT01634113|364765388|FG001|Overall Study|Not treated|0|||
105757805|NCT01634113|364765389|FG002|Overall Study|Not treated|1|||
105757806|NCT00324740|364765390|FG000|Overall Study|Withdrawal by Subject|1|||
105757807|NCT00324740|364765391|FG001|Overall Study|Withdrawal by Subject|0|||
105757808|NCT00324740|364765392|FG002|Overall Study|Withdrawal by Subject|1|||
105757809|NCT00520299|364765395|FG000|Overall Study|Withdrawal by Subject|0|||
105757810|NCT00520299|364765396|FG001|Overall Study|Withdrawal by Subject|0|||
105757811|NCT00520299|364765397|FG002|Overall Study|Withdrawal by Subject|2|||
105757812|NCT00520299|364765395|FG000|Overall Study|Progressive disease|0|||
105757813|NCT00520299|364765396|FG001|Overall Study|Progressive disease|3|||
105757814|NCT00520299|364765397|FG002|Overall Study|Progressive disease|4|||
105757815|NCT01352845|364765398|FG000|Overall Study|Lost to Follow-up|313|||
105757816|NCT01352845|364765399|FG001|Overall Study|Lost to Follow-up|92|||
105757817|NCT01352845|364765398|FG000|Overall Study|No Longer Willing to Participate|205|||
105757818|NCT01352845|364765399|FG001|Overall Study|No Longer Willing to Participate|58|||
105757819|NCT01352845|364765398|FG000|Overall Study|Withdrawal by Subject|48|||
105757820|NCT01352845|364765399|FG001|Overall Study|Withdrawal by Subject|16|||
105757821|NCT01352845|364765398|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
105757822|NCT01352845|364765399|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
105757823|NCT01352845|364765398|FG000|Overall Study|Pregnancy|27|||
105757824|NCT01352845|364765399|FG001|Overall Study|Pregnancy|7|||
105757825|NCT01352845|364765398|FG000|Overall Study|Adverse Event|22|||
105757826|NCT01352845|364765399|FG001|Overall Study|Adverse Event|6|||
105757827|NCT01352845|364765398|FG000|Overall Study|Other|17|||
105757828|NCT01352845|364765399|FG001|Overall Study|Other|7|||
105757829|NCT01352845|364765398|FG000|Overall Study|Protocol Violation|12|||
105757830|NCT01352845|364765399|FG001|Overall Study|Protocol Violation|6|||
105757831|NCT01352845|364765398|FG000|Overall Study|Death|3|||
105757832|NCT01352845|364765399|FG001|Overall Study|Death|0|||
105757833|NCT02528253|364765404|FG000|Overall Study|Adverse Event|3|||
105757834|NCT02528253|364765405|FG001|Overall Study|Adverse Event|4|||
105757835|NCT02528253|364765406|FG002|Overall Study|Adverse Event|4|||
105757836|NCT02528253|364765407|FG003|Overall Study|Adverse Event|8|||
105757837|NCT02528253|364765408|FG004|Overall Study|Adverse Event|18|||
105757838|NCT02528253|364765404|FG000|Overall Study|Death|2|||
105757839|NCT02528253|364765405|FG001|Overall Study|Death|2|||
105757840|NCT02528253|364765406|FG002|Overall Study|Death|1|||
105757841|NCT02528253|364765407|FG003|Overall Study|Death|0|||
105757842|NCT02528253|364765408|FG004|Overall Study|Death|1|||
105757843|NCT02528253|364765404|FG000|Overall Study|Insufficient clinical response|7|||
105757844|NCT02528253|364765405|FG001|Overall Study|Insufficient clinical response|10|||
105757845|NCT02528253|364765406|FG002|Overall Study|Insufficient clinical response|13|||
105757846|NCT02528253|364765407|FG003|Overall Study|Insufficient clinical response|12|||
105757847|NCT02528253|364765408|FG004|Overall Study|Insufficient clinical response|16|||
105757848|NCT02528253|364765404|FG000|Overall Study|Lost to Follow-up|16|||
105757849|NCT02528253|364765405|FG001|Overall Study|Lost to Follow-up|9|||
105757850|NCT02528253|364765406|FG002|Overall Study|Lost to Follow-up|31|||
105757851|NCT02528253|364765407|FG003|Overall Study|Lost to Follow-up|16|||
105757852|NCT02528253|364765408|FG004|Overall Study|Lost to Follow-up|34|||
105757853|NCT02528253|364765404|FG000|Overall Study|Other|21|||
105757854|NCT02528253|364765405|FG001|Overall Study|Other|22|||
105757855|NCT02528253|364765406|FG002|Overall Study|Other|58|||
105757856|NCT02528253|364765407|FG003|Overall Study|Other|52|||
105757857|NCT02528253|364765408|FG004|Overall Study|Other|76|||
105757858|NCT02528253|364765404|FG000|Overall Study|Withdrawal by Subject|25|||
105757859|NCT02528253|364765405|FG001|Overall Study|Withdrawal by Subject|20|||
105757860|NCT02528253|364765406|FG002|Overall Study|Withdrawal by Subject|29|||
105757861|NCT02528253|364765407|FG003|Overall Study|Withdrawal by Subject|48|||
105757862|NCT02528253|364765408|FG004|Overall Study|Withdrawal by Subject|73|||
105757863|NCT02528253|364765404|FG000|Overall Study|Protocol Violation|1|||
105757864|NCT02528253|364765405|FG001|Overall Study|Protocol Violation|2|||
105757865|NCT02528253|364765406|FG002|Overall Study|Protocol Violation|4|||
105757866|NCT02528253|364765407|FG003|Overall Study|Protocol Violation|0|||
105757867|NCT02528253|364765408|FG004|Overall Study|Protocol Violation|4|||
105757868|NCT02528253|364765404|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
105757869|NCT02528253|364765405|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
105757870|NCT02528253|364765406|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
105757871|NCT02528253|364765407|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
105757872|NCT02528253|364765408|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
105757873|NCT02293993|364765410|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
105757874|NCT02293993|364765411|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
105804251|NCT00472446|364940284|FG002|Overall Study|Reintervention|1|||
105757875|NCT02293993|364765412|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
105757876|NCT02293993|364765413|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
105757877|NCT02293993|364765410|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
105804252|NCT00472446|364940285|FG003|Overall Study|Reintervention|1|||
105804253|NCT00472446|364940282|FG000|Overall Study|Questionnaires not returned|5|||
105804254|NCT00472446|364940283|FG001|Overall Study|Questionnaires not returned|6|||
105804255|NCT00472446|364940284|FG002|Overall Study|Questionnaires not returned|6|||
105804256|NCT00472446|364940285|FG003|Overall Study|Questionnaires not returned|4|||
105804257|NCT00827827|364940286|FG000|Overall Study|Lost to Follow-up|3|||
105804258|NCT00827827|364940287|FG001|Overall Study|Lost to Follow-up|0|||
105804259|NCT00827827|364940286|FG000|Overall Study|Fall at home- hospitalization|1|||
105804260|NCT00827827|364940287|FG001|Overall Study|Fall at home- hospitalization|0|||
105804261|NCT00827827|364940286|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
105804262|NCT00827827|364940287|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
105804263|NCT00827827|364940286|FG000|Overall Study|Gout|1|||
105804264|NCT00827827|364940287|FG001|Overall Study|Gout|0|||
105804265|NCT00827827|364940286|FG000|Overall Study|Transportation issues|1|||
105804266|NCT00827827|364940287|FG001|Overall Study|Transportation issues|0|||
105804267|NCT00827827|364940286|FG000|Overall Study|Burned with water at home|1|||
105804268|NCT00827827|364940287|FG001|Overall Study|Burned with water at home|0|||
105804269|NCT01339910|364940295|FG000|Overall Study|Withdrawal by Subject|1|||
105804270|NCT01339910|364940296|FG001|Overall Study|Withdrawal by Subject|0|||
105804271|NCT01339910|364940295|FG000|Overall Study|Physician Decision|1|||
105804272|NCT01339910|364940296|FG001|Overall Study|Physician Decision|0|||
105804273|NCT01339910|364940295|FG000|Overall Study|Disease relapse|1|||
105804274|NCT01339910|364940296|FG001|Overall Study|Disease relapse|4|||
105804275|NCT01399723|364940297|FG000|Overall Study|Lost to Follow-up|0|||
105804276|NCT01399723|364940298|FG001|Overall Study|Lost to Follow-up|1|||
105804277|NCT00295854|364940300|FG000|Overall Study|Adverse Event|7|||
105804278|NCT00295854|364940301|FG001|Overall Study|Adverse Event|7|||
105804279|NCT00295854|364940302|FG002|Overall Study|Adverse Event|6|||
105804280|NCT00295854|364940300|FG000|Overall Study|Protocol Violation|1|||
105804281|NCT00295854|364940301|FG001|Overall Study|Protocol Violation|1|||
105804282|NCT00295854|364940302|FG002|Overall Study|Protocol Violation|1|||
105804283|NCT00295854|364940300|FG000|Overall Study|Lost to Follow-up|2|||
105804284|NCT00295854|364940301|FG001|Overall Study|Lost to Follow-up|0|||
105804285|NCT00295854|364940302|FG002|Overall Study|Lost to Follow-up|1|||
105804286|NCT00295854|364940300|FG000|Overall Study|Withdrawal by Subject|3|||
105804287|NCT00295854|364940301|FG001|Overall Study|Withdrawal by Subject|7|||
105804288|NCT00295854|364940302|FG002|Overall Study|Withdrawal by Subject|4|||
105804289|NCT00295854|364940300|FG000|Overall Study|did not continue to meet criteria|1|||
105804290|NCT00295854|364940301|FG001|Overall Study|did not continue to meet criteria|1|||
105804291|NCT00295854|364940302|FG002|Overall Study|did not continue to meet criteria|2|||
105804292|NCT00295854|364940300|FG000|Overall Study|required a prohibited medication|1|||
105804293|NCT00295854|364940301|FG001|Overall Study|required a prohibited medication|0|||
105804294|NCT00295854|364940302|FG002|Overall Study|required a prohibited medication|0|||
105804295|NCT00295854|364940300|FG000|Overall Study|Other|3|||
105804296|NCT00295854|364940301|FG001|Overall Study|Other|5|||
105804297|NCT00295854|364940302|FG002|Overall Study|Other|1|||
105804298|NCT00772577|364940303|FG000|Overall Study|Adverse Event|6|||
105804299|NCT00772577|364940304|FG001|Overall Study|Adverse Event|3|||
105804300|NCT00772577|364940303|FG000|Overall Study|Abnormal laboratory values|0|||
105804301|NCT00772577|364940304|FG001|Overall Study|Abnormal laboratory values|1|||
105804302|NCT00772577|364940303|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105804303|NCT00772577|364940304|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105804304|NCT00772577|364940303|FG000|Overall Study|Patient withdrew consent|8|||
105804305|NCT00772577|364940304|FG001|Overall Study|Patient withdrew consent|5|||
105804306|NCT00772577|364940303|FG000|Overall Study|Lost to Follow-up|4|||
105804307|NCT00772577|364940304|FG001|Overall Study|Lost to Follow-up|3|||
105804308|NCT00772577|364940303|FG000|Overall Study|Administrative problems|2|||
105804309|NCT00772577|364940304|FG001|Overall Study|Administrative problems|1|||
105804310|NCT00772577|364940303|FG000|Overall Study|Protocol Deviation|3|||
105804311|NCT00772577|364940304|FG001|Overall Study|Protocol Deviation|2|||
105804312|NCT03211156|364940305|FG000|Overall Study|Withdrawal by Subject|0|||
105804313|NCT03211156|364940306|FG001|Overall Study|Withdrawal by Subject|2|||
105804314|NCT03211156|364940305|FG000|Overall Study|Lost to Follow-up|1|||
105804315|NCT03211156|364940306|FG001|Overall Study|Lost to Follow-up|1|||
105804316|NCT03211156|364940305|FG000|Overall Study|Adverse Event|1|||
105804317|NCT03211156|364940306|FG001|Overall Study|Adverse Event|0|||
105804318|NCT05266456|364940308|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
105804319|NCT05266456|364940309|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
105804320|NCT05266456|364940310|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
105804321|NCT05266456|364940311|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
105804322|NCT05266456|364940308|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
105804323|NCT05266456|364940309|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
105950429|NCT00363311|365482400|FG000|Overall Study|Non-Compliance|1|||
105804324|NCT05266456|364940310|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
105804325|NCT05266456|364940311|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
105804326|NCT05266456|364940308|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
105804327|NCT05266456|364940309|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
105804328|NCT05266456|364940310|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
105804329|NCT05266456|364940311|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
105804330|NCT05266456|364940308|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
105804331|NCT05266456|364940309|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
105804332|NCT05266456|364940310|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
105804333|NCT05266456|364940311|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
105804334|NCT05266456|364940308|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
105804335|NCT05266456|364940309|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
105804336|NCT05266456|364940310|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
105804337|NCT05266456|364940311|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
105804338|NCT01724359|364940312|FG000|Overall Study|Adverse Event|10|||
105804339|NCT01724359|364940312|FG000|Overall Study|Death|1|||
105804340|NCT01724359|364940312|FG000|Overall Study|Other|20|||
105804341|NCT01821625|364940319|FG000|Overall Study|Withdrawal by Subject|2|||
105804342|NCT01821625|364940319|FG000|Overall Study|Lack of Efficacy|2|||
105804343|NCT01821625|364940319|FG000|Overall Study|Adverse Event|1|||
105804344|NCT01821625|364940319|FG000|Overall Study|Medical contraindication|1|||
105804345|NCT00320593|364940320|FG000|Overall Study|Lost to Follow-up|3|||
105804346|NCT00320593|364940321|FG001|Overall Study|Lost to Follow-up|0|||
105804347|NCT00320593|364940320|FG000|Overall Study|Moved to another state|1|||
105804348|NCT00320593|364940321|FG001|Overall Study|Moved to another state|0|||
105804349|NCT00320593|364940320|FG000|Overall Study|Withdrawal by Subject|2|||
105804350|NCT00320593|364940321|FG001|Overall Study|Withdrawal by Subject|1|||
105804351|NCT00320593|364940320|FG000|Overall Study|Withdrawal by clinical center|1|||
105804352|NCT00320593|364940321|FG001|Overall Study|Withdrawal by clinical center|0|||
105804353|NCT00457665|364940322|FG000|12 Months|Drug allergy|1|||
105804354|NCT00457665|364940323|FG001|12 Months|Drug allergy|1|||
105804355|NCT00457665|364940322|FG000|12 Months|High HIV viral load|5|||
105804356|NCT00457665|364940323|FG001|12 Months|High HIV viral load|1|||
105804357|NCT00457665|364940322|FG000|12 Months|Lipodystrophy|2|||
105804358|NCT00457665|364940323|FG001|12 Months|Lipodystrophy|0|||
105804359|NCT00457665|364940322|FG000|12 Months|Withdrawal by Subject|0|||
105804360|NCT00457665|364940323|FG001|12 Months|Withdrawal by Subject|2|||
105804361|NCT00457665|364940322|FG000|12 Months|Abnormal Liver function tests|0|||
105804362|NCT00457665|364940323|FG001|12 Months|Abnormal Liver function tests|5|||
105804363|NCT00457665|364940322|FG000|24 Months|Withdrawal by Subject|3|||
105804364|NCT00457665|364940323|FG001|24 Months|Withdrawal by Subject|2|||
105804365|NCT00457665|364940322|FG000|24 Months|Lipodystrophy|1|||
105804366|NCT00457665|364940323|FG001|24 Months|Lipodystrophy|1|||
105804367|NCT00457665|364940322|FG000|24 Months|Abnormal liver function tests|1|||
105804368|NCT00457665|364940323|FG001|24 Months|Abnormal liver function tests|5|||
105804369|NCT01722266|364940324|FG000|Overall Study|Withdrawal by Subject|1|||
105804370|NCT01722266|364940325|FG001|Overall Study|Withdrawal by Subject|2|||
105804371|NCT01722266|364940326|FG002|Overall Study|Withdrawal by Subject|0|||
105804372|NCT01722266|364940327|FG003|Overall Study|Withdrawal by Subject|0|||
105804373|NCT01722266|364940324|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
105804374|NCT01722266|364940325|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
105804375|NCT01722266|364940326|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
105804376|NCT01722266|364940327|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
105804377|NCT01722266|364940324|FG000|Overall Study|Dropped out due to Nausea|0|||
105804378|NCT01722266|364940325|FG001|Overall Study|Dropped out due to Nausea|0|||
105804379|NCT01722266|364940326|FG002|Overall Study|Dropped out due to Nausea|2|||
105804380|NCT01722266|364940327|FG003|Overall Study|Dropped out due to Nausea|0|||
105804381|NCT02535000|364940331|FG000|Overall Study|Cancellation of surgery.|1|||
105804382|NCT02535000|364940332|FG001|Overall Study|Cancellation of surgery.|2|||
105804383|NCT03811249|364940333|FG000|Overall Study|Withdrawal by Subject|44|||
105804384|NCT03811249|364940333|FG000|Overall Study|Missed Visit|24|||
105804385|NCT04317781|364940334|FG000|Overall Study|Adverse Event|1|||
105804386|NCT04317781|364940334|FG000|Overall Study|Disease relapse|1|||
105804387|NCT04317781|364940334|FG000|Overall Study|Withdrawal by Subject|1|||
105804388|NCT02151461|364940354|FG000|Overall Study|Adverse Event|5|||
105804389|NCT02151461|364940355|FG001|Overall Study|Adverse Event|1|||
105950430|NCT00363311|365482401|FG001|Overall Study|Non-Compliance|1|||
105950431|NCT00363311|365482400|FG000|Overall Study|Participant Refused Biopsy|1|||
105804390|NCT02151461|364940356|FG002|Overall Study|Adverse Event|0|||
105804391|NCT02151461|364940357|FG003|Overall Study|Adverse Event|2|||
105804392|NCT02151461|364940354|FG000|Overall Study|Lost to Follow-up|0|||
105804393|NCT02151461|364940355|FG001|Overall Study|Lost to Follow-up|0|||
105804394|NCT02151461|364940356|FG002|Overall Study|Lost to Follow-up|1|||
105804395|NCT02151461|364940357|FG003|Overall Study|Lost to Follow-up|1|||
105950432|NCT00363311|365482401|FG001|Overall Study|Participant Refused Biopsy|0|||
105950433|NCT00363311|365482400|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
105804396|NCT02151461|364940354|FG000|Overall Study|Withdrawal by Subject|1|||
105804397|NCT02151461|364940355|FG001|Overall Study|Withdrawal by Subject|0|||
105804398|NCT02151461|364940356|FG002|Overall Study|Withdrawal by Subject|1|||
106016591|NCT03748641|365724465|FG004|Overall Study|Ongoing|84|||
105804399|NCT02151461|364940357|FG003|Overall Study|Withdrawal by Subject|1|||
105804400|NCT02151461|364940354|FG000|Overall Study|Treatment discontinuation|0|||
105804401|NCT02151461|364940355|FG001|Overall Study|Treatment discontinuation|0|||
105804402|NCT02151461|364940356|FG002|Overall Study|Treatment discontinuation|1|||
105804403|NCT02151461|364940357|FG003|Overall Study|Treatment discontinuation|0|||
105804404|NCT00871169|364940358|FG000|Overall Study|Protocol Violation|1|||
105804405|NCT00871169|364940358|FG000|Overall Study|Patient did not receive study treatment|2|||
105804406|NCT02168270|364940359|FG000|Overall Study|Lack of Efficacy|4|||
105804407|NCT00638157|364940363|FG000|Overall Study|Adverse Event|0|||
105804408|NCT00638157|364940364|FG001|Overall Study|Adverse Event|1|||
105804409|NCT00638157|364940363|FG000|Overall Study|Clinical (symptomatic) failure|1|||
105804410|NCT00638157|364940364|FG001|Overall Study|Clinical (symptomatic) failure|1|||
105804411|NCT00638157|364940363|FG000|Overall Study|Microbiological failure|1|||
105804412|NCT00638157|364940364|FG001|Overall Study|Microbiological failure|0|||
105804413|NCT00638157|364940363|FG000|Overall Study|Lost to Follow-up|1|||
105804414|NCT00638157|364940364|FG001|Overall Study|Lost to Follow-up|0|||
105804415|NCT00638157|364940363|FG000|Overall Study|Physician Decision|1|||
105804416|NCT00638157|364940364|FG001|Overall Study|Physician Decision|0|||
105804417|NCT00638157|364940363|FG000|Overall Study|Other|1|||
105804418|NCT00638157|364940364|FG001|Overall Study|Other|2|||
105804419|NCT00638157|364940363|FG000|Overall Study|Randomized, not treated|2|||
105804420|NCT00638157|364940364|FG001|Overall Study|Randomized, not treated|0|||
105804421|NCT00593333|364940365|FG000|Overall Study|Lost to Follow-up|10|||
105804422|NCT00593333|364940366|FG001|Overall Study|Lost to Follow-up|11|||
105804423|NCT01851590|364940368|FG000|Overall Study|Withdrawal by Subject|0|||
105804424|NCT01851590|364940369|FG001|Overall Study|Withdrawal by Subject|0|||
105804425|NCT01851590|364940370|FG002|Overall Study|Withdrawal by Subject|1|||
105804426|NCT01851590|364940368|FG000|Overall Study|Adverse Event|0|||
105804427|NCT01851590|364940369|FG001|Overall Study|Adverse Event|0|||
105804428|NCT01851590|364940370|FG002|Overall Study|Adverse Event|2|||
105804429|NCT01851590|364940368|FG000|Overall Study|Lack of Efficacy|0|||
105804430|NCT01851590|364940369|FG001|Overall Study|Lack of Efficacy|1|||
105804431|NCT01851590|364940370|FG002|Overall Study|Lack of Efficacy|0|||
105804432|NCT03402893|364940379|FG000|Overall Study|Withdrawal by Subject|1|||
105804433|NCT01193517|364940381|FG000|Overall Study|Early Progression|1|||
105804434|NCT01193517|364940382|FG001|Overall Study|Early Progression|0|||
105804435|NCT01193517|364940383|FG002|Overall Study|Early Progression|0|||
105804436|NCT02115256|364940384|FG000|Overall Study|Withdrawal by Subject|0|||
105804437|NCT02115256|364940385|FG001|Overall Study|Withdrawal by Subject|1|||
105804438|NCT00753714|364940386|FG000|Overall Study|Lack of Efficacy|21|||
105804439|NCT00753714|364940387|FG001|Overall Study|Lack of Efficacy|34|||
105804440|NCT00753714|364940386|FG000|Overall Study|Adverse Event|26|||
105804441|NCT00753714|364940387|FG001|Overall Study|Adverse Event|18|||
105804442|NCT00753714|364940386|FG000|Overall Study|Protocol Violation|1|||
105804443|NCT00753714|364940387|FG001|Overall Study|Protocol Violation|0|||
105804444|NCT00753714|364940386|FG000|Overall Study|Lost to Follow-up|0|||
105804445|NCT00753714|364940387|FG001|Overall Study|Lost to Follow-up|1|||
105804446|NCT00753714|364940386|FG000|Overall Study|Withdrawal by Subject|2|||
105804447|NCT00753714|364940387|FG001|Overall Study|Withdrawal by Subject|1|||
105804448|NCT00753714|364940386|FG000|Overall Study|Death|3|||
105804449|NCT00753714|364940387|FG001|Overall Study|Death|3|||
105804450|NCT00753714|364940386|FG000|Overall Study|Other|7|||
105804451|NCT00753714|364940387|FG001|Overall Study|Other|5|||
105804452|NCT02607800|364940388|FG000|Overall Study|Lost to Follow-up|7|||
105804453|NCT02607800|364940389|FG001|Overall Study|Lost to Follow-up|10|||
105804454|NCT02607800|364940388|FG000|Overall Study|Withdrew Consent|2|||
105950434|NCT00363311|365482401|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
105950435|NCT00363311|365482400|FG000|Overall Study|Participant Opted for Treatment|1|||
105950436|NCT00363311|365482401|FG001|Overall Study|Participant Opted for Treatment|0|||
105950437|NCT00363311|365482400|FG000|Overall Study|Participant Moved to Another Country|1|||
105804455|NCT02607800|364940389|FG001|Overall Study|Withdrew Consent|0|||
105804456|NCT02607800|364940388|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
105804457|NCT02607800|364940389|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
105804458|NCT01512979|364940397|FG000|Overall Study|Adverse Event|2|||
105804459|NCT01512979|364940398|FG001|Overall Study|Adverse Event|2|||
105804460|NCT01512979|364940397|FG000|Overall Study|Protocol Violation|1|||
105804461|NCT01512979|364940398|FG001|Overall Study|Protocol Violation|4|||
105804462|NCT01512979|364940397|FG000|Overall Study|Lost to Follow-up|2|||
105804463|NCT01512979|364940398|FG001|Overall Study|Lost to Follow-up|5|||
105804464|NCT01512979|364940397|FG000|Overall Study|Withdrawal by Subject|1|||
105804465|NCT01512979|364940398|FG001|Overall Study|Withdrawal by Subject|2|||
105804466|NCT01512979|364940397|FG000|Overall Study|Reason other than stated above|13|||
105804467|NCT01512979|364940398|FG001|Overall Study|Reason other than stated above|9|||
105804468|NCT01533428|364940403|FG000|Overall Study|Adverse Event|0|||
105950438|NCT00363311|365482401|FG001|Overall Study|Participant Moved to Another Country|0|||
105804469|NCT01533428|364940404|FG001|Overall Study|Adverse Event|1|||
105804470|NCT01533428|364940403|FG000|Overall Study|Lost to Follow-up|2|||
105804471|NCT01533428|364940404|FG001|Overall Study|Lost to Follow-up|1|||
105757878|NCT02293993|364765411|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
105757879|NCT02293993|364765412|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
105757880|NCT02293993|364765413|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
105757881|NCT02293993|364765410|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
105757882|NCT02293993|364765411|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
105757883|NCT02293993|364765412|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
105757884|NCT02293993|364765413|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
105757885|NCT02293993|364765410|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
105757886|NCT02293993|364765411|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
105757887|NCT02293993|364765412|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
105757888|NCT02293993|364765413|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
105757889|NCT02293993|364765410|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
105757890|NCT02293993|364765411|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
105757891|NCT02293993|364765412|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
105757892|NCT02293993|364765413|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
105757893|NCT00094835|364765414|FG000|Overall Study|Physician Decision|1|||
105757894|NCT00094835|364765415|FG001|Overall Study|Physician Decision|0|||
105757895|NCT00094835|364765416|FG002|Overall Study|Physician Decision|0|||
105757896|NCT00094835|364765417|FG003|Overall Study|Physician Decision|0|||
105757897|NCT00094835|364765418|FG004|Overall Study|Physician Decision|0|||
105757898|NCT00094835|364765419|FG005|Overall Study|Physician Decision|1|||
105757899|NCT00094835|364765420|FG006|Overall Study|Physician Decision|0|||
105757900|NCT00094835|364765414|FG000|Overall Study|Withdrawal by Subject|0|||
105757901|NCT00094835|364765415|FG001|Overall Study|Withdrawal by Subject|0|||
105757902|NCT00094835|364765416|FG002|Overall Study|Withdrawal by Subject|0|||
105757903|NCT00094835|364765417|FG003|Overall Study|Withdrawal by Subject|0|||
105757904|NCT00094835|364765418|FG004|Overall Study|Withdrawal by Subject|0|||
105757905|NCT00094835|364765419|FG005|Overall Study|Withdrawal by Subject|0|||
105757906|NCT00094835|364765420|FG006|Overall Study|Withdrawal by Subject|1|||
105757907|NCT00094835|364765414|FG000|Overall Study|Lost to Follow-up|0|||
105757908|NCT00094835|364765415|FG001|Overall Study|Lost to Follow-up|0|||
105757909|NCT00094835|364765416|FG002|Overall Study|Lost to Follow-up|0|||
105757910|NCT00094835|364765417|FG003|Overall Study|Lost to Follow-up|0|||
105757911|NCT00094835|364765418|FG004|Overall Study|Lost to Follow-up|1|||
105757912|NCT00094835|364765419|FG005|Overall Study|Lost to Follow-up|0|||
105757913|NCT00094835|364765420|FG006|Overall Study|Lost to Follow-up|0|||
105757914|NCT00094835|364765414|FG000|Overall Study|Death|1|||
105757915|NCT00094835|364765415|FG001|Overall Study|Death|0|||
105757916|NCT00094835|364765416|FG002|Overall Study|Death|0|||
105757917|NCT00094835|364765417|FG003|Overall Study|Death|0|||
105757918|NCT00094835|364765418|FG004|Overall Study|Death|1|||
105757919|NCT00094835|364765419|FG005|Overall Study|Death|0|||
105757920|NCT00094835|364765420|FG006|Overall Study|Death|0|||
105757921|NCT00094835|364765414|FG000|Overall Study|Non-compliance|1|||
105757922|NCT00094835|364765415|FG001|Overall Study|Non-compliance|2|||
105757923|NCT00094835|364765416|FG002|Overall Study|Non-compliance|2|||
105757924|NCT00094835|364765417|FG003|Overall Study|Non-compliance|0|||
105757925|NCT00094835|364765418|FG004|Overall Study|Non-compliance|2|||
105757926|NCT00094835|364765419|FG005|Overall Study|Non-compliance|2|||
105757927|NCT00094835|364765420|FG006|Overall Study|Non-compliance|1|||
105757928|NCT00094835|364765414|FG000|Overall Study|Other|1|||
105757929|NCT00094835|364765415|FG001|Overall Study|Other|1|||
105757930|NCT00094835|364765416|FG002|Overall Study|Other|1|||
105757931|NCT00094835|364765417|FG003|Overall Study|Other|1|||
105757932|NCT00094835|364765418|FG004|Overall Study|Other|0|||
105757933|NCT00094835|364765419|FG005|Overall Study|Other|0|||
105757934|NCT00094835|364765420|FG006|Overall Study|Other|0|||
105757935|NCT03628599|364765421|FG000|Overall Study|Adverse Event|0|||
105757936|NCT03628599|364765422|FG001|Overall Study|Adverse Event|1|||
105757937|NCT00728936|364765426|FG000|Overall Study|Withdrawal by Subject|0|||
105757938|NCT00728936|364765427|FG001|Overall Study|Withdrawal by Subject|0|||
105757939|NCT00728936|364765428|FG002|Overall Study|Withdrawal by Subject|0|||
105757940|NCT00728936|364765429|FG003|Overall Study|Withdrawal by Subject|0|||
105757941|NCT00728936|364765430|FG004|Overall Study|Withdrawal by Subject|0|||
105757942|NCT00728936|364765431|FG005|Overall Study|Withdrawal by Subject|1|||
105757943|NCT00728936|364765432|FG006|Overall Study|Withdrawal by Subject|0|||
105757944|NCT00438464|364765433|FG000|Overall Study|Terminated Early|14|||
105757945|NCT00438464|364765434|FG001|Overall Study|Terminated Early|5|||
105757946|NCT00438464|364765433|FG000|Overall Study|Incomplete data submission|0|||
105757947|NCT00438464|364765434|FG001|Overall Study|Incomplete data submission|2|||
105757948|NCT00132314|364765435|FG000|Overall Study|Lost to Follow-up|70|||
105757949|NCT00132314|364765436|FG001|Overall Study|Lost to Follow-up|62|||
105757950|NCT00132314|364765435|FG000|Overall Study|Lacked SSN|1|||
105804472|NCT01533428|364940403|FG000|Overall Study|Withdrawal by Subject|7|||
105804473|NCT01533428|364940404|FG001|Overall Study|Withdrawal by Subject|6|||
105804474|NCT01078090|364940412|FG000|Overall Study|Lost to Follow-up|2363|||
105804475|NCT01078090|364940412|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
105804476|NCT01078090|364940412|FG000|Overall Study|Lack of Efficacy|1193|||
105804477|NCT01078090|364940412|FG000|Overall Study|ADR and lack of efficacy|61|||
105804478|NCT01078090|364940412|FG000|Overall Study|Other|523|||
105804479|NCT04535583|364940413|FG000|Overall Study|Lost to Follow-up|1|||
105804480|NCT04535583|364940413|FG000|Overall Study|Physician Decision|1|||
105804481|NCT04535583|364940413|FG000|Overall Study|Withdrawal by Subject|1|||
105804482|NCT00745251|364940414|FG000|Overall Study|Adverse Event|1|||
105804483|NCT00745251|364940415|FG001|Overall Study|Adverse Event|2|||
105804484|NCT00745251|364940414|FG000|Overall Study|Withdrawal by Subject|1|||
105804485|NCT00745251|364940415|FG001|Overall Study|Withdrawal by Subject|1|||
105804486|NCT02669264|364940417|FG000|Overall Study|Death|5|||
105804487|NCT02669264|364940418|FG001|Overall Study|Death|5|||
105757951|NCT00132314|364765436|FG001|Overall Study|Lacked SSN|3|||
105757952|NCT00132314|364765435|FG000|Overall Study|Refused intervention at baseline|2|||
105757953|NCT00132314|364765436|FG001|Overall Study|Refused intervention at baseline|7|||
105757954|NCT02905825|364765442|FG000|Overall Study|Protocol Violation|11|||
105757955|NCT02905825|364765442|FG000|Overall Study|Device Malfunction|1|||
105757956|NCT00092677|364765460|FG000|Overall Study|Lost to Follow-up|0|||
105757957|NCT00092677|364765461|FG001|Overall Study|Lost to Follow-up|2|||
105757958|NCT00092677|364765460|FG000|Overall Study|Adminstrative|5|||
105757959|NCT00092677|364765461|FG001|Overall Study|Adminstrative|9|||
105757960|NCT02966353|364765462|FG000|Overall Study|Withdrawal by Subject|7|||
105757961|NCT02966353|364765462|FG000|Overall Study|Adverse Event|4|||
105757962|NCT02966353|364765462|FG000|Overall Study|Death|4|||
105757963|NCT02966353|364765462|FG000|Overall Study|Physician Decision|3|||
105757964|NCT02966353|364765462|FG000|Overall Study|Progressive disease|2|||
105757965|NCT02966353|364765462|FG000|Overall Study|Protocol deviation|2|||
105757966|NCT01090102|364765463|FG000|First 12 Weeks|Withdrawal by Subject|1|||
105757967|NCT01090102|364765464|FG001|First 12 Weeks|Withdrawal by Subject|1|||
105757968|NCT01090102|364765463|FG000|First 12 Weeks|Adverse Event|2|||
105757969|NCT01090102|364765464|FG001|First 12 Weeks|Adverse Event|0|||
105757970|NCT01090102|364765463|FG000|First 12 Weeks|Death|1|||
105757971|NCT01090102|364765464|FG001|First 12 Weeks|Death|1|||
105757972|NCT01090102|364765463|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
105757973|NCT01090102|364765464|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
105757974|NCT01019252|364765467|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
105757975|NCT01019252|364765468|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
105757976|NCT01019252|364765467|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
105757977|NCT01019252|364765468|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
105757978|NCT01019252|364765467|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
105757979|NCT01019252|364765468|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
105757980|NCT01019252|364765467|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
105757981|NCT01019252|364765468|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
105757982|NCT04154943|364765469|FG000|Overall Study|Study Ongoing|68|||
105757983|NCT04154943|364765469|FG000|Overall Study|Lost to Follow-up|1|||
105757984|NCT04154943|364765469|FG000|Overall Study|Decision by the Investigator|1|||
105757985|NCT04154943|364765469|FG000|Overall Study|Death|5|||
105757986|NCT04154943|364765469|FG000|Overall Study|Withdrawal by Subject|4|||
105757987|NCT00985738|364765471|FG000|Overall Study|Study closed prematurely|8|||
105757988|NCT00985738|364765472|FG001|Overall Study|Study closed prematurely|8|||
105757989|NCT02227849|364765473|FG000|Overall Study|Adverse Event|4|||
105757990|NCT02227849|364765473|FG000|Overall Study|Physician Decision|1|||
105757991|NCT02227849|364765473|FG000|Overall Study|Withdrawal by Subject|3|||
105757992|NCT02563925|364765476|FG000|Overall Study|Withdrawal by Subject|2|||
105757993|NCT00879437|364765479|FG000|Overall Study|Protocol Violation|0|||
105757994|NCT00879437|364765480|FG001|Overall Study|Protocol Violation|1|||
105757995|NCT00879437|364765479|FG000|Overall Study|Death|1|||
105757996|NCT00879437|364765480|FG001|Overall Study|Death|0|||
105804488|NCT02669264|364940419|FG002|Overall Study|Death|3|||
105804489|NCT02669264|364940420|FG003|Overall Study|Death|3|||
105757997|NCT01315847|364765481|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
105757998|NCT01315847|364765482|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
105757999|NCT01315847|364765481|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
105758000|NCT01315847|364765482|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
105758001|NCT03448224|364765484|FG000|Overall Study|Provided same answer to every question|1|||
105804490|NCT02669264|364940421|FG004|Overall Study|Death|3|||
105804491|NCT02669264|364940422|FG005|Overall Study|Death|6|||
105804492|NCT02669264|364940423|FG006|Overall Study|Death|3|||
105804493|NCT02669264|364940417|FG000|Overall Study|Withdrawal by Subject|0|||
105804494|NCT02669264|364940418|FG001|Overall Study|Withdrawal by Subject|1|||
105804495|NCT02669264|364940419|FG002|Overall Study|Withdrawal by Subject|0|||
105804496|NCT02669264|364940420|FG003|Overall Study|Withdrawal by Subject|0|||
105804497|NCT02669264|364940421|FG004|Overall Study|Withdrawal by Subject|1|||
105758002|NCT03448224|364765485|FG001|Overall Study|Provided same answer to every question|0|||
105758003|NCT03495817|364765486|FG000|26 Week Open Label|Adverse Event|3|||
105758004|NCT03495817|364765486|FG000|26 Week Open Label|Withdrawal by Subject|4|||
105758005|NCT03495817|364765486|FG000|26 Week Open Label|Lost to Follow-up|1|||
105758006|NCT03495817|364765486|FG000|26 Week Extension|Lost to Follow-up|2|||
105758007|NCT01117012|364765487|FG000|Overall Study|Adverse Event|0|||
105758008|NCT01117012|364765488|FG001|Overall Study|Adverse Event|1|||
105758009|NCT01117012|364765487|FG000|Overall Study|Death|1|||
105758010|NCT01117012|364765488|FG001|Overall Study|Death|1|||
105758011|NCT01117012|364765487|FG000|Overall Study|Withdrawal by Subject|3|||
105758012|NCT01117012|364765488|FG001|Overall Study|Withdrawal by Subject|0|||
105758013|NCT01117012|364765487|FG000|Overall Study|Undefined|4|||
105758014|NCT01117012|364765488|FG001|Overall Study|Undefined|3|||
105758015|NCT03695393|364765489|FG000|Overall Study|Death|3|||
105758016|NCT03695393|364765490|FG001|Overall Study|Death|1|||
105758017|NCT03695393|364765489|FG000|Overall Study|Lost to Follow-up|0|||
105758018|NCT03695393|364765490|FG001|Overall Study|Lost to Follow-up|1|||
105758019|NCT00673894|364765493|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
105758020|NCT00673894|364765494|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
105758021|NCT00673894|364765493|FG000|First Intervention 4 Weeks|Adverse Event|1|||
105758022|NCT00673894|364765494|FG001|First Intervention 4 Weeks|Adverse Event|0|||
105758023|NCT00844285|364765496|FG000|Overall Study|Other|0|||
105758024|NCT00844285|364765497|FG001|Overall Study|Other|1|||
105758025|NCT00844285|364765498|FG002|Overall Study|Other|0|||
105758026|NCT00844285|364765496|FG000|Overall Study|Other than specified|95|||
105758027|NCT00844285|364765497|FG001|Overall Study|Other than specified|129|||
105758028|NCT00844285|364765498|FG002|Overall Study|Other than specified|12|||
105758029|NCT00844285|364765496|FG000|Overall Study|Site closure|256|||
105758030|NCT00844285|364765497|FG001|Overall Study|Site closure|450|||
105758031|NCT00844285|364765498|FG002|Overall Study|Site closure|50|||
105758032|NCT00844285|364765496|FG000|Overall Study|Follow-up < 8 years|16|||
105758033|NCT00844285|364765497|FG001|Overall Study|Follow-up < 8 years|23|||
105758034|NCT00844285|364765498|FG002|Overall Study|Follow-up < 8 years|4|||
105758035|NCT00844285|364765496|FG000|Overall Study|Protocol Violation|26|||
105758036|NCT00844285|364765497|FG001|Overall Study|Protocol Violation|28|||
105758037|NCT00844285|364765498|FG002|Overall Study|Protocol Violation|54|||
105758038|NCT00844285|364765496|FG000|Overall Study|Death|22|||
105758039|NCT00844285|364765497|FG001|Overall Study|Death|21|||
105758040|NCT00844285|364765498|FG002|Overall Study|Death|8|||
105758041|NCT00844285|364765496|FG000|Overall Study|Withdrew Consent|344|||
105758042|NCT00844285|364765497|FG001|Overall Study|Withdrew Consent|466|||
105758043|NCT00844285|364765498|FG002|Overall Study|Withdrew Consent|70|||
105758044|NCT00844285|364765496|FG000|Overall Study|Lost to Follow-up|330|||
105758045|NCT00844285|364765497|FG001|Overall Study|Lost to Follow-up|486|||
105758046|NCT00844285|364765498|FG002|Overall Study|Lost to Follow-up|74|||
105758047|NCT00405821|364765501|FG000|Overall Study|Death|5|||
105758048|NCT00405821|364765502|FG001|Overall Study|Death|7|||
105758049|NCT00405821|364765501|FG000|Overall Study|Lost to Follow-up|7|||
105758050|NCT00405821|364765502|FG001|Overall Study|Lost to Follow-up|7|||
105758051|NCT00405821|364765501|FG000|Overall Study|Protocol Violation|1|||
105758052|NCT00405821|364765502|FG001|Overall Study|Protocol Violation|0|||
105758053|NCT00405821|364765501|FG000|Overall Study|initiated ART|9|||
105758054|NCT00405821|364765502|FG001|Overall Study|initiated ART|8|||
105758055|NCT04682353|364765503|FG000|Overall Study|Lost to Follow-up|0|||
105758056|NCT04682353|364765504|FG001|Overall Study|Lost to Follow-up|1|||
105758057|NCT04682353|364765505|FG002|Overall Study|Lost to Follow-up|0|||
105758058|NCT04682353|364765506|FG003|Overall Study|Lost to Follow-up|1|||
105758059|NCT04682353|364765503|FG000|Overall Study|Personal reasons|0|||
105758060|NCT04682353|364765504|FG001|Overall Study|Personal reasons|1|||
105950439|NCT00363311|365482400|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
105758061|NCT04682353|364765505|FG002|Overall Study|Personal reasons|0|||
105758062|NCT04682353|364765506|FG003|Overall Study|Personal reasons|0|||
105758063|NCT01769469|364765516|FG000|Overall Study|Consent Withdrawn|5|||
105804498|NCT02669264|364940422|FG005|Overall Study|Withdrawal by Subject|0|||
105758064|NCT01769469|364765516|FG000|Overall Study|Moved Out Of Area|3|||
105758065|NCT01769469|364765516|FG000|Overall Study|Lost to Follow-up|17|||
105758066|NCT01769469|364765516|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
105758067|NCT01769469|364765516|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
105758068|NCT00862654|364765517|FG000|Overall Study|Lack of Efficacy|1|||
105758069|NCT00862654|364765518|FG001|Overall Study|Lack of Efficacy|0|||
105758070|NCT00862654|364765519|FG002|Overall Study|Lack of Efficacy|1|||
105758071|NCT00862654|364765520|FG003|Overall Study|Lack of Efficacy|0|||
105758072|NCT00862654|364765517|FG000|Overall Study|Lost to Follow-up|1|||
105758073|NCT00862654|364765518|FG001|Overall Study|Lost to Follow-up|2|||
105758074|NCT00862654|364765519|FG002|Overall Study|Lost to Follow-up|1|||
105758075|NCT00862654|364765520|FG003|Overall Study|Lost to Follow-up|3|||
105758076|NCT00862654|364765517|FG000|Overall Study|Adverse Event|0|||
105758077|NCT00862654|364765518|FG001|Overall Study|Adverse Event|1|||
105758078|NCT00862654|364765519|FG002|Overall Study|Adverse Event|1|||
105758079|NCT00862654|364765520|FG003|Overall Study|Adverse Event|0|||
105804499|NCT02669264|364940423|FG006|Overall Study|Withdrawal by Subject|0|||
105804500|NCT02669264|364940417|FG000|Overall Study|Lost to Follow-up|0|||
105804501|NCT02669264|364940418|FG001|Overall Study|Lost to Follow-up|0|||
105804502|NCT02669264|364940419|FG002|Overall Study|Lost to Follow-up|0|||
105804503|NCT02669264|364940420|FG003|Overall Study|Lost to Follow-up|0|||
105804504|NCT02669264|364940421|FG004|Overall Study|Lost to Follow-up|1|||
105804505|NCT02669264|364940422|FG005|Overall Study|Lost to Follow-up|0|||
105804506|NCT02669264|364940423|FG006|Overall Study|Lost to Follow-up|0|||
105804507|NCT02669264|364940417|FG000|Overall Study|Miscellaneous|0|||
105804508|NCT02669264|364940418|FG001|Overall Study|Miscellaneous|0|||
105804509|NCT02669264|364940419|FG002|Overall Study|Miscellaneous|0|||
105804510|NCT02669264|364940420|FG003|Overall Study|Miscellaneous|0|||
105804511|NCT02669264|364940421|FG004|Overall Study|Miscellaneous|0|||
105804512|NCT02669264|364940422|FG005|Overall Study|Miscellaneous|0|||
105804513|NCT02669264|364940423|FG006|Overall Study|Miscellaneous|2|||
105804514|NCT03280537|364940426|FG000|Overall Study|Withdrawal by Subject|2|||
105804515|NCT03280537|364940427|FG001|Overall Study|Withdrawal by Subject|4|||
105804516|NCT00669955|364940428|FG000|Overall Study|Adverse Event|3|||
105804517|NCT00669955|364940429|FG001|Overall Study|Adverse Event|5|||
105804518|NCT00669955|364940428|FG000|Overall Study|Death|0|||
105804519|NCT00669955|364940429|FG001|Overall Study|Death|1|||
105804520|NCT00669955|364940428|FG000|Overall Study|Withdrawal by Subject|2|||
105804521|NCT00669955|364940429|FG001|Overall Study|Withdrawal by Subject|3|||
105804522|NCT00669955|364940428|FG000|Overall Study|Lost to Follow-up|5|||
105804523|NCT00669955|364940429|FG001|Overall Study|Lost to Follow-up|7|||
105804524|NCT00669955|364940428|FG000|Overall Study|Protocol Violation|2|||
105804525|NCT00669955|364940429|FG001|Overall Study|Protocol Violation|7|||
105804526|NCT00669955|364940428|FG000|Overall Study|Investigator Sponsor Judgement|0|||
105804527|NCT00669955|364940429|FG001|Overall Study|Investigator Sponsor Judgement|1|||
105804528|NCT00669955|364940428|FG000|Overall Study|not compliant with study drug/visit|2|||
105804529|NCT00669955|364940429|FG001|Overall Study|not compliant with study drug/visit|3|||
105804530|NCT01890707|364940430|FG000|Overall Study|Lost to Follow-up|1|||
105804531|NCT01890707|364940431|FG001|Overall Study|Lost to Follow-up|1|||
105804532|NCT01859702|364940432|FG000|Overall Study|Protocol deviation|3|||
105804533|NCT01859702|364940432|FG000|Overall Study|Adverse Event|2|||
105804534|NCT04317053|364940438|FG000|Overall Study|Withdrawn (screen failure)|4|||
105804535|NCT04317053|364940439|FG001|Overall Study|Withdrawn (screen failure)|2|||
105804536|NCT01077713|364940440|FG000|Overall Study|Withdrawal by Subject|1|||
105804537|NCT01077713|364940441|FG001|Overall Study|Withdrawal by Subject|2|||
105804538|NCT01077713|364940440|FG000|Overall Study|Progressive Disease (PD)|0|||
105804539|NCT01077713|364940441|FG001|Overall Study|Progressive Disease (PD)|1|||
105804540|NCT01077713|364940440|FG000|Overall Study|Death|28|||
105804541|NCT01077713|364940441|FG001|Overall Study|Death|29|||
105804542|NCT01077713|364940440|FG000|Overall Study|Lost to Follow-up|1|||
105804543|NCT01077713|364940441|FG001|Overall Study|Lost to Follow-up|1|||
105804544|NCT01077713|364940440|FG000|Overall Study|Adverse Event|2|||
105804545|NCT01077713|364940441|FG001|Overall Study|Adverse Event|1|||
105804546|NCT01077713|364940440|FG000|Overall Study|Other|4|||
105804547|NCT01077713|364940441|FG001|Overall Study|Other|2|||
105804548|NCT00982410|364941829|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
105804549|NCT00982410|364941830|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
105804550|NCT00982410|364941829|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
105804551|NCT00982410|364941830|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
105804552|NCT00982410|364941829|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
105804553|NCT00982410|364941830|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
105804554|NCT00982410|364941829|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
105804555|NCT00982410|364941830|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
105804556|NCT00982410|364941829|FG000|6-month Follow-up Assessment|participant no transportation|1|||
105804557|NCT00982410|364941830|FG001|6-month Follow-up Assessment|participant no transportation|0|||
105804558|NCT00982410|364941829|FG000|6-month Follow-up Assessment|incarceration|0|||
105804559|NCT00982410|364941830|FG001|6-month Follow-up Assessment|incarceration|2|||
105950440|NCT00363311|365482401|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
105950441|NCT00363311|365482400|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
105950442|NCT00363311|365482401|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
105804560|NCT00982410|364941829|FG000|6-month Follow-up Assessment|patent surgery|0|||
105804561|NCT00982410|364941830|FG001|6-month Follow-up Assessment|patent surgery|1|||
105804562|NCT00982410|364941829|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
105804563|NCT00982410|364941830|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
105804564|NCT00982410|364941829|FG000|12-month Follow-up Assessment|Death|0|||
105804565|NCT00982410|364941830|FG001|12-month Follow-up Assessment|Death|2|||
105804566|NCT00982410|364941829|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
105804567|NCT00982410|364941830|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
105804568|NCT00982410|364941829|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
105804569|NCT00982410|364941830|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
105804570|NCT00982410|364941829|FG000|12-month Follow-up Assessment|incarceration|2|||
105804571|NCT00982410|364941830|FG001|12-month Follow-up Assessment|incarceration|1|||
105804572|NCT00982410|364941829|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
105804573|NCT00982410|364941830|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
105804574|NCT03322462|364941831|FG000|Overall Study|Technical difficulties|2|||
105804575|NCT03322462|364941831|FG000|Overall Study|Other|1|||
105804576|NCT01393990|364941832|FG000|Overall Study|Adverse Event|0|||
105804577|NCT01393990|364941833|FG001|Overall Study|Adverse Event|0|||
105804578|NCT01393990|364941834|FG002|Overall Study|Adverse Event|0|||
105804579|NCT01393990|364941835|FG003|Overall Study|Adverse Event|0|||
105804580|NCT01393990|364941836|FG004|Overall Study|Adverse Event|0|||
105804581|NCT01393990|364941837|FG005|Overall Study|Adverse Event|0|||
105804582|NCT01393990|364941838|FG006|Overall Study|Adverse Event|0|||
105804583|NCT01393990|364941839|FG007|Overall Study|Adverse Event|0|||
105804584|NCT01393990|364941840|FG008|Overall Study|Adverse Event|0|||
105804585|NCT01393990|364941841|FG009|Overall Study|Adverse Event|0|||
105804586|NCT01393990|364941842|FG010|Overall Study|Adverse Event|0|||
105804587|NCT01393990|364941843|FG011|Overall Study|Adverse Event|0|||
105804588|NCT01393990|364941844|FG012|Overall Study|Adverse Event|0|||
105804589|NCT01393990|364941845|FG013|Overall Study|Adverse Event|0|||
105804590|NCT01393990|364941846|FG014|Overall Study|Adverse Event|1|||
105804591|NCT01393990|364941847|FG015|Overall Study|Adverse Event|1|||
105804592|NCT01393990|364941848|FG016|Overall Study|Adverse Event|0|||
105804593|NCT01393990|364941849|FG017|Overall Study|Adverse Event|0|||
105804594|NCT01393990|364941832|FG000|Overall Study|Progressive Disease|1|||
105804595|NCT01393990|364941833|FG001|Overall Study|Progressive Disease|0|||
105804596|NCT01393990|364941834|FG002|Overall Study|Progressive Disease|0|||
105804597|NCT01393990|364941835|FG003|Overall Study|Progressive Disease|1|||
105804598|NCT01393990|364941836|FG004|Overall Study|Progressive Disease|1|||
105804599|NCT01393990|364941837|FG005|Overall Study|Progressive Disease|1|||
105804600|NCT01393990|364941838|FG006|Overall Study|Progressive Disease|1|||
105804601|NCT01393990|364941839|FG007|Overall Study|Progressive Disease|1|||
105804602|NCT01393990|364941840|FG008|Overall Study|Progressive Disease|3|||
105804603|NCT01393990|364941841|FG009|Overall Study|Progressive Disease|1|||
105804604|NCT01393990|364941842|FG010|Overall Study|Progressive Disease|0|||
105804605|NCT01393990|364941843|FG011|Overall Study|Progressive Disease|0|||
105804606|NCT01393990|364941844|FG012|Overall Study|Progressive Disease|0|||
106016592|NCT03748641|365724461|FG000|Overall Study|Death|54|||
106016593|NCT03748641|365724462|FG001|Overall Study|Death|59|||
106016594|NCT03748641|365724463|FG002|Overall Study|Death|51|||
106016595|NCT03748641|365724464|FG003|Overall Study|Death|42|||
106016596|NCT03748641|365724465|FG004|Overall Study|Death|9|||
106016597|NCT03748641|365724461|FG000|Overall Study|Lost to Follow-up|0|||
106016598|NCT03748641|365724462|FG001|Overall Study|Lost to Follow-up|2|||
106016599|NCT03748641|365724463|FG002|Overall Study|Lost to Follow-up|1|||
106016600|NCT03748641|365724464|FG003|Overall Study|Lost to Follow-up|0|||
106016601|NCT03748641|365724465|FG004|Overall Study|Lost to Follow-up|0|||
106016602|NCT03748641|365724461|FG000|Overall Study|Withdrawal by Subject|3|||
106016603|NCT03748641|365724462|FG001|Overall Study|Withdrawal by Subject|2|||
106016604|NCT03748641|365724463|FG002|Overall Study|Withdrawal by Subject|5|||
106016605|NCT03748641|365724464|FG003|Overall Study|Withdrawal by Subject|3|||
106016606|NCT03748641|365724465|FG004|Overall Study|Withdrawal by Subject|2|||
106016607|NCT04569032|365724468|FG000|Overall Study|Death|10|||
106016608|NCT04569032|365724469|FG001|Overall Study|Death|13|||
106016609|NCT04569032|365724468|FG000|Overall Study|Withdrawal by Subject|2|||
106016610|NCT04569032|365724469|FG001|Overall Study|Withdrawal by Subject|0|||
106016611|NCT04569032|365724468|FG000|Overall Study|Lost to Follow-up|0|||
106016612|NCT04569032|365724469|FG001|Overall Study|Lost to Follow-up|1|||
106016613|NCT04569032|365724468|FG000|Overall Study|In long term follow up|22|||
106016614|NCT04569032|365724469|FG001|Overall Study|In long term follow up|34|||
106016615|NCT03975647|365724470|FG000|Overall Study|Death|71|||
106016616|NCT03975647|365724471|FG001|Overall Study|Death|63|||
106016617|NCT03975647|365724470|FG000|Overall Study|Lost to Follow-up|2|||
106016618|NCT03975647|365724471|FG001|Overall Study|Lost to Follow-up|2|||
105758080|NCT00862654|364765517|FG000|Overall Study|Pregnancy|1|||
106016619|NCT03975647|365724470|FG000|Overall Study|Subject withdrawal of consent|7|||
106016620|NCT03975647|365724471|FG001|Overall Study|Subject withdrawal of consent|11|||
106016621|NCT03113487|365724472|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
106016622|NCT01918306|365724478|FG000|Overall Study|progresive disease|4|||
106016623|NCT01918306|365724479|FG001|Overall Study|progresive disease|0|||
105758081|NCT00862654|364765518|FG001|Overall Study|Pregnancy|1|||
105758082|NCT00862654|364765519|FG002|Overall Study|Pregnancy|0|||
105758083|NCT00862654|364765520|FG003|Overall Study|Pregnancy|0|||
105758084|NCT00862654|364765517|FG000|Overall Study|Withdrawal by Subject|2|||
105758085|NCT00862654|364765518|FG001|Overall Study|Withdrawal by Subject|2|||
105758086|NCT00862654|364765519|FG002|Overall Study|Withdrawal by Subject|2|||
105758087|NCT00862654|364765520|FG003|Overall Study|Withdrawal by Subject|3|||
105758088|NCT00862654|364765517|FG000|Overall Study|Subject mistake|0|||
105758089|NCT00862654|364765518|FG001|Overall Study|Subject mistake|1|||
105804607|NCT01393990|364941845|FG013|Overall Study|Progressive Disease|1|||
105804608|NCT01393990|364941846|FG014|Overall Study|Progressive Disease|6|||
105804609|NCT01393990|364941847|FG015|Overall Study|Progressive Disease|1|||
105804610|NCT01393990|364941848|FG016|Overall Study|Progressive Disease|0|||
105804611|NCT01393990|364941849|FG017|Overall Study|Progressive Disease|0|||
105804612|NCT01393990|364941832|FG000|Overall Study|Death|0|||
105804613|NCT01393990|364941833|FG001|Overall Study|Death|0|||
105804614|NCT01393990|364941834|FG002|Overall Study|Death|0|||
105804615|NCT01393990|364941835|FG003|Overall Study|Death|0|||
105804616|NCT01393990|364941836|FG004|Overall Study|Death|1|||
105950443|NCT00363311|365482400|FG000|Overall Study|Participant Moved to Louisiana|0|||
105950444|NCT00363311|365482401|FG001|Overall Study|Participant Moved to Louisiana|1|||
105804617|NCT01393990|364941837|FG005|Overall Study|Death|0|||
105804618|NCT01393990|364941838|FG006|Overall Study|Death|0|||
105804619|NCT01393990|364941839|FG007|Overall Study|Death|0|||
105804620|NCT01393990|364941840|FG008|Overall Study|Death|0|||
105804621|NCT01393990|364941841|FG009|Overall Study|Death|0|||
105950445|NCT04068922|365482404|FG000|Overall Study|Lost to Follow-up|5|||
105950446|NCT04068922|365482404|FG000|Overall Study|Withdrawal by Subject|7|||
105804622|NCT01393990|364941842|FG010|Overall Study|Death|0|||
105804623|NCT01393990|364941843|FG011|Overall Study|Death|0|||
105804624|NCT01393990|364941844|FG012|Overall Study|Death|0|||
105804625|NCT01393990|364941845|FG013|Overall Study|Death|1|||
105804626|NCT01393990|364941846|FG014|Overall Study|Death|1|||
105804627|NCT01393990|364941847|FG015|Overall Study|Death|0|||
105804628|NCT01393990|364941848|FG016|Overall Study|Death|0|||
105804629|NCT01393990|364941849|FG017|Overall Study|Death|0|||
105804630|NCT01393990|364941832|FG000|Overall Study|Withdrawal by Subject|0|||
105804631|NCT01393990|364941833|FG001|Overall Study|Withdrawal by Subject|0|||
105804632|NCT01393990|364941834|FG002|Overall Study|Withdrawal by Subject|0|||
105804633|NCT01393990|364941835|FG003|Overall Study|Withdrawal by Subject|0|||
105804634|NCT01393990|364941836|FG004|Overall Study|Withdrawal by Subject|0|||
105804635|NCT01393990|364941837|FG005|Overall Study|Withdrawal by Subject|0|||
105804636|NCT01393990|364941838|FG006|Overall Study|Withdrawal by Subject|0|||
105804637|NCT01393990|364941839|FG007|Overall Study|Withdrawal by Subject|0|||
105804638|NCT01393990|364941840|FG008|Overall Study|Withdrawal by Subject|0|||
105804639|NCT01393990|364941841|FG009|Overall Study|Withdrawal by Subject|0|||
105804640|NCT01393990|364941842|FG010|Overall Study|Withdrawal by Subject|0|||
105804641|NCT01393990|364941843|FG011|Overall Study|Withdrawal by Subject|0|||
105804642|NCT01393990|364941844|FG012|Overall Study|Withdrawal by Subject|0|||
105804643|NCT01393990|364941845|FG013|Overall Study|Withdrawal by Subject|0|||
105804644|NCT01393990|364941846|FG014|Overall Study|Withdrawal by Subject|1|||
105804645|NCT01393990|364941847|FG015|Overall Study|Withdrawal by Subject|1|||
105804646|NCT01393990|364941848|FG016|Overall Study|Withdrawal by Subject|0|||
105804647|NCT01393990|364941849|FG017|Overall Study|Withdrawal by Subject|0|||
105804648|NCT00331630|364941855|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
105804649|NCT00331630|364941855|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
105804650|NCT00331630|364941855|FG000|Follow up for 5 Years|Death|5|||
105804651|NCT00331630|364941855|FG000|Follow up for 5 Years|Data collection was stopped|24|||
105804652|NCT00720798|364941858|FG000|Overall Study|Adverse Event|304|||
105804653|NCT00720798|364941858|FG000|Overall Study|Death|39|||
105950447|NCT04068922|365482404|FG000|Overall Study|Adverse Event|1|||
105950448|NCT01508910|365482405|FG000|Treatment|Death|2|||
105950449|NCT01508910|365482406|FG001|Treatment|Death|3|||
105950450|NCT01508910|365482407|FG002|Treatment|Death|2|||
105950451|NCT01508910|365482408|FG003|Treatment|Death|0|||
105950452|NCT01508910|365482405|FG000|Treatment|Lost to Follow-up|0|||
105950453|NCT01508910|365482406|FG001|Treatment|Lost to Follow-up|0|||
105950454|NCT01508910|365482407|FG002|Treatment|Lost to Follow-up|2|||
105950455|NCT01508910|365482408|FG003|Treatment|Lost to Follow-up|1|||
105950456|NCT01508910|365482405|FG000|Treatment|Withdrawal by Subject|0|||
105804654|NCT00720798|364941858|FG000|Overall Study|Insufficient Therapeutic Response|129|||
105804655|NCT00720798|364941858|FG000|Overall Study|Protocol Violation|4|||
105804656|NCT00720798|364941858|FG000|Overall Study|Refused Treatment|151|||
105804657|NCT00720798|364941858|FG000|Overall Study|Failure to Return|46|||
105804658|NCT00720798|364941858|FG000|Overall Study|Reason not Specified|83|||
105950457|NCT01508910|365482406|FG001|Treatment|Withdrawal by Subject|1|||
105950458|NCT01508910|365482407|FG002|Treatment|Withdrawal by Subject|6|||
105804659|NCT03342898|364941859|FG000|Overall Study|Adverse Event|3|||
105804660|NCT03342898|364941860|FG001|Overall Study|Adverse Event|1|||
105804661|NCT03342898|364941861|FG002|Overall Study|Adverse Event|0|||
105804662|NCT03342898|364941859|FG000|Overall Study|Lost to Follow-up|44|||
105804663|NCT03342898|364941860|FG001|Overall Study|Lost to Follow-up|40|||
105804664|NCT03342898|364941861|FG002|Overall Study|Lost to Follow-up|42|||
105804665|NCT03342898|364941859|FG000|Overall Study|Withdrawal of Consent|5|||
105804666|NCT03342898|364941860|FG001|Overall Study|Withdrawal of Consent|9|||
105804667|NCT03342898|364941861|FG002|Overall Study|Withdrawal of Consent|11|||
105804668|NCT03342898|364941859|FG000|Overall Study|Death|0|||
105804669|NCT03342898|364941860|FG001|Overall Study|Death|1|||
105804670|NCT03342898|364941861|FG002|Overall Study|Death|1|||
105950459|NCT01508910|365482408|FG003|Treatment|Withdrawal by Subject|1|||
105950460|NCT01508910|365482405|FG000|Treatment|Sponsor Decision|0|||
105950461|NCT01508910|365482406|FG001|Treatment|Sponsor Decision|0|||
105950462|NCT01508910|365482407|FG002|Treatment|Sponsor Decision|0|||
105950463|NCT01508910|365482408|FG003|Treatment|Sponsor Decision|1|||
105950464|NCT04016714|365482409|FG000|Overall Study|Death|1|||
105950465|NCT04016714|365482410|FG001|Overall Study|Death|0|||
105950466|NCT04016714|365482409|FG000|Overall Study|Lost to Follow-up|3|||
105950467|NCT04016714|365482410|FG001|Overall Study|Lost to Follow-up|1|||
105950468|NCT04016714|365482409|FG000|Overall Study|Physician Decision|3|||
105950469|NCT04016714|365482410|FG001|Overall Study|Physician Decision|3|||
105950470|NCT04016714|365482409|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
105950471|NCT04016714|365482410|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
105950472|NCT01816048|365482414|FG000|Overall Study|Adverse Event|1|||
105950473|NCT01816048|365482414|FG000|Overall Study|Death|1|||
105950474|NCT01816048|365482414|FG000|Overall Study|Withdrawal by Subject|1|||
105950475|NCT01816048|365482414|FG000|Overall Study|Disease Progression|3|||
105950476|NCT01171677|365482415|FG000|Overall Study|Withdrawal by Subject|0|||
105950477|NCT01171677|365482416|FG001|Overall Study|Withdrawal by Subject|3|||
105950478|NCT01171677|365482415|FG000|Overall Study|Adverse Event|1|||
105950479|NCT01171677|365482416|FG001|Overall Study|Adverse Event|0|||
105950480|NCT01171677|365482415|FG000|Overall Study|completed <70% IntenSati classes|5|||
105950481|NCT01171677|365482416|FG001|Overall Study|completed <70% IntenSati classes|0|||
105950482|NCT03571971|365482417|FG000|Overall Study|Lost to Follow-up|2|||
105950483|NCT03571971|365482418|FG001|Overall Study|Lost to Follow-up|2|||
105950484|NCT03571971|365482417|FG000|Overall Study|Protocol Violation|2|||
105950485|NCT03571971|365482418|FG001|Overall Study|Protocol Violation|3|||
105950486|NCT03571971|365482417|FG000|Overall Study|Withdrawal by Subject|2|||
105950487|NCT03571971|365482418|FG001|Overall Study|Withdrawal by Subject|0|||
105950488|NCT03571971|365482417|FG000|Overall Study|Incomplete primary outcome data|2|||
105950489|NCT03571971|365482418|FG001|Overall Study|Incomplete primary outcome data|0|||
105950490|NCT04021290|365482420|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
105950491|NCT04021290|365482421|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
105758090|NCT00862654|364765519|FG002|Overall Study|Subject mistake|0|||
105758091|NCT00862654|364765520|FG003|Overall Study|Subject mistake|0|||
105758092|NCT00862654|364765517|FG000|Overall Study|Familly constraint|0|||
105758093|NCT00862654|364765518|FG001|Overall Study|Familly constraint|1|||
105758094|NCT00862654|364765519|FG002|Overall Study|Familly constraint|0|||
105758095|NCT00862654|364765520|FG003|Overall Study|Familly constraint|0|||
105758096|NCT00862654|364765517|FG000|Overall Study|Never used study drugs|1|||
105758097|NCT00862654|364765518|FG001|Overall Study|Never used study drugs|0|||
105758098|NCT00862654|364765519|FG002|Overall Study|Never used study drugs|0|||
105758099|NCT00862654|364765520|FG003|Overall Study|Never used study drugs|0|||
105758100|NCT00862654|364765517|FG000|Overall Study|Included after end of inclusions|0|||
105758101|NCT00862654|364765518|FG001|Overall Study|Included after end of inclusions|0|||
105758102|NCT00862654|364765519|FG002|Overall Study|Included after end of inclusions|1|||
105758103|NCT00862654|364765520|FG003|Overall Study|Included after end of inclusions|0|||
105758104|NCT00889681|364765530|FG000|Overall Study|Not meeting qualification Criteria|2|||
105758105|NCT00889681|364765530|FG000|Overall Study|Insurance disapproval|1|||
105758106|NCT00871572|364765531|FG000|Overall Study|Adverse Event|0|||
105758107|NCT00871572|364765532|FG001|Overall Study|Adverse Event|2|||
105758108|NCT00871572|364765533|FG002|Overall Study|Adverse Event|0|||
105758109|NCT00871572|364765534|FG003|Overall Study|Adverse Event|3|||
105758110|NCT00871572|364765531|FG000|Overall Study|Investigator Decision|0|||
105758111|NCT00871572|364765532|FG001|Overall Study|Investigator Decision|1|||
105758112|NCT00871572|364765533|FG002|Overall Study|Investigator Decision|0|||
105758113|NCT00871572|364765534|FG003|Overall Study|Investigator Decision|1|||
105758114|NCT00871572|364765531|FG000|Overall Study|Lost to Follow-up|0|||
105758115|NCT00871572|364765532|FG001|Overall Study|Lost to Follow-up|1|||
105758116|NCT00871572|364765533|FG002|Overall Study|Lost to Follow-up|0|||
105758117|NCT00871572|364765534|FG003|Overall Study|Lost to Follow-up|1|||
105758118|NCT00871572|364765531|FG000|Overall Study|Protocol Violation|0|||
105758119|NCT00871572|364765532|FG001|Overall Study|Protocol Violation|0|||
105950492|NCT04021290|365482422|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
105758120|NCT00871572|364765533|FG002|Overall Study|Protocol Violation|1|||
105758121|NCT00871572|364765534|FG003|Overall Study|Protocol Violation|1|||
105758122|NCT00871572|364765531|FG000|Overall Study|Sponsor Decision|1|||
105758123|NCT00871572|364765532|FG001|Overall Study|Sponsor Decision|0|||
105758124|NCT00871572|364765533|FG002|Overall Study|Sponsor Decision|0|||
105950493|NCT04021290|365482420|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
105950494|NCT04021290|365482421|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
105950495|NCT04021290|365482422|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
106016624|NCT01918306|365724480|FG002|Overall Study|progresive disease|1|||
105758125|NCT00871572|364765534|FG003|Overall Study|Sponsor Decision|0|||
105804671|NCT03342898|364941859|FG000|Overall Study|Reason not Specified|2|||
105804672|NCT03342898|364941860|FG001|Overall Study|Reason not Specified|2|||
105804673|NCT03342898|364941861|FG002|Overall Study|Reason not Specified|0|||
105804674|NCT02497391|364941862|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
105804675|NCT02497391|364941863|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
105804676|NCT02497391|364941864|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
105804677|NCT02497391|364941865|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
105804678|NCT02497391|364941866|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
105804679|NCT02497391|364941867|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
105804680|NCT02497391|364941862|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
105804681|NCT02497391|364941863|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
105804682|NCT02497391|364941864|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
105804683|NCT02497391|364941865|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
105804684|NCT02497391|364941866|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
105804685|NCT02497391|364941867|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
105804686|NCT02497391|364941862|FG000|Period 3 (14 Days)|Adverse Event|0|||
105804687|NCT02497391|364941863|FG001|Period 3 (14 Days)|Adverse Event|1|||
105804688|NCT02497391|364941864|FG002|Period 3 (14 Days)|Adverse Event|0|||
105804689|NCT02497391|364941865|FG003|Period 3 (14 Days)|Adverse Event|0|||
105804690|NCT02497391|364941866|FG004|Period 3 (14 Days)|Adverse Event|0|||
105804691|NCT02497391|364941867|FG005|Period 3 (14 Days)|Adverse Event|0|||
105804692|NCT02497391|364941862|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
105804693|NCT02497391|364941863|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
105804694|NCT02497391|364941864|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
105804695|NCT02497391|364941865|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
105804696|NCT02497391|364941866|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
105804697|NCT02497391|364941867|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
105804698|NCT02497391|364941862|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804699|NCT02497391|364941863|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804700|NCT02497391|364941864|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
105804701|NCT02497391|364941865|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
105950496|NCT04021290|365482420|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
105950497|NCT04021290|365482421|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
105950498|NCT04021290|365482422|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
105950499|NCT04021290|365482420|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
105950500|NCT04021290|365482421|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
105950501|NCT04021290|365482422|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
105950502|NCT04021290|365482420|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
105950503|NCT04021290|365482421|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
105950504|NCT04021290|365482422|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
105950505|NCT04021290|365482420|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
105950506|NCT04021290|365482421|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
105804702|NCT02497391|364941866|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804703|NCT02497391|364941867|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
105804704|NCT03031899|364941871|FG000|Overall Study|Protocol Violation|1|||
105804705|NCT03031899|364941871|FG000|Overall Study|lesion disappeared after stopping habit|1|||
105804706|NCT03705351|364941872|FG000|Overall Study|Study termination|3|||
105804707|NCT03705351|364941872|FG000|Overall Study|Death|1|||
105804708|NCT03705351|364941872|FG000|Overall Study|Lack of Efficacy|2|||
105804709|NCT03705351|364941872|FG000|Overall Study|Withdrawal by Subject|1|||
105804710|NCT03273387|364941874|FG000|Overall Study|Death|2|||
105804711|NCT03273387|364941875|FG001|Overall Study|Death|2|||
105804712|NCT03273387|364941874|FG000|Overall Study|Withdrawal by Subject|1|||
105804713|NCT03273387|364941875|FG001|Overall Study|Withdrawal by Subject|1|||
105804714|NCT01907087|364941876|FG000|Overall Study|Withdrawal by Subject|1|||
105804715|NCT05216978|364941877|FG000|Overall Study|Withdrawal by Subject|3|||
105804716|NCT05216978|364941877|FG000|Overall Study|Lost to Follow-up|5|||
105804717|NCT02180061|364941878|FG000|Overall Study|Adverse Event|4|||
105804718|NCT02180061|364941879|FG001|Overall Study|Adverse Event|2|||
105804719|NCT02180061|364941878|FG000|Overall Study|Clinical Progression|5|||
105804720|NCT02180061|364941879|FG001|Overall Study|Clinical Progression|1|||
105804721|NCT02180061|364941878|FG000|Overall Study|Progressive Disease|15|||
105804722|NCT02180061|364941879|FG001|Overall Study|Progressive Disease|5|||
105804723|NCT02180061|364941878|FG000|Overall Study|Physician Decision|1|||
105804724|NCT02180061|364941879|FG001|Overall Study|Physician Decision|0|||
105950507|NCT04021290|365482422|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
105804725|NCT00658320|364941884|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
105804726|NCT00658320|364941885|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
105804727|NCT00658320|364941884|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
105804728|NCT00658320|364941885|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
105804729|NCT00658320|364941884|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
105804730|NCT00658320|364941885|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
105804731|NCT00658320|364941884|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
105950508|NCT04021290|365482420|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
105758126|NCT00871572|364765531|FG000|Overall Study|Withdrawal by Subject|1|||
105758127|NCT00871572|364765532|FG001|Overall Study|Withdrawal by Subject|2|||
105758128|NCT00871572|364765533|FG002|Overall Study|Withdrawal by Subject|3|||
105758129|NCT00871572|364765534|FG003|Overall Study|Withdrawal by Subject|1|||
105758130|NCT04176445|364765538|FG000|Overall Study|Adverse Event|0|||
105758131|NCT04176445|364765539|FG001|Overall Study|Adverse Event|1|||
105758132|NCT04176445|364765538|FG000|Overall Study|change plans weaning after first intervention|0|||
105758133|NCT04176445|364765539|FG001|Overall Study|change plans weaning after first intervention|1|||
105758134|NCT01686958|364765540|FG000|Overall Study|Withdrawal by Subject|1|||
105758135|NCT03479216|364765541|FG000|Overall Study|Withdrawal by Subject|3|||
105758136|NCT03479216|364765542|FG001|Overall Study|Withdrawal by Subject|2|||
105758137|NCT03479216|364765541|FG000|Overall Study|Physician Decision|2|||
105758138|NCT03479216|364765542|FG001|Overall Study|Physician Decision|3|||
105758139|NCT01999946|364765547|FG000|Overall Study|Participant not released from jail|2|||
105758140|NCT01999946|364765548|FG001|Overall Study|Participant not released from jail|2|||
105758141|NCT01999946|364765549|FG002|Overall Study|Participant not released from jail|0|||
105758142|NCT01999946|364765547|FG000|Overall Study|Not included in primary outcome analysis|0|||
105758143|NCT01999946|364765548|FG001|Overall Study|Not included in primary outcome analysis|0|||
105758144|NCT01999946|364765549|FG002|Overall Study|Not included in primary outcome analysis|79|||
105758145|NCT03326869|364767141|FG000|Overall Study|Study data has been lost to natural disa|1|||
105758146|NCT03326869|364767142|FG001|Overall Study|Study data has been lost to natural disa|1|||
105758147|NCT03788967|364767143|FG000|Overall Study|Lost to Follow-up|14|||
105758148|NCT03788967|364767144|FG001|Overall Study|Lost to Follow-up|10|||
105758149|NCT03788967|364767143|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
105758150|NCT03788967|364767144|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
105758151|NCT03788967|364767143|FG000|Overall Study|Participant Withdrawal of Consent|13|||
105758152|NCT03788967|364767144|FG001|Overall Study|Participant Withdrawal of Consent|5|||
105758153|NCT03788967|364767143|FG000|Overall Study|Adverse Event|1|||
105758154|NCT03788967|364767144|FG001|Overall Study|Adverse Event|1|||
105758155|NCT03788967|364767143|FG000|Overall Study|COVID-19|1|||
105758156|NCT03788967|364767144|FG001|Overall Study|COVID-19|2|||
105758157|NCT04432376|364767145|FG000|Double-blind Treatment Period|Adverse Event|2|||
105758158|NCT04432376|364767146|FG001|Double-blind Treatment Period|Adverse Event|6|||
105758159|NCT04432376|364767147|FG002|Double-blind Treatment Period|Adverse Event|0|||
105758160|NCT04432376|364767145|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
105758161|NCT04432376|364767146|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
105758162|NCT04432376|364767147|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105758163|NCT04432376|364767145|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105758164|NCT04432376|364767146|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105758165|NCT04432376|364767147|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105758166|NCT04432376|364767145|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105758167|NCT04432376|364767146|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105758168|NCT04432376|364767147|FG002|Double-blind Treatment Period|Protocol Violation|0|||
105758169|NCT04432376|364767145|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
105758170|NCT04432376|364767146|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
105758171|NCT04432376|364767147|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
105758172|NCT01824693|364767148|FG000|Overall Study|Death|0|||
105758173|NCT01824693|364767149|FG001|Overall Study|Death|1|||
105758174|NCT01824693|364767150|FG002|Overall Study|Death|0|||
105758175|NCT01824693|364767148|FG000|Overall Study|Physician Decision|1|||
105758176|NCT01824693|364767149|FG001|Overall Study|Physician Decision|1|||
105758177|NCT01824693|364767150|FG002|Overall Study|Physician Decision|1|||
105758178|NCT01824693|364767148|FG000|Overall Study|Withdrawal by Subject|0|||
105758179|NCT01824693|364767149|FG001|Overall Study|Withdrawal by Subject|0|||
105758180|NCT01824693|364767150|FG002|Overall Study|Withdrawal by Subject|1|||
105758181|NCT01824693|364767148|FG000|Overall Study|Progressive Disease|0|||
105758182|NCT01824693|364767149|FG001|Overall Study|Progressive Disease|5|||
105758183|NCT01824693|364767150|FG002|Overall Study|Progressive Disease|0|||
105758184|NCT01824693|364767148|FG000|Overall Study|Ineligible|0|||
105758185|NCT01824693|364767149|FG001|Overall Study|Ineligible|0|||
105758186|NCT01824693|364767150|FG002|Overall Study|Ineligible|3|||
105758187|NCT01824693|364767148|FG000|Overall Study|No Transplant Planned|0|||
105758188|NCT01824693|364767149|FG001|Overall Study|No Transplant Planned|0|||
105758189|NCT01824693|364767150|FG002|Overall Study|No Transplant Planned|10|||
105758190|NCT02591238|364767151|FG000|Overall Study|Pregnancy|1|||
105758191|NCT02591238|364767152|FG001|Overall Study|Pregnancy|0|||
105758192|NCT02591238|364767153|FG002|Overall Study|Pregnancy|0|||
105758193|NCT02591238|364767154|FG003|Overall Study|Pregnancy|0|||
105758194|NCT02591238|364767151|FG000|Overall Study|Withdrawal by Subject|0|||
105758195|NCT02591238|364767152|FG001|Overall Study|Withdrawal by Subject|0|||
105758196|NCT02591238|364767153|FG002|Overall Study|Withdrawal by Subject|0|||
105758197|NCT02591238|364767154|FG003|Overall Study|Withdrawal by Subject|1|||
105758198|NCT02591238|364767151|FG000|Overall Study|influenza|0|||
105758199|NCT02591238|364767152|FG001|Overall Study|influenza|0|||
105950509|NCT04021290|365482421|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
105950510|NCT04021290|365482422|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
105758200|NCT02591238|364767153|FG002|Overall Study|influenza|0|||
105758201|NCT02591238|364767154|FG003|Overall Study|influenza|1|||
105758202|NCT02591238|364767151|FG000|Overall Study|personal circumstances|0|||
105758203|NCT02591238|364767152|FG001|Overall Study|personal circumstances|0|||
105758204|NCT02591238|364767153|FG002|Overall Study|personal circumstances|0|||
105758205|NCT02591238|364767154|FG003|Overall Study|personal circumstances|1|||
105758206|NCT02591238|364767151|FG000|Overall Study|personal circumstances|0|||
105758207|NCT02591238|364767152|FG001|Overall Study|personal circumstances|1|||
105758208|NCT02591238|364767153|FG002|Overall Study|personal circumstances|0|||
105758209|NCT02591238|364767154|FG003|Overall Study|personal circumstances|0|||
105758210|NCT00801892|364767155|FG000|Main Study Period|Withdrawal by Subject|0|||
105758211|NCT00801892|364767156|FG001|Main Study Period|Withdrawal by Subject|1|||
105758212|NCT00801892|364767155|FG000|Sham Crossover Period|Lost to Follow-up|0|||
105758213|NCT00801892|364767156|FG001|Sham Crossover Period|Lost to Follow-up|2|||
105758214|NCT01711541|364767157|FG000|Overall Study|Cancel prior to treatment|0|||
105758215|NCT01711541|364767158|FG001|Overall Study|Cancel prior to treatment|0|||
105758216|NCT01711541|364767159|FG002|Overall Study|Cancel prior to treatment|0|||
105758217|NCT01711541|364767160|FG003|Overall Study|Cancel prior to treatment|1|||
105758218|NCT01711541|364767161|FG004|Overall Study|Cancel prior to treatment|0|||
105758219|NCT01711541|364767157|FG000|Overall Study|Ineligible|0|||
105758220|NCT01711541|364767158|FG001|Overall Study|Ineligible|1|||
105758221|NCT01711541|364767159|FG002|Overall Study|Ineligible|0|||
105758222|NCT01711541|364767160|FG003|Overall Study|Ineligible|0|||
105758223|NCT01711541|364767161|FG004|Overall Study|Ineligible|0|||
105758224|NCT03943446|364767162|FG000|Overall Study|Lost to Follow-up|0|||
105758225|NCT03943446|364767163|FG001|Overall Study|Lost to Follow-up|0|||
105758226|NCT03943446|364767164|FG002|Overall Study|Lost to Follow-up|1|||
105758227|NCT03943446|364767162|FG000|Overall Study|Withdrawal by Subject|1|||
105758228|NCT03943446|364767163|FG001|Overall Study|Withdrawal by Subject|1|||
105758229|NCT03943446|364767164|FG002|Overall Study|Withdrawal by Subject|2|||
105758230|NCT03943446|364767162|FG000|Overall Study|Study Terminated by Sponsor|1|||
105758231|NCT03943446|364767163|FG001|Overall Study|Study Terminated by Sponsor|2|||
105758232|NCT03943446|364767164|FG002|Overall Study|Study Terminated by Sponsor|1|||
105758233|NCT03943446|364767162|FG000|Overall Study|Reason not Specified|5|||
105758234|NCT03943446|364767163|FG001|Overall Study|Reason not Specified|1|||
105758235|NCT03943446|364767164|FG002|Overall Study|Reason not Specified|3|||
105758236|NCT01136746|364767165|FG000|Overall Study|Lost to Follow-up|0|||
105758237|NCT01136746|364767166|FG001|Overall Study|Lost to Follow-up|2|||
105758238|NCT01136746|364767165|FG000|Overall Study|Protocol Violation|2|||
105758239|NCT01136746|364767166|FG001|Overall Study|Protocol Violation|1|||
105758240|NCT01136746|364767165|FG000|Overall Study|Death|1|||
105758241|NCT01136746|364767166|FG001|Overall Study|Death|0|||
105758242|NCT00093470|364767167|FG000|Overall Study|Disease progression|39|||
105758243|NCT00093470|364767168|FG001|Overall Study|Disease progression|0|||
105758244|NCT00093470|364767167|FG000|Overall Study|Adverse Event|15|||
105758245|NCT00093470|364767168|FG001|Overall Study|Adverse Event|0|||
105758246|NCT00093470|364767167|FG000|Overall Study|Death|2|||
105758247|NCT00093470|364767168|FG001|Overall Study|Death|0|||
105758248|NCT00093470|364767167|FG000|Overall Study|Withdrawal by Subject|8|||
105758249|NCT00093470|364767168|FG001|Overall Study|Withdrawal by Subject|0|||
105758250|NCT00093470|364767167|FG000|Overall Study|Alternative therapy|2|||
105758251|NCT00093470|364767168|FG001|Overall Study|Alternative therapy|0|||
105758252|NCT00093470|364767167|FG000|Overall Study|Other complicating disease|3|||
105758253|NCT00093470|364767168|FG001|Overall Study|Other complicating disease|0|||
105758254|NCT00093470|364767167|FG000|Overall Study|Physician Decision|2|||
105758255|NCT00093470|364767168|FG001|Overall Study|Physician Decision|0|||
105758256|NCT00093470|364767167|FG000|Overall Study|Never started treatment|1|||
105758257|NCT00093470|364767168|FG001|Overall Study|Never started treatment|0|||
105758258|NCT00093470|364767167|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
105758259|NCT00093470|364767168|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
105758260|NCT02514772|364767169|FG000|Overall Study|Adverse Event|1|||
105758261|NCT02514772|364767170|FG001|Overall Study|Adverse Event|0|||
105758262|NCT02514772|364767169|FG000|Overall Study|Death|0|||
105758263|NCT02514772|364767170|FG001|Overall Study|Death|1|||
105758264|NCT02514772|364767169|FG000|Overall Study|Withdrawal by Subject|2|||
105758265|NCT02514772|364767170|FG001|Overall Study|Withdrawal by Subject|1|||
105758266|NCT04671342|364767171|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
105758267|NCT04671342|364767171|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
105758268|NCT04671342|364767171|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
105758269|NCT04671342|364767171|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
105758270|NCT04671342|364767171|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
105758271|NCT04671342|364767171|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
105758272|NCT01415908|364767172|FG000|Overall Study|Withdrawal by Subject|1|||
105758273|NCT01415908|364767173|FG001|Overall Study|Withdrawal by Subject|0|||
105758274|NCT04067011|364767174|FG000|Overall Study|Not Treated|8|||
105758275|NCT04067011|364767175|FG001|Overall Study|Not Treated|7|||
105758276|NCT04067011|364767176|FG002|Overall Study|Not Treated|5|||
105758277|NCT04067011|364767174|FG000|Overall Study|Adverse Event|2|||
105758278|NCT04067011|364767175|FG001|Overall Study|Adverse Event|1|||
105758279|NCT04067011|364767176|FG002|Overall Study|Adverse Event|0|||
105758280|NCT04067011|364767174|FG000|Overall Study|Withdrawal by Subject|6|||
105758281|NCT04067011|364767175|FG001|Overall Study|Withdrawal by Subject|2|||
105758282|NCT04067011|364767176|FG002|Overall Study|Withdrawal by Subject|1|||
105758283|NCT04067011|364767174|FG000|Overall Study|Lost to Follow-up|0|||
105758284|NCT04067011|364767175|FG001|Overall Study|Lost to Follow-up|0|||
105758285|NCT04067011|364767176|FG002|Overall Study|Lost to Follow-up|1|||
105758286|NCT04067011|364767174|FG000|Overall Study|Physician Decision|1|||
105758287|NCT04067011|364767175|FG001|Overall Study|Physician Decision|1|||
105758288|NCT04067011|364767176|FG002|Overall Study|Physician Decision|0|||
105758289|NCT04067011|364767174|FG000|Overall Study|Other Reasons|2|||
105758290|NCT04067011|364767175|FG001|Overall Study|Other Reasons|0|||
105758291|NCT04067011|364767176|FG002|Overall Study|Other Reasons|1|||
105758292|NCT04067011|364767174|FG000|Overall Study|Missing|0|||
105758293|NCT04067011|364767175|FG001|Overall Study|Missing|2|||
105758294|NCT04067011|364767176|FG002|Overall Study|Missing|0|||
105758295|NCT02034552|364767177|FG000|Overall Study|Never treated|3|||
105758296|NCT02034552|364767178|FG001|Overall Study|Never treated|2|||
105758297|NCT02034552|364767179|FG002|Overall Study|Never treated|0|||
105758298|NCT02034552|364767177|FG000|Overall Study|Radiological progression|3|||
105758299|NCT02034552|364767178|FG001|Overall Study|Radiological progression|5|||
105758300|NCT02034552|364767179|FG002|Overall Study|Radiological progression|4|||
105758301|NCT02034552|364767177|FG000|Overall Study|AE not assoc. with disease progression|1|||
105758302|NCT02034552|364767178|FG001|Overall Study|AE not assoc. with disease progression|4|||
105758303|NCT02034552|364767179|FG002|Overall Study|AE not assoc. with disease progression|2|||
105758304|NCT02034552|364767177|FG000|Overall Study|AE associated with disease progression|0|||
105758305|NCT02034552|364767178|FG001|Overall Study|AE associated with disease progression|1|||
105758306|NCT02034552|364767179|FG002|Overall Study|AE associated with disease progression|0|||
105758307|NCT02034552|364767177|FG000|Overall Study|Withdrawal by Subject|2|||
105758308|NCT02034552|364767178|FG001|Overall Study|Withdrawal by Subject|1|||
105758309|NCT02034552|364767179|FG002|Overall Study|Withdrawal by Subject|1|||
105758310|NCT02034552|364767177|FG000|Overall Study|Non-compliance with study drug|0|||
105758311|NCT02034552|364767178|FG001|Overall Study|Non-compliance with study drug|0|||
105758312|NCT02034552|364767179|FG002|Overall Study|Non-compliance with study drug|1|||
105758313|NCT02034552|364767177|FG000|Overall Study|Clinical progression|5|||
105758314|NCT02034552|364767178|FG001|Overall Study|Clinical progression|7|||
105758315|NCT02034552|364767179|FG002|Overall Study|Clinical progression|9|||
105758316|NCT01419015|364767180|FG000|Overall Study|Death|2|||
105758317|NCT01188096|364767181|FG000|Overall Study|progression of disease|4|||
105758318|NCT01188096|364767181|FG000|Overall Study|Withdrawal by Subject|2|||
105758319|NCT04209530|364767185|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
105758320|NCT04209530|364767186|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
105758321|NCT04209530|364767185|FG000|Overall Study|Withdrawal by Subject|0|||
105758322|NCT04209530|364767186|FG001|Overall Study|Withdrawal by Subject|1|||
105758323|NCT02197897|364767187|FG000|Overall Study|not eligible|1|||
105758324|NCT02513771|364767191|FG000|Overall Study|Lost to Follow-up|1|||
105758325|NCT02513771|364767192|FG001|Overall Study|Lost to Follow-up|1|||
105758326|NCT02513771|364767191|FG000|Overall Study|Not being able to get to clinic|1|||
105758327|NCT02513771|364767192|FG001|Overall Study|Not being able to get to clinic|0|||
105758328|NCT00510484|364767197|FG000|Wash-out Period|Adverse Event|0|||
105758329|NCT00510484|364767198|FG001|Wash-out Period|Adverse Event|1|||
105758330|NCT01373918|364767199|FG000|Overall Study|Physician Decision|0|||
105758331|NCT01373918|364767200|FG001|Overall Study|Physician Decision|1|||
105758332|NCT03004976|364767201|FG000|Overall Study|Lost to Follow-up|7|||
105758333|NCT03004976|364767202|FG001|Overall Study|Lost to Follow-up|5|||
105758334|NCT03004976|364767201|FG000|Overall Study|Physician Decision|1|||
105758335|NCT03004976|364767202|FG001|Overall Study|Physician Decision|0|||
105950511|NCT04021290|365482420|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
105758336|NCT03004976|364767201|FG000|Overall Study|Withdrawal by Subject|1|||
105950512|NCT04021290|365482421|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
106016625|NCT01918306|365724481|FG003|Overall Study|progresive disease|1|||
105758337|NCT03004976|364767202|FG001|Overall Study|Withdrawal by Subject|0|||
105758338|NCT03004976|364767201|FG000|Overall Study|Death|4|||
105758339|NCT03004976|364767202|FG001|Overall Study|Death|1|||
105758340|NCT02533401|364767205|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
105758341|NCT02533401|364767205|FG000|Overall Study|Death|5|||
105758342|NCT02533401|364767205|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
105758343|NCT02533401|364767205|FG000|Overall Study|Lost to Follow-up|1|||
105758344|NCT02533401|364767205|FG000|Overall Study|Violation of Selection Criteria|1|||
105758345|NCT00291499|364767206|FG000|Overall Study|Adverse Event|3|||
105758346|NCT00291499|364767207|FG001|Overall Study|Adverse Event|8|||
105804732|NCT00658320|364941885|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
105804733|NCT01405950|364941886|FG000|Overall Study|Withdrawal by Subject|1|||
105804734|NCT01405950|364941887|FG001|Overall Study|Withdrawal by Subject|0|||
105804735|NCT01405950|364941888|FG002|Overall Study|Withdrawal by Subject|0|||
105804736|NCT01405950|364941889|FG003|Overall Study|Withdrawal by Subject|0|||
105804737|NCT01381900|364941898|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
105804738|NCT01381900|364941899|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
105804739|NCT01381900|364941900|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
105804740|NCT01381900|364941898|FG000|Overall Study|Adverse Event|4|||
105804741|NCT01381900|364941899|FG001|Overall Study|Adverse Event|6|||
105804742|NCT01381900|364941900|FG002|Overall Study|Adverse Event|7|||
105804743|NCT01381900|364941898|FG000|Overall Study|Noncompliance with study drug|0|||
105804744|NCT01381900|364941899|FG001|Overall Study|Noncompliance with study drug|0|||
105804745|NCT01381900|364941900|FG002|Overall Study|Noncompliance with study drug|1|||
105804746|NCT01381900|364941898|FG000|Overall Study|Physician Decision|0|||
105804747|NCT01381900|364941899|FG001|Overall Study|Physician Decision|1|||
105804748|NCT01381900|364941900|FG002|Overall Study|Physician Decision|1|||
105804749|NCT01381900|364941898|FG000|Overall Study|Protocol Violation|0|||
105804750|NCT01381900|364941899|FG001|Overall Study|Protocol Violation|1|||
105804751|NCT01381900|364941900|FG002|Overall Study|Protocol Violation|1|||
105804752|NCT01381900|364941898|FG000|Overall Study|Withdrawal by Subject|0|||
105804753|NCT01381900|364941899|FG001|Overall Study|Withdrawal by Subject|0|||
105804754|NCT01381900|364941900|FG002|Overall Study|Withdrawal by Subject|1|||
105804755|NCT01381900|364941898|FG000|Overall Study|Early withdraw|3|||
105804756|NCT01381900|364941899|FG001|Overall Study|Early withdraw|1|||
105804757|NCT01381900|364941900|FG002|Overall Study|Early withdraw|1|||
105804758|NCT02410252|364941901|FG000|Overall Study|Withdrawal by Subject|4|||
105804759|NCT02410252|364941901|FG000|Overall Study|Physician Decision|2|||
105804760|NCT00685919|364941902|FG000|Overall Study|Withdrawal by Subject|0|||
105804761|NCT00685919|364941903|FG001|Overall Study|Withdrawal by Subject|0|||
105804762|NCT00685919|364941904|FG002|Overall Study|Withdrawal by Subject|1|||
105804763|NCT00685919|364941905|FG003|Overall Study|Withdrawal by Subject|0|||
105804764|NCT00685919|364941902|FG000|Overall Study|Physician Decision|1|||
105804765|NCT00685919|364941903|FG001|Overall Study|Physician Decision|0|||
105804766|NCT00685919|364941904|FG002|Overall Study|Physician Decision|0|||
105804767|NCT00685919|364941905|FG003|Overall Study|Physician Decision|0|||
105804768|NCT01590433|364941908|FG000|Overall Study|Lost to Follow-up|20|||
105804769|NCT01590433|364941909|FG001|Overall Study|Lost to Follow-up|8|||
105804770|NCT01590433|364941908|FG000|Overall Study|Withdrawal by Subject|21|||
105804771|NCT01590433|364941909|FG001|Overall Study|Withdrawal by Subject|11|||
105804772|NCT01590433|364941908|FG000|Overall Study|Adverse Event|11|||
105804773|NCT01590433|364941909|FG001|Overall Study|Adverse Event|3|||
105804774|NCT02732561|364941912|FG000|Overall Study|Lost to Follow-up|1|||
105804775|NCT02732561|364941913|FG001|Overall Study|Lost to Follow-up|1|||
105804776|NCT02732561|364941912|FG000|Overall Study|Withdrawal by Subject|1|||
105804777|NCT02732561|364941913|FG001|Overall Study|Withdrawal by Subject|0|||
105804778|NCT01452529|364941917|FG000|Run-in Period|Adverse Event|96|||
105804779|NCT01452529|364941918|FG001|Run-in Period|Adverse Event|0|||
105804780|NCT01452529|364941919|FG002|Run-in Period|Adverse Event|0|||
105804781|NCT01452529|364941917|FG000|Run-in Period|Withdrawal by Subject|49|||
105804782|NCT01452529|364941918|FG001|Run-in Period|Withdrawal by Subject|0|||
105804783|NCT01452529|364941919|FG002|Run-in Period|Withdrawal by Subject|0|||
105804784|NCT01452529|364941917|FG000|Run-in Period|Lost to Follow-up|19|||
105804785|NCT01452529|364941918|FG001|Run-in Period|Lost to Follow-up|0|||
105804786|NCT01452529|364941919|FG002|Run-in Period|Lost to Follow-up|0|||
105804787|NCT01452529|364941917|FG000|Run-in Period|Lack of Efficacy|46|||
105804788|NCT01452529|364941918|FG001|Run-in Period|Lack of Efficacy|0|||
105804789|NCT01452529|364941919|FG002|Run-in Period|Lack of Efficacy|0|||
105804790|NCT01452529|364941917|FG000|Run-in Period|Confirmed or suspected diversion|23|||
105804791|NCT01452529|364941918|FG001|Run-in Period|Confirmed or suspected diversion|0|||
105804792|NCT01452529|364941919|FG002|Run-in Period|Confirmed or suspected diversion|0|||
105950513|NCT04021290|365482422|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
105950514|NCT04021290|365482420|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
105804793|NCT01452529|364941917|FG000|Run-in Period|Administrative|21|||
105804794|NCT01452529|364941918|FG001|Run-in Period|Administrative|0|||
105804795|NCT01452529|364941919|FG002|Run-in Period|Administrative|0|||
105804796|NCT01452529|364941917|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
105804797|NCT01452529|364941918|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
105804798|NCT01452529|364941919|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
105804799|NCT01452529|364941917|FG000|Double-blind (DB) Period|Adverse Event|0|||
105804800|NCT01452529|364941918|FG001|Double-blind (DB) Period|Adverse Event|18|||
105804801|NCT01452529|364941919|FG002|Double-blind (DB) Period|Adverse Event|11|||
105804802|NCT01452529|364941917|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
105804803|NCT01452529|364941918|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
105804804|NCT01452529|364941919|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
105758347|NCT00291499|364767206|FG000|Overall Study|Change to other therapy|2|||
105758348|NCT00291499|364767207|FG001|Overall Study|Change to other therapy|1|||
105758349|NCT00291499|364767206|FG000|Overall Study|Intercurrent illness|1|||
105758350|NCT00291499|364767207|FG001|Overall Study|Intercurrent illness|0|||
105758351|NCT00291499|364767206|FG000|Overall Study|Protocol Violation|2|||
105758352|NCT00291499|364767207|FG001|Overall Study|Protocol Violation|2|||
105758353|NCT00291499|364767206|FG000|Overall Study|Other reasons|1|||
105758354|NCT00291499|364767207|FG001|Overall Study|Other reasons|4|||
105758355|NCT01143714|364767213|FG000|Overall Study|Adverse Event|4|||
105758356|NCT01143714|364767214|FG001|Overall Study|Adverse Event|2|||
105758357|NCT01143714|364767213|FG000|Overall Study|Withdrawal by Subject|1|||
105758358|NCT01143714|364767214|FG001|Overall Study|Withdrawal by Subject|0|||
105758359|NCT01143714|364767213|FG000|Overall Study|Subject non-compliance|0|||
105758360|NCT01143714|364767214|FG001|Overall Study|Subject non-compliance|1|||
105758361|NCT01143714|364767213|FG000|Overall Study|wound closed = deemed healed|1|||
105758362|NCT01143714|364767214|FG001|Overall Study|wound closed = deemed healed|0|||
105758363|NCT01143714|364767213|FG000|Overall Study|wound size increased|1|||
105758364|NCT01143714|364767214|FG001|Overall Study|wound size increased|0|||
105758365|NCT01387074|364767215|FG000|Overall Study|Lost to Follow-up|7|||
105758366|NCT01387074|364767215|FG000|Overall Study|Lack of Efficacy|1|||
105758367|NCT03892707|364767218|FG000|Overall Study|Screen failure|6|||
105758368|NCT03892707|364767219|FG001|Overall Study|Screen failure|0|||
105758369|NCT03892707|364767218|FG000|Overall Study|Pain resolution|0|||
105758370|NCT03892707|364767219|FG001|Overall Study|Pain resolution|4|||
105758371|NCT03892707|364767218|FG000|Overall Study|Withdrawal by Subject|0|||
105758372|NCT03892707|364767219|FG001|Overall Study|Withdrawal by Subject|1|||
105758373|NCT03892707|364767218|FG000|Overall Study|Other (long business trip)|0|||
105758374|NCT03892707|364767219|FG001|Overall Study|Other (long business trip)|1|||
105758375|NCT01082367|364767220|FG000|Double-blind Period|Administrative problems|0|||
105758376|NCT01082367|364767221|FG001|Double-blind Period|Administrative problems|1|||
105758377|NCT01082367|364767220|FG000|Double-blind Period|Lack of Efficacy|5|||
105758378|NCT01082367|364767221|FG001|Double-blind Period|Lack of Efficacy|11|||
105758379|NCT01082367|364767220|FG000|Double-blind Period|Adverse Event|0|||
105758380|NCT01082367|364767221|FG001|Double-blind Period|Adverse Event|1|||
105758381|NCT01082367|364767220|FG000|Follow-up (F-U) Period|Administrative problems|1|||
105758382|NCT01082367|364767221|FG001|Follow-up (F-U) Period|Administrative problems|0|||
105758383|NCT01082367|364767220|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
105758384|NCT01082367|364767221|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
105758385|NCT01082367|364767220|FG000|Follow-up (F-U) Period|Adverse Event|0|||
105758386|NCT01082367|364767221|FG001|Follow-up (F-U) Period|Adverse Event|1|||
105758387|NCT02016898|364767222|FG000|Overall Study|Death|1|||
105758388|NCT02016898|364767223|FG001|Overall Study|Death|1|||
105758389|NCT02016898|364767222|FG000|Overall Study|Lost to Follow-up|4|||
105758390|NCT02016898|364767223|FG001|Overall Study|Lost to Follow-up|4|||
105758391|NCT01665768|364767226|FG000|Overall Study|Adverse Event|3|||
105758392|NCT01665768|364767226|FG000|Overall Study|Lack of Efficacy|19|||
105758393|NCT01665768|364767226|FG000|Overall Study|Withdrawal by Subject|1|||
105758394|NCT01588353|364767230|FG000|Step2|Withdrawal by Subject|0|||
105758395|NCT01588353|364767231|FG001|Step2|Withdrawal by Subject|1|||
105758396|NCT01588353|364767232|FG002|Step2|Withdrawal by Subject|0|||
105758397|NCT01588353|364767230|FG000|Step3|Adverse Event|0|||
105758398|NCT01588353|364767231|FG001|Step3|Adverse Event|0|||
105758399|NCT01588353|364767232|FG002|Step3|Adverse Event|2|||
105758400|NCT00810810|364767233|FG000|Overall Study|Withdrawal by Subject|0|||
105758401|NCT00810810|364767234|FG001|Overall Study|Withdrawal by Subject|8|||
105758402|NCT00810810|364767235|FG002|Overall Study|Withdrawal by Subject|10|||
105758403|NCT00810810|364767236|FG003|Overall Study|Withdrawal by Subject|8|||
105758404|NCT00810810|364767233|FG000|Overall Study|Physician Decision|0|||
105758405|NCT00810810|364767234|FG001|Overall Study|Physician Decision|3|||
105758406|NCT00810810|364767235|FG002|Overall Study|Physician Decision|1|||
105758407|NCT00810810|364767236|FG003|Overall Study|Physician Decision|5|||
105758408|NCT03074149|364767240|FG000|Overall Study|Reason unknown|22|||
105758409|NCT03074149|364767241|FG001|Overall Study|Reason unknown|35|||
105758410|NCT03074149|364767240|FG000|Overall Study|Death|10|||
105950515|NCT04021290|365482421|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
105758411|NCT03074149|364767241|FG001|Overall Study|Death|45|||
105758412|NCT01001234|364767243|FG000|Overall Study|Withdrawal by Subject|2|||
105758413|NCT01001234|364767244|FG001|Overall Study|Withdrawal by Subject|0|||
105758414|NCT01001234|364767245|FG002|Overall Study|Withdrawal by Subject|3|||
105758415|NCT01001234|364767246|FG003|Overall Study|Withdrawal by Subject|0|||
105758416|NCT01001234|364767247|FG004|Overall Study|Withdrawal by Subject|0|||
105758417|NCT01001234|364767243|FG000|Overall Study|Protocol Violation|34|||
105758418|NCT01001234|364767244|FG001|Overall Study|Protocol Violation|3|||
105758419|NCT01001234|364767245|FG002|Overall Study|Protocol Violation|19|||
105758420|NCT01001234|364767246|FG003|Overall Study|Protocol Violation|18|||
105758421|NCT01001234|364767247|FG004|Overall Study|Protocol Violation|0|||
105758422|NCT01001234|364767243|FG000|Overall Study|Lost to Follow-up|0|||
105758423|NCT01001234|364767244|FG001|Overall Study|Lost to Follow-up|0|||
105950516|NCT04021290|365482422|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
105950517|NCT04021290|365482420|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
105758424|NCT01001234|364767245|FG002|Overall Study|Lost to Follow-up|1|||
105758425|NCT01001234|364767246|FG003|Overall Study|Lost to Follow-up|2|||
105758426|NCT01001234|364767247|FG004|Overall Study|Lost to Follow-up|0|||
105758427|NCT01001234|364767243|FG000|Overall Study|Physician Decision|1|||
105758428|NCT01001234|364767244|FG001|Overall Study|Physician Decision|0|||
105758429|NCT01001234|364767245|FG002|Overall Study|Physician Decision|0|||
105758430|NCT01001234|364767246|FG003|Overall Study|Physician Decision|0|||
105758431|NCT01001234|364767247|FG004|Overall Study|Physician Decision|0|||
105758432|NCT01001234|364767243|FG000|Overall Study|Not Treated: Adverse Event|1|||
105758433|NCT01001234|364767244|FG001|Overall Study|Not Treated: Adverse Event|0|||
105758434|NCT01001234|364767245|FG002|Overall Study|Not Treated: Adverse Event|0|||
105758435|NCT01001234|364767246|FG003|Overall Study|Not Treated: Adverse Event|0|||
105758436|NCT01001234|364767247|FG004|Overall Study|Not Treated: Adverse Event|0|||
105758437|NCT01001234|364767243|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
105758438|NCT01001234|364767244|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
105758439|NCT01001234|364767245|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
105758440|NCT01001234|364767246|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
105758441|NCT01001234|364767247|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
105758442|NCT01001234|364767243|FG000|Overall Study|Not Treated: Protocol Violation|3|||
105758443|NCT01001234|364767244|FG001|Overall Study|Not Treated: Protocol Violation|0|||
105758444|NCT01001234|364767245|FG002|Overall Study|Not Treated: Protocol Violation|0|||
105758445|NCT01001234|364767246|FG003|Overall Study|Not Treated: Protocol Violation|0|||
105758446|NCT01001234|364767247|FG004|Overall Study|Not Treated: Protocol Violation|0|||
105758447|NCT01001234|364767243|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
105758448|NCT01001234|364767244|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
105758449|NCT01001234|364767245|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
105758450|NCT01001234|364767246|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
105758451|NCT01001234|364767247|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
105758452|NCT01001234|364767243|FG000|Overall Study|Not Treated: Pregnancy|3|||
105758453|NCT01001234|364767244|FG001|Overall Study|Not Treated: Pregnancy|0|||
105758454|NCT01001234|364767245|FG002|Overall Study|Not Treated: Pregnancy|0|||
105758455|NCT01001234|364767246|FG003|Overall Study|Not Treated: Pregnancy|0|||
105758456|NCT01001234|364767247|FG004|Overall Study|Not Treated: Pregnancy|0|||
105758457|NCT01001234|364767243|FG000|Overall Study|Not Treated: Physician Decision|37|||
105758458|NCT01001234|364767244|FG001|Overall Study|Not Treated: Physician Decision|4|||
105758459|NCT01001234|364767245|FG002|Overall Study|Not Treated: Physician Decision|0|||
105758460|NCT01001234|364767246|FG003|Overall Study|Not Treated: Physician Decision|0|||
105758461|NCT01001234|364767247|FG004|Overall Study|Not Treated: Physician Decision|0|||
105758462|NCT01001234|364767243|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
105758463|NCT01001234|364767244|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
105758464|NCT01001234|364767245|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
105758465|NCT01001234|364767246|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
105758466|NCT01001234|364767247|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
105758467|NCT02559713|364767248|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
105758468|NCT00326417|364767252|FG000|Overall Study|Withdrawal by Subject|0|||
105758469|NCT00326417|364767253|FG001|Overall Study|Withdrawal by Subject|0|||
105758470|NCT00326417|364767254|FG002|Overall Study|Withdrawal by Subject|1|||
105758471|NCT00326417|364767255|FG003|Overall Study|Withdrawal by Subject|0|||
105758472|NCT00326417|364767252|FG000|Overall Study|Arm Closed|7|||
105758473|NCT00326417|364767253|FG001|Overall Study|Arm Closed|0|||
105758474|NCT00326417|364767254|FG002|Overall Study|Arm Closed|0|||
105758475|NCT00326417|364767255|FG003|Overall Study|Arm Closed|3|||
105758476|NCT00326417|364767252|FG000|Overall Study|Death|7|||
105758477|NCT00326417|364767253|FG001|Overall Study|Death|0|||
105758478|NCT00326417|364767254|FG002|Overall Study|Death|0|||
105758479|NCT00326417|364767255|FG003|Overall Study|Death|0|||
105758480|NCT01164865|364767258|FG000|Overall Study|Lost to Follow-up|2|||
105758481|NCT01164865|364767259|FG001|Overall Study|Lost to Follow-up|1|||
105758482|NCT00192036|364767260|FG000|Overall Study|Protocol Violation|3|||
105758483|NCT00192036|364767260|FG000|Overall Study|Adverse Event|6|||
105758484|NCT00192036|364767260|FG000|Overall Study|Patient/Physician Perception|1|||
105758485|NCT00192036|364767260|FG000|Overall Study|Objective Tumor Progression|4|||
105758486|NCT00192036|364767260|FG000|Overall Study|Clinical Disease Progression|1|||
105758487|NCT00192036|364767260|FG000|Overall Study|Death|1|||
105758488|NCT00192036|364767260|FG000|Overall Study|Unknown or Not Specified|5|||
105950518|NCT04021290|365482421|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
105758489|NCT02394795|364767263|FG000|Overall Study|Adverse Event|92|||
105758490|NCT02394795|364767264|FG001|Overall Study|Adverse Event|70|||
105758491|NCT02394795|364767263|FG000|Overall Study|Lost to Follow-up|0|||
105758492|NCT02394795|364767264|FG001|Overall Study|Lost to Follow-up|1|||
105758493|NCT02394795|364767263|FG000|Overall Study|Withdrawal by Subject|17|||
105758494|NCT02394795|364767264|FG001|Overall Study|Withdrawal by Subject|26|||
105804805|NCT01452529|364941917|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
105804806|NCT01452529|364941918|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
105804807|NCT01452529|364941919|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
105804808|NCT01452529|364941917|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
105804809|NCT01452529|364941918|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
105804810|NCT01452529|364941919|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
105804811|NCT01452529|364941917|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
105804812|NCT01452529|364941918|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
105804813|NCT01452529|364941919|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
105804814|NCT01452529|364941917|FG000|Double-blind (DB) Period|Administrative|0|||
105804815|NCT01452529|364941918|FG001|Double-blind (DB) Period|Administrative|11|||
105804816|NCT01452529|364941919|FG002|Double-blind (DB) Period|Administrative|7|||
105804817|NCT03551730|364941920|FG000|Overall Study|Adverse Event|1|||
105804818|NCT03551730|364941921|FG001|Overall Study|Adverse Event|0|||
105804819|NCT03551730|364941922|FG002|Overall Study|Adverse Event|0|||
105804820|NCT03551730|364941923|FG003|Overall Study|Adverse Event|0|||
105804821|NCT01165684|364941927|FG000|Overall Study|Adverse Event|1|||
105804822|NCT01165684|364941928|FG001|Overall Study|Adverse Event|1|||
105804823|NCT01165684|364941927|FG000|Overall Study|Lack of Efficacy|2|||
105804824|NCT01165684|364941928|FG001|Overall Study|Lack of Efficacy|1|||
105804825|NCT01165684|364941927|FG000|Overall Study|Protocol Violation|7|||
105804826|NCT01165684|364941928|FG001|Overall Study|Protocol Violation|15|||
105804827|NCT01165684|364941927|FG000|Overall Study|Withdrawal Criteria|2|||
105804828|NCT01165684|364941928|FG001|Overall Study|Withdrawal Criteria|13|||
105804829|NCT01165684|364941927|FG000|Overall Study|Unclassified|16|||
105804830|NCT01165684|364941928|FG001|Overall Study|Unclassified|22|||
105804831|NCT03347695|364941929|FG000|Overall Study|Death|0|||
105804832|NCT03347695|364941930|FG001|Overall Study|Death|4|||
105804833|NCT03347695|364941929|FG000|Overall Study|Lost to Follow-up|0|||
105804834|NCT03347695|364941930|FG001|Overall Study|Lost to Follow-up|1|||
105804835|NCT00671879|364941935|FG000|Overall Study|Withdrawal by Subject|0|||
105804836|NCT00671879|364941936|FG001|Overall Study|Withdrawal by Subject|4|||
105804837|NCT00671879|364941937|FG002|Overall Study|Withdrawal by Subject|6|||
105804838|NCT04633837|364941938|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
105804839|NCT04633837|364941939|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
105804840|NCT01886300|364941940|FG000|Overall Study|Trial terminated by sponsor|16|||
105804841|NCT02884206|364941941|FG000|Valsartan Run-in Period|Death|1|||
105804842|NCT02884206|364941942|FG001|Valsartan Run-in Period|Death|0|||
105804843|NCT02884206|364941943|FG002|Valsartan Run-in Period|Death|0|||
105804844|NCT02884206|364941941|FG000|Valsartan Run-in Period|Adverse Event|31|||
105804845|NCT02884206|364941942|FG001|Valsartan Run-in Period|Adverse Event|0|||
105804846|NCT02884206|364941943|FG002|Valsartan Run-in Period|Adverse Event|0|||
105804847|NCT02884206|364941941|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
105804848|NCT02884206|364941942|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
105804849|NCT02884206|364941943|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
105804850|NCT02884206|364941941|FG000|Valsartan Run-in Period|Protocol deviation|4|||
105804851|NCT02884206|364941942|FG001|Valsartan Run-in Period|Protocol deviation|0|||
105804852|NCT02884206|364941943|FG002|Valsartan Run-in Period|Protocol deviation|0|||
105804853|NCT02884206|364941941|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
105804854|NCT02884206|364941942|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
105804855|NCT02884206|364941943|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
105804856|NCT02884206|364941941|FG000|Valsartan Run-in Period|Physician Decision|1|||
105804857|NCT02884206|364941942|FG001|Valsartan Run-in Period|Physician Decision|0|||
105804858|NCT02884206|364941943|FG002|Valsartan Run-in Period|Physician Decision|0|||
105804859|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Adverse Event|38|||
105804860|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Adverse Event|0|||
105804861|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Adverse Event|0|||
105804862|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Death|2|||
105804863|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Death|0|||
105804864|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Death|0|||
105804865|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
105804866|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
105804867|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
105804868|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
105804869|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
105804870|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
105804871|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
105804872|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
105804873|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
105804874|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Physician Decision|1|||
105804875|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Physician Decision|0|||
105804876|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Physician Decision|0|||
105804877|NCT02884206|364941941|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
105758495|NCT02394795|364767263|FG000|Overall Study|Lack of Efficacy|181|||
105758496|NCT02394795|364767264|FG001|Overall Study|Lack of Efficacy|211|||
105758497|NCT02394795|364767263|FG000|Overall Study|Death|4|||
105758498|NCT02394795|364767264|FG001|Overall Study|Death|5|||
105758499|NCT02394795|364767263|FG000|Overall Study|Physician Decision|109|||
105758500|NCT02394795|364767264|FG001|Overall Study|Physician Decision|93|||
105758501|NCT01957787|364767266|FG000|Overall Study|Death|18|||
105758502|NCT01957787|364767266|FG000|Overall Study|Lost to Follow-up|3|||
105758503|NCT01957787|364767266|FG000|Overall Study|Withdrawal by Subject|3|||
105758504|NCT01957787|364767266|FG000|Overall Study|Entered Hospice or Similar Program|2|||
105758505|NCT01957787|364767266|FG000|Overall Study|Index Tumor(s) Resected|2|||
105758506|NCT01957787|364767266|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
105758507|NCT01957787|364767266|FG000|Overall Study|Local therapy, not cryoablation|6|||
105758508|NCT03846219|364767270|FG000|Overall Study|Withdrawal by Subject|3|||
105758509|NCT03846219|364767271|FG001|Overall Study|Withdrawal by Subject|2|||
105758510|NCT03846219|364767272|FG002|Overall Study|Withdrawal by Subject|2|||
105758511|NCT03846219|364767270|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
105758512|NCT03846219|364767271|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
105758513|NCT03846219|364767272|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
105758514|NCT03846219|364767270|FG000|Overall Study|Physician Decision|0|||
105758515|NCT03846219|364767271|FG001|Overall Study|Physician Decision|0|||
105758516|NCT03846219|364767272|FG002|Overall Study|Physician Decision|2|||
105758517|NCT02671461|364767277|FG000|Treatment|Adverse Event|0|||
105758518|NCT02671461|364767278|FG001|Treatment|Adverse Event|0|||
105758519|NCT02671461|364767279|FG002|Treatment|Adverse Event|1|||
105758520|NCT02671461|364767277|FG000|Treatment|Administrative Reason by Sponsor|1|||
105758521|NCT02671461|364767278|FG001|Treatment|Administrative Reason by Sponsor|3|||
105758522|NCT02671461|364767279|FG002|Treatment|Administrative Reason by Sponsor|4|||
105758523|NCT02671461|364767277|FG000|Treatment|Randomized, not treated|1|||
105758524|NCT02671461|364767278|FG001|Treatment|Randomized, not treated|0|||
105758525|NCT02671461|364767279|FG002|Treatment|Randomized, not treated|0|||
105758526|NCT02671461|364767277|FG000|Follow-up|Withdrawal by Subject|1|||
105758527|NCT02671461|364767278|FG001|Follow-up|Withdrawal by Subject|0|||
105758528|NCT02671461|364767279|FG002|Follow-up|Withdrawal by Subject|0|||
105758529|NCT02671461|364767277|FG000|Follow-up|Lost to Follow-up|0|||
105758530|NCT02671461|364767278|FG001|Follow-up|Lost to Follow-up|0|||
105758531|NCT02671461|364767279|FG002|Follow-up|Lost to Follow-up|1|||
105758532|NCT02671461|364767277|FG000|Follow-up|Administrative Reason by Sponsor|0|||
105758533|NCT02671461|364767278|FG001|Follow-up|Administrative Reason by Sponsor|1|||
105758534|NCT02671461|364767279|FG002|Follow-up|Administrative Reason by Sponsor|0|||
105758535|NCT01181778|364767280|FG000|Overall Study|Physician Decision|48|||
105758536|NCT01924299|364767283|FG000|Period 2|Withdrawal by Subject|1|||
105758537|NCT01924299|364767284|FG001|Period 2|Withdrawal by Subject|0|||
105758538|NCT01924299|364767283|FG000|Period 2|Adverse Event|0|||
105758539|NCT01924299|364767284|FG001|Period 2|Adverse Event|1|||
105758540|NCT00617656|364767285|FG000|Overall Study|Inclusion error|4|||
105758541|NCT00617656|364767286|FG001|Overall Study|Inclusion error|4|||
105758542|NCT00617656|364767287|FG002|Overall Study|Inclusion error|0|||
105758543|NCT00617656|364767288|FG003|Overall Study|Inclusion error|0|||
105758544|NCT00617656|364767285|FG000|Overall Study|Missing data|44|||
105758545|NCT00617656|364767286|FG001|Overall Study|Missing data|30|||
105758546|NCT00617656|364767287|FG002|Overall Study|Missing data|13|||
105758547|NCT00617656|364767288|FG003|Overall Study|Missing data|6|||
105758548|NCT00617656|364767285|FG000|Overall Study|Withdrawal by Subject|0|||
105758549|NCT00617656|364767286|FG001|Overall Study|Withdrawal by Subject|2|||
105758550|NCT00617656|364767287|FG002|Overall Study|Withdrawal by Subject|0|||
105758551|NCT00617656|364767288|FG003|Overall Study|Withdrawal by Subject|0|||
105758552|NCT02079519|364767289|FG000|Overall Study|Disease Progression|9|||
105758553|NCT02079519|364767289|FG000|Overall Study|Adverse Event|1|||
105758554|NCT05200455|364767290|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
105758555|NCT01602549|364767293|FG000|Overall Study|Protocol Violation|0|||
105758556|NCT01602549|364767294|FG001|Overall Study|Protocol Violation|1|||
105758557|NCT01602549|364767293|FG000|Overall Study|Withdrawal by Subject|1|||
105758558|NCT01602549|364767294|FG001|Overall Study|Withdrawal by Subject|0|||
105758559|NCT03700736|364767295|FG000|Overall Study|Pregnancy|1|||
105758560|NCT03700736|364767296|FG001|Overall Study|Pregnancy|1|||
105758561|NCT03700736|364767295|FG000|Overall Study|Withdrawal by Subject|2|||
105758562|NCT03700736|364767296|FG001|Overall Study|Withdrawal by Subject|6|||
105758563|NCT00642018|364767297|FG000|Overall Study|Adverse Event|11|||
105758564|NCT00642018|364767298|FG001|Overall Study|Adverse Event|36|||
105758565|NCT00642018|364767297|FG000|Overall Study|Withdrawal by Subject|4|||
105758566|NCT00642018|364767298|FG001|Overall Study|Withdrawal by Subject|10|||
105758567|NCT00642018|364767297|FG000|Overall Study|Progressive Disease|13|||
105758568|NCT00642018|364767298|FG001|Overall Study|Progressive Disease|18|||
105758569|NCT00642018|364767297|FG000|Overall Study|Physician Decision|0|||
105758570|NCT00642018|364767298|FG001|Overall Study|Physician Decision|10|||
105758571|NCT00642018|364767297|FG000|Overall Study|Protocol Violation|0|||
105758572|NCT00642018|364767298|FG001|Overall Study|Protocol Violation|1|||
105950519|NCT04021290|365482422|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
105950520|NCT04021290|365482420|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
105950521|NCT04021290|365482421|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
105950522|NCT04021290|365482422|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
105950523|NCT04021290|365482420|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
105950524|NCT04021290|365482421|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
105950525|NCT04021290|365482422|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
105758573|NCT00642018|364767297|FG000|Overall Study|Death|0|||
105758574|NCT00642018|364767298|FG001|Overall Study|Death|3|||
105758575|NCT00642018|364767297|FG000|Overall Study|Entry Criteria Not Met|0|||
105758576|NCT00642018|364767298|FG001|Overall Study|Entry Criteria Not Met|1|||
105758577|NCT01601704|364769166|FG000|Overall Study|Randomized but not dispensed study med|1|||
105758578|NCT01601704|364769167|FG001|Overall Study|Randomized but not dispensed study med|4|||
105758579|NCT03518034|364769168|FG000|Overall Study|Not Treated|5|||
105758580|NCT03518034|364769169|FG001|Overall Study|Not Treated|1|||
105758581|NCT03518034|364769168|FG000|Overall Study|Withdrawal by Subject|309|||
105758582|NCT03518034|364769169|FG001|Overall Study|Withdrawal by Subject|351|||
105758583|NCT03518034|364769168|FG000|Overall Study|Lost to Follow-up|446|||
105758584|NCT03518034|364769169|FG001|Overall Study|Lost to Follow-up|458|||
105758585|NCT03518034|364769168|FG000|Overall Study|Adverse Event|138|||
105758586|NCT03518034|364769169|FG001|Overall Study|Adverse Event|130|||
105758587|NCT03518034|364769168|FG000|Overall Study|Lack of Efficacy|11|||
105758588|NCT03518034|364769169|FG001|Overall Study|Lack of Efficacy|23|||
105758589|NCT03518034|364769168|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
105758590|NCT03518034|364769169|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
105758591|NCT03518034|364769168|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
105758592|NCT03518034|364769169|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
105758593|NCT03518034|364769168|FG000|Overall Study|Other, Not Specified|84|||
105758594|NCT03518034|364769169|FG001|Overall Study|Other, Not Specified|53|||
105758595|NCT03518034|364769168|FG000|Overall Study|Reason Missing|2|||
105758596|NCT03518034|364769169|FG001|Overall Study|Reason Missing|3|||
105758597|NCT03351478|364769175|FG000|Overall Study|At the subject's own request|11|||
105758598|NCT03351478|364769176|FG001|Overall Study|At the subject's own request|12|||
105758599|NCT03351478|364769177|FG002|Overall Study|At the subject's own request|5|||
105758600|NCT03351478|364769175|FG000|Overall Study|Adverse Event|1|||
105758601|NCT03351478|364769176|FG001|Overall Study|Adverse Event|2|||
105758602|NCT03351478|364769177|FG002|Overall Study|Adverse Event|1|||
105758603|NCT03351478|364769175|FG000|Overall Study|Poor compliance to protocol|1|||
105758604|NCT03351478|364769176|FG001|Overall Study|Poor compliance to protocol|0|||
105758605|NCT03351478|364769177|FG002|Overall Study|Poor compliance to protocol|0|||
105758606|NCT03351478|364769175|FG000|Overall Study|Reason not Specified|1|||
105758607|NCT03351478|364769176|FG001|Overall Study|Reason not Specified|3|||
105758608|NCT03351478|364769177|FG002|Overall Study|Reason not Specified|0|||
105758609|NCT03351478|364769175|FG000|Overall Study|Lost to Follow-up|0|||
105758610|NCT03351478|364769176|FG001|Overall Study|Lost to Follow-up|0|||
105758611|NCT03351478|364769177|FG002|Overall Study|Lost to Follow-up|1|||
105758612|NCT03485222|364769180|FG000|Overall Study|Death|0|||
105758613|NCT03485222|364769181|FG001|Overall Study|Death|1|||
105758614|NCT03485222|364769180|FG000|Overall Study|Lost to Follow-up|2|||
105758615|NCT03485222|364769181|FG001|Overall Study|Lost to Follow-up|1|||
105758616|NCT03657810|364769182|FG000|Overall Study|Adverse Event|0|||
105758617|NCT03657810|364769183|FG001|Overall Study|Adverse Event|1|||
105758618|NCT03657810|364769184|FG002|Overall Study|Adverse Event|0|||
105758619|NCT03657810|364769182|FG000|Overall Study|Lack of Efficacy|4|||
105758620|NCT03657810|364769183|FG001|Overall Study|Lack of Efficacy|1|||
105758621|NCT03657810|364769184|FG002|Overall Study|Lack of Efficacy|3|||
105758622|NCT03657810|364769182|FG000|Overall Study|Protocol Violation|1|||
105758623|NCT03657810|364769183|FG001|Overall Study|Protocol Violation|0|||
105758624|NCT03657810|364769184|FG002|Overall Study|Protocol Violation|0|||
105758625|NCT03657810|364769182|FG000|Overall Study|Lost to Follow-up|0|||
105758626|NCT03657810|364769183|FG001|Overall Study|Lost to Follow-up|1|||
105758627|NCT03657810|364769184|FG002|Overall Study|Lost to Follow-up|0|||
105758628|NCT03657810|364769182|FG000|Overall Study|Not provided|0|||
105758629|NCT03657810|364769183|FG001|Overall Study|Not provided|1|||
105758630|NCT03657810|364769184|FG002|Overall Study|Not provided|0|||
105758631|NCT00688545|364769185|FG000|Overall Study|Lost to Follow-up|1|||
105758632|NCT00688545|364769186|FG001|Overall Study|Lost to Follow-up|4|||
105950526|NCT03092479|365482425|FG000|Overall Study|Lost to Follow-up|3|||
105758633|NCT00688545|364769185|FG000|Overall Study|Insurance/cost of drug|0|||
105758634|NCT00688545|364769186|FG001|Overall Study|Insurance/cost of drug|1|||
105758635|NCT00688545|364769185|FG000|Overall Study|Withdrawal by Subject|2|||
105758636|NCT00688545|364769186|FG001|Overall Study|Withdrawal by Subject|3|||
105758637|NCT00688545|364769185|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
105758638|NCT00688545|364769186|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
105758639|NCT03911869|364769187|FG000|Safety Lead-in Phase|Death|7|||
105758640|NCT03911869|364769188|FG001|Safety Lead-in Phase|Death|0|||
105758641|NCT03911869|364769189|FG002|Safety Lead-in Phase|Death|0|||
105950527|NCT03092479|365482426|FG001|Overall Study|Lost to Follow-up|2|||
105950528|NCT03092479|365482425|FG000|Overall Study|Withdrawal by Subject|4|||
105950529|NCT03092479|365482426|FG001|Overall Study|Withdrawal by Subject|0|||
105950530|NCT04422431|365482427|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
105950531|NCT04422431|365482427|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
105950532|NCT04422431|365482427|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
105950533|NCT04422431|365482427|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
105950534|NCT04422431|365482427|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
105758642|NCT03911869|364769187|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
105758643|NCT03911869|364769188|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
105758644|NCT03911869|364769189|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
105758645|NCT03911869|364769187|FG000|Safety Lead-in Phase|Other|1|||
105758646|NCT03911869|364769188|FG001|Safety Lead-in Phase|Other|0|||
105758647|NCT03911869|364769189|FG002|Safety Lead-in Phase|Other|0|||
105758648|NCT03911869|364769187|FG000|Phase 2|Death|0|||
105758649|NCT03911869|364769188|FG001|Phase 2|Death|3|||
105758650|NCT03911869|364769189|FG002|Phase 2|Death|0|||
105758651|NCT01878097|364769190|FG000|Baseline|Surveys not fully completed|2497|||
105758652|NCT01878097|364769191|FG001|Baseline|Surveys not fully completed|1800|||
105758653|NCT01878097|364769190|FG000|Implementation Year 1|Surveys not fully completed|3202|||
105758654|NCT01878097|364769191|FG001|Implementation Year 1|Surveys not fully completed|2549|||
105758655|NCT01878097|364769190|FG000|Implementation Year 2|Surveys not fully completed|3281|||
105758656|NCT01878097|364769191|FG001|Implementation Year 2|Surveys not fully completed|2841|||
105758657|NCT01878097|364769190|FG000|Implementation Year 3|Surveys not fully completed|3494|||
105758658|NCT01878097|364769191|FG001|Implementation Year 3|Surveys not fully completed|2980|||
105758659|NCT01878097|364769190|FG000|Implementation Year 4|Surveys not fully completed|3604|||
105758660|NCT01878097|364769191|FG001|Implementation Year 4|Surveys not fully completed|3007|||
105758661|NCT02580240|364769205|FG000|Overall Study|Physician Decision|2|||
105758662|NCT02580240|364769206|FG001|Overall Study|Physician Decision|0|||
105758663|NCT01527110|364769207|FG000|Overall Study|Adverse Event|1|||
105758664|NCT00527072|364769208|FG000|Overall Study|Adverse Event|13|||
105758665|NCT00527072|364769208|FG000|Overall Study|Lack of Efficacy|11|||
105758666|NCT00527072|364769208|FG000|Overall Study|Lost to Follow-up|3|||
105758667|NCT00527072|364769208|FG000|Overall Study|Protocol Violation|2|||
105758668|NCT00527072|364769208|FG000|Overall Study|Withdrawal by Subject|7|||
105758669|NCT01590212|364769209|FG000|Overall Study|Withdrawal by Subject|2|||
105758670|NCT01590212|364769210|FG001|Overall Study|Withdrawal by Subject|2|||
105758671|NCT01590212|364769211|FG002|Overall Study|Withdrawal by Subject|2|||
105758672|NCT01590212|364769209|FG000|Overall Study|Lost to Follow-up|1|||
105758673|NCT01590212|364769210|FG001|Overall Study|Lost to Follow-up|2|||
105758674|NCT01590212|364769211|FG002|Overall Study|Lost to Follow-up|3|||
105758675|NCT01532570|364769214|FG000|Overall Study|Lack of Efficacy|1|||
105758676|NCT01532570|364769215|FG001|Overall Study|Lack of Efficacy|0|||
105758677|NCT01532570|364769216|FG002|Overall Study|Lack of Efficacy|0|||
105758678|NCT01532570|364769217|FG003|Overall Study|Lack of Efficacy|0|||
105758679|NCT01532570|364769214|FG000|Overall Study|Withdrawal by Subject|0|||
105758680|NCT01532570|364769215|FG001|Overall Study|Withdrawal by Subject|1|||
105758681|NCT01532570|364769216|FG002|Overall Study|Withdrawal by Subject|0|||
105758682|NCT01532570|364769217|FG003|Overall Study|Withdrawal by Subject|0|||
105758683|NCT05552859|364769220|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
105758684|NCT05552859|364769221|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
105758685|NCT01807949|364769222|FG000|Overall Study|Adverse Event|1|||
105758686|NCT01807949|364769223|FG001|Overall Study|Adverse Event|2|||
105758687|NCT01807949|364769224|FG002|Overall Study|Adverse Event|2|||
105758688|NCT01807949|364769222|FG000|Overall Study|Withdrawal by Subject|1|||
105758689|NCT01807949|364769223|FG001|Overall Study|Withdrawal by Subject|2|||
105758690|NCT01807949|364769224|FG002|Overall Study|Withdrawal by Subject|2|||
105758691|NCT01807949|364769222|FG000|Overall Study|Non-Compliance|0|||
105758692|NCT01807949|364769223|FG001|Overall Study|Non-Compliance|0|||
105758693|NCT01807949|364769224|FG002|Overall Study|Non-Compliance|1|||
105758694|NCT01807949|364769222|FG000|Overall Study|Undefined|0|||
105758695|NCT01807949|364769223|FG001|Overall Study|Undefined|1|||
105758696|NCT01807949|364769224|FG002|Overall Study|Undefined|2|||
105758697|NCT01807949|364769222|FG000|Overall Study|Randomized But Not Treated|0|||
105758698|NCT01807949|364769223|FG001|Overall Study|Randomized But Not Treated|2|||
105758699|NCT01807949|364769224|FG002|Overall Study|Randomized But Not Treated|2|||
105758700|NCT01306032|364769225|FG000|First Intervention|Adverse Event|1|||
105758701|NCT01306032|364769226|FG001|First Intervention|Adverse Event|0|||
105758702|NCT01306032|364769227|FG002|First Intervention|Adverse Event|1|||
105758703|NCT01306032|364769228|FG003|First Intervention|Adverse Event|0|||
105758704|NCT01306032|364769229|FG004|First Intervention|Adverse Event|0|||
105758705|NCT01306032|364769230|FG005|First Intervention|Adverse Event|1|||
105950535|NCT04422431|365482427|FG000|Extension Period (48 Weeks)|Other than specified|2|||
105950536|NCT00543985|365482428|FG000|Overall Study|Withdrawal by Subject|4|||
105950537|NCT01074931|365482429|FG000|Overall Study|Economic reasons|1|||
105758706|NCT01306032|364769225|FG000|First Intervention|Withdrawal by Subject|0|||
105758707|NCT01306032|364769226|FG001|First Intervention|Withdrawal by Subject|2|||
105758708|NCT01306032|364769227|FG002|First Intervention|Withdrawal by Subject|0|||
105758709|NCT01306032|364769228|FG003|First Intervention|Withdrawal by Subject|1|||
105758710|NCT01306032|364769229|FG004|First Intervention|Withdrawal by Subject|0|||
105758711|NCT01306032|364769230|FG005|First Intervention|Withdrawal by Subject|0|||
105758712|NCT01306032|364769225|FG000|First Intervention|Death|0|||
105758713|NCT01306032|364769226|FG001|First Intervention|Death|0|||
105758714|NCT01306032|364769227|FG002|First Intervention|Death|1|||
105758715|NCT01306032|364769228|FG003|First Intervention|Death|0|||
105758716|NCT01306032|364769229|FG004|First Intervention|Death|0|||
105758717|NCT01306032|364769230|FG005|First Intervention|Death|0|||
105758718|NCT01306032|364769225|FG000|First Intervention|Ineligible|0|||
105758719|NCT01306032|364769226|FG001|First Intervention|Ineligible|0|||
105758720|NCT01306032|364769227|FG002|First Intervention|Ineligible|0|||
105758721|NCT01306032|364769228|FG003|First Intervention|Ineligible|0|||
105758722|NCT01306032|364769229|FG004|First Intervention|Ineligible|0|||
105758723|NCT01306032|364769230|FG005|First Intervention|Ineligible|1|||
105758724|NCT01306032|364769225|FG000|First Intervention|Progressive disease|0|||
105758725|NCT01306032|364769226|FG001|First Intervention|Progressive disease|0|||
105758726|NCT01306032|364769227|FG002|First Intervention|Progressive disease|0|||
105758727|NCT01306032|364769228|FG003|First Intervention|Progressive disease|0|||
105758728|NCT01306032|364769229|FG004|First Intervention|Progressive disease|2|||
105758729|NCT01306032|364769230|FG005|First Intervention|Progressive disease|0|||
105758730|NCT01306032|364769225|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758731|NCT01306032|364769226|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758732|NCT01306032|364769227|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758733|NCT01306032|364769228|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
105758734|NCT01306032|364769229|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758735|NCT01306032|364769230|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
105758736|NCT01306032|364769225|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
105758737|NCT01306032|364769226|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
105758738|NCT01306032|364769227|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
105758739|NCT01306032|364769228|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
105758740|NCT01306032|364769229|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
105758741|NCT01306032|364769230|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
105758742|NCT04992546|364769231|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
105758743|NCT04992546|364769231|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
105758744|NCT04992546|364769231|FG000|Open-Label Treatment Period|Adverse Event|3|||
105758745|NCT04992546|364769231|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
105758746|NCT00555568|364769232|FG000|Overall Study|Lost to Follow-up|26|||
105758747|NCT00555568|364769233|FG001|Overall Study|Lost to Follow-up|16|||
105758748|NCT00555568|364769234|FG002|Overall Study|Lost to Follow-up|16|||
105758749|NCT00064077|364769235|FG000|Overall Study|Improper prior treatment|1|||
105758750|NCT00064077|364769236|FG001|Overall Study|Improper prior treatment|0|||
105758751|NCT00064077|364769237|FG002|Overall Study|Improper prior treatment|0|||
105758752|NCT00064077|364769238|FG003|Overall Study|Improper prior treatment|0|||
105758753|NCT00064077|364769235|FG000|Overall Study|Poor risk|2|||
105758754|NCT00064077|364769236|FG001|Overall Study|Poor risk|0|||
105758755|NCT00064077|364769237|FG002|Overall Study|Poor risk|1|||
105758756|NCT00064077|364769238|FG003|Overall Study|Poor risk|1|||
105758757|NCT00064077|364769235|FG000|Overall Study|Pathology|10|||
105758758|NCT00064077|364769236|FG001|Overall Study|Pathology|7|||
105758759|NCT00064077|364769237|FG002|Overall Study|Pathology|3|||
105758760|NCT00064077|364769238|FG003|Overall Study|Pathology|4|||
105758761|NCT00064077|364769235|FG000|Overall Study|No surgery|0|||
105758762|NCT00064077|364769236|FG001|Overall Study|No surgery|0|||
105758763|NCT00064077|364769237|FG002|Overall Study|No surgery|1|||
105758764|NCT00064077|364769238|FG003|Overall Study|No surgery|0|||
105758765|NCT00064077|364769235|FG000|Overall Study|No tumor|0|||
105758766|NCT00064077|364769236|FG001|Overall Study|No tumor|0|||
105758767|NCT00064077|364769237|FG002|Overall Study|No tumor|1|||
105758768|NCT00064077|364769238|FG003|Overall Study|No tumor|0|||
105804878|NCT02884206|364941942|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
105758769|NCT00064077|364769235|FG000|Overall Study|Other reasons|2|||
105758770|NCT00064077|364769236|FG001|Overall Study|Other reasons|2|||
105758771|NCT00064077|364769237|FG002|Overall Study|Other reasons|1|||
105758772|NCT00064077|364769238|FG003|Overall Study|Other reasons|2|||
105758773|NCT00067470|364769239|FG000|Overall Study|Withdrawal by Subject|0|||
105758774|NCT00067470|364769240|FG001|Overall Study|Withdrawal by Subject|1|||
105758775|NCT01170221|364769246|FG000|Overall Study|Lost to Follow-up|22|||
105758776|NCT01170221|364769247|FG001|Overall Study|Lost to Follow-up|21|||
105758777|NCT01170221|364769246|FG000|Overall Study|Withdrawal by Subject|9|||
105758778|NCT01170221|364769247|FG001|Overall Study|Withdrawal by Subject|7|||
105758779|NCT01170221|364769246|FG000|Overall Study|Subject completed only screening and LFU|1|||
105758780|NCT01170221|364769247|FG001|Overall Study|Subject completed only screening and LFU|0|||
105758781|NCT01170221|364769246|FG000|Overall Study|Randomized but not treated|1|||
105758782|NCT01170221|364769247|FG001|Overall Study|Randomized but not treated|0|||
105758783|NCT02693691|364769248|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
105758784|NCT02693691|364769248|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
105758785|NCT02693691|364769248|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
105758786|NCT02693691|364769248|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
105758787|NCT02693691|364769248|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
105758788|NCT02693691|364769248|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
105758789|NCT02693691|364769248|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
105758790|NCT00636441|364769253|FG000|Overall Study|Adverse Event|0|||
105758791|NCT00636441|364769254|FG001|Overall Study|Adverse Event|1|||
105758792|NCT00636441|364769255|FG002|Overall Study|Adverse Event|1|||
105758793|NCT00636441|364769256|FG003|Overall Study|Adverse Event|0|||
105758794|NCT00636441|364769257|FG004|Overall Study|Adverse Event|0|||
105758795|NCT00636441|364769258|FG005|Overall Study|Adverse Event|1|||
105758796|NCT00636441|364769259|FG006|Overall Study|Adverse Event|0|||
105758797|NCT00636441|364769253|FG000|Overall Study|Late, ineligible|0|||
105758798|NCT00636441|364769254|FG001|Overall Study|Late, ineligible|0|||
105758799|NCT00636441|364769255|FG002|Overall Study|Late, ineligible|0|||
105758800|NCT00636441|364769256|FG003|Overall Study|Late, ineligible|0|||
105758801|NCT00636441|364769257|FG004|Overall Study|Late, ineligible|0|||
105758802|NCT00636441|364769258|FG005|Overall Study|Late, ineligible|0|||
105758803|NCT00636441|364769259|FG006|Overall Study|Late, ineligible|1|||
105758804|NCT00636441|364769253|FG000|Overall Study|Screen Failure|0|||
105758805|NCT00636441|364769254|FG001|Overall Study|Screen Failure|0|||
105758806|NCT00636441|364769255|FG002|Overall Study|Screen Failure|0|||
105758807|NCT00636441|364769256|FG003|Overall Study|Screen Failure|0|||
105758808|NCT00636441|364769257|FG004|Overall Study|Screen Failure|0|||
105758809|NCT00636441|364769258|FG005|Overall Study|Screen Failure|0|||
105758810|NCT00636441|364769259|FG006|Overall Study|Screen Failure|17|||
105758811|NCT01162304|364769261|FG000|Overall Study|Beck scale to high|11|||
105758812|NCT01192204|364769262|FG000|Overall Study|could not keep recall appointments|1|||
105758813|NCT01192204|364769263|FG001|Overall Study|could not keep recall appointments|0|||
105758814|NCT03379376|364769264|FG000|Overall Study|Lost to Follow-up|2|||
105758815|NCT03379376|364769264|FG000|Overall Study|Did not wish to complete follow up|1|||
105758816|NCT03379376|364769264|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
105758817|NCT03379376|364769264|FG000|Overall Study|Death|1|||
105758818|NCT00729326|364769265|FG000|Overall Study|Lost to Follow-up|2|||
105758819|NCT00729326|364769266|FG001|Overall Study|Lost to Follow-up|0|||
105758820|NCT00729326|364769265|FG000|Overall Study|Physician Decision|0|||
105758821|NCT00729326|364769266|FG001|Overall Study|Physician Decision|1|||
105758822|NCT00729326|364769265|FG000|Overall Study|Protocol Violation|3|||
105758823|NCT00729326|364769266|FG001|Overall Study|Protocol Violation|2|||
105758824|NCT00729326|364769265|FG000|Overall Study|Subject Decision|4|||
105758825|NCT00729326|364769266|FG001|Overall Study|Subject Decision|4|||
105758826|NCT00729326|364769265|FG000|Overall Study|Sponsor Decision|1|||
105758827|NCT00729326|364769266|FG001|Overall Study|Sponsor Decision|2|||
105758828|NCT02247401|364769267|FG000|Overall Study|Adverse Event|1|||
105758829|NCT02247401|364769268|FG001|Overall Study|Adverse Event|0|||
105758830|NCT02247401|364769269|FG002|Overall Study|Adverse Event|0|||
105758831|NCT02247401|364769267|FG000|Overall Study|Withdrawal by Subject|4|||
105758832|NCT02247401|364769268|FG001|Overall Study|Withdrawal by Subject|1|||
105758833|NCT02247401|364769269|FG002|Overall Study|Withdrawal by Subject|1|||
105758834|NCT02247401|364769267|FG000|Overall Study|Lost to Follow-up|1|||
105758835|NCT02247401|364769268|FG001|Overall Study|Lost to Follow-up|1|||
105758836|NCT02247401|364769269|FG002|Overall Study|Lost to Follow-up|1|||
105758837|NCT04169061|364769274|FG000|Overall Study|Adverse Event|2|||
105758838|NCT04169061|364769274|FG000|Overall Study|Death|1|||
105758839|NCT04169061|364769274|FG000|Overall Study|Withdrawal by Subject|1|||
105758840|NCT04169061|364769274|FG000|Overall Study|Protocol Violation|1|||
105758841|NCT04585451|364769275|FG000|Overall Study|Withdrawal by Subject|26|||
105758842|NCT04585451|364769276|FG001|Overall Study|Withdrawal by Subject|0|||
105758843|NCT05425719|364769279|FG000|Overall Study|Lost to Follow-up|4|||
105758844|NCT05425719|364769280|FG001|Overall Study|Lost to Follow-up|0|||
105758845|NCT05425719|364769279|FG000|Overall Study|Withdrew consent|1|||
105758846|NCT05425719|364769280|FG001|Overall Study|Withdrew consent|1|||
105758847|NCT02193828|364769283|FG000|Overall Study|Withdrawal by Subject|0|||
105758848|NCT02193828|364769284|FG001|Overall Study|Withdrawal by Subject|0|||
105758849|NCT02193828|364769285|FG002|Overall Study|Withdrawal by Subject|1|||
105758850|NCT02193828|364769286|FG003|Overall Study|Withdrawal by Subject|1|||
105758851|NCT04377672|364769287|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
105758852|NCT03954444|364769288|FG000|Overall Study|Withdrawal by Subject|5|||
105758853|NCT03954444|364769289|FG001|Overall Study|Withdrawal by Subject|5|||
105758854|NCT03954444|364769290|FG002|Overall Study|Withdrawal by Subject|5|||
105758855|NCT03954444|364769288|FG000|Overall Study|Adverse Event|1|||
105758856|NCT03954444|364769289|FG001|Overall Study|Adverse Event|3|||
105758857|NCT03954444|364769290|FG002|Overall Study|Adverse Event|2|||
105804879|NCT02884206|364941943|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
105804880|NCT02884206|364941941|FG000|Double-Blind Period|Death|0|||
105804881|NCT02884206|364941942|FG001|Double-Blind Period|Death|28|||
105804882|NCT02884206|364941943|FG002|Double-Blind Period|Death|39|||
105804883|NCT02884206|364941941|FG000|Double-Blind Period|Patient/guardian decision|0|||
105804884|NCT02884206|364941942|FG001|Double-Blind Period|Patient/guardian decision|10|||
105804885|NCT02884206|364941943|FG002|Double-Blind Period|Patient/guardian decision|13|||
105804886|NCT02884206|364941941|FG000|Double-Blind Period|Lost to Follow-up|0|||
105804887|NCT02884206|364941942|FG001|Double-Blind Period|Lost to Follow-up|4|||
105804888|NCT02884206|364941943|FG002|Double-Blind Period|Lost to Follow-up|4|||
105804889|NCT02884206|364941941|FG000|Double-Blind Period|Physician Decision|0|||
105950538|NCT01074931|365482429|FG000|Overall Study|Death|5|||
105950539|NCT03132467|365482430|FG000|Overall Study|Adverse Event|2|||
105950540|NCT03132467|365482430|FG000|Overall Study|Withdrawal by Subject|2|||
105950541|NCT05223673|365482432|FG000|Overall Study|Protocol Violation|1|||
105950542|NCT05223673|365482432|FG000|Overall Study|Study termination|6|||
105950543|NCT00457626|365482433|FG000|Overall Study|Adverse Event|3|||
105950544|NCT00457626|365482433|FG000|Overall Study|Administrative Problems|2|||
105950545|NCT00457626|365482433|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
105758858|NCT03954444|364769288|FG000|Overall Study|Protocol Violation|0|||
105758859|NCT03954444|364769289|FG001|Overall Study|Protocol Violation|3|||
105758860|NCT03954444|364769290|FG002|Overall Study|Protocol Violation|5|||
105758861|NCT03954444|364769288|FG000|Overall Study|Use of prohibited therapy|1|||
105758862|NCT03954444|364769289|FG001|Overall Study|Use of prohibited therapy|1|||
105758863|NCT03954444|364769290|FG002|Overall Study|Use of prohibited therapy|2|||
105758864|NCT03954444|364769288|FG000|Overall Study|Lost to Follow-up|1|||
105758865|NCT03954444|364769289|FG001|Overall Study|Lost to Follow-up|0|||
105758866|NCT03954444|364769290|FG002|Overall Study|Lost to Follow-up|1|||
105758867|NCT03954444|364769288|FG000|Overall Study|Non-compliant with study drug application|2|||
105758868|NCT03954444|364769289|FG001|Overall Study|Non-compliant with study drug application|2|||
105758869|NCT03954444|364769290|FG002|Overall Study|Non-compliant with study drug application|0|||
105758870|NCT03954444|364769288|FG000|Overall Study|Administrative reasons|0|||
105758871|NCT03954444|364769289|FG001|Overall Study|Administrative reasons|0|||
105758872|NCT03954444|364769290|FG002|Overall Study|Administrative reasons|1|||
105758873|NCT03954444|364769288|FG000|Overall Study|Miscellaneous|3|||
105758874|NCT03954444|364769289|FG001|Overall Study|Miscellaneous|2|||
105758875|NCT03954444|364769290|FG002|Overall Study|Miscellaneous|1|||
105758876|NCT02447458|364769293|FG000|Overall Study|Other|0|||
105758877|NCT02447458|364769294|FG001|Overall Study|Other|0|||
105758878|NCT02447458|364769295|FG002|Overall Study|Other|1|||
105758879|NCT02447458|364769296|FG003|Overall Study|Other|0|||
105758880|NCT02447458|364769297|FG004|Overall Study|Other|0|||
105758881|NCT02447458|364769298|FG005|Overall Study|Other|0|||
105758882|NCT02472795|364769302|FG000|Overall Study|Adverse Event|0|||
105758883|NCT02472795|364769303|FG001|Overall Study|Adverse Event|1|||
105758884|NCT02472795|364769304|FG002|Overall Study|Adverse Event|0|||
105758885|NCT02472795|364769305|FG003|Overall Study|Adverse Event|0|||
105758886|NCT02472795|364769306|FG004|Overall Study|Adverse Event|2|||
105758887|NCT02472795|364769302|FG000|Overall Study|Withdrawal by Subject|0|||
105758888|NCT02472795|364769303|FG001|Overall Study|Withdrawal by Subject|0|||
105758889|NCT02472795|364769304|FG002|Overall Study|Withdrawal by Subject|0|||
105758890|NCT02472795|364769305|FG003|Overall Study|Withdrawal by Subject|0|||
105758891|NCT02472795|364769306|FG004|Overall Study|Withdrawal by Subject|1|||
105758892|NCT01392378|364769307|FG000|Infant Series|Adverse Event|0|||
105758893|NCT01392378|364769308|FG001|Infant Series|Adverse Event|0|||
105758894|NCT01392378|364769309|FG002|Infant Series|Adverse Event|0|||
105758895|NCT01392378|364769310|FG003|Infant Series|Adverse Event|1|||
105758896|NCT01392378|364769311|FG004|Infant Series|Adverse Event|0|||
105758897|NCT01392378|364769307|FG000|Infant Series|Lost to Follow-up|0|||
105758898|NCT01392378|364769308|FG001|Infant Series|Lost to Follow-up|0|||
105758899|NCT01392378|364769309|FG002|Infant Series|Lost to Follow-up|0|||
105758900|NCT01392378|364769310|FG003|Infant Series|Lost to Follow-up|1|||
105758901|NCT01392378|364769311|FG004|Infant Series|Lost to Follow-up|0|||
105758902|NCT01392378|364769307|FG000|Infant Series|Protocol Violation|0|||
105758903|NCT01392378|364769308|FG001|Infant Series|Protocol Violation|1|||
105950546|NCT03384875|365482434|FG000|Overall Study|Death|1|||
105758904|NCT01392378|364769309|FG002|Infant Series|Protocol Violation|0|||
105758905|NCT01392378|364769310|FG003|Infant Series|Protocol Violation|0|||
105758906|NCT01392378|364769311|FG004|Infant Series|Protocol Violation|0|||
105758907|NCT01392378|364769307|FG000|Infant Series|Withdrawal by Parent|4|||
105758908|NCT01392378|364769308|FG001|Infant Series|Withdrawal by Parent|1|||
105804890|NCT02884206|364941942|FG001|Double-Blind Period|Physician Decision|2|||
105950547|NCT03384875|365482435|FG001|Overall Study|Death|1|||
105758909|NCT01392378|364769309|FG002|Infant Series|Withdrawal by Parent|0|||
105758910|NCT01392378|364769310|FG003|Infant Series|Withdrawal by Parent|0|||
105804891|NCT02884206|364941943|FG002|Double-Blind Period|Physician Decision|0|||
105804892|NCT02884206|364941941|FG000|Double-Blind Period|Adverse Event|0|||
105950548|NCT03384875|365482436|FG002|Overall Study|Death|0|||
105950549|NCT03384875|365482434|FG000|Overall Study|Reason not provided|1|||
105758911|NCT01392378|364769311|FG004|Infant Series|Withdrawal by Parent|0|||
105758912|NCT01392378|364769307|FG000|After Infant Series|Lost to Follow-up|0|||
105758913|NCT01392378|364769308|FG001|After Infant Series|Lost to Follow-up|0|||
105758914|NCT01392378|364769309|FG002|After Infant Series|Lost to Follow-up|1|||
105758915|NCT01392378|364769310|FG003|After Infant Series|Lost to Follow-up|0|||
105758916|NCT01392378|364769311|FG004|After Infant Series|Lost to Follow-up|0|||
105758917|NCT01392378|364769307|FG000|After Infant Series|Withdrawal by Parent|0|||
105758918|NCT01392378|364769308|FG001|After Infant Series|Withdrawal by Parent|1|||
105758919|NCT01392378|364769309|FG002|After Infant Series|Withdrawal by Parent|1|||
105758920|NCT01392378|364769310|FG003|After Infant Series|Withdrawal by Parent|0|||
105758921|NCT01392378|364769311|FG004|After Infant Series|Withdrawal by Parent|1|||
105758922|NCT01392378|364769307|FG000|Toddler Dose|Lost to Follow-up|0|||
105758923|NCT01392378|364769308|FG001|Toddler Dose|Lost to Follow-up|0|||
105758924|NCT01392378|364769309|FG002|Toddler Dose|Lost to Follow-up|0|||
105758925|NCT01392378|364769310|FG003|Toddler Dose|Lost to Follow-up|1|||
105758926|NCT01392378|364769311|FG004|Toddler Dose|Lost to Follow-up|0|||
105758927|NCT01392378|364769307|FG000|Toddler Dose|Withdrawal by Parent|0|||
105758928|NCT01392378|364769308|FG001|Toddler Dose|Withdrawal by Parent|1|||
105758929|NCT01392378|364769309|FG002|Toddler Dose|Withdrawal by Parent|0|||
105758930|NCT01392378|364769310|FG003|Toddler Dose|Withdrawal by Parent|1|||
105758931|NCT01392378|364769311|FG004|Toddler Dose|Withdrawal by Parent|1|||
105758932|NCT02322411|364769314|FG000|Overall Study|Lost to Follow-up|4|||
105758933|NCT02322411|364769315|FG001|Overall Study|Lost to Follow-up|7|||
105758934|NCT02322411|364769314|FG000|Overall Study|Withdrawal by Subject|1|||
105758935|NCT02322411|364769315|FG001|Overall Study|Withdrawal by Subject|0|||
105758936|NCT01419080|364769319|FG000|Overall Study|Withdrawal by Subject|75|||
105758937|NCT01419080|364769319|FG000|Overall Study|Death|30|||
105758938|NCT01419080|364769319|FG000|Overall Study|Lost to Follow-up|23|||
105758939|NCT01419080|364769319|FG000|Overall Study|Too Ill|3|||
105758940|NCT01998880|364769320|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
105758941|NCT01998880|364769321|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
105758942|NCT01998880|364769320|FG000|Overall Study|Disease Progression|1|||
105758943|NCT01998880|364769321|FG001|Overall Study|Disease Progression|8|||
105758944|NCT01998880|364769320|FG000|Overall Study|Withdrew Consent|2|||
105758945|NCT01998880|364769321|FG001|Overall Study|Withdrew Consent|1|||
105758946|NCT01998880|364769320|FG000|Overall Study|Death|3|||
105758947|NCT01998880|364769321|FG001|Overall Study|Death|6|||
105758948|NCT01998880|364769320|FG000|Overall Study|Insufficient Therapeutic Response|1|||
105758949|NCT01998880|364769321|FG001|Overall Study|Insufficient Therapeutic Response|5|||
105758950|NCT01998880|364769320|FG000|Overall Study|Administrative/Other|1|||
105758951|NCT01998880|364769321|FG001|Overall Study|Administrative/Other|1|||
105758952|NCT01998880|364769320|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
105758953|NCT01998880|364769321|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
105758954|NCT01998880|364769320|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
105758955|NCT01998880|364769321|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
105758956|NCT01998880|364769320|FG000|Overall Study|Did Not Receive Treatment|3|||
105758957|NCT01998880|364769321|FG001|Overall Study|Did Not Receive Treatment|2|||
105758958|NCT02248857|364769322|FG000|3 Month|Withdrawal by Subject|9|||
105758959|NCT02248857|364769323|FG001|3 Month|Withdrawal by Subject|3|||
105758960|NCT02248857|364769324|FG002|3 Month|Withdrawal by Subject|4|||
105758961|NCT02248857|364769322|FG000|3 Month|Unable to reach for 3 month|35|||
105758962|NCT02248857|364769323|FG001|3 Month|Unable to reach for 3 month|29|||
105758963|NCT02248857|364769324|FG002|3 Month|Unable to reach for 3 month|26|||
105758964|NCT02248857|364769322|FG000|3 Month|Partially completed, unable to finish|2|||
105758965|NCT02248857|364769323|FG001|3 Month|Partially completed, unable to finish|2|||
105758966|NCT02248857|364769324|FG002|3 Month|Partially completed, unable to finish|1|||
105758967|NCT02248857|364769322|FG000|6 Month|Lost to Follow-up|27|||
105758968|NCT02248857|364769323|FG001|6 Month|Lost to Follow-up|26|||
105758969|NCT02248857|364769324|FG002|6 Month|Lost to Follow-up|15|||
105758970|NCT02248857|364769322|FG000|6 Month|Partially completed, unable to finish|0|||
105758971|NCT02248857|364769323|FG001|6 Month|Partially completed, unable to finish|1|||
105758972|NCT02248857|364769324|FG002|6 Month|Partially completed, unable to finish|0|||
105758973|NCT02248857|364769322|FG000|6 Month|Withdrawal by Subject|0|||
105758974|NCT02248857|364769323|FG001|6 Month|Withdrawal by Subject|2|||
105758975|NCT02248857|364769324|FG002|6 Month|Withdrawal by Subject|2|||
105758976|NCT02248857|364769322|FG000|6 Month|Death|1|||
105758977|NCT02248857|364769323|FG001|6 Month|Death|0|||
105758978|NCT02248857|364769324|FG002|6 Month|Death|0|||
105758979|NCT01575899|364769327|FG000|Overall Study|Lost to Follow-up|3|||
105758980|NCT01575899|364769328|FG001|Overall Study|Lost to Follow-up|4|||
105758981|NCT01575899|364769329|FG002|Overall Study|Lost to Follow-up|2|||
105758982|NCT01575899|364769327|FG000|Overall Study|Protocol Violation|2|||
105758983|NCT01575899|364769328|FG001|Overall Study|Protocol Violation|1|||
105758984|NCT01575899|364769329|FG002|Overall Study|Protocol Violation|0|||
105758985|NCT03136367|364769330|FG000|T1 Consultation|discontinued mistakenly included|2|||
105758986|NCT03136367|364769331|FG001|T1 Consultation|discontinued mistakenly included|6|||
105758987|NCT03136367|364769332|FG002|T1 Consultation|discontinued mistakenly included|1|||
105804893|NCT02884206|364941942|FG001|Double-Blind Period|Adverse Event|0|||
105804894|NCT02884206|364941943|FG002|Double-Blind Period|Adverse Event|3|||
105804895|NCT02884206|364941941|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
105804896|NCT02884206|364941942|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
105804897|NCT02884206|364941943|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
105804898|NCT03907280|364941964|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
105804899|NCT03907280|364941965|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
105804900|NCT03907280|364941966|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
105804901|NCT05751629|364941967|FG000|Overall Study|Withdrawal by Subject|6|||
105804902|NCT05751629|364941967|FG000|Overall Study|Death|25|||
105804903|NCT05751629|364941967|FG000|Overall Study|Study Site Closed|9|||
105804904|NCT05751629|364941967|FG000|Overall Study|Physician Decision|1|||
105804905|NCT01909466|364941968|FG000|Overall Study|Lost to Follow-up|5|||
105804906|NCT01909466|364941969|FG001|Overall Study|Lost to Follow-up|7|||
105804907|NCT01909466|364941968|FG000|Overall Study|Adverse Event|3|||
105804908|NCT01909466|364941969|FG001|Overall Study|Adverse Event|4|||
105804909|NCT01909466|364941968|FG000|Overall Study|Met Withdrawal Criteria|0|||
105804910|NCT01909466|364941969|FG001|Overall Study|Met Withdrawal Criteria|3|||
105804911|NCT01909466|364941968|FG000|Overall Study|Physician Decision|2|||
105804912|NCT01909466|364941969|FG001|Overall Study|Physician Decision|0|||
105804913|NCT01909466|364941968|FG000|Overall Study|Withdrawal by Subject|11|||
105804914|NCT01909466|364941969|FG001|Overall Study|Withdrawal by Subject|9|||
105804915|NCT01909466|364941968|FG000|Overall Study|Lack of Efficacy|1|||
105804916|NCT01909466|364941969|FG001|Overall Study|Lack of Efficacy|0|||
105804917|NCT02231710|364941970|FG000|Overall Study|Physician Decision|1|||
105804918|NCT03487796|364941975|FG000|Overall Study|Lost to Follow-up|18|||
105804919|NCT03487796|364941976|FG001|Overall Study|Lost to Follow-up|6|||
105804920|NCT01894984|364941977|FG000|Overall Study|Other|314|||
105804921|NCT01894984|364941978|FG001|Overall Study|Other|175|||
105804922|NCT02555618|364941979|FG000|Overall Study|Sponsor's Circumstances|1|||
105804923|NCT02555618|364941980|FG001|Overall Study|Sponsor's Circumstances|0|||
105804924|NCT01798485|364941981|FG000|Overall Study|Adverse Event|32|||
105804925|NCT01798485|364941982|FG001|Overall Study|Adverse Event|40|||
105804926|NCT01798485|364941981|FG000|Overall Study|Withdrawal by Subject|27|||
105804927|NCT01798485|364941982|FG001|Overall Study|Withdrawal by Subject|31|||
105804928|NCT01798485|364941981|FG000|Overall Study|Lost to Follow-up|0|||
105804929|NCT01798485|364941982|FG001|Overall Study|Lost to Follow-up|3|||
105804930|NCT01798485|364941981|FG000|Overall Study|Physician Decision|14|||
105804931|NCT01798485|364941982|FG001|Overall Study|Physician Decision|10|||
105804932|NCT01798485|364941981|FG000|Overall Study|Objective Disease Progression|152|||
105804933|NCT01798485|364941982|FG001|Overall Study|Objective Disease Progression|106|||
105804934|NCT01798485|364941981|FG000|Overall Study|Death|25|||
105804935|NCT01798485|364941982|FG001|Overall Study|Death|22|||
105804936|NCT01798485|364941981|FG000|Overall Study|Sponsor Decision|61|||
105804937|NCT01798485|364941982|FG001|Overall Study|Sponsor Decision|54|||
105804938|NCT01798485|364941981|FG000|Overall Study|Clinical Progression|35|||
105804939|NCT01798485|364941982|FG001|Overall Study|Clinical Progression|24|||
105804940|NCT01620489|364941983|FG000|Overall Study|Adverse Event|17|||
105804941|NCT01620489|364941984|FG001|Overall Study|Adverse Event|4|||
105804942|NCT01620489|364941983|FG000|Overall Study|Protocol Violation|0|||
105804943|NCT01620489|364941984|FG001|Overall Study|Protocol Violation|3|||
105804944|NCT01620489|364941983|FG000|Overall Study|Withdrawal Criteria|17|||
105804945|NCT01620489|364941984|FG001|Overall Study|Withdrawal Criteria|25|||
105950550|NCT03384875|365482435|FG001|Overall Study|Reason not provided|0|||
105950551|NCT03384875|365482436|FG002|Overall Study|Reason not provided|0|||
105950552|NCT01978145|365484318|FG000|Treatment Period 1|Adverse Event|1|||
105950553|NCT01978145|365484319|FG001|Treatment Period 1|Adverse Event|9|||
105950554|NCT01978145|365484318|FG000|Treatment Period 1|Physician Decision|1|||
105950555|NCT01978145|365484319|FG001|Treatment Period 1|Physician Decision|0|||
105950556|NCT01978145|365484318|FG000|Treatment Period 1|Withdrawal by Subject|5|||
105950557|NCT01978145|365484319|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105950558|NCT01978145|365484318|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
105950559|NCT01978145|365484319|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
105950560|NCT01978145|365484318|FG000|Washout Period 1|Adverse Event|0|||
105950561|NCT01978145|365484319|FG001|Washout Period 1|Adverse Event|1|||
105950562|NCT01978145|365484318|FG000|Washout Period 1|Withdrawal by Subject|1|||
105804946|NCT01620489|364941983|FG000|Overall Study|Unclassified|1|||
105804947|NCT01620489|364941984|FG001|Overall Study|Unclassified|2|||
105804948|NCT01121900|364941985|FG000|First Intervention Period|Adverse Event|1|||
105804949|NCT01121900|364941986|FG001|First Intervention Period|Adverse Event|1|||
105804950|NCT01121900|364941985|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105804951|NCT01121900|364941986|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105804952|NCT00566709|364941991|FG000|Overall Study|Protocol Violation|5|||
105804953|NCT00566709|364941992|FG001|Overall Study|Protocol Violation|0|||
105950563|NCT01978145|365484319|FG001|Washout Period 1|Withdrawal by Subject|1|||
105950564|NCT01978145|365484318|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
105950565|NCT01978145|365484319|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
105950566|NCT01978145|365484318|FG000|Treatment Period 2|Adverse Event|3|||
105950567|NCT01978145|365484319|FG001|Treatment Period 2|Adverse Event|3|||
105950568|NCT01978145|365484318|FG000|Treatment Period 2|Protocol Violation|0|||
105758988|NCT03136367|364769330|FG000|T1 Consultation|Discontinued other|0|||
105758989|NCT03136367|364769331|FG001|T1 Consultation|Discontinued other|1|||
105758990|NCT03136367|364769332|FG002|T1 Consultation|Discontinued other|0|||
105758991|NCT03136367|364769330|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
105758992|NCT03136367|364769331|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
105758993|NCT03136367|364769332|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
105758994|NCT03136367|364769330|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
105758995|NCT03136367|364769331|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
105758996|NCT03136367|364769332|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
105758997|NCT03136367|364769330|FG000|T2 Post-consultation|Discontinued other|0|||
105758998|NCT03136367|364769331|FG001|T2 Post-consultation|Discontinued other|2|||
105758999|NCT03136367|364769332|FG002|T2 Post-consultation|Discontinued other|6|||
105759000|NCT03136367|364769330|FG000|T2 Post-consultation|Discontinued transferred care|0|||
105759001|NCT03136367|364769331|FG001|T2 Post-consultation|Discontinued transferred care|0|||
105759002|NCT03136367|364769332|FG002|T2 Post-consultation|Discontinued transferred care|3|||
105759003|NCT03136367|364769330|FG000|T2 Post-consultation|Discontinued lost contact|0|||
105759004|NCT03136367|364769331|FG001|T2 Post-consultation|Discontinued lost contact|1|||
105759005|NCT03136367|364769332|FG002|T2 Post-consultation|Discontinued lost contact|0|||
105759006|NCT03136367|364769330|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
105759007|NCT03136367|364769331|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
105759008|NCT03136367|364769332|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
105759009|NCT03136367|364769330|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
105759010|NCT03136367|364769331|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
105759011|NCT03136367|364769332|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
105759012|NCT03136367|364769330|FG000|T3 1 Week After Surgery|other discontinued|2|||
105759013|NCT03136367|364769331|FG001|T3 1 Week After Surgery|other discontinued|4|||
105759014|NCT03136367|364769332|FG002|T3 1 Week After Surgery|other discontinued|3|||
105759015|NCT03136367|364769330|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
105759016|NCT03136367|364769331|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
105759017|NCT03136367|364769332|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
105759018|NCT03136367|364769330|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
105759019|NCT03136367|364769331|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
105759020|NCT03136367|364769332|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
105759021|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
105759022|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
105759023|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
105759024|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|Death|0|||
105759025|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|Death|1|||
105759026|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|Death|3|||
105759027|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
105759028|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
105759029|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
105759030|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
105759031|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
105759032|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
105759033|NCT03136367|364769330|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
105950569|NCT01978145|365484319|FG001|Treatment Period 2|Protocol Violation|1|||
105950570|NCT01978145|365484318|FG000|Treatment Period 2|Lost to Follow-up|1|||
105950571|NCT01978145|365484319|FG001|Treatment Period 2|Lost to Follow-up|1|||
105950572|NCT01978145|365484318|FG000|Treatment Period 2|Withdrawal by Subject|7|||
105950573|NCT01978145|365484319|FG001|Treatment Period 2|Withdrawal by Subject|4|||
105950574|NCT01978145|365484318|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
105950575|NCT01978145|365484319|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
105804954|NCT01626859|364941995|FG000|Overall Study|Adverse Event|1|||
105804955|NCT01626859|364941996|FG001|Overall Study|Adverse Event|3|||
105804956|NCT01626859|364941997|FG002|Overall Study|Adverse Event|2|||
105950576|NCT02777086|365484320|FG000|Overall Study|Lost to Follow-up|96|||
105950577|NCT02777086|365484321|FG001|Overall Study|Lost to Follow-up|99|||
105759034|NCT03136367|364769331|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
105759035|NCT03136367|364769332|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
105759036|NCT03136367|364769330|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
105759037|NCT03136367|364769331|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
105759038|NCT03136367|364769332|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
105804957|NCT01626859|364941995|FG000|Overall Study|Physician Decision|0|||
105950578|NCT01770743|365484322|FG000|Overall Study|Adverse Event|1|||
105950579|NCT01770743|365484323|FG001|Overall Study|Adverse Event|0|||
105950580|NCT01770743|365484324|FG002|Overall Study|Adverse Event|0|||
105759039|NCT03136367|364769330|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
105759040|NCT03136367|364769331|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
105759041|NCT03136367|364769332|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
105759042|NCT03136367|364769330|FG000|T5 1 Year After Surgery|Death|0|||
105759043|NCT03136367|364769331|FG001|T5 1 Year After Surgery|Death|0|||
105759044|NCT03136367|364769332|FG002|T5 1 Year After Surgery|Death|1|||
105759045|NCT03136367|364769330|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
105759046|NCT03136367|364769331|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
105759047|NCT03136367|364769332|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
105759048|NCT03136367|364769330|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
105759049|NCT03136367|364769331|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
105759050|NCT03136367|364769332|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
105759051|NCT03136367|364769330|FG000|T5 1 Year After Surgery|study ended before due|31|||
105759052|NCT03136367|364769331|FG001|T5 1 Year After Surgery|study ended before due|103|||
105759053|NCT03136367|364769332|FG002|T5 1 Year After Surgery|study ended before due|110|||
105759054|NCT03136367|364769330|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
105759055|NCT03136367|364769331|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
105759056|NCT03136367|364769332|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
105759057|NCT01412151|364771493|FG000|Week 0 - 306 - Treatment Period|Death|1|||
105759058|NCT01412151|364771493|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
105759059|NCT01412151|364771493|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
105759060|NCT01412151|364771493|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
105759061|NCT02007252|364771500|FG000|Overall Study|Administrative problems|3|||
105759062|NCT02007252|364771501|FG001|Overall Study|Administrative problems|7|||
105759063|NCT02007252|364771500|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105759064|NCT02007252|364771501|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105759065|NCT02007252|364771500|FG000|Overall Study|Adverse Event|7|||
105759066|NCT02007252|364771501|FG001|Overall Study|Adverse Event|4|||
105759067|NCT04325906|364771502|FG000|Overall Study|Withdrawal by Subject|2|||
105759068|NCT04325906|364771503|FG001|Overall Study|Withdrawal by Subject|0|||
105759069|NCT02137837|364771504|FG000|Overall Study|Adverse Event|0|||
105759070|NCT02137837|364771505|FG001|Overall Study|Adverse Event|2|||
105759071|NCT02137837|364771506|FG002|Overall Study|Adverse Event|1|||
105759072|NCT02137837|364771504|FG000|Overall Study|Refusal unrelated to adverse event|2|||
105759073|NCT02137837|364771505|FG001|Overall Study|Refusal unrelated to adverse event|2|||
105759074|NCT02137837|364771506|FG002|Overall Study|Refusal unrelated to adverse event|1|||
105759075|NCT02137837|364771504|FG000|Overall Study|Progression/relapse|9|||
105759076|NCT02137837|364771505|FG001|Overall Study|Progression/relapse|7|||
105950581|NCT01770743|365484325|FG003|Overall Study|Adverse Event|0|||
105950582|NCT01770743|365484326|FG004|Overall Study|Adverse Event|0|||
105950583|NCT01770743|365484322|FG000|Overall Study|Withdrawal by Subject|0|||
105950584|NCT01770743|365484323|FG001|Overall Study|Withdrawal by Subject|0|||
105950585|NCT01770743|365484324|FG002|Overall Study|Withdrawal by Subject|1|||
105950586|NCT01770743|365484325|FG003|Overall Study|Withdrawal by Subject|1|||
105950587|NCT01770743|365484326|FG004|Overall Study|Withdrawal by Subject|1|||
105950588|NCT01770743|365484322|FG000|Overall Study|Lost to Follow-up|0|||
105950589|NCT01770743|365484323|FG001|Overall Study|Lost to Follow-up|2|||
105950590|NCT01770743|365484324|FG002|Overall Study|Lost to Follow-up|0|||
105950591|NCT01770743|365484325|FG003|Overall Study|Lost to Follow-up|0|||
105950592|NCT01770743|365484326|FG004|Overall Study|Lost to Follow-up|1|||
105950593|NCT01770743|365484322|FG000|Overall Study|Sponsor Terminated Subject|1|||
105950594|NCT01770743|365484323|FG001|Overall Study|Sponsor Terminated Subject|0|||
105950595|NCT01770743|365484324|FG002|Overall Study|Sponsor Terminated Subject|0|||
105950596|NCT01770743|365484325|FG003|Overall Study|Sponsor Terminated Subject|1|||
105950597|NCT01770743|365484326|FG004|Overall Study|Sponsor Terminated Subject|0|||
105950598|NCT01770743|365484322|FG000|Overall Study|Moving Out of State|0|||
105950599|NCT01770743|365484323|FG001|Overall Study|Moving Out of State|1|||
105950600|NCT01770743|365484324|FG002|Overall Study|Moving Out of State|0|||
105950601|NCT01770743|365484325|FG003|Overall Study|Moving Out of State|0|||
105950602|NCT01770743|365484326|FG004|Overall Study|Moving Out of State|0|||
105950603|NCT00276419|365484327|FG000|First Intervention|Adverse Event|1|||
105950604|NCT00276419|365484328|FG001|First Intervention|Adverse Event|0|||
105950605|NCT00276419|365484327|FG000|First Intervention|Withdrawal by Subject|0|||
105950606|NCT00276419|365484328|FG001|First Intervention|Withdrawal by Subject|2|||
105950607|NCT01334554|365484329|FG000|Overall Study|Adverse Event|4|||
105950608|NCT01334554|365484330|FG001|Overall Study|Adverse Event|2|||
105950609|NCT02393859|365484331|FG000|Overall Study|Decision by Sponsor|2|||
105950610|NCT02393859|365484332|FG001|Overall Study|Decision by Sponsor|4|||
105950611|NCT02393859|365484331|FG000|Overall Study|Withdrawal by Subject|11|||
105950612|NCT02393859|365484332|FG001|Overall Study|Withdrawal by Subject|6|||
105759077|NCT02137837|364771506|FG002|Overall Study|Progression/relapse|7|||
105759078|NCT02137837|364771504|FG000|Overall Study|Not protocol specified|2|||
105759079|NCT02137837|364771505|FG001|Overall Study|Not protocol specified|1|||
105759080|NCT02137837|364771506|FG002|Overall Study|Not protocol specified|3|||
105950613|NCT02393859|365484331|FG000|Overall Study|Death|27|||
105950614|NCT02393859|365484332|FG001|Overall Study|Death|10|||
105950615|NCT02393859|365484331|FG000|Overall Study|Lost to Follow-up|1|||
105950616|NCT02393859|365484332|FG001|Overall Study|Lost to Follow-up|1|||
105950617|NCT00948688|365484333|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
105950618|NCT00948688|365484334|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
105950619|NCT00948688|365484333|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
105950620|NCT00948688|365484334|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
105950621|NCT00948688|365484333|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
105950622|NCT00948688|365484334|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
105950623|NCT00524121|365484337|FG000|Overall Study|Disease progression|6|||
105950624|NCT00524121|365484337|FG000|Overall Study|Adverse Event|4|||
105950625|NCT00524121|365484337|FG000|Overall Study|Patient refused|2|||
105950626|NCT00524121|365484337|FG000|Overall Study|Other|1|||
105950627|NCT00524121|365484337|FG000|Overall Study|Death|1|||
105950628|NCT00524121|365484337|FG000|Overall Study|Not treated (became ineligible)|4|||
105950629|NCT00524121|365484337|FG000|Overall Study|Not treated (changed mind)|1|||
105950630|NCT01446874|365484338|FG000|Overall Study|Not eligible|1|||
105950631|NCT01446874|365484339|FG001|Overall Study|Not eligible|0|||
105950632|NCT01446874|365484340|FG002|Overall Study|Not eligible|0|||
105950633|NCT01446874|365484338|FG000|Overall Study|No surgery/No qualifying surgery|1|||
105950634|NCT01446874|365484339|FG001|Overall Study|No surgery/No qualifying surgery|0|||
105950635|NCT01446874|365484340|FG002|Overall Study|No surgery/No qualifying surgery|12|||
105950636|NCT01446874|365484338|FG000|Overall Study|Non-compliance|0|||
105950637|NCT01446874|365484339|FG001|Overall Study|Non-compliance|4|||
105950638|NCT01446874|365484340|FG002|Overall Study|Non-compliance|0|||
105950639|NCT01446874|365484338|FG000|Overall Study|Antibiotics for pre-op infection|0|||
105950640|NCT01446874|365484339|FG001|Overall Study|Antibiotics for pre-op infection|0|||
105950641|NCT01446874|365484340|FG002|Overall Study|Antibiotics for pre-op infection|2|||
105950642|NCT01446874|365484338|FG000|Overall Study|Withdrawal by Subject|0|||
105950643|NCT01446874|365484339|FG001|Overall Study|Withdrawal by Subject|0|||
105950644|NCT01446874|365484340|FG002|Overall Study|Withdrawal by Subject|4|||
105950645|NCT01977898|365484341|FG000|Overall Study|Non functioning catheter|1|||
105950646|NCT01977898|365484342|FG001|Overall Study|Non functioning catheter|1|||
105950647|NCT01466491|365484343|FG000|Overall Study|Protocol Violation|0|||
105950648|NCT01466491|365484344|FG001|Overall Study|Protocol Violation|3|||
105950649|NCT01466491|365484345|FG002|Overall Study|Protocol Violation|2|||
105950650|NCT01466491|365484346|FG003|Overall Study|Protocol Violation|0|||
105950651|NCT01466491|365484343|FG000|Overall Study|Missing Data|0|||
105950652|NCT01466491|365484344|FG001|Overall Study|Missing Data|0|||
105950653|NCT01466491|365484345|FG002|Overall Study|Missing Data|1|||
105950654|NCT01466491|365484346|FG003|Overall Study|Missing Data|0|||
105950655|NCT02852967|365484347|FG000|Overall Study|Adverse Event|3|||
105950656|NCT02852967|365484348|FG001|Overall Study|Adverse Event|1|||
105950657|NCT02852967|365484349|FG002|Overall Study|Adverse Event|0|||
105950658|NCT02852967|365484350|FG003|Overall Study|Adverse Event|1|||
105950659|NCT02852967|365484351|FG004|Overall Study|Adverse Event|0|||
105950660|NCT02852967|365484347|FG000|Overall Study|Death|1|||
105950661|NCT02852967|365484348|FG001|Overall Study|Death|0|||
105950662|NCT02852967|365484349|FG002|Overall Study|Death|0|||
105950663|NCT02852967|365484350|FG003|Overall Study|Death|0|||
105950664|NCT02852967|365484351|FG004|Overall Study|Death|0|||
105950665|NCT02852967|365484347|FG000|Overall Study|Lost to Follow-up|1|||
105950666|NCT02852967|365484348|FG001|Overall Study|Lost to Follow-up|2|||
105950667|NCT02852967|365484349|FG002|Overall Study|Lost to Follow-up|3|||
105950668|NCT02852967|365484350|FG003|Overall Study|Lost to Follow-up|4|||
105950669|NCT02852967|365484351|FG004|Overall Study|Lost to Follow-up|4|||
105950670|NCT02852967|365484347|FG000|Overall Study|Withdrawal by Subject|6|||
105950671|NCT02852967|365484348|FG001|Overall Study|Withdrawal by Subject|12|||
105950672|NCT02852967|365484349|FG002|Overall Study|Withdrawal by Subject|7|||
105950673|NCT02852967|365484350|FG003|Overall Study|Withdrawal by Subject|10|||
105950674|NCT02852967|365484351|FG004|Overall Study|Withdrawal by Subject|10|||
105950675|NCT02852967|365484347|FG000|Overall Study|SAE|0|||
105950676|NCT02852967|365484348|FG001|Overall Study|SAE|0|||
105950677|NCT02852967|365484349|FG002|Overall Study|SAE|0|||
105950678|NCT02852967|365484350|FG003|Overall Study|SAE|3|||
105950679|NCT02852967|365484351|FG004|Overall Study|SAE|0|||
105950680|NCT02852967|365484347|FG000|Overall Study|Elevated Liver Enzymes|2|||
105804958|NCT01626859|364941996|FG001|Overall Study|Physician Decision|1|||
106016626|NCT01918306|365724478|FG000|Overall Study|Withdrawal by Subject|0|||
105950681|NCT02852967|365484348|FG001|Overall Study|Elevated Liver Enzymes|0|||
105950682|NCT02852967|365484349|FG002|Overall Study|Elevated Liver Enzymes|0|||
105950683|NCT02852967|365484350|FG003|Overall Study|Elevated Liver Enzymes|2|||
105950684|NCT02852967|365484351|FG004|Overall Study|Elevated Liver Enzymes|2|||
105950685|NCT02852967|365484347|FG000|Overall Study|Physician Decision|0|||
106016627|NCT01918306|365724479|FG001|Overall Study|Withdrawal by Subject|0|||
105950686|NCT02852967|365484348|FG001|Overall Study|Physician Decision|0|||
105950687|NCT02852967|365484349|FG002|Overall Study|Physician Decision|0|||
105950688|NCT02852967|365484350|FG003|Overall Study|Physician Decision|1|||
105950689|NCT02852967|365484351|FG004|Overall Study|Physician Decision|0|||
105950690|NCT02852967|365484347|FG000|Overall Study|Lack of Efficacy|0|||
105950691|NCT02852967|365484348|FG001|Overall Study|Lack of Efficacy|1|||
105950692|NCT02852967|365484349|FG002|Overall Study|Lack of Efficacy|0|||
105950693|NCT02852967|365484350|FG003|Overall Study|Lack of Efficacy|0|||
105950694|NCT02852967|365484351|FG004|Overall Study|Lack of Efficacy|0|||
105950695|NCT02852967|365484347|FG000|Overall Study|Non-compliance|0|||
105950696|NCT02852967|365484348|FG001|Overall Study|Non-compliance|0|||
105950697|NCT02852967|365484349|FG002|Overall Study|Non-compliance|1|||
105950698|NCT02852967|365484350|FG003|Overall Study|Non-compliance|1|||
105950699|NCT02852967|365484351|FG004|Overall Study|Non-compliance|0|||
105950700|NCT02852967|365484347|FG000|Overall Study|Dispensing Drug Violation|0|||
105950701|NCT02852967|365484348|FG001|Overall Study|Dispensing Drug Violation|0|||
105950702|NCT02852967|365484349|FG002|Overall Study|Dispensing Drug Violation|1|||
105950703|NCT02852967|365484350|FG003|Overall Study|Dispensing Drug Violation|0|||
105950704|NCT02852967|365484351|FG004|Overall Study|Dispensing Drug Violation|0|||
105950705|NCT02852967|365484347|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
105950706|NCT02852967|365484348|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
105950707|NCT02852967|365484349|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
105950708|NCT02852967|365484350|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
105950709|NCT02852967|365484351|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
105950710|NCT00339040|365484352|FG000|Stage I|Not able to attend clinic|1|||
105950711|NCT00339040|365484353|FG001|Stage I|Not able to attend clinic|0|||
105950712|NCT00339040|365484352|FG000|Stage I|Protocol Violation|1|||
105950713|NCT00339040|365484353|FG001|Stage I|Protocol Violation|1|||
105950714|NCT00339040|365484352|FG000|Stage II|Lost to Follow-up|3|||
105950715|NCT00339040|365484353|FG001|Stage II|Lost to Follow-up|0|||
105950716|NCT00339040|365484352|FG000|Stage II|Withdrawal by Subject|1|||
105950717|NCT00339040|365484353|FG001|Stage II|Withdrawal by Subject|2|||
105950718|NCT00339040|365484352|FG000|Stage II|Protocol Violation|3|||
105950719|NCT00339040|365484353|FG001|Stage II|Protocol Violation|0|||
105950720|NCT00339040|365484352|FG000|Stage II|Not able to attend clinic|1|||
105950721|NCT00339040|365484353|FG001|Stage II|Not able to attend clinic|0|||
105950722|NCT00339040|365484352|FG000|Stage II|Site closing|2|||
105950723|NCT00339040|365484353|FG001|Stage II|Site closing|0|||
105950724|NCT03341637|365484354|FG000|Overall Study|Lost to Follow-up|1|||
105950725|NCT03341637|365484355|FG001|Overall Study|Lost to Follow-up|0|||
105950726|NCT03341637|365484354|FG000|Overall Study|Withdrawal by Subject|3|||
105950727|NCT03341637|365484355|FG001|Overall Study|Withdrawal by Subject|3|||
105950728|NCT03341637|365484354|FG000|Overall Study|Reason not Specified|1|||
105950729|NCT03341637|365484355|FG001|Overall Study|Reason not Specified|1|||
105950730|NCT01146613|365484356|FG000|Overall Study|Lost to Follow-up|3|||
105950731|NCT01146613|365484357|FG001|Overall Study|Lost to Follow-up|8|||
105950732|NCT01146613|365484356|FG000|Overall Study|Lack of Efficacy|0|||
105950733|NCT01146613|365484357|FG001|Overall Study|Lack of Efficacy|1|||
105950734|NCT01146613|365484356|FG000|Overall Study|Death|1|||
105950735|NCT01146613|365484357|FG001|Overall Study|Death|0|||
105950736|NCT01146613|365484356|FG000|Overall Study|Physician Decision|1|||
105950737|NCT01146613|365484357|FG001|Overall Study|Physician Decision|0|||
105950738|NCT01146613|365484356|FG000|Overall Study|Withdrawal by Subject|0|||
105950739|NCT01146613|365484357|FG001|Overall Study|Withdrawal by Subject|3|||
105950740|NCT01146613|365484356|FG000|Overall Study|schedule conflict|1|||
105950741|NCT01146613|365484357|FG001|Overall Study|schedule conflict|0|||
105950742|NCT01146613|365484356|FG000|Overall Study|Outpatient detox|1|||
105950743|NCT01146613|365484357|FG001|Overall Study|Outpatient detox|0|||
105950744|NCT00812955|365484358|FG000|Overall Study|Adverse Event|7|||
105950745|NCT00812955|365484359|FG001|Overall Study|Adverse Event|6|||
105950746|NCT00812955|365484360|FG002|Overall Study|Adverse Event|3|||
105950747|NCT00812955|365484361|FG003|Overall Study|Adverse Event|4|||
105950748|NCT00812955|365484358|FG000|Overall Study|Lost to Follow-up|2|||
105950749|NCT00812955|365484359|FG001|Overall Study|Lost to Follow-up|1|||
105950750|NCT00812955|365484360|FG002|Overall Study|Lost to Follow-up|1|||
105950751|NCT00812955|365484361|FG003|Overall Study|Lost to Follow-up|2|||
105950752|NCT00812955|365484358|FG000|Overall Study|Withdrawal by Subject|1|||
105950753|NCT00812955|365484359|FG001|Overall Study|Withdrawal by Subject|0|||
105950754|NCT00812955|365484360|FG002|Overall Study|Withdrawal by Subject|1|||
105950755|NCT00812955|365484361|FG003|Overall Study|Withdrawal by Subject|2|||
105950756|NCT00812955|365484358|FG000|Overall Study|randomized in error|0|||
105950757|NCT00812955|365484359|FG001|Overall Study|randomized in error|0|||
105950758|NCT00812955|365484360|FG002|Overall Study|randomized in error|1|||
105950759|NCT00812955|365484361|FG003|Overall Study|randomized in error|0|||
105950760|NCT00325143|365484362|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
105950761|NCT00325143|365484362|FG000|Overall Study|Migrated/moved from study area|1|||
105950762|NCT00325143|365484362|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
106016628|NCT01918306|365724480|FG002|Overall Study|Withdrawal by Subject|0|||
106016629|NCT01918306|365724481|FG003|Overall Study|Withdrawal by Subject|2|||
105950763|NCT00325143|365484362|FG000|Overall Study|Withdrawal by Subject|8|||
105950764|NCT03036852|365484363|FG000|Overall Study|Death|2|||
105950765|NCT03036852|365484363|FG000|Overall Study|Lack of Efficacy|2|||
105950766|NCT03036852|365484363|FG000|Overall Study|Adverse Event|1|||
105950767|NCT03036852|365484363|FG000|Overall Study|Lost to Follow-up|1|||
105950768|NCT00742625|365484364|FG000|Remission Induction|Progression|6|||
105950769|NCT00742625|365484364|FG000|Remission Induction|Failed induction|8|||
105950770|NCT00742625|365484364|FG000|Remission Induction|Adverse Event|3|||
105950771|NCT00742625|365484364|FG000|Remission Induction|Death|10|||
105950772|NCT00742625|365484364|FG000|Remission Induction|Refusal|5|||
105950773|NCT00742625|365484364|FG000|Remission Induction|Non protocol treatment|17|||
105950774|NCT00742625|365484364|FG000|Remission Induction|Other, not specified|5|||
105950775|NCT00742625|365484364|FG000|Consolidation|Progression|5|||
105950776|NCT00742625|365484364|FG000|Consolidation|Adverse Event|1|||
105950777|NCT00742625|365484364|FG000|Consolidation|Death|1|||
105950778|NCT00742625|365484364|FG000|Consolidation|Refused|1|||
105950779|NCT00742625|365484364|FG000|Consolidation|Non protocol therapy|13|||
105950780|NCT02897115|365484365|FG000|Overall Study|Early termination of study by sponsor|11|||
105950781|NCT02897115|365484366|FG001|Overall Study|Early termination of study by sponsor|8|||
105950782|NCT03848416|365484369|FG000|Overall Study|Withdrawal by Subject|1|||
105950783|NCT03848416|365484370|FG001|Overall Study|Withdrawal by Subject|0|||
105950784|NCT03848416|365484371|FG002|Overall Study|Withdrawal by Subject|0|||
105950785|NCT03848416|365484369|FG000|Overall Study|Death|0|||
105950786|NCT03848416|365484370|FG001|Overall Study|Death|0|||
105950787|NCT03848416|365484371|FG002|Overall Study|Death|1|||
105950788|NCT01908140|365484372|FG000|Overall Study|Other or Progressive Disease|5|||
105950789|NCT01908140|365484373|FG001|Overall Study|Other or Progressive Disease|12|||
105950790|NCT01908140|365484372|FG000|Overall Study|Lack of Efficacy|7|||
105950791|NCT01908140|365484373|FG001|Overall Study|Lack of Efficacy|5|||
105950792|NCT01908140|365484372|FG000|Overall Study|Withdrawal by Subject|23|||
105950793|NCT01908140|365484373|FG001|Overall Study|Withdrawal by Subject|24|||
105950794|NCT01908140|365484372|FG000|Overall Study|Lost to Follow-up|1|||
105950795|NCT01908140|365484373|FG001|Overall Study|Lost to Follow-up|6|||
105950796|NCT01908140|365484372|FG000|Overall Study|Protocol Violation|8|||
105950797|NCT01908140|365484373|FG001|Overall Study|Protocol Violation|9|||
105950798|NCT01908140|365484372|FG000|Overall Study|Adverse Event|22|||
105950799|NCT01908140|365484373|FG001|Overall Study|Adverse Event|23|||
105950800|NCT02639390|365484374|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
105950801|NCT02639390|365484375|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
105950802|NCT03273907|365484377|FG000|Overall Study|Death|1|||
105950803|NCT03273907|365484377|FG000|Overall Study|Lost to Follow-up|4|||
105950804|NCT03273907|365484377|FG000|Overall Study|Withdrawal by Subject|2|||
105950805|NCT03273907|365484377|FG000|Overall Study|COVID 19|2|||
105950806|NCT01331681|365484382|FG000|Overall Study|Adverse Event|10|||
105950807|NCT01331681|365484383|FG001|Overall Study|Adverse Event|13|||
105950808|NCT01331681|365484384|FG002|Overall Study|Adverse Event|10|||
105950809|NCT01331681|365484382|FG000|Overall Study|Death|6|||
105950810|NCT01331681|365484383|FG001|Overall Study|Death|6|||
105950811|NCT01331681|365484384|FG002|Overall Study|Death|2|||
105950812|NCT01331681|365484382|FG000|Overall Study|Lack of Efficacy|0|||
105950813|NCT01331681|365484383|FG001|Overall Study|Lack of Efficacy|1|||
105950814|NCT01331681|365484384|FG002|Overall Study|Lack of Efficacy|0|||
105950815|NCT01331681|365484382|FG000|Overall Study|Withdrawal by Subject|12|||
105950816|NCT01331681|365484383|FG001|Overall Study|Withdrawal by Subject|8|||
105950817|NCT01331681|365484384|FG002|Overall Study|Withdrawal by Subject|15|||
105950818|NCT01331681|365484382|FG000|Overall Study|Protocol Violation|1|||
105950819|NCT01331681|365484383|FG001|Overall Study|Protocol Violation|1|||
105950820|NCT01331681|365484384|FG002|Overall Study|Protocol Violation|0|||
105950821|NCT01331681|365484382|FG000|Overall Study|Lost to Follow-up|2|||
105950822|NCT01331681|365484383|FG001|Overall Study|Lost to Follow-up|4|||
105950823|NCT01331681|365484384|FG002|Overall Study|Lost to Follow-up|1|||
105950824|NCT01331681|365484382|FG000|Overall Study|Physician Decision|2|||
105950825|NCT01331681|365484383|FG001|Overall Study|Physician Decision|0|||
105950826|NCT01331681|365484384|FG002|Overall Study|Physician Decision|4|||
105950827|NCT01331681|365484382|FG000|Overall Study|Therapeutic procedure required|1|||
105950828|NCT01331681|365484383|FG001|Overall Study|Therapeutic procedure required|0|||
105950829|NCT01331681|365484384|FG002|Overall Study|Therapeutic procedure required|0|||
105950830|NCT01331681|365484382|FG000|Overall Study|Sponsor decision|1|||
105950831|NCT01331681|365484383|FG001|Overall Study|Sponsor decision|1|||
105950832|NCT01331681|365484384|FG002|Overall Study|Sponsor decision|0|||
105950833|NCT01331681|365484382|FG000|Overall Study|Switching to other therapy|0|||
105950834|NCT01331681|365484383|FG001|Overall Study|Switching to other therapy|0|||
105950835|NCT01331681|365484384|FG002|Overall Study|Switching to other therapy|1|||
105950836|NCT01331681|365484382|FG000|Overall Study|Not Received Study Treatment|0|||
105950837|NCT01331681|365484383|FG001|Overall Study|Not Received Study Treatment|0|||
105950838|NCT01331681|365484384|FG002|Overall Study|Not Received Study Treatment|2|||
105950839|NCT00616642|365484385|FG000|Overall Study|Withdrawal by Subject|0|||
105950840|NCT00616642|365484386|FG001|Overall Study|Withdrawal by Subject|1|||
105950841|NCT03886493|365484387|FG000|Overall Study|Adverse Event|1|||
105950842|NCT01023217|365484390|FG000|Overall Study|Withdrawal by Subject|1|||
105950843|NCT01023217|365484391|FG001|Overall Study|Withdrawal by Subject|0|||
105950844|NCT00589797|365484392|FG000|Overall Study|Death|1|||
105950845|NCT00589797|365484393|FG001|Overall Study|Death|0|||
105950846|NCT00589797|365484392|FG000|Overall Study|Lost to Follow-up|12|||
105950847|NCT00589797|365484393|FG001|Overall Study|Lost to Follow-up|9|||
105950848|NCT00589797|365484392|FG000|Overall Study|Physician Decision|8|||
105950849|NCT00589797|365484393|FG001|Overall Study|Physician Decision|3|||
105950850|NCT00589797|365484392|FG000|Overall Study|Withdrawal by Subject|6|||
105950851|NCT00589797|365484393|FG001|Overall Study|Withdrawal by Subject|5|||
105950852|NCT00589797|365484392|FG000|Overall Study|Non-Randomized Training Subjects|46|||
105950853|NCT00589797|365484393|FG001|Overall Study|Non-Randomized Training Subjects|6|||
105950854|NCT00658541|365484394|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
105950855|NCT00658541|365484395|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105950856|NCT00658541|365484394|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105950857|NCT00658541|365484395|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105950858|NCT05518461|365484396|FG000|Overall Study|Lost to Follow-up|25|||
105950859|NCT03326063|365484399|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
105950860|NCT03326063|365484400|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
105950861|NCT00501644|365484401|FG000|Overall Study|Adverse Event|4|||
105950862|NCT00501644|365484401|FG000|Overall Study|Withdrawal by Subject|1|||
105950863|NCT02394561|365484402|FG000|CORE Phase|Adverse Event|7|||
105950864|NCT02394561|365484403|FG001|CORE Phase|Adverse Event|9|||
105950865|NCT02394561|365484402|FG000|CORE Phase|Death|0|||
105950866|NCT02394561|365484403|FG001|CORE Phase|Death|1|||
105950867|NCT02394561|365484402|FG000|CORE Phase|Pregnancy|1|||
105950868|NCT02394561|365484403|FG001|CORE Phase|Pregnancy|0|||
105950869|NCT02394561|365484402|FG000|CORE Phase|Lost to Follow-up|1|||
105950870|NCT02394561|365484403|FG001|CORE Phase|Lost to Follow-up|0|||
105950871|NCT02394561|365484402|FG000|CORE Phase|Physician Decision|1|||
105950872|NCT02394561|365484403|FG001|CORE Phase|Physician Decision|1|||
105950873|NCT02394561|365484402|FG000|CORE Phase|Withdrawal by Subject|2|||
105950874|NCT02394561|365484403|FG001|CORE Phase|Withdrawal by Subject|2|||
105950875|NCT02394561|365484402|FG000|CORE Phase|Lack of Efficacy|1|||
105950876|NCT02394561|365484403|FG001|CORE Phase|Lack of Efficacy|6|||
105950877|NCT02394561|365484402|FG000|Extension Phase|Adverse Event|6|||
105759081|NCT02141217|364771507|FG000|Overall Study|Adverse Event|1|||
105759082|NCT02141217|364771508|FG001|Overall Study|Adverse Event|2|||
105759083|NCT02141217|364771507|FG000|Overall Study|Protocol Violation|1|||
105950878|NCT02394561|365484403|FG001|Extension Phase|Adverse Event|1|||
105950879|NCT02394561|365484402|FG000|Extension Phase|Death|0|||
105950880|NCT02394561|365484403|FG001|Extension Phase|Death|1|||
105950881|NCT02394561|365484402|FG000|Extension Phase|Protocol Violation|1|||
105950882|NCT02394561|365484403|FG001|Extension Phase|Protocol Violation|0|||
105950883|NCT02394561|365484402|FG000|Extension Phase|Lost to Follow-up|1|||
105950884|NCT02394561|365484403|FG001|Extension Phase|Lost to Follow-up|0|||
105950885|NCT02394561|365484402|FG000|Extension Phase|Physician Decision|0|||
105950886|NCT02394561|365484403|FG001|Extension Phase|Physician Decision|2|||
105950887|NCT02394561|365484402|FG000|Extension Phase|Withdrawal by Subject|0|||
105950888|NCT02394561|365484403|FG001|Extension Phase|Withdrawal by Subject|5|||
105950889|NCT02394561|365484402|FG000|Extension Phase|Lack of Efficacy|3|||
105950890|NCT02394561|365484403|FG001|Extension Phase|Lack of Efficacy|3|||
105950891|NCT02553629|365484404|FG000|Overall Study|Logistic reasons|3|||
105950892|NCT02553629|365484405|FG001|Overall Study|Logistic reasons|6|||
105950893|NCT02803203|365484406|FG000|Overall Study|Adverse Event|4|||
105950894|NCT02803203|365484406|FG000|Overall Study|Death|4|||
105950895|NCT02803203|365484406|FG000|Overall Study|Progressive disease|29|||
105950896|NCT02803203|365484406|FG000|Overall Study|Withdrawal by Subject|8|||
105950897|NCT02803203|365484406|FG000|Overall Study|Complete resection of target disease|2|||
105950898|NCT02803203|365484406|FG000|Overall Study|Switched to commercial Osi|1|||
105950899|NCT02803203|365484406|FG000|Overall Study|Participant moved away|1|||
105950900|NCT04577781|365484407|FG000|Overall Study|Adverse Event|2|||
105950901|NCT04577781|365484408|FG001|Overall Study|Adverse Event|2|||
105950902|NCT04577781|365484407|FG000|Overall Study|Physician Decision|1|||
105950903|NCT04577781|365484408|FG001|Overall Study|Physician Decision|0|||
105950904|NCT01464879|365484409|FG000|Overall Study|Physician Decision|1|||
105950905|NCT01464879|365484409|FG000|Overall Study|Non-compliance|1|||
105950906|NCT02712788|365484416|FG000|Overall Study|Physician Decision|1|||
105950907|NCT02712788|365484417|FG001|Overall Study|Physician Decision|0|||
105950908|NCT02712788|365484416|FG000|Overall Study|Protocol Violation|1|||
105950909|NCT02712788|365484417|FG001|Overall Study|Protocol Violation|0|||
105950910|NCT00127855|365484418|FG000|Primary Vaccination Course|Adverse Event|0|||
105950911|NCT00127855|365484419|FG001|Primary Vaccination Course|Adverse Event|0|||
105950912|NCT00127855|365484420|FG002|Primary Vaccination Course|Adverse Event|1|||
105950913|NCT00127855|365484421|FG003|Primary Vaccination Course|Adverse Event|0|||
105950914|NCT00127855|365484422|FG004|Primary Vaccination Course|Adverse Event|0|||
105950915|NCT00127855|365484418|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
105950916|NCT00127855|365484419|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
105950917|NCT00127855|365484420|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
105950918|NCT00127855|365484421|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
105950919|NCT00127855|365484422|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
105950920|NCT00127855|365484418|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
105950921|NCT00127855|365484419|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
105950922|NCT00127855|365484420|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
105950923|NCT00127855|365484421|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
105950924|NCT00127855|365484422|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
105950925|NCT00127855|365484418|FG000|Primary Vaccination Course|Other|0|||
105950926|NCT00127855|365484419|FG001|Primary Vaccination Course|Other|0|||
105950927|NCT00127855|365484420|FG002|Primary Vaccination Course|Other|0|||
105950928|NCT00127855|365484421|FG003|Primary Vaccination Course|Other|0|||
105950929|NCT00127855|365484422|FG004|Primary Vaccination Course|Other|1|||
105950930|NCT02343302|365484423|FG000|Overall Study|Physician Decision|1|||
105950931|NCT02343302|365484424|FG001|Overall Study|Physician Decision|1|||
105950932|NCT00508482|365484425|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
105950933|NCT00508482|365484426|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
105950934|NCT00508482|365484427|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
105950935|NCT00508482|365484425|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
105950936|NCT00508482|365484426|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
105950937|NCT00508482|365484427|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
105950938|NCT00508482|365484425|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
105950939|NCT00508482|365484426|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
105950940|NCT00508482|365484427|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
105950941|NCT02289469|365484428|FG000|Overall Study|Unable to match a control|6|||
105950942|NCT02289469|365484429|FG001|Overall Study|Unable to match a control|0|||
105950943|NCT02834819|365484433|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
105950944|NCT02834819|365484434|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
105950945|NCT01904721|365484436|FG000|Overall Study|Other Reasons|0|||
105950946|NCT01904721|365484437|FG001|Overall Study|Other Reasons|0|||
105950947|NCT01904721|365484438|FG002|Overall Study|Other Reasons|1|||
105950948|NCT01904721|365484439|FG003|Overall Study|Other Reasons|1|||
105950949|NCT01904721|365484440|FG004|Overall Study|Other Reasons|2|||
105950950|NCT01904721|365484441|FG005|Overall Study|Other Reasons|2|||
105950951|NCT01904721|365484442|FG006|Overall Study|Other Reasons|2|||
105950952|NCT01904721|365484436|FG000|Overall Study|Personal Reasons|0|||
105950953|NCT01904721|365484437|FG001|Overall Study|Personal Reasons|0|||
105950954|NCT01904721|365484438|FG002|Overall Study|Personal Reasons|0|||
105950955|NCT01904721|365484439|FG003|Overall Study|Personal Reasons|0|||
105950956|NCT01904721|365484440|FG004|Overall Study|Personal Reasons|2|||
105950957|NCT01904721|365484441|FG005|Overall Study|Personal Reasons|3|||
105759084|NCT02141217|364771508|FG001|Overall Study|Protocol Violation|4|||
105950958|NCT01904721|365484442|FG006|Overall Study|Personal Reasons|3|||
105950959|NCT01904721|365484436|FG000|Overall Study|Lost to Follow-up|0|||
105950960|NCT01904721|365484437|FG001|Overall Study|Lost to Follow-up|0|||
105950961|NCT01904721|365484438|FG002|Overall Study|Lost to Follow-up|0|||
105950962|NCT01904721|365484439|FG003|Overall Study|Lost to Follow-up|0|||
105950963|NCT01904721|365484440|FG004|Overall Study|Lost to Follow-up|1|||
105950964|NCT01904721|365484441|FG005|Overall Study|Lost to Follow-up|3|||
105950965|NCT01904721|365484442|FG006|Overall Study|Lost to Follow-up|1|||
105950966|NCT01904721|365484436|FG000|Overall Study|Lack of Efficacy|0|||
105759085|NCT02141217|364771507|FG000|Overall Study|Withdrawal by Subject|6|||
105759086|NCT02141217|364771508|FG001|Overall Study|Withdrawal by Subject|0|||
105950967|NCT01904721|365484437|FG001|Overall Study|Lack of Efficacy|0|||
105950968|NCT01904721|365484438|FG002|Overall Study|Lack of Efficacy|0|||
105950969|NCT01904721|365484439|FG003|Overall Study|Lack of Efficacy|0|||
105950970|NCT01904721|365484440|FG004|Overall Study|Lack of Efficacy|0|||
105950971|NCT01904721|365484441|FG005|Overall Study|Lack of Efficacy|0|||
105950972|NCT01904721|365484442|FG006|Overall Study|Lack of Efficacy|1|||
105950973|NCT01904721|365484436|FG000|Overall Study|Adverse Event|0|||
105950974|NCT01904721|365484437|FG001|Overall Study|Adverse Event|0|||
105950975|NCT01904721|365484438|FG002|Overall Study|Adverse Event|0|||
105950976|NCT01904721|365484439|FG003|Overall Study|Adverse Event|0|||
105950977|NCT01904721|365484440|FG004|Overall Study|Adverse Event|3|||
105950978|NCT01904721|365484441|FG005|Overall Study|Adverse Event|1|||
105950979|NCT01904721|365484442|FG006|Overall Study|Adverse Event|0|||
105950980|NCT01957865|365484443|FG000|Overall Study|Found HIV negative|0|||
105950981|NCT01957865|365484444|FG001|Overall Study|Found HIV negative|0|||
105950982|NCT01957865|365484445|FG002|Overall Study|Found HIV negative|1|||
105950983|NCT01957865|365484443|FG000|Overall Study|Lost to Follow-up|0|||
105950984|NCT01957865|365484444|FG001|Overall Study|Lost to Follow-up|2|||
105950985|NCT01957865|365484445|FG002|Overall Study|Lost to Follow-up|2|||
105950986|NCT01082614|365484446|FG000|Overall Study|Adverse Event|1|||
105950987|NCT01082614|365484447|FG001|Overall Study|Adverse Event|4|||
105950988|NCT01082614|365484446|FG000|Overall Study|Equipment Malfunction|0|||
105950989|NCT01082614|365484447|FG001|Overall Study|Equipment Malfunction|1|||
105950990|NCT01082614|365484446|FG000|Overall Study|Physician Decision|2|||
105950991|NCT01082614|365484447|FG001|Overall Study|Physician Decision|0|||
105950992|NCT01240863|365484448|FG000|Open-label Titration Period|Adverse Event|47|||
105950993|NCT01240863|365484449|FG001|Open-label Titration Period|Adverse Event|0|||
105950994|NCT01240863|365484450|FG002|Open-label Titration Period|Adverse Event|0|||
105950995|NCT01240863|365484448|FG000|Open-label Titration Period|Lack of Efficacy|19|||
105950996|NCT01240863|365484449|FG001|Open-label Titration Period|Lack of Efficacy|0|||
105950997|NCT01240863|365484450|FG002|Open-label Titration Period|Lack of Efficacy|0|||
105950998|NCT01240863|365484448|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
105950999|NCT01240863|365484449|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
105951000|NCT01240863|365484450|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
105951001|NCT01240863|365484448|FG000|Open-label Titration Period|Protocol Violation|7|||
105951002|NCT01240863|365484449|FG001|Open-label Titration Period|Protocol Violation|0|||
105951003|NCT01240863|365484450|FG002|Open-label Titration Period|Protocol Violation|0|||
105951004|NCT01240863|365484448|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
105951005|NCT01240863|365484449|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
105951006|NCT01240863|365484450|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
105951007|NCT01240863|365484448|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
105951008|NCT01240863|365484449|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
105951009|NCT01240863|365484450|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
105951010|NCT01240863|365484448|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
105951011|NCT01240863|365484449|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
105951012|NCT01240863|365484450|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
105951013|NCT01240863|365484448|FG000|Open-label Titration Period|Other|7|||
105951014|NCT01240863|365484449|FG001|Open-label Titration Period|Other|0|||
105951015|NCT01240863|365484450|FG002|Open-label Titration Period|Other|0|||
105951016|NCT01240863|365484448|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
105951017|NCT01240863|365484449|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
105951018|NCT01240863|365484450|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
105951019|NCT01240863|365484448|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105951020|NCT01240863|365484449|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
105951021|NCT01240863|365484450|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
105951022|NCT01240863|365484448|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105951023|NCT01240863|365484449|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
105951024|NCT01240863|365484450|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
105951025|NCT01240863|365484448|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
105951026|NCT01240863|365484449|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
105951027|NCT01240863|365484450|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
105951028|NCT01240863|365484448|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
105951029|NCT01240863|365484449|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
105951030|NCT01240863|365484450|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
105951031|NCT01240863|365484448|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
105951032|NCT01240863|365484449|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
105951033|NCT01240863|365484450|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
105951034|NCT01240863|365484448|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
105951035|NCT01240863|365484449|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
105804959|NCT01626859|364941997|FG002|Overall Study|Physician Decision|0|||
105804960|NCT01626859|364941995|FG000|Overall Study|Withdrawal by Subject|1|||
105804961|NCT01626859|364941996|FG001|Overall Study|Withdrawal by Subject|4|||
105804962|NCT01626859|364941997|FG002|Overall Study|Withdrawal by Subject|2|||
105804963|NCT02330081|364941998|FG000|Overall Study|Adverse Event|1|||
105804964|NCT02330081|364941998|FG000|Overall Study|Donation did not meet criteria|1|||
105804965|NCT02330081|364941998|FG000|Overall Study|Protocol Violation|6|||
105804966|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
105804967|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
105804968|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
105804969|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
105804970|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
105804971|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
105804972|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
105804973|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
105804974|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
105804975|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
105951036|NCT01240863|365484450|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
105951037|NCT01240863|365484448|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
105951038|NCT01240863|365484449|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
105951039|NCT01240863|365484450|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
105951040|NCT01077063|365484451|FG000|Overall Study|Adverse Event|3|||
105951041|NCT01077063|365484452|FG001|Overall Study|Adverse Event|0|||
105951042|NCT01077063|365484451|FG000|Overall Study|Death|1|||
105951043|NCT01077063|365484452|FG001|Overall Study|Death|1|||
105951044|NCT01077063|365484451|FG000|Overall Study|Withdrawal by Subject|0|||
105951045|NCT01077063|365484452|FG001|Overall Study|Withdrawal by Subject|2|||
105951046|NCT02750930|365484453|FG000|Overall Study|Study closed/terminated|8|||
105951047|NCT03894891|365484454|FG000|Overall Study|Withdrawal by Subject|1|||
105951048|NCT03894891|365484454|FG000|Overall Study|Completed protocol treatment per protocol|5|||
105951049|NCT00553631|365484458|FG000|Overall Study|Withdrawal by Subject|0|||
105951050|NCT00553631|365484459|FG001|Overall Study|Withdrawal by Subject|1|||
105951051|NCT00553631|365484458|FG000|Overall Study|Lost to Follow-up|1|||
105951052|NCT00553631|365484459|FG001|Overall Study|Lost to Follow-up|0|||
105951053|NCT03710889|365484462|FG000|Overall Study|Adverse Event|2|||
105951054|NCT03710889|365484462|FG000|Overall Study|Protocol Deviation|1|||
105951055|NCT02756403|365484463|FG000|Overall Study|Unable to swallow medication|0|||
105951056|NCT02756403|365484464|FG001|Overall Study|Unable to swallow medication|1|||
105951057|NCT02756403|365484465|FG002|Overall Study|Unable to swallow medication|1|||
105951058|NCT02756403|365484466|FG003|Overall Study|Unable to swallow medication|1|||
105951059|NCT02756403|365484463|FG000|Overall Study|Did not complete Procedure|0|||
105951060|NCT02756403|365484464|FG001|Overall Study|Did not complete Procedure|1|||
105951061|NCT02756403|365484465|FG002|Overall Study|Did not complete Procedure|0|||
105951062|NCT02756403|365484466|FG003|Overall Study|Did not complete Procedure|0|||
105951063|NCT02756403|365484463|FG000|Overall Study|Changed Mind About Procedure|0|||
105951064|NCT02756403|365484464|FG001|Overall Study|Changed Mind About Procedure|0|||
105951065|NCT02756403|365484465|FG002|Overall Study|Changed Mind About Procedure|1|||
105951066|NCT02756403|365484466|FG003|Overall Study|Changed Mind About Procedure|0|||
105951067|NCT02756403|365484463|FG000|Overall Study|Protocol Violation|0|||
105951068|NCT02756403|365484464|FG001|Overall Study|Protocol Violation|1|||
105951069|NCT02756403|365484465|FG002|Overall Study|Protocol Violation|0|||
105951070|NCT02756403|365484466|FG003|Overall Study|Protocol Violation|1|||
105951071|NCT01644643|365484467|FG000|Overall Study|Death|1|||
105951072|NCT01644643|365484468|FG001|Overall Study|Death|0|||
105951073|NCT01644643|365484469|FG002|Overall Study|Death|3|||
105951074|NCT01644643|365484470|FG003|Overall Study|Death|3|||
105951075|NCT01644643|365484467|FG000|Overall Study|Lost to Follow-up|0|||
105951076|NCT01644643|365484468|FG001|Overall Study|Lost to Follow-up|0|||
105951077|NCT01644643|365484469|FG002|Overall Study|Lost to Follow-up|0|||
105951078|NCT01644643|365484470|FG003|Overall Study|Lost to Follow-up|4|||
105951079|NCT01644643|365484467|FG000|Overall Study|Withdrawal by Subject|1|||
105951080|NCT01644643|365484468|FG001|Overall Study|Withdrawal by Subject|0|||
105951081|NCT01644643|365484469|FG002|Overall Study|Withdrawal by Subject|2|||
105951082|NCT01644643|365484470|FG003|Overall Study|Withdrawal by Subject|1|||
105951083|NCT01644643|365484467|FG000|Overall Study|Other Eligibility criteria|0|||
105951084|NCT01644643|365484468|FG001|Overall Study|Other Eligibility criteria|0|||
105951085|NCT01644643|365484469|FG002|Overall Study|Other Eligibility criteria|0|||
105804976|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
105804977|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
105951086|NCT01644643|365484470|FG003|Overall Study|Other Eligibility criteria|2|||
105951087|NCT00469833|365484473|FG000|Overall Study|No IV access|2|||
105804978|NCT01688037|364941999|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
105804979|NCT01688037|364942000|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
105951088|NCT01932788|365484476|FG000|Overall Study|Protocol Violation|18|||
105951089|NCT01932788|365484477|FG001|Overall Study|Protocol Violation|0|||
105951090|NCT01932788|365484476|FG000|Overall Study|Lost to Follow-up|18|||
105951091|NCT01932788|365484477|FG001|Overall Study|Lost to Follow-up|46|||
105951092|NCT01932788|365484476|FG000|Overall Study|Lack of Efficacy|2|||
105951093|NCT01932788|365484477|FG001|Overall Study|Lack of Efficacy|0|||
105951094|NCT01932788|365484476|FG000|Overall Study|Withdrawal by Subject|0|||
105951095|NCT01932788|365484477|FG001|Overall Study|Withdrawal by Subject|5|||
105951096|NCT01816984|365484485|FG000|Overall Study|declining health status|1|||
105951097|NCT02806414|365484486|FG000|Overall Study|Lost to Follow-up|2|||
105951098|NCT00636181|365484489|FG000|Overall Study|Withdrawal by Subject|8|||
105951099|NCT00636181|365484490|FG001|Overall Study|Withdrawal by Subject|6|||
105951100|NCT00636181|365484491|FG002|Overall Study|Withdrawal by Subject|10|||
105951101|NCT01928433|365484496|FG000|Overall Study|Adverse Event|5|||
105951102|NCT01928433|365484497|FG001|Overall Study|Adverse Event|2|||
105951103|NCT01928433|365484498|FG002|Overall Study|Adverse Event|5|||
105951104|NCT01928433|365484496|FG000|Overall Study|Protocol Violation|0|||
105951105|NCT01928433|365484497|FG001|Overall Study|Protocol Violation|0|||
105951106|NCT01928433|365484498|FG002|Overall Study|Protocol Violation|2|||
105951107|NCT01928433|365484496|FG000|Overall Study|Lack of Efficacy|5|||
105951108|NCT01928433|365484497|FG001|Overall Study|Lack of Efficacy|4|||
105951109|NCT01928433|365484498|FG002|Overall Study|Lack of Efficacy|4|||
105951110|NCT01928433|365484496|FG000|Overall Study|Withdrawal by Subject|0|||
105951111|NCT01928433|365484497|FG001|Overall Study|Withdrawal by Subject|4|||
105951112|NCT01928433|365484498|FG002|Overall Study|Withdrawal by Subject|0|||
105951113|NCT01928433|365484496|FG000|Overall Study|Negative screening urine culture|7|||
105951114|NCT01928433|365484497|FG001|Overall Study|Negative screening urine culture|6|||
105951115|NCT01928433|365484498|FG002|Overall Study|Negative screening urine culture|10|||
105951116|NCT01928433|365484496|FG000|Overall Study|Lost to Follow-up|0|||
105951117|NCT01928433|365484497|FG001|Overall Study|Lost to Follow-up|2|||
105951118|NCT01928433|365484498|FG002|Overall Study|Lost to Follow-up|3|||
105951119|NCT01928433|365484496|FG000|Overall Study|Other reasons|3|||
105759087|NCT02141217|364771507|FG000|Overall Study|Lost to Follow-up|1|||
105759088|NCT02141217|364771508|FG001|Overall Study|Lost to Follow-up|1|||
105759089|NCT02141217|364771507|FG000|Overall Study|Physician Decision|1|||
105759090|NCT02141217|364771508|FG001|Overall Study|Physician Decision|0|||
105759091|NCT02141217|364771507|FG000|Overall Study|Surgical Intervention|1|||
105759092|NCT02141217|364771508|FG001|Overall Study|Surgical Intervention|1|||
105759093|NCT01181141|364771511|FG000|Overall Study|Adverse Event|2|||
105759094|NCT01181141|364771512|FG001|Overall Study|Adverse Event|1|||
105759095|NCT01181141|364771511|FG000|Overall Study|Lack of Efficacy|1|||
105759096|NCT01181141|364771512|FG001|Overall Study|Lack of Efficacy|0|||
105759097|NCT01181141|364771511|FG000|Overall Study|Lost to Follow-up|1|||
105759098|NCT01181141|364771512|FG001|Overall Study|Lost to Follow-up|1|||
105759099|NCT01181141|364771511|FG000|Overall Study|Physician Decision|2|||
105759100|NCT01181141|364771512|FG001|Overall Study|Physician Decision|0|||
105759101|NCT01181141|364771511|FG000|Overall Study|Protocol Violation|3|||
105759102|NCT01181141|364771512|FG001|Overall Study|Protocol Violation|1|||
105759103|NCT01181141|364771511|FG000|Overall Study|Withdrawal by Subject|3|||
105759104|NCT01181141|364771512|FG001|Overall Study|Withdrawal by Subject|1|||
105759105|NCT02001688|364771513|FG000|Overall Study|Withdrawal by Subject|0|||
105759106|NCT02001688|364771514|FG001|Overall Study|Withdrawal by Subject|0|||
105951120|NCT01928433|365484497|FG001|Overall Study|Other reasons|3|||
105951121|NCT01928433|365484498|FG002|Overall Study|Other reasons|4|||
105951122|NCT02670473|365484499|FG000|Overall Study|Withdrawal by Subject|1|||
105951123|NCT01673126|365484500|FG000|Overall Study|change of diagnosis|4|||
105951124|NCT01673126|365484501|FG001|Overall Study|change of diagnosis|3|||
105951125|NCT00237042|365484502|FG000|Treatment|Became ineligible post-randomization|0|||
105951126|NCT00237042|365484503|FG001|Treatment|Became ineligible post-randomization|1|||
105951127|NCT00237042|365484504|FG002|Treatment|Became ineligible post-randomization|16|||
105951128|NCT00237042|365484502|FG000|Treatment|Moved out of state|1|||
105951129|NCT00237042|365484503|FG001|Treatment|Moved out of state|1|||
105951130|NCT00237042|365484504|FG002|Treatment|Moved out of state|1|||
105951131|NCT00237042|365484502|FG000|Treatment|Completed no treatment|5|||
105951132|NCT00237042|365484503|FG001|Treatment|Completed no treatment|5|||
105951133|NCT00237042|365484504|FG002|Treatment|Completed no treatment|21|||
105951134|NCT00237042|365484502|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
105951135|NCT00237042|365484503|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
105951136|NCT00237042|365484504|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
105951137|NCT00237042|365484502|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
105951138|NCT00237042|365484503|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
105951139|NCT00237042|365484504|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
105951140|NCT01897532|365484509|FG000|Discontinuation From Treatment|Not Treated|7|||
105951141|NCT01897532|365484510|FG001|Discontinuation From Treatment|Not Treated|5|||
105951142|NCT01897532|365484509|FG000|Discontinuation From Treatment|Other reason than specified|196|||
105951143|NCT01897532|365484510|FG001|Discontinuation From Treatment|Other reason than specified|176|||
105951144|NCT01897532|365484509|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
105951145|NCT01897532|365484510|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
105951146|NCT01897532|365484509|FG000|Discontinuation From Treatment|Non compliance|24|||
105951147|NCT01897532|365484510|FG001|Discontinuation From Treatment|Non compliance|15|||
105759107|NCT02001688|364771515|FG002|Overall Study|Withdrawal by Subject|1|||
105951148|NCT01897532|365484509|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
105951149|NCT01897532|365484510|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
105951150|NCT01897532|365484509|FG000|Discontinuation From Trial|Not Treated|7|||
105951151|NCT01897532|365484510|FG001|Discontinuation From Trial|Not Treated|5|||
105951152|NCT01897532|365484509|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
105759108|NCT02001688|364771513|FG000|Overall Study|Adverse Event|0|||
105759109|NCT02001688|364771514|FG001|Overall Study|Adverse Event|1|||
105759110|NCT02001688|364771515|FG002|Overall Study|Adverse Event|0|||
105759111|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759112|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
105759113|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105951153|NCT01897532|365484510|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
105951154|NCT00953706|365484513|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
105759114|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759115|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759116|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
105759117|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105951155|NCT00953706|365484514|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
105951156|NCT00953706|365484515|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
105951157|NCT00953706|365484516|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
105951158|NCT00953706|365484513|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
105951159|NCT00953706|365484514|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
105951160|NCT00953706|365484515|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
105951161|NCT00953706|365484516|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
105951162|NCT00953706|365484513|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
105951163|NCT00953706|365484514|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
105951164|NCT00953706|365484515|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
105951165|NCT00953706|365484516|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
105951166|NCT00953706|365484513|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
105951167|NCT00953706|365484514|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
105951168|NCT00953706|365484515|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
105951169|NCT00953706|365484516|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
105951170|NCT00953706|365484513|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
105951171|NCT00953706|365484514|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
105951172|NCT00953706|365484515|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
105951173|NCT00953706|365484516|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
105951174|NCT00953706|365484513|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
105951175|NCT00953706|365484514|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
105951176|NCT00953706|365484515|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
105951177|NCT00953706|365484516|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
105759118|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
105759119|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759120|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759121|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759122|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
105759123|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759124|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
105759125|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759126|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759127|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759128|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
105759129|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
105759130|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
105759131|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
105759132|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
105759133|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
105759134|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
105759135|NCT02151682|364771518|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
105759136|NCT02151682|364771519|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759137|NCT02151682|364771520|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759138|NCT02151682|364771521|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759139|NCT02151682|364771522|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759140|NCT02151682|364771523|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
105759141|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759142|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759143|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
105759144|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759145|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105759146|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
105951178|NCT00953706|365484513|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
105951179|NCT00953706|365484514|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
105951180|NCT00953706|365484515|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
105951181|NCT00953706|365484516|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
105951182|NCT00953706|365484513|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
105759147|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
105759148|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
105759149|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
105759150|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
105759151|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
105759152|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
105759153|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
105759154|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
105759155|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
105759156|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
105759157|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
105759158|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
105759159|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759160|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759161|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
105759162|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759163|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759164|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
105759165|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759166|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759167|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
105759168|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759169|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759170|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
105759171|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759172|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759173|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
105759174|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759175|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759176|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
105759177|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
105759178|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
105759179|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
105759180|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
105759181|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
105759182|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
105759183|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
105759184|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
105759185|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
105759186|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
105759187|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
105759188|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
105759189|NCT02151682|364771518|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759190|NCT02151682|364771519|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759191|NCT02151682|364771520|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
105759192|NCT02151682|364771521|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759193|NCT02151682|364771522|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759194|NCT02151682|364771523|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
105759195|NCT02151682|364771518|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759196|NCT02151682|364771519|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759197|NCT02151682|364771520|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759198|NCT02151682|364771521|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759199|NCT02151682|364771522|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
105759200|NCT02151682|364771523|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
105759201|NCT02151682|364771518|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759202|NCT02151682|364771519|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759203|NCT02151682|364771520|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759204|NCT02151682|364771521|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759205|NCT02151682|364771522|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
105759206|NCT02151682|364771523|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
105759207|NCT02151682|364771518|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105804980|NCT01688037|364942001|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
105759208|NCT02151682|364771519|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105951183|NCT00953706|365484514|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
105759209|NCT02151682|364771520|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105759210|NCT02151682|364771521|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105759211|NCT02151682|364771522|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
105759212|NCT02151682|364771523|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
105759213|NCT02151682|364771518|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759214|NCT02151682|364771519|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759215|NCT02151682|364771520|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759216|NCT02151682|364771521|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759217|NCT02151682|364771522|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
105759218|NCT02151682|364771523|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
105759219|NCT05441540|364771525|FG000|Overall Study|Withdrawal by Subject|2|||
105759220|NCT00813917|364771526|FG000|Overall Study|Adverse Event|0|||
105759221|NCT00813917|364771527|FG001|Overall Study|Adverse Event|1|||
105759222|NCT00813917|364771526|FG000|Overall Study|Withdrawal by Subject|3|||
105759223|NCT00813917|364771527|FG001|Overall Study|Withdrawal by Subject|4|||
105759224|NCT00813917|364771526|FG000|Overall Study|Lost to Follow-up|3|||
105759225|NCT00813917|364771527|FG001|Overall Study|Lost to Follow-up|1|||
105759226|NCT00168064|364771528|FG000|Overall Study|Adverse Event|26|||
105759227|NCT00168064|364771529|FG001|Overall Study|Adverse Event|22|||
105759228|NCT00168064|364771528|FG000|Overall Study|Withdrawal by Subject|3|||
105759229|NCT00168064|364771529|FG001|Overall Study|Withdrawal by Subject|4|||
105759230|NCT00168064|364771528|FG000|Overall Study|Lack of Efficacy|4|||
105759231|NCT00168064|364771529|FG001|Overall Study|Lack of Efficacy|4|||
105759232|NCT00168064|364771528|FG000|Overall Study|Lost to Follow-up|4|||
105759233|NCT00168064|364771529|FG001|Overall Study|Lost to Follow-up|3|||
105759234|NCT00168064|364771528|FG000|Overall Study|Non-compliance|2|||
105759235|NCT00168064|364771529|FG001|Overall Study|Non-compliance|3|||
105759236|NCT00168064|364771528|FG000|Overall Study|Concurrent Illness|4|||
105759237|NCT00168064|364771529|FG001|Overall Study|Concurrent Illness|3|||
105759238|NCT00168064|364771528|FG000|Overall Study|Subject's Best interest|2|||
105759239|NCT00168064|364771529|FG001|Overall Study|Subject's Best interest|2|||
105759240|NCT00168064|364771528|FG000|Overall Study|Various|4|||
105759241|NCT00168064|364771529|FG001|Overall Study|Various|3|||
105759242|NCT00290589|364771530|FG000|Overall Study|Lost to Follow-up|2|||
105759243|NCT00290589|364771531|FG001|Overall Study|Lost to Follow-up|2|||
105759244|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
105759245|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
105759246|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
105759247|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
105759248|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
105759249|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
105759250|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
105951184|NCT00953706|365484515|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
105951185|NCT00953706|365484516|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
105951186|NCT00953706|365484513|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
105951187|NCT00953706|365484514|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
105951188|NCT00953706|365484515|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
105951189|NCT00953706|365484516|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
105951190|NCT00953706|365484513|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
105951191|NCT00953706|365484514|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
105951192|NCT00953706|365484515|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
105951193|NCT00953706|365484516|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
105951194|NCT00953706|365484513|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
105951195|NCT00953706|365484514|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
105951196|NCT00953706|365484515|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
105951197|NCT00953706|365484516|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
105951198|NCT03761056|365484517|FG000|Overall Study|Death|8|||
105951199|NCT03761056|365484517|FG000|Overall Study|Enrolled but never treated|2|||
105951200|NCT03761056|365484517|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
105804981|NCT01688037|364941999|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
105804982|NCT01688037|364942000|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
105951201|NCT03761056|365484517|FG000|Overall Study|Investigator decision|1|||
105951202|NCT01492426|365485963|FG000|Treatment|Death|0|||
105951203|NCT01492426|365485964|FG001|Treatment|Death|1|||
105951204|NCT01492426|365485963|FG000|Treatment|Other|1|||
105951205|NCT01492426|365485964|FG001|Treatment|Other|0|||
105759251|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
105804983|NCT01688037|364942001|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
105759252|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
105759253|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
105759254|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
105759255|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
105759256|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
105759257|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
105759258|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
105759259|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
105759260|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
105759261|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
105759262|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
105951206|NCT01492426|365485963|FG000|Treatment|Adverse Event|25|||
105951207|NCT01492426|365485964|FG001|Treatment|Adverse Event|25|||
105951208|NCT01492426|365485963|FG000|Treatment|Lack of Efficacy|38|||
105951209|NCT01492426|365485964|FG001|Treatment|Lack of Efficacy|5|||
105951210|NCT01492426|365485963|FG000|Treatment|Participant withdrew consent|1|||
105951211|NCT01492426|365485964|FG001|Treatment|Participant withdrew consent|2|||
105951212|NCT01492426|365485963|FG000|Treatment|Poor compliance/noncompliance|1|||
105951213|NCT01492426|365485964|FG001|Treatment|Poor compliance/noncompliance|0|||
105951214|NCT01492426|365485963|FG000|Treatment|Subject requested discontinue study drug|7|||
105951215|NCT01492426|365485964|FG001|Treatment|Subject requested discontinue study drug|3|||
105951216|NCT01492426|365485963|FG000|Treatment|Lost to Follow-up|9|||
105951217|NCT01492426|365485964|FG001|Treatment|Lost to Follow-up|4|||
105951218|NCT01492426|365485963|FG000|Treatment|Participant does not meet study criteria|1|||
105951219|NCT01492426|365485964|FG001|Treatment|Participant does not meet study criteria|0|||
105951220|NCT01492426|365485963|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
105759263|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
105759264|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
105759265|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
105759266|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
105759267|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
105759268|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
105759269|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Other|1|||
105759270|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Other|0|||
105759271|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Other|0|||
105759272|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Other|0|||
105759273|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Other|1|||
105759274|NCT02980692|364771532|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
105759275|NCT02980692|364771533|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
105759276|NCT02980692|364771534|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
105759277|NCT02980692|364771535|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
105759278|NCT02980692|364771536|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
105759279|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Adverse Event|0|||
105759280|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Adverse Event|0|||
105759281|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Adverse Event|0|||
105759282|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Adverse Event|1|||
105759283|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Adverse Event|1|||
105759284|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
105759285|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
105759286|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
105759287|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
105951221|NCT01492426|365485964|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
105951222|NCT01492426|365485963|FG000|Follow-Up|Death|1|||
105951223|NCT01492426|365485964|FG001|Follow-Up|Death|0|||
105951224|NCT01492426|365485963|FG000|Follow-Up|Other|4|||
106016630|NCT01918306|365724478|FG000|Overall Study|neutropenia|1|||
106016631|NCT01918306|365724479|FG001|Overall Study|neutropenia|0|||
106016632|NCT01918306|365724480|FG002|Overall Study|neutropenia|0|||
106016633|NCT01918306|365724481|FG003|Overall Study|neutropenia|0|||
106016634|NCT01918306|365724478|FG000|Overall Study|Lack of Efficacy|1|||
106016635|NCT01918306|365724479|FG001|Overall Study|Lack of Efficacy|0|||
106016636|NCT01918306|365724480|FG002|Overall Study|Lack of Efficacy|0|||
106016637|NCT01918306|365724481|FG003|Overall Study|Lack of Efficacy|0|||
106016638|NCT01918306|365724478|FG000|Overall Study|progress disease, crossover|0|||
106016639|NCT01918306|365724479|FG001|Overall Study|progress disease, crossover|0|||
106016640|NCT01918306|365724480|FG002|Overall Study|progress disease, crossover|1|||
106016641|NCT01918306|365724481|FG003|Overall Study|progress disease, crossover|0|||
106016642|NCT03692052|365724482|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
106016643|NCT03692052|365724482|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
106016644|NCT03692052|365724482|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
106016645|NCT03692052|365724482|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
105759288|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
105759289|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
105759290|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
105759291|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
105759292|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
105759293|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
105759294|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Pregnancy|0|||
105759295|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Pregnancy|0|||
105759296|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Pregnancy|1|||
105759297|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Pregnancy|1|||
105759298|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Pregnancy|0|||
105759299|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
105759300|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
105951225|NCT01492426|365485964|FG001|Follow-Up|Other|2|||
105951226|NCT01492426|365485963|FG000|Follow-Up|Participant Withdrew Consent|6|||
105951227|NCT01492426|365485964|FG001|Follow-Up|Participant Withdrew Consent|1|||
105951228|NCT01492426|365485963|FG000|Follow-Up|Lost to Follow-up|12|||
105951229|NCT01492426|365485964|FG001|Follow-Up|Lost to Follow-up|6|||
105951230|NCT00322049|365485965|FG000|Overall Study|Moved out of area|0|||
105951231|NCT00322049|365485966|FG001|Overall Study|Moved out of area|0|||
105951232|NCT00322049|365485967|FG002|Overall Study|Moved out of area|0|||
105951233|NCT00322049|365485968|FG003|Overall Study|Moved out of area|1|||
105951234|NCT00322049|365485965|FG000|Overall Study|Infected with Dengue during study|0|||
105759301|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
105759302|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
105759303|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
105759304|NCT02980692|364771532|FG000|Double-blind Follow-up Period|Other|0|||
105759305|NCT02980692|364771533|FG001|Double-blind Follow-up Period|Other|0|||
105759306|NCT02980692|364771534|FG002|Double-blind Follow-up Period|Other|1|||
105759307|NCT02980692|364771535|FG003|Double-blind Follow-up Period|Other|1|||
105759308|NCT02980692|364771536|FG004|Double-blind Follow-up Period|Other|3|||
105759309|NCT01438307|364771539|FG000|Overall Study|Death|1|||
105759310|NCT01438307|364771540|FG001|Overall Study|Death|1|||
105759311|NCT04702984|364771543|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
105759312|NCT03862495|364771549|FG000|Overall Study|Lost to Follow-up|37|||
105759313|NCT03862495|364771550|FG001|Overall Study|Lost to Follow-up|35|||
105759314|NCT00615914|364771551|FG000|Overall Study|Adverse Event|274|||
105759315|NCT00615914|364771551|FG000|Overall Study|Death|20|||
105759316|NCT00615914|364771551|FG000|Overall Study|Lack of Efficacy|59|||
105759317|NCT00615914|364771551|FG000|Overall Study|Lost to Follow-up|187|||
105759318|NCT00615914|364771551|FG000|Overall Study|Withdrawal by Subject|16|||
105759319|NCT00615914|364771551|FG000|Overall Study|Physician Decision|4|||
105759320|NCT00615914|364771551|FG000|Overall Study|No data was collected.|65|||
105759321|NCT00615914|364771551|FG000|Overall Study|No treatment|2|||
105759322|NCT00615914|364771551|FG000|Overall Study|Irregularly enrolled patients|10|||
105759323|NCT01467661|364771552|FG000|Overall Study|Adverse Event|16|||
105759324|NCT01467661|364771552|FG000|Overall Study|Withdrawal by Subject|1|||
105759325|NCT01467661|364771552|FG000|Overall Study|Lack of Efficacy|3|||
105759326|NCT01467661|364771552|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
105759327|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
105759328|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
105759329|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
105759330|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
105759331|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
105759332|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
105759333|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
105759334|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
105759335|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
105759336|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
105759337|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
105759338|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
105951235|NCT00322049|365485966|FG001|Overall Study|Infected with Dengue during study|1|||
105951236|NCT00322049|365485967|FG002|Overall Study|Infected with Dengue during study|0|||
105951237|NCT00322049|365485968|FG003|Overall Study|Infected with Dengue during study|0|||
105759339|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
105759340|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
105759341|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
105759342|NCT03814005|364771555|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
105759343|NCT03814005|364771556|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
105759344|NCT03814005|364771557|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
105759345|NCT03395223|364771558|FG000|Overall Study|Lost to Follow-up|3|||
105759346|NCT03395223|364771558|FG000|Overall Study|Other|1|||
105951238|NCT05010070|365485969|FG000|Overall Study|Lost to Follow-up|1|||
105759347|NCT01409993|364771559|FG000|Overall Study|Adverse Event|4|||
105759348|NCT01409993|364771560|FG001|Overall Study|Adverse Event|4|||
105759349|NCT01409993|364771561|FG002|Overall Study|Adverse Event|3|||
105759350|NCT01409993|364771562|FG003|Overall Study|Adverse Event|1|||
105759351|NCT01409993|364771559|FG000|Overall Study|Withdrawal by Subject|0|||
105759352|NCT01409993|364771560|FG001|Overall Study|Withdrawal by Subject|0|||
105759353|NCT01409993|364771561|FG002|Overall Study|Withdrawal by Subject|0|||
105759354|NCT01409993|364771562|FG003|Overall Study|Withdrawal by Subject|4|||
105759355|NCT01409993|364771559|FG000|Overall Study|Lost to Follow-up|0|||
105759356|NCT01409993|364771560|FG001|Overall Study|Lost to Follow-up|1|||
105759357|NCT01409993|364771561|FG002|Overall Study|Lost to Follow-up|0|||
105759358|NCT01409993|364771562|FG003|Overall Study|Lost to Follow-up|0|||
105759359|NCT01148693|364771567|FG000|Overall Study|Attempts for cannulation were failed|13|||
105759360|NCT01148693|364771568|FG001|Overall Study|Attempts for cannulation were failed|10|||
105759361|NCT01074658|364771569|FG000|Overall Study|No implant attempted|19|||
105759362|NCT01732107|364771572|FG000|Overall Study|Adverse Event|2|||
105759363|NCT01732107|364771572|FG000|Overall Study|Disease Progression|8|||
105759364|NCT01732107|364771572|FG000|Overall Study|Physician Decision|1|||
105759365|NCT01732107|364771572|FG000|Overall Study|Withdrawal by Subject|2|||
105759366|NCT02849626|364771573|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
105759367|NCT02849626|364771574|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
105759368|NCT02849626|364771575|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
105759369|NCT02849626|364771576|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
105759370|NCT02849626|364771573|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
105759371|NCT02849626|364771574|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
105759372|NCT02849626|364771575|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
105759373|NCT02849626|364771576|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
105759374|NCT02849626|364771573|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
105759375|NCT02849626|364771574|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
105759376|NCT02849626|364771575|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
105759377|NCT02849626|364771576|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
105759378|NCT02849626|364771573|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
105759379|NCT02849626|364771574|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
105759380|NCT02849626|364771575|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
105759381|NCT02849626|364771576|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
105759382|NCT02849626|364771573|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
105759383|NCT02849626|364771574|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
105759384|NCT02849626|364771575|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
105759385|NCT02849626|364771576|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
105759386|NCT02849626|364771573|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
105759387|NCT02849626|364771574|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
105759388|NCT02849626|364771575|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
105759389|NCT02849626|364771576|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
105759390|NCT02849626|364771573|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
105759391|NCT02849626|364771574|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
105759392|NCT02849626|364771575|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
105759393|NCT02849626|364771576|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
105759394|NCT02849626|364771573|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
105759395|NCT02849626|364771574|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
105759396|NCT02849626|364771575|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
105759397|NCT02849626|364771576|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
105759398|NCT02849626|364771573|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
105759399|NCT02849626|364771574|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
105759400|NCT02849626|364771575|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
105759401|NCT02849626|364771576|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
105759402|NCT02849626|364771573|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
105759403|NCT02849626|364771574|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
105759404|NCT02849626|364771575|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
105759405|NCT02849626|364771576|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
105951239|NCT05010070|365485969|FG000|Overall Study|Withdrawal by Subject|1|||
105759406|NCT02849626|364771573|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
105759407|NCT02849626|364771574|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
105759408|NCT02849626|364771575|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
105759409|NCT02849626|364771576|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
105951240|NCT03247829|365485976|FG000|Overall Study|Death|3|||
105951241|NCT03247829|365485977|FG001|Overall Study|Death|4|||
105951242|NCT03247829|365485976|FG000|Overall Study|Enter Hospice Care|1|||
105951243|NCT03247829|365485977|FG001|Overall Study|Enter Hospice Care|0|||
105951244|NCT03247829|365485976|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
105951245|NCT03247829|365485977|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
105951246|NCT03247829|365485976|FG000|Overall Study|LVAD Explant|1|||
105951247|NCT03247829|365485977|FG001|Overall Study|LVAD Explant|1|||
105759410|NCT01185704|364771577|FG000|Overall Study|Randomized but not treated|3|||
105759411|NCT01185704|364771578|FG001|Overall Study|Randomized but not treated|3|||
105759412|NCT01185704|364771577|FG000|Overall Study|Lack of ovarian response|5|||
105759413|NCT01185704|364771578|FG001|Overall Study|Lack of ovarian response|1|||
105759414|NCT01185704|364771577|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
105759415|NCT01185704|364771578|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
105759416|NCT01185704|364771577|FG000|Overall Study|Ectopic pregnancy|0|||
105759417|NCT01185704|364771578|FG001|Overall Study|Ectopic pregnancy|1|||
105759418|NCT01654523|364771579|FG000|Overall Study|Withdrawal by Subject|1|||
105759419|NCT04354155|364771586|FG000|Overall Study|Withdrawal by Subject|1|||
105759420|NCT04354155|364771586|FG000|Overall Study|Did not meet criteria for study intervention|1|||
105759421|NCT00187889|364771587|FG000|Overall Study|Withdrawal by Subject|6|||
105759422|NCT00187889|364771588|FG001|Overall Study|Withdrawal by Subject|4|||
105759423|NCT04046341|364771589|FG000|Overall Study|Lost to Follow-up|2|||
105759424|NCT04046341|364771589|FG000|Overall Study|Withdrawal by Subject|1|||
105759425|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
105759426|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
105759427|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
105759428|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
105759429|NCT02133742|364771590|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
105759430|NCT00405652|364771591|FG000|Overall Study|Adverse Event|4|||
105759431|NCT03505749|364771592|FG000|Overall Study|Lost to Follow-up|7|||
105759432|NCT03505749|364771593|FG001|Overall Study|Lost to Follow-up|11|||
105759433|NCT03505749|364771592|FG000|Overall Study|Withdrawal by Subject|6|||
105759434|NCT03505749|364771593|FG001|Overall Study|Withdrawal by Subject|0|||
105759435|NCT03505749|364771592|FG000|Overall Study|Discharged from treatment|3|||
105759436|NCT03505749|364771593|FG001|Overall Study|Discharged from treatment|6|||
105759437|NCT00435994|364771595|FG000|Overall Study|Lost to Follow-up|7|||
105759438|NCT00435994|364771596|FG001|Overall Study|Lost to Follow-up|0|||
105759439|NCT00435994|364771597|FG002|Overall Study|Lost to Follow-up|0|||
105759440|NCT01151540|364771598|FG000|Overall Study|Other|2|||
105759441|NCT01151540|364771598|FG000|Overall Study|Adverse event, non-fatal|4|||
105759442|NCT01151540|364771598|FG000|Overall Study|Withdrawal by Subject|7|||
105759443|NCT02807844|364771601|FG000|Overall Study|Physician Decision|0|||
105759444|NCT02807844|364771602|FG001|Overall Study|Physician Decision|0|||
105759445|NCT02807844|364771603|FG002|Overall Study|Physician Decision|0|||
105759446|NCT02807844|364771604|FG003|Overall Study|Physician Decision|0|||
105759447|NCT02807844|364771605|FG004|Overall Study|Physician Decision|0|||
105759448|NCT02807844|364771606|FG005|Overall Study|Physician Decision|0|||
105759449|NCT02807844|364771607|FG006|Overall Study|Physician Decision|3|||
105759450|NCT02807844|364771608|FG007|Overall Study|Physician Decision|0|||
105759451|NCT02807844|364771609|FG008|Overall Study|Physician Decision|1|||
105759452|NCT02807844|364771610|FG009|Overall Study|Physician Decision|2|||
105759453|NCT02807844|364771601|FG000|Overall Study|Death|0|||
105759454|NCT02807844|364771602|FG001|Overall Study|Death|0|||
105759455|NCT02807844|364771603|FG002|Overall Study|Death|2|||
105759456|NCT02807844|364771604|FG003|Overall Study|Death|4|||
105759457|NCT02807844|364771605|FG004|Overall Study|Death|1|||
105759458|NCT02807844|364771606|FG005|Overall Study|Death|2|||
105759459|NCT02807844|364771607|FG006|Overall Study|Death|1|||
105759460|NCT02807844|364771608|FG007|Overall Study|Death|2|||
105759461|NCT02807844|364771609|FG008|Overall Study|Death|0|||
105759462|NCT02807844|364771610|FG009|Overall Study|Death|1|||
105759463|NCT02807844|364771601|FG000|Overall Study|Withdrawal by Subject|0|||
105759464|NCT02807844|364771602|FG001|Overall Study|Withdrawal by Subject|0|||
105759465|NCT02807844|364771603|FG002|Overall Study|Withdrawal by Subject|2|||
105759466|NCT02807844|364771604|FG003|Overall Study|Withdrawal by Subject|1|||
105804984|NCT01688037|364941999|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
105804985|NCT01688037|364942000|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
105951248|NCT03247829|365485976|FG000|Overall Study|Transplant|1|||
105951249|NCT03247829|365485977|FG001|Overall Study|Transplant|1|||
105951250|NCT01783444|365485978|FG000|Treatment Phase|Adverse Event|9|||
105951251|NCT01783444|365485979|FG001|Treatment Phase|Adverse Event|20|||
105951252|NCT01783444|365485980|FG002|Treatment Phase|Adverse Event|19|||
105759467|NCT02807844|364771605|FG004|Overall Study|Withdrawal by Subject|1|||
105951253|NCT01783444|365485978|FG000|Treatment Phase|Disease Progression|76|||
105951254|NCT01783444|365485979|FG001|Treatment Phase|Disease Progression|66|||
105951255|NCT01783444|365485980|FG002|Treatment Phase|Disease Progression|64|||
105759468|NCT02807844|364771606|FG005|Overall Study|Withdrawal by Subject|0|||
105759469|NCT02807844|364771607|FG006|Overall Study|Withdrawal by Subject|1|||
105759470|NCT02807844|364771608|FG007|Overall Study|Withdrawal by Subject|0|||
105759471|NCT02807844|364771609|FG008|Overall Study|Withdrawal by Subject|0|||
105759472|NCT02807844|364771610|FG009|Overall Study|Withdrawal by Subject|0|||
105759473|NCT02807844|364771601|FG000|Overall Study|Progressive disease|5|||
105759474|NCT02807844|364771602|FG001|Overall Study|Progressive disease|12|||
105759475|NCT02807844|364771603|FG002|Overall Study|Progressive disease|8|||
105759476|NCT02807844|364771604|FG003|Overall Study|Progressive disease|8|||
105759477|NCT02807844|364771605|FG004|Overall Study|Progressive disease|3|||
105759478|NCT02807844|364771606|FG005|Overall Study|Progressive disease|8|||
105759479|NCT02807844|364771607|FG006|Overall Study|Progressive disease|14|||
105759480|NCT02807844|364771608|FG007|Overall Study|Progressive disease|17|||
105759481|NCT02807844|364771609|FG008|Overall Study|Progressive disease|19|||
105759482|NCT02807844|364771610|FG009|Overall Study|Progressive disease|15|||
105759483|NCT02807844|364771601|FG000|Overall Study|Adverse Event|1|||
105759484|NCT02807844|364771602|FG001|Overall Study|Adverse Event|0|||
105759485|NCT02807844|364771603|FG002|Overall Study|Adverse Event|0|||
105759486|NCT02807844|364771604|FG003|Overall Study|Adverse Event|0|||
105759487|NCT02807844|364771605|FG004|Overall Study|Adverse Event|1|||
105759488|NCT02807844|364771606|FG005|Overall Study|Adverse Event|1|||
105759489|NCT02807844|364771607|FG006|Overall Study|Adverse Event|1|||
105759490|NCT02807844|364771608|FG007|Overall Study|Adverse Event|1|||
105759491|NCT02807844|364771609|FG008|Overall Study|Adverse Event|1|||
105759492|NCT02807844|364771610|FG009|Overall Study|Adverse Event|2|||
105759493|NCT03097029|364771611|FG000|Overall Study|Withdrawal by Subject|1|||
105759494|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
105759495|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
105759496|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
105759497|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
105759498|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
105759499|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
105759500|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
105759501|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
105759502|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
105759503|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
105759504|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
105759505|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
105759506|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
105759507|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
105759508|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
105759509|NCT01412060|364771612|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
105759510|NCT01412060|364771613|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
105759511|NCT01412060|364771614|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
105759512|NCT01412060|364771612|FG000|Period Between RIP and SP|Adverse Event|4|||
105759513|NCT01412060|364771613|FG001|Period Between RIP and SP|Adverse Event|0|||
105759514|NCT01412060|364771614|FG002|Period Between RIP and SP|Adverse Event|0|||
105759515|NCT01412060|364771612|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
105759516|NCT01412060|364771613|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
105759517|NCT01412060|364771614|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
105759518|NCT01412060|364771612|FG000|Period Between RIP and SP|Protocol Violation|2|||
105759519|NCT01412060|364771613|FG001|Period Between RIP and SP|Protocol Violation|0|||
105759520|NCT01412060|364771614|FG002|Period Between RIP and SP|Protocol Violation|0|||
105759521|NCT01412060|364771612|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
105759522|NCT01412060|364771613|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
105759523|NCT01412060|364771614|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
105759524|NCT01412060|364771612|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
105759525|NCT01412060|364771613|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
105759526|NCT01412060|364771614|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
105759527|NCT01412060|364771612|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
105759528|NCT01412060|364771613|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
105759529|NCT01412060|364771614|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
105759530|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
105759531|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
105759532|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
105759533|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
105759534|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
105759535|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
105759536|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
105759537|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
105759538|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
105759539|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
105759540|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
105759541|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
105759542|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
105759543|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
105759544|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
105759545|NCT01412060|364771612|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
105759546|NCT01412060|364771613|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
105759547|NCT01412060|364771614|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
105759548|NCT01412060|364771612|FG000|Period Between SP and DBP|Protocol Violation|2|||
105759549|NCT01412060|364771613|FG001|Period Between SP and DBP|Protocol Violation|0|||
105759550|NCT01412060|364771614|FG002|Period Between SP and DBP|Protocol Violation|0|||
105759551|NCT01412060|364771612|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
105759552|NCT01412060|364771613|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
105759553|NCT01412060|364771614|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
105759554|NCT01412060|364771612|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
105759555|NCT01412060|364771613|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
105759556|NCT01412060|364771614|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
105759557|NCT01412060|364771612|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
105759558|NCT01412060|364771613|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
105759559|NCT01412060|364771614|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
105759560|NCT01412060|364771612|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
105759561|NCT01412060|364771613|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
105759562|NCT01412060|364771614|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
105759563|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
105759564|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
105759565|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
105759566|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
105759567|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
105759568|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
105759569|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
105759570|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
105759571|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
105759572|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
105759573|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
105759574|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
105759575|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
105759576|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
105759577|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
105759578|NCT01412060|364771612|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
105759579|NCT01412060|364771613|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
105759580|NCT01412060|364771614|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
105804986|NCT01688037|364942001|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
105804987|NCT01688037|364941999|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
105804988|NCT01688037|364942000|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
105951256|NCT01783444|365485978|FG000|Treatment Phase|Death|2|||
105804989|NCT01688037|364942001|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
105951257|NCT01783444|365485979|FG001|Treatment Phase|Death|2|||
105951258|NCT01783444|365485980|FG002|Treatment Phase|Death|2|||
105951259|NCT01783444|365485978|FG000|Treatment Phase|Protocol Violation|1|||
105951260|NCT01783444|365485979|FG001|Treatment Phase|Protocol Violation|1|||
105951261|NCT01783444|365485980|FG002|Treatment Phase|Protocol Violation|2|||
105951262|NCT01783444|365485978|FG000|Treatment Phase|Withdrawal by Subject|6|||
105951263|NCT01783444|365485979|FG001|Treatment Phase|Withdrawal by Subject|8|||
105951264|NCT01783444|365485980|FG002|Treatment Phase|Withdrawal by Subject|9|||
105951265|NCT01783444|365485978|FG000|Treatment Phase|Administrative problems|2|||
105951266|NCT01783444|365485979|FG001|Treatment Phase|Administrative problems|0|||
105951267|NCT01783444|365485980|FG002|Treatment Phase|Administrative problems|1|||
105951268|NCT01783444|365485978|FG000|Treatment Phase|Physician Decision|8|||
105951269|NCT01783444|365485979|FG001|Treatment Phase|Physician Decision|6|||
105951270|NCT01783444|365485980|FG002|Treatment Phase|Physician Decision|5|||
105951271|NCT01783444|365485978|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
105951272|NCT01783444|365485979|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
105951273|NCT01783444|365485980|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
105951274|NCT01783444|365485978|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
105951275|NCT01783444|365485979|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
105951276|NCT01783444|365485980|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
105951277|NCT01783444|365485978|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
105759581|NCT00004732|364771617|FG000|Overall Study|Withdrawal by Subject|36|||
105759582|NCT00004732|364771618|FG001|Overall Study|Withdrawal by Subject|64|||
105951278|NCT01783444|365485979|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
105951279|NCT01783444|365485980|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
105759583|NCT00004732|364771617|FG000|Overall Study|Lost to Follow-up|33|||
105759584|NCT00004732|364771618|FG001|Overall Study|Lost to Follow-up|47|||
105759585|NCT00753688|364771619|FG000|Overall Study|Death|102|||
105951280|NCT01783444|365485978|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
105951281|NCT01783444|365485979|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
105951282|NCT01783444|365485980|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
105951283|NCT01783444|365485978|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
105951284|NCT01783444|365485979|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
105951285|NCT01783444|365485980|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
105951286|NCT01783444|365485978|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
105951287|NCT01783444|365485979|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
105951288|NCT01783444|365485980|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
105951289|NCT05111145|365485986|FG000|Overall Study|Commercial drug is available for participant|76|||
105759586|NCT00753688|364771620|FG001|Overall Study|Death|203|||
105759587|NCT00753688|364771619|FG000|Overall Study|Missing|4|||
105759588|NCT00753688|364771620|FG001|Overall Study|Missing|9|||
105759589|NCT00753688|364771619|FG000|Overall Study|Participant Withdrew Consent|2|||
105759590|NCT00753688|364771620|FG001|Overall Study|Participant Withdrew Consent|2|||
105759591|NCT00753688|364771619|FG000|Overall Study|Ongoing - in Follow-up|15|||
105759592|NCT00753688|364771620|FG001|Overall Study|Ongoing - in Follow-up|31|||
105759593|NCT00753688|364771619|FG000|Overall Study|Adverse Event|0|||
105759594|NCT00753688|364771620|FG001|Overall Study|Adverse Event|1|||
105759595|NCT00108953|364771621|FG000|Follow-up|Death|18|||
105759596|NCT00108953|364771622|FG001|Follow-up|Death|26|||
105759597|NCT00108953|364771621|FG000|Follow-up|Lost to Follow-up|1|||
105759598|NCT00108953|364771622|FG001|Follow-up|Lost to Follow-up|1|||
105759599|NCT00108953|364771621|FG000|Follow-up|Study terminated by sponsor|10|||
105759600|NCT00108953|364771622|FG001|Follow-up|Study terminated by sponsor|6|||
105759601|NCT04294095|364771625|FG000|Overall Study|Adverse Event|1|||
105759602|NCT04294095|364771626|FG001|Overall Study|Adverse Event|0|||
105759603|NCT04126031|364771628|FG000|Part A|Withdrawal by Subject|0|||
105759604|NCT04126031|364771629|FG001|Part A|Withdrawal by Subject|0|||
105759605|NCT04126031|364771630|FG002|Part A|Withdrawal by Subject|1|||
105759606|NCT04126031|364771631|FG003|Part A|Withdrawal by Subject|0|||
105759607|NCT04126031|364771632|FG004|Part A|Withdrawal by Subject|0|||
105759608|NCT04126031|364771633|FG005|Part A|Withdrawal by Subject|0|||
105759609|NCT04126031|364771628|FG000|Part A|Other|1|||
105759610|NCT04126031|364771629|FG001|Part A|Other|0|||
105759611|NCT04126031|364771630|FG002|Part A|Other|0|||
105759612|NCT04126031|364771631|FG003|Part A|Other|0|||
105759613|NCT04126031|364771632|FG004|Part A|Other|0|||
105759614|NCT04126031|364771633|FG005|Part A|Other|0|||
105759615|NCT04126031|364771628|FG000|Part B|Adverse Event|0|||
105759616|NCT04126031|364771629|FG001|Part B|Adverse Event|0|||
105759617|NCT04126031|364771630|FG002|Part B|Adverse Event|0|||
105759618|NCT04126031|364771631|FG003|Part B|Adverse Event|0|||
105759619|NCT04126031|364771632|FG004|Part B|Adverse Event|0|||
105804990|NCT01688037|364941999|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
105759620|NCT04126031|364771633|FG005|Part B|Adverse Event|2|||
105759621|NCT04126031|364771628|FG000|Part B|Pre-existing hypertransaminasemia|0|||
105759622|NCT04126031|364771629|FG001|Part B|Pre-existing hypertransaminasemia|0|||
105759623|NCT04126031|364771630|FG002|Part B|Pre-existing hypertransaminasemia|0|||
105759624|NCT04126031|364771631|FG003|Part B|Pre-existing hypertransaminasemia|0|||
105759625|NCT04126031|364771632|FG004|Part B|Pre-existing hypertransaminasemia|1|||
105759626|NCT04126031|364771633|FG005|Part B|Pre-existing hypertransaminasemia|0|||
105759627|NCT02177175|364771637|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
105759628|NCT02177175|364771638|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
105759629|NCT00260429|364771639|FG000|Overall Study|failure to follow appointments|1|||
105759630|NCT00260429|364771640|FG001|Overall Study|failure to follow appointments|0|||
105759631|NCT00260429|364771639|FG000|Overall Study|scheduled hand surgery|1|||
105759632|NCT00260429|364771640|FG001|Overall Study|scheduled hand surgery|0|||
105759633|NCT00131664|364771641|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
105759634|NCT00131664|364771642|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
105759635|NCT00131664|364771643|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
105759636|NCT00131664|364771644|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
105759637|NCT00131664|364771645|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
105759638|NCT00131664|364771646|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
105951290|NCT05111145|365485986|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
106142900|NCT04956575|366183555|FG002|Overall Study|Withdrawal by Subject|1|||
106142901|NCT04956575|366183556|FG003|Overall Study|Withdrawal by Subject|4|||
106142902|NCT04956575|366183557|FG004|Overall Study|Withdrawal by Subject|2|||
106142903|NCT04956575|366183558|FG005|Overall Study|Withdrawal by Subject|8|||
106142904|NCT04956575|366183559|FG006|Overall Study|Withdrawal by Subject|5|||
106142905|NCT04956575|366183560|FG007|Overall Study|Withdrawal by Subject|1|||
106142906|NCT04956575|366183561|FG008|Overall Study|Withdrawal by Subject|1|||
106142907|NCT04956575|366183562|FG009|Overall Study|Withdrawal by Subject|0|||
106142908|NCT04956575|366183563|FG010|Overall Study|Withdrawal by Subject|3|||
106142909|NCT04956575|366183564|FG011|Overall Study|Withdrawal by Subject|1|||
106142910|NCT00854906|366183566|FG000|Overall Study|One person had no ocular history|1|||
106142911|NCT00814346|366183569|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
106142912|NCT00814346|366183570|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
106142913|NCT00814346|366183569|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
106142914|NCT00814346|366183570|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
106142915|NCT00814346|366183569|FG000|Open Phase (17 Months)|Adverse Event|5|||
106142916|NCT00814346|366183570|FG001|Open Phase (17 Months)|Adverse Event|0|||
106142917|NCT00814346|366183569|FG000|Open Phase (17 Months)|Consent|2|||
106142918|NCT00814346|366183570|FG001|Open Phase (17 Months)|Consent|0|||
106142919|NCT00814346|366183569|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
106142920|NCT00814346|366183570|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
106142921|NCT00814346|366183569|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
106142922|NCT00814346|366183570|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
106142923|NCT05136443|366183572|FG000|Overall Study|Lost to Follow-up|2|||
106142924|NCT05136443|366183572|FG000|Overall Study|Adverse Event|2|||
106142925|NCT00507689|366183584|FG000|Pre-Randomization Period|Adverse Event|1|||
106142926|NCT00507689|366183585|FG001|Pre-Randomization Period|Adverse Event|0|||
106142927|NCT00507689|366183584|FG000|Pre-Randomization Period|Physician Decision|1|||
106142928|NCT00507689|366183585|FG001|Pre-Randomization Period|Physician Decision|0|||
106142929|NCT00507689|366183584|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
106142930|NCT00507689|366183585|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
106142931|NCT00507689|366183584|FG000|Randomized Period|Adverse Event|1|||
106142932|NCT00507689|366183585|FG001|Randomized Period|Adverse Event|1|||
106142933|NCT00507689|366183584|FG000|Randomized Period|Withdrawal by Subject|0|||
106142934|NCT00507689|366183585|FG001|Randomized Period|Withdrawal by Subject|1|||
106142935|NCT01241292|366183586|FG000|Overall Study|Administrative Reason by Sponsor|1|||
106142936|NCT01241292|366183587|FG001|Overall Study|Administrative Reason by Sponsor|0|||
106142937|NCT01241292|366183586|FG000|Overall Study|Disease Progression|2|||
106142938|NCT01241292|366183587|FG001|Overall Study|Disease Progression|0|||
106142939|NCT01241292|366183586|FG000|Overall Study|Study Drug Toxicity|0|||
106142940|NCT01241292|366183587|FG001|Overall Study|Study Drug Toxicity|1|||
106142941|NCT01241292|366183586|FG000|Overall Study|Participant Discontinued Treatment|0|||
106142942|NCT01241292|366183587|FG001|Overall Study|Participant Discontinued Treatment|2|||
106142943|NCT03034915|366183588|FG000|Overall Study|Adverse Event|29|||
106142944|NCT03034915|366183589|FG001|Overall Study|Adverse Event|32|||
106142945|NCT03034915|366183590|FG002|Overall Study|Adverse Event|22|||
106142946|NCT03034915|366183588|FG000|Overall Study|Lost to Follow-up|5|||
106142947|NCT03034915|366183589|FG001|Overall Study|Lost to Follow-up|13|||
106142948|NCT03034915|366183590|FG002|Overall Study|Lost to Follow-up|3|||
106142949|NCT03034915|366183588|FG000|Overall Study|Withdrawal by Subject|29|||
106142950|NCT03034915|366183589|FG001|Overall Study|Withdrawal by Subject|46|||
106142951|NCT03034915|366183590|FG002|Overall Study|Withdrawal by Subject|41|||
106142952|NCT03034915|366183588|FG000|Overall Study|Protocol Deviation|2|||
106142953|NCT03034915|366183589|FG001|Overall Study|Protocol Deviation|14|||
106142954|NCT03034915|366183590|FG002|Overall Study|Protocol Deviation|7|||
106142955|NCT03034915|366183588|FG000|Overall Study|Lack of Efficacy|8|||
106142956|NCT03034915|366183589|FG001|Overall Study|Lack of Efficacy|16|||
105759639|NCT00131664|364771641|FG000|First Period (First 6 Months)|Death|0|||
105759640|NCT00131664|364771642|FG001|First Period (First 6 Months)|Death|1|||
105759641|NCT00131664|364771643|FG002|First Period (First 6 Months)|Death|0|||
105759642|NCT00131664|364771644|FG003|First Period (First 6 Months)|Death|0|||
105759643|NCT00131664|364771645|FG004|First Period (First 6 Months)|Death|0|||
105759644|NCT00131664|364771646|FG005|First Period (First 6 Months)|Death|0|||
105759645|NCT00131664|364771641|FG000|First Period (First 6 Months)|Protocol Violation|2|||
105759646|NCT00131664|364771642|FG001|First Period (First 6 Months)|Protocol Violation|2|||
105759647|NCT00131664|364771643|FG002|First Period (First 6 Months)|Protocol Violation|1|||
106142957|NCT03034915|366183590|FG002|Overall Study|Lack of Efficacy|18|||
106142958|NCT03034915|366183588|FG000|Overall Study|Site closed|2|||
106142959|NCT03034915|366183589|FG001|Overall Study|Site closed|2|||
106142960|NCT03034915|366183590|FG002|Overall Study|Site closed|4|||
106142961|NCT03034915|366183588|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
106142962|NCT03034915|366183589|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
106142963|NCT03034915|366183590|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
106142964|NCT03034915|366183588|FG000|Overall Study|Physician Decision|1|||
106142965|NCT03034915|366183589|FG001|Overall Study|Physician Decision|5|||
106142966|NCT03034915|366183590|FG002|Overall Study|Physician Decision|2|||
106142967|NCT03861767|366183591|FG000|Overall Study|Withdrawal by Subject|2|||
106142968|NCT03861767|366183592|FG001|Overall Study|Withdrawal by Subject|1|||
106142969|NCT03861767|366183593|FG002|Overall Study|Withdrawal by Subject|0|||
106142970|NCT03861767|366183594|FG003|Overall Study|Withdrawal by Subject|5|||
106142971|NCT03861767|366183595|FG004|Overall Study|Withdrawal by Subject|2|||
106142972|NCT03861767|366183596|FG005|Overall Study|Withdrawal by Subject|1|||
106142973|NCT03861767|366183597|FG006|Overall Study|Withdrawal by Subject|3|||
106142974|NCT03861767|366183598|FG007|Overall Study|Withdrawal by Subject|1|||
105759648|NCT00131664|364771644|FG003|First Period (First 6 Months)|Protocol Violation|0|||
105759649|NCT00131664|364771645|FG004|First Period (First 6 Months)|Protocol Violation|0|||
105759650|NCT00131664|364771646|FG005|First Period (First 6 Months)|Protocol Violation|0|||
105759651|NCT00131664|364771641|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
105951291|NCT00441272|365485989|FG000|Overall Study|Study terminated prior to enrollment|25|||
105759652|NCT00131664|364771642|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
105759653|NCT00131664|364771643|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
105759654|NCT00131664|364771644|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
105759655|NCT00131664|364771645|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
105759656|NCT00131664|364771646|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
105759657|NCT00131664|364771641|FG000|First Period (First 6 Months)|Adverse Event|9|||
105759658|NCT00131664|364771642|FG001|First Period (First 6 Months)|Adverse Event|4|||
105759659|NCT00131664|364771643|FG002|First Period (First 6 Months)|Adverse Event|5|||
105759660|NCT00131664|364771644|FG003|First Period (First 6 Months)|Adverse Event|0|||
105951292|NCT00441272|365485990|FG001|Overall Study|Study terminated prior to enrollment|25|||
105804991|NCT01688037|364942000|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
105804992|NCT01688037|364942001|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
105804993|NCT01688037|364941999|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
105804994|NCT01688037|364942000|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
105804995|NCT01688037|364942001|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
105804996|NCT03111147|364942002|FG000|Overall Study|Lost to Follow-up|2|||
105951293|NCT01856322|365485991|FG000|Overall Study|off study due to lack of accrual|0|||
105951294|NCT01856322|365485992|FG001|Overall Study|off study due to lack of accrual|0|||
105951295|NCT01856322|365485993|FG002|Overall Study|off study due to lack of accrual|3|||
105951296|NCT00427011|365485994|FG000|Overall Study|Adverse Event|10|||
105951297|NCT00427011|365485994|FG000|Overall Study|Withdrawal by Subject|1|||
105951298|NCT00427011|365485994|FG000|Overall Study|Lack of Efficacy|2|||
105951299|NCT00427011|365485994|FG000|Overall Study|Other|12|||
105951300|NCT02336815|365485998|FG000|Overall Study|Disease Progression|45|||
105951301|NCT02336815|365485999|FG001|Overall Study|Disease Progression|70|||
105951302|NCT02336815|365485998|FG000|Overall Study|Adverse Event|18|||
105951303|NCT02336815|365485999|FG001|Overall Study|Adverse Event|39|||
105951304|NCT02336815|365485998|FG000|Overall Study|Physician Decision|11|||
105951305|NCT02336815|365485999|FG001|Overall Study|Physician Decision|4|||
105951306|NCT02336815|365485998|FG000|Overall Study|Withdrawal by Subject|3|||
105951307|NCT02336815|365485999|FG001|Overall Study|Withdrawal by Subject|2|||
105951308|NCT02336815|365485998|FG000|Overall Study|Lost to Follow-up|1|||
105951309|NCT02336815|365485999|FG001|Overall Study|Lost to Follow-up|3|||
105951310|NCT02336815|365485998|FG000|Overall Study|Other|1|||
105951311|NCT02336815|365485999|FG001|Overall Study|Other|5|||
105951312|NCT00954447|365486001|FG000|Overall Study|Adverse Event|33|||
105951313|NCT00954447|365486002|FG001|Overall Study|Adverse Event|25|||
105951314|NCT00954447|365486001|FG000|Overall Study|Lack of Efficacy|17|||
105951315|NCT00954447|365486002|FG001|Overall Study|Lack of Efficacy|3|||
105951316|NCT00954447|365486001|FG000|Overall Study|Protocol Violation|5|||
105951317|NCT00954447|365486002|FG001|Overall Study|Protocol Violation|7|||
105951318|NCT00954447|365486001|FG000|Overall Study|Lost to Follow-up|8|||
105951319|NCT00954447|365486002|FG001|Overall Study|Lost to Follow-up|14|||
105951320|NCT00954447|365486001|FG000|Overall Study|Withdrawal by Subject|26|||
105951321|NCT00954447|365486002|FG001|Overall Study|Withdrawal by Subject|21|||
105951322|NCT00954447|365486001|FG000|Overall Study|Other|21|||
105951323|NCT00954447|365486002|FG001|Overall Study|Other|18|||
105951324|NCT04592341|365486003|FG000|Overall Study|Physician Decision|5|||
105951325|NCT04592341|365486003|FG000|Overall Study|Study Terminated by Sponsor|5|||
105951326|NCT04592341|365486003|FG000|Overall Study|Withdrawal by Subject|53|||
105951327|NCT04592341|365486003|FG000|Overall Study|Lost to Follow-up|3|||
105951328|NCT04592341|365486003|FG000|Overall Study|Death|1|||
105951329|NCT04592341|365486003|FG000|Overall Study|Adverse Event|5|||
105951330|NCT04592341|365486003|FG000|Overall Study|other|4|||
105951331|NCT03759600|365486004|FG000|Overall Study|Adverse Event|2|||
105951332|NCT03759600|365486004|FG000|Overall Study|Progressive Disease|15|||
105951333|NCT03759600|365486004|FG000|Overall Study|Site Terminated by Sponsor|3|||
105951334|NCT05173974|365486005|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
105951335|NCT05173974|365486006|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
105951336|NCT05173974|365486007|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
105951337|NCT05173974|365486008|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
105951338|NCT05173974|365486005|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
105951339|NCT05173974|365486006|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
105951340|NCT05173974|365486007|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
105951341|NCT05173974|365486008|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
105951342|NCT00692003|365486009|FG000|Overall Study|Sponsor Decision|5|||
105951343|NCT00692003|365486010|FG001|Overall Study|Sponsor Decision|1|||
105951344|NCT03289143|365486011|FG000|Overall Study|Caregiver Unavailability|1|||
105951345|NCT03289143|365486012|FG001|Overall Study|Caregiver Unavailability|1|||
105951346|NCT03289143|365486013|FG002|Overall Study|Caregiver Unavailability|0|||
105951347|NCT03289143|365486014|FG003|Overall Study|Caregiver Unavailability|0|||
105951348|NCT03289143|365486011|FG000|Overall Study|Research Department Closure|0|||
105951349|NCT03289143|365486012|FG001|Overall Study|Research Department Closure|0|||
105951350|NCT03289143|365486013|FG002|Overall Study|Research Department Closure|1|||
105951351|NCT03289143|365486014|FG003|Overall Study|Research Department Closure|0|||
105951352|NCT03289143|365486011|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
105951353|NCT03289143|365486012|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
105951354|NCT03289143|365486013|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
105951355|NCT03289143|365486014|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
105951356|NCT03289143|365486011|FG000|Overall Study|Medical Monitor Decision|1|||
105951357|NCT03289143|365486012|FG001|Overall Study|Medical Monitor Decision|0|||
105951358|NCT03289143|365486013|FG002|Overall Study|Medical Monitor Decision|0|||
105951359|NCT03289143|365486014|FG003|Overall Study|Medical Monitor Decision|0|||
105951360|NCT03289143|365486011|FG000|Overall Study|Participant Non-Compliance|0|||
105951361|NCT03289143|365486012|FG001|Overall Study|Participant Non-Compliance|0|||
105951362|NCT03289143|365486013|FG002|Overall Study|Participant Non-Compliance|1|||
105951363|NCT03289143|365486014|FG003|Overall Study|Participant Non-Compliance|0|||
105951364|NCT03289143|365486011|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
105951365|NCT03289143|365486012|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
105951366|NCT03289143|365486013|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
105951367|NCT03289143|365486014|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
105951368|NCT03289143|365486011|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
105951369|NCT03289143|365486012|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
105951370|NCT03289143|365486013|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
105951371|NCT03289143|365486014|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
105951372|NCT03289143|365486011|FG000|Overall Study|Caregiver Passed Away|1|||
105951373|NCT03289143|365486012|FG001|Overall Study|Caregiver Passed Away|0|||
105951374|NCT03289143|365486013|FG002|Overall Study|Caregiver Passed Away|0|||
105951375|NCT03289143|365486014|FG003|Overall Study|Caregiver Passed Away|0|||
105951376|NCT03289143|365486011|FG000|Overall Study|Physician Decision|0|||
105951377|NCT03289143|365486012|FG001|Overall Study|Physician Decision|2|||
105951378|NCT03289143|365486013|FG002|Overall Study|Physician Decision|2|||
105951379|NCT03289143|365486014|FG003|Overall Study|Physician Decision|2|||
105951380|NCT03289143|365486011|FG000|Overall Study|Protocol Deviation|2|||
105951381|NCT03289143|365486012|FG001|Overall Study|Protocol Deviation|1|||
105759661|NCT00131664|364771645|FG004|First Period (First 6 Months)|Adverse Event|0|||
105759662|NCT00131664|364771646|FG005|First Period (First 6 Months)|Adverse Event|0|||
105759663|NCT00131664|364771641|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
105759664|NCT00131664|364771642|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
105759665|NCT00131664|364771643|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
105759666|NCT00131664|364771644|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
105759667|NCT00131664|364771645|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
105951382|NCT03289143|365486013|FG002|Overall Study|Protocol Deviation|3|||
105951383|NCT03289143|365486014|FG003|Overall Study|Protocol Deviation|1|||
105951384|NCT03289143|365486011|FG000|Overall Study|Study Terminated By Sponsor|101|||
105951385|NCT03289143|365486012|FG001|Overall Study|Study Terminated By Sponsor|75|||
105951386|NCT03289143|365486013|FG002|Overall Study|Study Terminated By Sponsor|100|||
105951387|NCT03289143|365486014|FG003|Overall Study|Study Terminated By Sponsor|69|||
105951388|NCT03289143|365486011|FG000|Overall Study|Withdrawal by Subject|14|||
105951389|NCT03289143|365486012|FG001|Overall Study|Withdrawal by Subject|6|||
105759668|NCT00131664|364771646|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
105759669|NCT00131664|364771641|FG000|First Period (First 6 Months)|Administrative reasons|2|||
105759670|NCT00131664|364771642|FG001|First Period (First 6 Months)|Administrative reasons|0|||
105759671|NCT00131664|364771643|FG002|First Period (First 6 Months)|Administrative reasons|5|||
105759672|NCT00131664|364771644|FG003|First Period (First 6 Months)|Administrative reasons|0|||
105759673|NCT00131664|364771645|FG004|First Period (First 6 Months)|Administrative reasons|0|||
105759674|NCT00131664|364771646|FG005|First Period (First 6 Months)|Administrative reasons|0|||
105759675|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
105759676|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
105804997|NCT03111147|364942003|FG001|Overall Study|Lost to Follow-up|5|||
105951390|NCT03289143|365486013|FG002|Overall Study|Withdrawal by Subject|14|||
105951391|NCT03289143|365486014|FG003|Overall Study|Withdrawal by Subject|12|||
105951392|NCT03289143|365486011|FG000|Overall Study|Adverse Event|10|||
105951393|NCT03289143|365486012|FG001|Overall Study|Adverse Event|7|||
105951394|NCT03289143|365486013|FG002|Overall Study|Adverse Event|6|||
105951395|NCT03289143|365486014|FG003|Overall Study|Adverse Event|5|||
105951396|NCT03289143|365486011|FG000|Overall Study|Death|2|||
105951397|NCT03289143|365486012|FG001|Overall Study|Death|0|||
105951398|NCT03289143|365486013|FG002|Overall Study|Death|2|||
105951399|NCT03289143|365486014|FG003|Overall Study|Death|1|||
105951400|NCT03289143|365486011|FG000|Overall Study|Lost to Follow-up|2|||
105951401|NCT03289143|365486012|FG001|Overall Study|Lost to Follow-up|1|||
105951402|NCT03289143|365486013|FG002|Overall Study|Lost to Follow-up|1|||
105951403|NCT03289143|365486014|FG003|Overall Study|Lost to Follow-up|0|||
105951404|NCT03289143|365486011|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
105951405|NCT03289143|365486012|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
105951406|NCT03289143|365486013|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
105951407|NCT03289143|365486014|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
105951408|NCT03289143|365486011|FG000|Overall Study|Withdrawal by Caregiver|0|||
105951409|NCT03289143|365486012|FG001|Overall Study|Withdrawal by Caregiver|1|||
105951410|NCT03289143|365486013|FG002|Overall Study|Withdrawal by Caregiver|0|||
105951411|NCT03289143|365486014|FG003|Overall Study|Withdrawal by Caregiver|0|||
105951412|NCT03289143|365486011|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
105951413|NCT03289143|365486012|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
105951414|NCT03289143|365486013|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
105951415|NCT03289143|365486014|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
105951416|NCT03289143|365486011|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
105951417|NCT03289143|365486012|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
105951418|NCT03289143|365486013|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
105951419|NCT03289143|365486014|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
105951420|NCT00730756|365486015|FG000|Overall Study|Adverse Event|2|||
105951421|NCT00730756|365486016|FG001|Overall Study|Adverse Event|0|||
105951422|NCT00730756|365486015|FG000|Overall Study|Lack of Efficacy|1|||
105951423|NCT00730756|365486016|FG001|Overall Study|Lack of Efficacy|1|||
105951424|NCT00730756|365486015|FG000|Overall Study|Protocol Deviation|1|||
105951425|NCT00730756|365486016|FG001|Overall Study|Protocol Deviation|2|||
105951426|NCT00730756|365486015|FG000|Overall Study|Lost to Follow-up|0|||
105951427|NCT00730756|365486016|FG001|Overall Study|Lost to Follow-up|1|||
105951428|NCT00730756|365486015|FG000|Overall Study|Withdrew Consent|0|||
105951429|NCT00730756|365486016|FG001|Overall Study|Withdrew Consent|1|||
105951430|NCT01475721|365486022|FG000|Overall Study|Death|3|||
105951431|NCT01475721|365486023|FG001|Overall Study|Death|6|||
105951432|NCT01475721|365486022|FG000|Overall Study|Withdrawal by Subject|8|||
105951433|NCT01475721|365486023|FG001|Overall Study|Withdrawal by Subject|8|||
105951434|NCT00690794|365486026|FG000|Overall Study|Adverse Event|12|||
105951435|NCT00690794|365486027|FG001|Overall Study|Adverse Event|10|||
105951436|NCT00690794|365486026|FG000|Overall Study|Lost to Follow-up|1|||
105951437|NCT00690794|365486027|FG001|Overall Study|Lost to Follow-up|4|||
105951438|NCT00690794|365486026|FG000|Overall Study|Withdrawal by Subject|0|||
105951439|NCT00690794|365486027|FG001|Overall Study|Withdrawal by Subject|9|||
105951440|NCT00690794|365486026|FG000|Overall Study|Protocol Violation|6|||
105951441|NCT00690794|365486027|FG001|Overall Study|Protocol Violation|7|||
105951442|NCT00690794|365486026|FG000|Overall Study|Noncompliance|1|||
105951443|NCT00690794|365486027|FG001|Overall Study|Noncompliance|2|||
105951444|NCT00690794|365486026|FG000|Overall Study|Other not specified|1|||
105951445|NCT00690794|365486027|FG001|Overall Study|Other not specified|3|||
105951446|NCT01496287|365486028|FG000|Overall Study|Lost to Follow-up|1|||
105951447|NCT01496287|365486028|FG000|Overall Study|Incomplete anesthesia|5|||
105951448|NCT03012334|365486029|FG000|Period 1|Withdrawal by Subject|0|||
105951449|NCT03012334|365486030|FG001|Period 1|Withdrawal by Subject|0|||
105951450|NCT03012334|365486031|FG002|Period 1|Withdrawal by Subject|0|||
105951451|NCT03012334|365486032|FG003|Period 1|Withdrawal by Subject|0|||
105951452|NCT03012334|365486033|FG004|Period 1|Withdrawal by Subject|0|||
105951453|NCT03012334|365486034|FG005|Period 1|Withdrawal by Subject|0|||
105951454|NCT03012334|365486035|FG006|Period 1|Withdrawal by Subject|0|||
105759677|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
106016646|NCT02827877|365724483|FG000|Overall Study|Withdrawal by Subject|1|||
106016647|NCT06083506|365724484|FG000|Overall Study|Physician Decision|2|||
105759678|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
106016648|NCT06083506|365724484|FG000|Overall Study|Lack of Efficacy|1|||
105951455|NCT03012334|365486036|FG007|Period 1|Withdrawal by Subject|0|||
105951456|NCT03012334|365486037|FG008|Period 1|Withdrawal by Subject|0|||
105951457|NCT03012334|365486038|FG009|Period 1|Withdrawal by Subject|1|||
105951458|NCT03012334|365486029|FG000|Period 2|Withdrawal by Subject|0|||
105951459|NCT03012334|365486030|FG001|Period 2|Withdrawal by Subject|1|||
105951460|NCT03012334|365486031|FG002|Period 2|Withdrawal by Subject|0|||
105951461|NCT03012334|365486032|FG003|Period 2|Withdrawal by Subject|0|||
105951462|NCT03012334|365486033|FG004|Period 2|Withdrawal by Subject|0|||
105951463|NCT03012334|365486034|FG005|Period 2|Withdrawal by Subject|0|||
105951464|NCT03012334|365486035|FG006|Period 2|Withdrawal by Subject|0|||
105951465|NCT03012334|365486036|FG007|Period 2|Withdrawal by Subject|0|||
105951466|NCT03012334|365486037|FG008|Period 2|Withdrawal by Subject|0|||
105951467|NCT03012334|365486038|FG009|Period 2|Withdrawal by Subject|0|||
105951468|NCT03012334|365486029|FG000|Period 2|Protocol Violation|0|||
105951469|NCT03012334|365486030|FG001|Period 2|Protocol Violation|0|||
105951470|NCT03012334|365486031|FG002|Period 2|Protocol Violation|1|||
105951471|NCT03012334|365486032|FG003|Period 2|Protocol Violation|0|||
105951472|NCT03012334|365486033|FG004|Period 2|Protocol Violation|0|||
105951473|NCT03012334|365486034|FG005|Period 2|Protocol Violation|0|||
105951474|NCT03012334|365486035|FG006|Period 2|Protocol Violation|0|||
105951475|NCT03012334|365486036|FG007|Period 2|Protocol Violation|1|||
105951476|NCT03012334|365486037|FG008|Period 2|Protocol Violation|0|||
105951477|NCT03012334|365486038|FG009|Period 2|Protocol Violation|0|||
105951478|NCT03012334|365486029|FG000|Period 4|Non-Compliance|0|||
105951479|NCT03012334|365486030|FG001|Period 4|Non-Compliance|0|||
105951480|NCT03012334|365486031|FG002|Period 4|Non-Compliance|0|||
105951481|NCT03012334|365486032|FG003|Period 4|Non-Compliance|0|||
105951482|NCT03012334|365486033|FG004|Period 4|Non-Compliance|0|||
105951483|NCT03012334|365486034|FG005|Period 4|Non-Compliance|0|||
105951484|NCT03012334|365486035|FG006|Period 4|Non-Compliance|1|||
105951485|NCT03012334|365486036|FG007|Period 4|Non-Compliance|0|||
105951486|NCT03012334|365486037|FG008|Period 4|Non-Compliance|0|||
105951487|NCT03012334|365486038|FG009|Period 4|Non-Compliance|0|||
105951488|NCT03012334|365486029|FG000|Period 4|Adverse Event|0|||
105951489|NCT03012334|365486030|FG001|Period 4|Adverse Event|0|||
105951490|NCT03012334|365486031|FG002|Period 4|Adverse Event|0|||
105951491|NCT03012334|365486032|FG003|Period 4|Adverse Event|0|||
105951492|NCT03012334|365486033|FG004|Period 4|Adverse Event|0|||
105951493|NCT03012334|365486034|FG005|Period 4|Adverse Event|0|||
105951494|NCT03012334|365486035|FG006|Period 4|Adverse Event|0|||
105951495|NCT03012334|365486036|FG007|Period 4|Adverse Event|0|||
105951496|NCT03012334|365486037|FG008|Period 4|Adverse Event|1|||
105951497|NCT03012334|365486038|FG009|Period 4|Adverse Event|0|||
105951498|NCT01823107|365486039|FG000|Overall Study|Withdrawal by Subject|1|||
105951499|NCT01008618|365486040|FG000|Period 1 (Titration Period)|Physician Decision|2|||
105951500|NCT01008618|365486041|FG001|Period 1 (Titration Period)|Physician Decision|0|||
105951501|NCT01008618|365486042|FG002|Period 1 (Titration Period)|Physician Decision|0|||
105951502|NCT01008618|365486040|FG000|Period 1 (Titration Period)|Adverse Event|33|||
105951503|NCT01008618|365486041|FG001|Period 1 (Titration Period)|Adverse Event|0|||
105951504|NCT01008618|365486042|FG002|Period 1 (Titration Period)|Adverse Event|0|||
105951505|NCT01008618|365486040|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
105951506|NCT01008618|365486041|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
105951507|NCT01008618|365486042|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
105951508|NCT01008618|365486040|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
105951509|NCT01008618|365486041|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
105951510|NCT01008618|365486042|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
105951511|NCT01008618|365486040|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
105951512|NCT01008618|365486041|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
105951513|NCT01008618|365486042|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
105951514|NCT01008618|365486040|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
105951515|NCT01008618|365486041|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
105951516|NCT01008618|365486042|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
105951517|NCT01008618|365486040|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
105951518|NCT01008618|365486041|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
105951519|NCT01008618|365486042|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
105951520|NCT01008618|365486040|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
105951521|NCT01008618|365486041|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
105951522|NCT01008618|365486042|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
105804998|NCT03111147|364942002|FG000|Overall Study|Withdrawal by Subject|4|||
105951523|NCT01008618|365486040|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
105951524|NCT01008618|365486041|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
105951525|NCT01008618|365486042|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
105951526|NCT01008618|365486040|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
105951527|NCT01008618|365486041|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
105951528|NCT01008618|365486042|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
105951529|NCT01008618|365486040|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
105759679|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
105759680|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
105759681|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
105759682|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
105759683|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
105759684|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
105759685|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
105759686|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
105759687|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
105759688|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759689|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759690|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759691|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759692|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
105759693|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
105759694|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
105759695|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
105759696|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
105759697|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
105759698|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
105759699|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759700|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759701|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759702|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
105759703|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759704|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
105759705|NCT00131664|364771641|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
105759706|NCT00131664|364771642|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
105759707|NCT00131664|364771643|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
105759708|NCT00131664|364771644|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
105759709|NCT00131664|364771645|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
105759710|NCT00131664|364771646|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
105759711|NCT00892957|364771647|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
105759712|NCT00892957|364771648|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
105759713|NCT00892957|364771647|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
105759714|NCT00892957|364771648|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
105759715|NCT02091921|364771649|FG000|Overall Study|Adverse Event|3|||
105759716|NCT01626989|364771657|FG000|Screening Period|Screen Failure|15|||
105759717|NCT01626989|364771658|FG001|Screening Period|Screen Failure|0|||
105759718|NCT01626989|364771659|FG002|Screening Period|Screen Failure|0|||
105759719|NCT01626989|364771657|FG000|Screening Period|Withdrawal by Subject|2|||
105759720|NCT01626989|364771658|FG001|Screening Period|Withdrawal by Subject|0|||
105759721|NCT01626989|364771659|FG002|Screening Period|Withdrawal by Subject|0|||
105759722|NCT04876599|364771662|FG000|Overall Study|Missed|2|||
105759723|NCT04876599|364771663|FG001|Overall Study|Missed|0|||
105759724|NCT04876599|364771662|FG000|Overall Study|Declined|2|||
105759725|NCT04876599|364771663|FG001|Overall Study|Declined|3|||
105759726|NCT03175562|364771664|FG000|Overall Study|Adverse Event|1|||
105759727|NCT03175562|364771664|FG000|Overall Study|Lost to Follow-up|3|||
105759728|NCT03175562|364771664|FG000|Overall Study|Withdrawal by Subject|7|||
105759729|NCT03175562|364771664|FG000|Overall Study|Other (Not Specified)|5|||
105759730|NCT02146833|364771665|FG000|Overall Study|Death|10|||
105759731|NCT02146833|364771665|FG000|Overall Study|No longer consented to study treatment|1|||
105759732|NCT01770145|364773748|FG000|Baseline|Adverse Event|20|||
105759733|NCT01770145|364773748|FG000|Baseline|Withdrawal by Subject|1|||
105759734|NCT01770145|364773748|FG000|Baseline|Lost to Follow-up|1|||
105759735|NCT01770145|364773748|FG000|Baseline|Unable to define optimal dose|4|||
105759736|NCT01770145|364773748|FG000|Treatment|Adverse Event|3|||
105951530|NCT01008618|365486041|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
105951531|NCT01008618|365486042|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
105951532|NCT01008618|365486040|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
105951533|NCT01008618|365486041|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
105951534|NCT01008618|365486042|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
105951535|NCT01213082|365486048|FG000|Overall Study|Lost to Follow-up|6|||
105951536|NCT01213082|365486049|FG001|Overall Study|Lost to Follow-up|7|||
105759737|NCT01770145|364773748|FG000|Treatment|Withdrawal by Subject|1|||
105759738|NCT02332798|364773749|FG000|Overall Study|Unwilling to Participate in Study|0|||
105759739|NCT02332798|364773750|FG001|Overall Study|Unwilling to Participate in Study|1|||
105951537|NCT01213082|365486050|FG002|Overall Study|Lost to Follow-up|4|||
105951538|NCT01213082|365486048|FG000|Overall Study|Physician Decision|0|||
105951539|NCT01213082|365486049|FG001|Overall Study|Physician Decision|0|||
105951540|NCT01213082|365486050|FG002|Overall Study|Physician Decision|1|||
105951541|NCT01627691|365486051|FG000|Overall Study|Death|11|||
106142975|NCT03861767|366183599|FG008|Overall Study|Withdrawal by Subject|0|||
106142976|NCT03861767|366183600|FG009|Overall Study|Withdrawal by Subject|5|||
106142977|NCT00346333|366183601|FG000|Overall Study|Death|1|||
106142978|NCT00346333|366183602|FG001|Overall Study|Death|0|||
106142979|NCT00346333|366183601|FG000|Overall Study|unwilling or unable to continue|4|||
106142980|NCT00346333|366183602|FG001|Overall Study|unwilling or unable to continue|8|||
106142981|NCT00424762|366183603|FG000|Overall Study|Withdrawal by Subject|18|||
106142982|NCT00424762|366183604|FG001|Overall Study|Withdrawal by Subject|19|||
106142983|NCT00424762|366183603|FG000|Overall Study|Lost to Follow-up|2|||
106142984|NCT00424762|366183604|FG001|Overall Study|Lost to Follow-up|3|||
106142985|NCT02506257|366183605|FG000|Overall Study|Adverse Event|0|||
106142986|NCT02506257|366183606|FG001|Overall Study|Adverse Event|2|||
105759740|NCT02332798|364773751|FG002|Overall Study|Unwilling to Participate in Study|1|||
105759741|NCT02332798|364773749|FG000|Overall Study|Positive Urine Drug Test|0|||
105759742|NCT02332798|364773750|FG001|Overall Study|Positive Urine Drug Test|1|||
105759743|NCT02332798|364773751|FG002|Overall Study|Positive Urine Drug Test|0|||
106142987|NCT02506257|366183607|FG002|Overall Study|Adverse Event|3|||
106142988|NCT02506257|366183608|FG003|Overall Study|Adverse Event|0|||
106142989|NCT02506257|366183605|FG000|Overall Study|Protocol Violation|0|||
106142990|NCT02506257|366183606|FG001|Overall Study|Protocol Violation|0|||
105759744|NCT02332798|364773749|FG000|Overall Study|Abnormal Laboratory Findings|1|||
105759745|NCT02332798|364773750|FG001|Overall Study|Abnormal Laboratory Findings|0|||
105759746|NCT02332798|364773751|FG002|Overall Study|Abnormal Laboratory Findings|0|||
105759747|NCT00595868|364773752|FG000|Overall Study|Lost to Follow-up|45|||
105759748|NCT00595868|364773753|FG001|Overall Study|Lost to Follow-up|50|||
105759749|NCT05406440|364773754|FG000|Overall Study|Lost to Follow-up|0|||
105759750|NCT05406440|364773755|FG001|Overall Study|Lost to Follow-up|0|||
105759751|NCT05406440|364773756|FG002|Overall Study|Lost to Follow-up|0|||
105759752|NCT05406440|364773757|FG003|Overall Study|Lost to Follow-up|0|||
105759753|NCT05406440|364773758|FG004|Overall Study|Lost to Follow-up|2|||
106142991|NCT02506257|366183607|FG002|Overall Study|Protocol Violation|1|||
106142992|NCT02506257|366183608|FG003|Overall Study|Protocol Violation|0|||
105759754|NCT05406440|364773759|FG005|Overall Study|Lost to Follow-up|0|||
105759755|NCT05406440|364773760|FG006|Overall Study|Lost to Follow-up|0|||
106142993|NCT01157182|366183612|FG000|Washout of 28 Days|Adverse Event|2|||
106142994|NCT01157182|366183613|FG001|Washout of 28 Days|Adverse Event|0|||
105759756|NCT05406440|364773754|FG000|Overall Study|Physician Decision|0|||
106142995|NCT00880048|366183619|FG000|Overall Study|Adverse Event|2|||
106142996|NCT00880048|366183620|FG001|Overall Study|Adverse Event|3|||
106142997|NCT00880048|366183621|FG002|Overall Study|Adverse Event|5|||
105759757|NCT05406440|364773755|FG001|Overall Study|Physician Decision|0|||
105951542|NCT01627691|365486051|FG000|Overall Study|Lost to Follow-up|3|||
105759758|NCT05406440|364773756|FG002|Overall Study|Physician Decision|0|||
105759759|NCT05406440|364773757|FG003|Overall Study|Physician Decision|0|||
105759760|NCT05406440|364773758|FG004|Overall Study|Physician Decision|1|||
105759761|NCT05406440|364773759|FG005|Overall Study|Physician Decision|0|||
105759762|NCT05406440|364773760|FG006|Overall Study|Physician Decision|0|||
105759763|NCT05406440|364773754|FG000|Overall Study|Withdrawal by Subject|0|||
105759764|NCT05406440|364773755|FG001|Overall Study|Withdrawal by Subject|0|||
105759765|NCT05406440|364773756|FG002|Overall Study|Withdrawal by Subject|0|||
105759766|NCT05406440|364773757|FG003|Overall Study|Withdrawal by Subject|0|||
105759767|NCT05406440|364773758|FG004|Overall Study|Withdrawal by Subject|0|||
105759768|NCT05406440|364773759|FG005|Overall Study|Withdrawal by Subject|2|||
105759769|NCT05406440|364773760|FG006|Overall Study|Withdrawal by Subject|0|||
106142998|NCT00880048|366183619|FG000|Overall Study|Lack of Efficacy|1|||
106142999|NCT00880048|366183620|FG001|Overall Study|Lack of Efficacy|2|||
106143000|NCT00880048|366183621|FG002|Overall Study|Lack of Efficacy|2|||
106143001|NCT00880048|366183619|FG000|Overall Study|Protocol Violation|4|||
106143002|NCT00880048|366183620|FG001|Overall Study|Protocol Violation|6|||
106143003|NCT00880048|366183621|FG002|Overall Study|Protocol Violation|5|||
106143004|NCT00880048|366183619|FG000|Overall Study|Lost to Follow-up|6|||
106143005|NCT00880048|366183620|FG001|Overall Study|Lost to Follow-up|6|||
106143006|NCT00880048|366183621|FG002|Overall Study|Lost to Follow-up|5|||
106143007|NCT00880048|366183619|FG000|Overall Study|Physician Decision|1|||
106143008|NCT00880048|366183620|FG001|Overall Study|Physician Decision|1|||
106143009|NCT00880048|366183621|FG002|Overall Study|Physician Decision|7|||
106143010|NCT00880048|366183619|FG000|Overall Study|Withdrawal by Subject|5|||
106143011|NCT00880048|366183620|FG001|Overall Study|Withdrawal by Subject|8|||
106143012|NCT00880048|366183621|FG002|Overall Study|Withdrawal by Subject|5|||
106143013|NCT00880048|366183619|FG000|Overall Study|Study closed/terminated|9|||
106143014|NCT00880048|366183620|FG001|Overall Study|Study closed/terminated|7|||
106143015|NCT00880048|366183621|FG002|Overall Study|Study closed/terminated|6|||
106143016|NCT05001945|366183624|FG000|Overall Study|Adverse Event|0|||
106143017|NCT05001945|366183625|FG001|Overall Study|Adverse Event|0|||
106143018|NCT05001945|366183626|FG002|Overall Study|Adverse Event|0|||
106143019|NCT05001945|366183627|FG003|Overall Study|Adverse Event|1|||
106143020|NCT05001945|366183628|FG004|Overall Study|Adverse Event|0|||
106143021|NCT05001945|366183629|FG005|Overall Study|Adverse Event|0|||
106143022|NCT05001945|366183630|FG006|Overall Study|Adverse Event|0|||
106143023|NCT05001945|366183631|FG007|Overall Study|Adverse Event|0|||
105759770|NCT02687711|364773761|FG000|Overall Study|Adverse Event|89|||
105759771|NCT02687711|364773761|FG000|Overall Study|Lack of Efficacy|70|||
105759772|NCT02687711|364773761|FG000|Overall Study|Lost to Follow-up|20|||
105951543|NCT01627691|365486051|FG000|Overall Study|Withdrawal by Subject|1|||
105951544|NCT01627691|365486051|FG000|Overall Study|Missed the visit|3|||
105951545|NCT00856323|365486052|FG000|Overall Study|Withdrawal by Subject|2|||
105951546|NCT02848092|365486053|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
105951547|NCT02848092|365486054|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
105951548|NCT02848092|365486053|FG000|1-month Post-training Follow-up|Adverse Event|2|||
105951549|NCT02848092|365486054|FG001|1-month Post-training Follow-up|Adverse Event|1|||
105951550|NCT02848092|365486053|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
105951551|NCT02848092|365486054|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
105951552|NCT02848092|365486053|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
105951553|NCT02848092|365486054|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
105951554|NCT02848092|365486053|FG000|1-month Post-training Follow-up|fatigue|0|||
105951555|NCT02848092|365486054|FG001|1-month Post-training Follow-up|fatigue|1|||
106016649|NCT02257736|365724485|FG000|Overall Study|Progressive disease|365|||
106016650|NCT02257736|365724486|FG001|Overall Study|Progressive disease|327|||
105759773|NCT02687711|364773761|FG000|Overall Study|Consent withdrawn|15|||
105759774|NCT02687711|364773761|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
105759775|NCT02687711|364773761|FG000|Overall Study|Too expensive|4|||
105759776|NCT02687711|364773761|FG000|Overall Study|Participant moved abroad|1|||
105759777|NCT02687711|364773761|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
106016651|NCT02257736|365724485|FG000|Overall Study|Adverse Event|45|||
106143024|NCT05001945|366183624|FG000|Overall Study|Lost to Follow-up|0|||
106143025|NCT05001945|366183625|FG001|Overall Study|Lost to Follow-up|1|||
106143026|NCT05001945|366183626|FG002|Overall Study|Lost to Follow-up|1|||
106143027|NCT05001945|366183627|FG003|Overall Study|Lost to Follow-up|2|||
106143028|NCT05001945|366183628|FG004|Overall Study|Lost to Follow-up|0|||
106143029|NCT05001945|366183629|FG005|Overall Study|Lost to Follow-up|1|||
106143030|NCT05001945|366183630|FG006|Overall Study|Lost to Follow-up|0|||
106143031|NCT05001945|366183631|FG007|Overall Study|Lost to Follow-up|0|||
106143032|NCT05001945|366183624|FG000|Overall Study|Protocol Violation|1|||
106143033|NCT05001945|366183625|FG001|Overall Study|Protocol Violation|0|||
106143034|NCT05001945|366183626|FG002|Overall Study|Protocol Violation|1|||
106143035|NCT05001945|366183627|FG003|Overall Study|Protocol Violation|1|||
106143036|NCT05001945|366183628|FG004|Overall Study|Protocol Violation|0|||
106143037|NCT05001945|366183629|FG005|Overall Study|Protocol Violation|1|||
106143038|NCT05001945|366183630|FG006|Overall Study|Protocol Violation|0|||
106143039|NCT05001945|366183631|FG007|Overall Study|Protocol Violation|0|||
106143040|NCT05001945|366183624|FG000|Overall Study|Withdrawal by Subject|0|||
106143041|NCT05001945|366183625|FG001|Overall Study|Withdrawal by Subject|0|||
106143042|NCT05001945|366183626|FG002|Overall Study|Withdrawal by Subject|0|||
106143043|NCT05001945|366183627|FG003|Overall Study|Withdrawal by Subject|1|||
106143044|NCT05001945|366183628|FG004|Overall Study|Withdrawal by Subject|1|||
106143045|NCT05001945|366183629|FG005|Overall Study|Withdrawal by Subject|1|||
106143046|NCT05001945|366183630|FG006|Overall Study|Withdrawal by Subject|0|||
106143047|NCT05001945|366183631|FG007|Overall Study|Withdrawal by Subject|1|||
106143048|NCT05001945|366183624|FG000|Overall Study|Not specified by Investigator|0|||
106143049|NCT05001945|366183625|FG001|Overall Study|Not specified by Investigator|3|||
106143050|NCT05001945|366183626|FG002|Overall Study|Not specified by Investigator|0|||
106143051|NCT05001945|366183627|FG003|Overall Study|Not specified by Investigator|0|||
106143052|NCT05001945|366183628|FG004|Overall Study|Not specified by Investigator|1|||
106143053|NCT05001945|366183629|FG005|Overall Study|Not specified by Investigator|0|||
106143054|NCT05001945|366183630|FG006|Overall Study|Not specified by Investigator|0|||
106143055|NCT05001945|366183631|FG007|Overall Study|Not specified by Investigator|0|||
106143056|NCT05382104|366183634|FG000|Period 2 (2 Days)|Adverse Event|0|||
106143057|NCT05382104|366183635|FG001|Period 2 (2 Days)|Adverse Event|1|||
106143058|NCT05382104|366183636|FG002|Period 2 (2 Days)|Adverse Event|0|||
106143059|NCT05382104|366183637|FG003|Period 2 (2 Days)|Adverse Event|0|||
106143060|NCT05382104|366183638|FG004|Period 2 (2 Days)|Adverse Event|0|||
105759778|NCT02687711|364773761|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
105759779|NCT02687711|364773761|FG000|Overall Study|Disliked taste|1|||
105759780|NCT02687711|364773761|FG000|Overall Study|Low mood|1|||
105759781|NCT02687711|364773761|FG000|Overall Study|Side effects|1|||
105951556|NCT02848092|365486053|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
106143061|NCT05382104|366183639|FG005|Period 2 (2 Days)|Adverse Event|0|||
106143062|NCT02547922|366183642|FG000|Overall Study|Withdrawal by Subject|9|||
106143063|NCT02547922|366183643|FG001|Overall Study|Withdrawal by Subject|6|||
106143064|NCT02547922|366183644|FG002|Overall Study|Withdrawal by Subject|10|||
106143065|NCT02547922|366183642|FG000|Overall Study|Adverse Event|3|||
106143066|NCT02547922|366183643|FG001|Overall Study|Adverse Event|1|||
105759782|NCT02687711|364773761|FG000|Overall Study|Change of Hospital|1|||
105759783|NCT02687711|364773761|FG000|Overall Study|Liver Encephalopathy|1|||
105759784|NCT02687711|364773761|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
105951557|NCT02848092|365486054|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
105951558|NCT02848092|365486053|FG000|6-month Post-training Follow-up|Adverse Event|1|||
105951559|NCT02848092|365486054|FG001|6-month Post-training Follow-up|Adverse Event|1|||
105951560|NCT02848092|365486053|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
105951561|NCT02848092|365486054|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
105951562|NCT02848092|365486053|FG000|6-month Post-training Follow-up|frustrated with task|1|||
105951563|NCT02848092|365486054|FG001|6-month Post-training Follow-up|frustrated with task|0|||
105951564|NCT02848092|365486053|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
105951565|NCT02848092|365486054|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
105951566|NCT02848092|365486053|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
105951567|NCT02848092|365486054|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
105951568|NCT01639469|365486058|FG000|Overall Study|Death|4|||
105951569|NCT01639469|365486059|FG001|Overall Study|Death|2|||
105951570|NCT01639469|365486058|FG000|Overall Study|Lost to Follow-up|1|||
105951571|NCT01639469|365486059|FG001|Overall Study|Lost to Follow-up|1|||
105951572|NCT01119443|365486060|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
105951573|NCT01119443|365486061|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
105951574|NCT04828707|365486064|FG000|Overall Study|Lost to Follow-up|3|||
105951575|NCT04828707|365486065|FG001|Overall Study|Lost to Follow-up|2|||
105951576|NCT04828707|365486064|FG000|Overall Study|Withdrawal by Subject|2|||
105951577|NCT04828707|365486065|FG001|Overall Study|Withdrawal by Subject|1|||
105951578|NCT01887717|365486066|FG000|Overall Study|Withdrawal by Subject|1|||
105951579|NCT01887717|365486067|FG001|Overall Study|Withdrawal by Subject|7|||
105951580|NCT01887717|365486066|FG000|Overall Study|Physician Decision|0|||
105951581|NCT01887717|365486067|FG001|Overall Study|Physician Decision|2|||
105951582|NCT01887717|365486066|FG000|Overall Study|Administrative reasons|5|||
105951583|NCT01887717|365486067|FG001|Overall Study|Administrative reasons|2|||
105951584|NCT00087698|365486069|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
105951585|NCT00087698|365486069|FG000|Overall Study|Death from Other Causes|3|||
105951586|NCT00087698|365486069|FG000|Overall Study|Adverse Event|4|||
105951587|NCT00087698|365486069|FG000|Overall Study|Withdrawal by Subject|4|||
105951588|NCT00087698|365486069|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
105951589|NCT00087698|365486069|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
105951590|NCT00087698|365486069|FG000|Overall Study|Clinical Relapse|1|||
105951591|NCT00087698|365486069|FG000|Overall Study|Death from Study Disease|2|||
105951592|NCT00087698|365486069|FG000|Overall Study|Death from Study Drug Toxicity|2|||
105951593|NCT00087698|365486069|FG000|Overall Study|Protocol Violation|1|||
105951594|NCT02765399|365486072|FG000|Overall Study|Nausea|1|||
105951595|NCT02765399|365486073|FG001|Overall Study|Nausea|0|||
106143067|NCT02547922|366183644|FG002|Overall Study|Adverse Event|2|||
106143068|NCT02547922|366183642|FG000|Overall Study|Lost to Follow-up|1|||
106143069|NCT02547922|366183643|FG001|Overall Study|Lost to Follow-up|0|||
106143070|NCT02547922|366183644|FG002|Overall Study|Lost to Follow-up|0|||
106143071|NCT02547922|366183642|FG000|Overall Study|Lack of Efficacy|5|||
106143072|NCT02547922|366183643|FG001|Overall Study|Lack of Efficacy|7|||
106143073|NCT02547922|366183644|FG002|Overall Study|Lack of Efficacy|4|||
106143074|NCT02547922|366183642|FG000|Overall Study|Death|1|||
106143075|NCT02547922|366183643|FG001|Overall Study|Death|0|||
106143076|NCT02547922|366183644|FG002|Overall Study|Death|0|||
106143077|NCT02547922|366183642|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
106143078|NCT02547922|366183643|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
106143079|NCT02547922|366183644|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
106143080|NCT02547922|366183642|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
106143081|NCT02547922|366183643|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
106143082|NCT02547922|366183644|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
106143083|NCT02547922|366183642|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
106143084|NCT02547922|366183643|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
106143085|NCT02547922|366183644|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
106143086|NCT02547922|366183642|FG000|Overall Study|Physician Decision|2|||
106143087|NCT02547922|366183643|FG001|Overall Study|Physician Decision|1|||
106143088|NCT02547922|366183644|FG002|Overall Study|Physician Decision|2|||
106143089|NCT02547922|366183642|FG000|Overall Study|Patients did not receive IP|1|||
105759785|NCT02687711|364773761|FG000|Overall Study|Withdrawn due to intake interruption|1|||
105951596|NCT00657267|365486081|FG000|Overall Study|Progressive disease|45|||
105951597|NCT00657267|365486081|FG000|Overall Study|Adverse Event|9|||
105951598|NCT04067492|365486082|FG000|Overall Study|Lost to Follow-up|0|||
105951599|NCT04067492|365486083|FG001|Overall Study|Lost to Follow-up|0|||
106143090|NCT02547922|366183643|FG001|Overall Study|Patients did not receive IP|1|||
105951600|NCT04067492|365486084|FG002|Overall Study|Lost to Follow-up|0|||
105951601|NCT04067492|365486085|FG003|Overall Study|Lost to Follow-up|0|||
105951602|NCT04067492|365486086|FG004|Overall Study|Lost to Follow-up|0|||
105759786|NCT02687711|364773761|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
105759787|NCT02687711|364773761|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
105759788|NCT02687711|364773761|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
105759789|NCT03077243|364773762|FG000|Overall Study|Death|1|||
105759790|NCT03077243|364773763|FG001|Overall Study|Death|2|||
105759791|NCT03077243|364773764|FG002|Overall Study|Death|0|||
105759792|NCT03077243|364773765|FG003|Overall Study|Death|0|||
105759793|NCT03077243|364773762|FG000|Overall Study|Withdrawal by Subject|1|||
105759794|NCT03077243|364773763|FG001|Overall Study|Withdrawal by Subject|3|||
105804999|NCT03111147|364942003|FG001|Overall Study|Withdrawal by Subject|3|||
105805000|NCT03111147|364942002|FG000|Overall Study|Protocol Violation|2|||
106143091|NCT02547922|366183644|FG002|Overall Study|Patients did not receive IP|0|||
106143092|NCT03194958|366183645|FG000|Overall Study|Death|0|||
106143093|NCT03194958|366183646|FG001|Overall Study|Death|1|||
106143094|NCT03194958|366183647|FG002|Overall Study|Death|1|||
106143095|NCT03194958|366183648|FG003|Overall Study|Death|1|||
106143096|NCT03194958|366183645|FG000|Overall Study|Withdrawal by Subject|24|||
106143097|NCT03194958|366183646|FG001|Overall Study|Withdrawal by Subject|27|||
106143098|NCT03194958|366183647|FG002|Overall Study|Withdrawal by Subject|7|||
106143099|NCT03194958|366183648|FG003|Overall Study|Withdrawal by Subject|22|||
106143100|NCT03194958|366183645|FG000|Overall Study|Lost to Follow-up|168|||
106143101|NCT03194958|366183646|FG001|Overall Study|Lost to Follow-up|196|||
106143102|NCT03194958|366183647|FG002|Overall Study|Lost to Follow-up|174|||
106143103|NCT03194958|366183648|FG003|Overall Study|Lost to Follow-up|186|||
106143104|NCT04707313|366183649|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
106143105|NCT04707313|366183650|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
106143106|NCT04707313|366183651|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
106143107|NCT04707313|366183652|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
106143108|NCT04707313|366183653|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
106143109|NCT04707313|366183654|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
106143110|NCT04707313|366183655|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
106143111|NCT04707313|366183656|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
106143112|NCT04707313|366183657|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
106143113|NCT04707313|366183658|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
106143114|NCT04707313|366183659|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
106143115|NCT04707313|366183660|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
106143116|NCT04707313|366183661|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
106143117|NCT04707313|366183649|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
106143118|NCT04707313|366183650|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
106143119|NCT04707313|366183651|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143120|NCT04707313|366183652|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143121|NCT04707313|366183653|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
106143122|NCT04707313|366183654|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143123|NCT04707313|366183655|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143124|NCT04707313|366183656|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143125|NCT04707313|366183657|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143126|NCT04707313|366183658|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143127|NCT04707313|366183659|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143128|NCT04707313|366183660|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143129|NCT04707313|366183661|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
106143130|NCT04707313|366183649|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
106143131|NCT04707313|366183650|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
106143132|NCT04707313|366183651|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
106143133|NCT04707313|366183652|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
106143134|NCT04707313|366183653|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
106143135|NCT04707313|366183654|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
106143136|NCT04707313|366183655|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
106143137|NCT04707313|366183656|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
106143138|NCT04707313|366183657|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
106143139|NCT04707313|366183658|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
106143140|NCT04707313|366183659|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
106143141|NCT04707313|366183660|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
106143142|NCT04707313|366183661|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
106143143|NCT04707313|366183649|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143144|NCT04707313|366183650|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
106143145|NCT04707313|366183651|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
106143146|NCT04707313|366183652|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143147|NCT04707313|366183653|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
106143148|NCT04707313|366183654|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
105759795|NCT03077243|364773764|FG002|Overall Study|Withdrawal by Subject|0|||
105759796|NCT03077243|364773765|FG003|Overall Study|Withdrawal by Subject|0|||
105759797|NCT03077243|364773762|FG000|Overall Study|Physician Decision|1|||
105759798|NCT03077243|364773763|FG001|Overall Study|Physician Decision|0|||
105759799|NCT03077243|364773764|FG002|Overall Study|Physician Decision|0|||
105759800|NCT03077243|364773765|FG003|Overall Study|Physician Decision|0|||
105759801|NCT03077243|364773762|FG000|Overall Study|Research at two study sites terminated early|0|||
105759802|NCT03077243|364773763|FG001|Overall Study|Research at two study sites terminated early|0|||
105759803|NCT03077243|364773764|FG002|Overall Study|Research at two study sites terminated early|0|||
105759804|NCT03077243|364773765|FG003|Overall Study|Research at two study sites terminated early|69|||
105759805|NCT02848313|364773766|FG000|Overall Study|Adverse Event|1|||
105759806|NCT02848313|364773767|FG001|Overall Study|Adverse Event|2|||
105759807|NCT02848313|364773766|FG000|Overall Study|Lack of Efficacy|0|||
105759808|NCT02848313|364773767|FG001|Overall Study|Lack of Efficacy|1|||
105759809|NCT02848313|364773766|FG000|Overall Study|Withdrawal by Subject|1|||
105759810|NCT02848313|364773767|FG001|Overall Study|Withdrawal by Subject|1|||
105759811|NCT02848313|364773766|FG000|Overall Study|Lost to follow up|1|||
105759812|NCT02848313|364773767|FG001|Overall Study|Lost to follow up|0|||
105759813|NCT01544478|364773768|FG000|Overall Study|Adverse Event|1|||
105759814|NCT01544478|364773768|FG000|Overall Study|Death|1|||
105759815|NCT01544478|364773768|FG000|Overall Study|Lost to Follow-up|48|||
105759816|NCT01544478|364773768|FG000|Overall Study|Physician Decision|15|||
105759817|NCT01544478|364773768|FG000|Overall Study|Pregnancy|1|||
105759818|NCT01544478|364773768|FG000|Overall Study|Withdrawal by Subject|52|||
105805001|NCT03111147|364942003|FG001|Overall Study|Protocol Violation|1|||
105805002|NCT03111147|364942002|FG000|Overall Study|Death|1|||
105805003|NCT03111147|364942003|FG001|Overall Study|Death|1|||
105805004|NCT00003782|364942007|FG000|Overall Study|No follow up data|30|||
105805005|NCT00003782|364942008|FG001|Overall Study|No follow up data|31|||
105805006|NCT00003782|364942009|FG002|Overall Study|No follow up data|26|||
105951603|NCT04067492|365486087|FG005|Overall Study|Lost to Follow-up|1|||
105951604|NCT04067492|365486082|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105805007|NCT03118739|364942010|FG000|Overall Study|Physician Decision|0|||
105805008|NCT03118739|364942011|FG001|Overall Study|Physician Decision|1|||
105805009|NCT03118739|364942010|FG000|Overall Study|Withdrawal by Subject|5|||
105805010|NCT03118739|364942011|FG001|Overall Study|Withdrawal by Subject|3|||
105805011|NCT03118739|364942010|FG000|Overall Study|Lost to Follow-up|2|||
105805012|NCT03118739|364942011|FG001|Overall Study|Lost to Follow-up|0|||
105805013|NCT00409188|364943331|FG000|Overall Study|Ongoing at data cut-off|383|||
105805014|NCT00409188|364943332|FG001|Overall Study|Ongoing at data cut-off|175|||
105805015|NCT02468557|364943337|FG000|Overall Study|Adverse Event|1|||
105805016|NCT02468557|364943337|FG000|Overall Study|Death|1|||
105805017|NCT02468557|364943337|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
105805018|NCT02468557|364943337|FG000|Overall Study|All Enrolled but Never Dosed|4|||
105805019|NCT04014959|364943339|FG000|Baseline MRI and Assessments|Physician Decision|2|||
105805020|NCT04014959|364943339|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
105805021|NCT04014959|364943339|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
105805022|NCT02004847|364943342|FG000|Overall Study|Protocol Violation|1|||
105805023|NCT02004847|364943343|FG001|Overall Study|Protocol Violation|1|||
105805024|NCT02034799|364943344|FG000|Overall Study|Withdrawal by Subject|0|||
105805025|NCT02034799|364943345|FG001|Overall Study|Withdrawal by Subject|2|||
105805026|NCT02034799|364943344|FG000|Overall Study|Lost to Follow-up|0|||
105805027|NCT02034799|364943345|FG001|Overall Study|Lost to Follow-up|1|||
105805028|NCT02034799|364943344|FG000|Overall Study|Death|2|||
105805029|NCT02034799|364943345|FG001|Overall Study|Death|1|||
105805030|NCT00759148|364943352|FG000|Overall Study|Adverse Event|1|||
105805031|NCT00759148|364943353|FG001|Overall Study|Adverse Event|6|||
105951605|NCT04067492|365486083|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
105951606|NCT04067492|365486084|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105951607|NCT04067492|365486085|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105951608|NCT04067492|365486086|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105951609|NCT04067492|365486087|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
105951610|NCT04067492|365486082|FG000|Overall Study|COVID-19 epidemiological situation|0|||
105805032|NCT00759148|364943352|FG000|Overall Study|Withdrawal by Subject|3|||
105951611|NCT04067492|365486083|FG001|Overall Study|COVID-19 epidemiological situation|0|||
105805033|NCT00759148|364943353|FG001|Overall Study|Withdrawal by Subject|7|||
105805034|NCT00759148|364943352|FG000|Overall Study|Lost to Follow-up|3|||
105805035|NCT00759148|364943353|FG001|Overall Study|Lost to Follow-up|9|||
105759819|NCT00212758|364773771|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
105759820|NCT00212758|364773772|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
105759821|NCT00212758|364773771|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
106143149|NCT04707313|366183655|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143150|NCT04707313|366183656|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143151|NCT04707313|366183657|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143152|NCT04707313|366183658|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143153|NCT04707313|366183659|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143154|NCT04707313|366183660|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143155|NCT04707313|366183661|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
106143156|NCT04707313|366183649|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
106143157|NCT04707313|366183650|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
106143158|NCT04707313|366183651|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
106143159|NCT04707313|366183652|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
106143160|NCT04707313|366183653|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
106143161|NCT04707313|366183654|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
106143162|NCT04707313|366183655|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
106143163|NCT04707313|366183656|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
106143164|NCT04707313|366183657|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
106143165|NCT04707313|366183658|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
106143166|NCT04707313|366183659|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
106143167|NCT04707313|366183660|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
106143168|NCT04707313|366183661|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
106143169|NCT04707313|366183649|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
106143170|NCT04707313|366183650|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
106143171|NCT04707313|366183651|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
106143172|NCT04707313|366183652|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
105759822|NCT00212758|364773772|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
105759823|NCT03510910|364773773|FG000|Overall Study|Incomplete Survey|2|||
105759824|NCT03510910|364773774|FG001|Overall Study|Incomplete Survey|3|||
105759825|NCT03170258|364773779|FG000|Overall Study|Physician Decision|4|||
105759826|NCT03170258|364773780|FG001|Overall Study|Physician Decision|0|||
105759827|NCT03170258|364773779|FG000|Overall Study|Equipment issues|1|||
105759828|NCT03170258|364773780|FG001|Overall Study|Equipment issues|0|||
105759829|NCT03170258|364773779|FG000|Overall Study|Medication|1|||
105759830|NCT03170258|364773780|FG001|Overall Study|Medication|0|||
105759831|NCT03170258|364773779|FG000|Overall Study|Sleep issues|1|||
105759832|NCT03170258|364773780|FG001|Overall Study|Sleep issues|0|||
105759833|NCT01563107|364773785|FG000|Overall Study|Physician Decision|0|||
105759834|NCT01563107|364773786|FG001|Overall Study|Physician Decision|1|||
105759835|NCT01563107|364773787|FG002|Overall Study|Physician Decision|1|||
105759836|NCT01563107|364773788|FG003|Overall Study|Physician Decision|3|||
105759837|NCT01563107|364773785|FG000|Overall Study|Withdrawal by Subject|1|||
105759838|NCT01563107|364773786|FG001|Overall Study|Withdrawal by Subject|2|||
105759839|NCT01563107|364773787|FG002|Overall Study|Withdrawal by Subject|1|||
105759840|NCT01563107|364773788|FG003|Overall Study|Withdrawal by Subject|2|||
105759841|NCT01175590|364773791|FG000|Overall Study|Lost to Follow-up|1|||
105759842|NCT01175590|364773792|FG001|Overall Study|Lost to Follow-up|0|||
105759843|NCT01175590|364773791|FG000|Overall Study|Withdrawal by Subject|0|||
105759844|NCT01175590|364773792|FG001|Overall Study|Withdrawal by Subject|2|||
105759845|NCT01175590|364773791|FG000|Overall Study|Adverse Event|4|||
105759846|NCT01175590|364773792|FG001|Overall Study|Adverse Event|0|||
105759847|NCT01175590|364773791|FG000|Overall Study|Physician Decision|1|||
105759848|NCT01175590|364773792|FG001|Overall Study|Physician Decision|4|||
106143173|NCT04707313|366183653|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
106143174|NCT04707313|366183654|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
106143175|NCT04707313|366183655|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
105759849|NCT01175590|364773791|FG000|Overall Study|Lack of Efficacy|1|||
105759850|NCT01175590|364773792|FG001|Overall Study|Lack of Efficacy|1|||
105759851|NCT01175590|364773791|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
105759852|NCT01175590|364773792|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
105759853|NCT01175590|364773791|FG000|Overall Study|Treated not as randomized|3|||
105759854|NCT01175590|364773792|FG001|Overall Study|Treated not as randomized|2|||
105759855|NCT01175590|364773791|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
105759856|NCT01175590|364773792|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
105759857|NCT01175590|364773791|FG000|Overall Study|Protocol Violation|0|||
105759858|NCT01175590|364773792|FG001|Overall Study|Protocol Violation|1|||
105759859|NCT00666536|364773793|FG000|Overall Study|Adverse Event|9|||
105759860|NCT00666536|364773794|FG001|Overall Study|Adverse Event|19|||
105759861|NCT00666536|364773793|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105759862|NCT00666536|364773794|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105759863|NCT00666536|364773793|FG000|Overall Study|Protocol deviation(s)|8|||
105759864|NCT00666536|364773794|FG001|Overall Study|Protocol deviation(s)|6|||
105759865|NCT00666536|364773793|FG000|Overall Study|Withdrawal by Subject|10|||
105759866|NCT00666536|364773794|FG001|Overall Study|Withdrawal by Subject|9|||
105759867|NCT00666536|364773793|FG000|Overall Study|Lost to Follow-up|4|||
105759868|NCT00666536|364773794|FG001|Overall Study|Lost to Follow-up|3|||
105759869|NCT02327078|364773795|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
105759870|NCT02327078|364773796|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
105759871|NCT02327078|364773797|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
105759872|NCT02327078|364773798|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
105759873|NCT02327078|364773799|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
105759874|NCT02327078|364773800|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
105759875|NCT02327078|364773801|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
105759876|NCT02327078|364773802|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
105759877|NCT02327078|364773803|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
105759878|NCT02327078|364773795|FG000|Overall Study|Death|2|||
105759879|NCT02327078|364773796|FG001|Overall Study|Death|4|||
105759880|NCT02327078|364773797|FG002|Overall Study|Death|10|||
105759881|NCT02327078|364773798|FG003|Overall Study|Death|6|||
105759882|NCT02327078|364773799|FG004|Overall Study|Death|4|||
105759883|NCT02327078|364773800|FG005|Overall Study|Death|3|||
105759884|NCT02327078|364773801|FG006|Overall Study|Death|2|||
105759885|NCT02327078|364773802|FG007|Overall Study|Death|51|||
105759886|NCT02327078|364773803|FG008|Overall Study|Death|97|||
105759887|NCT02327078|364773795|FG000|Overall Study|Lost to Follow-up|0|||
105759888|NCT02327078|364773796|FG001|Overall Study|Lost to Follow-up|1|||
105759889|NCT02327078|364773797|FG002|Overall Study|Lost to Follow-up|1|||
105759890|NCT02327078|364773798|FG003|Overall Study|Lost to Follow-up|0|||
105805036|NCT00759148|364943352|FG000|Overall Study|Treatment Failure|6|||
105805037|NCT00759148|364943353|FG001|Overall Study|Treatment Failure|10|||
105805038|NCT00759148|364943352|FG000|Overall Study|Reason not given|1|||
105805039|NCT00759148|364943353|FG001|Overall Study|Reason not given|0|||
105805040|NCT03381248|364943354|FG000|0-6 Months|Withdrawal by Subject|4|||
105805041|NCT03381248|364943355|FG001|0-6 Months|Withdrawal by Subject|1|||
105805042|NCT03381248|364943354|FG000|0-6 Months|Lost to Follow-up|3|||
105805043|NCT03381248|364943355|FG001|0-6 Months|Lost to Follow-up|2|||
105805044|NCT03381248|364943354|FG000|0-6 Months|Lack of Efficacy|1|||
105805045|NCT03381248|364943355|FG001|0-6 Months|Lack of Efficacy|0|||
105805046|NCT03381248|364943354|FG000|0-6 Months|Adverse Event|1|||
105805047|NCT03381248|364943355|FG001|0-6 Months|Adverse Event|0|||
105805048|NCT03381248|364943354|FG000|0-6 Months|Protocol Violation|2|||
105805049|NCT03381248|364943355|FG001|0-6 Months|Protocol Violation|1|||
105805050|NCT03381248|364943354|FG000|0-6 Months|Physician Decision|1|||
105805051|NCT03381248|364943355|FG001|0-6 Months|Physician Decision|0|||
105951612|NCT04067492|365486084|FG002|Overall Study|COVID-19 epidemiological situation|0|||
105951613|NCT04067492|365486085|FG003|Overall Study|COVID-19 epidemiological situation|1|||
105951614|NCT04067492|365486086|FG004|Overall Study|COVID-19 epidemiological situation|0|||
105951615|NCT04067492|365486087|FG005|Overall Study|COVID-19 epidemiological situation|0|||
105951616|NCT02268383|365486088|FG000|Overall Study|Death|12|||
105951617|NCT02268383|365486088|FG000|Overall Study|Lost to Follow-up|2|||
105951618|NCT02268383|365486088|FG000|Overall Study|Withdrawal by Subject|9|||
105951619|NCT02268383|365486088|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
105951620|NCT02268383|365486088|FG000|Overall Study|Protocol deviation|3|||
105951621|NCT02268383|365486088|FG000|Overall Study|Sponsor decision|22|||
105951622|NCT02268383|365486088|FG000|Overall Study|Not reported|12|||
105951623|NCT00714948|365486089|FG000|Overall Study|Adverse Event|2|||
105951624|NCT04288089|365486090|FG000|Overall Study|Ongoing Treatment|2|||
105951625|NCT04288089|365486091|FG001|Overall Study|Ongoing Treatment|1|||
105951626|NCT04288089|365486092|FG002|Overall Study|Ongoing Treatment|1|||
105951627|NCT04288089|365486093|FG003|Overall Study|Ongoing Treatment|4|||
105951628|NCT04749745|365486094|FG000|Overall Study|Withdrawal by Subject|1|||
105951629|NCT04749745|365486095|FG001|Overall Study|Withdrawal by Subject|0|||
105951630|NCT01365455|365486098|FG000|Induction Period|Adverse Event|5|||
105951631|NCT01365455|365486099|FG001|Induction Period|Adverse Event|3|||
105951632|NCT01365455|365486100|FG002|Induction Period|Adverse Event|4|||
105951633|NCT01365455|365486101|FG003|Induction Period|Adverse Event|0|||
105951634|NCT01365455|365486102|FG004|Induction Period|Adverse Event|0|||
105951635|NCT01365455|365486098|FG000|Induction Period|Lack of Efficacy|1|||
105951636|NCT01365455|365486099|FG001|Induction Period|Lack of Efficacy|1|||
105951637|NCT01365455|365486100|FG002|Induction Period|Lack of Efficacy|0|||
105951638|NCT01365455|365486101|FG003|Induction Period|Lack of Efficacy|0|||
105951639|NCT01365455|365486102|FG004|Induction Period|Lack of Efficacy|0|||
106143176|NCT04707313|366183656|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
106143177|NCT04707313|366183657|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
106143178|NCT04707313|366183658|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
106143179|NCT04707313|366183659|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
106143180|NCT04707313|366183660|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
106143181|NCT04707313|366183661|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
106143182|NCT04707313|366183649|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
106143183|NCT04707313|366183650|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
106143184|NCT04707313|366183651|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
106143185|NCT04707313|366183652|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
106143186|NCT04707313|366183653|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
106143187|NCT04707313|366183654|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
106143188|NCT04707313|366183655|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
106143189|NCT04707313|366183656|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
106143190|NCT04707313|366183657|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
106143191|NCT04707313|366183658|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
106143192|NCT04707313|366183659|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
106143193|NCT04707313|366183660|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
106143194|NCT04707313|366183661|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
106143195|NCT04707313|366183649|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143196|NCT04707313|366183650|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143197|NCT04707313|366183651|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
106143198|NCT04707313|366183652|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143199|NCT04707313|366183653|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
105805052|NCT03381248|364943354|FG000|0-6 Months|Planning another procedure|1|||
105805053|NCT03381248|364943355|FG001|0-6 Months|Planning another procedure|2|||
105805054|NCT03381248|364943354|FG000|6-12 Months|Withdrawal by Subject|1|||
105805055|NCT03381248|364943355|FG001|6-12 Months|Withdrawal by Subject|3|||
105951640|NCT01365455|365486098|FG000|Induction Period|Pregnancy|0|||
105951641|NCT01365455|365486099|FG001|Induction Period|Pregnancy|1|||
106143200|NCT04707313|366183654|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143201|NCT04707313|366183655|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143202|NCT04707313|366183656|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
106143203|NCT04707313|366183657|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143204|NCT04707313|366183658|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143205|NCT04707313|366183659|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143206|NCT04707313|366183660|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143207|NCT04707313|366183661|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
106143208|NCT04707313|366183649|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143209|NCT04707313|366183650|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143210|NCT04707313|366183651|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143211|NCT04707313|366183652|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143212|NCT04707313|366183653|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143213|NCT04707313|366183654|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143214|NCT04707313|366183655|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143215|NCT04707313|366183656|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143216|NCT04707313|366183657|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143217|NCT04707313|366183658|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
106143218|NCT04707313|366183659|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
106143219|NCT04707313|366183660|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
106143220|NCT04707313|366183661|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
106143221|NCT04707313|366183649|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143222|NCT04707313|366183650|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143223|NCT04707313|366183651|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143224|NCT04707313|366183652|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143225|NCT04707313|366183653|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143226|NCT04707313|366183654|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143227|NCT04707313|366183655|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143228|NCT04707313|366183656|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143229|NCT04707313|366183657|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143230|NCT04707313|366183658|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
106143231|NCT04707313|366183659|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
106143232|NCT04707313|366183660|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
106143233|NCT04707313|366183661|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
106143234|NCT04707313|366183649|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
106143235|NCT04707313|366183650|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
106143236|NCT04707313|366183651|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
106143237|NCT04707313|366183652|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
106143238|NCT04707313|366183653|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
106143239|NCT04707313|366183654|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
106143240|NCT04707313|366183655|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
105951642|NCT01365455|365486100|FG002|Induction Period|Pregnancy|0|||
106143241|NCT04707313|366183656|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
106143242|NCT04707313|366183657|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
106143243|NCT04707313|366183658|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
105759891|NCT02327078|364773799|FG004|Overall Study|Lost to Follow-up|0|||
105759892|NCT02327078|364773800|FG005|Overall Study|Lost to Follow-up|0|||
105759893|NCT02327078|364773801|FG006|Overall Study|Lost to Follow-up|0|||
105759894|NCT02327078|364773802|FG007|Overall Study|Lost to Follow-up|2|||
106143244|NCT04707313|366183659|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
106143245|NCT04707313|366183660|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
106143246|NCT04707313|366183661|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
106143247|NCT04707313|366183649|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143248|NCT04707313|366183650|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143249|NCT04707313|366183651|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143250|NCT04707313|366183652|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143251|NCT04707313|366183653|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143252|NCT04707313|366183654|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143253|NCT04707313|366183655|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143254|NCT04707313|366183656|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143255|NCT04707313|366183657|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143256|NCT04707313|366183658|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143257|NCT04707313|366183659|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
106143258|NCT04707313|366183660|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
106143259|NCT04707313|366183661|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
106143260|NCT04707313|366183649|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143261|NCT04707313|366183650|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143262|NCT04707313|366183651|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143263|NCT04707313|366183652|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143264|NCT04707313|366183653|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143265|NCT04707313|366183654|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143266|NCT04707313|366183655|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143267|NCT04707313|366183656|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143268|NCT04707313|366183657|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143269|NCT04707313|366183658|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
106143270|NCT04707313|366183659|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
106143271|NCT04707313|366183660|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
105759895|NCT02327078|364773803|FG008|Overall Study|Lost to Follow-up|5|||
105759896|NCT02327078|364773795|FG000|Overall Study|Site Terminated by Sponsor|1|||
106143272|NCT04707313|366183661|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
106143273|NCT04707313|366183649|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
106143274|NCT04707313|366183650|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
106143275|NCT04707313|366183651|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
105759897|NCT02327078|364773796|FG001|Overall Study|Site Terminated by Sponsor|0|||
105759898|NCT02327078|364773797|FG002|Overall Study|Site Terminated by Sponsor|1|||
106016652|NCT02257736|365724486|FG001|Overall Study|Adverse Event|56|||
106016653|NCT02257736|365724485|FG000|Overall Study|Withdrawal by Subject|21|||
106016654|NCT02257736|365724486|FG001|Overall Study|Withdrawal by Subject|38|||
106016655|NCT02257736|365724485|FG000|Overall Study|Death|11|||
106016656|NCT02257736|365724486|FG001|Overall Study|Death|6|||
106016657|NCT02257736|365724485|FG000|Overall Study|Physician Decision|5|||
105951643|NCT01365455|365486101|FG003|Induction Period|Pregnancy|0|||
105951644|NCT01365455|365486102|FG004|Induction Period|Pregnancy|0|||
105951645|NCT01365455|365486098|FG000|Induction Period|Protocol deviation|0|||
105951646|NCT01365455|365486099|FG001|Induction Period|Protocol deviation|1|||
105951647|NCT01365455|365486100|FG002|Induction Period|Protocol deviation|1|||
105951648|NCT01365455|365486101|FG003|Induction Period|Protocol deviation|0|||
105951649|NCT01365455|365486102|FG004|Induction Period|Protocol deviation|0|||
105951650|NCT01365455|365486098|FG000|Induction Period|Subject/guardian decision|9|||
105951651|NCT01365455|365486099|FG001|Induction Period|Subject/guardian decision|1|||
105951652|NCT01365455|365486100|FG002|Induction Period|Subject/guardian decision|8|||
105951653|NCT01365455|365486101|FG003|Induction Period|Subject/guardian decision|0|||
105951654|NCT01365455|365486102|FG004|Induction Period|Subject/guardian decision|0|||
105951655|NCT01365455|365486098|FG000|Induction Period|Lost to Follow-up|0|||
105951656|NCT01365455|365486099|FG001|Induction Period|Lost to Follow-up|0|||
105951657|NCT01365455|365486100|FG002|Induction Period|Lost to Follow-up|3|||
105951658|NCT01365455|365486101|FG003|Induction Period|Lost to Follow-up|0|||
105951659|NCT01365455|365486102|FG004|Induction Period|Lost to Follow-up|0|||
105951660|NCT01365455|365486098|FG000|Maintenance Period|Adverse Event|12|||
105951661|NCT01365455|365486099|FG001|Maintenance Period|Adverse Event|5|||
105951662|NCT01365455|365486100|FG002|Maintenance Period|Adverse Event|1|||
105951663|NCT01365455|365486101|FG003|Maintenance Period|Adverse Event|2|||
105951664|NCT01365455|365486102|FG004|Maintenance Period|Adverse Event|4|||
105951665|NCT01365455|365486098|FG000|Maintenance Period|Lack of Efficacy|10|||
105951666|NCT01365455|365486099|FG001|Maintenance Period|Lack of Efficacy|2|||
105951667|NCT01365455|365486100|FG002|Maintenance Period|Lack of Efficacy|0|||
105951668|NCT01365455|365486101|FG003|Maintenance Period|Lack of Efficacy|2|||
105951669|NCT01365455|365486102|FG004|Maintenance Period|Lack of Efficacy|2|||
105951670|NCT01365455|365486098|FG000|Maintenance Period|Lost to Follow-up|2|||
105951671|NCT01365455|365486099|FG001|Maintenance Period|Lost to Follow-up|4|||
105951672|NCT01365455|365486100|FG002|Maintenance Period|Lost to Follow-up|0|||
105951673|NCT01365455|365486101|FG003|Maintenance Period|Lost to Follow-up|0|||
105951674|NCT01365455|365486102|FG004|Maintenance Period|Lost to Follow-up|3|||
105951675|NCT01365455|365486098|FG000|Maintenance Period|Non-compliance with study treatment|0|||
105951676|NCT01365455|365486099|FG001|Maintenance Period|Non-compliance with study treatment|0|||
105951677|NCT01365455|365486100|FG002|Maintenance Period|Non-compliance with study treatment|0|||
105951678|NCT01365455|365486101|FG003|Maintenance Period|Non-compliance with study treatment|1|||
105951679|NCT01365455|365486102|FG004|Maintenance Period|Non-compliance with study treatment|0|||
105951680|NCT01365455|365486098|FG000|Maintenance Period|Physician Decision|0|||
105951681|NCT01365455|365486099|FG001|Maintenance Period|Physician Decision|1|||
105951682|NCT01365455|365486100|FG002|Maintenance Period|Physician Decision|0|||
105951683|NCT01365455|365486101|FG003|Maintenance Period|Physician Decision|0|||
105951684|NCT01365455|365486102|FG004|Maintenance Period|Physician Decision|1|||
105951685|NCT01365455|365486098|FG000|Maintenance Period|Pregnancy|0|||
105951686|NCT01365455|365486099|FG001|Maintenance Period|Pregnancy|4|||
105951687|NCT01365455|365486100|FG002|Maintenance Period|Pregnancy|0|||
105951688|NCT01365455|365486101|FG003|Maintenance Period|Pregnancy|0|||
105951689|NCT01365455|365486102|FG004|Maintenance Period|Pregnancy|2|||
105951690|NCT01365455|365486098|FG000|Maintenance Period|Protocol deviation|1|||
105951691|NCT01365455|365486099|FG001|Maintenance Period|Protocol deviation|1|||
105951692|NCT01365455|365486100|FG002|Maintenance Period|Protocol deviation|0|||
105951693|NCT01365455|365486101|FG003|Maintenance Period|Protocol deviation|0|||
105951694|NCT01365455|365486102|FG004|Maintenance Period|Protocol deviation|0|||
105951695|NCT01365455|365486098|FG000|Maintenance Period|Subject/guardian decision|4|||
105951696|NCT01365455|365486099|FG001|Maintenance Period|Subject/guardian decision|6|||
105951697|NCT01365455|365486100|FG002|Maintenance Period|Subject/guardian decision|2|||
105951698|NCT01365455|365486101|FG003|Maintenance Period|Subject/guardian decision|4|||
105951699|NCT01365455|365486102|FG004|Maintenance Period|Subject/guardian decision|1|||
105951700|NCT03559270|365486103|FG000|Overall Study|Adverse Event|6|||
105951701|NCT03559270|365486104|FG001|Overall Study|Adverse Event|5|||
105951702|NCT03559270|365486105|FG002|Overall Study|Adverse Event|3|||
105951703|NCT03559270|365486106|FG003|Overall Study|Adverse Event|0|||
105951704|NCT03559270|365486103|FG000|Overall Study|Lack of Efficacy|34|||
105951705|NCT03559270|365486104|FG001|Overall Study|Lack of Efficacy|52|||
105951706|NCT03559270|365486105|FG002|Overall Study|Lack of Efficacy|37|||
105951707|NCT03559270|365486106|FG003|Overall Study|Lack of Efficacy|2|||
105951708|NCT03559270|365486103|FG000|Overall Study|Death|0|||
105951709|NCT03559270|365486104|FG001|Overall Study|Death|2|||
105951710|NCT03559270|365486105|FG002|Overall Study|Death|0|||
105951711|NCT03559270|365486106|FG003|Overall Study|Death|0|||
105951712|NCT03559270|365486103|FG000|Overall Study|Lost to Follow-up|16|||
105951713|NCT03559270|365486104|FG001|Overall Study|Lost to Follow-up|4|||
105951714|NCT03559270|365486105|FG002|Overall Study|Lost to Follow-up|12|||
106143276|NCT04707313|366183652|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
106143277|NCT04707313|366183653|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
106143278|NCT04707313|366183654|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
106143279|NCT04707313|366183655|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
106143280|NCT04707313|366183656|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
106143281|NCT04707313|366183657|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
106143282|NCT04707313|366183658|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
106143283|NCT04707313|366183659|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
106143284|NCT04707313|366183660|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
106143285|NCT04707313|366183661|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
106143286|NCT00919763|366183662|FG000|Overall Study|Adverse Event|7|||
106143287|NCT00919763|366183663|FG001|Overall Study|Adverse Event|1|||
106143288|NCT00919763|366183662|FG000|Overall Study|Lost to Follow-up|1|||
106143289|NCT00919763|366183663|FG001|Overall Study|Lost to Follow-up|0|||
106143290|NCT00919763|366183662|FG000|Overall Study|Protocol Violation|1|||
106143291|NCT00919763|366183663|FG001|Overall Study|Protocol Violation|1|||
106143292|NCT00919763|366183662|FG000|Overall Study|Withdrawal by Subject|3|||
106143293|NCT00919763|366183663|FG001|Overall Study|Withdrawal by Subject|1|||
106143294|NCT00919763|366183662|FG000|Overall Study|Non-compliance|0|||
106143295|NCT00919763|366183663|FG001|Overall Study|Non-compliance|1|||
106143296|NCT00711958|366184993|FG000|Overall Study|Withdrawal by Subject|6|||
106143297|NCT00711958|366184994|FG001|Overall Study|Withdrawal by Subject|8|||
106143298|NCT00711958|366184993|FG000|Overall Study|Lack of Efficacy|3|||
106143299|NCT00711958|366184994|FG001|Overall Study|Lack of Efficacy|1|||
106143300|NCT00711958|366184993|FG000|Overall Study|Clinical deterioration|1|||
106143301|NCT00711958|366184994|FG001|Overall Study|Clinical deterioration|0|||
106143302|NCT00711958|366184993|FG000|Overall Study|Adverse Event|9|||
106143303|NCT00711958|366184994|FG001|Overall Study|Adverse Event|7|||
106143304|NCT00711958|366184993|FG000|Overall Study|Protocol Violation|1|||
106143305|NCT00711958|366184994|FG001|Overall Study|Protocol Violation|0|||
106143306|NCT00711958|366184993|FG000|Overall Study|Lost to Follow-up|2|||
106143307|NCT00711958|366184994|FG001|Overall Study|Lost to Follow-up|2|||
106143308|NCT00711958|366184993|FG000|Overall Study|Death|10|||
106143309|NCT00711958|366184994|FG001|Overall Study|Death|5|||
106143310|NCT00711958|366184993|FG000|Overall Study|Progression of disease|1|||
106143311|NCT00711958|366184994|FG001|Overall Study|Progression of disease|0|||
106143312|NCT00831415|366185000|FG000|Overall Study|Adverse Event|14|||
106143313|NCT00831415|366185000|FG000|Overall Study|Failed to return|3|||
106143314|NCT00831415|366185000|FG000|Overall Study|Physician Decision|6|||
105951715|NCT03559270|365486106|FG003|Overall Study|Lost to Follow-up|3|||
105951716|NCT03559270|365486103|FG000|Overall Study|Sponsor Decision|38|||
105951717|NCT03559270|365486104|FG001|Overall Study|Sponsor Decision|31|||
105951718|NCT03559270|365486105|FG002|Overall Study|Sponsor Decision|35|||
105951719|NCT03559270|365486106|FG003|Overall Study|Sponsor Decision|18|||
105951720|NCT03559270|365486103|FG000|Overall Study|Withdrawal by Subject|19|||
105951721|NCT03559270|365486104|FG001|Overall Study|Withdrawal by Subject|21|||
105951722|NCT03559270|365486105|FG002|Overall Study|Withdrawal by Subject|18|||
105951723|NCT03559270|365486106|FG003|Overall Study|Withdrawal by Subject|7|||
105951724|NCT03559270|365486103|FG000|Overall Study|Physician Decision|3|||
105951725|NCT03559270|365486104|FG001|Overall Study|Physician Decision|2|||
105951726|NCT03559270|365486105|FG002|Overall Study|Physician Decision|1|||
105951727|NCT03559270|365486106|FG003|Overall Study|Physician Decision|0|||
105951728|NCT03559270|365486103|FG000|Overall Study|Pregnancy|0|||
105951729|NCT03559270|365486104|FG001|Overall Study|Pregnancy|1|||
105805056|NCT03381248|364943354|FG000|6-12 Months|Lost to Follow-up|0|||
105951730|NCT03559270|365486105|FG002|Overall Study|Pregnancy|0|||
105951731|NCT03559270|365486106|FG003|Overall Study|Pregnancy|0|||
105951732|NCT03559270|365486103|FG000|Overall Study|Protocol Violation|1|||
105759899|NCT02327078|364773798|FG003|Overall Study|Site Terminated by Sponsor|4|||
105759900|NCT02327078|364773799|FG004|Overall Study|Site Terminated by Sponsor|0|||
106143315|NCT00831415|366185000|FG000|Overall Study|Lost to Follow-up|9|||
106143316|NCT00831415|366185000|FG000|Overall Study|Protocol Violation|3|||
106143317|NCT00831415|366185000|FG000|Overall Study|Withdrawal by Subject|35|||
106143318|NCT00831415|366185000|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
106143319|NCT00831415|366185000|FG000|Overall Study|Death|1|||
106143320|NCT01145885|366185001|FG000|Overall Study|Progressive Disease|7|||
106143321|NCT01391130|366185003|FG000|Overall Study|Withdrawal by Subject|3|||
106143322|NCT01391130|366185004|FG001|Overall Study|Withdrawal by Subject|2|||
106143323|NCT01391130|366185003|FG000|Overall Study|Physician Decision|2|||
106143324|NCT01391130|366185004|FG001|Overall Study|Physician Decision|3|||
106143325|NCT01391130|366185003|FG000|Overall Study|Did not Receive Drug|1|||
106143326|NCT01391130|366185004|FG001|Overall Study|Did not Receive Drug|1|||
106143327|NCT03257813|366185005|FG000|Overall Study|Protocol Violation|6|||
106143328|NCT03257813|366185006|FG001|Overall Study|Protocol Violation|3|||
106143329|NCT03520413|366185011|FG000|Overall Study|Lost to Follow-up|1|||
106143330|NCT03520413|366185012|FG001|Overall Study|Lost to Follow-up|1|||
106143331|NCT03520413|366185011|FG000|Overall Study|Withdrawal by Subject|1|||
106143332|NCT03520413|366185012|FG001|Overall Study|Withdrawal by Subject|2|||
106143333|NCT03520413|366185011|FG000|Overall Study|Death|0|||
106143334|NCT03520413|366185012|FG001|Overall Study|Death|1|||
106143335|NCT03520413|366185011|FG000|Overall Study|Physician Decision|3|||
106143336|NCT03520413|366185012|FG001|Overall Study|Physician Decision|3|||
106143337|NCT03520413|366185011|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
106143338|NCT03520413|366185012|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
106143339|NCT02808338|366185014|FG000|Screening|Screen Failure|10|||
106143340|NCT02808338|366185014|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
106143341|NCT02808338|366185014|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
106143342|NCT00891930|366185015|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
106143343|NCT00891930|366185015|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
106143344|NCT00891930|366185015|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
106143345|NCT00891930|366185015|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
106143346|NCT00891930|366185015|FG000|Part 2 Panitumumab + AMG479|Death|30|||
106143347|NCT02537522|366185021|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
106143348|NCT02537522|366185022|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
106143349|NCT02537522|366185023|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
106143350|NCT02537522|366185024|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
106143351|NCT02537522|366185021|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
106143352|NCT02537522|366185022|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
106143353|NCT02537522|366185023|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
106143354|NCT02537522|366185024|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
106143355|NCT02537522|366185021|FG000|Phase I - Contralateral|incorrect randomization|0|||
106143356|NCT02537522|366185022|FG001|Phase I - Contralateral|incorrect randomization|1|||
106143357|NCT02537522|366185023|FG002|Phase I - Contralateral|incorrect randomization|0|||
106143358|NCT02537522|366185024|FG003|Phase I - Contralateral|incorrect randomization|0|||
106143359|NCT02537522|366185021|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
106143360|NCT02537522|366185022|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
106143361|NCT02537522|366185023|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
106143362|NCT02537522|366185024|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
106143363|NCT02537522|366185021|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
106143364|NCT02537522|366185022|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
106143365|NCT02537522|366185023|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
106143366|NCT02537522|366185024|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
106143367|NCT02570711|366185025|FG000|Overall Study|Death|1|||
106143368|NCT02570711|366185026|FG001|Overall Study|Death|0|||
106143369|NCT02570711|366185025|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
106143370|NCT02570711|366185026|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
106143371|NCT01490086|366185027|FG000|Overall Study|Consent withdrawn|4|||
106143372|NCT01490086|366185028|FG001|Overall Study|Consent withdrawn|4|||
106143373|NCT01490086|366185029|FG002|Overall Study|Consent withdrawn|3|||
106143374|NCT01490086|366185030|FG003|Overall Study|Consent withdrawn|0|||
106143375|NCT01490086|366185031|FG004|Overall Study|Consent withdrawn|1|||
106143376|NCT01490086|366185027|FG000|Overall Study|Non-compliance|0|||
106143377|NCT01490086|366185028|FG001|Overall Study|Non-compliance|1|||
106143378|NCT01490086|366185029|FG002|Overall Study|Non-compliance|0|||
106143379|NCT01490086|366185030|FG003|Overall Study|Non-compliance|0|||
106143380|NCT01490086|366185031|FG004|Overall Study|Non-compliance|0|||
106143381|NCT01490086|366185027|FG000|Overall Study|Abnormal laboratory findings|1|||
106143382|NCT01490086|366185028|FG001|Overall Study|Abnormal laboratory findings|0|||
106143383|NCT01490086|366185029|FG002|Overall Study|Abnormal laboratory findings|0|||
106143384|NCT01490086|366185030|FG003|Overall Study|Abnormal laboratory findings|0|||
106143385|NCT01490086|366185031|FG004|Overall Study|Abnormal laboratory findings|0|||
106143386|NCT01490086|366185027|FG000|Overall Study|Lost to Follow-up|0|||
106143387|NCT01490086|366185028|FG001|Overall Study|Lost to Follow-up|0|||
106143388|NCT01490086|366185029|FG002|Overall Study|Lost to Follow-up|0|||
106143389|NCT01490086|366185030|FG003|Overall Study|Lost to Follow-up|0|||
106143390|NCT01490086|366185031|FG004|Overall Study|Lost to Follow-up|1|||
106143391|NCT01490086|366185027|FG000|Overall Study|Physician Decision|3|||
106143392|NCT01490086|366185028|FG001|Overall Study|Physician Decision|4|||
106143393|NCT01490086|366185029|FG002|Overall Study|Physician Decision|2|||
106143394|NCT01490086|366185030|FG003|Overall Study|Physician Decision|3|||
106143395|NCT01490086|366185031|FG004|Overall Study|Physician Decision|1|||
106143396|NCT01490086|366185027|FG000|Overall Study|Adverse Event|0|||
106143397|NCT01490086|366185028|FG001|Overall Study|Adverse Event|0|||
106143398|NCT01490086|366185029|FG002|Overall Study|Adverse Event|1|||
106143399|NCT01490086|366185030|FG003|Overall Study|Adverse Event|2|||
106143400|NCT01490086|366185031|FG004|Overall Study|Adverse Event|0|||
105951733|NCT03559270|365486104|FG001|Overall Study|Protocol Violation|0|||
106143401|NCT01490086|366185027|FG000|Overall Study|Lack of Efficacy|0|||
106143402|NCT01490086|366185028|FG001|Overall Study|Lack of Efficacy|3|||
106143403|NCT01490086|366185029|FG002|Overall Study|Lack of Efficacy|1|||
106143404|NCT01490086|366185030|FG003|Overall Study|Lack of Efficacy|0|||
106143405|NCT01490086|366185031|FG004|Overall Study|Lack of Efficacy|8|||
106143406|NCT01490086|366185027|FG000|Overall Study|Worsening of symptoms|0|||
105759901|NCT02327078|364773800|FG005|Overall Study|Site Terminated by Sponsor|0|||
105759902|NCT02327078|364773801|FG006|Overall Study|Site Terminated by Sponsor|0|||
105759903|NCT02327078|364773802|FG007|Overall Study|Site Terminated by Sponsor|11|||
106143407|NCT01490086|366185028|FG001|Overall Study|Worsening of symptoms|1|||
105759904|NCT02327078|364773803|FG008|Overall Study|Site Terminated by Sponsor|25|||
106143408|NCT01490086|366185029|FG002|Overall Study|Worsening of symptoms|0|||
106143409|NCT01490086|366185030|FG003|Overall Study|Worsening of symptoms|1|||
106143410|NCT01490086|366185031|FG004|Overall Study|Worsening of symptoms|0|||
106143411|NCT01490086|366185027|FG000|Overall Study|Subject uncontrollable and abusive|0|||
106143412|NCT01490086|366185028|FG001|Overall Study|Subject uncontrollable and abusive|1|||
106143413|NCT01490086|366185029|FG002|Overall Study|Subject uncontrollable and abusive|0|||
106143414|NCT01490086|366185030|FG003|Overall Study|Subject uncontrollable and abusive|0|||
106143415|NCT01490086|366185031|FG004|Overall Study|Subject uncontrollable and abusive|0|||
106143416|NCT01490086|366185027|FG000|Overall Study|Subject left hospital|0|||
106143417|NCT01490086|366185028|FG001|Overall Study|Subject left hospital|1|||
106143418|NCT01490086|366185029|FG002|Overall Study|Subject left hospital|0|||
106143419|NCT01490086|366185030|FG003|Overall Study|Subject left hospital|1|||
106143420|NCT01490086|366185031|FG004|Overall Study|Subject left hospital|0|||
106143421|NCT02798835|366185032|FG000|Overall Study|Protocol Violation|0|||
106143422|NCT02798835|366185033|FG001|Overall Study|Protocol Violation|0|||
106143423|NCT02798835|366185034|FG002|Overall Study|Protocol Violation|3|||
106143424|NCT02200770|366185046|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
106143425|NCT02200770|366185047|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
106143426|NCT02200770|366185046|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
106143427|NCT02200770|366185047|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
106143428|NCT02200770|366185046|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
106143429|NCT02200770|366185047|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
106143430|NCT02200770|366185046|FG000|Randomized-controlled Period (RCP)|Other|1|||
106143431|NCT02200770|366185047|FG001|Randomized-controlled Period (RCP)|Other|2|||
106143432|NCT02200770|366185046|FG000|Open-label Period (OLP)|Adverse Event|1|||
106143433|NCT02200770|366185047|FG001|Open-label Period (OLP)|Adverse Event|2|||
106143434|NCT02200770|366185046|FG000|Open-label Period (OLP)|Death|1|||
106143435|NCT02200770|366185047|FG001|Open-label Period (OLP)|Death|2|||
106143436|NCT02200770|366185046|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
106143437|NCT02200770|366185047|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
106143438|NCT02200770|366185046|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
106143439|NCT02200770|366185047|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
106143440|NCT02200770|366185046|FG000|Open-label Period (OLP)|Other|6|||
106143441|NCT02200770|366185047|FG001|Open-label Period (OLP)|Other|15|||
106143442|NCT02807493|366185049|FG000|Overall Study|Adverse Event|5|||
106143443|NCT02807493|366185050|FG001|Overall Study|Adverse Event|2|||
106143444|NCT02807493|366185049|FG000|Overall Study|Lost to Follow-up|6|||
106143445|NCT02807493|366185050|FG001|Overall Study|Lost to Follow-up|0|||
106143446|NCT02807493|366185049|FG000|Overall Study|Physician Decision|4|||
106143447|NCT02807493|366185050|FG001|Overall Study|Physician Decision|1|||
106143448|NCT02807493|366185049|FG000|Overall Study|Protocol Violation|7|||
106143449|NCT02807493|366185050|FG001|Overall Study|Protocol Violation|0|||
106143450|NCT02807493|366185049|FG000|Overall Study|Withdrawal by Subject|17|||
106143451|NCT02807493|366185050|FG001|Overall Study|Withdrawal by Subject|10|||
106143452|NCT02807493|366185049|FG000|Overall Study|Other withdrawal|17|||
106143453|NCT02807493|366185050|FG001|Overall Study|Other withdrawal|0|||
106143454|NCT02807493|366185049|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
106143455|NCT02807493|366185050|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
106143456|NCT00102063|366185051|FG000|Overall Study|Lack of Efficacy|5|||
106143457|NCT00102063|366185052|FG001|Overall Study|Lack of Efficacy|1|||
106143458|NCT00102063|366185053|FG002|Overall Study|Lack of Efficacy|1|||
106143459|NCT00102063|366185051|FG000|Overall Study|Adverse Event|7|||
106143460|NCT00102063|366185052|FG001|Overall Study|Adverse Event|4|||
106143461|NCT00102063|366185053|FG002|Overall Study|Adverse Event|2|||
106143462|NCT00102063|366185051|FG000|Overall Study|Withdrawal by Subject|4|||
106143463|NCT00102063|366185052|FG001|Overall Study|Withdrawal by Subject|12|||
106143464|NCT00102063|366185053|FG002|Overall Study|Withdrawal by Subject|5|||
106143465|NCT00102063|366185051|FG000|Overall Study|Lost to Follow-up|0|||
106143466|NCT00102063|366185052|FG001|Overall Study|Lost to Follow-up|0|||
105759905|NCT02327078|364773795|FG000|Overall Study|Physician Decision|0|||
106143467|NCT00102063|366185053|FG002|Overall Study|Lost to Follow-up|1|||
106143468|NCT00102063|366185051|FG000|Overall Study|Protocol Violation|0|||
105759906|NCT02327078|364773796|FG001|Overall Study|Physician Decision|0|||
105759907|NCT02327078|364773797|FG002|Overall Study|Physician Decision|0|||
105759908|NCT02327078|364773798|FG003|Overall Study|Physician Decision|1|||
105759909|NCT02327078|364773799|FG004|Overall Study|Physician Decision|0|||
105759910|NCT02327078|364773800|FG005|Overall Study|Physician Decision|0|||
105759911|NCT02327078|364773801|FG006|Overall Study|Physician Decision|0|||
105759912|NCT02327078|364773802|FG007|Overall Study|Physician Decision|0|||
105759913|NCT02327078|364773803|FG008|Overall Study|Physician Decision|1|||
105759914|NCT02327078|364773795|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
105759915|NCT02327078|364773796|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
105759916|NCT02327078|364773797|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
105759917|NCT02327078|364773798|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
105759918|NCT02327078|364773799|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
105759919|NCT02327078|364773800|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
105759920|NCT02327078|364773801|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
105759921|NCT02327078|364773802|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
105759922|NCT02327078|364773803|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
105759923|NCT02327078|364773795|FG000|Overall Study|Reason not Specified|0|||
105759924|NCT02327078|364773796|FG001|Overall Study|Reason not Specified|0|||
105759925|NCT02327078|364773797|FG002|Overall Study|Reason not Specified|0|||
105759926|NCT02327078|364773798|FG003|Overall Study|Reason not Specified|0|||
105759927|NCT02327078|364773799|FG004|Overall Study|Reason not Specified|0|||
105759928|NCT02327078|364773800|FG005|Overall Study|Reason not Specified|0|||
105759929|NCT02327078|364773801|FG006|Overall Study|Reason not Specified|0|||
105759930|NCT02327078|364773802|FG007|Overall Study|Reason not Specified|5|||
105759931|NCT02327078|364773803|FG008|Overall Study|Reason not Specified|12|||
105759932|NCT00247273|364773809|FG000|Overall Study|Adverse Event|85|||
105759933|NCT00247273|364773810|FG001|Overall Study|Adverse Event|80|||
105759934|NCT00247273|364773809|FG000|Overall Study|Physician Decision|6|||
105759935|NCT00247273|364773810|FG001|Overall Study|Physician Decision|3|||
105759936|NCT00247273|364773809|FG000|Overall Study|Lost to Follow-up|7|||
105759937|NCT00247273|364773810|FG001|Overall Study|Lost to Follow-up|7|||
105951734|NCT03559270|365486105|FG002|Overall Study|Protocol Violation|2|||
105951735|NCT03559270|365486106|FG003|Overall Study|Protocol Violation|0|||
105951736|NCT03816176|365486108|FG000|Overall Study|Miscellaneous|5|||
105951737|NCT03816176|365486108|FG000|Overall Study|Lack of Efficacy|4|||
105951738|NCT03816176|365486108|FG000|Overall Study|Adverse Event|3|||
105951739|NCT02026011|365488104|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
105951740|NCT02026011|365488105|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
106143469|NCT00102063|366185052|FG001|Overall Study|Protocol Violation|1|||
106143470|NCT00102063|366185053|FG002|Overall Study|Protocol Violation|1|||
106143471|NCT01179334|366185054|FG000|Treatment Period|Adverse Event|1|||
106143472|NCT01179334|366185055|FG001|Treatment Period|Adverse Event|0|||
106143473|NCT01179334|366185054|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
106143474|NCT01179334|366185055|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
106143475|NCT01179334|366185054|FG000|Long-term Extension (LTE) Period|Death|3|||
106143476|NCT01179334|366185055|FG001|Long-term Extension (LTE) Period|Death|0|||
106143477|NCT01179334|366185054|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
106143478|NCT01179334|366185055|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
106143479|NCT05190419|366185056|FG000|Overall Study|Lack of Efficacy|8|||
106143480|NCT05190419|366185057|FG001|Overall Study|Lack of Efficacy|0|||
106143481|NCT05190419|366185058|FG002|Overall Study|Lack of Efficacy|1|||
106143482|NCT05190419|366185059|FG003|Overall Study|Lack of Efficacy|0|||
106143483|NCT05190419|366185056|FG000|Overall Study|Withdrawal by Subject|7|||
106143484|NCT05190419|366185057|FG001|Overall Study|Withdrawal by Subject|1|||
106143485|NCT05190419|366185058|FG002|Overall Study|Withdrawal by Subject|2|||
106143486|NCT05190419|366185059|FG003|Overall Study|Withdrawal by Subject|2|||
106143487|NCT05190419|366185056|FG000|Overall Study|Adverse Event|2|||
106143488|NCT05190419|366185057|FG001|Overall Study|Adverse Event|10|||
106143489|NCT05190419|366185058|FG002|Overall Study|Adverse Event|11|||
106143490|NCT05190419|366185059|FG003|Overall Study|Adverse Event|21|||
106143491|NCT05190419|366185056|FG000|Overall Study|Lost to Follow-up|1|||
106143492|NCT05190419|366185057|FG001|Overall Study|Lost to Follow-up|2|||
106143493|NCT05190419|366185058|FG002|Overall Study|Lost to Follow-up|3|||
106143494|NCT05190419|366185059|FG003|Overall Study|Lost to Follow-up|1|||
106143495|NCT05190419|366185056|FG000|Overall Study|Other|1|||
106143496|NCT05190419|366185057|FG001|Overall Study|Other|1|||
106143497|NCT05190419|366185058|FG002|Overall Study|Other|0|||
105759938|NCT00247273|364773809|FG000|Overall Study|Withdrawal by Subject|46|||
105759939|NCT00247273|364773810|FG001|Overall Study|Withdrawal by Subject|47|||
105759940|NCT00247273|364773809|FG000|Overall Study|Did not take any study drug|2|||
106143498|NCT05190419|366185059|FG003|Overall Study|Other|3|||
106143499|NCT01909778|366185060|FG000|Overall Study|failed screening|1|||
106143500|NCT00258895|366185064|FG000|Overall Study|Lost to Follow-up|3|||
106143501|NCT00258895|366185065|FG001|Overall Study|Lost to Follow-up|1|||
106143502|NCT00258895|366185064|FG000|Overall Study|Protocol Violation|6|||
105805057|NCT03381248|364943355|FG001|6-12 Months|Lost to Follow-up|2|||
106016658|NCT02257736|365724486|FG001|Overall Study|Physician Decision|9|||
106016659|NCT02257736|365724485|FG000|Overall Study|Non-Compliance with study drug|1|||
106016660|NCT02257736|365724486|FG001|Overall Study|Non-Compliance with study drug|2|||
106016661|NCT02257736|365724485|FG000|Overall Study|Protocol Violation|1|||
106016662|NCT02257736|365724486|FG001|Overall Study|Protocol Violation|0|||
106016663|NCT02257736|365724485|FG000|Overall Study|Other|1|||
106016664|NCT02257736|365724486|FG001|Overall Study|Other|7|||
106016665|NCT02257736|365724485|FG000|Overall Study|Randomized, not treated|1|||
106016666|NCT02257736|365724486|FG001|Overall Study|Randomized, not treated|2|||
106016667|NCT04325828|365724487|FG000|Overall Study|Ongoing|26|||
106016668|NCT02000115|365724490|FG000|Overall Study|Death|56|||
106016669|NCT02000115|365724491|FG001|Overall Study|Death|45|||
106016670|NCT02000115|365724492|FG002|Overall Study|Death|0|||
106016671|NCT02000115|365724493|FG003|Overall Study|Death|0|||
106016672|NCT02000115|365724490|FG000|Overall Study|Missed Visit|6|||
106016673|NCT02000115|365724491|FG001|Overall Study|Missed Visit|8|||
106016674|NCT02000115|365724492|FG002|Overall Study|Missed Visit|1|||
106016675|NCT02000115|365724493|FG003|Overall Study|Missed Visit|0|||
106016676|NCT02000115|365724490|FG000|Overall Study|Protocol Violation|2|||
106016677|NCT02000115|365724491|FG001|Overall Study|Protocol Violation|1|||
106016678|NCT02000115|365724492|FG002|Overall Study|Protocol Violation|0|||
106016679|NCT02000115|365724493|FG003|Overall Study|Protocol Violation|0|||
106016680|NCT02000115|365724490|FG000|Overall Study|Physician Decision|2|||
106016681|NCT02000115|365724491|FG001|Overall Study|Physician Decision|0|||
106016682|NCT02000115|365724492|FG002|Overall Study|Physician Decision|0|||
106016683|NCT02000115|365724493|FG003|Overall Study|Physician Decision|0|||
106016684|NCT02000115|365724490|FG000|Overall Study|Withdrawal by Subject|11|||
106016685|NCT02000115|365724491|FG001|Overall Study|Withdrawal by Subject|11|||
106016686|NCT02000115|365724492|FG002|Overall Study|Withdrawal by Subject|0|||
106016687|NCT02000115|365724493|FG003|Overall Study|Withdrawal by Subject|0|||
106016688|NCT02000115|365724490|FG000|Overall Study|Lost to Follow-up|0|||
106016689|NCT02000115|365724491|FG001|Overall Study|Lost to Follow-up|1|||
106016690|NCT02000115|365724492|FG002|Overall Study|Lost to Follow-up|0|||
106016691|NCT02000115|365724493|FG003|Overall Study|Lost to Follow-up|0|||
106016692|NCT02000115|365724490|FG000|Overall Study|Non-compliance|2|||
106016693|NCT02000115|365724491|FG001|Overall Study|Non-compliance|1|||
106016694|NCT02000115|365724492|FG002|Overall Study|Non-compliance|0|||
106016695|NCT02000115|365724493|FG003|Overall Study|Non-compliance|0|||
106016696|NCT02000115|365724490|FG000|Overall Study|Withdrawn on day of randomization|0|||
106016697|NCT02000115|365724491|FG001|Overall Study|Withdrawn on day of randomization|1|||
106016698|NCT02000115|365724492|FG002|Overall Study|Withdrawn on day of randomization|0|||
106016699|NCT02000115|365724493|FG003|Overall Study|Withdrawn on day of randomization|0|||
106143503|NCT00258895|366185065|FG001|Overall Study|Protocol Violation|2|||
106143504|NCT00258895|366185064|FG000|Overall Study|Withdrawal by Subject|1|||
106143505|NCT00258895|366185065|FG001|Overall Study|Withdrawal by Subject|0|||
106143506|NCT00834834|366185066|FG000|Overall Study|Withdrawal by Subject|4|||
106143507|NCT00834834|366185067|FG001|Overall Study|Withdrawal by Subject|3|||
106143508|NCT00539292|366185068|FG000|Overall Study|Physician Decision|1|||
106143509|NCT00539292|366185069|FG001|Overall Study|Physician Decision|0|||
106143510|NCT02020616|366185072|FG000|Overall Study|Adverse Event|0|||
106143511|NCT02020616|366185073|FG001|Overall Study|Adverse Event|0|||
106143512|NCT02020616|366185074|FG002|Overall Study|Adverse Event|0|||
106143513|NCT02020616|366185075|FG003|Overall Study|Adverse Event|0|||
106143514|NCT02020616|366185076|FG004|Overall Study|Adverse Event|0|||
106143515|NCT02020616|366185077|FG005|Overall Study|Adverse Event|1|||
106143516|NCT02020616|366185078|FG006|Overall Study|Adverse Event|1|||
106143517|NCT02020616|366185072|FG000|Overall Study|Physician Decision|0|||
106143518|NCT02020616|366185073|FG001|Overall Study|Physician Decision|0|||
106143519|NCT02020616|366185074|FG002|Overall Study|Physician Decision|0|||
106143520|NCT02020616|366185075|FG003|Overall Study|Physician Decision|0|||
106143521|NCT02020616|366185076|FG004|Overall Study|Physician Decision|0|||
106143522|NCT02020616|366185077|FG005|Overall Study|Physician Decision|1|||
106143523|NCT02020616|366185078|FG006|Overall Study|Physician Decision|2|||
106143524|NCT02020616|366185072|FG000|Overall Study|Withdrawal by Subject|0|||
106143525|NCT02020616|366185073|FG001|Overall Study|Withdrawal by Subject|0|||
106143526|NCT02020616|366185074|FG002|Overall Study|Withdrawal by Subject|1|||
106143527|NCT02020616|366185075|FG003|Overall Study|Withdrawal by Subject|0|||
106143528|NCT02020616|366185076|FG004|Overall Study|Withdrawal by Subject|0|||
106143529|NCT02020616|366185077|FG005|Overall Study|Withdrawal by Subject|1|||
106143530|NCT02020616|366185078|FG006|Overall Study|Withdrawal by Subject|1|||
106143531|NCT02020616|366185072|FG000|Overall Study|Lost to Follow-up|0|||
106143532|NCT02020616|366185073|FG001|Overall Study|Lost to Follow-up|1|||
106143533|NCT02020616|366185074|FG002|Overall Study|Lost to Follow-up|0|||
106143534|NCT02020616|366185075|FG003|Overall Study|Lost to Follow-up|1|||
106143535|NCT02020616|366185076|FG004|Overall Study|Lost to Follow-up|1|||
106143536|NCT02020616|366185077|FG005|Overall Study|Lost to Follow-up|1|||
106143537|NCT02020616|366185078|FG006|Overall Study|Lost to Follow-up|0|||
106016700|NCT02000115|365724490|FG000|Overall Study|Still on Study|0|||
105805058|NCT03381248|364943354|FG000|6-12 Months|Protocol Violation|3|||
105951741|NCT02026011|365488104|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
105951742|NCT02026011|365488105|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
105951743|NCT02026011|365488104|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
105951744|NCT02026011|365488105|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
105951745|NCT02026011|365488104|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
105951746|NCT02026011|365488105|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
105951747|NCT00529243|365488108|FG000|Overall Study|Adverse Event|1|||
105951748|NCT00529243|365488108|FG000|Overall Study|Death|1|||
105951749|NCT00529243|365488108|FG000|Overall Study|Relocated|1|||
105951750|NCT00937495|365488111|FG000|Overall Study|Protocol Violation|2|||
105951751|NCT00661830|365488112|FG000|Overall Study|Death|37|||
105951752|NCT00661830|365488113|FG001|Overall Study|Death|33|||
106016701|NCT02000115|365724491|FG001|Overall Study|Still on Study|0|||
106016702|NCT02000115|365724492|FG002|Overall Study|Still on Study|0|||
106016703|NCT02000115|365724493|FG003|Overall Study|Still on Study|53|||
106016704|NCT04801420|365724494|FG000|Overall Study|Other|1|||
106016705|NCT04801420|365724495|FG001|Overall Study|Other|2|||
106016706|NCT04801420|365724496|FG002|Overall Study|Other|1|||
106016707|NCT04801420|365724494|FG000|Overall Study|Lost to Follow-up|7|||
106143538|NCT02020616|366185072|FG000|Overall Study|Early Termination Criteria Met|0|||
106143539|NCT02020616|366185073|FG001|Overall Study|Early Termination Criteria Met|0|||
106143540|NCT02020616|366185074|FG002|Overall Study|Early Termination Criteria Met|1|||
106143541|NCT02020616|366185075|FG003|Overall Study|Early Termination Criteria Met|0|||
106143542|NCT02020616|366185076|FG004|Overall Study|Early Termination Criteria Met|0|||
106143543|NCT02020616|366185077|FG005|Overall Study|Early Termination Criteria Met|1|||
106143544|NCT02020616|366185078|FG006|Overall Study|Early Termination Criteria Met|0|||
106143545|NCT02020616|366185072|FG000|Overall Study|Randomized in Error|0|||
106143546|NCT02020616|366185073|FG001|Overall Study|Randomized in Error|0|||
106143547|NCT02020616|366185074|FG002|Overall Study|Randomized in Error|0|||
106143548|NCT02020616|366185075|FG003|Overall Study|Randomized in Error|1|||
106143549|NCT02020616|366185076|FG004|Overall Study|Randomized in Error|0|||
106143550|NCT02020616|366185077|FG005|Overall Study|Randomized in Error|0|||
106143551|NCT02020616|366185078|FG006|Overall Study|Randomized in Error|0|||
106143552|NCT02020616|366185072|FG000|Overall Study|Lack of Efficacy|0|||
106143553|NCT02020616|366185073|FG001|Overall Study|Lack of Efficacy|0|||
106143554|NCT02020616|366185074|FG002|Overall Study|Lack of Efficacy|0|||
106143555|NCT02020616|366185075|FG003|Overall Study|Lack of Efficacy|0|||
106143556|NCT02020616|366185076|FG004|Overall Study|Lack of Efficacy|1|||
106143557|NCT02020616|366185077|FG005|Overall Study|Lack of Efficacy|0|||
106143558|NCT02020616|366185078|FG006|Overall Study|Lack of Efficacy|0|||
106143559|NCT02621424|366185081|FG000|Overall Study|Withdrawal by Subject|1|||
106143560|NCT02621424|366185082|FG001|Overall Study|Withdrawal by Subject|2|||
106143561|NCT00305695|366185087|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
106143562|NCT00305695|366185088|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
106143563|NCT00305695|366185087|FG000|Overall Study|Did not have baseline scan|1|||
106143564|NCT00305695|366185088|FG001|Overall Study|Did not have baseline scan|1|||
106143565|NCT03070483|366185089|FG000|Overall Study|Lost to Follow-up|2|||
106143566|NCT02031471|366185090|FG000|24 Week Treatment Period|Adverse Event|6|||
106143567|NCT02031471|366185090|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
106143568|NCT02031471|366185090|FG000|24 Week Treatment Period|Protocol Violation|1|||
106143569|NCT02031471|366185090|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
106143570|NCT02031471|366185090|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
106143571|NCT02031471|366185090|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
106143572|NCT02031471|366185090|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
106143573|NCT00837616|366185098|FG000|Overall Study|Withdrawal by Subject|0|||
106143574|NCT00837616|366185099|FG001|Overall Study|Withdrawal by Subject|1|||
106143575|NCT00961636|366185104|FG000|Overall Study|Adverse Event|35|||
106143576|NCT00961636|366185105|FG001|Overall Study|Adverse Event|54|||
106143577|NCT00961636|366185106|FG002|Overall Study|Adverse Event|13|||
106143578|NCT00961636|366185104|FG000|Overall Study|Flushing Symptoms|29|||
106143579|NCT00961636|366185105|FG001|Overall Study|Flushing Symptoms|46|||
106143580|NCT00961636|366185106|FG002|Overall Study|Flushing Symptoms|3|||
106143581|NCT00961636|366185104|FG000|Overall Study|Lost to Follow-up|2|||
106143582|NCT00961636|366185105|FG001|Overall Study|Lost to Follow-up|3|||
106143583|NCT00961636|366185106|FG002|Overall Study|Lost to Follow-up|1|||
106143584|NCT00961636|366185104|FG000|Overall Study|Physician Decision|3|||
106143585|NCT00961636|366185105|FG001|Overall Study|Physician Decision|1|||
106143586|NCT00961636|366185106|FG002|Overall Study|Physician Decision|1|||
106143587|NCT00961636|366185104|FG000|Overall Study|Protocol Violation|9|||
106143588|NCT00961636|366185105|FG001|Overall Study|Protocol Violation|5|||
106143589|NCT00961636|366185106|FG002|Overall Study|Protocol Violation|1|||
106143590|NCT00961636|366185104|FG000|Overall Study|Withdrawal by Subject|29|||
106016708|NCT04801420|365724495|FG001|Overall Study|Lost to Follow-up|9|||
106143591|NCT00961636|366185105|FG001|Overall Study|Withdrawal by Subject|22|||
105805059|NCT03381248|364943355|FG001|6-12 Months|Protocol Violation|2|||
105805060|NCT03381248|364943354|FG000|6-12 Months|Planning another procedure|6|||
105805061|NCT03381248|364943355|FG001|6-12 Months|Planning another procedure|2|||
105805062|NCT03381248|364943354|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
105805063|NCT03381248|364943355|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
105805064|NCT03381248|364943354|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
105805065|NCT03381248|364943355|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
105805066|NCT03381248|364943354|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
105805067|NCT03381248|364943355|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
105805068|NCT01387282|364943360|FG000|Overall Study|Death|47|||
105805069|NCT01387282|364943361|FG001|Overall Study|Death|16|||
105805070|NCT01387282|364943360|FG000|Overall Study|Other|5|||
105805071|NCT01387282|364943361|FG001|Overall Study|Other|1|||
105805072|NCT01387282|364943360|FG000|Overall Study|Unrelated AE|6|||
105805073|NCT01387282|364943361|FG001|Overall Study|Unrelated AE|4|||
105805074|NCT01387282|364943360|FG000|Overall Study|Withdrawal by patient|33|||
105805075|NCT01387282|364943361|FG001|Overall Study|Withdrawal by patient|23|||
105805076|NCT01387282|364943360|FG000|Overall Study|Study drug-related AE|2|||
105805077|NCT01387282|364943361|FG001|Overall Study|Study drug-related AE|2|||
105805078|NCT01387282|364943360|FG000|Overall Study|Lost to Follow-up|4|||
105805079|NCT01387282|364943361|FG001|Overall Study|Lost to Follow-up|1|||
105805080|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
105805081|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
105805082|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
105805083|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
105805084|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
105805085|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
105805086|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
105805087|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
105805088|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
105805089|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
105805090|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
105805091|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
105805092|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805093|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
105805094|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805095|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805096|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805097|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
105805098|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
105805099|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
105951753|NCT00661830|365488112|FG000|Overall Study|Lost to Follow-up|1|||
105951754|NCT00661830|365488113|FG001|Overall Study|Lost to Follow-up|3|||
105951755|NCT00661830|365488112|FG000|Overall Study|Withdrawal by Subject|1|||
105951756|NCT00661830|365488113|FG001|Overall Study|Withdrawal by Subject|1|||
105951757|NCT00661830|365488112|FG000|Overall Study|Other reason|1|||
105951758|NCT00661830|365488113|FG001|Overall Study|Other reason|5|||
105951759|NCT01669902|365488114|FG000|Overall Study|Adverse Event|11|||
105805100|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
105805101|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
105951760|NCT01669902|365488114|FG000|Overall Study|Lack of Efficacy|10|||
105951761|NCT01669902|365488114|FG000|Overall Study|Other|8|||
105951762|NCT01535287|365488117|FG000|Overall Study|drug not prepared in time|5|||
105951763|NCT01535287|365488118|FG001|Overall Study|drug not prepared in time|6|||
105951764|NCT02332187|365488121|FG000|Overall Study|Withdrawal by Subject|2|||
105951765|NCT02332187|365488122|FG001|Overall Study|Withdrawal by Subject|2|||
105951766|NCT02332187|365488121|FG000|Overall Study|Adverse Event|0|||
105951767|NCT02332187|365488122|FG001|Overall Study|Adverse Event|1|||
105951768|NCT01840943|365488123|FG000|Overall Study|Withdrawal by Subject|5|||
105951769|NCT01840943|365488124|FG001|Overall Study|Withdrawal by Subject|6|||
105951770|NCT01840943|365488123|FG000|Overall Study|Physician Decision|4|||
105951771|NCT01840943|365488124|FG001|Overall Study|Physician Decision|2|||
105951772|NCT01840943|365488123|FG000|Overall Study|Lost to Follow-up|4|||
105951773|NCT01840943|365488124|FG001|Overall Study|Lost to Follow-up|4|||
105805102|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
105951774|NCT02580877|365488125|FG000|Overall Study|Withdrawal by Subject|1|||
105951775|NCT02580877|365488126|FG001|Overall Study|Withdrawal by Subject|3|||
105951776|NCT02580877|365488125|FG000|Overall Study|Adverse Event|0|||
105951777|NCT02580877|365488126|FG001|Overall Study|Adverse Event|1|||
106016709|NCT04801420|365724496|FG002|Overall Study|Lost to Follow-up|10|||
105805103|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
105805104|NCT01806597|364943364|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105951778|NCT00980148|365488127|FG000|Overall Study|Discharged from facility|89|||
105951779|NCT00980148|365488128|FG001|Overall Study|Discharged from facility|96|||
106016710|NCT04801420|365724494|FG000|Overall Study|Moved from study area|0|||
106016711|NCT04801420|365724495|FG001|Overall Study|Moved from study area|1|||
106016712|NCT04801420|365724496|FG002|Overall Study|Moved from study area|1|||
106016713|NCT04801420|365724494|FG000|Overall Study|Withdrawal by Subject|5|||
106016714|NCT04801420|365724495|FG001|Overall Study|Withdrawal by Subject|1|||
106016715|NCT04801420|365724496|FG002|Overall Study|Withdrawal by Subject|4|||
106016716|NCT04801420|365724494|FG000|Overall Study|Individual stopping criteria reached|0|||
106016717|NCT04801420|365724495|FG001|Overall Study|Individual stopping criteria reached|1|||
106016718|NCT04801420|365724496|FG002|Overall Study|Individual stopping criteria reached|0|||
106016719|NCT04801420|365724494|FG000|Overall Study|Ongoing in the study|195|||
106016720|NCT04801420|365724495|FG001|Overall Study|Ongoing in the study|195|||
106016721|NCT04801420|365724496|FG002|Overall Study|Ongoing in the study|192|||
106016722|NCT03387085|365724497|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
106016723|NCT04487080|365724498|FG000|Overall Study|Withdrawal by Subject|19|||
106016724|NCT04487080|365724499|FG001|Overall Study|Withdrawal by Subject|18|||
105951780|NCT00980148|365488127|FG000|Overall Study|Received other antichlamydia treatment|20|||
105951781|NCT00980148|365488128|FG001|Overall Study|Received other antichlamydia treatment|14|||
105951782|NCT00980148|365488127|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
105951783|NCT00980148|365488128|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
105951784|NCT00980148|365488127|FG000|Overall Study|Various other reasons|8|||
105951785|NCT00980148|365488128|FG001|Overall Study|Various other reasons|9|||
105951786|NCT02903823|365488129|FG000|Overall Study|Physician Decision|5|||
105951787|NCT02903823|365488129|FG000|Overall Study|Could not advance catheter|1|||
105951788|NCT02903823|365488129|FG000|Overall Study|Catheter dislodgement|1|||
105951789|NCT01747915|365488130|FG000|Overall Study|Other|1|||
105951790|NCT01747915|365488131|FG001|Overall Study|Other|1|||
106016725|NCT04487080|365724500|FG002|Overall Study|Withdrawal by Subject|13|||
105951791|NCT01747915|365488132|FG002|Overall Study|Other|1|||
106016726|NCT04487080|365724498|FG000|Overall Study|Lost to Follow-up|3|||
105759941|NCT00247273|364773810|FG001|Overall Study|Did not take any study drug|0|||
105951792|NCT01747915|365488130|FG000|Overall Study|Adverse Event|8|||
105951793|NCT01747915|365488131|FG001|Overall Study|Adverse Event|5|||
105951794|NCT01747915|365488132|FG002|Overall Study|Adverse Event|2|||
105951795|NCT01747915|365488130|FG000|Overall Study|Death|0|||
105951796|NCT01747915|365488131|FG001|Overall Study|Death|0|||
105951797|NCT01747915|365488132|FG002|Overall Study|Death|1|||
105951798|NCT01747915|365488130|FG000|Overall Study|Lack of Efficacy|0|||
105951799|NCT01747915|365488131|FG001|Overall Study|Lack of Efficacy|1|||
105951800|NCT01747915|365488132|FG002|Overall Study|Lack of Efficacy|0|||
105951801|NCT01747915|365488130|FG000|Overall Study|Lost to Follow-up|1|||
105951802|NCT01747915|365488131|FG001|Overall Study|Lost to Follow-up|0|||
105951803|NCT01747915|365488132|FG002|Overall Study|Lost to Follow-up|0|||
105951804|NCT01747915|365488130|FG000|Overall Study|Withdrawal by Subject|4|||
105951805|NCT01747915|365488131|FG001|Overall Study|Withdrawal by Subject|4|||
105951806|NCT01747915|365488132|FG002|Overall Study|Withdrawal by Subject|1|||
105951807|NCT01747915|365488130|FG000|Overall Study|Protocol Violation|1|||
105951808|NCT01747915|365488131|FG001|Overall Study|Protocol Violation|0|||
105951809|NCT01747915|365488132|FG002|Overall Study|Protocol Violation|0|||
105951810|NCT01747915|365488130|FG000|Overall Study|Pregnancy|0|||
105951811|NCT01747915|365488131|FG001|Overall Study|Pregnancy|0|||
105951812|NCT01747915|365488132|FG002|Overall Study|Pregnancy|1|||
105951813|NCT00938912|365488133|FG000|Overall Study|Withdrawal by Subject|28|||
105951814|NCT00938912|365488133|FG000|Overall Study|Lost to Follow-up|4|||
105951815|NCT00938912|365488133|FG000|Overall Study|Lack of Efficacy|43|||
105951816|NCT00938912|365488133|FG000|Overall Study|Adverse event, non-fatal|24|||
105951817|NCT00938912|365488133|FG000|Overall Study|Adverse event, fatal|1|||
105951818|NCT00938912|365488133|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
105951819|NCT00938912|365488133|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
105951820|NCT00938912|365488133|FG000|Overall Study|Participant needed prohibit medication|1|||
105951821|NCT00938912|365488133|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
105951822|NCT00938912|365488133|FG000|Overall Study|Did not meet Eligibility criteria|1|||
105951823|NCT00938912|365488133|FG000|Overall Study|Participant relocated not related to AE|1|||
105951824|NCT00938912|365488133|FG000|Overall Study|Participant moved to another city|1|||
105951825|NCT00938912|365488133|FG000|Overall Study|Participant experienced break through seizures|1|||
105951826|NCT00938912|365488133|FG000|Overall Study|No longer wished to participate in the study|1|||
105951827|NCT00938912|365488133|FG000|Overall Study|Protocol Deviation|2|||
105951828|NCT00887159|365488140|FG000|Overall Study|Disease progression|6|||
105951829|NCT00887159|365488141|FG001|Overall Study|Disease progression|39|||
105951830|NCT00887159|365488142|FG002|Overall Study|Disease progression|33|||
105951831|NCT00887159|365488140|FG000|Overall Study|Adverse Event|3|||
105951832|NCT00887159|365488141|FG001|Overall Study|Adverse Event|4|||
105759942|NCT03805971|364773812|FG000|Overall Study|Withdrawal by Subject|1|||
105951833|NCT00887159|365488142|FG002|Overall Study|Adverse Event|17|||
105951834|NCT00887159|365488140|FG000|Overall Study|Death|2|||
105951835|NCT00887159|365488141|FG001|Overall Study|Death|2|||
105951836|NCT00887159|365488142|FG002|Overall Study|Death|0|||
105951837|NCT00887159|365488140|FG000|Overall Study|Withdrawal by Subject|4|||
105951838|NCT00887159|365488141|FG001|Overall Study|Withdrawal by Subject|4|||
105951839|NCT00887159|365488142|FG002|Overall Study|Withdrawal by Subject|2|||
105951840|NCT00887159|365488140|FG000|Overall Study|Alternative therapy|2|||
106143592|NCT00961636|366185106|FG002|Overall Study|Withdrawal by Subject|13|||
106143593|NCT00732381|366185109|FG000|Overall Study|Adverse Event|1|||
106143594|NCT00732381|366185110|FG001|Overall Study|Adverse Event|0|||
106143595|NCT00732381|366185109|FG000|Overall Study|Treatment Failure|1|||
106143596|NCT00732381|366185110|FG001|Overall Study|Treatment Failure|1|||
106143597|NCT00457691|366185114|FG000|Overall Study|Adverse Event|4|||
106143598|NCT00457691|366185115|FG001|Overall Study|Adverse Event|1|||
106143599|NCT00457691|366185114|FG000|Overall Study|Death|163|||
106143600|NCT00457691|366185115|FG001|Overall Study|Death|148|||
106143601|NCT00457691|366185114|FG000|Overall Study|Protocol Violation|1|||
106143602|NCT00457691|366185115|FG001|Overall Study|Protocol Violation|3|||
106143603|NCT00457691|366185114|FG000|Overall Study|Lost to Follow-up|23|||
106143604|NCT00457691|366185115|FG001|Overall Study|Lost to Follow-up|14|||
106143605|NCT00457691|366185114|FG000|Overall Study|Study terminated by Sponsor|1|||
106143606|NCT00457691|366185115|FG001|Overall Study|Study terminated by Sponsor|1|||
105759943|NCT03805971|364773812|FG000|Overall Study|Protocol Violation|2|||
105759944|NCT03276572|364773813|FG000|Overall Study|In follow-up|0|||
105759945|NCT03276572|364773814|FG001|Overall Study|In follow-up|0|||
105759946|NCT03276572|364773815|FG002|Overall Study|In follow-up|0|||
105759947|NCT03276572|364773816|FG003|Overall Study|In follow-up|0|||
105951841|NCT00887159|365488141|FG001|Overall Study|Alternative therapy|0|||
106143607|NCT00457691|366185114|FG000|Overall Study|Subject refused (reason other than AE)|14|||
106143608|NCT00457691|366185115|FG001|Overall Study|Subject refused (reason other than AE)|19|||
106143609|NCT00457691|366185114|FG000|Overall Study|Disease progression, study terminated|180|||
106143610|NCT00457691|366185115|FG001|Overall Study|Disease progression, study terminated|196|||
106016727|NCT04487080|365724499|FG001|Overall Study|Lost to Follow-up|1|||
106016728|NCT04487080|365724500|FG002|Overall Study|Lost to Follow-up|0|||
106016729|NCT04487080|365724498|FG000|Overall Study|Ongoing|313|||
106016730|NCT04487080|365724499|FG001|Overall Study|Ongoing|297|||
106016731|NCT04487080|365724500|FG002|Overall Study|Ongoing|149|||
106016732|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
106016733|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
106016734|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
106016735|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
106016736|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
106016737|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
106143611|NCT02999477|366185129|FG000|Overall Study|found ineligible after first dose|0|||
106143612|NCT02999477|366185130|FG001|Overall Study|found ineligible after first dose|1|||
106143613|NCT02999477|366185129|FG000|Overall Study|Withdrawal by Subject|1|||
106143614|NCT02999477|366185130|FG001|Overall Study|Withdrawal by Subject|1|||
106143615|NCT01049503|366186815|FG000|Overall Study|Lost to Follow-up|11|||
106143616|NCT01049503|366186816|FG001|Overall Study|Lost to Follow-up|12|||
106143617|NCT01049503|366186817|FG002|Overall Study|Lost to Follow-up|24|||
106143618|NCT01049503|366186818|FG003|Overall Study|Lost to Follow-up|26|||
106143619|NCT01049503|366186819|FG004|Overall Study|Lost to Follow-up|27|||
106143620|NCT01049503|366186820|FG005|Overall Study|Lost to Follow-up|8|||
106143621|NCT00726596|366186821|FG000|Overall Study|Adverse Event|2|||
106143622|NCT00726596|366186822|FG001|Overall Study|Adverse Event|1|||
106143623|NCT00726596|366186821|FG000|Overall Study|Withdrawal by Subject|3|||
106143624|NCT00726596|366186822|FG001|Overall Study|Withdrawal by Subject|3|||
106143625|NCT02015546|366186825|FG000|Overall Study|Withdrawal by Subject|1|||
106143626|NCT02015546|366186826|FG001|Overall Study|Withdrawal by Subject|1|||
106143627|NCT02015546|366186827|FG002|Overall Study|Withdrawal by Subject|1|||
106143628|NCT02015546|366186825|FG000|Overall Study|Screem Failure|2|||
106143629|NCT02015546|366186826|FG001|Overall Study|Screem Failure|1|||
106143630|NCT02015546|366186827|FG002|Overall Study|Screem Failure|3|||
106143631|NCT04424641|366186830|FG000|Overall Study|Death|1|||
106143632|NCT04424641|366186831|FG001|Overall Study|Death|2|||
106143633|NCT04424641|366186832|FG002|Overall Study|Death|3|||
106143634|NCT04424641|366186833|FG003|Overall Study|Death|0|||
106143635|NCT04424641|366186834|FG004|Overall Study|Death|3|||
106143636|NCT04424641|366186835|FG005|Overall Study|Death|0|||
106143637|NCT04424641|366186836|FG006|Overall Study|Death|1|||
106143638|NCT04424641|366186837|FG007|Overall Study|Death|2|||
106143639|NCT04424641|366186830|FG000|Overall Study|Sponsor decision|0|||
106143640|NCT04424641|366186831|FG001|Overall Study|Sponsor decision|2|||
106143641|NCT04424641|366186832|FG002|Overall Study|Sponsor decision|3|||
106143642|NCT04424641|366186833|FG003|Overall Study|Sponsor decision|7|||
106143643|NCT04424641|366186834|FG004|Overall Study|Sponsor decision|2|||
106143644|NCT04424641|366186835|FG005|Overall Study|Sponsor decision|2|||
106143645|NCT04424641|366186836|FG006|Overall Study|Sponsor decision|3|||
106143646|NCT04424641|366186837|FG007|Overall Study|Sponsor decision|4|||
106143647|NCT04424641|366186830|FG000|Overall Study|Withdrawal by Subject|0|||
106143648|NCT04424641|366186831|FG001|Overall Study|Withdrawal by Subject|0|||
106143649|NCT04424641|366186832|FG002|Overall Study|Withdrawal by Subject|0|||
106143650|NCT04424641|366186833|FG003|Overall Study|Withdrawal by Subject|0|||
106143651|NCT04424641|366186834|FG004|Overall Study|Withdrawal by Subject|1|||
106143652|NCT04424641|366186835|FG005|Overall Study|Withdrawal by Subject|0|||
106143653|NCT04424641|366186836|FG006|Overall Study|Withdrawal by Subject|0|||
106143654|NCT04424641|366186837|FG007|Overall Study|Withdrawal by Subject|0|||
106143655|NCT04424641|366186830|FG000|Overall Study|Other|0|||
106143656|NCT04424641|366186831|FG001|Overall Study|Other|0|||
106143657|NCT04424641|366186832|FG002|Overall Study|Other|1|||
106143658|NCT04424641|366186833|FG003|Overall Study|Other|0|||
106143659|NCT04424641|366186834|FG004|Overall Study|Other|0|||
106143660|NCT04424641|366186835|FG005|Overall Study|Other|0|||
105805105|NCT01806597|364943365|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
105951842|NCT00887159|365488142|FG002|Overall Study|Alternative therapy|0|||
106143661|NCT04424641|366186836|FG006|Overall Study|Other|0|||
106143662|NCT04424641|366186837|FG007|Overall Study|Other|0|||
106143663|NCT02694978|366186844|FG000|Overall Study|Adverse Event|10|||
106143664|NCT02694978|366186845|FG001|Overall Study|Adverse Event|9|||
106143665|NCT02694978|366186844|FG000|Overall Study|Withdrawal by Subject|22|||
105951843|NCT00887159|365488140|FG000|Overall Study|Physician Decision|1|||
105951844|NCT00887159|365488141|FG001|Overall Study|Physician Decision|1|||
105951845|NCT00887159|365488142|FG002|Overall Study|Physician Decision|0|||
105951846|NCT00887159|365488140|FG000|Overall Study|Sympomatic deterioration|1|||
105951847|NCT00887159|365488141|FG001|Overall Study|Sympomatic deterioration|0|||
105951848|NCT00887159|365488142|FG002|Overall Study|Sympomatic deterioration|0|||
105951849|NCT00887159|365488140|FG000|Overall Study|Treatment delayed|1|||
105951850|NCT00887159|365488141|FG001|Overall Study|Treatment delayed|1|||
105951851|NCT00887159|365488142|FG002|Overall Study|Treatment delayed|0|||
105805106|NCT01806597|364943366|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105805107|NCT01806597|364943367|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105805108|NCT01806597|364943368|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105805109|NCT01806597|364943369|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
105805110|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
105805111|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
105805112|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
105805113|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
105805114|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
105805115|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
105805116|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
105805117|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
105805118|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
105805119|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
105805120|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
105805121|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
105805122|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
105805123|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805124|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805125|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805126|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805127|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
105805128|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
105805129|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
105805130|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
105805131|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
105805132|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
105805133|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
105805134|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
105805135|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805136|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805137|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805138|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805139|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
105805140|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
105805141|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
105805142|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
105805143|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
105805144|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
105805145|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
105805146|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
105805147|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
105805148|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
105805149|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
105805150|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
105805151|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
105805152|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
105805153|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
105805154|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
105805155|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
105805156|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
105805157|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
105805158|NCT01806597|364943364|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
105805159|NCT01806597|364943365|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
105805160|NCT01806597|364943366|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
106143666|NCT02694978|366186845|FG001|Overall Study|Withdrawal by Subject|19|||
106143667|NCT02694978|366186844|FG000|Overall Study|Lost to Follow-up|14|||
106143668|NCT02694978|366186845|FG001|Overall Study|Lost to Follow-up|17|||
106143669|NCT02694978|366186844|FG000|Overall Study|Death|4|||
106143670|NCT02694978|366186845|FG001|Overall Study|Death|1|||
105805161|NCT01806597|364943367|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
106143671|NCT02694978|366186844|FG000|Overall Study|Other-Decision of Participant|6|||
106143672|NCT02694978|366186845|FG001|Overall Study|Other-Decision of Participant|1|||
106143673|NCT02694978|366186844|FG000|Overall Study|Other-Investigator's decision|1|||
105805162|NCT01806597|364943368|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
105805163|NCT01806597|364943369|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
105805164|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805165|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805166|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805167|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805168|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
105805169|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
105805170|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805171|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805172|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805173|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805174|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
105805175|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
105805176|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805177|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805178|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805179|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805180|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
105805181|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
105805182|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805183|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805184|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805185|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805186|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
105805187|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
105805188|NCT01806597|364943364|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805189|NCT01806597|364943365|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805190|NCT01806597|364943366|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805191|NCT01806597|364943367|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805192|NCT01806597|364943368|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
105805193|NCT01806597|364943369|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
105805194|NCT02482805|364943370|FG000|Overall Study|Lost to Follow-up|4|||
105805195|NCT02482805|364943371|FG001|Overall Study|Lost to Follow-up|4|||
105805196|NCT02482805|364943372|FG002|Overall Study|Lost to Follow-up|0|||
105805197|NCT01073020|364943373|FG000|Overall Study|Withdrawal by Subject|6|||
105805198|NCT01073020|364943374|FG001|Overall Study|Withdrawal by Subject|4|||
105805199|NCT01073020|364943375|FG002|Overall Study|Withdrawal by Subject|1|||
105805200|NCT01073020|364943376|FG003|Overall Study|Withdrawal by Subject|2|||
105805201|NCT01073020|364943373|FG000|Overall Study|Physician Decision|1|||
105805202|NCT01073020|364943374|FG001|Overall Study|Physician Decision|0|||
105805203|NCT01073020|364943375|FG002|Overall Study|Physician Decision|2|||
105805204|NCT01073020|364943376|FG003|Overall Study|Physician Decision|0|||
105805205|NCT01073020|364943373|FG000|Overall Study|Death|0|||
105805206|NCT01073020|364943374|FG001|Overall Study|Death|1|||
105805207|NCT01073020|364943375|FG002|Overall Study|Death|0|||
105805208|NCT01073020|364943376|FG003|Overall Study|Death|0|||
105805209|NCT01466686|364943377|FG000|Overall Study|Withdrawal by Subject|1|||
105805210|NCT01772368|364943381|FG000|Overall Study|Adverse Event|1|||
105805211|NCT01772368|364943381|FG000|Overall Study|Withdrawal by Subject|3|||
105805212|NCT01772368|364943381|FG000|Overall Study|Protocol Violation|2|||
105805213|NCT01772368|364943381|FG000|Overall Study|Other|1|||
105805214|NCT02008721|364943392|FG000|Overall Study|Withdrawal by Subject|5|||
105805215|NCT02008721|364943393|FG001|Overall Study|Withdrawal by Subject|1|||
105805216|NCT02008721|364943392|FG000|Overall Study|Death|4|||
105805217|NCT02008721|364943393|FG001|Overall Study|Death|2|||
105805218|NCT02008721|364943392|FG000|Overall Study|Adverse Event|3|||
105805219|NCT02008721|364943393|FG001|Overall Study|Adverse Event|5|||
105805220|NCT02008721|364943392|FG000|Overall Study|Protocol Violation|3|||
105805221|NCT02008721|364943393|FG001|Overall Study|Protocol Violation|2|||
105805222|NCT04081337|364943394|FG000|Overall Study|Adverse Event|0|||
105805223|NCT04081337|364943395|FG001|Overall Study|Adverse Event|1|||
105805224|NCT04081337|364943394|FG000|Overall Study|Withdrawal by Subject|2|||
105805225|NCT04081337|364943395|FG001|Overall Study|Withdrawal by Subject|0|||
105805226|NCT04081337|364943394|FG000|Overall Study|Physician Decision|1|||
105805227|NCT04081337|364943395|FG001|Overall Study|Physician Decision|2|||
105805228|NCT04081337|364943394|FG000|Overall Study|Lost to Follow-up|1|||
105805229|NCT04081337|364943395|FG001|Overall Study|Lost to Follow-up|0|||
106143674|NCT02694978|366186845|FG001|Overall Study|Other-Investigator's decision|0|||
105805230|NCT04272775|364943399|FG000|Overall Study|Study Terminated by Sponsor|1|||
106143675|NCT02694978|366186844|FG000|Overall Study|Other-Unable to be reached|0|||
105805231|NCT04272775|364943400|FG001|Overall Study|Study Terminated by Sponsor|0|||
105805232|NCT04272775|364943399|FG000|Overall Study|Protocol Violation|0|||
105805233|NCT04272775|364943400|FG001|Overall Study|Protocol Violation|1|||
105805234|NCT04272775|364943399|FG000|Overall Study|Symptomatic Deterioration|1|||
105805235|NCT04272775|364943400|FG001|Overall Study|Symptomatic Deterioration|1|||
105805236|NCT04272775|364943399|FG000|Overall Study|Withdrawal by Subject|1|||
105805237|NCT04272775|364943400|FG001|Overall Study|Withdrawal by Subject|2|||
105805238|NCT04272775|364943399|FG000|Overall Study|Adverse Event|1|||
105805239|NCT04272775|364943400|FG001|Overall Study|Adverse Event|2|||
105805240|NCT04272775|364943399|FG000|Overall Study|Progressive Disease|3|||
105805241|NCT04272775|364943400|FG001|Overall Study|Progressive Disease|1|||
105805242|NCT00738673|364943403|FG000|Overall Study|Adverse Event|1|||
105805243|NCT00738673|364943404|FG001|Overall Study|Adverse Event|0|||
105805244|NCT00738673|364943403|FG000|Overall Study|Lack of Efficacy|19|||
105805245|NCT00738673|364943404|FG001|Overall Study|Lack of Efficacy|8|||
105805246|NCT00738673|364943403|FG000|Overall Study|Protocol Violation|1|||
105805247|NCT00738673|364943404|FG001|Overall Study|Protocol Violation|2|||
105805248|NCT00738673|364943403|FG000|Overall Study|Withdrawal by Subject|3|||
105805249|NCT00738673|364943404|FG001|Overall Study|Withdrawal by Subject|1|||
106143676|NCT02694978|366186845|FG001|Overall Study|Other-Unable to be reached|1|||
106143677|NCT02694978|366186844|FG000|Overall Study|Other-Protocol noncompliant|2|||
106143678|NCT02694978|366186845|FG001|Overall Study|Other-Protocol noncompliant|1|||
106143679|NCT02694978|366186844|FG000|Overall Study|Other-Personal reasons|3|||
106143680|NCT02694978|366186845|FG001|Overall Study|Other-Personal reasons|3|||
106143681|NCT02694978|366186844|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
106143682|NCT02694978|366186845|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
106143683|NCT01426269|366186846|FG000|Period 1: 12 Weeks|Adverse Event|5|||
105805250|NCT00752791|364943405|FG000|Overall Study|Adverse Event|7|||
105805251|NCT00752791|364943405|FG000|Overall Study|Withdrawal by Subject|1|||
105805252|NCT00752791|364943405|FG000|Overall Study|Physician Decision|1|||
105805253|NCT00752791|364943405|FG000|Overall Study|Death|1|||
105805254|NCT00752791|364943405|FG000|Overall Study|Renal transplant|3|||
105805255|NCT00752791|364943405|FG000|Overall Study|Switched to hemodialysis|2|||
105805256|NCT00752791|364943405|FG000|Overall Study|Protocol deviation|1|||
105805257|NCT01977092|364943406|FG000|Overall Study|Death|3|||
105805258|NCT01977092|364943407|FG001|Overall Study|Death|4|||
105805259|NCT01977092|364943406|FG000|Overall Study|Lost to Follow-up|23|||
105805260|NCT01977092|364943407|FG001|Overall Study|Lost to Follow-up|14|||
105805261|NCT01977092|364943406|FG000|Overall Study|Withdrawal by Subject|2|||
105805262|NCT01977092|364943407|FG001|Overall Study|Withdrawal by Subject|1|||
105805263|NCT01977092|364943406|FG000|Overall Study|In prison|3|||
105805264|NCT01977092|364943407|FG001|Overall Study|In prison|11|||
105805265|NCT00678392|364943408|FG000|Overall Study|Adverse Event|0|||
105805266|NCT00678392|364943409|FG001|Overall Study|Adverse Event|6|||
105805267|NCT00678392|364943408|FG000|Overall Study|Death|280|||
105805268|NCT00678392|364943409|FG001|Overall Study|Death|269|||
105805269|NCT00678392|364943408|FG000|Overall Study|Lost to Follow-up|15|||
105805270|NCT00678392|364943409|FG001|Overall Study|Lost to Follow-up|13|||
105805271|NCT00678392|364943408|FG000|Overall Study|Objective Progression or Relapse|3|||
105805272|NCT00678392|364943409|FG001|Overall Study|Objective Progression or Relapse|8|||
105805273|NCT00678392|364943408|FG000|Overall Study|Sponsor's Decision|1|||
105805274|NCT00678392|364943409|FG001|Overall Study|Sponsor's Decision|2|||
105805275|NCT00678392|364943408|FG000|Overall Study|Withdrawal by Subject|4|||
106143684|NCT01426269|366186847|FG001|Period 1: 12 Weeks|Adverse Event|0|||
106143685|NCT01426269|366186848|FG002|Period 1: 12 Weeks|Adverse Event|0|||
106143686|NCT01426269|366186846|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
106143687|NCT01426269|366186847|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
106143688|NCT01426269|366186848|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
106143689|NCT01426269|366186846|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
106143690|NCT01426269|366186847|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
106143691|NCT01426269|366186848|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
106143692|NCT01426269|366186846|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
105805276|NCT00678392|364943409|FG001|Overall Study|Withdrawal by Subject|4|||
105805277|NCT00678392|364943408|FG000|Overall Study|Randomized But Not Treated|2|||
106143693|NCT01426269|366186847|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
106143694|NCT01426269|366186848|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
106143695|NCT01426269|366186846|FG000|Period 1: 12 Weeks|Pregnancy|1|||
106143696|NCT01426269|366186847|FG001|Period 1: 12 Weeks|Pregnancy|0|||
106143697|NCT01426269|366186848|FG002|Period 1: 12 Weeks|Pregnancy|0|||
105805278|NCT00678392|364943409|FG001|Overall Study|Randomized But Not Treated|7|||
105805279|NCT00678392|364943408|FG000|Overall Study|Other|56|||
105805280|NCT00678392|364943409|FG001|Overall Study|Other|53|||
105805281|NCT02385526|364943415|FG000|Overall Study|Withdrawal by Subject|0|||
105805282|NCT02385526|364943416|FG001|Overall Study|Withdrawal by Subject|2|||
105805283|NCT02385526|364943417|FG002|Overall Study|Withdrawal by Subject|0|||
105805284|NCT02385526|364943415|FG000|Overall Study|Lost to Follow-up|0|||
105805285|NCT02385526|364943416|FG001|Overall Study|Lost to Follow-up|1|||
105805286|NCT02385526|364943417|FG002|Overall Study|Lost to Follow-up|0|||
105805287|NCT02385526|364943415|FG000|Overall Study|Physician Decision|1|||
105805288|NCT02385526|364943416|FG001|Overall Study|Physician Decision|0|||
105805289|NCT02385526|364943417|FG002|Overall Study|Physician Decision|0|||
105805290|NCT02385526|364943415|FG000|Overall Study|Protocol Violation|1|||
105805291|NCT02385526|364943416|FG001|Overall Study|Protocol Violation|0|||
105805292|NCT02385526|364943417|FG002|Overall Study|Protocol Violation|0|||
105805293|NCT00441584|364943418|FG000|Overall Study|Lack of Efficacy|79|||
105805294|NCT00441584|364943418|FG000|Overall Study|Withdrawal by Subject|8|||
105805295|NCT00441584|364943418|FG000|Overall Study|Adverse Event|6|||
105805296|NCT00441584|364943418|FG000|Overall Study|Protocol Violation|5|||
105805297|NCT00441584|364943418|FG000|Overall Study|Lost to Follow-up|4|||
105805298|NCT00441584|364943418|FG000|Overall Study|Failure to meet eligibility criteria|3|||
105805299|NCT03263819|364943422|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
105805300|NCT03263819|364943423|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
105805301|NCT01952574|364943427|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
105805302|NCT01952574|364943428|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
105805303|NCT01952574|364943429|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
105805304|NCT01952574|364943430|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
105805305|NCT01952574|364943431|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105805306|NCT01952574|364943432|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105805307|NCT01952574|364943433|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
105805308|NCT01952574|364943427|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
105805309|NCT01952574|364943428|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
105805310|NCT01952574|364943429|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
105805311|NCT01952574|364943430|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
105805312|NCT01952574|364943431|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
105805313|NCT01952574|364943432|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
105805314|NCT01952574|364943433|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
105805315|NCT01952574|364943427|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
105805316|NCT01952574|364943428|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805317|NCT01952574|364943429|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
105805318|NCT01952574|364943430|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805319|NCT01952574|364943431|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805320|NCT01952574|364943432|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805321|NCT01952574|364943433|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
105805322|NCT01952574|364943427|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805323|NCT01952574|364943428|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805324|NCT01952574|364943429|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805325|NCT01952574|364943430|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805326|NCT01952574|364943431|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
105805327|NCT01952574|364943432|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805328|NCT01952574|364943433|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
105805329|NCT01952574|364943427|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
105805330|NCT01952574|364943428|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
105805331|NCT01952574|364943429|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
105805332|NCT01952574|364943430|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
105805333|NCT01952574|364943431|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
105805334|NCT01952574|364943432|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
105805335|NCT01952574|364943433|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
105805336|NCT01952574|364943427|FG000|Open-label Treatment Phase|Missing|0|||
105805337|NCT01952574|364943428|FG001|Open-label Treatment Phase|Missing|0|||
105805338|NCT01952574|364943429|FG002|Open-label Treatment Phase|Missing|0|||
105805339|NCT01952574|364943430|FG003|Open-label Treatment Phase|Missing|0|||
105805340|NCT01952574|364943431|FG004|Open-label Treatment Phase|Missing|4|||
105805341|NCT01952574|364943432|FG005|Open-label Treatment Phase|Missing|0|||
105805342|NCT01952574|364943433|FG006|Open-label Treatment Phase|Missing|0|||
105805343|NCT01952574|364943427|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
105805344|NCT01952574|364943428|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
105805345|NCT01952574|364943429|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
105805346|NCT01952574|364943430|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
105805347|NCT01952574|364943431|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
105805348|NCT01952574|364943432|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
105805349|NCT01952574|364943433|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
105805350|NCT01952574|364943427|FG000|Open-label Treatment Phase|Death|0|||
105805351|NCT01952574|364943428|FG001|Open-label Treatment Phase|Death|0|||
105805352|NCT01952574|364943429|FG002|Open-label Treatment Phase|Death|0|||
105805353|NCT01952574|364943430|FG003|Open-label Treatment Phase|Death|0|||
105805354|NCT01952574|364943431|FG004|Open-label Treatment Phase|Death|1|||
105805355|NCT01952574|364943432|FG005|Open-label Treatment Phase|Death|0|||
105805356|NCT01952574|364943433|FG006|Open-label Treatment Phase|Death|0|||
105805357|NCT01952574|364943427|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805358|NCT01952574|364943428|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805359|NCT01952574|364943429|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805360|NCT01952574|364943430|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805361|NCT01952574|364943431|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
106143698|NCT01426269|366186846|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
106143699|NCT01426269|366186847|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
106143700|NCT01426269|366186848|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
106143701|NCT01426269|366186846|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
106143702|NCT01426269|366186847|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
106143703|NCT01426269|366186848|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
105805362|NCT01952574|364943432|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
105805363|NCT01952574|364943433|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
105805364|NCT01952574|364943427|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805365|NCT01952574|364943428|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805366|NCT01952574|364943429|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805367|NCT01952574|364943430|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805368|NCT01952574|364943431|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
105805369|NCT01952574|364943432|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
105805370|NCT01952574|364943433|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
105805371|NCT00770991|364943436|FG000|Overall Study|Physician Decision|2|||
105805372|NCT00770991|364943437|FG001|Overall Study|Physician Decision|0|||
105805373|NCT00770991|364943436|FG000|Overall Study|Withdrawal by Subject|1|||
105805374|NCT00770991|364943437|FG001|Overall Study|Withdrawal by Subject|0|||
105805375|NCT00770991|364943436|FG000|Overall Study|Adverse Event|1|||
105805376|NCT00770991|364943437|FG001|Overall Study|Adverse Event|5|||
105805377|NCT00770991|364943436|FG000|Overall Study|Pregnancy|1|||
105805378|NCT00770991|364943437|FG001|Overall Study|Pregnancy|0|||
105805379|NCT01992107|364943440|FG000|Overall Study|Administrative reasons|2|||
105805380|NCT01992107|364943441|FG001|Overall Study|Administrative reasons|0|||
105805381|NCT01992107|364943442|FG002|Overall Study|Administrative reasons|0|||
105805382|NCT01992107|364943440|FG000|Overall Study|Adverse Event|0|||
105805383|NCT01992107|364943441|FG001|Overall Study|Adverse Event|1|||
105805384|NCT01992107|364943442|FG002|Overall Study|Adverse Event|0|||
105805385|NCT01992107|364943440|FG000|Overall Study|Lost to Follow-up|46|||
105805386|NCT01992107|364943441|FG001|Overall Study|Lost to Follow-up|22|||
105805387|NCT01992107|364943442|FG002|Overall Study|Lost to Follow-up|26|||
105805388|NCT01992107|364943440|FG000|Overall Study|noncompliance and were unavailable|7|||
105805389|NCT01992107|364943441|FG001|Overall Study|noncompliance and were unavailable|3|||
105805390|NCT01992107|364943442|FG002|Overall Study|noncompliance and were unavailable|2|||
105805391|NCT01992107|364943440|FG000|Overall Study|Withdrawal by Subject|13|||
105805392|NCT01992107|364943441|FG001|Overall Study|Withdrawal by Subject|7|||
105951852|NCT00887159|365488140|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
105805393|NCT01992107|364943442|FG002|Overall Study|Withdrawal by Subject|8|||
105805394|NCT01388647|364943453|FG000|Overall Study|Adverse Event|1|||
105805395|NCT01388647|364943454|FG001|Overall Study|Adverse Event|2|||
105805396|NCT01842958|364943455|FG000|Overall Study|Lost to Follow-up|1|||
105805397|NCT01842958|364943456|FG001|Overall Study|Lost to Follow-up|1|||
105805398|NCT01829477|364943457|FG000|Overall Study|Study Terminated by Sponsor|15|||
105805399|NCT01829477|364943458|FG001|Overall Study|Study Terminated by Sponsor|15|||
105951853|NCT00887159|365488141|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
105951854|NCT00887159|365488142|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
105951855|NCT00887159|365488140|FG000|Overall Study|Received more tx instead of observation|1|||
105951856|NCT00887159|365488141|FG001|Overall Study|Received more tx instead of observation|0|||
105951857|NCT00887159|365488142|FG002|Overall Study|Received more tx instead of observation|0|||
105951858|NCT00887159|365488140|FG000|Overall Study|Ineligible|5|||
105951859|NCT00887159|365488141|FG001|Overall Study|Ineligible|1|||
105951860|NCT00887159|365488142|FG002|Overall Study|Ineligible|0|||
105951861|NCT00887159|365488140|FG000|Overall Study|Never started assigned therapy|3|||
105951862|NCT00887159|365488141|FG001|Overall Study|Never started assigned therapy|3|||
106143704|NCT01426269|366186846|FG000|Period 2: 40 Weeks|Adverse Event|0|||
105805400|NCT01829477|364943457|FG000|Overall Study|Withdrawal by Subject|1|||
105805401|NCT01829477|364943458|FG001|Overall Study|Withdrawal by Subject|0|||
105805402|NCT01001169|364943459|FG000|Overall Study|Withdrawal by Subject|2|||
105805403|NCT01001169|364943460|FG001|Overall Study|Withdrawal by Subject|1|||
105805404|NCT02536378|364943463|FG000|Overall Study|Physician Decision|0|||
105805405|NCT02536378|364943464|FG001|Overall Study|Physician Decision|2|||
105951863|NCT00887159|365488142|FG002|Overall Study|Never started assigned therapy|4|||
105951864|NCT00803738|365488144|FG000|Overall Study|Adverse Event|3|||
106143705|NCT01426269|366186847|FG001|Period 2: 40 Weeks|Adverse Event|1|||
105805406|NCT02536378|364943463|FG000|Overall Study|Withdrawal by Subject|0|||
105805407|NCT02536378|364943464|FG001|Overall Study|Withdrawal by Subject|1|||
105805408|NCT02536378|364943463|FG000|Overall Study|Death|1|||
105805409|NCT02536378|364943464|FG001|Overall Study|Death|2|||
105805410|NCT02536378|364943463|FG000|Overall Study|Patient refused further follow up|6|||
105805411|NCT02536378|364943464|FG001|Overall Study|Patient refused further follow up|2|||
105951865|NCT00803738|365488145|FG001|Overall Study|Adverse Event|5|||
105805412|NCT00798889|364943465|FG000|Overall Study|Adverse Event|53|||
105805413|NCT00798889|364943465|FG000|Overall Study|Protocol Violation|2|||
105805414|NCT00798889|364943465|FG000|Overall Study|Withdrawal by Subject|31|||
105805415|NCT00798889|364943465|FG000|Overall Study|Lost to Follow-up|1|||
105805416|NCT00798889|364943465|FG000|Overall Study|Lack of Efficacy|213|||
105805417|NCT00798889|364943465|FG000|Overall Study|Decision of Sponsor|11|||
105805418|NCT00798889|364943465|FG000|Overall Study|Enrolled, Not treated|3|||
105805419|NCT00617461|364943466|FG000|First Treatment Intervention Period|Adverse Event|2|||
105805420|NCT00617461|364943467|FG001|First Treatment Intervention Period|Adverse Event|0|||
105805421|NCT00617461|364943466|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
105805422|NCT00617461|364943467|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
105805423|NCT00617461|364943466|FG000|First Treatment Intervention Period|Protocol Violation|2|||
105805424|NCT00617461|364943467|FG001|First Treatment Intervention Period|Protocol Violation|1|||
105805425|NCT00617461|364943466|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
105805426|NCT00617461|364943467|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
105805427|NCT00617461|364943466|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
105805428|NCT00617461|364943467|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
105805429|NCT00617461|364943466|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
105805430|NCT00617461|364943467|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
105805431|NCT00617461|364943466|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
105805432|NCT00617461|364943467|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
105805433|NCT00617461|364943466|FG000|Second Treatment Intervention Period|Adverse Event|0|||
105805434|NCT00617461|364943467|FG001|Second Treatment Intervention Period|Adverse Event|1|||
105805435|NCT00617461|364943466|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
105805436|NCT00617461|364943467|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
105805437|NCT00617461|364943466|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
105805438|NCT00617461|364943467|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
105805439|NCT00617461|364943466|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
105805440|NCT00617461|364943467|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
105805441|NCT01738581|364943469|FG000|Overall Study|Lost to Follow-up|1|||
105805442|NCT01738581|364943470|FG001|Overall Study|Lost to Follow-up|0|||
105805443|NCT00210626|364943471|FG000|Overall Study|Adverse Event|1|||
105805444|NCT00210626|364943472|FG001|Overall Study|Adverse Event|2|||
105805445|NCT00210626|364943471|FG000|Overall Study|Protocol Violation|1|||
105805446|NCT00210626|364943472|FG001|Overall Study|Protocol Violation|5|||
105805447|NCT00210626|364943471|FG000|Overall Study|Lost to Follow-up|11|||
105805448|NCT00210626|364943472|FG001|Overall Study|Lost to Follow-up|11|||
105805449|NCT00210626|364943471|FG000|Overall Study|Death|1|||
105805450|NCT00210626|364943472|FG001|Overall Study|Death|0|||
105805451|NCT00210626|364943471|FG000|Overall Study|Withdrawal by Subject|29|||
105805452|NCT00210626|364943472|FG001|Overall Study|Withdrawal by Subject|20|||
105805453|NCT00210626|364943471|FG000|Overall Study|Physician Decision|0|||
105805454|NCT00210626|364943472|FG001|Overall Study|Physician Decision|2|||
105805455|NCT00210626|364943471|FG000|Overall Study|Sponser Request|1|||
105805456|NCT00210626|364943472|FG001|Overall Study|Sponser Request|0|||
105805457|NCT00210626|364943471|FG000|Overall Study|Other|4|||
105805458|NCT00210626|364943472|FG001|Overall Study|Other|5|||
105805459|NCT01965652|364943473|FG000|Overall Study|Adverse Event|40|||
105805460|NCT01965652|364943474|FG001|Overall Study|Adverse Event|37|||
105805461|NCT01965652|364943473|FG000|Overall Study|Withdrawal by Subject|62|||
105805462|NCT01965652|364943474|FG001|Overall Study|Withdrawal by Subject|69|||
105805463|NCT01965652|364943473|FG000|Overall Study|Lost to Follow-up|53|||
105805464|NCT01965652|364943474|FG001|Overall Study|Lost to Follow-up|40|||
105805465|NCT01965652|364943473|FG000|Overall Study|Protocol Violation|34|||
105805466|NCT01965652|364943474|FG001|Overall Study|Protocol Violation|38|||
105805467|NCT01965652|364943473|FG000|Overall Study|Death|3|||
105805468|NCT01965652|364943474|FG001|Overall Study|Death|4|||
105805469|NCT01965652|364943473|FG000|Overall Study|Other - Miscellaneous|18|||
105805470|NCT01965652|364943474|FG001|Overall Study|Other - Miscellaneous|21|||
105805471|NCT01965652|364943473|FG000|Overall Study|Pregnancy|0|||
105805472|NCT01965652|364943474|FG001|Overall Study|Pregnancy|1|||
105805473|NCT01348542|364943475|FG000|Overall Study|Withdrawal by Subject|3|||
105805474|NCT01348542|364943476|FG001|Overall Study|Withdrawal by Subject|0|||
105805475|NCT01907737|364944916|FG000|Overall Study|Withdrawal by Subject|1|||
105805476|NCT04527471|364944922|FG000|Overall Study|Adverse Event|1|||
105805477|NCT04527471|364944923|FG001|Overall Study|Adverse Event|0|||
105805478|NCT04527471|364944922|FG000|Overall Study|Lost to Follow-up|1|||
105805479|NCT04527471|364944923|FG001|Overall Study|Lost to Follow-up|0|||
105805480|NCT01003886|364944926|FG000|Overall Study|Lack of Efficacy|5|||
105805481|NCT01003886|364944926|FG000|Overall Study|Lost to Follow-up|169|||
105805482|NCT01003886|364944926|FG000|Overall Study|Withdrawal by Subject|39|||
105805483|NCT01003886|364944926|FG000|Overall Study|Other|14|||
105805484|NCT01003886|364944926|FG000|Overall Study|Adverse Event|3|||
105805485|NCT04467697|364944927|FG000|Overall Study|Adverse Event|2|||
105805486|NCT04467697|364944927|FG000|Overall Study|Lost to Follow-up|6|||
105805487|NCT04467697|364944927|FG000|Overall Study|Withdrawal by Subject|9|||
106016738|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
106143706|NCT01426269|366186848|FG002|Period 2: 40 Weeks|Adverse Event|2|||
106143707|NCT01426269|366186846|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
106143708|NCT01426269|366186847|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
106143709|NCT01426269|366186848|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
106143710|NCT01426269|366186846|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
106143711|NCT01426269|366186847|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
106143712|NCT01426269|366186848|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
106143713|NCT01426269|366186846|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
106143714|NCT01426269|366186847|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
106143715|NCT01426269|366186848|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
106143716|NCT01426269|366186846|FG000|Period 2: 40 Weeks|Site closed|0|||
106143717|NCT01426269|366186847|FG001|Period 2: 40 Weeks|Site closed|6|||
106143718|NCT01426269|366186848|FG002|Period 2: 40 Weeks|Site closed|5|||
106143719|NCT01426269|366186846|FG000|Period 2: 40 Weeks|Relapsed|0|||
106143720|NCT01426269|366186847|FG001|Period 2: 40 Weeks|Relapsed|9|||
106143721|NCT01426269|366186848|FG002|Period 2: 40 Weeks|Relapsed|18|||
106143722|NCT01376089|366186849|FG000|Overall Study|Patient received no contrast media|3|||
106143723|NCT01376089|366186850|FG001|Overall Study|Patient received no contrast media|4|||
106143724|NCT03262935|366186851|FG000|Overall Study|Withdrawal by Subject|6|||
106143725|NCT03262935|366186852|FG001|Overall Study|Withdrawal by Subject|7|||
106143726|NCT03262935|366186851|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
106143727|NCT03262935|366186852|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
106143728|NCT03262935|366186851|FG000|Overall Study|Death|181|||
106143729|NCT03262935|366186852|FG001|Overall Study|Death|94|||
106143730|NCT03262935|366186851|FG000|Overall Study|Lost to Follow-up|9|||
106143731|NCT03262935|366186852|FG001|Overall Study|Lost to Follow-up|4|||
106143732|NCT03262935|366186851|FG000|Overall Study|Other reason|5|||
106143733|NCT03262935|366186852|FG001|Overall Study|Other reason|0|||
106143734|NCT01811706|366186853|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
106143735|NCT01811706|366186854|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
106143736|NCT02224924|366186855|FG000|Overall Study|Withdrawal by Subject|7|||
106143737|NCT02224924|366186856|FG001|Overall Study|Withdrawal by Subject|6|||
106143738|NCT02224924|366186855|FG000|Overall Study|Biopsy cancelled|20|||
106143739|NCT02224924|366186856|FG001|Overall Study|Biopsy cancelled|14|||
106143740|NCT02224924|366186855|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
106143741|NCT02224924|366186856|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
106143742|NCT02224924|366186855|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
106143743|NCT02224924|366186856|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
106143744|NCT03020745|366186857|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143745|NCT03020745|366186858|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143746|NCT03020745|366186859|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143747|NCT03020745|366186860|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143748|NCT03020745|366186861|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143749|NCT03020745|366186862|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143750|NCT03020745|366186863|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143751|NCT03020745|366186864|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143752|NCT03020745|366186865|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
106143753|NCT03020745|366186866|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
106143754|NCT03020745|366186857|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
106143755|NCT03020745|366186858|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
106143756|NCT03020745|366186859|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
106143757|NCT03020745|366186860|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
106143758|NCT03020745|366186861|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
106143759|NCT03020745|366186862|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
106143760|NCT03020745|366186863|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
106143761|NCT03020745|366186864|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
106143762|NCT03020745|366186865|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
106143763|NCT03020745|366186866|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
105759948|NCT03276572|364773817|FG004|Overall Study|In follow-up|0|||
105759949|NCT03276572|364773818|FG005|Overall Study|In follow-up|1|||
105759950|NCT03276572|364773819|FG006|Overall Study|In follow-up|1|||
105759951|NCT03276572|364773813|FG000|Overall Study|Lost to Follow-up|0|||
105759952|NCT03276572|364773814|FG001|Overall Study|Lost to Follow-up|0|||
105759953|NCT03276572|364773815|FG002|Overall Study|Lost to Follow-up|0|||
105759954|NCT03276572|364773816|FG003|Overall Study|Lost to Follow-up|0|||
105759955|NCT03276572|364773817|FG004|Overall Study|Lost to Follow-up|0|||
105759956|NCT03276572|364773818|FG005|Overall Study|Lost to Follow-up|0|||
105759957|NCT03276572|364773819|FG006|Overall Study|Lost to Follow-up|1|||
105759958|NCT01213264|364773826|FG000|Overall Study|Adverse Event|1|||
105759959|NCT01213264|364773827|FG001|Overall Study|Adverse Event|0|||
105759960|NCT01213264|364773828|FG002|Overall Study|Adverse Event|0|||
105759961|NCT01213264|364773826|FG000|Overall Study|Lost to Follow-up|1|||
105759962|NCT01213264|364773827|FG001|Overall Study|Lost to Follow-up|2|||
105759963|NCT01213264|364773828|FG002|Overall Study|Lost to Follow-up|6|||
106016739|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
106016740|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
106016741|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
106016742|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
106016743|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
106016744|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
106016745|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
106016746|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
106016747|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
106016748|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
106016749|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
106016750|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
106143764|NCT03020745|366186857|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
105759964|NCT00105183|364773832|FG000|Overall Study|Death|19|||
105759965|NCT00105183|364773833|FG001|Overall Study|Death|13|||
105759966|NCT00105183|364773834|FG002|Overall Study|Death|15|||
105759967|NCT00105183|364773832|FG000|Overall Study|Withdrawal by Subject|1|||
105759968|NCT00105183|364773833|FG001|Overall Study|Withdrawal by Subject|1|||
105759969|NCT00105183|364773834|FG002|Overall Study|Withdrawal by Subject|4|||
105759970|NCT00105183|364773832|FG000|Overall Study|Physician Decision|1|||
105759971|NCT00105183|364773833|FG001|Overall Study|Physician Decision|2|||
105759972|NCT00105183|364773834|FG002|Overall Study|Physician Decision|3|||
105759973|NCT00105183|364773832|FG000|Overall Study|Lost to Follow-up|0|||
105759974|NCT00105183|364773833|FG001|Overall Study|Lost to Follow-up|1|||
105759975|NCT00105183|364773834|FG002|Overall Study|Lost to Follow-up|1|||
105759976|NCT00105183|364773832|FG000|Overall Study|Other reason|1|||
105759977|NCT00105183|364773833|FG001|Overall Study|Other reason|2|||
105759978|NCT00105183|364773834|FG002|Overall Study|Other reason|0|||
105759979|NCT01855945|364773839|FG000|Overall Study|Adverse Event|0|||
105759980|NCT01855945|364773840|FG001|Overall Study|Adverse Event|0|||
105759981|NCT01855945|364773841|FG002|Overall Study|Adverse Event|0|||
105759982|NCT01855945|364773842|FG003|Overall Study|Adverse Event|0|||
105759983|NCT01855945|364773843|FG004|Overall Study|Adverse Event|0|||
105759984|NCT01855945|364773844|FG005|Overall Study|Adverse Event|0|||
105759985|NCT01855945|364773845|FG006|Overall Study|Adverse Event|1|||
105759986|NCT01855945|364773846|FG007|Overall Study|Adverse Event|0|||
105759987|NCT01855945|364773847|FG008|Overall Study|Adverse Event|0|||
105759988|NCT01855945|364773848|FG009|Overall Study|Adverse Event|0|||
105759989|NCT01855945|364773849|FG010|Overall Study|Adverse Event|0|||
105759990|NCT01855945|364773850|FG011|Overall Study|Adverse Event|0|||
105759991|NCT01855945|364773839|FG000|Overall Study|Death|0|||
105759992|NCT01855945|364773840|FG001|Overall Study|Death|0|||
105759993|NCT01855945|364773841|FG002|Overall Study|Death|0|||
105759994|NCT01855945|364773842|FG003|Overall Study|Death|0|||
105759995|NCT01855945|364773843|FG004|Overall Study|Death|0|||
105759996|NCT01855945|364773844|FG005|Overall Study|Death|0|||
105759997|NCT01855945|364773845|FG006|Overall Study|Death|2|||
105759998|NCT01855945|364773846|FG007|Overall Study|Death|0|||
105759999|NCT01855945|364773847|FG008|Overall Study|Death|0|||
105760000|NCT01855945|364773848|FG009|Overall Study|Death|0|||
105760001|NCT01855945|364773849|FG010|Overall Study|Death|0|||
105760002|NCT01855945|364773850|FG011|Overall Study|Death|0|||
105760003|NCT01855945|364773839|FG000|Overall Study|Lost to Follow-up|11|||
105760004|NCT01855945|364773840|FG001|Overall Study|Lost to Follow-up|10|||
105760005|NCT01855945|364773841|FG002|Overall Study|Lost to Follow-up|7|||
105760006|NCT01855945|364773842|FG003|Overall Study|Lost to Follow-up|3|||
105760007|NCT01855945|364773843|FG004|Overall Study|Lost to Follow-up|0|||
105760008|NCT01855945|364773844|FG005|Overall Study|Lost to Follow-up|3|||
105760009|NCT01855945|364773845|FG006|Overall Study|Lost to Follow-up|4|||
105760010|NCT01855945|364773846|FG007|Overall Study|Lost to Follow-up|7|||
105760011|NCT01855945|364773847|FG008|Overall Study|Lost to Follow-up|2|||
105760012|NCT01855945|364773848|FG009|Overall Study|Lost to Follow-up|0|||
105760013|NCT01855945|364773849|FG010|Overall Study|Lost to Follow-up|0|||
105760014|NCT01855945|364773850|FG011|Overall Study|Lost to Follow-up|2|||
105760015|NCT01855945|364773839|FG000|Overall Study|Other - Unclassified|1|||
105760016|NCT01855945|364773840|FG001|Overall Study|Other - Unclassified|1|||
105760017|NCT01855945|364773841|FG002|Overall Study|Other - Unclassified|1|||
106016751|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
105760018|NCT01855945|364773842|FG003|Overall Study|Other - Unclassified|0|||
105760019|NCT01855945|364773843|FG004|Overall Study|Other - Unclassified|0|||
105760020|NCT01855945|364773844|FG005|Overall Study|Other - Unclassified|0|||
105760021|NCT01855945|364773845|FG006|Overall Study|Other - Unclassified|2|||
105760022|NCT01855945|364773846|FG007|Overall Study|Other - Unclassified|1|||
105760023|NCT01855945|364773847|FG008|Overall Study|Other - Unclassified|0|||
105760024|NCT01855945|364773848|FG009|Overall Study|Other - Unclassified|0|||
105760025|NCT01855945|364773849|FG010|Overall Study|Other - Unclassified|1|||
105760026|NCT01855945|364773850|FG011|Overall Study|Other - Unclassified|0|||
105805488|NCT04467697|364944927|FG000|Overall Study|Protocol Violation|3|||
105805489|NCT02192905|364944928|FG000|Overall Study|Lost to Follow-up|1|||
105805490|NCT02637076|364944929|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
105805491|NCT02637076|364944930|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
105805492|NCT02637076|364944929|FG000|Overall Study|Withdrawal by Subject|0|||
105805493|NCT02637076|364944930|FG001|Overall Study|Withdrawal by Subject|4|||
105805494|NCT02043366|364944933|FG000|Overall Study|Lost to Follow-up|2|||
105805495|NCT02043366|364944934|FG001|Overall Study|Lost to Follow-up|2|||
105805496|NCT02043366|364944935|FG002|Overall Study|Lost to Follow-up|2|||
105805497|NCT02043366|364944936|FG003|Overall Study|Lost to Follow-up|2|||
105805498|NCT02043366|364944937|FG004|Overall Study|Lost to Follow-up|2|||
105805499|NCT02043366|364944938|FG005|Overall Study|Lost to Follow-up|2|||
105805500|NCT02736227|364944939|FG000|Overall Study|Withdrawal by Subject|0|||
105805501|NCT02736227|364944940|FG001|Overall Study|Withdrawal by Subject|0|||
105805502|NCT02736227|364944941|FG002|Overall Study|Withdrawal by Subject|1|||
105805503|NCT02736227|364944939|FG000|Overall Study|Physician Decision|0|||
105805504|NCT02736227|364944940|FG001|Overall Study|Physician Decision|0|||
105805505|NCT02736227|364944941|FG002|Overall Study|Physician Decision|5|||
105805506|NCT02736227|364944939|FG000|Overall Study|Non Compliant|0|||
105805507|NCT02736227|364944940|FG001|Overall Study|Non Compliant|0|||
105805508|NCT02736227|364944941|FG002|Overall Study|Non Compliant|2|||
105805509|NCT04120194|364944945|FG000|Overall Study|Lost to Follow-up|11|||
105805510|NCT04120194|364944946|FG001|Overall Study|Lost to Follow-up|8|||
105805511|NCT04120194|364944945|FG000|Overall Study|Adverse Event|4|||
105805512|NCT04120194|364944946|FG001|Overall Study|Adverse Event|5|||
105805513|NCT04120194|364944945|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
105805514|NCT04120194|364944946|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
105805515|NCT04120194|364944945|FG000|Overall Study|Miscellaneous|4|||
105805516|NCT04120194|364944946|FG001|Overall Study|Miscellaneous|5|||
105805517|NCT00989261|364944947|FG000|Overall Study|Still in follow up|12|||
105805518|NCT00989261|364944948|FG001|Overall Study|Still in follow up|21|||
105805519|NCT00989261|364944947|FG000|Overall Study|Withdrawal by Subject|0|||
105805520|NCT00989261|364944948|FG001|Overall Study|Withdrawal by Subject|1|||
105805521|NCT00989261|364944947|FG000|Overall Study|Lost to Follow-up|3|||
105805522|NCT00989261|364944948|FG001|Overall Study|Lost to Follow-up|0|||
105805523|NCT02927847|364944949|FG000|Overall Study|Lost to Follow-up|1|||
105805524|NCT02927847|364944950|FG001|Overall Study|Lost to Follow-up|0|||
105805525|NCT02927847|364944949|FG000|Overall Study|Withdrawal by Subject|4|||
105805526|NCT02927847|364944950|FG001|Overall Study|Withdrawal by Subject|2|||
105805527|NCT02927847|364944949|FG000|Overall Study|PI withdrawn due to missed visits|1|||
105805528|NCT02927847|364944950|FG001|Overall Study|PI withdrawn due to missed visits|1|||
105805529|NCT00553540|364944951|FG000|Overall Study|discharged after first visit|2|||
105805530|NCT00553540|364944952|FG001|Overall Study|discharged after first visit|5|||
105805531|NCT03882047|364944953|FG000|Overall Study|Adverse Event|0|||
105805532|NCT03882047|364944954|FG001|Overall Study|Adverse Event|2|||
105805533|NCT03882047|364944955|FG002|Overall Study|Adverse Event|2|||
105805534|NCT03882047|364944953|FG000|Overall Study|Treatment Failure|3|||
105805535|NCT03882047|364944954|FG001|Overall Study|Treatment Failure|3|||
105805536|NCT03882047|364944955|FG002|Overall Study|Treatment Failure|12|||
105805537|NCT03882047|364944953|FG000|Overall Study|Lost to Follow-up|0|||
105805538|NCT03882047|364944954|FG001|Overall Study|Lost to Follow-up|1|||
105805539|NCT03882047|364944955|FG002|Overall Study|Lost to Follow-up|0|||
105805540|NCT03882047|364944953|FG000|Overall Study|Did Not Wish to Continue|1|||
105805541|NCT03882047|364944954|FG001|Overall Study|Did Not Wish to Continue|4|||
105805542|NCT03882047|364944955|FG002|Overall Study|Did Not Wish to Continue|1|||
105805543|NCT03882047|364944953|FG000|Overall Study|Noncompliance With Protocol|2|||
105805544|NCT03882047|364944954|FG001|Overall Study|Noncompliance With Protocol|0|||
105805545|NCT03882047|364944955|FG002|Overall Study|Noncompliance With Protocol|0|||
105805546|NCT03882047|364944953|FG000|Overall Study|Did Not Meet Eligibility|0|||
105805547|NCT03882047|364944954|FG001|Overall Study|Did Not Meet Eligibility|0|||
105805548|NCT03882047|364944955|FG002|Overall Study|Did Not Meet Eligibility|1|||
105805549|NCT03870997|364944957|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
105805550|NCT03870997|364944958|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
105805551|NCT03870997|364944959|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
105805552|NCT03870997|364944960|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
105805553|NCT03870997|364944961|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
105805554|NCT03870997|364944962|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
105805555|NCT01689974|364944964|FG000|Overall Study|Termination of Study|5|||
105805556|NCT01689974|364944965|FG001|Overall Study|Termination of Study|5|||
105805557|NCT00681863|364944966|FG000|Overall Study|Adverse Event|1|||
105805558|NCT00681863|364944966|FG000|Overall Study|Lost to Follow-up|2|||
105805559|NCT00681863|364944966|FG000|Overall Study|Lack of Efficacy|2|||
105805560|NCT00681863|364944966|FG000|Overall Study|Other|18|||
105805561|NCT01107535|364944967|FG000|Overall Study|Death|5|||
105805562|NCT00585351|364944972|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
106143765|NCT03020745|366186858|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
106143766|NCT03020745|366186859|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
106143767|NCT03020745|366186860|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
106143768|NCT03020745|366186861|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
106143769|NCT03020745|366186862|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
106143770|NCT03020745|366186863|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
106143771|NCT03020745|366186864|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
106143772|NCT03020745|366186865|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
106143773|NCT03020745|366186866|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
106143774|NCT03020745|366186857|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143775|NCT03020745|366186858|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143776|NCT03020745|366186859|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143777|NCT03020745|366186860|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143778|NCT03020745|366186861|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143779|NCT03020745|366186862|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143780|NCT03020745|366186863|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143781|NCT03020745|366186864|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143782|NCT03020745|366186865|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
106143783|NCT03020745|366186866|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
106143784|NCT02296424|366186867|FG000|Part 1|New therapy for study indication|0|||
106143785|NCT02296424|366186868|FG001|Part 1|New therapy for study indication|1|||
106143786|NCT02296424|366186869|FG002|Part 1|New therapy for study indication|0|||
106143787|NCT02296424|366186870|FG003|Part 1|New therapy for study indication|0|||
106143788|NCT02296424|366186867|FG000|Part 1|Protocol Violation|0|||
106143789|NCT02296424|366186868|FG001|Part 1|Protocol Violation|1|||
106143790|NCT02296424|366186869|FG002|Part 1|Protocol Violation|0|||
106143791|NCT02296424|366186870|FG003|Part 1|Protocol Violation|0|||
106143792|NCT02296424|366186867|FG000|Part 1|Withdrawal by Subject|0|||
106143793|NCT02296424|366186868|FG001|Part 1|Withdrawal by Subject|2|||
106143794|NCT02296424|366186869|FG002|Part 1|Withdrawal by Subject|0|||
106143795|NCT02296424|366186870|FG003|Part 1|Withdrawal by Subject|0|||
105760027|NCT01855945|364773839|FG000|Overall Study|Withdrawal by Subject|4|||
105760028|NCT01855945|364773840|FG001|Overall Study|Withdrawal by Subject|0|||
105760029|NCT01855945|364773841|FG002|Overall Study|Withdrawal by Subject|4|||
105760030|NCT01855945|364773842|FG003|Overall Study|Withdrawal by Subject|1|||
105760031|NCT01855945|364773843|FG004|Overall Study|Withdrawal by Subject|1|||
105760032|NCT01855945|364773844|FG005|Overall Study|Withdrawal by Subject|0|||
105760033|NCT01855945|364773845|FG006|Overall Study|Withdrawal by Subject|1|||
105760034|NCT01855945|364773846|FG007|Overall Study|Withdrawal by Subject|0|||
105760035|NCT01855945|364773847|FG008|Overall Study|Withdrawal by Subject|0|||
105760036|NCT01855945|364773848|FG009|Overall Study|Withdrawal by Subject|2|||
105760037|NCT01855945|364773849|FG010|Overall Study|Withdrawal by Subject|4|||
105760038|NCT01855945|364773850|FG011|Overall Study|Withdrawal by Subject|1|||
105760039|NCT01135017|364773851|FG000|Overall Study|Adverse Event|3|||
105760040|NCT01135017|364773852|FG001|Overall Study|Adverse Event|8|||
105760041|NCT01135017|364773851|FG000|Overall Study|Other than above|3|||
105760042|NCT01135017|364773852|FG001|Overall Study|Other than above|4|||
105760043|NCT01803711|364773853|FG000|Overall Study|Adverse Event|1|||
105760044|NCT01803711|364773854|FG001|Overall Study|Adverse Event|1|||
105760045|NCT00432562|364773855|FG000|Overall Study|Death|3|||
105760046|NCT00432562|364773856|FG001|Overall Study|Death|0|||
105760047|NCT03332303|364773857|FG000|Overall Study|Participant did not dose|1|||
105760048|NCT03332303|364773858|FG001|Overall Study|Participant did not dose|2|||
105760049|NCT03332303|364773859|FG002|Overall Study|Participant did not dose|0|||
105760050|NCT03332303|364773857|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
105760051|NCT03332303|364773858|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
105951866|NCT00803738|365488144|FG000|Overall Study|Lost to Follow-up|4|||
106143796|NCT02296424|366186867|FG000|Part 1|Study terminated by sponsor|0|||
106143797|NCT02296424|366186868|FG001|Part 1|Study terminated by sponsor|1|||
105805563|NCT00585351|364944973|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
105805564|NCT00585351|364944974|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
105805565|NCT00585351|364944975|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
105805566|NCT00585351|364944976|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
105805567|NCT00585351|364944977|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
105805568|NCT00585351|364944978|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
105805569|NCT00585351|364944979|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
105805570|NCT00585351|364944972|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
105805571|NCT00585351|364944973|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
105805572|NCT00585351|364944974|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
105805573|NCT00585351|364944975|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
105805574|NCT00585351|364944976|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
105805575|NCT00585351|364944977|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
105805576|NCT00585351|364944978|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
105805577|NCT00585351|364944979|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
105805578|NCT00585351|364944972|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
105805579|NCT00585351|364944973|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
105805580|NCT00585351|364944974|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
105805581|NCT00585351|364944975|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
105805582|NCT00585351|364944976|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
105805583|NCT00585351|364944977|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
105805584|NCT00585351|364944978|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
105805585|NCT00585351|364944979|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
105805586|NCT00585351|364944972|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
105805587|NCT00585351|364944973|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
105805588|NCT00585351|364944974|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805589|NCT00585351|364944975|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805590|NCT00585351|364944976|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805591|NCT00585351|364944977|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
106016752|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
106016753|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
106016754|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
106016755|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
106016756|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
106016757|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
106016758|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
106016759|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
106016760|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
106016761|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
106016762|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
106016763|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
106016764|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
106016765|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
106016766|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
106016767|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
106016768|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
106016769|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
106016770|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
106016771|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
106016772|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
106016773|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
106143798|NCT02296424|366186869|FG002|Part 1|Study terminated by sponsor|0|||
106143799|NCT02296424|366186870|FG003|Part 1|Study terminated by sponsor|0|||
106143800|NCT02296424|366186867|FG000|Part 1|Adverse Event|2|||
106143801|NCT02296424|366186868|FG001|Part 1|Adverse Event|11|||
105760052|NCT03332303|364773859|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
105760053|NCT03332303|364773857|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
105760054|NCT03332303|364773858|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
105760055|NCT03332303|364773859|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
105760056|NCT03332303|364773857|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
105760057|NCT03332303|364773858|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
105760058|NCT03332303|364773859|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
105805592|NCT00585351|364944978|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805593|NCT00585351|364944979|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
105805594|NCT00585351|364944972|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805595|NCT00585351|364944973|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805596|NCT00585351|364944974|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805597|NCT00585351|364944975|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805598|NCT00585351|364944976|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805599|NCT00585351|364944977|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
105805600|NCT00585351|364944978|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
105805601|NCT00585351|364944979|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
105805602|NCT00585351|364944972|FG000|Enrollment Period (Intervention)|Death|0|||
105805603|NCT00585351|364944973|FG001|Enrollment Period (Intervention)|Death|0|||
105805604|NCT00585351|364944974|FG002|Enrollment Period (Intervention)|Death|0|||
105805605|NCT00585351|364944975|FG003|Enrollment Period (Intervention)|Death|0|||
105805606|NCT00585351|364944976|FG004|Enrollment Period (Intervention)|Death|1|||
105805607|NCT00585351|364944977|FG005|Enrollment Period (Intervention)|Death|0|||
105805608|NCT00585351|364944978|FG006|Enrollment Period (Intervention)|Death|1|||
105805609|NCT00585351|364944979|FG007|Enrollment Period (Intervention)|Death|0|||
105805610|NCT00585351|364944972|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805611|NCT00585351|364944973|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805612|NCT00585351|364944974|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805613|NCT00585351|364944975|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805614|NCT00585351|364944976|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
105805615|NCT00585351|364944977|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
105805616|NCT00585351|364944978|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805617|NCT00585351|364944979|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
105805618|NCT00192296|364944980|FG000|Overall Study|Withdrawal by Subject|0|||
105805619|NCT00192296|364944981|FG001|Overall Study|Withdrawal by Subject|1|||
105805620|NCT00192296|364944982|FG002|Overall Study|Withdrawal by Subject|0|||
105805621|NCT00192296|364944983|FG003|Overall Study|Withdrawal by Subject|0|||
105805622|NCT00358826|364944984|FG000|Core Study|Adverse Event|1|||
105805623|NCT00358826|364944985|FG001|Core Study|Adverse Event|3|||
105805624|NCT00358826|364944986|FG002|Core Study|Adverse Event|1|||
105951867|NCT00803738|365488145|FG001|Overall Study|Lost to Follow-up|4|||
105951868|NCT00803738|365488144|FG000|Overall Study|Protocol Violation|18|||
105951869|NCT00803738|365488145|FG001|Overall Study|Protocol Violation|10|||
105951870|NCT00803738|365488144|FG000|Overall Study|Withdrawal by Subject|1|||
105951871|NCT00803738|365488145|FG001|Overall Study|Withdrawal by Subject|4|||
105951872|NCT00803738|365488144|FG000|Overall Study|Lack of Efficacy|10|||
105951873|NCT00803738|365488145|FG001|Overall Study|Lack of Efficacy|16|||
105951874|NCT00803738|365488144|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
105951875|NCT00803738|365488145|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
105951876|NCT00803738|365488144|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
106016774|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
106016775|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
106016776|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
106016777|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
106016778|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
106016779|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
106016780|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
106016781|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
106016782|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
106016783|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
106016784|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
106016785|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
106016786|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
106016787|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
106016788|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
106016789|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
106016790|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
106016791|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
106016792|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
106143802|NCT02296424|366186869|FG002|Part 1|Adverse Event|0|||
105805625|NCT00358826|364944987|FG003|Core Study|Adverse Event|1|||
105805626|NCT00358826|364944988|FG004|Core Study|Adverse Event|0|||
105805627|NCT00358826|364944989|FG005|Core Study|Adverse Event|0|||
105805628|NCT00358826|364944990|FG006|Core Study|Adverse Event|0|||
105951877|NCT00803738|365488145|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
105951878|NCT02391311|365488146|FG000|Overall Study|Lost to Follow-up|2|||
105951879|NCT02391311|365488147|FG001|Overall Study|Lost to Follow-up|1|||
105805629|NCT00358826|364944991|FG007|Core Study|Adverse Event|0|||
105805630|NCT00358826|364944984|FG000|Core Study|Withdrawal by Subject|2|||
105805631|NCT00358826|364944985|FG001|Core Study|Withdrawal by Subject|2|||
105805632|NCT00358826|364944986|FG002|Core Study|Withdrawal by Subject|0|||
105805633|NCT00358826|364944987|FG003|Core Study|Withdrawal by Subject|0|||
105805634|NCT00358826|364944988|FG004|Core Study|Withdrawal by Subject|0|||
105805635|NCT00358826|364944989|FG005|Core Study|Withdrawal by Subject|0|||
105805636|NCT00358826|364944990|FG006|Core Study|Withdrawal by Subject|0|||
105805637|NCT00358826|364944991|FG007|Core Study|Withdrawal by Subject|0|||
105805638|NCT00358826|364944984|FG000|Core Study|Lost to Follow-up|0|||
105805639|NCT00358826|364944985|FG001|Core Study|Lost to Follow-up|0|||
105805640|NCT00358826|364944986|FG002|Core Study|Lost to Follow-up|0|||
105805641|NCT00358826|364944987|FG003|Core Study|Lost to Follow-up|1|||
105805642|NCT00358826|364944988|FG004|Core Study|Lost to Follow-up|0|||
105805643|NCT00358826|364944989|FG005|Core Study|Lost to Follow-up|0|||
105805644|NCT00358826|364944990|FG006|Core Study|Lost to Follow-up|0|||
105805645|NCT00358826|364944991|FG007|Core Study|Lost to Follow-up|0|||
105805646|NCT00358826|364944984|FG000|Core Study|Physician Decision|0|||
105805647|NCT00358826|364944985|FG001|Core Study|Physician Decision|0|||
105805648|NCT00358826|364944986|FG002|Core Study|Physician Decision|1|||
105951880|NCT02391311|365488146|FG000|Overall Study|deemed ineligible after baseline|1|||
105951881|NCT02391311|365488147|FG001|Overall Study|deemed ineligible after baseline|1|||
105951882|NCT02364037|365488148|FG000|Overall Study|Withdrawal by Subject|7|||
105951883|NCT02364037|365488149|FG001|Overall Study|Withdrawal by Subject|4|||
105951884|NCT02364037|365488148|FG000|Overall Study|Lost to Follow-up|37|||
105951885|NCT02364037|365488149|FG001|Overall Study|Lost to Follow-up|49|||
105951886|NCT01815424|365488152|FG000|Week 0 to 16|Adverse Event|1|||
106016793|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
105760059|NCT03332303|364773857|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
105760060|NCT03332303|364773858|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
105760061|NCT03332303|364773859|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
105760062|NCT03332303|364773857|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
105760063|NCT03332303|364773858|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
105760064|NCT03332303|364773859|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
105760065|NCT03332303|364773857|FG000|Overall Study|Participant had a significant protocol deviation|0|||
105760066|NCT03332303|364773858|FG001|Overall Study|Participant had a significant protocol deviation|1|||
105760067|NCT03332303|364773859|FG002|Overall Study|Participant had a significant protocol deviation|0|||
105760068|NCT01230749|364773867|FG000|Overall Study|Adverse Event|0|||
105760069|NCT01230749|364773868|FG001|Overall Study|Adverse Event|0|||
105760070|NCT01230749|364773869|FG002|Overall Study|Adverse Event|0|||
105760071|NCT01230749|364773870|FG003|Overall Study|Adverse Event|1|||
105760072|NCT01230749|364773867|FG000|Overall Study|Physician Decision|0|||
105760073|NCT01230749|364773868|FG001|Overall Study|Physician Decision|0|||
105760074|NCT01230749|364773869|FG002|Overall Study|Physician Decision|1|||
105760075|NCT01230749|364773870|FG003|Overall Study|Physician Decision|0|||
105760076|NCT01230749|364773867|FG000|Overall Study|Withdrawal by Subject|0|||
105760077|NCT01230749|364773868|FG001|Overall Study|Withdrawal by Subject|1|||
105760078|NCT01230749|364773869|FG002|Overall Study|Withdrawal by Subject|0|||
105760079|NCT01230749|364773870|FG003|Overall Study|Withdrawal by Subject|0|||
105760080|NCT01230749|364773867|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
105760081|NCT01230749|364773868|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
105760082|NCT01230749|364773869|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
105760083|NCT01230749|364773870|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
105760084|NCT00555906|364773871|FG000|Phase 1|Objective Progression or Relapse|3|||
105760085|NCT00555906|364773872|FG001|Phase 1|Objective Progression or Relapse|5|||
105760086|NCT00555906|364773873|FG002|Phase 1|Objective Progression or Relapse|3|||
105760087|NCT00555906|364773874|FG003|Phase 1|Objective Progression or Relapse|1|||
105760088|NCT00555906|364773875|FG004|Phase 1|Objective Progression or Relapse|0|||
105760089|NCT00555906|364773871|FG000|Phase 1|Global Deterioration of Health Status|0|||
105760090|NCT00555906|364773872|FG001|Phase 1|Global Deterioration of Health Status|1|||
105760091|NCT00555906|364773873|FG002|Phase 1|Global Deterioration of Health Status|1|||
105760092|NCT00555906|364773874|FG003|Phase 1|Global Deterioration of Health Status|1|||
105760093|NCT00555906|364773875|FG004|Phase 1|Global Deterioration of Health Status|0|||
105760094|NCT00555906|364773871|FG000|Phase 1|Adverse Event|0|||
105760095|NCT00555906|364773872|FG001|Phase 1|Adverse Event|0|||
105760096|NCT00555906|364773873|FG002|Phase 1|Adverse Event|3|||
105760097|NCT00555906|364773874|FG003|Phase 1|Adverse Event|2|||
105760098|NCT00555906|364773875|FG004|Phase 1|Adverse Event|0|||
105760099|NCT00555906|364773871|FG000|Phase 1|Withdrawal by Subject|0|||
105760100|NCT00555906|364773872|FG001|Phase 1|Withdrawal by Subject|0|||
105760101|NCT00555906|364773873|FG002|Phase 1|Withdrawal by Subject|0|||
105760102|NCT00555906|364773874|FG003|Phase 1|Withdrawal by Subject|1|||
105805649|NCT00358826|364944987|FG003|Core Study|Physician Decision|0|||
105805650|NCT00358826|364944988|FG004|Core Study|Physician Decision|0|||
105951887|NCT01815424|365488153|FG001|Week 0 to 16|Adverse Event|3|||
105805651|NCT00358826|364944989|FG005|Core Study|Physician Decision|0|||
105805652|NCT00358826|364944990|FG006|Core Study|Physician Decision|0|||
105805653|NCT00358826|364944991|FG007|Core Study|Physician Decision|0|||
105805654|NCT00358826|364944984|FG000|MDCT Substudy|Adverse Event|0|||
105805655|NCT00358826|364944985|FG001|MDCT Substudy|Adverse Event|0|||
105805656|NCT00358826|364944986|FG002|MDCT Substudy|Adverse Event|0|||
105805657|NCT00358826|364944987|FG003|MDCT Substudy|Adverse Event|0|||
105805658|NCT00358826|364944988|FG004|MDCT Substudy|Adverse Event|1|||
105805659|NCT00358826|364944989|FG005|MDCT Substudy|Adverse Event|0|||
105805660|NCT00358826|364944990|FG006|MDCT Substudy|Adverse Event|0|||
105805661|NCT00358826|364944991|FG007|MDCT Substudy|Adverse Event|0|||
105805662|NCT00358826|364944984|FG000|MDCT Substudy|Lost to Follow-up|0|||
105805663|NCT00358826|364944985|FG001|MDCT Substudy|Lost to Follow-up|0|||
105805664|NCT00358826|364944986|FG002|MDCT Substudy|Lost to Follow-up|0|||
105805665|NCT00358826|364944987|FG003|MDCT Substudy|Lost to Follow-up|0|||
105805666|NCT00358826|364944988|FG004|MDCT Substudy|Lost to Follow-up|0|||
105805667|NCT00358826|364944989|FG005|MDCT Substudy|Lost to Follow-up|1|||
105805668|NCT00358826|364944990|FG006|MDCT Substudy|Lost to Follow-up|0|||
105805669|NCT00358826|364944991|FG007|MDCT Substudy|Lost to Follow-up|0|||
105805670|NCT00358826|364944984|FG000|MDCT Substudy|Withdrawal by Subject|0|||
105805671|NCT00358826|364944985|FG001|MDCT Substudy|Withdrawal by Subject|0|||
105805672|NCT00358826|364944986|FG002|MDCT Substudy|Withdrawal by Subject|0|||
105805673|NCT00358826|364944987|FG003|MDCT Substudy|Withdrawal by Subject|0|||
105805674|NCT00358826|364944988|FG004|MDCT Substudy|Withdrawal by Subject|0|||
105805675|NCT00358826|364944989|FG005|MDCT Substudy|Withdrawal by Subject|1|||
105805676|NCT00358826|364944990|FG006|MDCT Substudy|Withdrawal by Subject|0|||
105805677|NCT00358826|364944991|FG007|MDCT Substudy|Withdrawal by Subject|0|||
105805678|NCT00283686|364944998|FG000|Overall Study|Death|1|||
105805679|NCT00283686|364944999|FG001|Overall Study|Death|1|||
105805680|NCT00283686|364945000|FG002|Overall Study|Death|1|||
105805681|NCT00283686|364945001|FG003|Overall Study|Death|0|||
105805682|NCT00283686|364944998|FG000|Overall Study|Lost to Follow-up|21|||
105805683|NCT00283686|364944999|FG001|Overall Study|Lost to Follow-up|31|||
105805684|NCT00283686|364945000|FG002|Overall Study|Lost to Follow-up|26|||
105805685|NCT00283686|364945001|FG003|Overall Study|Lost to Follow-up|20|||
105805686|NCT00283686|364944998|FG000|Overall Study|Less than full participation|7|||
105805687|NCT00283686|364944999|FG001|Overall Study|Less than full participation|9|||
105805688|NCT00283686|364945000|FG002|Overall Study|Less than full participation|6|||
105805689|NCT00283686|364945001|FG003|Overall Study|Less than full participation|12|||
105805690|NCT02649231|364945005|FG000|Overall Study|Adverse Event|0|||
105805691|NCT02649231|364945006|FG001|Overall Study|Adverse Event|0|||
105805692|NCT02649231|364945007|FG002|Overall Study|Adverse Event|0|||
105805693|NCT02649231|364945008|FG003|Overall Study|Adverse Event|1|||
105805694|NCT02649231|364945005|FG000|Overall Study|Lost to Follow-up|2|||
105805695|NCT02649231|364945006|FG001|Overall Study|Lost to Follow-up|1|||
105805696|NCT02649231|364945007|FG002|Overall Study|Lost to Follow-up|1|||
105805697|NCT02649231|364945008|FG003|Overall Study|Lost to Follow-up|0|||
105805698|NCT02649231|364945005|FG000|Overall Study|Withdrawal by Subject|0|||
105805699|NCT02649231|364945006|FG001|Overall Study|Withdrawal by Subject|1|||
105805700|NCT02649231|364945007|FG002|Overall Study|Withdrawal by Subject|0|||
105805701|NCT02649231|364945008|FG003|Overall Study|Withdrawal by Subject|1|||
105805702|NCT02649231|364945005|FG000|Overall Study|Protocol Violation|2|||
105805703|NCT02649231|364945006|FG001|Overall Study|Protocol Violation|1|||
105805704|NCT02649231|364945007|FG002|Overall Study|Protocol Violation|1|||
105805705|NCT02649231|364945008|FG003|Overall Study|Protocol Violation|0|||
105805706|NCT02175966|364945009|FG000|Follow-up Period|Lack of Efficacy|10|||
105805707|NCT02175966|364945010|FG001|Follow-up Period|Lack of Efficacy|6|||
105805708|NCT01752920|364945011|FG000|Overall Study|Adverse Event|1|||
105805709|NCT01752920|364945012|FG001|Overall Study|Adverse Event|0|||
105805710|NCT01752920|364945013|FG002|Overall Study|Adverse Event|5|||
105805711|NCT01752920|364945014|FG003|Overall Study|Adverse Event|10|||
105805712|NCT01752920|364945011|FG000|Overall Study|Clinical Disease Progression|6|||
105805713|NCT01752920|364945012|FG001|Overall Study|Clinical Disease Progression|4|||
105805714|NCT01752920|364945013|FG002|Overall Study|Clinical Disease Progression|1|||
105805715|NCT01752920|364945014|FG003|Overall Study|Clinical Disease Progression|13|||
105805716|NCT01752920|364945011|FG000|Overall Study|Physician Decision|1|||
105805717|NCT01752920|364945012|FG001|Overall Study|Physician Decision|0|||
105805718|NCT01752920|364945013|FG002|Overall Study|Physician Decision|0|||
105805719|NCT01752920|364945014|FG003|Overall Study|Physician Decision|3|||
105805720|NCT01752920|364945011|FG000|Overall Study|Radiographic Disease Progression|20|||
105805721|NCT01752920|364945012|FG001|Overall Study|Radiographic Disease Progression|7|||
105805722|NCT01752920|364945013|FG002|Overall Study|Radiographic Disease Progression|12|||
105805723|NCT01752920|364945014|FG003|Overall Study|Radiographic Disease Progression|29|||
105805724|NCT01752920|364945011|FG000|Overall Study|Study Terminated by Sponsor|0|||
105805725|NCT01752920|364945012|FG001|Overall Study|Study Terminated by Sponsor|0|||
105805726|NCT01752920|364945013|FG002|Overall Study|Study Terminated by Sponsor|0|||
105805727|NCT01752920|364945014|FG003|Overall Study|Study Terminated by Sponsor|1|||
105805728|NCT01752920|364945011|FG000|Overall Study|Withdrawal by Subject|0|||
105805729|NCT01752920|364945012|FG001|Overall Study|Withdrawal by Subject|1|||
105805730|NCT01752920|364945013|FG002|Overall Study|Withdrawal by Subject|0|||
105805731|NCT01752920|364945014|FG003|Overall Study|Withdrawal by Subject|1|||
105805732|NCT01752920|364945011|FG000|Overall Study|Lack of clinical benefit|1|||
105805733|NCT01752920|364945012|FG001|Overall Study|Lack of clinical benefit|1|||
105805734|NCT01752920|364945013|FG002|Overall Study|Lack of clinical benefit|1|||
105805735|NCT01752920|364945014|FG003|Overall Study|Lack of clinical benefit|1|||
105805736|NCT01154153|364945017|FG000|Overall Study|Poor compliance to protocol|2|||
105805737|NCT01154153|364945018|FG001|Overall Study|Poor compliance to protocol|0|||
105805738|NCT01154153|364945017|FG000|Overall Study|Unable to use labs|2|||
105805739|NCT01154153|364945018|FG001|Overall Study|Unable to use labs|3|||
105805740|NCT01154153|364945017|FG000|Overall Study|Withdrew consent|1|||
105805741|NCT01154153|364945018|FG001|Overall Study|Withdrew consent|0|||
105805742|NCT02611752|364945019|FG000|Overall Study|Adverse Event|0|||
105805743|NCT02611752|364945020|FG001|Overall Study|Adverse Event|1|||
105805744|NCT00321711|364945024|FG000|Part A|Adverse Event|3|||
105805745|NCT00321711|364945025|FG001|Part A|Adverse Event|3|||
105805746|NCT00321711|364945026|FG002|Part A|Adverse Event|2|||
105805747|NCT00321711|364945027|FG003|Part A|Adverse Event|0|||
105805748|NCT00321711|364945028|FG004|Part A|Adverse Event|0|||
105805749|NCT00321711|364945024|FG000|Part A|Withdrawal by Subject|1|||
105805750|NCT00321711|364945025|FG001|Part A|Withdrawal by Subject|1|||
105805751|NCT00321711|364945026|FG002|Part A|Withdrawal by Subject|1|||
105805752|NCT00321711|364945027|FG003|Part A|Withdrawal by Subject|0|||
105805753|NCT00321711|364945028|FG004|Part A|Withdrawal by Subject|0|||
105805754|NCT00321711|364945024|FG000|Part A|Disease progression|0|||
105805755|NCT00321711|364945025|FG001|Part A|Disease progression|1|||
105805756|NCT00321711|364945026|FG002|Part A|Disease progression|0|||
105805757|NCT00321711|364945027|FG003|Part A|Disease progression|0|||
105805758|NCT00321711|364945028|FG004|Part A|Disease progression|0|||
105805759|NCT00321711|364945024|FG000|Part A|Requirement for alternative therapy|0|||
105805760|NCT00321711|364945025|FG001|Part A|Requirement for alternative therapy|2|||
105805761|NCT00321711|364945026|FG002|Part A|Requirement for alternative therapy|1|||
105805762|NCT00321711|364945027|FG003|Part A|Requirement for alternative therapy|0|||
105805763|NCT00321711|364945028|FG004|Part A|Requirement for alternative therapy|0|||
105805764|NCT00321711|364945024|FG000|Part A|Physician Decision|0|||
105805765|NCT00321711|364945025|FG001|Part A|Physician Decision|1|||
105805766|NCT00321711|364945026|FG002|Part A|Physician Decision|3|||
105805767|NCT00321711|364945027|FG003|Part A|Physician Decision|0|||
105805768|NCT00321711|364945028|FG004|Part A|Physician Decision|0|||
105805769|NCT00321711|364945024|FG000|Part A|Other|1|||
105805770|NCT00321711|364945025|FG001|Part A|Other|2|||
105805771|NCT00321711|364945026|FG002|Part A|Other|3|||
105805772|NCT00321711|364945027|FG003|Part A|Other|0|||
105805773|NCT00321711|364945028|FG004|Part A|Other|0|||
105805774|NCT00321711|364945024|FG000|Part A|Protocol deviation|0|||
105805775|NCT00321711|364945025|FG001|Part A|Protocol deviation|0|||
105805776|NCT00321711|364945026|FG002|Part A|Protocol deviation|1|||
105805777|NCT00321711|364945027|FG003|Part A|Protocol deviation|0|||
105805778|NCT00321711|364945028|FG004|Part A|Protocol deviation|0|||
105805779|NCT00321711|364945024|FG000|Part B|Noncompliance|0|||
105805780|NCT00321711|364945025|FG001|Part B|Noncompliance|0|||
105805781|NCT00321711|364945026|FG002|Part B|Noncompliance|0|||
105805782|NCT00321711|364945027|FG003|Part B|Noncompliance|0|||
105805783|NCT00321711|364945028|FG004|Part B|Noncompliance|1|||
105805784|NCT00321711|364945024|FG000|Part B|Adverse Event|0|||
105805785|NCT00321711|364945025|FG001|Part B|Adverse Event|0|||
105805786|NCT00321711|364945026|FG002|Part B|Adverse Event|0|||
105805787|NCT00321711|364945027|FG003|Part B|Adverse Event|2|||
105805788|NCT00321711|364945028|FG004|Part B|Adverse Event|1|||
106143803|NCT02296424|366186870|FG003|Part 1|Adverse Event|0|||
106143804|NCT02296424|366186867|FG000|Part 1|Lack of Efficacy|5|||
105805789|NCT00321711|364945024|FG000|Part B|Disease progression|0|||
106143805|NCT02296424|366186868|FG001|Part 1|Lack of Efficacy|17|||
106143806|NCT02296424|366186869|FG002|Part 1|Lack of Efficacy|0|||
106143807|NCT02296424|366186870|FG003|Part 1|Lack of Efficacy|0|||
106143808|NCT02296424|366186867|FG000|Part 1|16 directly started part II|16|||
105805790|NCT00321711|364945025|FG001|Part B|Disease progression|0|||
105805791|NCT00321711|364945026|FG002|Part B|Disease progression|0|||
105805792|NCT00321711|364945027|FG003|Part B|Disease progression|1|||
105805793|NCT00321711|364945028|FG004|Part B|Disease progression|0|||
105805794|NCT00321711|364945024|FG000|Part B|Physician Decision|0|||
105805795|NCT00321711|364945025|FG001|Part B|Physician Decision|0|||
105805796|NCT00321711|364945026|FG002|Part B|Physician Decision|0|||
105805797|NCT00321711|364945027|FG003|Part B|Physician Decision|1|||
105805798|NCT00321711|364945028|FG004|Part B|Physician Decision|2|||
105805799|NCT00321711|364945024|FG000|Part B|Death|0|||
105805800|NCT00321711|364945025|FG001|Part B|Death|0|||
105805801|NCT00321711|364945026|FG002|Part B|Death|0|||
105805802|NCT00321711|364945027|FG003|Part B|Death|2|||
105805803|NCT00321711|364945028|FG004|Part B|Death|1|||
105805804|NCT02843074|364945029|FG000|Overall Study|Withdrawal by Subject|5|||
106143809|NCT02296424|366186868|FG001|Part 1|16 directly started part II|0|||
105760103|NCT00555906|364773875|FG004|Phase 1|Withdrawal by Subject|0|||
105760104|NCT00555906|364773871|FG000|Phase 2|Adverse Event|0|||
105760105|NCT00555906|364773872|FG001|Phase 2|Adverse Event|0|||
105760106|NCT00555906|364773873|FG002|Phase 2|Adverse Event|0|||
105760107|NCT00555906|364773874|FG003|Phase 2|Adverse Event|0|||
105760108|NCT00555906|364773875|FG004|Phase 2|Adverse Event|4|||
105760109|NCT00555906|364773871|FG000|Phase 2|Global Deterioration of Health Status|0|||
105760110|NCT00555906|364773872|FG001|Phase 2|Global Deterioration of Health Status|0|||
105760111|NCT00555906|364773873|FG002|Phase 2|Global Deterioration of Health Status|0|||
105760112|NCT00555906|364773874|FG003|Phase 2|Global Deterioration of Health Status|0|||
105760113|NCT00555906|364773875|FG004|Phase 2|Global Deterioration of Health Status|2|||
105760114|NCT00555906|364773871|FG000|Phase 2|Objective Progression or Relapse|0|||
105760115|NCT00555906|364773872|FG001|Phase 2|Objective Progression or Relapse|0|||
105760116|NCT00555906|364773873|FG002|Phase 2|Objective Progression or Relapse|0|||
105760117|NCT00555906|364773874|FG003|Phase 2|Objective Progression or Relapse|0|||
105760118|NCT00555906|364773875|FG004|Phase 2|Objective Progression or Relapse|16|||
105760119|NCT00555906|364773871|FG000|Phase 2|Withdrawal by Subject|0|||
105760120|NCT00555906|364773872|FG001|Phase 2|Withdrawal by Subject|0|||
105760121|NCT00555906|364773873|FG002|Phase 2|Withdrawal by Subject|0|||
105760122|NCT00555906|364773874|FG003|Phase 2|Withdrawal by Subject|0|||
105760123|NCT00555906|364773875|FG004|Phase 2|Withdrawal by Subject|2|||
105760124|NCT00555906|364773871|FG000|Phase 2|Other|0|||
105760125|NCT00555906|364773872|FG001|Phase 2|Other|0|||
105760126|NCT00555906|364773873|FG002|Phase 2|Other|0|||
105760127|NCT00555906|364773874|FG003|Phase 2|Other|0|||
105760128|NCT00555906|364773875|FG004|Phase 2|Other|6|||
105760129|NCT00555906|364773871|FG000|Phase 2|Randomized but not Treated|0|||
105760130|NCT00555906|364773872|FG001|Phase 2|Randomized but not Treated|0|||
105760131|NCT00555906|364773873|FG002|Phase 2|Randomized but not Treated|0|||
105760132|NCT00555906|364773874|FG003|Phase 2|Randomized but not Treated|0|||
105760133|NCT00555906|364773875|FG004|Phase 2|Randomized but not Treated|2|||
105760134|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
105760135|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
105760136|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
105760137|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
105760138|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
105760139|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
105760140|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
105760141|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
105760142|NCT01313208|364773876|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
105760143|NCT01313208|364773877|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
105760144|NCT01313208|364773876|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
105760145|NCT01313208|364773877|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
105760146|NCT01313208|364773876|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
105760147|NCT01313208|364773877|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
105760148|NCT01313208|364773876|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
105760149|NCT01313208|364773877|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
105760150|NCT01313208|364773876|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
105760151|NCT01313208|364773877|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
105760152|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
105760153|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
105760154|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
105760155|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
105805805|NCT02843074|364945029|FG000|Overall Study|Progressive disease|1|||
105805806|NCT02843074|364945029|FG000|Overall Study|Physician Decision|1|||
106016794|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
106016795|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
106016796|NCT00217737|365724501|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
105760156|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
105760157|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
105760158|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
105760159|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
105760160|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
105760161|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
105760162|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
105760163|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
105760164|NCT05109702|364773883|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
105760165|NCT05109702|364773884|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
105760166|NCT05109702|364773885|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
105760167|NCT03094832|364773886|FG000|Overall Study|Lost to Follow-up|0|||
106016797|NCT00217737|365724502|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
105760168|NCT03094832|364773887|FG001|Overall Study|Lost to Follow-up|0|||
105760169|NCT03094832|364773888|FG002|Overall Study|Lost to Follow-up|0|||
105760170|NCT03094832|364773889|FG003|Overall Study|Lost to Follow-up|1|||
105951888|NCT01815424|365488154|FG002|Week 0 to 16|Adverse Event|3|||
105951889|NCT01815424|365488155|FG003|Week 0 to 16|Adverse Event|0|||
106143810|NCT02296424|366186869|FG002|Part 1|16 directly started part II|0|||
105760171|NCT03094832|364773890|FG004|Overall Study|Lost to Follow-up|1|||
105760172|NCT03094832|364773886|FG000|Overall Study|Death|1|||
105760173|NCT03094832|364773887|FG001|Overall Study|Death|0|||
105760174|NCT03094832|364773888|FG002|Overall Study|Death|0|||
105760175|NCT03094832|364773889|FG003|Overall Study|Death|0|||
105760176|NCT03094832|364773890|FG004|Overall Study|Death|0|||
105760177|NCT03094832|364773886|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105760178|NCT03094832|364773887|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105760179|NCT03094832|364773888|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
105760180|NCT03094832|364773889|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
105760181|NCT03094832|364773890|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
105760182|NCT03094832|364773886|FG000|Overall Study|Other|13|||
105760183|NCT03094832|364773887|FG001|Overall Study|Other|20|||
105760184|NCT03094832|364773888|FG002|Overall Study|Other|1|||
105760185|NCT03094832|364773889|FG003|Overall Study|Other|7|||
105760186|NCT03094832|364773890|FG004|Overall Study|Other|1|||
105760187|NCT00788697|364773897|FG000|Overall Study|No study drug administered|12|||
105760188|NCT00788697|364773897|FG000|Overall Study|Training Patients|74|||
105760189|NCT00788697|364773897|FG000|Overall Study|no truth standard procedure available|5|||
105760190|NCT00788697|364773897|FG000|Overall Study|Technically inadequate truth standard|1|||
105760191|NCT00788697|364773897|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
105760192|NCT03199638|364773898|FG000|Overall Study|inability to drink glutamine during regularly|0|||
105760193|NCT03199638|364773899|FG001|Overall Study|inability to drink glutamine during regularly|2|||
105760194|NCT02261883|364773900|FG000|Overall Study|Death|3|||
105760195|NCT02261883|364773901|FG001|Overall Study|Death|2|||
105760196|NCT02261883|364773900|FG000|Overall Study|Physician Decision|1|||
105760197|NCT02261883|364773901|FG001|Overall Study|Physician Decision|0|||
105760198|NCT02261883|364773900|FG000|Overall Study|Protocol Violation|1|||
105760199|NCT02261883|364773901|FG001|Overall Study|Protocol Violation|0|||
105760200|NCT02261883|364773900|FG000|Overall Study|Withdrawal by Subject|0|||
105760201|NCT02261883|364773901|FG001|Overall Study|Withdrawal by Subject|1|||
105760202|NCT02261883|364773900|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
105760203|NCT02261883|364773901|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
105760204|NCT00709124|364773902|FG000|Overall Study|Death|3|||
105760205|NCT00709124|364773903|FG001|Overall Study|Death|1|||
105760206|NCT00709124|364773902|FG000|Overall Study|encephalopathy; can't do assessment|1|||
105760207|NCT00709124|364773903|FG001|Overall Study|encephalopathy; can't do assessment|0|||
105760208|NCT00373490|364773904|FG000|Overall Study|Adverse Event|0|||
105760209|NCT00373490|364773905|FG001|Overall Study|Adverse Event|1|||
105760210|NCT00373490|364773904|FG000|Overall Study|Lack of Efficacy|9|||
105760211|NCT00373490|364773905|FG001|Overall Study|Lack of Efficacy|4|||
105760212|NCT00373490|364773904|FG000|Overall Study|Withdrawal by Subject|0|||
105760213|NCT00373490|364773905|FG001|Overall Study|Withdrawal by Subject|1|||
105760214|NCT02674685|364773913|FG000|Overall Study|Withdrawal by Subject|4|||
105760215|NCT02713789|364773915|FG000|Overall Study|Lost to Follow-up|0|||
105760216|NCT02713789|364773916|FG001|Overall Study|Lost to Follow-up|1|||
105760217|NCT02713789|364773917|FG002|Overall Study|Lost to Follow-up|1|||
105760218|NCT03549117|364773918|FG000|Overall Study|Withdrawal by Subject|1|||
105760219|NCT03549117|364773919|FG001|Overall Study|Withdrawal by Subject|0|||
105760220|NCT00903370|364773920|FG000|Overall Study|Death|13|||
105760221|NCT00903370|364773921|FG001|Overall Study|Death|10|||
105760222|NCT00903370|364773920|FG000|Overall Study|Withdrawal by Subject|9|||
105760223|NCT00903370|364773921|FG001|Overall Study|Withdrawal by Subject|6|||
105760224|NCT00903370|364773920|FG000|Overall Study|Lost to Follow-up|6|||
105760225|NCT00903370|364773921|FG001|Overall Study|Lost to Follow-up|8|||
105760226|NCT00367432|364773922|FG000|First Period (16 Weeks)|Adverse Event|6|||
105760227|NCT00367432|364773923|FG001|First Period (16 Weeks)|Adverse Event|0|||
105760228|NCT00367432|364773922|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
105760229|NCT00367432|364773923|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
105760230|NCT00367432|364773922|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
105760231|NCT00367432|364773923|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
105760232|NCT00367432|364773922|FG000|First Period (16 Weeks)|Other Reason|2|||
105760233|NCT00367432|364773923|FG001|First Period (16 Weeks)|Other Reason|0|||
105760234|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
105760235|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
105760236|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
105760237|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
105760238|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
105760239|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
105760240|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
105760241|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
105760242|NCT00367432|364773922|FG000|Second Period (up to 54 Months)|Other Reason|6|||
105805807|NCT02843074|364945029|FG000|Overall Study|Lost to Follow-up|1|||
105805808|NCT02843074|364945029|FG000|Overall Study|Death|9|||
105805809|NCT01186978|364945030|FG000|Overall Study|Withdrawal by Subject|1|||
105805810|NCT00947856|364945031|FG000|Treatment Period|Progressive Disease|33|||
105805811|NCT00947856|364945032|FG001|Treatment Period|Progressive Disease|12|||
105805812|NCT00947856|364945031|FG000|Treatment Period|Adverse Event|15|||
105805813|NCT00947856|364945032|FG001|Treatment Period|Adverse Event|9|||
105805814|NCT00947856|364945031|FG000|Treatment Period|Physician Decision|14|||
105805815|NCT00947856|364945032|FG001|Treatment Period|Physician Decision|6|||
105805816|NCT00947856|364945031|FG000|Treatment Period|Study Stopped by Sponsor|4|||
105805817|NCT00947856|364945032|FG001|Treatment Period|Study Stopped by Sponsor|4|||
105805818|NCT00947856|364945031|FG000|Treatment Period|Withdrawal by Subject|12|||
105805819|NCT00947856|364945032|FG001|Treatment Period|Withdrawal by Subject|1|||
105805820|NCT00947856|364945031|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
105805821|NCT00947856|364945032|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
105805822|NCT00947856|364945031|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
105805823|NCT00947856|364945032|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
105805824|NCT00947856|364945031|FG000|Follow-up Period|Lost to Follow-up|7|||
105805825|NCT00947856|364945032|FG001|Follow-up Period|Lost to Follow-up|0|||
105805826|NCT00947856|364945031|FG000|Follow-up Period|Patient unavailable for site visits|1|||
105805827|NCT00947856|364945032|FG001|Follow-up Period|Patient unavailable for site visits|0|||
105805828|NCT00947856|364945031|FG000|Follow-up Period|Withdrawal by Subject|1|||
105805829|NCT00947856|364945032|FG001|Follow-up Period|Withdrawal by Subject|0|||
105805830|NCT00543439|364945036|FG000|Period 1|Adverse Event|0|||
105805831|NCT00543439|364945037|FG001|Period 1|Adverse Event|2|||
105805832|NCT00543439|364945038|FG002|Period 1|Adverse Event|1|||
105805833|NCT00543439|364945036|FG000|Period 1|Withdrawal by Subject|1|||
105805834|NCT00543439|364945037|FG001|Period 1|Withdrawal by Subject|1|||
105805835|NCT00543439|364945038|FG002|Period 1|Withdrawal by Subject|0|||
105805836|NCT00543439|364945036|FG000|Period 1|Physician Decision|0|||
105805837|NCT00543439|364945037|FG001|Period 1|Physician Decision|0|||
105805838|NCT00543439|364945038|FG002|Period 1|Physician Decision|1|||
105805839|NCT00543439|364945036|FG000|Period 2|Protocol Violation|1|||
105805840|NCT00543439|364945037|FG001|Period 2|Protocol Violation|0|||
105805841|NCT00543439|364945038|FG002|Period 2|Protocol Violation|1|||
105805842|NCT00543439|364945036|FG000|Period 2|Adverse Event|0|||
105805843|NCT00543439|364945037|FG001|Period 2|Adverse Event|1|||
105805844|NCT00543439|364945038|FG002|Period 2|Adverse Event|1|||
105805845|NCT05476679|364945039|FG000|Overall Study|Withdrawal by Subject|0|||
105805846|NCT05476679|364945040|FG001|Overall Study|Withdrawal by Subject|0|||
105805847|NCT05476679|364945041|FG002|Overall Study|Withdrawal by Subject|0|||
105805848|NCT05476679|364945042|FG003|Overall Study|Withdrawal by Subject|1|||
105805849|NCT05476679|364945043|FG004|Overall Study|Withdrawal by Subject|0|||
105805850|NCT05476679|364945039|FG000|Overall Study|Lost to Follow-up|0|||
105805851|NCT05476679|364945040|FG001|Overall Study|Lost to Follow-up|0|||
105805852|NCT05476679|364945041|FG002|Overall Study|Lost to Follow-up|0|||
105805853|NCT05476679|364945042|FG003|Overall Study|Lost to Follow-up|1|||
105805854|NCT05476679|364945043|FG004|Overall Study|Lost to Follow-up|0|||
105805855|NCT01211769|364945044|FG000|Overall Study|Lost to Follow-up|7|||
105805856|NCT01211769|364945045|FG001|Overall Study|Lost to Follow-up|9|||
105805857|NCT01211769|364945046|FG002|Overall Study|Lost to Follow-up|5|||
105805858|NCT01211769|364945047|FG003|Overall Study|Lost to Follow-up|9|||
105805859|NCT01211769|364945044|FG000|Overall Study|Physician Decision|2|||
105805860|NCT01211769|364945045|FG001|Overall Study|Physician Decision|0|||
105805861|NCT01211769|364945046|FG002|Overall Study|Physician Decision|2|||
105805862|NCT01211769|364945047|FG003|Overall Study|Physician Decision|1|||
105805863|NCT01211769|364945044|FG000|Overall Study|Adverse Event|0|||
105805864|NCT01211769|364945045|FG001|Overall Study|Adverse Event|1|||
105805865|NCT01211769|364945046|FG002|Overall Study|Adverse Event|1|||
105805866|NCT01211769|364945047|FG003|Overall Study|Adverse Event|1|||
105805867|NCT01214330|364945048|FG000|Overall Study|Withdrawal by Subject|2|||
105805868|NCT01214330|364945048|FG000|Overall Study|Withdrawal by Subject|2|||
105805869|NCT01862328|364945050|FG000|Overall Study|Progressive Disease|3|||
105805870|NCT01862328|364945051|FG001|Overall Study|Progressive Disease|11|||
105805871|NCT01862328|364945052|FG002|Overall Study|Progressive Disease|5|||
105805872|NCT01862328|364945053|FG003|Overall Study|Progressive Disease|6|||
105805873|NCT01862328|364945054|FG004|Overall Study|Progressive Disease|7|||
105805874|NCT01862328|364945055|FG005|Overall Study|Progressive Disease|4|||
105805875|NCT01862328|364945056|FG006|Overall Study|Progressive Disease|3|||
105805876|NCT01862328|364945050|FG000|Overall Study|Adverse Event|0|||
105805877|NCT01862328|364945051|FG001|Overall Study|Adverse Event|4|||
105805878|NCT01862328|364945052|FG002|Overall Study|Adverse Event|0|||
105805879|NCT01862328|364945053|FG003|Overall Study|Adverse Event|1|||
105805880|NCT01862328|364945054|FG004|Overall Study|Adverse Event|0|||
105805881|NCT01862328|364945055|FG005|Overall Study|Adverse Event|2|||
105805882|NCT01862328|364945056|FG006|Overall Study|Adverse Event|4|||
105805883|NCT01862328|364945050|FG000|Overall Study|Other|0|||
105805884|NCT01862328|364945051|FG001|Overall Study|Other|2|||
105805885|NCT01862328|364945052|FG002|Overall Study|Other|1|||
105805886|NCT01862328|364945053|FG003|Overall Study|Other|0|||
105805887|NCT01862328|364945054|FG004|Overall Study|Other|4|||
105760243|NCT00367432|364773923|FG001|Second Period (up to 54 Months)|Other Reason|2|||
105760244|NCT00014911|364773924|FG000|Overall Study|Adverse Event|1|||
105760245|NCT00014911|364773924|FG000|Overall Study|Lost to Follow-up|1|||
105760246|NCT00014911|364773924|FG000|Overall Study|Withdrawal by Subject|6|||
105760247|NCT00014911|364773924|FG000|Overall Study|Unknown Reasons|2|||
105760248|NCT00014911|364773924|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
105760249|NCT00676208|364773925|FG000|Overall Study|Lost to Follow-up|0|||
105760250|NCT00676208|364773926|FG001|Overall Study|Lost to Follow-up|2|||
105760251|NCT00676208|364773925|FG000|Overall Study|Incomplete data|2|||
105760252|NCT00676208|364773926|FG001|Overall Study|Incomplete data|4|||
105760253|NCT01270958|364773927|FG000|Overall Study|Lost to Follow-up|2|||
105760254|NCT01270958|364773927|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
105760255|NCT00888615|364773934|FG000|Overall Study|No treatment|2|||
105760256|NCT00628758|364773935|FG000|Overall Study|Adverse Event|2|||
105760257|NCT00628758|364773936|FG001|Overall Study|Adverse Event|3|||
105760258|NCT00628758|364773935|FG000|Overall Study|Withdrawal by Subject|6|||
105760259|NCT00628758|364773936|FG001|Overall Study|Withdrawal by Subject|3|||
105760260|NCT00628758|364773935|FG000|Overall Study|Death|1|||
105760261|NCT00628758|364773936|FG001|Overall Study|Death|0|||
105760262|NCT00628758|364773935|FG000|Overall Study|Protocol Violation|5|||
105760263|NCT00628758|364773936|FG001|Overall Study|Protocol Violation|1|||
105760264|NCT00628758|364773935|FG000|Overall Study|Lost to Follow-up|25|||
105760265|NCT00628758|364773936|FG001|Overall Study|Lost to Follow-up|31|||
105760266|NCT00628758|364773935|FG000|Overall Study|Pregnancy|2|||
105760267|NCT00628758|364773936|FG001|Overall Study|Pregnancy|2|||
105760268|NCT00628758|364773935|FG000|Overall Study|Investigator Moved|3|||
105760269|NCT00628758|364773936|FG001|Overall Study|Investigator Moved|0|||
105760270|NCT00628758|364773935|FG000|Overall Study|Treatment Failure|0|||
105760271|NCT00628758|364773936|FG001|Overall Study|Treatment Failure|2|||
105760272|NCT04179786|364773937|FG000|Overall Study|Withdrawal by Subject|8|||
105760273|NCT01938001|364773938|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
105760274|NCT01938001|364773939|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
105760275|NCT01938001|364773938|FG000|Pre-Treatment|Death|1|||
105760276|NCT01938001|364773939|FG001|Pre-Treatment|Death|0|||
105760277|NCT01938001|364773938|FG000|Treatment|Death|2|||
105760278|NCT01938001|364773939|FG001|Treatment|Death|0|||
105760279|NCT01938001|364773938|FG000|Treatment|Adverse Event|14|||
105760280|NCT01938001|364773939|FG001|Treatment|Adverse Event|8|||
105760281|NCT01938001|364773938|FG000|Treatment|Progressive Disease|21|||
105760282|NCT01938001|364773939|FG001|Treatment|Progressive Disease|54|||
105760283|NCT01938001|364773938|FG000|Treatment|Withdrawal by Subject|13|||
105760284|NCT01938001|364773939|FG001|Treatment|Withdrawal by Subject|7|||
105760285|NCT01938001|364773938|FG000|Treatment|Other reasons|2|||
105760286|NCT01938001|364773939|FG001|Treatment|Other reasons|1|||
105760287|NCT04186663|364773944|FG000|Overall Study|Lost to Follow-up|1|||
105760288|NCT04186663|364773944|FG000|Overall Study|Unable to complete blood draw|3|||
105760289|NCT00719862|364773945|FG000|Overall Study|Adverse Event|1|||
105760290|NCT00719862|364773946|FG001|Overall Study|Adverse Event|2|||
105760291|NCT00719862|364773945|FG000|Overall Study|Lack of Efficacy|3|||
105760292|NCT00719862|364773946|FG001|Overall Study|Lack of Efficacy|0|||
105760293|NCT00719862|364773945|FG000|Overall Study|Non-Compliance|1|||
105760294|NCT00719862|364773946|FG001|Overall Study|Non-Compliance|0|||
105760295|NCT00719862|364773945|FG000|Overall Study|Withdrawal by Subject|1|||
105760296|NCT00719862|364773946|FG001|Overall Study|Withdrawal by Subject|0|||
105760297|NCT00719862|364773945|FG000|Overall Study|Lost to Follow-up|0|||
105760298|NCT00719862|364773946|FG001|Overall Study|Lost to Follow-up|1|||
106143811|NCT02296424|366186870|FG003|Part 1|16 directly started part II|0|||
105760299|NCT00719862|364773945|FG000|Overall Study|Other|2|||
105760300|NCT00719862|364773946|FG001|Overall Study|Other|3|||
105760301|NCT01184846|364773947|FG000|Overall Study|Adverse Event|2|||
105760302|NCT01184846|364773947|FG000|Overall Study|Insufficient response|1|||
105760303|NCT02483078|364773948|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
105760304|NCT02483078|364773949|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
105760305|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
105760306|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
105760307|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
105760308|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
105760309|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
105760310|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
105760311|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
105760312|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
105760313|NCT02483078|364773948|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
105760314|NCT02483078|364773949|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
105760315|NCT02853032|364773950|FG000|Overall Study|Adverse Event|4|||
106143812|NCT02296424|366186867|FG000|Part 2|Lack of Efficacy|0|||
105760316|NCT02853032|364773951|FG001|Overall Study|Adverse Event|0|||
105760317|NCT02853032|364773950|FG000|Overall Study|Withdrawal by Subject|3|||
105760318|NCT02853032|364773951|FG001|Overall Study|Withdrawal by Subject|1|||
106143813|NCT02296424|366186868|FG001|Part 2|Lack of Efficacy|0|||
106143814|NCT02296424|366186869|FG002|Part 2|Lack of Efficacy|1|||
106143815|NCT02296424|366186870|FG003|Part 2|Lack of Efficacy|0|||
106143816|NCT02296424|366186867|FG000|Part 2|Adverse Event|0|||
106143817|NCT02296424|366186868|FG001|Part 2|Adverse Event|0|||
106143818|NCT02296424|366186869|FG002|Part 2|Adverse Event|1|||
106143819|NCT02296424|366186870|FG003|Part 2|Adverse Event|0|||
106143820|NCT02296424|366186867|FG000|Part 2|Lost to Follow-up|0|||
106143821|NCT02296424|366186868|FG001|Part 2|Lost to Follow-up|0|||
106143822|NCT02296424|366186869|FG002|Part 2|Lost to Follow-up|1|||
106143823|NCT02296424|366186870|FG003|Part 2|Lost to Follow-up|0|||
106143824|NCT00743444|366186871|FG000|First Intervention|Catheter placement problems|0|||
106143825|NCT00743444|366186872|FG001|First Intervention|Catheter placement problems|1|||
106143826|NCT00743444|366186871|FG000|Washout Period|Adverse Event|0|||
106143827|NCT00743444|366186872|FG001|Washout Period|Adverse Event|1|||
106143828|NCT02034916|366186875|FG000|Overall Study|Death|39|||
106143829|NCT02034916|366186876|FG001|Overall Study|Death|28|||
106143830|NCT02034916|366186875|FG000|Overall Study|Withdrawal by Subject|2|||
106143831|NCT02034916|366186876|FG001|Overall Study|Withdrawal by Subject|1|||
106143832|NCT02034916|366186875|FG000|Overall Study|Lost to Follow-up|4|||
106143833|NCT02034916|366186876|FG001|Overall Study|Lost to Follow-up|1|||
106143834|NCT02034916|366186875|FG000|Overall Study|Study terminated by sponsor|4|||
106143835|NCT02034916|366186876|FG001|Overall Study|Study terminated by sponsor|5|||
106143836|NCT03287622|366186877|FG000|Overall Study|Withdrawal by Subject|1|||
106143837|NCT03287622|366186878|FG001|Overall Study|Withdrawal by Subject|0|||
105760319|NCT02853032|364773950|FG000|Overall Study|Requested to withdraw from all treatment|2|||
105760320|NCT02853032|364773951|FG001|Overall Study|Requested to withdraw from all treatment|2|||
105760321|NCT00719953|364773952|FG000|Overall Study|Adverse Event|4|||
105760322|NCT01410799|364773953|FG000|Overall Study|PI decision|13|||
105760323|NCT03682055|364776029|FG000|Overall Study|Lack of Efficacy|1|||
105760324|NCT03682055|364776030|FG001|Overall Study|Lack of Efficacy|2|||
105760325|NCT03682055|364776031|FG002|Overall Study|Lack of Efficacy|1|||
105760326|NCT03682055|364776032|FG003|Overall Study|Lack of Efficacy|2|||
105760327|NCT03682055|364776033|FG004|Overall Study|Lack of Efficacy|1|||
105760328|NCT03682055|364776034|FG005|Overall Study|Lack of Efficacy|3|||
105760329|NCT03682055|364776029|FG000|Overall Study|Withdrawal by Subject|0|||
105760330|NCT03682055|364776030|FG001|Overall Study|Withdrawal by Subject|0|||
105760331|NCT03682055|364776031|FG002|Overall Study|Withdrawal by Subject|0|||
105760332|NCT03682055|364776032|FG003|Overall Study|Withdrawal by Subject|0|||
105760333|NCT03682055|364776033|FG004|Overall Study|Withdrawal by Subject|0|||
105760334|NCT03682055|364776034|FG005|Overall Study|Withdrawal by Subject|1|||
105760335|NCT03682055|364776029|FG000|Overall Study|Termination of Study by Sponsor|0|||
105760336|NCT03682055|364776030|FG001|Overall Study|Termination of Study by Sponsor|0|||
105760337|NCT03682055|364776031|FG002|Overall Study|Termination of Study by Sponsor|0|||
105760338|NCT03682055|364776032|FG003|Overall Study|Termination of Study by Sponsor|0|||
105760339|NCT03682055|364776033|FG004|Overall Study|Termination of Study by Sponsor|0|||
105760340|NCT03682055|364776034|FG005|Overall Study|Termination of Study by Sponsor|3|||
105760341|NCT03127852|364776036|FG000|Overall Study|Withdrawal by Subject|4|||
105760342|NCT03127852|364776037|FG001|Overall Study|Withdrawal by Subject|1|||
105760343|NCT03127852|364776036|FG000|Overall Study|Death|1|||
105760344|NCT03127852|364776037|FG001|Overall Study|Death|1|||
105760345|NCT00859573|364776038|FG000|Overall Study|Withdrawal by Subject|4|||
105760346|NCT00859573|364776039|FG001|Overall Study|Withdrawal by Subject|1|||
105760347|NCT00859573|364776038|FG000|Overall Study|Physician Decision|1|||
105760348|NCT00859573|364776039|FG001|Overall Study|Physician Decision|1|||
105760349|NCT03621189|364776040|FG000|Overall Study|Withdrawal by Subject|0|||
105760350|NCT03621189|364776041|FG001|Overall Study|Withdrawal by Subject|3|||
105760351|NCT03621189|364776040|FG000|Overall Study|Physician Decision|0|||
105760352|NCT03621189|364776041|FG001|Overall Study|Physician Decision|2|||
105760353|NCT02574481|364776042|FG000|Overall Study|Withdrawal by Subject|29|||
105760354|NCT02574481|364776043|FG001|Overall Study|Withdrawal by Subject|15|||
105760355|NCT02574481|364776044|FG002|Overall Study|Withdrawal by Subject|4|||
105760356|NCT02574481|364776045|FG003|Overall Study|Withdrawal by Subject|1|||
105760357|NCT02574481|364776042|FG000|Overall Study|Adverse Event|5|||
105760358|NCT02574481|364776043|FG001|Overall Study|Adverse Event|1|||
105760359|NCT02574481|364776044|FG002|Overall Study|Adverse Event|1|||
105760360|NCT02574481|364776045|FG003|Overall Study|Adverse Event|0|||
106143838|NCT03287622|366186877|FG000|Overall Study|Lost to Follow-up|27|||
106143839|NCT03287622|366186878|FG001|Overall Study|Lost to Follow-up|15|||
106143840|NCT03287622|366186877|FG000|Overall Study|No prescripion after surgery|28|||
106143841|NCT03287622|366186878|FG001|Overall Study|No prescripion after surgery|31|||
106143842|NCT03287622|366186877|FG000|Overall Study|prolonged Length of stay|2|||
106143843|NCT03287622|366186878|FG001|Overall Study|prolonged Length of stay|0|||
106143844|NCT03287622|366186877|FG000|Overall Study|surgery related|0|||
106143845|NCT03287622|366186878|FG001|Overall Study|surgery related|2|||
105805888|NCT01862328|364945055|FG005|Overall Study|Other|0|||
105805889|NCT01862328|364945056|FG006|Overall Study|Other|1|||
105805890|NCT01862328|364945050|FG000|Overall Study|Withdrawal by Subject|1|||
105805891|NCT01862328|364945051|FG001|Overall Study|Withdrawal by Subject|1|||
105805892|NCT01862328|364945052|FG002|Overall Study|Withdrawal by Subject|0|||
105805893|NCT01862328|364945053|FG003|Overall Study|Withdrawal by Subject|0|||
105805894|NCT01862328|364945054|FG004|Overall Study|Withdrawal by Subject|1|||
105805895|NCT01862328|364945055|FG005|Overall Study|Withdrawal by Subject|1|||
105805896|NCT01862328|364945056|FG006|Overall Study|Withdrawal by Subject|1|||
105805897|NCT01862328|364945050|FG000|Overall Study|Symptomatic Deterioration|0|||
105805898|NCT01862328|364945051|FG001|Overall Study|Symptomatic Deterioration|0|||
105805899|NCT01862328|364945052|FG002|Overall Study|Symptomatic Deterioration|0|||
105805900|NCT01862328|364945053|FG003|Overall Study|Symptomatic Deterioration|0|||
105805901|NCT01862328|364945054|FG004|Overall Study|Symptomatic Deterioration|0|||
105805902|NCT01862328|364945055|FG005|Overall Study|Symptomatic Deterioration|0|||
105805903|NCT01862328|364945056|FG006|Overall Study|Symptomatic Deterioration|1|||
105805904|NCT00686036|364945065|FG000|Overall Study|Adverse Event|3|||
105805905|NCT00686036|364945066|FG001|Overall Study|Adverse Event|0|||
105805906|NCT00686036|364945065|FG000|Overall Study|Withdrawal by Subject|3|||
105805907|NCT00686036|364945066|FG001|Overall Study|Withdrawal by Subject|1|||
105805908|NCT00686036|364945065|FG000|Overall Study|Study terminated by AstraZeneca|2|||
105805909|NCT00686036|364945066|FG001|Overall Study|Study terminated by AstraZeneca|1|||
105805910|NCT00686036|364945065|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
105805911|NCT00686036|364945066|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
105805912|NCT00686036|364945065|FG000|Overall Study|Other reasons not identified|0|||
105805913|NCT00686036|364945066|FG001|Overall Study|Other reasons not identified|4|||
105805914|NCT00467584|364945067|FG000|Overall Study|Withdrawal by Subject|4|||
105805915|NCT00467584|364945068|FG001|Overall Study|Withdrawal by Subject|5|||
105805916|NCT00467584|364945069|FG002|Overall Study|Withdrawal by Subject|1|||
105805917|NCT02292238|364945072|FG000|Overall Study|Protocol Violation|1|||
105805918|NCT02292238|364945073|FG001|Overall Study|Protocol Violation|2|||
105805919|NCT02292238|364945072|FG000|Overall Study|Withdrawal by Subject|2|||
105805920|NCT02292238|364945073|FG001|Overall Study|Withdrawal by Subject|1|||
105805921|NCT02292238|364945072|FG000|Overall Study|Lost to Follow-up|1|||
105805922|NCT02292238|364945073|FG001|Overall Study|Lost to Follow-up|0|||
105805923|NCT02292238|364945072|FG000|Overall Study|Physician Decision|0|||
105805924|NCT02292238|364945073|FG001|Overall Study|Physician Decision|1|||
105805925|NCT02666430|364945074|FG000|Period 1|Lost to Follow-up|1|||
105805926|NCT02666430|364945075|FG001|Period 1|Lost to Follow-up|0|||
105805927|NCT02666430|364945074|FG000|Period 1|Adverse Event|0|||
105805928|NCT02666430|364945075|FG001|Period 1|Adverse Event|1|||
105805929|NCT02666430|364945074|FG000|Period 2|Withdrawal by Subject|1|||
105805930|NCT02666430|364945075|FG001|Period 2|Withdrawal by Subject|4|||
105805931|NCT02666430|364945074|FG000|Period 3|Lost to Follow-up|1|||
105805932|NCT02666430|364945075|FG001|Period 3|Lost to Follow-up|0|||
105805933|NCT01960816|364945078|FG000|Overall Study|Lost to Follow-up|1|||
105805934|NCT01118728|364945082|FG000|Overall Study|Adverse Event|17|||
105805935|NCT01118728|364945082|FG000|Overall Study|Lack of Efficacy|27|||
105805936|NCT01118728|364945082|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
105805937|NCT01118728|364945082|FG000|Overall Study|Withdrawal by Subject|3|||
105805938|NCT01118728|364945082|FG000|Overall Study|Lost to Follow-up|4|||
105805939|NCT04345471|364945083|FG000|Overall Study|Adverse Event|8|||
105805940|NCT04345471|364945084|FG001|Overall Study|Adverse Event|5|||
105805941|NCT04345471|364945085|FG002|Overall Study|Adverse Event|6|||
105805942|NCT04345471|364945083|FG000|Overall Study|Lack of Efficacy|1|||
105805943|NCT04345471|364945084|FG001|Overall Study|Lack of Efficacy|1|||
105805944|NCT04345471|364945085|FG002|Overall Study|Lack of Efficacy|0|||
105805945|NCT04345471|364945083|FG000|Overall Study|Protocol Violation|0|||
105805946|NCT04345471|364945084|FG001|Overall Study|Protocol Violation|1|||
105805947|NCT04345471|364945085|FG002|Overall Study|Protocol Violation|2|||
105805948|NCT04345471|364945083|FG000|Overall Study|Withdrawal by Subject|10|||
105805949|NCT04345471|364945084|FG001|Overall Study|Withdrawal by Subject|5|||
105951890|NCT01815424|365488156|FG004|Week 0 to 16|Adverse Event|0|||
105951891|NCT01815424|365488152|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
106143846|NCT02527148|366186884|FG000|Overall Study|Did not receive study intervention|1|||
106143847|NCT02527148|366186885|FG001|Overall Study|Did not receive study intervention|0|||
105805950|NCT04345471|364945085|FG002|Overall Study|Withdrawal by Subject|10|||
105805951|NCT03896490|364945122|FG000|Overall Study|Withdrawal by Subject|1|||
105805952|NCT03896490|364945123|FG001|Overall Study|Withdrawal by Subject|1|||
105805953|NCT00433381|364946861|FG000|Overall Study|Ineligible / no protocol treatment|3|||
105805954|NCT00433381|364946862|FG001|Overall Study|Ineligible / no protocol treatment|3|||
105805955|NCT02806232|364946865|FG000|Overall Study|Lost to Follow-up|1|||
105805956|NCT02806232|364946866|FG001|Overall Study|Lost to Follow-up|2|||
105805957|NCT02806232|364946867|FG002|Overall Study|Lost to Follow-up|1|||
105805958|NCT02806232|364946868|FG003|Overall Study|Lost to Follow-up|0|||
105805959|NCT02806232|364946869|FG004|Overall Study|Lost to Follow-up|0|||
105805960|NCT02806232|364946870|FG005|Overall Study|Lost to Follow-up|1|||
105805961|NCT02806232|364946871|FG006|Overall Study|Lost to Follow-up|0|||
106143848|NCT00395018|366186886|FG000|On-Treatment|Death|4|||
106143849|NCT00395018|366186886|FG000|On-Treatment|Other Reason|2|||
106143850|NCT00395018|366186886|FG000|On-Treatment|Poor/non-compliance|2|||
106143851|NCT00395018|366186886|FG000|On-Treatment|Subject no longer meets study criteria|2|||
106143852|NCT00395018|366186886|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
106143853|NCT00395018|366186886|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
106143854|NCT00395018|366186886|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
106143855|NCT02878330|366186887|FG000|Overall Study|Death|3|||
106143856|NCT02878330|366186888|FG001|Overall Study|Death|2|||
106143857|NCT02878330|366186887|FG000|Overall Study|Lost to Follow-up|11|||
106143858|NCT02878330|366186888|FG001|Overall Study|Lost to Follow-up|26|||
106143859|NCT02878330|366186887|FG000|Overall Study|Withdrawal by Subject|11|||
106143860|NCT02878330|366186888|FG001|Overall Study|Withdrawal by Subject|21|||
106143861|NCT02878330|366186887|FG000|Overall Study|Other|4|||
106143862|NCT02878330|366186888|FG001|Overall Study|Other|7|||
106143863|NCT00346151|366186896|FG000|Overall Study|Withdrawal by Subject|3|||
106143864|NCT01184508|366186897|FG000|Overall Study|Adverse Event|4|||
106143865|NCT01184508|366186898|FG001|Overall Study|Adverse Event|6|||
106143866|NCT01184508|366186897|FG000|Overall Study|Lack of Efficacy|1|||
106143867|NCT01184508|366186898|FG001|Overall Study|Lack of Efficacy|1|||
106143868|NCT01184508|366186897|FG000|Overall Study|Lost to Follow-up|1|||
106143869|NCT01184508|366186898|FG001|Overall Study|Lost to Follow-up|1|||
106143870|NCT01184508|366186897|FG000|Overall Study|Physician Decision|1|||
106143871|NCT01184508|366186898|FG001|Overall Study|Physician Decision|0|||
106143872|NCT01184508|366186897|FG000|Overall Study|Protocol Violation|3|||
106143873|NCT01184508|366186898|FG001|Overall Study|Protocol Violation|1|||
106143874|NCT01184508|366186897|FG000|Overall Study|Sponsor Decision|5|||
106143875|NCT01184508|366186898|FG001|Overall Study|Sponsor Decision|2|||
106143876|NCT01184508|366186897|FG000|Overall Study|Withdrawal by Subject|1|||
106143877|NCT01184508|366186898|FG001|Overall Study|Withdrawal by Subject|3|||
106143878|NCT01184508|366186897|FG000|Overall Study|Randomized, Not Treated|0|||
106143879|NCT01184508|366186898|FG001|Overall Study|Randomized, Not Treated|1|||
106143880|NCT00869323|366186899|FG000|Maintenance Therapy|concurrent illness|1|||
106143881|NCT04054635|366186909|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
106143882|NCT04054635|366186910|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
106143883|NCT04054635|366186911|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
105760361|NCT02574481|364776042|FG000|Overall Study|Visit Missed|15|||
105760362|NCT02574481|364776043|FG001|Overall Study|Visit Missed|7|||
105760363|NCT02574481|364776044|FG002|Overall Study|Visit Missed|5|||
105760364|NCT02574481|364776045|FG003|Overall Study|Visit Missed|0|||
105760365|NCT02574481|364776042|FG000|Overall Study|Other|7|||
105760366|NCT02574481|364776043|FG001|Overall Study|Other|2|||
105760367|NCT02574481|364776044|FG002|Overall Study|Other|0|||
105760368|NCT02574481|364776045|FG003|Overall Study|Other|0|||
105760369|NCT02574481|364776042|FG000|Overall Study|Death|48|||
105760370|NCT02574481|364776043|FG001|Overall Study|Death|26|||
105760371|NCT02574481|364776044|FG002|Overall Study|Death|12|||
105760372|NCT02574481|364776045|FG003|Overall Study|Death|4|||
105760373|NCT02574481|364776042|FG000|Overall Study|Physician Decision|5|||
105760374|NCT02574481|364776043|FG001|Overall Study|Physician Decision|2|||
105760375|NCT02574481|364776044|FG002|Overall Study|Physician Decision|0|||
105760376|NCT02574481|364776045|FG003|Overall Study|Physician Decision|0|||
105760377|NCT02574481|364776042|FG000|Overall Study|Lost to Follow-up|5|||
105760378|NCT02574481|364776043|FG001|Overall Study|Lost to Follow-up|1|||
105760379|NCT02574481|364776044|FG002|Overall Study|Lost to Follow-up|3|||
105760380|NCT02574481|364776045|FG003|Overall Study|Lost to Follow-up|0|||
105760381|NCT02959970|364776048|FG000|Overall Study|Adverse Event|1|||
105760382|NCT02959970|364776049|FG001|Overall Study|Adverse Event|0|||
105760383|NCT02959970|364776048|FG000|Overall Study|Withdrawal by Subject|0|||
105760384|NCT02959970|364776049|FG001|Overall Study|Withdrawal by Subject|2|||
105760385|NCT02959970|364776048|FG000|Overall Study|Lost to Follow-up|1|||
105760386|NCT02959970|364776049|FG001|Overall Study|Lost to Follow-up|5|||
105760387|NCT00948428|364776052|FG000|Overall Study|Withdrawal by Subject|6|||
105760388|NCT00948428|364776053|FG001|Overall Study|Withdrawal by Subject|12|||
105760389|NCT00948428|364776054|FG002|Overall Study|Withdrawal by Subject|7|||
105760390|NCT00948428|364776052|FG000|Overall Study|Adverse Event|6|||
105760391|NCT00948428|364776053|FG001|Overall Study|Adverse Event|3|||
105760392|NCT00948428|364776054|FG002|Overall Study|Adverse Event|0|||
105760393|NCT00948428|364776052|FG000|Overall Study|Lost to Follow-up|2|||
105805962|NCT02806232|364946872|FG007|Overall Study|Lost to Follow-up|0|||
106143884|NCT04054635|366186909|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
106143885|NCT04054635|366186910|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
106143886|NCT04054635|366186911|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
106143887|NCT00057837|366186912|FG000|Overall Study|Progression/relapse|12|||
106143888|NCT00057837|366186913|FG001|Overall Study|Progression/relapse|14|||
106143889|NCT00057837|366186912|FG000|Overall Study|Adverse Event|2|||
105760394|NCT00948428|364776053|FG001|Overall Study|Lost to Follow-up|1|||
105760395|NCT00948428|364776054|FG002|Overall Study|Lost to Follow-up|1|||
105805963|NCT02806232|364946873|FG008|Overall Study|Lost to Follow-up|0|||
105805964|NCT02806232|364946865|FG000|Overall Study|Withdrawal by Subject|0|||
105805965|NCT02806232|364946866|FG001|Overall Study|Withdrawal by Subject|2|||
105805966|NCT02806232|364946867|FG002|Overall Study|Withdrawal by Subject|0|||
105805967|NCT02806232|364946868|FG003|Overall Study|Withdrawal by Subject|0|||
105805968|NCT02806232|364946869|FG004|Overall Study|Withdrawal by Subject|2|||
105805969|NCT02806232|364946870|FG005|Overall Study|Withdrawal by Subject|1|||
105805970|NCT02806232|364946871|FG006|Overall Study|Withdrawal by Subject|0|||
105805971|NCT02806232|364946872|FG007|Overall Study|Withdrawal by Subject|0|||
105805972|NCT02806232|364946873|FG008|Overall Study|Withdrawal by Subject|0|||
105805973|NCT00598559|364946874|FG000|Overall Study|Adverse Event|11|||
105805974|NCT00598559|364946875|FG001|Overall Study|Adverse Event|7|||
105805975|NCT00598559|364946876|FG002|Overall Study|Adverse Event|0|||
105805976|NCT00598559|364946874|FG000|Overall Study|Withdrawal by Subject|2|||
105805977|NCT00598559|364946875|FG001|Overall Study|Withdrawal by Subject|2|||
105805978|NCT00598559|364946876|FG002|Overall Study|Withdrawal by Subject|0|||
105805979|NCT00598559|364946874|FG000|Overall Study|Protocol Non-compliance|1|||
105805980|NCT00598559|364946875|FG001|Overall Study|Protocol Non-compliance|0|||
105805981|NCT00598559|364946876|FG002|Overall Study|Protocol Non-compliance|0|||
105805982|NCT00598559|364946874|FG000|Overall Study|Early discharge from hospital|9|||
105805983|NCT00598559|364946875|FG001|Overall Study|Early discharge from hospital|12|||
105805984|NCT00598559|364946876|FG002|Overall Study|Early discharge from hospital|3|||
105805985|NCT00598559|364946874|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
105805986|NCT00598559|364946875|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
105805987|NCT00598559|364946876|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
105805988|NCT01133821|364946877|FG000|Overall Study|Lost to Follow-up|8|||
105805989|NCT01133821|364946878|FG001|Overall Study|Lost to Follow-up|11|||
105805990|NCT01133821|364946877|FG000|Overall Study|Withdrawal by Subject|8|||
105805991|NCT01133821|364946878|FG001|Overall Study|Withdrawal by Subject|3|||
105805992|NCT01133821|364946877|FG000|Overall Study|preferred other treatment|1|||
105805993|NCT01133821|364946878|FG001|Overall Study|preferred other treatment|1|||
105805994|NCT01133821|364946877|FG000|Overall Study|Protocol Violation|0|||
105805995|NCT01133821|364946878|FG001|Overall Study|Protocol Violation|1|||
105805996|NCT01133821|364946877|FG000|Overall Study|Refused participation|1|||
105805997|NCT01133821|364946878|FG001|Overall Study|Refused participation|3|||
105805998|NCT00608205|364946879|FG000|Overall Study|Adverse Event|3|||
105805999|NCT00608205|364946880|FG001|Overall Study|Adverse Event|2|||
105806000|NCT00608205|364946879|FG000|Overall Study|Patient non-compliant|0|||
105806001|NCT00608205|364946880|FG001|Overall Study|Patient non-compliant|1|||
105806002|NCT01799590|364946883|FG000|Overall Study|Adverse Event|13|||
105806003|NCT01799590|364946884|FG001|Overall Study|Adverse Event|7|||
105806004|NCT01799590|364946885|FG002|Overall Study|Adverse Event|5|||
105806005|NCT01799590|364946883|FG000|Overall Study|Pregnancy|2|||
105806006|NCT01799590|364946884|FG001|Overall Study|Pregnancy|0|||
105806007|NCT01799590|364946885|FG002|Overall Study|Pregnancy|0|||
105806008|NCT01799590|364946883|FG000|Overall Study|Lack of Efficacy|3|||
105806009|NCT01799590|364946884|FG001|Overall Study|Lack of Efficacy|1|||
105806010|NCT01799590|364946885|FG002|Overall Study|Lack of Efficacy|3|||
105806011|NCT01799590|364946883|FG000|Overall Study|Participants convenience|4|||
105806012|NCT01799590|364946884|FG001|Overall Study|Participants convenience|4|||
105806013|NCT01799590|364946885|FG002|Overall Study|Participants convenience|2|||
105806014|NCT01799590|364946883|FG000|Overall Study|Aggravation of complications|0|||
105806015|NCT01799590|364946884|FG001|Overall Study|Aggravation of complications|1|||
105806016|NCT01799590|364946885|FG002|Overall Study|Aggravation of complications|1|||
105806017|NCT01799590|364946883|FG000|Overall Study|Using drugs with restricted days of use|0|||
105806018|NCT01799590|364946884|FG001|Overall Study|Using drugs with restricted days of use|3|||
105806019|NCT01799590|364946885|FG002|Overall Study|Using drugs with restricted days of use|2|||
105806020|NCT01799590|364946883|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
105806021|NCT01799590|364946884|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
105806022|NCT01799590|364946885|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
105806023|NCT01799590|364946883|FG000|Overall Study|Other|3|||
105806024|NCT01799590|364946884|FG001|Overall Study|Other|0|||
105806025|NCT01799590|364946885|FG002|Overall Study|Other|1|||
105806026|NCT00891774|364946886|FG000|Overall Study|Lost to Follow-up|5|||
105806027|NCT00891774|364946886|FG000|Overall Study|Illness (Self/Mother)|3|||
106016798|NCT00217737|365724503|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
106016799|NCT00217737|365724504|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
105806028|NCT00891774|364946886|FG000|Overall Study|Withdrawal by Subject|2|||
105806029|NCT00891774|364946886|FG000|Overall Study|Protocol Violation|4|||
105806030|NCT03175120|364946888|FG000|Overall Study|Adverse Event|2|||
105806031|NCT03175120|364946889|FG001|Overall Study|Adverse Event|2|||
105806032|NCT03175120|364946888|FG000|Overall Study|Protocol Violation|5|||
105806033|NCT03175120|364946889|FG001|Overall Study|Protocol Violation|2|||
105806034|NCT03175120|364946888|FG000|Overall Study|Lost to Follow-up|1|||
105806035|NCT03175120|364946889|FG001|Overall Study|Lost to Follow-up|0|||
105806036|NCT03175120|364946888|FG000|Overall Study|Withdrawal by Subject|2|||
105806037|NCT03175120|364946889|FG001|Overall Study|Withdrawal by Subject|5|||
106143890|NCT00057837|366186913|FG001|Overall Study|Adverse Event|12|||
106143891|NCT00057837|366186912|FG000|Overall Study|Death|5|||
106143892|NCT00057837|366186913|FG001|Overall Study|Death|4|||
106143893|NCT00057837|366186912|FG000|Overall Study|Withdrawal by Subject|5|||
106143894|NCT00057837|366186913|FG001|Overall Study|Withdrawal by Subject|3|||
106143895|NCT00057837|366186912|FG000|Overall Study|Alternative therapy|0|||
106143896|NCT00057837|366186913|FG001|Overall Study|Alternative therapy|1|||
106143897|NCT00057837|366186912|FG000|Overall Study|Other complicating disease|2|||
106143898|NCT00057837|366186913|FG001|Overall Study|Other complicating disease|1|||
106143899|NCT00057837|366186912|FG000|Overall Study|Physician Decision|1|||
106143900|NCT00057837|366186913|FG001|Overall Study|Physician Decision|0|||
106143901|NCT00057837|366186912|FG000|Overall Study|Ineligible|3|||
106143902|NCT00057837|366186913|FG001|Overall Study|Ineligible|3|||
106143903|NCT00057837|366186912|FG000|Overall Study|Never started treatment|1|||
106143904|NCT00057837|366186913|FG001|Overall Study|Never started treatment|1|||
106143905|NCT02448446|366186918|FG000|Overall Study|Withdrawal by Subject|1|||
106143906|NCT02448446|366186919|FG001|Overall Study|Withdrawal by Subject|0|||
106143907|NCT02425111|366186920|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
105806038|NCT03175120|364946888|FG000|Overall Study|Other|2|||
105806039|NCT03175120|364946889|FG001|Overall Study|Other|3|||
105806040|NCT01958281|364946890|FG000|Overall Study|Lack of Efficacy|5|||
105806041|NCT01958281|364946891|FG001|Overall Study|Lack of Efficacy|2|||
105806042|NCT01958281|364946892|FG002|Overall Study|Lack of Efficacy|0|||
105806043|NCT01958281|364946890|FG000|Overall Study|Adverse Event|0|||
105806044|NCT01958281|364946891|FG001|Overall Study|Adverse Event|2|||
105806045|NCT01958281|364946892|FG002|Overall Study|Adverse Event|0|||
105806046|NCT01958281|364946890|FG000|Overall Study|Withdrew Consent|1|||
105806047|NCT01958281|364946891|FG001|Overall Study|Withdrew Consent|0|||
105806048|NCT01958281|364946892|FG002|Overall Study|Withdrew Consent|0|||
105806049|NCT02784106|364946895|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
105806050|NCT02784106|364946896|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
105806051|NCT02784106|364946897|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
105806052|NCT02784106|364946898|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
105806053|NCT02784106|364946895|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
105806054|NCT02784106|364946896|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
105806055|NCT02784106|364946897|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105806056|NCT02784106|364946898|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
105806057|NCT02784106|364946895|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
105806058|NCT02784106|364946896|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
105806059|NCT02784106|364946897|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
105806060|NCT02784106|364946898|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
105806061|NCT02784106|364946895|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
105806062|NCT02784106|364946896|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105806063|NCT02784106|364946897|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105806064|NCT02784106|364946898|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
105806065|NCT02784106|364946895|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
105806066|NCT02784106|364946896|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
105806067|NCT02784106|364946897|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
105806068|NCT02784106|364946898|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
105806069|NCT02784106|364946895|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
105806070|NCT02784106|364946896|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
106143908|NCT02425111|366186920|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
106143909|NCT02425111|366186920|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
105806071|NCT02784106|364946897|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
105806072|NCT02784106|364946898|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
105806073|NCT03341507|364946900|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
105806074|NCT01338636|364946902|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
105806075|NCT03532009|364946903|FG000|Overall Study|Other|1|||
105806076|NCT03532009|364946904|FG001|Overall Study|Other|1|||
105806077|NCT03532009|364946903|FG000|Overall Study|Death|1|||
105806078|NCT03532009|364946904|FG001|Overall Study|Death|1|||
106143910|NCT02425111|366186920|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
106143911|NCT02425111|366186920|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
105806079|NCT03532009|364946903|FG000|Overall Study|Withdrawal by Patient|0|||
105806080|NCT03532009|364946904|FG001|Overall Study|Withdrawal by Patient|2|||
105806081|NCT02035137|364946905|FG000|Overall Study|Physician Decision|0|||
106143912|NCT02425111|366186920|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
106143913|NCT03621696|366186921|FG000|Overall Study|Not eligible|0|||
106143914|NCT03621696|366186922|FG001|Overall Study|Not eligible|0|||
106143915|NCT03621696|366186923|FG002|Overall Study|Not eligible|0|||
106143916|NCT03621696|366186924|FG003|Overall Study|Not eligible|5|||
106143917|NCT03621696|366186921|FG000|Overall Study|Withdrawal by Subject|1|||
105806082|NCT02035137|364946906|FG001|Overall Study|Physician Decision|0|||
105806083|NCT02035137|364946907|FG002|Overall Study|Physician Decision|1|||
105806084|NCT02035137|364946905|FG000|Overall Study|Withdrawal by Subject|0|||
105806085|NCT02035137|364946906|FG001|Overall Study|Withdrawal by Subject|1|||
105806086|NCT02035137|364946907|FG002|Overall Study|Withdrawal by Subject|2|||
105806087|NCT02035137|364946905|FG000|Overall Study|Ineligible|0|||
105806088|NCT02035137|364946906|FG001|Overall Study|Ineligible|1|||
105806089|NCT02035137|364946907|FG002|Overall Study|Ineligible|2|||
105806090|NCT02035137|364946905|FG000|Overall Study|Disease progression prior to treatment start|2|||
105806091|NCT02035137|364946906|FG001|Overall Study|Disease progression prior to treatment start|0|||
105806092|NCT02035137|364946907|FG002|Overall Study|Disease progression prior to treatment start|0|||
105806093|NCT02022007|364946908|FG000|Overall Study|Withdrawal by Subject|1|||
105806094|NCT02022007|364946909|FG001|Overall Study|Withdrawal by Subject|1|||
105806095|NCT02022007|364946910|FG002|Overall Study|Withdrawal by Subject|1|||
105806096|NCT02022007|364946908|FG000|Overall Study|Noncompliant|0|||
105806097|NCT02022007|364946909|FG001|Overall Study|Noncompliant|0|||
105806098|NCT02022007|364946910|FG002|Overall Study|Noncompliant|1|||
105806099|NCT02444533|364946917|FG000|Overall Study|Not able to complete forms|0|||
105806100|NCT02444533|364946918|FG001|Overall Study|Not able to complete forms|2|||
105806101|NCT02444533|364946917|FG000|Overall Study|Only gave post-procedure complications|2|||
105806102|NCT02444533|364946918|FG001|Overall Study|Only gave post-procedure complications|2|||
105806103|NCT03567057|364946920|FG000|Overall Study|Adverse Event|56|||
105806104|NCT03567057|364946921|FG001|Overall Study|Adverse Event|53|||
105806105|NCT03567057|364946922|FG002|Overall Study|Adverse Event|28|||
105806106|NCT03567057|364946920|FG000|Overall Study|Withdrawal by Subject|22|||
105806107|NCT03567057|364946921|FG001|Overall Study|Withdrawal by Subject|24|||
105806108|NCT03567057|364946922|FG002|Overall Study|Withdrawal by Subject|13|||
105806109|NCT03567057|364946920|FG000|Overall Study|Lost to Follow-up|3|||
105806110|NCT03567057|364946921|FG001|Overall Study|Lost to Follow-up|5|||
105806111|NCT03567057|364946922|FG002|Overall Study|Lost to Follow-up|2|||
105806112|NCT03567057|364946920|FG000|Overall Study|COVID-19 pandemic|4|||
105806113|NCT03567057|364946921|FG001|Overall Study|COVID-19 pandemic|3|||
105806114|NCT03567057|364946922|FG002|Overall Study|COVID-19 pandemic|0|||
105806115|NCT03567057|364946920|FG000|Overall Study|Non-compliance with study drug|4|||
105806116|NCT03567057|364946921|FG001|Overall Study|Non-compliance with study drug|2|||
105806117|NCT03567057|364946922|FG002|Overall Study|Non-compliance with study drug|0|||
105806118|NCT03567057|364946920|FG000|Overall Study|Lack of Efficacy|3|||
105806119|NCT03567057|364946921|FG001|Overall Study|Lack of Efficacy|0|||
105806120|NCT03567057|364946922|FG002|Overall Study|Lack of Efficacy|1|||
105806121|NCT03567057|364946920|FG000|Overall Study|Death|1|||
105806122|NCT03567057|364946921|FG001|Overall Study|Death|0|||
105806123|NCT03567057|364946922|FG002|Overall Study|Death|0|||
105806124|NCT03567057|364946920|FG000|Overall Study|Physician Decision|1|||
105806125|NCT03567057|364946921|FG001|Overall Study|Physician Decision|0|||
105806126|NCT03567057|364946922|FG002|Overall Study|Physician Decision|0|||
106016800|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
106016801|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
106016802|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
105806127|NCT03567057|364946920|FG000|Overall Study|Unstable medical condition|1|||
105806128|NCT03567057|364946921|FG001|Overall Study|Unstable medical condition|0|||
105806129|NCT03567057|364946922|FG002|Overall Study|Unstable medical condition|0|||
105806130|NCT03567057|364946920|FG000|Overall Study|Medical history event|0|||
105806131|NCT03567057|364946921|FG001|Overall Study|Medical history event|0|||
105806132|NCT03567057|364946922|FG002|Overall Study|Medical history event|1|||
105806133|NCT03567057|364946920|FG000|Overall Study|Other|0|||
105806134|NCT03567057|364946921|FG001|Overall Study|Other|0|||
105806135|NCT03567057|364946922|FG002|Overall Study|Other|1|||
105806136|NCT01006707|364946923|FG000|Study Session 1|Lost to Follow-up|2|||
105806137|NCT01006707|364946924|FG001|Study Session 1|Lost to Follow-up|0|||
105806138|NCT01006707|364946925|FG002|Study Session 1|Lost to Follow-up|0|||
105806139|NCT01006707|364946923|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
105806140|NCT01006707|364946924|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
105806141|NCT01006707|364946925|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
105806142|NCT00952484|364946926|FG000|Overall Study|Withdrawal by Subject|0|||
105806143|NCT00952484|364946927|FG001|Overall Study|Withdrawal by Subject|1|||
105806144|NCT00952484|364946928|FG002|Overall Study|Withdrawal by Subject|0|||
105806145|NCT00886483|364946930|FG000|Overall Study|Lost to Follow-up|0|||
105806146|NCT00886483|364946931|FG001|Overall Study|Lost to Follow-up|1|||
105806147|NCT00886483|364946930|FG000|Overall Study|Pursue medications|1|||
106016803|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
105806148|NCT00886483|364946931|FG001|Overall Study|Pursue medications|2|||
105806149|NCT00886483|364946930|FG000|Overall Study|Distance to center, poor grades|1|||
105806150|NCT00886483|364946931|FG001|Overall Study|Distance to center, poor grades|0|||
105806151|NCT03465891|364946934|FG000|Overall Study|Withdrawal by Subject|0|||
105806152|NCT03465891|364946935|FG001|Overall Study|Withdrawal by Subject|1|||
105806153|NCT03465891|364946934|FG000|Overall Study|Disease progression|1|||
105806154|NCT03465891|364946935|FG001|Overall Study|Disease progression|0|||
105951892|NCT01815424|365488153|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
105951893|NCT01815424|365488154|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
105760396|NCT00948428|364776052|FG000|Overall Study|Death|2|||
105760397|NCT00948428|364776053|FG001|Overall Study|Death|0|||
105760398|NCT00948428|364776054|FG002|Overall Study|Death|0|||
105760399|NCT00948428|364776052|FG000|Overall Study|Intercurrent Illness|1|||
105760400|NCT00948428|364776053|FG001|Overall Study|Intercurrent Illness|0|||
105760401|NCT00948428|364776054|FG002|Overall Study|Intercurrent Illness|0|||
105760402|NCT00948428|364776052|FG000|Overall Study|Non-compliance|1|||
105760403|NCT00948428|364776053|FG001|Overall Study|Non-compliance|2|||
105760404|NCT00948428|364776054|FG002|Overall Study|Non-compliance|0|||
105760405|NCT00010803|364776057|FG000|Overall Study|Withdrawal by Subject|97|||
105760406|NCT00010803|364776058|FG001|Overall Study|Withdrawal by Subject|98|||
105760407|NCT00607919|364776059|FG000|Acute Phase|Adverse Event|9|||
105760408|NCT00607919|364776060|FG001|Acute Phase|Adverse Event|2|||
105760409|NCT00607919|364776059|FG000|Acute Phase|Entry Criteria Not Met|1|||
105760410|NCT00607919|364776060|FG001|Acute Phase|Entry Criteria Not Met|1|||
105760411|NCT00607919|364776059|FG000|Acute Phase|Lack of Efficacy|1|||
105760412|NCT00607919|364776060|FG001|Acute Phase|Lack of Efficacy|2|||
105760413|NCT00607919|364776059|FG000|Acute Phase|Lost to Follow-up|9|||
105760414|NCT00607919|364776060|FG001|Acute Phase|Lost to Follow-up|3|||
105760415|NCT00607919|364776059|FG000|Acute Phase|Parent/Caregiver Decision|6|||
105760416|NCT00607919|364776060|FG001|Acute Phase|Parent/Caregiver Decision|4|||
105760417|NCT00607919|364776059|FG000|Acute Phase|Protocol Violation|5|||
105760418|NCT00607919|364776060|FG001|Acute Phase|Protocol Violation|1|||
105760419|NCT00607919|364776059|FG000|Acute Phase|Withdrawal by Subject|3|||
105760420|NCT00607919|364776060|FG001|Acute Phase|Withdrawal by Subject|3|||
105760421|NCT00607919|364776059|FG000|Open-Label Phase|Adverse Event|1|||
105760422|NCT00607919|364776060|FG001|Open-Label Phase|Adverse Event|5|||
105760423|NCT00607919|364776059|FG000|Open-Label Phase|Lost to Follow-up|4|||
105760424|NCT00607919|364776060|FG001|Open-Label Phase|Lost to Follow-up|1|||
105760425|NCT00607919|364776059|FG000|Open-Label Phase|Protocol Violation|2|||
105760426|NCT00607919|364776060|FG001|Open-Label Phase|Protocol Violation|2|||
105760427|NCT00607919|364776059|FG000|Open-Label Phase|Withdrawal by Subject|2|||
105760428|NCT00607919|364776060|FG001|Open-Label Phase|Withdrawal by Subject|2|||
105760429|NCT00607919|364776059|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
105760430|NCT00607919|364776060|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
105760431|NCT00762268|364776061|FG000|Overall Study|Withdrawal by Subject|3|||
105760432|NCT00762268|364776062|FG001|Overall Study|Withdrawal by Subject|3|||
105760433|NCT00150345|364776064|FG000|Overall Study|Death|5|||
105760434|NCT00150345|364776065|FG001|Overall Study|Death|2|||
105760435|NCT00150345|364776064|FG000|Overall Study|Adverse Event|8|||
105760436|NCT00150345|364776065|FG001|Overall Study|Adverse Event|6|||
105760437|NCT00150345|364776064|FG000|Overall Study|Lack of Efficacy|5|||
105760438|NCT00150345|364776065|FG001|Overall Study|Lack of Efficacy|4|||
105760439|NCT00150345|364776064|FG000|Overall Study|Withdrawal by Subject|3|||
105760440|NCT00150345|364776065|FG001|Overall Study|Withdrawal by Subject|4|||
105760441|NCT00150345|364776064|FG000|Overall Study|Laboratory abnormality|1|||
105760442|NCT00150345|364776065|FG001|Overall Study|Laboratory abnormality|2|||
105760443|NCT00150345|364776064|FG000|Overall Study|Other|12|||
105760444|NCT00150345|364776065|FG001|Overall Study|Other|14|||
105760445|NCT01392742|364776066|FG000|Overall Study|Premature study termination|42|||
105760446|NCT01392742|364776066|FG000|Overall Study|Failure to return|35|||
105760447|NCT01392742|364776066|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
105760448|NCT01392742|364776066|FG000|Overall Study|Lost to Follow-up|34|||
105760449|NCT01392742|364776066|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
105760450|NCT01392742|364776066|FG000|Overall Study|ITR and Protocol deviation|1|||
105760451|NCT01392742|364776066|FG000|Overall Study|Adverse event/intercurrent illness|17|||
105760452|NCT01392742|364776066|FG000|Overall Study|Protocol Violation|14|||
105760453|NCT01392742|364776066|FG000|Overall Study|Other|3|||
105760454|NCT01392742|364776066|FG000|Overall Study|Missing information|13|||
105760455|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
105760456|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
105760457|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
105760458|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
105760459|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
105951894|NCT01815424|365488155|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
105951895|NCT01815424|365488156|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
105760460|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
105760461|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
105760462|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
105760463|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
105760464|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
105760465|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
105760466|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
105760467|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
105760468|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
105760469|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
105760470|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
105760471|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
105760472|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
105760473|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
105760474|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
105760475|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
105760476|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
105760477|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
105760478|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
105760479|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
105760480|NCT01457924|364776067|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
105760481|NCT01457924|364776068|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
105760482|NCT01457924|364776069|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
105760483|NCT01457924|364776070|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
105760484|NCT01457924|364776071|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
105760485|NCT01457924|364776067|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
105760486|NCT01457924|364776068|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
105760487|NCT01457924|364776069|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
105760488|NCT01457924|364776070|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
105760489|NCT01457924|364776071|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
105760490|NCT01457924|364776067|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
105760491|NCT01457924|364776068|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
105760492|NCT01457924|364776069|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
105760493|NCT01457924|364776070|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
105760494|NCT01457924|364776071|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
105760495|NCT01457924|364776067|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
105760496|NCT01457924|364776068|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
105760497|NCT01457924|364776069|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
105760498|NCT01457924|364776070|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
105760499|NCT01457924|364776071|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
105760500|NCT01457924|364776067|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
105760501|NCT01457924|364776068|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
105760502|NCT01457924|364776069|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
105760503|NCT01457924|364776070|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
105760504|NCT01457924|364776071|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
105760505|NCT01457924|364776067|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
105760506|NCT01457924|364776068|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
105760507|NCT01457924|364776069|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
105760508|NCT01457924|364776070|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
105760509|NCT01457924|364776071|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
105760510|NCT01457924|364776067|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
105760511|NCT01457924|364776068|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
105760512|NCT01457924|364776069|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
105760513|NCT01457924|364776070|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
105760514|NCT01457924|364776071|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
105760515|NCT01457924|364776067|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
105760516|NCT01457924|364776068|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
105760517|NCT01457924|364776069|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
105760518|NCT01457924|364776070|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
105760519|NCT01457924|364776071|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
105760520|NCT01989754|364776072|FG000|Overall Study|Withdrawal by Subject|10|||
105760521|NCT01989754|364776073|FG001|Overall Study|Withdrawal by Subject|14|||
105760522|NCT01989754|364776072|FG000|Overall Study|Lost to Follow-up|28|||
105760523|NCT01989754|364776073|FG001|Overall Study|Lost to Follow-up|20|||
105760524|NCT01989754|364776072|FG000|Overall Study|Closed Site|1|||
105760525|NCT01989754|364776073|FG001|Overall Study|Closed Site|1|||
105760526|NCT01369225|364776076|FG000|Overall Study|Withdrawal by Subject|1|||
105760527|NCT01369225|364776077|FG001|Overall Study|Withdrawal by Subject|0|||
105760528|NCT01369225|364776078|FG002|Overall Study|Withdrawal by Subject|2|||
105760529|NCT01369225|364776079|FG003|Overall Study|Withdrawal by Subject|1|||
105760530|NCT01369225|364776080|FG004|Overall Study|Withdrawal by Subject|0|||
105760531|NCT01369225|364776081|FG005|Overall Study|Withdrawal by Subject|0|||
105760532|NCT01369225|364776076|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
105806155|NCT01716754|364946942|FG000|Overall Study|Death|0|||
105760533|NCT01369225|364776077|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
105760534|NCT01369225|364776078|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
105760535|NCT01369225|364776079|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
105760536|NCT01369225|364776080|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
105760537|NCT01369225|364776081|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
105760538|NCT01369225|364776076|FG000|Overall Study|Other|1|||
105760539|NCT01369225|364776077|FG001|Overall Study|Other|0|||
105760540|NCT01369225|364776078|FG002|Overall Study|Other|0|||
105760541|NCT01369225|364776079|FG003|Overall Study|Other|0|||
105760542|NCT01369225|364776080|FG004|Overall Study|Other|1|||
105760543|NCT01369225|364776081|FG005|Overall Study|Other|0|||
105760544|NCT01369225|364776076|FG000|Overall Study|Adverse Event|0|||
105760545|NCT01369225|364776077|FG001|Overall Study|Adverse Event|0|||
105760546|NCT01369225|364776078|FG002|Overall Study|Adverse Event|0|||
105760547|NCT01369225|364776079|FG003|Overall Study|Adverse Event|1|||
105760548|NCT01369225|364776080|FG004|Overall Study|Adverse Event|1|||
105760549|NCT01369225|364776081|FG005|Overall Study|Adverse Event|0|||
105760550|NCT00792701|364776082|FG000|Overall Study|Adverse Event|0|||
105760551|NCT00792701|364776083|FG001|Overall Study|Adverse Event|22|||
105760552|NCT00792701|364776082|FG000|Overall Study|Ineligible|1|||
105760553|NCT00792701|364776083|FG001|Overall Study|Ineligible|3|||
105760554|NCT00792701|364776082|FG000|Overall Study|Withdrawal by Subject|1|||
105760555|NCT00792701|364776083|FG001|Overall Study|Withdrawal by Subject|19|||
105760556|NCT00792701|364776082|FG000|Overall Study|Not protocol specified|17|||
105760557|NCT00792701|364776083|FG001|Overall Study|Not protocol specified|0|||
105760558|NCT00563368|364776086|FG000|Overall Study|Lost to Follow-up|14|||
105760559|NCT00563368|364776087|FG001|Overall Study|Lost to Follow-up|14|||
105760560|NCT00563368|364776088|FG002|Overall Study|Lost to Follow-up|12|||
105760561|NCT00563368|364776089|FG003|Overall Study|Lost to Follow-up|6|||
105760562|NCT00563368|364776090|FG004|Overall Study|Lost to Follow-up|9|||
105760563|NCT00563368|364776091|FG005|Overall Study|Lost to Follow-up|8|||
105760564|NCT00563368|364776092|FG006|Overall Study|Lost to Follow-up|9|||
105760565|NCT00563368|364776086|FG000|Overall Study|Adverse Event|3|||
105760566|NCT00563368|364776087|FG001|Overall Study|Adverse Event|4|||
105760567|NCT00563368|364776088|FG002|Overall Study|Adverse Event|5|||
105760568|NCT00563368|364776089|FG003|Overall Study|Adverse Event|9|||
105760569|NCT00563368|364776090|FG004|Overall Study|Adverse Event|6|||
105760570|NCT00563368|364776091|FG005|Overall Study|Adverse Event|10|||
105760571|NCT00563368|364776092|FG006|Overall Study|Adverse Event|17|||
105760572|NCT00563368|364776086|FG000|Overall Study|Withdrawal by Subject|11|||
105760573|NCT00563368|364776087|FG001|Overall Study|Withdrawal by Subject|6|||
105760574|NCT00563368|364776088|FG002|Overall Study|Withdrawal by Subject|5|||
105760575|NCT00563368|364776089|FG003|Overall Study|Withdrawal by Subject|7|||
105760576|NCT00563368|364776090|FG004|Overall Study|Withdrawal by Subject|8|||
105760577|NCT00563368|364776091|FG005|Overall Study|Withdrawal by Subject|5|||
105760578|NCT00563368|364776092|FG006|Overall Study|Withdrawal by Subject|4|||
105760579|NCT00563368|364776086|FG000|Overall Study|protocol non-compliance|1|||
105760580|NCT00563368|364776087|FG001|Overall Study|protocol non-compliance|1|||
105760581|NCT00563368|364776088|FG002|Overall Study|protocol non-compliance|2|||
105760582|NCT00563368|364776089|FG003|Overall Study|protocol non-compliance|1|||
105760583|NCT00563368|364776090|FG004|Overall Study|protocol non-compliance|0|||
105760584|NCT00563368|364776091|FG005|Overall Study|protocol non-compliance|1|||
105760585|NCT00563368|364776092|FG006|Overall Study|protocol non-compliance|3|||
105760586|NCT00563368|364776086|FG000|Overall Study|Pregnancy|1|||
105760587|NCT00563368|364776087|FG001|Overall Study|Pregnancy|0|||
105760588|NCT00563368|364776088|FG002|Overall Study|Pregnancy|1|||
105760589|NCT00563368|364776089|FG003|Overall Study|Pregnancy|2|||
105760590|NCT00563368|364776090|FG004|Overall Study|Pregnancy|1|||
105760591|NCT00563368|364776091|FG005|Overall Study|Pregnancy|2|||
105760592|NCT00563368|364776092|FG006|Overall Study|Pregnancy|0|||
105760593|NCT00563368|364776086|FG000|Overall Study|requirement for restricted medication|0|||
105760594|NCT00563368|364776087|FG001|Overall Study|requirement for restricted medication|0|||
105760595|NCT00563368|364776088|FG002|Overall Study|requirement for restricted medication|2|||
105760596|NCT00563368|364776089|FG003|Overall Study|requirement for restricted medication|0|||
105760597|NCT00563368|364776090|FG004|Overall Study|requirement for restricted medication|0|||
105760598|NCT00563368|364776091|FG005|Overall Study|requirement for restricted medication|0|||
105760599|NCT00563368|364776092|FG006|Overall Study|requirement for restricted medication|0|||
105760600|NCT00563368|364776086|FG000|Overall Study|Other|5|||
105760601|NCT00563368|364776087|FG001|Overall Study|Other|5|||
105760602|NCT00563368|364776088|FG002|Overall Study|Other|3|||
105760603|NCT00563368|364776089|FG003|Overall Study|Other|4|||
105760604|NCT00563368|364776090|FG004|Overall Study|Other|4|||
105760605|NCT00563368|364776091|FG005|Overall Study|Other|4|||
105760606|NCT00563368|364776092|FG006|Overall Study|Other|0|||
105760607|NCT01819506|364776095|FG000|Overall Study|Physician Decision|5|||
105760608|NCT01819506|364776096|FG001|Overall Study|Physician Decision|2|||
106143918|NCT03621696|366186922|FG001|Overall Study|Withdrawal by Subject|1|||
106143919|NCT03621696|366186923|FG002|Overall Study|Withdrawal by Subject|1|||
106143920|NCT03621696|366186924|FG003|Overall Study|Withdrawal by Subject|0|||
106143921|NCT03621696|366186921|FG000|Overall Study|Physician Decision|0|||
106143922|NCT03621696|366186922|FG001|Overall Study|Physician Decision|0|||
106143923|NCT03621696|366186923|FG002|Overall Study|Physician Decision|1|||
106143924|NCT03621696|366186924|FG003|Overall Study|Physician Decision|0|||
106143925|NCT00545077|366186925|FG000|Overall Study|Treatment not received|5|||
106143926|NCT00545077|366186926|FG001|Overall Study|Treatment not received|1|||
106143927|NCT00545077|366186925|FG000|Overall Study|Disease Progression|131|||
106143928|NCT00545077|366186926|FG001|Overall Study|Disease Progression|98|||
106143929|NCT00545077|366186925|FG000|Overall Study|Withdrawal by Subject|3|||
106143930|NCT00545077|366186926|FG001|Overall Study|Withdrawal by Subject|14|||
106143931|NCT00545077|366186925|FG000|Overall Study|Physician Decision|6|||
106143932|NCT00545077|366186926|FG001|Overall Study|Physician Decision|3|||
106143933|NCT00545077|366186925|FG000|Overall Study|Lost to Follow-up|2|||
106143934|NCT00545077|366186926|FG001|Overall Study|Lost to Follow-up|0|||
106143935|NCT00545077|366186925|FG000|Overall Study|Protocol Violation|1|||
106143936|NCT00545077|366186926|FG001|Overall Study|Protocol Violation|0|||
105760609|NCT01819506|364776095|FG000|Overall Study|Withdrawal by Subject|3|||
105760610|NCT01819506|364776096|FG001|Overall Study|Withdrawal by Subject|3|||
105760611|NCT00050622|364776097|FG000|Overall Study|Adverse Event|1|||
105760612|NCT04581863|364776098|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
105760613|NCT04581863|364776099|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
105760614|NCT02920450|364776100|FG000|Overall Study|Death|1|||
105760615|NCT02920450|364776101|FG001|Overall Study|Death|0|||
105760616|NCT02920450|364776102|FG002|Overall Study|Death|0|||
105760617|NCT02920450|364776103|FG003|Overall Study|Death|0|||
106143937|NCT00545077|366186925|FG000|Overall Study|Adverse Event|0|||
106143938|NCT00545077|366186926|FG001|Overall Study|Adverse Event|31|||
106143939|NCT00545077|366186925|FG000|Overall Study|Death|0|||
106143940|NCT00545077|366186926|FG001|Overall Study|Death|8|||
106143941|NCT00463788|366186927|FG000|Overall Study|Progressive Disease|86|||
106143942|NCT00463788|366186928|FG001|Overall Study|Progressive Disease|42|||
106143943|NCT00463788|366186927|FG000|Overall Study|Adverse Event|6|||
106143944|NCT00463788|366186928|FG001|Overall Study|Adverse Event|2|||
106143945|NCT00463788|366186927|FG000|Overall Study|Withdrawal by Subject|6|||
106143946|NCT00463788|366186928|FG001|Overall Study|Withdrawal by Subject|2|||
106143947|NCT00463788|366186927|FG000|Overall Study|Death|4|||
106143948|NCT00463788|366186928|FG001|Overall Study|Death|3|||
106143949|NCT00463788|366186927|FG000|Overall Study|Symptomatic Deterioration|2|||
106143950|NCT00463788|366186928|FG001|Overall Study|Symptomatic Deterioration|3|||
106143951|NCT00463788|366186927|FG000|Overall Study|Lost to Follow-up|1|||
106143952|NCT00463788|366186928|FG001|Overall Study|Lost to Follow-up|0|||
106143953|NCT00463788|366186927|FG000|Overall Study|Protocol Violation|0|||
106143954|NCT00463788|366186928|FG001|Overall Study|Protocol Violation|1|||
106143955|NCT00463788|366186927|FG000|Overall Study|Other|3|||
106143956|NCT00463788|366186928|FG001|Overall Study|Other|0|||
106143957|NCT00463788|366186927|FG000|Overall Study|Randomized but not treated|1|||
106143958|NCT00463788|366186928|FG001|Overall Study|Randomized but not treated|1|||
106143959|NCT00360698|366186929|FG000|Run-In|Physician Decision|0|||
106143960|NCT00360698|366186930|FG001|Run-In|Physician Decision|1|||
106143961|NCT00360698|366186929|FG000|Run-In|Withdrawal by Subject|0|||
106143962|NCT00360698|366186930|FG001|Run-In|Withdrawal by Subject|2|||
106143963|NCT00360698|366186929|FG000|Run-In|Non compliance with treatment procedure|0|||
106143964|NCT00360698|366186930|FG001|Run-In|Non compliance with treatment procedure|1|||
106143965|NCT00360698|366186929|FG000|Run-In|Sponsor request|0|||
105760618|NCT02920450|364776100|FG000|Overall Study|Withdrawal by Subject|1|||
105760619|NCT02920450|364776101|FG001|Overall Study|Withdrawal by Subject|0|||
105760620|NCT02920450|364776102|FG002|Overall Study|Withdrawal by Subject|0|||
105760621|NCT02920450|364776103|FG003|Overall Study|Withdrawal by Subject|0|||
105760622|NCT00225212|364776104|FG000|Overall Study|Disease progression|2|||
105760623|NCT00225212|364776104|FG000|Overall Study|Death|1|||
105760624|NCT00225212|364776104|FG000|Overall Study|Adverse Event|2|||
106143966|NCT00360698|366186930|FG001|Run-In|Sponsor request|2|||
106143967|NCT00360698|366186929|FG000|Run-In|Patient did not meet inclusion criteria|0|||
106143968|NCT00360698|366186930|FG001|Run-In|Patient did not meet inclusion criteria|1|||
106143969|NCT00360698|366186929|FG000|Run-In|Patient personal reasons|0|||
106143970|NCT00360698|366186930|FG001|Run-In|Patient personal reasons|2|||
106143971|NCT00360698|366186929|FG000|Run-In|Need of insulin with meals|0|||
106143972|NCT00360698|366186930|FG001|Run-In|Need of insulin with meals|1|||
106143973|NCT00360698|366186929|FG000|Treatment Period|Non compliance with treatment procedure|1|||
106143974|NCT00360698|366186930|FG001|Treatment Period|Non compliance with treatment procedure|0|||
106143975|NCT00360698|366186929|FG000|Treatment Period|Early termination by error|0|||
106143976|NCT00360698|366186930|FG001|Treatment Period|Early termination by error|1|||
106143977|NCT05082935|366186931|FG000|Overall Study|Lost to Follow-up|549|||
106143978|NCT05082935|366186932|FG001|Overall Study|Lost to Follow-up|631|||
106143979|NCT05082935|366186931|FG000|Overall Study|Withdrawal by Subject|27|||
105806156|NCT01716754|364946943|FG001|Overall Study|Death|0|||
105806157|NCT01716754|364946944|FG002|Overall Study|Death|0|||
105806158|NCT01716754|364946945|FG003|Overall Study|Death|1|||
105806159|NCT01716754|364946942|FG000|Overall Study|Protocol deviation|0|||
105806160|NCT01716754|364946943|FG001|Overall Study|Protocol deviation|2|||
105806161|NCT01716754|364946944|FG002|Overall Study|Protocol deviation|7|||
105806162|NCT01716754|364946945|FG003|Overall Study|Protocol deviation|2|||
105806163|NCT01716754|364946942|FG000|Overall Study|Non-compliance with study treatment|0|||
105951896|NCT01815424|365488152|FG000|Week 0 to 16|Lost to Follow-up|0|||
105951897|NCT01815424|365488153|FG001|Week 0 to 16|Lost to Follow-up|1|||
105951898|NCT01815424|365488154|FG002|Week 0 to 16|Lost to Follow-up|0|||
105951899|NCT01815424|365488155|FG003|Week 0 to 16|Lost to Follow-up|0|||
105951900|NCT01815424|365488156|FG004|Week 0 to 16|Lost to Follow-up|0|||
105951901|NCT01815424|365488152|FG000|Week 0 to 16|Withdrawal by Subject|0|||
105951902|NCT01815424|365488153|FG001|Week 0 to 16|Withdrawal by Subject|0|||
105951903|NCT01815424|365488154|FG002|Week 0 to 16|Withdrawal by Subject|1|||
105951904|NCT01815424|365488155|FG003|Week 0 to 16|Withdrawal by Subject|0|||
105951905|NCT01815424|365488156|FG004|Week 0 to 16|Withdrawal by Subject|0|||
106143980|NCT05082935|366186932|FG001|Overall Study|Withdrawal by Subject|58|||
105806164|NCT01716754|364946943|FG001|Overall Study|Non-compliance with study treatment|0|||
105806165|NCT01716754|364946944|FG002|Overall Study|Non-compliance with study treatment|1|||
105806166|NCT01716754|364946945|FG003|Overall Study|Non-compliance with study treatment|0|||
105806167|NCT01716754|364946942|FG000|Overall Study|Physician Decision|1|||
105806168|NCT01716754|364946943|FG001|Overall Study|Physician Decision|0|||
105806169|NCT01716754|364946944|FG002|Overall Study|Physician Decision|0|||
105806170|NCT01716754|364946945|FG003|Overall Study|Physician Decision|0|||
105806171|NCT01716754|364946942|FG000|Overall Study|Lost to Follow-up|1|||
105806172|NCT01716754|364946943|FG001|Overall Study|Lost to Follow-up|0|||
105806173|NCT01716754|364946944|FG002|Overall Study|Lost to Follow-up|0|||
105806174|NCT01716754|364946945|FG003|Overall Study|Lost to Follow-up|1|||
105806175|NCT01716754|364946942|FG000|Overall Study|Adverse Event|4|||
105806176|NCT01716754|364946943|FG001|Overall Study|Adverse Event|2|||
105806177|NCT01716754|364946944|FG002|Overall Study|Adverse Event|2|||
105806178|NCT01716754|364946945|FG003|Overall Study|Adverse Event|1|||
105806179|NCT01716754|364946942|FG000|Overall Study|Withdrawal by Subject|5|||
105806180|NCT01716754|364946943|FG001|Overall Study|Withdrawal by Subject|0|||
105806181|NCT01716754|364946944|FG002|Overall Study|Withdrawal by Subject|4|||
105806182|NCT01716754|364946945|FG003|Overall Study|Withdrawal by Subject|3|||
105806183|NCT00696709|364946948|FG000|Overall Study|Withdrawal by Subject|1|||
105806184|NCT00696709|364946949|FG001|Overall Study|Withdrawal by Subject|2|||
105806185|NCT00696709|364946950|FG002|Overall Study|Withdrawal by Subject|1|||
105806186|NCT00696709|364946951|FG003|Overall Study|Withdrawal by Subject|4|||
105806187|NCT00696709|364946952|FG004|Overall Study|Withdrawal by Subject|3|||
105806188|NCT00696709|364946948|FG000|Overall Study|Protocol Violation|1|||
105806189|NCT00696709|364946949|FG001|Overall Study|Protocol Violation|0|||
105806190|NCT00696709|364946950|FG002|Overall Study|Protocol Violation|0|||
105806191|NCT00696709|364946951|FG003|Overall Study|Protocol Violation|0|||
105806192|NCT00696709|364946952|FG004|Overall Study|Protocol Violation|0|||
105806193|NCT00696709|364946948|FG000|Overall Study|Lost to Follow-up|1|||
105806194|NCT00696709|364946949|FG001|Overall Study|Lost to Follow-up|1|||
105806195|NCT00696709|364946950|FG002|Overall Study|Lost to Follow-up|0|||
105806196|NCT00696709|364946951|FG003|Overall Study|Lost to Follow-up|0|||
105806197|NCT00696709|364946952|FG004|Overall Study|Lost to Follow-up|0|||
105806198|NCT00696709|364946948|FG000|Overall Study|Adverse Event|0|||
105806199|NCT00696709|364946949|FG001|Overall Study|Adverse Event|0|||
105806200|NCT00696709|364946950|FG002|Overall Study|Adverse Event|0|||
105806201|NCT00696709|364946951|FG003|Overall Study|Adverse Event|1|||
105806202|NCT00696709|364946952|FG004|Overall Study|Adverse Event|0|||
105806203|NCT00310856|364946953|FG000|Overall Study|Withdrawal by Subject|2|||
105806204|NCT00310856|364946954|FG001|Overall Study|Withdrawal by Subject|2|||
105951906|NCT01815424|365488152|FG000|Week 0 to 16|Other|1|||
105951907|NCT01815424|365488153|FG001|Week 0 to 16|Other|0|||
105951908|NCT01815424|365488154|FG002|Week 0 to 16|Other|3|||
105951909|NCT01815424|365488155|FG003|Week 0 to 16|Other|0|||
106143981|NCT01444417|366186933|FG000|Overall Study|Ineligibility Determined|0|||
105806205|NCT00310856|364946955|FG002|Overall Study|Withdrawal by Subject|2|||
105806206|NCT00310856|364946953|FG000|Overall Study|Lost to Follow-up|1|||
105806207|NCT00310856|364946954|FG001|Overall Study|Lost to Follow-up|2|||
105806208|NCT00310856|364946955|FG002|Overall Study|Lost to Follow-up|6|||
105806209|NCT00310856|364946953|FG000|Overall Study|Inappropriate enrollment|1|||
105806210|NCT00310856|364946954|FG001|Overall Study|Inappropriate enrollment|1|||
105806211|NCT00310856|364946955|FG002|Overall Study|Inappropriate enrollment|0|||
105806212|NCT00310856|364946953|FG000|Overall Study|Unable to classify|1|||
105806213|NCT00310856|364946954|FG001|Overall Study|Unable to classify|0|||
105806214|NCT00310856|364946955|FG002|Overall Study|Unable to classify|0|||
105951910|NCT01815424|365488156|FG004|Week 0 to 16|Other|0|||
105951911|NCT01815424|365488152|FG000|Week 0 to 16|Protocol Violation|1|||
105951912|NCT01815424|365488153|FG001|Week 0 to 16|Protocol Violation|0|||
105951913|NCT01815424|365488154|FG002|Week 0 to 16|Protocol Violation|0|||
105806215|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
105806216|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
105806217|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
105806218|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
105806219|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
105806220|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
105806221|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
105806222|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
105806223|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
105806224|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
105806225|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
105806226|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
105806227|NCT01227668|364946958|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
105806228|NCT01227668|364946959|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
105806229|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
105806230|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
105806231|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
105806232|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
105806233|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
105806234|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
105806235|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
105806236|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
105806237|NCT01227668|364946958|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
105806238|NCT01227668|364946959|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
105806239|NCT02473510|364946960|FG000|Overall Study|Lost to Follow-up|1|||
105806240|NCT02473510|364946961|FG001|Overall Study|Lost to Follow-up|2|||
105806241|NCT01709383|364946962|FG000|Overall Study|Lost to Follow-up|1|||
105806242|NCT01709383|364946963|FG001|Overall Study|Lost to Follow-up|0|||
105806243|NCT00278512|364946964|FG000|Overall Study|Death|1|||
105806244|NCT00278512|364946965|FG001|Overall Study|Death|0|||
105806245|NCT01202747|364946966|FG000|Overall Study|Withdrawal by Subject|1|||
105806246|NCT02521948|364946967|FG000|Overall Study|Adverse Event|2|||
105806247|NCT02521948|364946967|FG000|Overall Study|Death|4|||
105806248|NCT02521948|364946967|FG000|Overall Study|Lost to Follow-up|1|||
105806249|NCT02521948|364946967|FG000|Overall Study|Did not attend one or both follow-ups|6|||
105806250|NCT04000009|364946968|FG000|Overall Study|Adverse Event|13|||
105806251|NCT04000009|364946968|FG000|Overall Study|Lack of Efficacy|7|||
105806252|NCT04000009|364946968|FG000|Overall Study|Lost to Follow-up|8|||
105806253|NCT04000009|364946968|FG000|Overall Study|Noncompliance with study drug|4|||
105806254|NCT04000009|364946968|FG000|Overall Study|Physician Decision|1|||
105806255|NCT04000009|364946968|FG000|Overall Study|Use of prohibited medication|3|||
105806256|NCT04000009|364946968|FG000|Overall Study|Pregnancy|1|||
105806257|NCT04000009|364946968|FG000|Overall Study|Withdrawal by Subject|22|||
105806258|NCT04000009|364946968|FG000|Overall Study|Study terminated by sponsor|98|||
105806259|NCT04000009|364946968|FG000|Overall Study|Not further specified|8|||
105806260|NCT00679783|364946969|FG000|Overall Study|Adverse Event|0|||
105806261|NCT00679783|364946970|FG001|Overall Study|Adverse Event|0|||
105806262|NCT00679783|364946971|FG002|Overall Study|Adverse Event|0|||
105806263|NCT00679783|364946972|FG003|Overall Study|Adverse Event|3|||
105806264|NCT00679783|364946973|FG004|Overall Study|Adverse Event|0|||
105806265|NCT00679783|364946974|FG005|Overall Study|Adverse Event|0|||
105806266|NCT00679783|364946975|FG006|Overall Study|Adverse Event|1|||
105806267|NCT00679783|364946969|FG000|Overall Study|Lack of Efficacy|0|||
105806268|NCT00679783|364946970|FG001|Overall Study|Lack of Efficacy|1|||
105806269|NCT00679783|364946971|FG002|Overall Study|Lack of Efficacy|0|||
105806270|NCT00679783|364946972|FG003|Overall Study|Lack of Efficacy|2|||
106016804|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
106016805|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
106016806|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
106016807|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
106016808|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Study suspension|0|||
106016809|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Study suspension|45|||
106016810|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Study suspension|0|||
106016811|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Study suspension|0|||
105806271|NCT00679783|364946973|FG004|Overall Study|Lack of Efficacy|0|||
105806272|NCT00679783|364946974|FG005|Overall Study|Lack of Efficacy|0|||
105806273|NCT00679783|364946975|FG006|Overall Study|Lack of Efficacy|0|||
105806274|NCT00679783|364946969|FG000|Overall Study|Withdrawal by Subject|0|||
105806275|NCT00679783|364946970|FG001|Overall Study|Withdrawal by Subject|0|||
105806276|NCT00679783|364946971|FG002|Overall Study|Withdrawal by Subject|1|||
105806277|NCT00679783|364946972|FG003|Overall Study|Withdrawal by Subject|1|||
105806278|NCT00679783|364946973|FG004|Overall Study|Withdrawal by Subject|0|||
105806279|NCT00679783|364946974|FG005|Overall Study|Withdrawal by Subject|0|||
105806280|NCT00679783|364946975|FG006|Overall Study|Withdrawal by Subject|0|||
105806281|NCT00679783|364946969|FG000|Overall Study|Not Captured|0|||
105806282|NCT00679783|364946970|FG001|Overall Study|Not Captured|0|||
105806283|NCT00679783|364946971|FG002|Overall Study|Not Captured|0|||
105806284|NCT00679783|364946972|FG003|Overall Study|Not Captured|5|||
105806285|NCT00679783|364946973|FG004|Overall Study|Not Captured|0|||
105806286|NCT00679783|364946974|FG005|Overall Study|Not Captured|0|||
105806287|NCT00679783|364946975|FG006|Overall Study|Not Captured|0|||
105806288|NCT00679783|364946969|FG000|Overall Study|Ongoing at data cut-off|2|||
105806289|NCT00679783|364946970|FG001|Overall Study|Ongoing at data cut-off|2|||
105806290|NCT00679783|364946971|FG002|Overall Study|Ongoing at data cut-off|0|||
105806291|NCT00679783|364946972|FG003|Overall Study|Ongoing at data cut-off|9|||
105806292|NCT00679783|364946973|FG004|Overall Study|Ongoing at data cut-off|1|||
105806293|NCT00679783|364946974|FG005|Overall Study|Ongoing at data cut-off|0|||
105806294|NCT00679783|364946975|FG006|Overall Study|Ongoing at data cut-off|0|||
105806295|NCT00905489|364946976|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
105806296|NCT00905489|364946976|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
105806297|NCT00905489|364946976|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
105806298|NCT01754259|364946979|FG000|Overall Study|Withdrawal by Subject|2|||
105806299|NCT01754259|364946980|FG001|Overall Study|Withdrawal by Subject|4|||
105806300|NCT01754259|364946979|FG000|Overall Study|Adverse Event|3|||
105806301|NCT01754259|364946980|FG001|Overall Study|Adverse Event|1|||
105806302|NCT01754259|364946979|FG000|Overall Study|Lost to Follow-up|0|||
105806303|NCT01754259|364946980|FG001|Overall Study|Lost to Follow-up|1|||
105806304|NCT00814320|364946983|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
105806305|NCT00814320|364946984|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
105806306|NCT00814320|364946983|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
105806307|NCT00814320|364946984|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
105806308|NCT00814320|364946983|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
105806309|NCT00814320|364946984|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
105806310|NCT00814320|364946983|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
105806311|NCT00814320|364946984|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
105806312|NCT00814320|364946983|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
105806313|NCT00814320|364946984|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
105806314|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
105806315|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
105806316|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
105806317|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
105806318|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
105806319|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
105806320|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
105806321|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
105806322|NCT00814320|364946983|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
105806323|NCT00814320|364946984|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
105806324|NCT00491504|364946985|FG000|Overall Study|Adverse Event|0|||
105806325|NCT00491504|364946986|FG001|Overall Study|Adverse Event|1|||
105806326|NCT00491504|364946987|FG002|Overall Study|Adverse Event|0|||
105806327|NCT00491504|364946988|FG003|Overall Study|Adverse Event|0|||
105806328|NCT00491504|364946985|FG000|Overall Study|Withdrawal by Subject|0|||
105806329|NCT00491504|364946986|FG001|Overall Study|Withdrawal by Subject|0|||
105806330|NCT00491504|364946987|FG002|Overall Study|Withdrawal by Subject|1|||
105806331|NCT00491504|364946988|FG003|Overall Study|Withdrawal by Subject|2|||
105806332|NCT00491504|364946985|FG000|Overall Study|Protocol Violation|0|||
105806333|NCT00491504|364946986|FG001|Overall Study|Protocol Violation|0|||
105806334|NCT00491504|364946987|FG002|Overall Study|Protocol Violation|3|||
105806335|NCT00491504|364946988|FG003|Overall Study|Protocol Violation|2|||
105806336|NCT01748890|364947003|FG000|Overall Study|Insufficient recruitment for analysis|4|||
105806337|NCT03850509|364947004|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
105806338|NCT03850509|364947005|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
105806339|NCT01200394|364947006|FG000|Overall Study|Adverse Event|0|||
105806340|NCT01200394|364947007|FG001|Overall Study|Adverse Event|14|||
105806341|NCT01200394|364947006|FG000|Overall Study|Death|1|||
105951914|NCT01815424|365488155|FG003|Week 0 to 16|Protocol Violation|0|||
105951915|NCT01815424|365488156|FG004|Week 0 to 16|Protocol Violation|0|||
105951916|NCT01815424|365488152|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
105951917|NCT01815424|365488153|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
105951918|NCT01815424|365488154|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
105951919|NCT01815424|365488155|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
105951920|NCT01815424|365488156|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
105951921|NCT01815424|365488152|FG000|Week 16 to 52|Other|0|||
105806342|NCT01200394|364947007|FG001|Overall Study|Death|0|||
105806343|NCT01200394|364947006|FG000|Overall Study|Lost to Follow-up|0|||
105951922|NCT01815424|365488153|FG001|Week 16 to 52|Other|1|||
105951923|NCT01815424|365488154|FG002|Week 16 to 52|Other|0|||
105951924|NCT01815424|365488155|FG003|Week 16 to 52|Other|0|||
105951925|NCT01815424|365488156|FG004|Week 16 to 52|Other|0|||
105951926|NCT01815424|365488152|FG000|Week 16 to 52|Adverse Event|0|||
105951927|NCT01815424|365488153|FG001|Week 16 to 52|Adverse Event|0|||
105951928|NCT01815424|365488154|FG002|Week 16 to 52|Adverse Event|0|||
105760625|NCT00225212|364776104|FG000|Overall Study|Intercurrent illness|1|||
105760626|NCT00968708|364776106|FG000|Overall Study|Adverse Event|169|||
105760627|NCT00968708|364776107|FG001|Overall Study|Adverse Event|150|||
105760628|NCT00968708|364776106|FG000|Overall Study|Major Protocol Deviation|0|||
105760629|NCT00968708|364776107|FG001|Overall Study|Major Protocol Deviation|1|||
105760630|NCT00968708|364776106|FG000|Overall Study|Lost to Follow-up|19|||
105760631|NCT00968708|364776107|FG001|Overall Study|Lost to Follow-up|11|||
105760632|NCT00968708|364776106|FG000|Overall Study|Voluntary Withdrawal|104|||
105760633|NCT00968708|364776107|FG001|Overall Study|Voluntary Withdrawal|101|||
105760634|NCT00968708|364776106|FG000|Overall Study|Investigator Discretion|0|||
105760635|NCT00968708|364776107|FG001|Overall Study|Investigator Discretion|1|||
105760636|NCT00968708|364776106|FG000|Overall Study|Other|26|||
105760637|NCT00968708|364776107|FG001|Overall Study|Other|34|||
105760638|NCT01851863|364776108|FG000|Overall Study|Did not receive study medication|2|||
105760639|NCT01851863|364776109|FG001|Overall Study|Did not receive study medication|5|||
105760640|NCT01851863|364776110|FG002|Overall Study|Did not receive study medication|3|||
105760641|NCT01851863|364776111|FG003|Overall Study|Did not receive study medication|0|||
105760642|NCT01851863|364776108|FG000|Overall Study|Lost to Follow-up|3|||
105760643|NCT01851863|364776109|FG001|Overall Study|Lost to Follow-up|4|||
105760644|NCT01851863|364776110|FG002|Overall Study|Lost to Follow-up|2|||
105760645|NCT01851863|364776111|FG003|Overall Study|Lost to Follow-up|3|||
105760646|NCT02999100|364776116|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
105760647|NCT02999100|364776117|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
105760648|NCT02999100|364776118|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
105760649|NCT02999100|364776119|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
105760650|NCT02999100|364776120|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
105760651|NCT02999100|364776121|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
105760652|NCT02999100|364776116|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105806344|NCT01200394|364947007|FG001|Overall Study|Lost to Follow-up|1|||
105806345|NCT01200394|364947006|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
105951929|NCT01815424|365488155|FG003|Week 16 to 52|Adverse Event|0|||
105951930|NCT01815424|365488156|FG004|Week 16 to 52|Adverse Event|1|||
105951931|NCT01815424|365488152|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
105760653|NCT02999100|364776117|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105760654|NCT02999100|364776118|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105760655|NCT02999100|364776119|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105760656|NCT02999100|364776120|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
105760657|NCT02999100|364776121|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
105760658|NCT02999100|364776116|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105760659|NCT02999100|364776117|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105760660|NCT02999100|364776118|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
105760661|NCT02999100|364776119|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105760662|NCT02999100|364776120|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
105951932|NCT01815424|365488153|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
105951933|NCT01815424|365488154|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
105951934|NCT01815424|365488155|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
105951935|NCT01815424|365488156|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
105951936|NCT01815424|365488152|FG000|Week 16 to 52|Lost to Follow-up|0|||
105951937|NCT01815424|365488153|FG001|Week 16 to 52|Lost to Follow-up|2|||
105951938|NCT01815424|365488154|FG002|Week 16 to 52|Lost to Follow-up|0|||
105951939|NCT01815424|365488155|FG003|Week 16 to 52|Lost to Follow-up|2|||
105951940|NCT01815424|365488156|FG004|Week 16 to 52|Lost to Follow-up|1|||
105951941|NCT01815424|365488152|FG000|Week 16 to 52|Withdrawal by Subject|1|||
105951942|NCT01815424|365488153|FG001|Week 16 to 52|Withdrawal by Subject|2|||
105806346|NCT01200394|364947007|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
105806347|NCT01200394|364947006|FG000|Overall Study|Protocol Violation|0|||
105806348|NCT01200394|364947007|FG001|Overall Study|Protocol Violation|3|||
105806349|NCT01200394|364947006|FG000|Overall Study|Withdrawal by Subject|0|||
105806350|NCT01200394|364947007|FG001|Overall Study|Withdrawal by Subject|5|||
105806351|NCT01200394|364947006|FG000|Overall Study|Other|0|||
105806352|NCT01200394|364947007|FG001|Overall Study|Other|1|||
105951943|NCT01815424|365488154|FG002|Week 16 to 52|Withdrawal by Subject|0|||
105951944|NCT01815424|365488155|FG003|Week 16 to 52|Withdrawal by Subject|0|||
105951945|NCT01815424|365488156|FG004|Week 16 to 52|Withdrawal by Subject|0|||
105951946|NCT01309204|365488157|FG000|Overall Study|Adverse Event|48|||
105951947|NCT01309204|365488158|FG001|Overall Study|Adverse Event|58|||
105951948|NCT01309204|365488157|FG000|Overall Study|Lost to Follow-up|2|||
105951949|NCT01309204|365488158|FG001|Overall Study|Lost to Follow-up|2|||
105951950|NCT01309204|365488157|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
105951951|NCT01309204|365488158|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
105951952|NCT01309204|365488157|FG000|Overall Study|Inadequate control of IOP|4|||
105951953|NCT01309204|365488158|FG001|Overall Study|Inadequate control of IOP|4|||
105951954|NCT01309204|365488157|FG000|Overall Study|Other|4|||
105951955|NCT01309204|365488158|FG001|Overall Study|Other|1|||
105951956|NCT03183063|365488159|FG000|Overall Study|Withdrawal by Subject|2|||
105951957|NCT03183063|365488160|FG001|Overall Study|Withdrawal by Subject|0|||
105951958|NCT03183063|365488161|FG002|Overall Study|Withdrawal by Subject|0|||
105951959|NCT03183063|365488159|FG000|Overall Study|Physician Decision|3|||
105951960|NCT03183063|365488160|FG001|Overall Study|Physician Decision|4|||
105951961|NCT03183063|365488161|FG002|Overall Study|Physician Decision|4|||
105951962|NCT02808897|365488162|FG000|Overall Study|Lost to Follow-up|9|||
105951963|NCT02808897|365488163|FG001|Overall Study|Lost to Follow-up|11|||
105951964|NCT00558636|365488164|FG000|Treatment|Adverse Event|9|||
105951965|NCT00558636|365488165|FG001|Treatment|Adverse Event|2|||
105951966|NCT00558636|365488164|FG000|Treatment|Withdrawal by Subject|2|||
105951967|NCT00558636|365488165|FG001|Treatment|Withdrawal by Subject|0|||
105951968|NCT00558636|365488164|FG000|Treatment|Premature termination of the study|35|||
106143982|NCT01444417|366186934|FG001|Overall Study|Ineligibility Determined|1|||
106143983|NCT01444417|366186933|FG000|Overall Study|Withdrawal by Subject|2|||
106143984|NCT01444417|366186934|FG001|Overall Study|Withdrawal by Subject|0|||
106143985|NCT02423291|366186935|FG000|Overall Study|Lack of Efficacy|14|||
106143986|NCT02423291|366186935|FG000|Overall Study|Adverse Event|1|||
106143987|NCT05283395|366186938|FG000|Overall Study|Adverse Event|4|||
106143988|NCT05283395|366186939|FG001|Overall Study|Adverse Event|4|||
106143989|NCT05283395|366186940|FG002|Overall Study|Adverse Event|0|||
105806353|NCT02100956|364947008|FG000|At Least One Week Between Injections|Adverse Event|0|||
105806354|NCT02100956|364947009|FG001|At Least One Week Between Injections|Adverse Event|1|||
105806355|NCT01896297|364947011|FG000|Overall Study|Died in post treatment phase|1|||
105806356|NCT00385541|364947012|FG000|Overall Study|severe pain, clinician requested unblind|0|||
105806357|NCT00385541|364947013|FG001|Overall Study|severe pain, clinician requested unblind|1|||
105806358|NCT01893138|364947014|FG000|Double-Blind Period|Withdrawal by Subject|1|||
105806359|NCT01893138|364947015|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105951969|NCT00558636|365488165|FG001|Treatment|Premature termination of the study|37|||
106143990|NCT05283395|366186938|FG000|Overall Study|Patient Lost to Follow-Up|0|||
105951970|NCT00558636|365488164|FG000|Treatment|Disease progression|1|||
105951971|NCT00558636|365488165|FG001|Treatment|Disease progression|5|||
105951972|NCT00558636|365488164|FG000|Follow-up|Premature termination of the study|12|||
105951973|NCT00558636|365488165|FG001|Follow-up|Premature termination of the study|7|||
105951974|NCT03443687|365488166|FG000|Overall Study|Lost to Follow-up|3|||
105951975|NCT03443687|365488167|FG001|Overall Study|Lost to Follow-up|5|||
105951976|NCT03443687|365488166|FG000|Overall Study|Withdrawal by Subject|1|||
105951977|NCT03443687|365488167|FG001|Overall Study|Withdrawal by Subject|0|||
105951978|NCT03443687|365488166|FG000|Overall Study|Discontinued intervention|1|||
105951979|NCT03443687|365488167|FG001|Overall Study|Discontinued intervention|1|||
105951980|NCT04108273|365488168|FG000|Overall Study|COVID Pandemic|1|||
105951981|NCT04108273|365488169|FG001|Overall Study|COVID Pandemic|0|||
106143991|NCT05283395|366186939|FG001|Overall Study|Patient Lost to Follow-Up|0|||
106143992|NCT05283395|366186940|FG002|Overall Study|Patient Lost to Follow-Up|1|||
106143993|NCT05283395|366186938|FG000|Overall Study|Patient Withdrawal|2|||
105951982|NCT02808429|365488170|FG000|Overall Study|Lost to Follow-up|1|||
105951983|NCT02808429|365488171|FG001|Overall Study|Lost to Follow-up|0|||
105806360|NCT01893138|364947014|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
105806361|NCT01893138|364947015|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
105806362|NCT01893138|364947014|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
105806363|NCT01893138|364947015|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
105806364|NCT01893138|364947014|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
105806365|NCT01893138|364947015|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
105806366|NCT01893138|364947014|FG000|Open Label - Unblinded Period|Adverse Event|1|||
105806367|NCT01893138|364947015|FG001|Open Label - Unblinded Period|Adverse Event|0|||
105806368|NCT01326026|364947022|FG000|Overall Study|Adverse Event|4|||
105806369|NCT01326026|364947023|FG001|Overall Study|Adverse Event|3|||
105806370|NCT01326026|364947022|FG000|Overall Study|Withdrawal Criteria|5|||
105806371|NCT01326026|364947023|FG001|Overall Study|Withdrawal Criteria|7|||
105806372|NCT01326026|364947022|FG000|Overall Study|Other|3|||
105806373|NCT01326026|364947023|FG001|Overall Study|Other|3|||
105806374|NCT00434161|364948955|FG000|Overall Study|Adverse Event|5|||
105806375|NCT00434161|364948956|FG001|Overall Study|Adverse Event|1|||
105806376|NCT00434161|364948957|FG002|Overall Study|Adverse Event|4|||
105806377|NCT00434161|364948955|FG000|Overall Study|Lost to Follow-up|0|||
105806378|NCT00434161|364948956|FG001|Overall Study|Lost to Follow-up|1|||
105806379|NCT00434161|364948957|FG002|Overall Study|Lost to Follow-up|0|||
105806380|NCT00434161|364948955|FG000|Overall Study|Death|1|||
105806381|NCT00434161|364948956|FG001|Overall Study|Death|0|||
105806382|NCT00434161|364948957|FG002|Overall Study|Death|1|||
105806383|NCT00434161|364948955|FG000|Overall Study|Non-Compliance|1|||
105806384|NCT00434161|364948956|FG001|Overall Study|Non-Compliance|1|||
105806385|NCT00434161|364948957|FG002|Overall Study|Non-Compliance|0|||
105806386|NCT00434161|364948955|FG000|Overall Study|Withdrawal by Subject|2|||
105806387|NCT00434161|364948956|FG001|Overall Study|Withdrawal by Subject|0|||
105806388|NCT00434161|364948957|FG002|Overall Study|Withdrawal by Subject|3|||
105806389|NCT00434161|364948955|FG000|Overall Study|Logistical error study assessments|1|||
105806390|NCT00434161|364948956|FG001|Overall Study|Logistical error study assessments|0|||
105806391|NCT00434161|364948957|FG002|Overall Study|Logistical error study assessments|3|||
105806392|NCT02451670|364948962|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
105806393|NCT02451670|364948963|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
105806394|NCT00673361|364948979|FG000|Overall Study|Screen Failure|2|||
105806395|NCT00829413|364948980|FG000|Overall Study|No study drug admimnistered|13|||
105806396|NCT00829413|364948980|FG000|Overall Study|Training Patients|67|||
105806397|NCT00829413|364948980|FG000|Overall Study|No truth standard procedure available|9|||
105806398|NCT00829413|364948980|FG000|Overall Study|Technically inadequate truth standard|2|||
105806399|NCT00829413|364948980|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
105806400|NCT01464827|364948981|FG000|Overall Study|Adverse Event|0|||
105806401|NCT01464827|364948982|FG001|Overall Study|Adverse Event|0|||
105806402|NCT01464827|364948983|FG002|Overall Study|Adverse Event|0|||
105806403|NCT01464827|364948984|FG003|Overall Study|Adverse Event|0|||
105806404|NCT01464827|364948985|FG004|Overall Study|Adverse Event|0|||
105806405|NCT01464827|364948986|FG005|Overall Study|Adverse Event|0|||
105806406|NCT01464827|364948987|FG006|Overall Study|Adverse Event|0|||
105806407|NCT01464827|364948988|FG007|Overall Study|Adverse Event|0|||
105806408|NCT01464827|364948989|FG008|Overall Study|Adverse Event|0|||
105806409|NCT01464827|364948990|FG009|Overall Study|Adverse Event|0|||
105806410|NCT01464827|364948991|FG010|Overall Study|Adverse Event|0|||
105806411|NCT01464827|364948992|FG011|Overall Study|Adverse Event|0|||
105806412|NCT01464827|364948993|FG012|Overall Study|Adverse Event|1|||
105806413|NCT01464827|364948994|FG013|Overall Study|Adverse Event|0|||
105806414|NCT01464827|364948981|FG000|Overall Study|Withdrawal by Subject|1|||
105806415|NCT01464827|364948982|FG001|Overall Study|Withdrawal by Subject|0|||
105806416|NCT01464827|364948983|FG002|Overall Study|Withdrawal by Subject|0|||
106016812|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
106016813|NCT00217737|365724502|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
105806417|NCT01464827|364948984|FG003|Overall Study|Withdrawal by Subject|0|||
105806418|NCT01464827|364948985|FG004|Overall Study|Withdrawal by Subject|1|||
105806419|NCT01464827|364948986|FG005|Overall Study|Withdrawal by Subject|0|||
105806420|NCT01464827|364948987|FG006|Overall Study|Withdrawal by Subject|0|||
105806421|NCT01464827|364948988|FG007|Overall Study|Withdrawal by Subject|1|||
105806422|NCT01464827|364948989|FG008|Overall Study|Withdrawal by Subject|0|||
105806423|NCT01464827|364948990|FG009|Overall Study|Withdrawal by Subject|0|||
106016814|NCT00217737|365724503|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
106016815|NCT00217737|365724504|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
106016816|NCT00217737|365724501|FG000|Step 2 Randomization/Registration|Death|2|||
105806424|NCT01464827|364948991|FG010|Overall Study|Withdrawal by Subject|0|||
105806425|NCT01464827|364948992|FG011|Overall Study|Withdrawal by Subject|0|||
105806426|NCT01464827|364948993|FG012|Overall Study|Withdrawal by Subject|0|||
105806427|NCT01464827|364948994|FG013|Overall Study|Withdrawal by Subject|0|||
105806428|NCT01464827|364948981|FG000|Overall Study|Lost to Follow-up|0|||
105806429|NCT01464827|364948982|FG001|Overall Study|Lost to Follow-up|2|||
105806430|NCT01464827|364948983|FG002|Overall Study|Lost to Follow-up|0|||
106143994|NCT05283395|366186939|FG001|Overall Study|Patient Withdrawal|4|||
106143995|NCT05283395|366186940|FG002|Overall Study|Patient Withdrawal|2|||
106143996|NCT05283395|366186938|FG000|Overall Study|Investigator Decision|1|||
106143997|NCT05283395|366186939|FG001|Overall Study|Investigator Decision|0|||
106143998|NCT05283395|366186940|FG002|Overall Study|Investigator Decision|1|||
106143999|NCT05283395|366186938|FG000|Overall Study|Enrolled in error|0|||
106144000|NCT05283395|366186939|FG001|Overall Study|Enrolled in error|0|||
106144001|NCT05283395|366186940|FG002|Overall Study|Enrolled in error|1|||
106144002|NCT03401112|366186941|FG000|Overall Study|Adverse Event|1|||
106144003|NCT03401112|366186942|FG001|Overall Study|Adverse Event|2|||
106144004|NCT03401112|366186943|FG002|Overall Study|Adverse Event|3|||
106144005|NCT03401112|366186944|FG003|Overall Study|Adverse Event|2|||
106144006|NCT03401112|366186945|FG004|Overall Study|Adverse Event|0|||
106144007|NCT03401112|366186941|FG000|Overall Study|Lost to Follow-up|1|||
106144008|NCT03401112|366186942|FG001|Overall Study|Lost to Follow-up|0|||
106144009|NCT03401112|366186943|FG002|Overall Study|Lost to Follow-up|0|||
106144010|NCT03401112|366186944|FG003|Overall Study|Lost to Follow-up|0|||
106144011|NCT03401112|366186945|FG004|Overall Study|Lost to Follow-up|0|||
106144012|NCT03401112|366186941|FG000|Overall Study|Noncompliance|1|||
106144013|NCT03401112|366186942|FG001|Overall Study|Noncompliance|2|||
106144014|NCT03401112|366186943|FG002|Overall Study|Noncompliance|3|||
106144015|NCT03401112|366186944|FG003|Overall Study|Noncompliance|0|||
106144016|NCT03401112|366186945|FG004|Overall Study|Noncompliance|0|||
106144017|NCT03401112|366186941|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
106144018|NCT03401112|366186942|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
106144019|NCT03401112|366186943|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
106144020|NCT03401112|366186944|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
106144021|NCT03401112|366186945|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
106144022|NCT03401112|366186941|FG000|Overall Study|Withdrawal by Subject|0|||
106144023|NCT03401112|366186942|FG001|Overall Study|Withdrawal by Subject|3|||
106144024|NCT03401112|366186943|FG002|Overall Study|Withdrawal by Subject|2|||
106144025|NCT03401112|366186944|FG003|Overall Study|Withdrawal by Subject|1|||
106144026|NCT03401112|366186945|FG004|Overall Study|Withdrawal by Subject|0|||
106144027|NCT03401112|366186941|FG000|Overall Study|Physician Decision|0|||
106144028|NCT03401112|366186942|FG001|Overall Study|Physician Decision|0|||
106144029|NCT03401112|366186943|FG002|Overall Study|Physician Decision|0|||
106144030|NCT03401112|366186944|FG003|Overall Study|Physician Decision|2|||
106144031|NCT03401112|366186945|FG004|Overall Study|Physician Decision|0|||
106144032|NCT03401112|366186941|FG000|Overall Study|Study was Terminated by Sponsor|0|||
106144033|NCT03401112|366186942|FG001|Overall Study|Study was Terminated by Sponsor|0|||
106144034|NCT03401112|366186943|FG002|Overall Study|Study was Terminated by Sponsor|0|||
106144035|NCT03401112|366186944|FG003|Overall Study|Study was Terminated by Sponsor|1|||
106144036|NCT03401112|366186945|FG004|Overall Study|Study was Terminated by Sponsor|0|||
106144037|NCT03401112|366186941|FG000|Overall Study|Day 1 Assessment not Done|1|||
106144038|NCT03401112|366186942|FG001|Overall Study|Day 1 Assessment not Done|0|||
106144039|NCT03401112|366186943|FG002|Overall Study|Day 1 Assessment not Done|0|||
106144040|NCT03401112|366186944|FG003|Overall Study|Day 1 Assessment not Done|0|||
106144041|NCT03401112|366186945|FG004|Overall Study|Day 1 Assessment not Done|0|||
106144042|NCT03401112|366186941|FG000|Overall Study|Not Dosed|0|||
106144043|NCT03401112|366186942|FG001|Overall Study|Not Dosed|0|||
106144044|NCT03401112|366186943|FG002|Overall Study|Not Dosed|1|||
106144045|NCT03401112|366186944|FG003|Overall Study|Not Dosed|0|||
106144046|NCT03401112|366186945|FG004|Overall Study|Not Dosed|0|||
106144047|NCT03401112|366186941|FG000|Overall Study|Missed Clinical Visit|0|||
106144048|NCT03401112|366186942|FG001|Overall Study|Missed Clinical Visit|0|||
106144049|NCT03401112|366186943|FG002|Overall Study|Missed Clinical Visit|1|||
106144050|NCT03401112|366186944|FG003|Overall Study|Missed Clinical Visit|0|||
106144051|NCT03401112|366186945|FG004|Overall Study|Missed Clinical Visit|0|||
106144052|NCT03401112|366186941|FG000|Overall Study|Missed Doses|0|||
106144053|NCT03401112|366186942|FG001|Overall Study|Missed Doses|0|||
105951984|NCT02808429|365488172|FG002|Overall Study|Lost to Follow-up|0|||
105951985|NCT02808429|365488170|FG000|Overall Study|Protocol Violation|0|||
105951986|NCT02808429|365488171|FG001|Overall Study|Protocol Violation|1|||
105951987|NCT02808429|365488172|FG002|Overall Study|Protocol Violation|0|||
106144054|NCT03401112|366186943|FG002|Overall Study|Missed Doses|1|||
106144055|NCT03401112|366186944|FG003|Overall Study|Missed Doses|0|||
106144056|NCT03401112|366186945|FG004|Overall Study|Missed Doses|0|||
106144057|NCT03475316|366186947|FG000|6 Month Intervention|Adverse Event|2|||
106144058|NCT03475316|366186948|FG001|6 Month Intervention|Adverse Event|1|||
106144059|NCT03475316|366186947|FG000|6 Month Intervention|Withdrawal by Subject|2|||
106144060|NCT03475316|366186948|FG001|6 Month Intervention|Withdrawal by Subject|0|||
106144061|NCT03475316|366186947|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
106144062|NCT03475316|366186948|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
106144063|NCT03475316|366186947|FG000|9 Months|Study stopped due to COVID pandemic|3|||
106144064|NCT03475316|366186948|FG001|9 Months|Study stopped due to COVID pandemic|4|||
106144065|NCT01317420|366186949|FG000|Overall Study|Progressive disease according to RECIST|2|||
106144066|NCT01317420|366186950|FG001|Overall Study|Progressive disease according to RECIST|3|||
105806540|NCT03209570|364949015|FG000|Overall Study|Withdrawal by Subject|0|||
105806541|NCT03209570|364949016|FG001|Overall Study|Withdrawal by Subject|3|||
105806542|NCT00723554|364949017|FG000|Overall Study|Adverse Event|12|||
105806543|NCT00723554|364949017|FG000|Overall Study|Investigator's judgement|5|||
105806544|NCT00723554|364949017|FG000|Overall Study|Inhaled medication other than iloprost|4|||
105806545|NCT00723554|364949017|FG000|Overall Study|Withdrawal of consent|3|||
105806546|NCT00723554|364949017|FG000|Overall Study|Other|3|||
105806547|NCT00723554|364949017|FG000|Overall Study|Lost to Follow-up|1|||
105806548|NCT00723554|364949017|FG000|Overall Study|Non-compliance|1|||
105806549|NCT01405820|364949019|FG000|Randomized Treatment Period|Adverse Event|3|||
105806550|NCT01405820|364949020|FG001|Randomized Treatment Period|Adverse Event|3|||
105806551|NCT01405820|364949021|FG002|Randomized Treatment Period|Adverse Event|3|||
105806552|NCT01405820|364949022|FG003|Randomized Treatment Period|Adverse Event|0|||
105806553|NCT01405820|364949023|FG004|Randomized Treatment Period|Adverse Event|2|||
105806554|NCT01405820|364949024|FG005|Randomized Treatment Period|Adverse Event|1|||
105806555|NCT01405820|364949019|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
105806556|NCT01405820|364949020|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
105806557|NCT01405820|364949021|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
105806558|NCT01405820|364949022|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
105806559|NCT01405820|364949023|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
105806560|NCT01405820|364949024|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
105806561|NCT01405820|364949019|FG000|Randomized Treatment Period|Other|2|||
105806562|NCT01405820|364949020|FG001|Randomized Treatment Period|Other|2|||
105806563|NCT01405820|364949021|FG002|Randomized Treatment Period|Other|1|||
105806564|NCT01405820|364949022|FG003|Randomized Treatment Period|Other|1|||
105806565|NCT01405820|364949023|FG004|Randomized Treatment Period|Other|0|||
105806566|NCT01405820|364949024|FG005|Randomized Treatment Period|Other|0|||
105806567|NCT01405820|364949019|FG000|Randomized Treatment Period|Physician Decision|0|||
105806568|NCT01405820|364949020|FG001|Randomized Treatment Period|Physician Decision|2|||
105806569|NCT01405820|364949021|FG002|Randomized Treatment Period|Physician Decision|1|||
105806570|NCT01405820|364949022|FG003|Randomized Treatment Period|Physician Decision|0|||
105806571|NCT01405820|364949023|FG004|Randomized Treatment Period|Physician Decision|0|||
105806572|NCT01405820|364949024|FG005|Randomized Treatment Period|Physician Decision|0|||
105806573|NCT01405820|364949019|FG000|Randomized Treatment Period|Rescue|0|||
105806574|NCT01405820|364949020|FG001|Randomized Treatment Period|Rescue|1|||
105806575|NCT01405820|364949021|FG002|Randomized Treatment Period|Rescue|13|||
105806576|NCT01405820|364949022|FG003|Randomized Treatment Period|Rescue|10|||
105806577|NCT01405820|364949023|FG004|Randomized Treatment Period|Rescue|8|||
105806578|NCT01405820|364949024|FG005|Randomized Treatment Period|Rescue|8|||
105806579|NCT01405820|364949019|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
105806580|NCT01405820|364949020|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
105806581|NCT01405820|364949021|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
105806582|NCT01405820|364949022|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
105806583|NCT01405820|364949023|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
105806584|NCT01405820|364949024|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
105806585|NCT01405820|364949019|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
105806586|NCT01405820|364949020|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
105806587|NCT01405820|364949021|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
105806588|NCT01405820|364949022|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
105806589|NCT01405820|364949023|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
105806590|NCT01405820|364949024|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
105806591|NCT01405820|364949019|FG000|Randomized Treatment Period|Death|0|||
105806592|NCT01405820|364949020|FG001|Randomized Treatment Period|Death|0|||
105806593|NCT01405820|364949021|FG002|Randomized Treatment Period|Death|0|||
105806594|NCT01405820|364949022|FG003|Randomized Treatment Period|Death|1|||
105806595|NCT01405820|364949023|FG004|Randomized Treatment Period|Death|0|||
105806596|NCT01405820|364949024|FG005|Randomized Treatment Period|Death|0|||
105806597|NCT01405820|364949019|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806598|NCT01405820|364949020|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806599|NCT01405820|364949021|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806600|NCT01405820|364949022|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
105806601|NCT01405820|364949023|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806602|NCT01405820|364949024|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
105806603|NCT01405820|364949019|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
105806604|NCT01405820|364949020|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
105806605|NCT01405820|364949021|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
105806606|NCT01405820|364949022|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
105806607|NCT01405820|364949023|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
105806608|NCT01405820|364949024|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
105806609|NCT01405820|364949019|FG000|Open-Label Treatment Period|Other|1|||
105806610|NCT01405820|364949020|FG001|Open-Label Treatment Period|Other|1|||
105806611|NCT01405820|364949021|FG002|Open-Label Treatment Period|Other|1|||
105806612|NCT01405820|364949022|FG003|Open-Label Treatment Period|Other|1|||
105806613|NCT01405820|364949023|FG004|Open-Label Treatment Period|Other|1|||
105806614|NCT01405820|364949024|FG005|Open-Label Treatment Period|Other|1|||
105806615|NCT01405820|364949019|FG000|Open-Label Treatment Period|Physician Decision|0|||
105806616|NCT01405820|364949020|FG001|Open-Label Treatment Period|Physician Decision|0|||
105806617|NCT01405820|364949021|FG002|Open-Label Treatment Period|Physician Decision|1|||
105806618|NCT01405820|364949022|FG003|Open-Label Treatment Period|Physician Decision|2|||
105806619|NCT01405820|364949023|FG004|Open-Label Treatment Period|Physician Decision|1|||
105806620|NCT01405820|364949024|FG005|Open-Label Treatment Period|Physician Decision|0|||
105806621|NCT01405820|364949019|FG000|Open-Label Treatment Period|Adverse Event|0|||
105806622|NCT01405820|364949020|FG001|Open-Label Treatment Period|Adverse Event|0|||
105806623|NCT01405820|364949021|FG002|Open-Label Treatment Period|Adverse Event|0|||
105806624|NCT01405820|364949022|FG003|Open-Label Treatment Period|Adverse Event|1|||
105806625|NCT01405820|364949023|FG004|Open-Label Treatment Period|Adverse Event|0|||
105806626|NCT01405820|364949024|FG005|Open-Label Treatment Period|Adverse Event|0|||
105806627|NCT03222141|364949027|FG000|Overall Study|Death|15|||
105806628|NCT03222141|364949027|FG000|Overall Study|Lost to Follow-up|3|||
105806629|NCT02087046|364949028|FG000|Overall Study|Adverse Event|4|||
105806630|NCT02087046|364949028|FG000|Overall Study|Death|1|||
105806631|NCT02087046|364949028|FG000|Overall Study|Lost to Follow-up|3|||
105806632|NCT02087046|364949028|FG000|Overall Study|Withdrawal by Subject|2|||
105806633|NCT02087046|364949028|FG000|Overall Study|Physician Decision|1|||
105806634|NCT01214603|364949029|FG000|Overall Study|Adverse Event|0|||
106144118|NCT01317420|366186950|FG001|Overall Study|Reason other than those specified|0|||
106144119|NCT01317420|366186951|FG002|Overall Study|Reason other than those specified|0|||
106144120|NCT01317420|366186952|FG003|Overall Study|Reason other than those specified|0|||
105806635|NCT01214603|364949030|FG001|Overall Study|Adverse Event|0|||
105806636|NCT01214603|364949031|FG002|Overall Study|Adverse Event|1|||
105806637|NCT01214603|364949029|FG000|Overall Study|Death|1|||
105806638|NCT01214603|364949030|FG001|Overall Study|Death|0|||
105806639|NCT01214603|364949031|FG002|Overall Study|Death|0|||
105806640|NCT01214603|364949029|FG000|Overall Study|Progressive Disease|4|||
106144121|NCT01317420|366186953|FG004|Overall Study|Reason other than those specified|0|||
106144122|NCT01317420|366186954|FG005|Overall Study|Reason other than those specified|0|||
105806641|NCT01214603|364949030|FG001|Overall Study|Progressive Disease|1|||
105806642|NCT01214603|364949031|FG002|Overall Study|Progressive Disease|3|||
105806643|NCT01507896|364949032|FG000|Overall Study|Withdrawal by Subject|1|||
105806644|NCT01507896|364949032|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
105806645|NCT00490061|364949033|FG000|Overall Study|Physician Decision|1|||
105806646|NCT01155583|364949034|FG000|Phase I|Screen failure - did not start treatment|0|||
106144123|NCT01317420|366186955|FG006|Overall Study|Reason other than those specified|0|||
106144124|NCT01317420|366186956|FG007|Overall Study|Reason other than those specified|0|||
105806647|NCT01155583|364949035|FG001|Phase I|Screen failure - did not start treatment|0|||
105806648|NCT01155583|364949036|FG002|Phase I|Screen failure - did not start treatment|0|||
105806649|NCT01155583|364949037|FG003|Phase I|Screen failure - did not start treatment|0|||
105806650|NCT01155583|364949038|FG004|Phase I|Screen failure - did not start treatment|1|||
105806651|NCT01155583|364949039|FG005|Phase I|Screen failure - did not start treatment|0|||
105806652|NCT01155583|364949040|FG006|Phase I|Screen failure - did not start treatment|0|||
105806653|NCT01155583|364949041|FG007|Phase I|Screen failure - did not start treatment|2|||
105806654|NCT01155583|364949042|FG008|Phase I|Screen failure - did not start treatment|0|||
105806655|NCT01155583|364949034|FG000|Phase I|Withdrawal by Subject|0|||
105806656|NCT01155583|364949035|FG001|Phase I|Withdrawal by Subject|0|||
105806657|NCT01155583|364949036|FG002|Phase I|Withdrawal by Subject|0|||
105806658|NCT01155583|364949037|FG003|Phase I|Withdrawal by Subject|0|||
105806659|NCT01155583|364949038|FG004|Phase I|Withdrawal by Subject|0|||
105806660|NCT01155583|364949039|FG005|Phase I|Withdrawal by Subject|0|||
105806661|NCT01155583|364949040|FG006|Phase I|Withdrawal by Subject|0|||
105806662|NCT01155583|364949041|FG007|Phase I|Withdrawal by Subject|1|||
105806663|NCT01155583|364949042|FG008|Phase I|Withdrawal by Subject|0|||
105806664|NCT04274192|364949049|FG000|Overall Study|Protocol Violation|1|||
105806665|NCT04274192|364949050|FG001|Overall Study|Protocol Violation|0|||
105806666|NCT02482571|364949051|FG000|Overall Study|Adverse Event|1|||
105806667|NCT02482571|364949051|FG000|Overall Study|Scanner or Respiract failure|3|||
105806668|NCT02482571|364949051|FG000|Overall Study|Withdrawal by Subject|4|||
105806669|NCT01185288|364949052|FG000|Overall Study|Adverse Event|7|||
105806670|NCT01185288|364949053|FG001|Overall Study|Adverse Event|6|||
105806671|NCT01185288|364949052|FG000|Overall Study|Withdrawal by Subject|6|||
105806672|NCT01185288|364949053|FG001|Overall Study|Withdrawal by Subject|4|||
105806673|NCT01185288|364949052|FG000|Overall Study|Lost to Follow-up|2|||
105806674|NCT01185288|364949053|FG001|Overall Study|Lost to Follow-up|5|||
105806675|NCT01185288|364949052|FG000|Overall Study|Lack of Efficacy|2|||
105806676|NCT01185288|364949053|FG001|Overall Study|Lack of Efficacy|0|||
105806677|NCT01185288|364949052|FG000|Overall Study|Investigator discretion|1|||
105806678|NCT01185288|364949053|FG001|Overall Study|Investigator discretion|0|||
105806679|NCT01185288|364949052|FG000|Overall Study|Did not meet inclusion criteria|1|||
105806680|NCT01185288|364949053|FG001|Overall Study|Did not meet inclusion criteria|0|||
105806681|NCT01185288|364949052|FG000|Overall Study|Noncompliance|0|||
105806682|NCT01185288|364949053|FG001|Overall Study|Noncompliance|1|||
105806683|NCT01789320|364949054|FG000|Overall Study|Re-enrolled into study|1|||
105806684|NCT01789320|364949054|FG000|Overall Study|Lost to Follow-up|1|||
105806685|NCT03775681|364949055|FG000|Overall Study|Physician Decision|3|||
105806686|NCT02789111|364949056|FG000|Overall Study|Withdrawal by Subject|1|||
105806687|NCT02789111|364949057|FG001|Overall Study|Withdrawal by Subject|4|||
105806688|NCT01488578|364949058|FG000|Overall Study|Protocol Violation|1836|||
105806689|NCT01626885|364949059|FG000|Overall Study|Adverse Event|8|||
105806690|NCT01626885|364949059|FG000|Overall Study|Withdrawal by Subject|4|||
105806691|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
105806692|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
105806693|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
105806694|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
105806695|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
105806696|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
105806697|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
105806698|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
105806699|NCT03271528|364949060|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
105806700|NCT03271528|364949061|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
105806701|NCT03271528|364949060|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
105806702|NCT03271528|364949061|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
105952189|NCT03314935|365488195|FG011|Phase 2|Study Terminated by Sponsor|2|||
105952190|NCT03314935|365488196|FG012|Phase 2|Study Terminated by Sponsor|1|||
105952191|NCT03314935|365488197|FG013|Phase 2|Study Terminated by Sponsor|4|||
105806703|NCT03271528|364949060|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
105952192|NCT03314935|365488198|FG014|Phase 2|Study Terminated by Sponsor|4|||
105952193|NCT03314935|365488184|FG000|Phase 2|Lost to Follow-up|0|||
105952194|NCT03314935|365488185|FG001|Phase 2|Lost to Follow-up|0|||
105952195|NCT03314935|365488186|FG002|Phase 2|Lost to Follow-up|0|||
105952196|NCT03314935|365488187|FG003|Phase 2|Lost to Follow-up|0|||
105806704|NCT03271528|364949061|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
105806705|NCT00717756|364949063|FG000|Overall Study|Withdrawal by Subject|1|||
105806706|NCT00306384|364949064|FG000|Overall Study|Adverse Event|103|||
105806707|NCT00306384|364949065|FG001|Overall Study|Adverse Event|87|||
105806708|NCT00306384|364949066|FG002|Overall Study|Adverse Event|40|||
105806709|NCT00306384|364949064|FG000|Overall Study|Major protocol deviation|43|||
105952197|NCT03314935|365488188|FG004|Phase 2|Lost to Follow-up|0|||
105952198|NCT03314935|365488189|FG005|Phase 2|Lost to Follow-up|0|||
105952199|NCT03314935|365488190|FG006|Phase 2|Lost to Follow-up|0|||
105952200|NCT03314935|365488191|FG007|Phase 2|Lost to Follow-up|0|||
105806710|NCT00306384|364949065|FG001|Overall Study|Major protocol deviation|51|||
105806711|NCT00306384|364949066|FG002|Overall Study|Major protocol deviation|18|||
105806712|NCT00306384|364949064|FG000|Overall Study|Lost to Follow-up|57|||
105806713|NCT00306384|364949065|FG001|Overall Study|Lost to Follow-up|41|||
105806714|NCT00306384|364949066|FG002|Overall Study|Lost to Follow-up|35|||
105806715|NCT00306384|364949064|FG000|Overall Study|Voluntary withdrawal|199|||
105806716|NCT00306384|364949065|FG001|Overall Study|Voluntary withdrawal|187|||
105806717|NCT00306384|364949066|FG002|Overall Study|Voluntary withdrawal|91|||
105806718|NCT00306384|364949064|FG000|Overall Study|Study termination|1|||
105806719|NCT00306384|364949065|FG001|Overall Study|Study termination|0|||
105806720|NCT00306384|364949066|FG002|Overall Study|Study termination|1|||
105806721|NCT00306384|364949064|FG000|Overall Study|Pregnancy|3|||
105806722|NCT00306384|364949065|FG001|Overall Study|Pregnancy|1|||
105806723|NCT00306384|364949066|FG002|Overall Study|Pregnancy|1|||
105806724|NCT00306384|364949064|FG000|Overall Study|Lack of Efficacy|26|||
105806725|NCT00306384|364949065|FG001|Overall Study|Lack of Efficacy|40|||
105806726|NCT00306384|364949066|FG002|Overall Study|Lack of Efficacy|38|||
105806727|NCT00306384|364949064|FG000|Overall Study|Investigator discretion|28|||
105806728|NCT00306384|364949065|FG001|Overall Study|Investigator discretion|31|||
105806729|NCT00306384|364949066|FG002|Overall Study|Investigator discretion|21|||
105806730|NCT00306384|364949064|FG000|Overall Study|Other|80|||
105806731|NCT00306384|364949065|FG001|Overall Study|Other|70|||
105806732|NCT00306384|364949066|FG002|Overall Study|Other|32|||
105806733|NCT00306384|364949064|FG000|Overall Study|Site closure|2|||
105806734|NCT00306384|364949065|FG001|Overall Study|Site closure|0|||
105806735|NCT00306384|364949066|FG002|Overall Study|Site closure|0|||
105806736|NCT00673790|364949067|FG000|Overall Study|Adverse Event|23|||
105806737|NCT00673790|364949068|FG001|Overall Study|Adverse Event|14|||
105806738|NCT00673790|364949069|FG002|Overall Study|Adverse Event|2|||
105806739|NCT00673790|364949067|FG000|Overall Study|Lack of Efficacy|2|||
105806740|NCT00673790|364949068|FG001|Overall Study|Lack of Efficacy|2|||
105806741|NCT00673790|364949069|FG002|Overall Study|Lack of Efficacy|2|||
105806742|NCT00673790|364949067|FG000|Overall Study|Protocol Violation|6|||
105806743|NCT00673790|364949068|FG001|Overall Study|Protocol Violation|9|||
105806744|NCT00673790|364949069|FG002|Overall Study|Protocol Violation|1|||
105806745|NCT00673790|364949067|FG000|Overall Study|Withdrawal by Subject|7|||
105806746|NCT00673790|364949068|FG001|Overall Study|Withdrawal by Subject|4|||
105806747|NCT00673790|364949069|FG002|Overall Study|Withdrawal by Subject|1|||
105806748|NCT00673790|364949067|FG000|Overall Study|Lost to Follow-up|6|||
105806749|NCT00673790|364949068|FG001|Overall Study|Lost to Follow-up|6|||
105806750|NCT00673790|364949069|FG002|Overall Study|Lost to Follow-up|5|||
105806751|NCT00673790|364949067|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
105806752|NCT00673790|364949068|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
105806753|NCT00673790|364949069|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
105806754|NCT00673790|364949067|FG000|Overall Study|Poor compliance|1|||
105806755|NCT00673790|364949068|FG001|Overall Study|Poor compliance|0|||
105806756|NCT00673790|364949069|FG002|Overall Study|Poor compliance|0|||
105806757|NCT00673790|364949067|FG000|Overall Study|Participated in two Nebivolol studies|0|||
105806758|NCT00673790|364949068|FG001|Overall Study|Participated in two Nebivolol studies|0|||
105806759|NCT00673790|364949069|FG002|Overall Study|Participated in two Nebivolol studies|1|||
105806760|NCT00673790|364949067|FG000|Overall Study|Unconfirmed pregnancy|0|||
105806761|NCT00673790|364949068|FG001|Overall Study|Unconfirmed pregnancy|1|||
105806762|NCT00673790|364949069|FG002|Overall Study|Unconfirmed pregnancy|0|||
105806763|NCT00673790|364949067|FG000|Overall Study|Randomization criteria not met|0|||
105806764|NCT00673790|364949068|FG001|Overall Study|Randomization criteria not met|1|||
105806765|NCT00673790|364949069|FG002|Overall Study|Randomization criteria not met|0|||
106144125|NCT01317420|366186957|FG008|Overall Study|Reason other than those specified|0|||
106144126|NCT01317420|366186958|FG009|Overall Study|Reason other than those specified|1|||
106144127|NCT01317420|366186959|FG010|Overall Study|Reason other than those specified|0|||
106144128|NCT01317420|366186960|FG011|Overall Study|Reason other than those specified|0|||
106144129|NCT01317420|366186961|FG012|Overall Study|Reason other than those specified|0|||
106144130|NCT01430611|366186962|FG000|Overall Study|Adverse Event|0|||
106144131|NCT01430611|366186963|FG001|Overall Study|Adverse Event|1|||
106144132|NCT01430611|366186962|FG000|Overall Study|Protocol Violation|1|||
106144133|NCT01430611|366186963|FG001|Overall Study|Protocol Violation|0|||
105806766|NCT01873859|364949070|FG000|Overall Study|Withdrawal by Subject|0|||
105806767|NCT01873859|364949071|FG001|Overall Study|Withdrawal by Subject|4|||
105806768|NCT01364870|364949072|FG000|Overall Study|Withdrawal by Subject|13|||
105806769|NCT01364870|364949073|FG001|Overall Study|Withdrawal by Subject|24|||
105806770|NCT01364870|364949074|FG002|Overall Study|Withdrawal by Subject|10|||
105806771|NCT01364870|364949072|FG000|Overall Study|Adverse Event|8|||
105806772|NCT01364870|364949073|FG001|Overall Study|Adverse Event|6|||
105806773|NCT01364870|364949074|FG002|Overall Study|Adverse Event|4|||
106144134|NCT01430611|366186962|FG000|Overall Study|Lost to Follow-up|1|||
106144135|NCT01430611|366186963|FG001|Overall Study|Lost to Follow-up|0|||
105806774|NCT01364870|364949072|FG000|Overall Study|Protocol Violation|1|||
105806775|NCT01364870|364949073|FG001|Overall Study|Protocol Violation|0|||
105806776|NCT01364870|364949074|FG002|Overall Study|Protocol Violation|0|||
105806777|NCT00601484|364949075|FG000|Overall Study|Adverse Event|0|||
105806778|NCT00601484|364949076|FG001|Overall Study|Adverse Event|1|||
105806779|NCT00601484|364949075|FG000|Overall Study|Lost to Follow-up|4|||
105806780|NCT00601484|364949076|FG001|Overall Study|Lost to Follow-up|3|||
105806781|NCT00601484|364949075|FG000|Overall Study|Lack of Efficacy|0|||
105806782|NCT00601484|364949076|FG001|Overall Study|Lack of Efficacy|2|||
105806783|NCT00601484|364949075|FG000|Overall Study|Withdrawal by Subject|1|||
105806784|NCT00601484|364949076|FG001|Overall Study|Withdrawal by Subject|1|||
105806785|NCT00601484|364949075|FG000|Overall Study|Randomized, but not treated|0|||
105806786|NCT00601484|364949076|FG001|Overall Study|Randomized, but not treated|1|||
105806787|NCT00969332|364949081|FG000|Overall Study|Physician Decision|8|||
105806788|NCT00969332|364949081|FG000|Overall Study|Withdrawal by Subject|3|||
105806789|NCT03828461|364949082|FG000|Overall Study|Lost to Follow-up|1|||
105806790|NCT03828461|364949082|FG000|Overall Study|Withdrawal by Subject|3|||
105806791|NCT03035227|364949083|FG000|Overall Study|study stopped due to PI leaving institut|1|||
105806792|NCT03035227|364949084|FG001|Overall Study|study stopped due to PI leaving institut|1|||
105806793|NCT03529955|364949085|FG000|Overall Study|Adverse Event|1|||
105806794|NCT03529955|364949085|FG000|Overall Study|Lack of Efficacy|1|||
105806795|NCT00859469|364949086|FG000|Overall Study|Adverse Event|2|||
105806796|NCT00859469|364949086|FG000|Overall Study|Lack of Efficacy|9|||
105806797|NCT00859469|364949086|FG000|Overall Study|Withdrawal by Subject|1|||
105806798|NCT00859469|364949086|FG000|Overall Study|Death|16|||
105806799|NCT02742181|364949087|FG000|Overall Study|Physician Decision|1|||
105806800|NCT02742181|364949088|FG001|Overall Study|Physician Decision|0|||
105806801|NCT01309919|364949105|FG000|Overall Study|Did not receive a postpartum IUD|17|||
105806802|NCT01309919|364949106|FG001|Overall Study|Did not receive a postpartum IUD|48|||
105806803|NCT00319449|364949107|FG000|Overall Study|Subject did not wish to continue|1|||
105806804|NCT00319449|364949108|FG001|Overall Study|Subject did not wish to continue|0|||
105806805|NCT00319449|364949107|FG000|Overall Study|Noncompliance with the protocol|1|||
105806806|NCT00319449|364949108|FG001|Overall Study|Noncompliance with the protocol|0|||
105806807|NCT02102490|364949109|FG000|Overall Study|Death|6|||
105806808|NCT02102490|364949109|FG000|Overall Study|Lost to Follow-up|1|||
105806809|NCT00752856|364949114|FG000|Overall Study|randomized but did not do viral kinetics|0|||
105806810|NCT00752856|364949115|FG001|Overall Study|randomized but did not do viral kinetics|1|||
105806811|NCT02260492|364949116|FG000|Overall Study|Adverse Event|6|||
105806812|NCT02260492|364949117|FG001|Overall Study|Adverse Event|1|||
105806813|NCT02260492|364949118|FG002|Overall Study|Adverse Event|2|||
105806814|NCT02260492|364949116|FG000|Overall Study|Death|0|||
105806815|NCT02260492|364949117|FG001|Overall Study|Death|1|||
105806816|NCT02260492|364949118|FG002|Overall Study|Death|0|||
105806817|NCT02260492|364949116|FG000|Overall Study|Lost to Follow-up|12|||
105806818|NCT02260492|364949117|FG001|Overall Study|Lost to Follow-up|9|||
105806819|NCT02260492|364949118|FG002|Overall Study|Lost to Follow-up|0|||
105806820|NCT02260492|364949116|FG000|Overall Study|Physician Decision|2|||
105806821|NCT02260492|364949117|FG001|Overall Study|Physician Decision|0|||
105806822|NCT02260492|364949118|FG002|Overall Study|Physician Decision|1|||
105806823|NCT02260492|364949116|FG000|Overall Study|Withdrawal by Subject|3|||
105806824|NCT02260492|364949117|FG001|Overall Study|Withdrawal by Subject|2|||
105806825|NCT02260492|364949118|FG002|Overall Study|Withdrawal by Subject|2|||
105806826|NCT00996736|364949119|FG000|Overall Study|Death|1|||
105806827|NCT00996736|364949120|FG001|Overall Study|Death|1|||
105806828|NCT00996736|364949119|FG000|Overall Study|Lost to Follow-up|15|||
105806829|NCT00996736|364949120|FG001|Overall Study|Lost to Follow-up|14|||
105806830|NCT00996736|364949119|FG000|Overall Study|Visit not within 3-month window|5|||
105806831|NCT00996736|364949120|FG001|Overall Study|Visit not within 3-month window|3|||
105806832|NCT02688608|364949121|FG000|Overall Study|Lost to Follow-up|1|||
105806833|NCT02456909|364949122|FG000|Overall Study|Did not receive allocated intervention|24|||
105806834|NCT02456909|364949123|FG001|Overall Study|Did not receive allocated intervention|26|||
105806835|NCT02456909|364949122|FG000|Overall Study|Did not complete the primary outcome|0|||
105806836|NCT02456909|364949123|FG001|Overall Study|Did not complete the primary outcome|1|||
105806837|NCT03997448|364950508|FG000|Study Treatment|Disease Progression|1|||
105806838|NCT03997448|364950508|FG000|Study Treatment|Symptomatic Deterioration|1|||
105806839|NCT03997448|364950508|FG000|Follow up|Death|2|||
105806840|NCT03997448|364950508|FG000|Follow up|study terminated|1|||
105806841|NCT00125359|364950509|FG000|Overall Study|Death|4|||
105806842|NCT00125359|364950509|FG000|Overall Study|Adverse Event|5|||
105806843|NCT00125359|364950509|FG000|Overall Study|Physician Decision|14|||
105806844|NCT00461500|364950510|FG000|Overall Study|Adverse Event|1|||
105806845|NCT00461500|364950511|FG001|Overall Study|Adverse Event|0|||
105806846|NCT00461500|364950510|FG000|Overall Study|Lack of Efficacy|0|||
105806847|NCT00461500|364950511|FG001|Overall Study|Lack of Efficacy|1|||
105806848|NCT00461500|364950510|FG000|Overall Study|Expired Drug Treatment|1|||
105806849|NCT00461500|364950511|FG001|Overall Study|Expired Drug Treatment|1|||
105806850|NCT00461500|364950510|FG000|Overall Study|Study Stopped|1|||
105806851|NCT00461500|364950511|FG001|Overall Study|Study Stopped|2|||
105806852|NCT00461500|364950510|FG000|Overall Study|Drug Treatment Misuse|1|||
105806853|NCT00461500|364950511|FG001|Overall Study|Drug Treatment Misuse|0|||
105806854|NCT00461500|364950510|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
105806855|NCT00461500|364950511|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
105806856|NCT00461500|364950510|FG000|Overall Study|Lost to Follow-up|2|||
105806857|NCT00461500|364950511|FG001|Overall Study|Lost to Follow-up|2|||
105806858|NCT00555009|364950521|FG000|Overall Study|Withdrawal by Subject|0|||
105806859|NCT00555009|364950522|FG001|Overall Study|Withdrawal by Subject|1|||
105806860|NCT00555009|364950521|FG000|Overall Study|Terminated by Sponsor|2|||
105806861|NCT00555009|364950522|FG001|Overall Study|Terminated by Sponsor|5|||
105806862|NCT02058628|364950523|FG000|Overall Study|Adverse Event|1|||
105806863|NCT02058628|364950524|FG001|Overall Study|Adverse Event|0|||
105806864|NCT02058628|364950523|FG000|Overall Study|Withdrawal by Subject|2|||
105806865|NCT02058628|364950524|FG001|Overall Study|Withdrawal by Subject|2|||
105806866|NCT02058628|364950523|FG000|Overall Study|Lost to Follow-up|2|||
105806867|NCT02058628|364950524|FG001|Overall Study|Lost to Follow-up|4|||
105806868|NCT02058628|364950523|FG000|Overall Study|Not in time schedule|0|||
105806869|NCT02058628|364950524|FG001|Overall Study|Not in time schedule|1|||
105806870|NCT02058628|364950523|FG000|Overall Study|The visit date was not in timeline|0|||
105806871|NCT02058628|364950524|FG001|Overall Study|The visit date was not in timeline|1|||
105806872|NCT02058628|364950523|FG000|Overall Study|A lot of time for study for participant|1|||
105806873|NCT02058628|364950524|FG001|Overall Study|A lot of time for study for participant|0|||
105806874|NCT02058628|364950523|FG000|Overall Study|Non compliance|1|||
105806875|NCT02058628|364950524|FG001|Overall Study|Non compliance|0|||
105806876|NCT02961920|364950525|FG000|Overall Study|did not achive stydy protocol schedule|1|||
105806877|NCT02961920|364950526|FG001|Overall Study|did not achive stydy protocol schedule|1|||
105806878|NCT02668783|364950529|FG000|Overall Study|Pregnancy|0|||
105806879|NCT02668783|364950530|FG001|Overall Study|Pregnancy|1|||
105806880|NCT02668783|364950529|FG000|Overall Study|Protocol Violation|2|||
105806881|NCT02668783|364950530|FG001|Overall Study|Protocol Violation|1|||
105806882|NCT02668783|364950529|FG000|Overall Study|Study terminated by sponsor|9|||
105806883|NCT02668783|364950530|FG001|Overall Study|Study terminated by sponsor|10|||
105806884|NCT02668783|364950529|FG000|Overall Study|Subject moved|1|||
105806885|NCT02668783|364950530|FG001|Overall Study|Subject moved|0|||
105806886|NCT02668783|364950529|FG000|Overall Study|Withdrawal by Subject|1|||
105806887|NCT02668783|364950530|FG001|Overall Study|Withdrawal by Subject|0|||
105806888|NCT00909727|364950531|FG000|Overall Study|Adverse Event|1|||
105806889|NCT00909727|364950532|FG001|Overall Study|Adverse Event|0|||
105806890|NCT00909727|364950531|FG000|Overall Study|Wrong Genotype|1|||
105806891|NCT00909727|364950532|FG001|Overall Study|Wrong Genotype|0|||
105806892|NCT00909727|364950531|FG000|Overall Study|Withdrawal of Consent|1|||
105806893|NCT00909727|364950532|FG001|Overall Study|Withdrawal of Consent|0|||
105806894|NCT00909727|364950531|FG000|Overall Study|Prohibited Medication|1|||
105806895|NCT00909727|364950532|FG001|Overall Study|Prohibited Medication|0|||
105806896|NCT01296932|364950534|FG000|Overall Study|Dose limiting toxicity|0|||
105806897|NCT01296932|364950535|FG001|Overall Study|Dose limiting toxicity|0|||
105806898|NCT01296932|364950536|FG002|Overall Study|Dose limiting toxicity|0|||
105806899|NCT01296932|364950537|FG003|Overall Study|Dose limiting toxicity|0|||
105806900|NCT01296932|364950538|FG004|Overall Study|Dose limiting toxicity|0|||
105806901|NCT01296932|364950539|FG005|Overall Study|Dose limiting toxicity|0|||
105806902|NCT01296932|364950540|FG006|Overall Study|Dose limiting toxicity|1|||
105806903|NCT01296932|364950541|FG007|Overall Study|Dose limiting toxicity|0|||
105806904|NCT01296932|364950542|FG008|Overall Study|Dose limiting toxicity|1|||
105806905|NCT01296932|364950534|FG000|Overall Study|Progressive disease|2|||
105806906|NCT01296932|364950535|FG001|Overall Study|Progressive disease|0|||
105806907|NCT01296932|364950536|FG002|Overall Study|Progressive disease|1|||
105806908|NCT01296932|364950537|FG003|Overall Study|Progressive disease|1|||
106016899|NCT03847896|365725908|FG003|Overall Study|A severe exacerbation event|0|||
106016900|NCT03847896|365725909|FG004|Overall Study|A severe exacerbation event|3|||
106016901|NCT03847896|365725905|FG000|Overall Study|Protocol Violation|0|||
106016902|NCT03847896|365725906|FG001|Overall Study|Protocol Violation|2|||
106016903|NCT03847896|365725907|FG002|Overall Study|Protocol Violation|1|||
106016904|NCT03847896|365725908|FG003|Overall Study|Protocol Violation|0|||
106016905|NCT03847896|365725909|FG004|Overall Study|Protocol Violation|2|||
106016906|NCT03847896|365725905|FG000|Overall Study|Lost to Follow-up|0|||
106016907|NCT03847896|365725906|FG001|Overall Study|Lost to Follow-up|0|||
106016908|NCT03847896|365725907|FG002|Overall Study|Lost to Follow-up|0|||
106016909|NCT03847896|365725908|FG003|Overall Study|Lost to Follow-up|1|||
105806909|NCT01296932|364950538|FG004|Overall Study|Progressive disease|2|||
105806910|NCT01296932|364950539|FG005|Overall Study|Progressive disease|3|||
106016910|NCT03847896|365725909|FG004|Overall Study|Lost to Follow-up|0|||
105806911|NCT01296932|364950540|FG006|Overall Study|Progressive disease|1|||
105806912|NCT01296932|364950541|FG007|Overall Study|Progressive disease|0|||
105806913|NCT01296932|364950542|FG008|Overall Study|Progressive disease|0|||
105806914|NCT01296932|364950534|FG000|Overall Study|Withdrawal by Subject|0|||
105806915|NCT01296932|364950535|FG001|Overall Study|Withdrawal by Subject|0|||
105806916|NCT01296932|364950536|FG002|Overall Study|Withdrawal by Subject|1|||
105806917|NCT01296932|364950537|FG003|Overall Study|Withdrawal by Subject|1|||
105806918|NCT01296932|364950538|FG004|Overall Study|Withdrawal by Subject|0|||
105806919|NCT01296932|364950539|FG005|Overall Study|Withdrawal by Subject|0|||
105806920|NCT01296932|364950540|FG006|Overall Study|Withdrawal by Subject|3|||
105806921|NCT01296932|364950541|FG007|Overall Study|Withdrawal by Subject|0|||
105806922|NCT01296932|364950542|FG008|Overall Study|Withdrawal by Subject|0|||
105806923|NCT01296932|364950534|FG000|Overall Study|Adverse Event|1|||
105806924|NCT01296932|364950535|FG001|Overall Study|Adverse Event|1|||
105806925|NCT01296932|364950536|FG002|Overall Study|Adverse Event|1|||
105806926|NCT01296932|364950537|FG003|Overall Study|Adverse Event|2|||
105806927|NCT01296932|364950538|FG004|Overall Study|Adverse Event|1|||
105806928|NCT01296932|364950539|FG005|Overall Study|Adverse Event|0|||
105806929|NCT01296932|364950540|FG006|Overall Study|Adverse Event|0|||
105806930|NCT01296932|364950541|FG007|Overall Study|Adverse Event|0|||
105806931|NCT01296932|364950542|FG008|Overall Study|Adverse Event|1|||
105806932|NCT01296932|364950534|FG000|Overall Study|Investigator decision|0|||
105806933|NCT01296932|364950535|FG001|Overall Study|Investigator decision|1|||
105806934|NCT01296932|364950536|FG002|Overall Study|Investigator decision|0|||
105806935|NCT01296932|364950537|FG003|Overall Study|Investigator decision|1|||
105806936|NCT01296932|364950538|FG004|Overall Study|Investigator decision|0|||
105806937|NCT01296932|364950539|FG005|Overall Study|Investigator decision|0|||
105806938|NCT01296932|364950540|FG006|Overall Study|Investigator decision|1|||
105806939|NCT01296932|364950541|FG007|Overall Study|Investigator decision|0|||
105806940|NCT01296932|364950542|FG008|Overall Study|Investigator decision|1|||
105806941|NCT01296932|364950534|FG000|Overall Study|No clinical benefit anymore|0|||
105806942|NCT01296932|364950535|FG001|Overall Study|No clinical benefit anymore|1|||
105806943|NCT01296932|364950536|FG002|Overall Study|No clinical benefit anymore|0|||
105806944|NCT01296932|364950537|FG003|Overall Study|No clinical benefit anymore|0|||
105806945|NCT01296932|364950538|FG004|Overall Study|No clinical benefit anymore|0|||
105806946|NCT01296932|364950539|FG005|Overall Study|No clinical benefit anymore|0|||
105806947|NCT01296932|364950540|FG006|Overall Study|No clinical benefit anymore|0|||
105806948|NCT01296932|364950541|FG007|Overall Study|No clinical benefit anymore|0|||
105806949|NCT01296932|364950542|FG008|Overall Study|No clinical benefit anymore|0|||
105806950|NCT01296932|364950534|FG000|Overall Study|Physician Decision|0|||
105806951|NCT01296932|364950535|FG001|Overall Study|Physician Decision|0|||
105806952|NCT01296932|364950536|FG002|Overall Study|Physician Decision|1|||
105806953|NCT01296932|364950537|FG003|Overall Study|Physician Decision|0|||
105806954|NCT01296932|364950538|FG004|Overall Study|Physician Decision|0|||
105806955|NCT01296932|364950539|FG005|Overall Study|Physician Decision|0|||
105806956|NCT01296932|364950540|FG006|Overall Study|Physician Decision|0|||
105806957|NCT01296932|364950541|FG007|Overall Study|Physician Decision|0|||
105806958|NCT01296932|364950542|FG008|Overall Study|Physician Decision|0|||
105806959|NCT01296932|364950534|FG000|Overall Study|IV problems, administration not possible|0|||
105806960|NCT01296932|364950535|FG001|Overall Study|IV problems, administration not possible|0|||
105806961|NCT01296932|364950536|FG002|Overall Study|IV problems, administration not possible|1|||
105806962|NCT01296932|364950537|FG003|Overall Study|IV problems, administration not possible|0|||
105806963|NCT01296932|364950538|FG004|Overall Study|IV problems, administration not possible|0|||
105806964|NCT01296932|364950539|FG005|Overall Study|IV problems, administration not possible|0|||
105806965|NCT01296932|364950540|FG006|Overall Study|IV problems, administration not possible|0|||
106144136|NCT01430611|366186962|FG000|Overall Study|Withdrawal by Subject|15|||
106144137|NCT01430611|366186963|FG001|Overall Study|Withdrawal by Subject|14|||
106144138|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
106144139|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
105806966|NCT01296932|364950541|FG007|Overall Study|IV problems, administration not possible|0|||
105806967|NCT01296932|364950542|FG008|Overall Study|IV problems, administration not possible|0|||
105806968|NCT01296932|364950534|FG000|Overall Study|per protocol|0|||
105806969|NCT01296932|364950535|FG001|Overall Study|per protocol|0|||
105806970|NCT01296932|364950536|FG002|Overall Study|per protocol|1|||
105806971|NCT01296932|364950537|FG003|Overall Study|per protocol|1|||
105806972|NCT01296932|364950538|FG004|Overall Study|per protocol|0|||
106144140|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
105806973|NCT01296932|364950539|FG005|Overall Study|per protocol|0|||
105806974|NCT01296932|364950540|FG006|Overall Study|per protocol|0|||
105806975|NCT01296932|364950541|FG007|Overall Study|per protocol|0|||
105806976|NCT01296932|364950542|FG008|Overall Study|per protocol|0|||
105806977|NCT01296932|364950534|FG000|Overall Study|Low benefit and too many side effects|0|||
105806978|NCT01296932|364950535|FG001|Overall Study|Low benefit and too many side effects|0|||
105806979|NCT01296932|364950536|FG002|Overall Study|Low benefit and too many side effects|0|||
105952201|NCT03314935|365488192|FG008|Phase 2|Lost to Follow-up|0|||
106144141|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
106144142|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
106144143|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
106144144|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
106144145|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
106144146|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
105760984|NCT00861380|364778098|FG005|Overall Study|Withdrawal Information not recorded|6249|||
105760985|NCT00861380|364778099|FG006|Overall Study|Withdrawal Information not recorded|3020|||
105760986|NCT00659126|364778100|FG000|Overall Study|Adverse Event|2|||
105760987|NCT00659126|364778101|FG001|Overall Study|Adverse Event|2|||
105760988|NCT00659126|364778100|FG000|Overall Study|Screen failure|1|||
105760989|NCT00659126|364778101|FG001|Overall Study|Screen failure|1|||
105760990|NCT00659126|364778100|FG000|Overall Study|Technical problems with MRI|0|||
105760991|NCT00659126|364778101|FG001|Overall Study|Technical problems with MRI|1|||
105760992|NCT02228564|364778102|FG000|Overall Study|Withdrawal by Subject|10|||
105760993|NCT02228564|364778102|FG000|Overall Study|Death|11|||
105760994|NCT02228564|364778102|FG000|Overall Study|Physician Decision|5|||
105760995|NCT02228564|364778102|FG000|Overall Study|Lost to Follow-up|17|||
105760996|NCT02228564|364778102|FG000|Overall Study|Other|6|||
105760997|NCT00637377|364778103|FG000|Overall Study|Adverse Event|2|||
105760998|NCT00637377|364778104|FG001|Overall Study|Adverse Event|6|||
105760999|NCT00637377|364778105|FG002|Overall Study|Adverse Event|8|||
105761000|NCT00637377|364778106|FG003|Overall Study|Adverse Event|9|||
105761001|NCT00637377|364778103|FG000|Overall Study|Death|1|||
105761002|NCT00637377|364778104|FG001|Overall Study|Death|3|||
105761003|NCT00637377|364778105|FG002|Overall Study|Death|2|||
105761004|NCT00637377|364778106|FG003|Overall Study|Death|1|||
105761005|NCT00637377|364778103|FG000|Overall Study|Lack of Efficacy|0|||
105761006|NCT00637377|364778104|FG001|Overall Study|Lack of Efficacy|0|||
105761007|NCT00637377|364778105|FG002|Overall Study|Lack of Efficacy|1|||
105761008|NCT00637377|364778106|FG003|Overall Study|Lack of Efficacy|1|||
105761009|NCT00637377|364778103|FG000|Overall Study|Lost to Follow-up|4|||
105761010|NCT00637377|364778104|FG001|Overall Study|Lost to Follow-up|1|||
105761011|NCT00637377|364778105|FG002|Overall Study|Lost to Follow-up|2|||
105761012|NCT00637377|364778106|FG003|Overall Study|Lost to Follow-up|2|||
105761013|NCT00637377|364778103|FG000|Overall Study|Protocol Violation|2|||
105761014|NCT00637377|364778104|FG001|Overall Study|Protocol Violation|1|||
105761015|NCT00637377|364778105|FG002|Overall Study|Protocol Violation|1|||
105761016|NCT00637377|364778106|FG003|Overall Study|Protocol Violation|0|||
105761017|NCT00637377|364778103|FG000|Overall Study|Withdrawal by Subject|11|||
105761018|NCT00637377|364778104|FG001|Overall Study|Withdrawal by Subject|15|||
105761019|NCT00637377|364778105|FG002|Overall Study|Withdrawal by Subject|13|||
105761020|NCT00637377|364778106|FG003|Overall Study|Withdrawal by Subject|11|||
105761021|NCT00637377|364778103|FG000|Overall Study|Other (no further information available)|7|||
105761022|NCT00637377|364778104|FG001|Overall Study|Other (no further information available)|6|||
105761023|NCT00637377|364778105|FG002|Overall Study|Other (no further information available)|10|||
105761024|NCT00637377|364778106|FG003|Overall Study|Other (no further information available)|5|||
105761025|NCT02925312|364778107|FG000|Overall Study|Lost to Follow-up|25|||
105761026|NCT02925312|364778108|FG001|Overall Study|Lost to Follow-up|0|||
105761027|NCT02925312|364778107|FG000|Overall Study|Adverse Event|2|||
105761028|NCT02925312|364778108|FG001|Overall Study|Adverse Event|0|||
105761029|NCT01455415|364778116|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
105761030|NCT01455415|364778117|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
105761031|NCT01455415|364778116|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
105761032|NCT01455415|364778117|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
105761033|NCT01455415|364778116|FG000|Period 1|Drug Error not Associated to AE|0|||
105761034|NCT01455415|364778117|FG001|Period 1|Drug Error not Associated to AE|1|||
105761035|NCT01455415|364778116|FG000|Period 1|AE Not Related to Study Drug|2|||
105761036|NCT01455415|364778117|FG001|Period 1|AE Not Related to Study Drug|6|||
105761037|NCT01455415|364778116|FG000|Period 1|Withdrawal by Subject|4|||
105761038|NCT01455415|364778117|FG001|Period 1|Withdrawal by Subject|5|||
105761039|NCT01455415|364778116|FG000|Period 1|Unspecified Reason|1|||
105761040|NCT01455415|364778117|FG001|Period 1|Unspecified Reason|1|||
105761041|NCT01455415|364778116|FG000|Period 1|Protocol Violation|0|||
105761042|NCT01455415|364778117|FG001|Period 1|Protocol Violation|2|||
105761043|NCT01455415|364778116|FG000|Washout|AE Related to Study Drug|2|||
105761044|NCT01455415|364778117|FG001|Washout|AE Related to Study Drug|0|||
105761045|NCT01455415|364778116|FG000|Washout|Lost to Follow-up|1|||
105761046|NCT01455415|364778117|FG001|Washout|Lost to Follow-up|0|||
105761047|NCT01455415|364778116|FG000|Washout|Drug Error not Associated to AE|2|||
105761048|NCT01455415|364778117|FG001|Washout|Drug Error not Associated to AE|1|||
105806980|NCT01296932|364950537|FG003|Overall Study|Low benefit and too many side effects|0|||
105761049|NCT01455415|364778116|FG000|Washout|AE Not Related to Study Drug|2|||
105761050|NCT01455415|364778117|FG001|Washout|AE Not Related to Study Drug|3|||
105761051|NCT01455415|364778116|FG000|Washout|Unspecified Reason|1|||
105761052|NCT01455415|364778117|FG001|Washout|Unspecified Reason|2|||
105761053|NCT01455415|364778116|FG000|Washout|Protocol Violation|0|||
105952202|NCT03314935|365488193|FG009|Phase 2|Lost to Follow-up|1|||
105952203|NCT03314935|365488194|FG010|Phase 2|Lost to Follow-up|0|||
105952204|NCT03314935|365488195|FG011|Phase 2|Lost to Follow-up|0|||
105952205|NCT03314935|365488196|FG012|Phase 2|Lost to Follow-up|0|||
105952206|NCT03314935|365488197|FG013|Phase 2|Lost to Follow-up|0|||
105952207|NCT03314935|365488198|FG014|Phase 2|Lost to Follow-up|1|||
105952208|NCT03314935|365488184|FG000|Phase 2|Physician Decision|0|||
105952209|NCT03314935|365488185|FG001|Phase 2|Physician Decision|0|||
105952210|NCT03314935|365488186|FG002|Phase 2|Physician Decision|0|||
105952211|NCT03314935|365488187|FG003|Phase 2|Physician Decision|0|||
105952212|NCT03314935|365488188|FG004|Phase 2|Physician Decision|0|||
105952213|NCT03314935|365488189|FG005|Phase 2|Physician Decision|0|||
105952214|NCT03314935|365488190|FG006|Phase 2|Physician Decision|0|||
105952215|NCT03314935|365488191|FG007|Phase 2|Physician Decision|0|||
105806981|NCT01296932|364950538|FG004|Overall Study|Low benefit and too many side effects|0|||
105806982|NCT01296932|364950539|FG005|Overall Study|Low benefit and too many side effects|0|||
105952216|NCT03314935|365488192|FG008|Phase 2|Physician Decision|0|||
105952217|NCT03314935|365488193|FG009|Phase 2|Physician Decision|0|||
105952218|NCT03314935|365488194|FG010|Phase 2|Physician Decision|1|||
105952219|NCT03314935|365488195|FG011|Phase 2|Physician Decision|0|||
105952220|NCT03314935|365488196|FG012|Phase 2|Physician Decision|0|||
105952221|NCT03314935|365488197|FG013|Phase 2|Physician Decision|0|||
105952222|NCT03314935|365488198|FG014|Phase 2|Physician Decision|0|||
105952223|NCT00699413|365488201|FG000|Overall Study|Withdrawal by Subject|0|||
105952224|NCT00699413|365488202|FG001|Overall Study|Withdrawal by Subject|2|||
105952225|NCT00699413|365488201|FG000|Overall Study|Study terminated by sponsor|4|||
105952226|NCT00699413|365488202|FG001|Overall Study|Study terminated by sponsor|2|||
105952227|NCT00251693|365488203|FG000|Overall Study|Adverse Event|17|||
105952228|NCT00251693|365488204|FG001|Overall Study|Adverse Event|9|||
105952229|NCT00251693|365488205|FG002|Overall Study|Adverse Event|9|||
105952230|NCT00251693|365488203|FG000|Overall Study|Protocol Violation|2|||
105952231|NCT00251693|365488204|FG001|Overall Study|Protocol Violation|0|||
105952232|NCT00251693|365488205|FG002|Overall Study|Protocol Violation|2|||
105952233|NCT00251693|365488203|FG000|Overall Study|Lost to Follow-up|12|||
105952234|NCT00251693|365488204|FG001|Overall Study|Lost to Follow-up|7|||
105952235|NCT00251693|365488205|FG002|Overall Study|Lost to Follow-up|8|||
105952236|NCT00251693|365488203|FG000|Overall Study|Withdrawal by Subject|11|||
105952237|NCT00251693|365488204|FG001|Overall Study|Withdrawal by Subject|17|||
105952238|NCT00251693|365488205|FG002|Overall Study|Withdrawal by Subject|14|||
105952239|NCT00251693|365488203|FG000|Overall Study|Lack of Efficacy|0|||
105806983|NCT01296932|364950540|FG006|Overall Study|Low benefit and too many side effects|0|||
105806984|NCT01296932|364950541|FG007|Overall Study|Low benefit and too many side effects|1|||
105806985|NCT01296932|364950542|FG008|Overall Study|Low benefit and too many side effects|0|||
105806986|NCT01296932|364950534|FG000|Overall Study|No adequate treatment response|0|||
105806987|NCT01296932|364950535|FG001|Overall Study|No adequate treatment response|0|||
105806988|NCT01296932|364950536|FG002|Overall Study|No adequate treatment response|0|||
105806989|NCT01296932|364950537|FG003|Overall Study|No adequate treatment response|0|||
105806990|NCT01296932|364950538|FG004|Overall Study|No adequate treatment response|0|||
105806991|NCT01296932|364950539|FG005|Overall Study|No adequate treatment response|0|||
105806992|NCT01296932|364950540|FG006|Overall Study|No adequate treatment response|0|||
105952240|NCT00251693|365488204|FG001|Overall Study|Lack of Efficacy|1|||
105952241|NCT00251693|365488205|FG002|Overall Study|Lack of Efficacy|0|||
105952242|NCT00251693|365488203|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
105952243|NCT00251693|365488204|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
105952244|NCT00251693|365488205|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
105952245|NCT00251693|365488203|FG000|Overall Study|Noncompliant|0|||
105952246|NCT00251693|365488204|FG001|Overall Study|Noncompliant|0|||
105952247|NCT00251693|365488205|FG002|Overall Study|Noncompliant|2|||
105952248|NCT00251693|365488203|FG000|Overall Study|Possible Barrett's esophagus|3|||
105952249|NCT00251693|365488204|FG001|Overall Study|Possible Barrett's esophagus|5|||
105952250|NCT00251693|365488205|FG002|Overall Study|Possible Barrett's esophagus|2|||
105952251|NCT00251693|365488203|FG000|Overall Study|Subject request/subject unavailable|1|||
105952252|NCT00251693|365488204|FG001|Overall Study|Subject request/subject unavailable|2|||
105952253|NCT00251693|365488205|FG002|Overall Study|Subject request/subject unavailable|0|||
105952254|NCT00251693|365488203|FG000|Overall Study|Abnormal laboratory findings|0|||
105952255|NCT00251693|365488204|FG001|Overall Study|Abnormal laboratory findings|0|||
105952256|NCT00251693|365488205|FG002|Overall Study|Abnormal laboratory findings|1|||
105952257|NCT00442416|365488206|FG000|Overall Study|Adverse Event|4|||
105952258|NCT00442416|365488207|FG001|Overall Study|Adverse Event|1|||
105952259|NCT00442416|365488206|FG000|Overall Study|Death|1|||
105952260|NCT00442416|365488207|FG001|Overall Study|Death|0|||
105952261|NCT00442416|365488206|FG000|Overall Study|Lack of Efficacy|2|||
105952262|NCT00442416|365488207|FG001|Overall Study|Lack of Efficacy|0|||
105952263|NCT00442416|365488206|FG000|Overall Study|Protocol Violation|2|||
105952264|NCT00442416|365488207|FG001|Overall Study|Protocol Violation|3|||
105952265|NCT00442416|365488206|FG000|Overall Study|Withdrew consent|1|||
105952266|NCT00442416|365488207|FG001|Overall Study|Withdrew consent|2|||
105806993|NCT01296932|364950541|FG007|Overall Study|No adequate treatment response|1|||
105806994|NCT01296932|364950542|FG008|Overall Study|No adequate treatment response|0|||
105806995|NCT01296932|364950534|FG000|Overall Study|Dosage already reduced, AE still present|0|||
105761054|NCT01455415|364778117|FG001|Washout|Protocol Violation|1|||
105761055|NCT01455415|364778116|FG000|Period 2|AE Related to Study Drug|1|||
105761056|NCT01455415|364778117|FG001|Period 2|AE Related to Study Drug|2|||
105761057|NCT01455415|364778116|FG000|Period 2|Lost to Follow-up|2|||
105761058|NCT01455415|364778117|FG001|Period 2|Lost to Follow-up|1|||
105761059|NCT01455415|364778116|FG000|Period 2|AE Not Related to Study Drug|2|||
105761060|NCT01455415|364778117|FG001|Period 2|AE Not Related to Study Drug|1|||
105761061|NCT01455415|364778116|FG000|Period 2|Lack of Efficacy|2|||
105761062|NCT01455415|364778117|FG001|Period 2|Lack of Efficacy|0|||
105761063|NCT01455415|364778116|FG000|Period 2|Withdrawal by Subject|2|||
105761064|NCT01455415|364778117|FG001|Period 2|Withdrawal by Subject|3|||
105761065|NCT01455415|364778116|FG000|Period 2|Unspecified Reason|2|||
105761066|NCT01455415|364778117|FG001|Period 2|Unspecified Reason|3|||
105761067|NCT01455415|364778116|FG000|Period 2|Protocol Violation|2|||
105761068|NCT01455415|364778117|FG001|Period 2|Protocol Violation|0|||
105761069|NCT01455415|364778116|FG000|Follow-up|AE Related to Study Drug|0|||
105761070|NCT01455415|364778117|FG001|Follow-up|AE Related to Study Drug|1|||
105761071|NCT01455415|364778116|FG000|Follow-up|Lack of Efficacy|0|||
105761072|NCT01455415|364778117|FG001|Follow-up|Lack of Efficacy|1|||
105761073|NCT01455415|364778116|FG000|Follow-up|Withdrawal by Subject|2|||
105761074|NCT01455415|364778117|FG001|Follow-up|Withdrawal by Subject|0|||
105761075|NCT01455415|364778116|FG000|Follow-up|Unspecified Reason|1|||
105761076|NCT01455415|364778117|FG001|Follow-up|Unspecified Reason|0|||
105761077|NCT03205982|364778118|FG000|Overall Study|Lost to Follow-up|20|||
105761078|NCT03205982|364778119|FG001|Overall Study|Lost to Follow-up|19|||
105761079|NCT03205982|364778118|FG000|Overall Study|Withdrawal by Subject|4|||
105761080|NCT03205982|364778119|FG001|Overall Study|Withdrawal by Subject|3|||
105761081|NCT03205982|364778118|FG000|Overall Study|Withdrawal by PI|0|||
105761082|NCT03205982|364778119|FG001|Overall Study|Withdrawal by PI|1|||
105761083|NCT01496274|364778120|FG000|Overall Study|Protocol Violation|0|||
105761084|NCT01496274|364778121|FG001|Overall Study|Protocol Violation|1|||
105761085|NCT01496274|364778120|FG000|Overall Study|Adverse Event|1|||
105761086|NCT01496274|364778121|FG001|Overall Study|Adverse Event|1|||
105761087|NCT01496274|364778120|FG000|Overall Study|Withdrawal by Subject|2|||
105761088|NCT01496274|364778121|FG001|Overall Study|Withdrawal by Subject|0|||
105761089|NCT01496274|364778120|FG000|Overall Study|Lost to Follow-up|0|||
105761090|NCT01496274|364778121|FG001|Overall Study|Lost to Follow-up|3|||
105761091|NCT01459068|364778125|FG000|Overall Study|Withdrawal by Subject|8|||
105806996|NCT01296932|364950535|FG001|Overall Study|Dosage already reduced, AE still present|0|||
105806997|NCT01296932|364950536|FG002|Overall Study|Dosage already reduced, AE still present|0|||
105806998|NCT01296932|364950537|FG003|Overall Study|Dosage already reduced, AE still present|0|||
105806999|NCT01296932|364950538|FG004|Overall Study|Dosage already reduced, AE still present|0|||
105807000|NCT01296932|364950539|FG005|Overall Study|Dosage already reduced, AE still present|0|||
105807001|NCT01296932|364950540|FG006|Overall Study|Dosage already reduced, AE still present|0|||
105807002|NCT01296932|364950541|FG007|Overall Study|Dosage already reduced, AE still present|0|||
105807003|NCT01296932|364950542|FG008|Overall Study|Dosage already reduced, AE still present|1|||
105807004|NCT02688400|364950547|FG000|Overall Study|Protocol Violation|2|||
105807005|NCT02688400|364950548|FG001|Overall Study|Protocol Violation|5|||
105807006|NCT02688400|364950547|FG000|Overall Study|Lack of Efficacy|7|||
105807007|NCT02688400|364950548|FG001|Overall Study|Lack of Efficacy|7|||
105807008|NCT02688400|364950547|FG000|Overall Study|Adverse Event|21|||
105807009|NCT02688400|364950548|FG001|Overall Study|Adverse Event|12|||
105807010|NCT02688400|364950547|FG000|Overall Study|Withdrawal by Subject|15|||
106016911|NCT03847896|365725905|FG000|Overall Study|Condition under investigation worsened|0|||
106016912|NCT03847896|365725906|FG001|Overall Study|Condition under investigation worsened|0|||
106016913|NCT03847896|365725907|FG002|Overall Study|Condition under investigation worsened|0|||
106016914|NCT03847896|365725908|FG003|Overall Study|Condition under investigation worsened|1|||
106016915|NCT03847896|365725909|FG004|Overall Study|Condition under investigation worsened|1|||
106016916|NCT03847896|365725905|FG000|Overall Study|Lack of Efficacy|0|||
106016917|NCT03847896|365725906|FG001|Overall Study|Lack of Efficacy|0|||
105761092|NCT01459068|364778126|FG001|Overall Study|Withdrawal by Subject|18|||
105761093|NCT01459068|364778125|FG000|Overall Study|Lost to Follow-up|31|||
105807011|NCT02688400|364950548|FG001|Overall Study|Withdrawal by Subject|13|||
105807012|NCT02688400|364950547|FG000|Overall Study|No study medication intake|1|||
106016918|NCT03847896|365725907|FG002|Overall Study|Lack of Efficacy|0|||
105761094|NCT01459068|364778126|FG001|Overall Study|Lost to Follow-up|15|||
105761095|NCT01459068|364778125|FG000|Overall Study|Death|0|||
105761096|NCT01459068|364778126|FG001|Overall Study|Death|1|||
105761097|NCT00196196|364778127|FG000|Overall Study|Withdrawal by Subject|2|||
105761098|NCT00196196|364778127|FG000|Overall Study|Did not have required condition (hydroce|5|||
105761099|NCT02096042|364778128|FG000|Overall Study|Disease Progression|1|||
105761100|NCT02096042|364778129|FG001|Overall Study|Disease Progression|0|||
105761101|NCT02096042|364778130|FG002|Overall Study|Disease Progression|0|||
105807013|NCT02688400|364950548|FG001|Overall Study|No study medication intake|4|||
105807014|NCT02688400|364950547|FG000|Overall Study|Lost to Follow-up|0|||
105807015|NCT02688400|364950548|FG001|Overall Study|Lost to Follow-up|3|||
105807016|NCT01075763|364950551|FG000|Overall Study|Lost to Follow-up|2|||
105807017|NCT01075763|364950552|FG001|Overall Study|Lost to Follow-up|1|||
105807018|NCT01075763|364950551|FG000|Overall Study|Lack of Efficacy|0|||
106144147|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
106144148|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
106144149|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
106144150|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
106144151|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
106144152|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
106144153|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
106144154|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
106144155|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
106144156|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
106144157|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
106144158|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
106144159|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
106144160|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
106144161|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
106144162|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
106144163|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
106144164|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
106144165|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
106144166|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
106144167|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
106144168|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
106144169|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
105807019|NCT01075763|364950552|FG001|Overall Study|Lack of Efficacy|1|||
105807020|NCT01075763|364950551|FG000|Overall Study|Withdrawal by Subject|2|||
105807021|NCT01075763|364950552|FG001|Overall Study|Withdrawal by Subject|2|||
105807022|NCT00124020|364950554|FG000|Overall Study|Death|67|||
105807023|NCT00124020|364950555|FG001|Overall Study|Death|71|||
105807024|NCT00124020|364950554|FG000|Overall Study|Withdrawal by Subject|13|||
105807025|NCT00124020|364950555|FG001|Overall Study|Withdrawal by Subject|11|||
105807026|NCT00124020|364950554|FG000|Overall Study|Lost to Follow-up|5|||
105807027|NCT00124020|364950555|FG001|Overall Study|Lost to Follow-up|8|||
105807028|NCT00124020|364950554|FG000|Overall Study|Other|1|||
105807029|NCT00124020|364950555|FG001|Overall Study|Other|1|||
105807030|NCT00124020|364950554|FG000|Overall Study|Transfer to another hospital|2|||
105807031|NCT00124020|364950555|FG001|Overall Study|Transfer to another hospital|0|||
105807032|NCT00268346|364950557|FG000|Overall Study|Adverse Event|0|||
105807033|NCT00268346|364950558|FG001|Overall Study|Adverse Event|1|||
105807034|NCT00268346|364950557|FG000|Overall Study|Death|0|||
105807035|NCT00268346|364950558|FG001|Overall Study|Death|1|||
105807036|NCT00268346|364950557|FG000|Overall Study|Withdrawal by Subject|0|||
105807037|NCT00268346|364950558|FG001|Overall Study|Withdrawal by Subject|1|||
105807038|NCT01751412|364950559|FG000|Overall Study|Disease Progression Before Treatment|1|||
105807039|NCT01673009|364950560|FG000|Overall Study|Physician Decision|5|||
105807040|NCT01673009|364950560|FG000|Overall Study|Withdrawal by Subject|8|||
105807041|NCT04161144|364950563|FG000|Overall Study|Withdrawal by Subject|0|||
105807042|NCT04161144|364950564|FG001|Overall Study|Withdrawal by Subject|1|||
105807043|NCT04161144|364950563|FG000|Overall Study|Protocol Violation|1|||
105807044|NCT04161144|364950564|FG001|Overall Study|Protocol Violation|0|||
105807045|NCT00449072|364950565|FG000|Overall Study|Adverse Event|3|||
105807046|NCT00449072|364950566|FG001|Overall Study|Adverse Event|1|||
105807047|NCT00449072|364950565|FG000|Overall Study|Protocol Violation|14|||
105807048|NCT00449072|364950566|FG001|Overall Study|Protocol Violation|12|||
105807049|NCT00449072|364950565|FG000|Overall Study|Lost to Follow-up|5|||
105807050|NCT00449072|364950566|FG001|Overall Study|Lost to Follow-up|7|||
105807051|NCT00449072|364950565|FG000|Overall Study|Withdrawal by Subject|11|||
105807052|NCT00449072|364950566|FG001|Overall Study|Withdrawal by Subject|8|||
105807053|NCT00449072|364950565|FG000|Overall Study|Lack of Efficacy|1|||
105807054|NCT00449072|364950566|FG001|Overall Study|Lack of Efficacy|1|||
105807055|NCT00449072|364950565|FG000|Overall Study|Physician Decision|1|||
105807056|NCT00449072|364950566|FG001|Overall Study|Physician Decision|0|||
105807057|NCT00449072|364950565|FG000|Overall Study|Not treated|0|||
105807058|NCT00449072|364950566|FG001|Overall Study|Not treated|1|||
105807059|NCT00449072|364950565|FG000|Overall Study|Excluded medication|0|||
105807060|NCT00449072|364950566|FG001|Overall Study|Excluded medication|2|||
105807061|NCT00449072|364950565|FG000|Overall Study|Non-compliance|2|||
105807062|NCT00449072|364950566|FG001|Overall Study|Non-compliance|5|||
105807063|NCT00449072|364950565|FG000|Overall Study|Sponsor decision|1|||
105807064|NCT00449072|364950566|FG001|Overall Study|Sponsor decision|3|||
105807065|NCT00449072|364950565|FG000|Overall Study|Relocation|3|||
105807066|NCT00449072|364950566|FG001|Overall Study|Relocation|2|||
105807067|NCT00576901|364950576|FG000|Overall Study|Withdrawal by Subject|1|||
105807068|NCT00576901|364950576|FG000|Overall Study|Disease course|1|||
105807069|NCT00576901|364950576|FG000|Overall Study|Protocol Violation|1|||
105807070|NCT01259869|364950577|FG000|Overall Study|Duplicated registration|1|||
105807071|NCT01333033|364950578|FG000|Overall Study|Ineligible|0|||
105807072|NCT01333033|364950579|FG001|Overall Study|Ineligible|0|||
105807073|NCT01333033|364950580|FG002|Overall Study|Ineligible|0|||
105807074|NCT01333033|364950581|FG003|Overall Study|Ineligible|0|||
105807075|NCT01333033|364950582|FG004|Overall Study|Ineligible|6|||
105807076|NCT01333033|364950583|FG005|Overall Study|Ineligible|8|||
105807077|NCT01333033|364950578|FG000|Overall Study|Withdrawal by Subject|0|||
105807078|NCT01333033|364950579|FG001|Overall Study|Withdrawal by Subject|0|||
105807079|NCT01333033|364950580|FG002|Overall Study|Withdrawal by Subject|0|||
105807080|NCT01333033|364950581|FG003|Overall Study|Withdrawal by Subject|0|||
105807081|NCT01333033|364950582|FG004|Overall Study|Withdrawal by Subject|4|||
105807082|NCT01333033|364950583|FG005|Overall Study|Withdrawal by Subject|2|||
105807083|NCT01333033|364950578|FG000|Overall Study|PET inevaluable|0|||
105807084|NCT01333033|364950579|FG001|Overall Study|PET inevaluable|0|||
105807085|NCT01333033|364950580|FG002|Overall Study|PET inevaluable|0|||
105807086|NCT01333033|364950581|FG003|Overall Study|PET inevaluable|0|||
105807087|NCT01333033|364950582|FG004|Overall Study|PET inevaluable|2|||
105807088|NCT01333033|364950583|FG005|Overall Study|PET inevaluable|4|||
105807089|NCT01333033|364950578|FG000|Overall Study|Adverse Event|0|||
105807090|NCT01333033|364950579|FG001|Overall Study|Adverse Event|0|||
105807091|NCT01333033|364950580|FG002|Overall Study|Adverse Event|0|||
105807092|NCT01333033|364950581|FG003|Overall Study|Adverse Event|0|||
105807093|NCT01333033|364950582|FG004|Overall Study|Adverse Event|2|||
105807094|NCT01333033|364950583|FG005|Overall Study|Adverse Event|1|||
105807095|NCT01333033|364950578|FG000|Overall Study|Progression|0|||
105807096|NCT01333033|364950579|FG001|Overall Study|Progression|0|||
105807097|NCT01333033|364950580|FG002|Overall Study|Progression|0|||
105807098|NCT01333033|364950581|FG003|Overall Study|Progression|0|||
105807099|NCT01333033|364950582|FG004|Overall Study|Progression|0|||
105807100|NCT01333033|364950583|FG005|Overall Study|Progression|1|||
105807101|NCT01333033|364950578|FG000|Overall Study|MD Decision|0|||
105807102|NCT01333033|364950579|FG001|Overall Study|MD Decision|0|||
105807103|NCT01333033|364950580|FG002|Overall Study|MD Decision|0|||
105807104|NCT01333033|364950581|FG003|Overall Study|MD Decision|0|||
105807105|NCT01333033|364950582|FG004|Overall Study|MD Decision|0|||
105807106|NCT01333033|364950583|FG005|Overall Study|MD Decision|2|||
105807107|NCT03687125|364950584|FG000|Overall Study|Progressive Disease|2|||
105807108|NCT03687125|364950585|FG001|Overall Study|Progressive Disease|1|||
105807109|NCT03687125|364950584|FG000|Overall Study|Protocol Violation|1|||
105807110|NCT03687125|364950585|FG001|Overall Study|Protocol Violation|0|||
105807111|NCT05034731|364950586|FG000|Overall Study|Screen fail|1|||
105807112|NCT05034731|364950587|FG001|Overall Study|Screen fail|1|||
105807113|NCT00113490|364950588|FG000|Overall Study|Withdrawal by Subject|1|||
105807114|NCT00113490|364950589|FG001|Overall Study|Withdrawal by Subject|3|||
105807115|NCT00113490|364950588|FG000|Overall Study|Lost to Follow-up|1|||
105807116|NCT00113490|364950589|FG001|Overall Study|Lost to Follow-up|0|||
105807117|NCT02040766|364950590|FG000|Overall Study|Adverse Event|1|||
106016919|NCT03847896|365725908|FG003|Overall Study|Lack of Efficacy|2|||
106016920|NCT03847896|365725909|FG004|Overall Study|Lack of Efficacy|2|||
106016921|NCT03847896|365725905|FG000|Overall Study|Other reasons|3|||
106016922|NCT03847896|365725906|FG001|Overall Study|Other reasons|3|||
106016923|NCT03847896|365725907|FG002|Overall Study|Other reasons|1|||
105807118|NCT02040766|364950591|FG001|Overall Study|Adverse Event|1|||
105807119|NCT02040766|364950592|FG002|Overall Study|Adverse Event|1|||
105807120|NCT02040766|364950593|FG003|Overall Study|Adverse Event|0|||
105807121|NCT02040766|364950594|FG004|Overall Study|Adverse Event|2|||
105807122|NCT02040766|364950590|FG000|Overall Study|Withdrawal by Subject|4|||
105807123|NCT02040766|364950591|FG001|Overall Study|Withdrawal by Subject|3|||
105807124|NCT02040766|364950592|FG002|Overall Study|Withdrawal by Subject|2|||
105807125|NCT02040766|364950593|FG003|Overall Study|Withdrawal by Subject|3|||
105807126|NCT02040766|364950594|FG004|Overall Study|Withdrawal by Subject|2|||
105807127|NCT02040766|364950590|FG000|Overall Study|Non-compliance|0|||
105807128|NCT02040766|364950591|FG001|Overall Study|Non-compliance|1|||
105807129|NCT02040766|364950592|FG002|Overall Study|Non-compliance|0|||
105807130|NCT02040766|364950593|FG003|Overall Study|Non-compliance|0|||
105807131|NCT02040766|364950594|FG004|Overall Study|Non-compliance|0|||
106016924|NCT03847896|365725908|FG003|Overall Study|Other reasons|2|||
105807132|NCT02040766|364950590|FG000|Overall Study|Protocol Violation|2|||
105807133|NCT02040766|364950591|FG001|Overall Study|Protocol Violation|1|||
105807134|NCT02040766|364950592|FG002|Overall Study|Protocol Violation|2|||
105807135|NCT02040766|364950593|FG003|Overall Study|Protocol Violation|3|||
105807136|NCT02040766|364950594|FG004|Overall Study|Protocol Violation|0|||
105807137|NCT02040766|364950590|FG000|Overall Study|Lost to Follow-up|4|||
105807138|NCT02040766|364950591|FG001|Overall Study|Lost to Follow-up|1|||
105807139|NCT02040766|364950592|FG002|Overall Study|Lost to Follow-up|3|||
105807140|NCT02040766|364950593|FG003|Overall Study|Lost to Follow-up|1|||
105807141|NCT02040766|364950594|FG004|Overall Study|Lost to Follow-up|4|||
105807142|NCT02040766|364950590|FG000|Overall Study|Not reported|1|||
105807143|NCT02040766|364950591|FG001|Overall Study|Not reported|0|||
105807144|NCT02040766|364950592|FG002|Overall Study|Not reported|0|||
105807145|NCT02040766|364950593|FG003|Overall Study|Not reported|0|||
105807146|NCT02040766|364950594|FG004|Overall Study|Not reported|0|||
105807147|NCT02040766|364950590|FG000|Overall Study|Lack of Efficacy|6|||
105807148|NCT02040766|364950591|FG001|Overall Study|Lack of Efficacy|3|||
105807149|NCT02040766|364950592|FG002|Overall Study|Lack of Efficacy|4|||
105807150|NCT02040766|364950593|FG003|Overall Study|Lack of Efficacy|6|||
105807151|NCT02040766|364950594|FG004|Overall Study|Lack of Efficacy|5|||
105807152|NCT02970669|364950598|FG000|Double-blind Period|Adverse Event|4|||
105807153|NCT02970669|364950599|FG001|Double-blind Period|Adverse Event|0|||
105807154|NCT02970669|364950598|FG000|Double-blind Period|Death|1|||
105807155|NCT02970669|364950599|FG001|Double-blind Period|Death|0|||
105807156|NCT02970669|364950598|FG000|Double-blind Period|Study terminated by sponsor|1|||
105807157|NCT02970669|364950599|FG001|Double-blind Period|Study terminated by sponsor|2|||
105807158|NCT02970669|364950598|FG000|Double-blind Period|Physician Decision|0|||
105807159|NCT02970669|364950599|FG001|Double-blind Period|Physician Decision|2|||
105807160|NCT02970669|364950598|FG000|Double-blind Period|Withdrawal by Subject|2|||
105807161|NCT02970669|364950599|FG001|Double-blind Period|Withdrawal by Subject|2|||
105807162|NCT02970669|364950598|FG000|Open-label Period|Withdrawal by Subject|2|||
105807163|NCT02970669|364950599|FG001|Open-label Period|Withdrawal by Subject|2|||
105807164|NCT02970669|364950598|FG000|Open-label Period|Adverse Event|1|||
105807165|NCT02970669|364950599|FG001|Open-label Period|Adverse Event|0|||
105807166|NCT02970669|364950598|FG000|Open-label Period|Physician Decision|1|||
105807167|NCT02970669|364950599|FG001|Open-label Period|Physician Decision|0|||
105807168|NCT00876733|364950600|FG000|Overall Study|Adverse Event|34|||
105807169|NCT00876733|364950601|FG001|Overall Study|Adverse Event|20|||
105807170|NCT00876733|364950602|FG002|Overall Study|Adverse Event|10|||
105807171|NCT00876733|364950603|FG003|Overall Study|Adverse Event|3|||
105807172|NCT00876733|364950600|FG000|Overall Study|Lack of Efficacy|17|||
105807173|NCT00876733|364950601|FG001|Overall Study|Lack of Efficacy|9|||
105807174|NCT00876733|364950602|FG002|Overall Study|Lack of Efficacy|10|||
105807175|NCT00876733|364950603|FG003|Overall Study|Lack of Efficacy|1|||
105807176|NCT00876733|364950600|FG000|Overall Study|Lost to Follow-up|26|||
105807177|NCT00876733|364950601|FG001|Overall Study|Lost to Follow-up|10|||
105807178|NCT00876733|364950602|FG002|Overall Study|Lost to Follow-up|3|||
105807179|NCT00876733|364950603|FG003|Overall Study|Lost to Follow-up|2|||
105807180|NCT00876733|364950600|FG000|Overall Study|Data not available|14|||
105807181|NCT00876733|364950601|FG001|Overall Study|Data not available|3|||
105807182|NCT00876733|364950602|FG002|Overall Study|Data not available|7|||
105807183|NCT00876733|364950603|FG003|Overall Study|Data not available|1|||
105807184|NCT01564758|364950604|FG000|Overall Study|Death|8|||
105807185|NCT01564758|364950604|FG000|Overall Study|Adverse Event|3|||
105807186|NCT01564758|364950604|FG000|Overall Study|Other|3|||
105807187|NCT00601354|364950607|FG000|Overall Study|Lost to Follow-up|4|||
105807188|NCT00601354|364950608|FG001|Overall Study|Lost to Follow-up|5|||
105807189|NCT02486796|364950612|FG000|Overall Study|Withdrawal by Subject|1|||
105807190|NCT02486796|364950613|FG001|Overall Study|Withdrawal by Subject|1|||
105807191|NCT02486796|364950612|FG000|Overall Study|Physician Decision|1|||
105807192|NCT02486796|364950613|FG001|Overall Study|Physician Decision|0|||
105807193|NCT02041702|364950615|FG000|Overall Study|Lost to Follow-up|1|||
105807194|NCT02041702|364950616|FG001|Overall Study|Lost to Follow-up|6|||
105807195|NCT02041702|364950615|FG000|Overall Study|Death|4|||
105807196|NCT02041702|364950616|FG001|Overall Study|Death|0|||
105807197|NCT02041702|364950615|FG000|Overall Study|Withdrawal by Subject|4|||
105807198|NCT02041702|364950616|FG001|Overall Study|Withdrawal by Subject|3|||
105807199|NCT02041702|364950615|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
105807200|NCT02041702|364950616|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
105807201|NCT02041702|364950615|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
105807202|NCT02041702|364950616|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
105807203|NCT01855126|364950617|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
106016925|NCT03847896|365725909|FG004|Overall Study|Other reasons|1|||
106016926|NCT00118417|365725910|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
105807204|NCT01855126|364950618|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
105807205|NCT01855126|364950617|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
105807206|NCT01855126|364950618|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
105807207|NCT02308111|364950619|FG000|Overall Study|Adverse Event|31|||
106016927|NCT00118417|365725911|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
105807208|NCT02308111|364950620|FG001|Overall Study|Adverse Event|19|||
105807209|NCT02308111|364950619|FG000|Overall Study|Death|9|||
105807210|NCT02308111|364950620|FG001|Overall Study|Death|6|||
105807211|NCT02308111|364950619|FG000|Overall Study|Lost to Follow-up|2|||
105807212|NCT02308111|364950620|FG001|Overall Study|Lost to Follow-up|7|||
105807213|NCT02308111|364950619|FG000|Overall Study|Physician Decision|6|||
105807214|NCT02308111|364950620|FG001|Overall Study|Physician Decision|17|||
105807215|NCT02308111|364950619|FG000|Overall Study|Protocol Violation|0|||
105807216|NCT02308111|364950620|FG001|Overall Study|Protocol Violation|1|||
105807217|NCT02308111|364950619|FG000|Overall Study|Withdrawal by Subject|28|||
105807218|NCT02308111|364950620|FG001|Overall Study|Withdrawal by Subject|38|||
105807219|NCT02308111|364950619|FG000|Overall Study|Study Terminated by Sponsor|72|||
105807220|NCT02308111|364950620|FG001|Overall Study|Study Terminated by Sponsor|61|||
105807221|NCT02308111|364950619|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
105807222|NCT02308111|364950620|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
105807223|NCT02308111|364950619|FG000|Overall Study|Site Closure|3|||
105807224|NCT02308111|364950620|FG001|Overall Study|Site Closure|3|||
105807225|NCT02308111|364950619|FG000|Overall Study|Non-compliance with Study Drug|3|||
105807226|NCT02308111|364950620|FG001|Overall Study|Non-compliance with Study Drug|1|||
105807227|NCT02308111|364950619|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
105807228|NCT02308111|364950620|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
105807229|NCT02308111|364950619|FG000|Overall Study|Liver Transplant|3|||
105807230|NCT02308111|364950620|FG001|Overall Study|Liver Transplant|3|||
105807231|NCT02308111|364950619|FG000|Overall Study|Liver Transplant Waitlist|2|||
105807232|NCT02308111|364950620|FG001|Overall Study|Liver Transplant Waitlist|2|||
105807233|NCT02308111|364950619|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
105807234|NCT02308111|364950620|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
105807235|NCT00576199|364950623|FG000|Overall Study|Adverse Event|12|||
105807236|NCT00576199|364950623|FG000|Overall Study|Insufficient Therapeutic Response|14|||
105807237|NCT00576199|364950623|FG000|Overall Study|Refused Treatment|2|||
105807238|NCT00576199|364950623|FG000|Overall Study|Reason Unspecified|2|||
105807239|NCT01463683|364950627|FG000|Overall Study|Adverse Event|2|||
105807240|NCT01463683|364950628|FG001|Overall Study|Adverse Event|0|||
105807241|NCT01463683|364950629|FG002|Overall Study|Adverse Event|0|||
105807242|NCT01463683|364950627|FG000|Overall Study|Lost to Follow-up|10|||
105807243|NCT01463683|364950628|FG001|Overall Study|Lost to Follow-up|9|||
105807244|NCT01463683|364950629|FG002|Overall Study|Lost to Follow-up|7|||
105807245|NCT01463683|364950627|FG000|Overall Study|Physician Decision|0|||
105807246|NCT01463683|364950628|FG001|Overall Study|Physician Decision|3|||
105807247|NCT01463683|364950629|FG002|Overall Study|Physician Decision|1|||
105807248|NCT01463683|364950627|FG000|Overall Study|Pregnancy|2|||
105807249|NCT01463683|364950628|FG001|Overall Study|Pregnancy|2|||
105807250|NCT01463683|364950629|FG002|Overall Study|Pregnancy|1|||
105807251|NCT01463683|364950627|FG000|Overall Study|Withdrawal by Subject|5|||
105807252|NCT01463683|364950628|FG001|Overall Study|Withdrawal by Subject|17|||
105807253|NCT01463683|364950629|FG002|Overall Study|Withdrawal by Subject|2|||
105807254|NCT01618305|364950630|FG000|Overall Study|Death|0|||
105807255|NCT01618305|364950631|FG001|Overall Study|Death|1|||
105807256|NCT01618305|364950630|FG000|Overall Study|Lost to Follow-up|11|||
105807257|NCT01618305|364950631|FG001|Overall Study|Lost to Follow-up|7|||
105807258|NCT01618305|364950630|FG000|Overall Study|Protocol Violation|1|||
105807259|NCT01618305|364950631|FG001|Overall Study|Protocol Violation|0|||
105807260|NCT01618305|364950630|FG000|Overall Study|Withdrawal by Subject|3|||
105807261|NCT01618305|364950631|FG001|Overall Study|Withdrawal by Subject|2|||
105807262|NCT02708277|364950632|FG000|Overall Study|Lost to Follow-up|7|||
105807263|NCT02708277|364950633|FG001|Overall Study|Lost to Follow-up|4|||
105807264|NCT00911859|364950634|FG000|Treatment Period|Adverse Event|3|||
105807265|NCT00911859|364950635|FG001|Treatment Period|Adverse Event|3|||
105807266|NCT00911859|364950636|FG002|Treatment Period|Adverse Event|7|||
105807267|NCT00911859|364950634|FG000|Treatment Period|Death|1|||
105807268|NCT00911859|364950635|FG001|Treatment Period|Death|3|||
105807269|NCT00911859|364950636|FG002|Treatment Period|Death|5|||
105807270|NCT00911859|364950634|FG000|Treatment Period|Lack of Efficacy|1|||
105807271|NCT00911859|364950635|FG001|Treatment Period|Lack of Efficacy|7|||
105807272|NCT00911859|364950636|FG002|Treatment Period|Lack of Efficacy|5|||
105807273|NCT00911859|364950634|FG000|Treatment Period|Physician Decision|3|||
105807274|NCT00911859|364950635|FG001|Treatment Period|Physician Decision|3|||
105807275|NCT00911859|364950636|FG002|Treatment Period|Physician Decision|3|||
105807276|NCT00911859|364950634|FG000|Treatment Period|Withdrawal by Subject|0|||
105807277|NCT00911859|364950635|FG001|Treatment Period|Withdrawal by Subject|4|||
105807278|NCT00911859|364950636|FG002|Treatment Period|Withdrawal by Subject|5|||
105807279|NCT00911859|364950634|FG000|Treatment Period|Did not receive study treatment|0|||
105807280|NCT00911859|364950635|FG001|Treatment Period|Did not receive study treatment|1|||
105807281|NCT00911859|364950636|FG002|Treatment Period|Did not receive study treatment|0|||
105807282|NCT00911859|364950634|FG000|Maintainance Period|Lack of Efficacy|0|||
105807283|NCT00911859|364950635|FG001|Maintainance Period|Lack of Efficacy|0|||
105807284|NCT00911859|364950636|FG002|Maintainance Period|Lack of Efficacy|9|||
105807285|NCT00911859|364950634|FG000|Maintainance Period|Physician Decision|0|||
105807286|NCT00911859|364950635|FG001|Maintainance Period|Physician Decision|0|||
105807287|NCT00911859|364950636|FG002|Maintainance Period|Physician Decision|9|||
105807288|NCT00911859|364950634|FG000|Maintainance Period|Withdrawal by Subject|0|||
105807289|NCT00911859|364950635|FG001|Maintainance Period|Withdrawal by Subject|0|||
105807290|NCT00911859|364950636|FG002|Maintainance Period|Withdrawal by Subject|3|||
105807291|NCT00911859|364950634|FG000|Follow-up Period|Death|5|||
106144170|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
106144171|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
106144172|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
105807292|NCT00911859|364950635|FG001|Follow-up Period|Death|8|||
105807293|NCT00911859|364950636|FG002|Follow-up Period|Death|10|||
105807294|NCT00911859|364950634|FG000|Follow-up Period|Lost to Follow-up|1|||
105807295|NCT00911859|364950635|FG001|Follow-up Period|Lost to Follow-up|1|||
105807296|NCT00911859|364950636|FG002|Follow-up Period|Lost to Follow-up|0|||
105807297|NCT00911859|364950634|FG000|Follow-up Period|Withdrawal by Subject|0|||
105807298|NCT00911859|364950635|FG001|Follow-up Period|Withdrawal by Subject|4|||
105807299|NCT00911859|364950636|FG002|Follow-up Period|Withdrawal by Subject|4|||
105807300|NCT00911859|364950634|FG000|Follow-up Period|Study terminated by sponsor|5|||
105807301|NCT00911859|364950635|FG001|Follow-up Period|Study terminated by sponsor|33|||
105807302|NCT00911859|364950636|FG002|Follow-up Period|Study terminated by sponsor|27|||
106144173|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
106144174|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
106144175|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
105807303|NCT03538756|364950637|FG000|Long-Term Follow-up|Adverse Event|0|||
105807304|NCT03538756|364950638|FG001|Long-Term Follow-up|Adverse Event|0|||
105807305|NCT03538756|364950639|FG002|Long-Term Follow-up|Adverse Event|6|||
105807306|NCT03538756|364950637|FG000|Long-Term Follow-up|Death|0|||
105807307|NCT03538756|364950638|FG001|Long-Term Follow-up|Death|0|||
105807308|NCT03538756|364950639|FG002|Long-Term Follow-up|Death|1|||
105807309|NCT03538756|364950637|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
105807310|NCT03538756|364950638|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
105807311|NCT03538756|364950639|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
105807312|NCT03538756|364950637|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
105807313|NCT03538756|364950638|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
105807314|NCT03538756|364950639|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
105807315|NCT03538756|364950637|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
105807316|NCT03538756|364950638|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
105807317|NCT03538756|364950639|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
105807318|NCT01497938|364950642|FG000|Overall Study|Adverse Event|0|||
105807319|NCT01497938|364950643|FG001|Overall Study|Adverse Event|1|||
105807320|NCT01497938|364950642|FG000|Overall Study|Physician Decision|0|||
105807321|NCT01497938|364950643|FG001|Overall Study|Physician Decision|1|||
105807322|NCT01497938|364950642|FG000|Overall Study|Withdrawal by Subject|4|||
105807323|NCT01497938|364950643|FG001|Overall Study|Withdrawal by Subject|0|||
105807324|NCT01497938|364950642|FG000|Overall Study|Device Violation|1|||
105807325|NCT01497938|364950643|FG001|Overall Study|Device Violation|0|||
105807326|NCT03433001|364952066|FG000|Overall Study|Lack of Efficacy|109|||
105807327|NCT03433001|364952066|FG000|Overall Study|Adverse Event|69|||
105807328|NCT03433001|364952066|FG000|Overall Study|Withdrawal by Subject|10|||
105807329|NCT03433001|364952066|FG000|Overall Study|Death|12|||
105807330|NCT03433001|364952066|FG000|Overall Study|Lost to Follow-up|4|||
105807331|NCT03433001|364952066|FG000|Overall Study|Other|25|||
105807332|NCT00289458|364952067|FG000|Overall Study|Death|1|||
105807333|NCT00289458|364952068|FG001|Overall Study|Death|0|||
105807334|NCT00289458|364952069|FG002|Overall Study|Death|0|||
105807335|NCT00289458|364952067|FG000|Overall Study|Physician Decision|3|||
105807336|NCT00289458|364952068|FG001|Overall Study|Physician Decision|4|||
105807337|NCT00289458|364952069|FG002|Overall Study|Physician Decision|2|||
105807338|NCT00289458|364952067|FG000|Overall Study|Withdrawal by Subject|2|||
105807339|NCT00289458|364952068|FG001|Overall Study|Withdrawal by Subject|2|||
105807340|NCT00289458|364952069|FG002|Overall Study|Withdrawal by Subject|4|||
105807341|NCT01007916|364952073|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
105807342|NCT01007916|364952074|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
105807343|NCT01007916|364952073|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
105807344|NCT01007916|364952074|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
105807345|NCT00387712|364952075|FG000|Overall Study|Physician Decision|6|||
105807346|NCT00387712|364952076|FG001|Overall Study|Physician Decision|4|||
105807347|NCT00387712|364952075|FG000|Overall Study|Lost to Follow-up|17|||
105807348|NCT00387712|364952076|FG001|Overall Study|Lost to Follow-up|20|||
105807349|NCT00387712|364952075|FG000|Overall Study|Withdrawal by Subject|6|||
106144176|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
105807350|NCT00387712|364952076|FG001|Overall Study|Withdrawal by Subject|12|||
105807351|NCT00322556|364952077|FG000|Overall Study|Adverse Event|1|||
105807352|NCT00322556|364952077|FG000|Overall Study|Withdrawal by Subject|1|||
105807353|NCT00322556|364952077|FG000|Overall Study|Lost to Follow-up|3|||
105807354|NCT00322556|364952077|FG000|Overall Study|Other Reason|7|||
105807355|NCT02040428|364952078|FG000|Overall Study|Death|4|||
105807356|NCT02040428|364952079|FG001|Overall Study|Death|3|||
105807357|NCT02040428|364952078|FG000|Overall Study|Withdrawal by Subject|1|||
105807358|NCT02040428|364952079|FG001|Overall Study|Withdrawal by Subject|1|||
105807359|NCT00901628|364952080|FG000|Overall Study|disconnection of catheter|4|||
105807360|NCT00901628|364952081|FG001|Overall Study|disconnection of catheter|8|||
105807361|NCT00901628|364952080|FG000|Overall Study|disconnection of drain|0|||
105807362|NCT00901628|364952081|FG001|Overall Study|disconnection of drain|1|||
105807363|NCT00901628|364952080|FG000|Overall Study|peroneal nerve palsy|0|||
105807364|NCT00901628|364952081|FG001|Overall Study|peroneal nerve palsy|1|||
105807365|NCT01927757|364952082|FG000|Overall Study|Withdrawal by Subject|14|||
105807366|NCT01927757|364952082|FG000|Overall Study|Lost to Follow-up|2|||
105807367|NCT01927757|364952082|FG000|Overall Study|Decision by Sponsor|2|||
105807368|NCT01927757|364952082|FG000|Overall Study|Other|1|||
105807369|NCT01927757|364952082|FG000|Overall Study|Ethical Reasons|4|||
105807370|NCT04480463|364952083|FG000|Overall Study|Death|0|||
105807371|NCT04480463|364952084|FG001|Overall Study|Death|1|||
105807372|NCT04480463|364952083|FG000|Overall Study|Adverse Event|6|||
105807373|NCT04480463|364952084|FG001|Overall Study|Adverse Event|8|||
105807374|NCT04480463|364952083|FG000|Overall Study|Lost to Follow-up|3|||
105807375|NCT04480463|364952084|FG001|Overall Study|Lost to Follow-up|2|||
105807376|NCT04480463|364952083|FG000|Overall Study|Physician Decision|2|||
105807377|NCT04480463|364952084|FG001|Overall Study|Physician Decision|5|||
105807378|NCT04480463|364952083|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
105807379|NCT04480463|364952084|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
105807380|NCT04480463|364952083|FG000|Overall Study|Protocol Violation|2|||
105807381|NCT04480463|364952084|FG001|Overall Study|Protocol Violation|1|||
105807382|NCT04480463|364952083|FG000|Overall Study|Withdrawal by Subject|6|||
105807383|NCT04480463|364952084|FG001|Overall Study|Withdrawal by Subject|7|||
105807384|NCT04480463|364952083|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
105807385|NCT04480463|364952084|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
105807386|NCT04480463|364952083|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
105807387|NCT04480463|364952084|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
105807388|NCT04480463|364952083|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
105807389|NCT04480463|364952084|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
105807390|NCT04480463|364952083|FG000|Overall Study|Other|6|||
105807391|NCT04480463|364952084|FG001|Overall Study|Other|4|||
105807392|NCT01691859|364952086|FG000|Overall Study|Adverse Event|19|||
105807393|NCT01691859|364952086|FG000|Overall Study|Lack of Efficacy|11|||
105807394|NCT01691859|364952086|FG000|Overall Study|Protocol Violation|4|||
105807395|NCT01691859|364952086|FG000|Overall Study|Product commercially available|221|||
105807396|NCT01691859|364952086|FG000|Overall Study|Study closed/terminated|50|||
105807397|NCT01691859|364952086|FG000|Overall Study|Lost to Follow-up|5|||
105807398|NCT01691859|364952086|FG000|Overall Study|Physician Decision|6|||
105807399|NCT01691859|364952086|FG000|Overall Study|Withdrawal by Subject|31|||
105807400|NCT02295774|364952087|FG000|Overall Study|Physician Decision|1|||
105807401|NCT02295774|364952087|FG000|Overall Study|Withdrawal by Subject|2|||
105807402|NCT02710071|364952092|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
105807403|NCT02710071|364952093|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
105807404|NCT02710071|364952092|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
105807405|NCT02710071|364952093|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
105807406|NCT03731182|364952096|FG000|Overall Study|Lost to Follow-up|2|||
105807407|NCT03731182|364952097|FG001|Overall Study|Lost to Follow-up|0|||
105807408|NCT03731182|364952096|FG000|Overall Study|Physician Decision|1|||
105807409|NCT03731182|364952097|FG001|Overall Study|Physician Decision|0|||
105807410|NCT03731182|364952096|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
105807411|NCT03731182|364952097|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
105807412|NCT02637557|364952098|FG000|Overall Study|Adverse Event|3|||
105807413|NCT02637557|364952099|FG001|Overall Study|Adverse Event|1|||
105807414|NCT02637557|364952100|FG002|Overall Study|Adverse Event|3|||
105807415|NCT02637557|364952101|FG003|Overall Study|Adverse Event|3|||
106144177|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
106144178|NCT02709655|366186965|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
106144179|NCT02709655|366186966|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
106144180|NCT02709655|366186967|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
106144181|NCT02709655|366186968|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
106144182|NCT02709655|366186969|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
106144183|NCT02709655|366186965|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
106144184|NCT02709655|366186966|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
106144185|NCT02709655|366186967|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
106144186|NCT02709655|366186968|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
105807416|NCT02637557|364952098|FG000|Overall Study|Lost to Follow-up|1|||
105807417|NCT02637557|364952099|FG001|Overall Study|Lost to Follow-up|1|||
105807418|NCT02637557|364952100|FG002|Overall Study|Lost to Follow-up|0|||
105807419|NCT02637557|364952101|FG003|Overall Study|Lost to Follow-up|1|||
105807420|NCT02637557|364952098|FG000|Overall Study|Physician Decision|1|||
106144187|NCT02709655|366186969|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
106144188|NCT02709655|366186965|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
106144189|NCT02709655|366186966|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
105761102|NCT02762708|364778134|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
105761103|NCT02762708|364778135|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
105761104|NCT02762708|364778136|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
105761105|NCT02762708|364778137|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
105761106|NCT00669032|364778140|FG000|Overall Study|Lost to Follow-up|6|||
105761107|NCT00669032|364778141|FG001|Overall Study|Lost to Follow-up|5|||
105761108|NCT00669032|364778140|FG000|Overall Study|Lack of Efficacy|8|||
105761109|NCT00669032|364778141|FG001|Overall Study|Lack of Efficacy|19|||
105761110|NCT00669032|364778140|FG000|Overall Study|Withdrawal by Subject|12|||
105761111|NCT00669032|364778141|FG001|Overall Study|Withdrawal by Subject|13|||
105761112|NCT00669032|364778140|FG000|Overall Study|Adverse Event|12|||
105761113|NCT00669032|364778141|FG001|Overall Study|Adverse Event|16|||
105761114|NCT00669032|364778140|FG000|Overall Study|Physician Decision|1|||
105761115|NCT00669032|364778141|FG001|Overall Study|Physician Decision|1|||
105761116|NCT00669032|364778140|FG000|Overall Study|No fulfilment of the selection criteria|5|||
105761117|NCT00669032|364778141|FG001|Overall Study|No fulfilment of the selection criteria|5|||
105761118|NCT01468701|364778150|FG000|Overall Study|Not eligible|91|||
105761119|NCT01468701|364778151|FG001|Overall Study|Not eligible|140|||
105761120|NCT01468701|364778152|FG002|Overall Study|Not eligible|29|||
105761121|NCT01468701|364778153|FG003|Overall Study|Not eligible|12|||
105761122|NCT01468701|364778154|FG004|Overall Study|Not eligible|22|||
105761123|NCT01468701|364778155|FG005|Overall Study|Not eligible|2|||
105761124|NCT01468701|364778156|FG006|Overall Study|Not eligible|39|||
105761125|NCT01468701|364778157|FG007|Overall Study|Not eligible|1|||
105761126|NCT01468701|364778158|FG008|Overall Study|Not eligible|40|||
105761127|NCT01468701|364778159|FG009|Overall Study|Not eligible|126|||
105761128|NCT01468701|364778160|FG010|Overall Study|Not eligible|39|||
105761129|NCT01468701|364778161|FG011|Overall Study|Not eligible|33|||
105761130|NCT01468701|364778162|FG012|Overall Study|Not eligible|1|||
105761131|NCT01468701|364778163|FG013|Overall Study|Not eligible|19|||
105761132|NCT01468701|364778164|FG014|Overall Study|Not eligible|1|||
105761133|NCT01468701|364778165|FG015|Overall Study|Not eligible|32|||
105761134|NCT01468701|364778166|FG016|Overall Study|Not eligible|0|||
105761135|NCT01468701|364778150|FG000|Overall Study|Lost to Follow-up|306|||
105761136|NCT01468701|364778151|FG001|Overall Study|Lost to Follow-up|0|||
105761137|NCT01468701|364778152|FG002|Overall Study|Lost to Follow-up|0|||
105761138|NCT01468701|364778153|FG003|Overall Study|Lost to Follow-up|0|||
105761139|NCT01468701|364778154|FG004|Overall Study|Lost to Follow-up|0|||
105761140|NCT01468701|364778155|FG005|Overall Study|Lost to Follow-up|0|||
105761141|NCT01468701|364778156|FG006|Overall Study|Lost to Follow-up|0|||
105761142|NCT01468701|364778157|FG007|Overall Study|Lost to Follow-up|0|||
105761143|NCT01468701|364778158|FG008|Overall Study|Lost to Follow-up|215|||
105761144|NCT01468701|364778159|FG009|Overall Study|Lost to Follow-up|309|||
105761145|NCT01468701|364778160|FG010|Overall Study|Lost to Follow-up|224|||
105761146|NCT01468701|364778161|FG011|Overall Study|Lost to Follow-up|212|||
105761147|NCT01468701|364778162|FG012|Overall Study|Lost to Follow-up|11|||
105761148|NCT01468701|364778163|FG013|Overall Study|Lost to Follow-up|164|||
105761149|NCT01468701|364778164|FG014|Overall Study|Lost to Follow-up|17|||
105761150|NCT01468701|364778165|FG015|Overall Study|Lost to Follow-up|127|||
105761151|NCT01468701|364778166|FG016|Overall Study|Lost to Follow-up|1|||
105761152|NCT01468701|364778150|FG000|Overall Study|Withdrawal by Subject|165|||
105761153|NCT01468701|364778151|FG001|Overall Study|Withdrawal by Subject|0|||
105761154|NCT01468701|364778152|FG002|Overall Study|Withdrawal by Subject|0|||
105761155|NCT01468701|364778153|FG003|Overall Study|Withdrawal by Subject|0|||
105761156|NCT01468701|364778154|FG004|Overall Study|Withdrawal by Subject|0|||
105761157|NCT01468701|364778155|FG005|Overall Study|Withdrawal by Subject|0|||
105761158|NCT01468701|364778156|FG006|Overall Study|Withdrawal by Subject|0|||
105761159|NCT01468701|364778157|FG007|Overall Study|Withdrawal by Subject|0|||
105761160|NCT01468701|364778158|FG008|Overall Study|Withdrawal by Subject|83|||
105761161|NCT01468701|364778159|FG009|Overall Study|Withdrawal by Subject|88|||
105761162|NCT01468701|364778160|FG010|Overall Study|Withdrawal by Subject|100|||
105761163|NCT01468701|364778161|FG011|Overall Study|Withdrawal by Subject|114|||
105761164|NCT01468701|364778162|FG012|Overall Study|Withdrawal by Subject|9|||
105761165|NCT01468701|364778163|FG013|Overall Study|Withdrawal by Subject|47|||
105761166|NCT01468701|364778164|FG014|Overall Study|Withdrawal by Subject|6|||
105761167|NCT01468701|364778165|FG015|Overall Study|Withdrawal by Subject|31|||
105761168|NCT01468701|364778166|FG016|Overall Study|Withdrawal by Subject|0|||
105761169|NCT01468701|364778150|FG000|Overall Study|Other reasons than listed|437|||
105761170|NCT01468701|364778151|FG001|Overall Study|Other reasons than listed|0|||
105761171|NCT01468701|364778152|FG002|Overall Study|Other reasons than listed|0|||
105761172|NCT01468701|364778153|FG003|Overall Study|Other reasons than listed|0|||
105761173|NCT01468701|364778154|FG004|Overall Study|Other reasons than listed|0|||
105761174|NCT01468701|364778155|FG005|Overall Study|Other reasons than listed|0|||
105761175|NCT01468701|364778156|FG006|Overall Study|Other reasons than listed|0|||
105761176|NCT01468701|364778157|FG007|Overall Study|Other reasons than listed|0|||
105807421|NCT02637557|364952099|FG001|Overall Study|Physician Decision|0|||
105807422|NCT02637557|364952100|FG002|Overall Study|Physician Decision|0|||
105807423|NCT02637557|364952101|FG003|Overall Study|Physician Decision|0|||
105807424|NCT02637557|364952098|FG000|Overall Study|Protocol Violation|2|||
105807425|NCT02637557|364952099|FG001|Overall Study|Protocol Violation|0|||
105807426|NCT02637557|364952100|FG002|Overall Study|Protocol Violation|2|||
105807427|NCT02637557|364952101|FG003|Overall Study|Protocol Violation|1|||
105807428|NCT02637557|364952098|FG000|Overall Study|Withdrawal by Subject|1|||
105807429|NCT02637557|364952099|FG001|Overall Study|Withdrawal by Subject|3|||
105807430|NCT02637557|364952100|FG002|Overall Study|Withdrawal by Subject|4|||
105761177|NCT01468701|364778158|FG008|Overall Study|Other reasons than listed|318|||
105761178|NCT01468701|364778159|FG009|Overall Study|Other reasons than listed|658|||
105761179|NCT01468701|364778160|FG010|Overall Study|Other reasons than listed|433|||
105761180|NCT01468701|364778161|FG011|Overall Study|Other reasons than listed|504|||
105761181|NCT01468701|364778162|FG012|Overall Study|Other reasons than listed|28|||
105761182|NCT01468701|364778163|FG013|Overall Study|Other reasons than listed|239|||
105807431|NCT02637557|364952101|FG003|Overall Study|Withdrawal by Subject|2|||
105807432|NCT04604184|364952108|FG000|Overall Study|Adverse Event|5|||
105807433|NCT04604184|364952109|FG001|Overall Study|Adverse Event|5|||
105807434|NCT04604184|364952108|FG000|Overall Study|Death|2|||
105807435|NCT04604184|364952109|FG001|Overall Study|Death|1|||
105807436|NCT04604184|364952108|FG000|Overall Study|Withdrawal by Subject|1|||
105807437|NCT04604184|364952109|FG001|Overall Study|Withdrawal by Subject|3|||
105807438|NCT04604184|364952108|FG000|Overall Study|Not treated|2|||
105807439|NCT04604184|364952109|FG001|Overall Study|Not treated|2|||
105807440|NCT04604184|364952108|FG000|Overall Study|Due to sponsor decision|9|||
105807441|NCT04604184|364952109|FG001|Overall Study|Due to sponsor decision|7|||
105807442|NCT04604184|364952108|FG000|Overall Study|Physician Decision|0|||
105807443|NCT04604184|364952109|FG001|Overall Study|Physician Decision|1|||
105807444|NCT04604184|364952108|FG000|Overall Study|Transfer to healthcare|1|||
105807445|NCT04604184|364952109|FG001|Overall Study|Transfer to healthcare|0|||
105807446|NCT02711956|364952112|FG000|Overall Study|Adverse Event|0|||
105807447|NCT02711956|364952113|FG001|Overall Study|Adverse Event|0|||
105807448|NCT02711956|364952114|FG002|Overall Study|Adverse Event|0|||
105807449|NCT02711956|364952115|FG003|Overall Study|Adverse Event|1|||
105807450|NCT02711956|364952116|FG004|Overall Study|Adverse Event|2|||
105807451|NCT02711956|364952117|FG005|Overall Study|Adverse Event|0|||
105807452|NCT02711956|364952118|FG006|Overall Study|Adverse Event|0|||
105807453|NCT02711956|364952119|FG007|Overall Study|Adverse Event|1|||
105807454|NCT02711956|364952120|FG008|Overall Study|Adverse Event|1|||
105807455|NCT02711956|364952121|FG009|Overall Study|Adverse Event|1|||
105807456|NCT02711956|364952122|FG010|Overall Study|Adverse Event|1|||
105807457|NCT02711956|364952123|FG011|Overall Study|Adverse Event|0|||
105807458|NCT02711956|364952124|FG012|Overall Study|Adverse Event|0|||
105807459|NCT02711956|364952125|FG013|Overall Study|Adverse Event|0|||
106016928|NCT00118417|365725910|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
105761183|NCT01468701|364778164|FG014|Overall Study|Other reasons than listed|39|||
105761184|NCT01468701|364778165|FG015|Overall Study|Other reasons than listed|172|||
105761185|NCT01468701|364778166|FG016|Overall Study|Other reasons than listed|0|||
105761186|NCT01468701|364778150|FG000|Overall Study|No end of study case report form|0|||
105761187|NCT01468701|364778151|FG001|Overall Study|No end of study case report form|0|||
105761188|NCT01468701|364778152|FG002|Overall Study|No end of study case report form|0|||
105761189|NCT01468701|364778153|FG003|Overall Study|No end of study case report form|0|||
105761190|NCT01468701|364778154|FG004|Overall Study|No end of study case report form|0|||
105761191|NCT01468701|364778155|FG005|Overall Study|No end of study case report form|0|||
105761192|NCT01468701|364778156|FG006|Overall Study|No end of study case report form|0|||
105761193|NCT01468701|364778157|FG007|Overall Study|No end of study case report form|0|||
105761194|NCT01468701|364778158|FG008|Overall Study|No end of study case report form|4|||
105761195|NCT01468701|364778159|FG009|Overall Study|No end of study case report form|1|||
105761196|NCT01468701|364778160|FG010|Overall Study|No end of study case report form|2|||
105761197|NCT01468701|364778161|FG011|Overall Study|No end of study case report form|3|||
105761198|NCT01468701|364778162|FG012|Overall Study|No end of study case report form|0|||
105761199|NCT01468701|364778163|FG013|Overall Study|No end of study case report form|1|||
105761200|NCT01468701|364778164|FG014|Overall Study|No end of study case report form|0|||
105761201|NCT01468701|364778165|FG015|Overall Study|No end of study case report form|0|||
105761202|NCT01468701|364778166|FG016|Overall Study|No end of study case report form|0|||
105761203|NCT01468701|364778150|FG000|Overall Study|Not being followed up|0|||
105807460|NCT02711956|364952126|FG014|Overall Study|Adverse Event|2|||
105807461|NCT02711956|364952112|FG000|Overall Study|Physician Decision|0|||
105807462|NCT02711956|364952113|FG001|Overall Study|Physician Decision|0|||
105807463|NCT02711956|364952114|FG002|Overall Study|Physician Decision|0|||
105807464|NCT02711956|364952115|FG003|Overall Study|Physician Decision|2|||
105807465|NCT02711956|364952116|FG004|Overall Study|Physician Decision|0|||
105761204|NCT01468701|364778151|FG001|Overall Study|Not being followed up|4963|||
105807466|NCT02711956|364952117|FG005|Overall Study|Physician Decision|0|||
105807467|NCT02711956|364952118|FG006|Overall Study|Physician Decision|0|||
105807468|NCT02711956|364952119|FG007|Overall Study|Physician Decision|0|||
105807469|NCT02711956|364952120|FG008|Overall Study|Physician Decision|0|||
105807470|NCT02711956|364952121|FG009|Overall Study|Physician Decision|0|||
105807471|NCT02711956|364952122|FG010|Overall Study|Physician Decision|0|||
105807472|NCT02711956|364952123|FG011|Overall Study|Physician Decision|0|||
105807473|NCT02711956|364952124|FG012|Overall Study|Physician Decision|0|||
105807474|NCT02711956|364952125|FG013|Overall Study|Physician Decision|0|||
105807475|NCT02711956|364952126|FG014|Overall Study|Physician Decision|0|||
105807476|NCT02711956|364952112|FG000|Overall Study|Withdrawal by Subject|0|||
105807477|NCT02711956|364952113|FG001|Overall Study|Withdrawal by Subject|0|||
105807478|NCT02711956|364952114|FG002|Overall Study|Withdrawal by Subject|0|||
105807479|NCT02711956|364952115|FG003|Overall Study|Withdrawal by Subject|0|||
105807480|NCT02711956|364952116|FG004|Overall Study|Withdrawal by Subject|0|||
105807481|NCT02711956|364952117|FG005|Overall Study|Withdrawal by Subject|0|||
105807482|NCT02711956|364952118|FG006|Overall Study|Withdrawal by Subject|1|||
105807483|NCT02711956|364952119|FG007|Overall Study|Withdrawal by Subject|0|||
105807484|NCT02711956|364952120|FG008|Overall Study|Withdrawal by Subject|0|||
105807485|NCT02711956|364952121|FG009|Overall Study|Withdrawal by Subject|0|||
105807486|NCT02711956|364952122|FG010|Overall Study|Withdrawal by Subject|0|||
105807487|NCT02711956|364952123|FG011|Overall Study|Withdrawal by Subject|1|||
105807488|NCT02711956|364952124|FG012|Overall Study|Withdrawal by Subject|6|||
105807489|NCT02711956|364952125|FG013|Overall Study|Withdrawal by Subject|0|||
105807490|NCT02711956|364952126|FG014|Overall Study|Withdrawal by Subject|1|||
105807491|NCT02711956|364952112|FG000|Overall Study|Clinical progression|1|||
105807492|NCT02711956|364952113|FG001|Overall Study|Clinical progression|0|||
105807493|NCT02711956|364952114|FG002|Overall Study|Clinical progression|0|||
105807494|NCT02711956|364952115|FG003|Overall Study|Clinical progression|0|||
105807495|NCT02711956|364952116|FG004|Overall Study|Clinical progression|0|||
105807496|NCT02711956|364952117|FG005|Overall Study|Clinical progression|0|||
105807497|NCT02711956|364952118|FG006|Overall Study|Clinical progression|1|||
105807498|NCT02711956|364952119|FG007|Overall Study|Clinical progression|0|||
105807499|NCT02711956|364952120|FG008|Overall Study|Clinical progression|1|||
105807500|NCT02711956|364952121|FG009|Overall Study|Clinical progression|0|||
105807501|NCT02711956|364952122|FG010|Overall Study|Clinical progression|0|||
105807502|NCT02711956|364952123|FG011|Overall Study|Clinical progression|2|||
105807503|NCT02711956|364952124|FG012|Overall Study|Clinical progression|4|||
105807504|NCT02711956|364952125|FG013|Overall Study|Clinical progression|1|||
105807505|NCT02711956|364952126|FG014|Overall Study|Clinical progression|1|||
105807506|NCT02711956|364952112|FG000|Overall Study|Radiographic progression|1|||
105807507|NCT02711956|364952113|FG001|Overall Study|Radiographic progression|1|||
105807508|NCT02711956|364952114|FG002|Overall Study|Radiographic progression|2|||
105807509|NCT02711956|364952115|FG003|Overall Study|Radiographic progression|0|||
105807510|NCT02711956|364952116|FG004|Overall Study|Radiographic progression|1|||
105807511|NCT02711956|364952117|FG005|Overall Study|Radiographic progression|0|||
105807512|NCT02711956|364952118|FG006|Overall Study|Radiographic progression|0|||
105807513|NCT02711956|364952119|FG007|Overall Study|Radiographic progression|0|||
105807514|NCT02711956|364952120|FG008|Overall Study|Radiographic progression|2|||
105807515|NCT02711956|364952121|FG009|Overall Study|Radiographic progression|1|||
105807516|NCT02711956|364952122|FG010|Overall Study|Radiographic progression|0|||
105807517|NCT02711956|364952123|FG011|Overall Study|Radiographic progression|5|||
105807518|NCT02711956|364952124|FG012|Overall Study|Radiographic progression|3|||
105807519|NCT02711956|364952125|FG013|Overall Study|Radiographic progression|0|||
105807520|NCT02711956|364952126|FG014|Overall Study|Radiographic progression|1|||
105807521|NCT02711956|364952112|FG000|Overall Study|PSA progression with clinical progression|0|||
105807522|NCT02711956|364952113|FG001|Overall Study|PSA progression with clinical progression|0|||
106016929|NCT00118417|365725911|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
106016930|NCT00118417|365725910|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
106016931|NCT00118417|365725911|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
106016932|NCT00118417|365725910|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
106016933|NCT00118417|365725911|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
106016934|NCT00118417|365725910|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
105807523|NCT02711956|364952114|FG002|Overall Study|PSA progression with clinical progression|0|||
105807524|NCT02711956|364952115|FG003|Overall Study|PSA progression with clinical progression|0|||
106016935|NCT00118417|365725911|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
106016936|NCT03584789|365725914|FG000|Overall Study|refused EHR permission|19|||
106016937|NCT03584789|365725915|FG001|Overall Study|refused EHR permission|28|||
105807525|NCT02711956|364952116|FG004|Overall Study|PSA progression with clinical progression|1|||
105807526|NCT02711956|364952117|FG005|Overall Study|PSA progression with clinical progression|0|||
105807527|NCT02711956|364952118|FG006|Overall Study|PSA progression with clinical progression|0|||
105807528|NCT02711956|364952119|FG007|Overall Study|PSA progression with clinical progression|0|||
105807529|NCT02711956|364952120|FG008|Overall Study|PSA progression with clinical progression|0|||
105807530|NCT02711956|364952121|FG009|Overall Study|PSA progression with clinical progression|0|||
105807531|NCT02711956|364952122|FG010|Overall Study|PSA progression with clinical progression|0|||
106016938|NCT03584789|365725916|FG002|Overall Study|refused EHR permission|23|||
105807532|NCT02711956|364952123|FG011|Overall Study|PSA progression with clinical progression|0|||
105807533|NCT02711956|364952124|FG012|Overall Study|PSA progression with clinical progression|1|||
105807534|NCT02711956|364952125|FG013|Overall Study|PSA progression with clinical progression|1|||
105807535|NCT02711956|364952126|FG014|Overall Study|PSA progression with clinical progression|0|||
105807536|NCT02711956|364952112|FG000|Overall Study|PSA progression with radiographic progression|0|||
105807537|NCT02711956|364952113|FG001|Overall Study|PSA progression with radiographic progression|1|||
105807538|NCT02711956|364952114|FG002|Overall Study|PSA progression with radiographic progression|0|||
105807539|NCT02711956|364952115|FG003|Overall Study|PSA progression with radiographic progression|0|||
105807540|NCT02711956|364952116|FG004|Overall Study|PSA progression with radiographic progression|0|||
105807541|NCT02711956|364952117|FG005|Overall Study|PSA progression with radiographic progression|2|||
105807542|NCT02711956|364952118|FG006|Overall Study|PSA progression with radiographic progression|2|||
105807543|NCT02711956|364952119|FG007|Overall Study|PSA progression with radiographic progression|1|||
105807544|NCT02711956|364952120|FG008|Overall Study|PSA progression with radiographic progression|0|||
105807545|NCT02711956|364952121|FG009|Overall Study|PSA progression with radiographic progression|1|||
105807546|NCT02711956|364952122|FG010|Overall Study|PSA progression with radiographic progression|0|||
105807547|NCT02711956|364952123|FG011|Overall Study|PSA progression with radiographic progression|1|||
105807548|NCT02711956|364952124|FG012|Overall Study|PSA progression with radiographic progression|2|||
105807549|NCT02711956|364952125|FG013|Overall Study|PSA progression with radiographic progression|3|||
105807550|NCT02711956|364952126|FG014|Overall Study|PSA progression with radiographic progression|3|||
105807551|NCT03734237|364952127|FG000|Overall Study|Lost to Follow-up|1|||
105807552|NCT03734237|364952128|FG001|Overall Study|Lost to Follow-up|3|||
105807553|NCT03734237|364952129|FG002|Overall Study|Lost to Follow-up|0|||
105807554|NCT03734237|364952127|FG000|Overall Study|Withdrawal by Subject|7|||
105807555|NCT03734237|364952128|FG001|Overall Study|Withdrawal by Subject|9|||
105807556|NCT03734237|364952129|FG002|Overall Study|Withdrawal by Subject|10|||
106144190|NCT02709655|366186967|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
106144191|NCT02709655|366186968|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
105807557|NCT00175019|364952130|FG000|Overall Study|Adverse Event|54|||
105807558|NCT00175019|364952131|FG001|Overall Study|Adverse Event|22|||
105807559|NCT00175019|364952132|FG002|Overall Study|Adverse Event|2|||
105807560|NCT00175019|364952130|FG000|Overall Study|Protocol Violation|6|||
105807561|NCT00175019|364952131|FG001|Overall Study|Protocol Violation|3|||
105807562|NCT00175019|364952132|FG002|Overall Study|Protocol Violation|3|||
105807563|NCT00175019|364952130|FG000|Overall Study|Lost to Follow-up|42|||
105807564|NCT00175019|364952131|FG001|Overall Study|Lost to Follow-up|39|||
105807565|NCT00175019|364952132|FG002|Overall Study|Lost to Follow-up|9|||
105807566|NCT00175019|364952130|FG000|Overall Study|Did not continue under Amendment 4|1|||
105807567|NCT00175019|364952131|FG001|Overall Study|Did not continue under Amendment 4|1|||
105807568|NCT00175019|364952132|FG002|Overall Study|Did not continue under Amendment 4|2|||
105807569|NCT00175019|364952130|FG000|Overall Study|Personal Reason(s)|39|||
105807570|NCT00175019|364952131|FG001|Overall Study|Personal Reason(s)|31|||
105807571|NCT00175019|364952132|FG002|Overall Study|Personal Reason(s)|8|||
105807572|NCT00175019|364952130|FG000|Overall Study|Therapeutic Failure|10|||
105807573|NCT00175019|364952131|FG001|Overall Study|Therapeutic Failure|38|||
105807574|NCT00175019|364952132|FG002|Overall Study|Therapeutic Failure|22|||
105807575|NCT00175019|364952130|FG000|Overall Study|Gout Flare|2|||
105807576|NCT00175019|364952131|FG001|Overall Study|Gout Flare|3|||
105807577|NCT00175019|364952132|FG002|Overall Study|Gout Flare|0|||
105807578|NCT00175019|364952130|FG000|Overall Study|Reason Not Specified|40|||
105807579|NCT00175019|364952131|FG001|Overall Study|Reason Not Specified|34|||
105807580|NCT00175019|364952132|FG002|Overall Study|Reason Not Specified|11|||
105807581|NCT02324465|364952137|FG000|Overall Study|device failure|0|||
105807582|NCT02324465|364952138|FG001|Overall Study|device failure|1|||
105807583|NCT01612000|364952143|FG000|Overall Study|Lost to Follow-up|6|||
105807584|NCT01612000|364952144|FG001|Overall Study|Lost to Follow-up|4|||
105807585|NCT01612000|364952145|FG002|Overall Study|Lost to Follow-up|4|||
105807586|NCT01612000|364952146|FG003|Overall Study|Lost to Follow-up|8|||
105807587|NCT01612000|364952143|FG000|Overall Study|Physician Decision|0|||
105807588|NCT01612000|364952144|FG001|Overall Study|Physician Decision|0|||
105807589|NCT01612000|364952145|FG002|Overall Study|Physician Decision|1|||
105807590|NCT01612000|364952146|FG003|Overall Study|Physician Decision|0|||
105807591|NCT01612000|364952143|FG000|Overall Study|Withdrawal by Subject|3|||
105807592|NCT01612000|364952144|FG001|Overall Study|Withdrawal by Subject|1|||
105807593|NCT01612000|364952145|FG002|Overall Study|Withdrawal by Subject|2|||
105807594|NCT01612000|364952146|FG003|Overall Study|Withdrawal by Subject|2|||
105807595|NCT02173704|364952147|FG000|Overall Study|Adverse Event|1|||
105807596|NCT02173704|364952148|FG001|Overall Study|Adverse Event|0|||
105807597|NCT02173704|364952147|FG000|Overall Study|Lost to Follow-up|1|||
105807598|NCT02173704|364952148|FG001|Overall Study|Lost to Follow-up|0|||
105807599|NCT02173704|364952147|FG000|Overall Study|Other|1|||
106144192|NCT02709655|366186969|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
106144193|NCT02709655|366186965|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
105807600|NCT02173704|364952148|FG001|Overall Study|Other|0|||
105807601|NCT02173704|364952147|FG000|Overall Study|Protocol Violation|1|||
105807602|NCT02173704|364952148|FG001|Overall Study|Protocol Violation|0|||
105807603|NCT02173704|364952147|FG000|Overall Study|Withdrawal by Subject|9|||
105807604|NCT02173704|364952148|FG001|Overall Study|Withdrawal by Subject|4|||
105807605|NCT00419926|364952149|FG000|Overall Study|Withdrawal by Subject|7|||
105807606|NCT00419926|364952150|FG001|Overall Study|Withdrawal by Subject|3|||
105807607|NCT00419926|364952149|FG000|Overall Study|Administrative Problem|4|||
105807608|NCT00419926|364952150|FG001|Overall Study|Administrative Problem|4|||
105807609|NCT00419926|364952149|FG000|Overall Study|Lost to Follow-up|1|||
105807610|NCT00419926|364952150|FG001|Overall Study|Lost to Follow-up|2|||
105807611|NCT00419926|364952149|FG000|Overall Study|Death|2|||
105807612|NCT00419926|364952150|FG001|Overall Study|Death|1|||
105807613|NCT00368966|364952151|FG000|Infant Series|Withdrawal by Subject|11|||
105807614|NCT00368966|364952152|FG001|Infant Series|Withdrawal by Subject|6|||
105807615|NCT00368966|364952151|FG000|Infant Series|Protocol Violation|2|||
105807616|NCT00368966|364952152|FG001|Infant Series|Protocol Violation|1|||
105807617|NCT00368966|364952151|FG000|Infant Series|Lost to Follow-up|2|||
105807618|NCT00368966|364952152|FG001|Infant Series|Lost to Follow-up|0|||
105807619|NCT00368966|364952151|FG000|Infant Series|Randomization error|0|||
105807620|NCT00368966|364952152|FG001|Infant Series|Randomization error|1|||
105807621|NCT00368966|364952151|FG000|Infant Series|Failed to meet eligibility criteria|0|||
105807622|NCT00368966|364952152|FG001|Infant Series|Failed to meet eligibility criteria|1|||
105807623|NCT00368966|364952151|FG000|Infant Series|Adverse Event|0|||
105807624|NCT00368966|364952152|FG001|Infant Series|Adverse Event|1|||
105807625|NCT00368966|364952151|FG000|Infant Series|Failed to return|1|||
105807626|NCT00368966|364952152|FG001|Infant Series|Failed to return|0|||
105807627|NCT00368966|364952151|FG000|After Infant|Failed to return|3|||
105807628|NCT00368966|364952152|FG001|After Infant|Failed to return|1|||
105807629|NCT00368966|364952151|FG000|After Infant|Adverse Event|1|||
105807630|NCT00368966|364952152|FG001|After Infant|Adverse Event|2|||
105807631|NCT00368966|364952151|FG000|After Infant|Withdrawal by Subject|1|||
105807632|NCT00368966|364952152|FG001|After Infant|Withdrawal by Subject|1|||
106016939|NCT03584789|365725914|FG000|Overall Study|patients tied to a provider who retired|0|||
106016940|NCT03584789|365725915|FG001|Overall Study|patients tied to a provider who retired|0|||
106016941|NCT03584789|365725916|FG002|Overall Study|patients tied to a provider who retired|3|||
106016942|NCT01750229|365725920|FG000|Randomized Crossover Phase|Adverse Event|1|||
106016943|NCT01750229|365725920|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
106016944|NCT01750229|365725920|FG000|Long-term Follow-up Phase|Adverse Event|2|||
106016945|NCT01750229|365725920|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
106016946|NCT00998296|365725921|FG000|Overall Study|Progressive disease|0|||
106016947|NCT00998296|365725922|FG001|Overall Study|Progressive disease|1|||
106016948|NCT00998296|365725923|FG002|Overall Study|Progressive disease|0|||
106016949|NCT00998296|365725924|FG003|Overall Study|Progressive disease|0|||
106016950|NCT00998296|365725925|FG004|Overall Study|Progressive disease|0|||
106016951|NCT00998296|365725926|FG005|Overall Study|Progressive disease|0|||
106016952|NCT00998296|365725927|FG006|Overall Study|Progressive disease|1|||
106016953|NCT00998296|365725928|FG007|Overall Study|Progressive disease|0|||
106016954|NCT00998296|365725929|FG008|Overall Study|Progressive disease|0|||
106016955|NCT00998296|365725930|FG009|Overall Study|Progressive disease|14|||
106016956|NCT00998296|365725931|FG010|Overall Study|Progressive disease|5|||
106016957|NCT00998296|365725921|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
106016958|NCT00998296|365725922|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
106016959|NCT00998296|365725923|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
106016960|NCT00998296|365725924|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
106016961|NCT00998296|365725925|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
106016962|NCT00998296|365725926|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
106016963|NCT00998296|365725927|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
106016964|NCT00998296|365725928|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
106016965|NCT00998296|365725929|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
106016966|NCT00998296|365725930|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
106144194|NCT02709655|366186966|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
106144195|NCT02709655|366186967|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
105807633|NCT00368966|364952151|FG000|After Infant|Death|1|||
105807634|NCT00368966|364952152|FG001|After Infant|Death|0|||
105807635|NCT00368966|364952151|FG000|After Infant|Lost to Follow-up|0|||
105807636|NCT00368966|364952152|FG001|After Infant|Lost to Follow-up|1|||
105807637|NCT00368966|364952151|FG000|Toddler Dose|Withdrawal by Subject|1|||
105807638|NCT00368966|364952152|FG001|Toddler Dose|Withdrawal by Subject|1|||
106016967|NCT00998296|365725931|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
106016968|NCT00998296|365725921|FG000|Overall Study|Other adverse event|0|||
106016969|NCT00998296|365725922|FG001|Overall Study|Other adverse event|0|||
105807639|NCT00368966|364952151|FG000|Toddler Dose|Lost to Follow-up|0|||
105807640|NCT00368966|364952152|FG001|Toddler Dose|Lost to Follow-up|2|||
106016970|NCT00998296|365725923|FG002|Overall Study|Other adverse event|0|||
105807641|NCT01595009|364952153|FG000|Core|Patients completed per protocol|85|||
105952267|NCT00442416|365488206|FG000|Overall Study|Administrative/Other|27|||
105952268|NCT00442416|365488207|FG001|Overall Study|Administrative/Other|33|||
105952269|NCT01253369|365488209|FG000|Overall Study|Adverse Event|4|||
105952270|NCT01253369|365488209|FG000|Overall Study|Withdrawal by Subject|2|||
105761205|NCT01468701|364778152|FG002|Overall Study|Not being followed up|1755|||
105761206|NCT01468701|364778153|FG003|Overall Study|Not being followed up|703|||
105761207|NCT01468701|364778154|FG004|Overall Study|Not being followed up|1714|||
105761208|NCT01468701|364778155|FG005|Overall Study|Not being followed up|126|||
105761209|NCT01468701|364778156|FG006|Overall Study|Not being followed up|1170|||
105761210|NCT01468701|364778157|FG007|Overall Study|Not being followed up|4|||
105761211|NCT01468701|364778158|FG008|Overall Study|Not being followed up|0|||
105761212|NCT01468701|364778159|FG009|Overall Study|Not being followed up|0|||
105761213|NCT01468701|364778160|FG010|Overall Study|Not being followed up|0|||
105761214|NCT01468701|364778161|FG011|Overall Study|Not being followed up|0|||
105761215|NCT01468701|364778162|FG012|Overall Study|Not being followed up|0|||
105761216|NCT01468701|364778163|FG013|Overall Study|Not being followed up|0|||
105761217|NCT01468701|364778164|FG014|Overall Study|Not being followed up|0|||
105761218|NCT01468701|364778165|FG015|Overall Study|Not being followed up|0|||
105761219|NCT01468701|364778166|FG016|Overall Study|Not being followed up|0|||
105761220|NCT01068717|364778168|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
105761221|NCT01068717|364778169|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
105761222|NCT01068717|364778170|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
105761223|NCT01068717|364778171|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
105761224|NCT01822223|364778174|FG000|Overall Study|Death|0|||
105761225|NCT01822223|364778175|FG001|Overall Study|Death|1|||
105761226|NCT02679781|364778176|FG000|Overall Study|Lost to Follow-up|1|||
105761227|NCT02679781|364778177|FG001|Overall Study|Lost to Follow-up|2|||
105761228|NCT02679781|364778176|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
105761229|NCT02679781|364778177|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
105761230|NCT00631540|364778186|FG000|Overall Study|Withdrawal by Subject|5|||
105761231|NCT00631540|364778186|FG000|Overall Study|Death|4|||
105761232|NCT00631540|364778186|FG000|Overall Study|Lost to Follow-up|2|||
105761233|NCT00631540|364778186|FG000|Overall Study|Core Lab Data Unavailable|3|||
105761234|NCT00970268|364778187|FG000|Overall Study|Withdrawal by Subject|12|||
105761235|NCT00970268|364778188|FG001|Overall Study|Withdrawal by Subject|19|||
105761236|NCT00970268|364778187|FG000|Overall Study|Adverse Event|15|||
105761237|NCT00970268|364778188|FG001|Overall Study|Adverse Event|12|||
105761238|NCT00970268|364778187|FG000|Overall Study|Lack of Efficacy|3|||
105761239|NCT00970268|364778188|FG001|Overall Study|Lack of Efficacy|6|||
105761240|NCT00970268|364778187|FG000|Overall Study|Protocol Violation|4|||
105761241|NCT00970268|364778188|FG001|Overall Study|Protocol Violation|7|||
105761242|NCT00970268|364778187|FG000|Overall Study|Other Reason|3|||
105761243|NCT00970268|364778188|FG001|Overall Study|Other Reason|1|||
105761244|NCT00970268|364778187|FG000|Overall Study|COPD Exacerbation|4|||
105761245|NCT00970268|364778188|FG001|Overall Study|COPD Exacerbation|2|||
105761246|NCT00970268|364778187|FG000|Overall Study|Lost to Follow-up|1|||
105761247|NCT00970268|364778188|FG001|Overall Study|Lost to Follow-up|2|||
105761248|NCT00970268|364778187|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
105761249|NCT00970268|364778188|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
105761250|NCT03032510|364778189|FG000|Overall Study|Adverse Event|5|||
105761251|NCT03032510|364778190|FG001|Overall Study|Adverse Event|2|||
105761252|NCT03032510|364778189|FG000|Overall Study|Lost to Follow-up|8|||
105761253|NCT03032510|364778190|FG001|Overall Study|Lost to Follow-up|7|||
105761254|NCT03032510|364778189|FG000|Overall Study|Withdrawal by Subject|8|||
105761255|NCT03032510|364778190|FG001|Overall Study|Withdrawal by Subject|7|||
105761256|NCT03032510|364778189|FG000|Overall Study|Subject noncompliance|4|||
105761257|NCT03032510|364778190|FG001|Overall Study|Subject noncompliance|2|||
105761258|NCT03032510|364778189|FG000|Overall Study|Physician Decision|2|||
105761259|NCT03032510|364778190|FG001|Overall Study|Physician Decision|0|||
105761260|NCT01601470|364778191|FG000|Period 2 - LCZ696|Physician Decision|1|||
105761261|NCT01203787|364778192|FG000|Overall Study|Death|12|||
105761262|NCT01203787|364778193|FG001|Overall Study|Death|10|||
105761263|NCT01203787|364778192|FG000|Overall Study|Withdrawal by Subject|6|||
105761264|NCT01203787|364778193|FG001|Overall Study|Withdrawal by Subject|2|||
105761265|NCT01203787|364778192|FG000|Overall Study|Lost to Follow-up|2|||
105761266|NCT01203787|364778193|FG001|Overall Study|Lost to Follow-up|0|||
105761267|NCT01203787|364778192|FG000|Overall Study|Adverse Event|11|||
105761268|NCT01203787|364778193|FG001|Overall Study|Adverse Event|15|||
105761269|NCT03404518|364778194|FG000|Overall Study|Lost to Follow-up|28|||
105761270|NCT03404518|364778195|FG001|Overall Study|Lost to Follow-up|30|||
105761271|NCT03404518|364778194|FG000|Overall Study|Protocol Violation|13|||
105761272|NCT03404518|364778195|FG001|Overall Study|Protocol Violation|6|||
105761273|NCT04021706|364781316|FG000|Overall Study|Adverse Event|2|||
105761274|NCT04021706|364781317|FG001|Overall Study|Adverse Event|0|||
105761275|NCT04021706|364781316|FG000|Overall Study|Withdrawal by Subject|1|||
105952271|NCT01253369|365488209|FG000|Overall Study|Death|1|||
105807642|NCT01595009|364952154|FG001|Core|Patients completed per protocol|44|||
105807643|NCT01595009|364952155|FG002|Core|Patients completed per protocol|0|||
105807644|NCT01595009|364952156|FG003|Core|Patients completed per protocol|0|||
105807645|NCT01595009|364952153|FG000|Core|Adverse Event|19|||
105807646|NCT01595009|364952154|FG001|Core|Adverse Event|23|||
105807647|NCT01595009|364952155|FG002|Core|Adverse Event|0|||
105807648|NCT01595009|364952156|FG003|Core|Adverse Event|0|||
105807649|NCT01595009|364952153|FG000|Core|Disease progression|14|||
105807650|NCT01595009|364952154|FG001|Core|Disease progression|26|||
105807651|NCT01595009|364952155|FG002|Core|Disease progression|0|||
105807652|NCT01595009|364952156|FG003|Core|Disease progression|0|||
105761276|NCT04021706|364781317|FG001|Overall Study|Withdrawal by Subject|2|||
105761277|NCT04021706|364781316|FG000|Overall Study|Physician Decision|1|||
105761278|NCT04021706|364781317|FG001|Overall Study|Physician Decision|0|||
105761279|NCT00107172|364781325|FG000|Overall Study|Withdrawal by Subject|1|||
105761280|NCT00107172|364781326|FG001|Overall Study|Withdrawal by Subject|0|||
105761281|NCT00107172|364781325|FG000|Overall Study|Death|0|||
105761282|NCT00107172|364781326|FG001|Overall Study|Death|2|||
105761283|NCT00107172|364781325|FG000|Overall Study|Other Reason|4|||
105761284|NCT00107172|364781326|FG001|Overall Study|Other Reason|3|||
105761285|NCT02688153|364781327|FG000|Overall Study|Death|7|||
105761286|NCT02688153|364781328|FG001|Overall Study|Death|5|||
105761287|NCT02688153|364781327|FG000|Overall Study|Withdrawal by Subject|4|||
105761288|NCT02688153|364781328|FG001|Overall Study|Withdrawal by Subject|2|||
105761289|NCT02688153|364781327|FG000|Overall Study|Valve Explant|1|||
105761290|NCT02688153|364781328|FG001|Overall Study|Valve Explant|0|||
105761291|NCT02688153|364781327|FG000|Overall Study|Conversion to Commercial Valve|3|||
105761292|NCT02688153|364781328|FG001|Overall Study|Conversion to Commercial Valve|0|||
105761293|NCT01102140|364781329|FG000|Overall Study|Lost to Follow-up|1|||
105761294|NCT01102140|364781330|FG001|Overall Study|Lost to Follow-up|0|||
105761295|NCT01102140|364781329|FG000|Overall Study|Investigator terminated study|2|||
105761296|NCT01102140|364781330|FG001|Overall Study|Investigator terminated study|2|||
105761297|NCT04268303|364781334|FG000|Overall Study|Lost to Follow-up|1|||
105761298|NCT04268303|364781335|FG001|Overall Study|Lost to Follow-up|1|||
105761299|NCT04268303|364781336|FG002|Overall Study|Lost to Follow-up|2|||
105761300|NCT04268303|364781334|FG000|Overall Study|Withdrawal by Subject|0|||
105761301|NCT04268303|364781335|FG001|Overall Study|Withdrawal by Subject|1|||
105761302|NCT04268303|364781336|FG002|Overall Study|Withdrawal by Subject|1|||
105761303|NCT04268303|364781334|FG000|Overall Study|Adverse Event|2|||
105761304|NCT04268303|364781335|FG001|Overall Study|Adverse Event|0|||
105761305|NCT04268303|364781336|FG002|Overall Study|Adverse Event|0|||
105761306|NCT00355134|364781337|FG000|Core Phase|Withdrawal by Subject|35|||
105761307|NCT00355134|364781338|FG001|Core Phase|Withdrawal by Subject|24|||
105761308|NCT00355134|364781339|FG002|Core Phase|Withdrawal by Subject|35|||
105761309|NCT00355134|364781340|FG003|Core Phase|Withdrawal by Subject|0|||
105761310|NCT00355134|364781341|FG004|Core Phase|Withdrawal by Subject|0|||
105761311|NCT00355134|364781337|FG000|Core Phase|Adverse Event|28|||
105761312|NCT00355134|364781338|FG001|Core Phase|Adverse Event|22|||
105761313|NCT00355134|364781339|FG002|Core Phase|Adverse Event|16|||
105761314|NCT00355134|364781340|FG003|Core Phase|Adverse Event|0|||
105761315|NCT00355134|364781341|FG004|Core Phase|Adverse Event|0|||
105761316|NCT00355134|364781337|FG000|Core Phase|Lost to Follow-up|17|||
105761317|NCT00355134|364781338|FG001|Core Phase|Lost to Follow-up|13|||
105761318|NCT00355134|364781339|FG002|Core Phase|Lost to Follow-up|21|||
105761319|NCT00355134|364781340|FG003|Core Phase|Lost to Follow-up|0|||
105761320|NCT00355134|364781341|FG004|Core Phase|Lost to Follow-up|0|||
105761321|NCT00355134|364781337|FG000|Core Phase|Abnormal laboratory value(s)|19|||
105761322|NCT00355134|364781338|FG001|Core Phase|Abnormal laboratory value(s)|14|||
105761323|NCT00355134|364781339|FG002|Core Phase|Abnormal laboratory value(s)|2|||
105761324|NCT00355134|364781340|FG003|Core Phase|Abnormal laboratory value(s)|0|||
105761325|NCT00355134|364781341|FG004|Core Phase|Abnormal laboratory value(s)|0|||
105761326|NCT00355134|364781337|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
105761327|NCT00355134|364781338|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
105761328|NCT00355134|364781339|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
105761329|NCT00355134|364781340|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
105761330|NCT00355134|364781341|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
105761331|NCT00355134|364781337|FG000|Core Phase|Administrative problems|5|||
105761332|NCT00355134|364781338|FG001|Core Phase|Administrative problems|3|||
105761333|NCT00355134|364781339|FG002|Core Phase|Administrative problems|5|||
105761334|NCT00355134|364781340|FG003|Core Phase|Administrative problems|0|||
105952272|NCT01253369|365488209|FG000|Overall Study|Progressive disease|23|||
105761335|NCT00355134|364781341|FG004|Core Phase|Administrative problems|0|||
105761336|NCT00355134|364781337|FG000|Core Phase|Protocol Violation|3|||
105761337|NCT00355134|364781338|FG001|Core Phase|Protocol Violation|2|||
105761338|NCT00355134|364781339|FG002|Core Phase|Protocol Violation|2|||
105807653|NCT01595009|364952153|FG000|Core|Withdrawal by Subject|4|||
105761339|NCT00355134|364781340|FG003|Core Phase|Protocol Violation|0|||
105761340|NCT00355134|364781341|FG004|Core Phase|Protocol Violation|0|||
105761341|NCT00355134|364781337|FG000|Core Phase|Abnormal test procedure result(s)|1|||
105807654|NCT01595009|364952154|FG001|Core|Withdrawal by Subject|17|||
105807655|NCT01595009|364952155|FG002|Core|Withdrawal by Subject|0|||
105807656|NCT01595009|364952156|FG003|Core|Withdrawal by Subject|0|||
105807657|NCT01595009|364952153|FG000|Core|Death|3|||
105807658|NCT01595009|364952154|FG001|Core|Death|6|||
105807659|NCT01595009|364952155|FG002|Core|Death|0|||
105807660|NCT01595009|364952156|FG003|Core|Death|0|||
105807661|NCT01595009|364952153|FG000|Core|Lost to Follow-up|1|||
105807662|NCT01595009|364952154|FG001|Core|Lost to Follow-up|2|||
105807663|NCT01595009|364952155|FG002|Core|Lost to Follow-up|0|||
105807664|NCT01595009|364952156|FG003|Core|Lost to Follow-up|0|||
105807665|NCT01595009|364952153|FG000|Core|Protocol deviation|0|||
105807666|NCT01595009|364952154|FG001|Core|Protocol deviation|1|||
105807667|NCT01595009|364952155|FG002|Core|Protocol deviation|0|||
105807668|NCT01595009|364952156|FG003|Core|Protocol deviation|0|||
105807669|NCT01595009|364952153|FG000|Core|Administrative problems|0|||
105807670|NCT01595009|364952154|FG001|Core|Administrative problems|1|||
105807671|NCT01595009|364952155|FG002|Core|Administrative problems|0|||
105807672|NCT01595009|364952156|FG003|Core|Administrative problems|0|||
105807673|NCT01595009|364952153|FG000|Extension|Administrative problems|0|||
105807674|NCT01595009|364952154|FG001|Extension|Administrative problems|0|||
105807675|NCT01595009|364952155|FG002|Extension|Administrative problems|0|||
105807676|NCT01595009|364952156|FG003|Extension|Administrative problems|1|||
105807677|NCT01595009|364952153|FG000|Extension|Patients completed per protocol|0|||
105807678|NCT01595009|364952154|FG001|Extension|Patients completed per protocol|0|||
105807679|NCT01595009|364952155|FG002|Extension|Patients completed per protocol|0|||
105807680|NCT01595009|364952156|FG003|Extension|Patients completed per protocol|2|||
105807681|NCT01595009|364952153|FG000|Extension|Disease progression|0|||
105807682|NCT01595009|364952154|FG001|Extension|Disease progression|0|||
105807683|NCT01595009|364952155|FG002|Extension|Disease progression|4|||
105807684|NCT01595009|364952156|FG003|Extension|Disease progression|7|||
105807685|NCT01595009|364952153|FG000|Extension|Adverse Event|0|||
105807686|NCT01595009|364952154|FG001|Extension|Adverse Event|0|||
105807687|NCT01595009|364952155|FG002|Extension|Adverse Event|0|||
105807688|NCT01595009|364952156|FG003|Extension|Adverse Event|1|||
105807689|NCT00662025|364952157|FG000|Overall Study|Objective progression or relapse|51|||
105807690|NCT00662025|364952157|FG000|Overall Study|Adverse Event|7|||
105807691|NCT00662025|364952157|FG000|Overall Study|Withdrawal by Subject|1|||
105807692|NCT00662025|364952157|FG000|Overall Study|Results of other clinical study|2|||
105807693|NCT00662025|364952157|FG000|Overall Study|Target lesion cannot be evaluated|1|||
105807694|NCT00662025|364952157|FG000|Overall Study|Domestic circumstances|1|||
105807695|NCT00290745|364952158|FG000|Overall Study|Withdrawal by Subject|4|||
105807696|NCT00290745|364952158|FG000|Overall Study|Physician Decision|2|||
105807697|NCT00290745|364952158|FG000|Overall Study|Surgery after 3 months for progression|3|||
105807698|NCT00290745|364952158|FG000|Overall Study|Baseline MRI not available|3|||
105807699|NCT03267264|364952159|FG000|Overall Study|Withdrawal by Subject|1|||
105807700|NCT03267264|364952160|FG001|Overall Study|Withdrawal by Subject|0|||
105807701|NCT03267264|364952161|FG002|Overall Study|Withdrawal by Subject|2|||
105807702|NCT03267264|364952162|FG003|Overall Study|Withdrawal by Subject|4|||
105807703|NCT01336894|364952163|FG000|Follow-up|Study terminated prematurely|2|||
105807704|NCT01336894|364952164|FG001|Follow-up|Study terminated prematurely|7|||
105807705|NCT01498484|364952165|FG000|Overall Study|Death|6|||
105807706|NCT01498484|364952166|FG001|Overall Study|Death|3|||
105807707|NCT01498484|364952167|FG002|Overall Study|Death|1|||
105807708|NCT01498484|364952168|FG003|Overall Study|Death|1|||
105807709|NCT01498484|364952169|FG004|Overall Study|Death|0|||
105807710|NCT01498484|364952170|FG005|Overall Study|Death|0|||
105807711|NCT01498484|364952171|FG006|Overall Study|Death|10|||
105807712|NCT01498484|364952172|FG007|Overall Study|Death|1|||
105807713|NCT01498484|364952173|FG008|Overall Study|Death|0|||
105807714|NCT01498484|364952165|FG000|Overall Study|Physician Decision|3|||
105807715|NCT01498484|364952166|FG001|Overall Study|Physician Decision|2|||
105807716|NCT01498484|364952167|FG002|Overall Study|Physician Decision|1|||
105807717|NCT01498484|364952168|FG003|Overall Study|Physician Decision|1|||
106016971|NCT00998296|365725924|FG003|Overall Study|Other adverse event|0|||
106016972|NCT00998296|365725925|FG004|Overall Study|Other adverse event|1|||
106016973|NCT00998296|365725926|FG005|Overall Study|Other adverse event|0|||
106016974|NCT00998296|365725927|FG006|Overall Study|Other adverse event|0|||
106016975|NCT00998296|365725928|FG007|Overall Study|Other adverse event|0|||
106016976|NCT00998296|365725929|FG008|Overall Study|Other adverse event|0|||
106016977|NCT00998296|365725930|FG009|Overall Study|Other adverse event|1|||
105807718|NCT01498484|364952169|FG004|Overall Study|Physician Decision|0|||
105807719|NCT01498484|364952170|FG005|Overall Study|Physician Decision|0|||
105807720|NCT01498484|364952171|FG006|Overall Study|Physician Decision|8|||
105807721|NCT01498484|364952172|FG007|Overall Study|Physician Decision|13|||
105807722|NCT01498484|364952173|FG008|Overall Study|Physician Decision|1|||
106016978|NCT00998296|365725931|FG010|Overall Study|Other adverse event|2|||
105807723|NCT01498484|364952165|FG000|Overall Study|Adverse Event|0|||
105807724|NCT01498484|364952166|FG001|Overall Study|Adverse Event|0|||
105807725|NCT01498484|364952167|FG002|Overall Study|Adverse Event|0|||
105807726|NCT01498484|364952168|FG003|Overall Study|Adverse Event|0|||
105807727|NCT01498484|364952169|FG004|Overall Study|Adverse Event|0|||
105952273|NCT01253369|365488209|FG000|Overall Study|Not Evaluable|3|||
105952274|NCT01055613|365488215|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
106144196|NCT02709655|366186968|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
106144197|NCT02709655|366186969|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
106144198|NCT02709655|366186965|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
106144199|NCT02709655|366186966|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
106144200|NCT02709655|366186967|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
106144201|NCT02709655|366186968|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
106144202|NCT02709655|366186969|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
106144203|NCT02709655|366186965|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
106144204|NCT02709655|366186966|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
106144205|NCT02709655|366186967|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
106144206|NCT02709655|366186968|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
106144207|NCT02709655|366186969|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
106144208|NCT02709655|366186965|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
106144209|NCT02709655|366186966|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
106144210|NCT02709655|366186967|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
106144211|NCT02709655|366186968|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
106144212|NCT02709655|366186969|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
106144213|NCT02709655|366186965|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
106144214|NCT02709655|366186966|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
106144215|NCT02709655|366186967|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
106144216|NCT02709655|366186968|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
106144217|NCT02709655|366186969|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
106144218|NCT05082025|366186970|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
106144219|NCT04210180|366186971|FG000|Overall Study|Withdrawal by Subject|2|||
105952275|NCT01055613|365488216|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
105952276|NCT01055613|365488215|FG000|Overall Study|Unacceptable lens fit|1|||
105952277|NCT01055613|365488216|FG001|Overall Study|Unacceptable lens fit|0|||
105952278|NCT01055613|365488215|FG000|Overall Study|Discomfort|2|||
105952279|NCT01055613|365488216|FG001|Overall Study|Discomfort|1|||
105952280|NCT01055613|365488215|FG000|Overall Study|Lost to Follow-up|1|||
105952281|NCT01055613|365488216|FG001|Overall Study|Lost to Follow-up|1|||
105952282|NCT01055613|365488215|FG000|Overall Study|Protocol Violation|1|||
105952283|NCT01055613|365488216|FG001|Overall Study|Protocol Violation|1|||
105952284|NCT01055613|365488215|FG000|Overall Study|Subject Disinterest|1|||
105952285|NCT01055613|365488216|FG001|Overall Study|Subject Disinterest|1|||
105952286|NCT02103062|365488218|FG000|Overall Study|Adverse Event|1|||
105952287|NCT02103062|365488219|FG001|Overall Study|Adverse Event|2|||
105952288|NCT02103062|365488218|FG000|Overall Study|Progressive Disease|17|||
105952289|NCT02103062|365488219|FG001|Overall Study|Progressive Disease|20|||
105952290|NCT02103062|365488218|FG000|Overall Study|Death|0|||
105952291|NCT02103062|365488219|FG001|Overall Study|Death|1|||
105952292|NCT00120627|365488220|FG000|Overall Study|Withdrawal by Subject|5|||
105952293|NCT00120627|365488221|FG001|Overall Study|Withdrawal by Subject|5|||
105952294|NCT01595529|365488226|FG000|Overall Study|Adverse Event|2|||
105952295|NCT01595529|365488227|FG001|Overall Study|Adverse Event|0|||
105952296|NCT01595529|365488226|FG000|Overall Study|Subject Non-Compliant|2|||
105952297|NCT01595529|365488227|FG001|Overall Study|Subject Non-Compliant|0|||
105952298|NCT01595529|365488226|FG000|Overall Study|Lost to Follow-up|8|||
106144220|NCT00857649|366186972|FG000|Overall Study|Adverse Event|15|||
105807728|NCT01498484|364952170|FG005|Overall Study|Adverse Event|1|||
105952299|NCT01595529|365488227|FG001|Overall Study|Lost to Follow-up|14|||
105952300|NCT01595529|365488226|FG000|Overall Study|Protocol Violation|1|||
105952301|NCT01595529|365488227|FG001|Overall Study|Protocol Violation|2|||
105952302|NCT01595529|365488226|FG000|Overall Study|Physician Decision|1|||
105952303|NCT01595529|365488227|FG001|Overall Study|Physician Decision|0|||
105952304|NCT01595529|365488226|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
105952305|NCT01595529|365488227|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
105952306|NCT01595529|365488226|FG000|Overall Study|Administrative Decision|1|||
105952307|NCT01595529|365488227|FG001|Overall Study|Administrative Decision|0|||
105952308|NCT01595529|365488226|FG000|Overall Study|Entry Failure/Screening Failure|6|||
105952309|NCT01595529|365488227|FG001|Overall Study|Entry Failure/Screening Failure|1|||
105952310|NCT01822665|365488228|FG000|Overall Study|Adverse Event|3|||
105952311|NCT01822665|365488228|FG000|Overall Study|Other Reason|5|||
105952312|NCT00959907|365488230|FG000|Overall Study|Protocol Violation|0|||
106144221|NCT00857649|366186973|FG001|Overall Study|Adverse Event|10|||
105952313|NCT00959907|365488231|FG001|Overall Study|Protocol Violation|1|||
105952314|NCT00959907|365488230|FG000|Overall Study|Adverse Event|1|||
105952315|NCT00959907|365488231|FG001|Overall Study|Adverse Event|0|||
105952316|NCT00959907|365488230|FG000|Overall Study|Withdrawal by Subject|2|||
105952317|NCT00959907|365488231|FG001|Overall Study|Withdrawal by Subject|0|||
105952318|NCT04781816|365488232|FG000|Overall Study|Adverse Event|0|||
105952319|NCT04781816|365488233|FG001|Overall Study|Adverse Event|1|||
105807729|NCT01498484|364952171|FG006|Overall Study|Adverse Event|0|||
105807730|NCT01498484|364952172|FG007|Overall Study|Adverse Event|0|||
105807731|NCT01498484|364952173|FG008|Overall Study|Adverse Event|0|||
105807732|NCT01498484|364952165|FG000|Overall Study|Withdrawal by Subject|0|||
105807733|NCT01498484|364952166|FG001|Overall Study|Withdrawal by Subject|0|||
105807734|NCT01498484|364952167|FG002|Overall Study|Withdrawal by Subject|0|||
105807735|NCT01498484|364952168|FG003|Overall Study|Withdrawal by Subject|1|||
105807736|NCT01498484|364952169|FG004|Overall Study|Withdrawal by Subject|0|||
105807737|NCT01498484|364952170|FG005|Overall Study|Withdrawal by Subject|0|||
105807738|NCT01498484|364952171|FG006|Overall Study|Withdrawal by Subject|1|||
105807739|NCT01498484|364952172|FG007|Overall Study|Withdrawal by Subject|0|||
105807740|NCT01498484|364952173|FG008|Overall Study|Withdrawal by Subject|0|||
105807741|NCT01498484|364952165|FG000|Overall Study|Other|5|||
105807742|NCT01498484|364952166|FG001|Overall Study|Other|2|||
105807743|NCT01498484|364952167|FG002|Overall Study|Other|0|||
105807744|NCT01498484|364952168|FG003|Overall Study|Other|0|||
105807745|NCT01498484|364952169|FG004|Overall Study|Other|1|||
105807746|NCT01498484|364952170|FG005|Overall Study|Other|0|||
105807747|NCT01498484|364952171|FG006|Overall Study|Other|3|||
105807748|NCT01498484|364952172|FG007|Overall Study|Other|0|||
105807749|NCT01498484|364952173|FG008|Overall Study|Other|1|||
105807750|NCT01620177|364952175|FG000|Overall Study|Failure at Screening Visit|43|||
105807751|NCT01620177|364952175|FG000|Overall Study|Withdrawal by Subject|26|||
105807752|NCT01620177|364952175|FG000|Overall Study|Lost to Follow-up|7|||
105807753|NCT01620177|364952175|FG000|Overall Study|Physician Decision|2|||
105807754|NCT01620177|364952175|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
105807755|NCT01446913|364952179|FG000|Overall Study|Significant illness|1|||
105807756|NCT01446913|364952180|FG001|Overall Study|Significant illness|1|||
105807757|NCT01446913|364952181|FG002|Overall Study|Significant illness|1|||
105807758|NCT01446913|364952179|FG000|Overall Study|Withdrawal by Subject|5|||
105807759|NCT01446913|364952180|FG001|Overall Study|Withdrawal by Subject|3|||
105807760|NCT01446913|364952181|FG002|Overall Study|Withdrawal by Subject|5|||
105807761|NCT01446913|364952179|FG000|Overall Study|Physician Decision|0|||
105807762|NCT01446913|364952180|FG001|Overall Study|Physician Decision|0|||
105807763|NCT01446913|364952181|FG002|Overall Study|Physician Decision|2|||
105807764|NCT01446913|364952179|FG000|Overall Study|Lost to Follow-up|3|||
105807765|NCT01446913|364952180|FG001|Overall Study|Lost to Follow-up|5|||
105807766|NCT01446913|364952181|FG002|Overall Study|Lost to Follow-up|3|||
105807767|NCT00423800|364952182|FG000|Overall Study|Protocol Violation|0|||
105807768|NCT00423800|364952183|FG001|Overall Study|Protocol Violation|1|||
105807769|NCT00619385|364952186|FG000|Overall Study|Adverse Event|0|||
105807770|NCT00619385|364952187|FG001|Overall Study|Adverse Event|0|||
105807771|NCT00619385|364952188|FG002|Overall Study|Adverse Event|3|||
105807772|NCT00619385|364952186|FG000|Overall Study|Other|1|||
105807773|NCT00619385|364952187|FG001|Overall Study|Other|2|||
105807774|NCT00619385|364952188|FG002|Overall Study|Other|1|||
105807775|NCT00203307|364952193|FG000|First Intervention|Adverse Event|2|||
105807776|NCT00203307|364952194|FG001|First Intervention|Adverse Event|0|||
105807777|NCT03504852|364952195|FG000|Overall Study|Withdrawal of informed consent|2|||
105807778|NCT03504852|364952196|FG001|Overall Study|Withdrawal of informed consent|1|||
105807779|NCT03504852|364952197|FG002|Overall Study|Withdrawal of informed consent|0|||
106144222|NCT00857649|366186972|FG000|Overall Study|Non-compliance|1|||
106144223|NCT00857649|366186973|FG001|Overall Study|Non-compliance|1|||
106144224|NCT00857649|366186972|FG000|Overall Study|Protocol Violation|2|||
106144225|NCT00857649|366186973|FG001|Overall Study|Protocol Violation|2|||
105807780|NCT03504852|364952195|FG000|Overall Study|Withdrawal by Subject|5|||
105807781|NCT03504852|364952196|FG001|Overall Study|Withdrawal by Subject|5|||
105807782|NCT03504852|364952197|FG002|Overall Study|Withdrawal by Subject|1|||
105807783|NCT03504852|364952195|FG000|Overall Study|Lost to Follow-up|4|||
105807784|NCT03504852|364952196|FG001|Overall Study|Lost to Follow-up|1|||
105807785|NCT03504852|364952197|FG002|Overall Study|Lost to Follow-up|0|||
105807786|NCT03504852|364952195|FG000|Overall Study|New therapy for study indication|1|||
105807787|NCT03504852|364952196|FG001|Overall Study|New therapy for study indication|0|||
105807788|NCT03504852|364952197|FG002|Overall Study|New therapy for study indication|0|||
105807789|NCT03504852|364952195|FG000|Overall Study|Lack of Efficacy|1|||
105807790|NCT03504852|364952196|FG001|Overall Study|Lack of Efficacy|2|||
105807791|NCT03504852|364952197|FG002|Overall Study|Lack of Efficacy|0|||
105807792|NCT03504852|364952195|FG000|Overall Study|Death|0|||
105807793|NCT03504852|364952196|FG001|Overall Study|Death|1|||
105807794|NCT03504852|364952197|FG002|Overall Study|Death|0|||
105807795|NCT03504852|364952195|FG000|Overall Study|Adverse Event|4|||
105807796|NCT03504852|364952196|FG001|Overall Study|Adverse Event|8|||
105807797|NCT03504852|364952197|FG002|Overall Study|Adverse Event|2|||
105807798|NCT01066052|364952198|FG000|Overall Study|Enrolled But Not Treated|3|||
105807799|NCT01066052|364952199|FG001|Overall Study|Enrolled But Not Treated|0|||
105807800|NCT02220907|364952200|FG000|Overall Study|Adverse Event|7|||
106016979|NCT00998296|365725921|FG000|Overall Study|Refused to continue taking trial med.|0|||
105807801|NCT02220907|364952200|FG000|Overall Study|Physician Decision|1|||
106144226|NCT00857649|366186972|FG000|Overall Study|Withdrawal of Consent|10|||
105761342|NCT00355134|364781338|FG001|Core Phase|Abnormal test procedure result(s)|2|||
105761343|NCT00355134|364781339|FG002|Core Phase|Abnormal test procedure result(s)|1|||
105761344|NCT00355134|364781340|FG003|Core Phase|Abnormal test procedure result(s)|0|||
105761345|NCT00355134|364781341|FG004|Core Phase|Abnormal test procedure result(s)|0|||
105761346|NCT00355134|364781337|FG000|Core Phase|Condition no longer requires study drug|1|||
105761347|NCT00355134|364781338|FG001|Core Phase|Condition no longer requires study drug|0|||
105761348|NCT00355134|364781339|FG002|Core Phase|Condition no longer requires study drug|1|||
105761349|NCT00355134|364781340|FG003|Core Phase|Condition no longer requires study drug|0|||
105761350|NCT00355134|364781341|FG004|Core Phase|Condition no longer requires study drug|0|||
105761351|NCT00355134|364781337|FG000|Extension Phase|Withdrawal by Subject|7|||
105761352|NCT00355134|364781338|FG001|Extension Phase|Withdrawal by Subject|11|||
105761353|NCT00355134|364781339|FG002|Extension Phase|Withdrawal by Subject|0|||
105761354|NCT00355134|364781340|FG003|Extension Phase|Withdrawal by Subject|7|||
105761355|NCT00355134|364781341|FG004|Extension Phase|Withdrawal by Subject|5|||
105761356|NCT00355134|364781337|FG000|Extension Phase|Adverse Event|13|||
105761357|NCT00355134|364781338|FG001|Extension Phase|Adverse Event|9|||
105761358|NCT00355134|364781339|FG002|Extension Phase|Adverse Event|0|||
105761359|NCT00355134|364781340|FG003|Extension Phase|Adverse Event|3|||
105761360|NCT00355134|364781341|FG004|Extension Phase|Adverse Event|5|||
105761361|NCT00355134|364781337|FG000|Extension Phase|Lost to Follow-up|2|||
105761362|NCT00355134|364781338|FG001|Extension Phase|Lost to Follow-up|6|||
105761363|NCT00355134|364781339|FG002|Extension Phase|Lost to Follow-up|0|||
105761364|NCT00355134|364781340|FG003|Extension Phase|Lost to Follow-up|2|||
105761365|NCT00355134|364781341|FG004|Extension Phase|Lost to Follow-up|4|||
105761366|NCT00355134|364781337|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
105761367|NCT00355134|364781338|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
105761368|NCT00355134|364781339|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
105761369|NCT00355134|364781340|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
105761370|NCT00355134|364781341|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
105761371|NCT00355134|364781337|FG000|Extension Phase|Administrative problems|2|||
105761372|NCT00355134|364781338|FG001|Extension Phase|Administrative problems|4|||
105761373|NCT00355134|364781339|FG002|Extension Phase|Administrative problems|0|||
105761374|NCT00355134|364781340|FG003|Extension Phase|Administrative problems|1|||
105761375|NCT00355134|364781341|FG004|Extension Phase|Administrative problems|1|||
105761376|NCT00355134|364781337|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
105761377|NCT00355134|364781338|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
105761378|NCT00355134|364781339|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
105761379|NCT00355134|364781340|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
105761380|NCT00355134|364781341|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
105761381|NCT00355134|364781337|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
105761382|NCT00355134|364781338|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
105761383|NCT00355134|364781339|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
105761384|NCT00355134|364781340|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
105761385|NCT00355134|364781341|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
105761386|NCT00355134|364781337|FG000|Extension Phase|Protocol Violation|0|||
105761387|NCT00355134|364781338|FG001|Extension Phase|Protocol Violation|0|||
105761388|NCT00355134|364781339|FG002|Extension Phase|Protocol Violation|0|||
105761389|NCT00355134|364781340|FG003|Extension Phase|Protocol Violation|1|||
105761390|NCT00355134|364781341|FG004|Extension Phase|Protocol Violation|0|||
105761391|NCT01135394|364781345|FG000|Screening|Lost to Follow-up|2|||
105761392|NCT01135394|364781345|FG000|Screening|Withdrawal by Subject|10|||
105761393|NCT01135394|364781345|FG000|Screening|Screening failure|16|||
105761394|NCT01135394|364781345|FG000|Screening|Physician Decision|5|||
105761395|NCT01135394|364781345|FG000|Baseline Assessment|Withdrawal by Subject|9|||
105761396|NCT01135394|364781345|FG000|Baseline Assessment|Physician Decision|3|||
105761397|NCT01135394|364781345|FG000|Baseline Assessment|Lost to Follow-up|2|||
105761398|NCT01135394|364781345|FG000|Baseline Assessment|Adverse Event|1|||
105761399|NCT01135394|364781345|FG000|Study Treatment|Withdrawal by Subject|1|||
105761400|NCT01135394|364781345|FG000|Study Treatment|Physician Decision|1|||
105761401|NCT01135394|364781345|FG000|Study Treatment|Adverse Event|2|||
105761402|NCT01742091|364781348|FG000|Overall Study|Adverse Event|0|||
105761403|NCT01742091|364781349|FG001|Overall Study|Adverse Event|0|||
105761404|NCT01742091|364781350|FG002|Overall Study|Adverse Event|0|||
105761405|NCT01742091|364781351|FG003|Overall Study|Adverse Event|0|||
105761406|NCT01742091|364781352|FG004|Overall Study|Adverse Event|1|||
105761407|NCT01742091|364781353|FG005|Overall Study|Adverse Event|0|||
105761408|NCT01742091|364781348|FG000|Overall Study|Physician Decision|0|||
105761409|NCT01742091|364781349|FG001|Overall Study|Physician Decision|0|||
105761410|NCT01742091|364781350|FG002|Overall Study|Physician Decision|0|||
105761411|NCT01742091|364781351|FG003|Overall Study|Physician Decision|0|||
105761412|NCT01742091|364781352|FG004|Overall Study|Physician Decision|0|||
105761413|NCT01742091|364781353|FG005|Overall Study|Physician Decision|1|||
105761414|NCT01742091|364781348|FG000|Overall Study|Withdrawal by Subject|0|||
105761415|NCT01742091|364781349|FG001|Overall Study|Withdrawal by Subject|0|||
105761416|NCT01742091|364781350|FG002|Overall Study|Withdrawal by Subject|0|||
105807802|NCT02220907|364952200|FG000|Overall Study|Withdrawal by Subject|2|||
105807803|NCT02220907|364952200|FG000|Overall Study|Conflict with the stopping criteria|1|||
105807804|NCT02729896|364952201|FG000|Overall Study|Death|0|||
105807805|NCT02729896|364952202|FG001|Overall Study|Death|2|||
105807806|NCT02729896|364952203|FG002|Overall Study|Death|13|||
105807807|NCT02729896|364952201|FG000|Overall Study|Lost to Follow-up|0|||
105807808|NCT02729896|364952202|FG001|Overall Study|Lost to Follow-up|2|||
105807809|NCT02729896|364952203|FG002|Overall Study|Lost to Follow-up|3|||
105807810|NCT02729896|364952201|FG000|Overall Study|Other|0|||
105807811|NCT02729896|364952202|FG001|Overall Study|Other|2|||
105807812|NCT02729896|364952203|FG002|Overall Study|Other|0|||
105807813|NCT02729896|364952201|FG000|Overall Study|Physician Decision|1|||
105807814|NCT02729896|364952202|FG001|Overall Study|Physician Decision|2|||
105807815|NCT02729896|364952203|FG002|Overall Study|Physician Decision|3|||
105807816|NCT02729896|364952201|FG000|Overall Study|Progressive Disease|0|||
105807817|NCT02729896|364952202|FG001|Overall Study|Progressive Disease|1|||
105807818|NCT02729896|364952203|FG002|Overall Study|Progressive Disease|0|||
105807819|NCT02729896|364952201|FG000|Overall Study|Withdrawal by Subject|1|||
105807820|NCT02729896|364952202|FG001|Overall Study|Withdrawal by Subject|0|||
105807821|NCT02729896|364952203|FG002|Overall Study|Withdrawal by Subject|3|||
105807822|NCT00582309|364952204|FG000|Overall Study|Protocol Violation|0|||
105807823|NCT00582309|364952205|FG001|Overall Study|Protocol Violation|0|||
105807824|NCT00582309|364952206|FG002|Overall Study|Protocol Violation|2|||
105807825|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
105807826|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
105807827|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
105807828|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
105807829|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
105807830|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
105807831|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
105807832|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
105807833|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
105807834|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
105807835|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
105807836|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
105807837|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
105807838|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
105807839|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
105807840|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
105807841|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
105807842|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
105807843|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
105807844|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
105807845|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
105807846|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
105807847|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
105807848|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
105807849|NCT00455533|364952211|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
105807850|NCT00455533|364952212|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
105807851|NCT00455533|364952213|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
105807852|NCT00455533|364952211|FG000|Period Two: Randomized Period|Death|0|||
105807853|NCT00455533|364952212|FG001|Period Two: Randomized Period|Death|0|||
105807854|NCT00455533|364952213|FG002|Period Two: Randomized Period|Death|3|||
105807855|NCT00455533|364952211|FG000|Period Two: Randomized Period|Disease Progression|0|||
105807856|NCT00455533|364952212|FG001|Period Two: Randomized Period|Disease Progression|1|||
105807857|NCT00455533|364952213|FG002|Period Two: Randomized Period|Disease Progression|1|||
105807858|NCT00455533|364952211|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
105807859|NCT00455533|364952212|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
105807860|NCT00455533|364952213|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
105807861|NCT00455533|364952211|FG000|Period Two: Randomized Period|Other - need reasons|0|||
105807862|NCT00455533|364952212|FG001|Period Two: Randomized Period|Other - need reasons|1|||
105807863|NCT00455533|364952213|FG002|Period Two: Randomized Period|Other - need reasons|0|||
105807864|NCT00455533|364952211|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
105807865|NCT00455533|364952212|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
105807866|NCT00455533|364952213|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
105807867|NCT00455533|364952211|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
105807868|NCT00455533|364952212|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
105807869|NCT00455533|364952213|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
105807870|NCT01736553|364952218|FG000|Overall Study|Death|12|||
105807871|NCT01736553|364952219|FG001|Overall Study|Death|0|||
105807872|NCT01736553|364952218|FG000|Overall Study|Withdrawal by Subject|5|||
105807873|NCT01736553|364952219|FG001|Overall Study|Withdrawal by Subject|2|||
105807874|NCT01736553|364952218|FG000|Overall Study|Lost to Follow-up|2|||
105807875|NCT01736553|364952219|FG001|Overall Study|Lost to Follow-up|2|||
105807876|NCT02415959|364952220|FG000|Overall Study|Adverse Event|0|||
105807877|NCT02415959|364952221|FG001|Overall Study|Adverse Event|1|||
105807878|NCT02415959|364952222|FG002|Overall Study|Adverse Event|0|||
105807879|NCT02415959|364952223|FG003|Overall Study|Adverse Event|0|||
105807880|NCT02415959|364952224|FG004|Overall Study|Adverse Event|0|||
105807881|NCT02415959|364952220|FG000|Overall Study|Protocol Violation|0|||
105807882|NCT02415959|364952221|FG001|Overall Study|Protocol Violation|0|||
105807883|NCT02415959|364952222|FG002|Overall Study|Protocol Violation|0|||
105807884|NCT02415959|364952223|FG003|Overall Study|Protocol Violation|1|||
105807885|NCT02415959|364952224|FG004|Overall Study|Protocol Violation|0|||
105807886|NCT01048333|364952225|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807887|NCT01048333|364952226|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
105807888|NCT01048333|364952227|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807889|NCT01048333|364952228|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807890|NCT01048333|364952229|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807891|NCT01048333|364952230|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
105807892|NCT00634179|364952234|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
105807893|NCT00767325|364952235|FG000|Overall Study|Lack of Efficacy|2|||
105807894|NCT00767325|364952235|FG000|Overall Study|Adverse Event|7|||
105807895|NCT00767325|364952235|FG000|Overall Study|Lost to Follow-up|3|||
105807896|NCT00767325|364952235|FG000|Overall Study|No longer met study criteria|2|||
105807897|NCT00767325|364952235|FG000|Overall Study|Missed visit due to family reasons|1|||
105807898|NCT04603937|364952241|FG000|Overall Study|Adverse Event|9|||
105807899|NCT04603937|364952242|FG001|Overall Study|Adverse Event|10|||
105807900|NCT04603937|364952241|FG000|Overall Study|Withdrawal by Subject|7|||
105807901|NCT04603937|364952242|FG001|Overall Study|Withdrawal by Subject|6|||
105807902|NCT04603937|364952241|FG000|Overall Study|Lost to Follow-up|5|||
105807903|NCT04603937|364952242|FG001|Overall Study|Lost to Follow-up|6|||
105807904|NCT04603937|364952241|FG000|Overall Study|Physician Decision|0|||
105807905|NCT04603937|364952242|FG001|Overall Study|Physician Decision|1|||
105807906|NCT04603937|364952241|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
105807907|NCT04603937|364952242|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
105807908|NCT00770315|364952245|FG000|Overall Study|Adverse Event|11|||
105807909|NCT00770315|364952246|FG001|Overall Study|Adverse Event|17|||
105807910|NCT00770315|364952247|FG002|Overall Study|Adverse Event|16|||
105807911|NCT00770315|364952248|FG003|Overall Study|Adverse Event|6|||
105807912|NCT00770315|364952245|FG000|Overall Study|Lost to Follow-up|9|||
105807913|NCT00770315|364952246|FG001|Overall Study|Lost to Follow-up|5|||
105807914|NCT00770315|364952247|FG002|Overall Study|Lost to Follow-up|10|||
105807915|NCT00770315|364952248|FG003|Overall Study|Lost to Follow-up|3|||
105807916|NCT00770315|364952245|FG000|Overall Study|Withdrawal by Subject|13|||
105807917|NCT00770315|364952246|FG001|Overall Study|Withdrawal by Subject|17|||
105807918|NCT00770315|364952247|FG002|Overall Study|Withdrawal by Subject|24|||
105807919|NCT00770315|364952248|FG003|Overall Study|Withdrawal by Subject|20|||
105807920|NCT00770315|364952245|FG000|Overall Study|Noncompliance with Protocol|7|||
105807921|NCT00770315|364952246|FG001|Overall Study|Noncompliance with Protocol|4|||
105807922|NCT00770315|364952247|FG002|Overall Study|Noncompliance with Protocol|7|||
105807923|NCT00770315|364952248|FG003|Overall Study|Noncompliance with Protocol|9|||
105807924|NCT02585258|364952249|FG000|Overall Study|Adverse Event|28|||
105807925|NCT02585258|364952250|FG001|Overall Study|Adverse Event|29|||
105807926|NCT02585258|364952249|FG000|Overall Study|Death|3|||
105807927|NCT02585258|364952250|FG001|Overall Study|Death|2|||
105807928|NCT02585258|364952249|FG000|Overall Study|Lack of Efficacy|7|||
105807929|NCT02585258|364952250|FG001|Overall Study|Lack of Efficacy|9|||
105807930|NCT02585258|364952249|FG000|Overall Study|includes covid-related access problems|42|||
105807931|NCT02585258|364952250|FG001|Overall Study|includes covid-related access problems|46|||
105807932|NCT02585258|364952249|FG000|Overall Study|Lost to Follow-up|5|||
105807933|NCT02585258|364952250|FG001|Overall Study|Lost to Follow-up|2|||
105807934|NCT01621490|364954863|FG000|Overall Study|Subject no longer meets study criteria|0|||
105807935|NCT01621490|364954864|FG001|Overall Study|Subject no longer meets study criteria|0|||
105807936|NCT01621490|364954865|FG002|Overall Study|Subject no longer meets study criteria|0|||
105807937|NCT01621490|364954866|FG003|Overall Study|Subject no longer meets study criteria|0|||
105807938|NCT01621490|364954867|FG004|Overall Study|Subject no longer meets study criteria|1|||
105807939|NCT01621490|364954868|FG005|Overall Study|Subject no longer meets study criteria|0|||
105807940|NCT01621490|364954869|FG006|Overall Study|Subject no longer meets study criteria|0|||
105807941|NCT01621490|364954870|FG007|Overall Study|Subject no longer meets study criteria|0|||
105807942|NCT01621490|364954871|FG008|Overall Study|Subject no longer meets study criteria|0|||
105807943|NCT01621490|364954872|FG009|Overall Study|Subject no longer meets study criteria|0|||
105807944|NCT01621490|364954873|FG010|Overall Study|Subject no longer meets study criteria|0|||
105807945|NCT01621490|364954863|FG000|Overall Study|Maximum clinical benefit|3|||
105807946|NCT01621490|364954864|FG001|Overall Study|Maximum clinical benefit|2|||
105807947|NCT01621490|364954865|FG002|Overall Study|Maximum clinical benefit|0|||
105807948|NCT01621490|364954866|FG003|Overall Study|Maximum clinical benefit|0|||
105807949|NCT01621490|364954867|FG004|Overall Study|Maximum clinical benefit|0|||
105807950|NCT01621490|364954868|FG005|Overall Study|Maximum clinical benefit|0|||
105807951|NCT01621490|364954869|FG006|Overall Study|Maximum clinical benefit|1|||
105807952|NCT01621490|364954870|FG007|Overall Study|Maximum clinical benefit|2|||
105807953|NCT01621490|364954871|FG008|Overall Study|Maximum clinical benefit|2|||
105807954|NCT01621490|364954872|FG009|Overall Study|Maximum clinical benefit|0|||
105952320|NCT04781816|365488232|FG000|Overall Study|Withdrawal by Subject|1|||
105952321|NCT04781816|365488233|FG001|Overall Study|Withdrawal by Subject|1|||
105952322|NCT04781816|365488232|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
105952323|NCT04781816|365488233|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
105952324|NCT02030821|365488234|FG000|Overall Study|Physician Decision|2|||
105952325|NCT02030821|365488235|FG001|Overall Study|Physician Decision|2|||
105952326|NCT02030821|365488236|FG002|Overall Study|Physician Decision|5|||
105952327|NCT02030821|365488237|FG003|Overall Study|Physician Decision|2|||
105952328|NCT03192137|365488238|FG000|Overall Study|Adverse Event|10|||
105952329|NCT03192137|365488239|FG001|Overall Study|Adverse Event|11|||
105952330|NCT03192137|365488238|FG000|Overall Study|Physician Decision|1|||
105952331|NCT03192137|365488239|FG001|Overall Study|Physician Decision|0|||
105952332|NCT03192137|365488238|FG000|Overall Study|Lack of Efficacy|20|||
105952333|NCT03192137|365488239|FG001|Overall Study|Lack of Efficacy|37|||
105952334|NCT03192137|365488238|FG000|Overall Study|Withdrawal by Subject|3|||
105952335|NCT03192137|365488239|FG001|Overall Study|Withdrawal by Subject|3|||
105952336|NCT03192137|365488238|FG000|Overall Study|Protocol Violation|4|||
105952337|NCT03192137|365488239|FG001|Overall Study|Protocol Violation|3|||
105952338|NCT03192137|365488238|FG000|Overall Study|Surgery Cancelled|4|||
105952339|NCT03192137|365488239|FG001|Overall Study|Surgery Cancelled|1|||
105952340|NCT03192137|365488238|FG000|Overall Study|Other - Various Administrative Reasons|8|||
105952341|NCT03192137|365488239|FG001|Overall Study|Other - Various Administrative Reasons|3|||
105952342|NCT02737501|365488242|FG000|Randomized Phase|Died|41|||
105952343|NCT02737501|365488243|FG001|Randomized Phase|Died|29|||
105952344|NCT02737501|365488244|FG002|Randomized Phase|Died|0|||
105952345|NCT02737501|365488242|FG000|Randomized Phase|Withdrawal by Subject|16|||
106016980|NCT00998296|365725922|FG001|Overall Study|Refused to continue taking trial med.|0|||
105807955|NCT01621490|364954873|FG010|Overall Study|Maximum clinical benefit|0|||
105807956|NCT01621490|364954863|FG000|Overall Study|Withdrawal by Subject|1|||
105807957|NCT01621490|364954864|FG001|Overall Study|Withdrawal by Subject|0|||
105807958|NCT01621490|364954865|FG002|Overall Study|Withdrawal by Subject|0|||
105807959|NCT01621490|364954866|FG003|Overall Study|Withdrawal by Subject|0|||
105807960|NCT01621490|364954867|FG004|Overall Study|Withdrawal by Subject|0|||
105807961|NCT01621490|364954868|FG005|Overall Study|Withdrawal by Subject|1|||
105952346|NCT02737501|365488243|FG001|Randomized Phase|Withdrawal by Subject|6|||
105807962|NCT01621490|364954869|FG006|Overall Study|Withdrawal by Subject|0|||
105807963|NCT01621490|364954870|FG007|Overall Study|Withdrawal by Subject|0|||
105807964|NCT01621490|364954871|FG008|Overall Study|Withdrawal by Subject|0|||
105807965|NCT01621490|364954872|FG009|Overall Study|Withdrawal by Subject|0|||
105807966|NCT01621490|364954873|FG010|Overall Study|Withdrawal by Subject|0|||
105807967|NCT01621490|364954863|FG000|Overall Study|Subject request to discontinue study|1|||
105807968|NCT01621490|364954864|FG001|Overall Study|Subject request to discontinue study|3|||
105807969|NCT01621490|364954865|FG002|Overall Study|Subject request to discontinue study|1|||
105807970|NCT01621490|364954866|FG003|Overall Study|Subject request to discontinue study|1|||
105807971|NCT01621490|364954867|FG004|Overall Study|Subject request to discontinue study|0|||
105807972|NCT01621490|364954868|FG005|Overall Study|Subject request to discontinue study|2|||
105807973|NCT01621490|364954869|FG006|Overall Study|Subject request to discontinue study|1|||
105952347|NCT02737501|365488244|FG002|Randomized Phase|Withdrawal by Subject|0|||
105952348|NCT02737501|365488242|FG000|Randomized Phase|Lost to Follow-up|0|||
105952349|NCT02737501|365488243|FG001|Randomized Phase|Lost to Follow-up|1|||
105952350|NCT02737501|365488244|FG002|Randomized Phase|Lost to Follow-up|0|||
105952351|NCT02737501|365488242|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
105952352|NCT02737501|365488243|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
105952353|NCT02737501|365488244|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
105952354|NCT02737501|365488242|FG000|Randomized Phase|Reason not Specified|1|||
105952355|NCT02737501|365488243|FG001|Randomized Phase|Reason not Specified|1|||
105952356|NCT02737501|365488244|FG002|Randomized Phase|Reason not Specified|0|||
105952357|NCT02737501|365488242|FG000|Randomized Phase|Never Treated|1|||
105952358|NCT02737501|365488243|FG001|Randomized Phase|Never Treated|1|||
105952359|NCT02737501|365488244|FG002|Randomized Phase|Never Treated|0|||
105952360|NCT02737501|365488242|FG000|Crossover Phase|Died|0|||
105952361|NCT02737501|365488243|FG001|Crossover Phase|Died|0|||
105952362|NCT02737501|365488244|FG002|Crossover Phase|Died|22|||
105952363|NCT02737501|365488242|FG000|Crossover Phase|Withdrew Consent|0|||
105952364|NCT02737501|365488243|FG001|Crossover Phase|Withdrew Consent|0|||
105952365|NCT02737501|365488244|FG002|Crossover Phase|Withdrew Consent|9|||
105952366|NCT02737501|365488242|FG000|Crossover Phase|Physician Decision|0|||
105952367|NCT02737501|365488243|FG001|Crossover Phase|Physician Decision|0|||
105952368|NCT02737501|365488244|FG002|Crossover Phase|Physician Decision|1|||
105952369|NCT02737501|365488242|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
105952370|NCT02737501|365488243|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
105952371|NCT02737501|365488244|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
105952372|NCT04819113|365488245|FG000|Overall Study|Withdrawal by parent/guardian|3|||
105952373|NCT04819113|365488245|FG000|Overall Study|Lost to Follow-up|1|||
105807974|NCT01621490|364954870|FG007|Overall Study|Subject request to discontinue study|0|||
105807975|NCT01621490|364954871|FG008|Overall Study|Subject request to discontinue study|1|||
105807976|NCT01621490|364954872|FG009|Overall Study|Subject request to discontinue study|0|||
105807977|NCT01621490|364954873|FG010|Overall Study|Subject request to discontinue study|0|||
105807978|NCT01621490|364954863|FG000|Overall Study|Adverse event unrelated to study drug|1|||
105807979|NCT01621490|364954864|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105807980|NCT01621490|364954865|FG002|Overall Study|Adverse event unrelated to study drug|0|||
105807981|NCT01621490|364954866|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105807982|NCT01621490|364954867|FG004|Overall Study|Adverse event unrelated to study drug|0|||
105807983|NCT01621490|364954868|FG005|Overall Study|Adverse event unrelated to study drug|0|||
105807984|NCT01621490|364954869|FG006|Overall Study|Adverse event unrelated to study drug|0|||
106144227|NCT00857649|366186973|FG001|Overall Study|Withdrawal of Consent|7|||
106144228|NCT00857649|366186972|FG000|Overall Study|Nursing Home Placement|2|||
106144229|NCT00857649|366186973|FG001|Overall Study|Nursing Home Placement|9|||
106144230|NCT00857649|366186972|FG000|Overall Study|Other Reasons|1|||
106144231|NCT00857649|366186973|FG001|Overall Study|Other Reasons|3|||
106144232|NCT02471755|366186975|FG000|Overall Study|Withdrawal by Subject|1|||
106144233|NCT02471755|366186976|FG001|Overall Study|Withdrawal by Subject|0|||
106144234|NCT02471755|366186975|FG000|Overall Study|Lost to Follow-up|0|||
106144235|NCT02471755|366186976|FG001|Overall Study|Lost to Follow-up|1|||
106144236|NCT04740164|366186977|FG000|Overall Study|Lack of Efficacy|4|||
106144237|NCT04740164|366186978|FG001|Overall Study|Lack of Efficacy|0|||
106144238|NCT04740164|366186977|FG000|Overall Study|Physician Decision|3|||
106144239|NCT04740164|366186978|FG001|Overall Study|Physician Decision|3|||
106144240|NCT02158091|366186979|FG000|Overall Study|DLT|2|||
106144241|NCT02158091|366186980|FG001|Overall Study|DLT|1|||
106144242|NCT02158091|366186981|FG002|Overall Study|DLT|0|||
106144243|NCT01152190|366186982|FG000|Overall Study|Adverse Event|2|||
106144244|NCT01152190|366186983|FG001|Overall Study|Adverse Event|4|||
106144245|NCT01152190|366186982|FG000|Overall Study|Death|1|||
106144246|NCT01152190|366186983|FG001|Overall Study|Death|0|||
106144247|NCT01152190|366186982|FG000|Overall Study|Protocol Violation|1|||
106144248|NCT01152190|366186983|FG001|Overall Study|Protocol Violation|1|||
106144249|NCT01152190|366186982|FG000|Overall Study|Withdrawal by Subject|1|||
106144250|NCT01152190|366186983|FG001|Overall Study|Withdrawal by Subject|3|||
106144251|NCT00997386|366186986|FG000|Overall Study|Death|7|||
106144252|NCT02994654|366186990|FG000|Overall Study|Lost to Follow-up|1|||
106144253|NCT00573833|366186993|FG000|Overall Study|Not Treated|2|||
106144254|NCT04257058|366189066|FG000|Overall Study|Lost to Follow-up|31|||
106144255|NCT05147233|366189073|FG000|Overall Study|Adverse Event|0|||
106144256|NCT05147233|366189074|FG001|Overall Study|Adverse Event|1|||
106144257|NCT05147233|366189073|FG000|Overall Study|Lost to Follow-up|1|||
106144258|NCT05147233|366189074|FG001|Overall Study|Lost to Follow-up|1|||
106144259|NCT05147233|366189073|FG000|Overall Study|Protocol Violation|0|||
106144260|NCT05147233|366189074|FG001|Overall Study|Protocol Violation|1|||
106144261|NCT05147233|366189073|FG000|Overall Study|Withdrawal by Subject|2|||
106144262|NCT05147233|366189074|FG001|Overall Study|Withdrawal by Subject|1|||
106144263|NCT04513522|366189075|FG000|Overall Study|Other reasons|1|||
106144264|NCT04513522|366189075|FG000|Overall Study|Adverse event unrelated to study drug|9|||
106144265|NCT04513522|366189075|FG000|Overall Study|Study drug toxicity|14|||
106144266|NCT04513522|366189075|FG000|Overall Study|Disease progression|39|||
106144267|NCT04513522|366189075|FG000|Overall Study|Participants withdrew consent|2|||
106144268|NCT03266016|366189076|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
106144269|NCT03266016|366189077|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
106144270|NCT03266016|366189078|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
106144271|NCT03266016|366189079|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
106144272|NCT03266016|366189076|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
106144273|NCT03266016|366189077|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
106144274|NCT03266016|366189078|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
106144275|NCT03266016|366189079|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
106144276|NCT03538041|366189082|FG000|12-Week Treatment Period|Adverse Event|1|||
106144277|NCT03538041|366189083|FG001|12-Week Treatment Period|Adverse Event|1|||
106144278|NCT03538041|366189082|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
106144279|NCT03538041|366189083|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
106144280|NCT03538041|366189082|FG000|Treatment Extension Period|Adverse Event|4|||
106144281|NCT03538041|366189083|FG001|Treatment Extension Period|Adverse Event|1|||
106144282|NCT03538041|366189082|FG000|Treatment Extension Period|Physician Decision|1|||
106144283|NCT03538041|366189083|FG001|Treatment Extension Period|Physician Decision|1|||
106144284|NCT03538041|366189082|FG000|Treatment Extension Period|Lack of Efficacy|1|||
106144285|NCT03538041|366189083|FG001|Treatment Extension Period|Lack of Efficacy|4|||
106144286|NCT03538041|366189082|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
106144287|NCT03538041|366189083|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
106144288|NCT03538041|366189082|FG000|Treatment Extension Period|Death|0|||
106144289|NCT03538041|366189083|FG001|Treatment Extension Period|Death|1|||
106144290|NCT00925899|366189088|FG000|Part 1|Death|1|||
105807985|NCT01621490|364954870|FG007|Overall Study|Adverse event unrelated to study drug|2|||
105807986|NCT01621490|364954871|FG008|Overall Study|Adverse event unrelated to study drug|0|||
105807987|NCT01621490|364954872|FG009|Overall Study|Adverse event unrelated to study drug|0|||
105807988|NCT01621490|364954873|FG010|Overall Study|Adverse event unrelated to study drug|0|||
105807989|NCT01621490|364954863|FG000|Overall Study|Disease progression|27|||
105952374|NCT04819113|365488245|FG000|Overall Study|Withdrawn before vaccination|2|||
105952375|NCT00833027|365488246|FG000|Overall Study|Adverse Event|33|||
105952376|NCT00833027|365488246|FG000|Overall Study|Death|1|||
105952377|NCT00833027|365488246|FG000|Overall Study|Lack of Efficacy|12|||
105952378|NCT00833027|365488246|FG000|Overall Study|Lost to Follow-up|24|||
105952379|NCT00833027|365488246|FG000|Overall Study|Protocol Violation|115|||
105807990|NCT01621490|364954864|FG001|Overall Study|Disease progression|28|||
105807991|NCT01621490|364954865|FG002|Overall Study|Disease progression|1|||
105807992|NCT01621490|364954866|FG003|Overall Study|Disease progression|5|||
105807993|NCT01621490|364954867|FG004|Overall Study|Disease progression|3|||
105807994|NCT01621490|364954868|FG005|Overall Study|Disease progression|8|||
105952380|NCT00833027|365488246|FG000|Overall Study|Withdrawal by Subject|16|||
106144291|NCT00925899|366189089|FG001|Part 1|Death|2|||
106144292|NCT00925899|366189088|FG000|Part 1|Withdrawal by Subject|10|||
106144293|NCT00925899|366189089|FG001|Part 1|Withdrawal by Subject|9|||
106144294|NCT03544515|366189090|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
106144295|NCT03544515|366189091|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
106144296|NCT03544515|366189090|FG000|Overall Study|Lost to Follow-up|2|||
106144297|NCT03544515|366189091|FG001|Overall Study|Lost to Follow-up|0|||
105807995|NCT01621490|364954869|FG006|Overall Study|Disease progression|7|||
105807996|NCT01621490|364954870|FG007|Overall Study|Disease progression|1|||
105807997|NCT01621490|364954871|FG008|Overall Study|Disease progression|4|||
105807998|NCT01621490|364954872|FG009|Overall Study|Disease progression|1|||
105807999|NCT01621490|364954873|FG010|Overall Study|Disease progression|1|||
105808000|NCT01621490|364954863|FG000|Overall Study|Study drug toxicity|1|||
105808001|NCT01621490|364954864|FG001|Overall Study|Study drug toxicity|4|||
105808002|NCT01621490|364954865|FG002|Overall Study|Study drug toxicity|5|||
106144298|NCT03169244|366189092|FG000|Overall Study|Lost to Follow-up|1|||
106144299|NCT03169244|366189093|FG001|Overall Study|Lost to Follow-up|2|||
106144300|NCT03169244|366189092|FG000|Overall Study|Adverse Event|1|||
106144301|NCT03169244|366189093|FG001|Overall Study|Adverse Event|0|||
106144302|NCT03169244|366189092|FG000|Overall Study|Withdrawal by Subject|2|||
106144303|NCT03169244|366189093|FG001|Overall Study|Withdrawal by Subject|2|||
106016981|NCT00998296|365725923|FG002|Overall Study|Refused to continue taking trial med.|0|||
105761417|NCT01742091|364781351|FG003|Overall Study|Withdrawal by Subject|1|||
105761418|NCT01742091|364781352|FG004|Overall Study|Withdrawal by Subject|0|||
105761419|NCT01742091|364781353|FG005|Overall Study|Withdrawal by Subject|0|||
105761420|NCT01742091|364781348|FG000|Overall Study|Lost to Follow-up|0|||
105761421|NCT01742091|364781349|FG001|Overall Study|Lost to Follow-up|0|||
105761422|NCT01742091|364781350|FG002|Overall Study|Lost to Follow-up|0|||
105761423|NCT01742091|364781351|FG003|Overall Study|Lost to Follow-up|0|||
105761424|NCT01742091|364781352|FG004|Overall Study|Lost to Follow-up|0|||
105761425|NCT01742091|364781353|FG005|Overall Study|Lost to Follow-up|1|||
105761426|NCT02088541|364781354|FG000|Overall Study|Adverse Event|3|||
105761427|NCT02088541|364781355|FG001|Overall Study|Adverse Event|0|||
105761428|NCT02088541|364781356|FG002|Overall Study|Adverse Event|3|||
105761429|NCT02088541|364781357|FG003|Overall Study|Adverse Event|3|||
105761430|NCT02088541|364781358|FG004|Overall Study|Adverse Event|0|||
105761431|NCT02088541|364781354|FG000|Overall Study|Death|51|||
105761432|NCT02088541|364781355|FG001|Overall Study|Death|21|||
105761433|NCT02088541|364781356|FG002|Overall Study|Death|85|||
105761434|NCT02088541|364781357|FG003|Overall Study|Death|28|||
105761435|NCT02088541|364781358|FG004|Overall Study|Death|38|||
105761436|NCT02088541|364781354|FG000|Overall Study|Lost to Follow-up|2|||
105761437|NCT02088541|364781355|FG001|Overall Study|Lost to Follow-up|0|||
105761438|NCT02088541|364781356|FG002|Overall Study|Lost to Follow-up|1|||
105761439|NCT02088541|364781357|FG003|Overall Study|Lost to Follow-up|0|||
105761440|NCT02088541|364781358|FG004|Overall Study|Lost to Follow-up|0|||
105761441|NCT02088541|364781354|FG000|Overall Study|Physician Decision|2|||
105761442|NCT02088541|364781355|FG001|Overall Study|Physician Decision|1|||
105761443|NCT02088541|364781356|FG002|Overall Study|Physician Decision|2|||
105761444|NCT02088541|364781357|FG003|Overall Study|Physician Decision|0|||
105761445|NCT02088541|364781358|FG004|Overall Study|Physician Decision|2|||
105761446|NCT02088541|364781354|FG000|Overall Study|Disease progression|7|||
105761447|NCT02088541|364781355|FG001|Overall Study|Disease progression|1|||
105761448|NCT02088541|364781356|FG002|Overall Study|Disease progression|2|||
105761449|NCT02088541|364781357|FG003|Overall Study|Disease progression|3|||
105761450|NCT02088541|364781358|FG004|Overall Study|Disease progression|1|||
105761451|NCT02088541|364781354|FG000|Overall Study|Study terminated by sponsor|1|||
105761452|NCT02088541|364781355|FG001|Overall Study|Study terminated by sponsor|1|||
105761453|NCT02088541|364781356|FG002|Overall Study|Study terminated by sponsor|12|||
105761454|NCT02088541|364781357|FG003|Overall Study|Study terminated by sponsor|2|||
105761455|NCT02088541|364781358|FG004|Overall Study|Study terminated by sponsor|6|||
105761456|NCT02088541|364781354|FG000|Overall Study|Withdrawal by Subject|3|||
105808003|NCT01621490|364954866|FG003|Overall Study|Study drug toxicity|3|||
105761457|NCT02088541|364781355|FG001|Overall Study|Withdrawal by Subject|2|||
105761458|NCT02088541|364781356|FG002|Overall Study|Withdrawal by Subject|9|||
105761459|NCT02088541|364781357|FG003|Overall Study|Withdrawal by Subject|7|||
105761460|NCT02088541|364781358|FG004|Overall Study|Withdrawal by Subject|10|||
105808004|NCT01621490|364954867|FG004|Overall Study|Study drug toxicity|1|||
105808005|NCT01621490|364954868|FG005|Overall Study|Study drug toxicity|10|||
105808006|NCT01621490|364954869|FG006|Overall Study|Study drug toxicity|1|||
105808007|NCT01621490|364954870|FG007|Overall Study|Study drug toxicity|4|||
105808008|NCT01621490|364954871|FG008|Overall Study|Study drug toxicity|1|||
105761461|NCT02088541|364781354|FG000|Overall Study|Other|2|||
105761462|NCT02088541|364781355|FG001|Overall Study|Other|1|||
105761463|NCT02088541|364781356|FG002|Overall Study|Other|3|||
105761464|NCT02088541|364781357|FG003|Overall Study|Other|1|||
105761465|NCT02088541|364781358|FG004|Overall Study|Other|1|||
105761466|NCT03750240|364781359|FG000|Overall Study|Technical Difficulties|2|||
105761467|NCT03706040|364781360|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
105761468|NCT03706040|364781361|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
105761469|NCT03706040|364781362|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
105761470|NCT03706040|364781363|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
105761471|NCT03706040|364781364|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
105761472|NCT03706040|364781365|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
105761473|NCT03706040|364781366|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
105761474|NCT03706040|364781360|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
105761475|NCT03706040|364781361|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
105761476|NCT03706040|364781362|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
105761477|NCT03706040|364781363|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
105761478|NCT03706040|364781364|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
105761479|NCT03706040|364781365|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
105761480|NCT03706040|364781366|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
105761481|NCT03706040|364781360|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
105761482|NCT03706040|364781361|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
105761483|NCT03706040|364781362|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
105761484|NCT03706040|364781363|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
105761485|NCT03706040|364781364|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
105761486|NCT03706040|364781365|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
105761487|NCT03706040|364781366|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
105761488|NCT03706040|364781360|FG000|Period A (Week 0 to Week 16)|Other|2|||
105761489|NCT03706040|364781361|FG001|Period A (Week 0 to Week 16)|Other|0|||
105761490|NCT03706040|364781362|FG002|Period A (Week 0 to Week 16)|Other|2|||
105761491|NCT03706040|364781363|FG003|Period A (Week 0 to Week 16)|Other|0|||
105761492|NCT03706040|364781364|FG004|Period A (Week 0 to Week 16)|Other|0|||
105761493|NCT03706040|364781365|FG005|Period A (Week 0 to Week 16)|Other|0|||
105761494|NCT03706040|364781366|FG006|Period A (Week 0 to Week 16)|Other|0|||
105761495|NCT03706040|364781360|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
105761496|NCT03706040|364781361|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
105761497|NCT03706040|364781362|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
105761498|NCT03706040|364781363|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
105761499|NCT03706040|364781364|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
105761500|NCT03706040|364781365|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
105761501|NCT03706040|364781366|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
105761502|NCT03706040|364781360|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
105761503|NCT03706040|364781361|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
105761504|NCT03706040|364781362|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
105761505|NCT03706040|364781363|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
105761506|NCT03706040|364781364|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
105761507|NCT03706040|364781365|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
105761508|NCT03706040|364781366|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
105761509|NCT03706040|364781360|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761510|NCT03706040|364781361|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761511|NCT03706040|364781362|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761512|NCT03706040|364781363|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761513|NCT03706040|364781364|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
105761514|NCT03706040|364781365|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
105761515|NCT03706040|364781366|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
105761516|NCT03706040|364781360|FG000|Period B (Week 16 to Week 52)|Other|0|||
105761517|NCT03706040|364781361|FG001|Period B (Week 16 to Week 52)|Other|0|||
105761518|NCT03706040|364781362|FG002|Period B (Week 16 to Week 52)|Other|0|||
105808009|NCT01621490|364954872|FG009|Overall Study|Study drug toxicity|0|||
106016982|NCT00998296|365725924|FG003|Overall Study|Refused to continue taking trial med.|0|||
105761519|NCT03706040|364781363|FG003|Period B (Week 16 to Week 52)|Other|4|||
105761520|NCT03706040|364781364|FG004|Period B (Week 16 to Week 52)|Other|5|||
105808010|NCT01621490|364954873|FG010|Overall Study|Study drug toxicity|0|||
105808011|NCT01621490|364954863|FG000|Overall Study|Death|0|||
105808012|NCT01621490|364954864|FG001|Overall Study|Death|0|||
105808013|NCT01621490|364954865|FG002|Overall Study|Death|0|||
105808014|NCT01621490|364954866|FG003|Overall Study|Death|0|||
105808015|NCT01621490|364954867|FG004|Overall Study|Death|0|||
105808016|NCT01621490|364954868|FG005|Overall Study|Death|0|||
105808017|NCT01621490|364954869|FG006|Overall Study|Death|0|||
105808018|NCT01621490|364954870|FG007|Overall Study|Death|0|||
105808019|NCT01621490|364954871|FG008|Overall Study|Death|1|||
105808020|NCT01621490|364954872|FG009|Overall Study|Death|0|||
105808021|NCT01621490|364954873|FG010|Overall Study|Death|0|||
105808022|NCT01621490|364954863|FG000|Overall Study|Other reasons|7|||
105808023|NCT01621490|364954864|FG001|Overall Study|Other reasons|6|||
105808024|NCT01621490|364954865|FG002|Overall Study|Other reasons|4|||
105808025|NCT01621490|364954866|FG003|Overall Study|Other reasons|1|||
105808026|NCT01621490|364954867|FG004|Overall Study|Other reasons|1|||
105808027|NCT01621490|364954868|FG005|Overall Study|Other reasons|3|||
105808028|NCT01621490|364954869|FG006|Overall Study|Other reasons|1|||
105808029|NCT01621490|364954870|FG007|Overall Study|Other reasons|1|||
105808030|NCT01621490|364954871|FG008|Overall Study|Other reasons|1|||
105808031|NCT01621490|364954872|FG009|Overall Study|Other reasons|0|||
105808032|NCT01621490|364954873|FG010|Overall Study|Other reasons|0|||
105808033|NCT01144663|364954878|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
105808034|NCT01144663|364954879|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
105808035|NCT01144663|364954880|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
105808036|NCT01144663|364954881|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
105808037|NCT01144663|364954878|FG000|Primary Vaccination Phase|Adverse Event|1|||
105808038|NCT01144663|364954879|FG001|Primary Vaccination Phase|Adverse Event|0|||
105808039|NCT01144663|364954880|FG002|Primary Vaccination Phase|Adverse Event|0|||
106144304|NCT03169244|366189092|FG000|Overall Study|Physician Decision|1|||
106144305|NCT03169244|366189093|FG001|Overall Study|Physician Decision|0|||
106144306|NCT01266265|366189094|FG000|Overall Study|Death|95|||
106144307|NCT01266265|366189095|FG001|Overall Study|Death|73|||
106144308|NCT01266265|366189094|FG000|Overall Study|Lost to Follow-up|23|||
106144309|NCT01266265|366189095|FG001|Overall Study|Lost to Follow-up|28|||
106144310|NCT01266265|366189094|FG000|Overall Study|Withdrawal by Subject|13|||
106144311|NCT01266265|366189095|FG001|Overall Study|Withdrawal by Subject|11|||
106144312|NCT01266265|366189094|FG000|Overall Study|Respiratory-related adverse event|2|||
106144313|NCT01266265|366189095|FG001|Overall Study|Respiratory-related adverse event|1|||
106144314|NCT01266265|366189094|FG000|Overall Study|Transferred care to another provider|22|||
106144315|NCT01266265|366189095|FG001|Overall Study|Transferred care to another provider|28|||
106144316|NCT01266265|366189094|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
106144317|NCT01266265|366189095|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
106144318|NCT01266265|366189094|FG000|Overall Study|Enrolled in another clinical study|15|||
105808040|NCT01144663|364954881|FG003|Primary Vaccination Phase|Adverse Event|1|||
105808041|NCT01144663|364954878|FG000|Primary Vaccination Phase|Protocol Violation|2|||
106144319|NCT01266265|366189095|FG001|Overall Study|Enrolled in another clinical study|26|||
105808042|NCT01144663|364954879|FG001|Primary Vaccination Phase|Protocol Violation|0|||
106144320|NCT01266265|366189094|FG000|Overall Study|Non-compliance|8|||
106144321|NCT01266265|366189095|FG001|Overall Study|Non-compliance|5|||
106144322|NCT01266265|366189094|FG000|Overall Study|Lung transplant|6|||
106144323|NCT01266265|366189095|FG001|Overall Study|Lung transplant|5|||
106144324|NCT01266265|366189094|FG000|Overall Study|Site closed early|4|||
106144325|NCT01266265|366189095|FG001|Overall Study|Site closed early|3|||
105808043|NCT01144663|364954880|FG002|Primary Vaccination Phase|Protocol Violation|1|||
105808044|NCT01144663|364954881|FG003|Primary Vaccination Phase|Protocol Violation|0|||
106144326|NCT01266265|366189094|FG000|Overall Study|Clinical worsening|1|||
105808045|NCT01144663|364954878|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
105808046|NCT01144663|364954879|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
105808047|NCT01144663|364954880|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
105808048|NCT01144663|364954881|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
105808049|NCT01144663|364954878|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
105808050|NCT01144663|364954879|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
105808051|NCT01144663|364954880|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
105808052|NCT01144663|364954881|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
105808053|NCT01144663|364954878|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
105808054|NCT01144663|364954879|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
105808055|NCT01144663|364954880|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
105808056|NCT01144663|364954881|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
105808057|NCT01144663|364954878|FG000|Primary Vaccination Phase|Other|0|||
105808058|NCT01144663|364954879|FG001|Primary Vaccination Phase|Other|1|||
105808059|NCT01144663|364954880|FG002|Primary Vaccination Phase|Other|0|||
105808060|NCT01144663|364954881|FG003|Primary Vaccination Phase|Other|2|||
105808061|NCT01144663|364954878|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
106016983|NCT00998296|365725925|FG004|Overall Study|Refused to continue taking trial med.|0|||
106016984|NCT00998296|365725926|FG005|Overall Study|Refused to continue taking trial med.|0|||
106016985|NCT00998296|365725927|FG006|Overall Study|Refused to continue taking trial med.|0|||
106016986|NCT00998296|365725928|FG007|Overall Study|Refused to continue taking trial med.|0|||
105808062|NCT01144663|364954879|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
105761521|NCT03706040|364781365|FG005|Period B (Week 16 to Week 52)|Other|23|||
105761522|NCT03706040|364781366|FG006|Period B (Week 16 to Week 52)|Other|17|||
105761523|NCT00927758|364781367|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
105761524|NCT00927758|364781368|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
105761525|NCT00927758|364781369|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
105761526|NCT00927758|364781370|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
105761527|NCT00927758|364781371|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
105761528|NCT00927758|364781372|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
105761529|NCT00927758|364781367|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
105761530|NCT00927758|364781368|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
105761531|NCT00927758|364781369|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
105761532|NCT00927758|364781370|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
105761533|NCT00927758|364781371|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
105761534|NCT00927758|364781372|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
105761535|NCT00439725|364781374|FG000|Treatment Period|Withdrawal by Subject|22|||
105761536|NCT00439725|364781375|FG001|Treatment Period|Withdrawal by Subject|19|||
105761537|NCT00439725|364781374|FG000|Treatment Period|Study terminated by sponsor|156|||
105761538|NCT00439725|364781375|FG001|Treatment Period|Study terminated by sponsor|148|||
105761539|NCT00439725|364781374|FG000|Treatment Period|Site closed by investigator|1|||
105761540|NCT00439725|364781375|FG001|Treatment Period|Site closed by investigator|2|||
105761541|NCT00439725|364781374|FG000|Treatment Period|Adverse Event|39|||
105761542|NCT00439725|364781375|FG001|Treatment Period|Adverse Event|18|||
105761543|NCT00439725|364781374|FG000|Treatment Period|Physician Decision|1|||
105761544|NCT00439725|364781375|FG001|Treatment Period|Physician Decision|1|||
105761545|NCT00439725|364781374|FG000|Treatment Period|Protocol Violation|2|||
105761546|NCT00439725|364781375|FG001|Treatment Period|Protocol Violation|1|||
105761547|NCT00439725|364781374|FG000|Treatment Period|Clinical endpoint reached|6|||
105761548|NCT00439725|364781375|FG001|Treatment Period|Clinical endpoint reached|50|||
105761549|NCT00439725|364781374|FG000|Treatment Period|Technical problems|1|||
105761550|NCT00439725|364781375|FG001|Treatment Period|Technical problems|0|||
105761551|NCT00439725|364781374|FG000|Treatment Period|Lost to Follow-up|1|||
105761552|NCT00439725|364781375|FG001|Treatment Period|Lost to Follow-up|1|||
105761553|NCT00439725|364781374|FG000|Treatment Period|Participant convenience|1|||
105761554|NCT00439725|364781375|FG001|Treatment Period|Participant convenience|0|||
105761555|NCT00439725|364781374|FG000|Treatment Period|Protocol driven decision point|1|||
105761556|NCT00439725|364781375|FG001|Treatment Period|Protocol driven decision point|1|||
105761557|NCT00439725|364781374|FG000|Treatment Period|Death|1|||
105761558|NCT00439725|364781375|FG001|Treatment Period|Death|1|||
105761559|NCT00439725|364781374|FG000|Treatment Period|Participant did not receive treatment|4|||
105761560|NCT00439725|364781375|FG001|Treatment Period|Participant did not receive treatment|4|||
105761561|NCT00439725|364781374|FG000|Observational Period|Withdrawal by Subject|2|||
105761562|NCT00439725|364781375|FG001|Observational Period|Withdrawal by Subject|2|||
105761563|NCT00439725|364781374|FG000|Observational Period|Lost to Follow-up|0|||
105761564|NCT00439725|364781375|FG001|Observational Period|Lost to Follow-up|1|||
105761565|NCT00439725|364781374|FG000|Observational Period|Death|0|||
105761566|NCT00439725|364781375|FG001|Observational Period|Death|2|||
105761567|NCT00439725|364781374|FG000|Observational Period|Study termination by sponsor|1|||
105761568|NCT00439725|364781375|FG001|Observational Period|Study termination by sponsor|1|||
105761569|NCT00439725|364781374|FG000|Observational Period|Clinical endpoint reached|3|||
105761570|NCT00439725|364781375|FG001|Observational Period|Clinical endpoint reached|1|||
105761571|NCT00439725|364781374|FG000|Observational Period|Technical problems|1|||
105761572|NCT00439725|364781375|FG001|Observational Period|Technical problems|0|||
105761573|NCT00439725|364781374|FG000|Observational Period|Participant convenience|1|||
105761574|NCT00439725|364781375|FG001|Observational Period|Participant convenience|0|||
105761575|NCT01432457|364781376|FG000|Overall Study|Adverse Event|7|||
105761576|NCT01432457|364781377|FG001|Overall Study|Adverse Event|10|||
105761577|NCT01432457|364781378|FG002|Overall Study|Adverse Event|16|||
105761578|NCT01432457|364781376|FG000|Overall Study|Lack of Efficacy|2|||
105761579|NCT01432457|364781377|FG001|Overall Study|Lack of Efficacy|1|||
105761580|NCT01432457|364781378|FG002|Overall Study|Lack of Efficacy|1|||
105761581|NCT01432457|364781376|FG000|Overall Study|Lost to Follow-up|11|||
105761582|NCT01432457|364781377|FG001|Overall Study|Lost to Follow-up|15|||
105761583|NCT01432457|364781378|FG002|Overall Study|Lost to Follow-up|20|||
105761584|NCT01432457|364781376|FG000|Overall Study|Protocol Violation|3|||
105761585|NCT01432457|364781377|FG001|Overall Study|Protocol Violation|2|||
105761586|NCT01432457|364781378|FG002|Overall Study|Protocol Violation|6|||
105761587|NCT01432457|364781376|FG000|Overall Study|Withdrawal by Subject|6|||
105761588|NCT01432457|364781377|FG001|Overall Study|Withdrawal by Subject|11|||
105761589|NCT01432457|364781378|FG002|Overall Study|Withdrawal by Subject|9|||
105761590|NCT01432457|364781376|FG000|Overall Study|Reasons not defined|2|||
105761591|NCT01432457|364781377|FG001|Overall Study|Reasons not defined|3|||
105952381|NCT00833027|365488246|FG000|Overall Study|Missing|10|||
105808063|NCT01144663|364954880|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
106016987|NCT00998296|365725929|FG008|Overall Study|Refused to continue taking trial med.|0|||
105952382|NCT01342926|365488260|FG000|Overall Study|Adverse Event|5|||
105952383|NCT01342926|365488261|FG001|Overall Study|Adverse Event|8|||
105952384|NCT01342926|365488262|FG002|Overall Study|Adverse Event|10|||
105952385|NCT01342926|365488263|FG003|Overall Study|Adverse Event|7|||
105952386|NCT01342926|365488260|FG000|Overall Study|Lost to Follow-up|0|||
105952387|NCT01342926|365488261|FG001|Overall Study|Lost to Follow-up|1|||
105952388|NCT01342926|365488262|FG002|Overall Study|Lost to Follow-up|1|||
105952389|NCT01342926|365488263|FG003|Overall Study|Lost to Follow-up|0|||
105952390|NCT01342926|365488260|FG000|Overall Study|Investigator Discretion|2|||
105952391|NCT01342926|365488261|FG001|Overall Study|Investigator Discretion|2|||
105952392|NCT01342926|365488262|FG002|Overall Study|Investigator Discretion|0|||
105952393|NCT01342926|365488263|FG003|Overall Study|Investigator Discretion|0|||
105952394|NCT01342926|365488260|FG000|Overall Study|Withdrawal by Subject|2|||
105952395|NCT01342926|365488261|FG001|Overall Study|Withdrawal by Subject|4|||
105952396|NCT01342926|365488262|FG002|Overall Study|Withdrawal by Subject|3|||
105952397|NCT01342926|365488263|FG003|Overall Study|Withdrawal by Subject|5|||
105952398|NCT03382912|365488264|FG000|Overall Study|Physician Decision|0|||
105952399|NCT03382912|365488265|FG001|Overall Study|Physician Decision|1|||
105952400|NCT03382912|365488264|FG000|Overall Study|Sponsor Decision|6|||
105952401|NCT03382912|365488265|FG001|Overall Study|Sponsor Decision|6|||
105952402|NCT03382912|365488264|FG000|Overall Study|Withdrawal by Subject|0|||
105952403|NCT03382912|365488265|FG001|Overall Study|Withdrawal by Subject|5|||
105952404|NCT02891226|365488270|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
105952405|NCT02891226|365488271|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
105952406|NCT02891226|365488272|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
105952407|NCT02891226|365488273|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952408|NCT02891226|365488274|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105808064|NCT01144663|364954881|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
105952409|NCT02891226|365488275|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952410|NCT02891226|365488276|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952411|NCT02891226|365488277|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952412|NCT02891226|365488278|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952413|NCT02891226|365488279|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952414|NCT02891226|365488280|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952415|NCT02891226|365488281|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952416|NCT02891226|365488282|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952417|NCT02891226|365488283|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952418|NCT02891226|365488284|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952419|NCT02891226|365488285|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
105952420|NCT02891226|365488270|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
105952421|NCT02891226|365488271|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
105952422|NCT02891226|365488272|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952423|NCT02891226|365488273|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952424|NCT02891226|365488274|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952425|NCT02891226|365488275|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952426|NCT02891226|365488276|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952427|NCT02891226|365488277|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952428|NCT02891226|365488278|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952429|NCT02891226|365488279|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952430|NCT02891226|365488280|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952431|NCT02891226|365488281|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952432|NCT02891226|365488282|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952433|NCT02891226|365488283|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952434|NCT02891226|365488284|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952435|NCT02891226|365488285|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105952436|NCT02891226|365488270|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952437|NCT02891226|365488271|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952438|NCT02891226|365488272|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952439|NCT02891226|365488273|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
105952440|NCT02891226|365488274|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952441|NCT02891226|365488275|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952442|NCT02891226|365488276|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952443|NCT02891226|365488277|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952444|NCT02891226|365488278|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952445|NCT02891226|365488279|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952446|NCT02891226|365488280|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
106144327|NCT01266265|366189095|FG001|Overall Study|Clinical worsening|1|||
106144328|NCT00955825|366189098|FG000|Overall Study|Adverse Event|15|||
106144329|NCT00955825|366189099|FG001|Overall Study|Adverse Event|2|||
106144330|NCT00955825|366189098|FG000|Overall Study|Withdrawal by Subject|4|||
106144331|NCT00955825|366189099|FG001|Overall Study|Withdrawal by Subject|6|||
106144332|NCT00955825|366189098|FG000|Overall Study|Any other reason not above-mentioned|7|||
106144333|NCT00955825|366189099|FG001|Overall Study|Any other reason not above-mentioned|9|||
106144334|NCT01759264|366189102|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
106144335|NCT01759264|366189102|FG000|Overall Study|Adverse Event|1|||
106144336|NCT01759264|366189102|FG000|Overall Study|Other|2|||
106144337|NCT01759264|366189102|FG000|Overall Study|Lost to Follow-up|2|||
106144338|NCT01759264|366189102|FG000|Overall Study|Withdrawal by Subject|3|||
106144339|NCT01759264|366189102|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
106144340|NCT00114244|366189104|FG000|Overall Study|Adverse Event|2|||
106144341|NCT00114244|366189105|FG001|Overall Study|Adverse Event|5|||
106144342|NCT00114244|366189104|FG000|Overall Study|Withdrawal by Subject|0|||
106144343|NCT00114244|366189105|FG001|Overall Study|Withdrawal by Subject|2|||
106144344|NCT02383472|366189106|FG000|Overall Study|Withdrawal by Subject|1|||
106144345|NCT02383472|366189107|FG001|Overall Study|Withdrawal by Subject|1|||
106144346|NCT02013830|366189108|FG000|Overall Study|Adverse Event|3|||
106144347|NCT02013830|366189108|FG000|Overall Study|Death|1|||
106144348|NCT02013830|366189108|FG000|Overall Study|Insufficient therapeutic response|25|||
106144349|NCT02013830|366189108|FG000|Overall Study|Refused treatment|1|||
106144350|NCT01111526|366189109|FG000|Overall Study|GVHD Disease Progression|0|||
106144351|NCT01111526|366189110|FG001|Overall Study|GVHD Disease Progression|1|||
106144352|NCT01111526|366189111|FG002|Overall Study|GVHD Disease Progression|2|||
106144353|NCT00186186|366189112|FG000|Overall Study|Lack of Efficacy|3|||
106144354|NCT00186186|366189112|FG000|Overall Study|Withdrawal by Subject|3|||
106144355|NCT00186186|366189112|FG000|Overall Study|Not reported as to reason|2|||
106144356|NCT01307267|366189115|FG000|Overall Study|Death|4|||
106144357|NCT01307267|366189116|FG001|Overall Study|Death|3|||
106144358|NCT01307267|366189117|FG002|Overall Study|Death|5|||
106144359|NCT01307267|366189118|FG003|Overall Study|Death|3|||
106144360|NCT01307267|366189119|FG004|Overall Study|Death|1|||
106144361|NCT01307267|366189120|FG005|Overall Study|Death|26|||
106144362|NCT01307267|366189121|FG006|Overall Study|Death|2|||
106144363|NCT01307267|366189122|FG007|Overall Study|Death|2|||
106144364|NCT01307267|366189123|FG008|Overall Study|Death|21|||
106144365|NCT01307267|366189124|FG009|Overall Study|Death|2|||
106144366|NCT01307267|366189125|FG010|Overall Study|Death|3|||
106144367|NCT01307267|366189126|FG011|Overall Study|Death|9|||
106144368|NCT01307267|366189127|FG012|Overall Study|Death|0|||
106144369|NCT01307267|366189128|FG013|Overall Study|Death|0|||
106144370|NCT01307267|366189129|FG014|Overall Study|Death|0|||
106144371|NCT01307267|366189130|FG015|Overall Study|Death|0|||
106144372|NCT01307267|366189131|FG016|Overall Study|Death|1|||
106144373|NCT01307267|366189132|FG017|Overall Study|Death|1|||
106144374|NCT01307267|366189133|FG018|Overall Study|Death|2|||
106144375|NCT01307267|366189134|FG019|Overall Study|Death|8|||
106144376|NCT01307267|366189135|FG020|Overall Study|Death|1|||
106144377|NCT01307267|366189136|FG021|Overall Study|Death|2|||
106144378|NCT01307267|366189137|FG022|Overall Study|Death|2|||
106144379|NCT01307267|366189115|FG000|Overall Study|Lost to Follow-up|0|||
106144380|NCT01307267|366189116|FG001|Overall Study|Lost to Follow-up|0|||
106144381|NCT01307267|366189117|FG002|Overall Study|Lost to Follow-up|0|||
106144382|NCT01307267|366189118|FG003|Overall Study|Lost to Follow-up|0|||
106144383|NCT01307267|366189119|FG004|Overall Study|Lost to Follow-up|0|||
106144384|NCT01307267|366189120|FG005|Overall Study|Lost to Follow-up|7|||
106144385|NCT01307267|366189121|FG006|Overall Study|Lost to Follow-up|0|||
106144386|NCT01307267|366189122|FG007|Overall Study|Lost to Follow-up|0|||
106144387|NCT01307267|366189123|FG008|Overall Study|Lost to Follow-up|1|||
106144388|NCT01307267|366189124|FG009|Overall Study|Lost to Follow-up|2|||
106144389|NCT01307267|366189125|FG010|Overall Study|Lost to Follow-up|1|||
106144390|NCT01307267|366189126|FG011|Overall Study|Lost to Follow-up|0|||
106144391|NCT01307267|366189127|FG012|Overall Study|Lost to Follow-up|0|||
106144392|NCT01307267|366189128|FG013|Overall Study|Lost to Follow-up|0|||
106144393|NCT01307267|366189129|FG014|Overall Study|Lost to Follow-up|0|||
106144394|NCT01307267|366189130|FG015|Overall Study|Lost to Follow-up|0|||
106144395|NCT01307267|366189131|FG016|Overall Study|Lost to Follow-up|0|||
106144396|NCT01307267|366189132|FG017|Overall Study|Lost to Follow-up|0|||
106144397|NCT01307267|366189133|FG018|Overall Study|Lost to Follow-up|0|||
106144398|NCT01307267|366189134|FG019|Overall Study|Lost to Follow-up|2|||
106144399|NCT01307267|366189135|FG020|Overall Study|Lost to Follow-up|0|||
106144400|NCT01307267|366189136|FG021|Overall Study|Lost to Follow-up|0|||
106144401|NCT01307267|366189137|FG022|Overall Study|Lost to Follow-up|0|||
106144402|NCT01307267|366189115|FG000|Overall Study|Withdrawal by Subject|0|||
106144403|NCT01307267|366189116|FG001|Overall Study|Withdrawal by Subject|0|||
106144404|NCT01307267|366189117|FG002|Overall Study|Withdrawal by Subject|0|||
106144405|NCT01307267|366189118|FG003|Overall Study|Withdrawal by Subject|0|||
106144406|NCT01307267|366189119|FG004|Overall Study|Withdrawal by Subject|0|||
106144407|NCT01307267|366189120|FG005|Overall Study|Withdrawal by Subject|1|||
106144408|NCT01307267|366189121|FG006|Overall Study|Withdrawal by Subject|0|||
106144409|NCT01307267|366189122|FG007|Overall Study|Withdrawal by Subject|1|||
106144410|NCT01307267|366189123|FG008|Overall Study|Withdrawal by Subject|5|||
106144411|NCT01307267|366189124|FG009|Overall Study|Withdrawal by Subject|1|||
106144412|NCT01307267|366189125|FG010|Overall Study|Withdrawal by Subject|1|||
106144413|NCT01307267|366189126|FG011|Overall Study|Withdrawal by Subject|1|||
106144414|NCT01307267|366189127|FG012|Overall Study|Withdrawal by Subject|0|||
106144415|NCT01307267|366189128|FG013|Overall Study|Withdrawal by Subject|0|||
105761592|NCT01432457|364781378|FG002|Overall Study|Reasons not defined|4|||
105761593|NCT01432457|364781376|FG000|Overall Study|Did not take study drug|6|||
105761594|NCT01432457|364781377|FG001|Overall Study|Did not take study drug|6|||
105761595|NCT01432457|364781378|FG002|Overall Study|Did not take study drug|3|||
105761596|NCT01105936|364781379|FG000|Period 1|Adverse Event|0|||
105761597|NCT01105936|364781380|FG001|Period 1|Adverse Event|0|||
105761598|NCT01105936|364781381|FG002|Period 1|Adverse Event|0|||
105761599|NCT01105936|364781382|FG003|Period 1|Adverse Event|1|||
105761600|NCT01105936|364781379|FG000|Period 2|Adverse Event|1|||
105761601|NCT01105936|364781380|FG001|Period 2|Adverse Event|0|||
105761602|NCT01105936|364781381|FG002|Period 2|Adverse Event|0|||
105761603|NCT01105936|364781382|FG003|Period 2|Adverse Event|0|||
105761604|NCT01105936|364781379|FG000|Period 3|Protocol Violation|0|||
105761605|NCT01105936|364781380|FG001|Period 3|Protocol Violation|2|||
105761606|NCT01105936|364781381|FG002|Period 3|Protocol Violation|0|||
105761607|NCT01105936|364781382|FG003|Period 3|Protocol Violation|0|||
105761608|NCT01673490|364781383|FG000|Overall Study|Lost to Follow-up|1|||
105761609|NCT01673490|364781383|FG000|Overall Study|Adverse Event|3|||
105761610|NCT01673490|364781383|FG000|Overall Study|Withdrawal by Subject|3|||
105761611|NCT04134728|364781384|FG000|Overall Study|Adverse Event|3|||
105761612|NCT04134728|364781385|FG001|Overall Study|Adverse Event|2|||
105761613|NCT04134728|364781386|FG002|Overall Study|Adverse Event|9|||
105761614|NCT04134728|364781387|FG003|Overall Study|Adverse Event|0|||
105761615|NCT04134728|364781388|FG004|Overall Study|Adverse Event|0|||
105761616|NCT04134728|364781389|FG005|Overall Study|Adverse Event|0|||
105761617|NCT04134728|364781384|FG000|Overall Study|Lack of Efficacy|3|||
105761618|NCT04134728|364781385|FG001|Overall Study|Lack of Efficacy|3|||
105761619|NCT04134728|364781386|FG002|Overall Study|Lack of Efficacy|1|||
105761620|NCT04134728|364781387|FG003|Overall Study|Lack of Efficacy|2|||
105761621|NCT04134728|364781388|FG004|Overall Study|Lack of Efficacy|0|||
105761622|NCT04134728|364781389|FG005|Overall Study|Lack of Efficacy|0|||
105761623|NCT04134728|364781384|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
105761624|NCT04134728|364781385|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105761625|NCT04134728|364781386|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
105761626|NCT04134728|364781387|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105761627|NCT04134728|364781388|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105761628|NCT04134728|364781389|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105808065|NCT01144663|364954878|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
105761629|NCT04134728|364781384|FG000|Overall Study|Protocol Deviation|0|||
105761630|NCT04134728|364781385|FG001|Overall Study|Protocol Deviation|0|||
105761631|NCT04134728|364781386|FG002|Overall Study|Protocol Deviation|1|||
105761632|NCT04134728|364781387|FG003|Overall Study|Protocol Deviation|0|||
105761633|NCT04134728|364781388|FG004|Overall Study|Protocol Deviation|0|||
105761634|NCT04134728|364781389|FG005|Overall Study|Protocol Deviation|0|||
105761635|NCT04134728|364781384|FG000|Overall Study|Informed Consent Withdrawn|3|||
105761636|NCT04134728|364781385|FG001|Overall Study|Informed Consent Withdrawn|6|||
105761637|NCT04134728|364781386|FG002|Overall Study|Informed Consent Withdrawn|8|||
105952447|NCT02891226|365488281|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952448|NCT02891226|365488282|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952449|NCT02891226|365488283|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952450|NCT02891226|365488284|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952451|NCT02891226|365488285|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105952452|NCT02891226|365488270|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952453|NCT02891226|365488271|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952454|NCT02891226|365488272|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
106144416|NCT01307267|366189129|FG014|Overall Study|Withdrawal by Subject|0|||
106144417|NCT01307267|366189130|FG015|Overall Study|Withdrawal by Subject|0|||
106144418|NCT01307267|366189131|FG016|Overall Study|Withdrawal by Subject|0|||
106144419|NCT01307267|366189132|FG017|Overall Study|Withdrawal by Subject|0|||
106144420|NCT01307267|366189133|FG018|Overall Study|Withdrawal by Subject|0|||
106144421|NCT01307267|366189134|FG019|Overall Study|Withdrawal by Subject|3|||
106144422|NCT01307267|366189135|FG020|Overall Study|Withdrawal by Subject|0|||
106144423|NCT01307267|366189136|FG021|Overall Study|Withdrawal by Subject|0|||
106144424|NCT01307267|366189137|FG022|Overall Study|Withdrawal by Subject|0|||
106144425|NCT01307267|366189115|FG000|Overall Study|Other|0|||
106144426|NCT01307267|366189116|FG001|Overall Study|Other|0|||
106144427|NCT01307267|366189117|FG002|Overall Study|Other|0|||
106144428|NCT01307267|366189118|FG003|Overall Study|Other|0|||
106144429|NCT01307267|366189119|FG004|Overall Study|Other|0|||
106144430|NCT01307267|366189120|FG005|Overall Study|Other|7|||
106144431|NCT01307267|366189121|FG006|Overall Study|Other|0|||
106144432|NCT01307267|366189122|FG007|Overall Study|Other|1|||
106144433|NCT01307267|366189123|FG008|Overall Study|Other|3|||
106144434|NCT01307267|366189124|FG009|Overall Study|Other|0|||
106144435|NCT01307267|366189125|FG010|Overall Study|Other|1|||
106144436|NCT01307267|366189126|FG011|Overall Study|Other|1|||
106144437|NCT01307267|366189127|FG012|Overall Study|Other|1|||
106144438|NCT01307267|366189128|FG013|Overall Study|Other|0|||
106144439|NCT01307267|366189129|FG014|Overall Study|Other|2|||
106144440|NCT01307267|366189130|FG015|Overall Study|Other|1|||
106144441|NCT01307267|366189131|FG016|Overall Study|Other|0|||
106144442|NCT01307267|366189132|FG017|Overall Study|Other|0|||
106144443|NCT01307267|366189133|FG018|Overall Study|Other|0|||
106144444|NCT01307267|366189134|FG019|Overall Study|Other|19|||
106144445|NCT01307267|366189135|FG020|Overall Study|Other|2|||
106144446|NCT01307267|366189136|FG021|Overall Study|Other|3|||
106144447|NCT01307267|366189137|FG022|Overall Study|Other|2|||
106144448|NCT05174013|366189138|FG000|Overall Study|Lost to Follow-up|0|||
106144449|NCT05174013|366189139|FG001|Overall Study|Lost to Follow-up|0|||
106144450|NCT05174013|366189140|FG002|Overall Study|Lost to Follow-up|0|||
106144451|NCT05174013|366189141|FG003|Overall Study|Lost to Follow-up|1|||
106144452|NCT05174013|366189142|FG004|Overall Study|Lost to Follow-up|0|||
106144453|NCT05174013|366189143|FG005|Overall Study|Lost to Follow-up|0|||
106144454|NCT05174013|366189138|FG000|Overall Study|Withdrawal by Subject|0|||
106144455|NCT05174013|366189139|FG001|Overall Study|Withdrawal by Subject|0|||
106144456|NCT05174013|366189140|FG002|Overall Study|Withdrawal by Subject|1|||
106144457|NCT05174013|366189141|FG003|Overall Study|Withdrawal by Subject|0|||
106144458|NCT05174013|366189142|FG004|Overall Study|Withdrawal by Subject|0|||
106144459|NCT05174013|366189143|FG005|Overall Study|Withdrawal by Subject|0|||
106144460|NCT03593876|366189144|FG000|Overall Study|Withdrawal by Subject|1|||
106144461|NCT03593876|366189144|FG000|Overall Study|Discharged home before intervention completion|2|||
106144462|NCT03622580|366189147|FG000|Overall Study|Death|16|||
106144463|NCT03622580|366189148|FG001|Overall Study|Death|21|||
106144464|NCT03622580|366189149|FG002|Overall Study|Death|13|||
106144465|NCT03622580|366189147|FG000|Overall Study|Adverse Event|6|||
106144466|NCT03622580|366189148|FG001|Overall Study|Adverse Event|6|||
106144467|NCT03622580|366189149|FG002|Overall Study|Adverse Event|5|||
106144468|NCT03622580|366189147|FG000|Overall Study|Withdrawal by Subject|12|||
106144469|NCT03622580|366189148|FG001|Overall Study|Withdrawal by Subject|7|||
106144470|NCT03622580|366189149|FG002|Overall Study|Withdrawal by Subject|19|||
106144471|NCT03622580|366189147|FG000|Overall Study|Lost to Follow-up|12|||
106144472|NCT03622580|366189148|FG001|Overall Study|Lost to Follow-up|9|||
106144473|NCT03622580|366189149|FG002|Overall Study|Lost to Follow-up|9|||
106144474|NCT03622580|366189147|FG000|Overall Study|Protocol Violation|1|||
106144475|NCT03622580|366189148|FG001|Overall Study|Protocol Violation|0|||
106144476|NCT03622580|366189149|FG002|Overall Study|Protocol Violation|1|||
106144477|NCT03622580|366189147|FG000|Overall Study|Physician Decision|3|||
106144478|NCT03622580|366189148|FG001|Overall Study|Physician Decision|0|||
106144479|NCT03622580|366189149|FG002|Overall Study|Physician Decision|1|||
106144480|NCT03622580|366189147|FG000|Overall Study|Pregnancy|0|||
105952455|NCT02891226|365488273|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
106144481|NCT03622580|366189148|FG001|Overall Study|Pregnancy|1|||
106144482|NCT03622580|366189149|FG002|Overall Study|Pregnancy|0|||
106144483|NCT03622580|366189147|FG000|Overall Study|Lack of Efficacy|0|||
106144484|NCT03622580|366189148|FG001|Overall Study|Lack of Efficacy|0|||
106144485|NCT03622580|366189149|FG002|Overall Study|Lack of Efficacy|1|||
106144486|NCT03622580|366189147|FG000|Overall Study|Other|2|||
105808066|NCT01144663|364954879|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
105808067|NCT01144663|364954880|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
105808068|NCT01144663|364954881|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
105808069|NCT01144663|364954878|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
105808070|NCT01144663|364954879|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
106016988|NCT00998296|365725930|FG009|Overall Study|Refused to continue taking trial med.|2|||
106016989|NCT00998296|365725931|FG010|Overall Study|Refused to continue taking trial med.|0|||
106016990|NCT00998296|365725921|FG000|Overall Study|Reason other than those specified above|0|||
106016991|NCT00998296|365725922|FG001|Overall Study|Reason other than those specified above|0|||
106016992|NCT00998296|365725923|FG002|Overall Study|Reason other than those specified above|0|||
106016993|NCT00998296|365725924|FG003|Overall Study|Reason other than those specified above|0|||
106016994|NCT00998296|365725925|FG004|Overall Study|Reason other than those specified above|0|||
106016995|NCT00998296|365725926|FG005|Overall Study|Reason other than those specified above|0|||
106016996|NCT00998296|365725927|FG006|Overall Study|Reason other than those specified above|0|||
106016997|NCT00998296|365725928|FG007|Overall Study|Reason other than those specified above|0|||
106016998|NCT00998296|365725929|FG008|Overall Study|Reason other than those specified above|0|||
106016999|NCT00998296|365725930|FG009|Overall Study|Reason other than those specified above|1|||
106017000|NCT00998296|365725931|FG010|Overall Study|Reason other than those specified above|0|||
106017001|NCT02346721|365725932|FG000|Overall Study|Withdrew Consent|3|||
106017002|NCT02346721|365725932|FG000|Overall Study|Lack of Efficacy|1|||
106017003|NCT04396639|365725933|FG000|Overall Study|Withdrawal by Subject|1|||
106017004|NCT04396639|365725933|FG000|Overall Study|Other|1|||
106017005|NCT04988295|365725939|FG000|Overall Study|Withdrawal by Subject|9|||
106017006|NCT04988295|365725940|FG001|Overall Study|Withdrawal by Subject|29|||
106017007|NCT04988295|365725941|FG002|Overall Study|Withdrawal by Subject|6|||
106017008|NCT04988295|365725942|FG003|Overall Study|Withdrawal by Subject|0|||
106017009|NCT04988295|365725939|FG000|Overall Study|Lost to Follow-up|1|||
106017010|NCT04988295|365725940|FG001|Overall Study|Lost to Follow-up|0|||
106017011|NCT04988295|365725941|FG002|Overall Study|Lost to Follow-up|0|||
106017012|NCT04988295|365725942|FG003|Overall Study|Lost to Follow-up|0|||
106017013|NCT04988295|365725939|FG000|Overall Study|Study participation ongoing|186|||
106017014|NCT04988295|365725940|FG001|Overall Study|Study participation ongoing|169|||
105808071|NCT01144663|364954880|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
106017015|NCT04988295|365725941|FG002|Overall Study|Study participation ongoing|99|||
106017016|NCT04988295|365725942|FG003|Overall Study|Study participation ongoing|119|||
106017017|NCT03126591|365725943|FG000|Overall Study|Death|6|||
106017018|NCT03126591|365725944|FG001|Overall Study|Death|3|||
105952456|NCT02891226|365488274|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952457|NCT02891226|365488275|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952458|NCT02891226|365488276|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952459|NCT02891226|365488277|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952460|NCT02891226|365488278|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952461|NCT02891226|365488279|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952462|NCT02891226|365488280|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952463|NCT02891226|365488281|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952464|NCT02891226|365488282|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952465|NCT02891226|365488283|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952466|NCT02891226|365488284|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952467|NCT02891226|365488285|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
105952468|NCT02891226|365488270|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952469|NCT02891226|365488271|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952470|NCT02891226|365488272|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952471|NCT02891226|365488273|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
105952472|NCT02891226|365488274|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952473|NCT02891226|365488275|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952474|NCT02891226|365488276|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952475|NCT02891226|365488277|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952476|NCT02891226|365488278|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952477|NCT02891226|365488279|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952478|NCT02891226|365488280|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952479|NCT02891226|365488281|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952480|NCT02891226|365488282|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952481|NCT02891226|365488283|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952482|NCT02891226|365488284|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952483|NCT02891226|365488285|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
105952484|NCT02891226|365488270|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952485|NCT02891226|365488271|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952486|NCT02891226|365488272|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952487|NCT02891226|365488273|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
105952488|NCT02891226|365488274|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952489|NCT02891226|365488275|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952490|NCT02891226|365488276|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952491|NCT02891226|365488277|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
106144487|NCT03622580|366189148|FG001|Overall Study|Other|0|||
106144488|NCT03622580|366189149|FG002|Overall Study|Other|3|||
106144489|NCT03959241|366189150|FG000|Overall Study|Withdrawal by Subject|7|||
106144490|NCT03959241|366189151|FG001|Overall Study|Withdrawal by Subject|8|||
106144491|NCT03959241|366189150|FG000|Overall Study|Lost to Follow-up|1|||
106144492|NCT03959241|366189151|FG001|Overall Study|Lost to Follow-up|0|||
106144493|NCT03959241|366189150|FG000|Overall Study|Move to Hospice Care|1|||
106144494|NCT03959241|366189151|FG001|Overall Study|Move to Hospice Care|0|||
106144495|NCT03959241|366189150|FG000|Overall Study|Screen Failure|1|||
106144496|NCT03959241|366189151|FG001|Overall Study|Screen Failure|0|||
106144497|NCT03959241|366189150|FG000|Overall Study|Disease Relapse|0|||
106144498|NCT03959241|366189151|FG001|Overall Study|Disease Relapse|1|||
106144499|NCT03959241|366189150|FG000|Overall Study|Off Study|1|||
106144500|NCT03959241|366189151|FG001|Overall Study|Off Study|0|||
106144501|NCT01087762|366189152|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
106144502|NCT01087762|366189153|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
106144503|NCT01087762|366189154|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
106144504|NCT01087762|366189155|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
106144505|NCT01087762|366189156|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
106144506|NCT01087762|366189152|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
106144507|NCT01087762|366189153|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
106144508|NCT01087762|366189154|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
106144509|NCT01087762|366189155|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
105952492|NCT02891226|365488278|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952493|NCT02891226|365488279|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105808072|NCT01144663|364954881|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
105808073|NCT01144663|364954878|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
105808074|NCT01144663|364954879|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
105808075|NCT01144663|364954880|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
105808076|NCT01144663|364954881|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
105808077|NCT01144663|364954878|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
105808078|NCT01144663|364954879|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
105808079|NCT01144663|364954880|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
105808080|NCT01144663|364954881|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
105808081|NCT01144663|364954878|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
105808082|NCT01144663|364954879|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
105808083|NCT01144663|364954880|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
105808084|NCT01144663|364954881|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
105808085|NCT01267266|364954883|FG000|Enrollment Phase|Withdrawal by Subject|2|||
105808086|NCT01267266|364954884|FG001|Enrollment Phase|Withdrawal by Subject|0|||
105808087|NCT01267266|364954883|FG000|Lead-in Phase|Lack of Efficacy|20|||
105808088|NCT01267266|364954884|FG001|Lead-in Phase|Lack of Efficacy|0|||
105808089|NCT01267266|364954883|FG000|Lead-in Phase|Adverse Event|2|||
105808090|NCT01267266|364954884|FG001|Lead-in Phase|Adverse Event|0|||
105808091|NCT01267266|364954883|FG000|Lead-in Phase|Withdrawal by Subject|1|||
105808092|NCT01267266|364954884|FG001|Lead-in Phase|Withdrawal by Subject|0|||
105808093|NCT01335477|364954885|FG000|Overall Study|Adverse Event|30|||
105808094|NCT01335477|364954886|FG001|Overall Study|Adverse Event|42|||
105808095|NCT01335477|364954885|FG000|Overall Study|Non compliant with protocol|0|||
105808096|NCT01335477|364954886|FG001|Overall Study|Non compliant with protocol|2|||
105808097|NCT01335477|364954885|FG000|Overall Study|Lost to Follow-up|1|||
105808098|NCT01335477|364954886|FG001|Overall Study|Lost to Follow-up|2|||
105808099|NCT01335477|364954885|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
105808100|NCT01335477|364954886|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
105808101|NCT01335477|364954885|FG000|Overall Study|Not treated|1|||
106144510|NCT01087762|366189156|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
106144511|NCT01087762|366189152|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
106144512|NCT01087762|366189153|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
106144513|NCT01087762|366189154|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
106144514|NCT01087762|366189155|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
106144515|NCT01087762|366189156|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
106144516|NCT01087762|366189152|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
106144517|NCT01087762|366189153|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
106144518|NCT01087762|366189154|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
106144519|NCT01087762|366189155|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
106144520|NCT01087762|366189156|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
106144521|NCT01087762|366189152|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
106144522|NCT01087762|366189153|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
106144523|NCT01087762|366189154|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
106144524|NCT01087762|366189155|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
106144525|NCT01087762|366189156|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
106144526|NCT01087762|366189152|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
106144527|NCT01087762|366189153|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
106144528|NCT01087762|366189154|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
106144529|NCT01087762|366189155|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
106144530|NCT01087762|366189156|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
106144531|NCT01087762|366189152|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
106144532|NCT01087762|366189153|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
106144533|NCT01087762|366189154|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
106144534|NCT01087762|366189155|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
106144535|NCT01087762|366189156|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
106144536|NCT01087762|366189152|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
106144537|NCT01087762|366189153|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
106144538|NCT01087762|366189154|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
106144539|NCT01087762|366189155|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
106144540|NCT01087762|366189156|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
106144541|NCT01087762|366189152|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
106144542|NCT01087762|366189153|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
106144543|NCT01087762|366189154|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
106144544|NCT01087762|366189155|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
106144545|NCT01087762|366189156|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
106144546|NCT01087762|366189152|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
105808102|NCT01335477|364954886|FG001|Overall Study|Not treated|2|||
105808103|NCT01335477|364954885|FG000|Overall Study|Reason other than those stated above|2|||
105808104|NCT01335477|364954886|FG001|Overall Study|Reason other than those stated above|2|||
105808105|NCT03740698|364954887|FG000|Overall Study|Physician Decision|0|||
105808106|NCT03740698|364954888|FG001|Overall Study|Physician Decision|1|||
105808107|NCT03740698|364954889|FG002|Overall Study|Physician Decision|1|||
105808108|NCT01469364|364954890|FG000|Overall Study|Adverse Event|1|||
105808109|NCT01469364|364954890|FG000|Overall Study|Withdrawal by Subject|1|||
105808110|NCT00832078|364954891|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
105808111|NCT00832078|364954892|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
105808112|NCT00832078|364954891|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
105808113|NCT00832078|364954892|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
105808114|NCT01767597|364954893|FG000|Overall Study|Incomplete intervention|3|||
105808115|NCT01767597|364954894|FG001|Overall Study|Incomplete intervention|1|||
105808116|NCT01767597|364954893|FG000|Overall Study|Withdrawal by Subject|1|||
105808117|NCT01767597|364954894|FG001|Overall Study|Withdrawal by Subject|0|||
105808118|NCT00836927|364954896|FG000|Overall Study|Progressive disease|2|||
105808119|NCT00836927|364954897|FG001|Overall Study|Progressive disease|0|||
105808120|NCT00836927|364954898|FG002|Overall Study|Progressive disease|0|||
105808121|NCT00836927|364954899|FG003|Overall Study|Progressive disease|1|||
105808122|NCT00836927|364954900|FG004|Overall Study|Progressive disease|1|||
106144547|NCT01087762|366189153|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
106144548|NCT01087762|366189154|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
106144549|NCT01087762|366189155|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
106144550|NCT01087762|366189156|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
106144551|NCT01087762|366189152|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
106144552|NCT01087762|366189153|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
106144553|NCT01087762|366189154|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
106144554|NCT01087762|366189155|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
106144555|NCT01087762|366189156|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
106144556|NCT01087762|366189152|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
106144557|NCT01087762|366189153|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
106144558|NCT01087762|366189154|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
106144559|NCT01087762|366189155|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
106144560|NCT01087762|366189156|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
106144561|NCT01087762|366189152|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
106144562|NCT01087762|366189153|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
106144563|NCT01087762|366189154|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
106144564|NCT01087762|366189155|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
106144565|NCT01087762|366189156|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
106144566|NCT01140048|366189162|FG000|Overall Study|Physician Decision|1|||
106144567|NCT01140048|366189162|FG000|Overall Study|Withdrawal by Subject|13|||
106144568|NCT01140048|366189162|FG000|Overall Study|Lost to Follow-up|31|||
106144569|NCT00494780|366189163|FG000|Overall Study|Adverse Event|1|||
106144570|NCT00494780|366189164|FG001|Overall Study|Adverse Event|0|||
106144571|NCT00494780|366189163|FG000|Overall Study|Withdrew before Dosed|0|||
106144572|NCT00494780|366189164|FG001|Overall Study|Withdrew before Dosed|1|||
106144573|NCT00494780|366189163|FG000|Overall Study|Progression of Study Disease|7|||
106144574|NCT00494780|366189164|FG001|Overall Study|Progression of Study Disease|8|||
106144575|NCT00494780|366189163|FG000|Overall Study|New Treatment|2|||
106144576|NCT00494780|366189164|FG001|Overall Study|New Treatment|2|||
106144577|NCT00494780|366189163|FG000|Overall Study|Non-compliance|1|||
106144578|NCT00494780|366189164|FG001|Overall Study|Non-compliance|0|||
106144579|NCT00494780|366189163|FG000|Overall Study|Residual Tumour Mass|0|||
106144580|NCT00494780|366189164|FG001|Overall Study|Residual Tumour Mass|1|||
106144581|NCT00494780|366189163|FG000|Overall Study|Insurance Issues|0|||
106144582|NCT00494780|366189164|FG001|Overall Study|Insurance Issues|1|||
106144583|NCT01190007|366189165|FG000|Overall Study|Withdrawal by Subject|4|||
106144584|NCT01190007|366189165|FG000|Overall Study|Adverse Event|8|||
106144585|NCT01190007|366189165|FG000|Overall Study|Difficulty of visit for complications|1|||
106144586|NCT01190007|366189165|FG000|Overall Study|Participant was arrested|1|||
106144587|NCT03061474|366189170|FG000|Overall Study|Adverse Event|2|||
106144588|NCT03061474|366189171|FG001|Overall Study|Adverse Event|0|||
106144589|NCT03061474|366189170|FG000|Overall Study|Safety Risk|0|||
106144590|NCT03061474|366189171|FG001|Overall Study|Safety Risk|1|||
106144591|NCT03061474|366189170|FG000|Overall Study|Participant unwilling or unable to participate|0|||
106144592|NCT03061474|366189171|FG001|Overall Study|Participant unwilling or unable to participate|2|||
106144593|NCT03061474|366189170|FG000|Overall Study|Lost to Follow-up|0|||
106144594|NCT03061474|366189171|FG001|Overall Study|Lost to Follow-up|1|||
106144595|NCT01147341|366189172|FG000|Double Blind Period|Lack of Efficacy|1|||
106144596|NCT01147341|366189173|FG001|Double Blind Period|Lack of Efficacy|1|||
106144597|NCT01147341|366189172|FG000|Double Blind Period|Withdrawal by Subject|0|||
106144598|NCT01147341|366189173|FG001|Double Blind Period|Withdrawal by Subject|1|||
105808123|NCT00836927|364954896|FG000|Overall Study|Withdrawal by Subject|1|||
105808124|NCT00836927|364954897|FG001|Overall Study|Withdrawal by Subject|0|||
105808125|NCT00836927|364954898|FG002|Overall Study|Withdrawal by Subject|0|||
105808126|NCT00836927|364954899|FG003|Overall Study|Withdrawal by Subject|0|||
105808127|NCT00836927|364954900|FG004|Overall Study|Withdrawal by Subject|0|||
105808128|NCT00614055|364954902|FG000|Overall Study|Adverse Event|1|||
105808129|NCT00614055|364954903|FG001|Overall Study|Adverse Event|0|||
105808130|NCT00614055|364954904|FG002|Overall Study|Adverse Event|0|||
105808131|NCT00614055|364954902|FG000|Overall Study|Protocol Violation|2|||
105808132|NCT00614055|364954903|FG001|Overall Study|Protocol Violation|2|||
105808133|NCT00614055|364954904|FG002|Overall Study|Protocol Violation|1|||
105808134|NCT00614055|364954902|FG000|Overall Study|Lack of Efficacy|0|||
105808135|NCT00614055|364954903|FG001|Overall Study|Lack of Efficacy|0|||
105808136|NCT00614055|364954904|FG002|Overall Study|Lack of Efficacy|2|||
105952494|NCT02891226|365488280|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
106144599|NCT01147341|366189172|FG000|Open Label Period|Lack of Efficacy|3|||
106144600|NCT01147341|366189173|FG001|Open Label Period|Lack of Efficacy|0|||
106144601|NCT01147341|366189172|FG000|Open Label Period|Subject moved|1|||
106144602|NCT01147341|366189173|FG001|Open Label Period|Subject moved|0|||
106144603|NCT02888080|366189174|FG000|Overall Study|Subject / Guardian decision|1|||
106144604|NCT02888080|366189175|FG001|Overall Study|Subject / Guardian decision|3|||
106144605|NCT02888080|366189174|FG000|Overall Study|New Therapy for study indication|1|||
106144606|NCT02888080|366189175|FG001|Overall Study|New Therapy for study indication|0|||
106144607|NCT02888080|366189174|FG000|Overall Study|Lack of Efficacy|0|||
106144608|NCT02888080|366189175|FG001|Overall Study|Lack of Efficacy|1|||
106144609|NCT02888080|366189174|FG000|Overall Study|Adverse Event|0|||
106144610|NCT02888080|366189175|FG001|Overall Study|Adverse Event|1|||
106144611|NCT02314117|366189176|FG000|Overall Study|Lost to Follow-up|9|||
106144612|NCT02314117|366189177|FG001|Overall Study|Lost to Follow-up|14|||
106144613|NCT02314117|366189176|FG000|Overall Study|Withdrawal by Subject|3|||
106144614|NCT02314117|366189177|FG001|Overall Study|Withdrawal by Subject|2|||
106144615|NCT04439799|366189178|FG000|Overall Study|Lost to Follow-up|6|||
106144616|NCT04439799|366189179|FG001|Overall Study|Lost to Follow-up|6|||
106144617|NCT04439799|366189178|FG000|Overall Study|Withdrawal by Subject|2|||
106144618|NCT04439799|366189179|FG001|Overall Study|Withdrawal by Subject|6|||
106144619|NCT04439799|366189178|FG000|Overall Study|Adverse Event|2|||
106144620|NCT04439799|366189179|FG001|Overall Study|Adverse Event|5|||
106144621|NCT00666276|366189184|FG000|Overall Study|Protocol Violation|34|||
106144622|NCT00101010|366189188|FG000|Overall Study|Physician Decision|1|||
106144623|NCT00712335|366189193|FG000|Overall Study|Withdrawal by Subject|0|||
106144624|NCT00712335|366189194|FG001|Overall Study|Withdrawal by Subject|7|||
106144625|NCT00712335|366189195|FG002|Overall Study|Withdrawal by Subject|2|||
106144626|NCT00712335|366189196|FG003|Overall Study|Withdrawal by Subject|3|||
106144627|NCT00712335|366189197|FG004|Overall Study|Withdrawal by Subject|0|||
106144628|NCT00712335|366189193|FG000|Overall Study|Lost to Follow-up|2|||
106144629|NCT00712335|366189194|FG001|Overall Study|Lost to Follow-up|5|||
106144630|NCT00712335|366189195|FG002|Overall Study|Lost to Follow-up|0|||
106144631|NCT00712335|366189196|FG003|Overall Study|Lost to Follow-up|1|||
106144632|NCT00712335|366189197|FG004|Overall Study|Lost to Follow-up|0|||
106144633|NCT00712335|366189193|FG000|Overall Study|Protocol Violation|1|||
106144634|NCT00712335|366189194|FG001|Overall Study|Protocol Violation|2|||
106144635|NCT00712335|366189195|FG002|Overall Study|Protocol Violation|1|||
106144636|NCT00712335|366189196|FG003|Overall Study|Protocol Violation|0|||
106144637|NCT00712335|366189197|FG004|Overall Study|Protocol Violation|0|||
106144638|NCT00712335|366189193|FG000|Overall Study|Lack of Efficacy|0|||
106144639|NCT00712335|366189194|FG001|Overall Study|Lack of Efficacy|0|||
106144640|NCT00712335|366189195|FG002|Overall Study|Lack of Efficacy|1|||
106144641|NCT00712335|366189196|FG003|Overall Study|Lack of Efficacy|1|||
106144642|NCT00712335|366189197|FG004|Overall Study|Lack of Efficacy|0|||
106144643|NCT00712335|366189193|FG000|Overall Study|Other Reason|0|||
106144644|NCT00712335|366189194|FG001|Overall Study|Other Reason|3|||
106144645|NCT00712335|366189195|FG002|Overall Study|Other Reason|1|||
106144646|NCT00712335|366189196|FG003|Overall Study|Other Reason|0|||
106144647|NCT00712335|366189197|FG004|Overall Study|Other Reason|0|||
106144648|NCT03144674|366189200|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
106144649|NCT03144674|366189201|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
106144650|NCT03144674|366189202|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
106144651|NCT03144674|366189203|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
106144652|NCT03144674|366189200|FG000|Overall Study|Death|3|||
106144653|NCT03144674|366189201|FG001|Overall Study|Death|2|||
106144654|NCT03144674|366189202|FG002|Overall Study|Death|6|||
106144655|NCT03144674|366189203|FG003|Overall Study|Death|24|||
106144656|NCT03144674|366189200|FG000|Overall Study|Lost to Follow-up|0|||
106144657|NCT03144674|366189201|FG001|Overall Study|Lost to Follow-up|1|||
106144658|NCT03144674|366189202|FG002|Overall Study|Lost to Follow-up|0|||
106144659|NCT03144674|366189203|FG003|Overall Study|Lost to Follow-up|4|||
106144660|NCT03144674|366189200|FG000|Overall Study|Withdrawal by Participant|0|||
106144661|NCT03144674|366189201|FG001|Overall Study|Withdrawal by Participant|0|||
106144662|NCT03144674|366189202|FG002|Overall Study|Withdrawal by Participant|2|||
106144663|NCT03144674|366189203|FG003|Overall Study|Withdrawal by Participant|6|||
105808137|NCT00614055|364954902|FG000|Overall Study|Unclassified|1|||
105808138|NCT00614055|364954903|FG001|Overall Study|Unclassified|4|||
105808139|NCT00614055|364954904|FG002|Overall Study|Unclassified|2|||
106017019|NCT03126591|365725945|FG002|Overall Study|Death|17|||
105808140|NCT00096265|364954915|FG000|Overall Study|Ineligible|1|||
105808141|NCT00096265|364954916|FG001|Overall Study|Ineligible|0|||
105808142|NCT00096265|364954917|FG002|Overall Study|Ineligible|0|||
105808143|NCT02891200|364954918|FG000|Overall Study|Lost to Follow-up|31|||
105808144|NCT02891200|364954919|FG001|Overall Study|Lost to Follow-up|36|||
105808145|NCT02891200|364954918|FG000|Overall Study|Death|10|||
105808146|NCT02891200|364954919|FG001|Overall Study|Death|9|||
105808147|NCT02891200|364954918|FG000|Overall Study|Withdrawal by Subject|1|||
106017020|NCT03126591|365725943|FG000|Overall Study|Progressive Disease|0|||
105808148|NCT02891200|364954919|FG001|Overall Study|Withdrawal by Subject|4|||
105761638|NCT04134728|364781387|FG003|Overall Study|Informed Consent Withdrawn|1|||
105808149|NCT02232074|364954920|FG000|Overall Study|Withdrawal by Subject|5|||
105808150|NCT02232074|364954921|FG001|Overall Study|Withdrawal by Subject|3|||
105808151|NCT02232074|364954920|FG000|Overall Study|No legal concerns at baseline|36|||
105808152|NCT02232074|364954921|FG001|Overall Study|No legal concerns at baseline|41|||
105808153|NCT02232074|364954920|FG000|Overall Study|deemed ineligible|0|||
105808154|NCT02232074|364954921|FG001|Overall Study|deemed ineligible|1|||
105808155|NCT04820842|364954922|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105808156|NCT04820842|364954923|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
105808157|NCT04820842|364954924|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
105808158|NCT04820842|364954925|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105808159|NCT04820842|364954926|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105808160|NCT04820842|364954927|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105761639|NCT04134728|364781388|FG004|Overall Study|Informed Consent Withdrawn|1|||
105808161|NCT04820842|364954928|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
105808162|NCT04820842|364954922|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
105808163|NCT04820842|364954923|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
105808164|NCT04820842|364954924|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
105808165|NCT04820842|364954925|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808166|NCT04820842|364954926|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808167|NCT04820842|364954927|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808168|NCT04820842|364954928|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808169|NCT04820842|364954922|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808170|NCT04820842|364954923|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
105952495|NCT02891226|365488281|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952496|NCT02891226|365488282|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105761640|NCT04134728|364781389|FG005|Overall Study|Informed Consent Withdrawn|0|||
105761641|NCT04134728|364781384|FG000|Overall Study|Physician Decision|2|||
105761642|NCT04134728|364781385|FG001|Overall Study|Physician Decision|0|||
105761643|NCT04134728|364781386|FG002|Overall Study|Physician Decision|0|||
105761644|NCT04134728|364781387|FG003|Overall Study|Physician Decision|0|||
105761645|NCT04134728|364781388|FG004|Overall Study|Physician Decision|0|||
105761646|NCT04134728|364781389|FG005|Overall Study|Physician Decision|0|||
105808171|NCT04820842|364954924|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808172|NCT04820842|364954925|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808173|NCT04820842|364954926|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808174|NCT04820842|364954927|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808175|NCT04820842|364954928|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
105808176|NCT04820842|364954922|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808177|NCT04820842|364954923|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808178|NCT04820842|364954924|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808179|NCT04820842|364954925|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
105808180|NCT04820842|364954926|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808181|NCT04820842|364954927|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
105808182|NCT04820842|364954928|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
105808183|NCT01579474|364954929|FG000|Overall Study|Adverse Event|1|||
105808184|NCT01579474|364954930|FG001|Overall Study|Adverse Event|13|||
105808185|NCT01579474|364954931|FG002|Overall Study|Adverse Event|2|||
105808186|NCT01579474|364954932|FG003|Overall Study|Adverse Event|0|||
105808187|NCT01579474|364954933|FG004|Overall Study|Adverse Event|0|||
105808188|NCT01579474|364954934|FG005|Overall Study|Adverse Event|1|||
105808189|NCT01579474|364954929|FG000|Overall Study|Lack of Efficacy|1|||
105808190|NCT01579474|364954930|FG001|Overall Study|Lack of Efficacy|0|||
105808191|NCT01579474|364954931|FG002|Overall Study|Lack of Efficacy|0|||
105808192|NCT01579474|364954932|FG003|Overall Study|Lack of Efficacy|0|||
105808193|NCT01579474|364954933|FG004|Overall Study|Lack of Efficacy|1|||
105761647|NCT04134728|364781384|FG000|Overall Study|Lost to Follow-up|1|||
105761648|NCT04134728|364781385|FG001|Overall Study|Lost to Follow-up|2|||
105761649|NCT04134728|364781386|FG002|Overall Study|Lost to Follow-up|1|||
105761650|NCT04134728|364781387|FG003|Overall Study|Lost to Follow-up|0|||
105761651|NCT04134728|364781388|FG004|Overall Study|Lost to Follow-up|0|||
105761652|NCT04134728|364781389|FG005|Overall Study|Lost to Follow-up|1|||
105761653|NCT04134728|364781384|FG000|Overall Study|Investigator Site Closed|0|||
105761654|NCT04134728|364781385|FG001|Overall Study|Investigator Site Closed|1|||
105761655|NCT04134728|364781386|FG002|Overall Study|Investigator Site Closed|1|||
105761656|NCT04134728|364781387|FG003|Overall Study|Investigator Site Closed|0|||
105761657|NCT04134728|364781388|FG004|Overall Study|Investigator Site Closed|0|||
105761658|NCT04134728|364781389|FG005|Overall Study|Investigator Site Closed|0|||
105761659|NCT00379236|364781390|FG000|Double-blind|Adverse Event|11|||
105761660|NCT00379236|364781391|FG001|Double-blind|Adverse Event|6|||
105761661|NCT00379236|364781392|FG002|Double-blind|Adverse Event|0|||
105761662|NCT00379236|364781390|FG000|Double-blind|Protocol Violation|3|||
105761663|NCT00379236|364781391|FG001|Double-blind|Protocol Violation|3|||
105761664|NCT00379236|364781392|FG002|Double-blind|Protocol Violation|0|||
105761665|NCT00379236|364781390|FG000|Double-blind|Withdrawal by Subject|12|||
105761666|NCT00379236|364781391|FG001|Double-blind|Withdrawal by Subject|13|||
105761667|NCT00379236|364781392|FG002|Double-blind|Withdrawal by Subject|0|||
105761668|NCT00379236|364781390|FG000|Double-blind|Lost to Follow-up|4|||
105761669|NCT00379236|364781391|FG001|Double-blind|Lost to Follow-up|3|||
105761670|NCT00379236|364781392|FG002|Double-blind|Lost to Follow-up|0|||
105761671|NCT00379236|364781390|FG000|Double-blind|Use of exclusionary medication|1|||
105761672|NCT00379236|364781391|FG001|Double-blind|Use of exclusionary medication|2|||
105761673|NCT00379236|364781392|FG002|Double-blind|Use of exclusionary medication|0|||
105761674|NCT00379236|364781390|FG000|Double-blind|Other|3|||
105761675|NCT00379236|364781391|FG001|Double-blind|Other|7|||
105761676|NCT00379236|364781392|FG002|Double-blind|Other|0|||
105761677|NCT00379236|364781390|FG000|Double-blind|Data could not be retrieved|2|||
105761678|NCT00379236|364781391|FG001|Double-blind|Data could not be retrieved|2|||
105761679|NCT00379236|364781392|FG002|Double-blind|Data could not be retrieved|0|||
105761680|NCT00379236|364781390|FG000|Open-label Extension|Adverse Event|0|||
105761681|NCT00379236|364781391|FG001|Open-label Extension|Adverse Event|0|||
105761682|NCT00379236|364781392|FG002|Open-label Extension|Adverse Event|13|||
105761683|NCT00379236|364781390|FG000|Open-label Extension|Protocol Violation|0|||
105761684|NCT00379236|364781391|FG001|Open-label Extension|Protocol Violation|0|||
105761685|NCT00379236|364781392|FG002|Open-label Extension|Protocol Violation|7|||
105761686|NCT00379236|364781390|FG000|Open-label Extension|Withdrawal by Subject|0|||
105761687|NCT00379236|364781391|FG001|Open-label Extension|Withdrawal by Subject|0|||
105761688|NCT00379236|364781392|FG002|Open-label Extension|Withdrawal by Subject|13|||
105761689|NCT00379236|364781390|FG000|Open-label Extension|Lost to Follow-up|0|||
105761690|NCT00379236|364781391|FG001|Open-label Extension|Lost to Follow-up|0|||
105761691|NCT00379236|364781392|FG002|Open-label Extension|Lost to Follow-up|12|||
105761692|NCT00379236|364781390|FG000|Open-label Extension|Use of exclusionary medication|0|||
105761693|NCT00379236|364781391|FG001|Open-label Extension|Use of exclusionary medication|0|||
105808194|NCT01579474|364954934|FG005|Overall Study|Lack of Efficacy|0|||
105808195|NCT01579474|364954929|FG000|Overall Study|Withdrawal by Subject|1|||
105808196|NCT01579474|364954930|FG001|Overall Study|Withdrawal by Subject|0|||
105808197|NCT01579474|364954931|FG002|Overall Study|Withdrawal by Subject|0|||
105808198|NCT01579474|364954932|FG003|Overall Study|Withdrawal by Subject|0|||
105808199|NCT01579474|364954933|FG004|Overall Study|Withdrawal by Subject|0|||
105808200|NCT01579474|364954934|FG005|Overall Study|Withdrawal by Subject|0|||
105808201|NCT00130520|364954935|FG000|Overall Study|Adverse Event|11|||
105808202|NCT00130520|364954935|FG000|Overall Study|Death|1|||
105808203|NCT00130520|364954935|FG000|Overall Study|Physician Decision|1|||
105808204|NCT00130520|364954935|FG000|Overall Study|Withdrawal by Subject|1|||
105808205|NCT00130520|364954935|FG000|Overall Study|Disease Progression|23|||
105808206|NCT00130520|364954935|FG000|Overall Study|Protocol non-compliance|1|||
105808207|NCT00130520|364954935|FG000|Overall Study|Did not meet re-treatment criteria|1|||
105808208|NCT02006706|364954943|FG000|Overall Study|Lost to Follow-up|1|||
105808209|NCT05487456|364954944|FG000|Overall Study|Withdrawal by Subject|0|||
105808210|NCT05487456|364954945|FG001|Overall Study|Withdrawal by Subject|0|||
105808211|NCT05487456|364954946|FG002|Overall Study|Withdrawal by Subject|1|||
105808212|NCT05487456|364954947|FG003|Overall Study|Withdrawal by Subject|0|||
105808213|NCT01844583|364954948|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
105808214|NCT01844583|364954949|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
105808215|NCT01625377|364954950|FG000|Overall Study|Death|1|||
105808216|NCT01625377|364954951|FG001|Overall Study|Death|1|||
105808217|NCT01625377|364954950|FG000|Overall Study|Administrative Problem|1|||
105808218|NCT01625377|364954951|FG001|Overall Study|Administrative Problem|1|||
105808219|NCT01625377|364954950|FG000|Overall Study|Protocol Violation|0|||
105808220|NCT01625377|364954951|FG001|Overall Study|Protocol Violation|3|||
105808221|NCT01625377|364954950|FG000|Overall Study|Adverse Event|3|||
105808222|NCT01625377|364954951|FG001|Overall Study|Adverse Event|16|||
105808223|NCT01625377|364954950|FG000|Overall Study|Graft loss|1|||
105808224|NCT01625377|364954951|FG001|Overall Study|Graft loss|0|||
105808225|NCT01625377|364954950|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105808226|NCT01625377|364954951|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105808227|NCT01625377|364954950|FG000|Overall Study|Abnormal laboratory values|1|||
105808228|NCT01625377|364954951|FG001|Overall Study|Abnormal laboratory values|0|||
105808229|NCT03294538|364954952|FG000|Overall Study|Adverse Event|0|||
105952497|NCT02891226|365488283|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952498|NCT02891226|365488284|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952499|NCT02891226|365488285|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
105952500|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952501|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952502|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952503|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952504|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952505|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952506|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
105952507|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
105952508|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
105952509|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
105952510|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952511|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952512|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952513|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952514|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952515|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
105952516|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952517|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952518|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952519|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952520|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952521|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
105952522|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952523|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952524|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105808230|NCT03294538|364954953|FG001|Overall Study|Adverse Event|1|||
105808231|NCT03294538|364954954|FG002|Overall Study|Adverse Event|1|||
105808232|NCT03294538|364954952|FG000|Overall Study|Lost to Follow-up|1|||
105808233|NCT03294538|364954953|FG001|Overall Study|Lost to Follow-up|0|||
105808234|NCT03294538|364954954|FG002|Overall Study|Lost to Follow-up|0|||
105808235|NCT03294538|364954952|FG000|Overall Study|Outside of Visit Window|4|||
105808236|NCT03294538|364954953|FG001|Overall Study|Outside of Visit Window|4|||
105808237|NCT03294538|364954954|FG002|Overall Study|Outside of Visit Window|1|||
105808238|NCT02207621|364954956|FG000|Overall Study|Adverse Event|71|||
105808239|NCT02207621|364954957|FG001|Overall Study|Adverse Event|15|||
105808240|NCT02207621|364954958|FG002|Overall Study|Adverse Event|132|||
105952525|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
105808241|NCT02207621|364954956|FG000|Overall Study|Withdrawal by Subject|9|||
105808242|NCT02207621|364954957|FG001|Overall Study|Withdrawal by Subject|9|||
105808243|NCT02207621|364954958|FG002|Overall Study|Withdrawal by Subject|13|||
105808244|NCT02207621|364954956|FG000|Overall Study|Non-Compliant|3|||
105808245|NCT02207621|364954957|FG001|Overall Study|Non-Compliant|3|||
105808246|NCT02207621|364954958|FG002|Overall Study|Non-Compliant|1|||
105808247|NCT02207621|364954956|FG000|Overall Study|Lost to Follow-up|1|||
105808248|NCT02207621|364954957|FG001|Overall Study|Lost to Follow-up|0|||
105808249|NCT02207621|364954958|FG002|Overall Study|Lost to Follow-up|3|||
105808250|NCT02207621|364954956|FG000|Overall Study|Lack of Efficacy|10|||
105808251|NCT02207621|364954957|FG001|Overall Study|Lack of Efficacy|2|||
105808252|NCT02207621|364954958|FG002|Overall Study|Lack of Efficacy|4|||
105808253|NCT02207621|364954956|FG000|Overall Study|Disallowed Concurrent Medication|2|||
105808254|NCT02207621|364954957|FG001|Overall Study|Disallowed Concurrent Medication|5|||
105808255|NCT02207621|364954958|FG002|Overall Study|Disallowed Concurrent Medication|2|||
105808256|NCT02207621|364954956|FG000|Overall Study|Physician Decision|1|||
105808257|NCT02207621|364954957|FG001|Overall Study|Physician Decision|2|||
105808258|NCT02207621|364954958|FG002|Overall Study|Physician Decision|2|||
105808259|NCT02207621|364954956|FG000|Overall Study|Protocol Violation|4|||
105808260|NCT02207621|364954957|FG001|Overall Study|Protocol Violation|10|||
105808261|NCT02207621|364954958|FG002|Overall Study|Protocol Violation|6|||
105808262|NCT02207621|364954956|FG000|Overall Study|Death|2|||
105808263|NCT02207621|364954957|FG001|Overall Study|Death|0|||
105808264|NCT02207621|364954958|FG002|Overall Study|Death|0|||
105808265|NCT02207621|364954956|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
105808266|NCT02207621|364954957|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
105808267|NCT02207621|364954958|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
105808268|NCT00958256|364954961|FG000|Overall Study|Adverse Event|3|||
105808269|NCT03036579|364954968|FG000|2 Years|Lost to Follow-up|1|||
105808270|NCT03036579|364954969|FG001|2 Years|Lost to Follow-up|0|||
105808271|NCT03036579|364954968|FG000|3 Years|Lost to Follow-up|0|||
105808272|NCT03036579|364954969|FG001|3 Years|Lost to Follow-up|1|||
105808273|NCT01090765|364954970|FG000|Overall Study|Patient withdrew consent|0|||
105808274|NCT01090765|364954971|FG001|Overall Study|Patient withdrew consent|0|||
105808275|NCT01090765|364954972|FG002|Overall Study|Patient withdrew consent|0|||
105808276|NCT01090765|364954973|FG003|Overall Study|Patient withdrew consent|0|||
105808277|NCT01090765|364954974|FG004|Overall Study|Patient withdrew consent|1|||
105808278|NCT01090765|364954975|FG005|Overall Study|Patient withdrew consent|1|||
105808279|NCT01090765|364954970|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808280|NCT01090765|364954971|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808281|NCT01090765|364954972|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808282|NCT01090765|364954973|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
105808283|NCT01090765|364954974|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808284|NCT01090765|364954975|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
105808285|NCT01090765|364954970|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
105808286|NCT01090765|364954971|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
105808287|NCT01090765|364954972|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
105808288|NCT01090765|364954973|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
105808289|NCT01090765|364954974|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
105808290|NCT01090765|364954975|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
105808291|NCT02398188|364954978|FG000|Overall Study|Adverse Event|2|||
106144664|NCT03144674|366189200|FG000|Overall Study|Discharged from the Trust|0|||
106144665|NCT03144674|366189201|FG001|Overall Study|Discharged from the Trust|0|||
106144666|NCT03144674|366189202|FG002|Overall Study|Discharged from the Trust|1|||
106144667|NCT03144674|366189203|FG003|Overall Study|Discharged from the Trust|0|||
106144668|NCT03144674|366189200|FG000|Overall Study|Exclusion Criteria Met|0|||
106144669|NCT03144674|366189201|FG001|Overall Study|Exclusion Criteria Met|0|||
106144670|NCT03144674|366189202|FG002|Overall Study|Exclusion Criteria Met|1|||
106144671|NCT03144674|366189203|FG003|Overall Study|Exclusion Criteria Met|0|||
105808292|NCT02398188|364954979|FG001|Overall Study|Adverse Event|3|||
105808293|NCT02398188|364954978|FG000|Overall Study|Lost to Follow-up|5|||
105808294|NCT02398188|364954979|FG001|Overall Study|Lost to Follow-up|0|||
105808295|NCT02398188|364954978|FG000|Overall Study|Non-compliance|4|||
105808296|NCT02398188|364954979|FG001|Overall Study|Non-compliance|4|||
105808297|NCT02398188|364954978|FG000|Overall Study|Protocol Violation|6|||
105808298|NCT02398188|364954979|FG001|Overall Study|Protocol Violation|10|||
105808299|NCT02398188|364954978|FG000|Overall Study|Sponsor Decision|2|||
105808300|NCT02398188|364954979|FG001|Overall Study|Sponsor Decision|1|||
105808301|NCT02398188|364954978|FG000|Overall Study|Pregnancy|1|||
105808302|NCT02398188|364954979|FG001|Overall Study|Pregnancy|0|||
105808303|NCT02398188|364954978|FG000|Overall Study|Withdrawal by Subject|7|||
106144672|NCT03144674|366189200|FG000|Overall Study|Changed Physicians|0|||
105808304|NCT02398188|364954979|FG001|Overall Study|Withdrawal by Subject|16|||
105808305|NCT00782509|364954980|FG000|Overall Study|Adverse Event|20|||
105808306|NCT00782509|364954981|FG001|Overall Study|Adverse Event|10|||
105808307|NCT00782509|364954982|FG002|Overall Study|Adverse Event|20|||
105808308|NCT00782509|364954980|FG000|Overall Study|Lost to Follow-up|1|||
105808309|NCT00782509|364954981|FG001|Overall Study|Lost to Follow-up|2|||
105808310|NCT00782509|364954982|FG002|Overall Study|Lost to Follow-up|3|||
105808311|NCT00782509|364954980|FG000|Overall Study|Withdrawal by Subject|3|||
105808312|NCT00782509|364954981|FG001|Overall Study|Withdrawal by Subject|5|||
105808313|NCT00782509|364954982|FG002|Overall Study|Withdrawal by Subject|8|||
105808314|NCT00782509|364954980|FG000|Overall Study|Non compliance with protocol|2|||
105808315|NCT00782509|364954981|FG001|Overall Study|Non compliance with protocol|0|||
105808316|NCT00782509|364954982|FG002|Overall Study|Non compliance with protocol|0|||
105808317|NCT00782509|364954980|FG000|Overall Study|Other reasons not stated above|5|||
105808318|NCT00782509|364954981|FG001|Overall Study|Other reasons not stated above|2|||
105808319|NCT00782509|364954982|FG002|Overall Study|Other reasons not stated above|3|||
105808320|NCT00782509|364954980|FG000|Overall Study|Lack of Efficacy|10|||
105808321|NCT00782509|364954981|FG001|Overall Study|Lack of Efficacy|5|||
105808322|NCT00782509|364954982|FG002|Overall Study|Lack of Efficacy|2|||
105808323|NCT04041570|364954988|FG000|Overall Study|Moved from Area|0|||
105808324|NCT04041570|364954989|FG001|Overall Study|Moved from Area|2|||
105808325|NCT02419313|364954990|FG000|First Intervention|Lost to Follow-up|2|||
105808326|NCT02419313|364954991|FG001|First Intervention|Lost to Follow-up|0|||
105808327|NCT02419313|364954990|FG000|Second Intervention|Lost to Follow-up|1|||
105808328|NCT02419313|364954991|FG001|Second Intervention|Lost to Follow-up|0|||
105808329|NCT02204371|364954992|FG000|Overall Study|Adverse Event|1|||
105808330|NCT01180244|364954993|FG000|Overall Study|Lack of Efficacy|0|||
105808331|NCT01180244|364954994|FG001|Overall Study|Lack of Efficacy|7|||
105808332|NCT01180244|364954993|FG000|Overall Study|Physician Decision|3|||
105808333|NCT01180244|364954994|FG001|Overall Study|Physician Decision|0|||
105808334|NCT01180244|364954993|FG000|Overall Study|Adverse Event|1|||
105808335|NCT01180244|364954994|FG001|Overall Study|Adverse Event|0|||
105808336|NCT01180244|364954993|FG000|Overall Study|Withdrawal by Subject|0|||
105808337|NCT01180244|364954994|FG001|Overall Study|Withdrawal by Subject|1|||
105808338|NCT01180244|364954993|FG000|Overall Study|Protocol Violation|1|||
105808339|NCT01180244|364954994|FG001|Overall Study|Protocol Violation|0|||
105808340|NCT01180244|364954993|FG000|Overall Study|Lost to Follow-up|1|||
105808341|NCT01180244|364954994|FG001|Overall Study|Lost to Follow-up|0|||
105808342|NCT00384033|364954995|FG000|Overall Study|Adverse Event|10|||
105808343|NCT00384033|364954996|FG001|Overall Study|Adverse Event|8|||
105808344|NCT00384033|364954997|FG002|Overall Study|Adverse Event|11|||
105808345|NCT00384033|364954998|FG003|Overall Study|Adverse Event|20|||
105808346|NCT00384033|364954995|FG000|Overall Study|Failed to return|1|||
105808347|NCT00384033|364954996|FG001|Overall Study|Failed to return|3|||
105808348|NCT00384033|364954997|FG002|Overall Study|Failed to return|2|||
105808349|NCT00384033|364954998|FG003|Overall Study|Failed to return|2|||
105808350|NCT00384033|364954995|FG000|Overall Study|Physician Decision|1|||
105808351|NCT00384033|364954996|FG001|Overall Study|Physician Decision|0|||
105808352|NCT00384033|364954997|FG002|Overall Study|Physician Decision|0|||
106144673|NCT03144674|366189201|FG001|Overall Study|Changed Physicians|0|||
106144674|NCT03144674|366189202|FG002|Overall Study|Changed Physicians|0|||
106144675|NCT03144674|366189203|FG003|Overall Study|Changed Physicians|1|||
106144676|NCT03144674|366189200|FG000|Overall Study|Removed for Safety|0|||
105761694|NCT00379236|364781392|FG002|Open-label Extension|Use of exclusionary medication|3|||
105761695|NCT00379236|364781390|FG000|Open-label Extension|Other|0|||
105761696|NCT00379236|364781391|FG001|Open-label Extension|Other|0|||
105761697|NCT00379236|364781392|FG002|Open-label Extension|Other|7|||
105761698|NCT03382262|364781395|FG000|Overall Study|Physician Decision|0|||
105761699|NCT03382262|364781396|FG001|Overall Study|Physician Decision|0|||
105761700|NCT03382262|364781397|FG002|Overall Study|Physician Decision|1|||
105761701|NCT03382262|364781398|FG003|Overall Study|Physician Decision|0|||
105761702|NCT03382262|364781395|FG000|Overall Study|Withdrawal by Subject|0|||
105761703|NCT03382262|364781396|FG001|Overall Study|Withdrawal by Subject|0|||
105761704|NCT03382262|364781397|FG002|Overall Study|Withdrawal by Subject|0|||
105761705|NCT03382262|364781398|FG003|Overall Study|Withdrawal by Subject|1|||
105761706|NCT02940860|364781399|FG000|Overall Study|Non-serious AE|1|||
105761707|NCT02940860|364781400|FG001|Overall Study|Non-serious AE|2|||
105761708|NCT02940860|364781399|FG000|Overall Study|Serious AE|7|||
105761709|NCT02940860|364781400|FG001|Overall Study|Serious AE|3|||
105761710|NCT02940860|364781399|FG000|Overall Study|Withdrawal by Subject|19|||
105761711|NCT02940860|364781400|FG001|Overall Study|Withdrawal by Subject|9|||
105761712|NCT02940860|364781399|FG000|Overall Study|Lost to Follow-up|13|||
105761713|NCT02940860|364781400|FG001|Overall Study|Lost to Follow-up|7|||
105761714|NCT02940860|364781399|FG000|Overall Study|Physician Decision|5|||
105761715|NCT02940860|364781400|FG001|Overall Study|Physician Decision|3|||
105761716|NCT02940860|364781399|FG000|Overall Study|Sponsor Decision|0|||
105761717|NCT02940860|364781400|FG001|Overall Study|Sponsor Decision|1|||
105761718|NCT02940860|364781399|FG000|Overall Study|Protocol Violation|0|||
105761719|NCT02940860|364781400|FG001|Overall Study|Protocol Violation|2|||
105761720|NCT02940860|364781399|FG000|Overall Study|Death|3|||
105761721|NCT02940860|364781400|FG001|Overall Study|Death|2|||
105761722|NCT02940860|364781399|FG000|Overall Study|Moved, poor venous access, transport|6|||
105761723|NCT02940860|364781400|FG001|Overall Study|Moved, poor venous access, transport|4|||
105761724|NCT02940860|364781399|FG000|Overall Study|Not treated|2|||
105761725|NCT02940860|364781400|FG001|Overall Study|Not treated|2|||
105761726|NCT04914819|364781401|FG000|Overall Study|Pregnancy|3|||
105761727|NCT04914819|364781402|FG001|Overall Study|Pregnancy|1|||
105761728|NCT04914819|364781401|FG000|Overall Study|Discontinued study|4|||
105761729|NCT04914819|364781402|FG001|Overall Study|Discontinued study|1|||
105761730|NCT04914819|364781401|FG000|Overall Study|Lost to Follow-up|7|||
105761731|NCT04914819|364781402|FG001|Overall Study|Lost to Follow-up|0|||
105761732|NCT02431793|364781408|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
105761733|NCT02431793|364781409|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
105761734|NCT02431793|364781410|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
105761735|NCT02431793|364781408|FG000|Overall Study|Withdrawal by Subject|7|||
105761736|NCT02431793|364781409|FG001|Overall Study|Withdrawal by Subject|5|||
105761737|NCT02431793|364781410|FG002|Overall Study|Withdrawal by Subject|5|||
105761738|NCT02431793|364781408|FG000|Overall Study|Lost to Follow-up|101|||
105761739|NCT02431793|364781409|FG001|Overall Study|Lost to Follow-up|122|||
105761740|NCT02431793|364781410|FG002|Overall Study|Lost to Follow-up|104|||
105761741|NCT00233324|364781411|FG000|Main Study|Death|68|||
105761742|NCT00233324|364781412|FG001|Main Study|Death|60|||
105761743|NCT00233324|364781413|FG002|Main Study|Death|62|||
105761744|NCT00233324|364781414|FG003|Main Study|Death|47|||
105761745|NCT00233324|364781411|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
105761746|NCT00233324|364781412|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
105761747|NCT00233324|364781413|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
105761748|NCT00233324|364781414|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
105761749|NCT00233324|364781411|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
105761750|NCT00233324|364781412|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
106144677|NCT03144674|366189201|FG001|Overall Study|Removed for Safety|0|||
106144678|NCT03144674|366189202|FG002|Overall Study|Removed for Safety|0|||
105761751|NCT00233324|364781413|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
105761752|NCT00233324|364781414|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
105761753|NCT03907969|364781419|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
105761754|NCT03907969|364781420|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
105761755|NCT03907969|364781421|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
105761756|NCT03907969|364781422|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
105761757|NCT03907969|364781423|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
105761758|NCT03907969|364781424|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
105761759|NCT03907969|364781425|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
105761760|NCT03907969|364781426|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
105761761|NCT03907969|364781427|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
105761762|NCT03907969|364781428|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
105761763|NCT03907969|364781429|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
105761764|NCT03907969|364781419|FG000|Monotherapy Part A|Progressive Disease|0|||
105952526|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952527|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952528|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952529|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952530|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105952531|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
105761765|NCT03907969|364781420|FG001|Monotherapy Part A|Progressive Disease|1|||
105761766|NCT03907969|364781421|FG002|Monotherapy Part A|Progressive Disease|0|||
105761767|NCT03907969|364781422|FG003|Monotherapy Part A|Progressive Disease|0|||
105761768|NCT03907969|364781423|FG004|Monotherapy Part A|Progressive Disease|0|||
105761769|NCT03907969|364781424|FG005|Monotherapy Part A|Progressive Disease|1|||
105761770|NCT03907969|364781425|FG006|Monotherapy Part A|Progressive Disease|2|||
105761771|NCT03907969|364781426|FG007|Monotherapy Part A|Progressive Disease|0|||
105761772|NCT03907969|364781427|FG008|Monotherapy Part A|Progressive Disease|0|||
105761773|NCT03907969|364781428|FG009|Monotherapy Part A|Progressive Disease|0|||
105761774|NCT03907969|364781429|FG010|Monotherapy Part A|Progressive Disease|0|||
105761775|NCT03907969|364781419|FG000|Monotherapy Part A|Death|0|||
105761776|NCT03907969|364781420|FG001|Monotherapy Part A|Death|0|||
105761777|NCT03907969|364781421|FG002|Monotherapy Part A|Death|1|||
105761778|NCT03907969|364781422|FG003|Monotherapy Part A|Death|1|||
105761779|NCT03907969|364781423|FG004|Monotherapy Part A|Death|0|||
105761780|NCT03907969|364781424|FG005|Monotherapy Part A|Death|1|||
105761781|NCT03907969|364781425|FG006|Monotherapy Part A|Death|0|||
105761782|NCT03907969|364781426|FG007|Monotherapy Part A|Death|0|||
105761783|NCT03907969|364781427|FG008|Monotherapy Part A|Death|0|||
105761784|NCT03907969|364781428|FG009|Monotherapy Part A|Death|0|||
105761785|NCT03907969|364781429|FG010|Monotherapy Part A|Death|0|||
105761786|NCT03907969|364781419|FG000|Combination Therapy Part A|Adverse Event|0|||
105761787|NCT03907969|364781420|FG001|Combination Therapy Part A|Adverse Event|0|||
105761788|NCT03907969|364781421|FG002|Combination Therapy Part A|Adverse Event|0|||
105761789|NCT03907969|364781422|FG003|Combination Therapy Part A|Adverse Event|0|||
105761790|NCT03907969|364781423|FG004|Combination Therapy Part A|Adverse Event|0|||
105761791|NCT03907969|364781424|FG005|Combination Therapy Part A|Adverse Event|0|||
105761792|NCT03907969|364781425|FG006|Combination Therapy Part A|Adverse Event|0|||
105761793|NCT03907969|364781426|FG007|Combination Therapy Part A|Adverse Event|0|||
105761794|NCT03907969|364781427|FG008|Combination Therapy Part A|Adverse Event|0|||
105761795|NCT03907969|364781428|FG009|Combination Therapy Part A|Adverse Event|1|||
105761796|NCT03907969|364781429|FG010|Combination Therapy Part A|Adverse Event|1|||
105761797|NCT03907969|364781419|FG000|Combination Therapy Part A|Progressive disease|0|||
105761798|NCT03907969|364781420|FG001|Combination Therapy Part A|Progressive disease|0|||
105761799|NCT03907969|364781421|FG002|Combination Therapy Part A|Progressive disease|0|||
105761800|NCT03907969|364781422|FG003|Combination Therapy Part A|Progressive disease|0|||
105761801|NCT03907969|364781423|FG004|Combination Therapy Part A|Progressive disease|0|||
105761802|NCT03907969|364781424|FG005|Combination Therapy Part A|Progressive disease|0|||
105761803|NCT03907969|364781425|FG006|Combination Therapy Part A|Progressive disease|0|||
105761804|NCT03907969|364781426|FG007|Combination Therapy Part A|Progressive disease|1|||
105761805|NCT03907969|364781427|FG008|Combination Therapy Part A|Progressive disease|0|||
105761806|NCT03907969|364781428|FG009|Combination Therapy Part A|Progressive disease|2|||
105761807|NCT03907969|364781429|FG010|Combination Therapy Part A|Progressive disease|3|||
105761808|NCT03907969|364781419|FG000|Combination Therapy Part A|Death|0|||
105761809|NCT03907969|364781420|FG001|Combination Therapy Part A|Death|0|||
105761810|NCT03907969|364781421|FG002|Combination Therapy Part A|Death|0|||
105761811|NCT03907969|364781422|FG003|Combination Therapy Part A|Death|0|||
105761812|NCT03907969|364781423|FG004|Combination Therapy Part A|Death|0|||
105761813|NCT03907969|364781424|FG005|Combination Therapy Part A|Death|0|||
105761814|NCT03907969|364781425|FG006|Combination Therapy Part A|Death|0|||
105761815|NCT03907969|364781426|FG007|Combination Therapy Part A|Death|0|||
105761816|NCT03907969|364781427|FG008|Combination Therapy Part A|Death|1|||
105761817|NCT03907969|364781428|FG009|Combination Therapy Part A|Death|0|||
105761818|NCT03907969|364781429|FG010|Combination Therapy Part A|Death|1|||
105761819|NCT03907969|364781419|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
105761820|NCT03907969|364781420|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
105761821|NCT03907969|364781421|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
105761822|NCT03907969|364781422|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
105761823|NCT03907969|364781423|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
105761824|NCT03907969|364781424|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
105761825|NCT03907969|364781425|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
105952532|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105761826|NCT03907969|364781426|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
105761827|NCT03907969|364781427|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
105761828|NCT03907969|364781428|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
105761829|NCT03907969|364781429|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
105761830|NCT03907969|364781419|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
105761831|NCT03907969|364781420|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
105761832|NCT03907969|364781421|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
105808353|NCT00384033|364954998|FG003|Overall Study|Physician Decision|0|||
105808354|NCT00384033|364954995|FG000|Overall Study|Lost to Follow-up|6|||
105808355|NCT00384033|364954996|FG001|Overall Study|Lost to Follow-up|12|||
105952533|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952534|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952535|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952536|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952537|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105761833|NCT03907969|364781422|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
105761834|NCT03907969|364781423|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
105761835|NCT03907969|364781424|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
105761836|NCT03907969|364781425|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
105761837|NCT03907969|364781426|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
105761838|NCT03907969|364781427|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
105761839|NCT03907969|364781428|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
105761840|NCT03907969|364781429|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
105761841|NCT03907969|364781419|FG000|Combination Therapy Part A|Physician Decision|0|||
105761842|NCT03907969|364781420|FG001|Combination Therapy Part A|Physician Decision|0|||
105761843|NCT03907969|364781421|FG002|Combination Therapy Part A|Physician Decision|0|||
105761844|NCT03907969|364781422|FG003|Combination Therapy Part A|Physician Decision|0|||
105761845|NCT03907969|364781423|FG004|Combination Therapy Part A|Physician Decision|0|||
105761846|NCT03907969|364781424|FG005|Combination Therapy Part A|Physician Decision|0|||
105761847|NCT03907969|364781425|FG006|Combination Therapy Part A|Physician Decision|0|||
105761848|NCT03907969|364781426|FG007|Combination Therapy Part A|Physician Decision|1|||
105761849|NCT03907969|364781427|FG008|Combination Therapy Part A|Physician Decision|0|||
105761850|NCT03907969|364781428|FG009|Combination Therapy Part A|Physician Decision|0|||
105761851|NCT03907969|364781429|FG010|Combination Therapy Part A|Physician Decision|1|||
105761852|NCT04839393|364781431|FG000|Overall Study|Adverse Event|0|||
105761853|NCT04839393|364781432|FG001|Overall Study|Adverse Event|0|||
105761854|NCT04839393|364781433|FG002|Overall Study|Adverse Event|2|||
105761855|NCT04839393|364781431|FG000|Overall Study|Withdrawal by participant|0|||
105761856|NCT04839393|364781432|FG001|Overall Study|Withdrawal by participant|0|||
105761857|NCT04839393|364781433|FG002|Overall Study|Withdrawal by participant|1|||
105761858|NCT01709708|364781434|FG000|Overall Study|Protocol Violation|1|||
105761859|NCT01709708|364781435|FG001|Overall Study|Protocol Violation|2|||
105761860|NCT00653328|364781440|FG000|Overall Study|Withdrawal by Subject|1|||
105761861|NCT00653328|364781440|FG000|Overall Study|Adverse Event|2|||
105761862|NCT00653328|364781440|FG000|Overall Study|Disease progression|10|||
105761863|NCT00653328|364781440|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
105761864|NCT02911519|364781445|FG000|Overall Study|Lost to Follow-up|2|||
105761865|NCT02911519|364781446|FG001|Overall Study|Lost to Follow-up|2|||
105761866|NCT02911519|364781445|FG000|Overall Study|Death|0|||
105761867|NCT02911519|364781446|FG001|Overall Study|Death|2|||
105761868|NCT00407550|364781447|FG000|Overall Study|Adverse Event|0|||
105761869|NCT00407550|364781448|FG001|Overall Study|Adverse Event|1|||
105761870|NCT00407550|364781447|FG000|Overall Study|Withdrawal by Subject|0|||
105761871|NCT00407550|364781448|FG001|Overall Study|Withdrawal by Subject|2|||
105761872|NCT00407550|364781447|FG000|Overall Study|Death|1|||
105761873|NCT00407550|364781448|FG001|Overall Study|Death|0|||
105761874|NCT00407550|364781447|FG000|Overall Study|Insurance or Other medical condition|2|||
105761875|NCT00407550|364781448|FG001|Overall Study|Insurance or Other medical condition|1|||
105761876|NCT00724815|364781450|FG000|Overall Study|Randomized, not treated|31|||
105761877|NCT00724815|364781451|FG001|Overall Study|Randomized, not treated|30|||
105761878|NCT00724815|364781450|FG000|Overall Study|Adverse Event|5|||
105761879|NCT00724815|364781451|FG001|Overall Study|Adverse Event|3|||
105761880|NCT00724815|364781450|FG000|Overall Study|Lost to Follow-up|4|||
105761881|NCT00724815|364781451|FG001|Overall Study|Lost to Follow-up|1|||
105761882|NCT00724815|364781450|FG000|Overall Study|Other Various|3|||
105761883|NCT00724815|364781451|FG001|Overall Study|Other Various|5|||
105761884|NCT00810043|364781452|FG000|Overall Study|Withdrawal by Subject|1|||
105761885|NCT00810043|364781453|FG001|Overall Study|Withdrawal by Subject|0|||
105761886|NCT00810043|364781454|FG002|Overall Study|Withdrawal by Subject|2|||
105761887|NCT00810043|364781452|FG000|Overall Study|Lost to Follow-up|1|||
105761888|NCT00810043|364781453|FG001|Overall Study|Lost to Follow-up|0|||
105761889|NCT00810043|364781454|FG002|Overall Study|Lost to Follow-up|0|||
105761890|NCT00810043|364781452|FG000|Overall Study|Physician Decision|0|||
105761891|NCT00810043|364781453|FG001|Overall Study|Physician Decision|0|||
105761892|NCT00810043|364781454|FG002|Overall Study|Physician Decision|2|||
105761893|NCT00810043|364781452|FG000|Overall Study|Death|2|||
105761894|NCT00810043|364781453|FG001|Overall Study|Death|0|||
105761895|NCT00810043|364781454|FG002|Overall Study|Death|0|||
105761896|NCT00810043|364781452|FG000|Overall Study|Unrelated medical problem|0|||
105761897|NCT00810043|364781453|FG001|Overall Study|Unrelated medical problem|1|||
105761898|NCT00810043|364781454|FG002|Overall Study|Unrelated medical problem|0|||
105761899|NCT00810043|364781452|FG000|Overall Study|Non-medical problem|0|||
105808356|NCT00384033|364954997|FG002|Overall Study|Lost to Follow-up|7|||
105808357|NCT00384033|364954998|FG003|Overall Study|Lost to Follow-up|7|||
105808358|NCT00384033|364954995|FG000|Overall Study|Other|2|||
105808359|NCT00384033|364954996|FG001|Overall Study|Other|0|||
105808360|NCT00384033|364954997|FG002|Overall Study|Other|0|||
105808361|NCT00384033|364954998|FG003|Overall Study|Other|0|||
105808362|NCT00384033|364954995|FG000|Overall Study|Protocol Violation|5|||
105808363|NCT00384033|364954996|FG001|Overall Study|Protocol Violation|0|||
105808364|NCT00384033|364954997|FG002|Overall Study|Protocol Violation|5|||
105808365|NCT00384033|364954998|FG003|Overall Study|Protocol Violation|6|||
105808366|NCT00384033|364954995|FG000|Overall Study|Withdrawal by Subject|6|||
105808367|NCT00384033|364954996|FG001|Overall Study|Withdrawal by Subject|2|||
105808368|NCT00384033|364954997|FG002|Overall Study|Withdrawal by Subject|5|||
105808369|NCT00384033|364954998|FG003|Overall Study|Withdrawal by Subject|2|||
105808370|NCT00384033|364954995|FG000|Overall Study|Lack of Efficacy|7|||
105808371|NCT00384033|364954996|FG001|Overall Study|Lack of Efficacy|3|||
105808372|NCT00384033|364954997|FG002|Overall Study|Lack of Efficacy|3|||
105808373|NCT00384033|364954998|FG003|Overall Study|Lack of Efficacy|1|||
105808374|NCT00384033|364954995|FG000|Overall Study|Randomized but not treated|3|||
105808375|NCT00384033|364954996|FG001|Overall Study|Randomized but not treated|7|||
105808376|NCT00384033|364954997|FG002|Overall Study|Randomized but not treated|10|||
105808377|NCT00384033|364954998|FG003|Overall Study|Randomized but not treated|2|||
105808378|NCT03349333|364954999|FG000|Overall Study|Progression of Disease|36|||
105808379|NCT03349333|364954999|FG000|Overall Study|Adverse Event|11|||
105808380|NCT03349333|364954999|FG000|Overall Study|Other|6|||
105808381|NCT03349333|364954999|FG000|Overall Study|Withdrawal by Subject|5|||
105808382|NCT03349333|364954999|FG000|Overall Study|Conditions interfere with participation|2|||
105808383|NCT03349333|364954999|FG000|Overall Study|Physician Decision|2|||
105808384|NCT03349333|364954999|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
105808385|NCT03349333|364954999|FG000|Overall Study|Patients in treatment less than 24 month|8|||
105808386|NCT00760383|364955000|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
105808387|NCT00760383|364955001|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
105808388|NCT02737306|364955006|FG000|Overall Study|Adverse Event|3|||
105808389|NCT02737306|364955007|FG001|Overall Study|Adverse Event|0|||
105808390|NCT02737306|364955006|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
105808391|NCT02737306|364955007|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
105808392|NCT01966042|364955008|FG000|Overall Study|Death|2|||
105808393|NCT03361423|364955009|FG000|Overall Study|Withdrawal by Subject|4|||
105808394|NCT03361423|364955010|FG001|Overall Study|Withdrawal by Subject|3|||
105808395|NCT03361423|364955009|FG000|Overall Study|Did not treat|19|||
105808396|NCT03361423|364955010|FG001|Overall Study|Did not treat|18|||
105808397|NCT03361423|364955009|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
105808398|NCT03361423|364955010|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
105808399|NCT03361423|364955009|FG000|Overall Study|Missing data|4|||
105808400|NCT03361423|364955010|FG001|Overall Study|Missing data|1|||
105808401|NCT01254409|364955011|FG000|Overall Study|Adverse Event|0|||
105808402|NCT01254409|364955012|FG001|Overall Study|Adverse Event|1|||
105808403|NCT01254409|364955013|FG002|Overall Study|Adverse Event|0|||
105808404|NCT01254409|364955014|FG003|Overall Study|Adverse Event|0|||
105808405|NCT02015793|364955017|FG000|Overall Study|Adverse Event|3|||
105808406|NCT02015793|364955018|FG001|Overall Study|Adverse Event|3|||
105808407|NCT02015793|364955017|FG000|Overall Study|Withdrawal by Subject|1|||
105808408|NCT02015793|364955018|FG001|Overall Study|Withdrawal by Subject|1|||
105808409|NCT00249821|364955021|FG000|Overall Study|Technical problem|0|||
105952538|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
105952539|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
105952540|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
105952541|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
105952542|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952543|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952544|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952545|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952546|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952547|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
105952548|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952549|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952550|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952551|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952552|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
105952553|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952554|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952555|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952556|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952557|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952558|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952559|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952560|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952561|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105808410|NCT00249821|364955022|FG001|Overall Study|Technical problem|1|||
105808411|NCT04104646|364955023|FG000|Overall Study|Withdrawal by Subject|1|||
105808412|NCT04104646|364955024|FG001|Overall Study|Withdrawal by Subject|1|||
105808413|NCT04104646|364955023|FG000|Overall Study|Lost to Follow-up|1|||
105808414|NCT04104646|364955024|FG001|Overall Study|Lost to Follow-up|0|||
105808415|NCT04104646|364955023|FG000|Overall Study|Physician Decision|2|||
105808416|NCT04104646|364955024|FG001|Overall Study|Physician Decision|0|||
105808417|NCT00319956|364955025|FG000|Overall Study|Death|20|||
105808418|NCT00319956|364955026|FG001|Overall Study|Death|24|||
105808419|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
105808420|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
105808421|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Death|0|||
105808422|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Death|1|||
105952562|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952563|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
105952564|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952565|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952566|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952567|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952568|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952569|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952570|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
105952571|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952572|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
106144679|NCT03144674|366189203|FG003|Overall Study|Removed for Safety|1|||
106144680|NCT03144674|366189200|FG000|Overall Study|Site Closed|0|||
106144681|NCT03144674|366189201|FG001|Overall Study|Site Closed|0|||
105952573|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952574|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952575|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952576|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952577|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952578|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952579|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
105952580|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952581|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
106144682|NCT03144674|366189202|FG002|Overall Study|Site Closed|0|||
106144683|NCT03144674|366189203|FG003|Overall Study|Site Closed|1|||
106144684|NCT03144674|366189200|FG000|Overall Study|Histological Criteria Not Met|0|||
106144685|NCT03144674|366189201|FG001|Overall Study|Histological Criteria Not Met|0|||
106144686|NCT03144674|366189202|FG002|Overall Study|Histological Criteria Not Met|0|||
106144687|NCT03144674|366189203|FG003|Overall Study|Histological Criteria Not Met|1|||
106144688|NCT03144674|366189200|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
106144689|NCT03144674|366189201|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
106144690|NCT03144674|366189202|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
106144691|NCT03144674|366189203|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
106144692|NCT03144674|366189200|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
106144693|NCT03144674|366189201|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
106144694|NCT03144674|366189202|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
106144695|NCT03144674|366189203|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
106144696|NCT04789408|366189206|FG000|Overall Study|Death|4|||
106144697|NCT04789408|366189207|FG001|Overall Study|Death|3|||
106144698|NCT04789408|366189208|FG002|Overall Study|Death|6|||
106144699|NCT04789408|366189206|FG000|Overall Study|Did not meet eligibility criteria|1|||
106144700|NCT04789408|366189207|FG001|Overall Study|Did not meet eligibility criteria|0|||
106144701|NCT04789408|366189208|FG002|Overall Study|Did not meet eligibility criteria|0|||
106144702|NCT04789408|366189206|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
106144703|NCT04789408|366189207|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
106144704|NCT04789408|366189208|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
106144705|NCT05328297|366190711|FG000|Overall Study|Adverse Event|5|||
106144706|NCT05328297|366190712|FG001|Overall Study|Adverse Event|7|||
106144707|NCT05328297|366190711|FG000|Overall Study|Withdrawal by Subject|4|||
106144708|NCT05328297|366190712|FG001|Overall Study|Withdrawal by Subject|3|||
106144709|NCT05328297|366190711|FG000|Overall Study|Lack of Efficacy|1|||
106144710|NCT05328297|366190712|FG001|Overall Study|Lack of Efficacy|0|||
106144711|NCT05328297|366190711|FG000|Overall Study|Lost to Follow-up|1|||
106144712|NCT05328297|366190712|FG001|Overall Study|Lost to Follow-up|0|||
106144713|NCT05328297|366190711|FG000|Overall Study|Protocol Violation|1|||
105808423|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
105808424|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
105808425|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
105808426|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
105808427|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
105808428|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
105808429|NCT01656889|364955027|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
105808430|NCT01656889|364955028|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
105808431|NCT01656889|364955027|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
105808432|NCT01656889|364955028|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
105808433|NCT01656889|364955027|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
105808434|NCT01656889|364955028|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
105808435|NCT01656889|364955027|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
105808436|NCT01656889|364955028|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
105808437|NCT01656889|364955027|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
105808438|NCT01656889|364955028|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
105808439|NCT01565083|364955032|FG000|Overall Study|Withdrawal by Subject|6|||
105808440|NCT01565083|364955033|FG001|Overall Study|Withdrawal by Subject|4|||
105808441|NCT01565083|364955032|FG000|Overall Study|Lost to Follow-up|2|||
105808442|NCT01565083|364955033|FG001|Overall Study|Lost to Follow-up|7|||
105808443|NCT01565083|364955032|FG000|Overall Study|Death|22|||
105808444|NCT01565083|364955033|FG001|Overall Study|Death|23|||
105808445|NCT01565083|364955032|FG000|Overall Study|Other|3|||
105808446|NCT01565083|364955033|FG001|Overall Study|Other|5|||
105808447|NCT01346410|364955034|FG000|Overall Study|Death|1|||
105808448|NCT02576990|364955035|FG000|Overall Study|Death|29|||
105808449|NCT02576990|364955036|FG001|Overall Study|Death|18|||
105808450|NCT02576990|364955035|FG000|Overall Study|Physician Decision|1|||
105808451|NCT02576990|364955036|FG001|Overall Study|Physician Decision|0|||
105808452|NCT02576990|364955035|FG000|Overall Study|Screen failure|2|||
105808453|NCT02576990|364955036|FG001|Overall Study|Screen failure|0|||
105808454|NCT02576990|364955035|FG000|Overall Study|Sponsor's decision|24|||
105808455|NCT02576990|364955036|FG001|Overall Study|Sponsor's decision|4|||
105808456|NCT02576990|364955035|FG000|Overall Study|Withdrawal by Subject|0|||
105808457|NCT02576990|364955036|FG001|Overall Study|Withdrawal by Subject|2|||
105808458|NCT00979628|364955037|FG000|Overall Study|received regimen < 24 hours|7|||
105808459|NCT00979628|364955038|FG001|Overall Study|received regimen < 24 hours|6|||
105808460|NCT00979628|364955039|FG002|Overall Study|received regimen < 24 hours|5|||
105808461|NCT00979628|364955037|FG000|Overall Study|received steroids|1|||
105808462|NCT00979628|364955038|FG001|Overall Study|received steroids|1|||
105808463|NCT00979628|364955039|FG002|Overall Study|received steroids|0|||
105808464|NCT00979628|364955037|FG000|Overall Study|transferred to ICU|1|||
105808465|NCT00979628|364955038|FG001|Overall Study|transferred to ICU|2|||
105808466|NCT00979628|364955039|FG002|Overall Study|transferred to ICU|1|||
105808467|NCT03008460|364955042|FG000|Overall Study|Protocol deviation|0|||
105808468|NCT03008460|364955043|FG001|Overall Study|Protocol deviation|2|||
105808469|NCT03008460|364955042|FG000|Overall Study|Study drug not dispensed|0|||
105808470|NCT03008460|364955043|FG001|Overall Study|Study drug not dispensed|1|||
105808471|NCT03008460|364955042|FG000|Overall Study|Adverse Event|0|||
105952582|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952583|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952584|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952585|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952586|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105808472|NCT03008460|364955043|FG001|Overall Study|Adverse Event|1|||
105808473|NCT03008460|364955042|FG000|Overall Study|Withdrawal by Subject|5|||
105808474|NCT03008460|364955043|FG001|Overall Study|Withdrawal by Subject|6|||
105808475|NCT03008460|364955042|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
106017021|NCT03126591|365725944|FG001|Overall Study|Progressive Disease|1|||
106017022|NCT03126591|365725945|FG002|Overall Study|Progressive Disease|2|||
106017023|NCT03126591|365725943|FG000|Overall Study|Terminated by Sponsor|0|||
106017024|NCT03126591|365725944|FG001|Overall Study|Terminated by Sponsor|1|||
106017025|NCT03126591|365725945|FG002|Overall Study|Terminated by Sponsor|4|||
106017026|NCT03126591|365725943|FG000|Overall Study|Withdrawal by Subject|1|||
106017027|NCT03126591|365725944|FG001|Overall Study|Withdrawal by Subject|1|||
106017028|NCT03126591|365725945|FG002|Overall Study|Withdrawal by Subject|4|||
106017029|NCT03722238|365725946|FG000|Overall Study|Protocol Violation|1|||
106017030|NCT03722238|365725947|FG001|Overall Study|Protocol Violation|0|||
106017031|NCT03722238|365725946|FG000|Overall Study|Physician Decision|1|||
106017032|NCT03722238|365725947|FG001|Overall Study|Physician Decision|0|||
106017033|NCT03722238|365725946|FG000|Overall Study|Death|1|||
106017034|NCT03722238|365725947|FG001|Overall Study|Death|0|||
106017035|NCT03722238|365725946|FG000|Overall Study|Lost to Follow-up|6|||
106017036|NCT03722238|365725947|FG001|Overall Study|Lost to Follow-up|0|||
106017037|NCT03722238|365725946|FG000|Overall Study|Partial missing data|44|||
106017038|NCT03722238|365725947|FG001|Overall Study|Partial missing data|1|||
106017039|NCT03722238|365725946|FG000|Overall Study|Withdrawal by Subject|2|||
106144714|NCT05328297|366190712|FG001|Overall Study|Protocol Violation|0|||
106144715|NCT05328297|366190711|FG000|Overall Study|Randomized but not treated|1|||
105761900|NCT00810043|364781453|FG001|Overall Study|Non-medical problem|0|||
106144716|NCT05328297|366190712|FG001|Overall Study|Randomized but not treated|1|||
106144717|NCT04517864|366190713|FG000|Placebo-Controlled Phase|Adverse Event|1|||
106144718|NCT04517864|366190714|FG001|Placebo-Controlled Phase|Adverse Event|0|||
106144719|NCT04517864|366190715|FG002|Placebo-Controlled Phase|Adverse Event|0|||
106144720|NCT04517864|366190713|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
106144721|NCT04517864|366190714|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
105952587|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
105952588|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
105952589|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
105952590|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952591|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952592|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952593|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952594|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
105952595|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
106144722|NCT04517864|366190715|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
106144723|NCT04517864|366190713|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
106144724|NCT04517864|366190714|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
106144725|NCT04517864|366190715|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
106144726|NCT04517864|366190713|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
106144727|NCT04517864|366190714|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
106144728|NCT04517864|366190715|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
106144729|NCT04517864|366190713|FG000|Active Therapy Extension Phase|Adverse Event|1|||
106144730|NCT04517864|366190714|FG001|Active Therapy Extension Phase|Adverse Event|0|||
106144731|NCT04517864|366190715|FG002|Active Therapy Extension Phase|Adverse Event|0|||
106144732|NCT04517864|366190713|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
106144733|NCT04517864|366190714|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
106144734|NCT04517864|366190715|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
106144735|NCT04517864|366190713|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
106144736|NCT04517864|366190714|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
106144737|NCT04517864|366190715|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
106144738|NCT04517864|366190713|FG000|Active Therapy Extension Phase|Physician Decision|1|||
106144739|NCT04517864|366190714|FG001|Active Therapy Extension Phase|Physician Decision|0|||
106144740|NCT04517864|366190715|FG002|Active Therapy Extension Phase|Physician Decision|0|||
106144741|NCT04517864|366190713|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
106144742|NCT04517864|366190714|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
106144743|NCT04517864|366190715|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
106144744|NCT04517864|366190713|FG000|Extension Phase|Adverse Event|0|||
106144745|NCT04517864|366190714|FG001|Extension Phase|Adverse Event|0|||
106144746|NCT04517864|366190715|FG002|Extension Phase|Adverse Event|1|||
106144747|NCT04517864|366190713|FG000|Extension Phase|Lack of Efficacy|0|||
106144748|NCT04517864|366190714|FG001|Extension Phase|Lack of Efficacy|0|||
106144749|NCT04517864|366190715|FG002|Extension Phase|Lack of Efficacy|2|||
106144750|NCT04517864|366190713|FG000|Extension Phase|Study Terminated By Sponsor|0|||
106144751|NCT04517864|366190714|FG001|Extension Phase|Study Terminated By Sponsor|0|||
106144752|NCT04517864|366190715|FG002|Extension Phase|Study Terminated By Sponsor|32|||
106144753|NCT04517864|366190713|FG000|Extension Phase|Withdrawal by Subject|0|||
106144754|NCT04517864|366190714|FG001|Extension Phase|Withdrawal by Subject|0|||
106144755|NCT04517864|366190715|FG002|Extension Phase|Withdrawal by Subject|3|||
106144756|NCT04517864|366190713|FG000|Extension Phase|Approved Drug Available for Indication|0|||
106144757|NCT04517864|366190714|FG001|Extension Phase|Approved Drug Available for Indication|0|||
106144758|NCT04517864|366190715|FG002|Extension Phase|Approved Drug Available for Indication|7|||
106144759|NCT00493649|366190716|FG000|Overall Study|Adverse Event|44|||
106144760|NCT00493649|366190716|FG000|Overall Study|Patient Request|21|||
106144761|NCT00493649|366190716|FG000|Overall Study|Investigator Request|2|||
106144762|NCT00493649|366190716|FG000|Overall Study|Disease Progression|1|||
106144763|NCT00493649|366190716|FG000|Overall Study|Lost to Follow-up|1|||
106144764|NCT00493649|366190716|FG000|Overall Study|Other|13|||
106144765|NCT03175172|366190717|FG000|Overall Study|Death|3|||
106144766|NCT03175172|366190717|FG000|Overall Study|Withdrawal by Subject|3|||
106144767|NCT03175172|366190717|FG000|Overall Study|Lost to Follow-up|1|||
106144768|NCT03175172|366190717|FG000|Overall Study|Study Terminated by Sponsor|3|||
106144769|NCT01662336|366190718|FG000|Overall Study|Adverse Event|1|||
106144770|NCT01662336|366190718|FG000|Overall Study|No longer on LPV/r|30|||
106144771|NCT01662336|366190718|FG000|Overall Study|Other|29|||
106144772|NCT01662336|366190718|FG000|Overall Study|Withdrawal by Subject|6|||
106144773|NCT05731700|366190719|FG000|Overall Study|Death|1|||
106144774|NCT04668339|366190720|FG000|Overall Study|Physician Decision|1|||
106144775|NCT04668339|366190721|FG001|Overall Study|Physician Decision|0|||
106144776|NCT04668339|366190722|FG002|Overall Study|Physician Decision|1|||
106144777|NCT04668339|366190723|FG003|Overall Study|Physician Decision|1|||
106144778|NCT04668339|366190720|FG000|Overall Study|Lost to Follow-up|14|||
106144779|NCT04668339|366190721|FG001|Overall Study|Lost to Follow-up|12|||
106144780|NCT04668339|366190722|FG002|Overall Study|Lost to Follow-up|8|||
106144781|NCT04668339|366190723|FG003|Overall Study|Lost to Follow-up|5|||
106144782|NCT04668339|366190720|FG000|Overall Study|Adverse Event|0|||
106144783|NCT04668339|366190721|FG001|Overall Study|Adverse Event|0|||
106144784|NCT04668339|366190722|FG002|Overall Study|Adverse Event|1|||
106144785|NCT04668339|366190723|FG003|Overall Study|Adverse Event|0|||
106144786|NCT04668339|366190720|FG000|Overall Study|Other than specified|3|||
105761901|NCT00810043|364781454|FG002|Overall Study|Non-medical problem|1|||
105808476|NCT03008460|364955043|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
105808477|NCT03008460|364955042|FG000|Overall Study|End of study visit outside permitted time window|0|||
105808478|NCT03008460|364955043|FG001|Overall Study|End of study visit outside permitted time window|1|||
106144787|NCT04668339|366190721|FG001|Overall Study|Other than specified|0|||
106144788|NCT04668339|366190722|FG002|Overall Study|Other than specified|1|||
106144789|NCT04668339|366190723|FG003|Overall Study|Other than specified|0|||
106144790|NCT04668339|366190720|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
106144791|NCT04668339|366190721|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
106144792|NCT04668339|366190722|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
106144793|NCT04668339|366190723|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
106144794|NCT04668339|366190720|FG000|Overall Study|Vaccine not Administered|0|||
106144795|NCT04668339|366190721|FG001|Overall Study|Vaccine not Administered|0|||
106144796|NCT04668339|366190722|FG002|Overall Study|Vaccine not Administered|1|||
106144797|NCT04668339|366190723|FG003|Overall Study|Vaccine not Administered|0|||
106144798|NCT04668339|366190720|FG000|Overall Study|Protocol Violation|18|||
106144799|NCT04668339|366190721|FG001|Overall Study|Protocol Violation|23|||
106144800|NCT04668339|366190722|FG002|Overall Study|Protocol Violation|12|||
106144801|NCT04668339|366190723|FG003|Overall Study|Protocol Violation|20|||
106144802|NCT04668339|366190720|FG000|Overall Study|Withdrawal by Subject|45|||
106144803|NCT04668339|366190721|FG001|Overall Study|Withdrawal by Subject|46|||
106144804|NCT04668339|366190722|FG002|Overall Study|Withdrawal by Subject|46|||
106144805|NCT04668339|366190723|FG003|Overall Study|Withdrawal by Subject|27|||
106144806|NCT04668339|366190720|FG000|Overall Study|Study Terminated by Sponsor|59|||
106144807|NCT04668339|366190721|FG001|Overall Study|Study Terminated by Sponsor|59|||
106144808|NCT04668339|366190722|FG002|Overall Study|Study Terminated by Sponsor|71|||
106144809|NCT04668339|366190723|FG003|Overall Study|Study Terminated by Sponsor|1|||
105761902|NCT00810043|364781452|FG000|Overall Study|No longer met enrollment criteria|0|||
105761903|NCT00810043|364781453|FG001|Overall Study|No longer met enrollment criteria|0|||
105761904|NCT00810043|364781454|FG002|Overall Study|No longer met enrollment criteria|3|||
105761905|NCT03235726|364781455|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761906|NCT03235726|364781456|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761907|NCT03235726|364781457|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761908|NCT03235726|364781458|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761909|NCT03235726|364781459|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
105761910|NCT03235726|364781460|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761911|NCT03235726|364781461|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761912|NCT03235726|364781462|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761913|NCT03235726|364781463|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761914|NCT03235726|364781464|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
105761915|NCT03235726|364781455|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761916|NCT03235726|364781456|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761917|NCT03235726|364781457|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761918|NCT03235726|364781458|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761919|NCT03235726|364781459|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
105761920|NCT03235726|364781460|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761921|NCT03235726|364781461|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761922|NCT03235726|364781462|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761923|NCT03235726|364781463|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761924|NCT03235726|364781464|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
105761925|NCT01628393|364781468|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
105761926|NCT01628393|364781469|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105761927|NCT01628393|364781470|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105761928|NCT01628393|364781471|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105761929|NCT01628393|364781472|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
105761930|NCT01628393|364781468|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
105761931|NCT01628393|364781469|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
105761932|NCT01628393|364781470|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
105761933|NCT01628393|364781471|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
105761934|NCT01628393|364781472|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
105761935|NCT01628393|364781468|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
105761936|NCT01628393|364781469|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
105761937|NCT01628393|364781470|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
105761938|NCT01628393|364781471|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
105761939|NCT01628393|364781472|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
105761940|NCT01628393|364781468|FG000|Blinded Active Extension Period|Adverse Event|0|||
105808479|NCT03008460|364955042|FG000|Overall Study|Lost to Follow-up|1|||
105808480|NCT03008460|364955043|FG001|Overall Study|Lost to Follow-up|3|||
105808481|NCT03131999|364955046|FG000|Overall Study|Withdrawal by Subject|0|||
105808482|NCT03131999|364955047|FG001|Overall Study|Withdrawal by Subject|1|||
105808483|NCT04634409|364955048|FG000|Overall Study|Death|0|||
105952596|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952597|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952598|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952599|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105808484|NCT04634409|364955049|FG001|Overall Study|Death|0|||
105808485|NCT04634409|364955050|FG002|Overall Study|Death|0|||
105808486|NCT04634409|364955051|FG003|Overall Study|Death|0|||
105952600|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952601|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952602|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952603|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
105952604|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105808487|NCT04634409|364955052|FG004|Overall Study|Death|0|||
105952605|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952606|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952607|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952608|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952609|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952610|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952611|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
105952612|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952613|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952614|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952615|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952616|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952617|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952618|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952619|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952620|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
105952621|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952622|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952623|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105808488|NCT04634409|364955053|FG005|Overall Study|Death|0|||
105808489|NCT04634409|364955054|FG006|Overall Study|Death|0|||
105808490|NCT04634409|364955055|FG007|Overall Study|Death|0|||
105808491|NCT04634409|364955056|FG008|Overall Study|Death|0|||
105808492|NCT04634409|364955057|FG009|Overall Study|Death|0|||
105808493|NCT04634409|364955058|FG010|Overall Study|Death|1|||
105808494|NCT04634409|364955059|FG011|Overall Study|Death|0|||
105808495|NCT04634409|364955060|FG012|Overall Study|Death|1|||
105808496|NCT04634409|364955061|FG013|Overall Study|Death|0|||
105808497|NCT04634409|364955062|FG014|Overall Study|Death|0|||
105808498|NCT04634409|364955063|FG015|Overall Study|Death|0|||
105952624|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952625|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952626|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952627|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
105952628|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952629|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952630|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952631|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952632|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952633|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
106017040|NCT03722238|365725947|FG001|Overall Study|Withdrawal by Subject|0|||
106017041|NCT03722238|365725946|FG000|Overall Study|Other|4|||
105808499|NCT04634409|364955064|FG016|Overall Study|Death|0|||
105808500|NCT04634409|364955065|FG017|Overall Study|Death|0|||
106017042|NCT03722238|365725947|FG001|Overall Study|Other|0|||
105808501|NCT04634409|364955066|FG018|Overall Study|Death|0|||
105808502|NCT04634409|364955067|FG019|Overall Study|Death|0|||
105808503|NCT04634409|364955068|FG020|Overall Study|Death|0|||
105808504|NCT04634409|364955069|FG021|Overall Study|Death|0|||
105808505|NCT04634409|364955070|FG022|Overall Study|Death|0|||
105808506|NCT04634409|364955071|FG023|Overall Study|Death|0|||
105808507|NCT04634409|364955072|FG024|Overall Study|Death|0|||
105952634|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952635|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952636|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952637|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
105952638|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952639|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952640|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952641|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952642|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952643|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
105952644|NCT02891226|365488270|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952645|NCT02891226|365488271|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952646|NCT02891226|365488272|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952647|NCT02891226|365488273|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952648|NCT02891226|365488274|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952649|NCT02891226|365488275|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952650|NCT02891226|365488276|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952651|NCT02891226|365488277|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952652|NCT02891226|365488278|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952653|NCT02891226|365488279|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
105952654|NCT02891226|365488280|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952655|NCT02891226|365488281|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952656|NCT02891226|365488282|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
106144810|NCT01393119|366190727|FG000|Overall Study|Adverse Event|1|||
105808508|NCT04634409|364955073|FG025|Overall Study|Death|0|||
105808509|NCT04634409|364955074|FG026|Overall Study|Death|0|||
105808510|NCT04634409|364955048|FG000|Overall Study|Adverse Event|0|||
105808511|NCT04634409|364955049|FG001|Overall Study|Adverse Event|0|||
105808512|NCT04634409|364955050|FG002|Overall Study|Adverse Event|1|||
105808513|NCT04634409|364955051|FG003|Overall Study|Adverse Event|0|||
105808514|NCT04634409|364955052|FG004|Overall Study|Adverse Event|0|||
105808515|NCT04634409|364955053|FG005|Overall Study|Adverse Event|1|||
105808516|NCT04634409|364955054|FG006|Overall Study|Adverse Event|0|||
105808517|NCT04634409|364955055|FG007|Overall Study|Adverse Event|0|||
105808518|NCT04634409|364955056|FG008|Overall Study|Adverse Event|0|||
105808519|NCT04634409|364955057|FG009|Overall Study|Adverse Event|0|||
105808520|NCT04634409|364955058|FG010|Overall Study|Adverse Event|0|||
105808521|NCT04634409|364955059|FG011|Overall Study|Adverse Event|0|||
105808522|NCT04634409|364955060|FG012|Overall Study|Adverse Event|0|||
105808523|NCT04634409|364955061|FG013|Overall Study|Adverse Event|0|||
105808524|NCT04634409|364955062|FG014|Overall Study|Adverse Event|0|||
105808525|NCT04634409|364955063|FG015|Overall Study|Adverse Event|0|||
105808526|NCT04634409|364955064|FG016|Overall Study|Adverse Event|0|||
105808527|NCT04634409|364955065|FG017|Overall Study|Adverse Event|0|||
105808528|NCT04634409|364955066|FG018|Overall Study|Adverse Event|0|||
105808529|NCT04634409|364955067|FG019|Overall Study|Adverse Event|0|||
105808530|NCT04634409|364955068|FG020|Overall Study|Adverse Event|0|||
105808531|NCT04634409|364955069|FG021|Overall Study|Adverse Event|0|||
105808532|NCT04634409|364955070|FG022|Overall Study|Adverse Event|0|||
105808533|NCT04634409|364955071|FG023|Overall Study|Adverse Event|0|||
105808534|NCT04634409|364955072|FG024|Overall Study|Adverse Event|0|||
105808535|NCT04634409|364955073|FG025|Overall Study|Adverse Event|0|||
105808536|NCT04634409|364955074|FG026|Overall Study|Adverse Event|0|||
105808537|NCT04634409|364955048|FG000|Overall Study|Lost to Follow-up|3|||
105808538|NCT04634409|364955049|FG001|Overall Study|Lost to Follow-up|1|||
105808539|NCT04634409|364955050|FG002|Overall Study|Lost to Follow-up|1|||
105808540|NCT04634409|364955051|FG003|Overall Study|Lost to Follow-up|3|||
105808541|NCT04634409|364955052|FG004|Overall Study|Lost to Follow-up|1|||
105808542|NCT04634409|364955053|FG005|Overall Study|Lost to Follow-up|1|||
105808543|NCT04634409|364955054|FG006|Overall Study|Lost to Follow-up|1|||
105808544|NCT04634409|364955055|FG007|Overall Study|Lost to Follow-up|3|||
105808545|NCT04634409|364955056|FG008|Overall Study|Lost to Follow-up|3|||
105808546|NCT04634409|364955057|FG009|Overall Study|Lost to Follow-up|11|||
105952657|NCT02891226|365488283|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952658|NCT02891226|365488284|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
106144811|NCT01393119|366190728|FG001|Overall Study|Adverse Event|1|||
105808547|NCT04634409|364955058|FG010|Overall Study|Lost to Follow-up|8|||
105808548|NCT04634409|364955059|FG011|Overall Study|Lost to Follow-up|15|||
105808549|NCT04634409|364955060|FG012|Overall Study|Lost to Follow-up|3|||
105808550|NCT04634409|364955061|FG013|Overall Study|Lost to Follow-up|2|||
105808551|NCT04634409|364955062|FG014|Overall Study|Lost to Follow-up|7|||
105808552|NCT04634409|364955063|FG015|Overall Study|Lost to Follow-up|0|||
105808553|NCT04634409|364955064|FG016|Overall Study|Lost to Follow-up|0|||
105808554|NCT04634409|364955065|FG017|Overall Study|Lost to Follow-up|0|||
105808555|NCT04634409|364955066|FG018|Overall Study|Lost to Follow-up|0|||
105808556|NCT04634409|364955067|FG019|Overall Study|Lost to Follow-up|0|||
105808557|NCT04634409|364955068|FG020|Overall Study|Lost to Follow-up|0|||
105808558|NCT04634409|364955069|FG021|Overall Study|Lost to Follow-up|0|||
105808559|NCT04634409|364955070|FG022|Overall Study|Lost to Follow-up|0|||
105808560|NCT04634409|364955071|FG023|Overall Study|Lost to Follow-up|0|||
105808561|NCT04634409|364955072|FG024|Overall Study|Lost to Follow-up|0|||
105808562|NCT04634409|364955073|FG025|Overall Study|Lost to Follow-up|0|||
105808563|NCT04634409|364955074|FG026|Overall Study|Lost to Follow-up|0|||
105808564|NCT04634409|364955048|FG000|Overall Study|Withdrawal by Subject|3|||
105808565|NCT04634409|364955049|FG001|Overall Study|Withdrawal by Subject|1|||
105808566|NCT04634409|364955050|FG002|Overall Study|Withdrawal by Subject|6|||
105808567|NCT04634409|364955051|FG003|Overall Study|Withdrawal by Subject|4|||
105808568|NCT04634409|364955052|FG004|Overall Study|Withdrawal by Subject|2|||
105808569|NCT04634409|364955053|FG005|Overall Study|Withdrawal by Subject|0|||
105808570|NCT04634409|364955054|FG006|Overall Study|Withdrawal by Subject|0|||
105808571|NCT04634409|364955055|FG007|Overall Study|Withdrawal by Subject|2|||
105808572|NCT04634409|364955056|FG008|Overall Study|Withdrawal by Subject|3|||
105808573|NCT04634409|364955057|FG009|Overall Study|Withdrawal by Subject|2|||
105808574|NCT04634409|364955058|FG010|Overall Study|Withdrawal by Subject|3|||
105808575|NCT04634409|364955059|FG011|Overall Study|Withdrawal by Subject|2|||
105808576|NCT04634409|364955060|FG012|Overall Study|Withdrawal by Subject|2|||
105808577|NCT04634409|364955061|FG013|Overall Study|Withdrawal by Subject|1|||
105808578|NCT04634409|364955062|FG014|Overall Study|Withdrawal by Subject|5|||
105808579|NCT04634409|364955063|FG015|Overall Study|Withdrawal by Subject|0|||
105808580|NCT04634409|364955064|FG016|Overall Study|Withdrawal by Subject|0|||
105808581|NCT04634409|364955065|FG017|Overall Study|Withdrawal by Subject|1|||
105808582|NCT04634409|364955066|FG018|Overall Study|Withdrawal by Subject|0|||
105808583|NCT04634409|364955067|FG019|Overall Study|Withdrawal by Subject|0|||
105808584|NCT04634409|364955068|FG020|Overall Study|Withdrawal by Subject|0|||
105808585|NCT04634409|364955069|FG021|Overall Study|Withdrawal by Subject|0|||
105808586|NCT04634409|364955070|FG022|Overall Study|Withdrawal by Subject|0|||
105808587|NCT04634409|364955071|FG023|Overall Study|Withdrawal by Subject|1|||
105808588|NCT04634409|364955072|FG024|Overall Study|Withdrawal by Subject|0|||
105808589|NCT04634409|364955073|FG025|Overall Study|Withdrawal by Subject|0|||
105808590|NCT04634409|364955074|FG026|Overall Study|Withdrawal by Subject|0|||
105808591|NCT04634409|364955048|FG000|Overall Study|Other - As reported by Investigator|1|||
105808592|NCT04634409|364955049|FG001|Overall Study|Other - As reported by Investigator|0|||
105808593|NCT04634409|364955050|FG002|Overall Study|Other - As reported by Investigator|0|||
105808594|NCT04634409|364955051|FG003|Overall Study|Other - As reported by Investigator|0|||
105808595|NCT04634409|364955052|FG004|Overall Study|Other - As reported by Investigator|0|||
105808596|NCT04634409|364955053|FG005|Overall Study|Other - As reported by Investigator|0|||
105808597|NCT04634409|364955054|FG006|Overall Study|Other - As reported by Investigator|0|||
105808598|NCT04634409|364955055|FG007|Overall Study|Other - As reported by Investigator|6|||
105808599|NCT04634409|364955056|FG008|Overall Study|Other - As reported by Investigator|4|||
105808600|NCT04634409|364955057|FG009|Overall Study|Other - As reported by Investigator|0|||
105808601|NCT04634409|364955058|FG010|Overall Study|Other - As reported by Investigator|1|||
105808602|NCT04634409|364955059|FG011|Overall Study|Other - As reported by Investigator|2|||
105808603|NCT04634409|364955060|FG012|Overall Study|Other - As reported by Investigator|2|||
105808604|NCT04634409|364955061|FG013|Overall Study|Other - As reported by Investigator|1|||
105808605|NCT04634409|364955062|FG014|Overall Study|Other - As reported by Investigator|0|||
105808606|NCT04634409|364955063|FG015|Overall Study|Other - As reported by Investigator|0|||
105808607|NCT04634409|364955064|FG016|Overall Study|Other - As reported by Investigator|0|||
105808608|NCT04634409|364955065|FG017|Overall Study|Other - As reported by Investigator|0|||
105808609|NCT04634409|364955066|FG018|Overall Study|Other - As reported by Investigator|0|||
105808610|NCT04634409|364955067|FG019|Overall Study|Other - As reported by Investigator|0|||
105808611|NCT04634409|364955068|FG020|Overall Study|Other - As reported by Investigator|0|||
105808612|NCT04634409|364955069|FG021|Overall Study|Other - As reported by Investigator|0|||
105808613|NCT04634409|364955070|FG022|Overall Study|Other - As reported by Investigator|0|||
105808614|NCT04634409|364955071|FG023|Overall Study|Other - As reported by Investigator|0|||
105808615|NCT04634409|364955072|FG024|Overall Study|Other - As reported by Investigator|0|||
105808616|NCT04634409|364955073|FG025|Overall Study|Other - As reported by Investigator|0|||
105952659|NCT02891226|365488285|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
105952660|NCT02891226|365488270|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952661|NCT02891226|365488271|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952662|NCT02891226|365488272|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105808617|NCT04634409|364955074|FG026|Overall Study|Other - As reported by Investigator|0|||
105808618|NCT02154529|364955075|FG000|Overall Study|Death|1|||
105808619|NCT02154529|364955076|FG001|Overall Study|Death|1|||
105808620|NCT02154529|364955077|FG002|Overall Study|Death|5|||
105808621|NCT02154529|364955078|FG003|Overall Study|Death|1|||
105808622|NCT02154529|364955075|FG000|Overall Study|Termination of study by sponsor|2|||
105808623|NCT02154529|364955076|FG001|Overall Study|Termination of study by sponsor|2|||
105808624|NCT02154529|364955077|FG002|Overall Study|Termination of study by sponsor|3|||
105808625|NCT02154529|364955078|FG003|Overall Study|Termination of study by sponsor|1|||
105761941|NCT01628393|364781469|FG001|Blinded Active Extension Period|Adverse Event|1|||
105761942|NCT01628393|364781470|FG002|Blinded Active Extension Period|Adverse Event|0|||
105761943|NCT01628393|364781471|FG003|Blinded Active Extension Period|Adverse Event|2|||
105761944|NCT01628393|364781472|FG004|Blinded Active Extension Period|Adverse Event|2|||
105761945|NCT01628393|364781468|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
105761946|NCT01628393|364781469|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
105761947|NCT01628393|364781470|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
105761948|NCT01628393|364781471|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
105761949|NCT01628393|364781472|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
105761950|NCT01628393|364781468|FG000|Blinded Active Extension Period|Physician Decision|0|||
105761951|NCT01628393|364781469|FG001|Blinded Active Extension Period|Physician Decision|3|||
105761952|NCT01628393|364781470|FG002|Blinded Active Extension Period|Physician Decision|0|||
105761953|NCT01628393|364781471|FG003|Blinded Active Extension Period|Physician Decision|1|||
105761954|NCT01628393|364781472|FG004|Blinded Active Extension Period|Physician Decision|0|||
105761955|NCT01628393|364781468|FG000|Blinded Active Extension Period|Protocol Violation|0|||
105761956|NCT01628393|364781469|FG001|Blinded Active Extension Period|Protocol Violation|0|||
105761957|NCT01628393|364781470|FG002|Blinded Active Extension Period|Protocol Violation|2|||
105761958|NCT01628393|364781471|FG003|Blinded Active Extension Period|Protocol Violation|1|||
105761959|NCT01628393|364781472|FG004|Blinded Active Extension Period|Protocol Violation|0|||
105761960|NCT01628393|364781468|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
105761961|NCT01628393|364781469|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
105761962|NCT01628393|364781470|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
105761963|NCT01628393|364781471|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
105761964|NCT01628393|364781472|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
105761965|NCT03934541|364781479|FG000|Overall Study|Study Terminated by Sponsor|0|||
105761966|NCT03934541|364781480|FG001|Overall Study|Study Terminated by Sponsor|1|||
105761967|NCT03934541|364781481|FG002|Overall Study|Study Terminated by Sponsor|0|||
105761968|NCT03934541|364781482|FG003|Overall Study|Study Terminated by Sponsor|0|||
105761969|NCT04539262|364781485|FG000|Overall Study|Adverse Event|0|||
105761970|NCT04539262|364781486|FG001|Overall Study|Adverse Event|0|||
105761971|NCT04539262|364781487|FG002|Overall Study|Adverse Event|1|||
105761972|NCT04539262|364781488|FG003|Overall Study|Adverse Event|0|||
105761973|NCT04539262|364781489|FG004|Overall Study|Adverse Event|0|||
105761974|NCT04539262|364781490|FG005|Overall Study|Adverse Event|0|||
105761975|NCT04539262|364781491|FG006|Overall Study|Adverse Event|0|||
105761976|NCT04539262|364781492|FG007|Overall Study|Adverse Event|0|||
105761977|NCT04539262|364781485|FG000|Overall Study|Withdrew Consent|0|||
105761978|NCT04539262|364781486|FG001|Overall Study|Withdrew Consent|0|||
105761979|NCT04539262|364781487|FG002|Overall Study|Withdrew Consent|0|||
105761980|NCT04539262|364781488|FG003|Overall Study|Withdrew Consent|1|||
105761981|NCT04539262|364781489|FG004|Overall Study|Withdrew Consent|0|||
105761982|NCT04539262|364781490|FG005|Overall Study|Withdrew Consent|0|||
105761983|NCT04539262|364781491|FG006|Overall Study|Withdrew Consent|0|||
105761984|NCT04539262|364781492|FG007|Overall Study|Withdrew Consent|0|||
105761985|NCT04539262|364781485|FG000|Overall Study|Randomized, Not treated|0|||
105761986|NCT04539262|364781486|FG001|Overall Study|Randomized, Not treated|1|||
105761987|NCT04539262|364781487|FG002|Overall Study|Randomized, Not treated|0|||
105761988|NCT04539262|364781488|FG003|Overall Study|Randomized, Not treated|0|||
105761989|NCT04539262|364781489|FG004|Overall Study|Randomized, Not treated|0|||
105761990|NCT04539262|364781490|FG005|Overall Study|Randomized, Not treated|0|||
105761991|NCT04539262|364781491|FG006|Overall Study|Randomized, Not treated|1|||
105761992|NCT04539262|364781492|FG007|Overall Study|Randomized, Not treated|0|||
105761993|NCT00282568|364781493|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
105761994|NCT00282568|364781493|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
105761995|NCT00282568|364781493|FG000|Extended Treatment Period|Adverse Event|17|||
105761996|NCT00282568|364781493|FG000|Extended Treatment Period|Non-compliance|4|||
105761997|NCT00282568|364781493|FG000|Extended Treatment Period|Physician Decision|1|||
105761998|NCT00282568|364781493|FG000|Extended Treatment Period|Lost to Follow-up|2|||
105761999|NCT03725293|364781494|FG000|Overall Study|Physician Decision|9|||
105762000|NCT03725293|364781495|FG001|Overall Study|Physician Decision|6|||
105762001|NCT03725293|364781494|FG000|Overall Study|alternative vascular access needs|1|||
105762002|NCT03725293|364781495|FG001|Overall Study|alternative vascular access needs|2|||
105762003|NCT03725293|364781494|FG000|Overall Study|venous anatomy screen failures|2|||
105762004|NCT03725293|364781495|FG001|Overall Study|venous anatomy screen failures|1|||
105762005|NCT02143141|364781496|FG000|Overall Study|pain scores at 24 hours not collected|1|||
105762006|NCT02143141|364781497|FG001|Overall Study|pain scores at 24 hours not collected|0|||
105762007|NCT03673956|364781498|FG000|Overall Study|Lost to Follow-up|1|||
105762008|NCT03673956|364781499|FG001|Overall Study|Lost to Follow-up|0|||
105762009|NCT03673956|364781500|FG002|Overall Study|Lost to Follow-up|0|||
105762010|NCT03673956|364781501|FG003|Overall Study|Lost to Follow-up|0|||
105762011|NCT03673956|364781498|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
105762012|NCT03673956|364781499|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
105952663|NCT02891226|365488273|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952664|NCT02891226|365488274|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952665|NCT02891226|365488275|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952666|NCT02891226|365488276|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952667|NCT02891226|365488277|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952668|NCT02891226|365488278|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952669|NCT02891226|365488279|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952670|NCT02891226|365488280|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
105952671|NCT02891226|365488281|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952672|NCT02891226|365488282|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952673|NCT02891226|365488283|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952674|NCT02891226|365488284|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952675|NCT02891226|365488285|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
105952676|NCT02891226|365488270|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952677|NCT02891226|365488271|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952678|NCT02891226|365488272|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952679|NCT02891226|365488273|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952680|NCT02891226|365488274|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952681|NCT02891226|365488275|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952682|NCT02891226|365488276|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952683|NCT02891226|365488277|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952684|NCT02891226|365488278|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952685|NCT02891226|365488279|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952686|NCT02891226|365488280|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
105952687|NCT02891226|365488281|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952688|NCT02891226|365488282|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952689|NCT02891226|365488283|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952690|NCT02891226|365488284|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952691|NCT02891226|365488285|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
105952692|NCT02891226|365488270|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952693|NCT02891226|365488271|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952694|NCT02891226|365488272|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952695|NCT02891226|365488273|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952696|NCT02891226|365488274|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952697|NCT02891226|365488275|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952698|NCT02891226|365488276|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105762013|NCT03673956|364781500|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
105762014|NCT03673956|364781501|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
105762015|NCT04397796|364781502|FG000|Overall Study|Death|3|||
105762016|NCT04397796|364781503|FG001|Overall Study|Death|1|||
105762017|NCT03168555|364781504|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
105762018|NCT03168555|364781504|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
105762019|NCT03168555|364781504|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
105762020|NCT03168555|364781504|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
105762021|NCT01040845|364781505|FG000|Overall Study|Withdrawal by Subject|1|||
105762022|NCT01040845|364781506|FG001|Overall Study|Withdrawal by Subject|1|||
105762023|NCT01040845|364781505|FG000|Overall Study|Physician Decision|1|||
105762024|NCT01040845|364781506|FG001|Overall Study|Physician Decision|0|||
105762025|NCT01981109|364781507|FG000|Overall Study|Death|36|||
105762026|NCT01981109|364781507|FG000|Overall Study|Withdrawal by Subject|40|||
105762027|NCT01981109|364781507|FG000|Overall Study|Lost to Follow-up|9|||
105762028|NCT01981109|364781507|FG000|Overall Study|No Discontinuation Documentation|37|||
105762029|NCT01981109|364781507|FG000|Overall Study|Study Termination|100|||
105762030|NCT01981109|364781507|FG000|Overall Study|No data available|2|||
105762031|NCT00928512|364781522|FG000|Overall Study|Adverse Event|4|||
105762032|NCT00928512|364781523|FG001|Overall Study|Adverse Event|3|||
105762033|NCT00928512|364781524|FG002|Overall Study|Adverse Event|2|||
105762034|NCT00928512|364781525|FG003|Overall Study|Adverse Event|8|||
105762035|NCT00928512|364781526|FG004|Overall Study|Adverse Event|6|||
105762036|NCT00928512|364781522|FG000|Overall Study|Lack of Efficacy|2|||
105762037|NCT00928512|364781523|FG001|Overall Study|Lack of Efficacy|0|||
105808626|NCT02154529|364955075|FG000|Overall Study|Lost to Follow-up|1|||
105952699|NCT02891226|365488277|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952700|NCT02891226|365488278|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
106017043|NCT03722238|365725946|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
106017044|NCT03722238|365725947|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
106017045|NCT03722238|365725946|FG000|Overall Study|Did not meet risk classification group criteria|90|||
106017046|NCT03722238|365725947|FG001|Overall Study|Did not meet risk classification group criteria|0|||
105762038|NCT00928512|364781524|FG002|Overall Study|Lack of Efficacy|4|||
105762039|NCT00928512|364781525|FG003|Overall Study|Lack of Efficacy|7|||
105762040|NCT00928512|364781526|FG004|Overall Study|Lack of Efficacy|3|||
105762041|NCT00928512|364781522|FG000|Overall Study|Protocol Violation|0|||
105762042|NCT00928512|364781523|FG001|Overall Study|Protocol Violation|1|||
105762043|NCT00928512|364781524|FG002|Overall Study|Protocol Violation|0|||
105762044|NCT00928512|364781525|FG003|Overall Study|Protocol Violation|1|||
105762045|NCT00928512|364781526|FG004|Overall Study|Protocol Violation|3|||
105762046|NCT00928512|364781522|FG000|Overall Study|Withdrawal by Subject|3|||
105762047|NCT00928512|364781523|FG001|Overall Study|Withdrawal by Subject|0|||
105762048|NCT00928512|364781524|FG002|Overall Study|Withdrawal by Subject|3|||
105762049|NCT00928512|364781525|FG003|Overall Study|Withdrawal by Subject|4|||
105762050|NCT00928512|364781526|FG004|Overall Study|Withdrawal by Subject|0|||
105762051|NCT00928512|364781522|FG000|Overall Study|Lost to Follow-up|1|||
105762052|NCT00928512|364781523|FG001|Overall Study|Lost to Follow-up|1|||
105762053|NCT00928512|364781524|FG002|Overall Study|Lost to Follow-up|2|||
105762054|NCT00928512|364781525|FG003|Overall Study|Lost to Follow-up|1|||
105762055|NCT00928512|364781526|FG004|Overall Study|Lost to Follow-up|3|||
105762056|NCT00928512|364781522|FG000|Overall Study|Administrative Problems|0|||
105762057|NCT00928512|364781523|FG001|Overall Study|Administrative Problems|1|||
105762058|NCT00928512|364781524|FG002|Overall Study|Administrative Problems|0|||
105762059|NCT00928512|364781525|FG003|Overall Study|Administrative Problems|0|||
105762060|NCT00928512|364781526|FG004|Overall Study|Administrative Problems|0|||
105762061|NCT04083794|364781527|FG000|Overall Study|Lost to Follow-up|9|||
105762062|NCT03383614|364781528|FG000|Overall Study|Withdrawal by Subject|0|||
105762063|NCT03383614|364781529|FG001|Overall Study|Withdrawal by Subject|1|||
105762064|NCT03383614|364781530|FG002|Overall Study|Withdrawal by Subject|0|||
105762065|NCT03383614|364781531|FG003|Overall Study|Withdrawal by Subject|0|||
105762066|NCT01296698|364781534|FG000|Overall Study|Adverse Event|1|||
105762067|NCT01296698|364781535|FG001|Overall Study|Adverse Event|0|||
105762068|NCT01296698|364781534|FG000|Overall Study|Death|1|||
105762069|NCT01296698|364781535|FG001|Overall Study|Death|0|||
105762070|NCT01296698|364781534|FG000|Overall Study|Lost to Follow-up|19|||
105762071|NCT01296698|364781535|FG001|Overall Study|Lost to Follow-up|1|||
105762072|NCT01296698|364781534|FG000|Overall Study|Withdrawal by Subject|12|||
105762073|NCT01296698|364781535|FG001|Overall Study|Withdrawal by Subject|0|||
105762074|NCT01296698|364781534|FG000|Overall Study|Difficulty Contacting Subject|2|||
105762075|NCT01296698|364781535|FG001|Overall Study|Difficulty Contacting Subject|0|||
105762076|NCT01296698|364781534|FG000|Overall Study|Study Terminated by Sponsor|209|||
105762077|NCT01296698|364781535|FG001|Overall Study|Study Terminated by Sponsor|12|||
105762078|NCT03639987|364781538|FG000|Overall Study|Study terminated by sponsor|26|||
105762079|NCT03639987|364781539|FG001|Overall Study|Study terminated by sponsor|25|||
105762080|NCT03639987|364781538|FG000|Overall Study|Lost to Follow-up|0|||
105762081|NCT03639987|364781539|FG001|Overall Study|Lost to Follow-up|1|||
105762082|NCT02810951|364781545|FG000|Overall Study|Adverse Event|1|||
105762083|NCT01250756|364781546|FG000|Infant Series|Withdrawal by Subject|4|||
105762084|NCT01250756|364781547|FG001|Infant Series|Withdrawal by Subject|5|||
105762085|NCT01250756|364781546|FG000|Infant Series|Randomized, Not Vaccinated|2|||
105762086|NCT01250756|364781547|FG001|Infant Series|Randomized, Not Vaccinated|2|||
105762087|NCT01250756|364781546|FG000|Infant Series|Other|22|||
105762088|NCT01250756|364781547|FG001|Infant Series|Other|0|||
105762089|NCT01250756|364781546|FG000|After Infant Series|Adverse Event|5|||
105762090|NCT01250756|364781547|FG001|After Infant Series|Adverse Event|2|||
105762091|NCT01250756|364781546|FG000|After Infant Series|Withdrawal by Subject|4|||
105762092|NCT01250756|364781547|FG001|After Infant Series|Withdrawal by Subject|1|||
105762093|NCT01250756|364781546|FG000|After Infant Series|Other|2|||
105762094|NCT01250756|364781547|FG001|After Infant Series|Other|1|||
105762095|NCT01250756|364781546|FG000|Toddler Dose|Adverse Event|0|||
105762096|NCT01250756|364781547|FG001|Toddler Dose|Adverse Event|1|||
105762097|NCT01250756|364781546|FG000|After Toddler Dose|Adverse Event|0|||
105762098|NCT01250756|364781547|FG001|After Toddler Dose|Adverse Event|1|||
105762099|NCT03803202|364781548|FG000|Overall Study|Other|0|||
105762100|NCT03803202|364781549|FG001|Overall Study|Other|1|||
105762101|NCT03803202|364781550|FG002|Overall Study|Other|0|||
105762102|NCT03803202|364781551|FG003|Overall Study|Other|0|||
105762103|NCT03803202|364781552|FG004|Overall Study|Other|0|||
105762104|NCT03803202|364781553|FG005|Overall Study|Other|0|||
105762105|NCT03803202|364781554|FG006|Overall Study|Other|0|||
105762106|NCT03803202|364781555|FG007|Overall Study|Other|0|||
105762107|NCT03803202|364781556|FG008|Overall Study|Other|0|||
105762108|NCT03803202|364781548|FG000|Overall Study|Death|0|||
105762109|NCT03803202|364781549|FG001|Overall Study|Death|0|||
105762110|NCT03803202|364781550|FG002|Overall Study|Death|0|||
105762111|NCT03803202|364781551|FG003|Overall Study|Death|0|||
105762112|NCT03803202|364781552|FG004|Overall Study|Death|0|||
105762113|NCT03803202|364781553|FG005|Overall Study|Death|1|||
105762114|NCT03803202|364781554|FG006|Overall Study|Death|0|||
105762115|NCT03803202|364781555|FG007|Overall Study|Death|0|||
105762116|NCT03803202|364781556|FG008|Overall Study|Death|0|||
105762117|NCT03803202|364781548|FG000|Overall Study|Withdrawal by Subject|0|||
105762118|NCT03803202|364781549|FG001|Overall Study|Withdrawal by Subject|0|||
105952701|NCT02891226|365488279|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952702|NCT02891226|365488280|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
105952703|NCT02891226|365488281|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952704|NCT02891226|365488282|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952705|NCT02891226|365488283|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952706|NCT02891226|365488284|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952707|NCT02891226|365488285|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
105952708|NCT02891226|365488270|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952709|NCT02891226|365488271|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952710|NCT02891226|365488272|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952711|NCT02891226|365488273|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952712|NCT02891226|365488274|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952713|NCT02891226|365488275|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952714|NCT02891226|365488276|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952715|NCT02891226|365488277|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952716|NCT02891226|365488278|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952717|NCT02891226|365488279|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952718|NCT02891226|365488280|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
105952719|NCT02891226|365488281|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952720|NCT02891226|365488282|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952721|NCT02891226|365488283|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952722|NCT02891226|365488284|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952723|NCT02891226|365488285|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
105952724|NCT02891226|365488270|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952725|NCT02891226|365488271|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952726|NCT02891226|365488272|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105762119|NCT03803202|364781550|FG002|Overall Study|Withdrawal by Subject|1|||
105762120|NCT03803202|364781551|FG003|Overall Study|Withdrawal by Subject|0|||
105762121|NCT03803202|364781552|FG004|Overall Study|Withdrawal by Subject|0|||
105762122|NCT03803202|364781553|FG005|Overall Study|Withdrawal by Subject|0|||
105762123|NCT03803202|364781554|FG006|Overall Study|Withdrawal by Subject|0|||
105762124|NCT03803202|364781555|FG007|Overall Study|Withdrawal by Subject|1|||
105762125|NCT03803202|364781556|FG008|Overall Study|Withdrawal by Subject|0|||
105762126|NCT03803202|364781548|FG000|Overall Study|Lost to Follow-up|0|||
105762127|NCT03803202|364781549|FG001|Overall Study|Lost to Follow-up|0|||
105762128|NCT03803202|364781550|FG002|Overall Study|Lost to Follow-up|0|||
105762129|NCT03803202|364781551|FG003|Overall Study|Lost to Follow-up|1|||
105762130|NCT03803202|364781552|FG004|Overall Study|Lost to Follow-up|1|||
105762131|NCT03803202|364781553|FG005|Overall Study|Lost to Follow-up|0|||
105762132|NCT03803202|364781554|FG006|Overall Study|Lost to Follow-up|1|||
105762133|NCT03803202|364781555|FG007|Overall Study|Lost to Follow-up|0|||
105762134|NCT03803202|364781556|FG008|Overall Study|Lost to Follow-up|0|||
105762135|NCT01815580|364781557|FG000|Overall Study|Lost to Follow-up|4|||
105762136|NCT01815580|364781558|FG001|Overall Study|Lost to Follow-up|7|||
105762137|NCT01815580|364781557|FG000|Overall Study|Withdrawal by Subject|3|||
105762138|NCT01815580|364781558|FG001|Overall Study|Withdrawal by Subject|4|||
105762139|NCT01815580|364781557|FG000|Overall Study|Excluded from analysis|5|||
105762140|NCT01815580|364781558|FG001|Overall Study|Excluded from analysis|4|||
105762141|NCT00345540|364781559|FG000|Overall Study|Withdrawal by Subject|1|||
105762142|NCT02999191|364781564|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
105762143|NCT02999191|364781565|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
105762144|NCT02999191|364781566|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
105762145|NCT02657434|364783075|FG000|Overall Study|Study Terminated By Sponsor|64|||
105762146|NCT02657434|364783076|FG001|Overall Study|Study Terminated By Sponsor|82|||
105762147|NCT02657434|364783075|FG000|Overall Study|Death|189|||
105762148|NCT02657434|364783076|FG001|Overall Study|Death|190|||
105762149|NCT02657434|364783075|FG000|Overall Study|Lost to Follow-up|2|||
105762150|NCT02657434|364783076|FG001|Overall Study|Lost to Follow-up|2|||
105762151|NCT02657434|364783075|FG000|Overall Study|Randomization by Error|2|||
105762152|NCT02657434|364783076|FG001|Overall Study|Randomization by Error|0|||
105762153|NCT02657434|364783075|FG000|Overall Study|Withdrawal by Subject|28|||
105762154|NCT02657434|364783076|FG001|Overall Study|Withdrawal by Subject|17|||
105762155|NCT02657434|364783075|FG000|Overall Study|Protocol Violation|1|||
105762156|NCT02657434|364783076|FG001|Overall Study|Protocol Violation|0|||
105762157|NCT02657434|364783075|FG000|Overall Study|Physician Decision|0|||
105762158|NCT02657434|364783076|FG001|Overall Study|Physician Decision|1|||
105762159|NCT00608881|364783077|FG000|Overall Study|Death|22|||
105762160|NCT00608881|364783078|FG001|Overall Study|Death|13|||
105762161|NCT00608881|364783077|FG000|Overall Study|Adverse Event|5|||
105762162|NCT00608881|364783078|FG001|Overall Study|Adverse Event|3|||
105762163|NCT00608881|364783077|FG000|Overall Study|Lost to Follow-up|28|||
105762164|NCT00608881|364783078|FG001|Overall Study|Lost to Follow-up|14|||
105762165|NCT00608881|364783077|FG000|Overall Study|Withdrawal by Subject|18|||
105762166|NCT00608881|364783078|FG001|Overall Study|Withdrawal by Subject|29|||
105808627|NCT02154529|364955076|FG001|Overall Study|Lost to Follow-up|0|||
105808628|NCT02154529|364955077|FG002|Overall Study|Lost to Follow-up|0|||
105808629|NCT02154529|364955078|FG003|Overall Study|Lost to Follow-up|0|||
105808630|NCT00365352|364955079|FG000|Overall Study|Adverse Event|6|||
105808631|NCT00365352|364955080|FG001|Overall Study|Adverse Event|7|||
105808632|NCT00365352|364955081|FG002|Overall Study|Adverse Event|8|||
105808633|NCT00365352|364955079|FG000|Overall Study|Participant Withdrew Consent|8|||
105808634|NCT00365352|364955080|FG001|Overall Study|Participant Withdrew Consent|3|||
105808635|NCT00365352|364955081|FG002|Overall Study|Participant Withdrew Consent|4|||
105808636|NCT00365352|364955079|FG000|Overall Study|Lack of Efficacy|3|||
105808637|NCT00365352|364955080|FG001|Overall Study|Lack of Efficacy|0|||
105808638|NCT00365352|364955081|FG002|Overall Study|Lack of Efficacy|0|||
105808639|NCT00365352|364955079|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
105808640|NCT00365352|364955080|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
105808641|NCT00365352|364955081|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
105808642|NCT00365352|364955079|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
105808643|NCT00365352|364955080|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
105808644|NCT00365352|364955081|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
105808645|NCT00365352|364955079|FG000|Overall Study|Lost to Follow-up|1|||
105808646|NCT00365352|364955080|FG001|Overall Study|Lost to Follow-up|1|||
105808647|NCT00365352|364955081|FG002|Overall Study|Lost to Follow-up|0|||
105808648|NCT00365352|364955079|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
105808649|NCT00365352|364955080|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
105808650|NCT00365352|364955081|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
105808651|NCT02109133|364955083|FG000|Overall Study|Lost to Follow-up|1|||
105808652|NCT02109133|364955084|FG001|Overall Study|Lost to Follow-up|0|||
105808653|NCT00409578|364955085|FG000|Overall Study|Adverse Event|27|||
105808654|NCT00409578|364955086|FG001|Overall Study|Adverse Event|37|||
105808655|NCT00409578|364955087|FG002|Overall Study|Adverse Event|25|||
105808656|NCT00409578|364955088|FG003|Overall Study|Adverse Event|33|||
105808657|NCT00409578|364955085|FG000|Overall Study|Abnormal laboratory value(s)|2|||
105808658|NCT00409578|364955086|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105808659|NCT00409578|364955087|FG002|Overall Study|Abnormal laboratory value(s)|2|||
105808660|NCT00409578|364955088|FG003|Overall Study|Abnormal laboratory value(s)|4|||
105808661|NCT00409578|364955085|FG000|Overall Study|Lack of Efficacy|0|||
105808662|NCT00409578|364955086|FG001|Overall Study|Lack of Efficacy|0|||
105808663|NCT00409578|364955087|FG002|Overall Study|Lack of Efficacy|0|||
105808664|NCT00409578|364955088|FG003|Overall Study|Lack of Efficacy|2|||
105808665|NCT00409578|364955085|FG000|Overall Study|Subject no longer requires study drug|0|||
105808666|NCT00409578|364955086|FG001|Overall Study|Subject no longer requires study drug|0|||
105808667|NCT00409578|364955087|FG002|Overall Study|Subject no longer requires study drug|0|||
105808668|NCT00409578|364955088|FG003|Overall Study|Subject no longer requires study drug|1|||
105808669|NCT00409578|364955085|FG000|Overall Study|Withdrawal by Subject|8|||
105808670|NCT00409578|364955086|FG001|Overall Study|Withdrawal by Subject|15|||
105808671|NCT00409578|364955087|FG002|Overall Study|Withdrawal by Subject|16|||
105808672|NCT00409578|364955088|FG003|Overall Study|Withdrawal by Subject|17|||
105808673|NCT00409578|364955085|FG000|Overall Study|Lost to Follow-up|2|||
105808674|NCT00409578|364955086|FG001|Overall Study|Lost to Follow-up|0|||
105808675|NCT00409578|364955087|FG002|Overall Study|Lost to Follow-up|2|||
105808676|NCT00409578|364955088|FG003|Overall Study|Lost to Follow-up|2|||
105808677|NCT00409578|364955085|FG000|Overall Study|Administrative problems|8|||
105808678|NCT00409578|364955086|FG001|Overall Study|Administrative problems|9|||
105808679|NCT00409578|364955087|FG002|Overall Study|Administrative problems|2|||
105808680|NCT00409578|364955088|FG003|Overall Study|Administrative problems|4|||
105808681|NCT00409578|364955085|FG000|Overall Study|Death|2|||
105808682|NCT00409578|364955086|FG001|Overall Study|Death|4|||
105808683|NCT00409578|364955087|FG002|Overall Study|Death|4|||
105808684|NCT00409578|364955088|FG003|Overall Study|Death|2|||
105808685|NCT00409578|364955085|FG000|Overall Study|Protocol Violation|3|||
105808686|NCT00409578|364955086|FG001|Overall Study|Protocol Violation|2|||
105808687|NCT00409578|364955087|FG002|Overall Study|Protocol Violation|3|||
105808688|NCT00409578|364955088|FG003|Overall Study|Protocol Violation|1|||
105808689|NCT00409578|364955085|FG000|Overall Study|Missing|0|||
105808690|NCT00409578|364955086|FG001|Overall Study|Missing|1|||
105808691|NCT00409578|364955087|FG002|Overall Study|Missing|0|||
105808692|NCT00409578|364955088|FG003|Overall Study|Missing|1|||
105808693|NCT01922349|364955089|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
105808694|NCT01922349|364955090|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
106144812|NCT01393119|366190729|FG002|Overall Study|Adverse Event|0|||
106144813|NCT01393119|366190730|FG003|Overall Study|Adverse Event|1|||
106144814|NCT01393119|366190727|FG000|Overall Study|Withdrawal by Subject|0|||
106144815|NCT01393119|366190728|FG001|Overall Study|Withdrawal by Subject|1|||
105808695|NCT01922349|364955091|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
105808696|NCT01922349|364955092|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
105808697|NCT00458302|364956749|FG000|Overall Study|Adverse Event|4|||
105808698|NCT00458302|364956750|FG001|Overall Study|Adverse Event|14|||
105808699|NCT00458302|364956749|FG000|Overall Study|Pregnancy|2|||
105808700|NCT00458302|364956750|FG001|Overall Study|Pregnancy|1|||
105808701|NCT00458302|364956749|FG000|Overall Study|Protocol Violation|0|||
105808702|NCT00458302|364956750|FG001|Overall Study|Protocol Violation|2|||
105808703|NCT00458302|364956749|FG000|Overall Study|Withdrawal by Subject|6|||
105808704|NCT00458302|364956750|FG001|Overall Study|Withdrawal by Subject|4|||
105808705|NCT00458302|364956749|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
105808706|NCT00458302|364956750|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
105808707|NCT00458302|364956749|FG000|Overall Study|Study Termination By Sponsor|1|||
105808708|NCT00458302|364956750|FG001|Overall Study|Study Termination By Sponsor|0|||
105808709|NCT00458302|364956749|FG000|Overall Study|Lost to Follow-up|2|||
105808710|NCT00458302|364956750|FG001|Overall Study|Lost to Follow-up|0|||
105808711|NCT00458302|364956749|FG000|Overall Study|Other|4|||
105808712|NCT00458302|364956750|FG001|Overall Study|Other|2|||
105808713|NCT04582266|364956751|FG000|Overall Study|Lost to Follow-up|7|||
105808714|NCT04582266|364956752|FG001|Overall Study|Lost to Follow-up|5|||
105808715|NCT04582266|364956751|FG000|Overall Study|Withdrawal by Subject|1|||
105808716|NCT04582266|364956752|FG001|Overall Study|Withdrawal by Subject|0|||
105808717|NCT04582266|364956751|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
105808718|NCT04582266|364956752|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
105808719|NCT01341639|364956753|FG000|Infant Series|Protocol Violation|1|||
105808720|NCT01341639|364956754|FG001|Infant Series|Protocol Violation|0|||
105808721|NCT01341639|364956753|FG000|Infant Series|Not Vaccinated|0|||
105808722|NCT01341639|364956754|FG001|Infant Series|Not Vaccinated|1|||
105808723|NCT01341639|364956753|FG000|Infant Series|Adverse Event|0|||
105808724|NCT01341639|364956754|FG001|Infant Series|Adverse Event|5|||
105808725|NCT01341639|364956753|FG000|Infant Series|Withdrawal by Subject|11|||
105808726|NCT01341639|364956754|FG001|Infant Series|Withdrawal by Subject|8|||
105808727|NCT01341639|364956753|FG000|Infant Series|Lost to Follow-up|0|||
105808728|NCT01341639|364956754|FG001|Infant Series|Lost to Follow-up|2|||
105808729|NCT01341639|364956753|FG000|Infant Series|Site 0048 Participants|17|||
105808730|NCT01341639|364956754|FG001|Infant Series|Site 0048 Participants|16|||
105808731|NCT01341639|364956753|FG000|Interim Period|Withdrawal by Subject|6|||
105808732|NCT01341639|364956754|FG001|Interim Period|Withdrawal by Subject|7|||
105808733|NCT01341639|364956753|FG000|Interim Period|Lost to Follow-up|2|||
105808734|NCT01341639|364956754|FG001|Interim Period|Lost to Follow-up|0|||
105808735|NCT01341639|364956753|FG000|Interim Period|Physician Decision|0|||
105808736|NCT01341639|364956754|FG001|Interim Period|Physician Decision|1|||
105808737|NCT01341639|364956753|FG000|Interim Period|Protocol Violation|0|||
105808738|NCT01341639|364956754|FG001|Interim Period|Protocol Violation|1|||
105808739|NCT01341639|364956753|FG000|Post-Treatment|Withdrawal by Subject|0|||
105808740|NCT01341639|364956754|FG001|Post-Treatment|Withdrawal by Subject|1|||
105808741|NCT01341639|364956753|FG000|Post-Treatment|Adverse Event|0|||
105808742|NCT01341639|364956754|FG001|Post-Treatment|Adverse Event|2|||
105808743|NCT01299038|364956757|FG000|Overall Study|Withdrawal by Subject|1|||
105808744|NCT01299038|364956758|FG001|Overall Study|Withdrawal by Subject|0|||
105808745|NCT01162499|364956759|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
105808746|NCT01162499|364956760|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
105808747|NCT03355742|364956761|FG000|Overall Study|Lost to Follow-up|4|||
105808748|NCT03355742|364956761|FG000|Overall Study|Withdrawal by Subject|29|||
105808749|NCT03355742|364956761|FG000|Overall Study|Physician Decision|6|||
105808750|NCT03355742|364956761|FG000|Overall Study|Death|55|||
106144816|NCT01393119|366190729|FG002|Overall Study|Withdrawal by Subject|1|||
106144817|NCT01393119|366190730|FG003|Overall Study|Withdrawal by Subject|0|||
106144818|NCT01393119|366190727|FG000|Overall Study|Lack of Efficacy|1|||
106144819|NCT01393119|366190728|FG001|Overall Study|Lack of Efficacy|0|||
106144820|NCT01393119|366190729|FG002|Overall Study|Lack of Efficacy|2|||
106144821|NCT01393119|366190730|FG003|Overall Study|Lack of Efficacy|1|||
105808751|NCT03355742|364956761|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
105808752|NCT01165996|364956763|FG000|Overall Study|Death|1|||
105808753|NCT01165996|364956763|FG000|Overall Study|Physician Decision|1|||
105808754|NCT00444795|364956768|FG000|Overall Study|Not Treated|1|||
105808755|NCT00444795|364956768|FG000|Overall Study|Treated Prior to the Contract Date|2|||
105808756|NCT00988169|364956769|FG000|Overall Study|Withdrawal by Subject|1|||
105808757|NCT02322879|364956770|FG000|First Intervention|Physician Decision|1|||
105808758|NCT02322879|364956771|FG001|First Intervention|Physician Decision|0|||
105808759|NCT00582036|364956772|FG000|Overall Study|Withdrawal by Subject|0|||
105808760|NCT00582036|364956773|FG001|Overall Study|Withdrawal by Subject|1|||
105808761|NCT02848599|364956777|FG000|Overall Study|Protocol Violation|7|||
105808762|NCT02848599|364956778|FG001|Overall Study|Protocol Violation|9|||
105808763|NCT02352337|364956779|FG000|Overall Study|Patients never treated|4|||
105808764|NCT02352337|364956780|FG001|Overall Study|Patients never treated|1|||
106017047|NCT03722238|365725946|FG000|Overall Study|Did not sign consent|17|||
106144822|NCT01393119|366190727|FG000|Overall Study|Protocol Violation|0|||
105808765|NCT02352337|364956781|FG002|Overall Study|Patients never treated|2|||
105808766|NCT01787825|364956782|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
106144823|NCT01393119|366190728|FG001|Overall Study|Protocol Violation|0|||
105808767|NCT01787825|364956783|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
105808768|NCT01787825|364956782|FG000|Overall Study|Data Not Analyzable|5|||
105808769|NCT01787825|364956783|FG001|Overall Study|Data Not Analyzable|1|||
105808770|NCT00718159|364956784|FG000|Overall Study|Progressive Disease|3|||
105808771|NCT00718159|364956785|FG001|Overall Study|Progressive Disease|3|||
105808772|NCT00718159|364956786|FG002|Overall Study|Progressive Disease|2|||
105808773|NCT00718159|364956787|FG003|Overall Study|Progressive Disease|0|||
105808774|NCT00718159|364956788|FG004|Overall Study|Progressive Disease|6|||
105808775|NCT00718159|364956789|FG005|Overall Study|Progressive Disease|0|||
105808776|NCT00718159|364956790|FG006|Overall Study|Progressive Disease|0|||
105808777|NCT00718159|364956784|FG000|Overall Study|Death due to Adverse Event|0|||
105808778|NCT00718159|364956785|FG001|Overall Study|Death due to Adverse Event|0|||
105808779|NCT00718159|364956786|FG002|Overall Study|Death due to Adverse Event|0|||
105808780|NCT00718159|364956787|FG003|Overall Study|Death due to Adverse Event|2|||
105808781|NCT00718159|364956788|FG004|Overall Study|Death due to Adverse Event|2|||
105808782|NCT00718159|364956789|FG005|Overall Study|Death due to Adverse Event|0|||
105808783|NCT00718159|364956790|FG006|Overall Study|Death due to Adverse Event|0|||
105808784|NCT00718159|364956784|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
105808785|NCT00718159|364956785|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
105808786|NCT00718159|364956786|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
105808787|NCT00718159|364956787|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
105808788|NCT00718159|364956788|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
105808789|NCT00718159|364956789|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
105808790|NCT00718159|364956790|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
105808791|NCT00718159|364956784|FG000|Overall Study|Investigator Decision|0|||
105808792|NCT00718159|364956785|FG001|Overall Study|Investigator Decision|0|||
105808793|NCT00718159|364956786|FG002|Overall Study|Investigator Decision|0|||
105808794|NCT00718159|364956787|FG003|Overall Study|Investigator Decision|0|||
105808795|NCT00718159|364956788|FG004|Overall Study|Investigator Decision|0|||
105808796|NCT00718159|364956789|FG005|Overall Study|Investigator Decision|1|||
105808797|NCT00718159|364956790|FG006|Overall Study|Investigator Decision|1|||
105808798|NCT02228382|364956791|FG000|Overall Study|Death|5|||
105808799|NCT02228382|364956792|FG001|Overall Study|Death|7|||
105808800|NCT02228382|364956793|FG002|Overall Study|Death|5|||
105808801|NCT02228382|364956794|FG003|Overall Study|Death|0|||
105808802|NCT02228382|364956795|FG004|Overall Study|Death|2|||
105808803|NCT02228382|364956791|FG000|Overall Study|Participant refused further follow-up|0|||
105808804|NCT02228382|364956792|FG001|Overall Study|Participant refused further follow-up|0|||
105808805|NCT02228382|364956793|FG002|Overall Study|Participant refused further follow-up|1|||
105808806|NCT02228382|364956794|FG003|Overall Study|Participant refused further follow-up|0|||
105808807|NCT02228382|364956795|FG004|Overall Study|Participant refused further follow-up|0|||
105808808|NCT02228382|364956791|FG000|Overall Study|Study terminated by sponsor|3|||
105808809|NCT02228382|364956792|FG001|Overall Study|Study terminated by sponsor|5|||
105808810|NCT02228382|364956793|FG002|Overall Study|Study terminated by sponsor|7|||
105808811|NCT02228382|364956794|FG003|Overall Study|Study terminated by sponsor|0|||
105808812|NCT02228382|364956795|FG004|Overall Study|Study terminated by sponsor|0|||
105808813|NCT02228382|364956791|FG000|Overall Study|Lost to Follow-up|0|||
105808814|NCT02228382|364956792|FG001|Overall Study|Lost to Follow-up|0|||
105808815|NCT02228382|364956793|FG002|Overall Study|Lost to Follow-up|3|||
105808816|NCT02228382|364956794|FG003|Overall Study|Lost to Follow-up|1|||
105808817|NCT02228382|364956795|FG004|Overall Study|Lost to Follow-up|0|||
105808818|NCT02228382|364956791|FG000|Overall Study|Withdrawal by Subject|0|||
105808819|NCT02228382|364956792|FG001|Overall Study|Withdrawal by Subject|3|||
105808820|NCT02228382|364956793|FG002|Overall Study|Withdrawal by Subject|2|||
105808821|NCT02228382|364956794|FG003|Overall Study|Withdrawal by Subject|1|||
105808822|NCT02228382|364956795|FG004|Overall Study|Withdrawal by Subject|0|||
105808823|NCT02228382|364956791|FG000|Overall Study|Other|2|||
105808824|NCT02228382|364956792|FG001|Overall Study|Other|3|||
105808825|NCT02228382|364956793|FG002|Overall Study|Other|3|||
105808826|NCT02228382|364956794|FG003|Overall Study|Other|0|||
105808827|NCT02228382|364956795|FG004|Overall Study|Other|0|||
105808828|NCT01238848|364956797|FG000|Overall Study|Physician Decision|13|||
105808829|NCT01238848|364956798|FG001|Overall Study|Physician Decision|5|||
105808830|NCT02396381|364956801|FG000|Overall Study|Adverse Event|3|||
105808831|NCT02396381|364956802|FG001|Overall Study|Adverse Event|2|||
105808832|NCT02396381|364956801|FG000|Overall Study|Withdrawal by Subject|33|||
105808833|NCT02396381|364956802|FG001|Overall Study|Withdrawal by Subject|24|||
106144824|NCT01393119|366190729|FG002|Overall Study|Protocol Violation|1|||
105808834|NCT02396381|364956801|FG000|Overall Study|Lost to Follow-up|49|||
105808835|NCT02396381|364956802|FG001|Overall Study|Lost to Follow-up|31|||
105808836|NCT02396381|364956801|FG000|Overall Study|Protocol Violation|1|||
105808837|NCT02396381|364956802|FG001|Overall Study|Protocol Violation|0|||
105808838|NCT02396381|364956801|FG000|Overall Study|Site terminated by sponsor|7|||
105808839|NCT02396381|364956802|FG001|Overall Study|Site terminated by sponsor|8|||
105808840|NCT02396381|364956801|FG000|Overall Study|Physician Decision|5|||
105808841|NCT02396381|364956802|FG001|Overall Study|Physician Decision|5|||
105808842|NCT02396381|364956801|FG000|Overall Study|Pregnancy|2|||
105808843|NCT02396381|364956802|FG001|Overall Study|Pregnancy|0|||
105808844|NCT02396381|364956801|FG000|Overall Study|Non-compliance with study procedures|1|||
105808845|NCT02396381|364956802|FG001|Overall Study|Non-compliance with study procedures|0|||
105808846|NCT02396381|364956801|FG000|Overall Study|Moved out of town/state|1|||
105808847|NCT02396381|364956802|FG001|Overall Study|Moved out of town/state|3|||
105808848|NCT02396381|364956801|FG000|Overall Study|Could not complete visit|1|||
105808849|NCT02396381|364956802|FG001|Overall Study|Could not complete visit|0|||
105808850|NCT02396381|364956801|FG000|Overall Study|Possible conflict of interest|1|||
105808851|NCT02396381|364956802|FG001|Overall Study|Possible conflict of interest|0|||
105808852|NCT02396381|364956801|FG000|Overall Study|Randomization/Screening Error|3|||
105808853|NCT02396381|364956802|FG001|Overall Study|Randomization/Screening Error|1|||
105808854|NCT00576381|364956807|FG000|Overall Study|Reoperation|3|||
105808855|NCT00576381|364956807|FG000|Overall Study|Adverse Event|4|||
105808856|NCT00797108|364956808|FG000|Overall Study|Adverse Event|1|||
105808857|NCT00797108|364956809|FG001|Overall Study|Adverse Event|0|||
105808858|NCT00797108|364956810|FG002|Overall Study|Adverse Event|3|||
105808859|NCT00797108|364956808|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
105808860|NCT00797108|364956809|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
105808861|NCT00797108|364956810|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
105808862|NCT00797108|364956808|FG000|Overall Study|Global Deterioration of Health Status|0|||
105808863|NCT00797108|364956809|FG001|Overall Study|Global Deterioration of Health Status|1|||
105808864|NCT00797108|364956810|FG002|Overall Study|Global Deterioration of Health Status|0|||
105808865|NCT00797108|364956808|FG000|Overall Study|Lack of Efficacy|1|||
105808866|NCT00797108|364956809|FG001|Overall Study|Lack of Efficacy|0|||
105808867|NCT00797108|364956810|FG002|Overall Study|Lack of Efficacy|1|||
105808868|NCT00797108|364956808|FG000|Overall Study|Other|0|||
105808869|NCT00797108|364956809|FG001|Overall Study|Other|0|||
105808870|NCT00797108|364956810|FG002|Overall Study|Other|2|||
105808871|NCT00797108|364956808|FG000|Overall Study|Randomized but not Treated|2|||
105808872|NCT00797108|364956809|FG001|Overall Study|Randomized but not Treated|0|||
105808873|NCT00797108|364956810|FG002|Overall Study|Randomized but not Treated|0|||
105808874|NCT02270736|364956811|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
105808875|NCT02270736|364956812|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
105808876|NCT02270736|364956813|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
105808877|NCT02270736|364956814|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
105808878|NCT02270736|364956815|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
105808879|NCT02270736|364956811|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
105808880|NCT02270736|364956812|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
105808881|NCT02270736|364956813|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
105808882|NCT02270736|364956814|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
105808883|NCT02270736|364956815|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
105808884|NCT02270736|364956811|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
105808885|NCT02270736|364956812|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
105808886|NCT02270736|364956813|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
105808887|NCT02270736|364956814|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
105808888|NCT02270736|364956815|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
105808889|NCT02270736|364956811|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
105808890|NCT02270736|364956812|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
105808891|NCT02270736|364956813|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
105808892|NCT02270736|364956814|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
105808893|NCT02270736|364956815|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
105808894|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
105808895|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
105808896|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
105808897|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
105808898|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
105808899|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
105808900|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
105808901|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
105808902|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
106144825|NCT01393119|366190730|FG003|Overall Study|Protocol Violation|0|||
106144826|NCT01393119|366190727|FG000|Overall Study|Death|0|||
105808903|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
105808904|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
105808905|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
105808906|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
105808907|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
105808908|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
105808909|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
105808910|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
105952727|NCT02891226|365488273|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105808911|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
105808912|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
105808913|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
105808914|NCT02270736|364956811|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
105808915|NCT02270736|364956812|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
105808916|NCT02270736|364956813|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
105808917|NCT02270736|364956814|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
105808918|NCT02270736|364956815|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
105808919|NCT00262600|364956816|FG000|Overall Study|Lost to Follow-up|17|||
105808920|NCT00262600|364956817|FG001|Overall Study|Lost to Follow-up|31|||
105808921|NCT00262600|364956818|FG002|Overall Study|Lost to Follow-up|41|||
105808922|NCT00262600|364956816|FG000|Overall Study|Withdrawal by Subject|128|||
105808923|NCT00262600|364956817|FG001|Overall Study|Withdrawal by Subject|145|||
105808924|NCT00262600|364956818|FG002|Overall Study|Withdrawal by Subject|139|||
105808925|NCT00262600|364956816|FG000|Overall Study|Not Treated|32|||
105808926|NCT00262600|364956817|FG001|Overall Study|Not Treated|17|||
105808927|NCT00262600|364956818|FG002|Overall Study|Not Treated|24|||
105808928|NCT00262600|364956816|FG000|Overall Study|Other|58|||
105808929|NCT00262600|364956817|FG001|Overall Study|Other|59|||
105808930|NCT00262600|364956818|FG002|Overall Study|Other|62|||
105808931|NCT04471207|364956821|FG000|Overall Study|Lost to Follow-up|4|||
105808932|NCT04471207|364956822|FG001|Overall Study|Lost to Follow-up|1|||
105808933|NCT04471207|364956821|FG000|Overall Study|Medication Contraindication|0|||
105808934|NCT04471207|364956822|FG001|Overall Study|Medication Contraindication|1|||
105808935|NCT04471207|364956821|FG000|Overall Study|Loss of Interest|2|||
105808936|NCT04471207|364956822|FG001|Overall Study|Loss of Interest|1|||
105952728|NCT02891226|365488274|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105808937|NCT04471207|364956821|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
105808938|NCT04471207|364956822|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
105808939|NCT04471207|364956821|FG000|Overall Study|Scheduling Conflicts|3|||
105808940|NCT04471207|364956822|FG001|Overall Study|Scheduling Conflicts|1|||
105952729|NCT02891226|365488275|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952730|NCT02891226|365488276|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952731|NCT02891226|365488277|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952732|NCT02891226|365488278|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952733|NCT02891226|365488279|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952734|NCT02891226|365488280|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
105952735|NCT02891226|365488281|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952736|NCT02891226|365488282|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952737|NCT02891226|365488283|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952738|NCT02891226|365488284|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952739|NCT02891226|365488285|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
105952740|NCT02891226|365488270|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952741|NCT02891226|365488271|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952742|NCT02891226|365488272|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952743|NCT02891226|365488273|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952744|NCT02891226|365488274|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952745|NCT02891226|365488275|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952746|NCT02891226|365488276|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952747|NCT02891226|365488277|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
106144827|NCT01393119|366190728|FG001|Overall Study|Death|0|||
106144828|NCT01393119|366190729|FG002|Overall Study|Death|0|||
105808941|NCT04471207|364956821|FG000|Overall Study|Physician Decision|1|||
105808942|NCT04471207|364956822|FG001|Overall Study|Physician Decision|0|||
105808943|NCT04471207|364956821|FG000|Overall Study|Unwilling to Use System|0|||
105808944|NCT04471207|364956822|FG001|Overall Study|Unwilling to Use System|1|||
105808945|NCT01860976|364956827|FG000|Blinded Treatment|Adverse Event|1|||
105952748|NCT02891226|365488278|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952749|NCT02891226|365488279|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952750|NCT02891226|365488280|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
105952751|NCT02891226|365488281|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952752|NCT02891226|365488282|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952753|NCT02891226|365488283|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105808946|NCT01860976|364956828|FG001|Blinded Treatment|Adverse Event|3|||
105808947|NCT01860976|364956827|FG000|Blinded Treatment|Lack of Efficacy|5|||
105808948|NCT01860976|364956828|FG001|Blinded Treatment|Lack of Efficacy|12|||
105808949|NCT01860976|364956827|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
105808950|NCT01860976|364956828|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
105808951|NCT01860976|364956827|FG000|Blinded Treatment|Withdrawal by Subject|3|||
105808952|NCT01860976|364956828|FG001|Blinded Treatment|Withdrawal by Subject|5|||
105808953|NCT01860976|364956827|FG000|Blinded Treatment|Subject no longer met criteria|1|||
105808954|NCT01860976|364956828|FG001|Blinded Treatment|Subject no longer met criteria|0|||
105808955|NCT01860976|364956827|FG000|Blinded Treatment|Entered Open-Label in error|0|||
105808956|NCT01860976|364956828|FG001|Blinded Treatment|Entered Open-Label in error|1|||
105808957|NCT01860976|364956827|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
105808958|NCT01860976|364956828|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
105808959|NCT01860976|364956827|FG000|Open-Label|Adverse Event|2|||
105808960|NCT01860976|364956828|FG001|Open-Label|Adverse Event|4|||
105808961|NCT01860976|364956827|FG000|Open-Label|Lack of Efficacy|16|||
105808962|NCT01860976|364956828|FG001|Open-Label|Lack of Efficacy|8|||
105808963|NCT01860976|364956827|FG000|Open-Label|Lost to Follow-up|1|||
105808964|NCT01860976|364956828|FG001|Open-Label|Lost to Follow-up|2|||
105808965|NCT01860976|364956827|FG000|Open-Label|Subject request discontinue treatment|4|||
105808966|NCT01860976|364956828|FG001|Open-Label|Subject request discontinue treatment|3|||
105808967|NCT01860976|364956827|FG000|Open-Label|Withdrawal by Subject|4|||
105808968|NCT01860976|364956828|FG001|Open-Label|Withdrawal by Subject|1|||
105808969|NCT01860976|364956827|FG000|Open-Label|Other Reasons|1|||
105808970|NCT01860976|364956828|FG001|Open-Label|Other Reasons|1|||
105808971|NCT01860976|364956827|FG000|Long Term Extension|Adverse Event|4|||
105808972|NCT01860976|364956828|FG001|Long Term Extension|Adverse Event|0|||
105808973|NCT01860976|364956827|FG000|Long Term Extension|Lack of Efficacy|2|||
105808974|NCT01860976|364956828|FG001|Long Term Extension|Lack of Efficacy|0|||
105808975|NCT01860976|364956827|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
105808976|NCT01860976|364956828|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
105808977|NCT01860976|364956827|FG000|Long Term Extension|Lost to Follow-up|2|||
105808978|NCT01860976|364956828|FG001|Long Term Extension|Lost to Follow-up|0|||
105808979|NCT01860976|364956827|FG000|Long Term Extension|subject withdrew consent|7|||
105808980|NCT01860976|364956828|FG001|Long Term Extension|subject withdrew consent|0|||
105808981|NCT02374918|364956831|FG000|Overall Study|Protocol Violation|2|||
105808982|NCT02374918|364956832|FG001|Overall Study|Protocol Violation|0|||
105808983|NCT02374918|364956833|FG002|Overall Study|Protocol Violation|2|||
105808984|NCT02374918|364956834|FG003|Overall Study|Protocol Violation|1|||
105808985|NCT02374918|364956831|FG000|Overall Study|Withdrawal by Subject|1|||
105808986|NCT02374918|364956832|FG001|Overall Study|Withdrawal by Subject|1|||
105808987|NCT02374918|364956833|FG002|Overall Study|Withdrawal by Subject|1|||
105808988|NCT02374918|364956834|FG003|Overall Study|Withdrawal by Subject|0|||
105808989|NCT02374918|364956831|FG000|Overall Study|Lack of Efficacy|0|||
106144829|NCT01393119|366190730|FG003|Overall Study|Death|1|||
106144830|NCT01393119|366190727|FG000|Overall Study|Randomized but Not treated|1|||
106144831|NCT01393119|366190728|FG001|Overall Study|Randomized but Not treated|0|||
106144832|NCT01393119|366190729|FG002|Overall Study|Randomized but Not treated|1|||
106144833|NCT01393119|366190730|FG003|Overall Study|Randomized but Not treated|1|||
106144834|NCT01393119|366190727|FG000|Overall Study|Sponsor Termination of Study|11|||
106144835|NCT01393119|366190728|FG001|Overall Study|Sponsor Termination of Study|12|||
106144836|NCT01393119|366190729|FG002|Overall Study|Sponsor Termination of Study|9|||
106144837|NCT01393119|366190730|FG003|Overall Study|Sponsor Termination of Study|12|||
106144838|NCT03557008|366190731|FG000|Overall Study|Withdrawal by Subject|2|||
106144839|NCT03557008|366190732|FG001|Overall Study|Withdrawal by Subject|2|||
106144840|NCT03557008|366190731|FG000|Overall Study|Early termination from study|3|||
106144841|NCT03557008|366190732|FG001|Overall Study|Early termination from study|1|||
106144842|NCT05876949|366190735|FG000|Overall Study|Withdrawal by Subject|1|||
106144843|NCT05876949|366190736|FG001|Overall Study|Withdrawal by Subject|3|||
106144844|NCT05876949|366190735|FG000|Overall Study|Physician Decision|0|||
106144845|NCT05876949|366190736|FG001|Overall Study|Physician Decision|2|||
106144846|NCT05876949|366190735|FG000|Overall Study|Death|0|||
106144847|NCT05876949|366190736|FG001|Overall Study|Death|1|||
106144848|NCT03823300|366190737|FG000|Overall Study|Withdrawal by Subject|16|||
106144849|NCT03823300|366190738|FG001|Overall Study|Withdrawal by Subject|22|||
106144850|NCT03823300|366190737|FG000|Overall Study|Death|10|||
106144851|NCT03823300|366190738|FG001|Overall Study|Death|14|||
106144852|NCT03823300|366190737|FG000|Overall Study|Adverse Event|3|||
106144853|NCT03823300|366190738|FG001|Overall Study|Adverse Event|5|||
106144854|NCT03823300|366190737|FG000|Overall Study|Physician Decision|1|||
105808990|NCT02374918|364956832|FG001|Overall Study|Lack of Efficacy|0|||
105808991|NCT02374918|364956833|FG002|Overall Study|Lack of Efficacy|1|||
105808992|NCT02374918|364956834|FG003|Overall Study|Lack of Efficacy|1|||
105808993|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
105808994|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
106017048|NCT03722238|365725947|FG001|Overall Study|Did not sign consent|0|||
105808995|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
106144855|NCT03823300|366190738|FG001|Overall Study|Physician Decision|7|||
105808996|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
106017049|NCT03722238|365725946|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
106144856|NCT03823300|366190737|FG000|Overall Study|Lost to Follow-up|1|||
105808997|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
105808998|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
105808999|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
105809000|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
105809001|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
105809002|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
105809003|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
105809004|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
105809005|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
105809006|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
105809007|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
105809008|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
105809009|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
105809010|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
105809011|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105809012|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105809013|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
105809014|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
105809015|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
105809016|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
105809017|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809018|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809019|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809020|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809021|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
105809022|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
105809023|NCT01957488|364956835|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
105809024|NCT01957488|364956836|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
105809025|NCT01957488|364956837|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
105809026|NCT01957488|364956838|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
105809027|NCT01957488|364956839|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
105809028|NCT01957488|364956840|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
105809029|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
105809030|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
105809031|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
105809032|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
105809033|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
105809034|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
105809035|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Other|1|||
105809036|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Other|0|||
105809037|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Other|0|||
105809038|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Other|0|||
105809039|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Other|0|||
105809040|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Other|0|||
105809041|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809042|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
105809043|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809044|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809045|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809046|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
105809047|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809048|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809049|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809050|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809051|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
105809052|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
105809053|NCT01957488|364956835|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809054|NCT01957488|364956836|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809055|NCT01957488|364956837|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809056|NCT01957488|364956838|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809057|NCT01957488|364956839|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
105809058|NCT01957488|364956840|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
106017050|NCT03722238|365725947|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
106017051|NCT03722238|365725946|FG000|Overall Study|Not willing to purchase study medication|142|||
106017052|NCT03722238|365725947|FG001|Overall Study|Not willing to purchase study medication|0|||
106017053|NCT03722238|365725946|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
106017054|NCT03722238|365725947|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
106017055|NCT00885170|365725948|FG000|Overall Study|Adverse Event|12|||
106017056|NCT00885170|365725949|FG001|Overall Study|Adverse Event|4|||
106017057|NCT00885170|365725948|FG000|Overall Study|Excessive bone loss|6|||
105952754|NCT02891226|365488284|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952755|NCT02891226|365488285|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
105952756|NCT02891226|365488270|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952757|NCT02891226|365488271|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952758|NCT02891226|365488272|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105762167|NCT00608881|364783077|FG000|Overall Study|Physician Decision|5|||
105762168|NCT00608881|364783078|FG001|Overall Study|Physician Decision|5|||
105762169|NCT00608881|364783077|FG000|Overall Study|Institutionalized|1|||
105762170|NCT00608881|364783078|FG001|Overall Study|Institutionalized|2|||
105762171|NCT03210220|364783081|FG000|Overall Study|Physician Decision|1|||
105762172|NCT03210220|364783082|FG001|Overall Study|Physician Decision|0|||
105762173|NCT00109772|364783083|FG000|Double-blind Treatment|Adverse Event|14|||
105762174|NCT00109772|364783084|FG001|Double-blind Treatment|Adverse Event|5|||
105762175|NCT00109772|364783083|FG000|Double-blind Treatment|Lack of Efficacy|1|||
105762176|NCT00109772|364783084|FG001|Double-blind Treatment|Lack of Efficacy|0|||
105762177|NCT00109772|364783083|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
105762178|NCT00109772|364783084|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
105762179|NCT00109772|364783083|FG000|Double-blind Treatment|Lost to Follow-up|2|||
105762180|NCT00109772|364783084|FG001|Double-blind Treatment|Lost to Follow-up|3|||
105762181|NCT00109772|364783083|FG000|Double-blind Treatment|Protocol Violation|0|||
105762182|NCT00109772|364783084|FG001|Double-blind Treatment|Protocol Violation|1|||
105762183|NCT00109772|364783083|FG000|Double-blind Treatment|Other|0|||
105762184|NCT00109772|364783084|FG001|Double-blind Treatment|Other|4|||
105762185|NCT00109772|364783083|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
105762186|NCT00109772|364783084|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
105762187|NCT00109772|364783083|FG000|Open-label Extension|Adverse Event|10|||
105762188|NCT00109772|364783084|FG001|Open-label Extension|Adverse Event|19|||
105762189|NCT00109772|364783083|FG000|Open-label Extension|Lack of Efficacy|19|||
105762190|NCT00109772|364783084|FG001|Open-label Extension|Lack of Efficacy|11|||
105762191|NCT00109772|364783083|FG000|Open-label Extension|Withdrawal by Subject|9|||
105762192|NCT00109772|364783084|FG001|Open-label Extension|Withdrawal by Subject|6|||
105762193|NCT00109772|364783083|FG000|Open-label Extension|Lost to Follow-up|1|||
105762194|NCT00109772|364783084|FG001|Open-label Extension|Lost to Follow-up|0|||
105762195|NCT00109772|364783083|FG000|Open-label Extension|Death|0|||
105762196|NCT00109772|364783084|FG001|Open-label Extension|Death|1|||
105762197|NCT00109772|364783083|FG000|Open-label Extension|Protocol Violation|2|||
105762198|NCT00109772|364783084|FG001|Open-label Extension|Protocol Violation|2|||
105762199|NCT00109772|364783083|FG000|Open-label Extension|Other|4|||
105762200|NCT00109772|364783084|FG001|Open-label Extension|Other|10|||
105762201|NCT01599806|364783087|FG000|Overall Study|Lost to Follow-up|20|||
105762202|NCT01599806|364783088|FG001|Overall Study|Lost to Follow-up|20|||
105762203|NCT01599806|364783087|FG000|Overall Study|Withdrawal by Subject|12|||
105762204|NCT01599806|364783088|FG001|Overall Study|Withdrawal by Subject|12|||
105762205|NCT01599806|364783087|FG000|Overall Study|Other Eligibility criteria|11|||
105762206|NCT01599806|364783088|FG001|Overall Study|Other Eligibility criteria|9|||
105762207|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
105762208|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
105762209|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
105762210|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
105762211|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
105762212|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
105762213|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
105762214|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
105762215|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
105762216|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
105762217|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
105762218|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
105762219|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
105762220|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
105762221|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
105762222|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
105762223|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
105762224|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
105762225|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
105762226|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
105762227|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
105762228|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
105762229|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
105762230|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
105952759|NCT02891226|365488273|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
106017058|NCT00885170|365725949|FG001|Overall Study|Excessive bone loss|3|||
105762231|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
105762232|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
105762233|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
105762234|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
105762235|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
105762236|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
105762237|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
105762238|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
105762239|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
105762240|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
105762241|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
105762242|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
105762243|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
105762244|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
105762245|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
105762246|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
105762247|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
105762248|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
105762249|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
105762250|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
105762251|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
105762252|NCT03689972|364783092|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
105762253|NCT03689972|364783093|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
105762254|NCT03689972|364783094|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
105762255|NCT03689972|364783095|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
105762256|NCT03689972|364783096|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
105762257|NCT03689972|364783092|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
105762258|NCT03689972|364783093|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
105762259|NCT03689972|364783094|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
105762260|NCT03689972|364783095|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
105762261|NCT03689972|364783096|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
105762262|NCT03689972|364783092|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
105762263|NCT03689972|364783093|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
105762264|NCT03689972|364783094|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
105762265|NCT03689972|364783095|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
105762266|NCT03689972|364783096|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
105762267|NCT03689972|364783092|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
105762268|NCT03689972|364783093|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
105762269|NCT03689972|364783094|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
105762270|NCT03689972|364783095|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
105762271|NCT03689972|364783096|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
105762272|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
105762273|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
105762274|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
105762275|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
105762276|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
105762277|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
105762278|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
105762279|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
105762280|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
105762281|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
105762282|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
105762283|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
105762284|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
105762285|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
105762286|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
105762287|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
105762288|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
105762289|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
105762290|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
105762291|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
105762292|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
105762293|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
105809059|NCT01957488|364956835|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
105809060|NCT01957488|364956836|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809061|NCT01957488|364956837|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809062|NCT01957488|364956838|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809063|NCT01957488|364956839|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809064|NCT01957488|364956840|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
105809065|NCT01957488|364956835|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809066|NCT01957488|364956836|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
105809067|NCT01957488|364956837|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809068|NCT01957488|364956838|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809069|NCT01957488|364956839|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809070|NCT01957488|364956840|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
105809071|NCT00688064|364956843|FG000|Overall Study|Protocol Violation|0|||
105809072|NCT00688064|364956844|FG001|Overall Study|Protocol Violation|1|||
105809073|NCT00688064|364956843|FG000|Overall Study|Adverse Event|2|||
105809074|NCT00688064|364956844|FG001|Overall Study|Adverse Event|4|||
105809075|NCT00688064|364956843|FG000|Overall Study|Withdrawal by Subject|7|||
105809076|NCT00688064|364956844|FG001|Overall Study|Withdrawal by Subject|7|||
105809077|NCT00688064|364956843|FG000|Overall Study|Lost to Follow-up|10|||
105809078|NCT00688064|364956844|FG001|Overall Study|Lost to Follow-up|10|||
105809079|NCT00688064|364956843|FG000|Overall Study|Lack of Efficacy|0|||
105809080|NCT00688064|364956844|FG001|Overall Study|Lack of Efficacy|1|||
105809081|NCT00688064|364956843|FG000|Overall Study|Pregnancy|1|||
105809082|NCT00688064|364956844|FG001|Overall Study|Pregnancy|0|||
105809083|NCT00688064|364956843|FG000|Overall Study|Any other reasons|1|||
105809084|NCT00688064|364956844|FG001|Overall Study|Any other reasons|3|||
105809085|NCT02866175|364956847|FG000|Overall Study|Adverse Event|56|||
105809086|NCT02866175|364956848|FG001|Overall Study|Adverse Event|54|||
105809087|NCT02866175|364956847|FG000|Overall Study|Withdrawal by Subject|31|||
105809088|NCT02866175|364956848|FG001|Overall Study|Withdrawal by Subject|52|||
105809089|NCT02866175|364956847|FG000|Overall Study|Death|30|||
105809090|NCT02866175|364956848|FG001|Overall Study|Death|23|||
105809091|NCT02866175|364956847|FG000|Overall Study|Other|7|||
105809092|NCT02866175|364956848|FG001|Overall Study|Other|14|||
105809093|NCT02866175|364956847|FG000|Overall Study|Progressive disease|1|||
105809094|NCT02866175|364956848|FG001|Overall Study|Progressive disease|1|||
105809095|NCT02866175|364956847|FG000|Overall Study|Lost to Follow-up|2|||
105809096|NCT02866175|364956848|FG001|Overall Study|Lost to Follow-up|0|||
105809097|NCT02866175|364956847|FG000|Overall Study|Lack of Efficacy|0|||
105809098|NCT02866175|364956848|FG001|Overall Study|Lack of Efficacy|1|||
105809099|NCT02866175|364956847|FG000|Overall Study|Physician Decision|3|||
105809100|NCT02866175|364956848|FG001|Overall Study|Physician Decision|15|||
105809101|NCT02866175|364956847|FG000|Overall Study|Did not receive treatment|5|||
105809102|NCT02866175|364956848|FG001|Overall Study|Did not receive treatment|15|||
105809103|NCT02907203|364956850|FG000|Overall Study|Death|1|||
105809104|NCT02907203|364956850|FG000|Overall Study|Lost to Follow-up|3|||
105809105|NCT02907203|364956850|FG000|Overall Study|Withdrawal by Subject|3|||
105809106|NCT02907203|364956850|FG000|Overall Study|Surgical bypass|1|||
105809107|NCT04956666|364956851|FG000|Overall Study|Adverse Event|18|||
105809108|NCT04956666|364956851|FG000|Overall Study|Physician Decision|5|||
105809109|NCT00729859|364956852|FG000|Overall Study|Adverse Event|0|||
105809110|NCT00729859|364956853|FG001|Overall Study|Adverse Event|1|||
105809111|NCT00729859|364956854|FG002|Overall Study|Adverse Event|0|||
105809112|NCT00729859|364956852|FG000|Overall Study|Withdrawal by Subject|0|||
105809113|NCT00729859|364956853|FG001|Overall Study|Withdrawal by Subject|1|||
105809114|NCT00729859|364956854|FG002|Overall Study|Withdrawal by Subject|0|||
105809115|NCT02623829|364956861|FG000|Overall Study|Lost to Follow-up|1|||
105809116|NCT02623829|364956862|FG001|Overall Study|Lost to Follow-up|1|||
105809117|NCT02985151|364956864|FG000|Original Randomization|Withdrawal by Subject|0|||
105809118|NCT02985151|364956865|FG001|Original Randomization|Withdrawal by Subject|1|||
105809119|NCT02750306|364956866|FG000|Overall Study|Withdrawal by Subject|5|||
105809120|NCT02750306|364956867|FG001|Overall Study|Withdrawal by Subject|2|||
105809121|NCT02750306|364956866|FG000|Overall Study|Protocol Violation|1|||
105809122|NCT02750306|364956867|FG001|Overall Study|Protocol Violation|0|||
105809123|NCT00626925|364956869|FG000|Overall Study|Lost to Follow-up|1|||
105809124|NCT00626925|364956870|FG001|Overall Study|Lost to Follow-up|2|||
105809125|NCT00626925|364956869|FG000|Overall Study|relapse|1|||
105809126|NCT00626925|364956870|FG001|Overall Study|relapse|0|||
105809127|NCT00626925|364956869|FG000|Overall Study|Adverse effect|6|||
105809128|NCT00626925|364956870|FG001|Overall Study|Adverse effect|2|||
105809129|NCT00626925|364956869|FG000|Overall Study|Lack of Efficacy|1|||
105809130|NCT00626925|364956870|FG001|Overall Study|Lack of Efficacy|4|||
105809131|NCT00626925|364956869|FG000|Overall Study|Time constraints|3|||
105809132|NCT00626925|364956870|FG001|Overall Study|Time constraints|1|||
105869064|NCT01995513|365171605|FG003|Period 1: Second Open Label Treatment|Other|0|||
105869065|NCT01995513|365171602|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
105869066|NCT01995513|365171603|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
105809133|NCT02315898|364956872|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
105809134|NCT02315898|364956873|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
105809135|NCT02315898|364956874|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
105809136|NCT02315898|364956875|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
105809137|NCT02224391|364956876|FG000|Overall Study|Lost to Follow-up|26|||
105809138|NCT02224391|364956877|FG001|Overall Study|Lost to Follow-up|19|||
105809139|NCT02224391|364956876|FG000|Overall Study|Withdrawal by Subject|6|||
105809140|NCT02224391|364956877|FG001|Overall Study|Withdrawal by Subject|5|||
105809141|NCT00818623|364956881|FG000|Overall Study|Adverse Event|1|||
105809142|NCT00818623|364956882|FG001|Overall Study|Adverse Event|0|||
105809143|NCT00818623|364956883|FG002|Overall Study|Adverse Event|1|||
105809144|NCT00818623|364956884|FG003|Overall Study|Adverse Event|0|||
105809145|NCT00818623|364956885|FG004|Overall Study|Adverse Event|0|||
105809146|NCT00818623|364956886|FG005|Overall Study|Adverse Event|1|||
105809147|NCT00818623|364956887|FG006|Overall Study|Adverse Event|0|||
105809148|NCT00818623|364956888|FG007|Overall Study|Adverse Event|0|||
105809149|NCT00818623|364956881|FG000|Overall Study|Bad prostate specific antigen response|0|||
105809150|NCT00818623|364956882|FG001|Overall Study|Bad prostate specific antigen response|3|||
105809151|NCT00818623|364956883|FG002|Overall Study|Bad prostate specific antigen response|2|||
105809152|NCT00818623|364956884|FG003|Overall Study|Bad prostate specific antigen response|5|||
105809153|NCT00818623|364956885|FG004|Overall Study|Bad prostate specific antigen response|0|||
105809154|NCT00818623|364956886|FG005|Overall Study|Bad prostate specific antigen response|1|||
105809155|NCT00818623|364956887|FG006|Overall Study|Bad prostate specific antigen response|0|||
105809156|NCT00818623|364956888|FG007|Overall Study|Bad prostate specific antigen response|0|||
105809157|NCT00818623|364956881|FG000|Overall Study|Withdrawal by Subject|0|||
105809158|NCT00818623|364956882|FG001|Overall Study|Withdrawal by Subject|1|||
105809159|NCT00818623|364956883|FG002|Overall Study|Withdrawal by Subject|1|||
105809160|NCT00818623|364956884|FG003|Overall Study|Withdrawal by Subject|0|||
105809161|NCT00818623|364956885|FG004|Overall Study|Withdrawal by Subject|0|||
105809162|NCT00818623|364956886|FG005|Overall Study|Withdrawal by Subject|1|||
105809163|NCT00818623|364956887|FG006|Overall Study|Withdrawal by Subject|1|||
105809164|NCT00818623|364956888|FG007|Overall Study|Withdrawal by Subject|1|||
105809165|NCT00818623|364956881|FG000|Overall Study|Protocol Violation|1|||
105809166|NCT00818623|364956882|FG001|Overall Study|Protocol Violation|0|||
105809167|NCT00818623|364956883|FG002|Overall Study|Protocol Violation|0|||
105809168|NCT00818623|364956884|FG003|Overall Study|Protocol Violation|0|||
105809169|NCT00818623|364956885|FG004|Overall Study|Protocol Violation|1|||
105809170|NCT00818623|364956886|FG005|Overall Study|Protocol Violation|0|||
105809171|NCT00818623|364956887|FG006|Overall Study|Protocol Violation|1|||
105809172|NCT00818623|364956888|FG007|Overall Study|Protocol Violation|0|||
105809173|NCT00818623|364956881|FG000|Overall Study|Need of additional treatment|0|||
105809174|NCT00818623|364956882|FG001|Overall Study|Need of additional treatment|0|||
105809175|NCT00818623|364956883|FG002|Overall Study|Need of additional treatment|0|||
105809176|NCT00818623|364956884|FG003|Overall Study|Need of additional treatment|0|||
105809177|NCT00818623|364956885|FG004|Overall Study|Need of additional treatment|1|||
105809178|NCT00818623|364956886|FG005|Overall Study|Need of additional treatment|0|||
105809179|NCT00818623|364956887|FG006|Overall Study|Need of additional treatment|0|||
105809180|NCT00818623|364956888|FG007|Overall Study|Need of additional treatment|0|||
105809181|NCT00818623|364956881|FG000|Overall Study|Lack of trial drug at site|0|||
105809182|NCT00818623|364956882|FG001|Overall Study|Lack of trial drug at site|0|||
105762294|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
105762295|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
105762296|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
105762297|NCT03689972|364783092|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
105762298|NCT03689972|364783093|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
105762299|NCT03689972|364783094|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
105762300|NCT03689972|364783095|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
105762301|NCT03689972|364783096|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
105762302|NCT00973622|364783097|FG000|Overall Study|did not attend MRI|14|||
105762303|NCT00973622|364783098|FG001|Overall Study|did not attend MRI|3|||
105762304|NCT00973622|364783097|FG000|Overall Study|did not pass MRI screen|6|||
105809183|NCT00818623|364956883|FG002|Overall Study|Lack of trial drug at site|0|||
105809184|NCT00818623|364956884|FG003|Overall Study|Lack of trial drug at site|0|||
105809185|NCT00818623|364956885|FG004|Overall Study|Lack of trial drug at site|2|||
105809186|NCT00818623|364956886|FG005|Overall Study|Lack of trial drug at site|0|||
105809187|NCT00818623|364956887|FG006|Overall Study|Lack of trial drug at site|1|||
105762305|NCT00973622|364783098|FG001|Overall Study|did not pass MRI screen|0|||
105762306|NCT00973622|364783097|FG000|Overall Study|did not complete rTMS sessions|11|||
105762307|NCT00973622|364783098|FG001|Overall Study|did not complete rTMS sessions|2|||
105762308|NCT01548417|364783099|FG000|Overall Study|Withdrawal by Subject|0|||
105952760|NCT02891226|365488274|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952761|NCT02891226|365488275|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952762|NCT02891226|365488276|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952763|NCT02891226|365488277|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952764|NCT02891226|365488278|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952765|NCT02891226|365488279|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952766|NCT02891226|365488280|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
105952767|NCT02891226|365488281|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105762309|NCT01548417|364783100|FG001|Overall Study|Withdrawal by Subject|2|||
105762310|NCT00802867|364783103|FG000|Overall Study|Lost to Follow-up|6|||
105762311|NCT00802867|364783103|FG000|Overall Study|Protocol Violation|6|||
105762312|NCT00802867|364783103|FG000|Overall Study|Withdrawal by Subject|1|||
105762313|NCT01156532|364783104|FG000|Overall Study|Family Reasons|1|||
105762314|NCT01156532|364783104|FG000|Overall Study|Lost to Follow-up|1|||
105762315|NCT03841526|364783105|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
105762316|NCT03841526|364783106|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
105762317|NCT03841526|364783107|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
105762318|NCT03841526|364783108|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
105762319|NCT03841526|364783109|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
105762320|NCT03841526|364783110|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
105762321|NCT03841526|364783105|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
105762322|NCT03841526|364783106|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
105762323|NCT03841526|364783107|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
105762324|NCT03841526|364783108|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
105762325|NCT03841526|364783109|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
105762326|NCT03841526|364783110|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
105762327|NCT03841526|364783105|FG000|Outpatient Phase Treatment|Physician Decision|0|||
105762328|NCT03841526|364783106|FG001|Outpatient Phase Treatment|Physician Decision|1|||
105762329|NCT03841526|364783107|FG002|Outpatient Phase Treatment|Physician Decision|0|||
105762330|NCT03841526|364783108|FG003|Outpatient Phase Treatment|Physician Decision|0|||
105762331|NCT03841526|364783109|FG004|Outpatient Phase Treatment|Physician Decision|0|||
105762332|NCT03841526|364783110|FG005|Outpatient Phase Treatment|Physician Decision|0|||
105762333|NCT03841526|364783105|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
105762334|NCT03841526|364783106|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
105762335|NCT03841526|364783107|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
105762336|NCT03841526|364783108|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
105762337|NCT03841526|364783109|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
105762338|NCT03841526|364783110|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
105762339|NCT00114218|364783111|FG000|Overall Study|Wrong Cell Type|2|||
105762340|NCT00114218|364783111|FG000|Overall Study|Wrong Primary|1|||
105762341|NCT00114218|364783111|FG000|Overall Study|Never Treated|1|||
105762342|NCT00615459|364783113|FG000|Period I|Adverse Event|2|||
105762343|NCT00615459|364783114|FG001|Period I|Adverse Event|0|||
105762344|NCT00615459|364783115|FG002|Period I|Adverse Event|1|||
105762345|NCT00615459|364783116|FG003|Period I|Adverse Event|0|||
105762346|NCT00615459|364783113|FG000|Period I|Subject withdrew consent|1|||
105762347|NCT00615459|364783114|FG001|Period I|Subject withdrew consent|0|||
105762348|NCT00615459|364783115|FG002|Period I|Subject withdrew consent|0|||
105762349|NCT00615459|364783116|FG003|Period I|Subject withdrew consent|1|||
105762350|NCT00615459|364783113|FG000|Period I|Abnormal test procedure results|1|||
105762351|NCT00615459|364783114|FG001|Period I|Abnormal test procedure results|1|||
105762352|NCT00615459|364783115|FG002|Period I|Abnormal test procedure results|1|||
105762353|NCT00615459|364783116|FG003|Period I|Abnormal test procedure results|0|||
105762354|NCT00615459|364783113|FG000|Period II|Adverse Event|1|||
105762355|NCT00615459|364783114|FG001|Period II|Adverse Event|0|||
105762356|NCT00615459|364783115|FG002|Period II|Adverse Event|0|||
105762357|NCT00615459|364783116|FG003|Period II|Adverse Event|0|||
105762358|NCT00615459|364783113|FG000|Period II|Lost to Follow-up|0|||
105762359|NCT00615459|364783114|FG001|Period II|Lost to Follow-up|0|||
105762360|NCT00615459|364783115|FG002|Period II|Lost to Follow-up|0|||
105762361|NCT00615459|364783116|FG003|Period II|Lost to Follow-up|1|||
105762362|NCT00615459|364783113|FG000|Period III|Adverse Event|0|||
105762363|NCT00615459|364783114|FG001|Period III|Adverse Event|1|||
105762364|NCT00615459|364783115|FG002|Period III|Adverse Event|0|||
105762365|NCT00615459|364783116|FG003|Period III|Adverse Event|0|||
105762366|NCT00615459|364783113|FG000|Period III|Administrative problems|0|||
105762367|NCT00615459|364783114|FG001|Period III|Administrative problems|1|||
105762368|NCT00615459|364783115|FG002|Period III|Administrative problems|1|||
105762369|NCT00615459|364783116|FG003|Period III|Administrative problems|0|||
105762370|NCT00615459|364783113|FG000|Period III|Unsatisfactory therapeutic effect|0|||
105762371|NCT00615459|364783114|FG001|Period III|Unsatisfactory therapeutic effect|1|||
105762372|NCT00615459|364783115|FG002|Period III|Unsatisfactory therapeutic effect|0|||
105809188|NCT00818623|364956888|FG007|Overall Study|Lack of trial drug at site|0|||
105809189|NCT00818623|364956881|FG000|Overall Study|Disease progression|0|||
105809190|NCT00818623|364956882|FG001|Overall Study|Disease progression|0|||
105809191|NCT00818623|364956883|FG002|Overall Study|Disease progression|0|||
105809192|NCT00818623|364956884|FG003|Overall Study|Disease progression|0|||
105809193|NCT00818623|364956885|FG004|Overall Study|Disease progression|0|||
105809194|NCT00818623|364956886|FG005|Overall Study|Disease progression|0|||
105809195|NCT00818623|364956887|FG006|Overall Study|Disease progression|1|||
105809196|NCT00818623|364956888|FG007|Overall Study|Disease progression|0|||
105809197|NCT00602030|364956891|FG000|Lead-in Phase|Disease Progression|2|||
105809198|NCT00602030|364956892|FG001|Lead-in Phase|Disease Progression|3|||
105809199|NCT00602030|364956893|FG002|Lead-in Phase|Disease Progression|0|||
105809200|NCT00602030|364956894|FG003|Lead-in Phase|Disease Progression|0|||
105809201|NCT00602030|364956895|FG004|Lead-in Phase|Disease Progression|0|||
105809202|NCT00602030|364956891|FG000|Lead-in Phase|Adverse Event|0|||
105809203|NCT00602030|364956892|FG001|Lead-in Phase|Adverse Event|2|||
105809204|NCT00602030|364956893|FG002|Lead-in Phase|Adverse Event|0|||
105809205|NCT00602030|364956894|FG003|Lead-in Phase|Adverse Event|0|||
105809206|NCT00602030|364956895|FG004|Lead-in Phase|Adverse Event|0|||
105809207|NCT00602030|364956891|FG000|Double-blind Phase|Disease progression|0|||
105809208|NCT00602030|364956892|FG001|Double-blind Phase|Disease progression|0|||
105809209|NCT00602030|364956893|FG002|Double-blind Phase|Disease progression|33|||
105809210|NCT00602030|364956894|FG003|Double-blind Phase|Disease progression|30|||
105809211|NCT00602030|364956895|FG004|Double-blind Phase|Disease progression|0|||
105809212|NCT00602030|364956891|FG000|Double-blind Phase|Adverse Event|0|||
105809213|NCT00602030|364956892|FG001|Double-blind Phase|Adverse Event|0|||
105809214|NCT00602030|364956893|FG002|Double-blind Phase|Adverse Event|9|||
105809215|NCT00602030|364956894|FG003|Double-blind Phase|Adverse Event|18|||
105809216|NCT00602030|364956895|FG004|Double-blind Phase|Adverse Event|0|||
105809217|NCT00602030|364956891|FG000|Double-blind Phase|Consent withdrawal|0|||
105809218|NCT00602030|364956892|FG001|Double-blind Phase|Consent withdrawal|0|||
105809219|NCT00602030|364956893|FG002|Double-blind Phase|Consent withdrawal|4|||
105809220|NCT00602030|364956894|FG003|Double-blind Phase|Consent withdrawal|3|||
105809221|NCT00602030|364956895|FG004|Double-blind Phase|Consent withdrawal|0|||
105809222|NCT00602030|364956891|FG000|Double-blind Phase|Death|0|||
105809223|NCT00602030|364956892|FG001|Double-blind Phase|Death|0|||
105809224|NCT00602030|364956893|FG002|Double-blind Phase|Death|3|||
105809225|NCT00602030|364956894|FG003|Double-blind Phase|Death|3|||
105809226|NCT00602030|364956895|FG004|Double-blind Phase|Death|0|||
105809227|NCT00602030|364956891|FG000|Double-blind Phase|Administrative decision|0|||
105809228|NCT00602030|364956892|FG001|Double-blind Phase|Administrative decision|0|||
105809229|NCT00602030|364956893|FG002|Double-blind Phase|Administrative decision|0|||
105809230|NCT00602030|364956894|FG003|Double-blind Phase|Administrative decision|2|||
105809231|NCT00602030|364956895|FG004|Double-blind Phase|Administrative decision|0|||
105809232|NCT00602030|364956891|FG000|Double-blind Phase|Ineligibility|0|||
105809233|NCT00602030|364956892|FG001|Double-blind Phase|Ineligibility|0|||
105809234|NCT00602030|364956893|FG002|Double-blind Phase|Ineligibility|0|||
105809235|NCT00602030|364956894|FG003|Double-blind Phase|Ineligibility|1|||
105809236|NCT00602030|364956895|FG004|Double-blind Phase|Ineligibility|0|||
105809237|NCT00602030|364956891|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
105809238|NCT00602030|364956892|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
105809239|NCT00602030|364956893|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
105809240|NCT00602030|364956894|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
105809241|NCT00602030|364956895|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
105809242|NCT00602030|364956891|FG000|Double-blind Phase|Reason not specified|0|||
105809243|NCT00602030|364956892|FG001|Double-blind Phase|Reason not specified|0|||
105809244|NCT00602030|364956893|FG002|Double-blind Phase|Reason not specified|4|||
105809245|NCT00602030|364956894|FG003|Double-blind Phase|Reason not specified|2|||
105809246|NCT00602030|364956895|FG004|Double-blind Phase|Reason not specified|0|||
106144857|NCT03823300|366190738|FG001|Overall Study|Lost to Follow-up|3|||
105809247|NCT00602030|364956891|FG000|Crossover Phase|Disease Progression|0|||
106144858|NCT03823300|366190737|FG000|Overall Study|Protocol Violation|1|||
105809248|NCT00602030|364956892|FG001|Crossover Phase|Disease Progression|0|||
105809249|NCT00602030|364956893|FG002|Crossover Phase|Disease Progression|0|||
105809250|NCT00602030|364956894|FG003|Crossover Phase|Disease Progression|0|||
105809251|NCT00602030|364956895|FG004|Crossover Phase|Disease Progression|11|||
106144859|NCT03823300|366190738|FG001|Overall Study|Protocol Violation|1|||
105809252|NCT00602030|364956891|FG000|Crossover Phase|Adverse Event|0|||
105809253|NCT00602030|364956892|FG001|Crossover Phase|Adverse Event|0|||
105809254|NCT00602030|364956893|FG002|Crossover Phase|Adverse Event|0|||
105809255|NCT00602030|364956894|FG003|Crossover Phase|Adverse Event|0|||
105809256|NCT00602030|364956895|FG004|Crossover Phase|Adverse Event|3|||
105809257|NCT00602030|364956891|FG000|Crossover Phase|Consent withdrawal|0|||
105809258|NCT00602030|364956892|FG001|Crossover Phase|Consent withdrawal|0|||
105809259|NCT00602030|364956893|FG002|Crossover Phase|Consent withdrawal|0|||
105809260|NCT00602030|364956894|FG003|Crossover Phase|Consent withdrawal|0|||
105809261|NCT00602030|364956895|FG004|Crossover Phase|Consent withdrawal|2|||
106017059|NCT00885170|365725948|FG000|Overall Study|Lost to Follow-up|2|||
106017060|NCT00885170|365725949|FG001|Overall Study|Lost to Follow-up|1|||
106017061|NCT00885170|365725948|FG000|Overall Study|Physician Decision|2|||
106017062|NCT00885170|365725949|FG001|Overall Study|Physician Decision|1|||
106017063|NCT00885170|365725948|FG000|Overall Study|Protocol Violation|3|||
106017064|NCT00885170|365725949|FG001|Overall Study|Protocol Violation|1|||
105762373|NCT00615459|364783116|FG003|Period III|Unsatisfactory therapeutic effect|0|||
105762374|NCT02475629|364783117|FG000|Overall Study|Adverse Event|1|||
105762375|NCT02475629|364783117|FG000|Overall Study|Death|4|||
105762376|NCT02475629|364783117|FG000|Overall Study|Physician Decision|1|||
105762377|NCT02475629|364783117|FG000|Overall Study|Withdrawal by Subject|1|||
105762378|NCT02475629|364783117|FG000|Overall Study|Lost to Follow-up|1|||
105762379|NCT02475629|364783117|FG000|Overall Study|Subject non-compliance|1|||
105762380|NCT03238352|364783118|FG000|Overall Study|Lost to Follow-up|0|||
105762381|NCT03238352|364783119|FG001|Overall Study|Lost to Follow-up|2|||
105762382|NCT03238352|364783120|FG002|Overall Study|Lost to Follow-up|1|||
105762383|NCT03238352|364783118|FG000|Overall Study|Withdrawal by Subject|0|||
105762384|NCT03238352|364783119|FG001|Overall Study|Withdrawal by Subject|1|||
105762385|NCT03238352|364783120|FG002|Overall Study|Withdrawal by Subject|0|||
105762386|NCT01963780|364783121|FG000|Overall Study|Death|7|||
105762387|NCT04153929|364783122|FG000|Overall Study|Other than listed|2|||
105762388|NCT04153929|364783123|FG001|Overall Study|Other than listed|2|||
105762389|NCT04153929|364783124|FG002|Overall Study|Other than listed|0|||
105762390|NCT04153929|364783125|FG003|Overall Study|Other than listed|1|||
105762391|NCT04153929|364783126|FG004|Overall Study|Other than listed|0|||
105762392|NCT04153929|364783127|FG005|Overall Study|Other than listed|2|||
105762393|NCT04153929|364783128|FG006|Overall Study|Other than listed|2|||
105762394|NCT04153929|364783129|FG007|Overall Study|Other than listed|1|||
105762395|NCT04153929|364783122|FG000|Overall Study|Lost to Follow-up|2|||
105762396|NCT04153929|364783123|FG001|Overall Study|Lost to Follow-up|1|||
105762397|NCT04153929|364783124|FG002|Overall Study|Lost to Follow-up|0|||
105762398|NCT04153929|364783125|FG003|Overall Study|Lost to Follow-up|1|||
105762399|NCT04153929|364783126|FG004|Overall Study|Lost to Follow-up|1|||
105762400|NCT04153929|364783127|FG005|Overall Study|Lost to Follow-up|0|||
105762401|NCT04153929|364783128|FG006|Overall Study|Lost to Follow-up|0|||
105762402|NCT04153929|364783129|FG007|Overall Study|Lost to Follow-up|0|||
105762403|NCT04153929|364783122|FG000|Overall Study|Withdrawal by Subject|3|||
105762404|NCT04153929|364783123|FG001|Overall Study|Withdrawal by Subject|1|||
105762405|NCT04153929|364783124|FG002|Overall Study|Withdrawal by Subject|0|||
105762406|NCT04153929|364783125|FG003|Overall Study|Withdrawal by Subject|3|||
105762407|NCT04153929|364783126|FG004|Overall Study|Withdrawal by Subject|1|||
105762408|NCT04153929|364783127|FG005|Overall Study|Withdrawal by Subject|0|||
105762409|NCT04153929|364783128|FG006|Overall Study|Withdrawal by Subject|1|||
105762410|NCT04153929|364783129|FG007|Overall Study|Withdrawal by Subject|0|||
105762411|NCT04153929|364783122|FG000|Overall Study|Protocol Violation|0|||
105762412|NCT04153929|364783123|FG001|Overall Study|Protocol Violation|0|||
105762413|NCT04153929|364783124|FG002|Overall Study|Protocol Violation|0|||
105762414|NCT04153929|364783125|FG003|Overall Study|Protocol Violation|0|||
105762415|NCT04153929|364783126|FG004|Overall Study|Protocol Violation|0|||
105762416|NCT04153929|364783127|FG005|Overall Study|Protocol Violation|0|||
105762417|NCT04153929|364783128|FG006|Overall Study|Protocol Violation|1|||
105762418|NCT04153929|364783129|FG007|Overall Study|Protocol Violation|2|||
105762419|NCT04153929|364783122|FG000|Overall Study|Adverse Event|3|||
105762420|NCT04153929|364783123|FG001|Overall Study|Adverse Event|5|||
105762421|NCT04153929|364783124|FG002|Overall Study|Adverse Event|5|||
105762422|NCT04153929|364783125|FG003|Overall Study|Adverse Event|11|||
105762423|NCT04153929|364783126|FG004|Overall Study|Adverse Event|15|||
105762424|NCT04153929|364783127|FG005|Overall Study|Adverse Event|4|||
105762425|NCT04153929|364783128|FG006|Overall Study|Adverse Event|8|||
105762426|NCT04153929|364783129|FG007|Overall Study|Adverse Event|2|||
105762427|NCT04153929|364783122|FG000|Overall Study|Not treated|1|||
105762428|NCT04153929|364783123|FG001|Overall Study|Not treated|0|||
105762429|NCT04153929|364783124|FG002|Overall Study|Not treated|0|||
105762430|NCT04153929|364783125|FG003|Overall Study|Not treated|0|||
105809262|NCT01654380|364956896|FG000|Part B, Period 1|Physician Decision|0|||
105762431|NCT04153929|364783126|FG004|Overall Study|Not treated|0|||
105762432|NCT04153929|364783127|FG005|Overall Study|Not treated|0|||
105762433|NCT04153929|364783128|FG006|Overall Study|Not treated|1|||
105762434|NCT04153929|364783129|FG007|Overall Study|Not treated|0|||
105762435|NCT00753623|364783130|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
105762436|NCT00753623|364783131|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
105762437|NCT00753623|364783130|FG000|Phase I (14 Days)|Physician Decision|1|||
105762438|NCT00753623|364783131|FG001|Phase I (14 Days)|Physician Decision|2|||
105762439|NCT00753623|364783130|FG000|Phase I (14 Days)|Adverse Event|0|||
105762440|NCT00753623|364783131|FG001|Phase I (14 Days)|Adverse Event|1|||
105762441|NCT00753623|364783130|FG000|Washout (7 Days)|Physician Decision|1|||
105762442|NCT00753623|364783131|FG001|Washout (7 Days)|Physician Decision|0|||
105762443|NCT00753623|364783130|FG000|Phase II (14 Days)|Physician Decision|0|||
105762444|NCT00753623|364783131|FG001|Phase II (14 Days)|Physician Decision|1|||
106017065|NCT00885170|365725948|FG000|Overall Study|Withdrawal by Subject|13|||
105762445|NCT04423757|364783132|FG000|Overall Study|Adverse Event|2|||
105762446|NCT04423757|364783133|FG001|Overall Study|Adverse Event|0|||
105762447|NCT04423757|364783132|FG000|Overall Study|Not treated|1|||
105762448|NCT04423757|364783133|FG001|Overall Study|Not treated|1|||
105762449|NCT01928082|364783134|FG000|Overall Study|Study terminated.|1|||
105762450|NCT01125293|364783135|FG000|Overall Study|Disease Progression|1|||
105762451|NCT01125293|364783136|FG001|Overall Study|Disease Progression|3|||
105762452|NCT01125293|364783137|FG002|Overall Study|Disease Progression|4|||
105762453|NCT01125293|364783138|FG003|Overall Study|Disease Progression|3|||
105762454|NCT01125293|364783139|FG004|Overall Study|Disease Progression|5|||
105762455|NCT01125293|364783140|FG005|Overall Study|Disease Progression|12|||
105762456|NCT01125293|364783135|FG000|Overall Study|Adverse Event|1|||
105762457|NCT01125293|364783136|FG001|Overall Study|Adverse Event|0|||
105762458|NCT01125293|364783137|FG002|Overall Study|Adverse Event|0|||
105762459|NCT01125293|364783138|FG003|Overall Study|Adverse Event|0|||
105762460|NCT01125293|364783139|FG004|Overall Study|Adverse Event|2|||
105762461|NCT01125293|364783140|FG005|Overall Study|Adverse Event|8|||
105762462|NCT01125293|364783135|FG000|Overall Study|Symptomatic Deterioration|1|||
105762463|NCT01125293|364783136|FG001|Overall Study|Symptomatic Deterioration|0|||
105762464|NCT01125293|364783137|FG002|Overall Study|Symptomatic Deterioration|0|||
105762465|NCT01125293|364783138|FG003|Overall Study|Symptomatic Deterioration|0|||
105762466|NCT01125293|364783139|FG004|Overall Study|Symptomatic Deterioration|0|||
105762467|NCT01125293|364783140|FG005|Overall Study|Symptomatic Deterioration|0|||
105762468|NCT01125293|364783135|FG000|Overall Study|Death|0|||
105762469|NCT01125293|364783136|FG001|Overall Study|Death|0|||
105762470|NCT01125293|364783137|FG002|Overall Study|Death|0|||
105762471|NCT01125293|364783138|FG003|Overall Study|Death|0|||
105762472|NCT01125293|364783139|FG004|Overall Study|Death|1|||
105762473|NCT01125293|364783140|FG005|Overall Study|Death|0|||
105762474|NCT01125293|364783135|FG000|Overall Study|Withdrawal by Subject|0|||
105762475|NCT01125293|364783136|FG001|Overall Study|Withdrawal by Subject|0|||
105762476|NCT01125293|364783137|FG002|Overall Study|Withdrawal by Subject|0|||
105762477|NCT01125293|364783138|FG003|Overall Study|Withdrawal by Subject|0|||
105762478|NCT01125293|364783139|FG004|Overall Study|Withdrawal by Subject|2|||
105762479|NCT01125293|364783140|FG005|Overall Study|Withdrawal by Subject|1|||
105762480|NCT01125293|364783135|FG000|Overall Study|Physician Decision|0|||
105762481|NCT01125293|364783136|FG001|Overall Study|Physician Decision|0|||
105762482|NCT01125293|364783137|FG002|Overall Study|Physician Decision|0|||
105762483|NCT01125293|364783138|FG003|Overall Study|Physician Decision|0|||
105762484|NCT01125293|364783139|FG004|Overall Study|Physician Decision|0|||
105762485|NCT01125293|364783140|FG005|Overall Study|Physician Decision|2|||
105762486|NCT01946412|364783142|FG000|Overall Study|Adverse Event|1|||
105762487|NCT01946412|364783142|FG000|Overall Study|Non-Compliance|1|||
105762488|NCT01946412|364783142|FG000|Overall Study|Continued with commercial Kalydeco|2|||
105762489|NCT01946412|364783142|FG000|Overall Study|Difficulty in swallowing|1|||
105762490|NCT03148756|364783143|FG000|Overall Study|Study Terminated|0|||
105762491|NCT03148756|364783144|FG001|Overall Study|Study Terminated|1|||
105762492|NCT03820726|364783147|FG000|Overall Study|Other than listed|23|||
105762493|NCT03820726|364783147|FG000|Overall Study|Withdrawal by Subject|37|||
105762494|NCT03820726|364783147|FG000|Overall Study|Lost to Follow-up|3|||
105762495|NCT03820726|364783147|FG000|Overall Study|Protocol deviation|1|||
105762496|NCT03820726|364783147|FG000|Overall Study|Adverse Event|146|||
105762497|NCT03820726|364783147|FG000|Overall Study|Not treated|1|||
105762498|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
105762499|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
105762500|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
105762501|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
105762502|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
105762503|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
105762504|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
105762505|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
105762506|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762507|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762508|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762509|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762510|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762511|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
105762512|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
105762513|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
105762514|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
105762515|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
105762516|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
105762517|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
105762518|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
105762519|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
105762520|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
106144860|NCT03823300|366190737|FG000|Overall Study|Lack of Efficacy|1|||
106144861|NCT03823300|366190738|FG001|Overall Study|Lack of Efficacy|1|||
106144862|NCT03823300|366190737|FG000|Overall Study|Not Eligible|0|||
106144863|NCT03823300|366190738|FG001|Overall Study|Not Eligible|1|||
106144864|NCT03823300|366190737|FG000|Overall Study|Other|1|||
106144865|NCT03823300|366190738|FG001|Overall Study|Other|0|||
106144866|NCT00189202|366190743|FG000|Overall Study|Physician Decision|5|||
106144867|NCT01692938|366190751|FG000|Overall Study|Protocol Deviation|1|||
106144868|NCT01692938|366190752|FG001|Overall Study|Protocol Deviation|1|||
105809263|NCT01654380|364956897|FG001|Part B, Period 1|Physician Decision|0|||
105809264|NCT01654380|364956898|FG002|Part B, Period 1|Physician Decision|1|||
105809265|NCT01654380|364956899|FG003|Part B, Period 1|Physician Decision|0|||
105809266|NCT00947427|364956900|FG000|Overall Study|Withdrawal by Subject|1|||
106017066|NCT00885170|365725949|FG001|Overall Study|Withdrawal by Subject|13|||
106017067|NCT01635153|365725951|FG000|Overall Study|Lost to Follow-up|40|||
106017068|NCT01635153|365725952|FG001|Overall Study|Lost to Follow-up|43|||
106017069|NCT02454517|365725954|FG000|Overall Study|Withdrawal by Subject|3|||
106017070|NCT02454517|365725955|FG001|Overall Study|Withdrawal by Subject|0|||
106017071|NCT02454517|365725954|FG000|Overall Study|Lost to Follow-up|4|||
106017072|NCT02454517|365725955|FG001|Overall Study|Lost to Follow-up|7|||
106017073|NCT02454517|365725954|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
106017074|NCT02454517|365725955|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
106017075|NCT01470326|365725956|FG000|Overall Study|Protocol Violation|32|||
106017076|NCT01470326|365725956|FG000|Overall Study|No Drug Administration Information|2|||
106017077|NCT01470326|365725956|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
106017078|NCT01166282|365725957|FG000|Open-label Period|Adverse Event|0|||
106017079|NCT01166282|365725958|FG001|Open-label Period|Adverse Event|0|||
106017080|NCT01166282|365725959|FG002|Open-label Period|Adverse Event|6|||
106017081|NCT01166282|365725957|FG000|Open-label Period|Withdrawal by Subject|0|||
106017082|NCT01166282|365725958|FG001|Open-label Period|Withdrawal by Subject|0|||
106017083|NCT01166282|365725959|FG002|Open-label Period|Withdrawal by Subject|4|||
106017084|NCT01166282|365725957|FG000|Open-label Period|Lack of Efficacy|0|||
106017085|NCT01166282|365725958|FG001|Open-label Period|Lack of Efficacy|0|||
106017086|NCT01166282|365725959|FG002|Open-label Period|Lack of Efficacy|2|||
106017087|NCT01166282|365725957|FG000|Open-label Period|Remission|0|||
106017088|NCT01166282|365725958|FG001|Open-label Period|Remission|0|||
106017089|NCT01166282|365725959|FG002|Open-label Period|Remission|4|||
106017090|NCT01166282|365725957|FG000|Open-label Period|Irregular Compliance|0|||
106017091|NCT01166282|365725958|FG001|Open-label Period|Irregular Compliance|0|||
106017092|NCT01166282|365725959|FG002|Open-label Period|Irregular Compliance|1|||
106017093|NCT01995838|365725960|FG000|Overall Study|Lost to Follow-up|0|||
106017094|NCT01995838|365725961|FG001|Overall Study|Lost to Follow-up|1|||
106017095|NCT01995838|365725962|FG002|Overall Study|Lost to Follow-up|0|||
106017096|NCT01995838|365725963|FG003|Overall Study|Lost to Follow-up|0|||
106017097|NCT01995838|365725964|FG004|Overall Study|Lost to Follow-up|0|||
106017098|NCT01995838|365725965|FG005|Overall Study|Lost to Follow-up|0|||
106017099|NCT01995838|365725966|FG006|Overall Study|Lost to Follow-up|1|||
106017100|NCT01995838|365725960|FG000|Overall Study|Participant choice|2|||
106017101|NCT01995838|365725961|FG001|Overall Study|Participant choice|0|||
106017102|NCT01995838|365725962|FG002|Overall Study|Participant choice|0|||
106017103|NCT01995838|365725963|FG003|Overall Study|Participant choice|0|||
106017104|NCT01995838|365725964|FG004|Overall Study|Participant choice|0|||
106017105|NCT01995838|365725965|FG005|Overall Study|Participant choice|1|||
106017106|NCT01995838|365725966|FG006|Overall Study|Participant choice|1|||
106017107|NCT01995838|365725960|FG000|Overall Study|Adverse Event|0|||
106017108|NCT01995838|365725961|FG001|Overall Study|Adverse Event|0|||
106017109|NCT01995838|365725962|FG002|Overall Study|Adverse Event|0|||
106017110|NCT01995838|365725963|FG003|Overall Study|Adverse Event|0|||
106017111|NCT01995838|365725964|FG004|Overall Study|Adverse Event|0|||
106017112|NCT01995838|365725965|FG005|Overall Study|Adverse Event|0|||
106017113|NCT01995838|365725966|FG006|Overall Study|Adverse Event|1|||
106017114|NCT01995838|365725960|FG000|Overall Study|Withdrawal by Subject|0|||
106017115|NCT01995838|365725961|FG001|Overall Study|Withdrawal by Subject|0|||
106017116|NCT01995838|365725962|FG002|Overall Study|Withdrawal by Subject|0|||
106017117|NCT01995838|365725963|FG003|Overall Study|Withdrawal by Subject|0|||
106144869|NCT01692938|366190751|FG000|Overall Study|Study completed prior to site completion|3|||
106144870|NCT01692938|366190752|FG001|Overall Study|Study completed prior to site completion|3|||
105809267|NCT00947427|364956901|FG001|Overall Study|Withdrawal by Subject|3|||
106017118|NCT01995838|365725964|FG004|Overall Study|Withdrawal by Subject|1|||
106017119|NCT01995838|365725965|FG005|Overall Study|Withdrawal by Subject|0|||
106017120|NCT01995838|365725966|FG006|Overall Study|Withdrawal by Subject|0|||
106017121|NCT01995838|365725960|FG000|Overall Study|Other|3|||
106017122|NCT01995838|365725961|FG001|Overall Study|Other|1|||
106017123|NCT01995838|365725962|FG002|Overall Study|Other|0|||
106017124|NCT01995838|365725963|FG003|Overall Study|Other|2|||
106017125|NCT01995838|365725964|FG004|Overall Study|Other|1|||
106017126|NCT01995838|365725965|FG005|Overall Study|Other|1|||
106017127|NCT01995838|365725966|FG006|Overall Study|Other|2|||
105809268|NCT00947427|364956900|FG000|Overall Study|Protocol Violation|0|||
105809269|NCT00947427|364956901|FG001|Overall Study|Protocol Violation|1|||
105809270|NCT01937364|364956904|FG000|Overall Study|Adverse Event|2|||
105809271|NCT01937364|364956905|FG001|Overall Study|Adverse Event|1|||
105809272|NCT00936975|364956906|FG000|Overall Study|Withdrawal by Subject|1|||
105809273|NCT00936975|364956906|FG000|Overall Study|Disease progression|3|||
105809274|NCT00936975|364956906|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
105809275|NCT00662129|364956907|FG000|Overall Study|Protocol Violation|1|||
105809276|NCT00662129|364956907|FG000|Overall Study|Cancel prior to beginning treatment|1|||
105809277|NCT00662129|364956907|FG000|Overall Study|Ineligible|1|||
105809278|NCT02427607|364956908|FG000|Overall Study|Withdrawal by Subject|1|||
105809279|NCT02153736|364956909|FG000|Overall Study|Lost to Follow-up|1|||
105809280|NCT02153736|364956910|FG001|Overall Study|Lost to Follow-up|0|||
105809281|NCT02153736|364956909|FG000|Overall Study|Medical status change made ineligible|1|||
105809282|NCT02153736|364956910|FG001|Overall Study|Medical status change made ineligible|0|||
105809283|NCT02153736|364956909|FG000|Overall Study|Death|0|||
105809284|NCT02153736|364956910|FG001|Overall Study|Death|1|||
105809285|NCT02153736|364956909|FG000|Overall Study|Withdrawal by Subject|0|||
105809286|NCT02153736|364956910|FG001|Overall Study|Withdrawal by Subject|1|||
105809287|NCT03283709|364956913|FG000|Overall Study|trial terminated|0|||
105809288|NCT03283709|364956914|FG001|Overall Study|trial terminated|1|||
105809289|NCT03730103|364956915|FG000|Overall Study|Did not meet inclusion criteria|0|||
105809290|NCT03730103|364956916|FG001|Overall Study|Did not meet inclusion criteria|5|||
105809291|NCT00663871|364956917|FG000|Overall Study|Lost to Follow-up|5|||
105809292|NCT00663871|364956918|FG001|Overall Study|Lost to Follow-up|5|||
105809293|NCT00663871|364956917|FG000|Overall Study|Withdrawal by Subject|5|||
105809294|NCT00663871|364956918|FG001|Overall Study|Withdrawal by Subject|2|||
105809295|NCT01058421|364956919|FG000|1 Month Outcomes|Death|10|||
105809296|NCT01058421|364956920|FG001|1 Month Outcomes|Death|6|||
105809297|NCT01058421|364956919|FG000|1 Month Outcomes|Lost to Follow-up|8|||
105809298|NCT01058421|364956920|FG001|1 Month Outcomes|Lost to Follow-up|7|||
105809299|NCT01058421|364956919|FG000|1 Month Outcomes|Remained in Hospital|5|||
105809300|NCT01058421|364956920|FG001|1 Month Outcomes|Remained in Hospital|12|||
105809301|NCT01058421|364956919|FG000|1 Month Outcomes|Remained in Other Facility|16|||
105809302|NCT01058421|364956920|FG001|1 Month Outcomes|Remained in Other Facility|17|||
105809303|NCT01058421|364956919|FG000|3 Month Outcomes|Death|3|||
105809304|NCT01058421|364956920|FG001|3 Month Outcomes|Death|5|||
105809305|NCT01058421|364956919|FG000|3 Month Outcomes|Lost to Follow-up|12|||
105809306|NCT01058421|364956920|FG001|3 Month Outcomes|Lost to Follow-up|11|||
105809307|NCT01058421|364956919|FG000|3 Month Outcomes|Remained in Hospital|0|||
105809308|NCT01058421|364956920|FG001|3 Month Outcomes|Remained in Hospital|2|||
105809309|NCT01058421|364956919|FG000|3 Month Outcomes|Remained in Other Facility|5|||
105809310|NCT01058421|364956920|FG001|3 Month Outcomes|Remained in Other Facility|8|||
105809311|NCT01058421|364956919|FG000|6 Month Outcomes|Death|2|||
105809312|NCT01058421|364956920|FG001|6 Month Outcomes|Death|2|||
105809313|NCT01058421|364956919|FG000|6 Month Outcomes|Lost to Follow-up|16|||
105809314|NCT01058421|364956920|FG001|6 Month Outcomes|Lost to Follow-up|21|||
105809315|NCT01058421|364956919|FG000|6 Month Outcomes|Remained in Other Facility|1|||
105809316|NCT01058421|364956920|FG001|6 Month Outcomes|Remained in Other Facility|3|||
105809317|NCT05200858|364956923|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
105809318|NCT05200858|364956924|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
105809319|NCT05200858|364956925|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
105809320|NCT05200858|364956926|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
105809321|NCT01611090|364956927|FG000|Randomized Period|Lost to Follow-up|8|||
105809322|NCT01611090|364956928|FG001|Randomized Period|Lost to Follow-up|3|||
105809323|NCT01611090|364956929|FG002|Randomized Period|Lost to Follow-up|0|||
105809324|NCT01611090|364956927|FG000|Randomized Period|Withdrawal by Subject|22|||
105809325|NCT01611090|364956928|FG001|Randomized Period|Withdrawal by Subject|26|||
105809326|NCT01611090|364956929|FG002|Randomized Period|Withdrawal by Subject|0|||
105809327|NCT01611090|364956927|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
105809328|NCT01611090|364956928|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
105809329|NCT01611090|364956929|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
105809330|NCT01611090|364956927|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
105809331|NCT01611090|364956928|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
105809332|NCT01611090|364956929|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
105809333|NCT01628120|364959366|FG000|Overall Study|Withdrawal by Subject|7|||
105809334|NCT01628120|364959366|FG000|Overall Study|Adverse Event|12|||
105809335|NCT01628120|364959366|FG000|Overall Study|Lost to Follow-up|1|||
105809336|NCT01628120|364959366|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
105809337|NCT01628120|364959366|FG000|Overall Study|Non-compliant with Study Procedures|1|||
105809338|NCT01628120|364959366|FG000|Overall Study|Not Treated|3|||
105809339|NCT01628120|364959366|FG000|Overall Study|Sponsor Decision|5|||
105809340|NCT01628120|364959366|FG000|Overall Study|Switched Dialysis Method|2|||
105809341|NCT01628120|364959366|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
105809342|NCT01628120|364959366|FG000|Overall Study|Moved or Relocated|5|||
105809343|NCT01628120|364959366|FG000|Overall Study|Kidney Transplant|2|||
105809344|NCT01628120|364959366|FG000|Overall Study|Use of Standard of Care|1|||
105809345|NCT00704418|364959367|FG000|Overall Study|Withdrawal by Subject|2|||
105809346|NCT00704418|364959368|FG001|Overall Study|Withdrawal by Subject|0|||
105809347|NCT00704418|364959367|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
105809348|NCT00704418|364959368|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
105809349|NCT04583579|364959370|FG000|Overall Study|Lost to Follow-up|4|||
105809350|NCT01031537|364959371|FG000|Overall Study|medical reasons not related to study|3|||
105809351|NCT01031537|364959371|FG000|Overall Study|Lack of Efficacy|1|||
105809352|NCT01031537|364959371|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
105809353|NCT01031537|364959371|FG000|Overall Study|moved, met exclusion criteria|10|||
105809354|NCT01031537|364959371|FG000|Overall Study|Withdrawal by Subject|5|||
105809355|NCT01031537|364959371|FG000|Overall Study|PI removal, no longer met eligibility|12|||
105809356|NCT01000337|364959381|FG000|Overall Study|Lost to Follow-up|4|||
105809357|NCT01000337|364959382|FG001|Overall Study|Lost to Follow-up|3|||
105809358|NCT00755326|364959383|FG000|Overall Study|Lost to Follow-up|2|||
105809359|NCT00755326|364959384|FG001|Overall Study|Lost to Follow-up|3|||
105809360|NCT01694485|364959387|FG000|Overall Study|Withdrawal by Subject|20|||
105809361|NCT01694485|364959388|FG001|Overall Study|Withdrawal by Subject|6|||
105809362|NCT01694485|364959389|FG002|Overall Study|Withdrawal by Subject|7|||
105809363|NCT01694485|364959390|FG003|Overall Study|Withdrawal by Subject|25|||
105809364|NCT01694485|364959391|FG004|Overall Study|Withdrawal by Subject|18|||
105809365|NCT01694485|364959387|FG000|Overall Study|Sponsor Decision|3|||
105809366|NCT01694485|364959388|FG001|Overall Study|Sponsor Decision|0|||
105809367|NCT01694485|364959389|FG002|Overall Study|Sponsor Decision|0|||
105809368|NCT01694485|364959390|FG003|Overall Study|Sponsor Decision|2|||
105809369|NCT01694485|364959391|FG004|Overall Study|Sponsor Decision|0|||
105809370|NCT01694485|364959387|FG000|Overall Study|Lost to Follow-up|9|||
105809371|NCT01694485|364959388|FG001|Overall Study|Lost to Follow-up|1|||
105809372|NCT01694485|364959389|FG002|Overall Study|Lost to Follow-up|6|||
105809373|NCT01694485|364959390|FG003|Overall Study|Lost to Follow-up|10|||
105809374|NCT01694485|364959391|FG004|Overall Study|Lost to Follow-up|7|||
105809375|NCT01694485|364959387|FG000|Overall Study|Death|1|||
105809376|NCT01694485|364959388|FG001|Overall Study|Death|0|||
105809377|NCT01694485|364959389|FG002|Overall Study|Death|0|||
105809378|NCT01694485|364959390|FG003|Overall Study|Death|1|||
105809379|NCT01694485|364959391|FG004|Overall Study|Death|0|||
105809380|NCT00625807|364959392|FG000|Overall Study|schedule conflict|2|||
105809381|NCT00625807|364959393|FG001|Overall Study|schedule conflict|8|||
105809382|NCT03522948|364959394|FG000|Overall Study|Lost to Follow-up|1|||
105809383|NCT03937466|364959395|FG000|Overall Study|not eligbile after the 2-week diary|9|||
105809384|NCT03937466|364959395|FG000|Overall Study|never returned their diary|6|||
105809385|NCT03937466|364959395|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
105809386|NCT03937466|364959395|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
105809387|NCT03305055|364959397|FG000|Overall Study|Withdrawal by Subject|0|||
105809388|NCT03305055|364959398|FG001|Overall Study|Withdrawal by Subject|1|||
105809389|NCT03305055|364959397|FG000|Overall Study|Adverse Event|1|||
105809390|NCT03305055|364959398|FG001|Overall Study|Adverse Event|1|||
105809391|NCT00622908|364959399|FG000|Overall Study|Protocol Violation|1|||
105809392|NCT00622908|364959400|FG001|Overall Study|Protocol Violation|0|||
105809393|NCT00622908|364959399|FG000|Overall Study|Adverse Event|0|||
105809394|NCT00622908|364959400|FG001|Overall Study|Adverse Event|1|||
105809395|NCT00622908|364959399|FG000|Overall Study|Lack of Efficacy|1|||
105809396|NCT00622908|364959400|FG001|Overall Study|Lack of Efficacy|7|||
105809397|NCT00622908|364959399|FG000|Overall Study|Lost to Follow-up|1|||
105809398|NCT00622908|364959400|FG001|Overall Study|Lost to Follow-up|0|||
105809399|NCT00622908|364959399|FG000|Overall Study|Refusal|0|||
105809400|NCT00622908|364959400|FG001|Overall Study|Refusal|1|||
105809401|NCT00622908|364959399|FG000|Overall Study|Termination by study sponser|0|||
105809402|NCT00622908|364959400|FG001|Overall Study|Termination by study sponser|1|||
105809403|NCT00819247|364959406|FG000|Overall Study|Adverse Event|0|||
105809404|NCT00819247|364959407|FG001|Overall Study|Adverse Event|5|||
105809405|NCT00819247|364959408|FG002|Overall Study|Adverse Event|3|||
105809406|NCT00819247|364959406|FG000|Overall Study|Insufficient testosterone response|5|||
105809407|NCT00819247|364959407|FG001|Overall Study|Insufficient testosterone response|8|||
105809408|NCT00819247|364959408|FG002|Overall Study|Insufficient testosterone response|10|||
105809409|NCT00819247|364959406|FG000|Overall Study|Withdrawal by Subject|1|||
105809410|NCT00819247|364959407|FG001|Overall Study|Withdrawal by Subject|0|||
105809411|NCT00819247|364959408|FG002|Overall Study|Withdrawal by Subject|0|||
105809412|NCT00819247|364959406|FG000|Overall Study|Protocol Violation|1|||
105809413|NCT00819247|364959407|FG001|Overall Study|Protocol Violation|0|||
105809414|NCT00819247|364959408|FG002|Overall Study|Protocol Violation|1|||
105809415|NCT00819247|364959406|FG000|Overall Study|Mistakenly withdrawn|0|||
105809416|NCT00819247|364959407|FG001|Overall Study|Mistakenly withdrawn|1|||
105809417|NCT00819247|364959408|FG002|Overall Study|Mistakenly withdrawn|0|||
105809418|NCT00819247|364959406|FG000|Overall Study|Bad prostate-specific antigen response|3|||
105809419|NCT00819247|364959407|FG001|Overall Study|Bad prostate-specific antigen response|2|||
105809420|NCT00819247|364959408|FG002|Overall Study|Bad prostate-specific antigen response|0|||
105809421|NCT00819247|364959406|FG000|Overall Study|Other|1|||
105809422|NCT00819247|364959407|FG001|Overall Study|Other|0|||
105809423|NCT00819247|364959408|FG002|Overall Study|Other|0|||
105809424|NCT01325207|364959414|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809425|NCT01325207|364959415|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809426|NCT01325207|364959416|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809427|NCT01325207|364959417|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809428|NCT01325207|364959418|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
105809429|NCT01325207|364959419|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
105809430|NCT01325207|364959414|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
105809431|NCT01325207|364959415|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
105809432|NCT01325207|364959416|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
105809433|NCT01325207|364959417|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
105809434|NCT01325207|364959418|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
105809435|NCT01325207|364959419|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
105809436|NCT01325207|364959414|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
105809437|NCT01325207|364959415|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
105809438|NCT01325207|364959416|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
105809439|NCT01325207|364959417|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
105809440|NCT01325207|364959418|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
105809441|NCT01325207|364959419|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
105809442|NCT01325207|364959414|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809443|NCT01325207|364959415|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
105809444|NCT01325207|364959416|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809445|NCT01325207|364959417|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809446|NCT01325207|364959418|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809447|NCT01325207|364959419|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
105809448|NCT01325207|364959414|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809449|NCT01325207|364959415|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809450|NCT01325207|364959416|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809451|NCT01325207|364959417|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809452|NCT01325207|364959418|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
105809453|NCT01325207|364959419|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
105809454|NCT01325207|364959414|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809455|NCT01325207|364959415|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809456|NCT01325207|364959416|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809457|NCT01325207|364959417|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809458|NCT01325207|364959418|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
105809459|NCT01325207|364959419|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
105809460|NCT01325207|364959414|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809461|NCT01325207|364959415|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809462|NCT01325207|364959416|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809463|NCT01325207|364959417|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809464|NCT01325207|364959418|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
105809465|NCT01325207|364959419|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
105809466|NCT01974895|364959423|FG000|Overall Study|Protocol Violation|1|||
105809467|NCT01974895|364959424|FG001|Overall Study|Protocol Violation|0|||
105809468|NCT01974895|364959423|FG000|Overall Study|Lost to Follow-up|4|||
105809469|NCT01974895|364959424|FG001|Overall Study|Lost to Follow-up|6|||
105809470|NCT01974895|364959423|FG000|Overall Study|Withdrawal by Subject|0|||
105809471|NCT01974895|364959424|FG001|Overall Study|Withdrawal by Subject|1|||
105809472|NCT01974895|364959423|FG000|Overall Study|Other (Missed Visit)|1|||
105809473|NCT01974895|364959424|FG001|Overall Study|Other (Missed Visit)|0|||
105809474|NCT01974895|364959423|FG000|Overall Study|Other (Reason unknown)|9|||
105809475|NCT01974895|364959424|FG001|Overall Study|Other (Reason unknown)|8|||
105809476|NCT01513148|364959429|FG000|Overall Study|Protocol Violation|2|||
105809477|NCT01513148|364959430|FG001|Overall Study|Protocol Violation|2|||
105809478|NCT01166568|364959436|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
105809479|NCT01166568|364959437|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
105809480|NCT01166568|364959438|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
106144871|NCT00959946|366190753|FG000|Overall Study|Adverse Event|0|||
105809481|NCT01166568|364959436|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
105809482|NCT01166568|364959437|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
105809483|NCT01166568|364959438|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
105987402|NCT03495102|365614449|FG001|Overall Study|Participant Duplicated at Another Site|0|||
106144872|NCT00959946|366190754|FG001|Overall Study|Adverse Event|0|||
106144873|NCT00959946|366190755|FG002|Overall Study|Adverse Event|2|||
105809484|NCT01166568|364959436|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
105809485|NCT01166568|364959437|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
105809486|NCT01166568|364959438|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
105809487|NCT01984242|364959439|FG000|Overall Study|Death|52|||
105809488|NCT01984242|364959440|FG001|Overall Study|Death|50|||
105809489|NCT01984242|364959441|FG002|Overall Study|Death|52|||
105809490|NCT01984242|364959439|FG000|Overall Study|Withdrawal by Subject|5|||
105809491|NCT01984242|364959440|FG001|Overall Study|Withdrawal by Subject|3|||
105809492|NCT01984242|364959441|FG002|Overall Study|Withdrawal by Subject|10|||
105809493|NCT01984242|364959439|FG000|Overall Study|Physician Decision|0|||
105809494|NCT01984242|364959440|FG001|Overall Study|Physician Decision|0|||
105809495|NCT01984242|364959441|FG002|Overall Study|Physician Decision|1|||
105809496|NCT01984242|364959439|FG000|Overall Study|Lost to Follow-up|4|||
105809497|NCT01984242|364959440|FG001|Overall Study|Lost to Follow-up|0|||
105809498|NCT01984242|364959441|FG002|Overall Study|Lost to Follow-up|3|||
105809499|NCT01984242|364959439|FG000|Overall Study|Sponsor Decision|1|||
105809500|NCT01984242|364959440|FG001|Overall Study|Sponsor Decision|0|||
105809501|NCT01984242|364959441|FG002|Overall Study|Sponsor Decision|0|||
105809502|NCT01984242|364959439|FG000|Overall Study|Non-Compliance|1|||
105809503|NCT01984242|364959440|FG001|Overall Study|Non-Compliance|0|||
105809504|NCT01984242|364959441|FG002|Overall Study|Non-Compliance|0|||
105809505|NCT01984242|364959439|FG000|Overall Study|Study terminated by Sponsor|38|||
105809506|NCT01984242|364959440|FG001|Overall Study|Study terminated by Sponsor|50|||
105809507|NCT01984242|364959441|FG002|Overall Study|Study terminated by Sponsor|34|||
105809508|NCT01984242|364959439|FG000|Overall Study|Disease Progression|0|||
105809509|NCT01984242|364959440|FG001|Overall Study|Disease Progression|0|||
105809510|NCT01984242|364959441|FG002|Overall Study|Disease Progression|1|||
105809511|NCT03335371|364959442|FG000|Overall Study|Lost to Follow-up|0|||
105809512|NCT03335371|364959443|FG001|Overall Study|Lost to Follow-up|0|||
105809513|NCT03335371|364959444|FG002|Overall Study|Lost to Follow-up|0|||
105809514|NCT03335371|364959445|FG003|Overall Study|Lost to Follow-up|0|||
105809515|NCT03335371|364959446|FG004|Overall Study|Lost to Follow-up|1|||
105809516|NCT03335371|364959442|FG000|Overall Study|Withdrawal by Subject|0|||
105809517|NCT03335371|364959443|FG001|Overall Study|Withdrawal by Subject|0|||
105809518|NCT03335371|364959444|FG002|Overall Study|Withdrawal by Subject|0|||
105809519|NCT03335371|364959445|FG003|Overall Study|Withdrawal by Subject|0|||
105809520|NCT03335371|364959446|FG004|Overall Study|Withdrawal by Subject|1|||
105809521|NCT03335371|364959442|FG000|Overall Study|Randomization Error|0|||
105809522|NCT03335371|364959443|FG001|Overall Study|Randomization Error|0|||
105809523|NCT03335371|364959444|FG002|Overall Study|Randomization Error|1|||
105809524|NCT03335371|364959445|FG003|Overall Study|Randomization Error|0|||
105809525|NCT03335371|364959446|FG004|Overall Study|Randomization Error|0|||
105809526|NCT00684671|364959447|FG000|Overall Study|Adverse Event|1|||
105809527|NCT00684671|364959448|FG001|Overall Study|Adverse Event|0|||
105809528|NCT00684671|364959449|FG002|Overall Study|Adverse Event|0|||
105809529|NCT00684671|364959447|FG000|Overall Study|Lost to Follow-up|1|||
105809530|NCT00684671|364959448|FG001|Overall Study|Lost to Follow-up|0|||
105809531|NCT00684671|364959449|FG002|Overall Study|Lost to Follow-up|0|||
105809532|NCT00684671|364959447|FG000|Overall Study|Alcoholic dependance|1|||
105809533|NCT00684671|364959448|FG001|Overall Study|Alcoholic dependance|0|||
105809534|NCT00684671|364959449|FG002|Overall Study|Alcoholic dependance|0|||
105809535|NCT01725451|364959452|FG000|Period 1|Withdrawal by Subject|1|||
105809536|NCT01725451|364959453|FG001|Period 1|Withdrawal by Subject|0|||
105809537|NCT01725451|364959454|FG002|Period 1|Withdrawal by Subject|0|||
105809538|NCT01725451|364959455|FG003|Period 1|Withdrawal by Subject|0|||
105809539|NCT01725451|364959452|FG000|Washout From Period 3|Protocol Violation|0|||
105809540|NCT01725451|364959453|FG001|Washout From Period 3|Protocol Violation|0|||
105809541|NCT01725451|364959454|FG002|Washout From Period 3|Protocol Violation|1|||
105809542|NCT01725451|364959455|FG003|Washout From Period 3|Protocol Violation|0|||
105809543|NCT01725451|364959452|FG000|Washout From Period 3|Adverse Event|0|||
106017128|NCT02892448|365725982|FG000|Overall Study|Screening failure|2|||
106017129|NCT02892448|365725983|FG001|Overall Study|Screening failure|2|||
106017130|NCT02892448|365725984|FG002|Overall Study|Screening failure|1|||
106017131|NCT00499083|365725985|FG000|Overall Study|Not evaluable|3|||
106017132|NCT00439517|365725987|FG000|Overall Study|Subject on treatment|1|||
105809544|NCT01725451|364959453|FG001|Washout From Period 3|Adverse Event|1|||
105809545|NCT01725451|364959454|FG002|Washout From Period 3|Adverse Event|0|||
106017133|NCT00439517|365725988|FG001|Overall Study|Subject on treatment|0|||
105809546|NCT01725451|364959455|FG003|Washout From Period 3|Adverse Event|0|||
105809547|NCT01725451|364959452|FG000|Period 4|Adverse Event|0|||
105809548|NCT01725451|364959453|FG001|Period 4|Adverse Event|0|||
105809549|NCT01725451|364959454|FG002|Period 4|Adverse Event|1|||
105809550|NCT01725451|364959455|FG003|Period 4|Adverse Event|0|||
105809551|NCT04543136|364959456|FG000|Overall Study|Withdrawal by Subject|0|||
105809552|NCT04543136|364959457|FG001|Overall Study|Withdrawal by Subject|1|||
105809553|NCT04543136|364959458|FG002|Overall Study|Withdrawal by Subject|0|||
106017134|NCT00439517|365725987|FG000|Overall Study|Subject in survival follow-up|1|||
105809554|NCT04543136|364959459|FG003|Overall Study|Withdrawal by Subject|1|||
105809555|NCT04543136|364959460|FG004|Overall Study|Withdrawal by Subject|0|||
105809556|NCT04543136|364959461|FG005|Overall Study|Withdrawal by Subject|0|||
105809557|NCT02978326|364959463|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
105809558|NCT02978326|364959464|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
105809559|NCT02978326|364959465|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
105809560|NCT02978326|364959463|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
105809561|NCT02978326|364959464|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
105809562|NCT02978326|364959465|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
105809563|NCT02978326|364959463|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
105809564|NCT02978326|364959464|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
105809565|NCT02978326|364959465|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
105809566|NCT02978326|364959463|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
105809567|NCT02978326|364959464|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
105809568|NCT02978326|364959465|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
105809569|NCT00437281|364959466|FG000|Overall Study|Adverse Event|0|||
105809570|NCT00437281|364959467|FG001|Overall Study|Adverse Event|0|||
105809571|NCT00437281|364959468|FG002|Overall Study|Adverse Event|0|||
105809572|NCT00437281|364959469|FG003|Overall Study|Adverse Event|1|||
105809573|NCT00437281|364959470|FG004|Overall Study|Adverse Event|0|||
105809574|NCT00437281|364959471|FG005|Overall Study|Adverse Event|1|||
105809575|NCT00437281|364959472|FG006|Overall Study|Adverse Event|0|||
105809576|NCT00437281|364959473|FG007|Overall Study|Adverse Event|0|||
105809577|NCT00437281|364959474|FG008|Overall Study|Adverse Event|0|||
105809578|NCT00437281|364959475|FG009|Overall Study|Adverse Event|1|||
105809579|NCT00437281|364959476|FG010|Overall Study|Adverse Event|0|||
105809580|NCT00437281|364959477|FG011|Overall Study|Adverse Event|0|||
105809581|NCT00437281|364959478|FG012|Overall Study|Adverse Event|0|||
105809582|NCT00437281|364959479|FG013|Overall Study|Adverse Event|1|||
105809583|NCT00437281|364959480|FG014|Overall Study|Adverse Event|1|||
105809584|NCT00437281|364959481|FG015|Overall Study|Adverse Event|0|||
105809585|NCT00437281|364959482|FG016|Overall Study|Adverse Event|0|||
105809586|NCT00437281|364959483|FG017|Overall Study|Adverse Event|0|||
105809587|NCT00437281|364959484|FG018|Overall Study|Adverse Event|1|||
105809588|NCT00437281|364959485|FG019|Overall Study|Adverse Event|0|||
105809589|NCT00437281|364959466|FG000|Overall Study|Lost to Follow-up|0|||
105809590|NCT00437281|364959467|FG001|Overall Study|Lost to Follow-up|0|||
105809591|NCT00437281|364959468|FG002|Overall Study|Lost to Follow-up|0|||
105809592|NCT00437281|364959469|FG003|Overall Study|Lost to Follow-up|0|||
105809593|NCT00437281|364959470|FG004|Overall Study|Lost to Follow-up|0|||
105809594|NCT00437281|364959471|FG005|Overall Study|Lost to Follow-up|0|||
105809595|NCT00437281|364959472|FG006|Overall Study|Lost to Follow-up|0|||
105809596|NCT00437281|364959473|FG007|Overall Study|Lost to Follow-up|0|||
105809597|NCT00437281|364959474|FG008|Overall Study|Lost to Follow-up|0|||
105809598|NCT00437281|364959475|FG009|Overall Study|Lost to Follow-up|0|||
105809599|NCT00437281|364959476|FG010|Overall Study|Lost to Follow-up|0|||
105809600|NCT00437281|364959477|FG011|Overall Study|Lost to Follow-up|0|||
105809601|NCT00437281|364959478|FG012|Overall Study|Lost to Follow-up|0|||
105809602|NCT00437281|364959479|FG013|Overall Study|Lost to Follow-up|0|||
105809603|NCT00437281|364959480|FG014|Overall Study|Lost to Follow-up|0|||
105809604|NCT00437281|364959481|FG015|Overall Study|Lost to Follow-up|0|||
105809605|NCT00437281|364959482|FG016|Overall Study|Lost to Follow-up|0|||
105809606|NCT00437281|364959483|FG017|Overall Study|Lost to Follow-up|0|||
105809607|NCT00437281|364959484|FG018|Overall Study|Lost to Follow-up|0|||
106017135|NCT00439517|365725988|FG001|Overall Study|Subject in survival follow-up|0|||
106017136|NCT00686686|365725989|FG000|Overall Study|Non-compliance|1|||
106017137|NCT00686686|365725989|FG000|Overall Study|Adverse Event|2|||
106017138|NCT00686686|365725989|FG000|Overall Study|Lost to Follow-up|3|||
106017139|NCT01012440|365725992|FG000|Overall Study|Withdrawal by Subject|2|||
106017140|NCT00594815|365725993|FG000|Overall Study|Never Treated|3|||
106017141|NCT00594815|365725993|FG000|Overall Study|Withdrawal by Subject|2|||
106017142|NCT00594815|365725993|FG000|Overall Study|Toxicity|4|||
105809608|NCT00437281|364959485|FG019|Overall Study|Lost to Follow-up|1|||
105809609|NCT03521999|364959489|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
105809610|NCT03521999|364959490|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
105809611|NCT03521999|364959489|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
105809612|NCT03521999|364959490|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
105809613|NCT03521999|364959489|FG000|Completed 3 Month Follow up|Death|0|||
105809614|NCT03521999|364959490|FG001|Completed 3 Month Follow up|Death|1|||
105809615|NCT03521999|364959489|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
105809616|NCT03521999|364959490|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
105809617|NCT00865709|364959493|FG000|Treatment|Adverse Event|9|||
105809618|NCT00865709|364959494|FG001|Treatment|Adverse Event|6|||
105809619|NCT00865709|364959493|FG000|Treatment|Withdrawal by Subject|10|||
105809620|NCT00865709|364959494|FG001|Treatment|Withdrawal by Subject|7|||
105809621|NCT00865709|364959493|FG000|Treatment|Physician Decision|3|||
105809622|NCT00865709|364959494|FG001|Treatment|Physician Decision|2|||
105809623|NCT00865709|364959493|FG000|Treatment|Surgery|8|||
106017143|NCT03214666|365725996|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
105809624|NCT00865709|364959494|FG001|Treatment|Surgery|3|||
105809625|NCT01485536|364959497|FG000|Overall Study|Withdrawal by Subject|3|||
105809626|NCT01485536|364959497|FG000|Overall Study|Adverse Event|1|||
105809627|NCT00577460|364959498|FG000|Overall Study|Adverse Event|11|||
105809628|NCT00577460|364959499|FG001|Overall Study|Adverse Event|7|||
105809629|NCT00577460|364959500|FG002|Overall Study|Adverse Event|14|||
105809630|NCT00577460|364959498|FG000|Overall Study|Protocol Violation|0|||
105809631|NCT00577460|364959499|FG001|Overall Study|Protocol Violation|1|||
105809632|NCT00577460|364959500|FG002|Overall Study|Protocol Violation|1|||
105809633|NCT00577460|364959498|FG000|Overall Study|Lost to Follow-up|0|||
105809634|NCT00577460|364959499|FG001|Overall Study|Lost to Follow-up|3|||
105809635|NCT00577460|364959500|FG002|Overall Study|Lost to Follow-up|4|||
105809636|NCT00577460|364959498|FG000|Overall Study|Withdrawal by Subject|5|||
105809637|NCT00577460|364959499|FG001|Overall Study|Withdrawal by Subject|5|||
105809638|NCT00577460|364959500|FG002|Overall Study|Withdrawal by Subject|6|||
105809639|NCT00577460|364959498|FG000|Overall Study|Other|0|||
105809640|NCT00577460|364959499|FG001|Overall Study|Other|3|||
105809641|NCT00577460|364959500|FG002|Overall Study|Other|2|||
105809642|NCT01734772|364959501|FG000|Overall Study|Adverse Event|1|||
105809643|NCT01734772|364959502|FG001|Overall Study|Adverse Event|2|||
105809644|NCT01734772|364959501|FG000|Overall Study|Withdrawal by Subject|0|||
105809645|NCT01734772|364959502|FG001|Overall Study|Withdrawal by Subject|1|||
105809646|NCT00329602|364959505|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
105809647|NCT00329602|364959506|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
105809648|NCT00329602|364959507|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
105809649|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
105809650|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
105809651|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
105809652|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
105809653|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
105809654|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
105809655|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
105809656|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
105809657|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
105809658|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
105809659|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
105809660|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
105809661|NCT00329602|364959505|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
105809662|NCT00329602|364959506|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
105809663|NCT00329602|364959507|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
105809664|NCT01867242|364959508|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
105809665|NCT01867242|364959509|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
105809666|NCT01867242|364959510|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
105809667|NCT02275364|364959511|FG000|Period 1|Withdrawal by Subject|1|||
105809668|NCT02275364|364959512|FG001|Period 1|Withdrawal by Subject|0|||
105809669|NCT02275364|364959511|FG000|Period 1|Other reason|1|||
105809670|NCT02275364|364959512|FG001|Period 1|Other reason|0|||
105809671|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
105809672|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
105809673|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
105809674|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
105809675|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
105809676|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
105809677|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
105809678|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
105809679|NCT02579096|364959515|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
105809680|NCT02579096|364959516|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
105809681|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Death|2|||
105809682|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Death|4|||
105809683|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
105809684|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
105809685|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
105809686|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
105809687|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
105809688|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
105809689|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
105809690|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
105809691|NCT02579096|364959515|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
105809692|NCT02579096|364959516|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
105809693|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Death|3|||
105809694|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Death|2|||
105809695|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
105809696|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
105809697|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
105809698|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
105809699|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
105809700|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
105809701|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
105809702|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
105809703|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
105809704|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
105809705|NCT02579096|364959515|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
105809706|NCT02579096|364959516|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
105809707|NCT03977584|364959517|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
105809708|NCT03977584|364959518|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
105809709|NCT03977584|364959519|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
105809710|NCT04591626|364959524|FG000|Overall Study|Adverse Event|4|||
105809711|NCT04591626|364959525|FG001|Overall Study|Adverse Event|0|||
105809712|NCT04591626|364959524|FG000|Overall Study|Withdrawal by Subject|5|||
105809713|NCT04591626|364959525|FG001|Overall Study|Withdrawal by Subject|3|||
105809714|NCT04591626|364959524|FG000|Overall Study|Physician Decision|0|||
105809715|NCT04591626|364959525|FG001|Overall Study|Physician Decision|1|||
105809716|NCT04591626|364959524|FG000|Overall Study|Death|0|||
105809717|NCT04591626|364959525|FG001|Overall Study|Death|1|||
105809718|NCT04591626|364959524|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105809719|NCT04591626|364959525|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105809720|NCT02097121|364959526|FG000|Overall Study|Other, not specified|4|||
105809721|NCT02097121|364959527|FG001|Overall Study|Other, not specified|2|||
105809722|NCT02097121|364959528|FG002|Overall Study|Other, not specified|3|||
105809723|NCT02097121|364959526|FG000|Overall Study|Lack of Efficacy|2|||
105809724|NCT02097121|364959527|FG001|Overall Study|Lack of Efficacy|1|||
105809725|NCT02097121|364959528|FG002|Overall Study|Lack of Efficacy|3|||
105809726|NCT02097121|364959526|FG000|Overall Study|Withdrawal by Subject|0|||
105809727|NCT02097121|364959527|FG001|Overall Study|Withdrawal by Subject|1|||
105809728|NCT02097121|364959528|FG002|Overall Study|Withdrawal by Subject|2|||
105809729|NCT02097121|364959526|FG000|Overall Study|Adverse Event|0|||
105809730|NCT02097121|364959527|FG001|Overall Study|Adverse Event|1|||
105809731|NCT02097121|364959528|FG002|Overall Study|Adverse Event|0|||
105809732|NCT02097121|364959526|FG000|Overall Study|Lost to Follow-up|1|||
105809733|NCT02097121|364959527|FG001|Overall Study|Lost to Follow-up|1|||
105809734|NCT02097121|364959528|FG002|Overall Study|Lost to Follow-up|2|||
105809735|NCT03066999|364959530|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
105809736|NCT03066999|364959531|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
105809737|NCT00661999|364959532|FG000|Overall Study|Adverse Event|11|||
105809738|NCT00661999|364959533|FG001|Overall Study|Adverse Event|5|||
105809739|NCT00661999|364959534|FG002|Overall Study|Adverse Event|8|||
105809740|NCT00661999|364959532|FG000|Overall Study|Death|8|||
105809741|NCT00661999|364959533|FG001|Overall Study|Death|6|||
105809742|NCT00661999|364959534|FG002|Overall Study|Death|3|||
105809743|NCT00661999|364959532|FG000|Overall Study|Other Reasons|5|||
105809744|NCT00661999|364959533|FG001|Overall Study|Other Reasons|12|||
105809745|NCT00661999|364959534|FG002|Overall Study|Other Reasons|23|||
105809746|NCT00661999|364959532|FG000|Overall Study|Withdrawal by Subject|30|||
105809747|NCT00661999|364959533|FG001|Overall Study|Withdrawal by Subject|23|||
105809748|NCT00661999|364959534|FG002|Overall Study|Withdrawal by Subject|14|||
105809749|NCT00661999|364959532|FG000|Overall Study|Alternative Treatment|1|||
105809750|NCT00661999|364959533|FG001|Overall Study|Alternative Treatment|0|||
105809751|NCT00661999|364959534|FG002|Overall Study|Alternative Treatment|0|||
105809752|NCT00661999|364959532|FG000|Overall Study|Other Medical Problems|4|||
105809753|NCT00661999|364959533|FG001|Overall Study|Other Medical Problems|4|||
105952768|NCT02891226|365488282|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952769|NCT02891226|365488283|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952770|NCT02891226|365488284|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952771|NCT02891226|365488285|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
105952772|NCT02891226|365488270|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952773|NCT02891226|365488271|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952774|NCT02891226|365488272|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105987403|NCT03495102|365614450|FG002|Overall Study|Participant Duplicated at Another Site|1|||
105809754|NCT00661999|364959534|FG002|Overall Study|Other Medical Problems|9|||
105809755|NCT00510510|364959535|FG000|Overall Study|Adverse Event|4|||
105809756|NCT00510510|364959536|FG001|Overall Study|Adverse Event|3|||
105809757|NCT00510510|364959537|FG002|Overall Study|Adverse Event|6|||
105809758|NCT00510510|364959535|FG000|Overall Study|Lack of Efficacy|0|||
105809759|NCT00510510|364959536|FG001|Overall Study|Lack of Efficacy|1|||
105809760|NCT00510510|364959537|FG002|Overall Study|Lack of Efficacy|1|||
105809761|NCT00510510|364959535|FG000|Overall Study|Subjects no longer requires study drug|0|||
105809762|NCT00510510|364959536|FG001|Overall Study|Subjects no longer requires study drug|0|||
106144874|NCT00959946|366190756|FG003|Overall Study|Adverse Event|1|||
106144875|NCT00959946|366190757|FG004|Overall Study|Adverse Event|0|||
106144876|NCT00959946|366190758|FG005|Overall Study|Adverse Event|1|||
106144877|NCT00959946|366190759|FG006|Overall Study|Adverse Event|0|||
106144878|NCT00959946|366190760|FG007|Overall Study|Adverse Event|0|||
106144879|NCT00959946|366190753|FG000|Overall Study|Death|0|||
106144880|NCT00959946|366190754|FG001|Overall Study|Death|0|||
106144881|NCT00959946|366190755|FG002|Overall Study|Death|0|||
105762521|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762522|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762523|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762524|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762525|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
105762526|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
105762527|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762528|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762529|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762530|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762531|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762532|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
105762533|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
105762534|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762535|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762536|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762537|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762538|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762539|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
105762540|NCT02120352|364783150|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
105762541|NCT02120352|364783151|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
105762542|NCT02120352|364783152|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
105762543|NCT02120352|364783153|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
105762544|NCT02120352|364783154|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
105762545|NCT02120352|364783155|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
105762546|NCT02120352|364783156|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
105762547|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
105762548|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
105762549|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
105762550|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
105762551|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
105762552|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
105762553|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
105762554|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762555|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
105762556|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762557|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
105762558|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762559|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762560|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
105762561|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762562|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
105762563|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
105762564|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762565|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762566|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762567|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
105762568|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762569|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762570|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
105762571|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
105762572|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762573|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762574|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
105762575|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762576|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762577|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762578|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
106144882|NCT00959946|366190756|FG003|Overall Study|Death|0|||
105809763|NCT00510510|364959537|FG002|Overall Study|Subjects no longer requires study drug|2|||
105809764|NCT00510510|364959535|FG000|Overall Study|Withdrawal by Subject|1|||
105809765|NCT00510510|364959536|FG001|Overall Study|Withdrawal by Subject|2|||
105809766|NCT00510510|364959537|FG002|Overall Study|Withdrawal by Subject|3|||
105809767|NCT00510510|364959535|FG000|Overall Study|Lost to Follow-up|0|||
105809768|NCT00510510|364959536|FG001|Overall Study|Lost to Follow-up|0|||
105809769|NCT00510510|364959537|FG002|Overall Study|Lost to Follow-up|1|||
105809770|NCT00510510|364959535|FG000|Overall Study|Protocol Violation|0|||
105809771|NCT00510510|364959536|FG001|Overall Study|Protocol Violation|3|||
105809772|NCT00510510|364959537|FG002|Overall Study|Protocol Violation|4|||
105809773|NCT01361126|364959538|FG000|Overall Study|Sponsor decision|0|||
105809774|NCT01361126|364959539|FG001|Overall Study|Sponsor decision|2|||
105809775|NCT02928848|364959540|FG000|Arm 2|Withdrawal by Subject|1|||
105809776|NCT02928848|364959541|FG001|Arm 2|Withdrawal by Subject|0|||
105809777|NCT00264810|364959542|FG000|Baseline|Withdrawal by Subject|10|||
105809778|NCT00264810|364959543|FG001|Baseline|Withdrawal by Subject|10|||
105809779|NCT00264810|364959542|FG000|Baseline|Physician Decision|7|||
105809780|NCT00264810|364959543|FG001|Baseline|Physician Decision|8|||
105809781|NCT00264810|364959542|FG000|Baseline|Subject Compliance Failure|3|||
105809782|NCT00264810|364959543|FG001|Baseline|Subject Compliance Failure|3|||
105809783|NCT00264810|364959542|FG000|Baseline|Insufficient Seizure Frequency|2|||
105809784|NCT00264810|364959543|FG001|Baseline|Insufficient Seizure Frequency|2|||
105809785|NCT00264810|364959542|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
105809786|NCT00264810|364959543|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
105809787|NCT00264810|364959542|FG000|Baseline|Other|0|||
105809788|NCT00264810|364959543|FG001|Baseline|Other|1|||
105809789|NCT00264810|364959542|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
105809790|NCT00264810|364959543|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
105809791|NCT00264810|364959542|FG000|Stimulation Optimization Period|Death|0|||
105809792|NCT00264810|364959543|FG001|Stimulation Optimization Period|Death|1|||
105809793|NCT00264810|364959542|FG000|Blinded Evaluation Period|Explant due to infection|1|||
105809794|NCT00264810|364959543|FG001|Blinded Evaluation Period|Explant due to infection|1|||
105809795|NCT00264810|364959542|FG000|Open Label Evaluation Period|Explant due to infection|1|||
105809796|NCT00264810|364959543|FG001|Open Label Evaluation Period|Explant due to infection|1|||
105809797|NCT00264810|364959542|FG000|Open Label Evaluation Period|Death|3|||
105809798|NCT00264810|364959543|FG001|Open Label Evaluation Period|Death|2|||
105809799|NCT00264810|364959542|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
105809800|NCT00264810|364959543|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
105809801|NCT02994056|364959545|FG000|Overall Study|Death|8|||
105809802|NCT02994056|364959545|FG000|Overall Study|Withdrew Consent|1|||
105809803|NCT00182091|364959546|FG000|Overall Study|Withdrawal by Subject|1|||
105809804|NCT00182091|364959547|FG001|Overall Study|Withdrawal by Subject|0|||
105809805|NCT00182091|364959548|FG002|Overall Study|Withdrawal by Subject|0|||
105809806|NCT00182091|364959549|FG003|Overall Study|Withdrawal by Subject|0|||
105809807|NCT01835145|364959550|FG000|Overall Study|Ineligible prior to treatment|1|||
105809808|NCT01835145|364959551|FG001|Overall Study|Ineligible prior to treatment|0|||
105809809|NCT04094870|364959552|FG000|Overall Study|Lost to Follow-up|1|||
105809810|NCT04094870|364959553|FG001|Overall Study|Lost to Follow-up|1|||
105809811|NCT02984683|364959556|FG000|Overall Study|Adverse Event|3|||
105809812|NCT02984683|364959557|FG001|Overall Study|Adverse Event|3|||
105809813|NCT02984683|364959556|FG000|Overall Study|Withdrawal by Subject|1|||
105809814|NCT02984683|364959557|FG001|Overall Study|Withdrawal by Subject|0|||
105809815|NCT02984683|364959556|FG000|Overall Study|Disease progression|7|||
105809816|NCT02984683|364959557|FG001|Overall Study|Disease progression|9|||
105809817|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809818|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809819|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809820|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
105809821|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809822|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
105809823|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809824|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809825|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
105809826|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809827|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809828|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
105809829|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
105809830|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
105809831|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
105809832|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
105809833|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
105809834|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
105809835|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
105809836|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
105809837|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
105809838|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
105809839|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
105809840|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
105809841|NCT04947579|364959560|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
105809842|NCT04947579|364959561|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809843|NCT04947579|364959562|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809844|NCT04947579|364959563|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809845|NCT04947579|364959564|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809846|NCT04947579|364959565|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
105809847|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809848|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809849|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
105809850|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809851|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809852|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
105809853|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
105809854|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
105809855|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
105809856|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
105809857|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
105809858|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
105809859|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809860|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809861|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
105809862|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809863|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809864|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
105809865|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
105809866|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
105809867|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
105809868|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
105809869|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
105809870|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
105809871|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
105809872|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
105809873|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
105809874|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
105809875|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
105809876|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
105809877|NCT04947579|364959560|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
105809878|NCT04947579|364959561|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
105809879|NCT04947579|364959562|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
105809880|NCT04947579|364959563|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
105809881|NCT04947579|364959564|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
105809882|NCT04947579|364959565|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
105809883|NCT00929708|364959566|FG000|Overall Study|Protocol Violation|2|||
105809884|NCT00929708|364959567|FG001|Overall Study|Protocol Violation|1|||
105809885|NCT00929708|364959568|FG002|Overall Study|Protocol Violation|1|||
105809886|NCT00929708|364959569|FG003|Overall Study|Protocol Violation|1|||
105809887|NCT00929708|364959570|FG004|Overall Study|Protocol Violation|1|||
105809888|NCT00929708|364959566|FG000|Overall Study|Withdrawal by Subject|2|||
105809889|NCT00929708|364959567|FG001|Overall Study|Withdrawal by Subject|0|||
105809890|NCT00929708|364959568|FG002|Overall Study|Withdrawal by Subject|0|||
105809891|NCT00929708|364959569|FG003|Overall Study|Withdrawal by Subject|2|||
105809892|NCT00929708|364959570|FG004|Overall Study|Withdrawal by Subject|1|||
105809893|NCT00929708|364959566|FG000|Overall Study|Adverse Event|0|||
105809894|NCT00929708|364959567|FG001|Overall Study|Adverse Event|0|||
105809895|NCT00929708|364959568|FG002|Overall Study|Adverse Event|0|||
105809896|NCT00929708|364959569|FG003|Overall Study|Adverse Event|0|||
105809897|NCT00929708|364959570|FG004|Overall Study|Adverse Event|3|||
105809898|NCT00929708|364959566|FG000|Overall Study|Physician Decision|0|||
105809899|NCT00929708|364959567|FG001|Overall Study|Physician Decision|2|||
105809900|NCT00929708|364959568|FG002|Overall Study|Physician Decision|2|||
105809901|NCT00929708|364959569|FG003|Overall Study|Physician Decision|2|||
105809902|NCT00929708|364959570|FG004|Overall Study|Physician Decision|1|||
105809903|NCT00929708|364959566|FG000|Overall Study|Lost to Follow-up|0|||
105809904|NCT00929708|364959567|FG001|Overall Study|Lost to Follow-up|0|||
105809905|NCT00929708|364959568|FG002|Overall Study|Lost to Follow-up|0|||
105809906|NCT00929708|364959569|FG003|Overall Study|Lost to Follow-up|1|||
105809907|NCT00929708|364959570|FG004|Overall Study|Lost to Follow-up|0|||
105809908|NCT01575054|364959571|FG000|Overall Study|Other Reasons|5|||
105809909|NCT01575054|364959572|FG001|Overall Study|Other Reasons|3|||
105809910|NCT01575054|364959571|FG000|Overall Study|Protocol Violation|2|||
105809911|NCT01575054|364959572|FG001|Overall Study|Protocol Violation|1|||
105809912|NCT01575054|364959571|FG000|Overall Study|Personal Reasons|10|||
105809913|NCT01575054|364959572|FG001|Overall Study|Personal Reasons|11|||
105809914|NCT01575054|364959571|FG000|Overall Study|Lost to Follow-up|3|||
105809915|NCT01575054|364959572|FG001|Overall Study|Lost to Follow-up|3|||
105809916|NCT01575054|364959571|FG000|Overall Study|Adverse Event|9|||
105809917|NCT01575054|364959572|FG001|Overall Study|Adverse Event|8|||
105809918|NCT03309956|364959573|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
105809919|NCT03495869|364959574|FG000|Overall Study|Lost to Follow-up|4|||
105809920|NCT03495869|364959575|FG001|Overall Study|Lost to Follow-up|17|||
105809921|NCT03495869|364959576|FG002|Overall Study|Lost to Follow-up|8|||
105809922|NCT03495869|364959577|FG003|Overall Study|Lost to Follow-up|14|||
105809923|NCT03495869|364959574|FG000|Overall Study|Withdrawal by Subject|0|||
105809924|NCT03495869|364959575|FG001|Overall Study|Withdrawal by Subject|3|||
105809925|NCT03495869|364959576|FG002|Overall Study|Withdrawal by Subject|0|||
105809926|NCT03495869|364959577|FG003|Overall Study|Withdrawal by Subject|3|||
105809927|NCT03495869|364959574|FG000|Overall Study|Dropped from study|0|||
105809928|NCT03495869|364959575|FG001|Overall Study|Dropped from study|7|||
105809929|NCT03495869|364959576|FG002|Overall Study|Dropped from study|2|||
105809930|NCT03495869|364959577|FG003|Overall Study|Dropped from study|4|||
105809931|NCT02768298|364959578|FG000|Overall Study|Adverse Event|1|||
105809932|NCT02768298|364959579|FG001|Overall Study|Adverse Event|4|||
105809933|NCT02768298|364959578|FG000|Overall Study|Death|2|||
105809934|NCT02768298|364959579|FG001|Overall Study|Death|1|||
105809935|NCT02768298|364959578|FG000|Overall Study|Non-compliance with study treatment|0|||
105809936|NCT02768298|364959579|FG001|Overall Study|Non-compliance with study treatment|1|||
105809937|NCT02768298|364959578|FG000|Overall Study|Subject/guardian decision|1|||
105809938|NCT02768298|364959579|FG001|Overall Study|Subject/guardian decision|0|||
105809939|NCT02768298|364959578|FG000|Overall Study|Withdrawal of informed consent|0|||
105809940|NCT02768298|364959579|FG001|Overall Study|Withdrawal of informed consent|1|||
105809941|NCT02346201|364959580|FG000|Overall Study|Adverse Event|3|||
105809942|NCT02346201|364959581|FG001|Overall Study|Adverse Event|2|||
105809943|NCT02346201|364959580|FG000|Overall Study|Lost to Follow-up|1|||
105809944|NCT02346201|364959581|FG001|Overall Study|Lost to Follow-up|0|||
105809945|NCT02346201|364959580|FG000|Overall Study|Withdrawal by Subject|6|||
105809946|NCT02346201|364959581|FG001|Overall Study|Withdrawal by Subject|3|||
105809947|NCT02346201|364959580|FG000|Overall Study|Unavailable for future follow-up|0|||
105809948|NCT02346201|364959581|FG001|Overall Study|Unavailable for future follow-up|1|||
105809949|NCT02346201|364959580|FG000|Overall Study|Physician Decision|0|||
105809950|NCT02346201|364959581|FG001|Overall Study|Physician Decision|1|||
105809951|NCT02346201|364959580|FG000|Overall Study|Missed final visit|0|||
105809952|NCT02346201|364959581|FG001|Overall Study|Missed final visit|2|||
105809953|NCT03708211|364959583|FG000|Overall Study|Progressive Disease|10|||
105809954|NCT03708211|364959584|FG001|Overall Study|Progressive Disease|7|||
105809955|NCT03708211|364959583|FG000|Overall Study|Withdrawal by Subject|0|||
105809956|NCT03708211|364959584|FG001|Overall Study|Withdrawal by Subject|1|||
105809957|NCT03708211|364959583|FG000|Overall Study|Other|2|||
105809958|NCT03708211|364959584|FG001|Overall Study|Other|0|||
105809959|NCT01508936|364959589|FG000|Overall Study|Adverse Event|11|||
105809960|NCT01508936|364959590|FG001|Overall Study|Adverse Event|32|||
105809961|NCT01508936|364959589|FG000|Overall Study|Lack of Efficacy|0|||
105809962|NCT01508936|364959590|FG001|Overall Study|Lack of Efficacy|1|||
105809963|NCT01508936|364959589|FG000|Overall Study|Withdrawal by Subject|4|||
105809964|NCT01508936|364959590|FG001|Overall Study|Withdrawal by Subject|18|||
106144883|NCT00959946|366190757|FG004|Overall Study|Death|0|||
106144884|NCT00959946|366190758|FG005|Overall Study|Death|1|||
105809965|NCT01508936|364959589|FG000|Overall Study|Protocol Violation|2|||
105809966|NCT01508936|364959590|FG001|Overall Study|Protocol Violation|3|||
105809967|NCT01508936|364959589|FG000|Overall Study|Lost to Follow-up|2|||
106144885|NCT00959946|366190759|FG006|Overall Study|Death|0|||
105809968|NCT01508936|364959590|FG001|Overall Study|Lost to Follow-up|9|||
105809969|NCT01508936|364959589|FG000|Overall Study|Other|0|||
105809970|NCT01508936|364959590|FG001|Overall Study|Other|5|||
106144886|NCT00959946|366190760|FG007|Overall Study|Death|0|||
106144887|NCT00959946|366190753|FG000|Overall Study|Disease Progression|2|||
105809971|NCT01508936|364959589|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
105809972|NCT01508936|364959590|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
105809973|NCT02518685|364959593|FG000|Overall Study|Adverse Event|29|||
105809974|NCT02518685|364959594|FG001|Overall Study|Adverse Event|1|||
105809975|NCT02518685|364959593|FG000|Overall Study|Withdrawal by Subject|10|||
106144888|NCT00959946|366190754|FG001|Overall Study|Disease Progression|4|||
105952775|NCT02891226|365488273|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952776|NCT02891226|365488274|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952777|NCT02891226|365488275|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952778|NCT02891226|365488276|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952779|NCT02891226|365488277|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952780|NCT02891226|365488278|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952781|NCT02891226|365488279|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952782|NCT02891226|365488280|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
105952783|NCT02891226|365488281|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952784|NCT02891226|365488282|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952785|NCT02891226|365488283|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952786|NCT02891226|365488284|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952787|NCT02891226|365488285|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
105952788|NCT02891226|365488270|FG000|Follow-up Period|Withdrawal by Subject|0|||
105952789|NCT02891226|365488271|FG001|Follow-up Period|Withdrawal by Subject|0|||
105952790|NCT02891226|365488272|FG002|Follow-up Period|Withdrawal by Subject|0|||
105952791|NCT02891226|365488273|FG003|Follow-up Period|Withdrawal by Subject|0|||
105952792|NCT02891226|365488274|FG004|Follow-up Period|Withdrawal by Subject|0|||
105952793|NCT02891226|365488275|FG005|Follow-up Period|Withdrawal by Subject|0|||
105952794|NCT02891226|365488276|FG006|Follow-up Period|Withdrawal by Subject|0|||
105952795|NCT02891226|365488277|FG007|Follow-up Period|Withdrawal by Subject|0|||
105952796|NCT02891226|365488278|FG008|Follow-up Period|Withdrawal by Subject|0|||
105952797|NCT02891226|365488279|FG009|Follow-up Period|Withdrawal by Subject|0|||
105952798|NCT02891226|365488280|FG010|Follow-up Period|Withdrawal by Subject|0|||
105952799|NCT02891226|365488281|FG011|Follow-up Period|Withdrawal by Subject|1|||
105952800|NCT02891226|365488282|FG012|Follow-up Period|Withdrawal by Subject|0|||
105952801|NCT02891226|365488283|FG013|Follow-up Period|Withdrawal by Subject|0|||
105952802|NCT02891226|365488284|FG014|Follow-up Period|Withdrawal by Subject|1|||
105952803|NCT02891226|365488285|FG015|Follow-up Period|Withdrawal by Subject|1|||
105952804|NCT01445847|365488286|FG000|Overall Study|Protocol Violation|13|||
105952805|NCT01445847|365488287|FG001|Overall Study|Protocol Violation|14|||
105952806|NCT01445847|365488286|FG000|Overall Study|Missed Data|1|||
105952807|NCT01445847|365488287|FG001|Overall Study|Missed Data|0|||
105952808|NCT01985022|365488288|FG000|Overall Study|Lost to Follow-up|0|||
105952809|NCT01985022|365488289|FG001|Overall Study|Lost to Follow-up|1|||
105952810|NCT01985022|365488288|FG000|Overall Study|Protocol Violation|0|||
105952811|NCT01985022|365488289|FG001|Overall Study|Protocol Violation|1|||
105952812|NCT01985022|365488288|FG000|Overall Study|Withdrawal by Subject|4|||
105952813|NCT01985022|365488289|FG001|Overall Study|Withdrawal by Subject|1|||
105952814|NCT02015039|365488290|FG000|Overall Study|Not eligible|0|||
105952815|NCT02015039|365488291|FG001|Overall Study|Not eligible|1|||
105952816|NCT04570384|365488292|FG000|Overall Study|Adverse Event|2|||
105952817|NCT04570384|365488293|FG001|Overall Study|Adverse Event|1|||
105952818|NCT04570384|365488292|FG000|Overall Study|Death|2|||
105952819|NCT04570384|365488293|FG001|Overall Study|Death|5|||
105952820|NCT04570384|365488292|FG000|Overall Study|Lost to Follow-up|1|||
105952821|NCT04570384|365488293|FG001|Overall Study|Lost to Follow-up|0|||
105952822|NCT04570384|365488292|FG000|Overall Study|Other|1|||
105952823|NCT04570384|365488293|FG001|Overall Study|Other|0|||
105952824|NCT04570384|365488292|FG000|Overall Study|Protocol Violation|0|||
105952825|NCT04570384|365488293|FG001|Overall Study|Protocol Violation|1|||
105952826|NCT04570384|365488292|FG000|Overall Study|Sponsor Decision|1|||
105952827|NCT04570384|365488293|FG001|Overall Study|Sponsor Decision|0|||
105952828|NCT04570384|365488292|FG000|Overall Study|Withdrawal by Subject|4|||
105952829|NCT04570384|365488293|FG001|Overall Study|Withdrawal by Subject|2|||
105952830|NCT01404234|365488296|FG000|Overall Study|Withdrawal by Subject|2|||
105952831|NCT00403130|365488297|FG000|2 Years From Start of Treatment|Not Eligible|3|||
106017144|NCT03214666|365725997|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
106017145|NCT03214666|365725998|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
106017146|NCT03214666|365725999|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
105952832|NCT00403130|365488297|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
105952833|NCT00403130|365488297|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
105952834|NCT00403130|365488297|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
105952835|NCT00806260|365488298|FG000|Period 1 (1 Day)|Adverse Event|0|||
105952836|NCT00806260|365488299|FG001|Period 1 (1 Day)|Adverse Event|0|||
105952837|NCT00806260|365488300|FG002|Period 1 (1 Day)|Adverse Event|0|||
105952838|NCT00806260|365488301|FG003|Period 1 (1 Day)|Adverse Event|0|||
105952839|NCT00806260|365488302|FG004|Period 1 (1 Day)|Adverse Event|3|||
105952840|NCT00806260|365488303|FG005|Period 1 (1 Day)|Adverse Event|0|||
105952841|NCT00806260|365488298|FG000|Period 2|Adverse Event|0|||
105952842|NCT00806260|365488299|FG001|Period 2|Adverse Event|0|||
106017147|NCT03214666|365726000|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
106017148|NCT03214666|365726001|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
105809976|NCT02518685|364959594|FG001|Overall Study|Withdrawal by Subject|3|||
105809977|NCT02518685|364959593|FG000|Overall Study|relocation, study fatigue|7|||
105809978|NCT02518685|364959594|FG001|Overall Study|relocation, study fatigue|2|||
105809979|NCT02518685|364959593|FG000|Overall Study|Pregnancy|1|||
105809980|NCT02518685|364959594|FG001|Overall Study|Pregnancy|0|||
105809981|NCT02518685|364959593|FG000|Overall Study|Physician Decision|1|||
105809982|NCT02518685|364959594|FG001|Overall Study|Physician Decision|0|||
105809983|NCT02518685|364959593|FG000|Overall Study|Lost to Follow-up|1|||
105809984|NCT02518685|364959594|FG001|Overall Study|Lost to Follow-up|4|||
105809985|NCT02683187|364959595|FG000|Overall Study|Failed IV access|3|||
105809986|NCT02683187|364959595|FG000|Overall Study|Withdrawal by Subject|5|||
105809987|NCT03507439|364961107|FG000|Overall Study|Other|2|||
105809988|NCT03507439|364961108|FG001|Overall Study|Other|1|||
105809989|NCT03507439|364961107|FG000|Overall Study|Withdrawal by Subject|1|||
105809990|NCT03507439|364961108|FG001|Overall Study|Withdrawal by Subject|0|||
105809991|NCT03507439|364961107|FG000|Overall Study|Death|1|||
105809992|NCT03507439|364961108|FG001|Overall Study|Death|1|||
105809993|NCT02742090|364961109|FG000|Overall Study|Adverse Event|10|||
105809994|NCT02742090|364961109|FG000|Overall Study|Death|3|||
105809995|NCT02742090|364961109|FG000|Overall Study|Disease Progression|25|||
105809996|NCT02742090|364961109|FG000|Overall Study|Investigator's Decision|1|||
105809997|NCT02742090|364961109|FG000|Overall Study|Lost to Follow-up|1|||
105809998|NCT02742090|364961109|FG000|Overall Study|Non-compliance with Study|1|||
105809999|NCT02742090|364961109|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
105810000|NCT02742090|364961109|FG000|Overall Study|Withdrawal by Subject|4|||
105810001|NCT02742090|364961109|FG000|Overall Study|Reason Not Specified|1|||
105810002|NCT01506323|364961110|FG000|Overall Study|Lost to Follow-up|5|||
105810003|NCT01506323|364961111|FG001|Overall Study|Lost to Follow-up|4|||
105810004|NCT01506323|364961110|FG000|Overall Study|Withdrawal by Subject|4|||
105810005|NCT01506323|364961111|FG001|Overall Study|Withdrawal by Subject|4|||
105810006|NCT01506323|364961110|FG000|Overall Study|Lack of Efficacy|1|||
105810007|NCT01506323|364961111|FG001|Overall Study|Lack of Efficacy|3|||
105810008|NCT01506323|364961110|FG000|Overall Study|Moved out of area|5|||
105810009|NCT01506323|364961111|FG001|Overall Study|Moved out of area|2|||
105810010|NCT01506323|364961110|FG000|Overall Study|Schedule or Transportation conflict|8|||
105810011|NCT01506323|364961111|FG001|Overall Study|Schedule or Transportation conflict|0|||
105810012|NCT01506323|364961110|FG000|Overall Study|Started another treatment|1|||
105810013|NCT01506323|364961111|FG001|Overall Study|Started another treatment|0|||
105810014|NCT00586521|364961112|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
105810015|NCT03083483|364961120|FG000|Overall Study|Adverse Event|1|||
105810016|NCT03083483|364961121|FG001|Overall Study|Adverse Event|1|||
105810017|NCT03083483|364961122|FG002|Overall Study|Adverse Event|1|||
105810018|NCT03083483|364961120|FG000|Overall Study|Lost to Follow-up|2|||
105810019|NCT03083483|364961121|FG001|Overall Study|Lost to Follow-up|1|||
105810020|NCT03083483|364961122|FG002|Overall Study|Lost to Follow-up|1|||
105810021|NCT03083483|364961120|FG000|Overall Study|technological issues|1|||
105810022|NCT03083483|364961121|FG001|Overall Study|technological issues|0|||
105810023|NCT03083483|364961122|FG002|Overall Study|technological issues|1|||
105810024|NCT00613574|364961123|FG000|Overall Study|Adverse Event|3|||
105810025|NCT00613574|364961123|FG000|Overall Study|Lost to Follow-up|2|||
105810026|NCT00613574|364961123|FG000|Overall Study|Other|1|||
105810027|NCT01769378|364961124|FG000|Overall Study|Adverse Event|10|||
105810028|NCT01769378|364961125|FG001|Overall Study|Adverse Event|0|||
105810029|NCT01769378|364961124|FG000|Overall Study|Entry criteria not met|1|||
105810030|NCT01769378|364961125|FG001|Overall Study|Entry criteria not met|0|||
105810031|NCT01769378|364961124|FG000|Overall Study|Protocol Violation|1|||
105810032|NCT01769378|364961125|FG001|Overall Study|Protocol Violation|1|||
105810033|NCT01769378|364961124|FG000|Overall Study|Withdrawal by Subject|10|||
105810034|NCT01769378|364961125|FG001|Overall Study|Withdrawal by Subject|3|||
105810035|NCT01769378|364961124|FG000|Overall Study|Sponsor Decision|1|||
105810036|NCT01769378|364961125|FG001|Overall Study|Sponsor Decision|0|||
105810037|NCT01769378|364961124|FG000|Overall Study|Lost to Follow-up|2|||
105810038|NCT01769378|364961125|FG001|Overall Study|Lost to Follow-up|0|||
105810039|NCT03519256|364961126|FG000|Overall Study|Disease recurrence|4|||
105810040|NCT03519256|364961127|FG001|Overall Study|Disease recurrence|4|||
105810041|NCT03519256|364961128|FG002|Overall Study|Disease recurrence|5|||
105810042|NCT03519256|364961129|FG003|Overall Study|Disease recurrence|2|||
105810043|NCT03519256|364961126|FG000|Overall Study|Study drug toxicity|0|||
105810044|NCT03519256|364961127|FG001|Overall Study|Study drug toxicity|2|||
105810045|NCT03519256|364961128|FG002|Overall Study|Study drug toxicity|5|||
105810046|NCT03519256|364961129|FG003|Overall Study|Study drug toxicity|2|||
105810047|NCT03519256|364961126|FG000|Overall Study|Adverse event unrelated to study drug|0|||
105810048|NCT03519256|364961127|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105810049|NCT03519256|364961128|FG002|Overall Study|Adverse event unrelated to study drug|1|||
105810050|NCT03519256|364961129|FG003|Overall Study|Adverse event unrelated to study drug|0|||
105810051|NCT03519256|364961126|FG000|Overall Study|Participant request to discontinue study treatment|0|||
105810052|NCT03519256|364961127|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105952843|NCT00806260|365488300|FG002|Period 2|Adverse Event|0|||
105810053|NCT03519256|364961128|FG002|Overall Study|Participant request to discontinue study treatment|0|||
105810054|NCT03519256|364961129|FG003|Overall Study|Participant request to discontinue study treatment|2|||
105810055|NCT03519256|364961126|FG000|Overall Study|Other reasons|0|||
105810056|NCT03519256|364961127|FG001|Overall Study|Other reasons|0|||
105810057|NCT03519256|364961128|FG002|Overall Study|Other reasons|2|||
105810058|NCT03519256|364961129|FG003|Overall Study|Other reasons|0|||
105810059|NCT03519256|364961126|FG000|Overall Study|Disease progression|6|||
105810060|NCT03519256|364961127|FG001|Overall Study|Disease progression|3|||
105810061|NCT03519256|364961128|FG002|Overall Study|Disease progression|2|||
105810062|NCT03519256|364961129|FG003|Overall Study|Disease progression|1|||
105810063|NCT03519256|364961126|FG000|Overall Study|Lost to Follow-up|0|||
105810064|NCT03519256|364961127|FG001|Overall Study|Lost to Follow-up|1|||
105810065|NCT03519256|364961128|FG002|Overall Study|Lost to Follow-up|0|||
105810066|NCT03519256|364961129|FG003|Overall Study|Lost to Follow-up|0|||
105810067|NCT04828161|364961130|FG000|Overall Study|Withdrawal by Subject|0|||
105810068|NCT04828161|364961131|FG001|Overall Study|Withdrawal by Subject|3|||
105810069|NCT04828161|364961132|FG002|Overall Study|Withdrawal by Subject|3|||
105810070|NCT04828161|364961133|FG003|Overall Study|Withdrawal by Subject|4|||
105810071|NCT04828161|364961130|FG000|Overall Study|Lost to Follow-up|1|||
105810072|NCT04828161|364961131|FG001|Overall Study|Lost to Follow-up|4|||
105810073|NCT04828161|364961132|FG002|Overall Study|Lost to Follow-up|2|||
105810074|NCT04828161|364961133|FG003|Overall Study|Lost to Follow-up|2|||
105810075|NCT04828161|364961130|FG000|Overall Study|Other|2|||
105810076|NCT04828161|364961131|FG001|Overall Study|Other|0|||
105810077|NCT04828161|364961132|FG002|Overall Study|Other|2|||
105810078|NCT04828161|364961133|FG003|Overall Study|Other|0|||
105810079|NCT04828161|364961130|FG000|Overall Study|Death|0|||
105810080|NCT04828161|364961131|FG001|Overall Study|Death|0|||
105810081|NCT04828161|364961132|FG002|Overall Study|Death|0|||
105810082|NCT04828161|364961133|FG003|Overall Study|Death|2|||
105810083|NCT02336737|364961136|FG000|Overall Study|Withdrawal by Subject|5|||
105810084|NCT02336737|364961136|FG000|Overall Study|Physician Decision|8|||
105810085|NCT01755858|364961137|FG000|Overall Study|Adverse Event|1|||
105810086|NCT01755858|364961138|FG001|Overall Study|Adverse Event|1|||
105810087|NCT01631864|364961139|FG000|Overall Study|Withdrawal by Subject|0|||
105810088|NCT01631864|364961140|FG001|Overall Study|Withdrawal by Subject|1|||
105810089|NCT01631864|364961139|FG000|Overall Study|Adverse Event|2|||
105810090|NCT01631864|364961140|FG001|Overall Study|Adverse Event|3|||
105810091|NCT01047345|364961142|FG000|Base Study|Adverse Event|3|||
105810092|NCT01047345|364961143|FG001|Base Study|Adverse Event|0|||
105810093|NCT01047345|364961144|FG002|Base Study|Adverse Event|0|||
105810094|NCT01047345|364961142|FG000|Base Study|Lost to Follow-up|4|||
105810095|NCT01047345|364961143|FG001|Base Study|Lost to Follow-up|1|||
105810096|NCT01047345|364961144|FG002|Base Study|Lost to Follow-up|0|||
105810097|NCT01047345|364961142|FG000|Base Study|Protocol Violation|3|||
105810098|NCT01047345|364961143|FG001|Base Study|Protocol Violation|1|||
105810099|NCT01047345|364961144|FG002|Base Study|Protocol Violation|0|||
105810100|NCT01047345|364961142|FG000|Base Study|Withdrawal by Subject|12|||
105810101|NCT01047345|364961143|FG001|Base Study|Withdrawal by Subject|4|||
105810102|NCT01047345|364961144|FG002|Base Study|Withdrawal by Subject|0|||
105810103|NCT01047345|364961142|FG000|Extension|Withdrawal by Subject|0|||
105810104|NCT01047345|364961143|FG001|Extension|Withdrawal by Subject|0|||
105810105|NCT01047345|364961144|FG002|Extension|Withdrawal by Subject|1|||
105810106|NCT01047345|364961142|FG000|Extension|Lost to Follow-up|0|||
105810107|NCT01047345|364961143|FG001|Extension|Lost to Follow-up|0|||
105810108|NCT01047345|364961144|FG002|Extension|Lost to Follow-up|5|||
105810109|NCT01816477|364961145|FG000|Overall Study|Withdrawal by Subject|13|||
105810110|NCT01816477|364961146|FG001|Overall Study|Withdrawal by Subject|1|||
105810111|NCT01816477|364961145|FG000|Overall Study|Unable to tolerate catheter placement|3|||
105810112|NCT01816477|364961146|FG001|Overall Study|Unable to tolerate catheter placement|0|||
105810113|NCT02162758|364961147|FG000|Overall Study|Study termination|0|||
105810114|NCT02162758|364961148|FG001|Overall Study|Study termination|1|||
105810115|NCT00108732|364961149|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
105810116|NCT00108732|364961149|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
105810117|NCT00108732|364961149|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
105810118|NCT00108732|364961149|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
105810119|NCT00108732|364961149|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
105810120|NCT00108732|364961149|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
105810121|NCT00108732|364961149|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
105810122|NCT02187042|364961150|FG000|Overall Study|Death|1|||
105810123|NCT02187042|364961151|FG001|Overall Study|Death|1|||
105810124|NCT02187042|364961150|FG000|Overall Study|Toxicity|6|||
105810125|NCT02187042|364961151|FG001|Overall Study|Toxicity|5|||
105810126|NCT02187042|364961150|FG000|Overall Study|Participant choice|1|||
105810127|NCT02187042|364961151|FG001|Overall Study|Participant choice|0|||
105810128|NCT02187042|364961150|FG000|Overall Study|Doctor choice|1|||
105810129|NCT02187042|364961151|FG001|Overall Study|Doctor choice|0|||
105810130|NCT02187042|364961150|FG000|Overall Study|Progressive disease|4|||
105810131|NCT02187042|364961151|FG001|Overall Study|Progressive disease|8|||
105952844|NCT00806260|365488301|FG003|Period 2|Adverse Event|1|||
105952845|NCT00806260|365488302|FG004|Period 2|Adverse Event|0|||
105952846|NCT00806260|365488303|FG005|Period 2|Adverse Event|0|||
105810132|NCT01659567|364961154|FG000|Overall Study|Lack of Efficacy|22|||
105810133|NCT01659567|364961154|FG000|Overall Study|Switched to Pegferon|6|||
105810134|NCT01659567|364961154|FG000|Overall Study|Adverse Event|12|||
105810135|NCT01659567|364961154|FG000|Overall Study|Good result at early stage of treatment|5|||
105810136|NCT01659567|364961154|FG000|Overall Study|Withdrawal by Subject|64|||
105810137|NCT01659567|364961154|FG000|Overall Study|Progression of the main disease|1|||
105952847|NCT00806260|365488298|FG000|Period 2|Protocol Violation|1|||
105952848|NCT00806260|365488299|FG001|Period 2|Protocol Violation|0|||
105952849|NCT00806260|365488300|FG002|Period 2|Protocol Violation|1|||
105952850|NCT00806260|365488301|FG003|Period 2|Protocol Violation|0|||
105952851|NCT00806260|365488302|FG004|Period 2|Protocol Violation|0|||
105952852|NCT00806260|365488303|FG005|Period 2|Protocol Violation|0|||
105952853|NCT00806260|365488298|FG000|Period 2|Need to take concomitant medication|1|||
105952854|NCT00806260|365488299|FG001|Period 2|Need to take concomitant medication|0|||
105952855|NCT00806260|365488300|FG002|Period 2|Need to take concomitant medication|0|||
105952856|NCT00806260|365488301|FG003|Period 2|Need to take concomitant medication|0|||
105810138|NCT01659567|364961154|FG000|Overall Study|Other|13|||
105810139|NCT03213210|364961155|FG000|Overall Study|Lost to Follow-up|2|||
105810140|NCT03213210|364961155|FG000|Overall Study|Study termination|3|||
105810141|NCT01915732|364961156|FG000|Overall Study|Withdrawal by Subject|18|||
105810142|NCT01915732|364961157|FG001|Overall Study|Withdrawal by Subject|18|||
105810143|NCT01915732|364961156|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
105810144|NCT01915732|364961157|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
105810145|NCT01915732|364961156|FG000|Overall Study|Adverse Event|12|||
105810146|NCT01915732|364961157|FG001|Overall Study|Adverse Event|4|||
105810147|NCT01915732|364961156|FG000|Overall Study|Protocol Violation|5|||
105810148|NCT01915732|364961157|FG001|Overall Study|Protocol Violation|5|||
105810149|NCT01915732|364961156|FG000|Overall Study|Lack of Efficacy|6|||
105810150|NCT01915732|364961157|FG001|Overall Study|Lack of Efficacy|11|||
105810151|NCT01915732|364961156|FG000|Overall Study|Lost to Follow-up|22|||
105810152|NCT01915732|364961157|FG001|Overall Study|Lost to Follow-up|26|||
105810153|NCT01915732|364961156|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
105810154|NCT01915732|364961157|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
105810155|NCT01915732|364961156|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
105810156|NCT01915732|364961157|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
105810157|NCT01915732|364961156|FG000|Overall Study|Drug Release Error|1|||
105810158|NCT01915732|364961157|FG001|Overall Study|Drug Release Error|0|||
105810159|NCT01915732|364961156|FG000|Overall Study|Recovered|1|||
105810160|NCT01915732|364961157|FG001|Overall Study|Recovered|0|||
105810161|NCT01915732|364961156|FG000|Overall Study|Pregnancy|1|||
105810162|NCT01915732|364961157|FG001|Overall Study|Pregnancy|0|||
105810163|NCT01915732|364961156|FG000|Overall Study|Poor Perceived Efficacy|1|||
105810164|NCT01915732|364961157|FG001|Overall Study|Poor Perceived Efficacy|0|||
105810165|NCT01915732|364961156|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
105810166|NCT01915732|364961157|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
105810167|NCT01915732|364961156|FG000|Overall Study|Got Well|0|||
105810168|NCT01915732|364961157|FG001|Overall Study|Got Well|1|||
105810169|NCT01915732|364961156|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
105810170|NCT01915732|364961157|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
105810171|NCT01915732|364961156|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
105810172|NCT01915732|364961157|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
105810173|NCT01915732|364961156|FG000|Overall Study|Job Transfer|0|||
105810174|NCT01915732|364961157|FG001|Overall Study|Job Transfer|1|||
105952857|NCT00806260|365488302|FG004|Period 2|Need to take concomitant medication|0|||
105952858|NCT00806260|365488303|FG005|Period 2|Need to take concomitant medication|0|||
105952859|NCT00806260|365488298|FG000|Period 2|sponsor request|0|||
105952860|NCT00806260|365488299|FG001|Period 2|sponsor request|0|||
105952861|NCT00806260|365488300|FG002|Period 2|sponsor request|1|||
105952862|NCT00806260|365488301|FG003|Period 2|sponsor request|1|||
105952863|NCT00806260|365488302|FG004|Period 2|sponsor request|0|||
105952864|NCT00806260|365488303|FG005|Period 2|sponsor request|0|||
105810175|NCT01915732|364961156|FG000|Overall Study|Improper Facial Procedure|0|||
105810176|NCT01915732|364961157|FG001|Overall Study|Improper Facial Procedure|1|||
105952865|NCT00806260|365488298|FG000|Period 3|Protocol Violation|0|||
105952866|NCT00806260|365488299|FG001|Period 3|Protocol Violation|1|||
105952867|NCT00806260|365488300|FG002|Period 3|Protocol Violation|1|||
105810177|NCT01915732|364961156|FG000|Overall Study|Poor Conscious Effect|0|||
105810178|NCT01915732|364961157|FG001|Overall Study|Poor Conscious Effect|1|||
105952868|NCT00806260|365488301|FG003|Period 3|Protocol Violation|0|||
105952869|NCT00806260|365488302|FG004|Period 3|Protocol Violation|0|||
105952870|NCT00806260|365488303|FG005|Period 3|Protocol Violation|0|||
105952871|NCT00806260|365488298|FG000|Period 3|Pregnancy|1|||
105952872|NCT00806260|365488299|FG001|Period 3|Pregnancy|0|||
105952873|NCT00806260|365488300|FG002|Period 3|Pregnancy|0|||
105952874|NCT00806260|365488301|FG003|Period 3|Pregnancy|0|||
105952875|NCT00806260|365488302|FG004|Period 3|Pregnancy|0|||
105952876|NCT00806260|365488303|FG005|Period 3|Pregnancy|0|||
105952877|NCT01088906|365488306|FG000|Overall Study|Inclusion error|1|||
105952878|NCT01088906|365488306|FG000|Overall Study|Did not receive study treatment|3|||
105952879|NCT01088906|365488306|FG000|Overall Study|Missing data|1|||
105952880|NCT03965403|365488312|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
105952881|NCT01772550|365490241|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
105952882|NCT01772550|365490242|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
105952883|NCT01772550|365490243|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
105952884|NCT01772550|365490241|FG000|Overall Study|Adverse Event|0|||
105952885|NCT01772550|365490242|FG001|Overall Study|Adverse Event|0|||
105952886|NCT01772550|365490243|FG002|Overall Study|Adverse Event|1|||
105952887|NCT03374358|365490246|FG000|Overall Study|Withdrawal by Subject|0|||
105810179|NCT00282256|364961158|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
105810180|NCT00282256|364961158|FG000|Extension Treatment Period|Adverse Event|2|||
105810181|NCT00698685|364961159|FG000|Overall Study|Sister withdrew as donor|1|||
105810182|NCT00698685|364961159|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
105810183|NCT00708422|364961160|FG000|Overall Study|Adverse Event|3|||
105810184|NCT00708422|364961161|FG001|Overall Study|Adverse Event|1|||
105810185|NCT00708422|364961160|FG000|Overall Study|Withdrawal by Subject|1|||
105810186|NCT00708422|364961161|FG001|Overall Study|Withdrawal by Subject|0|||
105810187|NCT00299156|364961167|FG000|Period 2 (Randomized)|Screen Failure|0|||
105810188|NCT00299156|364961168|FG001|Period 2 (Randomized)|Screen Failure|1|||
105810189|NCT00299156|364961169|FG002|Period 2 (Randomized)|Screen Failure|0|||
105810190|NCT04652453|364961176|FG000|Overall Study|Death|8|||
105810191|NCT04652453|364961177|FG001|Overall Study|Death|2|||
105810192|NCT04652453|364961178|FG002|Overall Study|Death|0|||
105810193|NCT04652453|364961176|FG000|Overall Study|Hospice|5|||
105810194|NCT04652453|364961177|FG001|Overall Study|Hospice|5|||
105810195|NCT04652453|364961178|FG002|Overall Study|Hospice|0|||
105810196|NCT04652453|364961176|FG000|Overall Study|Withdrawal by Subject|2|||
105810197|NCT04652453|364961177|FG001|Overall Study|Withdrawal by Subject|0|||
105810198|NCT04652453|364961178|FG002|Overall Study|Withdrawal by Subject|0|||
105810199|NCT00536575|364961179|FG000|Overall Study|Withdrawal by Subject|1|||
105810200|NCT00536575|364961179|FG000|Overall Study|Death|1|||
105810201|NCT01089647|364961180|FG000|Overall Study|Lost to Follow-up|2|||
105810202|NCT01089647|364961181|FG001|Overall Study|Lost to Follow-up|2|||
105810203|NCT01089647|364961180|FG000|Overall Study|Withdrawal by Subject|2|||
105810204|NCT01089647|364961181|FG001|Overall Study|Withdrawal by Subject|1|||
105810205|NCT01089647|364961180|FG000|Overall Study|Adverse Event|0|||
105810206|NCT01089647|364961181|FG001|Overall Study|Adverse Event|1|||
105810207|NCT00198029|364961185|FG000|Overall Study|Withdrawal by Subject|4|||
105810208|NCT04117607|364961187|FG000|Overall Study|Early Termination|0|||
105810209|NCT04117607|364961188|FG001|Overall Study|Early Termination|1|||
105810210|NCT04117607|364961189|FG002|Overall Study|Early Termination|0|||
105810211|NCT04117607|364961190|FG003|Overall Study|Early Termination|0|||
105810212|NCT04117607|364961191|FG004|Overall Study|Early Termination|0|||
105810213|NCT04117607|364961192|FG005|Overall Study|Early Termination|0|||
105810214|NCT04117607|364961193|FG006|Overall Study|Early Termination|1|||
105810215|NCT04117607|364961194|FG007|Overall Study|Early Termination|0|||
105952888|NCT03374358|365490247|FG001|Overall Study|Withdrawal by Subject|2|||
105810216|NCT04117607|364961195|FG008|Overall Study|Early Termination|0|||
105810217|NCT04117607|364961196|FG009|Overall Study|Early Termination|0|||
105810218|NCT04117607|364961197|FG010|Overall Study|Early Termination|0|||
105810219|NCT04117607|364961198|FG011|Overall Study|Early Termination|0|||
105810220|NCT04117607|364961199|FG012|Overall Study|Early Termination|0|||
105952889|NCT01127633|365490248|FG000|Overall Study|Adverse Event|74|||
105952890|NCT01127633|365490249|FG001|Overall Study|Adverse Event|73|||
105952891|NCT01127633|365490248|FG000|Overall Study|Death|40|||
105952892|NCT01127633|365490249|FG001|Overall Study|Death|43|||
105952893|NCT01127633|365490248|FG000|Overall Study|Lost to Follow-up|4|||
105952894|NCT01127633|365490249|FG001|Overall Study|Lost to Follow-up|0|||
105952895|NCT01127633|365490248|FG000|Overall Study|Parent/Caregiver Decision|246|||
105952896|NCT01127633|365490249|FG001|Overall Study|Parent/Caregiver Decision|228|||
105952897|NCT01127633|365490248|FG000|Overall Study|Physician Decision|60|||
105952898|NCT01127633|365490249|FG001|Overall Study|Physician Decision|45|||
105952899|NCT01127633|365490248|FG000|Overall Study|Withdrawal by Subject|57|||
105952900|NCT01127633|365490249|FG001|Overall Study|Withdrawal by Subject|72|||
105952901|NCT01127633|365490248|FG000|Overall Study|Sponsor Decision|163|||
105952902|NCT01127633|365490249|FG001|Overall Study|Sponsor Decision|195|||
105952903|NCT01127633|365490248|FG000|Overall Study|Protocol Violation|8|||
105810221|NCT04117607|364961200|FG013|Overall Study|Early Termination|0|||
105810222|NCT01411995|364961208|FG000|Overall Study|Failed IUD insertion|0|||
105810223|NCT01411995|364961209|FG001|Overall Study|Failed IUD insertion|1|||
105810224|NCT04799158|364961210|FG000|Run-In Period|Adverse Event|6|||
105952904|NCT01127633|365490249|FG001|Overall Study|Protocol Violation|16|||
105952905|NCT01127633|365490248|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
105952906|NCT01127633|365490249|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
105810225|NCT04799158|364961211|FG001|Run-In Period|Adverse Event|0|||
105810226|NCT04799158|364961212|FG002|Run-In Period|Adverse Event|0|||
105810227|NCT04799158|364961213|FG003|Run-In Period|Adverse Event|0|||
105810228|NCT04799158|364961214|FG004|Run-In Period|Adverse Event|0|||
105810229|NCT04799158|364961210|FG000|Run-In Period|Lost to Follow-up|4|||
105810230|NCT04799158|364961211|FG001|Run-In Period|Lost to Follow-up|0|||
105810231|NCT04799158|364961212|FG002|Run-In Period|Lost to Follow-up|0|||
105810232|NCT04799158|364961213|FG003|Run-In Period|Lost to Follow-up|0|||
105810233|NCT04799158|364961214|FG004|Run-In Period|Lost to Follow-up|0|||
105810234|NCT04799158|364961210|FG000|Run-In Period|Significant Protocol Deviation|1|||
105810235|NCT04799158|364961211|FG001|Run-In Period|Significant Protocol Deviation|0|||
105810236|NCT04799158|364961212|FG002|Run-In Period|Significant Protocol Deviation|0|||
105810237|NCT04799158|364961213|FG003|Run-In Period|Significant Protocol Deviation|0|||
105810238|NCT04799158|364961214|FG004|Run-In Period|Significant Protocol Deviation|0|||
105810239|NCT04799158|364961210|FG000|Run-In Period|Withdrawal by Subject|11|||
105810240|NCT04799158|364961211|FG001|Run-In Period|Withdrawal by Subject|0|||
105810241|NCT04799158|364961212|FG002|Run-In Period|Withdrawal by Subject|0|||
105810242|NCT04799158|364961213|FG003|Run-In Period|Withdrawal by Subject|0|||
105810243|NCT04799158|364961214|FG004|Run-In Period|Withdrawal by Subject|0|||
105810244|NCT04799158|364961210|FG000|Run-In Period|Miscellaneous|3|||
105810245|NCT04799158|364961211|FG001|Run-In Period|Miscellaneous|0|||
105810246|NCT04799158|364961212|FG002|Run-In Period|Miscellaneous|0|||
105810247|NCT04799158|364961213|FG003|Run-In Period|Miscellaneous|0|||
105810248|NCT04799158|364961214|FG004|Run-In Period|Miscellaneous|0|||
105810249|NCT04799158|364961210|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
105810250|NCT04799158|364961211|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
105810251|NCT04799158|364961212|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
105810252|NCT04799158|364961213|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
105810253|NCT04799158|364961214|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
105810254|NCT04799158|364961210|FG000|On-Demand Treatment Period|Adverse Event|0|||
105810255|NCT04799158|364961211|FG001|On-Demand Treatment Period|Adverse Event|1|||
105810256|NCT04799158|364961212|FG002|On-Demand Treatment Period|Adverse Event|0|||
105810257|NCT04799158|364961213|FG003|On-Demand Treatment Period|Adverse Event|0|||
105810258|NCT04799158|364961214|FG004|On-Demand Treatment Period|Adverse Event|1|||
105810259|NCT04799158|364961210|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
105952907|NCT01127633|365490248|FG000|Overall Study|Not treated|1|||
105952908|NCT01127633|365490249|FG001|Overall Study|Not treated|0|||
105952909|NCT00688467|365490250|FG000|Treatment Period 1|Adverse Event|2|||
105952910|NCT00688467|365490251|FG001|Treatment Period 1|Adverse Event|1|||
105952911|NCT00688467|365490250|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
105952912|NCT00688467|365490251|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
105952913|NCT00688467|365490250|FG000|Treatment Period 2|Protocol Violation|0|||
105952914|NCT00688467|365490251|FG001|Treatment Period 2|Protocol Violation|1|||
105952915|NCT00688467|365490250|FG000|Treatment Period 2|Adverse Event|0|||
105952916|NCT00688467|365490251|FG001|Treatment Period 2|Adverse Event|1|||
105952917|NCT01343888|365490254|FG000|Overall Study|Adverse Event|12|||
105952918|NCT01343888|365490255|FG001|Overall Study|Adverse Event|22|||
105952919|NCT01343888|365490256|FG002|Overall Study|Adverse Event|5|||
105952920|NCT01343888|365490254|FG000|Overall Study|Lack of Efficacy|9|||
105952921|NCT01343888|365490255|FG001|Overall Study|Lack of Efficacy|9|||
105952922|NCT01343888|365490256|FG002|Overall Study|Lack of Efficacy|13|||
105952923|NCT01343888|365490254|FG000|Overall Study|Lost to Follow-up|0|||
105952924|NCT01343888|365490255|FG001|Overall Study|Lost to Follow-up|2|||
105952925|NCT01343888|365490256|FG002|Overall Study|Lost to Follow-up|1|||
105952926|NCT01343888|365490254|FG000|Overall Study|Protocol Violation|0|||
105952927|NCT01343888|365490255|FG001|Overall Study|Protocol Violation|2|||
105952928|NCT01343888|365490256|FG002|Overall Study|Protocol Violation|0|||
105952929|NCT01343888|365490254|FG000|Overall Study|Withdrawal by Subject|4|||
105952930|NCT01343888|365490255|FG001|Overall Study|Withdrawal by Subject|4|||
105952931|NCT01343888|365490256|FG002|Overall Study|Withdrawal by Subject|2|||
105952932|NCT01343888|365490254|FG000|Overall Study|other than stated above|0|||
105952933|NCT01343888|365490255|FG001|Overall Study|other than stated above|0|||
105952934|NCT01343888|365490256|FG002|Overall Study|other than stated above|1|||
105952935|NCT02805790|365490258|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
105952936|NCT02805790|365490259|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
105952937|NCT04567524|365490260|FG000|Overall Study|Adverse Event|1|||
105952938|NCT04567524|365490261|FG001|Overall Study|Adverse Event|1|||
105952939|NCT04567524|365490262|FG002|Overall Study|Adverse Event|0|||
105952940|NCT04567524|365490263|FG003|Overall Study|Adverse Event|0|||
105952941|NCT04567524|365490260|FG000|Overall Study|Withdrawal by Subject|2|||
105952942|NCT04567524|365490261|FG001|Overall Study|Withdrawal by Subject|0|||
105952943|NCT04567524|365490262|FG002|Overall Study|Withdrawal by Subject|0|||
105952944|NCT04567524|365490263|FG003|Overall Study|Withdrawal by Subject|1|||
105952945|NCT04460183|365490266|FG000|Overall Study|Lost to Follow-up|3|||
105952946|NCT04460183|365490267|FG001|Overall Study|Lost to Follow-up|1|||
105810260|NCT04799158|364961211|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
105810261|NCT04799158|364961212|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
105810262|NCT04799158|364961213|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
105810263|NCT04799158|364961214|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
105810264|NCT04799158|364961210|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
105810265|NCT04799158|364961211|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
105810266|NCT04799158|364961212|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
105810267|NCT04799158|364961213|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
105810268|NCT04799158|364961214|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
105810269|NCT04799158|364961210|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
105810270|NCT04799158|364961211|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
105810271|NCT04799158|364961212|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
105810272|NCT04799158|364961213|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
105810273|NCT04799158|364961214|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
105810274|NCT04799158|364961210|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
105810275|NCT04799158|364961211|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
105810276|NCT04799158|364961212|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
105810277|NCT04799158|364961213|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
105810278|NCT04799158|364961214|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
105810279|NCT04799158|364961210|FG000|On-Demand Treatment Period|Miscellaneous|0|||
105810280|NCT04799158|364961211|FG001|On-Demand Treatment Period|Miscellaneous|0|||
105810281|NCT04799158|364961212|FG002|On-Demand Treatment Period|Miscellaneous|0|||
105810282|NCT04799158|364961213|FG003|On-Demand Treatment Period|Miscellaneous|0|||
105810283|NCT04799158|364961214|FG004|On-Demand Treatment Period|Miscellaneous|1|||
105810284|NCT03276975|364961215|FG000|Overall Study|Withdrawal by Subject|1|||
105810285|NCT03276975|364961216|FG001|Overall Study|Withdrawal by Subject|0|||
105810286|NCT02974153|364961217|FG000|Overall Study|Adverse Event|6|||
105810287|NCT02974153|364961218|FG001|Overall Study|Adverse Event|0|||
105810288|NCT02974153|364961219|FG002|Overall Study|Adverse Event|1|||
105810289|NCT02974153|364961217|FG000|Overall Study|Lack of Efficacy|6|||
105810290|NCT02974153|364961218|FG001|Overall Study|Lack of Efficacy|5|||
105810291|NCT02974153|364961219|FG002|Overall Study|Lack of Efficacy|10|||
105810292|NCT02974153|364961217|FG000|Overall Study|Lost to Follow-up|9|||
105810293|NCT02974153|364961218|FG001|Overall Study|Lost to Follow-up|10|||
105810294|NCT02974153|364961219|FG002|Overall Study|Lost to Follow-up|17|||
105810295|NCT02974153|364961217|FG000|Overall Study|Physician Decision|0|||
105810296|NCT02974153|364961218|FG001|Overall Study|Physician Decision|2|||
105810297|NCT02974153|364961219|FG002|Overall Study|Physician Decision|1|||
105810298|NCT02974153|364961217|FG000|Overall Study|Withdrawal by Subject|9|||
105810299|NCT02974153|364961218|FG001|Overall Study|Withdrawal by Subject|16|||
105810300|NCT02974153|364961219|FG002|Overall Study|Withdrawal by Subject|11|||
105810301|NCT02974153|364961217|FG000|Overall Study|Study Burden|8|||
105810302|NCT02974153|364961218|FG001|Overall Study|Study Burden|7|||
105810303|NCT02974153|364961219|FG002|Overall Study|Study Burden|3|||
105810304|NCT02974153|364961217|FG000|Overall Study|Other|14|||
105810305|NCT02974153|364961218|FG001|Overall Study|Other|8|||
105810306|NCT02974153|364961219|FG002|Overall Study|Other|7|||
105810307|NCT02568384|364961224|FG000|Overall Study|Mobile devices incompatible with App|2|||
105810308|NCT00796510|364961235|FG000|Overall Study|Death|1|||
106017149|NCT00477386|365726007|FG000|Overall Study|Adverse Event|4|||
106017150|NCT00477386|365726008|FG001|Overall Study|Adverse Event|8|||
106017151|NCT00477386|365726007|FG000|Overall Study|Disease progression, relapse|3|||
106017152|NCT00477386|365726008|FG001|Overall Study|Disease progression, relapse|4|||
106017153|NCT00477386|365726007|FG000|Overall Study|Disease progression, refractory|1|||
106017154|NCT00477386|365726008|FG001|Overall Study|Disease progression, refractory|3|||
106017155|NCT00477386|365726007|FG000|Overall Study|Other|1|||
106017156|NCT00477386|365726008|FG001|Overall Study|Other|2|||
106017157|NCT00477386|365726007|FG000|Overall Study|Physician Decision|1|||
106017158|NCT00477386|365726008|FG001|Overall Study|Physician Decision|0|||
106017159|NCT00477386|365726007|FG000|Overall Study|Withdrawal by Subject|1|||
106144889|NCT00959946|366190755|FG002|Overall Study|Disease Progression|2|||
105810309|NCT00796510|364961236|FG001|Overall Study|Death|0|||
105810310|NCT00796510|364961235|FG000|Overall Study|Study Terminated|2|||
105810311|NCT00796510|364961236|FG001|Overall Study|Study Terminated|0|||
105810312|NCT01226797|364961237|FG000|Overall Study|Adverse Event|1|||
105810313|NCT01226797|364961238|FG001|Overall Study|Adverse Event|0|||
105810314|NCT01226797|364961237|FG000|Overall Study|No longer willing to participate|1|||
105810315|NCT01226797|364961238|FG001|Overall Study|No longer willing to participate|0|||
105810316|NCT01226797|364961237|FG000|Overall Study|Protocol Violation|0|||
105810317|NCT01226797|364961238|FG001|Overall Study|Protocol Violation|1|||
105810318|NCT02799602|364961239|FG000|Overall Study|Protocol Violation|1|||
105810319|NCT02799602|364961240|FG001|Overall Study|Protocol Violation|0|||
105810320|NCT02799602|364961239|FG000|Overall Study|Physician Decision|5|||
105810321|NCT02799602|364961240|FG001|Overall Study|Physician Decision|6|||
106017160|NCT00477386|365726008|FG001|Overall Study|Withdrawal by Subject|0|||
106017161|NCT01254422|365726009|FG000|Overall Study|Protocol Violation|1|||
105810322|NCT02799602|364961239|FG000|Overall Study|Lost to Follow-up|4|||
105810323|NCT02799602|364961240|FG001|Overall Study|Lost to Follow-up|2|||
105810324|NCT02799602|364961239|FG000|Overall Study|Additional primary malignancy|11|||
105810325|NCT02799602|364961240|FG001|Overall Study|Additional primary malignancy|6|||
105810326|NCT02799602|364961239|FG000|Overall Study|Non-compliance with study drug|14|||
105810327|NCT02799602|364961240|FG001|Overall Study|Non-compliance with study drug|12|||
105810328|NCT02799602|364961239|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
105810329|NCT02799602|364961240|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
105810330|NCT02799602|364961239|FG000|Overall Study|Withdrawal by Subject|26|||
105810331|NCT02799602|364961240|FG001|Overall Study|Withdrawal by Subject|40|||
105810332|NCT02799602|364961239|FG000|Overall Study|Progressive disease - clinical progression|131|||
105810333|NCT02799602|364961240|FG001|Overall Study|Progressive disease - clinical progression|276|||
105810334|NCT02799602|364961239|FG000|Overall Study|Progressive disease - radiological progression|90|||
105810335|NCT02799602|364961240|FG001|Overall Study|Progressive disease - radiological progression|133|||
105810336|NCT02799602|364961239|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
105810337|NCT02799602|364961240|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
105810338|NCT02799602|364961239|FG000|Overall Study|Death|9|||
105810339|NCT02799602|364961240|FG001|Overall Study|Death|5|||
105810340|NCT02799602|364961239|FG000|Overall Study|Other|287|||
105810341|NCT02799602|364961240|FG001|Overall Study|Other|118|||
105810342|NCT02799602|364961239|FG000|Overall Study|Study drug never administered|0|||
105810343|NCT02799602|364961240|FG001|Overall Study|Study drug never administered|3|||
105810344|NCT02626949|364961241|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
105810345|NCT02626949|364961242|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
105810346|NCT02626949|364961241|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
105810347|NCT02626949|364961242|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
105810348|NCT02626949|364961241|FG000|Enrolled|Lost to Follow-up|7|||
105810349|NCT02626949|364961242|FG001|Enrolled|Lost to Follow-up|6|||
105810350|NCT02626949|364961241|FG000|Enrolled|Withdrawal by Subject|3|||
105810351|NCT02626949|364961242|FG001|Enrolled|Withdrawal by Subject|2|||
105810352|NCT00720122|364961245|FG000|Overall Study|Lost to Follow-up|1|||
105810353|NCT00720122|364961245|FG000|Overall Study|Physician Decision|1|||
105810354|NCT00720122|364961245|FG000|Overall Study|Withdrawal by Subject|7|||
105810355|NCT03072459|364961246|FG000|Overall Study|Device revised/removed|1|||
105810356|NCT03072459|364961246|FG000|Overall Study|Subject not able to return|1|||
105810357|NCT01790568|364961247|FG000|Overall Study|Progression prior to transplant|0|||
105810358|NCT01790568|364961248|FG001|Overall Study|Progression prior to transplant|1|||
105810359|NCT03595657|364961249|FG000|Overall Study|Adverse Event|14|||
105810360|NCT03595657|364961249|FG000|Overall Study|Death|1|||
105810361|NCT03595657|364961249|FG000|Overall Study|Lack of Efficacy|40|||
105810362|NCT03595657|364961249|FG000|Overall Study|Withdrawal by Subject|10|||
105810363|NCT03595657|364961249|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
105810364|NCT03595657|364961249|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
105810365|NCT02199509|364961254|FG000|Overall Study|Suicidal Ideation|0|||
105810366|NCT02199509|364961255|FG001|Overall Study|Suicidal Ideation|1|||
105810367|NCT02199509|364961254|FG000|Overall Study|Misunderstood titration schedule|1|||
105810368|NCT02199509|364961255|FG001|Overall Study|Misunderstood titration schedule|0|||
105810369|NCT00462982|364961261|FG000|Overall Study|Adverse Event|1|||
105810370|NCT00462982|364961261|FG000|Overall Study|Patient Not Treated|2|||
105810371|NCT05188521|364962800|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
105810372|NCT05188521|364962801|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
105810373|NCT00506753|364962802|FG000|Overall Study|Lost to Follow-up|21|||
105810374|NCT00506753|364962803|FG001|Overall Study|Lost to Follow-up|15|||
105810375|NCT01513551|364962804|FG000|Overall Study|Death|0|||
105810376|NCT01513551|364962805|FG001|Overall Study|Death|1|||
105810377|NCT01513551|364962806|FG002|Overall Study|Death|0|||
105810378|NCT01513551|364962804|FG000|Overall Study|Lost to Follow-up|3|||
105810379|NCT01513551|364962805|FG001|Overall Study|Lost to Follow-up|5|||
105810380|NCT01513551|364962806|FG002|Overall Study|Lost to Follow-up|2|||
105810381|NCT01513551|364962804|FG000|Overall Study|Withdrawal by Subject|1|||
105810382|NCT01513551|364962805|FG001|Overall Study|Withdrawal by Subject|0|||
105810383|NCT01513551|364962806|FG002|Overall Study|Withdrawal by Subject|2|||
105810384|NCT01513551|364962804|FG000|Overall Study|Randomized but not vaccinated|0|||
105810385|NCT01513551|364962805|FG001|Overall Study|Randomized but not vaccinated|0|||
105810386|NCT01513551|364962806|FG002|Overall Study|Randomized but not vaccinated|1|||
105810387|NCT02178709|364962807|FG000|Overall Study|Adverse Event|5|||
105810388|NCT02178709|364962807|FG000|Overall Study|Death|2|||
105810389|NCT02178709|364962807|FG000|Overall Study|Withdrawal by Subject|2|||
105810390|NCT02178709|364962807|FG000|Overall Study|Physician Decision|2|||
105810391|NCT02178709|364962807|FG000|Overall Study|Disease Progression|5|||
105810392|NCT01241461|364962808|FG000|Overall Study|Progressive Disease|3|||
105810393|NCT01241461|364962809|FG001|Overall Study|Progressive Disease|6|||
105810394|NCT01379781|364962813|FG000|Overall Study|Lost to Follow-up|11|||
105810395|NCT01379781|364962814|FG001|Overall Study|Lost to Follow-up|8|||
105810396|NCT02247479|364962816|FG000|Overall Study|Adverse Event|8|||
105810397|NCT02247479|364962817|FG001|Overall Study|Adverse Event|9|||
105810398|NCT02247479|364962818|FG002|Overall Study|Adverse Event|8|||
105810399|NCT02247479|364962816|FG000|Overall Study|Death|5|||
105810400|NCT02247479|364962817|FG001|Overall Study|Death|4|||
105810401|NCT02247479|364962818|FG002|Overall Study|Death|6|||
105810402|NCT02247479|364962816|FG000|Overall Study|Lost to Follow-up|3|||
105810403|NCT02247479|364962817|FG001|Overall Study|Lost to Follow-up|3|||
105810404|NCT02247479|364962818|FG002|Overall Study|Lost to Follow-up|1|||
105810405|NCT02247479|364962816|FG000|Overall Study|Non-compliance|0|||
105810406|NCT02247479|364962817|FG001|Overall Study|Non-compliance|0|||
105810407|NCT02247479|364962818|FG002|Overall Study|Non-compliance|1|||
105810408|NCT02247479|364962816|FG000|Overall Study|Withdrawal by Subject|25|||
105810409|NCT02247479|364962817|FG001|Overall Study|Withdrawal by Subject|29|||
105810410|NCT02247479|364962818|FG002|Overall Study|Withdrawal by Subject|24|||
105810411|NCT02247479|364962816|FG000|Overall Study|Study Terminated by Sponsor|98|||
105810412|NCT02247479|364962817|FG001|Overall Study|Study Terminated by Sponsor|88|||
105810413|NCT02247479|364962818|FG002|Overall Study|Study Terminated by Sponsor|94|||
105810414|NCT02247479|364962816|FG000|Overall Study|Physician Decision|1|||
105810415|NCT02247479|364962817|FG001|Overall Study|Physician Decision|0|||
105810416|NCT02247479|364962818|FG002|Overall Study|Physician Decision|2|||
105810417|NCT02247479|364962816|FG000|Overall Study|Unspecified Reason|2|||
105810418|NCT02247479|364962817|FG001|Overall Study|Unspecified Reason|5|||
105810419|NCT02247479|364962818|FG002|Overall Study|Unspecified Reason|2|||
105810420|NCT01132118|364962819|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
105810421|NCT01132118|364962820|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
105810422|NCT01132118|364962819|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
105810423|NCT01132118|364962820|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
105810424|NCT01132118|364962819|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
105810425|NCT01132118|364962820|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
105810426|NCT00094302|364962825|FG000|Overall Study|Lost to Follow-up|43|||
105810427|NCT00094302|364962826|FG001|Overall Study|Lost to Follow-up|41|||
105810428|NCT00094302|364962825|FG000|Overall Study|Physician Decision|5|||
105810429|NCT00094302|364962826|FG001|Overall Study|Physician Decision|8|||
105810430|NCT00094302|364962825|FG000|Overall Study|Withdrawal by Subject|103|||
105810431|NCT00094302|364962826|FG001|Overall Study|Withdrawal by Subject|111|||
105810432|NCT00094302|364962825|FG000|Overall Study|Death|266|||
105810433|NCT00094302|364962826|FG001|Overall Study|Death|246|||
105810434|NCT03329027|364962827|FG000|Overall Study|Lost to Follow-up|1|||
105810435|NCT03329027|364962828|FG001|Overall Study|Lost to Follow-up|0|||
105810436|NCT03329027|364962829|FG002|Overall Study|Lost to Follow-up|1|||
105810437|NCT03329027|364962827|FG000|Overall Study|Protocol Violation|9|||
105810438|NCT03329027|364962828|FG001|Overall Study|Protocol Violation|5|||
105810439|NCT03329027|364962829|FG002|Overall Study|Protocol Violation|7|||
105810440|NCT04849988|364962836|FG000|Overall Study|Lack of Efficacy|3|||
105810441|NCT04849988|364962837|FG001|Overall Study|Lack of Efficacy|4|||
105810442|NCT04849988|364962838|FG002|Overall Study|Lack of Efficacy|1|||
105810443|NCT04849988|364962839|FG003|Overall Study|Lack of Efficacy|4|||
105810444|NCT04849988|364962836|FG000|Overall Study|Other reasons|1|||
105952947|NCT04460183|365490266|FG000|Overall Study|Withdrawal by Subject|1|||
105952948|NCT04460183|365490267|FG001|Overall Study|Withdrawal by Subject|0|||
105952949|NCT01865487|365490268|FG000|Overall Study|Lost to Follow-up|0|||
105952950|NCT01865487|365490269|FG001|Overall Study|Lost to Follow-up|0|||
105952951|NCT01865487|365490270|FG002|Overall Study|Lost to Follow-up|0|||
105952952|NCT01865487|365490271|FG003|Overall Study|Lost to Follow-up|1|||
105952953|NCT01865487|365490272|FG004|Overall Study|Lost to Follow-up|0|||
105952954|NCT01865487|365490273|FG005|Overall Study|Lost to Follow-up|0|||
105952955|NCT01865487|365490274|FG006|Overall Study|Lost to Follow-up|1|||
105810445|NCT04849988|364962837|FG001|Overall Study|Other reasons|2|||
105810446|NCT04849988|364962838|FG002|Overall Study|Other reasons|2|||
105810447|NCT04849988|364962839|FG003|Overall Study|Other reasons|1|||
105810448|NCT00992407|364962849|FG000|Overall Study|Protocol Violation|2|||
105952956|NCT01865487|365490275|FG007|Overall Study|Lost to Follow-up|0|||
105952957|NCT01865487|365490276|FG008|Overall Study|Lost to Follow-up|0|||
105952958|NCT01865487|365490277|FG009|Overall Study|Lost to Follow-up|0|||
105952959|NCT01865487|365490268|FG000|Overall Study|Withdrawal by Subject|0|||
106017162|NCT01254422|365726010|FG001|Overall Study|Protocol Violation|0|||
105810449|NCT00992407|364962850|FG001|Overall Study|Protocol Violation|1|||
105810450|NCT00992407|364962849|FG000|Overall Study|Lost to Follow-up|3|||
105810451|NCT00992407|364962850|FG001|Overall Study|Lost to Follow-up|3|||
105810452|NCT00992407|364962849|FG000|Overall Study|Adverse Event|3|||
105810453|NCT00992407|364962850|FG001|Overall Study|Adverse Event|2|||
105810454|NCT00992407|364962849|FG000|Overall Study|protocol Violation & Adverse events|2|||
105810455|NCT00992407|364962850|FG001|Overall Study|protocol Violation & Adverse events|4|||
105810456|NCT00992407|364962849|FG000|Overall Study|Other|2|||
105810457|NCT00992407|364962850|FG001|Overall Study|Other|0|||
105810458|NCT00992407|364962849|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
105952960|NCT01865487|365490269|FG001|Overall Study|Withdrawal by Subject|0|||
105952961|NCT01865487|365490270|FG002|Overall Study|Withdrawal by Subject|0|||
105810459|NCT00992407|364962850|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
105810460|NCT00992407|364962849|FG000|Overall Study|Study medication not administered|17|||
105810461|NCT00992407|364962850|FG001|Overall Study|Study medication not administered|13|||
105810462|NCT03738332|364962853|FG000|Overall Study|Withdrawal by Subject|1|||
105810463|NCT00635778|364962863|FG000|Overall Study|Adverse Event|1|||
105810464|NCT00635778|364962864|FG001|Overall Study|Adverse Event|0|||
105810465|NCT00635778|364962865|FG002|Overall Study|Adverse Event|0|||
105810466|NCT00635778|364962866|FG003|Overall Study|Adverse Event|3|||
105810467|NCT00635778|364962867|FG004|Overall Study|Adverse Event|3|||
105810468|NCT00635778|364962868|FG005|Overall Study|Adverse Event|6|||
105810469|NCT00635778|364962869|FG006|Overall Study|Adverse Event|1|||
105810470|NCT00635778|364962863|FG000|Overall Study|Withdrawal by Subject|0|||
105810471|NCT00635778|364962864|FG001|Overall Study|Withdrawal by Subject|0|||
105810472|NCT00635778|364962865|FG002|Overall Study|Withdrawal by Subject|0|||
105810473|NCT00635778|364962866|FG003|Overall Study|Withdrawal by Subject|1|||
105810474|NCT00635778|364962867|FG004|Overall Study|Withdrawal by Subject|0|||
105810475|NCT00635778|364962868|FG005|Overall Study|Withdrawal by Subject|1|||
105810476|NCT00635778|364962869|FG006|Overall Study|Withdrawal by Subject|1|||
105810477|NCT00635778|364962863|FG000|Overall Study|Progressive disease|0|||
105810478|NCT00635778|364962864|FG001|Overall Study|Progressive disease|3|||
105810479|NCT00635778|364962865|FG002|Overall Study|Progressive disease|3|||
105810480|NCT00635778|364962866|FG003|Overall Study|Progressive disease|4|||
105810481|NCT00635778|364962867|FG004|Overall Study|Progressive disease|5|||
105810482|NCT00635778|364962868|FG005|Overall Study|Progressive disease|14|||
105810483|NCT00635778|364962869|FG006|Overall Study|Progressive disease|4|||
105810484|NCT00812253|364962871|FG000|Overall Study|Withdrawal by Subject|3|||
105810485|NCT00812253|364962872|FG001|Overall Study|Withdrawal by Subject|2|||
105810486|NCT00812253|364962871|FG000|Overall Study|Protocol Violation|1|||
105810487|NCT00812253|364962872|FG001|Overall Study|Protocol Violation|1|||
105810488|NCT00812253|364962871|FG000|Overall Study|Lost to Follow-up|2|||
105810489|NCT00812253|364962872|FG001|Overall Study|Lost to Follow-up|0|||
105810490|NCT01884025|364962873|FG000|Overall Study|Lost to Follow-up|3|||
105810491|NCT01884025|364962874|FG001|Overall Study|Lost to Follow-up|4|||
105810492|NCT02918162|364962876|FG000|Overall Study|Withdrawal by Subject|1|||
105810493|NCT02918162|364962876|FG000|Overall Study|Omental Disease|1|||
105810494|NCT00395226|364962877|FG000|Overall Study|Adverse Event|4|||
105810495|NCT00395226|364962878|FG001|Overall Study|Adverse Event|3|||
105810496|NCT00395226|364962877|FG000|Overall Study|Withdrawal by Subject|0|||
105810497|NCT00395226|364962878|FG001|Overall Study|Withdrawal by Subject|1|||
105810498|NCT00395226|364962877|FG000|Overall Study|Lost to Follow-up|0|||
105810499|NCT00395226|364962878|FG001|Overall Study|Lost to Follow-up|1|||
105810500|NCT02655237|364962885|FG000|Overall Study|Adverse Event|10|||
105810501|NCT02655237|364962886|FG001|Overall Study|Adverse Event|7|||
105810502|NCT02655237|364962885|FG000|Overall Study|Protocol Deviation|2|||
105810503|NCT02655237|364962886|FG001|Overall Study|Protocol Deviation|0|||
105810504|NCT02655237|364962885|FG000|Overall Study|Withdrawal by Participant|1|||
105810505|NCT02655237|364962886|FG001|Overall Study|Withdrawal by Participant|2|||
105810506|NCT02655237|364962885|FG000|Overall Study|Lack of Efficacy|0|||
105810507|NCT02655237|364962886|FG001|Overall Study|Lack of Efficacy|1|||
105810508|NCT02655237|364962885|FG000|Overall Study|Recovery Leading to Surgery|2|||
105810509|NCT02655237|364962886|FG001|Overall Study|Recovery Leading to Surgery|1|||
105810510|NCT02655237|364962885|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
105810511|NCT02655237|364962886|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
105810512|NCT02655237|364962885|FG000|Overall Study|Randomized but Not Treated|1|||
105810513|NCT02655237|364962886|FG001|Overall Study|Randomized but Not Treated|0|||
105810514|NCT02132247|364962887|FG000|Overall Study|Protocol Violation|1|||
105810515|NCT02132247|364962888|FG001|Overall Study|Protocol Violation|0|||
105810516|NCT00220701|364962891|FG000|Overall Study|Lost to Follow-up|5|||
105952962|NCT01865487|365490271|FG003|Overall Study|Withdrawal by Subject|0|||
105952963|NCT01865487|365490272|FG004|Overall Study|Withdrawal by Subject|1|||
105952964|NCT01865487|365490273|FG005|Overall Study|Withdrawal by Subject|0|||
105952965|NCT01865487|365490274|FG006|Overall Study|Withdrawal by Subject|0|||
105952966|NCT01865487|365490275|FG007|Overall Study|Withdrawal by Subject|0|||
105952967|NCT01865487|365490276|FG008|Overall Study|Withdrawal by Subject|0|||
105810517|NCT00220701|364962892|FG001|Overall Study|Lost to Follow-up|4|||
105810518|NCT02354586|364962895|FG000|Overall Study|Death|230|||
105952968|NCT01865487|365490277|FG009|Overall Study|Withdrawal by Subject|0|||
105952969|NCT00856609|365490284|FG000|Overall Study|Adverse Event|1|||
105952970|NCT00856609|365490285|FG001|Overall Study|Adverse Event|0|||
105810519|NCT02354586|364962895|FG000|Overall Study|Withdrawal by Subject|59|||
105810520|NCT02354586|364962895|FG000|Overall Study|Lost to Follow-up|11|||
105810521|NCT02354586|364962895|FG000|Overall Study|Sponsor decision|51|||
105810522|NCT02354586|364962895|FG000|Overall Study|Site closure|2|||
105810523|NCT02354586|364962895|FG000|Overall Study|Intercurrent illness|1|||
105810524|NCT02354586|364962895|FG000|Overall Study|Protocol Violation|3|||
105952971|NCT01428219|365490286|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
105952972|NCT02078752|365490287|FG000|Overall Study|Death|0|||
105952973|NCT02078752|365490288|FG001|Overall Study|Death|3|||
105952974|NCT02078752|365490289|FG002|Overall Study|Death|0|||
105952975|NCT02078752|365490290|FG003|Overall Study|Death|0|||
105952976|NCT02078752|365490291|FG004|Overall Study|Death|0|||
105952977|NCT02078752|365490292|FG005|Overall Study|Death|1|||
105952978|NCT02078752|365490293|FG006|Overall Study|Death|0|||
105952979|NCT02078752|365490294|FG007|Overall Study|Death|1|||
105952980|NCT02078752|365490295|FG008|Overall Study|Death|0|||
105952981|NCT02078752|365490296|FG009|Overall Study|Death|4|||
105952982|NCT02078752|365490287|FG000|Overall Study|Lost to Follow-up|1|||
105952983|NCT02078752|365490288|FG001|Overall Study|Lost to Follow-up|0|||
105952984|NCT02078752|365490289|FG002|Overall Study|Lost to Follow-up|0|||
105952985|NCT02078752|365490290|FG003|Overall Study|Lost to Follow-up|1|||
105952986|NCT02078752|365490291|FG004|Overall Study|Lost to Follow-up|0|||
105952987|NCT02078752|365490292|FG005|Overall Study|Lost to Follow-up|0|||
105952988|NCT02078752|365490293|FG006|Overall Study|Lost to Follow-up|0|||
105952989|NCT02078752|365490294|FG007|Overall Study|Lost to Follow-up|0|||
105952990|NCT02078752|365490295|FG008|Overall Study|Lost to Follow-up|0|||
105952991|NCT02078752|365490296|FG009|Overall Study|Lost to Follow-up|0|||
105952992|NCT02078752|365490287|FG000|Overall Study|Withdrawal by Subject|1|||
105952993|NCT02078752|365490288|FG001|Overall Study|Withdrawal by Subject|1|||
105952994|NCT02078752|365490289|FG002|Overall Study|Withdrawal by Subject|1|||
105952995|NCT02078752|365490290|FG003|Overall Study|Withdrawal by Subject|1|||
105952996|NCT02078752|365490291|FG004|Overall Study|Withdrawal by Subject|0|||
105952997|NCT02078752|365490292|FG005|Overall Study|Withdrawal by Subject|3|||
105952998|NCT02078752|365490293|FG006|Overall Study|Withdrawal by Subject|2|||
105952999|NCT02078752|365490294|FG007|Overall Study|Withdrawal by Subject|1|||
105953000|NCT02078752|365490295|FG008|Overall Study|Withdrawal by Subject|0|||
105953001|NCT02078752|365490296|FG009|Overall Study|Withdrawal by Subject|1|||
105953002|NCT02078752|365490287|FG000|Overall Study|Other|0|||
105953003|NCT02078752|365490288|FG001|Overall Study|Other|3|||
105953004|NCT02078752|365490289|FG002|Overall Study|Other|0|||
105953005|NCT02078752|365490290|FG003|Overall Study|Other|0|||
105953006|NCT02078752|365490291|FG004|Overall Study|Other|1|||
105953007|NCT02078752|365490292|FG005|Overall Study|Other|0|||
105762579|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762580|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105953008|NCT02078752|365490293|FG006|Overall Study|Other|0|||
105953009|NCT02078752|365490294|FG007|Overall Study|Other|1|||
105953010|NCT02078752|365490295|FG008|Overall Study|Other|0|||
105953011|NCT02078752|365490296|FG009|Overall Study|Other|0|||
105762581|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
105762582|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
105762583|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
105762584|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
105762585|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
105762586|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
105762587|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
105762588|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
105762589|NCT02120352|364783150|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762590|NCT02120352|364783151|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
105762591|NCT02120352|364783152|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762592|NCT02120352|364783153|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762593|NCT02120352|364783154|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762594|NCT02120352|364783155|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105953012|NCT02078752|365490287|FG000|Overall Study|Study terminated by sponsor|0|||
105953013|NCT02078752|365490288|FG001|Overall Study|Study terminated by sponsor|0|||
105953014|NCT02078752|365490289|FG002|Overall Study|Study terminated by sponsor|0|||
105953015|NCT02078752|365490290|FG003|Overall Study|Study terminated by sponsor|0|||
105953016|NCT02078752|365490291|FG004|Overall Study|Study terminated by sponsor|0|||
105953017|NCT02078752|365490292|FG005|Overall Study|Study terminated by sponsor|0|||
105953018|NCT02078752|365490293|FG006|Overall Study|Study terminated by sponsor|0|||
105810525|NCT02354586|364962895|FG000|Overall Study|Physician Decision|13|||
105810526|NCT02354586|364962895|FG000|Overall Study|Lack of Efficacy|86|||
105810527|NCT02354586|364962895|FG000|Overall Study|Adverse Event|7|||
105810528|NCT00620763|364962899|FG000|Period: First Intervention|Withdrawal by Subject|0|||
105810529|NCT00620763|364962900|FG001|Period: First Intervention|Withdrawal by Subject|2|||
105810530|NCT00620763|364962899|FG000|Period: First Intervention|Protocol Violation|0|||
105953019|NCT02078752|365490294|FG007|Overall Study|Study terminated by sponsor|0|||
105953020|NCT02078752|365490295|FG008|Overall Study|Study terminated by sponsor|0|||
105953021|NCT02078752|365490296|FG009|Overall Study|Study terminated by sponsor|5|||
105953022|NCT01847092|365490302|FG000|Overall Study|Adverse Event|12|||
105953023|NCT01847092|365490303|FG001|Overall Study|Adverse Event|3|||
105953024|NCT01847092|365490302|FG000|Overall Study|Withdrawal by Subject|5|||
105953025|NCT01847092|365490303|FG001|Overall Study|Withdrawal by Subject|5|||
105953026|NCT01847092|365490302|FG000|Overall Study|Protocol Specified|8|||
105953027|NCT01847092|365490303|FG001|Overall Study|Protocol Specified|0|||
105953028|NCT01847092|365490302|FG000|Overall Study|Physician Decision|1|||
105953029|NCT01847092|365490303|FG001|Overall Study|Physician Decision|1|||
105953030|NCT01847092|365490302|FG000|Overall Study|Protocol Violation|0|||
105953031|NCT01847092|365490303|FG001|Overall Study|Protocol Violation|2|||
105953032|NCT00775268|365490305|FG000|Baseline|Drug not synthesize dose|1|||
105953033|NCT00775268|365490306|FG001|Baseline|Drug not synthesize dose|0|||
105953034|NCT00775268|365490305|FG000|Baseline|Not treated-ineligible per CT|0|||
105810531|NCT00620763|364962900|FG001|Period: First Intervention|Protocol Violation|3|||
105810532|NCT00620763|364962899|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
105810533|NCT00620763|364962900|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
105810534|NCT00524459|364962901|FG000|Overall Study|Withdrawal by Subject|1|||
105953035|NCT00775268|365490306|FG001|Baseline|Not treated-ineligible per CT|1|||
105953036|NCT00775268|365490305|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
105953037|NCT00775268|365490306|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
105953038|NCT00775268|365490305|FG000|After Completion|Participant missed scan appointment|1|||
105953039|NCT00775268|365490306|FG001|After Completion|Participant missed scan appointment|0|||
105953040|NCT03604497|365490307|FG000|Overall Study|Protocol Violation|52|||
105953041|NCT00811954|365490308|FG000|Overall Study|Death|10|||
105953042|NCT00811954|365490309|FG001|Overall Study|Death|6|||
105953043|NCT00811954|365490310|FG002|Overall Study|Death|13|||
105953044|NCT00811954|365490308|FG000|Overall Study|Lost to Follow-up|29|||
105953045|NCT00811954|365490309|FG001|Overall Study|Lost to Follow-up|23|||
105953046|NCT00811954|365490310|FG002|Overall Study|Lost to Follow-up|34|||
105953047|NCT00811954|365490308|FG000|Overall Study|Not able to get to clinic|28|||
105953048|NCT00811954|365490309|FG001|Overall Study|Not able to get to clinic|35|||
105953049|NCT00811954|365490310|FG002|Overall Study|Not able to get to clinic|30|||
105953050|NCT00811954|365490308|FG000|Overall Study|Not willing to adhere to requirements|12|||
105953051|NCT00811954|365490309|FG001|Overall Study|Not willing to adhere to requirements|2|||
105953052|NCT00811954|365490310|FG002|Overall Study|Not willing to adhere to requirements|16|||
105953053|NCT00811954|365490308|FG000|Overall Study|Withdraw consent prior study completion|4|||
105953054|NCT00811954|365490309|FG001|Overall Study|Withdraw consent prior study completion|6|||
105953055|NCT00811954|365490310|FG002|Overall Study|Withdraw consent prior study completion|5|||
105953056|NCT00811954|365490308|FG000|Overall Study|Site Closure|4|||
105953057|NCT00811954|365490309|FG001|Overall Study|Site Closure|0|||
105953058|NCT00811954|365490310|FG002|Overall Study|Site Closure|1|||
105953059|NCT00811954|365490308|FG000|Overall Study|Severe Debilitation|2|||
105953060|NCT00811954|365490309|FG001|Overall Study|Severe Debilitation|0|||
105953061|NCT00811954|365490310|FG002|Overall Study|Severe Debilitation|1|||
105953062|NCT00811954|365490308|FG000|Overall Study|Complete Protocol: No follow-up|0|||
105953063|NCT00811954|365490309|FG001|Overall Study|Complete Protocol: No follow-up|0|||
105953064|NCT00811954|365490310|FG002|Overall Study|Complete Protocol: No follow-up|1|||
105953065|NCT00825994|365490311|FG000|Overall Study|Withdrawal by Subject|2|||
105953066|NCT00825994|365490311|FG000|Overall Study|Lost to Follow-up|1|||
105953067|NCT00825994|365490311|FG000|Overall Study|Protocol Violation|1|||
105810535|NCT00524459|364962901|FG000|Overall Study|Other|1|||
105810536|NCT00783796|364962905|FG000|Overall Study|Did not receive any stent|4|||
105810537|NCT00783796|364962905|FG000|Overall Study|Received non-XIENCE V stent|1|||
105953068|NCT00825994|365490311|FG000|Overall Study|Placebo Responder at V2|1|||
105953069|NCT00800982|365490315|FG000|Overall Study|Lost to Follow-up|1|||
105953070|NCT00800982|365490316|FG001|Overall Study|Lost to Follow-up|2|||
105953071|NCT00800982|365490315|FG000|Overall Study|Withdrawal by Subject|0|||
105810538|NCT00783796|364962905|FG000|Overall Study|Received commercial XIENCE V stent|1|||
105810539|NCT00084084|364962910|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
105953072|NCT00800982|365490316|FG001|Overall Study|Withdrawal by Subject|1|||
105953073|NCT00800982|365490315|FG000|Overall Study|Patient moved out of state|1|||
105953074|NCT00800982|365490316|FG001|Overall Study|Patient moved out of state|0|||
105953075|NCT03465722|365490317|FG000|Overall Study|Withdrawal by Subject|21|||
105953076|NCT03465722|365490318|FG001|Overall Study|Withdrawal by Subject|14|||
105953077|NCT03465722|365490317|FG000|Overall Study|Death|89|||
105953078|NCT03465722|365490318|FG001|Overall Study|Death|87|||
105953079|NCT03465722|365490317|FG000|Overall Study|Lost to Follow-up|5|||
105953080|NCT03465722|365490318|FG001|Overall Study|Lost to Follow-up|3|||
105953081|NCT03465722|365490317|FG000|Overall Study|Administrative/Other|33|||
105953082|NCT03465722|365490318|FG001|Overall Study|Administrative/Other|32|||
105953083|NCT03465722|365490317|FG000|Overall Study|Not treated|1|||
105953084|NCT03465722|365490318|FG001|Overall Study|Not treated|2|||
105953085|NCT03465722|365490317|FG000|Overall Study|Sponsor decision|91|||
105953086|NCT03465722|365490318|FG001|Overall Study|Sponsor decision|98|||
105810540|NCT00084084|364962910|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
105810541|NCT01802879|364962911|FG000|Overall Study|Administrative problems|2|||
105810542|NCT01802879|364962911|FG000|Overall Study|Disease progression|6|||
105810543|NCT02116803|364962916|FG000|Overall Study|Adverse Event|2|||
105810544|NCT02116803|364962917|FG001|Overall Study|Adverse Event|1|||
105810545|NCT02116803|364962916|FG000|Overall Study|Physician Decision|1|||
105810546|NCT02116803|364962917|FG001|Overall Study|Physician Decision|0|||
105810547|NCT02116803|364962916|FG000|Overall Study|Progressive disease|4|||
105810548|NCT02116803|364962917|FG001|Overall Study|Progressive disease|0|||
105810549|NCT02116803|364962916|FG000|Overall Study|Study terminated by sponsor|2|||
105953087|NCT02240121|365490321|FG000|Overall Study|Protocol Violation|1|||
105953088|NCT02240121|365490322|FG001|Overall Study|Protocol Violation|2|||
105953089|NCT02240121|365490321|FG000|Overall Study|Physician Decision|0|||
105953090|NCT02240121|365490322|FG001|Overall Study|Physician Decision|1|||
105953091|NCT02240121|365490321|FG000|Overall Study|Change in protocol interpretation|1|||
105810550|NCT02116803|364962917|FG001|Overall Study|Study terminated by sponsor|1|||
105810551|NCT02116803|364962916|FG000|Overall Study|Death|1|||
105810552|NCT02116803|364962917|FG001|Overall Study|Death|0|||
105810553|NCT03019965|364962920|FG000|Overall Study|Withdrawal by Subject|1|||
105810554|NCT03019965|364962921|FG001|Overall Study|Withdrawal by Subject|0|||
105810555|NCT03019965|364962920|FG000|Overall Study|Protocol Violation|1|||
105810556|NCT03019965|364962921|FG001|Overall Study|Protocol Violation|3|||
105810557|NCT03019965|364962920|FG000|Overall Study|viral or fungal infection|3|||
105810558|NCT03019965|364962921|FG001|Overall Study|viral or fungal infection|4|||
105810559|NCT03019965|364962920|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
105810560|NCT03019965|364962921|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
105810561|NCT03019965|364962920|FG000|Overall Study|Physician Decision|1|||
105810562|NCT03019965|364962921|FG001|Overall Study|Physician Decision|1|||
105810563|NCT00927810|364962922|FG000|Overall Study|Withdrawal by Subject|0|||
105810564|NCT00927810|364962923|FG001|Overall Study|Withdrawal by Subject|3|||
105810565|NCT00927810|364962924|FG002|Overall Study|Withdrawal by Subject|0|||
105810566|NCT00927810|364962925|FG003|Overall Study|Withdrawal by Subject|1|||
105810567|NCT00927810|364962922|FG000|Overall Study|Lost to Follow-up|0|||
105810568|NCT00927810|364962923|FG001|Overall Study|Lost to Follow-up|2|||
105810569|NCT00927810|364962924|FG002|Overall Study|Lost to Follow-up|1|||
105810570|NCT00927810|364962925|FG003|Overall Study|Lost to Follow-up|1|||
105810571|NCT00927810|364962922|FG000|Overall Study|Death|0|||
105810572|NCT00927810|364962923|FG001|Overall Study|Death|2|||
105810573|NCT00927810|364962924|FG002|Overall Study|Death|0|||
105810574|NCT00927810|364962925|FG003|Overall Study|Death|0|||
105810575|NCT00927810|364962922|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105810576|NCT00927810|364962923|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105810577|NCT00927810|364962924|FG002|Overall Study|Abnormal laboratory value(s)|0|||
105810578|NCT00927810|364962925|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105810579|NCT00950807|364962927|FG000|Treatment Period 1|Lack of Efficacy|1|||
105810580|NCT00950807|364962928|FG001|Treatment Period 1|Lack of Efficacy|0|||
105810581|NCT00950807|364962929|FG002|Treatment Period 1|Lack of Efficacy|0|||
105810582|NCT00950807|364962930|FG003|Treatment Period 1|Lack of Efficacy|0|||
105810583|NCT00950807|364962931|FG004|Treatment Period 1|Lack of Efficacy|0|||
105810584|NCT00950807|364962932|FG005|Treatment Period 1|Lack of Efficacy|1|||
105810585|NCT00950807|364962933|FG006|Treatment Period 1|Lack of Efficacy|0|||
105810586|NCT00950807|364962934|FG007|Treatment Period 1|Lack of Efficacy|0|||
105810587|NCT00950807|364962935|FG008|Treatment Period 1|Lack of Efficacy|0|||
105953092|NCT02240121|365490322|FG001|Overall Study|Change in protocol interpretation|0|||
105953093|NCT02240121|365490321|FG000|Overall Study|Lack of Efficacy|2|||
105953094|NCT02240121|365490322|FG001|Overall Study|Lack of Efficacy|3|||
105953095|NCT02240121|365490321|FG000|Overall Study|Site closed|1|||
105953096|NCT02240121|365490322|FG001|Overall Study|Site closed|1|||
105953097|NCT02240121|365490321|FG000|Overall Study|Pregnancy|1|||
105953098|NCT02240121|365490322|FG001|Overall Study|Pregnancy|0|||
105810588|NCT00950807|364962936|FG009|Treatment Period 1|Lack of Efficacy|0|||
105810589|NCT00950807|364962927|FG000|Treatment Period 1|Protocol Violation|1|||
105953099|NCT02240121|365490321|FG000|Overall Study|Adverse Event|2|||
105953100|NCT02240121|365490322|FG001|Overall Study|Adverse Event|4|||
105953101|NCT02240121|365490321|FG000|Overall Study|Withdrawal by Subject|6|||
105953102|NCT02240121|365490322|FG001|Overall Study|Withdrawal by Subject|2|||
105762595|NCT02120352|364783156|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
105762596|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
105762597|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
105762598|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
105762599|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
105762600|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
105762601|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
105762602|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
105762603|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762604|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762605|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762606|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762607|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
105762608|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762609|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
105762610|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
105762611|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
105762612|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
105762613|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
105762614|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
105762615|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
105762616|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
105762617|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
105762618|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
105762619|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
105762620|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
105762621|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
105762622|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
105762623|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
105762624|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
105762625|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
105762626|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
105762627|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
105762628|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
105762629|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
105762630|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
105762631|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762632|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
105762633|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
105762634|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762635|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762636|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762637|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
105762638|NCT02120352|364783150|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
105762639|NCT02120352|364783151|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
105762640|NCT02120352|364783152|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
105762641|NCT02120352|364783153|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
105762642|NCT02120352|364783154|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
105762643|NCT02120352|364783155|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
105762644|NCT02120352|364783156|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
105762645|NCT02120352|364783150|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762646|NCT02120352|364783151|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762647|NCT02120352|364783152|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762648|NCT02120352|364783153|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762649|NCT02120352|364783154|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762650|NCT02120352|364783155|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
105762651|NCT02120352|364783156|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
105762652|NCT00617591|364783157|FG000|Overall Study|Withdrew consent during Induction|4|||
105762653|NCT00617591|364783157|FG000|Overall Study|Withdrew consent during Maintenance|6|||
105810590|NCT00950807|364962928|FG001|Treatment Period 1|Protocol Violation|0|||
105953103|NCT02240121|365490321|FG000|Overall Study|Lost to Follow-up|3|||
105810591|NCT00950807|364962929|FG002|Treatment Period 1|Protocol Violation|0|||
105810592|NCT00950807|364962930|FG003|Treatment Period 1|Protocol Violation|0|||
105810593|NCT00950807|364962931|FG004|Treatment Period 1|Protocol Violation|0|||
105810594|NCT00950807|364962932|FG005|Treatment Period 1|Protocol Violation|0|||
105810595|NCT00950807|364962933|FG006|Treatment Period 1|Protocol Violation|0|||
105810596|NCT00950807|364962934|FG007|Treatment Period 1|Protocol Violation|0|||
105810597|NCT00950807|364962935|FG008|Treatment Period 1|Protocol Violation|0|||
105810598|NCT00950807|364962936|FG009|Treatment Period 1|Protocol Violation|0|||
105810599|NCT00950807|364962927|FG000|Treatment Period 1|Lost to Follow-up|0|||
105810600|NCT00950807|364962928|FG001|Treatment Period 1|Lost to Follow-up|0|||
105810601|NCT00950807|364962929|FG002|Treatment Period 1|Lost to Follow-up|1|||
105810602|NCT00950807|364962930|FG003|Treatment Period 1|Lost to Follow-up|0|||
105810603|NCT00950807|364962931|FG004|Treatment Period 1|Lost to Follow-up|0|||
105953104|NCT02240121|365490322|FG001|Overall Study|Lost to Follow-up|4|||
105953105|NCT02240121|365490321|FG000|Overall Study|Other than specified|1|||
105953106|NCT02240121|365490322|FG001|Overall Study|Other than specified|3|||
105953107|NCT00648037|365490325|FG000|Overall Study|Not Treated|1|||
105953108|NCT00648037|365490325|FG000|Overall Study|Withdrawal by Subject|1|||
105953109|NCT00648037|365490325|FG000|Overall Study|Adverse Event|11|||
105953110|NCT00648037|365490325|FG000|Overall Study|Relapse|2|||
105953111|NCT00648037|365490325|FG000|Overall Study|Other|1|||
105953112|NCT04419467|365490326|FG000|Overall Study|Not treated with IP|0|||
105953113|NCT04419467|365490327|FG001|Overall Study|Not treated with IP|0|||
105953114|NCT04419467|365490328|FG002|Overall Study|Not treated with IP|2|||
105953115|NCT04419467|365490326|FG000|Overall Study|Adverse Event|0|||
105953116|NCT04419467|365490327|FG001|Overall Study|Adverse Event|2|||
105953117|NCT04419467|365490328|FG002|Overall Study|Adverse Event|0|||
105953118|NCT04419467|365490326|FG000|Overall Study|Death|1|||
105953119|NCT04419467|365490327|FG001|Overall Study|Death|0|||
105953120|NCT04419467|365490328|FG002|Overall Study|Death|0|||
105953121|NCT04419467|365490326|FG000|Overall Study|Lost to Follow-up|0|||
105953122|NCT04419467|365490327|FG001|Overall Study|Lost to Follow-up|1|||
105953123|NCT04419467|365490328|FG002|Overall Study|Lost to Follow-up|2|||
105953124|NCT04419467|365490326|FG000|Overall Study|Withdrawal by Subject|0|||
105953125|NCT04419467|365490327|FG001|Overall Study|Withdrawal by Subject|0|||
105953126|NCT04419467|365490328|FG002|Overall Study|Withdrawal by Subject|4|||
106017163|NCT01254422|365726009|FG000|Overall Study|Adverse Event|1|||
106017164|NCT01254422|365726010|FG001|Overall Study|Adverse Event|0|||
106017165|NCT01254422|365726009|FG000|Overall Study|Serious adverse event|0|||
106017166|NCT01254422|365726010|FG001|Overall Study|Serious adverse event|1|||
106017167|NCT01254422|365726009|FG000|Overall Study|Lost to Follow-up|1|||
106017168|NCT01254422|365726010|FG001|Overall Study|Lost to Follow-up|0|||
106017169|NCT00643162|365726011|FG000|Overall Study|Withdrawal by Subject|1|||
106017170|NCT00643162|365726012|FG001|Overall Study|Withdrawal by Subject|1|||
106017171|NCT01143246|365726017|FG000|Overall Study|Adverse Event|24|||
106017172|NCT01143246|365726018|FG001|Overall Study|Adverse Event|28|||
106017173|NCT01143246|365726017|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
106017174|NCT01143246|365726018|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
106017175|NCT01143246|365726017|FG000|Overall Study|Lost to Follow-up|0|||
106017176|NCT01143246|365726018|FG001|Overall Study|Lost to Follow-up|1|||
106017177|NCT01143246|365726017|FG000|Overall Study|Death|16|||
106017178|NCT01143246|365726018|FG001|Overall Study|Death|15|||
106017179|NCT01143246|365726017|FG000|Overall Study|Reason not Specified|3|||
106017180|NCT01143246|365726018|FG001|Overall Study|Reason not Specified|5|||
106017181|NCT02365597|365726019|FG000|Overall Study|Lost to Follow-up|0|||
106017182|NCT02365597|365726020|FG001|Overall Study|Lost to Follow-up|1|||
106017183|NCT02365597|365726021|FG002|Overall Study|Lost to Follow-up|0|||
106017184|NCT02365597|365726022|FG003|Overall Study|Lost to Follow-up|1|||
106017185|NCT02365597|365726019|FG000|Overall Study|Withdrawal by Subject|1|||
106017186|NCT02365597|365726020|FG001|Overall Study|Withdrawal by Subject|8|||
106017187|NCT02365597|365726021|FG002|Overall Study|Withdrawal by Subject|5|||
106017188|NCT02365597|365726022|FG003|Overall Study|Withdrawal by Subject|1|||
105810604|NCT00950807|364962932|FG005|Treatment Period 1|Lost to Follow-up|0|||
105810605|NCT00950807|364962933|FG006|Treatment Period 1|Lost to Follow-up|0|||
105953127|NCT04419467|365490326|FG000|Overall Study|Pandemic related|0|||
105953128|NCT04419467|365490327|FG001|Overall Study|Pandemic related|0|||
105953129|NCT04419467|365490328|FG002|Overall Study|Pandemic related|1|||
105953130|NCT04419467|365490326|FG000|Overall Study|Reason not known|1|||
106017189|NCT02365597|365726019|FG000|Overall Study|Sponsor's decision|1|||
105810606|NCT00950807|364962934|FG007|Treatment Period 1|Lost to Follow-up|0|||
105810607|NCT00950807|364962935|FG008|Treatment Period 1|Lost to Follow-up|0|||
105810608|NCT00950807|364962936|FG009|Treatment Period 1|Lost to Follow-up|0|||
105953131|NCT04419467|365490327|FG001|Overall Study|Reason not known|0|||
105953132|NCT04419467|365490328|FG002|Overall Study|Reason not known|0|||
105953133|NCT01925768|365490329|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
105953134|NCT01925768|365490330|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
105953135|NCT01925768|365490329|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
106017190|NCT02365597|365726020|FG001|Overall Study|Sponsor's decision|3|||
106017191|NCT02365597|365726021|FG002|Overall Study|Sponsor's decision|13|||
105953136|NCT01925768|365490330|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
105953137|NCT01925768|365490329|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
105953138|NCT01925768|365490330|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
105953139|NCT01925768|365490329|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
105953140|NCT01925768|365490330|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
105953141|NCT01925768|365490329|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
105953142|NCT01925768|365490330|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
105953143|NCT01925768|365490329|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
105953144|NCT01925768|365490330|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
105953145|NCT01925768|365490329|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
105953146|NCT01925768|365490330|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
105953147|NCT01925768|365490329|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
105953148|NCT01925768|365490330|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
105953149|NCT01925768|365490329|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
105953150|NCT01925768|365490330|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
105953151|NCT01925768|365490329|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
105953152|NCT01925768|365490330|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
105953153|NCT01925768|365490329|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
105953154|NCT01925768|365490330|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
105953155|NCT02967679|365490334|FG000|Overall Study|Adverse Event|1|||
105953156|NCT00600067|365490344|FG000|Overall Study|Adverse Event|0|||
105953157|NCT00600067|365490345|FG001|Overall Study|Adverse Event|1|||
105953158|NCT00600067|365490344|FG000|Overall Study|Lost to Follow-up|2|||
105953159|NCT00600067|365490345|FG001|Overall Study|Lost to Follow-up|3|||
105953160|NCT00600067|365490344|FG000|Overall Study|protocol non-compliance|0|||
106017192|NCT02365597|365726022|FG003|Overall Study|Sponsor's decision|0|||
106017193|NCT02365597|365726019|FG000|Overall Study|Other|0|||
106017194|NCT02365597|365726020|FG001|Overall Study|Other|4|||
105810609|NCT00950807|364962927|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105810610|NCT00950807|364962928|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105810611|NCT00950807|364962929|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105810612|NCT00950807|364962930|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105810613|NCT00950807|364962931|FG004|Treatment Period 1|Withdrawal by Subject|1|||
105810614|NCT00950807|364962932|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105810615|NCT00950807|364962933|FG006|Treatment Period 1|Withdrawal by Subject|0|||
105810616|NCT00950807|364962934|FG007|Treatment Period 1|Withdrawal by Subject|0|||
105810617|NCT00950807|364962935|FG008|Treatment Period 1|Withdrawal by Subject|1|||
105810618|NCT00950807|364962936|FG009|Treatment Period 1|Withdrawal by Subject|0|||
105810619|NCT00950807|364962927|FG000|Treatment Period 1|Adverse Event|0|||
105810620|NCT00950807|364962928|FG001|Treatment Period 1|Adverse Event|0|||
105810621|NCT00950807|364962929|FG002|Treatment Period 1|Adverse Event|0|||
105810622|NCT00950807|364962930|FG003|Treatment Period 1|Adverse Event|0|||
105810623|NCT00950807|364962931|FG004|Treatment Period 1|Adverse Event|0|||
105810624|NCT00950807|364962932|FG005|Treatment Period 1|Adverse Event|1|||
105810625|NCT00950807|364962933|FG006|Treatment Period 1|Adverse Event|0|||
105810626|NCT00950807|364962934|FG007|Treatment Period 1|Adverse Event|0|||
105810627|NCT00950807|364962935|FG008|Treatment Period 1|Adverse Event|0|||
105810628|NCT00950807|364962936|FG009|Treatment Period 1|Adverse Event|0|||
105810629|NCT00950807|364962927|FG000|Washout Period 1|Lack of Efficacy|0|||
105810630|NCT00950807|364962928|FG001|Washout Period 1|Lack of Efficacy|0|||
105810631|NCT00950807|364962929|FG002|Washout Period 1|Lack of Efficacy|0|||
105810632|NCT00950807|364962930|FG003|Washout Period 1|Lack of Efficacy|0|||
105810633|NCT00950807|364962931|FG004|Washout Period 1|Lack of Efficacy|0|||
105810634|NCT00950807|364962932|FG005|Washout Period 1|Lack of Efficacy|0|||
105810635|NCT00950807|364962933|FG006|Washout Period 1|Lack of Efficacy|1|||
105810636|NCT00950807|364962934|FG007|Washout Period 1|Lack of Efficacy|0|||
105810637|NCT00950807|364962935|FG008|Washout Period 1|Lack of Efficacy|0|||
105810638|NCT00950807|364962936|FG009|Washout Period 1|Lack of Efficacy|0|||
105810639|NCT00950807|364962927|FG000|Washout Period 1|Withdrawal by Subject|0|||
105810640|NCT00950807|364962928|FG001|Washout Period 1|Withdrawal by Subject|0|||
105810641|NCT00950807|364962929|FG002|Washout Period 1|Withdrawal by Subject|0|||
105810642|NCT00950807|364962930|FG003|Washout Period 1|Withdrawal by Subject|0|||
105810643|NCT00950807|364962931|FG004|Washout Period 1|Withdrawal by Subject|0|||
106017195|NCT02365597|365726021|FG002|Overall Study|Other|0|||
105810644|NCT00950807|364962932|FG005|Washout Period 1|Withdrawal by Subject|0|||
105810645|NCT00950807|364962933|FG006|Washout Period 1|Withdrawal by Subject|0|||
105810646|NCT00950807|364962934|FG007|Washout Period 1|Withdrawal by Subject|0|||
105810647|NCT00950807|364962935|FG008|Washout Period 1|Withdrawal by Subject|1|||
105810648|NCT00950807|364962936|FG009|Washout Period 1|Withdrawal by Subject|0|||
105810649|NCT00950807|364962927|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
105810650|NCT00950807|364962928|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810651|NCT00950807|364962929|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105953161|NCT00600067|365490345|FG001|Overall Study|protocol non-compliance|3|||
106017196|NCT02365597|365726022|FG003|Overall Study|Other|0|||
105810652|NCT00950807|364962930|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810653|NCT00950807|364962931|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810654|NCT00950807|364962932|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810655|NCT00950807|364962933|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
105810656|NCT00950807|364962934|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
105810657|NCT00950807|364962935|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810658|NCT00950807|364962936|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
105810659|NCT00950807|364962927|FG000|Washout Period 1|Adverse Event|2|||
105810660|NCT00950807|364962928|FG001|Washout Period 1|Adverse Event|0|||
105810661|NCT00950807|364962929|FG002|Washout Period 1|Adverse Event|0|||
105810662|NCT00950807|364962930|FG003|Washout Period 1|Adverse Event|1|||
105810663|NCT00950807|364962931|FG004|Washout Period 1|Adverse Event|1|||
105810664|NCT00950807|364962932|FG005|Washout Period 1|Adverse Event|0|||
105810665|NCT00950807|364962933|FG006|Washout Period 1|Adverse Event|0|||
105810666|NCT00950807|364962934|FG007|Washout Period 1|Adverse Event|0|||
105810667|NCT00950807|364962935|FG008|Washout Period 1|Adverse Event|0|||
105810668|NCT00950807|364962936|FG009|Washout Period 1|Adverse Event|0|||
105810669|NCT00950807|364962927|FG000|Treatment Period 2|Lack of Efficacy|1|||
105810670|NCT00950807|364962928|FG001|Treatment Period 2|Lack of Efficacy|0|||
105810671|NCT00950807|364962929|FG002|Treatment Period 2|Lack of Efficacy|0|||
105810672|NCT00950807|364962930|FG003|Treatment Period 2|Lack of Efficacy|0|||
105810673|NCT00950807|364962931|FG004|Treatment Period 2|Lack of Efficacy|0|||
105810674|NCT00950807|364962932|FG005|Treatment Period 2|Lack of Efficacy|0|||
105810675|NCT00950807|364962933|FG006|Treatment Period 2|Lack of Efficacy|0|||
105810676|NCT00950807|364962934|FG007|Treatment Period 2|Lack of Efficacy|0|||
105810677|NCT00950807|364962935|FG008|Treatment Period 2|Lack of Efficacy|0|||
105810678|NCT00950807|364962936|FG009|Treatment Period 2|Lack of Efficacy|0|||
105810679|NCT00950807|364962927|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105810680|NCT00950807|364962928|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105810681|NCT00950807|364962929|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105810682|NCT00950807|364962930|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105810683|NCT00950807|364962931|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105810684|NCT00950807|364962932|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105810685|NCT00950807|364962933|FG006|Treatment Period 2|Withdrawal by Subject|1|||
105810686|NCT00950807|364962934|FG007|Treatment Period 2|Withdrawal by Subject|2|||
105810687|NCT00950807|364962935|FG008|Treatment Period 2|Withdrawal by Subject|0|||
105810688|NCT00950807|364962936|FG009|Treatment Period 2|Withdrawal by Subject|0|||
105810689|NCT00950807|364962927|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
105810690|NCT00950807|364962928|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810691|NCT00950807|364962929|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810692|NCT00950807|364962930|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810693|NCT00950807|364962931|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810694|NCT00950807|364962932|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810695|NCT00950807|364962933|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810696|NCT00950807|364962934|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810697|NCT00950807|364962935|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810698|NCT00950807|364962936|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
105810699|NCT00950807|364962927|FG000|Treatment Period 2|Adverse Event|0|||
105810700|NCT00950807|364962928|FG001|Treatment Period 2|Adverse Event|1|||
105810701|NCT00950807|364962929|FG002|Treatment Period 2|Adverse Event|0|||
105810702|NCT00950807|364962930|FG003|Treatment Period 2|Adverse Event|1|||
105810703|NCT00950807|364962931|FG004|Treatment Period 2|Adverse Event|0|||
105810704|NCT00950807|364962932|FG005|Treatment Period 2|Adverse Event|1|||
105810705|NCT00950807|364962933|FG006|Treatment Period 2|Adverse Event|0|||
105810706|NCT00950807|364962934|FG007|Treatment Period 2|Adverse Event|1|||
105810707|NCT00950807|364962935|FG008|Treatment Period 2|Adverse Event|0|||
105810708|NCT00950807|364962936|FG009|Treatment Period 2|Adverse Event|0|||
105810709|NCT00950807|364962927|FG000|Washout Period 2|Lack of Efficacy|1|||
105810710|NCT00950807|364962928|FG001|Washout Period 2|Lack of Efficacy|0|||
105810711|NCT00950807|364962929|FG002|Washout Period 2|Lack of Efficacy|0|||
105810712|NCT00950807|364962930|FG003|Washout Period 2|Lack of Efficacy|0|||
105810713|NCT00950807|364962931|FG004|Washout Period 2|Lack of Efficacy|0|||
105810714|NCT00950807|364962932|FG005|Washout Period 2|Lack of Efficacy|0|||
105810715|NCT00950807|364962933|FG006|Washout Period 2|Lack of Efficacy|0|||
105810716|NCT00950807|364962934|FG007|Washout Period 2|Lack of Efficacy|0|||
105810717|NCT00950807|364962935|FG008|Washout Period 2|Lack of Efficacy|0|||
105810718|NCT00950807|364962936|FG009|Washout Period 2|Lack of Efficacy|0|||
105810719|NCT00950807|364962927|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810720|NCT00950807|364962928|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
105810721|NCT00950807|364962929|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105953162|NCT00600067|365490344|FG000|Overall Study|Lack of Efficacy|1|||
105810722|NCT00950807|364962930|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810723|NCT00950807|364962931|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
105810724|NCT00950807|364962932|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810725|NCT00950807|364962933|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
105810726|NCT00950807|364962934|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
105810727|NCT00950807|364962935|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810728|NCT00950807|364962936|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
105810729|NCT00950807|364962927|FG000|Washout Period 2|Adverse Event|3|||
105810730|NCT00950807|364962928|FG001|Washout Period 2|Adverse Event|0|||
105810731|NCT00950807|364962929|FG002|Washout Period 2|Adverse Event|0|||
105810732|NCT00950807|364962930|FG003|Washout Period 2|Adverse Event|1|||
105810733|NCT00950807|364962931|FG004|Washout Period 2|Adverse Event|0|||
105810734|NCT00950807|364962932|FG005|Washout Period 2|Adverse Event|0|||
105810735|NCT00950807|364962933|FG006|Washout Period 2|Adverse Event|0|||
105810736|NCT00950807|364962934|FG007|Washout Period 2|Adverse Event|0|||
105810737|NCT00950807|364962935|FG008|Washout Period 2|Adverse Event|0|||
105810738|NCT00950807|364962936|FG009|Washout Period 2|Adverse Event|0|||
105810739|NCT00950807|364962927|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105810740|NCT00950807|364962928|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105810741|NCT00950807|364962929|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105810742|NCT00950807|364962930|FG003|Treatment Period 3|Withdrawal by Subject|0|||
105810743|NCT00950807|364962931|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105810744|NCT00950807|364962932|FG005|Treatment Period 3|Withdrawal by Subject|0|||
105810745|NCT00950807|364962933|FG006|Treatment Period 3|Withdrawal by Subject|0|||
105810746|NCT00950807|364962934|FG007|Treatment Period 3|Withdrawal by Subject|0|||
105810747|NCT00950807|364962935|FG008|Treatment Period 3|Withdrawal by Subject|0|||
105810748|NCT00950807|364962936|FG009|Treatment Period 3|Withdrawal by Subject|1|||
105810749|NCT00950807|364962927|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
105810750|NCT00950807|364962928|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810751|NCT00950807|364962929|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810752|NCT00950807|364962930|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810753|NCT00950807|364962931|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810754|NCT00950807|364962932|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810755|NCT00950807|364962933|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810756|NCT00950807|364962934|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
105810757|NCT00950807|364962935|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810758|NCT00950807|364962936|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
105810759|NCT00950807|364962927|FG000|Treatment Period 3|Adverse Event|0|||
105810760|NCT00950807|364962928|FG001|Treatment Period 3|Adverse Event|0|||
105810761|NCT00950807|364962929|FG002|Treatment Period 3|Adverse Event|0|||
105810762|NCT00950807|364962930|FG003|Treatment Period 3|Adverse Event|0|||
105810763|NCT00950807|364962931|FG004|Treatment Period 3|Adverse Event|0|||
105810764|NCT00950807|364962932|FG005|Treatment Period 3|Adverse Event|0|||
105810765|NCT00950807|364962933|FG006|Treatment Period 3|Adverse Event|1|||
105810766|NCT00950807|364962934|FG007|Treatment Period 3|Adverse Event|0|||
105810767|NCT00950807|364962935|FG008|Treatment Period 3|Adverse Event|0|||
105810768|NCT00950807|364962936|FG009|Treatment Period 3|Adverse Event|0|||
105810769|NCT00891293|364962937|FG000|Overall Study|Adverse Event|2|||
105810770|NCT00891293|364962937|FG000|Overall Study|Protocol Violation|2|||
105810771|NCT00891293|364962937|FG000|Overall Study|Laboratory abnormality|4|||
105810772|NCT00891293|364962937|FG000|Overall Study|Lost to Follow-up|7|||
105810773|NCT00891293|364962937|FG000|Overall Study|Subject withdrew consent|7|||
105810774|NCT00891293|364962937|FG000|Overall Study|Sponsor termination|62|||
105810775|NCT03982433|364962938|FG000|Overall Study|Lost to Follow-up|1|||
105810776|NCT00906347|364962939|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
105810777|NCT00906347|364962940|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
105810778|NCT00906347|364962939|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
105810779|NCT00906347|364962940|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
105810780|NCT00906347|364962939|FG000|Received Study Drug|Refused study drug|1|||
105810781|NCT00906347|364962940|FG001|Received Study Drug|Refused study drug|0|||
105810782|NCT00906347|364962939|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
105810783|NCT00906347|364962940|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
105810784|NCT00984295|364962941|FG000|Overall Study|Lost to Follow-up|31|||
105810785|NCT00984295|364962942|FG001|Overall Study|Lost to Follow-up|12|||
105810786|NCT00984295|364962943|FG002|Overall Study|Lost to Follow-up|13|||
105810787|NCT00984295|364962941|FG000|Overall Study|Protocol Violation|2|||
105810788|NCT00984295|364962942|FG001|Overall Study|Protocol Violation|1|||
105810789|NCT00984295|364962943|FG002|Overall Study|Protocol Violation|4|||
105810790|NCT00984295|364962941|FG000|Overall Study|Withdrawal by Subject|18|||
106017197|NCT02365597|365726019|FG000|Overall Study|Enrolled but not treated|0|||
106017198|NCT02365597|365726020|FG001|Overall Study|Enrolled but not treated|1|||
106017199|NCT02365597|365726021|FG002|Overall Study|Enrolled but not treated|1|||
106017200|NCT02365597|365726022|FG003|Overall Study|Enrolled but not treated|0|||
106017201|NCT02365597|365726019|FG000|Overall Study|Ongoing|0|||
106017202|NCT02365597|365726020|FG001|Overall Study|Ongoing|0|||
106017203|NCT02365597|365726021|FG002|Overall Study|Ongoing|0|||
106017204|NCT02365597|365726022|FG003|Overall Study|Ongoing|17|||
105810791|NCT00984295|364962942|FG001|Overall Study|Withdrawal by Subject|9|||
105810792|NCT00984295|364962943|FG002|Overall Study|Withdrawal by Subject|12|||
105810793|NCT00984295|364962941|FG000|Overall Study|CAE - discontinued test vaccine|0|||
105810794|NCT00984295|364962942|FG001|Overall Study|CAE - discontinued test vaccine|1|||
105810795|NCT00984295|364962943|FG002|Overall Study|CAE - discontinued test vaccine|3|||
105810796|NCT00984295|364962941|FG000|Overall Study|Missed one or more blood samplings|3|||
105810797|NCT00984295|364962942|FG001|Overall Study|Missed one or more blood samplings|7|||
105810798|NCT00984295|364962943|FG002|Overall Study|Missed one or more blood samplings|2|||
105810799|NCT00984295|364962941|FG000|Overall Study|Incomplete safety follow-up|11|||
105810800|NCT00984295|364962942|FG001|Overall Study|Incomplete safety follow-up|2|||
105810801|NCT00984295|364962943|FG002|Overall Study|Incomplete safety follow-up|3|||
105810802|NCT00788957|364962952|FG000|Part 1|Death|8|||
105810803|NCT00788957|364962953|FG001|Part 1|Death|0|||
105810804|NCT00788957|364962954|FG002|Part 1|Death|0|||
105810805|NCT00788957|364962955|FG003|Part 1|Death|0|||
105810806|NCT00788957|364962956|FG004|Part 1|Death|0|||
105810807|NCT00788957|364962957|FG005|Part 1|Death|0|||
105810808|NCT00788957|364962952|FG000|Part 1|Lost to Follow-up|1|||
105810809|NCT00788957|364962953|FG001|Part 1|Lost to Follow-up|0|||
105810810|NCT00788957|364962954|FG002|Part 1|Lost to Follow-up|0|||
105810811|NCT00788957|364962955|FG003|Part 1|Lost to Follow-up|0|||
105810812|NCT00788957|364962956|FG004|Part 1|Lost to Follow-up|0|||
105810813|NCT00788957|364962957|FG005|Part 1|Lost to Follow-up|0|||
105810814|NCT00788957|364962952|FG000|Part 2|Withdrawal by Subject|0|||
105810815|NCT00788957|364962953|FG001|Part 2|Withdrawal by Subject|9|||
105810816|NCT00788957|364962954|FG002|Part 2|Withdrawal by Subject|5|||
105810817|NCT00788957|364962955|FG003|Part 2|Withdrawal by Subject|3|||
105810818|NCT00788957|364962956|FG004|Part 2|Withdrawal by Subject|0|||
105810819|NCT00788957|364962957|FG005|Part 2|Withdrawal by Subject|0|||
105810820|NCT00788957|364962952|FG000|Part 2|Death|0|||
105810821|NCT00788957|364962953|FG001|Part 2|Death|32|||
105810822|NCT00788957|364962954|FG002|Part 2|Death|35|||
105810823|NCT00788957|364962955|FG003|Part 2|Death|37|||
105810824|NCT00788957|364962956|FG004|Part 2|Death|0|||
105953163|NCT00600067|365490345|FG001|Overall Study|Lack of Efficacy|0|||
105953164|NCT04339413|365490346|FG000|Overall Study|Reason Not Specified|2|||
105953165|NCT04339413|365490347|FG001|Overall Study|Reason Not Specified|7|||
105953166|NCT04339413|365490346|FG000|Overall Study|Study Terminated by Sponsor|30|||
105953167|NCT04339413|365490347|FG001|Overall Study|Study Terminated by Sponsor|33|||
105953168|NCT04339413|365490346|FG000|Overall Study|Progressive Disease|9|||
105953169|NCT04339413|365490347|FG001|Overall Study|Progressive Disease|6|||
105953170|NCT04339413|365490346|FG000|Overall Study|Withdrawal by Subject|9|||
105953171|NCT04339413|365490347|FG001|Overall Study|Withdrawal by Subject|10|||
105953172|NCT04339413|365490346|FG000|Overall Study|Physician Decision|3|||
105953173|NCT04339413|365490347|FG001|Overall Study|Physician Decision|1|||
105953174|NCT04339413|365490346|FG000|Overall Study|Death|2|||
105953175|NCT04339413|365490347|FG001|Overall Study|Death|0|||
105953176|NCT04339413|365490346|FG000|Overall Study|Adverse Event|3|||
105953177|NCT04339413|365490347|FG001|Overall Study|Adverse Event|0|||
105953178|NCT03188263|365490351|FG000|Overall Study|Withdrawal by Subject|3|||
105953179|NCT03188263|365490352|FG001|Overall Study|Withdrawal by Subject|0|||
105953180|NCT03188263|365490351|FG000|Overall Study|Physician Decision|1|||
105953181|NCT03188263|365490352|FG001|Overall Study|Physician Decision|0|||
105953182|NCT00539240|365490353|FG000|Overall Study|Withdrawal by Subject|0|||
105953183|NCT00539240|365490354|FG001|Overall Study|Withdrawal by Subject|2|||
105953184|NCT00539240|365490355|FG002|Overall Study|Withdrawal by Subject|0|||
105953185|NCT00539240|365490353|FG000|Overall Study|Protocol Violation|1|||
105953186|NCT00539240|365490354|FG001|Overall Study|Protocol Violation|1|||
105953187|NCT00539240|365490355|FG002|Overall Study|Protocol Violation|4|||
105953188|NCT00539240|365490353|FG000|Overall Study|Lost to Follow-up|2|||
105953189|NCT00539240|365490354|FG001|Overall Study|Lost to Follow-up|3|||
105953190|NCT00539240|365490355|FG002|Overall Study|Lost to Follow-up|1|||
105810825|NCT00788957|364962957|FG005|Part 2|Death|0|||
105953191|NCT00539240|365490353|FG000|Overall Study|Adverse Event|3|||
105810826|NCT00788957|364962952|FG000|Part 2|Lost to Follow-up|0|||
105810827|NCT00788957|364962953|FG001|Part 2|Lost to Follow-up|0|||
105810828|NCT00788957|364962954|FG002|Part 2|Lost to Follow-up|3|||
105810829|NCT00788957|364962955|FG003|Part 2|Lost to Follow-up|0|||
105953192|NCT00539240|365490354|FG001|Overall Study|Adverse Event|1|||
105953193|NCT00539240|365490355|FG002|Overall Study|Adverse Event|10|||
105953194|NCT01284959|365490356|FG000|Overall Study|Withdrawal by Subject|1|||
105810830|NCT00788957|364962956|FG004|Part 2|Lost to Follow-up|0|||
105810831|NCT00788957|364962957|FG005|Part 2|Lost to Follow-up|0|||
105810832|NCT00788957|364962952|FG000|Part 2|On-study at time of data cut-off|0|||
105810833|NCT00788957|364962953|FG001|Part 2|On-study at time of data cut-off|1|||
105810834|NCT00788957|364962954|FG002|Part 2|On-study at time of data cut-off|1|||
105810835|NCT00788957|364962955|FG003|Part 2|On-study at time of data cut-off|1|||
105953195|NCT01284959|365490357|FG001|Overall Study|Withdrawal by Subject|0|||
105953196|NCT01284959|365490358|FG002|Overall Study|Withdrawal by Subject|0|||
105953197|NCT01284959|365490356|FG000|Overall Study|Adverse Event|0|||
105953198|NCT01284959|365490357|FG001|Overall Study|Adverse Event|0|||
105953199|NCT01284959|365490358|FG002|Overall Study|Adverse Event|1|||
105953200|NCT00326599|365490365|FG000|Overall Study|Withdrawal by Subject|1|||
105953201|NCT00326599|365490366|FG001|Overall Study|Withdrawal by Subject|0|||
105953202|NCT00326599|365490367|FG002|Overall Study|Withdrawal by Subject|5|||
105953203|NCT00326599|365490368|FG003|Overall Study|Withdrawal by Subject|2|||
105953204|NCT00326599|365490365|FG000|Overall Study|Adverse Event|1|||
105953205|NCT00326599|365490366|FG001|Overall Study|Adverse Event|0|||
105953206|NCT00326599|365490367|FG002|Overall Study|Adverse Event|32|||
105953207|NCT00326599|365490368|FG003|Overall Study|Adverse Event|3|||
105953208|NCT00326599|365490365|FG000|Overall Study|Disease Progression|3|||
105953209|NCT00326599|365490366|FG001|Overall Study|Disease Progression|1|||
105953210|NCT00326599|365490367|FG002|Overall Study|Disease Progression|13|||
105953211|NCT00326599|365490368|FG003|Overall Study|Disease Progression|11|||
105953212|NCT00326599|365490365|FG000|Overall Study|Alternate Treatment|1|||
105953213|NCT00326599|365490366|FG001|Overall Study|Alternate Treatment|0|||
106144890|NCT00959946|366190756|FG003|Overall Study|Disease Progression|4|||
105953214|NCT00326599|365490367|FG002|Overall Study|Alternate Treatment|0|||
105953215|NCT00326599|365490368|FG003|Overall Study|Alternate Treatment|0|||
105953216|NCT00326599|365490365|FG000|Overall Study|Death|0|||
105953217|NCT00326599|365490366|FG001|Overall Study|Death|0|||
105953218|NCT00326599|365490367|FG002|Overall Study|Death|1|||
105953219|NCT00326599|365490368|FG003|Overall Study|Death|2|||
105953220|NCT00326599|365490365|FG000|Overall Study|Other Unspecified Reason|0|||
105953221|NCT00326599|365490366|FG001|Overall Study|Other Unspecified Reason|0|||
105953222|NCT00326599|365490367|FG002|Overall Study|Other Unspecified Reason|2|||
105953223|NCT00326599|365490368|FG003|Overall Study|Other Unspecified Reason|1|||
105953224|NCT01182298|365490369|FG000|Overall Study|Lack of Efficacy|4|||
105953225|NCT01182298|365490369|FG000|Overall Study|Withdrawal by Subject|2|||
105953226|NCT01991483|365490372|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
105953227|NCT01991483|365490373|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
105953228|NCT01991483|365490374|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
105953229|NCT01991483|365490375|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
105953230|NCT01991483|365490372|FG000|Dose Level 600 mg|Physician Decision|0|||
105953231|NCT01991483|365490373|FG001|Dose Level 600 mg|Physician Decision|0|||
105953232|NCT01991483|365490374|FG002|Dose Level 600 mg|Physician Decision|1|||
105953233|NCT01991483|365490375|FG003|Dose Level 600 mg|Physician Decision|0|||
105953234|NCT01991483|365490372|FG000|Dose Level 1000 mg|Protocol Violation|0|||
105953235|NCT01991483|365490373|FG001|Dose Level 1000 mg|Protocol Violation|0|||
105953236|NCT01991483|365490374|FG002|Dose Level 1000 mg|Protocol Violation|0|||
105953237|NCT01991483|365490375|FG003|Dose Level 1000 mg|Protocol Violation|1|||
105953238|NCT01261975|365490379|FG000|Overall Study|Surgical complication|1|||
105953239|NCT00716274|365490380|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
105953240|NCT00716274|365490381|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105953241|NCT00716274|365490382|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105953242|NCT00716274|365490383|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105953243|NCT00716274|365490384|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105953244|NCT00716274|365490385|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
105953245|NCT00716274|365490380|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
105953246|NCT00716274|365490381|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
105953247|NCT00716274|365490382|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
105953248|NCT00716274|365490383|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
105953249|NCT00716274|365490384|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
105953250|NCT00716274|365490385|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
105953251|NCT00716274|365490380|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
105953252|NCT00716274|365490381|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105953253|NCT00716274|365490382|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105953254|NCT00716274|365490383|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105953255|NCT00716274|365490384|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105953256|NCT00716274|365490385|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
105953257|NCT00716274|365490380|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
105953258|NCT00716274|365490381|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
105953259|NCT00716274|365490382|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
105953260|NCT00716274|365490383|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
105953261|NCT00716274|365490384|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
106144891|NCT00959946|366190757|FG004|Overall Study|Disease Progression|4|||
106144892|NCT00959946|366190758|FG005|Overall Study|Disease Progression|6|||
106144893|NCT00959946|366190759|FG006|Overall Study|Disease Progression|2|||
105953262|NCT00716274|365490385|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
105953263|NCT00716274|365490380|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
105953264|NCT00716274|365490381|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
105953265|NCT00716274|365490382|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
105953266|NCT00716274|365490383|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
105953267|NCT00716274|365490384|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
105953268|NCT00716274|365490385|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
105810836|NCT00788957|364962956|FG004|Part 2|On-study at time of data cut-off|0|||
105810837|NCT00788957|364962957|FG005|Part 2|On-study at time of data cut-off|0|||
105810838|NCT00788957|364962952|FG000|Part 3|Withdrawal by Subject|0|||
105810839|NCT00788957|364962953|FG001|Part 3|Withdrawal by Subject|0|||
105810840|NCT00788957|364962954|FG002|Part 3|Withdrawal by Subject|0|||
105810841|NCT00788957|364962955|FG003|Part 3|Withdrawal by Subject|0|||
105810842|NCT00788957|364962956|FG004|Part 3|Withdrawal by Subject|0|||
105810843|NCT00788957|364962957|FG005|Part 3|Withdrawal by Subject|2|||
105810844|NCT00788957|364962952|FG000|Part 3|Death|0|||
105810845|NCT00788957|364962953|FG001|Part 3|Death|0|||
105810846|NCT00788957|364962954|FG002|Part 3|Death|0|||
105810847|NCT00788957|364962955|FG003|Part 3|Death|0|||
105810848|NCT00788957|364962956|FG004|Part 3|Death|8|||
105810849|NCT00788957|364962957|FG005|Part 3|Death|8|||
105810850|NCT00788957|364962952|FG000|Part 3|On-study at time of data cut-off|0|||
105810851|NCT00788957|364962953|FG001|Part 3|On-study at time of data cut-off|0|||
105810852|NCT00788957|364962954|FG002|Part 3|On-study at time of data cut-off|0|||
105810853|NCT00788957|364962955|FG003|Part 3|On-study at time of data cut-off|0|||
105810854|NCT00788957|364962956|FG004|Part 3|On-study at time of data cut-off|1|||
105810855|NCT00788957|364962957|FG005|Part 3|On-study at time of data cut-off|0|||
105810856|NCT03387098|364962958|FG000|Overall Study|progressive disease|1|||
105810857|NCT03387098|364962958|FG000|Overall Study|Withdrawal by Subject|2|||
105810858|NCT03387098|364962958|FG000|Overall Study|study terminated by sponsor|1|||
105810859|NCT02277769|364962959|FG000|Overall Study|Protocol Violation|3|||
105810860|NCT02277769|364962960|FG001|Overall Study|Protocol Violation|3|||
105810861|NCT02277769|364962961|FG002|Overall Study|Protocol Violation|5|||
105810862|NCT02277769|364962959|FG000|Overall Study|Lack of Efficacy|17|||
105810863|NCT02277769|364962960|FG001|Overall Study|Lack of Efficacy|0|||
105810864|NCT02277769|364962961|FG002|Overall Study|Lack of Efficacy|4|||
105810865|NCT02277769|364962959|FG000|Overall Study|Adverse Event|14|||
105810866|NCT02277769|364962960|FG001|Overall Study|Adverse Event|2|||
105810867|NCT02277769|364962961|FG002|Overall Study|Adverse Event|4|||
105810868|NCT02277769|364962959|FG000|Overall Study|Other than specified above|12|||
105810869|NCT02277769|364962960|FG001|Overall Study|Other than specified above|8|||
105810870|NCT02277769|364962961|FG002|Overall Study|Other than specified above|5|||
105810871|NCT03384745|364962962|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
105810872|NCT03384745|364962963|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
105810873|NCT03384745|364962964|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
105810874|NCT03384745|364962965|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
105810875|NCT03384745|364962966|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
105810876|NCT03384745|364962967|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
105810877|NCT03384745|364962962|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
105810878|NCT03384745|364962963|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
105810879|NCT03384745|364962964|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
105810880|NCT03384745|364962965|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
105810881|NCT03384745|364962966|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
105810882|NCT03384745|364962967|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
105810883|NCT03384745|364962962|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
105810884|NCT03384745|364962963|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
105810885|NCT03384745|364962964|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
105810886|NCT03384745|364962965|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
105810887|NCT03384745|364962966|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
105810888|NCT03384745|364962967|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
105810889|NCT03384745|364962962|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810890|NCT03384745|364962963|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810891|NCT03384745|364962964|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
105810892|NCT03384745|364962965|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810893|NCT03384745|364962966|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810894|NCT03384745|364962967|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
105810895|NCT03384745|364962962|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
105810896|NCT03384745|364962963|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
105810897|NCT03384745|364962964|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
105810898|NCT03384745|364962965|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
105810899|NCT03384745|364962966|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
105810900|NCT03384745|364962967|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
105810901|NCT03384745|364962962|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105810902|NCT03384745|364962963|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105810903|NCT03384745|364962964|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105810904|NCT03384745|364962965|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
105810905|NCT03384745|364962966|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
105810906|NCT03384745|364962967|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
106017205|NCT02175030|365726023|FG000|Overall Study|Failed screen after consent|7|||
105953269|NCT00716274|365490380|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105953270|NCT00716274|365490381|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
105953271|NCT00716274|365490382|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105953272|NCT00716274|365490383|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105953273|NCT00716274|365490384|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105953274|NCT00716274|365490385|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
105953275|NCT00716274|365490380|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105953276|NCT00716274|365490381|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105953277|NCT00716274|365490382|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
105953278|NCT00716274|365490383|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105953279|NCT00716274|365490384|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105953280|NCT00716274|365490385|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
105953281|NCT00716274|365490380|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
105953282|NCT00716274|365490381|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
105953283|NCT00716274|365490382|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
105953284|NCT00716274|365490383|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
105953285|NCT00716274|365490384|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
105953286|NCT00716274|365490385|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
105953287|NCT00716274|365490380|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
105953288|NCT00716274|365490381|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
105953289|NCT00716274|365490382|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
105953290|NCT00716274|365490383|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
105953291|NCT00716274|365490384|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
105953292|NCT00716274|365490385|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
105953293|NCT00716274|365490380|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
105953294|NCT00716274|365490381|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
106017206|NCT02175030|365726024|FG001|Overall Study|Failed screen after consent|6|||
106017207|NCT02175030|365726023|FG000|Overall Study|Failed IUD Insertion|20|||
106017208|NCT02175030|365726024|FG001|Overall Study|Failed IUD Insertion|21|||
106017209|NCT02175030|365726023|FG000|Overall Study|Physician Decision|1|||
106017210|NCT02175030|365726024|FG001|Overall Study|Physician Decision|1|||
106017211|NCT02175030|365726023|FG000|Overall Study|Lost to Follow-up|6|||
106017212|NCT02175030|365726024|FG001|Overall Study|Lost to Follow-up|6|||
106017213|NCT02175030|365726023|FG000|Overall Study|Withdrawal by Subject|1|||
106017214|NCT02175030|365726024|FG001|Overall Study|Withdrawal by Subject|4|||
106017215|NCT00888940|365726027|FG000|Overall Study|Adverse Event|12|||
106017216|NCT00888940|365726028|FG001|Overall Study|Adverse Event|3|||
106017217|NCT00888940|365726027|FG000|Overall Study|Lost to Follow-up|5|||
106017218|NCT00888940|365726028|FG001|Overall Study|Lost to Follow-up|5|||
106017219|NCT00888940|365726027|FG000|Overall Study|Randomized Not Treated|11|||
106017220|NCT00888940|365726028|FG001|Overall Study|Randomized Not Treated|13|||
106017221|NCT01106248|365726029|FG000|Overall Study|Adverse Event|1|||
105810907|NCT03384745|364962962|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
105810908|NCT03384745|364962963|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
105810909|NCT03384745|364962964|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
105810910|NCT03384745|364962965|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
105810911|NCT03384745|364962966|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
105810912|NCT03384745|364962967|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
105810913|NCT03384745|364962962|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
105810914|NCT03384745|364962963|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
105810915|NCT03384745|364962964|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
105810916|NCT03384745|364962965|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
105810917|NCT03384745|364962966|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
105810918|NCT03384745|364962967|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
105810919|NCT03384745|364962962|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
105810920|NCT03384745|364962963|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
105810921|NCT03384745|364962964|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
105810922|NCT03384745|364962965|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
105810923|NCT03384745|364962966|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
105810924|NCT03384745|364962967|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
105810925|NCT03384745|364962962|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105810926|NCT03384745|364962963|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105810927|NCT03384745|364962964|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105810928|NCT03384745|364962965|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
105810929|NCT03384745|364962966|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
106017222|NCT01106248|365726029|FG000|Overall Study|Administrative|2|||
105953295|NCT00716274|365490382|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
105810930|NCT03384745|364962967|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
105810931|NCT03384745|364962962|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
105953296|NCT00716274|365490383|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
105953297|NCT00716274|365490384|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
105953298|NCT00716274|365490385|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
105953299|NCT00444925|365490386|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
105953300|NCT00444925|365490387|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
105953301|NCT00444925|365490388|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
105953302|NCT00444925|365490386|FG000|Double-blind Treatment Period|Death|2|||
105953303|NCT00444925|365490387|FG001|Double-blind Treatment Period|Death|0|||
105953304|NCT00444925|365490388|FG002|Double-blind Treatment Period|Death|0|||
105953305|NCT00444925|365490386|FG000|Double-blind Treatment Period|Adverse Event|6|||
105953306|NCT00444925|365490387|FG001|Double-blind Treatment Period|Adverse Event|28|||
105953307|NCT00444925|365490388|FG002|Double-blind Treatment Period|Adverse Event|44|||
105953308|NCT00444925|365490386|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
105953309|NCT00444925|365490387|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
105953310|NCT00444925|365490388|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
105953311|NCT00444925|365490386|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
105953312|NCT00444925|365490387|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
105953313|NCT00444925|365490388|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
105953314|NCT00444925|365490386|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
105953315|NCT00444925|365490387|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
105953316|NCT00444925|365490388|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
105953317|NCT00444925|365490386|FG000|Double-blind Treatment Period|Other|7|||
105953318|NCT00444925|365490387|FG001|Double-blind Treatment Period|Other|7|||
105953319|NCT00444925|365490388|FG002|Double-blind Treatment Period|Other|12|||
106017223|NCT00357903|365726030|FG000|Overall Study|Adverse Event|87|||
105953320|NCT00943761|365490392|FG000|Overall Study|Lost to Follow-up|2|||
105953321|NCT00943761|365490393|FG001|Overall Study|Lost to Follow-up|0|||
105953322|NCT00943761|365490392|FG000|Overall Study|Withdrawal by Subject|2|||
105953323|NCT00943761|365490393|FG001|Overall Study|Withdrawal by Subject|1|||
105953324|NCT02735421|365491736|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
105953325|NCT02735421|365491736|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
105953326|NCT02735421|365491736|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
105953327|NCT02735421|365491736|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
105953328|NCT02735421|365491736|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
105953329|NCT02735421|365491736|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
105953330|NCT02735421|365491736|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
105953331|NCT00269113|365491737|FG000|Overall Study|Adverse Event|14|||
105953332|NCT00269113|365491738|FG001|Overall Study|Adverse Event|7|||
105953333|NCT00269113|365491737|FG000|Overall Study|Lack of Efficacy|35|||
105953334|NCT00269113|365491738|FG001|Overall Study|Lack of Efficacy|18|||
105953335|NCT00269113|365491737|FG000|Overall Study|Early Improvement|2|||
105953336|NCT00269113|365491738|FG001|Overall Study|Early Improvement|0|||
105953337|NCT00269113|365491737|FG000|Overall Study|Withdrawal by Subject|0|||
106017224|NCT00357903|365726031|FG001|Overall Study|Adverse Event|4|||
106017225|NCT00357903|365726030|FG000|Overall Study|Death|33|||
106017226|NCT00357903|365726031|FG001|Overall Study|Death|0|||
106017227|NCT00357903|365726030|FG000|Overall Study|Lost to Follow-up|23|||
106017228|NCT00357903|365726031|FG001|Overall Study|Lost to Follow-up|4|||
106017229|NCT00357903|365726030|FG000|Overall Study|Physician Decision|39|||
106017230|NCT00357903|365726031|FG001|Overall Study|Physician Decision|5|||
106017231|NCT00357903|365726030|FG000|Overall Study|Withdrawal by Subject|57|||
106017232|NCT00357903|365726031|FG001|Overall Study|Withdrawal by Subject|7|||
106017233|NCT00357903|365726030|FG000|Overall Study|Completed month 12 only|0|||
106017234|NCT00357903|365726031|FG001|Overall Study|Completed month 12 only|1|||
106017235|NCT00357903|365726030|FG000|Overall Study|Protocol issues|14|||
106017236|NCT00357903|365726031|FG001|Overall Study|Protocol issues|3|||
106017237|NCT00357903|365726030|FG000|Overall Study|Response status|61|||
106017238|NCT00357903|365726031|FG001|Overall Study|Response status|9|||
106017239|NCT00357903|365726030|FG000|Overall Study|Other|49|||
106017240|NCT00357903|365726031|FG001|Overall Study|Other|10|||
106017241|NCT00606593|365726032|FG000|Overall Study|Adverse Event|0|||
106017242|NCT00606593|365726033|FG001|Overall Study|Adverse Event|0|||
106017243|NCT00606593|365726034|FG002|Overall Study|Adverse Event|0|||
106017244|NCT00606593|365726035|FG003|Overall Study|Adverse Event|1|||
106017245|NCT00606593|365726036|FG004|Overall Study|Adverse Event|1|||
105953338|NCT00269113|365491738|FG001|Overall Study|Withdrawal by Subject|2|||
105953339|NCT00269113|365491737|FG000|Overall Study|Death|6|||
105953340|NCT00269113|365491738|FG001|Overall Study|Death|2|||
105953341|NCT00269113|365491737|FG000|Overall Study|Lost to Follow-up|2|||
105953342|NCT00269113|365491738|FG001|Overall Study|Lost to Follow-up|1|||
106017246|NCT00606593|365726037|FG005|Overall Study|Adverse Event|0|||
105953343|NCT00269113|365491737|FG000|Overall Study|Protocol Violation|15|||
105953344|NCT00269113|365491738|FG001|Overall Study|Protocol Violation|5|||
106017247|NCT00606593|365726038|FG006|Overall Study|Adverse Event|1|||
106017248|NCT00606593|365726039|FG007|Overall Study|Adverse Event|2|||
105953345|NCT00269113|365491737|FG000|Overall Study|Other|0|||
105810932|NCT03384745|364962963|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
105810933|NCT03384745|364962964|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
105810934|NCT03384745|364962965|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
105810935|NCT03384745|364962966|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
105810936|NCT03384745|364962967|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
105810937|NCT02739984|364962969|FG000|Overall Study|Sponsor Decision|1|||
105810938|NCT02739984|364962970|FG001|Overall Study|Sponsor Decision|0|||
105810939|NCT02739984|364962969|FG000|Overall Study|Withdrawal by Subject|1|||
105810940|NCT02739984|364962970|FG001|Overall Study|Withdrawal by Subject|1|||
105810941|NCT02739984|364962969|FG000|Overall Study|Death|0|||
105953346|NCT00269113|365491738|FG001|Overall Study|Other|2|||
105953347|NCT01979614|365491741|FG000|Overall Study|Adverse Event|1|||
105953348|NCT01979614|365491742|FG001|Overall Study|Adverse Event|1|||
105953349|NCT00488514|365491743|FG000|Overall Study|Adverse Event|41|||
105953350|NCT00488514|365491743|FG000|Overall Study|Lost to Follow-up|44|||
105953351|NCT00488514|365491743|FG000|Overall Study|Protocol Violation|32|||
105953352|NCT00488514|365491743|FG000|Overall Study|Withdrawal by Subject|106|||
105953353|NCT00488514|365491743|FG000|Overall Study|Lack of Efficacy|28|||
105953354|NCT00488514|365491743|FG000|Overall Study|Did not meet criteria for treatment|30|||
105953355|NCT00488514|365491743|FG000|Overall Study|Postive drug screen|1|||
105953356|NCT00488514|365491743|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
105953357|NCT00488514|365491743|FG000|Overall Study|Investigator decision|1|||
105953358|NCT00488514|365491743|FG000|Overall Study|Participant had too few migraines|5|||
105953359|NCT00488514|365491743|FG000|Overall Study|Increase in number of migraines|2|||
105953360|NCT00488514|365491743|FG000|Overall Study|Increased use of concomitant medication|1|||
105953361|NCT01248793|365491744|FG000|Overall Study|Lost to Follow-up|0|||
105953362|NCT01248793|365491745|FG001|Overall Study|Lost to Follow-up|1|||
105953363|NCT01248793|365491744|FG000|Overall Study|Adverse Event|1|||
105953364|NCT01248793|365491745|FG001|Overall Study|Adverse Event|1|||
105953365|NCT01248793|365491744|FG000|Overall Study|Protocol Violation|0|||
105953366|NCT01248793|365491745|FG001|Overall Study|Protocol Violation|1|||
105953367|NCT01248793|365491744|FG000|Overall Study|Withdrawal by Subject|3|||
105953368|NCT01248793|365491745|FG001|Overall Study|Withdrawal by Subject|3|||
105953369|NCT00517699|365491746|FG000|Overall Study|Withdrawal by Subject|1|||
105953370|NCT00517699|365491746|FG000|Overall Study|Lack of Efficacy|1|||
105953371|NCT00517699|365491746|FG000|Overall Study|Administrative error|1|||
105953372|NCT00517699|365491746|FG000|Overall Study|Study terminated by Sponsor|2|||
105953373|NCT06164691|365491747|FG000|Overall Study|Withdrawal by Subject|2|||
105953374|NCT06164691|365491748|FG001|Overall Study|Withdrawal by Subject|0|||
105953375|NCT06164691|365491749|FG002|Overall Study|Withdrawal by Subject|0|||
105953376|NCT02477527|365491755|FG000|Overall Study|Lost to Follow-up|2|||
105953377|NCT02477527|365491755|FG000|Overall Study|Withdrawal by Subject|1|||
105953378|NCT02477527|365491755|FG000|Overall Study|Screen Failure|3|||
105953379|NCT00800735|365491756|FG000|Overall Study|Administrative/Other|2|||
105953380|NCT00800735|365491756|FG000|Overall Study|Insufficient Therapeutic Response|2|||
105953381|NCT00800735|365491756|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
105953382|NCT00800735|365491756|FG000|Overall Study|Withdrew Consent|3|||
105953383|NCT03500211|365491761|FG000|Overall Study|Withdrawal by Subject|1|||
105953384|NCT03500211|365491762|FG001|Overall Study|Withdrawal by Subject|1|||
105953385|NCT00420381|365491767|FG000|Overall Study|Protocol Violation|1|||
105953386|NCT02329743|365491768|FG000|Overall Study|Adverse Event|1|||
105953387|NCT02329743|365491769|FG001|Overall Study|Adverse Event|1|||
105953388|NCT02329743|365491770|FG002|Overall Study|Adverse Event|3|||
105953389|NCT02329743|365491768|FG000|Overall Study|Lost to Follow-up|1|||
105953390|NCT02329743|365491769|FG001|Overall Study|Lost to Follow-up|0|||
105953391|NCT02329743|365491770|FG002|Overall Study|Lost to Follow-up|1|||
105953392|NCT02329743|365491768|FG000|Overall Study|Withdrawal by Subject|4|||
105953393|NCT02329743|365491769|FG001|Overall Study|Withdrawal by Subject|4|||
105953394|NCT02329743|365491770|FG002|Overall Study|Withdrawal by Subject|1|||
105953395|NCT02329743|365491768|FG000|Overall Study|Other|0|||
105953396|NCT02329743|365491769|FG001|Overall Study|Other|2|||
105953397|NCT02329743|365491770|FG002|Overall Study|Other|3|||
105953398|NCT02071771|365491781|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
105953399|NCT02071771|365491782|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
105810942|NCT02739984|364962970|FG001|Overall Study|Death|1|||
105810943|NCT02739984|364962969|FG000|Overall Study|Lost to Follow-up|3|||
105810944|NCT02739984|364962970|FG001|Overall Study|Lost to Follow-up|0|||
105953400|NCT02071771|365491781|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
105953401|NCT02071771|365491782|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
105810945|NCT01054599|364962971|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
105953402|NCT02479880|365491784|FG000|Overall Study|Study Terminated by Sponsor|13|||
105953403|NCT02479880|365491785|FG001|Overall Study|Study Terminated by Sponsor|12|||
105953404|NCT02479880|365491784|FG000|Overall Study|Pregnancy|0|||
105953405|NCT02479880|365491785|FG001|Overall Study|Pregnancy|1|||
105953406|NCT00110214|365491802|FG000|Overall Study|Never started treatment|21|||
105953407|NCT00110214|365491803|FG001|Overall Study|Never started treatment|20|||
105953408|NCT00110214|365491802|FG000|Overall Study|Disease progression or death|260|||
106017249|NCT00606593|365726040|FG008|Overall Study|Adverse Event|1|||
106017250|NCT00606593|365726041|FG009|Overall Study|Adverse Event|0|||
106017251|NCT00606593|365726032|FG000|Overall Study|Withdrawal of consent|1|||
106017252|NCT00606593|365726033|FG001|Overall Study|Withdrawal of consent|0|||
106017253|NCT00606593|365726034|FG002|Overall Study|Withdrawal of consent|1|||
106017254|NCT00606593|365726035|FG003|Overall Study|Withdrawal of consent|0|||
106017255|NCT00606593|365726036|FG004|Overall Study|Withdrawal of consent|0|||
106017256|NCT00606593|365726037|FG005|Overall Study|Withdrawal of consent|0|||
106017257|NCT00606593|365726038|FG006|Overall Study|Withdrawal of consent|0|||
106017258|NCT00606593|365726039|FG007|Overall Study|Withdrawal of consent|0|||
106017259|NCT00606593|365726040|FG008|Overall Study|Withdrawal of consent|0|||
106017260|NCT00606593|365726041|FG009|Overall Study|Withdrawal of consent|0|||
106017261|NCT00606593|365726032|FG000|Overall Study|Administrative/Other|0|||
106017262|NCT00606593|365726033|FG001|Overall Study|Administrative/Other|0|||
106017263|NCT00606593|365726034|FG002|Overall Study|Administrative/Other|1|||
106017264|NCT00606593|365726035|FG003|Overall Study|Administrative/Other|0|||
106017265|NCT00606593|365726036|FG004|Overall Study|Administrative/Other|0|||
106017266|NCT00606593|365726037|FG005|Overall Study|Administrative/Other|0|||
106017267|NCT00606593|365726038|FG006|Overall Study|Administrative/Other|0|||
106017268|NCT00606593|365726039|FG007|Overall Study|Administrative/Other|0|||
106017269|NCT00606593|365726040|FG008|Overall Study|Administrative/Other|0|||
106017270|NCT00606593|365726041|FG009|Overall Study|Administrative/Other|0|||
106017271|NCT04697628|365726044|FG000|Overall Study|Withdrawal by Subject|17|||
106017272|NCT04697628|365726045|FG001|Overall Study|Withdrawal by Subject|23|||
106017273|NCT04697628|365726044|FG000|Overall Study|Lost to Follow-up|0|||
106017274|NCT04697628|365726045|FG001|Overall Study|Lost to Follow-up|4|||
106017275|NCT04697628|365726044|FG000|Overall Study|On-going in study|122|||
106017276|NCT04697628|365726045|FG001|Overall Study|On-going in study|91|||
106017277|NCT01946204|365726046|FG000|Overall Study|Death|38|||
106017278|NCT01946204|365726047|FG001|Overall Study|Death|59|||
106017279|NCT01946204|365726046|FG000|Overall Study|Withdrawal by Subject|37|||
106017280|NCT01946204|365726047|FG001|Overall Study|Withdrawal by Subject|50|||
106017281|NCT01946204|365726046|FG000|Overall Study|Lost to Follow-up|3|||
106017282|NCT01946204|365726047|FG001|Overall Study|Lost to Follow-up|7|||
106017283|NCT01946204|365726046|FG000|Overall Study|Ongoing|316|||
106017284|NCT01946204|365726047|FG001|Overall Study|Ongoing|687|||
106017285|NCT01946204|365726046|FG000|Overall Study|Other|7|||
106017286|NCT01946204|365726047|FG001|Overall Study|Other|3|||
106017287|NCT02908672|365726048|FG000|Run-in Period|Death|12|||
106017288|NCT02908672|365726049|FG001|Run-in Period|Death|10|||
106017289|NCT02908672|365726050|FG002|Run-in Period|Death|0|||
106017290|NCT02908672|365726051|FG003|Run-in Period|Death|0|||
106017291|NCT02908672|365726048|FG000|Run-in Period|Lost to Follow-up|1|||
106017292|NCT02908672|365726049|FG001|Run-in Period|Lost to Follow-up|1|||
106017293|NCT02908672|365726050|FG002|Run-in Period|Lost to Follow-up|0|||
106017294|NCT02908672|365726051|FG003|Run-in Period|Lost to Follow-up|0|||
106017295|NCT02908672|365726048|FG000|Run-in Period|Reason Not Specified|2|||
106017296|NCT02908672|365726049|FG001|Run-in Period|Reason Not Specified|0|||
106017297|NCT02908672|365726050|FG002|Run-in Period|Reason Not Specified|0|||
106017298|NCT02908672|365726051|FG003|Run-in Period|Reason Not Specified|0|||
106017299|NCT02908672|365726048|FG000|Run-in Period|Protocol Violation|1|||
105762654|NCT00376246|364783158|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
105762655|NCT00376246|364783159|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
105762656|NCT00376246|364783158|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
106017300|NCT02908672|365726049|FG001|Run-in Period|Protocol Violation|1|||
106017301|NCT02908672|365726050|FG002|Run-in Period|Protocol Violation|0|||
106017302|NCT02908672|365726051|FG003|Run-in Period|Protocol Violation|0|||
106017303|NCT02908672|365726048|FG000|Run-in Period|Study Ended by Sponsor|5|||
106017304|NCT02908672|365726049|FG001|Run-in Period|Study Ended by Sponsor|1|||
106017305|NCT02908672|365726050|FG002|Run-in Period|Study Ended by Sponsor|0|||
106017306|NCT02908672|365726051|FG003|Run-in Period|Study Ended by Sponsor|0|||
106017307|NCT02908672|365726048|FG000|Run-in Period|Withdrawal by Subject|3|||
106017308|NCT02908672|365726049|FG001|Run-in Period|Withdrawal by Subject|9|||
106017309|NCT02908672|365726050|FG002|Run-in Period|Withdrawal by Subject|0|||
106017310|NCT02908672|365726051|FG003|Run-in Period|Withdrawal by Subject|0|||
106017311|NCT02908672|365726048|FG000|Triple Combination Period|Death|0|||
106017312|NCT02908672|365726049|FG001|Triple Combination Period|Death|0|||
106017313|NCT02908672|365726050|FG002|Triple Combination Period|Death|150|||
106017314|NCT02908672|365726051|FG003|Triple Combination Period|Death|127|||
105762657|NCT00376246|364783159|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
105762658|NCT00376246|364783158|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
105762659|NCT00376246|364783159|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
106017315|NCT02908672|365726048|FG000|Triple Combination Period|Lost to Follow-up|0|||
106017316|NCT02908672|365726049|FG001|Triple Combination Period|Lost to Follow-up|0|||
106017317|NCT02908672|365726050|FG002|Triple Combination Period|Lost to Follow-up|6|||
105762660|NCT01072448|364783164|FG000|Overall Study|Adverse Event|9|||
106017318|NCT02908672|365726051|FG003|Triple Combination Period|Lost to Follow-up|8|||
105810946|NCT01054599|364962972|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
105810947|NCT01054599|364962971|FG000|Overall Study|Protocol Violation|1|||
105810948|NCT01054599|364962972|FG001|Overall Study|Protocol Violation|0|||
105810949|NCT01054599|364962971|FG000|Overall Study|Spells/seizure-like episodes|1|||
105810950|NCT01054599|364962972|FG001|Overall Study|Spells/seizure-like episodes|1|||
105810951|NCT01054599|364962971|FG000|Overall Study|Timing/scheduling difficulties|1|||
105810952|NCT01054599|364962972|FG001|Overall Study|Timing/scheduling difficulties|1|||
105810953|NCT01054599|364962971|FG000|Overall Study|Visual impairment, WTAR <80|0|||
105810954|NCT01054599|364962972|FG001|Overall Study|Visual impairment, WTAR <80|1|||
105810955|NCT01054599|364962971|FG000|Overall Study|Lost to Follow-up|0|||
105810956|NCT01054599|364962972|FG001|Overall Study|Lost to Follow-up|2|||
105810957|NCT01054599|364962971|FG000|Overall Study|Adverse Event|0|||
105810958|NCT01054599|364962972|FG001|Overall Study|Adverse Event|1|||
105810959|NCT01054599|364962971|FG000|Overall Study|Withdrawal by Subject|0|||
105810960|NCT01054599|364962972|FG001|Overall Study|Withdrawal by Subject|1|||
105810961|NCT00475020|364962973|FG000|Overall Study|Physician Decision|3|||
105810962|NCT00475020|364962973|FG000|Overall Study|Insurance Denial|1|||
105810963|NCT00475020|364962973|FG000|Overall Study|Donor not able to donate the last minute|1|||
105810964|NCT03481309|364962977|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
105810965|NCT03481309|364962978|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810966|NCT03481309|364962979|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810967|NCT03481309|364962980|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810968|NCT03481309|364962981|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810969|NCT03481309|364962982|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
105810970|NCT00278200|364964851|FG000|Overall Study|Death|1|||
105810971|NCT00278200|364964852|FG001|Overall Study|Death|3|||
105810972|NCT00278200|364964851|FG000|Overall Study|Physician Decision|0|||
105953409|NCT00110214|365491803|FG001|Overall Study|Disease progression or death|151|||
105953410|NCT00110214|365491802|FG000|Overall Study|Adverse Event|115|||
105953411|NCT00110214|365491803|FG001|Overall Study|Adverse Event|192|||
106144894|NCT00959946|366190760|FG007|Overall Study|Disease Progression|2|||
106144895|NCT00959946|366190753|FG000|Overall Study|Withdrawal by Subject|0|||
106144896|NCT00959946|366190754|FG001|Overall Study|Withdrawal by Subject|0|||
106144897|NCT00959946|366190755|FG002|Overall Study|Withdrawal by Subject|0|||
106144898|NCT00959946|366190756|FG003|Overall Study|Withdrawal by Subject|0|||
106144899|NCT00959946|366190757|FG004|Overall Study|Withdrawal by Subject|0|||
105953412|NCT00110214|365491802|FG000|Overall Study|Refused further treatment|52|||
105953413|NCT00110214|365491803|FG001|Overall Study|Refused further treatment|65|||
105953414|NCT00110214|365491802|FG000|Overall Study|Other (not specified)|61|||
105953415|NCT00110214|365491803|FG001|Overall Study|Other (not specified)|75|||
105953416|NCT01016067|365491806|FG000|Overall Study|Lost to Follow-up|1|||
105953417|NCT01016067|365491807|FG001|Overall Study|Lost to Follow-up|2|||
105953418|NCT01016067|365491806|FG000|Overall Study|Physician Decision|1|||
105953419|NCT01016067|365491807|FG001|Overall Study|Physician Decision|1|||
105953420|NCT01016067|365491806|FG000|Overall Study|Withdrew due to Relocation|0|||
105953421|NCT01016067|365491807|FG001|Overall Study|Withdrew due to Relocation|1|||
105953422|NCT03745768|365491812|FG000|Overall Study|discontinued study|2|||
105953423|NCT03745768|365491813|FG001|Overall Study|discontinued study|0|||
105953424|NCT01194245|365491814|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
105953425|NCT01194245|365491815|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
105953426|NCT01194245|365491816|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
105953427|NCT01194245|365491817|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
105953428|NCT01194245|365491818|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
105953429|NCT01194245|365491814|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
105953430|NCT01194245|365491815|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
105953431|NCT01194245|365491816|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
105953432|NCT01194245|365491817|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
105953433|NCT01194245|365491818|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
105953434|NCT01194245|365491814|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
105953435|NCT01194245|365491815|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
105953436|NCT01194245|365491816|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
105953437|NCT01194245|365491817|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
106144900|NCT00959946|366190758|FG005|Overall Study|Withdrawal by Subject|1|||
106144901|NCT00959946|366190759|FG006|Overall Study|Withdrawal by Subject|0|||
105810973|NCT00278200|364964852|FG001|Overall Study|Physician Decision|1|||
105810974|NCT01691508|364964853|FG000|Overall Study|Adverse Event|3|||
105810975|NCT01691508|364964854|FG001|Overall Study|Adverse Event|3|||
105810976|NCT01691508|364964853|FG000|Overall Study|Withdrawal by Subject|1|||
105953438|NCT01194245|365491818|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
105953439|NCT01194245|365491814|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
105953440|NCT01194245|365491815|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
105953441|NCT01194245|365491816|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
105953442|NCT01194245|365491817|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
105953443|NCT01194245|365491818|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
105953444|NCT01194245|365491814|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105953445|NCT01194245|365491815|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105953446|NCT01194245|365491816|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105953447|NCT01194245|365491817|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
105953448|NCT01194245|365491818|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
105953449|NCT01194245|365491814|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105953450|NCT01194245|365491815|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
105953451|NCT01194245|365491816|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
105953452|NCT01194245|365491817|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
105953453|NCT01194245|365491818|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
105953454|NCT02651116|365491820|FG000|Overall Study|Adverse Event|0|||
105953455|NCT02651116|365491821|FG001|Overall Study|Adverse Event|1|||
105953456|NCT02651116|365491820|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
105953457|NCT02651116|365491821|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
105953458|NCT01847755|365491824|FG000|Overall Study|Adverse Event|2|||
105953459|NCT01847755|365491824|FG000|Overall Study|Withdrawal by Subject|2|||
105953460|NCT01847755|365491824|FG000|Overall Study|Physician Decision|1|||
105953461|NCT00846846|365491825|FG000|Overall Study|Death|56|||
105953462|NCT00846846|365491825|FG000|Overall Study|Withdrawal by Subject|19|||
105953463|NCT00401843|365491828|FG000|Overall Study|Achieved Complete Response|1|||
105953464|NCT00401843|365491829|FG001|Overall Study|Achieved Complete Response|5|||
105953465|NCT00401843|365491830|FG002|Overall Study|Achieved Complete Response|11|||
105953466|NCT00401843|365491828|FG000|Overall Study|Adverse Event|7|||
105953467|NCT00401843|365491829|FG001|Overall Study|Adverse Event|26|||
105953468|NCT00401843|365491830|FG002|Overall Study|Adverse Event|27|||
105953469|NCT00401843|365491828|FG000|Overall Study|Death|0|||
105953470|NCT00401843|365491829|FG001|Overall Study|Death|8|||
105953471|NCT00401843|365491830|FG002|Overall Study|Death|10|||
105953472|NCT00401843|365491828|FG000|Overall Study|Disease progression|10|||
105953473|NCT00401843|365491829|FG001|Overall Study|Disease progression|60|||
105953474|NCT00401843|365491830|FG002|Overall Study|Disease progression|49|||
105953475|NCT00401843|365491828|FG000|Overall Study|End of Study|1|||
105953476|NCT00401843|365491829|FG001|Overall Study|End of Study|1|||
105953477|NCT00401843|365491830|FG002|Overall Study|End of Study|2|||
105953478|NCT00401843|365491828|FG000|Overall Study|Lost to Follow-up|0|||
105953479|NCT00401843|365491829|FG001|Overall Study|Lost to Follow-up|0|||
105953480|NCT00401843|365491830|FG002|Overall Study|Lost to Follow-up|2|||
105953481|NCT00401843|365491828|FG000|Overall Study|Other Unspecified|0|||
105953482|NCT00401843|365491829|FG001|Overall Study|Other Unspecified|3|||
105953483|NCT00401843|365491830|FG002|Overall Study|Other Unspecified|5|||
105953484|NCT00401843|365491828|FG000|Overall Study|Physician Decision|0|||
105953485|NCT00401843|365491829|FG001|Overall Study|Physician Decision|16|||
105953486|NCT00401843|365491830|FG002|Overall Study|Physician Decision|10|||
106017319|NCT02908672|365726048|FG000|Triple Combination Period|Reason Not Specified|0|||
106017320|NCT02908672|365726049|FG001|Triple Combination Period|Reason Not Specified|0|||
106017321|NCT02908672|365726050|FG002|Triple Combination Period|Reason Not Specified|0|||
106017322|NCT02908672|365726051|FG003|Triple Combination Period|Reason Not Specified|1|||
106017323|NCT02908672|365726048|FG000|Triple Combination Period|Physician Decision|0|||
106017324|NCT02908672|365726049|FG001|Triple Combination Period|Physician Decision|0|||
106017325|NCT02908672|365726050|FG002|Triple Combination Period|Physician Decision|1|||
106017326|NCT02908672|365726051|FG003|Triple Combination Period|Physician Decision|1|||
106017327|NCT02908672|365726048|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
106017328|NCT02908672|365726049|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
106017329|NCT02908672|365726050|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
106017330|NCT02908672|365726051|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
106017331|NCT02908672|365726048|FG000|Triple Combination Period|Withdrawal by Subject|0|||
106017332|NCT02908672|365726049|FG001|Triple Combination Period|Withdrawal by Subject|0|||
106017333|NCT02908672|365726050|FG002|Triple Combination Period|Withdrawal by Subject|13|||
106017334|NCT02908672|365726051|FG003|Triple Combination Period|Withdrawal by Subject|16|||
106017335|NCT04538664|365726055|FG000|Overall Study|Withdrawal by Subject|5|||
106017336|NCT04538664|365726056|FG001|Overall Study|Withdrawal by Subject|9|||
106017337|NCT04538664|365726055|FG000|Overall Study|Lost to Follow-up|2|||
105953487|NCT00401843|365491828|FG000|Overall Study|Protocol Violation|0|||
105953488|NCT00401843|365491829|FG001|Overall Study|Protocol Violation|0|||
105953489|NCT00401843|365491830|FG002|Overall Study|Protocol Violation|1|||
105953490|NCT00401843|365491828|FG000|Overall Study|Withdrawal by Subject|1|||
105953491|NCT00401843|365491829|FG001|Overall Study|Withdrawal by Subject|5|||
105953492|NCT00401843|365491830|FG002|Overall Study|Withdrawal by Subject|5|||
105953493|NCT00401843|365491828|FG000|Overall Study|Withdrawal of consent to study agent|1|||
105953494|NCT00401843|365491829|FG001|Overall Study|Withdrawal of consent to study agent|15|||
105810977|NCT01691508|364964854|FG001|Overall Study|Withdrawal by Subject|0|||
105810978|NCT02322047|364964860|FG000|Overall Study|Physician Decision|1|||
105810979|NCT02322047|364964861|FG001|Overall Study|Physician Decision|0|||
105810980|NCT02322047|364964862|FG002|Overall Study|Physician Decision|0|||
105810981|NCT02322047|364964863|FG003|Overall Study|Physician Decision|0|||
105810982|NCT02322047|364964860|FG000|Overall Study|Withdrawal by Subject|1|||
105810983|NCT02322047|364964861|FG001|Overall Study|Withdrawal by Subject|0|||
105810984|NCT02322047|364964862|FG002|Overall Study|Withdrawal by Subject|0|||
105810985|NCT02322047|364964863|FG003|Overall Study|Withdrawal by Subject|1|||
105810986|NCT02322047|364964860|FG000|Overall Study|Adverse Event|0|||
105810987|NCT02322047|364964861|FG001|Overall Study|Adverse Event|1|||
105810988|NCT02322047|364964862|FG002|Overall Study|Adverse Event|0|||
105810989|NCT02322047|364964863|FG003|Overall Study|Adverse Event|0|||
105810990|NCT02322047|364964860|FG000|Overall Study|Lost to Follow-up|0|||
105810991|NCT02322047|364964861|FG001|Overall Study|Lost to Follow-up|0|||
105810992|NCT02322047|364964862|FG002|Overall Study|Lost to Follow-up|1|||
105810993|NCT02322047|364964863|FG003|Overall Study|Lost to Follow-up|1|||
105810994|NCT05431153|364964864|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105810995|NCT05431153|364964865|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105810996|NCT05431153|364964866|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105810997|NCT05431153|364964867|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105810998|NCT05431153|364964868|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
105810999|NCT05431153|364964869|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105811000|NCT02623959|364964875|FG000|Overall Study|Progression|0|||
105811001|NCT02623959|364964876|FG001|Overall Study|Progression|1|||
105811002|NCT00135707|364964879|FG000|Overall Study|Lost to Follow-up|94|||
105811003|NCT00135707|364964880|FG001|Overall Study|Lost to Follow-up|89|||
105811004|NCT00135707|364964879|FG000|Overall Study|Withdrawal by Subject|0|||
105811005|NCT00135707|364964880|FG001|Overall Study|Withdrawal by Subject|1|||
105811006|NCT00135707|364964879|FG000|Overall Study|Institutional review board request|1|||
105811007|NCT00135707|364964880|FG001|Overall Study|Institutional review board request|0|||
105811008|NCT03093454|364964881|FG000|Overall Study|Withdrawal by Subject|1|||
105811009|NCT03093454|364964882|FG001|Overall Study|Withdrawal by Subject|1|||
105811010|NCT03093454|364964881|FG000|Overall Study|Scheduling conflict|3|||
105811011|NCT03093454|364964882|FG001|Overall Study|Scheduling conflict|1|||
105811012|NCT03093454|364964881|FG000|Overall Study|Physician Decision|2|||
105811013|NCT03093454|364964882|FG001|Overall Study|Physician Decision|1|||
105811014|NCT00421174|364964886|FG000|Overall Study|Withdrawal by Subject|0|||
105811015|NCT00421174|364964887|FG001|Overall Study|Withdrawal by Subject|1|||
105811016|NCT00421174|364964886|FG000|Overall Study|Ineligible due to infection|2|||
105811017|NCT00421174|364964887|FG001|Overall Study|Ineligible due to infection|0|||
105811018|NCT02524379|364964888|FG000|Overall Study|Death|1|||
105811019|NCT02016300|364964890|FG000|Overall Study|Lost to Follow-up|0|||
105811020|NCT02016300|364964891|FG001|Overall Study|Lost to Follow-up|3|||
105811021|NCT02309099|364964892|FG000|Overall Study|Adverse Event|2|||
105811022|NCT02309099|364964893|FG001|Overall Study|Adverse Event|0|||
105811023|NCT00356200|364964894|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
105811024|NCT00356200|364964895|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
105811025|NCT00356200|364964894|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
105811026|NCT00356200|364964895|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
105811027|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
105811028|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
105811029|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
105811030|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
105811031|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
105811032|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
105811033|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
105811034|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
105811035|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
105811036|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
105811037|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
105811038|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
105811039|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
105811040|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
105811041|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
105811042|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
105811043|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
105811044|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
106017338|NCT04538664|365726056|FG001|Overall Study|Lost to Follow-up|1|||
106017339|NCT04538664|365726055|FG000|Overall Study|Ongoing|106|||
106017340|NCT04538664|365726056|FG001|Overall Study|Ongoing|115|||
106017341|NCT04770779|365726057|FG000|Overall Study|Randomized, never treated|0|||
106017342|NCT04770779|365726058|FG001|Overall Study|Randomized, never treated|1|||
106017343|NCT04770779|365726057|FG000|Overall Study|Adverse Event|9|||
106017344|NCT04770779|365726058|FG001|Overall Study|Adverse Event|1|||
106017345|NCT04770779|365726057|FG000|Overall Study|Withdrawal by Subject|7|||
106017346|NCT04770779|365726058|FG001|Overall Study|Withdrawal by Subject|1|||
106017347|NCT04770779|365726057|FG000|Overall Study|Pregnancy|0|||
106017348|NCT04770779|365726058|FG001|Overall Study|Pregnancy|1|||
106017349|NCT03529422|365726059|FG000|Overall Study|Withdrawal by Subject|1|||
106017350|NCT03529422|365726059|FG000|Overall Study|Protocol Violation|1|||
106017351|NCT03529422|365726059|FG000|Overall Study|Disease progression|2|||
106017352|NCT05006573|365726062|FG000|Double-blind Treatment Period|Physician Decision|2|||
106017353|NCT05006573|365726063|FG001|Double-blind Treatment Period|Physician Decision|0|||
106017354|NCT05006573|365726062|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
106017355|NCT05006573|365726063|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
106017356|NCT05006573|365726062|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
106017357|NCT05006573|365726063|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
106017358|NCT05006573|365726062|FG000|Double-blind Treatment Period|Protocol Violation|2|||
106017359|NCT05006573|365726063|FG001|Double-blind Treatment Period|Protocol Violation|0|||
106017360|NCT05006573|365726062|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
106017361|NCT05006573|365726063|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
106017362|NCT05006573|365726062|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
106017363|NCT05006573|365726063|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
106017364|NCT04484142|365726064|FG000|Overall Study|Adverse Event|13|||
106017365|NCT04484142|365726064|FG000|Overall Study|Progressive Disease|87|||
106017366|NCT04484142|365726064|FG000|Overall Study|Clinical Progression|10|||
106017367|NCT04484142|365726064|FG000|Overall Study|Withdrawal by Subject|6|||
106017368|NCT04484142|365726064|FG000|Overall Study|Physician Decision|1|||
106017369|NCT04922216|365726065|FG000|Overall Study|Withdrawal by Subject|0|||
106017370|NCT04922216|365726066|FG001|Overall Study|Withdrawal by Subject|1|||
106017371|NCT04922216|365726067|FG002|Overall Study|Withdrawal by Subject|0|||
106017372|NCT04922216|365726068|FG003|Overall Study|Withdrawal by Subject|0|||
106017373|NCT04922216|365726069|FG004|Overall Study|Withdrawal by Subject|0|||
106017374|NCT04922216|365726070|FG005|Overall Study|Withdrawal by Subject|0|||
106017375|NCT04922216|365726071|FG006|Overall Study|Withdrawal by Subject|0|||
106017376|NCT04922216|365726072|FG007|Overall Study|Withdrawal by Subject|2|||
106017377|NCT04922216|365726073|FG008|Overall Study|Withdrawal by Subject|0|||
106017378|NCT04922216|365726074|FG009|Overall Study|Withdrawal by Subject|0|||
106144902|NCT00959946|366190760|FG007|Overall Study|Withdrawal by Subject|0|||
106144903|NCT01202955|366190763|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
106144904|NCT01202955|366190764|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
105762661|NCT01072448|364783165|FG001|Overall Study|Adverse Event|10|||
105953495|NCT00401843|365491830|FG002|Overall Study|Withdrawal of consent to study agent|17|||
105953496|NCT00401843|365491828|FG000|Overall Study|Randomized but not Treated|0|||
105953497|NCT00401843|365491829|FG001|Overall Study|Randomized but not Treated|2|||
105953498|NCT00401843|365491830|FG002|Overall Study|Randomized but not Treated|3|||
105953499|NCT00401843|365491828|FG000|Overall Study|Received incorrect treatment|0|||
105953500|NCT00401843|365491829|FG001|Overall Study|Received incorrect treatment|3|||
105953501|NCT00401843|365491830|FG002|Overall Study|Received incorrect treatment|0|||
105953502|NCT00003869|365491831|FG000|Overall Study|Adverse Event|14|||
105953503|NCT00003869|365491832|FG001|Overall Study|Adverse Event|3|||
105953504|NCT00003869|365491831|FG000|Overall Study|Withdrawal by Subject|21|||
105953505|NCT00003869|365491832|FG001|Overall Study|Withdrawal by Subject|3|||
105953506|NCT00003869|365491831|FG000|Overall Study|Death|1|||
105953507|NCT00003869|365491832|FG001|Overall Study|Death|2|||
105953508|NCT00003869|365491831|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
105953509|NCT00003869|365491832|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
105953510|NCT01964378|365491833|FG000|Overall Study|Disc. due to death before first dosing|0|||
105953511|NCT01964378|365491834|FG001|Overall Study|Disc. due to death before first dosing|1|||
105953512|NCT01964378|365491833|FG000|Overall Study|Disc. due to AE before first dosing|1|||
105953513|NCT01964378|365491834|FG001|Overall Study|Disc. due to AE before first dosing|0|||
105953514|NCT01964378|365491833|FG000|Overall Study|Death|3|||
105953515|NCT01964378|365491834|FG001|Overall Study|Death|2|||
105953516|NCT01964378|365491833|FG000|Overall Study|Adverse Event|12|||
105953517|NCT01964378|365491834|FG001|Overall Study|Adverse Event|5|||
105953518|NCT01964378|365491833|FG000|Overall Study|Lack of Efficacy|0|||
105953519|NCT01964378|365491834|FG001|Overall Study|Lack of Efficacy|1|||
105953520|NCT01964378|365491833|FG000|Overall Study|Protocol Violation|0|||
105953521|NCT01964378|365491834|FG001|Overall Study|Protocol Violation|1|||
105953522|NCT01964378|365491833|FG000|Overall Study|Lost to Follow-up|0|||
105953523|NCT01964378|365491834|FG001|Overall Study|Lost to Follow-up|1|||
105953524|NCT01964378|365491833|FG000|Overall Study|Withdrawal by Subject|7|||
106017379|NCT04922216|365726075|FG010|Overall Study|Withdrawal by Subject|0|||
106144905|NCT02928224|366190767|FG000|Overall Study|Lost to Follow-up|1|||
106144906|NCT02928224|366190768|FG001|Overall Study|Lost to Follow-up|1|||
105953525|NCT01964378|365491834|FG001|Overall Study|Withdrawal by Subject|5|||
105953526|NCT01964378|365491833|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
105953527|NCT01964378|365491834|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
106017380|NCT04922216|365726076|FG011|Overall Study|Withdrawal by Subject|0|||
106017381|NCT04922216|365726077|FG012|Overall Study|Withdrawal by Subject|1|||
106017382|NCT04922216|365726078|FG013|Overall Study|Withdrawal by Subject|1|||
106017383|NCT04922216|365726079|FG014|Overall Study|Withdrawal by Subject|1|||
106017384|NCT04922216|365726080|FG015|Overall Study|Withdrawal by Subject|0|||
106017385|NCT04922216|365726081|FG016|Overall Study|Withdrawal by Subject|0|||
106017386|NCT04922216|365726082|FG017|Overall Study|Withdrawal by Subject|1|||
106017387|NCT04922216|365726083|FG018|Overall Study|Withdrawal by Subject|1|||
106017388|NCT04922216|365726084|FG019|Overall Study|Withdrawal by Subject|1|||
106017389|NCT04922216|365726085|FG020|Overall Study|Withdrawal by Subject|1|||
106017390|NCT04922216|365726086|FG021|Overall Study|Withdrawal by Subject|0|||
106017391|NCT04922216|365726087|FG022|Overall Study|Withdrawal by Subject|0|||
106017392|NCT04922216|365726088|FG023|Overall Study|Withdrawal by Subject|2|||
106017393|NCT04922216|365726089|FG024|Overall Study|Withdrawal by Subject|0|||
106017394|NCT04922216|365726090|FG025|Overall Study|Withdrawal by Subject|0|||
106144907|NCT02928224|366190769|FG002|Overall Study|Lost to Follow-up|3|||
105811045|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
105811046|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
105811047|NCT01545076|364964896|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
105811048|NCT01545076|364964897|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
105811049|NCT01545076|364964898|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
105811050|NCT01545076|364964899|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
105811051|NCT01545076|364964900|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
105811052|NCT01545076|364964896|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
105811053|NCT01545076|364964897|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
105811054|NCT01545076|364964898|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
105811055|NCT01545076|364964899|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
105811056|NCT01545076|364964900|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
105811057|NCT01545076|364964896|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
105811058|NCT01545076|364964897|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
105811059|NCT01545076|364964898|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
105811060|NCT01545076|364964899|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
105811061|NCT01545076|364964900|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
105811062|NCT01545076|364964896|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
105811063|NCT01545076|364964897|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
105811064|NCT01545076|364964898|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
105811065|NCT01545076|364964899|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
105811066|NCT01545076|364964900|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
105811067|NCT01545076|364964896|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
105811068|NCT01545076|364964897|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
105811069|NCT01545076|364964898|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
105811070|NCT01545076|364964899|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
105811071|NCT01545076|364964900|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
105811072|NCT02518113|364964901|FG000|Overall Study|Adverse Event|1|||
106017395|NCT04922216|365726091|FG026|Overall Study|Withdrawal by Subject|1|||
106017396|NCT04922216|365726092|FG027|Overall Study|Withdrawal by Subject|0|||
106144908|NCT02928224|366190770|FG003|Overall Study|Lost to Follow-up|0|||
106144909|NCT02928224|366190767|FG000|Overall Study|Death|30|||
106144910|NCT02928224|366190768|FG001|Overall Study|Death|209|||
106144911|NCT02928224|366190769|FG002|Overall Study|Death|193|||
106144912|NCT02928224|366190770|FG003|Overall Study|Death|198|||
106144913|NCT02928224|366190767|FG000|Overall Study|Withdrawal by Subject|0|||
106144914|NCT02928224|366190768|FG001|Overall Study|Withdrawal by Subject|3|||
106144915|NCT02928224|366190769|FG002|Overall Study|Withdrawal by Subject|7|||
106144916|NCT02928224|366190770|FG003|Overall Study|Withdrawal by Subject|20|||
106144917|NCT02928224|366190767|FG000|Overall Study|Study participation terminated by sponsor|3|||
106144918|NCT02928224|366190768|FG001|Overall Study|Study participation terminated by sponsor|8|||
105811073|NCT02518113|364964902|FG001|Overall Study|Adverse Event|0|||
105811074|NCT02518113|364964903|FG002|Overall Study|Adverse Event|1|||
106017397|NCT04922216|365726093|FG028|Overall Study|Withdrawal by Subject|0|||
106017398|NCT04922216|365726094|FG029|Overall Study|Withdrawal by Subject|0|||
106017399|NCT04922216|365726095|FG030|Overall Study|Withdrawal by Subject|1|||
106017400|NCT04922216|365726096|FG031|Overall Study|Withdrawal by Subject|0|||
106017401|NCT04922216|365726065|FG000|Overall Study|Lost to Follow-up|1|||
106017402|NCT04922216|365726066|FG001|Overall Study|Lost to Follow-up|0|||
106144919|NCT02928224|366190769|FG002|Overall Study|Study participation terminated by sponsor|12|||
106144920|NCT02928224|366190770|FG003|Overall Study|Study participation terminated by sponsor|3|||
106144921|NCT02928224|366190767|FG000|Overall Study|Other|3|||
106144922|NCT02928224|366190768|FG001|Overall Study|Other|3|||
106144923|NCT02928224|366190769|FG002|Overall Study|Other|5|||
106144924|NCT02928224|366190770|FG003|Overall Study|Other|0|||
106017403|NCT04922216|365726067|FG002|Overall Study|Lost to Follow-up|2|||
106017404|NCT04922216|365726068|FG003|Overall Study|Lost to Follow-up|0|||
106017405|NCT04922216|365726069|FG004|Overall Study|Lost to Follow-up|0|||
106017406|NCT04922216|365726070|FG005|Overall Study|Lost to Follow-up|2|||
106017407|NCT04922216|365726071|FG006|Overall Study|Lost to Follow-up|0|||
105762662|NCT01072448|364783164|FG000|Overall Study|Subject withdrew consent|4|||
105762663|NCT01072448|364783165|FG001|Overall Study|Subject withdrew consent|9|||
105762664|NCT01072448|364783164|FG000|Overall Study|Protocol deviation|3|||
105762665|NCT01072448|364783165|FG001|Overall Study|Protocol deviation|4|||
105762666|NCT01072448|364783164|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105762667|NCT01072448|364783165|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105762668|NCT01072448|364783164|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105762669|NCT01072448|364783165|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105762670|NCT01072448|364783164|FG000|Overall Study|Lost to Follow-up|1|||
105762671|NCT01072448|364783165|FG001|Overall Study|Lost to Follow-up|1|||
105762672|NCT01072448|364783164|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105762673|NCT01072448|364783165|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105762674|NCT01072448|364783164|FG000|Overall Study|Death|0|||
105762675|NCT01072448|364783165|FG001|Overall Study|Death|2|||
105762676|NCT01400139|364783166|FG000|HYD Core Study|Adverse Event|210|||
105762677|NCT01400139|364783166|FG000|HYD Core Study|Lack of Efficacy|59|||
105762678|NCT01400139|364783166|FG000|HYD Core Study|Withdrawal by Subject|114|||
105762679|NCT01400139|364783166|FG000|HYD Core Study|Lost to Follow-up|39|||
105762680|NCT01400139|364783166|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
105762681|NCT01400139|364783166|FG000|HYD Core Study|Administrative|56|||
105762682|NCT01400139|364783166|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
105762683|NCT01400139|364783166|FG000|HYD Extension Period|Adverse Event|8|||
105762684|NCT01400139|364783166|FG000|HYD Extension Period|Withdrawal by Subject|5|||
105762685|NCT01400139|364783166|FG000|HYD Extension Period|Administrative|10|||
105762686|NCT00249795|364783167|FG000|Overall Study|Not treated|16|||
105762687|NCT00249795|364783168|FG001|Overall Study|Not treated|14|||
105762688|NCT00249795|364783167|FG000|Overall Study|Symptomatic hypotension|127|||
105762689|NCT00249795|364783168|FG001|Overall Study|Symptomatic hypotension|64|||
105762690|NCT00249795|364783167|FG000|Overall Study|Other Serious Adverse Event|84|||
105762691|NCT00249795|364783168|FG001|Overall Study|Other Serious Adverse Event|93|||
105762692|NCT00249795|364783167|FG000|Overall Study|Qualifying condition not present|26|||
105762693|NCT00249795|364783168|FG001|Overall Study|Qualifying condition not present|29|||
105762694|NCT00249795|364783167|FG000|Overall Study|Withdrawal by Subject|678|||
105762695|NCT00249795|364783168|FG001|Overall Study|Withdrawal by Subject|742|||
105762696|NCT00249795|364783167|FG000|Overall Study|Thromboembolic / outcome event|39|||
105762697|NCT00249795|364783168|FG001|Overall Study|Thromboembolic / outcome event|45|||
105762698|NCT00249795|364783167|FG000|Overall Study|Oral anticoagulant required|2|||
105762699|NCT00249795|364783168|FG001|Overall Study|Oral anticoagulant required|0|||
105762700|NCT00249795|364783167|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
105762701|NCT00249795|364783168|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
105762702|NCT00249795|364783167|FG000|Overall Study|Non-compliance|71|||
105762703|NCT00249795|364783168|FG001|Overall Study|Non-compliance|69|||
105762704|NCT00249795|364783167|FG000|Overall Study|Study drug intolerance|3|||
105762705|NCT00249795|364783168|FG001|Overall Study|Study drug intolerance|3|||
105762706|NCT00249795|364783167|FG000|Overall Study|Other adverse events (non-serious)|188|||
105762707|NCT00249795|364783168|FG001|Overall Study|Other adverse events (non-serious)|159|||
105762708|NCT00249795|364783167|FG000|Overall Study|Physician withdrew consent|71|||
105762709|NCT00249795|364783168|FG001|Overall Study|Physician withdrew consent|63|||
105762710|NCT00249795|364783167|FG000|Overall Study|Surgery / procedure|4|||
105762711|NCT00249795|364783168|FG001|Overall Study|Surgery / procedure|5|||
105953528|NCT01964378|365491833|FG000|Overall Study|Other|1|||
105953529|NCT01964378|365491834|FG001|Overall Study|Other|2|||
105953530|NCT00786422|365491835|FG000|Rivaroxaban Treatment|Death|2|||
105953531|NCT00786422|365491835|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
105953532|NCT00786422|365491835|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
105953533|NCT00786422|365491835|FG000|Rivaroxaban Treatment|Physician Decision|1|||
105953534|NCT00786422|365491835|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
105953535|NCT00786422|365491835|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
105953536|NCT00786422|365491835|FG000|Rivaroxaban Treatment|Adverse Event|2|||
105953537|NCT00786422|365491835|FG000|Follow-up Period|Death|1|||
105953538|NCT00786422|365491835|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
105953539|NCT05653700|365491840|FG000|Overall Study|Non Responders|9|||
105953540|NCT05653700|365491841|FG001|Overall Study|Non Responders|0|||
105953541|NCT01900665|365491846|FG000|Placebo Controlled Period|Death|9|||
105953542|NCT01900665|365491847|FG001|Placebo Controlled Period|Death|16|||
105953543|NCT01900665|365491846|FG000|Placebo Controlled Period|Adverse Event|48|||
105953544|NCT01900665|365491847|FG001|Placebo Controlled Period|Adverse Event|39|||
105953545|NCT01900665|365491846|FG000|Placebo Controlled Period|Protocol Violation|1|||
105762712|NCT00249795|364783167|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
105953546|NCT01900665|365491847|FG001|Placebo Controlled Period|Protocol Violation|7|||
105811075|NCT02518113|364964904|FG003|Overall Study|Adverse Event|0|||
105811076|NCT02518113|364964901|FG000|Overall Study|Death|1|||
105811077|NCT02518113|364964902|FG001|Overall Study|Death|2|||
105811078|NCT02518113|364964903|FG002|Overall Study|Death|0|||
105811079|NCT02518113|364964904|FG003|Overall Study|Death|0|||
105811080|NCT02518113|364964901|FG000|Overall Study|Physician Decision|0|||
105811081|NCT02518113|364964902|FG001|Overall Study|Physician Decision|1|||
105811082|NCT02518113|364964903|FG002|Overall Study|Physician Decision|0|||
105811083|NCT02518113|364964904|FG003|Overall Study|Physician Decision|0|||
105811084|NCT02518113|364964901|FG000|Overall Study|Progressive Disease|1|||
105811085|NCT02518113|364964902|FG001|Overall Study|Progressive Disease|2|||
105811086|NCT02518113|364964903|FG002|Overall Study|Progressive Disease|3|||
105811087|NCT02518113|364964904|FG003|Overall Study|Progressive Disease|0|||
105811088|NCT00561730|364964913|FG000|Overall Study|Adverse Event|2|||
105811089|NCT00561730|364964913|FG000|Overall Study|Handling of the drug|1|||
105811090|NCT00561730|364964913|FG000|Overall Study|Lost to Follow-up|5|||
105811091|NCT00561730|364964913|FG000|Overall Study|Not specified reasons|1|||
105811092|NCT00527423|364964918|FG000|Overall Study|Protocol Violation|1|||
105953547|NCT01900665|365491846|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
105953548|NCT01900665|365491847|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
105953549|NCT01900665|365491846|FG000|Placebo Controlled Period|Physician Decision|11|||
105953550|NCT01900665|365491847|FG001|Placebo Controlled Period|Physician Decision|7|||
105953551|NCT01900665|365491846|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
105953552|NCT01900665|365491847|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
105953553|NCT01900665|365491846|FG000|Placebo Controlled Period|Caregiver Decision|33|||
105953554|NCT01900665|365491847|FG001|Placebo Controlled Period|Caregiver Decision|41|||
105953555|NCT01900665|365491846|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
105953556|NCT01900665|365491847|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
105953557|NCT01900665|365491846|FG000|Open Label Period|Adverse Event|16|||
105953558|NCT01900665|365491847|FG001|Open Label Period|Adverse Event|20|||
105953559|NCT01900665|365491846|FG000|Open Label Period|Death|5|||
105953560|NCT01900665|365491847|FG001|Open Label Period|Death|6|||
105953561|NCT01900665|365491846|FG000|Open Label Period|Lost to Follow-up|1|||
105953562|NCT01900665|365491847|FG001|Open Label Period|Lost to Follow-up|1|||
105953563|NCT01900665|365491846|FG000|Open Label Period|Parent/Caregiver Decision|33|||
105953564|NCT01900665|365491847|FG001|Open Label Period|Parent/Caregiver Decision|34|||
105953565|NCT01900665|365491846|FG000|Open Label Period|Physician Decision|4|||
105953566|NCT01900665|365491847|FG001|Open Label Period|Physician Decision|4|||
105953567|NCT01900665|365491846|FG000|Open Label Period|Protocol Violation|0|||
105953568|NCT01900665|365491847|FG001|Open Label Period|Protocol Violation|1|||
105953569|NCT01900665|365491846|FG000|Open Label Period|Sponsor Decision|802|||
105953570|NCT01900665|365491847|FG001|Open Label Period|Sponsor Decision|765|||
105953571|NCT01900665|365491846|FG000|Open Label Period|Withdrawal by Subject|20|||
105953572|NCT01900665|365491847|FG001|Open Label Period|Withdrawal by Subject|28|||
105953573|NCT04749914|365491850|FG000|Period 1|Adverse Event|1|||
105953574|NCT04749914|365491851|FG001|Period 1|Adverse Event|0|||
105953575|NCT04749914|365491852|FG002|Period 1|Adverse Event|0|||
105953576|NCT04749914|365491853|FG003|Period 1|Adverse Event|0|||
105953577|NCT04749914|365491850|FG000|Period 1|Withdrawal by Subject|1|||
105953578|NCT04749914|365491851|FG001|Period 1|Withdrawal by Subject|0|||
105953579|NCT04749914|365491852|FG002|Period 1|Withdrawal by Subject|1|||
105953580|NCT04749914|365491853|FG003|Period 1|Withdrawal by Subject|0|||
105953581|NCT01913327|365491856|FG000|Overall Study|Withdrawal by Subject|0|||
105953582|NCT01913327|365491857|FG001|Overall Study|Withdrawal by Subject|1|||
105953583|NCT03654274|365491859|FG000|Overall Study|Adverse Event|19|||
105953584|NCT03654274|365491860|FG001|Overall Study|Adverse Event|23|||
105953585|NCT03654274|365491861|FG002|Overall Study|Adverse Event|24|||
105953586|NCT03654274|365491859|FG000|Overall Study|Protocol Deviation|0|||
105953587|NCT03654274|365491860|FG001|Overall Study|Protocol Deviation|2|||
105953588|NCT03654274|365491861|FG002|Overall Study|Protocol Deviation|0|||
105953589|NCT03654274|365491859|FG000|Overall Study|Lost to Follow-up|8|||
105953590|NCT03654274|365491860|FG001|Overall Study|Lost to Follow-up|6|||
105953591|NCT03654274|365491861|FG002|Overall Study|Lost to Follow-up|5|||
105953592|NCT03654274|365491859|FG000|Overall Study|Withdrawal by Subject|46|||
105811093|NCT00527423|364964918|FG000|Overall Study|Adverse Event|5|||
105811094|NCT00527423|364964918|FG000|Overall Study|Physician Decision|4|||
105811095|NCT00527423|364964918|FG000|Overall Study|Withdrawal by Subject|10|||
105811096|NCT00527423|364964918|FG000|Overall Study|Lost to Follow-up|4|||
105811097|NCT00527423|364964918|FG000|Overall Study|OTHER|4|||
105811098|NCT00527423|364964918|FG000|Overall Study|Death|9|||
105811099|NCT02750761|364964925|FG000|Overall Study|Lost to Follow-up|0|||
105811100|NCT02750761|364964926|FG001|Overall Study|Lost to Follow-up|0|||
105811101|NCT02750761|364964927|FG002|Overall Study|Lost to Follow-up|1|||
105953593|NCT03654274|365491860|FG001|Overall Study|Withdrawal by Subject|25|||
105953594|NCT03654274|365491861|FG002|Overall Study|Withdrawal by Subject|33|||
105811102|NCT02750761|364964928|FG003|Overall Study|Lost to Follow-up|0|||
105953595|NCT03654274|365491859|FG000|Overall Study|Lack of Efficacy|4|||
105811103|NCT02750761|364964929|FG004|Overall Study|Lost to Follow-up|0|||
105811104|NCT02750761|364964930|FG005|Overall Study|Lost to Follow-up|0|||
105811105|NCT02906709|364964931|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
105811106|NCT02906709|364964932|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
105811107|NCT02906709|364964931|FG000|Phase A (Week 0 to Week 16)|Death|0|||
105811108|NCT02906709|364964932|FG001|Phase A (Week 0 to Week 16)|Death|1|||
105811109|NCT02906709|364964931|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
105811110|NCT02906709|364964932|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
105811111|NCT02906709|364964931|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
105811112|NCT02906709|364964932|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
105811113|NCT03331042|364964934|FG000|Overall Study|Protocol Violation|1|||
105811114|NCT03331042|364964935|FG001|Overall Study|Protocol Violation|0|||
105811115|NCT03331042|364964936|FG002|Overall Study|Protocol Violation|0|||
105811116|NCT03331042|364964937|FG003|Overall Study|Protocol Violation|0|||
105811117|NCT03331042|364964934|FG000|Overall Study|Physician Decision|0|||
105811118|NCT03331042|364964935|FG001|Overall Study|Physician Decision|0|||
105811119|NCT03331042|364964936|FG002|Overall Study|Physician Decision|1|||
105811120|NCT03331042|364964937|FG003|Overall Study|Physician Decision|0|||
105811121|NCT03331042|364964934|FG000|Overall Study|Lost to Follow-up|0|||
105811122|NCT03331042|364964935|FG001|Overall Study|Lost to Follow-up|0|||
105811123|NCT03331042|364964936|FG002|Overall Study|Lost to Follow-up|0|||
105953596|NCT03654274|365491860|FG001|Overall Study|Lack of Efficacy|5|||
105953597|NCT03654274|365491861|FG002|Overall Study|Lack of Efficacy|7|||
105953598|NCT03654274|365491859|FG000|Overall Study|Pregnancy|2|||
105953599|NCT03654274|365491860|FG001|Overall Study|Pregnancy|2|||
105953600|NCT03654274|365491861|FG002|Overall Study|Pregnancy|1|||
105953601|NCT03654274|365491859|FG000|Overall Study|Other|27|||
105953602|NCT03654274|365491860|FG001|Overall Study|Other|29|||
105953603|NCT03654274|365491861|FG002|Overall Study|Other|32|||
105953604|NCT03654274|365491859|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
105953605|NCT03654274|365491860|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
105953606|NCT03654274|365491861|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
105953607|NCT00038948|365491865|FG000|Overall Study|Adverse Event|131|||
105953608|NCT00038948|365491866|FG001|Overall Study|Adverse Event|43|||
105953609|NCT00038948|365491865|FG000|Overall Study|Lost to Follow-up|4|||
105953610|NCT00038948|365491866|FG001|Overall Study|Lost to Follow-up|4|||
105953611|NCT00038948|365491865|FG000|Overall Study|Nonmedical event|5|||
105953612|NCT00038948|365491866|FG001|Overall Study|Nonmedical event|7|||
105953613|NCT00038948|365491865|FG000|Overall Study|Withdrawal by Subject|23|||
105953614|NCT00038948|365491866|FG001|Overall Study|Withdrawal by Subject|10|||
105953615|NCT00038948|365491865|FG000|Overall Study|Protocol Violation|3|||
105953616|NCT00038948|365491866|FG001|Overall Study|Protocol Violation|7|||
105953617|NCT00038948|365491865|FG000|Overall Study|Lack of Efficacy|3|||
105953618|NCT00038948|365491866|FG001|Overall Study|Lack of Efficacy|6|||
105953619|NCT00652743|365493189|FG000|Months 12-18|Lost to Follow-up|1|||
105953620|NCT00652743|365493190|FG001|Months 12-18|Lost to Follow-up|2|||
105953621|NCT00652743|365493191|FG002|Months 12-18|Lost to Follow-up|7|||
105953622|NCT00652743|365493189|FG000|Months 24-30|Other|5|||
105953623|NCT00652743|365493190|FG001|Months 24-30|Other|1|||
105953624|NCT00652743|365493191|FG002|Months 24-30|Other|11|||
105953625|NCT00652743|365493189|FG000|Months 36-42|Serious Adverse Events|0|||
105953626|NCT00652743|365493190|FG001|Months 36-42|Serious Adverse Events|1|||
105953627|NCT00652743|365493191|FG002|Months 36-42|Serious Adverse Events|1|||
105953628|NCT00652743|365493189|FG000|Months 36-42|Withdrawal by Subject|1|||
105953629|NCT00652743|365493190|FG001|Months 36-42|Withdrawal by Subject|1|||
105953630|NCT00652743|365493191|FG002|Months 36-42|Withdrawal by Subject|0|||
105953631|NCT00652743|365493189|FG000|Months 36-42|Lost to Follow-up|0|||
106144925|NCT05061693|366190774|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
106144926|NCT05061693|366190775|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
106144927|NCT05061693|366190776|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
106144928|NCT05061693|366190777|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
106144929|NCT05061693|366190778|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
106144930|NCT05061693|366190779|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105811124|NCT03331042|364964937|FG003|Overall Study|Lost to Follow-up|1|||
105811125|NCT00623103|364964938|FG000|Overall Study|Adverse Event|70|||
105811126|NCT00623103|364964939|FG001|Overall Study|Adverse Event|60|||
105811127|NCT00623103|364964938|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105811128|NCT00623103|364964939|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
105811129|NCT00623103|364964938|FG000|Overall Study|Withdrawal by Subject|18|||
105811130|NCT00623103|364964939|FG001|Overall Study|Withdrawal by Subject|24|||
105811131|NCT00623103|364964938|FG000|Overall Study|Lost to Follow-up|4|||
105811132|NCT00623103|364964939|FG001|Overall Study|Lost to Follow-up|1|||
105811133|NCT00623103|364964938|FG000|Overall Study|Administrative problems|2|||
105953632|NCT00652743|365493190|FG001|Months 36-42|Lost to Follow-up|1|||
105953633|NCT00652743|365493191|FG002|Months 36-42|Lost to Follow-up|0|||
105953634|NCT00652743|365493189|FG000|Months 36-42|Migrated/moved from study area|1|||
106017408|NCT04922216|365726072|FG007|Overall Study|Lost to Follow-up|1|||
106017409|NCT04922216|365726073|FG008|Overall Study|Lost to Follow-up|1|||
106017410|NCT04922216|365726074|FG009|Overall Study|Lost to Follow-up|2|||
106017411|NCT04922216|365726075|FG010|Overall Study|Lost to Follow-up|2|||
105811134|NCT00623103|364964939|FG001|Overall Study|Administrative problems|4|||
105811135|NCT00623103|364964938|FG000|Overall Study|Death|11|||
105811136|NCT00623103|364964939|FG001|Overall Study|Death|11|||
105811137|NCT00623103|364964938|FG000|Overall Study|Protocol deviation|2|||
105811138|NCT00623103|364964939|FG001|Overall Study|Protocol deviation|1|||
105811139|NCT01215942|364964951|FG000|Treatment Period|Adverse Event|15|||
105811140|NCT01215942|364964952|FG001|Treatment Period|Adverse Event|26|||
105811141|NCT01215942|364964951|FG000|Treatment Period|Death|2|||
105811142|NCT01215942|364964952|FG001|Treatment Period|Death|4|||
105811143|NCT01215942|364964951|FG000|Treatment Period|Lack of Efficacy|23|||
105811144|NCT01215942|364964952|FG001|Treatment Period|Lack of Efficacy|62|||
105811145|NCT01215942|364964951|FG000|Treatment Period|Lost to Follow-up|3|||
105811146|NCT01215942|364964952|FG001|Treatment Period|Lost to Follow-up|4|||
105811147|NCT01215942|364964951|FG000|Treatment Period|Withdrawal by Subject|17|||
105811148|NCT01215942|364964952|FG001|Treatment Period|Withdrawal by Subject|40|||
105811149|NCT01215942|364964951|FG000|Treatment Period|Physician Decision|5|||
105811150|NCT01215942|364964952|FG001|Treatment Period|Physician Decision|5|||
105811151|NCT01215942|364964951|FG000|Treatment Period|Protocol Violation|0|||
105811152|NCT01215942|364964952|FG001|Treatment Period|Protocol Violation|1|||
105811153|NCT01215942|364964951|FG000|Treatment Period|Sponsor Decision|349|||
105811154|NCT01215942|364964952|FG001|Treatment Period|Sponsor Decision|530|||
105811155|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Death|0|||
105811156|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Death|1|||
105811157|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
105811158|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
105811159|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
105811160|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
105811161|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
105811162|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
105811163|NCT01215942|364964951|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
105811164|NCT01215942|364964952|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
105811165|NCT01193608|364964953|FG000|Overall Study|Other|0|||
105811166|NCT01193608|364964954|FG001|Overall Study|Other|1|||
105811167|NCT01193608|364964955|FG002|Overall Study|Other|0|||
105811168|NCT01193608|364964956|FG003|Overall Study|Other|0|||
105811169|NCT01193608|364964957|FG004|Overall Study|Other|0|||
105811170|NCT01193608|364964958|FG005|Overall Study|Other|0|||
106017412|NCT04922216|365726076|FG011|Overall Study|Lost to Follow-up|1|||
106017413|NCT04922216|365726077|FG012|Overall Study|Lost to Follow-up|1|||
106017414|NCT04922216|365726078|FG013|Overall Study|Lost to Follow-up|0|||
106017415|NCT04922216|365726079|FG014|Overall Study|Lost to Follow-up|1|||
106017416|NCT04922216|365726080|FG015|Overall Study|Lost to Follow-up|0|||
106017417|NCT04922216|365726081|FG016|Overall Study|Lost to Follow-up|0|||
106017418|NCT04922216|365726082|FG017|Overall Study|Lost to Follow-up|2|||
106017419|NCT04922216|365726083|FG018|Overall Study|Lost to Follow-up|1|||
106017420|NCT04922216|365726084|FG019|Overall Study|Lost to Follow-up|0|||
105811171|NCT01193608|364964953|FG000|Overall Study|Withdrawal by Subject|0|||
105811172|NCT01193608|364964954|FG001|Overall Study|Withdrawal by Subject|1|||
106017421|NCT04922216|365726085|FG020|Overall Study|Lost to Follow-up|1|||
106017422|NCT04922216|365726086|FG021|Overall Study|Lost to Follow-up|0|||
106017423|NCT04922216|365726087|FG022|Overall Study|Lost to Follow-up|2|||
106017424|NCT04922216|365726088|FG023|Overall Study|Lost to Follow-up|1|||
106017425|NCT04922216|365726089|FG024|Overall Study|Lost to Follow-up|0|||
106017426|NCT04922216|365726090|FG025|Overall Study|Lost to Follow-up|2|||
106017427|NCT04922216|365726091|FG026|Overall Study|Lost to Follow-up|0|||
106017428|NCT04922216|365726092|FG027|Overall Study|Lost to Follow-up|0|||
106017429|NCT04922216|365726093|FG028|Overall Study|Lost to Follow-up|1|||
106144931|NCT05061693|366190780|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
106144932|NCT05061693|366190781|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
106144933|NCT05061693|366190782|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
106017430|NCT04922216|365726094|FG029|Overall Study|Lost to Follow-up|0|||
106017431|NCT04922216|365726095|FG030|Overall Study|Lost to Follow-up|2|||
106017432|NCT04922216|365726096|FG031|Overall Study|Lost to Follow-up|1|||
106017433|NCT04610281|365727230|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
105811173|NCT01193608|364964955|FG002|Overall Study|Withdrawal by Subject|2|||
105811174|NCT01193608|364964956|FG003|Overall Study|Withdrawal by Subject|3|||
105811175|NCT01193608|364964957|FG004|Overall Study|Withdrawal by Subject|3|||
105811176|NCT01193608|364964958|FG005|Overall Study|Withdrawal by Subject|0|||
105811177|NCT01193608|364964953|FG000|Overall Study|Lost to Follow-up|0|||
105811178|NCT01193608|364964954|FG001|Overall Study|Lost to Follow-up|0|||
105811179|NCT01193608|364964955|FG002|Overall Study|Lost to Follow-up|0|||
106017434|NCT04610281|365727231|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
106017435|NCT02351856|365727232|FG000|Overall Study|Adverse Event|2|||
105953635|NCT00652743|365493190|FG001|Months 36-42|Migrated/moved from study area|0|||
105953636|NCT00652743|365493191|FG002|Months 36-42|Migrated/moved from study area|0|||
105953637|NCT00652743|365493189|FG000|Months 36-42|Other|4|||
105953638|NCT00652743|365493190|FG001|Months 36-42|Other|2|||
105953639|NCT00652743|365493191|FG002|Months 36-42|Other|8|||
105953640|NCT00456755|365493193|FG000|Overall Study|Lost to Follow-up|2|||
105953641|NCT00456755|365493194|FG001|Overall Study|Lost to Follow-up|1|||
105953642|NCT00387088|365493195|FG000|Overall Study|Adverse Event|143|||
105953643|NCT00387088|365493196|FG001|Overall Study|Adverse Event|156|||
105953644|NCT00387088|365493195|FG000|Overall Study|Protocol Violation|47|||
105953645|NCT00387088|365493196|FG001|Overall Study|Protocol Violation|35|||
105953646|NCT00387088|365493195|FG000|Overall Study|Withdrawal by Subject|20|||
105953647|NCT00387088|365493196|FG001|Overall Study|Withdrawal by Subject|35|||
105953648|NCT00387088|365493195|FG000|Overall Study|Lack of Efficacy|28|||
105953649|NCT00387088|365493196|FG001|Overall Study|Lack of Efficacy|67|||
105953650|NCT00387088|365493195|FG000|Overall Study|Lost to Follow-up|22|||
105953651|NCT00387088|365493196|FG001|Overall Study|Lost to Follow-up|28|||
105953652|NCT00387088|365493195|FG000|Overall Study|Other|58|||
105953653|NCT00387088|365493196|FG001|Overall Study|Other|52|||
105762713|NCT00249795|364783168|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
105762714|NCT00249795|364783167|FG000|Overall Study|Lightheadedness / dizziness|15|||
105762715|NCT00249795|364783168|FG001|Overall Study|Lightheadedness / dizziness|11|||
105762716|NCT00249795|364783167|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
105762717|NCT00249795|364783168|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
105762718|NCT00249795|364783167|FG000|Overall Study|Other contraindicated medication|1|||
105762719|NCT00249795|364783168|FG001|Overall Study|Other contraindicated medication|1|||
105762720|NCT00249795|364783167|FG000|Overall Study|Event related to cardiac condition|17|||
105762721|NCT00249795|364783168|FG001|Overall Study|Event related to cardiac condition|16|||
105762722|NCT00249795|364783167|FG000|Overall Study|Patient not wish to continue after May08|4|||
105762723|NCT00249795|364783168|FG001|Overall Study|Patient not wish to continue after May08|6|||
105762724|NCT00249795|364783167|FG000|Overall Study|Site not agree to continue after May08|1|||
105762725|NCT00249795|364783168|FG001|Overall Study|Site not agree to continue after May08|1|||
105762726|NCT00249795|364783167|FG000|Overall Study|Lost to Follow-up|0|||
105762727|NCT00249795|364783168|FG001|Overall Study|Lost to Follow-up|2|||
105762728|NCT00249795|364783167|FG000|Overall Study|Missing|0|||
105762729|NCT00249795|364783168|FG001|Overall Study|Missing|1|||
105762730|NCT01142193|364783169|FG000|Overall Study|Adverse Event|12|||
105762731|NCT01142193|364783170|FG001|Overall Study|Adverse Event|4|||
105762732|NCT01142193|364783169|FG000|Overall Study|Lack of Efficacy|2|||
105762733|NCT01142193|364783170|FG001|Overall Study|Lack of Efficacy|1|||
105762734|NCT01142193|364783169|FG000|Overall Study|Physician Decision|1|||
105762735|NCT01142193|364783170|FG001|Overall Study|Physician Decision|1|||
105762736|NCT01142193|364783169|FG000|Overall Study|Withdrawal by Subject|4|||
105762737|NCT01142193|364783170|FG001|Overall Study|Withdrawal by Subject|3|||
105762738|NCT01142193|364783169|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
105762739|NCT01142193|364783170|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
105762740|NCT01142193|364783169|FG000|Overall Study|Other|1|||
105762741|NCT01142193|364783170|FG001|Overall Study|Other|2|||
105762742|NCT01425749|364783173|FG000|Overall Study|progression of melanoma|0|||
105762743|NCT01425749|364783174|FG001|Overall Study|progression of melanoma|1|||
105762744|NCT02910219|364783175|FG000|Overall Study|Withdrawal by Subject|1|||
105762745|NCT02910219|364783176|FG001|Overall Study|Withdrawal by Subject|1|||
105762746|NCT01293084|364783177|FG000|Overall Study|Physician Decision|3|||
105762747|NCT01293084|364783177|FG000|Overall Study|Withdrawal by Subject|2|||
105762748|NCT00701441|364783178|FG000|Overall Study|failure in cpap compliance|0|||
105762749|NCT00701441|364783179|FG001|Overall Study|failure in cpap compliance|4|||
105762750|NCT01015820|364783180|FG000|Overall Study|Suboptimal measurements|1|||
105762751|NCT01015820|364783181|FG001|Overall Study|Suboptimal measurements|0|||
105762752|NCT00718523|364783189|FG000|Overall Study|Withdrawal by Subject|5|||
105762753|NCT00718523|364783190|FG001|Overall Study|Withdrawal by Subject|7|||
105762754|NCT00718523|364783189|FG000|Overall Study|Death|13|||
105762755|NCT00718523|364783190|FG001|Overall Study|Death|17|||
105762756|NCT01313078|364783191|FG000|Overall Study|Death|1|||
105762757|NCT01313078|364783191|FG000|Overall Study|Discontinued study drug|1|||
105762758|NCT01313078|364783191|FG000|Overall Study|Withdrawal by Subject|1|||
105762759|NCT03365947|364783192|FG000|Overall Study|Lost to Follow-up|0|||
105762760|NCT03365947|364783193|FG001|Overall Study|Lost to Follow-up|0|||
105953654|NCT01306643|365493197|FG000|Overall Study|Adverse Event|5|||
105953655|NCT01306643|365493197|FG000|Overall Study|Disease Progression|7|||
105953656|NCT01306643|365493197|FG000|Overall Study|Other: Change in Eligibility Status|1|||
105953657|NCT01147393|365493202|FG000|Dose Level 1|Dose limiting Toxicity|2|||
106017436|NCT02351856|365727232|FG000|Overall Study|Physician Decision|5|||
106017437|NCT02351856|365727232|FG000|Overall Study|Study terminated by sponsor|1|||
106017438|NCT00865566|365727237|FG000|Overall Study|Death|1|||
106017439|NCT00865566|365727238|FG001|Overall Study|Death|11|||
106017440|NCT00865566|365727237|FG000|Overall Study|Lost to Follow-up|314|||
106017441|NCT00865566|365727238|FG001|Overall Study|Lost to Follow-up|315|||
106017442|NCT00865566|365727237|FG000|Overall Study|Withdrawal by Subject|45|||
106017443|NCT00865566|365727238|FG001|Overall Study|Withdrawal by Subject|65|||
106017444|NCT00865566|365727237|FG000|Overall Study|Physician Decision|0|||
106017445|NCT00865566|365727238|FG001|Overall Study|Physician Decision|1|||
106017446|NCT00865566|365727237|FG000|Overall Study|Participant relocated|78|||
106017447|NCT00865566|365727238|FG001|Overall Study|Participant relocated|107|||
106017448|NCT00865566|365727237|FG000|Overall Study|Participant unable to adhere|27|||
106017449|NCT00865566|365727238|FG001|Overall Study|Participant unable to adhere|42|||
106017450|NCT00865566|365727237|FG000|Overall Study|Other; N=245 due to early study closure|154|||
106017451|NCT00865566|365727238|FG001|Overall Study|Other; N=245 due to early study closure|139|||
106017452|NCT00865566|365727237|FG000|Overall Study|HIV infection|5|||
106017453|NCT00865566|365727238|FG001|Overall Study|HIV infection|7|||
106017454|NCT00602472|365727241|FG000|Overall Study|Adverse Event|5|||
106017455|NCT00602472|365727242|FG001|Overall Study|Adverse Event|23|||
106017456|NCT00602472|365727241|FG000|Overall Study|Protocol Violation|4|||
106017457|NCT00602472|365727242|FG001|Overall Study|Protocol Violation|19|||
106017458|NCT00602472|365727241|FG000|Overall Study|Withdrawal by Subject|8|||
106017459|NCT00602472|365727242|FG001|Overall Study|Withdrawal by Subject|14|||
106017460|NCT00602472|365727241|FG000|Overall Study|Other incl. lack of efficacy|4|||
106017461|NCT00602472|365727242|FG001|Overall Study|Other incl. lack of efficacy|2|||
106017462|NCT02803580|365727243|FG000|Overall Study|Death|13|||
106017463|NCT02803580|365727243|FG000|Overall Study|Lost to Follow-up|19|||
106017464|NCT02803580|365727243|FG000|Overall Study|Withdrawal by Subject|3|||
106017465|NCT02803580|365727243|FG000|Overall Study|Inclusion in clinical trial|1|||
106017466|NCT02404025|365727246|FG000|Overall Study|Adverse Event|1|||
106017467|NCT02404025|365727246|FG000|Overall Study|Lack of Efficacy|3|||
106017468|NCT02118961|365727247|FG000|Overall Study|Withdrawal by Subject|1|||
106017469|NCT02118961|365727248|FG001|Overall Study|Withdrawal by Subject|0|||
106017470|NCT01544335|365727251|FG000|Overall Study|Lost to Follow-up|27|||
106017471|NCT01544335|365727251|FG000|Overall Study|Death|4|||
106017472|NCT01544335|365727251|FG000|Overall Study|Disease progression|3|||
105811180|NCT01193608|364964956|FG003|Overall Study|Lost to Follow-up|0|||
105811181|NCT01193608|364964957|FG004|Overall Study|Lost to Follow-up|1|||
105811182|NCT01193608|364964958|FG005|Overall Study|Lost to Follow-up|2|||
105811183|NCT01193608|364964953|FG000|Overall Study|Adverse Event|0|||
105811184|NCT01193608|364964954|FG001|Overall Study|Adverse Event|0|||
105811185|NCT01193608|364964955|FG002|Overall Study|Adverse Event|0|||
105811186|NCT01193608|364964956|FG003|Overall Study|Adverse Event|0|||
105811187|NCT01193608|364964957|FG004|Overall Study|Adverse Event|1|||
105811188|NCT01193608|364964958|FG005|Overall Study|Adverse Event|0|||
105811189|NCT04471935|364964959|FG000|Overall Study|Withdrawal by Subject|1|||
105811190|NCT04471935|364964959|FG000|Overall Study|Deemed ineligible to participate|1|||
105811191|NCT01766921|364964960|FG000|Overall Study|Administrative Reason|5|||
105811192|NCT01766921|364964961|FG001|Overall Study|Administrative Reason|5|||
105811193|NCT01766921|364964960|FG000|Overall Study|Death|1|||
105811194|NCT01766921|364964961|FG001|Overall Study|Death|1|||
105811195|NCT01766921|364964960|FG000|Overall Study|Lost to Follow-up|1|||
105811196|NCT01766921|364964961|FG001|Overall Study|Lost to Follow-up|3|||
105811197|NCT01766921|364964960|FG000|Overall Study|Unclassified|2|||
105953658|NCT01147393|365493202|FG000|Dose Level -1|Dose Limited Toxicity|1|||
105953659|NCT04294459|365493203|FG000|Overall Study|Adverse Event|0|||
105953660|NCT04294459|365493204|FG001|Overall Study|Adverse Event|1|||
105953661|NCT00592631|365493205|FG000|Overall Study|Lost to Follow-up|0|||
105953662|NCT00592631|365493206|FG001|Overall Study|Lost to Follow-up|2|||
105953663|NCT01244035|365493207|FG000|Part 1: Period 1|Adverse Event|0|||
105953664|NCT01244035|365493208|FG001|Part 1: Period 1|Adverse Event|0|||
105953665|NCT01244035|365493209|FG002|Part 1: Period 1|Adverse Event|0|||
105953666|NCT01244035|365493210|FG003|Part 1: Period 1|Adverse Event|0|||
105953667|NCT01244035|365493211|FG004|Part 1: Period 1|Adverse Event|0|||
105953668|NCT01244035|365493212|FG005|Part 1: Period 1|Adverse Event|1|||
105953669|NCT01244035|365493207|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
105953670|NCT01244035|365493208|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
105953671|NCT01244035|365493209|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
105953672|NCT01244035|365493210|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
105953673|NCT01244035|365493211|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
105953674|NCT01244035|365493212|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
105953675|NCT01244035|365493207|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
106017473|NCT01544335|365727251|FG000|Overall Study|Baseline Measurements not Available|19|||
106017474|NCT00705016|365727252|FG000|Overall Study|Adverse Event|6|||
106017475|NCT00705016|365727253|FG001|Overall Study|Adverse Event|11|||
106017476|NCT00705016|365727254|FG002|Overall Study|Adverse Event|10|||
105811198|NCT01766921|364964961|FG001|Overall Study|Unclassified|2|||
105811199|NCT01766921|364964960|FG000|Overall Study|Protocol Violation|1|||
105811200|NCT01766921|364964961|FG001|Overall Study|Protocol Violation|1|||
106144934|NCT05061693|366190783|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
106144935|NCT05061693|366190784|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
105811201|NCT01766921|364964960|FG000|Overall Study|Withdrawal by Subject|14|||
105811202|NCT01766921|364964961|FG001|Overall Study|Withdrawal by Subject|5|||
105811203|NCT00368277|364964967|FG000|Overall Study|Adverse Event|33|||
105811204|NCT00368277|364964968|FG001|Overall Study|Adverse Event|49|||
105811205|NCT00368277|364964967|FG000|Overall Study|Death|2|||
105811206|NCT00368277|364964968|FG001|Overall Study|Death|1|||
105811207|NCT00368277|364964967|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
105811208|NCT00368277|364964968|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
105811209|NCT00368277|364964967|FG000|Overall Study|Protocol deviation|7|||
105811210|NCT00368277|364964968|FG001|Overall Study|Protocol deviation|0|||
105811211|NCT00368277|364964967|FG000|Overall Study|Patient withdrew consent|32|||
105811212|NCT00368277|364964968|FG001|Overall Study|Patient withdrew consent|28|||
105811213|NCT00368277|364964967|FG000|Overall Study|Lost to Follow-up|8|||
105811214|NCT00368277|364964968|FG001|Overall Study|Lost to Follow-up|6|||
105811215|NCT03922477|364964969|FG000|Overall Study|Death|9|||
105811216|NCT03922477|364964969|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
105811217|NCT03922477|364964969|FG000|Overall Study|Physician Decision|1|||
105811218|NCT03922477|364964969|FG000|Overall Study|Withdrawal by Subject|2|||
105811219|NCT04646109|364964971|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
105811220|NCT04646109|364964972|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
105811221|NCT01606306|364964974|FG000|Overall Study|Lack of Efficacy|2|||
105811222|NCT01606306|364964975|FG001|Overall Study|Lack of Efficacy|1|||
105811223|NCT01606306|364964976|FG002|Overall Study|Lack of Efficacy|4|||
105811224|NCT01606306|364964977|FG003|Overall Study|Lack of Efficacy|4|||
105811225|NCT01606306|364964978|FG004|Overall Study|Lack of Efficacy|1|||
105811226|NCT01606306|364964979|FG005|Overall Study|Lack of Efficacy|2|||
105811227|NCT01606306|364964974|FG000|Overall Study|Adverse Event|1|||
105811228|NCT01606306|364964975|FG001|Overall Study|Adverse Event|0|||
105811229|NCT01606306|364964976|FG002|Overall Study|Adverse Event|1|||
105811230|NCT01606306|364964977|FG003|Overall Study|Adverse Event|1|||
105811231|NCT01606306|364964978|FG004|Overall Study|Adverse Event|2|||
105811232|NCT01606306|364964979|FG005|Overall Study|Adverse Event|0|||
105811233|NCT01606306|364964974|FG000|Overall Study|Lost to Follow-up|7|||
105811234|NCT01606306|364964975|FG001|Overall Study|Lost to Follow-up|4|||
105811235|NCT01606306|364964976|FG002|Overall Study|Lost to Follow-up|5|||
105811236|NCT01606306|364964977|FG003|Overall Study|Lost to Follow-up|4|||
105811237|NCT01606306|364964978|FG004|Overall Study|Lost to Follow-up|3|||
105811238|NCT01606306|364964979|FG005|Overall Study|Lost to Follow-up|5|||
105811239|NCT01606306|364964974|FG000|Overall Study|Withdrawal by Subject|4|||
105811240|NCT01606306|364964975|FG001|Overall Study|Withdrawal by Subject|3|||
105811241|NCT01606306|364964976|FG002|Overall Study|Withdrawal by Subject|4|||
105811242|NCT01606306|364964977|FG003|Overall Study|Withdrawal by Subject|4|||
105811243|NCT01606306|364964978|FG004|Overall Study|Withdrawal by Subject|5|||
105811244|NCT01606306|364964979|FG005|Overall Study|Withdrawal by Subject|4|||
105811245|NCT01606306|364964974|FG000|Overall Study|Physician Decision|1|||
105811246|NCT01606306|364964975|FG001|Overall Study|Physician Decision|2|||
105811247|NCT01606306|364964976|FG002|Overall Study|Physician Decision|0|||
105811248|NCT01606306|364964977|FG003|Overall Study|Physician Decision|0|||
105811249|NCT01606306|364964978|FG004|Overall Study|Physician Decision|0|||
105811250|NCT01606306|364964979|FG005|Overall Study|Physician Decision|0|||
105811251|NCT01759290|364964980|FG000|Overall Study|Subjects withdrawn consent|5|||
105811252|NCT01759290|364964980|FG000|Overall Study|Physician Decision|2|||
105811253|NCT01759290|364964980|FG000|Overall Study|Death|17|||
105811254|NCT01759290|364964980|FG000|Overall Study|Lost to Follow-up|53|||
105811255|NCT01759290|364964980|FG000|Overall Study|Unknown reason|4|||
105811256|NCT00841100|364964981|FG000|Phase 1 (28 Days)|Adverse Event|1|||
105953676|NCT01244035|365493208|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
105953677|NCT01244035|365493209|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
105953678|NCT01244035|365493210|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
105953679|NCT01244035|365493211|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
105953680|NCT01244035|365493212|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
105953681|NCT01244035|365493207|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105953682|NCT01244035|365493208|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105953683|NCT01244035|365493209|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
105953684|NCT01244035|365493210|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105953685|NCT01244035|365493211|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105953686|NCT01244035|365493212|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
105811257|NCT00841100|364964981|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
105811258|NCT01355081|364964984|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
105811259|NCT01355081|364964985|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
105811260|NCT01355081|364964986|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
105811261|NCT01355081|364964984|FG000|Overall Study|Major Protocol Deviation|0|||
105953687|NCT01244035|365493207|FG000|Part 1: Period 3|Adverse Event|0|||
105953688|NCT01244035|365493208|FG001|Part 1: Period 3|Adverse Event|0|||
105953689|NCT01244035|365493209|FG002|Part 1: Period 3|Adverse Event|0|||
105953690|NCT01244035|365493210|FG003|Part 1: Period 3|Adverse Event|0|||
105953691|NCT01244035|365493211|FG004|Part 1: Period 3|Adverse Event|0|||
105953692|NCT01244035|365493212|FG005|Part 1: Period 3|Adverse Event|1|||
105953693|NCT01244035|365493207|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
105953694|NCT01244035|365493208|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
105953695|NCT01244035|365493209|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
105953696|NCT01244035|365493210|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
105953697|NCT01244035|365493211|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
105953698|NCT01244035|365493212|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
105953699|NCT01244035|365493207|FG000|Part 1: Period 3|Protocol Deviation|0|||
105953700|NCT01244035|365493208|FG001|Part 1: Period 3|Protocol Deviation|1|||
105953701|NCT01244035|365493209|FG002|Part 1: Period 3|Protocol Deviation|0|||
105953702|NCT01244035|365493210|FG003|Part 1: Period 3|Protocol Deviation|0|||
105953703|NCT01244035|365493211|FG004|Part 1: Period 3|Protocol Deviation|0|||
105953704|NCT01244035|365493212|FG005|Part 1: Period 3|Protocol Deviation|0|||
105953705|NCT02383862|365493214|FG000|3 Month Follow up|Lost to Follow-up|23|||
105953706|NCT02383862|365493215|FG001|3 Month Follow up|Lost to Follow-up|21|||
105953707|NCT01696773|365493216|FG000|Days 15-27, Washout|Adverse Event|1|||
105953708|NCT01696773|365493217|FG001|Days 15-27, Washout|Adverse Event|0|||
105953709|NCT01833494|365493218|FG000|Overall Study|Adverse Event|24|||
105953710|NCT01833494|365493218|FG000|Overall Study|Physician Decision|6|||
105953711|NCT01833494|365493218|FG000|Overall Study|Withdrawal by Subject|6|||
105953712|NCT01833494|365493218|FG000|Overall Study|Decrease in serum phosphorus|4|||
105953713|NCT01833494|365493218|FG000|Overall Study|Decrease in serum calcium|4|||
105953714|NCT01833494|365493218|FG000|Overall Study|Increase in serum ferritin|1|||
105953715|NCT01694433|365493219|FG000|Overall Study|Adverse Event|7|||
105953716|NCT01694433|365493220|FG001|Overall Study|Adverse Event|0|||
105953717|NCT01694433|365493219|FG000|Overall Study|Physician Decision|1|||
105953718|NCT01694433|365493220|FG001|Overall Study|Physician Decision|0|||
105953719|NCT01694433|365493219|FG000|Overall Study|Withdrawal by Subject|3|||
105953720|NCT01694433|365493220|FG001|Overall Study|Withdrawal by Subject|4|||
105953721|NCT00374595|365493223|FG000|Overall Study|Death|23|||
105953722|NCT00374595|365493223|FG000|Overall Study|Withdrawal by Subject|39|||
105953723|NCT00374595|365493223|FG000|Overall Study|Lost to Follow-up|3|||
105953724|NCT00374595|365493223|FG000|Overall Study|too much time commitment|1|||
105953725|NCT00374595|365493223|FG000|Overall Study|transfer care to other clinical site|1|||
105953726|NCT00374595|365493223|FG000|Overall Study|relocation|3|||
105953727|NCT00443118|365493225|FG000|Overall Study|unknown primary outcome|3|||
105953728|NCT00443118|365493226|FG001|Overall Study|unknown primary outcome|1|||
105953729|NCT00443118|365493227|FG002|Overall Study|unknown primary outcome|0|||
105953730|NCT00443118|365493225|FG000|Overall Study|Withdrawal by Subject|1|||
105953731|NCT00443118|365493226|FG001|Overall Study|Withdrawal by Subject|0|||
105953732|NCT00443118|365493227|FG002|Overall Study|Withdrawal by Subject|0|||
105953733|NCT00347932|365493228|FG000|Overall Study|Adverse Event|4|||
105953734|NCT00347932|365493229|FG001|Overall Study|Adverse Event|5|||
105953735|NCT00347932|365493228|FG000|Overall Study|Lack of Efficacy|3|||
105953736|NCT00347932|365493229|FG001|Overall Study|Lack of Efficacy|14|||
105953737|NCT00347932|365493228|FG000|Overall Study|Lost to Follow-up|10|||
105953738|NCT00347932|365493229|FG001|Overall Study|Lost to Follow-up|9|||
105953739|NCT00347932|365493228|FG000|Overall Study|Withdrawal by Subject|10|||
105953740|NCT00347932|365493229|FG001|Overall Study|Withdrawal by Subject|16|||
105953741|NCT00347932|365493228|FG000|Overall Study|Did not meet inclusion criteria|4|||
105953742|NCT00347932|365493229|FG001|Overall Study|Did not meet inclusion criteria|8|||
105953743|NCT01106157|365493237|FG000|Overall Study|Withdrawal by Subject|1|||
105953744|NCT01106157|365493238|FG001|Overall Study|Withdrawal by Subject|0|||
105953745|NCT02141672|365493239|FG000|Overall Study|Adverse Event|0|||
105953746|NCT02141672|365493240|FG001|Overall Study|Adverse Event|1|||
105953747|NCT02141672|365493241|FG002|Overall Study|Adverse Event|0|||
105953748|NCT02141672|365493239|FG000|Overall Study|Death|10|||
105953749|NCT02141672|365493240|FG001|Overall Study|Death|2|||
105953750|NCT02141672|365493241|FG002|Overall Study|Death|1|||
105953751|NCT02141672|365493239|FG000|Overall Study|Lack of Efficacy|0|||
105953752|NCT02141672|365493240|FG001|Overall Study|Lack of Efficacy|0|||
105953753|NCT02141672|365493241|FG002|Overall Study|Lack of Efficacy|2|||
105953754|NCT02141672|365493239|FG000|Overall Study|Lost to Follow-up|1|||
105953755|NCT02141672|365493240|FG001|Overall Study|Lost to Follow-up|1|||
105953756|NCT02141672|365493241|FG002|Overall Study|Lost to Follow-up|3|||
105953757|NCT02141672|365493239|FG000|Overall Study|Physician Decision|1|||
105953758|NCT02141672|365493240|FG001|Overall Study|Physician Decision|2|||
105953759|NCT02141672|365493241|FG002|Overall Study|Physician Decision|5|||
105953760|NCT02141672|365493239|FG000|Overall Study|Protocol Violation|0|||
105953761|NCT02141672|365493240|FG001|Overall Study|Protocol Violation|0|||
105953762|NCT02141672|365493241|FG002|Overall Study|Protocol Violation|1|||
105953763|NCT02141672|365493239|FG000|Overall Study|Withdrawal by Subject|3|||
105953764|NCT02141672|365493240|FG001|Overall Study|Withdrawal by Subject|2|||
105811262|NCT01355081|364964985|FG001|Overall Study|Major Protocol Deviation|1|||
105811263|NCT01355081|364964986|FG002|Overall Study|Major Protocol Deviation|0|||
105811264|NCT01355081|364964984|FG000|Overall Study|Lost to Follow-up|0|||
105811265|NCT01355081|364964985|FG001|Overall Study|Lost to Follow-up|0|||
105811266|NCT01355081|364964986|FG002|Overall Study|Lost to Follow-up|1|||
105811267|NCT01355081|364964984|FG000|Overall Study|Withdrawal of Consent|2|||
105811268|NCT01355081|364964985|FG001|Overall Study|Withdrawal of Consent|3|||
105811269|NCT01355081|364964986|FG002|Overall Study|Withdrawal of Consent|3|||
105811270|NCT01355081|364964984|FG000|Overall Study|Lack of Efficacy|2|||
105811271|NCT01355081|364964985|FG001|Overall Study|Lack of Efficacy|1|||
105811272|NCT01355081|364964986|FG002|Overall Study|Lack of Efficacy|1|||
105811273|NCT01355081|364964984|FG000|Overall Study|Non Compliance with Study Medication|0|||
105811274|NCT01355081|364964985|FG001|Overall Study|Non Compliance with Study Medication|1|||
105811275|NCT01355081|364964986|FG002|Overall Study|Non Compliance with Study Medication|0|||
105811276|NCT03184441|364964987|FG000|Overall Study|Withdrawal by Subject|1|||
105811277|NCT01868009|364964988|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
105811278|NCT01868009|364964989|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
105811279|NCT01868009|364964988|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
105811280|NCT01868009|364964989|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
105811281|NCT01868009|364964988|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
105811282|NCT01868009|364964989|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
105811283|NCT01046253|364964992|FG000|Second Intervention|Adverse Event|0|||
105811284|NCT01046253|364964993|FG001|Second Intervention|Adverse Event|1|||
105811285|NCT01046253|364964992|FG000|Second Intervention|Protocol Violation|0|||
105811286|NCT01046253|364964993|FG001|Second Intervention|Protocol Violation|1|||
105811287|NCT02514174|364964996|FG000|Overall Study|Patient refused to continue medication|1|||
105811288|NCT02514174|364964996|FG000|Overall Study|Adverse Event|2|||
105811289|NCT02514174|364964996|FG000|Overall Study|Study closed by sponsor|9|||
105811290|NCT02514174|364964996|FG000|Overall Study|Progressive disease|11|||
105811291|NCT02514174|364964996|FG000|Overall Study|Treatment change|1|||
105811292|NCT02514174|364964996|FG000|Overall Study|Treated off study with Afatinib.|1|||
105811293|NCT02070744|364964997|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
105811294|NCT02070744|364964998|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
105811295|NCT02070744|364964999|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
105811296|NCT02070744|364965000|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
105811297|NCT02070744|364965001|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
105811298|NCT02070744|364964997|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
105811299|NCT02070744|364964998|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
105811300|NCT02070744|364964999|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
105811301|NCT02070744|364965000|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
105811302|NCT02070744|364965001|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
105811303|NCT02070744|364964997|FG000|OLE Phase (48 Weeks)|Other|0|||
105811304|NCT02070744|364964998|FG001|OLE Phase (48 Weeks)|Other|0|||
105811305|NCT02070744|364964999|FG002|OLE Phase (48 Weeks)|Other|0|||
105811306|NCT02070744|364965000|FG003|OLE Phase (48 Weeks)|Other|0|||
105811307|NCT02070744|364965001|FG004|OLE Phase (48 Weeks)|Other|1|||
105811308|NCT00922779|364965005|FG000|Overall Study|Adverse Event|67|||
105811309|NCT00922779|364965005|FG000|Overall Study|Pregnancy|7|||
105811310|NCT00922779|364965005|FG000|Overall Study|Withdrawal by Subject|308|||
105811311|NCT00922779|364965005|FG000|Overall Study|Lost to Follow-up|44|||
105811312|NCT00922779|364965005|FG000|Overall Study|Other|27|||
105811313|NCT00922779|364965005|FG000|Overall Study|Missing|1874|||
105811314|NCT02507375|364965006|FG000|Overall Study|Progressive Disease|4|||
105811315|NCT02507375|364965007|FG001|Overall Study|Progressive Disease|5|||
105811316|NCT02507375|364965006|FG000|Overall Study|Death|0|||
105811317|NCT02507375|364965007|FG001|Overall Study|Death|1|||
105811318|NCT02507375|364965006|FG000|Overall Study|Refused treatment|0|||
105811319|NCT02507375|364965007|FG001|Overall Study|Refused treatment|1|||
105811320|NCT02507375|364965006|FG000|Overall Study|Adverse Event|0|||
106017477|NCT00705016|365727252|FG000|Overall Study|Death|5|||
105811321|NCT02507375|364965007|FG001|Overall Study|Adverse Event|1|||
105811322|NCT02158936|364965008|FG000|Overall Study|Study closed/ terminated|57|||
105811323|NCT02158936|364965009|FG001|Overall Study|Study closed/ terminated|77|||
105811324|NCT02158936|364965008|FG000|Overall Study|Azacitidine tx discontinued|53|||
105811325|NCT02158936|364965009|FG001|Overall Study|Azacitidine tx discontinued|46|||
105811326|NCT02158936|364965008|FG000|Overall Study|Adverse Event|39|||
105811327|NCT02158936|364965009|FG001|Overall Study|Adverse Event|24|||
105811328|NCT02158936|364965008|FG000|Overall Study|Withdrawal by Subject|15|||
105811329|NCT02158936|364965009|FG001|Overall Study|Withdrawal by Subject|16|||
105811330|NCT02158936|364965008|FG000|Overall Study|Physician Decision|15|||
105811331|NCT02158936|364965009|FG001|Overall Study|Physician Decision|13|||
105811332|NCT02158936|364965008|FG000|Overall Study|Lost to Follow-up|0|||
105811333|NCT02158936|364965009|FG001|Overall Study|Lost to Follow-up|1|||
105811334|NCT00993616|364965010|FG000|Overall Study|No tumor at entry|1|||
105811335|NCT00993616|364965010|FG000|Overall Study|Never treated|1|||
105811336|NCT02224456|364966511|FG000|Overall Study|Lack of Efficacy|1|||
105811337|NCT02224456|364966511|FG000|Overall Study|Lost to Follow-up|15|||
105811338|NCT02224456|364966511|FG000|Overall Study|Withdrawal by Subject|9|||
105811339|NCT02224456|364966511|FG000|Overall Study|Physician Decision|3|||
105811340|NCT02224456|364966511|FG000|Overall Study|Death|2|||
105811341|NCT02224456|364966511|FG000|Overall Study|Pregnancy|4|||
105811342|NCT02224456|364966511|FG000|Overall Study|Protocol Violation|1|||
105811343|NCT02224456|364966511|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
105811344|NCT02946385|364966512|FG000|Overall Study|Lost to Follow-up|0|||
105811345|NCT02946385|364966513|FG001|Overall Study|Lost to Follow-up|0|||
105811346|NCT02946385|364966514|FG002|Overall Study|Lost to Follow-up|3|||
105811347|NCT02946385|364966515|FG003|Overall Study|Lost to Follow-up|0|||
105811348|NCT02946385|364966516|FG004|Overall Study|Lost to Follow-up|2|||
105811349|NCT02946385|364966517|FG005|Overall Study|Lost to Follow-up|1|||
105811350|NCT01644890|364966518|FG000|Overall Study|Adverse Event|7|||
105811351|NCT01644890|364966519|FG001|Overall Study|Adverse Event|20|||
105811352|NCT01644890|364966518|FG000|Overall Study|Death|1|||
105811353|NCT01644890|364966519|FG001|Overall Study|Death|3|||
105811354|NCT01644890|364966518|FG000|Overall Study|Physician Decision|3|||
105811355|NCT01644890|364966519|FG001|Overall Study|Physician Decision|9|||
105811356|NCT01644890|364966518|FG000|Overall Study|Protocol Violation|6|||
105811357|NCT01644890|364966519|FG001|Overall Study|Protocol Violation|7|||
105811358|NCT01644890|364966518|FG000|Overall Study|Withdrawal by Subject|19|||
105811359|NCT01644890|364966519|FG001|Overall Study|Withdrawal by Subject|27|||
105811360|NCT01644890|364966518|FG000|Overall Study|Progression Disease|160|||
105811361|NCT01644890|364966519|FG001|Overall Study|Progression Disease|131|||
105811362|NCT01644890|364966518|FG000|Overall Study|Clinical Progression|6|||
105811363|NCT01644890|364966519|FG001|Overall Study|Clinical Progression|6|||
105811364|NCT01644890|364966518|FG000|Overall Study|> 28 days since last dose of study drug|6|||
105811365|NCT01644890|364966519|FG001|Overall Study|> 28 days since last dose of study drug|3|||
105811366|NCT01644890|364966518|FG000|Overall Study|Other|8|||
105811367|NCT01644890|364966519|FG001|Overall Study|Other|9|||
105811368|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
105811369|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
105811370|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
105811371|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
105811372|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
105811373|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
105811374|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
105811375|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
105811376|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
105811377|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
105811378|NCT00056160|364966520|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
105811379|NCT00056160|364966521|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
105811380|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
105811381|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
105811382|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
105811383|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
105811384|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
105811385|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
105811386|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
105811387|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
105953765|NCT02141672|365493241|FG002|Overall Study|Withdrawal by Subject|5|||
105953766|NCT02141672|365493239|FG000|Overall Study|refused to follow-up|1|||
105953767|NCT02141672|365493240|FG001|Overall Study|refused to follow-up|0|||
105953768|NCT02141672|365493241|FG002|Overall Study|refused to follow-up|1|||
105953769|NCT02457247|365493242|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
105953770|NCT02457247|365493243|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
105953771|NCT02457247|365493244|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
105953772|NCT02457247|365493245|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
105953773|NCT02457247|365493242|FG000|Period 1|Significant Protocol Deviation|1|||
105953774|NCT02457247|365493243|FG001|Period 1|Significant Protocol Deviation|1|||
105953775|NCT02457247|365493244|FG002|Period 1|Significant Protocol Deviation|0|||
105953776|NCT02457247|365493245|FG003|Period 1|Significant Protocol Deviation|0|||
105953777|NCT02457247|365493242|FG000|Period 1|Voluntary Withdrawal|1|||
105811388|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
105811389|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
105811390|NCT00056160|364966520|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
105811391|NCT00056160|364966521|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
105811392|NCT00056160|364966520|FG000|Final Follow-up|Transferred into expanded access study.|3|||
105811393|NCT00056160|364966521|FG001|Final Follow-up|Transferred into expanded access study.|0|||
105811394|NCT00056160|364966520|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
105811395|NCT00056160|364966521|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
105811396|NCT00056160|364966520|FG000|Final Follow-up|Adverse Event|1|||
105811397|NCT00056160|364966521|FG001|Final Follow-up|Adverse Event|0|||
106144936|NCT05061693|366190785|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
106144937|NCT05061693|366190774|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
106144938|NCT05061693|366190775|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
105811398|NCT03312530|364966523|FG000|Overall Study|Death|5|||
105811399|NCT03312530|364966524|FG001|Overall Study|Death|5|||
105811400|NCT03312530|364966525|FG002|Overall Study|Death|4|||
105811401|NCT03312530|364966526|FG003|Overall Study|Death|10|||
105811402|NCT03312530|364966527|FG004|Overall Study|Death|8|||
105811403|NCT03312530|364966523|FG000|Overall Study|Lost to Follow-up|0|||
105811404|NCT03312530|364966524|FG001|Overall Study|Lost to Follow-up|0|||
105811405|NCT03312530|364966525|FG002|Overall Study|Lost to Follow-up|0|||
105811406|NCT03312530|364966526|FG003|Overall Study|Lost to Follow-up|1|||
105811407|NCT03312530|364966527|FG004|Overall Study|Lost to Follow-up|0|||
105811408|NCT03312530|364966523|FG000|Overall Study|Participant in another sponsor study.|0|||
105811409|NCT03312530|364966524|FG001|Overall Study|Participant in another sponsor study.|0|||
105811410|NCT03312530|364966525|FG002|Overall Study|Participant in another sponsor study.|0|||
105811411|NCT03312530|364966526|FG003|Overall Study|Participant in another sponsor study.|1|||
105811412|NCT03312530|364966527|FG004|Overall Study|Participant in another sponsor study.|0|||
105811413|NCT03312530|364966523|FG000|Overall Study|Study terminated by sponsor|1|||
105811414|NCT03312530|364966524|FG001|Overall Study|Study terminated by sponsor|0|||
105811415|NCT03312530|364966525|FG002|Overall Study|Study terminated by sponsor|2|||
105811416|NCT03312530|364966526|FG003|Overall Study|Study terminated by sponsor|3|||
105811417|NCT03312530|364966527|FG004|Overall Study|Study terminated by sponsor|7|||
105811418|NCT03312530|364966523|FG000|Overall Study|Withdrawal by Subject|0|||
105811419|NCT03312530|364966524|FG001|Overall Study|Withdrawal by Subject|1|||
105811420|NCT03312530|364966525|FG002|Overall Study|Withdrawal by Subject|0|||
105811421|NCT03312530|364966526|FG003|Overall Study|Withdrawal by Subject|0|||
105811422|NCT03312530|364966527|FG004|Overall Study|Withdrawal by Subject|0|||
105811423|NCT03312530|364966523|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
105811424|NCT03312530|364966524|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
105811425|NCT03312530|364966525|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
105811426|NCT03312530|364966526|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
105811427|NCT03312530|364966527|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
105811428|NCT03093324|364966529|FG000|Overall Study|Adverse Event|4|||
106144939|NCT05061693|366190776|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
106144940|NCT05061693|366190777|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
106144941|NCT05061693|366190778|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
106144942|NCT05061693|366190779|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
105953778|NCT02457247|365493243|FG001|Period 1|Voluntary Withdrawal|0|||
105811429|NCT03093324|364966530|FG001|Overall Study|Adverse Event|15|||
105811430|NCT03093324|364966529|FG000|Overall Study|Lost to Follow-up|1|||
105811431|NCT03093324|364966530|FG001|Overall Study|Lost to Follow-up|0|||
105811432|NCT03093324|364966529|FG000|Overall Study|Protocol Deviation|2|||
106144943|NCT05061693|366190780|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
106144944|NCT05061693|366190781|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
105811433|NCT03093324|364966530|FG001|Overall Study|Protocol Deviation|2|||
105811434|NCT03093324|364966529|FG000|Overall Study|Withdrawal by Subject|2|||
105811435|NCT03093324|364966530|FG001|Overall Study|Withdrawal by Subject|2|||
105811436|NCT02458638|364966537|FG000|Overall Study|Death|309|||
105811437|NCT02458638|364966537|FG000|Overall Study|End of Cohort/End of Study|67|||
105811438|NCT02458638|364966537|FG000|Overall Study|Lost to Follow-up|31|||
105811439|NCT02458638|364966537|FG000|Overall Study|Other Reasons|4|||
105811440|NCT02458638|364966537|FG000|Overall Study|Physician Decision|1|||
105811441|NCT02458638|364966537|FG000|Overall Study|Withdrawal by Subject|47|||
105811442|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
105811443|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
105811444|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
105811445|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
105811446|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
105811447|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
105811448|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
105811449|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
105811450|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
105811451|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
105811452|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
105811453|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
105811454|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
105811455|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
105811456|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
105811457|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
105811458|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
105811459|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
105811460|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
105811461|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
105811462|NCT02207231|364966538|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
105811463|NCT02207231|364966539|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
105811464|NCT02207231|364966540|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
105811465|NCT02207231|364966541|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
105811466|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
105811467|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
105811468|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
105811469|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
105811470|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
105811471|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
105811472|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
105811473|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
105811474|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
105811475|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
105953779|NCT02457247|365493244|FG002|Period 1|Voluntary Withdrawal|0|||
105953780|NCT02457247|365493245|FG003|Period 1|Voluntary Withdrawal|0|||
105953781|NCT02457247|365493242|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
105811476|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
105811477|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
105953782|NCT02457247|365493243|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
105953783|NCT02457247|365493244|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
105953784|NCT02457247|365493245|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
105953785|NCT02457247|365493242|FG000|Period 2|Significant Protocol Deviation|1|||
105953786|NCT02457247|365493243|FG001|Period 2|Significant Protocol Deviation|0|||
105953787|NCT02457247|365493244|FG002|Period 2|Significant Protocol Deviation|0|||
105953788|NCT02457247|365493245|FG003|Period 2|Significant Protocol Deviation|0|||
105953789|NCT02457247|365493242|FG000|Period 2|Lost to Follow-up|0|||
105953790|NCT02457247|365493243|FG001|Period 2|Lost to Follow-up|1|||
105953791|NCT02457247|365493244|FG002|Period 2|Lost to Follow-up|0|||
105953792|NCT02457247|365493245|FG003|Period 2|Lost to Follow-up|0|||
105953793|NCT02457247|365493242|FG000|Period 2|Voluntary Withdrawal|1|||
105953794|NCT02457247|365493243|FG001|Period 2|Voluntary Withdrawal|1|||
105953795|NCT02457247|365493244|FG002|Period 2|Voluntary Withdrawal|0|||
105953796|NCT02457247|365493245|FG003|Period 2|Voluntary Withdrawal|0|||
105953797|NCT00244621|365493253|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105811478|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
105953798|NCT00244621|365493254|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105953799|NCT00244621|365493255|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
105953800|NCT00244621|365493253|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
106017478|NCT00705016|365727253|FG001|Overall Study|Death|7|||
105953801|NCT00244621|365493254|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
106017479|NCT00705016|365727254|FG002|Overall Study|Death|5|||
105811479|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
105811480|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
106017480|NCT00705016|365727252|FG000|Overall Study|Protocol Violation|0|||
106017481|NCT00705016|365727253|FG001|Overall Study|Protocol Violation|1|||
106017482|NCT00705016|365727254|FG002|Overall Study|Protocol Violation|1|||
106017483|NCT00705016|365727252|FG000|Overall Study|Withdrawal by Subject|4|||
106017484|NCT00705016|365727253|FG001|Overall Study|Withdrawal by Subject|3|||
106017485|NCT00705016|365727254|FG002|Overall Study|Withdrawal by Subject|2|||
106017486|NCT00705016|365727252|FG000|Overall Study|Progressive Disease|33|||
106017487|NCT00705016|365727253|FG001|Overall Study|Progressive Disease|29|||
106017488|NCT00705016|365727254|FG002|Overall Study|Progressive Disease|33|||
106017489|NCT00705016|365727252|FG000|Overall Study|Symptomatic Deterioration|3|||
106017490|NCT00705016|365727253|FG001|Overall Study|Symptomatic Deterioration|1|||
106017491|NCT00705016|365727254|FG002|Overall Study|Symptomatic Deterioration|1|||
106017492|NCT00705016|365727252|FG000|Overall Study|Other|9|||
106017493|NCT00705016|365727253|FG001|Overall Study|Other|6|||
106017494|NCT00705016|365727254|FG002|Overall Study|Other|6|||
106017495|NCT02284243|365727255|FG000|Overall Study|Lack of Efficacy|3|||
106017496|NCT02284243|365727256|FG001|Overall Study|Lack of Efficacy|3|||
106017497|NCT02284243|365727255|FG000|Overall Study|Adverse Event|1|||
106017498|NCT02284243|365727256|FG001|Overall Study|Adverse Event|0|||
106017499|NCT01721044|365727262|FG000|Treatment Period|Adverse Event|7|||
106017500|NCT01721044|365727263|FG001|Treatment Period|Adverse Event|7|||
106017501|NCT01721044|365727264|FG002|Treatment Period|Adverse Event|10|||
106017502|NCT01721044|365727262|FG000|Treatment Period|Death|0|||
106017503|NCT01721044|365727263|FG001|Treatment Period|Death|0|||
106017504|NCT01721044|365727264|FG002|Treatment Period|Death|1|||
106017505|NCT01721044|365727262|FG000|Treatment Period|Lack of Efficacy|16|||
106017506|NCT01721044|365727263|FG001|Treatment Period|Lack of Efficacy|4|||
106017507|NCT01721044|365727264|FG002|Treatment Period|Lack of Efficacy|4|||
106017508|NCT01721044|365727262|FG000|Treatment Period|Lost to Follow-up|0|||
106017509|NCT01721044|365727263|FG001|Treatment Period|Lost to Follow-up|0|||
106144945|NCT05061693|366190782|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
106144946|NCT05061693|366190783|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
106144947|NCT05061693|366190784|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
105811481|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
105811482|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
105811483|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
105811484|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
105811485|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
105811486|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
105953802|NCT00244621|365493255|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105953803|NCT00244621|365493253|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105953804|NCT00244621|365493254|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
105953805|NCT00244621|365493255|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
105953806|NCT00244621|365493253|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
105953807|NCT00244621|365493254|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
105953808|NCT00244621|365493255|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
105953809|NCT00244621|365493253|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105953810|NCT00244621|365493254|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
105953811|NCT00244621|365493255|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
105953812|NCT00244621|365493253|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
105953813|NCT00244621|365493254|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105953814|NCT00244621|365493255|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
105953815|NCT00244621|365493253|FG000|Open-label Treatment Period|Adverse Event|0|||
105953816|NCT00244621|365493254|FG001|Open-label Treatment Period|Adverse Event|0|||
105953817|NCT00244621|365493255|FG002|Open-label Treatment Period|Adverse Event|1|||
105953818|NCT00244621|365493253|FG000|Open-label Treatment Period|Moved abroad|0|||
105953819|NCT00244621|365493254|FG001|Open-label Treatment Period|Moved abroad|0|||
105953820|NCT00244621|365493255|FG002|Open-label Treatment Period|Moved abroad|1|||
105953821|NCT00532844|365493258|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
105953822|NCT00532844|365493259|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
105953823|NCT00532844|365493258|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
106017510|NCT01721044|365727264|FG002|Treatment Period|Lost to Follow-up|1|||
106017511|NCT01721044|365727262|FG000|Treatment Period|Physician Decision|1|||
106017512|NCT01721044|365727263|FG001|Treatment Period|Physician Decision|0|||
106017513|NCT01721044|365727264|FG002|Treatment Period|Physician Decision|2|||
106017514|NCT01721044|365727262|FG000|Treatment Period|Protocol Violation|1|||
106017515|NCT01721044|365727263|FG001|Treatment Period|Protocol Violation|0|||
106144948|NCT05061693|366190785|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
106017516|NCT01721044|365727264|FG002|Treatment Period|Protocol Violation|0|||
106017517|NCT01721044|365727262|FG000|Treatment Period|Withdrawal by Subject|7|||
106017518|NCT01721044|365727263|FG001|Treatment Period|Withdrawal by Subject|6|||
106144949|NCT05061693|366190774|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
106144950|NCT05061693|366190775|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144951|NCT05061693|366190776|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144952|NCT05061693|366190777|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144953|NCT05061693|366190778|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144954|NCT05061693|366190779|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144955|NCT05061693|366190780|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144956|NCT05061693|366190781|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144957|NCT05061693|366190782|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144958|NCT05061693|366190783|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144959|NCT05061693|366190784|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144960|NCT05061693|366190785|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
106144961|NCT05061693|366190774|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144962|NCT05061693|366190775|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144963|NCT05061693|366190776|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
106144964|NCT05061693|366190777|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144965|NCT05061693|366190778|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144966|NCT05061693|366190779|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144967|NCT05061693|366190780|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144968|NCT05061693|366190781|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144969|NCT05061693|366190782|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144970|NCT05061693|366190783|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144971|NCT05061693|366190784|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144972|NCT05061693|366190785|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
106144973|NCT05061693|366190774|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
106144974|NCT05061693|366190775|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
106144975|NCT05061693|366190776|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
106144976|NCT05061693|366190777|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
106144977|NCT05061693|366190778|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
106144978|NCT05061693|366190779|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
106144979|NCT05061693|366190780|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
106144980|NCT05061693|366190781|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
106144981|NCT05061693|366190782|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
106144982|NCT05061693|366190783|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
106144983|NCT05061693|366190784|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
106144984|NCT05061693|366190785|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
106144985|NCT05061693|366190774|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
106144986|NCT05061693|366190775|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
106144987|NCT05061693|366190776|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
106144988|NCT05061693|366190777|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
106144989|NCT05061693|366190778|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
106144990|NCT05061693|366190779|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
106144991|NCT05061693|366190780|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
106144992|NCT05061693|366190781|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
106144993|NCT05061693|366190782|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
106144994|NCT05061693|366190783|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
106144995|NCT05061693|366190784|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
106144996|NCT05061693|366190785|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
106144997|NCT05061693|366190774|FG000|24-week Extension Period|Adverse Event|0|||
106144998|NCT05061693|366190775|FG001|24-week Extension Period|Adverse Event|0|||
106144999|NCT05061693|366190776|FG002|24-week Extension Period|Adverse Event|0|||
105953824|NCT00532844|365493259|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
105953825|NCT00532844|365493258|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
105953826|NCT00532844|365493259|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
105953827|NCT00532844|365493258|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
105953828|NCT00532844|365493259|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
105953829|NCT00532844|365493258|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
105953830|NCT00532844|365493259|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
105953831|NCT00811720|365493260|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
105953832|NCT00811720|365493261|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
105953833|NCT00811720|365493260|FG000|All Treated Patients|Adverse Event|20|||
105953834|NCT00811720|365493261|FG001|All Treated Patients|Adverse Event|62|||
105953835|NCT00811720|365493260|FG000|All Treated Patients|Lack of Efficacy|22|||
105953836|NCT00811720|365493261|FG001|All Treated Patients|Lack of Efficacy|18|||
105953837|NCT00811720|365493260|FG000|All Treated Patients|Non-compliance|0|||
105953838|NCT00811720|365493261|FG001|All Treated Patients|Non-compliance|14|||
105953839|NCT00811720|365493260|FG000|All Treated Patients|Protocol Violation|9|||
105811487|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
105811488|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
105811489|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
105811490|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
105811491|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
105811492|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
105811493|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
105811494|NCT02207231|364966538|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
105811495|NCT02207231|364966539|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
105811496|NCT02207231|364966540|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
105811497|NCT02207231|364966541|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
105811498|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
105811499|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
105953840|NCT00811720|365493261|FG001|All Treated Patients|Protocol Violation|16|||
105953841|NCT00811720|365493260|FG000|All Treated Patients|Withdrawal by Subject|28|||
105811500|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
105811501|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
105953842|NCT00811720|365493261|FG001|All Treated Patients|Withdrawal by Subject|34|||
105953843|NCT00811720|365493260|FG000|All Treated Patients|Lost to Follow-up|10|||
105953844|NCT00811720|365493261|FG001|All Treated Patients|Lost to Follow-up|16|||
105953845|NCT00811720|365493260|FG000|All Treated Patients|Other Reason|7|||
105953846|NCT00811720|365493261|FG001|All Treated Patients|Other Reason|4|||
105953847|NCT04389866|365493262|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
105953848|NCT04389866|365493263|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
105953849|NCT00928187|365493266|FG000|Overall Study|Death|1|||
105953850|NCT00928187|365493267|FG001|Overall Study|Death|2|||
105953851|NCT00928187|365493268|FG002|Overall Study|Death|3|||
105953852|NCT00928187|365493266|FG000|Overall Study|Lost to Follow-up|1|||
105953853|NCT00928187|365493267|FG001|Overall Study|Lost to Follow-up|2|||
105953854|NCT00928187|365493268|FG002|Overall Study|Lost to Follow-up|1|||
105953855|NCT00928187|365493266|FG000|Overall Study|Withdrawal by Subject|0|||
105953856|NCT00928187|365493267|FG001|Overall Study|Withdrawal by Subject|1|||
105953857|NCT00928187|365493268|FG002|Overall Study|Withdrawal by Subject|1|||
105953858|NCT00928187|365493266|FG000|Overall Study|Protocol Violation|0|||
105953859|NCT00928187|365493267|FG001|Overall Study|Protocol Violation|1|||
105953860|NCT00928187|365493268|FG002|Overall Study|Protocol Violation|0|||
105953861|NCT01490918|365493269|FG000|Overall Study|Lost to Follow-up|2|||
105953862|NCT01490918|365493270|FG001|Overall Study|Lost to Follow-up|1|||
105953863|NCT01490918|365493271|FG002|Overall Study|Lost to Follow-up|0|||
105953864|NCT01490918|365493269|FG000|Overall Study|Withdrawal by Subject|7|||
105953865|NCT01490918|365493270|FG001|Overall Study|Withdrawal by Subject|8|||
105953866|NCT01490918|365493271|FG002|Overall Study|Withdrawal by Subject|3|||
105953867|NCT01490918|365493269|FG000|Overall Study|Adverse Event|0|||
105953868|NCT01490918|365493270|FG001|Overall Study|Adverse Event|0|||
105953869|NCT01490918|365493271|FG002|Overall Study|Adverse Event|1|||
105953870|NCT01490918|365493269|FG000|Overall Study|other cause|4|||
105953871|NCT01490918|365493270|FG001|Overall Study|other cause|5|||
105953872|NCT01490918|365493271|FG002|Overall Study|other cause|8|||
105953873|NCT04940130|365493275|FG000|Overall Study|Travel|1|||
105953874|NCT04940130|365493276|FG001|Overall Study|Travel|0|||
105953875|NCT04940130|365493277|FG002|Overall Study|Travel|2|||
105953876|NCT04940130|365493275|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
105953877|NCT04940130|365493276|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
105953878|NCT04940130|365493277|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
105953879|NCT04940130|365493275|FG000|Overall Study|Adverse Event|0|||
105953880|NCT04940130|365493276|FG001|Overall Study|Adverse Event|0|||
105953881|NCT04940130|365493277|FG002|Overall Study|Adverse Event|2|||
105953882|NCT04940130|365493275|FG000|Overall Study|Disease progression/treatment failure|0|||
105953883|NCT04940130|365493276|FG001|Overall Study|Disease progression/treatment failure|0|||
105953884|NCT04940130|365493277|FG002|Overall Study|Disease progression/treatment failure|1|||
105953885|NCT04940130|365493275|FG000|Overall Study|Participant refusal|0|||
105953886|NCT04940130|365493276|FG001|Overall Study|Participant refusal|0|||
105953887|NCT04940130|365493277|FG002|Overall Study|Participant refusal|1|||
105953888|NCT02779777|365493284|FG000|Overall Study|Disease Progression|1|||
105953889|NCT02779777|365493285|FG001|Overall Study|Disease Progression|0|||
105953890|NCT02779777|365493286|FG002|Overall Study|Disease Progression|0|||
105953891|NCT02779777|365493284|FG000|Overall Study|Adverse Event|3|||
105953892|NCT02779777|365493285|FG001|Overall Study|Adverse Event|1|||
105953893|NCT02779777|365493286|FG002|Overall Study|Adverse Event|0|||
105953894|NCT02779777|365493284|FG000|Overall Study|Physician Decision|9|||
105953895|NCT02779777|365493285|FG001|Overall Study|Physician Decision|0|||
105953896|NCT02779777|365493286|FG002|Overall Study|Physician Decision|1|||
105953897|NCT02779777|365493284|FG000|Overall Study|Withdrawal by Subject|1|||
105953898|NCT02779777|365493285|FG001|Overall Study|Withdrawal by Subject|0|||
106017519|NCT01721044|365727264|FG002|Treatment Period|Withdrawal by Subject|1|||
106017520|NCT03155841|365727265|FG000|Overall Study|Protocol Violation|3|||
106017521|NCT03155841|365727266|FG001|Overall Study|Protocol Violation|4|||
106017522|NCT01526733|365727267|FG000|Phase 1|Protocol Violation|1|||
106017523|NCT01526733|365727268|FG001|Phase 1|Protocol Violation|0|||
106017524|NCT01526733|365727267|FG000|Phase 1|Withdrawal by Subject|1|||
106017525|NCT01526733|365727268|FG001|Phase 1|Withdrawal by Subject|1|||
106017526|NCT04032093|365727271|FG000|Overall Study|Lost to Follow-up|7|||
106017527|NCT04032093|365727272|FG001|Overall Study|Lost to Follow-up|7|||
106017528|NCT04032093|365727273|FG002|Overall Study|Lost to Follow-up|6|||
106017529|NCT04032093|365727274|FG003|Overall Study|Lost to Follow-up|10|||
106017530|NCT04032093|365727275|FG004|Overall Study|Lost to Follow-up|13|||
106017531|NCT04032093|365727276|FG005|Overall Study|Lost to Follow-up|7|||
106017532|NCT04032093|365727277|FG006|Overall Study|Lost to Follow-up|7|||
106017533|NCT04032093|365727278|FG007|Overall Study|Lost to Follow-up|5|||
106017534|NCT04032093|365727279|FG008|Overall Study|Lost to Follow-up|9|||
106017535|NCT04032093|365727280|FG009|Overall Study|Lost to Follow-up|12|||
106017536|NCT04032093|365727271|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
106017537|NCT04032093|365727272|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
106017538|NCT04032093|365727273|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
106017539|NCT04032093|365727274|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
106017540|NCT04032093|365727275|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
106017541|NCT04032093|365727276|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
106017542|NCT04032093|365727277|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
106017543|NCT04032093|365727278|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
106017544|NCT04032093|365727279|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
106017545|NCT04032093|365727280|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
106017546|NCT04032093|365727271|FG000|Overall Study|Other|1|||
106017547|NCT04032093|365727272|FG001|Overall Study|Other|0|||
106017548|NCT04032093|365727273|FG002|Overall Study|Other|0|||
106017549|NCT04032093|365727274|FG003|Overall Study|Other|1|||
106017550|NCT04032093|365727275|FG004|Overall Study|Other|1|||
106017551|NCT04032093|365727276|FG005|Overall Study|Other|0|||
106017552|NCT04032093|365727277|FG006|Overall Study|Other|0|||
106017553|NCT04032093|365727278|FG007|Overall Study|Other|0|||
106017554|NCT04032093|365727279|FG008|Overall Study|Other|0|||
106017555|NCT04032093|365727280|FG009|Overall Study|Other|1|||
106017556|NCT04032093|365727271|FG000|Overall Study|Withdrawal by Subject|1|||
106017557|NCT04032093|365727272|FG001|Overall Study|Withdrawal by Subject|3|||
106017558|NCT04032093|365727273|FG002|Overall Study|Withdrawal by Subject|2|||
106017559|NCT04032093|365727274|FG003|Overall Study|Withdrawal by Subject|2|||
106017560|NCT04032093|365727275|FG004|Overall Study|Withdrawal by Subject|3|||
106017561|NCT04032093|365727276|FG005|Overall Study|Withdrawal by Subject|0|||
106017562|NCT04032093|365727277|FG006|Overall Study|Withdrawal by Subject|0|||
106017563|NCT04032093|365727278|FG007|Overall Study|Withdrawal by Subject|0|||
106017564|NCT04032093|365727279|FG008|Overall Study|Withdrawal by Subject|0|||
106017565|NCT04032093|365727280|FG009|Overall Study|Withdrawal by Subject|0|||
106017566|NCT04032093|365727271|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
106017567|NCT04032093|365727272|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
106017568|NCT04032093|365727273|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
106017569|NCT04032093|365727274|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
106017570|NCT04032093|365727275|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
106017571|NCT04032093|365727276|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
106017572|NCT04032093|365727277|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
106017573|NCT04032093|365727278|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
106017574|NCT04032093|365727279|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
106017575|NCT04032093|365727280|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
106017576|NCT04032093|365727271|FG000|Overall Study|Adverse Event|0|||
106017577|NCT04032093|365727272|FG001|Overall Study|Adverse Event|0|||
106017578|NCT04032093|365727273|FG002|Overall Study|Adverse Event|0|||
105953899|NCT02779777|365493286|FG002|Overall Study|Withdrawal by Subject|0|||
105953900|NCT04179305|365493290|FG000|Overall Study|Death|1|||
105953901|NCT04179305|365493291|FG001|Overall Study|Death|1|||
105953902|NCT04179305|365493292|FG002|Overall Study|Death|0|||
105953903|NCT04179305|365493293|FG003|Overall Study|Death|0|||
105953904|NCT04179305|365493290|FG000|Overall Study|Lost to Follow-up|1|||
105953905|NCT04179305|365493291|FG001|Overall Study|Lost to Follow-up|1|||
105953906|NCT04179305|365493292|FG002|Overall Study|Lost to Follow-up|0|||
105953907|NCT04179305|365493293|FG003|Overall Study|Lost to Follow-up|0|||
105953908|NCT04179305|365493290|FG000|Overall Study|Withdrawal by Subject|0|||
105953909|NCT04179305|365493291|FG001|Overall Study|Withdrawal by Subject|1|||
106017579|NCT04032093|365727274|FG003|Overall Study|Adverse Event|0|||
106017580|NCT04032093|365727275|FG004|Overall Study|Adverse Event|0|||
106017581|NCT04032093|365727276|FG005|Overall Study|Adverse Event|0|||
106017582|NCT04032093|365727277|FG006|Overall Study|Adverse Event|0|||
106017583|NCT04032093|365727278|FG007|Overall Study|Adverse Event|0|||
106017584|NCT04032093|365727279|FG008|Overall Study|Adverse Event|0|||
106017585|NCT04032093|365727280|FG009|Overall Study|Adverse Event|1|||
106017586|NCT04032093|365727271|FG000|Overall Study|Physician Decision|0|||
106017587|NCT04032093|365727272|FG001|Overall Study|Physician Decision|0|||
106017588|NCT04032093|365727273|FG002|Overall Study|Physician Decision|0|||
106017589|NCT04032093|365727274|FG003|Overall Study|Physician Decision|0|||
106017590|NCT04032093|365727275|FG004|Overall Study|Physician Decision|0|||
106017591|NCT04032093|365727276|FG005|Overall Study|Physician Decision|1|||
106017592|NCT04032093|365727277|FG006|Overall Study|Physician Decision|0|||
106017593|NCT04032093|365727278|FG007|Overall Study|Physician Decision|0|||
106017594|NCT04032093|365727279|FG008|Overall Study|Physician Decision|0|||
106017595|NCT04032093|365727280|FG009|Overall Study|Physician Decision|0|||
106017596|NCT04139018|365727284|FG000|Overall Study|Screen fail|1|||
106017597|NCT04139018|365727285|FG001|Overall Study|Screen fail|0|||
106017598|NCT04139018|365727284|FG000|Overall Study|Withdrawal by Subject|2|||
106017599|NCT04139018|365727285|FG001|Overall Study|Withdrawal by Subject|0|||
106017600|NCT04139018|365727284|FG000|Overall Study|Lost to Follow-up|0|||
106017601|NCT04139018|365727285|FG001|Overall Study|Lost to Follow-up|1|||
106017602|NCT01147874|365727287|FG000|Overall Study|Adverse Event|5|||
106017603|NCT01147874|365727287|FG000|Overall Study|Investigator's Request|1|||
106017604|NCT01147874|365727287|FG000|Overall Study|Lost to Follow-up|25|||
106017605|NCT01147874|365727287|FG000|Overall Study|Other|5|||
106017606|NCT01147874|365727287|FG000|Overall Study|Protocol Violation|5|||
106017607|NCT01147874|365727287|FG000|Overall Study|Sponsor's Decision|2|||
106017608|NCT01147874|365727287|FG000|Overall Study|Withdrawal by Subject|24|||
106017609|NCT02721966|365727290|FG000|Overall Study|Protocol Violation|1|||
106017610|NCT02721966|365727291|FG001|Overall Study|Protocol Violation|0|||
106017611|NCT02721966|365727292|FG002|Overall Study|Protocol Violation|0|||
106017612|NCT02721966|365727293|FG003|Overall Study|Protocol Violation|0|||
106017613|NCT02721966|365727294|FG004|Overall Study|Protocol Violation|0|||
106017614|NCT02721966|365727290|FG000|Overall Study|Withdrawal by Subject|9|||
106017615|NCT02721966|365727291|FG001|Overall Study|Withdrawal by Subject|2|||
106017616|NCT02721966|365727292|FG002|Overall Study|Withdrawal by Subject|3|||
106017617|NCT02721966|365727293|FG003|Overall Study|Withdrawal by Subject|7|||
106017618|NCT02721966|365727294|FG004|Overall Study|Withdrawal by Subject|0|||
106017619|NCT02721966|365727290|FG000|Overall Study|Adverse Event|4|||
106017620|NCT02721966|365727291|FG001|Overall Study|Adverse Event|4|||
106017621|NCT02721966|365727292|FG002|Overall Study|Adverse Event|3|||
106017622|NCT02721966|365727293|FG003|Overall Study|Adverse Event|0|||
106017623|NCT02721966|365727294|FG004|Overall Study|Adverse Event|0|||
106145000|NCT05061693|366190777|FG003|24-week Extension Period|Adverse Event|0|||
106145001|NCT05061693|366190778|FG004|24-week Extension Period|Adverse Event|0|||
106145002|NCT05061693|366190779|FG005|24-week Extension Period|Adverse Event|0|||
106145003|NCT05061693|366190780|FG006|24-week Extension Period|Adverse Event|0|||
106145004|NCT05061693|366190781|FG007|24-week Extension Period|Adverse Event|2|||
106145005|NCT05061693|366190782|FG008|24-week Extension Period|Adverse Event|2|||
106145006|NCT05061693|366190783|FG009|24-week Extension Period|Adverse Event|0|||
106145007|NCT05061693|366190784|FG010|24-week Extension Period|Adverse Event|1|||
106145008|NCT05061693|366190785|FG011|24-week Extension Period|Adverse Event|3|||
105953910|NCT04179305|365493292|FG002|Overall Study|Withdrawal by Subject|0|||
105953911|NCT04179305|365493293|FG003|Overall Study|Withdrawal by Subject|0|||
105953912|NCT04179305|365493290|FG000|Overall Study|Did not have scan|1|||
105953913|NCT04179305|365493291|FG001|Overall Study|Did not have scan|0|||
105953914|NCT04179305|365493292|FG002|Overall Study|Did not have scan|0|||
105953915|NCT04179305|365493293|FG003|Overall Study|Did not have scan|0|||
105953916|NCT04179305|365493290|FG000|Overall Study|In hospice care|3|||
105953917|NCT04179305|365493291|FG001|Overall Study|In hospice care|0|||
105953918|NCT04179305|365493292|FG002|Overall Study|In hospice care|0|||
105953919|NCT04179305|365493293|FG003|Overall Study|In hospice care|0|||
105953920|NCT00503425|365493294|FG000|Overall Study|Participant files lost|6|||
105953921|NCT00503425|365493294|FG000|Overall Study|Adverse Event|5|||
105953922|NCT00503425|365493294|FG000|Overall Study|Lack of Efficacy|25|||
105953923|NCT00503425|365493294|FG000|Overall Study|Withdrawal by Subject|8|||
105953924|NCT00503425|365493294|FG000|Overall Study|Lost to Follow-up|3|||
105953925|NCT00503425|365493294|FG000|Overall Study|Death|3|||
105953926|NCT00503425|365493294|FG000|Overall Study|Missing Data/Unknown|4|||
105953927|NCT03364231|365493295|FG000|Overall Study|Adverse Event|1|||
105953928|NCT03364231|365493296|FG001|Overall Study|Adverse Event|4|||
105953929|NCT03364231|365493295|FG000|Overall Study|Death|1|||
105953930|NCT03364231|365493296|FG001|Overall Study|Death|0|||
105953931|NCT03364231|365493295|FG000|Overall Study|Investigator Decision|2|||
105953932|NCT03364231|365493296|FG001|Overall Study|Investigator Decision|2|||
105953933|NCT03364231|365493295|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
105953934|NCT03364231|365493296|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
106017624|NCT02721966|365727290|FG000|Overall Study|Death|1|||
105953935|NCT03364231|365493295|FG000|Overall Study|Withdrawal of Subject Consent|1|||
105953936|NCT03364231|365493296|FG001|Overall Study|Withdrawal of Subject Consent|0|||
105953937|NCT03364231|365493295|FG000|Overall Study|Reason Not Specified|1|||
105953938|NCT03364231|365493296|FG001|Overall Study|Reason Not Specified|0|||
105953939|NCT03364231|365493295|FG000|Overall Study|Disease Progression|0|||
105953940|NCT03364231|365493296|FG001|Overall Study|Disease Progression|6|||
106017625|NCT02721966|365727291|FG001|Overall Study|Death|0|||
105811502|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
105811503|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
105811504|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
105811505|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
105811506|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
105811507|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
105811508|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
105811509|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
105811510|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
105953941|NCT03386435|365493297|FG000|Overall Study|Protocol Violation|5|||
105953942|NCT03386435|365493298|FG001|Overall Study|Protocol Violation|7|||
105953943|NCT03328832|365493300|FG000|Overall Study|Lost to Follow-up|0|||
105953944|NCT03328832|365493301|FG001|Overall Study|Lost to Follow-up|1|||
105953945|NCT00437268|365493304|FG000|Overall Study|Adverse Event|1|||
105953946|NCT00437268|365493305|FG001|Overall Study|Adverse Event|1|||
105953947|NCT00437268|365493304|FG000|Overall Study|Withdrawal by Subject|2|||
105953948|NCT00437268|365493305|FG001|Overall Study|Withdrawal by Subject|2|||
105953949|NCT00437268|365493304|FG000|Overall Study|Progressive disease|9|||
105953950|NCT00437268|365493305|FG001|Overall Study|Progressive disease|9|||
105953951|NCT00437268|365493304|FG000|Overall Study|Physician Decision|1|||
105953952|NCT00437268|365493305|FG001|Overall Study|Physician Decision|0|||
105953953|NCT00437268|365493304|FG000|Overall Study|Death|0|||
105953954|NCT00437268|365493305|FG001|Overall Study|Death|1|||
105953955|NCT03484429|365493310|FG000|Overall Study|Withdrawal by Subject|1|||
105953956|NCT03484429|365493311|FG001|Overall Study|Withdrawal by Subject|0|||
105953957|NCT03484429|365493310|FG000|Overall Study|Adverse Event|2|||
105953958|NCT03484429|365493311|FG001|Overall Study|Adverse Event|0|||
105953959|NCT03666988|365493312|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
105953960|NCT03666988|365493313|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
105953961|NCT03666988|365493314|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
105953962|NCT03666988|365493315|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
105953963|NCT03666988|365493316|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
105953964|NCT03666988|365493317|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
105953965|NCT03666988|365493312|FG000|Part 1 (Up to 28 Months)|Other|0|||
105953966|NCT03666988|365493313|FG001|Part 1 (Up to 28 Months)|Other|1|||
105953967|NCT03666988|365493314|FG002|Part 1 (Up to 28 Months)|Other|1|||
105953968|NCT03666988|365493315|FG003|Part 1 (Up to 28 Months)|Other|0|||
105953969|NCT03666988|365493316|FG004|Part 1 (Up to 28 Months)|Other|0|||
105953970|NCT03666988|365493317|FG005|Part 1 (Up to 28 Months)|Other|0|||
105953971|NCT03666988|365493312|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
105953972|NCT03666988|365493313|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
105953973|NCT03666988|365493314|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
105953974|NCT03666988|365493315|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
105953975|NCT03666988|365493316|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
105953976|NCT03666988|365493317|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
105953977|NCT03666988|365493312|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
105953978|NCT03666988|365493313|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
105953979|NCT03666988|365493314|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
105953980|NCT03666988|365493315|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
105953981|NCT03666988|365493316|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
105953982|NCT03666988|365493317|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
105953983|NCT03666988|365493312|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
105953984|NCT03666988|365493313|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105953985|NCT03666988|365493314|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105953986|NCT03666988|365493315|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105953987|NCT03666988|365493316|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105953988|NCT03666988|365493317|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
105953989|NCT05588440|365493322|FG000|Overall Study|Sponsor Decision|2|||
105953990|NCT05588440|365493323|FG001|Overall Study|Sponsor Decision|0|||
105953991|NCT05588440|365493324|FG002|Overall Study|Sponsor Decision|1|||
105953992|NCT05588440|365493322|FG000|Overall Study|Death|1|||
105953993|NCT05588440|365493323|FG001|Overall Study|Death|1|||
105953994|NCT05588440|365493324|FG002|Overall Study|Death|1|||
106017626|NCT02721966|365727292|FG002|Overall Study|Death|0|||
105811511|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
105811512|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
105811513|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
105811514|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
105953995|NCT05588440|365493322|FG000|Overall Study|Screen Fail|0|||
105953996|NCT05588440|365493323|FG001|Overall Study|Screen Fail|1|||
105953997|NCT05588440|365493324|FG002|Overall Study|Screen Fail|1|||
105953998|NCT05588440|365493322|FG000|Overall Study|Withdrawal by Subject|0|||
105953999|NCT05588440|365493323|FG001|Overall Study|Withdrawal by Subject|0|||
105954000|NCT05588440|365493324|FG002|Overall Study|Withdrawal by Subject|1|||
106017627|NCT02721966|365727293|FG003|Overall Study|Death|0|||
106017628|NCT02721966|365727294|FG004|Overall Study|Death|0|||
106017629|NCT02721966|365727290|FG000|Overall Study|Lack of Efficacy|7|||
106017630|NCT02721966|365727291|FG001|Overall Study|Lack of Efficacy|4|||
106017631|NCT02721966|365727292|FG002|Overall Study|Lack of Efficacy|0|||
106017632|NCT02721966|365727293|FG003|Overall Study|Lack of Efficacy|0|||
106017633|NCT02721966|365727294|FG004|Overall Study|Lack of Efficacy|0|||
106017634|NCT02721966|365727290|FG000|Overall Study|Lost to Follow-up|0|||
106017635|NCT02721966|365727291|FG001|Overall Study|Lost to Follow-up|0|||
106017636|NCT02721966|365727292|FG002|Overall Study|Lost to Follow-up|3|||
106017637|NCT02721966|365727293|FG003|Overall Study|Lost to Follow-up|0|||
106017638|NCT02721966|365727294|FG004|Overall Study|Lost to Follow-up|0|||
106017639|NCT02721966|365727290|FG000|Overall Study|Physician Decision|1|||
106017640|NCT02721966|365727291|FG001|Overall Study|Physician Decision|1|||
106017641|NCT02721966|365727292|FG002|Overall Study|Physician Decision|0|||
106017642|NCT02721966|365727293|FG003|Overall Study|Physician Decision|0|||
106017643|NCT02721966|365727294|FG004|Overall Study|Physician Decision|0|||
106017644|NCT02721966|365727290|FG000|Overall Study|Pregnancy|1|||
106017645|NCT02721966|365727291|FG001|Overall Study|Pregnancy|0|||
106017646|NCT02721966|365727292|FG002|Overall Study|Pregnancy|0|||
106017647|NCT02721966|365727293|FG003|Overall Study|Pregnancy|0|||
106145009|NCT05061693|366190774|FG000|24-week Extension Period|Lack of Efficacy|0|||
106145010|NCT05061693|366190775|FG001|24-week Extension Period|Lack of Efficacy|0|||
106145011|NCT05061693|366190776|FG002|24-week Extension Period|Lack of Efficacy|0|||
106145012|NCT05061693|366190777|FG003|24-week Extension Period|Lack of Efficacy|0|||
106145013|NCT05061693|366190778|FG004|24-week Extension Period|Lack of Efficacy|0|||
106145014|NCT05061693|366190779|FG005|24-week Extension Period|Lack of Efficacy|0|||
106145015|NCT05061693|366190780|FG006|24-week Extension Period|Lack of Efficacy|0|||
106145016|NCT05061693|366190781|FG007|24-week Extension Period|Lack of Efficacy|0|||
106145017|NCT05061693|366190782|FG008|24-week Extension Period|Lack of Efficacy|0|||
106145018|NCT05061693|366190783|FG009|24-week Extension Period|Lack of Efficacy|0|||
106145019|NCT05061693|366190784|FG010|24-week Extension Period|Lack of Efficacy|2|||
106145020|NCT05061693|366190785|FG011|24-week Extension Period|Lack of Efficacy|0|||
106145021|NCT05061693|366190774|FG000|24-week Extension Period|Lost to Follow-up|0|||
106145022|NCT05061693|366190775|FG001|24-week Extension Period|Lost to Follow-up|0|||
106145023|NCT05061693|366190776|FG002|24-week Extension Period|Lost to Follow-up|0|||
106145024|NCT05061693|366190777|FG003|24-week Extension Period|Lost to Follow-up|0|||
106145025|NCT05061693|366190778|FG004|24-week Extension Period|Lost to Follow-up|0|||
106145026|NCT05061693|366190779|FG005|24-week Extension Period|Lost to Follow-up|0|||
106145027|NCT05061693|366190780|FG006|24-week Extension Period|Lost to Follow-up|1|||
106145028|NCT05061693|366190781|FG007|24-week Extension Period|Lost to Follow-up|0|||
106145029|NCT05061693|366190782|FG008|24-week Extension Period|Lost to Follow-up|1|||
106145030|NCT05061693|366190783|FG009|24-week Extension Period|Lost to Follow-up|1|||
105762761|NCT03365947|364783194|FG002|Overall Study|Lost to Follow-up|0|||
105762762|NCT03365947|364783195|FG003|Overall Study|Lost to Follow-up|0|||
105762763|NCT03365947|364783196|FG004|Overall Study|Lost to Follow-up|0|||
105762764|NCT03365947|364783197|FG005|Overall Study|Lost to Follow-up|1|||
105762765|NCT03365947|364783198|FG006|Overall Study|Lost to Follow-up|0|||
105762766|NCT03365947|364783199|FG007|Overall Study|Lost to Follow-up|0|||
105762767|NCT03365947|364783200|FG008|Overall Study|Lost to Follow-up|0|||
105762768|NCT03365947|364783201|FG009|Overall Study|Lost to Follow-up|0|||
105762769|NCT03365947|364783202|FG010|Overall Study|Lost to Follow-up|0|||
105762770|NCT03365947|364783203|FG011|Overall Study|Lost to Follow-up|0|||
105762771|NCT03365947|364783204|FG012|Overall Study|Lost to Follow-up|0|||
105762772|NCT03365947|364783205|FG013|Overall Study|Lost to Follow-up|0|||
105762773|NCT03365947|364783206|FG014|Overall Study|Lost to Follow-up|0|||
105762774|NCT03365947|364783207|FG015|Overall Study|Lost to Follow-up|0|||
105762775|NCT03365947|364783208|FG016|Overall Study|Lost to Follow-up|0|||
105762776|NCT03365947|364783209|FG017|Overall Study|Lost to Follow-up|0|||
105762777|NCT03365947|364783210|FG018|Overall Study|Lost to Follow-up|0|||
105762778|NCT01915095|364783211|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
105762779|NCT01915095|364783212|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
105762780|NCT01915095|364783213|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
105762781|NCT01915095|364783214|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
105762782|NCT01915095|364783215|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
105762783|NCT04018612|364783216|FG000|Overall Study|Withdrawal by Subject|1|||
105762784|NCT04018612|364783217|FG001|Overall Study|Withdrawal by Subject|0|||
105762785|NCT04018612|364783218|FG002|Overall Study|Withdrawal by Subject|1|||
105762786|NCT00462488|364784789|FG000|Overall Study|Protocol Violation|1|||
106017648|NCT02721966|365727294|FG004|Overall Study|Pregnancy|0|||
105762787|NCT00462488|364784790|FG001|Overall Study|Protocol Violation|0|||
105762788|NCT00462488|364784789|FG000|Overall Study|Lack of Efficacy|19|||
105762789|NCT00462488|364784790|FG001|Overall Study|Lack of Efficacy|17|||
105762790|NCT03984812|364784792|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762791|NCT03984812|364784793|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
106017649|NCT02721966|365727290|FG000|Overall Study|Did not continue to period 2|5|||
106017650|NCT02721966|365727291|FG001|Overall Study|Did not continue to period 2|12|||
106017651|NCT02721966|365727292|FG002|Overall Study|Did not continue to period 2|0|||
106017652|NCT02721966|365727293|FG003|Overall Study|Did not continue to period 2|0|||
106017653|NCT02721966|365727294|FG004|Overall Study|Did not continue to period 2|5|||
106017654|NCT00467753|365727295|FG000|Overall Study|Lost to Follow-up|1|||
106017655|NCT00467753|365727296|FG001|Overall Study|Lost to Follow-up|2|||
106017656|NCT00467753|365727295|FG000|Overall Study|Adverse Event|2|||
106017657|NCT00467753|365727296|FG001|Overall Study|Adverse Event|0|||
106017658|NCT01869764|365727297|FG000|Overall Study|Withdrawal by Subject|0|||
106017659|NCT01869764|365727298|FG001|Overall Study|Withdrawal by Subject|2|||
106017660|NCT01286480|365727299|FG000|Overall Study|Withdrawal by Subject|5|||
106017661|NCT01286480|365727300|FG001|Overall Study|Withdrawal by Subject|3|||
106017662|NCT00834093|365727301|FG000|Overall Study|Progressive Disease|3|||
106017663|NCT00834093|365727301|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
106017664|NCT00960999|365727302|FG000|Overall Study|Withdrawal by Subject|1|||
106017665|NCT00960999|365727303|FG001|Overall Study|Withdrawal by Subject|0|||
106017666|NCT00960999|365727302|FG000|Overall Study|Protocol Violation|5|||
106017667|NCT00960999|365727303|FG001|Overall Study|Protocol Violation|2|||
106017668|NCT00960999|365727302|FG000|Overall Study|RT dose constraints not met|2|||
106017669|NCT00960999|365727303|FG001|Overall Study|RT dose constraints not met|0|||
106017670|NCT01578486|365727304|FG000|Overall Study|Physician Decision|3|||
106017671|NCT01578486|365727304|FG000|Overall Study|Withdrawal by Subject|2|||
106017672|NCT02536963|365727305|FG000|Overall Study|Withdrawal by Subject|18|||
106017673|NCT04292899|365727306|FG000|Overall Study|Death|21|||
106017674|NCT04292899|365727307|FG001|Overall Study|Death|28|||
106017675|NCT04292899|365727308|FG002|Overall Study|Death|188|||
106017676|NCT04292899|365727309|FG003|Overall Study|Death|371|||
106017677|NCT04292899|365727306|FG000|Overall Study|Lost to Follow-up|8|||
106017678|NCT04292899|365727307|FG001|Overall Study|Lost to Follow-up|4|||
106017679|NCT04292899|365727308|FG002|Overall Study|Lost to Follow-up|22|||
106017680|NCT04292899|365727309|FG003|Overall Study|Lost to Follow-up|235|||
106017681|NCT04292899|365727306|FG000|Overall Study|Withdrew consent|1|||
106017682|NCT04292899|365727307|FG001|Overall Study|Withdrew consent|0|||
106017683|NCT04292899|365727308|FG002|Overall Study|Withdrew consent|11|||
106017684|NCT04292899|365727309|FG003|Overall Study|Withdrew consent|32|||
106017685|NCT04292899|365727306|FG000|Overall Study|Adverse Event|2|||
106017686|NCT04292899|365727307|FG001|Overall Study|Adverse Event|1|||
106017687|NCT04292899|365727308|FG002|Overall Study|Adverse Event|2|||
106017688|NCT04292899|365727309|FG003|Overall Study|Adverse Event|2|||
106017689|NCT04292899|365727306|FG000|Overall Study|Investigator's Discretion|0|||
106017690|NCT04292899|365727307|FG001|Overall Study|Investigator's Discretion|0|||
106017691|NCT04292899|365727308|FG002|Overall Study|Investigator's Discretion|0|||
106017692|NCT04292899|365727309|FG003|Overall Study|Investigator's Discretion|3|||
106017693|NCT04292899|365727306|FG000|Overall Study|Non-compliance With Study Drug|0|||
106017694|NCT04292899|365727307|FG001|Overall Study|Non-compliance With Study Drug|0|||
106017695|NCT04292899|365727308|FG002|Overall Study|Non-compliance With Study Drug|0|||
106017696|NCT04292899|365727309|FG003|Overall Study|Non-compliance With Study Drug|1|||
106017697|NCT04292899|365727306|FG000|Overall Study|Protocol Violation|0|||
106017698|NCT04292899|365727307|FG001|Overall Study|Protocol Violation|0|||
106017699|NCT04292899|365727308|FG002|Overall Study|Protocol Violation|0|||
106017700|NCT04292899|365727309|FG003|Overall Study|Protocol Violation|1|||
106017701|NCT02425943|365727310|FG000|Overall Study|Adverse Event|3|||
106017702|NCT02425943|365727311|FG001|Overall Study|Adverse Event|1|||
106017703|NCT02425943|365727310|FG000|Overall Study|Lost to Follow-up|59|||
106017704|NCT02425943|365727311|FG001|Overall Study|Lost to Follow-up|37|||
106017705|NCT02425943|365727310|FG000|Overall Study|Protocol Violation|4|||
106017706|NCT02425943|365727311|FG001|Overall Study|Protocol Violation|1|||
106145031|NCT05061693|366190784|FG010|24-week Extension Period|Lost to Follow-up|0|||
106145032|NCT05061693|366190785|FG011|24-week Extension Period|Lost to Follow-up|0|||
106145033|NCT05061693|366190774|FG000|24-week Extension Period|Withdrawal by Subject|0|||
106145034|NCT05061693|366190775|FG001|24-week Extension Period|Withdrawal by Subject|0|||
106145035|NCT05061693|366190776|FG002|24-week Extension Period|Withdrawal by Subject|0|||
106017707|NCT02425943|365727310|FG000|Overall Study|Withdrawal by Subject|64|||
106017708|NCT02425943|365727311|FG001|Overall Study|Withdrawal by Subject|31|||
106017709|NCT02425943|365727310|FG000|Overall Study|Other|6|||
106017710|NCT02425943|365727311|FG001|Overall Study|Other|0|||
106017711|NCT02141204|365727314|FG000|Overall Study|Lost to Follow-up|2|||
106017712|NCT02141204|365727315|FG001|Overall Study|Lost to Follow-up|1|||
106017713|NCT02141204|365727314|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
106017714|NCT02141204|365727315|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
106017715|NCT02141204|365727314|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
106017716|NCT02141204|365727315|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
106017717|NCT02141204|365727314|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
106017718|NCT02141204|365727315|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
106017719|NCT03313037|365727322|FG000|Overall Study|Protocol Violation|4|||
105811515|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
105954001|NCT00444106|365493325|FG000|Overall Study|Lost to Follow-up|2|||
105954002|NCT00444106|365493326|FG001|Overall Study|Lost to Follow-up|1|||
105954003|NCT00444106|365493327|FG002|Overall Study|Lost to Follow-up|0|||
105954004|NCT00444106|365493325|FG000|Overall Study|Abnormal Test Procedure Results|0|||
105954005|NCT00444106|365493326|FG001|Overall Study|Abnormal Test Procedure Results|0|||
105954006|NCT00444106|365493327|FG002|Overall Study|Abnormal Test Procedure Results|1|||
105954007|NCT04409834|365493334|FG000|Overall Study|Death|55|||
105954008|NCT04409834|365493335|FG001|Overall Study|Death|62|||
105954009|NCT05414175|365493336|FG000|Overall Study|Withdrawal by Subject|1|||
105954010|NCT05414175|365493336|FG000|Overall Study|Other Reasons|1|||
105954011|NCT02137070|365493337|FG000|Overall Study|Adverse Event|12|||
105954012|NCT02137070|365493338|FG001|Overall Study|Adverse Event|3|||
105954013|NCT02137070|365493337|FG000|Overall Study|Death|2|||
105954014|NCT02137070|365493338|FG001|Overall Study|Death|0|||
105954015|NCT02137070|365493337|FG000|Overall Study|Lost to Follow-up|24|||
105954016|NCT02137070|365493338|FG001|Overall Study|Lost to Follow-up|9|||
105954017|NCT02137070|365493337|FG000|Overall Study|Physician Decision|0|||
105954018|NCT02137070|365493338|FG001|Overall Study|Physician Decision|1|||
105954019|NCT02137070|365493337|FG000|Overall Study|Protocol Violation|18|||
105954020|NCT02137070|365493338|FG001|Overall Study|Protocol Violation|4|||
105954021|NCT02137070|365493337|FG000|Overall Study|Withdrawal by Subject|18|||
105954022|NCT02137070|365493338|FG001|Overall Study|Withdrawal by Subject|1|||
105954023|NCT03549338|365495053|FG000|Overall Study|Progressive Disease|1|||
105954024|NCT03549338|365495054|FG001|Overall Study|Progressive Disease|0|||
105954025|NCT03549338|365495055|FG002|Overall Study|Progressive Disease|0|||
105954026|NCT03549338|365495053|FG000|Overall Study|Clinical Progression|0|||
105954027|NCT03549338|365495054|FG001|Overall Study|Clinical Progression|1|||
105954028|NCT03549338|365495055|FG002|Overall Study|Clinical Progression|0|||
105954029|NCT00939107|365495056|FG000|Overall Study|Lost to Follow-up|14|||
105954030|NCT00939107|365495057|FG001|Overall Study|Lost to Follow-up|12|||
105954031|NCT01047007|365495060|FG000|Overall Study|Adverse Event|0|||
105954032|NCT01047007|365495061|FG001|Overall Study|Adverse Event|2|||
105954033|NCT01047007|365495062|FG002|Overall Study|Adverse Event|1|||
105954034|NCT01047007|365495063|FG003|Overall Study|Adverse Event|0|||
105954035|NCT01047007|365495060|FG000|Overall Study|Progressive Disease|2|||
105954036|NCT01047007|365495061|FG001|Overall Study|Progressive Disease|4|||
105954037|NCT01047007|365495062|FG002|Overall Study|Progressive Disease|1|||
105954038|NCT01047007|365495063|FG003|Overall Study|Progressive Disease|0|||
105954039|NCT04776161|365495064|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
105954040|NCT04776161|365495065|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
105954041|NCT04776161|365495066|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
105954042|NCT04776161|365495064|FG000|Overall Study|Withdrawal by Subject|1|||
105954043|NCT04776161|365495065|FG001|Overall Study|Withdrawal by Subject|0|||
105954044|NCT04776161|365495066|FG002|Overall Study|Withdrawal by Subject|1|||
105954045|NCT04776161|365495064|FG000|Overall Study|Adverse Event|0|||
105954046|NCT04776161|365495065|FG001|Overall Study|Adverse Event|1|||
105954047|NCT04776161|365495066|FG002|Overall Study|Adverse Event|1|||
105954048|NCT04551898|365495069|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
105954049|NCT04551898|365495070|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
105954050|NCT04551898|365495071|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
105954051|NCT04551898|365495072|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
105954052|NCT04551898|365495069|FG000|Overall Study|Withdrawal by Subject|5|||
105954053|NCT04551898|365495070|FG001|Overall Study|Withdrawal by Subject|1|||
105954054|NCT04551898|365495071|FG002|Overall Study|Withdrawal by Subject|2|||
105954055|NCT04551898|365495072|FG003|Overall Study|Withdrawal by Subject|2|||
105954056|NCT04551898|365495069|FG000|Overall Study|Lost to Follow-up|2|||
105954057|NCT04551898|365495070|FG001|Overall Study|Lost to Follow-up|1|||
105954058|NCT04551898|365495071|FG002|Overall Study|Lost to Follow-up|2|||
105954059|NCT04551898|365495072|FG003|Overall Study|Lost to Follow-up|2|||
105954060|NCT04551898|365495069|FG000|Overall Study|Death|1|||
105954061|NCT04551898|365495070|FG001|Overall Study|Death|0|||
105954062|NCT04551898|365495071|FG002|Overall Study|Death|0|||
105954063|NCT04551898|365495072|FG003|Overall Study|Death|0|||
105954064|NCT04551898|365495069|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
105954065|NCT04551898|365495070|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
105954066|NCT04551898|365495071|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
105954067|NCT04551898|365495072|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
105811516|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
105811517|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
105811518|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
105811519|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
105811520|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
105811521|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
105811522|NCT02207231|364966538|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
105811523|NCT02207231|364966539|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
105811524|NCT02207231|364966540|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
105811525|NCT02207231|364966541|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
105811526|NCT01829464|364966550|FG000|Overall Study|Adverse Event|1|||
105811527|NCT01829464|364966551|FG001|Overall Study|Adverse Event|0|||
105811528|NCT01829464|364966552|FG002|Overall Study|Adverse Event|0|||
105811529|NCT01829464|364966550|FG000|Overall Study|Lost to Follow-up|0|||
105811530|NCT01829464|364966551|FG001|Overall Study|Lost to Follow-up|0|||
105811531|NCT01829464|364966552|FG002|Overall Study|Lost to Follow-up|1|||
105811532|NCT01829464|364966550|FG000|Overall Study|Withdrawal by Subject|2|||
105811533|NCT01829464|364966551|FG001|Overall Study|Withdrawal by Subject|0|||
105811534|NCT01829464|364966552|FG002|Overall Study|Withdrawal by Subject|0|||
105811535|NCT01829464|364966550|FG000|Overall Study|Study terminated by sponsor|25|||
105811536|NCT01829464|364966551|FG001|Overall Study|Study terminated by sponsor|28|||
105811537|NCT01829464|364966552|FG002|Overall Study|Study terminated by sponsor|25|||
105811538|NCT01829464|364966550|FG000|Overall Study|Lack of Efficacy|0|||
105811539|NCT01829464|364966551|FG001|Overall Study|Lack of Efficacy|1|||
105811540|NCT01829464|364966552|FG002|Overall Study|Lack of Efficacy|0|||
105811541|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
105811542|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
105811543|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
105811544|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
105811545|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
105811546|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
105811547|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
105811548|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
105811549|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
105811550|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
105811551|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
105811552|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
105811553|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
105811554|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
105811555|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
105811556|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
105811557|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
106017720|NCT03313037|365727323|FG001|Overall Study|Protocol Violation|1|||
105811558|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
105811559|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
105811560|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
105811561|NCT04700449|364966557|FG000|Stage 1: Double-Blind Period|Other|0|||
105954068|NCT03846427|365495073|FG000|Overall Study|Death|13|||
105954069|NCT03846427|365495073|FG000|Overall Study|Withdrawal by Subject|3|||
105954070|NCT03846427|365495073|FG000|Overall Study|Physician Decision|1|||
105954071|NCT00628446|365495074|FG000|Overall Study|Lost to Follow-up|3|||
105954072|NCT00628446|365495074|FG000|Overall Study|Withdrawal by Subject|1|||
105954073|NCT00628446|365495074|FG000|Overall Study|Protocol Violation|3|||
105954074|NCT01898286|365495075|FG000|Overall Study|Withdrawal by Subject|1|||
105954075|NCT01898286|365495075|FG000|Overall Study|Protocol Violation|1|||
105954076|NCT01898286|365495075|FG000|Overall Study|Lost to Follow-up|1|||
105954077|NCT01976299|365495080|FG000|Overall Study|Withdrawal by Subject|3|||
105954078|NCT01976299|365495081|FG001|Overall Study|Withdrawal by Subject|1|||
105954079|NCT01976299|365495080|FG000|Overall Study|Death|4|||
105954080|NCT01976299|365495081|FG001|Overall Study|Death|2|||
105954081|NCT01976299|365495080|FG000|Overall Study|Lost to Follow-up|7|||
105954082|NCT01976299|365495081|FG001|Overall Study|Lost to Follow-up|1|||
105954083|NCT01976299|365495080|FG000|Overall Study|See clarification above in comments|9|||
105954084|NCT01976299|365495081|FG001|Overall Study|See clarification above in comments|2|||
105954085|NCT03692403|365495082|FG000|Overall Study|Withdrawal by Subject|1|||
105954086|NCT03692403|365495083|FG001|Overall Study|Withdrawal by Subject|0|||
105811562|NCT04700449|364966558|FG001|Stage 1: Double-Blind Period|Other|0|||
105954087|NCT03692403|365495084|FG002|Overall Study|Withdrawal by Subject|1|||
105811563|NCT04700449|364966559|FG002|Stage 1: Double-Blind Period|Other|1|||
105811564|NCT04700449|364966560|FG003|Stage 1: Double-Blind Period|Other|0|||
105954088|NCT03692403|365495085|FG003|Overall Study|Withdrawal by Subject|0|||
105954089|NCT03692403|365495082|FG000|Overall Study|Adverse Event|0|||
105954090|NCT03692403|365495083|FG001|Overall Study|Adverse Event|0|||
105954091|NCT03692403|365495084|FG002|Overall Study|Adverse Event|0|||
105954092|NCT03692403|365495085|FG003|Overall Study|Adverse Event|1|||
105954093|NCT03692403|365495082|FG000|Overall Study|Pregnancy|0|||
105954094|NCT03692403|365495083|FG001|Overall Study|Pregnancy|1|||
105954095|NCT03692403|365495084|FG002|Overall Study|Pregnancy|0|||
105954096|NCT03692403|365495085|FG003|Overall Study|Pregnancy|0|||
105954097|NCT03692403|365495082|FG000|Overall Study|Other|0|||
105954098|NCT03692403|365495083|FG001|Overall Study|Other|0|||
105954099|NCT03692403|365495084|FG002|Overall Study|Other|1|||
105954100|NCT03692403|365495085|FG003|Overall Study|Other|0|||
105954101|NCT02197572|365495090|FG000|Overall Study|Progressive Disease|28|||
105954102|NCT02197572|365495090|FG000|Overall Study|Withdrawal by Subject|9|||
105954103|NCT02197572|365495090|FG000|Overall Study|Adverse Event|3|||
105954104|NCT02197572|365495090|FG000|Overall Study|Reason Not Specified|4|||
105954105|NCT00355368|365495091|FG000|Overall Study|Protocol Violation|8|||
105954106|NCT00355368|365495092|FG001|Overall Study|Protocol Violation|7|||
105954107|NCT00355368|365495091|FG000|Overall Study|cardiac arrest prior to intubation|2|||
105954108|NCT00355368|365495092|FG001|Overall Study|cardiac arrest prior to intubation|2|||
105954109|NCT01349673|365495094|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
105954110|NCT01349673|365495094|FG000|Overall Study|No Longer Qualified For Study|1|||
105954111|NCT01349673|365495094|FG000|Overall Study|Site Closure|10|||
105954112|NCT01349673|365495094|FG000|Overall Study|Withdrawal by Subject|21|||
105954113|NCT01349673|365495094|FG000|Overall Study|Lost to Follow-up|6|||
105954114|NCT01349673|365495094|FG000|Overall Study|Adverse Event|17|||
105954115|NCT01349673|365495094|FG000|Overall Study|Study Terminated By Sponsor|50|||
105954116|NCT01349673|365495094|FG000|Overall Study|Lack of Efficacy|8|||
105954117|NCT02820844|365495097|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
105954118|NCT02820844|365495098|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
105954119|NCT02820844|365495099|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
105954120|NCT02820844|365495100|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
105954121|NCT02820844|365495101|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
105954122|NCT02820844|365495102|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
105954123|NCT02820844|365495097|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
105954124|NCT02820844|365495098|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
105954125|NCT02820844|365495099|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
105954126|NCT02820844|365495100|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
105954127|NCT02820844|365495101|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
105954128|NCT02820844|365495102|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
106017721|NCT03313037|365727322|FG000|Overall Study|Other|1|||
106017722|NCT03313037|365727323|FG001|Overall Study|Other|1|||
106017723|NCT03313037|365727322|FG000|Overall Study|Withdrawal by Subject|4|||
106017724|NCT03313037|365727323|FG001|Overall Study|Withdrawal by Subject|3|||
106017725|NCT03313037|365727322|FG000|Overall Study|No longer meets eligibility criteria|1|||
106017726|NCT03313037|365727323|FG001|Overall Study|No longer meets eligibility criteria|7|||
106017727|NCT03313037|365727322|FG000|Overall Study|Lost to Follow-up|9|||
106017728|NCT03313037|365727323|FG001|Overall Study|Lost to Follow-up|8|||
106017729|NCT03313037|365727322|FG000|Overall Study|Randomized but not treated|1|||
106017730|NCT03313037|365727323|FG001|Overall Study|Randomized but not treated|0|||
106017731|NCT02506244|365727324|FG000|Overall Study|Did not undergo active monitoring|458|||
106145036|NCT05061693|366190777|FG003|24-week Extension Period|Withdrawal by Subject|0|||
105762792|NCT03984812|364784794|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
105762793|NCT03984812|364784795|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762794|NCT03984812|364784796|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762795|NCT03984812|364784797|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762796|NCT03984812|364784798|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762797|NCT03984812|364784799|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762798|NCT03984812|364784800|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762799|NCT03984812|364784801|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762800|NCT03984812|364784802|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
105762801|NCT00446641|364784803|FG000|Overall Study|Withdrawal by Subject|8|||
105762802|NCT00446641|364784804|FG001|Overall Study|Withdrawal by Subject|3|||
105762803|NCT00446641|364784803|FG000|Overall Study|poor compliance|8|||
105762804|NCT00446641|364784804|FG001|Overall Study|poor compliance|6|||
105762805|NCT00446641|364784803|FG000|Overall Study|Lost to Follow-up|1|||
105762806|NCT00446641|364784804|FG001|Overall Study|Lost to Follow-up|1|||
105762807|NCT00443846|364784812|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
105762808|NCT00443846|364784813|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
105762809|NCT00443846|364784812|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
105762810|NCT00443846|364784813|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
105762811|NCT00443846|364784812|FG000|Overall Study|Adverse Event|0|||
105762812|NCT00443846|364784813|FG001|Overall Study|Adverse Event|1|||
105762813|NCT00443846|364784812|FG000|Overall Study|Personal reason|8|||
105762814|NCT00443846|364784813|FG001|Overall Study|Personal reason|3|||
105954129|NCT02820844|365495097|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105811565|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
105811566|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
105811567|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
105811568|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
105811569|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
105811570|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
105811571|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
105811572|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
105811573|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
105811574|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
105811575|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
105811576|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
105811577|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
105811578|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
105811579|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
105811580|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
105954130|NCT02820844|365495098|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
105954131|NCT02820844|365495099|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105954132|NCT02820844|365495100|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105954133|NCT02820844|365495101|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105954134|NCT02820844|365495102|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
105954135|NCT02820844|365495097|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
105954136|NCT02820844|365495098|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
105954137|NCT02820844|365495099|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
105954138|NCT02820844|365495100|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
105954139|NCT02820844|365495101|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
105954140|NCT02820844|365495102|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
105954141|NCT02820844|365495097|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
105954142|NCT02820844|365495098|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105954143|NCT02820844|365495099|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105954144|NCT02820844|365495100|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105954145|NCT02820844|365495101|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105954146|NCT02820844|365495102|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
105954147|NCT02820844|365495097|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
105954148|NCT02820844|365495098|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
105954149|NCT02820844|365495099|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
105954150|NCT02820844|365495100|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
105954151|NCT02820844|365495101|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
105954152|NCT02820844|365495102|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
105954153|NCT02820844|365495097|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105954154|NCT02820844|365495098|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105954155|NCT02820844|365495099|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
105954156|NCT02820844|365495100|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105954157|NCT02820844|365495101|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105954158|NCT02820844|365495102|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
105954159|NCT02820844|365495097|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105954160|NCT02820844|365495098|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105954161|NCT02820844|365495099|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
105954162|NCT02820844|365495100|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
105954163|NCT02820844|365495101|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105954164|NCT02820844|365495102|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105954165|NCT02820844|365495097|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105954166|NCT02820844|365495098|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105954167|NCT02820844|365495099|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105954168|NCT02820844|365495100|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105954169|NCT02820844|365495101|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
105954170|NCT02820844|365495102|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
105954171|NCT02820844|365495097|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105954172|NCT02820844|365495098|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105954173|NCT02820844|365495099|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105954174|NCT02820844|365495100|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
106017732|NCT02506244|365727325|FG001|Overall Study|Did not undergo active monitoring|459|||
106145037|NCT05061693|366190778|FG004|24-week Extension Period|Withdrawal by Subject|0|||
105811581|NCT04700449|364966557|FG000|Stage 2 Sub-study 1|Other|1|||
105811582|NCT04700449|364966558|FG001|Stage 2 Sub-study 1|Other|2|||
105811583|NCT04700449|364966559|FG002|Stage 2 Sub-study 1|Other|0|||
105811584|NCT04700449|364966560|FG003|Stage 2 Sub-study 1|Other|0|||
106017733|NCT02506244|365727326|FG002|Overall Study|Did not undergo active monitoring|0|||
106017734|NCT04163016|365727331|FG000|Enrollment|Adverse Event|1|||
106017735|NCT04163016|365727332|FG001|Enrollment|Adverse Event|0|||
106017736|NCT04163016|365727333|FG002|Enrollment|Adverse Event|0|||
106017737|NCT04163016|365727334|FG003|Enrollment|Adverse Event|0|||
106017738|NCT04163016|365727331|FG000|Treatment|Adverse Event|0|||
106017739|NCT04163016|365727332|FG001|Treatment|Adverse Event|1|||
106017740|NCT04163016|365727333|FG002|Treatment|Adverse Event|0|||
106017741|NCT04163016|365727334|FG003|Treatment|Adverse Event|0|||
106017742|NCT04163016|365727331|FG000|Treatment|Withdrawal by Subject|0|||
106017743|NCT04163016|365727332|FG001|Treatment|Withdrawal by Subject|2|||
106017744|NCT04163016|365727333|FG002|Treatment|Withdrawal by Subject|0|||
106017745|NCT04163016|365727334|FG003|Treatment|Withdrawal by Subject|0|||
106017746|NCT04163016|365727331|FG000|Treatment|Indeterminate TB-test|0|||
106017747|NCT04163016|365727332|FG001|Treatment|Indeterminate TB-test|0|||
106017748|NCT04163016|365727333|FG002|Treatment|Indeterminate TB-test|0|||
106017749|NCT04163016|365727334|FG003|Treatment|Indeterminate TB-test|1|||
106017750|NCT04163016|365727331|FG000|Treatment|Participant did not want to continue in study|0|||
106017751|NCT04163016|365727332|FG001|Treatment|Participant did not want to continue in study|0|||
106017752|NCT04163016|365727333|FG002|Treatment|Participant did not want to continue in study|0|||
106017753|NCT04163016|365727334|FG003|Treatment|Participant did not want to continue in study|1|||
106017754|NCT04193189|365727341|FG000|Overall Study|Lost to Follow-up|9|||
106017755|NCT04193189|365727342|FG001|Overall Study|Lost to Follow-up|7|||
106017756|NCT04193189|365727343|FG002|Overall Study|Lost to Follow-up|9|||
106017757|NCT04193189|365727344|FG003|Overall Study|Lost to Follow-up|0|||
106017758|NCT04193189|365727341|FG000|Overall Study|Withdrawal by Subject|1|||
106017759|NCT04193189|365727342|FG001|Overall Study|Withdrawal by Subject|2|||
106017760|NCT04193189|365727343|FG002|Overall Study|Withdrawal by Subject|2|||
106017761|NCT04193189|365727344|FG003|Overall Study|Withdrawal by Subject|0|||
106017762|NCT04193189|365727341|FG000|Overall Study|Death|1|||
106017763|NCT04193189|365727342|FG001|Overall Study|Death|1|||
106017764|NCT04193189|365727343|FG002|Overall Study|Death|0|||
106017765|NCT04193189|365727344|FG003|Overall Study|Death|0|||
106017766|NCT04193189|365727341|FG000|Overall Study|Protocol Violation|0|||
106017767|NCT04193189|365727342|FG001|Overall Study|Protocol Violation|0|||
106017768|NCT04193189|365727343|FG002|Overall Study|Protocol Violation|0|||
106017769|NCT04193189|365727344|FG003|Overall Study|Protocol Violation|1|||
106017770|NCT03474965|365727345|FG000|Overall Study|Pregnancy|1|||
106017771|NCT03474965|365727346|FG001|Overall Study|Pregnancy|0|||
106017772|NCT03474965|365727347|FG002|Overall Study|Pregnancy|0|||
106017773|NCT03474965|365727348|FG003|Overall Study|Pregnancy|0|||
106017774|NCT03474965|365727345|FG000|Overall Study|Lost to Follow-up|0|||
106017775|NCT03474965|365727346|FG001|Overall Study|Lost to Follow-up|0|||
106017776|NCT03474965|365727347|FG002|Overall Study|Lost to Follow-up|1|||
106017777|NCT03474965|365727348|FG003|Overall Study|Lost to Follow-up|0|||
106017778|NCT03474965|365727345|FG000|Overall Study|Death|1|||
106017779|NCT03474965|365727346|FG001|Overall Study|Death|0|||
106017780|NCT03474965|365727347|FG002|Overall Study|Death|0|||
106017781|NCT03474965|365727348|FG003|Overall Study|Death|0|||
106017782|NCT03474965|365727345|FG000|Overall Study|Adverse Event|1|||
106017783|NCT03474965|365727346|FG001|Overall Study|Adverse Event|0|||
106017784|NCT03474965|365727347|FG002|Overall Study|Adverse Event|0|||
106017785|NCT03474965|365727348|FG003|Overall Study|Adverse Event|1|||
106017786|NCT03474965|365727345|FG000|Overall Study|Physician Decision|3|||
106017787|NCT03474965|365727346|FG001|Overall Study|Physician Decision|1|||
106017788|NCT03474965|365727347|FG002|Overall Study|Physician Decision|2|||
106017789|NCT03474965|365727348|FG003|Overall Study|Physician Decision|0|||
106017790|NCT03474965|365727345|FG000|Overall Study|Participant Decision|7|||
106017791|NCT03474965|365727346|FG001|Overall Study|Participant Decision|0|||
106017792|NCT03474965|365727347|FG002|Overall Study|Participant Decision|1|||
106017793|NCT03474965|365727348|FG003|Overall Study|Participant Decision|0|||
106017794|NCT03474965|365727345|FG000|Overall Study|Guardian Decision|4|||
106017795|NCT03474965|365727346|FG001|Overall Study|Guardian Decision|2|||
106017796|NCT03474965|365727347|FG002|Overall Study|Guardian Decision|7|||
106017797|NCT03474965|365727348|FG003|Overall Study|Guardian Decision|2|||
106017798|NCT03349034|365729183|FG000|Overall Study|catheters dislodged during transport|2|||
106017799|NCT03349034|365729184|FG001|Overall Study|catheters dislodged during transport|0|||
106017800|NCT03349034|365729183|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
106017801|NCT03349034|365729184|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
106017802|NCT03349034|365729183|FG000|Overall Study|soft tissue flap used|1|||
106017803|NCT03349034|365729184|FG001|Overall Study|soft tissue flap used|0|||
106017804|NCT03349034|365729183|FG000|Overall Study|Other|0|||
106017805|NCT03349034|365729184|FG001|Overall Study|Other|1|||
106017806|NCT00815659|365729185|FG000|Overall Study|Adverse Event|9|||
106017807|NCT00815659|365729185|FG000|Overall Study|Withdrawal by Subject|9|||
106017808|NCT00815659|365729185|FG000|Overall Study|Lost to Follow-up|4|||
106017809|NCT00815659|365729185|FG000|Overall Study|Protocol Violation|1|||
106017810|NCT02978781|365729186|FG000|Part A|Adverse Event|1|||
106017811|NCT02978781|365729187|FG001|Part A|Adverse Event|1|||
105811585|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
105811586|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
105811587|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
105811588|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
105811589|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
105811590|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
105811591|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
105811592|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
105811593|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
105811594|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
105811595|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
105811596|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
105811597|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
105811598|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
105811599|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
105811600|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
105811601|NCT04700449|364966557|FG000|Stage 2 Sub-study 2|Other|0|||
105811602|NCT04700449|364966558|FG001|Stage 2 Sub-study 2|Other|0|||
105811603|NCT04700449|364966559|FG002|Stage 2 Sub-study 2|Other|0|||
105811604|NCT04700449|364966560|FG003|Stage 2 Sub-study 2|Other|5|||
105811605|NCT00502775|364966561|FG000|Overall Study|Adverse Event|1|||
105811606|NCT00502775|364966562|FG001|Overall Study|Adverse Event|2|||
105811607|NCT00502775|364966563|FG002|Overall Study|Adverse Event|1|||
105811608|NCT00502775|364966561|FG000|Overall Study|Protocol Violation|1|||
105811609|NCT00502775|364966562|FG001|Overall Study|Protocol Violation|5|||
105811610|NCT00502775|364966563|FG002|Overall Study|Protocol Violation|2|||
105811611|NCT00502775|364966561|FG000|Overall Study|Withdrawal by Subject|1|||
105811612|NCT00502775|364966562|FG001|Overall Study|Withdrawal by Subject|1|||
105811613|NCT00502775|364966563|FG002|Overall Study|Withdrawal by Subject|2|||
105811614|NCT00502775|364966561|FG000|Overall Study|Sponsor Terminated Study|1|||
105811615|NCT00502775|364966562|FG001|Overall Study|Sponsor Terminated Study|0|||
105811616|NCT00502775|364966563|FG002|Overall Study|Sponsor Terminated Study|1|||
105811617|NCT00502775|364966561|FG000|Overall Study|Non-compliance with eDiary|4|||
105811618|NCT00502775|364966562|FG001|Overall Study|Non-compliance with eDiary|1|||
105811619|NCT00502775|364966563|FG002|Overall Study|Non-compliance with eDiary|1|||
105811620|NCT00502775|364966561|FG000|Overall Study|Subject unable to swallow capsule|1|||
105811621|NCT00502775|364966562|FG001|Overall Study|Subject unable to swallow capsule|0|||
105811622|NCT00502775|364966563|FG002|Overall Study|Subject unable to swallow capsule|1|||
105811623|NCT00502775|364966561|FG000|Overall Study|Logpad compliance <80%|1|||
105811624|NCT00502775|364966562|FG001|Overall Study|Logpad compliance <80%|0|||
105811625|NCT00502775|364966563|FG002|Overall Study|Logpad compliance <80%|0|||
105811626|NCT00502775|364966561|FG000|Overall Study|Randomized in error|0|||
105811627|NCT00502775|364966562|FG001|Overall Study|Randomized in error|1|||
106145038|NCT05061693|366190779|FG005|24-week Extension Period|Withdrawal by Subject|0|||
106145039|NCT05061693|366190780|FG006|24-week Extension Period|Withdrawal by Subject|0|||
105811628|NCT00502775|364966563|FG002|Overall Study|Randomized in error|1|||
105811629|NCT00502775|364966561|FG000|Overall Study|Non-compliance|0|||
105811630|NCT00502775|364966562|FG001|Overall Study|Non-compliance|2|||
105811631|NCT00502775|364966563|FG002|Overall Study|Non-compliance|2|||
105811632|NCT00502775|364966561|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
105811633|NCT00502775|364966562|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
105811634|NCT00502775|364966563|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
105954175|NCT02820844|365495101|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
105954176|NCT02820844|365495102|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
105954177|NCT01791517|365495113|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
105954178|NCT01791517|365495114|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
105954179|NCT01791517|365495115|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
105954180|NCT01791517|365495116|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
105954181|NCT01791517|365495117|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
105954182|NCT01791517|365495118|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
105954183|NCT01791517|365495119|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
105954184|NCT01791517|365495120|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
105954185|NCT01791517|365495121|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
105954186|NCT01791517|365495122|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
105811635|NCT00502775|364966561|FG000|Overall Study|Declining pollen counts|0|||
105811636|NCT00502775|364966562|FG001|Overall Study|Declining pollen counts|1|||
105811637|NCT00502775|364966563|FG002|Overall Study|Declining pollen counts|1|||
105954187|NCT01791517|365495123|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
106145040|NCT05061693|366190781|FG007|24-week Extension Period|Withdrawal by Subject|0|||
105954188|NCT01791517|365495124|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
105954189|NCT01791517|365495113|FG000|Phase I: Period 1|Adverse Event|0|||
105954190|NCT01791517|365495114|FG001|Phase I: Period 1|Adverse Event|0|||
106145041|NCT05061693|366190782|FG008|24-week Extension Period|Withdrawal by Subject|1|||
105811638|NCT00502775|364966561|FG000|Overall Study|Subject in jail|0|||
105811639|NCT00502775|364966562|FG001|Overall Study|Subject in jail|1|||
106145042|NCT05061693|366190783|FG009|24-week Extension Period|Withdrawal by Subject|2|||
105811640|NCT00502775|364966563|FG002|Overall Study|Subject in jail|0|||
105811641|NCT00502775|364966561|FG000|Overall Study|Subject took disallowed drug|0|||
105811642|NCT00502775|364966562|FG001|Overall Study|Subject took disallowed drug|0|||
105811643|NCT00502775|364966563|FG002|Overall Study|Subject took disallowed drug|1|||
105811644|NCT01521559|364966564|FG000|Overall Study|Adverse Event|0|||
105811645|NCT01521559|364966565|FG001|Overall Study|Adverse Event|4|||
105811646|NCT01521559|364966564|FG000|Overall Study|Death|1|||
105811647|NCT01521559|364966565|FG001|Overall Study|Death|0|||
105811648|NCT01521559|364966564|FG000|Overall Study|Withdrawal by Subject|9|||
105811649|NCT01521559|364966565|FG001|Overall Study|Withdrawal by Subject|11|||
105811650|NCT01521559|364966564|FG000|Overall Study|Lost to Follow-up|3|||
105811651|NCT01521559|364966565|FG001|Overall Study|Lost to Follow-up|1|||
105811652|NCT01521559|364966564|FG000|Overall Study|Protocol Violation|1|||
105811653|NCT01521559|364966565|FG001|Overall Study|Protocol Violation|0|||
105811654|NCT01521559|364966564|FG000|Overall Study|Other|1|||
105811655|NCT01521559|364966565|FG001|Overall Study|Other|2|||
105811656|NCT00520741|364966568|FG000|Overall Study|Adverse Event|16|||
105811657|NCT00520741|364966569|FG001|Overall Study|Adverse Event|56|||
105811658|NCT00520741|364966568|FG000|Overall Study|Lack of Efficacy|11|||
105811659|NCT00520741|364966569|FG001|Overall Study|Lack of Efficacy|30|||
105811660|NCT00520741|364966568|FG000|Overall Study|Withdrawal by Subject|0|||
105811661|NCT00520741|364966569|FG001|Overall Study|Withdrawal by Subject|11|||
105811662|NCT00520741|364966568|FG000|Overall Study|Protocol Violation|2|||
105811663|NCT00520741|364966569|FG001|Overall Study|Protocol Violation|15|||
106017812|NCT02978781|365729188|FG002|Part A|Adverse Event|0|||
106017813|NCT02978781|365729189|FG003|Part A|Adverse Event|0|||
106017814|NCT02978781|365729190|FG004|Part A|Adverse Event|0|||
106017815|NCT02978781|365729186|FG000|Part A|Withdrawal by Subject|0|||
106017816|NCT02978781|365729187|FG001|Part A|Withdrawal by Subject|1|||
106017817|NCT02978781|365729188|FG002|Part A|Withdrawal by Subject|0|||
106017818|NCT02978781|365729189|FG003|Part A|Withdrawal by Subject|0|||
106017819|NCT02978781|365729190|FG004|Part A|Withdrawal by Subject|0|||
106017820|NCT02978781|365729186|FG000|Part B|Withdrawal by Subject|0|||
106017821|NCT02978781|365729187|FG001|Part B|Withdrawal by Subject|0|||
106017822|NCT02978781|365729188|FG002|Part B|Withdrawal by Subject|0|||
106017823|NCT02978781|365729189|FG003|Part B|Withdrawal by Subject|1|||
106017824|NCT02978781|365729190|FG004|Part B|Withdrawal by Subject|0|||
106017825|NCT02978781|365729186|FG000|Part C|Adverse Event|0|||
106017826|NCT02978781|365729187|FG001|Part C|Adverse Event|0|||
106017827|NCT02978781|365729188|FG002|Part C|Adverse Event|0|||
106017828|NCT02978781|365729189|FG003|Part C|Adverse Event|0|||
106017829|NCT02978781|365729190|FG004|Part C|Adverse Event|2|||
106017830|NCT02978781|365729186|FG000|Part C|Withdrawal by Subject|0|||
106017831|NCT02978781|365729187|FG001|Part C|Withdrawal by Subject|0|||
106017832|NCT02978781|365729188|FG002|Part C|Withdrawal by Subject|0|||
106017833|NCT02978781|365729189|FG003|Part C|Withdrawal by Subject|0|||
106017834|NCT02978781|365729190|FG004|Part C|Withdrawal by Subject|1|||
106017835|NCT02978781|365729186|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
106017836|NCT02978781|365729187|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
106017837|NCT02978781|365729188|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
106017838|NCT02978781|365729189|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
106017839|NCT02978781|365729190|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
106017840|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
106017841|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
106017842|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Adverse Event|31|||
105811664|NCT00520741|364966568|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
105811665|NCT00520741|364966569|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
105811666|NCT00520741|364966568|FG000|Overall Study|Lost to Follow-up|4|||
105811667|NCT00520741|364966569|FG001|Overall Study|Lost to Follow-up|4|||
105811668|NCT00520741|364966568|FG000|Overall Study|Other reasons for premature termination|0|||
106017843|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Adverse Event|21|||
106017844|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
106017845|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
106017846|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
106145043|NCT05061693|366190784|FG010|24-week Extension Period|Withdrawal by Subject|2|||
106145044|NCT05061693|366190785|FG011|24-week Extension Period|Withdrawal by Subject|1|||
105811669|NCT00520741|364966569|FG001|Overall Study|Other reasons for premature termination|6|||
105811670|NCT03103100|364966570|FG000|Overall Study|Adverse Event|1|||
105811671|NCT03103100|364966571|FG001|Overall Study|Adverse Event|0|||
105811672|NCT03103100|364966572|FG002|Overall Study|Adverse Event|0|||
106017847|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
106017848|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
106017849|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
106017850|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
106017851|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
106017852|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Administrative problems|3|||
105811673|NCT03103100|364966570|FG000|Overall Study|Physician Decision|1|||
105811674|NCT03103100|364966571|FG001|Overall Study|Physician Decision|0|||
105811675|NCT03103100|364966572|FG002|Overall Study|Physician Decision|2|||
105811676|NCT00531206|364966573|FG000|Overall Study|Adverse Event related|5|||
105811677|NCT00531206|364966573|FG000|Overall Study|Lack of Efficacy|2|||
105811678|NCT00531206|364966573|FG000|Overall Study|Lost to Follow-up|5|||
105954191|NCT01791517|365495115|FG002|Phase I: Period 1|Adverse Event|1|||
105954192|NCT01791517|365495116|FG003|Phase I: Period 1|Adverse Event|1|||
105954193|NCT01791517|365495117|FG004|Phase I: Period 1|Adverse Event|0|||
105954194|NCT01791517|365495118|FG005|Phase I: Period 1|Adverse Event|0|||
105954195|NCT01791517|365495119|FG006|Phase I: Period 1|Adverse Event|0|||
105954196|NCT01791517|365495120|FG007|Phase I: Period 1|Adverse Event|0|||
105954197|NCT01791517|365495121|FG008|Phase I: Period 1|Adverse Event|0|||
105954198|NCT01791517|365495122|FG009|Phase I: Period 1|Adverse Event|0|||
105954199|NCT01791517|365495123|FG010|Phase I: Period 1|Adverse Event|0|||
105954200|NCT01791517|365495124|FG011|Phase I: Period 1|Adverse Event|0|||
105954201|NCT01791517|365495113|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
105954202|NCT01791517|365495114|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954203|NCT01791517|365495115|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954204|NCT01791517|365495116|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954205|NCT01791517|365495117|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954206|NCT01791517|365495118|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954207|NCT01791517|365495119|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954208|NCT01791517|365495120|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954209|NCT01791517|365495121|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954210|NCT01791517|365495122|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954211|NCT01791517|365495123|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954212|NCT01791517|365495124|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
105954213|NCT01791517|365495113|FG000|Phase I: Period 1|Protocol Violation|0|||
105954214|NCT01791517|365495114|FG001|Phase I: Period 1|Protocol Violation|1|||
105954215|NCT01791517|365495115|FG002|Phase I: Period 1|Protocol Violation|0|||
105811679|NCT00531206|364966573|FG000|Overall Study|including non-related adverse events|8|||
105811680|NCT02227862|364966574|FG000|Overall Study|Protocol Violation|7|||
105811681|NCT02227862|364966575|FG001|Overall Study|Protocol Violation|9|||
105811682|NCT02227862|364966574|FG000|Overall Study|Other|0|||
105811683|NCT02227862|364966575|FG001|Overall Study|Other|2|||
105811684|NCT02227862|364966574|FG000|Overall Study|Adverse Event|4|||
105811685|NCT02227862|364966575|FG001|Overall Study|Adverse Event|3|||
105811686|NCT02227862|364966574|FG000|Overall Study|Withdrawal by Subject|7|||
105811687|NCT02227862|364966575|FG001|Overall Study|Withdrawal by Subject|6|||
105811688|NCT02227862|364966574|FG000|Overall Study|Lost to Follow-up|1|||
105811689|NCT02227862|364966575|FG001|Overall Study|Lost to Follow-up|2|||
105811690|NCT01124149|364966576|FG000|Acute Phase|Withdrawal by Subject|22|||
105811691|NCT01124149|364966576|FG000|Acute Phase|Adverse Event|21|||
105811692|NCT01124149|364966576|FG000|Acute Phase|Lack of Efficacy|17|||
105811693|NCT01124149|364966576|FG000|Acute Phase|Protocol Violation|14|||
105811694|NCT01124149|364966576|FG000|Acute Phase|Lost to Follow-up|2|||
105811695|NCT01124149|364966576|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
105811696|NCT01124149|364966576|FG000|Acute Phase|Sponsor request|1|||
105811697|NCT01124149|364966576|FG000|Acute Phase|UC symptoms not ameliorated|1|||
105811698|NCT01124149|364966576|FG000|Acute Phase|Non-compliance|1|||
105811699|NCT01124149|364966576|FG000|Acute Phase|Low hemoglobin|1|||
105811700|NCT01124149|364966576|FG000|Acute Phase|Travelling to another country|1|||
105811701|NCT01124149|364966576|FG000|Acute Phase|Sponsor decision|1|||
105811702|NCT01124149|364966576|FG000|Maintenance Phase|Lack of Efficacy|40|||
105811703|NCT01124149|364966576|FG000|Maintenance Phase|Adverse Event|24|||
105954216|NCT01791517|365495116|FG003|Phase I: Period 1|Protocol Violation|0|||
105954217|NCT01791517|365495117|FG004|Phase I: Period 1|Protocol Violation|0|||
105954218|NCT01791517|365495118|FG005|Phase I: Period 1|Protocol Violation|0|||
105954219|NCT01791517|365495119|FG006|Phase I: Period 1|Protocol Violation|0|||
105954220|NCT01791517|365495120|FG007|Phase I: Period 1|Protocol Violation|0|||
105954221|NCT01791517|365495121|FG008|Phase I: Period 1|Protocol Violation|0|||
105954222|NCT01791517|365495122|FG009|Phase I: Period 1|Protocol Violation|0|||
105954223|NCT01791517|365495123|FG010|Phase I: Period 1|Protocol Violation|0|||
105954224|NCT01791517|365495124|FG011|Phase I: Period 1|Protocol Violation|0|||
105954225|NCT01791517|365495113|FG000|Phase I: Period 1|Lost to Follow-up|0|||
105954226|NCT01791517|365495114|FG001|Phase I: Period 1|Lost to Follow-up|0|||
105811704|NCT01124149|364966576|FG000|Maintenance Phase|Lost to Follow-up|15|||
105811705|NCT01124149|364966576|FG000|Maintenance Phase|Withdrawal by Subject|10|||
105811706|NCT01124149|364966576|FG000|Maintenance Phase|Protocol Violation|5|||
105811707|NCT01124149|364966576|FG000|Maintenance Phase|Coordinator error|1|||
105811708|NCT01124149|364966576|FG000|Maintenance Phase|Non-compliance|1|||
105811709|NCT01644500|364966579|FG000|Overall Study|Adverse Event|6|||
105811710|NCT01644500|364966580|FG001|Overall Study|Adverse Event|1|||
105811711|NCT01644500|364966581|FG002|Overall Study|Adverse Event|2|||
105954227|NCT01791517|365495115|FG002|Phase I: Period 1|Lost to Follow-up|0|||
106145045|NCT05061693|366190774|FG000|24-week Extension Period|Sponsor Decision|0|||
106017853|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Administrative problems|3|||
106017854|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Death|5|||
106017855|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Death|8|||
106017856|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Disease progression|139|||
106017857|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Disease progression|119|||
106017858|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
106017859|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
105811712|NCT01644500|364966579|FG000|Overall Study|Death|0|||
105811713|NCT01644500|364966580|FG001|Overall Study|Death|1|||
105811714|NCT01644500|364966581|FG002|Overall Study|Death|0|||
105811715|NCT01644500|364966579|FG000|Overall Study|Lost to Follow-up|3|||
105811716|NCT01644500|364966580|FG001|Overall Study|Lost to Follow-up|8|||
105811717|NCT01644500|364966581|FG002|Overall Study|Lost to Follow-up|0|||
105811718|NCT01644500|364966579|FG000|Overall Study|Protocol Violation|1|||
105811719|NCT01644500|364966580|FG001|Overall Study|Protocol Violation|1|||
105811720|NCT01644500|364966581|FG002|Overall Study|Protocol Violation|0|||
105811721|NCT01644500|364966579|FG000|Overall Study|Withdrawal by Subject|11|||
105811722|NCT01644500|364966580|FG001|Overall Study|Withdrawal by Subject|12|||
105811723|NCT01644500|364966581|FG002|Overall Study|Withdrawal by Subject|12|||
105811724|NCT01644500|364966579|FG000|Overall Study|Physician Decision|1|||
105811725|NCT01644500|364966580|FG001|Overall Study|Physician Decision|1|||
105811726|NCT01644500|364966581|FG002|Overall Study|Physician Decision|1|||
105811727|NCT00634907|364966582|FG000|Overall Study|Withdrawal by Subject|3|||
105811728|NCT00634907|364966583|FG001|Overall Study|Withdrawal by Subject|0|||
105811729|NCT00634907|364966582|FG000|Overall Study|Physician Decision|3|||
105811730|NCT00634907|364966583|FG001|Overall Study|Physician Decision|9|||
105811731|NCT00634907|364966582|FG000|Overall Study|Withdrawal by Subject|11|||
105811732|NCT00634907|364966583|FG001|Overall Study|Withdrawal by Subject|8|||
105811733|NCT00810368|364966588|FG000|Overall Study|Lost to Follow-up|4|||
105811734|NCT00810368|364966589|FG001|Overall Study|Lost to Follow-up|2|||
105811735|NCT00810368|364966588|FG000|Overall Study|Lack of Efficacy|2|||
105811736|NCT00810368|364966589|FG001|Overall Study|Lack of Efficacy|0|||
105811737|NCT00322491|364966592|FG000|Overall Study|Adverse Event|1|||
105811738|NCT00322491|364966593|FG001|Overall Study|Adverse Event|0|||
105811739|NCT00322491|364966592|FG000|Overall Study|Death|1|||
105811740|NCT00322491|364966593|FG001|Overall Study|Death|2|||
105811741|NCT00001849|364966595|FG000|Overall Study|Death|4|||
105811742|NCT00001849|364966595|FG000|Overall Study|Lost to Follow-up|2|||
105811743|NCT00001849|364966595|FG000|Overall Study|Withdrawal by Subject|2|||
105811744|NCT00001849|364966595|FG000|Overall Study|tumor remained occult|6|||
105811745|NCT02166697|364966597|FG000|Overall Study|Protocol Violation|347|||
105811746|NCT01618266|364966601|FG000|Overall Study|Lost to Follow-up|9|||
105811747|NCT01618266|364966601|FG000|Overall Study|Treatment satisfaction|10|||
105811748|NCT01618266|364966601|FG000|Overall Study|Other reasons|11|||
105811749|NCT01618266|364966601|FG000|Overall Study|Lack of Efficacy|23|||
105811750|NCT01618266|364966601|FG000|Overall Study|Protocol Violation|43|||
105811751|NCT02752776|364966604|FG000|Overall Study|Adverse Event|15|||
105811752|NCT02752776|364966605|FG001|Overall Study|Adverse Event|23|||
105811753|NCT02752776|364966606|FG002|Overall Study|Adverse Event|11|||
105811754|NCT02752776|364966604|FG000|Overall Study|Lack of Efficacy|2|||
105811755|NCT02752776|364966605|FG001|Overall Study|Lack of Efficacy|6|||
105811756|NCT02752776|364966606|FG002|Overall Study|Lack of Efficacy|14|||
105811757|NCT02752776|364966604|FG000|Overall Study|Lost to Follow-up|11|||
105811758|NCT02752776|364966605|FG001|Overall Study|Lost to Follow-up|12|||
105811759|NCT02752776|364966606|FG002|Overall Study|Lost to Follow-up|4|||
105811760|NCT02752776|364966604|FG000|Overall Study|Non-compliance with study treatment|0|||
105811761|NCT02752776|364966605|FG001|Overall Study|Non-compliance with study treatment|0|||
105811762|NCT02752776|364966606|FG002|Overall Study|Non-compliance with study treatment|1|||
105811763|NCT02752776|364966604|FG000|Overall Study|Physician Decision|2|||
105811764|NCT02752776|364966605|FG001|Overall Study|Physician Decision|6|||
105811765|NCT02752776|364966606|FG002|Overall Study|Physician Decision|2|||
105811766|NCT02752776|364966604|FG000|Overall Study|Pregnancy|1|||
105811767|NCT02752776|364966605|FG001|Overall Study|Pregnancy|6|||
105811768|NCT02752776|364966606|FG002|Overall Study|Pregnancy|3|||
105811769|NCT02752776|364966604|FG000|Overall Study|Protocol Violation|10|||
105811770|NCT02752776|364966605|FG001|Overall Study|Protocol Violation|13|||
105811771|NCT02752776|364966606|FG002|Overall Study|Protocol Violation|6|||
105811772|NCT02752776|364966604|FG000|Overall Study|Subject/guardian decision|8|||
105811773|NCT02752776|364966605|FG001|Overall Study|Subject/guardian decision|6|||
105811774|NCT02752776|364966606|FG002|Overall Study|Subject/guardian decision|4|||
105811775|NCT02752776|364966604|FG000|Overall Study|Death|0|||
105811776|NCT02752776|364966605|FG001|Overall Study|Death|0|||
105811777|NCT02752776|364966606|FG002|Overall Study|Death|1|||
105811778|NCT02752776|364966604|FG000|Overall Study|Withdrawal by Subject|3|||
105811779|NCT02752776|364966605|FG001|Overall Study|Withdrawal by Subject|4|||
105811780|NCT02752776|364966606|FG002|Overall Study|Withdrawal by Subject|2|||
105811781|NCT02492958|364966607|FG000|Overall Study|Withdrawal by Subject|0|||
106145046|NCT05061693|366190775|FG001|24-week Extension Period|Sponsor Decision|0|||
106145047|NCT05061693|366190776|FG002|24-week Extension Period|Sponsor Decision|0|||
106145048|NCT05061693|366190777|FG003|24-week Extension Period|Sponsor Decision|0|||
106145049|NCT05061693|366190778|FG004|24-week Extension Period|Sponsor Decision|0|||
106145050|NCT05061693|366190779|FG005|24-week Extension Period|Sponsor Decision|0|||
106145051|NCT05061693|366190780|FG006|24-week Extension Period|Sponsor Decision|0|||
106145052|NCT05061693|366190781|FG007|24-week Extension Period|Sponsor Decision|1|||
106145053|NCT05061693|366190782|FG008|24-week Extension Period|Sponsor Decision|0|||
106145054|NCT05061693|366190783|FG009|24-week Extension Period|Sponsor Decision|0|||
106145055|NCT05061693|366190784|FG010|24-week Extension Period|Sponsor Decision|0|||
106145056|NCT05061693|366190785|FG011|24-week Extension Period|Sponsor Decision|0|||
106145057|NCT05061693|366190774|FG000|24-week Extension Period|Site Closure|0|||
106145058|NCT05061693|366190775|FG001|24-week Extension Period|Site Closure|0|||
106145059|NCT05061693|366190776|FG002|24-week Extension Period|Site Closure|0|||
106145060|NCT05061693|366190777|FG003|24-week Extension Period|Site Closure|0|||
106145061|NCT05061693|366190778|FG004|24-week Extension Period|Site Closure|0|||
106145062|NCT05061693|366190779|FG005|24-week Extension Period|Site Closure|0|||
106145063|NCT05061693|366190780|FG006|24-week Extension Period|Site Closure|0|||
106145064|NCT05061693|366190781|FG007|24-week Extension Period|Site Closure|0|||
106145065|NCT05061693|366190782|FG008|24-week Extension Period|Site Closure|1|||
106145066|NCT05061693|366190783|FG009|24-week Extension Period|Site Closure|0|||
105811782|NCT02492958|364966608|FG001|Overall Study|Withdrawal by Subject|0|||
105811783|NCT02492958|364966609|FG002|Overall Study|Withdrawal by Subject|1|||
105811784|NCT02492958|364966610|FG003|Overall Study|Withdrawal by Subject|0|||
105811785|NCT02492958|364966607|FG000|Overall Study|Adverse Event|1|||
105811786|NCT02492958|364966608|FG001|Overall Study|Adverse Event|0|||
105811787|NCT02492958|364966609|FG002|Overall Study|Adverse Event|1|||
105954228|NCT01791517|365495116|FG003|Phase I: Period 1|Lost to Follow-up|1|||
106145067|NCT05061693|366190784|FG010|24-week Extension Period|Site Closure|0|||
106145068|NCT05061693|366190785|FG011|24-week Extension Period|Site Closure|1|||
106145069|NCT00658996|366190801|FG000|First Intervention|Positive slit lamp finding|1|||
106145070|NCT00658996|366190802|FG001|First Intervention|Positive slit lamp finding|0|||
106145071|NCT00658996|366190801|FG000|First Intervention|Lack of lenses|0|||
105954229|NCT01791517|365495117|FG004|Phase I: Period 1|Lost to Follow-up|0|||
105954230|NCT01791517|365495118|FG005|Phase I: Period 1|Lost to Follow-up|0|||
105954231|NCT01791517|365495119|FG006|Phase I: Period 1|Lost to Follow-up|1|||
105954232|NCT01791517|365495120|FG007|Phase I: Period 1|Lost to Follow-up|0|||
105954233|NCT01791517|365495121|FG008|Phase I: Period 1|Lost to Follow-up|1|||
105954234|NCT01791517|365495122|FG009|Phase I: Period 1|Lost to Follow-up|1|||
105954235|NCT01791517|365495123|FG010|Phase I: Period 1|Lost to Follow-up|0|||
105954236|NCT01791517|365495124|FG011|Phase I: Period 1|Lost to Follow-up|0|||
105954237|NCT01791517|365495113|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954238|NCT01791517|365495114|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954239|NCT01791517|365495115|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954240|NCT01791517|365495116|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954241|NCT01791517|365495117|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954242|NCT01791517|365495118|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954243|NCT01791517|365495119|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954244|NCT01791517|365495120|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954245|NCT01791517|365495121|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954246|NCT01791517|365495122|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954247|NCT01791517|365495123|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
105954248|NCT01791517|365495124|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
105954249|NCT01791517|365495113|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
105954250|NCT01791517|365495114|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954251|NCT01791517|365495115|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954252|NCT01791517|365495116|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954253|NCT01791517|365495117|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954254|NCT01791517|365495118|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954255|NCT01791517|365495119|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954256|NCT01791517|365495120|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
106017860|NCT00785785|365729191|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
106017861|NCT00785785|365729192|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
105954257|NCT01791517|365495121|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
106017862|NCT00785785|365729191|FG000|Optional Extension Phase|Adverse Event|4|||
106017863|NCT00785785|365729192|FG001|Optional Extension Phase|Adverse Event|5|||
106145072|NCT00658996|366190802|FG001|First Intervention|Lack of lenses|1|||
106145073|NCT00658996|366190801|FG000|Crossover Period|Physician Decision|1|||
106145074|NCT00658996|366190802|FG001|Crossover Period|Physician Decision|0|||
105811788|NCT02492958|364966610|FG003|Overall Study|Adverse Event|0|||
105811789|NCT01901055|364966611|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
106145075|NCT00658996|366190801|FG000|Crossover Period|Ineligible|1|||
106145076|NCT00658996|366190802|FG001|Crossover Period|Ineligible|1|||
105811790|NCT01901055|364966612|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
105811791|NCT01901055|364966611|FG000|Randomization But Not Titrated|Physician Decision|0|||
105811792|NCT01901055|364966612|FG001|Randomization But Not Titrated|Physician Decision|1|||
105811793|NCT01901055|364966611|FG000|Started Protocol to Week 6|Physician Decision|2|||
105811794|NCT01901055|364966612|FG001|Started Protocol to Week 6|Physician Decision|1|||
105811795|NCT01901055|364966611|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
105811796|NCT01901055|364966612|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
105811797|NCT01901055|364966611|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
105811798|NCT01901055|364966612|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
105811799|NCT01901055|364966611|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
105811800|NCT01901055|364966612|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
105811801|NCT01901055|364966611|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
105811802|NCT01901055|364966612|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
105811803|NCT01901055|364966611|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
105811804|NCT01901055|364966612|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
105811805|NCT01901055|364966611|FG000|Week 24|Withdrawal by Subject|13|||
105811806|NCT01901055|364966612|FG001|Week 24|Withdrawal by Subject|19|||
105811807|NCT01901055|364966611|FG000|Week 24|Physician Decision|1|||
105811808|NCT01901055|364966612|FG001|Week 24|Physician Decision|0|||
105811809|NCT01901055|364966611|FG000|Week 36|Withdrawal by Subject|0|||
105811810|NCT01901055|364966612|FG001|Week 36|Withdrawal by Subject|5|||
105811811|NCT00635154|364966613|FG000|Overall Study|Alternative Treatment|8|||
105811812|NCT00635154|364966613|FG000|Overall Study|Other|4|||
105811813|NCT00635154|364966613|FG000|Overall Study|Still on treatment|21|||
105811814|NCT02540356|364966614|FG000|Overall Study|Terminated due to disease progression|1|||
105811815|NCT02540356|364966615|FG001|Overall Study|Terminated due to disease progression|0|||
105811816|NCT02795104|364966616|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
105954258|NCT01791517|365495122|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954259|NCT01791517|365495123|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954260|NCT01791517|365495124|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
105954261|NCT01791517|365495113|FG000|Phase I: Period 2|Protocol Violation|0|||
105954262|NCT01791517|365495114|FG001|Phase I: Period 2|Protocol Violation|0|||
105954263|NCT01791517|365495115|FG002|Phase I: Period 2|Protocol Violation|0|||
105954264|NCT01791517|365495116|FG003|Phase I: Period 2|Protocol Violation|1|||
105954265|NCT01791517|365495117|FG004|Phase I: Period 2|Protocol Violation|0|||
105954266|NCT01791517|365495118|FG005|Phase I: Period 2|Protocol Violation|0|||
105954267|NCT01791517|365495119|FG006|Phase I: Period 2|Protocol Violation|0|||
105954268|NCT01791517|365495120|FG007|Phase I: Period 2|Protocol Violation|0|||
105954269|NCT01791517|365495121|FG008|Phase I: Period 2|Protocol Violation|0|||
105954270|NCT01791517|365495122|FG009|Phase I: Period 2|Protocol Violation|0|||
105954271|NCT01791517|365495123|FG010|Phase I: Period 2|Protocol Violation|0|||
105954272|NCT01791517|365495124|FG011|Phase I: Period 2|Protocol Violation|0|||
105954273|NCT01791517|365495113|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
105954274|NCT01791517|365495114|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
105954275|NCT01791517|365495115|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
105954276|NCT01791517|365495116|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
105954277|NCT01791517|365495117|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
105954278|NCT01791517|365495118|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
105954279|NCT01791517|365495119|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
105954280|NCT01791517|365495120|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
105954281|NCT01791517|365495121|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
105954282|NCT01791517|365495122|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
105954283|NCT01791517|365495123|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
105954284|NCT01791517|365495124|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
105954285|NCT01791517|365495113|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954286|NCT01791517|365495114|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954287|NCT01791517|365495115|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954288|NCT01791517|365495116|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954289|NCT01791517|365495117|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954290|NCT01791517|365495118|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954291|NCT01791517|365495119|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954292|NCT01791517|365495120|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954293|NCT01791517|365495121|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
106145077|NCT00658996|366190801|FG000|Second Intervention|Developed a stye on upper lid|1|||
106145078|NCT00658996|366190802|FG001|Second Intervention|Developed a stye on upper lid|0|||
105811817|NCT02795104|364966617|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
105811818|NCT02795104|364966618|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
105811819|NCT02795104|364966616|FG000|Overall Study|Withdrawal by Subject|0|||
105954294|NCT01791517|365495122|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105954295|NCT01791517|365495123|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
105954296|NCT01791517|365495124|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
105811820|NCT02795104|364966617|FG001|Overall Study|Withdrawal by Subject|2|||
105811821|NCT02795104|364966618|FG002|Overall Study|Withdrawal by Subject|0|||
105811822|NCT02795104|364966616|FG000|Overall Study|Lost to Follow-up|0|||
105811823|NCT02795104|364966617|FG001|Overall Study|Lost to Follow-up|0|||
105811824|NCT02795104|364966618|FG002|Overall Study|Lost to Follow-up|1|||
105811825|NCT02674334|364966619|FG000|Overall Study|Lost to Follow-up|5|||
105811826|NCT02674334|364966620|FG001|Overall Study|Lost to Follow-up|3|||
105811827|NCT02674334|364966619|FG000|Overall Study|participant difficulty breathing|1|||
105811828|NCT02674334|364966620|FG001|Overall Study|participant difficulty breathing|0|||
105811829|NCT02674334|364966619|FG000|Overall Study|NIRS not recording|1|||
105811830|NCT02674334|364966620|FG001|Overall Study|NIRS not recording|0|||
105811831|NCT00386009|364966624|FG000|Overall Study|Adverse Event|0|||
105811832|NCT00386009|364966625|FG001|Overall Study|Adverse Event|2|||
105811833|NCT00386009|364966624|FG000|Overall Study|Death|1|||
105954297|NCT01791517|365495113|FG000|Phase I: Period 2|Lens Discomfort|0|||
105954298|NCT01791517|365495114|FG001|Phase I: Period 2|Lens Discomfort|0|||
105954299|NCT01791517|365495115|FG002|Phase I: Period 2|Lens Discomfort|0|||
105954300|NCT01791517|365495116|FG003|Phase I: Period 2|Lens Discomfort|0|||
105954301|NCT01791517|365495117|FG004|Phase I: Period 2|Lens Discomfort|0|||
105954302|NCT01791517|365495118|FG005|Phase I: Period 2|Lens Discomfort|1|||
105954303|NCT01791517|365495119|FG006|Phase I: Period 2|Lens Discomfort|0|||
105954304|NCT01791517|365495120|FG007|Phase I: Period 2|Lens Discomfort|0|||
105954305|NCT01791517|365495121|FG008|Phase I: Period 2|Lens Discomfort|0|||
105954306|NCT01791517|365495122|FG009|Phase I: Period 2|Lens Discomfort|0|||
105954307|NCT01791517|365495123|FG010|Phase I: Period 2|Lens Discomfort|0|||
105954308|NCT01791517|365495124|FG011|Phase I: Period 2|Lens Discomfort|0|||
105954309|NCT01791517|365495113|FG000|Phase I: Period 2|Lost to Follow-up|0|||
105954310|NCT01791517|365495114|FG001|Phase I: Period 2|Lost to Follow-up|3|||
105954311|NCT01791517|365495115|FG002|Phase I: Period 2|Lost to Follow-up|2|||
105954312|NCT01791517|365495116|FG003|Phase I: Period 2|Lost to Follow-up|0|||
105954313|NCT01791517|365495117|FG004|Phase I: Period 2|Lost to Follow-up|0|||
105954314|NCT01791517|365495118|FG005|Phase I: Period 2|Lost to Follow-up|0|||
105954315|NCT01791517|365495119|FG006|Phase I: Period 2|Lost to Follow-up|0|||
105954316|NCT01791517|365495120|FG007|Phase I: Period 2|Lost to Follow-up|0|||
105954317|NCT01791517|365495121|FG008|Phase I: Period 2|Lost to Follow-up|0|||
105954318|NCT01791517|365495122|FG009|Phase I: Period 2|Lost to Follow-up|0|||
105954319|NCT01791517|365495123|FG010|Phase I: Period 2|Lost to Follow-up|0|||
105954320|NCT01791517|365495124|FG011|Phase I: Period 2|Lost to Follow-up|0|||
105954321|NCT01791517|365495113|FG000|Phase I: Period 3|Lens Discomfort|0|||
105954322|NCT01791517|365495114|FG001|Phase I: Period 3|Lens Discomfort|0|||
105954323|NCT01791517|365495115|FG002|Phase I: Period 3|Lens Discomfort|0|||
105954324|NCT01791517|365495116|FG003|Phase I: Period 3|Lens Discomfort|0|||
105954325|NCT01791517|365495117|FG004|Phase I: Period 3|Lens Discomfort|0|||
105954326|NCT01791517|365495118|FG005|Phase I: Period 3|Lens Discomfort|0|||
105954327|NCT01791517|365495119|FG006|Phase I: Period 3|Lens Discomfort|0|||
105954328|NCT01791517|365495120|FG007|Phase I: Period 3|Lens Discomfort|0|||
105954329|NCT01791517|365495121|FG008|Phase I: Period 3|Lens Discomfort|0|||
105954330|NCT01791517|365495122|FG009|Phase I: Period 3|Lens Discomfort|0|||
105954331|NCT01791517|365495123|FG010|Phase I: Period 3|Lens Discomfort|0|||
105954332|NCT01791517|365495124|FG011|Phase I: Period 3|Lens Discomfort|1|||
105954333|NCT01791517|365495113|FG000|Phase I: Period 3|Lost to Follow-up|0|||
105954334|NCT01791517|365495114|FG001|Phase I: Period 3|Lost to Follow-up|1|||
105954335|NCT01791517|365495115|FG002|Phase I: Period 3|Lost to Follow-up|0|||
105954336|NCT01791517|365495116|FG003|Phase I: Period 3|Lost to Follow-up|0|||
105954337|NCT01791517|365495117|FG004|Phase I: Period 3|Lost to Follow-up|1|||
105954338|NCT01791517|365495118|FG005|Phase I: Period 3|Lost to Follow-up|0|||
105954339|NCT01791517|365495119|FG006|Phase I: Period 3|Lost to Follow-up|0|||
105954340|NCT01791517|365495120|FG007|Phase I: Period 3|Lost to Follow-up|0|||
105954341|NCT01791517|365495121|FG008|Phase I: Period 3|Lost to Follow-up|0|||
105954342|NCT01791517|365495122|FG009|Phase I: Period 3|Lost to Follow-up|0|||
105954343|NCT01791517|365495123|FG010|Phase I: Period 3|Lost to Follow-up|0|||
105954344|NCT01791517|365495124|FG011|Phase I: Period 3|Lost to Follow-up|0|||
105954345|NCT01791517|365495113|FG000|Phase I: Period 3|Adverse Event|0|||
105954346|NCT01791517|365495114|FG001|Phase I: Period 3|Adverse Event|0|||
105954347|NCT01791517|365495115|FG002|Phase I: Period 3|Adverse Event|0|||
105954348|NCT01791517|365495116|FG003|Phase I: Period 3|Adverse Event|1|||
105811834|NCT00386009|364966625|FG001|Overall Study|Death|0|||
105954349|NCT01791517|365495117|FG004|Phase I: Period 3|Adverse Event|0|||
105954350|NCT01791517|365495118|FG005|Phase I: Period 3|Adverse Event|0|||
105954351|NCT01791517|365495119|FG006|Phase I: Period 3|Adverse Event|0|||
105954352|NCT01791517|365495120|FG007|Phase I: Period 3|Adverse Event|0|||
105954353|NCT01791517|365495121|FG008|Phase I: Period 3|Adverse Event|0|||
105954354|NCT01791517|365495122|FG009|Phase I: Period 3|Adverse Event|0|||
105954355|NCT01791517|365495123|FG010|Phase I: Period 3|Adverse Event|0|||
105954356|NCT01791517|365495124|FG011|Phase I: Period 3|Adverse Event|0|||
105954357|NCT01791517|365495113|FG000|Phase II|Lost to Follow-up|1|||
105954358|NCT01791517|365495114|FG001|Phase II|Lost to Follow-up|0|||
105954359|NCT01791517|365495115|FG002|Phase II|Lost to Follow-up|1|||
105954360|NCT01791517|365495116|FG003|Phase II|Lost to Follow-up|0|||
105811835|NCT00386009|364966624|FG000|Overall Study|Entry Criteria Not Met|0|||
105811836|NCT00386009|364966625|FG001|Overall Study|Entry Criteria Not Met|2|||
105811837|NCT00386009|364966624|FG000|Overall Study|Lost to Follow-up|1|||
105811838|NCT00386009|364966625|FG001|Overall Study|Lost to Follow-up|1|||
105811839|NCT00386009|364966624|FG000|Overall Study|Protocol Violation|1|||
105811840|NCT00386009|364966625|FG001|Overall Study|Protocol Violation|0|||
105811841|NCT00386009|364966624|FG000|Overall Study|Sponsor Decision|1|||
105811842|NCT00386009|364966625|FG001|Overall Study|Sponsor Decision|1|||
105811843|NCT00386009|364966624|FG000|Overall Study|Withdrawal by Subject|5|||
105811844|NCT00386009|364966625|FG001|Overall Study|Withdrawal by Subject|4|||
105811845|NCT00429923|364966630|FG000|Overall Study|Adverse Event|0|||
105811846|NCT00429923|364966631|FG001|Overall Study|Adverse Event|2|||
105811847|NCT00429923|364966632|FG002|Overall Study|Adverse Event|3|||
105811848|NCT00429923|364966630|FG000|Overall Study|Lack of Efficacy|4|||
105811849|NCT00429923|364966631|FG001|Overall Study|Lack of Efficacy|1|||
105811850|NCT00429923|364966632|FG002|Overall Study|Lack of Efficacy|33|||
105811851|NCT00429923|364966630|FG000|Overall Study|Lost to Follow-up|0|||
105811852|NCT00429923|364966631|FG001|Overall Study|Lost to Follow-up|0|||
105811853|NCT00429923|364966632|FG002|Overall Study|Lost to Follow-up|2|||
105811854|NCT00429923|364966630|FG000|Overall Study|Withdrew Consent|1|||
105811855|NCT00429923|364966631|FG001|Overall Study|Withdrew Consent|0|||
105811856|NCT00429923|364966632|FG002|Overall Study|Withdrew Consent|1|||
105811857|NCT00429923|364966630|FG000|Overall Study|Early Termination|0|||
105811858|NCT00429923|364966631|FG001|Overall Study|Early Termination|1|||
105811859|NCT00429923|364966632|FG002|Overall Study|Early Termination|0|||
105811860|NCT02545998|364966639|FG000|Overall Study|Lost to Follow-up|12|||
105811861|NCT02545998|364966640|FG001|Overall Study|Lost to Follow-up|3|||
105811862|NCT02545998|364966639|FG000|Overall Study|Withdrawal by Subject|3|||
105811863|NCT02545998|364966640|FG001|Overall Study|Withdrawal by Subject|2|||
105811864|NCT00918567|364966645|FG000|Overall Study|Lack of Efficacy|3|||
105811865|NCT00918567|364966646|FG001|Overall Study|Lack of Efficacy|1|||
106145079|NCT00658996|366190801|FG000|Second Intervention|Positive slit lamp finding|0|||
106145080|NCT00658996|366190802|FG001|Second Intervention|Positive slit lamp finding|1|||
106145081|NCT00794118|366190803|FG000|Overall Study|Lost to Follow-up|16|||
105811866|NCT00918567|364966645|FG000|Overall Study|Withdrawal by Subject|1|||
105811867|NCT00918567|364966646|FG001|Overall Study|Withdrawal by Subject|1|||
105811868|NCT00918567|364966645|FG000|Overall Study|Adverse Event|1|||
105811869|NCT00918567|364966646|FG001|Overall Study|Adverse Event|0|||
105811870|NCT00313703|364968339|FG000|Overall Study|Lost to Follow-up|11|||
105811871|NCT00313703|364968340|FG001|Overall Study|Lost to Follow-up|2|||
105811872|NCT00313703|364968341|FG002|Overall Study|Lost to Follow-up|5|||
105811873|NCT00313703|364968342|FG003|Overall Study|Lost to Follow-up|12|||
105811874|NCT01060670|364968345|FG000|Run In|screen failure|0|||
105811875|NCT01060670|364968346|FG001|Run In|screen failure|238|||
105811876|NCT01929109|364968347|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
105811877|NCT01929109|364968348|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
105811878|NCT01929109|364968349|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
105811879|NCT01929109|364968350|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
105811880|NCT01929109|364968351|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
105811881|NCT02761980|364968352|FG000|Overall Study|Adverse Event|4|||
105811882|NCT02761980|364968353|FG001|Overall Study|Adverse Event|6|||
105811883|NCT02761980|364968354|FG002|Overall Study|Adverse Event|5|||
105811884|NCT02761980|364968355|FG003|Overall Study|Adverse Event|6|||
105811885|NCT02761980|364968352|FG000|Overall Study|Withdrawal by Subject|0|||
105811886|NCT02761980|364968353|FG001|Overall Study|Withdrawal by Subject|1|||
105811887|NCT02761980|364968354|FG002|Overall Study|Withdrawal by Subject|0|||
105811888|NCT02761980|364968355|FG003|Overall Study|Withdrawal by Subject|0|||
105811889|NCT02761980|364968352|FG000|Overall Study|Other|0|||
105811890|NCT02761980|364968353|FG001|Overall Study|Other|0|||
105811891|NCT02761980|364968354|FG002|Overall Study|Other|1|||
105811892|NCT02761980|364968355|FG003|Overall Study|Other|0|||
105811893|NCT01052116|364968358|FG000|Overall Study|Lost to Follow-up|11|||
105811894|NCT01052116|364968359|FG001|Overall Study|Lost to Follow-up|17|||
105811895|NCT01052116|364968358|FG000|Overall Study|Withdrawal by Subject|3|||
105811896|NCT01052116|364968359|FG001|Overall Study|Withdrawal by Subject|6|||
105811897|NCT01052116|364968358|FG000|Overall Study|Spirometry not performed|0|||
105811898|NCT01052116|364968359|FG001|Overall Study|Spirometry not performed|4|||
106145082|NCT00794118|366190803|FG000|Overall Study|Withdrawal by Subject|9|||
106145083|NCT00794118|366190803|FG000|Overall Study|Changed hospital center|2|||
105811899|NCT00101582|364968365|FG000|Overall Study|Ineligibility determined|0|||
105811900|NCT00101582|364968366|FG001|Overall Study|Ineligibility determined|1|||
105811901|NCT00101582|364968365|FG000|Overall Study|Adverse Event|1|||
105811902|NCT00101582|364968366|FG001|Overall Study|Adverse Event|4|||
105811903|NCT00101582|364968365|FG000|Overall Study|Withdrawal by Subject|6|||
105811904|NCT00101582|364968366|FG001|Overall Study|Withdrawal by Subject|4|||
105811905|NCT00101582|364968365|FG000|Overall Study|Physician Decision|1|||
105811906|NCT00101582|364968366|FG001|Overall Study|Physician Decision|0|||
105811907|NCT00101582|364968365|FG000|Overall Study|Death|3|||
105811908|NCT00101582|364968366|FG001|Overall Study|Death|5|||
105811909|NCT00101582|364968365|FG000|Overall Study|Other|0|||
105811910|NCT00101582|364968366|FG001|Overall Study|Other|1|||
105811911|NCT01402908|364968369|FG000|Overall Study|Withdrawal by Subject|30|||
105811912|NCT01402908|364968370|FG001|Overall Study|Withdrawal by Subject|17|||
105811913|NCT01402908|364968369|FG000|Overall Study|Lost to Follow-up|3|||
105811914|NCT01402908|364968370|FG001|Overall Study|Lost to Follow-up|1|||
105811915|NCT01402908|364968369|FG000|Overall Study|Physician Decision|1|||
105811916|NCT01402908|364968370|FG001|Overall Study|Physician Decision|0|||
105811917|NCT01919190|364968371|FG000|Overall Study|Intra-op findings, etc.|3|||
105811918|NCT01919190|364968372|FG001|Overall Study|Intra-op findings, etc.|0|||
105811919|NCT01739790|364968373|FG000|Overall Study|Early Trial Termination|2|||
105811920|NCT01739790|364968374|FG001|Overall Study|Early Trial Termination|4|||
105811921|NCT02146430|364968375|FG000|Overall Study|Protocol Violation|5|||
105811922|NCT02146430|364968376|FG001|Overall Study|Protocol Violation|4|||
105811923|NCT02146430|364968377|FG002|Overall Study|Protocol Violation|8|||
105811924|NCT02146430|364968378|FG003|Overall Study|Protocol Violation|6|||
105811925|NCT02146430|364968375|FG000|Overall Study|Lack of Efficacy|13|||
105811926|NCT02146430|364968376|FG001|Overall Study|Lack of Efficacy|11|||
105811927|NCT02146430|364968377|FG002|Overall Study|Lack of Efficacy|8|||
105811928|NCT02146430|364968378|FG003|Overall Study|Lack of Efficacy|5|||
105811929|NCT02146430|364968375|FG000|Overall Study|Adverse Event|20|||
105811930|NCT02146430|364968376|FG001|Overall Study|Adverse Event|40|||
105811931|NCT02146430|364968377|FG002|Overall Study|Adverse Event|32|||
105811932|NCT02146430|364968378|FG003|Overall Study|Adverse Event|49|||
105811933|NCT02146430|364968375|FG000|Overall Study|Reason missing or not reported|2|||
105811934|NCT02146430|364968376|FG001|Overall Study|Reason missing or not reported|3|||
105811935|NCT02146430|364968377|FG002|Overall Study|Reason missing or not reported|4|||
105811936|NCT02146430|364968378|FG003|Overall Study|Reason missing or not reported|5|||
105811937|NCT02146430|364968375|FG000|Overall Study|Withdrawal by Subject|27|||
105811938|NCT02146430|364968376|FG001|Overall Study|Withdrawal by Subject|29|||
105811939|NCT02146430|364968377|FG002|Overall Study|Withdrawal by Subject|30|||
105811940|NCT02146430|364968378|FG003|Overall Study|Withdrawal by Subject|34|||
105811941|NCT02581345|364968379|FG000|Part 1: up to Week 16|Adverse Event|3|||
105811942|NCT02581345|364968380|FG001|Part 1: up to Week 16|Adverse Event|8|||
105811943|NCT02581345|364968381|FG002|Part 1: up to Week 16|Adverse Event|0|||
105811944|NCT02581345|364968382|FG003|Part 1: up to Week 16|Adverse Event|0|||
105811945|NCT02581345|364968379|FG000|Part 1: up to Week 16|Physician Decision|2|||
105811946|NCT02581345|364968380|FG001|Part 1: up to Week 16|Physician Decision|4|||
105811947|NCT02581345|364968381|FG002|Part 1: up to Week 16|Physician Decision|0|||
105811948|NCT02581345|364968382|FG003|Part 1: up to Week 16|Physician Decision|0|||
105811949|NCT02581345|364968379|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
105811950|NCT02581345|364968380|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
105811951|NCT02581345|364968381|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
105811952|NCT02581345|364968382|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
105811953|NCT02581345|364968379|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
105811954|NCT02581345|364968380|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
105811955|NCT02581345|364968381|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
105811956|NCT02581345|364968382|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
105954361|NCT01791517|365495117|FG004|Phase II|Lost to Follow-up|1|||
105954362|NCT01791517|365495118|FG005|Phase II|Lost to Follow-up|2|||
105954363|NCT01791517|365495119|FG006|Phase II|Lost to Follow-up|0|||
105954364|NCT01791517|365495120|FG007|Phase II|Lost to Follow-up|1|||
105954365|NCT01791517|365495121|FG008|Phase II|Lost to Follow-up|1|||
105954366|NCT01791517|365495122|FG009|Phase II|Lost to Follow-up|1|||
105954367|NCT01791517|365495123|FG010|Phase II|Lost to Follow-up|0|||
105954368|NCT01791517|365495124|FG011|Phase II|Lost to Follow-up|0|||
105954369|NCT01791517|365495113|FG000|Phase II|Withdrawal by Subject|1|||
105954370|NCT01791517|365495114|FG001|Phase II|Withdrawal by Subject|0|||
105954371|NCT01791517|365495115|FG002|Phase II|Withdrawal by Subject|0|||
105954372|NCT01791517|365495116|FG003|Phase II|Withdrawal by Subject|0|||
105954373|NCT01791517|365495117|FG004|Phase II|Withdrawal by Subject|0|||
105954374|NCT01791517|365495118|FG005|Phase II|Withdrawal by Subject|2|||
105811957|NCT02581345|364968379|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
105811958|NCT02581345|364968380|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
105811959|NCT02581345|364968381|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
105811960|NCT02581345|364968382|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
105811961|NCT02581345|364968379|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
105954375|NCT01791517|365495119|FG006|Phase II|Withdrawal by Subject|0|||
105954376|NCT01791517|365495120|FG007|Phase II|Withdrawal by Subject|1|||
105954377|NCT01791517|365495121|FG008|Phase II|Withdrawal by Subject|0|||
105954378|NCT01791517|365495122|FG009|Phase II|Withdrawal by Subject|0|||
105811962|NCT02581345|364968380|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
105811963|NCT02581345|364968381|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
105954379|NCT01791517|365495123|FG010|Phase II|Withdrawal by Subject|1|||
105954380|NCT01791517|365495124|FG011|Phase II|Withdrawal by Subject|0|||
105954381|NCT01791517|365495113|FG000|Phase II|Lack of Efficacy|0|||
105954382|NCT01791517|365495114|FG001|Phase II|Lack of Efficacy|0|||
105954383|NCT01791517|365495115|FG002|Phase II|Lack of Efficacy|0|||
105811964|NCT02581345|364968382|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
105811965|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
105811966|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
105811967|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
105811968|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
105811969|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
105811970|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
105811971|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
105811972|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
105954384|NCT01791517|365495116|FG003|Phase II|Lack of Efficacy|0|||
105954385|NCT01791517|365495117|FG004|Phase II|Lack of Efficacy|1|||
105954386|NCT01791517|365495118|FG005|Phase II|Lack of Efficacy|0|||
105954387|NCT01791517|365495119|FG006|Phase II|Lack of Efficacy|0|||
105954388|NCT01791517|365495120|FG007|Phase II|Lack of Efficacy|0|||
105954389|NCT01791517|365495121|FG008|Phase II|Lack of Efficacy|0|||
105954390|NCT01791517|365495122|FG009|Phase II|Lack of Efficacy|0|||
105954391|NCT01791517|365495123|FG010|Phase II|Lack of Efficacy|0|||
105954392|NCT01791517|365495124|FG011|Phase II|Lack of Efficacy|0|||
105954393|NCT01791517|365495113|FG000|Phase II|Adverse Event|0|||
106017864|NCT00785785|365729191|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
106017865|NCT00785785|365729192|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
106017866|NCT00785785|365729191|FG000|Optional Extension Phase|Lost to Follow-up|1|||
106017867|NCT00785785|365729192|FG001|Optional Extension Phase|Lost to Follow-up|0|||
106017868|NCT00785785|365729191|FG000|Optional Extension Phase|Administrative problems|2|||
106017869|NCT00785785|365729192|FG001|Optional Extension Phase|Administrative problems|0|||
106017870|NCT00785785|365729191|FG000|Optional Extension Phase|Death|1|||
106017871|NCT00785785|365729192|FG001|Optional Extension Phase|Death|5|||
105811973|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
105811974|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
105811975|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
105811976|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
105811977|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
105811978|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
105811979|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
105811980|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
106017872|NCT00785785|365729191|FG000|Optional Extension Phase|Disease progression|22|||
106017873|NCT00785785|365729192|FG001|Optional Extension Phase|Disease progression|70|||
106017874|NCT00785785|365729191|FG000|Optional Extension Phase|Protocol deviation|0|||
106017875|NCT00785785|365729192|FG001|Optional Extension Phase|Protocol deviation|2|||
106017876|NCT00785785|365729191|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
106017877|NCT00785785|365729192|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
106017878|NCT02453321|365729193|FG000|Overall Study|Weakness|1|||
106017879|NCT02453321|365729194|FG001|Overall Study|Weakness|1|||
106017880|NCT02453321|365729195|FG002|Overall Study|Weakness|2|||
106017881|NCT02453321|365729193|FG000|Overall Study|Deep Venous Thrombosis|0|||
106017882|NCT02453321|365729194|FG001|Overall Study|Deep Venous Thrombosis|1|||
106017883|NCT02453321|365729195|FG002|Overall Study|Deep Venous Thrombosis|0|||
106017884|NCT00357552|365729196|FG000|Screening|Did not meet eligibility criteria|84|||
106017885|NCT00357552|365729196|FG000|Weeks 0 to 24|Death|1|||
106017886|NCT00357552|365729196|FG000|Weeks 24 to 104|Death|3|||
106017887|NCT00357552|365729196|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
106017888|NCT00521404|365729199|FG000|Overall Study|Adverse Event|13|||
106017889|NCT00521404|365729199|FG000|Overall Study|Disease Progression|33|||
106017890|NCT00521404|365729199|FG000|Overall Study|Investigator decision|5|||
106017891|NCT00521404|365729199|FG000|Overall Study|Withdrawal of consent|3|||
106017892|NCT00521404|365729199|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
105811981|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
105811982|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
105811983|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
105811984|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
105811985|NCT02581345|364968379|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
105954394|NCT01791517|365495114|FG001|Phase II|Adverse Event|0|||
105954395|NCT01791517|365495115|FG002|Phase II|Adverse Event|0|||
105954396|NCT01791517|365495116|FG003|Phase II|Adverse Event|0|||
105954397|NCT01791517|365495117|FG004|Phase II|Adverse Event|0|||
106017893|NCT00521404|365729199|FG000|Overall Study|Other|7|||
106017894|NCT01528969|365729201|FG000|Overall Study|absent from the school at baseline|2|||
106017895|NCT01528969|365729202|FG001|Overall Study|absent from the school at baseline|0|||
106017896|NCT01938716|365729208|FG000|Overall Study|Physician Decision|2|||
106017897|NCT01938716|365729208|FG000|Overall Study|Withdrawal by Subject|2|||
106017898|NCT02054104|365729209|FG000|Overall Study|Did not want to continue due to college classes|1|||
106017899|NCT02054104|365729210|FG001|Overall Study|Did not want to continue due to college classes|0|||
106017900|NCT02054104|365729209|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
106017901|NCT02054104|365729210|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
105811986|NCT02581345|364968380|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
105811987|NCT02581345|364968381|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
105811988|NCT02581345|364968382|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
105811989|NCT01893905|364968383|FG000|Overall Study|Withdrawal by Subject|1|||
105811990|NCT01893905|364968384|FG001|Overall Study|Withdrawal by Subject|0|||
105811991|NCT01893905|364968383|FG000|Overall Study|Adverse Event|9|||
105811992|NCT01893905|364968384|FG001|Overall Study|Adverse Event|3|||
105811993|NCT01893905|364968383|FG000|Overall Study|Lack of Efficacy|5|||
105811994|NCT01893905|364968384|FG001|Overall Study|Lack of Efficacy|7|||
105811995|NCT01893905|364968383|FG000|Overall Study|Lost to Follow-up|1|||
105811996|NCT01893905|364968384|FG001|Overall Study|Lost to Follow-up|0|||
105811997|NCT01893905|364968383|FG000|Overall Study|Protocol Violation|6|||
105811998|NCT01893905|364968384|FG001|Overall Study|Protocol Violation|1|||
105811999|NCT01893905|364968383|FG000|Overall Study|Lack of adherence to treatment|2|||
105812000|NCT01893905|364968384|FG001|Overall Study|Lack of adherence to treatment|0|||
105812001|NCT01893905|364968383|FG000|Overall Study|Other reason|1|||
105812002|NCT01893905|364968384|FG001|Overall Study|Other reason|3|||
105812003|NCT01768858|364968385|FG000|Overall Study|Lost to Follow-up|9|||
105812004|NCT01768858|364968385|FG000|Overall Study|Lack of Efficacy|8|||
105812005|NCT01768858|364968385|FG000|Overall Study|Serious Adverse Event|1|||
105812006|NCT01768858|364968385|FG000|Overall Study|Participant moved to Germany|1|||
105812007|NCT01768858|364968385|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
105812008|NCT01768858|364968385|FG000|Overall Study|Exanthema|1|||
105812009|NCT01768858|364968385|FG000|Overall Study|Withdrawal by Subject|1|||
105812010|NCT01367275|364968388|FG000|Overall Study|Ineligible|1|||
105812011|NCT01367275|364968388|FG000|Overall Study|Disease Progression|2|||
105812012|NCT01290263|364968394|FG000|Overall Study|Adverse Event|0|||
105812013|NCT01290263|364968395|FG001|Overall Study|Adverse Event|0|||
105812014|NCT01290263|364968396|FG002|Overall Study|Adverse Event|0|||
105812015|NCT01290263|364968397|FG003|Overall Study|Adverse Event|1|||
105812016|NCT01290263|364968398|FG004|Overall Study|Adverse Event|1|||
105812017|NCT01290263|364968394|FG000|Overall Study|Lack of Efficacy|8|||
105812018|NCT01290263|364968395|FG001|Overall Study|Lack of Efficacy|2|||
105812019|NCT01290263|364968396|FG002|Overall Study|Lack of Efficacy|7|||
105812020|NCT01290263|364968397|FG003|Overall Study|Lack of Efficacy|24|||
105812021|NCT01290263|364968398|FG004|Overall Study|Lack of Efficacy|33|||
105812022|NCT01290263|364968394|FG000|Overall Study|Withdrawal by Subject|3|||
105812023|NCT01290263|364968395|FG001|Overall Study|Withdrawal by Subject|1|||
105812024|NCT01290263|364968396|FG002|Overall Study|Withdrawal by Subject|0|||
105812025|NCT01290263|364968397|FG003|Overall Study|Withdrawal by Subject|1|||
105812026|NCT01290263|364968398|FG004|Overall Study|Withdrawal by Subject|2|||
105812027|NCT01290263|364968394|FG000|Overall Study|Participant Non-Compliance|0|||
105812028|NCT01290263|364968395|FG001|Overall Study|Participant Non-Compliance|0|||
105812029|NCT01290263|364968396|FG002|Overall Study|Participant Non-Compliance|0|||
105812030|NCT01290263|364968397|FG003|Overall Study|Participant Non-Compliance|1|||
105812031|NCT01290263|364968398|FG004|Overall Study|Participant Non-Compliance|1|||
105812032|NCT05346055|364968399|FG000|Overall Study|Withdrawal by Subject|1|||
105812033|NCT05346055|364968399|FG000|Overall Study|Protocol Violation|1|||
105812034|NCT05346055|364968399|FG000|Overall Study|Therapist decision|1|||
105812035|NCT00376220|364968400|FG000|Overall Study|Lost to Follow-up|7|||
105812036|NCT00376220|364968401|FG001|Overall Study|Lost to Follow-up|10|||
105812037|NCT00376220|364968400|FG000|Overall Study|Withdrawal by Subject|3|||
105812038|NCT00376220|364968401|FG001|Overall Study|Withdrawal by Subject|2|||
105812039|NCT03702621|364968416|FG000|Overall Study|Physician Decision|6|||
105812040|NCT03702621|364968417|FG001|Overall Study|Physician Decision|6|||
105812041|NCT00920140|364968418|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
105812042|NCT00920140|364968419|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
105812043|NCT00920140|364968420|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
105812044|NCT00920140|364968421|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
105812045|NCT00920140|364968422|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
105812046|NCT00920140|364968418|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
105812047|NCT00920140|364968419|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
105812048|NCT00920140|364968420|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
105812049|NCT00920140|364968421|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
105812050|NCT00920140|364968422|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
105812051|NCT00920140|364968418|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105812052|NCT00920140|364968419|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
105812053|NCT00920140|364968420|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105812054|NCT00920140|364968421|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105812055|NCT00920140|364968422|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
105812056|NCT00920140|364968418|FG000|Phase 2|Adverse Event|0|||
105812057|NCT00920140|364968419|FG001|Phase 2|Adverse Event|0|||
105812058|NCT00920140|364968420|FG002|Phase 2|Adverse Event|14|||
105812059|NCT00920140|364968421|FG003|Phase 2|Adverse Event|2|||
105812060|NCT00920140|364968422|FG004|Phase 2|Adverse Event|3|||
105812061|NCT00920140|364968418|FG000|Phase 2|Lack of Efficacy|0|||
105812062|NCT00920140|364968419|FG001|Phase 2|Lack of Efficacy|0|||
105812063|NCT00920140|364968420|FG002|Phase 2|Lack of Efficacy|29|||
105812064|NCT00920140|364968421|FG003|Phase 2|Lack of Efficacy|14|||
105812065|NCT00920140|364968422|FG004|Phase 2|Lack of Efficacy|5|||
105762815|NCT00443846|364784812|FG000|Overall Study|Lost to Follow-up|1|||
105762816|NCT00443846|364784813|FG001|Overall Study|Lost to Follow-up|2|||
105762817|NCT02580591|364784814|FG000|Overall Study|Adverse Event|0|||
105762818|NCT02580591|364784815|FG001|Overall Study|Adverse Event|1|||
105762819|NCT02580591|364784816|FG002|Overall Study|Adverse Event|2|||
105762820|NCT02580591|364784817|FG003|Overall Study|Adverse Event|5|||
105762821|NCT02580591|364784814|FG000|Overall Study|Protocol Violation|3|||
105762822|NCT02580591|364784815|FG001|Overall Study|Protocol Violation|2|||
105762823|NCT02580591|364784816|FG002|Overall Study|Protocol Violation|1|||
105762824|NCT02580591|364784817|FG003|Overall Study|Protocol Violation|1|||
105762825|NCT02580591|364784814|FG000|Overall Study|Lost to Follow-up|5|||
105762826|NCT02580591|364784815|FG001|Overall Study|Lost to Follow-up|3|||
105762827|NCT02580591|364784816|FG002|Overall Study|Lost to Follow-up|3|||
105762828|NCT02580591|364784817|FG003|Overall Study|Lost to Follow-up|1|||
105762829|NCT02580591|364784814|FG000|Overall Study|Withdrawal by Subject|6|||
105762830|NCT02580591|364784815|FG001|Overall Study|Withdrawal by Subject|1|||
105762831|NCT02580591|364784816|FG002|Overall Study|Withdrawal by Subject|2|||
105762832|NCT02580591|364784817|FG003|Overall Study|Withdrawal by Subject|3|||
105762833|NCT02580591|364784814|FG000|Overall Study|Not treated|1|||
105762834|NCT02580591|364784815|FG001|Overall Study|Not treated|1|||
105762835|NCT02580591|364784816|FG002|Overall Study|Not treated|0|||
105762836|NCT02580591|364784817|FG003|Overall Study|Not treated|0|||
105762837|NCT02580591|364784814|FG000|Overall Study|Other than specified|3|||
105762838|NCT02580591|364784815|FG001|Overall Study|Other than specified|2|||
105762839|NCT02580591|364784816|FG002|Overall Study|Other than specified|5|||
105762840|NCT02580591|364784817|FG003|Overall Study|Other than specified|2|||
105762841|NCT00561340|364784818|FG000|Overall Study|refused to drink pediasure|6|||
105762842|NCT00561340|364784819|FG001|Overall Study|refused to drink pediasure|0|||
105762843|NCT00445341|364784820|FG000|Overall Study|refused further treatment|1|||
105762844|NCT00445341|364784820|FG000|Overall Study|taken off treatment too early|1|||
105762845|NCT00391807|364784822|FG000|Overall Study|Did not receive study medication|23|||
105762846|NCT00391807|364784822|FG000|Overall Study|Adverse Event|177|||
105762847|NCT00391807|364784822|FG000|Overall Study|Pregnancy|25|||
105762848|NCT00391807|364784822|FG000|Overall Study|Lost to Follow-up|227|||
105762849|NCT00391807|364784822|FG000|Overall Study|Withdrawal by Subject|147|||
105762850|NCT00391807|364784822|FG000|Overall Study|Protocol Violation|20|||
105762851|NCT00391807|364784822|FG000|Overall Study|Various|96|||
105762852|NCT01359046|364784823|FG000|Overall Study|Did not receive allocated intervention|6|||
105762853|NCT01359046|364784824|FG001|Overall Study|Did not receive allocated intervention|6|||
105762854|NCT01359046|364784823|FG000|Overall Study|Physician Decision|1|||
105762855|NCT01359046|364784824|FG001|Overall Study|Physician Decision|11|||
105762856|NCT00990249|364784841|FG000|Overall Study|Disease Progression|8|||
105762857|NCT00990249|364784841|FG000|Overall Study|Non-Compliance|1|||
105762858|NCT00990249|364784841|FG000|Overall Study|Death|2|||
105762859|NCT00990249|364784841|FG000|Overall Study|Not treated|2|||
105762860|NCT01061567|364784848|FG000|Overall Study|Adverse Event|32|||
105762861|NCT01061567|364784848|FG000|Overall Study|Death|2|||
105812066|NCT00920140|364968418|FG000|Phase 2|Lost to Follow-up|0|||
105762862|NCT01061567|364784848|FG000|Overall Study|Lack of Efficacy|3|||
105762863|NCT01061567|364784848|FG000|Overall Study|Lost to Follow-up|24|||
105762864|NCT01061567|364784848|FG000|Overall Study|Protocol Violation|1|||
105762865|NCT01061567|364784848|FG000|Overall Study|Withdrawal by Subject|11|||
105762866|NCT01061567|364784848|FG000|Overall Study|Other reason than stated above|3|||
105762867|NCT01809197|364784849|FG000|Overall Study|Lost to Follow-up|4|||
105762868|NCT01809197|364784850|FG001|Overall Study|Lost to Follow-up|2|||
105762869|NCT01809197|364784849|FG000|Overall Study|Adverse Event|2|||
105762870|NCT01809197|364784850|FG001|Overall Study|Adverse Event|3|||
105762871|NCT01809197|364784849|FG000|Overall Study|Failed slit lamp exam|1|||
105762872|NCT01809197|364784850|FG001|Overall Study|Failed slit lamp exam|0|||
105762873|NCT01809197|364784849|FG000|Overall Study|Non-Compliance|1|||
105762874|NCT01809197|364784850|FG001|Overall Study|Non-Compliance|1|||
105762875|NCT01809197|364784849|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
105762876|NCT01809197|364784850|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
105762877|NCT01809197|364784849|FG000|Overall Study|Withdrawal by Subject|1|||
105762878|NCT01809197|364784850|FG001|Overall Study|Withdrawal by Subject|1|||
105762879|NCT01809197|364784849|FG000|Overall Study|Product not available|0|||
105762880|NCT01809197|364784850|FG001|Overall Study|Product not available|1|||
105762881|NCT03228394|364784853|FG000|Overall Study|Lost to Follow-up|0|||
105762882|NCT03228394|364784854|FG001|Overall Study|Lost to Follow-up|0|||
105762883|NCT03228394|364784855|FG002|Overall Study|Lost to Follow-up|1|||
105812067|NCT00920140|364968419|FG001|Phase 2|Lost to Follow-up|0|||
106017902|NCT02054104|365729209|FG000|Overall Study|No evidence of immunologic response|2|||
106017903|NCT02054104|365729210|FG001|Overall Study|No evidence of immunologic response|2|||
106017904|NCT02054104|365729209|FG000|Overall Study|Disease Progression On Study|4|||
106017905|NCT02054104|365729210|FG001|Overall Study|Disease Progression On Study|5|||
106017906|NCT02054104|365729209|FG000|Overall Study|Diagnosis of lymphoma|0|||
106017907|NCT02054104|365729210|FG001|Overall Study|Diagnosis of lymphoma|1|||
106017908|NCT02054104|365729209|FG000|Overall Study|Inconclusive response|0|||
106017909|NCT02054104|365729210|FG001|Overall Study|Inconclusive response|1|||
106017910|NCT01908803|365729211|FG000|Overall Study|Adverse Event|1|||
106017911|NCT01908803|365729212|FG001|Overall Study|Adverse Event|0|||
106017912|NCT01908803|365729211|FG000|Overall Study|Physician Decision|0|||
106017913|NCT01908803|365729212|FG001|Overall Study|Physician Decision|1|||
106017914|NCT01908803|365729211|FG000|Overall Study|Withdrawal by Subject|1|||
106017915|NCT01908803|365729212|FG001|Overall Study|Withdrawal by Subject|0|||
105762884|NCT03228394|364784856|FG003|Overall Study|Lost to Follow-up|1|||
105762885|NCT03228394|364784857|FG004|Overall Study|Lost to Follow-up|0|||
105762886|NCT03228394|364784858|FG005|Overall Study|Lost to Follow-up|0|||
105762887|NCT03228394|364784859|FG006|Overall Study|Lost to Follow-up|2|||
105762888|NCT03228394|364784860|FG007|Overall Study|Lost to Follow-up|0|||
105762889|NCT03228394|364784853|FG000|Overall Study|Withdrawal by Subject|0|||
105762890|NCT03228394|364784854|FG001|Overall Study|Withdrawal by Subject|0|||
105762891|NCT03228394|364784855|FG002|Overall Study|Withdrawal by Subject|1|||
105762892|NCT03228394|364784856|FG003|Overall Study|Withdrawal by Subject|0|||
105762893|NCT03228394|364784857|FG004|Overall Study|Withdrawal by Subject|0|||
105762894|NCT03228394|364784858|FG005|Overall Study|Withdrawal by Subject|0|||
105762895|NCT03228394|364784859|FG006|Overall Study|Withdrawal by Subject|1|||
105762896|NCT03228394|364784860|FG007|Overall Study|Withdrawal by Subject|3|||
105762897|NCT03228394|364784853|FG000|Overall Study|Protocol Violation|0|||
105762898|NCT03228394|364784854|FG001|Overall Study|Protocol Violation|0|||
105762899|NCT03228394|364784855|FG002|Overall Study|Protocol Violation|0|||
105762900|NCT03228394|364784856|FG003|Overall Study|Protocol Violation|1|||
105762901|NCT03228394|364784857|FG004|Overall Study|Protocol Violation|0|||
105762902|NCT03228394|364784858|FG005|Overall Study|Protocol Violation|0|||
105762903|NCT03228394|364784859|FG006|Overall Study|Protocol Violation|0|||
105762904|NCT03228394|364784860|FG007|Overall Study|Protocol Violation|0|||
105762905|NCT03228394|364784853|FG000|Overall Study|Physician Decision|0|||
105762906|NCT03228394|364784854|FG001|Overall Study|Physician Decision|0|||
105762907|NCT03228394|364784855|FG002|Overall Study|Physician Decision|0|||
105762908|NCT03228394|364784856|FG003|Overall Study|Physician Decision|0|||
105762909|NCT03228394|364784857|FG004|Overall Study|Physician Decision|0|||
105762910|NCT03228394|364784858|FG005|Overall Study|Physician Decision|0|||
105762911|NCT03228394|364784859|FG006|Overall Study|Physician Decision|1|||
105762912|NCT03228394|364784860|FG007|Overall Study|Physician Decision|0|||
105762913|NCT03228394|364784853|FG000|Overall Study|Noncompliance|0|||
105762914|NCT03228394|364784854|FG001|Overall Study|Noncompliance|0|||
105762915|NCT03228394|364784855|FG002|Overall Study|Noncompliance|0|||
105762916|NCT03228394|364784856|FG003|Overall Study|Noncompliance|0|||
105762917|NCT03228394|364784857|FG004|Overall Study|Noncompliance|0|||
105762918|NCT03228394|364784858|FG005|Overall Study|Noncompliance|0|||
105762919|NCT03228394|364784859|FG006|Overall Study|Noncompliance|1|||
105762920|NCT03228394|364784860|FG007|Overall Study|Noncompliance|0|||
105762921|NCT00268463|364784863|FG000|Overall Study|study terminated due to low accrual|10|||
105762922|NCT00268463|364784864|FG001|Overall Study|study terminated due to low accrual|12|||
105762923|NCT03000686|364784865|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
105762924|NCT03000686|364784866|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
105762925|NCT03000686|364784867|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
105762926|NCT03000686|364784868|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
105762927|NCT01484561|364784871|FG000|Overall Study|Lack of Efficacy|3|||
105762928|NCT01484561|364784872|FG001|Overall Study|Lack of Efficacy|1|||
105762929|NCT01484561|364784871|FG000|Overall Study|Lost to Follow-up|1|||
105762930|NCT01484561|364784872|FG001|Overall Study|Lost to Follow-up|0|||
105762931|NCT01484561|364784871|FG000|Overall Study|Withdrawal by Subject|3|||
105762932|NCT01484561|364784872|FG001|Overall Study|Withdrawal by Subject|0|||
105762933|NCT01484561|364784871|FG000|Overall Study|Other|1|||
105762934|NCT01484561|364784872|FG001|Overall Study|Other|1|||
105762935|NCT01484561|364784871|FG000|Overall Study|Adverse Event|1|||
105762936|NCT01484561|364784872|FG001|Overall Study|Adverse Event|4|||
105762937|NCT00291187|364784873|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
105762938|NCT00291187|364784874|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
105762939|NCT00291187|364784875|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
105762940|NCT00291187|364784876|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
105762941|NCT02443805|364784878|FG000|Overall Study|Adverse Event|100|||
105762942|NCT02443805|364784879|FG001|Overall Study|Adverse Event|18|||
106017916|NCT01908803|365729211|FG000|Overall Study|Randomization Error|1|||
106017917|NCT01908803|365729212|FG001|Overall Study|Randomization Error|0|||
106145084|NCT01579916|366190806|FG000|Overall Study|Lost to Follow-up|6|||
106145085|NCT01579916|366190807|FG001|Overall Study|Lost to Follow-up|1|||
106145086|NCT01579916|366190806|FG000|Overall Study|Withdrawal by Subject|1|||
105812068|NCT00920140|364968420|FG002|Phase 2|Lost to Follow-up|0|||
105812069|NCT00920140|364968421|FG003|Phase 2|Lost to Follow-up|1|||
105812070|NCT00920140|364968422|FG004|Phase 2|Lost to Follow-up|0|||
105812071|NCT00920140|364968418|FG000|Phase 2|Physician Decision|0|||
105812072|NCT00920140|364968419|FG001|Phase 2|Physician Decision|0|||
105812073|NCT00920140|364968420|FG002|Phase 2|Physician Decision|3|||
105812074|NCT00920140|364968421|FG003|Phase 2|Physician Decision|3|||
105812075|NCT00920140|364968422|FG004|Phase 2|Physician Decision|2|||
105812076|NCT00920140|364968418|FG000|Phase 2|Withdrawal by Subject|0|||
105812077|NCT00920140|364968419|FG001|Phase 2|Withdrawal by Subject|0|||
105812078|NCT00920140|364968420|FG002|Phase 2|Withdrawal by Subject|4|||
105812079|NCT00920140|364968421|FG003|Phase 2|Withdrawal by Subject|2|||
105812080|NCT00920140|364968422|FG004|Phase 2|Withdrawal by Subject|1|||
105812081|NCT02720510|364968423|FG000|Overall Study|Study Terminated by the sponsor|2|||
106017918|NCT01908803|365729211|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
106017919|NCT01908803|365729212|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
105812082|NCT02720510|364968424|FG001|Overall Study|Study Terminated by the sponsor|0|||
105812083|NCT02720510|364968423|FG000|Overall Study|Adverse Event|0|||
105812084|NCT02720510|364968424|FG001|Overall Study|Adverse Event|1|||
105812085|NCT02720510|364968423|FG000|Overall Study|Physician Decision|1|||
105812086|NCT02720510|364968424|FG001|Overall Study|Physician Decision|2|||
105812087|NCT00449150|364968425|FG000|Overall Study|Adverse Event|11|||
105812088|NCT00449150|364968426|FG001|Overall Study|Adverse Event|18|||
105812089|NCT00449150|364968427|FG002|Overall Study|Adverse Event|9|||
105812090|NCT00449150|364968425|FG000|Overall Study|Lack of Efficacy|1|||
105812091|NCT00449150|364968426|FG001|Overall Study|Lack of Efficacy|2|||
105812092|NCT00449150|364968427|FG002|Overall Study|Lack of Efficacy|2|||
105812093|NCT00449150|364968425|FG000|Overall Study|Other|16|||
105812094|NCT00449150|364968426|FG001|Overall Study|Other|13|||
105812095|NCT00449150|364968427|FG002|Overall Study|Other|14|||
105812096|NCT00449150|364968425|FG000|Overall Study|Withdrawal by Subject|17|||
105812097|NCT00449150|364968426|FG001|Overall Study|Withdrawal by Subject|18|||
105812098|NCT00449150|364968427|FG002|Overall Study|Withdrawal by Subject|21|||
105812099|NCT00449150|364968425|FG000|Overall Study|Protocol Violation|1|||
105812100|NCT00449150|364968426|FG001|Overall Study|Protocol Violation|2|||
105812101|NCT00449150|364968427|FG002|Overall Study|Protocol Violation|1|||
105812102|NCT00770510|364968428|FG000|Overall Study|Lost to Follow-up|2|||
105812103|NCT00770510|364968428|FG000|Overall Study|Pregnancy|1|||
105812104|NCT00770510|364968428|FG000|Overall Study|Withdrawal by Subject|2|||
105812105|NCT03830164|364968429|FG000|Overall Study|Adverse Event|0|||
105812106|NCT03830164|364968430|FG001|Overall Study|Adverse Event|2|||
105812107|NCT03830164|364968431|FG002|Overall Study|Adverse Event|0|||
105812108|NCT03830164|364968429|FG000|Overall Study|Lack of Efficacy|1|||
105812109|NCT03830164|364968430|FG001|Overall Study|Lack of Efficacy|5|||
105812110|NCT03830164|364968431|FG002|Overall Study|Lack of Efficacy|0|||
105812111|NCT03830164|364968429|FG000|Overall Study|Lost to Follow-up|0|||
105812112|NCT03830164|364968430|FG001|Overall Study|Lost to Follow-up|1|||
105812113|NCT03830164|364968431|FG002|Overall Study|Lost to Follow-up|0|||
105812114|NCT03830164|364968429|FG000|Overall Study|Withdrawal by Subject|1|||
105812115|NCT03830164|364968430|FG001|Overall Study|Withdrawal by Subject|0|||
105812116|NCT03830164|364968431|FG002|Overall Study|Withdrawal by Subject|0|||
105812117|NCT00995553|364968438|FG000|Overall Study|Withdrawal by Subject|2|||
105812118|NCT00995553|364968439|FG001|Overall Study|Withdrawal by Subject|6|||
105812119|NCT01531205|364968440|FG000|Overall Study|Did not proceed to surgery|1|||
105812120|NCT02001558|364968443|FG000|Overall Study|Lost to Follow-up|8|||
106017920|NCT00823615|365729213|FG000|Period 2|Lost to Follow-up|2|||
106017921|NCT00823615|365729214|FG001|Period 2|Lost to Follow-up|0|||
106017922|NCT00823615|365729213|FG000|Period 2|Time/Job Conflict|1|||
106017923|NCT00823615|365729214|FG001|Period 2|Time/Job Conflict|2|||
106017924|NCT01864603|365729219|FG000|Stage 2|DSMB design modification|86056|||
106017925|NCT01864603|365729220|FG001|Stage 2|DSMB design modification|92558|||
106017926|NCT00098813|365729221|FG000|Overall Study|Death|8|||
106017927|NCT00098813|365729221|FG000|Overall Study|Protocol Violation|1|||
105812121|NCT02001558|364968444|FG001|Overall Study|Lost to Follow-up|14|||
106017928|NCT00098813|365729221|FG000|Overall Study|Withdrawal by Subject|7|||
106017929|NCT00098813|365729221|FG000|Overall Study|Progression of Disease|1|||
106145087|NCT01579916|366190807|FG001|Overall Study|Withdrawal by Subject|1|||
106145088|NCT01579916|366190806|FG000|Overall Study|Death|1|||
105812122|NCT04128007|364968445|FG000|Overall Study|Withdrawal by Subject|9|||
105812123|NCT04128007|364968446|FG001|Overall Study|Withdrawal by Subject|6|||
105812124|NCT04128007|364968445|FG000|Overall Study|Protocol Violation|1|||
105812125|NCT04128007|364968446|FG001|Overall Study|Protocol Violation|0|||
105812126|NCT04128007|364968445|FG000|Overall Study|Lost to Follow-up|8|||
105812127|NCT04128007|364968446|FG001|Overall Study|Lost to Follow-up|7|||
105812128|NCT04128007|364968445|FG000|Overall Study|Adverse Event|5|||
105812129|NCT04128007|364968446|FG001|Overall Study|Adverse Event|2|||
105812130|NCT04128007|364968445|FG000|Overall Study|Not reported|0|||
106017930|NCT00098813|365729221|FG000|Overall Study|Other complicating disease|1|||
106017931|NCT00098813|365729221|FG000|Overall Study|Reversal of RAI resistance|1|||
106145089|NCT01579916|366190807|FG001|Overall Study|Death|0|||
105812131|NCT04128007|364968446|FG001|Overall Study|Not reported|2|||
105812132|NCT01225146|364968447|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
105812133|NCT01225146|364968448|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
105812134|NCT03049488|364968450|FG000|Overall Study|Lost to Follow-up|1|||
105812135|NCT03049488|364968451|FG001|Overall Study|Lost to Follow-up|1|||
105812136|NCT03049488|364968452|FG002|Overall Study|Lost to Follow-up|0|||
105812137|NCT03049488|364968453|FG003|Overall Study|Lost to Follow-up|0|||
105812138|NCT03049488|364968454|FG004|Overall Study|Lost to Follow-up|0|||
105812139|NCT03049488|364968455|FG005|Overall Study|Lost to Follow-up|0|||
105812140|NCT03049488|364968450|FG000|Overall Study|Moved from Area|1|||
105812141|NCT03049488|364968451|FG001|Overall Study|Moved from Area|0|||
105812142|NCT03049488|364968452|FG002|Overall Study|Moved from Area|0|||
105812143|NCT03049488|364968453|FG003|Overall Study|Moved from Area|1|||
105812144|NCT03049488|364968454|FG004|Overall Study|Moved from Area|1|||
105812145|NCT03049488|364968455|FG005|Overall Study|Moved from Area|0|||
105812146|NCT03049488|364968450|FG000|Overall Study|Physician Decision|0|||
105812147|NCT03049488|364968451|FG001|Overall Study|Physician Decision|1|||
105812148|NCT03049488|364968452|FG002|Overall Study|Physician Decision|0|||
105812149|NCT03049488|364968453|FG003|Overall Study|Physician Decision|0|||
105812150|NCT03049488|364968454|FG004|Overall Study|Physician Decision|0|||
105812151|NCT03049488|364968455|FG005|Overall Study|Physician Decision|0|||
105812152|NCT03049488|364968450|FG000|Overall Study|Withdrawal by Subject|0|||
105812153|NCT03049488|364968451|FG001|Overall Study|Withdrawal by Subject|0|||
105812154|NCT03049488|364968452|FG002|Overall Study|Withdrawal by Subject|0|||
105812155|NCT03049488|364968453|FG003|Overall Study|Withdrawal by Subject|1|||
105812156|NCT03049488|364968454|FG004|Overall Study|Withdrawal by Subject|1|||
105812157|NCT03049488|364968455|FG005|Overall Study|Withdrawal by Subject|0|||
105812158|NCT02353169|364968457|FG000|Overall Study|QTc > 450 msec|1|||
105812159|NCT02353169|364968458|FG001|Overall Study|QTc > 450 msec|1|||
105812160|NCT02353169|364968459|FG002|Overall Study|QTc > 450 msec|1|||
105812161|NCT02353169|364968460|FG003|Overall Study|QTc > 450 msec|1|||
105812162|NCT02353169|364968457|FG000|Overall Study|OR team declined|2|||
105812163|NCT02353169|364968458|FG001|Overall Study|OR team declined|0|||
105812164|NCT02353169|364968459|FG002|Overall Study|OR team declined|0|||
105812165|NCT02353169|364968460|FG003|Overall Study|OR team declined|0|||
105812166|NCT02353169|364968457|FG000|Overall Study|Inhalational induction|0|||
105812167|NCT02353169|364968458|FG001|Overall Study|Inhalational induction|2|||
105812168|NCT02353169|364968459|FG002|Overall Study|Inhalational induction|0|||
105812169|NCT02353169|364968460|FG003|Overall Study|Inhalational induction|0|||
105812170|NCT02353169|364968457|FG000|Overall Study|ECG data error|0|||
105812171|NCT02353169|364968458|FG001|Overall Study|ECG data error|3|||
105812172|NCT02353169|364968459|FG002|Overall Study|ECG data error|2|||
105812173|NCT02353169|364968460|FG003|Overall Study|ECG data error|2|||
105812174|NCT02353169|364968457|FG000|Overall Study|Pre-op medication|0|||
105812175|NCT02353169|364968458|FG001|Overall Study|Pre-op medication|0|||
105812176|NCT02353169|364968459|FG002|Overall Study|Pre-op medication|1|||
105812177|NCT02353169|364968460|FG003|Overall Study|Pre-op medication|0|||
105812178|NCT03883906|364968462|FG000|Overall Study|Withdrawal by Subject|2|||
105812179|NCT03883906|364968462|FG000|Overall Study|Physician Decision|5|||
105812180|NCT00874237|364968463|FG000|Overall Study|Physician Decision|0|||
105812181|NCT00874237|364968464|FG001|Overall Study|Physician Decision|1|||
105812182|NCT00874237|364968465|FG002|Overall Study|Physician Decision|0|||
105812183|NCT00874237|364968466|FG003|Overall Study|Physician Decision|0|||
105812184|NCT00874237|364968467|FG004|Overall Study|Physician Decision|0|||
105812185|NCT00874237|364968468|FG005|Overall Study|Physician Decision|0|||
105812186|NCT00874237|364968463|FG000|Overall Study|Withdrawal by Subject|0|||
105812187|NCT00874237|364968464|FG001|Overall Study|Withdrawal by Subject|0|||
105812188|NCT00874237|364968465|FG002|Overall Study|Withdrawal by Subject|1|||
105812189|NCT00874237|364968466|FG003|Overall Study|Withdrawal by Subject|0|||
105812190|NCT00874237|364968467|FG004|Overall Study|Withdrawal by Subject|0|||
105954398|NCT01791517|365495118|FG005|Phase II|Adverse Event|0|||
105954399|NCT01791517|365495119|FG006|Phase II|Adverse Event|2|||
105812191|NCT00874237|364968468|FG005|Overall Study|Withdrawal by Subject|0|||
105954400|NCT01791517|365495120|FG007|Phase II|Adverse Event|1|||
105954401|NCT01791517|365495121|FG008|Phase II|Adverse Event|0|||
105954402|NCT01791517|365495122|FG009|Phase II|Adverse Event|1|||
105954403|NCT01791517|365495123|FG010|Phase II|Adverse Event|0|||
105812192|NCT02468778|364968471|FG000|Overall Study|Death|2|||
105812193|NCT02468778|364968472|FG001|Overall Study|Death|1|||
105812194|NCT02468778|364968473|FG002|Overall Study|Death|0|||
105812195|NCT02468778|364968471|FG000|Overall Study|Lost to Follow-up|1|||
105812196|NCT02468778|364968472|FG001|Overall Study|Lost to Follow-up|2|||
105812197|NCT02468778|364968473|FG002|Overall Study|Lost to Follow-up|2|||
105812198|NCT02468778|364968471|FG000|Overall Study|Withdrawal by Subject|0|||
105812199|NCT02468778|364968472|FG001|Overall Study|Withdrawal by Subject|1|||
106145090|NCT03368664|366190808|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
105812200|NCT02468778|364968473|FG002|Overall Study|Withdrawal by Subject|1|||
105812201|NCT02672553|364968474|FG000|Overall Study|Death|3|||
105954404|NCT01791517|365495124|FG011|Phase II|Adverse Event|0|||
105954405|NCT01791517|365495113|FG000|Phase II|Lens Handling Difficulties|0|||
105812202|NCT02672553|364968475|FG001|Overall Study|Death|5|||
105812203|NCT02672553|364968474|FG000|Overall Study|Valve Explant|1|||
105812204|NCT02672553|364968475|FG001|Overall Study|Valve Explant|0|||
105812205|NCT02672553|364968474|FG000|Overall Study|Conversion to Commercial Valve|3|||
105812206|NCT02672553|364968475|FG001|Overall Study|Conversion to Commercial Valve|0|||
105812207|NCT02672553|364968474|FG000|Overall Study|Withdrawal by Subject|3|||
105812208|NCT02672553|364968475|FG001|Overall Study|Withdrawal by Subject|3|||
105812209|NCT02672553|364968474|FG000|Overall Study|Intraoperative screen failure|2|||
105812210|NCT02672553|364968475|FG001|Overall Study|Intraoperative screen failure|0|||
105812211|NCT00970281|364968480|FG000|Overall Study|Lack of Efficacy|1|||
105812212|NCT00970281|364968481|FG001|Overall Study|Lack of Efficacy|14|||
105812213|NCT00970281|364968480|FG000|Overall Study|Withdrawal by Subject|0|||
105812214|NCT00970281|364968481|FG001|Overall Study|Withdrawal by Subject|1|||
105812215|NCT00970281|364968480|FG000|Overall Study|Physician Decision|1|||
105812216|NCT00970281|364968481|FG001|Overall Study|Physician Decision|1|||
105812217|NCT01139164|364968484|FG000|Overall Study|Withdrawn prior to study start|0|||
105812218|NCT01139164|364968485|FG001|Overall Study|Withdrawn prior to study start|2|||
105812219|NCT01139164|364968486|FG002|Overall Study|Withdrawn prior to study start|0|||
105812220|NCT00878995|364968489|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
105812221|NCT00878995|364968490|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
105812222|NCT02130466|364968494|FG000|Overall Study|Death|4|||
105812223|NCT02130466|364968495|FG001|Overall Study|Death|1|||
105812224|NCT02130466|364968496|FG002|Overall Study|Death|1|||
105954406|NCT01791517|365495114|FG001|Phase II|Lens Handling Difficulties|0|||
105954407|NCT01791517|365495115|FG002|Phase II|Lens Handling Difficulties|0|||
105954408|NCT01791517|365495116|FG003|Phase II|Lens Handling Difficulties|0|||
105954409|NCT01791517|365495117|FG004|Phase II|Lens Handling Difficulties|0|||
105954410|NCT01791517|365495118|FG005|Phase II|Lens Handling Difficulties|0|||
105762943|NCT02443805|364784878|FG000|Overall Study|Withdrawal by Subject|73|||
105762944|NCT02443805|364784879|FG001|Overall Study|Withdrawal by Subject|74|||
105762945|NCT02443805|364784878|FG000|Overall Study|Lost to Follow-up|19|||
105762946|NCT02443805|364784879|FG001|Overall Study|Lost to Follow-up|14|||
105762947|NCT02443805|364784878|FG000|Overall Study|Pregnancy|6|||
105762948|NCT02443805|364784879|FG001|Overall Study|Pregnancy|5|||
105762949|NCT02443805|364784878|FG000|Overall Study|Protocol Violation|2|||
105762950|NCT02443805|364784879|FG001|Overall Study|Protocol Violation|4|||
105762951|NCT02443805|364784878|FG000|Overall Study|Lack of Efficacy|1|||
105762952|NCT02443805|364784879|FG001|Overall Study|Lack of Efficacy|1|||
105762953|NCT02443805|364784878|FG000|Overall Study|Non-compliance with study drug|6|||
105762954|NCT02443805|364784879|FG001|Overall Study|Non-compliance with study drug|4|||
105762955|NCT02443805|364784878|FG000|Overall Study|Withdrawal by parent/guardian|3|||
105762956|NCT02443805|364784879|FG001|Overall Study|Withdrawal by parent/guardian|5|||
105762957|NCT02443805|364784878|FG000|Overall Study|Any other reason not above-mentioned|3|||
105762958|NCT02443805|364784879|FG001|Overall Study|Any other reason not above-mentioned|2|||
105762959|NCT02708966|364784880|FG000|Overall Study|Lost to Follow-up|2|||
105762960|NCT02708966|364784881|FG001|Overall Study|Lost to Follow-up|2|||
105762961|NCT00389441|364784882|FG000|Overall Study|Adverse Event|7|||
105762962|NCT00389441|364784882|FG000|Overall Study|Death|4|||
105762963|NCT00389441|364784882|FG000|Overall Study|Lost to Follow-up|2|||
105762964|NCT00389441|364784882|FG000|Overall Study|Withdrawal by Subject|4|||
105762965|NCT00389441|364784882|FG000|Overall Study|Physician Decision|1|||
105762966|NCT00389441|364784882|FG000|Overall Study|Protocol Violation|1|||
105762967|NCT00389441|364784882|FG000|Overall Study|Global deterioration of health status|4|||
105762968|NCT00389441|364784882|FG000|Overall Study|Objective progression or relapse|26|||
105762969|NCT00389441|364784882|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
105762970|NCT00389441|364784882|FG000|Overall Study|Clinical progression|1|||
105762971|NCT02076334|364784884|FG000|Overall Study|Protocol Violation|1|||
105762972|NCT02076334|364784885|FG001|Overall Study|Protocol Violation|0|||
105762973|NCT02076334|364784886|FG002|Overall Study|Protocol Violation|0|||
105762974|NCT02076334|364784887|FG003|Overall Study|Protocol Violation|0|||
105762975|NCT02076334|364784884|FG000|Overall Study|Lost to Follow-up|0|||
105762976|NCT02076334|364784885|FG001|Overall Study|Lost to Follow-up|1|||
105762977|NCT02076334|364784886|FG002|Overall Study|Lost to Follow-up|1|||
105762978|NCT02076334|364784887|FG003|Overall Study|Lost to Follow-up|0|||
105762979|NCT02076334|364784884|FG000|Overall Study|muscle soreness|0|||
105762980|NCT02076334|364784885|FG001|Overall Study|muscle soreness|0|||
105812225|NCT02130466|364968497|FG003|Overall Study|Death|3|||
105812226|NCT02130466|364968498|FG004|Overall Study|Death|2|||
105812227|NCT02130466|364968499|FG005|Overall Study|Death|30|||
105812228|NCT02130466|364968500|FG006|Overall Study|Death|45|||
105762981|NCT02076334|364784886|FG002|Overall Study|muscle soreness|0|||
105762982|NCT02076334|364784887|FG003|Overall Study|muscle soreness|1|||
105762983|NCT01611298|364784888|FG000|Overall Study|Relapsed|2|||
105762984|NCT01975675|364784889|FG000|Overall Study|Death|0|||
105762985|NCT01975675|364784890|FG001|Overall Study|Death|1|||
105762986|NCT01975675|364784891|FG002|Overall Study|Death|0|||
105762987|NCT01975675|364784892|FG003|Overall Study|Death|0|||
105762988|NCT00224003|364784893|FG000|Overall Study|Adverse Event|1|||
105812229|NCT02130466|364968501|FG007|Overall Study|Death|2|||
105812230|NCT02130466|364968502|FG008|Overall Study|Death|3|||
105812231|NCT02130466|364968503|FG009|Overall Study|Death|4|||
105812232|NCT02130466|364968504|FG010|Overall Study|Death|5|||
105812233|NCT02130466|364968505|FG011|Overall Study|Death|3|||
105812234|NCT02130466|364968506|FG012|Overall Study|Death|11|||
105812235|NCT02130466|364968507|FG013|Overall Study|Death|7|||
105812236|NCT02130466|364968494|FG000|Overall Study|Lost to Follow-up|1|||
105812237|NCT02130466|364968495|FG001|Overall Study|Lost to Follow-up|0|||
105812238|NCT02130466|364968496|FG002|Overall Study|Lost to Follow-up|0|||
105812239|NCT02130466|364968497|FG003|Overall Study|Lost to Follow-up|0|||
105812240|NCT02130466|364968498|FG004|Overall Study|Lost to Follow-up|0|||
105812241|NCT02130466|364968499|FG005|Overall Study|Lost to Follow-up|1|||
105812242|NCT02130466|364968500|FG006|Overall Study|Lost to Follow-up|0|||
105812243|NCT02130466|364968501|FG007|Overall Study|Lost to Follow-up|0|||
105812244|NCT02130466|364968502|FG008|Overall Study|Lost to Follow-up|0|||
105812245|NCT02130466|364968503|FG009|Overall Study|Lost to Follow-up|0|||
105812246|NCT02130466|364968504|FG010|Overall Study|Lost to Follow-up|0|||
105812247|NCT02130466|364968505|FG011|Overall Study|Lost to Follow-up|0|||
105812248|NCT02130466|364968506|FG012|Overall Study|Lost to Follow-up|1|||
105812249|NCT02130466|364968507|FG013|Overall Study|Lost to Follow-up|0|||
105812250|NCT02130466|364968494|FG000|Overall Study|Physician Decision|0|||
105812251|NCT02130466|364968495|FG001|Overall Study|Physician Decision|0|||
105812252|NCT02130466|364968496|FG002|Overall Study|Physician Decision|0|||
105812253|NCT02130466|364968497|FG003|Overall Study|Physician Decision|0|||
105812254|NCT02130466|364968498|FG004|Overall Study|Physician Decision|0|||
105812255|NCT02130466|364968499|FG005|Overall Study|Physician Decision|1|||
105812256|NCT02130466|364968500|FG006|Overall Study|Physician Decision|1|||
105812257|NCT02130466|364968501|FG007|Overall Study|Physician Decision|0|||
105812258|NCT02130466|364968502|FG008|Overall Study|Physician Decision|0|||
105812259|NCT02130466|364968503|FG009|Overall Study|Physician Decision|0|||
105812260|NCT02130466|364968504|FG010|Overall Study|Physician Decision|0|||
105812261|NCT02130466|364968505|FG011|Overall Study|Physician Decision|0|||
105812262|NCT02130466|364968506|FG012|Overall Study|Physician Decision|0|||
105812263|NCT02130466|364968507|FG013|Overall Study|Physician Decision|0|||
105812264|NCT02130466|364968494|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812265|NCT02130466|364968495|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
105812266|NCT02130466|364968496|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812267|NCT02130466|364968497|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
105812268|NCT02130466|364968498|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
105812269|NCT02130466|364968499|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
105812270|NCT02130466|364968500|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
105812271|NCT02130466|364968501|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812272|NCT02130466|364968502|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
105812273|NCT02130466|364968503|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812274|NCT02130466|364968504|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
105812275|NCT02130466|364968505|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
105812276|NCT02130466|364968506|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
105812277|NCT02130466|364968507|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
105812278|NCT02130466|364968494|FG000|Overall Study|Withdrawal by Subject|1|||
105812279|NCT02130466|364968495|FG001|Overall Study|Withdrawal by Subject|0|||
105812280|NCT02130466|364968496|FG002|Overall Study|Withdrawal by Subject|0|||
105812281|NCT02130466|364968497|FG003|Overall Study|Withdrawal by Subject|0|||
105812282|NCT02130466|364968498|FG004|Overall Study|Withdrawal by Subject|0|||
105812283|NCT02130466|364968499|FG005|Overall Study|Withdrawal by Subject|1|||
105812284|NCT02130466|364968500|FG006|Overall Study|Withdrawal by Subject|0|||
105812285|NCT02130466|364968501|FG007|Overall Study|Withdrawal by Subject|0|||
105812286|NCT02130466|364968502|FG008|Overall Study|Withdrawal by Subject|1|||
105812287|NCT02130466|364968503|FG009|Overall Study|Withdrawal by Subject|0|||
105812288|NCT02130466|364968504|FG010|Overall Study|Withdrawal by Subject|0|||
105812289|NCT02130466|364968505|FG011|Overall Study|Withdrawal by Subject|0|||
105812290|NCT02130466|364968506|FG012|Overall Study|Withdrawal by Subject|0|||
105812291|NCT02130466|364968507|FG013|Overall Study|Withdrawal by Subject|0|||
105812292|NCT01411332|364968508|FG000|Enrollment|Protocol Violation|0|||
105812293|NCT01411332|364968509|FG001|Enrollment|Protocol Violation|1|||
105812294|NCT01411332|364968508|FG000|Enrollment|Withdrawal by Subject|0|||
105812295|NCT01411332|364968509|FG001|Enrollment|Withdrawal by Subject|1|||
105812296|NCT01411332|364968508|FG000|Treatment|Lost to Follow-up|1|||
105812297|NCT01411332|364968509|FG001|Treatment|Lost to Follow-up|0|||
105812298|NCT02170688|364968510|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
105812299|NCT02170688|364968511|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
105812300|NCT02170688|364968512|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
105812301|NCT02170688|364968513|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
105812302|NCT02170688|364968514|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
105812303|NCT02170688|364968510|FG000|Overall Study|Full dose not received|0|||
105954411|NCT01791517|365495119|FG006|Phase II|Lens Handling Difficulties|0|||
105954412|NCT01791517|365495120|FG007|Phase II|Lens Handling Difficulties|0|||
105954413|NCT01791517|365495121|FG008|Phase II|Lens Handling Difficulties|1|||
105954414|NCT01791517|365495122|FG009|Phase II|Lens Handling Difficulties|0|||
105954415|NCT01791517|365495123|FG010|Phase II|Lens Handling Difficulties|0|||
105954416|NCT01791517|365495124|FG011|Phase II|Lens Handling Difficulties|0|||
105954417|NCT01791517|365495113|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
105954418|NCT01791517|365495114|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
105954419|NCT01791517|365495115|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
105954420|NCT01791517|365495116|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
105954421|NCT01791517|365495117|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
105954422|NCT01791517|365495118|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
105954423|NCT01791517|365495119|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
105954424|NCT01791517|365495120|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
105954425|NCT01791517|365495121|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
105954426|NCT01791517|365495122|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
105954427|NCT01791517|365495123|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
106017932|NCT02446899|365729223|FG000|Overall Study|Adverse Event|4|||
106017933|NCT02446899|365729224|FG001|Overall Study|Adverse Event|7|||
106017934|NCT02446899|365729223|FG000|Overall Study|Condition Under Investigation Worsened|1|||
105762989|NCT00224003|364784893|FG000|Overall Study|Protocol Violation|2|||
105762990|NCT00224003|364784893|FG000|Overall Study|Withdrawal by Subject|1|||
105762991|NCT00224003|364784893|FG000|Overall Study|unk|3|||
105762992|NCT02709109|364784898|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
105762993|NCT02709109|364784899|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
105762994|NCT02709109|364784900|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
105762995|NCT02709109|364784901|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
105762996|NCT02709109|364784898|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
105762997|NCT02709109|364784899|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
105762998|NCT02709109|364784900|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
105762999|NCT02709109|364784901|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
105763000|NCT02709109|364784898|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
105763001|NCT02709109|364784899|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
105763002|NCT02709109|364784900|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
105763003|NCT02709109|364784901|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
105763004|NCT02709109|364784898|FG000|Washout Period (28 Days)|Other|2|||
105763005|NCT02709109|364784899|FG001|Washout Period (28 Days)|Other|2|||
105763006|NCT02709109|364784900|FG002|Washout Period (28 Days)|Other|3|||
105763007|NCT02709109|364784901|FG003|Washout Period (28 Days)|Other|0|||
105763008|NCT02709109|364784898|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
105763009|NCT02709109|364784899|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
105763010|NCT02709109|364784900|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
105763011|NCT02709109|364784901|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
105763012|NCT02709109|364784898|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
105763013|NCT02709109|364784899|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
105763014|NCT02709109|364784900|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
105763015|NCT02709109|364784901|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
105763016|NCT02709109|364784898|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
105763017|NCT02709109|364784899|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
105763018|NCT02709109|364784900|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
105763019|NCT02709109|364784901|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
105763020|NCT02709109|364784898|FG000|Treatment Period 2 (28 Days)|Other|0|||
105763021|NCT02709109|364784899|FG001|Treatment Period 2 (28 Days)|Other|0|||
105763022|NCT02709109|364784900|FG002|Treatment Period 2 (28 Days)|Other|1|||
105763023|NCT02709109|364784901|FG003|Treatment Period 2 (28 Days)|Other|0|||
105763024|NCT01202760|364784903|FG000|Overall Study|Entry Criteria Not Met|0|||
105763025|NCT01202760|364784904|FG001|Overall Study|Entry Criteria Not Met|3|||
105763026|NCT01202760|364784905|FG002|Overall Study|Entry Criteria Not Met|1|||
105763027|NCT01202760|364784903|FG000|Overall Study|Adverse Event|11|||
105763028|NCT01202760|364784904|FG001|Overall Study|Adverse Event|9|||
105763029|NCT01202760|364784905|FG002|Overall Study|Adverse Event|10|||
105763030|NCT01202760|364784903|FG000|Overall Study|Death|2|||
105763031|NCT01202760|364784904|FG001|Overall Study|Death|1|||
105763032|NCT01202760|364784905|FG002|Overall Study|Death|0|||
105763033|NCT01202760|364784903|FG000|Overall Study|Lack of Efficacy|6|||
105763034|NCT01202760|364784904|FG001|Overall Study|Lack of Efficacy|8|||
105763035|NCT01202760|364784905|FG002|Overall Study|Lack of Efficacy|7|||
105763036|NCT01202760|364784903|FG000|Overall Study|Lost to Follow-up|0|||
105763037|NCT01202760|364784904|FG001|Overall Study|Lost to Follow-up|2|||
105763038|NCT01202760|364784905|FG002|Overall Study|Lost to Follow-up|1|||
105954428|NCT01791517|365495124|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
105954429|NCT01791517|365495113|FG000|Phase II|Pre-Existing Ocular Issue|0|||
105812304|NCT02170688|364968511|FG001|Overall Study|Full dose not received|1|||
105812305|NCT02170688|364968512|FG002|Overall Study|Full dose not received|0|||
105812306|NCT02170688|364968513|FG003|Overall Study|Full dose not received|0|||
105812307|NCT02170688|364968514|FG004|Overall Study|Full dose not received|0|||
105812308|NCT02170688|364968510|FG000|Overall Study|Physician Decision|0|||
105812309|NCT02170688|364968511|FG001|Overall Study|Physician Decision|0|||
105812310|NCT02170688|364968512|FG002|Overall Study|Physician Decision|1|||
105812311|NCT02170688|364968513|FG003|Overall Study|Physician Decision|0|||
105812312|NCT02170688|364968514|FG004|Overall Study|Physician Decision|0|||
105812313|NCT00679367|364968515|FG000|Overall Study|Adverse Event|7|||
105812314|NCT00679367|364968515|FG000|Overall Study|inability to swallow oral drugs|1|||
105812315|NCT00679367|364968515|FG000|Overall Study|Lack of Efficacy|3|||
105812316|NCT00679367|364968515|FG000|Overall Study|Withdrawal by Subject|1|||
105812317|NCT02448771|364968519|FG000|Overall Study|Disease Progression|30|||
105812318|NCT02448771|364968519|FG000|Overall Study|Unacceptable Toxicity|1|||
105812319|NCT02448771|364968519|FG000|Overall Study|Physician Decision|3|||
105812320|NCT02448771|364968519|FG000|Overall Study|Started new therapy|2|||
105812321|NCT00522457|364968520|FG000|Overall Study|Due to disease progression|16|||
105812322|NCT00522457|364968520|FG000|Overall Study|Adverse Event|2|||
105812323|NCT01691248|364968521|FG000|Overall Study|Protocol Violation|43|||
105812324|NCT01691248|364968522|FG001|Overall Study|Protocol Violation|27|||
105812325|NCT01691248|364968521|FG000|Overall Study|Adverse Event|24|||
105812326|NCT01691248|364968522|FG001|Overall Study|Adverse Event|22|||
105812327|NCT01691248|364968521|FG000|Overall Study|Withdrawal by Subject|20|||
105812328|NCT01691248|364968522|FG001|Overall Study|Withdrawal by Subject|18|||
105812329|NCT01691248|364968521|FG000|Overall Study|Confirmed CDAD|14|||
105812330|NCT01691248|364968522|FG001|Overall Study|Confirmed CDAD|31|||
105812331|NCT01691248|364968521|FG000|Overall Study|Lost to Follow-up|2|||
105812332|NCT01691248|364968522|FG001|Overall Study|Lost to Follow-up|5|||
105812333|NCT01691248|364968521|FG000|Overall Study|Reason not provided|4|||
105812334|NCT01691248|364968522|FG001|Overall Study|Reason not provided|4|||
105812335|NCT01691248|364968521|FG000|Overall Study|Not Treated|4|||
105812336|NCT01691248|364968522|FG001|Overall Study|Not Treated|7|||
105812337|NCT02863575|364968523|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
105812338|NCT02863575|364968524|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
105812339|NCT02863575|364968525|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
105812340|NCT02863575|364968523|FG000|Overall Study|Withdrawal by Subject|0|||
105812341|NCT02863575|364968524|FG001|Overall Study|Withdrawal by Subject|1|||
105812342|NCT02863575|364968525|FG002|Overall Study|Withdrawal by Subject|1|||
105812343|NCT02863575|364968523|FG000|Overall Study|Adverse Event|0|||
106017935|NCT02446899|365729224|FG001|Overall Study|Condition Under Investigation Worsened|4|||
106017936|NCT02446899|365729223|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
106017937|NCT02446899|365729224|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
106017938|NCT02446899|365729223|FG000|Overall Study|Lack of Efficacy|2|||
106017939|NCT02446899|365729224|FG001|Overall Study|Lack of Efficacy|8|||
106017940|NCT02446899|365729223|FG000|Overall Study|Lost to Follow-up|1|||
106017941|NCT02446899|365729224|FG001|Overall Study|Lost to Follow-up|3|||
106017942|NCT02446899|365729223|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
106017943|NCT02446899|365729224|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
106017944|NCT02446899|365729223|FG000|Overall Study|Withdrawal by Subject|11|||
106017945|NCT02446899|365729224|FG001|Overall Study|Withdrawal by Subject|19|||
106017946|NCT02446899|365729223|FG000|Overall Study|Miscellaneous|5|||
106017947|NCT02446899|365729224|FG001|Overall Study|Miscellaneous|4|||
106017948|NCT02446899|365729223|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
106017949|NCT02446899|365729224|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
106017950|NCT00084136|365729225|FG000|PI Comparison|Death|10|||
106017951|NCT00084136|365729226|FG001|PI Comparison|Death|9|||
106017952|NCT00084136|365729227|FG002|PI Comparison|Death|0|||
106017953|NCT00084136|365729225|FG000|PI Comparison|Lost to Follow-up|11|||
106017954|NCT00084136|365729226|FG001|PI Comparison|Lost to Follow-up|8|||
106017955|NCT00084136|365729227|FG002|PI Comparison|Lost to Follow-up|0|||
106017956|NCT00084136|365729225|FG000|PI Comparison|Withdrawal by Subject|33|||
106017957|NCT00084136|365729226|FG001|PI Comparison|Withdrawal by Subject|30|||
106017958|NCT00084136|365729227|FG002|PI Comparison|Withdrawal by Subject|0|||
106017959|NCT00084136|365729225|FG000|PI Comparison|Clinic site closed|1|||
105812344|NCT02863575|364968524|FG001|Overall Study|Adverse Event|1|||
105812345|NCT02863575|364968525|FG002|Overall Study|Adverse Event|0|||
105812346|NCT02785913|364970773|FG000|Overall Study|Adverse Event|5|||
105812347|NCT02785913|364970773|FG000|Overall Study|Death|2|||
105812348|NCT02785913|364970773|FG000|Overall Study|Progression|18|||
105812349|NCT02785913|364970773|FG000|Overall Study|Not protocol specified|1|||
105812350|NCT04540497|364970774|FG000|Overall Study|Adverse Event|0|||
105812351|NCT04540497|364970775|FG001|Overall Study|Adverse Event|2|||
106017960|NCT00084136|365729226|FG001|PI Comparison|Clinic site closed|0|||
106017961|NCT00084136|365729227|FG002|PI Comparison|Clinic site closed|0|||
106017962|NCT00084136|365729225|FG000|NRTI Comparison|Death|20|||
106017963|NCT00084136|365729226|FG001|NRTI Comparison|Death|0|||
106017964|NCT00084136|365729227|FG002|NRTI Comparison|Death|18|||
105954430|NCT01791517|365495114|FG001|Phase II|Pre-Existing Ocular Issue|0|||
105954431|NCT01791517|365495115|FG002|Phase II|Pre-Existing Ocular Issue|0|||
105954432|NCT01791517|365495116|FG003|Phase II|Pre-Existing Ocular Issue|0|||
105954433|NCT01791517|365495117|FG004|Phase II|Pre-Existing Ocular Issue|0|||
105954434|NCT01791517|365495118|FG005|Phase II|Pre-Existing Ocular Issue|0|||
105763039|NCT01202760|364784903|FG000|Overall Study|Parent / Caregiver Decision|0|||
105763040|NCT01202760|364784904|FG001|Overall Study|Parent / Caregiver Decision|1|||
105763041|NCT01202760|364784905|FG002|Overall Study|Parent / Caregiver Decision|0|||
105763042|NCT01202760|364784903|FG000|Overall Study|Withdrawal by Subject|17|||
105763043|NCT01202760|364784904|FG001|Overall Study|Withdrawal by Subject|18|||
105763044|NCT01202760|364784905|FG002|Overall Study|Withdrawal by Subject|14|||
105763045|NCT01202760|364784903|FG000|Overall Study|Physician Decision|0|||
105763046|NCT01202760|364784904|FG001|Overall Study|Physician Decision|1|||
105763047|NCT01202760|364784905|FG002|Overall Study|Physician Decision|0|||
105763048|NCT01202760|364784903|FG000|Overall Study|Protocol Violation|7|||
105763049|NCT01202760|364784904|FG001|Overall Study|Protocol Violation|5|||
105763050|NCT01202760|364784905|FG002|Overall Study|Protocol Violation|2|||
105763051|NCT01202760|364784903|FG000|Overall Study|Sponsor Decision|4|||
105763052|NCT01202760|364784904|FG001|Overall Study|Sponsor Decision|4|||
105763053|NCT01202760|364784905|FG002|Overall Study|Sponsor Decision|0|||
105763054|NCT03595384|364784909|FG000|Overall Study|Other time commitments|8|||
105763055|NCT03595384|364784909|FG000|Overall Study|Changes to session time|7|||
105763056|NCT03595384|364784909|FG000|Overall Study|Relocation out of country|1|||
105763057|NCT02224638|364784910|FG000|Overall Study|Adverse Event|1|||
105763058|NCT02224638|364784911|FG001|Overall Study|Adverse Event|1|||
105763059|NCT05563714|364784912|FG000|Overall Study|Death|2|||
105763060|NCT05563714|364784913|FG001|Overall Study|Death|2|||
105763061|NCT05563714|364784914|FG002|Overall Study|Death|0|||
105763062|NCT05563714|364784915|FG003|Overall Study|Death|0|||
105763063|NCT05563714|364784912|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
105763064|NCT05563714|364784913|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
105763065|NCT05563714|364784914|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
105763066|NCT05563714|364784915|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
105763067|NCT05563714|364784912|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
105763068|NCT05563714|364784913|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
105763069|NCT05563714|364784914|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
105763070|NCT05563714|364784915|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
105763071|NCT05563714|364784912|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
105763072|NCT05563714|364784913|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
105763073|NCT05563714|364784914|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
105763074|NCT05563714|364784915|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
105763075|NCT05563714|364784912|FG000|Overall Study|Lost to Follow-up|22|||
105763076|NCT05563714|364784913|FG001|Overall Study|Lost to Follow-up|19|||
105763077|NCT05563714|364784914|FG002|Overall Study|Lost to Follow-up|0|||
105763078|NCT05563714|364784915|FG003|Overall Study|Lost to Follow-up|0|||
105763079|NCT02633046|364784922|FG000|Overall Study|Adverse Event|8|||
105763080|NCT02633046|364784922|FG000|Overall Study|Physician Decision|7|||
105763081|NCT02633046|364784922|FG000|Overall Study|Withdrawal by Subject|8|||
105763082|NCT02633046|364784922|FG000|Overall Study|Increased proteinuria|2|||
105763083|NCT02633046|364784922|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
105763084|NCT02633046|364784922|FG000|Overall Study|Mutual decision patient and physician|1|||
105763085|NCT02142504|364784923|FG000|Overall Study|Protocol Violation|2|||
105763086|NCT02142504|364784924|FG001|Overall Study|Protocol Violation|1|||
105763087|NCT02142504|364784925|FG002|Overall Study|Protocol Violation|2|||
105763088|NCT02142504|364784923|FG000|Overall Study|Adverse Event|2|||
105763089|NCT02142504|364784924|FG001|Overall Study|Adverse Event|3|||
105763090|NCT02142504|364784925|FG002|Overall Study|Adverse Event|4|||
105763091|NCT02142504|364784923|FG000|Overall Study|Lost to Follow-up|12|||
105812352|NCT04540497|364970774|FG000|Overall Study|Lost to Follow-up|1|||
105812353|NCT04540497|364970775|FG001|Overall Study|Lost to Follow-up|0|||
105763092|NCT02142504|364784924|FG001|Overall Study|Lost to Follow-up|19|||
105763093|NCT02142504|364784925|FG002|Overall Study|Lost to Follow-up|17|||
105763094|NCT02142504|364784923|FG000|Overall Study|Withdrawal by Subject|7|||
105763095|NCT02142504|364784924|FG001|Overall Study|Withdrawal by Subject|9|||
105763096|NCT02142504|364784925|FG002|Overall Study|Withdrawal by Subject|11|||
105763097|NCT02142504|364784923|FG000|Overall Study|Pregnancy|4|||
105763098|NCT02142504|364784924|FG001|Overall Study|Pregnancy|4|||
105812354|NCT04540497|364970774|FG000|Overall Study|Withdrawal by Subject|1|||
105812355|NCT04540497|364970775|FG001|Overall Study|Withdrawal by Subject|1|||
105812356|NCT04540497|364970774|FG000|Overall Study|Miscellaneous|2|||
105812357|NCT04540497|364970775|FG001|Overall Study|Miscellaneous|1|||
105812358|NCT00275002|364970776|FG000|Overall Study|Death|1|||
105812359|NCT00275002|364970777|FG001|Overall Study|Death|0|||
105812360|NCT00275002|364970776|FG000|Overall Study|Disease progression|21|||
105812361|NCT00275002|364970777|FG001|Overall Study|Disease progression|15|||
105812362|NCT00275002|364970776|FG000|Overall Study|Adverse Event|0|||
105812363|NCT00275002|364970777|FG001|Overall Study|Adverse Event|1|||
105812364|NCT06165744|364970778|FG000|Overall Study|Non device-related adverse event|1|||
105812365|NCT01648166|364970779|FG000|Overall Study|inadequate toenail samples|53|||
105812366|NCT01648166|364970780|FG001|Overall Study|inadequate toenail samples|100|||
105812367|NCT03679741|364970783|FG000|Period 1|No longer meet eligibility criteria|1|||
105812368|NCT03679741|364970784|FG001|Period 1|No longer meet eligibility criteria|0|||
105812369|NCT03679741|364970783|FG000|Period 1|Lost to Follow-up|0|||
105812370|NCT03679741|364970784|FG001|Period 1|Lost to Follow-up|1|||
105812371|NCT03679741|364970783|FG000|Period 1|Adverse Event|1|||
105812372|NCT03679741|364970784|FG001|Period 1|Adverse Event|1|||
105812373|NCT03679741|364970783|FG000|Period 1|Withdrawal by Subject|0|||
106145091|NCT03368664|366190808|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
106145092|NCT03368664|366190808|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
106145093|NCT03368664|366190808|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
106145094|NCT01810263|366190809|FG000|Overall Study|Lost to Follow-up|8|||
106145095|NCT01810263|366190810|FG001|Overall Study|Lost to Follow-up|7|||
105812374|NCT03679741|364970784|FG001|Period 1|Withdrawal by Subject|1|||
105812375|NCT03679741|364970783|FG000|Period 2|Adverse Event|2|||
105812376|NCT03679741|364970784|FG001|Period 2|Adverse Event|1|||
105812377|NCT03679741|364970783|FG000|Period 2|Withdrawal by Subject|1|||
105812378|NCT03679741|364970784|FG001|Period 2|Withdrawal by Subject|1|||
105812379|NCT03194464|364970789|FG000|Overall Study|data not usable|2|||
105812380|NCT00977106|364970790|FG000|Overall Study|Adverse Event|5|||
105812381|NCT00977106|364970791|FG001|Overall Study|Adverse Event|6|||
105812382|NCT00977106|364970790|FG000|Overall Study|Withdrawal by Subject|2|||
105812383|NCT00977106|364970791|FG001|Overall Study|Withdrawal by Subject|2|||
105812384|NCT00977106|364970790|FG000|Overall Study|Lack of Efficacy|2|||
105812385|NCT00977106|364970791|FG001|Overall Study|Lack of Efficacy|2|||
105812386|NCT00977106|364970790|FG000|Overall Study|Protocol Violation|0|||
106145096|NCT01616459|366190812|FG000|Overall Study|Adverse Event|1|||
105812387|NCT00977106|364970791|FG001|Overall Study|Protocol Violation|1|||
105812388|NCT00977106|364970790|FG000|Overall Study|Other|1|||
105812389|NCT00977106|364970791|FG001|Overall Study|Other|0|||
105812390|NCT00436007|364970801|FG000|Overall Study|Withdrawal by Subject|5|||
105812391|NCT00436007|364970802|FG001|Overall Study|Withdrawal by Subject|3|||
105812392|NCT00436007|364970803|FG002|Overall Study|Withdrawal by Subject|4|||
105812393|NCT00436007|364970801|FG000|Overall Study|Lost to Follow-up|14|||
105812394|NCT00436007|364970802|FG001|Overall Study|Lost to Follow-up|10|||
105812395|NCT00436007|364970803|FG002|Overall Study|Lost to Follow-up|13|||
105812396|NCT00436007|364970801|FG000|Overall Study|Physician Decision|0|||
105812397|NCT00436007|364970802|FG001|Overall Study|Physician Decision|0|||
105812398|NCT00436007|364970803|FG002|Overall Study|Physician Decision|2|||
105812399|NCT00436007|364970801|FG000|Overall Study|Death|0|||
105812400|NCT00436007|364970802|FG001|Overall Study|Death|1|||
105812401|NCT00436007|364970803|FG002|Overall Study|Death|3|||
106145097|NCT01616459|366190813|FG001|Overall Study|Adverse Event|1|||
105812402|NCT00436007|364970801|FG000|Overall Study|Other|0|||
105812403|NCT00436007|364970802|FG001|Overall Study|Other|0|||
105812404|NCT00436007|364970803|FG002|Overall Study|Other|1|||
105812405|NCT02153398|364970804|FG000|Overall Study|Withdrawal by Subject|1|||
106145098|NCT01616459|366190814|FG002|Overall Study|Adverse Event|2|||
106145099|NCT01616459|366190815|FG003|Overall Study|Adverse Event|0|||
106145100|NCT01616459|366190812|FG000|Overall Study|Lost to Follow-up|1|||
105812406|NCT02153398|364970805|FG001|Overall Study|Withdrawal by Subject|0|||
105812407|NCT02153398|364970806|FG002|Overall Study|Withdrawal by Subject|0|||
105812408|NCT02153398|364970807|FG003|Overall Study|Withdrawal by Subject|0|||
105812409|NCT02153398|364970808|FG004|Overall Study|Withdrawal by Subject|0|||
105812410|NCT02153398|364970804|FG000|Overall Study|Adverse Event|0|||
106145101|NCT01616459|366190813|FG001|Overall Study|Lost to Follow-up|11|||
106145102|NCT01616459|366190814|FG002|Overall Study|Lost to Follow-up|3|||
106145103|NCT01616459|366190815|FG003|Overall Study|Lost to Follow-up|2|||
105812411|NCT02153398|364970805|FG001|Overall Study|Adverse Event|0|||
105812412|NCT02153398|364970806|FG002|Overall Study|Adverse Event|1|||
105812413|NCT02153398|364970807|FG003|Overall Study|Adverse Event|1|||
105812414|NCT02153398|364970808|FG004|Overall Study|Adverse Event|0|||
106145104|NCT01616459|366190812|FG000|Overall Study|Protocol Violation|0|||
105812415|NCT00721409|364970809|FG000|Overall Study|Global deterioration of health status|2|||
105812416|NCT00721409|364970810|FG001|Overall Study|Global deterioration of health status|6|||
105812417|NCT00721409|364970811|FG002|Overall Study|Global deterioration of health status|3|||
105812418|NCT00721409|364970809|FG000|Overall Study|Death|0|||
105954435|NCT01791517|365495119|FG006|Phase II|Pre-Existing Ocular Issue|0|||
105812419|NCT00721409|364970810|FG001|Overall Study|Death|1|||
105812420|NCT00721409|364970811|FG002|Overall Study|Death|0|||
105812421|NCT00721409|364970809|FG000|Overall Study|Randomized not Treated|0|||
105812422|NCT00721409|364970810|FG001|Overall Study|Randomized not Treated|1|||
105812423|NCT00721409|364970811|FG002|Overall Study|Randomized not Treated|4|||
105812424|NCT00721409|364970809|FG000|Overall Study|Reason not specified|1|||
105812425|NCT00721409|364970810|FG001|Overall Study|Reason not specified|0|||
105812426|NCT00721409|364970811|FG002|Overall Study|Reason not specified|2|||
105812427|NCT00721409|364970809|FG000|Overall Study|Adverse Event|0|||
105812428|NCT00721409|364970810|FG001|Overall Study|Adverse Event|13|||
105812429|NCT00721409|364970811|FG002|Overall Study|Adverse Event|2|||
105812430|NCT00721409|364970809|FG000|Overall Study|Lost to Follow-up|0|||
105812431|NCT00721409|364970810|FG001|Overall Study|Lost to Follow-up|0|||
105812432|NCT00721409|364970811|FG002|Overall Study|Lost to Follow-up|1|||
105812433|NCT00721409|364970809|FG000|Overall Study|Withdrawal by Subject|1|||
105812434|NCT00721409|364970810|FG001|Overall Study|Withdrawal by Subject|6|||
105812435|NCT00721409|364970811|FG002|Overall Study|Withdrawal by Subject|5|||
105812436|NCT00721409|364970809|FG000|Overall Study|Objective progression or relapse|8|||
105812437|NCT00721409|364970810|FG001|Overall Study|Objective progression or relapse|55|||
105812438|NCT00721409|364970811|FG002|Overall Study|Objective progression or relapse|62|||
105812439|NCT02402166|364970813|FG000|Overall Study|Adverse Event|2|||
105812440|NCT02402166|364970813|FG000|Overall Study|Withdrawal by Subject|2|||
105812441|NCT02402166|364970813|FG000|Overall Study|Lost to Follow-up|1|||
105812442|NCT02433678|364970814|FG000|Overall Study|Lost to Follow-up|1|||
105812443|NCT02433678|364970815|FG001|Overall Study|Lost to Follow-up|2|||
105812444|NCT01458405|364970820|FG000|Phase 1 (up to 12 Months)|Other|0|||
105812445|NCT01458405|364970821|FG001|Phase 1 (up to 12 Months)|Other|1|||
105812446|NCT01458405|364970822|FG002|Phase 1 (up to 12 Months)|Other|0|||
105812447|NCT01458405|364970823|FG003|Phase 1 (up to 12 Months)|Other|0|||
105812448|NCT01458405|364970820|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
105812449|NCT01458405|364970821|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
105812450|NCT01458405|364970822|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
105812451|NCT01458405|364970823|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
105812452|NCT01458405|364970820|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
105812453|NCT01458405|364970821|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
105954436|NCT01791517|365495120|FG007|Phase II|Pre-Existing Ocular Issue|0|||
105954437|NCT01791517|365495121|FG008|Phase II|Pre-Existing Ocular Issue|0|||
105954438|NCT01791517|365495122|FG009|Phase II|Pre-Existing Ocular Issue|0|||
105954439|NCT01791517|365495123|FG010|Phase II|Pre-Existing Ocular Issue|0|||
105763099|NCT02142504|364784925|FG002|Overall Study|Pregnancy|2|||
105763100|NCT02142504|364784923|FG000|Overall Study|Physician Decision|0|||
105763101|NCT02142504|364784924|FG001|Overall Study|Physician Decision|1|||
105763102|NCT02142504|364784925|FG002|Overall Study|Physician Decision|3|||
105763103|NCT02142504|364784923|FG000|Overall Study|Reason Not Specified|4|||
105763104|NCT02142504|364784924|FG001|Overall Study|Reason Not Specified|5|||
105763105|NCT02142504|364784925|FG002|Overall Study|Reason Not Specified|4|||
105763106|NCT02427100|364784928|FG000|Overall Study|Lost to Follow-up|0|||
105763107|NCT02427100|364784929|FG001|Overall Study|Lost to Follow-up|2|||
105763108|NCT00166517|364784940|FG000|Overall Study|Lost to Follow-up|1|||
105763109|NCT00166517|364784941|FG001|Overall Study|Lost to Follow-up|0|||
105763110|NCT00166517|364784940|FG000|Overall Study|Protocol Violation|4|||
105763111|NCT00166517|364784941|FG001|Overall Study|Protocol Violation|1|||
105763112|NCT00166517|364784940|FG000|Overall Study|Withdrawal by Subject|0|||
105763113|NCT00166517|364784941|FG001|Overall Study|Withdrawal by Subject|1|||
105763114|NCT02186561|364784943|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
105763115|NCT02186561|364784943|FG000|Enrollment|Enrollment Cap Reached|5|||
105763116|NCT02186561|364784943|FG000|Enrollment|Insurance Denial|2|||
105763117|NCT02186561|364784943|FG000|Enrollment|Withdrawal by Subject|2|||
105763118|NCT02186561|364784943|FG000|Enrollment|Investigator Withdrew Consent|1|||
105763119|NCT02186561|364784943|FG000|30-Day Post Index Procedure Visit|Death|1|||
105763120|NCT02186561|364784943|FG000|1- Year Post Index Procedure Visit|Death|1|||
105763121|NCT02186561|364784943|FG000|1- Year Post Index Procedure Visit|Missed|1|||
105763122|NCT02758613|364784944|FG000|Treatment|Physician and Sponsor Decision|1|||
105763123|NCT02758613|364784945|FG001|Treatment|Physician and Sponsor Decision|0|||
105763124|NCT02758613|364784946|FG002|Treatment|Physician and Sponsor Decision|0|||
105763125|NCT02758613|364784947|FG003|Treatment|Physician and Sponsor Decision|0|||
105763126|NCT02758613|364784944|FG000|Treatment|Withdrawal by Subject|1|||
105763127|NCT02758613|364784945|FG001|Treatment|Withdrawal by Subject|0|||
105763128|NCT02758613|364784946|FG002|Treatment|Withdrawal by Subject|1|||
105763129|NCT02758613|364784947|FG003|Treatment|Withdrawal by Subject|0|||
105763130|NCT00351819|364784948|FG000|Overall Study|Lost to Follow-up|4|||
105763131|NCT00351819|364784949|FG001|Overall Study|Lost to Follow-up|4|||
105812454|NCT01458405|364970822|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
105812455|NCT01458405|364970823|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
105812456|NCT01458405|364970820|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
105812457|NCT01458405|364970821|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
105812458|NCT01458405|364970822|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
105812459|NCT01458405|364970823|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
105812460|NCT00266409|364970824|FG000|Overall Study|Lack of Efficacy|2|||
105812461|NCT00266409|364970825|FG001|Overall Study|Lack of Efficacy|6|||
105812462|NCT00266409|364970826|FG002|Overall Study|Lack of Efficacy|1|||
105812463|NCT00266409|364970827|FG003|Overall Study|Lack of Efficacy|2|||
105812464|NCT00266409|364970824|FG000|Overall Study|Adverse Event|7|||
105812465|NCT00266409|364970825|FG001|Overall Study|Adverse Event|2|||
105812466|NCT00266409|364970826|FG002|Overall Study|Adverse Event|1|||
105812467|NCT00266409|364970827|FG003|Overall Study|Adverse Event|1|||
105812468|NCT00266409|364970824|FG000|Overall Study|Lost to Follow-up|18|||
105812469|NCT00266409|364970825|FG001|Overall Study|Lost to Follow-up|21|||
105812470|NCT00266409|364970826|FG002|Overall Study|Lost to Follow-up|6|||
105812471|NCT00266409|364970827|FG003|Overall Study|Lost to Follow-up|8|||
105812472|NCT00266409|364970824|FG000|Overall Study|Withdrawal by Subject|6|||
105812473|NCT00266409|364970825|FG001|Overall Study|Withdrawal by Subject|10|||
105812474|NCT00266409|364970826|FG002|Overall Study|Withdrawal by Subject|3|||
105812475|NCT00266409|364970827|FG003|Overall Study|Withdrawal by Subject|9|||
105812476|NCT00266409|364970824|FG000|Overall Study|Protocol Violation|5|||
105812477|NCT00266409|364970825|FG001|Overall Study|Protocol Violation|3|||
105812478|NCT00266409|364970826|FG002|Overall Study|Protocol Violation|4|||
105812479|NCT00266409|364970827|FG003|Overall Study|Protocol Violation|2|||
105812480|NCT00266409|364970824|FG000|Overall Study|Other|7|||
105812481|NCT00266409|364970825|FG001|Overall Study|Other|4|||
105812482|NCT00266409|364970826|FG002|Overall Study|Other|2|||
105812483|NCT00266409|364970827|FG003|Overall Study|Other|0|||
105812484|NCT00712010|364970828|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
105812485|NCT01946165|364970829|FG000|Overall Study|Physician Decision|2|||
105812486|NCT01946165|364970830|FG001|Overall Study|Physician Decision|0|||
105812487|NCT01946165|364970829|FG000|Overall Study|Withdrawal by Subject|0|||
105812488|NCT01946165|364970830|FG001|Overall Study|Withdrawal by Subject|2|||
105812489|NCT00454636|364970831|FG000|Overall Study|Adverse Event|10|||
105812490|NCT00454636|364970832|FG001|Overall Study|Adverse Event|6|||
105812491|NCT00454636|364970833|FG002|Overall Study|Adverse Event|9|||
105812492|NCT00454636|364970834|FG003|Overall Study|Adverse Event|15|||
105812493|NCT00454636|364970831|FG000|Overall Study|Disease Progression|11|||
105812494|NCT00454636|364970832|FG001|Overall Study|Disease Progression|12|||
105812495|NCT00454636|364970833|FG002|Overall Study|Disease Progression|4|||
105812496|NCT00454636|364970834|FG003|Overall Study|Disease Progression|11|||
105812497|NCT00454636|364970831|FG000|Overall Study|Protocol Violation|3|||
105812498|NCT00454636|364970832|FG001|Overall Study|Protocol Violation|2|||
105812499|NCT00454636|364970833|FG002|Overall Study|Protocol Violation|3|||
105812500|NCT00454636|364970834|FG003|Overall Study|Protocol Violation|3|||
105812501|NCT00454636|364970831|FG000|Overall Study|Death|6|||
105812502|NCT00454636|364970832|FG001|Overall Study|Death|1|||
105812503|NCT00454636|364970833|FG002|Overall Study|Death|1|||
106017965|NCT00084136|365729225|FG000|NRTI Comparison|Lost to Follow-up|14|||
105812504|NCT00454636|364970834|FG003|Overall Study|Death|1|||
105812505|NCT00454636|364970831|FG000|Overall Study|Patient refusal|1|||
105812506|NCT00454636|364970832|FG001|Overall Study|Patient refusal|1|||
105812507|NCT00454636|364970833|FG002|Overall Study|Patient refusal|3|||
105812508|NCT00454636|364970834|FG003|Overall Study|Patient refusal|2|||
105812509|NCT00454636|364970831|FG000|Overall Study|Lost to Follow-up|0|||
105812510|NCT00454636|364970832|FG001|Overall Study|Lost to Follow-up|1|||
105954440|NCT01791517|365495124|FG011|Phase II|Pre-Existing Ocular Issue|1|||
105954441|NCT01673646|365495128|FG000|Overall Study|Adverse Event|2|||
105954442|NCT01673646|365495129|FG001|Overall Study|Adverse Event|1|||
105954443|NCT01673646|365495130|FG002|Overall Study|Adverse Event|1|||
105954444|NCT01673646|365495128|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105954445|NCT01673646|365495129|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105954446|NCT01673646|365495130|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105954447|NCT01673646|365495128|FG000|Overall Study|Condition no longer requires study drug|0|||
105812511|NCT00454636|364970833|FG002|Overall Study|Lost to Follow-up|0|||
105812512|NCT00454636|364970834|FG003|Overall Study|Lost to Follow-up|0|||
105812513|NCT00337571|364970843|FG000|Overall Study|Lack of Efficacy|3|||
105812514|NCT00337571|364970844|FG001|Overall Study|Lack of Efficacy|0|||
105812515|NCT00337571|364970845|FG002|Overall Study|Lack of Efficacy|0|||
105812516|NCT00337571|364970846|FG003|Overall Study|Lack of Efficacy|0|||
105812517|NCT00337571|364970843|FG000|Overall Study|Adverse Event|4|||
105812518|NCT00337571|364970844|FG001|Overall Study|Adverse Event|5|||
105812519|NCT00337571|364970845|FG002|Overall Study|Adverse Event|8|||
105954448|NCT01673646|365495129|FG001|Overall Study|Condition no longer requires study drug|1|||
106017966|NCT00084136|365729226|FG001|NRTI Comparison|Lost to Follow-up|0|||
105812520|NCT00337571|364970846|FG003|Overall Study|Adverse Event|4|||
105812521|NCT00337571|364970843|FG000|Overall Study|Withdrawal by Subject|2|||
105812522|NCT00337571|364970844|FG001|Overall Study|Withdrawal by Subject|2|||
105812523|NCT00337571|364970845|FG002|Overall Study|Withdrawal by Subject|1|||
105812524|NCT00337571|364970846|FG003|Overall Study|Withdrawal by Subject|0|||
105812525|NCT00337571|364970843|FG000|Overall Study|Lost to Follow-up|3|||
105812526|NCT00337571|364970844|FG001|Overall Study|Lost to Follow-up|1|||
105812527|NCT00337571|364970845|FG002|Overall Study|Lost to Follow-up|0|||
105812528|NCT00337571|364970846|FG003|Overall Study|Lost to Follow-up|1|||
105812529|NCT00337571|364970843|FG000|Overall Study|Poor/noncompliance|1|||
105812530|NCT00337571|364970844|FG001|Overall Study|Poor/noncompliance|1|||
105812531|NCT00337571|364970845|FG002|Overall Study|Poor/noncompliance|1|||
105812532|NCT00337571|364970846|FG003|Overall Study|Poor/noncompliance|1|||
105812533|NCT00337571|364970843|FG000|Overall Study|No longer met study criteria|1|||
105812534|NCT00337571|364970844|FG001|Overall Study|No longer met study criteria|0|||
105812535|NCT00337571|364970845|FG002|Overall Study|No longer met study criteria|0|||
105812536|NCT00337571|364970846|FG003|Overall Study|No longer met study criteria|0|||
105812537|NCT00337571|364970843|FG000|Overall Study|High Potassium level|0|||
105812538|NCT00337571|364970844|FG001|Overall Study|High Potassium level|0|||
105812539|NCT00337571|364970845|FG002|Overall Study|High Potassium level|0|||
105812540|NCT00337571|364970846|FG003|Overall Study|High Potassium level|1|||
105812541|NCT02114697|364970847|FG000|Overall Study|Study terminated|5|||
105812542|NCT02114697|364970848|FG001|Overall Study|Study terminated|4|||
105812543|NCT01399736|364970849|FG000|Overall Study|Withdrawal by Subject|4|||
105812544|NCT01399736|364970850|FG001|Overall Study|Withdrawal by Subject|2|||
105812545|NCT01399736|364970849|FG000|Overall Study|Lost to Follow-up|0|||
105812546|NCT01399736|364970850|FG001|Overall Study|Lost to Follow-up|2|||
105812547|NCT03500484|364970851|FG000|Overall Study|Adverse Event|2|||
105812548|NCT03500484|364970852|FG001|Overall Study|Adverse Event|0|||
105812549|NCT03500484|364970851|FG000|Overall Study|Physician Decision|1|||
105812550|NCT03500484|364970852|FG001|Overall Study|Physician Decision|0|||
105812551|NCT03500484|364970851|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
105812552|NCT03500484|364970852|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
105812553|NCT00948675|364970853|FG000|Overall Study|Lost to Follow-up|1|||
105812554|NCT00948675|364970854|FG001|Overall Study|Lost to Follow-up|0|||
105812555|NCT02143102|364970860|FG000|Overall Study|Lost to Follow-up|11|||
105812556|NCT02143102|364970861|FG001|Overall Study|Lost to Follow-up|0|||
105812557|NCT01370408|364970865|FG000|Overall Study|treatment failure|9|||
105812558|NCT01440283|364970867|FG000|Overall Study|Death|3|||
105812559|NCT01440283|364970867|FG000|Overall Study|Withdrawal by Subject|4|||
105812560|NCT01440283|364970867|FG000|Overall Study|Physician Decision|3|||
105812561|NCT02780687|364970870|FG000|Overall Study|Adverse Event|1|||
105812562|NCT02780687|364970871|FG001|Overall Study|Adverse Event|1|||
105812563|NCT02780687|364970870|FG000|Overall Study|Withdrawal by Subject|2|||
105812564|NCT02780687|364970871|FG001|Overall Study|Withdrawal by Subject|1|||
105812565|NCT02780687|364970870|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
105812566|NCT02780687|364970871|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
105812567|NCT02780687|364970870|FG000|Overall Study|progressive disease|29|||
105812568|NCT02780687|364970871|FG001|Overall Study|progressive disease|6|||
105812569|NCT02430870|364970872|FG000|Part 2|Voluntary Withdrawal|0|||
105812570|NCT02430870|364970873|FG001|Part 2|Voluntary Withdrawal|0|||
105812571|NCT02430870|364970874|FG002|Part 2|Voluntary Withdrawal|0|||
105812572|NCT02430870|364970875|FG003|Part 2|Voluntary Withdrawal|0|||
105812573|NCT02430870|364970876|FG004|Part 2|Voluntary Withdrawal|0|||
105812574|NCT02430870|364970877|FG005|Part 2|Voluntary Withdrawal|0|||
105812575|NCT02430870|364970878|FG006|Part 2|Voluntary Withdrawal|1|||
105812576|NCT02430870|364970879|FG007|Part 2|Voluntary Withdrawal|0|||
105812577|NCT02430870|364970872|FG000|Part 2|Other Reason Not Specified|0|||
105812578|NCT02430870|364970873|FG001|Part 2|Other Reason Not Specified|0|||
105812579|NCT02430870|364970874|FG002|Part 2|Other Reason Not Specified|0|||
105812580|NCT02430870|364970875|FG003|Part 2|Other Reason Not Specified|0|||
106017967|NCT00084136|365729227|FG002|NRTI Comparison|Lost to Follow-up|12|||
106017968|NCT00084136|365729225|FG000|NRTI Comparison|Withdrawal by Subject|54|||
106017969|NCT00084136|365729226|FG001|NRTI Comparison|Withdrawal by Subject|0|||
105812581|NCT02430870|364970876|FG004|Part 2|Other Reason Not Specified|0|||
105812582|NCT02430870|364970877|FG005|Part 2|Other Reason Not Specified|0|||
105812583|NCT02430870|364970878|FG006|Part 2|Other Reason Not Specified|0|||
105812584|NCT02430870|364970879|FG007|Part 2|Other Reason Not Specified|1|||
105812585|NCT01199861|364970880|FG000|Overall Study|Administrative problems|1|||
105812586|NCT01199861|364970881|FG001|Overall Study|Administrative problems|0|||
105812587|NCT01199861|364970880|FG000|Overall Study|Adverse Event|1|||
105812588|NCT01199861|364970881|FG001|Overall Study|Adverse Event|0|||
105812589|NCT00669864|364970882|FG000|Overall Study|Lost to Follow-up|2|||
105812590|NCT00669864|364970882|FG000|Overall Study|Protocol Violation|2|||
105812591|NCT00669864|364970882|FG000|Overall Study|Withdrawal by Subject|3|||
105812592|NCT00669864|364970882|FG000|Overall Study|Other|2|||
105812593|NCT01265784|364970883|FG000|Overall Study|Lost to Follow-up|5|||
106017970|NCT00084136|365729227|FG002|NRTI Comparison|Withdrawal by Subject|38|||
105954449|NCT01673646|365495130|FG002|Overall Study|Condition no longer requires study drug|0|||
105954450|NCT01673646|365495128|FG000|Overall Study|Withdrawal by Subject|0|||
105763132|NCT00351819|364784948|FG000|Overall Study|Withdrawal by Subject|0|||
105763133|NCT00351819|364784949|FG001|Overall Study|Withdrawal by Subject|4|||
105763134|NCT00351819|364784948|FG000|Overall Study|Elevated PSA|1|||
105763135|NCT00351819|364784949|FG001|Overall Study|Elevated PSA|1|||
105763136|NCT00351819|364784948|FG000|Overall Study|Traumatic ankle fracture|1|||
105763137|NCT00351819|364784949|FG001|Overall Study|Traumatic ankle fracture|0|||
105763138|NCT00351819|364784948|FG000|Overall Study|Unprofessional behavior|1|||
105763139|NCT00351819|364784949|FG001|Overall Study|Unprofessional behavior|0|||
105763140|NCT00351819|364784948|FG000|Overall Study|Non-compliance|0|||
105763141|NCT00351819|364784949|FG001|Overall Study|Non-compliance|1|||
105763142|NCT00351819|364784948|FG000|Overall Study|Incarcerated|0|||
105763143|NCT00351819|364784949|FG001|Overall Study|Incarcerated|1|||
105763144|NCT00351819|364784948|FG000|Overall Study|Enrolled in another trial|0|||
105763145|NCT00351819|364784949|FG001|Overall Study|Enrolled in another trial|1|||
105763146|NCT00719537|364784952|FG000|Overall Study|Withdrawal by Subject|1|||
105763147|NCT00719537|364784953|FG001|Overall Study|Withdrawal by Subject|0|||
105763148|NCT00719537|364784952|FG000|Overall Study|Lost to Follow-up|0|||
105763149|NCT00719537|364784953|FG001|Overall Study|Lost to Follow-up|1|||
105763150|NCT03565991|364787045|FG000|Overall Study|Other|11|||
105763151|NCT03565991|364787046|FG001|Overall Study|Other|0|||
105763152|NCT03565991|364787045|FG000|Overall Study|Global deterioration of health status|14|||
105763153|NCT03565991|364787046|FG001|Overall Study|Global deterioration of health status|4|||
105763154|NCT03565991|364787045|FG000|Overall Study|Withdrawal by Subject|2|||
105763155|NCT03565991|364787046|FG001|Overall Study|Withdrawal by Subject|6|||
105763156|NCT03565991|364787045|FG000|Overall Study|Progressive disease|121|||
105763157|NCT03565991|364787046|FG001|Overall Study|Progressive disease|29|||
105763158|NCT03565991|364787045|FG000|Overall Study|Death|3|||
105763159|NCT03565991|364787046|FG001|Overall Study|Death|0|||
105763160|NCT03565991|364787045|FG000|Overall Study|Adverse Event|7|||
105763161|NCT03565991|364787046|FG001|Overall Study|Adverse Event|2|||
105763162|NCT02715804|364787052|FG000|Overall Study|Death|222|||
105763163|NCT02715804|364787053|FG001|Overall Study|Death|106|||
105763164|NCT02715804|364787052|FG000|Overall Study|Withdrawal by Subject|5|||
105763165|NCT02715804|364787053|FG001|Overall Study|Withdrawal by Subject|4|||
105763166|NCT02715804|364787052|FG000|Overall Study|Other than specified|2|||
105763167|NCT02715804|364787053|FG001|Overall Study|Other than specified|3|||
105763168|NCT00402285|364787055|FG000|Overall Study|insufficient RNA quality|7|||
105763169|NCT00402285|364787056|FG001|Overall Study|insufficient RNA quality|6|||
105763170|NCT00402285|364787057|FG002|Overall Study|insufficient RNA quality|2|||
105763171|NCT00693420|364787061|FG000|Overall Study|Adverse Event|4|||
105763172|NCT00693420|364787062|FG001|Overall Study|Adverse Event|4|||
105763173|NCT00693420|364787061|FG000|Overall Study|Lost to Follow-up|0|||
105763174|NCT00693420|364787062|FG001|Overall Study|Lost to Follow-up|3|||
105763175|NCT00693420|364787061|FG000|Overall Study|Withdrawal by Subject|1|||
105763176|NCT00693420|364787062|FG001|Overall Study|Withdrawal by Subject|0|||
105763177|NCT00693420|364787061|FG000|Overall Study|Protocol Violation|0|||
105763178|NCT00693420|364787062|FG001|Overall Study|Protocol Violation|2|||
105763179|NCT00693420|364787061|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
105763180|NCT00693420|364787062|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
105763181|NCT00693420|364787061|FG000|Overall Study|Personal Reasons|1|||
105763182|NCT00693420|364787062|FG001|Overall Study|Personal Reasons|4|||
105763183|NCT00254163|364787067|FG000|Overall Study|Adverse Event|29|||
105763184|NCT00254163|364787068|FG001|Overall Study|Adverse Event|26|||
105763185|NCT00254163|364787067|FG000|Overall Study|Patient request/withdrew consent|6|||
105763186|NCT00254163|364787068|FG001|Overall Study|Patient request/withdrew consent|4|||
105763187|NCT00254163|364787067|FG000|Overall Study|Investigator request|1|||
105812594|NCT01265784|364970884|FG001|Overall Study|Lost to Follow-up|3|||
105954451|NCT01673646|365495129|FG001|Overall Study|Withdrawal by Subject|2|||
105763188|NCT00254163|364787068|FG001|Overall Study|Investigator request|3|||
105763189|NCT00254163|364787067|FG000|Overall Study|Failed entry|1|||
105763190|NCT00254163|364787068|FG001|Overall Study|Failed entry|3|||
105763191|NCT00254163|364787067|FG000|Overall Study|Progressive disease|0|||
105763192|NCT00254163|364787068|FG001|Overall Study|Progressive disease|1|||
105763193|NCT00254163|364787067|FG000|Overall Study|Death|0|||
105763194|NCT00254163|364787068|FG001|Overall Study|Death|1|||
105763195|NCT00254163|364787067|FG000|Overall Study|Other|8|||
105763196|NCT00254163|364787068|FG001|Overall Study|Other|8|||
105763197|NCT05091918|364787071|FG000|Overall Study|Adverse Event|1|||
105763198|NCT05091918|364787071|FG000|Overall Study|Withdrawal by Subject|81|||
105763199|NCT04897594|364787072|FG000|Overall Study|Lost to Follow-up|0|||
105763200|NCT04897594|364787073|FG001|Overall Study|Lost to Follow-up|1|||
105763201|NCT04897594|364787074|FG002|Overall Study|Lost to Follow-up|1|||
105763202|NCT04897594|364787072|FG000|Overall Study|Sponsor Decision|0|||
106145105|NCT01616459|366190813|FG001|Overall Study|Protocol Violation|0|||
106145106|NCT01616459|366190814|FG002|Overall Study|Protocol Violation|0|||
106145107|NCT01616459|366190815|FG003|Overall Study|Protocol Violation|2|||
105812595|NCT01265784|364970885|FG002|Overall Study|Lost to Follow-up|2|||
105812596|NCT01265784|364970883|FG000|Overall Study|Withdrawal by Subject|0|||
105812597|NCT01265784|364970884|FG001|Overall Study|Withdrawal by Subject|5|||
105812598|NCT01265784|364970885|FG002|Overall Study|Withdrawal by Subject|0|||
105812599|NCT01265784|364970883|FG000|Overall Study|Physician Decision|1|||
105812600|NCT01265784|364970884|FG001|Overall Study|Physician Decision|0|||
105812601|NCT01265784|364970885|FG002|Overall Study|Physician Decision|1|||
105812602|NCT01265784|364970883|FG000|Overall Study|Adverse Event|1|||
105812603|NCT01265784|364970884|FG001|Overall Study|Adverse Event|0|||
105812604|NCT01265784|364970885|FG002|Overall Study|Adverse Event|0|||
105812605|NCT01265784|364970883|FG000|Overall Study|Death|3|||
105812606|NCT01265784|364970884|FG001|Overall Study|Death|0|||
105812607|NCT01265784|364970885|FG002|Overall Study|Death|0|||
105812608|NCT01265784|364970883|FG000|Overall Study|Protocol Violation|2|||
105812609|NCT01265784|364970884|FG001|Overall Study|Protocol Violation|0|||
105812610|NCT01265784|364970885|FG002|Overall Study|Protocol Violation|0|||
105812611|NCT01265784|364970883|FG000|Overall Study|Incorrectly Randomized|0|||
105812612|NCT01265784|364970884|FG001|Overall Study|Incorrectly Randomized|0|||
105812613|NCT01265784|364970885|FG002|Overall Study|Incorrectly Randomized|1|||
105812614|NCT00796822|364970886|FG000|Overall Study|Lost to Follow-up|2|||
105812615|NCT00796822|364970887|FG001|Overall Study|Lost to Follow-up|0|||
105812616|NCT00796822|364970886|FG000|Overall Study|Adverse Event|1|||
105812617|NCT00796822|364970887|FG001|Overall Study|Adverse Event|0|||
105812618|NCT00680121|364970888|FG000|Overall Study|Lost to Follow-up|27|||
105812619|NCT00680121|364970889|FG001|Overall Study|Lost to Follow-up|23|||
105812620|NCT02603952|364970904|FG000|Overall Study|Withdrawal by Subject|1|||
105812621|NCT02603952|364970905|FG001|Overall Study|Withdrawal by Subject|0|||
105812622|NCT02603952|364970906|FG002|Overall Study|Withdrawal by Subject|0|||
105812623|NCT02603952|364970907|FG003|Overall Study|Withdrawal by Subject|0|||
105812624|NCT02603952|364970904|FG000|Overall Study|Received oseltamivir by error|0|||
105812625|NCT02603952|364970905|FG001|Overall Study|Received oseltamivir by error|0|||
105812626|NCT02603952|364970906|FG002|Overall Study|Received oseltamivir by error|0|||
105812627|NCT02603952|364970907|FG003|Overall Study|Received oseltamivir by error|1|||
105812628|NCT00162123|364970909|FG000|Overall Study|Disease progression|27|||
105812629|NCT00162123|364970910|FG001|Overall Study|Disease progression|19|||
105812630|NCT00162123|364970911|FG002|Overall Study|Disease progression|10|||
105812631|NCT00162123|364970912|FG003|Overall Study|Disease progression|4|||
105812632|NCT00162123|364970913|FG004|Overall Study|Disease progression|8|||
105812633|NCT00162123|364970914|FG005|Overall Study|Disease progression|3|||
105812634|NCT00162123|364970915|FG006|Overall Study|Disease progression|1|||
105812635|NCT00162123|364970916|FG007|Overall Study|Disease progression|0|||
105812636|NCT00162123|364970909|FG000|Overall Study|Study drug toxicity|6|||
105812637|NCT00162123|364970910|FG001|Overall Study|Study drug toxicity|1|||
105812638|NCT00162123|364970911|FG002|Overall Study|Study drug toxicity|5|||
105812639|NCT00162123|364970912|FG003|Overall Study|Study drug toxicity|0|||
105812640|NCT00162123|364970913|FG004|Overall Study|Study drug toxicity|4|||
105812641|NCT00162123|364970914|FG005|Overall Study|Study drug toxicity|1|||
105812642|NCT00162123|364970915|FG006|Overall Study|Study drug toxicity|1|||
105812643|NCT00162123|364970916|FG007|Overall Study|Study drug toxicity|0|||
105812644|NCT00162123|364970909|FG000|Overall Study|Death|3|||
105812645|NCT00162123|364970910|FG001|Overall Study|Death|3|||
105812646|NCT00162123|364970911|FG002|Overall Study|Death|1|||
105812647|NCT00162123|364970912|FG003|Overall Study|Death|1|||
105812648|NCT00162123|364970913|FG004|Overall Study|Death|1|||
105812649|NCT00162123|364970914|FG005|Overall Study|Death|1|||
105812650|NCT00162123|364970915|FG006|Overall Study|Death|0|||
105812651|NCT00162123|364970916|FG007|Overall Study|Death|0|||
105812652|NCT00162123|364970909|FG000|Overall Study|Withdrawal by Subject|2|||
105812653|NCT00162123|364970910|FG001|Overall Study|Withdrawal by Subject|0|||
105812654|NCT00162123|364970911|FG002|Overall Study|Withdrawal by Subject|2|||
105812655|NCT00162123|364970912|FG003|Overall Study|Withdrawal by Subject|1|||
105812656|NCT00162123|364970913|FG004|Overall Study|Withdrawal by Subject|1|||
105812657|NCT00162123|364970914|FG005|Overall Study|Withdrawal by Subject|2|||
105812658|NCT00162123|364970915|FG006|Overall Study|Withdrawal by Subject|1|||
105812659|NCT00162123|364970916|FG007|Overall Study|Withdrawal by Subject|0|||
105812660|NCT00162123|364970909|FG000|Overall Study|Deterioration without progression|2|||
105812661|NCT00162123|364970910|FG001|Overall Study|Deterioration without progression|2|||
105812662|NCT00162123|364970911|FG002|Overall Study|Deterioration without progression|3|||
105812663|NCT00162123|364970912|FG003|Overall Study|Deterioration without progression|0|||
105812664|NCT00162123|364970913|FG004|Overall Study|Deterioration without progression|1|||
105812665|NCT00162123|364970914|FG005|Overall Study|Deterioration without progression|0|||
105812666|NCT00162123|364970915|FG006|Overall Study|Deterioration without progression|0|||
105812667|NCT00162123|364970916|FG007|Overall Study|Deterioration without progression|0|||
105954452|NCT01673646|365495130|FG002|Overall Study|Withdrawal by Subject|2|||
105812668|NCT00162123|364970909|FG000|Overall Study|Adverse Event|1|||
105812669|NCT00162123|364970910|FG001|Overall Study|Adverse Event|2|||
105812670|NCT00162123|364970911|FG002|Overall Study|Adverse Event|0|||
105812671|NCT00162123|364970912|FG003|Overall Study|Adverse Event|2|||
105812672|NCT00162123|364970913|FG004|Overall Study|Adverse Event|1|||
105812673|NCT00162123|364970914|FG005|Overall Study|Adverse Event|0|||
105812674|NCT00162123|364970915|FG006|Overall Study|Adverse Event|0|||
105812675|NCT00162123|364970916|FG007|Overall Study|Adverse Event|0|||
105812676|NCT00162123|364970909|FG000|Overall Study|Not specified (before treatment)|2|||
105812677|NCT00162123|364970910|FG001|Overall Study|Not specified (before treatment)|0|||
105812678|NCT00162123|364970911|FG002|Overall Study|Not specified (before treatment)|0|||
105812679|NCT00162123|364970912|FG003|Overall Study|Not specified (before treatment)|0|||
105812680|NCT00162123|364970913|FG004|Overall Study|Not specified (before treatment)|12|||
105812681|NCT00162123|364970914|FG005|Overall Study|Not specified (before treatment)|1|||
105812682|NCT00162123|364970915|FG006|Overall Study|Not specified (before treatment)|0|||
105812683|NCT00162123|364970916|FG007|Overall Study|Not specified (before treatment)|0|||
105812684|NCT00162123|364970909|FG000|Overall Study|Not specified (after start of treatment)|0|||
105812685|NCT00162123|364970910|FG001|Overall Study|Not specified (after start of treatment)|0|||
105812686|NCT00162123|364970911|FG002|Overall Study|Not specified (after start of treatment)|0|||
105812687|NCT00162123|364970912|FG003|Overall Study|Not specified (after start of treatment)|0|||
105812688|NCT00162123|364970913|FG004|Overall Study|Not specified (after start of treatment)|3|||
105812689|NCT00162123|364970914|FG005|Overall Study|Not specified (after start of treatment)|0|||
105812690|NCT00162123|364970915|FG006|Overall Study|Not specified (after start of treatment)|0|||
105812691|NCT00162123|364970916|FG007|Overall Study|Not specified (after start of treatment)|0|||
105812692|NCT00162123|364970909|FG000|Overall Study|Physician Decision|1|||
105812693|NCT00162123|364970910|FG001|Overall Study|Physician Decision|2|||
105812694|NCT00162123|364970911|FG002|Overall Study|Physician Decision|0|||
105812695|NCT00162123|364970912|FG003|Overall Study|Physician Decision|0|||
105812696|NCT00162123|364970913|FG004|Overall Study|Physician Decision|0|||
105812697|NCT00162123|364970914|FG005|Overall Study|Physician Decision|1|||
105812698|NCT00162123|364970915|FG006|Overall Study|Physician Decision|1|||
105812699|NCT00162123|364970916|FG007|Overall Study|Physician Decision|0|||
105812700|NCT00162123|364970909|FG000|Overall Study|Tumor assessment only (not treated)|0|||
105812701|NCT00162123|364970910|FG001|Overall Study|Tumor assessment only (not treated)|0|||
105812702|NCT00162123|364970911|FG002|Overall Study|Tumor assessment only (not treated)|0|||
105812703|NCT00162123|364970912|FG003|Overall Study|Tumor assessment only (not treated)|0|||
105812704|NCT00162123|364970913|FG004|Overall Study|Tumor assessment only (not treated)|0|||
105812705|NCT00162123|364970914|FG005|Overall Study|Tumor assessment only (not treated)|0|||
105812706|NCT00162123|364970915|FG006|Overall Study|Tumor assessment only (not treated)|0|||
105812707|NCT00162123|364970916|FG007|Overall Study|Tumor assessment only (not treated)|1|||
105812708|NCT00162123|364970909|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
105812709|NCT00162123|364970910|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
105812710|NCT00162123|364970911|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
105812711|NCT00162123|364970912|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
105812712|NCT00162123|364970913|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
105812713|NCT00162123|364970914|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
105812714|NCT00162123|364970915|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
105812715|NCT00162123|364970916|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
105812716|NCT01347710|364970919|FG000|Overall Study|Withdrawal by Subject|2|||
105812717|NCT01347710|364970919|FG000|Overall Study|Adverse Event|4|||
105812718|NCT01347710|364970919|FG000|Overall Study|Angio or SPECT not completed|18|||
105812719|NCT01347710|364970919|FG000|Overall Study|issue with vitals prior to dosing|1|||
105812720|NCT01347710|364970919|FG000|Overall Study|Lost to Follow-up|1|||
105812721|NCT01347710|364970919|FG000|Overall Study|Physician Decision|2|||
105812722|NCT01347710|364970919|FG000|Overall Study|Other|3|||
105812723|NCT01706926|364970920|FG000|Overall Study|Lost to Follow-up|0|||
105812724|NCT01706926|364970921|FG001|Overall Study|Lost to Follow-up|0|||
105812725|NCT01706926|364970922|FG002|Overall Study|Lost to Follow-up|1|||
105812726|NCT01706926|364970923|FG003|Overall Study|Lost to Follow-up|0|||
105812727|NCT01706926|364970920|FG000|Overall Study|Withdrawal by Subject|2|||
105812728|NCT01706926|364970921|FG001|Overall Study|Withdrawal by Subject|0|||
105812729|NCT01706926|364970922|FG002|Overall Study|Withdrawal by Subject|1|||
105812730|NCT01706926|364970923|FG003|Overall Study|Withdrawal by Subject|2|||
105812731|NCT01706926|364970920|FG000|Overall Study|Other|4|||
105812732|NCT01706926|364970921|FG001|Overall Study|Other|4|||
105812733|NCT01706926|364970922|FG002|Overall Study|Other|4|||
105812734|NCT01706926|364970923|FG003|Overall Study|Other|3|||
105812735|NCT01439165|364972394|FG000|Overall Study|Protocol Violation|3|||
105812736|NCT01439165|364972395|FG001|Overall Study|Protocol Violation|0|||
105812737|NCT01439165|364972394|FG000|Overall Study|Lost to Follow-up|11|||
105812738|NCT01439165|364972395|FG001|Overall Study|Lost to Follow-up|1|||
105812739|NCT01439165|364972394|FG000|Overall Study|Withdrawal by Subject|7|||
105812740|NCT01439165|364972395|FG001|Overall Study|Withdrawal by Subject|1|||
105812741|NCT03831048|364972403|FG000|Overall Study|Protocol Violation|9|||
105812742|NCT03831048|364972404|FG001|Overall Study|Protocol Violation|3|||
105954453|NCT01673646|365495128|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
105954454|NCT01673646|365495129|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
105954455|NCT01673646|365495130|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
105954456|NCT01881009|365495131|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
105954457|NCT01881009|365495132|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
105954458|NCT04011735|365495133|FG000|Overall Study|Withdrawal by Subject|1|||
106145108|NCT01616459|366190812|FG000|Overall Study|Withdrawal by Subject|2|||
106145109|NCT01616459|366190813|FG001|Overall Study|Withdrawal by Subject|4|||
106145110|NCT01616459|366190814|FG002|Overall Study|Withdrawal by Subject|4|||
106145111|NCT01616459|366190815|FG003|Overall Study|Withdrawal by Subject|4|||
106145112|NCT01616459|366190812|FG000|Overall Study|Other reason|0|||
106145113|NCT01616459|366190813|FG001|Overall Study|Other reason|1|||
106145114|NCT01616459|366190814|FG002|Overall Study|Other reason|1|||
106145115|NCT01616459|366190815|FG003|Overall Study|Other reason|0|||
106145116|NCT01420549|366190816|FG000|Overall Study|Adverse Event|1|||
106145117|NCT01420549|366190817|FG001|Overall Study|Adverse Event|1|||
106145118|NCT01420549|366190816|FG000|Overall Study|Lost to Follow-up|2|||
106145119|NCT01420549|366190817|FG001|Overall Study|Lost to Follow-up|2|||
106145120|NCT01420549|366190816|FG000|Overall Study|Protocol Violation|0|||
106145121|NCT01420549|366190817|FG001|Overall Study|Protocol Violation|1|||
105763203|NCT04897594|364787073|FG001|Overall Study|Sponsor Decision|0|||
105763204|NCT04897594|364787074|FG002|Overall Study|Sponsor Decision|1|||
105763205|NCT04897594|364787072|FG000|Overall Study|Withdrawal by Subject|1|||
105763206|NCT04897594|364787073|FG001|Overall Study|Withdrawal by Subject|0|||
105763207|NCT04897594|364787074|FG002|Overall Study|Withdrawal by Subject|1|||
105763208|NCT03051217|364787079|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
105763209|NCT03051217|364787080|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763210|NCT03051217|364787081|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
105763211|NCT03051217|364787082|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763212|NCT03051217|364787083|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763213|NCT03051217|364787084|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763214|NCT03051217|364787085|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
105763215|NCT03051217|364787079|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763216|NCT03051217|364787080|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
105763217|NCT03051217|364787081|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763218|NCT03051217|364787082|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763219|NCT03051217|364787083|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763220|NCT03051217|364787084|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763221|NCT03051217|364787085|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
105763222|NCT03051217|364787079|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
105763223|NCT03051217|364787080|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
105763224|NCT03051217|364787081|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
105763225|NCT03051217|364787082|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105763226|NCT03051217|364787083|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105763227|NCT03051217|364787084|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105763228|NCT03051217|364787085|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
105763229|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
105763230|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
105763231|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
105763232|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
105763233|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
105763234|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
105763235|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
105763236|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763237|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763238|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763239|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
105763240|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763241|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763242|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
105763243|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763244|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105812743|NCT03831048|364972403|FG000|Overall Study|Death|4|||
105812744|NCT03831048|364972404|FG001|Overall Study|Death|9|||
105954459|NCT04011735|365495134|FG001|Overall Study|Withdrawal by Subject|0|||
106145122|NCT01420549|366190816|FG000|Overall Study|Non-adherence to medication|4|||
106145123|NCT01420549|366190817|FG001|Overall Study|Non-adherence to medication|1|||
106145124|NCT04980755|366190818|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
106145125|NCT04980755|366190818|FG000|Body Reprogramming Courses|Work commitment|2|||
106145126|NCT04980755|366190818|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
106145127|NCT04980755|366190818|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
105812745|NCT03831048|364972403|FG000|Overall Study|Re-transplant|0|||
105812746|NCT03831048|364972404|FG001|Overall Study|Re-transplant|2|||
105812747|NCT03831048|364972403|FG000|Overall Study|Protocol violation and death|1|||
105812748|NCT03831048|364972404|FG001|Overall Study|Protocol violation and death|1|||
105812749|NCT00560235|364972406|FG000|Phase 1|Discontinued|8|||
105812750|NCT00560235|364972407|FG001|Phase 1|Discontinued|0|||
105812751|NCT00560235|364972408|FG002|Phase 1|Discontinued|0|||
106145128|NCT00589667|366191886|FG000|Overall Study|Adverse Event|2|||
106145129|NCT00589667|366191886|FG000|Overall Study|Withdrawal by Subject|1|||
106145130|NCT02544152|366191894|FG000|Overall Study|Adverse Event|0|||
106145131|NCT02544152|366191895|FG001|Overall Study|Adverse Event|4|||
106145132|NCT02544152|366191894|FG000|Overall Study|Withdrawal by Subject|0|||
106145133|NCT02544152|366191895|FG001|Overall Study|Withdrawal by Subject|3|||
106145134|NCT02544152|366191894|FG000|Overall Study|Other|1|||
106145135|NCT02544152|366191895|FG001|Overall Study|Other|0|||
106145136|NCT00845832|366191899|FG000|Treatment Period|Adverse Event|0|||
106145137|NCT00845832|366191900|FG001|Treatment Period|Adverse Event|2|||
105812752|NCT00560235|364972406|FG000|Phase 1B|Discontinued|0|||
105812753|NCT00560235|364972407|FG001|Phase 1B|Discontinued|19|||
105812754|NCT00560235|364972408|FG002|Phase 1B|Discontinued|0|||
105812755|NCT00560235|364972406|FG000|Phase 2|Discontinued|0|||
105812756|NCT00560235|364972407|FG001|Phase 2|Discontinued|0|||
105812757|NCT00560235|364972408|FG002|Phase 2|Discontinued|96|||
105812758|NCT00560235|364972406|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
105812759|NCT00560235|364972407|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
105812760|NCT00560235|364972408|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
105812761|NCT00720096|364972409|FG000|Overall Study|Withdrawal by Subject|0|||
105812762|NCT00720096|364972410|FG001|Overall Study|Withdrawal by Subject|2|||
105812763|NCT00442936|364972411|FG000|Overall Study|Protocol Violation|1|||
105954460|NCT04011735|365495135|FG002|Overall Study|Withdrawal by Subject|1|||
105954461|NCT04011735|365495133|FG000|Overall Study|Met exclusion criteria after study entry|0|||
105954462|NCT04011735|365495134|FG001|Overall Study|Met exclusion criteria after study entry|1|||
105954463|NCT04011735|365495135|FG002|Overall Study|Met exclusion criteria after study entry|0|||
105954464|NCT01000506|365495136|FG000|Overall Study|Adverse Event|6|||
105954465|NCT01000506|365495137|FG001|Overall Study|Adverse Event|5|||
105954466|NCT01000506|365495138|FG002|Overall Study|Adverse Event|8|||
105954467|NCT01000506|365495139|FG003|Overall Study|Adverse Event|9|||
105954468|NCT01000506|365495136|FG000|Overall Study|Lack of Efficacy|8|||
105954469|NCT01000506|365495137|FG001|Overall Study|Lack of Efficacy|6|||
105954470|NCT01000506|365495138|FG002|Overall Study|Lack of Efficacy|4|||
105954471|NCT01000506|365495139|FG003|Overall Study|Lack of Efficacy|4|||
105954472|NCT01000506|365495136|FG000|Overall Study|Protocol Violation|1|||
105954473|NCT01000506|365495137|FG001|Overall Study|Protocol Violation|1|||
105954474|NCT01000506|365495138|FG002|Overall Study|Protocol Violation|0|||
105954475|NCT01000506|365495139|FG003|Overall Study|Protocol Violation|0|||
105954476|NCT01000506|365495136|FG000|Overall Study|Lost to Follow-up|1|||
105954477|NCT01000506|365495137|FG001|Overall Study|Lost to Follow-up|1|||
105954478|NCT01000506|365495138|FG002|Overall Study|Lost to Follow-up|4|||
105954479|NCT01000506|365495139|FG003|Overall Study|Lost to Follow-up|0|||
105954480|NCT01000506|365495136|FG000|Overall Study|Physician Decision|1|||
105954481|NCT01000506|365495137|FG001|Overall Study|Physician Decision|3|||
105954482|NCT01000506|365495138|FG002|Overall Study|Physician Decision|3|||
105954483|NCT01000506|365495139|FG003|Overall Study|Physician Decision|3|||
105954484|NCT01000506|365495136|FG000|Overall Study|Withdrawal by Subject|11|||
105954485|NCT01000506|365495137|FG001|Overall Study|Withdrawal by Subject|8|||
105954486|NCT01000506|365495138|FG002|Overall Study|Withdrawal by Subject|2|||
105954487|NCT01000506|365495139|FG003|Overall Study|Withdrawal by Subject|7|||
105954488|NCT03064074|365495140|FG000|Overall Study|Physician Decision|0|||
105954489|NCT03064074|365495141|FG001|Overall Study|Physician Decision|0|||
105954490|NCT03064074|365495142|FG002|Overall Study|Physician Decision|0|||
106145138|NCT00845832|366191901|FG002|Treatment Period|Adverse Event|0|||
106145139|NCT00845832|366191899|FG000|Treatment Period|Protocol Violation|1|||
105812764|NCT00442936|364972412|FG001|Overall Study|Protocol Violation|0|||
105812765|NCT00442936|364972413|FG002|Overall Study|Protocol Violation|1|||
105812766|NCT00442936|364972414|FG003|Overall Study|Protocol Violation|1|||
105812767|NCT02428699|364972419|FG000|Washout Period 1|Screen Failure|1|||
105812768|NCT02428699|364972420|FG001|Washout Period 1|Screen Failure|2|||
105812769|NCT01506947|364972422|FG000|Overall Study|Lost to Follow-up|7|||
105812770|NCT01506947|364972422|FG000|Overall Study|Adverse Event|5|||
105954491|NCT03064074|365495143|FG003|Overall Study|Physician Decision|1|||
105954492|NCT01722994|365495145|FG000|Overall Study|Missing data|25|||
105954493|NCT01722994|365495146|FG001|Overall Study|Missing data|17|||
105954494|NCT01063348|365495150|FG000|Overall Study|Lost to Follow-up|3|||
105812771|NCT01506947|364972422|FG000|Overall Study|Death|1|||
105812772|NCT01506947|364972422|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
105812773|NCT02319148|364972429|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
105812774|NCT02319148|364972430|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
105812775|NCT02319148|364972431|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
105812776|NCT02319148|364972432|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
105812777|NCT02319148|364972429|FG000|Second Intervention Period|No longer willing to participate|0|||
105812778|NCT02319148|364972430|FG001|Second Intervention Period|No longer willing to participate|1|||
105812779|NCT02319148|364972431|FG002|Second Intervention Period|No longer willing to participate|0|||
105812780|NCT02319148|364972432|FG003|Second Intervention Period|No longer willing to participate|0|||
105812781|NCT02319148|364972429|FG000|Second Intervention Period|Other|0|||
105812782|NCT02319148|364972430|FG001|Second Intervention Period|Other|0|||
105812783|NCT02319148|364972431|FG002|Second Intervention Period|Other|0|||
105812784|NCT02319148|364972432|FG003|Second Intervention Period|Other|1|||
105812785|NCT01574248|364972433|FG000|Overall Study|Withdrawal by Subject|2|||
105812786|NCT01574248|364972434|FG001|Overall Study|Withdrawal by Subject|0|||
105812787|NCT01574248|364972433|FG000|Overall Study|Missing primary endpoint data|1|||
105812788|NCT01574248|364972434|FG001|Overall Study|Missing primary endpoint data|0|||
105812789|NCT04109222|364972435|FG000|Overall Study|Adverse Event|1|||
105812790|NCT04109222|364972436|FG001|Overall Study|Adverse Event|0|||
105812791|NCT04109222|364972437|FG002|Overall Study|Adverse Event|0|||
105812792|NCT01424722|364972438|FG000|Overall Study|Sponsor terminated investigation|2258|||
105812793|NCT01781286|364972439|FG000|Overall Study|Lost to Follow-up|0|||
105812794|NCT01781286|364972440|FG001|Overall Study|Lost to Follow-up|0|||
105812795|NCT01781286|364972441|FG002|Overall Study|Lost to Follow-up|0|||
105812796|NCT01781286|364972442|FG003|Overall Study|Lost to Follow-up|0|||
105812797|NCT01781286|364972443|FG004|Overall Study|Lost to Follow-up|0|||
105812798|NCT01781286|364972444|FG005|Overall Study|Lost to Follow-up|1|||
105812799|NCT01781286|364972439|FG000|Overall Study|Time Constraints|2|||
105812800|NCT01781286|364972440|FG001|Overall Study|Time Constraints|0|||
105812801|NCT01781286|364972441|FG002|Overall Study|Time Constraints|2|||
105812802|NCT01781286|364972442|FG003|Overall Study|Time Constraints|0|||
105812803|NCT01781286|364972443|FG004|Overall Study|Time Constraints|0|||
105812804|NCT01781286|364972444|FG005|Overall Study|Time Constraints|0|||
105812805|NCT01781286|364972439|FG000|Overall Study|Noncompliance|0|||
105812806|NCT01781286|364972440|FG001|Overall Study|Noncompliance|0|||
105812807|NCT01781286|364972441|FG002|Overall Study|Noncompliance|0|||
105812808|NCT01781286|364972442|FG003|Overall Study|Noncompliance|1|||
105812809|NCT01781286|364972443|FG004|Overall Study|Noncompliance|0|||
105812810|NCT01781286|364972444|FG005|Overall Study|Noncompliance|0|||
105812811|NCT00995410|364972445|FG000|Overall Study|Adverse Event|51|||
105812812|NCT00995410|364972445|FG000|Overall Study|Withdrawal by Subject|7|||
105812813|NCT00995410|364972445|FG000|Overall Study|Lost to Follow-up|2|||
105812814|NCT00995410|364972445|FG000|Overall Study|Misc|28|||
105812815|NCT02483975|364972446|FG000|Overall Study|Adverse Event|0|||
105812816|NCT02483975|364972447|FG001|Overall Study|Adverse Event|1|||
105812817|NCT02483975|364972446|FG000|Overall Study|Lost to Follow-up|0|||
105812818|NCT02483975|364972447|FG001|Overall Study|Lost to Follow-up|1|||
105812819|NCT02483975|364972446|FG000|Overall Study|Physician Decision|2|||
105812820|NCT02483975|364972447|FG001|Overall Study|Physician Decision|0|||
105812821|NCT00818883|364972448|FG000|Overall Study|Adverse Event|28|||
105812822|NCT00818883|364972449|FG001|Overall Study|Adverse Event|19|||
105812823|NCT00818883|364972448|FG000|Overall Study|Protocol Violation|2|||
105812824|NCT00818883|364972449|FG001|Overall Study|Protocol Violation|2|||
105812825|NCT00818883|364972448|FG000|Overall Study|Lost to Follow-up|3|||
105954495|NCT01063348|365495151|FG001|Overall Study|Lost to Follow-up|10|||
105954496|NCT02688192|365495152|FG000|Overall Study|Lost to Follow-up|11|||
105954497|NCT02688192|365495153|FG001|Overall Study|Lost to Follow-up|5|||
105812826|NCT00818883|364972449|FG001|Overall Study|Lost to Follow-up|2|||
105812827|NCT00818883|364972448|FG000|Overall Study|Withdrawal by Subject|16|||
105812828|NCT00818883|364972449|FG001|Overall Study|Withdrawal by Subject|14|||
105954498|NCT02688192|365495152|FG000|Overall Study|Physician Decision|1|||
105954499|NCT02688192|365495153|FG001|Overall Study|Physician Decision|0|||
105812829|NCT00818883|364972448|FG000|Overall Study|Lack of Efficacy|0|||
105812830|NCT00818883|364972449|FG001|Overall Study|Lack of Efficacy|2|||
105812831|NCT00818883|364972448|FG000|Overall Study|Other|2|||
105812832|NCT00818883|364972449|FG001|Overall Study|Other|7|||
105812833|NCT00048048|364972450|FG000|Core Treatment|Withdrawal by Subject|0|||
105812834|NCT00048048|364972451|FG001|Core Treatment|Withdrawal by Subject|0|||
105812835|NCT00048048|364972452|FG002|Core Treatment|Withdrawal by Subject|1|||
105812836|NCT00048048|364972453|FG003|Core Treatment|Withdrawal by Subject|0|||
105812837|NCT00048048|364972454|FG004|Core Treatment|Withdrawal by Subject|0|||
105812838|NCT00048048|364972455|FG005|Core Treatment|Withdrawal by Subject|0|||
105812839|NCT00048048|364972456|FG006|Core Treatment|Withdrawal by Subject|0|||
105812840|NCT00048048|364972457|FG007|Core Treatment|Withdrawal by Subject|0|||
105812841|NCT00048048|364972458|FG008|Core Treatment|Withdrawal by Subject|0|||
105954500|NCT01118780|365495154|FG000|Overall Study|Adverse Event|15|||
106017971|NCT00084136|365729225|FG000|NRTI Comparison|Clinic site closed|12|||
106017972|NCT00084136|365729226|FG001|NRTI Comparison|Clinic site closed|0|||
106017973|NCT00084136|365729227|FG002|NRTI Comparison|Clinic site closed|14|||
106017974|NCT00084136|365729225|FG000|NRTI Comparison|Not reason above|1|||
106017975|NCT00084136|365729226|FG001|NRTI Comparison|Not reason above|0|||
106017976|NCT00084136|365729227|FG002|NRTI Comparison|Not reason above|0|||
106017977|NCT02230670|365729228|FG000|Overall Study|Adverse Event|1|||
106017978|NCT02230670|365729229|FG001|Overall Study|Adverse Event|2|||
106017979|NCT02230670|365729228|FG000|Overall Study|Withdrawal by Subject|2|||
106017980|NCT02230670|365729229|FG001|Overall Study|Withdrawal by Subject|2|||
106017981|NCT02230670|365729228|FG000|Overall Study|Physician Decision|0|||
106017982|NCT02230670|365729229|FG001|Overall Study|Physician Decision|1|||
106017983|NCT02230670|365729228|FG000|Overall Study|Protocol Violation|0|||
106017984|NCT02230670|365729229|FG001|Overall Study|Protocol Violation|1|||
106145140|NCT00845832|366191900|FG001|Treatment Period|Protocol Violation|1|||
105812842|NCT00048048|364972459|FG009|Core Treatment|Withdrawal by Subject|0|||
105812843|NCT00048048|364972460|FG010|Core Treatment|Withdrawal by Subject|0|||
105812844|NCT00048048|364972461|FG011|Core Treatment|Withdrawal by Subject|0|||
105812845|NCT00048048|364972450|FG000|Core Treatment|Adverse Event|0|||
105812846|NCT00048048|364972451|FG001|Core Treatment|Adverse Event|0|||
105812847|NCT00048048|364972452|FG002|Core Treatment|Adverse Event|0|||
105812848|NCT00048048|364972453|FG003|Core Treatment|Adverse Event|0|||
105812849|NCT00048048|364972454|FG004|Core Treatment|Adverse Event|0|||
105812850|NCT00048048|364972455|FG005|Core Treatment|Adverse Event|0|||
105812851|NCT00048048|364972456|FG006|Core Treatment|Adverse Event|0|||
105812852|NCT00048048|364972457|FG007|Core Treatment|Adverse Event|1|||
105812853|NCT00048048|364972458|FG008|Core Treatment|Adverse Event|0|||
105812854|NCT00048048|364972459|FG009|Core Treatment|Adverse Event|0|||
105812855|NCT00048048|364972460|FG010|Core Treatment|Adverse Event|0|||
105812856|NCT00048048|364972461|FG011|Core Treatment|Adverse Event|0|||
105812857|NCT00048048|364972450|FG000|Extension Year 1|Early withdrawals|0|||
105812858|NCT00048048|364972451|FG001|Extension Year 1|Early withdrawals|0|||
105812859|NCT00048048|364972452|FG002|Extension Year 1|Early withdrawals|0|||
105812860|NCT00048048|364972453|FG003|Extension Year 1|Early withdrawals|0|||
105812861|NCT00048048|364972454|FG004|Extension Year 1|Early withdrawals|0|||
105812862|NCT00048048|364972455|FG005|Extension Year 1|Early withdrawals|0|||
105812863|NCT00048048|364972456|FG006|Extension Year 1|Early withdrawals|0|||
105812864|NCT00048048|364972457|FG007|Extension Year 1|Early withdrawals|0|||
105812865|NCT00048048|364972458|FG008|Extension Year 1|Early withdrawals|0|||
105812866|NCT00048048|364972459|FG009|Extension Year 1|Early withdrawals|2|||
105812867|NCT00048048|364972460|FG010|Extension Year 1|Early withdrawals|2|||
105812868|NCT00048048|364972461|FG011|Extension Year 1|Early withdrawals|4|||
105812869|NCT00048048|364972450|FG000|Extension Year 2|Early withdrawals|0|||
105812870|NCT00048048|364972451|FG001|Extension Year 2|Early withdrawals|0|||
105812871|NCT00048048|364972452|FG002|Extension Year 2|Early withdrawals|0|||
105812872|NCT00048048|364972453|FG003|Extension Year 2|Early withdrawals|0|||
105812873|NCT00048048|364972454|FG004|Extension Year 2|Early withdrawals|0|||
105812874|NCT00048048|364972455|FG005|Extension Year 2|Early withdrawals|0|||
105812875|NCT00048048|364972456|FG006|Extension Year 2|Early withdrawals|0|||
105812876|NCT00048048|364972457|FG007|Extension Year 2|Early withdrawals|0|||
105812877|NCT00048048|364972458|FG008|Extension Year 2|Early withdrawals|0|||
105812878|NCT00048048|364972459|FG009|Extension Year 2|Early withdrawals|0|||
105812879|NCT00048048|364972460|FG010|Extension Year 2|Early withdrawals|4|||
105812880|NCT00048048|364972461|FG011|Extension Year 2|Early withdrawals|2|||
105812881|NCT02684578|364972462|FG000|Overall Study|Withdrawal by Subject|10|||
106145141|NCT00845832|366191901|FG002|Treatment Period|Protocol Violation|0|||
105763245|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763246|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
105763247|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763248|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763249|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
105763250|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763251|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763252|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763253|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105812882|NCT02684578|364972463|FG001|Overall Study|Withdrawal by Subject|7|||
105812883|NCT02684578|364972462|FG000|Overall Study|Lost to Follow-up|0|||
105812884|NCT02684578|364972463|FG001|Overall Study|Lost to Follow-up|3|||
105812885|NCT02684578|364972462|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
105812886|NCT02684578|364972463|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
106017985|NCT02230670|365729228|FG000|Overall Study|Progression to Child-Pugh C|1|||
106017986|NCT02230670|365729229|FG001|Overall Study|Progression to Child-Pugh C|2|||
106017987|NCT00892099|365729235|FG000|Overall Study|Death|1|||
106017988|NCT00892099|365729236|FG001|Overall Study|Death|0|||
106017989|NCT00892099|365729237|FG002|Overall Study|Death|1|||
106145142|NCT00845832|366191899|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
106145143|NCT00845832|366191900|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
105763254|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
105763255|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763256|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
105763257|NCT03051217|364787079|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763258|NCT03051217|364787080|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763259|NCT03051217|364787081|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763260|NCT03051217|364787082|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763261|NCT03051217|364787083|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763262|NCT03051217|364787084|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
105763263|NCT03051217|364787085|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
105763264|NCT00641706|364787086|FG000|Overall Study|Adverse Event|2|||
105763265|NCT00641706|364787087|FG001|Overall Study|Adverse Event|1|||
105763266|NCT00641706|364787086|FG000|Overall Study|Withdrawal by Subject|6|||
105763267|NCT00641706|364787087|FG001|Overall Study|Withdrawal by Subject|1|||
105763268|NCT00641706|364787086|FG000|Overall Study|Clinical Decline|1|||
105763269|NCT00641706|364787087|FG001|Overall Study|Clinical Decline|0|||
105763270|NCT00641706|364787086|FG000|Overall Study|Lead Investigator Decision|0|||
105763271|NCT00641706|364787087|FG001|Overall Study|Lead Investigator Decision|1|||
105763272|NCT05166603|364787089|FG000|Overall Study|Withdrawal by Subject|68|||
105763273|NCT05166603|364787090|FG001|Overall Study|Withdrawal by Subject|0|||
105763274|NCT03375203|364787091|FG000|Overall Study|Protocol Violation|0|||
105763275|NCT03375203|364787092|FG001|Overall Study|Protocol Violation|0|||
105763276|NCT03375203|364787093|FG002|Overall Study|Protocol Violation|1|||
105763277|NCT03375203|364787094|FG003|Overall Study|Protocol Violation|0|||
105763278|NCT03375203|364787095|FG004|Overall Study|Protocol Violation|0|||
105763279|NCT03375203|364787091|FG000|Overall Study|Adverse Event|2|||
105763280|NCT03375203|364787092|FG001|Overall Study|Adverse Event|3|||
105763281|NCT03375203|364787093|FG002|Overall Study|Adverse Event|0|||
105763282|NCT03375203|364787094|FG003|Overall Study|Adverse Event|2|||
105763283|NCT03375203|364787095|FG004|Overall Study|Adverse Event|2|||
105763284|NCT03375203|364787091|FG000|Overall Study|Withdrawal by Subject|3|||
105763285|NCT03375203|364787092|FG001|Overall Study|Withdrawal by Subject|0|||
105763286|NCT03375203|364787093|FG002|Overall Study|Withdrawal by Subject|1|||
105763287|NCT03375203|364787094|FG003|Overall Study|Withdrawal by Subject|0|||
105763288|NCT03375203|364787095|FG004|Overall Study|Withdrawal by Subject|2|||
105763289|NCT03375203|364787091|FG000|Overall Study|Non-compliance with study drug|1|||
105763290|NCT03375203|364787092|FG001|Overall Study|Non-compliance with study drug|0|||
105763291|NCT03375203|364787093|FG002|Overall Study|Non-compliance with study drug|0|||
105763292|NCT03375203|364787094|FG003|Overall Study|Non-compliance with study drug|0|||
105763293|NCT03375203|364787095|FG004|Overall Study|Non-compliance with study drug|0|||
105763294|NCT03375203|364787091|FG000|Overall Study|Randomized, not treated.|0|||
105763295|NCT03375203|364787092|FG001|Overall Study|Randomized, not treated.|1|||
105763296|NCT03375203|364787093|FG002|Overall Study|Randomized, not treated.|0|||
105763297|NCT03375203|364787094|FG003|Overall Study|Randomized, not treated.|0|||
105763298|NCT03375203|364787095|FG004|Overall Study|Randomized, not treated.|0|||
105763299|NCT01112982|364787097|FG000|Overall Study|Withdrawal by Subject|1|||
105763300|NCT01112982|364787097|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
105763301|NCT02959190|364787098|FG000|Open Label|Adverse Event|5|||
105763302|NCT02959190|364787099|FG001|Open Label|Adverse Event|7|||
105763303|NCT02959190|364787100|FG002|Open Label|Adverse Event|3|||
105763304|NCT02959190|364787101|FG003|Open Label|Adverse Event|4|||
105763305|NCT02959190|364787098|FG000|Open Label|Pregnancy|0|||
105763306|NCT02959190|364787099|FG001|Open Label|Pregnancy|1|||
105763307|NCT02959190|364787100|FG002|Open Label|Pregnancy|0|||
105763308|NCT02959190|364787101|FG003|Open Label|Pregnancy|0|||
105763309|NCT02959190|364787098|FG000|Open Label|Withdrawal by Subject|2|||
105763310|NCT02959190|364787099|FG001|Open Label|Withdrawal by Subject|8|||
105763311|NCT02959190|364787100|FG002|Open Label|Withdrawal by Subject|0|||
105763312|NCT02959190|364787101|FG003|Open Label|Withdrawal by Subject|0|||
105763313|NCT02959190|364787098|FG000|Open Label|Physician Decision|0|||
105763314|NCT02959190|364787099|FG001|Open Label|Physician Decision|0|||
105763315|NCT02959190|364787100|FG002|Open Label|Physician Decision|1|||
105763316|NCT02959190|364787101|FG003|Open Label|Physician Decision|0|||
105763317|NCT02959190|364787098|FG000|Open Label|Protocol Violation|0|||
105763318|NCT02959190|364787099|FG001|Open Label|Protocol Violation|0|||
105763319|NCT02959190|364787100|FG002|Open Label|Protocol Violation|0|||
105763320|NCT02959190|364787101|FG003|Open Label|Protocol Violation|2|||
105763321|NCT02959190|364787098|FG000|Post Treatment Follow Up|Adverse Event|1|||
105763322|NCT02959190|364787099|FG001|Post Treatment Follow Up|Adverse Event|1|||
105763323|NCT02959190|364787100|FG002|Post Treatment Follow Up|Adverse Event|0|||
105763324|NCT02959190|364787101|FG003|Post Treatment Follow Up|Adverse Event|0|||
105763325|NCT02959190|364787098|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
105763326|NCT02959190|364787099|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
105812887|NCT02684578|364972462|FG000|Overall Study|Missing follow-up data|0|||
105812888|NCT02684578|364972463|FG001|Overall Study|Missing follow-up data|1|||
105812889|NCT00973700|364972464|FG000|Overall Study|Withdrawal by Subject|2|||
105812890|NCT00973700|364972465|FG001|Overall Study|Withdrawal by Subject|2|||
105812891|NCT00973700|364972466|FG002|Overall Study|Withdrawal by Subject|8|||
105812892|NCT00973700|364972467|FG003|Overall Study|Withdrawal by Subject|4|||
105812893|NCT00973700|364972468|FG004|Overall Study|Withdrawal by Subject|4|||
105812894|NCT00973700|364972464|FG000|Overall Study|Lost to Follow-up|5|||
105812895|NCT00973700|364972465|FG001|Overall Study|Lost to Follow-up|0|||
105812896|NCT00973700|364972466|FG002|Overall Study|Lost to Follow-up|1|||
105812897|NCT00973700|364972467|FG003|Overall Study|Lost to Follow-up|8|||
105812898|NCT00973700|364972468|FG004|Overall Study|Lost to Follow-up|5|||
105812899|NCT00973700|364972464|FG000|Overall Study|Inappropriate enrolment|0|||
105812900|NCT00973700|364972465|FG001|Overall Study|Inappropriate enrolment|0|||
105812901|NCT00973700|364972466|FG002|Overall Study|Inappropriate enrolment|0|||
105812902|NCT00973700|364972467|FG003|Overall Study|Inappropriate enrolment|4|||
105812903|NCT00973700|364972468|FG004|Overall Study|Inappropriate enrolment|0|||
105812904|NCT00973700|364972464|FG000|Overall Study|Unable to Classify|0|||
105812905|NCT00973700|364972465|FG001|Overall Study|Unable to Classify|0|||
105812906|NCT00973700|364972466|FG002|Overall Study|Unable to Classify|1|||
105812907|NCT00973700|364972467|FG003|Overall Study|Unable to Classify|2|||
105812908|NCT00973700|364972468|FG004|Overall Study|Unable to Classify|1|||
105812909|NCT01179919|364972469|FG000|Overall Study|Protocol Violation|1|||
105812910|NCT01179919|364972469|FG000|Overall Study|Adverse Event|1|||
105812911|NCT00525590|364972470|FG000|Overall Study|Adverse Event|3|||
105812912|NCT00525590|364972470|FG000|Overall Study|Physician Decision|3|||
105812913|NCT00525590|364972470|FG000|Overall Study|Withdrawal by Subject|16|||
105812914|NCT00525590|364972470|FG000|Overall Study|Lost to Follow-up|1|||
105812915|NCT00525590|364972470|FG000|Overall Study|Death|9|||
105812916|NCT00525590|364972470|FG000|Overall Study|Other|13|||
105812917|NCT01890915|364972471|FG000|Overall Study|Adverse Event|1|||
105812918|NCT01890915|364972472|FG001|Overall Study|Adverse Event|0|||
105812919|NCT01890915|364972471|FG000|Overall Study|Protocol Violation|2|||
105812920|NCT01890915|364972472|FG001|Overall Study|Protocol Violation|0|||
105812921|NCT01890915|364972471|FG000|Overall Study|Equipment Malfunction|0|||
105954501|NCT01118780|365495155|FG001|Overall Study|Adverse Event|15|||
105954502|NCT01118780|365495154|FG000|Overall Study|Death|1|||
105954503|NCT01118780|365495155|FG001|Overall Study|Death|0|||
105954504|NCT01118780|365495154|FG000|Overall Study|Lack of Efficacy|2|||
105812922|NCT01890915|364972472|FG001|Overall Study|Equipment Malfunction|1|||
105954505|NCT01118780|365495155|FG001|Overall Study|Lack of Efficacy|6|||
105954506|NCT01118780|365495154|FG000|Overall Study|Physician Decision|2|||
105954507|NCT01118780|365495155|FG001|Overall Study|Physician Decision|0|||
105954508|NCT01118780|365495154|FG000|Overall Study|Protocol Violation|3|||
105954509|NCT01118780|365495155|FG001|Overall Study|Protocol Violation|6|||
105954510|NCT01118780|365495154|FG000|Overall Study|Withdrawal by Subject|13|||
105954511|NCT01118780|365495155|FG001|Overall Study|Withdrawal by Subject|8|||
105954512|NCT00269087|365495160|FG000|Overall Study|Adverse Event|20|||
105954513|NCT00269087|365495160|FG000|Overall Study|Withdrawal by Subject|1|||
105954514|NCT00269087|365495160|FG000|Overall Study|Exacerbation of COPD|13|||
105954515|NCT03962855|365495166|FG000|Overall Study|Death|0|||
105954516|NCT03962855|365495167|FG001|Overall Study|Death|1|||
105954517|NCT03962855|365495166|FG000|Overall Study|Lost to Follow-up|0|||
105954518|NCT03962855|365495167|FG001|Overall Study|Lost to Follow-up|1|||
105954519|NCT03962855|365495166|FG000|Overall Study|Adverse Event|0|||
105954520|NCT03962855|365495167|FG001|Overall Study|Adverse Event|1|||
105954521|NCT03962855|365495166|FG000|Overall Study|Physician Decision|0|||
105954522|NCT03962855|365495167|FG001|Overall Study|Physician Decision|2|||
105954523|NCT05384834|365495168|FG000|Overall Study|Lost to Follow-up|43|||
105954524|NCT05384834|365495168|FG000|Overall Study|Withdrawal by Subject|5|||
105954525|NCT01071954|365495169|FG000|Overall Study|Noncompliance|4|||
105954526|NCT01071954|365495169|FG000|Overall Study|Adverse Event|1|||
105812923|NCT00424489|364972473|FG000|Overall Study|Death|3|||
105812924|NCT02660242|364972482|FG000|Glucose Tabs|Lost to Follow-up|1|||
105812925|NCT02660242|364972482|FG000|Glucagon Injection|Lost to Follow-up|1|||
105812926|NCT01345019|364972484|FG000|Blinded Treatment Phase|Death|147|||
105812927|NCT01345019|364972485|FG001|Blinded Treatment Phase|Death|137|||
105812928|NCT01345019|364972484|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
105812929|NCT01345019|364972485|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
105812930|NCT01345019|364972484|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
105812931|NCT01345019|364972485|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
105812932|NCT01345019|364972484|FG000|Blinded Treatment Phase|Disease Progression|12|||
105954527|NCT01071954|365495169|FG000|Overall Study|Withdrawal by Subject|11|||
105954528|NCT01071954|365495169|FG000|Overall Study|Requirement for Alternative Therapy|5|||
105954529|NCT01071954|365495169|FG000|Overall Study|Administrative Decision|5|||
105954530|NCT01071954|365495169|FG000|Overall Study|Protocol Specified Criteria|1|||
105954531|NCT01061385|365495170|FG000|Overall Study|Lost to Follow-up|1|||
105954532|NCT01061385|365495171|FG001|Overall Study|Lost to Follow-up|0|||
105954533|NCT01061385|365495170|FG000|Overall Study|subject decision not related to AE|0|||
105812933|NCT01345019|364972485|FG001|Blinded Treatment Phase|Disease Progression|10|||
105812934|NCT01345019|364972484|FG000|Blinded Treatment Phase|Adverse Event|6|||
105812935|NCT01345019|364972485|FG001|Blinded Treatment Phase|Adverse Event|13|||
105812936|NCT01345019|364972484|FG000|Blinded Treatment Phase|Administrative Decision|10|||
105812937|NCT01345019|364972485|FG001|Blinded Treatment Phase|Administrative Decision|8|||
105812938|NCT01345019|364972484|FG000|Blinded Treatment Phase|Noncompliance|5|||
105812939|NCT01345019|364972485|FG001|Blinded Treatment Phase|Noncompliance|3|||
105812940|NCT01345019|364972484|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
105812941|NCT01345019|364972485|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
105812942|NCT01345019|364972484|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
105812943|NCT01345019|364972485|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
105812944|NCT01345019|364972484|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
105812945|NCT01345019|364972485|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
105812946|NCT01345019|364972484|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
105812947|NCT01345019|364972485|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
105812948|NCT01345019|364972484|FG000|Open Label Treatment Phase|Death|49|||
105812949|NCT01345019|364972485|FG001|Open Label Treatment Phase|Death|48|||
105812950|NCT01345019|364972484|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
105812951|NCT01345019|364972485|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
105812952|NCT01345019|364972484|FG000|Open Label Treatment Phase|Adverse Event|30|||
105812953|NCT01345019|364972485|FG001|Open Label Treatment Phase|Adverse Event|51|||
105812954|NCT01345019|364972484|FG000|Open Label Treatment Phase|Administrative Decision|30|||
105812955|NCT01345019|364972485|FG001|Open Label Treatment Phase|Administrative Decision|15|||
105812956|NCT01345019|364972484|FG000|Open Label Treatment Phase|Disease Progression|17|||
105812957|NCT01345019|364972485|FG001|Open Label Treatment Phase|Disease Progression|18|||
105812958|NCT01345019|364972484|FG000|Open Label Treatment Phase|Noncompliance|5|||
105812959|NCT01345019|364972485|FG001|Open Label Treatment Phase|Noncompliance|4|||
105812960|NCT01345019|364972484|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
105812961|NCT01345019|364972485|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
105812962|NCT01345019|364972484|FG000|Open Label Treatment Phase|Pregnancy|1|||
105812963|NCT01345019|364972485|FG001|Open Label Treatment Phase|Pregnancy|0|||
105812964|NCT01345019|364972484|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
105812965|NCT01345019|364972485|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
105812966|NCT01345019|364972484|FG000|Open Label Treatment Phase|Protocol Violation|0|||
105812967|NCT01345019|364972485|FG001|Open Label Treatment Phase|Protocol Violation|1|||
105812968|NCT01492400|364972494|FG000|Overall Study|Miscellaneous Reasons|2|||
105812969|NCT01492400|364972495|FG001|Overall Study|Miscellaneous Reasons|3|||
105812970|NCT01492400|364972494|FG000|Overall Study|Personal Reasons|0|||
105812971|NCT01492400|364972495|FG001|Overall Study|Personal Reasons|5|||
105812972|NCT01492400|364972494|FG000|Overall Study|Lost to Follow-up|3|||
105812973|NCT01492400|364972495|FG001|Overall Study|Lost to Follow-up|1|||
105812974|NCT01492400|364972494|FG000|Overall Study|Pregnancy|0|||
105812975|NCT01492400|364972495|FG001|Overall Study|Pregnancy|1|||
105812976|NCT01492400|364972494|FG000|Overall Study|Lack of Efficacy|1|||
105812977|NCT01492400|364972495|FG001|Overall Study|Lack of Efficacy|1|||
105812978|NCT01492400|364972494|FG000|Overall Study|Adverse Event|10|||
105812979|NCT01492400|364972495|FG001|Overall Study|Adverse Event|5|||
105812980|NCT02899338|364972497|FG000|Overall Study|Adverse Event|1|||
105812981|NCT02899338|364972498|FG001|Overall Study|Adverse Event|2|||
105812982|NCT02899338|364972497|FG000|Overall Study|Withdrawal by Subject|2|||
105812983|NCT02899338|364972498|FG001|Overall Study|Withdrawal by Subject|0|||
105812984|NCT01457053|364972500|FG000|Overall Study|Unable to undergo selected treatment|1|||
105812985|NCT01457053|364972501|FG001|Overall Study|Unable to undergo selected treatment|1|||
105954534|NCT01061385|365495171|FG001|Overall Study|subject decision not related to AE|1|||
105954535|NCT01492088|365495172|FG000|Overall Study|Withdrawal by Patient|0|||
105954536|NCT01492088|365495173|FG001|Overall Study|Withdrawal by Patient|2|||
105954537|NCT01492088|365495174|FG002|Overall Study|Withdrawal by Patient|0|||
105954538|NCT01492088|365495172|FG000|Overall Study|Death|1|||
105954539|NCT01492088|365495173|FG001|Overall Study|Death|6|||
105954540|NCT01492088|365495174|FG002|Overall Study|Death|2|||
105954541|NCT01492088|365495172|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
105954542|NCT01492088|365495173|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
105812986|NCT00814463|364972502|FG000|Overall Study|Lost to Follow-up|1|||
105812987|NCT01939197|364972506|FG000|Overall Study|Withdrawal by Subject|1|||
105812988|NCT01939197|364972507|FG001|Overall Study|Withdrawal by Subject|0|||
105954543|NCT01492088|365495174|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
105812989|NCT01939197|364972508|FG002|Overall Study|Withdrawal by Subject|0|||
105812990|NCT01939197|364972509|FG003|Overall Study|Withdrawal by Subject|0|||
105812991|NCT01939197|364972510|FG004|Overall Study|Withdrawal by Subject|1|||
105812992|NCT01939197|364972511|FG005|Overall Study|Withdrawal by Subject|0|||
105812993|NCT01939197|364972512|FG006|Overall Study|Withdrawal by Subject|0|||
105812994|NCT01939197|364972506|FG000|Overall Study|Lost to Follow-up|0|||
105954544|NCT01492088|365495172|FG000|Overall Study|Alive at Last Follow-up|0|||
105954545|NCT01492088|365495173|FG001|Overall Study|Alive at Last Follow-up|6|||
105812995|NCT01939197|364972507|FG001|Overall Study|Lost to Follow-up|1|||
105812996|NCT01939197|364972508|FG002|Overall Study|Lost to Follow-up|0|||
105812997|NCT01939197|364972509|FG003|Overall Study|Lost to Follow-up|1|||
105812998|NCT01939197|364972510|FG004|Overall Study|Lost to Follow-up|3|||
105812999|NCT01939197|364972511|FG005|Overall Study|Lost to Follow-up|1|||
105813000|NCT01939197|364972512|FG006|Overall Study|Lost to Follow-up|2|||
105813001|NCT00408902|364972520|FG000|Overall Study|Lack of Efficacy|7|||
105813002|NCT00408902|364972520|FG000|Overall Study|Adverse Event|3|||
105813003|NCT01475474|364972522|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
105813004|NCT01475474|364972522|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
105813005|NCT02343120|364972523|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
105813006|NCT02343120|364972524|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
105813007|NCT02343120|364972525|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
105813008|NCT02343120|364972526|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
105813009|NCT02343120|364972527|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
105813010|NCT02343120|364972523|FG000|Part 1: Dose Escalation|Death|1|||
105813011|NCT02343120|364972524|FG001|Part 1: Dose Escalation|Death|2|||
105813012|NCT02343120|364972525|FG002|Part 1: Dose Escalation|Death|2|||
105813013|NCT02343120|364972526|FG003|Part 1: Dose Escalation|Death|2|||
105813014|NCT02343120|364972527|FG004|Part 1: Dose Escalation|Death|1|||
105813015|NCT02343120|364972523|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
105813016|NCT02343120|364972524|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
105813017|NCT02343120|364972525|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
105813018|NCT02343120|364972526|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
105813019|NCT02343120|364972527|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
105813020|NCT02343120|364972523|FG000|Part 2: Expansion|Sponsor decision|0|||
105813021|NCT02343120|364972524|FG001|Part 2: Expansion|Sponsor decision|0|||
105813022|NCT02343120|364972525|FG002|Part 2: Expansion|Sponsor decision|0|||
105813023|NCT02343120|364972526|FG003|Part 2: Expansion|Sponsor decision|165|||
105813024|NCT02343120|364972527|FG004|Part 2: Expansion|Sponsor decision|67|||
105813025|NCT02343120|364972523|FG000|Part 2: Expansion|Death|0|||
105813026|NCT02343120|364972524|FG001|Part 2: Expansion|Death|0|||
105813027|NCT02343120|364972525|FG002|Part 2: Expansion|Death|0|||
105813028|NCT02343120|364972526|FG003|Part 2: Expansion|Death|74|||
105813029|NCT02343120|364972527|FG004|Part 2: Expansion|Death|17|||
105813030|NCT02343120|364972523|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
105813031|NCT02343120|364972524|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
105813032|NCT02343120|364972525|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
105813033|NCT02343120|364972526|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
105813034|NCT02343120|364972527|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
105813035|NCT02343120|364972523|FG000|Part 2: Expansion|Lost to Follow-up|0|||
105813036|NCT02343120|364972524|FG001|Part 2: Expansion|Lost to Follow-up|0|||
105813037|NCT02343120|364972525|FG002|Part 2: Expansion|Lost to Follow-up|0|||
105813038|NCT02343120|364972526|FG003|Part 2: Expansion|Lost to Follow-up|5|||
105813039|NCT02343120|364972527|FG004|Part 2: Expansion|Lost to Follow-up|2|||
105813040|NCT02343120|364972523|FG000|Part 2: Expansion|Other|0|||
105813041|NCT02343120|364972524|FG001|Part 2: Expansion|Other|0|||
105813042|NCT02343120|364972525|FG002|Part 2: Expansion|Other|0|||
105813043|NCT02343120|364972526|FG003|Part 2: Expansion|Other|1|||
105813044|NCT02343120|364972527|FG004|Part 2: Expansion|Other|5|||
105813045|NCT02343120|364972523|FG000|Part 2: Expansion|Adverse Event|0|||
105813046|NCT02343120|364972524|FG001|Part 2: Expansion|Adverse Event|0|||
105813047|NCT02343120|364972525|FG002|Part 2: Expansion|Adverse Event|0|||
105813048|NCT02343120|364972526|FG003|Part 2: Expansion|Adverse Event|1|||
105813049|NCT02343120|364972527|FG004|Part 2: Expansion|Adverse Event|1|||
105813050|NCT02534493|364972531|FG000|Overall Study|Lost to Follow-up|1|||
105954546|NCT01492088|365495174|FG002|Overall Study|Alive at Last Follow-up|11|||
105954547|NCT00533429|365495175|FG000|Overall Study|Adverse Event|3|||
105954548|NCT00533429|365495176|FG001|Overall Study|Adverse Event|1|||
105954549|NCT00533429|365495175|FG000|Overall Study|Death|1|||
105954550|NCT00533429|365495176|FG001|Overall Study|Death|0|||
105954551|NCT00533429|365495175|FG000|Overall Study|Withdrawal by Subject|2|||
105954552|NCT00533429|365495176|FG001|Overall Study|Withdrawal by Subject|0|||
105954553|NCT00533429|365495175|FG000|Overall Study|Progressive Disease|12|||
105813051|NCT02534493|364972531|FG000|Overall Study|Withdrawal by Subject|1|||
105813052|NCT02339909|364972532|FG000|Overall Study|Became ineligible after randomisation|89|||
105813053|NCT02339909|364972533|FG001|Overall Study|Became ineligible after randomisation|63|||
105813054|NCT02339909|364972534|FG002|Overall Study|Became ineligible after randomisation|71|||
105813055|NCT00860028|364972541|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
105813056|NCT00860028|364972542|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
105813057|NCT01478620|364972543|FG000|Overall Study|Lost to Follow-up|6|||
105813058|NCT04025879|364972544|FG000|Randomization|Participant withdrew consent|0|||
105813059|NCT04025879|364972545|FG001|Randomization|Participant withdrew consent|1|||
105813060|NCT04025879|364972544|FG000|Randomization|Participant no longer met study criteria|1|||
105813061|NCT04025879|364972545|FG001|Randomization|Participant no longer met study criteria|1|||
105954554|NCT00533429|365495176|FG001|Overall Study|Progressive Disease|13|||
105954555|NCT00533429|365495175|FG000|Overall Study|Symptomatic deterioration|1|||
105813062|NCT04025879|364972544|FG000|Treatment|Ongoing treatment|10|||
105813063|NCT04025879|364972545|FG001|Treatment|Ongoing treatment|8|||
105813064|NCT04025879|364972544|FG000|Treatment|Disease progression/recurrence|36|||
105813065|NCT04025879|364972545|FG001|Treatment|Disease progression/recurrence|72|||
105813066|NCT04025879|364972544|FG000|Treatment|Study drug toxicity|36|||
105813067|NCT04025879|364972545|FG001|Treatment|Study drug toxicity|13|||
105813068|NCT04025879|364972544|FG000|Treatment|Death|2|||
105813069|NCT04025879|364972545|FG001|Treatment|Death|0|||
105813070|NCT04025879|364972544|FG000|Treatment|Adverse event unrelated to study drug|21|||
105813071|NCT04025879|364972545|FG001|Treatment|Adverse event unrelated to study drug|14|||
105813072|NCT04025879|364972544|FG000|Treatment|Participant request to discontinue study treatment|16|||
105813073|NCT04025879|364972545|FG001|Treatment|Participant request to discontinue study treatment|8|||
105813074|NCT04025879|364972544|FG000|Treatment|Participant withdrew consent|1|||
105813075|NCT04025879|364972545|FG001|Treatment|Participant withdrew consent|3|||
105813076|NCT04025879|364972544|FG000|Treatment|Participant no longer meets study criteria|3|||
105813077|NCT04025879|364972545|FG001|Treatment|Participant no longer meets study criteria|2|||
105813078|NCT04025879|364972544|FG000|Treatment|Lost to Follow-up|1|||
105813079|NCT04025879|364972545|FG001|Treatment|Lost to Follow-up|0|||
105813080|NCT04025879|364972544|FG000|Treatment|Other reasons|15|||
105813081|NCT04025879|364972545|FG001|Treatment|Other reasons|17|||
105813082|NCT04025879|364972544|FG000|Treatment|Administrative reason by sponsor|0|||
105813083|NCT04025879|364972545|FG001|Treatment|Administrative reason by sponsor|1|||
105813084|NCT04025879|364972544|FG000|Treatment|Not reported|2|||
105813085|NCT04025879|364972545|FG001|Treatment|Not reported|0|||
105813086|NCT00154102|364972548|FG000|Overall Study|investigational study phase ongoing|7|||
105813087|NCT00154102|364972549|FG001|Overall Study|investigational study phase ongoing|2|||
105813088|NCT01471522|364972551|FG000|Overall Study|Withdrawal by Subject|28|||
105813089|NCT01471522|364972552|FG001|Overall Study|Withdrawal by Subject|22|||
105813090|NCT01471522|364972551|FG000|Overall Study|Lost to Follow-up|36|||
105813091|NCT01471522|364972552|FG001|Overall Study|Lost to Follow-up|26|||
105813092|NCT01432171|364972553|FG000|Overall Study|Death|1|||
105813093|NCT01432171|364972554|FG001|Overall Study|Death|2|||
105813094|NCT01432171|364972553|FG000|Overall Study|Lost to Follow-up|6|||
105813095|NCT01432171|364972554|FG001|Overall Study|Lost to Follow-up|5|||
105813096|NCT01432171|364972553|FG000|Overall Study|Withdrawal by Subject|3|||
105813097|NCT01432171|364972554|FG001|Overall Study|Withdrawal by Subject|1|||
105813098|NCT01432171|364972553|FG000|Overall Study|Noncompliance|2|||
105813099|NCT01432171|364972554|FG001|Overall Study|Noncompliance|3|||
105813100|NCT01432171|364972553|FG000|Overall Study|Insurance denial trial coverage|1|||
105813101|NCT01432171|364972554|FG001|Overall Study|Insurance denial trial coverage|0|||
105813102|NCT01432171|364972553|FG000|Overall Study|Patient moved to palliative care|1|||
105813103|NCT01432171|364972554|FG001|Overall Study|Patient moved to palliative care|0|||
105813104|NCT04888507|364974565|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
105813105|NCT01298570|364974566|FG000|Overall Study|Disease progression, relapse during acti|64|||
105813106|NCT01298570|364974567|FG001|Overall Study|Disease progression, relapse during acti|40|||
105813107|NCT01298570|364974566|FG000|Overall Study|Adverse Event|20|||
105813108|NCT01298570|364974567|FG001|Overall Study|Adverse Event|2|||
105813109|NCT01298570|364974566|FG000|Overall Study|Withdrawal by Subject|21|||
105813110|NCT01298570|364974567|FG001|Overall Study|Withdrawal by Subject|6|||
105813111|NCT01298570|364974566|FG000|Overall Study|Treatment delay > 4 weeks|4|||
105813112|NCT01298570|364974567|FG001|Overall Study|Treatment delay > 4 weeks|5|||
105813113|NCT01298570|364974566|FG000|Overall Study|Physician Decision|4|||
105813114|NCT01298570|364974567|FG001|Overall Study|Physician Decision|2|||
105813115|NCT01298570|364974566|FG000|Overall Study|Other complicating disease|2|||
105813116|NCT01298570|364974567|FG001|Overall Study|Other complicating disease|1|||
105813117|NCT01298570|364974566|FG000|Overall Study|Surgery|2|||
105813118|NCT01298570|364974567|FG001|Overall Study|Surgery|1|||
105813119|NCT01298570|364974566|FG000|Overall Study|Symptomatic progression/deterioration|3|||
105813120|NCT01298570|364974567|FG001|Overall Study|Symptomatic progression/deterioration|2|||
105813121|NCT01298570|364974566|FG000|Overall Study|Death|0|||
105813122|NCT01298570|364974567|FG001|Overall Study|Death|1|||
106017990|NCT00892099|365729235|FG000|Overall Study|Adverse Event|1|||
106017991|NCT00892099|365729236|FG001|Overall Study|Adverse Event|0|||
106145144|NCT00845832|366191901|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
105813123|NCT01298570|364974566|FG000|Overall Study|Ineligibility|0|||
105813124|NCT01298570|364974567|FG001|Overall Study|Ineligibility|1|||
105813125|NCT05456529|364974577|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
105813126|NCT05456529|364974577|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
105813127|NCT05456529|364974577|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
105813128|NCT05456529|364974577|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
105813129|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
105813130|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
105813131|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Physician Decision|2|||
106017992|NCT00892099|365729237|FG002|Overall Study|Adverse Event|0|||
106017993|NCT00892099|365729235|FG000|Overall Study|replocated|1|||
105813132|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
105813133|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
105813134|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
105813135|NCT05456529|364974577|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
105813136|NCT00287118|364974578|FG000|Overall Study|Adverse Event|30|||
105813137|NCT00287118|364974578|FG000|Overall Study|Death|1|||
105813138|NCT00287118|364974578|FG000|Overall Study|Lack of Efficacy|11|||
105813139|NCT00287118|364974578|FG000|Overall Study|Lost to Follow-up|1|||
105813140|NCT00287118|364974578|FG000|Overall Study|Protocol Violation|2|||
105813141|NCT00287118|364974578|FG000|Overall Study|Other|7|||
105813142|NCT02564263|364974579|FG000|Overall Study|Adverse Event|31|||
105813143|NCT02564263|364974580|FG001|Overall Study|Adverse Event|29|||
105813144|NCT02564263|364974579|FG000|Overall Study|Death|270|||
105813145|NCT02564263|364974580|FG001|Overall Study|Death|262|||
105813146|NCT02564263|364974579|FG000|Overall Study|Withdrawal by Subject|4|||
105813147|NCT02564263|364974580|FG001|Overall Study|Withdrawal by Subject|19|||
105954556|NCT00533429|365495176|FG001|Overall Study|Symptomatic deterioration|2|||
105954557|NCT01881789|365495177|FG000|Overall Study|Withdrawal by Subject|0|||
105954558|NCT01881789|365495178|FG001|Overall Study|Withdrawal by Subject|2|||
105954559|NCT01881789|365495179|FG002|Overall Study|Withdrawal by Subject|1|||
105954560|NCT01881789|365495180|FG003|Overall Study|Withdrawal by Subject|0|||
105954561|NCT01881789|365495181|FG004|Overall Study|Withdrawal by Subject|1|||
105954562|NCT01881789|365495182|FG005|Overall Study|Withdrawal by Subject|1|||
105954563|NCT01881789|365495177|FG000|Overall Study|Study Terminated by Sponsor|0|||
105954564|NCT01881789|365495178|FG001|Overall Study|Study Terminated by Sponsor|0|||
105954565|NCT01881789|365495179|FG002|Overall Study|Study Terminated by Sponsor|0|||
105954566|NCT01881789|365495180|FG003|Overall Study|Study Terminated by Sponsor|0|||
105954567|NCT01881789|365495181|FG004|Overall Study|Study Terminated by Sponsor|0|||
105954568|NCT01881789|365495182|FG005|Overall Study|Study Terminated by Sponsor|1|||
105954569|NCT01881789|365495177|FG000|Overall Study|Other|3|||
105954570|NCT01881789|365495178|FG001|Overall Study|Other|5|||
105954571|NCT01881789|365495179|FG002|Overall Study|Other|2|||
105954572|NCT01881789|365495180|FG003|Overall Study|Other|3|||
105954573|NCT01881789|365495181|FG004|Overall Study|Other|1|||
105954574|NCT01881789|365495182|FG005|Overall Study|Other|1|||
105954575|NCT02379052|365495190|FG000|Overall Study|Protocol Violation|0|||
105954576|NCT02379052|365495191|FG001|Overall Study|Protocol Violation|1|||
105954577|NCT02379052|365495190|FG000|Overall Study|Adverse Event|0|||
105954578|NCT02379052|365495191|FG001|Overall Study|Adverse Event|1|||
105954579|NCT02379052|365495190|FG000|Overall Study|Physician Decision|1|||
105954580|NCT02379052|365495191|FG001|Overall Study|Physician Decision|1|||
105954581|NCT02379052|365495190|FG000|Overall Study|Withdrawal by Subject|2|||
105763327|NCT02959190|364787100|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
105763328|NCT02959190|364787101|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
105763329|NCT02023268|364787102|FG000|Overall Study|Lack of Efficacy|0|||
105763330|NCT02023268|364787103|FG001|Overall Study|Lack of Efficacy|1|||
105763331|NCT02023268|364787102|FG000|Overall Study|Adverse Event|0|||
105763332|NCT02023268|364787103|FG001|Overall Study|Adverse Event|2|||
105763333|NCT02023268|364787102|FG000|Overall Study|Withdrawal by Subject|0|||
105763334|NCT02023268|364787103|FG001|Overall Study|Withdrawal by Subject|1|||
105763335|NCT04445688|364787104|FG000|Washout (One Week)|Adverse Event|2|||
105763336|NCT04445688|364787104|FG000|Washout (One Week)|Withdrawal by Subject|1|||
105763337|NCT00126672|364787106|FG000|Overall Study|Adverse Event|4|||
105763338|NCT00126672|364787106|FG000|Overall Study|Lost to Follow-up|4|||
105763339|NCT01998399|364787108|FG000|Overall Study|Lost to Follow-up|1|||
105763340|NCT01998399|364787109|FG001|Overall Study|Lost to Follow-up|3|||
105763341|NCT01998399|364787108|FG000|Overall Study|Death|4|||
105763342|NCT01998399|364787109|FG001|Overall Study|Death|2|||
105763343|NCT01998399|364787108|FG000|Overall Study|Study stopped before dosing completed|3|||
105763344|NCT01998399|364787109|FG001|Overall Study|Study stopped before dosing completed|3|||
105763345|NCT01998399|364787108|FG000|Overall Study|Withdrawal by Subject|0|||
105763346|NCT01998399|364787109|FG001|Overall Study|Withdrawal by Subject|1|||
105954582|NCT02379052|365495191|FG001|Overall Study|Withdrawal by Subject|0|||
105954583|NCT02379052|365495190|FG000|Overall Study|Lost to Follow-up|2|||
105954584|NCT02379052|365495191|FG001|Overall Study|Lost to Follow-up|1|||
105763347|NCT01610206|364787110|FG000|Overall Study|Adverse Event|10|||
105763348|NCT01610206|364787111|FG001|Overall Study|Adverse Event|30|||
105763349|NCT04114539|364787112|FG000|Overall Study|Adverse Event|14|||
105954585|NCT02379052|365495190|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
105763350|NCT04114539|364787112|FG000|Overall Study|Lost to Follow-up|2|||
105763351|NCT04114539|364787112|FG000|Overall Study|Non-compliance with Protocol|2|||
105813148|NCT02564263|364974579|FG000|Overall Study|Sponsor's decision|9|||
105813149|NCT02564263|364974580|FG001|Overall Study|Sponsor's decision|4|||
105813150|NCT01475838|364974581|FG000|Randomized Phase|Randomized but Not Treated|0|||
105813151|NCT01475838|364974582|FG001|Randomized Phase|Randomized but Not Treated|5|||
105954586|NCT02379052|365495191|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
105954587|NCT02379052|365495190|FG000|Overall Study|Subject was Incarcerated|0|||
105954588|NCT02379052|365495191|FG001|Overall Study|Subject was Incarcerated|1|||
105954589|NCT02347085|365495194|FG000|Overall Study|Adverse Event|2|||
105954590|NCT02347085|365495194|FG000|Overall Study|Lack of Efficacy|1|||
105954591|NCT02347085|365495194|FG000|Overall Study|Withdrawal by Subject|4|||
105954592|NCT02347085|365495194|FG000|Overall Study|Lost to Follow-up|1|||
105954593|NCT02347085|365495194|FG000|Overall Study|Protocol Criteria|2|||
105954594|NCT02185534|365495201|FG000|First Period|Withdrawal by Subject|0|||
105954595|NCT02185534|365495202|FG001|First Period|Withdrawal by Subject|0|||
105954596|NCT02185534|365495203|FG002|First Period|Withdrawal by Subject|0|||
105954597|NCT02185534|365495204|FG003|First Period|Withdrawal by Subject|1|||
105954598|NCT02185534|365495205|FG004|First Period|Withdrawal by Subject|0|||
105954599|NCT02185534|365495206|FG005|First Period|Withdrawal by Subject|0|||
105954600|NCT02185534|365495201|FG000|First Washout Period|Withdrawal by Subject|1|||
105954601|NCT02185534|365495202|FG001|First Washout Period|Withdrawal by Subject|0|||
105763352|NCT04114539|364787112|FG000|Overall Study|Non-compliance with Study Drug|1|||
105763353|NCT04114539|364787112|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
105763354|NCT04114539|364787112|FG000|Overall Study|Withdrew consent|10|||
105763355|NCT04114539|364787112|FG000|Overall Study|Others not specified|5|||
105763356|NCT04114539|364787112|FG000|Overall Study|Investigator Decision|2|||
105763357|NCT00045630|364787113|FG000|Overall Study|Adverse Event|1|||
105763358|NCT00045630|364787113|FG000|Overall Study|Refusal unrelated to adverse event|1|||
105763359|NCT00045630|364787113|FG000|Overall Study|Progression/relapse|1|||
105763360|NCT00045630|364787113|FG000|Overall Study|Death|1|||
105763361|NCT00045630|364787113|FG000|Overall Study|Ineligible|2|||
105763362|NCT02983799|364787114|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
105763363|NCT02983799|364787115|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
105763364|NCT02983799|364787116|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
105763365|NCT02983799|364787117|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
105763366|NCT02983799|364787118|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
105763367|NCT02983799|364787114|FG000|Overall Study|Death|20|||
105763368|NCT02983799|364787115|FG001|Overall Study|Death|5|||
105763369|NCT02983799|364787116|FG002|Overall Study|Death|23|||
105763370|NCT02983799|364787117|FG003|Overall Study|Death|47|||
105763371|NCT02983799|364787118|FG004|Overall Study|Death|7|||
105763372|NCT02983799|364787114|FG000|Overall Study|Withdrawal by Subject|1|||
105763373|NCT02983799|364787115|FG001|Overall Study|Withdrawal by Subject|0|||
105763374|NCT02983799|364787116|FG002|Overall Study|Withdrawal by Subject|3|||
105763375|NCT02983799|364787117|FG003|Overall Study|Withdrawal by Subject|4|||
105763376|NCT02983799|364787118|FG004|Overall Study|Withdrawal by Subject|1|||
105763377|NCT02983799|364787114|FG000|Overall Study|Protocol Violation|0|||
105763378|NCT02983799|364787115|FG001|Overall Study|Protocol Violation|1|||
105763379|NCT02983799|364787116|FG002|Overall Study|Protocol Violation|0|||
105763380|NCT02983799|364787117|FG003|Overall Study|Protocol Violation|0|||
105763381|NCT02983799|364787118|FG004|Overall Study|Protocol Violation|1|||
105763382|NCT02983799|364787114|FG000|Overall Study|Lost to Follow-up|1|||
105763383|NCT02983799|364787115|FG001|Overall Study|Lost to Follow-up|0|||
105763384|NCT02983799|364787116|FG002|Overall Study|Lost to Follow-up|1|||
105763385|NCT02983799|364787117|FG003|Overall Study|Lost to Follow-up|0|||
105763386|NCT02983799|364787118|FG004|Overall Study|Lost to Follow-up|0|||
105763387|NCT00981747|364787119|FG000|Losartan|Withdrawal by Subject|1|||
105763388|NCT00981747|364787119|FG000|Losartan|Death|1|||
105763389|NCT00981747|364787119|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
105763390|NCT01225172|364787120|FG000|Overall Study|Subject decision to stop|1|||
105763391|NCT01225172|364787121|FG001|Overall Study|Subject decision to stop|0|||
105763392|NCT01225172|364787120|FG000|Overall Study|Subject request to discontinue treatment|3|||
105763393|NCT01225172|364787121|FG001|Overall Study|Subject request to discontinue treatment|1|||
105763394|NCT01225172|364787120|FG000|Overall Study|Subject no longer meets study criteria|1|||
105763395|NCT01225172|364787121|FG001|Overall Study|Subject no longer meets study criteria|0|||
105763396|NCT01225172|364787120|FG000|Overall Study|Withdrawal by Subject|1|||
105763397|NCT01225172|364787121|FG001|Overall Study|Withdrawal by Subject|0|||
105763398|NCT00179517|364787122|FG000|Overall Study|Withdrawal by Subject|2|||
105763399|NCT00179517|364787123|FG001|Overall Study|Withdrawal by Subject|1|||
105763400|NCT03136484|364787124|FG000|Overall Study|Withdrawal by Subject|19|||
105763401|NCT03136484|364787125|FG001|Overall Study|Withdrawal by Subject|14|||
105763402|NCT03136484|364787124|FG000|Overall Study|Lost to Follow-up|7|||
105763403|NCT03136484|364787125|FG001|Overall Study|Lost to Follow-up|8|||
105763404|NCT03136484|364787124|FG000|Overall Study|Death|1|||
105954602|NCT02185534|365495203|FG002|First Washout Period|Withdrawal by Subject|0|||
105954603|NCT02185534|365495204|FG003|First Washout Period|Withdrawal by Subject|0|||
106145145|NCT00845832|366191899|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
105763405|NCT03136484|364787125|FG001|Overall Study|Death|0|||
106145146|NCT00845832|366191900|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
106145147|NCT00845832|366191901|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
106145148|NCT00980330|366191903|FG000|Overall Study|Adverse Event|0|||
106145149|NCT00980330|366191904|FG001|Overall Study|Adverse Event|0|||
106145150|NCT00980330|366191905|FG002|Overall Study|Adverse Event|0|||
105954604|NCT02185534|365495205|FG004|First Washout Period|Withdrawal by Subject|1|||
106145151|NCT00980330|366191906|FG003|Overall Study|Adverse Event|1|||
106145152|NCT00980330|366191907|FG004|Overall Study|Adverse Event|0|||
106145153|NCT00980330|366191908|FG005|Overall Study|Adverse Event|0|||
106145154|NCT00980330|366191909|FG006|Overall Study|Adverse Event|0|||
105954605|NCT02185534|365495206|FG005|First Washout Period|Withdrawal by Subject|0|||
105954606|NCT02185534|365495201|FG000|First Washout Period|Protocol Violation|0|||
105954607|NCT02185534|365495202|FG001|First Washout Period|Protocol Violation|0|||
105954608|NCT02185534|365495203|FG002|First Washout Period|Protocol Violation|0|||
105954609|NCT02185534|365495204|FG003|First Washout Period|Protocol Violation|0|||
105954610|NCT02185534|365495205|FG004|First Washout Period|Protocol Violation|0|||
105954611|NCT02185534|365495206|FG005|First Washout Period|Protocol Violation|1|||
105954612|NCT01824290|365495207|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
105954613|NCT01824290|365495208|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
105954614|NCT01824290|365495209|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
105954615|NCT01824290|365495210|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
105954616|NCT01824290|365495207|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
105954617|NCT01824290|365495208|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
105954618|NCT01824290|365495209|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
105954619|NCT01824290|365495210|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
105954620|NCT01824290|365495207|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
105954621|NCT01824290|365495208|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
105954622|NCT01824290|365495209|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
105954623|NCT01824290|365495210|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
105954624|NCT01824290|365495207|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
105954625|NCT01824290|365495208|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
105954626|NCT01824290|365495209|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
105954627|NCT01824290|365495210|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
105954628|NCT01824290|365495207|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
105954629|NCT01824290|365495208|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
105954630|NCT01824290|365495209|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
105954631|NCT01824290|365495210|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
105954632|NCT01824290|365495207|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
105954633|NCT01824290|365495208|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
105954634|NCT01824290|365495209|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
105954635|NCT01824290|365495210|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
105954636|NCT03542266|365495217|FG000|Treatment Phase|Withdrawal by Subject|1|||
105954637|NCT03542266|365495217|FG000|Treatment Phase|Adverse Event|1|||
105954638|NCT03542266|365495217|FG000|Treatment Phase|PD|1|||
105954639|NCT03688919|365496594|FG000|Overall Study|Lost to Follow-up|2|||
105954640|NCT03688919|365496595|FG001|Overall Study|Lost to Follow-up|1|||
105954641|NCT03688919|365496594|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
105954642|NCT03688919|365496595|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
105954643|NCT04512001|365496602|FG000|Week 0 to Week 24|Adverse Event|14|||
105954644|NCT04512001|365496603|FG001|Week 0 to Week 24|Adverse Event|10|||
105954645|NCT04512001|365496604|FG002|Week 0 to Week 24|Adverse Event|0|||
105954646|NCT04512001|365496605|FG003|Week 0 to Week 24|Adverse Event|0|||
106145155|NCT00980330|366191903|FG000|Overall Study|Lost to Follow-up|1|||
105763406|NCT00437203|364787126|FG000|Overall Study|Death|0|||
105763407|NCT00437203|364787127|FG001|Overall Study|Death|0|||
105763408|NCT00437203|364787128|FG002|Overall Study|Death|1|||
105763409|NCT00437203|364787129|FG003|Overall Study|Death|0|||
105763410|NCT00437203|364787130|FG004|Overall Study|Death|0|||
105763411|NCT00437203|364787131|FG005|Overall Study|Death|0|||
105763412|NCT00437203|364787132|FG006|Overall Study|Death|0|||
105763413|NCT00437203|364787133|FG007|Overall Study|Death|1|||
105763414|NCT00437203|364787134|FG008|Overall Study|Death|0|||
105763415|NCT00437203|364787135|FG009|Overall Study|Death|1|||
105763416|NCT00437203|364787126|FG000|Overall Study|Adverse Event|1|||
105763417|NCT00437203|364787127|FG001|Overall Study|Adverse Event|1|||
105763418|NCT00437203|364787128|FG002|Overall Study|Adverse Event|0|||
105763419|NCT00437203|364787129|FG003|Overall Study|Adverse Event|0|||
105763420|NCT00437203|364787130|FG004|Overall Study|Adverse Event|0|||
105763421|NCT00437203|364787131|FG005|Overall Study|Adverse Event|0|||
105763422|NCT00437203|364787132|FG006|Overall Study|Adverse Event|0|||
105763423|NCT00437203|364787133|FG007|Overall Study|Adverse Event|1|||
105763424|NCT00437203|364787134|FG008|Overall Study|Adverse Event|0|||
105763425|NCT00437203|364787135|FG009|Overall Study|Adverse Event|1|||
105763426|NCT00437203|364787126|FG000|Overall Study|Study terminated by sponsor|0|||
105954647|NCT04512001|365496606|FG004|Week 0 to Week 24|Adverse Event|0|||
105954648|NCT04512001|365496602|FG000|Week 0 to Week 24|Death|0|||
105954649|NCT04512001|365496603|FG001|Week 0 to Week 24|Death|2|||
105954650|NCT04512001|365496604|FG002|Week 0 to Week 24|Death|0|||
105763427|NCT00437203|364787127|FG001|Overall Study|Study terminated by sponsor|0|||
105763428|NCT00437203|364787128|FG002|Overall Study|Study terminated by sponsor|0|||
105954651|NCT04512001|365496605|FG003|Week 0 to Week 24|Death|0|||
105954652|NCT04512001|365496606|FG004|Week 0 to Week 24|Death|0|||
105954653|NCT04512001|365496602|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
105954654|NCT04512001|365496603|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
105954655|NCT04512001|365496604|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
105954656|NCT04512001|365496605|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
105954657|NCT04512001|365496606|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
106145156|NCT00980330|366191904|FG001|Overall Study|Lost to Follow-up|1|||
106145157|NCT00980330|366191905|FG002|Overall Study|Lost to Follow-up|4|||
106145158|NCT00980330|366191906|FG003|Overall Study|Lost to Follow-up|2|||
106145159|NCT00980330|366191907|FG004|Overall Study|Lost to Follow-up|1|||
106145160|NCT00980330|366191908|FG005|Overall Study|Lost to Follow-up|1|||
106145161|NCT00980330|366191909|FG006|Overall Study|Lost to Follow-up|2|||
106145162|NCT00980330|366191903|FG000|Overall Study|Withdrawal by Subject|2|||
106145163|NCT00980330|366191904|FG001|Overall Study|Withdrawal by Subject|4|||
106145164|NCT00980330|366191905|FG002|Overall Study|Withdrawal by Subject|4|||
106145165|NCT00980330|366191906|FG003|Overall Study|Withdrawal by Subject|1|||
106145166|NCT00980330|366191907|FG004|Overall Study|Withdrawal by Subject|3|||
106145167|NCT00980330|366191908|FG005|Overall Study|Withdrawal by Subject|2|||
106145168|NCT00980330|366191909|FG006|Overall Study|Withdrawal by Subject|5|||
106145169|NCT00980330|366191903|FG000|Overall Study|(not specified)|2|||
105954658|NCT04512001|365496602|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
105954659|NCT04512001|365496603|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
105954660|NCT04512001|365496604|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
105954661|NCT04512001|365496605|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
105954662|NCT04512001|365496606|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
105954663|NCT04512001|365496602|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
105954664|NCT04512001|365496603|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
105954665|NCT04512001|365496604|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
105954666|NCT04512001|365496605|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
105954667|NCT04512001|365496606|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
105954668|NCT04512001|365496602|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
105954669|NCT04512001|365496603|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
106017994|NCT00892099|365729236|FG001|Overall Study|replocated|0|||
106017995|NCT00892099|365729237|FG002|Overall Study|replocated|2|||
106017996|NCT00892099|365729235|FG000|Overall Study|Prolonged hospitalization|1|||
106017997|NCT00892099|365729236|FG001|Overall Study|Prolonged hospitalization|0|||
106017998|NCT00892099|365729237|FG002|Overall Study|Prolonged hospitalization|1|||
106017999|NCT00892099|365729235|FG000|Overall Study|no further details|1|||
106018000|NCT00892099|365729236|FG001|Overall Study|no further details|0|||
106018001|NCT00892099|365729237|FG002|Overall Study|no further details|1|||
106018002|NCT00892099|365729235|FG000|Overall Study|kidney function recovered|0|||
106018003|NCT00892099|365729236|FG001|Overall Study|kidney function recovered|1|||
106018004|NCT00892099|365729237|FG002|Overall Study|kidney function recovered|0|||
106018005|NCT00892099|365729235|FG000|Overall Study|investigator decision|0|||
106018006|NCT00892099|365729236|FG001|Overall Study|investigator decision|0|||
106018007|NCT00892099|365729237|FG002|Overall Study|investigator decision|1|||
106018008|NCT00892099|365729235|FG000|Overall Study|Lost to Follow-up|0|||
106018009|NCT00892099|365729236|FG001|Overall Study|Lost to Follow-up|0|||
106145170|NCT00980330|366191904|FG001|Overall Study|(not specified)|0|||
106145171|NCT00980330|366191905|FG002|Overall Study|(not specified)|0|||
106145172|NCT00980330|366191906|FG003|Overall Study|(not specified)|1|||
106145173|NCT00980330|366191907|FG004|Overall Study|(not specified)|1|||
105763429|NCT00437203|364787129|FG003|Overall Study|Study terminated by sponsor|0|||
105763430|NCT00437203|364787130|FG004|Overall Study|Study terminated by sponsor|0|||
105763431|NCT00437203|364787131|FG005|Overall Study|Study terminated by sponsor|0|||
105763432|NCT00437203|364787132|FG006|Overall Study|Study terminated by sponsor|0|||
105763433|NCT00437203|364787133|FG007|Overall Study|Study terminated by sponsor|0|||
105763434|NCT00437203|364787134|FG008|Overall Study|Study terminated by sponsor|1|||
105763435|NCT00437203|364787135|FG009|Overall Study|Study terminated by sponsor|0|||
105763436|NCT00437203|364787126|FG000|Overall Study|Objective progression or relapse|5|||
105763437|NCT00437203|364787127|FG001|Overall Study|Objective progression or relapse|6|||
105763438|NCT00437203|364787128|FG002|Overall Study|Objective progression or relapse|2|||
105763439|NCT00437203|364787129|FG003|Overall Study|Objective progression or relapse|3|||
105763440|NCT00437203|364787130|FG004|Overall Study|Objective progression or relapse|3|||
106018010|NCT00892099|365729237|FG002|Overall Study|Lost to Follow-up|1|||
106018011|NCT01657019|365729238|FG000|Overall Study|Withdrawal by Subject|65|||
106018012|NCT01657019|365729238|FG000|Overall Study|Adverse Event|55|||
106018013|NCT01657019|365729238|FG000|Overall Study|Lost to Follow-up|48|||
106145174|NCT00980330|366191908|FG005|Overall Study|(not specified)|1|||
106145175|NCT00980330|366191909|FG006|Overall Study|(not specified)|0|||
106145176|NCT01039688|366191910|FG000|Overall Study|Adverse Event|38|||
106145177|NCT01039688|366191911|FG001|Overall Study|Adverse Event|39|||
106145178|NCT01039688|366191912|FG002|Overall Study|Adverse Event|24|||
106145179|NCT01039688|366191910|FG000|Overall Study|Lack of Efficacy|20|||
105954670|NCT04512001|365496604|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
105954671|NCT04512001|365496605|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
105954672|NCT04512001|365496606|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
105954673|NCT04512001|365496602|FG000|Week 24 to Week 63|Adverse Event|0|||
105954674|NCT04512001|365496603|FG001|Week 24 to Week 63|Adverse Event|0|||
105954675|NCT04512001|365496604|FG002|Week 24 to Week 63|Adverse Event|13|||
105954676|NCT04512001|365496605|FG003|Week 24 to Week 63|Adverse Event|8|||
105954677|NCT04512001|365496606|FG004|Week 24 to Week 63|Adverse Event|6|||
105954678|NCT04512001|365496602|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
105954679|NCT04512001|365496603|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
105954680|NCT04512001|365496604|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
105954681|NCT04512001|365496605|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
105954682|NCT04512001|365496606|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
105954683|NCT04512001|365496602|FG000|Week 24 to Week 63|Death|0|||
105954684|NCT04512001|365496603|FG001|Week 24 to Week 63|Death|0|||
105954685|NCT04512001|365496604|FG002|Week 24 to Week 63|Death|0|||
105954686|NCT04512001|365496605|FG003|Week 24 to Week 63|Death|1|||
105954687|NCT04512001|365496606|FG004|Week 24 to Week 63|Death|1|||
105954688|NCT04512001|365496602|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
105954689|NCT04512001|365496603|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
105954690|NCT04512001|365496604|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
105954691|NCT04512001|365496605|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
105954692|NCT04512001|365496606|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
105954693|NCT04512001|365496602|FG000|Week 24 to Week 63|Miscellaneous|0|||
105954694|NCT04512001|365496603|FG001|Week 24 to Week 63|Miscellaneous|0|||
105954695|NCT04512001|365496604|FG002|Week 24 to Week 63|Miscellaneous|3|||
105954696|NCT04512001|365496605|FG003|Week 24 to Week 63|Miscellaneous|2|||
105954697|NCT04512001|365496606|FG004|Week 24 to Week 63|Miscellaneous|1|||
105954698|NCT03389308|365496607|FG000|Overall Study|Withdrawal by Subject|5|||
105954699|NCT03389308|365496607|FG000|Overall Study|Lost to Follow-up|3|||
105954700|NCT03389308|365496607|FG000|Overall Study|Adverse Event|2|||
105954701|NCT03389308|365496607|FG000|Overall Study|Sponsor Request|2|||
106018014|NCT01657019|365729238|FG000|Overall Study|Protocol Violation|6|||
105763441|NCT00437203|364787131|FG005|Overall Study|Objective progression or relapse|3|||
105763442|NCT00437203|364787132|FG006|Overall Study|Objective progression or relapse|6|||
105763443|NCT00437203|364787133|FG007|Overall Study|Objective progression or relapse|1|||
105763444|NCT00437203|364787134|FG008|Overall Study|Objective progression or relapse|2|||
105763445|NCT00437203|364787135|FG009|Overall Study|Objective progression or relapse|2|||
105763446|NCT00437203|364787126|FG000|Overall Study|Other|0|||
105763447|NCT00437203|364787127|FG001|Overall Study|Other|1|||
105763448|NCT00437203|364787128|FG002|Overall Study|Other|0|||
105763449|NCT00437203|364787129|FG003|Overall Study|Other|0|||
105763450|NCT00437203|364787130|FG004|Overall Study|Other|0|||
105763451|NCT00437203|364787131|FG005|Overall Study|Other|0|||
105763452|NCT00437203|364787132|FG006|Overall Study|Other|1|||
105763453|NCT00437203|364787133|FG007|Overall Study|Other|0|||
105763454|NCT00437203|364787134|FG008|Overall Study|Other|0|||
105763455|NCT00437203|364787135|FG009|Overall Study|Other|0|||
105763456|NCT04209400|364787136|FG000|Overall Study|Withdrawal by Subject|0|||
105763457|NCT04209400|364787137|FG001|Overall Study|Withdrawal by Subject|1|||
105763458|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
105763459|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
105763460|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
105763461|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
105954702|NCT00506779|365496608|FG000|Overall Study|Withdrawal by Subject|1|||
105954703|NCT00506779|365496609|FG001|Overall Study|Withdrawal by Subject|0|||
105954704|NCT00506779|365496610|FG002|Overall Study|Withdrawal by Subject|1|||
105954705|NCT00506779|365496611|FG003|Overall Study|Withdrawal by Subject|0|||
105954706|NCT00506779|365496608|FG000|Overall Study|Adverse Event|0|||
105954707|NCT00506779|365496609|FG001|Overall Study|Adverse Event|1|||
105954708|NCT00506779|365496610|FG002|Overall Study|Adverse Event|1|||
105954709|NCT00506779|365496611|FG003|Overall Study|Adverse Event|1|||
105954710|NCT04263766|365496612|FG000|Overall Study|Withdrawal by Subject|6|||
105954711|NCT04263766|365496613|FG001|Overall Study|Withdrawal by Subject|4|||
105954712|NCT04263766|365496612|FG000|Overall Study|Lack of Efficacy|1|||
105954713|NCT04263766|365496613|FG001|Overall Study|Lack of Efficacy|3|||
105954714|NCT04232943|365496616|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
105954715|NCT04232943|365496617|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
105763462|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
105763463|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
105763464|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
105813152|NCT01475838|364974581|FG000|Randomized Phase|Adverse Event|6|||
105954716|NCT04232943|365496618|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
105954717|NCT04232943|365496616|FG000|Overall Study|Withdrawal by Subject|1|||
105954718|NCT04232943|365496617|FG001|Overall Study|Withdrawal by Subject|1|||
105954719|NCT04232943|365496618|FG002|Overall Study|Withdrawal by Subject|0|||
105954720|NCT02639247|365496619|FG000|Overall Study|Lost to Follow-up|2|||
105954721|NCT02639247|365496620|FG001|Overall Study|Lost to Follow-up|1|||
105954722|NCT02639247|365496619|FG000|Overall Study|Death|2|||
105954723|NCT02639247|365496620|FG001|Overall Study|Death|0|||
105954724|NCT02639247|365496619|FG000|Overall Study|Withdrew Consent|0|||
105954725|NCT02639247|365496620|FG001|Overall Study|Withdrew Consent|1|||
105954726|NCT02639247|365496619|FG000|Overall Study|Protocol Violation|1|||
105954727|NCT02639247|365496620|FG001|Overall Study|Protocol Violation|0|||
105954728|NCT03462758|365496621|FG000|Overall Study|Chose no or other method of contraception|20|||
105954729|NCT03462758|365496622|FG001|Overall Study|Chose no or other method of contraception|23|||
105954730|NCT03462758|365496621|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
105954731|NCT03462758|365496622|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
105954732|NCT03462758|365496621|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
105954733|NCT03462758|365496622|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
105954734|NCT03462758|365496621|FG000|Overall Study|Medical contraindication|2|||
105954735|NCT03462758|365496622|FG001|Overall Study|Medical contraindication|2|||
105954736|NCT03462758|365496621|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
105954737|NCT03462758|365496622|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
105954738|NCT00573391|365496626|FG000|Overall Study|study stopped|2|||
105954739|NCT00573391|365496627|FG001|Overall Study|study stopped|2|||
105954740|NCT00573391|365496626|FG000|Overall Study|Death|1|||
105954741|NCT00573391|365496627|FG001|Overall Study|Death|0|||
105954742|NCT00413660|365496628|FG000|Up To Week 12|Adverse Event|1|||
105954743|NCT00413660|365496629|FG001|Up To Week 12|Adverse Event|3|||
105954744|NCT00413660|365496630|FG002|Up To Week 12|Adverse Event|1|||
105954745|NCT00413660|365496631|FG003|Up To Week 12|Adverse Event|4|||
105954746|NCT00413660|365496632|FG004|Up To Week 12|Adverse Event|6|||
105954747|NCT00413660|365496633|FG005|Up To Week 12|Adverse Event|4|||
105954748|NCT00413660|365496634|FG006|Up To Week 12|Adverse Event|1|||
105954749|NCT00413660|365496635|FG007|Up To Week 12|Adverse Event|0|||
105954750|NCT00413660|365496636|FG008|Up To Week 12|Adverse Event|0|||
105954751|NCT00413660|365496637|FG009|Up To Week 12|Adverse Event|0|||
105954752|NCT00413660|365496638|FG010|Up To Week 12|Adverse Event|0|||
105954753|NCT00413660|365496628|FG000|Up To Week 12|Lack of Efficacy|2|||
105954754|NCT00413660|365496629|FG001|Up To Week 12|Lack of Efficacy|0|||
105954755|NCT00413660|365496630|FG002|Up To Week 12|Lack of Efficacy|0|||
105954756|NCT00413660|365496631|FG003|Up To Week 12|Lack of Efficacy|0|||
105954757|NCT00413660|365496632|FG004|Up To Week 12|Lack of Efficacy|0|||
105954758|NCT00413660|365496633|FG005|Up To Week 12|Lack of Efficacy|0|||
105954759|NCT00413660|365496634|FG006|Up To Week 12|Lack of Efficacy|5|||
105954760|NCT00413660|365496635|FG007|Up To Week 12|Lack of Efficacy|0|||
105954761|NCT00413660|365496636|FG008|Up To Week 12|Lack of Efficacy|0|||
105813153|NCT01475838|364974582|FG001|Randomized Phase|Adverse Event|1|||
105813154|NCT01475838|364974581|FG000|Randomized Phase|Pregnancy|0|||
105813155|NCT01475838|364974582|FG001|Randomized Phase|Pregnancy|1|||
105813156|NCT01475838|364974581|FG000|Randomized Phase|Investigators Discretion|1|||
105813157|NCT01475838|364974582|FG001|Randomized Phase|Investigators Discretion|2|||
105813158|NCT01475838|364974581|FG000|Randomized Phase|Withdrew Consent|10|||
105954762|NCT00413660|365496637|FG009|Up To Week 12|Lack of Efficacy|0|||
105954763|NCT00413660|365496638|FG010|Up To Week 12|Lack of Efficacy|0|||
105954764|NCT00413660|365496628|FG000|Up To Week 12|Lost to Follow-up|0|||
105954765|NCT00413660|365496629|FG001|Up To Week 12|Lost to Follow-up|1|||
105954766|NCT00413660|365496630|FG002|Up To Week 12|Lost to Follow-up|0|||
105954767|NCT00413660|365496631|FG003|Up To Week 12|Lost to Follow-up|0|||
105954768|NCT00413660|365496632|FG004|Up To Week 12|Lost to Follow-up|1|||
105954769|NCT00413660|365496633|FG005|Up To Week 12|Lost to Follow-up|0|||
105954770|NCT00413660|365496634|FG006|Up To Week 12|Lost to Follow-up|0|||
106018015|NCT01657019|365729238|FG000|Overall Study|Lack of Efficacy|3|||
106018016|NCT01657019|365729238|FG000|Overall Study|Other|58|||
106018017|NCT00419952|365729239|FG000|Overall Study|Adverse Event|8|||
106018018|NCT00419952|365729240|FG001|Overall Study|Adverse Event|10|||
106018019|NCT00419952|365729239|FG000|Overall Study|Withdrawal by Subject|44|||
106018020|NCT00419952|365729240|FG001|Overall Study|Withdrawal by Subject|43|||
106018021|NCT00419952|365729239|FG000|Overall Study|Lost to Follow-up|43|||
106018022|NCT00419952|365729240|FG001|Overall Study|Lost to Follow-up|34|||
106018023|NCT00419952|365729239|FG000|Overall Study|Protocol Violation|32|||
105954771|NCT00413660|365496635|FG007|Up To Week 12|Lost to Follow-up|0|||
105954772|NCT00413660|365496636|FG008|Up To Week 12|Lost to Follow-up|0|||
106018024|NCT00419952|365729240|FG001|Overall Study|Protocol Violation|24|||
105813159|NCT01475838|364974582|FG001|Randomized Phase|Withdrew Consent|14|||
105813160|NCT01475838|364974581|FG000|Randomized Phase|Lost to Follow-up|3|||
105813161|NCT01475838|364974582|FG001|Randomized Phase|Lost to Follow-up|4|||
105813162|NCT01475838|364974581|FG000|Randomized Phase|Participant Noncompliance|1|||
105813163|NCT01475838|364974582|FG001|Randomized Phase|Participant Noncompliance|5|||
105813164|NCT01475838|364974581|FG000|Randomized Phase|Protocol Violation|9|||
105813165|NCT01475838|364974582|FG001|Randomized Phase|Protocol Violation|4|||
105813166|NCT01475838|364974581|FG000|Extension Phase|Participant Noncompliance|1|||
105813167|NCT01475838|364974582|FG001|Extension Phase|Participant Noncompliance|0|||
106018025|NCT00419952|365729239|FG000|Overall Study|Pregnancy|4|||
106018026|NCT00419952|365729240|FG001|Overall Study|Pregnancy|2|||
105813168|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
105813169|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
105813170|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
105813171|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
105813172|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
105813173|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
105813174|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
105813175|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
105813176|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
105813177|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
105813178|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
105813179|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
105813180|NCT00048568|364974588|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
105813181|NCT00048568|364974589|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
105813182|NCT00048568|364974590|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
105813183|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Death|1|||
105813184|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Death|1|||
105813185|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Death|0|||
105813186|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
105813187|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
105813188|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
105813189|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
105813190|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
105813191|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
105813192|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
105813193|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
105813194|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
105813195|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
105813196|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
105813197|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
105813198|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
105813199|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
105813200|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
105813201|NCT00048568|364974588|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
105813202|NCT00048568|364974589|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
105813203|NCT00048568|364974590|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
105813204|NCT00048568|364974588|FG000|Open-Label Period|Death|0|||
105813205|NCT00048568|364974589|FG001|Open-Label Period|Death|0|||
105813206|NCT00048568|364974590|FG002|Open-Label Period|Death|13|||
105813207|NCT00048568|364974588|FG000|Open-Label Period|Adverse Event|0|||
105813208|NCT00048568|364974589|FG001|Open-Label Period|Adverse Event|0|||
105813209|NCT00048568|364974590|FG002|Open-Label Period|Adverse Event|49|||
105813210|NCT00048568|364974588|FG000|Open-Label Period|Lack of Efficacy|0|||
105813211|NCT00048568|364974589|FG001|Open-Label Period|Lack of Efficacy|0|||
105813212|NCT00048568|364974590|FG002|Open-Label Period|Lack of Efficacy|32|||
105813213|NCT00048568|364974588|FG000|Open-Label Period|Withdrawal by Subject|0|||
105813214|NCT00048568|364974589|FG001|Open-Label Period|Withdrawal by Subject|0|||
105813215|NCT00048568|364974590|FG002|Open-Label Period|Withdrawal by Subject|26|||
105813216|NCT00048568|364974588|FG000|Open-Label Period|Pregnancy|0|||
105813217|NCT00048568|364974589|FG001|Open-Label Period|Pregnancy|0|||
105813218|NCT00048568|364974590|FG002|Open-Label Period|Pregnancy|5|||
105813219|NCT00048568|364974588|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
105813220|NCT00048568|364974589|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
105813221|NCT00048568|364974590|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
105813222|NCT00048568|364974588|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
105813223|NCT00048568|364974589|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
105813224|NCT00048568|364974590|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
105813225|NCT00048568|364974588|FG000|Open-Label Period|Unknown Reasons|0|||
105813226|NCT00048568|364974589|FG001|Open-Label Period|Unknown Reasons|0|||
105813227|NCT00048568|364974590|FG002|Open-Label Period|Unknown Reasons|25|||
105813228|NCT00048568|364974588|FG000|Open-Label Period|Lost to Follow-up|0|||
106018027|NCT00419952|365729239|FG000|Overall Study|Physician Decision|1|||
105813229|NCT00048568|364974589|FG001|Open-Label Period|Lost to Follow-up|0|||
105813230|NCT00048568|364974590|FG002|Open-Label Period|Lost to Follow-up|7|||
105813231|NCT01400425|364974591|FG000|Overall Study|Withdrawal by Subject|10|||
105813232|NCT03594123|364974594|FG000|Overall Study|Lost to Follow-up|0|||
105813233|NCT03594123|364974595|FG001|Overall Study|Lost to Follow-up|1|||
106018028|NCT00419952|365729240|FG001|Overall Study|Physician Decision|3|||
105813234|NCT03594123|364974594|FG000|Overall Study|Adverse Event|8|||
105813235|NCT03594123|364974595|FG001|Overall Study|Adverse Event|5|||
105813236|NCT03594123|364974594|FG000|Overall Study|Site Terminated by Sponsor|4|||
106018029|NCT00419952|365729239|FG000|Overall Study|Incorrectly enrolled|10|||
106145180|NCT01039688|366191911|FG001|Overall Study|Lack of Efficacy|11|||
106145181|NCT01039688|366191912|FG002|Overall Study|Lack of Efficacy|26|||
106145182|NCT01039688|366191910|FG000|Overall Study|Lost to Follow-up|11|||
106145183|NCT01039688|366191911|FG001|Overall Study|Lost to Follow-up|9|||
106145184|NCT01039688|366191912|FG002|Overall Study|Lost to Follow-up|5|||
105813237|NCT03594123|364974595|FG001|Overall Study|Site Terminated by Sponsor|1|||
105813238|NCT03594123|364974594|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
105813239|NCT03594123|364974595|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
105813240|NCT03594123|364974594|FG000|Overall Study|Lack of Efficacy|1|||
105813241|NCT03594123|364974595|FG001|Overall Study|Lack of Efficacy|0|||
105813242|NCT03594123|364974594|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
105813243|NCT03594123|364974595|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
105813244|NCT01700621|364974596|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
105813245|NCT01700621|364974597|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
105813246|NCT01700621|364974596|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
105813247|NCT01700621|364974597|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
105813248|NCT01700621|364974596|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
105813249|NCT01700621|364974597|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
105813250|NCT03365375|364974598|FG000|Overall Study|Withdrawal by Subject|0|||
105813251|NCT03365375|364974599|FG001|Overall Study|Withdrawal by Subject|1|||
105813252|NCT03365375|364974598|FG000|Overall Study|Lost to Follow-up|0|||
105813253|NCT03365375|364974599|FG001|Overall Study|Lost to Follow-up|4|||
105813254|NCT03992196|364974600|FG000|Enrollment|lost to follow-up prior dosing|1|||
105813255|NCT03992196|364974601|FG001|Enrollment|lost to follow-up prior dosing|0|||
105813256|NCT03992196|364974602|FG002|Enrollment|lost to follow-up prior dosing|0|||
105813257|NCT03992196|364974600|FG000|Treatment|Protocol Violation|0|||
105813258|NCT03992196|364974601|FG001|Treatment|Protocol Violation|0|||
105813259|NCT03992196|364974602|FG002|Treatment|Protocol Violation|1|||
105813260|NCT03992196|364974600|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
105813261|NCT03992196|364974601|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
105813262|NCT03992196|364974602|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
105813263|NCT03992196|364974600|FG000|Treatment|Withdrawal due to non-compliance|0|||
105813264|NCT03992196|364974601|FG001|Treatment|Withdrawal due to non-compliance|0|||
105813265|NCT03992196|364974602|FG002|Treatment|Withdrawal due to non-compliance|1|||
105813266|NCT03992196|364974600|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
105954773|NCT00413660|365496637|FG009|Up To Week 12|Lost to Follow-up|0|||
105954774|NCT00413660|365496638|FG010|Up To Week 12|Lost to Follow-up|0|||
105954775|NCT00413660|365496628|FG000|Up To Week 12|Withdrawal by Subject|0|||
105954776|NCT00413660|365496629|FG001|Up To Week 12|Withdrawal by Subject|2|||
105954777|NCT00413660|365496630|FG002|Up To Week 12|Withdrawal by Subject|0|||
106145185|NCT01039688|366191910|FG000|Overall Study|Other|13|||
105954778|NCT00413660|365496631|FG003|Up To Week 12|Withdrawal by Subject|2|||
105954779|NCT00413660|365496632|FG004|Up To Week 12|Withdrawal by Subject|0|||
105954780|NCT00413660|365496633|FG005|Up To Week 12|Withdrawal by Subject|2|||
105954781|NCT00413660|365496634|FG006|Up To Week 12|Withdrawal by Subject|2|||
105954782|NCT00413660|365496635|FG007|Up To Week 12|Withdrawal by Subject|0|||
105954783|NCT00413660|365496636|FG008|Up To Week 12|Withdrawal by Subject|0|||
106145186|NCT01039688|366191911|FG001|Overall Study|Other|25|||
106145187|NCT01039688|366191912|FG002|Overall Study|Other|12|||
105954784|NCT00413660|365496637|FG009|Up To Week 12|Withdrawal by Subject|0|||
105954785|NCT00413660|365496638|FG010|Up To Week 12|Withdrawal by Subject|0|||
105954786|NCT00413660|365496628|FG000|Up To Week 12|Randomized, Not Treated|1|||
105954787|NCT00413660|365496629|FG001|Up To Week 12|Randomized, Not Treated|0|||
105954788|NCT00413660|365496630|FG002|Up To Week 12|Randomized, Not Treated|0|||
105954789|NCT00413660|365496631|FG003|Up To Week 12|Randomized, Not Treated|1|||
105954790|NCT00413660|365496632|FG004|Up To Week 12|Randomized, Not Treated|0|||
105954791|NCT00413660|365496633|FG005|Up To Week 12|Randomized, Not Treated|0|||
105954792|NCT00413660|365496634|FG006|Up To Week 12|Randomized, Not Treated|0|||
105954793|NCT00413660|365496635|FG007|Up To Week 12|Randomized, Not Treated|0|||
105954794|NCT00413660|365496636|FG008|Up To Week 12|Randomized, Not Treated|0|||
105954795|NCT00413660|365496637|FG009|Up To Week 12|Randomized, Not Treated|0|||
105954796|NCT00413660|365496638|FG010|Up To Week 12|Randomized, Not Treated|0|||
105954797|NCT00413660|365496628|FG000|Up To Week 12|Other|3|||
105954798|NCT00413660|365496629|FG001|Up To Week 12|Other|1|||
105954799|NCT00413660|365496630|FG002|Up To Week 12|Other|6|||
105954800|NCT00413660|365496631|FG003|Up To Week 12|Other|1|||
105813267|NCT03992196|364974601|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
105954801|NCT00413660|365496632|FG004|Up To Week 12|Other|2|||
106145188|NCT01039688|366191910|FG000|Overall Study|Withdrawal by Subject|23|||
106145189|NCT01039688|366191911|FG001|Overall Study|Withdrawal by Subject|27|||
105954802|NCT00413660|365496633|FG005|Up To Week 12|Other|4|||
105954803|NCT00413660|365496634|FG006|Up To Week 12|Other|3|||
105954804|NCT00413660|365496635|FG007|Up To Week 12|Other|0|||
105954805|NCT00413660|365496636|FG008|Up To Week 12|Other|0|||
105813268|NCT03992196|364974602|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
105813269|NCT03992196|364974600|FG000|Treatment|Withdrawal by parent/guardian|0|||
105813270|NCT03992196|364974601|FG001|Treatment|Withdrawal by parent/guardian|0|||
105813271|NCT03992196|364974602|FG002|Treatment|Withdrawal by parent/guardian|2|||
105813272|NCT01505530|364974605|FG000|Overall Study|Progressive Disease|19|||
105813273|NCT01505530|364974606|FG001|Overall Study|Progressive Disease|17|||
105813274|NCT01505530|364974607|FG002|Overall Study|Progressive Disease|18|||
105813275|NCT01505530|364974605|FG000|Overall Study|Adverse Event|1|||
105813276|NCT01505530|364974606|FG001|Overall Study|Adverse Event|1|||
105813277|NCT01505530|364974607|FG002|Overall Study|Adverse Event|0|||
105813278|NCT01505530|364974605|FG000|Overall Study|Withdrawal by Subject|7|||
105813279|NCT01505530|364974606|FG001|Overall Study|Withdrawal by Subject|8|||
105813280|NCT01505530|364974607|FG002|Overall Study|Withdrawal by Subject|6|||
105813281|NCT01505530|364974605|FG000|Overall Study|Physician Decision|6|||
105813282|NCT01505530|364974606|FG001|Overall Study|Physician Decision|2|||
105813283|NCT01505530|364974607|FG002|Overall Study|Physician Decision|5|||
105813284|NCT01505530|364974605|FG000|Overall Study|Sponsor Decision|1|||
105813285|NCT01505530|364974606|FG001|Overall Study|Sponsor Decision|8|||
105813286|NCT01505530|364974607|FG002|Overall Study|Sponsor Decision|7|||
105813287|NCT01505530|364974605|FG000|Overall Study|Death|7|||
105813288|NCT01505530|364974606|FG001|Overall Study|Death|6|||
105813289|NCT01505530|364974607|FG002|Overall Study|Death|5|||
105813290|NCT01505530|364974605|FG000|Overall Study|entry criteria not met|0|||
105813291|NCT01505530|364974606|FG001|Overall Study|entry criteria not met|1|||
105813292|NCT01505530|364974607|FG002|Overall Study|entry criteria not met|0|||
105954806|NCT00413660|365496637|FG009|Up To Week 12|Other|0|||
105954807|NCT00413660|365496638|FG010|Up To Week 12|Other|0|||
105954808|NCT00413660|365496628|FG000|Post Week 12|Adverse Event|2|||
105954809|NCT00413660|365496629|FG001|Post Week 12|Adverse Event|0|||
105954810|NCT00413660|365496630|FG002|Post Week 12|Adverse Event|2|||
105954811|NCT00413660|365496631|FG003|Post Week 12|Adverse Event|1|||
105954812|NCT00413660|365496632|FG004|Post Week 12|Adverse Event|4|||
105954813|NCT00413660|365496633|FG005|Post Week 12|Adverse Event|2|||
105954814|NCT00413660|365496634|FG006|Post Week 12|Adverse Event|2|||
105954815|NCT00413660|365496635|FG007|Post Week 12|Adverse Event|0|||
105954816|NCT00413660|365496636|FG008|Post Week 12|Adverse Event|0|||
105954817|NCT00413660|365496637|FG009|Post Week 12|Adverse Event|0|||
105954818|NCT00413660|365496638|FG010|Post Week 12|Adverse Event|0|||
105954819|NCT00413660|365496628|FG000|Post Week 12|Lack of Efficacy|0|||
105954820|NCT00413660|365496629|FG001|Post Week 12|Lack of Efficacy|0|||
105954821|NCT00413660|365496630|FG002|Post Week 12|Lack of Efficacy|1|||
105954822|NCT00413660|365496631|FG003|Post Week 12|Lack of Efficacy|0|||
105954823|NCT00413660|365496632|FG004|Post Week 12|Lack of Efficacy|0|||
105954824|NCT00413660|365496633|FG005|Post Week 12|Lack of Efficacy|0|||
105954825|NCT00413660|365496634|FG006|Post Week 12|Lack of Efficacy|0|||
105954826|NCT00413660|365496635|FG007|Post Week 12|Lack of Efficacy|0|||
105954827|NCT00413660|365496636|FG008|Post Week 12|Lack of Efficacy|0|||
105954828|NCT00413660|365496637|FG009|Post Week 12|Lack of Efficacy|1|||
105954829|NCT00413660|365496638|FG010|Post Week 12|Lack of Efficacy|0|||
105954830|NCT00413660|365496628|FG000|Post Week 12|Lost to Follow-up|0|||
105954831|NCT00413660|365496629|FG001|Post Week 12|Lost to Follow-up|1|||
105954832|NCT00413660|365496630|FG002|Post Week 12|Lost to Follow-up|1|||
105954833|NCT00413660|365496631|FG003|Post Week 12|Lost to Follow-up|0|||
105954834|NCT00413660|365496632|FG004|Post Week 12|Lost to Follow-up|0|||
106018030|NCT00419952|365729240|FG001|Overall Study|Incorrectly enrolled|3|||
106018031|NCT00419952|365729239|FG000|Overall Study|Intake of prohibited medication|2|||
106018032|NCT00419952|365729240|FG001|Overall Study|Intake of prohibited medication|2|||
106018033|NCT00419952|365729239|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
106018034|NCT00419952|365729240|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
106018035|NCT00419952|365729239|FG000|Overall Study|Diary or medication non-compliance|2|||
106145190|NCT01039688|366191912|FG002|Overall Study|Withdrawal by Subject|13|||
106145191|NCT01039688|366191910|FG000|Overall Study|Death|2|||
105954835|NCT00413660|365496633|FG005|Post Week 12|Lost to Follow-up|0|||
105813293|NCT02388763|364974613|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
105813294|NCT02388763|364974614|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
105813295|NCT02388763|364974613|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
105813296|NCT02388763|364974614|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
105813297|NCT02636907|364974619|FG000|Autoinjector Assessment Period|Adverse Event|2|||
105813298|NCT02636907|364974619|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
105954836|NCT00413660|365496634|FG006|Post Week 12|Lost to Follow-up|0|||
105954837|NCT00413660|365496635|FG007|Post Week 12|Lost to Follow-up|0|||
105954838|NCT00413660|365496636|FG008|Post Week 12|Lost to Follow-up|0|||
105954839|NCT00413660|365496637|FG009|Post Week 12|Lost to Follow-up|0|||
105954840|NCT00413660|365496638|FG010|Post Week 12|Lost to Follow-up|0|||
105954841|NCT00413660|365496628|FG000|Post Week 12|Withdrawal by Subject|0|||
105954842|NCT00413660|365496629|FG001|Post Week 12|Withdrawal by Subject|1|||
105954843|NCT00413660|365496630|FG002|Post Week 12|Withdrawal by Subject|1|||
106018036|NCT00419952|365729240|FG001|Overall Study|Diary or medication non-compliance|4|||
105954844|NCT00413660|365496631|FG003|Post Week 12|Withdrawal by Subject|0|||
105954845|NCT00413660|365496632|FG004|Post Week 12|Withdrawal by Subject|1|||
105954846|NCT00413660|365496633|FG005|Post Week 12|Withdrawal by Subject|0|||
105954847|NCT00413660|365496634|FG006|Post Week 12|Withdrawal by Subject|0|||
105954848|NCT00413660|365496635|FG007|Post Week 12|Withdrawal by Subject|0|||
105954849|NCT00413660|365496636|FG008|Post Week 12|Withdrawal by Subject|0|||
105954850|NCT00413660|365496637|FG009|Post Week 12|Withdrawal by Subject|0|||
105954851|NCT00413660|365496638|FG010|Post Week 12|Withdrawal by Subject|1|||
105954852|NCT00413660|365496628|FG000|Post Week 12|Other|1|||
105954853|NCT00413660|365496629|FG001|Post Week 12|Other|2|||
105954854|NCT00413660|365496630|FG002|Post Week 12|Other|3|||
105954855|NCT00413660|365496631|FG003|Post Week 12|Other|0|||
105954856|NCT00413660|365496632|FG004|Post Week 12|Other|1|||
105954857|NCT00413660|365496633|FG005|Post Week 12|Other|1|||
105813299|NCT02636907|364974619|FG000|Extension Phase|Adverse Event|2|||
105813300|NCT02636907|364974619|FG000|Extension Phase|Withdrawal by Subject|4|||
105813301|NCT02636907|364974619|FG000|Extension Phase|Physician Decision|1|||
105813302|NCT02636907|364974619|FG000|Extension Phase|Lost to Follow-up|2|||
105813303|NCT02636907|364974619|FG000|Extension Phase|Lack of Efficacy|1|||
105813304|NCT02796664|364974620|FG000|Overall Study|Withdrawal by Subject|0|||
105813305|NCT02796664|364974621|FG001|Overall Study|Withdrawal by Subject|3|||
105813306|NCT02796664|364974620|FG000|Overall Study|Noncompliance|1|||
105813307|NCT02796664|364974621|FG001|Overall Study|Noncompliance|1|||
105813308|NCT02796664|364974620|FG000|Overall Study|Death|0|||
105813309|NCT02796664|364974621|FG001|Overall Study|Death|1|||
105813310|NCT02246478|364974622|FG000|Multiple-dose Phase|Protocol Violation|1|||
105813311|NCT02246478|364974623|FG001|Multiple-dose Phase|Protocol Violation|0|||
105813312|NCT02246478|364974624|FG002|Multiple-dose Phase|Protocol Violation|0|||
105813313|NCT02246478|364974625|FG003|Multiple-dose Phase|Protocol Violation|1|||
105813314|NCT00860405|364974628|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
105813315|NCT00860405|364974629|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
105813316|NCT03980483|364974630|FG000|Overall Study|Adverse Event|13|||
105813317|NCT03980483|364974631|FG001|Overall Study|Adverse Event|29|||
105813318|NCT03980483|364974632|FG002|Overall Study|Adverse Event|11|||
105813319|NCT03980483|364974633|FG003|Overall Study|Adverse Event|2|||
105813320|NCT03980483|364974634|FG004|Overall Study|Adverse Event|2|||
105813321|NCT03980483|364974635|FG005|Overall Study|Adverse Event|2|||
105813322|NCT03980483|364974630|FG000|Overall Study|Lack of Efficacy|7|||
105813323|NCT03980483|364974631|FG001|Overall Study|Lack of Efficacy|6|||
105813324|NCT03980483|364974632|FG002|Overall Study|Lack of Efficacy|0|||
105813325|NCT03980483|364974633|FG003|Overall Study|Lack of Efficacy|3|||
105813326|NCT03980483|364974634|FG004|Overall Study|Lack of Efficacy|1|||
105813327|NCT03980483|364974635|FG005|Overall Study|Lack of Efficacy|1|||
105813328|NCT03980483|364974630|FG000|Overall Study|Lost to Follow-up|2|||
105813329|NCT03980483|364974631|FG001|Overall Study|Lost to Follow-up|4|||
105813330|NCT03980483|364974632|FG002|Overall Study|Lost to Follow-up|2|||
105813331|NCT03980483|364974633|FG003|Overall Study|Lost to Follow-up|1|||
105954858|NCT00413660|365496634|FG006|Post Week 12|Other|1|||
105954859|NCT00413660|365496635|FG007|Post Week 12|Other|0|||
105954860|NCT00413660|365496636|FG008|Post Week 12|Other|0|||
105954861|NCT00413660|365496637|FG009|Post Week 12|Other|0|||
105954862|NCT00413660|365496638|FG010|Post Week 12|Other|0|||
105813332|NCT03980483|364974634|FG004|Overall Study|Lost to Follow-up|2|||
105813333|NCT03980483|364974635|FG005|Overall Study|Lost to Follow-up|0|||
105813334|NCT03980483|364974630|FG000|Overall Study|Protocol Violation|4|||
105813335|NCT03980483|364974631|FG001|Overall Study|Protocol Violation|2|||
105813336|NCT03980483|364974632|FG002|Overall Study|Protocol Violation|1|||
105954863|NCT01282866|365496639|FG000|Overall Study|Adverse Event|1|||
105954864|NCT00920556|365496640|FG000|Overall Study|Adverse Event|16|||
106018037|NCT00419952|365729239|FG000|Overall Study|Abnormal ECG|1|||
105813337|NCT03980483|364974633|FG003|Overall Study|Protocol Violation|1|||
105954865|NCT00920556|365496640|FG000|Overall Study|Physician Decision|7|||
105954866|NCT00920556|365496640|FG000|Overall Study|Withdrawal by Subject|1|||
105954867|NCT00886769|365496650|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
105954868|NCT00886769|365496651|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
106145192|NCT01039688|366191911|FG001|Overall Study|Death|0|||
106145193|NCT01039688|366191912|FG002|Overall Study|Death|0|||
106145194|NCT00665444|366191913|FG000|Overall Study|Physician Decision|1|||
105813338|NCT03980483|364974634|FG004|Overall Study|Protocol Violation|0|||
105813339|NCT03980483|364974635|FG005|Overall Study|Protocol Violation|0|||
105954869|NCT01070979|365496653|FG000|Overall Study|Adverse Event|2|||
105813340|NCT03980483|364974630|FG000|Overall Study|Physician Decision|14|||
105813341|NCT03980483|364974631|FG001|Overall Study|Physician Decision|10|||
105813342|NCT03980483|364974632|FG002|Overall Study|Physician Decision|7|||
105813343|NCT03980483|364974633|FG003|Overall Study|Physician Decision|4|||
105813344|NCT03980483|364974634|FG004|Overall Study|Physician Decision|4|||
105813345|NCT03980483|364974635|FG005|Overall Study|Physician Decision|2|||
105813346|NCT03980483|364974630|FG000|Overall Study|Withdrawal by Subject|38|||
105954870|NCT01070979|365496654|FG001|Overall Study|Adverse Event|3|||
106018038|NCT00419952|365729240|FG001|Overall Study|Abnormal ECG|0|||
105813347|NCT03980483|364974631|FG001|Overall Study|Withdrawal by Subject|21|||
105813348|NCT03980483|364974632|FG002|Overall Study|Withdrawal by Subject|15|||
105813349|NCT03980483|364974633|FG003|Overall Study|Withdrawal by Subject|5|||
105813350|NCT03980483|364974634|FG004|Overall Study|Withdrawal by Subject|3|||
105813351|NCT03980483|364974635|FG005|Overall Study|Withdrawal by Subject|4|||
105813352|NCT03980483|364974630|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
105813353|NCT03980483|364974631|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105813354|NCT03980483|364974632|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105813355|NCT03980483|364974633|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105813356|NCT03980483|364974634|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105813357|NCT03980483|364974635|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105813358|NCT03980483|364974630|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813359|NCT03980483|364974631|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
105813360|NCT03980483|364974632|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813361|NCT03980483|364974633|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813362|NCT03980483|364974634|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813363|NCT03980483|364974635|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
105813364|NCT03980483|364974630|FG000|Overall Study|Other|0|||
105813365|NCT03980483|364974631|FG001|Overall Study|Other|1|||
105813366|NCT03980483|364974632|FG002|Overall Study|Other|0|||
105813367|NCT03980483|364974633|FG003|Overall Study|Other|0|||
105813368|NCT03980483|364974634|FG004|Overall Study|Other|0|||
105813369|NCT03980483|364974635|FG005|Overall Study|Other|0|||
105813370|NCT00497796|364974636|FG000|Overall Study|Adverse event (not related)|9|||
105813371|NCT00497796|364974637|FG001|Overall Study|Adverse event (not related)|9|||
105813372|NCT00497796|364974636|FG000|Overall Study|Adverse event (related)|5|||
105813373|NCT00497796|364974637|FG001|Overall Study|Adverse event (related)|4|||
105813374|NCT00497796|364974636|FG000|Overall Study|CMV infection or disease treatment|30|||
105813375|NCT00497796|364974637|FG001|Overall Study|CMV infection or disease treatment|4|||
105813376|NCT00497796|364974636|FG000|Overall Study|Consent withdrawn|10|||
105813377|NCT00497796|364974637|FG001|Overall Study|Consent withdrawn|3|||
105813378|NCT00497796|364974636|FG000|Overall Study|Investigator/sponsor discretion|31|||
105813379|NCT00497796|364974637|FG001|Overall Study|Investigator/sponsor discretion|34|||
105813380|NCT00497796|364974636|FG000|Overall Study|Lost to Follow-up|0|||
105813381|NCT00497796|364974637|FG001|Overall Study|Lost to Follow-up|1|||
105813382|NCT00497796|364974636|FG000|Overall Study|Not applicable (randomized not treated)|0|||
105813383|NCT00497796|364974637|FG001|Overall Study|Not applicable (randomized not treated)|4|||
105813384|NCT04276883|364974640|FG000|Overall Study|Withdrawal by Subject|2|||
105813385|NCT04276883|364974641|FG001|Overall Study|Withdrawal by Subject|3|||
105813386|NCT04276883|364974642|FG002|Overall Study|Withdrawal by Subject|6|||
105813387|NCT04276883|364974640|FG000|Overall Study|Lost to Follow-up|1|||
105813388|NCT04276883|364974641|FG001|Overall Study|Lost to Follow-up|3|||
105813389|NCT04276883|364974642|FG002|Overall Study|Lost to Follow-up|0|||
105813390|NCT04276883|364974640|FG000|Overall Study|Adverse Event|0|||
105813391|NCT04276883|364974641|FG001|Overall Study|Adverse Event|1|||
105813392|NCT04276883|364974642|FG002|Overall Study|Adverse Event|0|||
105813393|NCT04276883|364974640|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
105813394|NCT04276883|364974641|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
105813395|NCT04276883|364974642|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
105813396|NCT05277389|364974648|FG000|Overall Study|Lost to Follow-up|1|||
105813397|NCT05277389|364974649|FG001|Overall Study|Lost to Follow-up|4|||
105813398|NCT06096168|364974650|FG000|Overall Study|Death|30|||
105813399|NCT06096168|364974650|FG000|Overall Study|Revision|2|||
105813400|NCT03125200|364974655|FG000|Overall Study|Study Termination|0|||
105813401|NCT03125200|364974656|FG001|Overall Study|Study Termination|0|||
106145195|NCT00665444|366191913|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
106145196|NCT02957136|366191914|FG000|Overall Study|Withdrawal by Subject|2|||
106145197|NCT02957136|366191915|FG001|Overall Study|Withdrawal by Subject|1|||
106145198|NCT00159783|366191917|FG000|Overall Study|Adverse Event|5|||
106145199|NCT00159783|366191918|FG001|Overall Study|Adverse Event|7|||
105763465|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
105763466|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
105763467|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
105763468|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
105763469|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
105763470|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
105763471|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
105763472|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
105763473|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
105813402|NCT03125200|364974657|FG002|Overall Study|Study Termination|0|||
105813403|NCT03125200|364974658|FG003|Overall Study|Study Termination|1|||
105813404|NCT03125200|364974659|FG004|Overall Study|Study Termination|1|||
105813405|NCT03125200|364974660|FG005|Overall Study|Study Termination|2|||
105813406|NCT03125200|364974661|FG006|Overall Study|Study Termination|1|||
105813407|NCT03125200|364974655|FG000|Overall Study|Clinical Progression|0|||
105813408|NCT03125200|364974656|FG001|Overall Study|Clinical Progression|0|||
105813409|NCT03125200|364974657|FG002|Overall Study|Clinical Progression|0|||
105813410|NCT03125200|364974658|FG003|Overall Study|Clinical Progression|1|||
105813411|NCT03125200|364974659|FG004|Overall Study|Clinical Progression|0|||
105813412|NCT03125200|364974660|FG005|Overall Study|Clinical Progression|1|||
105813413|NCT03125200|364974661|FG006|Overall Study|Clinical Progression|0|||
105813414|NCT03125200|364974655|FG000|Overall Study|Progressive Disease|2|||
105813415|NCT03125200|364974656|FG001|Overall Study|Progressive Disease|1|||
105813416|NCT03125200|364974657|FG002|Overall Study|Progressive Disease|2|||
105813417|NCT03125200|364974658|FG003|Overall Study|Progressive Disease|1|||
105813418|NCT03125200|364974659|FG004|Overall Study|Progressive Disease|2|||
105813419|NCT03125200|364974660|FG005|Overall Study|Progressive Disease|0|||
105813420|NCT03125200|364974661|FG006|Overall Study|Progressive Disease|1|||
105813421|NCT03125200|364974655|FG000|Overall Study|Lack of Efficacy|0|||
105813422|NCT03125200|364974656|FG001|Overall Study|Lack of Efficacy|0|||
105813423|NCT03125200|364974657|FG002|Overall Study|Lack of Efficacy|0|||
105813424|NCT03125200|364974658|FG003|Overall Study|Lack of Efficacy|1|||
105813425|NCT03125200|364974659|FG004|Overall Study|Lack of Efficacy|0|||
105813426|NCT03125200|364974660|FG005|Overall Study|Lack of Efficacy|0|||
105813427|NCT03125200|364974661|FG006|Overall Study|Lack of Efficacy|0|||
105813428|NCT03125200|364974655|FG000|Overall Study|Toxicity|0|||
105813429|NCT03125200|364974656|FG001|Overall Study|Toxicity|0|||
105813430|NCT03125200|364974657|FG002|Overall Study|Toxicity|0|||
105813431|NCT03125200|364974658|FG003|Overall Study|Toxicity|1|||
105813432|NCT03125200|364974659|FG004|Overall Study|Toxicity|0|||
105813433|NCT03125200|364974660|FG005|Overall Study|Toxicity|0|||
105813434|NCT03125200|364974661|FG006|Overall Study|Toxicity|0|||
105813435|NCT03125200|364974655|FG000|Overall Study|Consent Withdrawn by Subject|0|||
105813436|NCT03125200|364974656|FG001|Overall Study|Consent Withdrawn by Subject|1|||
105813437|NCT03125200|364974657|FG002|Overall Study|Consent Withdrawn by Subject|0|||
105813438|NCT03125200|364974658|FG003|Overall Study|Consent Withdrawn by Subject|0|||
105813439|NCT03125200|364974659|FG004|Overall Study|Consent Withdrawn by Subject|1|||
105813440|NCT03125200|364974660|FG005|Overall Study|Consent Withdrawn by Subject|0|||
105813441|NCT03125200|364974661|FG006|Overall Study|Consent Withdrawn by Subject|1|||
105813442|NCT01569152|364974662|FG000|Phase IIa, Period 1|Early Escape|5|||
105813443|NCT01569152|364974663|FG001|Phase IIa, Period 1|Early Escape|22|||
105813444|NCT01569152|364974664|FG002|Phase IIa, Period 1|Early Escape|0|||
105813445|NCT01569152|364974662|FG000|Phase IIa, Period 1|Adverse Event|4|||
105813446|NCT01569152|364974663|FG001|Phase IIa, Period 1|Adverse Event|0|||
105813447|NCT01569152|364974664|FG002|Phase IIa, Period 1|Adverse Event|0|||
105813448|NCT01569152|364974662|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
105813449|NCT01569152|364974663|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
105813450|NCT01569152|364974664|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
105813451|NCT01569152|364974662|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
105813452|NCT01569152|364974663|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
105813453|NCT01569152|364974664|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
105813454|NCT01569152|364974662|FG000|Phase IIa, Period 1|Protocol Violation|0|||
105813455|NCT01569152|364974663|FG001|Phase IIa, Period 1|Protocol Violation|1|||
105813456|NCT01569152|364974664|FG002|Phase IIa, Period 1|Protocol Violation|0|||
105813457|NCT01569152|364974662|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
105813458|NCT01569152|364974663|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
105813459|NCT01569152|364974664|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
105813460|NCT01569152|364974662|FG000|Safety Extension, Period 3|Adverse Event|0|||
105813461|NCT01569152|364974663|FG001|Safety Extension, Period 3|Adverse Event|0|||
105813462|NCT01569152|364974664|FG002|Safety Extension, Period 3|Adverse Event|4|||
105813463|NCT01569152|364974662|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
105813464|NCT01569152|364974663|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
105813465|NCT01569152|364974664|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
105813466|NCT01569152|364974662|FG000|Safety Extension, Period 3|Physician Decision|0|||
105813467|NCT01569152|364974663|FG001|Safety Extension, Period 3|Physician Decision|0|||
105813468|NCT01569152|364974664|FG002|Safety Extension, Period 3|Physician Decision|2|||
105813469|NCT01569152|364974662|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
105813470|NCT01569152|364974663|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
105813471|NCT01569152|364974664|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
105813472|NCT01766778|364974665|FG000|Overall Study|Adverse Event|4|||
105813473|NCT01766778|364974666|FG001|Overall Study|Adverse Event|4|||
105813474|NCT01766778|364974665|FG000|Overall Study|Withdrawal by Subject|1|||
105954871|NCT01070979|365496655|FG002|Overall Study|Adverse Event|3|||
105954872|NCT01070979|365496653|FG000|Overall Study|Lost to Follow-up|2|||
105813475|NCT01766778|364974666|FG001|Overall Study|Withdrawal by Subject|0|||
105813476|NCT02093689|364974669|FG000|Overall Study|Physician Decision|4|||
105813477|NCT02093689|364974670|FG001|Overall Study|Physician Decision|0|||
105813478|NCT02093689|364974671|FG002|Overall Study|Physician Decision|0|||
105813479|NCT03144687|364974672|FG000|Overall Study|Death|0|||
105954873|NCT01070979|365496654|FG001|Overall Study|Lost to Follow-up|1|||
105813480|NCT03144687|364974673|FG001|Overall Study|Death|2|||
105813481|NCT03144687|364974672|FG000|Overall Study|Lost to Follow-up|0|||
105954874|NCT01070979|365496655|FG002|Overall Study|Lost to Follow-up|1|||
105954875|NCT01070979|365496653|FG000|Overall Study|Protocol Violation|0|||
105954876|NCT01070979|365496654|FG001|Overall Study|Protocol Violation|2|||
105954877|NCT01070979|365496655|FG002|Overall Study|Protocol Violation|6|||
105954878|NCT01070979|365496653|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
105954879|NCT01070979|365496654|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
105954880|NCT01070979|365496655|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
105954881|NCT01070979|365496653|FG000|Overall Study|Withdrawal by Subject|3|||
105954882|NCT01070979|365496654|FG001|Overall Study|Withdrawal by Subject|1|||
105954883|NCT01070979|365496655|FG002|Overall Study|Withdrawal by Subject|1|||
105954884|NCT01070979|365496653|FG000|Overall Study|No study drug taken|0|||
105954885|NCT01070979|365496654|FG001|Overall Study|No study drug taken|1|||
105954886|NCT01070979|365496655|FG002|Overall Study|No study drug taken|0|||
105954887|NCT00142792|365496659|FG000|Overall Study|Death|0|||
105954888|NCT00142792|365496660|FG001|Overall Study|Death|0|||
105954889|NCT00142792|365496661|FG002|Overall Study|Death|1|||
105954890|NCT00142792|365496659|FG000|Overall Study|Withdrawal by Subject|3|||
105954891|NCT00142792|365496660|FG001|Overall Study|Withdrawal by Subject|2|||
105954892|NCT00142792|365496661|FG002|Overall Study|Withdrawal by Subject|3|||
105954893|NCT00142792|365496659|FG000|Overall Study|Lost to Follow-up|8|||
105954894|NCT00142792|365496660|FG001|Overall Study|Lost to Follow-up|11|||
105954895|NCT00142792|365496661|FG002|Overall Study|Lost to Follow-up|7|||
105954896|NCT00142792|365496659|FG000|Overall Study|No category|1|||
105954897|NCT00142792|365496660|FG001|Overall Study|No category|2|||
105954898|NCT00142792|365496661|FG002|Overall Study|No category|1|||
105954899|NCT02382991|365496664|FG000|Overall Study|Adverse Event|1|||
105954900|NCT02382991|365496665|FG001|Overall Study|Adverse Event|2|||
105954901|NCT02382991|365496664|FG000|Overall Study|Lost to Follow-up|1|||
105954902|NCT02382991|365496665|FG001|Overall Study|Lost to Follow-up|0|||
105954903|NCT02382991|365496664|FG000|Overall Study|Withdrawal by Subject|0|||
105954904|NCT02382991|365496665|FG001|Overall Study|Withdrawal by Subject|1|||
105954905|NCT02708680|365496666|FG000|Overall Study|Withdrawal by Subject|4|||
105954906|NCT02708680|365496667|FG001|Overall Study|Withdrawal by Subject|12|||
105954907|NCT02708680|365496668|FG002|Overall Study|Withdrawal by Subject|12|||
105954908|NCT02708680|365496666|FG000|Overall Study|Death|4|||
105954909|NCT02708680|365496667|FG001|Overall Study|Death|19|||
105954910|NCT02708680|365496668|FG002|Overall Study|Death|21|||
105954911|NCT02708680|365496666|FG000|Overall Study|Lost to Follow-up|0|||
105954912|NCT02708680|365496667|FG001|Overall Study|Lost to Follow-up|3|||
105954913|NCT02708680|365496668|FG002|Overall Study|Lost to Follow-up|3|||
105954914|NCT02708680|365496666|FG000|Overall Study|Study Terminated By Sponsor|0|||
105954915|NCT02708680|365496667|FG001|Overall Study|Study Terminated By Sponsor|5|||
105954916|NCT02708680|365496668|FG002|Overall Study|Study Terminated By Sponsor|4|||
105954917|NCT02708680|365496666|FG000|Overall Study|Other than Specified|0|||
105954918|NCT02708680|365496667|FG001|Overall Study|Other than Specified|0|||
105954919|NCT02708680|365496668|FG002|Overall Study|Other than Specified|1|||
105954920|NCT02708680|365496666|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
106145200|NCT00159783|366191919|FG002|Overall Study|Adverse Event|9|||
105763474|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
105763475|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
105763476|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
105763477|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
105763478|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
105763479|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
105763480|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
105763481|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
105763482|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
105763483|NCT00856986|364787140|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
105763484|NCT00856986|364787141|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
105763485|NCT00856986|364787142|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
105763486|NCT00856986|364787143|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
105763487|NCT00856986|364787144|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
105763488|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
105763489|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
105763490|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
105954921|NCT02708680|365496667|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
105954922|NCT02708680|365496668|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
105954923|NCT04162470|365496669|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
105954924|NCT03554018|365496670|FG000|Overall Study|Lost to Follow-up|3|||
105954925|NCT03554018|365496671|FG001|Overall Study|Lost to Follow-up|7|||
105954926|NCT02131662|365496672|FG000|Overall Study|Protocol Violation|1|||
105954927|NCT02131662|365496673|FG001|Overall Study|Protocol Violation|0|||
105763491|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
105763492|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
105763493|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
105954928|NCT02131662|365496674|FG002|Overall Study|Protocol Violation|0|||
105954929|NCT02131662|365496675|FG003|Overall Study|Protocol Violation|0|||
105954930|NCT02131662|365496676|FG004|Overall Study|Protocol Violation|0|||
105954931|NCT02131662|365496672|FG000|Overall Study|Other|2|||
105954932|NCT02131662|365496673|FG001|Overall Study|Other|4|||
105954933|NCT02131662|365496674|FG002|Overall Study|Other|3|||
105954934|NCT02131662|365496675|FG003|Overall Study|Other|3|||
105954935|NCT02131662|365496676|FG004|Overall Study|Other|4|||
105954936|NCT02131662|365496672|FG000|Overall Study|Adverse Event|0|||
105954937|NCT02131662|365496673|FG001|Overall Study|Adverse Event|1|||
105954938|NCT02131662|365496674|FG002|Overall Study|Adverse Event|1|||
105763494|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
105763495|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
105763496|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
105763497|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
105763498|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
105763499|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
105763500|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
105763501|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
105763502|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
105763503|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
105763504|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
105763505|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
105763506|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
105763507|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
105763508|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
105763509|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
105763510|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
105763511|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
105763512|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
105763513|NCT00856986|364787140|FG000|Main Period, Weeks 0-26|Unclassified|7|||
105763514|NCT00856986|364787141|FG001|Main Period, Weeks 0-26|Unclassified|6|||
105763515|NCT00856986|364787142|FG002|Main Period, Weeks 0-26|Unclassified|7|||
105763516|NCT00856986|364787143|FG003|Main Period, Weeks 0-26|Unclassified|0|||
105763517|NCT00856986|364787144|FG004|Main Period, Weeks 0-26|Unclassified|0|||
105763518|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
105763519|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
105763520|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
105763521|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
105763522|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
105763523|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
105763524|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
105763525|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
105763526|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
105763527|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
105763528|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
105763529|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
105763530|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
105763531|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
105763532|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
105763533|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
105763534|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
105763535|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
105763536|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
105763537|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
105763538|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
105763539|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
105763540|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
105763541|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
105763542|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
105763543|NCT00856986|364787140|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
105763544|NCT00856986|364787141|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
105763545|NCT00856986|364787142|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
105763546|NCT00856986|364787143|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
105763547|NCT00856986|364787144|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
105763548|NCT05041062|364787147|FG000|Overall Study|Adverse Event|2|||
105763549|NCT02650895|364787148|FG000|Overall Study|Withdrawal by Subject|0|||
105763550|NCT02650895|364787149|FG001|Overall Study|Withdrawal by Subject|1|||
105763551|NCT02650895|364787150|FG002|Overall Study|Withdrawal by Subject|0|||
105763552|NCT02650895|364787151|FG003|Overall Study|Withdrawal by Subject|0|||
105763553|NCT02650895|364787152|FG004|Overall Study|Withdrawal by Subject|0|||
105763554|NCT02650895|364787153|FG005|Overall Study|Withdrawal by Subject|0|||
105763555|NCT03693404|364787167|FG000|Overall Study|Withdrawal by Subject|1|||
105954939|NCT02131662|365496675|FG003|Overall Study|Adverse Event|1|||
105954940|NCT02131662|365496676|FG004|Overall Study|Adverse Event|3|||
105813482|NCT03144687|364974673|FG001|Overall Study|Lost to Follow-up|1|||
105813483|NCT03144687|364974672|FG000|Overall Study|Physician Decision|0|||
105813484|NCT03144687|364974673|FG001|Overall Study|Physician Decision|1|||
105813485|NCT03144687|364974672|FG000|Overall Study|Withdrawal by Subject|1|||
105813486|NCT03144687|364974673|FG001|Overall Study|Withdrawal by Subject|3|||
105813487|NCT03144687|364974672|FG000|Overall Study|Not Reported|2|||
105813488|NCT03144687|364974673|FG001|Overall Study|Not Reported|0|||
105813489|NCT00683293|364974676|FG000|Overall Study|Withdrawal by Subject|2|||
105813490|NCT00683293|364974677|FG001|Overall Study|Withdrawal by Subject|3|||
105813491|NCT01104662|364974678|FG000|Overall Study|Adverse Event|2|||
105813492|NCT01104662|364974679|FG001|Overall Study|Adverse Event|2|||
105813493|NCT01104662|364974680|FG002|Overall Study|Adverse Event|0|||
105813494|NCT01104662|364974681|FG003|Overall Study|Adverse Event|1|||
105813495|NCT01104662|364974682|FG004|Overall Study|Adverse Event|1|||
105813496|NCT01104662|364974683|FG005|Overall Study|Adverse Event|1|||
105813497|NCT01104662|364974684|FG006|Overall Study|Adverse Event|0|||
105813498|NCT01104662|364974685|FG007|Overall Study|Adverse Event|0|||
105813499|NCT01104662|364974678|FG000|Overall Study|Clinical Failure|1|||
105813500|NCT01104662|364974679|FG001|Overall Study|Clinical Failure|0|||
105813501|NCT01104662|364974680|FG002|Overall Study|Clinical Failure|0|||
105813502|NCT01104662|364974681|FG003|Overall Study|Clinical Failure|0|||
105813503|NCT01104662|364974682|FG004|Overall Study|Clinical Failure|0|||
105813504|NCT01104662|364974683|FG005|Overall Study|Clinical Failure|1|||
105813505|NCT01104662|364974684|FG006|Overall Study|Clinical Failure|0|||
105813506|NCT01104662|364974685|FG007|Overall Study|Clinical Failure|0|||
105813507|NCT01104662|364974678|FG000|Overall Study|Participant left investigator's care|1|||
105813508|NCT01104662|364974679|FG001|Overall Study|Participant left investigator's care|1|||
105813509|NCT01104662|364974680|FG002|Overall Study|Participant left investigator's care|0|||
105813510|NCT01104662|364974681|FG003|Overall Study|Participant left investigator's care|0|||
105813511|NCT01104662|364974682|FG004|Overall Study|Participant left investigator's care|0|||
105813512|NCT01104662|364974683|FG005|Overall Study|Participant left investigator's care|0|||
105813513|NCT01104662|364974684|FG006|Overall Study|Participant left investigator's care|0|||
105813514|NCT01104662|364974685|FG007|Overall Study|Participant left investigator's care|0|||
105813515|NCT01104662|364974678|FG000|Overall Study|Reason not specified|3|||
105813516|NCT01104662|364974679|FG001|Overall Study|Reason not specified|3|||
105813517|NCT01104662|364974680|FG002|Overall Study|Reason not specified|0|||
105813518|NCT01104662|364974681|FG003|Overall Study|Reason not specified|0|||
105813519|NCT01104662|364974682|FG004|Overall Study|Reason not specified|0|||
105813520|NCT01104662|364974683|FG005|Overall Study|Reason not specified|1|||
105813521|NCT01104662|364974684|FG006|Overall Study|Reason not specified|0|||
105813522|NCT01104662|364974685|FG007|Overall Study|Reason not specified|0|||
105813523|NCT01104662|364974678|FG000|Overall Study|Randomized but not treated|3|||
105813524|NCT01104662|364974679|FG001|Overall Study|Randomized but not treated|4|||
105813525|NCT01104662|364974680|FG002|Overall Study|Randomized but not treated|1|||
105813526|NCT01104662|364974681|FG003|Overall Study|Randomized but not treated|0|||
105813527|NCT01104662|364974682|FG004|Overall Study|Randomized but not treated|0|||
105813528|NCT01104662|364974683|FG005|Overall Study|Randomized but not treated|1|||
105813529|NCT01104662|364974684|FG006|Overall Study|Randomized but not treated|0|||
105813530|NCT01104662|364974685|FG007|Overall Study|Randomized but not treated|0|||
105954941|NCT02131662|365496672|FG000|Overall Study|Pregnancy|0|||
105954942|NCT02131662|365496673|FG001|Overall Study|Pregnancy|1|||
105954943|NCT02131662|365496674|FG002|Overall Study|Pregnancy|0|||
105954944|NCT02131662|365496675|FG003|Overall Study|Pregnancy|1|||
105954945|NCT02131662|365496676|FG004|Overall Study|Pregnancy|0|||
105954946|NCT02131662|365496672|FG000|Overall Study|Wish for pregnancy|0|||
105954947|NCT02131662|365496673|FG001|Overall Study|Wish for pregnancy|0|||
105954948|NCT02131662|365496674|FG002|Overall Study|Wish for pregnancy|0|||
106145201|NCT00159783|366191917|FG000|Overall Study|Lack of Efficacy|1|||
105813531|NCT00743197|364974686|FG000|Overall Study|Study terminated due to departure of PI.|1|||
105813532|NCT00743197|364974687|FG001|Overall Study|Study terminated due to departure of PI.|2|||
105813533|NCT01469546|364974688|FG000|Received 5 mg Dose|Adverse Event|13|||
105813534|NCT01469546|364974688|FG000|Received 5 mg Dose|Death|2|||
105813535|NCT01469546|364974688|FG000|Received 5 mg Dose|Protocol Violation|2|||
106145202|NCT00159783|366191918|FG001|Overall Study|Lack of Efficacy|2|||
105813536|NCT01469546|364974688|FG000|Received 5 mg Dose|Progressive Disease|3|||
105813537|NCT01469546|364974688|FG000|Received 5 mg Dose|Physician Decision|3|||
106145203|NCT00159783|366191919|FG002|Overall Study|Lack of Efficacy|3|||
106145204|NCT00159783|366191917|FG000|Overall Study|Withdrawal by Subject|7|||
106145205|NCT00159783|366191918|FG001|Overall Study|Withdrawal by Subject|11|||
106145206|NCT00159783|366191919|FG002|Overall Study|Withdrawal by Subject|12|||
105813538|NCT02888171|364974693|FG000|Overall Study|Lost to Follow-up|2|||
105813539|NCT02888171|364974694|FG001|Overall Study|Lost to Follow-up|1|||
105813540|NCT02888171|364974693|FG000|Overall Study|Withdrawal by Subject|3|||
105813541|NCT02888171|364974694|FG001|Overall Study|Withdrawal by Subject|2|||
105813542|NCT02888171|364974693|FG000|Overall Study|Adverse Event|0|||
105813543|NCT02888171|364974694|FG001|Overall Study|Adverse Event|1|||
105954949|NCT02131662|365496675|FG003|Overall Study|Wish for pregnancy|0|||
105954950|NCT02131662|365496676|FG004|Overall Study|Wish for pregnancy|1|||
105954951|NCT02131662|365496672|FG000|Overall Study|Lack of Efficacy|1|||
105954952|NCT02131662|365496673|FG001|Overall Study|Lack of Efficacy|0|||
105954953|NCT02131662|365496674|FG002|Overall Study|Lack of Efficacy|0|||
105954954|NCT02131662|365496675|FG003|Overall Study|Lack of Efficacy|0|||
105954955|NCT02131662|365496676|FG004|Overall Study|Lack of Efficacy|1|||
105954956|NCT02131662|365496672|FG000|Overall Study|Withdrawal by Subject|1|||
105954957|NCT02131662|365496673|FG001|Overall Study|Withdrawal by Subject|5|||
105954958|NCT02131662|365496674|FG002|Overall Study|Withdrawal by Subject|1|||
105954959|NCT02131662|365496675|FG003|Overall Study|Withdrawal by Subject|5|||
105954960|NCT02131662|365496676|FG004|Overall Study|Withdrawal by Subject|6|||
105954961|NCT02131662|365496672|FG000|Overall Study|Lost to Follow-up|1|||
105954962|NCT02131662|365496673|FG001|Overall Study|Lost to Follow-up|3|||
105954963|NCT02131662|365496674|FG002|Overall Study|Lost to Follow-up|0|||
105954964|NCT02131662|365496675|FG003|Overall Study|Lost to Follow-up|9|||
105954965|NCT02131662|365496676|FG004|Overall Study|Lost to Follow-up|0|||
105954966|NCT02131662|365496672|FG000|Overall Study|Not treated|2|||
105954967|NCT02131662|365496673|FG001|Overall Study|Not treated|0|||
105954968|NCT02131662|365496674|FG002|Overall Study|Not treated|2|||
105954969|NCT02131662|365496675|FG003|Overall Study|Not treated|2|||
105954970|NCT02131662|365496676|FG004|Overall Study|Not treated|3|||
105954971|NCT03929913|365496677|FG000|Overall Study|Death|4|||
105954972|NCT03929913|365496677|FG000|Overall Study|Lost to Follow-up|1|||
105954973|NCT03929913|365496677|FG000|Overall Study|Failed Procedure|2|||
105954974|NCT01154452|365496678|FG000|Phase Ib|Not Treated|1|||
105954975|NCT01154452|365496679|FG001|Phase Ib|Not Treated|0|||
105954976|NCT01154452|365496680|FG002|Phase Ib|Not Treated|0|||
105954977|NCT01154452|365496681|FG003|Phase Ib|Not Treated|0|||
105813544|NCT04529109|364974695|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
105813545|NCT04529109|364974696|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
105813546|NCT02801877|364974697|FG000|Overall Study|Lost to Follow-up|1|||
105813547|NCT02801877|364974698|FG001|Overall Study|Lost to Follow-up|1|||
105813548|NCT02801877|364974699|FG002|Overall Study|Lost to Follow-up|2|||
105813549|NCT02801877|364974700|FG003|Overall Study|Lost to Follow-up|0|||
105813550|NCT02801877|364974697|FG000|Overall Study|Never Started Treatment|2|||
105813551|NCT02801877|364974698|FG001|Overall Study|Never Started Treatment|0|||
105813552|NCT02801877|364974699|FG002|Overall Study|Never Started Treatment|4|||
105813553|NCT02801877|364974700|FG003|Overall Study|Never Started Treatment|0|||
105813554|NCT02424188|364975988|FG000|Overall Study|Death|2|||
105813555|NCT02424188|364975989|FG001|Overall Study|Death|2|||
105813556|NCT02424188|364975988|FG000|Overall Study|Lost to Follow-up|1|||
105813557|NCT02424188|364975989|FG001|Overall Study|Lost to Follow-up|3|||
105813558|NCT02424188|364975988|FG000|Overall Study|Incarceration|1|||
105813559|NCT02424188|364975989|FG001|Overall Study|Incarceration|0|||
105813560|NCT00863746|364975990|FG000|Treatment|Not treated|4|||
105813561|NCT00863746|364975991|FG001|Treatment|Not treated|2|||
105813562|NCT00863746|364975990|FG000|Treatment|Adverse Event|41|||
105813563|NCT00863746|364975991|FG001|Treatment|Adverse Event|16|||
105813564|NCT00863746|364975990|FG000|Treatment|non-compliant with study medication|4|||
105813565|NCT00863746|364975991|FG001|Treatment|non-compliant with study medication|0|||
105813566|NCT00863746|364975990|FG000|Treatment|Consent withdrawn|15|||
105813567|NCT00863746|364975991|FG001|Treatment|Consent withdrawn|14|||
105813568|NCT00863746|364975990|FG000|Treatment|Lost to Follow-up|1|||
105813569|NCT00863746|364975991|FG001|Treatment|Lost to Follow-up|0|||
105813570|NCT00863746|364975990|FG000|Treatment|Protocol Violation|5|||
105954978|NCT01154452|365496678|FG000|Phase Ib|Adverse Event|2|||
105954979|NCT01154452|365496679|FG001|Phase Ib|Adverse Event|1|||
105954980|NCT01154452|365496680|FG002|Phase Ib|Adverse Event|0|||
105954981|NCT01154452|365496681|FG003|Phase Ib|Adverse Event|0|||
105954982|NCT01154452|365496678|FG000|Phase II|Withdrawal by Subject|0|||
105954983|NCT01154452|365496679|FG001|Phase II|Withdrawal by Subject|0|||
105954984|NCT01154452|365496680|FG002|Phase II|Withdrawal by Subject|1|||
105954985|NCT01154452|365496681|FG003|Phase II|Withdrawal by Subject|2|||
105954986|NCT01154452|365496678|FG000|Phase II|Adverse Event|0|||
105954987|NCT01154452|365496679|FG001|Phase II|Adverse Event|0|||
105954988|NCT01154452|365496680|FG002|Phase II|Adverse Event|4|||
105954989|NCT01154452|365496681|FG003|Phase II|Adverse Event|4|||
105954990|NCT01544348|365496682|FG000|Overall Study|Lost to Follow-up|1|||
105954991|NCT01544348|365496683|FG001|Overall Study|Lost to Follow-up|0|||
105954992|NCT01544348|365496684|FG002|Overall Study|Lost to Follow-up|0|||
105954993|NCT01544348|365496685|FG003|Overall Study|Lost to Follow-up|0|||
106018039|NCT00196313|365729241|FG000|Overall Study|Protocol Violation|2|||
105813571|NCT00863746|364975991|FG001|Treatment|Protocol Violation|3|||
105813572|NCT00863746|364975990|FG000|Treatment|Other|1|||
105813573|NCT00863746|364975991|FG001|Treatment|Other|0|||
105954994|NCT01544348|365496686|FG004|Overall Study|Lost to Follow-up|0|||
105813574|NCT00863746|364975990|FG000|Survival Follow up|Death|244|||
105813575|NCT00863746|364975991|FG001|Survival Follow up|Death|271|||
105813576|NCT00863746|364975990|FG000|Survival Follow up|Lost to Follow-up|2|||
105813577|NCT00863746|364975991|FG001|Survival Follow up|Lost to Follow-up|1|||
105954995|NCT01544348|365496687|FG005|Overall Study|Lost to Follow-up|0|||
105954996|NCT01544348|365496688|FG006|Overall Study|Lost to Follow-up|1|||
105813578|NCT00863746|364975990|FG000|Survival Follow up|Consent Withdrawn|7|||
105813579|NCT00863746|364975991|FG001|Survival Follow up|Consent Withdrawn|8|||
105813580|NCT03292653|364975992|FG000|Overall Study|Adverse Event|0|||
105813581|NCT03292653|364975993|FG001|Overall Study|Adverse Event|0|||
105813582|NCT03292653|364975994|FG002|Overall Study|Adverse Event|1|||
105813583|NCT03292653|364975992|FG000|Overall Study|Did not Receive Treatment|1|||
105813584|NCT03292653|364975993|FG001|Overall Study|Did not Receive Treatment|0|||
105813585|NCT03292653|364975994|FG002|Overall Study|Did not Receive Treatment|0|||
105813586|NCT05628675|364975995|FG000|Overall Study|Lost to Follow-up|2|||
105813587|NCT05628675|364975995|FG000|Overall Study|Withdrawal by Subject|1|||
105813588|NCT05818137|364975996|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
105813589|NCT05818137|364975996|FG000|Extension Treatment Period|Ongoing participants|44|||
105813590|NCT02497781|364976006|FG000|Overall Study|Withdrawal by Subject|2|||
105813591|NCT02497781|364976007|FG001|Overall Study|Withdrawal by Subject|0|||
105813592|NCT02497781|364976006|FG000|Overall Study|Lack of Efficacy|0|||
105813593|NCT02497781|364976007|FG001|Overall Study|Lack of Efficacy|1|||
105813594|NCT02497781|364976006|FG000|Overall Study|Randomised but not treated|1|||
105813595|NCT02497781|364976007|FG001|Overall Study|Randomised but not treated|1|||
105813596|NCT02497781|364976006|FG000|Overall Study|Lost to Follow-up|1|||
105813597|NCT02497781|364976007|FG001|Overall Study|Lost to Follow-up|1|||
105813598|NCT01249664|364976008|FG000|Overall Study|Withdrawal by Subject|5|||
105813599|NCT01249664|364976009|FG001|Overall Study|Withdrawal by Subject|0|||
105813600|NCT01249664|364976008|FG000|Overall Study|Adverse Event|1|||
105813601|NCT01249664|364976009|FG001|Overall Study|Adverse Event|0|||
105813602|NCT01400113|364976010|FG000|Overall Study|Withdrawal by Subject|1|||
105813603|NCT01400113|364976011|FG001|Overall Study|Withdrawal by Subject|1|||
105813604|NCT00806156|364976014|FG000|Overall Study|Death|35|||
105813605|NCT00806156|364976015|FG001|Overall Study|Death|95|||
105813606|NCT00806156|364976014|FG000|Overall Study|Did not meet eligibility criteria|1|||
105813607|NCT00806156|364976015|FG001|Overall Study|Did not meet eligibility criteria|0|||
105813608|NCT00806156|364976014|FG000|Overall Study|Study terminated by Sponsor|2|||
105813609|NCT00806156|364976015|FG001|Overall Study|Study terminated by Sponsor|40|||
105813610|NCT00806156|364976014|FG000|Overall Study|Consent withdrawn by subject|1|||
105813611|NCT00806156|364976015|FG001|Overall Study|Consent withdrawn by subject|3|||
105813612|NCT00806156|364976014|FG000|Overall Study|Lost to Follow-up|0|||
105813613|NCT00806156|364976015|FG001|Overall Study|Lost to Follow-up|1|||
105813614|NCT01025037|364976020|FG000|Overall Study|Adverse Event|3|||
105813615|NCT01025037|364976020|FG000|Overall Study|Lost to Follow-up|7|||
105813616|NCT01025037|364976020|FG000|Overall Study|Withdrawal by Subject|1|||
105813617|NCT02192099|364976025|FG000|Overall Study|Adverse Event|1|||
105813618|NCT02192099|364976025|FG000|Overall Study|Lost to Follow-up|2|||
105813619|NCT02192099|364976025|FG000|Overall Study|Physician Decision|1|||
105813620|NCT02192099|364976025|FG000|Overall Study|Pregnancy|1|||
105813621|NCT02192099|364976025|FG000|Overall Study|Protocol Violation|8|||
105813622|NCT02192099|364976025|FG000|Overall Study|Study Terminated by Sponsor|32|||
105813623|NCT02192099|364976025|FG000|Overall Study|Withdrawal by Subject|11|||
105813624|NCT02192099|364976025|FG000|Overall Study|Miscellaneous Reasons|5|||
105813625|NCT03247556|364976028|FG000|Overall Study|Adverse Event|1|||
105813626|NCT03247556|364976029|FG001|Overall Study|Adverse Event|4|||
105813627|NCT03247556|364976030|FG002|Overall Study|Adverse Event|5|||
105813628|NCT03247556|364976028|FG000|Overall Study|Lost to Follow-up|5|||
105813629|NCT03247556|364976029|FG001|Overall Study|Lost to Follow-up|5|||
105813630|NCT03247556|364976030|FG002|Overall Study|Lost to Follow-up|4|||
105813631|NCT03247556|364976028|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
105813632|NCT03247556|364976029|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
105813633|NCT03247556|364976030|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
105813634|NCT03247556|364976028|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
105813635|NCT03247556|364976029|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
105813636|NCT03247556|364976030|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
105813637|NCT03247556|364976028|FG000|Overall Study|Protocol Violation|2|||
105813638|NCT03247556|364976029|FG001|Overall Study|Protocol Violation|0|||
105813639|NCT03247556|364976030|FG002|Overall Study|Protocol Violation|1|||
105813640|NCT03247556|364976028|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
105813641|NCT03247556|364976029|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
105813642|NCT03247556|364976030|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
105813643|NCT01856309|364976042|FG000|Overall Study|Death|4|||
105954997|NCT01544348|365496689|FG007|Overall Study|Lost to Follow-up|0|||
105954998|NCT01544348|365496682|FG000|Overall Study|Withdrawal by Subject|1|||
105954999|NCT01544348|365496683|FG001|Overall Study|Withdrawal by Subject|0|||
105813644|NCT01856309|364976043|FG001|Overall Study|Death|6|||
105813645|NCT01856309|364976044|FG002|Overall Study|Death|11|||
105813646|NCT01856309|364976045|FG003|Overall Study|Death|6|||
105813647|NCT01856309|364976042|FG000|Overall Study|Lost to Follow-up|6|||
105813648|NCT01856309|364976043|FG001|Overall Study|Lost to Follow-up|2|||
105813649|NCT01856309|364976044|FG002|Overall Study|Lost to Follow-up|4|||
105813650|NCT01856309|364976045|FG003|Overall Study|Lost to Follow-up|8|||
105813651|NCT01856309|364976042|FG000|Overall Study|Withdrawal by Subject|11|||
105955000|NCT01544348|365496684|FG002|Overall Study|Withdrawal by Subject|0|||
105955001|NCT01544348|365496685|FG003|Overall Study|Withdrawal by Subject|0|||
105955002|NCT01544348|365496686|FG004|Overall Study|Withdrawal by Subject|1|||
105955003|NCT01544348|365496687|FG005|Overall Study|Withdrawal by Subject|2|||
105955004|NCT01544348|365496688|FG006|Overall Study|Withdrawal by Subject|1|||
105955005|NCT01544348|365496689|FG007|Overall Study|Withdrawal by Subject|0|||
105955006|NCT01544348|365496682|FG000|Overall Study|Physician Decision|0|||
105955007|NCT01544348|365496683|FG001|Overall Study|Physician Decision|0|||
105955008|NCT01544348|365496684|FG002|Overall Study|Physician Decision|0|||
105955009|NCT01544348|365496685|FG003|Overall Study|Physician Decision|0|||
105955010|NCT01544348|365496686|FG004|Overall Study|Physician Decision|0|||
105955011|NCT01544348|365496687|FG005|Overall Study|Physician Decision|1|||
105955012|NCT01544348|365496688|FG006|Overall Study|Physician Decision|0|||
105955013|NCT01544348|365496689|FG007|Overall Study|Physician Decision|0|||
105955014|NCT00145626|365496690|FG000|Overall Study|Did not have NK infusions|2|||
105955015|NCT00145626|365496690|FG000|Overall Study|Turned 2 years old before treatment|1|||
105955016|NCT00145626|365496690|FG000|Overall Study|Death|1|||
105955017|NCT00145626|365496690|FG000|Overall Study|Withdrawal by Subject|1|||
105813652|NCT01856309|364976043|FG001|Overall Study|Withdrawal by Subject|13|||
105813653|NCT01856309|364976044|FG002|Overall Study|Withdrawal by Subject|28|||
105813654|NCT01856309|364976045|FG003|Overall Study|Withdrawal by Subject|26|||
105813655|NCT01856309|364976042|FG000|Overall Study|Other|227|||
105813656|NCT01856309|364976043|FG001|Overall Study|Other|225|||
105813657|NCT01856309|364976044|FG002|Overall Study|Other|447|||
105813658|NCT01856309|364976045|FG003|Overall Study|Other|469|||
105813659|NCT01856309|364976042|FG000|Overall Study|Lack of Efficacy|14|||
105813660|NCT01856309|364976043|FG001|Overall Study|Lack of Efficacy|9|||
105813661|NCT01856309|364976044|FG002|Overall Study|Lack of Efficacy|40|||
105813662|NCT01856309|364976045|FG003|Overall Study|Lack of Efficacy|25|||
105813663|NCT01856309|364976042|FG000|Overall Study|Adverse Event|31|||
105813664|NCT01856309|364976043|FG001|Overall Study|Adverse Event|31|||
105813665|NCT01856309|364976044|FG002|Overall Study|Adverse Event|55|||
105813666|NCT01856309|364976045|FG003|Overall Study|Adverse Event|65|||
105813667|NCT01856309|364976042|FG000|Overall Study|Pregnancy|0|||
105813668|NCT01856309|364976043|FG001|Overall Study|Pregnancy|0|||
105813669|NCT01856309|364976044|FG002|Overall Study|Pregnancy|0|||
105813670|NCT01856309|364976045|FG003|Overall Study|Pregnancy|1|||
105813671|NCT01856309|364976042|FG000|Overall Study|Physician Decision|6|||
105813672|NCT01856309|364976043|FG001|Overall Study|Physician Decision|1|||
105813673|NCT01856309|364976044|FG002|Overall Study|Physician Decision|6|||
105813674|NCT01856309|364976045|FG003|Overall Study|Physician Decision|8|||
105813675|NCT01856309|364976042|FG000|Overall Study|Noncompliance With Study Drug|0|||
105813676|NCT01856309|364976043|FG001|Overall Study|Noncompliance With Study Drug|1|||
105813677|NCT01856309|364976044|FG002|Overall Study|Noncompliance With Study Drug|4|||
105813678|NCT01856309|364976045|FG003|Overall Study|Noncompliance With Study Drug|1|||
105813679|NCT01273181|364976048|FG000|Phase I, Dose 1|Study termination|1|||
105813680|NCT01273181|364976049|FG001|Phase I, Dose 1|Study termination|0|||
105813681|NCT01273181|364976050|FG002|Phase I, Dose 1|Study termination|0|||
105813682|NCT01273181|364976051|FG003|Phase I, Dose 1|Study termination|0|||
105813683|NCT01273181|364976048|FG000|Phase I, Dose 2|Death during treatment|0|||
105813684|NCT01273181|364976049|FG001|Phase I, Dose 2|Death during treatment|1|||
105813685|NCT01273181|364976050|FG002|Phase I, Dose 2|Death during treatment|0|||
105813686|NCT01273181|364976051|FG003|Phase I, Dose 2|Death during treatment|0|||
105813687|NCT01273181|364976048|FG000|Phase 2, Dose 1|Study termination|0|||
105813688|NCT01273181|364976049|FG001|Phase 2, Dose 1|Study termination|0|||
105813689|NCT01273181|364976050|FG002|Phase 2, Dose 1|Study termination|1|||
105813690|NCT01273181|364976051|FG003|Phase 2, Dose 1|Study termination|0|||
105955018|NCT02573948|365496691|FG000|Longitudinal Cohort|Death|9|||
105955019|NCT02573948|365496691|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
105955020|NCT02573948|365496691|FG000|Longitudinal Cohort|Incarcerated|25|||
105955021|NCT00707993|365496692|FG000|Overall Study|Adverse Event|16|||
105813691|NCT01273181|364976048|FG000|Phase 2, Dose 2|Death during treatment|0|||
105813692|NCT01273181|364976049|FG001|Phase 2, Dose 2|Death during treatment|0|||
105955022|NCT00707993|365496693|FG001|Overall Study|Adverse Event|20|||
105955023|NCT00707993|365496692|FG000|Overall Study|Protocol Violation|4|||
105955024|NCT00707993|365496693|FG001|Overall Study|Protocol Violation|7|||
105955025|NCT00707993|365496692|FG000|Overall Study|Lost to Follow-up|0|||
105955026|NCT00707993|365496693|FG001|Overall Study|Lost to Follow-up|4|||
105955027|NCT00707993|365496692|FG000|Overall Study|Withdrawal by Subject|12|||
105955028|NCT00707993|365496693|FG001|Overall Study|Withdrawal by Subject|16|||
105813693|NCT01273181|364976050|FG002|Phase 2, Dose 2|Death during treatment|0|||
105813694|NCT01273181|364976051|FG003|Phase 2, Dose 2|Death during treatment|1|||
105955029|NCT00707993|365496692|FG000|Overall Study|Hyperglycemic Rescue|55|||
105955030|NCT00707993|365496693|FG001|Overall Study|Hyperglycemic Rescue|47|||
105955031|NCT00707993|365496692|FG000|Overall Study|Other|2|||
105955032|NCT00707993|365496693|FG001|Overall Study|Other|0|||
105813695|NCT00337077|364976052|FG000|Overall Study|Progressive disease|25|||
105813696|NCT00337077|364976053|FG001|Overall Study|Progressive disease|37|||
105813697|NCT00337077|364976054|FG002|Overall Study|Progressive disease|19|||
105813698|NCT00337077|364976052|FG000|Overall Study|Adverse Event|7|||
105813699|NCT00337077|364976053|FG001|Overall Study|Adverse Event|7|||
105813700|NCT00337077|364976054|FG002|Overall Study|Adverse Event|1|||
105813701|NCT00337077|364976052|FG000|Overall Study|Death|0|||
105813702|NCT00337077|364976053|FG001|Overall Study|Death|1|||
105813703|NCT00337077|364976054|FG002|Overall Study|Death|0|||
105813704|NCT00337077|364976052|FG000|Overall Study|Withdrawal by Subject|7|||
105955033|NCT03381287|365496699|FG000|Overall Study|Withdrawal by Subject|0|||
105955034|NCT03381287|365496700|FG001|Overall Study|Withdrawal by Subject|1|||
105813705|NCT00337077|364976053|FG001|Overall Study|Withdrawal by Subject|2|||
105813706|NCT00337077|364976054|FG002|Overall Study|Withdrawal by Subject|2|||
105813707|NCT00337077|364976052|FG000|Overall Study|Alternative therapy|1|||
105813708|NCT00337077|364976053|FG001|Overall Study|Alternative therapy|0|||
105813709|NCT00337077|364976054|FG002|Overall Study|Alternative therapy|0|||
105813710|NCT00337077|364976052|FG000|Overall Study|Physician Decision|1|||
105813711|NCT00337077|364976053|FG001|Overall Study|Physician Decision|4|||
105813712|NCT00337077|364976054|FG002|Overall Study|Physician Decision|2|||
105813713|NCT00337077|364976052|FG000|Overall Study|Never started treatment|1|||
105813714|NCT00337077|364976053|FG001|Overall Study|Never started treatment|1|||
105813715|NCT00337077|364976054|FG002|Overall Study|Never started treatment|0|||
105813716|NCT00337077|364976052|FG000|Overall Study|Ineligible|1|||
105813717|NCT00337077|364976053|FG001|Overall Study|Ineligible|1|||
105813718|NCT00337077|364976054|FG002|Overall Study|Ineligible|1|||
105813719|NCT00944697|364976055|FG000|Overall Study|Withdrawal by Subject|1|||
105813720|NCT00944697|364976056|FG001|Overall Study|Withdrawal by Subject|1|||
105813721|NCT00944697|364976055|FG000|Overall Study|Adverse Event|0|||
105813722|NCT00944697|364976056|FG001|Overall Study|Adverse Event|3|||
105813723|NCT00944697|364976055|FG000|Overall Study|Administrative|1|||
105813724|NCT00944697|364976056|FG001|Overall Study|Administrative|1|||
105813725|NCT03657160|364976061|FG000|Overall Study|Adverse Event|5|||
105813726|NCT03657160|364976062|FG001|Overall Study|Adverse Event|6|||
105813727|NCT03657160|364976061|FG000|Overall Study|Protocol Deviation|3|||
105813728|NCT03657160|364976062|FG001|Overall Study|Protocol Deviation|0|||
105813729|NCT03657160|364976061|FG000|Overall Study|Withdrawal by Subject|18|||
105813730|NCT03657160|364976062|FG001|Overall Study|Withdrawal by Subject|16|||
105813731|NCT03657160|364976061|FG000|Overall Study|Site Termination|1|||
105813732|NCT03657160|364976062|FG001|Overall Study|Site Termination|0|||
105813733|NCT03657160|364976061|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
105813734|NCT03657160|364976062|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
105813735|NCT03657160|364976061|FG000|Overall Study|Death|33|||
105813736|NCT03657160|364976062|FG001|Overall Study|Death|26|||
105955035|NCT03381287|365496701|FG002|Overall Study|Withdrawal by Subject|0|||
105955036|NCT03381287|365496702|FG003|Overall Study|Withdrawal by Subject|0|||
105955037|NCT03381287|365496699|FG000|Overall Study|Adverse Event|0|||
105955038|NCT03381287|365496700|FG001|Overall Study|Adverse Event|0|||
105955039|NCT03381287|365496701|FG002|Overall Study|Adverse Event|0|||
105955040|NCT03381287|365496702|FG003|Overall Study|Adverse Event|1|||
105955041|NCT03381287|365496699|FG000|Overall Study|Physician Decision|0|||
105955042|NCT03381287|365496700|FG001|Overall Study|Physician Decision|0|||
105955043|NCT03381287|365496701|FG002|Overall Study|Physician Decision|0|||
105955044|NCT03381287|365496702|FG003|Overall Study|Physician Decision|1|||
105955045|NCT03960684|365496703|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
105955046|NCT03154476|365496704|FG000|Overall Study|Lost to Follow-up|4|||
105955047|NCT03154476|365496705|FG001|Overall Study|Lost to Follow-up|4|||
105955048|NCT02685826|365496706|FG000|Overall Study|Adverse Event|2|||
105955049|NCT02685826|365496707|FG001|Overall Study|Adverse Event|0|||
105955050|NCT02685826|365496708|FG002|Overall Study|Adverse Event|1|||
105955051|NCT02685826|365496706|FG000|Overall Study|Progressive Disease|2|||
106018040|NCT00196313|365729242|FG001|Overall Study|Protocol Violation|3|||
105813737|NCT03657160|364976061|FG000|Overall Study|Death (COVID-19-Related)|1|||
105813738|NCT03657160|364976062|FG001|Overall Study|Death (COVID-19-Related)|0|||
105813739|NCT03657160|364976061|FG000|Overall Study|Reason Not Specified|5|||
105813740|NCT03657160|364976062|FG001|Overall Study|Reason Not Specified|5|||
106018041|NCT00196313|365729241|FG000|Overall Study|Withdrawal by Subject|3|||
106018042|NCT00196313|365729242|FG001|Overall Study|Withdrawal by Subject|1|||
105813741|NCT03657160|364976061|FG000|Overall Study|Other (COVID-19-Related)|0|||
105813742|NCT03657160|364976062|FG001|Overall Study|Other (COVID-19-Related)|1|||
105813743|NCT00604500|364976063|FG000|Overall Study|Adverse Event|2|||
105813744|NCT00604500|364976063|FG000|Overall Study|Protocol Violation|2|||
105813745|NCT00604500|364976063|FG000|Overall Study|Treatment Failure|1|||
105813746|NCT00604500|364976063|FG000|Overall Study|Withdrawal by Subject|4|||
105813747|NCT00604500|364976063|FG000|Overall Study|Administrative|1|||
105813748|NCT00604500|364976063|FG000|Overall Study|Did not meet protocol eligibility|1|||
105813749|NCT00320112|364976064|FG000|Overall Study|Lost to Follow-up|3|||
105813750|NCT00320112|364976065|FG001|Overall Study|Lost to Follow-up|4|||
105955052|NCT02685826|365496707|FG001|Overall Study|Progressive Disease|1|||
105955053|NCT02685826|365496708|FG002|Overall Study|Progressive Disease|0|||
106018043|NCT00196313|365729241|FG000|Overall Study|Adverse Event|3|||
105813751|NCT00320112|364976064|FG000|Overall Study|Withdrawal by Subject|3|||
105813752|NCT00320112|364976065|FG001|Overall Study|Withdrawal by Subject|0|||
105813753|NCT00320112|364976064|FG000|Overall Study|Death|2|||
105813754|NCT00320112|364976065|FG001|Overall Study|Death|1|||
105813755|NCT02191891|364976066|FG000|Overall Study|Withdrawal by Subject|0|||
105813756|NCT02191891|364976067|FG001|Overall Study|Withdrawal by Subject|1|||
105813757|NCT02191891|364976068|FG002|Overall Study|Withdrawal by Subject|0|||
105813758|NCT02191891|364976069|FG003|Overall Study|Withdrawal by Subject|0|||
105813759|NCT02191891|364976070|FG004|Overall Study|Withdrawal by Subject|1|||
105813760|NCT02191891|364976066|FG000|Overall Study|Adverse Event|0|||
105813761|NCT02191891|364976067|FG001|Overall Study|Adverse Event|1|||
105813762|NCT02191891|364976068|FG002|Overall Study|Adverse Event|0|||
105813763|NCT02191891|364976069|FG003|Overall Study|Adverse Event|0|||
105813764|NCT02191891|364976070|FG004|Overall Study|Adverse Event|2|||
105813765|NCT02191891|364976066|FG000|Overall Study|Disease Progression|4|||
105813766|NCT02191891|364976067|FG001|Overall Study|Disease Progression|10|||
105813767|NCT02191891|364976068|FG002|Overall Study|Disease Progression|4|||
105813768|NCT02191891|364976069|FG003|Overall Study|Disease Progression|2|||
105813769|NCT02191891|364976070|FG004|Overall Study|Disease Progression|7|||
105813770|NCT04006171|364976071|FG000|Overall Study|Withdrawal by Subject|8|||
105813771|NCT04006171|364976072|FG001|Overall Study|Withdrawal by Subject|7|||
105813772|NCT04006171|364976071|FG000|Overall Study|missing serum samples|2|||
105813773|NCT04006171|364976072|FG001|Overall Study|missing serum samples|2|||
105813774|NCT04006171|364976071|FG000|Overall Study|insufficient sample volume|2|||
105813775|NCT04006171|364976072|FG001|Overall Study|insufficient sample volume|3|||
105813776|NCT01448057|364976073|FG000|Overall Study|Protocol Violation|3|||
105813777|NCT01448057|364976074|FG001|Overall Study|Protocol Violation|2|||
105955054|NCT02685826|365496706|FG000|Overall Study|Withdrawal by Subject|2|||
105955055|NCT02685826|365496707|FG001|Overall Study|Withdrawal by Subject|0|||
105955056|NCT02685826|365496708|FG002|Overall Study|Withdrawal by Subject|0|||
105955057|NCT02685826|365496706|FG000|Overall Study|Full Clinical Hold by FDA|19|||
105813778|NCT01448057|364976073|FG000|Overall Study|Lost to Follow-up|3|||
105813779|NCT01448057|364976074|FG001|Overall Study|Lost to Follow-up|0|||
105813780|NCT01448057|364976073|FG000|Overall Study|Adverse Event|0|||
105813781|NCT01448057|364976074|FG001|Overall Study|Adverse Event|2|||
105813782|NCT01448057|364976073|FG000|Overall Study|Withdrawal by Subject|2|||
105813783|NCT01448057|364976074|FG001|Overall Study|Withdrawal by Subject|0|||
105813784|NCT00486837|364976076|FG000|Overall Study|Withdrawal by Subject|1|||
105813785|NCT00486837|364976077|FG001|Overall Study|Withdrawal by Subject|0|||
105813786|NCT00486837|364976076|FG000|Overall Study|Adverse Event|1|||
105813787|NCT00486837|364976077|FG001|Overall Study|Adverse Event|1|||
105813788|NCT00486837|364976076|FG000|Overall Study|Protocol Violation|4|||
105813789|NCT00486837|364976077|FG001|Overall Study|Protocol Violation|2|||
105955058|NCT02685826|365496707|FG001|Overall Study|Full Clinical Hold by FDA|9|||
105955059|NCT02685826|365496708|FG002|Overall Study|Full Clinical Hold by FDA|20|||
105955060|NCT01444430|365496709|FG000|Overall Study|Withdrawal by Subject|53|||
105955061|NCT01444430|365496710|FG001|Overall Study|Withdrawal by Subject|72|||
105955062|NCT01444430|365496709|FG000|Overall Study|Death|6|||
105955063|NCT01444430|365496710|FG001|Overall Study|Death|8|||
105955064|NCT01444430|365496709|FG000|Overall Study|Lost to Follow-up|2|||
105955065|NCT01444430|365496710|FG001|Overall Study|Lost to Follow-up|0|||
105955066|NCT01444430|365496709|FG000|Overall Study|CRF termination module not completed.|0|||
105955067|NCT01444430|365496710|FG001|Overall Study|CRF termination module not completed.|1|||
105955068|NCT04472650|365498200|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
105955069|NCT04472650|365498201|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
105955070|NCT00552071|365498204|FG000|Overall Study|Adverse Event|1|||
105955071|NCT00552071|365498205|FG001|Overall Study|Adverse Event|0|||
105955072|NCT00552071|365498204|FG000|Overall Study|Lack of Efficacy|1|||
105955073|NCT00552071|365498205|FG001|Overall Study|Lack of Efficacy|0|||
105955074|NCT00552071|365498204|FG000|Overall Study|Physician Decision|1|||
105955075|NCT00552071|365498205|FG001|Overall Study|Physician Decision|0|||
105813790|NCT00486837|364976076|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
105813791|NCT00486837|364976077|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
105955076|NCT00552071|365498204|FG000|Overall Study|Pregnancy|1|||
105955077|NCT00552071|365498205|FG001|Overall Study|Pregnancy|0|||
105813792|NCT00414765|364976078|FG000|Overall Study|Adverse Event|5|||
105813793|NCT00414765|364976079|FG001|Overall Study|Adverse Event|9|||
105813794|NCT00414765|364976078|FG000|Overall Study|Withdrawal by Subject|1|||
105813795|NCT00414765|364976079|FG001|Overall Study|Withdrawal by Subject|1|||
105813796|NCT00414765|364976078|FG000|Overall Study|Disease Progression|0|||
105955078|NCT00552071|365498204|FG000|Overall Study|Death|0|||
105955079|NCT00552071|365498205|FG001|Overall Study|Death|1|||
105955080|NCT00552071|365498204|FG000|Overall Study|Withdrawal by Subject|0|||
105955081|NCT00552071|365498205|FG001|Overall Study|Withdrawal by Subject|1|||
105813797|NCT00414765|364976079|FG001|Overall Study|Disease Progression|1|||
105955082|NCT02549989|365498206|FG000|Overall Study|Adverse Event|4|||
105955083|NCT02549989|365498206|FG000|Overall Study|Death|1|||
105955084|NCT02549989|365498206|FG000|Overall Study|Lack of Efficacy|19|||
105955085|NCT02549989|365498206|FG000|Overall Study|Withdrawal by Subject|3|||
105955086|NCT00972023|365498207|FG000|Overall Study|Withdrawal by Subject|1|||
105955087|NCT02628444|365498208|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
105955088|NCT02628444|365498209|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105955089|NCT02628444|365498210|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105955090|NCT02628444|365498211|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105955091|NCT02628444|365498212|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105813798|NCT03130699|364976080|FG000|Overall Study|Lost to Follow-up|34|||
105813799|NCT03130699|364976081|FG001|Overall Study|Lost to Follow-up|37|||
105813800|NCT03130699|364976082|FG002|Overall Study|Lost to Follow-up|26|||
105813801|NCT03130699|364976080|FG000|Overall Study|Withdrawal by Subject|5|||
105813802|NCT03130699|364976081|FG001|Overall Study|Withdrawal by Subject|1|||
105813803|NCT03130699|364976082|FG002|Overall Study|Withdrawal by Subject|0|||
105813804|NCT03130699|364976080|FG000|Overall Study|Withdrawal by PI|1|||
105813805|NCT03130699|364976081|FG001|Overall Study|Withdrawal by PI|2|||
105813806|NCT03130699|364976082|FG002|Overall Study|Withdrawal by PI|5|||
105955092|NCT02628444|365498213|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105955093|NCT02628444|365498214|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105955094|NCT02628444|365498215|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105955095|NCT02628444|365498216|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
105955096|NCT02628444|365498208|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105955097|NCT02628444|365498209|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
105955098|NCT02628444|365498210|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
105955099|NCT02628444|365498211|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105955100|NCT02628444|365498212|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105955101|NCT02628444|365498213|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105955102|NCT02628444|365498214|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105955103|NCT02628444|365498215|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105955104|NCT02628444|365498216|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
105955105|NCT02628444|365498208|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
105955106|NCT02628444|365498209|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
105955107|NCT02628444|365498210|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
105955108|NCT02628444|365498211|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955109|NCT02628444|365498212|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955110|NCT02628444|365498213|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955111|NCT02628444|365498214|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955112|NCT02628444|365498215|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955113|NCT02628444|365498216|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955114|NCT02628444|365498208|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
105955115|NCT02628444|365498209|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
105955116|NCT02628444|365498210|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
105955117|NCT02628444|365498211|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105955118|NCT02628444|365498212|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105763556|NCT03693404|364787168|FG001|Overall Study|Withdrawal by Subject|0|||
105813807|NCT03130699|364976080|FG000|Overall Study|Death|0|||
105813808|NCT03130699|364976081|FG001|Overall Study|Death|0|||
105813809|NCT03130699|364976082|FG002|Overall Study|Death|1|||
105813810|NCT04977336|364976085|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
105813811|NCT04977336|364976086|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105813812|NCT04977336|364976087|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
105813813|NCT04977336|364976088|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
105813814|NCT04977336|364976089|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
105813815|NCT04977336|364976085|FG000|Overall Study|Lost to Follow-up|0|||
105813816|NCT04977336|364976086|FG001|Overall Study|Lost to Follow-up|0|||
105763557|NCT03693404|364787167|FG000|Overall Study|Lost to Follow-up|0|||
105763558|NCT03693404|364787168|FG001|Overall Study|Lost to Follow-up|5|||
105763559|NCT03693404|364787167|FG000|Overall Study|Excluded from Analysis|0|||
105763560|NCT03693404|364787168|FG001|Overall Study|Excluded from Analysis|1|||
105763561|NCT01802515|364787169|FG000|Overall Study|Withdrawal by Subject|3|||
105763562|NCT01802515|364787170|FG001|Overall Study|Withdrawal by Subject|0|||
105763563|NCT01802515|364787171|FG002|Overall Study|Withdrawal by Subject|0|||
105763564|NCT01906476|364787174|FG000|Overall Study|Lost to Follow-up|17|||
105813817|NCT04977336|364976087|FG002|Overall Study|Lost to Follow-up|1|||
105813818|NCT04977336|364976088|FG003|Overall Study|Lost to Follow-up|0|||
105813819|NCT04977336|364976089|FG004|Overall Study|Lost to Follow-up|0|||
105813820|NCT01004172|364976090|FG000|Overall Study|Progressive Disease in CNS Only|16|||
105813821|NCT01004172|364976090|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
105813822|NCT01004172|364976090|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
105813823|NCT01004172|364976090|FG000|Overall Study|Adverse Event|1|||
105813824|NCT01004172|364976090|FG000|Overall Study|Physician Decision|1|||
105813825|NCT01004172|364976090|FG000|Overall Study|Symptomatic Deterioration|2|||
105813826|NCT00950872|364976091|FG000|Overall Study|Withdrawal by Subject|1|||
105813827|NCT00950872|364976091|FG000|Overall Study|Did not have surgery|2|||
105813828|NCT00352690|364976093|FG000|Overall Study|Determined to be ineligible|2|||
105813829|NCT00352690|364976094|FG001|Overall Study|Determined to be ineligible|0|||
105813830|NCT01378975|364976095|FG000|Overall Study|Death|77|||
105813831|NCT01378975|364976096|FG001|Overall Study|Death|46|||
105813832|NCT01378975|364976095|FG000|Overall Study|Investigator Request|1|||
105813833|NCT01378975|364976096|FG001|Overall Study|Investigator Request|0|||
105813834|NCT01378975|364976095|FG000|Overall Study|Lost to Follow-up|4|||
105813835|NCT01378975|364976096|FG001|Overall Study|Lost to Follow-up|1|||
105813836|NCT01378975|364976095|FG000|Overall Study|Withdrew Consent|4|||
105813837|NCT01378975|364976096|FG001|Overall Study|Withdrew Consent|3|||
105813838|NCT01030965|364976098|FG000|Overall Study|Lack of Efficacy|3|||
105813839|NCT01030965|364976099|FG001|Overall Study|Lack of Efficacy|2|||
105813840|NCT01030965|364976100|FG002|Overall Study|Lack of Efficacy|0|||
105813841|NCT01030965|364976101|FG003|Overall Study|Lack of Efficacy|3|||
105813842|NCT01030965|364976098|FG000|Overall Study|Protocol Violation|1|||
105813843|NCT01030965|364976099|FG001|Overall Study|Protocol Violation|1|||
105813844|NCT01030965|364976100|FG002|Overall Study|Protocol Violation|1|||
105813845|NCT01030965|364976101|FG003|Overall Study|Protocol Violation|1|||
105813846|NCT01030965|364976098|FG000|Overall Study|Adverse Event|0|||
105813847|NCT01030965|364976099|FG001|Overall Study|Adverse Event|1|||
105813848|NCT01030965|364976100|FG002|Overall Study|Adverse Event|2|||
105813849|NCT01030965|364976101|FG003|Overall Study|Adverse Event|1|||
105813850|NCT01030965|364976098|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
105813851|NCT01030965|364976099|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
105813852|NCT01030965|364976100|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
105813853|NCT01030965|364976101|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
105813854|NCT01030965|364976098|FG000|Overall Study|Withdrawal by Subject|0|||
105813855|NCT01030965|364976099|FG001|Overall Study|Withdrawal by Subject|1|||
105813856|NCT01030965|364976100|FG002|Overall Study|Withdrawal by Subject|0|||
105813857|NCT01030965|364976101|FG003|Overall Study|Withdrawal by Subject|2|||
105813858|NCT02097290|364976102|FG000|Overall Study|Death|6|||
105813859|NCT02097290|364976102|FG000|Overall Study|Total Withdrawals|3|||
105813860|NCT02097290|364976102|FG000|Overall Study|Attempt|8|||
105813861|NCT04803357|364976105|FG000|Overall Study|Withdrawal by Subject|31|||
105813862|NCT04803357|364976106|FG001|Overall Study|Withdrawal by Subject|5|||
105813863|NCT00694551|364976107|FG000|Overall Study|Disease Progression|1|||
105813864|NCT00694551|364976108|FG001|Overall Study|Disease Progression|0|||
105813865|NCT00694551|364976109|FG002|Overall Study|Disease Progression|1|||
105813866|NCT01658943|364976110|FG000|Overall Study|Adverse Event|6|||
105813867|NCT01658943|364976111|FG001|Overall Study|Adverse Event|13|||
105813868|NCT01658943|364976110|FG000|Overall Study|Withdrawal by Subject|9|||
105813869|NCT01658943|364976111|FG001|Overall Study|Withdrawal by Subject|2|||
105813870|NCT01658943|364976110|FG000|Overall Study|Progression/Relapse|39|||
105813871|NCT01658943|364976111|FG001|Overall Study|Progression/Relapse|40|||
105813872|NCT01658943|364976110|FG000|Overall Study|Death|4|||
105813873|NCT01658943|364976111|FG001|Overall Study|Death|2|||
105813874|NCT01658943|364976110|FG000|Overall Study|not protocol specified|4|||
105813875|NCT01658943|364976111|FG001|Overall Study|not protocol specified|1|||
105955119|NCT02628444|365498213|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105955120|NCT02628444|365498214|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
106145207|NCT00159783|366191917|FG000|Overall Study|Lost to Follow-up|6|||
106145208|NCT00159783|366191918|FG001|Overall Study|Lost to Follow-up|5|||
105813876|NCT01658943|364976110|FG000|Overall Study|Not eligible|7|||
106145209|NCT00159783|366191919|FG002|Overall Study|Lost to Follow-up|11|||
105813877|NCT01658943|364976111|FG001|Overall Study|Not eligible|9|||
105813878|NCT01658943|364976110|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
105813879|NCT01658943|364976111|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
105813880|NCT03544138|364976112|FG000|Overall Study|Lost to Follow-up|29|||
105813881|NCT03815942|364977744|FG000|Overall Study|Withdrawal by Subject|0|||
105813882|NCT03815942|364977745|FG001|Overall Study|Withdrawal by Subject|17|||
105955121|NCT02628444|365498215|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105955122|NCT02628444|365498216|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
105813883|NCT03717064|364977746|FG000|Period 2|Adverse Event|1|||
105813884|NCT02841709|364977747|FG000|5th Intervention|Adverse Event|2|||
105813885|NCT02841709|364977748|FG001|5th Intervention|Adverse Event|0|||
105813886|NCT02841709|364977749|FG002|5th Intervention|Adverse Event|0|||
105813887|NCT02841709|364977750|FG003|5th Intervention|Adverse Event|0|||
105813888|NCT02841709|364977751|FG004|5th Intervention|Adverse Event|2|||
105813889|NCT01210001|364977752|FG000|Overall Study|Not treated|1|||
105813890|NCT01210001|364977753|FG001|Overall Study|Not treated|0|||
105813891|NCT01210001|364977754|FG002|Overall Study|Not treated|0|||
105813892|NCT01210001|364977752|FG000|Overall Study|Adverse Event|4|||
105813893|NCT01210001|364977753|FG001|Overall Study|Adverse Event|2|||
105955123|NCT02628444|365498208|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
105955124|NCT02628444|365498209|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
105955125|NCT02628444|365498210|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
105955126|NCT02628444|365498211|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105955127|NCT02628444|365498212|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105955128|NCT02628444|365498213|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105955129|NCT02628444|365498214|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105955130|NCT02628444|365498215|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
106145210|NCT00159783|366191917|FG000|Overall Study|Other|0|||
105955131|NCT02628444|365498216|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
105955132|NCT02628444|365498208|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105955133|NCT02628444|365498209|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105955134|NCT02628444|365498210|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105955135|NCT02628444|365498211|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
105955136|NCT02628444|365498212|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105955137|NCT02628444|365498213|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105955138|NCT02628444|365498214|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105955139|NCT02628444|365498215|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105955140|NCT02628444|365498216|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
105955141|NCT02628444|365498208|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
105955142|NCT02628444|365498209|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
105955143|NCT02628444|365498210|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
105955144|NCT02628444|365498211|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
105955145|NCT02628444|365498212|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
105955146|NCT02628444|365498213|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
105955147|NCT02628444|365498214|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
105955148|NCT02628444|365498215|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
105955149|NCT02628444|365498216|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
105955150|NCT02628444|365498208|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955151|NCT02628444|365498209|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955152|NCT02628444|365498210|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
105955153|NCT02628444|365498211|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
105955154|NCT02628444|365498212|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
105955155|NCT02628444|365498213|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
105955156|NCT02628444|365498214|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
105955157|NCT02628444|365498215|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
105955158|NCT02628444|365498216|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
105813894|NCT01210001|364977754|FG002|Overall Study|Adverse Event|5|||
105813895|NCT01210001|364977752|FG000|Overall Study|Non compliant with protocol|2|||
105813896|NCT01210001|364977753|FG001|Overall Study|Non compliant with protocol|2|||
105813897|NCT01210001|364977754|FG002|Overall Study|Non compliant with protocol|3|||
105813898|NCT01210001|364977752|FG000|Overall Study|Lost to Follow-up|4|||
105813899|NCT01210001|364977753|FG001|Overall Study|Lost to Follow-up|3|||
105813900|NCT01210001|364977754|FG002|Overall Study|Lost to Follow-up|2|||
105955159|NCT02628444|365498208|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105955160|NCT02628444|365498209|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105955161|NCT02628444|365498210|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105955162|NCT02628444|365498211|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105955163|NCT02628444|365498212|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
106145211|NCT00159783|366191918|FG001|Overall Study|Other|2|||
106145212|NCT00159783|366191919|FG002|Overall Study|Other|4|||
106145213|NCT02486718|366191920|FG000|Enrollment Phase|Death|19|||
106145214|NCT02486718|366191921|FG001|Enrollment Phase|Death|0|||
106145215|NCT02486718|366191922|FG002|Enrollment Phase|Death|0|||
106145216|NCT02486718|366191920|FG000|Enrollment Phase|Symptomatic deterioration|1|||
106145217|NCT02486718|366191921|FG001|Enrollment Phase|Symptomatic deterioration|0|||
105813901|NCT01210001|364977752|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
105813902|NCT01210001|364977753|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
106145218|NCT02486718|366191922|FG002|Enrollment Phase|Symptomatic deterioration|0|||
105813903|NCT01210001|364977754|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
105813904|NCT01210001|364977752|FG000|Overall Study|Other reason not defined above|2|||
105813905|NCT01210001|364977753|FG001|Overall Study|Other reason not defined above|2|||
105813906|NCT01210001|364977754|FG002|Overall Study|Other reason not defined above|1|||
105813907|NCT00788125|364977755|FG000|Overall Study|Death|6|||
105813908|NCT02684344|364977760|FG000|Overall Study|Withdrawal by Subject|0|||
105813909|NCT02684344|364977761|FG001|Overall Study|Withdrawal by Subject|1|||
105813910|NCT03480425|364977762|FG000|Overall Study|Force transducer technical failure|1|||
105813911|NCT01244126|364977763|FG000|Overall Study|Protocol Violation|3|||
105813912|NCT01244126|364977764|FG001|Overall Study|Protocol Violation|3|||
105813913|NCT01244126|364977765|FG002|Overall Study|Protocol Violation|9|||
105813914|NCT02473640|364977770|FG000|Treatment Period 1|Adverse Event|1|||
105813915|NCT02395822|364977773|FG000|Overall Study|Withdrawal by Subject|1|||
105813916|NCT02395822|364977773|FG000|Overall Study|Death|1|||
105813917|NCT02777528|364977774|FG000|Overall Study|Still in study|24|||
105813918|NCT02777528|364977775|FG001|Overall Study|Still in study|10|||
105813919|NCT02777528|364977776|FG002|Overall Study|Still in study|1|||
105813920|NCT02777528|364977774|FG000|Overall Study|Study Device Explanted|1|||
105813921|NCT02777528|364977775|FG001|Overall Study|Study Device Explanted|0|||
105813922|NCT02777528|364977776|FG002|Overall Study|Study Device Explanted|0|||
105813923|NCT02777528|364977774|FG000|Overall Study|Death|14|||
105813924|NCT02777528|364977775|FG001|Overall Study|Death|7|||
105813925|NCT02777528|364977776|FG002|Overall Study|Death|1|||
105813926|NCT02777528|364977774|FG000|Overall Study|Withdrawal by Subject|2|||
105813927|NCT02777528|364977775|FG001|Overall Study|Withdrawal by Subject|2|||
105813928|NCT02777528|364977776|FG002|Overall Study|Withdrawal by Subject|1|||
105813929|NCT02777528|364977774|FG000|Overall Study|Physician Decision|2|||
105813930|NCT02777528|364977775|FG001|Overall Study|Physician Decision|1|||
105813931|NCT02777528|364977776|FG002|Overall Study|Physician Decision|0|||
105813932|NCT02777528|364977774|FG000|Overall Study|Lost to Follow-up|2|||
105813933|NCT02777528|364977775|FG001|Overall Study|Lost to Follow-up|0|||
105813934|NCT02777528|364977776|FG002|Overall Study|Lost to Follow-up|0|||
105813935|NCT02777528|364977774|FG000|Overall Study|Discontinued due to Other|1|||
105813936|NCT02777528|364977775|FG001|Overall Study|Discontinued due to Other|0|||
105813937|NCT02777528|364977776|FG002|Overall Study|Discontinued due to Other|0|||
105813938|NCT00453362|364977779|FG000|Overall Study|Adverse Event|5|||
105955164|NCT02628444|365498213|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105955165|NCT02628444|365498214|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
105955166|NCT02628444|365498215|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
105955167|NCT02628444|365498216|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
105955168|NCT02628444|365498208|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
105955169|NCT02628444|365498209|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
105955170|NCT02628444|365498210|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
105955171|NCT02628444|365498211|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
105955172|NCT02628444|365498212|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
105955173|NCT02628444|365498213|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
105955174|NCT02628444|365498214|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
105955175|NCT02628444|365498215|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
105955176|NCT02628444|365498216|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
105955177|NCT00288015|365498217|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
105955178|NCT00288015|365498217|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
105955179|NCT00288015|365498217|FG000|First Response Assessment|Withdrawal by Subject|1|||
105955180|NCT00288015|365498217|FG000|First Response Assessment|Death|1|||
105955181|NCT00288015|365498217|FG000|First Response Assessment|Physician Decision|2|||
105955182|NCT00288015|365498217|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
105955183|NCT00288015|365498217|FG000|Follow up for Survival x 2 Years|Death|13|||
105955184|NCT00288015|365498217|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
105955185|NCT00288015|365498217|FG000|Follow up for Survival x 2 Years|Other|9|||
105955186|NCT00532129|365498218|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
105955187|NCT00532129|365498218|FG000|Treatment Period|Physician Decision|15|||
105955188|NCT00532129|365498218|FG000|Treatment Period|Disease progression|3|||
105955189|NCT00532129|365498218|FG000|Treatment Period|Protocol Violation|1|||
106145219|NCT02486718|366191920|FG000|Enrollment Phase|Withdrawal by Subject|86|||
106145220|NCT02486718|366191921|FG001|Enrollment Phase|Withdrawal by Subject|0|||
105813939|NCT00453362|364977779|FG000|Overall Study|Death|7|||
105813940|NCT00453362|364977779|FG000|Overall Study|Physician Decision|2|||
105813941|NCT00453362|364977779|FG000|Overall Study|Withdrawal by Subject|3|||
105813942|NCT00453362|364977779|FG000|Overall Study|Progression of disease|56|||
105955190|NCT00532129|365498218|FG000|Treatment Period|Other|5|||
105955191|NCT00532129|365498218|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
105813943|NCT00453362|364977779|FG000|Overall Study|Screening Failure|14|||
105813944|NCT02127281|364977780|FG000|Overall Study|Lost to Follow-up|1|||
105813945|NCT02127281|364977781|FG001|Overall Study|Lost to Follow-up|0|||
105813946|NCT04885296|364977782|FG000|Period 1|Covid-19 Related|1|||
105813947|NCT04885296|364977783|FG001|Period 1|Covid-19 Related|0|||
105813948|NCT04885296|364977782|FG000|Period 1|Adverse Event|0|||
105813949|NCT04885296|364977783|FG001|Period 1|Adverse Event|1|||
105813950|NCT04885296|364977782|FG000|Period 1|Withdrawal by Subject|1|||
105813951|NCT04885296|364977783|FG001|Period 1|Withdrawal by Subject|1|||
105813952|NCT04885296|364977782|FG000|Period 1|Test Article No Longer Available|1|||
105813953|NCT04885296|364977783|FG001|Period 1|Test Article No Longer Available|0|||
105813954|NCT04885296|364977782|FG000|Period 1|Dispensed Study lens in Error|1|||
105813955|NCT04885296|364977783|FG001|Period 1|Dispensed Study lens in Error|0|||
105813956|NCT04885296|364977782|FG000|Period 1|Lost to Follow-up|1|||
105813957|NCT04885296|364977783|FG001|Period 1|Lost to Follow-up|0|||
105955192|NCT00532129|365498218|FG000|Follow-up Period|Disease progression|57|||
105955193|NCT00532129|365498218|FG000|Follow-up Period|Lost to Follow-up|1|||
105955194|NCT00532129|365498218|FG000|Follow-up Period|Other|6|||
105955195|NCT00443703|365498219|FG000|Overall Study|Never Treated|3|||
105955196|NCT00443703|365498220|FG001|Overall Study|Never Treated|1|||
105955197|NCT00443703|365498219|FG000|Overall Study|Adverse Event|7|||
105955198|NCT00443703|365498220|FG001|Overall Study|Adverse Event|3|||
105955199|NCT00443703|365498219|FG000|Overall Study|Lack of Efficacy|3|||
105955200|NCT00443703|365498220|FG001|Overall Study|Lack of Efficacy|1|||
105955201|NCT00443703|365498219|FG000|Overall Study|Lost to Follow-up|0|||
105955202|NCT00443703|365498220|FG001|Overall Study|Lost to Follow-up|4|||
105955203|NCT00443703|365498219|FG000|Overall Study|Physician Decision|4|||
105955204|NCT00443703|365498220|FG001|Overall Study|Physician Decision|2|||
105955205|NCT00443703|365498219|FG000|Overall Study|Protocol Violation|1|||
105955206|NCT00443703|365498220|FG001|Overall Study|Protocol Violation|1|||
105955207|NCT00443703|365498219|FG000|Overall Study|Withdrawal by Subject|9|||
105955208|NCT00443703|365498220|FG001|Overall Study|Withdrawal by Subject|6|||
105955209|NCT00443703|365498219|FG000|Overall Study|Progressive Disease|1|||
105955210|NCT00443703|365498220|FG001|Overall Study|Progressive Disease|0|||
105955211|NCT01333722|365498221|FG000|Overall Study|Lack of Efficacy|0|||
105955212|NCT01333722|365498222|FG001|Overall Study|Lack of Efficacy|2|||
105955213|NCT01333722|365498221|FG000|Overall Study|Withdrawal by Subject|0|||
105955214|NCT01333722|365498222|FG001|Overall Study|Withdrawal by Subject|1|||
105955215|NCT01650831|365498225|FG000|Overall Study|Screen failure|1|||
105955216|NCT01462929|365498226|FG000|Overall Study|Adverse Event|3|||
105955217|NCT01462929|365498227|FG001|Overall Study|Adverse Event|3|||
105955218|NCT01462929|365498228|FG002|Overall Study|Adverse Event|4|||
105955219|NCT01462929|365498226|FG000|Overall Study|Withdrawal by Subject|2|||
105955220|NCT01462929|365498227|FG001|Overall Study|Withdrawal by Subject|1|||
105955221|NCT01462929|365498228|FG002|Overall Study|Withdrawal by Subject|0|||
105955222|NCT01462929|365498226|FG000|Overall Study|Lack of Efficacy|0|||
105955223|NCT01462929|365498227|FG001|Overall Study|Lack of Efficacy|0|||
105955224|NCT01462929|365498228|FG002|Overall Study|Lack of Efficacy|1|||
105955225|NCT01897727|365498229|FG000|Overall Study|Exclusion: central sleep apnea|0|||
105955226|NCT01897727|365498230|FG001|Overall Study|Exclusion: central sleep apnea|1|||
105955227|NCT03432494|365498231|FG000|Overall Study|Death|1|||
105955228|NCT03432494|365498231|FG000|Overall Study|Noncompliance|1|||
105955229|NCT00833469|365498232|FG000|Overall Study|Withdrawal by Subject|1|||
106145221|NCT02486718|366191922|FG002|Enrollment Phase|Withdrawal by Subject|0|||
106145222|NCT02486718|366191920|FG000|Enrollment Phase|Protocol Violation|18|||
105813958|NCT04885296|364977782|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
105813959|NCT04885296|364977783|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
105813960|NCT00862979|364977784|FG000|Overall Study|Adverse Event|6|||
105813961|NCT00862979|364977785|FG001|Overall Study|Adverse Event|3|||
105813962|NCT00862979|364977784|FG000|Overall Study|Protocol Violation|0|||
105813963|NCT00862979|364977785|FG001|Overall Study|Protocol Violation|1|||
105813964|NCT00862979|364977784|FG000|Overall Study|Patient withdrew consent|2|||
105813965|NCT00862979|364977785|FG001|Overall Study|Patient withdrew consent|1|||
105813966|NCT00862979|364977784|FG000|Overall Study|Administrative problems|0|||
105813967|NCT00862979|364977785|FG001|Overall Study|Administrative problems|1|||
105813968|NCT00862979|364977784|FG000|Overall Study|Death|0|||
105813969|NCT00862979|364977785|FG001|Overall Study|Death|1|||
105813970|NCT03100903|364977786|FG000|Overall Study|Withdrawal by Subject|0|||
105813971|NCT03100903|364977787|FG001|Overall Study|Withdrawal by Subject|0|||
105813972|NCT03100903|364977788|FG002|Overall Study|Withdrawal by Subject|1|||
105813973|NCT03127137|364977793|FG000|Overall Study|Requested sedation after consent|1|||
105813974|NCT03127137|364977794|FG001|Overall Study|Requested sedation after consent|0|||
105813975|NCT03127137|364977793|FG000|Overall Study|Malfunction in electronic data collection|1|||
105955230|NCT00833469|365498232|FG000|Overall Study|Lost to Follow-up|1|||
105955231|NCT01665911|365498233|FG000|Overall Study|Protocol Violation|4|||
106145223|NCT02486718|366191921|FG001|Enrollment Phase|Protocol Violation|0|||
106145224|NCT02486718|366191922|FG002|Enrollment Phase|Protocol Violation|0|||
105955232|NCT01665911|365498233|FG000|Overall Study|Withdrawal by Subject|1|||
105955233|NCT01665911|365498233|FG000|Overall Study|Adverse Event|1|||
105955234|NCT03801928|365498234|FG000|Overall Study|Adverse Event|1|||
105955235|NCT03801928|365498235|FG001|Overall Study|Adverse Event|0|||
105813976|NCT03127137|364977794|FG001|Overall Study|Malfunction in electronic data collection|0|||
105813977|NCT03127137|364977793|FG000|Overall Study|Post procedure testing could not be obtained|0|||
105813978|NCT03127137|364977794|FG001|Overall Study|Post procedure testing could not be obtained|1|||
105955236|NCT03801928|365498236|FG002|Overall Study|Adverse Event|1|||
105813979|NCT02460159|364977795|FG000|Overall Study|Adverse Event|4|||
105813980|NCT02460159|364977796|FG001|Overall Study|Adverse Event|1|||
105813981|NCT02460159|364977795|FG000|Overall Study|Withdrawal by Subject|2|||
105813982|NCT02460159|364977796|FG001|Overall Study|Withdrawal by Subject|0|||
105813983|NCT05518487|364977797|FG000|Overall Study|Withdrawal by Subject|3|||
105813984|NCT02194998|364977805|FG000|On-HCV Treatment|Did not pick up study medication|0|||
105813985|NCT02194998|364977806|FG001|On-HCV Treatment|Did not pick up study medication|1|||
105813986|NCT02194998|364977807|FG002|On-HCV Treatment|Did not pick up study medication|0|||
105813987|NCT02194998|364977808|FG003|On-HCV Treatment|Did not pick up study medication|0|||
105813988|NCT02194998|364977805|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
105813989|NCT02194998|364977806|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
105813990|NCT02194998|364977807|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
105813991|NCT02194998|364977808|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
105813992|NCT02236130|364977809|FG000|Overall Study|Lost to Follow-up|7|||
105813993|NCT02236130|364977810|FG001|Overall Study|Lost to Follow-up|12|||
105813994|NCT01626079|364977813|FG000|Overall Study|Death|167|||
105813995|NCT01626079|364977814|FG001|Overall Study|Death|192|||
105813996|NCT01626079|364977815|FG002|Overall Study|Death|39|||
105813997|NCT01626079|364977813|FG000|Overall Study|Withdrawal by Subject|23|||
105813998|NCT01626079|364977814|FG001|Overall Study|Withdrawal by Subject|37|||
105813999|NCT01626079|364977815|FG002|Overall Study|Withdrawal by Subject|5|||
105814000|NCT01626079|364977813|FG000|Overall Study|Lost to Follow-up|7|||
105814001|NCT01626079|364977814|FG001|Overall Study|Lost to Follow-up|4|||
105814002|NCT01626079|364977815|FG002|Overall Study|Lost to Follow-up|2|||
105814003|NCT01626079|364977813|FG000|Overall Study|Missed Visits|1|||
105814004|NCT01626079|364977814|FG001|Overall Study|Missed Visits|4|||
105814005|NCT01626079|364977815|FG002|Overall Study|Missed Visits|6|||
105814006|NCT01074554|364977816|FG000|Overall Study|Adverse Event|3|||
105814007|NCT01074554|364977817|FG001|Overall Study|Adverse Event|3|||
105814008|NCT01074554|364977816|FG000|Overall Study|Lost to Follow-up|0|||
105814009|NCT01074554|364977817|FG001|Overall Study|Lost to Follow-up|1|||
105814010|NCT05150964|364977818|FG000|Overall Study|Lost to Follow-up|2|||
105814011|NCT00661505|364977819|FG000|Overall Study|Adverse Event|3|||
105814012|NCT00661505|364977819|FG000|Overall Study|Protocol Violation|14|||
105814013|NCT00661505|364977819|FG000|Overall Study|Withdrawal by Subject|8|||
105814014|NCT00661505|364977819|FG000|Overall Study|Lost to Follow-up|3|||
105814015|NCT00661505|364977819|FG000|Overall Study|Other|2|||
105814016|NCT03561883|364977820|FG000|Overall Study|Adverse Event|10|||
105814017|NCT03561883|364977821|FG001|Overall Study|Adverse Event|13|||
105814018|NCT03561883|364977820|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105814019|NCT03561883|364977821|FG001|Overall Study|Non-Compliance With Study Drug|2|||
105814020|NCT03561883|364977820|FG000|Overall Study|Protocol Violation|2|||
105814021|NCT03561883|364977821|FG001|Overall Study|Protocol Violation|3|||
105814022|NCT03561883|364977820|FG000|Overall Study|Withdrawal by Subject|14|||
105955237|NCT03801928|365498237|FG003|Overall Study|Adverse Event|2|||
105955238|NCT03801928|365498238|FG004|Overall Study|Adverse Event|0|||
105955239|NCT03801928|365498239|FG005|Overall Study|Adverse Event|2|||
105955240|NCT03801928|365498234|FG000|Overall Study|Lack of Efficacy|0|||
105955241|NCT03801928|365498235|FG001|Overall Study|Lack of Efficacy|0|||
105955242|NCT03801928|365498236|FG002|Overall Study|Lack of Efficacy|1|||
105955243|NCT03801928|365498237|FG003|Overall Study|Lack of Efficacy|0|||
105955244|NCT03801928|365498238|FG004|Overall Study|Lack of Efficacy|0|||
105955245|NCT03801928|365498239|FG005|Overall Study|Lack of Efficacy|0|||
105955246|NCT03801928|365498234|FG000|Overall Study|Lost to Follow-up|5|||
105955247|NCT03801928|365498235|FG001|Overall Study|Lost to Follow-up|1|||
105955248|NCT03801928|365498236|FG002|Overall Study|Lost to Follow-up|1|||
105955249|NCT03801928|365498237|FG003|Overall Study|Lost to Follow-up|4|||
105955250|NCT03801928|365498238|FG004|Overall Study|Lost to Follow-up|4|||
105955251|NCT03801928|365498239|FG005|Overall Study|Lost to Follow-up|2|||
106145225|NCT02486718|366191920|FG000|Enrollment Phase|Physician Decision|18|||
106145226|NCT02486718|366191921|FG001|Enrollment Phase|Physician Decision|0|||
106145227|NCT02486718|366191922|FG002|Enrollment Phase|Physician Decision|0|||
105814023|NCT03561883|364977821|FG001|Overall Study|Withdrawal by Subject|6|||
105814024|NCT03561883|364977820|FG000|Overall Study|Lost to Follow-up|2|||
105814025|NCT03561883|364977821|FG001|Overall Study|Lost to Follow-up|6|||
105955252|NCT03801928|365498234|FG000|Overall Study|Withdrawal by Subject|0|||
105955253|NCT03801928|365498235|FG001|Overall Study|Withdrawal by Subject|0|||
105955254|NCT03801928|365498236|FG002|Overall Study|Withdrawal by Subject|2|||
106145228|NCT02486718|366191920|FG000|Enrollment Phase|Reason not provided|41|||
105814026|NCT03561883|364977820|FG000|Overall Study|Study Terminated by Sponsor|12|||
105814027|NCT03561883|364977821|FG001|Overall Study|Study Terminated by Sponsor|11|||
105814028|NCT03561883|364977820|FG000|Overall Study|Physician Decision|1|||
105814029|NCT03561883|364977821|FG001|Overall Study|Physician Decision|0|||
105955255|NCT03801928|365498237|FG003|Overall Study|Withdrawal by Subject|1|||
106145229|NCT02486718|366191921|FG001|Enrollment Phase|Reason not provided|0|||
105814030|NCT03561883|364977820|FG000|Overall Study|Randomized by Mistake|1|||
105814031|NCT03561883|364977821|FG001|Overall Study|Randomized by Mistake|0|||
105955256|NCT03801928|365498238|FG004|Overall Study|Withdrawal by Subject|0|||
105955257|NCT03801928|365498239|FG005|Overall Study|Withdrawal by Subject|0|||
105955258|NCT03801928|365498234|FG000|Overall Study|Other|0|||
105955259|NCT03801928|365498235|FG001|Overall Study|Other|2|||
105955260|NCT03801928|365498236|FG002|Overall Study|Other|0|||
105955261|NCT03801928|365498237|FG003|Overall Study|Other|1|||
105955262|NCT03801928|365498238|FG004|Overall Study|Other|0|||
105955263|NCT03801928|365498239|FG005|Overall Study|Other|1|||
105955264|NCT02370368|365498242|FG000|Overall Study|Adverse Event|1|||
105955265|NCT02370368|365498243|FG001|Overall Study|Adverse Event|2|||
105955266|NCT02370368|365498242|FG000|Overall Study|Withdrawal by Subject|5|||
105955267|NCT02370368|365498243|FG001|Overall Study|Withdrawal by Subject|4|||
105955268|NCT02776683|365498244|FG000|Pre-switch Period|Protocol Violation|1|||
105955269|NCT02776683|365498245|FG001|Pre-switch Period|Protocol Violation|0|||
106018044|NCT00196313|365729242|FG001|Overall Study|Adverse Event|1|||
106018045|NCT00196313|365729241|FG000|Overall Study|Subject Pregnant|1|||
105763565|NCT01906476|364787175|FG001|Overall Study|Lost to Follow-up|16|||
105763566|NCT01041404|364787180|FG000|Overall Study|Adverse Event|45|||
105763567|NCT01041404|364787181|FG001|Overall Study|Adverse Event|35|||
105763568|NCT01041404|364787180|FG000|Overall Study|Lack of Efficacy|200|||
105763569|NCT01041404|364787181|FG001|Overall Study|Lack of Efficacy|210|||
105763570|NCT01041404|364787180|FG000|Overall Study|Violation of Selection Criteria|0|||
105763571|NCT01041404|364787181|FG001|Overall Study|Violation of Selection Criteria|1|||
105763572|NCT01041404|364787180|FG000|Overall Study|Protocol Violation|4|||
105763573|NCT01041404|364787181|FG001|Overall Study|Protocol Violation|0|||
105763574|NCT01041404|364787180|FG000|Overall Study|Withdrawal by Subject|29|||
105763575|NCT01041404|364787181|FG001|Overall Study|Withdrawal by Subject|23|||
105763576|NCT01041404|364787180|FG000|Overall Study|Failure to Return|1|||
105763577|NCT01041404|364787181|FG001|Overall Study|Failure to Return|2|||
105763578|NCT01041404|364787180|FG000|Overall Study|Other|11|||
105763579|NCT01041404|364787181|FG001|Overall Study|Other|23|||
105763580|NCT01993667|364787182|FG000|Overall Study|Insufficient data to analyze|16|||
105763581|NCT01993667|364787183|FG001|Overall Study|Insufficient data to analyze|16|||
105763582|NCT01993667|364787182|FG000|Overall Study|Insufficient altitude reached|3|||
105763583|NCT01993667|364787183|FG001|Overall Study|Insufficient altitude reached|1|||
105763584|NCT01993667|364787182|FG000|Overall Study|Lost to Follow-up|2|||
105763585|NCT01993667|364787183|FG001|Overall Study|Lost to Follow-up|2|||
105763586|NCT02896192|364787184|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
105763587|NCT02896192|364787184|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
105763588|NCT02896192|364787184|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
105763589|NCT00383708|364787185|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
105763590|NCT00383708|364787185|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
105763591|NCT00383708|364787185|FG000|Run-in Period|Protocol Violation|4|||
105763592|NCT00383708|364787185|FG000|Run-in Period|Adverse Event|2|||
105763593|NCT00383708|364787185|FG000|Run-in Period|Claustrophobia|1|||
105763594|NCT00383708|364787185|FG000|Co-administration Period|Adverse Event|5|||
105763595|NCT00318370|364787186|FG000|Period 1|Lack of Efficacy|5|||
105763596|NCT00318370|364787187|FG001|Period 1|Lack of Efficacy|0|||
105763597|NCT00318370|364787188|FG002|Period 1|Lack of Efficacy|0|||
105763598|NCT00318370|364787186|FG000|Period 1|Physician Decision|1|||
105763599|NCT00318370|364787187|FG001|Period 1|Physician Decision|0|||
105763600|NCT00318370|364787188|FG002|Period 1|Physician Decision|0|||
105763601|NCT00318370|364787186|FG000|Period 1|Withdrawal by Subject|1|||
105763602|NCT00318370|364787187|FG001|Period 1|Withdrawal by Subject|0|||
105763603|NCT00318370|364787188|FG002|Period 1|Withdrawal by Subject|0|||
105763604|NCT00318370|364787186|FG000|Period 2|Adverse Event|0|||
105763605|NCT00318370|364787187|FG001|Period 2|Adverse Event|3|||
105763606|NCT00318370|364787188|FG002|Period 2|Adverse Event|0|||
105763607|NCT00318370|364787186|FG000|Period 2|Lack of Efficacy|0|||
105763608|NCT00318370|364787187|FG001|Period 2|Lack of Efficacy|5|||
105763609|NCT00318370|364787188|FG002|Period 2|Lack of Efficacy|0|||
105763610|NCT00318370|364787186|FG000|Period 2|Physician Decision|0|||
105763611|NCT00318370|364787187|FG001|Period 2|Physician Decision|1|||
105763612|NCT00318370|364787188|FG002|Period 2|Physician Decision|0|||
105763613|NCT00318370|364787186|FG000|Period 2|Withdrawal by Subject|0|||
105763614|NCT00318370|364787187|FG001|Period 2|Withdrawal by Subject|1|||
105763615|NCT00318370|364787188|FG002|Period 2|Withdrawal by Subject|0|||
105763616|NCT00318370|364787186|FG000|Period 2|Other|0|||
105763617|NCT00318370|364787187|FG001|Period 2|Other|1|||
105763618|NCT00318370|364787188|FG002|Period 2|Other|0|||
105763619|NCT00318370|364787186|FG000|Period 3|Adverse Event|0|||
105763620|NCT00318370|364787187|FG001|Period 3|Adverse Event|0|||
105763621|NCT00318370|364787188|FG002|Period 3|Adverse Event|1|||
105763622|NCT00318370|364787186|FG000|Period 3|Lack of Efficacy|0|||
105763623|NCT00318370|364787187|FG001|Period 3|Lack of Efficacy|0|||
105763624|NCT00318370|364787188|FG002|Period 3|Lack of Efficacy|24|||
105763625|NCT00318370|364787186|FG000|Period 3|Death|0|||
105763626|NCT00318370|364787187|FG001|Period 3|Death|0|||
105763627|NCT00318370|364787188|FG002|Period 3|Death|1|||
105763628|NCT00318370|364787186|FG000|Period 3|Physician Decision|0|||
105955270|NCT02776683|365498244|FG000|Pre-switch Period|Adverse Event|21|||
105955271|NCT02776683|365498245|FG001|Pre-switch Period|Adverse Event|0|||
106145230|NCT02486718|366191922|FG002|Enrollment Phase|Reason not provided|0|||
105814032|NCT03561883|364977820|FG000|Overall Study|Other, Not Specified|3|||
105814033|NCT03561883|364977821|FG001|Overall Study|Other, Not Specified|2|||
105814034|NCT06354270|364977822|FG000|Overall Study|Withdrawal by Subject|1|||
105814035|NCT06354270|364977823|FG001|Overall Study|Withdrawal by Subject|0|||
105814036|NCT00745095|364977825|FG000|Overall Study|Declined to participate|1|||
105814037|NCT00745095|364977826|FG001|Overall Study|Declined to participate|0|||
105814038|NCT00745095|364977827|FG002|Overall Study|Declined to participate|0|||
105814039|NCT00745095|364977828|FG003|Overall Study|Declined to participate|0|||
105814040|NCT00745095|364977829|FG004|Overall Study|Declined to participate|92|||
105814041|NCT00745095|364977830|FG005|Overall Study|Declined to participate|95|||
105814042|NCT00745095|364977825|FG000|Overall Study|Ineligible due to GFR criteria|0|||
105814043|NCT00745095|364977826|FG001|Overall Study|Ineligible due to GFR criteria|2|||
105814044|NCT00745095|364977827|FG002|Overall Study|Ineligible due to GFR criteria|3|||
105814045|NCT00745095|364977828|FG003|Overall Study|Ineligible due to GFR criteria|3|||
105814046|NCT00745095|364977829|FG004|Overall Study|Ineligible due to GFR criteria|30|||
105814047|NCT00745095|364977830|FG005|Overall Study|Ineligible due to GFR criteria|28|||
105814048|NCT00117949|364977835|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
105814049|NCT00117949|364977836|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
105814050|NCT00117949|364977837|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
105814051|NCT00117949|364977838|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
105814052|NCT00117949|364977835|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
105814053|NCT00117949|364977836|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
105814054|NCT00117949|364977837|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
105814055|NCT00117949|364977838|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
105814056|NCT00117949|364977835|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
105814057|NCT00117949|364977836|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
105814058|NCT00117949|364977837|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
105814059|NCT00117949|364977838|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
105814060|NCT00117949|364977835|FG000|Overall Study|PSA increase >=10ng/mL|0|||
105814061|NCT00117949|364977836|FG001|Overall Study|PSA increase >=10ng/mL|1|||
105814062|NCT00117949|364977837|FG002|Overall Study|PSA increase >=10ng/mL|1|||
105814063|NCT00117949|364977838|FG003|Overall Study|PSA increase >=10ng/mL|0|||
105814064|NCT00117949|364977835|FG000|Overall Study|PSA reduction <=50%|0|||
105814065|NCT00117949|364977836|FG001|Overall Study|PSA reduction <=50%|2|||
105814066|NCT00117949|364977837|FG002|Overall Study|PSA reduction <=50%|2|||
105814067|NCT00117949|364977838|FG003|Overall Study|PSA reduction <=50%|4|||
105814068|NCT00117949|364977835|FG000|Overall Study|Hepatic abnormalities|0|||
105814069|NCT00117949|364977836|FG001|Overall Study|Hepatic abnormalities|1|||
105814070|NCT00117949|364977837|FG002|Overall Study|Hepatic abnormalities|0|||
105814071|NCT00117949|364977838|FG003|Overall Study|Hepatic abnormalities|1|||
105814072|NCT01974141|364977842|FG000|Overall Study|Other Reasons|28|||
105814073|NCT01974141|364977843|FG001|Overall Study|Other Reasons|18|||
105814074|NCT01974141|364977842|FG000|Overall Study|Protocol Violation|2|||
105814075|NCT01974141|364977843|FG001|Overall Study|Protocol Violation|6|||
105814076|NCT01974141|364977842|FG000|Overall Study|Personal Reasons|21|||
105955272|NCT02776683|365498244|FG000|Pre-switch Period|Withdrawal by Subject|9|||
105955273|NCT02776683|365498245|FG001|Pre-switch Period|Withdrawal by Subject|0|||
105955274|NCT02776683|365498244|FG000|Pre-switch Period|Physician Decision|7|||
105955275|NCT02776683|365498245|FG001|Pre-switch Period|Physician Decision|0|||
105955276|NCT02776683|365498244|FG000|Pre-switch Period|Progressive disease|39|||
105955277|NCT02776683|365498245|FG001|Pre-switch Period|Progressive disease|0|||
105955278|NCT02776683|365498244|FG000|Pre-switch Period|Other than listed|3|||
105955279|NCT02776683|365498245|FG001|Pre-switch Period|Other than listed|0|||
105955280|NCT02776683|365498244|FG000|Post-switch Period|Adverse Event|0|||
106145231|NCT02486718|366191920|FG000|Enrollment Phase|Disease relapse|54|||
106145232|NCT02486718|366191921|FG001|Enrollment Phase|Disease relapse|0|||
106145233|NCT02486718|366191922|FG002|Enrollment Phase|Disease relapse|0|||
106145234|NCT02486718|366191920|FG000|Enrollment Phase|Lost to Follow-up|4|||
106145235|NCT02486718|366191921|FG001|Enrollment Phase|Lost to Follow-up|0|||
106145236|NCT02486718|366191922|FG002|Enrollment Phase|Lost to Follow-up|0|||
106145237|NCT02486718|366191920|FG000|Enrollment Phase|Adverse Event|34|||
106145238|NCT02486718|366191921|FG001|Enrollment Phase|Adverse Event|0|||
106145239|NCT02486718|366191922|FG002|Enrollment Phase|Adverse Event|0|||
106145240|NCT02486718|366191920|FG000|Randomized Phase|Withdrawal by Subject|0|||
105814077|NCT01974141|364977843|FG001|Overall Study|Personal Reasons|20|||
105814078|NCT01974141|364977842|FG000|Overall Study|Lost to Follow-up|38|||
105814079|NCT01974141|364977843|FG001|Overall Study|Lost to Follow-up|29|||
105814080|NCT01974141|364977842|FG000|Overall Study|Pregnancy|3|||
105814081|NCT01974141|364977843|FG001|Overall Study|Pregnancy|3|||
105814082|NCT01974141|364977842|FG000|Overall Study|Lack of Efficacy|0|||
105955281|NCT02776683|365498245|FG001|Post-switch Period|Adverse Event|3|||
105955282|NCT02776683|365498244|FG000|Post-switch Period|Withdrawal by Subject|0|||
106145241|NCT02486718|366191921|FG001|Randomized Phase|Withdrawal by Subject|44|||
106145242|NCT02486718|366191922|FG002|Randomized Phase|Withdrawal by Subject|47|||
106145243|NCT02486718|366191920|FG000|Randomized Phase|Protocol Violation|0|||
106145244|NCT02486718|366191921|FG001|Randomized Phase|Protocol Violation|2|||
106145245|NCT02486718|366191922|FG002|Randomized Phase|Protocol Violation|0|||
105763629|NCT00318370|364787187|FG001|Period 3|Physician Decision|0|||
105763630|NCT00318370|364787188|FG002|Period 3|Physician Decision|1|||
105763631|NCT00318370|364787186|FG000|Period 3|Withdrawal by Subject|0|||
105763632|NCT00318370|364787187|FG001|Period 3|Withdrawal by Subject|0|||
105763633|NCT00318370|364787188|FG002|Period 3|Withdrawal by Subject|3|||
105763634|NCT00318370|364787186|FG000|Period 3|Other|0|||
105763635|NCT00318370|364787187|FG001|Period 3|Other|0|||
105763636|NCT00318370|364787188|FG002|Period 3|Other|3|||
105763637|NCT01750840|364787192|FG000|Overall Study|Lost to Follow-up|4|||
105763638|NCT02820038|364787193|FG000|Overall Study|Lost to Follow-up|7|||
105763639|NCT02820038|364787194|FG001|Overall Study|Lost to Follow-up|11|||
105763640|NCT02820038|364787195|FG002|Overall Study|Lost to Follow-up|2|||
105763641|NCT02820038|364787196|FG003|Overall Study|Lost to Follow-up|9|||
105763642|NCT02820038|364787193|FG000|Overall Study|Withdrawal by Subject|3|||
105763643|NCT02820038|364787194|FG001|Overall Study|Withdrawal by Subject|14|||
105763644|NCT02820038|364787195|FG002|Overall Study|Withdrawal by Subject|3|||
105763645|NCT02820038|364787196|FG003|Overall Study|Withdrawal by Subject|13|||
105763646|NCT00479167|364787197|FG000|Overall Study|Withdrawal by Subject|1|||
105763647|NCT01997281|364787198|FG000|Overall Study|Withdrawal by Subject|1|||
105763648|NCT01997281|364787199|FG001|Overall Study|Withdrawal by Subject|0|||
105763649|NCT01570309|364787202|FG000|Overall Study|Withdrawal by Subject|3|||
105763650|NCT01570309|364787203|FG001|Overall Study|Withdrawal by Subject|3|||
105763651|NCT00560794|364787204|FG000|Overall Study|Adverse Event|2|||
105763652|NCT00560794|364787204|FG000|Overall Study|Patient was not Compliant|1|||
105763653|NCT00560794|364787204|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
105763654|NCT00560794|364787204|FG000|Overall Study|Hematological Relapse|1|||
105763655|NCT00560794|364787204|FG000|Overall Study|Received Bone Marrow Transplant|6|||
105763656|NCT03619837|364787205|FG000|Screening|received organs from HCV-negative donors|47|||
105763657|NCT03619837|364787205|FG000|Screening|died on the wait-list|2|||
105763658|NCT03619837|364787205|FG000|Screening|remained on the wait list|40|||
105763659|NCT03619837|364787205|FG000|Screening|didn't meet eligibility criteria|3|||
105763660|NCT03619837|364787205|FG000|Screening|withdrew consent|2|||
105763661|NCT03619837|364787205|FG000|Screening|never listed for HCV-viremic donor|1|||
105763662|NCT03619837|364787205|FG000|Screening|developed exclusion criteria|2|||
105763663|NCT03619837|364787205|FG000|Screening|excluded by the investigator due to non-compliance|1|||
105763664|NCT02290340|364787207|FG000|Overall Study|Lost to Follow-up|0|||
105763665|NCT02290340|364787208|FG001|Overall Study|Lost to Follow-up|0|||
105763666|NCT02290340|364787209|FG002|Overall Study|Lost to Follow-up|0|||
105763667|NCT02290340|364787210|FG003|Overall Study|Lost to Follow-up|1|||
105763668|NCT02290340|364787207|FG000|Overall Study|Withdrawal by Subject|1|||
105763669|NCT02290340|364787208|FG001|Overall Study|Withdrawal by Subject|0|||
105763670|NCT02290340|364787209|FG002|Overall Study|Withdrawal by Subject|0|||
105763671|NCT02290340|364787210|FG003|Overall Study|Withdrawal by Subject|0|||
105763672|NCT02290340|364787207|FG000|Overall Study|Other|1|||
105763673|NCT02290340|364787208|FG001|Overall Study|Other|0|||
105763674|NCT02290340|364787209|FG002|Overall Study|Other|0|||
105763675|NCT02290340|364787210|FG003|Overall Study|Other|1|||
105763676|NCT00651313|364787211|FG000|Overall Study|Adverse Event|0|||
105763677|NCT00651313|364787212|FG001|Overall Study|Adverse Event|1|||
105763678|NCT00651313|364787211|FG000|Overall Study|Withdrawal by Subject|3|||
105763679|NCT00651313|364787212|FG001|Overall Study|Withdrawal by Subject|1|||
105763680|NCT00651313|364787211|FG000|Overall Study|Lost to Follow-up|1|||
105763681|NCT00651313|364787212|FG001|Overall Study|Lost to Follow-up|1|||
105763682|NCT00651313|364787211|FG000|Overall Study|Adminstrative Discontinuation|2|||
105763683|NCT00651313|364787212|FG001|Overall Study|Adminstrative Discontinuation|3|||
105763684|NCT00643448|364787224|FG000|Overall Study|Lack of Efficacy|2|||
105763685|NCT00643448|364787225|FG001|Overall Study|Lack of Efficacy|0|||
105763686|NCT00643448|364787226|FG002|Overall Study|Lack of Efficacy|4|||
105763687|NCT00643448|364787224|FG000|Overall Study|Adverse Event|2|||
105763688|NCT00643448|364787225|FG001|Overall Study|Adverse Event|2|||
105763689|NCT00643448|364787226|FG002|Overall Study|Adverse Event|2|||
105763690|NCT00643448|364787224|FG000|Overall Study|QTcF>550 ms|0|||
105763691|NCT00643448|364787225|FG001|Overall Study|QTcF>550 ms|3|||
105763692|NCT00643448|364787226|FG002|Overall Study|QTcF>550 ms|0|||
105763693|NCT00089999|364787227|FG000|Overall Study|Adverse Event|4|||
105763694|NCT00089999|364787228|FG001|Overall Study|Adverse Event|7|||
105763695|NCT00089999|364787227|FG000|Overall Study|Withdrawal by Subject|0|||
105763696|NCT00089999|364787228|FG001|Overall Study|Withdrawal by Subject|4|||
105763697|NCT00089999|364787227|FG000|Overall Study|Lost to Follow-up|2|||
105763698|NCT00089999|364787228|FG001|Overall Study|Lost to Follow-up|1|||
105763699|NCT00089999|364787227|FG000|Overall Study|Radiological Progression of Cancer|52|||
105763700|NCT00089999|364787228|FG001|Overall Study|Radiological Progression of Cancer|44|||
105763701|NCT00089999|364787227|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
105763702|NCT00089999|364787228|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
105763703|NCT00089999|364787227|FG000|Overall Study|Death|3|||
105763704|NCT00089999|364787228|FG001|Overall Study|Death|3|||
105814083|NCT01974141|364977843|FG001|Overall Study|Lack of Efficacy|1|||
105814084|NCT01974141|364977842|FG000|Overall Study|Adverse Event|4|||
105814085|NCT01974141|364977843|FG001|Overall Study|Adverse Event|5|||
105814086|NCT02480764|364977848|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
105814087|NCT02480764|364977849|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
105814088|NCT02480764|364977850|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
105814089|NCT02480764|364977848|FG000|Overall Study|Major Protocol Deviation|1|||
105814090|NCT02480764|364977849|FG001|Overall Study|Major Protocol Deviation|4|||
105814091|NCT02480764|364977850|FG002|Overall Study|Major Protocol Deviation|3|||
105814092|NCT02480764|364977848|FG000|Overall Study|Lost to Follow-up|0|||
105814093|NCT02480764|364977849|FG001|Overall Study|Lost to Follow-up|1|||
105814094|NCT02480764|364977850|FG002|Overall Study|Lost to Follow-up|2|||
105814095|NCT02480764|364977848|FG000|Overall Study|Voluntary Withdrawal|6|||
105814096|NCT02480764|364977849|FG001|Overall Study|Voluntary Withdrawal|5|||
105814097|NCT02480764|364977850|FG002|Overall Study|Voluntary Withdrawal|10|||
105814098|NCT02480764|364977848|FG000|Overall Study|Lack of Efficacy|0|||
105814099|NCT02480764|364977849|FG001|Overall Study|Lack of Efficacy|3|||
105814100|NCT02480764|364977850|FG002|Overall Study|Lack of Efficacy|3|||
105814101|NCT02480764|364977848|FG000|Overall Study|Reason not Specified|0|||
105814102|NCT02480764|364977849|FG001|Overall Study|Reason not Specified|1|||
105814103|NCT02480764|364977850|FG002|Overall Study|Reason not Specified|0|||
105814104|NCT03629249|364977851|FG000|Overall Study|Study terminated by sponsor|197|||
105814105|NCT03629249|364977852|FG001|Overall Study|Study terminated by sponsor|197|||
105814106|NCT03629249|364977853|FG002|Overall Study|Study terminated by sponsor|194|||
105814107|NCT03629249|364977851|FG000|Overall Study|Protocol deviation|0|||
105814108|NCT03629249|364977852|FG001|Overall Study|Protocol deviation|2|||
105814109|NCT03629249|364977853|FG002|Overall Study|Protocol deviation|5|||
105814110|NCT03629249|364977851|FG000|Overall Study|Subject decision|1|||
105814111|NCT03629249|364977852|FG001|Overall Study|Subject decision|1|||
105814112|NCT03629249|364977853|FG002|Overall Study|Subject decision|3|||
105814113|NCT03629249|364977851|FG000|Overall Study|Adverse Event|1|||
105814114|NCT03629249|364977852|FG001|Overall Study|Adverse Event|1|||
105814115|NCT03629249|364977853|FG002|Overall Study|Adverse Event|0|||
105814116|NCT03629249|364977851|FG000|Overall Study|Death|1|||
105814117|NCT03629249|364977852|FG001|Overall Study|Death|0|||
105814118|NCT03629249|364977853|FG002|Overall Study|Death|0|||
105814119|NCT03629249|364977851|FG000|Overall Study|Physician Decision|1|||
105814120|NCT03629249|364977852|FG001|Overall Study|Physician Decision|0|||
105814121|NCT03629249|364977853|FG002|Overall Study|Physician Decision|0|||
105814122|NCT02079532|364977858|FG000|Overall Study|Adverse Event|7|||
105814123|NCT02079532|364977858|FG000|Overall Study|Additional or changed therapy|2|||
105814124|NCT02079532|364977858|FG000|Overall Study|Lack of Efficacy|9|||
105814125|NCT02079532|364977858|FG000|Overall Study|Protocol Violation|3|||
105814126|NCT02079532|364977858|FG000|Overall Study|Withdrawal by Subject|1|||
105814127|NCT02079532|364977858|FG000|Overall Study|Administrative problems|1|||
105814128|NCT02079532|364977858|FG000|Overall Study|Inclusion into ReFIRST|3|||
105814129|NCT02079532|364977858|FG000|Overall Study|Other|3|||
105814130|NCT00591630|364977859|FG000|Overall Study|Death|0|||
105814131|NCT00591630|364977860|FG001|Overall Study|Death|0|||
105814132|NCT00591630|364977861|FG002|Overall Study|Death|1|||
105814133|NCT00591630|364977862|FG003|Overall Study|Death|0|||
105814134|NCT00463606|364977863|FG000|Overall Study|Adverse Event|21|||
105814135|NCT00463606|364977864|FG001|Overall Study|Adverse Event|18|||
105814136|NCT00463606|364977865|FG002|Overall Study|Adverse Event|11|||
105814137|NCT00463606|364977863|FG000|Overall Study|Withdrawal by Subject|11|||
105814138|NCT00463606|364977864|FG001|Overall Study|Withdrawal by Subject|11|||
105814139|NCT00463606|364977865|FG002|Overall Study|Withdrawal by Subject|5|||
105814140|NCT00463606|364977863|FG000|Overall Study|Lost to Follow-up|2|||
106018046|NCT00196313|365729242|FG001|Overall Study|Subject Pregnant|1|||
106018047|NCT00196313|365729241|FG000|Overall Study|Lost to Follow-up|2|||
106018048|NCT00196313|365729242|FG001|Overall Study|Lost to Follow-up|2|||
106018049|NCT01189032|365729243|FG000|Overall Study|Adverse Event|1|||
106018050|NCT01189032|365729244|FG001|Overall Study|Adverse Event|3|||
106018051|NCT01189032|365729245|FG002|Overall Study|Adverse Event|4|||
106018052|NCT01189032|365729243|FG000|Overall Study|Lack of Efficacy|2|||
106018053|NCT01189032|365729244|FG001|Overall Study|Lack of Efficacy|3|||
105814141|NCT00463606|364977864|FG001|Overall Study|Lost to Follow-up|2|||
105814142|NCT00463606|364977865|FG002|Overall Study|Lost to Follow-up|3|||
105814143|NCT00463606|364977863|FG000|Overall Study|Subject noncompliance|1|||
105814144|NCT00463606|364977864|FG001|Overall Study|Subject noncompliance|1|||
105814145|NCT00463606|364977865|FG002|Overall Study|Subject noncompliance|0|||
105814146|NCT00463606|364977863|FG000|Overall Study|Subject moved out of town|1|||
105814147|NCT00463606|364977864|FG001|Overall Study|Subject moved out of town|0|||
105814148|NCT00463606|364977865|FG002|Overall Study|Subject moved out of town|0|||
105814149|NCT00463606|364977863|FG000|Overall Study|Physician Decision|0|||
105814150|NCT00463606|364977864|FG001|Overall Study|Physician Decision|1|||
106018054|NCT01189032|365729245|FG002|Overall Study|Lack of Efficacy|0|||
106018055|NCT01189032|365729243|FG000|Overall Study|Withdrawal by Subject|1|||
106018056|NCT01189032|365729244|FG001|Overall Study|Withdrawal by Subject|0|||
106018057|NCT01189032|365729245|FG002|Overall Study|Withdrawal by Subject|1|||
106018058|NCT01189032|365729243|FG000|Overall Study|Protocol Violation|1|||
106018059|NCT01189032|365729244|FG001|Overall Study|Protocol Violation|1|||
106018060|NCT01189032|365729245|FG002|Overall Study|Protocol Violation|1|||
106018061|NCT01134055|365729246|FG000|Overall Study|Adverse Event|5|||
106018062|NCT01134055|365729247|FG001|Overall Study|Adverse Event|2|||
106018063|NCT01134055|365729248|FG002|Overall Study|Adverse Event|2|||
106018064|NCT01134055|365729249|FG003|Overall Study|Adverse Event|2|||
106018065|NCT01134055|365729250|FG004|Overall Study|Adverse Event|5|||
105763705|NCT00089999|364787227|FG000|Overall Study|Poor General Condition|1|||
105763706|NCT00089999|364787228|FG001|Overall Study|Poor General Condition|0|||
105763707|NCT00089999|364787227|FG000|Overall Study|Clinical Progression|1|||
105763708|NCT00089999|364787228|FG001|Overall Study|Clinical Progression|2|||
105763709|NCT00089999|364787227|FG000|Overall Study|Physician Decision|2|||
105763710|NCT00089999|364787228|FG001|Overall Study|Physician Decision|2|||
105763711|NCT00089999|364787227|FG000|Overall Study|Patient Underwent Surgery|2|||
105763712|NCT00089999|364787228|FG001|Overall Study|Patient Underwent Surgery|0|||
105763713|NCT00089999|364787227|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
105763714|NCT00089999|364787228|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
105763715|NCT01607073|364787229|FG000|Overall Study|Adverse Event|1|||
105763716|NCT03906136|364788849|FG000|Overall Study|Adverse Event|1|||
105763717|NCT03906136|364788850|FG001|Overall Study|Adverse Event|0|||
105763718|NCT03906136|364788849|FG000|Overall Study|Lost to Follow-up|7|||
105763719|NCT03906136|364788850|FG001|Overall Study|Lost to Follow-up|4|||
105763720|NCT03906136|364788849|FG000|Overall Study|Physician Decision|1|||
105763721|NCT03906136|364788850|FG001|Overall Study|Physician Decision|0|||
105763722|NCT03906136|364788849|FG000|Overall Study|Withdrawal by Subject|3|||
105763723|NCT03906136|364788850|FG001|Overall Study|Withdrawal by Subject|7|||
105763724|NCT01375647|364788851|FG000|Overall Study|Lost to Follow-up|3|||
105763725|NCT01375647|364788852|FG001|Overall Study|Lost to Follow-up|3|||
105763726|NCT01375647|364788853|FG002|Overall Study|Lost to Follow-up|7|||
105763727|NCT01375647|364788854|FG003|Overall Study|Lost to Follow-up|10|||
105763728|NCT01375647|364788851|FG000|Overall Study|Death|1|||
105763729|NCT01375647|364788852|FG001|Overall Study|Death|2|||
105763730|NCT01375647|364788853|FG002|Overall Study|Death|1|||
105763731|NCT01375647|364788854|FG003|Overall Study|Death|0|||
105763732|NCT01375647|364788851|FG000|Overall Study|Withdrawal by Subject|17|||
105763733|NCT01375647|364788852|FG001|Overall Study|Withdrawal by Subject|20|||
105763734|NCT01375647|364788853|FG002|Overall Study|Withdrawal by Subject|26|||
105763735|NCT01375647|364788854|FG003|Overall Study|Withdrawal by Subject|14|||
105763736|NCT01375647|364788851|FG000|Overall Study|Physician Decision|1|||
105763737|NCT01375647|364788852|FG001|Overall Study|Physician Decision|0|||
105763738|NCT01375647|364788853|FG002|Overall Study|Physician Decision|0|||
105763739|NCT01375647|364788854|FG003|Overall Study|Physician Decision|0|||
105763740|NCT03366844|364788855|FG000|Overall Study|Physician Decision|1|||
105763741|NCT03366844|364788855|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
105763742|NCT01826448|364788856|FG000|Overall Study|Adverse Event|1|||
105763743|NCT01826448|364788857|FG001|Overall Study|Adverse Event|3|||
105763744|NCT01826448|364788856|FG000|Overall Study|Disease progression|2|||
105763745|NCT01826448|364788857|FG001|Overall Study|Disease progression|4|||
105763746|NCT01826448|364788856|FG000|Overall Study|Withdrawal by Subject|1|||
105763747|NCT01826448|364788857|FG001|Overall Study|Withdrawal by Subject|0|||
105763748|NCT01826448|364788856|FG000|Overall Study|Physician Decision|0|||
105763749|NCT01826448|364788857|FG001|Overall Study|Physician Decision|1|||
105763750|NCT01826448|364788856|FG000|Overall Study|2 active cancers|0|||
105763751|NCT01826448|364788857|FG001|Overall Study|2 active cancers|1|||
105763752|NCT04038385|364788858|FG000|Overall Study|Completed baseline assessment only|7|||
105763753|NCT04038385|364788859|FG001|Overall Study|Completed baseline assessment only|4|||
105763754|NCT04038385|364788858|FG000|Overall Study|Moved out of area|4|||
105763755|NCT04038385|364788859|FG001|Overall Study|Moved out of area|2|||
105763756|NCT04038385|364788858|FG000|Overall Study|Discontinued study involvement|6|||
105763757|NCT04038385|364788859|FG001|Overall Study|Discontinued study involvement|1|||
105763758|NCT03424044|364788860|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763759|NCT03424044|364788861|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763760|NCT03424044|364788862|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
105763761|NCT03424044|364788863|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763762|NCT03424044|364788864|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763763|NCT03424044|364788865|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763764|NCT03424044|364788866|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763765|NCT03424044|364788867|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763766|NCT03424044|364788868|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
105763767|NCT03424044|364788860|FG000|First Intervention (76 Hours)|Adverse Event|0|||
105763768|NCT03424044|364788861|FG001|First Intervention (76 Hours)|Adverse Event|0|||
105814151|NCT00463606|364977865|FG002|Overall Study|Physician Decision|0|||
105814152|NCT00463606|364977863|FG000|Overall Study|Sponsor request|0|||
105814153|NCT00463606|364977864|FG001|Overall Study|Sponsor request|1|||
105814154|NCT00463606|364977865|FG002|Overall Study|Sponsor request|0|||
105814155|NCT00463606|364977863|FG000|Overall Study|Exclusion criteria violation|2|||
105814156|NCT00463606|364977864|FG001|Overall Study|Exclusion criteria violation|0|||
105814157|NCT00463606|364977865|FG002|Overall Study|Exclusion criteria violation|0|||
105814158|NCT00463606|364977863|FG000|Overall Study|Coordinator error|1|||
105814159|NCT00463606|364977864|FG001|Overall Study|Coordinator error|0|||
105814160|NCT00463606|364977865|FG002|Overall Study|Coordinator error|0|||
105814161|NCT00463606|364977863|FG000|Overall Study|Patient randomized in error|1|||
105814162|NCT00463606|364977864|FG001|Overall Study|Patient randomized in error|0|||
105814163|NCT00463606|364977865|FG002|Overall Study|Patient randomized in error|0|||
105814164|NCT00463606|364977863|FG000|Overall Study|Participation in another ABT-335 trial|1|||
105814165|NCT00463606|364977864|FG001|Overall Study|Participation in another ABT-335 trial|0|||
105814166|NCT00463606|364977865|FG002|Overall Study|Participation in another ABT-335 trial|0|||
105814167|NCT00463606|364977863|FG000|Overall Study|Protocol Violation|0|||
105814168|NCT00463606|364977864|FG001|Overall Study|Protocol Violation|0|||
105814169|NCT00463606|364977865|FG002|Overall Study|Protocol Violation|1|||
105814170|NCT01027143|364979206|FG000|Overall Study|Lost to Follow-up|9|||
105814171|NCT01027143|364979207|FG001|Overall Study|Lost to Follow-up|4|||
105814172|NCT02918877|364979208|FG000|Overall Study|Withdrawal by Subject|2|||
105814173|NCT02918877|364979209|FG001|Overall Study|Withdrawal by Subject|2|||
105814174|NCT02918877|364979208|FG000|Overall Study|Surgery cancelled|1|||
105814175|NCT02918877|364979209|FG001|Overall Study|Surgery cancelled|0|||
105814176|NCT02918877|364979208|FG000|Overall Study|Physician Decision|1|||
105814177|NCT02918877|364979209|FG001|Overall Study|Physician Decision|0|||
105814178|NCT02918877|364979208|FG000|Overall Study|Received intraoperative steroids|1|||
105814179|NCT02918877|364979209|FG001|Overall Study|Received intraoperative steroids|0|||
105814180|NCT02918877|364979208|FG000|Overall Study|Unable to obtain lab samples|1|||
105814181|NCT02918877|364979209|FG001|Overall Study|Unable to obtain lab samples|0|||
105814182|NCT02918877|364979208|FG000|Overall Study|Unsafe to perform BAL|0|||
105814183|NCT02918877|364979209|FG001|Overall Study|Unsafe to perform BAL|1|||
105814184|NCT04455633|364979210|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
105814185|NCT04455633|364979211|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
105814186|NCT04455633|364979212|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
105814187|NCT04455633|364979210|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
105814188|NCT04455633|364979211|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
105814189|NCT04455633|364979212|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
105814190|NCT04455633|364979210|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
105814191|NCT04455633|364979211|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
105814192|NCT04455633|364979212|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
105814193|NCT04455633|364979210|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
105814194|NCT04455633|364979211|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
105814195|NCT04455633|364979212|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
105814196|NCT02532764|364979213|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814197|NCT02532764|364979214|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814198|NCT02532764|364979215|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814199|NCT02532764|364979216|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814200|NCT02532764|364979217|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814201|NCT02532764|364979218|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814202|NCT02532764|364979219|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
105814203|NCT02532764|364979220|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
105814204|NCT02532764|364979221|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
105814205|NCT02532764|364979222|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
105814206|NCT01492361|364979223|FG000|Overall Study|Withdrawal by Subject|281|||
105814207|NCT01492361|364979224|FG001|Overall Study|Withdrawal by Subject|297|||
105814208|NCT01492361|364979223|FG000|Overall Study|Physician Decision|12|||
105814209|NCT01492361|364979224|FG001|Overall Study|Physician Decision|12|||
105814210|NCT01492361|364979223|FG000|Overall Study|Lost to Follow-up|6|||
105814211|NCT01492361|364979224|FG001|Overall Study|Lost to Follow-up|13|||
105814212|NCT01492361|364979223|FG000|Overall Study|Other than specified above|106|||
105814213|NCT01492361|364979224|FG001|Overall Study|Other than specified above|138|||
105814214|NCT03444038|364979227|FG000|Overall Study|Adverse Event|12|||
105814215|NCT03444038|364979227|FG000|Overall Study|Withdrawal by Subject|7|||
105814216|NCT03444038|364979227|FG000|Overall Study|Lost to Follow-up|1|||
105814217|NCT03444038|364979227|FG000|Overall Study|Physician Decision|2|||
105814218|NCT03444038|364979227|FG000|Overall Study|Lack of Efficacy|7|||
105814219|NCT01717976|364979228|FG000|Overall Study|Protocol Violation|0|||
105955283|NCT02776683|365498245|FG001|Post-switch Period|Withdrawal by Subject|2|||
105955284|NCT02776683|365498244|FG000|Post-switch Period|Physician Decision|0|||
105814220|NCT01717976|364979229|FG001|Overall Study|Protocol Violation|1|||
105814221|NCT01087970|364979230|FG000|Overall Study|Protocol Violation|2|||
105814222|NCT00755196|364979232|FG000|Overall Study|Lost to Follow-up|1|||
105814223|NCT00755196|364979232|FG000|Overall Study|Lack of Efficiency|1|||
105814224|NCT01604850|364979233|FG000|Overall Study|Enrolled but never treated|0|||
105814225|NCT01604850|364979234|FG001|Overall Study|Enrolled but never treated|1|||
105814226|NCT01604850|364979233|FG000|Overall Study|Efficacy Failure|50|||
105814227|NCT01604850|364979234|FG001|Overall Study|Efficacy Failure|29|||
105814228|NCT01604850|364979233|FG000|Overall Study|Lost to Follow-up|1|||
105814229|NCT01604850|364979234|FG001|Overall Study|Lost to Follow-up|0|||
105814230|NCT01604850|364979233|FG000|Overall Study|Subject withdrew consent|1|||
105814231|NCT01604850|364979234|FG001|Overall Study|Subject withdrew consent|0|||
105814232|NCT01703832|364979235|FG000|Overall Study|Withdrawal by Subject|1|||
105814233|NCT01703832|364979236|FG001|Overall Study|Withdrawal by Subject|0|||
105814234|NCT01991470|364979237|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
105814235|NCT01991470|364979237|FG000|Enlite 1 Period|Adverse Event|1|||
105814236|NCT01991470|364979237|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
105814237|NCT01991470|364979237|FG000|Enlite 3 Period|Lost to Follow-up|1|||
105814238|NCT01991470|364979237|FG000|Enlite 3 Period|Physician Decision|2|||
105814239|NCT01991470|364979237|FG000|Enlite 3 Period|Physician Decision|8|||
105814240|NCT01991470|364979237|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
105814241|NCT00543309|364979238|FG000|Overall Study|Physician Decision|0|||
105814242|NCT00543309|364979239|FG001|Overall Study|Physician Decision|1|||
105814243|NCT00543309|364979240|FG002|Overall Study|Physician Decision|0|||
105814244|NCT03552757|364979241|FG000|Overall Study|Withdrawal by Subject|10|||
105814245|NCT03552757|364979242|FG001|Overall Study|Withdrawal by Subject|5|||
105814246|NCT03552757|364979243|FG002|Overall Study|Withdrawal by Subject|12|||
105814247|NCT03552757|364979241|FG000|Overall Study|Lost to Follow-up|2|||
105814248|NCT03552757|364979242|FG001|Overall Study|Lost to Follow-up|7|||
105814249|NCT03552757|364979243|FG002|Overall Study|Lost to Follow-up|7|||
105814250|NCT03552757|364979241|FG000|Overall Study|Death|1|||
105814251|NCT03552757|364979242|FG001|Overall Study|Death|1|||
105814252|NCT03552757|364979243|FG002|Overall Study|Death|1|||
105814253|NCT00762086|364979244|FG000|Overall Study|Adverse Event|2|||
105814254|NCT00762086|364979245|FG001|Overall Study|Adverse Event|0|||
105814255|NCT00762086|364979244|FG000|Overall Study|Lost to Follow-up|0|||
105814256|NCT00762086|364979245|FG001|Overall Study|Lost to Follow-up|2|||
105814257|NCT00762086|364979244|FG000|Overall Study|Non compliance|1|||
105814258|NCT00762086|364979245|FG001|Overall Study|Non compliance|0|||
105814259|NCT00762086|364979244|FG000|Overall Study|Withdrawal by Subject|2|||
105814260|NCT00762086|364979245|FG001|Overall Study|Withdrawal by Subject|2|||
105814261|NCT00762086|364979244|FG000|Overall Study|Ineligible to participate in the study|1|||
105814262|NCT00762086|364979245|FG001|Overall Study|Ineligible to participate in the study|0|||
105814263|NCT01203878|364979248|FG000|Overall Study|Withdrawal by Subject|0|||
105955285|NCT02776683|365498245|FG001|Post-switch Period|Physician Decision|3|||
105955286|NCT02776683|365498244|FG000|Post-switch Period|Progressive disease|0|||
105955287|NCT02776683|365498245|FG001|Post-switch Period|Progressive disease|20|||
105955288|NCT02776683|365498244|FG000|Post-switch Period|Other than listed|0|||
105955289|NCT02776683|365498245|FG001|Post-switch Period|Other than listed|15|||
105955290|NCT03198767|365498246|FG000|Overall Study|Protocol Violation|0|||
105955291|NCT03198767|365498247|FG001|Overall Study|Protocol Violation|0|||
105955292|NCT03198767|365498248|FG002|Overall Study|Protocol Violation|0|||
105955293|NCT03198767|365498249|FG003|Overall Study|Protocol Violation|6|||
105955294|NCT03198767|365498250|FG004|Overall Study|Protocol Violation|0|||
105955295|NCT03198767|365498251|FG005|Overall Study|Protocol Violation|0|||
106018066|NCT01134055|365729251|FG005|Overall Study|Adverse Event|7|||
105955296|NCT03198767|365498252|FG006|Overall Study|Protocol Violation|0|||
106018067|NCT01134055|365729252|FG006|Overall Study|Adverse Event|2|||
106018068|NCT01134055|365729246|FG000|Overall Study|Lost to Follow-up|0|||
105814264|NCT01203878|364979249|FG001|Overall Study|Withdrawal by Subject|0|||
105814265|NCT01203878|364979250|FG002|Overall Study|Withdrawal by Subject|1|||
105814266|NCT01203878|364979248|FG000|Overall Study|Adverse Event|0|||
105814267|NCT01203878|364979249|FG001|Overall Study|Adverse Event|0|||
105814268|NCT01203878|364979250|FG002|Overall Study|Adverse Event|2|||
105814269|NCT03952143|364979251|FG000|Lead-In Period|Adverse Event|2|||
105814270|NCT03952143|364979252|FG001|Lead-In Period|Adverse Event|0|||
105814271|NCT03952143|364979253|FG002|Lead-In Period|Adverse Event|0|||
105814272|NCT03952143|364979251|FG000|Lead-In Period|Lack of Efficacy|2|||
105814273|NCT03952143|364979252|FG001|Lead-In Period|Lack of Efficacy|0|||
105814274|NCT03952143|364979253|FG002|Lead-In Period|Lack of Efficacy|0|||
105814275|NCT03952143|364979251|FG000|Lead-In Period|Physician Decision|5|||
105955297|NCT04703192|365498253|FG000|Overall Study|Withdrawal by Subject|2|||
105955298|NCT04703192|365498254|FG001|Overall Study|Withdrawal by Subject|0|||
105955299|NCT04703192|365498253|FG000|Overall Study|Death|3|||
105955300|NCT04703192|365498254|FG001|Overall Study|Death|1|||
106018069|NCT01134055|365729247|FG001|Overall Study|Lost to Follow-up|1|||
106018070|NCT01134055|365729248|FG002|Overall Study|Lost to Follow-up|0|||
105955301|NCT04703192|365498253|FG000|Overall Study|Adverse Event|13|||
105955302|NCT04703192|365498254|FG001|Overall Study|Adverse Event|2|||
105955303|NCT04703192|365498253|FG000|Overall Study|Progressive or Relapsed Disease|46|||
105955304|NCT04703192|365498254|FG001|Overall Study|Progressive or Relapsed Disease|7|||
105814276|NCT03952143|364979252|FG001|Lead-In Period|Physician Decision|0|||
105814277|NCT03952143|364979253|FG002|Lead-In Period|Physician Decision|0|||
105814278|NCT03952143|364979251|FG000|Lead-In Period|Protocol Violation|5|||
105814279|NCT03952143|364979252|FG001|Lead-In Period|Protocol Violation|0|||
105814280|NCT03952143|364979253|FG002|Lead-In Period|Protocol Violation|0|||
105814281|NCT03952143|364979251|FG000|Lead-In Period|Withdrawal by Subject|19|||
105814282|NCT03952143|364979252|FG001|Lead-In Period|Withdrawal by Subject|0|||
105814283|NCT03952143|364979253|FG002|Lead-In Period|Withdrawal by Subject|0|||
105814284|NCT03952143|364979251|FG000|Treatment Period|Adverse Event|0|||
105814285|NCT03952143|364979252|FG001|Treatment Period|Adverse Event|0|||
105814286|NCT03952143|364979253|FG002|Treatment Period|Adverse Event|1|||
105814287|NCT03952143|364979251|FG000|Treatment Period|Lost to Follow-up|0|||
105814288|NCT03952143|364979252|FG001|Treatment Period|Lost to Follow-up|2|||
105814289|NCT03952143|364979253|FG002|Treatment Period|Lost to Follow-up|0|||
105814290|NCT03952143|364979251|FG000|Treatment Period|Physician Decision|0|||
105814291|NCT03952143|364979252|FG001|Treatment Period|Physician Decision|0|||
105814292|NCT03952143|364979253|FG002|Treatment Period|Physician Decision|2|||
105814293|NCT03952143|364979251|FG000|Treatment Period|Protocol Violation|0|||
105814294|NCT03952143|364979252|FG001|Treatment Period|Protocol Violation|0|||
105814295|NCT03952143|364979253|FG002|Treatment Period|Protocol Violation|1|||
105814296|NCT03952143|364979251|FG000|Treatment Period|Withdrawal by Subject|0|||
105814297|NCT03952143|364979252|FG001|Treatment Period|Withdrawal by Subject|5|||
105814298|NCT03952143|364979253|FG002|Treatment Period|Withdrawal by Subject|26|||
105814299|NCT03952143|364979251|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
105814300|NCT03952143|364979252|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
105814301|NCT03952143|364979253|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
105814302|NCT03952143|364979251|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
105814303|NCT03952143|364979252|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
105814304|NCT03952143|364979253|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
105814305|NCT01239121|364979254|FG000|Overall Study|Withdrawal by Subject|2|||
105814306|NCT01239121|364979255|FG001|Overall Study|Withdrawal by Subject|4|||
105814307|NCT01239121|364979256|FG002|Overall Study|Withdrawal by Subject|0|||
105814308|NCT00220337|364979257|FG000|Overall Study|Adverse Event|70|||
105814309|NCT00220337|364979257|FG000|Overall Study|Lack of Efficacy|17|||
105814310|NCT00220337|364979257|FG000|Overall Study|Withdrawal by Subject|68|||
105814311|NCT00220337|364979257|FG000|Overall Study|Protocol Violation|2|||
105814312|NCT00220337|364979257|FG000|Overall Study|Lost to Follow-up|5|||
105814313|NCT00220337|364979257|FG000|Overall Study|Other|12|||
105814314|NCT00220337|364979257|FG000|Overall Study|Unsatisfactory compliance|5|||
105814315|NCT03661528|364979258|FG000|Overall Study|Death|1|||
105814316|NCT03661528|364979259|FG001|Overall Study|Death|0|||
105814317|NCT03661528|364979258|FG000|Overall Study|Physician Decision|3|||
105814318|NCT03661528|364979259|FG001|Overall Study|Physician Decision|1|||
105814319|NCT03661528|364979258|FG000|Overall Study|Other than Specified|5|||
105814320|NCT03661528|364979259|FG001|Overall Study|Other than Specified|2|||
105814321|NCT03661528|364979258|FG000|Overall Study|Withdrawal by Subject|5|||
105814322|NCT03661528|364979259|FG001|Overall Study|Withdrawal by Subject|3|||
105814323|NCT03661528|364979258|FG000|Overall Study|Disease Progression|8|||
105814324|NCT03661528|364979259|FG001|Overall Study|Disease Progression|13|||
105814325|NCT03661528|364979258|FG000|Overall Study|Adverse Event|61|||
105814326|NCT03661528|364979259|FG001|Overall Study|Adverse Event|55|||
105814327|NCT01617668|364979260|FG000|Overall Study|Adverse Event|7|||
105814328|NCT01617668|364979261|FG001|Overall Study|Adverse Event|0|||
105814329|NCT01617668|364979262|FG002|Overall Study|Adverse Event|12|||
105814330|NCT01617668|364979263|FG003|Overall Study|Adverse Event|5|||
105955305|NCT04703192|365498253|FG000|Overall Study|Clinical Progression|19|||
105955306|NCT04703192|365498254|FG001|Overall Study|Clinical Progression|8|||
105814331|NCT01617668|364979260|FG000|Overall Study|Physician Decision|1|||
105814332|NCT01617668|364979261|FG001|Overall Study|Physician Decision|2|||
105955307|NCT04703192|365498253|FG000|Overall Study|Lost to Follow-up|1|||
105814333|NCT01617668|364979262|FG002|Overall Study|Physician Decision|3|||
105814334|NCT01617668|364979263|FG003|Overall Study|Physician Decision|0|||
105814335|NCT01617668|364979260|FG000|Overall Study|Progressive Disease|4|||
105814336|NCT01617668|364979261|FG001|Overall Study|Progressive Disease|4|||
105814337|NCT01617668|364979262|FG002|Overall Study|Progressive Disease|6|||
105814338|NCT01617668|364979263|FG003|Overall Study|Progressive Disease|9|||
105814339|NCT01617668|364979260|FG000|Overall Study|Subject/guardian decision|1|||
105955308|NCT04703192|365498254|FG001|Overall Study|Lost to Follow-up|0|||
105955309|NCT04703192|365498253|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
105955310|NCT04703192|365498254|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
105955311|NCT04703192|365498253|FG000|Overall Study|Other|5|||
105955312|NCT04703192|365498254|FG001|Overall Study|Other|1|||
105814340|NCT01617668|364979261|FG001|Overall Study|Subject/guardian decision|3|||
105814341|NCT01617668|364979262|FG002|Overall Study|Subject/guardian decision|2|||
105814342|NCT01617668|364979263|FG003|Overall Study|Subject/guardian decision|1|||
105814343|NCT01876706|364979264|FG000|Overall Study|BPH Intervention|9|||
105814344|NCT01876706|364979264|FG000|Overall Study|Lost to Follow-up|7|||
105955313|NCT02266147|365498257|FG000|PART 1: Dose Escalation|Physician Decision|0|||
105955314|NCT02266147|365498258|FG001|PART 1: Dose Escalation|Physician Decision|0|||
105955315|NCT02266147|365498259|FG002|PART 1: Dose Escalation|Physician Decision|1|||
105955316|NCT02266147|365498260|FG003|PART 1: Dose Escalation|Physician Decision|0|||
105955317|NCT02266147|365498257|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
105955318|NCT02266147|365498258|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
105955319|NCT02266147|365498259|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
105955320|NCT02266147|365498260|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
105955321|NCT02266147|365498257|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
105955322|NCT02266147|365498258|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
105955323|NCT02266147|365498259|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
105955324|NCT02266147|365498260|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
105955325|NCT02266147|365498257|FG000|PART 1: Dose Escalation|Other|1|||
105955326|NCT02266147|365498258|FG001|PART 1: Dose Escalation|Other|1|||
105955327|NCT02266147|365498259|FG002|PART 1: Dose Escalation|Other|0|||
105955328|NCT02266147|365498260|FG003|PART 1: Dose Escalation|Other|0|||
105955329|NCT02266147|365498257|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
105955330|NCT02266147|365498258|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
105955331|NCT02266147|365498259|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
105955332|NCT02266147|365498260|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
105955333|NCT02266147|365498257|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
105955334|NCT02266147|365498258|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
105955335|NCT02266147|365498259|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
105955336|NCT02266147|365498260|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
105955337|NCT03896477|365498261|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
105955338|NCT03896477|365498262|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
105955339|NCT03896477|365498263|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
105955340|NCT03896477|365498261|FG000|Overall Study|Parent Requested Withdrawal|8|||
105955341|NCT03896477|365498262|FG001|Overall Study|Parent Requested Withdrawal|12|||
105955342|NCT03896477|365498263|FG002|Overall Study|Parent Requested Withdrawal|9|||
105955343|NCT03896477|365498261|FG000|Overall Study|Adverse Event|0|||
105955344|NCT03896477|365498262|FG001|Overall Study|Adverse Event|0|||
105955345|NCT03896477|365498263|FG002|Overall Study|Adverse Event|1|||
105955346|NCT03896477|365498261|FG000|Overall Study|Death|1|||
105955347|NCT03896477|365498262|FG001|Overall Study|Death|0|||
105955348|NCT03896477|365498263|FG002|Overall Study|Death|0|||
105955349|NCT03896477|365498261|FG000|Overall Study|Other|5|||
105955350|NCT03896477|365498262|FG001|Overall Study|Other|6|||
105955351|NCT03896477|365498263|FG002|Overall Study|Other|7|||
105814345|NCT01876706|364979264|FG000|Overall Study|Withdrawals|6|||
105814346|NCT01876706|364979264|FG000|Overall Study|Death|3|||
105814347|NCT00659607|364979265|FG000|Overall Study|No blood pressure recorded|147|||
105814348|NCT00659607|364979265|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
105814349|NCT00659607|364979265|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
105814350|NCT00659607|364979265|FG000|Overall Study|No recorded efficacy data|15|||
105814351|NCT00659607|364979265|FG000|Overall Study|Inconsistent BP measuring date|2|||
105814352|NCT02073643|364979272|FG000|Overall Study|Lost to Follow-up|24|||
105814353|NCT01062256|364979273|FG000|Overall Study|Adverse Event|1|||
105814354|NCT01062256|364979274|FG001|Overall Study|Adverse Event|0|||
105814355|NCT01062256|364979275|FG002|Overall Study|Adverse Event|0|||
105955352|NCT03896477|365498261|FG000|Overall Study|Lost to Follow-up|2|||
105955353|NCT03896477|365498262|FG001|Overall Study|Lost to Follow-up|1|||
105955354|NCT03896477|365498263|FG002|Overall Study|Lost to Follow-up|1|||
105955355|NCT02553928|365498264|FG000|Overall Study|Adverse Event|2|||
105955356|NCT02553928|365498265|FG001|Overall Study|Adverse Event|1|||
105955357|NCT02553928|365498264|FG000|Overall Study|Lost to Follow-up|0|||
105955358|NCT02553928|365498265|FG001|Overall Study|Lost to Follow-up|1|||
106018071|NCT01134055|365729249|FG003|Overall Study|Lost to Follow-up|1|||
106018072|NCT01134055|365729250|FG004|Overall Study|Lost to Follow-up|0|||
105955359|NCT02553928|365498264|FG000|Overall Study|Administrative reason(s)|0|||
105955360|NCT02553928|365498265|FG001|Overall Study|Administrative reason(s)|1|||
105955361|NCT00400517|365498266|FG000|Overall Study|Withdrawal by Subject|1|||
106018073|NCT01134055|365729251|FG005|Overall Study|Lost to Follow-up|0|||
105814356|NCT01062256|364979273|FG000|Overall Study|Withdrawal by Subject|1|||
105814357|NCT01062256|364979274|FG001|Overall Study|Withdrawal by Subject|1|||
105814358|NCT01062256|364979275|FG002|Overall Study|Withdrawal by Subject|1|||
105814359|NCT01062256|364979273|FG000|Overall Study|Ineligible|1|||
105814360|NCT01062256|364979274|FG001|Overall Study|Ineligible|4|||
105814361|NCT01062256|364979275|FG002|Overall Study|Ineligible|3|||
105814362|NCT01062256|364979273|FG000|Overall Study|Administrative|0|||
105814363|NCT01062256|364979274|FG001|Overall Study|Administrative|2|||
105814364|NCT01062256|364979275|FG002|Overall Study|Administrative|0|||
105814365|NCT03752528|364979286|FG000|Part A|Lost to Follow-up|1|||
105814366|NCT03752528|364979286|FG000|Part A|Protocol Violation|1|||
105814367|NCT03752528|364979286|FG000|Part B|Protocol Violation|1|||
105814368|NCT03752528|364979286|FG000|Part B|Study terminated by sponsor|3|||
105814369|NCT04534283|364979288|FG000|Overall Study|Physician Decision|2|||
105814370|NCT04534283|364979288|FG000|Overall Study|Withdrawal by Subject|1|||
105814371|NCT04534283|364979288|FG000|Overall Study|Disease Progression|12|||
105814372|NCT04534283|364979288|FG000|Overall Study|Adverse Event|1|||
105814373|NCT01941030|364979293|FG000|Overall Study|Death|3|||
105814374|NCT01941030|364979294|FG001|Overall Study|Death|2|||
105814375|NCT01941030|364979293|FG000|Overall Study|Lost to Follow-up|6|||
105814376|NCT01941030|364979294|FG001|Overall Study|Lost to Follow-up|5|||
105814377|NCT01941030|364979293|FG000|Overall Study|Withdrawal by Subject|4|||
105814378|NCT01941030|364979294|FG001|Overall Study|Withdrawal by Subject|6|||
105814379|NCT02930005|364979301|FG000|Overall Study|Lost to Follow-up|1|||
105814380|NCT02930005|364979302|FG001|Overall Study|Lost to Follow-up|5|||
105814381|NCT02003183|364979305|FG000|Overall Study|Lost to Follow-up|0|||
105814382|NCT02003183|364979306|FG001|Overall Study|Lost to Follow-up|2|||
105814383|NCT00406848|364979307|FG000|Overall Study|Withdrawal by Subject|27|||
105814384|NCT00406848|364979308|FG001|Overall Study|Withdrawal by Subject|22|||
105814385|NCT00406848|364979307|FG000|Overall Study|Adverse Event|38|||
105814386|NCT00406848|364979308|FG001|Overall Study|Adverse Event|7|||
105814387|NCT00406848|364979307|FG000|Overall Study|Lack of Efficacy|9|||
105814388|NCT00406848|364979308|FG001|Overall Study|Lack of Efficacy|14|||
105814389|NCT00406848|364979307|FG000|Overall Study|Protocol Violation|10|||
105814390|NCT00406848|364979308|FG001|Overall Study|Protocol Violation|6|||
105814391|NCT00406848|364979307|FG000|Overall Study|Lost to Follow-up|6|||
105814392|NCT00406848|364979308|FG001|Overall Study|Lost to Follow-up|2|||
105814393|NCT00406848|364979307|FG000|Overall Study|Physician Decision|2|||
105814394|NCT00406848|364979308|FG001|Overall Study|Physician Decision|2|||
105814395|NCT00406848|364979307|FG000|Overall Study|Sponsor Decision|1|||
105814396|NCT00406848|364979308|FG001|Overall Study|Sponsor Decision|1|||
105814397|NCT03262012|364979326|FG000|Overall Study|Withdrawal by Subject|15|||
105814398|NCT03262012|364979327|FG001|Overall Study|Withdrawal by Subject|13|||
105814399|NCT03262012|364979328|FG002|Overall Study|Withdrawal by Subject|8|||
105814400|NCT03262012|364979329|FG003|Overall Study|Withdrawal by Subject|7|||
105814401|NCT03262012|364979326|FG000|Overall Study|Adverse Event|10|||
105814402|NCT03262012|364979327|FG001|Overall Study|Adverse Event|12|||
105814403|NCT03262012|364979328|FG002|Overall Study|Adverse Event|4|||
105814404|NCT03262012|364979329|FG003|Overall Study|Adverse Event|6|||
105814405|NCT03262012|364979326|FG000|Overall Study|Physician Decision|2|||
105814406|NCT03262012|364979327|FG001|Overall Study|Physician Decision|5|||
105814407|NCT03262012|364979328|FG002|Overall Study|Physician Decision|1|||
105814408|NCT03262012|364979329|FG003|Overall Study|Physician Decision|0|||
105814409|NCT03262012|364979326|FG000|Overall Study|Lack of Efficacy|0|||
105814410|NCT03262012|364979327|FG001|Overall Study|Lack of Efficacy|5|||
105814411|NCT03262012|364979328|FG002|Overall Study|Lack of Efficacy|1|||
105814412|NCT03262012|364979329|FG003|Overall Study|Lack of Efficacy|2|||
105814413|NCT03262012|364979326|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
105814414|NCT03262012|364979327|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
105814415|NCT03262012|364979328|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
105814416|NCT03262012|364979329|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
105814417|NCT00076102|364980673|FG000|Overall Study|Clinical progression|1|||
105814418|NCT00076102|364980673|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
105814419|NCT00076102|364980673|FG000|Overall Study|plexiform neurofibroma surgery|1|||
105814420|NCT00076102|364980673|FG000|Overall Study|refusal of further therapy|2|||
105814421|NCT00090857|364980675|FG000|Overall Study|Lost to Follow-up|0|||
105814422|NCT00090857|364980676|FG001|Overall Study|Lost to Follow-up|1|||
105814423|NCT00090857|364980675|FG000|Overall Study|Withdrawal by Subject|2|||
105814424|NCT00090857|364980676|FG001|Overall Study|Withdrawal by Subject|0|||
105814425|NCT00090857|364980675|FG000|Overall Study|Adverse Event|2|||
105814426|NCT00090857|364980676|FG001|Overall Study|Adverse Event|2|||
105814427|NCT05097326|364980677|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
105814428|NCT05097326|364980678|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
105814429|NCT01451762|364980679|FG000|Overall Study|Lost to Follow-up|3|||
105955362|NCT00400517|365498266|FG000|Overall Study|Physician Decision|1|||
105955363|NCT00075764|365498267|FG000|Overall Study|Adverse Event|5|||
105814430|NCT01451762|364980680|FG001|Overall Study|Lost to Follow-up|6|||
105814431|NCT01451762|364980681|FG002|Overall Study|Lost to Follow-up|6|||
105814432|NCT00630305|364980684|FG000|Overall Study|Withdrawal by Subject|1|||
105814433|NCT00630305|364980684|FG000|Overall Study|Inability to insert contact lens|1|||
105814434|NCT01494506|364980687|FG000|Overall Study|Lack of Efficacy|77|||
105814435|NCT01494506|364980688|FG001|Overall Study|Lack of Efficacy|83|||
105814436|NCT01494506|364980689|FG002|Overall Study|Lack of Efficacy|57|||
105814437|NCT01494506|364980687|FG000|Overall Study|Adverse Event|17|||
105814438|NCT01494506|364980688|FG001|Overall Study|Adverse Event|10|||
105814439|NCT01494506|364980689|FG002|Overall Study|Adverse Event|11|||
105814440|NCT01494506|364980687|FG000|Overall Study|Death|9|||
105814441|NCT01494506|364980688|FG001|Overall Study|Death|5|||
105814442|NCT01494506|364980689|FG002|Overall Study|Death|2|||
105814443|NCT01494506|364980687|FG000|Overall Study|Physician Decision|7|||
105814444|NCT01494506|364980688|FG001|Overall Study|Physician Decision|5|||
105814445|NCT01494506|364980689|FG002|Overall Study|Physician Decision|4|||
105814446|NCT01494506|364980687|FG000|Overall Study|Withdrawal by Subject|17|||
105955364|NCT00075764|365498268|FG001|Overall Study|Adverse Event|12|||
105955365|NCT00075764|365498267|FG000|Overall Study|Death|4|||
105955366|NCT00075764|365498268|FG001|Overall Study|Death|8|||
105955367|NCT00075764|365498267|FG000|Overall Study|Withdrawal by Subject|28|||
105955368|NCT00075764|365498268|FG001|Overall Study|Withdrawal by Subject|18|||
105955369|NCT00075764|365498267|FG000|Overall Study|Progression|269|||
105955370|NCT00075764|365498268|FG001|Overall Study|Progression|274|||
105955371|NCT00075764|365498267|FG000|Overall Study|Still on treatment|8|||
105955372|NCT00075764|365498268|FG001|Overall Study|Still on treatment|15|||
105955373|NCT00075764|365498267|FG000|Overall Study|Delinquent|4|||
105955374|NCT00075764|365498268|FG001|Overall Study|Delinquent|2|||
105955375|NCT00075764|365498267|FG000|Overall Study|Not protocol specified|27|||
105955376|NCT00075764|365498268|FG001|Overall Study|Not protocol specified|19|||
105955377|NCT00075764|365498267|FG000|Overall Study|Under review|0|||
105955378|NCT00075764|365498268|FG001|Overall Study|Under review|1|||
105955379|NCT00041470|365498269|FG000|Overall Study|Loss of Funding|38|||
105955380|NCT01871545|365498270|FG000|Overall Study|Death|2|||
105955381|NCT01871545|365498271|FG001|Overall Study|Death|0|||
105955382|NCT01871545|365498270|FG000|Overall Study|Lack of Efficacy|11|||
105955383|NCT01871545|365498271|FG001|Overall Study|Lack of Efficacy|2|||
105955384|NCT01871545|365498270|FG000|Overall Study|Physician Decision|4|||
105955385|NCT01871545|365498271|FG001|Overall Study|Physician Decision|0|||
105955386|NCT01871545|365498270|FG000|Overall Study|Withdrawal by Subject|0|||
105955387|NCT01871545|365498271|FG001|Overall Study|Withdrawal by Subject|1|||
105955388|NCT00739310|365498272|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
105955389|NCT00739310|365498272|FG000|Overall Study|Withdrawal by Subject|1|||
105955390|NCT00739310|365498272|FG000|Overall Study|Lost to Follow-up|2|||
105955391|NCT00988052|365498275|FG000|Overall Study|Missing|1|||
105955392|NCT00988052|365498276|FG001|Overall Study|Missing|0|||
105955393|NCT00988052|365498275|FG000|Overall Study|Teva requested subject withdrawal|3|||
105955394|NCT00988052|365498276|FG001|Overall Study|Teva requested subject withdrawal|1|||
105955395|NCT00988052|365498275|FG000|Overall Study|Death|1|||
105955396|NCT00988052|365498276|FG001|Overall Study|Death|3|||
105955397|NCT00988052|365498275|FG000|Overall Study|Protocol Violation|6|||
105955398|NCT00988052|365498276|FG001|Overall Study|Protocol Violation|5|||
105955399|NCT00988052|365498275|FG000|Overall Study|Pregnancy|6|||
105955400|NCT00988052|365498276|FG001|Overall Study|Pregnancy|6|||
105955401|NCT00988052|365498275|FG000|Overall Study|Lack of Efficacy|8|||
105955402|NCT00988052|365498276|FG001|Overall Study|Lack of Efficacy|7|||
105955403|NCT00988052|365498275|FG000|Overall Study|Lost to Follow-up|6|||
105955404|NCT00988052|365498276|FG001|Overall Study|Lost to Follow-up|11|||
105955405|NCT00988052|365498275|FG000|Overall Study|Physician Decision|27|||
106018074|NCT01134055|365729252|FG006|Overall Study|Lost to Follow-up|0|||
106018075|NCT01134055|365729246|FG000|Overall Study|Withdrawal by Subject|3|||
106018076|NCT01134055|365729247|FG001|Overall Study|Withdrawal by Subject|3|||
105814447|NCT01494506|364980688|FG001|Overall Study|Withdrawal by Subject|20|||
105814448|NCT01494506|364980689|FG002|Overall Study|Withdrawal by Subject|14|||
105814449|NCT01494506|364980687|FG000|Overall Study|Clinical Deterioration|21|||
105814450|NCT01494506|364980688|FG001|Overall Study|Clinical Deterioration|17|||
105814451|NCT01494506|364980689|FG002|Overall Study|Clinical Deterioration|13|||
105814452|NCT01494506|364980687|FG000|Overall Study|Sponsor Decision|0|||
105814453|NCT01494506|364980688|FG001|Overall Study|Sponsor Decision|0|||
105814454|NCT01494506|364980689|FG002|Overall Study|Sponsor Decision|1|||
105814455|NCT01494506|364980687|FG000|Overall Study|Other|0|||
105814456|NCT01494506|364980688|FG001|Overall Study|Other|3|||
105814457|NCT01494506|364980689|FG002|Overall Study|Other|1|||
105814458|NCT01882647|364980695|FG000|Overall Study|Lost to Follow-up|2|||
105955406|NCT00988052|365498276|FG001|Overall Study|Physician Decision|28|||
105955407|NCT00988052|365498275|FG000|Overall Study|Adverse Event|35|||
105955408|NCT00988052|365498276|FG001|Overall Study|Adverse Event|28|||
105955409|NCT00988052|365498275|FG000|Overall Study|Withdrawal by Subject|90|||
105955410|NCT00988052|365498276|FG001|Overall Study|Withdrawal by Subject|91|||
105955411|NCT00988052|365498275|FG000|Overall Study|Study terminated by sponsor|240|||
105955412|NCT00988052|365498276|FG001|Overall Study|Study terminated by sponsor|236|||
105814459|NCT01882647|364980696|FG001|Overall Study|Lost to Follow-up|2|||
105814460|NCT01882647|364980695|FG000|Overall Study|Withdrawal by Subject|0|||
105814461|NCT01882647|364980696|FG001|Overall Study|Withdrawal by Subject|4|||
105955413|NCT02954887|365498277|FG000|Overall Study|Withdrawal by Subject|3|||
106018077|NCT01134055|365729248|FG002|Overall Study|Withdrawal by Subject|1|||
105814462|NCT04720664|364980697|FG000|Overall Study|Adverse Event|2|||
105814463|NCT04720664|364980697|FG000|Overall Study|Lack of Efficacy|9|||
105814464|NCT01941095|364980698|FG000|Overall Study|Insufficient therapeutic response|13|||
105814465|NCT01941095|364980698|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
105814466|NCT01941095|364980698|FG000|Overall Study|Adverse Event|11|||
105814467|NCT01941095|364980698|FG000|Overall Study|Physician Decision|3|||
105814468|NCT01941095|364980698|FG000|Overall Study|Withdrawal by Subject|17|||
105814469|NCT01941095|364980698|FG000|Overall Study|Lost to Follow-up|10|||
105814470|NCT03311646|364980699|FG000|Overall Study|Physician Decision|1|||
105814471|NCT03311646|364980699|FG000|Overall Study|Withdrawal by Subject|5|||
105814472|NCT03311646|364980699|FG000|Overall Study|Lost to Follow-up|5|||
105814473|NCT03311646|364980699|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
105814474|NCT00883090|364980700|FG000|Overall Study|Sponsor's decision|1|||
105814475|NCT00883090|364980700|FG000|Overall Study|Withdrawal by Subject|1|||
105814476|NCT03527745|364980701|FG000|Overall Study|Lost to Follow-up|3|||
105814477|NCT03527745|364980702|FG001|Overall Study|Lost to Follow-up|6|||
105814478|NCT03527745|364980703|FG002|Overall Study|Lost to Follow-up|7|||
105814479|NCT03527745|364980704|FG003|Overall Study|Lost to Follow-up|9|||
105814480|NCT03527745|364980705|FG004|Overall Study|Lost to Follow-up|0|||
105814481|NCT03527745|364980706|FG005|Overall Study|Lost to Follow-up|2|||
105814482|NCT03527745|364980707|FG006|Overall Study|Lost to Follow-up|3|||
105814483|NCT03527745|364980708|FG007|Overall Study|Lost to Follow-up|2|||
105814484|NCT03527745|364980709|FG008|Overall Study|Lost to Follow-up|3|||
105814485|NCT03527745|364980710|FG009|Overall Study|Lost to Follow-up|2|||
105814486|NCT03527745|364980711|FG010|Overall Study|Lost to Follow-up|1|||
105814487|NCT03527745|364980712|FG011|Overall Study|Lost to Follow-up|1|||
105814488|NCT03527745|364980713|FG012|Overall Study|Lost to Follow-up|0|||
105814489|NCT03527745|364980714|FG013|Overall Study|Lost to Follow-up|0|||
105814490|NCT03527745|364980715|FG014|Overall Study|Lost to Follow-up|0|||
105814491|NCT03527745|364980716|FG015|Overall Study|Lost to Follow-up|0|||
105814492|NCT03527745|364980717|FG016|Overall Study|Lost to Follow-up|1|||
105814493|NCT03527745|364980718|FG017|Overall Study|Lost to Follow-up|0|||
105814494|NCT03527745|364980719|FG018|Overall Study|Lost to Follow-up|0|||
105814495|NCT03527745|364980720|FG019|Overall Study|Lost to Follow-up|1|||
105814496|NCT03527745|364980721|FG020|Overall Study|Lost to Follow-up|1|||
105814497|NCT03527745|364980722|FG021|Overall Study|Lost to Follow-up|5|||
105814498|NCT03527745|364980723|FG022|Overall Study|Lost to Follow-up|6|||
105814499|NCT03527745|364980724|FG023|Overall Study|Lost to Follow-up|8|||
105814500|NCT03527745|364980725|FG024|Overall Study|Lost to Follow-up|1|||
105814501|NCT03527745|364980726|FG025|Overall Study|Lost to Follow-up|3|||
105814502|NCT00728949|364980730|FG000|Overall Study|Adverse Event|8|||
105814503|NCT00728949|364980731|FG001|Overall Study|Adverse Event|0|||
105814504|NCT00728949|364980730|FG000|Overall Study|Withdrawal by Subject|2|||
105814505|NCT00728949|364980731|FG001|Overall Study|Withdrawal by Subject|2|||
105814506|NCT00728949|364980730|FG000|Overall Study|Abnormal Lab Results|0|||
105814507|NCT00728949|364980731|FG001|Overall Study|Abnormal Lab Results|2|||
105814508|NCT00728949|364980730|FG000|Overall Study|On treatment at cutoff date|1|||
105814509|NCT00728949|364980731|FG001|Overall Study|On treatment at cutoff date|0|||
105814510|NCT04015232|364980732|FG000|Overall Study|Withdrawal by Subject|7|||
105814511|NCT04015232|364980733|FG001|Overall Study|Withdrawal by Subject|4|||
105814512|NCT04015232|364980732|FG000|Overall Study|Protocol Violation|1|||
105814513|NCT04015232|364980733|FG001|Overall Study|Protocol Violation|0|||
105814514|NCT04015232|364980732|FG000|Overall Study|Medical Grounds|3|||
105814515|NCT04015232|364980733|FG001|Overall Study|Medical Grounds|3|||
105814516|NCT01996033|364980734|FG000|Overall Study|Death|1|||
105814517|NCT01996033|364980734|FG000|Overall Study|Physician Decision|1|||
105814518|NCT01996033|364980734|FG000|Overall Study|Withdrawal by Subject|4|||
105814519|NCT01996033|364980734|FG000|Overall Study|Lost to Follow-up|3|||
105814520|NCT01315249|364980735|FG000|Overall Study|Adverse Event|22|||
105814521|NCT01315249|364980736|FG001|Overall Study|Adverse Event|26|||
105814522|NCT01315249|364980735|FG000|Overall Study|Withdrawal by Subject|11|||
105814523|NCT01315249|364980736|FG001|Overall Study|Withdrawal by Subject|10|||
105814524|NCT01315249|364980735|FG000|Overall Study|Protocol Violation|8|||
105814525|NCT01315249|364980736|FG001|Overall Study|Protocol Violation|5|||
105814526|NCT01315249|364980735|FG000|Overall Study|Abnormal test results|1|||
105814527|NCT01315249|364980736|FG001|Overall Study|Abnormal test results|2|||
106145246|NCT02486718|366191920|FG000|Randomized Phase|Physician Decision|0|||
106145247|NCT02486718|366191921|FG001|Randomized Phase|Physician Decision|0|||
106145248|NCT02486718|366191922|FG002|Randomized Phase|Physician Decision|3|||
106145249|NCT02486718|366191920|FG000|Randomized Phase|Lost to Follow-up|0|||
105814528|NCT01315249|364980735|FG000|Overall Study|Administrative problems|1|||
105814529|NCT01315249|364980736|FG001|Overall Study|Administrative problems|0|||
105814530|NCT01315249|364980735|FG000|Overall Study|inability to use device|1|||
106145250|NCT02486718|366191921|FG001|Randomized Phase|Lost to Follow-up|5|||
105814531|NCT01315249|364980736|FG001|Overall Study|inability to use device|0|||
105814532|NCT01315249|364980735|FG000|Overall Study|Lack of Efficacy|0|||
105814533|NCT01315249|364980736|FG001|Overall Study|Lack of Efficacy|1|||
105814534|NCT01315249|364980735|FG000|Overall Study|Lost to Follow-up|0|||
105814535|NCT01315249|364980736|FG001|Overall Study|Lost to Follow-up|2|||
106018078|NCT01134055|365729249|FG003|Overall Study|Withdrawal by Subject|2|||
106018079|NCT01134055|365729250|FG004|Overall Study|Withdrawal by Subject|0|||
106018080|NCT01134055|365729251|FG005|Overall Study|Withdrawal by Subject|0|||
106018081|NCT01134055|365729252|FG006|Overall Study|Withdrawal by Subject|8|||
106018082|NCT01134055|365729246|FG000|Overall Study|Protocol Violation|0|||
106018083|NCT01134055|365729247|FG001|Overall Study|Protocol Violation|0|||
106018084|NCT01134055|365729248|FG002|Overall Study|Protocol Violation|0|||
106018085|NCT01134055|365729249|FG003|Overall Study|Protocol Violation|1|||
106018086|NCT01134055|365729250|FG004|Overall Study|Protocol Violation|1|||
106018087|NCT01134055|365729251|FG005|Overall Study|Protocol Violation|0|||
105814536|NCT01315249|364980735|FG000|Overall Study|Death|0|||
105814537|NCT01315249|364980736|FG001|Overall Study|Death|1|||
105814538|NCT03558828|364980739|FG000|Overall Study|Lost to Follow-up|4|||
105814539|NCT03558828|364980740|FG001|Overall Study|Lost to Follow-up|3|||
105814540|NCT03558828|364980741|FG002|Overall Study|Lost to Follow-up|3|||
105814541|NCT03558828|364980742|FG003|Overall Study|Lost to Follow-up|5|||
105814542|NCT03558828|364980743|FG004|Overall Study|Lost to Follow-up|2|||
105814543|NCT03558828|364980744|FG005|Overall Study|Lost to Follow-up|3|||
105814544|NCT03558828|364980739|FG000|Overall Study|dropped before the intervention|1|||
105814545|NCT03558828|364980740|FG001|Overall Study|dropped before the intervention|1|||
105814546|NCT03558828|364980741|FG002|Overall Study|dropped before the intervention|0|||
105814547|NCT03558828|364980742|FG003|Overall Study|dropped before the intervention|0|||
105814548|NCT03558828|364980743|FG004|Overall Study|dropped before the intervention|0|||
105814549|NCT03558828|364980744|FG005|Overall Study|dropped before the intervention|0|||
105814550|NCT00264797|364980747|FG000|Overall Study|Withdrawal by Subject|11|||
105814551|NCT00264797|364980748|FG001|Overall Study|Withdrawal by Subject|11|||
105814552|NCT00264797|364980747|FG000|Overall Study|Lost to Follow-up|9|||
105814553|NCT00264797|364980748|FG001|Overall Study|Lost to Follow-up|17|||
105814554|NCT00264797|364980747|FG000|Overall Study|Moved from area|3|||
105814555|NCT00264797|364980748|FG001|Overall Study|Moved from area|1|||
105814556|NCT00264797|364980747|FG000|Overall Study|Practical Problems|2|||
105814557|NCT00264797|364980748|FG001|Overall Study|Practical Problems|3|||
105814558|NCT00264797|364980747|FG000|Overall Study|Incarceration|4|||
105814559|NCT00264797|364980748|FG001|Overall Study|Incarceration|5|||
105814560|NCT00264797|364980747|FG000|Overall Study|Pressure/advice from Outsiders|1|||
105814561|NCT00264797|364980748|FG001|Overall Study|Pressure/advice from Outsiders|1|||
105814562|NCT00264797|364980747|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
105814563|NCT00264797|364980748|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
105814564|NCT00264797|364980747|FG000|Overall Study|Other|3|||
105814565|NCT00264797|364980748|FG001|Overall Study|Other|4|||
105814566|NCT03227445|364980749|FG000|Period 1 (28 Days)|Adverse Event|1|||
105814567|NCT03227445|364980750|FG001|Period 1 (28 Days)|Adverse Event|2|||
105814568|NCT03227445|364980751|FG002|Period 1 (28 Days)|Adverse Event|0|||
105814569|NCT03227445|364980752|FG003|Period 1 (28 Days)|Adverse Event|1|||
105814570|NCT03227445|364980749|FG000|Period 1 (28 Days)|Protocol Violation|1|||
105814571|NCT03227445|364980750|FG001|Period 1 (28 Days)|Protocol Violation|0|||
105814572|NCT03227445|364980751|FG002|Period 1 (28 Days)|Protocol Violation|0|||
105814573|NCT03227445|364980752|FG003|Period 1 (28 Days)|Protocol Violation|0|||
105814574|NCT03227445|364980749|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
105814575|NCT03227445|364980750|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
105814576|NCT03227445|364980751|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
105814577|NCT03227445|364980752|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
105814578|NCT03227445|364980749|FG000|Period 2 (28 Days)|Adverse Event|1|||
105814579|NCT03227445|364980750|FG001|Period 2 (28 Days)|Adverse Event|0|||
105814580|NCT03227445|364980751|FG002|Period 2 (28 Days)|Adverse Event|2|||
105814581|NCT03227445|364980752|FG003|Period 2 (28 Days)|Adverse Event|1|||
105814582|NCT03227445|364980749|FG000|Period 2 (28 Days)|Protocol Violation|0|||
105814583|NCT03227445|364980750|FG001|Period 2 (28 Days)|Protocol Violation|0|||
105814584|NCT03227445|364980751|FG002|Period 2 (28 Days)|Protocol Violation|0|||
105814585|NCT03227445|364980752|FG003|Period 2 (28 Days)|Protocol Violation|1|||
105814586|NCT03227445|364980749|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
105814587|NCT03227445|364980750|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
105814588|NCT03227445|364980751|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
106018088|NCT01134055|365729252|FG006|Overall Study|Protocol Violation|0|||
106018089|NCT01134055|365729246|FG000|Overall Study|Physician Decision|0|||
105814589|NCT03227445|364980752|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
105814590|NCT02731157|364980755|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
105814591|NCT00623779|364980757|FG000|Overall Study|Adverse Event|1|||
105814592|NCT00623779|364980758|FG001|Overall Study|Adverse Event|3|||
105814593|NCT00623779|364980759|FG002|Overall Study|Adverse Event|0|||
105814594|NCT00623779|364980757|FG000|Overall Study|Criteria from CSR|2|||
105814595|NCT00623779|364980758|FG001|Overall Study|Criteria from CSR|0|||
105814596|NCT00623779|364980759|FG002|Overall Study|Criteria from CSR|1|||
106018090|NCT01134055|365729247|FG001|Overall Study|Physician Decision|0|||
106018091|NCT01134055|365729248|FG002|Overall Study|Physician Decision|0|||
106018092|NCT01134055|365729249|FG003|Overall Study|Physician Decision|0|||
106018093|NCT01134055|365729250|FG004|Overall Study|Physician Decision|0|||
106018094|NCT01134055|365729251|FG005|Overall Study|Physician Decision|0|||
105955414|NCT02954887|365498277|FG000|Overall Study|Lack of Efficacy|3|||
105955415|NCT02954887|365498277|FG000|Overall Study|Other|1|||
105955416|NCT01459666|365498279|FG000|Overall Study|PI left institution|5|||
105763769|NCT03424044|364788862|FG002|First Intervention (76 Hours)|Adverse Event|0|||
105763770|NCT03424044|364788863|FG003|First Intervention (76 Hours)|Adverse Event|0|||
105763771|NCT03424044|364788864|FG004|First Intervention (76 Hours)|Adverse Event|1|||
105763772|NCT03424044|364788865|FG005|First Intervention (76 Hours)|Adverse Event|0|||
105763773|NCT03424044|364788866|FG006|First Intervention (76 Hours)|Adverse Event|0|||
105763774|NCT03424044|364788867|FG007|First Intervention (76 Hours)|Adverse Event|0|||
105763775|NCT03424044|364788868|FG008|First Intervention (76 Hours)|Adverse Event|0|||
105763776|NCT03424044|364788860|FG000|First Intervention (76 Hours)|device issues|0|||
105763777|NCT03424044|364788861|FG001|First Intervention (76 Hours)|device issues|0|||
105763778|NCT03424044|364788862|FG002|First Intervention (76 Hours)|device issues|0|||
105763779|NCT03424044|364788863|FG003|First Intervention (76 Hours)|device issues|0|||
105763780|NCT03424044|364788864|FG004|First Intervention (76 Hours)|device issues|0|||
105763781|NCT03424044|364788865|FG005|First Intervention (76 Hours)|device issues|0|||
105763782|NCT03424044|364788866|FG006|First Intervention (76 Hours)|device issues|1|||
105763783|NCT03424044|364788867|FG007|First Intervention (76 Hours)|device issues|1|||
105763784|NCT03424044|364788868|FG008|First Intervention (76 Hours)|device issues|1|||
105763785|NCT03424044|364788860|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
105763786|NCT03424044|364788861|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
105763787|NCT03424044|364788862|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
105763788|NCT03424044|364788863|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
105763789|NCT03424044|364788864|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
105763790|NCT03424044|364788865|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
105763791|NCT03424044|364788866|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
105763792|NCT03424044|364788867|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
105763793|NCT03424044|364788868|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
105763794|NCT03424044|364788860|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763795|NCT03424044|364788861|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763796|NCT03424044|364788862|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763797|NCT03424044|364788863|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
105763798|NCT03424044|364788864|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763799|NCT03424044|364788865|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763800|NCT03424044|364788866|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763801|NCT03424044|364788867|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763802|NCT03424044|364788868|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
105763803|NCT02971007|364788869|FG000|Overall Study|Adverse Event|1|||
105763804|NCT02971007|364788870|FG001|Overall Study|Adverse Event|0|||
105763805|NCT02971007|364788871|FG002|Overall Study|Adverse Event|0|||
105763806|NCT02971007|364788869|FG000|Overall Study|Lost to Follow-up|0|||
105763807|NCT02971007|364788870|FG001|Overall Study|Lost to Follow-up|1|||
105763808|NCT02971007|364788871|FG002|Overall Study|Lost to Follow-up|1|||
105763809|NCT02971007|364788869|FG000|Overall Study|Withdrawal by Subject|0|||
105763810|NCT02971007|364788870|FG001|Overall Study|Withdrawal by Subject|1|||
105763811|NCT02971007|364788871|FG002|Overall Study|Withdrawal by Subject|0|||
105763812|NCT02971007|364788869|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
105763813|NCT02971007|364788870|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
105763814|NCT02971007|364788871|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
105763815|NCT02971007|364788869|FG000|Overall Study|Patient discontinued study drug|0|||
105763816|NCT02971007|364788870|FG001|Overall Study|Patient discontinued study drug|1|||
105763817|NCT02971007|364788871|FG002|Overall Study|Patient discontinued study drug|0|||
105763818|NCT01625611|364788873|FG000|Overall Study|No adlib drinks Lab 1|3|||
105763819|NCT01625611|364788874|FG001|Overall Study|No adlib drinks Lab 1|0|||
105763820|NCT01625611|364788873|FG000|Overall Study|Technical issues with PET|1|||
105763821|NCT01625611|364788874|FG001|Overall Study|Technical issues with PET|0|||
105763822|NCT01625611|364788873|FG000|Overall Study|Unable to complete study procedures|1|||
105763823|NCT01625611|364788874|FG001|Overall Study|Unable to complete study procedures|0|||
105763824|NCT01625611|364788873|FG000|Overall Study|Withdrawal by Subject|3|||
105763825|NCT01625611|364788874|FG001|Overall Study|Withdrawal by Subject|0|||
105763826|NCT02038790|364788875|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
105763827|NCT02038790|364788876|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
105763828|NCT00948194|364788877|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
105763829|NCT00948194|364788878|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
105763830|NCT05282121|364788880|FG000|Overall Study|Adverse Event|1|||
105763831|NCT05282121|364788881|FG001|Overall Study|Adverse Event|1|||
105763832|NCT05282121|364788882|FG002|Overall Study|Adverse Event|4|||
105763833|NCT05282121|364788883|FG003|Overall Study|Adverse Event|1|||
105763834|NCT05282121|364788880|FG000|Overall Study|Study Terminated by Sponsor|1|||
105955417|NCT01459666|365498280|FG001|Overall Study|PI left institution|4|||
105763835|NCT05282121|364788881|FG001|Overall Study|Study Terminated by Sponsor|2|||
105955418|NCT01152788|365498282|FG000|Overall Study|Withdrawal by Subject|0|||
105814597|NCT00925769|364980762|FG000|Overall Study|Major toxicity|1|||
105814598|NCT00925769|364980763|FG001|Overall Study|Major toxicity|0|||
105814599|NCT00925769|364980764|FG002|Overall Study|Major toxicity|1|||
105814600|NCT00925769|364980765|FG003|Overall Study|Major toxicity|1|||
105814601|NCT00925769|364980766|FG004|Overall Study|Major toxicity|0|||
105814602|NCT00925769|364980767|FG005|Overall Study|Major toxicity|0|||
105814603|NCT00925769|364980762|FG000|Overall Study|Disease progression|4|||
105814604|NCT00925769|364980763|FG001|Overall Study|Disease progression|5|||
105814605|NCT00925769|364980764|FG002|Overall Study|Disease progression|3|||
105814606|NCT00925769|364980765|FG003|Overall Study|Disease progression|4|||
105814607|NCT00925769|364980766|FG004|Overall Study|Disease progression|2|||
105814608|NCT00925769|364980767|FG005|Overall Study|Disease progression|3|||
105814609|NCT00925769|364980762|FG000|Overall Study|Death|0|||
105814610|NCT00925769|364980763|FG001|Overall Study|Death|0|||
105814611|NCT00925769|364980764|FG002|Overall Study|Death|1|||
105814612|NCT00925769|364980765|FG003|Overall Study|Death|0|||
105814613|NCT00925769|364980766|FG004|Overall Study|Death|0|||
105814614|NCT00925769|364980767|FG005|Overall Study|Death|0|||
105814615|NCT00925769|364980762|FG000|Overall Study|Physician Decision|1|||
105814616|NCT00925769|364980763|FG001|Overall Study|Physician Decision|0|||
105814617|NCT00925769|364980764|FG002|Overall Study|Physician Decision|0|||
105814618|NCT00925769|364980765|FG003|Overall Study|Physician Decision|0|||
105814619|NCT00925769|364980766|FG004|Overall Study|Physician Decision|0|||
105814620|NCT00925769|364980767|FG005|Overall Study|Physician Decision|0|||
105955419|NCT01152788|365498283|FG001|Overall Study|Withdrawal by Subject|3|||
105955420|NCT01152788|365498282|FG000|Overall Study|No treatment|0|||
105955421|NCT01152788|365498283|FG001|Overall Study|No treatment|1|||
105955422|NCT00590967|365498284|FG000|Overall Study|Withdrawal by Subject|1|||
105955423|NCT00590967|365498285|FG001|Overall Study|Withdrawal by Subject|1|||
105955424|NCT00590967|365498284|FG000|Overall Study|Ineligible|1|||
105955425|NCT00590967|365498285|FG001|Overall Study|Ineligible|0|||
105955426|NCT00590967|365498284|FG000|Overall Study|Poor performance status|0|||
105955427|NCT00590967|365498285|FG001|Overall Study|Poor performance status|1|||
105955428|NCT00590967|365498284|FG000|Overall Study|Non-compliant|0|||
105955429|NCT00590967|365498285|FG001|Overall Study|Non-compliant|2|||
105955430|NCT00590967|365498284|FG000|Overall Study|Did not sign consent form|0|||
105955431|NCT00590967|365498285|FG001|Overall Study|Did not sign consent form|1|||
105955432|NCT00590967|365498284|FG000|Overall Study|Did not receive chemo per protocol|1|||
105955433|NCT00590967|365498285|FG001|Overall Study|Did not receive chemo per protocol|0|||
105955434|NCT03824392|365498286|FG000|Overall Study|Adverse Event|1|||
105955435|NCT03824392|365498287|FG001|Overall Study|Adverse Event|0|||
105955436|NCT03824392|365498288|FG002|Overall Study|Adverse Event|0|||
105955437|NCT03824392|365498289|FG003|Overall Study|Adverse Event|0|||
105955438|NCT03824392|365498286|FG000|Overall Study|Investigator Decision|0|||
105763836|NCT05282121|364788882|FG002|Overall Study|Study Terminated by Sponsor|2|||
105763837|NCT05282121|364788883|FG003|Overall Study|Study Terminated by Sponsor|2|||
105763838|NCT05282121|364788880|FG000|Overall Study|Other than listed|0|||
105763839|NCT05282121|364788881|FG001|Overall Study|Other than listed|0|||
105763840|NCT05282121|364788882|FG002|Overall Study|Other than listed|1|||
105763841|NCT05282121|364788883|FG003|Overall Study|Other than listed|0|||
105763842|NCT05282121|364788880|FG000|Overall Study|No reason available|0|||
105763843|NCT05282121|364788881|FG001|Overall Study|No reason available|0|||
105763844|NCT05282121|364788882|FG002|Overall Study|No reason available|1|||
105763845|NCT05282121|364788883|FG003|Overall Study|No reason available|0|||
105763846|NCT03250624|364788891|FG000|Overall Study|Lack of Efficacy|1|||
105763847|NCT03250624|364788892|FG001|Overall Study|Lack of Efficacy|4|||
105763848|NCT03250624|364788891|FG000|Overall Study|Adverse Event|0|||
105763849|NCT03250624|364788892|FG001|Overall Study|Adverse Event|1|||
105763850|NCT03250624|364788891|FG000|Overall Study|Other|1|||
105763851|NCT03250624|364788892|FG001|Overall Study|Other|2|||
105763852|NCT00063986|364788894|FG000|Overall Study|Withdrawal by Subject|1|||
105763853|NCT00063986|364788894|FG000|Overall Study|Ineligible|1|||
105763854|NCT00063986|364788894|FG000|Overall Study|Intra-operatively ineligible|4|||
105763855|NCT00509028|364788895|FG000|Overall Study|Adverse Event|2|||
105814621|NCT00925769|364980762|FG000|Overall Study|Missing documentation|0|||
105814622|NCT00925769|364980763|FG001|Overall Study|Missing documentation|1|||
105814623|NCT00925769|364980764|FG002|Overall Study|Missing documentation|0|||
105814624|NCT00925769|364980765|FG003|Overall Study|Missing documentation|0|||
105814625|NCT00925769|364980766|FG004|Overall Study|Missing documentation|0|||
105814626|NCT00925769|364980767|FG005|Overall Study|Missing documentation|0|||
105955439|NCT03824392|365498287|FG001|Overall Study|Investigator Decision|1|||
105763856|NCT00509028|364788896|FG001|Overall Study|Adverse Event|0|||
105955440|NCT03824392|365498288|FG002|Overall Study|Investigator Decision|0|||
105955441|NCT03824392|365498289|FG003|Overall Study|Investigator Decision|0|||
105987404|NCT03495102|365614448|FG000|Overall Study|Primary Care Physician Recommendation|0|||
105987405|NCT03495102|365614449|FG001|Overall Study|Primary Care Physician Recommendation|1|||
105987406|NCT03495102|365614450|FG002|Overall Study|Primary Care Physician Recommendation|0|||
105987407|NCT03495102|365614448|FG000|Overall Study|Relocated to Another Country|0|||
105987408|NCT03495102|365614449|FG001|Overall Study|Relocated to Another Country|1|||
105955442|NCT03824392|365498286|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
105955443|NCT03824392|365498287|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
105955444|NCT03824392|365498288|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
105955445|NCT03824392|365498289|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
105955446|NCT02655887|365498291|FG000|Overall Study|Lost to Follow-up|3|||
105955447|NCT02655887|365498291|FG000|Overall Study|Death|4|||
105955448|NCT02655887|365498291|FG000|Overall Study|Withdrawal by Subject|3|||
105955449|NCT02655887|365498291|FG000|Overall Study|Missed 12-month follow-up visit|4|||
105955450|NCT01299389|365498293|FG000|Double-blind|Adverse Event|45|||
105955451|NCT01299389|365498294|FG001|Double-blind|Adverse Event|27|||
105955452|NCT01299389|365498295|FG002|Double-blind|Adverse Event|0|||
105955453|NCT01299389|365498296|FG003|Double-blind|Adverse Event|0|||
105955454|NCT01299389|365498293|FG000|Double-blind|Lack of Efficacy|45|||
105955455|NCT01299389|365498294|FG001|Double-blind|Lack of Efficacy|21|||
105955456|NCT01299389|365498295|FG002|Double-blind|Lack of Efficacy|0|||
105955457|NCT01299389|365498296|FG003|Double-blind|Lack of Efficacy|0|||
105955458|NCT01299389|365498293|FG000|Double-blind|Lost to Follow-up|2|||
105955459|NCT01299389|365498294|FG001|Double-blind|Lost to Follow-up|1|||
105955460|NCT01299389|365498295|FG002|Double-blind|Lost to Follow-up|0|||
105955461|NCT01299389|365498296|FG003|Double-blind|Lost to Follow-up|0|||
105955462|NCT01299389|365498293|FG000|Double-blind|Withdrawal by Subject|16|||
105955463|NCT01299389|365498294|FG001|Double-blind|Withdrawal by Subject|13|||
105955464|NCT01299389|365498295|FG002|Double-blind|Withdrawal by Subject|0|||
105955465|NCT01299389|365498296|FG003|Double-blind|Withdrawal by Subject|0|||
105955466|NCT01299389|365498293|FG000|Double-blind|Other|1|||
105955467|NCT01299389|365498294|FG001|Double-blind|Other|1|||
105955468|NCT01299389|365498295|FG002|Double-blind|Other|0|||
105955469|NCT01299389|365498296|FG003|Double-blind|Other|0|||
105955470|NCT01299389|365498293|FG000|Double-blind|"fail to meet study population criteria"|0|||
105955471|NCT01299389|365498294|FG001|Double-blind|"fail to meet study population criteria"|1|||
105955472|NCT01299389|365498295|FG002|Double-blind|"fail to meet study population criteria"|0|||
105955473|NCT01299389|365498296|FG003|Double-blind|"fail to meet study population criteria"|0|||
105955474|NCT01299389|365498293|FG000|Post-observational|Other|0|||
105955475|NCT01299389|365498294|FG001|Post-observational|Other|0|||
105955476|NCT01299389|365498295|FG002|Post-observational|Other|12|||
105763857|NCT00509028|364788895|FG000|Overall Study|Withdrawal by Subject|4|||
105763858|NCT00509028|364788896|FG001|Overall Study|Withdrawal by Subject|3|||
105763859|NCT00509028|364788895|FG000|Overall Study|Lost to Follow-up|0|||
105763860|NCT00509028|364788896|FG001|Overall Study|Lost to Follow-up|1|||
105763861|NCT00509028|364788895|FG000|Overall Study|Protocol Violation|4|||
105763862|NCT00509028|364788896|FG001|Overall Study|Protocol Violation|2|||
105763863|NCT00509028|364788895|FG000|Overall Study|Non-compliance|2|||
105763864|NCT00509028|364788896|FG001|Overall Study|Non-compliance|1|||
105763865|NCT02408484|364788900|FG000|Overall Study|Withdrawal by Subject|3|||
105763866|NCT02408484|364788900|FG000|Overall Study|Not treated during study period|1|||
105763867|NCT01510028|364788913|FG000|Overall Study|Lack of Efficacy|1|||
105763868|NCT01510028|364788914|FG001|Overall Study|Lack of Efficacy|0|||
105763869|NCT01510028|364788915|FG002|Overall Study|Lack of Efficacy|0|||
105763870|NCT01510028|364788916|FG003|Overall Study|Lack of Efficacy|0|||
105763871|NCT00633893|364788917|FG000|Overall Study|Death|1|||
105763872|NCT00633893|364788918|FG001|Overall Study|Death|3|||
105763873|NCT00633893|364788919|FG002|Overall Study|Death|9|||
105763874|NCT00633893|364788917|FG000|Overall Study|Adverse Event|65|||
105763875|NCT00633893|364788918|FG001|Overall Study|Adverse Event|58|||
105763876|NCT00633893|364788919|FG002|Overall Study|Adverse Event|126|||
105763877|NCT00633893|364788917|FG000|Overall Study|Withdrawal by Subject|7|||
105763878|NCT00633893|364788918|FG001|Overall Study|Withdrawal by Subject|12|||
105763879|NCT00633893|364788919|FG002|Overall Study|Withdrawal by Subject|6|||
105763880|NCT00633893|364788917|FG000|Overall Study|Lost to Follow-up|2|||
105763881|NCT00633893|364788918|FG001|Overall Study|Lost to Follow-up|4|||
105763882|NCT00633893|364788919|FG002|Overall Study|Lost to Follow-up|8|||
105955477|NCT01299389|365498296|FG003|Post-observational|Other|6|||
105955478|NCT04245709|365498297|FG000|Overall Study|Adverse Event|13|||
105955479|NCT04245709|365498297|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
105763883|NCT00633893|364788917|FG000|Overall Study|Poor/non-compliance|5|||
105955480|NCT01434654|365498298|FG000|Overall Study|Withdrawal by Subject|1|||
105955481|NCT01434654|365498299|FG001|Overall Study|Withdrawal by Subject|0|||
105955482|NCT01434654|365498298|FG000|Overall Study|Lost to Follow-up|1|||
105955483|NCT01434654|365498299|FG001|Overall Study|Lost to Follow-up|0|||
105763884|NCT00633893|364788918|FG001|Overall Study|Poor/non-compliance|12|||
105763885|NCT00633893|364788919|FG002|Overall Study|Poor/non-compliance|3|||
105763886|NCT00633893|364788917|FG000|Overall Study|Pregnancy|2|||
105763887|NCT00633893|364788918|FG001|Overall Study|Pregnancy|1|||
105763888|NCT00633893|364788919|FG002|Overall Study|Pregnancy|1|||
105814627|NCT00925769|364980762|FG000|Overall Study|End of study visit not done|0|||
105814628|NCT00925769|364980763|FG001|Overall Study|End of study visit not done|0|||
105814629|NCT00925769|364980764|FG002|Overall Study|End of study visit not done|1|||
105814630|NCT00925769|364980765|FG003|Overall Study|End of study visit not done|0|||
105814631|NCT00925769|364980766|FG004|Overall Study|End of study visit not done|0|||
105955484|NCT00889707|365498300|FG000|Overall Study|Adverse Event|1|||
105814632|NCT00925769|364980767|FG005|Overall Study|End of study visit not done|0|||
105814633|NCT00925769|364980762|FG000|Overall Study|Participant is unable to swallow drug|0|||
105814634|NCT00925769|364980763|FG001|Overall Study|Participant is unable to swallow drug|0|||
105814635|NCT00925769|364980764|FG002|Overall Study|Participant is unable to swallow drug|0|||
105814636|NCT00925769|364980765|FG003|Overall Study|Participant is unable to swallow drug|1|||
105814637|NCT00925769|364980766|FG004|Overall Study|Participant is unable to swallow drug|0|||
105814638|NCT00925769|364980767|FG005|Overall Study|Participant is unable to swallow drug|0|||
105814639|NCT00925769|364980762|FG000|Overall Study|Adverse Event|0|||
105814640|NCT00925769|364980763|FG001|Overall Study|Adverse Event|0|||
105814641|NCT00925769|364980764|FG002|Overall Study|Adverse Event|0|||
105814642|NCT00925769|364980765|FG003|Overall Study|Adverse Event|0|||
105814643|NCT00925769|364980766|FG004|Overall Study|Adverse Event|1|||
105814644|NCT00925769|364980767|FG005|Overall Study|Adverse Event|0|||
105814645|NCT02017964|364980768|FG000|Overall Study|Patient deemed ineligible|1|||
105814646|NCT02732210|364980769|FG000|Overall Study|Site Closed|0|||
105814647|NCT02732210|364980770|FG001|Overall Study|Site Closed|11|||
105814648|NCT02732210|364980769|FG000|Overall Study|Study Ended|13|||
105814649|NCT02732210|364980770|FG001|Overall Study|Study Ended|13|||
105814650|NCT02732210|364980769|FG000|Overall Study|Withdrawal by Subject|28|||
105814651|NCT02732210|364980770|FG001|Overall Study|Withdrawal by Subject|87|||
105814652|NCT02732210|364980769|FG000|Overall Study|Lost to Follow-up|5|||
105814653|NCT02732210|364980770|FG001|Overall Study|Lost to Follow-up|57|||
105814654|NCT02732210|364980769|FG000|Overall Study|Death|4|||
105814655|NCT02732210|364980770|FG001|Overall Study|Death|15|||
105814656|NCT02732210|364980769|FG000|Overall Study|Other|35|||
105814657|NCT02732210|364980770|FG001|Overall Study|Other|103|||
105814658|NCT02732210|364980769|FG000|Overall Study|Missing|0|||
105814659|NCT02732210|364980770|FG001|Overall Study|Missing|8|||
105814660|NCT00686959|364980774|FG000|Overall Study|Participants censored (no death events)|124|||
105814661|NCT00686959|364980775|FG001|Overall Study|Participants censored (no death events)|117|||
105814662|NCT01038856|364980776|FG000|Overall Study|Adverse Event|2|||
105814663|NCT04638153|364980780|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105814664|NCT04638153|364980781|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105814665|NCT04638153|364980782|FG002|Overall Study|Withdrawal by parent/guardian|1|||
105814666|NCT04638153|364980780|FG000|Overall Study|Study terminated by sponsor|4|||
105814667|NCT04638153|364980781|FG001|Overall Study|Study terminated by sponsor|2|||
105814668|NCT04638153|364980782|FG002|Overall Study|Study terminated by sponsor|14|||
105814669|NCT01434693|364980785|FG000|Overall Study|Adverse Event|1|||
105814670|NCT01434693|364980786|FG001|Overall Study|Adverse Event|0|||
105814671|NCT01434693|364980787|FG002|Overall Study|Adverse Event|0|||
105814672|NCT01434693|364980788|FG003|Overall Study|Adverse Event|0|||
105814673|NCT01434693|364980785|FG000|Overall Study|Withdrawal by Subject|1|||
105814674|NCT01434693|364980786|FG001|Overall Study|Withdrawal by Subject|0|||
105814675|NCT01434693|364980787|FG002|Overall Study|Withdrawal by Subject|1|||
105814676|NCT01434693|364980788|FG003|Overall Study|Withdrawal by Subject|1|||
105814677|NCT01434693|364980785|FG000|Overall Study|Lost to Follow-up|1|||
105814678|NCT01434693|364980786|FG001|Overall Study|Lost to Follow-up|0|||
105814679|NCT01434693|364980787|FG002|Overall Study|Lost to Follow-up|0|||
105814680|NCT01434693|364980788|FG003|Overall Study|Lost to Follow-up|0|||
105814681|NCT03912337|364980792|FG000|Overall Study|Withdrawal of Consent From Study|1|||
105814682|NCT03912337|364980793|FG001|Overall Study|Withdrawal of Consent From Study|0|||
105814683|NCT03912337|364980792|FG000|Overall Study|Lost to Follow-up|1|||
105814684|NCT03912337|364980793|FG001|Overall Study|Lost to Follow-up|1|||
105955485|NCT00889707|365498301|FG001|Overall Study|Adverse Event|0|||
105955486|NCT00889707|365498300|FG000|Overall Study|Withdrawal by Subject|4|||
105814685|NCT00537030|364980794|FG000|Overall Study|Physician Decision|2|||
105814686|NCT00537030|364980794|FG000|Overall Study|Withdrawal by Subject|2|||
105814687|NCT00537030|364980794|FG000|Overall Study|≥ Grade 2 allergy|7|||
105814688|NCT00537030|364980794|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
105814689|NCT00537030|364980794|FG000|Overall Study|Ineligible|2|||
105814690|NCT00537030|364980794|FG000|Overall Study|Inevaluable|2|||
105955487|NCT00889707|365498301|FG001|Overall Study|Withdrawal by Subject|3|||
105814691|NCT02458469|364980795|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105814692|NCT02458469|364980796|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105814693|NCT02458469|364980797|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
105814694|NCT02458469|364980798|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105814695|NCT02458469|364980799|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105955488|NCT00889707|365498300|FG000|Overall Study|Lost to Follow-up|0|||
105955489|NCT00889707|365498301|FG001|Overall Study|Lost to Follow-up|2|||
106018095|NCT01134055|365729252|FG006|Overall Study|Physician Decision|1|||
106018096|NCT02577718|365729253|FG000|Overall Study|Death|6|||
106018097|NCT02577718|365729253|FG000|Overall Study|Withdrawal by Subject|2|||
106018098|NCT01967576|365729254|FG000|Overall Study|Withdrawal by Subject|3|||
106018099|NCT01967576|365729254|FG000|Overall Study|Progressed/Removed from treatment|1|||
106018100|NCT01967576|365729254|FG000|Overall Study|Study closing at site|1|||
106018101|NCT01967576|365729254|FG000|Overall Study|Adverse Event|1|||
105763889|NCT00633893|364788917|FG000|Overall Study|Not meet/no longer meets criteria|4|||
105763890|NCT00633893|364788918|FG001|Overall Study|Not meet/no longer meets criteria|6|||
105763891|NCT00633893|364788919|FG002|Overall Study|Not meet/no longer meets criteria|4|||
105763892|NCT00633893|364788917|FG000|Overall Study|Other|28|||
105763893|NCT00633893|364788918|FG001|Overall Study|Other|33|||
105763894|NCT00633893|364788919|FG002|Overall Study|Other|31|||
105763895|NCT01675141|364788920|FG000|Overall Study|Lenalidomide outside NIH|3|||
105763896|NCT01675141|364788920|FG000|Overall Study|Withdrawal by Subject|3|||
105763897|NCT01675141|364788920|FG000|Overall Study|Physician Decision|4|||
105763898|NCT01675141|364788920|FG000|Overall Study|No treatment, per protocol|1|||
105763899|NCT01838213|364788923|FG000|Overall Study|Ineligible|166|||
105763900|NCT01838213|364788924|FG001|Overall Study|Ineligible|191|||
105763901|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
105763902|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
105763903|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
105763904|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
105763905|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
105763906|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
105763907|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
105763908|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
105763909|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
105763910|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
105763911|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
105763912|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
105763913|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
105763914|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
105763915|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
105763916|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
105763917|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
105763918|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
105763919|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
105763920|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
105763921|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
105763922|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
105763923|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
105763924|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
105763925|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
105763926|NCT02918318|364788925|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
105763927|NCT02918318|364788926|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
105763928|NCT02918318|364788927|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
105763929|NCT02918318|364788928|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
105763930|NCT02918318|364788929|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
105955490|NCT00889707|365498300|FG000|Overall Study|Lack of Efficacy|2|||
105955491|NCT00889707|365498301|FG001|Overall Study|Lack of Efficacy|5|||
105955492|NCT02948582|365498302|FG000|Washout Period 1|Adverse Event|0|||
105955493|NCT02948582|365498303|FG001|Washout Period 1|Adverse Event|2|||
105955494|NCT02948582|365498304|FG002|Washout Period 1|Adverse Event|0|||
105955495|NCT02948582|365498305|FG003|Washout Period 1|Adverse Event|0|||
105955496|NCT02948582|365498306|FG004|Washout Period 1|Adverse Event|0|||
105955497|NCT02948582|365498307|FG005|Washout Period 1|Adverse Event|0|||
105955498|NCT02948582|365498302|FG000|Washout Period 1|Protocol Violation|0|||
105955499|NCT02948582|365498303|FG001|Washout Period 1|Protocol Violation|0|||
105955500|NCT02948582|365498304|FG002|Washout Period 1|Protocol Violation|0|||
105955501|NCT02948582|365498305|FG003|Washout Period 1|Protocol Violation|0|||
106018102|NCT01967576|365729254|FG000|Overall Study|Refused further treatment|1|||
106018103|NCT01605799|365729261|FG000|Overall Study|Withdrawal by Subject|2|||
105763931|NCT02918318|364788925|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
105763932|NCT02918318|364788926|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
105763933|NCT02918318|364788927|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
105955502|NCT02948582|365498306|FG004|Washout Period 1|Protocol Violation|0|||
105955503|NCT02948582|365498307|FG005|Washout Period 1|Protocol Violation|1|||
105955504|NCT02948582|365498302|FG000|Washout Period 2|Adverse Event|0|||
105955505|NCT02948582|365498303|FG001|Washout Period 2|Adverse Event|1|||
106018104|NCT01605799|365729262|FG001|Overall Study|Withdrawal by Subject|1|||
105955506|NCT02948582|365498304|FG002|Washout Period 2|Adverse Event|0|||
105955507|NCT02948582|365498305|FG003|Washout Period 2|Adverse Event|0|||
105955508|NCT02948582|365498306|FG004|Washout Period 2|Adverse Event|0|||
105955509|NCT02948582|365498307|FG005|Washout Period 2|Adverse Event|0|||
105955510|NCT02948582|365498302|FG000|Washout Period 2|personal reasons|0|||
105955511|NCT02948582|365498303|FG001|Washout Period 2|personal reasons|0|||
105955512|NCT02948582|365498304|FG002|Washout Period 2|personal reasons|0|||
105955513|NCT02948582|365498305|FG003|Washout Period 2|personal reasons|1|||
105955514|NCT02948582|365498306|FG004|Washout Period 2|personal reasons|0|||
105955515|NCT02948582|365498307|FG005|Washout Period 2|personal reasons|0|||
105955516|NCT02948582|365498302|FG000|Washout Period 4|Adverse Event|1|||
105955517|NCT02948582|365498303|FG001|Washout Period 4|Adverse Event|0|||
105955518|NCT02948582|365498304|FG002|Washout Period 4|Adverse Event|1|||
105955519|NCT02948582|365498305|FG003|Washout Period 4|Adverse Event|0|||
105955520|NCT02948582|365498306|FG004|Washout Period 4|Adverse Event|0|||
105955521|NCT02948582|365498307|FG005|Washout Period 4|Adverse Event|0|||
105955522|NCT01151020|365498311|FG000|Overall Study|Death|25|||
105955523|NCT01151020|365498311|FG000|Overall Study|Conversion to open repair|1|||
105955524|NCT01151020|365498311|FG000|Overall Study|Lost to Follow-up|4|||
105955525|NCT01151020|365498311|FG000|Overall Study|Withdrawal by Subject|22|||
105763934|NCT02918318|364788928|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
105763935|NCT02918318|364788929|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
105763936|NCT02918318|364788925|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
105763937|NCT02918318|364788926|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763938|NCT02918318|364788927|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
105763939|NCT02918318|364788928|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
105763940|NCT02918318|364788929|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763941|NCT02918318|364788925|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
105763942|NCT02918318|364788926|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
105763943|NCT02918318|364788927|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
105763944|NCT02918318|364788928|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
105763945|NCT02918318|364788929|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
105763946|NCT02918318|364788925|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
105763947|NCT02918318|364788926|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
105763948|NCT02918318|364788927|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
105763949|NCT02918318|364788928|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
105763950|NCT02918318|364788929|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
105763951|NCT02918318|364788925|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
105763952|NCT02918318|364788926|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
105763953|NCT02918318|364788927|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
105763954|NCT02918318|364788928|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
105763955|NCT02918318|364788929|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
105763956|NCT02918318|364788925|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763957|NCT02918318|364788926|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763958|NCT02918318|364788927|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763959|NCT02918318|364788928|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
105763960|NCT02918318|364788929|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
105763961|NCT04685538|364788930|FG000|Overall Study|Adverse Event|0|||
105763962|NCT04685538|364788931|FG001|Overall Study|Adverse Event|1|||
105763963|NCT04685538|364788930|FG000|Overall Study|Lost to Follow-up|0|||
105763964|NCT04685538|364788931|FG001|Overall Study|Lost to Follow-up|2|||
105763965|NCT00770224|364788936|FG000|Step 1: Induction|Adverse Event|3|||
105763966|NCT00770224|364788937|FG001|Step 1: Induction|Adverse Event|0|||
105763967|NCT00770224|364788936|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
105763968|NCT00770224|364788937|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
105763969|NCT00770224|364788936|FG000|Step 1: Induction|Other reason not protocol specified|2|||
105763970|NCT00770224|364788937|FG001|Step 1: Induction|Other reason not protocol specified|0|||
105763971|NCT00770224|364788936|FG000|Step 1: Induction|Ineligible|2|||
105763972|NCT00770224|364788937|FG001|Step 1: Induction|Ineligible|0|||
105763973|NCT00770224|364788936|FG000|Step 1: Induction|No protocol treatment given|1|||
105763974|NCT00770224|364788937|FG001|Step 1: Induction|No protocol treatment given|0|||
105763975|NCT00770224|364788936|FG000|Step 2: Maintenance|Adverse Event|0|||
105955526|NCT01151020|365498311|FG000|Overall Study|Patients did not receive the device|2|||
105955527|NCT02041299|365498312|FG000|Overall Study|Adverse Event|9|||
105955528|NCT02041299|365498313|FG001|Overall Study|Adverse Event|3|||
105955529|NCT02041299|365498312|FG000|Overall Study|Lost to Follow-up|4|||
105955530|NCT02041299|365498313|FG001|Overall Study|Lost to Follow-up|1|||
105955531|NCT02041299|365498312|FG000|Overall Study|Physician Decision|1|||
105955532|NCT02041299|365498313|FG001|Overall Study|Physician Decision|1|||
105763976|NCT00770224|364788937|FG001|Step 2: Maintenance|Adverse Event|10|||
105763977|NCT00770224|364788936|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
105763978|NCT00770224|364788937|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
106018105|NCT00392769|365729263|FG000|Overall Study|Clinical Deterioration|9|||
105814696|NCT02458469|364980800|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
105814697|NCT02458469|364980795|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
105814698|NCT02458469|364980796|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
105814699|NCT02458469|364980797|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
105814700|NCT02458469|364980798|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
105814701|NCT02458469|364980799|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
105814702|NCT02458469|364980800|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
105814703|NCT02458469|364980795|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814704|NCT02458469|364980796|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814705|NCT02458469|364980797|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814706|NCT02458469|364980798|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814707|NCT02458469|364980799|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
105814708|NCT02458469|364980800|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
105814709|NCT02849652|364980801|FG000|Overall Study|Lost to Follow-up|104|||
105814710|NCT02849652|364980802|FG001|Overall Study|Lost to Follow-up|35|||
105814711|NCT02849652|364980803|FG002|Overall Study|Lost to Follow-up|116|||
105814712|NCT02849652|364980804|FG003|Overall Study|Lost to Follow-up|22|||
105814713|NCT02849652|364980801|FG000|Overall Study|Withdrawal by Subject|10|||
105814714|NCT02849652|364980802|FG001|Overall Study|Withdrawal by Subject|2|||
105814715|NCT02849652|364980803|FG002|Overall Study|Withdrawal by Subject|8|||
105814716|NCT02849652|364980804|FG003|Overall Study|Withdrawal by Subject|4|||
105814717|NCT00472290|364980805|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
105814718|NCT00472290|364980805|FG000|Overall Study|Protocol Specified Criteria|7|||
105814719|NCT00472290|364980805|FG000|Overall Study|Administrative Decision|37|||
105814720|NCT00472290|364980805|FG000|Overall Study|Death|3|||
105814721|NCT00472290|364980805|FG000|Overall Study|Lost to Follow-up|1|||
105814722|NCT00472290|364980805|FG000|Overall Study|Lack of Efficacy|1|||
106018106|NCT00392769|365729263|FG000|Overall Study|Adverse Event|1|||
106018107|NCT00345358|365729264|FG000|Primary Vaccination Phase|Other|0|||
106018108|NCT00345358|365729265|FG001|Primary Vaccination Phase|Other|1|||
106018109|NCT00345358|365729266|FG002|Primary Vaccination Phase|Other|1|||
105955533|NCT02041299|365498312|FG000|Overall Study|Withdrawal by Subject|13|||
105955534|NCT02041299|365498313|FG001|Overall Study|Withdrawal by Subject|7|||
105955535|NCT02041299|365498312|FG000|Overall Study|Protocol Violation|11|||
105955536|NCT02041299|365498313|FG001|Overall Study|Protocol Violation|4|||
105955537|NCT02041299|365498312|FG000|Overall Study|Termination of the study|7|||
105955538|NCT02041299|365498313|FG001|Overall Study|Termination of the study|3|||
105955539|NCT02041299|365498312|FG000|Overall Study|Required bone marrow transplant|0|||
105955540|NCT02041299|365498313|FG001|Overall Study|Required bone marrow transplant|1|||
106018110|NCT00345358|365729267|FG003|Primary Vaccination Phase|Other|0|||
106018111|NCT00345358|365729264|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
106018112|NCT00345358|365729265|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
106018113|NCT00345358|365729266|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
106018114|NCT00345358|365729267|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
106018115|NCT00345358|365729264|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
106018116|NCT00345358|365729265|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
106018117|NCT00345358|365729266|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
106018118|NCT00345358|365729267|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
106018119|NCT00345358|365729264|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
106018120|NCT00345358|365729265|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
106018121|NCT00345358|365729266|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
106018122|NCT00345358|365729267|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
106018123|NCT00345358|365729264|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
105814723|NCT00472290|364980805|FG000|Overall Study|Disease Progression|4|||
105814724|NCT00472290|364980805|FG000|Overall Study|Withdrawal by Subject|5|||
105814725|NCT00472290|364980805|FG000|Overall Study|Adverse Event|6|||
105814726|NCT00472290|364980805|FG000|Overall Study|Requirement for alternative therapy|7|||
105814727|NCT00610363|364980812|FG000|Overall Study|Non-compliance with protocol|0|||
105814728|NCT00610363|364980813|FG001|Overall Study|Non-compliance with protocol|1|||
105814729|NCT00610363|364980812|FG000|Overall Study|Adverse Event|3|||
105814730|NCT00610363|364980813|FG001|Overall Study|Adverse Event|1|||
106018124|NCT00345358|365729265|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
106145251|NCT02486718|366191922|FG002|Randomized Phase|Lost to Follow-up|11|||
106145252|NCT02486718|366191920|FG000|Randomized Phase|Disease Relapse|0|||
105814731|NCT00610363|364980812|FG000|Overall Study|Lack of Efficacy|2|||
105814732|NCT00610363|364980813|FG001|Overall Study|Lack of Efficacy|0|||
105814733|NCT00610363|364980812|FG000|Overall Study|Lost to Follow-up|4|||
105814734|NCT00610363|364980813|FG001|Overall Study|Lost to Follow-up|0|||
105814735|NCT00610363|364980812|FG000|Overall Study|Withdrawal by Subject|1|||
105955541|NCT02041299|365498312|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
105814736|NCT00610363|364980813|FG001|Overall Study|Withdrawal by Subject|0|||
106018125|NCT00345358|365729266|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
106145253|NCT02486718|366191921|FG001|Randomized Phase|Disease Relapse|1|||
105814737|NCT00610363|364980812|FG000|Overall Study|Other than specified above|1|||
105814738|NCT00610363|364980813|FG001|Overall Study|Other than specified above|1|||
105814739|NCT00870870|364980816|FG000|Overall Study|Withdrawal by Subject|0|||
105814740|NCT00870870|364980817|FG001|Overall Study|Withdrawal by Subject|1|||
105814741|NCT00870870|364980818|FG002|Overall Study|Withdrawal by Subject|1|||
105814742|NCT00870870|364980819|FG003|Overall Study|Withdrawal by Subject|3|||
105814743|NCT00870870|364980816|FG000|Overall Study|Adverse Event|0|||
105814744|NCT00870870|364980817|FG001|Overall Study|Adverse Event|0|||
105814745|NCT00870870|364980818|FG002|Overall Study|Adverse Event|2|||
105814746|NCT00870870|364980819|FG003|Overall Study|Adverse Event|2|||
105814747|NCT00319735|364980826|FG000|Overall Study|Death|2|||
105814748|NCT00119379|364980827|FG000|Overall Study|Adverse Event|4|||
105814749|NCT00119379|364980828|FG001|Overall Study|Adverse Event|1|||
105814750|NCT00444145|364981872|FG000|Overall Study|Withdrawal by Subject|2|||
105814751|NCT00444145|364981872|FG000|Overall Study|Lost to Follow-up|1|||
105814752|NCT00444145|364981872|FG000|Overall Study|non-compliant|11|||
105814753|NCT00444145|364981872|FG000|Overall Study|Screen Failures|5|||
105814754|NCT01374919|364981873|FG000|Overall Study|Withdrawal by Subject|2|||
105814755|NCT03805438|364981874|FG000|Overall Study|Lack of Efficacy|1|||
105814756|NCT03805438|364981874|FG000|Overall Study|Protocol Violation|1|||
105814757|NCT00366899|364981875|FG000|Infant Series|Withdrawal by Subject|4|||
105814758|NCT00366899|364981876|FG001|Infant Series|Withdrawal by Subject|7|||
105814759|NCT00366899|364981875|FG000|Infant Series|Protocol Violation|2|||
105814760|NCT00366899|364981876|FG001|Infant Series|Protocol Violation|1|||
105814761|NCT00366899|364981875|FG000|Infant Series|Failed to return|1|||
105814762|NCT00366899|364981876|FG001|Infant Series|Failed to return|1|||
105814763|NCT00366899|364981875|FG000|Infant Series|Lost to Follow-up|0|||
105814764|NCT00366899|364981876|FG001|Infant Series|Lost to Follow-up|2|||
105814765|NCT00366899|364981875|FG000|Infant Series|Adverse Event|0|||
105814766|NCT00366899|364981876|FG001|Infant Series|Adverse Event|1|||
105814767|NCT00366899|364981875|FG000|Infant Series|Physician Decision|1|||
105814768|NCT00366899|364981876|FG001|Infant Series|Physician Decision|0|||
105814769|NCT00366899|364981875|FG000|Infant Series|Randomized but not consented|1|||
105814770|NCT00366899|364981876|FG001|Infant Series|Randomized but not consented|0|||
105814771|NCT00366899|364981875|FG000|After Infant Series|Lost to Follow-up|4|||
105814772|NCT00366899|364981876|FG001|After Infant Series|Lost to Follow-up|3|||
105814773|NCT00366899|364981875|FG000|After Infant Series|Withdrawal by Subject|1|||
105814774|NCT00366899|364981876|FG001|After Infant Series|Withdrawal by Subject|4|||
105814775|NCT00366899|364981875|FG000|After Infant Series|Adverse Event|1|||
105814776|NCT00366899|364981876|FG001|After Infant Series|Adverse Event|2|||
105814777|NCT00366899|364981875|FG000|After Infant Series|Protocol Violation|1|||
105814778|NCT00366899|364981876|FG001|After Infant Series|Protocol Violation|0|||
105814779|NCT00366899|364981875|FG000|Toddler Dose|Withdrawal by Subject|1|||
105814780|NCT00366899|364981876|FG001|Toddler Dose|Withdrawal by Subject|1|||
105814781|NCT00366899|364981875|FG000|Toddler Dose|Protocol Violation|1|||
105814782|NCT00366899|364981876|FG001|Toddler Dose|Protocol Violation|0|||
105814783|NCT00419770|364981878|FG000|Overall Study|Withdrawal by Subject|5|||
105814784|NCT00419770|364981879|FG001|Overall Study|Withdrawal by Subject|1|||
105814785|NCT02848326|364981881|FG000|Treatment Period|Adverse Event|5|||
105814786|NCT02848326|364981882|FG001|Treatment Period|Adverse Event|4|||
105814787|NCT02848326|364981883|FG002|Treatment Period|Adverse Event|11|||
105814788|NCT02848326|364981884|FG003|Treatment Period|Adverse Event|6|||
105814789|NCT02848326|364981885|FG004|Treatment Period|Adverse Event|5|||
105814790|NCT02848326|364981886|FG005|Treatment Period|Adverse Event|7|||
105955542|NCT02041299|365498313|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
105955543|NCT02389465|365498314|FG000|Overall Study|Lost to Follow-up|1|||
105814791|NCT02848326|364981881|FG000|Treatment Period|Withdrawal of Consent|20|||
105955544|NCT02389465|365498315|FG001|Overall Study|Lost to Follow-up|3|||
105955545|NCT02389465|365498316|FG002|Overall Study|Lost to Follow-up|3|||
105955546|NCT02389465|365498317|FG003|Overall Study|Lost to Follow-up|0|||
105955547|NCT02389465|365498314|FG000|Overall Study|Physician Decision|0|||
105955548|NCT02389465|365498315|FG001|Overall Study|Physician Decision|0|||
105955549|NCT02389465|365498316|FG002|Overall Study|Physician Decision|0|||
106145254|NCT02486718|366191922|FG002|Randomized Phase|Disease Relapse|0|||
106145255|NCT02486718|366191920|FG000|Randomized Phase|Death|0|||
106145256|NCT02486718|366191921|FG001|Randomized Phase|Death|154|||
105814792|NCT02848326|364981882|FG001|Treatment Period|Withdrawal of Consent|6|||
105814793|NCT02848326|364981883|FG002|Treatment Period|Withdrawal of Consent|9|||
105814794|NCT02848326|364981884|FG003|Treatment Period|Withdrawal of Consent|6|||
105814795|NCT02848326|364981885|FG004|Treatment Period|Withdrawal of Consent|9|||
105814796|NCT02848326|364981886|FG005|Treatment Period|Withdrawal of Consent|6|||
105814797|NCT02848326|364981881|FG000|Treatment Period|Lost to Follow-up|5|||
105814798|NCT02848326|364981882|FG001|Treatment Period|Lost to Follow-up|1|||
105814799|NCT02848326|364981883|FG002|Treatment Period|Lost to Follow-up|11|||
105814800|NCT02848326|364981884|FG003|Treatment Period|Lost to Follow-up|7|||
105814801|NCT02848326|364981885|FG004|Treatment Period|Lost to Follow-up|2|||
105814802|NCT02848326|364981886|FG005|Treatment Period|Lost to Follow-up|3|||
105814803|NCT02848326|364981881|FG000|Treatment Period|Pregnancy|0|||
105955550|NCT02389465|365498317|FG003|Overall Study|Physician Decision|1|||
105955551|NCT02389465|365498314|FG000|Overall Study|Withdrawal by Subject|0|||
105955552|NCT02389465|365498315|FG001|Overall Study|Withdrawal by Subject|1|||
105955553|NCT02389465|365498316|FG002|Overall Study|Withdrawal by Subject|2|||
105955554|NCT02389465|365498317|FG003|Overall Study|Withdrawal by Subject|2|||
105955555|NCT01635998|365498318|FG000|Overall Study|Death|1|||
105955556|NCT01635998|365498319|FG001|Overall Study|Death|1|||
105955557|NCT01635998|365498318|FG000|Overall Study|Lost to Follow-up|2|||
105955558|NCT01635998|365498319|FG001|Overall Study|Lost to Follow-up|1|||
105955559|NCT01635998|365498318|FG000|Overall Study|Withdrawal by Subject|1|||
105955560|NCT01635998|365498319|FG001|Overall Study|Withdrawal by Subject|5|||
105955561|NCT03072043|365498326|FG000|Overall Study|Death|0|||
105955562|NCT03072043|365498327|FG001|Overall Study|Death|0|||
105955563|NCT03072043|365498328|FG002|Overall Study|Death|3|||
105955564|NCT03072043|365498326|FG000|Overall Study|Adverse Event|0|||
105955565|NCT03072043|365498327|FG001|Overall Study|Adverse Event|0|||
105955566|NCT03072043|365498328|FG002|Overall Study|Adverse Event|2|||
105955567|NCT03072043|365498326|FG000|Overall Study|Withdrawal by Subject|0|||
105955568|NCT03072043|365498327|FG001|Overall Study|Withdrawal by Subject|0|||
105955569|NCT03072043|365498328|FG002|Overall Study|Withdrawal by Subject|4|||
105955570|NCT01637584|365498331|FG000|Overall Study|Withdrawal by Subject|1|||
105955571|NCT01637584|365498332|FG001|Overall Study|Withdrawal by Subject|3|||
105955572|NCT02534883|365498337|FG000|Overall Study|Early Termination|8|||
105955573|NCT02534883|365498338|FG001|Overall Study|Early Termination|3|||
105955574|NCT00414076|365498339|FG000|Overall Study|Progression|1|||
105955575|NCT00414076|365498340|FG001|Overall Study|Progression|2|||
105955576|NCT00414076|365498339|FG000|Overall Study|Withdrawal by Subject|1|||
105955577|NCT00414076|365498340|FG001|Overall Study|Withdrawal by Subject|3|||
105955578|NCT00414076|365498339|FG000|Overall Study|Adverse Event|1|||
105955579|NCT00414076|365498340|FG001|Overall Study|Adverse Event|0|||
105955580|NCT00049257|365498343|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
105955581|NCT00049257|365498343|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
105955582|NCT00049257|365498343|FG000|Carboplatin, Paclitaxel|Death|2|||
105955583|NCT00049257|365498343|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
105955584|NCT00132301|365498344|FG000|Overall Study|Death|7|||
105955585|NCT00132301|365498345|FG001|Overall Study|Death|6|||
105955586|NCT00132301|365498344|FG000|Overall Study|Withdrawal by Subject|5|||
105955587|NCT00132301|365498345|FG001|Overall Study|Withdrawal by Subject|2|||
105955588|NCT00132301|365498344|FG000|Overall Study|Physician Decision|1|||
105955589|NCT00132301|365498345|FG001|Overall Study|Physician Decision|1|||
105955590|NCT00132301|365498344|FG000|Overall Study|Lost to Follow-up|5|||
105955591|NCT00132301|365498345|FG001|Overall Study|Lost to Follow-up|3|||
105955592|NCT00132301|365498344|FG000|Overall Study|Other|1|||
105955593|NCT00132301|365498345|FG001|Overall Study|Other|1|||
105955594|NCT00132301|365498344|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
105955595|NCT00132301|365498345|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
105955596|NCT00200967|365498350|FG000|First Treatment Period|Withdrawal by Subject|5|||
105955597|NCT00200967|365498351|FG001|First Treatment Period|Withdrawal by Subject|1|||
105955598|NCT00200967|365498350|FG000|First Treatment Period|Pregnancy|1|||
105955599|NCT00200967|365498351|FG001|First Treatment Period|Pregnancy|0|||
105955600|NCT00200967|365498350|FG000|Wash-out Period|Lost to Follow-up|0|||
105955601|NCT00200967|365498351|FG001|Wash-out Period|Lost to Follow-up|1|||
105955602|NCT00200967|365498350|FG000|Second Treatment Period|Withdrawal by Subject|1|||
105955603|NCT00200967|365498351|FG001|Second Treatment Period|Withdrawal by Subject|2|||
105955604|NCT00200967|365498350|FG000|Run-out Period|Lost to Follow-up|1|||
105955605|NCT00200967|365498351|FG001|Run-out Period|Lost to Follow-up|0|||
105955606|NCT00810277|365499653|FG000|Overall Study|Adverse Event|1|||
105955607|NCT00784368|365499660|FG000|Overall Study|Physician Decision|0|||
105955608|NCT00784368|365499661|FG001|Overall Study|Physician Decision|0|||
105955609|NCT00784368|365499662|FG002|Overall Study|Physician Decision|6|||
105955610|NCT00784368|365499660|FG000|Overall Study|Lack of Efficacy|2|||
105955611|NCT00784368|365499661|FG001|Overall Study|Lack of Efficacy|0|||
105955612|NCT00784368|365499662|FG002|Overall Study|Lack of Efficacy|1|||
105955613|NCT00784368|365499660|FG000|Overall Study|Adverse Event|6|||
106018126|NCT00345358|365729267|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
106018127|NCT00345358|365729264|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
106018128|NCT00345358|365729265|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
106018129|NCT00345358|365729266|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
106018130|NCT00345358|365729267|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
105955614|NCT00784368|365499661|FG001|Overall Study|Adverse Event|9|||
105955615|NCT00784368|365499662|FG002|Overall Study|Adverse Event|2|||
105955616|NCT00784368|365499660|FG000|Overall Study|Diagnosis of fever|0|||
105955617|NCT00784368|365499661|FG001|Overall Study|Diagnosis of fever|0|||
105955618|NCT00784368|365499662|FG002|Overall Study|Diagnosis of fever|1|||
105955619|NCT00784368|365499660|FG000|Overall Study|Worsening of complications|0|||
105955620|NCT00784368|365499661|FG001|Overall Study|Worsening of complications|0|||
105955621|NCT00784368|365499662|FG002|Overall Study|Worsening of complications|1|||
105955622|NCT00784368|365499660|FG000|Overall Study|Worsening of symptoms|0|||
106145257|NCT02486718|366191922|FG002|Randomized Phase|Death|155|||
105814804|NCT02848326|364981882|FG001|Treatment Period|Pregnancy|0|||
105814805|NCT02848326|364981883|FG002|Treatment Period|Pregnancy|1|||
105814806|NCT02848326|364981884|FG003|Treatment Period|Pregnancy|1|||
105814807|NCT02848326|364981885|FG004|Treatment Period|Pregnancy|0|||
105814808|NCT02848326|364981886|FG005|Treatment Period|Pregnancy|1|||
105814809|NCT02848326|364981881|FG000|Treatment Period|Protocol Violation|4|||
105814810|NCT02848326|364981882|FG001|Treatment Period|Protocol Violation|3|||
105814811|NCT02848326|364981883|FG002|Treatment Period|Protocol Violation|4|||
105814812|NCT02848326|364981884|FG003|Treatment Period|Protocol Violation|2|||
105814813|NCT02848326|364981885|FG004|Treatment Period|Protocol Violation|3|||
105814814|NCT02848326|364981886|FG005|Treatment Period|Protocol Violation|3|||
105814815|NCT02848326|364981881|FG000|Treatment Period|Non-compliance with Study Drug|4|||
105814816|NCT02848326|364981882|FG001|Treatment Period|Non-compliance with Study Drug|0|||
105814817|NCT02848326|364981883|FG002|Treatment Period|Non-compliance with Study Drug|0|||
105814818|NCT02848326|364981884|FG003|Treatment Period|Non-compliance with Study Drug|1|||
105814819|NCT02848326|364981885|FG004|Treatment Period|Non-compliance with Study Drug|0|||
105814820|NCT02848326|364981886|FG005|Treatment Period|Non-compliance with Study Drug|0|||
105814821|NCT02848326|364981881|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
105814822|NCT02848326|364981882|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
105814823|NCT02848326|364981883|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
105814824|NCT02848326|364981884|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
105814825|NCT02848326|364981885|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
105814826|NCT02848326|364981886|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
105814827|NCT02848326|364981881|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
105814828|NCT02848326|364981882|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
105814829|NCT02848326|364981883|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
105814830|NCT02848326|364981884|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
105814831|NCT02848326|364981885|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
105814832|NCT02848326|364981886|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
105814833|NCT00414466|364981887|FG000|Overall Study|Adverse Event|0|||
105814834|NCT00414466|364981888|FG001|Overall Study|Adverse Event|0|||
105814835|NCT00414466|364981889|FG002|Overall Study|Adverse Event|1|||
105814836|NCT00414466|364981890|FG003|Overall Study|Adverse Event|1|||
105814837|NCT00414466|364981887|FG000|Overall Study|Lack of Efficacy|1|||
105814838|NCT00414466|364981888|FG001|Overall Study|Lack of Efficacy|0|||
105814839|NCT00414466|364981889|FG002|Overall Study|Lack of Efficacy|0|||
105814840|NCT00414466|364981890|FG003|Overall Study|Lack of Efficacy|0|||
105814841|NCT00414466|364981887|FG000|Overall Study|Withdrawn by Sponsor|1|||
105814842|NCT00414466|364981888|FG001|Overall Study|Withdrawn by Sponsor|0|||
105814843|NCT00414466|364981889|FG002|Overall Study|Withdrawn by Sponsor|0|||
105814844|NCT00414466|364981890|FG003|Overall Study|Withdrawn by Sponsor|0|||
105814845|NCT04526210|364981896|FG000|Overall Study|Sponsor decision|7|||
105814846|NCT04526210|364981897|FG001|Overall Study|Sponsor decision|5|||
105814847|NCT04526210|364981896|FG000|Overall Study|Withdrawal by Subject|3|||
105814848|NCT04526210|364981897|FG001|Overall Study|Withdrawal by Subject|2|||
105814849|NCT01781637|364981898|FG000|Overall Study|Adverse Event|1|||
105814850|NCT01781637|364981899|FG001|Overall Study|Adverse Event|0|||
105814851|NCT01781637|364981898|FG000|Overall Study|Lack of Efficacy|2|||
105955623|NCT00784368|365499661|FG001|Overall Study|Worsening of symptoms|1|||
105955624|NCT00784368|365499662|FG002|Overall Study|Worsening of symptoms|0|||
105955625|NCT00784368|365499660|FG000|Overall Study|Withdrawal of informed consent|0|||
105955626|NCT00784368|365499661|FG001|Overall Study|Withdrawal of informed consent|1|||
105955627|NCT00784368|365499662|FG002|Overall Study|Withdrawal of informed consent|0|||
105955628|NCT00720356|365499665|FG000|Registration to Study|Determined to have methylated MGMT|67|||
105955629|NCT00720356|365499665|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
105955630|NCT00720356|365499665|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
105955631|NCT00720356|365499665|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
105955632|NCT00720356|365499665|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
105814852|NCT01781637|364981899|FG001|Overall Study|Lack of Efficacy|6|||
105814853|NCT01781637|364981898|FG000|Overall Study|Withdrawal by Subject|1|||
105814854|NCT01781637|364981899|FG001|Overall Study|Withdrawal by Subject|0|||
105814855|NCT02637232|364981900|FG000|Overall Study|Lost to Follow-up|42|||
105955633|NCT00720356|365499665|FG000|Follow up Until Death|Withdrawal by Subject|1|||
105955634|NCT00720356|365499665|FG000|Follow up Until Death|Alive at last data collection|4|||
105955635|NCT02237001|365499666|FG000|Overall Study|Lost to Follow-up|2|||
106145258|NCT02486718|366191920|FG000|Randomized Phase|Ongoing|0|||
105814856|NCT02637232|364981900|FG000|Overall Study|Adverse Event|11|||
105814857|NCT02637232|364981900|FG000|Overall Study|patient 's decision|2|||
105814858|NCT02999178|364981901|FG000|Overall Study|Adverse Event|85|||
105814859|NCT02999178|364981902|FG001|Overall Study|Adverse Event|62|||
105814860|NCT02999178|364981901|FG000|Overall Study|Protocol Violation|1|||
105814861|NCT02999178|364981902|FG001|Overall Study|Protocol Violation|2|||
105814862|NCT02999178|364981901|FG000|Overall Study|Lost to Follow-up|0|||
105814863|NCT02999178|364981902|FG001|Overall Study|Lost to Follow-up|2|||
105814864|NCT02999178|364981901|FG000|Overall Study|Withdrawal by Subject|21|||
105955636|NCT02237001|365499666|FG000|Overall Study|Withdrawal by Subject|1|||
105955637|NCT02237001|365499666|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
105955638|NCT02237001|365499666|FG000|Overall Study|Re-operation|4|||
105955639|NCT02237001|365499666|FG000|Overall Study|Incarceration|1|||
105955640|NCT03427814|365499667|FG000|Overall Study|Withdrawal by Subject|4|||
105955641|NCT03427814|365499668|FG001|Overall Study|Withdrawal by Subject|4|||
105955642|NCT03427814|365499667|FG000|Overall Study|Lost to Follow-up|0|||
105955643|NCT03427814|365499668|FG001|Overall Study|Lost to Follow-up|2|||
105955644|NCT03427814|365499667|FG000|Overall Study|Death|42|||
105955645|NCT03427814|365499668|FG001|Overall Study|Death|31|||
105955646|NCT03427814|365499667|FG000|Overall Study|Sponsor's Decision|1|||
105955647|NCT03427814|365499668|FG001|Overall Study|Sponsor's Decision|0|||
105955648|NCT03427814|365499667|FG000|Overall Study|Investigator's Decision|1|||
105955649|NCT03427814|365499668|FG001|Overall Study|Investigator's Decision|2|||
105955650|NCT03427814|365499667|FG000|Overall Study|Disease progression|1|||
105955651|NCT03427814|365499668|FG001|Overall Study|Disease progression|0|||
105955652|NCT03427814|365499667|FG000|Overall Study|Treatment Completed|0|||
105955653|NCT03427814|365499668|FG001|Overall Study|Treatment Completed|1|||
105955654|NCT03427814|365499667|FG000|Overall Study|Sponsor's Decision to End study|21|||
105955655|NCT03427814|365499668|FG001|Overall Study|Sponsor's Decision to End study|25|||
105814865|NCT02999178|364981902|FG001|Overall Study|Withdrawal by Subject|21|||
105814866|NCT02999178|364981901|FG000|Overall Study|Other reason not defined above|7|||
105814867|NCT02999178|364981902|FG001|Overall Study|Other reason not defined above|13|||
105814868|NCT00433147|364981904|FG000|Overall Study|Adverse Event|0|||
105814869|NCT00433147|364981905|FG001|Overall Study|Adverse Event|1|||
105814870|NCT00433147|364981906|FG002|Overall Study|Adverse Event|0|||
105814871|NCT00433147|364981907|FG003|Overall Study|Adverse Event|0|||
105814872|NCT02937701|364981908|FG000|Day 1 to Week 22|Adverse Event|11|||
105814873|NCT02937701|364981909|FG001|Day 1 to Week 22|Adverse Event|14|||
105814874|NCT02937701|364981910|FG002|Day 1 to Week 22|Adverse Event|0|||
105814875|NCT02937701|364981911|FG003|Day 1 to Week 22|Adverse Event|0|||
105814876|NCT02937701|364981912|FG004|Day 1 to Week 22|Adverse Event|0|||
105814877|NCT02937701|364981908|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
105814878|NCT02937701|364981909|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
105814879|NCT02937701|364981910|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
105814880|NCT02937701|364981911|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
105814881|NCT02937701|364981912|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
105814882|NCT02937701|364981908|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
105814883|NCT02937701|364981909|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
105814884|NCT02937701|364981910|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
105814885|NCT02937701|364981911|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
105814886|NCT02937701|364981912|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
105814887|NCT02937701|364981908|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
105814888|NCT02937701|364981909|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
105814889|NCT02937701|364981910|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
105814890|NCT02937701|364981911|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
105814891|NCT02937701|364981912|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
105814892|NCT02937701|364981908|FG000|Day 1 to Week 22|Death|1|||
105814893|NCT02937701|364981909|FG001|Day 1 to Week 22|Death|1|||
105814894|NCT02937701|364981910|FG002|Day 1 to Week 22|Death|0|||
105814895|NCT02937701|364981911|FG003|Day 1 to Week 22|Death|0|||
105814896|NCT02937701|364981912|FG004|Day 1 to Week 22|Death|0|||
105814897|NCT02937701|364981908|FG000|Day 1 to Week 22|Protocol Violation|1|||
105814898|NCT02937701|364981909|FG001|Day 1 to Week 22|Protocol Violation|1|||
105814899|NCT02937701|364981910|FG002|Day 1 to Week 22|Protocol Violation|0|||
105814900|NCT02937701|364981911|FG003|Day 1 to Week 22|Protocol Violation|0|||
105814901|NCT02937701|364981912|FG004|Day 1 to Week 22|Protocol Violation|0|||
105814902|NCT02937701|364981908|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
105955656|NCT03427814|365499667|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
105955657|NCT03427814|365499668|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
105955658|NCT01396187|365499671|FG000|Overall Study|Adverse Event|0|||
105955659|NCT01396187|365499672|FG001|Overall Study|Adverse Event|1|||
105955660|NCT01396187|365499673|FG002|Overall Study|Adverse Event|0|||
105814903|NCT02937701|364981909|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
105955661|NCT01396187|365499674|FG003|Overall Study|Adverse Event|0|||
105955662|NCT01396187|365499675|FG004|Overall Study|Adverse Event|0|||
105955663|NCT01396187|365499671|FG000|Overall Study|Withdrawal by Subject|0|||
105955664|NCT01396187|365499672|FG001|Overall Study|Withdrawal by Subject|1|||
105814904|NCT02937701|364981910|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
105955665|NCT01396187|365499673|FG002|Overall Study|Withdrawal by Subject|1|||
105955666|NCT01396187|365499674|FG003|Overall Study|Withdrawal by Subject|0|||
105955667|NCT01396187|365499675|FG004|Overall Study|Withdrawal by Subject|0|||
105814905|NCT02937701|364981911|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
105814906|NCT02937701|364981912|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
105814907|NCT02937701|364981908|FG000|Day 1 to Week 22|Physician Decision|2|||
105955668|NCT01396187|365499671|FG000|Overall Study|Other|1|||
105814908|NCT02937701|364981909|FG001|Day 1 to Week 22|Physician Decision|0|||
105814909|NCT02937701|364981910|FG002|Day 1 to Week 22|Physician Decision|0|||
105814910|NCT02937701|364981911|FG003|Day 1 to Week 22|Physician Decision|0|||
105814911|NCT02937701|364981912|FG004|Day 1 to Week 22|Physician Decision|0|||
105814912|NCT02937701|364981908|FG000|Day 1 to Week 22|Other|1|||
105814913|NCT02937701|364981909|FG001|Day 1 to Week 22|Other|0|||
105814914|NCT02937701|364981910|FG002|Day 1 to Week 22|Other|0|||
105814915|NCT02937701|364981911|FG003|Day 1 to Week 22|Other|0|||
105814916|NCT02937701|364981912|FG004|Day 1 to Week 22|Other|0|||
105814917|NCT02937701|364981908|FG000|Week 22 to Week 50|Adverse Event|0|||
105814918|NCT02937701|364981909|FG001|Week 22 to Week 50|Adverse Event|0|||
105814919|NCT02937701|364981910|FG002|Week 22 to Week 50|Adverse Event|10|||
105814920|NCT02937701|364981911|FG003|Week 22 to Week 50|Adverse Event|3|||
105814921|NCT02937701|364981912|FG004|Week 22 to Week 50|Adverse Event|3|||
105814922|NCT02937701|364981908|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
105814923|NCT02937701|364981909|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
105814924|NCT02937701|364981910|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
105814925|NCT02937701|364981911|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
105814926|NCT02937701|364981912|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
105814927|NCT02937701|364981908|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
105814928|NCT02937701|364981909|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
105814929|NCT02937701|364981910|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
105814930|NCT02937701|364981911|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
105814931|NCT02937701|364981912|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
105814932|NCT02937701|364981908|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
105814933|NCT02937701|364981909|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
105814934|NCT02937701|364981910|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
105814935|NCT02937701|364981911|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
105814936|NCT02937701|364981912|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
105814937|NCT02937701|364981908|FG000|Week 22 to Week 50|Physician Decision|0|||
105814938|NCT02937701|364981909|FG001|Week 22 to Week 50|Physician Decision|0|||
105814939|NCT02937701|364981910|FG002|Week 22 to Week 50|Physician Decision|2|||
105814940|NCT02937701|364981911|FG003|Week 22 to Week 50|Physician Decision|0|||
105814941|NCT02937701|364981912|FG004|Week 22 to Week 50|Physician Decision|1|||
105814942|NCT02937701|364981908|FG000|Week 22 to Week 50|Other|0|||
105814943|NCT02937701|364981909|FG001|Week 22 to Week 50|Other|0|||
105814944|NCT02937701|364981910|FG002|Week 22 to Week 50|Other|0|||
105814945|NCT02937701|364981911|FG003|Week 22 to Week 50|Other|0|||
105814946|NCT02937701|364981912|FG004|Week 22 to Week 50|Other|1|||
105814947|NCT01153984|364981915|FG000|Overall Study|Withdrawal by Subject|1|||
105814948|NCT01153984|364981915|FG000|Overall Study|Adverse Event|1|||
105814949|NCT00243932|364981916|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
105814950|NCT00243932|364981917|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
105814951|NCT00243932|364981918|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
105814952|NCT00727571|364981922|FG000|Overall Study|Ineligibility determined|1|||
106145259|NCT02486718|366191921|FG001|Randomized Phase|Ongoing|301|||
106145260|NCT02486718|366191922|FG002|Randomized Phase|Ongoing|282|||
106145261|NCT05516108|366191923|FG000|Overall Study|Time Commitment|3|||
106145262|NCT05516108|366191924|FG001|Overall Study|Time Commitment|1|||
106145263|NCT05516108|366191923|FG000|Overall Study|Reason Unknown|2|||
106145264|NCT05516108|366191924|FG001|Overall Study|Reason Unknown|4|||
105763979|NCT00770224|364788936|FG000|Step 2: Maintenance|Progression/relapse|0|||
105763980|NCT00770224|364788937|FG001|Step 2: Maintenance|Progression/relapse|1|||
105763981|NCT00770224|364788936|FG000|Step 2: Maintenance|Death|0|||
105763982|NCT00770224|364788937|FG001|Step 2: Maintenance|Death|2|||
105763983|NCT00770224|364788936|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
105763984|NCT00770224|364788937|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
105763985|NCT00770224|364788936|FG000|Step 2: Maintenance|Ineligible|0|||
105763986|NCT00770224|364788937|FG001|Step 2: Maintenance|Ineligible|2|||
105763987|NCT03371251|364788946|FG000|Overall Study|Withdrawal by Subject|1|||
105763988|NCT03371251|364788947|FG001|Overall Study|Withdrawal by Subject|0|||
105763989|NCT03371251|364788948|FG002|Overall Study|Withdrawal by Subject|1|||
105763990|NCT03371251|364788949|FG003|Overall Study|Withdrawal by Subject|0|||
105763991|NCT03371251|364788950|FG004|Overall Study|Withdrawal by Subject|2|||
105763992|NCT03371251|364788951|FG005|Overall Study|Withdrawal by Subject|2|||
105763993|NCT03371251|364788946|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
105763994|NCT03371251|364788947|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
105763995|NCT03371251|364788948|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
105763996|NCT03371251|364788949|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
105814953|NCT00727571|364981923|FG001|Overall Study|Ineligibility determined|1|||
105814954|NCT00727571|364981924|FG002|Overall Study|Ineligibility determined|1|||
105814955|NCT00727571|364981925|FG003|Overall Study|Ineligibility determined|0|||
106145265|NCT04177394|366191925|FG000|Overall Study|Death|16|||
105814956|NCT00727571|364981922|FG000|Overall Study|Death|0|||
105814957|NCT00727571|364981923|FG001|Overall Study|Death|19|||
106145266|NCT04177394|366191925|FG000|Overall Study|Withdrawal by Subject|19|||
105763997|NCT03371251|364788950|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
105763998|NCT03371251|364788951|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
105763999|NCT03371251|364788946|FG000|Overall Study|Adverse Event|0|||
105764000|NCT03371251|364788947|FG001|Overall Study|Adverse Event|0|||
105764001|NCT03371251|364788948|FG002|Overall Study|Adverse Event|0|||
105764002|NCT03371251|364788949|FG003|Overall Study|Adverse Event|0|||
105764003|NCT03371251|364788950|FG004|Overall Study|Adverse Event|1|||
105764004|NCT03371251|364788951|FG005|Overall Study|Adverse Event|0|||
105764005|NCT03371251|364788946|FG000|Overall Study|Decision by Sponsor|0|||
105764006|NCT03371251|364788947|FG001|Overall Study|Decision by Sponsor|0|||
105764007|NCT03371251|364788948|FG002|Overall Study|Decision by Sponsor|0|||
105764008|NCT03371251|364788949|FG003|Overall Study|Decision by Sponsor|0|||
105764009|NCT03371251|364788950|FG004|Overall Study|Decision by Sponsor|2|||
105764010|NCT03371251|364788951|FG005|Overall Study|Decision by Sponsor|0|||
105764011|NCT02017704|364788952|FG000|Overall Study|Withdrawal by Subject|2|||
105764012|NCT02017704|364788953|FG001|Overall Study|Withdrawal by Subject|0|||
105764013|NCT01641081|364788954|FG000|Period 1|Sponsor request (potential unblinding)|0|||
105764014|NCT01641081|364788955|FG001|Period 1|Sponsor request (potential unblinding)|0|||
105764015|NCT01641081|364788956|FG002|Period 1|Sponsor request (potential unblinding)|0|||
105764016|NCT01641081|364788957|FG003|Period 1|Sponsor request (potential unblinding)|0|||
105764017|NCT01641081|364788958|FG004|Period 1|Sponsor request (potential unblinding)|0|||
105764018|NCT01641081|364788959|FG005|Period 1|Sponsor request (potential unblinding)|0|||
105764019|NCT01641081|364788960|FG006|Period 1|Sponsor request (potential unblinding)|1|||
105764020|NCT01641081|364788961|FG007|Period 1|Sponsor request (potential unblinding)|0|||
105764021|NCT01641081|364788962|FG008|Period 1|Sponsor request (potential unblinding)|0|||
105764022|NCT01641081|364788963|FG009|Period 1|Sponsor request (potential unblinding)|0|||
105764023|NCT01641081|364788954|FG000|Period 1|Protocol Violation|0|||
105764024|NCT01641081|364788955|FG001|Period 1|Protocol Violation|0|||
105764025|NCT01641081|364788956|FG002|Period 1|Protocol Violation|0|||
105764026|NCT01641081|364788957|FG003|Period 1|Protocol Violation|0|||
105764027|NCT01641081|364788958|FG004|Period 1|Protocol Violation|1|||
105764028|NCT01641081|364788959|FG005|Period 1|Protocol Violation|0|||
105764029|NCT01641081|364788960|FG006|Period 1|Protocol Violation|0|||
105764030|NCT01641081|364788961|FG007|Period 1|Protocol Violation|1|||
105764031|NCT01641081|364788962|FG008|Period 1|Protocol Violation|0|||
105764032|NCT01641081|364788963|FG009|Period 1|Protocol Violation|0|||
105764033|NCT01641081|364788954|FG000|Period 1|Adverse Event|1|||
105764034|NCT01641081|364788955|FG001|Period 1|Adverse Event|0|||
105764035|NCT01641081|364788956|FG002|Period 1|Adverse Event|0|||
105764036|NCT01641081|364788957|FG003|Period 1|Adverse Event|0|||
105764037|NCT01641081|364788958|FG004|Period 1|Adverse Event|0|||
105764038|NCT01641081|364788959|FG005|Period 1|Adverse Event|0|||
105764039|NCT01641081|364788960|FG006|Period 1|Adverse Event|0|||
105764040|NCT01641081|364788961|FG007|Period 1|Adverse Event|2|||
105764041|NCT01641081|364788962|FG008|Period 1|Adverse Event|0|||
105764042|NCT01641081|364788963|FG009|Period 1|Adverse Event|0|||
105764043|NCT01641081|364788954|FG000|Period 2|Adverse Event|0|||
105764044|NCT01641081|364788955|FG001|Period 2|Adverse Event|0|||
105764045|NCT01641081|364788956|FG002|Period 2|Adverse Event|0|||
105764046|NCT01641081|364788957|FG003|Period 2|Adverse Event|0|||
105764047|NCT01641081|364788958|FG004|Period 2|Adverse Event|0|||
105764048|NCT01641081|364788959|FG005|Period 2|Adverse Event|1|||
105764049|NCT01641081|364788960|FG006|Period 2|Adverse Event|0|||
105764050|NCT01641081|364788961|FG007|Period 2|Adverse Event|0|||
105764051|NCT01641081|364788962|FG008|Period 2|Adverse Event|0|||
105764052|NCT01641081|364788963|FG009|Period 2|Adverse Event|0|||
105764053|NCT01641081|364788954|FG000|Period 2|Withdrawal by Subject|0|||
105764054|NCT01641081|364788955|FG001|Period 2|Withdrawal by Subject|0|||
105764055|NCT01641081|364788956|FG002|Period 2|Withdrawal by Subject|0|||
105764056|NCT01641081|364788957|FG003|Period 2|Withdrawal by Subject|1|||
105764057|NCT01641081|364788958|FG004|Period 2|Withdrawal by Subject|0|||
105764058|NCT01641081|364788959|FG005|Period 2|Withdrawal by Subject|0|||
105764059|NCT01641081|364788960|FG006|Period 2|Withdrawal by Subject|2|||
105764060|NCT01641081|364788961|FG007|Period 2|Withdrawal by Subject|0|||
105764061|NCT01641081|364788962|FG008|Period 2|Withdrawal by Subject|0|||
105764062|NCT01641081|364788963|FG009|Period 2|Withdrawal by Subject|0|||
105764063|NCT01641081|364788954|FG000|Period 2|Protocol Violation|1|||
105764064|NCT01641081|364788955|FG001|Period 2|Protocol Violation|0|||
105764065|NCT01641081|364788956|FG002|Period 2|Protocol Violation|0|||
105764066|NCT01641081|364788957|FG003|Period 2|Protocol Violation|0|||
105764067|NCT01641081|364788958|FG004|Period 2|Protocol Violation|0|||
105764068|NCT01641081|364788959|FG005|Period 2|Protocol Violation|0|||
105764069|NCT01641081|364788960|FG006|Period 2|Protocol Violation|0|||
105764070|NCT01641081|364788961|FG007|Period 2|Protocol Violation|0|||
105764071|NCT01641081|364788962|FG008|Period 2|Protocol Violation|0|||
105764072|NCT01641081|364788963|FG009|Period 2|Protocol Violation|0|||
105764073|NCT01641081|364788954|FG000|Period 3|Adverse Event|0|||
105764074|NCT01641081|364788955|FG001|Period 3|Adverse Event|0|||
105764075|NCT01641081|364788956|FG002|Period 3|Adverse Event|1|||
105814958|NCT00727571|364981924|FG002|Overall Study|Death|5|||
105814959|NCT00727571|364981925|FG003|Overall Study|Death|1|||
105955669|NCT01396187|365499672|FG001|Overall Study|Other|1|||
105955670|NCT01396187|365499673|FG002|Overall Study|Other|0|||
105955671|NCT01396187|365499674|FG003|Overall Study|Other|0|||
105955672|NCT01396187|365499675|FG004|Overall Study|Other|1|||
105955673|NCT00682929|365499678|FG000|Overall Study|Adverse Event|4|||
105955674|NCT00682929|365499679|FG001|Overall Study|Adverse Event|1|||
105955675|NCT00682929|365499680|FG002|Overall Study|Adverse Event|1|||
105955676|NCT00682929|365499678|FG000|Overall Study|Withdrawal by Subject|1|||
105955677|NCT00682929|365499679|FG001|Overall Study|Withdrawal by Subject|2|||
105814960|NCT00727571|364981922|FG000|Overall Study|Physician Decision|0|||
105814961|NCT00727571|364981923|FG001|Overall Study|Physician Decision|5|||
105955678|NCT00682929|365499680|FG002|Overall Study|Withdrawal by Subject|1|||
105955679|NCT00682929|365499678|FG000|Overall Study|dosing compliance < 80%|0|||
105955680|NCT00682929|365499679|FG001|Overall Study|dosing compliance < 80%|2|||
105955681|NCT00682929|365499680|FG002|Overall Study|dosing compliance < 80%|0|||
105955682|NCT00682929|365499678|FG000|Overall Study|lag in DEA renewal|1|||
105955683|NCT00682929|365499679|FG001|Overall Study|lag in DEA renewal|0|||
105955684|NCT00682929|365499680|FG002|Overall Study|lag in DEA renewal|0|||
105955685|NCT01048242|365499683|FG000|Overall Study|See study flow chart|4|||
105955686|NCT01048242|365499684|FG001|Overall Study|See study flow chart|2|||
105955687|NCT04072835|365499685|FG000|Overall Study|Overall trial ended|603|||
105955688|NCT04072835|365499685|FG000|Overall Study|Ablation|97|||
105955689|NCT04072835|365499685|FG000|Overall Study|Withdrawal of consent|66|||
105955690|NCT04072835|365499685|FG000|Overall Study|Physician Decision|50|||
105955691|NCT04072835|365499685|FG000|Overall Study|Lost to Follow-up|39|||
105955692|NCT04072835|365499685|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
105955693|NCT04072835|365499685|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
105955694|NCT04072835|365499685|FG000|Overall Study|Adverse Event|25|||
105955695|NCT04072835|365499685|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
105955696|NCT04072835|365499685|FG000|Overall Study|Death|11|||
105955697|NCT04072835|365499685|FG000|Overall Study|Participant felt the drug did not work|8|||
105955698|NCT04072835|365499685|FG000|Overall Study|Participant tolerability|5|||
106018131|NCT02304367|365729268|FG000|Overall Study|Lack of Response to Bruosumab|1|||
106018132|NCT02304367|365729268|FG000|Overall Study|Sponsor Decision|3|||
106018133|NCT02304367|365729268|FG000|Overall Study|Death|2|||
106018134|NCT02304367|365729268|FG000|Overall Study|Physician Decision|1|||
105814962|NCT00727571|364981924|FG002|Overall Study|Physician Decision|0|||
105814963|NCT00727571|364981925|FG003|Overall Study|Physician Decision|0|||
105814964|NCT00727571|364981922|FG000|Overall Study|Withdrawal by Subject|0|||
105814965|NCT00727571|364981923|FG001|Overall Study|Withdrawal by Subject|10|||
105814966|NCT00727571|364981924|FG002|Overall Study|Withdrawal by Subject|11|||
105814967|NCT00727571|364981925|FG003|Overall Study|Withdrawal by Subject|0|||
105814968|NCT00727571|364981922|FG000|Overall Study|Subject Non Compliance|0|||
105814969|NCT00727571|364981923|FG001|Overall Study|Subject Non Compliance|6|||
105814970|NCT00727571|364981924|FG002|Overall Study|Subject Non Compliance|0|||
105814971|NCT00727571|364981925|FG003|Overall Study|Subject Non Compliance|4|||
105814972|NCT00727571|364981922|FG000|Overall Study|Dismissed from nursing home|0|||
105814973|NCT00727571|364981923|FG001|Overall Study|Dismissed from nursing home|9|||
105814974|NCT00727571|364981924|FG002|Overall Study|Dismissed from nursing home|5|||
105814975|NCT00727571|364981925|FG003|Overall Study|Dismissed from nursing home|0|||
105814976|NCT00727571|364981922|FG000|Overall Study|Hospitalization|0|||
105814977|NCT00727571|364981923|FG001|Overall Study|Hospitalization|1|||
105955699|NCT04072835|365499685|FG000|Overall Study|Missing|5|||
106018135|NCT02304367|365729268|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
106018136|NCT03599089|365729269|FG000|Overall Study|Lost to Follow-up|1|||
106018137|NCT03599089|365729270|FG001|Overall Study|Lost to Follow-up|0|||
106018138|NCT03599089|365729271|FG002|Overall Study|Lost to Follow-up|0|||
106018139|NCT03599089|365729272|FG003|Overall Study|Lost to Follow-up|0|||
106018140|NCT03599089|365729269|FG000|Overall Study|Withdrawal by Subject|2|||
106145267|NCT04177394|366191925|FG000|Overall Study|Missed visits|61|||
106145268|NCT04177394|366191925|FG000|Overall Study|Expected Visits|15|||
105814978|NCT00727571|364981924|FG002|Overall Study|Hospitalization|0|||
105955700|NCT04072835|365499685|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
105955701|NCT04072835|365499685|FG000|Overall Study|Pregnancy|3|||
105955702|NCT01336712|365499686|FG000|Overall Study|Death|2|||
105955703|NCT01336712|365499686|FG000|Overall Study|Lack of Efficacy|1|||
105955704|NCT01273038|365499689|FG000|Second Intervention (14 Days)|Adverse Event|0|||
105955705|NCT01273038|365499690|FG001|Second Intervention (14 Days)|Adverse Event|1|||
106018141|NCT03599089|365729270|FG001|Overall Study|Withdrawal by Subject|1|||
106018142|NCT03599089|365729271|FG002|Overall Study|Withdrawal by Subject|0|||
106145269|NCT03823911|366191926|FG000|Overall Study|Lost to Follow-up|1|||
106145270|NCT03823911|366191927|FG001|Overall Study|Lost to Follow-up|5|||
105814979|NCT00727571|364981925|FG003|Overall Study|Hospitalization|1|||
105814980|NCT00727571|364981922|FG000|Overall Study|AE not leading to hospitalization|0|||
106018143|NCT03599089|365729272|FG003|Overall Study|Withdrawal by Subject|0|||
105764076|NCT01641081|364788957|FG003|Period 3|Adverse Event|0|||
105764077|NCT01641081|364788958|FG004|Period 3|Adverse Event|0|||
105764078|NCT01641081|364788959|FG005|Period 3|Adverse Event|0|||
105764079|NCT01641081|364788960|FG006|Period 3|Adverse Event|0|||
105764080|NCT01641081|364788961|FG007|Period 3|Adverse Event|0|||
105764081|NCT01641081|364788962|FG008|Period 3|Adverse Event|0|||
105764082|NCT01641081|364788963|FG009|Period 3|Adverse Event|0|||
105764083|NCT01641081|364788954|FG000|Period 3|Withdrawal by Subject|0|||
105764084|NCT01641081|364788955|FG001|Period 3|Withdrawal by Subject|0|||
105764085|NCT01641081|364788956|FG002|Period 3|Withdrawal by Subject|0|||
105764086|NCT01641081|364788957|FG003|Period 3|Withdrawal by Subject|0|||
105764087|NCT01641081|364788958|FG004|Period 3|Withdrawal by Subject|0|||
105764088|NCT01641081|364788959|FG005|Period 3|Withdrawal by Subject|0|||
105764089|NCT01641081|364788960|FG006|Period 3|Withdrawal by Subject|0|||
105764090|NCT01641081|364788961|FG007|Period 3|Withdrawal by Subject|0|||
105764091|NCT01641081|364788962|FG008|Period 3|Withdrawal by Subject|1|||
105764092|NCT01641081|364788963|FG009|Period 3|Withdrawal by Subject|0|||
105764093|NCT01641081|364788954|FG000|Period 4|Adverse Event|0|||
105764094|NCT01641081|364788955|FG001|Period 4|Adverse Event|1|||
105764095|NCT01641081|364788956|FG002|Period 4|Adverse Event|0|||
105764096|NCT01641081|364788957|FG003|Period 4|Adverse Event|1|||
105764097|NCT01641081|364788958|FG004|Period 4|Adverse Event|0|||
105764098|NCT01641081|364788959|FG005|Period 4|Adverse Event|0|||
105764099|NCT01641081|364788960|FG006|Period 4|Adverse Event|0|||
105764100|NCT01641081|364788961|FG007|Period 4|Adverse Event|0|||
105764101|NCT01641081|364788962|FG008|Period 4|Adverse Event|0|||
105764102|NCT01641081|364788963|FG009|Period 4|Adverse Event|0|||
105764103|NCT01641081|364788954|FG000|Period 5|Adverse Event|0|||
105764104|NCT01641081|364788955|FG001|Period 5|Adverse Event|0|||
105764105|NCT01641081|364788956|FG002|Period 5|Adverse Event|2|||
105764106|NCT01641081|364788957|FG003|Period 5|Adverse Event|0|||
105764107|NCT01641081|364788958|FG004|Period 5|Adverse Event|0|||
105764108|NCT01641081|364788959|FG005|Period 5|Adverse Event|0|||
105764109|NCT01641081|364788960|FG006|Period 5|Adverse Event|0|||
105764110|NCT01641081|364788961|FG007|Period 5|Adverse Event|0|||
105764111|NCT01641081|364788962|FG008|Period 5|Adverse Event|0|||
105764112|NCT01641081|364788963|FG009|Period 5|Adverse Event|0|||
105764113|NCT01451398|364788968|FG000|Overall Study|Adverse Event|7|||
105764114|NCT01451398|364788969|FG001|Overall Study|Adverse Event|9|||
105764115|NCT01451398|364788968|FG000|Overall Study|Protocol Violation|1|||
105764116|NCT01451398|364788969|FG001|Overall Study|Protocol Violation|2|||
105764117|NCT01451398|364788968|FG000|Overall Study|Physician Decision|1|||
105764118|NCT01451398|364788969|FG001|Overall Study|Physician Decision|1|||
105764119|NCT01451398|364788968|FG000|Overall Study|Withdrawal by Subject|10|||
105764120|NCT01451398|364788969|FG001|Overall Study|Withdrawal by Subject|14|||
105764121|NCT01451398|364788968|FG000|Overall Study|Lost to Follow-up|6|||
105764122|NCT01451398|364788969|FG001|Overall Study|Lost to Follow-up|4|||
105764123|NCT01451398|364788968|FG000|Overall Study|Non-compliance with study drug|1|||
105764124|NCT01451398|364788969|FG001|Overall Study|Non-compliance with study drug|3|||
105764125|NCT01451398|364788968|FG000|Overall Study|Non-compliance with protocol|1|||
105764126|NCT01451398|364788969|FG001|Overall Study|Non-compliance with protocol|1|||
105764127|NCT01451398|364788968|FG000|Overall Study|Moved out of country|0|||
105764128|NCT01451398|364788969|FG001|Overall Study|Moved out of country|1|||
105764129|NCT01451398|364788968|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
105764130|NCT01451398|364788969|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
105764131|NCT01451398|364788968|FG000|Overall Study|Lack of Efficacy|0|||
105764132|NCT01451398|364788969|FG001|Overall Study|Lack of Efficacy|1|||
105764133|NCT01000025|364788970|FG000|Overall Study|Adverse Event|43|||
105764134|NCT01000025|364788971|FG001|Overall Study|Adverse Event|2|||
105764135|NCT01000025|364788970|FG000|Overall Study|Withdrawal by Subject|13|||
105764136|NCT01000025|364788971|FG001|Overall Study|Withdrawal by Subject|8|||
105764137|NCT01000025|364788970|FG000|Overall Study|Death|23|||
105764138|NCT01000025|364788971|FG001|Overall Study|Death|13|||
105764139|NCT01000025|364788970|FG000|Overall Study|Lack of Efficacy|363|||
105764140|NCT01000025|364788971|FG001|Overall Study|Lack of Efficacy|208|||
105764141|NCT01000025|364788970|FG000|Overall Study|Intercurrent Illness|26|||
105764142|NCT01000025|364788971|FG001|Overall Study|Intercurrent Illness|7|||
105764143|NCT00842361|364788983|FG000|Overall Study|Protocol Violation|1|||
105764144|NCT00842361|364788984|FG001|Overall Study|Protocol Violation|0|||
105764145|NCT00842361|364788983|FG000|Overall Study|Unclassified|0|||
105764146|NCT00842361|364788984|FG001|Overall Study|Unclassified|2|||
105764147|NCT04285853|364788985|FG000|Overall Study|Withdrawal by Subject|1|||
105764148|NCT04285853|364788986|FG001|Overall Study|Withdrawal by Subject|0|||
105764149|NCT04285853|364788985|FG000|Overall Study|Lost to Follow-up|9|||
105764150|NCT04285853|364788986|FG001|Overall Study|Lost to Follow-up|5|||
105764151|NCT00587301|364788987|FG000|Overall Study|Screen Failure|9|||
105764152|NCT00587301|364788987|FG000|Overall Study|Lost to Follow-up|22|||
105764153|NCT00587301|364788987|FG000|Overall Study|Withdrawal by Subject|7|||
105764154|NCT00587301|364788987|FG000|Overall Study|Protocol Violation|7|||
106018144|NCT03599089|365729269|FG000|Overall Study|Lack of Efficacy|0|||
105814981|NCT00727571|364981923|FG001|Overall Study|AE not leading to hospitalization|0|||
105814982|NCT00727571|364981924|FG002|Overall Study|AE not leading to hospitalization|2|||
105814983|NCT00727571|364981925|FG003|Overall Study|AE not leading to hospitalization|0|||
105814984|NCT00727571|364981922|FG000|Overall Study|Other|0|||
105814985|NCT00727571|364981923|FG001|Overall Study|Other|4|||
105814986|NCT00727571|364981924|FG002|Overall Study|Other|6|||
105814987|NCT00727571|364981925|FG003|Overall Study|Other|0|||
105814988|NCT04099888|364981929|FG000|Overall Study|Study terminated by sponsor|9|||
105814989|NCT04099888|364981930|FG001|Overall Study|Study terminated by sponsor|11|||
105814990|NCT04099888|364981929|FG000|Overall Study|Lost to Follow-up|1|||
105814991|NCT04099888|364981930|FG001|Overall Study|Lost to Follow-up|1|||
105814992|NCT04099888|364981929|FG000|Overall Study|Withdrawal by Subject|5|||
105814993|NCT04099888|364981930|FG001|Overall Study|Withdrawal by Subject|6|||
105814994|NCT04099888|364981929|FG000|Overall Study|Death|5|||
105814995|NCT04099888|364981930|FG001|Overall Study|Death|2|||
105814996|NCT04099888|364981929|FG000|Overall Study|Other|1|||
105814997|NCT04099888|364981930|FG001|Overall Study|Other|0|||
105814998|NCT04538170|364981931|FG000|Overall Study|Withdrawal by Subject|104|||
105814999|NCT04538170|364981932|FG001|Overall Study|Withdrawal by Subject|210|||
105815000|NCT03002077|364981934|FG000|Overall Study|Non-compliance with Study Drug|4|||
105815001|NCT03002077|364981934|FG000|Overall Study|Non-compliance w/Background ADT|1|||
105815002|NCT03002077|364981934|FG000|Overall Study|Study Terminated by Sponsor|257|||
105815003|NCT03002077|364981934|FG000|Overall Study|Site Terminated by Sponsor|5|||
105815004|NCT03002077|364981934|FG000|Overall Study|Miscellaneous Reasons|10|||
105815005|NCT03002077|364981934|FG000|Overall Study|Adverse Event|23|||
105815006|NCT03002077|364981934|FG000|Overall Study|Lack of Efficacy|20|||
105815007|NCT03002077|364981934|FG000|Overall Study|Withdrawal by Subject|72|||
105815008|NCT03002077|364981934|FG000|Overall Study|Lost to Follow-up|21|||
105815009|NCT03002077|364981934|FG000|Overall Study|Pregnancy|4|||
105815010|NCT03002077|364981934|FG000|Overall Study|Protocol Violation|21|||
105815011|NCT03370276|364981938|FG000|Overall Study|Death|0|||
105815012|NCT03370276|364981939|FG001|Overall Study|Death|2|||
105815013|NCT03370276|364981940|FG002|Overall Study|Death|5|||
105815014|NCT00777829|364981941|FG000|Overall Study|Withdrawal by Subject|0|||
105815015|NCT00777829|364981942|FG001|Overall Study|Withdrawal by Subject|2|||
105815016|NCT00854308|364981944|FG000|Overall Study|Disease progression|42|||
105815017|NCT00854308|364981945|FG001|Overall Study|Disease progression|50|||
105815018|NCT00854308|364981944|FG000|Overall Study|Adverse Event|8|||
105815019|NCT00854308|364981945|FG001|Overall Study|Adverse Event|3|||
105815020|NCT00854308|364981944|FG000|Overall Study|Death|2|||
105815021|NCT00854308|364981945|FG001|Overall Study|Death|5|||
105815022|NCT00854308|364981944|FG000|Overall Study|Physician Decision|6|||
105815023|NCT00854308|364981945|FG001|Overall Study|Physician Decision|6|||
105815024|NCT00854308|364981944|FG000|Overall Study|Withdrawal by Subject|4|||
105815025|NCT00854308|364981945|FG001|Overall Study|Withdrawal by Subject|2|||
105815026|NCT00854308|364981944|FG000|Overall Study|Sponsor's decision to terminate study|0|||
105815027|NCT00854308|364981945|FG001|Overall Study|Sponsor's decision to terminate study|1|||
105815028|NCT01390844|364981946|FG000|Treatment Phase|Adverse Event|12|||
105815029|NCT01390844|364981947|FG001|Treatment Phase|Adverse Event|2|||
105815030|NCT01390844|364981948|FG002|Treatment Phase|Adverse Event|3|||
105815031|NCT01390844|364981949|FG003|Treatment Phase|Adverse Event|2|||
105815032|NCT01390844|364981946|FG000|Treatment Phase|Treatment Failure|23|||
105815033|NCT01390844|364981947|FG001|Treatment Phase|Treatment Failure|25|||
105815034|NCT01390844|364981948|FG002|Treatment Phase|Treatment Failure|10|||
105815035|NCT01390844|364981949|FG003|Treatment Phase|Treatment Failure|13|||
105815036|NCT01390844|364981946|FG000|Treatment Phase|Non-Medical Reasons|5|||
105815037|NCT01390844|364981947|FG001|Treatment Phase|Non-Medical Reasons|1|||
105815038|NCT01390844|364981948|FG002|Treatment Phase|Non-Medical Reasons|8|||
105815039|NCT01390844|364981949|FG003|Treatment Phase|Non-Medical Reasons|1|||
105815040|NCT01390844|364981946|FG000|Treatment Phase|Non-GCP Compliant|0|||
105815041|NCT01390844|364981947|FG001|Treatment Phase|Non-GCP Compliant|0|||
105815042|NCT01390844|364981948|FG002|Treatment Phase|Non-GCP Compliant|10|||
105815043|NCT01390844|364981949|FG003|Treatment Phase|Non-GCP Compliant|3|||
105815044|NCT01390844|364981946|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
105815045|NCT01390844|364981947|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
105815046|NCT01390844|364981948|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
105815047|NCT01390844|364981949|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
105815048|NCT00958243|364981952|FG000|Overall Study|Withdrawal by Subject|0|||
105815049|NCT00958243|364981953|FG001|Overall Study|Withdrawal by Subject|1|||
105815050|NCT00958243|364981954|FG002|Overall Study|Withdrawal by Subject|3|||
105815051|NCT00958243|364981955|FG003|Overall Study|Withdrawal by Subject|1|||
105815052|NCT00958243|364981956|FG004|Overall Study|Withdrawal by Subject|1|||
105815053|NCT00958243|364981957|FG005|Overall Study|Withdrawal by Subject|5|||
105815054|NCT00958243|364981952|FG000|Overall Study|Lost to Follow-up|2|||
105815055|NCT00958243|364981953|FG001|Overall Study|Lost to Follow-up|5|||
105815056|NCT00958243|364981954|FG002|Overall Study|Lost to Follow-up|11|||
105815057|NCT00958243|364981955|FG003|Overall Study|Lost to Follow-up|2|||
105955706|NCT01273038|365499689|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
106018145|NCT03599089|365729270|FG001|Overall Study|Lack of Efficacy|0|||
105815058|NCT00958243|364981956|FG004|Overall Study|Lost to Follow-up|8|||
105815059|NCT00958243|364981957|FG005|Overall Study|Lost to Follow-up|5|||
105815060|NCT02016170|364981968|FG000|Overall Study|Adverse Event|1|||
105815061|NCT02016170|364981969|FG001|Overall Study|Adverse Event|1|||
105815062|NCT02016170|364981970|FG002|Overall Study|Adverse Event|0|||
105815063|NCT02016170|364981968|FG000|Overall Study|Protocol Violation|1|||
105815064|NCT02016170|364981969|FG001|Overall Study|Protocol Violation|0|||
105815065|NCT02016170|364981970|FG002|Overall Study|Protocol Violation|0|||
105815066|NCT00336479|364981972|FG000|Overall Study|Adverse Event|8|||
105815067|NCT00336479|364981973|FG001|Overall Study|Adverse Event|11|||
105815068|NCT00336479|364981974|FG002|Overall Study|Adverse Event|18|||
105815069|NCT00336479|364981975|FG003|Overall Study|Adverse Event|4|||
105815070|NCT00336479|364981972|FG000|Overall Study|Noncompliant|1|||
105815071|NCT00336479|364981973|FG001|Overall Study|Noncompliant|7|||
105815072|NCT00336479|364981974|FG002|Overall Study|Noncompliant|3|||
105815073|NCT00336479|364981975|FG003|Overall Study|Noncompliant|0|||
105815074|NCT00336479|364981972|FG000|Overall Study|Physician Decision|2|||
105815075|NCT00336479|364981973|FG001|Overall Study|Physician Decision|3|||
105815076|NCT00336479|364981974|FG002|Overall Study|Physician Decision|1|||
105815077|NCT00336479|364981975|FG003|Overall Study|Physician Decision|0|||
105815078|NCT00336479|364981972|FG000|Overall Study|Lost to Follow-up|3|||
105815079|NCT00336479|364981973|FG001|Overall Study|Lost to Follow-up|2|||
105815080|NCT00336479|364981974|FG002|Overall Study|Lost to Follow-up|0|||
105815081|NCT00336479|364981975|FG003|Overall Study|Lost to Follow-up|0|||
105815082|NCT00336479|364981972|FG000|Overall Study|Withdrawal by Subject|3|||
105815083|NCT00336479|364981973|FG001|Overall Study|Withdrawal by Subject|2|||
105815084|NCT00336479|364981974|FG002|Overall Study|Withdrawal by Subject|3|||
105815085|NCT00336479|364981975|FG003|Overall Study|Withdrawal by Subject|0|||
105815086|NCT00336479|364981972|FG000|Overall Study|Other|0|||
105815087|NCT00336479|364981973|FG001|Overall Study|Other|0|||
105815088|NCT00336479|364981974|FG002|Overall Study|Other|1|||
105815089|NCT00336479|364981975|FG003|Overall Study|Other|0|||
105815090|NCT00336479|364981972|FG000|Overall Study|Virologic Stopping Rule|20|||
105815091|NCT00336479|364981973|FG001|Overall Study|Virologic Stopping Rule|0|||
105815092|NCT00336479|364981974|FG002|Overall Study|Virologic Stopping Rule|0|||
105815093|NCT00336479|364981975|FG003|Overall Study|Virologic Stopping Rule|0|||
105815094|NCT01479439|364981980|FG000|Overall Study|Adverse Event|1|||
105815095|NCT01479439|364981981|FG001|Overall Study|Adverse Event|0|||
105815096|NCT01479439|364981982|FG002|Overall Study|Adverse Event|0|||
105815097|NCT01479439|364981980|FG000|Overall Study|Lost to Follow-up|0|||
105815098|NCT01479439|364981981|FG001|Overall Study|Lost to Follow-up|1|||
105815099|NCT01479439|364981982|FG002|Overall Study|Lost to Follow-up|0|||
105815100|NCT01479439|364981980|FG000|Overall Study|Protocol Violation|0|||
105815101|NCT01479439|364981981|FG001|Overall Study|Protocol Violation|0|||
105815102|NCT01479439|364981982|FG002|Overall Study|Protocol Violation|2|||
105815103|NCT02365207|364981983|FG000|Overall Study|Withdrawal by Subject|1|||
105815104|NCT02365207|364981983|FG000|Overall Study|Physician Decision|1|||
105815105|NCT01936948|364981984|FG000|Overall Study|no 30-day follow-up data|0|||
105815106|NCT01936948|364981985|FG001|Overall Study|no 30-day follow-up data|3|||
105815107|NCT01936948|364981986|FG002|Overall Study|no 30-day follow-up data|3|||
105815108|NCT01936948|364981987|FG003|Overall Study|no 30-day follow-up data|3|||
105815109|NCT01318499|364981988|FG000|Overall Study|Adverse Event|16|||
105815110|NCT01318499|364981989|FG001|Overall Study|Adverse Event|11|||
105815111|NCT01318499|364981990|FG002|Overall Study|Adverse Event|6|||
105955707|NCT01273038|365499690|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
105955708|NCT01465386|365499691|FG000|Overall Study|Lack of Efficacy|3|||
105955709|NCT01465386|365499691|FG000|Overall Study|Adverse Event|1|||
105955710|NCT00570323|365499693|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
105955711|NCT00570323|365499694|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
105955712|NCT00570323|365499693|FG000|Started Treatment After Randomization|Protocol Violation|1|||
105955713|NCT00570323|365499694|FG001|Started Treatment After Randomization|Protocol Violation|0|||
105815112|NCT01318499|364981988|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
105815113|NCT01318499|364981989|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
105815114|NCT01318499|364981990|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
105815115|NCT01318499|364981988|FG000|Overall Study|Noncompliance|2|||
105815116|NCT01318499|364981989|FG001|Overall Study|Noncompliance|3|||
105815117|NCT01318499|364981990|FG002|Overall Study|Noncompliance|0|||
105815118|NCT01318499|364981988|FG000|Overall Study|Treatment Failure|19|||
105815119|NCT01318499|364981989|FG001|Overall Study|Treatment Failure|19|||
105815120|NCT01318499|364981990|FG002|Overall Study|Treatment Failure|101|||
105815121|NCT01318499|364981988|FG000|Overall Study|Protocol Violation|2|||
105815122|NCT01318499|364981989|FG001|Overall Study|Protocol Violation|4|||
105815123|NCT01318499|364981990|FG002|Overall Study|Protocol Violation|2|||
105815124|NCT01318499|364981988|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
105955714|NCT00570323|365499693|FG000|Started Treatment After Randomization|Physician Decision|1|||
105815125|NCT01318499|364981989|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
105815126|NCT01318499|364981990|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
105815127|NCT01318499|364981988|FG000|Overall Study|Other|7|||
105815128|NCT01318499|364981989|FG001|Overall Study|Other|10|||
105815129|NCT01318499|364981990|FG002|Overall Study|Other|22|||
105815130|NCT01722877|364981991|FG000|Overall Study|Death|1|||
105815131|NCT01722877|364981991|FG000|Overall Study|Lost to Follow-up|1|||
105815132|NCT00822926|364981992|FG000|Second Injection Visit|Lost to Follow-up|1|||
105815133|NCT00822926|364981993|FG001|Second Injection Visit|Lost to Follow-up|0|||
105815134|NCT00822926|364981992|FG000|Second Injection Visit|Withdrawal by Subject|0|||
105815135|NCT00822926|364981993|FG001|Second Injection Visit|Withdrawal by Subject|1|||
105815136|NCT02719522|364982000|FG000|Overall Study|Implant Failure|4|||
105815137|NCT02719522|364982000|FG000|Overall Study|Death|2|||
105815138|NCT02719522|364982000|FG000|Overall Study|Lost to Follow-up|5|||
105815139|NCT01044732|364982009|FG000|Overall Study|Lost to Follow-up|2|||
105815140|NCT01044732|364982010|FG001|Overall Study|Lost to Follow-up|1|||
105815141|NCT01044732|364982009|FG000|Overall Study|Physician Decision|5|||
105815142|NCT01044732|364982010|FG001|Overall Study|Physician Decision|3|||
105815143|NCT01044732|364982009|FG000|Overall Study|Protocol Violation|11|||
105815144|NCT01044732|364982010|FG001|Overall Study|Protocol Violation|12|||
105815145|NCT01044732|364982009|FG000|Overall Study|Withdrawal by Subject|0|||
105815146|NCT01044732|364982010|FG001|Overall Study|Withdrawal by Subject|1|||
105815147|NCT01044732|364982009|FG000|Overall Study|Inadequate bowel preparation|11|||
105815148|NCT01044732|364982010|FG001|Overall Study|Inadequate bowel preparation|17|||
105815149|NCT01044732|364982009|FG000|Overall Study|Inability to reach cecum|5|||
105815150|NCT01044732|364982010|FG001|Overall Study|Inability to reach cecum|2|||
105815151|NCT01044732|364982009|FG000|Overall Study|Technical error or malfunction|15|||
105815152|NCT01044732|364982010|FG001|Overall Study|Technical error or malfunction|14|||
105815153|NCT00385684|364982015|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
105815154|NCT00385684|364982016|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
105815155|NCT00385684|364982015|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
105815156|NCT00385684|364982016|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
105815157|NCT00385684|364982015|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
105815158|NCT00385684|364982016|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
105815159|NCT00880568|364983428|FG000|Overall Study|Disease progression|3|||
106018146|NCT03599089|365729271|FG002|Overall Study|Lack of Efficacy|1|||
106018147|NCT03599089|365729272|FG003|Overall Study|Lack of Efficacy|2|||
106018148|NCT00131248|365729273|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
106018149|NCT00131248|365729274|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
106018150|NCT04308291|365729275|FG000|Run-In Phase|Withdrawal by Subject|4|||
106018151|NCT04308291|365729275|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
106018152|NCT04308291|365729275|FG000|Study Phase 6-M|Physician Decision|2|||
106018153|NCT04308291|365729275|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
106018154|NCT04308291|365729275|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
106018155|NCT04308291|365729275|FG000|Study Phase 12-M|Physician Decision|2|||
106018156|NCT04308291|365729275|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
106018157|NCT02699749|365729282|FG000|Overall Study|Other|0|||
106018158|NCT02699749|365729283|FG001|Overall Study|Other|0|||
106018159|NCT02699749|365729284|FG002|Overall Study|Other|2|||
106018160|NCT02699749|365729285|FG003|Overall Study|Other|0|||
106018161|NCT02699749|365729286|FG004|Overall Study|Other|0|||
106018162|NCT02699749|365729287|FG005|Overall Study|Other|1|||
106018163|NCT02699749|365729288|FG006|Overall Study|Other|1|||
106018164|NCT02699749|365729289|FG007|Overall Study|Other|0|||
106018165|NCT02699749|365729290|FG008|Overall Study|Other|0|||
106018166|NCT02699749|365729291|FG009|Overall Study|Other|0|||
106018167|NCT02699749|365729292|FG010|Overall Study|Other|1|||
106018168|NCT02699749|365729293|FG011|Overall Study|Other|0|||
106018169|NCT02699749|365729294|FG012|Overall Study|Other|0|||
106018170|NCT02699749|365729295|FG013|Overall Study|Other|0|||
106018171|NCT02699749|365729282|FG000|Overall Study|Progressive Disease|3|||
106018172|NCT02699749|365729283|FG001|Overall Study|Progressive Disease|3|||
105815160|NCT00880568|364983429|FG001|Overall Study|Disease progression|3|||
105815161|NCT00880568|364983430|FG002|Overall Study|Disease progression|3|||
105815162|NCT00880568|364983431|FG003|Overall Study|Disease progression|1|||
105815163|NCT00880568|364983432|FG004|Overall Study|Disease progression|3|||
105815164|NCT00880568|364983433|FG005|Overall Study|Disease progression|3|||
105815165|NCT00880568|364983434|FG006|Overall Study|Disease progression|5|||
105815166|NCT00880568|364983435|FG007|Overall Study|Disease progression|0|||
105815167|NCT00880568|364983436|FG008|Overall Study|Disease progression|3|||
105815168|NCT00880568|364983428|FG000|Overall Study|Adverse Event|0|||
105815169|NCT00880568|364983429|FG001|Overall Study|Adverse Event|0|||
105815170|NCT00880568|364983430|FG002|Overall Study|Adverse Event|0|||
105815171|NCT00880568|364983431|FG003|Overall Study|Adverse Event|0|||
106018173|NCT02699749|365729284|FG002|Overall Study|Progressive Disease|14|||
106018174|NCT02699749|365729285|FG003|Overall Study|Progressive Disease|3|||
106018175|NCT02699749|365729286|FG004|Overall Study|Progressive Disease|3|||
106018176|NCT02699749|365729287|FG005|Overall Study|Progressive Disease|7|||
106018177|NCT02699749|365729288|FG006|Overall Study|Progressive Disease|5|||
106018178|NCT02699749|365729289|FG007|Overall Study|Progressive Disease|5|||
106018179|NCT02699749|365729290|FG008|Overall Study|Progressive Disease|6|||
105815172|NCT00880568|364983432|FG004|Overall Study|Adverse Event|0|||
105815173|NCT00880568|364983433|FG005|Overall Study|Adverse Event|0|||
105815174|NCT00880568|364983434|FG006|Overall Study|Adverse Event|1|||
105815175|NCT00880568|364983435|FG007|Overall Study|Adverse Event|1|||
105815176|NCT00880568|364983436|FG008|Overall Study|Adverse Event|0|||
105815177|NCT00880568|364983428|FG000|Overall Study|Withdrawal by Subject|0|||
105815178|NCT00880568|364983429|FG001|Overall Study|Withdrawal by Subject|0|||
105815179|NCT00880568|364983430|FG002|Overall Study|Withdrawal by Subject|0|||
105815180|NCT00880568|364983431|FG003|Overall Study|Withdrawal by Subject|0|||
105815181|NCT00880568|364983432|FG004|Overall Study|Withdrawal by Subject|0|||
105815182|NCT00880568|364983433|FG005|Overall Study|Withdrawal by Subject|0|||
105815183|NCT00880568|364983434|FG006|Overall Study|Withdrawal by Subject|0|||
105815184|NCT00880568|364983435|FG007|Overall Study|Withdrawal by Subject|1|||
105815185|NCT00880568|364983436|FG008|Overall Study|Withdrawal by Subject|0|||
105815186|NCT02152566|364983439|FG000|Overall Study|Lost to Follow-up|1|||
105815187|NCT02152566|364983439|FG000|Overall Study|Withdrawal by Subject|2|||
105815188|NCT01866319|364983442|FG000|Overall Study|Adverse Event|12|||
105815189|NCT01866319|364983443|FG001|Overall Study|Adverse Event|5|||
105815190|NCT01866319|364983444|FG002|Overall Study|Adverse Event|9|||
105815191|NCT01866319|364983442|FG000|Overall Study|Clinical progression|3|||
106145271|NCT03823911|366191928|FG002|Overall Study|Lost to Follow-up|2|||
106145272|NCT03823911|366191926|FG000|Overall Study|Did not meet eligibility criteria|13|||
105815192|NCT01866319|364983443|FG001|Overall Study|Clinical progression|2|||
105815193|NCT01866319|364983444|FG002|Overall Study|Clinical progression|2|||
105815194|NCT01866319|364983442|FG000|Overall Study|Death|153|||
105815195|NCT01866319|364983443|FG001|Overall Study|Death|154|||
105815196|NCT01866319|364983444|FG002|Overall Study|Death|147|||
105815197|NCT01866319|364983442|FG000|Overall Study|Lost to Follow-up|6|||
105815198|NCT01866319|364983443|FG001|Overall Study|Lost to Follow-up|3|||
105815199|NCT01866319|364983444|FG002|Overall Study|Lost to Follow-up|8|||
105815200|NCT01866319|364983442|FG000|Overall Study|Physician Decision|1|||
105815201|NCT01866319|364983443|FG001|Overall Study|Physician Decision|0|||
105815202|NCT01866319|364983444|FG002|Overall Study|Physician Decision|1|||
105815203|NCT01866319|364983442|FG000|Overall Study|Protocol Violation|0|||
105815204|NCT01866319|364983443|FG001|Overall Study|Protocol Violation|0|||
105815205|NCT01866319|364983444|FG002|Overall Study|Protocol Violation|1|||
105815206|NCT01866319|364983442|FG000|Overall Study|Withdrawal by Subject|32|||
105815207|NCT01866319|364983443|FG001|Overall Study|Withdrawal by Subject|14|||
105815208|NCT01866319|364983444|FG002|Overall Study|Withdrawal by Subject|12|||
105815209|NCT01328093|364983447|FG000|Double-Blind Phase|Adverse Event|78|||
105815210|NCT01328093|364983448|FG001|Double-Blind Phase|Adverse Event|15|||
105815211|NCT01328093|364983447|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
105815212|NCT01328093|364983448|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
105815213|NCT01328093|364983447|FG000|Double-Blind Phase|Lost to Follow-up|39|||
105815214|NCT01328093|364983448|FG001|Double-Blind Phase|Lost to Follow-up|14|||
105815215|NCT01328093|364983447|FG000|Double-Blind Phase|Protocol Violation|30|||
105815216|NCT01328093|364983448|FG001|Double-Blind Phase|Protocol Violation|10|||
105815217|NCT01328093|364983447|FG000|Double-Blind Phase|Lack of Efficacy|55|||
105815218|NCT01328093|364983448|FG001|Double-Blind Phase|Lack of Efficacy|13|||
105955715|NCT00570323|365499694|FG001|Started Treatment After Randomization|Physician Decision|0|||
105955716|NCT00570323|365499693|FG000|Complete Study After Start|Lost to Follow-up|0|||
105955717|NCT00570323|365499694|FG001|Complete Study After Start|Lost to Follow-up|1|||
105955718|NCT00570323|365499693|FG000|Complete Study After Start|Withdrawal by Subject|2|||
105955719|NCT00570323|365499694|FG001|Complete Study After Start|Withdrawal by Subject|0|||
106145273|NCT03823911|366191927|FG001|Overall Study|Did not meet eligibility criteria|7|||
105815219|NCT01328093|364983447|FG000|Double-Blind Phase|Sponsor Decision|17|||
105815220|NCT01328093|364983448|FG001|Double-Blind Phase|Sponsor Decision|3|||
105815221|NCT01328093|364983447|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
105815222|NCT01328093|364983448|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
105815223|NCT01328093|364983447|FG000|Double-Blind Phase|Scheduling conflict|8|||
105815224|NCT01328093|364983448|FG001|Double-Blind Phase|Scheduling conflict|3|||
105815225|NCT01328093|364983447|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
105955720|NCT00570323|365499693|FG000|Complete Study After Start|Physician Decision|1|||
105815226|NCT01328093|364983448|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
105815227|NCT01328093|364983447|FG000|Double-Blind Phase|Death|1|||
105815228|NCT01328093|364983448|FG001|Double-Blind Phase|Death|0|||
105815229|NCT01328093|364983447|FG000|Open-Label Phase|Sponsor Decision|98|||
105955721|NCT00570323|365499694|FG001|Complete Study After Start|Physician Decision|0|||
105955722|NCT03369665|365499695|FG000|Overall Study|Adverse Event|3|||
105815230|NCT01328093|364983448|FG001|Open-Label Phase|Sponsor Decision|34|||
105955723|NCT03369665|365499695|FG000|Overall Study|Lost to Follow-up|7|||
105815231|NCT01328093|364983447|FG000|Open-Label Phase|Protocol Violation|8|||
105815232|NCT01328093|364983448|FG001|Open-Label Phase|Protocol Violation|3|||
105815233|NCT01328093|364983447|FG000|Open-Label Phase|Lost to Follow-up|10|||
105815234|NCT01328093|364983448|FG001|Open-Label Phase|Lost to Follow-up|1|||
105955724|NCT03369665|365499695|FG000|Overall Study|Withdrawal by Subject|15|||
106145274|NCT03823911|366191928|FG002|Overall Study|Did not meet eligibility criteria|4|||
105815235|NCT01328093|364983447|FG000|Open-Label Phase|Adverse Event|10|||
105815236|NCT01328093|364983448|FG001|Open-Label Phase|Adverse Event|4|||
105815237|NCT01328093|364983447|FG000|Open-Label Phase|Lack of Efficacy|5|||
105815238|NCT01328093|364983448|FG001|Open-Label Phase|Lack of Efficacy|6|||
105815239|NCT01328093|364983447|FG000|Open-Label Phase|Withdrawal by Subject|4|||
105815240|NCT01328093|364983448|FG001|Open-Label Phase|Withdrawal by Subject|1|||
105815241|NCT01328093|364983447|FG000|Open-Label Phase|Scheduling conflict|2|||
105815242|NCT01328093|364983448|FG001|Open-Label Phase|Scheduling conflict|1|||
105815243|NCT01328093|364983447|FG000|Open-Label Phase|Subject is moving or has moved|2|||
105815244|NCT01328093|364983448|FG001|Open-Label Phase|Subject is moving or has moved|0|||
105815245|NCT01328093|364983447|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
105815246|NCT01328093|364983448|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
105815247|NCT00760266|364983451|FG000|Overall Study|Adverse Event|13|||
105815248|NCT00760266|364983452|FG001|Overall Study|Adverse Event|7|||
105815249|NCT00760266|364983451|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105815250|NCT00760266|364983452|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105815251|NCT00760266|364983451|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105815252|NCT00760266|364983452|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105815253|NCT00760266|364983451|FG000|Overall Study|Lack of Efficacy|2|||
105815254|NCT00760266|364983452|FG001|Overall Study|Lack of Efficacy|2|||
105815255|NCT00760266|364983451|FG000|Overall Study|Protocol deviation|2|||
105815256|NCT00760266|364983452|FG001|Overall Study|Protocol deviation|4|||
105815257|NCT00760266|364983451|FG000|Overall Study|Patient withdrew consent|3|||
105815258|NCT00760266|364983452|FG001|Overall Study|Patient withdrew consent|3|||
105815259|NCT00760266|364983451|FG000|Overall Study|Lost to Follow-up|2|||
105815260|NCT00760266|364983452|FG001|Overall Study|Lost to Follow-up|1|||
105815261|NCT00760266|364983451|FG000|Overall Study|Administrative Problems|0|||
105815262|NCT00760266|364983452|FG001|Overall Study|Administrative Problems|1|||
105815263|NCT03340727|364983455|FG000|Overall Study|Death|1|||
105815264|NCT03340727|364983456|FG001|Overall Study|Death|0|||
105815265|NCT03340727|364983455|FG000|Overall Study|Lost to Follow-up|31|||
105815266|NCT03340727|364983456|FG001|Overall Study|Lost to Follow-up|35|||
105815267|NCT03340727|364983455|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
105815268|NCT03340727|364983456|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
105815269|NCT03340727|364983455|FG000|Overall Study|Transferred to another facility|10|||
105815270|NCT03340727|364983456|FG001|Overall Study|Transferred to another facility|7|||
105815271|NCT03340727|364983455|FG000|Overall Study|Withdrawal by Subject|28|||
105815272|NCT03340727|364983456|FG001|Overall Study|Withdrawal by Subject|17|||
105815273|NCT01572948|364983457|FG000|Overall Study|Lost to Follow-up|1|||
105815274|NCT01572948|364983458|FG001|Overall Study|Lost to Follow-up|0|||
105815275|NCT01572948|364983457|FG000|Overall Study|unable to contact|0|||
105815276|NCT01572948|364983458|FG001|Overall Study|unable to contact|1|||
105815277|NCT03603314|364983459|FG000|Overall Study|Lost to Follow-up|0|||
105815278|NCT03603314|364983460|FG001|Overall Study|Lost to Follow-up|3|||
105815279|NCT03603314|364983461|FG002|Overall Study|Lost to Follow-up|0|||
105815280|NCT03603314|364983459|FG000|Overall Study|Protocol Violation|0|||
105815281|NCT03603314|364983460|FG001|Overall Study|Protocol Violation|1|||
105815282|NCT03603314|364983461|FG002|Overall Study|Protocol Violation|0|||
105815283|NCT03603314|364983459|FG000|Overall Study|Adverse Event|2|||
105815284|NCT03603314|364983460|FG001|Overall Study|Adverse Event|0|||
105815285|NCT03603314|364983461|FG002|Overall Study|Adverse Event|0|||
105815286|NCT03603314|364983459|FG000|Overall Study|Physician Decision|1|||
105815287|NCT03603314|364983460|FG001|Overall Study|Physician Decision|1|||
105815288|NCT03603314|364983461|FG002|Overall Study|Physician Decision|0|||
105815289|NCT03603314|364983459|FG000|Overall Study|Withdrawal by Subject|4|||
105815290|NCT03603314|364983460|FG001|Overall Study|Withdrawal by Subject|5|||
105815291|NCT03603314|364983461|FG002|Overall Study|Withdrawal by Subject|3|||
105815292|NCT03603314|364983459|FG000|Overall Study|Other|0|||
105815293|NCT03603314|364983460|FG001|Overall Study|Other|1|||
105815294|NCT03603314|364983461|FG002|Overall Study|Other|0|||
105815295|NCT00050778|364983462|FG000|Overall Study|Adverse Event|13|||
105815296|NCT00050778|364983463|FG001|Overall Study|Adverse Event|3|||
105815297|NCT00050778|364983464|FG002|Overall Study|Adverse Event|2|||
105815298|NCT00050778|364983462|FG000|Overall Study|Death|0|||
105815299|NCT00050778|364983463|FG001|Overall Study|Death|1|||
105815300|NCT00050778|364983464|FG002|Overall Study|Death|1|||
105815301|NCT00050778|364983462|FG000|Overall Study|Lack of Efficacy|16|||
106018180|NCT02699749|365729291|FG009|Overall Study|Progressive Disease|6|||
105815302|NCT00050778|364983463|FG001|Overall Study|Lack of Efficacy|2|||
105815303|NCT00050778|364983464|FG002|Overall Study|Lack of Efficacy|2|||
105815304|NCT00050778|364983462|FG000|Overall Study|Lost to Follow-up|0|||
105815305|NCT00050778|364983463|FG001|Overall Study|Lost to Follow-up|2|||
105815306|NCT00050778|364983464|FG002|Overall Study|Lost to Follow-up|4|||
105815307|NCT00050778|364983462|FG000|Overall Study|Physician Decision|3|||
105815308|NCT00050778|364983463|FG001|Overall Study|Physician Decision|0|||
105815309|NCT00050778|364983464|FG002|Overall Study|Physician Decision|2|||
105815310|NCT00050778|364983462|FG000|Overall Study|Protocol Violation|2|||
105815311|NCT00050778|364983463|FG001|Overall Study|Protocol Violation|0|||
106018181|NCT02699749|365729292|FG010|Overall Study|Progressive Disease|5|||
105815312|NCT00050778|364983464|FG002|Overall Study|Protocol Violation|1|||
105815313|NCT00050778|364983462|FG000|Overall Study|Withdrawal by Subject|6|||
105815314|NCT00050778|364983463|FG001|Overall Study|Withdrawal by Subject|8|||
105815315|NCT00050778|364983464|FG002|Overall Study|Withdrawal by Subject|4|||
105815316|NCT00050778|364983462|FG000|Overall Study|Randomized but not treated|4|||
105815317|NCT00050778|364983463|FG001|Overall Study|Randomized but not treated|5|||
105815318|NCT00050778|364983464|FG002|Overall Study|Randomized but not treated|2|||
105815319|NCT00050778|364983462|FG000|Overall Study|Familial and personal reasons|1|||
105815320|NCT00050778|364983463|FG001|Overall Study|Familial and personal reasons|0|||
105815321|NCT00050778|364983464|FG002|Overall Study|Familial and personal reasons|0|||
105815322|NCT02910037|364983467|FG000|Overall Study|Withdrawal by Subject|4|||
105815323|NCT02910037|364983467|FG000|Overall Study|Lost to Follow-up|6|||
105815324|NCT00813293|364983468|FG000|Overall Study|Intercurrent illness|1|||
105815325|NCT00813293|364983469|FG001|Overall Study|Intercurrent illness|0|||
105815326|NCT00813293|364983468|FG000|Overall Study|Adverse Event|0|||
105815327|NCT00813293|364983469|FG001|Overall Study|Adverse Event|1|||
105815328|NCT01544127|364983470|FG000|Overall Study|Lost to Follow-up|4|||
105815329|NCT01544127|364983471|FG001|Overall Study|Lost to Follow-up|2|||
105815330|NCT01544127|364983472|FG002|Overall Study|Lost to Follow-up|9|||
105815331|NCT01544127|364983470|FG000|Overall Study|Withdrawal by Subject|2|||
105815332|NCT01544127|364983471|FG001|Overall Study|Withdrawal by Subject|2|||
105815333|NCT01544127|364983472|FG002|Overall Study|Withdrawal by Subject|1|||
105815334|NCT01544127|364983470|FG000|Overall Study|Discharged out of catchment area|1|||
105815335|NCT01544127|364983471|FG001|Overall Study|Discharged out of catchment area|1|||
105815336|NCT01544127|364983472|FG002|Overall Study|Discharged out of catchment area|1|||
105815337|NCT01544127|364983470|FG000|Overall Study|Death|1|||
105815338|NCT01544127|364983471|FG001|Overall Study|Death|0|||
105815339|NCT01544127|364983472|FG002|Overall Study|Death|0|||
105815340|NCT01544127|364983470|FG000|Overall Study|Jail or Prison|1|||
105815341|NCT01544127|364983471|FG001|Overall Study|Jail or Prison|1|||
105815342|NCT01544127|364983472|FG002|Overall Study|Jail or Prison|2|||
105815343|NCT01544127|364983470|FG000|Overall Study|Became Psychotic|1|||
105955725|NCT03369665|365499695|FG000|Overall Study|Progression Disease|2|||
105955726|NCT03369665|365499695|FG000|Overall Study|Not classified|3|||
105955727|NCT00131352|365499696|FG000|Initial Treatment Period|Adverse Event|1|||
105955728|NCT00131352|365499697|FG001|Initial Treatment Period|Adverse Event|3|||
105955729|NCT00131352|365499696|FG000|Initial Treatment Period|Non-compliant|1|||
105955730|NCT00131352|365499697|FG001|Initial Treatment Period|Non-compliant|2|||
105955731|NCT00131352|365499696|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
105955732|NCT00131352|365499697|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
105955733|NCT00131352|365499696|FG000|Initial Treatment Period|Lack of Efficacy|6|||
105955734|NCT00131352|365499697|FG001|Initial Treatment Period|Lack of Efficacy|4|||
105955735|NCT00131352|365499696|FG000|Initial Treatment Period|Other|0|||
105955736|NCT00131352|365499697|FG001|Initial Treatment Period|Other|2|||
105955737|NCT00131352|365499696|FG000|Repeat Treatment Period|Adverse Event|1|||
105955738|NCT00131352|365499697|FG001|Repeat Treatment Period|Adverse Event|0|||
105955739|NCT00131352|365499696|FG000|Repeat Treatment Period|Other|1|||
105955740|NCT00131352|365499697|FG001|Repeat Treatment Period|Other|0|||
105955741|NCT03810014|365499704|FG000|Overall Study|Pregnancy|2|||
105955742|NCT03810014|365499705|FG001|Overall Study|Pregnancy|2|||
105955743|NCT03810014|365499706|FG002|Overall Study|Pregnancy|0|||
105955744|NCT03810014|365499707|FG003|Overall Study|Pregnancy|2|||
105955745|NCT00003631|365499709|FG000|Overall Study|Patient not treated|1|||
105955746|NCT00003631|365499710|FG001|Overall Study|Patient not treated|0|||
105955747|NCT00003631|365499711|FG002|Overall Study|Patient not treated|1|||
105955748|NCT00003631|365499709|FG000|Overall Study|Protocol Violation|1|||
105955749|NCT00003631|365499710|FG001|Overall Study|Protocol Violation|0|||
105955750|NCT00003631|365499711|FG002|Overall Study|Protocol Violation|0|||
105955751|NCT00003631|365499709|FG000|Overall Study|Adverse Event|1|||
105955752|NCT00003631|365499710|FG001|Overall Study|Adverse Event|1|||
105955753|NCT00003631|365499711|FG002|Overall Study|Adverse Event|5|||
105955754|NCT00003631|365499709|FG000|Overall Study|Death|0|||
105955755|NCT00003631|365499710|FG001|Overall Study|Death|0|||
105955756|NCT00003631|365499711|FG002|Overall Study|Death|1|||
105955757|NCT00003631|365499709|FG000|Overall Study|Evaluable for toxicity only|0|||
105955758|NCT00003631|365499710|FG001|Overall Study|Evaluable for toxicity only|0|||
105955759|NCT00003631|365499711|FG002|Overall Study|Evaluable for toxicity only|2|||
105955760|NCT04571060|365499717|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
105955761|NCT04571060|365499718|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
105955762|NCT04571060|365499717|FG000|Overall Study|Never treated migraine|47|||
105815344|NCT01544127|364983471|FG001|Overall Study|Became Psychotic|0|||
105815345|NCT01544127|364983472|FG002|Overall Study|Became Psychotic|0|||
105815346|NCT01544127|364983470|FG000|Overall Study|Researcher withdrew|1|||
105955763|NCT04571060|365499718|FG001|Overall Study|Never treated migraine|36|||
105955764|NCT04571060|365499717|FG000|Overall Study|Protocol Violation|4|||
105815347|NCT01544127|364983471|FG001|Overall Study|Researcher withdrew|0|||
105815348|NCT01544127|364983472|FG002|Overall Study|Researcher withdrew|0|||
105815349|NCT01544127|364983470|FG000|Overall Study|Went active duty|0|||
105815350|NCT01544127|364983471|FG001|Overall Study|Went active duty|0|||
105815351|NCT01544127|364983472|FG002|Overall Study|Went active duty|1|||
105815352|NCT00615069|364983474|FG000|Overall Study|Death|10|||
105815353|NCT00615069|364983474|FG000|Overall Study|Physician Decision|2|||
105815354|NCT00615069|364983474|FG000|Overall Study|Withdrawal by Subject|4|||
105815355|NCT02914600|364983475|FG000|Overall Study|Adverse Event|298|||
105815356|NCT02914600|364983476|FG001|Overall Study|Adverse Event|35|||
105815357|NCT02914600|364983477|FG002|Overall Study|Adverse Event|25|||
105815358|NCT02914600|364983475|FG000|Overall Study|Sponsors decision|287|||
105815359|NCT02914600|364983476|FG001|Overall Study|Sponsors decision|41|||
105815360|NCT02914600|364983477|FG002|Overall Study|Sponsors decision|12|||
105815361|NCT02914600|364983475|FG000|Overall Study|Withdrawal by Subject|158|||
105815362|NCT02914600|364983476|FG001|Overall Study|Withdrawal by Subject|20|||
105815363|NCT02914600|364983477|FG002|Overall Study|Withdrawal by Subject|18|||
105815364|NCT02914600|364983475|FG000|Overall Study|Investigators discretion|169|||
105815365|NCT02914600|364983476|FG001|Overall Study|Investigators discretion|14|||
105815366|NCT02914600|364983477|FG002|Overall Study|Investigators discretion|13|||
105815367|NCT02914600|364983475|FG000|Overall Study|Lost to Follow-up|10|||
105815368|NCT02914600|364983476|FG001|Overall Study|Lost to Follow-up|4|||
105815369|NCT02914600|364983477|FG002|Overall Study|Lost to Follow-up|0|||
105815370|NCT02914600|364983475|FG000|Overall Study|Pregnancy|8|||
105815371|NCT02914600|364983476|FG001|Overall Study|Pregnancy|0|||
105815372|NCT02914600|364983477|FG002|Overall Study|Pregnancy|0|||
105815373|NCT02914600|364983475|FG000|Overall Study|Protocol Violation|5|||
105815374|NCT02914600|364983476|FG001|Overall Study|Protocol Violation|3|||
105815375|NCT02914600|364983477|FG002|Overall Study|Protocol Violation|0|||
105815376|NCT02914600|364983475|FG000|Overall Study|Non-compliance with study drug|6|||
105815377|NCT02914600|364983476|FG001|Overall Study|Non-compliance with study drug|1|||
105815378|NCT02914600|364983477|FG002|Overall Study|Non-compliance with study drug|0|||
105815379|NCT02914600|364983475|FG000|Overall Study|Death|3|||
105815380|NCT02914600|364983476|FG001|Overall Study|Death|1|||
105815381|NCT02914600|364983477|FG002|Overall Study|Death|1|||
105815382|NCT02914600|364983475|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
105815383|NCT02914600|364983476|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
105815384|NCT02914600|364983477|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
105815385|NCT02914600|364983475|FG000|Overall Study|Enrolled but not treated|1|||
105815386|NCT02914600|364983476|FG001|Overall Study|Enrolled but not treated|0|||
105815387|NCT02914600|364983477|FG002|Overall Study|Enrolled but not treated|0|||
105815388|NCT01395030|364983481|FG000|Overall Study|Did not complete FCH PET/CT|7|||
105815389|NCT02079766|364983482|FG000|Overall Study|Physician Decision|1|||
105815390|NCT02079766|364983483|FG001|Overall Study|Physician Decision|0|||
105815391|NCT02079766|364983482|FG000|Overall Study|Withdrawal by Subject|1|||
105815392|NCT02079766|364983483|FG001|Overall Study|Withdrawal by Subject|0|||
105815393|NCT02008565|364983488|FG000|Overall Study|Protocol Violation|1|||
105815394|NCT02008565|364983489|FG001|Overall Study|Protocol Violation|1|||
105815395|NCT02008565|364983490|FG002|Overall Study|Protocol Violation|2|||
105815396|NCT02008565|364983491|FG003|Overall Study|Protocol Violation|0|||
105815397|NCT02781727|364983492|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
105815398|NCT02781727|364983493|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
105815399|NCT02781727|364983492|FG000|Treatment Period|Withdrawal by Subject|1|||
105815400|NCT02781727|364983493|FG001|Treatment Period|Withdrawal by Subject|0|||
105815401|NCT02781727|364983492|FG000|Treatment Period|Lost to Follow-up|0|||
105815402|NCT02781727|364983493|FG001|Treatment Period|Lost to Follow-up|1|||
105815403|NCT02327130|364983494|FG000|Overall Study|Discharged in less than 5 days|5|||
105815404|NCT02327130|364983494|FG000|Overall Study|Physician Decision|2|||
105815405|NCT02327130|364983494|FG000|Overall Study|Unable to provide breath sample|1|||
105815406|NCT02327130|364983494|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
105815407|NCT02327130|364983494|FG000|Overall Study|Met exclusion criteria|3|||
105815408|NCT00857623|364983495|FG000|Overall Study|Adverse Event|5|||
105815409|NCT00857623|364983496|FG001|Overall Study|Adverse Event|2|||
105815410|NCT00857623|364983495|FG000|Overall Study|Study-specific discontinuation criteria|5|||
105815411|NCT00857623|364983496|FG001|Overall Study|Study-specific discontinuation criteria|3|||
105815412|NCT00857623|364983495|FG000|Overall Study|Withdrawal by Subject|2|||
105815413|NCT00857623|364983496|FG001|Overall Study|Withdrawal by Subject|1|||
105815414|NCT00857623|364983495|FG000|Overall Study|Lack of Efficacy|1|||
105815415|NCT00857623|364983496|FG001|Overall Study|Lack of Efficacy|1|||
105815416|NCT00857623|364983495|FG000|Overall Study|Severe non-compliance to protocol|1|||
105815417|NCT00857623|364983496|FG001|Overall Study|Severe non-compliance to protocol|1|||
105815418|NCT00857623|364983495|FG000|Overall Study|Intake of prohibited medication|0|||
105815419|NCT00857623|364983496|FG001|Overall Study|Intake of prohibited medication|1|||
105815420|NCT00857623|364983495|FG000|Overall Study|Positive for HEP C|0|||
105815421|NCT00857623|364983496|FG001|Overall Study|Positive for HEP C|1|||
105815422|NCT02193178|364983497|FG000|Overall Study|Lost to Follow-up|1|||
105815423|NCT02193178|364983497|FG000|Overall Study|Dry eyes|1|||
105815424|NCT03435081|364983498|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
105815425|NCT03435081|364983499|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
105815426|NCT03435081|364983500|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
105815427|NCT03435081|364983498|FG000|Week 0 to Week 16|Adverse Event|2|||
105815428|NCT03435081|364983499|FG001|Week 0 to Week 16|Adverse Event|2|||
105815429|NCT03435081|364983500|FG002|Week 0 to Week 16|Adverse Event|2|||
105815430|NCT03435081|364983498|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
105815431|NCT03435081|364983499|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
105815432|NCT03435081|364983500|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
105815433|NCT03435081|364983498|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
105815434|NCT03435081|364983499|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
105815435|NCT03435081|364983500|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
105815436|NCT03435081|364983498|FG000|Week 0 to Week 16|Pregnancy|1|||
105815437|NCT03435081|364983499|FG001|Week 0 to Week 16|Pregnancy|0|||
105815438|NCT03435081|364983500|FG002|Week 0 to Week 16|Pregnancy|0|||
105815439|NCT03435081|364983498|FG000|Week 0 to Week 16|Non-compliance|1|||
105815440|NCT03435081|364983499|FG001|Week 0 to Week 16|Non-compliance|0|||
105815441|NCT03435081|364983500|FG002|Week 0 to Week 16|Non-compliance|2|||
105815442|NCT03435081|364983498|FG000|Week 0 to Week 16|Inadequate Response|0|||
105815443|NCT03435081|364983499|FG001|Week 0 to Week 16|Inadequate Response|1|||
105815444|NCT03435081|364983500|FG002|Week 0 to Week 16|Inadequate Response|0|||
105815445|NCT03435081|364983498|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
105815446|NCT03435081|364983499|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
105815447|NCT03435081|364983500|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
105815448|NCT03435081|364983498|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
105815449|NCT03435081|364983499|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
105815450|NCT03435081|364983500|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
105815451|NCT03435081|364983498|FG000|Week 16 to Week 104|Adverse Event|1|||
105815452|NCT03435081|364983499|FG001|Week 16 to Week 104|Adverse Event|0|||
105815453|NCT03435081|364983500|FG002|Week 16 to Week 104|Adverse Event|2|||
105815454|NCT03435081|364983498|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
105815455|NCT03435081|364983499|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
105815456|NCT03435081|364983500|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
105815457|NCT03435081|364983498|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
105815458|NCT03435081|364983499|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
105815459|NCT03435081|364983500|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
105815460|NCT03435081|364983498|FG000|Week 16 to Week 104|Non--Compliance|0|||
105815461|NCT03435081|364983499|FG001|Week 16 to Week 104|Non--Compliance|0|||
105815462|NCT03435081|364983500|FG002|Week 16 to Week 104|Non--Compliance|1|||
105815463|NCT00420238|364983502|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
105815464|NCT00420238|364983503|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
105815465|NCT00420238|364983502|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
105815466|NCT00420238|364983503|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
105815467|NCT00420238|364983502|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
105815468|NCT00420238|364983503|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
105815469|NCT00420238|364983502|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
105815470|NCT00420238|364983503|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
105815471|NCT00420238|364983502|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
105815472|NCT00420238|364983503|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
105815473|NCT00420238|364983502|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
105815474|NCT00420238|364983503|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
105815475|NCT05214560|364983504|FG000|Overall Study|Screening Failure|1|||
105815476|NCT05214560|364983504|FG000|Overall Study|Physician Decision|4|||
105815477|NCT05214560|364983504|FG000|Overall Study|Withdrawal by Subject|1|||
105815478|NCT05214560|364983504|FG000|Overall Study|Lost to Follow-up|2|||
105815479|NCT05214560|364983504|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
105815480|NCT05214560|364983504|FG000|Overall Study|Study physician not available for the anesthesia|3|||
105815481|NCT05214560|364983504|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
105815482|NCT05214560|364983504|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
105815483|NCT05214560|364983504|FG000|Overall Study|Surgery not performed|3|||
105815484|NCT04510285|364983505|FG000|Overall Study|Death|1|||
105815485|NCT01417078|364983506|FG000|Overall Study|Withdrawal by Subject|1|||
105815486|NCT00626548|364983508|FG000|Overall Study|Adverse Event|164|||
105815487|NCT00626548|364983509|FG001|Overall Study|Adverse Event|44|||
106145275|NCT03823911|366191926|FG000|Overall Study|Death|0|||
106145276|NCT03823911|366191927|FG001|Overall Study|Death|1|||
106145277|NCT03823911|366191928|FG002|Overall Study|Death|0|||
105815488|NCT00626548|364983508|FG000|Overall Study|Withdrawal by Subject|42|||
105815489|NCT00626548|364983509|FG001|Overall Study|Withdrawal by Subject|46|||
105815490|NCT00626548|364983508|FG000|Overall Study|Protocol Violation|4|||
105815491|NCT00626548|364983509|FG001|Overall Study|Protocol Violation|11|||
105815492|NCT00626548|364983508|FG000|Overall Study|Lost to Follow-up|2|||
105815493|NCT00626548|364983509|FG001|Overall Study|Lost to Follow-up|2|||
105815494|NCT00626548|364983508|FG000|Overall Study|Other termination reason|493|||
105815495|NCT00626548|364983509|FG001|Overall Study|Other termination reason|613|||
106145278|NCT01595321|366191929|FG000|Overall Study|Adverse Event|1|||
105955765|NCT04571060|365499718|FG001|Overall Study|Protocol Violation|2|||
105955766|NCT04571060|365499717|FG000|Overall Study|Withdrawal by Subject|6|||
105955767|NCT04571060|365499718|FG001|Overall Study|Withdrawal by Subject|2|||
105955768|NCT04571060|365499717|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
105955769|NCT04571060|365499718|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
105955770|NCT02625220|365499719|FG000|Overall Study|Adverse Event|2|||
105955771|NCT02625220|365499719|FG000|Overall Study|Lost to Follow-up|2|||
105955772|NCT02625220|365499719|FG000|Overall Study|Protocol Violation|1|||
105764155|NCT00418717|364788989|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
105764156|NCT00418717|364788989|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
105764157|NCT02460978|364788991|FG000|Overall Study|Adverse Event|17|||
105764158|NCT02460978|364788992|FG001|Overall Study|Adverse Event|11|||
105764159|NCT02460978|364788993|FG002|Overall Study|Adverse Event|11|||
105764160|NCT02460978|364788991|FG000|Overall Study|Withdrawal by Subject|5|||
105764161|NCT02460978|364788992|FG001|Overall Study|Withdrawal by Subject|5|||
105764162|NCT02460978|364788993|FG002|Overall Study|Withdrawal by Subject|14|||
105764163|NCT02460978|364788991|FG000|Overall Study|Lost to Follow-up|2|||
105764164|NCT02460978|364788992|FG001|Overall Study|Lost to Follow-up|3|||
105764165|NCT02460978|364788993|FG002|Overall Study|Lost to Follow-up|1|||
105764166|NCT02460978|364788991|FG000|Overall Study|Protocol Violation|1|||
105764167|NCT02460978|364788992|FG001|Overall Study|Protocol Violation|1|||
105764168|NCT02460978|364788993|FG002|Overall Study|Protocol Violation|1|||
105764169|NCT02460978|364788991|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
105764170|NCT02460978|364788992|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
105764171|NCT02460978|364788993|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
105764172|NCT02460978|364788991|FG000|Overall Study|Pregnancy|0|||
105764173|NCT02460978|364788992|FG001|Overall Study|Pregnancy|0|||
105764174|NCT02460978|364788993|FG002|Overall Study|Pregnancy|2|||
105764175|NCT00994162|364788994|FG000|Overall Study|Withdrawal by Subject|1|||
105764176|NCT00994162|364788994|FG000|Overall Study|Lost to Follow-up|2|||
105764177|NCT00994162|364788994|FG000|Overall Study|Product Complaint|1|||
105764178|NCT00994162|364788994|FG000|Overall Study|Poor Compliance|5|||
105764179|NCT00994162|364788994|FG000|Overall Study|Lack of Response|3|||
105764180|NCT00994162|364788994|FG000|Overall Study|Discharged from Hospital|4|||
105764181|NCT00994162|364788994|FG000|Overall Study|Death|2|||
105764182|NCT00994162|364788994|FG000|Overall Study|Care Transferred to Another Physician|2|||
105764183|NCT00994162|364788994|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
105764184|NCT00994162|364788994|FG000|Overall Study|Physician Decision|2|||
105764185|NCT00994162|364788994|FG000|Overall Study|Surrounding Wound Erythematous|1|||
105764186|NCT00994162|364788994|FG000|Overall Study|Machine Losing Vaccum|1|||
105764187|NCT00994162|364788994|FG000|Overall Study|Patient Lived Too Far Away|1|||
105955773|NCT02625220|365499719|FG000|Overall Study|Study discontinued at site|2|||
105955774|NCT04872569|365499722|FG000|Overall Study|Withdrawal by Subject|2|||
105955775|NCT02375373|365499727|FG000|Overall Study|Withdrawal by Subject|11|||
105955776|NCT01890265|365499728|FG000|Overall Study|Other (Unspecified reason)|0|||
105955777|NCT01890265|365499729|FG001|Overall Study|Other (Unspecified reason)|1|||
105955778|NCT01890265|365499730|FG002|Overall Study|Other (Unspecified reason)|0|||
105955779|NCT01890265|365499731|FG003|Overall Study|Other (Unspecified reason)|0|||
105955780|NCT01890265|365499732|FG004|Overall Study|Other (Unspecified reason)|0|||
105955781|NCT01890265|365499733|FG005|Overall Study|Other (Unspecified reason)|0|||
105955782|NCT01890265|365499728|FG000|Overall Study|Progressive disease|6|||
105955783|NCT01890265|365499729|FG001|Overall Study|Progressive disease|6|||
105955784|NCT01890265|365499730|FG002|Overall Study|Progressive disease|0|||
105955785|NCT01890265|365499731|FG003|Overall Study|Progressive disease|0|||
105764188|NCT00994162|364788994|FG000|Overall Study|Above Knee Amputation|1|||
105764189|NCT00994162|364788994|FG000|Overall Study|Reason Not Reported By Site|1|||
105764190|NCT01814826|364788995|FG000|Overall Study|Other|3|||
105764191|NCT01814826|364788996|FG001|Overall Study|Other|5|||
105764192|NCT01814826|364788997|FG002|Overall Study|Other|0|||
105764193|NCT01814826|364788995|FG000|Overall Study|Death|29|||
105764194|NCT01814826|364788996|FG001|Overall Study|Death|24|||
105764195|NCT01814826|364788997|FG002|Overall Study|Death|3|||
105764196|NCT01042938|364789002|FG000|Overall Study|Withdrawal by Subject|1|||
105764197|NCT01042938|364789003|FG001|Overall Study|Withdrawal by Subject|1|||
105764198|NCT01042938|364789002|FG000|Overall Study|Protocol Violation|1|||
105764199|NCT01042938|364789003|FG001|Overall Study|Protocol Violation|1|||
105764200|NCT01042938|364789002|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
105764201|NCT01042938|364789003|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
105764202|NCT04095793|364789008|FG000|Overall Study|Adverse Event|3|||
105764203|NCT04095793|364789008|FG000|Overall Study|Study Terminated by Sponsor|103|||
105764204|NCT04095793|364789008|FG000|Overall Study|Withdrawal by Subject|4|||
105764205|NCT02384993|364789009|FG000|Overall Study|Adverse Event|0|||
105764206|NCT02384993|364789010|FG001|Overall Study|Adverse Event|1|||
105764207|NCT02571972|364789013|FG000|Overall Study|Protocol Violation|2|||
105955786|NCT01890265|365499732|FG004|Overall Study|Progressive disease|0|||
105955787|NCT01890265|365499733|FG005|Overall Study|Progressive disease|0|||
105955788|NCT01890265|365499728|FG000|Overall Study|Adverse Event|2|||
106145279|NCT01595321|366191930|FG001|Overall Study|Adverse Event|1|||
106145280|NCT01595321|366191931|FG002|Overall Study|Adverse Event|1|||
106145281|NCT01595321|366191929|FG000|Overall Study|Lack of Efficacy|0|||
106145282|NCT01595321|366191930|FG001|Overall Study|Lack of Efficacy|0|||
106145283|NCT01595321|366191931|FG002|Overall Study|Lack of Efficacy|4|||
106145284|NCT00442117|366191932|FG000|Overall Study|Adverse Event|3|||
106145285|NCT00442117|366191933|FG001|Overall Study|Adverse Event|2|||
106145286|NCT00442117|366191932|FG000|Overall Study|Lack of Efficacy|2|||
106145287|NCT00442117|366191933|FG001|Overall Study|Lack of Efficacy|6|||
106145288|NCT00442117|366191932|FG000|Overall Study|Lost to Follow-up|1|||
106145289|NCT00442117|366191933|FG001|Overall Study|Lost to Follow-up|2|||
106145290|NCT00442117|366191932|FG000|Overall Study|Withdrawal by Subject|2|||
106145291|NCT00442117|366191933|FG001|Overall Study|Withdrawal by Subject|2|||
106145292|NCT00442117|366191932|FG000|Overall Study|Major Deviation|25|||
106145293|NCT00442117|366191933|FG001|Overall Study|Major Deviation|20|||
106145294|NCT00442117|366191932|FG000|Overall Study|Non compliance with protocol|3|||
106145295|NCT00442117|366191933|FG001|Overall Study|Non compliance with protocol|5|||
106145296|NCT00442117|366191932|FG000|Overall Study|Met Withdrawal Criteria|2|||
106145297|NCT00442117|366191933|FG001|Overall Study|Met Withdrawal Criteria|1|||
106145298|NCT01395758|366191941|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
106145299|NCT01395758|366191942|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
106145300|NCT01395758|366191943|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
106145301|NCT00433199|366191944|FG000|Double-Blind Period|Adverse Event|0|||
106145302|NCT00433199|366191945|FG001|Double-Blind Period|Adverse Event|25|||
106145303|NCT00433199|366191944|FG000|Double-Blind Period|Lack of Efficacy|0|||
106145304|NCT00433199|366191945|FG001|Double-Blind Period|Lack of Efficacy|2|||
106145305|NCT00433199|366191944|FG000|Double-Blind Period|Lost to Follow-up|2|||
106145306|NCT00433199|366191945|FG001|Double-Blind Period|Lost to Follow-up|5|||
105764208|NCT02571972|364789013|FG000|Overall Study|Withdrawal by Subject|2|||
106145307|NCT00433199|366191944|FG000|Double-Blind Period|Withdrawal by Subject|8|||
106145308|NCT00433199|366191945|FG001|Double-Blind Period|Withdrawal by Subject|19|||
105764209|NCT00634751|364791633|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
105764210|NCT00634751|364791634|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
105764211|NCT00634751|364791635|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
105764212|NCT00634751|364791636|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
105764213|NCT00634751|364791633|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
105764214|NCT00634751|364791634|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
105764215|NCT00634751|364791635|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
105764216|NCT00634751|364791636|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
105764217|NCT00634751|364791633|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
105764218|NCT00634751|364791634|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
105764219|NCT00634751|364791635|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
105764220|NCT00634751|364791636|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
105764221|NCT00216086|364791646|FG000|Overall Study|Protocol Violation|1|||
105764222|NCT00216086|364791646|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
105764223|NCT00216086|364791646|FG000|Overall Study|Social Reasons|2|||
105764224|NCT00239356|364791649|FG000|Overall Study|Lack of Efficacy|1|||
105764225|NCT00239356|364791650|FG001|Overall Study|Lack of Efficacy|0|||
105764226|NCT00239356|364791649|FG000|Overall Study|Adverse Event|6|||
105764227|NCT00239356|364791650|FG001|Overall Study|Adverse Event|0|||
105764228|NCT00239356|364791649|FG000|Overall Study|Withdrawal by Subject|15|||
105764229|NCT00239356|364791650|FG001|Overall Study|Withdrawal by Subject|6|||
105764230|NCT00239356|364791649|FG000|Overall Study|Lost to Follow-up|3|||
105764231|NCT00239356|364791650|FG001|Overall Study|Lost to Follow-up|0|||
105764232|NCT00239356|364791649|FG000|Overall Study|poor/non-compliance|2|||
105764233|NCT00239356|364791650|FG001|Overall Study|poor/non-compliance|0|||
105764234|NCT00239356|364791649|FG000|Overall Study|Pregnancy|1|||
105764235|NCT00239356|364791650|FG001|Overall Study|Pregnancy|0|||
105764236|NCT00239356|364791649|FG000|Overall Study|Administrative reason|0|||
105764237|NCT00239356|364791650|FG001|Overall Study|Administrative reason|1|||
105764238|NCT00239356|364791649|FG000|Overall Study|Drug available on market|11|||
105764239|NCT00239356|364791650|FG001|Overall Study|Drug available on market|2|||
105764240|NCT01094808|364791651|FG000|Overall Study|Withdrawal by Subject|1|||
105764241|NCT01094808|364791652|FG001|Overall Study|Withdrawal by Subject|1|||
105764242|NCT01094808|364791653|FG002|Overall Study|Withdrawal by Subject|0|||
105764243|NCT00369278|364791654|FG000|Overall Study|Adverse Event|14|||
105764244|NCT00369278|364791655|FG001|Overall Study|Adverse Event|11|||
105764245|NCT00369278|364791654|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105764246|NCT00369278|364791655|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
105764247|NCT00369278|364791654|FG000|Overall Study|Protocol Violation|2|||
105764248|NCT00369278|364791655|FG001|Overall Study|Protocol Violation|1|||
105764249|NCT00369278|364791654|FG000|Overall Study|Withdrawal by Subject|2|||
105764250|NCT00369278|364791655|FG001|Overall Study|Withdrawal by Subject|2|||
105815496|NCT03338972|364983510|FG000|Overall Study|Death|1|||
105764251|NCT00369278|364791654|FG000|Overall Study|Lost to Follow-up|1|||
105764252|NCT00369278|364791655|FG001|Overall Study|Lost to Follow-up|0|||
105764253|NCT00369278|364791654|FG000|Overall Study|Graft loss|1|||
105764254|NCT00369278|364791655|FG001|Overall Study|Graft loss|2|||
105764255|NCT00711412|364791658|FG000|Induction Treatment|Death|2|||
105764256|NCT00711412|364791658|FG000|Induction Treatment|Adverse Event|1|||
105764257|NCT00711412|364791658|FG000|Induction Treatment|Other|1|||
105764258|NCT00711412|364791658|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
105764259|NCT00711412|364791658|FG000|Evaluated for Combination Treatment|Death|1|||
105764260|NCT00711412|364791658|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
105764261|NCT00711412|364791658|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
105764262|NCT00711412|364791658|FG000|Combination Treatment|Progressive Disease|1|||
105764263|NCT00711412|364791658|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
105764264|NCT00711412|364791658|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
105764265|NCT00711412|364791658|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
105764266|NCT00711412|364791658|FG000|Evaluation for Response and Surgery|Death|1|||
105764267|NCT00711412|364791658|FG000|Survival Follow up Until Death|Other|12|||
105764268|NCT04179032|364791661|FG000|Part B (Up to Week 52)|Adverse Event|1|||
105764269|NCT04179032|364791661|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
105764270|NCT04179032|364791661|FG000|Access Extension Phase|Ongoing|11|||
105764271|NCT01998958|364791662|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764272|NCT01998958|364791663|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
105764273|NCT01998958|364791664|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764274|NCT01998958|364791665|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764275|NCT01998958|364791666|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764276|NCT01998958|364791667|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764277|NCT01998958|364791668|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764278|NCT01998958|364791669|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764279|NCT01998958|364791670|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764280|NCT01998958|364791671|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764281|NCT01998958|364791672|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764282|NCT01998958|364791673|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764283|NCT01998958|364791674|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764284|NCT01998958|364791675|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764285|NCT01998958|364791676|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764286|NCT01998958|364791677|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764287|NCT01998958|364791678|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764288|NCT01998958|364791679|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764289|NCT01998958|364791680|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764290|NCT01998958|364791681|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764291|NCT01998958|364791682|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764292|NCT01998958|364791683|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764293|NCT01998958|364791684|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764294|NCT01998958|364791685|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764295|NCT01998958|364791686|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764296|NCT01998958|364791687|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764297|NCT01998958|364791688|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764298|NCT01998958|364791689|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764299|NCT01998958|364791690|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764300|NCT01998958|364791691|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764301|NCT01998958|364791692|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764302|NCT01998958|364791693|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
105764303|NCT01998958|364791662|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764304|NCT01998958|364791663|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
105764305|NCT01998958|364791664|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764306|NCT01998958|364791665|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764307|NCT01998958|364791666|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764308|NCT01998958|364791667|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764309|NCT01998958|364791668|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764310|NCT01998958|364791669|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764311|NCT01998958|364791670|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764312|NCT01998958|364791671|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764313|NCT01998958|364791672|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764314|NCT01998958|364791673|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764315|NCT01998958|364791674|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764316|NCT01998958|364791675|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764317|NCT01998958|364791676|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764318|NCT01998958|364791677|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764319|NCT01998958|364791678|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764320|NCT01998958|364791679|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105955789|NCT01890265|365499729|FG001|Overall Study|Adverse Event|1|||
105955790|NCT01890265|365499730|FG002|Overall Study|Adverse Event|0|||
105955791|NCT01890265|365499731|FG003|Overall Study|Adverse Event|0|||
105955792|NCT01890265|365499732|FG004|Overall Study|Adverse Event|0|||
105764321|NCT01998958|364791680|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764322|NCT01998958|364791681|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764323|NCT01998958|364791682|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764324|NCT01998958|364791683|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764325|NCT01998958|364791684|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764326|NCT01998958|364791685|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764327|NCT01998958|364791686|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764328|NCT01998958|364791687|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764329|NCT01998958|364791688|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764330|NCT01998958|364791689|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764331|NCT01998958|364791690|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764332|NCT01998958|364791691|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764333|NCT01998958|364791692|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764334|NCT01998958|364791693|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
105764335|NCT01998958|364791662|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
105764336|NCT01998958|364791663|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
105764337|NCT01998958|364791664|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
105764338|NCT01998958|364791665|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
105764339|NCT01998958|364791666|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
105764340|NCT01998958|364791667|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
105764341|NCT01998958|364791668|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
105764342|NCT01998958|364791669|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
105764343|NCT01998958|364791670|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
105764344|NCT01998958|364791671|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
105764345|NCT01998958|364791672|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
105764346|NCT01998958|364791673|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
105764347|NCT01998958|364791674|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
105764348|NCT01998958|364791675|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
105764349|NCT01998958|364791676|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
105764350|NCT01998958|364791677|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
105764351|NCT01998958|364791678|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
105764352|NCT01998958|364791679|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
105764353|NCT01998958|364791680|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
105764354|NCT01998958|364791681|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
105764355|NCT01998958|364791682|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
105764356|NCT01998958|364791683|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
105764357|NCT01998958|364791684|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
105764358|NCT01998958|364791685|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
105764359|NCT01998958|364791686|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
105764360|NCT01998958|364791687|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
105764361|NCT01998958|364791688|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
105764362|NCT01998958|364791689|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
105764363|NCT01998958|364791690|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
105764364|NCT01998958|364791691|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
105955793|NCT01890265|365499733|FG005|Overall Study|Adverse Event|0|||
105955794|NCT01890265|365499728|FG000|Overall Study|Death|2|||
105955795|NCT01890265|365499729|FG001|Overall Study|Death|3|||
105764365|NCT01998958|364791692|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
105815497|NCT03338972|364983511|FG001|Overall Study|Death|1|||
105815498|NCT03338972|364983512|FG002|Overall Study|Death|0|||
105815499|NCT03338972|364983513|FG003|Overall Study|Death|0|||
105815500|NCT03338972|364983510|FG000|Overall Study|Withdrawal by Subject|1|||
105815501|NCT03338972|364983511|FG001|Overall Study|Withdrawal by Subject|0|||
105815502|NCT03338972|364983512|FG002|Overall Study|Withdrawal by Subject|0|||
105815503|NCT03338972|364983513|FG003|Overall Study|Withdrawal by Subject|0|||
105815504|NCT03991494|364983520|FG000|Overall Study|Progressive Disease|4|||
105815505|NCT03420300|364983522|FG000|Overall Study|Death|2|||
105815506|NCT02421952|364983527|FG000|Overall Study|Diary Not Returned|93|||
105815507|NCT02421952|364983527|FG000|Overall Study|Failed seriation task|13|||
105815508|NCT02421952|364983527|FG000|Overall Study|Subject uncooperative for baseline test|2|||
105815509|NCT02421952|364983527|FG000|Overall Study|Surgery cancelled|1|||
105815510|NCT01937390|364983530|FG000|Overall Study|Death|2|||
105815511|NCT01937390|364983530|FG000|Overall Study|Lost to Follow-up|7|||
105815512|NCT01937390|364983530|FG000|Overall Study|Withdrawal by Subject|5|||
105815513|NCT01937390|364983530|FG000|Overall Study|Fail to return|21|||
105815514|NCT01706536|364983535|FG000|Overall Study|Withdrawal by Subject|1|||
105815515|NCT01706536|364983536|FG001|Overall Study|Withdrawal by Subject|0|||
105815516|NCT01706536|364983537|FG002|Overall Study|Withdrawal by Subject|1|||
105815517|NCT01706536|364983538|FG003|Overall Study|Withdrawal by Subject|0|||
105815518|NCT01706536|364983539|FG004|Overall Study|Withdrawal by Subject|0|||
105815519|NCT01706536|364983535|FG000|Overall Study|Adverse Event|2|||
105815520|NCT01706536|364983536|FG001|Overall Study|Adverse Event|3|||
105815521|NCT01706536|364983537|FG002|Overall Study|Adverse Event|4|||
105815522|NCT01706536|364983538|FG003|Overall Study|Adverse Event|3|||
105815523|NCT01706536|364983539|FG004|Overall Study|Adverse Event|2|||
105815524|NCT01706536|364983535|FG000|Overall Study|Lack of Efficacy|1|||
105815525|NCT01706536|364983536|FG001|Overall Study|Lack of Efficacy|0|||
105815526|NCT01706536|364983537|FG002|Overall Study|Lack of Efficacy|0|||
105815527|NCT01706536|364983538|FG003|Overall Study|Lack of Efficacy|1|||
105815528|NCT01706536|364983539|FG004|Overall Study|Lack of Efficacy|0|||
105815529|NCT01706536|364983535|FG000|Overall Study|non compliance|0|||
105815530|NCT01706536|364983536|FG001|Overall Study|non compliance|1|||
105815531|NCT01706536|364983537|FG002|Overall Study|non compliance|0|||
105815532|NCT01706536|364983538|FG003|Overall Study|non compliance|0|||
105815533|NCT01706536|364983539|FG004|Overall Study|non compliance|0|||
105815534|NCT00824265|364983540|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
105815535|NCT00824265|364983541|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
105815536|NCT00824265|364983540|FG000|Treatment Phase|Protocol Violation|1|||
105815537|NCT00824265|364983541|FG001|Treatment Phase|Protocol Violation|0|||
105955796|NCT01890265|365499730|FG002|Overall Study|Death|1|||
105955797|NCT01890265|365499731|FG003|Overall Study|Death|0|||
105955798|NCT01890265|365499732|FG004|Overall Study|Death|0|||
105955799|NCT01890265|365499733|FG005|Overall Study|Death|0|||
105955800|NCT01890265|365499728|FG000|Overall Study|Withdrawal by Subject|0|||
105955801|NCT01890265|365499729|FG001|Overall Study|Withdrawal by Subject|2|||
105955802|NCT01890265|365499730|FG002|Overall Study|Withdrawal by Subject|3|||
105815538|NCT00824265|364983540|FG000|Treatment Phase|Lost to Follow-up|1|||
105815539|NCT00824265|364983541|FG001|Treatment Phase|Lost to Follow-up|1|||
105815540|NCT00824265|364983540|FG000|Treatment Phase|Physician Decision|6|||
105815541|NCT00824265|364983541|FG001|Treatment Phase|Physician Decision|12|||
105815542|NCT00824265|364983540|FG000|Treatment Phase|Withdrawal by Subject|6|||
105815543|NCT00824265|364983541|FG001|Treatment Phase|Withdrawal by Subject|15|||
105815544|NCT00824265|364983540|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
105815545|NCT00824265|364983541|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
105815546|NCT00824265|364983540|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
105815547|NCT00824265|364983541|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
105815548|NCT04149964|364983542|FG000|Overall Study|Lost to Follow-up|19|||
105955803|NCT01890265|365499731|FG003|Overall Study|Withdrawal by Subject|0|||
105955804|NCT01890265|365499732|FG004|Overall Study|Withdrawal by Subject|2|||
105815549|NCT04149964|364983543|FG001|Overall Study|Lost to Follow-up|18|||
105815550|NCT01402947|364983544|FG000|First Intervention|Adverse Event|0|||
105815551|NCT01402947|364983545|FG001|First Intervention|Adverse Event|1|||
105815552|NCT01223365|364983546|FG000|Open-label Titration Period|Enrolled but not treated|1|||
105815553|NCT01223365|364983546|FG000|Open-label Titration Period|Adverse Event|23|||
105815554|NCT01223365|364983546|FG000|Open-label Titration Period|Lack of Efficacy|3|||
105815555|NCT01223365|364983546|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
105815556|NCT01223365|364983546|FG000|Open-label Titration Period|Protocol Violation|1|||
105815557|NCT01223365|364983546|FG000|Open-label Titration Period|Lost to Follow-up|2|||
105815558|NCT01223365|364983546|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
105815559|NCT01223365|364983546|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
105815560|NCT01223365|364983546|FG000|Open-label Titration Period|Starting physical therapy|1|||
105815561|NCT01223365|364983546|FG000|Open-label Treatment Period|Adverse Event|39|||
105815562|NCT01223365|364983546|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
105815563|NCT01223365|364983546|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
105815564|NCT01223365|364983546|FG000|Open-label Treatment Period|Protocol Violation|15|||
105815565|NCT01223365|364983546|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
105815566|NCT01223365|364983546|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
105815567|NCT01223365|364983546|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
105815568|NCT01223365|364983546|FG000|Open-label Treatment Period|Moved out of area|2|||
105815569|NCT01223365|364983546|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
105815570|NCT01223365|364983546|FG000|Open-label Treatment Period|"Out of window"|1|||
105815571|NCT01223365|364983546|FG000|Open-label Treatment Period|Starting physical therapy|1|||
105815572|NCT01223365|364983546|FG000|Open-label Treatment Period|Physician Decision|2|||
105815573|NCT02682602|364983547|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
105815574|NCT02682602|364983548|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
105815575|NCT02682602|364983547|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
105815576|NCT02682602|364983548|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
105815577|NCT02140060|364983549|FG000|Overall Study|Adverse Event|0|||
105815578|NCT02140060|364983550|FG001|Overall Study|Adverse Event|0|||
105815579|NCT02140060|364983551|FG002|Overall Study|Adverse Event|0|||
105815580|NCT02140060|364983552|FG003|Overall Study|Adverse Event|1|||
105815581|NCT02140060|364983553|FG004|Overall Study|Adverse Event|1|||
105815582|NCT02140060|364983554|FG005|Overall Study|Adverse Event|1|||
105815583|NCT02140060|364983549|FG000|Overall Study|Lack of Efficacy|0|||
105815584|NCT02140060|364983550|FG001|Overall Study|Lack of Efficacy|0|||
105815585|NCT02140060|364983551|FG002|Overall Study|Lack of Efficacy|0|||
105815586|NCT02140060|364983552|FG003|Overall Study|Lack of Efficacy|1|||
105815587|NCT02140060|364983553|FG004|Overall Study|Lack of Efficacy|0|||
105815588|NCT02140060|364983554|FG005|Overall Study|Lack of Efficacy|0|||
105815589|NCT02039908|364983555|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
105815590|NCT02039908|364983556|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
105815591|NCT02039908|364983557|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
105815592|NCT02039908|364983558|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
105815593|NCT02039908|364983555|FG000|Phase 1-Summer|Protocol Violation|6|||
105815594|NCT02039908|364983556|FG001|Phase 1-Summer|Protocol Violation|0|||
105815595|NCT02039908|364983557|FG002|Phase 1-Summer|Protocol Violation|0|||
105815596|NCT02039908|364983558|FG003|Phase 1-Summer|Protocol Violation|0|||
105815597|NCT02039908|364983555|FG000|Phase 2-School Year|Lost to Follow-up|0|||
105815598|NCT02039908|364983556|FG001|Phase 2-School Year|Lost to Follow-up|0|||
105815599|NCT02039908|364983557|FG002|Phase 2-School Year|Lost to Follow-up|1|||
105815600|NCT02039908|364983558|FG003|Phase 2-School Year|Lost to Follow-up|3|||
105815601|NCT02039908|364983555|FG000|Phase 2-School Year|Protocol Violation|0|||
105955805|NCT01890265|365499733|FG005|Overall Study|Withdrawal by Subject|0|||
105955806|NCT01445613|365499734|FG000|30-day Follow-up|Withdrawal by Subject|6|||
105955807|NCT01445613|365499734|FG000|30-day Follow-up|Physician Decision|3|||
105955808|NCT01445613|365499734|FG000|30-day Follow-up|Missed visit|23|||
105955809|NCT01445613|365499734|FG000|30-day Follow-up|Death|3|||
105955810|NCT01445613|365499734|FG000|1-year Follow-up|Withdrawal by Subject|12|||
105955811|NCT01445613|365499734|FG000|1-year Follow-up|Missed visit|29|||
105955812|NCT01445613|365499734|FG000|1-year Follow-up|Lost to Follow-up|2|||
105955813|NCT01445613|365499734|FG000|1-year Follow-up|Death|30|||
105815602|NCT02039908|364983556|FG001|Phase 2-School Year|Protocol Violation|0|||
105815603|NCT02039908|364983557|FG002|Phase 2-School Year|Protocol Violation|3|||
105815604|NCT02039908|364983558|FG003|Phase 2-School Year|Protocol Violation|0|||
105815605|NCT02039908|364983555|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
105815606|NCT02039908|364983556|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
105815607|NCT02039908|364983557|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
105815608|NCT02039908|364983558|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
105815609|NCT03471078|364985303|FG000|Overall Study|Withdrawal by Subject|9|||
105955814|NCT01445613|365499734|FG000|1-year Follow-up|Physician Decision|2|||
105955815|NCT01445613|365499734|FG000|1-year Follow-up|Received a non-study stent|2|||
105815610|NCT03471078|364985304|FG001|Overall Study|Withdrawal by Subject|1|||
105955816|NCT01603043|365499735|FG000|Overall Study|Study Futility|7|||
105955817|NCT01603043|365499736|FG001|Overall Study|Study Futility|3|||
105955818|NCT01402869|365499745|FG000|Overall Study|Required Tooth Extraction|0|||
105955819|NCT01402869|365499746|FG001|Overall Study|Required Tooth Extraction|0|||
105955820|NCT01402869|365499747|FG002|Overall Study|Required Tooth Extraction|1|||
105955821|NCT01740687|365499748|FG000|Overall Study|Lost to Follow-up|11|||
105955822|NCT01740687|365499748|FG000|Overall Study|Withdrawal by Subject|2|||
105955823|NCT01740687|365499748|FG000|Overall Study|other reason|22|||
105955824|NCT01740687|365499748|FG000|Overall Study|treatment not received|2|||
105764366|NCT01998958|364791693|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
105764367|NCT01998958|364791662|FG000|Period 1 (Panel A and B)|Other|1|||
105764368|NCT01998958|364791663|FG001|Period 1 (Panel A and B)|Other|0|||
105764369|NCT01998958|364791664|FG002|Period 1 (Panel A and B)|Other|0|||
105764370|NCT01998958|364791665|FG003|Period 1 (Panel A and B)|Other|0|||
105764371|NCT01998958|364791666|FG004|Period 1 (Panel A and B)|Other|0|||
105764372|NCT01998958|364791667|FG005|Period 1 (Panel A and B)|Other|0|||
105764373|NCT01998958|364791668|FG006|Period 1 (Panel A and B)|Other|0|||
105764374|NCT01998958|364791669|FG007|Period 1 (Panel A and B)|Other|0|||
105764375|NCT01998958|364791670|FG008|Period 1 (Panel A and B)|Other|0|||
105764376|NCT01998958|364791671|FG009|Period 1 (Panel A and B)|Other|0|||
105764377|NCT01998958|364791672|FG010|Period 1 (Panel A and B)|Other|0|||
105764378|NCT01998958|364791673|FG011|Period 1 (Panel A and B)|Other|0|||
105764379|NCT01998958|364791674|FG012|Period 1 (Panel A and B)|Other|0|||
105764380|NCT01998958|364791675|FG013|Period 1 (Panel A and B)|Other|0|||
105764381|NCT01998958|364791676|FG014|Period 1 (Panel A and B)|Other|0|||
105764382|NCT01998958|364791677|FG015|Period 1 (Panel A and B)|Other|0|||
105764383|NCT01998958|364791678|FG016|Period 1 (Panel A and B)|Other|0|||
105764384|NCT01998958|364791679|FG017|Period 1 (Panel A and B)|Other|0|||
105764385|NCT01998958|364791680|FG018|Period 1 (Panel A and B)|Other|0|||
105764386|NCT01998958|364791681|FG019|Period 1 (Panel A and B)|Other|0|||
105764387|NCT01998958|364791682|FG020|Period 1 (Panel A and B)|Other|0|||
105764388|NCT01998958|364791683|FG021|Period 1 (Panel A and B)|Other|0|||
105764389|NCT01998958|364791684|FG022|Period 1 (Panel A and B)|Other|0|||
105764390|NCT01998958|364791685|FG023|Period 1 (Panel A and B)|Other|0|||
105764391|NCT01998958|364791686|FG024|Period 1 (Panel A and B)|Other|0|||
105764392|NCT01998958|364791687|FG025|Period 1 (Panel A and B)|Other|0|||
105764393|NCT01998958|364791688|FG026|Period 1 (Panel A and B)|Other|0|||
105764394|NCT01998958|364791689|FG027|Period 1 (Panel A and B)|Other|0|||
105764395|NCT01998958|364791690|FG028|Period 1 (Panel A and B)|Other|0|||
105764396|NCT01998958|364791691|FG029|Period 1 (Panel A and B)|Other|0|||
105764397|NCT01998958|364791692|FG030|Period 1 (Panel A and B)|Other|0|||
105764398|NCT01998958|364791693|FG031|Period 1 (Panel A and B)|Other|0|||
105764399|NCT01998958|364791662|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
105764400|NCT01998958|364791663|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
105764401|NCT01998958|364791664|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
105764402|NCT01998958|364791665|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
105764403|NCT01998958|364791666|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
105764404|NCT01998958|364791667|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
105764405|NCT01998958|364791668|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
105764406|NCT01998958|364791669|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
105764407|NCT01998958|364791670|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
105764408|NCT01998958|364791671|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
105764409|NCT01998958|364791672|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
105764410|NCT01998958|364791673|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
105764411|NCT01998958|364791674|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
105764412|NCT01998958|364791675|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
105764413|NCT01998958|364791676|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
105955825|NCT01392573|365499752|FG000|Overall Study|Adverse Event|1|||
105764414|NCT01998958|364791677|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
105764415|NCT01998958|364791678|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
105955826|NCT01392573|365499753|FG001|Overall Study|Adverse Event|3|||
105815611|NCT03471078|364985303|FG000|Overall Study|Adverse Event|4|||
105815612|NCT03471078|364985304|FG001|Overall Study|Adverse Event|1|||
105815613|NCT03471078|364985303|FG000|Overall Study|Physician Decision|3|||
105815614|NCT03471078|364985304|FG001|Overall Study|Physician Decision|2|||
105815615|NCT03471078|364985303|FG000|Overall Study|Death|2|||
105815616|NCT03471078|364985304|FG001|Overall Study|Death|0|||
105815617|NCT03471078|364985303|FG000|Overall Study|Other|3|||
105815618|NCT03471078|364985304|FG001|Overall Study|Other|2|||
105815619|NCT01108094|364985306|FG000|Overall Study|Adverse Event|2|||
105815620|NCT01108094|364985307|FG001|Overall Study|Adverse Event|0|||
105815621|NCT01108094|364985308|FG002|Overall Study|Adverse Event|0|||
105815622|NCT01108094|364985309|FG003|Overall Study|Adverse Event|0|||
105815623|NCT01108094|364985306|FG000|Overall Study|Withdrawal by Subject|1|||
105815624|NCT01108094|364985307|FG001|Overall Study|Withdrawal by Subject|0|||
105815625|NCT01108094|364985308|FG002|Overall Study|Withdrawal by Subject|0|||
105815626|NCT01108094|364985309|FG003|Overall Study|Withdrawal by Subject|0|||
105815627|NCT02896361|364985334|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
105815628|NCT02896361|364985335|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
105815629|NCT02896361|364985336|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
105815630|NCT02896361|364985334|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
105815631|NCT02896361|364985335|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
105815632|NCT02896361|364985336|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
105815633|NCT03164772|364985338|FG000|Overall Study|Death|4|||
105815634|NCT03164772|364985339|FG001|Overall Study|Death|2|||
105815635|NCT03164772|364985338|FG000|Overall Study|Adverse Event|1|||
105815636|NCT03164772|364985339|FG001|Overall Study|Adverse Event|4|||
105815637|NCT03164772|364985338|FG000|Overall Study|Progressive Disease|11|||
105815638|NCT03164772|364985339|FG001|Overall Study|Progressive Disease|21|||
105815639|NCT03164772|364985338|FG000|Overall Study|Physician Decision|2|||
105815640|NCT03164772|364985339|FG001|Overall Study|Physician Decision|0|||
105815641|NCT03164772|364985338|FG000|Overall Study|Withdrawal by Subject|0|||
105815642|NCT03164772|364985339|FG001|Overall Study|Withdrawal by Subject|4|||
105815643|NCT01029353|364985340|FG000|Overall Study|Lost to Follow-up|4|||
105815644|NCT01029353|364985341|FG001|Overall Study|Lost to Follow-up|5|||
105815645|NCT01029353|364985342|FG002|Overall Study|Lost to Follow-up|5|||
105815646|NCT01029353|364985343|FG003|Overall Study|Lost to Follow-up|4|||
105815647|NCT01029353|364985340|FG000|Overall Study|Consent Withdrawn|2|||
105815648|NCT01029353|364985341|FG001|Overall Study|Consent Withdrawn|0|||
105815649|NCT01029353|364985342|FG002|Overall Study|Consent Withdrawn|0|||
105815650|NCT01029353|364985343|FG003|Overall Study|Consent Withdrawn|0|||
105815651|NCT01029353|364985340|FG000|Overall Study|Primary Outcome Indeterminate|1|||
105815652|NCT01029353|364985341|FG001|Overall Study|Primary Outcome Indeterminate|3|||
105815653|NCT01029353|364985342|FG002|Overall Study|Primary Outcome Indeterminate|2|||
105815654|NCT01029353|364985343|FG003|Overall Study|Primary Outcome Indeterminate|0|||
105815655|NCT01287013|364985345|FG000|Overall Study|Non-evaluable|3|||
105815656|NCT01287013|364985346|FG001|Overall Study|Non-evaluable|5|||
105815657|NCT01287013|364985347|FG002|Overall Study|Non-evaluable|21|||
105815658|NCT00051025|364985351|FG000|Overall Study|Progressive Disease|1|||
105815659|NCT00051025|364985352|FG001|Overall Study|Progressive Disease|1|||
105815660|NCT00051025|364985351|FG000|Overall Study|Adverse Event|1|||
105815661|NCT00051025|364985352|FG001|Overall Study|Adverse Event|1|||
105815662|NCT00051025|364985351|FG000|Overall Study|Withdrawal by Subject|0|||
105815663|NCT00051025|364985352|FG001|Overall Study|Withdrawal by Subject|1|||
106018182|NCT02699749|365729293|FG011|Overall Study|Progressive Disease|4|||
106018183|NCT02699749|365729294|FG012|Overall Study|Progressive Disease|3|||
106018184|NCT02699749|365729295|FG013|Overall Study|Progressive Disease|5|||
106018185|NCT02699749|365729282|FG000|Overall Study|Death|0|||
106018186|NCT02699749|365729283|FG001|Overall Study|Death|0|||
106018187|NCT02699749|365729284|FG002|Overall Study|Death|0|||
106145309|NCT00433199|366191944|FG000|Double-Blind Period|Protocol Violation|1|||
106145310|NCT00433199|366191945|FG001|Double-Blind Period|Protocol Violation|10|||
106018188|NCT02699749|365729285|FG003|Overall Study|Death|0|||
106018189|NCT02699749|365729286|FG004|Overall Study|Death|0|||
106145311|NCT00433199|366191944|FG000|Double-Blind Period|Administrative|1|||
106145312|NCT00433199|366191945|FG001|Double-Blind Period|Administrative|5|||
105815664|NCT00051025|364985351|FG000|Overall Study|Death|0|||
105815665|NCT00051025|364985352|FG001|Overall Study|Death|1|||
105815666|NCT02189941|364985353|FG000|Overall Study|Non-compliance|0|||
105815667|NCT02189941|364985354|FG001|Overall Study|Non-compliance|0|||
105815668|NCT02189941|364985355|FG002|Overall Study|Non-compliance|1|||
105815669|NCT01682083|364985357|FG000|Overall Study|Lost to Follow-up|11|||
105815670|NCT01682083|364985358|FG001|Overall Study|Lost to Follow-up|18|||
105815671|NCT01682083|364985357|FG000|Overall Study|Withdrawal by Subject|31|||
105815672|NCT01682083|364985358|FG001|Overall Study|Withdrawal by Subject|40|||
105815673|NCT01682083|364985357|FG000|Overall Study|Death|60|||
105815674|NCT01682083|364985358|FG001|Overall Study|Death|93|||
106018190|NCT02699749|365729287|FG005|Overall Study|Death|0|||
106018191|NCT02699749|365729288|FG006|Overall Study|Death|0|||
106018192|NCT02699749|365729289|FG007|Overall Study|Death|0|||
106018193|NCT02699749|365729290|FG008|Overall Study|Death|0|||
106018194|NCT02699749|365729291|FG009|Overall Study|Death|0|||
106018195|NCT02699749|365729292|FG010|Overall Study|Death|0|||
106018196|NCT02699749|365729293|FG011|Overall Study|Death|0|||
106018197|NCT02699749|365729294|FG012|Overall Study|Death|0|||
106018198|NCT02699749|365729295|FG013|Overall Study|Death|1|||
106018199|NCT02699749|365729282|FG000|Overall Study|Lost to Follow-up|0|||
106018200|NCT02699749|365729283|FG001|Overall Study|Lost to Follow-up|0|||
106018201|NCT02699749|365729284|FG002|Overall Study|Lost to Follow-up|0|||
106018202|NCT02699749|365729285|FG003|Overall Study|Lost to Follow-up|0|||
106018203|NCT02699749|365729286|FG004|Overall Study|Lost to Follow-up|0|||
106018204|NCT02699749|365729287|FG005|Overall Study|Lost to Follow-up|1|||
106018205|NCT02699749|365729288|FG006|Overall Study|Lost to Follow-up|0|||
106018206|NCT02699749|365729289|FG007|Overall Study|Lost to Follow-up|1|||
106018207|NCT02699749|365729290|FG008|Overall Study|Lost to Follow-up|0|||
106018208|NCT02699749|365729291|FG009|Overall Study|Lost to Follow-up|0|||
106018209|NCT02699749|365729292|FG010|Overall Study|Lost to Follow-up|0|||
106018210|NCT02699749|365729293|FG011|Overall Study|Lost to Follow-up|0|||
106018211|NCT02699749|365729294|FG012|Overall Study|Lost to Follow-up|0|||
106018212|NCT02699749|365729295|FG013|Overall Study|Lost to Follow-up|0|||
106018213|NCT02377817|365729296|FG000|Overall Study|Transportation/childcare barriers.|2|||
106018214|NCT02377817|365729297|FG001|Overall Study|Transportation/childcare barriers.|0|||
106018215|NCT02377817|365729296|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
106018216|NCT02377817|365729297|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
106018217|NCT03895840|365729298|FG000|Overall Study|Withdrawal by Subject|21|||
106018218|NCT02565108|365729299|FG000|Overall Study|Adverse Event|1|||
106018219|NCT02565108|365729300|FG001|Overall Study|Adverse Event|0|||
106018220|NCT02565108|365729299|FG000|Overall Study|Withdrew Consent|1|||
106018221|NCT02565108|365729300|FG001|Overall Study|Withdrew Consent|0|||
106018222|NCT01310075|365729301|FG000|Overall Study|Lost to Follow-up|1|||
106018223|NCT01310075|365729302|FG001|Overall Study|Lost to Follow-up|0|||
106018224|NCT01310075|365729301|FG000|Overall Study|Physician Decision|10|||
106018225|NCT01310075|365729302|FG001|Overall Study|Physician Decision|7|||
106018226|NCT01310075|365729301|FG000|Overall Study|Protocol Violation|2|||
106018227|NCT01310075|365729302|FG001|Overall Study|Protocol Violation|2|||
106018228|NCT01310075|365729301|FG000|Overall Study|Withdrawal by Subject|1|||
106018229|NCT01310075|365729302|FG001|Overall Study|Withdrawal by Subject|1|||
106018230|NCT03614156|365729303|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
106018231|NCT03614156|365729304|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
106018232|NCT03614156|365729305|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
106145313|NCT00433199|366191944|FG000|Open-Label Period|Adverse Event|0|||
106145314|NCT00433199|366191945|FG001|Open-Label Period|Adverse Event|19|||
106145315|NCT00433199|366191944|FG000|Open-Label Period|Lack of Efficacy|0|||
106145316|NCT00433199|366191945|FG001|Open-Label Period|Lack of Efficacy|2|||
105764416|NCT01998958|364791679|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
105764417|NCT01998958|364791680|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
105764418|NCT01998958|364791681|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
105764419|NCT01998958|364791682|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
105764420|NCT01998958|364791683|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
105764421|NCT01998958|364791684|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
105764422|NCT01998958|364791685|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
105764423|NCT01998958|364791686|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
105764424|NCT01998958|364791687|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
105764425|NCT01998958|364791688|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
105764426|NCT01998958|364791689|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
105764427|NCT01998958|364791690|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
105764428|NCT01998958|364791691|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
105764429|NCT01998958|364791692|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
105764430|NCT01998958|364791693|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
105764431|NCT01998958|364791662|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764432|NCT01998958|364791663|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764433|NCT01998958|364791664|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764434|NCT01998958|364791665|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764435|NCT01998958|364791666|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764436|NCT01998958|364791667|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764437|NCT01998958|364791668|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764438|NCT01998958|364791669|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
106018233|NCT03614156|365729306|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
106018234|NCT03614156|365729303|FG000|Open-Label Treatment Period|Adverse Event|7|||
106018235|NCT03614156|365729304|FG001|Open-Label Treatment Period|Adverse Event|0|||
106018236|NCT03614156|365729305|FG002|Open-Label Treatment Period|Adverse Event|0|||
106018237|NCT03614156|365729306|FG003|Open-Label Treatment Period|Adverse Event|0|||
106018238|NCT03614156|365729303|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
106018239|NCT03614156|365729304|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
106018240|NCT03614156|365729305|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
106018241|NCT03614156|365729306|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
106018242|NCT03614156|365729303|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
106018243|NCT03614156|365729304|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
106018244|NCT03614156|365729305|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
105764439|NCT01998958|364791670|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764440|NCT01998958|364791671|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764441|NCT01998958|364791672|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764442|NCT01998958|364791673|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764443|NCT01998958|364791674|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764444|NCT01998958|364791675|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764445|NCT01998958|364791676|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
105764446|NCT01998958|364791677|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764447|NCT01998958|364791678|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764448|NCT01998958|364791679|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764449|NCT01998958|364791680|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
105764450|NCT01998958|364791681|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764451|NCT01998958|364791682|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764452|NCT01998958|364791683|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764453|NCT01998958|364791684|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764454|NCT01998958|364791685|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764455|NCT01998958|364791686|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764456|NCT01998958|364791687|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764457|NCT01998958|364791688|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764458|NCT01998958|364791689|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764459|NCT01998958|364791690|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764460|NCT01998958|364791691|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764461|NCT01998958|364791692|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764462|NCT01998958|364791693|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
105764463|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Adverse Event|0|||
105764464|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Adverse Event|0|||
105764465|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Adverse Event|0|||
105764466|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Adverse Event|0|||
105764467|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Adverse Event|0|||
105764468|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Adverse Event|0|||
105764469|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Adverse Event|0|||
105764470|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Adverse Event|0|||
105764471|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Adverse Event|0|||
105764472|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Adverse Event|0|||
105955827|NCT01392573|365499752|FG000|Overall Study|Lack of Efficacy|1|||
105955828|NCT01392573|365499753|FG001|Overall Study|Lack of Efficacy|2|||
105955829|NCT01392573|365499752|FG000|Overall Study|Protocol Violation|0|||
105955830|NCT01392573|365499753|FG001|Overall Study|Protocol Violation|2|||
105955831|NCT01392573|365499752|FG000|Overall Study|Withdrawal Criteria|13|||
105955832|NCT01392573|365499753|FG001|Overall Study|Withdrawal Criteria|15|||
105955833|NCT01392573|365499752|FG000|Overall Study|Site closure|8|||
105955834|NCT01392573|365499753|FG001|Overall Study|Site closure|7|||
105955835|NCT01392573|365499752|FG000|Overall Study|Unclassified|9|||
105955836|NCT01392573|365499753|FG001|Overall Study|Unclassified|6|||
105955837|NCT00100802|365499754|FG000|Overall Study|Adverse Event|9|||
105955838|NCT00100802|365499754|FG000|Overall Study|Death|1|||
105955839|NCT00100802|365499754|FG000|Overall Study|Lack of Efficacy|47|||
105955840|NCT00100802|365499754|FG000|Overall Study|Physician Decision|5|||
105955841|NCT00100802|365499754|FG000|Overall Study|Protocol Violation|1|||
105955842|NCT00100802|365499754|FG000|Overall Study|Withdrawal by Subject|5|||
105955843|NCT00100802|365499754|FG000|Overall Study|Ineligible|12|||
105955844|NCT02712996|365499755|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
105955845|NCT02712996|365499756|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
105955846|NCT00436436|365499757|FG000|Overall Study|Progression|4|||
105955847|NCT00436436|365499757|FG000|Overall Study|Adverse Event|2|||
105955848|NCT00436436|365499757|FG000|Overall Study|Death|6|||
105955849|NCT03941483|365499759|FG000|Overall Study|Miscellaneous|2|||
105955850|NCT03941483|365499760|FG001|Overall Study|Miscellaneous|3|||
105955851|NCT03941483|365499761|FG002|Overall Study|Miscellaneous|0|||
105955852|NCT03941483|365499759|FG000|Overall Study|Study Terminated by Sponsor|1|||
105955853|NCT03941483|365499760|FG001|Overall Study|Study Terminated by Sponsor|0|||
105955854|NCT03941483|365499761|FG002|Overall Study|Study Terminated by Sponsor|0|||
105955855|NCT03941483|365499759|FG000|Overall Study|Withdrawal by Subject|1|||
105955856|NCT03941483|365499760|FG001|Overall Study|Withdrawal by Subject|4|||
105955857|NCT03941483|365499761|FG002|Overall Study|Withdrawal by Subject|1|||
105955858|NCT03941483|365499759|FG000|Overall Study|Lost to Follow-up|2|||
105955859|NCT03941483|365499760|FG001|Overall Study|Lost to Follow-up|1|||
105955860|NCT03941483|365499761|FG002|Overall Study|Lost to Follow-up|8|||
105955861|NCT03941483|365499759|FG000|Overall Study|Death|3|||
105955862|NCT03941483|365499760|FG001|Overall Study|Death|2|||
105955863|NCT03941483|365499761|FG002|Overall Study|Death|6|||
105955864|NCT00670930|365499762|FG000|Overall Study|Adminstrative Problem|0|||
105815675|NCT01682083|364985357|FG000|Overall Study|Physician Decision|5|||
105815676|NCT01682083|364985358|FG001|Overall Study|Physician Decision|4|||
105815677|NCT00445003|364985360|FG000|Overall Study|Death|1|||
105815678|NCT00445003|364985361|FG001|Overall Study|Death|2|||
105815679|NCT00445003|364985362|FG002|Overall Study|Death|1|||
105815680|NCT00445003|364985360|FG000|Overall Study|Missed Visit|3|||
105815681|NCT00445003|364985361|FG001|Overall Study|Missed Visit|5|||
105815682|NCT00445003|364985362|FG002|Overall Study|Missed Visit|1|||
105815683|NCT00445003|364985360|FG000|Overall Study|Dropped|1|||
106018245|NCT03614156|365729306|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
106018246|NCT03614156|365729303|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
106018247|NCT03614156|365729304|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
105815684|NCT00445003|364985361|FG001|Overall Study|Dropped|3|||
105815685|NCT00445003|364985362|FG002|Overall Study|Dropped|2|||
105815686|NCT00528606|364985365|FG000|Overall Study|Withdrew consent|4|||
105815687|NCT00528606|364985366|FG001|Overall Study|Withdrew consent|3|||
105815688|NCT00528606|364985365|FG000|Overall Study|Lost to Follow-up|4|||
105815689|NCT00528606|364985366|FG001|Overall Study|Lost to Follow-up|1|||
105815690|NCT00528606|364985365|FG000|Overall Study|Adverse Event|3|||
105815691|NCT00528606|364985366|FG001|Overall Study|Adverse Event|0|||
105815692|NCT00528606|364985365|FG000|Overall Study|Other|2|||
105815693|NCT00528606|364985366|FG001|Overall Study|Other|0|||
105815694|NCT01471093|364985367|FG000|Overall Study|Adverse Event|1|||
105815695|NCT01471093|364985368|FG001|Overall Study|Adverse Event|0|||
105815696|NCT01471093|364985369|FG002|Overall Study|Adverse Event|0|||
105815697|NCT01471093|364985370|FG003|Overall Study|Adverse Event|0|||
105815698|NCT02475954|364985371|FG000|Overall Study|Withdrawal by Subject|2|||
105815699|NCT02475954|364985372|FG001|Overall Study|Withdrawal by Subject|2|||
105815700|NCT02475954|364985371|FG000|Overall Study|Lost to Follow-up|11|||
105815701|NCT02475954|364985372|FG001|Overall Study|Lost to Follow-up|9|||
105815702|NCT02475954|364985371|FG000|Overall Study|Death|1|||
105815703|NCT02475954|364985372|FG001|Overall Study|Death|1|||
105815704|NCT02932878|364985374|FG000|Overall Study|Due to Lab Results|2|||
105815705|NCT02932878|364985375|FG001|Overall Study|Due to Lab Results|1|||
106018248|NCT03614156|365729305|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
106018249|NCT03614156|365729306|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
106018250|NCT03614156|365729303|FG000|Open-Label Treatment Period|Protocol Violation|2|||
106018251|NCT03614156|365729304|FG001|Open-Label Treatment Period|Protocol Violation|0|||
106018252|NCT03614156|365729305|FG002|Open-Label Treatment Period|Protocol Violation|0|||
106018253|NCT03614156|365729306|FG003|Open-Label Treatment Period|Protocol Violation|0|||
106018254|NCT03614156|365729303|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
106018255|NCT03614156|365729304|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
106018256|NCT03614156|365729305|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
106018257|NCT03614156|365729306|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
106018258|NCT03614156|365729303|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
106018259|NCT03614156|365729304|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
106018260|NCT03614156|365729305|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
106018261|NCT03614156|365729306|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
106018262|NCT03614156|365729303|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
106018263|NCT03614156|365729304|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
106018264|NCT03614156|365729305|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
105815706|NCT01918397|364985376|FG000|Overall Study|Never started treatment|2|||
105815707|NCT01918397|364985377|FG001|Overall Study|Never started treatment|1|||
105815708|NCT01918397|364985378|FG002|Overall Study|Never started treatment|0|||
106018265|NCT03614156|365729306|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
106018266|NCT03614156|365729303|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
106018267|NCT03614156|365729304|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
106018268|NCT03614156|365729305|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
106018269|NCT03614156|365729306|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
106018270|NCT03614156|365729303|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
106018271|NCT03614156|365729304|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
106018272|NCT03614156|365729305|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
106018273|NCT03614156|365729306|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
106018274|NCT03614156|365729303|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
105815709|NCT01918397|364985379|FG003|Overall Study|Never started treatment|0|||
105815710|NCT01918397|364985376|FG000|Overall Study|Adverse Event|1|||
105815711|NCT01918397|364985377|FG001|Overall Study|Adverse Event|1|||
105815712|NCT01918397|364985378|FG002|Overall Study|Adverse Event|1|||
105815713|NCT01918397|364985379|FG003|Overall Study|Adverse Event|0|||
105815714|NCT01918397|364985376|FG000|Overall Study|Lack of compliance|2|||
105815715|NCT01918397|364985377|FG001|Overall Study|Lack of compliance|2|||
105815716|NCT01918397|364985378|FG002|Overall Study|Lack of compliance|3|||
105815717|NCT01918397|364985379|FG003|Overall Study|Lack of compliance|0|||
105815718|NCT01918397|364985376|FG000|Overall Study|Pregnancy|0|||
105815719|NCT01918397|364985377|FG001|Overall Study|Pregnancy|1|||
105815720|NCT01918397|364985378|FG002|Overall Study|Pregnancy|0|||
105815721|NCT01918397|364985379|FG003|Overall Study|Pregnancy|0|||
105815722|NCT01918397|364985376|FG000|Overall Study|Rifampin susceptible|0|||
105815723|NCT01918397|364985377|FG001|Overall Study|Rifampin susceptible|0|||
105815724|NCT01918397|364985378|FG002|Overall Study|Rifampin susceptible|0|||
105815725|NCT01918397|364985379|FG003|Overall Study|Rifampin susceptible|2|||
105815726|NCT01918397|364985376|FG000|Overall Study|Treatment failure|0|||
105815727|NCT01918397|364985377|FG001|Overall Study|Treatment failure|0|||
105815728|NCT01918397|364985378|FG002|Overall Study|Treatment failure|0|||
105815729|NCT01918397|364985379|FG003|Overall Study|Treatment failure|1|||
105815730|NCT01918397|364985376|FG000|Overall Study|Withdrawal by Subject|3|||
105815731|NCT01918397|364985377|FG001|Overall Study|Withdrawal by Subject|2|||
105815732|NCT01918397|364985378|FG002|Overall Study|Withdrawal by Subject|1|||
105815733|NCT01918397|364985379|FG003|Overall Study|Withdrawal by Subject|1|||
105815734|NCT01918397|364985376|FG000|Overall Study|XDR at baseline|0|||
105815735|NCT01918397|364985377|FG001|Overall Study|XDR at baseline|0|||
105815736|NCT01918397|364985378|FG002|Overall Study|XDR at baseline|1|||
105815737|NCT01918397|364985379|FG003|Overall Study|XDR at baseline|0|||
105815738|NCT01918397|364985376|FG000|Overall Study|Lost to Follow-up|2|||
105815739|NCT01918397|364985377|FG001|Overall Study|Lost to Follow-up|1|||
105815740|NCT01918397|364985378|FG002|Overall Study|Lost to Follow-up|1|||
105815741|NCT01918397|364985379|FG003|Overall Study|Lost to Follow-up|1|||
105815742|NCT01918397|364985376|FG000|Overall Study|Increased QTc|1|||
105815743|NCT01918397|364985377|FG001|Overall Study|Increased QTc|0|||
105815744|NCT01918397|364985378|FG002|Overall Study|Increased QTc|0|||
105815745|NCT01918397|364985379|FG003|Overall Study|Increased QTc|1|||
105815746|NCT01918397|364985376|FG000|Overall Study|Death|0|||
105815747|NCT01918397|364985377|FG001|Overall Study|Death|0|||
105815748|NCT01918397|364985378|FG002|Overall Study|Death|1|||
105815749|NCT01918397|364985379|FG003|Overall Study|Death|0|||
105815750|NCT01918397|364985376|FG000|Overall Study|Involved in another investigative trial|0|||
105815751|NCT01918397|364985377|FG001|Overall Study|Involved in another investigative trial|0|||
105815752|NCT01918397|364985378|FG002|Overall Study|Involved in another investigative trial|0|||
105815753|NCT01918397|364985379|FG003|Overall Study|Involved in another investigative trial|1|||
105815754|NCT00849901|364985383|FG000|Acute Treatment Phase|Adverse Event|9|||
105815755|NCT00849901|364985384|FG001|Acute Treatment Phase|Adverse Event|1|||
105815756|NCT00849901|364985385|FG002|Acute Treatment Phase|Adverse Event|3|||
105815757|NCT00849901|364985383|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
105815758|NCT00849901|364985384|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
105815759|NCT00849901|364985385|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
105815760|NCT00849901|364985383|FG000|Acute Treatment Phase|Protocol Violation|0|||
105815761|NCT00849901|364985384|FG001|Acute Treatment Phase|Protocol Violation|2|||
105815762|NCT00849901|364985385|FG002|Acute Treatment Phase|Protocol Violation|1|||
105815763|NCT00849901|364985383|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
105815764|NCT00849901|364985384|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
105815765|NCT00849901|364985385|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
105815766|NCT00849901|364985383|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
105815767|NCT00849901|364985384|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
105815768|NCT00849901|364985385|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
105815769|NCT00849901|364985383|FG000|Acute Treatment Phase|Physician Decision|1|||
105815770|NCT00849901|364985384|FG001|Acute Treatment Phase|Physician Decision|1|||
105955865|NCT00670930|365499763|FG001|Overall Study|Adminstrative Problem|1|||
105955866|NCT00670930|365499762|FG000|Overall Study|Lost to Follow-up|1|||
105955867|NCT00670930|365499763|FG001|Overall Study|Lost to Follow-up|0|||
105955868|NCT04790279|365501391|FG000|Overall Study|Did not meet medication start criteria|27|||
105955869|NCT04790279|365501392|FG001|Overall Study|Did not meet medication start criteria|15|||
105955870|NCT04790279|365501391|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
105955871|NCT04790279|365501392|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
105815771|NCT00849901|364985385|FG002|Acute Treatment Phase|Physician Decision|1|||
105955872|NCT04790279|365501391|FG000|Overall Study|Protocol Violation|8|||
105955873|NCT04790279|365501392|FG001|Overall Study|Protocol Violation|3|||
105955874|NCT04790279|365501391|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
105815772|NCT00849901|364985383|FG000|Acute Treatment Phase|Sponsor Decision|1|||
105815773|NCT00849901|364985384|FG001|Acute Treatment Phase|Sponsor Decision|0|||
105815774|NCT00849901|364985385|FG002|Acute Treatment Phase|Sponsor Decision|0|||
105815775|NCT00849901|364985383|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
105815776|NCT00849901|364985384|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
105815777|NCT00849901|364985385|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
105815778|NCT00849901|364985383|FG000|Extension Phase|Adverse Event|2|||
105815779|NCT00849901|364985384|FG001|Extension Phase|Adverse Event|8|||
105987409|NCT03495102|365614450|FG002|Overall Study|Relocated to Another Country|0|||
105815780|NCT00849901|364985385|FG002|Extension Phase|Adverse Event|4|||
105815781|NCT00849901|364985383|FG000|Extension Phase|Lost to Follow-up|3|||
105815782|NCT00849901|364985384|FG001|Extension Phase|Lost to Follow-up|0|||
105815783|NCT00849901|364985385|FG002|Extension Phase|Lost to Follow-up|1|||
106018275|NCT03614156|365729304|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
106018276|NCT03614156|365729305|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
105764473|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Adverse Event|0|||
105764474|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Adverse Event|0|||
105764475|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Adverse Event|0|||
105764476|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Adverse Event|0|||
105764477|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Adverse Event|0|||
105764478|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Adverse Event|0|||
105764479|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Adverse Event|0|||
105764480|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Adverse Event|0|||
105764481|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Adverse Event|0|||
105764482|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Adverse Event|0|||
105764483|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Adverse Event|0|||
105764484|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Adverse Event|0|||
105764485|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Adverse Event|0|||
105764486|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Adverse Event|1|||
105764487|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Adverse Event|0|||
105764488|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Adverse Event|0|||
105764489|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Adverse Event|0|||
105764490|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Adverse Event|0|||
105764491|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Adverse Event|0|||
105764492|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Adverse Event|0|||
105764493|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Adverse Event|0|||
105764494|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Adverse Event|0|||
105764495|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Other|0|||
105764496|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Other|0|||
105764497|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Other|0|||
105764498|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Other|0|||
105764499|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Other|0|||
105764500|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Other|0|||
105764501|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Other|0|||
105764502|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Other|0|||
105764503|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Other|0|||
105764504|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Other|0|||
105764505|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Other|0|||
105764506|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Other|0|||
105764507|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Other|0|||
105764508|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Other|0|||
105764509|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Other|0|||
105764510|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Other|0|||
105764511|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Other|0|||
105764512|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Other|0|||
105764513|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Other|0|||
105764514|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Other|0|||
105764515|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Other|0|||
105764516|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Other|0|||
105764517|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Other|5|||
105764518|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Other|1|||
105764519|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Other|0|||
105764520|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Other|0|||
105764521|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Other|0|||
105764522|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Other|0|||
105764523|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Other|0|||
105764524|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Other|0|||
105764525|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Other|0|||
105764526|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Other|0|||
105764527|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764528|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764529|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764530|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764531|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764532|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764533|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764534|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764535|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764536|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764537|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764538|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764539|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764540|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764541|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764542|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764543|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764544|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764545|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764546|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
106018277|NCT03614156|365729306|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
106018278|NCT03614156|365729303|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
106018279|NCT03614156|365729304|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
106018280|NCT03614156|365729305|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
106018281|NCT03614156|365729306|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
106018282|NCT03614156|365729303|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
106018283|NCT03614156|365729304|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
106018284|NCT03614156|365729305|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
106018285|NCT03614156|365729306|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
106018286|NCT03614156|365729303|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
106018287|NCT03614156|365729304|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
106018288|NCT03614156|365729305|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
106018289|NCT03614156|365729306|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
106018290|NCT03614156|365729303|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
106018291|NCT03614156|365729304|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
106018292|NCT03614156|365729305|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
106018293|NCT03614156|365729306|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
106018294|NCT03614156|365729303|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
106018295|NCT03614156|365729304|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
106018296|NCT03614156|365729305|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
106018297|NCT03614156|365729306|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
106018298|NCT02395081|365729307|FG000|Overall Study|Withdrawal by Subject|1|||
106018299|NCT02395081|365729308|FG001|Overall Study|Withdrawal by Subject|1|||
106018300|NCT02395081|365729309|FG002|Overall Study|Withdrawal by Subject|0|||
106018301|NCT02395081|365729307|FG000|Overall Study|Moved where blood couldn't be collected|4|||
106018302|NCT02395081|365729308|FG001|Overall Study|Moved where blood couldn't be collected|1|||
106018303|NCT02395081|365729309|FG002|Overall Study|Moved where blood couldn't be collected|3|||
106018304|NCT02395081|365729307|FG000|Overall Study|Fetal Loss|2|||
106018305|NCT02395081|365729308|FG001|Overall Study|Fetal Loss|3|||
106018306|NCT02395081|365729309|FG002|Overall Study|Fetal Loss|1|||
106018307|NCT04287517|365729310|FG000|Overall Study|Withdrawal by Subject|1|||
106018308|NCT04287517|365729311|FG001|Overall Study|Withdrawal by Subject|1|||
106018309|NCT03857867|365729312|FG000|Overall Study|Physician Decision|1|||
106018310|NCT03181529|365729313|FG000|Overall Study|Withdrawal by Subject|1|||
106018311|NCT03181529|365729314|FG001|Overall Study|Withdrawal by Subject|1|||
106018312|NCT03181529|365729313|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
106018313|NCT03181529|365729314|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
106018314|NCT00607373|365729315|FG000|Treatment Period|Adverse Event|0|||
106018315|NCT00607373|365729316|FG001|Treatment Period|Adverse Event|4|||
106018316|NCT00607373|365729315|FG000|Treatment Period|Physician Decision|0|||
106018317|NCT00607373|365729316|FG001|Treatment Period|Physician Decision|1|||
106018318|NCT00607373|365729315|FG000|Treatment Period|Withdrawal by Subject|0|||
106018319|NCT00607373|365729316|FG001|Treatment Period|Withdrawal by Subject|1|||
106018320|NCT00607373|365729315|FG000|Follow-up Period|Other|0|||
106018321|NCT00607373|365729316|FG001|Follow-up Period|Other|1|||
106018322|NCT00607373|365729315|FG000|Follow-up Period|Protocol Violation|0|||
106018323|NCT00607373|365729316|FG001|Follow-up Period|Protocol Violation|1|||
106018324|NCT00607373|365729315|FG000|Follow-up Period|Withdrawal by Subject|1|||
106018325|NCT00607373|365729316|FG001|Follow-up Period|Withdrawal by Subject|3|||
106018326|NCT00092443|365729317|FG000|Overall Study|Adverse Event|9|||
106018327|NCT00092443|365729318|FG001|Overall Study|Adverse Event|13|||
106018328|NCT00092443|365729317|FG000|Overall Study|Lost to Follow-up|7|||
106018329|NCT00092443|365729318|FG001|Overall Study|Lost to Follow-up|3|||
106018330|NCT00092443|365729317|FG000|Overall Study|Protocol Violation|11|||
106018331|NCT00092443|365729318|FG001|Overall Study|Protocol Violation|9|||
106018332|NCT00092443|365729317|FG000|Overall Study|Withdrawal by Subject|9|||
106018333|NCT00092443|365729318|FG001|Overall Study|Withdrawal by Subject|11|||
106018334|NCT00092443|365729317|FG000|Overall Study|Moved|5|||
106018335|NCT00092443|365729318|FG001|Overall Study|Moved|5|||
106018336|NCT00092443|365729317|FG000|Overall Study|Other|17|||
106018337|NCT00092443|365729318|FG001|Overall Study|Other|13|||
106018338|NCT00928408|365729321|FG000|Overall Study|Other|2|||
106018339|NCT00928408|365729321|FG000|Overall Study|Withdrawal by Subject|4|||
106018340|NCT00928408|365729321|FG000|Overall Study|Death|5|||
106018341|NCT00928408|365729321|FG000|Overall Study|Lost to Follow-up|12|||
106018342|NCT02876601|365729323|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
106018343|NCT02876601|365729324|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
106018344|NCT02876601|365729325|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
106018345|NCT02876601|365729326|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
106018346|NCT00256997|365729329|FG000|Overall Study|Protocol Violation|1|||
106018347|NCT00256997|365729330|FG001|Overall Study|Protocol Violation|4|||
106145317|NCT00433199|366191944|FG000|Open-Label Period|Lost to Follow-up|0|||
106145318|NCT00433199|366191945|FG001|Open-Label Period|Lost to Follow-up|3|||
106145319|NCT00433199|366191944|FG000|Open-Label Period|Withdrawal by Subject|0|||
106145320|NCT00433199|366191945|FG001|Open-Label Period|Withdrawal by Subject|7|||
106145321|NCT00433199|366191944|FG000|Open-Label Period|Protocol Violation|0|||
105815784|NCT00849901|364985383|FG000|Extension Phase|Protocol Violation|2|||
105815785|NCT00849901|364985384|FG001|Extension Phase|Protocol Violation|2|||
105815786|NCT00849901|364985385|FG002|Extension Phase|Protocol Violation|4|||
105815787|NCT00849901|364985383|FG000|Extension Phase|Withdrawal by Subject|7|||
105815788|NCT00849901|364985384|FG001|Extension Phase|Withdrawal by Subject|6|||
105815789|NCT00849901|364985385|FG002|Extension Phase|Withdrawal by Subject|3|||
105815790|NCT00849901|364985383|FG000|Extension Phase|Parent or Caregiver Decision|10|||
105815791|NCT00849901|364985384|FG001|Extension Phase|Parent or Caregiver Decision|4|||
105815792|NCT00849901|364985385|FG002|Extension Phase|Parent or Caregiver Decision|4|||
105815793|NCT00849901|364985383|FG000|Extension Phase|Physician Decision|1|||
105815794|NCT00849901|364985384|FG001|Extension Phase|Physician Decision|2|||
105815795|NCT00849901|364985385|FG002|Extension Phase|Physician Decision|0|||
105815796|NCT00849901|364985383|FG000|Extension Phase|Lack of Efficacy|2|||
105815797|NCT00849901|364985384|FG001|Extension Phase|Lack of Efficacy|4|||
105815798|NCT00849901|364985385|FG002|Extension Phase|Lack of Efficacy|1|||
105815799|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
105815800|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
105815801|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
105815802|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
105815803|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
105815804|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
105815805|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
105815806|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
105815807|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
105815808|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
105815809|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
105815810|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
105815811|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
105815812|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
105955875|NCT04790279|365501392|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
105955876|NCT00678288|365501393|FG000|Overall Study|Adverse Event|0|||
106145322|NCT00433199|366191945|FG001|Open-Label Period|Protocol Violation|2|||
105815813|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
105815814|NCT00437658|364985386|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
105815815|NCT00437658|364985387|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
105815816|NCT00437658|364985388|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
105815817|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
105815818|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
105815819|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
105815820|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
105815821|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
105815822|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
105815823|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
105815824|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
105815825|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
105815826|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
105815827|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
105815828|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
105815829|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
105815830|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
105815831|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
105815832|NCT00437658|364985386|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
105815833|NCT00437658|364985387|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
105815834|NCT00437658|364985388|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
105815835|NCT02465567|364985389|FG000|Overall Study|Adverse Event|118|||
105815836|NCT02465567|364985390|FG001|Overall Study|Adverse Event|113|||
106145323|NCT00433199|366191944|FG000|Open-Label Period|Administrative|0|||
106145324|NCT00433199|366191945|FG001|Open-Label Period|Administrative|1|||
106145325|NCT00206375|366191946|FG000|Overall Study|Lost to Follow-up|1|||
106145326|NCT00206375|366191947|FG001|Overall Study|Lost to Follow-up|0|||
106145327|NCT00206375|366191948|FG002|Overall Study|Lost to Follow-up|0|||
105815837|NCT02465567|364985391|FG002|Overall Study|Adverse Event|147|||
106145328|NCT00206375|366191946|FG000|Overall Study|Withdrawal by Subject|2|||
105815838|NCT02465567|364985392|FG003|Overall Study|Adverse Event|138|||
105815839|NCT02465567|364985389|FG000|Overall Study|Lack of Efficacy|103|||
105815840|NCT02465567|364985390|FG001|Overall Study|Lack of Efficacy|102|||
105815841|NCT02465567|364985391|FG002|Overall Study|Lack of Efficacy|171|||
105815842|NCT02465567|364985392|FG003|Overall Study|Lack of Efficacy|135|||
105955877|NCT00678288|365501394|FG001|Overall Study|Adverse Event|2|||
105955878|NCT00678288|365501393|FG000|Overall Study|Withdrawal by Subject|1|||
105955879|NCT00678288|365501394|FG001|Overall Study|Withdrawal by Subject|1|||
105955880|NCT00678288|365501393|FG000|Overall Study|Study terminated by the sponsor|2|||
105955881|NCT00678288|365501394|FG001|Overall Study|Study terminated by the sponsor|0|||
105955882|NCT00678288|365501393|FG000|Overall Study|Not compliant with study medication|0|||
105955883|NCT00678288|365501394|FG001|Overall Study|Not compliant with study medication|1|||
105955884|NCT00678288|365501393|FG000|Overall Study|Switch to commercial drug|0|||
105955885|NCT00678288|365501394|FG001|Overall Study|Switch to commercial drug|1|||
105955886|NCT00678288|365501393|FG000|Overall Study|Reason not reported|1|||
105955887|NCT00678288|365501394|FG001|Overall Study|Reason not reported|0|||
105955888|NCT00678288|365501393|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
105955889|NCT00678288|365501394|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
105955890|NCT02079909|365501395|FG000|Overall Study|Adverse Event|23|||
105955891|NCT02079909|365501396|FG001|Overall Study|Adverse Event|23|||
105955892|NCT02079909|365501397|FG002|Overall Study|Adverse Event|7|||
105955893|NCT02079909|365501395|FG000|Overall Study|Withdrawal by Subject|9|||
105955894|NCT02079909|365501396|FG001|Overall Study|Withdrawal by Subject|17|||
105955895|NCT02079909|365501397|FG002|Overall Study|Withdrawal by Subject|4|||
105955896|NCT02079909|365501395|FG000|Overall Study|Lost to Follow-up|2|||
105955897|NCT02079909|365501396|FG001|Overall Study|Lost to Follow-up|3|||
105955898|NCT02079909|365501397|FG002|Overall Study|Lost to Follow-up|1|||
105955899|NCT02079909|365501395|FG000|Overall Study|Death|2|||
106145329|NCT00206375|366191947|FG001|Overall Study|Withdrawal by Subject|1|||
106145330|NCT00206375|366191948|FG002|Overall Study|Withdrawal by Subject|3|||
106145331|NCT00206375|366191946|FG000|Overall Study|Study terminated due to lack of funds|0|||
106145332|NCT00206375|366191947|FG001|Overall Study|Study terminated due to lack of funds|1|||
106145333|NCT00206375|366191948|FG002|Overall Study|Study terminated due to lack of funds|1|||
106145334|NCT01170962|366191949|FG000|Treatment Period|Lack of Efficacy|96|||
106145335|NCT01170962|366191950|FG001|Treatment Period|Lack of Efficacy|91|||
106145336|NCT01170962|366191951|FG002|Treatment Period|Lack of Efficacy|7|||
105764547|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764548|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764549|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
105764550|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764551|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764552|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764553|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764554|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764555|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764556|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764557|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764558|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
105764559|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764560|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764561|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764562|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764563|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764564|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764565|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764566|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764567|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764568|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764569|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764570|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764571|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764572|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764573|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764574|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
105955900|NCT02079909|365501396|FG001|Overall Study|Death|2|||
105955901|NCT02079909|365501397|FG002|Overall Study|Death|0|||
105955902|NCT02079909|365501395|FG000|Overall Study|Lack of Efficacy|0|||
105955903|NCT02079909|365501396|FG001|Overall Study|Lack of Efficacy|0|||
105955904|NCT02079909|365501397|FG002|Overall Study|Lack of Efficacy|1|||
105955905|NCT02079909|365501395|FG000|Overall Study|Protocol Violation|0|||
105955906|NCT02079909|365501396|FG001|Overall Study|Protocol Violation|1|||
105955907|NCT02079909|365501397|FG002|Overall Study|Protocol Violation|1|||
105955908|NCT02079909|365501395|FG000|Overall Study|Physician Decision|0|||
105955909|NCT02079909|365501396|FG001|Overall Study|Physician Decision|1|||
105955910|NCT02079909|365501397|FG002|Overall Study|Physician Decision|1|||
105764575|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764576|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
105955911|NCT02079909|365501395|FG000|Overall Study|Relocation etc.|2|||
105955912|NCT02079909|365501396|FG001|Overall Study|Relocation etc.|2|||
105955913|NCT02079909|365501397|FG002|Overall Study|Relocation etc.|3|||
105815843|NCT02465567|364985389|FG000|Overall Study|Withdrawal by Subject|104|||
105815844|NCT02465567|364985390|FG001|Overall Study|Withdrawal by Subject|94|||
105955914|NCT00342628|365501401|FG000|Overall Study|Withdrawal by Subject|19|||
105955915|NCT00342628|365501402|FG001|Overall Study|Withdrawal by Subject|19|||
105955916|NCT00342628|365501403|FG002|Overall Study|Withdrawal by Subject|18|||
105955917|NCT00342628|365501401|FG000|Overall Study|Death|1|||
105955918|NCT00342628|365501402|FG001|Overall Study|Death|1|||
105955919|NCT00342628|365501403|FG002|Overall Study|Death|0|||
105955920|NCT00342628|365501401|FG000|Overall Study|moved residence|0|||
105955921|NCT00342628|365501402|FG001|Overall Study|moved residence|1|||
105955922|NCT00342628|365501403|FG002|Overall Study|moved residence|1|||
105955923|NCT01693250|365501404|FG000|Overall Study|Lost to Follow-up|2|||
105955924|NCT01693250|365501405|FG001|Overall Study|Lost to Follow-up|2|||
105955925|NCT00756275|365501406|FG000|Overall Study|Lost to Follow-up|25|||
105955926|NCT00756275|365501407|FG001|Overall Study|Lost to Follow-up|21|||
105955927|NCT00756275|365501406|FG000|Overall Study|Withdrawal by Subject|4|||
105955928|NCT00756275|365501407|FG001|Overall Study|Withdrawal by Subject|7|||
105955929|NCT02257242|365501408|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
105955930|NCT02257242|365501409|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105955931|NCT02257242|365501410|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105955932|NCT02257242|365501411|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105955933|NCT02257242|365501412|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105955934|NCT02257242|365501413|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105955935|NCT02257242|365501414|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105955936|NCT02257242|365501415|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105955937|NCT02257242|365501416|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
105955938|NCT00551031|365501420|FG000|Overall Study|Adverse Event|0|||
105955939|NCT00551031|365501421|FG001|Overall Study|Adverse Event|1|||
105955940|NCT00551031|365501422|FG002|Overall Study|Adverse Event|0|||
105955941|NCT00551031|365501423|FG003|Overall Study|Adverse Event|0|||
105955942|NCT00551031|365501424|FG004|Overall Study|Adverse Event|0|||
105955943|NCT00551031|365501420|FG000|Overall Study|Protocol Violation|1|||
106145337|NCT01170962|366191949|FG000|Treatment Period|Adverse Event|11|||
105764577|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764578|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764579|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764580|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
105764581|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
105764582|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764583|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764584|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764585|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764586|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764587|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764588|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764589|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764590|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
105764591|NCT01998958|364791662|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764592|NCT01998958|364791663|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764593|NCT01998958|364791664|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764594|NCT01998958|364791665|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764595|NCT01998958|364791666|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764596|NCT01998958|364791667|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764597|NCT01998958|364791668|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764598|NCT01998958|364791669|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764599|NCT01998958|364791670|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764600|NCT01998958|364791671|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764601|NCT01998958|364791672|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764602|NCT01998958|364791673|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764603|NCT01998958|364791674|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764604|NCT01998958|364791675|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764605|NCT01998958|364791676|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764606|NCT01998958|364791677|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764607|NCT01998958|364791678|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764608|NCT01998958|364791679|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764609|NCT01998958|364791680|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764610|NCT01998958|364791681|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764611|NCT01998958|364791682|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105815845|NCT02465567|364985391|FG002|Overall Study|Withdrawal by Subject|123|||
105815846|NCT02465567|364985392|FG003|Overall Study|Withdrawal by Subject|130|||
105815847|NCT02465567|364985389|FG000|Overall Study|Physician Decision|23|||
105815848|NCT02465567|364985390|FG001|Overall Study|Physician Decision|33|||
105815849|NCT02465567|364985391|FG002|Overall Study|Physician Decision|38|||
105815850|NCT02465567|364985392|FG003|Overall Study|Physician Decision|28|||
105815851|NCT02465567|364985389|FG000|Overall Study|Major Protocol Deviation|24|||
105815852|NCT02465567|364985390|FG001|Overall Study|Major Protocol Deviation|26|||
105815853|NCT02465567|364985391|FG002|Overall Study|Major Protocol Deviation|22|||
105815854|NCT02465567|364985392|FG003|Overall Study|Major Protocol Deviation|25|||
105815855|NCT02465567|364985389|FG000|Overall Study|Lost to Follow-up|25|||
105815856|NCT02465567|364985390|FG001|Overall Study|Lost to Follow-up|21|||
105815857|NCT02465567|364985391|FG002|Overall Study|Lost to Follow-up|19|||
105815858|NCT02465567|364985392|FG003|Overall Study|Lost to Follow-up|15|||
105815859|NCT02465567|364985389|FG000|Overall Study|Protocol Specified Criteria|20|||
105815860|NCT02465567|364985390|FG001|Overall Study|Protocol Specified Criteria|10|||
105815861|NCT02465567|364985391|FG002|Overall Study|Protocol Specified Criteria|9|||
105815862|NCT02465567|364985392|FG003|Overall Study|Protocol Specified Criteria|12|||
105815863|NCT02465567|364985389|FG000|Overall Study|Administrative Reasons|12|||
105815864|NCT02465567|364985390|FG001|Overall Study|Administrative Reasons|9|||
105815865|NCT02465567|364985391|FG002|Overall Study|Administrative Reasons|11|||
105815866|NCT02465567|364985392|FG003|Overall Study|Administrative Reasons|5|||
105815867|NCT02465567|364985389|FG000|Overall Study|Randomized but not treated|1|||
105815868|NCT02465567|364985390|FG001|Overall Study|Randomized but not treated|5|||
105815869|NCT02465567|364985391|FG002|Overall Study|Randomized but not treated|4|||
105815870|NCT02465567|364985392|FG003|Overall Study|Randomized but not treated|5|||
105815871|NCT02465567|364985389|FG000|Overall Study|enrolled in >1 studies|18|||
105815872|NCT02465567|364985390|FG001|Overall Study|enrolled in >1 studies|11|||
105815873|NCT02465567|364985391|FG002|Overall Study|enrolled in >1 studies|19|||
105815874|NCT02465567|364985392|FG003|Overall Study|enrolled in >1 studies|15|||
105815875|NCT02465567|364985389|FG000|Overall Study|missing PI Signature|1|||
105815876|NCT02465567|364985390|FG001|Overall Study|missing PI Signature|0|||
105815877|NCT02465567|364985391|FG002|Overall Study|missing PI Signature|0|||
105815878|NCT02465567|364985392|FG003|Overall Study|missing PI Signature|0|||
105815879|NCT00832377|364985394|FG000|Overall Study|Protocol Violation|1|||
105815880|NCT00569374|364985396|FG000|Overall Study|Withdrawal by Subject|4|||
105815881|NCT01666730|364985397|FG000|Overall Study|Adverse Event|16|||
105815882|NCT01666730|364985397|FG000|Overall Study|Death|2|||
105815883|NCT01666730|364985397|FG000|Overall Study|Physician Decision|5|||
105815884|NCT01666730|364985397|FG000|Overall Study|Withdrawal by Subject|9|||
105815885|NCT01666730|364985397|FG000|Overall Study|Disease progression/relapse|18|||
105815886|NCT00912288|364985398|FG000|Overall Study|Death|0|||
105815887|NCT00912288|364985399|FG001|Overall Study|Death|1|||
105815888|NCT00912288|364985398|FG000|Overall Study|Adverse Event|1|||
105815889|NCT00912288|364985399|FG001|Overall Study|Adverse Event|1|||
105815890|NCT00912288|364985398|FG000|Overall Study|Lost to Follow-up|1|||
105815891|NCT00912288|364985399|FG001|Overall Study|Lost to Follow-up|0|||
105815892|NCT00912288|364985398|FG000|Overall Study|Protocol Violation|1|||
105815893|NCT00912288|364985399|FG001|Overall Study|Protocol Violation|0|||
105815894|NCT00912288|364985398|FG000|Overall Study|Withdrawal by Subject|3|||
105815895|NCT00912288|364985399|FG001|Overall Study|Withdrawal by Subject|3|||
105815896|NCT00912288|364985398|FG000|Overall Study|Study terminated by sponsor|34|||
105815897|NCT00912288|364985399|FG001|Overall Study|Study terminated by sponsor|35|||
105815898|NCT00912288|364985398|FG000|Overall Study|Other|1|||
105815899|NCT00912288|364985399|FG001|Overall Study|Other|0|||
105815900|NCT02087904|364985400|FG000|Overall Study|Did Not Receive Study Drug|0|||
105815901|NCT02087904|364985401|FG001|Overall Study|Did Not Receive Study Drug|0|||
105815902|NCT02087904|364985402|FG002|Overall Study|Did Not Receive Study Drug|2|||
105815903|NCT02087904|364985403|FG003|Overall Study|Did Not Receive Study Drug|1|||
105815904|NCT02087904|364985400|FG000|Overall Study|Adverse Event|8|||
105815905|NCT02087904|364985401|FG001|Overall Study|Adverse Event|4|||
105955944|NCT00551031|365501421|FG001|Overall Study|Protocol Violation|1|||
105955945|NCT00551031|365501422|FG002|Overall Study|Protocol Violation|0|||
105955946|NCT00551031|365501423|FG003|Overall Study|Protocol Violation|0|||
105815906|NCT02087904|364985402|FG002|Overall Study|Adverse Event|4|||
105815907|NCT02087904|364985403|FG003|Overall Study|Adverse Event|12|||
105815908|NCT02087904|364985400|FG000|Overall Study|Lack of Efficacy|3|||
105815909|NCT02087904|364985401|FG001|Overall Study|Lack of Efficacy|6|||
105815910|NCT02087904|364985402|FG002|Overall Study|Lack of Efficacy|3|||
105815911|NCT02087904|364985403|FG003|Overall Study|Lack of Efficacy|2|||
105815912|NCT02087904|364985400|FG000|Overall Study|Other|6|||
105815913|NCT02087904|364985401|FG001|Overall Study|Other|2|||
105815914|NCT02087904|364985402|FG002|Overall Study|Other|4|||
105815915|NCT02087904|364985403|FG003|Overall Study|Other|4|||
105815916|NCT02087904|364985400|FG000|Overall Study|Withdrawal by Subject|8|||
105815917|NCT02087904|364985401|FG001|Overall Study|Withdrawal by Subject|3|||
105815918|NCT02087904|364985402|FG002|Overall Study|Withdrawal by Subject|7|||
105955947|NCT00551031|365501424|FG004|Overall Study|Protocol Violation|0|||
105955948|NCT00551031|365501420|FG000|Overall Study|Lost to Follow-up|0|||
105815919|NCT02087904|364985403|FG003|Overall Study|Withdrawal by Subject|4|||
105815920|NCT02087904|364985400|FG000|Overall Study|Lost to Follow-up|0|||
105815921|NCT02087904|364985401|FG001|Overall Study|Lost to Follow-up|4|||
105815922|NCT02087904|364985402|FG002|Overall Study|Lost to Follow-up|2|||
105815923|NCT02087904|364985403|FG003|Overall Study|Lost to Follow-up|2|||
105815924|NCT01735630|364985404|FG000|Overall Study|Adverse Event|8|||
105815925|NCT01735630|364985405|FG001|Overall Study|Adverse Event|7|||
105815926|NCT01735630|364985404|FG000|Overall Study|Lost to Follow-up|1|||
105815927|NCT01735630|364985405|FG001|Overall Study|Lost to Follow-up|0|||
105815928|NCT01735630|364985404|FG000|Overall Study|Physician Decision|0|||
105815929|NCT01735630|364985405|FG001|Overall Study|Physician Decision|1|||
105815930|NCT01735630|364985404|FG000|Overall Study|Sponsor Decision|2|||
105815931|NCT01735630|364985405|FG001|Overall Study|Sponsor Decision|1|||
105815932|NCT01735630|364985404|FG000|Overall Study|Withdrawal by Subject|7|||
105815933|NCT01735630|364985405|FG001|Overall Study|Withdrawal by Subject|9|||
105815934|NCT03099538|364985406|FG000|Overall Study|Lack of Efficacy|3|||
105815935|NCT01196052|364985407|FG000|Overall Study|Adverse Event|9|||
105815936|NCT01196052|364985407|FG000|Overall Study|Lost to Follow-up|1|||
105815937|NCT01196052|364985407|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
105815938|NCT01196052|364985407|FG000|Overall Study|Reason not Specified|5|||
105815939|NCT01196052|364985407|FG000|Overall Study|Withdrawal by Subject|6|||
105815940|NCT02178722|364985408|FG000|Overall Study|Withdrawal by Subject|0|||
105815941|NCT02178722|364985409|FG001|Overall Study|Withdrawal by Subject|0|||
105815942|NCT02178722|364985410|FG002|Overall Study|Withdrawal by Subject|0|||
105815943|NCT02178722|364985411|FG003|Overall Study|Withdrawal by Subject|2|||
105815944|NCT02178722|364985412|FG004|Overall Study|Withdrawal by Subject|33|||
105955949|NCT00551031|365501421|FG001|Overall Study|Lost to Follow-up|1|||
105955950|NCT00551031|365501422|FG002|Overall Study|Lost to Follow-up|0|||
105955951|NCT00551031|365501423|FG003|Overall Study|Lost to Follow-up|1|||
105955952|NCT00551031|365501424|FG004|Overall Study|Lost to Follow-up|1|||
105955953|NCT00551031|365501420|FG000|Overall Study|Withdrawal by Subject|0|||
105955954|NCT00551031|365501421|FG001|Overall Study|Withdrawal by Subject|4|||
106018348|NCT00256997|365729329|FG000|Overall Study|Lack of Efficacy|1|||
106018349|NCT00256997|365729330|FG001|Overall Study|Lack of Efficacy|4|||
106018350|NCT00256997|365729329|FG000|Overall Study|Death|2|||
106018351|NCT00256997|365729330|FG001|Overall Study|Death|0|||
106018352|NCT00256997|365729329|FG000|Overall Study|Adverse Event|4|||
106018353|NCT00256997|365729330|FG001|Overall Study|Adverse Event|0|||
106018354|NCT00256997|365729329|FG000|Overall Study|Lost to Follow-up|3|||
106018355|NCT00256997|365729330|FG001|Overall Study|Lost to Follow-up|5|||
106018356|NCT00256997|365729329|FG000|Overall Study|Withdrawal by Subject|13|||
106018357|NCT00256997|365729330|FG001|Overall Study|Withdrawal by Subject|3|||
106018358|NCT00256997|365729329|FG000|Overall Study|Started but not treated|2|||
106018359|NCT00256997|365729330|FG001|Overall Study|Started but not treated|0|||
106018360|NCT00256997|365729329|FG000|Overall Study|Other|5|||
106018361|NCT00256997|365729330|FG001|Overall Study|Other|8|||
106018362|NCT00256997|365729329|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
106018363|NCT00256997|365729330|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
106018364|NCT00256997|365729329|FG000|Overall Study|Participant Non-compliant|3|||
106018365|NCT00256997|365729330|FG001|Overall Study|Participant Non-compliant|6|||
106018366|NCT00256997|365729329|FG000|Overall Study|Investigator Withdrew Participant|2|||
106018367|NCT00256997|365729330|FG001|Overall Study|Investigator Withdrew Participant|1|||
106018368|NCT02736578|365729331|FG000|Overall Study|Adverse Event|1|||
106018369|NCT02736578|365729332|FG001|Overall Study|Adverse Event|0|||
105815945|NCT02178722|364985408|FG000|Overall Study|Death|2|||
105815946|NCT02178722|364985409|FG001|Overall Study|Death|13|||
105815947|NCT02178722|364985410|FG002|Overall Study|Death|12|||
105955955|NCT00551031|365501422|FG002|Overall Study|Withdrawal by Subject|1|||
105955956|NCT00551031|365501423|FG003|Overall Study|Withdrawal by Subject|2|||
105955957|NCT00551031|365501424|FG004|Overall Study|Withdrawal by Subject|0|||
105955958|NCT00551031|365501420|FG000|Overall Study|Serious Adverse Event|0|||
105955959|NCT00551031|365501421|FG001|Overall Study|Serious Adverse Event|2|||
105955960|NCT00551031|365501422|FG002|Overall Study|Serious Adverse Event|1|||
105815948|NCT02178722|364985411|FG003|Overall Study|Death|12|||
105815949|NCT02178722|364985412|FG004|Overall Study|Death|205|||
105815950|NCT02178722|364985408|FG000|Overall Study|Lost to Follow-up|0|||
105815951|NCT02178722|364985409|FG001|Overall Study|Lost to Follow-up|0|||
105955961|NCT00551031|365501423|FG003|Overall Study|Serious Adverse Event|0|||
105955962|NCT00551031|365501424|FG004|Overall Study|Serious Adverse Event|0|||
105815952|NCT02178722|364985410|FG002|Overall Study|Lost to Follow-up|0|||
105815953|NCT02178722|364985411|FG003|Overall Study|Lost to Follow-up|2|||
105815954|NCT02178722|364985412|FG004|Overall Study|Lost to Follow-up|11|||
106018370|NCT00354432|365729333|FG000|Overall Study|Adverse Event|3|||
106018371|NCT00354432|365729334|FG001|Overall Study|Adverse Event|1|||
106018372|NCT00354432|365729335|FG002|Overall Study|Adverse Event|5|||
105815955|NCT02178722|364985408|FG000|Overall Study|Study terminated by Sponsor|2|||
105815956|NCT02178722|364985409|FG001|Overall Study|Study terminated by Sponsor|7|||
105815957|NCT02178722|364985410|FG002|Overall Study|Study terminated by Sponsor|6|||
106018373|NCT00354432|365729336|FG003|Overall Study|Adverse Event|5|||
105815958|NCT02178722|364985411|FG003|Overall Study|Study terminated by Sponsor|4|||
105815959|NCT02178722|364985412|FG004|Overall Study|Study terminated by Sponsor|128|||
105815960|NCT02178722|364985408|FG000|Overall Study|Physician Decision|0|||
105815961|NCT02178722|364985409|FG001|Overall Study|Physician Decision|0|||
105815962|NCT02178722|364985410|FG002|Overall Study|Physician Decision|0|||
105815963|NCT02178722|364985411|FG003|Overall Study|Physician Decision|0|||
105815964|NCT02178722|364985412|FG004|Overall Study|Physician Decision|3|||
105815965|NCT02178722|364985408|FG000|Overall Study|Other|0|||
105815966|NCT02178722|364985409|FG001|Overall Study|Other|0|||
105815967|NCT02178722|364985410|FG002|Overall Study|Other|0|||
105815968|NCT02178722|364985411|FG003|Overall Study|Other|0|||
105815969|NCT02178722|364985412|FG004|Overall Study|Other|2|||
105815970|NCT00440557|364985413|FG000|Overall Study|Withdrawal by Subject|10|||
105815971|NCT00440557|364985414|FG001|Overall Study|Withdrawal by Subject|5|||
105815972|NCT00440557|364985415|FG002|Overall Study|Withdrawal by Subject|11|||
105815973|NCT00440557|364985413|FG000|Overall Study|Lost to Follow-up|1|||
105815974|NCT00440557|364985414|FG001|Overall Study|Lost to Follow-up|2|||
105815975|NCT00440557|364985415|FG002|Overall Study|Lost to Follow-up|6|||
105815976|NCT00440557|364985413|FG000|Overall Study|Adverse Event|3|||
105815977|NCT00440557|364985414|FG001|Overall Study|Adverse Event|3|||
105815978|NCT00440557|364985415|FG002|Overall Study|Adverse Event|5|||
105815979|NCT00440557|364985413|FG000|Overall Study|Death|2|||
106145338|NCT01170962|366191950|FG001|Treatment Period|Adverse Event|12|||
105815980|NCT00440557|364985414|FG001|Overall Study|Death|6|||
105815981|NCT00440557|364985415|FG002|Overall Study|Death|3|||
105815982|NCT00440557|364985413|FG000|Overall Study|Began Dialysis|4|||
105815983|NCT00440557|364985414|FG001|Overall Study|Began Dialysis|1|||
105815984|NCT00440557|364985415|FG002|Overall Study|Began Dialysis|4|||
105815985|NCT00440557|364985413|FG000|Overall Study|Principal Investigator decision|0|||
105815986|NCT00440557|364985414|FG001|Overall Study|Principal Investigator decision|3|||
105815987|NCT00440557|364985415|FG002|Overall Study|Principal Investigator decision|1|||
105815988|NCT00440557|364985413|FG000|Overall Study|Patient moved|1|||
105815989|NCT00440557|364985414|FG001|Overall Study|Patient moved|2|||
105955963|NCT00551031|365501420|FG000|Overall Study|Did not receive vaccine|1|||
105955964|NCT00551031|365501421|FG001|Overall Study|Did not receive vaccine|2|||
105955965|NCT00551031|365501422|FG002|Overall Study|Did not receive vaccine|0|||
105955966|NCT00551031|365501423|FG003|Overall Study|Did not receive vaccine|0|||
106145339|NCT01170962|366191951|FG002|Treatment Period|Adverse Event|3|||
106145340|NCT01170962|366191949|FG000|Treatment Period|Withdrawal by Subject|2|||
106145341|NCT01170962|366191950|FG001|Treatment Period|Withdrawal by Subject|1|||
106145342|NCT01170962|366191951|FG002|Treatment Period|Withdrawal by Subject|0|||
106145343|NCT01170962|366191949|FG000|Treatment Period|Lost to Follow-up|1|||
106145344|NCT01170962|366191950|FG001|Treatment Period|Lost to Follow-up|1|||
106145345|NCT01170962|366191951|FG002|Treatment Period|Lost to Follow-up|1|||
105955967|NCT00551031|365501424|FG004|Overall Study|Did not receive vaccine|0|||
105955968|NCT04240886|365501426|FG000|Treatment Phase|Death|4|||
105955969|NCT04240886|365501426|FG000|Treatment Phase|Discontinuation by Subject|1|||
105955970|NCT04240886|365501426|FG000|Treatment Phase|Adverse Event|5|||
105955971|NCT04240886|365501426|FG000|Follow-up Phase|Withdrawal by Subject|1|||
105955972|NCT04240886|365501426|FG000|Follow-up Phase|Discontinuation by Subject|1|||
105955973|NCT04240886|365501426|FG000|Follow-up Phase|Death|2|||
105955974|NCT00399568|365501427|FG000|Overall Study|Adverse Event|1|||
105955975|NCT00399568|365501428|FG001|Overall Study|Adverse Event|2|||
105955976|NCT00399568|365501427|FG000|Overall Study|Withdrawal by Subject|7|||
105955977|NCT00399568|365501428|FG001|Overall Study|Withdrawal by Subject|3|||
105815990|NCT00440557|364985415|FG002|Overall Study|Patient moved|1|||
105815991|NCT00440557|364985413|FG000|Overall Study|Principal Investigator's office closed|3|||
105815992|NCT00440557|364985414|FG001|Overall Study|Principal Investigator's office closed|6|||
105815993|NCT00440557|364985415|FG002|Overall Study|Principal Investigator's office closed|4|||
105815994|NCT00440557|364985413|FG000|Overall Study|Patient transferred to nursing home|0|||
105815995|NCT00440557|364985414|FG001|Overall Study|Patient transferred to nursing home|1|||
105815996|NCT00440557|364985415|FG002|Overall Study|Patient transferred to nursing home|0|||
105815997|NCT00440557|364985413|FG000|Overall Study|Patient had surgery|1|||
105815998|NCT00440557|364985414|FG001|Overall Study|Patient had surgery|0|||
105955978|NCT00399568|365501427|FG000|Overall Study|Protocol non-compliance|2|||
105955979|NCT00399568|365501428|FG001|Overall Study|Protocol non-compliance|2|||
105815999|NCT00440557|364985415|FG002|Overall Study|Patient had surgery|0|||
105816000|NCT03553823|364985416|FG000|Overall Study|Physician Decision|0|||
105816001|NCT03553823|364985417|FG001|Overall Study|Physician Decision|1|||
105816002|NCT00893464|364985418|FG000|Overall Study|Did not complete therapy/experience PD|0|||
105816003|NCT00893464|364985419|FG001|Overall Study|Did not complete therapy/experience PD|0|||
105955980|NCT00399568|365501427|FG000|Overall Study|Lost to Follow-up|2|||
105955981|NCT00399568|365501428|FG001|Overall Study|Lost to Follow-up|2|||
105955982|NCT00078806|365501429|FG000|Part 1A|Adverse Event|2|||
105816004|NCT00893464|364985420|FG002|Overall Study|Did not complete therapy/experience PD|0|||
105816005|NCT00893464|364985421|FG003|Overall Study|Did not complete therapy/experience PD|0|||
105816006|NCT00893464|364985422|FG004|Overall Study|Did not complete therapy/experience PD|0|||
105816007|NCT00893464|364985423|FG005|Overall Study|Did not complete therapy/experience PD|0|||
105816008|NCT00893464|364985424|FG006|Overall Study|Did not complete therapy/experience PD|2|||
105816009|NCT00893464|364985425|FG007|Overall Study|Did not complete therapy/experience PD|2|||
105816010|NCT03450070|364985426|FG000|Overall Study|Withdrawal by Subject|8|||
105816011|NCT01035060|364985431|FG000|Overall Study|Lost to Follow-up|0|||
105816012|NCT01035060|364985432|FG001|Overall Study|Lost to Follow-up|7|||
105816013|NCT01035060|364985431|FG000|Overall Study|Did not quality after 2nd screening|14|||
105816014|NCT01035060|364985432|FG001|Overall Study|Did not quality after 2nd screening|1|||
105816015|NCT01035060|364985431|FG000|Overall Study|Withdrawal by Subject|8|||
105816016|NCT01035060|364985432|FG001|Overall Study|Withdrawal by Subject|6|||
105816017|NCT01035060|364985431|FG000|Overall Study|Physician Decision|2|||
106145346|NCT01170962|366191949|FG000|Treatment Period|Participant no longer meets criteria|0|||
106145347|NCT01170962|366191950|FG001|Treatment Period|Participant no longer meets criteria|1|||
106145348|NCT01170962|366191951|FG002|Treatment Period|Participant no longer meets criteria|0|||
105816018|NCT01035060|364985432|FG001|Overall Study|Physician Decision|0|||
105816019|NCT01126736|364985433|FG000|Overall Study|Death|2|||
105816020|NCT01126736|364985434|FG001|Overall Study|Death|2|||
106145349|NCT01170962|366191949|FG000|Treatment Period|Request to discontinue treatment|7|||
106145350|NCT01170962|366191950|FG001|Treatment Period|Request to discontinue treatment|3|||
106145351|NCT01170962|366191951|FG002|Treatment Period|Request to discontinue treatment|1|||
106145352|NCT01170962|366191949|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
106145353|NCT01170962|366191950|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
106145354|NCT01170962|366191951|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
106145355|NCT01170962|366191949|FG000|Follow up Period|Withdrawal by Subject|14|||
106145356|NCT01170962|366191950|FG001|Follow up Period|Withdrawal by Subject|10|||
106145357|NCT01170962|366191951|FG002|Follow up Period|Withdrawal by Subject|2|||
106145358|NCT01170962|366191949|FG000|Follow up Period|Lost to Follow-up|13|||
105816021|NCT01126736|364985435|FG002|Overall Study|Death|1|||
105816022|NCT01126736|364985436|FG003|Overall Study|Death|19|||
105816023|NCT01126736|364985437|FG004|Overall Study|Death|19|||
105816024|NCT01126736|364985433|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
105816025|NCT01126736|364985434|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
105816026|NCT01126736|364985435|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
105816027|NCT01126736|364985436|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
105816028|NCT01126736|364985437|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
105816029|NCT01126736|364985433|FG000|Overall Study|Lost to Follow-up|0|||
105816030|NCT01126736|364985434|FG001|Overall Study|Lost to Follow-up|0|||
105816031|NCT01126736|364985435|FG002|Overall Study|Lost to Follow-up|0|||
105816032|NCT01126736|364985436|FG003|Overall Study|Lost to Follow-up|1|||
105816033|NCT01126736|364985437|FG004|Overall Study|Lost to Follow-up|1|||
105816034|NCT01126736|364985433|FG000|Overall Study|Administrative reasons|0|||
105816035|NCT01126736|364985434|FG001|Overall Study|Administrative reasons|0|||
105816036|NCT01126736|364985435|FG002|Overall Study|Administrative reasons|0|||
105816037|NCT01126736|364985436|FG003|Overall Study|Administrative reasons|0|||
105816038|NCT01126736|364985437|FG004|Overall Study|Administrative reasons|1|||
105816039|NCT01126736|364985433|FG000|Overall Study|Progressive disease|0|||
105816040|NCT01126736|364985434|FG001|Overall Study|Progressive disease|0|||
105816041|NCT01126736|364985435|FG002|Overall Study|Progressive disease|0|||
105816042|NCT01126736|364985436|FG003|Overall Study|Progressive disease|2|||
105816043|NCT01126736|364985437|FG004|Overall Study|Progressive disease|1|||
105816044|NCT01126736|364985433|FG000|Overall Study|Withdrawal by Subject|0|||
105816045|NCT01126736|364985434|FG001|Overall Study|Withdrawal by Subject|0|||
105816046|NCT01126736|364985435|FG002|Overall Study|Withdrawal by Subject|0|||
105816047|NCT01126736|364985436|FG003|Overall Study|Withdrawal by Subject|1|||
105816048|NCT01126736|364985437|FG004|Overall Study|Withdrawal by Subject|1|||
105816049|NCT01126736|364985433|FG000|Overall Study|Other|2|||
106145359|NCT01170962|366191950|FG001|Follow up Period|Lost to Follow-up|8|||
106145360|NCT01170962|366191951|FG002|Follow up Period|Lost to Follow-up|1|||
106145361|NCT01170962|366191949|FG000|Follow up Period|Death|2|||
105816050|NCT01126736|364985434|FG001|Overall Study|Other|4|||
106145362|NCT01170962|366191950|FG001|Follow up Period|Death|2|||
106145363|NCT01170962|366191951|FG002|Follow up Period|Death|0|||
105816051|NCT01126736|364985435|FG002|Overall Study|Other|4|||
105816052|NCT01126736|364985436|FG003|Overall Study|Other|16|||
105816053|NCT01126736|364985437|FG004|Overall Study|Other|15|||
105816054|NCT00877032|364985443|FG000|Overall Study|Did not meet entrance criteria|0|||
105816055|NCT00877032|364985444|FG001|Overall Study|Did not meet entrance criteria|0|||
106145364|NCT01170962|366191949|FG000|Follow up Period|Others|10|||
105816056|NCT00877032|364985445|FG002|Overall Study|Did not meet entrance criteria|0|||
105816057|NCT00877032|364985446|FG003|Overall Study|Did not meet entrance criteria|1|||
105816058|NCT00877032|364985447|FG004|Overall Study|Did not meet entrance criteria|0|||
105816059|NCT00877032|364985448|FG005|Overall Study|Did not meet entrance criteria|0|||
106145365|NCT01170962|366191950|FG001|Follow up Period|Others|7|||
106145366|NCT01170962|366191951|FG002|Follow up Period|Others|3|||
106145367|NCT02674750|366191952|FG000|Overall Study|Death|4|||
105816060|NCT00877032|364985449|FG006|Overall Study|Did not meet entrance criteria|2|||
105816061|NCT02107092|364985451|FG000|Overall Study|Miscellaneous|3|||
105816062|NCT02107092|364985451|FG000|Overall Study|Subject compliance|3|||
105816063|NCT02107092|364985451|FG000|Overall Study|Hypo-or hyperkalemia|2|||
105816064|NCT02107092|364985451|FG000|Overall Study|Met ECG withdrawal criteria|3|||
105816065|NCT02107092|364985451|FG000|Overall Study|Physician Decision|3|||
105816066|NCT02107092|364985451|FG000|Overall Study|Lost to Follow-up|2|||
105816067|NCT02107092|364985451|FG000|Overall Study|Withdrawal by Subject|9|||
105816068|NCT02107092|364985451|FG000|Overall Study|Adverse Event|7|||
105816069|NCT02107092|364985451|FG000|Overall Study|Expected progression of CKD|12|||
105816070|NCT03522675|364985453|FG000|Overall Study|Screen fail|1|||
105816071|NCT03522675|364985453|FG000|Overall Study|Non-reactive to histamine|1|||
105816072|NCT02076022|364985454|FG000|Overall Study|Withdrawal by Subject|2|||
105816073|NCT02076022|364985455|FG001|Overall Study|Withdrawal by Subject|0|||
105816074|NCT01536405|364985456|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
105816075|NCT01536405|364985457|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
105816076|NCT01536405|364985456|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
105816077|NCT01536405|364985457|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
105816078|NCT01536405|364985456|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
105816079|NCT01536405|364985457|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
105816080|NCT01536405|364985456|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
105816081|NCT01536405|364985457|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
105816082|NCT01536405|364985456|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
105816083|NCT01536405|364985457|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
105816084|NCT01536405|364985456|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
105816085|NCT01536405|364985457|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
105816086|NCT01536405|364985456|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
105816087|NCT01536405|364985457|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
105816088|NCT01536405|364985456|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
105816089|NCT01536405|364985457|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
105816090|NCT01536405|364985456|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
105816091|NCT01536405|364985457|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
105816092|NCT01536405|364985456|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
105816093|NCT01536405|364985457|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
105816094|NCT01536405|364985456|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
105816095|NCT01536405|364985457|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
105816096|NCT01536405|364985456|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
105816097|NCT01536405|364985457|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
105816098|NCT01536405|364985456|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
105816099|NCT01536405|364985457|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
105816100|NCT02549092|364985458|FG000|Treatment Period|Adverse Event|2|||
105816101|NCT02549092|364985459|FG001|Treatment Period|Adverse Event|2|||
105816102|NCT02549092|364985458|FG000|Treatment Period|Withdrawal by Subject|1|||
105816103|NCT02549092|364985459|FG001|Treatment Period|Withdrawal by Subject|3|||
105816104|NCT02549092|364985458|FG000|Treatment Period|Lack of Efficacy|0|||
105816105|NCT02549092|364985459|FG001|Treatment Period|Lack of Efficacy|2|||
105816106|NCT02549092|364985458|FG000|Extension/Transition Period|Adverse Event|1|||
105816107|NCT02549092|364985459|FG001|Extension/Transition Period|Adverse Event|1|||
105955983|NCT00078806|365501430|FG001|Part 1A|Adverse Event|0|||
105955984|NCT00078806|365501431|FG002|Part 1A|Adverse Event|0|||
105955985|NCT00078806|365501432|FG003|Part 1A|Adverse Event|0|||
105955986|NCT00078806|365501429|FG000|Part 1A|Lack of Efficacy|7|||
105955987|NCT00078806|365501430|FG001|Part 1A|Lack of Efficacy|0|||
105955988|NCT00078806|365501431|FG002|Part 1A|Lack of Efficacy|0|||
105955989|NCT00078806|365501432|FG003|Part 1A|Lack of Efficacy|0|||
105955990|NCT00078806|365501429|FG000|Part 1A|Other|1|||
105955991|NCT00078806|365501430|FG001|Part 1A|Other|0|||
105955992|NCT00078806|365501431|FG002|Part 1A|Other|0|||
105955993|NCT00078806|365501432|FG003|Part 1A|Other|0|||
105955994|NCT00078806|365501429|FG000|Part 1B|Adverse Event|1|||
105955995|NCT00078806|365501430|FG001|Part 1B|Adverse Event|0|||
105955996|NCT00078806|365501431|FG002|Part 1B|Adverse Event|0|||
105816108|NCT02549092|364985458|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
105955997|NCT00078806|365501432|FG003|Part 1B|Adverse Event|0|||
105955998|NCT00078806|365501429|FG000|Part 1B|Lack of Efficacy|7|||
105955999|NCT00078806|365501430|FG001|Part 1B|Lack of Efficacy|0|||
105956000|NCT00078806|365501431|FG002|Part 1B|Lack of Efficacy|0|||
105956001|NCT00078806|365501432|FG003|Part 1B|Lack of Efficacy|0|||
105956002|NCT00078806|365501429|FG000|Part 2|Adverse Event|0|||
105956003|NCT00078806|365501430|FG001|Part 2|Adverse Event|1|||
105956004|NCT00078806|365501431|FG002|Part 2|Adverse Event|0|||
105816109|NCT02549092|364985459|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
105956005|NCT00078806|365501432|FG003|Part 2|Adverse Event|0|||
105956006|NCT00566982|365501433|FG000|Overall Study|Adverse Event|6|||
105816110|NCT02549092|364985458|FG000|Extension/Transition Period|Other, Not Specified|4|||
105816111|NCT02549092|364985459|FG001|Extension/Transition Period|Other, Not Specified|2|||
105816112|NCT02511782|364985462|FG000|Overall Study|Withdrawal by Subject|1|||
105816113|NCT02511782|364985463|FG001|Overall Study|Withdrawal by Subject|0|||
105816114|NCT02511782|364985464|FG002|Overall Study|Withdrawal by Subject|0|||
105816115|NCT00450190|364985465|FG000|Overall Study|Withdrawal by Subject|2|||
105816116|NCT04625114|364985473|FG000|Overall Study|Adverse Event|3|||
105816117|NCT04625114|364985474|FG001|Overall Study|Adverse Event|1|||
105816118|NCT04625114|364985473|FG000|Overall Study|Withdrawal by Subject|2|||
105816119|NCT04625114|364985474|FG001|Overall Study|Withdrawal by Subject|0|||
105816120|NCT00565448|364985482|FG000|Overall Study|Adverse Event|1|||
105816121|NCT00565448|364985483|FG001|Overall Study|Adverse Event|2|||
105816122|NCT00565448|364985482|FG000|Overall Study|Disease progression|1|||
105816123|NCT00565448|364985483|FG001|Overall Study|Disease progression|0|||
105816124|NCT00565448|364985482|FG000|Overall Study|Withdrawal by Subject|1|||
105816125|NCT00565448|364985483|FG001|Overall Study|Withdrawal by Subject|0|||
105816126|NCT00193609|364985484|FG000|Overall Study|Lack of Efficacy|2|||
105816127|NCT00193609|364985484|FG000|Overall Study|Adverse Event|2|||
105816128|NCT03048500|364985485|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
105816129|NCT03048500|364985485|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
105816130|NCT03048500|364985485|FG000|Reached 1st Response/Continued Treatment|Death|1|||
105816131|NCT03048500|364985485|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
105816132|NCT03048500|364985485|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
105816133|NCT03048500|364985485|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
105816134|NCT03048500|364985485|FG000|Follow up for 3 Years|Death|12|||
105816135|NCT00048581|364985486|FG000|Double-Blind Period|Adverse Event|9|||
105816136|NCT00048581|364985487|FG001|Double-Blind Period|Adverse Event|5|||
105816137|NCT00048581|364985488|FG002|Double-Blind Period|Adverse Event|0|||
105816138|NCT00048581|364985486|FG000|Double-Blind Period|Lack of Efficacy|14|||
105816139|NCT00048581|364985487|FG001|Double-Blind Period|Lack of Efficacy|27|||
105816140|NCT00048581|364985488|FG002|Double-Blind Period|Lack of Efficacy|0|||
105816141|NCT00048581|364985486|FG000|Double-Blind Period|Lost to Follow-up|5|||
105816142|NCT00048581|364985487|FG001|Double-Blind Period|Lost to Follow-up|0|||
105816143|NCT00048581|364985488|FG002|Double-Blind Period|Lost to Follow-up|0|||
105816144|NCT00048581|364985486|FG000|Double-Blind Period|Withdrawal by Subject|5|||
105816145|NCT00048581|364985487|FG001|Double-Blind Period|Withdrawal by Subject|2|||
105816146|NCT00048581|364985488|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105816147|NCT00048581|364985486|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
105816148|NCT00048581|364985487|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
105816149|NCT00048581|364985488|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
105816150|NCT00048581|364985486|FG000|Double-Blind Period|Investigator Decision|1|||
105816151|NCT00048581|364985487|FG001|Double-Blind Period|Investigator Decision|0|||
105816152|NCT00048581|364985488|FG002|Double-Blind Period|Investigator Decision|0|||
105816153|NCT00048581|364985486|FG000|Open-Label Period|Death|0|||
105764612|NCT01998958|364791683|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
105764613|NCT01998958|364791684|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
105764614|NCT01998958|364791685|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
105764615|NCT01998958|364791686|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764616|NCT01998958|364791687|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764617|NCT01998958|364791688|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764618|NCT01998958|364791689|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764619|NCT01998958|364791690|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764620|NCT01998958|364791691|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764621|NCT01998958|364791692|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764622|NCT01998958|364791693|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
105764623|NCT03551626|364791694|FG000|Overall Study|Adverse Event|88|||
105764624|NCT03551626|364791694|FG000|Overall Study|Disease relapse|18|||
105764625|NCT03551626|364791694|FG000|Overall Study|Withdrawal of informed consent|6|||
105764626|NCT03551626|364791694|FG000|Overall Study|Patient decision|5|||
105764627|NCT03551626|364791694|FG000|Overall Study|Physician Decision|4|||
105764628|NCT03551626|364791694|FG000|Overall Study|Lost to Follow-up|3|||
105764629|NCT03551626|364791694|FG000|Overall Study|Pregnancy|1|||
105816154|NCT00048581|364985487|FG001|Open-Label Period|Death|0|||
105816155|NCT00048581|364985488|FG002|Open-Label Period|Death|4|||
105816156|NCT00048581|364985486|FG000|Open-Label Period|Adverse Event|0|||
105816157|NCT00048581|364985487|FG001|Open-Label Period|Adverse Event|0|||
105956007|NCT00566982|365501434|FG001|Overall Study|Adverse Event|48|||
105956008|NCT00566982|365501433|FG000|Overall Study|Withdrawal by Subject|1|||
105956009|NCT00566982|365501434|FG001|Overall Study|Withdrawal by Subject|14|||
105956010|NCT00566982|365501433|FG000|Overall Study|Protocol Violation|1|||
105956011|NCT00566982|365501434|FG001|Overall Study|Protocol Violation|4|||
105816158|NCT00048581|364985488|FG002|Open-Label Period|Adverse Event|37|||
105764630|NCT03551626|364791694|FG000|Overall Study|Protocol deviation|1|||
105764631|NCT03551626|364791694|FG000|Overall Study|Technical problems|1|||
105816159|NCT00048581|364985486|FG000|Open-Label Period|Lack of Efficacy|0|||
105816160|NCT00048581|364985487|FG001|Open-Label Period|Lack of Efficacy|0|||
105816161|NCT00048581|364985488|FG002|Open-Label Period|Lack of Efficacy|69|||
105816162|NCT00048581|364985486|FG000|Open-Label Period|Lost to Follow-up|0|||
105816163|NCT00048581|364985487|FG001|Open-Label Period|Lost to Follow-up|0|||
105816164|NCT00048581|364985488|FG002|Open-Label Period|Lost to Follow-up|14|||
105816165|NCT00048581|364985486|FG000|Open-Label Period|Withdrawal by Subject|0|||
105816166|NCT00048581|364985487|FG001|Open-Label Period|Withdrawal by Subject|0|||
105816167|NCT00048581|364985488|FG002|Open-Label Period|Withdrawal by Subject|20|||
105816168|NCT00048581|364985486|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
105816169|NCT00048581|364985487|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
105816170|NCT00048581|364985488|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
105816171|NCT00048581|364985486|FG000|Open-Label Period|Poor/Non-compliance|0|||
105816172|NCT00048581|364985487|FG001|Open-Label Period|Poor/Non-compliance|0|||
105816173|NCT00048581|364985488|FG002|Open-Label Period|Poor/Non-compliance|5|||
105816174|NCT00048581|364985486|FG000|Open-Label Period|Pregnancy|0|||
105816175|NCT00048581|364985487|FG001|Open-Label Period|Pregnancy|0|||
105816176|NCT00048581|364985488|FG002|Open-Label Period|Pregnancy|7|||
105816177|NCT00048581|364985486|FG000|Open-Label Period|Study Site Closure|0|||
105816178|NCT00048581|364985487|FG001|Open-Label Period|Study Site Closure|0|||
105816179|NCT00048581|364985488|FG002|Open-Label Period|Study Site Closure|2|||
105816180|NCT00048581|364985486|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
105816181|NCT00048581|364985487|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
105816182|NCT00048581|364985488|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
105816183|NCT00048581|364985486|FG000|Open-Label Period|Problem With Transportation To Site|0|||
105816184|NCT00048581|364985487|FG001|Open-Label Period|Problem With Transportation To Site|0|||
105816185|NCT00048581|364985488|FG002|Open-Label Period|Problem With Transportation To Site|1|||
105816186|NCT00048581|364985486|FG000|Open-Label Period|Primary Investigator Retired|0|||
105816187|NCT00048581|364985487|FG001|Open-Label Period|Primary Investigator Retired|0|||
105816188|NCT00048581|364985488|FG002|Open-Label Period|Primary Investigator Retired|2|||
105816189|NCT00048581|364985486|FG000|Open-Label Period|Study Ended By Sponsor|0|||
105816190|NCT00048581|364985487|FG001|Open-Label Period|Study Ended By Sponsor|0|||
105816191|NCT00048581|364985488|FG002|Open-Label Period|Study Ended By Sponsor|1|||
105816192|NCT01406795|364985489|FG000|Overall Study|Withdrawal by Subject|1|||
105816193|NCT03897088|364985490|FG000|Overall Study|Withdrawal by Subject|12|||
105816194|NCT03897088|364985491|FG001|Overall Study|Withdrawal by Subject|12|||
105816195|NCT03897088|364985490|FG000|Overall Study|Lost to Follow-up|7|||
105956012|NCT00566982|365501433|FG000|Overall Study|Lost to Follow-up|0|||
105956013|NCT00566982|365501434|FG001|Overall Study|Lost to Follow-up|1|||
105956014|NCT00566982|365501433|FG000|Overall Study|Other-family problems & doctor's request|0|||
105956015|NCT00566982|365501434|FG001|Overall Study|Other-family problems & doctor's request|2|||
105956016|NCT00841776|365501438|FG000|Overall Study|Lack of Efficacy|0|||
105956017|NCT00841776|365501439|FG001|Overall Study|Lack of Efficacy|1|||
105956018|NCT00841776|365501438|FG000|Overall Study|Lost to Follow-up|2|||
105956019|NCT00841776|365501439|FG001|Overall Study|Lost to Follow-up|1|||
105956020|NCT00841776|365501438|FG000|Overall Study|Withdrawal by Subject|0|||
105956021|NCT00841776|365501439|FG001|Overall Study|Withdrawal by Subject|1|||
105956022|NCT01279044|365501442|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
105956023|NCT01279044|365501443|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
105956024|NCT01279044|365501444|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
105956025|NCT01279044|365501442|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
105956026|NCT01279044|365501443|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
105956027|NCT01279044|365501444|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
105956028|NCT01279044|365501442|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
105956029|NCT01279044|365501443|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
105956030|NCT01279044|365501444|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
105956031|NCT00473889|365501445|FG000|Overall Study|Did not receive study medication|1|||
105956032|NCT00473889|365501446|FG001|Overall Study|Did not receive study medication|4|||
105956033|NCT00473889|365501445|FG000|Overall Study|Adverse Event|30|||
105956034|NCT00473889|365501446|FG001|Overall Study|Adverse Event|17|||
105956035|NCT00473889|365501445|FG000|Overall Study|Protocol Violation|4|||
105956036|NCT00473889|365501446|FG001|Overall Study|Protocol Violation|2|||
105956037|NCT00473889|365501445|FG000|Overall Study|Lack of Efficacy|28|||
105956038|NCT00473889|365501446|FG001|Overall Study|Lack of Efficacy|29|||
105956039|NCT00473889|365501445|FG000|Overall Study|Lost to Follow-up|2|||
105956040|NCT00473889|365501446|FG001|Overall Study|Lost to Follow-up|1|||
105816196|NCT03897088|364985491|FG001|Overall Study|Lost to Follow-up|15|||
105816197|NCT03897088|364985490|FG000|Overall Study|Sponsor Decision|1|||
105816198|NCT03897088|364985491|FG001|Overall Study|Sponsor Decision|2|||
105816199|NCT03897088|364985490|FG000|Overall Study|COVID-19|2|||
105816200|NCT03897088|364985491|FG001|Overall Study|COVID-19|0|||
105956041|NCT00473889|365501445|FG000|Overall Study|Physician Decision|10|||
105956042|NCT00473889|365501446|FG001|Overall Study|Physician Decision|5|||
105956043|NCT00473889|365501445|FG000|Overall Study|Trial Terminated|3|||
105816201|NCT03897088|364985490|FG000|Overall Study|Other|3|||
105816202|NCT03897088|364985491|FG001|Overall Study|Other|0|||
105816203|NCT03897088|364985490|FG000|Overall Study|Non-compliance with Study Drug|1|||
105816204|NCT03897088|364985491|FG001|Overall Study|Non-compliance with Study Drug|1|||
105816205|NCT03897088|364985490|FG000|Overall Study|Pregnancy|0|||
105816206|NCT03897088|364985491|FG001|Overall Study|Pregnancy|1|||
105816207|NCT00385593|364985492|FG000|Overall Study|Adverse Event|3|||
105816208|NCT00385593|364985493|FG001|Overall Study|Adverse Event|2|||
105816209|NCT00385593|364985492|FG000|Overall Study|Withdrawal by Subject|17|||
105816210|NCT00385593|364985493|FG001|Overall Study|Withdrawal by Subject|7|||
105816211|NCT00385593|364985492|FG000|Overall Study|Lost to Follow-up|12|||
105816212|NCT00385593|364985493|FG001|Overall Study|Lost to Follow-up|8|||
105816213|NCT00385593|364985492|FG000|Overall Study|Protocol Violation|7|||
105816214|NCT00385593|364985493|FG001|Overall Study|Protocol Violation|4|||
105816215|NCT00385593|364985492|FG000|Overall Study|Several reasons|17|||
105816216|NCT00385593|364985493|FG001|Overall Study|Several reasons|15|||
105816217|NCT00385593|364985492|FG000|Overall Study|Incorrect inclusion|2|||
105816218|NCT00385593|364985493|FG001|Overall Study|Incorrect inclusion|0|||
105816219|NCT00385593|364985492|FG000|Overall Study|Incorrect randomization|0|||
105816220|NCT00385593|364985493|FG001|Overall Study|Incorrect randomization|1|||
105816221|NCT03725605|364985494|FG000|Overall Study|Unsuccessful TIL expansion|2|||
105816222|NCT01619800|364986807|FG000|Overall Study|study terminated|2|||
105816223|NCT01619800|364986808|FG001|Overall Study|study terminated|0|||
105816224|NCT00416520|364986815|FG000|Open-label Period|Adverse Event|28|||
105816225|NCT00416520|364986816|FG001|Open-label Period|Adverse Event|10|||
105816226|NCT00416520|364986817|FG002|Open-label Period|Adverse Event|0|||
105816227|NCT00416520|364986818|FG003|Open-label Period|Adverse Event|0|||
105816228|NCT00416520|364986815|FG000|Open-label Period|Death|2|||
105816229|NCT00416520|364986816|FG001|Open-label Period|Death|1|||
105816230|NCT00416520|364986817|FG002|Open-label Period|Death|0|||
105816231|NCT00416520|364986818|FG003|Open-label Period|Death|0|||
105816232|NCT00416520|364986815|FG000|Open-label Period|Lack of Efficacy|8|||
105816233|NCT00416520|364986816|FG001|Open-label Period|Lack of Efficacy|1|||
105816234|NCT00416520|364986817|FG002|Open-label Period|Lack of Efficacy|0|||
105816235|NCT00416520|364986818|FG003|Open-label Period|Lack of Efficacy|0|||
105816236|NCT00416520|364986815|FG000|Open-label Period|Protocol Violation|3|||
105816237|NCT00416520|364986816|FG001|Open-label Period|Protocol Violation|3|||
105816238|NCT00416520|364986817|FG002|Open-label Period|Protocol Violation|0|||
105816239|NCT00416520|364986818|FG003|Open-label Period|Protocol Violation|0|||
105816240|NCT00416520|364986815|FG000|Open-label Period|Withdrawal by Subject|16|||
105816241|NCT00416520|364986816|FG001|Open-label Period|Withdrawal by Subject|5|||
105816242|NCT00416520|364986817|FG002|Open-label Period|Withdrawal by Subject|0|||
105956044|NCT00473889|365501446|FG001|Overall Study|Trial Terminated|6|||
105956045|NCT00473889|365501445|FG000|Overall Study|Withdrawal by Subject|5|||
105956046|NCT00473889|365501446|FG001|Overall Study|Withdrawal by Subject|0|||
105956047|NCT03783962|365501447|FG000|Overall Study|Lost to Follow-up|3|||
105956048|NCT03783962|365501448|FG001|Overall Study|Lost to Follow-up|6|||
105956049|NCT03783962|365501447|FG000|Overall Study|Protocol Violation|0|||
105956050|NCT03783962|365501448|FG001|Overall Study|Protocol Violation|1|||
105956051|NCT00856635|365501449|FG000|Overall Study|Lost to Follow-up|2|||
105956052|NCT00856635|365501450|FG001|Overall Study|Lost to Follow-up|5|||
105956053|NCT00856635|365501449|FG000|Overall Study|Pregnancy|1|||
105956054|NCT00856635|365501450|FG001|Overall Study|Pregnancy|0|||
105956055|NCT00856635|365501449|FG000|Overall Study|Withdrawal by Subject|3|||
105956056|NCT00856635|365501450|FG001|Overall Study|Withdrawal by Subject|1|||
105956057|NCT00856635|365501449|FG000|Overall Study|Serious Adverse Event|1|||
105956058|NCT00856635|365501450|FG001|Overall Study|Serious Adverse Event|0|||
105956059|NCT00856635|365501449|FG000|Overall Study|Other|1|||
105956060|NCT00856635|365501450|FG001|Overall Study|Other|0|||
105956061|NCT00856635|365501449|FG000|Overall Study|Discontinued at Randomization|2|||
105956062|NCT00856635|365501450|FG001|Overall Study|Discontinued at Randomization|2|||
105956063|NCT03592771|365501453|FG000|Overall Study|Adverse Event|2|||
105956064|NCT03592771|365501454|FG001|Overall Study|Adverse Event|0|||
105956065|NCT03592771|365501455|FG002|Overall Study|Adverse Event|1|||
105956066|NCT03592771|365501453|FG000|Overall Study|Death|0|||
105956067|NCT03592771|365501454|FG001|Overall Study|Death|1|||
105956068|NCT03592771|365501455|FG002|Overall Study|Death|1|||
105956069|NCT03592771|365501453|FG000|Overall Study|Lost to Follow-up|5|||
105956070|NCT03592771|365501454|FG001|Overall Study|Lost to Follow-up|11|||
105816243|NCT00416520|364986818|FG003|Open-label Period|Withdrawal by Subject|0|||
105816244|NCT00416520|364986815|FG000|Open-label Period|Other Reasons|3|||
105956071|NCT03592771|365501455|FG002|Overall Study|Lost to Follow-up|15|||
106145368|NCT02674750|366191953|FG001|Overall Study|Death|5|||
105956072|NCT03592771|365501453|FG000|Overall Study|Withdrawal by Subject|0|||
105956073|NCT03592771|365501454|FG001|Overall Study|Withdrawal by Subject|2|||
105956074|NCT03592771|365501455|FG002|Overall Study|Withdrawal by Subject|0|||
106145369|NCT02674750|366191954|FG002|Overall Study|Death|8|||
105816245|NCT00416520|364986816|FG001|Open-label Period|Other Reasons|12|||
105956075|NCT01724216|365501456|FG000|Overall Study|Scan was not completed|1|||
106018374|NCT00354432|365729333|FG000|Overall Study|Off/Toxicity|3|||
105816246|NCT00416520|364986817|FG002|Open-label Period|Other Reasons|0|||
105816247|NCT00416520|364986818|FG003|Open-label Period|Other Reasons|0|||
105816248|NCT00416520|364986815|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
105816249|NCT00416520|364986816|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
105816250|NCT00416520|364986817|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
105816251|NCT00416520|364986818|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
105816252|NCT00416520|364986815|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
105816253|NCT00416520|364986816|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
105816254|NCT00416520|364986817|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
105816255|NCT00416520|364986818|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
105816256|NCT00416520|364986815|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
105816257|NCT00416520|364986816|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
105816258|NCT00416520|364986817|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
105816259|NCT00416520|364986818|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
105816260|NCT03601637|364986819|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
105816261|NCT03601637|364986820|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
105816262|NCT03601637|364986819|FG000|Overall Study|Adverse Event|1|||
105816263|NCT03601637|364986820|FG001|Overall Study|Adverse Event|1|||
105816264|NCT03601637|364986819|FG000|Overall Study|Other|0|||
105816265|NCT03601637|364986820|FG001|Overall Study|Other|1|||
105816266|NCT01042522|364986825|FG000|Overall Study|Adverse Event|1|||
105816267|NCT01042522|364986826|FG001|Overall Study|Adverse Event|2|||
105816268|NCT01042522|364986825|FG000|Overall Study|Disease Progression|5|||
105816269|NCT01042522|364986826|FG001|Overall Study|Disease Progression|0|||
105816270|NCT01042522|364986825|FG000|Overall Study|Death|1|||
105816271|NCT01042522|364986826|FG001|Overall Study|Death|0|||
105816272|NCT01042522|364986825|FG000|Overall Study|Patient Refused|0|||
105816273|NCT01042522|364986826|FG001|Overall Study|Patient Refused|3|||
105816274|NCT01042522|364986825|FG000|Overall Study|Withdrawal by Subject|1|||
105816275|NCT01042522|364986826|FG001|Overall Study|Withdrawal by Subject|1|||
105816276|NCT00549718|364986827|FG000|Overall Study|Insufficient clinical response|20|||
105816277|NCT00549718|364986828|FG001|Overall Study|Insufficient clinical response|7|||
105816278|NCT00549718|364986829|FG002|Overall Study|Insufficient clinical response|18|||
105816279|NCT00549718|364986830|FG003|Overall Study|Insufficient clinical response|32|||
105816280|NCT00549718|364986827|FG000|Overall Study|Adverse Event|6|||
105816281|NCT00549718|364986828|FG001|Overall Study|Adverse Event|8|||
105816282|NCT00549718|364986829|FG002|Overall Study|Adverse Event|7|||
105816283|NCT00549718|364986830|FG003|Overall Study|Adverse Event|3|||
105816284|NCT00549718|364986827|FG000|Overall Study|Lost to Follow-up|4|||
105816285|NCT00549718|364986828|FG001|Overall Study|Lost to Follow-up|2|||
105816286|NCT00549718|364986829|FG002|Overall Study|Lost to Follow-up|0|||
105816287|NCT00549718|364986830|FG003|Overall Study|Lost to Follow-up|6|||
105816288|NCT00549718|364986827|FG000|Overall Study|Withdrawal by Subject|9|||
105816289|NCT00549718|364986828|FG001|Overall Study|Withdrawal by Subject|18|||
105816290|NCT00549718|364986829|FG002|Overall Study|Withdrawal by Subject|12|||
105816291|NCT00549718|364986830|FG003|Overall Study|Withdrawal by Subject|13|||
105816292|NCT00549718|364986827|FG000|Overall Study|Administrative|2|||
105816293|NCT00549718|364986828|FG001|Overall Study|Administrative|2|||
105816294|NCT00549718|364986829|FG002|Overall Study|Administrative|2|||
105816295|NCT00549718|364986830|FG003|Overall Study|Administrative|1|||
105816296|NCT03597256|364986831|FG000|Overall Study|Lost to Follow-up|3|||
105816297|NCT03597256|364986832|FG001|Overall Study|Lost to Follow-up|1|||
105816298|NCT03597256|364986831|FG000|Overall Study|Withdrawal by Subject|0|||
105816299|NCT03597256|364986832|FG001|Overall Study|Withdrawal by Subject|1|||
105816300|NCT03597256|364986831|FG000|Overall Study|Could not return for treatment|0|||
105816301|NCT03597256|364986832|FG001|Overall Study|Could not return for treatment|1|||
105816302|NCT03597256|364986831|FG000|Overall Study|Moved from location|0|||
105816303|NCT03597256|364986832|FG001|Overall Study|Moved from location|1|||
105816304|NCT03597256|364986831|FG000|Overall Study|Not accepted the treatment|0|||
105816305|NCT03597256|364986832|FG001|Overall Study|Not accepted the treatment|1|||
105816306|NCT01045096|364986833|FG000|Overall Study|Withdrawal by Subject|2|||
105816307|NCT01045096|364986834|FG001|Overall Study|Withdrawal by Subject|0|||
105816308|NCT01045096|364986835|FG002|Overall Study|Withdrawal by Subject|0|||
105816309|NCT01045096|364986833|FG000|Overall Study|Other|1|||
105816310|NCT01045096|364986834|FG001|Overall Study|Other|0|||
105816311|NCT01045096|364986835|FG002|Overall Study|Other|0|||
105816312|NCT02109042|364986837|FG000|Overall Study|Sponsor Decision|15|||
105816313|NCT01511939|364986838|FG000|Overall Study|Withdrawal by Subject|2|||
106018375|NCT00354432|365729334|FG001|Overall Study|Off/Toxicity|7|||
105816314|NCT01511939|364986839|FG001|Overall Study|Withdrawal by Subject|1|||
105816315|NCT01511939|364986840|FG002|Overall Study|Withdrawal by Subject|0|||
105816316|NCT04407806|364986844|FG000|Overall Study|Withdrawal by Subject|1|||
105816317|NCT04407806|364986845|FG001|Overall Study|Withdrawal by Subject|2|||
105816318|NCT01520909|364986846|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
105816319|NCT01520909|364986847|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
105816320|NCT01520909|364986848|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
106018376|NCT00354432|365729335|FG002|Overall Study|Off/Toxicity|5|||
106018377|NCT00354432|365729336|FG003|Overall Study|Off/Toxicity|5|||
106018378|NCT01967238|365729339|FG000|Overall Study|Adverse Event|1|||
106018379|NCT01967238|365729340|FG001|Overall Study|Adverse Event|1|||
106018380|NCT01967238|365729341|FG002|Overall Study|Adverse Event|0|||
106018381|NCT01967238|365729339|FG000|Overall Study|Lost to Follow-up|1|||
106018382|NCT01967238|365729340|FG001|Overall Study|Lost to Follow-up|0|||
106018383|NCT01967238|365729341|FG002|Overall Study|Lost to Follow-up|1|||
106018384|NCT01967238|365729339|FG000|Overall Study|Withdrawal by Subject|0|||
106018385|NCT01967238|365729340|FG001|Overall Study|Withdrawal by Subject|0|||
106018386|NCT01967238|365729341|FG002|Overall Study|Withdrawal by Subject|1|||
106018387|NCT04434937|365729344|FG000|Overall Study|Death|4|||
106018388|NCT04434937|365729344|FG000|Overall Study|Withdrawal by Subject|1|||
106018389|NCT04434937|365729344|FG000|Overall Study|Transitioned to Rollover Study|19|||
106018390|NCT04434937|365729344|FG000|Overall Study|Progressive Disease|18|||
106018391|NCT00777153|365730660|FG000|Overall Study|Lost to Follow-up|1|||
106018392|NCT00777153|365730661|FG001|Overall Study|Lost to Follow-up|1|||
106018393|NCT00777153|365730662|FG002|Overall Study|Lost to Follow-up|0|||
106018394|NCT00777153|365730660|FG000|Overall Study|Death|85|||
106018395|NCT00777153|365730661|FG001|Overall Study|Death|73|||
106018396|NCT00777153|365730662|FG002|Overall Study|Death|33|||
106018397|NCT00777153|365730660|FG000|Overall Study|Withdrawal by Subject|3|||
106018398|NCT00777153|365730661|FG001|Overall Study|Withdrawal by Subject|4|||
106018399|NCT00777153|365730662|FG002|Overall Study|Withdrawal by Subject|3|||
106018400|NCT00777153|365730660|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
106018401|NCT00777153|365730661|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
106018402|NCT00777153|365730662|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
106018403|NCT05097963|365730664|FG000|Overall Study|Protocol Violation|13|||
106018404|NCT05097963|365730664|FG000|Overall Study|Withdrawal by Subject|21|||
106018405|NCT01413204|365730665|FG000|Overall Study|Adverse Event|1|||
106018406|NCT01413204|365730666|FG001|Overall Study|Adverse Event|2|||
106018407|NCT01413204|365730667|FG002|Overall Study|Adverse Event|2|||
106018408|NCT01413204|365730665|FG000|Overall Study|Physician Decision|3|||
105764632|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
105764633|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
105764634|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
105764635|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
105764636|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
105764637|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
105764638|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Other|2|||
105764639|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Other|2|||
105764640|NCT02133001|364791695|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
105764641|NCT02133001|364791696|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
105764642|NCT02133001|364791695|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
105764643|NCT02133001|364791696|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
105764644|NCT02133001|364791695|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
105764645|NCT02133001|364791696|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
105764646|NCT02133001|364791695|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
105764647|NCT02133001|364791696|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
105764648|NCT02062827|364791699|FG000|Overall Study|Death|1|||
105764649|NCT02062827|364791700|FG001|Overall Study|Death|0|||
105764650|NCT02062827|364791701|FG002|Overall Study|Death|0|||
105764651|NCT02062827|364791702|FG003|Overall Study|Death|0|||
105764652|NCT02062827|364791703|FG004|Overall Study|Death|0|||
105764653|NCT02062827|364791704|FG005|Overall Study|Death|0|||
105764654|NCT02062827|364791705|FG006|Overall Study|Death|0|||
105764655|NCT02062827|364791706|FG007|Overall Study|Death|0|||
105764656|NCT02062827|364791699|FG000|Overall Study|Withdrawal by Subject|3|||
105764657|NCT02062827|364791700|FG001|Overall Study|Withdrawal by Subject|1|||
105764658|NCT02062827|364791701|FG002|Overall Study|Withdrawal by Subject|1|||
105764659|NCT02062827|364791702|FG003|Overall Study|Withdrawal by Subject|2|||
105764660|NCT02062827|364791703|FG004|Overall Study|Withdrawal by Subject|6|||
105764661|NCT02062827|364791704|FG005|Overall Study|Withdrawal by Subject|0|||
105816321|NCT01520909|364986846|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
105816322|NCT01520909|364986847|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
106018409|NCT01413204|365730666|FG001|Overall Study|Physician Decision|0|||
106018410|NCT01413204|365730667|FG002|Overall Study|Physician Decision|2|||
106018411|NCT01413204|365730665|FG000|Overall Study|Withdrawal by Subject|1|||
106018412|NCT01413204|365730666|FG001|Overall Study|Withdrawal by Subject|4|||
105764662|NCT02062827|364791705|FG006|Overall Study|Withdrawal by Subject|5|||
105764663|NCT02062827|364791706|FG007|Overall Study|Withdrawal by Subject|0|||
105764664|NCT02062827|364791699|FG000|Overall Study|Screen Fail|0|||
105764665|NCT02062827|364791700|FG001|Overall Study|Screen Fail|0|||
105764666|NCT02062827|364791701|FG002|Overall Study|Screen Fail|0|||
105764667|NCT02062827|364791702|FG003|Overall Study|Screen Fail|0|||
105764668|NCT02062827|364791703|FG004|Overall Study|Screen Fail|0|||
106018413|NCT01413204|365730667|FG002|Overall Study|Withdrawal by Subject|4|||
106018414|NCT01413204|365730665|FG000|Overall Study|Clearly not eligible for the study|0|||
105816323|NCT01520909|364986848|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
105816324|NCT01520909|364986846|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
105816325|NCT01520909|364986847|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
105816326|NCT01520909|364986848|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
105816327|NCT01520909|364986846|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
105816328|NCT01520909|364986847|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
105816329|NCT01520909|364986848|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
105816330|NCT01882257|364986851|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
105816331|NCT01882257|364986852|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
105816332|NCT01882257|364986853|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
105816333|NCT01882257|364986851|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
105816334|NCT01882257|364986852|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
105816335|NCT01882257|364986853|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
105816336|NCT03478397|364986856|FG000|Overall Study|Refused to participate|31|||
105816337|NCT03478397|364986857|FG001|Overall Study|Refused to participate|7|||
105816338|NCT02942264|364986858|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816339|NCT02942264|364986859|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
105816340|NCT02942264|364986860|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816341|NCT02942264|364986861|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816342|NCT02942264|364986862|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816343|NCT02942264|364986863|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816344|NCT02942264|364986864|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
105816345|NCT02942264|364986865|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105956076|NCT01014767|365501457|FG000|Overall Study|PI left institution, data unavailable|12|||
105956077|NCT01014767|365501458|FG001|Overall Study|PI left institution, data unavailable|1|||
105956078|NCT01014767|365501459|FG002|Overall Study|PI left institution, data unavailable|4|||
105956079|NCT01014767|365501460|FG003|Overall Study|PI left institution, data unavailable|1|||
105956080|NCT01891396|365501461|FG000|Overall Study|Withdrawal by Subject|4|||
105956081|NCT01891396|365501462|FG001|Overall Study|Withdrawal by Subject|4|||
105956082|NCT01891396|365501463|FG002|Overall Study|Withdrawal by Subject|3|||
105956083|NCT01891396|365501461|FG000|Overall Study|Lost to Follow-up|0|||
105956084|NCT01891396|365501462|FG001|Overall Study|Lost to Follow-up|1|||
105956085|NCT01891396|365501463|FG002|Overall Study|Lost to Follow-up|0|||
105956086|NCT00540592|365501464|FG000|Overall Study|Adverse Event|0|||
105956087|NCT00540592|365501465|FG001|Overall Study|Adverse Event|1|||
105956088|NCT00540592|365501466|FG002|Overall Study|Adverse Event|0|||
105956089|NCT00540592|365501467|FG003|Overall Study|Adverse Event|0|||
105956090|NCT00540592|365501468|FG004|Overall Study|Adverse Event|1|||
105956091|NCT00540592|365501469|FG005|Overall Study|Adverse Event|0|||
105956092|NCT00540592|365501470|FG006|Overall Study|Adverse Event|0|||
105956093|NCT00540592|365501471|FG007|Overall Study|Adverse Event|1|||
105956094|NCT00540592|365501472|FG008|Overall Study|Adverse Event|1|||
105956095|NCT00540592|365501473|FG009|Overall Study|Adverse Event|2|||
105956096|NCT00540592|365501464|FG000|Overall Study|Lost to Follow-up|2|||
105956097|NCT00540592|365501465|FG001|Overall Study|Lost to Follow-up|0|||
105956098|NCT00540592|365501466|FG002|Overall Study|Lost to Follow-up|0|||
105956099|NCT00540592|365501467|FG003|Overall Study|Lost to Follow-up|0|||
106018415|NCT01413204|365730666|FG001|Overall Study|Clearly not eligible for the study|0|||
106018416|NCT01413204|365730667|FG002|Overall Study|Clearly not eligible for the study|1|||
106018417|NCT01413204|365730665|FG000|Overall Study|Fasting plasma glucose level increased|1|||
106018418|NCT01413204|365730666|FG001|Overall Study|Fasting plasma glucose level increased|0|||
106018419|NCT01413204|365730667|FG002|Overall Study|Fasting plasma glucose level increased|10|||
106018420|NCT00372593|365730670|FG000|Overall Study|Adverse Event|43|||
106018421|NCT00372593|365730671|FG001|Overall Study|Adverse Event|45|||
106018422|NCT00372593|365730672|FG002|Overall Study|Adverse Event|0|||
106018423|NCT00372593|365730670|FG000|Overall Study|Death|16|||
106018424|NCT00372593|365730671|FG001|Overall Study|Death|20|||
106018425|NCT00372593|365730672|FG002|Overall Study|Death|1|||
106018426|NCT00372593|365730670|FG000|Overall Study|Lack of Efficacy|82|||
106018427|NCT00372593|365730671|FG001|Overall Study|Lack of Efficacy|71|||
106018428|NCT00372593|365730672|FG002|Overall Study|Lack of Efficacy|2|||
105956100|NCT00540592|365501468|FG004|Overall Study|Lost to Follow-up|0|||
105956101|NCT00540592|365501469|FG005|Overall Study|Lost to Follow-up|0|||
105956102|NCT00540592|365501470|FG006|Overall Study|Lost to Follow-up|0|||
105956103|NCT00540592|365501471|FG007|Overall Study|Lost to Follow-up|0|||
105956104|NCT00540592|365501472|FG008|Overall Study|Lost to Follow-up|0|||
106018429|NCT00372593|365730670|FG000|Overall Study|Lost to Follow-up|1|||
106145370|NCT02674750|366191952|FG000|Overall Study|Lost to Follow-up|0|||
105956105|NCT00540592|365501473|FG009|Overall Study|Lost to Follow-up|0|||
105956106|NCT00540592|365501464|FG000|Overall Study|Withdrawal by Subject|0|||
106018430|NCT00372593|365730671|FG001|Overall Study|Lost to Follow-up|0|||
106018431|NCT00372593|365730672|FG002|Overall Study|Lost to Follow-up|0|||
106018432|NCT00372593|365730670|FG000|Overall Study|Physician Decision|42|||
106018433|NCT00372593|365730671|FG001|Overall Study|Physician Decision|41|||
105816346|NCT02942264|364986866|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
105816347|NCT02942264|364986858|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816348|NCT02942264|364986859|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816349|NCT02942264|364986860|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816350|NCT02942264|364986861|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816351|NCT02942264|364986862|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816352|NCT02942264|364986863|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816353|NCT02942264|364986864|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816354|NCT02942264|364986865|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
105816355|NCT02942264|364986866|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
105816356|NCT02188303|364986867|FG000|Overall Study|Adverse Event|0|||
105816357|NCT02188303|364986868|FG001|Overall Study|Adverse Event|0|||
105816358|NCT02188303|364986869|FG002|Overall Study|Adverse Event|0|||
105816359|NCT02188303|364986870|FG003|Overall Study|Adverse Event|0|||
105816360|NCT02188303|364986871|FG004|Overall Study|Adverse Event|0|||
105816361|NCT02188303|364986872|FG005|Overall Study|Adverse Event|2|||
105816362|NCT02188303|364986873|FG006|Overall Study|Adverse Event|0|||
105816363|NCT02188303|364986874|FG007|Overall Study|Adverse Event|2|||
105956107|NCT00540592|365501465|FG001|Overall Study|Withdrawal by Subject|0|||
105956108|NCT00540592|365501466|FG002|Overall Study|Withdrawal by Subject|1|||
105956109|NCT00540592|365501467|FG003|Overall Study|Withdrawal by Subject|1|||
105956110|NCT00540592|365501468|FG004|Overall Study|Withdrawal by Subject|0|||
105956111|NCT00540592|365501469|FG005|Overall Study|Withdrawal by Subject|0|||
105956112|NCT00540592|365501470|FG006|Overall Study|Withdrawal by Subject|0|||
105956113|NCT00540592|365501471|FG007|Overall Study|Withdrawal by Subject|0|||
105956114|NCT00540592|365501472|FG008|Overall Study|Withdrawal by Subject|0|||
105956115|NCT00540592|365501473|FG009|Overall Study|Withdrawal by Subject|0|||
105956116|NCT01456130|365501474|FG000|Overall Study|Adverse Event|4|||
105956117|NCT01456130|365501474|FG000|Overall Study|Voluntary Withdrawal|1|||
105956118|NCT01456130|365501474|FG000|Overall Study|Lack of Efficacy|4|||
105956119|NCT01456130|365501474|FG000|Overall Study|Other|1|||
105956120|NCT01664247|365501475|FG000|Overall Study|Adverse Event|5|||
105956121|NCT01664247|365501476|FG001|Overall Study|Adverse Event|3|||
105956122|NCT01664247|365501475|FG000|Overall Study|Protocol Violation|3|||
105956123|NCT01664247|365501476|FG001|Overall Study|Protocol Violation|5|||
105956124|NCT01664247|365501475|FG000|Overall Study|Withdrawal Criteria|1|||
105956125|NCT01664247|365501476|FG001|Overall Study|Withdrawal Criteria|4|||
105956126|NCT01664247|365501475|FG000|Overall Study|Unclassified|5|||
105956127|NCT01664247|365501476|FG001|Overall Study|Unclassified|29|||
105956128|NCT03230318|365501477|FG000|Overall Study|Radiographic disease progression|72|||
105956129|NCT03230318|365501478|FG001|Overall Study|Radiographic disease progression|19|||
105956130|NCT03230318|365501477|FG000|Overall Study|Clinical progression|17|||
105956131|NCT03230318|365501478|FG001|Overall Study|Clinical progression|7|||
105956132|NCT03230318|365501477|FG000|Overall Study|Adverse Event|5|||
105956133|NCT03230318|365501478|FG001|Overall Study|Adverse Event|3|||
105956134|NCT03230318|365501477|FG000|Overall Study|Physician Decision|2|||
105956135|NCT03230318|365501478|FG001|Overall Study|Physician Decision|3|||
105956136|NCT03230318|365501477|FG000|Overall Study|Death|3|||
105956137|NCT03230318|365501478|FG001|Overall Study|Death|2|||
105956138|NCT03230318|365501477|FG000|Overall Study|Lost to Follow-up|1|||
105956139|NCT03230318|365501478|FG001|Overall Study|Lost to Follow-up|0|||
105956140|NCT03230318|365501477|FG000|Overall Study|Withdrawal by Subject|1|||
105956141|NCT03230318|365501478|FG001|Overall Study|Withdrawal by Subject|3|||
105956142|NCT03230318|365501477|FG000|Overall Study|Other|3|||
105956143|NCT03230318|365501478|FG001|Overall Study|Other|7|||
105956144|NCT00635349|365501480|FG000|Overall Study|Other|8|||
105956145|NCT00635349|365501481|FG001|Overall Study|Other|6|||
105956146|NCT00635349|365501480|FG000|Overall Study|Protocol Violation|18|||
105956147|NCT00635349|365501481|FG001|Overall Study|Protocol Violation|22|||
105956148|NCT00635349|365501480|FG000|Overall Study|Withdrawal by Subject|3|||
105956149|NCT00635349|365501481|FG001|Overall Study|Withdrawal by Subject|8|||
105956150|NCT00635349|365501480|FG000|Overall Study|Lost to Follow-up|4|||
105956151|NCT00635349|365501481|FG001|Overall Study|Lost to Follow-up|3|||
105956152|NCT00635349|365501480|FG000|Overall Study|Adverse Event|11|||
105956153|NCT00635349|365501481|FG001|Overall Study|Adverse Event|9|||
105956154|NCT04860869|365501486|FG000|Overall Study|Withdrawal by Subject|1|||
105956155|NCT04860869|365501487|FG001|Overall Study|Withdrawal by Subject|0|||
105956156|NCT03951766|365501488|FG000|Treatment Phase|Lost to Follow-up|1|||
105956157|NCT03951766|365501488|FG000|Follow-up Phase|Lost to Follow-up|10|||
105956158|NCT04834726|365501491|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
105956159|NCT04834726|365501492|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
105956160|NCT04834726|365501493|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
105956161|NCT04834726|365501494|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
105956162|NCT04834726|365501495|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
105956163|NCT04834726|365501496|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
105764669|NCT02062827|364791704|FG005|Overall Study|Screen Fail|0|||
105764670|NCT02062827|364791705|FG006|Overall Study|Screen Fail|0|||
105764671|NCT02062827|364791706|FG007|Overall Study|Screen Fail|8|||
105764672|NCT02498392|364791707|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
105764673|NCT02498392|364791708|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
105764674|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
105764675|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
105764676|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
105764677|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
105764678|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
105764679|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
105764680|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
105764681|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
105764682|NCT02498392|364791707|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
105764683|NCT02498392|364791708|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
105764684|NCT03135262|364791710|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
105764685|NCT03135262|364791711|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
105764686|NCT03135262|364791712|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
105764687|NCT03135262|364791713|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
105764688|NCT03135262|364791714|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
105764689|NCT03135262|364791710|FG000|Overall Study|Progression of disease|0|||
105764690|NCT03135262|364791711|FG001|Overall Study|Progression of disease|0|||
105764691|NCT03135262|364791712|FG002|Overall Study|Progression of disease|0|||
105764692|NCT03135262|364791713|FG003|Overall Study|Progression of disease|1|||
105764693|NCT03135262|364791714|FG004|Overall Study|Progression of disease|0|||
105764694|NCT03135262|364791710|FG000|Overall Study|Death|6|||
105764695|NCT03135262|364791711|FG001|Overall Study|Death|2|||
105764696|NCT03135262|364791712|FG002|Overall Study|Death|2|||
105764697|NCT03135262|364791713|FG003|Overall Study|Death|2|||
105764698|NCT03135262|364791714|FG004|Overall Study|Death|0|||
105764699|NCT03135262|364791710|FG000|Overall Study|Withdrawal by Subject|0|||
105764700|NCT03135262|364791711|FG001|Overall Study|Withdrawal by Subject|0|||
105764701|NCT03135262|364791712|FG002|Overall Study|Withdrawal by Subject|1|||
105764702|NCT03135262|364791713|FG003|Overall Study|Withdrawal by Subject|0|||
105764703|NCT03135262|364791714|FG004|Overall Study|Withdrawal by Subject|1|||
105764704|NCT03135262|364791710|FG000|Overall Study|Study terminated by sponsor|2|||
105764705|NCT03135262|364791711|FG001|Overall Study|Study terminated by sponsor|4|||
105764706|NCT03135262|364791712|FG002|Overall Study|Study terminated by sponsor|4|||
105764707|NCT03135262|364791713|FG003|Overall Study|Study terminated by sponsor|3|||
105764708|NCT03135262|364791714|FG004|Overall Study|Study terminated by sponsor|0|||
105764709|NCT01266070|364791718|FG000|Overall Study|Adverse Event|3|||
105764710|NCT01266070|364791718|FG000|Overall Study|Protocol Violation|1|||
105764711|NCT03006926|364791719|FG000|Overall Study|Adverse Event|0|||
105764712|NCT03006926|364791720|FG001|Overall Study|Adverse Event|27|||
105764713|NCT03006926|364791719|FG000|Overall Study|Withdrawal by Subject|0|||
105764714|NCT03006926|364791720|FG001|Overall Study|Withdrawal by Subject|1|||
105764715|NCT03006926|364791719|FG000|Overall Study|Radiological Disease Progression|0|||
105956164|NCT04834726|365501497|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
105956165|NCT04834726|365501498|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
105956166|NCT04834726|365501499|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
105956167|NCT03782064|365501503|FG000|Overall Study|Lack of Efficacy|2|||
105956168|NCT03782064|365501503|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
105956169|NCT01541865|365501504|FG000|Overall Study|Lost to Follow-up|11|||
105956170|NCT01541865|365501504|FG000|Overall Study|Withdrawal by Subject|9|||
105956171|NCT01541865|365501504|FG000|Overall Study|Adverse Event|1|||
105956172|NCT01541865|365501504|FG000|Overall Study|Protocol Violation|1|||
105956173|NCT03606486|365501506|FG000|Overall Study|Unable to collect sample|5|||
105956174|NCT02446769|365501507|FG000|Screening Period|Screen Failure|11|||
105956175|NCT02446769|365501508|FG001|Screening Period|Screen Failure|0|||
105956176|NCT02446769|365501509|FG002|Screening Period|Screen Failure|0|||
105956177|NCT02446769|365501507|FG000|Study Period|Randomized in Error|0|||
105956178|NCT02446769|365501508|FG001|Study Period|Randomized in Error|2|||
105956179|NCT02446769|365501509|FG002|Study Period|Randomized in Error|0|||
105956180|NCT00049322|365501514|FG000|Overall Study|disease burden|0|||
105956181|NCT00049322|365501515|FG001|Overall Study|disease burden|3|||
105956182|NCT00049322|365501514|FG000|Overall Study|Adverse Event|1|||
105956183|NCT00049322|365501515|FG001|Overall Study|Adverse Event|0|||
105956184|NCT00049322|365501514|FG000|Overall Study|refused angio|0|||
105956185|NCT00049322|365501515|FG001|Overall Study|refused angio|3|||
105956186|NCT00703963|365501516|FG000|Overall Study|Withdrawal by Subject|7|||
105956187|NCT00703963|365501517|FG001|Overall Study|Withdrawal by Subject|13|||
106145371|NCT02674750|366191953|FG001|Overall Study|Lost to Follow-up|8|||
106145372|NCT02674750|366191954|FG002|Overall Study|Lost to Follow-up|0|||
105816364|NCT02188303|364986867|FG000|Overall Study|Dose Termination Criteria Met|0|||
105816365|NCT02188303|364986868|FG001|Overall Study|Dose Termination Criteria Met|0|||
105816366|NCT02188303|364986869|FG002|Overall Study|Dose Termination Criteria Met|0|||
105816367|NCT02188303|364986870|FG003|Overall Study|Dose Termination Criteria Met|0|||
105816368|NCT02188303|364986871|FG004|Overall Study|Dose Termination Criteria Met|0|||
105816369|NCT02188303|364986872|FG005|Overall Study|Dose Termination Criteria Met|0|||
105816370|NCT02188303|364986873|FG006|Overall Study|Dose Termination Criteria Met|2|||
105816371|NCT02188303|364986874|FG007|Overall Study|Dose Termination Criteria Met|4|||
105816372|NCT00856388|364986875|FG000|Overall Study|Other|1|||
105816373|NCT04091971|364986878|FG000|Overall Study|Withdrawal by Subject|1|||
105816374|NCT04091971|364986878|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
105816375|NCT04091971|364986878|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
105816376|NCT01720264|364986881|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
105816377|NCT01720264|364986881|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
105816378|NCT01720264|364986881|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
105816379|NCT04869787|364986882|FG000|Screening|Physician Decision|1|||
105816380|NCT04869787|364986882|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
105816381|NCT01387022|364986883|FG000|Overall Study|Death|1|||
105816382|NCT01387022|364986884|FG001|Overall Study|Death|1|||
105816383|NCT01387022|364986883|FG000|Overall Study|Lost to Follow-up|0|||
105816384|NCT01387022|364986884|FG001|Overall Study|Lost to Follow-up|3|||
105816385|NCT01496183|364986886|FG000|Overall Study|Physician Decision|3|||
105816386|NCT01496183|364986887|FG001|Overall Study|Physician Decision|1|||
105816387|NCT01496183|364986886|FG000|Overall Study|Withdrawal by Subject|0|||
105816388|NCT01496183|364986887|FG001|Overall Study|Withdrawal by Subject|1|||
105816389|NCT01376167|364986888|FG000|Overall Study|Lost to Follow-up|2|||
105816390|NCT01376167|364986889|FG001|Overall Study|Lost to Follow-up|4|||
105816391|NCT01376167|364986890|FG002|Overall Study|Lost to Follow-up|2|||
105816392|NCT01376167|364986888|FG000|Overall Study|Physician Decision|1|||
105816393|NCT01376167|364986889|FG001|Overall Study|Physician Decision|1|||
105816394|NCT01376167|364986890|FG002|Overall Study|Physician Decision|0|||
105816395|NCT01376167|364986888|FG000|Overall Study|Withdrawal by Subject|1|||
105816396|NCT01376167|364986889|FG001|Overall Study|Withdrawal by Subject|5|||
105816397|NCT01376167|364986890|FG002|Overall Study|Withdrawal by Subject|4|||
105816398|NCT04786184|364986891|FG000|Overall Study|Adverse Event|4|||
105816399|NCT04786184|364986892|FG001|Overall Study|Adverse Event|0|||
105816400|NCT04786184|364986891|FG000|Overall Study|Withdrawal by Subject|3|||
105816401|NCT04786184|364986892|FG001|Overall Study|Withdrawal by Subject|1|||
105816402|NCT04786184|364986891|FG000|Overall Study|Lost to Follow-up|4|||
105816403|NCT04786184|364986892|FG001|Overall Study|Lost to Follow-up|2|||
105816404|NCT03693430|364986895|FG000|Overall Study|Lost to Follow-up|3|||
105816405|NCT03693430|364986896|FG001|Overall Study|Lost to Follow-up|14|||
105816406|NCT03693430|364986895|FG000|Overall Study|Death|1|||
105816407|NCT03693430|364986896|FG001|Overall Study|Death|0|||
105816408|NCT03693430|364986895|FG000|Overall Study|Withdrawal by Subject|0|||
105816409|NCT03693430|364986896|FG001|Overall Study|Withdrawal by Subject|4|||
105816410|NCT00585689|364986897|FG000|Overall Study|Received different ABI-007 schedule|3|||
105816411|NCT00585689|364986897|FG000|Overall Study|Adverse Event|1|||
105816412|NCT00585689|364986897|FG000|Overall Study|Patient Declined Surgery|1|||
105816413|NCT00585689|364986897|FG000|Overall Study|Patient had unresectable disease|1|||
105956188|NCT00703963|365501516|FG000|Overall Study|Physician Decision|0|||
105956189|NCT00703963|365501517|FG001|Overall Study|Physician Decision|1|||
105956190|NCT01340664|365501526|FG000|Overall Study|Adverse Event|0|||
105956191|NCT01340664|365501527|FG001|Overall Study|Adverse Event|1|||
105956192|NCT01340664|365501528|FG002|Overall Study|Adverse Event|7|||
105956193|NCT01340664|365501526|FG000|Overall Study|Lost to Follow-up|2|||
105956194|NCT01340664|365501527|FG001|Overall Study|Lost to Follow-up|0|||
105956195|NCT01340664|365501528|FG002|Overall Study|Lost to Follow-up|2|||
105956196|NCT01340664|365501526|FG000|Overall Study|Withdrawal by Subject|2|||
105956197|NCT01340664|365501527|FG001|Overall Study|Withdrawal by Subject|4|||
105956198|NCT01340664|365501528|FG002|Overall Study|Withdrawal by Subject|0|||
105956199|NCT01340664|365501526|FG000|Overall Study|Glycemic withdrawal criteria|2|||
105956200|NCT01340664|365501527|FG001|Overall Study|Glycemic withdrawal criteria|0|||
105956201|NCT01340664|365501528|FG002|Overall Study|Glycemic withdrawal criteria|0|||
105956202|NCT01340664|365501526|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
105956203|NCT01340664|365501527|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
105956204|NCT01340664|365501528|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
105956205|NCT01340664|365501526|FG000|Overall Study|Other|1|||
105956206|NCT01340664|365501527|FG001|Overall Study|Other|2|||
105956207|NCT01340664|365501528|FG002|Overall Study|Other|2|||
105956208|NCT01277822|365501531|FG000|Overall Study|Adverse Event|2|||
105956209|NCT01277822|365501532|FG001|Overall Study|Adverse Event|1|||
105816414|NCT00585689|364986897|FG000|Overall Study|Death|1|||
105816415|NCT02373098|364986898|FG000|Overall Study|Lost to Follow-up|1|||
105816416|NCT02373098|364986899|FG001|Overall Study|Lost to Follow-up|0|||
105816417|NCT02373098|364986898|FG000|Overall Study|Protocol Violation|3|||
105816418|NCT02373098|364986899|FG001|Overall Study|Protocol Violation|0|||
105816419|NCT02373098|364986898|FG000|Overall Study|Withdrawal by Subject|5|||
105816420|NCT02373098|364986899|FG001|Overall Study|Withdrawal by Subject|0|||
105816421|NCT02373098|364986898|FG000|Overall Study|Adverse Event|3|||
105816422|NCT02373098|364986899|FG001|Overall Study|Adverse Event|0|||
105816423|NCT05067647|364986903|FG000|Overall Study|Lost to Follow-up|1|||
105816424|NCT04185909|364986905|FG000|Overall Study|Lost to Follow-up|1|||
105816425|NCT01059903|364986906|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
105816426|NCT01059903|364986907|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
105816427|NCT03639311|364986908|FG000|Maintenance Phase|Lost to Follow-up|1|||
105816428|NCT03639311|364986909|FG001|Maintenance Phase|Lost to Follow-up|0|||
105816429|NCT03639311|364986910|FG002|Maintenance Phase|Lost to Follow-up|0|||
105816430|NCT03639311|364986908|FG000|Maintenance Phase|Adverse Event|1|||
105816431|NCT03639311|364986909|FG001|Maintenance Phase|Adverse Event|0|||
105816432|NCT03639311|364986910|FG002|Maintenance Phase|Adverse Event|0|||
105816433|NCT03639311|364986908|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
105816434|NCT03639311|364986909|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
105816435|NCT03639311|364986910|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
105816436|NCT03639311|364986908|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
105816437|NCT03639311|364986909|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
105816438|NCT03639311|364986910|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
105816439|NCT03639311|364986908|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
105816440|NCT03639311|364986909|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
105816441|NCT03639311|364986910|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
105816442|NCT03639311|364986908|FG000|Maintenance Phase|Lack of Efficacy|1|||
105816443|NCT03639311|364986909|FG001|Maintenance Phase|Lack of Efficacy|0|||
105816444|NCT03639311|364986910|FG002|Maintenance Phase|Lack of Efficacy|0|||
105816445|NCT04320849|364986913|FG000|Overall Study|Withdrawal by Subject|4|||
105816446|NCT04320849|364986913|FG000|Overall Study|Imaging data unavailable|2|||
105816447|NCT04320849|364986913|FG000|Overall Study|Incomplete imaging|2|||
105816448|NCT00214422|364986915|FG000|Overall Study|Physician Decision|2|||
105816449|NCT00214422|364986916|FG001|Overall Study|Physician Decision|0|||
105816450|NCT00214422|364986917|FG002|Overall Study|Physician Decision|0|||
105816451|NCT00214422|364986915|FG000|Overall Study|Developed esophageal ca|1|||
105816452|NCT00214422|364986916|FG001|Overall Study|Developed esophageal ca|0|||
105816453|NCT00214422|364986917|FG002|Overall Study|Developed esophageal ca|0|||
105816454|NCT00214422|364986915|FG000|Overall Study|Pt taken off study|1|||
105816455|NCT00214422|364986916|FG001|Overall Study|Pt taken off study|1|||
105816456|NCT00214422|364986917|FG002|Overall Study|Pt taken off study|0|||
105816457|NCT00214422|364986915|FG000|Overall Study|Disease progression on study|1|||
105816458|NCT00214422|364986916|FG001|Overall Study|Disease progression on study|0|||
105816459|NCT00214422|364986917|FG002|Overall Study|Disease progression on study|0|||
105816460|NCT00214422|364986915|FG000|Overall Study|Unable to make a radiation treatment|0|||
105816461|NCT00214422|364986916|FG001|Overall Study|Unable to make a radiation treatment|0|||
105816462|NCT00214422|364986917|FG002|Overall Study|Unable to make a radiation treatment|1|||
105816463|NCT00854100|364986918|FG000|Overall Study|Inability to complete the study visits|0|||
105816464|NCT00854100|364986919|FG001|Overall Study|Inability to complete the study visits|0|||
105816465|NCT00854100|364986920|FG002|Overall Study|Inability to complete the study visits|1|||
105816466|NCT00854100|364986918|FG000|Overall Study|Lost to Follow-up|2|||
105816467|NCT00854100|364986919|FG001|Overall Study|Lost to Follow-up|0|||
105816468|NCT00854100|364986920|FG002|Overall Study|Lost to Follow-up|3|||
105816469|NCT00854100|364986918|FG000|Overall Study|Withdrawal by Subject|3|||
105816470|NCT00854100|364986919|FG001|Overall Study|Withdrawal by Subject|1|||
105816471|NCT00854100|364986920|FG002|Overall Study|Withdrawal by Subject|2|||
105816472|NCT00854100|364986918|FG000|Overall Study|Protocol Violation|2|||
105816473|NCT00854100|364986919|FG001|Overall Study|Protocol Violation|4|||
105816474|NCT00854100|364986920|FG002|Overall Study|Protocol Violation|3|||
105816475|NCT00854100|364986918|FG000|Overall Study|Adverse Event|2|||
105816476|NCT00854100|364986919|FG001|Overall Study|Adverse Event|1|||
105816477|NCT00854100|364986920|FG002|Overall Study|Adverse Event|2|||
105816478|NCT00389064|364986921|FG000|Overall Study|Adverse Event|11|||
105816479|NCT00389064|364986922|FG001|Overall Study|Adverse Event|3|||
105816480|NCT00389064|364986921|FG000|Overall Study|Lack of Efficacy|3|||
105816481|NCT00389064|364986922|FG001|Overall Study|Lack of Efficacy|14|||
105816482|NCT00389064|364986921|FG000|Overall Study|Withdrawal by Subject|17|||
105956210|NCT01277822|365501531|FG000|Overall Study|Withdrawal by Subject|6|||
105956211|NCT01277822|365501532|FG001|Overall Study|Withdrawal by Subject|7|||
105816483|NCT00389064|364986922|FG001|Overall Study|Withdrawal by Subject|27|||
105956212|NCT01277822|365501531|FG000|Overall Study|Physician Decision|1|||
105816484|NCT00389064|364986921|FG000|Overall Study|Physician Decision|2|||
105816485|NCT00389064|364986922|FG001|Overall Study|Physician Decision|2|||
105816486|NCT00389064|364986921|FG000|Overall Study|Lost to Follow-up|1|||
105816487|NCT00389064|364986922|FG001|Overall Study|Lost to Follow-up|2|||
105816488|NCT00389064|364986921|FG000|Overall Study|Protocol Violation|2|||
105816489|NCT00389064|364986922|FG001|Overall Study|Protocol Violation|0|||
105816490|NCT00389064|364986921|FG000|Overall Study|Multiple Reasons|9|||
105816491|NCT00389064|364986922|FG001|Overall Study|Multiple Reasons|11|||
105816492|NCT04753437|364986927|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105816493|NCT04753437|364986928|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105816494|NCT04753437|364986927|FG000|Overall Study|Liver Function Test Abnormalities|2|||
105816495|NCT04753437|364986928|FG001|Overall Study|Liver Function Test Abnormalities|4|||
105816496|NCT02920996|364986929|FG000|Overall Study|Adverse Event|8|||
105816497|NCT02920996|364986930|FG001|Overall Study|Adverse Event|0|||
105816498|NCT02920996|364986929|FG000|Overall Study|Physician Decision|1|||
105816499|NCT02920996|364986930|FG001|Overall Study|Physician Decision|0|||
105816500|NCT02920996|364986929|FG000|Overall Study|Death|1|||
105816501|NCT02920996|364986930|FG001|Overall Study|Death|0|||
105816502|NCT02920996|364986929|FG000|Overall Study|Missing|1|||
105816503|NCT02920996|364986930|FG001|Overall Study|Missing|0|||
105816504|NCT02920996|364986929|FG000|Overall Study|Subject Non-Compliance|1|||
105816505|NCT02920996|364986930|FG001|Overall Study|Subject Non-Compliance|0|||
105816506|NCT02272777|364986931|FG000|Overall Study|Adverse Event|0|||
105816507|NCT02272777|364986932|FG001|Overall Study|Adverse Event|1|||
105816508|NCT02272777|364986931|FG000|Overall Study|Withdrawal by Subject|0|||
105816509|NCT02272777|364986932|FG001|Overall Study|Withdrawal by Subject|3|||
105816510|NCT02272777|364986931|FG000|Overall Study|Lost to Follow-up|2|||
105816511|NCT02272777|364986932|FG001|Overall Study|Lost to Follow-up|0|||
105816512|NCT02272777|364986931|FG000|Overall Study|Other|2|||
105816513|NCT02272777|364986932|FG001|Overall Study|Other|0|||
105816514|NCT02066922|364986933|FG000|Overall Study|Adverse Event|1|||
105816515|NCT00440297|364986935|FG000|Overall Study|Adverse Event|8|||
105816516|NCT00440297|364986936|FG001|Overall Study|Adverse Event|5|||
105816517|NCT00440297|364986935|FG000|Overall Study|Lost to Follow-up|1|||
105816518|NCT00440297|364986936|FG001|Overall Study|Lost to Follow-up|0|||
105816519|NCT00440297|364986935|FG000|Overall Study|Physician Decision|1|||
105816520|NCT00440297|364986936|FG001|Overall Study|Physician Decision|0|||
105816521|NCT00440297|364986935|FG000|Overall Study|Protocol Violation|11|||
105816522|NCT00440297|364986936|FG001|Overall Study|Protocol Violation|7|||
105816523|NCT00440297|364986935|FG000|Overall Study|Withdrawal by Subject|1|||
105816524|NCT00440297|364986936|FG001|Overall Study|Withdrawal by Subject|6|||
105816525|NCT00440297|364986935|FG000|Overall Study|Randomized by mistake|1|||
105816526|NCT00440297|364986936|FG001|Overall Study|Randomized by mistake|0|||
105816527|NCT03567174|364986937|FG000|Overall Study|Death|24|||
105816528|NCT03567174|364986938|FG001|Overall Study|Death|31|||
105816529|NCT03567174|364986937|FG000|Overall Study|Lost to Follow-up|165|||
105816530|NCT03567174|364986938|FG001|Overall Study|Lost to Follow-up|174|||
105816531|NCT03243630|364986939|FG000|Overall Study|Protocol Violation|1|||
105816532|NCT03243630|364986939|FG000|Overall Study|Physician Decision|1|||
105816533|NCT03707912|364986940|FG000|Overall Study|Violation of inclusion criteria|1|||
105816534|NCT03707912|364986941|FG001|Overall Study|Violation of inclusion criteria|0|||
105816535|NCT01085045|364988236|FG000|Part A|Withdrawal by Subject|4|||
105816536|NCT01085045|364988236|FG000|Part A|Adverse Event|6|||
105816537|NCT01085045|364988236|FG000|Part A|Protocol Violation|1|||
105816538|NCT01085045|364988236|FG000|Part A|Protocol Specified Criteria|7|||
105816539|NCT01085045|364988236|FG000|Part B|Withdrawal by Subject|2|||
105816540|NCT01085045|364988236|FG000|Part B|Protocol Specified Criteria|6|||
105816541|NCT01085045|364988236|FG000|Part B|Lost to Follow-up|1|||
105816542|NCT01085045|364988236|FG000|Part B|Adverse Event|6|||
105816543|NCT01248247|364988237|FG000|Overall Study|Adverse Event|2|||
105816544|NCT01248247|364988238|FG001|Overall Study|Adverse Event|4|||
105816545|NCT01248247|364988239|FG002|Overall Study|Adverse Event|4|||
105816546|NCT01248247|364988240|FG003|Overall Study|Adverse Event|2|||
105816547|NCT01248247|364988237|FG000|Overall Study|Death|0|||
105956213|NCT01277822|365501532|FG001|Overall Study|Physician Decision|1|||
105956214|NCT01277822|365501531|FG000|Overall Study|Protocol Violation|1|||
105816548|NCT01248247|364988238|FG001|Overall Study|Death|1|||
105816549|NCT01248247|364988239|FG002|Overall Study|Death|4|||
105816550|NCT01248247|364988240|FG003|Overall Study|Death|7|||
105816551|NCT01248247|364988237|FG000|Overall Study|Lost to Follow-up|0|||
105956215|NCT01277822|365501532|FG001|Overall Study|Protocol Violation|0|||
105956216|NCT01277822|365501531|FG000|Overall Study|Lost to Follow-up|2|||
105956217|NCT01277822|365501532|FG001|Overall Study|Lost to Follow-up|1|||
105956218|NCT01277822|365501531|FG000|Overall Study|Contraindicated medication used|2|||
106145373|NCT02674750|366191952|FG000|Overall Study|Lack of Efficacy|1|||
106145374|NCT02674750|366191953|FG001|Overall Study|Lack of Efficacy|17|||
105816552|NCT01248247|364988238|FG001|Overall Study|Lost to Follow-up|1|||
105816553|NCT01248247|364988239|FG002|Overall Study|Lost to Follow-up|1|||
105816554|NCT01248247|364988240|FG003|Overall Study|Lost to Follow-up|0|||
105816555|NCT01248247|364988237|FG000|Overall Study|Alternative treatment|0|||
105816556|NCT01248247|364988238|FG001|Overall Study|Alternative treatment|1|||
105816557|NCT01248247|364988239|FG002|Overall Study|Alternative treatment|0|||
105816558|NCT01248247|364988240|FG003|Overall Study|Alternative treatment|0|||
105816559|NCT01248247|364988237|FG000|Overall Study|Other|2|||
105816560|NCT01248247|364988238|FG001|Overall Study|Other|8|||
105816561|NCT01248247|364988239|FG002|Overall Study|Other|8|||
105816562|NCT01248247|364988240|FG003|Overall Study|Other|5|||
105816563|NCT01248247|364988237|FG000|Overall Study|Progression|18|||
105816564|NCT01248247|364988238|FG001|Overall Study|Progression|27|||
105816565|NCT01248247|364988239|FG002|Overall Study|Progression|56|||
105816566|NCT01248247|364988240|FG003|Overall Study|Progression|44|||
105816567|NCT01248247|364988237|FG000|Overall Study|Refuse further treatment|0|||
105816568|NCT01248247|364988238|FG001|Overall Study|Refuse further treatment|0|||
105816569|NCT01248247|364988239|FG002|Overall Study|Refuse further treatment|1|||
105816570|NCT01248247|364988240|FG003|Overall Study|Refuse further treatment|2|||
105816571|NCT01248247|364988237|FG000|Overall Study|Complicating disease|0|||
105816572|NCT01248247|364988238|FG001|Overall Study|Complicating disease|0|||
105816573|NCT01248247|364988239|FG002|Overall Study|Complicating disease|1|||
105816574|NCT01248247|364988240|FG003|Overall Study|Complicating disease|1|||
105816575|NCT02817841|364988244|FG000|Overall Study|Lost to Follow-up|287|||
105816576|NCT02817841|364988244|FG000|Overall Study|Withdrawal by Subject|183|||
105816577|NCT02817841|364988244|FG000|Overall Study|Adverse event not related to bleeding|131|||
105816578|NCT02817841|364988244|FG000|Overall Study|Adverse event related to bleeding|51|||
105816579|NCT02817841|364988244|FG000|Overall Study|Pregnancy|32|||
105816580|NCT02817841|364988244|FG000|Overall Study|Pregnancy wish|17|||
105816581|NCT02817841|364988244|FG000|Overall Study|Other reasons|53|||
105816582|NCT02817841|364988244|FG000|Overall Study|Protocol Violation|94|||
105816583|NCT04349917|364988247|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
105816584|NCT04349917|364988248|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
105816585|NCT04349917|364988247|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
105816586|NCT04349917|364988248|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
105816587|NCT00705536|364988249|FG000|Start Period 1|Withdrawal by Subject|0|||
105816588|NCT00705536|364988250|FG001|Start Period 1|Withdrawal by Subject|0|||
105816589|NCT00705536|364988251|FG002|Start Period 1|Withdrawal by Subject|0|||
105816590|NCT00705536|364988252|FG003|Start Period 1|Withdrawal by Subject|1|||
105816591|NCT04188106|364988253|FG000|Overall Study|Lost to Follow-up|5|||
105816592|NCT04188106|364988253|FG000|Overall Study|Non-Compliance|1|||
105816593|NCT00441467|364988259|FG000|Overall Study|Adverse Event|6|||
105816594|NCT00441467|364988259|FG000|Overall Study|Withdrawal by Subject|3|||
105816595|NCT00441467|364988259|FG000|Overall Study|Progressive disease|9|||
105816596|NCT00420303|364988260|FG000|Overall Study|Serious Adverse Event|1|||
105816597|NCT00420303|364988261|FG001|Overall Study|Serious Adverse Event|0|||
105816598|NCT00420303|364988260|FG000|Overall Study|Lack of Efficacy|0|||
105816599|NCT00420303|364988261|FG001|Overall Study|Lack of Efficacy|3|||
105816600|NCT00420303|364988260|FG000|Overall Study|Physician Decision|0|||
105816601|NCT00420303|364988261|FG001|Overall Study|Physician Decision|1|||
105816602|NCT01948258|364988262|FG000|Overall Study|Pregnancy|41|||
105816603|NCT01948258|364988262|FG000|Overall Study|Did not complete by cut-off date|35|||
105816604|NCT01948258|364988262|FG000|Overall Study|Lost to Follow-up|27|||
105816605|NCT01948258|364988262|FG000|Overall Study|Withdrawal by SPD|8|||
105816606|NCT01948258|364988262|FG000|Overall Study|Withdrawal by Subject|6|||
105816607|NCT01948258|364988262|FG000|Overall Study|Health Care Professional|43|||
105816608|NCT01948258|364988262|FG000|Overall Study|Removed from statistical analysis|2|||
105816609|NCT04657770|364988266|FG000|Overall Study|Withdrawal by Subject|3|||
105816610|NCT04657770|364988266|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
105816611|NCT00088829|364988267|FG000|Overall Study|PI left institution and study was close|22|||
105816612|NCT00365300|364988271|FG000|Open-label Phase|Adverse Event|4|||
105816613|NCT00365300|364988272|FG001|Open-label Phase|Adverse Event|0|||
105816614|NCT00365300|364988271|FG000|Open-label Phase|Failed to Return|1|||
105816615|NCT00365300|364988272|FG001|Open-label Phase|Failed to Return|0|||
105816616|NCT00365300|364988271|FG000|Open-label Phase|Physician Decision|1|||
105816617|NCT00365300|364988272|FG001|Open-label Phase|Physician Decision|0|||
105816618|NCT00365300|364988271|FG000|Open-label Phase|Noncompliance|9|||
105816619|NCT00365300|364988272|FG001|Open-label Phase|Noncompliance|0|||
105816620|NCT00365300|364988271|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
106018434|NCT00372593|365730672|FG002|Overall Study|Physician Decision|0|||
105816621|NCT00365300|364988272|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
105816622|NCT00365300|364988271|FG000|Open-label Phase|Protocol Violation|1|||
105816623|NCT00365300|364988272|FG001|Open-label Phase|Protocol Violation|0|||
105816624|NCT00365300|364988271|FG000|Open-label Phase|Lack of Efficacy|1|||
106018435|NCT00372593|365730670|FG000|Overall Study|Ineligible|20|||
105816625|NCT00365300|364988272|FG001|Open-label Phase|Lack of Efficacy|0|||
105816626|NCT00365300|364988271|FG000|Open-label Phase|Patient skipped open label phase|1|||
106018436|NCT00372593|365730671|FG001|Overall Study|Ineligible|21|||
106018437|NCT00372593|365730672|FG002|Overall Study|Ineligible|1|||
106018438|NCT00433004|365730673|FG000|Overall Study|Lost to Follow-up|5|||
106018439|NCT00433004|365730674|FG001|Overall Study|Lost to Follow-up|7|||
106018440|NCT02636595|365730679|FG000|Overall Study|Lost to Follow-up|1|||
105816627|NCT00365300|364988272|FG001|Open-label Phase|Patient skipped open label phase|0|||
105816628|NCT00365300|364988271|FG000|Double-blind Phase|Failed to return|1|||
105816629|NCT00365300|364988272|FG001|Double-blind Phase|Failed to return|0|||
106018441|NCT02636595|365730679|FG000|Overall Study|Other|1|||
106018442|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
105956219|NCT01277822|365501532|FG001|Overall Study|Contraindicated medication used|1|||
105956220|NCT01277822|365501531|FG000|Overall Study|Participant moved|1|||
105764716|NCT03006926|364791720|FG001|Overall Study|Radiological Disease Progression|52|||
105764717|NCT03006926|364791719|FG000|Overall Study|Clinical Disease Progression|0|||
105764718|NCT03006926|364791720|FG001|Overall Study|Clinical Disease Progression|10|||
105764719|NCT03006926|364791719|FG000|Overall Study|Other|0|||
105764720|NCT03006926|364791720|FG001|Overall Study|Other|8|||
105764721|NCT04882072|364791721|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
105764722|NCT04882072|364791722|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
105764723|NCT04882072|364791721|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
105764724|NCT04882072|364791722|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
105764725|NCT04882072|364791721|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
105764726|NCT04882072|364791722|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
105764727|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
105764728|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
105764729|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
105764730|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
105764731|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
105764732|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
105764733|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
105764734|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
105764735|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
105764736|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
105764737|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
105764738|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
105764739|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
105764740|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
105764741|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
105764742|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
105764743|NCT03185819|364791727|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
105764744|NCT03185819|364791728|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
105764745|NCT03185819|364791729|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
105764746|NCT03185819|364791730|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
105764747|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
105764748|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
105764749|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
105764750|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
105764751|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
105764752|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
105764753|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
105764754|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
105764755|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
105764756|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
105764757|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
105764758|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
105764759|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
105764760|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
105764761|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
105764762|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
105764763|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
105764764|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
105764765|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
105764766|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
105764767|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
105764768|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
105764769|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
105764770|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
105764771|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
105764772|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
105764773|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
105764774|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
105764775|NCT03185819|364791727|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
105816630|NCT00365300|364988271|FG000|Double-blind Phase|Noncompliance|1|||
105816631|NCT00365300|364988272|FG001|Double-blind Phase|Noncompliance|1|||
105816632|NCT00365300|364988271|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105816633|NCT00365300|364988272|FG001|Double-blind Phase|Withdrawal by Subject|1|||
105816634|NCT00365300|364988271|FG000|Double-blind Phase|Protocol Violation|3|||
105816635|NCT00365300|364988272|FG001|Double-blind Phase|Protocol Violation|1|||
105816636|NCT00365300|364988271|FG000|Double-blind Phase|Lack of Efficacy|6|||
105816637|NCT00365300|364988272|FG001|Double-blind Phase|Lack of Efficacy|6|||
105816638|NCT00274937|364988273|FG000|Overall Study|Physician Decision|10|||
105816639|NCT00274937|364988273|FG000|Overall Study|Withdrawal by Subject|6|||
105816640|NCT00274937|364988273|FG000|Overall Study|Progressive Disease|4|||
105816641|NCT01367457|364988275|FG000|Overall Study|Death|2|||
105816642|NCT01367457|364988276|FG001|Overall Study|Death|0|||
105816643|NCT01367457|364988277|FG002|Overall Study|Death|0|||
105816644|NCT01367457|364988275|FG000|Overall Study|Investigator's decision|2|||
105816645|NCT01367457|364988276|FG001|Overall Study|Investigator's decision|0|||
105816646|NCT01367457|364988277|FG002|Overall Study|Investigator's decision|0|||
105816647|NCT01367457|364988275|FG000|Overall Study|Clinical decline (CD)|2|||
105816648|NCT01367457|364988276|FG001|Overall Study|Clinical decline (CD)|0|||
105816649|NCT01367457|364988277|FG002|Overall Study|Clinical decline (CD)|0|||
105816650|NCT01367457|364988275|FG000|Overall Study|Progression and death|8|||
105816651|NCT01367457|364988276|FG001|Overall Study|Progression and death|0|||
105816652|NCT01367457|364988277|FG002|Overall Study|Progression and death|0|||
105816653|NCT01367457|364988275|FG000|Overall Study|Toxicity|16|||
105816654|NCT01367457|364988276|FG001|Overall Study|Toxicity|0|||
105816655|NCT01367457|364988277|FG002|Overall Study|Toxicity|0|||
105816656|NCT01367457|364988275|FG000|Overall Study|Progression|137|||
105816657|NCT01367457|364988276|FG001|Overall Study|Progression|0|||
105816658|NCT01367457|364988277|FG002|Overall Study|Progression|0|||
105816659|NCT01367457|364988275|FG000|Overall Study|Patient asks for rest + slow progression|1|||
105816660|NCT01367457|364988276|FG001|Overall Study|Patient asks for rest + slow progression|0|||
105816661|NCT01367457|364988277|FG002|Overall Study|Patient asks for rest + slow progression|0|||
105816662|NCT01367457|364988275|FG000|Overall Study|Investigator's opinion, stable disease|1|||
105816663|NCT01367457|364988276|FG001|Overall Study|Investigator's opinion, stable disease|0|||
105816664|NCT01367457|364988277|FG002|Overall Study|Investigator's opinion, stable disease|0|||
105816665|NCT01367457|364988275|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
105816666|NCT01367457|364988276|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
105816667|NCT01367457|364988277|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
105816668|NCT01367457|364988275|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
105816669|NCT01367457|364988276|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
105816670|NCT01367457|364988277|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
105816671|NCT01367457|364988275|FG000|Overall Study|low grade toxicities + stable disease|1|||
105816672|NCT01367457|364988276|FG001|Overall Study|low grade toxicities + stable disease|0|||
105816673|NCT01367457|364988277|FG002|Overall Study|low grade toxicities + stable disease|0|||
105816674|NCT01367457|364988275|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
105816675|NCT01367457|364988276|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
105816676|NCT01367457|364988277|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
105816677|NCT01367457|364988275|FG000|Overall Study|Withdrawal by Subject|1|||
105816678|NCT01367457|364988276|FG001|Overall Study|Withdrawal by Subject|0|||
105816679|NCT01367457|364988277|FG002|Overall Study|Withdrawal by Subject|0|||
105816680|NCT01367457|364988275|FG000|Overall Study|CD, associated leukaemia|1|||
105816681|NCT01367457|364988276|FG001|Overall Study|CD, associated leukaemia|0|||
105816682|NCT01367457|364988277|FG002|Overall Study|CD, associated leukaemia|0|||
105816683|NCT01367457|364988275|FG000|Overall Study|Uncontrolled pain|1|||
105816684|NCT01367457|364988276|FG001|Overall Study|Uncontrolled pain|0|||
105816685|NCT01367457|364988277|FG002|Overall Study|Uncontrolled pain|0|||
105816686|NCT01367457|364988275|FG000|Overall Study|Overall status worsens to grade 4|1|||
105816687|NCT01367457|364988276|FG001|Overall Study|Overall status worsens to grade 4|0|||
105816688|NCT01367457|364988277|FG002|Overall Study|Overall status worsens to grade 4|0|||
105816689|NCT01367457|364988275|FG000|Overall Study|Stabilisation + frequent infections|1|||
105816690|NCT01367457|364988276|FG001|Overall Study|Stabilisation + frequent infections|0|||
105816691|NCT01367457|364988277|FG002|Overall Study|Stabilisation + frequent infections|0|||
105816692|NCT01367457|364988275|FG000|Overall Study|No clinical benefit|1|||
105816693|NCT01367457|364988276|FG001|Overall Study|No clinical benefit|0|||
105816694|NCT01367457|364988277|FG002|Overall Study|No clinical benefit|0|||
105816695|NCT01367457|364988275|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
105816696|NCT01367457|364988276|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
106145375|NCT02674750|366191954|FG002|Overall Study|Lack of Efficacy|3|||
105816697|NCT01367457|364988277|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
105816698|NCT01367457|364988275|FG000|Overall Study|Overall decline|1|||
105816699|NCT01367457|364988276|FG001|Overall Study|Overall decline|0|||
105816700|NCT01367457|364988277|FG002|Overall Study|Overall decline|0|||
106145376|NCT02674750|366191952|FG000|Overall Study|Withdrawal by Subject|0|||
106145377|NCT02674750|366191953|FG001|Overall Study|Withdrawal by Subject|7|||
105816701|NCT01367457|364988275|FG000|Overall Study|Rejection of treatment|1|||
105816702|NCT01367457|364988276|FG001|Overall Study|Rejection of treatment|0|||
105816703|NCT01367457|364988277|FG002|Overall Study|Rejection of treatment|0|||
105816704|NCT01367457|364988275|FG000|Overall Study|Lost to Follow-up|1|||
105816705|NCT01367457|364988276|FG001|Overall Study|Lost to Follow-up|0|||
105816706|NCT01367457|364988277|FG002|Overall Study|Lost to Follow-up|0|||
105816707|NCT01367457|364988275|FG000|Overall Study|Death from septic shock|1|||
105816708|NCT01367457|364988276|FG001|Overall Study|Death from septic shock|0|||
105816709|NCT01367457|364988277|FG002|Overall Study|Death from septic shock|0|||
105816710|NCT01367457|364988275|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
105816711|NCT01367457|364988276|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
105816712|NCT01367457|364988277|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
105816713|NCT01367457|364988275|FG000|Overall Study|Patient's Wish|1|||
105816714|NCT01367457|364988276|FG001|Overall Study|Patient's Wish|0|||
105816715|NCT01367457|364988277|FG002|Overall Study|Patient's Wish|0|||
105816716|NCT01367457|364988275|FG000|Overall Study|Palliative. Overall decline|1|||
105816717|NCT01367457|364988276|FG001|Overall Study|Palliative. Overall decline|0|||
105816718|NCT01367457|364988277|FG002|Overall Study|Palliative. Overall decline|0|||
105816719|NCT01367457|364988275|FG000|Overall Study|Suspected DP/suspected active infection|1|||
105816720|NCT01367457|364988276|FG001|Overall Study|Suspected DP/suspected active infection|0|||
105816721|NCT01367457|364988277|FG002|Overall Study|Suspected DP/suspected active infection|0|||
105816722|NCT02058498|364988278|FG000|Overall Study|Withdrawal by Subject|4|||
105816723|NCT01449630|364988281|FG000|Period 1|Physician Decision|1|||
105816724|NCT01449630|364988282|FG001|Period 1|Physician Decision|0|||
105816725|NCT01449630|364988283|FG002|Period 1|Physician Decision|0|||
105816726|NCT01449630|364988284|FG003|Period 1|Physician Decision|1|||
105816727|NCT01449630|364988285|FG004|Period 1|Physician Decision|0|||
105816728|NCT01449630|364988286|FG005|Period 1|Physician Decision|0|||
105816729|NCT01449630|364988287|FG006|Period 1|Physician Decision|0|||
105816730|NCT01449630|364988288|FG007|Period 1|Physician Decision|0|||
105816731|NCT01449630|364988289|FG008|Period 1|Physician Decision|0|||
105816732|NCT01449630|364988281|FG000|Period 1|Sponsor Decision|0|||
105816733|NCT01449630|364988282|FG001|Period 1|Sponsor Decision|0|||
105816734|NCT01449630|364988283|FG002|Period 1|Sponsor Decision|0|||
105816735|NCT01449630|364988284|FG003|Period 1|Sponsor Decision|0|||
105816736|NCT01449630|364988285|FG004|Period 1|Sponsor Decision|0|||
105816737|NCT01449630|364988286|FG005|Period 1|Sponsor Decision|1|||
105816738|NCT01449630|364988287|FG006|Period 1|Sponsor Decision|0|||
105816739|NCT01449630|364988288|FG007|Period 1|Sponsor Decision|0|||
105816740|NCT01449630|364988289|FG008|Period 1|Sponsor Decision|0|||
105816741|NCT01449630|364988281|FG000|Period 2|Sponsor Decision|0|||
105816742|NCT01449630|364988282|FG001|Period 2|Sponsor Decision|0|||
105816743|NCT01449630|364988283|FG002|Period 2|Sponsor Decision|0|||
105816744|NCT01449630|364988284|FG003|Period 2|Sponsor Decision|0|||
105816745|NCT01449630|364988285|FG004|Period 2|Sponsor Decision|0|||
105816746|NCT01449630|364988286|FG005|Period 2|Sponsor Decision|0|||
105816747|NCT01449630|364988287|FG006|Period 2|Sponsor Decision|1|||
105816748|NCT01449630|364988288|FG007|Period 2|Sponsor Decision|0|||
105816749|NCT01449630|364988289|FG008|Period 2|Sponsor Decision|0|||
105816750|NCT01389102|364988290|FG000|Overall Study|Adverse Event|1|||
105816751|NCT01389102|364988291|FG001|Overall Study|Adverse Event|3|||
105816752|NCT01389102|364988292|FG002|Overall Study|Adverse Event|2|||
105816753|NCT01389102|364988293|FG003|Overall Study|Adverse Event|2|||
105816754|NCT01389102|364988294|FG004|Overall Study|Adverse Event|2|||
105816755|NCT01389102|364988295|FG005|Overall Study|Adverse Event|2|||
105816756|NCT01389102|364988290|FG000|Overall Study|Hurricane Katrina|4|||
105816757|NCT01389102|364988291|FG001|Overall Study|Hurricane Katrina|2|||
105816758|NCT01389102|364988292|FG002|Overall Study|Hurricane Katrina|3|||
105816759|NCT01389102|364988293|FG003|Overall Study|Hurricane Katrina|0|||
105816760|NCT01389102|364988294|FG004|Overall Study|Hurricane Katrina|3|||
105816761|NCT01389102|364988295|FG005|Overall Study|Hurricane Katrina|1|||
105816762|NCT01389102|364988290|FG000|Overall Study|Lost to Follow-up|4|||
105816763|NCT01389102|364988291|FG001|Overall Study|Lost to Follow-up|1|||
105816764|NCT01389102|364988292|FG002|Overall Study|Lost to Follow-up|1|||
105816765|NCT01389102|364988293|FG003|Overall Study|Lost to Follow-up|2|||
105816766|NCT01389102|364988294|FG004|Overall Study|Lost to Follow-up|4|||
105816767|NCT01389102|364988295|FG005|Overall Study|Lost to Follow-up|1|||
105816768|NCT01389102|364988290|FG000|Overall Study|Protocol Violation|0|||
105816769|NCT01389102|364988291|FG001|Overall Study|Protocol Violation|0|||
105816770|NCT01389102|364988292|FG002|Overall Study|Protocol Violation|3|||
105816771|NCT01389102|364988293|FG003|Overall Study|Protocol Violation|0|||
105956221|NCT01277822|365501532|FG001|Overall Study|Participant moved|0|||
105956222|NCT00997984|365501533|FG000|Overall Study|Adverse Event|1|||
105956223|NCT00997984|365501534|FG001|Overall Study|Adverse Event|8|||
105956224|NCT00997984|365501535|FG002|Overall Study|Adverse Event|8|||
105956225|NCT00997984|365501533|FG000|Overall Study|Protocol Violation|1|||
105956226|NCT00997984|365501534|FG001|Overall Study|Protocol Violation|3|||
105816772|NCT01389102|364988294|FG004|Overall Study|Protocol Violation|1|||
105816773|NCT01389102|364988295|FG005|Overall Study|Protocol Violation|1|||
105816774|NCT01389102|364988290|FG000|Overall Study|Withdrawal by Subject|7|||
105816775|NCT01389102|364988291|FG001|Overall Study|Withdrawal by Subject|4|||
105816776|NCT01389102|364988292|FG002|Overall Study|Withdrawal by Subject|9|||
105816777|NCT01389102|364988293|FG003|Overall Study|Withdrawal by Subject|2|||
105816778|NCT01389102|364988294|FG004|Overall Study|Withdrawal by Subject|3|||
105816779|NCT01389102|364988295|FG005|Overall Study|Withdrawal by Subject|3|||
105816780|NCT01389102|364988290|FG000|Overall Study|Subject Traveling Out of Country|0|||
105816781|NCT01389102|364988291|FG001|Overall Study|Subject Traveling Out of Country|0|||
105816782|NCT01389102|364988292|FG002|Overall Study|Subject Traveling Out of Country|0|||
105816783|NCT01389102|364988293|FG003|Overall Study|Subject Traveling Out of Country|1|||
105816784|NCT01389102|364988294|FG004|Overall Study|Subject Traveling Out of Country|0|||
105816785|NCT01389102|364988295|FG005|Overall Study|Subject Traveling Out of Country|0|||
105816786|NCT01389102|364988290|FG000|Overall Study|Subject Moved|2|||
105816787|NCT01389102|364988291|FG001|Overall Study|Subject Moved|0|||
105816788|NCT01389102|364988292|FG002|Overall Study|Subject Moved|1|||
105816789|NCT01389102|364988293|FG003|Overall Study|Subject Moved|0|||
105816790|NCT01389102|364988294|FG004|Overall Study|Subject Moved|0|||
105816791|NCT01389102|364988295|FG005|Overall Study|Subject Moved|0|||
105816792|NCT01389102|364988290|FG000|Overall Study|Unavailable due to husband's illness|0|||
105816793|NCT01389102|364988291|FG001|Overall Study|Unavailable due to husband's illness|1|||
105816794|NCT01389102|364988292|FG002|Overall Study|Unavailable due to husband's illness|0|||
105816795|NCT01389102|364988293|FG003|Overall Study|Unavailable due to husband's illness|0|||
105816796|NCT01389102|364988294|FG004|Overall Study|Unavailable due to husband's illness|0|||
105816797|NCT01389102|364988295|FG005|Overall Study|Unavailable due to husband's illness|0|||
105816798|NCT01389102|364988290|FG000|Overall Study|Investigator Judgement|0|||
105816799|NCT01389102|364988291|FG001|Overall Study|Investigator Judgement|1|||
105816800|NCT01389102|364988292|FG002|Overall Study|Investigator Judgement|0|||
105816801|NCT01389102|364988293|FG003|Overall Study|Investigator Judgement|0|||
105816802|NCT01389102|364988294|FG004|Overall Study|Investigator Judgement|0|||
105816803|NCT01389102|364988295|FG005|Overall Study|Investigator Judgement|0|||
105816804|NCT00553280|364988299|FG000|Overall Study|Adverse Event|19|||
105816805|NCT00553280|364988299|FG000|Overall Study|Lack of Efficacy|3|||
105816806|NCT00553280|364988299|FG000|Overall Study|Withdrawal by Subject|3|||
105816807|NCT00553280|364988299|FG000|Overall Study|Physician Decision|1|||
105816808|NCT01182415|364988300|FG000|Overall Study|Lost to Follow-up|1|||
105816809|NCT00454909|364988301|FG000|Overall Study|Withdrawal by Subject|1|||
105816810|NCT00454909|364988302|FG001|Overall Study|Withdrawal by Subject|0|||
105816811|NCT00454909|364988303|FG002|Overall Study|Withdrawal by Subject|0|||
105816812|NCT00454909|364988301|FG000|Overall Study|Migrated/moved from study area|0|||
105816813|NCT00454909|364988302|FG001|Overall Study|Migrated/moved from study area|0|||
105816814|NCT00454909|364988303|FG002|Overall Study|Migrated/moved from study area|1|||
105816815|NCT00454909|364988301|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
105816816|NCT00454909|364988302|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
105816817|NCT00454909|364988303|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
105816818|NCT00454909|364988301|FG000|Overall Study|Others|1|||
105816819|NCT00454909|364988302|FG001|Overall Study|Others|0|||
105816820|NCT00454909|364988303|FG002|Overall Study|Others|0|||
105816821|NCT02996682|364988304|FG000|Overall Study|Death|0|||
105816822|NCT02996682|364988305|FG001|Overall Study|Death|3|||
105816823|NCT02457520|364988306|FG000|Active Treatment Phase|Adverse Event|10|||
105816824|NCT02457520|364988306|FG000|Active Treatment Phase|Lost to Follow-up|8|||
105816825|NCT02457520|364988306|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
105816826|NCT02457520|364988306|FG000|Active Treatment Phase|other|4|||
105816827|NCT02457520|364988306|FG000|Active Treatment Phase|Physician Decision|1|||
105816828|NCT02457520|364988306|FG000|Active Treatment Phase|Protocol Violation|1|||
105816829|NCT02457520|364988306|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
105816830|NCT02457520|364988306|FG000|Post-treatment Period|Other: Retreatment Required|7|||
105816831|NCT02457520|364988306|FG000|Post-treatment Period|Lost to Follow-up|23|||
105816832|NCT02457520|364988306|FG000|Post-treatment Period|Other|3|||
105816833|NCT02457520|364988306|FG000|Post-treatment Period|Physician Decision|1|||
105816834|NCT02457520|364988306|FG000|Post-treatment Period|Withdrawal by Subject|14|||
105816835|NCT02587962|364988307|FG000|Overall Study|Adverse Event|0|||
105816836|NCT02587962|364988308|FG001|Overall Study|Adverse Event|0|||
105816837|NCT02587962|364988309|FG002|Overall Study|Adverse Event|1|||
105816838|NCT02587962|364988310|FG003|Overall Study|Adverse Event|0|||
105816839|NCT02587962|364988311|FG004|Overall Study|Adverse Event|0|||
105816840|NCT02587962|364988307|FG000|Overall Study|Withdrawal by Subject|0|||
105816841|NCT02587962|364988308|FG001|Overall Study|Withdrawal by Subject|0|||
105816842|NCT02587962|364988309|FG002|Overall Study|Withdrawal by Subject|1|||
105816843|NCT02587962|364988310|FG003|Overall Study|Withdrawal by Subject|1|||
105816844|NCT02587962|364988311|FG004|Overall Study|Withdrawal by Subject|4|||
105816845|NCT02587962|364988307|FG000|Overall Study|Radiological progression|2|||
105816846|NCT02587962|364988308|FG001|Overall Study|Radiological progression|2|||
105816847|NCT02587962|364988309|FG002|Overall Study|Radiological progression|2|||
105816848|NCT02587962|364988310|FG003|Overall Study|Radiological progression|5|||
105956227|NCT00997984|365501535|FG002|Overall Study|Protocol Violation|0|||
105956228|NCT00997984|365501533|FG000|Overall Study|Withdrawal by Subject|6|||
105956229|NCT00997984|365501534|FG001|Overall Study|Withdrawal by Subject|9|||
105956230|NCT00997984|365501535|FG002|Overall Study|Withdrawal by Subject|5|||
105956231|NCT00997984|365501533|FG000|Overall Study|Lost to Follow-up|8|||
105956232|NCT00997984|365501534|FG001|Overall Study|Lost to Follow-up|5|||
105956233|NCT00997984|365501535|FG002|Overall Study|Lost to Follow-up|4|||
105956234|NCT00997984|365501533|FG000|Overall Study|Lack of Efficacy|20|||
105956235|NCT00997984|365501534|FG001|Overall Study|Lack of Efficacy|6|||
105956236|NCT00997984|365501535|FG002|Overall Study|Lack of Efficacy|3|||
105956237|NCT00997984|365501533|FG000|Overall Study|Met exclusion criteria|1|||
105956238|NCT00997984|365501534|FG001|Overall Study|Met exclusion criteria|0|||
105956239|NCT00997984|365501535|FG002|Overall Study|Met exclusion criteria|0|||
105956240|NCT00997984|365501533|FG000|Overall Study|non-compliance|0|||
105956241|NCT00997984|365501534|FG001|Overall Study|non-compliance|2|||
105956242|NCT00997984|365501535|FG002|Overall Study|non-compliance|3|||
105956243|NCT00997984|365501533|FG000|Overall Study|Wrong medication dispensed|0|||
105956244|NCT00997984|365501534|FG001|Overall Study|Wrong medication dispensed|1|||
105956245|NCT00997984|365501535|FG002|Overall Study|Wrong medication dispensed|0|||
105956246|NCT00997984|365501533|FG000|Overall Study|Suicidal ideation|0|||
105956247|NCT00997984|365501534|FG001|Overall Study|Suicidal ideation|0|||
105956248|NCT00997984|365501535|FG002|Overall Study|Suicidal ideation|1|||
105956249|NCT00997984|365501533|FG000|Overall Study|Work schedule|0|||
105764776|NCT03185819|364791728|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
105764777|NCT03185819|364791729|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
105764778|NCT03185819|364791730|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
105764779|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
105764780|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
105764781|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
105764782|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
105764783|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
105764784|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
105764785|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
105764786|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
105764787|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
105764788|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
105764789|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
105764790|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
105764791|NCT03321526|364791731|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
105764792|NCT03321526|364791732|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
105764793|NCT03321526|364791731|FG000|Follow-up Phase (2 Weeks)|Other|24|||
105764794|NCT03321526|364791732|FG001|Follow-up Phase (2 Weeks)|Other|24|||
105764795|NCT04583969|364791733|FG000|Overall Study|Death|31|||
105764796|NCT04583969|364791734|FG001|Overall Study|Death|38|||
105764797|NCT04583969|364791733|FG000|Overall Study|Lost to Follow-up|16|||
105764798|NCT04583969|364791734|FG001|Overall Study|Lost to Follow-up|13|||
105764799|NCT04583969|364791733|FG000|Overall Study|Protocol Violation|1|||
105764800|NCT04583969|364791734|FG001|Overall Study|Protocol Violation|0|||
105764801|NCT04583969|364791733|FG000|Overall Study|Withdrawal by Subject|3|||
105764802|NCT04583969|364791734|FG001|Overall Study|Withdrawal by Subject|3|||
105764803|NCT04583969|364791733|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
105764804|NCT04583969|364791734|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
105764805|NCT04583969|364791733|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
105764806|NCT04583969|364791734|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
105764807|NCT04583969|364791733|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
105764808|NCT04583969|364791734|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
105764809|NCT04583969|364791733|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
105764810|NCT04583969|364791734|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
105764811|NCT04583969|364791733|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
105764812|NCT04583969|364791734|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
105764813|NCT02873208|364791737|FG000|Overall Study|Withdrawal by Subject|36|||
105764814|NCT02873208|364791737|FG000|Overall Study|Lost to Follow-up|22|||
105764815|NCT02873208|364791737|FG000|Overall Study|Adverse Event|15|||
105764816|NCT02873208|364791737|FG000|Overall Study|Non-compliance with study drug|12|||
105764817|NCT02873208|364791737|FG000|Overall Study|Protocol Violation|8|||
105764818|NCT02873208|364791737|FG000|Overall Study|Pregnancy|2|||
105764819|NCT02873208|364791737|FG000|Overall Study|Incarceration|1|||
105764820|NCT02873208|364791737|FG000|Overall Study|Lack of Efficacy|1|||
105764821|NCT02873208|364791737|FG000|Overall Study|Physician Decision|1|||
105764822|NCT02910089|364791738|FG000|Overall Study|Lost insurance eligibility|22|||
105764823|NCT02910089|364791739|FG001|Overall Study|Lost insurance eligibility|16|||
105956250|NCT00997984|365501534|FG001|Overall Study|Work schedule|0|||
105956251|NCT00997984|365501535|FG002|Overall Study|Work schedule|2|||
105764824|NCT01057862|364791740|FG000|Overall Study|Withdrawal by Subject|1|||
105764825|NCT01057862|364791741|FG001|Overall Study|Withdrawal by Subject|2|||
105764826|NCT04080752|364791742|FG000|Overall Study|Adverse Event|2|||
105764827|NCT04080752|364791743|FG001|Overall Study|Adverse Event|3|||
105764828|NCT04080752|364791742|FG000|Overall Study|Lack of Efficacy|1|||
105764829|NCT04080752|364791743|FG001|Overall Study|Lack of Efficacy|0|||
105764830|NCT04080752|364791742|FG000|Overall Study|Lost to Follow-up|1|||
105764831|NCT04080752|364791743|FG001|Overall Study|Lost to Follow-up|0|||
105764832|NCT04080752|364791742|FG000|Overall Study|Pregnancy|0|||
105764833|NCT04080752|364791743|FG001|Overall Study|Pregnancy|1|||
105764834|NCT04080752|364791742|FG000|Overall Study|Withdrawal by Subject|7|||
105764835|NCT04080752|364791743|FG001|Overall Study|Withdrawal by Subject|0|||
105764836|NCT04080752|364791742|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105764837|NCT04080752|364791743|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105764838|NCT04080752|364791742|FG000|Overall Study|Other|2|||
105764839|NCT04080752|364791743|FG001|Overall Study|Other|1|||
105764840|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
105764841|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
105764842|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
105764843|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
105764844|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
105764845|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
105764846|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
105764847|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
105764848|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
105764849|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
105764850|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
105764851|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
105764852|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
105764853|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
105764854|NCT03434041|364791744|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
105764855|NCT03434041|364791745|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
105764856|NCT03434041|364791744|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
105764857|NCT03434041|364791745|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
105764858|NCT03434041|364791744|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
105764859|NCT03434041|364791745|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
105764860|NCT03434041|364791744|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
105764861|NCT03434041|364791745|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
105764862|NCT03363165|364791746|FG000|3-month Follow-up|Death|0|||
105764863|NCT03363165|364791747|FG001|3-month Follow-up|Death|1|||
105764864|NCT03363165|364791746|FG000|6-month Follow-up|Death|0|||
105764865|NCT03363165|364791747|FG001|6-month Follow-up|Death|1|||
105764866|NCT03363165|364791746|FG000|6-month Follow-up|Withdrawal by Subject|1|||
105764867|NCT03363165|364791747|FG001|6-month Follow-up|Withdrawal by Subject|1|||
105764868|NCT03363165|364791746|FG000|12-month Follow-up|Death|1|||
105764869|NCT03363165|364791747|FG001|12-month Follow-up|Death|1|||
105764870|NCT03363165|364791746|FG000|12-month Follow-up|Withdrawal by Subject|1|||
105764871|NCT03363165|364791747|FG001|12-month Follow-up|Withdrawal by Subject|1|||
105764872|NCT01585168|364791748|FG000|Overall Study|Lost to Follow-up|3|||
105764873|NCT01585168|364791749|FG001|Overall Study|Lost to Follow-up|1|||
105764874|NCT01585168|364791750|FG002|Overall Study|Lost to Follow-up|1|||
105764875|NCT01585168|364791751|FG003|Overall Study|Lost to Follow-up|1|||
105764876|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
105764877|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
105764878|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
105764879|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
105764880|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
105764881|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
105764882|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
105764883|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
105764884|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
105764885|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
105764886|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
105764887|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
105764888|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
105764889|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
105764890|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
105764891|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
106145378|NCT02674750|366191954|FG002|Overall Study|Withdrawal by Subject|1|||
106145379|NCT02674750|366191952|FG000|Overall Study|Other|0|||
105816849|NCT02587962|364988311|FG004|Overall Study|Radiological progression|10|||
105956252|NCT01220401|365501536|FG000|Overall Study|Withdrawal by Subject|2|||
105956253|NCT01220401|365501536|FG000|Overall Study|Protocol Violation|1|||
105956254|NCT01853462|365501537|FG000|Overall Study|Withdrawal by Subject|1|||
105956255|NCT01853462|365501538|FG001|Overall Study|Withdrawal by Subject|1|||
105816850|NCT02587962|364988307|FG000|Overall Study|Clinical progression|0|||
105816851|NCT02587962|364988308|FG001|Overall Study|Clinical progression|1|||
105816852|NCT02587962|364988309|FG002|Overall Study|Clinical progression|2|||
105816853|NCT02587962|364988310|FG003|Overall Study|Clinical progression|0|||
105816854|NCT02587962|364988311|FG004|Overall Study|Clinical progression|1|||
105816855|NCT00282048|364988312|FG000|Overall Study|Lack of Efficacy|30|||
105816856|NCT00282048|364988312|FG000|Overall Study|Adverse Event|22|||
105816857|NCT00282048|364988312|FG000|Overall Study|Withdrawal by Subject|1|||
105816858|NCT00282048|364988312|FG000|Overall Study|Other|8|||
105816859|NCT00282048|364988312|FG000|Overall Study|Ongoing|1|||
105816860|NCT00259012|364988313|FG000|Overall Study|Adverse Event|0|||
105816861|NCT00259012|364988314|FG001|Overall Study|Adverse Event|1|||
105816862|NCT00259012|364988313|FG000|Overall Study|Withdrawal by Subject|1|||
105816863|NCT00259012|364988314|FG001|Overall Study|Withdrawal by Subject|0|||
105816864|NCT00259012|364988313|FG000|Overall Study|Physician Decision|0|||
105816865|NCT00259012|364988314|FG001|Overall Study|Physician Decision|1|||
105816866|NCT00259012|364988313|FG000|Overall Study|Lost to Follow-up|0|||
105816867|NCT00259012|364988314|FG001|Overall Study|Lost to Follow-up|1|||
105816868|NCT00259012|364988313|FG000|Overall Study|Protocol Violation|1|||
105816869|NCT00259012|364988314|FG001|Overall Study|Protocol Violation|1|||
105816870|NCT00312663|364988315|FG000|Immunization Phase|Adverse Event|0|||
105816871|NCT00312663|364988316|FG001|Immunization Phase|Adverse Event|1|||
105816872|NCT00312663|364988317|FG002|Immunization Phase|Adverse Event|0|||
105816873|NCT00376623|364988318|FG000|Overall Study|Progressive disease|35|||
105816874|NCT00376623|364988319|FG001|Overall Study|Progressive disease|22|||
105816875|NCT00376623|364988320|FG002|Overall Study|Progressive disease|17|||
105816876|NCT00376623|364988318|FG000|Overall Study|Lost to Follow-up|0|||
105816877|NCT00376623|364988319|FG001|Overall Study|Lost to Follow-up|1|||
105816878|NCT00376623|364988320|FG002|Overall Study|Lost to Follow-up|0|||
105816879|NCT00376623|364988318|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
105816880|NCT00376623|364988319|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
105816881|NCT00376623|364988320|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
105816882|NCT00376623|364988318|FG000|Overall Study|Not treated with BI 2536|1|||
105816883|NCT00376623|364988319|FG001|Overall Study|Not treated with BI 2536|0|||
105816884|NCT00376623|364988320|FG002|Overall Study|Not treated with BI 2536|0|||
105816885|NCT00376623|364988318|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
105816886|NCT00376623|364988319|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816887|NCT00376623|364988320|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816888|NCT00376623|364988318|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
105816889|NCT00376623|364988319|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
105816890|NCT00376623|364988320|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
105816891|NCT00376623|364988318|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
105816892|NCT00376623|364988319|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816893|NCT00376623|364988320|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816894|NCT00376623|364988318|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
105816895|NCT00376623|364988319|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
105816896|NCT00376623|364988320|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
105816897|NCT00376623|364988318|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816898|NCT00376623|364988319|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
105816899|NCT00376623|364988320|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
105816900|NCT00376623|364988318|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
105816901|NCT00376623|364988319|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
105816902|NCT00376623|364988320|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
105816903|NCT00376623|364988318|FG000|Overall Study|Increase of tumour markers|0|||
105816904|NCT00376623|364988319|FG001|Overall Study|Increase of tumour markers|1|||
105816905|NCT00376623|364988320|FG002|Overall Study|Increase of tumour markers|0|||
105816906|NCT00376623|364988318|FG000|Overall Study|Bone metastasis|1|||
105816907|NCT00376623|364988319|FG001|Overall Study|Bone metastasis|0|||
105816908|NCT00376623|364988320|FG002|Overall Study|Bone metastasis|0|||
105816909|NCT00286754|364988327|FG000|Overall Study|Adverse Event|2|||
105816910|NCT00286754|364988328|FG001|Overall Study|Adverse Event|2|||
105816911|NCT00286754|364988329|FG002|Overall Study|Adverse Event|3|||
105956256|NCT01119066|365501539|FG000|Overall Study|Withdrawal by Subject|4|||
106145380|NCT02674750|366191953|FG001|Overall Study|Other|8|||
105956257|NCT01119066|365501540|FG001|Overall Study|Withdrawal by Subject|6|||
105956258|NCT01119066|365501541|FG002|Overall Study|Withdrawal by Subject|0|||
105956259|NCT01119066|365501542|FG003|Overall Study|Withdrawal by Subject|0|||
105956260|NCT01119066|365501539|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
105956261|NCT01119066|365501540|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
105956262|NCT01119066|365501541|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
105956263|NCT01119066|365501542|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
105956264|NCT01119066|365501539|FG000|Overall Study|Relapse identified before transplant|1|||
105956265|NCT01119066|365501540|FG001|Overall Study|Relapse identified before transplant|0|||
105956266|NCT01119066|365501541|FG002|Overall Study|Relapse identified before transplant|0|||
105956267|NCT01119066|365501542|FG003|Overall Study|Relapse identified before transplant|0|||
105956268|NCT01119066|365501539|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
105956269|NCT01119066|365501540|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
105956270|NCT01119066|365501541|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
105956271|NCT01119066|365501542|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
105956272|NCT01119066|365501539|FG000|Overall Study|Relapse identified before transplant|0|||
105956273|NCT01119066|365501540|FG001|Overall Study|Relapse identified before transplant|4|||
105956274|NCT01119066|365501541|FG002|Overall Study|Relapse identified before transplant|0|||
105956275|NCT01119066|365501542|FG003|Overall Study|Relapse identified before transplant|0|||
105956276|NCT00295646|365501543|FG000|Overall Study|Protocol Violation|18|||
105956277|NCT00295646|365501544|FG001|Overall Study|Protocol Violation|20|||
105956278|NCT00295646|365501545|FG002|Overall Study|Protocol Violation|20|||
105956279|NCT00295646|365501546|FG003|Overall Study|Protocol Violation|18|||
105956280|NCT00295646|365501543|FG000|Overall Study|Withdrawal by Subject|8|||
105956281|NCT00295646|365501544|FG001|Overall Study|Withdrawal by Subject|9|||
105956282|NCT00295646|365501545|FG002|Overall Study|Withdrawal by Subject|11|||
105956283|NCT00295646|365501546|FG003|Overall Study|Withdrawal by Subject|14|||
105956284|NCT00295646|365501543|FG000|Overall Study|Lost to Follow-up|0|||
105956285|NCT00295646|365501544|FG001|Overall Study|Lost to Follow-up|5|||
105956286|NCT00295646|365501545|FG002|Overall Study|Lost to Follow-up|1|||
105956287|NCT00295646|365501546|FG003|Overall Study|Lost to Follow-up|5|||
105956288|NCT00295646|365501543|FG000|Overall Study|Death|9|||
105956289|NCT00295646|365501544|FG001|Overall Study|Death|7|||
105956290|NCT00295646|365501545|FG002|Overall Study|Death|18|||
105956291|NCT00295646|365501546|FG003|Overall Study|Death|8|||
105956292|NCT02441101|365501547|FG000|Overall Study|Withdrawal by Subject|1|||
105956293|NCT02441101|365501548|FG001|Overall Study|Withdrawal by Subject|0|||
105956294|NCT02441101|365501547|FG000|Overall Study|Lost to Follow-up|1|||
105956295|NCT02441101|365501548|FG001|Overall Study|Lost to Follow-up|0|||
105956296|NCT02441101|365501547|FG000|Overall Study|PI relocated and study terminated|1|||
105956297|NCT02441101|365501548|FG001|Overall Study|PI relocated and study terminated|0|||
105956298|NCT02528942|365501551|FG000|Overall Study|Did not meet imaging criteria|9|||
105956299|NCT02528942|365501551|FG000|Overall Study|Lost to Follow-up|25|||
105764892|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
105764893|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
105764894|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
105764895|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
105764896|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
105764897|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
105764898|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
105764899|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
105764900|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Other|0|||
105764901|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Other|1|||
105764902|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Other|0|||
105764903|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Other|0|||
105764904|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
105764905|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
105764906|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
105764907|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
105764908|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
105764909|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
105764910|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
105956300|NCT02148263|365501552|FG000|Overall Study|Withdrawal by Subject|3|||
105956301|NCT02148263|365501553|FG001|Overall Study|Withdrawal by Subject|2|||
105956302|NCT03145064|365502836|FG000|Overall Study|Death|24|||
105956303|NCT03145064|365502836|FG000|Overall Study|Lost to Follow-up|3|||
105956304|NCT03145064|365502836|FG000|Overall Study|Withdrawal by Subject|6|||
105956305|NCT03145064|365502836|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
105956306|NCT03145064|365502836|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
105956307|NCT04245449|365502847|FG000|Overall Study|COVID shutdown|7|||
105816912|NCT00286754|364988327|FG000|Overall Study|Withdrawal by Subject|6|||
105816913|NCT00286754|364988328|FG001|Overall Study|Withdrawal by Subject|2|||
105816914|NCT00286754|364988329|FG002|Overall Study|Withdrawal by Subject|0|||
105816915|NCT00286754|364988327|FG000|Overall Study|Lost to Follow-up|12|||
105816916|NCT00286754|364988328|FG001|Overall Study|Lost to Follow-up|14|||
105816917|NCT00286754|364988329|FG002|Overall Study|Lost to Follow-up|6|||
105956308|NCT01408277|365502851|FG000|Overall Study|Adverse Event|3|||
105956309|NCT01408277|365502852|FG001|Overall Study|Adverse Event|4|||
105956310|NCT01408277|365502851|FG000|Overall Study|Lost to Follow-up|1|||
105956311|NCT01408277|365502852|FG001|Overall Study|Lost to Follow-up|0|||
105956312|NCT01408277|365502851|FG000|Overall Study|Withdrawal by Subject|2|||
105956313|NCT01408277|365502852|FG001|Overall Study|Withdrawal by Subject|0|||
105956314|NCT01408277|365502851|FG000|Overall Study|Protocol Violation|2|||
105956315|NCT01408277|365502852|FG001|Overall Study|Protocol Violation|0|||
105956316|NCT01582009|365502853|FG000|Overall Study|Withdrawal by Subject|1|||
105956317|NCT01582009|365502853|FG000|Overall Study|Physician Decision|1|||
105956318|NCT02840253|365502855|FG000|Overall Study|Unsuccessful block|4|||
105956319|NCT01947283|365502856|FG000|Overall Study|Death|1|||
105956320|NCT01947283|365502857|FG001|Overall Study|Death|1|||
105956321|NCT01947283|365502858|FG002|Overall Study|Death|1|||
105956322|NCT01947283|365502859|FG003|Overall Study|Death|0|||
105956323|NCT01947283|365502860|FG004|Overall Study|Death|0|||
105956324|NCT01947283|365502861|FG005|Overall Study|Death|0|||
105764911|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
105764912|NCT01194414|364791752|FG000|24 Weeks Double Blind Period|Death|0|||
105764913|NCT01194414|364791753|FG001|24 Weeks Double Blind Period|Death|1|||
105764914|NCT01194414|364791754|FG002|24 Weeks Double Blind Period|Death|0|||
105764915|NCT01194414|364791755|FG003|24 Weeks Double Blind Period|Death|0|||
105764916|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
105764917|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
105764918|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
105764919|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
105764920|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
105764921|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
105764922|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
105764923|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
105764924|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
105764925|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
105764926|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
105764927|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
105764928|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
105764929|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
105764930|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
105764931|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
105764932|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
105764933|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
105764934|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
105764935|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
105764936|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
105764937|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
105764938|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
105764939|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
105764940|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Other|2|||
105764941|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Other|1|||
105764942|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Other|0|||
105764943|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Other|0|||
105764944|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
105764945|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
105764946|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
105764947|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
105764948|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
105764949|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
105764950|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
105764951|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
105764952|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
105764953|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
105764954|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
105816918|NCT00286754|364988327|FG000|Overall Study|Moved out of state|0|||
105956325|NCT01947283|365502862|FG006|Overall Study|Death|0|||
105956326|NCT01947283|365502856|FG000|Overall Study|Lost to Follow-up|4|||
106018443|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
106018444|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
106018445|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
106018446|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
106018447|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
106018448|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
106018449|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
106018450|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
106018451|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
106018452|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
106018453|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
106018454|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
105764955|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
105764956|NCT01194414|364791752|FG000|72 Weeks Open Label Extension|Death|1|||
105764957|NCT01194414|364791753|FG001|72 Weeks Open Label Extension|Death|2|||
105764958|NCT01194414|364791754|FG002|72 Weeks Open Label Extension|Death|0|||
105764959|NCT01194414|364791755|FG003|72 Weeks Open Label Extension|Death|2|||
105764960|NCT04737759|364791759|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
105764961|NCT04737759|364791760|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
105764962|NCT04737759|364791759|FG000|Overall Study|Death|2|||
105764963|NCT04737759|364791760|FG001|Overall Study|Death|0|||
105764964|NCT04737759|364791759|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
105764965|NCT04737759|364791760|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
105764966|NCT04737759|364791759|FG000|Overall Study|Lost to Follow-up|4|||
105764967|NCT04737759|364791760|FG001|Overall Study|Lost to Follow-up|12|||
105764968|NCT02260388|364791765|FG000|Overall Study|Lost to Follow-up|2|||
105764969|NCT02260388|364791766|FG001|Overall Study|Lost to Follow-up|8|||
105764970|NCT02260388|364791767|FG002|Overall Study|Lost to Follow-up|3|||
105764971|NCT02260388|364791768|FG003|Overall Study|Lost to Follow-up|4|||
105764972|NCT00422669|364791773|FG000|Overall Study|The study was terminated early.|98|||
105764973|NCT00422669|364791774|FG001|Overall Study|The study was terminated early.|100|||
105764974|NCT00422669|364791775|FG002|Overall Study|The study was terminated early.|7|||
105764975|NCT02738580|364791776|FG000|Overall Study|Adverse Event|1|||
105764976|NCT02738580|364791777|FG001|Overall Study|Adverse Event|0|||
105764977|NCT02738580|364791776|FG000|Overall Study|Lack of Efficacy|3|||
105764978|NCT02738580|364791777|FG001|Overall Study|Lack of Efficacy|2|||
105764979|NCT02738580|364791776|FG000|Overall Study|Withdrawal by Subject|0|||
105764980|NCT02738580|364791777|FG001|Overall Study|Withdrawal by Subject|1|||
105764981|NCT02738580|364791776|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
105764982|NCT02738580|364791777|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
105764983|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
105764984|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
105764985|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
105764986|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
105764987|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
105764988|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
105764989|NCT00996593|364791778|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
105764990|NCT00996593|364791778|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
105764991|NCT00996593|364791778|FG000|Long-Term Follow-Up|Site Closed|1|||
105764992|NCT00741260|364791779|FG000|Overall Study|Disease Progression|3|||
105764993|NCT00741260|364791780|FG001|Overall Study|Disease Progression|5|||
105764994|NCT00741260|364791781|FG002|Overall Study|Disease Progression|3|||
105764995|NCT00741260|364791782|FG003|Overall Study|Disease Progression|3|||
105764996|NCT00741260|364791783|FG004|Overall Study|Disease Progression|5|||
105764997|NCT00741260|364791784|FG005|Overall Study|Disease Progression|37|||
105764998|NCT00741260|364791785|FG006|Overall Study|Disease Progression|4|||
105764999|NCT00741260|364791779|FG000|Overall Study|Death|0|||
105765000|NCT00741260|364791780|FG001|Overall Study|Death|1|||
105765001|NCT00741260|364791781|FG002|Overall Study|Death|0|||
105765002|NCT00741260|364791782|FG003|Overall Study|Death|1|||
105765003|NCT00741260|364791783|FG004|Overall Study|Death|2|||
105765004|NCT00741260|364791784|FG005|Overall Study|Death|2|||
105765005|NCT00741260|364791785|FG006|Overall Study|Death|1|||
105765006|NCT00741260|364791779|FG000|Overall Study|Withdrawal by Subject|0|||
105765007|NCT00741260|364791780|FG001|Overall Study|Withdrawal by Subject|0|||
105765008|NCT00741260|364791781|FG002|Overall Study|Withdrawal by Subject|0|||
105765009|NCT00741260|364791782|FG003|Overall Study|Withdrawal by Subject|0|||
105765010|NCT00741260|364791783|FG004|Overall Study|Withdrawal by Subject|1|||
105765011|NCT00741260|364791784|FG005|Overall Study|Withdrawal by Subject|3|||
105765012|NCT00741260|364791785|FG006|Overall Study|Withdrawal by Subject|1|||
105765013|NCT00741260|364791779|FG000|Overall Study|Physician Decision|1|||
105765014|NCT00741260|364791780|FG001|Overall Study|Physician Decision|1|||
105765015|NCT00741260|364791781|FG002|Overall Study|Physician Decision|0|||
105765016|NCT00741260|364791782|FG003|Overall Study|Physician Decision|0|||
105765017|NCT00741260|364791783|FG004|Overall Study|Physician Decision|0|||
105765018|NCT00741260|364791784|FG005|Overall Study|Physician Decision|0|||
105765019|NCT00741260|364791785|FG006|Overall Study|Physician Decision|0|||
105765020|NCT00741260|364791779|FG000|Overall Study|Other|2|||
105765021|NCT00741260|364791780|FG001|Overall Study|Other|1|||
105765022|NCT00741260|364791781|FG002|Overall Study|Other|1|||
105765023|NCT00741260|364791782|FG003|Overall Study|Other|2|||
105765024|NCT00741260|364791783|FG004|Overall Study|Other|1|||
105765025|NCT00741260|364791784|FG005|Overall Study|Other|3|||
105765026|NCT00741260|364791785|FG006|Overall Study|Other|1|||
105765027|NCT03094611|364791790|FG000|Overall Study|Lack of Efficacy|1|||
105765028|NCT03094611|364791790|FG000|Overall Study|Stem Cell Transplant|1|||
105765029|NCT01614795|364791793|FG000|Overall Study|Adverse Event|0|||
105765030|NCT01614795|364791794|FG001|Overall Study|Adverse Event|0|||
105765031|NCT01614795|364791795|FG002|Overall Study|Adverse Event|1|||
105765032|NCT01614795|364791796|FG003|Overall Study|Adverse Event|1|||
105765033|NCT01614795|364791793|FG000|Overall Study|Lack of Efficacy|10|||
105765034|NCT01614795|364791794|FG001|Overall Study|Lack of Efficacy|10|||
105765035|NCT01614795|364791795|FG002|Overall Study|Lack of Efficacy|9|||
105765036|NCT01614795|364791796|FG003|Overall Study|Lack of Efficacy|8|||
105765037|NCT01614795|364791793|FG000|Overall Study|Physician Decision|1|||
105765038|NCT01614795|364791794|FG001|Overall Study|Physician Decision|0|||
105765039|NCT01614795|364791795|FG002|Overall Study|Physician Decision|1|||
105765040|NCT01614795|364791796|FG003|Overall Study|Physician Decision|1|||
105765041|NCT01614795|364791793|FG000|Overall Study|Withdrawal by Subject|0|||
105765042|NCT01614795|364791794|FG001|Overall Study|Withdrawal by Subject|1|||
105765043|NCT01614795|364791795|FG002|Overall Study|Withdrawal by Subject|0|||
105765044|NCT01614795|364791796|FG003|Overall Study|Withdrawal by Subject|2|||
105765045|NCT01614795|364791793|FG000|Overall Study|Ineligible|0|||
105765046|NCT01614795|364791794|FG001|Overall Study|Ineligible|1|||
105765047|NCT01614795|364791795|FG002|Overall Study|Ineligible|0|||
105765048|NCT01614795|364791796|FG003|Overall Study|Ineligible|0|||
105765049|NCT01929707|364791800|FG000|Intervention Period 1|Lost to Follow-up|0|||
105765050|NCT01929707|364791801|FG001|Intervention Period 1|Lost to Follow-up|0|||
105765051|NCT01929707|364791802|FG002|Intervention Period 1|Lost to Follow-up|0|||
105765052|NCT01929707|364791803|FG003|Intervention Period 1|Lost to Follow-up|1|||
105765053|NCT01929707|364791804|FG004|Intervention Period 1|Lost to Follow-up|0|||
105765054|NCT01929707|364791805|FG005|Intervention Period 1|Lost to Follow-up|0|||
105765055|NCT01929707|364791806|FG006|Intervention Period 1|Lost to Follow-up|0|||
105765056|NCT01929707|364791807|FG007|Intervention Period 1|Lost to Follow-up|0|||
105765057|NCT01929707|364791800|FG000|Intervention Period 1|Withdrawal by Subject|0|||
105765058|NCT01929707|364791801|FG001|Intervention Period 1|Withdrawal by Subject|0|||
105765059|NCT01929707|364791802|FG002|Intervention Period 1|Withdrawal by Subject|0|||
105765060|NCT01929707|364791803|FG003|Intervention Period 1|Withdrawal by Subject|2|||
105765061|NCT01929707|364791804|FG004|Intervention Period 1|Withdrawal by Subject|0|||
105765062|NCT01929707|364791805|FG005|Intervention Period 1|Withdrawal by Subject|0|||
105765063|NCT01929707|364791806|FG006|Intervention Period 1|Withdrawal by Subject|0|||
105765064|NCT01929707|364791807|FG007|Intervention Period 1|Withdrawal by Subject|0|||
105765065|NCT01929707|364791800|FG000|Intervention Period 2|Withdrawal by Subject|0|||
105765066|NCT01929707|364791801|FG001|Intervention Period 2|Withdrawal by Subject|0|||
105765067|NCT01929707|364791802|FG002|Intervention Period 2|Withdrawal by Subject|0|||
105765068|NCT01929707|364791803|FG003|Intervention Period 2|Withdrawal by Subject|0|||
105765069|NCT01929707|364791804|FG004|Intervention Period 2|Withdrawal by Subject|0|||
105765070|NCT01929707|364791805|FG005|Intervention Period 2|Withdrawal by Subject|2|||
105765071|NCT01929707|364791806|FG006|Intervention Period 2|Withdrawal by Subject|0|||
105765072|NCT01929707|364791807|FG007|Intervention Period 2|Withdrawal by Subject|0|||
105765073|NCT02566109|364791808|FG000|Overall Study|Withdrawal by Subject|1|||
105765074|NCT01685203|364791814|FG000|Overall Study|Lost to Follow-up|3|||
105765075|NCT01685203|364791815|FG001|Overall Study|Lost to Follow-up|3|||
105765076|NCT01685203|364791816|FG002|Overall Study|Lost to Follow-up|0|||
105765077|NCT01685203|364791817|FG003|Overall Study|Lost to Follow-up|1|||
105765078|NCT01685203|364791818|FG004|Overall Study|Lost to Follow-up|0|||
106018455|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
105765079|NCT01685203|364791819|FG005|Overall Study|Lost to Follow-up|0|||
105765080|NCT01685203|364791820|FG006|Overall Study|Lost to Follow-up|0|||
105765081|NCT01685203|364791814|FG000|Overall Study|Adverse Event|0|||
105765082|NCT01685203|364791815|FG001|Overall Study|Adverse Event|0|||
106018456|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
106018457|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105765083|NCT01685203|364791816|FG002|Overall Study|Adverse Event|0|||
105765084|NCT01685203|364791817|FG003|Overall Study|Adverse Event|0|||
105765085|NCT01685203|364791818|FG004|Overall Study|Adverse Event|0|||
105765086|NCT01685203|364791819|FG005|Overall Study|Adverse Event|2|||
105765087|NCT01685203|364791820|FG006|Overall Study|Adverse Event|0|||
105765088|NCT01685203|364791814|FG000|Overall Study|Adverse event and withdrew consent|1|||
105765089|NCT01685203|364791815|FG001|Overall Study|Adverse event and withdrew consent|0|||
105816919|NCT00286754|364988328|FG001|Overall Study|Moved out of state|0|||
105816920|NCT00286754|364988329|FG002|Overall Study|Moved out of state|1|||
105816921|NCT01173692|364988332|FG000|Overall Study|Adverse Event|1|||
105816922|NCT01173692|364988333|FG001|Overall Study|Adverse Event|2|||
105816923|NCT01173692|364988332|FG000|Overall Study|Withdrawal by Subject|1|||
105816924|NCT01173692|364988333|FG001|Overall Study|Withdrawal by Subject|3|||
105816925|NCT00579670|364988334|FG000|Overall Study|Death|1|||
105816926|NCT00579670|364988335|FG001|Overall Study|Death|0|||
105816927|NCT00579670|364988336|FG002|Overall Study|Death|0|||
105816928|NCT00579670|364988337|FG003|Overall Study|Death|0|||
105816929|NCT00579670|364988338|FG004|Overall Study|Death|0|||
105816930|NCT00579670|364988334|FG000|Overall Study|Adverse Event|1|||
105816931|NCT00579670|364988335|FG001|Overall Study|Adverse Event|0|||
105816932|NCT00579670|364988336|FG002|Overall Study|Adverse Event|1|||
105816933|NCT00579670|364988337|FG003|Overall Study|Adverse Event|2|||
105816934|NCT00579670|364988338|FG004|Overall Study|Adverse Event|0|||
105816935|NCT00579670|364988334|FG000|Overall Study|Lack of Efficacy|0|||
105816936|NCT00579670|364988335|FG001|Overall Study|Lack of Efficacy|0|||
105816937|NCT00579670|364988336|FG002|Overall Study|Lack of Efficacy|1|||
105816938|NCT00579670|364988337|FG003|Overall Study|Lack of Efficacy|14|||
105816939|NCT00579670|364988338|FG004|Overall Study|Lack of Efficacy|0|||
105816940|NCT00579670|364988334|FG000|Overall Study|Lost to Follow-up|0|||
105816941|NCT00579670|364988335|FG001|Overall Study|Lost to Follow-up|1|||
105816942|NCT00579670|364988336|FG002|Overall Study|Lost to Follow-up|0|||
105816943|NCT00579670|364988337|FG003|Overall Study|Lost to Follow-up|4|||
105816944|NCT00579670|364988338|FG004|Overall Study|Lost to Follow-up|0|||
105816945|NCT00579670|364988334|FG000|Overall Study|Other|0|||
105816946|NCT00579670|364988335|FG001|Overall Study|Other|0|||
105816947|NCT00579670|364988336|FG002|Overall Study|Other|1|||
105816948|NCT00579670|364988337|FG003|Overall Study|Other|2|||
105816949|NCT00579670|364988338|FG004|Overall Study|Other|0|||
105816950|NCT00579670|364988334|FG000|Overall Study|Withdrawal by Subject|0|||
105816951|NCT00579670|364988335|FG001|Overall Study|Withdrawal by Subject|0|||
105816952|NCT00579670|364988336|FG002|Overall Study|Withdrawal by Subject|1|||
105816953|NCT00579670|364988337|FG003|Overall Study|Withdrawal by Subject|0|||
105816954|NCT00579670|364988338|FG004|Overall Study|Withdrawal by Subject|0|||
105816955|NCT03361228|364988340|FG000|Overall Study|Other|1|||
105816956|NCT03361228|364988341|FG001|Overall Study|Other|1|||
105816957|NCT03361228|364988340|FG000|Overall Study|Death|3|||
105816958|NCT03361228|364988341|FG001|Overall Study|Death|0|||
105816959|NCT00302952|364988342|FG000|Overall Study|Physician Decision|1|||
105816960|NCT00302952|364988343|FG001|Overall Study|Physician Decision|1|||
105816961|NCT00302952|364988342|FG000|Overall Study|Withdrawal by Subject|2|||
105816962|NCT00302952|364988343|FG001|Overall Study|Withdrawal by Subject|3|||
105816963|NCT00302952|364988342|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
105816964|NCT00302952|364988343|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
105816965|NCT02979353|364988348|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
105816966|NCT02979353|364988349|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
105816967|NCT02979353|364988348|FG000|Overall Study|Withdrawal by Subject|16|||
105816968|NCT02979353|364988349|FG001|Overall Study|Withdrawal by Subject|12|||
105816969|NCT02979353|364988348|FG000|Overall Study|Death|10|||
105816970|NCT02979353|364988349|FG001|Overall Study|Death|11|||
105816971|NCT02979353|364988348|FG000|Overall Study|Transfer to Hospice Care|19|||
105816972|NCT02979353|364988349|FG001|Overall Study|Transfer to Hospice Care|14|||
105816973|NCT02979353|364988348|FG000|Overall Study|Lost to Follow-up|1|||
105816974|NCT02979353|364988349|FG001|Overall Study|Lost to Follow-up|5|||
105816975|NCT03018249|364988352|FG000|Overall Study|Withdrawal by Subject|2|||
105816976|NCT03018249|364988353|FG001|Overall Study|Withdrawal by Subject|2|||
105816977|NCT02924038|364990430|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
105816978|NCT02924038|364990431|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
105816979|NCT02289963|364990445|FG000|Overall Study|Adverse Event|1|||
105816980|NCT02289963|364990446|FG001|Overall Study|Adverse Event|2|||
105816981|NCT02289963|364990445|FG000|Overall Study|Poor compliance to protocol|1|||
105816982|NCT02289963|364990446|FG001|Overall Study|Poor compliance to protocol|0|||
105816983|NCT02289963|364990445|FG000|Overall Study|Withdrawal by Subject|1|||
105816984|NCT02289963|364990446|FG001|Overall Study|Withdrawal by Subject|0|||
105816985|NCT02289963|364990445|FG000|Overall Study|Last injection missed|2|||
105816986|NCT02289963|364990446|FG001|Overall Study|Last injection missed|2|||
105816987|NCT02289963|364990445|FG000|Overall Study|End treatment visit outside visit window|0|||
105816988|NCT02289963|364990446|FG001|Overall Study|End treatment visit outside visit window|4|||
105816989|NCT02289963|364990445|FG000|Overall Study|Other than specified above|0|||
105816990|NCT02289963|364990446|FG001|Overall Study|Other than specified above|2|||
105816991|NCT00485472|364990447|FG000|Overall Study|Adverse Event|8|||
105816992|NCT00485472|364990448|FG001|Overall Study|Adverse Event|5|||
105816993|NCT00485472|364990447|FG000|Overall Study|Lack of Efficacy|5|||
105816994|NCT00485472|364990448|FG001|Overall Study|Lack of Efficacy|4|||
105816995|NCT00485472|364990447|FG000|Overall Study|Withdrawal by Subject|1|||
105816996|NCT00485472|364990448|FG001|Overall Study|Withdrawal by Subject|0|||
105765090|NCT01685203|364791816|FG002|Overall Study|Adverse event and withdrew consent|0|||
105765091|NCT01685203|364791817|FG003|Overall Study|Adverse event and withdrew consent|0|||
105765092|NCT01685203|364791818|FG004|Overall Study|Adverse event and withdrew consent|0|||
105765093|NCT01685203|364791819|FG005|Overall Study|Adverse event and withdrew consent|0|||
105765094|NCT01685203|364791820|FG006|Overall Study|Adverse event and withdrew consent|0|||
105765095|NCT01685203|364791814|FG000|Overall Study|Patient's decision|0|||
105765096|NCT01685203|364791815|FG001|Overall Study|Patient's decision|0|||
105765097|NCT01685203|364791816|FG002|Overall Study|Patient's decision|0|||
105765098|NCT01685203|364791817|FG003|Overall Study|Patient's decision|0|||
105765099|NCT01685203|364791818|FG004|Overall Study|Patient's decision|0|||
105765100|NCT01685203|364791819|FG005|Overall Study|Patient's decision|1|||
105765101|NCT01685203|364791820|FG006|Overall Study|Patient's decision|0|||
105765102|NCT03215667|364791827|FG000|Overall Study|Physician Decision|4|||
105765103|NCT04857892|364791828|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
105765104|NCT04857892|364791829|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
105765105|NCT04857892|364791830|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
105765106|NCT04857892|364791831|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
105765107|NCT04857892|364791832|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
105765108|NCT04857892|364791828|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
105765109|NCT04857892|364791829|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
105765110|NCT04857892|364791830|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
105765111|NCT04857892|364791831|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
105765112|NCT04857892|364791832|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
105765113|NCT04857892|364791828|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
105765114|NCT04857892|364791829|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
105765115|NCT04857892|364791830|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
105765116|NCT04857892|364791831|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
105765117|NCT04857892|364791832|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
105765118|NCT01390038|364791833|FG000|Overall Study|Death|1|||
105765119|NCT01390038|364791833|FG000|Overall Study|Lost to Follow-up|1|||
105765120|NCT01390038|364791833|FG000|Overall Study|Withdrawal by Subject|4|||
105765121|NCT01390038|364791833|FG000|Overall Study|Simpliciti System Removal|2|||
105765122|NCT00368472|364791836|FG000|Overall Study|Adverse Event|22|||
105765123|NCT00368472|364791836|FG000|Overall Study|Medication non-compliance|4|||
105765124|NCT00368472|364791836|FG000|Overall Study|Protocol Violation|2|||
105765125|NCT00368472|364791836|FG000|Overall Study|Request of Investigator or Sponsor|3|||
105765126|NCT00368472|364791836|FG000|Overall Study|Withdrawal by Subject|40|||
105765127|NCT00368472|364791836|FG000|Overall Study|Diary non-compliance|1|||
105765128|NCT00368472|364791836|FG000|Overall Study|Other|32|||
105765129|NCT00368472|364791836|FG000|Overall Study|Missing Final Disposition Date|1|||
105765130|NCT00251589|364791845|FG000|Overall Study|Adverse Event|5|||
105765131|NCT00251589|364791846|FG001|Overall Study|Adverse Event|1|||
105765132|NCT00251589|364791847|FG002|Overall Study|Adverse Event|2|||
105765133|NCT00251589|364791848|FG003|Overall Study|Adverse Event|1|||
105765134|NCT00251589|364791845|FG000|Overall Study|Withdrawal by Subject|1|||
105765135|NCT00251589|364791846|FG001|Overall Study|Withdrawal by Subject|1|||
105765136|NCT00251589|364791847|FG002|Overall Study|Withdrawal by Subject|0|||
105765137|NCT00251589|364791848|FG003|Overall Study|Withdrawal by Subject|0|||
105765138|NCT00251589|364791845|FG000|Overall Study|Discontinued due to progressive disease|9|||
105765139|NCT00251589|364791846|FG001|Overall Study|Discontinued due to progressive disease|1|||
105765140|NCT00251589|364791847|FG002|Overall Study|Discontinued due to progressive disease|0|||
105765141|NCT00251589|364791848|FG003|Overall Study|Discontinued due to progressive disease|1|||
105765142|NCT03039192|364791849|FG000|Overall Study|Lost to Follow-up|4|||
105765143|NCT03039192|364791850|FG001|Overall Study|Lost to Follow-up|4|||
105765144|NCT03039192|364791849|FG000|Overall Study|Adverse event, serious fatal|0|||
105765145|NCT03039192|364791850|FG001|Overall Study|Adverse event, serious fatal|1|||
105765146|NCT03039192|364791849|FG000|Overall Study|Adverse event, non-fatal|0|||
105765147|NCT03039192|364791850|FG001|Overall Study|Adverse event, non-fatal|2|||
105765148|NCT03039192|364791849|FG000|Overall Study|Withdrawal by Subject|6|||
105765149|NCT03039192|364791850|FG001|Overall Study|Withdrawal by Subject|9|||
105765150|NCT03039192|364791849|FG000|Overall Study|Discontinued from treatment phase|19|||
105765151|NCT03039192|364791850|FG001|Overall Study|Discontinued from treatment phase|12|||
105765152|NCT03039192|364791849|FG000|Overall Study|Other|3|||
105765153|NCT03039192|364791850|FG001|Overall Study|Other|2|||
105765154|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
105765155|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
105765156|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
105765157|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
105765158|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
105765159|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
105765160|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
105765161|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
105816997|NCT00485472|364990447|FG000|Overall Study|Protocol Violation|0|||
105816998|NCT00485472|364990448|FG001|Overall Study|Protocol Violation|1|||
105816999|NCT00485472|364990447|FG000|Overall Study|Other|2|||
105817000|NCT00485472|364990448|FG001|Overall Study|Other|1|||
105817001|NCT00485472|364990447|FG000|Overall Study|Lost to Follow-up|0|||
105817002|NCT00485472|364990448|FG001|Overall Study|Lost to Follow-up|1|||
105817003|NCT00746798|364990449|FG000|Overall Study|Protocol Violation|0|||
105817004|NCT00746798|364990450|FG001|Overall Study|Protocol Violation|1|||
105817005|NCT00746798|364990451|FG002|Overall Study|Protocol Violation|0|||
105817006|NCT00746798|364990452|FG003|Overall Study|Protocol Violation|0|||
105817007|NCT00746798|364990449|FG000|Overall Study|Withdrawal by Subject|0|||
105817008|NCT00746798|364990450|FG001|Overall Study|Withdrawal by Subject|1|||
105817009|NCT00746798|364990451|FG002|Overall Study|Withdrawal by Subject|1|||
105817010|NCT00746798|364990452|FG003|Overall Study|Withdrawal by Subject|0|||
105817011|NCT00746798|364990449|FG000|Overall Study|Death|0|||
105817012|NCT00746798|364990450|FG001|Overall Study|Death|0|||
105817013|NCT00746798|364990451|FG002|Overall Study|Death|2|||
105817014|NCT00746798|364990452|FG003|Overall Study|Death|0|||
105817015|NCT00746798|364990449|FG000|Overall Study|Participant unable to return for visit|1|||
105817016|NCT00746798|364990450|FG001|Overall Study|Participant unable to return for visit|0|||
105817017|NCT00746798|364990451|FG002|Overall Study|Participant unable to return for visit|0|||
105817018|NCT00746798|364990452|FG003|Overall Study|Participant unable to return for visit|0|||
105817019|NCT02262377|364990453|FG000|Overall Study|Lost to Follow-up|5|||
105817020|NCT02262377|364990454|FG001|Overall Study|Lost to Follow-up|6|||
105817021|NCT02262377|364990453|FG000|Overall Study|Found ineligible after enrollment|3|||
105817022|NCT02262377|364990454|FG001|Overall Study|Found ineligible after enrollment|0|||
105817023|NCT02262377|364990453|FG000|Overall Study|Withdrawal by Subject|4|||
105817024|NCT02262377|364990454|FG001|Overall Study|Withdrawal by Subject|0|||
105817025|NCT01900730|364990460|FG000|Overall Study|Withdrawal by Subject|1|||
105956327|NCT01947283|365502857|FG001|Overall Study|Lost to Follow-up|6|||
105817026|NCT01900730|364990461|FG001|Overall Study|Withdrawal by Subject|0|||
105817027|NCT01900730|364990460|FG000|Overall Study|Screen Failure|1|||
105817028|NCT01900730|364990461|FG001|Overall Study|Screen Failure|0|||
105817029|NCT01179048|364990462|FG000|Overall Study|Withdrawn - does not allow contact|4|||
105817030|NCT01179048|364990463|FG001|Overall Study|Withdrawn - does not allow contact|8|||
105817031|NCT01179048|364990462|FG000|Overall Study|Lost to Follow-up|8|||
105956328|NCT01947283|365502858|FG002|Overall Study|Lost to Follow-up|5|||
105956329|NCT01947283|365502859|FG003|Overall Study|Lost to Follow-up|5|||
105956330|NCT01947283|365502860|FG004|Overall Study|Lost to Follow-up|0|||
105956331|NCT01947283|365502861|FG005|Overall Study|Lost to Follow-up|2|||
105956332|NCT01947283|365502862|FG006|Overall Study|Lost to Follow-up|5|||
105956333|NCT01947283|365502856|FG000|Overall Study|Withdrawal by Subject|10|||
105956334|NCT01947283|365502857|FG001|Overall Study|Withdrawal by Subject|8|||
105956335|NCT01947283|365502858|FG002|Overall Study|Withdrawal by Subject|4|||
105956336|NCT01947283|365502859|FG003|Overall Study|Withdrawal by Subject|1|||
105956337|NCT01947283|365502860|FG004|Overall Study|Withdrawal by Subject|0|||
105956338|NCT01947283|365502861|FG005|Overall Study|Withdrawal by Subject|0|||
105956339|NCT01947283|365502862|FG006|Overall Study|Withdrawal by Subject|2|||
105956340|NCT01947283|365502856|FG000|Overall Study|No Clinical Recording|12|||
105956341|NCT01947283|365502857|FG001|Overall Study|No Clinical Recording|6|||
105956342|NCT01947283|365502858|FG002|Overall Study|No Clinical Recording|8|||
105956343|NCT01947283|365502859|FG003|Overall Study|No Clinical Recording|10|||
105956344|NCT01947283|365502860|FG004|Overall Study|No Clinical Recording|0|||
105956345|NCT01947283|365502861|FG005|Overall Study|No Clinical Recording|0|||
105956346|NCT01947283|365502862|FG006|Overall Study|No Clinical Recording|0|||
105956347|NCT01947283|365502856|FG000|Overall Study|Non-coding Clinical Recording language|0|||
105956348|NCT01947283|365502857|FG001|Overall Study|Non-coding Clinical Recording language|0|||
105956349|NCT01947283|365502858|FG002|Overall Study|Non-coding Clinical Recording language|0|||
105956350|NCT01947283|365502859|FG003|Overall Study|Non-coding Clinical Recording language|1|||
105956351|NCT01947283|365502860|FG004|Overall Study|Non-coding Clinical Recording language|0|||
105956352|NCT01947283|365502861|FG005|Overall Study|Non-coding Clinical Recording language|0|||
105956353|NCT01947283|365502862|FG006|Overall Study|Non-coding Clinical Recording language|0|||
105956354|NCT01947283|365502856|FG000|Overall Study|Missing Follow-up Assessment|2|||
105956355|NCT01947283|365502857|FG001|Overall Study|Missing Follow-up Assessment|2|||
105956356|NCT01947283|365502858|FG002|Overall Study|Missing Follow-up Assessment|3|||
105956357|NCT01947283|365502859|FG003|Overall Study|Missing Follow-up Assessment|0|||
105956358|NCT01947283|365502860|FG004|Overall Study|Missing Follow-up Assessment|0|||
105956359|NCT01947283|365502861|FG005|Overall Study|Missing Follow-up Assessment|2|||
105956360|NCT01947283|365502862|FG006|Overall Study|Missing Follow-up Assessment|0|||
105956361|NCT01947283|365502856|FG000|Overall Study|No patients were enrolled in study|0|||
105956362|NCT01947283|365502857|FG001|Overall Study|No patients were enrolled in study|0|||
105956363|NCT01947283|365502858|FG002|Overall Study|No patients were enrolled in study|0|||
105956364|NCT01947283|365502859|FG003|Overall Study|No patients were enrolled in study|0|||
105956365|NCT01947283|365502860|FG004|Overall Study|No patients were enrolled in study|0|||
105956366|NCT01947283|365502861|FG005|Overall Study|No patients were enrolled in study|3|||
106145381|NCT02674750|366191954|FG002|Overall Study|Other|0|||
105817032|NCT01179048|364990463|FG001|Overall Study|Lost to Follow-up|9|||
105817033|NCT01179048|364990462|FG000|Overall Study|Alive|127|||
105817034|NCT01179048|364990463|FG001|Overall Study|Alive|142|||
105817035|NCT03203447|364990468|FG000|Overall Study|Withdrawal by Subject|2|||
105817036|NCT03203447|364990469|FG001|Overall Study|Withdrawal by Subject|1|||
105817037|NCT03203447|364990468|FG000|Overall Study|Lost to Follow-up|1|||
105817038|NCT03203447|364990469|FG001|Overall Study|Lost to Follow-up|10|||
105817039|NCT03203447|364990468|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
105817040|NCT03203447|364990469|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
105817041|NCT00324168|364990470|FG000|Overall Study|Lost to Follow-up|19|||
105817042|NCT00324168|364990471|FG001|Overall Study|Lost to Follow-up|18|||
105817043|NCT00324168|364990470|FG000|Overall Study|Death|3|||
105817044|NCT00324168|364990471|FG001|Overall Study|Death|3|||
106018458|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
106018459|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
106018460|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
106018461|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
106018462|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
106018463|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
106018464|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
106018465|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
106018466|NCT01106690|365730680|FG000|Core Period: Baseline to Week 26|Other|10|||
106018467|NCT01106690|365730681|FG001|Core Period: Baseline to Week 26|Other|2|||
106018468|NCT01106690|365730682|FG002|Core Period: Baseline to Week 26|Other|6|||
106018469|NCT01106690|365730680|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
106018470|NCT01106690|365730681|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
106018471|NCT01106690|365730682|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
106018472|NCT01106690|365730680|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
106018473|NCT01106690|365730681|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
106018474|NCT01106690|365730682|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
106018475|NCT01106690|365730680|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
106018476|NCT01106690|365730681|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
106018477|NCT01106690|365730682|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
106018478|NCT01106690|365730680|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
106018479|NCT01106690|365730681|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
106018480|NCT01106690|365730682|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
106018481|NCT01106690|365730680|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
106018482|NCT01106690|365730681|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
106018483|NCT01106690|365730682|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
106018484|NCT01106690|365730680|FG000|Extension Period: Week 26 to Week 52|Other|8|||
106018485|NCT01106690|365730681|FG001|Extension Period: Week 26 to Week 52|Other|3|||
106018486|NCT01106690|365730682|FG002|Extension Period: Week 26 to Week 52|Other|4|||
106018487|NCT01106690|365730680|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
106018488|NCT01106690|365730681|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
106018489|NCT01106690|365730682|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
106018490|NCT02578706|365730683|FG000|Overall Study|Withdrawal by Subject|1|||
106018491|NCT02578706|365730684|FG001|Overall Study|Withdrawal by Subject|0|||
106018492|NCT02578706|365730685|FG002|Overall Study|Withdrawal by Subject|0|||
106018493|NCT02578706|365730683|FG000|Overall Study|Lost to Follow-up|0|||
106018494|NCT02578706|365730684|FG001|Overall Study|Lost to Follow-up|4|||
106018495|NCT02578706|365730685|FG002|Overall Study|Lost to Follow-up|0|||
106018496|NCT02578706|365730683|FG000|Overall Study|Physician Decision|0|||
106018497|NCT02578706|365730684|FG001|Overall Study|Physician Decision|1|||
106018498|NCT02578706|365730685|FG002|Overall Study|Physician Decision|0|||
106018499|NCT02015637|365730688|FG000|Overall Study|Lost to Follow-up|3|||
106018500|NCT02015637|365730689|FG001|Overall Study|Lost to Follow-up|5|||
106018501|NCT02015637|365730688|FG000|Overall Study|Adverse Event|3|||
106018502|NCT02015637|365730689|FG001|Overall Study|Adverse Event|0|||
106018503|NCT02015637|365730688|FG000|Overall Study|Did not take study drug|2|||
106018504|NCT02015637|365730689|FG001|Overall Study|Did not take study drug|0|||
106018505|NCT02106390|365730692|FG000|Overall Study|Withdrawal by Subject|15|||
105817045|NCT00324168|364990470|FG000|Overall Study|Patient did not visit in f/u window|6|||
106018506|NCT02106390|365730693|FG001|Overall Study|Withdrawal by Subject|16|||
106018507|NCT02106390|365730694|FG002|Overall Study|Withdrawal by Subject|15|||
105817046|NCT00324168|364990471|FG001|Overall Study|Patient did not visit in f/u window|9|||
105817047|NCT01591785|364990475|FG000|Overall Study|worsening condition|1|||
105817048|NCT01591785|364990476|FG001|Overall Study|worsening condition|2|||
105817049|NCT01591785|364990475|FG000|Overall Study|Protocol Violation|2|||
105817050|NCT01591785|364990476|FG001|Overall Study|Protocol Violation|0|||
105817051|NCT01591785|364990475|FG000|Overall Study|Lost to Follow-up|1|||
105817052|NCT01591785|364990476|FG001|Overall Study|Lost to Follow-up|0|||
105817053|NCT00358449|364990477|FG000|Overall Study|Adverse Event|1|||
105817054|NCT00358449|364990478|FG001|Overall Study|Adverse Event|0|||
105817055|NCT00358449|364990479|FG002|Overall Study|Adverse Event|1|||
105817056|NCT00358449|364990477|FG000|Overall Study|Lost to Follow-up|1|||
105817057|NCT00358449|364990478|FG001|Overall Study|Lost to Follow-up|0|||
105817058|NCT00358449|364990479|FG002|Overall Study|Lost to Follow-up|0|||
105817059|NCT00358449|364990477|FG000|Overall Study|Withdrawal by Subject|2|||
105817060|NCT00358449|364990478|FG001|Overall Study|Withdrawal by Subject|0|||
105817061|NCT00358449|364990479|FG002|Overall Study|Withdrawal by Subject|0|||
105817062|NCT00358449|364990477|FG000|Overall Study|Lack of Efficacy|0|||
105817063|NCT00358449|364990478|FG001|Overall Study|Lack of Efficacy|1|||
105817064|NCT00358449|364990479|FG002|Overall Study|Lack of Efficacy|0|||
105817065|NCT00358449|364990477|FG000|Overall Study|Steriod Inhaler was Increased|0|||
105817066|NCT00358449|364990478|FG001|Overall Study|Steriod Inhaler was Increased|0|||
105817067|NCT00358449|364990479|FG002|Overall Study|Steriod Inhaler was Increased|1|||
105817068|NCT00496964|364990483|FG000|Overall Study|Withdrawal by Subject|0|||
105817069|NCT00496964|364990484|FG001|Overall Study|Withdrawal by Subject|1|||
105817070|NCT05327491|364990485|FG000|Periods 1 & 2|Miscellaneous|0|||
105817071|NCT05327491|364990486|FG001|Periods 1 & 2|Miscellaneous|1|||
105817072|NCT05327491|364990487|FG002|Periods 1 & 2|Miscellaneous|0|||
105817073|NCT05327491|364990488|FG003|Periods 1 & 2|Miscellaneous|0|||
105817074|NCT05327491|364990485|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
105817075|NCT05327491|364990486|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
105817076|NCT05327491|364990487|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
105817077|NCT05327491|364990488|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
105817078|NCT02334722|364990489|FG000|Overall Study|Lost to Follow-up|4|||
105817079|NCT02334722|364990490|FG001|Overall Study|Lost to Follow-up|0|||
105817080|NCT02334722|364990489|FG000|Overall Study|6 week questionnaire not completed|2|||
105817081|NCT02334722|364990490|FG001|Overall Study|6 week questionnaire not completed|0|||
105817082|NCT02334722|364990489|FG000|Overall Study|Unable to obtain medication|1|||
105817083|NCT02334722|364990490|FG001|Overall Study|Unable to obtain medication|1|||
105817084|NCT02334722|364990489|FG000|Overall Study|Withdrawal by Subject|0|||
105817085|NCT02334722|364990490|FG001|Overall Study|Withdrawal by Subject|3|||
105817086|NCT02334722|364990489|FG000|Overall Study|Adverse Event|0|||
105817087|NCT02334722|364990490|FG001|Overall Study|Adverse Event|2|||
105817088|NCT02334722|364990489|FG000|Overall Study|Physician Decision|0|||
105817089|NCT02334722|364990490|FG001|Overall Study|Physician Decision|1|||
105817090|NCT04088760|364990491|FG000|Overall Study|Physician Decision|1|||
105817091|NCT01391793|364990494|FG000|Overall Study|Ineligible|3|||
105817092|NCT01391793|364990495|FG001|Overall Study|Ineligible|0|||
105817093|NCT01391793|364990494|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
105817094|NCT01391793|364990495|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
105817095|NCT01391793|364990494|FG000|Overall Study|No DMSA|73|||
105817096|NCT01391793|364990495|FG001|Overall Study|No DMSA|57|||
105817097|NCT00436553|364990496|FG000|Overall Study|Adverse Event|4|||
105817098|NCT00436553|364990497|FG001|Overall Study|Adverse Event|3|||
105817099|NCT00436553|364990498|FG002|Overall Study|Adverse Event|4|||
105817100|NCT00436553|364990496|FG000|Overall Study|Death|3|||
105817101|NCT00436553|364990497|FG001|Overall Study|Death|1|||
105817102|NCT00436553|364990498|FG002|Overall Study|Death|3|||
105817103|NCT00436553|364990496|FG000|Overall Study|Lost to Follow-up|0|||
105817104|NCT00436553|364990497|FG001|Overall Study|Lost to Follow-up|2|||
105817105|NCT00436553|364990498|FG002|Overall Study|Lost to Follow-up|0|||
106018508|NCT02106390|365730692|FG000|Overall Study|Lost to Follow-up|25|||
106018509|NCT02106390|365730693|FG001|Overall Study|Lost to Follow-up|20|||
106018510|NCT02106390|365730694|FG002|Overall Study|Lost to Follow-up|13|||
106018511|NCT02106390|365730692|FG000|Overall Study|Other: Administrative Reason|8|||
106018512|NCT02106390|365730693|FG001|Overall Study|Other: Administrative Reason|5|||
106018513|NCT02106390|365730694|FG002|Overall Study|Other: Administrative Reason|12|||
106018514|NCT02106390|365730692|FG000|Overall Study|Other: Unspecified|1|||
106018515|NCT02106390|365730693|FG001|Overall Study|Other: Unspecified|4|||
106018516|NCT02106390|365730694|FG002|Overall Study|Other: Unspecified|2|||
106018517|NCT02106390|365730692|FG000|Overall Study|Adverse Event|0|||
106018518|NCT02106390|365730693|FG001|Overall Study|Adverse Event|2|||
106018519|NCT02106390|365730694|FG002|Overall Study|Adverse Event|1|||
106018520|NCT02106390|365730692|FG000|Overall Study|Protocol Violation|0|||
106018521|NCT02106390|365730693|FG001|Overall Study|Protocol Violation|1|||
106145382|NCT00688519|366191959|FG000|Overall Study|Adverse Event|2|||
105817106|NCT00436553|364990496|FG000|Overall Study|Protocol Violation|1|||
105817107|NCT00436553|364990497|FG001|Overall Study|Protocol Violation|0|||
105817108|NCT00436553|364990498|FG002|Overall Study|Protocol Violation|0|||
105817109|NCT00436553|364990496|FG000|Overall Study|Withdrawal by Subject|5|||
105817110|NCT00436553|364990497|FG001|Overall Study|Withdrawal by Subject|6|||
105817111|NCT00436553|364990498|FG002|Overall Study|Withdrawal by Subject|3|||
105817112|NCT00064753|364990499|FG000|Overall Study|Death|251|||
106018522|NCT02106390|365730694|FG002|Overall Study|Protocol Violation|0|||
106018523|NCT01532986|365730695|FG000|Overall Study|Death|9|||
106018524|NCT01532986|365730696|FG001|Overall Study|Death|9|||
105817113|NCT00064753|364990500|FG001|Overall Study|Death|242|||
105817114|NCT00064753|364990499|FG000|Overall Study|Withdrawal by Subject|198|||
105817115|NCT00064753|364990500|FG001|Overall Study|Withdrawal by Subject|171|||
105817116|NCT00064753|364990499|FG000|Overall Study|Lost to Follow-up|225|||
105817117|NCT00064753|364990500|FG001|Overall Study|Lost to Follow-up|235|||
105817118|NCT00533273|364990510|FG000|Double-blind|Withdrew consent|0|||
105817119|NCT00533273|364990511|FG001|Double-blind|Withdrew consent|2|||
105817120|NCT00533273|364990510|FG000|Open-label|Withdrawal by Subject|6|||
105817121|NCT00533273|364990511|FG001|Open-label|Withdrawal by Subject|0|||
105817122|NCT00669942|364990513|FG000|Parts 2 and 3|Adverse Event|0|||
105817123|NCT00669942|364990514|FG001|Parts 2 and 3|Adverse Event|0|||
105817124|NCT00669942|364990515|FG002|Parts 2 and 3|Adverse Event|0|||
105817125|NCT00669942|364990516|FG003|Parts 2 and 3|Adverse Event|0|||
105817126|NCT00669942|364990517|FG004|Parts 2 and 3|Adverse Event|0|||
105817127|NCT00669942|364990518|FG005|Parts 2 and 3|Adverse Event|0|||
105817128|NCT00669942|364990519|FG006|Parts 2 and 3|Adverse Event|0|||
105817129|NCT00669942|364990520|FG007|Parts 2 and 3|Adverse Event|2|||
105817130|NCT00669942|364990521|FG008|Parts 2 and 3|Adverse Event|1|||
105817131|NCT00669942|364990522|FG009|Parts 2 and 3|Adverse Event|0|||
105817132|NCT00669942|364990523|FG010|Parts 2 and 3|Adverse Event|0|||
105817133|NCT00669942|364990524|FG011|Parts 2 and 3|Adverse Event|0|||
105817134|NCT00669942|364990513|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
105817135|NCT00669942|364990514|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
105817136|NCT00669942|364990515|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
105817137|NCT00669942|364990516|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
105817138|NCT00669942|364990517|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
105817139|NCT00669942|364990518|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
105817140|NCT00669942|364990519|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
105817141|NCT00669942|364990520|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
105817142|NCT00669942|364990521|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
105817143|NCT00669942|364990522|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
105817144|NCT00669942|364990523|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
105817145|NCT00669942|364990524|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
105817146|NCT00669942|364990513|FG000|Parts 2 and 3|Protocol Violation|0|||
105817147|NCT00669942|364990514|FG001|Parts 2 and 3|Protocol Violation|0|||
105817148|NCT00669942|364990515|FG002|Parts 2 and 3|Protocol Violation|0|||
105817149|NCT00669942|364990516|FG003|Parts 2 and 3|Protocol Violation|0|||
105817150|NCT00669942|364990517|FG004|Parts 2 and 3|Protocol Violation|0|||
105817151|NCT00669942|364990518|FG005|Parts 2 and 3|Protocol Violation|1|||
105817152|NCT00669942|364990519|FG006|Parts 2 and 3|Protocol Violation|0|||
105817153|NCT00669942|364990520|FG007|Parts 2 and 3|Protocol Violation|0|||
105817154|NCT00669942|364990521|FG008|Parts 2 and 3|Protocol Violation|0|||
105817155|NCT00669942|364990522|FG009|Parts 2 and 3|Protocol Violation|0|||
105817156|NCT00669942|364990523|FG010|Parts 2 and 3|Protocol Violation|0|||
105817157|NCT00669942|364990524|FG011|Parts 2 and 3|Protocol Violation|0|||
105817158|NCT04213326|364990530|FG000|Overall Study|Consent withdrawn|51|||
105817159|NCT04213326|364990531|FG001|Overall Study|Consent withdrawn|241|||
105817160|NCT04213326|364990530|FG000|Overall Study|Lost to Follow-up|50|||
105817161|NCT04213326|364990531|FG001|Overall Study|Lost to Follow-up|902|||
105817162|NCT04213326|364990530|FG000|Overall Study|Protocol Violation|3|||
105817163|NCT04213326|364990531|FG001|Overall Study|Protocol Violation|25|||
105817164|NCT04213326|364990530|FG000|Overall Study|Participant eligibility changed|106|||
105817165|NCT04213326|364990531|FG001|Overall Study|Participant eligibility changed|19|||
105817166|NCT04213326|364990530|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
105817167|NCT04213326|364990531|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
105817168|NCT04213326|364990530|FG000|Overall Study|Incomplete study visit|0|||
105817169|NCT04213326|364990531|FG001|Overall Study|Incomplete study visit|367|||
105817170|NCT02865850|364990536|FG000|Overall Study|Death|15|||
105956367|NCT01947283|365502862|FG006|Overall Study|No patients were enrolled in study|1|||
105956368|NCT00564733|365502863|FG000|Overall Study|Withdrawal by Subject|4|||
105817171|NCT02865850|364990537|FG001|Overall Study|Death|19|||
105817172|NCT02865850|364990536|FG000|Overall Study|Withdrawal by Subject|3|||
105817173|NCT02865850|364990537|FG001|Overall Study|Withdrawal by Subject|2|||
105817174|NCT02865850|364990536|FG000|Overall Study|Lost to Follow-up|3|||
105817175|NCT02865850|364990537|FG001|Overall Study|Lost to Follow-up|2|||
105817176|NCT02726581|364990538|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
105817177|NCT02726581|364990539|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
105817178|NCT02726581|364990540|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
105817179|NCT02726581|364990538|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
105817180|NCT02726581|364990539|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
105817181|NCT02726581|364990540|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
105817182|NCT02726581|364990538|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105817183|NCT02726581|364990539|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105817184|NCT02726581|364990540|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105817185|NCT02726581|364990538|FG000|Treatment Period|Disease progression|47|||
105817186|NCT02726581|364990539|FG001|Treatment Period|Disease progression|50|||
105817187|NCT02726581|364990540|FG002|Treatment Period|Disease progression|16|||
105817188|NCT02726581|364990538|FG000|Treatment Period|Other reasons|9|||
105817189|NCT02726581|364990539|FG001|Treatment Period|Other reasons|8|||
105817190|NCT02726581|364990540|FG002|Treatment Period|Other reasons|2|||
105817191|NCT02726581|364990538|FG000|Treatment Period|Study drug toxicity|6|||
105817192|NCT02726581|364990539|FG001|Treatment Period|Study drug toxicity|3|||
105817193|NCT02726581|364990540|FG002|Treatment Period|Study drug toxicity|2|||
105817194|NCT02726581|364990538|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
105817195|NCT02726581|364990539|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
105817196|NCT02726581|364990540|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
105817197|NCT02726581|364990538|FG000|Treatment Period|Participant withdrew consent|3|||
105817198|NCT02726581|364990539|FG001|Treatment Period|Participant withdrew consent|1|||
105817199|NCT02726581|364990540|FG002|Treatment Period|Participant withdrew consent|1|||
105817200|NCT02726581|364990538|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
105817201|NCT02726581|364990539|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
105817202|NCT02726581|364990540|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
105817203|NCT02726581|364990538|FG000|Treatment Period|Maximum clinical benefit|0|||
105817204|NCT02726581|364990539|FG001|Treatment Period|Maximum clinical benefit|2|||
105817205|NCT02726581|364990540|FG002|Treatment Period|Maximum clinical benefit|0|||
105817206|NCT02726581|364990538|FG000|Treatment Period|Death|1|||
105817207|NCT02726581|364990539|FG001|Treatment Period|Death|0|||
105817208|NCT02726581|364990540|FG002|Treatment Period|Death|0|||
105817209|NCT02726581|364990538|FG000|Treatment Period|Poor/non-compliance|1|||
105817210|NCT02726581|364990539|FG001|Treatment Period|Poor/non-compliance|0|||
105817211|NCT02726581|364990540|FG002|Treatment Period|Poor/non-compliance|0|||
105817212|NCT02726581|364990538|FG000|Treatment Period|Participant no longer meets study criteria|0|||
105817213|NCT02726581|364990539|FG001|Treatment Period|Participant no longer meets study criteria|1|||
105817214|NCT02726581|364990540|FG002|Treatment Period|Participant no longer meets study criteria|0|||
105817215|NCT01772537|364990545|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
105817216|NCT01772537|364990546|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
105817217|NCT01772537|364990547|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
105817218|NCT03195491|364990548|FG000|Overall Study|Study drug toxicity|25|||
105817219|NCT03195491|364990549|FG001|Overall Study|Study drug toxicity|3|||
105817220|NCT03195491|364990548|FG000|Overall Study|Maximum clinical benefit|5|||
105817221|NCT03195491|364990549|FG001|Overall Study|Maximum clinical benefit|0|||
105817222|NCT03195491|364990548|FG000|Overall Study|Lost to Follow-up|1|||
105817223|NCT03195491|364990549|FG001|Overall Study|Lost to Follow-up|0|||
105817224|NCT03195491|364990548|FG000|Overall Study|Death|3|||
105817225|NCT03195491|364990549|FG001|Overall Study|Death|0|||
105817226|NCT03195491|364990548|FG000|Overall Study|Adverse event unrelated to study drug|19|||
105817227|NCT03195491|364990549|FG001|Overall Study|Adverse event unrelated to study drug|2|||
105817228|NCT03195491|364990548|FG000|Overall Study|Disease progression|266|||
105817229|NCT03195491|364990549|FG001|Overall Study|Disease progression|8|||
105817230|NCT03195491|364990548|FG000|Overall Study|Other reasons|10|||
105817231|NCT03195491|364990549|FG001|Overall Study|Other reasons|0|||
105817232|NCT03195491|364990548|FG000|Overall Study|Participant withdrew consent|8|||
105817233|NCT03195491|364990549|FG001|Overall Study|Participant withdrew consent|1|||
105817234|NCT03195491|364990548|FG000|Overall Study|Participant no longer meets study criteria|0|||
105817235|NCT03195491|364990549|FG001|Overall Study|Participant no longer meets study criteria|1|||
105817236|NCT03195491|364990548|FG000|Overall Study|Participant request to discontinue study treatment|10|||
105817237|NCT03195491|364990549|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105817238|NCT01263704|364990550|FG000|Overall Study|Progressive disease|18|||
105817239|NCT01263704|364990550|FG000|Overall Study|Adverse Event|3|||
105817240|NCT01263704|364990550|FG000|Overall Study|Death|2|||
105817241|NCT01263704|364990550|FG000|Overall Study|Patient withdrew consent|2|||
105817242|NCT01263704|364990550|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
105817243|NCT01263704|364990550|FG000|Overall Study|Lost to Follow-up|1|||
105817244|NCT01263704|364990550|FG000|Overall Study|Colon metastases|1|||
105817245|NCT01263704|364990550|FG000|Overall Study|Principal Investigator (PI) decision|1|||
105817246|NCT00112463|364990567|FG000|Overall Study|Physician Decision|1|||
105817247|NCT00112463|364990567|FG000|Overall Study|Progression|30|||
105817248|NCT00112463|364990567|FG000|Overall Study|Second Primary|1|||
105817249|NCT00112463|364990567|FG000|Overall Study|Toxicity|3|||
105817250|NCT00112463|364990567|FG000|Overall Study|Withdrawal by Subject|2|||
105817251|NCT00112463|364990567|FG000|Overall Study|Never started treatment|2|||
105817252|NCT01185821|364990577|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105817253|NCT01185821|364990578|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105817254|NCT01185821|364990579|FG002|Overall Study|Abnormal laboratory value(s)|1|||
105817255|NCT01185821|364990580|FG003|Overall Study|Abnormal laboratory value(s)|0|||
105817256|NCT01185821|364990581|FG004|Overall Study|Abnormal laboratory value(s)|0|||
105817257|NCT01185821|364990577|FG000|Overall Study|Protocol Violation|0|||
105817258|NCT01185821|364990578|FG001|Overall Study|Protocol Violation|0|||
105817259|NCT01185821|364990579|FG002|Overall Study|Protocol Violation|0|||
105817260|NCT01185821|364990580|FG003|Overall Study|Protocol Violation|1|||
105817261|NCT01185821|364990581|FG004|Overall Study|Protocol Violation|1|||
105817262|NCT01185821|364990577|FG000|Overall Study|Abnormal test procedure result|0|||
105817263|NCT01185821|364990578|FG001|Overall Study|Abnormal test procedure result|0|||
105817264|NCT01185821|364990579|FG002|Overall Study|Abnormal test procedure result|0|||
105817265|NCT01185821|364990580|FG003|Overall Study|Abnormal test procedure result|0|||
105817266|NCT01185821|364990581|FG004|Overall Study|Abnormal test procedure result|1|||
105817267|NCT01185821|364990577|FG000|Overall Study|Death|0|||
105817268|NCT01185821|364990578|FG001|Overall Study|Death|1|||
105817269|NCT01185821|364990579|FG002|Overall Study|Death|0|||
105817270|NCT01185821|364990580|FG003|Overall Study|Death|0|||
105817271|NCT01185821|364990581|FG004|Overall Study|Death|0|||
105817272|NCT01185821|364990577|FG000|Overall Study|Condition no longer required study drug|0|||
105817273|NCT01185821|364990578|FG001|Overall Study|Condition no longer required study drug|0|||
105817274|NCT01185821|364990579|FG002|Overall Study|Condition no longer required study drug|0|||
105817275|NCT01185821|364990580|FG003|Overall Study|Condition no longer required study drug|0|||
105817276|NCT01185821|364990581|FG004|Overall Study|Condition no longer required study drug|1|||
105817277|NCT01185821|364990577|FG000|Overall Study|Adverse Event|2|||
105817278|NCT01185821|364990578|FG001|Overall Study|Adverse Event|3|||
105817279|NCT01185821|364990579|FG002|Overall Study|Adverse Event|1|||
105956369|NCT00564733|365502863|FG000|Overall Study|Ineligible|5|||
105956370|NCT02010593|365502868|FG000|Overall Study|Lost to Follow-up|1|||
105956371|NCT02010593|365502869|FG001|Overall Study|Lost to Follow-up|0|||
105956372|NCT02010593|365502868|FG000|Overall Study|Physician Decision|1|||
105956373|NCT02010593|365502869|FG001|Overall Study|Physician Decision|0|||
105956374|NCT02010593|365502868|FG000|Overall Study|Unable to adhere to visit schedule|0|||
105956375|NCT02010593|365502869|FG001|Overall Study|Unable to adhere to visit schedule|2|||
105956376|NCT01135459|365502870|FG000|Overall Study|Adverse Event|8|||
105956377|NCT01135459|365502871|FG001|Overall Study|Adverse Event|10|||
105956378|NCT01135459|365502870|FG000|Overall Study|Lack of Efficacy|3|||
105956379|NCT01135459|365502871|FG001|Overall Study|Lack of Efficacy|1|||
105956380|NCT01135459|365502870|FG000|Overall Study|Withdrawal by Subject|2|||
106145383|NCT00688519|366191960|FG001|Overall Study|Adverse Event|3|||
106145384|NCT00688519|366191959|FG000|Overall Study|Lost to Follow-up|3|||
105765162|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
105765163|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
105765164|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
105765165|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
105765166|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
105765167|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Death|0|||
105765168|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Death|0|||
105765169|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Death|1|||
105765170|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Death|0|||
105765171|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Death|0|||
105765172|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Death|0|||
105765173|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Death|0|||
105765174|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Death|0|||
105765175|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Death|0|||
105765176|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Death|0|||
105765177|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Death|0|||
105765178|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Death|0|||
105765179|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Death|0|||
105765180|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
105765181|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
105765182|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
105765183|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765184|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765185|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765186|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765187|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765188|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765189|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765190|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765191|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765192|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
105765193|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765194|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105817280|NCT01185821|364990580|FG003|Overall Study|Adverse Event|2|||
106145385|NCT00688519|366191960|FG001|Overall Study|Lost to Follow-up|3|||
106145386|NCT00688519|366191959|FG000|Overall Study|Lack of Efficacy|3|||
105817281|NCT01185821|364990581|FG004|Overall Study|Adverse Event|5|||
105817282|NCT01185821|364990577|FG000|Overall Study|Lack of Efficacy|0|||
105765195|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
105765196|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765197|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765198|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765199|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765200|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765201|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765202|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765203|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765204|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765205|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
105765206|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
105765207|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
105765208|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
105765209|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
105765210|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
105765211|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
105765212|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
105765213|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
105765214|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
105765215|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
105765216|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
105765217|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
105765218|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
105765219|NCT02407236|364791851|FG000|Induction Study (8 Weeks)|Other|2|||
105765220|NCT02407236|364791852|FG001|Induction Study (8 Weeks)|Other|1|||
105765221|NCT02407236|364791853|FG002|Induction Study (8 Weeks)|Other|5|||
105765222|NCT02407236|364791854|FG003|Induction Study (8 Weeks)|Other|0|||
105765223|NCT02407236|364791855|FG004|Induction Study (8 Weeks)|Other|0|||
105765224|NCT02407236|364791856|FG005|Induction Study (8 Weeks)|Other|0|||
105765225|NCT02407236|364791857|FG006|Induction Study (8 Weeks)|Other|0|||
105765226|NCT02407236|364791858|FG007|Induction Study (8 Weeks)|Other|0|||
105765227|NCT02407236|364791859|FG008|Induction Study (8 Weeks)|Other|0|||
105765228|NCT02407236|364791860|FG009|Induction Study (8 Weeks)|Other|0|||
105765229|NCT02407236|364791861|FG010|Induction Study (8 Weeks)|Other|0|||
105765230|NCT02407236|364791862|FG011|Induction Study (8 Weeks)|Other|0|||
105765231|NCT02407236|364791863|FG012|Induction Study (8 Weeks)|Other|0|||
105765232|NCT02407236|364791851|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765233|NCT02407236|364791852|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765234|NCT02407236|364791853|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765235|NCT02407236|364791854|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
105765236|NCT02407236|364791855|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
105765237|NCT02407236|364791856|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
105765238|NCT02407236|364791857|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
105765239|NCT02407236|364791858|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
105765240|NCT02407236|364791859|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765241|NCT02407236|364791860|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765242|NCT02407236|364791861|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765243|NCT02407236|364791862|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765244|NCT02407236|364791863|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
105765245|NCT02407236|364791851|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765246|NCT02407236|364791852|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765247|NCT02407236|364791853|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765248|NCT02407236|364791854|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
105765249|NCT02407236|364791855|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
105765250|NCT02407236|364791856|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
105765251|NCT02407236|364791857|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
105765252|NCT02407236|364791858|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
105765253|NCT02407236|364791859|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765254|NCT02407236|364791860|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765255|NCT02407236|364791861|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765256|NCT02407236|364791862|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765257|NCT02407236|364791863|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
105765258|NCT02407236|364791851|FG000|Maintenance Study (44 Weeks)|Other|0|||
105765259|NCT02407236|364791852|FG001|Maintenance Study (44 Weeks)|Other|0|||
105765260|NCT02407236|364791853|FG002|Maintenance Study (44 Weeks)|Other|0|||
105765261|NCT02407236|364791854|FG003|Maintenance Study (44 Weeks)|Other|5|||
105765262|NCT02407236|364791855|FG004|Maintenance Study (44 Weeks)|Other|7|||
105765263|NCT02407236|364791856|FG005|Maintenance Study (44 Weeks)|Other|8|||
105765264|NCT02407236|364791857|FG006|Maintenance Study (44 Weeks)|Other|4|||
105765265|NCT02407236|364791858|FG007|Maintenance Study (44 Weeks)|Other|6|||
105765266|NCT02407236|364791859|FG008|Maintenance Study (44 Weeks)|Other|0|||
105765267|NCT02407236|364791860|FG009|Maintenance Study (44 Weeks)|Other|0|||
105765268|NCT02407236|364791861|FG010|Maintenance Study (44 Weeks)|Other|0|||
105765269|NCT02407236|364791862|FG011|Maintenance Study (44 Weeks)|Other|0|||
105765270|NCT02407236|364791863|FG012|Maintenance Study (44 Weeks)|Other|0|||
105765271|NCT02407236|364791851|FG000|Maintenance Study (44 Weeks)|Death|0|||
105765272|NCT02407236|364791852|FG001|Maintenance Study (44 Weeks)|Death|0|||
105765273|NCT02407236|364791853|FG002|Maintenance Study (44 Weeks)|Death|0|||
105765274|NCT02407236|364791854|FG003|Maintenance Study (44 Weeks)|Death|0|||
105765275|NCT02407236|364791855|FG004|Maintenance Study (44 Weeks)|Death|0|||
105765276|NCT02407236|364791856|FG005|Maintenance Study (44 Weeks)|Death|0|||
105765277|NCT02407236|364791857|FG006|Maintenance Study (44 Weeks)|Death|0|||
105765278|NCT02407236|364791858|FG007|Maintenance Study (44 Weeks)|Death|1|||
105765279|NCT02407236|364791859|FG008|Maintenance Study (44 Weeks)|Death|0|||
105765280|NCT02407236|364791860|FG009|Maintenance Study (44 Weeks)|Death|0|||
105765281|NCT02407236|364791861|FG010|Maintenance Study (44 Weeks)|Death|0|||
105765282|NCT02407236|364791862|FG011|Maintenance Study (44 Weeks)|Death|0|||
105765283|NCT02407236|364791863|FG012|Maintenance Study (44 Weeks)|Death|0|||
105765284|NCT02407236|364791851|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765285|NCT02407236|364791852|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765286|NCT02407236|364791853|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765287|NCT02407236|364791854|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765288|NCT02407236|364791855|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765289|NCT02407236|364791856|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765290|NCT02407236|364791857|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765291|NCT02407236|364791858|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
105765292|NCT02407236|364791859|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
105765293|NCT02407236|364791860|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
105765294|NCT02407236|364791861|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
105765295|NCT02407236|364791862|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
105765296|NCT02407236|364791863|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
105765297|NCT02407236|364791851|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765298|NCT02407236|364791852|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765299|NCT02407236|364791853|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765300|NCT02407236|364791854|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765301|NCT02407236|364791855|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765302|NCT02407236|364791856|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765303|NCT02407236|364791857|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765304|NCT02407236|364791858|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765305|NCT02407236|364791859|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765306|NCT02407236|364791860|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765307|NCT02407236|364791861|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
105765308|NCT02407236|364791862|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765309|NCT02407236|364791863|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
105765310|NCT02407236|364791851|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765311|NCT02407236|364791852|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765312|NCT02407236|364791853|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765313|NCT02407236|364791854|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765314|NCT02407236|364791855|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765315|NCT02407236|364791856|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765316|NCT02407236|364791857|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765317|NCT02407236|364791858|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
105765318|NCT02407236|364791859|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
105765319|NCT02407236|364791860|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
105765320|NCT02407236|364791861|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
105765321|NCT02407236|364791862|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
105765322|NCT02407236|364791863|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
105765323|NCT02407236|364791851|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
105765324|NCT02407236|364791852|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
105765325|NCT02407236|364791853|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
105765326|NCT02407236|364791854|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
105765327|NCT02407236|364791855|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
105765328|NCT02407236|364791856|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
105765329|NCT02407236|364791857|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
105765330|NCT02407236|364791858|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
105765331|NCT02407236|364791859|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
105765332|NCT02407236|364791860|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
105765333|NCT02407236|364791861|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
105765334|NCT02407236|364791862|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
105817283|NCT01185821|364990578|FG001|Overall Study|Lack of Efficacy|0|||
105817284|NCT01185821|364990579|FG002|Overall Study|Lack of Efficacy|3|||
105817285|NCT01185821|364990580|FG003|Overall Study|Lack of Efficacy|0|||
105817286|NCT01185821|364990581|FG004|Overall Study|Lack of Efficacy|9|||
105817287|NCT01185821|364990577|FG000|Overall Study|Withdrawal by Subject|3|||
105817288|NCT01185821|364990578|FG001|Overall Study|Withdrawal by Subject|2|||
105817289|NCT01185821|364990579|FG002|Overall Study|Withdrawal by Subject|2|||
105817290|NCT01185821|364990580|FG003|Overall Study|Withdrawal by Subject|1|||
105817291|NCT01185821|364990581|FG004|Overall Study|Withdrawal by Subject|3|||
105817292|NCT01185821|364990577|FG000|Overall Study|Lost to Follow-up|1|||
105817293|NCT01185821|364990578|FG001|Overall Study|Lost to Follow-up|1|||
105817294|NCT01185821|364990579|FG002|Overall Study|Lost to Follow-up|2|||
105817295|NCT01185821|364990580|FG003|Overall Study|Lost to Follow-up|1|||
105817296|NCT01185821|364990581|FG004|Overall Study|Lost to Follow-up|2|||
105817297|NCT01185821|364990577|FG000|Overall Study|Administrative problems|0|||
105817298|NCT01185821|364990578|FG001|Overall Study|Administrative problems|0|||
105817299|NCT01185821|364990579|FG002|Overall Study|Administrative problems|1|||
105817300|NCT01185821|364990580|FG003|Overall Study|Administrative problems|1|||
105817301|NCT01185821|364990581|FG004|Overall Study|Administrative problems|2|||
105817302|NCT01546545|364990583|FG000|Overall Study|Withdrawal by Subject|1|||
105817303|NCT00296647|364990584|FG000|Overall Study|Death|4|||
105817304|NCT00296647|364990585|FG001|Overall Study|Death|1|||
105817305|NCT00296647|364990586|FG002|Overall Study|Death|2|||
105817306|NCT00296647|364990587|FG003|Overall Study|Death|1|||
105817307|NCT00296647|364990588|FG004|Overall Study|Death|1|||
105817308|NCT00296647|364990584|FG000|Overall Study|Withdrawal by Subject|28|||
105817309|NCT00296647|364990585|FG001|Overall Study|Withdrawal by Subject|27|||
105817310|NCT00296647|364990586|FG002|Overall Study|Withdrawal by Subject|32|||
105817311|NCT00296647|364990587|FG003|Overall Study|Withdrawal by Subject|16|||
105817312|NCT00296647|364990588|FG004|Overall Study|Withdrawal by Subject|19|||
105817313|NCT01001208|364990597|FG000|Overall Study|Adverse Event|10|||
105817314|NCT01001208|364990598|FG001|Overall Study|Adverse Event|5|||
105817315|NCT01001208|364990597|FG000|Overall Study|Lost to Follow-up|5|||
105817316|NCT01001208|364990598|FG001|Overall Study|Lost to Follow-up|9|||
105817317|NCT01001208|364990597|FG000|Overall Study|Physician Decision|1|||
105817318|NCT01001208|364990598|FG001|Overall Study|Physician Decision|0|||
105817319|NCT01001208|364990597|FG000|Overall Study|Withdrawal by Subject|4|||
105817320|NCT01001208|364990598|FG001|Overall Study|Withdrawal by Subject|5|||
105817321|NCT01001208|364990597|FG000|Overall Study|Ineligibility Determined|4|||
105817322|NCT01001208|364990598|FG001|Overall Study|Ineligibility Determined|2|||
105817323|NCT01001208|364990597|FG000|Overall Study|Noncompliance|4|||
105817324|NCT01001208|364990598|FG001|Overall Study|Noncompliance|7|||
105817325|NCT01001208|364990597|FG000|Overall Study|Disease Progression|0|||
105817326|NCT01001208|364990598|FG001|Overall Study|Disease Progression|3|||
105817327|NCT01001208|364990597|FG000|Overall Study|Other|0|||
105817328|NCT01001208|364990598|FG001|Overall Study|Other|2|||
105817329|NCT00855738|364990599|FG000|Overall Study|Lost to Follow-up|2|||
105817330|NCT00855738|364990599|FG000|Overall Study|Adverse Event|1|||
105817331|NCT00855738|364990599|FG000|Overall Study|Subject Defaulted|1|||
105817332|NCT00855738|364990599|FG000|Overall Study|Death|1|||
105817333|NCT02100228|364990602|FG000|Overall Study|Other|19|||
105817334|NCT02100228|364990603|FG001|Overall Study|Other|19|||
105817335|NCT02100228|364990602|FG000|Overall Study|Administrative reason|0|||
105817336|NCT02100228|364990603|FG001|Overall Study|Administrative reason|1|||
105817337|NCT02100228|364990602|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
105765335|NCT02407236|364791863|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
105765336|NCT02177812|364791866|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765337|NCT02177812|364791867|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765338|NCT02177812|364791868|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765339|NCT02177812|364791869|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765340|NCT02177812|364791870|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105765341|NCT02177812|364791871|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
105765342|NCT02177812|364791872|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
105765343|NCT02177812|364791873|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
105765344|NCT02177812|364791874|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
105817338|NCT02100228|364990603|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
105817339|NCT02100228|364990602|FG000|Overall Study|Non-compliance|0|||
105817340|NCT02100228|364990603|FG001|Overall Study|Non-compliance|3|||
105956381|NCT01135459|365502871|FG001|Overall Study|Withdrawal by Subject|3|||
105956382|NCT01135459|365502870|FG000|Overall Study|Protocol Violation|5|||
105956383|NCT01135459|365502871|FG001|Overall Study|Protocol Violation|3|||
105817341|NCT02100228|364990602|FG000|Overall Study|Lost to Follow-up|0|||
105817342|NCT02100228|364990603|FG001|Overall Study|Lost to Follow-up|1|||
105817343|NCT02100228|364990602|FG000|Overall Study|Withdrawal by Subject|27|||
105817344|NCT02100228|364990603|FG001|Overall Study|Withdrawal by Subject|37|||
105817345|NCT02100228|364990602|FG000|Overall Study|Adverse Event|16|||
105817346|NCT02100228|364990603|FG001|Overall Study|Adverse Event|12|||
105817347|NCT02100228|364990602|FG000|Overall Study|Death|1|||
105817348|NCT02100228|364990603|FG001|Overall Study|Death|1|||
105765345|NCT02177812|364791866|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765346|NCT02177812|364791867|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765347|NCT02177812|364791868|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765348|NCT02177812|364791869|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765349|NCT02177812|364791870|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765350|NCT02177812|364791871|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
105765351|NCT02177812|364791872|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
105765352|NCT02177812|364791873|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765353|NCT02177812|364791874|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
105765354|NCT02177812|364791866|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
105765355|NCT02177812|364791867|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
105765356|NCT02177812|364791868|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
105765357|NCT02177812|364791869|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
105765358|NCT02177812|364791870|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
105765359|NCT02177812|364791871|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
105765360|NCT02177812|364791872|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
105765361|NCT02177812|364791873|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
105765362|NCT02177812|364791874|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
105765363|NCT02000219|364793661|FG000|14-Week Study Period|Physician Decision|1|||
105765364|NCT02000219|364793661|FG000|14-Week Study Period|Adverse Event|1|||
105765365|NCT02000219|364793661|FG000|14-Week Study Period|Underwent transplantation|1|||
105765366|NCT02000219|364793661|FG000|Continuation Period|Withdrawal by Subject|1|||
105765367|NCT02000219|364793661|FG000|Continuation Period|Had liver transplant|2|||
105765368|NCT02000219|364793661|FG000|Continuation Period|Non-compliance with study drug|2|||
105765369|NCT00784459|364793667|FG000|Overall Study|Adverse Event|0|||
105765370|NCT00784459|364793668|FG001|Overall Study|Adverse Event|2|||
105765371|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
105765372|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765373|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765374|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765375|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765376|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765377|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
105765378|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
105765379|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765380|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765381|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765382|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765383|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
105765384|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
105765385|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
105765386|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765387|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765388|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765389|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765390|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
105765391|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
105765392|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
105765393|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765394|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765395|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765396|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765397|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
105765398|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
105765399|NCT02431702|364793669|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
105765400|NCT02431702|364793670|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765401|NCT02431702|364793671|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765402|NCT02431702|364793672|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765403|NCT02431702|364793673|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765404|NCT02431702|364793674|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765405|NCT02431702|364793675|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
105765406|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105765407|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
105765408|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
105765409|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105765410|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105765411|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105817349|NCT03929393|364990606|FG000|Overall Study|Death|1|||
105956384|NCT01135459|365502870|FG000|Overall Study|Lost to Follow-up|2|||
105817350|NCT03929393|364990607|FG001|Overall Study|Death|0|||
105817351|NCT03929393|364990606|FG000|Overall Study|Time Commitment|2|||
105817352|NCT03929393|364990607|FG001|Overall Study|Time Commitment|5|||
105817353|NCT03929393|364990606|FG000|Overall Study|Motor Vehicle Accident|0|||
105817354|NCT03929393|364990607|FG001|Overall Study|Motor Vehicle Accident|1|||
105817355|NCT03929393|364990606|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
105817356|NCT03929393|364990607|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
105817357|NCT03929393|364990606|FG000|Overall Study|Other|1|||
105817358|NCT03929393|364990607|FG001|Overall Study|Other|3|||
105817359|NCT03500692|364990629|FG000|Overall Study|Death|163|||
105817360|NCT03500692|364990629|FG000|Overall Study|Lost to Follow-up|75|||
105817361|NCT03500692|364990629|FG000|Overall Study|Termination Reasons|3|||
105817362|NCT05593965|364990630|FG000|1st Intervention (1 Day)|Technical error|1|||
105817363|NCT05593965|364990631|FG001|1st Intervention (1 Day)|Technical error|0|||
105817364|NCT01387737|364992311|FG000|Overall Study|Adverse Event|20|||
105817365|NCT01387737|364992312|FG001|Overall Study|Adverse Event|30|||
105817366|NCT01387737|364992311|FG000|Overall Study|Lack of Efficacy|1|||
105817367|NCT01387737|364992312|FG001|Overall Study|Lack of Efficacy|0|||
105817368|NCT01387737|364992311|FG000|Overall Study|Physician Decision|3|||
105817369|NCT01387737|364992312|FG001|Overall Study|Physician Decision|10|||
105817370|NCT01387737|364992311|FG000|Overall Study|Withdrawal by Subject|27|||
105817371|NCT01387737|364992312|FG001|Overall Study|Withdrawal by Subject|31|||
105817372|NCT01387737|364992311|FG000|Overall Study|Clearly not eligible for the study|1|||
105817373|NCT01387737|364992312|FG001|Overall Study|Clearly not eligible for the study|3|||
105817374|NCT01746017|364992315|FG000|Period 1|Withdrawal by Subject|0|||
105817375|NCT01746017|364992316|FG001|Period 1|Withdrawal by Subject|0|||
105817376|NCT01746017|364992317|FG002|Period 1|Withdrawal by Subject|0|||
105817377|NCT01746017|364992318|FG003|Period 1|Withdrawal by Subject|0|||
105817378|NCT01746017|364992319|FG004|Period 1|Withdrawal by Subject|0|||
105817379|NCT01746017|364992320|FG005|Period 1|Withdrawal by Subject|0|||
105817380|NCT01746017|364992321|FG006|Period 1|Withdrawal by Subject|1|||
105817381|NCT01746017|364992322|FG007|Period 1|Withdrawal by Subject|0|||
105817382|NCT01746017|364992323|FG008|Period 1|Withdrawal by Subject|0|||
105817383|NCT01746017|364992324|FG009|Period 1|Withdrawal by Subject|0|||
105817384|NCT01746017|364992325|FG010|Period 1|Withdrawal by Subject|0|||
105817385|NCT01746017|364992315|FG000|Period 3|Withdrawal by Subject|0|||
105817386|NCT01746017|364992316|FG001|Period 3|Withdrawal by Subject|0|||
105817387|NCT01746017|364992317|FG002|Period 3|Withdrawal by Subject|0|||
105817388|NCT01746017|364992318|FG003|Period 3|Withdrawal by Subject|0|||
105817389|NCT01746017|364992319|FG004|Period 3|Withdrawal by Subject|0|||
105817390|NCT01746017|364992320|FG005|Period 3|Withdrawal by Subject|1|||
105817391|NCT01746017|364992321|FG006|Period 3|Withdrawal by Subject|0|||
105817392|NCT01746017|364992322|FG007|Period 3|Withdrawal by Subject|0|||
105817393|NCT01746017|364992323|FG008|Period 3|Withdrawal by Subject|0|||
105817394|NCT01746017|364992324|FG009|Period 3|Withdrawal by Subject|0|||
105817395|NCT01746017|364992325|FG010|Period 3|Withdrawal by Subject|0|||
105956385|NCT01135459|365502871|FG001|Overall Study|Lost to Follow-up|1|||
105956386|NCT01135459|365502870|FG000|Overall Study|Non-compliance to study procedures|0|||
105956387|NCT01135459|365502871|FG001|Overall Study|Non-compliance to study procedures|1|||
105956388|NCT01135459|365502870|FG000|Overall Study|Other than specified|1|||
105956389|NCT01135459|365502871|FG001|Overall Study|Other than specified|1|||
105956390|NCT01803880|365502872|FG000|Overall Study|Adverse Event|1|||
105956391|NCT01803880|365502873|FG001|Overall Study|Adverse Event|0|||
106145387|NCT00688519|366191960|FG001|Overall Study|Lack of Efficacy|1|||
106145388|NCT00688519|366191959|FG000|Overall Study|Withdrawal by Subject|7|||
105817396|NCT00397488|364992326|FG000|Overall Study|Withdrawal by Subject|3|||
105817397|NCT00397488|364992326|FG000|Overall Study|Adverse Event|3|||
105817398|NCT00397488|364992326|FG000|Overall Study|Death|1|||
105817399|NCT02424097|364992329|FG000|Overall Study|Lost to Follow-up|1|||
105817400|NCT02424097|364992330|FG001|Overall Study|Lost to Follow-up|2|||
105817401|NCT01215981|364992333|FG000|Overall Study|Physician Decision|0|||
105817402|NCT01215981|364992334|FG001|Overall Study|Physician Decision|1|||
105817403|NCT01215981|364992333|FG000|Overall Study|Protocol Violation|1|||
105817404|NCT01215981|364992334|FG001|Overall Study|Protocol Violation|0|||
105817405|NCT01215981|364992333|FG000|Overall Study|Withdrawal by Subject|1|||
105817406|NCT01215981|364992334|FG001|Overall Study|Withdrawal by Subject|0|||
105817407|NCT01507051|364992335|FG000|Overall Study|Withdrawal by Subject|1|||
105817408|NCT01507051|364992336|FG001|Overall Study|Withdrawal by Subject|3|||
105817409|NCT01507051|364992337|FG002|Overall Study|Withdrawal by Subject|1|||
105817410|NCT01507051|364992338|FG003|Overall Study|Withdrawal by Subject|6|||
105817411|NCT01507051|364992335|FG000|Overall Study|Physician Decision|0|||
105817412|NCT01507051|364992336|FG001|Overall Study|Physician Decision|0|||
105817413|NCT01507051|364992337|FG002|Overall Study|Physician Decision|0|||
105817414|NCT01507051|364992338|FG003|Overall Study|Physician Decision|1|||
105817415|NCT01507051|364992335|FG000|Overall Study|Adverse Event|1|||
105817416|NCT01507051|364992336|FG001|Overall Study|Adverse Event|0|||
105817417|NCT01507051|364992337|FG002|Overall Study|Adverse Event|0|||
105817418|NCT01507051|364992338|FG003|Overall Study|Adverse Event|0|||
105817419|NCT01675622|364992339|FG000|Overall Study|Withdrawal by Subject|2|||
105817420|NCT01675622|364992340|FG001|Overall Study|Withdrawal by Subject|2|||
105817421|NCT01675622|364992339|FG000|Overall Study|Adverse Event|12|||
105817422|NCT01675622|364992340|FG001|Overall Study|Adverse Event|10|||
105817423|NCT01675622|364992339|FG000|Overall Study|Protocol Violation|4|||
105817424|NCT01675622|364992340|FG001|Overall Study|Protocol Violation|1|||
105817425|NCT01675622|364992339|FG000|Overall Study|Lack of Efficacy|2|||
105956392|NCT01803880|365502874|FG002|Overall Study|Adverse Event|0|||
105956393|NCT01803880|365502872|FG000|Overall Study|Withdrawal by Subject|1|||
105956394|NCT01803880|365502873|FG001|Overall Study|Withdrawal by Subject|1|||
105956395|NCT01803880|365502874|FG002|Overall Study|Withdrawal by Subject|4|||
105956396|NCT01803880|365502872|FG000|Overall Study|Physician Decision|0|||
105956397|NCT01803880|365502873|FG001|Overall Study|Physician Decision|0|||
105956398|NCT01803880|365502874|FG002|Overall Study|Physician Decision|1|||
105956399|NCT01803880|365502872|FG000|Overall Study|Unable to return for follow-up visits|0|||
105956400|NCT01803880|365502873|FG001|Overall Study|Unable to return for follow-up visits|1|||
105956401|NCT01803880|365502874|FG002|Overall Study|Unable to return for follow-up visits|2|||
105956402|NCT01803880|365502872|FG000|Overall Study|Lost to Follow-up|1|||
105956403|NCT01803880|365502873|FG001|Overall Study|Lost to Follow-up|2|||
105956404|NCT01803880|365502874|FG002|Overall Study|Lost to Follow-up|3|||
105956405|NCT01803880|365502872|FG000|Overall Study|Protocol Violation|1|||
105956406|NCT01803880|365502873|FG001|Overall Study|Protocol Violation|0|||
105956407|NCT01803880|365502874|FG002|Overall Study|Protocol Violation|0|||
105956408|NCT01803880|365502872|FG000|Overall Study|Early study termination|0|||
105956409|NCT01803880|365502873|FG001|Overall Study|Early study termination|6|||
105956410|NCT01803880|365502874|FG002|Overall Study|Early study termination|5|||
105956411|NCT01803880|365502872|FG000|Overall Study|Incomplete data entry by sites|2|||
105956412|NCT01803880|365502873|FG001|Overall Study|Incomplete data entry by sites|0|||
105956413|NCT01803880|365502874|FG002|Overall Study|Incomplete data entry by sites|0|||
105956414|NCT01766037|365502875|FG000|Overall Study|Adverse Event|1|||
105956415|NCT01766037|365502876|FG001|Overall Study|Adverse Event|0|||
105956416|NCT01766037|365502875|FG000|Overall Study|Lack of Efficacy|1|||
105956417|NCT01766037|365502876|FG001|Overall Study|Lack of Efficacy|0|||
105956418|NCT01766037|365502875|FG000|Overall Study|Lost to Follow-up|0|||
105956419|NCT01766037|365502876|FG001|Overall Study|Lost to Follow-up|10|||
105765412|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
105765413|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765414|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
105765415|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
105765416|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765417|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765418|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765419|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
105765420|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765421|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
105765422|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
105765423|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765424|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765425|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765426|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
105765427|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765428|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
105765429|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765430|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765431|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765432|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765433|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
105765434|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
105765435|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
105765436|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
105765437|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
105765438|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
105765439|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
105765440|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
105765441|NCT02431702|364793669|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105817426|NCT01675622|364992340|FG001|Overall Study|Lack of Efficacy|4|||
105817427|NCT01675622|364992339|FG000|Overall Study|Lost to Follow-up|1|||
105817428|NCT01675622|364992340|FG001|Overall Study|Lost to Follow-up|3|||
105817429|NCT01675622|364992339|FG000|Overall Study|Other|5|||
105817430|NCT01675622|364992340|FG001|Overall Study|Other|4|||
105817431|NCT04032977|364992341|FG000|Overall Study|Withdrawal by Subject|6|||
106018525|NCT01532986|365730695|FG000|Overall Study|Withdrawal by Subject|7|||
106018526|NCT01532986|365730696|FG001|Overall Study|Withdrawal by Subject|10|||
106018527|NCT01532986|365730695|FG000|Overall Study|Physician Decision|7|||
106018528|NCT01532986|365730696|FG001|Overall Study|Physician Decision|5|||
106018529|NCT02120898|365730699|FG000|Overall Study|Withdrawal by Subject|4|||
106018530|NCT02120898|365730700|FG001|Overall Study|Withdrawal by Subject|2|||
106018531|NCT02120898|365730701|FG002|Overall Study|Withdrawal by Subject|2|||
106018532|NCT02120898|365730699|FG000|Overall Study|Non-compliance with study drug|3|||
106018533|NCT02120898|365730700|FG001|Overall Study|Non-compliance with study drug|0|||
106018534|NCT02120898|365730701|FG002|Overall Study|Non-compliance with study drug|0|||
106018535|NCT02120898|365730699|FG000|Overall Study|Adverse Event|1|||
106018536|NCT02120898|365730700|FG001|Overall Study|Adverse Event|2|||
105817432|NCT04032977|364992342|FG001|Overall Study|Withdrawal by Subject|1|||
105817433|NCT04032977|364992341|FG000|Overall Study|Lost to Follow-up|2|||
106018537|NCT02120898|365730701|FG002|Overall Study|Adverse Event|1|||
106018538|NCT02120898|365730699|FG000|Overall Study|Protocol Violation|1|||
106018539|NCT02120898|365730700|FG001|Overall Study|Protocol Violation|2|||
106018540|NCT02120898|365730701|FG002|Overall Study|Protocol Violation|0|||
106018541|NCT02120898|365730699|FG000|Overall Study|Lost to Follow-up|0|||
106018542|NCT02120898|365730700|FG001|Overall Study|Lost to Follow-up|0|||
106018543|NCT02120898|365730701|FG002|Overall Study|Lost to Follow-up|1|||
106018544|NCT00831181|365730702|FG000|Overall Study|Adverse Event|12|||
106018545|NCT02754440|365730703|FG000|Overall Study|Protocol Violation|3|||
106018546|NCT02754440|365730704|FG001|Overall Study|Protocol Violation|2|||
106018547|NCT02754440|365730705|FG002|Overall Study|Protocol Violation|2|||
106018548|NCT02754440|365730706|FG003|Overall Study|Protocol Violation|6|||
106018549|NCT02754440|365730703|FG000|Overall Study|Adverse Event|3|||
106018550|NCT02754440|365730704|FG001|Overall Study|Adverse Event|1|||
106018551|NCT02754440|365730705|FG002|Overall Study|Adverse Event|0|||
106018552|NCT02754440|365730706|FG003|Overall Study|Adverse Event|9|||
106018553|NCT02754440|365730703|FG000|Overall Study|Withdrawal by Subject|0|||
106018554|NCT02754440|365730704|FG001|Overall Study|Withdrawal by Subject|0|||
105817434|NCT04032977|364992342|FG001|Overall Study|Lost to Follow-up|7|||
105817435|NCT04032977|364992341|FG000|Overall Study|Pregnancy|1|||
105817436|NCT04032977|364992342|FG001|Overall Study|Pregnancy|0|||
105817437|NCT01101022|364992344|FG000|Overall Study|Adverse Event|6|||
105817438|NCT01101022|364992345|FG001|Overall Study|Adverse Event|2|||
105817439|NCT01101022|364992344|FG000|Overall Study|Protocol Violation|4|||
105817440|NCT01101022|364992345|FG001|Overall Study|Protocol Violation|3|||
105817441|NCT01101022|364992344|FG000|Overall Study|Withdrawal by Subject|3|||
106018555|NCT02754440|365730705|FG002|Overall Study|Withdrawal by Subject|0|||
106018556|NCT02754440|365730706|FG003|Overall Study|Withdrawal by Subject|1|||
106018557|NCT02754440|365730703|FG000|Overall Study|Equipment failure|0|||
106018558|NCT02754440|365730704|FG001|Overall Study|Equipment failure|5|||
106018559|NCT02754440|365730705|FG002|Overall Study|Equipment failure|5|||
106018560|NCT02754440|365730706|FG003|Overall Study|Equipment failure|7|||
106018561|NCT02754440|365730703|FG000|Overall Study|Subject issues not resulting in AE|0|||
105817442|NCT01101022|364992345|FG001|Overall Study|Withdrawal by Subject|8|||
105817443|NCT01101022|364992344|FG000|Overall Study|Lost to Follow-up|1|||
105817444|NCT01101022|364992345|FG001|Overall Study|Lost to Follow-up|4|||
105817445|NCT01101022|364992344|FG000|Overall Study|Lack of Efficacy|0|||
105817446|NCT01101022|364992345|FG001|Overall Study|Lack of Efficacy|7|||
105817447|NCT01101022|364992344|FG000|Overall Study|Sponsor decision|1|||
105817448|NCT01101022|364992345|FG001|Overall Study|Sponsor decision|1|||
105817449|NCT01101022|364992344|FG000|Overall Study|Non-compliance|1|||
105817450|NCT01101022|364992345|FG001|Overall Study|Non-compliance|0|||
105817451|NCT01101022|364992344|FG000|Overall Study|Work schedule|1|||
105817452|NCT01101022|364992345|FG001|Overall Study|Work schedule|1|||
105817453|NCT01101022|364992344|FG000|Overall Study|Vacation|0|||
105817454|NCT01101022|364992345|FG001|Overall Study|Vacation|1|||
106018562|NCT02754440|365730704|FG001|Overall Study|Subject issues not resulting in AE|0|||
106018563|NCT02754440|365730705|FG002|Overall Study|Subject issues not resulting in AE|0|||
106018564|NCT02754440|365730706|FG003|Overall Study|Subject issues not resulting in AE|12|||
106018565|NCT02560558|365730709|FG000|Overall Study|Adverse Event|1|||
106018566|NCT02560558|365730710|FG001|Overall Study|Adverse Event|0|||
106018567|NCT02560558|365730709|FG000|Overall Study|Death|0|||
106018568|NCT02560558|365730710|FG001|Overall Study|Death|2|||
106018569|NCT02560558|365730709|FG000|Overall Study|Lost to Follow-up|0|||
106018570|NCT02560558|365730710|FG001|Overall Study|Lost to Follow-up|4|||
105817455|NCT01519661|364992346|FG000|Overall Study|Protocol deviation|6|||
105817456|NCT01519661|364992346|FG000|Overall Study|Lost to Follow-up|3|||
105817457|NCT01519661|364992346|FG000|Overall Study|Withdrawal by Subject|17|||
105817458|NCT01519661|364992346|FG000|Overall Study|Lack of Efficacy|6|||
105817459|NCT01519661|364992346|FG000|Overall Study|Adverse Event|29|||
105817460|NCT03075761|364992347|FG000|Overall Study|Lost to Follow-up|1|||
105817461|NCT03075761|364992348|FG001|Overall Study|Lost to Follow-up|6|||
105817462|NCT02880761|364992349|FG000|Overall Study|Death|6|||
106018571|NCT02560558|365730709|FG000|Overall Study|Protocol Violation|3|||
106018572|NCT02560558|365730710|FG001|Overall Study|Protocol Violation|0|||
106018573|NCT02560558|365730709|FG000|Overall Study|Withdrawal by Subject|3|||
106018574|NCT02560558|365730710|FG001|Overall Study|Withdrawal by Subject|0|||
106018575|NCT00473382|365730712|FG000|Core Study|Adverse Event|3|||
106018576|NCT00473382|365730713|FG001|Core Study|Adverse Event|1|||
106018577|NCT00473382|365730714|FG002|Core Study|Adverse Event|1|||
106018578|NCT00473382|365730712|FG000|Core Study|Death|3|||
106018579|NCT00473382|365730713|FG001|Core Study|Death|5|||
105817463|NCT02880761|364992350|FG001|Overall Study|Death|8|||
105817464|NCT02880761|364992349|FG000|Overall Study|Withdrawal by Subject|3|||
105817465|NCT02880761|364992350|FG001|Overall Study|Withdrawal by Subject|6|||
105817466|NCT02880761|364992349|FG000|Overall Study|Protocol Violation|4|||
105817467|NCT02880761|364992350|FG001|Overall Study|Protocol Violation|3|||
105817468|NCT02880761|364992349|FG000|Overall Study|Lost to Follow-up|3|||
105817469|NCT02880761|364992350|FG001|Overall Study|Lost to Follow-up|4|||
105817470|NCT01139047|364992351|FG000|Overall Study|Withdrawal by Subject|1|||
105817471|NCT02106156|364992352|FG000|Overall Study|Patient Died|19|||
105817472|NCT02106156|364992353|FG001|Overall Study|Patient Died|0|||
105817473|NCT02106156|364992354|FG002|Overall Study|Patient Died|0|||
105817474|NCT02106156|364992352|FG000|Overall Study|Lack of Tolerability|305|||
105817475|NCT02106156|364992353|FG001|Overall Study|Lack of Tolerability|3|||
105817476|NCT02106156|364992354|FG002|Overall Study|Lack of Tolerability|0|||
105817477|NCT02106156|364992352|FG000|Overall Study|Lack of Virological Response|1044|||
105817478|NCT02106156|364992353|FG001|Overall Study|Lack of Virological Response|8|||
105817479|NCT02106156|364992354|FG002|Overall Study|Lack of Virological Response|0|||
105817480|NCT02106156|364992352|FG000|Overall Study|Concomitant Disease|74|||
105817481|NCT02106156|364992353|FG001|Overall Study|Concomitant Disease|2|||
105817482|NCT02106156|364992354|FG002|Overall Study|Concomitant Disease|0|||
105817483|NCT02106156|364992352|FG000|Overall Study|Lack of Compliance|211|||
105817484|NCT02106156|364992353|FG001|Overall Study|Lack of Compliance|7|||
105817485|NCT02106156|364992354|FG002|Overall Study|Lack of Compliance|0|||
105817486|NCT02106156|364992352|FG000|Overall Study|Patients Request|307|||
105817487|NCT02106156|364992353|FG001|Overall Study|Patients Request|9|||
105817488|NCT02106156|364992354|FG002|Overall Study|Patients Request|0|||
105817489|NCT02106156|364992352|FG000|Overall Study|Lost to Follow-up|451|||
105817490|NCT02106156|364992353|FG001|Overall Study|Lost to Follow-up|8|||
105817491|NCT02106156|364992354|FG002|Overall Study|Lost to Follow-up|0|||
105817492|NCT02106156|364992352|FG000|Overall Study|Unplanned Event|82|||
105817493|NCT02106156|364992353|FG001|Overall Study|Unplanned Event|2|||
105817494|NCT02106156|364992354|FG002|Overall Study|Unplanned Event|0|||
105817495|NCT02106156|364992352|FG000|Overall Study|Change of Laboratory Parameter|10|||
105817496|NCT02106156|364992353|FG001|Overall Study|Change of Laboratory Parameter|0|||
105817497|NCT02106156|364992354|FG002|Overall Study|Change of Laboratory Parameter|0|||
105817498|NCT02106156|364992352|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
105817499|NCT02106156|364992353|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
105817500|NCT02106156|364992354|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
105817501|NCT02106156|364992352|FG000|Overall Study|Relocation/Change of Physician|40|||
105817502|NCT02106156|364992353|FG001|Overall Study|Relocation/Change of Physician|1|||
105817503|NCT02106156|364992354|FG002|Overall Study|Relocation/Change of Physician|0|||
105817504|NCT02943447|364992355|FG000|Blinded Study Phase|Withdrew Consent|1|||
105817505|NCT02943447|364992356|FG001|Blinded Study Phase|Withdrew Consent|2|||
105817506|NCT02943447|364992357|FG002|Blinded Study Phase|Withdrew Consent|1|||
105817507|NCT02943447|364992355|FG000|Blinded Study Phase|Adverse Event|3|||
105817508|NCT02943447|364992356|FG001|Blinded Study Phase|Adverse Event|0|||
106018580|NCT00473382|365730714|FG002|Core Study|Death|10|||
106018581|NCT00473382|365730712|FG000|Core Study|Lost to Follow-up|3|||
106018582|NCT00473382|365730713|FG001|Core Study|Lost to Follow-up|3|||
106018583|NCT00473382|365730714|FG002|Core Study|Lost to Follow-up|3|||
106018584|NCT00473382|365730712|FG000|Core Study|Physician Decision|1|||
106018585|NCT00473382|365730713|FG001|Core Study|Physician Decision|2|||
106018586|NCT00473382|365730714|FG002|Core Study|Physician Decision|2|||
106018587|NCT00473382|365730712|FG000|Core Study|Subject non-compliance|5|||
106018588|NCT00473382|365730713|FG001|Core Study|Subject non-compliance|2|||
105817509|NCT02943447|364992357|FG002|Blinded Study Phase|Adverse Event|0|||
105817510|NCT02943447|364992355|FG000|Blinded Study Phase|Investigator's discretion|1|||
105817511|NCT02943447|364992356|FG001|Blinded Study Phase|Investigator's discretion|0|||
105817512|NCT02943447|364992357|FG002|Blinded Study Phase|Investigator's discretion|0|||
105817513|NCT02943447|364992355|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
105817514|NCT02943447|364992356|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
105817515|NCT02943447|364992357|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
105817516|NCT02943447|364992355|FG000|Open-Label Extension Phase|Adverse Event|4|||
106018589|NCT00473382|365730714|FG002|Core Study|Subject non-compliance|1|||
106018590|NCT00473382|365730712|FG000|Core Study|Subject needed other treatment|1|||
105817517|NCT02943447|364992356|FG001|Open-Label Extension Phase|Adverse Event|7|||
105817518|NCT02943447|364992357|FG002|Open-Label Extension Phase|Adverse Event|3|||
105817519|NCT02943447|364992355|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
105817520|NCT02943447|364992356|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
106018591|NCT00473382|365730713|FG001|Core Study|Subject needed other treatment|3|||
106018592|NCT00473382|365730714|FG002|Core Study|Subject needed other treatment|2|||
106018593|NCT00473382|365730712|FG000|Core Study|Subject's decision|12|||
106018594|NCT00473382|365730713|FG001|Core Study|Subject's decision|11|||
106018595|NCT00473382|365730714|FG002|Core Study|Subject's decision|10|||
106018596|NCT00473382|365730712|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
106018597|NCT00473382|365730713|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
106018598|NCT00473382|365730714|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
106018599|NCT00473382|365730712|FG000|Open-label Extension Through Month 48|Death|1|||
106018600|NCT00473382|365730713|FG001|Open-label Extension Through Month 48|Death|3|||
106018601|NCT00473382|365730714|FG002|Open-label Extension Through Month 48|Death|3|||
106018602|NCT00473382|365730712|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
106018603|NCT00473382|365730713|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
106018604|NCT00473382|365730714|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
106018605|NCT00473382|365730712|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
106018606|NCT00473382|365730713|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
106018607|NCT00473382|365730714|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
106018608|NCT00473382|365730712|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
106018609|NCT00473382|365730713|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
106018610|NCT00473382|365730714|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
106018611|NCT00473382|365730712|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
106018612|NCT00473382|365730713|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
106018613|NCT00473382|365730714|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
106018614|NCT00473382|365730712|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
106018615|NCT00473382|365730713|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
106018616|NCT00473382|365730714|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
106018617|NCT00473382|365730712|FG000|Open-label Extension Through Month 60|Death|1|||
106018618|NCT00473382|365730713|FG001|Open-label Extension Through Month 60|Death|7|||
106018619|NCT00473382|365730714|FG002|Open-label Extension Through Month 60|Death|4|||
106018620|NCT00473382|365730712|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
106018621|NCT00473382|365730713|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
106018622|NCT00473382|365730714|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
106018623|NCT00473382|365730712|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
106018624|NCT00473382|365730713|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
106018625|NCT00473382|365730714|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
106018626|NCT00473382|365730712|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
106018627|NCT00473382|365730713|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
106018628|NCT00473382|365730714|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
106018629|NCT00473382|365730712|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
106018630|NCT00473382|365730713|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
106018631|NCT00473382|365730714|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
106018632|NCT03048578|365730717|FG000|Overall Study|Withdrawal by Subject|5|||
106018633|NCT03048578|365730718|FG001|Overall Study|Withdrawal by Subject|6|||
106018634|NCT03048578|365730717|FG000|Overall Study|Lost to Follow-up|22|||
106018635|NCT03048578|365730718|FG001|Overall Study|Lost to Follow-up|10|||
106018636|NCT03048578|365730717|FG000|Overall Study|Adverse Event|1|||
106018637|NCT03048578|365730718|FG001|Overall Study|Adverse Event|2|||
106018638|NCT03048578|365730717|FG000|Overall Study|Terminated|3|||
106018639|NCT03048578|365730718|FG001|Overall Study|Terminated|2|||
106018640|NCT00526071|365730719|FG000|Overall Study|Adverse Event|1|||
106018641|NCT00526071|365730719|FG000|Overall Study|Withdrawal by Subject|1|||
106018642|NCT00526071|365730719|FG000|Overall Study|Lack of Response to Study Drug|4|||
106018643|NCT02207088|365730722|FG000|Overall Study|Adverse Event|2|||
106018644|NCT00318643|365730725|FG000|Overall Study|Adverse Event|0|||
106018645|NCT00318643|365730726|FG001|Overall Study|Adverse Event|0|||
106018646|NCT00318643|365730727|FG002|Overall Study|Adverse Event|0|||
106018647|NCT00318643|365730728|FG003|Overall Study|Adverse Event|0|||
106018648|NCT00318643|365730729|FG004|Overall Study|Adverse Event|1|||
106018649|NCT00318643|365730725|FG000|Overall Study|Participant's Decision|0|||
106018650|NCT00318643|365730726|FG001|Overall Study|Participant's Decision|0|||
106018651|NCT00318643|365730727|FG002|Overall Study|Participant's Decision|0|||
106018652|NCT00318643|365730728|FG003|Overall Study|Participant's Decision|0|||
106018653|NCT00318643|365730729|FG004|Overall Study|Participant's Decision|1|||
106018654|NCT00318643|365730725|FG000|Overall Study|Investigator's Decision|0|||
106018655|NCT00318643|365730726|FG001|Overall Study|Investigator's Decision|0|||
106018656|NCT00318643|365730727|FG002|Overall Study|Investigator's Decision|0|||
106018657|NCT00318643|365730728|FG003|Overall Study|Investigator's Decision|0|||
106018658|NCT00318643|365730729|FG004|Overall Study|Investigator's Decision|1|||
106018659|NCT01812252|365730730|FG000|Overall Study|Persistent Disease|1|||
106018660|NCT01812252|365730731|FG001|Overall Study|Persistent Disease|0|||
106018661|NCT01812252|365730730|FG000|Overall Study|Not transplanted|11|||
106145389|NCT00688519|366191960|FG001|Overall Study|Withdrawal by Subject|6|||
106145390|NCT00688519|366191959|FG000|Overall Study|Prohibited medication|1|||
106145391|NCT00688519|366191960|FG001|Overall Study|Prohibited medication|0|||
106145392|NCT00688519|366191959|FG000|Overall Study|Non-compliance|0|||
106145393|NCT00688519|366191960|FG001|Overall Study|Non-compliance|1|||
106145394|NCT00688519|366191959|FG000|Overall Study|Subject moved out of state|1|||
106145395|NCT00688519|366191960|FG001|Overall Study|Subject moved out of state|0|||
106145396|NCT00688519|366191959|FG000|Overall Study|Investigator decision|1|||
106145397|NCT00688519|366191960|FG001|Overall Study|Investigator decision|0|||
106145398|NCT00688519|366191959|FG000|Overall Study|Subject moved out of area|1|||
105765442|NCT02431702|364793670|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765443|NCT02431702|364793671|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
105817521|NCT02943447|364992357|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
105817522|NCT02943447|364992355|FG000|Open-Label Extension Phase|Withdrew consent|1|||
105817523|NCT02943447|364992356|FG001|Open-Label Extension Phase|Withdrew consent|1|||
105817524|NCT02943447|364992357|FG002|Open-Label Extension Phase|Withdrew consent|1|||
105817525|NCT02943447|364992355|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
105817526|NCT02943447|364992356|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
105817527|NCT02943447|364992357|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
105817528|NCT00840632|364992367|FG000|First Intervention|Withdrawal by Subject|0|||
105817529|NCT00840632|364992368|FG001|First Intervention|Withdrawal by Subject|1|||
105817530|NCT00840632|364992367|FG000|Washout|Withdrawal by Subject|1|||
105956420|NCT01766037|365502875|FG000|Overall Study|Physician Decision|0|||
105956421|NCT01766037|365502876|FG001|Overall Study|Physician Decision|1|||
105956422|NCT01766037|365502875|FG000|Overall Study|Withdrawal by Subject|18|||
105956423|NCT01766037|365502876|FG001|Overall Study|Withdrawal by Subject|16|||
105956424|NCT01766037|365502875|FG000|Overall Study|Moved from area|5|||
105956425|NCT01766037|365502876|FG001|Overall Study|Moved from area|0|||
105956426|NCT01766037|365502875|FG000|Overall Study|medical - unrelated|1|||
105956427|NCT01766037|365502876|FG001|Overall Study|medical - unrelated|2|||
105956428|NCT01766037|365502875|FG000|Overall Study|nausea / discomfort|3|||
105956429|NCT01766037|365502876|FG001|Overall Study|nausea / discomfort|0|||
105956430|NCT01194219|365502877|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
105956431|NCT01194219|365502878|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
105956432|NCT01194219|365502879|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105956433|NCT01194219|365502880|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105956434|NCT01194219|365502881|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105956435|NCT01194219|365502882|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105956436|NCT01194219|365502883|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105956437|NCT01194219|365502884|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105956438|NCT01194219|365502885|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105956439|NCT01194219|365502886|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
105956440|NCT01194219|365502877|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
105956441|NCT01194219|365502878|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
106145399|NCT00688519|366191960|FG001|Overall Study|Subject moved out of area|0|||
105765444|NCT02431702|364793672|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765445|NCT02431702|364793673|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765446|NCT02431702|364793674|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765447|NCT02431702|364793675|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
105765448|NCT02431702|364793669|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765449|NCT02431702|364793670|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765450|NCT02431702|364793671|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765451|NCT02431702|364793672|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
105765452|NCT02431702|364793673|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
105765453|NCT02431702|364793674|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765454|NCT02431702|364793675|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
105765455|NCT02431702|364793669|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105817531|NCT00840632|364992368|FG001|Washout|Withdrawal by Subject|1|||
105817532|NCT05017480|364992369|FG000|Stage 1 Study|Withdrawal by Subject|8|||
105817533|NCT05017480|364992370|FG001|Stage 1 Study|Withdrawal by Subject|6|||
105817534|NCT05017480|364992371|FG002|Stage 1 Study|Withdrawal by Subject|0|||
105956442|NCT01194219|365502879|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105817535|NCT05017480|364992372|FG003|Stage 1 Study|Withdrawal by Subject|0|||
106145400|NCT00688519|366191959|FG000|Overall Study|Pregnancy|0|||
106145401|NCT00688519|366191960|FG001|Overall Study|Pregnancy|1|||
105765456|NCT02431702|364793670|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105765457|NCT02431702|364793671|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105765458|NCT02431702|364793672|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
105765459|NCT02431702|364793673|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105765460|NCT02431702|364793674|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
105765461|NCT02431702|364793675|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
105765462|NCT02431702|364793669|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
105765463|NCT02431702|364793670|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
105765464|NCT02431702|364793671|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
105765465|NCT02431702|364793672|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
105765466|NCT02431702|364793673|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
105765467|NCT02431702|364793674|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
105765468|NCT02431702|364793675|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
105765469|NCT02431702|364793669|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
105765470|NCT02431702|364793670|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
105765471|NCT02431702|364793671|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
105765472|NCT02431702|364793672|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
105765473|NCT02431702|364793673|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
105765474|NCT02431702|364793674|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
105765475|NCT02431702|364793675|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
105765476|NCT04984876|364793676|FG000|Overall Study|Subject decision|2|||
105765477|NCT04984876|364793677|FG001|Overall Study|Subject decision|10|||
105765478|NCT04984876|364793678|FG002|Overall Study|Subject decision|3|||
105765479|NCT04984876|364793679|FG003|Overall Study|Subject decision|3|||
105765480|NCT04984876|364793680|FG004|Overall Study|Subject decision|3|||
105765481|NCT04984876|364793681|FG005|Overall Study|Subject decision|0|||
105765482|NCT04984876|364793676|FG000|Overall Study|Guardian decision|0|||
105765483|NCT04984876|364793677|FG001|Overall Study|Guardian decision|1|||
105765484|NCT04984876|364793678|FG002|Overall Study|Guardian decision|0|||
105765485|NCT04984876|364793679|FG003|Overall Study|Guardian decision|2|||
105765486|NCT04984876|364793680|FG004|Overall Study|Guardian decision|0|||
105765487|NCT04984876|364793681|FG005|Overall Study|Guardian decision|1|||
105765488|NCT04984876|364793676|FG000|Overall Study|Lost to Follow-up|0|||
105765489|NCT04984876|364793677|FG001|Overall Study|Lost to Follow-up|0|||
105765490|NCT04984876|364793678|FG002|Overall Study|Lost to Follow-up|1|||
105765491|NCT04984876|364793679|FG003|Overall Study|Lost to Follow-up|1|||
105765492|NCT04984876|364793680|FG004|Overall Study|Lost to Follow-up|0|||
105765493|NCT04984876|364793681|FG005|Overall Study|Lost to Follow-up|0|||
105765494|NCT04984876|364793676|FG000|Overall Study|Physician Decision|1|||
105765495|NCT04984876|364793677|FG001|Overall Study|Physician Decision|0|||
105765496|NCT04984876|364793678|FG002|Overall Study|Physician Decision|0|||
105765497|NCT04984876|364793679|FG003|Overall Study|Physician Decision|1|||
105765498|NCT04984876|364793680|FG004|Overall Study|Physician Decision|0|||
105765499|NCT04984876|364793681|FG005|Overall Study|Physician Decision|0|||
105765500|NCT04984876|364793676|FG000|Overall Study|Adverse Event|0|||
105765501|NCT04984876|364793677|FG001|Overall Study|Adverse Event|0|||
105956443|NCT01194219|365502880|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105956444|NCT01194219|365502881|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105956445|NCT01194219|365502882|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105956446|NCT01194219|365502883|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105956447|NCT01194219|365502884|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105956448|NCT01194219|365502885|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105956449|NCT01194219|365502886|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
105956450|NCT01194219|365502877|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
105956451|NCT01194219|365502878|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105956452|NCT01194219|365502879|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105956453|NCT01194219|365502880|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105956454|NCT01194219|365502881|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105956455|NCT01194219|365502882|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105956456|NCT01194219|365502883|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105956457|NCT01194219|365502884|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105956458|NCT01194219|365502885|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
106018662|NCT01812252|365730731|FG001|Overall Study|Not transplanted|11|||
106145402|NCT01685606|366191961|FG000|Overall Study|Withdrawal by Subject|1|||
105765502|NCT04984876|364793678|FG002|Overall Study|Adverse Event|1|||
105765503|NCT04984876|364793679|FG003|Overall Study|Adverse Event|0|||
105765504|NCT04984876|364793680|FG004|Overall Study|Adverse Event|0|||
105765505|NCT04984876|364793681|FG005|Overall Study|Adverse Event|0|||
105765506|NCT02204410|364793682|FG000|Overall Study|Lost to Follow-up|5|||
105765507|NCT02204410|364793682|FG000|Overall Study|Physician Decision|2|||
105765508|NCT02204410|364793682|FG000|Overall Study|Protocol Violation|1|||
105817536|NCT05017480|364992373|FG004|Stage 1 Study|Withdrawal by Subject|0|||
105817537|NCT05017480|364992369|FG000|Stage 1 Study|Adverse Event|1|||
105817538|NCT05017480|364992370|FG001|Stage 1 Study|Adverse Event|1|||
105817539|NCT05017480|364992371|FG002|Stage 1 Study|Adverse Event|0|||
105817540|NCT05017480|364992372|FG003|Stage 1 Study|Adverse Event|0|||
105817541|NCT05017480|364992373|FG004|Stage 1 Study|Adverse Event|0|||
105817542|NCT05017480|364992369|FG000|Stage 1 Study|Poor Compliance|1|||
105817543|NCT05017480|364992370|FG001|Stage 1 Study|Poor Compliance|1|||
105817544|NCT05017480|364992371|FG002|Stage 1 Study|Poor Compliance|0|||
105817545|NCT05017480|364992372|FG003|Stage 1 Study|Poor Compliance|0|||
105817546|NCT05017480|364992373|FG004|Stage 1 Study|Poor Compliance|0|||
105817547|NCT05017480|364992369|FG000|Stage 1 Study|Physician Decision|0|||
105817548|NCT05017480|364992370|FG001|Stage 1 Study|Physician Decision|1|||
105817549|NCT05017480|364992371|FG002|Stage 1 Study|Physician Decision|0|||
105817550|NCT05017480|364992372|FG003|Stage 1 Study|Physician Decision|0|||
105817551|NCT05017480|364992373|FG004|Stage 1 Study|Physician Decision|0|||
105817552|NCT05017480|364992369|FG000|Stage 2 Study|Withdrawal by Subject|0|||
105817553|NCT05017480|364992370|FG001|Stage 2 Study|Withdrawal by Subject|0|||
105817554|NCT05017480|364992371|FG002|Stage 2 Study|Withdrawal by Subject|6|||
105817555|NCT05017480|364992372|FG003|Stage 2 Study|Withdrawal by Subject|9|||
105817556|NCT05017480|364992373|FG004|Stage 2 Study|Withdrawal by Subject|11|||
105817557|NCT05017480|364992369|FG000|Stage 2 Study|Lost to Follow-up|0|||
105817558|NCT05017480|364992370|FG001|Stage 2 Study|Lost to Follow-up|0|||
105817559|NCT05017480|364992371|FG002|Stage 2 Study|Lost to Follow-up|0|||
105817560|NCT05017480|364992372|FG003|Stage 2 Study|Lost to Follow-up|2|||
105817561|NCT05017480|364992373|FG004|Stage 2 Study|Lost to Follow-up|1|||
105817562|NCT05017480|364992369|FG000|Stage 2 Study|Adverse Event|0|||
105817563|NCT05017480|364992370|FG001|Stage 2 Study|Adverse Event|0|||
105817564|NCT05017480|364992371|FG002|Stage 2 Study|Adverse Event|0|||
105817565|NCT05017480|364992372|FG003|Stage 2 Study|Adverse Event|1|||
105817566|NCT05017480|364992373|FG004|Stage 2 Study|Adverse Event|0|||
105817567|NCT05017480|364992369|FG000|Stage 2 Study|COVID-19|0|||
105817568|NCT05017480|364992370|FG001|Stage 2 Study|COVID-19|0|||
105817569|NCT05017480|364992371|FG002|Stage 2 Study|COVID-19|0|||
105817570|NCT05017480|364992372|FG003|Stage 2 Study|COVID-19|1|||
105817571|NCT05017480|364992373|FG004|Stage 2 Study|COVID-19|0|||
105817572|NCT05017480|364992369|FG000|Stage 2 Study|Pregnancy|0|||
105817573|NCT05017480|364992370|FG001|Stage 2 Study|Pregnancy|0|||
105817574|NCT05017480|364992371|FG002|Stage 2 Study|Pregnancy|0|||
105817575|NCT05017480|364992372|FG003|Stage 2 Study|Pregnancy|0|||
105817576|NCT05017480|364992373|FG004|Stage 2 Study|Pregnancy|1|||
105817577|NCT01136382|364992374|FG000|Overall Study|Other|8|||
105817578|NCT01136382|364992375|FG001|Overall Study|Other|3|||
105817579|NCT01136382|364992374|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
105817580|NCT01136382|364992375|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
105817581|NCT01136382|364992374|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
105817582|NCT01136382|364992375|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
105817583|NCT01136382|364992374|FG000|Overall Study|Withdrawal by Subject|4|||
105817584|NCT01136382|364992375|FG001|Overall Study|Withdrawal by Subject|1|||
105817585|NCT02311361|364992382|FG000|Overall Study|Did not receive treatment|0|||
105817586|NCT02311361|364992383|FG001|Overall Study|Did not receive treatment|1|||
105817587|NCT02311361|364992384|FG002|Overall Study|Did not receive treatment|0|||
105817588|NCT02311361|364992385|FG003|Overall Study|Did not receive treatment|1|||
105817589|NCT01725529|364992386|FG000|Overall Study|Adverse Event|1|||
105817590|NCT01725529|364992387|FG001|Overall Study|Adverse Event|0|||
105817591|NCT01725529|364992388|FG002|Overall Study|Adverse Event|0|||
106018663|NCT01812252|365730730|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
106018664|NCT01812252|365730731|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
106018665|NCT01812252|365730730|FG000|Overall Study|Withdrawal by Subject|1|||
105817592|NCT01725529|364992386|FG000|Overall Study|Lost to Follow-up|2|||
105817593|NCT01725529|364992387|FG001|Overall Study|Lost to Follow-up|1|||
105817594|NCT01725529|364992388|FG002|Overall Study|Lost to Follow-up|1|||
105817595|NCT01725529|364992386|FG000|Overall Study|Protocol Violation|0|||
105817596|NCT01725529|364992387|FG001|Overall Study|Protocol Violation|1|||
105817597|NCT01725529|364992388|FG002|Overall Study|Protocol Violation|1|||
105817598|NCT01725529|364992386|FG000|Overall Study|Withdrawal by Subject|12|||
105817599|NCT01725529|364992387|FG001|Overall Study|Withdrawal by Subject|14|||
105817600|NCT01725529|364992388|FG002|Overall Study|Withdrawal by Subject|8|||
105817601|NCT00633594|364992395|FG000|Overall Study|Adverse Event|0|||
105817602|NCT00633594|364992396|FG001|Overall Study|Adverse Event|4|||
105817603|NCT00633594|364992397|FG002|Overall Study|Adverse Event|7|||
105817604|NCT00633594|364992395|FG000|Overall Study|Death|0|||
105817605|NCT00633594|364992396|FG001|Overall Study|Death|1|||
105817606|NCT00633594|364992397|FG002|Overall Study|Death|2|||
105817607|NCT00633594|364992395|FG000|Overall Study|Disease Progression|0|||
105817608|NCT00633594|364992396|FG001|Overall Study|Disease Progression|0|||
105817609|NCT00633594|364992397|FG002|Overall Study|Disease Progression|1|||
105817610|NCT00864097|364992398|FG000|Overall Study|Death|0|||
105817611|NCT00864097|364992399|FG001|Overall Study|Death|1|||
105817612|NCT00864097|364992400|FG002|Overall Study|Death|0|||
105817613|NCT00864097|364992401|FG003|Overall Study|Death|0|||
105817614|NCT00864097|364992398|FG000|Overall Study|Adverse Event|6|||
105817615|NCT00864097|364992399|FG001|Overall Study|Adverse Event|8|||
105817616|NCT00864097|364992400|FG002|Overall Study|Adverse Event|11|||
105817617|NCT00864097|364992401|FG003|Overall Study|Adverse Event|9|||
105817618|NCT00864097|364992398|FG000|Overall Study|Lack of Efficacy|9|||
105817619|NCT00864097|364992399|FG001|Overall Study|Lack of Efficacy|3|||
105817620|NCT00864097|364992400|FG002|Overall Study|Lack of Efficacy|7|||
105817621|NCT00864097|364992401|FG003|Overall Study|Lack of Efficacy|2|||
105817622|NCT00864097|364992398|FG000|Overall Study|Lost to Follow-up|0|||
105817623|NCT00864097|364992399|FG001|Overall Study|Lost to Follow-up|1|||
105817624|NCT00864097|364992400|FG002|Overall Study|Lost to Follow-up|0|||
105817625|NCT00864097|364992401|FG003|Overall Study|Lost to Follow-up|1|||
105817626|NCT00864097|364992398|FG000|Overall Study|Withdrawal by Subject|15|||
105817627|NCT00864097|364992399|FG001|Overall Study|Withdrawal by Subject|11|||
105817628|NCT00864097|364992400|FG002|Overall Study|Withdrawal by Subject|11|||
105817629|NCT00864097|364992401|FG003|Overall Study|Withdrawal by Subject|12|||
105817630|NCT00864097|364992398|FG000|Overall Study|Protocol Violation|2|||
105817631|NCT00864097|364992399|FG001|Overall Study|Protocol Violation|1|||
105817632|NCT00864097|364992400|FG002|Overall Study|Protocol Violation|0|||
105817633|NCT00864097|364992401|FG003|Overall Study|Protocol Violation|1|||
105817634|NCT00864097|364992398|FG000|Overall Study|Terminated by sponsor|105|||
105817635|NCT00864097|364992399|FG001|Overall Study|Terminated by sponsor|112|||
105817636|NCT00864097|364992400|FG002|Overall Study|Terminated by sponsor|102|||
105817637|NCT00864097|364992401|FG003|Overall Study|Terminated by sponsor|99|||
105817638|NCT00864097|364992398|FG000|Overall Study|Randomized but not treated|2|||
105817639|NCT00864097|364992399|FG001|Overall Study|Randomized but not treated|0|||
105817640|NCT00864097|364992400|FG002|Overall Study|Randomized but not treated|1|||
105817641|NCT00864097|364992401|FG003|Overall Study|Randomized but not treated|0|||
105817642|NCT00864097|364992398|FG000|Overall Study|Other|0|||
105817643|NCT00864097|364992399|FG001|Overall Study|Other|0|||
105817644|NCT00864097|364992400|FG002|Overall Study|Other|0|||
105817645|NCT00864097|364992401|FG003|Overall Study|Other|1|||
105817646|NCT00620022|364992402|FG000|Treatment Period 1|Adverse Event|4|||
105817647|NCT00620022|364992403|FG001|Treatment Period 1|Adverse Event|6|||
105817648|NCT00620022|364992402|FG000|Treatment Period 1|Subject withdrew consent|1|||
105817649|NCT00620022|364992403|FG001|Treatment Period 1|Subject withdrew consent|0|||
105817650|NCT00620022|364992402|FG000|Treatment Period 2|Adverse Event|2|||
105817651|NCT00620022|364992403|FG001|Treatment Period 2|Adverse Event|2|||
105817652|NCT00262223|364992404|FG000|Treatment Phase|Withdrawal by Subject|3|||
105817653|NCT00262223|364992405|FG001|Treatment Phase|Withdrawal by Subject|6|||
105817654|NCT00262223|364992404|FG000|Treatment Phase|Adverse Event|1|||
105817655|NCT00262223|364992405|FG001|Treatment Phase|Adverse Event|2|||
105817656|NCT00262223|364992404|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
105817657|NCT00262223|364992405|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
105817658|NCT00262223|364992404|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
105817659|NCT00262223|364992405|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
105817660|NCT00262223|364992404|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
105817661|NCT00262223|364992405|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
105817662|NCT01804270|364992406|FG000|Overall Study|Withdrawal by Subject|1|||
105817663|NCT01804270|364992407|FG001|Overall Study|Withdrawal by Subject|1|||
105817664|NCT05038293|364992412|FG000|Overall Study|device was not operating properly for one subject.|1|||
105817665|NCT05038293|364992413|FG001|Overall Study|device was not operating properly for one subject.|0|||
105817666|NCT05038293|364992412|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
105817667|NCT05038293|364992413|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
105817668|NCT00418184|364992414|FG000|Double-blind Phase|Withdrawal by Subject|22|||
105817669|NCT00418184|364992415|FG001|Double-blind Phase|Withdrawal by Subject|9|||
105817670|NCT00418184|364992414|FG000|Double-blind Phase|Adverse Event|2|||
106018666|NCT01812252|365730731|FG001|Overall Study|Withdrawal by Subject|1|||
106018667|NCT01812252|365730730|FG000|Overall Study|Screen Failure|1|||
105817671|NCT00418184|364992415|FG001|Double-blind Phase|Adverse Event|1|||
105817672|NCT00418184|364992414|FG000|Double-blind Phase|Poor compliance|3|||
105817673|NCT00418184|364992415|FG001|Double-blind Phase|Poor compliance|1|||
105817674|NCT00150462|364992417|FG000|Overall Study|Disease Progression or Relapse|3|||
105817675|NCT00150462|364992418|FG001|Overall Study|Disease Progression or Relapse|1|||
105817676|NCT00150462|364992419|FG002|Overall Study|Disease Progression or Relapse|2|||
105817677|NCT00150462|364992420|FG003|Overall Study|Disease Progression or Relapse|1|||
105817678|NCT00150462|364992421|FG004|Overall Study|Disease Progression or Relapse|2|||
105817679|NCT00150462|364992422|FG005|Overall Study|Disease Progression or Relapse|2|||
105817680|NCT00150462|364992423|FG006|Overall Study|Disease Progression or Relapse|3|||
105817681|NCT00150462|364992424|FG007|Overall Study|Disease Progression or Relapse|5|||
105817682|NCT00150462|364992425|FG008|Overall Study|Disease Progression or Relapse|5|||
105817683|NCT00150462|364992426|FG009|Overall Study|Disease Progression or Relapse|3|||
106018668|NCT01812252|365730731|FG001|Overall Study|Screen Failure|0|||
106018669|NCT01519921|365730732|FG000|Overall Study|Adverse Event|10|||
105817684|NCT00150462|364992427|FG010|Overall Study|Disease Progression or Relapse|2|||
105817685|NCT00150462|364992417|FG000|Overall Study|Withdrawal by Subject|0|||
105817686|NCT00150462|364992418|FG001|Overall Study|Withdrawal by Subject|1|||
105817687|NCT00150462|364992419|FG002|Overall Study|Withdrawal by Subject|1|||
105817688|NCT00150462|364992420|FG003|Overall Study|Withdrawal by Subject|0|||
105817689|NCT00150462|364992421|FG004|Overall Study|Withdrawal by Subject|1|||
105817690|NCT00150462|364992422|FG005|Overall Study|Withdrawal by Subject|2|||
105817691|NCT00150462|364992423|FG006|Overall Study|Withdrawal by Subject|0|||
105817692|NCT00150462|364992424|FG007|Overall Study|Withdrawal by Subject|1|||
105817693|NCT00150462|364992425|FG008|Overall Study|Withdrawal by Subject|0|||
105817694|NCT00150462|364992426|FG009|Overall Study|Withdrawal by Subject|1|||
105817695|NCT00150462|364992427|FG010|Overall Study|Withdrawal by Subject|0|||
105817696|NCT00150462|364992417|FG000|Overall Study|Death|0|||
105817697|NCT00150462|364992418|FG001|Overall Study|Death|1|||
105817698|NCT00150462|364992419|FG002|Overall Study|Death|0|||
105817699|NCT00150462|364992420|FG003|Overall Study|Death|0|||
105817700|NCT00150462|364992421|FG004|Overall Study|Death|0|||
105817701|NCT00150462|364992422|FG005|Overall Study|Death|0|||
105817702|NCT00150462|364992423|FG006|Overall Study|Death|0|||
105817703|NCT00150462|364992424|FG007|Overall Study|Death|0|||
105817704|NCT00150462|364992425|FG008|Overall Study|Death|1|||
105817705|NCT00150462|364992426|FG009|Overall Study|Death|0|||
105817706|NCT00150462|364992427|FG010|Overall Study|Death|0|||
105817707|NCT00150462|364992417|FG000|Overall Study|Adverse Event|0|||
105817708|NCT00150462|364992418|FG001|Overall Study|Adverse Event|0|||
105817709|NCT00150462|364992419|FG002|Overall Study|Adverse Event|0|||
105817710|NCT00150462|364992420|FG003|Overall Study|Adverse Event|1|||
105817711|NCT00150462|364992421|FG004|Overall Study|Adverse Event|0|||
105817712|NCT00150462|364992422|FG005|Overall Study|Adverse Event|0|||
105817713|NCT00150462|364992423|FG006|Overall Study|Adverse Event|0|||
105817714|NCT00150462|364992424|FG007|Overall Study|Adverse Event|2|||
105817715|NCT00150462|364992425|FG008|Overall Study|Adverse Event|0|||
105817716|NCT00150462|364992426|FG009|Overall Study|Adverse Event|1|||
105817717|NCT00150462|364992427|FG010|Overall Study|Adverse Event|0|||
105817718|NCT00150462|364992417|FG000|Overall Study|Physician Decision|0|||
105817719|NCT00150462|364992418|FG001|Overall Study|Physician Decision|0|||
105817720|NCT00150462|364992419|FG002|Overall Study|Physician Decision|1|||
105817721|NCT00150462|364992420|FG003|Overall Study|Physician Decision|1|||
105817722|NCT00150462|364992421|FG004|Overall Study|Physician Decision|0|||
105817723|NCT00150462|364992422|FG005|Overall Study|Physician Decision|0|||
105817724|NCT00150462|364992423|FG006|Overall Study|Physician Decision|0|||
105817725|NCT00150462|364992424|FG007|Overall Study|Physician Decision|0|||
105817726|NCT00150462|364992425|FG008|Overall Study|Physician Decision|0|||
105817727|NCT00150462|364992426|FG009|Overall Study|Physician Decision|0|||
105817728|NCT00150462|364992427|FG010|Overall Study|Physician Decision|0|||
105817729|NCT00150462|364992417|FG000|Overall Study|Other|0|||
105817730|NCT00150462|364992418|FG001|Overall Study|Other|0|||
105817731|NCT00150462|364992419|FG002|Overall Study|Other|0|||
105817732|NCT00150462|364992420|FG003|Overall Study|Other|0|||
105817733|NCT00150462|364992421|FG004|Overall Study|Other|0|||
105817734|NCT00150462|364992422|FG005|Overall Study|Other|0|||
105817735|NCT00150462|364992423|FG006|Overall Study|Other|0|||
105817736|NCT00150462|364992424|FG007|Overall Study|Other|0|||
105817737|NCT00150462|364992425|FG008|Overall Study|Other|0|||
105817738|NCT00150462|364992426|FG009|Overall Study|Other|1|||
105817739|NCT00150462|364992427|FG010|Overall Study|Other|1|||
105817740|NCT00625443|364992428|FG000|Overall Study|Adverse Event|1|||
105817741|NCT00625443|364992429|FG001|Overall Study|Adverse Event|4|||
105817742|NCT00625443|364992430|FG002|Overall Study|Adverse Event|0|||
105817743|NCT00625443|364992428|FG000|Overall Study|Non-compliance with protocol|0|||
105817744|NCT00625443|364992429|FG001|Overall Study|Non-compliance with protocol|1|||
105956459|NCT01194219|365502886|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
105956460|NCT01194219|365502877|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
105956461|NCT01194219|365502878|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
105956462|NCT01194219|365502879|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105956463|NCT01194219|365502880|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105817745|NCT00625443|364992430|FG002|Overall Study|Non-compliance with protocol|0|||
105817746|NCT00625443|364992428|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
105817747|NCT00625443|364992429|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
105956464|NCT01194219|365502881|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105817748|NCT00625443|364992430|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
105817749|NCT00625443|364992428|FG000|Overall Study|Withdrawal by Subject|0|||
105817750|NCT00625443|364992429|FG001|Overall Study|Withdrawal by Subject|1|||
105817751|NCT00625443|364992430|FG002|Overall Study|Withdrawal by Subject|2|||
105817752|NCT00625443|364992428|FG000|Overall Study|Physician Decision|0|||
105817753|NCT00625443|364992429|FG001|Overall Study|Physician Decision|4|||
105817754|NCT00625443|364992430|FG002|Overall Study|Physician Decision|2|||
105817755|NCT00625443|364992428|FG000|Overall Study|Other|0|||
105817756|NCT00625443|364992429|FG001|Overall Study|Other|1|||
105817757|NCT00625443|364992430|FG002|Overall Study|Other|1|||
105817758|NCT02015390|364992432|FG000|Overall Study|Lost to Follow-up|1|||
105817759|NCT02015390|364992433|FG001|Overall Study|Lost to Follow-up|0|||
105817760|NCT02015390|364992432|FG000|Overall Study|Adverse Event|0|||
105817761|NCT02015390|364992433|FG001|Overall Study|Adverse Event|3|||
105817762|NCT02015390|364992432|FG000|Overall Study|Physician Decision|0|||
105817763|NCT02015390|364992433|FG001|Overall Study|Physician Decision|1|||
105817764|NCT00184600|364992439|FG000|Overall Study|Adverse Event|9|||
105817765|NCT00184600|364992440|FG001|Overall Study|Adverse Event|0|||
105817766|NCT00184600|364992441|FG002|Overall Study|Adverse Event|5|||
105817767|NCT00184600|364992439|FG000|Overall Study|Death|3|||
105817768|NCT00184600|364992440|FG001|Overall Study|Death|9|||
105817769|NCT00184600|364992441|FG002|Overall Study|Death|7|||
105817770|NCT00184600|364992439|FG000|Overall Study|Lack of Efficacy|3|||
105817771|NCT00184600|364992440|FG001|Overall Study|Lack of Efficacy|1|||
105817772|NCT00184600|364992441|FG002|Overall Study|Lack of Efficacy|3|||
105817773|NCT00184600|364992439|FG000|Overall Study|Lost to Follow-up|4|||
105817774|NCT00184600|364992440|FG001|Overall Study|Lost to Follow-up|6|||
105817775|NCT00184600|364992441|FG002|Overall Study|Lost to Follow-up|1|||
105817776|NCT00184600|364992439|FG000|Overall Study|Protocol Violation|2|||
105817777|NCT00184600|364992440|FG001|Overall Study|Protocol Violation|2|||
105817778|NCT00184600|364992441|FG002|Overall Study|Protocol Violation|3|||
105817779|NCT00184600|364992439|FG000|Overall Study|Withdrawal by Subject|20|||
105817780|NCT00184600|364992440|FG001|Overall Study|Withdrawal by Subject|28|||
105817781|NCT00184600|364992441|FG002|Overall Study|Withdrawal by Subject|12|||
105817782|NCT00184600|364992439|FG000|Overall Study|Unclassified|4|||
105817783|NCT00184600|364992440|FG001|Overall Study|Unclassified|5|||
105817784|NCT00184600|364992441|FG002|Overall Study|Unclassified|3|||
105817785|NCT00707161|364992442|FG000|Overall Study|Physician Decision|6|||
105817786|NCT00624065|364992443|FG000|Overall Study|Adverse Event|5|||
105817787|NCT00624065|364992444|FG001|Overall Study|Adverse Event|6|||
105817788|NCT00624065|364992443|FG000|Overall Study|Lost to Follow-up|4|||
105817789|NCT00624065|364992444|FG001|Overall Study|Lost to Follow-up|1|||
105817790|NCT00624065|364992443|FG000|Overall Study|Consent withdrawn|6|||
105817791|NCT00624065|364992444|FG001|Overall Study|Consent withdrawn|5|||
105817792|NCT00624065|364992443|FG000|Overall Study|Lack of Efficacy|0|||
105817793|NCT00624065|364992444|FG001|Overall Study|Lack of Efficacy|3|||
105817794|NCT00624065|364992443|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
105817795|NCT00624065|364992444|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
105817796|NCT02661295|364992446|FG000|Overall Study|Death|1|||
105817797|NCT02661295|364992446|FG000|Overall Study|Transferred Out|1|||
105817798|NCT02661295|364992446|FG000|Overall Study|Kidney Transplant|1|||
105817799|NCT02661295|364992446|FG000|Overall Study|Withdrawn due to side effects|8|||
105817800|NCT02661295|364992446|FG000|Overall Study|Withdrawn due to access type|1|||
105817801|NCT02661295|364992446|FG000|Overall Study|Withdrawn due to allergies|1|||
105817802|NCT02661295|364992446|FG000|Overall Study|Withdrawn due to non-compliance|1|||
105817803|NCT02661295|364992446|FG000|Overall Study|Withdrawal by Subject|3|||
105817804|NCT02661295|364992446|FG000|Overall Study|Failed screening|2|||
105817805|NCT00301366|364992447|FG000|Overall Study|Adverse Event|1|||
105817806|NCT01079988|364992448|FG000|Overall Study|Lost to Follow-up|0|||
105817807|NCT01079988|364992449|FG001|Overall Study|Lost to Follow-up|0|||
105817808|NCT01079988|364992450|FG002|Overall Study|Lost to Follow-up|0|||
105817809|NCT01079988|364992451|FG003|Overall Study|Lost to Follow-up|1|||
105817810|NCT01079988|364992452|FG004|Overall Study|Lost to Follow-up|0|||
105817811|NCT01079988|364992448|FG000|Overall Study|Lack of Efficacy|1|||
105817812|NCT01079988|364992449|FG001|Overall Study|Lack of Efficacy|0|||
105817813|NCT01079988|364992450|FG002|Overall Study|Lack of Efficacy|0|||
105817814|NCT01079988|364992451|FG003|Overall Study|Lack of Efficacy|0|||
105817815|NCT01079988|364992452|FG004|Overall Study|Lack of Efficacy|0|||
105817816|NCT01079988|364992448|FG000|Overall Study|Other|0|||
105817817|NCT01079988|364992449|FG001|Overall Study|Other|0|||
105817818|NCT01079988|364992450|FG002|Overall Study|Other|0|||
105817819|NCT01079988|364992451|FG003|Overall Study|Other|2|||
105817820|NCT01079988|364992452|FG004|Overall Study|Other|1|||
105817821|NCT00304083|364992457|FG000|Overall Study|Withdrawal by Subject|4|||
105817822|NCT00304083|364992458|FG001|Overall Study|Withdrawal by Subject|2|||
105817823|NCT00304083|364992457|FG000|Overall Study|Physician Decision|8|||
105817824|NCT00304083|364992458|FG001|Overall Study|Physician Decision|3|||
105817825|NCT00304083|364992457|FG000|Overall Study|Disease Progression|5|||
105817826|NCT00304083|364992458|FG001|Overall Study|Disease Progression|1|||
105817827|NCT00304083|364992457|FG000|Overall Study|Other|5|||
105817828|NCT00304083|364992458|FG001|Overall Study|Other|2|||
105817829|NCT04419311|364992459|FG000|Overall Study|Lost to Follow-up|1|||
105817830|NCT04419311|364992460|FG001|Overall Study|Lost to Follow-up|0|||
105817831|NCT03555305|364992461|FG000|Period 1|Physician Decision|0|||
105817832|NCT03555305|364992462|FG001|Period 1|Physician Decision|1|||
105817833|NCT03555305|364992461|FG000|Period 1|Adverse Event|0|||
105817834|NCT03555305|364992462|FG001|Period 1|Adverse Event|1|||
105817835|NCT03966365|364992463|FG000|Overall Study|Protocol Violation|1|||
105817836|NCT03966365|364992464|FG001|Overall Study|Protocol Violation|0|||
105817837|NCT00095212|364992465|FG000|Overall Study|Withdrawal by Subject|1|||
105817838|NCT00095212|364992466|FG001|Overall Study|Withdrawal by Subject|3|||
105817839|NCT02216071|364992467|FG000|Overall Study|Withdrawal by Subject|7|||
105817840|NCT02216071|364992468|FG001|Overall Study|Withdrawal by Subject|2|||
105817841|NCT02216071|364992467|FG000|Overall Study|Lost to Follow-up|3|||
105817842|NCT02216071|364992468|FG001|Overall Study|Lost to Follow-up|3|||
105817843|NCT02216071|364992467|FG000|Overall Study|Protocol Violation|3|||
105817844|NCT02216071|364992468|FG001|Overall Study|Protocol Violation|5|||
105817845|NCT02216071|364992467|FG000|Overall Study|Other|2|||
105817846|NCT02216071|364992468|FG001|Overall Study|Other|2|||
105817847|NCT02335658|364992469|FG000|Overall Study|Adverse Event|18|||
105817848|NCT02335658|364992470|FG001|Overall Study|Adverse Event|12|||
105817849|NCT02335658|364992469|FG000|Overall Study|Lack of Efficacy|4|||
105817850|NCT02335658|364992470|FG001|Overall Study|Lack of Efficacy|5|||
105817851|NCT02335658|364992469|FG000|Overall Study|Pregnancy|1|||
105817852|NCT02335658|364992470|FG001|Overall Study|Pregnancy|0|||
105817853|NCT02335658|364992469|FG000|Overall Study|Withdrawal by Subject|13|||
105817854|NCT02335658|364992470|FG001|Overall Study|Withdrawal by Subject|21|||
105817855|NCT02335658|364992469|FG000|Overall Study|non-compliance|2|||
105817856|NCT02335658|364992470|FG001|Overall Study|non-compliance|3|||
105817857|NCT02335658|364992469|FG000|Overall Study|other reason|2|||
105817858|NCT02335658|364992470|FG001|Overall Study|other reason|3|||
105817859|NCT05341622|364992471|FG000|Overall Study|Death|0|||
105817860|NCT05341622|364992472|FG001|Overall Study|Death|0|||
105817861|NCT05341622|364992473|FG002|Overall Study|Death|0|||
105817862|NCT05341622|364992474|FG003|Overall Study|Death|0|||
105817863|NCT05341622|364992475|FG004|Overall Study|Death|1|||
105817864|NCT05341622|364992476|FG005|Overall Study|Death|0|||
105817865|NCT05341622|364992477|FG006|Overall Study|Death|0|||
105817866|NCT05341622|364992478|FG007|Overall Study|Death|1|||
105817867|NCT05341622|364992471|FG000|Overall Study|Invalid Address|0|||
105817868|NCT05341622|364992472|FG001|Overall Study|Invalid Address|1|||
105817869|NCT05341622|364992473|FG002|Overall Study|Invalid Address|0|||
105817870|NCT05341622|364992474|FG003|Overall Study|Invalid Address|0|||
105817871|NCT05341622|364992475|FG004|Overall Study|Invalid Address|0|||
105817872|NCT05341622|364992476|FG005|Overall Study|Invalid Address|0|||
105817873|NCT05341622|364992477|FG006|Overall Study|Invalid Address|0|||
105817874|NCT05341622|364992478|FG007|Overall Study|Invalid Address|0|||
105817875|NCT05341622|364992471|FG000|Overall Study|Ineligible|26|||
105817876|NCT05341622|364992472|FG001|Overall Study|Ineligible|21|||
105817877|NCT05341622|364992473|FG002|Overall Study|Ineligible|28|||
105817878|NCT05341622|364992474|FG003|Overall Study|Ineligible|24|||
105817879|NCT05341622|364992475|FG004|Overall Study|Ineligible|29|||
105817880|NCT05341622|364992476|FG005|Overall Study|Ineligible|31|||
105817881|NCT05341622|364992477|FG006|Overall Study|Ineligible|28|||
105956465|NCT01194219|365502882|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105956466|NCT01194219|365502883|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105956467|NCT01194219|365502884|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105956468|NCT01194219|365502885|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105956469|NCT01194219|365502886|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
105956470|NCT01194219|365502877|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956471|NCT01194219|365502878|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
105956472|NCT01194219|365502879|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956473|NCT01194219|365502880|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956474|NCT01194219|365502881|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956475|NCT01194219|365502882|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956476|NCT01194219|365502883|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956477|NCT01194219|365502884|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956478|NCT01194219|365502885|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956479|NCT01194219|365502886|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
105956480|NCT01194219|365502877|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
105956481|NCT01194219|365502878|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
105956482|NCT01194219|365502879|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105817882|NCT05341622|364992478|FG007|Overall Study|Ineligible|26|||
105817883|NCT02658084|364992479|FG000|Overall Study|Withdrawal by Subject|1|||
105817884|NCT02658084|364992480|FG001|Overall Study|Withdrawal by Subject|0|||
105956483|NCT01194219|365502880|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105956484|NCT01194219|365502881|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105956485|NCT01194219|365502882|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105956486|NCT01194219|365502883|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105956487|NCT01194219|365502884|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105956488|NCT01194219|365502885|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
105956489|NCT01194219|365502886|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
106018670|NCT01519921|365730733|FG001|Overall Study|Adverse Event|9|||
105817885|NCT02658084|364992479|FG000|Overall Study|Study Termination|1|||
105817886|NCT02658084|364992480|FG001|Overall Study|Study Termination|0|||
105817887|NCT01880593|364992483|FG000|Overall Study|Adverse Event|1|||
105817888|NCT01880593|364992484|FG001|Overall Study|Adverse Event|0|||
105817889|NCT01880593|364992483|FG000|Overall Study|Lack of Efficacy|1|||
105817890|NCT01880593|364992484|FG001|Overall Study|Lack of Efficacy|5|||
105817891|NCT01880593|364992483|FG000|Overall Study|Withdrawal by Subject|6|||
105817892|NCT01880593|364992484|FG001|Overall Study|Withdrawal by Subject|1|||
105817893|NCT05275205|364992492|FG000|Overall Study|Adverse Event|1|||
105817894|NCT05275205|364992493|FG001|Overall Study|Adverse Event|2|||
105817895|NCT05275205|364992492|FG000|Overall Study|Physician Decision|1|||
105817896|NCT05275205|364992493|FG001|Overall Study|Physician Decision|1|||
105817897|NCT05275205|364992492|FG000|Overall Study|Withdrawal by Subject|2|||
105817898|NCT05275205|364992493|FG001|Overall Study|Withdrawal by Subject|3|||
105817899|NCT05275205|364992492|FG000|Overall Study|Death|1|||
105817900|NCT05275205|364992493|FG001|Overall Study|Death|0|||
105817901|NCT05275205|364992492|FG000|Overall Study|Patient unable to attend visits|1|||
105817902|NCT05275205|364992493|FG001|Overall Study|Patient unable to attend visits|0|||
105817903|NCT02024932|364992494|FG000|Overall Study|Adverse Event|2|||
105817904|NCT02024932|364992495|FG001|Overall Study|Adverse Event|3|||
105817905|NCT02024932|364992496|FG002|Overall Study|Adverse Event|0|||
105817906|NCT02024932|364992497|FG003|Overall Study|Adverse Event|0|||
105817907|NCT02024932|364992498|FG004|Overall Study|Adverse Event|2|||
105817908|NCT02024932|364992499|FG005|Overall Study|Adverse Event|0|||
105817909|NCT02024932|364992494|FG000|Overall Study|Abnormal laboratory value|0|||
105817910|NCT02024932|364992495|FG001|Overall Study|Abnormal laboratory value|0|||
105817911|NCT02024932|364992496|FG002|Overall Study|Abnormal laboratory value|0|||
105817912|NCT02024932|364992497|FG003|Overall Study|Abnormal laboratory value|2|||
105817913|NCT02024932|364992498|FG004|Overall Study|Abnormal laboratory value|0|||
105817914|NCT02024932|364992499|FG005|Overall Study|Abnormal laboratory value|0|||
105817915|NCT03020641|364992500|FG000|Overall Study|Lost to Follow-up|0|||
105817916|NCT03020641|364992501|FG001|Overall Study|Lost to Follow-up|1|||
105817917|NCT03020641|364992500|FG000|Overall Study|Converted to open surgery|2|||
105817918|NCT03020641|364992501|FG001|Overall Study|Converted to open surgery|1|||
105817919|NCT03020641|364992500|FG000|Overall Study|for surgery not performed|0|||
105817920|NCT03020641|364992501|FG001|Overall Study|for surgery not performed|1|||
105817921|NCT02653664|364994224|FG000|Post-Treatment|Withdrawal by Subject|6|||
105817922|NCT02653664|364994225|FG001|Post-Treatment|Withdrawal by Subject|5|||
105817923|NCT02653664|364994226|FG002|Post-Treatment|Withdrawal by Subject|7|||
105817924|NCT02653664|364994224|FG000|Post-Treatment|Lost to Follow-up|8|||
105817925|NCT02653664|364994225|FG001|Post-Treatment|Lost to Follow-up|1|||
105817926|NCT02653664|364994226|FG002|Post-Treatment|Lost to Follow-up|7|||
105817927|NCT02653664|364994224|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
105817928|NCT02653664|364994225|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
105817929|NCT02653664|364994226|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
105817930|NCT02653664|364994224|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
105817931|NCT02653664|364994225|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
105817932|NCT02653664|364994226|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
105817933|NCT02653664|364994224|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
105817934|NCT02653664|364994225|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
105817935|NCT02653664|364994226|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
105817936|NCT02653664|364994224|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
105817937|NCT02653664|364994225|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
105817938|NCT02653664|364994226|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
105817939|NCT02653664|364994224|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
105817940|NCT02653664|364994225|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
105817941|NCT02653664|364994226|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
105817942|NCT02653664|364994224|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
105817943|NCT02653664|364994225|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
105817944|NCT02653664|364994226|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
105817945|NCT02653664|364994224|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
105817946|NCT02653664|364994225|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
105817947|NCT02653664|364994226|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
105817948|NCT02653664|364994224|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
105817949|NCT02653664|364994225|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
105817950|NCT02653664|364994226|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
105817951|NCT03655106|364994227|FG000|Overall Study|Withdrawal by Subject|3|||
105817952|NCT03655106|364994228|FG001|Overall Study|Withdrawal by Subject|2|||
105817953|NCT03655106|364994227|FG000|Overall Study|Lost to Follow-up|2|||
105817954|NCT03655106|364994228|FG001|Overall Study|Lost to Follow-up|1|||
105817955|NCT03655106|364994227|FG000|Overall Study|Duplicate Enrollment|1|||
105817956|NCT03655106|364994228|FG001|Overall Study|Duplicate Enrollment|1|||
106145403|NCT03473340|366191962|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
105817957|NCT03655106|364994227|FG000|Overall Study|Protocol Violation|3|||
105817958|NCT03655106|364994228|FG001|Overall Study|Protocol Violation|0|||
105817959|NCT03497897|364994231|FG000|Overall Study|Adverse Event|1|||
105817960|NCT03497897|364994232|FG001|Overall Study|Adverse Event|1|||
105817961|NCT03497897|364994233|FG002|Overall Study|Adverse Event|1|||
105817962|NCT03497897|364994231|FG000|Overall Study|Lost to Follow-up|2|||
105817963|NCT03497897|364994232|FG001|Overall Study|Lost to Follow-up|0|||
105817964|NCT03497897|364994233|FG002|Overall Study|Lost to Follow-up|2|||
105817965|NCT03497897|364994231|FG000|Overall Study|Physician Decision|1|||
105817966|NCT03497897|364994232|FG001|Overall Study|Physician Decision|0|||
105817967|NCT03497897|364994233|FG002|Overall Study|Physician Decision|0|||
105817968|NCT03497897|364994231|FG000|Overall Study|Subject/Guardian Decision|2|||
105817969|NCT03497897|364994232|FG001|Overall Study|Subject/Guardian Decision|1|||
105817970|NCT03497897|364994233|FG002|Overall Study|Subject/Guardian Decision|3|||
105817971|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817972|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817973|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
105817974|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817975|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817976|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817977|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
105817978|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
105817979|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817980|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817981|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817982|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817983|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817984|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
105817985|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
105956490|NCT01194219|365502877|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
105956491|NCT01194219|365502878|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
105956492|NCT01194219|365502879|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105956493|NCT01194219|365502880|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105956494|NCT01194219|365502881|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105956495|NCT01194219|365502882|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105956496|NCT01194219|365502883|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105956497|NCT01194219|365502884|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105956498|NCT01194219|365502885|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105956499|NCT01194219|365502886|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
105956500|NCT01194219|365502877|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
105956501|NCT01194219|365502878|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
105956502|NCT01194219|365502879|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105956503|NCT01194219|365502880|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105956504|NCT01194219|365502881|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105956505|NCT01194219|365502882|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105956506|NCT01194219|365502883|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105956507|NCT01194219|365502884|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105956508|NCT01194219|365502885|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105956509|NCT01194219|365502886|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
105956510|NCT01194219|365502877|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
105956511|NCT01194219|365502878|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
105956512|NCT01194219|365502879|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
105956513|NCT01194219|365502880|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
105956514|NCT01194219|365502881|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
105956515|NCT01194219|365502882|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
105956516|NCT01194219|365502883|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
105956517|NCT01194219|365502884|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
105956518|NCT01194219|365502885|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
105956519|NCT01194219|365502886|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
105956520|NCT01194219|365502877|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105956521|NCT01194219|365502878|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105956522|NCT01194219|365502879|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
106018671|NCT01519921|365730732|FG000|Overall Study|Lack of Efficacy|4|||
106018672|NCT01519921|365730733|FG001|Overall Study|Lack of Efficacy|3|||
106018673|NCT01519921|365730732|FG000|Overall Study|Withdrawal by Subject|3|||
105817986|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
105817987|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
105817988|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
105817989|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
105817990|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
105956523|NCT01194219|365502880|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
105956524|NCT01194219|365502881|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105956525|NCT01194219|365502882|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105956526|NCT01194219|365502883|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
106018674|NCT01519921|365730733|FG001|Overall Study|Withdrawal by Subject|0|||
106018675|NCT01519921|365730732|FG000|Overall Study|Lost to Follow-up|2|||
105817991|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
105817992|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817993|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817994|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
105817995|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817996|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817997|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817998|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
105817999|NCT00723528|364994236|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
105818000|NCT00723528|364994237|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818001|NCT00723528|364994238|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
105818002|NCT00723528|364994239|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818003|NCT00723528|364994240|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818004|NCT00723528|364994241|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818005|NCT00723528|364994242|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
105818006|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
105818007|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
105818008|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
105818009|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
105818010|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
105818011|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
105818012|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
105818013|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818014|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818015|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818016|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818017|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818018|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
105818019|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
105818020|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Other|0|||
105818021|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Other|0|||
105818022|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Other|0|||
105818023|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Other|0|||
105818024|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Other|1|||
105818025|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Other|4|||
105818026|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Other|0|||
105818027|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Adverse Event|0|||
105818028|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Adverse Event|0|||
105818029|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Adverse Event|0|||
105818030|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Adverse Event|0|||
105818031|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Adverse Event|1|||
105818032|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Adverse Event|0|||
105818033|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Adverse Event|1|||
105818034|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818035|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818036|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818037|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818038|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818039|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
105818040|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
106018676|NCT01519921|365730733|FG001|Overall Study|Lost to Follow-up|1|||
106018677|NCT01519921|365730732|FG000|Overall Study|Treatment refusal|2|||
105818041|NCT00723528|364994236|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818042|NCT00723528|364994237|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818043|NCT00723528|364994238|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818044|NCT00723528|364994239|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818045|NCT00723528|364994240|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818046|NCT00723528|364994241|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
105818047|NCT00723528|364994242|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
105818048|NCT03785548|364994243|FG000|Overall Study|age > 80|1|||
105818049|NCT03785548|364994244|FG001|Overall Study|age > 80|0|||
105818050|NCT03785548|364994243|FG000|Overall Study|no Postop queries|1|||
106018678|NCT01519921|365730733|FG001|Overall Study|Treatment refusal|1|||
106018679|NCT01519921|365730732|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
105818051|NCT03785548|364994244|FG001|Overall Study|no Postop queries|0|||
105818052|NCT01710657|364994247|FG000|Overall Study|Lost to Follow-up|2|||
105818053|NCT01710657|364994248|FG001|Overall Study|Lost to Follow-up|0|||
105818054|NCT01710657|364994249|FG002|Overall Study|Lost to Follow-up|1|||
105818055|NCT01710657|364994247|FG000|Overall Study|Protocol Violation|2|||
105818056|NCT01710657|364994248|FG001|Overall Study|Protocol Violation|2|||
105818057|NCT01710657|364994249|FG002|Overall Study|Protocol Violation|0|||
105818058|NCT01710657|364994247|FG000|Overall Study|Adverse Event|14|||
105818059|NCT01710657|364994248|FG001|Overall Study|Adverse Event|8|||
105818060|NCT01710657|364994249|FG002|Overall Study|Adverse Event|28|||
105818061|NCT01710657|364994247|FG000|Overall Study|Withdrawal by Subject|0|||
105818062|NCT01710657|364994248|FG001|Overall Study|Withdrawal by Subject|1|||
105818063|NCT01710657|364994249|FG002|Overall Study|Withdrawal by Subject|2|||
105818064|NCT01710657|364994247|FG000|Overall Study|Lack of Efficacy|0|||
105818065|NCT01710657|364994248|FG001|Overall Study|Lack of Efficacy|1|||
105818066|NCT01710657|364994249|FG002|Overall Study|Lack of Efficacy|1|||
105818067|NCT00905346|364994261|FG000|Period 1|Withdrawal by Subject|1|||
105818068|NCT00905346|364994262|FG001|Period 1|Withdrawal by Subject|0|||
105818069|NCT04605094|364994263|FG000|Overall Study|Adverse Event|2|||
105818070|NCT04605094|364994264|FG001|Overall Study|Adverse Event|2|||
105818071|NCT04605094|364994263|FG000|Overall Study|Lost to Follow-up|1|||
105818072|NCT04605094|364994264|FG001|Overall Study|Lost to Follow-up|4|||
105818073|NCT04605094|364994263|FG000|Overall Study|Physician Decision|2|||
105818074|NCT04605094|364994264|FG001|Overall Study|Physician Decision|2|||
105818075|NCT04605094|364994263|FG000|Overall Study|Study terminated by Sponsor|31|||
105818076|NCT04605094|364994264|FG001|Overall Study|Study terminated by Sponsor|33|||
105818077|NCT04605094|364994263|FG000|Overall Study|Withdrawal by Subject|22|||
105818078|NCT04605094|364994264|FG001|Overall Study|Withdrawal by Subject|19|||
105818079|NCT04605094|364994263|FG000|Overall Study|Other|1|||
105818080|NCT04605094|364994264|FG001|Overall Study|Other|1|||
105818081|NCT01149473|364994265|FG000|First Intervention|Adverse Event|1|||
105818082|NCT01149473|364994266|FG001|First Intervention|Adverse Event|1|||
105818083|NCT01149473|364994265|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105818084|NCT01149473|364994266|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105818085|NCT00469417|364994267|FG000|Overall Study|Treatment failure all lesions|18|||
105818086|NCT00469417|364994268|FG001|Overall Study|Treatment failure all lesions|11|||
105818087|NCT00469417|364994267|FG000|Overall Study|Consent withdrawn|1|||
105818088|NCT00469417|364994268|FG001|Overall Study|Consent withdrawn|1|||
105818089|NCT00469417|364994267|FG000|Overall Study|Adverse Event|8|||
105818090|NCT00469417|364994268|FG001|Overall Study|Adverse Event|2|||
105818091|NCT00469417|364994267|FG000|Overall Study|Lost to Follow-up|1|||
105818092|NCT00469417|364994268|FG001|Overall Study|Lost to Follow-up|2|||
105818093|NCT00469417|364994267|FG000|Overall Study|Intercurrent disease|0|||
105818094|NCT00469417|364994268|FG001|Overall Study|Intercurrent disease|1|||
105818095|NCT00469417|364994267|FG000|Overall Study|Randomized but not treated|2|||
105818096|NCT00469417|364994268|FG001|Overall Study|Randomized but not treated|0|||
105818097|NCT04206332|364994274|FG000|Part A|Lost to Follow-up|0|||
105818098|NCT04206332|364994275|FG001|Part A|Lost to Follow-up|1|||
105818099|NCT04206332|364994276|FG002|Part A|Lost to Follow-up|0|||
105818100|NCT04206332|364994277|FG003|Part A|Lost to Follow-up|0|||
105818101|NCT04206332|364994278|FG004|Part A|Lost to Follow-up|0|||
105818102|NCT04206332|364994279|FG005|Part A|Lost to Follow-up|0|||
105818103|NCT04206332|364994280|FG006|Part A|Lost to Follow-up|0|||
105818104|NCT04206332|364994281|FG007|Part A|Lost to Follow-up|0|||
105818105|NCT04206332|364994282|FG008|Part A|Lost to Follow-up|0|||
105818106|NCT04206332|364994283|FG009|Part A|Lost to Follow-up|0|||
105818107|NCT04206332|364994284|FG010|Part A|Lost to Follow-up|0|||
105818108|NCT04206332|364994285|FG011|Part A|Lost to Follow-up|0|||
106018680|NCT01519921|365730733|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
106018681|NCT02500797|365730734|FG000|Overall Study|Cancel (rapid disease progression)|0|||
106018682|NCT02500797|365730735|FG001|Overall Study|Cancel (rapid disease progression)|0|||
105818109|NCT04206332|364994286|FG012|Part A|Lost to Follow-up|0|||
105818110|NCT04206332|364994287|FG013|Part A|Lost to Follow-up|0|||
105818111|NCT04206332|364994288|FG014|Part A|Lost to Follow-up|0|||
105818112|NCT04206332|364994289|FG015|Part A|Lost to Follow-up|0|||
105818113|NCT04206332|364994290|FG016|Part A|Lost to Follow-up|0|||
105818114|NCT04206332|364994274|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818115|NCT04206332|364994275|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818116|NCT04206332|364994276|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818117|NCT04206332|364994277|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
106018683|NCT02500797|365730736|FG002|Overall Study|Cancel (rapid disease progression)|0|||
105818118|NCT04206332|364994278|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818119|NCT04206332|364994279|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
105818120|NCT04206332|364994280|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818121|NCT04206332|364994281|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105956527|NCT01194219|365502884|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105956528|NCT01194219|365502885|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105956529|NCT01194219|365502886|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
105956530|NCT01194219|365502877|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105956531|NCT01194219|365502878|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105956532|NCT01194219|365502879|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
105956533|NCT01194219|365502880|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
105956534|NCT01194219|365502881|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105956535|NCT01194219|365502882|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105956536|NCT01194219|365502883|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105956537|NCT01194219|365502884|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105956538|NCT01194219|365502885|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
106018684|NCT02500797|365730737|FG003|Overall Study|Cancel (rapid disease progression)|0|||
105765509|NCT02204410|364793682|FG000|Overall Study|Withdrawal by Subject|3|||
105765510|NCT00209092|364793687|FG000|Overall Study|Progression of disease|7|||
105765511|NCT00209092|364793688|FG001|Overall Study|Progression of disease|1|||
105765512|NCT00209092|364793687|FG000|Overall Study|Adverse Event|0|||
105765513|NCT00209092|364793688|FG001|Overall Study|Adverse Event|1|||
105765514|NCT00209092|364793687|FG000|Overall Study|Withdrawal by Subject|1|||
105765515|NCT00209092|364793688|FG001|Overall Study|Withdrawal by Subject|0|||
105765516|NCT02853123|364793690|FG000|Treatment Period 1|Adverse Event|0|||
105765517|NCT02853123|364793691|FG001|Treatment Period 1|Adverse Event|3|||
105765518|NCT02853123|364793690|FG000|Washout Period|Worsening of COPD|0|||
105765519|NCT02853123|364793691|FG001|Washout Period|Worsening of COPD|3|||
105765520|NCT02853123|364793690|FG000|Washout Period|Adverse Event|1|||
105765521|NCT02853123|364793691|FG001|Washout Period|Adverse Event|0|||
105765522|NCT01235338|364793692|FG000|Overall Study|Adverse Event|3|||
105765523|NCT01235338|364793693|FG001|Overall Study|Adverse Event|2|||
105765524|NCT01235338|364793692|FG000|Overall Study|Protocol Violation|1|||
105765525|NCT01235338|364793693|FG001|Overall Study|Protocol Violation|1|||
105765526|NCT01235338|364793692|FG000|Overall Study|Withdrawal by Subject|5|||
105765527|NCT01235338|364793693|FG001|Overall Study|Withdrawal by Subject|0|||
105765528|NCT01235338|364793692|FG000|Overall Study|Exclusion criteria violations|1|||
105765529|NCT01235338|364793693|FG001|Overall Study|Exclusion criteria violations|1|||
105765530|NCT01235338|364793692|FG000|Overall Study|Positive drug screen|0|||
105765531|NCT01235338|364793693|FG001|Overall Study|Positive drug screen|1|||
105765532|NCT01235338|364793692|FG000|Overall Study|Prohibited meds|1|||
105765533|NCT01235338|364793693|FG001|Overall Study|Prohibited meds|0|||
105765534|NCT02809118|364793696|FG000|Overall Study|Withdrawal by Subject|0|||
105765535|NCT02809118|364793697|FG001|Overall Study|Withdrawal by Subject|1|||
105765536|NCT02809118|364793698|FG002|Overall Study|Withdrawal by Subject|1|||
105765537|NCT01495689|364793703|FG000|Overall Study|Death|0|||
105765538|NCT01495689|364793704|FG001|Overall Study|Death|1|||
105765539|NCT01495689|364793703|FG000|Overall Study|Withdrawal by Subject|3|||
105765540|NCT01495689|364793704|FG001|Overall Study|Withdrawal by Subject|0|||
105765541|NCT01495689|364793703|FG000|Overall Study|Lost to Follow-up|7|||
105765542|NCT01495689|364793704|FG001|Overall Study|Lost to Follow-up|6|||
105765543|NCT01843205|364793705|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
105765544|NCT01843205|364793706|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
105765545|NCT00517413|364793707|FG000|Overall Study|Adverse Event|7|||
105765546|NCT00517413|364793707|FG000|Overall Study|Death|13|||
105765547|NCT00517413|364793707|FG000|Overall Study|Protocol Violation|15|||
105765548|NCT00517413|364793707|FG000|Overall Study|Withdrawal by Subject|2|||
105765549|NCT00517413|364793707|FG000|Overall Study|Failure to return|1|||
105765550|NCT00517413|364793707|FG000|Overall Study|Other-Reasons|23|||
105765551|NCT01355497|364793708|FG000|Overall Study|Death|19|||
105765552|NCT01355497|364793709|FG001|Overall Study|Death|18|||
105765553|NCT01355497|364793708|FG000|Overall Study|Lost to Follow-up|3|||
105765554|NCT01355497|364793709|FG001|Overall Study|Lost to Follow-up|0|||
105765555|NCT01355497|364793708|FG000|Overall Study|Protocol Violation|0|||
105765556|NCT01355497|364793709|FG001|Overall Study|Protocol Violation|1|||
105765557|NCT01355497|364793708|FG000|Overall Study|other-not provided|9|||
105765558|NCT01355497|364793709|FG001|Overall Study|other-not provided|4|||
105765559|NCT01355497|364793708|FG000|Overall Study|Withdrawal by Subject|12|||
105765560|NCT01355497|364793709|FG001|Overall Study|Withdrawal by Subject|20|||
105765561|NCT01355497|364793708|FG000|Overall Study|noncompliance|1|||
105765562|NCT01355497|364793709|FG001|Overall Study|noncompliance|2|||
105765563|NCT01355497|364793708|FG000|Overall Study|progressive disease|11|||
105765564|NCT01355497|364793709|FG001|Overall Study|progressive disease|8|||
105765565|NCT01355497|364793708|FG000|Overall Study|Adverse Event|11|||
105765566|NCT01355497|364793709|FG001|Overall Study|Adverse Event|10|||
105765567|NCT02741310|364793710|FG000|Overall Study|Sponsor Decision|2|||
105765568|NCT02741310|364793711|FG001|Overall Study|Sponsor Decision|2|||
105765569|NCT01784211|364793715|FG000|Part A (Days 1-15)|Adverse Event|1|||
105765570|NCT01784211|364793716|FG001|Part A (Days 1-15)|Adverse Event|1|||
105765571|NCT01784211|364793717|FG002|Part A (Days 1-15)|Adverse Event|0|||
105818122|NCT04206332|364994282|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818123|NCT04206332|364994283|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818124|NCT04206332|364994284|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818125|NCT04206332|364994285|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818126|NCT04206332|364994286|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818127|NCT04206332|364994287|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818128|NCT04206332|364994288|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818129|NCT04206332|364994289|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818130|NCT04206332|364994290|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
105818131|NCT04206332|364994274|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818132|NCT04206332|364994275|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818133|NCT04206332|364994276|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818134|NCT04206332|364994277|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818135|NCT04206332|364994278|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818136|NCT04206332|364994279|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818137|NCT04206332|364994280|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818138|NCT04206332|364994281|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
105818139|NCT04206332|364994282|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818140|NCT04206332|364994283|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818141|NCT04206332|364994284|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
105818142|NCT04206332|364994285|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818143|NCT04206332|364994286|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818144|NCT04206332|364994287|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105956539|NCT01194219|365502886|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
105956540|NCT01194219|365502877|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105818145|NCT04206332|364994288|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818146|NCT04206332|364994289|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818147|NCT04206332|364994290|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818148|NCT04206332|364994274|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818149|NCT04206332|364994275|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818150|NCT04206332|364994276|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818151|NCT04206332|364994277|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818152|NCT04206332|364994278|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818153|NCT04206332|364994279|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818154|NCT04206332|364994280|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818155|NCT04206332|364994281|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818156|NCT04206332|364994282|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818157|NCT04206332|364994283|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818158|NCT04206332|364994284|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818159|NCT04206332|364994285|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818160|NCT04206332|364994286|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818161|NCT04206332|364994287|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818162|NCT04206332|364994288|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818163|NCT04206332|364994289|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
105818164|NCT04206332|364994290|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
105818165|NCT04206332|364994274|FG000|Part C|Withdrawal by Subject|0|||
105818166|NCT04206332|364994275|FG001|Part C|Withdrawal by Subject|0|||
105956541|NCT01194219|365502878|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105956542|NCT01194219|365502879|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
105956543|NCT01194219|365502880|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
105956544|NCT01194219|365502881|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105956545|NCT01194219|365502882|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105818167|NCT04206332|364994276|FG002|Part C|Withdrawal by Subject|0|||
105818168|NCT04206332|364994277|FG003|Part C|Withdrawal by Subject|0|||
105818169|NCT04206332|364994278|FG004|Part C|Withdrawal by Subject|0|||
105818170|NCT04206332|364994279|FG005|Part C|Withdrawal by Subject|0|||
105818171|NCT04206332|364994280|FG006|Part C|Withdrawal by Subject|0|||
105818172|NCT04206332|364994281|FG007|Part C|Withdrawal by Subject|0|||
105818173|NCT04206332|364994282|FG008|Part C|Withdrawal by Subject|0|||
105818174|NCT04206332|364994283|FG009|Part C|Withdrawal by Subject|0|||
105818175|NCT04206332|364994284|FG010|Part C|Withdrawal by Subject|0|||
105818176|NCT04206332|364994285|FG011|Part C|Withdrawal by Subject|0|||
105818177|NCT04206332|364994286|FG012|Part C|Withdrawal by Subject|0|||
105818178|NCT04206332|364994287|FG013|Part C|Withdrawal by Subject|0|||
105818179|NCT04206332|364994288|FG014|Part C|Withdrawal by Subject|2|||
105818180|NCT04206332|364994289|FG015|Part C|Withdrawal by Subject|0|||
105818181|NCT04206332|364994290|FG016|Part C|Withdrawal by Subject|0|||
105818182|NCT04567186|364994300|FG000|Period 1|COVID-19 related|1|||
105818183|NCT04567186|364994301|FG001|Period 1|COVID-19 related|0|||
105818184|NCT04567186|364994300|FG000|Period 1|Protocol Violation|0|||
105818185|NCT04567186|364994301|FG001|Period 1|Protocol Violation|1|||
105818186|NCT04567186|364994300|FG000|Period 1|Adverse Event|0|||
105818187|NCT04567186|364994301|FG001|Period 1|Adverse Event|2|||
105818188|NCT04567186|364994300|FG000|Period 2|COVID-19 Related|0|||
105818189|NCT04567186|364994301|FG001|Period 2|COVID-19 Related|1|||
105818190|NCT04567186|364994300|FG000|Period 2|Protocol Violation|0|||
105818191|NCT04567186|364994301|FG001|Period 2|Protocol Violation|1|||
105818192|NCT04567186|364994300|FG000|Period 2|Lost to Follow-up|0|||
105818193|NCT04567186|364994301|FG001|Period 2|Lost to Follow-up|1|||
105818194|NCT04567186|364994300|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
105818195|NCT04567186|364994301|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
105818196|NCT02193880|364994302|FG000|Overall Study|patients did not collect enough HPC|3|||
105818197|NCT03136380|364994303|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105818198|NCT03136380|364994304|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
105818199|NCT03136380|364994305|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105818200|NCT03136380|364994306|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105818201|NCT03136380|364994307|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
105818202|NCT02728102|364994308|FG000|Overall Study|Death|3|||
105818203|NCT02728102|364994309|FG001|Overall Study|Death|0|||
105818204|NCT02728102|364994310|FG002|Overall Study|Death|1|||
105818205|NCT02728102|364994308|FG000|Overall Study|Withdrawal by Subject|0|||
105818206|NCT02728102|364994309|FG001|Overall Study|Withdrawal by Subject|2|||
105818207|NCT02728102|364994310|FG002|Overall Study|Withdrawal by Subject|3|||
105818208|NCT02728102|364994308|FG000|Overall Study|Physician Decision|1|||
105818209|NCT02728102|364994309|FG001|Overall Study|Physician Decision|1|||
105818210|NCT02728102|364994310|FG002|Overall Study|Physician Decision|0|||
105818211|NCT02728102|364994308|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
105818212|NCT02728102|364994309|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
105818213|NCT02728102|364994310|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
105818214|NCT02728102|364994308|FG000|Overall Study|Covid|0|||
105818215|NCT02728102|364994309|FG001|Overall Study|Covid|0|||
105818216|NCT02728102|364994310|FG002|Overall Study|Covid|1|||
105818217|NCT02419937|364994313|FG000|Overall Study|Lost to Follow-up|1|||
105818218|NCT02419937|364994314|FG001|Overall Study|Lost to Follow-up|0|||
105818219|NCT02924883|364994315|FG000|Overall Study|Death|39|||
105818220|NCT02924883|364994316|FG001|Overall Study|Death|20|||
105818221|NCT02924883|364994315|FG000|Overall Study|Lost to Follow-up|1|||
105818222|NCT02924883|364994316|FG001|Overall Study|Lost to Follow-up|0|||
105818223|NCT02924883|364994315|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
105818224|NCT02924883|364994316|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
105818225|NCT02924883|364994315|FG000|Overall Study|Protocol Violation|1|||
105818226|NCT02924883|364994316|FG001|Overall Study|Protocol Violation|0|||
105818227|NCT02924883|364994315|FG000|Overall Study|Withdrawal by Subject|22|||
105818228|NCT02924883|364994316|FG001|Overall Study|Withdrawal by Subject|16|||
105818229|NCT02924883|364994315|FG000|Overall Study|Progressive Disease|1|||
105818230|NCT02924883|364994316|FG001|Overall Study|Progressive Disease|0|||
105956546|NCT01194219|365502883|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105818231|NCT02924883|364994315|FG000|Overall Study|Study Terminated by Sponsor|69|||
105818232|NCT02924883|364994316|FG001|Overall Study|Study Terminated by Sponsor|32|||
105818233|NCT02794974|364994321|FG000|Overall Study|Physician Decision|0|||
105818234|NCT02794974|364994322|FG001|Overall Study|Physician Decision|1|||
105818235|NCT03699020|364994323|FG000|Overall Study|Withdrawal by Subject|3|||
105818236|NCT03699020|364994324|FG001|Overall Study|Withdrawal by Subject|2|||
105818237|NCT01873586|364994325|FG000|Overall Study|Lost to Follow-up|3|||
105818238|NCT01256684|364994326|FG000|Overall Study|Adverse Event|1|||
105956547|NCT01194219|365502884|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105818239|NCT01256684|364994327|FG001|Overall Study|Adverse Event|4|||
105818240|NCT01256684|364994328|FG002|Overall Study|Adverse Event|2|||
105818241|NCT01256684|364994326|FG000|Overall Study|Withdrawal by Subject|4|||
105818242|NCT01256684|364994327|FG001|Overall Study|Withdrawal by Subject|0|||
105818243|NCT01256684|364994328|FG002|Overall Study|Withdrawal by Subject|2|||
105818244|NCT01256684|364994326|FG000|Overall Study|Physician Decision|0|||
105818245|NCT01256684|364994327|FG001|Overall Study|Physician Decision|1|||
105818246|NCT01256684|364994328|FG002|Overall Study|Physician Decision|0|||
105818247|NCT01256684|364994326|FG000|Overall Study|Lack of Efficacy|0|||
105818248|NCT01256684|364994327|FG001|Overall Study|Lack of Efficacy|1|||
105818249|NCT01256684|364994328|FG002|Overall Study|Lack of Efficacy|1|||
105818250|NCT01256684|364994326|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
105818251|NCT01256684|364994327|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
105818252|NCT01256684|364994328|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
105818253|NCT01981720|364994329|FG000|Overall Study|Adverse Event|1|||
105818254|NCT01981720|364994329|FG000|Overall Study|Withdrawal by Subject|3|||
105818255|NCT01981720|364994329|FG000|Overall Study|Pregnancy|1|||
105818256|NCT02246920|364994330|FG000|Overall Study|Adverse Event|3|||
105818257|NCT02246920|364994331|FG001|Overall Study|Adverse Event|1|||
105818258|NCT02246920|364994332|FG002|Overall Study|Adverse Event|1|||
105818259|NCT02246920|364994330|FG000|Overall Study|Lost to Follow-up|2|||
105818260|NCT02246920|364994331|FG001|Overall Study|Lost to Follow-up|1|||
105818261|NCT02246920|364994332|FG002|Overall Study|Lost to Follow-up|0|||
105818262|NCT02246920|364994330|FG000|Overall Study|Protocol Violation|2|||
105818263|NCT02246920|364994331|FG001|Overall Study|Protocol Violation|5|||
105818264|NCT02246920|364994332|FG002|Overall Study|Protocol Violation|1|||
105818265|NCT02246920|364994330|FG000|Overall Study|Withdrawal by Subject|0|||
105818266|NCT02246920|364994331|FG001|Overall Study|Withdrawal by Subject|0|||
105818267|NCT02246920|364994332|FG002|Overall Study|Withdrawal by Subject|1|||
105818268|NCT01185548|364994333|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
105818269|NCT02678286|364994334|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
105818270|NCT02678286|364994335|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
105818271|NCT02678286|364994334|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
105818272|NCT02678286|364994335|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
105818273|NCT02678286|364994334|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
105818274|NCT02678286|364994335|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
105818275|NCT02678286|364994334|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
105818276|NCT02678286|364994335|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
105818277|NCT02678286|364994334|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
105818278|NCT02678286|364994335|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
105818279|NCT00086996|364994337|FG000|Overall Study|Adverse Event|29|||
105818280|NCT00086996|364994337|FG000|Overall Study|Death|4|||
105818281|NCT00086996|364994337|FG000|Overall Study|progression/relapse|7|||
105818282|NCT00086996|364994337|FG000|Overall Study|Withdrawal by Subject|13|||
105818283|NCT00086996|364994337|FG000|Overall Study|Other|6|||
105818284|NCT00086996|364994337|FG000|Overall Study|not eligible|5|||
105818285|NCT01422538|364994340|FG000|Overall Study|Lost to Follow-up|0|||
105818286|NCT01422538|364994341|FG001|Overall Study|Lost to Follow-up|1|||
105818287|NCT01422538|364994342|FG002|Overall Study|Lost to Follow-up|1|||
105818288|NCT01422538|364994340|FG000|Overall Study|Missed visit|0|||
105818289|NCT01422538|364994341|FG001|Overall Study|Missed visit|1|||
105956548|NCT01194219|365502885|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105956549|NCT01194219|365502886|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
105956550|NCT01194219|365502877|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956551|NCT01194219|365502878|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956552|NCT01194219|365502879|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
105956553|NCT01194219|365502880|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956554|NCT01194219|365502881|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956555|NCT01194219|365502882|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956556|NCT01194219|365502883|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956557|NCT01194219|365502884|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956558|NCT01194219|365502885|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956559|NCT01194219|365502886|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
105956560|NCT01194219|365502877|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956561|NCT01194219|365502878|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956562|NCT01194219|365502879|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956563|NCT01194219|365502880|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
105818290|NCT01422538|364994342|FG002|Overall Study|Missed visit|1|||
105818291|NCT02674477|364994343|FG000|Overall Study|Protocol Violation|8|||
105818292|NCT02674477|364994344|FG001|Overall Study|Protocol Violation|2|||
105818293|NCT00004562|364994345|FG000|Overall Study|Lost to Follow-up|102|||
105818294|NCT00004562|364994346|FG001|Overall Study|Lost to Follow-up|91|||
105818295|NCT02770820|364994347|FG000|Overall Study|Death|1|||
105818296|NCT02770820|364994347|FG000|Overall Study|Physician Decision|2|||
105818297|NCT00696020|364994348|FG000|Overall Study|Adverse Event|3|||
105818298|NCT00696020|364994349|FG001|Overall Study|Adverse Event|1|||
105818299|NCT00696020|364994350|FG002|Overall Study|Adverse Event|2|||
105818300|NCT00696020|364994351|FG003|Overall Study|Adverse Event|1|||
105818301|NCT00696020|364994348|FG000|Overall Study|Lack of Efficacy|1|||
105818302|NCT00696020|364994349|FG001|Overall Study|Lack of Efficacy|0|||
105818303|NCT00696020|364994350|FG002|Overall Study|Lack of Efficacy|0|||
105818304|NCT00696020|364994351|FG003|Overall Study|Lack of Efficacy|0|||
105818305|NCT00696020|364994348|FG000|Overall Study|Protocol Violation|0|||
105818306|NCT00696020|364994349|FG001|Overall Study|Protocol Violation|0|||
105818307|NCT00696020|364994350|FG002|Overall Study|Protocol Violation|0|||
105818308|NCT00696020|364994351|FG003|Overall Study|Protocol Violation|1|||
105818309|NCT00696020|364994348|FG000|Overall Study|Withdrawal by Subject|0|||
105818310|NCT00696020|364994349|FG001|Overall Study|Withdrawal by Subject|1|||
105818311|NCT00696020|364994350|FG002|Overall Study|Withdrawal by Subject|0|||
105818312|NCT00696020|364994351|FG003|Overall Study|Withdrawal by Subject|1|||
105818313|NCT00696020|364994348|FG000|Overall Study|Other not stated above|0|||
105818314|NCT00696020|364994349|FG001|Overall Study|Other not stated above|0|||
105818315|NCT00696020|364994350|FG002|Overall Study|Other not stated above|1|||
105818316|NCT00696020|364994351|FG003|Overall Study|Other not stated above|1|||
105818317|NCT04274686|364994355|FG000|Overall Study|Physician Decision|1|||
105818318|NCT04274686|364994356|FG001|Overall Study|Physician Decision|0|||
105818319|NCT02331394|364994357|FG000|Overall Study|Disease progression|1|||
105818320|NCT02336165|364994358|FG000|Overall Study|Death|3|||
105818321|NCT02336165|364994359|FG001|Overall Study|Death|0|||
105818322|NCT02336165|364994360|FG002|Overall Study|Death|0|||
105818323|NCT02336165|364994361|FG003|Overall Study|Death|0|||
105818324|NCT02336165|364994362|FG004|Overall Study|Death|1|||
105818325|NCT02336165|364994358|FG000|Overall Study|Physician Decision|2|||
105818326|NCT02336165|364994359|FG001|Overall Study|Physician Decision|2|||
105818327|NCT02336165|364994360|FG002|Overall Study|Physician Decision|1|||
105818328|NCT02336165|364994361|FG003|Overall Study|Physician Decision|1|||
105818329|NCT02336165|364994362|FG004|Overall Study|Physician Decision|0|||
105818330|NCT02336165|364994358|FG000|Overall Study|Withdrawal by Subject|0|||
105818331|NCT02336165|364994359|FG001|Overall Study|Withdrawal by Subject|0|||
105818332|NCT02336165|364994360|FG002|Overall Study|Withdrawal by Subject|1|||
105818333|NCT02336165|364994361|FG003|Overall Study|Withdrawal by Subject|0|||
105818334|NCT02336165|364994362|FG004|Overall Study|Withdrawal by Subject|1|||
105818335|NCT02336165|364994358|FG000|Overall Study|Adverse Event|4|||
105818336|NCT02336165|364994359|FG001|Overall Study|Adverse Event|1|||
105818337|NCT02336165|364994360|FG002|Overall Study|Adverse Event|2|||
105818338|NCT02336165|364994361|FG003|Overall Study|Adverse Event|4|||
105818339|NCT02336165|364994362|FG004|Overall Study|Adverse Event|1|||
105818340|NCT02336165|364994358|FG000|Overall Study|Progressive disease|23|||
105818341|NCT02336165|364994359|FG001|Overall Study|Progressive disease|22|||
105956564|NCT01194219|365502881|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956565|NCT01194219|365502882|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956566|NCT01194219|365502883|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956567|NCT01194219|365502884|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956568|NCT01194219|365502885|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956569|NCT01194219|365502886|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
105956570|NCT01194219|365502877|FG000|Maintenance Phase Weeks16-32|Other|0|||
105956571|NCT01194219|365502878|FG001|Maintenance Phase Weeks16-32|Other|0|||
105956572|NCT01194219|365502879|FG002|Maintenance Phase Weeks16-32|Other|2|||
105956573|NCT01194219|365502880|FG003|Maintenance Phase Weeks16-32|Other|1|||
105956574|NCT01194219|365502881|FG004|Maintenance Phase Weeks16-32|Other|0|||
105956575|NCT01194219|365502882|FG005|Maintenance Phase Weeks16-32|Other|0|||
105956576|NCT01194219|365502883|FG006|Maintenance Phase Weeks16-32|Other|0|||
105956577|NCT01194219|365502884|FG007|Maintenance Phase Weeks16-32|Other|0|||
105956578|NCT01194219|365502885|FG008|Maintenance Phase Weeks16-32|Other|0|||
105956579|NCT01194219|365502886|FG009|Maintenance Phase Weeks16-32|Other|0|||
105956580|NCT01194219|365502877|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105956581|NCT01194219|365502878|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105956582|NCT01194219|365502879|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105956583|NCT01194219|365502880|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105956584|NCT01194219|365502881|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105818342|NCT02336165|364994360|FG002|Overall Study|Progressive disease|27|||
105818343|NCT02336165|364994361|FG003|Overall Study|Progressive disease|24|||
105818344|NCT02336165|364994362|FG004|Overall Study|Progressive disease|19|||
105818345|NCT02336165|364994358|FG000|Overall Study|Non-compliance|1|||
105818346|NCT02336165|364994359|FG001|Overall Study|Non-compliance|0|||
105956585|NCT01194219|365502882|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
105956586|NCT01194219|365502883|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
105956587|NCT01194219|365502884|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
105956588|NCT01194219|365502885|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105818347|NCT02336165|364994360|FG002|Overall Study|Non-compliance|0|||
105818348|NCT02336165|364994361|FG003|Overall Study|Non-compliance|1|||
105956589|NCT01194219|365502886|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
105956590|NCT01194219|365502877|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105818349|NCT02336165|364994362|FG004|Overall Study|Non-compliance|0|||
106018685|NCT02500797|365730738|FG004|Overall Study|Cancel (rapid disease progression)|1|||
105765572|NCT01784211|364793718|FG003|Part A (Days 1-15)|Adverse Event|0|||
105765573|NCT01784211|364793719|FG004|Part A (Days 1-15)|Adverse Event|0|||
105765574|NCT01784211|364793720|FG005|Part A (Days 1-15)|Adverse Event|0|||
105765575|NCT01784211|364793715|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
105765576|NCT01784211|364793716|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
105765577|NCT01784211|364793717|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
105765578|NCT01784211|364793718|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
105765579|NCT01784211|364793719|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
105765580|NCT01784211|364793720|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
105765581|NCT00441727|364793721|FG000|Overall Study|Protocol Violation|19|||
105765582|NCT00441727|364793722|FG001|Overall Study|Protocol Violation|28|||
105765583|NCT00441727|364793723|FG002|Overall Study|Protocol Violation|32|||
105765584|NCT00441727|364793721|FG000|Overall Study|Adverse Event|26|||
105765585|NCT00441727|364793722|FG001|Overall Study|Adverse Event|33|||
105765586|NCT00441727|364793723|FG002|Overall Study|Adverse Event|28|||
105765587|NCT00441727|364793721|FG000|Overall Study|Lack of Efficacy|7|||
105765588|NCT00441727|364793722|FG001|Overall Study|Lack of Efficacy|8|||
105765589|NCT00441727|364793723|FG002|Overall Study|Lack of Efficacy|48|||
105765590|NCT00441727|364793721|FG000|Overall Study|Withdrawal by Subject|40|||
105765591|NCT00441727|364793722|FG001|Overall Study|Withdrawal by Subject|34|||
105765592|NCT00441727|364793723|FG002|Overall Study|Withdrawal by Subject|47|||
105765593|NCT00441727|364793721|FG000|Overall Study|Lost to Follow-up|5|||
105765594|NCT00441727|364793722|FG001|Overall Study|Lost to Follow-up|6|||
105765595|NCT00441727|364793723|FG002|Overall Study|Lost to Follow-up|5|||
105765596|NCT00441727|364793721|FG000|Overall Study|Safety Reasons|3|||
105765597|NCT00441727|364793722|FG001|Overall Study|Safety Reasons|1|||
105765598|NCT00441727|364793723|FG002|Overall Study|Safety Reasons|3|||
105765599|NCT00441727|364793721|FG000|Overall Study|Various reason specified|6|||
105765600|NCT00441727|364793722|FG001|Overall Study|Various reason specified|8|||
105765601|NCT00441727|364793723|FG002|Overall Study|Various reason specified|5|||
105765602|NCT00364832|364793724|FG000|Core Period|Early Withdrawals|2|||
105765603|NCT00364832|364793725|FG001|Core Period|Early Withdrawals|2|||
105765604|NCT00364832|364793726|FG002|Core Period|Early Withdrawals|1|||
105765605|NCT00364832|364793727|FG003|Core Period|Early Withdrawals|1|||
105765606|NCT00364832|364793728|FG004|Core Period|Early Withdrawals|0|||
105765607|NCT00364832|364793729|FG005|Core Period|Early Withdrawals|0|||
105765608|NCT00364832|364793730|FG006|Core Period|Early Withdrawals|4|||
105765609|NCT00364832|364793731|FG007|Core Period|Early Withdrawals|1|||
105765610|NCT00364832|364793732|FG008|Core Period|Early Withdrawals|0|||
105765611|NCT00364832|364793733|FG009|Core Period|Early Withdrawals|0|||
105765612|NCT00364832|364793734|FG010|Core Period|Early Withdrawals|0|||
105765613|NCT00364832|364793735|FG011|Core Period|Early Withdrawals|0|||
105765614|NCT00364832|364793724|FG000|Extension Year 1|Early Withdrawals|0|||
105765615|NCT00364832|364793725|FG001|Extension Year 1|Early Withdrawals|0|||
105765616|NCT00364832|364793726|FG002|Extension Year 1|Early Withdrawals|0|||
105765617|NCT00364832|364793727|FG003|Extension Year 1|Early Withdrawals|0|||
105765618|NCT00364832|364793728|FG004|Extension Year 1|Early Withdrawals|0|||
105765619|NCT00364832|364793729|FG005|Extension Year 1|Early Withdrawals|0|||
105765620|NCT00364832|364793730|FG006|Extension Year 1|Early Withdrawals|0|||
105765621|NCT00364832|364793731|FG007|Extension Year 1|Early Withdrawals|0|||
105765622|NCT00364832|364793732|FG008|Extension Year 1|Early Withdrawals|0|||
105765623|NCT00364832|364793733|FG009|Extension Year 1|Early Withdrawals|4|||
105765624|NCT00364832|364793734|FG010|Extension Year 1|Early Withdrawals|2|||
105765625|NCT00364832|364793735|FG011|Extension Year 1|Early Withdrawals|10|||
105765626|NCT00364832|364793724|FG000|Extension Year 2|Early Withdrawals|0|||
105765627|NCT00364832|364793725|FG001|Extension Year 2|Early Withdrawals|0|||
105765628|NCT00364832|364793726|FG002|Extension Year 2|Early Withdrawals|0|||
105765629|NCT00364832|364793727|FG003|Extension Year 2|Early Withdrawals|0|||
105765630|NCT00364832|364793728|FG004|Extension Year 2|Early Withdrawals|0|||
105765631|NCT00364832|364793729|FG005|Extension Year 2|Early Withdrawals|0|||
105765632|NCT00364832|364793730|FG006|Extension Year 2|Early Withdrawals|0|||
105765633|NCT00364832|364793731|FG007|Extension Year 2|Early Withdrawals|0|||
105765634|NCT00364832|364793732|FG008|Extension Year 2|Early Withdrawals|0|||
105765635|NCT00364832|364793733|FG009|Extension Year 2|Early Withdrawals|5|||
105765636|NCT00364832|364793734|FG010|Extension Year 2|Early Withdrawals|5|||
105765637|NCT00364832|364793735|FG011|Extension Year 2|Early Withdrawals|3|||
105765638|NCT02954952|364793738|FG000|Overall Study|Withdrawal by Subject|1|||
105765639|NCT02954952|364793739|FG001|Overall Study|Withdrawal by Subject|0|||
105765640|NCT02954952|364793740|FG002|Overall Study|Withdrawal by Subject|0|||
105765641|NCT02954952|364793738|FG000|Overall Study|No data collected|0|||
105765642|NCT02954952|364793739|FG001|Overall Study|No data collected|1|||
105765643|NCT02954952|364793740|FG002|Overall Study|No data collected|0|||
105765644|NCT02432703|364793741|FG000|Overall Study|Adverse Event|1|||
105765645|NCT02432703|364793742|FG001|Overall Study|Adverse Event|4|||
105765646|NCT02432703|364793741|FG000|Overall Study|Lack of Efficacy|1|||
105765647|NCT02432703|364793742|FG001|Overall Study|Lack of Efficacy|0|||
105765648|NCT02432703|364793741|FG000|Overall Study|Lost to Follow-up|5|||
105818350|NCT02336165|364994358|FG000|Overall Study|Other|1|||
105818351|NCT02336165|364994359|FG001|Overall Study|Other|0|||
105818352|NCT02336165|364994360|FG002|Overall Study|Other|0|||
105818353|NCT02336165|364994361|FG003|Overall Study|Other|1|||
105818354|NCT02336165|364994362|FG004|Overall Study|Other|0|||
105818355|NCT00910663|364994365|FG000|Period 1|Withdrawal by Subject|0|||
105818356|NCT00910663|364994366|FG001|Period 1|Withdrawal by Subject|1|||
105818357|NCT00552669|364994367|FG000|Overall Study|Death|3|||
105818358|NCT00552669|364994368|FG001|Overall Study|Death|7|||
105818359|NCT03687736|364994369|FG000|Overall Study|Lost to Follow-up|7|||
105818360|NCT03687736|364994369|FG000|Overall Study|Withdrawal by Subject|3|||
105818361|NCT01844375|364994370|FG000|Overall Study|Protocol Violation|1|||
105818362|NCT01844375|364994371|FG001|Overall Study|Protocol Violation|1|||
105818363|NCT02098876|364994374|FG000|Overall Study|Withdrawal by Subject|5|||
105818364|NCT02098876|364994375|FG001|Overall Study|Withdrawal by Subject|5|||
105818365|NCT03627091|364994376|FG000|Overall Study|Adverse Event|0|||
105818366|NCT03627091|364994377|FG001|Overall Study|Adverse Event|0|||
105818367|NCT03627091|364994378|FG002|Overall Study|Adverse Event|2|||
105818368|NCT03627091|364994376|FG000|Overall Study|Withdrawal by Subject|2|||
105818369|NCT03627091|364994377|FG001|Overall Study|Withdrawal by Subject|0|||
105818370|NCT03627091|364994378|FG002|Overall Study|Withdrawal by Subject|2|||
105818371|NCT03627091|364994376|FG000|Overall Study|Physician Decision|2|||
105818372|NCT03627091|364994377|FG001|Overall Study|Physician Decision|0|||
105818373|NCT03627091|364994378|FG002|Overall Study|Physician Decision|0|||
105818374|NCT03627091|364994376|FG000|Overall Study|Site terminated by sponsor|0|||
105818375|NCT03627091|364994377|FG001|Overall Study|Site terminated by sponsor|1|||
105818376|NCT03627091|364994378|FG002|Overall Study|Site terminated by sponsor|0|||
105818377|NCT03627091|364994376|FG000|Overall Study|Disease relapse|7|||
105818378|NCT03627091|364994377|FG001|Overall Study|Disease relapse|5|||
106018686|NCT02500797|365730739|FG005|Overall Study|Cancel (rapid disease progression)|1|||
106018687|NCT02500797|365730740|FG006|Overall Study|Cancel (rapid disease progression)|0|||
106018688|NCT02500797|365730741|FG007|Overall Study|Cancel (rapid disease progression)|0|||
106018689|NCT02500797|365730734|FG000|Overall Study|Withdrawal by Subject|1|||
106018690|NCT02500797|365730735|FG001|Overall Study|Withdrawal by Subject|0|||
106018691|NCT02500797|365730736|FG002|Overall Study|Withdrawal by Subject|0|||
106018692|NCT02500797|365730737|FG003|Overall Study|Withdrawal by Subject|0|||
105818379|NCT03627091|364994378|FG002|Overall Study|Disease relapse|1|||
105818380|NCT03627091|364994376|FG000|Overall Study|Other|1|||
105818381|NCT03627091|364994377|FG001|Overall Study|Other|0|||
105818382|NCT03627091|364994378|FG002|Overall Study|Other|0|||
105818383|NCT01061866|364994379|FG000|Overall Study|Adverse Event|2|||
105818384|NCT01270503|364994380|FG000|Overall Study|Lost to Follow-up|1|||
105818385|NCT03020615|364994381|FG000|Overall Study|Physician Decision|3|||
105818386|NCT03020615|364994382|FG001|Overall Study|Physician Decision|1|||
105818387|NCT03020615|364994383|FG002|Overall Study|Physician Decision|2|||
105818388|NCT03020615|364994381|FG000|Overall Study|Parent/guardian/patient choice|3|||
105818389|NCT03020615|364994382|FG001|Overall Study|Parent/guardian/patient choice|0|||
105818390|NCT03020615|364994383|FG002|Overall Study|Parent/guardian/patient choice|4|||
105818391|NCT03020615|364994381|FG000|Overall Study|Screen failure|0|||
105818392|NCT03020615|364994382|FG001|Overall Study|Screen failure|0|||
105818393|NCT03020615|364994383|FG002|Overall Study|Screen failure|1|||
105818394|NCT03020615|364994381|FG000|Overall Study|Death|1|||
105818395|NCT03020615|364994382|FG001|Overall Study|Death|0|||
106018693|NCT02500797|365730738|FG004|Overall Study|Withdrawal by Subject|0|||
106018694|NCT02500797|365730739|FG005|Overall Study|Withdrawal by Subject|0|||
106018695|NCT02500797|365730740|FG006|Overall Study|Withdrawal by Subject|0|||
106018696|NCT02500797|365730741|FG007|Overall Study|Withdrawal by Subject|0|||
106018697|NCT00357006|365730744|FG000|Overall Study|Lost to Follow-up|1|||
106018698|NCT00357006|365730745|FG001|Overall Study|Lost to Follow-up|2|||
106018699|NCT00357006|365730746|FG002|Overall Study|Lost to Follow-up|1|||
106018700|NCT00357006|365730744|FG000|Overall Study|Withdrawal by Subject|1|||
106018701|NCT00357006|365730745|FG001|Overall Study|Withdrawal by Subject|3|||
106018702|NCT00357006|365730746|FG002|Overall Study|Withdrawal by Subject|2|||
105818396|NCT03020615|364994383|FG002|Overall Study|Death|0|||
105818397|NCT03020615|364994381|FG000|Overall Study|Lost to Follow-up|0|||
105818398|NCT03020615|364994382|FG001|Overall Study|Lost to Follow-up|1|||
105818399|NCT03020615|364994383|FG002|Overall Study|Lost to Follow-up|0|||
105818400|NCT01536574|364994385|FG000|Overall Study|Adverse Event|4|||
105818401|NCT01536574|364994386|FG001|Overall Study|Adverse Event|5|||
105818402|NCT01536574|364994385|FG000|Overall Study|Withdrawal by Subject|1|||
105818403|NCT01536574|364994386|FG001|Overall Study|Withdrawal by Subject|2|||
106018703|NCT03710161|365730748|FG000|Overall Study|Study halted due to COVID pandemic|3|||
106018704|NCT03710161|365730749|FG001|Overall Study|Study halted due to COVID pandemic|2|||
105818404|NCT01536574|364994385|FG000|Overall Study|Lack of Efficacy|1|||
105818405|NCT01536574|364994386|FG001|Overall Study|Lack of Efficacy|0|||
105818406|NCT02481830|364994387|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
105818407|NCT02481830|364994388|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
105818408|NCT02481830|364994387|FG000|Pre-treatment|Withdrawal by Subject|0|||
106018705|NCT03070964|365730750|FG000|Overall Study|Progressive disease|8|||
106145404|NCT03473340|366191963|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
106145405|NCT03473340|366191962|FG000|Overall Study|Withdrawal by Subject|1|||
106145406|NCT03473340|366191963|FG001|Overall Study|Withdrawal by Subject|0|||
106145407|NCT03473340|366191962|FG000|Overall Study|Lost to Follow-up|1|||
106145408|NCT03473340|366191963|FG001|Overall Study|Lost to Follow-up|2|||
106145409|NCT02079844|366191964|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
106145410|NCT02079844|366191965|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
106145411|NCT02079844|366191966|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
106145412|NCT02079844|366191964|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
106145413|NCT02079844|366191965|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
106145414|NCT02079844|366191966|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
105818409|NCT02481830|364994388|FG001|Pre-treatment|Withdrawal by Subject|10|||
105818410|NCT02481830|364994387|FG000|Pre-treatment|Disease Progression|1|||
105818411|NCT02481830|364994388|FG001|Pre-treatment|Disease Progression|1|||
105818412|NCT02481830|364994387|FG000|Pre-treatment|Other reasons|0|||
105818413|NCT02481830|364994388|FG001|Pre-treatment|Other reasons|1|||
105818414|NCT02481830|364994387|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
105818415|NCT02481830|364994388|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
105818416|NCT02481830|364994387|FG000|Treatment|Disease Progression|233|||
105818417|NCT02481830|364994388|FG001|Treatment|Disease Progression|171|||
105818418|NCT02481830|364994387|FG000|Treatment|Study drug toxicity|18|||
105818419|NCT02481830|364994388|FG001|Treatment|Study drug toxicity|38|||
105818420|NCT02481830|364994387|FG000|Treatment|Death|1|||
105818421|NCT02481830|364994388|FG001|Treatment|Death|1|||
105818422|NCT02481830|364994387|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
105818423|NCT02481830|364994388|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
105818424|NCT02481830|364994387|FG000|Treatment|Participants request to discontinue Study treatment|6|||
105818425|NCT02481830|364994388|FG001|Treatment|Participants request to discontinue Study treatment|34|||
105818426|NCT02481830|364994387|FG000|Treatment|Withdrawal by Subject|2|||
105818427|NCT02481830|364994388|FG001|Treatment|Withdrawal by Subject|3|||
105818428|NCT02481830|364994387|FG000|Treatment|Lost to Follow-up|1|||
105818429|NCT02481830|364994388|FG001|Treatment|Lost to Follow-up|0|||
105818430|NCT02481830|364994387|FG000|Treatment|Maximum Clinical Benefit|0|||
105818431|NCT02481830|364994388|FG001|Treatment|Maximum Clinical Benefit|5|||
105818432|NCT02481830|364994387|FG000|Treatment|Administrative reason by sponsor|1|||
105818433|NCT02481830|364994388|FG001|Treatment|Administrative reason by sponsor|1|||
105818434|NCT02481830|364994387|FG000|Treatment|Other reasons|6|||
105818435|NCT02481830|364994388|FG001|Treatment|Other reasons|1|||
105818436|NCT00102440|364994389|FG000|Overall Study|Lost to Follow-up|25|||
105818437|NCT00102440|364994390|FG001|Overall Study|Lost to Follow-up|18|||
105818438|NCT00102440|364994391|FG002|Overall Study|Lost to Follow-up|21|||
105818439|NCT00102440|364994389|FG000|Overall Study|Adverse Event|16|||
105818440|NCT00102440|364994390|FG001|Overall Study|Adverse Event|23|||
105818441|NCT00102440|364994391|FG002|Overall Study|Adverse Event|8|||
105818442|NCT00102440|364994389|FG000|Overall Study|Gout Flare|10|||
105818443|NCT00102440|364994390|FG001|Overall Study|Gout Flare|28|||
105818444|NCT00102440|364994391|FG002|Overall Study|Gout Flare|9|||
105818445|NCT00102440|364994389|FG000|Overall Study|Personal Reason(s)|19|||
105818446|NCT00102440|364994390|FG001|Overall Study|Personal Reason(s)|13|||
105818447|NCT00102440|364994391|FG002|Overall Study|Personal Reason(s)|13|||
105818448|NCT00102440|364994389|FG000|Overall Study|Other|11|||
105818449|NCT00102440|364994390|FG001|Overall Study|Other|14|||
105818450|NCT00102440|364994391|FG002|Overall Study|Other|14|||
105818451|NCT00102440|364994389|FG000|Overall Study|Protocol Violation|7|||
105818452|NCT00102440|364994390|FG001|Overall Study|Protocol Violation|2|||
105818453|NCT00102440|364994391|FG002|Overall Study|Protocol Violation|1|||
105818454|NCT01745120|364994397|FG000|Overall Study|Investigator decision|1|||
105818455|NCT01745120|364994398|FG001|Overall Study|Investigator decision|0|||
105818456|NCT02902211|364994404|FG000|First Three Months|Withdrawal by Subject|7|||
105818457|NCT02902211|364994405|FG001|First Three Months|Withdrawal by Subject|3|||
105818458|NCT00909610|364995869|FG000|Period: First Intervention|Adverse Event|0|||
106145415|NCT00801983|366191969|FG000|Period 1|Lost to Follow-up|2|||
106145416|NCT00801983|366191970|FG001|Period 1|Lost to Follow-up|0|||
105818459|NCT00909610|364995870|FG001|Period: First Intervention|Adverse Event|1|||
105818460|NCT00909610|364995869|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
105818461|NCT00909610|364995870|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
105818462|NCT00909610|364995869|FG000|Period: Second Intervention|Adverse Event|1|||
105818463|NCT00909610|364995870|FG001|Period: Second Intervention|Adverse Event|0|||
105818464|NCT01034358|364995876|FG000|Overall Study|Withdrawal by Subject|1|||
105818465|NCT01034358|364995876|FG000|Overall Study|Protocol Violation|1|||
105818466|NCT00829790|364995877|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
105818467|NCT00829790|364995878|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
105818468|NCT00834743|364995879|FG000|Second Intervention|Withdrawal by Subject|1|||
105818469|NCT00834743|364995880|FG001|Second Intervention|Withdrawal by Subject|0|||
105818470|NCT00829530|364995883|FG000|First Intervention|Adverse Event|0|||
105818471|NCT00829530|364995884|FG001|First Intervention|Adverse Event|1|||
105818472|NCT00829530|364995883|FG000|First Intervention|Intolerance to Venopuncture|0|||
105818473|NCT00829530|364995884|FG001|First Intervention|Intolerance to Venopuncture|1|||
105818474|NCT00829530|364995883|FG000|Second Intervention|Intolerance to Venopuncture|1|||
105818475|NCT00829530|364995884|FG001|Second Intervention|Intolerance to Venopuncture|0|||
105818476|NCT04466111|364995885|FG000|Prior to Trial Phase|Physician Decision|1|||
105818477|NCT00105196|364995887|FG000|Overall Study|Lack of Efficacy|2|||
105818478|NCT00105196|364995888|FG001|Overall Study|Lack of Efficacy|3|||
105818479|NCT00105196|364995887|FG000|Overall Study|Adverse Event|11|||
105818480|NCT00105196|364995888|FG001|Overall Study|Adverse Event|3|||
105818481|NCT00105196|364995887|FG000|Overall Study|Withdrawal by Subject|6|||
105818482|NCT00105196|364995888|FG001|Overall Study|Withdrawal by Subject|6|||
105818483|NCT00105196|364995887|FG000|Overall Study|Lost to Follow-up|3|||
105818484|NCT00105196|364995888|FG001|Overall Study|Lost to Follow-up|2|||
105818485|NCT00105196|364995887|FG000|Overall Study|Poor/noncompliance|3|||
105818486|NCT00105196|364995888|FG001|Overall Study|Poor/noncompliance|4|||
105818487|NCT00105196|364995887|FG000|Overall Study|Protocol Violation|5|||
105818488|NCT00105196|364995888|FG001|Overall Study|Protocol Violation|2|||
105818489|NCT00105196|364995887|FG000|Overall Study|pending surgery|0|||
105818490|NCT00105196|364995888|FG001|Overall Study|pending surgery|1|||
105818491|NCT00105196|364995887|FG000|Overall Study|marijuana use|0|||
105818492|NCT00105196|364995888|FG001|Overall Study|marijuana use|1|||
105818493|NCT00105196|364995887|FG000|Overall Study|Subject became unblinded|0|||
105818494|NCT00105196|364995888|FG001|Overall Study|Subject became unblinded|1|||
105818495|NCT03025880|364995889|FG000|Overall Study|Adverse Event|1|||
105818496|NCT03025880|364995890|FG001|Overall Study|Adverse Event|0|||
105818497|NCT03025880|364995889|FG000|Overall Study|Death|1|||
105818498|NCT03025880|364995890|FG001|Overall Study|Death|1|||
105818499|NCT03025880|364995889|FG000|Overall Study|Withdrawal by Subject|0|||
105818500|NCT03025880|364995890|FG001|Overall Study|Withdrawal by Subject|1|||
105818501|NCT03025880|364995889|FG000|Overall Study|Physician Decision|0|||
105818502|NCT03025880|364995890|FG001|Overall Study|Physician Decision|1|||
105818503|NCT03025880|364995889|FG000|Overall Study|Progressive Disease|12|||
105818504|NCT03025880|364995890|FG001|Overall Study|Progressive Disease|19|||
105818505|NCT01661686|364995895|FG000|Overall Study|Lost to Follow-up|2|||
105818506|NCT01661686|364995896|FG001|Overall Study|Lost to Follow-up|1|||
105818507|NCT01661686|364995895|FG000|Overall Study|did not receive allocated intervention|0|||
105818508|NCT01661686|364995896|FG001|Overall Study|did not receive allocated intervention|1|||
105818509|NCT02202850|364995899|FG000|Overall Study|Other|2|||
105818510|NCT02202850|364995900|FG001|Overall Study|Other|2|||
105818511|NCT02202850|364995899|FG000|Overall Study|Enbrel treatment discontinued|15|||
105818512|NCT02202850|364995900|FG001|Overall Study|Enbrel treatment discontinued|3|||
105818513|NCT02202850|364995899|FG000|Overall Study|Lost to Follow-up|7|||
105818514|NCT02202850|364995900|FG001|Overall Study|Lost to Follow-up|1|||
105818515|NCT00772941|364995904|FG000|Overall Study|CRFs not available|195|||
105818516|NCT00772941|364995904|FG000|Overall Study|Study not completed|16|||
105818517|NCT00772941|364995904|FG000|Overall Study|Missed Visits|374|||
105818518|NCT00772941|364995904|FG000|Overall Study|Poor Compliance|7|||
105818519|NCT00772941|364995904|FG000|Overall Study|GPSP Violation|90|||
105818520|NCT04627038|364995905|FG000|Overall Study|Adverse Event|36|||
105818521|NCT04627038|364995906|FG001|Overall Study|Adverse Event|8|||
105818522|NCT04627038|364995905|FG000|Overall Study|Lost to Follow-up|1|||
105818523|NCT04627038|364995906|FG001|Overall Study|Lost to Follow-up|0|||
105818524|NCT04627038|364995905|FG000|Overall Study|Physician Decision|0|||
105818525|NCT04627038|364995906|FG001|Overall Study|Physician Decision|1|||
106018706|NCT03070964|365730750|FG000|Overall Study|Treatment-unrelated adverse event|2|||
106018707|NCT03070964|365730750|FG000|Overall Study|Never treated|1|||
106018708|NCT03070964|365730750|FG000|Overall Study|Physician Decision|1|||
106018709|NCT03070964|365730750|FG000|Overall Study|Withdrawal by Subject|1|||
106018710|NCT03070964|365730750|FG000|Overall Study|Adverse Event|1|||
106018711|NCT02745119|365730752|FG000|Overall Study|Adverse Event|1|||
105818526|NCT04627038|364995905|FG000|Overall Study|Protocol Violation|3|||
105818527|NCT04627038|364995906|FG001|Overall Study|Protocol Violation|1|||
105818528|NCT04627038|364995905|FG000|Overall Study|Withdrawal by Subject|13|||
105818529|NCT04627038|364995906|FG001|Overall Study|Withdrawal by Subject|3|||
105818530|NCT04627038|364995905|FG000|Overall Study|Non-compliance with study drug|0|||
105818531|NCT04627038|364995906|FG001|Overall Study|Non-compliance with study drug|1|||
105818532|NCT04627038|364995905|FG000|Overall Study|Prohibited Concomitant Medication|1|||
105818533|NCT04627038|364995906|FG001|Overall Study|Prohibited Concomitant Medication|0|||
105818534|NCT00834756|364995907|FG000|First Intervention|Adverse Event|1|||
105818535|NCT00834756|364995908|FG001|First Intervention|Adverse Event|0|||
105818536|NCT00834756|364995907|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
105818537|NCT00834756|364995908|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
105818538|NCT02193165|364995909|FG000|4 Week Product Use|Lost to Follow-up|1|||
105818539|NCT02193165|364995910|FG001|4 Week Product Use|Lost to Follow-up|1|||
105818540|NCT02193165|364995911|FG002|4 Week Product Use|Lost to Follow-up|1|||
105818541|NCT02193165|364995909|FG000|6 Week Product Use|Lost to Follow-up|0|||
105818542|NCT02193165|364995910|FG001|6 Week Product Use|Lost to Follow-up|1|||
106018712|NCT02745119|365730753|FG001|Overall Study|Adverse Event|0|||
106018713|NCT02745119|365730754|FG002|Overall Study|Adverse Event|1|||
106018714|NCT02745119|365730755|FG003|Overall Study|Adverse Event|3|||
106018715|NCT02745119|365730752|FG000|Overall Study|Death|3|||
106018716|NCT02745119|365730753|FG001|Overall Study|Death|3|||
106018717|NCT02745119|365730754|FG002|Overall Study|Death|0|||
106018718|NCT02745119|365730755|FG003|Overall Study|Death|4|||
106018719|NCT02745119|365730752|FG000|Overall Study|Lost to Follow-up|0|||
106018720|NCT02745119|365730753|FG001|Overall Study|Lost to Follow-up|0|||
106018721|NCT02745119|365730754|FG002|Overall Study|Lost to Follow-up|0|||
106018722|NCT02745119|365730755|FG003|Overall Study|Lost to Follow-up|1|||
106018723|NCT02745119|365730752|FG000|Overall Study|Protocol Deviation|0|||
106018724|NCT02745119|365730753|FG001|Overall Study|Protocol Deviation|0|||
106018725|NCT02745119|365730754|FG002|Overall Study|Protocol Deviation|0|||
106018726|NCT02745119|365730755|FG003|Overall Study|Protocol Deviation|1|||
106018727|NCT02745119|365730752|FG000|Overall Study|Withdrawal by Subject|7|||
106018728|NCT02745119|365730753|FG001|Overall Study|Withdrawal by Subject|15|||
106018729|NCT02745119|365730754|FG002|Overall Study|Withdrawal by Subject|8|||
106018730|NCT02745119|365730755|FG003|Overall Study|Withdrawal by Subject|14|||
106018731|NCT02745119|365730752|FG000|Overall Study|Study Terminated by Sponsor|134|||
106018732|NCT02745119|365730753|FG001|Overall Study|Study Terminated by Sponsor|252|||
106018733|NCT02745119|365730754|FG002|Overall Study|Study Terminated by Sponsor|135|||
106018734|NCT02745119|365730755|FG003|Overall Study|Study Terminated by Sponsor|251|||
106018735|NCT02745119|365730752|FG000|Overall Study|Physician Decision|0|||
106018736|NCT02745119|365730753|FG001|Overall Study|Physician Decision|2|||
106018737|NCT02745119|365730754|FG002|Overall Study|Physician Decision|2|||
106018738|NCT02745119|365730755|FG003|Overall Study|Physician Decision|2|||
106018739|NCT02745119|365730752|FG000|Overall Study|Reason Not Specified|0|||
106018740|NCT02745119|365730753|FG001|Overall Study|Reason Not Specified|2|||
106018741|NCT02745119|365730754|FG002|Overall Study|Reason Not Specified|0|||
106018742|NCT02745119|365730755|FG003|Overall Study|Reason Not Specified|1|||
106018743|NCT01587924|365730756|FG000|Overall Study|Adverse Event|0|||
106018744|NCT01587924|365730757|FG001|Overall Study|Adverse Event|2|||
106018745|NCT01587924|365730758|FG002|Overall Study|Adverse Event|0|||
106018746|NCT01587924|365730759|FG003|Overall Study|Adverse Event|0|||
106018747|NCT01587924|365730756|FG000|Overall Study|Protocol Violation|2|||
106018748|NCT01587924|365730757|FG001|Overall Study|Protocol Violation|1|||
106018749|NCT01587924|365730758|FG002|Overall Study|Protocol Violation|2|||
105818543|NCT02193165|364995911|FG002|6 Week Product Use|Lost to Follow-up|0|||
105818544|NCT02514122|364995912|FG000|Overall Study|Withdrawal by Subject|2|||
105818545|NCT02514122|364995913|FG001|Overall Study|Withdrawal by Subject|0|||
105818546|NCT04239872|364995914|FG000|Overall Study|Lost to Follow-up|0|||
105818547|NCT04239872|364995915|FG001|Overall Study|Lost to Follow-up|1|||
105818548|NCT01498120|364995920|FG000|Overall Study|Lost to Follow-up|1|||
105818549|NCT01498120|364995920|FG000|Overall Study|Withdrawal by Subject|5|||
105818550|NCT01498120|364995920|FG000|Overall Study|AE, non-serious non-fatal|3|||
105818551|NCT01498120|364995920|FG000|Overall Study|Other|4|||
105818552|NCT00850174|364995923|FG000|Washout: One Week|Withdrawal by Subject|0|||
105818553|NCT00850174|364995924|FG001|Washout: One Week|Withdrawal by Subject|2|||
105818554|NCT00850174|364995923|FG000|Second Intervention|Withdrawal by Subject|1|||
105818555|NCT00850174|364995924|FG001|Second Intervention|Withdrawal by Subject|0|||
105818556|NCT01513174|364995925|FG000|Overall Study|Inclusion Error|1|||
105818557|NCT01513174|364995926|FG001|Overall Study|Inclusion Error|7|||
105818558|NCT01513174|364995925|FG000|Overall Study|Not receive study treatment|3|||
105818559|NCT01513174|364995926|FG001|Overall Study|Not receive study treatment|1|||
105818560|NCT00635492|364995927|FG000|Overall Study|Death|12|||
105818561|NCT00635492|364995928|FG001|Overall Study|Death|40|||
105818562|NCT00635492|364995927|FG000|Overall Study|Lost to Follow-up|151|||
106018750|NCT01587924|365730759|FG003|Overall Study|Protocol Violation|1|||
106145417|NCT00801983|366191969|FG000|Period 1|Withdrawal by Subject|2|||
106145418|NCT00801983|366191970|FG001|Period 1|Withdrawal by Subject|8|||
106145419|NCT00801983|366191969|FG000|Period 2|Withdrawal by Subject|2|||
105818563|NCT00635492|364995928|FG001|Overall Study|Lost to Follow-up|172|||
105818564|NCT00635492|364995927|FG000|Overall Study|Physician Decision|32|||
105818565|NCT00635492|364995928|FG001|Overall Study|Physician Decision|22|||
105818566|NCT00635492|364995927|FG000|Overall Study|Sponsor decision|2|||
105818567|NCT00635492|364995928|FG001|Overall Study|Sponsor decision|3|||
106018751|NCT01587924|365730756|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
106018752|NCT01587924|365730757|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
106018753|NCT01587924|365730758|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
105818568|NCT00635492|364995927|FG000|Overall Study|Withdrawal by Subject|82|||
106018754|NCT01587924|365730759|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
106018755|NCT01587924|365730756|FG000|Overall Study|Withdrawal by Subject|0|||
106018756|NCT01587924|365730757|FG001|Overall Study|Withdrawal by Subject|1|||
106018757|NCT01587924|365730758|FG002|Overall Study|Withdrawal by Subject|1|||
106018758|NCT01587924|365730759|FG003|Overall Study|Withdrawal by Subject|0|||
106018759|NCT02157883|365730760|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
106018760|NCT02157883|365730760|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
106018761|NCT02157883|365730760|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
105818569|NCT00635492|364995928|FG001|Overall Study|Withdrawal by Subject|45|||
105818570|NCT01900626|364995929|FG000|Overall Study|study was closed due to low enrollment|1|||
105818571|NCT01900626|364995930|FG001|Overall Study|study was closed due to low enrollment|1|||
105818572|NCT01702987|364995931|FG000|Overall Study|Withdrawal by Subject|1|||
105818573|NCT01702987|364995932|FG001|Overall Study|Withdrawal by Subject|0|||
105818574|NCT04263649|364995933|FG000|Overall Study|Adverse Event|53|||
105818575|NCT04263649|364995933|FG000|Overall Study|Lost to Follow-up|3|||
105818576|NCT04263649|364995933|FG000|Overall Study|Death|29|||
105818577|NCT04263649|364995933|FG000|Overall Study|Device deficiency|19|||
105818578|NCT04263649|364995933|FG000|Overall Study|other reasons|11|||
105818579|NCT02057458|364995934|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
105818580|NCT02057458|364995935|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
105818581|NCT02057458|364995936|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
105818582|NCT02057458|364995934|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
105818583|NCT02057458|364995935|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
105818584|NCT02057458|364995936|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
105818585|NCT02057458|364995934|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
105818586|NCT02057458|364995935|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
105818587|NCT02057458|364995936|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
105818588|NCT01629381|364995937|FG000|Overall Study|Withdrawal by Subject|2|||
105818589|NCT01629381|364995938|FG001|Overall Study|Withdrawal by Subject|5|||
105818590|NCT01534520|364995939|FG000|Overall Study|Adverse Event|0|||
105818591|NCT01534520|364995940|FG001|Overall Study|Adverse Event|1|||
105818592|NCT01214850|364995943|FG000|Overall Study|Withdrawal by Subject|38|||
105818593|NCT01214850|364995944|FG001|Overall Study|Withdrawal by Subject|31|||
105818594|NCT01214850|364995945|FG002|Overall Study|Withdrawal by Subject|28|||
105818595|NCT01214850|364995943|FG000|Overall Study|Lost to Follow-up|124|||
105818596|NCT01214850|364995944|FG001|Overall Study|Lost to Follow-up|98|||
105818597|NCT01214850|364995945|FG002|Overall Study|Lost to Follow-up|123|||
105818598|NCT01214850|364995943|FG000|Overall Study|Protocol Violation|5|||
105818599|NCT01214850|364995944|FG001|Overall Study|Protocol Violation|5|||
105818600|NCT01214850|364995945|FG002|Overall Study|Protocol Violation|6|||
105818601|NCT01214850|364995943|FG000|Overall Study|Adverse event or death|11|||
105818602|NCT01214850|364995944|FG001|Overall Study|Adverse event or death|8|||
105818603|NCT01214850|364995945|FG002|Overall Study|Adverse event or death|3|||
105818604|NCT01214850|364995943|FG000|Overall Study|Inappropriate enrollment|2|||
105818605|NCT01214850|364995944|FG001|Overall Study|Inappropriate enrollment|1|||
105818606|NCT01214850|364995945|FG002|Overall Study|Inappropriate enrollment|0|||
105818607|NCT01214850|364995943|FG000|Overall Study|Administrative reason|1|||
105818608|NCT01214850|364995944|FG001|Overall Study|Administrative reason|0|||
105818609|NCT01214850|364995945|FG002|Overall Study|Administrative reason|0|||
105818610|NCT01214850|364995943|FG000|Overall Study|Unable to classify|2|||
105818611|NCT01214850|364995944|FG001|Overall Study|Unable to classify|1|||
105818612|NCT01214850|364995945|FG002|Overall Study|Unable to classify|1|||
105818613|NCT01863745|364995951|FG000|Overall Study|Disease Progression|9|||
105818614|NCT01863745|364995951|FG000|Overall Study|Adverse Event|2|||
105818615|NCT01863745|364995951|FG000|Overall Study|Death|1|||
105818616|NCT01863745|364995951|FG000|Overall Study|Withdrawal by Subject|1|||
105818617|NCT00735904|364995952|FG000|Overall Study|Adverse Event|3|||
105818618|NCT00735904|364995952|FG000|Overall Study|Death|20|||
105818619|NCT00735904|364995952|FG000|Overall Study|Protocol Violation|1|||
105818620|NCT00735904|364995952|FG000|Overall Study|Withdrawal by Subject|1|||
105818621|NCT00735904|364995952|FG000|Overall Study|Study Terminated by Sponsor|5|||
105818622|NCT00735904|364995952|FG000|Overall Study|Other|8|||
105818623|NCT03204539|364995953|FG000|Overall Study|Loss of funding|0|||
105818624|NCT03204539|364995954|FG001|Overall Study|Loss of funding|1|||
105818625|NCT01171963|364995957|FG000|Overall Study|Adverse Event|10|||
105818626|NCT01171963|364995958|FG001|Overall Study|Adverse Event|15|||
105818627|NCT01171963|364995957|FG000|Overall Study|Lost to Follow-up|23|||
105818628|NCT01171963|364995958|FG001|Overall Study|Lost to Follow-up|24|||
105818629|NCT01171963|364995957|FG000|Overall Study|Other - diarrhoea|1|||
105818630|NCT01171963|364995958|FG001|Overall Study|Other - diarrhoea|0|||
105818631|NCT01171963|364995957|FG000|Overall Study|Withdrawal by Subject|114|||
105818632|NCT01171963|364995958|FG001|Overall Study|Withdrawal by Subject|129|||
105818633|NCT05093205|364995959|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
105818634|NCT05093205|364995960|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
105818635|NCT05093205|364995961|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
105818636|NCT05093205|364995962|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
105818637|NCT05093205|364995963|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
105818638|NCT05093205|364995964|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
106018762|NCT02157883|365730760|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
106018763|NCT02157883|365730760|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
106145420|NCT00801983|366191970|FG001|Period 2|Withdrawal by Subject|1|||
105818639|NCT05093205|364995965|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
105818640|NCT05093205|364995966|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
105818641|NCT05093205|364995967|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
105818642|NCT05093205|364995968|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
105818643|NCT05093205|364995969|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
105818644|NCT05093205|364995970|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
105818645|NCT05093205|364995971|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
105818646|NCT05093205|364995959|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818647|NCT05093205|364995960|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818648|NCT05093205|364995961|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
105818649|NCT05093205|364995962|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818650|NCT05093205|364995963|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818651|NCT05093205|364995964|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818652|NCT05093205|364995965|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818653|NCT05093205|364995966|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818654|NCT05093205|364995967|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818655|NCT05093205|364995968|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818656|NCT05093205|364995969|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818657|NCT05093205|364995970|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818658|NCT05093205|364995971|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
105818659|NCT05093205|364995959|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
105818660|NCT05093205|364995960|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
105818661|NCT05093205|364995961|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
105818662|NCT05093205|364995962|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
105818663|NCT05093205|364995963|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
105818664|NCT05093205|364995964|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
105818665|NCT05093205|364995965|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
105818666|NCT05093205|364995966|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
105818667|NCT05093205|364995967|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
105818668|NCT05093205|364995968|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
105818669|NCT05093205|364995969|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
105818670|NCT05093205|364995970|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
105818671|NCT05093205|364995971|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
105818672|NCT05093205|364995959|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
105818673|NCT05093205|364995960|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
105818674|NCT05093205|364995961|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
105818675|NCT05093205|364995962|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
105818676|NCT05093205|364995963|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
105818677|NCT05093205|364995964|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
105818678|NCT05093205|364995965|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
105818679|NCT05093205|364995966|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
105818680|NCT05093205|364995967|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
105818681|NCT05093205|364995968|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
105818682|NCT05093205|364995969|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
105818683|NCT05093205|364995970|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
105818684|NCT05093205|364995971|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
105818685|NCT05093205|364995959|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
105818686|NCT05093205|364995960|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
105818687|NCT05093205|364995961|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
105818688|NCT05093205|364995962|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
105818689|NCT05093205|364995963|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
105818690|NCT05093205|364995964|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
105818691|NCT05093205|364995965|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
105818692|NCT05093205|364995966|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
105818693|NCT05093205|364995967|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
105818694|NCT05093205|364995968|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
105818695|NCT05093205|364995969|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
105818696|NCT05093205|364995970|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
105818697|NCT05093205|364995971|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
105818698|NCT05093205|364995959|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
105956591|NCT01194219|365502878|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105956592|NCT01194219|365502879|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105956593|NCT01194219|365502880|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105956594|NCT01194219|365502881|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
105956595|NCT01194219|365502882|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
105956596|NCT01194219|365502883|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
105956597|NCT01194219|365502884|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
105956598|NCT01194219|365502885|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105818699|NCT05093205|364995960|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
105818700|NCT05093205|364995961|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
105818701|NCT05093205|364995962|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
105818702|NCT05093205|364995963|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
105818703|NCT05093205|364995964|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
105818704|NCT05093205|364995965|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
105818705|NCT05093205|364995966|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
105818706|NCT05093205|364995967|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
105818707|NCT05093205|364995968|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
105818708|NCT05093205|364995969|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
105818709|NCT05093205|364995970|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
105818710|NCT05093205|364995971|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
105818711|NCT05093205|364995959|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
105818712|NCT05093205|364995960|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
105818713|NCT05093205|364995961|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
105818714|NCT05093205|364995962|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
105818715|NCT05093205|364995963|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
105818716|NCT05093205|364995964|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
105818717|NCT05093205|364995965|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
105818718|NCT05093205|364995966|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
105818719|NCT05093205|364995967|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
105818720|NCT05093205|364995968|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
105818721|NCT05093205|364995969|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
105818722|NCT05093205|364995970|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
105818723|NCT05093205|364995971|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
105818724|NCT05093205|364995959|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
105818725|NCT05093205|364995960|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
105818726|NCT05093205|364995961|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
105818727|NCT05093205|364995962|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
105818728|NCT05093205|364995963|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
105818729|NCT05093205|364995964|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
105818730|NCT05093205|364995965|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
105818731|NCT05093205|364995966|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
105818732|NCT05093205|364995967|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
105818733|NCT05093205|364995968|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
105818734|NCT05093205|364995969|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
105818735|NCT05093205|364995970|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
105818736|NCT05093205|364995971|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
105818737|NCT05093205|364995959|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818738|NCT05093205|364995960|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818739|NCT05093205|364995961|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818740|NCT05093205|364995962|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818741|NCT05093205|364995963|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818742|NCT05093205|364995964|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818743|NCT05093205|364995965|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818744|NCT05093205|364995966|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818745|NCT05093205|364995967|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818746|NCT05093205|364995968|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
105818747|NCT05093205|364995969|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818748|NCT05093205|364995970|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818749|NCT05093205|364995971|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
105818750|NCT05093205|364995959|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
105818751|NCT05093205|364995960|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
105956599|NCT01194219|365502886|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
105956600|NCT01194219|365502877|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105956601|NCT01194219|365502878|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105956602|NCT01194219|365502879|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105956603|NCT01194219|365502880|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105956604|NCT01194219|365502881|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
105956605|NCT01194219|365502882|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105956606|NCT01194219|365502883|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
105956607|NCT01194219|365502884|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105956608|NCT01194219|365502885|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105956609|NCT01194219|365502886|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
105956610|NCT01194219|365502877|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105956611|NCT01194219|365502878|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105956612|NCT01194219|365502879|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105956613|NCT01194219|365502880|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105956614|NCT01194219|365502881|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
105956615|NCT01194219|365502882|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105956616|NCT01194219|365502883|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
105956617|NCT01194219|365502884|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
105956618|NCT01194219|365502885|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105818752|NCT05093205|364995961|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
105818753|NCT05093205|364995962|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
105818754|NCT05093205|364995963|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
105818755|NCT05093205|364995964|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
105818756|NCT05093205|364995965|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
105818757|NCT05093205|364995966|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
105818758|NCT05093205|364995967|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
105818759|NCT05093205|364995968|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
105818760|NCT05093205|364995969|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
105818761|NCT05093205|364995970|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
105818762|NCT05093205|364995971|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
105818763|NCT05093205|364995959|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818764|NCT05093205|364995960|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818765|NCT05093205|364995961|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818766|NCT05093205|364995962|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818767|NCT05093205|364995963|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818768|NCT05093205|364995964|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818769|NCT05093205|364995965|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818770|NCT05093205|364995966|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818771|NCT05093205|364995967|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818772|NCT05093205|364995968|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818773|NCT05093205|364995969|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
105818774|NCT05093205|364995970|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818775|NCT05093205|364995971|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
105818776|NCT05093205|364995959|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818777|NCT05093205|364995960|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818778|NCT05093205|364995961|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818779|NCT05093205|364995962|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818780|NCT05093205|364995963|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818781|NCT05093205|364995964|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818782|NCT05093205|364995965|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818783|NCT05093205|364995966|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818784|NCT05093205|364995967|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818785|NCT05093205|364995968|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818786|NCT05093205|364995969|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818787|NCT05093205|364995970|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
105818788|NCT05093205|364995971|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
105818789|NCT05093205|364995959|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
105818790|NCT05093205|364995960|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
105818791|NCT05093205|364995961|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
105818792|NCT05093205|364995962|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
105818793|NCT05093205|364995963|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
105818794|NCT05093205|364995964|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
105818795|NCT05093205|364995965|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
105818796|NCT05093205|364995966|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
105818797|NCT05093205|364995967|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
105818798|NCT05093205|364995968|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
105818799|NCT05093205|364995969|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
105818800|NCT05093205|364995970|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
105818801|NCT05093205|364995971|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
105818802|NCT05093205|364995959|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818803|NCT05093205|364995960|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818804|NCT05093205|364995961|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818805|NCT05093205|364995962|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818806|NCT05093205|364995963|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818807|NCT05093205|364995964|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818808|NCT05093205|364995965|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818809|NCT05093205|364995966|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818810|NCT05093205|364995967|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818811|NCT05093205|364995968|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818812|NCT05093205|364995969|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818813|NCT05093205|364995970|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
105818814|NCT05093205|364995971|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
105818815|NCT00846495|364995977|FG000|Overall Study|Lost to Follow-up|1|||
105956619|NCT01194219|365502886|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
105956620|NCT01194219|365502877|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105818816|NCT00846495|364995978|FG001|Overall Study|Lost to Follow-up|0|||
105818817|NCT00846495|364995977|FG000|Overall Study|Adverse Event|5|||
105818818|NCT00846495|364995978|FG001|Overall Study|Adverse Event|1|||
105818819|NCT00846495|364995977|FG000|Overall Study|Lack of Efficacy|1|||
106018764|NCT01696188|365730762|FG000|Overall Study|Protocol Violation|1|||
105818820|NCT00846495|364995978|FG001|Overall Study|Lack of Efficacy|2|||
105818821|NCT00846495|364995977|FG000|Overall Study|Physician Decision|1|||
105818822|NCT00846495|364995978|FG001|Overall Study|Physician Decision|0|||
105818823|NCT00984126|364995979|FG000|Overall Study|Protocol Violation|0|||
105818824|NCT00984126|364995980|FG001|Overall Study|Protocol Violation|0|||
105818825|NCT00984126|364995981|FG002|Overall Study|Protocol Violation|1|||
105818826|NCT00984126|364995982|FG003|Overall Study|Protocol Violation|2|||
105818827|NCT00984126|364995979|FG000|Overall Study|Adverse Event|0|||
105818828|NCT00984126|364995980|FG001|Overall Study|Adverse Event|0|||
105818829|NCT00984126|364995981|FG002|Overall Study|Adverse Event|0|||
105818830|NCT00984126|364995982|FG003|Overall Study|Adverse Event|2|||
105818831|NCT00984126|364995979|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
105818832|NCT00984126|364995980|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
105818833|NCT00984126|364995981|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
105818834|NCT00984126|364995982|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
105818835|NCT00984126|364995979|FG000|Overall Study|Withdrawal criteria|0|||
105818836|NCT00984126|364995980|FG001|Overall Study|Withdrawal criteria|1|||
105818837|NCT00984126|364995981|FG002|Overall Study|Withdrawal criteria|3|||
105818838|NCT00984126|364995982|FG003|Overall Study|Withdrawal criteria|9|||
105818839|NCT03459807|364995985|FG000|Overall Study|Withdrawal due to transplant|0|||
105818840|NCT03459807|364995986|FG001|Overall Study|Withdrawal due to transplant|1|||
105818841|NCT00359281|364995987|FG000|Overall Study|Adverse Event|1|||
105818842|NCT00359281|364995988|FG001|Overall Study|Adverse Event|0|||
105818843|NCT00359281|364995989|FG002|Overall Study|Adverse Event|0|||
105818844|NCT00359281|364995990|FG003|Overall Study|Adverse Event|0|||
105818845|NCT00359281|364995991|FG004|Overall Study|Adverse Event|0|||
105818846|NCT00359281|364995992|FG005|Overall Study|Adverse Event|0|||
105818847|NCT00359281|364995993|FG006|Overall Study|Adverse Event|1|||
105818848|NCT00359281|364995994|FG007|Overall Study|Adverse Event|0|||
105818849|NCT00359281|364995995|FG008|Overall Study|Adverse Event|0|||
105818850|NCT00359281|364995987|FG000|Overall Study|Withdrawal by Subject|0|||
105818851|NCT00359281|364995988|FG001|Overall Study|Withdrawal by Subject|0|||
105818852|NCT00359281|364995989|FG002|Overall Study|Withdrawal by Subject|0|||
105818853|NCT00359281|364995990|FG003|Overall Study|Withdrawal by Subject|0|||
105818854|NCT00359281|364995991|FG004|Overall Study|Withdrawal by Subject|0|||
105818855|NCT00359281|364995992|FG005|Overall Study|Withdrawal by Subject|0|||
105818856|NCT00359281|364995993|FG006|Overall Study|Withdrawal by Subject|1|||
105818857|NCT00359281|364995994|FG007|Overall Study|Withdrawal by Subject|0|||
105818858|NCT00359281|364995995|FG008|Overall Study|Withdrawal by Subject|0|||
105818859|NCT02392000|364995996|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
106018765|NCT01696188|365730763|FG001|Overall Study|Protocol Violation|1|||
106018766|NCT00432172|365730764|FG000|Overall Study|Physician Decision|0|||
106018767|NCT00432172|365730765|FG001|Overall Study|Physician Decision|0|||
106018768|NCT00432172|365730766|FG002|Overall Study|Physician Decision|2|||
106018769|NCT00432172|365730767|FG003|Overall Study|Physician Decision|0|||
106018770|NCT00432172|365730764|FG000|Overall Study|Adverse Event|4|||
106018771|NCT00432172|365730765|FG001|Overall Study|Adverse Event|2|||
106018772|NCT00432172|365730766|FG002|Overall Study|Adverse Event|4|||
106018773|NCT00432172|365730767|FG003|Overall Study|Adverse Event|3|||
106018774|NCT00432172|365730764|FG000|Overall Study|Disease progression|0|||
106018775|NCT00432172|365730765|FG001|Overall Study|Disease progression|2|||
106018776|NCT00432172|365730766|FG002|Overall Study|Disease progression|5|||
106018777|NCT00432172|365730767|FG003|Overall Study|Disease progression|1|||
106018778|NCT00432172|365730764|FG000|Overall Study|Withdrawal by Subject|0|||
106018779|NCT00432172|365730765|FG001|Overall Study|Withdrawal by Subject|1|||
106018780|NCT00432172|365730766|FG002|Overall Study|Withdrawal by Subject|0|||
106018781|NCT00432172|365730767|FG003|Overall Study|Withdrawal by Subject|2|||
106018782|NCT00432172|365730764|FG000|Overall Study|No treatment received|2|||
106018783|NCT00432172|365730765|FG001|Overall Study|No treatment received|2|||
106018784|NCT00432172|365730766|FG002|Overall Study|No treatment received|0|||
106018785|NCT00432172|365730767|FG003|Overall Study|No treatment received|1|||
105818860|NCT02392000|364995996|FG000|Overall Study|Withdrawal by Subject|1|||
105818861|NCT02392000|364995996|FG000|Overall Study|Lost to Follow-up|8|||
106018786|NCT02668393|365730768|FG000|Overall Study|Progressive disease|6|||
106018787|NCT02668393|365730769|FG001|Overall Study|Progressive disease|3|||
105818862|NCT04384978|364995998|FG000|Overall Study|Withdrawal by Subject|4|||
105818863|NCT04384978|364995999|FG001|Overall Study|Withdrawal by Subject|0|||
105818864|NCT02612337|364996002|FG000|Overall Study|Lack of Efficacy|1|||
105818865|NCT02612337|364996003|FG001|Overall Study|Lack of Efficacy|0|||
105818866|NCT02612337|364996002|FG000|Overall Study|Withdrawal by Subject|2|||
105818867|NCT02612337|364996003|FG001|Overall Study|Withdrawal by Subject|2|||
105818868|NCT02612337|364996002|FG000|Overall Study|Did not receive study drug|0|||
105818869|NCT02612337|364996003|FG001|Overall Study|Did not receive study drug|1|||
105818870|NCT02089997|364996006|FG000|Overall Study|Case report forms uncollected|99|||
106018788|NCT02668393|365730768|FG000|Overall Study|Adverse Event|0|||
106018789|NCT02668393|365730769|FG001|Overall Study|Adverse Event|2|||
106018790|NCT02668393|365730768|FG000|Overall Study|Withdrawal from the trial|0|||
106018791|NCT02668393|365730769|FG001|Overall Study|Withdrawal from the trial|1|||
106018792|NCT02668393|365730768|FG000|Overall Study|Lack of benefit and side effects|1|||
106018793|NCT02668393|365730769|FG001|Overall Study|Lack of benefit and side effects|0|||
105818871|NCT02089997|364996006|FG000|Overall Study|Protocol Violation|147|||
105818872|NCT02441309|364996007|FG000|Overall Study|Disease progression|2|||
105818873|NCT02441309|364996008|FG001|Overall Study|Disease progression|1|||
105818874|NCT02441309|364996009|FG002|Overall Study|Disease progression|2|||
105818875|NCT02441309|364996007|FG000|Overall Study|Adverse Event|0|||
105818876|NCT02441309|364996008|FG001|Overall Study|Adverse Event|1|||
105818877|NCT02441309|364996009|FG002|Overall Study|Adverse Event|0|||
105818878|NCT02441309|364996007|FG000|Overall Study|Withdrawal by Subject|1|||
105818879|NCT02441309|364996008|FG001|Overall Study|Withdrawal by Subject|0|||
105818880|NCT02441309|364996009|FG002|Overall Study|Withdrawal by Subject|1|||
105818881|NCT00415363|364996010|FG000|Overall Study|Withdrawal by Subject|4|||
105818882|NCT00415363|364996011|FG001|Overall Study|Withdrawal by Subject|4|||
105818883|NCT00415363|364996010|FG000|Overall Study|Adverse Event|4|||
105818884|NCT00415363|364996011|FG001|Overall Study|Adverse Event|4|||
105818885|NCT00415363|364996010|FG000|Overall Study|Lost to Follow-up|2|||
105818886|NCT00415363|364996011|FG001|Overall Study|Lost to Follow-up|1|||
105818887|NCT00415363|364996010|FG000|Overall Study|Physician Decision|3|||
105818888|NCT00415363|364996011|FG001|Overall Study|Physician Decision|1|||
105818889|NCT00415363|364996010|FG000|Overall Study|Death|16|||
105818890|NCT00415363|364996011|FG001|Overall Study|Death|12|||
105818891|NCT00415363|364996010|FG000|Overall Study|Progressive disease|26|||
105818892|NCT00415363|364996011|FG001|Overall Study|Progressive disease|32|||
105818893|NCT02374853|364996015|FG000|Overall Study|Surgery Cancelled|5|||
105818894|NCT02374853|364996016|FG001|Overall Study|Surgery Cancelled|11|||
105818895|NCT00819741|364996021|FG000|Overall Study|Adverse Event|5|||
105818896|NCT00819741|364996022|FG001|Overall Study|Adverse Event|2|||
105818897|NCT00819741|364996021|FG000|Overall Study|Lack of Efficacy|0|||
105818898|NCT00819741|364996022|FG001|Overall Study|Lack of Efficacy|2|||
105818899|NCT00819741|364996021|FG000|Overall Study|Lost to Follow-up|3|||
105818900|NCT00819741|364996022|FG001|Overall Study|Lost to Follow-up|1|||
105818901|NCT00819741|364996021|FG000|Overall Study|Protocol Violation|3|||
105818902|NCT00819741|364996022|FG001|Overall Study|Protocol Violation|4|||
105818903|NCT00819741|364996021|FG000|Overall Study|Withdrawal by Subject|2|||
105818904|NCT00819741|364996022|FG001|Overall Study|Withdrawal by Subject|2|||
105818905|NCT00819741|364996021|FG000|Overall Study|Unclassified|6|||
105818906|NCT00819741|364996022|FG001|Overall Study|Unclassified|0|||
105818907|NCT00819741|364996021|FG000|Overall Study|Reasons unknown|3|||
105818908|NCT00819741|364996022|FG001|Overall Study|Reasons unknown|3|||
105818909|NCT00396279|364997228|FG000|Overall Study|Ongoing in study|26|||
105818910|NCT00396279|364997228|FG000|Overall Study|Disease progression|2|||
105818911|NCT00396279|364997228|FG000|Overall Study|Withdrawal by Subject|1|||
105818912|NCT00396279|364997228|FG000|Overall Study|Physician Decision|1|||
105818913|NCT00667095|364997229|FG000|Overall Study|Withdrawal by Subject|0|||
105818914|NCT00667095|364997230|FG001|Overall Study|Withdrawal by Subject|1|||
105818915|NCT03447262|364997231|FG000|Overall Study|Adverse Event|7|||
105818916|NCT03447262|364997231|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
105818917|NCT03447262|364997231|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
105818918|NCT03447262|364997231|FG000|Overall Study|Death|2|||
105818919|NCT03447262|364997231|FG000|Overall Study|Study Termination by Sponsor|455|||
105818920|NCT03447262|364997231|FG000|Overall Study|Other|4|||
105818921|NCT00830206|364997232|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
105818922|NCT00830206|364997233|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
105818923|NCT03351335|364997236|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
105818924|NCT03351335|364997237|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
105818925|NCT03351335|364997238|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
105818926|NCT04000815|364997240|FG000|Overall Study|Lost to Follow-up|9|||
105818927|NCT04000815|364997241|FG001|Overall Study|Lost to Follow-up|2|||
105818928|NCT04000815|364997242|FG002|Overall Study|Lost to Follow-up|3|||
105818929|NCT04000815|364997240|FG000|Overall Study|Withdrawal by Subject|4|||
105818930|NCT04000815|364997241|FG001|Overall Study|Withdrawal by Subject|3|||
105818931|NCT04000815|364997242|FG002|Overall Study|Withdrawal by Subject|2|||
105818932|NCT04000815|364997240|FG000|Overall Study|Right ovarian cyst occured|1|||
105818933|NCT04000815|364997241|FG001|Overall Study|Right ovarian cyst occured|0|||
105818934|NCT04000815|364997242|FG002|Overall Study|Right ovarian cyst occured|0|||
106018794|NCT03532451|365730778|FG000|Overall Study|Withdrawal by Subject|0|||
106018795|NCT03532451|365730779|FG001|Overall Study|Withdrawal by Subject|1|||
105818935|NCT04000815|364997240|FG000|Overall Study|Hypertension occured on follow up|0|||
105818936|NCT04000815|364997241|FG001|Overall Study|Hypertension occured on follow up|0|||
105818937|NCT04000815|364997242|FG002|Overall Study|Hypertension occured on follow up|2|||
105818938|NCT00620074|364997243|FG000|Overall Study|Adverse Event|1|||
105818939|NCT02246166|364997245|FG000|Overall Study|Protocol Violation|1|||
105818940|NCT02246166|364997246|FG001|Overall Study|Protocol Violation|0|||
105818941|NCT02472366|364997247|FG000|Overall Study|Lost to Follow-up|1|||
105818942|NCT02472366|364997248|FG001|Overall Study|Lost to Follow-up|0|||
105818943|NCT00252720|364997252|FG000|Overall Study|Withdrawal by Subject|95|||
105818944|NCT00252720|364997253|FG001|Overall Study|Withdrawal by Subject|97|||
105818945|NCT00252720|364997252|FG000|Overall Study|Death|7|||
105818946|NCT00252720|364997253|FG001|Overall Study|Death|8|||
105818947|NCT00252720|364997252|FG000|Overall Study|Moving|23|||
105818948|NCT00252720|364997253|FG001|Overall Study|Moving|42|||
105818949|NCT00252720|364997252|FG000|Overall Study|Mainly patients lost to follow-up|7|||
105818950|NCT00252720|364997253|FG001|Overall Study|Mainly patients lost to follow-up|18|||
105818951|NCT02255097|364997254|FG000|Overall Study|Death|151|||
105818952|NCT02255097|364997254|FG000|Overall Study|Lost to Follow-up|5|||
105818953|NCT02255097|364997254|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
105818954|NCT02255097|364997254|FG000|Overall Study|Withdrawal by Subject|7|||
105818955|NCT02255097|364997254|FG000|Overall Study|Allocated but not treated|1|||
105818956|NCT01118312|364997261|FG000|Overall Study|Lost to Follow-up|33|||
105818957|NCT01118312|364997262|FG001|Overall Study|Lost to Follow-up|32|||
105818958|NCT01118312|364997261|FG000|Overall Study|Withdrawal by Subject|1|||
105818959|NCT01118312|364997262|FG001|Overall Study|Withdrawal by Subject|3|||
105818960|NCT02017223|364997263|FG000|Overall Study|Algorithm problems|2|||
105818961|NCT00678639|364997264|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
105818962|NCT00678639|364997265|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
105818963|NCT04060147|364997267|FG000|Overall Study|Withdrew consent|1|||
105818964|NCT00986245|364997268|FG000|First Intervention|Poor compliance|8|||
105818965|NCT00986245|364997269|FG001|First Intervention|Poor compliance|4|||
105818966|NCT00986245|364997268|FG000|First Intervention|Lack of Efficacy|1|||
105818967|NCT00986245|364997269|FG001|First Intervention|Lack of Efficacy|2|||
105818968|NCT00986245|364997268|FG000|First Intervention|Withdrawal by Subject|0|||
105818969|NCT00986245|364997269|FG001|First Intervention|Withdrawal by Subject|1|||
105818970|NCT00986245|364997268|FG000|First Intervention|Protocol Violation|0|||
105818971|NCT00986245|364997269|FG001|First Intervention|Protocol Violation|1|||
105818972|NCT00986245|364997268|FG000|First Intervention|Out of indication|1|||
105818973|NCT00986245|364997269|FG001|First Intervention|Out of indication|0|||
105818974|NCT00986245|364997268|FG000|Second Intervention|Poor compliance|1|||
105818975|NCT00986245|364997269|FG001|Second Intervention|Poor compliance|0|||
105818976|NCT00986245|364997268|FG000|Second Intervention|Lost to Follow-up|1|||
105818977|NCT00986245|364997269|FG001|Second Intervention|Lost to Follow-up|0|||
105818978|NCT00986245|364997268|FG000|Second Intervention|Protocol Violation|0|||
105818979|NCT00986245|364997269|FG001|Second Intervention|Protocol Violation|1|||
105818980|NCT05169710|364997270|FG000|Overall Study|Adverse Event|1|||
105818981|NCT05169710|364997271|FG001|Overall Study|Adverse Event|2|||
105818982|NCT05169710|364997272|FG002|Overall Study|Adverse Event|2|||
105818983|NCT05169710|364997270|FG000|Overall Study|Lost to Follow-up|0|||
105818984|NCT05169710|364997271|FG001|Overall Study|Lost to Follow-up|0|||
105818985|NCT05169710|364997272|FG002|Overall Study|Lost to Follow-up|1|||
106018796|NCT03532451|365730778|FG000|Overall Study|Did not undergo surgery|1|||
106018797|NCT03532451|365730779|FG001|Overall Study|Did not undergo surgery|1|||
106018798|NCT02116205|365730780|FG000|Overall Study|Withdrawal by Subject|2|||
106018799|NCT02116205|365730781|FG001|Overall Study|Withdrawal by Subject|4|||
106018800|NCT02116205|365730782|FG002|Overall Study|Withdrawal by Subject|1|||
106018801|NCT02116205|365730783|FG003|Overall Study|Withdrawal by Subject|3|||
106018802|NCT02116205|365730780|FG000|Overall Study|Lost to Follow-up|0|||
106018803|NCT02116205|365730781|FG001|Overall Study|Lost to Follow-up|2|||
105765649|NCT02432703|364793742|FG001|Overall Study|Lost to Follow-up|3|||
105765650|NCT02432703|364793741|FG000|Overall Study|Withdrawal by Subject|9|||
105765651|NCT02432703|364793742|FG001|Overall Study|Withdrawal by Subject|6|||
105765652|NCT02432703|364793741|FG000|Overall Study|Other|6|||
105765653|NCT02432703|364793742|FG001|Overall Study|Other|5|||
105765654|NCT00415584|364793743|FG000|Overall Study|Withdrawal by Subject|1|||
105765655|NCT02640755|364793746|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
105765656|NCT02640755|364793747|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
105765657|NCT02640755|364793746|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
105765658|NCT02640755|364793747|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
105765659|NCT02640755|364793746|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
105765660|NCT02640755|364793747|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
105765661|NCT02255760|364793748|FG000|Overall Study|Lost to Follow-up|0|||
105765662|NCT02255760|364793749|FG001|Overall Study|Lost to Follow-up|1|||
105765663|NCT02255760|364793750|FG002|Overall Study|Lost to Follow-up|0|||
105765664|NCT02255760|364793751|FG003|Overall Study|Lost to Follow-up|0|||
105765665|NCT02255760|364793752|FG004|Overall Study|Lost to Follow-up|0|||
105765666|NCT00003838|364793753|FG000|Overall Study|Death|0|||
105765667|NCT00003838|364793754|FG001|Overall Study|Death|12|||
105765668|NCT00003838|364793755|FG002|Overall Study|Death|7|||
105765669|NCT00003838|364793753|FG000|Overall Study|Lost to Follow-up|0|||
105765670|NCT00003838|364793754|FG001|Overall Study|Lost to Follow-up|1|||
105765671|NCT00003838|364793755|FG002|Overall Study|Lost to Follow-up|1|||
105765672|NCT00003838|364793753|FG000|Overall Study|Disease Progression|0|||
105765673|NCT00003838|364793754|FG001|Overall Study|Disease Progression|12|||
105765674|NCT00003838|364793755|FG002|Overall Study|Disease Progression|0|||
105765675|NCT00618813|364793756|FG000|Overall Study|Lack of Efficacy|1|||
105765676|NCT00618813|364793756|FG000|Overall Study|Physician Decision|2|||
105818986|NCT05169710|364997270|FG000|Overall Study|Withdrawal by Subject|2|||
105818987|NCT05169710|364997271|FG001|Overall Study|Withdrawal by Subject|1|||
105818988|NCT05169710|364997272|FG002|Overall Study|Withdrawal by Subject|0|||
105818989|NCT05169710|364997270|FG000|Overall Study|Other Study Discontinuation Reason|0|||
105818990|NCT05169710|364997271|FG001|Overall Study|Other Study Discontinuation Reason|2|||
105818991|NCT05169710|364997272|FG002|Overall Study|Other Study Discontinuation Reason|0|||
105818992|NCT04400890|364997273|FG000|Overall Study|Withdrawal by Subject|3|||
105818993|NCT04400890|364997274|FG001|Overall Study|Withdrawal by Subject|2|||
105818994|NCT00836056|364997287|FG000|First Intervention|Adverse Event|1|||
105818995|NCT00836056|364997288|FG001|First Intervention|Adverse Event|0|||
105818996|NCT01686438|364997289|FG000|Overall Study|Lost to Follow-up|8|||
105818997|NCT01686438|364997290|FG001|Overall Study|Lost to Follow-up|9|||
105818998|NCT01686438|364997291|FG002|Overall Study|Lost to Follow-up|10|||
105818999|NCT01686438|364997289|FG000|Overall Study|Adverse Event|0|||
105819000|NCT01686438|364997290|FG001|Overall Study|Adverse Event|0|||
105819001|NCT01686438|364997291|FG002|Overall Study|Adverse Event|1|||
105819002|NCT01686438|364997289|FG000|Overall Study|Protocol Violation|0|||
105819003|NCT01686438|364997290|FG001|Overall Study|Protocol Violation|0|||
105819004|NCT01686438|364997291|FG002|Overall Study|Protocol Violation|1|||
105819005|NCT01686438|364997289|FG000|Overall Study|Withdrawal by Subject|0|||
105819006|NCT01686438|364997290|FG001|Overall Study|Withdrawal by Subject|0|||
105819007|NCT01686438|364997291|FG002|Overall Study|Withdrawal by Subject|1|||
105819008|NCT00550537|364997292|FG000|Overall Study|Death|18|||
105819009|NCT00550537|364997292|FG000|Overall Study|Adverse Event|20|||
105819010|NCT00550537|364997292|FG000|Overall Study|Disease progression before|46|||
105819011|NCT00550537|364997292|FG000|Overall Study|Withdrawal by Subject|7|||
105819012|NCT00550537|364997292|FG000|Overall Study|Change in treatment plan|4|||
105819013|NCT00550537|364997292|FG000|Overall Study|Other complicating ilness|3|||
105819014|NCT00550537|364997292|FG000|Overall Study|Declining performance status|2|||
105819015|NCT00550537|364997292|FG000|Overall Study|Treated closer to home|4|||
105819016|NCT01029340|364997294|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
105819017|NCT01029340|364997295|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
105819018|NCT01029340|364997296|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
105819019|NCT01029340|364997297|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
105819020|NCT01029340|364997298|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
105819021|NCT01029340|364997299|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
105819022|NCT01029340|364997294|FG000|Part B Treatment Period|Protocol Violation|0|||
105819023|NCT01029340|364997295|FG001|Part B Treatment Period|Protocol Violation|0|||
105819024|NCT01029340|364997296|FG002|Part B Treatment Period|Protocol Violation|1|||
105819025|NCT01029340|364997297|FG003|Part B Treatment Period|Protocol Violation|0|||
105819026|NCT01029340|364997298|FG004|Part B Treatment Period|Protocol Violation|0|||
105819027|NCT01029340|364997299|FG005|Part B Treatment Period|Protocol Violation|0|||
105819028|NCT01029340|364997294|FG000|Extension Period|Adverse Event|0|||
105819029|NCT01029340|364997295|FG001|Extension Period|Adverse Event|0|||
105819030|NCT01029340|364997296|FG002|Extension Period|Adverse Event|0|||
105819031|NCT01029340|364997297|FG003|Extension Period|Adverse Event|0|||
105819032|NCT01029340|364997298|FG004|Extension Period|Adverse Event|0|||
105819033|NCT01029340|364997299|FG005|Extension Period|Adverse Event|1|||
105819034|NCT01029340|364997294|FG000|Extension Period|starting another study|0|||
105819035|NCT01029340|364997295|FG001|Extension Period|starting another study|0|||
105819036|NCT01029340|364997296|FG002|Extension Period|starting another study|0|||
105819037|NCT01029340|364997297|FG003|Extension Period|starting another study|0|||
105819038|NCT01029340|364997298|FG004|Extension Period|starting another study|0|||
105819039|NCT01029340|364997299|FG005|Extension Period|starting another study|8|||
105819040|NCT01029340|364997294|FG000|Extension Period|non-compliance|0|||
105819041|NCT01029340|364997295|FG001|Extension Period|non-compliance|0|||
105819042|NCT01029340|364997296|FG002|Extension Period|non-compliance|0|||
105956621|NCT01194219|365502878|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105956622|NCT01194219|365502879|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105956623|NCT01194219|365502880|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105956624|NCT01194219|365502881|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
105956625|NCT01194219|365502882|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
105956626|NCT01194219|365502883|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
105956627|NCT01194219|365502884|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105956628|NCT01194219|365502885|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105956629|NCT01194219|365502886|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
105956630|NCT01194219|365502877|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105956631|NCT01194219|365502878|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105956632|NCT01194219|365502879|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105956633|NCT01194219|365502880|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105956634|NCT01194219|365502881|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105819043|NCT01029340|364997297|FG003|Extension Period|non-compliance|0|||
105819044|NCT01029340|364997298|FG004|Extension Period|non-compliance|0|||
105819045|NCT01029340|364997299|FG005|Extension Period|non-compliance|1|||
105819046|NCT01029340|364997294|FG000|Extension Period|Withdrawal by Subject|0|||
105819047|NCT01029340|364997295|FG001|Extension Period|Withdrawal by Subject|0|||
105819048|NCT01029340|364997296|FG002|Extension Period|Withdrawal by Subject|0|||
105819049|NCT01029340|364997297|FG003|Extension Period|Withdrawal by Subject|0|||
105819050|NCT01029340|364997298|FG004|Extension Period|Withdrawal by Subject|0|||
105819051|NCT01029340|364997299|FG005|Extension Period|Withdrawal by Subject|1|||
105819052|NCT01029340|364997294|FG000|Extension Period|Physician Decision|0|||
105819053|NCT01029340|364997295|FG001|Extension Period|Physician Decision|0|||
105819054|NCT01029340|364997296|FG002|Extension Period|Physician Decision|0|||
105819055|NCT01029340|364997297|FG003|Extension Period|Physician Decision|0|||
105819056|NCT01029340|364997298|FG004|Extension Period|Physician Decision|0|||
105819057|NCT01029340|364997299|FG005|Extension Period|Physician Decision|1|||
105819058|NCT00268905|364997300|FG000|Overall Study|Adverse Event|3|||
105819059|NCT00268905|364997301|FG001|Overall Study|Adverse Event|0|||
105819060|NCT00268905|364997302|FG002|Overall Study|Adverse Event|4|||
105819061|NCT00268905|364997300|FG000|Overall Study|Lost to Follow-up|0|||
105819062|NCT00268905|364997301|FG001|Overall Study|Lost to Follow-up|1|||
105819063|NCT00268905|364997302|FG002|Overall Study|Lost to Follow-up|0|||
105819064|NCT00268905|364997300|FG000|Overall Study|Withdrawal by Subject|0|||
105819065|NCT00268905|364997301|FG001|Overall Study|Withdrawal by Subject|0|||
105819066|NCT00268905|364997302|FG002|Overall Study|Withdrawal by Subject|3|||
105819067|NCT00268905|364997300|FG000|Overall Study|Progressive Disease|28|||
105819068|NCT00268905|364997301|FG001|Overall Study|Progressive Disease|4|||
105819069|NCT00268905|364997302|FG002|Overall Study|Progressive Disease|3|||
105819070|NCT00268905|364997300|FG000|Overall Study|Physician Decision|3|||
105819071|NCT00268905|364997301|FG001|Overall Study|Physician Decision|0|||
105819072|NCT00268905|364997302|FG002|Overall Study|Physician Decision|1|||
105819073|NCT00268905|364997300|FG000|Overall Study|Clinical Progression|9|||
105819074|NCT00268905|364997301|FG001|Overall Study|Clinical Progression|4|||
105819075|NCT00268905|364997302|FG002|Overall Study|Clinical Progression|1|||
105819076|NCT01864174|364997303|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
105819077|NCT01864174|364997304|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
105819078|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
105819079|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
105956635|NCT01194219|365502882|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105956636|NCT01194219|365502883|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105956637|NCT01194219|365502884|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
105956638|NCT01194219|365502885|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105956639|NCT01194219|365502886|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
105956640|NCT01194219|365502877|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956641|NCT01194219|365502878|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956642|NCT01194219|365502879|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956643|NCT01194219|365502880|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956644|NCT01194219|365502881|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956645|NCT01194219|365502882|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956646|NCT01194219|365502883|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
105956647|NCT01194219|365502884|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956648|NCT01194219|365502885|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956649|NCT01194219|365502886|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
105956650|NCT01194219|365502877|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105956651|NCT01194219|365502878|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105956652|NCT01194219|365502879|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105956653|NCT01194219|365502880|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105956654|NCT01194219|365502881|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105956655|NCT01194219|365502882|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105956656|NCT01194219|365502883|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105956657|NCT01194219|365502884|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
105956658|NCT01194219|365502885|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
105956659|NCT01194219|365502886|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
105956660|NCT01194219|365502877|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105956661|NCT01194219|365502878|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105819080|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
105819081|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
105819082|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
105819083|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
105819084|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Death|1|||
105956662|NCT01194219|365502879|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105956663|NCT01194219|365502880|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105956664|NCT01194219|365502881|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105956665|NCT01194219|365502882|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105956666|NCT01194219|365502883|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105956667|NCT01194219|365502884|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
105956668|NCT01194219|365502885|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
105956669|NCT01194219|365502886|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
105956670|NCT01194219|365502877|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105956671|NCT01194219|365502878|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105956672|NCT01194219|365502879|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105956673|NCT01194219|365502880|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105956674|NCT01194219|365502881|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105956675|NCT01194219|365502882|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105956676|NCT01194219|365502883|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105956677|NCT01194219|365502884|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
105956678|NCT01194219|365502885|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
105956679|NCT01194219|365502886|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
105956680|NCT01194219|365502877|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105956681|NCT01194219|365502878|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105956682|NCT01194219|365502879|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105956683|NCT01194219|365502880|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105956684|NCT01194219|365502881|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105956685|NCT01194219|365502882|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105956686|NCT01194219|365502883|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105956687|NCT01194219|365502884|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
105956688|NCT01194219|365502885|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
105956689|NCT01194219|365502886|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
105956690|NCT01194219|365502877|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
105956691|NCT01194219|365502878|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
105956692|NCT01194219|365502879|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
105956693|NCT01194219|365502880|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
105956694|NCT01194219|365502881|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
105956695|NCT01194219|365502882|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
105956696|NCT01194219|365502883|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
105956697|NCT01194219|365502884|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
105956698|NCT01194219|365502885|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
105956699|NCT01194219|365502886|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
105956700|NCT01194219|365502877|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105956701|NCT01194219|365502878|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105956702|NCT01194219|365502879|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105956703|NCT01194219|365502880|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105956704|NCT01194219|365502881|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105956705|NCT01194219|365502882|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105956706|NCT01194219|365502883|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105956707|NCT01194219|365502884|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
105956708|NCT01194219|365502885|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
105956709|NCT01194219|365502886|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
105956710|NCT01194219|365502877|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956711|NCT01194219|365502878|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956712|NCT01194219|365502879|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956713|NCT01194219|365502880|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956714|NCT01194219|365502881|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956715|NCT01194219|365502882|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956716|NCT01194219|365502883|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956717|NCT01194219|365502884|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956718|NCT01194219|365502885|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
105956719|NCT01194219|365502886|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
105956720|NCT01194219|365502877|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
106018804|NCT02116205|365730782|FG002|Overall Study|Lost to Follow-up|1|||
106018805|NCT02116205|365730783|FG003|Overall Study|Lost to Follow-up|2|||
106018806|NCT02116205|365730780|FG000|Overall Study|Physician Decision|0|||
106018807|NCT02116205|365730781|FG001|Overall Study|Physician Decision|1|||
106018808|NCT02116205|365730782|FG002|Overall Study|Physician Decision|1|||
105956721|NCT01194219|365502878|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105956722|NCT01194219|365502879|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105956723|NCT01194219|365502880|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105956724|NCT01194219|365502881|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105956725|NCT01194219|365502882|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
106018809|NCT02116205|365730783|FG003|Overall Study|Physician Decision|1|||
106145421|NCT05094141|366191974|FG000|Overall Study|Death|0|||
106145422|NCT05094141|366191975|FG001|Overall Study|Death|0|||
106018810|NCT02116205|365730780|FG000|Overall Study|Exclusion criteria|0|||
105819085|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Death|0|||
105819086|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
105819087|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
105819088|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
105819089|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
105819090|NCT01864174|364997303|FG000|Double Blind - Compliant Randomized|Other|6|||
105819091|NCT01864174|364997304|FG001|Double Blind - Compliant Randomized|Other|10|||
105819092|NCT01864174|364997303|FG000|Off Treatment Follow-Up|Other|2|||
105819093|NCT01864174|364997304|FG001|Off Treatment Follow-Up|Other|0|||
105819094|NCT01864174|364997303|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
105819095|NCT01864174|364997304|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
105819096|NCT02648347|364997308|FG000|Overall Study|Death|174|||
105819097|NCT02648347|364997309|FG001|Overall Study|Death|167|||
105819098|NCT02648347|364997308|FG000|Overall Study|Withdrawal by Subject|16|||
105819099|NCT02648347|364997309|FG001|Overall Study|Withdrawal by Subject|9|||
105819100|NCT02648347|364997308|FG000|Overall Study|Lost to Follow-up|18|||
105819101|NCT02648347|364997309|FG001|Overall Study|Lost to Follow-up|21|||
105819102|NCT02648347|364997308|FG000|Overall Study|Missing|1|||
105819103|NCT02648347|364997309|FG001|Overall Study|Missing|0|||
105819104|NCT03546842|364997310|FG000|Overall Study|Protocol Violation|1|||
105819105|NCT03546842|364997310|FG000|Overall Study|Withdrawal by Subject|2|||
105819106|NCT02739997|364997314|FG000|Overall Study|Death|1|||
105819107|NCT02739997|364997314|FG000|Overall Study|Withdrawal by Subject|1|||
105819108|NCT00617305|364997318|FG000|Overall Study|Adverse Event|4|||
105819109|NCT00617305|364997319|FG001|Overall Study|Adverse Event|0|||
105819110|NCT00617305|364997320|FG002|Overall Study|Adverse Event|0|||
105819111|NCT00617305|364997318|FG000|Overall Study|Death|1|||
105819112|NCT00617305|364997319|FG001|Overall Study|Death|0|||
105819113|NCT00617305|364997320|FG002|Overall Study|Death|0|||
105819114|NCT00617305|364997318|FG000|Overall Study|Physician Decision|1|||
105819115|NCT00617305|364997319|FG001|Overall Study|Physician Decision|0|||
105819116|NCT00617305|364997320|FG002|Overall Study|Physician Decision|0|||
105819117|NCT00617305|364997318|FG000|Overall Study|Protocol Violation|1|||
105819118|NCT00617305|364997319|FG001|Overall Study|Protocol Violation|0|||
105819119|NCT00617305|364997320|FG002|Overall Study|Protocol Violation|1|||
105819120|NCT00617305|364997318|FG000|Overall Study|Withdrawal by Subject|1|||
105819121|NCT00617305|364997319|FG001|Overall Study|Withdrawal by Subject|0|||
105819122|NCT00617305|364997320|FG002|Overall Study|Withdrawal by Subject|0|||
105819123|NCT02158663|364997322|FG000|Overall Study|Withdrawal by Subject|5|||
105819124|NCT02158663|364997323|FG001|Overall Study|Withdrawal by Subject|4|||
105819125|NCT01265056|364997324|FG000|Initial Study Period|Withdrawal by Subject|1|||
105819126|NCT01265056|364997325|FG001|Initial Study Period|Withdrawal by Subject|1|||
105819127|NCT01265056|364997324|FG000|Initial Study Period|Withdrawal by Subject|1|||
105819128|NCT01265056|364997325|FG001|Initial Study Period|Withdrawal by Subject|1|||
105819129|NCT01265056|364997324|FG000|Follow up|Lost to Follow-up|7|||
105819130|NCT01265056|364997325|FG001|Follow up|Lost to Follow-up|3|||
105819131|NCT02453386|364997329|FG000|Overall Study|Adverse Event|22|||
105819132|NCT02453386|364997330|FG001|Overall Study|Adverse Event|30|||
105819133|NCT02453386|364997331|FG002|Overall Study|Adverse Event|15|||
105819134|NCT02453386|364997329|FG000|Overall Study|Protocol Violation|1|||
105819135|NCT02453386|364997330|FG001|Overall Study|Protocol Violation|0|||
105956726|NCT01194219|365502883|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105956727|NCT01194219|365502884|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
105956728|NCT01194219|365502885|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
105956729|NCT01194219|365502886|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
105956730|NCT00292045|365502887|FG000|Core Study (Through Week 13)|Adverse Event|1|||
105956731|NCT00292045|365502887|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
105956732|NCT04474197|365502888|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
105956733|NCT04474197|365502889|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
105956734|NCT04474197|365502890|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
105956735|NCT04474197|365502891|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
105956736|NCT02236572|365502892|FG000|Overall Study|Withdrawal by Subject|1|||
105819136|NCT02453386|364997331|FG002|Overall Study|Protocol Violation|1|||
105819137|NCT02453386|364997329|FG000|Overall Study|Withdrawal by Subject|10|||
105819138|NCT02453386|364997330|FG001|Overall Study|Withdrawal by Subject|9|||
105819139|NCT02453386|364997331|FG002|Overall Study|Withdrawal by Subject|9|||
105819140|NCT02453386|364997329|FG000|Overall Study|Sponsor Terminated Study|14|||
105819141|NCT02453386|364997330|FG001|Overall Study|Sponsor Terminated Study|8|||
105819142|NCT02453386|364997331|FG002|Overall Study|Sponsor Terminated Study|11|||
105819143|NCT02453386|364997329|FG000|Overall Study|Subject Terminated by Sponsor|1|||
105819144|NCT02453386|364997330|FG001|Overall Study|Subject Terminated by Sponsor|1|||
105819145|NCT02453386|364997331|FG002|Overall Study|Subject Terminated by Sponsor|1|||
105765677|NCT00618813|364793756|FG000|Overall Study|Withdrawal by Subject|1|||
105765678|NCT01192100|364793757|FG000|Overall Study|Withdrawal by Subject|0|||
105765679|NCT01192100|364793758|FG001|Overall Study|Withdrawal by Subject|0|||
105765680|NCT01192100|364793759|FG002|Overall Study|Withdrawal by Subject|0|||
105765681|NCT01192100|364793760|FG003|Overall Study|Withdrawal by Subject|0|||
105765682|NCT01192100|364793761|FG004|Overall Study|Withdrawal by Subject|1|||
105765683|NCT01192100|364793762|FG005|Overall Study|Withdrawal by Subject|0|||
105765684|NCT01192100|364793757|FG000|Overall Study|Protocol Violation|0|||
105765685|NCT01192100|364793758|FG001|Overall Study|Protocol Violation|0|||
105765686|NCT01192100|364793759|FG002|Overall Study|Protocol Violation|0|||
105765687|NCT01192100|364793760|FG003|Overall Study|Protocol Violation|1|||
105765688|NCT01192100|364793761|FG004|Overall Study|Protocol Violation|0|||
105765689|NCT01192100|364793762|FG005|Overall Study|Protocol Violation|0|||
105765690|NCT01235507|364793768|FG000|Overall Study|Adverse Event|1|||
105765691|NCT01235507|364793768|FG000|Overall Study|Withdrawal by Subject|1|||
105765692|NCT00918346|364793772|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
105765693|NCT00918346|364793773|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
105765694|NCT01421069|364793774|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
105765695|NCT01421069|364793774|FG000|Parent Study|Failed to return|3|||
105765696|NCT01421069|364793774|FG000|Parent Study|Withdrawal by Subject|1|||
105765697|NCT01421069|364793774|FG000|Parent Study|Lost to Follow-up|2|||
105765698|NCT01421069|364793774|FG000|Parent Study|Lack of Efficacy|1|||
105765699|NCT01421069|364793774|FG000|Overall Period for Extension Study|Other|2|||
105765700|NCT01421069|364793774|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
105765701|NCT01421069|364793774|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
105765702|NCT01421069|364793774|FG000|Overall Period for Extension Study|Pregnancy|1|||
105765703|NCT01421069|364793774|FG000|Overall Period for Extension Study|Adverse Event|1|||
105765704|NCT01421069|364793774|FG000|Overall Period for Extension Study|Protocol Violation|1|||
105765705|NCT01421069|364793774|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
105765706|NCT01421069|364793774|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
105765707|NCT01421069|364793774|FG000|Active Treatment Period|Other|1|||
105765708|NCT01421069|364793774|FG000|Active Treatment Period|No longer willing to participate in study|8|||
105765709|NCT01421069|364793774|FG000|Active Treatment Period|Insufficient clinical response|1|||
105765710|NCT01421069|364793774|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
105765711|NCT01421069|364793774|FG000|Active Treatment Period|Pregnancy|1|||
105765712|NCT01421069|364793774|FG000|Active Treatment Period|Adverse Event|1|||
105765713|NCT01421069|364793774|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
105765714|NCT01421069|364793774|FG000|Active Treatment Period|Enrolled in observational period|29|||
105765715|NCT01421069|364793774|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
105765716|NCT01421069|364793774|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
105765717|NCT01421069|364793774|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
105765718|NCT01421069|364793774|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
105765719|NCT01421069|364793774|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
105765720|NCT01421069|364793774|FG000|2b. Retreatment Period|Protocol Violation|1|||
105765721|NCT01421069|364793774|FG000|Observational Period|Other|1|||
105765722|NCT01421069|364793774|FG000|Observational Period|No longer willing to participate in study|4|||
105765723|NCT01421069|364793774|FG000|Observational Period|Lost to Follow-up|3|||
105765724|NCT01095666|364793775|FG000|Overall Study|Lack of Efficacy|0|||
105765725|NCT01095666|364793776|FG001|Overall Study|Lack of Efficacy|0|||
105765726|NCT01095666|364793777|FG002|Overall Study|Lack of Efficacy|1|||
105765727|NCT01095666|364793775|FG000|Overall Study|Adverse Event|2|||
105765728|NCT01095666|364793776|FG001|Overall Study|Adverse Event|1|||
105765729|NCT01095666|364793777|FG002|Overall Study|Adverse Event|3|||
105765730|NCT01095666|364793775|FG000|Overall Study|Lost to Follow-up|2|||
105765731|NCT01095666|364793776|FG001|Overall Study|Lost to Follow-up|2|||
105765732|NCT01095666|364793777|FG002|Overall Study|Lost to Follow-up|0|||
105765733|NCT01095666|364793775|FG000|Overall Study|Withdrawal by Subject|6|||
105765734|NCT01095666|364793776|FG001|Overall Study|Withdrawal by Subject|6|||
105765735|NCT01095666|364793777|FG002|Overall Study|Withdrawal by Subject|1|||
105765736|NCT01095666|364793775|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
105765737|NCT01095666|364793776|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
105765738|NCT01095666|364793777|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
105765739|NCT01749800|364793781|FG000|Overall Study|not meeting inclusion criteria|3|||
105765740|NCT01749800|364793782|FG001|Overall Study|not meeting inclusion criteria|0|||
105765741|NCT01749800|364793783|FG002|Overall Study|not meeting inclusion criteria|0|||
105765742|NCT01749800|364793781|FG000|Overall Study|Withdrawal by Subject|0|||
105765743|NCT01749800|364793782|FG001|Overall Study|Withdrawal by Subject|1|||
105765744|NCT01749800|364793783|FG002|Overall Study|Withdrawal by Subject|0|||
105765745|NCT03074318|364793784|FG000|Overall Study|Adverse Event|0|||
105765746|NCT03074318|364793785|FG001|Overall Study|Adverse Event|1|||
105765747|NCT03074318|364793786|FG002|Overall Study|Adverse Event|1|||
105765748|NCT03074318|364793787|FG003|Overall Study|Adverse Event|1|||
105765749|NCT03074318|364793784|FG000|Overall Study|Death|1|||
105956737|NCT02236572|365502892|FG000|Overall Study|Protocol Violation|1|||
105956738|NCT02236572|365502892|FG000|Overall Study|Lost to Follow-up|1|||
105956739|NCT01057693|365502893|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
105956740|NCT01057693|365502894|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
105956741|NCT01057693|365502895|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
105956742|NCT01057693|365502893|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
105956743|NCT01057693|365502894|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
105956744|NCT01057693|365502895|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
105956745|NCT01057693|365502893|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
105956746|NCT01057693|365502894|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
105956747|NCT01057693|365502895|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
105956748|NCT01057693|365502893|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
105956749|NCT01057693|365502894|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
105956750|NCT01057693|365502895|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
105956751|NCT01057693|365502893|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
105956752|NCT01057693|365502894|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
105956753|NCT01057693|365502895|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
105956754|NCT01057693|365502893|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
105956755|NCT01057693|365502894|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
105956756|NCT01057693|365502895|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
105956757|NCT01057693|365502893|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
105956758|NCT01057693|365502894|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
105956759|NCT01057693|365502895|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
105956760|NCT01057693|365502893|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
105956761|NCT01057693|365502894|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
105956762|NCT01057693|365502895|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
105956763|NCT01057693|365502893|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
105956764|NCT01057693|365502894|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
105956765|NCT01057693|365502895|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
105956766|NCT01057693|365502893|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
105956767|NCT01057693|365502894|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
105956768|NCT01057693|365502895|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
105956769|NCT01057693|365502893|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
105956770|NCT01057693|365502894|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
105956771|NCT01057693|365502895|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
105956772|NCT01057693|365502893|FG000|Between Single-Blind and Double-Blind|Other|6|||
105956773|NCT01057693|365502894|FG001|Between Single-Blind and Double-Blind|Other|0|||
105956774|NCT01057693|365502895|FG002|Between Single-Blind and Double-Blind|Other|0|||
105956775|NCT01057693|365502893|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
105956776|NCT01057693|365502894|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
105956777|NCT01057693|365502895|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
105956778|NCT01057693|365502893|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
105956779|NCT01057693|365502894|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
105956780|NCT01057693|365502895|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
105956781|NCT01057693|365502893|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
105956782|NCT01057693|365502894|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
105956783|NCT01057693|365502895|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
105956784|NCT01057693|365502893|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
105956785|NCT01057693|365502894|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
105956786|NCT01057693|365502895|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
105956787|NCT01057693|365502893|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
105956788|NCT01057693|365502894|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
105956789|NCT01057693|365502895|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
105956790|NCT01057693|365502893|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
105956791|NCT01057693|365502894|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
105956792|NCT01057693|365502895|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
105956793|NCT01057693|365502893|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
105956794|NCT01057693|365502894|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
105956795|NCT01057693|365502895|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
105956796|NCT02413996|365502896|FG000|Overall Study|not comfortable with the intervention|9|||
105956797|NCT02413996|365502897|FG001|Overall Study|not comfortable with the intervention|2|||
105956798|NCT02443337|365502898|FG000|Overall Study|Adverse Event|0|||
105956799|NCT02443337|365502899|FG001|Overall Study|Adverse Event|1|||
105956800|NCT02443337|365502898|FG000|Overall Study|Clinical Progressive Disease|3|||
105819146|NCT02453386|364997329|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
105819147|NCT02453386|364997330|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
105819148|NCT02453386|364997331|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
105819149|NCT02453386|364997329|FG000|Overall Study|Lost to Follow-up|0|||
105819150|NCT02453386|364997330|FG001|Overall Study|Lost to Follow-up|0|||
105819151|NCT02453386|364997331|FG002|Overall Study|Lost to Follow-up|1|||
105819152|NCT02453386|364997329|FG000|Overall Study|Other|1|||
105819153|NCT02453386|364997330|FG001|Overall Study|Other|0|||
105819154|NCT02453386|364997331|FG002|Overall Study|Other|1|||
105819155|NCT00465270|364997341|FG000|Overall Study|Death|7|||
105819156|NCT00465270|364997342|FG001|Overall Study|Death|11|||
105819157|NCT00465270|364997341|FG000|Overall Study|Withdrawal by Subject|34|||
105819158|NCT00465270|364997342|FG001|Overall Study|Withdrawal by Subject|78|||
105819159|NCT00465270|364997341|FG000|Overall Study|Lost to Follow-up|60|||
105819160|NCT00465270|364997342|FG001|Overall Study|Lost to Follow-up|67|||
105819161|NCT00465270|364997341|FG000|Overall Study|Investigator request|3|||
105819162|NCT00465270|364997342|FG001|Overall Study|Investigator request|4|||
105819163|NCT01576042|364997343|FG000|Overall Study|Physician Decision|2|||
105819164|NCT01576042|364997344|FG001|Overall Study|Physician Decision|0|||
105819165|NCT03586726|364997345|FG000|Overall Study|Withdrawal by Subject|1|||
105819166|NCT03197883|364997346|FG000|Overall Study|Adverse Event|1|||
105819167|NCT03197883|364997347|FG001|Overall Study|Adverse Event|1|||
105819168|NCT03197883|364997346|FG000|Overall Study|Lost to Follow-up|1|||
105819169|NCT03197883|364997347|FG001|Overall Study|Lost to Follow-up|0|||
105819170|NCT03197883|364997346|FG000|Overall Study|Protocol Violation|1|||
105819171|NCT03197883|364997347|FG001|Overall Study|Protocol Violation|0|||
105819172|NCT03197883|364997346|FG000|Overall Study|Other (Not Specified)|0|||
105819173|NCT03197883|364997347|FG001|Overall Study|Other (Not Specified)|5|||
105819174|NCT02605928|364997350|FG000|Overall Study|Model tuning phase|28|||
105819175|NCT02605928|364997350|FG000|Overall Study|Lack of Efficacy|5|||
105819176|NCT01697696|364997354|FG000|Overall Study|Study terminated by sponsor|0|||
105819177|NCT01697696|364997355|FG001|Overall Study|Study terminated by sponsor|3|||
105819178|NCT01697696|364997354|FG000|Overall Study|Protocol deviation|1|||
105819179|NCT01697696|364997355|FG001|Overall Study|Protocol deviation|0|||
105819180|NCT01697696|364997354|FG000|Overall Study|Physician Decision|1|||
105819181|NCT01697696|364997355|FG001|Overall Study|Physician Decision|0|||
105819182|NCT01697696|364997354|FG000|Overall Study|Death|4|||
105819183|NCT01697696|364997355|FG001|Overall Study|Death|2|||
105819184|NCT01697696|364997354|FG000|Overall Study|Lost to Follow-up|10|||
105819185|NCT01697696|364997355|FG001|Overall Study|Lost to Follow-up|7|||
105819186|NCT01697696|364997354|FG000|Overall Study|Subject/guardian decision|31|||
105819187|NCT01697696|364997355|FG001|Overall Study|Subject/guardian decision|35|||
105819188|NCT01424644|364997356|FG000|Overall Study|Adverse Event|2|||
105819189|NCT01424644|364997357|FG001|Overall Study|Adverse Event|0|||
105819190|NCT01424644|364997356|FG000|Overall Study|Withdrawal by Subject|9|||
105819191|NCT01424644|364997357|FG001|Overall Study|Withdrawal by Subject|12|||
105819192|NCT01424644|364997356|FG000|Overall Study|Lost to Follow-up|16|||
105819193|NCT01424644|364997357|FG001|Overall Study|Lost to Follow-up|12|||
105819194|NCT01424644|364997356|FG000|Overall Study|Protocol Violation|4|||
105819195|NCT01424644|364997357|FG001|Overall Study|Protocol Violation|3|||
105819196|NCT01424644|364997356|FG000|Overall Study|Administrative Reason|1|||
105819197|NCT01424644|364997357|FG001|Overall Study|Administrative Reason|0|||
105819198|NCT01424644|364997356|FG000|Overall Study|Unable to Classify|1|||
105819199|NCT01424644|364997357|FG001|Overall Study|Unable to Classify|0|||
105819200|NCT00939003|364997361|FG000|Double-blind Treatment Period|Adverse Event|1|||
105819201|NCT00939003|364997362|FG001|Double-blind Treatment Period|Adverse Event|1|||
105819202|NCT00939003|364997361|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105819203|NCT00939003|364997362|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
105819204|NCT00939003|364997361|FG000|Double-blind Treatment Period|Pregnancy|0|||
105819205|NCT00939003|364997362|FG001|Double-blind Treatment Period|Pregnancy|1|||
105819206|NCT00939003|364997361|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
105819207|NCT00939003|364997362|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
105819208|NCT00939003|364997361|FG000|Open-label Treatment Period|Adverse Event|4|||
105819209|NCT00939003|364997362|FG001|Open-label Treatment Period|Adverse Event|8|||
105819210|NCT00939003|364997361|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
105819211|NCT00939003|364997362|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
105819212|NCT00939003|364997361|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
105819213|NCT00939003|364997362|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
105819214|NCT00939003|364997361|FG000|Open-label Treatment Period|Pregnancy|1|||
105819215|NCT00939003|364997362|FG001|Open-label Treatment Period|Pregnancy|1|||
105819216|NCT00939003|364997361|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
105819217|NCT00939003|364997362|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
105819218|NCT00939003|364997361|FG000|Open-label Treatment Period|Site Closure|3|||
105819219|NCT00939003|364997362|FG001|Open-label Treatment Period|Site Closure|4|||
105819220|NCT04611789|364997363|FG000|Overall Study|Lost to Follow-up|1|||
105819221|NCT04611789|364997364|FG001|Overall Study|Lost to Follow-up|0|||
105819222|NCT04611789|364997365|FG002|Overall Study|Lost to Follow-up|0|||
106018811|NCT02116205|365730781|FG001|Overall Study|Exclusion criteria|0|||
106018812|NCT02116205|365730782|FG002|Overall Study|Exclusion criteria|1|||
106018813|NCT02116205|365730783|FG003|Overall Study|Exclusion criteria|0|||
106018814|NCT05767749|365730795|FG000|Overall Study|Withdrawal by Subject|0|||
106018815|NCT05767749|365730796|FG001|Overall Study|Withdrawal by Subject|0|||
106018816|NCT05767749|365730797|FG002|Overall Study|Withdrawal by Subject|2|||
106018817|NCT05767749|365730798|FG003|Overall Study|Withdrawal by Subject|2|||
106018818|NCT05767749|365730799|FG004|Overall Study|Withdrawal by Subject|2|||
106018819|NCT05767749|365730800|FG005|Overall Study|Withdrawal by Subject|2|||
106018820|NCT00114517|365730801|FG000|Overall Study|Adverse Event|6|||
106018821|NCT00114517|365730802|FG001|Overall Study|Adverse Event|1|||
106018822|NCT00114517|365730803|FG002|Overall Study|Adverse Event|6|||
106018823|NCT00114517|365730804|FG003|Overall Study|Adverse Event|3|||
106018824|NCT00114517|365730801|FG000|Overall Study|Lost to Follow-up|2|||
106018825|NCT00114517|365730802|FG001|Overall Study|Lost to Follow-up|2|||
106018826|NCT00114517|365730803|FG002|Overall Study|Lost to Follow-up|2|||
106018827|NCT00114517|365730804|FG003|Overall Study|Lost to Follow-up|1|||
106018828|NCT00114517|365730801|FG000|Overall Study|Too busy|3|||
106018829|NCT00114517|365730802|FG001|Overall Study|Too busy|1|||
106018830|NCT00114517|365730803|FG002|Overall Study|Too busy|1|||
106018831|NCT00114517|365730804|FG003|Overall Study|Too busy|2|||
106018832|NCT00114517|365730801|FG000|Overall Study|Moved from area|0|||
106018833|NCT00114517|365730802|FG001|Overall Study|Moved from area|3|||
106018834|NCT00114517|365730803|FG002|Overall Study|Moved from area|2|||
106018835|NCT00114517|365730804|FG003|Overall Study|Moved from area|1|||
106018836|NCT00114517|365730801|FG000|Overall Study|Did not want estradiol|1|||
106018837|NCT00114517|365730802|FG001|Overall Study|Did not want estradiol|1|||
106018838|NCT00114517|365730803|FG002|Overall Study|Did not want estradiol|0|||
106018839|NCT00114517|365730804|FG003|Overall Study|Did not want estradiol|0|||
106018840|NCT00114517|365730801|FG000|Overall Study|Armed-services duty|0|||
106018841|NCT00114517|365730802|FG001|Overall Study|Armed-services duty|1|||
106018842|NCT00114517|365730803|FG002|Overall Study|Armed-services duty|0|||
106145423|NCT05094141|366191976|FG002|Overall Study|Death|1|||
105819223|NCT02131129|364997366|FG000|Overall Study|Withdrawal by Subject|1|||
105819224|NCT02131129|364997367|FG001|Overall Study|Withdrawal by Subject|0|||
105819225|NCT00727961|364997368|FG000|Overall Study|Lost to Follow-up|1|||
105819226|NCT00727961|364997368|FG000|Overall Study|Adverse Event|4|||
105819227|NCT00727961|364997368|FG000|Overall Study|Patient's refusal|2|||
105819228|NCT00727961|364997368|FG000|Overall Study|Progression|30|||
105819229|NCT02865122|364997369|FG000|Overall Study|Adverse Event|1|||
105819230|NCT02865122|364997370|FG001|Overall Study|Adverse Event|0|||
105819231|NCT02865122|364997371|FG002|Overall Study|Adverse Event|0|||
105819232|NCT00837486|364997374|FG000|Blinded-treatment Phase|Physician Decision|1|||
105819233|NCT00837486|364997375|FG001|Blinded-treatment Phase|Physician Decision|0|||
105819234|NCT00837486|364997374|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
105819235|NCT00837486|364997375|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
105819236|NCT00837486|364997374|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
105819237|NCT00837486|364997375|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
105819238|NCT00837486|364997374|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
105819239|NCT00837486|364997375|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
105819240|NCT01313780|364997376|FG000|Overall Study|Lack of Efficacy|4|||
105819241|NCT01313780|364997377|FG001|Overall Study|Lack of Efficacy|2|||
105819242|NCT01313780|364997376|FG000|Overall Study|Adverse Event|6|||
105819243|NCT01313780|364997377|FG001|Overall Study|Adverse Event|11|||
105819244|NCT01313780|364997376|FG000|Overall Study|Withdrawal by Subject|2|||
105819245|NCT01313780|364997377|FG001|Overall Study|Withdrawal by Subject|8|||
106145424|NCT05094141|366191974|FG000|Overall Study|Withdrawal by Subject|0|||
105819246|NCT01313780|364997376|FG000|Overall Study|Protocol Violation|10|||
105819247|NCT01313780|364997377|FG001|Overall Study|Protocol Violation|4|||
105819248|NCT01313780|364997376|FG000|Overall Study|missing data|3|||
105819249|NCT01313780|364997377|FG001|Overall Study|missing data|3|||
105819250|NCT01294787|364999161|FG000|Period 1|Adverse Event|0|||
105819251|NCT01294787|364999162|FG001|Period 1|Adverse Event|0|||
105819252|NCT01294787|364999163|FG002|Period 1|Adverse Event|0|||
105819253|NCT01294787|364999164|FG003|Period 1|Adverse Event|0|||
106018843|NCT00114517|365730804|FG003|Overall Study|Armed-services duty|1|||
106018844|NCT00114517|365730801|FG000|Overall Study|Competing family issue|0|||
106145425|NCT05094141|366191975|FG001|Overall Study|Withdrawal by Subject|0|||
105819254|NCT01294787|364999165|FG004|Period 1|Adverse Event|1|||
105819255|NCT01294787|364999166|FG005|Period 1|Adverse Event|0|||
105819256|NCT01294787|364999161|FG000|Period 1|Withdrawal by Subject|0|||
105819257|NCT01294787|364999162|FG001|Period 1|Withdrawal by Subject|0|||
105819258|NCT01294787|364999163|FG002|Period 1|Withdrawal by Subject|0|||
106018845|NCT00114517|365730802|FG001|Overall Study|Competing family issue|1|||
106018846|NCT00114517|365730803|FG002|Overall Study|Competing family issue|0|||
106018847|NCT00114517|365730804|FG003|Overall Study|Competing family issue|1|||
106018848|NCT00114517|365730801|FG000|Overall Study|Physician Decision|0|||
106018849|NCT00114517|365730802|FG001|Overall Study|Physician Decision|1|||
106018850|NCT00114517|365730803|FG002|Overall Study|Physician Decision|0|||
106018851|NCT00114517|365730804|FG003|Overall Study|Physician Decision|0|||
105819259|NCT01294787|364999164|FG003|Period 1|Withdrawal by Subject|1|||
105819260|NCT01294787|364999165|FG004|Period 1|Withdrawal by Subject|1|||
105819261|NCT01294787|364999166|FG005|Period 1|Withdrawal by Subject|1|||
105819262|NCT01294787|364999161|FG000|Period 1|Administrative problem|0|||
105819263|NCT01294787|364999162|FG001|Period 1|Administrative problem|0|||
105819264|NCT01294787|364999163|FG002|Period 1|Administrative problem|1|||
105819265|NCT01294787|364999164|FG003|Period 1|Administrative problem|0|||
105819266|NCT01294787|364999165|FG004|Period 1|Administrative problem|0|||
105819267|NCT01294787|364999166|FG005|Period 1|Administrative problem|1|||
105819268|NCT01294787|364999161|FG000|Period 2|Adverse Event|0|||
105819269|NCT01294787|364999162|FG001|Period 2|Adverse Event|3|||
105819270|NCT01294787|364999163|FG002|Period 2|Adverse Event|0|||
105819271|NCT01294787|364999164|FG003|Period 2|Adverse Event|1|||
105819272|NCT01294787|364999165|FG004|Period 2|Adverse Event|0|||
105819273|NCT01294787|364999166|FG005|Period 2|Adverse Event|0|||
105819274|NCT01294787|364999161|FG000|Period 2|No longer needs study drug|0|||
105819275|NCT01294787|364999162|FG001|Period 2|No longer needs study drug|0|||
105819276|NCT01294787|364999163|FG002|Period 2|No longer needs study drug|0|||
105819277|NCT01294787|364999164|FG003|Period 2|No longer needs study drug|1|||
105819278|NCT01294787|364999165|FG004|Period 2|No longer needs study drug|0|||
105819279|NCT01294787|364999166|FG005|Period 2|No longer needs study drug|0|||
105819280|NCT01294787|364999161|FG000|Period 3|Adverse Event|0|||
105819281|NCT01294787|364999162|FG001|Period 3|Adverse Event|0|||
105819282|NCT01294787|364999163|FG002|Period 3|Adverse Event|0|||
105819283|NCT01294787|364999164|FG003|Period 3|Adverse Event|0|||
105819284|NCT01294787|364999165|FG004|Period 3|Adverse Event|1|||
105819285|NCT01294787|364999166|FG005|Period 3|Adverse Event|0|||
105819286|NCT00942968|364999167|FG000|Overall Study|Adverse Event|60|||
105819287|NCT00942968|364999167|FG000|Overall Study|Death|76|||
105819288|NCT00942968|364999167|FG000|Overall Study|Protocol Violation|9|||
105819289|NCT00942968|364999167|FG000|Overall Study|Lost to Follow-up|4|||
105819290|NCT00942968|364999167|FG000|Overall Study|Withdrawal by Subject|44|||
105819291|NCT00942968|364999167|FG000|Overall Study|Sponsor request|5|||
105819292|NCT00942968|364999167|FG000|Overall Study|Physician Decision|11|||
105819293|NCT00942968|364999167|FG000|Overall Study|Progression of disease|12|||
105819294|NCT00942968|364999167|FG000|Overall Study|Inferior vena cava filter placement|4|||
105819295|NCT00942968|364999167|FG000|Overall Study|Pulmonary embolism (PE)|1|||
105819296|NCT00942968|364999167|FG000|Overall Study|Participant required pancreatic biopsy|1|||
105819297|NCT00942968|364999167|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
105819298|NCT00745420|364999168|FG000|Overall Study|Ineligible|1|||
105819299|NCT01993030|364999169|FG000|Overall Study|Adverse Event|0|||
105819300|NCT01993030|364999170|FG001|Overall Study|Adverse Event|4|||
105819301|NCT03874715|364999172|FG000|Overall Study|Adverse Event|2|||
105819302|NCT03874715|364999173|FG001|Overall Study|Adverse Event|0|||
105819303|NCT03874715|364999172|FG000|Overall Study|Poor compliance to protocol|5|||
105819304|NCT03874715|364999173|FG001|Overall Study|Poor compliance to protocol|1|||
105819305|NCT03874715|364999172|FG000|Overall Study|Withdrawal by Subject|1|||
105819306|NCT03874715|364999173|FG001|Overall Study|Withdrawal by Subject|0|||
105819307|NCT03874715|364999172|FG000|Overall Study|Other-unspecified|1|||
105819308|NCT03874715|364999173|FG001|Overall Study|Other-unspecified|0|||
105819309|NCT01802320|364999176|FG000|Overall Study|Death|1|||
105819310|NCT01802320|364999176|FG000|Overall Study|Withdrawal by Subject|1|||
105819311|NCT04123548|364999177|FG000|Overall Study|Withdrawal by Subject|1|||
105819312|NCT04123548|364999177|FG000|Overall Study|Lost to Follow-up|8|||
105819313|NCT04123548|364999177|FG000|Overall Study|Death|4|||
105819314|NCT04123548|364999177|FG000|Overall Study|Reason Not Specified|1|||
105819315|NCT00328926|364999178|FG000|Overall Study|Pregnancy|2|||
105819316|NCT00328926|364999179|FG001|Overall Study|Pregnancy|1|||
105819317|NCT00328926|364999180|FG002|Overall Study|Pregnancy|0|||
105819318|NCT00328926|364999178|FG000|Overall Study|Lost to Follow-up|0|||
105819319|NCT00328926|364999179|FG001|Overall Study|Lost to Follow-up|1|||
105819320|NCT00328926|364999180|FG002|Overall Study|Lost to Follow-up|0|||
105819321|NCT00328926|364999178|FG000|Overall Study|Death|0|||
105819322|NCT00328926|364999179|FG001|Overall Study|Death|0|||
105956801|NCT02443337|365502899|FG001|Overall Study|Clinical Progressive Disease|0|||
106145426|NCT05094141|366191976|FG002|Overall Study|Withdrawal by Subject|1|||
106145427|NCT05094141|366191974|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
106145428|NCT05094141|366191975|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
105819323|NCT00328926|364999180|FG002|Overall Study|Death|1|||
105819324|NCT00328926|364999178|FG000|Overall Study|In vitro fertilization treatment|0|||
105819325|NCT00328926|364999179|FG001|Overall Study|In vitro fertilization treatment|0|||
105819326|NCT00328926|364999180|FG002|Overall Study|In vitro fertilization treatment|1|||
105819327|NCT00328926|364999178|FG000|Overall Study|Lack of ovarian response|0|||
105819328|NCT00328926|364999179|FG001|Overall Study|Lack of ovarian response|1|||
105819329|NCT00328926|364999180|FG002|Overall Study|Lack of ovarian response|0|||
105819330|NCT02269657|364999181|FG000|Overall Study|Protocol Violation|3|||
105819331|NCT01171989|364999187|FG000|Overall Study|Lost to Follow-up|0|||
105819332|NCT01171989|364999188|FG001|Overall Study|Lost to Follow-up|0|||
105819333|NCT01171989|364999189|FG002|Overall Study|Lost to Follow-up|1|||
105819334|NCT02440711|364999191|FG000|Second Intervention|Lost to Follow-up|1|||
105819335|NCT02440711|364999192|FG001|Second Intervention|Lost to Follow-up|0|||
105819336|NCT03450057|364999194|FG000|Overall Study|Death|17|||
105819337|NCT03450057|364999194|FG000|Overall Study|ICF withdrawal|4|||
105819338|NCT03450057|364999194|FG000|Overall Study|Lost to Follow-up|2|||
105819339|NCT02146105|364999195|FG000|Overall Study|Adverse Event|1|||
105819340|NCT02146105|364999195|FG000|Overall Study|Withdrawal by Subject|5|||
105819341|NCT05755282|364999196|FG000|Overall Study|Protocol Violation|0|||
105819342|NCT05755282|364999197|FG001|Overall Study|Protocol Violation|1|||
105819343|NCT04129346|364999198|FG000|Overall Study|Death|1|||
105819344|NCT04129346|364999199|FG001|Overall Study|Death|0|||
105819345|NCT00573066|364999200|FG000|Overall Study|Exclusion criteria|18|||
105819346|NCT00573066|364999200|FG000|Overall Study|IV malfunction|1|||
105819347|NCT00573066|364999200|FG000|Overall Study|Postoperative bleeding|1|||
105819348|NCT01838941|364999202|FG000|Overall Study|Adverse Event|1|||
105819349|NCT01838941|364999202|FG000|Overall Study|Withdrawal by Subject|1|||
105819350|NCT02822235|364999203|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
105819351|NCT02822235|364999204|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
105819352|NCT02822235|364999203|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
105819353|NCT02822235|364999204|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
105819354|NCT02822235|364999203|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
105819355|NCT02822235|364999204|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
105819356|NCT02822235|364999203|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
105819357|NCT02822235|364999204|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
105819358|NCT02822235|364999203|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
105819359|NCT02822235|364999204|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
105819360|NCT02822235|364999203|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
105819361|NCT02822235|364999204|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
105819362|NCT03375463|364999207|FG000|Period 1|Lost to Follow-up|0|||
105819363|NCT03375463|364999208|FG001|Period 1|Lost to Follow-up|0|||
105819364|NCT03375463|364999209|FG002|Period 1|Lost to Follow-up|1|||
105819365|NCT03375463|364999210|FG003|Period 1|Lost to Follow-up|0|||
105819366|NCT03375463|364999211|FG004|Period 1|Lost to Follow-up|0|||
105819367|NCT03375463|364999212|FG005|Period 1|Lost to Follow-up|0|||
105819368|NCT03375463|364999207|FG000|Period 1|Adverse Event|0|||
105819369|NCT03375463|364999208|FG001|Period 1|Adverse Event|0|||
105819370|NCT03375463|364999209|FG002|Period 1|Adverse Event|0|||
105819371|NCT03375463|364999210|FG003|Period 1|Adverse Event|0|||
105819372|NCT03375463|364999211|FG004|Period 1|Adverse Event|1|||
105819373|NCT03375463|364999212|FG005|Period 1|Adverse Event|0|||
105819374|NCT03375463|364999207|FG000|Period 2|Lost to Follow-up|1|||
105819375|NCT03375463|364999208|FG001|Period 2|Lost to Follow-up|1|||
105819376|NCT03375463|364999209|FG002|Period 2|Lost to Follow-up|0|||
105819377|NCT03375463|364999210|FG003|Period 2|Lost to Follow-up|0|||
105819378|NCT03375463|364999211|FG004|Period 2|Lost to Follow-up|0|||
105819379|NCT03375463|364999212|FG005|Period 2|Lost to Follow-up|0|||
105819380|NCT03138967|364999213|FG000|Overall Study|Death|0|||
105819381|NCT03138967|364999214|FG001|Overall Study|Death|1|||
105819382|NCT03138967|364999213|FG000|Overall Study|Physician Decision|1|||
105819383|NCT03138967|364999214|FG001|Overall Study|Physician Decision|3|||
105819384|NCT02258074|364999215|FG000|Overall Study|Withdrawal by Subject|1|||
105819385|NCT02258074|364999216|FG001|Overall Study|Withdrawal by Subject|0|||
105819386|NCT02258074|364999217|FG002|Overall Study|Withdrawal by Subject|0|||
105819387|NCT02258074|364999218|FG003|Overall Study|Withdrawal by Subject|0|||
105819388|NCT00468286|364999219|FG000|Overall Study|Adverse Event|1|||
105819389|NCT00468286|364999220|FG001|Overall Study|Adverse Event|6|||
105819390|NCT00468286|364999219|FG000|Overall Study|Protocol Violation|2|||
105819391|NCT00468286|364999220|FG001|Overall Study|Protocol Violation|2|||
105819392|NCT00468286|364999219|FG000|Overall Study|Withdrawal by Subject|4|||
105819393|NCT00468286|364999220|FG001|Overall Study|Withdrawal by Subject|3|||
105819394|NCT00468286|364999219|FG000|Overall Study|Physician Decision|0|||
105819395|NCT00468286|364999220|FG001|Overall Study|Physician Decision|1|||
105819396|NCT02196675|364999223|FG000|Overall Study|Withdrawal by Subject|1|||
105819397|NCT02196675|364999224|FG001|Overall Study|Withdrawal by Subject|0|||
105819398|NCT02196675|364999225|FG002|Overall Study|Withdrawal by Subject|0|||
105819399|NCT02196675|364999223|FG000|Overall Study|Intra-operative surgical exclusion|1|||
105819400|NCT02196675|364999224|FG001|Overall Study|Intra-operative surgical exclusion|1|||
105819401|NCT02196675|364999225|FG002|Overall Study|Intra-operative surgical exclusion|0|||
105819402|NCT02196675|364999223|FG000|Overall Study|Protocol Violation|0|||
105819403|NCT02196675|364999224|FG001|Overall Study|Protocol Violation|1|||
105819404|NCT02196675|364999225|FG002|Overall Study|Protocol Violation|0|||
105819405|NCT02196675|364999223|FG000|Overall Study|Death|0|||
105819406|NCT02196675|364999224|FG001|Overall Study|Death|0|||
105819407|NCT02196675|364999225|FG002|Overall Study|Death|1|||
105819408|NCT02711852|364999227|FG000|Overall Study|Death|5|||
105819409|NCT02711852|364999227|FG000|Overall Study|Lost to Follow-up|1|||
105819410|NCT02711852|364999227|FG000|Overall Study|Completed follow-up|3|||
105819411|NCT02711852|364999227|FG000|Overall Study|Withdrawal by Subject|1|||
105819412|NCT00537979|364999229|FG000|Overall Study|Adverse Event|2|||
105819413|NCT00537979|364999230|FG001|Overall Study|Adverse Event|2|||
105819414|NCT00537979|364999229|FG000|Overall Study|Withdrawal by Subject|1|||
105819415|NCT00537979|364999230|FG001|Overall Study|Withdrawal by Subject|4|||
105819416|NCT00537979|364999229|FG000|Overall Study|Lost to Follow-up|1|||
105819417|NCT00537979|364999230|FG001|Overall Study|Lost to Follow-up|4|||
105819418|NCT00537979|364999229|FG000|Overall Study|Lack of Efficacy|0|||
105819419|NCT00537979|364999230|FG001|Overall Study|Lack of Efficacy|1|||
105819420|NCT00537979|364999229|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
105819421|NCT00537979|364999230|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
105819422|NCT00537979|364999229|FG000|Overall Study|Death|0|||
105819423|NCT00537979|364999230|FG001|Overall Study|Death|3|||
105819424|NCT00537979|364999229|FG000|Overall Study|Kidney transplant|0|||
105819425|NCT00537979|364999230|FG001|Overall Study|Kidney transplant|3|||
105819426|NCT00537979|364999229|FG000|Overall Study|Heart failure|0|||
105819427|NCT00537979|364999230|FG001|Overall Study|Heart failure|1|||
105819428|NCT02601560|364999233|FG000|Overall Study|Other|0|||
105819429|NCT02601560|364999234|FG001|Overall Study|Other|0|||
105819430|NCT02601560|364999235|FG002|Overall Study|Other|0|||
105819431|NCT02601560|364999236|FG003|Overall Study|Other|0|||
105819432|NCT02601560|364999237|FG004|Overall Study|Other|0|||
105819433|NCT02601560|364999238|FG005|Overall Study|Other|0|||
105819434|NCT02601560|364999239|FG006|Overall Study|Other|1|||
105819435|NCT02601560|364999240|FG007|Overall Study|Other|0|||
105819436|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
105819437|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
105819438|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
105819439|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
105819440|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
105819441|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
105819442|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
105819443|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
105819444|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
105819445|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
105819446|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
105819447|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
105819448|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
105819449|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
105819450|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
105819451|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
105819452|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
105819453|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
105819454|NCT02009163|364999245|FG000|Open-label Period (Non-randomized)|Other|13|||
105819455|NCT02009163|364999246|FG001|Open-label Period (Non-randomized)|Other|0|||
105819456|NCT02009163|364999247|FG002|Open-label Period (Non-randomized)|Other|0|||
105819457|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
105819458|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
105819459|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
105819460|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
105819461|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
105819462|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
105819463|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Adverse Event|0|||
105819464|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Adverse Event|0|||
105819465|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Adverse Event|6|||
105819466|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
105819467|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
105819468|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
105819469|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
105819470|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
105819471|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
105819472|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Pregnancy|0|||
105819473|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Pregnancy|0|||
105819474|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Pregnancy|2|||
105819475|NCT02009163|364999245|FG000|Randomized-withdrawal Period|Other|0|||
105819476|NCT02009163|364999246|FG001|Randomized-withdrawal Period|Other|9|||
105819477|NCT02009163|364999247|FG002|Randomized-withdrawal Period|Other|5|||
105819478|NCT02414152|364999250|FG000|Overall Study|Withdrawal by Subject|1|||
105819479|NCT02414152|364999250|FG000|Overall Study|Lack of Efficacy|1|||
105819480|NCT01474551|364999252|FG000|Overall Study|Death|1|||
105819481|NCT00833937|364999253|FG000|Washout|Withdrawal by Subject|1|||
105819482|NCT00833937|364999254|FG001|Washout|Withdrawal by Subject|0|||
105819483|NCT02388191|364999270|FG000|Overall Study|Patient did not receive IUD|1|||
105819484|NCT02388191|364999271|FG001|Overall Study|Patient did not receive IUD|0|||
105819485|NCT03135834|364999272|FG000|Stage 1|Adverse Event|1|||
105819486|NCT03135834|364999273|FG001|Stage 1|Adverse Event|2|||
105819487|NCT03135834|364999274|FG002|Stage 1|Adverse Event|2|||
105819488|NCT03135834|364999275|FG003|Stage 1|Adverse Event|1|||
105819489|NCT03135834|364999272|FG000|Stage 1|Death|1|||
105819490|NCT03135834|364999273|FG001|Stage 1|Death|0|||
105819491|NCT03135834|364999274|FG002|Stage 1|Death|0|||
105819492|NCT03135834|364999275|FG003|Stage 1|Death|0|||
105819493|NCT03135834|364999272|FG000|Stage 1|Lost to Follow-up|17|||
105819494|NCT03135834|364999273|FG001|Stage 1|Lost to Follow-up|24|||
105819495|NCT03135834|364999274|FG002|Stage 1|Lost to Follow-up|21|||
105819496|NCT03135834|364999275|FG003|Stage 1|Lost to Follow-up|38|||
105819497|NCT03135834|364999272|FG000|Stage 1|No longer met eligibility criteria|1|||
105819498|NCT03135834|364999273|FG001|Stage 1|No longer met eligibility criteria|6|||
105819499|NCT03135834|364999274|FG002|Stage 1|No longer met eligibility criteria|2|||
105819500|NCT03135834|364999275|FG003|Stage 1|No longer met eligibility criteria|5|||
105819501|NCT03135834|364999272|FG000|Stage 1|Other|0|||
105819502|NCT03135834|364999273|FG001|Stage 1|Other|2|||
105819503|NCT03135834|364999274|FG002|Stage 1|Other|1|||
105819504|NCT03135834|364999275|FG003|Stage 1|Other|0|||
105819505|NCT03135834|364999272|FG000|Stage 1|Physician Decision|0|||
105819506|NCT03135834|364999273|FG001|Stage 1|Physician Decision|1|||
105819507|NCT03135834|364999274|FG002|Stage 1|Physician Decision|0|||
105819508|NCT03135834|364999275|FG003|Stage 1|Physician Decision|0|||
105819509|NCT03135834|364999272|FG000|Stage 1|Pregnancy|0|||
105819510|NCT03135834|364999273|FG001|Stage 1|Pregnancy|4|||
105819511|NCT03135834|364999274|FG002|Stage 1|Pregnancy|2|||
105819512|NCT03135834|364999275|FG003|Stage 1|Pregnancy|4|||
105819513|NCT03135834|364999272|FG000|Stage 1|Protocol Violation|1|||
105819514|NCT03135834|364999273|FG001|Stage 1|Protocol Violation|1|||
105819515|NCT03135834|364999274|FG002|Stage 1|Protocol Violation|2|||
105819516|NCT03135834|364999275|FG003|Stage 1|Protocol Violation|1|||
105819517|NCT03135834|364999272|FG000|Stage 1|Withdrawal by parent/guardian|2|||
105819518|NCT03135834|364999273|FG001|Stage 1|Withdrawal by parent/guardian|10|||
105819519|NCT03135834|364999274|FG002|Stage 1|Withdrawal by parent/guardian|2|||
105819520|NCT03135834|364999275|FG003|Stage 1|Withdrawal by parent/guardian|1|||
105819521|NCT03135834|364999272|FG000|Stage 1|Withdrawal by Subject|16|||
105819522|NCT03135834|364999273|FG001|Stage 1|Withdrawal by Subject|22|||
105819523|NCT03135834|364999274|FG002|Stage 1|Withdrawal by Subject|7|||
105819524|NCT03135834|364999275|FG003|Stage 1|Withdrawal by Subject|10|||
105819525|NCT03135834|364999272|FG000|Stage 1|Randomized but not Vaccinated|0|||
105819526|NCT03135834|364999273|FG001|Stage 1|Randomized but not Vaccinated|3|||
105819527|NCT03135834|364999274|FG002|Stage 1|Randomized but not Vaccinated|1|||
105819528|NCT03135834|364999275|FG003|Stage 1|Randomized but not Vaccinated|6|||
105819529|NCT03135834|364999272|FG000|Stage 2|Lost to Follow-up|0|||
105819530|NCT03135834|364999273|FG001|Stage 2|Lost to Follow-up|1|||
105819531|NCT03135834|364999274|FG002|Stage 2|Lost to Follow-up|0|||
105819532|NCT03135834|364999275|FG003|Stage 2|Lost to Follow-up|0|||
105819533|NCT03135834|364999272|FG000|Stage 2|Withdrawal by Subject|0|||
105819534|NCT03135834|364999273|FG001|Stage 2|Withdrawal by Subject|1|||
105819535|NCT03135834|364999274|FG002|Stage 2|Withdrawal by Subject|0|||
105819536|NCT03135834|364999275|FG003|Stage 2|Withdrawal by Subject|0|||
105819537|NCT03135834|364999272|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
105819538|NCT03135834|364999273|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
105819539|NCT03135834|364999274|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
105819540|NCT03135834|364999275|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
105819541|NCT03135834|364999272|FG000|Stage 2|Did not receive Booster Vaccination|1|||
105819542|NCT03135834|364999273|FG001|Stage 2|Did not receive Booster Vaccination|1|||
105819543|NCT03135834|364999274|FG002|Stage 2|Did not receive Booster Vaccination|0|||
105819544|NCT03135834|364999275|FG003|Stage 2|Did not receive Booster Vaccination|0|||
105819545|NCT00965185|364999276|FG000|Overall Study|Lost to Follow-up|2|||
105819546|NCT00965185|364999277|FG001|Overall Study|Lost to Follow-up|0|||
105819547|NCT00965185|364999276|FG000|Overall Study|Withdrawal by Subject|0|||
105819548|NCT00965185|364999277|FG001|Overall Study|Withdrawal by Subject|1|||
105819549|NCT01854047|364999278|FG000|Overall Study|Lack of Efficacy|1|||
105819550|NCT01854047|364999279|FG001|Overall Study|Lack of Efficacy|0|||
105819551|NCT01854047|364999280|FG002|Overall Study|Lack of Efficacy|0|||
105819552|NCT01854047|364999281|FG003|Overall Study|Lack of Efficacy|0|||
105819553|NCT01854047|364999282|FG004|Overall Study|Lack of Efficacy|0|||
105819554|NCT01854047|364999278|FG000|Overall Study|Poor compliance to protocol|3|||
105819555|NCT01854047|364999279|FG001|Overall Study|Poor compliance to protocol|0|||
105819556|NCT01854047|364999280|FG002|Overall Study|Poor compliance to protocol|2|||
105819557|NCT01854047|364999281|FG003|Overall Study|Poor compliance to protocol|0|||
105819558|NCT01854047|364999282|FG004|Overall Study|Poor compliance to protocol|0|||
105819559|NCT01854047|364999278|FG000|Overall Study|Adverse Event|5|||
105819560|NCT01854047|364999279|FG001|Overall Study|Adverse Event|4|||
105819561|NCT01854047|364999280|FG002|Overall Study|Adverse Event|6|||
105819562|NCT01854047|364999281|FG003|Overall Study|Adverse Event|10|||
105819563|NCT01854047|364999282|FG004|Overall Study|Adverse Event|7|||
105819564|NCT01854047|364999278|FG000|Overall Study|Randomized but not treated|0|||
105819565|NCT01854047|364999279|FG001|Overall Study|Randomized but not treated|1|||
105819566|NCT01854047|364999280|FG002|Overall Study|Randomized but not treated|2|||
105819567|NCT01854047|364999281|FG003|Overall Study|Randomized but not treated|0|||
105819568|NCT01854047|364999282|FG004|Overall Study|Randomized but not treated|4|||
105819569|NCT01854047|364999278|FG000|Overall Study|Other than specified above|3|||
105819570|NCT01854047|364999279|FG001|Overall Study|Other than specified above|3|||
105819571|NCT01854047|364999280|FG002|Overall Study|Other than specified above|3|||
105819572|NCT01854047|364999281|FG003|Overall Study|Other than specified above|5|||
105819573|NCT01854047|364999282|FG004|Overall Study|Other than specified above|8|||
105819574|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
105819575|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
105819576|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
105819577|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
105819578|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
105819579|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
105819580|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
105819581|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
105819582|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
105819583|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
105819584|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
105819585|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
105819586|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
105819587|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
105819588|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
105819589|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
105819590|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
105819591|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
105819592|NCT01045161|364999283|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
105819593|NCT01045161|364999284|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
105819594|NCT01045161|364999285|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
105819595|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
105819596|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
105819597|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
105819598|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
105819599|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
105819600|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
105819601|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
105819602|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
105819603|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
105819604|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
105819605|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
105819606|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
105819607|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
105819608|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
105819609|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
105819610|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
105819611|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
105765750|NCT03074318|364793785|FG001|Overall Study|Death|0|||
105765751|NCT03074318|364793786|FG002|Overall Study|Death|0|||
105765752|NCT03074318|364793787|FG003|Overall Study|Death|0|||
105765753|NCT03074318|364793784|FG000|Overall Study|Withdrawal by Subject|1|||
105765754|NCT03074318|364793785|FG001|Overall Study|Withdrawal by Subject|2|||
105765755|NCT03074318|364793786|FG002|Overall Study|Withdrawal by Subject|2|||
105765756|NCT03074318|364793787|FG003|Overall Study|Withdrawal by Subject|4|||
105765757|NCT03074318|364793784|FG000|Overall Study|Trial Closure|2|||
105765758|NCT03074318|364793785|FG001|Overall Study|Trial Closure|2|||
105765759|NCT03074318|364793786|FG002|Overall Study|Trial Closure|3|||
105765760|NCT03074318|364793787|FG003|Overall Study|Trial Closure|11|||
105765761|NCT03549429|364793796|FG000|Overall Study|Protocol Violation|5|||
105765762|NCT03549429|364793797|FG001|Overall Study|Protocol Violation|3|||
105765763|NCT00924729|364793798|FG000|Overall Study|insufficient volume for analysis|1|||
105765764|NCT00924729|364793799|FG001|Overall Study|insufficient volume for analysis|0|||
105765765|NCT00924729|364793798|FG000|Overall Study|Protocol Violation|1|||
105765766|NCT00924729|364793799|FG001|Overall Study|Protocol Violation|0|||
105765767|NCT00588523|364793803|FG000|Overall Study|Not treated|3|||
105765768|NCT04449276|364793804|FG000|Overall Study|Adverse Event|1|||
105765769|NCT04449276|364793805|FG001|Overall Study|Adverse Event|2|||
105956802|NCT02443337|365502898|FG000|Overall Study|Withdrawal by Subject|2|||
105956803|NCT02443337|365502899|FG001|Overall Study|Withdrawal by Subject|1|||
105956804|NCT00955474|365502900|FG000|Overall Study|Physician Decision|7|||
105956805|NCT00955474|365502901|FG001|Overall Study|Physician Decision|5|||
105956806|NCT02366923|365502902|FG000|Overall Study|Withdrawal by Subject|1|||
105956807|NCT02366923|365502902|FG000|Overall Study|Positive Slit Lamp Findings|2|||
105956808|NCT02366923|365502902|FG000|Overall Study|High Astigmatism|3|||
106145429|NCT05094141|366191976|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
105765770|NCT04449276|364793806|FG002|Overall Study|Adverse Event|0|||
105765771|NCT04449276|364793807|FG003|Overall Study|Adverse Event|0|||
105765772|NCT04449276|364793808|FG004|Overall Study|Adverse Event|2|||
105765773|NCT04449276|364793809|FG005|Overall Study|Adverse Event|0|||
105765774|NCT04449276|364793810|FG006|Overall Study|Adverse Event|0|||
105765775|NCT04449276|364793811|FG007|Overall Study|Adverse Event|1|||
105765776|NCT04449276|364793804|FG000|Overall Study|Withdrawal by Subject|2|||
105765777|NCT04449276|364793805|FG001|Overall Study|Withdrawal by Subject|0|||
105765778|NCT04449276|364793806|FG002|Overall Study|Withdrawal by Subject|0|||
105765779|NCT04449276|364793807|FG003|Overall Study|Withdrawal by Subject|1|||
105765780|NCT04449276|364793808|FG004|Overall Study|Withdrawal by Subject|0|||
105765781|NCT04449276|364793809|FG005|Overall Study|Withdrawal by Subject|0|||
105765782|NCT04449276|364793810|FG006|Overall Study|Withdrawal by Subject|0|||
105765783|NCT04449276|364793811|FG007|Overall Study|Withdrawal by Subject|0|||
105765784|NCT04449276|364793804|FG000|Overall Study|Other|0|||
105765785|NCT04449276|364793805|FG001|Overall Study|Other|2|||
105765786|NCT04449276|364793806|FG002|Overall Study|Other|3|||
105765787|NCT04449276|364793807|FG003|Overall Study|Other|2|||
105765788|NCT04449276|364793808|FG004|Overall Study|Other|0|||
105765789|NCT04449276|364793809|FG005|Overall Study|Other|0|||
105765790|NCT04449276|364793810|FG006|Overall Study|Other|0|||
105765791|NCT04449276|364793811|FG007|Overall Study|Other|1|||
105765792|NCT02023112|364793816|FG000|Overall Study|Withdrawal by Subject|2|||
105765793|NCT02023112|364793817|FG001|Overall Study|Withdrawal by Subject|1|||
105765794|NCT03034057|364793820|FG000|Overall Study|Withdrawal by Subject|10|||
105765795|NCT03034057|364793820|FG000|Overall Study|Protocol Violation|1|||
105765796|NCT03034057|364793820|FG000|Overall Study|Not defined|2|||
105765797|NCT03034057|364793820|FG000|Overall Study|Lost to Follow-up|19|||
105765798|NCT03034057|364793820|FG000|Overall Study|Adverse Event|22|||
105765799|NCT03034057|364793820|FG000|Overall Study|Medication error without associated AE|1|||
105765800|NCT02917629|364793821|FG000|Overall Study|Withdrawal by Subject|0|||
105765801|NCT02917629|364793822|FG001|Overall Study|Withdrawal by Subject|1|||
105765802|NCT03339401|364793823|FG000|Overall Study|Death|2|||
105765803|NCT03339401|364793824|FG001|Overall Study|Death|1|||
105765804|NCT03339401|364793823|FG000|Overall Study|Withdrawal by Subject|2|||
105765805|NCT03339401|364793824|FG001|Overall Study|Withdrawal by Subject|0|||
105765806|NCT03339401|364793823|FG000|Overall Study|Study terminated|4|||
105765807|NCT03339401|364793824|FG001|Overall Study|Study terminated|3|||
105765808|NCT03339401|364793823|FG000|Overall Study|Investigator Decision|1|||
105765809|NCT03339401|364793824|FG001|Overall Study|Investigator Decision|0|||
105765810|NCT00701103|364793825|FG000|Overall Study|Adverse Event|0|||
105765811|NCT00701103|364793826|FG001|Overall Study|Adverse Event|0|||
105765812|NCT00701103|364793827|FG002|Overall Study|Adverse Event|1|||
105765813|NCT00701103|364793828|FG003|Overall Study|Adverse Event|1|||
105765814|NCT00701103|364793829|FG004|Overall Study|Adverse Event|0|||
105765815|NCT00701103|364793830|FG005|Overall Study|Adverse Event|1|||
105765816|NCT00701103|364793831|FG006|Overall Study|Adverse Event|1|||
105765817|NCT00701103|364793832|FG007|Overall Study|Adverse Event|0|||
105765818|NCT00701103|364793833|FG008|Overall Study|Adverse Event|0|||
105765819|NCT00701103|364793834|FG009|Overall Study|Adverse Event|2|||
105765820|NCT00701103|364793835|FG010|Overall Study|Adverse Event|0|||
105765821|NCT00701103|364793825|FG000|Overall Study|Progressive Disease|5|||
105765822|NCT00701103|364793826|FG001|Overall Study|Progressive Disease|2|||
105765823|NCT00701103|364793827|FG002|Overall Study|Progressive Disease|6|||
105765824|NCT00701103|364793828|FG003|Overall Study|Progressive Disease|5|||
105765825|NCT00701103|364793829|FG004|Overall Study|Progressive Disease|6|||
105765826|NCT00701103|364793830|FG005|Overall Study|Progressive Disease|5|||
105765827|NCT00701103|364793831|FG006|Overall Study|Progressive Disease|7|||
105765828|NCT00701103|364793832|FG007|Overall Study|Progressive Disease|7|||
105765829|NCT00701103|364793833|FG008|Overall Study|Progressive Disease|8|||
105765830|NCT00701103|364793834|FG009|Overall Study|Progressive Disease|8|||
105765831|NCT00701103|364793835|FG010|Overall Study|Progressive Disease|11|||
105765832|NCT00701103|364793825|FG000|Overall Study|Withdrawal by Subject|0|||
105765833|NCT00701103|364793826|FG001|Overall Study|Withdrawal by Subject|1|||
105765834|NCT00701103|364793827|FG002|Overall Study|Withdrawal by Subject|1|||
105765835|NCT00701103|364793828|FG003|Overall Study|Withdrawal by Subject|0|||
105765836|NCT00701103|364793829|FG004|Overall Study|Withdrawal by Subject|0|||
105765837|NCT00701103|364793830|FG005|Overall Study|Withdrawal by Subject|0|||
105765838|NCT00701103|364793831|FG006|Overall Study|Withdrawal by Subject|0|||
105819612|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
105819613|NCT01045161|364999283|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
105819614|NCT01045161|364999284|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
105819615|NCT01045161|364999285|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
105819616|NCT01353664|364999287|FG000|Overall Study|Other|3|||
105819617|NCT01353664|364999287|FG000|Overall Study|Disease Progression|16|||
105819618|NCT01110005|364999288|FG000|Overall Study|ineligible|1|||
105819619|NCT01110005|364999289|FG001|Overall Study|ineligible|2|||
105819620|NCT01110005|364999288|FG000|Overall Study|missing consent|3|||
105819621|NCT01110005|364999289|FG001|Overall Study|missing consent|2|||
105819622|NCT01110005|364999288|FG000|Overall Study|Withdrawal by Subject|0|||
105819623|NCT01110005|364999289|FG001|Overall Study|Withdrawal by Subject|1|||
105819624|NCT02242201|364999296|FG000|Overall Study|preoperative identified neuropathy|2|||
105819625|NCT02242201|364999297|FG001|Overall Study|preoperative identified neuropathy|0|||
105819626|NCT02242201|364999298|FG002|Overall Study|preoperative identified neuropathy|0|||
105819627|NCT02242201|364999296|FG000|Overall Study|planned post-op anticoagulation|1|||
105819628|NCT02242201|364999297|FG001|Overall Study|planned post-op anticoagulation|0|||
105819629|NCT02242201|364999298|FG002|Overall Study|planned post-op anticoagulation|0|||
105819630|NCT02242201|364999296|FG000|Overall Study|changed surgical procedure|1|||
105819631|NCT02242201|364999297|FG001|Overall Study|changed surgical procedure|0|||
105819632|NCT02242201|364999298|FG002|Overall Study|changed surgical procedure|0|||
105819633|NCT02242201|364999296|FG000|Overall Study|postponed surgery|0|||
105819634|NCT02242201|364999297|FG001|Overall Study|postponed surgery|0|||
105819635|NCT02242201|364999298|FG002|Overall Study|postponed surgery|1|||
105819636|NCT02242201|364999296|FG000|Overall Study|preoperative opioid consumption|0|||
105819637|NCT02242201|364999297|FG001|Overall Study|preoperative opioid consumption|1|||
105819638|NCT02242201|364999298|FG002|Overall Study|preoperative opioid consumption|0|||
105819639|NCT03616106|364999312|FG000|Overall Study|Removed by PI|6|||
105819640|NCT03616106|364999313|FG001|Overall Study|Removed by PI|0|||
105819641|NCT03616106|364999312|FG000|Overall Study|Withdrawal by Subject|1|||
105819642|NCT03616106|364999313|FG001|Overall Study|Withdrawal by Subject|1|||
105819643|NCT03616106|364999312|FG000|Overall Study|Lost to Follow-up|7|||
105819644|NCT03616106|364999313|FG001|Overall Study|Lost to Follow-up|0|||
105819645|NCT03041025|364999314|FG000|Overall Study|Adverse Event|0|||
105819646|NCT03041025|364999315|FG001|Overall Study|Adverse Event|0|||
105819647|NCT03041025|364999316|FG002|Overall Study|Adverse Event|1|||
105819648|NCT03041025|364999314|FG000|Overall Study|Lost to Follow-up|1|||
105819649|NCT03041025|364999315|FG001|Overall Study|Lost to Follow-up|0|||
105819650|NCT03041025|364999316|FG002|Overall Study|Lost to Follow-up|0|||
105819651|NCT03041025|364999314|FG000|Overall Study|Withdrawal by Subject|0|||
105819652|NCT03041025|364999315|FG001|Overall Study|Withdrawal by Subject|0|||
105819653|NCT03041025|364999316|FG002|Overall Study|Withdrawal by Subject|1|||
105819654|NCT00119015|364999317|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
105819655|NCT00119015|364999318|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
105819656|NCT00119015|364999319|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
105819657|NCT01811953|365000715|FG000|Overall Study|Adverse Event|0|||
105819658|NCT01811953|365000716|FG001|Overall Study|Adverse Event|0|||
105819659|NCT01811953|365000717|FG002|Overall Study|Adverse Event|0|||
105819660|NCT01811953|365000718|FG003|Overall Study|Adverse Event|1|||
105819661|NCT01811953|365000719|FG004|Overall Study|Adverse Event|0|||
105819662|NCT01811953|365000720|FG005|Overall Study|Adverse Event|1|||
105819663|NCT01811953|365000715|FG000|Overall Study|Protocol Violation|0|||
105819664|NCT01811953|365000716|FG001|Overall Study|Protocol Violation|0|||
105819665|NCT01811953|365000717|FG002|Overall Study|Protocol Violation|0|||
105819666|NCT01811953|365000718|FG003|Overall Study|Protocol Violation|0|||
105819667|NCT01811953|365000719|FG004|Overall Study|Protocol Violation|1|||
105819668|NCT01811953|365000720|FG005|Overall Study|Protocol Violation|0|||
105819669|NCT01049334|365000723|FG000|Overall Study|Withdrawal by Subject|5|||
105819670|NCT01049334|365000724|FG001|Overall Study|Withdrawal by Subject|3|||
105819671|NCT01049334|365000723|FG000|Overall Study|Adverse Event|2|||
105819672|NCT01049334|365000724|FG001|Overall Study|Adverse Event|3|||
105819673|NCT01049334|365000723|FG000|Overall Study|Physician Decision|2|||
105819674|NCT01049334|365000724|FG001|Overall Study|Physician Decision|0|||
105819675|NCT01049334|365000723|FG000|Overall Study|Protocol Violation|0|||
105819676|NCT01049334|365000724|FG001|Overall Study|Protocol Violation|1|||
105819677|NCT02495857|365000725|FG000|Overall Study|Adverse Event|5|||
105819678|NCT02495857|365000726|FG001|Overall Study|Adverse Event|0|||
105819679|NCT02495857|365000727|FG002|Overall Study|Adverse Event|1|||
105819680|NCT02495857|365000725|FG000|Overall Study|Withdrawal by Subject|9|||
105819681|NCT02495857|365000726|FG001|Overall Study|Withdrawal by Subject|6|||
105819682|NCT02495857|365000727|FG002|Overall Study|Withdrawal by Subject|10|||
105819683|NCT02495857|365000725|FG000|Overall Study|Physician Decision|0|||
105819684|NCT02495857|365000726|FG001|Overall Study|Physician Decision|1|||
105819685|NCT02495857|365000727|FG002|Overall Study|Physician Decision|0|||
105819686|NCT02495857|365000725|FG000|Overall Study|Protocol Violation|1|||
105819687|NCT02495857|365000726|FG001|Overall Study|Protocol Violation|1|||
105819688|NCT02495857|365000727|FG002|Overall Study|Protocol Violation|2|||
105819689|NCT02495857|365000725|FG000|Overall Study|Lost to Follow-up|4|||
105819690|NCT02495857|365000726|FG001|Overall Study|Lost to Follow-up|5|||
105819691|NCT02495857|365000727|FG002|Overall Study|Lost to Follow-up|3|||
105819692|NCT02495857|365000725|FG000|Overall Study|Other|3|||
105819693|NCT02495857|365000726|FG001|Overall Study|Other|3|||
105819694|NCT02495857|365000727|FG002|Overall Study|Other|2|||
105819695|NCT02883452|365000728|FG000|Overall Study|Withdrawal by Subject|1|||
105819696|NCT02883452|365000729|FG001|Overall Study|Withdrawal by Subject|1|||
105819697|NCT02883452|365000730|FG002|Overall Study|Withdrawal by Subject|3|||
105819698|NCT02883452|365000731|FG003|Overall Study|Withdrawal by Subject|0|||
105819699|NCT02883452|365000732|FG004|Overall Study|Withdrawal by Subject|2|||
105819700|NCT02883452|365000733|FG005|Overall Study|Withdrawal by Subject|5|||
105819701|NCT02883452|365000728|FG000|Overall Study|Disease progression|1|||
105819702|NCT02883452|365000729|FG001|Overall Study|Disease progression|0|||
105819703|NCT02883452|365000730|FG002|Overall Study|Disease progression|0|||
105819704|NCT02883452|365000731|FG003|Overall Study|Disease progression|1|||
105819705|NCT02883452|365000732|FG004|Overall Study|Disease progression|4|||
105819706|NCT02883452|365000733|FG005|Overall Study|Disease progression|5|||
105819707|NCT02883452|365000728|FG000|Overall Study|Adverse Event|2|||
105819708|NCT02883452|365000729|FG001|Overall Study|Adverse Event|1|||
105819709|NCT02883452|365000730|FG002|Overall Study|Adverse Event|1|||
105819710|NCT02883452|365000731|FG003|Overall Study|Adverse Event|1|||
105819711|NCT02883452|365000732|FG004|Overall Study|Adverse Event|1|||
105819712|NCT02883452|365000733|FG005|Overall Study|Adverse Event|3|||
105819713|NCT02883452|365000728|FG000|Overall Study|Physician Decision|0|||
105819714|NCT02883452|365000729|FG001|Overall Study|Physician Decision|0|||
105819715|NCT02883452|365000730|FG002|Overall Study|Physician Decision|0|||
105819716|NCT02883452|365000731|FG003|Overall Study|Physician Decision|0|||
105819717|NCT02883452|365000732|FG004|Overall Study|Physician Decision|4|||
105819718|NCT02883452|365000733|FG005|Overall Study|Physician Decision|1|||
105819719|NCT02883452|365000728|FG000|Overall Study|Death|1|||
105819720|NCT02883452|365000729|FG001|Overall Study|Death|0|||
105819721|NCT02883452|365000730|FG002|Overall Study|Death|1|||
105819722|NCT02883452|365000731|FG003|Overall Study|Death|0|||
105819723|NCT02883452|365000732|FG004|Overall Study|Death|0|||
105819724|NCT02883452|365000733|FG005|Overall Study|Death|0|||
105819725|NCT02883452|365000728|FG000|Overall Study|Other|0|||
105819726|NCT02883452|365000729|FG001|Overall Study|Other|0|||
105819727|NCT02883452|365000730|FG002|Overall Study|Other|0|||
105819728|NCT02883452|365000731|FG003|Overall Study|Other|0|||
105819729|NCT02883452|365000732|FG004|Overall Study|Other|0|||
105819730|NCT02883452|365000733|FG005|Overall Study|Other|1|||
105819731|NCT00834522|365000735|FG000|Washout|Adverse Event|1|||
105819732|NCT00834522|365000736|FG001|Washout|Adverse Event|0|||
105819733|NCT00834522|365000735|FG000|Washout|Withdrawal by Subject|2|||
105819734|NCT00834522|365000736|FG001|Washout|Withdrawal by Subject|1|||
105819735|NCT01313273|365000749|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
105819736|NCT01313273|365000750|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
105819737|NCT01313273|365000749|FG000|Overall Study|Withdrawal by Subject|1|||
105819738|NCT01313273|365000750|FG001|Overall Study|Withdrawal by Subject|0|||
105819739|NCT01313273|365000749|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
105819740|NCT01313273|365000750|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
105819741|NCT01602419|365000751|FG000|Overall Study|Not treated with Wilate|9|||
105819742|NCT01602419|365000751|FG000|Overall Study|Adverse Drug Reaction|4|||
105819743|NCT01602419|365000751|FG000|Overall Study|Insurance issues|3|||
105819744|NCT01602419|365000751|FG000|Overall Study|Changed treatment centre|1|||
105819745|NCT01602419|365000751|FG000|Overall Study|Treatment centre closed|1|||
105819746|NCT01602419|365000751|FG000|Overall Study|Withdrawal by Subject|5|||
105819747|NCT01602419|365000751|FG000|Overall Study|Lost to Follow-up|6|||
105819748|NCT01010542|365000752|FG000|Overall Study|Adverse Event|0|||
105819749|NCT01010542|365000753|FG001|Overall Study|Adverse Event|1|||
105956809|NCT03083665|365502904|FG000|Double-Blind Period|Adverse Event|5|||
105956810|NCT03083665|365502905|FG001|Double-Blind Period|Adverse Event|4|||
105819750|NCT01010542|365000754|FG002|Overall Study|Adverse Event|0|||
105819751|NCT01010542|365000752|FG000|Overall Study|Lost to Follow-up|0|||
105819752|NCT01010542|365000753|FG001|Overall Study|Lost to Follow-up|1|||
105819753|NCT01010542|365000754|FG002|Overall Study|Lost to Follow-up|0|||
105819754|NCT01010542|365000752|FG000|Overall Study|Withdrawal by Subject|0|||
105819755|NCT01010542|365000753|FG001|Overall Study|Withdrawal by Subject|3|||
105819756|NCT01010542|365000754|FG002|Overall Study|Withdrawal by Subject|2|||
105819757|NCT03956862|365000755|FG000|Overall Study|Lost to Follow-up|1|||
105819758|NCT03956862|365000756|FG001|Overall Study|Lost to Follow-up|1|||
105819759|NCT03956862|365000755|FG000|Overall Study|Withdrawal by Subject|1|||
105819760|NCT03956862|365000756|FG001|Overall Study|Withdrawal by Subject|1|||
105819761|NCT01472341|365000757|FG000|Overall Study|Started insulin therapy|55|||
105819762|NCT01472341|365000757|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
105819763|NCT01472341|365000757|FG000|Overall Study|Withdrawal by Subject|39|||
105819764|NCT01472341|365000757|FG000|Overall Study|Lost to Follow-up|52|||
105819765|NCT01472341|365000757|FG000|Overall Study|Laboratory parameters unavailable|25|||
105819766|NCT01472341|365000757|FG000|Overall Study|Death|9|||
105819767|NCT01363765|365000760|FG000|Overall Study|non-diagnostic|2621|||
105819768|NCT01363765|365000761|FG001|Overall Study|non-diagnostic|1124|||
105819769|NCT01363765|365000760|FG000|Overall Study|duplicate records|736|||
105819770|NCT01363765|365000761|FG001|Overall Study|duplicate records|3177|||
105819771|NCT01363765|365000760|FG000|Overall Study|non-resident|156|||
105819772|NCT01363765|365000761|FG001|Overall Study|non-resident|76|||
105819773|NCT01363765|365000760|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
105819774|NCT01363765|365000761|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
105819775|NCT01363765|365000760|FG000|Overall Study|smear during intervention|2170|||
105819776|NCT01363765|365000761|FG001|Overall Study|smear during intervention|0|||
105819777|NCT01975948|365000763|FG000|Overall Study|Withdrawal by Subject|17|||
105819778|NCT01975948|365000764|FG001|Overall Study|Withdrawal by Subject|21|||
105819779|NCT01975948|365000765|FG002|Overall Study|Withdrawal by Subject|7|||
105819780|NCT01975948|365000766|FG003|Overall Study|Withdrawal by Subject|6|||
105819781|NCT01200810|365000768|FG000|Overall Study|Physician Decision|1|||
105819782|NCT01200810|365000769|FG001|Overall Study|Physician Decision|0|||
105819783|NCT01200810|365000768|FG000|Overall Study|Withdrawal by Subject|1|||
105819784|NCT01200810|365000769|FG001|Overall Study|Withdrawal by Subject|2|||
105819785|NCT01200810|365000768|FG000|Overall Study|Sponsor stopped making study drug|3|||
105819786|NCT01200810|365000769|FG001|Overall Study|Sponsor stopped making study drug|3|||
105819787|NCT00365846|365000770|FG000|Overall Study|Lost to Follow-up|1|||
105819788|NCT03925532|365000776|FG000|Overall Study|Lost to Follow-up|1|||
105819789|NCT04499963|365000777|FG000|Overall Study|Adverse Event|3|||
105819790|NCT04499963|365000778|FG001|Overall Study|Adverse Event|0|||
105819791|NCT04499963|365000777|FG000|Overall Study|Death|3|||
105819792|NCT04499963|365000778|FG001|Overall Study|Death|0|||
105819793|NCT04499963|365000777|FG000|Overall Study|Lack of Efficacy|7|||
105819794|NCT04499963|365000778|FG001|Overall Study|Lack of Efficacy|0|||
105819795|NCT04499963|365000777|FG000|Overall Study|Lost to Follow-up|2|||
105819796|NCT04499963|365000778|FG001|Overall Study|Lost to Follow-up|0|||
105819797|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Adverse Event|11|||
105819798|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Adverse Event|23|||
105819799|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Adverse Event|29|||
105819800|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Adverse Event|2|||
105956811|NCT03083665|365502906|FG002|Double-Blind Period|Adverse Event|5|||
105956812|NCT03083665|365502907|FG003|Double-Blind Period|Adverse Event|0|||
105956813|NCT03083665|365502908|FG004|Double-Blind Period|Adverse Event|0|||
105956814|NCT03083665|365502909|FG005|Double-Blind Period|Adverse Event|0|||
105956815|NCT03083665|365502904|FG000|Double-Blind Period|Lack of Efficacy|0|||
105956816|NCT03083665|365502905|FG001|Double-Blind Period|Lack of Efficacy|0|||
105956817|NCT03083665|365502906|FG002|Double-Blind Period|Lack of Efficacy|1|||
105956818|NCT03083665|365502907|FG003|Double-Blind Period|Lack of Efficacy|0|||
105956819|NCT03083665|365502908|FG004|Double-Blind Period|Lack of Efficacy|0|||
105956820|NCT03083665|365502909|FG005|Double-Blind Period|Lack of Efficacy|0|||
105956821|NCT03083665|365502904|FG000|Double-Blind Period|Protocol Violation|1|||
105956822|NCT03083665|365502905|FG001|Double-Blind Period|Protocol Violation|0|||
105956823|NCT03083665|365502906|FG002|Double-Blind Period|Protocol Violation|1|||
105956824|NCT03083665|365502907|FG003|Double-Blind Period|Protocol Violation|0|||
105956825|NCT03083665|365502908|FG004|Double-Blind Period|Protocol Violation|0|||
105956826|NCT03083665|365502909|FG005|Double-Blind Period|Protocol Violation|0|||
105956827|NCT03083665|365502904|FG000|Double-Blind Period|Lost to Follow-up|1|||
105956828|NCT03083665|365502905|FG001|Double-Blind Period|Lost to Follow-up|0|||
105956829|NCT03083665|365502906|FG002|Double-Blind Period|Lost to Follow-up|1|||
105956830|NCT03083665|365502907|FG003|Double-Blind Period|Lost to Follow-up|0|||
105956831|NCT03083665|365502908|FG004|Double-Blind Period|Lost to Follow-up|0|||
105956832|NCT03083665|365502909|FG005|Double-Blind Period|Lost to Follow-up|0|||
105956833|NCT03083665|365502904|FG000|Double-Blind Period|Withdrawal by Subject|3|||
105956834|NCT03083665|365502905|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105956835|NCT03083665|365502906|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105956836|NCT03083665|365502907|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105956837|NCT03083665|365502908|FG004|Double-Blind Period|Withdrawal by Subject|0|||
105819801|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Adverse Event|8|||
105819802|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
105819803|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
105819804|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
105819805|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
105819806|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
105819807|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
105819808|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
105819809|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
105956838|NCT03083665|365502909|FG005|Double-Blind Period|Withdrawal by Subject|0|||
105819810|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
105819811|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
105819812|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
105819813|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
106018852|NCT00114517|365730801|FG000|Overall Study|Lost interest|0|||
106018853|NCT00114517|365730802|FG001|Overall Study|Lost interest|0|||
106018854|NCT00114517|365730803|FG002|Overall Study|Lost interest|1|||
106018855|NCT00114517|365730804|FG003|Overall Study|Lost interest|0|||
106018856|NCT00114517|365730801|FG000|Overall Study|Weight increase|0|||
106018857|NCT00114517|365730802|FG001|Overall Study|Weight increase|0|||
106018858|NCT00114517|365730803|FG002|Overall Study|Weight increase|1|||
106018859|NCT00114517|365730804|FG003|Overall Study|Weight increase|0|||
106018860|NCT00114517|365730801|FG000|Overall Study|Concern about blood clots|0|||
106018861|NCT00114517|365730802|FG001|Overall Study|Concern about blood clots|0|||
106018862|NCT00114517|365730803|FG002|Overall Study|Concern about blood clots|1|||
106018863|NCT00114517|365730804|FG003|Overall Study|Concern about blood clots|0|||
106018864|NCT00114517|365730801|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
105765839|NCT00701103|364793832|FG007|Overall Study|Withdrawal by Subject|0|||
105765840|NCT00701103|364793833|FG008|Overall Study|Withdrawal by Subject|0|||
105765841|NCT00701103|364793834|FG009|Overall Study|Withdrawal by Subject|0|||
105765842|NCT00701103|364793835|FG010|Overall Study|Withdrawal by Subject|0|||
105765843|NCT00701103|364793825|FG000|Overall Study|Other|0|||
105765844|NCT00701103|364793826|FG001|Overall Study|Other|0|||
105765845|NCT00701103|364793827|FG002|Overall Study|Other|0|||
105765846|NCT00701103|364793828|FG003|Overall Study|Other|0|||
105765847|NCT00701103|364793829|FG004|Overall Study|Other|0|||
105765848|NCT00701103|364793830|FG005|Overall Study|Other|0|||
105765849|NCT00701103|364793831|FG006|Overall Study|Other|0|||
105765850|NCT00701103|364793832|FG007|Overall Study|Other|0|||
105765851|NCT00701103|364793833|FG008|Overall Study|Other|1|||
105765852|NCT00701103|364793834|FG009|Overall Study|Other|1|||
105765853|NCT00701103|364793835|FG010|Overall Study|Other|0|||
105765854|NCT03271307|364793836|FG000|Overall Study|Lost to Follow-up|0|||
105765855|NCT03271307|364793837|FG001|Overall Study|Lost to Follow-up|0|||
105765856|NCT03271307|364793838|FG002|Overall Study|Lost to Follow-up|0|||
105765857|NCT03271307|364793839|FG003|Overall Study|Lost to Follow-up|28|||
105765858|NCT03271307|364793840|FG004|Overall Study|Lost to Follow-up|91|||
105765859|NCT01449955|364793841|FG000|Overall Study|Withdrawal by Subject|1|||
105765860|NCT01449955|364793842|FG001|Overall Study|Withdrawal by Subject|2|||
105765861|NCT02067533|364793849|FG000|Overall Study|Lost to Follow-up|4|||
105765862|NCT02067533|364793850|FG001|Overall Study|Lost to Follow-up|2|||
105765863|NCT01176240|364793851|FG000|Study 306A|Lack of Efficacy|2|||
105765864|NCT01176240|364793852|FG001|Study 306A|Lack of Efficacy|1|||
105765865|NCT01176240|364793851|FG000|Study 306A|Protocol Violation|0|||
105765866|NCT01176240|364793852|FG001|Study 306A|Protocol Violation|1|||
105765867|NCT01176240|364793851|FG000|Study 306A|Withdrawal by Subject|0|||
105765868|NCT01176240|364793852|FG001|Study 306A|Withdrawal by Subject|1|||
105765869|NCT01176240|364793851|FG000|Study 306A|Stop due to diverse problems|1|||
105765870|NCT01176240|364793852|FG001|Study 306A|Stop due to diverse problems|0|||
105765871|NCT01176240|364793851|FG000|Study 306B|Lack of Efficacy|5|||
105765872|NCT01176240|364793852|FG001|Study 306B|Lack of Efficacy|3|||
105765873|NCT01176240|364793851|FG000|Study 306B|Adverse Event|10|||
105765874|NCT01176240|364793852|FG001|Study 306B|Adverse Event|5|||
105765875|NCT01176240|364793851|FG000|Study 306B|Protocol Violation|2|||
105765876|NCT01176240|364793852|FG001|Study 306B|Protocol Violation|3|||
105765877|NCT01176240|364793851|FG000|Study 306B|Withdrawal by Subject|4|||
105765878|NCT01176240|364793852|FG001|Study 306B|Withdrawal by Subject|1|||
105765879|NCT01176240|364793851|FG000|Study 306B|Physician Decision|2|||
105765880|NCT01176240|364793852|FG001|Study 306B|Physician Decision|1|||
105765881|NCT01176240|364793851|FG000|Study 306B|Supine Hypertension|1|||
105765882|NCT01176240|364793852|FG001|Study 306B|Supine Hypertension|2|||
105765883|NCT01176240|364793851|FG000|Study 306B|Lost to Follow-up|0|||
105765884|NCT01176240|364793852|FG001|Study 306B|Lost to Follow-up|1|||
105765885|NCT01176240|364793851|FG000|Study 306B|withdrew prior to dosing|2|||
105765886|NCT01176240|364793852|FG001|Study 306B|withdrew prior to dosing|1|||
105765887|NCT01931150|364793853|FG000|Overall Study|Withdrawal by Subject|1|||
105765888|NCT01931150|364793854|FG001|Overall Study|Withdrawal by Subject|2|||
105765889|NCT04968353|364793855|FG000|Overall Study|Non-compliance|1|||
105765890|NCT04968353|364793856|FG001|Overall Study|Non-compliance|0|||
105765891|NCT04968353|364793857|FG002|Overall Study|Non-compliance|2|||
105765892|NCT04968353|364793858|FG003|Overall Study|Non-compliance|0|||
105765893|NCT02967692|364795917|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
105765894|NCT02967692|364795918|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
105765895|NCT02967692|364795919|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
105765896|NCT02967692|364795920|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
105765897|NCT02967692|364795917|FG000|Overall Study|Progressive disease|3|||
105765898|NCT02967692|364795918|FG001|Overall Study|Progressive disease|15|||
105765899|NCT02967692|364795919|FG002|Overall Study|Progressive disease|99|||
105765900|NCT02967692|364795920|FG003|Overall Study|Progressive disease|128|||
105765901|NCT02967692|364795917|FG000|Overall Study|Subject/guardian decision|1|||
106018865|NCT00114517|365730802|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
105819814|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
105819815|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
105819816|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
105819817|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
105819818|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
105819819|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
105819820|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
105819821|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
105819822|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
105819823|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
105819824|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
105819825|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
105819826|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
105819827|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
105819828|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
105819829|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
105819830|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
105819831|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
105819832|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Move|0|||
105819833|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Move|1|||
105819834|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Move|0|||
105819835|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Move|0|||
105819836|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Move|0|||
105819837|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
105819838|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
105819839|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
105819840|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
105819841|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
105819842|NCT00318461|365000781|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
105819843|NCT00318461|365000782|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
105819844|NCT00318461|365000783|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
105819845|NCT00318461|365000784|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
105819846|NCT00318461|365000785|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
105819847|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Work commitment|0|||
105819848|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Work commitment|0|||
105819849|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Work commitment|0|||
105819850|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Work commitment|0|||
105819851|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Work commitment|1|||
105819852|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Investigator decision|0|||
105819853|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Investigator decision|0|||
105819854|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Investigator decision|0|||
105819855|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Investigator decision|0|||
105819856|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Investigator decision|1|||
105819857|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Lack of time|1|||
105819858|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Lack of time|0|||
105819859|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Lack of time|0|||
105819860|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Lack of time|0|||
105819861|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Lack of time|0|||
105819862|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
105819863|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
105819864|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
105819865|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
105819866|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
105819867|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
105819868|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
105819869|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
105819870|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
105819871|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
105819872|NCT00318461|365000781|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
105819873|NCT00318461|365000782|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
105819874|NCT00318461|365000783|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
105819875|NCT00318461|365000784|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
105819876|NCT00318461|365000785|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
105819877|NCT00318461|365000781|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
105819878|NCT00318461|365000782|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
105956839|NCT03083665|365502904|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
105956840|NCT03083665|365502905|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105819879|NCT00318461|365000783|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
105819880|NCT00318461|365000784|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
105819881|NCT00318461|365000785|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
105819882|NCT00318461|365000781|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
105819883|NCT00318461|365000782|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
105819884|NCT00318461|365000783|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
105819885|NCT00318461|365000784|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
105819886|NCT00318461|365000785|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
105819887|NCT00318461|365000781|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
105819888|NCT00318461|365000782|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
105819889|NCT00318461|365000783|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
105819890|NCT00318461|365000784|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
105819891|NCT00318461|365000785|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
105819892|NCT00318461|365000781|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
105819893|NCT00318461|365000782|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
105819894|NCT00318461|365000783|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
105819895|NCT00318461|365000784|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
105819896|NCT00318461|365000785|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
105819897|NCT00318461|365000781|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
105819898|NCT00318461|365000782|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
105819899|NCT00318461|365000783|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
105819900|NCT00318461|365000784|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
105819901|NCT00318461|365000785|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
105819902|NCT01723397|365000786|FG000|Study Period 1|Protocol Violation|0|||
105819903|NCT01723397|365000787|FG001|Study Period 1|Protocol Violation|1|||
105819904|NCT01723397|365000786|FG000|Study Period 2|Protocol Violation|0|||
105819905|NCT01723397|365000787|FG001|Study Period 2|Protocol Violation|1|||
105819906|NCT00838279|365000792|FG000|Washout|Protocol Violation|1|||
105819907|NCT00838279|365000793|FG001|Washout|Protocol Violation|0|||
105819908|NCT00838279|365000792|FG000|Washout|Withdrawal by Subject|0|||
105819909|NCT00838279|365000793|FG001|Washout|Withdrawal by Subject|1|||
105819910|NCT03233724|365000798|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
105819911|NCT03233724|365000799|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
105819912|NCT03233724|365000800|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
105819913|NCT03233724|365000801|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
105819914|NCT03233724|365000802|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
105819915|NCT03233724|365000798|FG000|Phase I Dose Escalation|Best interest of participant|1|||
105819916|NCT03233724|365000799|FG001|Phase I Dose Escalation|Best interest of participant|1|||
105819917|NCT03233724|365000800|FG002|Phase I Dose Escalation|Best interest of participant|1|||
105819918|NCT03233724|365000801|FG003|Phase I Dose Escalation|Best interest of participant|0|||
105819919|NCT03233724|365000802|FG004|Phase I Dose Escalation|Best interest of participant|0|||
105819920|NCT03233724|365000798|FG000|Phase I Dose Escalation|Physician Decision|0|||
105819921|NCT03233724|365000799|FG001|Phase I Dose Escalation|Physician Decision|0|||
105819922|NCT03233724|365000800|FG002|Phase I Dose Escalation|Physician Decision|1|||
105819923|NCT03233724|365000801|FG003|Phase I Dose Escalation|Physician Decision|0|||
105819924|NCT03233724|365000802|FG004|Phase I Dose Escalation|Physician Decision|0|||
105819925|NCT03233724|365000798|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
105819926|NCT03233724|365000799|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
105819927|NCT03233724|365000800|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
105819928|NCT03233724|365000801|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
105819929|NCT03233724|365000802|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
105819930|NCT03482882|365000803|FG000|Overall Study|Adverse Event|3|||
105956841|NCT03083665|365502906|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105956842|NCT03083665|365502907|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105956843|NCT03083665|365502908|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105956844|NCT03083665|365502909|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
105956845|NCT03083665|365502904|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
105956846|NCT03083665|365502905|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
105956847|NCT03083665|365502906|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
105956848|NCT03083665|365502907|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
105956849|NCT03083665|365502908|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
106145430|NCT05094141|366191974|FG000|Overall Study|Did not participate in randomization|0|||
106145431|NCT05094141|366191975|FG001|Overall Study|Did not participate in randomization|0|||
106145432|NCT05094141|366191976|FG002|Overall Study|Did not participate in randomization|33|||
105819931|NCT03482882|365000803|FG000|Overall Study|Lost to Follow-up|1|||
105819932|NCT03482882|365000803|FG000|Overall Study|Protocol Violation|2|||
105819933|NCT03482882|365000803|FG000|Overall Study|Not further specified|1|||
105819934|NCT04646213|365000804|FG000|Overall Study|Physician Decision|3|||
105819935|NCT04646213|365000804|FG000|Overall Study|Withdrawal by Subject|2|||
105819936|NCT02281084|365000806|FG000|Overall Study|Death|21|||
105819937|NCT02281084|365000807|FG001|Overall Study|Death|18|||
105819938|NCT02281084|365000808|FG002|Overall Study|Death|3|||
105819939|NCT02281084|365000809|FG003|Overall Study|Death|5|||
105819940|NCT02281084|365000806|FG000|Overall Study|Adverse Event|1|||
105819941|NCT02281084|365000807|FG001|Overall Study|Adverse Event|0|||
105819942|NCT02281084|365000808|FG002|Overall Study|Adverse Event|0|||
105819943|NCT02281084|365000809|FG003|Overall Study|Adverse Event|0|||
105819944|NCT02281084|365000806|FG000|Overall Study|Withdrawal by Subject|2|||
105819945|NCT02281084|365000807|FG001|Overall Study|Withdrawal by Subject|2|||
105819946|NCT02281084|365000808|FG002|Overall Study|Withdrawal by Subject|0|||
105819947|NCT02281084|365000809|FG003|Overall Study|Withdrawal by Subject|0|||
105819948|NCT02281084|365000806|FG000|Overall Study|Site Closure by Sponsor|5|||
105819949|NCT02281084|365000807|FG001|Overall Study|Site Closure by Sponsor|1|||
105819950|NCT02281084|365000808|FG002|Overall Study|Site Closure by Sponsor|2|||
105819951|NCT02281084|365000809|FG003|Overall Study|Site Closure by Sponsor|0|||
105819952|NCT01686477|365000810|FG000|Feeding Intervention|Death|1|||
105819953|NCT01686477|365000811|FG001|Feeding Intervention|Death|0|||
105819954|NCT01686477|365000812|FG002|Feeding Intervention|Death|1|||
105819955|NCT01686477|365000810|FG000|Feeding Intervention|Withdrawal by Subject|0|||
105819956|NCT01686477|365000811|FG001|Feeding Intervention|Withdrawal by Subject|6|||
105819957|NCT01686477|365000812|FG002|Feeding Intervention|Withdrawal by Subject|0|||
105819958|NCT01686477|365000810|FG000|Feeding Intervention|Physician Decision|1|||
105819959|NCT01686477|365000811|FG001|Feeding Intervention|Physician Decision|2|||
105819960|NCT01686477|365000812|FG002|Feeding Intervention|Physician Decision|0|||
105819961|NCT01686477|365000810|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
105819962|NCT01686477|365000811|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
105819963|NCT01686477|365000812|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
105819964|NCT01686477|365000810|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
105819965|NCT01686477|365000811|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
105819966|NCT01686477|365000812|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
105819967|NCT01686477|365000810|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
105819968|NCT01686477|365000811|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
105819969|NCT01686477|365000812|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
105819970|NCT01686477|365000810|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
105819971|NCT01686477|365000811|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
105819972|NCT01686477|365000812|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
105819973|NCT01686477|365000810|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
105819974|NCT01686477|365000811|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
105819975|NCT01686477|365000812|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
105819976|NCT01686477|365000810|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
105819977|NCT01686477|365000811|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
105819978|NCT01686477|365000812|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
105819979|NCT01686477|365000810|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
105819980|NCT01686477|365000811|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
105819981|NCT01686477|365000812|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
105819982|NCT02305758|365000813|FG000|Overall Study|Death|27|||
105819983|NCT02305758|365000814|FG001|Overall Study|Death|27|||
105819984|NCT02305758|365000813|FG000|Overall Study|Withdrew consent|9|||
105819985|NCT02305758|365000814|FG001|Overall Study|Withdrew consent|2|||
105819986|NCT02305758|365000813|FG000|Overall Study|Lost to Follow-up|6|||
105819987|NCT02305758|365000814|FG001|Overall Study|Lost to Follow-up|1|||
105819988|NCT02305758|365000813|FG000|Overall Study|Study Terminated by Sponsor|21|||
105819989|NCT02305758|365000814|FG001|Overall Study|Study Terminated by Sponsor|34|||
105819990|NCT02305758|365000813|FG000|Overall Study|Other, not specified|2|||
105819991|NCT02305758|365000814|FG001|Overall Study|Other, not specified|1|||
105956850|NCT03083665|365502909|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
105956851|NCT03083665|365502904|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105819992|NCT02032888|365000815|FG000|Treatment Period|Poor compliance/noncompliance|1|||
105819993|NCT02032888|365000816|FG001|Treatment Period|Poor compliance/noncompliance|1|||
105819994|NCT02032888|365000817|FG002|Treatment Period|Poor compliance/noncompliance|0|||
105819995|NCT02032888|365000815|FG000|Treatment Period|Other|1|||
105819996|NCT02032888|365000816|FG001|Treatment Period|Other|1|||
105819997|NCT02032888|365000817|FG002|Treatment Period|Other|0|||
105819998|NCT02032888|365000815|FG000|Follow-up Period|Lost to Follow-up|1|||
105819999|NCT02032888|365000816|FG001|Follow-up Period|Lost to Follow-up|1|||
105820000|NCT02032888|365000817|FG002|Follow-up Period|Lost to Follow-up|0|||
105820001|NCT02032888|365000815|FG000|Follow-up Period|Death|1|||
105820002|NCT02032888|365000816|FG001|Follow-up Period|Death|1|||
105820003|NCT02032888|365000817|FG002|Follow-up Period|Death|0|||
105820004|NCT02032888|365000815|FG000|Follow-up Period|Other|1|||
106145433|NCT05219253|366193079|FG000|Overall Study|Withdrawal by Subject|1|||
105765902|NCT02967692|364795918|FG001|Overall Study|Subject/guardian decision|1|||
105765903|NCT02967692|364795919|FG002|Overall Study|Subject/guardian decision|6|||
105765904|NCT02967692|364795920|FG003|Overall Study|Subject/guardian decision|13|||
105765905|NCT02967692|364795917|FG000|Overall Study|Death|0|||
105765906|NCT02967692|364795918|FG001|Overall Study|Death|1|||
105765907|NCT02967692|364795919|FG002|Overall Study|Death|10|||
105765908|NCT02967692|364795920|FG003|Overall Study|Death|9|||
105765909|NCT02967692|364795917|FG000|Overall Study|Protocol deviation|1|||
105765910|NCT02967692|364795918|FG001|Overall Study|Protocol deviation|0|||
105765911|NCT02967692|364795919|FG002|Overall Study|Protocol deviation|1|||
105765912|NCT02967692|364795920|FG003|Overall Study|Protocol deviation|1|||
105765913|NCT02967692|364795917|FG000|Overall Study|Lost to Follow-up|0|||
105765914|NCT02967692|364795918|FG001|Overall Study|Lost to Follow-up|0|||
105765915|NCT02967692|364795919|FG002|Overall Study|Lost to Follow-up|1|||
105765916|NCT02967692|364795920|FG003|Overall Study|Lost to Follow-up|0|||
105765917|NCT02967692|364795917|FG000|Overall Study|Physician Decision|0|||
105765918|NCT02967692|364795918|FG001|Overall Study|Physician Decision|0|||
105765919|NCT02967692|364795919|FG002|Overall Study|Physician Decision|13|||
105765920|NCT02967692|364795920|FG003|Overall Study|Physician Decision|9|||
105765921|NCT02967692|364795917|FG000|Overall Study|Adverse Event|1|||
105765922|NCT02967692|364795918|FG001|Overall Study|Adverse Event|9|||
105765923|NCT02967692|364795919|FG002|Overall Study|Adverse Event|51|||
105765924|NCT02967692|364795920|FG003|Overall Study|Adverse Event|23|||
105765925|NCT03038672|364795921|FG000|Initial Treatment|Unacceptable chemistry|0|||
105765926|NCT03038672|364795922|FG001|Initial Treatment|Unacceptable chemistry|1|||
105765927|NCT03038672|364795921|FG000|Initial Treatment|Progression prior to treatment|1|||
105765928|NCT03038672|364795922|FG001|Initial Treatment|Progression prior to treatment|0|||
105765929|NCT03038672|364795921|FG000|Initial Treatment|No treatment per protocol|1|||
105765930|NCT03038672|364795922|FG001|Initial Treatment|No treatment per protocol|0|||
105765931|NCT01731990|364795923|FG000|Overall Study|Adverse Event|1|||
105765932|NCT01731990|364795924|FG001|Overall Study|Adverse Event|5|||
105765933|NCT01731990|364795923|FG000|Overall Study|Withdrawal by Subject|1|||
105765934|NCT01731990|364795924|FG001|Overall Study|Withdrawal by Subject|1|||
105765935|NCT01731990|364795923|FG000|Overall Study|Protocol deviation|1|||
105765936|NCT01731990|364795924|FG001|Overall Study|Protocol deviation|2|||
105765937|NCT01731990|364795923|FG000|Overall Study|Death|1|||
105765938|NCT01731990|364795924|FG001|Overall Study|Death|0|||
105765939|NCT01280812|364795925|FG000|Overall Study|Withdrawal by Subject|2|||
105765940|NCT01280812|364795926|FG001|Overall Study|Withdrawal by Subject|1|||
105765941|NCT01280812|364795927|FG002|Overall Study|Withdrawal by Subject|0|||
105765942|NCT01280812|364795925|FG000|Overall Study|Lost to Follow-up|1|||
105765943|NCT01280812|364795926|FG001|Overall Study|Lost to Follow-up|1|||
105765944|NCT01280812|364795927|FG002|Overall Study|Lost to Follow-up|1|||
105765945|NCT04483544|364795928|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
105765946|NCT04483544|364795928|FG000|Post-Treatment|Admitted to hospice|2|||
105765947|NCT04483544|364795928|FG000|Post-Treatment|Study terminated|3|||
105765948|NCT01131078|364795931|FG000|Overall Study|Adverse Event|22|||
105765949|NCT01131078|364795932|FG001|Overall Study|Adverse Event|12|||
105765950|NCT01131078|364795933|FG002|Overall Study|Adverse Event|17|||
105765951|NCT01131078|364795931|FG000|Overall Study|Progressive Disease|58|||
105765952|NCT01131078|364795932|FG001|Overall Study|Progressive Disease|77|||
105765953|NCT01131078|364795933|FG002|Overall Study|Progressive Disease|71|||
105765954|NCT01131078|364795931|FG000|Overall Study|Protocol Violation|1|||
105765955|NCT01131078|364795932|FG001|Overall Study|Protocol Violation|0|||
105765956|NCT01131078|364795933|FG002|Overall Study|Protocol Violation|0|||
105765957|NCT01131078|364795931|FG000|Overall Study|Lost to Follow-up|1|||
105765958|NCT01131078|364795932|FG001|Overall Study|Lost to Follow-up|1|||
105765959|NCT01131078|364795933|FG002|Overall Study|Lost to Follow-up|1|||
105765960|NCT01131078|364795931|FG000|Overall Study|Withdrawal by Subject|2|||
105765961|NCT01131078|364795932|FG001|Overall Study|Withdrawal by Subject|4|||
105765962|NCT01131078|364795933|FG002|Overall Study|Withdrawal by Subject|3|||
105765963|NCT01131078|364795931|FG000|Overall Study|Non-compliance|3|||
105765964|NCT01131078|364795932|FG001|Overall Study|Non-compliance|0|||
105765965|NCT01131078|364795933|FG002|Overall Study|Non-compliance|0|||
105820005|NCT02032888|365000816|FG001|Follow-up Period|Other|0|||
105820006|NCT02032888|365000817|FG002|Follow-up Period|Other|0|||
105820007|NCT02445339|365000818|FG000|Overall Study|Physician Decision|1|||
105820008|NCT02445339|365000819|FG001|Overall Study|Physician Decision|0|||
105765966|NCT01131078|364795931|FG000|Overall Study|Physician Decision|10|||
105820009|NCT02445339|365000818|FG000|Overall Study|Lost to Follow-up|11|||
105820010|NCT02445339|365000819|FG001|Overall Study|Lost to Follow-up|15|||
105765967|NCT01131078|364795932|FG001|Overall Study|Physician Decision|6|||
105765968|NCT01131078|364795933|FG002|Overall Study|Physician Decision|8|||
105765969|NCT01131078|364795931|FG000|Overall Study|Death|4|||
105765970|NCT01131078|364795932|FG001|Overall Study|Death|0|||
105820011|NCT03161405|365000820|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
105765971|NCT01131078|364795933|FG002|Overall Study|Death|2|||
105765972|NCT01131078|364795931|FG000|Overall Study|Other|0|||
105765973|NCT01131078|364795932|FG001|Overall Study|Other|1|||
105820012|NCT02186821|365000821|FG000|Overall Study|Adverse Event|9|||
105820013|NCT02186821|365000821|FG000|Overall Study|Death|2|||
105820014|NCT02186821|365000821|FG000|Overall Study|Disease progression|32|||
105820015|NCT02186821|365000821|FG000|Overall Study|Protocol Violation|1|||
105820016|NCT02186821|365000821|FG000|Overall Study|Physician Decision|1|||
105820017|NCT02186821|365000821|FG000|Overall Study|Study terminated by sponsor|2|||
105820018|NCT02820350|365000822|FG000|Overall Study|Withdrawal by Subject|3|||
105820019|NCT02820350|365000822|FG000|Overall Study|Death|4|||
105820020|NCT03649477|365000823|FG000|Overall Study|Adverse Event|2|||
105820021|NCT03649477|365000824|FG001|Overall Study|Adverse Event|0|||
105820022|NCT03649477|365000825|FG002|Overall Study|Adverse Event|0|||
105820023|NCT00787254|365000826|FG000|Overall Study|Adverse Event|24|||
105820024|NCT00787254|365000827|FG001|Overall Study|Adverse Event|23|||
105820025|NCT00787254|365000826|FG000|Overall Study|Protocol Violation|26|||
105820026|NCT00787254|365000827|FG001|Overall Study|Protocol Violation|23|||
105820027|NCT00787254|365000826|FG000|Overall Study|Withdrawal by Subject|16|||
105820028|NCT00787254|365000827|FG001|Overall Study|Withdrawal by Subject|11|||
105820029|NCT00787254|365000826|FG000|Overall Study|Lack of Efficacy|4|||
105820030|NCT00787254|365000827|FG001|Overall Study|Lack of Efficacy|15|||
105820031|NCT00787254|365000826|FG000|Overall Study|NSAIDs discontinuation|1|||
105820032|NCT00787254|365000827|FG001|Overall Study|NSAIDs discontinuation|2|||
105820033|NCT00787254|365000826|FG000|Overall Study|Institution closed|1|||
105820034|NCT00787254|365000827|FG001|Overall Study|Institution closed|0|||
105820035|NCT00787254|365000826|FG000|Overall Study|Physician Decision|4|||
105820036|NCT00787254|365000827|FG001|Overall Study|Physician Decision|8|||
105820037|NCT00731783|365000835|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
105820038|NCT00731783|365000836|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
105820039|NCT00731783|365000835|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
105820040|NCT00731783|365000836|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
105820041|NCT00731783|365000835|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
105820042|NCT00731783|365000836|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
105820043|NCT00731783|365000835|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
105820044|NCT00731783|365000836|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
105820045|NCT00316186|365000840|FG000|Overall Study|Adverse Event|6|||
105820046|NCT00316186|365000840|FG000|Overall Study|Disease Progression|4|||
105820047|NCT00316186|365000840|FG000|Overall Study|Lost to Follow-up|1|||
105820048|NCT00316186|365000840|FG000|Overall Study|Other|1|||
105820049|NCT00859430|365000841|FG000|First Intervention|Withdrawal by Subject|0|||
105820050|NCT00859430|365000842|FG001|First Intervention|Withdrawal by Subject|1|||
105820051|NCT03235739|365002555|FG000|Overall Study|Withdrawal by Subject|2|||
105820052|NCT03235739|365002556|FG001|Overall Study|Withdrawal by Subject|2|||
105820053|NCT03235739|365002555|FG000|Overall Study|Physician Decision|0|||
105820054|NCT03235739|365002556|FG001|Overall Study|Physician Decision|1|||
105820055|NCT01066143|365002558|FG000|Overall Study|ineligible for the study|8|||
105820056|NCT02847650|365002559|FG000|Overall Study|Adverse Event|2|||
105820057|NCT02847650|365002560|FG001|Overall Study|Adverse Event|4|||
105820058|NCT02847650|365002559|FG000|Overall Study|Lost to Follow-up|1|||
105820059|NCT02847650|365002560|FG001|Overall Study|Lost to Follow-up|0|||
105820060|NCT02847650|365002559|FG000|Overall Study|Protocol Violation|0|||
105820061|NCT02847650|365002560|FG001|Overall Study|Protocol Violation|1|||
105820062|NCT02847650|365002559|FG000|Overall Study|Withdrawal by Subject|1|||
105820063|NCT02847650|365002560|FG001|Overall Study|Withdrawal by Subject|1|||
105820064|NCT03772522|365002561|FG000|Pre-intervention|Withdrawal by Subject|3|||
105820065|NCT03772522|365002562|FG001|Pre-intervention|Withdrawal by Subject|4|||
105820066|NCT03772522|365002561|FG000|Intervention|Withdrawal by Subject|1|||
105820067|NCT03772522|365002562|FG001|Intervention|Withdrawal by Subject|0|||
105820068|NCT03772522|365002561|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
105820069|NCT03772522|365002562|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
105820070|NCT05376319|365002563|FG000|Overall Study|Funding termination|2|||
105820071|NCT05376319|365002564|FG001|Overall Study|Funding termination|4|||
105820072|NCT00218257|365002567|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
105820073|NCT00218257|365002568|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
105820074|NCT00579345|365002569|FG000|Overall Study|Withdrawal by Subject|2|||
105820075|NCT00579345|365002570|FG001|Overall Study|Withdrawal by Subject|0|||
105820076|NCT00579345|365002571|FG002|Overall Study|Withdrawal by Subject|0|||
105820077|NCT00579345|365002572|FG003|Overall Study|Withdrawal by Subject|0|||
105820078|NCT00579345|365002573|FG004|Overall Study|Withdrawal by Subject|0|||
105820079|NCT00579345|365002574|FG005|Overall Study|Withdrawal by Subject|0|||
105820080|NCT00579345|365002575|FG006|Overall Study|Withdrawal by Subject|0|||
105956852|NCT03083665|365502905|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105956853|NCT03083665|365502906|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105956854|NCT03083665|365502907|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
105956855|NCT03083665|365502908|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105956856|NCT03083665|365502909|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
105956857|NCT03083665|365502904|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105820081|NCT00579345|365002576|FG007|Overall Study|Withdrawal by Subject|1|||
106018866|NCT00114517|365730803|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
106018867|NCT00114517|365730804|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
105820082|NCT00579345|365002569|FG000|Overall Study|Lost to Follow-up|1|||
105820083|NCT00579345|365002570|FG001|Overall Study|Lost to Follow-up|0|||
105820084|NCT00579345|365002571|FG002|Overall Study|Lost to Follow-up|0|||
105820085|NCT00579345|365002572|FG003|Overall Study|Lost to Follow-up|0|||
105820086|NCT00579345|365002573|FG004|Overall Study|Lost to Follow-up|0|||
105820087|NCT00579345|365002574|FG005|Overall Study|Lost to Follow-up|0|||
105820088|NCT00579345|365002575|FG006|Overall Study|Lost to Follow-up|0|||
105820089|NCT00579345|365002576|FG007|Overall Study|Lost to Follow-up|0|||
105820090|NCT00579345|365002569|FG000|Overall Study|Adverse Event|0|||
105820091|NCT00579345|365002570|FG001|Overall Study|Adverse Event|0|||
105820092|NCT00579345|365002571|FG002|Overall Study|Adverse Event|1|||
105820093|NCT00579345|365002572|FG003|Overall Study|Adverse Event|0|||
105820094|NCT00579345|365002573|FG004|Overall Study|Adverse Event|0|||
105820095|NCT00579345|365002574|FG005|Overall Study|Adverse Event|0|||
105820096|NCT00579345|365002575|FG006|Overall Study|Adverse Event|0|||
105820097|NCT00579345|365002576|FG007|Overall Study|Adverse Event|0|||
105820098|NCT00579345|365002569|FG000|Overall Study|Protocol Violation|1|||
105820099|NCT00579345|365002570|FG001|Overall Study|Protocol Violation|0|||
105820100|NCT00579345|365002571|FG002|Overall Study|Protocol Violation|0|||
105820101|NCT00579345|365002572|FG003|Overall Study|Protocol Violation|0|||
105820102|NCT00579345|365002573|FG004|Overall Study|Protocol Violation|0|||
105820103|NCT00579345|365002574|FG005|Overall Study|Protocol Violation|0|||
105820104|NCT00579345|365002575|FG006|Overall Study|Protocol Violation|0|||
105820105|NCT00579345|365002576|FG007|Overall Study|Protocol Violation|1|||
105820106|NCT00579345|365002569|FG000|Overall Study|Death|1|||
105820107|NCT00579345|365002570|FG001|Overall Study|Death|1|||
105820108|NCT00579345|365002571|FG002|Overall Study|Death|1|||
105820109|NCT00579345|365002572|FG003|Overall Study|Death|1|||
105820110|NCT00579345|365002573|FG004|Overall Study|Death|0|||
105820111|NCT00579345|365002574|FG005|Overall Study|Death|0|||
105820112|NCT00579345|365002575|FG006|Overall Study|Death|0|||
105820113|NCT00579345|365002576|FG007|Overall Study|Death|0|||
105820114|NCT01466166|365002577|FG000|Overall Study|Death|1|||
105820115|NCT01466166|365002577|FG000|Overall Study|Lost to Follow-up|7|||
105820116|NCT01466166|365002577|FG000|Overall Study|Infusion Reaction (IR)|27|||
105820117|NCT01466166|365002577|FG000|Overall Study|Adverse Event (Other than IR)|11|||
105820118|NCT01466166|365002577|FG000|Overall Study|Elevated Serum Uric Acid|78|||
105820119|NCT01466166|365002577|FG000|Overall Study|Withdrawal by Subject|13|||
105820120|NCT01466166|365002577|FG000|Overall Study|Sponsor Decision|4|||
105820121|NCT01466166|365002577|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
105820122|NCT01466166|365002577|FG000|Overall Study|Other|20|||
105820123|NCT02175095|365002580|FG000|Overall Study|Withdrawal by Subject|3|||
105820124|NCT01340495|365002581|FG000|Overall Study|Withdrawal by Subject|1|||
105820125|NCT00667862|365002582|FG000|Overall Study|Adverse Event|9|||
105820126|NCT00667862|365002582|FG000|Overall Study|Death|1|||
105820127|NCT00667862|365002582|FG000|Overall Study|Disease Progression|22|||
105820128|NCT00667862|365002582|FG000|Overall Study|Withdrawal by Subject|3|||
105820129|NCT01954394|365002585|FG000|Overall Study|Enrolled but not treated|1|||
105820130|NCT01954394|365002586|FG001|Overall Study|Enrolled but not treated|0|||
105820131|NCT01954394|365002585|FG000|Overall Study|Adverse Event|10|||
105820132|NCT01954394|365002586|FG001|Overall Study|Adverse Event|23|||
105820133|NCT01954394|365002585|FG000|Overall Study|Poor compliance to protocol|7|||
105820134|NCT01954394|365002586|FG001|Overall Study|Poor compliance to protocol|7|||
105820135|NCT01954394|365002585|FG000|Overall Study|Participant Moved|0|||
105820136|NCT01954394|365002586|FG001|Overall Study|Participant Moved|4|||
105820137|NCT01954394|365002585|FG000|Overall Study|Related to Study Drug administration|2|||
105820138|NCT01954394|365002586|FG001|Overall Study|Related to Study Drug administration|2|||
105820139|NCT01954394|365002585|FG000|Overall Study|Other than specified above|10|||
105820140|NCT01954394|365002586|FG001|Overall Study|Other than specified above|21|||
105820141|NCT05612724|365002588|FG000|Overall Study|Lost to Follow-up|4|||
105820142|NCT02128997|365002590|FG000|Overall Study|Lost to Follow-up|6|||
105820143|NCT02128997|365002591|FG001|Overall Study|Lost to Follow-up|11|||
105820144|NCT00239577|365002594|FG000|Primary Phase|Adverse Event|0|||
105820145|NCT00239577|365002595|FG001|Primary Phase|Adverse Event|0|||
105820146|NCT00239577|365002596|FG002|Primary Phase|Adverse Event|1|||
105820147|NCT00239577|365002597|FG003|Primary Phase|Adverse Event|0|||
105820148|NCT00239577|365002594|FG000|Primary Phase|Other|5|||
105820149|NCT00239577|365002595|FG001|Primary Phase|Other|3|||
105820150|NCT00239577|365002596|FG002|Primary Phase|Other|2|||
105820151|NCT00239577|365002597|FG003|Primary Phase|Other|0|||
105820152|NCT03988803|365002598|FG000|Period 2|Prematurely discontinued from medication|2|||
106018868|NCT01987453|365732659|FG000|Overall Study|Death|0|||
105820153|NCT03988803|365002598|FG000|Period 2|Adverse Event|1|||
105820154|NCT03021018|365002601|FG000|Overall Study|Adverse Event|1|||
105820155|NCT03021018|365002602|FG001|Overall Study|Adverse Event|0|||
105820156|NCT03021018|365002603|FG002|Overall Study|Adverse Event|0|||
105820157|NCT03021018|365002601|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
105820158|NCT03021018|365002602|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
105765974|NCT01131078|364795933|FG002|Overall Study|Other|0|||
105765975|NCT00959894|364795936|FG000|Overall Study|Lost to Follow-up|10|||
105765976|NCT00959894|364795936|FG000|Overall Study|Adverse Event|3|||
105765977|NCT00959894|364795936|FG000|Overall Study|Withdrawal by Subject|1|||
105765978|NCT00959894|364795936|FG000|Overall Study|Need for contraindicated medication|1|||
105765979|NCT00959894|364795936|FG000|Overall Study|Subject moved out of town|1|||
105765980|NCT00922974|364795937|FG000|Phase II Component|Protocol Violation|2|||
105765981|NCT00922974|364795938|FG001|Phase II Component|Protocol Violation|0|||
105765982|NCT00922974|364795937|FG000|Phase II Component|Not evaluable for treatment review|5|||
105765983|NCT00922974|364795938|FG001|Phase II Component|Not evaluable for treatment review|0|||
105765984|NCT00922974|364795937|FG000|Phase III Component|Protocol Violation|8|||
105765985|NCT00922974|364795938|FG001|Phase III Component|Protocol Violation|6|||
105765986|NCT00653068|364795939|FG000|Overall Study|Death|9|||
105765987|NCT00653068|364795939|FG000|Overall Study|Lack of Efficacy|34|||
105765988|NCT00653068|364795939|FG000|Overall Study|Physician Decision|4|||
105765989|NCT00653068|364795939|FG000|Overall Study|Withdrawal by Subject|1|||
105765990|NCT00653068|364795939|FG000|Overall Study|Ineligible|2|||
105765991|NCT03950440|364795940|FG000|Overall Study|Death|8|||
105765992|NCT03950440|364795941|FG001|Overall Study|Death|2|||
105765993|NCT03950440|364795942|FG002|Overall Study|Death|1|||
105765994|NCT02043509|364795943|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
105765995|NCT02043509|364795944|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
105765996|NCT02043509|364795943|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
105765997|NCT02043509|364795944|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
105765998|NCT02043509|364795943|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
105765999|NCT02043509|364795944|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
105766000|NCT02043509|364795943|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
105766001|NCT02043509|364795944|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
105766002|NCT00608244|364795945|FG000|Overall Study|Adverse Event|1|||
105766003|NCT00608244|364795945|FG000|Overall Study|Low trough levels|1|||
105766004|NCT01957215|364795950|FG000|Overall Study|Adverse Event|2|||
105766005|NCT01957215|364795951|FG001|Overall Study|Adverse Event|2|||
105766006|NCT01957215|364795950|FG000|Overall Study|Lost to Follow-up|3|||
105766007|NCT01957215|364795951|FG001|Overall Study|Lost to Follow-up|3|||
105766008|NCT01957215|364795950|FG000|Overall Study|Protocol Violation|1|||
105766009|NCT01957215|364795951|FG001|Overall Study|Protocol Violation|2|||
105766010|NCT01957215|364795950|FG000|Overall Study|Withdrawal by Subject|7|||
105766011|NCT01957215|364795951|FG001|Overall Study|Withdrawal by Subject|5|||
105766012|NCT03597503|364795952|FG000|Overall Study|Withdrawal by Subject|0|||
105766013|NCT03597503|364795953|FG001|Overall Study|Withdrawal by Subject|2|||
105766014|NCT03597503|364795952|FG000|Overall Study|Lost to Follow-up|1|||
105766015|NCT03597503|364795953|FG001|Overall Study|Lost to Follow-up|2|||
105766016|NCT03597503|364795952|FG000|Overall Study|Protocol Violation|1|||
105766017|NCT03597503|364795953|FG001|Overall Study|Protocol Violation|0|||
105766018|NCT00323310|364795954|FG000|Overall Study|Withdrawal by Subject|1|||
105766019|NCT00323310|364795954|FG000|Overall Study|a parent refused blood draw|1|||
105766020|NCT00323310|364795954|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
105766021|NCT02443155|364795962|FG000|Overall Study|Adverse Event|3|||
105766022|NCT02443155|364795963|FG001|Overall Study|Adverse Event|4|||
105766023|NCT02443155|364795964|FG002|Overall Study|Adverse Event|1|||
105766024|NCT02443155|364795965|FG003|Overall Study|Adverse Event|2|||
105766025|NCT02443155|364795962|FG000|Overall Study|Unclassified|0|||
105766026|NCT02443155|364795963|FG001|Overall Study|Unclassified|0|||
105766027|NCT02443155|364795964|FG002|Overall Study|Unclassified|2|||
105766028|NCT02443155|364795965|FG003|Overall Study|Unclassified|1|||
105766029|NCT02443155|364795962|FG000|Overall Study|Withdrawal by Subject|4|||
105766030|NCT02443155|364795963|FG001|Overall Study|Withdrawal by Subject|7|||
105766031|NCT02443155|364795964|FG002|Overall Study|Withdrawal by Subject|3|||
105766032|NCT02443155|364795965|FG003|Overall Study|Withdrawal by Subject|9|||
105766033|NCT02443155|364795962|FG000|Overall Study|Pregnancy|3|||
105766034|NCT02443155|364795963|FG001|Overall Study|Pregnancy|1|||
105766035|NCT02443155|364795964|FG002|Overall Study|Pregnancy|1|||
105766036|NCT02443155|364795965|FG003|Overall Study|Pregnancy|2|||
105766037|NCT02443155|364795962|FG000|Overall Study|Lost to Follow-up|1|||
105766038|NCT02443155|364795963|FG001|Overall Study|Lost to Follow-up|2|||
105766039|NCT02443155|364795964|FG002|Overall Study|Lost to Follow-up|0|||
105766040|NCT02443155|364795965|FG003|Overall Study|Lost to Follow-up|1|||
105766041|NCT02443155|364795962|FG000|Overall Study|Protocol Violation|1|||
105766042|NCT02443155|364795963|FG001|Overall Study|Protocol Violation|0|||
105766043|NCT02443155|364795964|FG002|Overall Study|Protocol Violation|1|||
105766044|NCT02443155|364795965|FG003|Overall Study|Protocol Violation|1|||
105766045|NCT02443155|364795962|FG000|Overall Study|Death|0|||
105766046|NCT02443155|364795963|FG001|Overall Study|Death|0|||
105766047|NCT02443155|364795964|FG002|Overall Study|Death|1|||
105766048|NCT02443155|364795965|FG003|Overall Study|Death|0|||
105766049|NCT00405275|364795967|FG000|Overall Study|Death|1|||
105766050|NCT00405275|364795968|FG001|Overall Study|Death|0|||
105766051|NCT00405275|364795967|FG000|Overall Study|Lost to Follow-up|5|||
105766052|NCT00405275|364795968|FG001|Overall Study|Lost to Follow-up|1|||
105820159|NCT03021018|365002603|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
105820160|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
105820161|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
105820162|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Death|2|||
105820163|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Death|1|||
105820164|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
105820165|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
105820166|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
105820167|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
105820168|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Other|8|||
105820169|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Other|13|||
105820170|NCT01439880|365002613|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
105820171|NCT01439880|365002614|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
105820172|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
105820173|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
105820174|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
105820175|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
105820176|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Death|3|||
105820177|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Death|13|||
105820178|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
105820179|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
105820180|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Other|14|||
105820181|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Other|31|||
105820182|NCT01439880|365002613|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
105820183|NCT01439880|365002614|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
105820184|NCT02956460|365002617|FG000|Lens 1|Lost to Follow-up|1|||
105820185|NCT02956460|365002618|FG001|Lens 1|Lost to Follow-up|0|||
105820186|NCT00834249|365002619|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105820187|NCT00834249|365002620|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
105820188|NCT00834249|365002619|FG000|Second Intervention|Adverse Event|1|||
105820189|NCT00834249|365002620|FG001|Second Intervention|Adverse Event|0|||
105820190|NCT00851877|365002621|FG000|Phase I-1|Death|1|||
105820191|NCT00851877|365002622|FG001|Phase I-1|Death|0|||
105820192|NCT00851877|365002623|FG002|Phase I-1|Death|0|||
105820193|NCT00851877|365002621|FG000|Phase II|Withdrawal by Subject|0|||
105820194|NCT00851877|365002622|FG001|Phase II|Withdrawal by Subject|0|||
105820195|NCT00851877|365002623|FG002|Phase II|Withdrawal by Subject|3|||
105820196|NCT00834067|365002626|FG000|Washout of 21 Days|Protocol Violation|0|||
105820197|NCT00834067|365002627|FG001|Washout of 21 Days|Protocol Violation|1|||
105820198|NCT01247701|365002628|FG000|Overall Study|Death|2|||
105820199|NCT01247701|365002628|FG000|Overall Study|Relapsed|8|||
105820200|NCT04166630|365002629|FG000|Overall Study|Withdrawal by Subject|0|||
105820201|NCT04166630|365002630|FG001|Overall Study|Withdrawal by Subject|1|||
105820202|NCT00272779|365002631|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
105820203|NCT00272779|365002632|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
105820204|NCT00272779|365002631|FG000|Baseline Through Week 48|Death before Week 48|4|||
105820205|NCT00272779|365002632|FG001|Baseline Through Week 48|Death before Week 48|4|||
105820206|NCT00272779|365002631|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
105820207|NCT00272779|365002632|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
105820208|NCT00272779|365002631|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
105820209|NCT00272779|365002632|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
105820210|NCT00272779|365002631|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
105820211|NCT00272779|365002632|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
105820212|NCT00272779|365002631|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
105820213|NCT00272779|365002632|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
105820214|NCT00272779|365002631|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
105820215|NCT00272779|365002632|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
105820216|NCT00272779|365002631|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
105820217|NCT00272779|365002632|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
105820218|NCT00272779|365002631|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
105820219|NCT00272779|365002632|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
105820220|NCT00272779|365002631|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
105820221|NCT00272779|365002632|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
105820222|NCT00272779|365002631|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
105820223|NCT00272779|365002632|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
105820224|NCT00272779|365002631|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
105820225|NCT00272779|365002632|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
105820226|NCT00272779|365002631|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
105820227|NCT00272779|365002632|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
106018869|NCT01987453|365732660|FG001|Overall Study|Death|0|||
105820228|NCT00272779|365002631|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
105820229|NCT00272779|365002632|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
105820230|NCT00272779|365002631|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
105820231|NCT00272779|365002632|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
105820232|NCT00272779|365002631|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
105820233|NCT00272779|365002632|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
105820234|NCT00272779|365002631|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
105820235|NCT00272779|365002632|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
105820236|NCT00272779|365002631|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
105820237|NCT00272779|365002632|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
105820238|NCT00272779|365002631|FG000|Baseline Through Week 48|Continuing treatment|385|||
105820239|NCT00272779|365002632|FG001|Baseline Through Week 48|Continuing treatment|368|||
105820240|NCT00272779|365002631|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
105820241|NCT00272779|365002632|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
105820242|NCT00272779|365002631|FG000|Baseline Through Week 48|Never treated|2|||
105820243|NCT00272779|365002632|FG001|Baseline Through Week 48|Never treated|3|||
105820244|NCT00272779|365002631|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
105820245|NCT00272779|365002632|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
105820246|NCT00272779|365002631|FG000|Baseline Through Week 96|Death before Week 96|6|||
105820247|NCT00272779|365002632|FG001|Baseline Through Week 96|Death before Week 96|5|||
105820248|NCT00272779|365002631|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
105820249|NCT00272779|365002632|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
105820250|NCT00272779|365002631|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
105820251|NCT00272779|365002632|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
105820252|NCT00272779|365002631|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
105820253|NCT00272779|365002632|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
105820254|NCT00272779|365002631|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
105820255|NCT00272779|365002632|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
105820256|NCT00272779|365002631|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
105820257|NCT00272779|365002632|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
105820258|NCT00272779|365002631|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
105820259|NCT00272779|365002632|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
105820260|NCT00272779|365002631|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
105820261|NCT00272779|365002632|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
105820262|NCT00272779|365002631|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
105820263|NCT00272779|365002632|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
105820264|NCT00272779|365002631|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
105820265|NCT00272779|365002632|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
105820266|NCT00272779|365002631|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
105820267|NCT00272779|365002632|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
105820268|NCT00272779|365002631|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
105820269|NCT00272779|365002632|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
105820270|NCT00272779|365002631|FG000|Baseline Through Week 96|Never treated|2|||
105820271|NCT00272779|365002632|FG001|Baseline Through Week 96|Never treated|3|||
105820272|NCT00272779|365002631|FG000|Baseline Through Week 96|Continuing on treatment|61|||
105820273|NCT00272779|365002632|FG001|Baseline Through Week 96|Continuing on treatment|38|||
105820274|NCT00561015|365002633|FG000|Overall Study|Adverse Event|0|||
105820275|NCT00561015|365002634|FG001|Overall Study|Adverse Event|0|||
105820276|NCT00561015|365002635|FG002|Overall Study|Adverse Event|0|||
105820277|NCT00561015|365002636|FG003|Overall Study|Adverse Event|0|||
105820278|NCT00561015|365002637|FG004|Overall Study|Adverse Event|1|||
105820279|NCT00561015|365002638|FG005|Overall Study|Adverse Event|0|||
105820280|NCT00561015|365002633|FG000|Overall Study|Lost to Follow-up|2|||
105820281|NCT00561015|365002634|FG001|Overall Study|Lost to Follow-up|0|||
105820282|NCT00561015|365002635|FG002|Overall Study|Lost to Follow-up|0|||
105820283|NCT00561015|365002636|FG003|Overall Study|Lost to Follow-up|1|||
105820284|NCT00561015|365002637|FG004|Overall Study|Lost to Follow-up|0|||
105820285|NCT00561015|365002638|FG005|Overall Study|Lost to Follow-up|3|||
105820286|NCT00561015|365002633|FG000|Overall Study|Participant non-compliance|2|||
105820287|NCT00561015|365002634|FG001|Overall Study|Participant non-compliance|0|||
106018870|NCT01987453|365732661|FG002|Overall Study|Death|1|||
105820288|NCT00561015|365002635|FG002|Overall Study|Participant non-compliance|0|||
105820289|NCT00561015|365002636|FG003|Overall Study|Participant non-compliance|0|||
105820290|NCT00561015|365002637|FG004|Overall Study|Participant non-compliance|0|||
105820291|NCT00561015|365002638|FG005|Overall Study|Participant non-compliance|0|||
105820292|NCT00096447|365002641|FG000|Overall Study|Never treated|1|||
105820293|NCT00163657|365002642|FG000|Overall Study|Death|12|||
105820294|NCT00163657|365002643|FG001|Overall Study|Death|14|||
105820295|NCT00163657|365002644|FG002|Overall Study|Death|19|||
105820296|NCT00163657|365002642|FG000|Overall Study|graft loss|4|||
106018871|NCT01987453|365732659|FG000|Overall Study|Lack of Efficacy|1|||
105820297|NCT00163657|365002643|FG001|Overall Study|graft loss|1|||
105820298|NCT00163657|365002644|FG002|Overall Study|graft loss|2|||
105820299|NCT00163657|365002642|FG000|Overall Study|Withdrawal by Subject|2|||
105820300|NCT00163657|365002643|FG001|Overall Study|Withdrawal by Subject|3|||
105820301|NCT00163657|365002644|FG002|Overall Study|Withdrawal by Subject|2|||
105820302|NCT00163657|365002642|FG000|Overall Study|Physician Decision|0|||
105820303|NCT00163657|365002643|FG001|Overall Study|Physician Decision|1|||
105820304|NCT00163657|365002644|FG002|Overall Study|Physician Decision|1|||
105820305|NCT00163657|365002642|FG000|Overall Study|Non Compliance|1|||
105820306|NCT00163657|365002643|FG001|Overall Study|Non Compliance|0|||
105820307|NCT00163657|365002644|FG002|Overall Study|Non Compliance|0|||
105820308|NCT00163657|365002642|FG000|Overall Study|Lost to Follow-up|1|||
105820309|NCT00163657|365002643|FG001|Overall Study|Lost to Follow-up|3|||
105820310|NCT00163657|365002644|FG002|Overall Study|Lost to Follow-up|10|||
105820311|NCT00163657|365002642|FG000|Overall Study|Other reason|0|||
105820312|NCT00163657|365002643|FG001|Overall Study|Other reason|1|||
105820313|NCT00163657|365002644|FG002|Overall Study|Other reason|3|||
105820314|NCT03214952|365002647|FG000|Overall Study|Protocol Deviation|45|||
105820315|NCT03214952|365002647|FG000|Overall Study|Case Report Forms Uncollected|13|||
105820316|NCT03769896|365002648|FG000|Open-label Phase|Lack of Efficacy|5|||
105820317|NCT03769896|365002649|FG001|Open-label Phase|Lack of Efficacy|0|||
105820318|NCT03769896|365002648|FG000|Open-label Phase|Adverse Event|3|||
105820319|NCT03769896|365002649|FG001|Open-label Phase|Adverse Event|0|||
105820320|NCT03769896|365002648|FG000|Open-label Phase|Withdrawal by Subject|1|||
105820321|NCT03769896|365002649|FG001|Open-label Phase|Withdrawal by Subject|0|||
105820322|NCT02300103|365002657|FG000|Overall Study|Lack of Efficacy|3|||
105820323|NCT02300103|365002657|FG000|Overall Study|Protocol Violation|1|||
105820324|NCT02300103|365002657|FG000|Overall Study|Withdrew Consent|2|||
105820325|NCT01015625|365002658|FG000|Overall Study|Lost to Follow-up|3|||
105820326|NCT01015625|365002659|FG001|Overall Study|Lost to Follow-up|1|||
105820327|NCT01015625|365002658|FG000|Overall Study|Withdrawal by Subject|2|||
105820328|NCT01015625|365002659|FG001|Overall Study|Withdrawal by Subject|3|||
105820329|NCT01015625|365002658|FG000|Overall Study|Physician Decision|2|||
105820330|NCT01015625|365002659|FG001|Overall Study|Physician Decision|0|||
105820331|NCT01015625|365002658|FG000|Overall Study|Death|30|||
105820332|NCT01015625|365002659|FG001|Overall Study|Death|22|||
105820333|NCT04112823|365002660|FG000|Overall Study|Lost to Follow-up|2|||
105820334|NCT04112823|365002661|FG001|Overall Study|Lost to Follow-up|3|||
105820335|NCT02682784|365002664|FG000|Overall Study|Withdrawal by Subject|0|||
105820336|NCT02682784|365002665|FG001|Overall Study|Withdrawal by Subject|2|||
105820337|NCT02682784|365002666|FG002|Overall Study|Withdrawal by Subject|1|||
105820338|NCT02682784|365002667|FG003|Overall Study|Withdrawal by Subject|2|||
105820339|NCT02682784|365002664|FG000|Overall Study|Physician Decision|1|||
105820340|NCT02682784|365002665|FG001|Overall Study|Physician Decision|0|||
105820341|NCT02682784|365002666|FG002|Overall Study|Physician Decision|1|||
105956858|NCT03083665|365502905|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
106145434|NCT05219253|366193080|FG001|Overall Study|Withdrawal by Subject|2|||
106145435|NCT02396316|366193081|FG000|Overall Study|Physician Decision|1|||
106145436|NCT02396316|366193082|FG001|Overall Study|Physician Decision|0|||
106145437|NCT02396316|366193081|FG000|Overall Study|Progressive disease|6|||
105766053|NCT00405275|364795967|FG000|Overall Study|Withdrawal by Subject|7|||
105766054|NCT00405275|364795968|FG001|Overall Study|Withdrawal by Subject|9|||
105766055|NCT00405275|364795967|FG000|Overall Study|Unwilling to continue|10|||
105766056|NCT00405275|364795968|FG001|Overall Study|Unwilling to continue|9|||
105766057|NCT01376388|364795972|FG000|Overall Study|Adverse Event|13|||
105766058|NCT01376388|364795972|FG000|Overall Study|Lack of Efficacy|2|||
105766059|NCT01376388|364795972|FG000|Overall Study|Withdrawal by Subject|3|||
105766060|NCT00136357|364795984|FG000|Overall Study|Withdrawal by Subject|3|||
105766061|NCT00136357|364795985|FG001|Overall Study|Withdrawal by Subject|2|||
105766062|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
105766063|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
105766064|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
105766065|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
105766066|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
105766067|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
105766068|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
105766069|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
105766070|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
105766071|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
105766072|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
105766073|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
105766074|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
105766075|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
105820342|NCT02682784|365002667|FG003|Overall Study|Physician Decision|1|||
105820343|NCT00467363|365002668|FG000|Overall Study|Lost to Follow-up|80|||
105820344|NCT00467363|365002669|FG001|Overall Study|Lost to Follow-up|70|||
105820345|NCT01401647|365002673|FG000|Overall Study|Withdrawal by Subject|1|||
105820346|NCT01401647|365002674|FG001|Overall Study|Withdrawal by Subject|5|||
105820347|NCT01401647|365002675|FG002|Overall Study|Withdrawal by Subject|2|||
105820348|NCT01401647|365002673|FG000|Overall Study|Lost to Follow-up|3|||
105820349|NCT01401647|365002674|FG001|Overall Study|Lost to Follow-up|3|||
105820350|NCT01401647|365002675|FG002|Overall Study|Lost to Follow-up|1|||
105820351|NCT01527006|365002679|FG000|Core Study|Adverse Event|0|||
105820352|NCT01527006|365002680|FG001|Core Study|Adverse Event|2|||
105820353|NCT01527006|365002679|FG000|Core Study|Lost to Follow-up|0|||
105820354|NCT01527006|365002680|FG001|Core Study|Lost to Follow-up|1|||
105820355|NCT01527006|365002679|FG000|Core Study|Subject Choice|1|||
105820356|NCT01527006|365002680|FG001|Core Study|Subject Choice|0|||
105820357|NCT01527006|365002679|FG000|Core Study|Inadequate Therapeutic Effect|1|||
105820358|NCT01527006|365002680|FG001|Core Study|Inadequate Therapeutic Effect|0|||
105820359|NCT01527006|365002679|FG000|Core Study|Withdrawal by Subject|0|||
105820360|NCT01527006|365002680|FG001|Core Study|Withdrawal by Subject|1|||
105820361|NCT01527006|365002679|FG000|Core Study|Other|0|||
105820362|NCT01527006|365002680|FG001|Core Study|Other|2|||
105820363|NCT01527006|365002679|FG000|Extension Phase|Adverse Event|4|||
105820364|NCT01527006|365002680|FG001|Extension Phase|Adverse Event|2|||
105820365|NCT01527006|365002679|FG000|Extension Phase|Lost to Follow-up|0|||
105820366|NCT01527006|365002680|FG001|Extension Phase|Lost to Follow-up|1|||
105820367|NCT01527006|365002679|FG000|Extension Phase|Subject Choice|1|||
105820368|NCT01527006|365002680|FG001|Extension Phase|Subject Choice|1|||
105820369|NCT01527006|365002679|FG000|Extension Phase|Inadequate therapeutic effect|1|||
105820370|NCT01527006|365002680|FG001|Extension Phase|Inadequate therapeutic effect|1|||
105820371|NCT01527006|365002679|FG000|Extension Phase|Other|0|||
105820372|NCT01527006|365002680|FG001|Extension Phase|Other|3|||
105820373|NCT00904215|365002681|FG000|Overall Study|Adverse Event|25|||
105820374|NCT00904215|365002681|FG000|Overall Study|Protocol Violation|10|||
105820375|NCT00904215|365002681|FG000|Overall Study|Lost to Follow-up|63|||
105820376|NCT00904215|365002681|FG000|Overall Study|Withdrawal by Subject|9|||
105820377|NCT00904215|365002681|FG000|Overall Study|Other|28|||
105820378|NCT00838630|365002683|FG000|First Intervention|Adverse Event|1|||
105820379|NCT00838630|365002684|FG001|First Intervention|Adverse Event|0|||
105820380|NCT00838630|365002683|FG000|Washout: 7 Days|Protocol Violation|1|||
105820381|NCT00838630|365002684|FG001|Washout: 7 Days|Protocol Violation|0|||
105820382|NCT02159183|365002693|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
105820383|NCT02159183|365002694|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
105820384|NCT02159183|365002693|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
105820385|NCT02159183|365002694|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
105820386|NCT02159183|365002693|FG000|Analysis After the 36 Months Follow-up|Death|0|||
105820387|NCT02159183|365002694|FG001|Analysis After the 36 Months Follow-up|Death|1|||
105820388|NCT02159183|365002693|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
105820389|NCT02159183|365002694|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
105820390|NCT02159183|365002693|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
105820391|NCT02159183|365002694|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
105820392|NCT03017885|365002695|FG000|Overall Study|Adverse Event|2|||
105820393|NCT03017885|365002696|FG001|Overall Study|Adverse Event|0|||
105820394|NCT03017885|365002697|FG002|Overall Study|Adverse Event|0|||
105820395|NCT03017885|365002698|FG003|Overall Study|Adverse Event|0|||
105820396|NCT03017885|365002699|FG004|Overall Study|Adverse Event|0|||
105820397|NCT03017885|365002700|FG005|Overall Study|Adverse Event|0|||
105820398|NCT03017885|365002695|FG000|Overall Study|Progression of disease|4|||
105820399|NCT03017885|365002696|FG001|Overall Study|Progression of disease|3|||
105820400|NCT03017885|365002697|FG002|Overall Study|Progression of disease|4|||
105820401|NCT03017885|365002698|FG003|Overall Study|Progression of disease|0|||
105820402|NCT03017885|365002699|FG004|Overall Study|Progression of disease|0|||
105820403|NCT03017885|365002700|FG005|Overall Study|Progression of disease|0|||
105820404|NCT03017885|365002695|FG000|Overall Study|Other than listed|1|||
105820405|NCT03017885|365002696|FG001|Overall Study|Other than listed|2|||
105820406|NCT03017885|365002697|FG002|Overall Study|Other than listed|1|||
105820407|NCT03017885|365002698|FG003|Overall Study|Other than listed|0|||
105820408|NCT03017885|365002699|FG004|Overall Study|Other than listed|0|||
105820409|NCT03017885|365002700|FG005|Overall Study|Other than listed|0|||
105820410|NCT03017885|365002695|FG000|Overall Study|Lost to Follow-up|2|||
105820411|NCT03017885|365002696|FG001|Overall Study|Lost to Follow-up|0|||
105820412|NCT03017885|365002697|FG002|Overall Study|Lost to Follow-up|3|||
105820413|NCT03017885|365002698|FG003|Overall Study|Lost to Follow-up|0|||
105820414|NCT03017885|365002699|FG004|Overall Study|Lost to Follow-up|0|||
105820415|NCT03017885|365002700|FG005|Overall Study|Lost to Follow-up|0|||
105820416|NCT03017885|365002695|FG000|Overall Study|Change to other anti-cancer therapy|0|||
105820417|NCT03017885|365002696|FG001|Overall Study|Change to other anti-cancer therapy|0|||
105820418|NCT03017885|365002697|FG002|Overall Study|Change to other anti-cancer therapy|1|||
105820419|NCT03017885|365002698|FG003|Overall Study|Change to other anti-cancer therapy|0|||
105820420|NCT03017885|365002699|FG004|Overall Study|Change to other anti-cancer therapy|0|||
105820421|NCT03017885|365002700|FG005|Overall Study|Change to other anti-cancer therapy|0|||
105820422|NCT00723710|365002705|FG000|Overall Study|Disease progression|48|||
105820423|NCT00723710|365002705|FG000|Overall Study|Adverse Event|88|||
105820424|NCT00723710|365002705|FG000|Overall Study|Withdrawal by Subject|36|||
105820425|NCT00723710|365002705|FG000|Overall Study|Physician Decision|2|||
105820426|NCT04405570|365002706|FG000|Overall Study|Adverse Event|0|||
105820427|NCT04405570|365002707|FG001|Overall Study|Adverse Event|1|||
105820428|NCT04405570|365002708|FG002|Overall Study|Adverse Event|1|||
105820429|NCT04405570|365002709|FG003|Overall Study|Adverse Event|1|||
105820430|NCT04405570|365002706|FG000|Overall Study|Lost to Follow-up|0|||
105820431|NCT04405570|365002707|FG001|Overall Study|Lost to Follow-up|1|||
105820432|NCT04405570|365002708|FG002|Overall Study|Lost to Follow-up|0|||
105820433|NCT04405570|365002709|FG003|Overall Study|Lost to Follow-up|0|||
105820434|NCT04405570|365002706|FG000|Overall Study|Physician Decision|0|||
105820435|NCT04405570|365002707|FG001|Overall Study|Physician Decision|0|||
105820436|NCT04405570|365002708|FG002|Overall Study|Physician Decision|1|||
105820437|NCT04405570|365002709|FG003|Overall Study|Physician Decision|0|||
105820438|NCT04405570|365002706|FG000|Overall Study|Withdrawal by Subject|0|||
105820439|NCT04405570|365002707|FG001|Overall Study|Withdrawal by Subject|1|||
105820440|NCT04405570|365002708|FG002|Overall Study|Withdrawal by Subject|1|||
105820441|NCT04405570|365002709|FG003|Overall Study|Withdrawal by Subject|0|||
105820442|NCT04405570|365002706|FG000|Overall Study|Randomized not dosed|0|||
105820443|NCT04405570|365002707|FG001|Overall Study|Randomized not dosed|2|||
105820444|NCT04405570|365002708|FG002|Overall Study|Randomized not dosed|0|||
105820445|NCT04405570|365002709|FG003|Overall Study|Randomized not dosed|0|||
105820446|NCT00858845|365002711|FG000|Overall Study|Patient underwent heart transplant.|0|||
105820447|NCT00858845|365002712|FG001|Overall Study|Patient underwent heart transplant.|1|||
105820448|NCT03880266|365002714|FG000|Overall Study|Withdrawal by Subject|0|||
105820449|NCT03880266|365002715|FG001|Overall Study|Withdrawal by Subject|1|||
105820450|NCT03880266|365002716|FG002|Overall Study|Withdrawal by Subject|1|||
105820451|NCT03880266|365002717|FG003|Overall Study|Withdrawal by Subject|0|||
105820452|NCT03880266|365002718|FG004|Overall Study|Withdrawal by Subject|0|||
105820453|NCT03880266|365002719|FG005|Overall Study|Withdrawal by Subject|0|||
105820454|NCT03880266|365002720|FG006|Overall Study|Withdrawal by Subject|0|||
105820455|NCT03880266|365002721|FG007|Overall Study|Withdrawal by Subject|0|||
105820456|NCT01796171|365004368|FG000|Enrolled|Death|0|||
105820457|NCT01796171|365004369|FG001|Enrolled|Death|0|||
105820458|NCT01796171|365004370|FG002|Enrolled|Death|0|||
105820459|NCT01796171|365004371|FG003|Enrolled|Death|0|||
105820460|NCT01796171|365004372|FG004|Enrolled|Death|0|||
105820461|NCT01796171|365004373|FG005|Enrolled|Death|0|||
105820462|NCT01796171|365004374|FG006|Enrolled|Death|0|||
105820463|NCT01796171|365004375|FG007|Enrolled|Death|0|||
105820464|NCT01796171|365004376|FG008|Enrolled|Death|0|||
105820465|NCT01796171|365004377|FG009|Enrolled|Death|0|||
105820466|NCT01796171|365004378|FG010|Enrolled|Death|0|||
105820467|NCT01796171|365004379|FG011|Enrolled|Death|0|||
105820468|NCT01796171|365004380|FG012|Enrolled|Death|0|||
105820469|NCT01796171|365004381|FG013|Enrolled|Death|0|||
105820470|NCT01796171|365004382|FG014|Enrolled|Death|1|||
105820471|NCT01796171|365004368|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
105820472|NCT01796171|365004369|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
105820473|NCT01796171|365004370|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
105820474|NCT01796171|365004371|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
105820475|NCT01796171|365004372|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
105766076|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
105766077|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
105766078|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
105766079|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
105766080|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
105766081|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
105766082|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
105766083|NCT01001572|364795989|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
105766084|NCT01001572|364795990|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
105766085|NCT01001572|364795991|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
105766086|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105766087|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
105766088|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
105820476|NCT01796171|365004373|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
105820477|NCT01796171|365004374|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
105820478|NCT01796171|365004375|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
105820479|NCT01796171|365004376|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
105820480|NCT01796171|365004377|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
105820481|NCT01796171|365004378|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
105820482|NCT01796171|365004379|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
105820483|NCT01796171|365004380|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
105820484|NCT01796171|365004381|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
105820485|NCT01796171|365004382|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
106018872|NCT01987453|365732660|FG001|Overall Study|Lack of Efficacy|12|||
105820486|NCT01796171|365004368|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820487|NCT01796171|365004369|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820488|NCT01796171|365004370|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820489|NCT01796171|365004371|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820490|NCT01796171|365004372|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820491|NCT01796171|365004373|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820492|NCT01796171|365004374|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820493|NCT01796171|365004375|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820494|NCT01796171|365004376|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820495|NCT01796171|365004377|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820496|NCT01796171|365004378|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820497|NCT01796171|365004379|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820498|NCT01796171|365004380|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820499|NCT01796171|365004381|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
105820500|NCT01796171|365004382|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
105820501|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Progressive disease|0|||
105820502|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Progressive disease|1|||
105820503|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Progressive disease|0|||
105820504|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Progressive disease|0|||
105820505|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Progressive disease|0|||
105820506|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Progressive disease|0|||
105820507|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Progressive disease|0|||
105820508|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Progressive disease|0|||
105820509|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Progressive disease|0|||
105820510|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Progressive disease|0|||
105820511|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Progressive disease|0|||
105820512|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Progressive disease|0|||
105820513|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Progressive disease|0|||
105820514|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Progressive disease|0|||
105820515|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Progressive disease|0|||
105820516|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820517|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
106018873|NCT01987453|365732661|FG002|Overall Study|Lack of Efficacy|0|||
105820518|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820519|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820520|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820521|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820522|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820523|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820524|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
105820525|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820526|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
105820527|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
105820528|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820529|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820530|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
105820531|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Physician Decision|0|||
105820532|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Physician Decision|0|||
105820533|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Physician Decision|0|||
105820534|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Physician Decision|0|||
106018874|NCT02904954|365732666|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
106018875|NCT02904954|365732667|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
106018876|NCT02904954|365732666|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
106018877|NCT02904954|365732667|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
105766089|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105766090|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
105766091|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
105766092|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
105766093|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
105766094|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
105820535|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Physician Decision|0|||
105820536|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Physician Decision|0|||
105820537|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Physician Decision|0|||
106145438|NCT02396316|366193082|FG001|Overall Study|Progressive disease|3|||
105820538|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Physician Decision|0|||
105820539|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Physician Decision|0|||
105820540|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Physician Decision|0|||
105820541|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Physician Decision|5|||
105820542|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Physician Decision|1|||
105820543|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Physician Decision|1|||
105820544|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Physician Decision|0|||
105820545|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Physician Decision|0|||
105820546|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Death|0|||
105820547|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Death|0|||
105820548|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Death|0|||
105820549|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Death|0|||
105820550|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Death|0|||
105820551|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Death|0|||
105820552|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Death|0|||
105820553|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Death|0|||
105820554|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Death|0|||
105820555|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Death|0|||
105820556|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Death|2|||
105820557|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Death|0|||
105820558|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Death|0|||
105820559|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Death|0|||
105820560|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Death|0|||
105820561|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
105820562|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
105820563|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
105820564|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
105820565|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
105820566|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
105820567|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
105820568|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
105820569|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
105820570|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
105820571|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
105820572|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
105820573|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
105820574|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
105820575|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
105820576|NCT01796171|365004368|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820577|NCT01796171|365004369|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820578|NCT01796171|365004370|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820579|NCT01796171|365004371|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820580|NCT01796171|365004372|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820581|NCT01796171|365004373|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820582|NCT01796171|365004374|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820583|NCT01796171|365004375|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820584|NCT01796171|365004376|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820585|NCT01796171|365004377|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820586|NCT01796171|365004378|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
105820587|NCT01796171|365004379|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
105820588|NCT01796171|365004380|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820589|NCT01796171|365004381|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820590|NCT01796171|365004382|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
105820591|NCT01796171|365004368|FG000|Follow-up Period|Start of further anticancer therapy|4|||
105820592|NCT01796171|365004369|FG001|Follow-up Period|Start of further anticancer therapy|25|||
105820593|NCT01796171|365004370|FG002|Follow-up Period|Start of further anticancer therapy|2|||
105820594|NCT01796171|365004371|FG003|Follow-up Period|Start of further anticancer therapy|1|||
105820595|NCT01796171|365004372|FG004|Follow-up Period|Start of further anticancer therapy|2|||
105820596|NCT01796171|365004373|FG005|Follow-up Period|Start of further anticancer therapy|2|||
105820597|NCT01796171|365004374|FG006|Follow-up Period|Start of further anticancer therapy|1|||
105820598|NCT01796171|365004375|FG007|Follow-up Period|Start of further anticancer therapy|15|||
105820599|NCT01796171|365004376|FG008|Follow-up Period|Start of further anticancer therapy|2|||
105820600|NCT01796171|365004377|FG009|Follow-up Period|Start of further anticancer therapy|0|||
105820601|NCT01796171|365004378|FG010|Follow-up Period|Start of further anticancer therapy|0|||
105820602|NCT01796171|365004379|FG011|Follow-up Period|Start of further anticancer therapy|0|||
105820603|NCT01796171|365004380|FG012|Follow-up Period|Start of further anticancer therapy|0|||
105820604|NCT01796171|365004381|FG013|Follow-up Period|Start of further anticancer therapy|0|||
105820605|NCT01796171|365004382|FG014|Follow-up Period|Start of further anticancer therapy|0|||
105820606|NCT01796171|365004368|FG000|Follow-up Period|Progressive disease|0|||
105820607|NCT01796171|365004369|FG001|Follow-up Period|Progressive disease|1|||
105820608|NCT01796171|365004370|FG002|Follow-up Period|Progressive disease|0|||
105820609|NCT01796171|365004371|FG003|Follow-up Period|Progressive disease|0|||
105820610|NCT01796171|365004372|FG004|Follow-up Period|Progressive disease|0|||
105820611|NCT01796171|365004373|FG005|Follow-up Period|Progressive disease|0|||
105820612|NCT01796171|365004374|FG006|Follow-up Period|Progressive disease|0|||
105820613|NCT01796171|365004375|FG007|Follow-up Period|Progressive disease|3|||
105820614|NCT01796171|365004376|FG008|Follow-up Period|Progressive disease|0|||
105820615|NCT01796171|365004377|FG009|Follow-up Period|Progressive disease|0|||
105820616|NCT01796171|365004378|FG010|Follow-up Period|Progressive disease|0|||
105820617|NCT01796171|365004379|FG011|Follow-up Period|Progressive disease|0|||
105820618|NCT01796171|365004380|FG012|Follow-up Period|Progressive disease|0|||
105820619|NCT01796171|365004381|FG013|Follow-up Period|Progressive disease|0|||
105820620|NCT01796171|365004382|FG014|Follow-up Period|Progressive disease|0|||
105820621|NCT01796171|365004368|FG000|Follow-up Period|Physician Decision|0|||
105820622|NCT01796171|365004369|FG001|Follow-up Period|Physician Decision|2|||
105820623|NCT01796171|365004370|FG002|Follow-up Period|Physician Decision|0|||
105820624|NCT01796171|365004371|FG003|Follow-up Period|Physician Decision|0|||
105820625|NCT01796171|365004372|FG004|Follow-up Period|Physician Decision|0|||
105820626|NCT01796171|365004373|FG005|Follow-up Period|Physician Decision|0|||
105820627|NCT01796171|365004374|FG006|Follow-up Period|Physician Decision|0|||
105820628|NCT01796171|365004375|FG007|Follow-up Period|Physician Decision|0|||
105820629|NCT01796171|365004376|FG008|Follow-up Period|Physician Decision|0|||
105820630|NCT01796171|365004377|FG009|Follow-up Period|Physician Decision|0|||
105820631|NCT01796171|365004378|FG010|Follow-up Period|Physician Decision|5|||
105820632|NCT01796171|365004379|FG011|Follow-up Period|Physician Decision|0|||
105820633|NCT01796171|365004380|FG012|Follow-up Period|Physician Decision|0|||
105820634|NCT01796171|365004381|FG013|Follow-up Period|Physician Decision|0|||
105820635|NCT01796171|365004382|FG014|Follow-up Period|Physician Decision|0|||
105820636|NCT01796171|365004368|FG000|Follow-up Period|Withdrawal by Subject|0|||
105820637|NCT01796171|365004369|FG001|Follow-up Period|Withdrawal by Subject|1|||
105820638|NCT01796171|365004370|FG002|Follow-up Period|Withdrawal by Subject|0|||
105820639|NCT01796171|365004371|FG003|Follow-up Period|Withdrawal by Subject|0|||
105820640|NCT01796171|365004372|FG004|Follow-up Period|Withdrawal by Subject|0|||
105820641|NCT01796171|365004373|FG005|Follow-up Period|Withdrawal by Subject|1|||
105820642|NCT01796171|365004374|FG006|Follow-up Period|Withdrawal by Subject|0|||
105820643|NCT01796171|365004375|FG007|Follow-up Period|Withdrawal by Subject|0|||
105956859|NCT03083665|365502906|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105956860|NCT03083665|365502907|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105956861|NCT03083665|365502908|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
105956862|NCT03083665|365502909|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
105956863|NCT03083665|365502904|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
105956864|NCT03083665|365502905|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
105956865|NCT03083665|365502906|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
105956866|NCT03083665|365502907|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
105956867|NCT03083665|365502908|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
105956868|NCT03083665|365502909|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
105956869|NCT03083665|365502904|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105956870|NCT03083665|365502905|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105956871|NCT03083665|365502906|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105956872|NCT03083665|365502907|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105956873|NCT03083665|365502908|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
105956874|NCT03083665|365502909|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
105956875|NCT03083665|365502904|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105956876|NCT03083665|365502905|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105956877|NCT03083665|365502906|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105956878|NCT03083665|365502907|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
105956879|NCT03083665|365502908|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105956880|NCT03083665|365502909|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
105956881|NCT03083665|365502904|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105956882|NCT03083665|365502905|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105956883|NCT03083665|365502906|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105956884|NCT03083665|365502907|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
106145439|NCT02396316|366193081|FG000|Overall Study|Protocol Violation|0|||
105820644|NCT01796171|365004376|FG008|Follow-up Period|Withdrawal by Subject|0|||
105820645|NCT01796171|365004377|FG009|Follow-up Period|Withdrawal by Subject|0|||
105820646|NCT01796171|365004378|FG010|Follow-up Period|Withdrawal by Subject|3|||
105820647|NCT01796171|365004379|FG011|Follow-up Period|Withdrawal by Subject|1|||
106018878|NCT02904954|365732666|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
106018879|NCT02904954|365732667|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
106018880|NCT02904954|365732666|FG000|Adjuvant Durvalumab|Recurrence|2|||
106018881|NCT02904954|365732667|FG001|Adjuvant Durvalumab|Recurrence|0|||
106018882|NCT02904954|365732666|FG000|Adjuvant Durvalumab|Adverse Event|2|||
106145440|NCT02396316|366193082|FG001|Overall Study|Protocol Violation|1|||
106145441|NCT02396316|366193081|FG000|Overall Study|Treatment unblinded|0|||
106145442|NCT02396316|366193082|FG001|Overall Study|Treatment unblinded|1|||
106145443|NCT03622593|366193085|FG000|Overall Study|Withdrawal by Subject|11|||
106145444|NCT03622593|366193086|FG001|Overall Study|Withdrawal by Subject|9|||
106145445|NCT03622593|366193087|FG002|Overall Study|Withdrawal by Subject|13|||
106145446|NCT03622593|366193085|FG000|Overall Study|Death|12|||
106145447|NCT03622593|366193086|FG001|Overall Study|Death|9|||
106145448|NCT03622593|366193087|FG002|Overall Study|Death|10|||
106145449|NCT03622593|366193085|FG000|Overall Study|Lost to Follow-up|11|||
106145450|NCT03622593|366193086|FG001|Overall Study|Lost to Follow-up|5|||
106145451|NCT03622593|366193087|FG002|Overall Study|Lost to Follow-up|8|||
106145452|NCT03622593|366193085|FG000|Overall Study|Adverse Event|4|||
106145453|NCT03622593|366193086|FG001|Overall Study|Adverse Event|5|||
106145454|NCT03622593|366193087|FG002|Overall Study|Adverse Event|6|||
106145455|NCT03622593|366193085|FG000|Overall Study|Physician Decision|2|||
106145456|NCT03622593|366193086|FG001|Overall Study|Physician Decision|1|||
106145457|NCT03622593|366193087|FG002|Overall Study|Physician Decision|6|||
106145458|NCT03622593|366193085|FG000|Overall Study|Other|2|||
106145459|NCT03622593|366193086|FG001|Overall Study|Other|2|||
106145460|NCT03622593|366193087|FG002|Overall Study|Other|3|||
106145461|NCT03622593|366193085|FG000|Overall Study|Protocol Violation|0|||
106145462|NCT03622593|366193086|FG001|Overall Study|Protocol Violation|0|||
106145463|NCT03622593|366193087|FG002|Overall Study|Protocol Violation|1|||
106145464|NCT03622593|366193085|FG000|Overall Study|Pregnancy|0|||
106145465|NCT03622593|366193086|FG001|Overall Study|Pregnancy|0|||
106145466|NCT03622593|366193087|FG002|Overall Study|Pregnancy|1|||
106145467|NCT00516321|366193090|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
106145468|NCT00516321|366193091|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
106145469|NCT00516321|366193092|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
106145470|NCT00516321|366193090|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
106145471|NCT00516321|366193091|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
106145472|NCT00516321|366193092|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
105820648|NCT01796171|365004380|FG012|Follow-up Period|Withdrawal by Subject|0|||
105820649|NCT01796171|365004381|FG013|Follow-up Period|Withdrawal by Subject|0|||
105820650|NCT01796171|365004382|FG014|Follow-up Period|Withdrawal by Subject|0|||
105820651|NCT01796171|365004368|FG000|Follow-up Period|Death|0|||
106145473|NCT00516321|366193090|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
106145474|NCT00516321|366193091|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
106145475|NCT00516321|366193092|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
106145476|NCT00516321|366193090|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
106145477|NCT00516321|366193091|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
105820652|NCT01796171|365004369|FG001|Follow-up Period|Death|0|||
105820653|NCT01796171|365004370|FG002|Follow-up Period|Death|0|||
105820654|NCT01796171|365004371|FG003|Follow-up Period|Death|0|||
105820655|NCT01796171|365004372|FG004|Follow-up Period|Death|0|||
105820656|NCT01796171|365004373|FG005|Follow-up Period|Death|0|||
105820657|NCT01796171|365004374|FG006|Follow-up Period|Death|1|||
105820658|NCT01796171|365004375|FG007|Follow-up Period|Death|0|||
105820659|NCT01796171|365004376|FG008|Follow-up Period|Death|0|||
105820660|NCT01796171|365004377|FG009|Follow-up Period|Death|0|||
105820661|NCT01796171|365004378|FG010|Follow-up Period|Death|17|||
105820662|NCT01796171|365004379|FG011|Follow-up Period|Death|9|||
105820663|NCT01796171|365004380|FG012|Follow-up Period|Death|1|||
105820664|NCT01796171|365004381|FG013|Follow-up Period|Death|0|||
105820665|NCT01796171|365004382|FG014|Follow-up Period|Death|0|||
105820666|NCT01796171|365004368|FG000|Follow-up Period|Patient transferred to other hospital|0|||
105820667|NCT01796171|365004369|FG001|Follow-up Period|Patient transferred to other hospital|1|||
105820668|NCT01796171|365004370|FG002|Follow-up Period|Patient transferred to other hospital|0|||
105820669|NCT01796171|365004371|FG003|Follow-up Period|Patient transferred to other hospital|0|||
106145478|NCT00516321|366193092|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
105820670|NCT01796171|365004372|FG004|Follow-up Period|Patient transferred to other hospital|0|||
106145479|NCT00516321|366193090|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
106145480|NCT00516321|366193091|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
106145481|NCT00516321|366193092|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
105820671|NCT01796171|365004373|FG005|Follow-up Period|Patient transferred to other hospital|0|||
105820672|NCT01796171|365004374|FG006|Follow-up Period|Patient transferred to other hospital|0|||
105820673|NCT01796171|365004375|FG007|Follow-up Period|Patient transferred to other hospital|0|||
105820674|NCT01796171|365004376|FG008|Follow-up Period|Patient transferred to other hospital|0|||
106018883|NCT02904954|365732667|FG001|Adjuvant Durvalumab|Adverse Event|6|||
105820675|NCT01796171|365004377|FG009|Follow-up Period|Patient transferred to other hospital|0|||
105820676|NCT01796171|365004378|FG010|Follow-up Period|Patient transferred to other hospital|0|||
105820677|NCT01796171|365004379|FG011|Follow-up Period|Patient transferred to other hospital|0|||
105820678|NCT01796171|365004380|FG012|Follow-up Period|Patient transferred to other hospital|0|||
105820679|NCT01796171|365004381|FG013|Follow-up Period|Patient transferred to other hospital|0|||
105820680|NCT01796171|365004382|FG014|Follow-up Period|Patient transferred to other hospital|0|||
105820681|NCT01796171|365004368|FG000|Follow-up Period|Sponsor Decision|0|||
105820682|NCT01796171|365004369|FG001|Follow-up Period|Sponsor Decision|0|||
105820683|NCT01796171|365004370|FG002|Follow-up Period|Sponsor Decision|0|||
105820684|NCT01796171|365004371|FG003|Follow-up Period|Sponsor Decision|0|||
105820685|NCT01796171|365004372|FG004|Follow-up Period|Sponsor Decision|0|||
105820686|NCT01796171|365004373|FG005|Follow-up Period|Sponsor Decision|0|||
105820687|NCT01796171|365004374|FG006|Follow-up Period|Sponsor Decision|0|||
105820688|NCT01796171|365004375|FG007|Follow-up Period|Sponsor Decision|0|||
105820689|NCT01796171|365004376|FG008|Follow-up Period|Sponsor Decision|0|||
105820690|NCT01796171|365004377|FG009|Follow-up Period|Sponsor Decision|0|||
105820691|NCT01796171|365004378|FG010|Follow-up Period|Sponsor Decision|40|||
105820692|NCT01796171|365004379|FG011|Follow-up Period|Sponsor Decision|15|||
105820693|NCT01796171|365004380|FG012|Follow-up Period|Sponsor Decision|7|||
105820694|NCT01796171|365004381|FG013|Follow-up Period|Sponsor Decision|0|||
105820695|NCT01796171|365004382|FG014|Follow-up Period|Sponsor Decision|0|||
105820696|NCT01083693|365004385|FG000|Overall Study|Adverse Event|1|||
105820697|NCT01083693|365004386|FG001|Overall Study|Adverse Event|1|||
105820698|NCT01083693|365004387|FG002|Overall Study|Adverse Event|0|||
105820699|NCT01083693|365004385|FG000|Overall Study|Lost to Follow-up|2|||
105820700|NCT01083693|365004386|FG001|Overall Study|Lost to Follow-up|0|||
105820701|NCT01083693|365004387|FG002|Overall Study|Lost to Follow-up|2|||
105820702|NCT01083693|365004385|FG000|Overall Study|Lack of effectiveness|13|||
105820703|NCT01083693|365004386|FG001|Overall Study|Lack of effectiveness|2|||
105956885|NCT03083665|365502908|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
105956886|NCT03083665|365502909|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
105956887|NCT03083665|365502904|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105956888|NCT03083665|365502905|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
106018884|NCT02904954|365732666|FG000|Adjuvant Durvalumab|Participant wishes|12|||
105956889|NCT03083665|365502906|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105956890|NCT03083665|365502907|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105956891|NCT03083665|365502908|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
105956892|NCT03083665|365502909|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
105956893|NCT01467466|365502912|FG000|Overall Study|Withdrawal by Subject|15|||
105956894|NCT01467466|365502913|FG001|Overall Study|Withdrawal by Subject|18|||
105956895|NCT01467466|365502914|FG002|Overall Study|Withdrawal by Subject|13|||
105956896|NCT01467466|365502915|FG003|Overall Study|Withdrawal by Subject|11|||
105956897|NCT01467466|365502912|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
105956898|NCT01467466|365502913|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
105956899|NCT01467466|365502914|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
105956900|NCT01467466|365502915|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
105956901|NCT01467466|365502912|FG000|Overall Study|Procedure Cancelled|46|||
106018885|NCT02904954|365732667|FG001|Adjuvant Durvalumab|Participant wishes|7|||
106018886|NCT02904954|365732666|FG000|Adjuvant Durvalumab|Physician Decision|2|||
106018887|NCT02904954|365732667|FG001|Adjuvant Durvalumab|Physician Decision|1|||
106018888|NCT02904954|365732666|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
106018889|NCT02904954|365732667|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
106018890|NCT02904954|365732666|FG000|Adjuvant Durvalumab|Death|0|||
106018891|NCT02904954|365732667|FG001|Adjuvant Durvalumab|Death|1|||
106018892|NCT02904954|365732666|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
106018893|NCT02904954|365732667|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
106018894|NCT03252925|365732672|FG000|Overall Study|Withdrawal by Subject|1|||
106018895|NCT03252925|365732673|FG001|Overall Study|Withdrawal by Subject|0|||
106018896|NCT03252925|365732672|FG000|Overall Study|Protocol Violation|6|||
106018897|NCT03252925|365732673|FG001|Overall Study|Protocol Violation|0|||
106018898|NCT03252925|365732672|FG000|Overall Study|Adverse Event|1|||
106018899|NCT03252925|365732673|FG001|Overall Study|Adverse Event|0|||
106145482|NCT00516321|366193090|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
106018900|NCT03252925|365732672|FG000|Overall Study|Lost to Follow-up|6|||
106018901|NCT03252925|365732673|FG001|Overall Study|Lost to Follow-up|6|||
106018902|NCT03038880|365732674|FG000|Overall Study|Death|1|||
105820704|NCT01083693|365004387|FG002|Overall Study|Lack of effectiveness|2|||
105820705|NCT01083693|365004385|FG000|Overall Study|Patient Moved|0|||
105820706|NCT01083693|365004386|FG001|Overall Study|Patient Moved|1|||
105820707|NCT01083693|365004387|FG002|Overall Study|Patient Moved|0|||
105820708|NCT01083693|365004385|FG000|Overall Study|Complete remission|0|||
105820709|NCT01083693|365004386|FG001|Overall Study|Complete remission|1|||
106018903|NCT03038880|365732675|FG001|Overall Study|Death|2|||
105820710|NCT01083693|365004387|FG002|Overall Study|Complete remission|0|||
105820711|NCT01083693|365004385|FG000|Overall Study|Other medical condition/surgery|1|||
105820712|NCT01083693|365004386|FG001|Overall Study|Other medical condition/surgery|1|||
105820713|NCT01083693|365004387|FG002|Overall Study|Other medical condition/surgery|0|||
105820714|NCT01083693|365004385|FG000|Overall Study|Withdrawal by Subject|3|||
105820715|NCT01083693|365004386|FG001|Overall Study|Withdrawal by Subject|0|||
105820716|NCT01083693|365004387|FG002|Overall Study|Withdrawal by Subject|2|||
105820717|NCT01083693|365004385|FG000|Overall Study|Reason unknown|0|||
105820718|NCT01083693|365004386|FG001|Overall Study|Reason unknown|0|||
105820719|NCT01083693|365004387|FG002|Overall Study|Reason unknown|1|||
105820720|NCT00905840|365004390|FG000|Overall Study|Lost to Follow-up|11|||
105820721|NCT00905840|365004390|FG000|Overall Study|Death|3|||
105820722|NCT00905840|365004390|FG000|Overall Study|Withdrawal by Subject|1|||
105820723|NCT00905840|365004390|FG000|Overall Study|Adverse Event|1|||
105820724|NCT02459951|365004391|FG000|Overall Study|Unable to meet holding requirement|1|||
105820725|NCT03620747|365004395|FG000|Overall Study|Participant decision|7|||
105820726|NCT03620747|365004395|FG000|Overall Study|Adverse Event|6|||
105820727|NCT03620747|365004395|FG000|Overall Study|Lack of Efficacy|1|||
105820728|NCT03620747|365004395|FG000|Overall Study|Poor compliance to protocol|2|||
105820729|NCT03620747|365004395|FG000|Overall Study|Other-unspecified|3|||
105820730|NCT02714062|365004396|FG000|Overall Study|Adverse Event|0|||
105820731|NCT02714062|365004397|FG001|Overall Study|Adverse Event|0|||
105820732|NCT02714062|365004398|FG002|Overall Study|Adverse Event|2|||
105820733|NCT02714062|365004396|FG000|Overall Study|Withdrawal by Subject|1|||
105820734|NCT02714062|365004397|FG001|Overall Study|Withdrawal by Subject|0|||
105820735|NCT02714062|365004398|FG002|Overall Study|Withdrawal by Subject|1|||
105820736|NCT02714062|365004396|FG000|Overall Study|Protocol Violation|0|||
105820737|NCT02714062|365004397|FG001|Overall Study|Protocol Violation|1|||
105820738|NCT02714062|365004398|FG002|Overall Study|Protocol Violation|0|||
105820739|NCT04533594|365004404|FG000|Overall Study|Death|26|||
105820740|NCT00473330|365004405|FG000|Core Study|Adverse Event|4|||
105820741|NCT00473330|365004406|FG001|Core Study|Adverse Event|4|||
105820742|NCT00473330|365004407|FG002|Core Study|Adverse Event|1|||
105820743|NCT00473330|365004405|FG000|Core Study|Death|6|||
105820744|NCT00473330|365004406|FG001|Core Study|Death|4|||
105820745|NCT00473330|365004407|FG002|Core Study|Death|4|||
105820746|NCT00473330|365004405|FG000|Core Study|Lost to Follow-up|5|||
105820747|NCT00473330|365004406|FG001|Core Study|Lost to Follow-up|5|||
105820748|NCT00473330|365004407|FG002|Core Study|Lost to Follow-up|10|||
105820749|NCT00473330|365004405|FG000|Core Study|Physician Decision|2|||
105820750|NCT00473330|365004406|FG001|Core Study|Physician Decision|1|||
105820751|NCT00473330|365004407|FG002|Core Study|Physician Decision|3|||
105820752|NCT00473330|365004405|FG000|Core Study|Subject Non-compliance|1|||
105820753|NCT00473330|365004406|FG001|Core Study|Subject Non-compliance|2|||
105820754|NCT00473330|365004407|FG002|Core Study|Subject Non-compliance|1|||
105820755|NCT00473330|365004405|FG000|Core Study|Subject Required Other Therapy|0|||
105820756|NCT00473330|365004406|FG001|Core Study|Subject Required Other Therapy|1|||
105820757|NCT00473330|365004407|FG002|Core Study|Subject Required Other Therapy|3|||
105820758|NCT00473330|365004405|FG000|Core Study|Subject's Decision|9|||
105820759|NCT00473330|365004406|FG001|Core Study|Subject's Decision|8|||
105820760|NCT00473330|365004407|FG002|Core Study|Subject's Decision|19|||
105820761|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
105820762|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
105820763|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
105820764|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Death|2|||
105820765|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Death|0|||
105820766|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Death|0|||
106145483|NCT00516321|366193091|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
106145484|NCT00516321|366193092|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
105820767|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
105820768|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
106145485|NCT00516321|366193090|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
106145486|NCT00516321|366193091|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
106145487|NCT00516321|366193092|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
106145488|NCT00516321|366193090|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
106145489|NCT00516321|366193091|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
106145490|NCT00516321|366193092|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
105820769|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
105820770|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
105820771|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
105820772|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
105820773|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
105820774|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
105820775|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
105820776|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
105820777|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
105820778|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
105820779|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
105956902|NCT01467466|365502913|FG001|Overall Study|Procedure Cancelled|45|||
105956903|NCT01467466|365502914|FG002|Overall Study|Procedure Cancelled|25|||
105766095|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
105766096|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
105766097|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
105766098|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
105766099|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
105766100|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
105766101|NCT01001572|364795989|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766102|NCT01001572|364795990|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766103|NCT01001572|364795991|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105766104|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Death|3|||
105766105|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Death|0|||
105766106|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Death|0|||
105766107|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Death|0|||
105766108|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Death|0|||
105766109|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
105766110|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
105766111|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
105766112|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
105766113|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
105766114|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105766115|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
105766116|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
105766117|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105766118|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
105766119|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Other|0|||
105766120|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Other|0|||
105766121|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Other|1|||
105766122|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Other|0|||
105766123|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Other|0|||
105766124|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
105766125|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
105766126|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
105766127|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
105766128|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
105766129|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
105766130|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
105766131|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
105766132|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
105766133|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
105766134|NCT01224106|364795992|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105766135|NCT01224106|364795993|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766136|NCT01224106|364795994|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105766137|NCT01224106|364795995|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766138|NCT01224106|364795996|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105766139|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Death|0|||
105766140|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Death|0|||
105766141|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Death|0|||
105766142|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Death|1|||
105766143|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Death|3|||
105766144|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
105766145|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
105766146|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
105766147|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
105766148|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
105766149|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
105766150|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
105766151|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
105766152|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
105766153|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
105766154|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
105766155|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
105956904|NCT01467466|365502915|FG003|Overall Study|Procedure Cancelled|29|||
105820780|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
105820781|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
105820782|NCT00473330|365004405|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
105820783|NCT00473330|365004406|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
105820784|NCT00473330|365004407|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
105820785|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
105820786|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
105820787|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
105820788|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Death|2|||
105820789|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Death|2|||
105820790|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Death|1|||
105820791|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
105820792|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
105820793|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
105820794|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
105820795|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
105820796|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
105820797|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
105820798|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
105820799|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
105820800|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
105820801|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
105820802|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
105820803|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
105820804|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
105820805|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
105820806|NCT00473330|365004405|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
105820807|NCT00473330|365004406|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
105820808|NCT00473330|365004407|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
105820809|NCT00960297|365004410|FG000|Overall Study|Physician Decision|1|||
105820810|NCT00960297|365004410|FG000|Overall Study|Venous port infection|1|||
105820811|NCT00960297|365004410|FG000|Overall Study|Disease progression|1|||
105820812|NCT03965091|365004416|FG000|Overall Study|Adverse Event|0|||
105820813|NCT03965091|365004417|FG001|Overall Study|Adverse Event|2|||
105820814|NCT03965091|365004418|FG002|Overall Study|Adverse Event|3|||
105820815|NCT03965091|365004416|FG000|Overall Study|Withdrawal by Subject|11|||
105820816|NCT03965091|365004417|FG001|Overall Study|Withdrawal by Subject|3|||
105820817|NCT03965091|365004418|FG002|Overall Study|Withdrawal by Subject|5|||
105820818|NCT03965091|365004416|FG000|Overall Study|Non-compliance with study drug|0|||
105820819|NCT03965091|365004417|FG001|Overall Study|Non-compliance with study drug|0|||
105820820|NCT03965091|365004418|FG002|Overall Study|Non-compliance with study drug|1|||
105820821|NCT03965091|365004416|FG000|Overall Study|Lost to Follow-up|1|||
105820822|NCT03965091|365004417|FG001|Overall Study|Lost to Follow-up|1|||
105820823|NCT03965091|365004418|FG002|Overall Study|Lost to Follow-up|1|||
105820824|NCT03965091|365004416|FG000|Overall Study|Lack of Efficacy|2|||
105820825|NCT03965091|365004417|FG001|Overall Study|Lack of Efficacy|0|||
105820826|NCT03965091|365004418|FG002|Overall Study|Lack of Efficacy|0|||
105820827|NCT03965091|365004416|FG000|Overall Study|Other than specified|9|||
105820828|NCT03965091|365004417|FG001|Overall Study|Other than specified|11|||
105820829|NCT03965091|365004418|FG002|Overall Study|Other than specified|8|||
105820830|NCT03500341|365004419|FG000|Overall Study|Withdrawn prior to Completion|2|||
105820831|NCT02576938|365004420|FG000|Overall Study|Adverse Event|5|||
105820832|NCT02576938|365004421|FG001|Overall Study|Adverse Event|3|||
105820833|NCT02576938|365004422|FG002|Overall Study|Adverse Event|6|||
105820834|NCT02576938|365004420|FG000|Overall Study|Protocol Violation|1|||
105820835|NCT02576938|365004421|FG001|Overall Study|Protocol Violation|1|||
105820836|NCT02576938|365004422|FG002|Overall Study|Protocol Violation|1|||
105820837|NCT02576938|365004420|FG000|Overall Study|Withdrawal by Subject|3|||
105820838|NCT02576938|365004421|FG001|Overall Study|Withdrawal by Subject|2|||
105820839|NCT02576938|365004422|FG002|Overall Study|Withdrawal by Subject|4|||
105820840|NCT02576938|365004420|FG000|Overall Study|Lack of Efficacy|9|||
105820841|NCT02576938|365004421|FG001|Overall Study|Lack of Efficacy|4|||
105820842|NCT02576938|365004422|FG002|Overall Study|Lack of Efficacy|0|||
105820843|NCT02576938|365004420|FG000|Overall Study|Lost to Follow-up|2|||
105820844|NCT02576938|365004421|FG001|Overall Study|Lost to Follow-up|0|||
105820845|NCT02576938|365004422|FG002|Overall Study|Lost to Follow-up|1|||
105820846|NCT02576938|365004420|FG000|Overall Study|Physician Decision|0|||
105820847|NCT02576938|365004421|FG001|Overall Study|Physician Decision|1|||
105820848|NCT02576938|365004422|FG002|Overall Study|Physician Decision|0|||
105820849|NCT02576938|365004420|FG000|Overall Study|Met Exclusion Criteria|0|||
105820850|NCT02576938|365004421|FG001|Overall Study|Met Exclusion Criteria|1|||
105820851|NCT02576938|365004422|FG002|Overall Study|Met Exclusion Criteria|0|||
105820852|NCT00123734|365004423|FG000|Overall Study|Death|3|||
105820853|NCT00123734|365004423|FG000|Overall Study|Lost to Follow-up|3|||
105820854|NCT00123734|365004423|FG000|Overall Study|Dropout|1|||
105820855|NCT00123734|365004423|FG000|Overall Study|Withdrawal by Subject|1|||
105820856|NCT00834340|365004424|FG000|Washout|Adverse Event|1|||
105820857|NCT00834340|365004425|FG001|Washout|Adverse Event|0|||
105820858|NCT00834340|365004424|FG000|Washout|Withdrawal by Subject|1|||
105820859|NCT00834340|365004425|FG001|Washout|Withdrawal by Subject|0|||
105820860|NCT00448591|365004426|FG000|Overall Study|Withdrawal by Subject|178|||
105820861|NCT00448591|365004426|FG000|Overall Study|Progressive Disease|1382|||
105820862|NCT00448591|365004426|FG000|Overall Study|Adverse Event|382|||
105820863|NCT00448591|365004426|FG000|Overall Study|Protocol Violation|41|||
105820864|NCT00448591|365004426|FG000|Overall Study|Lost to Follow-up|19|||
105820865|NCT00448591|365004426|FG000|Overall Study|Treatment Regimen Completed|70|||
105820866|NCT00448591|365004426|FG000|Overall Study|Other|154|||
105820867|NCT00448591|365004426|FG000|Overall Study|Termination of Study|70|||
105820868|NCT02937870|365004429|FG000|Overall Study|Adverse Event|1|||
105820869|NCT02937870|365004429|FG000|Overall Study|Protocol Deviation|2|||
105820870|NCT00609674|365004430|FG000|Overall Study|Adverse Event|1|||
105820871|NCT00609674|365004431|FG001|Overall Study|Adverse Event|1|||
105820872|NCT00609674|365004430|FG000|Overall Study|Protocol Violation|3|||
105820873|NCT00609674|365004431|FG001|Overall Study|Protocol Violation|5|||
105820874|NCT00609674|365004430|FG000|Overall Study|Lost to Follow-up|1|||
105820875|NCT00609674|365004431|FG001|Overall Study|Lost to Follow-up|0|||
105820876|NCT00609674|365004430|FG000|Overall Study|Withdrew consent|2|||
105820877|NCT00609674|365004431|FG001|Overall Study|Withdrew consent|1|||
105820878|NCT04408794|365004433|FG000|Overall Study|Adverse Event|43|||
105820879|NCT04408794|365004433|FG000|Overall Study|Infrequent study drug usage|43|||
105820880|NCT04408794|365004433|FG000|Overall Study|Lack of Efficacy|61|||
105820881|NCT04408794|365004433|FG000|Overall Study|Lost to Follow-up|33|||
105820882|NCT04408794|365004433|FG000|Overall Study|Non-compliance|6|||
105820883|NCT04408794|365004433|FG000|Overall Study|Physician Decision|1|||
105820884|NCT04408794|365004433|FG000|Overall Study|Pregnancy|6|||
105820885|NCT04408794|365004433|FG000|Overall Study|Protocol Deviation|9|||
105820886|NCT04408794|365004433|FG000|Overall Study|Sheehan-STS Result|1|||
105820887|NCT04408794|365004433|FG000|Overall Study|Withdrawal by Subject|57|||
105820888|NCT04408794|365004433|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
105820889|NCT04408794|365004433|FG000|Overall Study|Never Treated Migraine|5|||
105820890|NCT00571064|365004436|FG000|Overall Study|Adverse Event|13|||
105820891|NCT00571064|365004436|FG000|Overall Study|Protocol Violation|4|||
105820892|NCT00571064|365004436|FG000|Overall Study|Withdrawal by Subject|2|||
105820893|NCT00571064|365004436|FG000|Overall Study|Other|2|||
105820894|NCT04238754|365004437|FG000|Washout - 1 Week|Lost to Follow-up|1|||
105820895|NCT04238754|365004438|FG001|Washout - 1 Week|Lost to Follow-up|0|||
105820896|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
105820897|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
105820898|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
105820899|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
105820900|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
105820901|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
105820902|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
105820903|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
105820904|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
105820905|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
105820906|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
105820907|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
105820908|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
105820909|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
105820910|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
105820911|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
105820912|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
105820913|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
105820914|NCT01667679|365004441|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
105820915|NCT01667679|365004442|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
105820916|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
105820917|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
105820918|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
105820919|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
105820920|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
105820921|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
105820922|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
105820923|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
105820924|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
105820925|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
105820926|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
105820927|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
105820928|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
105820929|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
105820930|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
105820931|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
105820932|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
105820933|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
105820934|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
105820935|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
105820936|NCT01667679|365004441|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
105820937|NCT01667679|365004442|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
105820938|NCT02159950|365004443|FG000|Overall Study|Adverse Event|0|||
105820939|NCT02159950|365004444|FG001|Overall Study|Adverse Event|1|||
105820940|NCT02159950|365004443|FG000|Overall Study|Progression|0|||
105820941|NCT02159950|365004444|FG001|Overall Study|Progression|1|||
105820942|NCT03285594|365004447|FG000|Overall Study|At the Participant's Own Request|10|||
105820943|NCT03285594|365004448|FG001|Overall Study|At the Participant's Own Request|5|||
105820944|NCT03285594|365004449|FG002|Overall Study|At the Participant's Own Request|21|||
105820945|NCT03285594|365004447|FG000|Overall Study|Adverse Event|2|||
105820946|NCT03285594|365004448|FG001|Overall Study|Adverse Event|2|||
105820947|NCT03285594|365004449|FG002|Overall Study|Adverse Event|6|||
105820948|NCT03285594|365004447|FG000|Overall Study|Poor Compliance to Protocol|0|||
105820949|NCT03285594|365004448|FG001|Overall Study|Poor Compliance to Protocol|0|||
105820950|NCT03285594|365004449|FG002|Overall Study|Poor Compliance to Protocol|1|||
105820951|NCT03285594|365004447|FG000|Overall Study|Lost to Follow-up|0|||
105820952|NCT03285594|365004448|FG001|Overall Study|Lost to Follow-up|0|||
105820953|NCT03285594|365004449|FG002|Overall Study|Lost to Follow-up|1|||
105820954|NCT03285594|365004447|FG000|Overall Study|Reason Not Specified|3|||
105820955|NCT03285594|365004448|FG001|Overall Study|Reason Not Specified|4|||
105820956|NCT03285594|365004449|FG002|Overall Study|Reason Not Specified|8|||
105820957|NCT00556322|365004452|FG000|Overall Study|Insufficient therapeutic response|158|||
105820958|NCT00556322|365004453|FG001|Overall Study|Insufficient therapeutic response|168|||
105820959|NCT00556322|365004452|FG000|Overall Study|Adverse Event|7|||
105820960|NCT00556322|365004453|FG001|Overall Study|Adverse Event|4|||
105820961|NCT00556322|365004452|FG000|Overall Study|Other|4|||
105820962|NCT00556322|365004453|FG001|Overall Study|Other|1|||
105820963|NCT00556322|365004452|FG000|Overall Study|Lost to Follow-up|5|||
105820964|NCT00556322|365004453|FG001|Overall Study|Lost to Follow-up|3|||
106145491|NCT00516321|366193090|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
105820965|NCT00556322|365004452|FG000|Overall Study|Withdrawal by Subject|19|||
105820966|NCT00556322|365004453|FG001|Overall Study|Withdrawal by Subject|7|||
105820967|NCT00556322|365004452|FG000|Overall Study|Protocol Violation|5|||
105820968|NCT00556322|365004453|FG001|Overall Study|Protocol Violation|1|||
105820969|NCT00556322|365004452|FG000|Overall Study|Ongoing at data cutoff|3|||
105956905|NCT01467466|365502912|FG000|Overall Study|No Endpoint Blood Draw|38|||
105956906|NCT01467466|365502913|FG001|Overall Study|No Endpoint Blood Draw|32|||
105956907|NCT01467466|365502914|FG002|Overall Study|No Endpoint Blood Draw|51|||
105956908|NCT01467466|365502915|FG003|Overall Study|No Endpoint Blood Draw|43|||
105956909|NCT02484443|365502916|FG000|Overall Study|Lack of Efficacy|28|||
105956910|NCT02484443|365502916|FG000|Overall Study|Physician Decision|2|||
106145492|NCT00516321|366193091|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
106145493|NCT00516321|366193092|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
105820970|NCT00556322|365004453|FG001|Overall Study|Ongoing at data cutoff|5|||
105820971|NCT00556322|365004452|FG000|Overall Study|Death|20|||
105820972|NCT00556322|365004453|FG001|Overall Study|Death|14|||
105820973|NCT03733444|365004454|FG000|Overall Study|Adverse Event|8|||
105820974|NCT03733444|365004455|FG001|Overall Study|Adverse Event|10|||
105820975|NCT03733444|365004456|FG002|Overall Study|Adverse Event|5|||
105820976|NCT03733444|365004454|FG000|Overall Study|Death|20|||
105820977|NCT03733444|365004455|FG001|Overall Study|Death|19|||
105956911|NCT02484443|365502916|FG000|Overall Study|Ineligible|2|||
106145494|NCT00516321|366193090|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
105820978|NCT03733444|365004456|FG002|Overall Study|Death|11|||
105820979|NCT03733444|365004454|FG000|Overall Study|Lost to Follow-up|3|||
105820980|NCT03733444|365004455|FG001|Overall Study|Lost to Follow-up|0|||
105820981|NCT03733444|365004456|FG002|Overall Study|Lost to Follow-up|1|||
105820982|NCT03733444|365004454|FG000|Overall Study|Lack of Efficacy|0|||
105820983|NCT03733444|365004455|FG001|Overall Study|Lack of Efficacy|1|||
105820984|NCT03733444|365004456|FG002|Overall Study|Lack of Efficacy|1|||
105820985|NCT03733444|365004454|FG000|Overall Study|Physician Decision|2|||
105956912|NCT02012218|365502921|FG000|Overall Study|Withdrawal by Subject|1|||
105956913|NCT02012218|365502922|FG001|Overall Study|Withdrawal by Subject|0|||
105956914|NCT02012218|365502923|FG002|Overall Study|Withdrawal by Subject|1|||
105956915|NCT02012218|365502924|FG003|Overall Study|Withdrawal by Subject|1|||
105956916|NCT02012218|365502925|FG004|Overall Study|Withdrawal by Subject|1|||
105956917|NCT02012218|365502921|FG000|Overall Study|Adverse Event|1|||
105956918|NCT02012218|365502922|FG001|Overall Study|Adverse Event|0|||
105956919|NCT02012218|365502923|FG002|Overall Study|Adverse Event|0|||
105956920|NCT02012218|365502924|FG003|Overall Study|Adverse Event|1|||
105956921|NCT02012218|365502925|FG004|Overall Study|Adverse Event|0|||
105956922|NCT02012218|365502921|FG000|Overall Study|Lost to Follow-up|0|||
105956923|NCT02012218|365502922|FG001|Overall Study|Lost to Follow-up|1|||
105956924|NCT02012218|365502923|FG002|Overall Study|Lost to Follow-up|1|||
105956925|NCT02012218|365502924|FG003|Overall Study|Lost to Follow-up|0|||
106145495|NCT00516321|366193091|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
106145496|NCT00516321|366193092|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
106145497|NCT00516321|366193090|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
106145498|NCT00516321|366193091|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
106145499|NCT00516321|366193092|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
106145500|NCT01254019|366193094|FG000|Overall Study|Adverse Event|0|||
106145501|NCT01254019|366193095|FG001|Overall Study|Adverse Event|2|||
106145502|NCT01254019|366193094|FG000|Overall Study|Protocol Violation|1|||
106145503|NCT01254019|366193095|FG001|Overall Study|Protocol Violation|0|||
106145504|NCT01254019|366193094|FG000|Overall Study|Withdrawal by Subject|0|||
106145505|NCT01254019|366193095|FG001|Overall Study|Withdrawal by Subject|2|||
106145506|NCT03615924|366193096|FG000|Overall Study|Withdrawal by Subject|2|||
106145507|NCT03615924|366193097|FG001|Overall Study|Withdrawal by Subject|5|||
106145508|NCT03615924|366193096|FG000|Overall Study|Death|3|||
106145509|NCT03615924|366193097|FG001|Overall Study|Death|1|||
106145510|NCT03615924|366193096|FG000|Overall Study|Lost to Follow-up|1|||
106145511|NCT03615924|366193097|FG001|Overall Study|Lost to Follow-up|0|||
106145512|NCT03615924|366193096|FG000|Overall Study|Randomized in error|1|||
106145513|NCT03615924|366193097|FG001|Overall Study|Randomized in error|0|||
106145514|NCT03615924|366193096|FG000|Overall Study|Study termination by Sponsor|94|||
106145515|NCT03615924|366193097|FG001|Overall Study|Study termination by Sponsor|86|||
106145516|NCT02529995|366193098|FG000|Part A|Ongoing Study at Data Cut-off|14|||
106145517|NCT02529995|366193099|FG001|Part A|Ongoing Study at Data Cut-off|16|||
106145518|NCT02529995|366193098|FG000|Part A|Discontinued Study|1|||
105766156|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
105766157|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
105766158|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
105766159|NCT01224106|364795992|FG000|Open-Label Extension (OLE) Phase|Other|0|||
105766160|NCT01224106|364795993|FG001|Open-Label Extension (OLE) Phase|Other|0|||
105766161|NCT01224106|364795994|FG002|Open-Label Extension (OLE) Phase|Other|0|||
105766162|NCT01224106|364795995|FG003|Open-Label Extension (OLE) Phase|Other|5|||
105766163|NCT01224106|364795996|FG004|Open-Label Extension (OLE) Phase|Other|3|||
105766164|NCT00446797|364795997|FG000|Overall Study|Lack of Efficacy|0|||
105766165|NCT00446797|364795998|FG001|Overall Study|Lack of Efficacy|2|||
105766166|NCT00446797|364795997|FG000|Overall Study|Lost to Follow-up|5|||
105766167|NCT00446797|364795998|FG001|Overall Study|Lost to Follow-up|3|||
105766168|NCT00446797|364795997|FG000|Overall Study|Withdrawal by Subject|2|||
105766169|NCT00446797|364795998|FG001|Overall Study|Withdrawal by Subject|2|||
105766170|NCT00446797|364795997|FG000|Overall Study|Protocol Violation|1|||
105766171|NCT00446797|364795998|FG001|Overall Study|Protocol Violation|3|||
105820986|NCT03733444|365004455|FG001|Overall Study|Physician Decision|1|||
105820987|NCT03733444|365004456|FG002|Overall Study|Physician Decision|0|||
105820988|NCT03733444|365004454|FG000|Overall Study|Protocol Violation|2|||
105956926|NCT02012218|365502925|FG004|Overall Study|Lost to Follow-up|0|||
106145519|NCT02529995|366193099|FG001|Part A|Discontinued Study|0|||
106145520|NCT02529995|366193098|FG000|Part B|Ongoing Study at Data Cut-off|0|||
106145521|NCT02529995|366193099|FG001|Part B|Ongoing Study at Data Cut-off|7|||
106145522|NCT02529995|366193098|FG000|Part B|Discontinued Study|6|||
106145523|NCT02529995|366193099|FG001|Part B|Discontinued Study|5|||
106145524|NCT00638963|366193104|FG000|Overall Study|Withdrawal by Subject|1|||
106145525|NCT00638963|366193105|FG001|Overall Study|Withdrawal by Subject|0|||
106145526|NCT02512965|366193106|FG000|Overall Study|Withdrawal by Subject|0|||
106145527|NCT02512965|366193107|FG001|Overall Study|Withdrawal by Subject|4|||
106145528|NCT00835770|366193108|FG000|Overall Study|MS Relapse|17|||
106145529|NCT00835770|366193109|FG001|Overall Study|MS Relapse|23|||
105820989|NCT03733444|365004455|FG001|Overall Study|Protocol Violation|1|||
105820990|NCT03733444|365004456|FG002|Overall Study|Protocol Violation|0|||
105820991|NCT03733444|365004454|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
105820992|NCT03733444|365004455|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
105820993|NCT03733444|365004456|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
105820994|NCT03733444|365004454|FG000|Overall Study|Study Terminated by Sponsor|203|||
105820995|NCT03733444|365004455|FG001|Overall Study|Study Terminated by Sponsor|209|||
105820996|NCT03733444|365004456|FG002|Overall Study|Study Terminated by Sponsor|221|||
105820997|NCT03733444|365004454|FG000|Overall Study|Withdrawal by Subject|19|||
105820998|NCT03733444|365004455|FG001|Overall Study|Withdrawal by Subject|18|||
105820999|NCT03733444|365004456|FG002|Overall Study|Withdrawal by Subject|16|||
105821000|NCT03733444|365004454|FG000|Overall Study|Miscellaneous|1|||
105821001|NCT03733444|365004455|FG001|Overall Study|Miscellaneous|0|||
105821002|NCT03733444|365004456|FG002|Overall Study|Miscellaneous|1|||
105821003|NCT03733444|365004454|FG000|Overall Study|Not Treated|1|||
105821004|NCT03733444|365004455|FG001|Overall Study|Not Treated|2|||
105821005|NCT03733444|365004456|FG002|Overall Study|Not Treated|1|||
105821006|NCT03663179|365004457|FG000|Overall Study|Withdrawal by Subject|2|||
105821007|NCT03663179|365004458|FG001|Overall Study|Withdrawal by Subject|0|||
105821008|NCT03663179|365004457|FG000|Overall Study|Lost to Follow-up|1|||
105821009|NCT03663179|365004458|FG001|Overall Study|Lost to Follow-up|1|||
105821010|NCT03663179|365004457|FG000|Overall Study|Revealed exclusionary condition|1|||
105821011|NCT03663179|365004458|FG001|Overall Study|Revealed exclusionary condition|0|||
105821012|NCT00651820|365004461|FG000|Overall Study|Lost to Follow-up|2|||
105821013|NCT00576056|365004462|FG000|Overall Study|Adverse Event|1|||
105821014|NCT00576056|365004462|FG000|Overall Study|Death|1|||
105821015|NCT00576056|365004462|FG000|Overall Study|Lack of Efficacy|1|||
105821016|NCT00576056|365004462|FG000|Overall Study|Withdrawal by Subject|2|||
105821017|NCT00576056|365004462|FG000|Overall Study|did not meet eligibility criteria|8|||
105821018|NCT00576056|365004462|FG000|Overall Study|Physician Decision|1|||
105821019|NCT03686033|365004463|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821020|NCT03686033|365004464|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821021|NCT03686033|365004465|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821022|NCT03686033|365004466|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821023|NCT03686033|365004467|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
105821024|NCT03686033|365004468|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
105821025|NCT00657553|365004475|FG000|Overall Study|low accrual, no analysis run|5|||
105821026|NCT00657553|365004476|FG001|Overall Study|low accrual, no analysis run|5|||
105821027|NCT03031847|365004477|FG000|Overall Study|Death|1|||
105821028|NCT03031847|365004478|FG001|Overall Study|Death|1|||
105821029|NCT03031847|365004479|FG002|Overall Study|Death|2|||
105821030|NCT03031847|365004480|FG003|Overall Study|Death|3|||
105821031|NCT03031847|365004477|FG000|Overall Study|Lost to Follow-up|1|||
105821032|NCT03031847|365004478|FG001|Overall Study|Lost to Follow-up|1|||
105821033|NCT03031847|365004479|FG002|Overall Study|Lost to Follow-up|2|||
105821034|NCT03031847|365004480|FG003|Overall Study|Lost to Follow-up|3|||
106018904|NCT03038880|365732676|FG002|Overall Study|Death|0|||
106018905|NCT03038880|365732674|FG000|Overall Study|Physician Decision|2|||
106018906|NCT03038880|365732675|FG001|Overall Study|Physician Decision|1|||
106018907|NCT03038880|365732676|FG002|Overall Study|Physician Decision|0|||
105821035|NCT03173547|365004481|FG000|Overall Study|Adverse Event|2|||
105821036|NCT03173547|365004482|FG001|Overall Study|Adverse Event|0|||
105821037|NCT03173547|365004481|FG000|Overall Study|Withdrawal by Subject|2|||
105821038|NCT03173547|365004482|FG001|Overall Study|Withdrawal by Subject|2|||
105821039|NCT00446563|365004483|FG000|Overall Study|Adverse Event|4|||
105821040|NCT00446563|365004484|FG001|Overall Study|Adverse Event|3|||
105821041|NCT00446563|365004483|FG000|Overall Study|Abnormal laboratory value(s)|0|||
105821042|NCT00446563|365004484|FG001|Overall Study|Abnormal laboratory value(s)|1|||
105821043|NCT00446563|365004483|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105821044|NCT00446563|365004484|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105821045|NCT00446563|365004483|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105821046|NCT00446563|365004484|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105821047|NCT00446563|365004483|FG000|Overall Study|Withdrawal by Subject|2|||
105821048|NCT00446563|365004484|FG001|Overall Study|Withdrawal by Subject|1|||
105821049|NCT00446563|365004483|FG000|Overall Study|Administrative problems|0|||
105821050|NCT00446563|365004484|FG001|Overall Study|Administrative problems|1|||
105821051|NCT03769025|365004485|FG000|Overall Study|Withdrawal by Subject|1|||
105821052|NCT03769025|365004486|FG001|Overall Study|Withdrawal by Subject|1|||
105821053|NCT03769025|365004485|FG000|Overall Study|Lost to Follow-up|4|||
105821054|NCT03769025|365004486|FG001|Overall Study|Lost to Follow-up|3|||
105821055|NCT01302548|365004487|FG000|Overall Study|Lost to Follow-up|2|||
105821056|NCT01302548|365004488|FG001|Overall Study|Lost to Follow-up|1|||
105821057|NCT03600376|365004489|FG000|Overall Study|Adverse Event|1|||
105821058|NCT03600376|365004490|FG001|Overall Study|Adverse Event|1|||
105821059|NCT03600376|365004489|FG000|Overall Study|Transferred to other facility|1|||
105821060|NCT03600376|365004490|FG001|Overall Study|Transferred to other facility|0|||
106018908|NCT01358721|365732681|FG000|Overall Study|Withdrawal by Subject|0|||
105821061|NCT03600376|365004489|FG000|Overall Study|Investigator Decision|0|||
105821062|NCT03600376|365004490|FG001|Overall Study|Investigator Decision|4|||
105821063|NCT03600376|365004489|FG000|Overall Study|Determined to be ineligible for study|0|||
105821064|NCT03600376|365004490|FG001|Overall Study|Determined to be ineligible for study|1|||
105821065|NCT03290781|365004493|FG000|Overall Study|Adverse Event|5|||
105821066|NCT03290781|365004494|FG001|Overall Study|Adverse Event|7|||
105821067|NCT03290781|365004495|FG002|Overall Study|Adverse Event|4|||
105821068|NCT03290781|365004496|FG003|Overall Study|Adverse Event|1|||
105821069|NCT03290781|365004497|FG004|Overall Study|Adverse Event|0|||
105821070|NCT03290781|365004498|FG005|Overall Study|Adverse Event|0|||
105821071|NCT03290781|365004499|FG006|Overall Study|Adverse Event|0|||
105821072|NCT03290781|365004493|FG000|Overall Study|Death|0|||
105821073|NCT03290781|365004494|FG001|Overall Study|Death|0|||
105821074|NCT03290781|365004495|FG002|Overall Study|Death|1|||
105821075|NCT03290781|365004496|FG003|Overall Study|Death|0|||
105821076|NCT03290781|365004497|FG004|Overall Study|Death|1|||
105821077|NCT03290781|365004498|FG005|Overall Study|Death|0|||
105821078|NCT03290781|365004499|FG006|Overall Study|Death|0|||
105821079|NCT03290781|365004493|FG000|Overall Study|Withdrawal by Subject|6|||
105821080|NCT03290781|365004494|FG001|Overall Study|Withdrawal by Subject|5|||
105821081|NCT03290781|365004495|FG002|Overall Study|Withdrawal by Subject|9|||
105821082|NCT03290781|365004496|FG003|Overall Study|Withdrawal by Subject|10|||
105821083|NCT03290781|365004497|FG004|Overall Study|Withdrawal by Subject|1|||
105821084|NCT03290781|365004498|FG005|Overall Study|Withdrawal by Subject|2|||
105821085|NCT03290781|365004499|FG006|Overall Study|Withdrawal by Subject|0|||
105821086|NCT03290781|365004493|FG000|Overall Study|Physician Decision|0|||
105821087|NCT03290781|365004494|FG001|Overall Study|Physician Decision|1|||
105821088|NCT03290781|365004495|FG002|Overall Study|Physician Decision|0|||
105821089|NCT03290781|365004496|FG003|Overall Study|Physician Decision|0|||
105821090|NCT03290781|365004497|FG004|Overall Study|Physician Decision|0|||
105821091|NCT03290781|365004498|FG005|Overall Study|Physician Decision|0|||
105821092|NCT03290781|365004499|FG006|Overall Study|Physician Decision|0|||
105821093|NCT03290781|365004493|FG000|Overall Study|Site Terminated by Sponsor|1|||
105821094|NCT03290781|365004494|FG001|Overall Study|Site Terminated by Sponsor|0|||
105821095|NCT03290781|365004495|FG002|Overall Study|Site Terminated by Sponsor|2|||
105821096|NCT03290781|365004496|FG003|Overall Study|Site Terminated by Sponsor|1|||
105821097|NCT03290781|365004497|FG004|Overall Study|Site Terminated by Sponsor|0|||
105821098|NCT03290781|365004498|FG005|Overall Study|Site Terminated by Sponsor|0|||
105821099|NCT03290781|365004499|FG006|Overall Study|Site Terminated by Sponsor|0|||
105821100|NCT03290781|365004493|FG000|Overall Study|Lost to Follow-up|0|||
105821101|NCT03290781|365004494|FG001|Overall Study|Lost to Follow-up|0|||
105821102|NCT03290781|365004495|FG002|Overall Study|Lost to Follow-up|0|||
105821103|NCT03290781|365004496|FG003|Overall Study|Lost to Follow-up|1|||
105821104|NCT03290781|365004497|FG004|Overall Study|Lost to Follow-up|0|||
105821105|NCT03290781|365004498|FG005|Overall Study|Lost to Follow-up|0|||
105821106|NCT03290781|365004499|FG006|Overall Study|Lost to Follow-up|0|||
105821107|NCT03290781|365004493|FG000|Overall Study|Protocol Deviation|2|||
105821108|NCT03290781|365004494|FG001|Overall Study|Protocol Deviation|0|||
105821109|NCT03290781|365004495|FG002|Overall Study|Protocol Deviation|0|||
105821110|NCT03290781|365004496|FG003|Overall Study|Protocol Deviation|1|||
105821111|NCT03290781|365004497|FG004|Overall Study|Protocol Deviation|0|||
106018909|NCT01358721|365732682|FG001|Overall Study|Withdrawal by Subject|0|||
106018910|NCT01358721|365732683|FG002|Overall Study|Withdrawal by Subject|0|||
106018911|NCT01358721|365732684|FG003|Overall Study|Withdrawal by Subject|1|||
106018912|NCT01358721|365732681|FG000|Overall Study|Death|0|||
106018913|NCT01358721|365732682|FG001|Overall Study|Death|2|||
106018914|NCT01358721|365732683|FG002|Overall Study|Death|0|||
106018915|NCT01358721|365732684|FG003|Overall Study|Death|0|||
106018916|NCT01358721|365732681|FG000|Overall Study|Study Drug Toxicity|1|||
106018917|NCT01358721|365732682|FG001|Overall Study|Study Drug Toxicity|3|||
106018918|NCT01358721|365732683|FG002|Overall Study|Study Drug Toxicity|4|||
106145530|NCT00835770|366193108|FG000|Overall Study|MS Progression|14|||
105821112|NCT03290781|365004498|FG005|Overall Study|Protocol Deviation|0|||
105821113|NCT03290781|365004499|FG006|Overall Study|Protocol Deviation|0|||
105821114|NCT03290781|365004493|FG000|Overall Study|Disease Relapse|32|||
105821115|NCT03290781|365004494|FG001|Overall Study|Disease Relapse|5|||
105821116|NCT03290781|365004495|FG002|Overall Study|Disease Relapse|38|||
105821117|NCT03290781|365004496|FG003|Overall Study|Disease Relapse|7|||
105821118|NCT03290781|365004497|FG004|Overall Study|Disease Relapse|3|||
105821119|NCT03290781|365004498|FG005|Overall Study|Disease Relapse|1|||
106018919|NCT01358721|365732684|FG003|Overall Study|Study Drug Toxicity|5|||
106018920|NCT01358721|365732681|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
105821120|NCT03290781|365004499|FG006|Overall Study|Disease Relapse|4|||
105821121|NCT03290781|365004493|FG000|Overall Study|Other|3|||
105821122|NCT03290781|365004494|FG001|Overall Study|Other|0|||
105821123|NCT03290781|365004495|FG002|Overall Study|Other|2|||
105821124|NCT03290781|365004496|FG003|Overall Study|Other|2|||
105821125|NCT03290781|365004497|FG004|Overall Study|Other|0|||
105821126|NCT03290781|365004498|FG005|Overall Study|Other|0|||
106018921|NCT01358721|365732682|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
105821127|NCT03290781|365004499|FG006|Overall Study|Other|0|||
105821128|NCT03238781|365004500|FG000|Overall Study|Adverse Event|1|||
105821129|NCT03238781|365004501|FG001|Overall Study|Adverse Event|1|||
105821130|NCT03238781|365004502|FG002|Overall Study|Adverse Event|2|||
105821131|NCT03238781|365004500|FG000|Overall Study|Lost to Follow-up|2|||
105821132|NCT03238781|365004501|FG001|Overall Study|Lost to Follow-up|1|||
105821133|NCT03238781|365004502|FG002|Overall Study|Lost to Follow-up|2|||
105821134|NCT03238781|365004500|FG000|Overall Study|Withdrawal by Subject|23|||
105821135|NCT03238781|365004501|FG001|Overall Study|Withdrawal by Subject|14|||
105821136|NCT03238781|365004502|FG002|Overall Study|Withdrawal by Subject|16|||
105821137|NCT03238781|365004500|FG000|Overall Study|Decision by sponsor|0|||
105821138|NCT03238781|365004501|FG001|Overall Study|Decision by sponsor|1|||
105821139|NCT03238781|365004502|FG002|Overall Study|Decision by sponsor|0|||
105821140|NCT01577381|365004505|FG000|Overall Study|Discontinued|2|||
105821141|NCT01577381|365004506|FG001|Overall Study|Discontinued|1|||
105821142|NCT01577381|365004507|FG002|Overall Study|Discontinued|2|||
105821143|NCT01577381|365004508|FG003|Overall Study|Discontinued|2|||
105821144|NCT01577381|365004505|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
105821145|NCT01577381|365004506|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
105821146|NCT01577381|365004507|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
105821147|NCT01577381|365004508|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
105821148|NCT01421277|365004511|FG000|Overall Study|Lack of qualifying event|0|||
105821149|NCT01421277|365004512|FG001|Overall Study|Lack of qualifying event|61|||
105821150|NCT01421277|365004511|FG000|Overall Study|Incomplete baseline data|0|||
105821151|NCT01421277|365004512|FG001|Overall Study|Incomplete baseline data|31|||
105821152|NCT00813592|365004513|FG000|Overall Study|Disease assessment was not completed per|2|||
105821153|NCT01097577|365004514|FG000|Overall Study|Adverse Event|0|||
105821154|NCT01097577|365004515|FG001|Overall Study|Adverse Event|1|||
105821155|NCT00467896|365006498|FG000|Overall Study|Consent Withdrawal|18|||
105821156|NCT00467896|365006498|FG000|Overall Study|Adverse Event|7|||
105821157|NCT00467896|365006498|FG000|Overall Study|Serious Adverse Event|13|||
105821158|NCT00467896|365006498|FG000|Overall Study|Non-compliance|3|||
105821159|NCT00467896|365006498|FG000|Overall Study|Changed therapy|2|||
105821160|NCT00467896|365006498|FG000|Overall Study|Patient received transplant|2|||
105821161|NCT00467896|365006498|FG000|Overall Study|Patient had atrial septostomy|1|||
105821162|NCT00467896|365006498|FG000|Overall Study|Patient weaned off iloprost|1|||
105821163|NCT00467896|365006498|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
105821164|NCT00467896|365006498|FG000|Overall Study|Started intravenous prostacyclin|1|||
105821165|NCT00467896|365006498|FG000|Overall Study|Started inhaled Remodulin|1|||
105821166|NCT00467896|365006498|FG000|Overall Study|Patient had no improvement|1|||
105821167|NCT01124175|365006499|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
105821168|NCT01124175|365006500|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
105821169|NCT00462345|365006512|FG000|Overall Study|Withdrawal by Subject|2|||
105821170|NCT00462345|365006512|FG000|Overall Study|Did not complete second course|1|||
105821171|NCT00070291|365006515|FG000|Step 1|Withdrawal by Subject|1|||
105821172|NCT00070291|365006515|FG000|Step 1|Adverse Event|1|||
105821173|NCT00070291|365006515|FG000|Step 2|Adverse Event|1|||
105821174|NCT02028715|365006518|FG000|Overall Study|Adverse Event|2|||
105821175|NCT02028715|365006519|FG001|Overall Study|Adverse Event|2|||
105821176|NCT02028715|365006518|FG000|Overall Study|Physician Decision|1|||
105821177|NCT02028715|365006519|FG001|Overall Study|Physician Decision|0|||
106018922|NCT01358721|365732683|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
106018923|NCT01358721|365732684|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
106018924|NCT01358721|365732681|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
106018925|NCT01358721|365732682|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
106018926|NCT01358721|365732683|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
106018927|NCT01358721|365732684|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
106018928|NCT01358721|365732681|FG000|Overall Study|Adverse Event related to study drug|1|||
106018929|NCT01358721|365732682|FG001|Overall Study|Adverse Event related to study drug|0|||
105821178|NCT02028715|365006518|FG000|Overall Study|Did not complete satisfaction surveys|2|||
105821179|NCT02028715|365006519|FG001|Overall Study|Did not complete satisfaction surveys|2|||
105821180|NCT00520130|365006522|FG000|Overall Study|Disease progression on study|4|||
105821181|NCT00520130|365006523|FG001|Overall Study|Disease progression on study|0|||
105821182|NCT00520130|365006522|FG000|Overall Study|Physician Decision|1|||
105821183|NCT00520130|365006523|FG001|Overall Study|Physician Decision|1|||
105821184|NCT00371839|365006524|FG000|Overall Study|Death|4|||
105821185|NCT00371839|365006525|FG001|Overall Study|Death|0|||
105821186|NCT00371839|365006526|FG002|Overall Study|Death|0|||
105821187|NCT00371839|365006524|FG000|Overall Study|Withdrawal by Subject|7|||
106018930|NCT01358721|365732683|FG002|Overall Study|Adverse Event related to study drug|0|||
106145531|NCT00835770|366193109|FG001|Overall Study|MS Progression|9|||
105821188|NCT00371839|365006525|FG001|Overall Study|Withdrawal by Subject|4|||
105821189|NCT00371839|365006526|FG002|Overall Study|Withdrawal by Subject|0|||
105821190|NCT00371839|365006524|FG000|Overall Study|Lost to Follow-up|6|||
105821191|NCT00371839|365006525|FG001|Overall Study|Lost to Follow-up|3|||
105821192|NCT00371839|365006526|FG002|Overall Study|Lost to Follow-up|2|||
105821193|NCT02724462|365006527|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
105821194|NCT02724462|365006528|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
105821195|NCT02724462|365006527|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
105821196|NCT02724462|365006528|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
105821197|NCT02724462|365006527|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
106018931|NCT01358721|365732684|FG003|Overall Study|Adverse Event related to study drug|1|||
106018932|NCT01358721|365732681|FG000|Overall Study|Disease Progression|19|||
106018933|NCT01358721|365732682|FG001|Overall Study|Disease Progression|15|||
106018934|NCT01358721|365732683|FG002|Overall Study|Disease Progression|17|||
106018935|NCT01358721|365732684|FG003|Overall Study|Disease Progression|15|||
106018936|NCT01358721|365732681|FG000|Overall Study|Out of State/Unmet Criteria|0|||
106018937|NCT01358721|365732682|FG001|Overall Study|Out of State/Unmet Criteria|0|||
106018938|NCT01358721|365732683|FG002|Overall Study|Out of State/Unmet Criteria|1|||
106018939|NCT01358721|365732684|FG003|Overall Study|Out of State/Unmet Criteria|0|||
106018940|NCT00790088|365732685|FG000|Overall Study|Protocol Violation|11|||
106018941|NCT00790088|365732685|FG000|Overall Study|Withdrawal by Subject|17|||
106018942|NCT00790088|365732685|FG000|Overall Study|Lost to Follow-up|7|||
106018943|NCT00790088|365732685|FG000|Overall Study|Physician Decision|4|||
106018944|NCT02863419|365732688|FG000|Overall Study|Lost to Follow-up|0|||
106018945|NCT02863419|365732689|FG001|Overall Study|Lost to Follow-up|1|||
106018946|NCT02863419|365732690|FG002|Overall Study|Lost to Follow-up|4|||
106018947|NCT02863419|365732688|FG000|Overall Study|Withdrawal by Subject|5|||
106018948|NCT02863419|365732689|FG001|Overall Study|Withdrawal by Subject|5|||
106018949|NCT02863419|365732690|FG002|Overall Study|Withdrawal by Subject|3|||
106018950|NCT02863419|365732688|FG000|Overall Study|Died|3|||
106018951|NCT02863419|365732689|FG001|Overall Study|Died|4|||
106018952|NCT02863419|365732690|FG002|Overall Study|Died|1|||
106018953|NCT03682770|365732691|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
106018954|NCT03682770|365732692|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
106018955|NCT03682770|365732693|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
106018956|NCT03682770|365732694|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
106018957|NCT03682770|365732695|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
106018958|NCT03682770|365732696|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
106018959|NCT03682770|365732697|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
106018960|NCT03682770|365732691|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
106018961|NCT03682770|365732692|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
106018962|NCT03682770|365732693|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
106018963|NCT03682770|365732694|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
106018964|NCT03682770|365732695|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
106018965|NCT03682770|365732696|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
106018966|NCT03682770|365732697|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
106018967|NCT03682770|365732691|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
106018968|NCT03682770|365732692|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
106018969|NCT03682770|365732693|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
106018970|NCT03682770|365732694|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
106018971|NCT03682770|365732695|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
106018972|NCT03682770|365732696|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
106018973|NCT03682770|365732697|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
106018974|NCT03682770|365732691|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
106018975|NCT03682770|365732692|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
106018976|NCT03682770|365732693|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
106018977|NCT03682770|365732694|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
106018978|NCT03682770|365732695|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
106018979|NCT03682770|365732696|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
106018980|NCT03682770|365732697|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
106018981|NCT03682770|365732691|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
106018982|NCT03682770|365732692|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
106018983|NCT03682770|365732693|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
106018984|NCT03682770|365732694|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
106018985|NCT03682770|365732695|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
105821198|NCT02724462|365006528|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
106018986|NCT03682770|365732696|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
106018987|NCT03682770|365732697|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
106018988|NCT03682770|365732691|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
106018989|NCT03682770|365732692|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
106018990|NCT03682770|365732693|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
106018991|NCT03682770|365732694|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
106018992|NCT03682770|365732695|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
106018993|NCT03682770|365732696|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
105821199|NCT02724462|365006527|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
105821200|NCT02724462|365006528|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
105821201|NCT02724462|365006527|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
105821202|NCT02724462|365006528|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
105821203|NCT02724462|365006527|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
105821204|NCT02724462|365006528|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
105821205|NCT01900691|365006529|FG000|Overall Study|Death|7|||
105821206|NCT01900691|365006529|FG000|Overall Study|Lost to Follow-up|4|||
105821207|NCT01900691|365006529|FG000|Overall Study|Study Device Not Placed|3|||
105821208|NCT01900691|365006529|FG000|Overall Study|Non study stent placed|2|||
105821209|NCT01900691|365006529|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
105821210|NCT01900691|365006529|FG000|Overall Study|Complete stent migration through digestive tract|1|||
105821211|NCT04089735|365006530|FG000|Overall Study|Adverse Event|1|||
105821212|NCT04089735|365006531|FG001|Overall Study|Adverse Event|0|||
105821213|NCT04089735|365006532|FG002|Overall Study|Adverse Event|1|||
105821214|NCT04089735|365006533|FG003|Overall Study|Adverse Event|1|||
105821215|NCT04089735|365006534|FG004|Overall Study|Adverse Event|0|||
105821216|NCT04089735|365006535|FG005|Overall Study|Adverse Event|0|||
105821217|NCT04089735|365006530|FG000|Overall Study|Physician Decision|0|||
105821218|NCT04089735|365006531|FG001|Overall Study|Physician Decision|3|||
105821219|NCT04089735|365006532|FG002|Overall Study|Physician Decision|0|||
105821220|NCT04089735|365006533|FG003|Overall Study|Physician Decision|0|||
105821221|NCT04089735|365006534|FG004|Overall Study|Physician Decision|0|||
105821222|NCT04089735|365006535|FG005|Overall Study|Physician Decision|0|||
105821223|NCT04089735|365006530|FG000|Overall Study|Withdrawal by Subject|0|||
105821224|NCT04089735|365006531|FG001|Overall Study|Withdrawal by Subject|0|||
105821225|NCT04089735|365006532|FG002|Overall Study|Withdrawal by Subject|1|||
105821226|NCT04089735|365006533|FG003|Overall Study|Withdrawal by Subject|0|||
105821227|NCT04089735|365006534|FG004|Overall Study|Withdrawal by Subject|0|||
105821228|NCT04089735|365006535|FG005|Overall Study|Withdrawal by Subject|0|||
105821229|NCT04089735|365006530|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
105821230|NCT04089735|365006531|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
105821231|NCT04089735|365006532|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
105821232|NCT04089735|365006533|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
105821233|NCT04089735|365006534|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
105821234|NCT04089735|365006535|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
105821235|NCT02736721|365006540|FG000|Overall Study|Adverse Event|8|||
105821236|NCT02736721|365006540|FG000|Overall Study|Lost to Follow-up|3|||
105821237|NCT02736721|365006540|FG000|Overall Study|Other|5|||
105821238|NCT02422264|365006541|FG000|Overall Study|Serious Adverse Event|1|||
105821239|NCT02422264|365006542|FG001|Overall Study|Serious Adverse Event|0|||
105821240|NCT02422264|365006541|FG000|Overall Study|Withdrawal by Subject|1|||
105821241|NCT02422264|365006542|FG001|Overall Study|Withdrawal by Subject|2|||
105821242|NCT02422264|365006541|FG000|Overall Study|Migrated/moved from study area|3|||
105821243|NCT02422264|365006542|FG001|Overall Study|Migrated/moved from study area|1|||
105821244|NCT02422264|365006541|FG000|Overall Study|Subject vaccinated outside of the study|0|||
106018994|NCT03682770|365732697|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
106018995|NCT03682770|365732691|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
106018996|NCT03682770|365732692|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
106018997|NCT03682770|365732693|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
106018998|NCT03682770|365732694|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
106018999|NCT03682770|365732695|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
106019000|NCT03682770|365732696|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
106019001|NCT03682770|365732697|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
106019002|NCT03682770|365732691|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
106019003|NCT03682770|365732692|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
106019004|NCT03682770|365732693|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
106019005|NCT03682770|365732694|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
105821245|NCT02422264|365006542|FG001|Overall Study|Subject vaccinated outside of the study|1|||
105821246|NCT00934050|365006547|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
105821247|NCT00934050|365006548|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
105821248|NCT00934050|365006549|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
105821249|NCT00934050|365006550|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
106019006|NCT03682770|365732695|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
105821250|NCT00934050|365006551|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
105821251|NCT00934050|365006552|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
106019007|NCT03682770|365732696|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
106019008|NCT03682770|365732697|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
105821252|NCT00934050|365006547|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
105821253|NCT00934050|365006548|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
105821254|NCT00934050|365006549|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
105821255|NCT00934050|365006550|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
105821256|NCT00934050|365006551|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
105821257|NCT00934050|365006552|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
105821258|NCT00934050|365006547|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821259|NCT00934050|365006548|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821260|NCT00934050|365006549|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
105821261|NCT00934050|365006550|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821262|NCT00934050|365006551|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821263|NCT00934050|365006552|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
105821264|NCT00934050|365006547|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821265|NCT00934050|365006548|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821266|NCT00934050|365006549|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821267|NCT00934050|365006550|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821268|NCT00934050|365006551|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
105821269|NCT00934050|365006552|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
105821270|NCT00934050|365006547|FG000|Enrolled After 15 Dec 2009|Death|0|||
105821271|NCT00934050|365006548|FG001|Enrolled After 15 Dec 2009|Death|0|||
105821272|NCT00934050|365006549|FG002|Enrolled After 15 Dec 2009|Death|0|||
105821273|NCT00934050|365006550|FG003|Enrolled After 15 Dec 2009|Death|0|||
105821274|NCT00934050|365006551|FG004|Enrolled After 15 Dec 2009|Death|0|||
105821275|NCT00934050|365006552|FG005|Enrolled After 15 Dec 2009|Death|1|||
105821276|NCT00934050|365006547|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105821277|NCT00934050|365006548|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105821278|NCT00934050|365006549|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
106019009|NCT03682770|365732691|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
105821279|NCT00934050|365006550|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105821280|NCT00934050|365006551|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
105821281|NCT00934050|365006552|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
105821282|NCT00934050|365006547|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
105956927|NCT02012218|365502921|FG000|Overall Study|Protocol Specified|1|||
105956928|NCT02012218|365502922|FG001|Overall Study|Protocol Specified|0|||
105956929|NCT02012218|365502923|FG002|Overall Study|Protocol Specified|0|||
105956930|NCT02012218|365502924|FG003|Overall Study|Protocol Specified|0|||
105956931|NCT02012218|365502925|FG004|Overall Study|Protocol Specified|0|||
105956932|NCT02012218|365502921|FG000|Overall Study|Protocol Deviation|1|||
105956933|NCT02012218|365502922|FG001|Overall Study|Protocol Deviation|0|||
105956934|NCT02012218|365502923|FG002|Overall Study|Protocol Deviation|0|||
105956935|NCT02012218|365502924|FG003|Overall Study|Protocol Deviation|0|||
105956936|NCT02012218|365502925|FG004|Overall Study|Protocol Deviation|0|||
105956937|NCT01232127|365502926|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
105956938|NCT01232127|365502927|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
105956939|NCT01232127|365502928|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
105956940|NCT02709720|365502932|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
105956941|NCT02709720|365502932|FG000|Overall Study|Protocol Violation|1|||
105956942|NCT02709720|365502932|FG000|Overall Study|Not take study medication|1|||
105956943|NCT01451749|365502933|FG000|Overall Study|Protocol Violation|14|||
105956944|NCT01451749|365502934|FG001|Overall Study|Protocol Violation|7|||
105956945|NCT01451749|365502933|FG000|Overall Study|Lost to Follow-up|15|||
105956946|NCT01451749|365502934|FG001|Overall Study|Lost to Follow-up|5|||
105956947|NCT01451749|365502933|FG000|Overall Study|Meet the exclusion criteria,and|1|||
105956948|NCT01451749|365502934|FG001|Overall Study|Meet the exclusion criteria,and|1|||
105956949|NCT01451749|365502933|FG000|Overall Study|Adverse Event|2|||
105956950|NCT01451749|365502934|FG001|Overall Study|Adverse Event|0|||
105956951|NCT01451749|365502933|FG000|Overall Study|Withdrawal by Subject|0|||
105956952|NCT01451749|365502934|FG001|Overall Study|Withdrawal by Subject|1|||
105956953|NCT01265992|365502935|FG000|Overall Study|Lost to Follow-up|1|||
105956954|NCT01265992|365502935|FG000|Overall Study|Withdrawal by Subject|1|||
105956955|NCT01265992|365502935|FG000|Overall Study|Adverse Event|1|||
105956956|NCT01265992|365502935|FG000|Overall Study|Administrative reasons|2|||
105956957|NCT01265992|365502935|FG000|Overall Study|Stopped treatment|3|||
105956958|NCT01265992|365502935|FG000|Overall Study|Did not receive treatment|1|||
105821283|NCT00934050|365006548|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
105821284|NCT00934050|365006549|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
105821285|NCT00934050|365006550|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
105821286|NCT00934050|365006551|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
105956959|NCT01198574|365502964|FG000|Overall Study|Resigned from schools|4|||
105956960|NCT01198574|365502965|FG001|Overall Study|Resigned from schools|1|||
105956961|NCT01198574|365502966|FG002|Overall Study|Resigned from schools|1|||
105956962|NCT01198574|365502967|FG003|Overall Study|Resigned from schools|4|||
105956963|NCT01837680|365502968|FG000|Overall Study|Lost to Follow-up|2|||
105956964|NCT01837680|365502969|FG001|Overall Study|Lost to Follow-up|2|||
105821287|NCT00934050|365006552|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
105821288|NCT00461786|365006553|FG000|Overall Study|Entry Criteria Not Met|2|||
105821289|NCT00461786|365006553|FG000|Overall Study|Inevaluable (Never Treated)|1|||
105821290|NCT00835991|365006554|FG000|First Intervention|Adverse Event|0|||
105821291|NCT00835991|365006555|FG001|First Intervention|Adverse Event|1|||
105821292|NCT00835991|365006554|FG000|Washout|Protocol Violation|0|||
105821293|NCT00835991|365006555|FG001|Washout|Protocol Violation|2|||
105821294|NCT00835991|365006554|FG000|Washout|Withdrawal by Subject|3|||
105821295|NCT00835991|365006555|FG001|Washout|Withdrawal by Subject|1|||
105821296|NCT02149420|365006556|FG000|Core Study|Administrative problems|0|||
105821297|NCT02149420|365006557|FG001|Core Study|Administrative problems|1|||
105821298|NCT02149420|365006558|FG002|Core Study|Administrative problems|2|||
105821299|NCT02149420|365006556|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
105821300|NCT02149420|365006557|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
105821301|NCT02149420|365006558|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
105821302|NCT00829673|365006559|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105821303|NCT00829673|365006560|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105821304|NCT02378935|365006561|FG000|Overall Study|Lack of Efficacy|10|||
105821305|NCT02378935|365006562|FG001|Overall Study|Lack of Efficacy|0|||
105821306|NCT02378935|365006563|FG002|Overall Study|Lack of Efficacy|2|||
105821307|NCT02378935|365006564|FG003|Overall Study|Lack of Efficacy|6|||
105821308|NCT02378935|365006565|FG004|Overall Study|Lack of Efficacy|0|||
105821309|NCT02378935|365006566|FG005|Overall Study|Lack of Efficacy|0|||
105821310|NCT02378935|365006567|FG006|Overall Study|Lack of Efficacy|0|||
105821311|NCT02378935|365006561|FG000|Overall Study|Death|0|||
105821312|NCT02378935|365006562|FG001|Overall Study|Death|0|||
105821313|NCT02378935|365006563|FG002|Overall Study|Death|1|||
105821314|NCT02378935|365006564|FG003|Overall Study|Death|0|||
105821315|NCT02378935|365006565|FG004|Overall Study|Death|0|||
105821316|NCT02378935|365006566|FG005|Overall Study|Death|0|||
105821317|NCT02378935|365006567|FG006|Overall Study|Death|0|||
105821318|NCT01015703|365006570|FG000|Overall Study|Withdrawal by Subject|0|||
105821319|NCT01015703|365006571|FG001|Overall Study|Withdrawal by Subject|1|||
105821320|NCT01015703|365006572|FG002|Overall Study|Withdrawal by Subject|0|||
105821321|NCT01015703|365006573|FG003|Overall Study|Withdrawal by Subject|0|||
105821322|NCT01015703|365006574|FG004|Overall Study|Withdrawal by Subject|0|||
105821323|NCT01015703|365006570|FG000|Overall Study|Adverse Event|1|||
105821324|NCT01015703|365006571|FG001|Overall Study|Adverse Event|0|||
105821325|NCT01015703|365006572|FG002|Overall Study|Adverse Event|0|||
105821326|NCT01015703|365006573|FG003|Overall Study|Adverse Event|0|||
105821327|NCT01015703|365006574|FG004|Overall Study|Adverse Event|0|||
105821328|NCT01015703|365006570|FG000|Overall Study|Protocol Violation|1|||
105821329|NCT01015703|365006571|FG001|Overall Study|Protocol Violation|0|||
105821330|NCT01015703|365006572|FG002|Overall Study|Protocol Violation|0|||
105821331|NCT01015703|365006573|FG003|Overall Study|Protocol Violation|0|||
105821332|NCT01015703|365006574|FG004|Overall Study|Protocol Violation|0|||
105821333|NCT00627016|365006575|FG000|Overall Study|Adverse Event|1|||
105821334|NCT00627016|365006576|FG001|Overall Study|Adverse Event|1|||
105821335|NCT00627016|365006575|FG000|Overall Study|Protocol Violation|0|||
105821336|NCT00627016|365006576|FG001|Overall Study|Protocol Violation|2|||
105821337|NCT00627016|365006575|FG000|Overall Study|Lost to Follow-up|0|||
105821338|NCT00627016|365006576|FG001|Overall Study|Lost to Follow-up|1|||
105821339|NCT00627016|365006575|FG000|Overall Study|Withdrawal by Subject|2|||
105821340|NCT00627016|365006576|FG001|Overall Study|Withdrawal by Subject|1|||
105821341|NCT00627016|365006575|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
105821342|NCT00627016|365006576|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
105821343|NCT00627016|365006575|FG000|Overall Study|Lack of Efficacy|1|||
105821344|NCT00627016|365006576|FG001|Overall Study|Lack of Efficacy|0|||
105821345|NCT00627016|365006575|FG000|Overall Study|Placed on Excluded Drugs|1|||
105821346|NCT00627016|365006576|FG001|Overall Study|Placed on Excluded Drugs|0|||
105821347|NCT00627016|365006575|FG000|Overall Study|Pregnancy|1|||
105821348|NCT00627016|365006576|FG001|Overall Study|Pregnancy|0|||
105821349|NCT01534663|365006577|FG000|Overall Study|Lost to Follow-up|0|||
105956965|NCT01837680|365502968|FG000|Overall Study|lack of insurance|0|||
105956966|NCT01837680|365502969|FG001|Overall Study|lack of insurance|2|||
105956967|NCT01837680|365502968|FG000|Overall Study|allergic reaction|6|||
105956968|NCT01837680|365502969|FG001|Overall Study|allergic reaction|0|||
105956969|NCT01837680|365502968|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
105956970|NCT01837680|365502969|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
105956971|NCT03533660|365502970|FG000|Overall Study|Withdrawal by Subject|2|||
105821350|NCT01534663|365006578|FG001|Overall Study|Lost to Follow-up|2|||
105821351|NCT01534663|365006577|FG000|Overall Study|Adverse Event|2|||
105821352|NCT01534663|365006578|FG001|Overall Study|Adverse Event|1|||
105821353|NCT02718326|365006579|FG000|Overall Study|Adverse Event|4|||
105821354|NCT02718326|365006580|FG001|Overall Study|Adverse Event|9|||
105821355|NCT02718326|365006581|FG002|Overall Study|Adverse Event|0|||
105821356|NCT02718326|365006579|FG000|Overall Study|Death|8|||
105821357|NCT02718326|365006580|FG001|Overall Study|Death|1|||
105821358|NCT02718326|365006581|FG002|Overall Study|Death|2|||
106019010|NCT03682770|365732692|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
106019011|NCT03682770|365732693|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
106019012|NCT03682770|365732694|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
106019013|NCT03682770|365732695|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
106019014|NCT03682770|365732696|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
106019015|NCT03682770|365732697|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
106019016|NCT03682770|365732691|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
106019017|NCT03682770|365732692|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
106019018|NCT03682770|365732693|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
106019019|NCT03682770|365732694|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
106019020|NCT03682770|365732695|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
106019021|NCT03682770|365732696|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
106019022|NCT03682770|365732697|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
106019023|NCT03682770|365732691|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
106019024|NCT03682770|365732692|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
106019025|NCT03682770|365732693|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
106019026|NCT03682770|365732694|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
106019027|NCT03682770|365732695|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
106019028|NCT03682770|365732696|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
106019029|NCT03682770|365732697|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
106019030|NCT03682770|365732691|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
106019031|NCT03682770|365732692|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
106019032|NCT03682770|365732693|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
106019033|NCT03682770|365732694|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
106019034|NCT03682770|365732695|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
106019035|NCT03682770|365732696|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
106019036|NCT03682770|365732697|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
106019037|NCT02362282|365732698|FG000|Overall Study|Withdrawal by Subject|1|||
106019038|NCT02362282|365732699|FG001|Overall Study|Withdrawal by Subject|0|||
106019039|NCT04085289|365732700|FG000|Overall Study|Withdrawal by Subject|0|||
106019040|NCT04085289|365732701|FG001|Overall Study|Withdrawal by Subject|0|||
106019041|NCT04085289|365732702|FG002|Overall Study|Withdrawal by Subject|1|||
106019042|NCT01216189|365732714|FG000|Overall Study|Lost to Follow-up|21|||
106019043|NCT01216189|365732715|FG001|Overall Study|Lost to Follow-up|3|||
106019044|NCT01216189|365732714|FG000|Overall Study|Death|4|||
106019045|NCT01216189|365732715|FG001|Overall Study|Death|2|||
106019046|NCT01301027|365732718|FG000|Overall Study|Physician Decision|2|||
106019047|NCT01301027|365732719|FG001|Overall Study|Physician Decision|0|||
106019048|NCT01301027|365732718|FG000|Overall Study|Withdrawal by Subject|2|||
106019049|NCT01301027|365732719|FG001|Overall Study|Withdrawal by Subject|3|||
106019050|NCT01301027|365732718|FG000|Overall Study|Adverse Event|0|||
106019051|NCT01301027|365732719|FG001|Overall Study|Adverse Event|2|||
106019052|NCT01301027|365732718|FG000|Overall Study|Fracture|1|||
106019053|NCT01301027|365732719|FG001|Overall Study|Fracture|3|||
106019054|NCT01301027|365732718|FG000|Overall Study|Transplant|0|||
106019055|NCT01301027|365732719|FG001|Overall Study|Transplant|2|||
106019056|NCT01301027|365732718|FG000|Overall Study|Volume Overload|3|||
106019057|NCT01301027|365732719|FG001|Overall Study|Volume Overload|0|||
106019058|NCT00541385|365732720|FG000|Overall Study|Adverse Event|6|||
105821359|NCT02718326|365006579|FG000|Overall Study|Withdrawal by Subject|4|||
105821360|NCT02718326|365006580|FG001|Overall Study|Withdrawal by Subject|9|||
105821361|NCT02718326|365006581|FG002|Overall Study|Withdrawal by Subject|6|||
105821362|NCT02718326|365006579|FG000|Overall Study|Lost to Follow-up|18|||
105821363|NCT02718326|365006580|FG001|Overall Study|Lost to Follow-up|5|||
105821364|NCT02718326|365006581|FG002|Overall Study|Lost to Follow-up|14|||
105821365|NCT02718326|365006579|FG000|Overall Study|Protocol Deviation|1|||
105821366|NCT02718326|365006580|FG001|Overall Study|Protocol Deviation|0|||
105821367|NCT02718326|365006581|FG002|Overall Study|Protocol Deviation|0|||
106019059|NCT00541385|365732721|FG001|Overall Study|Adverse Event|3|||
105821368|NCT02718326|365006579|FG000|Overall Study|Pregnancy|1|||
105821369|NCT02718326|365006580|FG001|Overall Study|Pregnancy|0|||
105821370|NCT02718326|365006581|FG002|Overall Study|Pregnancy|0|||
105821371|NCT00377260|365006583|FG000|Overall Study|Lost to Follow-up|0|||
105821372|NCT00377260|365006584|FG001|Overall Study|Lost to Follow-up|1|||
106019060|NCT00541385|365732720|FG000|Overall Study|Withdrawal by Subject|2|||
105821373|NCT00377260|365006583|FG000|Overall Study|Withdrawal by Subject|2|||
106019061|NCT00541385|365732721|FG001|Overall Study|Withdrawal by Subject|2|||
106019062|NCT00541385|365732720|FG000|Overall Study|Lost to Follow-up|6|||
105821374|NCT00377260|365006584|FG001|Overall Study|Withdrawal by Subject|4|||
105821375|NCT03154047|365006585|FG000|Overall Study|Death|1|||
105821376|NCT03154047|365006585|FG000|Overall Study|Study terminated by sponsor|76|||
105821377|NCT03154047|365006585|FG000|Overall Study|Withdrawal by Subject|3|||
105821378|NCT02436005|365006586|FG000|Second Intervention|Adverse Event|0|||
105821379|NCT02436005|365006587|FG001|Second Intervention|Adverse Event|1|||
105821380|NCT01558635|365006588|FG000|Overall Study|Death|1|||
105821381|NCT01558635|365006588|FG000|Overall Study|Withdrawal by Subject|2|||
106019063|NCT00541385|365732721|FG001|Overall Study|Lost to Follow-up|1|||
106019064|NCT00541385|365732720|FG000|Overall Study|Parasite reappearance/malaria|67|||
106019065|NCT00541385|365732721|FG001|Overall Study|Parasite reappearance/malaria|32|||
106019066|NCT01469377|365732722|FG000|Overall Study|Protocol Deviation|7|||
106019067|NCT01469377|365732723|FG001|Overall Study|Protocol Deviation|10|||
106019068|NCT01469377|365732724|FG002|Overall Study|Protocol Deviation|10|||
106019069|NCT01469377|365732722|FG000|Overall Study|Lost to Follow-up|3|||
106019070|NCT01469377|365732723|FG001|Overall Study|Lost to Follow-up|2|||
106019071|NCT01469377|365732724|FG002|Overall Study|Lost to Follow-up|5|||
106019072|NCT01469377|365732722|FG000|Overall Study|Withdrawal of Consent|12|||
106019073|NCT01469377|365732723|FG001|Overall Study|Withdrawal of Consent|14|||
106019074|NCT01469377|365732724|FG002|Overall Study|Withdrawal of Consent|15|||
106019075|NCT01469377|365732722|FG000|Overall Study|Adverse Event|8|||
106019076|NCT01469377|365732723|FG001|Overall Study|Adverse Event|18|||
106019077|NCT01469377|365732724|FG002|Overall Study|Adverse Event|36|||
106019078|NCT01469377|365732722|FG000|Overall Study|Insufficient Therapeutic Response|3|||
106019079|NCT01469377|365732723|FG001|Overall Study|Insufficient Therapeutic Response|4|||
106019080|NCT01469377|365732724|FG002|Overall Study|Insufficient Therapeutic Response|0|||
106019081|NCT01469377|365732722|FG000|Overall Study|Other Miscellaneous Reasons|2|||
106019082|NCT01469377|365732723|FG001|Overall Study|Other Miscellaneous Reasons|0|||
106019083|NCT01469377|365732724|FG002|Overall Study|Other Miscellaneous Reasons|0|||
106019084|NCT01733680|365732725|FG000|Overall Study|Withdrawal by Subject|0|||
106019085|NCT01733680|365732726|FG001|Overall Study|Withdrawal by Subject|1|||
106019086|NCT00074490|365732727|FG000|Overall Study|Progressive malignancy|0|||
106019087|NCT00074490|365732728|FG001|Overall Study|Progressive malignancy|7|||
106019088|NCT00074490|365732729|FG002|Overall Study|Progressive malignancy|0|||
106019089|NCT00074490|365732730|FG003|Overall Study|Progressive malignancy|0|||
106019090|NCT00074490|365732731|FG004|Overall Study|Progressive malignancy|3|||
106019091|NCT00074490|365732732|FG005|Overall Study|Progressive malignancy|0|||
106019092|NCT02722499|365732733|FG000|Overall Study|Lost to Follow-up|2|||
106019093|NCT02722499|365732734|FG001|Overall Study|Lost to Follow-up|0|||
106019094|NCT02722499|365732735|FG002|Overall Study|Lost to Follow-up|1|||
106019095|NCT03566485|365732736|FG000|Overall Study|Disease progression|5|||
106019096|NCT03566485|365732737|FG001|Overall Study|Disease progression|4|||
106019097|NCT03566485|365732736|FG000|Overall Study|Clinical progression|0|||
106019098|NCT03566485|365732737|FG001|Overall Study|Clinical progression|1|||
106019099|NCT03566485|365732736|FG000|Overall Study|Toxicity|0|||
106019100|NCT03566485|365732737|FG001|Overall Study|Toxicity|2|||
106019101|NCT04269889|365732740|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
106019102|NCT01354314|365732745|FG000|Overall Study|Lost to Follow-up|1|||
106019103|NCT01354314|365732746|FG001|Overall Study|Lost to Follow-up|0|||
106019104|NCT01354314|365732747|FG002|Overall Study|Lost to Follow-up|1|||
106019105|NCT01354314|365732748|FG003|Overall Study|Lost to Follow-up|1|||
106019106|NCT01354314|365732745|FG000|Overall Study|Withdrawal by Subject|0|||
106019107|NCT01354314|365732746|FG001|Overall Study|Withdrawal by Subject|0|||
106019108|NCT01354314|365732747|FG002|Overall Study|Withdrawal by Subject|1|||
106019109|NCT01354314|365732748|FG003|Overall Study|Withdrawal by Subject|0|||
106019110|NCT01354314|365732745|FG000|Overall Study|Adverse Event|0|||
106019111|NCT01354314|365732746|FG001|Overall Study|Adverse Event|0|||
106019112|NCT01354314|365732747|FG002|Overall Study|Adverse Event|0|||
106019113|NCT01354314|365732748|FG003|Overall Study|Adverse Event|1|||
106019114|NCT01354314|365732745|FG000|Overall Study|Protocol Violation|1|||
106019115|NCT01354314|365732746|FG001|Overall Study|Protocol Violation|1|||
106019116|NCT01354314|365732747|FG002|Overall Study|Protocol Violation|0|||
106145532|NCT00835770|366193108|FG000|Overall Study|Adverse Event|113|||
106145533|NCT00835770|366193109|FG001|Overall Study|Adverse Event|124|||
106019117|NCT01354314|365732748|FG003|Overall Study|Protocol Violation|0|||
106019118|NCT01354314|365732745|FG000|Overall Study|Less than 90% Adherence|4|||
106019119|NCT01354314|365732746|FG001|Overall Study|Less than 90% Adherence|2|||
106019120|NCT01354314|365732747|FG002|Overall Study|Less than 90% Adherence|6|||
106019121|NCT01354314|365732748|FG003|Overall Study|Less than 90% Adherence|4|||
106019122|NCT00478023|365732750|FG000|Overall Study|Adverse Event|11|||
106019123|NCT00478023|365732751|FG001|Overall Study|Adverse Event|7|||
106019124|NCT00478023|365732752|FG002|Overall Study|Adverse Event|8|||
106019125|NCT00478023|365732753|FG003|Overall Study|Adverse Event|14|||
106019126|NCT00478023|365732754|FG004|Overall Study|Adverse Event|6|||
106145534|NCT00835770|366193108|FG000|Overall Study|Lost to Follow-up|22|||
105821382|NCT01558635|365006588|FG000|Overall Study|Physician Decision|1|||
106019127|NCT00478023|365732750|FG000|Overall Study|Death|1|||
106019128|NCT00478023|365732751|FG001|Overall Study|Death|0|||
106019129|NCT00478023|365732752|FG002|Overall Study|Death|0|||
106019130|NCT00478023|365732753|FG003|Overall Study|Death|0|||
106019131|NCT00478023|365732754|FG004|Overall Study|Death|0|||
106019132|NCT00478023|365732750|FG000|Overall Study|Lack of Efficacy|11|||
106019133|NCT00478023|365732751|FG001|Overall Study|Lack of Efficacy|10|||
106019134|NCT00478023|365732752|FG002|Overall Study|Lack of Efficacy|4|||
106019135|NCT00478023|365732753|FG003|Overall Study|Lack of Efficacy|5|||
106019136|NCT00478023|365732754|FG004|Overall Study|Lack of Efficacy|41|||
106019137|NCT00478023|365732750|FG000|Overall Study|Lost to Follow-up|3|||
106019138|NCT00478023|365732751|FG001|Overall Study|Lost to Follow-up|1|||
106019139|NCT00478023|365732752|FG002|Overall Study|Lost to Follow-up|1|||
106019140|NCT00478023|365732753|FG003|Overall Study|Lost to Follow-up|1|||
106019141|NCT00478023|365732754|FG004|Overall Study|Lost to Follow-up|0|||
106019142|NCT00478023|365732750|FG000|Overall Study|Withdrawal by Subject|2|||
106019143|NCT00478023|365732751|FG001|Overall Study|Withdrawal by Subject|3|||
106019144|NCT00478023|365732752|FG002|Overall Study|Withdrawal by Subject|2|||
106019145|NCT00478023|365732753|FG003|Overall Study|Withdrawal by Subject|4|||
106019146|NCT00478023|365732754|FG004|Overall Study|Withdrawal by Subject|5|||
106019147|NCT00478023|365732750|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
106019148|NCT00478023|365732751|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
106019149|NCT00478023|365732752|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
106019150|NCT00478023|365732753|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
106019151|NCT00478023|365732754|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
106019152|NCT00369265|365732756|FG000|Overall Study|Study terminated|4|||
106019153|NCT00369265|365732757|FG001|Overall Study|Study terminated|7|||
106019154|NCT00714870|365732758|FG000|Overall Study|Lost to Follow-up|22|||
106019155|NCT00714870|365732759|FG001|Overall Study|Lost to Follow-up|5|||
106019156|NCT00714870|365732758|FG000|Overall Study|patient unable to come b/c back pain|1|||
106019157|NCT00714870|365732759|FG001|Overall Study|patient unable to come b/c back pain|0|||
106019158|NCT00714870|365732758|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
106019159|NCT00714870|365732759|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
106019160|NCT03399552|365732760|FG000|Overall Study|No evidence of disease|1|||
106019161|NCT03399552|365732760|FG000|Overall Study|Unevaluable|1|||
106019162|NCT00611026|365732763|FG000|Randomized to Double-blind Treatment|Not treated|2|||
106019163|NCT00611026|365732764|FG001|Randomized to Double-blind Treatment|Not treated|1|||
106019164|NCT00611026|365732765|FG002|Randomized to Double-blind Treatment|Not treated|3|||
106019165|NCT00611026|365732763|FG000|Double-blind Treatment Period|Death|1|||
106019166|NCT00611026|365732764|FG001|Double-blind Treatment Period|Death|0|||
106145535|NCT00835770|366193109|FG001|Overall Study|Lost to Follow-up|19|||
105821383|NCT01558635|365006588|FG000|Overall Study|Subject received other treatment|1|||
106019167|NCT00611026|365732765|FG002|Double-blind Treatment Period|Death|0|||
106019168|NCT00611026|365732763|FG000|Double-blind Treatment Period|Adverse Event|9|||
106019169|NCT00611026|365732764|FG001|Double-blind Treatment Period|Adverse Event|28|||
106019170|NCT00611026|365732765|FG002|Double-blind Treatment Period|Adverse Event|46|||
106019171|NCT00611026|365732763|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
106019172|NCT00611026|365732764|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
106019173|NCT00611026|365732765|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
106019174|NCT00611026|365732763|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
106019175|NCT00611026|365732764|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
106019176|NCT00611026|365732765|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
106019177|NCT00611026|365732763|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
106019178|NCT00611026|365732764|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
106019179|NCT00611026|365732765|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
106019180|NCT00611026|365732763|FG000|Double-blind Treatment Period|Other|13|||
106019181|NCT00611026|365732764|FG001|Double-blind Treatment Period|Other|20|||
106019182|NCT00611026|365732765|FG002|Double-blind Treatment Period|Other|18|||
106019183|NCT00760617|365732766|FG000|Overall Study|Adverse Event|5|||
106019184|NCT00760617|365732767|FG001|Overall Study|Adverse Event|2|||
106019185|NCT00760617|365732768|FG002|Overall Study|Adverse Event|0|||
106019186|NCT00760617|365732766|FG000|Overall Study|Lost to Follow-up|0|||
106019187|NCT00760617|365732767|FG001|Overall Study|Lost to Follow-up|0|||
106019188|NCT00760617|365732768|FG002|Overall Study|Lost to Follow-up|5|||
106019189|NCT02991040|365732769|FG000|Overall Study|Withdrawal by Subject|2|||
106019190|NCT02991040|365732769|FG000|Overall Study|Lost to Follow-up|2|||
105821384|NCT01558635|365006588|FG000|Overall Study|Reveal XT was explanted|1|||
105821385|NCT00448019|365006594|FG000|Overall Study|Withdrawal by Subject|3|||
105821386|NCT00448019|365006594|FG000|Overall Study|Disease progression|1|||
106019191|NCT00396253|365732778|FG000|Overall Study|Protocol Violation|1|||
106019192|NCT00396253|365732778|FG000|Overall Study|Withdrawal by Subject|7|||
106019193|NCT00396253|365732778|FG000|Overall Study|Death|3|||
106019194|NCT00396253|365732778|FG000|Overall Study|Physician Decision|1|||
106019195|NCT00396253|365732778|FG000|Overall Study|Change in eligibility status|1|||
106019196|NCT04200352|365732786|FG000|Overall Study|Death|1|||
106019197|NCT04200352|365732786|FG000|Overall Study|Adverse Event|6|||
106019198|NCT04200352|365732786|FG000|Overall Study|Withdrawal by parent/guardian|6|||
106019199|NCT04200352|365732786|FG000|Overall Study|Lack of Efficacy|1|||
106019200|NCT04200352|365732786|FG000|Overall Study|Other than specified|6|||
106145536|NCT00835770|366193108|FG000|Overall Study|Consent Withdrawn|144|||
106145537|NCT00835770|366193109|FG001|Overall Study|Consent Withdrawn|156|||
106145538|NCT00835770|366193108|FG000|Overall Study|Investigator Decision|42|||
106019201|NCT00828204|365732787|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
106019202|NCT00828204|365732788|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
106019203|NCT00828204|365732787|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
106019204|NCT00828204|365732788|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
106019205|NCT00828204|365732787|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
106019206|NCT00828204|365732788|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
106019207|NCT00828204|365732787|FG000|Main Study: After Study Restart|Adverse Event|0|||
106019208|NCT00828204|365732788|FG001|Main Study: After Study Restart|Adverse Event|2|||
106019209|NCT00828204|365732787|FG000|Main Study: After Study Restart|Noncompliance|0|||
106019210|NCT00828204|365732788|FG001|Main Study: After Study Restart|Noncompliance|1|||
106019211|NCT00828204|365732787|FG000|Extension Study|Lost to Follow-up|0|||
106019212|NCT00828204|365732788|FG001|Extension Study|Lost to Follow-up|1|||
106019213|NCT00828204|365732787|FG000|Extension Study|Physician Decision|0|||
106019214|NCT00828204|365732788|FG001|Extension Study|Physician Decision|2|||
106019215|NCT02447003|365732789|FG000|Overall Study|Other|0|||
106019216|NCT02447003|365732790|FG001|Overall Study|Other|4|||
106019217|NCT02447003|365732789|FG000|Overall Study|Site discontinued|0|||
106019218|NCT02447003|365732790|FG001|Overall Study|Site discontinued|2|||
106019219|NCT02447003|365732789|FG000|Overall Study|Physician Decision|0|||
106019220|NCT02447003|365732790|FG001|Overall Study|Physician Decision|1|||
106019221|NCT02447003|365732789|FG000|Overall Study|Withdrawal by Subject|4|||
106019222|NCT02447003|365732790|FG001|Overall Study|Withdrawal by Subject|3|||
106019223|NCT02447003|365732789|FG000|Overall Study|Sponsor Decision|6|||
106019224|NCT02447003|365732790|FG001|Overall Study|Sponsor Decision|11|||
106019225|NCT02447003|365732789|FG000|Overall Study|Progressive Disease|1|||
106019226|NCT02447003|365732790|FG001|Overall Study|Progressive Disease|0|||
106019227|NCT02447003|365732789|FG000|Overall Study|Lost to Follow-up|5|||
106019228|NCT02447003|365732790|FG001|Overall Study|Lost to Follow-up|0|||
106019229|NCT02447003|365732789|FG000|Overall Study|Death|154|||
106019230|NCT02447003|365732790|FG001|Overall Study|Death|63|||
106019231|NCT00233064|365732793|FG000|Overall Study|Lost to Follow-up|7|||
106019232|NCT00233064|365732794|FG001|Overall Study|Lost to Follow-up|7|||
106019233|NCT00233064|365732793|FG000|Overall Study|Withdrawal by Subject|5|||
106019234|NCT00233064|365732794|FG001|Overall Study|Withdrawal by Subject|3|||
106019235|NCT00233064|365732793|FG000|Overall Study|Death|0|||
106019236|NCT00233064|365732794|FG001|Overall Study|Death|1|||
106019237|NCT00233064|365732793|FG000|Overall Study|Relocation|0|||
106019238|NCT00233064|365732794|FG001|Overall Study|Relocation|1|||
106019239|NCT00233064|365732793|FG000|Overall Study|Protocol Violation|1|||
106019240|NCT00233064|365732794|FG001|Overall Study|Protocol Violation|0|||
106019241|NCT00233064|365732793|FG000|Overall Study|Moved to Dom. Republic|1|||
106019242|NCT00233064|365732794|FG001|Overall Study|Moved to Dom. Republic|0|||
106019243|NCT02302339|365732795|FG000|Overall Study|Lost to Follow-up|1|||
106019244|NCT02302339|365732796|FG001|Overall Study|Lost to Follow-up|0|||
106019245|NCT02302339|365732797|FG002|Overall Study|Lost to Follow-up|0|||
106019246|NCT02302339|365732798|FG003|Overall Study|Lost to Follow-up|0|||
106019247|NCT02302339|365732795|FG000|Overall Study|Withdrawal by Subject|0|||
105956972|NCT03533660|365502971|FG001|Overall Study|Withdrawal by Subject|2|||
105956973|NCT03533660|365502970|FG000|Overall Study|Death|2|||
105956974|NCT03533660|365502971|FG001|Overall Study|Death|4|||
105956975|NCT03533660|365502970|FG000|Overall Study|Adverse Event|0|||
105956976|NCT03533660|365502971|FG001|Overall Study|Adverse Event|2|||
105956977|NCT03008070|365502972|FG000|Overall Study|Adverse Event|3|||
105956978|NCT03008070|365502973|FG001|Overall Study|Adverse Event|3|||
105956979|NCT03008070|365502974|FG002|Overall Study|Adverse Event|3|||
105956980|NCT03008070|365502972|FG000|Overall Study|Lost to Follow-up|1|||
105956981|NCT03008070|365502973|FG001|Overall Study|Lost to Follow-up|1|||
105956982|NCT03008070|365502974|FG002|Overall Study|Lost to Follow-up|0|||
105956983|NCT03008070|365502972|FG000|Overall Study|Non compliance|0|||
105956984|NCT03008070|365502973|FG001|Overall Study|Non compliance|1|||
105956985|NCT03008070|365502974|FG002|Overall Study|Non compliance|1|||
105956986|NCT03008070|365502972|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
105956987|NCT03008070|365502973|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
105956988|NCT03008070|365502974|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
105956989|NCT03008070|365502972|FG000|Overall Study|Withdrawal by Subject|2|||
105956990|NCT03008070|365502973|FG001|Overall Study|Withdrawal by Subject|0|||
106019248|NCT02302339|365732796|FG001|Overall Study|Withdrawal by Subject|2|||
106019249|NCT02302339|365732797|FG002|Overall Study|Withdrawal by Subject|1|||
106019250|NCT02302339|365732798|FG003|Overall Study|Withdrawal by Subject|0|||
106019251|NCT01642589|365732806|FG000|Overall Study|Withdrawal by Subject|1|||
106019252|NCT01642589|365732807|FG001|Overall Study|Withdrawal by Subject|1|||
105956991|NCT03008070|365502974|FG002|Overall Study|Withdrawal by Subject|1|||
106019253|NCT01120964|365732808|FG000|Overall Study|Did not receive full treatment|1|||
105956992|NCT03008070|365502972|FG000|Overall Study|Use of prohibited drug|0|||
106019254|NCT01120964|365732809|FG001|Overall Study|Did not receive full treatment|0|||
106019255|NCT00472030|365732816|FG000|Overall Study|Physician Decision|1|||
106019256|NCT00472030|365732817|FG001|Overall Study|Physician Decision|0|||
106019257|NCT03212144|365732818|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
106019258|NCT03212144|365732819|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
106019259|NCT03212144|365732818|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
105766172|NCT00446797|364795997|FG000|Overall Study|subject entered at another site|0|||
105766173|NCT00446797|364795998|FG001|Overall Study|subject entered at another site|1|||
105766174|NCT00446797|364795997|FG000|Overall Study|did not meet entrance criteria|0|||
105766175|NCT00446797|364795998|FG001|Overall Study|did not meet entrance criteria|1|||
105766176|NCT00511108|364795999|FG000|Overall Study|Adverse Event|2|||
105766177|NCT00511108|364796000|FG001|Overall Study|Adverse Event|0|||
105766178|NCT00511108|364796001|FG002|Overall Study|Adverse Event|1|||
105766179|NCT00511108|364796002|FG003|Overall Study|Adverse Event|2|||
105766180|NCT00511108|364795999|FG000|Overall Study|Lost to Follow-up|0|||
105766181|NCT00511108|364796000|FG001|Overall Study|Lost to Follow-up|2|||
105766182|NCT00511108|364796001|FG002|Overall Study|Lost to Follow-up|1|||
105766183|NCT00511108|364796002|FG003|Overall Study|Lost to Follow-up|0|||
105766184|NCT00511108|364795999|FG000|Overall Study|Physician Decision|0|||
105766185|NCT00511108|364796000|FG001|Overall Study|Physician Decision|0|||
105766186|NCT00511108|364796001|FG002|Overall Study|Physician Decision|0|||
105766187|NCT00511108|364796002|FG003|Overall Study|Physician Decision|1|||
105766188|NCT00511108|364795999|FG000|Overall Study|Withdrawal by Subject|4|||
105766189|NCT00511108|364796000|FG001|Overall Study|Withdrawal by Subject|0|||
105766190|NCT00511108|364796001|FG002|Overall Study|Withdrawal by Subject|3|||
105766191|NCT00511108|364796002|FG003|Overall Study|Withdrawal by Subject|2|||
105766192|NCT02044822|364796003|FG000|Overall Study|Study Terminated by Sponsor|77|||
105766193|NCT02044822|364796003|FG000|Overall Study|Investigator's Discretion|10|||
105766194|NCT02044822|364796003|FG000|Overall Study|Withdrew Consent|3|||
105766195|NCT02044822|364796003|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
105766196|NCT02044822|364796003|FG000|Overall Study|Lost to Follow-up|1|||
105766197|NCT02147691|364796004|FG000|Overall Study|Withdrawal by Subject|2|||
105766198|NCT02147691|364796005|FG001|Overall Study|Withdrawal by Subject|0|||
105766199|NCT02147691|364796004|FG000|Overall Study|Adverse Event|2|||
105766200|NCT02147691|364796005|FG001|Overall Study|Adverse Event|0|||
105766201|NCT02147691|364796004|FG000|Overall Study|Lost to Follow-up|0|||
105766202|NCT02147691|364796005|FG001|Overall Study|Lost to Follow-up|1|||
105766203|NCT02025530|364796008|FG000|Overall Study|No longer met elligibility criteria|5|||
105766204|NCT02025530|364796009|FG001|Overall Study|No longer met elligibility criteria|1|||
105766205|NCT03417505|364796010|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
105766206|NCT03417505|364796011|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
105766207|NCT04211961|364796018|FG000|Overall Study|Death|0|||
105766208|NCT04211961|364796019|FG001|Overall Study|Death|1|||
105766209|NCT04211961|364796018|FG000|Overall Study|Lost to Follow-up|0|||
105766210|NCT04211961|364796019|FG001|Overall Study|Lost to Follow-up|1|||
105766211|NCT04211961|364796018|FG000|Overall Study|Withdrawal by Subject|0|||
105766212|NCT04211961|364796019|FG001|Overall Study|Withdrawal by Subject|1|||
105766213|NCT00420342|364796020|FG000|Overall Study|Lost to Follow-up|1|||
105766214|NCT00420342|364796021|FG001|Overall Study|Lost to Follow-up|0|||
105766215|NCT00420342|364796022|FG002|Overall Study|Lost to Follow-up|1|||
105766216|NCT00420342|364796020|FG000|Overall Study|Withdrawal by Subject|0|||
105766217|NCT00420342|364796021|FG001|Overall Study|Withdrawal by Subject|2|||
105766218|NCT00420342|364796022|FG002|Overall Study|Withdrawal by Subject|0|||
105766219|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
105766220|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766221|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766222|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766223|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766224|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
105766225|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
105766226|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766227|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766228|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766229|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766230|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
105766231|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
105766232|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766233|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766234|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766235|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766236|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
105766237|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
105766238|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
106019260|NCT03212144|365732819|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
105821387|NCT00448019|365006594|FG000|Overall Study|Death|2|||
105821388|NCT00448019|365006594|FG000|Overall Study|Insurance Issues|1|||
105821389|NCT02543203|365006595|FG000|Overall Study|Unpalatable Fragrance|2|||
105821390|NCT02543203|365006596|FG001|Overall Study|Unpalatable Fragrance|2|||
105821391|NCT02543203|365006595|FG000|Overall Study|Lost to Follow-up|1|||
105821392|NCT02543203|365006596|FG001|Overall Study|Lost to Follow-up|0|||
105821393|NCT02543203|365006595|FG000|Overall Study|Increased Irritability|1|||
105821394|NCT02543203|365006596|FG001|Overall Study|Increased Irritability|0|||
105821395|NCT02543203|365006595|FG000|Overall Study|Family|1|||
105821396|NCT02543203|365006596|FG001|Overall Study|Family|2|||
105821397|NCT02543203|365006595|FG000|Overall Study|Negative Behavior|1|||
105821398|NCT02543203|365006596|FG001|Overall Study|Negative Behavior|0|||
105821399|NCT02543203|365006595|FG000|Overall Study|Withdrawal by Subject|0|||
105821400|NCT02543203|365006596|FG001|Overall Study|Withdrawal by Subject|1|||
105821401|NCT00089661|365006597|FG000|Overall Study|Adverse Event|0|||
105821402|NCT00089661|365006598|FG001|Overall Study|Adverse Event|2|||
105821403|NCT00089661|365006597|FG000|Overall Study|Death|1|||
105821404|NCT00089661|365006598|FG001|Overall Study|Death|0|||
105821405|NCT00089661|365006597|FG000|Overall Study|Lost to Follow-up|0|||
105821406|NCT00089661|365006598|FG001|Overall Study|Lost to Follow-up|3|||
105821407|NCT00089661|365006597|FG000|Overall Study|Withdrawal by Subject|11|||
105956993|NCT03008070|365502973|FG001|Overall Study|Use of prohibited drug|0|||
106019261|NCT01185080|365732820|FG000|Overall Study|Adverse Event|1|||
106019262|NCT01185080|365732821|FG001|Overall Study|Adverse Event|1|||
106019263|NCT01185080|365732822|FG002|Overall Study|Adverse Event|0|||
106019264|NCT01185080|365732820|FG000|Overall Study|Personal reasons|0|||
106019265|NCT01185080|365732821|FG001|Overall Study|Personal reasons|0|||
105956994|NCT03008070|365502974|FG002|Overall Study|Use of prohibited drug|2|||
105956995|NCT05005273|365502977|FG000|Overall Study|Study Terminated|1|||
105956996|NCT05005273|365502978|FG001|Overall Study|Study Terminated|0|||
105956997|NCT00104728|365502979|FG000|Overall Study|screen failures|19|||
105956998|NCT01963767|365502980|FG000|Overall Study|Withdrawal by Subject|4|||
105956999|NCT01963767|365502981|FG001|Overall Study|Withdrawal by Subject|2|||
105957000|NCT01963767|365502980|FG000|Overall Study|Adverse Event|2|||
105957001|NCT01963767|365502981|FG001|Overall Study|Adverse Event|0|||
105957002|NCT02701764|365502982|FG000|Overall Study|Lost to Follow-up|0|||
105957003|NCT02701764|365502983|FG001|Overall Study|Lost to Follow-up|1|||
105957004|NCT00996658|365502987|FG000|Overall Study|Adverse Event|2|||
105957005|NCT00996658|365502988|FG001|Overall Study|Adverse Event|5|||
105957006|NCT00996658|365502987|FG000|Overall Study|Protocol Violation|0|||
105957007|NCT00996658|365502988|FG001|Overall Study|Protocol Violation|1|||
105957008|NCT00996658|365502987|FG000|Overall Study|Lost to Follow-up|2|||
105957009|NCT00996658|365502988|FG001|Overall Study|Lost to Follow-up|5|||
105957010|NCT00996658|365502987|FG000|Overall Study|Non-compliance issues|3|||
105957011|NCT00996658|365502988|FG001|Overall Study|Non-compliance issues|3|||
105957012|NCT00996658|365502987|FG000|Overall Study|Other|9|||
105957013|NCT00996658|365502988|FG001|Overall Study|Other|7|||
105957014|NCT02524145|365502990|FG000|Overall Study|Withdrawal by Subject|2|||
105957015|NCT02524145|365502991|FG001|Overall Study|Withdrawal by Subject|2|||
105957016|NCT02524145|365502992|FG002|Overall Study|Withdrawal by Subject|3|||
105957017|NCT03640325|365504417|FG000|Overall Study|Withdrawal by Subject|4|||
105957018|NCT03640325|365504418|FG001|Overall Study|Withdrawal by Subject|1|||
105957019|NCT03640325|365504419|FG002|Overall Study|Withdrawal by Subject|0|||
105957020|NCT03640325|365504417|FG000|Overall Study|Lost to Follow-up|4|||
105957021|NCT03640325|365504418|FG001|Overall Study|Lost to Follow-up|5|||
105957022|NCT03640325|365504419|FG002|Overall Study|Lost to Follow-up|21|||
105957023|NCT03640325|365504417|FG000|Overall Study|Death|5|||
105957024|NCT03640325|365504418|FG001|Overall Study|Death|5|||
105957025|NCT03640325|365504419|FG002|Overall Study|Death|0|||
105957026|NCT03276728|365504420|FG000|Overall Study|Lost to Follow-up|0|||
105957027|NCT03276728|365504421|FG001|Overall Study|Lost to Follow-up|0|||
105957028|NCT03276728|365504422|FG002|Overall Study|Lost to Follow-up|2|||
105957029|NCT03276728|365504423|FG003|Overall Study|Lost to Follow-up|2|||
105957030|NCT03276728|365504424|FG004|Overall Study|Lost to Follow-up|0|||
105957031|NCT03276728|365504425|FG005|Overall Study|Lost to Follow-up|0|||
105957032|NCT03276728|365504426|FG006|Overall Study|Lost to Follow-up|0|||
105957033|NCT03276728|365504427|FG007|Overall Study|Lost to Follow-up|0|||
105957034|NCT03276728|365504420|FG000|Overall Study|Withdrawal by Subject|0|||
105957035|NCT03276728|365504421|FG001|Overall Study|Withdrawal by Subject|0|||
105957036|NCT03276728|365504422|FG002|Overall Study|Withdrawal by Subject|0|||
105957037|NCT03276728|365504423|FG003|Overall Study|Withdrawal by Subject|3|||
106019266|NCT01185080|365732822|FG002|Overall Study|Personal reasons|1|||
106019267|NCT00802945|365732824|FG000|Overall Study|Death|27|||
106019268|NCT00802945|365732825|FG001|Overall Study|Death|23|||
105821408|NCT00089661|365006598|FG001|Overall Study|Withdrawal by Subject|9|||
105821409|NCT00089661|365006597|FG000|Overall Study|Disease progression|1|||
105821410|NCT00089661|365006598|FG001|Overall Study|Disease progression|3|||
105821411|NCT00089661|365006597|FG000|Overall Study|Ineligibility determined|4|||
105821412|NCT00089661|365006598|FG001|Overall Study|Ineligibility determined|4|||
106019269|NCT00802945|365732824|FG000|Overall Study|Terminated by sponsor|8|||
106019270|NCT00802945|365732825|FG001|Overall Study|Terminated by sponsor|12|||
106019271|NCT00494676|365732826|FG000|Allocation|Withdrawal by Subject|2|||
106019272|NCT00494676|365732827|FG001|Allocation|Withdrawal by Subject|4|||
106019273|NCT00494676|365732826|FG000|First Intervention|Withdrawal by Subject|1|||
106019274|NCT00494676|365732827|FG001|First Intervention|Withdrawal by Subject|3|||
106019275|NCT00494676|365732826|FG000|Second Intervention|Withdrawal by Subject|1|||
106019276|NCT00494676|365732827|FG001|Second Intervention|Withdrawal by Subject|1|||
106019277|NCT00560352|365732828|FG000|Overall Study|Adverse event unrelated to study drug|2|||
106019278|NCT00560352|365732829|FG001|Overall Study|Adverse event unrelated to study drug|1|||
106019279|NCT00560352|365732830|FG002|Overall Study|Adverse event unrelated to study drug|1|||
106019280|NCT00560352|365732828|FG000|Overall Study|Study drug toxicity|3|||
106019281|NCT00560352|365732829|FG001|Overall Study|Study drug toxicity|0|||
106019282|NCT00560352|365732830|FG002|Overall Study|Study drug toxicity|1|||
106019283|NCT00560352|365732828|FG000|Overall Study|Disease progression|0|||
106019284|NCT00560352|365732829|FG001|Overall Study|Disease progression|1|||
106019285|NCT00560352|365732830|FG002|Overall Study|Disease progression|1|||
106019286|NCT00560352|365732828|FG000|Overall Study|Withdrawal by Subject|1|||
106019287|NCT00560352|365732829|FG001|Overall Study|Withdrawal by Subject|1|||
106019288|NCT00560352|365732830|FG002|Overall Study|Withdrawal by Subject|1|||
106019289|NCT00560352|365732828|FG000|Overall Study|Maximum clinical benefit|1|||
106019290|NCT00560352|365732829|FG001|Overall Study|Maximum clinical benefit|0|||
106019291|NCT00560352|365732830|FG002|Overall Study|Maximum clinical benefit|0|||
106019292|NCT01104311|365732831|FG000|Overall Study|Withdrawal by Subject|6|||
106019293|NCT01104311|365732832|FG001|Overall Study|Withdrawal by Subject|6|||
106019294|NCT01104311|365732831|FG000|Overall Study|Protocol Violation|0|||
106019295|NCT01104311|365732832|FG001|Overall Study|Protocol Violation|1|||
106019296|NCT01104311|365732831|FG000|Overall Study|Physician Decision|2|||
106019297|NCT01104311|365732832|FG001|Overall Study|Physician Decision|2|||
106019298|NCT01104311|365732831|FG000|Overall Study|low compliance|1|||
106019299|NCT01104311|365732832|FG001|Overall Study|low compliance|1|||
105821413|NCT00089661|365006597|FG000|Overall Study|Noncompliance|2|||
105821414|NCT00089661|365006598|FG001|Overall Study|Noncompliance|4|||
106019300|NCT01104311|365732831|FG000|Overall Study|Adverse Event|1|||
106019301|NCT01104311|365732832|FG001|Overall Study|Adverse Event|2|||
106019302|NCT01442103|365734900|FG000|Overall Study|Lost to Follow-up|2|||
106019303|NCT01590888|365734901|FG000|Overall Study|Adverse Event|3|||
106019304|NCT01590888|365734902|FG001|Overall Study|Adverse Event|0|||
106019305|NCT01590888|365734903|FG002|Overall Study|Adverse Event|1|||
106019306|NCT01590888|365734901|FG000|Overall Study|Lost to Follow-up|1|||
106019307|NCT01590888|365734902|FG001|Overall Study|Lost to Follow-up|0|||
106019308|NCT01590888|365734903|FG002|Overall Study|Lost to Follow-up|0|||
106019309|NCT04953728|365734904|FG000|Overall Study|Withdrawal by Subject|3|||
106019310|NCT04953728|365734904|FG000|Overall Study|Physician Decision|1|||
105821415|NCT00089661|365006597|FG000|Overall Study|Other|2|||
105821416|NCT00089661|365006598|FG001|Overall Study|Other|1|||
105821417|NCT01273805|365006603|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
105821418|NCT01273805|365006604|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
105821419|NCT02647944|365006605|FG000|Overall Study|Withdrawal by Subject|0|||
105821420|NCT02647944|365006606|FG001|Overall Study|Withdrawal by Subject|3|||
105821421|NCT02647944|365006605|FG000|Overall Study|Adverse Event|2|||
105821422|NCT02647944|365006606|FG001|Overall Study|Adverse Event|0|||
105821423|NCT02077465|365006607|FG000|Overall Study|Withdrew Consent|0|||
105821424|NCT02077465|365006608|FG001|Overall Study|Withdrew Consent|1|||
105821425|NCT02077465|365006607|FG000|Overall Study|Lost to Follow-up|1|||
105821426|NCT02077465|365006608|FG001|Overall Study|Lost to Follow-up|0|||
105821427|NCT02760368|365006610|FG000|Overall Study|Withdrawal by Subject|8|||
105821428|NCT02760368|365006611|FG001|Overall Study|Withdrawal by Subject|12|||
105821429|NCT02760368|365006612|FG002|Overall Study|Withdrawal by Subject|9|||
105821430|NCT02760368|365006610|FG000|Overall Study|Screen Failure|0|||
105821431|NCT02760368|365006611|FG001|Overall Study|Screen Failure|0|||
105821432|NCT02760368|365006612|FG002|Overall Study|Screen Failure|1|||
105821433|NCT02760368|365006610|FG000|Overall Study|Death|0|||
105821434|NCT02760368|365006611|FG001|Overall Study|Death|1|||
105821435|NCT02760368|365006612|FG002|Overall Study|Death|0|||
106019311|NCT01148979|365734905|FG000|Overall Study|Lost to Follow-up|0|||
106019312|NCT01148979|365734906|FG001|Overall Study|Lost to Follow-up|1|||
106019313|NCT00990704|365734910|FG000|Overall Study|Adverse Event|1|||
106019314|NCT00990704|365734911|FG001|Overall Study|Adverse Event|1|||
106145539|NCT00835770|366193109|FG001|Overall Study|Investigator Decision|42|||
106019315|NCT00990704|365734910|FG000|Overall Study|Physician Decision|0|||
106019316|NCT00990704|365734911|FG001|Overall Study|Physician Decision|1|||
106019317|NCT01376804|365734912|FG000|Treatment Period|Withdrawal by Subject|1|||
106019318|NCT01376804|365734912|FG000|Treatment Period|Adverse Event|6|||
105821436|NCT02760368|365006610|FG000|Overall Study|Withdrawal by Sponsor|0|||
105821437|NCT02760368|365006611|FG001|Overall Study|Withdrawal by Sponsor|0|||
105821438|NCT02760368|365006612|FG002|Overall Study|Withdrawal by Sponsor|1|||
106019319|NCT01376804|365734912|FG000|Treatment Period|Patient did not receive study drug|1|||
106019320|NCT01357850|365734913|FG000|Overall Study|Lost to Follow-up|1|||
105821439|NCT01827163|365006613|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
105821440|NCT01827163|365006613|FG000|Overall Study|Adverse Event|9|||
105821441|NCT01037114|365006614|FG000|Year 20|Others|1|||
105821442|NCT01792635|365006619|FG000|Part B|Adverse Event|0|||
105821443|NCT01792635|365006620|FG001|Part B|Adverse Event|0|||
105821444|NCT01792635|365006621|FG002|Part B|Adverse Event|1|||
105821445|NCT01792635|365006619|FG000|Part B|Study terminated|0|||
105821446|NCT01792635|365006620|FG001|Part B|Study terminated|4|||
105821447|NCT01792635|365006621|FG002|Part B|Study terminated|3|||
105821448|NCT02294604|365006624|FG000|Overall Study|Did not provide samples for culture|0|||
105821449|NCT02294604|365006625|FG001|Overall Study|Did not provide samples for culture|1|||
105821450|NCT02294604|365006626|FG002|Overall Study|Did not provide samples for culture|0|||
105821451|NCT02294604|365006624|FG000|Overall Study|Culture contamination|1|||
105821452|NCT02294604|365006625|FG001|Overall Study|Culture contamination|2|||
105821453|NCT02294604|365006626|FG002|Overall Study|Culture contamination|0|||
105821454|NCT00968812|365006630|FG000|Overall Study|Adverse Event|30|||
105821455|NCT00968812|365006631|FG001|Overall Study|Adverse Event|46|||
105821456|NCT00968812|365006632|FG002|Overall Study|Adverse Event|33|||
105821457|NCT00968812|365006630|FG000|Overall Study|Death|2|||
105821458|NCT00968812|365006631|FG001|Overall Study|Death|2|||
105821459|NCT00968812|365006632|FG002|Overall Study|Death|1|||
105821460|NCT00968812|365006630|FG000|Overall Study|Lack of Efficacy|9|||
105821461|NCT00968812|365006631|FG001|Overall Study|Lack of Efficacy|7|||
105821462|NCT00968812|365006632|FG002|Overall Study|Lack of Efficacy|16|||
105821463|NCT00968812|365006630|FG000|Overall Study|Lost to Follow-up|17|||
105821464|NCT00968812|365006631|FG001|Overall Study|Lost to Follow-up|12|||
105821465|NCT00968812|365006632|FG002|Overall Study|Lost to Follow-up|11|||
105821466|NCT00968812|365006630|FG000|Overall Study|Physician Decision|8|||
105821467|NCT00968812|365006631|FG001|Overall Study|Physician Decision|5|||
105821468|NCT00968812|365006632|FG002|Overall Study|Physician Decision|9|||
105821469|NCT00968812|365006630|FG000|Overall Study|Protocol Violation|7|||
105821470|NCT00968812|365006631|FG001|Overall Study|Protocol Violation|4|||
105821471|NCT00968812|365006632|FG002|Overall Study|Protocol Violation|3|||
105821472|NCT00968812|365006630|FG000|Overall Study|Withdrawal by Subject|17|||
105821473|NCT00968812|365006631|FG001|Overall Study|Withdrawal by Subject|23|||
105821474|NCT00968812|365006632|FG002|Overall Study|Withdrawal by Subject|25|||
105821475|NCT00968812|365006630|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
105821476|NCT00968812|365006631|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
105821477|NCT00968812|365006632|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
105821478|NCT00968812|365006630|FG000|Overall Study|Noncompliance with study drug|4|||
105821479|NCT00968812|365006631|FG001|Overall Study|Noncompliance with study drug|1|||
105821480|NCT00968812|365006632|FG002|Overall Study|Noncompliance with study drug|6|||
105821481|NCT00968812|365006630|FG000|Overall Study|Unable to take rescue therapy|12|||
105821482|NCT00968812|365006631|FG001|Overall Study|Unable to take rescue therapy|12|||
105821483|NCT00968812|365006632|FG002|Overall Study|Unable to take rescue therapy|17|||
105821484|NCT00968812|365006630|FG000|Overall Study|Other|25|||
105821485|NCT00968812|365006631|FG001|Overall Study|Other|37|||
105821486|NCT00968812|365006632|FG002|Overall Study|Other|40|||
105821487|NCT03098394|365006636|FG000|Overall Study|Pregnancy|0|||
105821488|NCT03098394|365006637|FG001|Overall Study|Pregnancy|1|||
105821489|NCT01294917|365006644|FG000|Overall Study|Relocation|5|||
105821490|NCT01294917|365006644|FG000|Overall Study|Inconvenience|1|||
105821491|NCT01208337|365006649|FG000|Overall Study|Death|3|||
105821492|NCT02645409|365006650|FG000|Overall Study|Withdrawal by Subject|3|||
105821493|NCT02645409|365006651|FG001|Overall Study|Withdrawal by Subject|0|||
105821494|NCT02645409|365006650|FG000|Overall Study|Physician Decision|1|||
105821495|NCT02645409|365006651|FG001|Overall Study|Physician Decision|0|||
105821496|NCT03084471|365006654|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
105821497|NCT03084471|365006654|FG000|Overall Study|Condition under investigation worsened|84|||
105821498|NCT03084471|365006654|FG000|Overall Study|Lack of therapeutic response|2|||
105821499|NCT03084471|365006654|FG000|Overall Study|Protocol Violation|1|||
105957038|NCT03276728|365504424|FG004|Overall Study|Withdrawal by Subject|0|||
105957039|NCT03276728|365504425|FG005|Overall Study|Withdrawal by Subject|0|||
105957040|NCT03276728|365504426|FG006|Overall Study|Withdrawal by Subject|0|||
105957041|NCT03276728|365504427|FG007|Overall Study|Withdrawal by Subject|0|||
105957042|NCT03276728|365504420|FG000|Overall Study|Decision by sponsor|0|||
105957043|NCT03276728|365504421|FG001|Overall Study|Decision by sponsor|0|||
105957044|NCT03276728|365504422|FG002|Overall Study|Decision by sponsor|0|||
105957045|NCT03276728|365504423|FG003|Overall Study|Decision by sponsor|0|||
105957046|NCT03276728|365504424|FG004|Overall Study|Decision by sponsor|1|||
105957047|NCT03276728|365504425|FG005|Overall Study|Decision by sponsor|0|||
105957048|NCT03276728|365504426|FG006|Overall Study|Decision by sponsor|2|||
105957049|NCT03276728|365504427|FG007|Overall Study|Decision by sponsor|1|||
105957050|NCT04971967|365504430|FG000|Overall Study|Lost to Follow-up|6|||
105957051|NCT04971967|365504431|FG001|Overall Study|Lost to Follow-up|7|||
105957052|NCT02297815|365504438|FG000|Overall Study|Lost to Follow-up|236|||
105957053|NCT02297815|365504439|FG001|Overall Study|Lost to Follow-up|140|||
105957054|NCT00662831|365504443|FG000|Overall Study|Death|4|||
105821500|NCT03084471|365006654|FG000|Overall Study|Adverse Event|73|||
105821501|NCT03084471|365006654|FG000|Overall Study|Withdrawal by Subject|12|||
105821502|NCT03084471|365006654|FG000|Overall Study|Disease relapse|181|||
105821503|NCT03084471|365006654|FG000|Overall Study|Subjective disease progression|359|||
106019321|NCT01357850|365734914|FG001|Overall Study|Lost to Follow-up|0|||
106019322|NCT01357850|365734915|FG002|Overall Study|Lost to Follow-up|0|||
106019323|NCT01357850|365734916|FG003|Overall Study|Lost to Follow-up|0|||
106019324|NCT00753649|365734917|FG000|Overall Study|Migrated/moved from study area|1|||
106019325|NCT00753649|365734918|FG001|Overall Study|Migrated/moved from study area|0|||
106019326|NCT00753649|365734917|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
106019327|NCT00753649|365734918|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
106019328|NCT00753649|365734917|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
106019329|NCT00753649|365734918|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
106019330|NCT00753649|365734917|FG000|Overall Study|Protocol Violation|2|||
106019331|NCT00753649|365734918|FG001|Overall Study|Protocol Violation|0|||
106019332|NCT01039376|365734919|FG000|Overall Study|Lost to Follow-up|5|||
106019333|NCT01039376|365734920|FG001|Overall Study|Lost to Follow-up|12|||
106019334|NCT01039376|365734919|FG000|Overall Study|Physician Decision|15|||
106019335|NCT01039376|365734920|FG001|Overall Study|Physician Decision|10|||
106019336|NCT01039376|365734919|FG000|Overall Study|Withdrawal by Subject|20|||
106019337|NCT01039376|365734920|FG001|Overall Study|Withdrawal by Subject|32|||
106145540|NCT00835770|366193108|FG000|Overall Study|Participant Non-Compliance|11|||
106145541|NCT00835770|366193109|FG001|Overall Study|Participant Non-Compliance|9|||
106145542|NCT00835770|366193108|FG000|Overall Study|Death|4|||
105766239|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105766240|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105821504|NCT03084471|365006654|FG000|Overall Study|Other (as recorded)|33|||
105821505|NCT03084471|365006654|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
105821506|NCT00505622|365006655|FG000|Overall Study|Adverse Event|5|||
105821507|NCT00505622|365006656|FG001|Overall Study|Adverse Event|6|||
105821508|NCT00505622|365006657|FG002|Overall Study|Adverse Event|4|||
105821509|NCT00505622|365006655|FG000|Overall Study|Protocol Violation|1|||
105821510|NCT00505622|365006656|FG001|Overall Study|Protocol Violation|1|||
105821511|NCT00505622|365006657|FG002|Overall Study|Protocol Violation|0|||
105821512|NCT00505622|365006655|FG000|Overall Study|Withdrawal by Subject|0|||
105821513|NCT00505622|365006656|FG001|Overall Study|Withdrawal by Subject|3|||
105821514|NCT00505622|365006657|FG002|Overall Study|Withdrawal by Subject|2|||
105821515|NCT00505622|365006655|FG000|Overall Study|Study termination by sponsor|115|||
105821516|NCT00505622|365006656|FG001|Overall Study|Study termination by sponsor|98|||
105821517|NCT00505622|365006657|FG002|Overall Study|Study termination by sponsor|90|||
105821518|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
105821519|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
105821520|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
105821521|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
105821522|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
105821523|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
105821524|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105821525|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
105821526|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
105766241|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105766242|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
105766243|NCT01237223|364796029|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
105766244|NCT01237223|364796030|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766245|NCT01237223|364796031|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766246|NCT01237223|364796032|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766247|NCT01237223|364796033|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766248|NCT01237223|364796034|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
105766249|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
105766250|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
105766251|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
105766252|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
105821527|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
105821528|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
106019338|NCT01039376|365734919|FG000|Overall Study|Study terminated by Sponsor|90|||
106019339|NCT01039376|365734920|FG001|Overall Study|Study terminated by Sponsor|72|||
106019340|NCT00123422|365734921|FG000|Overall Study|Physician Decision|2|||
106019341|NCT00123422|365734922|FG001|Overall Study|Physician Decision|2|||
106019342|NCT00123422|365734923|FG002|Overall Study|Physician Decision|6|||
105821529|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
106019343|NCT00123422|365734921|FG000|Overall Study|Withdrawal by Subject|1|||
106145543|NCT00835770|366193109|FG001|Overall Study|Death|6|||
106145544|NCT00835770|366193108|FG000|Overall Study|Other|115|||
105957055|NCT00662831|365504444|FG001|Overall Study|Death|1|||
105957056|NCT00662831|365504443|FG000|Overall Study|Lack of Efficacy|6|||
105957057|NCT00662831|365504444|FG001|Overall Study|Lack of Efficacy|6|||
105957058|NCT00662831|365504443|FG000|Overall Study|Lost to Follow-up|1|||
105957059|NCT00662831|365504444|FG001|Overall Study|Lost to Follow-up|0|||
105957060|NCT00662831|365504443|FG000|Overall Study|Withdrawal by Subject|2|||
105957061|NCT00662831|365504444|FG001|Overall Study|Withdrawal by Subject|1|||
105957062|NCT00662831|365504443|FG000|Overall Study|Other|62|||
105957063|NCT00662831|365504444|FG001|Overall Study|Other|31|||
105957064|NCT00662831|365504443|FG000|Overall Study|Protocol Violation|8|||
105957065|NCT00662831|365504444|FG001|Overall Study|Protocol Violation|4|||
106019344|NCT00123422|365734922|FG001|Overall Study|Withdrawal by Subject|2|||
106019345|NCT00123422|365734923|FG002|Overall Study|Withdrawal by Subject|2|||
106019346|NCT00123422|365734921|FG000|Overall Study|Lost to Follow-up|1|||
106019347|NCT00123422|365734922|FG001|Overall Study|Lost to Follow-up|2|||
106019348|NCT00123422|365734923|FG002|Overall Study|Lost to Follow-up|2|||
106019349|NCT04555616|365734924|FG000|Overall Study|Death|1|||
106019350|NCT04555616|365734925|FG001|Overall Study|Death|0|||
106019351|NCT04555616|365734926|FG002|Overall Study|Death|1|||
106019352|NCT04555616|365734924|FG000|Overall Study|Withdrawal by Subject|2|||
106019353|NCT04555616|365734925|FG001|Overall Study|Withdrawal by Subject|1|||
106019354|NCT04555616|365734926|FG002|Overall Study|Withdrawal by Subject|0|||
106019355|NCT01229267|365734931|FG000|Overall Study|Adverse Event|4|||
106019356|NCT01229267|365734932|FG001|Overall Study|Adverse Event|6|||
106019357|NCT01229267|365734933|FG002|Overall Study|Adverse Event|3|||
105821530|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
105821531|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
105821532|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
105821533|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
105821534|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
105821535|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
105821536|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
105821537|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
105821538|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Death|0|||
105821539|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Death|1|||
105821540|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Death|0|||
105821541|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Death|0|||
105821542|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
105821543|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
105821544|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
105821545|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
105821546|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
105821547|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
105821548|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
105821549|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
105821550|NCT01940341|365006658|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105821551|NCT01940341|365006659|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
105821552|NCT01940341|365006660|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105821553|NCT01940341|365006661|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
105821554|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
105821555|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
105821556|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
105821557|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
105821558|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
105821559|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
105821560|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
105821561|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
105821562|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105821563|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105957066|NCT00662831|365504443|FG000|Overall Study|Adverse Event|23|||
105957067|NCT00662831|365504444|FG001|Overall Study|Adverse Event|16|||
106019358|NCT01229267|365734934|FG003|Overall Study|Adverse Event|2|||
106019359|NCT01229267|365734935|FG004|Overall Study|Adverse Event|10|||
105821564|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
105957068|NCT02964273|365504445|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
105957069|NCT02964273|365504446|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
105957070|NCT02964273|365504447|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
105957071|NCT02964273|365504448|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
106019360|NCT01229267|365734931|FG000|Overall Study|Death|40|||
106019361|NCT01229267|365734932|FG001|Overall Study|Death|37|||
106145545|NCT00835770|366193109|FG001|Overall Study|Other|104|||
106145546|NCT00835770|366193108|FG000|Overall Study|Other|2|||
105821565|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
105821566|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
105821567|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
105821568|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
105821569|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
105821570|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105821571|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105821572|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
105821573|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
105821574|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
105821575|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
105821576|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
105821577|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
105821578|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105821579|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105821580|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
105821581|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
105821582|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105821583|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105821584|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
105821585|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
105821586|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105821587|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105821588|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
105821589|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
105821590|NCT01940341|365006658|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
105821591|NCT01940341|365006659|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
105821592|NCT01940341|365006660|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
105821593|NCT01940341|365006661|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
105821594|NCT03552393|365006662|FG000|Core Period|Kidney Transplant|1|||
105821595|NCT03552393|365006662|FG000|Core Period|Prohibited Medication|1|||
105821596|NCT03552393|365006662|FG000|Safety Extension Period|Kidney Transplant|4|||
105821597|NCT02601625|365006663|FG000|Overall Study|Lost to Follow-up|0|||
105821598|NCT02601625|365006664|FG001|Overall Study|Lost to Follow-up|0|||
105821599|NCT02601625|365006665|FG002|Overall Study|Lost to Follow-up|1|||
105821600|NCT02601625|365006666|FG003|Overall Study|Lost to Follow-up|1|||
105821601|NCT01289262|365006669|FG000|Overall Study|Lost to Follow-up|29|||
105821602|NCT01289262|365006670|FG001|Overall Study|Lost to Follow-up|16|||
105821603|NCT01289262|365006669|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
105821604|NCT01289262|365006670|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
105821605|NCT04887415|365006671|FG000|Overall Study|Lost to Follow-up|2|||
105821606|NCT01250912|365006672|FG000|Overall Study|Lost to Follow-up|1|||
105821607|NCT01218867|365006673|FG000|Overall Study|Death during treatment|0|||
105821608|NCT01218867|365006674|FG001|Overall Study|Death during treatment|0|||
105821609|NCT01218867|365006675|FG002|Overall Study|Death during treatment|0|||
105821610|NCT01218867|365006676|FG003|Overall Study|Death during treatment|0|||
105821611|NCT01218867|365006677|FG004|Overall Study|Death during treatment|0|||
105821612|NCT01218867|365006678|FG005|Overall Study|Death during treatment|0|||
105821613|NCT01218867|365006679|FG006|Overall Study|Death during treatment|1|||
105821614|NCT01218867|365006680|FG007|Overall Study|Death during treatment|0|||
105821615|NCT01218867|365006681|FG008|Overall Study|Death during treatment|0|||
105821616|NCT01218867|365006682|FG009|Overall Study|Death during treatment|0|||
105821617|NCT01218867|365006683|FG010|Overall Study|Death during treatment|0|||
105821618|NCT03681470|365006686|FG000|Overall Study|Lack of Efficacy|3|||
105821619|NCT03681470|365006686|FG000|Overall Study|Lost to Follow-up|1|||
105821620|NCT03681470|365006686|FG000|Overall Study|Protocol Violation|3|||
105821621|NCT03681470|365006686|FG000|Overall Study|Withdrawal by Subject|1|||
105821622|NCT03206177|365006688|FG000|Overall Study|Withdrawal by Subject|1|||
105821623|NCT02963259|365006689|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
105821624|NCT02963259|365006689|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
105821625|NCT02963259|365006689|FG000|Overall Study|Death|1|||
105821626|NCT02963259|365006689|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
105821627|NCT01136174|365006690|FG000|Overall Study|Adverse Event|0|||
105821628|NCT01136174|365006691|FG001|Overall Study|Adverse Event|0|||
105821629|NCT01136174|365006692|FG002|Overall Study|Adverse Event|0|||
105821630|NCT01136174|365006693|FG003|Overall Study|Adverse Event|4|||
105821631|NCT02655679|365006694|FG000|Overall Study|Adverse Event|0|||
105821632|NCT02655679|365006695|FG001|Overall Study|Adverse Event|1|||
105821633|NCT02655679|365006696|FG002|Overall Study|Adverse Event|0|||
105821634|NCT02655679|365006697|FG003|Overall Study|Adverse Event|0|||
105821635|NCT02655679|365006698|FG004|Overall Study|Adverse Event|0|||
105821636|NCT02655679|365006694|FG000|Overall Study|Withdrawal by Subject|1|||
105821637|NCT02655679|365006695|FG001|Overall Study|Withdrawal by Subject|1|||
105821638|NCT02655679|365006696|FG002|Overall Study|Withdrawal by Subject|0|||
105821639|NCT02655679|365006697|FG003|Overall Study|Withdrawal by Subject|3|||
105821640|NCT02655679|365006698|FG004|Overall Study|Withdrawal by Subject|1|||
105821641|NCT02655679|365006694|FG000|Overall Study|Inability to Comply with the Protocol|1|||
105821642|NCT02655679|365006695|FG001|Overall Study|Inability to Comply with the Protocol|0|||
105821643|NCT02655679|365006696|FG002|Overall Study|Inability to Comply with the Protocol|0|||
105821644|NCT02655679|365006697|FG003|Overall Study|Inability to Comply with the Protocol|0|||
105821645|NCT02655679|365006698|FG004|Overall Study|Inability to Comply with the Protocol|0|||
105821646|NCT02655679|365006694|FG000|Overall Study|Lost to Follow-up|0|||
105821647|NCT02655679|365006695|FG001|Overall Study|Lost to Follow-up|1|||
105821648|NCT02655679|365006696|FG002|Overall Study|Lost to Follow-up|1|||
105821649|NCT02655679|365006697|FG003|Overall Study|Lost to Follow-up|1|||
105821650|NCT02655679|365006698|FG004|Overall Study|Lost to Follow-up|0|||
105821651|NCT02655679|365006694|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105821652|NCT02655679|365006695|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105821653|NCT02655679|365006696|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105821654|NCT02655679|365006697|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105821655|NCT02655679|365006698|FG004|Overall Study|Other Miscellaneous Reasons|0|||
105821656|NCT02178787|365006699|FG000|Overall Study|Lost to Follow-up|1|||
105821657|NCT02178787|365006700|FG001|Overall Study|Lost to Follow-up|0|||
105821658|NCT02178787|365006699|FG000|Overall Study|Withdrawal by Subject|0|||
105821659|NCT02178787|365006700|FG001|Overall Study|Withdrawal by Subject|2|||
105821660|NCT02178787|365006699|FG000|Overall Study|No TCD window|3|||
105821661|NCT02178787|365006700|FG001|Overall Study|No TCD window|7|||
105821662|NCT02178787|365006699|FG000|Overall Study|Physician Decision|1|||
105821663|NCT02178787|365006700|FG001|Overall Study|Physician Decision|0|||
105821664|NCT03873272|365006701|FG000|Overall Study|Withdrawal by Subject|2|||
105821665|NCT03873272|365006702|FG001|Overall Study|Withdrawal by Subject|0|||
105821666|NCT03873272|365006703|FG002|Overall Study|Withdrawal by Subject|1|||
105821667|NCT03873272|365006701|FG000|Overall Study|Death|0|||
105821668|NCT03873272|365006702|FG001|Overall Study|Death|2|||
105821669|NCT03873272|365006703|FG002|Overall Study|Death|1|||
105821670|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
105821671|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
105821672|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
105821673|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
105821674|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821675|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821676|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821677|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821678|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821679|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821680|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821681|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821682|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821683|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821684|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821685|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821686|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821687|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821688|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821689|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821690|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
105821691|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
105821692|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
105821693|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
105821694|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
105821695|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821696|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821697|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821698|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821699|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821700|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821701|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821702|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821703|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821704|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
106019362|NCT01229267|365734933|FG002|Overall Study|Death|35|||
105957072|NCT02964273|365504445|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
105957073|NCT02964273|365504446|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
105957074|NCT02964273|365504447|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
105957075|NCT02964273|365504448|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
105957076|NCT02964273|365504445|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
105957077|NCT02964273|365504446|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
105766253|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
105766254|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
105766255|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
105766256|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
105766257|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
105766258|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
105766259|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
105766260|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
105766261|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
105766262|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
105766263|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
105766264|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
105766265|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
105766266|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
105766267|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766268|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766269|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766270|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766271|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
105766272|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
105766273|NCT01237223|364796029|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
105766274|NCT01237223|364796030|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
105766275|NCT01237223|364796031|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
105766276|NCT01237223|364796032|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
105766277|NCT01237223|364796033|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
105766278|NCT01237223|364796034|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
105766279|NCT00839436|364796035|FG000|Overall Study|Developed exclusionary condition|1|||
105766280|NCT00839436|364796036|FG001|Overall Study|Developed exclusionary condition|0|||
105766281|NCT00839436|364796037|FG002|Overall Study|Developed exclusionary condition|0|||
105766282|NCT00839436|364796035|FG000|Overall Study|Withdrawal by Subject|0|||
105766283|NCT00839436|364796036|FG001|Overall Study|Withdrawal by Subject|1|||
105766284|NCT00839436|364796037|FG002|Overall Study|Withdrawal by Subject|0|||
105766285|NCT00839436|364796035|FG000|Overall Study|Study drug no longer available|0|||
105766286|NCT00839436|364796036|FG001|Overall Study|Study drug no longer available|0|||
105766287|NCT00839436|364796037|FG002|Overall Study|Study drug no longer available|1|||
105766288|NCT05784129|364796038|FG000|Overall Study|Study terminated by sponsor|2|||
105766289|NCT05784129|364796039|FG001|Overall Study|Study terminated by sponsor|2|||
105766290|NCT01156363|364796042|FG000|Overall Study|Adverse Event|6|||
105766291|NCT01156363|364796042|FG000|Overall Study|Insufficient Therapeutic Response|5|||
105766292|NCT01156363|364796042|FG000|Overall Study|Failure to Return|1|||
105766293|NCT01156363|364796042|FG000|Overall Study|Refused Treatment|4|||
105766294|NCT01156363|364796042|FG000|Overall Study|Other|6|||
105766295|NCT00047008|364796051|FG000|Overall Study|Withdrawn consent|2|||
105766296|NCT00047008|364796052|FG001|Overall Study|Withdrawn consent|3|||
105766297|NCT00047008|364796051|FG000|Overall Study|Ineligible|9|||
105766298|NCT00047008|364796052|FG001|Overall Study|Ineligible|8|||
105766299|NCT00429572|364796053|FG000|Overall Study|Disease progression|1|||
105766300|NCT01782885|364796056|FG000|Overall Study|Lost to Follow-up|4|||
105766301|NCT01782885|364796057|FG001|Overall Study|Lost to Follow-up|6|||
105766302|NCT01587274|364796058|FG000|Overall Study|Lost to Follow-up|4|||
105766303|NCT01587274|364796059|FG001|Overall Study|Lost to Follow-up|5|||
105766304|NCT01587274|364796060|FG002|Overall Study|Lost to Follow-up|3|||
105766305|NCT00361218|364796064|FG000|Overall Study|Lost to Follow-up|11|||
105766306|NCT00361218|364796064|FG000|Overall Study|Personal Reasons|7|||
105766307|NCT00361218|364796064|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
105766308|NCT00608842|364796070|FG000|Overall Study|Participant's Request|0|||
105766309|NCT00608842|364796071|FG001|Overall Study|Participant's Request|1|||
105766310|NCT00608842|364796072|FG002|Overall Study|Participant's Request|2|||
105766311|NCT00608842|364796073|FG003|Overall Study|Participant's Request|1|||
105766312|NCT00608842|364796070|FG000|Overall Study|Lost to Follow-up|1|||
105766313|NCT00608842|364796071|FG001|Overall Study|Lost to Follow-up|0|||
105766314|NCT00608842|364796072|FG002|Overall Study|Lost to Follow-up|0|||
105821705|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821706|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821707|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821708|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821709|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821710|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821711|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
105821712|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
105821713|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
105821714|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
105821715|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
105821716|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821717|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821718|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821719|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821720|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821721|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821722|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821723|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821724|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821725|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821726|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821727|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821728|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821729|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821730|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821731|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821732|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
105821733|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
105821734|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
105821735|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
105821736|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821737|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821738|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821739|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821740|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821741|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
106019363|NCT01229267|365734934|FG003|Overall Study|Death|13|||
106019364|NCT01229267|365734935|FG004|Overall Study|Death|103|||
105821742|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821743|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821744|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821745|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821746|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821747|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821748|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821749|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821750|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821751|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821752|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821753|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
105821754|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
105821755|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821756|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821757|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
105821758|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821759|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821760|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821761|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821762|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
106019365|NCT01229267|365734931|FG000|Overall Study|Withdrawal by Subject|23|||
106019366|NCT01229267|365734932|FG001|Overall Study|Withdrawal by Subject|22|||
106019367|NCT01229267|365734933|FG002|Overall Study|Withdrawal by Subject|32|||
106019368|NCT01229267|365734934|FG003|Overall Study|Withdrawal by Subject|14|||
106019369|NCT01229267|365734935|FG004|Overall Study|Withdrawal by Subject|59|||
106145547|NCT00835770|366193109|FG001|Overall Study|Other|1|||
106145548|NCT02555215|366193121|FG000|Overall Study|Other|1|||
105766315|NCT00608842|364796073|FG003|Overall Study|Lost to Follow-up|0|||
105766316|NCT00412113|364796078|FG000|Overall Study|Adverse Event|11|||
105766317|NCT00412113|364796079|FG001|Overall Study|Adverse Event|15|||
105766318|NCT00412113|364796078|FG000|Overall Study|did not receive treatment|1|||
105766319|NCT00412113|364796079|FG001|Overall Study|did not receive treatment|0|||
105766320|NCT01190020|364796080|FG000|Overall Study|Adverse Event|2|||
105766321|NCT01190020|364796081|FG001|Overall Study|Adverse Event|0|||
105766322|NCT01190020|364796080|FG000|Overall Study|Lost to Follow-up|2|||
105766323|NCT01190020|364796081|FG001|Overall Study|Lost to Follow-up|0|||
105766324|NCT01190020|364796080|FG000|Overall Study|Withdrawal by Subject|3|||
105766325|NCT01190020|364796081|FG001|Overall Study|Withdrawal by Subject|0|||
105957078|NCT02964273|365504447|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
105957079|NCT02964273|365504448|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
105957080|NCT02964273|365504445|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
105957081|NCT02964273|365504446|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
105957082|NCT02964273|365504447|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
105957083|NCT02964273|365504448|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
105957084|NCT02964273|365504445|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
105957085|NCT02964273|365504446|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
105957086|NCT02964273|365504447|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
105957087|NCT02964273|365504448|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
105957088|NCT02964273|365504445|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
105957089|NCT02964273|365504446|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
105957090|NCT02964273|365504447|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
105957091|NCT02964273|365504448|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
105957092|NCT03333928|365504450|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
105957093|NCT03333928|365504451|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
105957094|NCT03333928|365504452|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
105957095|NCT03333928|365504450|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
105957096|NCT03333928|365504451|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
105957097|NCT03333928|365504452|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
105957098|NCT03333928|365504450|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
105957099|NCT03333928|365504451|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
105957100|NCT03333928|365504452|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
105957101|NCT03333928|365504450|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
105957102|NCT03333928|365504451|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
105957103|NCT03333928|365504452|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
105957104|NCT03333928|365504450|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
105957105|NCT03333928|365504451|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
105957106|NCT03333928|365504452|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
105957107|NCT03333928|365504450|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
105957108|NCT03333928|365504451|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
105957109|NCT03333928|365504452|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
105957110|NCT03333928|365504450|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
105957111|NCT03333928|365504451|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
105957112|NCT03333928|365504452|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
105957113|NCT03333928|365504450|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
105957114|NCT03333928|365504451|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
105957115|NCT03333928|365504452|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
105957116|NCT01453036|365504453|FG000|Overall Study|Lost to Follow-up|26|||
105957117|NCT01453036|365504454|FG001|Overall Study|Lost to Follow-up|115|||
105957118|NCT01453036|365504455|FG002|Overall Study|Lost to Follow-up|31|||
105957119|NCT00559104|365504456|FG000|Overall Study|Lack of Efficacy|9|||
105957120|NCT00559104|365504457|FG001|Overall Study|Lack of Efficacy|0|||
105957121|NCT04723355|365504458|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
105957122|NCT04723355|365504458|FG000|Overall Study|Errors in the informed consent form|2|||
105957123|NCT03073525|365504460|FG000|Overall Study|Withdrawal by Subject|0|||
105957124|NCT03073525|365504461|FG001|Overall Study|Withdrawal by Subject|0|||
105957125|NCT03073525|365504462|FG002|Overall Study|Withdrawal by Subject|3|||
105957126|NCT03458325|365504463|FG000|Overall Study|Withdrawal by Subject|1|||
105957127|NCT00735553|365504471|FG000|Overall Study|Study prematurely terminated|77|||
105957128|NCT00175916|365504472|FG000|Overall Study|Death|19|||
105766326|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Adverse Event|22|||
105766327|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Adverse Event|0|||
105766328|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
105766329|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
105766330|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
105957129|NCT00175916|365504472|FG000|Overall Study|Adverse Event|81|||
105957130|NCT00175916|365504472|FG000|Overall Study|Lack of Efficacy|354|||
105957131|NCT00175916|365504472|FG000|Overall Study|Lost to Follow-up|17|||
105957132|NCT00175916|365504472|FG000|Overall Study|Subject Choice|98|||
105957133|NCT00175916|365504472|FG000|Overall Study|Lack of compliance|8|||
105957134|NCT00175916|365504472|FG000|Overall Study|Patient cannot record seizures|1|||
105957135|NCT00175916|365504472|FG000|Overall Study|Sponsor decision|17|||
105957136|NCT00175916|365504472|FG000|Overall Study|Vigabatrin intake|1|||
105957137|NCT00175916|365504472|FG000|Overall Study|Suicidal behaviour|1|||
105957138|NCT00175916|365504472|FG000|Overall Study|Withdrawal by Subject|1|||
105957139|NCT00175916|365504472|FG000|Overall Study|Seizure - free|4|||
105957140|NCT00175916|365504472|FG000|Overall Study|Administrative reason|1|||
105957141|NCT00175916|365504472|FG000|Overall Study|Pregnancy|1|||
105957142|NCT00175916|365504472|FG000|Overall Study|Patient's request|2|||
105957143|NCT00175916|365504472|FG000|Overall Study|Treating physiciant's choice|1|||
105957144|NCT00175916|365504472|FG000|Overall Study|Moved overseas|1|||
105957145|NCT00175916|365504472|FG000|Overall Study|Loss of job and economic burden|1|||
105957146|NCT00175916|365504472|FG000|Overall Study|Site was closed|9|||
105957147|NCT00175916|365504472|FG000|Overall Study|Patient went to prison|1|||
105957148|NCT02298868|365504474|FG000|Overall Study|Adverse Event|1|||
105957149|NCT02298868|365504474|FG000|Overall Study|Death|1|||
105957150|NCT02298868|365504474|FG000|Overall Study|Patient underwent transplant|1|||
105957151|NCT02831855|365504475|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
105957152|NCT02831855|365504476|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
105957153|NCT02831855|365504477|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
105957154|NCT02831855|365504475|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
105957155|NCT02831855|365504476|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
105957156|NCT02831855|365504477|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
105957157|NCT02831855|365504475|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
105957158|NCT02831855|365504476|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
105957159|NCT02831855|365504477|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
105957160|NCT02831855|365504475|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
105957161|NCT02831855|365504476|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
105957162|NCT02831855|365504477|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
105957163|NCT02831855|365504475|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
105957164|NCT02831855|365504476|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
105957165|NCT02831855|365504477|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
105957166|NCT02831855|365504475|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
105957167|NCT02831855|365504476|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
105957168|NCT02831855|365504477|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
105957169|NCT02831855|365504475|FG000|Open Label Phase (24 Weeks)|Other|4|||
105957170|NCT02831855|365504476|FG001|Open Label Phase (24 Weeks)|Other|0|||
105957171|NCT02831855|365504477|FG002|Open Label Phase (24 Weeks)|Other|0|||
105957172|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
105957173|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
105957174|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
105957175|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Death|0|||
105957176|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Death|0|||
105957177|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Death|2|||
105957178|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
105957179|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
105957180|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
105957181|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
105957182|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
105957183|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
105957184|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
105957185|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
105957186|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
105957187|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Other|0|||
105957188|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Other|2|||
105957189|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Other|5|||
105957190|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
105957191|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
105957192|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
105957193|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
106019370|NCT01229267|365734931|FG000|Overall Study|Protocol Violation|0|||
105957194|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
106019371|NCT01229267|365734932|FG001|Overall Study|Protocol Violation|1|||
106019372|NCT01229267|365734933|FG002|Overall Study|Protocol Violation|0|||
106019373|NCT01229267|365734934|FG003|Overall Study|Protocol Violation|0|||
106019374|NCT01229267|365734935|FG004|Overall Study|Protocol Violation|0|||
106019375|NCT01229267|365734931|FG000|Overall Study|Progressive disease|0|||
105957195|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
105957196|NCT02831855|365504475|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
105957197|NCT02831855|365504476|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
105957198|NCT02831855|365504477|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
105957199|NCT01206140|365504479|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
105957200|NCT01206140|365504480|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
105957201|NCT01773967|365504481|FG000|Overall Study|Lost to Follow-up|15|||
105957202|NCT01773967|365504482|FG001|Overall Study|Lost to Follow-up|13|||
105957203|NCT00709319|365504490|FG000|Overall Study|Death|4|||
105957204|NCT00709319|365504490|FG000|Overall Study|Withdrawal by Subject|2|||
105957205|NCT00579553|365504491|FG000|Overall Study|Lost to Follow-up|16|||
105957206|NCT00579553|365504492|FG001|Overall Study|Lost to Follow-up|13|||
105957207|NCT01318135|365504493|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
105957208|NCT01318135|365504494|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105957209|NCT01318135|365504495|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105957210|NCT01318135|365504496|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105957211|NCT01318135|365504497|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105957212|NCT01318135|365504498|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105957213|NCT01318135|365504499|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105957214|NCT01318135|365504500|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105957215|NCT01318135|365504493|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
105957216|NCT01318135|365504494|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105957217|NCT01318135|365504495|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105957218|NCT01318135|365504496|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105957219|NCT01318135|365504497|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105957220|NCT01318135|365504498|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105957221|NCT01318135|365504499|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105957222|NCT01318135|365504500|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
105957223|NCT01318135|365504493|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
105957224|NCT01318135|365504494|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
105957225|NCT01318135|365504495|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
105957226|NCT01318135|365504496|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
105957227|NCT01318135|365504497|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
105957228|NCT01318135|365504498|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
105957229|NCT01318135|365504499|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
105957230|NCT01318135|365504500|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
105957231|NCT01318135|365504493|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
105957232|NCT01318135|365504494|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
105957233|NCT01318135|365504495|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
105957234|NCT01318135|365504496|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
105957235|NCT01318135|365504497|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
105957236|NCT01318135|365504498|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
105957237|NCT01318135|365504499|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
105957238|NCT01318135|365504500|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
105957239|NCT01318135|365504493|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105957240|NCT01318135|365504494|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105957241|NCT01318135|365504495|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105957242|NCT01318135|365504496|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105957243|NCT01318135|365504497|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105957244|NCT01318135|365504498|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105957245|NCT01318135|365504499|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105957246|NCT01318135|365504500|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105957247|NCT01318135|365504493|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
105957248|NCT01318135|365504494|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
105957249|NCT01318135|365504495|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
105957250|NCT01318135|365504496|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
105957251|NCT01318135|365504497|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
105957252|NCT01318135|365504498|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
105957253|NCT01318135|365504499|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105957254|NCT01318135|365504500|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105957255|NCT01318135|365504493|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105957256|NCT01318135|365504494|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105957257|NCT01318135|365504495|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105957258|NCT01318135|365504496|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105957259|NCT01318135|365504497|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105957260|NCT01318135|365504498|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
106019376|NCT01229267|365734932|FG001|Overall Study|Progressive disease|0|||
106019377|NCT01229267|365734933|FG002|Overall Study|Progressive disease|0|||
106019378|NCT01229267|365734934|FG003|Overall Study|Progressive disease|0|||
106019379|NCT01229267|365734935|FG004|Overall Study|Progressive disease|1|||
106019380|NCT01229267|365734931|FG000|Overall Study|Physician Decision|8|||
106019381|NCT01229267|365734932|FG001|Overall Study|Physician Decision|11|||
106019382|NCT01229267|365734933|FG002|Overall Study|Physician Decision|8|||
106019383|NCT01229267|365734934|FG003|Overall Study|Physician Decision|3|||
106019384|NCT01229267|365734935|FG004|Overall Study|Physician Decision|25|||
106019385|NCT01229267|365734931|FG000|Overall Study|Lost to Follow-up|6|||
106019386|NCT01229267|365734932|FG001|Overall Study|Lost to Follow-up|5|||
106019387|NCT01229267|365734933|FG002|Overall Study|Lost to Follow-up|8|||
106019388|NCT01229267|365734934|FG003|Overall Study|Lost to Follow-up|3|||
106019389|NCT01229267|365734935|FG004|Overall Study|Lost to Follow-up|22|||
106019390|NCT00808080|365734943|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
106019391|NCT00001213|365734944|FG000|Overall Study|Death|18|||
106019392|NCT01554241|365734946|FG000|Overall Study|Death|3|||
106019393|NCT01554241|365734947|FG001|Overall Study|Death|1|||
106019394|NCT01554241|365734948|FG002|Overall Study|Death|1|||
105821763|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821764|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821765|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821766|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821767|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821768|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821769|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821770|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821771|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821772|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821773|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821774|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
105821775|NCT01597245|365006706|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
105821776|NCT01597245|365006707|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
105821777|NCT01597245|365006708|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
106019395|NCT01554241|365734949|FG003|Overall Study|Death|0|||
106019396|NCT01554241|365734946|FG000|Overall Study|protocol specified renal stone|0|||
106019397|NCT01554241|365734947|FG001|Overall Study|protocol specified renal stone|0|||
106019398|NCT01554241|365734948|FG002|Overall Study|protocol specified renal stone|0|||
106019399|NCT01554241|365734949|FG003|Overall Study|protocol specified renal stone|1|||
106019400|NCT01554241|365734946|FG000|Overall Study|protocol specified change in eGFR|0|||
106019401|NCT01554241|365734947|FG001|Overall Study|protocol specified change in eGFR|0|||
106019402|NCT01554241|365734948|FG002|Overall Study|protocol specified change in eGFR|1|||
106019403|NCT01554241|365734949|FG003|Overall Study|protocol specified change in eGFR|0|||
106019404|NCT01554241|365734946|FG000|Overall Study|Withdrawal by Subject|0|||
106019405|NCT01554241|365734947|FG001|Overall Study|Withdrawal by Subject|0|||
106019406|NCT01554241|365734948|FG002|Overall Study|Withdrawal by Subject|2|||
106019407|NCT01554241|365734949|FG003|Overall Study|Withdrawal by Subject|0|||
106019408|NCT02974543|365734950|FG000|Overall Study|Withdrawal by Subject|1|||
106019409|NCT02974543|365734951|FG001|Overall Study|Withdrawal by Subject|0|||
106019410|NCT03534180|365734952|FG000|Overall Study|Withdrawal by Subject|1|||
106019411|NCT00220636|365734953|FG000|Overall Study|Withdrawal by Subject|4|||
106019412|NCT00330967|365734954|FG000|Overall Study|Withdrawal by Subject|0|||
106019413|NCT00330967|365734955|FG001|Overall Study|Withdrawal by Subject|5|||
106019414|NCT00330967|365734954|FG000|Overall Study|Physician Decision|0|||
106019415|NCT00330967|365734955|FG001|Overall Study|Physician Decision|9|||
106019416|NCT02999672|365734959|FG000|Overall Study|Death|0|||
106019417|NCT02999672|365734960|FG001|Overall Study|Death|1|||
106019418|NCT02999672|365734959|FG000|Overall Study|Study Terminated by Sponsor|0|||
106019419|NCT02999672|365734960|FG001|Overall Study|Study Terminated by Sponsor|1|||
106019420|NCT02999672|365734959|FG000|Overall Study|Progressive Disease|9|||
106019421|NCT02999672|365734960|FG001|Overall Study|Progressive Disease|5|||
106019422|NCT02999672|365734959|FG000|Overall Study|Adverse Event|4|||
106019423|NCT02999672|365734960|FG001|Overall Study|Adverse Event|0|||
105821778|NCT01597245|365006709|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821779|NCT01597245|365006710|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821780|NCT01597245|365006711|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821781|NCT01597245|365006712|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
106019424|NCT00275509|365734965|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
106019425|NCT00275509|365734966|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
106019426|NCT01821118|365734972|FG000|Overall Study|Death|0|||
106019427|NCT01821118|365734973|FG001|Overall Study|Death|1|||
106019428|NCT00470275|365734975|FG000|Overall Study|Death|1|||
106019429|NCT00470275|365734975|FG000|Overall Study|Lack of Efficacy|7|||
106019430|NCT00470275|365734975|FG000|Overall Study|Withdrawal by Subject|2|||
105821782|NCT01597245|365006713|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821783|NCT01597245|365006714|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821784|NCT01597245|365006715|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821785|NCT01597245|365006716|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821786|NCT01597245|365006717|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821787|NCT01597245|365006718|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821788|NCT01597245|365006719|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821789|NCT01597245|365006720|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821790|NCT01597245|365006721|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821791|NCT01597245|365006722|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821792|NCT01597245|365006723|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821793|NCT01597245|365006724|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821794|NCT01597245|365006725|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105821795|NCT01597245|365006726|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
105957261|NCT01318135|365504499|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
105957262|NCT01318135|365504500|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
105957263|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
105957264|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
105957265|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
105957266|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
105957267|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
105957268|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
105957269|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
105957270|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
105957271|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
105957272|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
105957273|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
105957274|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
105957275|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
105957276|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
105957277|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
105957278|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
105957279|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
105957280|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
105957281|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
105957282|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
105957283|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
105957284|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
105957285|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
105957286|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
105957287|NCT01672879|365504501|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
105957288|NCT01672879|365504502|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
105957289|NCT01672879|365504503|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
105957290|NCT01672879|365504501|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
105957291|NCT01672879|365504502|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
105957292|NCT01672879|365504503|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
105957293|NCT01672879|365504501|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
105957294|NCT01672879|365504502|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
105957295|NCT01672879|365504503|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
105957296|NCT01672879|365504501|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
105957297|NCT01672879|365504502|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
105957298|NCT01672879|365504503|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
105957299|NCT01672879|365504501|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
105957300|NCT01672879|365504502|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
105957301|NCT01672879|365504503|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
105957302|NCT03748706|365504505|FG000|Overall Study|Lost to Follow-up|1|||
105957303|NCT01775553|365504506|FG000|Overall Study|Adverse Event|1|||
105957304|NCT01775553|365504506|FG000|Overall Study|Disease Progression|12|||
105957305|NCT00803361|365504509|FG000|Overall Study|Adverse Event|13|||
105957306|NCT00803361|365504510|FG001|Overall Study|Adverse Event|3|||
105957307|NCT00803361|365504509|FG000|Overall Study|Lack of Efficacy|4|||
105957308|NCT00803361|365504510|FG001|Overall Study|Lack of Efficacy|13|||
105957309|NCT00803361|365504509|FG000|Overall Study|Lost to Follow-up|1|||
105821796|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821797|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821798|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
106019431|NCT00775593|365734976|FG000|Overall Study|Unmet eligibility criteria|6|||
106019432|NCT00775593|365734976|FG000|Overall Study|Death|1|||
106019433|NCT00996333|365734977|FG000|Overall Study|Screen failure|1|||
106019434|NCT00996333|365734977|FG000|Overall Study|Withdrawal by Subject|1|||
106019435|NCT00996333|365734977|FG000|Overall Study|Death|4|||
106019436|NCT00996333|365734977|FG000|Overall Study|Adverse Event|1|||
106019437|NCT00996333|365734977|FG000|Overall Study|Physician Decision|1|||
106019438|NCT00996333|365734977|FG000|Overall Study|Other|5|||
106019439|NCT01327482|365734978|FG000|Overall Study|Adverse Event|1|||
106019440|NCT02023697|365734979|FG000|Treatment Period|Radiological progression|13|||
106019441|NCT02023697|365734980|FG001|Treatment Period|Radiological progression|17|||
106019442|NCT02023697|365734981|FG002|Treatment Period|Radiological progression|26|||
106019443|NCT02023697|365734979|FG000|Treatment Period|Never Treated|5|||
106019444|NCT02023697|365734980|FG001|Treatment Period|Never Treated|6|||
106019445|NCT02023697|365734981|FG002|Treatment Period|Never Treated|10|||
106019446|NCT02023697|365734979|FG000|Treatment Period|Adverse Event|13|||
106019447|NCT02023697|365734980|FG001|Treatment Period|Adverse Event|25|||
106019448|NCT02023697|365734981|FG002|Treatment Period|Adverse Event|23|||
106019449|NCT02023697|365734979|FG000|Treatment Period|Logistical difficulties|1|||
106019450|NCT02023697|365734980|FG001|Treatment Period|Logistical difficulties|1|||
106019451|NCT02023697|365734981|FG002|Treatment Period|Logistical difficulties|1|||
106019452|NCT02023697|365734979|FG000|Treatment Period|Clinical progression|10|||
106019453|NCT02023697|365734980|FG001|Treatment Period|Clinical progression|8|||
106019454|NCT02023697|365734981|FG002|Treatment Period|Clinical progression|28|||
106019455|NCT02023697|365734979|FG000|Treatment Period|Withdrawal by Subject|4|||
106019456|NCT02023697|365734980|FG001|Treatment Period|Withdrawal by Subject|5|||
106019457|NCT02023697|365734981|FG002|Treatment Period|Withdrawal by Subject|13|||
106019458|NCT02023697|365734979|FG000|Treatment Period|Safety outcome reached|0|||
106019459|NCT02023697|365734980|FG001|Treatment Period|Safety outcome reached|1|||
106019460|NCT02023697|365734981|FG002|Treatment Period|Safety outcome reached|0|||
106019461|NCT02023697|365734979|FG000|Treatment Period|Physician Decision|0|||
106019462|NCT02023697|365734980|FG001|Treatment Period|Physician Decision|0|||
106019463|NCT02023697|365734981|FG002|Treatment Period|Physician Decision|1|||
106019464|NCT02023697|365734979|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
106019465|NCT02023697|365734980|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
106019466|NCT02023697|365734981|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
106019467|NCT02023697|365734979|FG000|Active Follow-up Period|Lost to Follow-up|1|||
106019468|NCT02023697|365734980|FG001|Active Follow-up Period|Lost to Follow-up|1|||
106019469|NCT02023697|365734981|FG002|Active Follow-up Period|Lost to Follow-up|1|||
106019470|NCT02023697|365734979|FG000|Active Follow-up Period|Deterioration of general condition|1|||
106019471|NCT02023697|365734980|FG001|Active Follow-up Period|Deterioration of general condition|1|||
106019472|NCT02023697|365734981|FG002|Active Follow-up Period|Deterioration of general condition|1|||
106019473|NCT02023697|365734979|FG000|Active Follow-up Period|Other unspecified|2|||
106019474|NCT02023697|365734980|FG001|Active Follow-up Period|Other unspecified|0|||
106019475|NCT02023697|365734981|FG002|Active Follow-up Period|Other unspecified|1|||
106019476|NCT02023697|365734979|FG000|Active Follow-up Period|Clinical progression|0|||
106019477|NCT02023697|365734980|FG001|Active Follow-up Period|Clinical progression|2|||
106019478|NCT02023697|365734981|FG002|Active Follow-up Period|Clinical progression|1|||
106019479|NCT02023697|365734979|FG000|Active Follow-up Period|Radiological progression|0|||
106019480|NCT02023697|365734980|FG001|Active Follow-up Period|Radiological progression|0|||
106019481|NCT02023697|365734981|FG002|Active Follow-up Period|Radiological progression|1|||
106019482|NCT02023697|365734979|FG000|Active Follow-up Period|Death|83|||
106019483|NCT02023697|365734980|FG001|Active Follow-up Period|Death|82|||
106019484|NCT02023697|365734981|FG002|Active Follow-up Period|Death|87|||
106019485|NCT02023697|365734979|FG000|Long-term Follow-up Period|Death|9|||
106019486|NCT02023697|365734980|FG001|Long-term Follow-up Period|Death|6|||
106145549|NCT02555215|366193121|FG000|Overall Study|Investigator Decision|2|||
105766331|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
105766332|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
105766333|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
105766334|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
105766335|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
105766336|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
105766337|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
106019487|NCT02023697|365734981|FG002|Long-term Follow-up Period|Death|4|||
106019488|NCT02023697|365734979|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
106019489|NCT02023697|365734980|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
106019490|NCT02023697|365734981|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
106019491|NCT02023697|365734979|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
106019492|NCT02023697|365734980|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
106019493|NCT02023697|365734981|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
106019494|NCT02023697|365734979|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
106019495|NCT02023697|365734980|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
105766338|NCT02493868|364796082|FG000|Induction Phase: DE Participants|Other|8|||
106019496|NCT02023697|365734981|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
105766339|NCT02493868|364796083|FG001|Induction Phase: DE Participants|Other|0|||
105766340|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
105766341|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
105766342|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
105766343|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
105766344|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
105766345|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
105766346|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
105766347|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
105766348|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
105766349|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
105766350|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
105766351|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
105766352|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
105766353|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
105766354|NCT02493868|364796082|FG000|Optimization Phase: DE+TE Participants|Other|10|||
105766355|NCT02493868|364796083|FG001|Optimization Phase: DE+TE Participants|Other|2|||
105766356|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
105821799|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821800|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821801|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
105821802|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
105821803|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821804|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821805|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821806|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821807|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821808|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821809|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821810|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821811|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821812|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821813|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821814|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105957310|NCT00803361|365504510|FG001|Overall Study|Lost to Follow-up|2|||
105957311|NCT00803361|365504509|FG000|Overall Study|Physician Decision|1|||
105957312|NCT00803361|365504510|FG001|Overall Study|Physician Decision|0|||
105957313|NCT00803361|365504509|FG000|Overall Study|Protocol Violation|2|||
105957314|NCT00803361|365504510|FG001|Overall Study|Protocol Violation|4|||
105957315|NCT00803361|365504509|FG000|Overall Study|Withdrawal by Subject|5|||
105957316|NCT00803361|365504510|FG001|Overall Study|Withdrawal by Subject|6|||
105957317|NCT00402324|365504513|FG000|Overall Study|Lost to Follow-up|11|||
105957318|NCT00402324|365504514|FG001|Overall Study|Lost to Follow-up|11|||
105957319|NCT00402324|365504513|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
105957320|NCT00402324|365504514|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
105957321|NCT00402324|365504513|FG000|Overall Study|Protocol Violation|8|||
105957322|NCT00402324|365504514|FG001|Overall Study|Protocol Violation|7|||
105957323|NCT00402324|365504513|FG000|Overall Study|Withdrawal by Subject|5|||
105957324|NCT00402324|365504514|FG001|Overall Study|Withdrawal by Subject|2|||
105957325|NCT00402324|365504513|FG000|Overall Study|Physician Decision|2|||
105957326|NCT00402324|365504514|FG001|Overall Study|Physician Decision|4|||
105957327|NCT00402324|365504513|FG000|Overall Study|Sponsor Decision|4|||
105957328|NCT00402324|365504514|FG001|Overall Study|Sponsor Decision|5|||
105957329|NCT00402324|365504513|FG000|Overall Study|Lack of Efficacy|1|||
105957330|NCT00402324|365504514|FG001|Overall Study|Lack of Efficacy|4|||
105957331|NCT00402324|365504513|FG000|Overall Study|Adverse Event|6|||
105957332|NCT00402324|365504514|FG001|Overall Study|Adverse Event|4|||
105957333|NCT00402324|365504513|FG000|Overall Study|Death|1|||
105957334|NCT00402324|365504514|FG001|Overall Study|Death|0|||
105957335|NCT02997865|365504517|FG000|Overall Study|Death|2|||
105957336|NCT02997865|365504518|FG001|Overall Study|Death|1|||
105957337|NCT02997865|365504517|FG000|Overall Study|Lost to Follow-up|6|||
105957338|NCT02997865|365504518|FG001|Overall Study|Lost to Follow-up|3|||
105957339|NCT02997865|365504517|FG000|Overall Study|Withdrawal by Subject|5|||
105957340|NCT02997865|365504518|FG001|Overall Study|Withdrawal by Subject|0|||
105957341|NCT01926444|365504519|FG000|Overall Study|Colonoscopy not performed|0|||
105957342|NCT01926444|365504520|FG001|Overall Study|Colonoscopy not performed|0|||
105957343|NCT01926444|365504521|FG002|Overall Study|Colonoscopy not performed|4|||
105957344|NCT01926444|365504522|FG003|Overall Study|Colonoscopy not performed|2|||
105957345|NCT01945996|365504523|FG000|Overall Study|Lost to Follow-up|3|||
105821815|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821816|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
105821817|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821818|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821819|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821820|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821821|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
105821822|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
105821823|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
105821824|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
105821825|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821826|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
105821827|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821828|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821829|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821830|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821831|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821832|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821833|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821834|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821835|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821836|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821837|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
105821838|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821839|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821840|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821841|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821842|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821843|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
105821844|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821845|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821846|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
105821847|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821848|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
105821849|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
105821850|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
105821851|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821852|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821853|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821854|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821855|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821856|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821857|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105821858|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
105957346|NCT01945996|365504524|FG001|Overall Study|Lost to Follow-up|5|||
105957347|NCT00625586|365504525|FG000|Overall Study|Adverse Event|1|||
105957348|NCT00625586|365504525|FG000|Overall Study|Progressive disease|1|||
105957349|NCT02969915|365504526|FG000|Overall Study|Death|104|||
105957350|NCT02969915|365504527|FG001|Overall Study|Death|125|||
105957351|NCT02969915|365504526|FG000|Overall Study|Lost to Follow-up|108|||
105957352|NCT02969915|365504527|FG001|Overall Study|Lost to Follow-up|112|||
105957353|NCT02969915|365504526|FG000|Overall Study|Censored due to COVID-19|481|||
105957354|NCT02969915|365504527|FG001|Overall Study|Censored due to COVID-19|471|||
105957355|NCT02503085|365504528|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
105957356|NCT02503085|365504529|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
105957357|NCT02503085|365504530|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
105957358|NCT02503085|365504531|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
105957359|NCT04466384|365504535|FG000|First Phase|Protocol Violation|1|||
105957360|NCT04466384|365504536|FG001|First Phase|Protocol Violation|0|||
105957361|NCT04466384|365504535|FG000|First Phase|Missing data|1|||
105957362|NCT04466384|365504536|FG001|First Phase|Missing data|0|||
105957363|NCT04466384|365504535|FG000|Cross Over Phase|Physician Decision|1|||
105957364|NCT04466384|365504536|FG001|Cross Over Phase|Physician Decision|0|||
105957365|NCT04466384|365504535|FG000|Cross Over Phase|Withdrawal by Subject|0|||
105957366|NCT04466384|365504536|FG001|Cross Over Phase|Withdrawal by Subject|1|||
105957367|NCT03599518|365504537|FG000|Overall Study|Clinical progression|0|||
105821859|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105957368|NCT03599518|365504538|FG001|Overall Study|Clinical progression|0|||
105957369|NCT03599518|365504539|FG002|Overall Study|Clinical progression|0|||
105957370|NCT03599518|365504540|FG003|Overall Study|Clinical progression|0|||
105957371|NCT03599518|365504541|FG004|Overall Study|Clinical progression|1|||
105821860|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821861|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821862|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821863|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
105766357|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
105766358|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
105766359|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
105766360|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
105766361|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
105766362|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
105766363|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
105766364|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
105766365|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
105821864|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
105957372|NCT03599518|365504537|FG000|Overall Study|Adverse Event|0|||
105957373|NCT03599518|365504538|FG001|Overall Study|Adverse Event|0|||
105957374|NCT03599518|365504539|FG002|Overall Study|Adverse Event|0|||
105957375|NCT03599518|365504540|FG003|Overall Study|Adverse Event|0|||
105957376|NCT03599518|365504541|FG004|Overall Study|Adverse Event|1|||
105957377|NCT03599518|365504537|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
105957378|NCT03599518|365504538|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
105957379|NCT03599518|365504539|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
105957380|NCT03599518|365504540|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
105957381|NCT03599518|365504541|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
105957382|NCT03599518|365504537|FG000|Overall Study|Participant withdrawal from study treatment|0|||
105957383|NCT03599518|365504538|FG001|Overall Study|Participant withdrawal from study treatment|0|||
105957384|NCT03599518|365504539|FG002|Overall Study|Participant withdrawal from study treatment|1|||
105957385|NCT03599518|365504540|FG003|Overall Study|Participant withdrawal from study treatment|0|||
105957386|NCT03599518|365504541|FG004|Overall Study|Participant withdrawal from study treatment|0|||
105957387|NCT01016132|365504542|FG000|Overall Study|Discomfort|1|||
105957388|NCT02151786|365504543|FG000|Overall Study|Unavailability of Case Report Form|26|||
105957389|NCT02151786|365504543|FG000|Overall Study|Outside the Contract Period|1|||
105957390|NCT02151786|365504543|FG000|Overall Study|Randomized, not Treated|1|||
105957391|NCT02151786|365504543|FG000|Overall Study|Unavailability of Information|8|||
105957392|NCT02949024|365504544|FG000|Overall Study|Withdrawal by Subject|0|||
105957393|NCT02949024|365504545|FG001|Overall Study|Withdrawal by Subject|1|||
105957394|NCT01082081|365504548|FG000|Overall Study|Lost to Follow-up|0|||
105957395|NCT01082081|365504549|FG001|Overall Study|Lost to Follow-up|0|||
105957396|NCT01082081|365504550|FG002|Overall Study|Lost to Follow-up|1|||
105957397|NCT01082081|365504548|FG000|Overall Study|Withdrawal by Subject|0|||
105957398|NCT01082081|365504549|FG001|Overall Study|Withdrawal by Subject|0|||
105957399|NCT01082081|365504550|FG002|Overall Study|Withdrawal by Subject|1|||
105957400|NCT01082081|365504548|FG000|Overall Study|Other Reason|0|||
105957401|NCT01082081|365504549|FG001|Overall Study|Other Reason|1|||
105957402|NCT01082081|365504550|FG002|Overall Study|Other Reason|0|||
105957403|NCT01042158|365504555|FG000|Overall Study|Physician Decision|1|||
105957404|NCT01575808|365504557|FG000|Overall Study|Death|2|||
105957405|NCT01575808|365504558|FG001|Overall Study|Death|0|||
105957406|NCT01575808|365504557|FG000|Overall Study|Withdrawal by Subject|1|||
105957407|NCT01575808|365504558|FG001|Overall Study|Withdrawal by Subject|0|||
105957408|NCT03159468|365504559|FG000|Overall Study|Withdrawal by Subject|0|||
105957409|NCT03159468|365504560|FG001|Overall Study|Withdrawal by Subject|0|||
105957410|NCT03159468|365504561|FG002|Overall Study|Withdrawal by Subject|3|||
105957411|NCT03159468|365504562|FG003|Overall Study|Withdrawal by Subject|0|||
105957412|NCT03159468|365504563|FG004|Overall Study|Withdrawal by Subject|0|||
105957413|NCT03159468|365504564|FG005|Overall Study|Withdrawal by Subject|0|||
105957414|NCT00375674|365504567|FG000|Overall Study|Other|26|||
105957415|NCT00375674|365504568|FG001|Overall Study|Other|18|||
105957416|NCT00375674|365504567|FG000|Overall Study|Death|67|||
105957417|NCT00375674|365504568|FG001|Overall Study|Death|76|||
105957418|NCT00375674|365504567|FG000|Overall Study|Participants refused further follow-up|31|||
105957419|NCT00375674|365504568|FG001|Overall Study|Participants refused further follow-up|30|||
105957420|NCT00375674|365504567|FG000|Overall Study|Lost to Follow-up|17|||
105957421|NCT00375674|365504568|FG001|Overall Study|Lost to Follow-up|15|||
105957422|NCT00375674|365504567|FG000|Overall Study|Enrolled but not treated|3|||
105957423|NCT00375674|365504568|FG001|Overall Study|Enrolled but not treated|2|||
105957424|NCT00912782|365504569|FG000|Overall Study|Death|2|||
105957425|NCT00912782|365504570|FG001|Overall Study|Death|1|||
105957426|NCT00912782|365504569|FG000|Overall Study|Lost to Follow-up|0|||
105957427|NCT00912782|365504570|FG001|Overall Study|Lost to Follow-up|1|||
105957428|NCT00912782|365504569|FG000|Overall Study|Did not receive vascular access type|1|||
105821865|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
105821866|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
105821867|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
105821868|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
105821869|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
105821870|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
105821871|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
105821872|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821873|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821874|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821875|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821876|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821877|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821878|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821879|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
105821880|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821881|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821882|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821883|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821884|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
105821885|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
105821886|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
105821887|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821888|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
105821889|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
105821890|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
105821891|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
105821892|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
105821893|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821894|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821895|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821896|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821897|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821898|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821899|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821900|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
105821901|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821902|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821903|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821904|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821905|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
105821906|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821907|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821908|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821909|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
105821910|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
105821911|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
105821912|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821913|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
105821914|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821915|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821916|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821917|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821918|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821919|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821920|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821921|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
105821922|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105957429|NCT00912782|365504570|FG001|Overall Study|Did not receive vascular access type|2|||
105957430|NCT00912782|365504569|FG000|Overall Study|Relocated before study completion|0|||
105821923|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105957431|NCT00912782|365504570|FG001|Overall Study|Relocated before study completion|1|||
105957432|NCT01566149|365506526|FG000|Overall Study|Adverse Event|0|||
105957433|NCT01566149|365506527|FG001|Overall Study|Adverse Event|1|||
105957434|NCT01566149|365506526|FG000|Overall Study|Non-compliance with study medication|2|||
105957435|NCT01566149|365506527|FG001|Overall Study|Non-compliance with study medication|0|||
105957436|NCT01566149|365506526|FG000|Overall Study|Protocol Violation|0|||
105957437|NCT01566149|365506527|FG001|Overall Study|Protocol Violation|1|||
105957438|NCT01566149|365506526|FG000|Overall Study|Withdrawal by Subject|1|||
105957439|NCT01566149|365506527|FG001|Overall Study|Withdrawal by Subject|0|||
105957440|NCT02982772|365506530|FG000|Intervention|Lost to Follow-up|19|||
105957441|NCT02982772|365506531|FG001|Intervention|Lost to Follow-up|13|||
105957442|NCT02982772|365506530|FG000|1M Follow-Up|Lost to Follow-up|21|||
105957443|NCT02982772|365506531|FG001|1M Follow-Up|Lost to Follow-up|18|||
105957444|NCT02982772|365506530|FG000|3M Follow-Up|Lost to Follow-up|17|||
105957445|NCT02982772|365506531|FG001|3M Follow-Up|Lost to Follow-up|11|||
105957446|NCT02982772|365506530|FG000|6M Follow-Up|Lost to Follow-up|11|||
105957447|NCT02982772|365506531|FG001|6M Follow-Up|Lost to Follow-up|9|||
105957448|NCT02982772|365506530|FG000|12M Follow-Up|Lost to Follow-up|11|||
105957449|NCT02982772|365506531|FG001|12M Follow-Up|Lost to Follow-up|5|||
105957450|NCT01713582|365506532|FG000|Overall Study|Disease progression|3|||
105957451|NCT01713582|365506533|FG001|Overall Study|Disease progression|3|||
105957452|NCT01713582|365506534|FG002|Overall Study|Disease progression|3|||
105957453|NCT01713582|365506535|FG003|Overall Study|Disease progression|2|||
105957454|NCT01713582|365506536|FG004|Overall Study|Disease progression|3|||
105957455|NCT01713582|365506537|FG005|Overall Study|Disease progression|3|||
105957456|NCT01713582|365506538|FG006|Overall Study|Disease progression|3|||
105957457|NCT01713582|365506539|FG007|Overall Study|Disease progression|3|||
105957458|NCT01713582|365506540|FG008|Overall Study|Disease progression|3|||
105957459|NCT01713582|365506541|FG009|Overall Study|Disease progression|11|||
105957460|NCT01713582|365506542|FG010|Overall Study|Disease progression|10|||
105957461|NCT01713582|365506543|FG011|Overall Study|Disease progression|5|||
105957462|NCT01713582|365506544|FG012|Overall Study|Disease progression|3|||
105957463|NCT01713582|365506545|FG013|Overall Study|Disease progression|3|||
105957464|NCT01713582|365506546|FG014|Overall Study|Disease progression|6|||
105957465|NCT01713582|365506547|FG015|Overall Study|Disease progression|6|||
105957466|NCT01713582|365506548|FG016|Overall Study|Disease progression|5|||
105957467|NCT01713582|365506549|FG017|Overall Study|Disease progression|2|||
105957468|NCT01713582|365506550|FG018|Overall Study|Disease progression|3|||
105957469|NCT01713582|365506551|FG019|Overall Study|Disease progression|5|||
105957470|NCT01713582|365506552|FG020|Overall Study|Disease progression|15|||
105957471|NCT01713582|365506532|FG000|Overall Study|Death|0|||
105957472|NCT01713582|365506533|FG001|Overall Study|Death|0|||
105957473|NCT01713582|365506534|FG002|Overall Study|Death|0|||
105957474|NCT01713582|365506535|FG003|Overall Study|Death|1|||
105957475|NCT01713582|365506536|FG004|Overall Study|Death|1|||
105957476|NCT01713582|365506537|FG005|Overall Study|Death|3|||
105957477|NCT01713582|365506538|FG006|Overall Study|Death|3|||
105957478|NCT01713582|365506539|FG007|Overall Study|Death|2|||
105957479|NCT01713582|365506540|FG008|Overall Study|Death|3|||
105957480|NCT01713582|365506541|FG009|Overall Study|Death|4|||
105957481|NCT01713582|365506542|FG010|Overall Study|Death|3|||
105957482|NCT01713582|365506543|FG011|Overall Study|Death|0|||
105957483|NCT01713582|365506544|FG012|Overall Study|Death|0|||
105957484|NCT01713582|365506545|FG013|Overall Study|Death|0|||
105957485|NCT01713582|365506546|FG014|Overall Study|Death|0|||
105957486|NCT01713582|365506547|FG015|Overall Study|Death|0|||
105957487|NCT01713582|365506548|FG016|Overall Study|Death|0|||
105957488|NCT01713582|365506549|FG017|Overall Study|Death|0|||
105957489|NCT01713582|365506550|FG018|Overall Study|Death|0|||
105957490|NCT01713582|365506551|FG019|Overall Study|Death|0|||
105957491|NCT01713582|365506552|FG020|Overall Study|Death|0|||
105957492|NCT01713582|365506532|FG000|Overall Study|Adverse event-related|0|||
105957493|NCT01713582|365506533|FG001|Overall Study|Adverse event-related|0|||
105957494|NCT01713582|365506534|FG002|Overall Study|Adverse event-related|0|||
105957495|NCT01713582|365506535|FG003|Overall Study|Adverse event-related|0|||
105957496|NCT01713582|365506536|FG004|Overall Study|Adverse event-related|0|||
105957497|NCT01713582|365506537|FG005|Overall Study|Adverse event-related|0|||
105957498|NCT01713582|365506538|FG006|Overall Study|Adverse event-related|0|||
105957499|NCT01713582|365506539|FG007|Overall Study|Adverse event-related|0|||
105957500|NCT01713582|365506540|FG008|Overall Study|Adverse event-related|0|||
105957501|NCT01713582|365506541|FG009|Overall Study|Adverse event-related|1|||
105957502|NCT01713582|365506542|FG010|Overall Study|Adverse event-related|1|||
105957503|NCT01713582|365506543|FG011|Overall Study|Adverse event-related|0|||
105957504|NCT01713582|365506544|FG012|Overall Study|Adverse event-related|0|||
106145550|NCT00566527|366193122|FG000|Overall Study|Reason not provided|3|||
106145551|NCT00566527|366193123|FG001|Overall Study|Reason not provided|11|||
105957505|NCT01713582|365506545|FG013|Overall Study|Adverse event-related|0|||
105957506|NCT01713582|365506546|FG014|Overall Study|Adverse event-related|0|||
105957507|NCT01713582|365506547|FG015|Overall Study|Adverse event-related|0|||
105957508|NCT01713582|365506548|FG016|Overall Study|Adverse event-related|0|||
105957509|NCT01713582|365506549|FG017|Overall Study|Adverse event-related|0|||
105957510|NCT01713582|365506550|FG018|Overall Study|Adverse event-related|1|||
106145552|NCT00566527|366193124|FG002|Overall Study|Reason not provided|10|||
106145553|NCT00566527|366193122|FG000|Overall Study|Adverse Event|2|||
106145554|NCT00566527|366193123|FG001|Overall Study|Adverse Event|0|||
106145555|NCT00566527|366193124|FG002|Overall Study|Adverse Event|1|||
106145556|NCT00566527|366193122|FG000|Overall Study|Physician Decision|3|||
106145557|NCT00566527|366193123|FG001|Overall Study|Physician Decision|8|||
106145558|NCT00566527|366193124|FG002|Overall Study|Physician Decision|20|||
106145559|NCT00566527|366193122|FG000|Overall Study|Lost to Follow-up|3|||
106145560|NCT00566527|366193123|FG001|Overall Study|Lost to Follow-up|4|||
106145561|NCT00566527|366193124|FG002|Overall Study|Lost to Follow-up|4|||
105821924|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821925|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821926|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
105821927|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
105821928|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
105821929|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821930|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
105821931|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
105821932|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
105821933|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
105821934|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
105821935|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821936|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821937|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821938|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821939|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821940|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821941|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821942|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
105821943|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821944|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821945|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821946|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821947|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105957511|NCT01713582|365506551|FG019|Overall Study|Adverse event-related|0|||
105957512|NCT01713582|365506552|FG020|Overall Study|Adverse event-related|0|||
105957513|NCT01713582|365506532|FG000|Overall Study|Adverse event-unrelated|0|||
105957514|NCT01713582|365506533|FG001|Overall Study|Adverse event-unrelated|0|||
105957515|NCT01713582|365506534|FG002|Overall Study|Adverse event-unrelated|0|||
105957516|NCT01713582|365506535|FG003|Overall Study|Adverse event-unrelated|0|||
105957517|NCT01713582|365506536|FG004|Overall Study|Adverse event-unrelated|0|||
105957518|NCT01713582|365506537|FG005|Overall Study|Adverse event-unrelated|1|||
105957519|NCT01713582|365506538|FG006|Overall Study|Adverse event-unrelated|1|||
105957520|NCT01713582|365506539|FG007|Overall Study|Adverse event-unrelated|1|||
105957521|NCT01713582|365506540|FG008|Overall Study|Adverse event-unrelated|0|||
105957522|NCT01713582|365506541|FG009|Overall Study|Adverse event-unrelated|0|||
105957523|NCT01713582|365506542|FG010|Overall Study|Adverse event-unrelated|0|||
105957524|NCT01713582|365506543|FG011|Overall Study|Adverse event-unrelated|0|||
105957525|NCT01713582|365506544|FG012|Overall Study|Adverse event-unrelated|0|||
105957526|NCT01713582|365506545|FG013|Overall Study|Adverse event-unrelated|1|||
105957527|NCT01713582|365506546|FG014|Overall Study|Adverse event-unrelated|1|||
105957528|NCT01713582|365506547|FG015|Overall Study|Adverse event-unrelated|0|||
105957529|NCT01713582|365506548|FG016|Overall Study|Adverse event-unrelated|0|||
105957530|NCT01713582|365506549|FG017|Overall Study|Adverse event-unrelated|0|||
105957531|NCT01713582|365506550|FG018|Overall Study|Adverse event-unrelated|0|||
105957532|NCT01713582|365506551|FG019|Overall Study|Adverse event-unrelated|0|||
105957533|NCT01713582|365506552|FG020|Overall Study|Adverse event-unrelated|0|||
105957534|NCT01713582|365506532|FG000|Overall Study|Withdrawal of consent|0|||
105957535|NCT01713582|365506533|FG001|Overall Study|Withdrawal of consent|0|||
105957536|NCT01713582|365506534|FG002|Overall Study|Withdrawal of consent|1|||
105821948|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821949|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105957537|NCT01713582|365506535|FG003|Overall Study|Withdrawal of consent|0|||
105957538|NCT01713582|365506536|FG004|Overall Study|Withdrawal of consent|0|||
105957539|NCT01713582|365506537|FG005|Overall Study|Withdrawal of consent|1|||
105957540|NCT01713582|365506538|FG006|Overall Study|Withdrawal of consent|0|||
106145562|NCT00566527|366193122|FG000|Overall Study|Withdrawal by Subject|6|||
106145563|NCT00566527|366193123|FG001|Overall Study|Withdrawal by Subject|43|||
106145564|NCT00566527|366193124|FG002|Overall Study|Withdrawal by Subject|43|||
106145565|NCT04975308|366193125|FG000|Overall Study|Withdrawal by Subject|6|||
105957541|NCT01713582|365506539|FG007|Overall Study|Withdrawal of consent|0|||
105957542|NCT01713582|365506540|FG008|Overall Study|Withdrawal of consent|0|||
105957543|NCT01713582|365506541|FG009|Overall Study|Withdrawal of consent|1|||
105957544|NCT01713582|365506542|FG010|Overall Study|Withdrawal of consent|0|||
105957545|NCT01713582|365506543|FG011|Overall Study|Withdrawal of consent|0|||
105957546|NCT01713582|365506544|FG012|Overall Study|Withdrawal of consent|0|||
105957547|NCT01713582|365506545|FG013|Overall Study|Withdrawal of consent|0|||
105957548|NCT01713582|365506546|FG014|Overall Study|Withdrawal of consent|0|||
105957549|NCT01713582|365506547|FG015|Overall Study|Withdrawal of consent|0|||
105957550|NCT01713582|365506548|FG016|Overall Study|Withdrawal of consent|0|||
105957551|NCT01713582|365506549|FG017|Overall Study|Withdrawal of consent|0|||
105957552|NCT01713582|365506550|FG018|Overall Study|Withdrawal of consent|1|||
105957553|NCT01713582|365506551|FG019|Overall Study|Withdrawal of consent|0|||
105957554|NCT01713582|365506552|FG020|Overall Study|Withdrawal of consent|0|||
105957555|NCT01713582|365506532|FG000|Overall Study|Lack of Efficacy|0|||
105957556|NCT01713582|365506533|FG001|Overall Study|Lack of Efficacy|0|||
105957557|NCT01713582|365506534|FG002|Overall Study|Lack of Efficacy|0|||
105957558|NCT01713582|365506535|FG003|Overall Study|Lack of Efficacy|0|||
105957559|NCT01713582|365506536|FG004|Overall Study|Lack of Efficacy|0|||
105957560|NCT01713582|365506537|FG005|Overall Study|Lack of Efficacy|0|||
105957561|NCT01713582|365506538|FG006|Overall Study|Lack of Efficacy|0|||
105957562|NCT01713582|365506539|FG007|Overall Study|Lack of Efficacy|0|||
105957563|NCT01713582|365506540|FG008|Overall Study|Lack of Efficacy|0|||
105957564|NCT01713582|365506541|FG009|Overall Study|Lack of Efficacy|1|||
105957565|NCT01713582|365506542|FG010|Overall Study|Lack of Efficacy|2|||
105957566|NCT01713582|365506543|FG011|Overall Study|Lack of Efficacy|0|||
105957567|NCT01713582|365506544|FG012|Overall Study|Lack of Efficacy|0|||
105957568|NCT01713582|365506545|FG013|Overall Study|Lack of Efficacy|0|||
105957569|NCT01713582|365506546|FG014|Overall Study|Lack of Efficacy|0|||
105957570|NCT01713582|365506547|FG015|Overall Study|Lack of Efficacy|0|||
105957571|NCT01713582|365506548|FG016|Overall Study|Lack of Efficacy|0|||
105957572|NCT01713582|365506549|FG017|Overall Study|Lack of Efficacy|0|||
105957573|NCT01713582|365506550|FG018|Overall Study|Lack of Efficacy|0|||
105957574|NCT01713582|365506551|FG019|Overall Study|Lack of Efficacy|0|||
105957575|NCT01713582|365506552|FG020|Overall Study|Lack of Efficacy|0|||
105957576|NCT01713582|365506532|FG000|Overall Study|Withdrawal by Subject|0|||
105957577|NCT01713582|365506533|FG001|Overall Study|Withdrawal by Subject|0|||
105957578|NCT01713582|365506534|FG002|Overall Study|Withdrawal by Subject|0|||
105957579|NCT01713582|365506535|FG003|Overall Study|Withdrawal by Subject|0|||
105957580|NCT01713582|365506536|FG004|Overall Study|Withdrawal by Subject|0|||
105957581|NCT01713582|365506537|FG005|Overall Study|Withdrawal by Subject|0|||
105957582|NCT01713582|365506538|FG006|Overall Study|Withdrawal by Subject|0|||
105957583|NCT01713582|365506539|FG007|Overall Study|Withdrawal by Subject|0|||
105957584|NCT01713582|365506540|FG008|Overall Study|Withdrawal by Subject|0|||
105957585|NCT01713582|365506541|FG009|Overall Study|Withdrawal by Subject|0|||
105957586|NCT01713582|365506542|FG010|Overall Study|Withdrawal by Subject|0|||
105957587|NCT01713582|365506543|FG011|Overall Study|Withdrawal by Subject|0|||
105957588|NCT01713582|365506544|FG012|Overall Study|Withdrawal by Subject|0|||
105957589|NCT01713582|365506545|FG013|Overall Study|Withdrawal by Subject|0|||
105957590|NCT01713582|365506546|FG014|Overall Study|Withdrawal by Subject|0|||
105766366|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
105766367|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
105766368|NCT02493868|364796082|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
105766369|NCT02493868|364796083|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
105766370|NCT02493868|364796082|FG000|Follow-up Phase|Lost to Follow-up|1|||
105766371|NCT02493868|364796083|FG001|Follow-up Phase|Lost to Follow-up|0|||
105766372|NCT02493868|364796082|FG000|Follow-up Phase|Withdrawal by Subject|3|||
105766373|NCT02493868|364796083|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105766374|NCT02493868|364796082|FG000|Follow-up Phase|Investigator Decision|5|||
105766375|NCT02493868|364796083|FG001|Follow-up Phase|Investigator Decision|1|||
105766376|NCT02493868|364796082|FG000|Follow-up Phase|Other|2|||
105766377|NCT02493868|364796083|FG001|Follow-up Phase|Other|1|||
105766378|NCT00430027|364798188|FG000|Overall Study|Study terminated|8|||
105766379|NCT01685060|364798194|FG000|Overall Study|Rollover patients|16|||
105766380|NCT01685060|364798194|FG000|Overall Study|Adverse Event|12|||
105766381|NCT01685060|364798194|FG000|Overall Study|Progressive disease|69|||
105957591|NCT01713582|365506547|FG015|Overall Study|Withdrawal by Subject|0|||
105957592|NCT01713582|365506548|FG016|Overall Study|Withdrawal by Subject|0|||
105957593|NCT01713582|365506549|FG017|Overall Study|Withdrawal by Subject|1|||
105957594|NCT01713582|365506550|FG018|Overall Study|Withdrawal by Subject|0|||
105957595|NCT01713582|365506551|FG019|Overall Study|Withdrawal by Subject|0|||
105957596|NCT01713582|365506552|FG020|Overall Study|Withdrawal by Subject|0|||
106019497|NCT02023697|365734979|FG000|Long-term Follow-up Period|Technical problems|0|||
105766382|NCT01685060|364798194|FG000|Overall Study|Physician Decision|14|||
105957597|NCT01713582|365506532|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
105957598|NCT01713582|365506533|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
105821950|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821951|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821952|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821953|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821954|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
105821955|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821956|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821957|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821958|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821959|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821960|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821961|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821962|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821963|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
105821964|NCT01597245|365006706|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821965|NCT01597245|365006707|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821966|NCT01597245|365006708|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821967|NCT01597245|365006709|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821968|NCT01597245|365006710|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821969|NCT01597245|365006711|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821970|NCT01597245|365006712|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821971|NCT01597245|365006713|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821972|NCT01597245|365006714|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821973|NCT01597245|365006715|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821974|NCT01597245|365006716|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
105821975|NCT01597245|365006717|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821976|NCT01597245|365006718|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821977|NCT01597245|365006719|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821978|NCT01597245|365006720|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821979|NCT01597245|365006721|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821980|NCT01597245|365006722|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821981|NCT01597245|365006723|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821982|NCT01597245|365006724|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821983|NCT01597245|365006725|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821984|NCT01597245|365006726|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
105821985|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821986|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821987|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821988|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821989|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821990|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821991|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821992|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821993|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821994|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821995|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821996|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
106019498|NCT02023697|365734980|FG001|Long-term Follow-up Period|Technical problems|0|||
106019499|NCT02023697|365734981|FG002|Long-term Follow-up Period|Technical problems|1|||
106019500|NCT02023697|365734979|FG000|Long-term Follow-up Period|Other unspecified|6|||
106019501|NCT02023697|365734980|FG001|Long-term Follow-up Period|Other unspecified|3|||
106019502|NCT02023697|365734981|FG002|Long-term Follow-up Period|Other unspecified|5|||
106019503|NCT04139798|365734982|FG000|Overall Study|Withdrawal by Subject|6|||
106019504|NCT04139798|365734983|FG001|Overall Study|Withdrawal by Subject|5|||
106019505|NCT04139798|365734982|FG000|Overall Study|Lost to Follow-up|2|||
106019506|NCT04139798|365734983|FG001|Overall Study|Lost to Follow-up|5|||
106019507|NCT04139798|365734982|FG000|Overall Study|Discontinued|4|||
106019508|NCT04139798|365734983|FG001|Overall Study|Discontinued|2|||
106019509|NCT04139798|365734982|FG000|Overall Study|Adverse Event|1|||
106019510|NCT04139798|365734983|FG001|Overall Study|Adverse Event|3|||
106145566|NCT04975308|366193126|FG001|Overall Study|Withdrawal by Subject|16|||
106145567|NCT04975308|366193127|FG002|Overall Study|Withdrawal by Subject|6|||
106145568|NCT04975308|366193125|FG000|Overall Study|Physician Decision|0|||
106145569|NCT04975308|366193126|FG001|Overall Study|Physician Decision|3|||
106145570|NCT04975308|366193127|FG002|Overall Study|Physician Decision|1|||
106145571|NCT04975308|366193125|FG000|Overall Study|Adverse Event|10|||
106145572|NCT04975308|366193126|FG001|Overall Study|Adverse Event|1|||
106145573|NCT04975308|366193127|FG002|Overall Study|Adverse Event|12|||
106019511|NCT04139798|365734982|FG000|Overall Study|Protocol Violation|1|||
106019512|NCT04139798|365734983|FG001|Overall Study|Protocol Violation|0|||
106019513|NCT04634253|365734984|FG000|Overall Study|Adverse Event|1|||
106019514|NCT04634253|365734985|FG001|Overall Study|Adverse Event|1|||
106019515|NCT04634253|365734986|FG002|Overall Study|Adverse Event|0|||
106019516|NCT04634253|365734984|FG000|Overall Study|Physician Decision|0|||
106019517|NCT04634253|365734985|FG001|Overall Study|Physician Decision|1|||
106019518|NCT04634253|365734986|FG002|Overall Study|Physician Decision|0|||
106019519|NCT04634253|365734984|FG000|Overall Study|Withdrawal by Subject|1|||
106019520|NCT04634253|365734985|FG001|Overall Study|Withdrawal by Subject|0|||
106019521|NCT04634253|365734986|FG002|Overall Study|Withdrawal by Subject|3|||
106019522|NCT01499355|365734987|FG000|Run-In Period|Study Termination|15|||
106019523|NCT01499355|365734988|FG001|Run-In Period|Study Termination|0|||
106019524|NCT01499355|365734989|FG002|Run-In Period|Study Termination|0|||
106019525|NCT01499355|365734990|FG003|Run-In Period|Study Termination|0|||
106145574|NCT04975308|366193125|FG000|Overall Study|On study treatment (Ongoing)|65|||
106145575|NCT04975308|366193126|FG001|Overall Study|On study treatment (Ongoing)|43|||
106145576|NCT04975308|366193127|FG002|Overall Study|On study treatment (Ongoing)|75|||
106145577|NCT04975308|366193125|FG000|Overall Study|Protocol Deviation|4|||
105766383|NCT01685060|364798194|FG000|Overall Study|Subject/guardian decision|20|||
105766384|NCT01685060|364798194|FG000|Overall Study|Lost to Follow-up|1|||
105766385|NCT01685060|364798194|FG000|Overall Study|Death|8|||
105766386|NCT02944513|364798195|FG000|Overall Study|Withdrawal by Subject|4|||
106145578|NCT04975308|366193126|FG001|Overall Study|Protocol Deviation|3|||
106145579|NCT04975308|366193127|FG002|Overall Study|Protocol Deviation|2|||
106145580|NCT04281485|366193128|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
105766387|NCT02944513|364798196|FG001|Overall Study|Withdrawal by Subject|1|||
105766388|NCT00937326|364798197|FG000|Overall Study|Adverse Event|0|||
105766389|NCT00937326|364798198|FG001|Overall Study|Adverse Event|3|||
105766390|NCT00937326|364798199|FG002|Overall Study|Adverse Event|1|||
105766391|NCT00937326|364798200|FG003|Overall Study|Adverse Event|1|||
105766392|NCT00937326|364798201|FG004|Overall Study|Adverse Event|2|||
105766393|NCT00937326|364798197|FG000|Overall Study|Death|0|||
105766394|NCT00937326|364798198|FG001|Overall Study|Death|0|||
105766395|NCT00937326|364798199|FG002|Overall Study|Death|1|||
105766396|NCT00937326|364798200|FG003|Overall Study|Death|0|||
105766397|NCT00937326|364798201|FG004|Overall Study|Death|0|||
105766398|NCT00937326|364798197|FG000|Overall Study|Withdrawal by Subject|3|||
105766399|NCT00937326|364798198|FG001|Overall Study|Withdrawal by Subject|4|||
105766400|NCT00937326|364798199|FG002|Overall Study|Withdrawal by Subject|1|||
105766401|NCT00937326|364798200|FG003|Overall Study|Withdrawal by Subject|4|||
105766402|NCT00937326|364798201|FG004|Overall Study|Withdrawal by Subject|3|||
105766403|NCT00937326|364798197|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
105766404|NCT00937326|364798198|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
105766405|NCT00937326|364798199|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
105766406|NCT00937326|364798200|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
105766407|NCT00937326|364798201|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
105766408|NCT02578992|364798202|FG000|Overall Study|equipment not available or malfunction|3|||
105766409|NCT02578992|364798203|FG001|Overall Study|equipment not available or malfunction|3|||
105766410|NCT00790218|364798206|FG000|Overall Study|Death|1|||
105766411|NCT00790218|364798207|FG001|Overall Study|Death|0|||
105766412|NCT00790218|364798208|FG002|Overall Study|Death|0|||
105766413|NCT00086385|364798209|FG000|Overall Study|Death|2|||
105766414|NCT00086385|364798210|FG001|Overall Study|Death|2|||
105766415|NCT00086385|364798211|FG002|Overall Study|Death|1|||
105766416|NCT00086385|364798212|FG003|Overall Study|Death|1|||
105766417|NCT00880100|364798215|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
105766418|NCT00880100|364798215|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
106145581|NCT04281485|366193129|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
106145582|NCT04281485|366193128|FG000|Overall Study|Ongoing (Safety data collection)|10|||
106145583|NCT04281485|366193129|FG001|Overall Study|Ongoing (Safety data collection)|5|||
105766419|NCT00880100|364798215|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
105766420|NCT01431521|364798216|FG000|Overall Study|Withdrawal by Subject|0|||
105766421|NCT01431521|364798217|FG001|Overall Study|Withdrawal by Subject|0|||
105766422|NCT01431521|364798218|FG002|Overall Study|Withdrawal by Subject|1|||
105766423|NCT01431521|364798219|FG003|Overall Study|Withdrawal by Subject|0|||
105766424|NCT00731666|364798220|FG000|Overall Study|Adverse Event|2|||
105766425|NCT00731666|364798220|FG000|Overall Study|Lost to Follow-up|8|||
106145584|NCT01278394|366193130|FG000|Overall Study|Lost to Follow-up|1|||
106145585|NCT00468910|366193131|FG000|Overall Study|Lost to Follow-up|2|||
106145586|NCT00468910|366193132|FG001|Overall Study|Lost to Follow-up|1|||
105766426|NCT00731666|364798220|FG000|Overall Study|Withdrawal by Subject|2|||
105766427|NCT00608894|364798221|FG000|Overall Study|Withdrawal by Subject|0|||
106145587|NCT00468910|366193131|FG000|Overall Study|Withdrawal by Subject|2|||
105766428|NCT00608894|364798222|FG001|Overall Study|Withdrawal by Subject|2|||
105766429|NCT03654560|364798223|FG000|Overall Study|Death|3|||
106019526|NCT01499355|365734987|FG000|Run-In Period|Other|3|||
106019527|NCT01499355|365734988|FG001|Run-In Period|Other|0|||
106019528|NCT01499355|365734989|FG002|Run-In Period|Other|0|||
106019529|NCT01499355|365734990|FG003|Run-In Period|Other|0|||
106019530|NCT01499355|365734987|FG000|Run-In Period|Death|2|||
106019531|NCT01499355|365734988|FG001|Run-In Period|Death|0|||
106019532|NCT01499355|365734989|FG002|Run-In Period|Death|0|||
106019533|NCT01499355|365734990|FG003|Run-In Period|Death|0|||
106019534|NCT01499355|365734987|FG000|Run-In Period|Investigator Decision|2|||
106019535|NCT01499355|365734988|FG001|Run-In Period|Investigator Decision|0|||
106019536|NCT01499355|365734989|FG002|Run-In Period|Investigator Decision|0|||
106019537|NCT01499355|365734990|FG003|Run-In Period|Investigator Decision|0|||
106019538|NCT01499355|365734987|FG000|Run-In Period|Consent Withdrawn|1|||
106019539|NCT01499355|365734988|FG001|Run-In Period|Consent Withdrawn|0|||
106019540|NCT01499355|365734989|FG002|Run-In Period|Consent Withdrawn|0|||
106019541|NCT01499355|365734990|FG003|Run-In Period|Consent Withdrawn|0|||
106019542|NCT01499355|365734987|FG000|Run-In Period|Adverse Event|8|||
106019543|NCT01499355|365734988|FG001|Run-In Period|Adverse Event|0|||
106019544|NCT01499355|365734989|FG002|Run-In Period|Adverse Event|0|||
106019545|NCT01499355|365734990|FG003|Run-In Period|Adverse Event|0|||
106019546|NCT01499355|365734987|FG000|Double-Blind Period|Adverse Event|0|||
106019547|NCT01499355|365734988|FG001|Double-Blind Period|Adverse Event|2|||
106019548|NCT01499355|365734989|FG002|Double-Blind Period|Adverse Event|3|||
106019549|NCT01499355|365734990|FG003|Double-Blind Period|Adverse Event|2|||
106019550|NCT01499355|365734987|FG000|Double-Blind Period|Study Termination|0|||
106019551|NCT01499355|365734988|FG001|Double-Blind Period|Study Termination|18|||
106019552|NCT01499355|365734989|FG002|Double-Blind Period|Study Termination|16|||
106019553|NCT01499355|365734990|FG003|Double-Blind Period|Study Termination|14|||
106019554|NCT01499355|365734987|FG000|Double-Blind Period|Other|0|||
106019555|NCT01499355|365734988|FG001|Double-Blind Period|Other|1|||
105766430|NCT03654560|364798224|FG001|Overall Study|Death|1|||
105766431|NCT03654560|364798223|FG000|Overall Study|Lost to Follow-up|1|||
105766432|NCT03654560|364798224|FG001|Overall Study|Lost to Follow-up|0|||
105766433|NCT01473355|364798225|FG000|Overall Study|Protocol Violation|2|||
105766434|NCT01473355|364798225|FG000|Overall Study|Adverse Event|2|||
105766435|NCT01473355|364798225|FG000|Overall Study|Lost to Follow-up|2|||
105766436|NCT00106249|364798226|FG000|Overall Study|Lost to Follow-up|3|||
105766437|NCT00106249|364798227|FG001|Overall Study|Lost to Follow-up|2|||
105766438|NCT01462045|364798230|FG000|Overall Study|Family matter|0|||
105766439|NCT01462045|364798231|FG001|Overall Study|Family matter|1|||
105766440|NCT01462045|364798232|FG002|Overall Study|Family matter|0|||
105766441|NCT02471586|364798233|FG000|Overall Study|Lost to Follow-up|3|||
105766442|NCT02471586|364798234|FG001|Overall Study|Lost to Follow-up|8|||
105766443|NCT02471586|364798235|FG002|Overall Study|Lost to Follow-up|4|||
105766444|NCT02471586|364798233|FG000|Overall Study|Death|2|||
105766445|NCT02471586|364798234|FG001|Overall Study|Death|2|||
105766446|NCT02471586|364798235|FG002|Overall Study|Death|0|||
105766447|NCT01117181|364798237|FG000|Overall Study|Lost to Follow-up|1|||
105766448|NCT01117181|364798238|FG001|Overall Study|Lost to Follow-up|0|||
105766449|NCT01117181|364798237|FG000|Overall Study|Withdrawal by Subject|0|||
105766450|NCT01117181|364798238|FG001|Overall Study|Withdrawal by Subject|2|||
105766451|NCT01119963|364798239|FG000|Overall Study|Lost to Follow-up|1|||
105766452|NCT01119963|364798240|FG001|Overall Study|Lost to Follow-up|1|||
105766453|NCT03938636|364798241|FG000|Overall Study|Protocol Violation|0|||
105766454|NCT03938636|364798242|FG001|Overall Study|Protocol Violation|1|||
105766455|NCT03938636|364798243|FG002|Overall Study|Protocol Violation|1|||
105766456|NCT03938636|364798241|FG000|Overall Study|Subject withdrew due to death in family|0|||
105766457|NCT03938636|364798242|FG001|Overall Study|Subject withdrew due to death in family|1|||
105766458|NCT03938636|364798243|FG002|Overall Study|Subject withdrew due to death in family|0|||
105766459|NCT03938636|364798241|FG000|Overall Study|Missed visit|0|||
105766460|NCT03938636|364798242|FG001|Overall Study|Missed visit|1|||
105766461|NCT03938636|364798243|FG002|Overall Study|Missed visit|0|||
105766462|NCT03938636|364798241|FG000|Overall Study|Adverse Event|0|||
105766463|NCT03938636|364798242|FG001|Overall Study|Adverse Event|0|||
105766464|NCT03938636|364798243|FG002|Overall Study|Adverse Event|1|||
105766465|NCT03938636|364798241|FG000|Overall Study|Lost to Follow-up|0|||
105766466|NCT03938636|364798242|FG001|Overall Study|Lost to Follow-up|0|||
105766467|NCT03938636|364798243|FG002|Overall Study|Lost to Follow-up|1|||
105766468|NCT00606177|364798244|FG000|Overall Study|Adverse Event|9|||
105766469|NCT00606177|364798245|FG001|Overall Study|Adverse Event|5|||
105766470|NCT00606177|364798244|FG000|Overall Study|Lack of Efficacy|3|||
105766471|NCT00606177|364798245|FG001|Overall Study|Lack of Efficacy|7|||
105766472|NCT00606177|364798244|FG000|Overall Study|Physician Decision|1|||
105766473|NCT00606177|364798245|FG001|Overall Study|Physician Decision|0|||
105766474|NCT00606177|364798244|FG000|Overall Study|Protocol Violation|1|||
105766475|NCT00606177|364798245|FG001|Overall Study|Protocol Violation|4|||
105766476|NCT00606177|364798244|FG000|Overall Study|Withdrawal by Subject|5|||
105766477|NCT00606177|364798245|FG001|Overall Study|Withdrawal by Subject|6|||
106019556|NCT01499355|365734989|FG002|Double-Blind Period|Other|2|||
106019557|NCT01499355|365734990|FG003|Double-Blind Period|Other|2|||
106019558|NCT01499355|365734987|FG000|Double-Blind Period|Death|0|||
106019559|NCT01499355|365734988|FG001|Double-Blind Period|Death|1|||
105821997|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105821998|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
105821999|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
105822000|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
105822001|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822002|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822003|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822004|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822005|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
105822006|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822007|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822008|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822009|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822010|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822011|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822012|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822013|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822014|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822015|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822016|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822017|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822018|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822019|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
105822020|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
105822021|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
105822022|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822023|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822024|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822025|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822026|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
105822027|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822028|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822029|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822030|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822031|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822032|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822033|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822034|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822035|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822036|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822037|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822038|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822039|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822040|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822041|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
105822042|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
105822043|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822044|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822045|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822046|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822047|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
105822048|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822049|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822050|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822051|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822052|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822053|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822054|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822055|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822056|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
106145588|NCT00468910|366193132|FG001|Overall Study|Withdrawal by Subject|1|||
106145589|NCT00468910|366193131|FG000|Overall Study|Medical Contraindication|0|||
106145590|NCT00468910|366193132|FG001|Overall Study|Medical Contraindication|1|||
105957599|NCT01713582|365506534|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
105957600|NCT01713582|365506535|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
105957601|NCT01713582|365506536|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
105957602|NCT01713582|365506537|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
105957603|NCT01713582|365506538|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
105957604|NCT01713582|365506539|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
105957605|NCT01713582|365506540|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
105957606|NCT01713582|365506541|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
105957607|NCT01713582|365506542|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
105957608|NCT01713582|365506543|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
105957609|NCT01713582|365506544|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
105957610|NCT01713582|365506545|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
105957611|NCT01713582|365506546|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
105957612|NCT01713582|365506547|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
105957613|NCT01713582|365506548|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
105957614|NCT01713582|365506549|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
105957615|NCT01713582|365506550|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
105957616|NCT01713582|365506551|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
105957617|NCT01713582|365506552|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
105957618|NCT01713582|365506532|FG000|Overall Study|Disease progression and adverse event|0|||
105957619|NCT01713582|365506533|FG001|Overall Study|Disease progression and adverse event|0|||
105957620|NCT01713582|365506534|FG002|Overall Study|Disease progression and adverse event|0|||
105957621|NCT01713582|365506535|FG003|Overall Study|Disease progression and adverse event|0|||
105957622|NCT01713582|365506536|FG004|Overall Study|Disease progression and adverse event|0|||
105957623|NCT01713582|365506537|FG005|Overall Study|Disease progression and adverse event|0|||
105957624|NCT01713582|365506538|FG006|Overall Study|Disease progression and adverse event|0|||
105957625|NCT01713582|365506539|FG007|Overall Study|Disease progression and adverse event|0|||
105957626|NCT01713582|365506540|FG008|Overall Study|Disease progression and adverse event|0|||
105957627|NCT01713582|365506541|FG009|Overall Study|Disease progression and adverse event|0|||
105957628|NCT01713582|365506542|FG010|Overall Study|Disease progression and adverse event|0|||
105957629|NCT01713582|365506543|FG011|Overall Study|Disease progression and adverse event|0|||
105957630|NCT01713582|365506544|FG012|Overall Study|Disease progression and adverse event|0|||
105957631|NCT01713582|365506545|FG013|Overall Study|Disease progression and adverse event|0|||
105957632|NCT01713582|365506546|FG014|Overall Study|Disease progression and adverse event|0|||
105957633|NCT01713582|365506547|FG015|Overall Study|Disease progression and adverse event|0|||
105957634|NCT01713582|365506548|FG016|Overall Study|Disease progression and adverse event|1|||
105957635|NCT01713582|365506549|FG017|Overall Study|Disease progression and adverse event|0|||
105957636|NCT01713582|365506550|FG018|Overall Study|Disease progression and adverse event|0|||
105957637|NCT01713582|365506551|FG019|Overall Study|Disease progression and adverse event|0|||
105957638|NCT01713582|365506552|FG020|Overall Study|Disease progression and adverse event|0|||
105957639|NCT00620373|365506556|FG000|Overall Study|Unverified cancer status|33|||
105957640|NCT01061723|365506557|FG000|Overall Study|Adverse Event|0|||
105957641|NCT01061723|365506558|FG001|Overall Study|Adverse Event|2|||
105957642|NCT01061723|365506559|FG002|Overall Study|Adverse Event|5|||
105957643|NCT01061723|365506560|FG003|Overall Study|Adverse Event|5|||
105957644|NCT01061723|365506561|FG004|Overall Study|Adverse Event|2|||
105957645|NCT01061723|365506562|FG005|Overall Study|Adverse Event|6|||
105957646|NCT01061723|365506557|FG000|Overall Study|Lack of Efficacy|2|||
105957647|NCT01061723|365506558|FG001|Overall Study|Lack of Efficacy|3|||
105957648|NCT01061723|365506559|FG002|Overall Study|Lack of Efficacy|4|||
105957649|NCT01061723|365506560|FG003|Overall Study|Lack of Efficacy|2|||
105957650|NCT01061723|365506561|FG004|Overall Study|Lack of Efficacy|1|||
105957651|NCT01061723|365506562|FG005|Overall Study|Lack of Efficacy|1|||
105957652|NCT01061723|365506557|FG000|Overall Study|Randomized but not treated|0|||
105957653|NCT01061723|365506558|FG001|Overall Study|Randomized but not treated|0|||
105957654|NCT01061723|365506559|FG002|Overall Study|Randomized but not treated|0|||
105957655|NCT01061723|365506560|FG003|Overall Study|Randomized but not treated|0|||
105957656|NCT01061723|365506561|FG004|Overall Study|Randomized but not treated|0|||
105957657|NCT01061723|365506562|FG005|Overall Study|Randomized but not treated|1|||
105957658|NCT01061723|365506557|FG000|Overall Study|Other than specified above|2|||
105957659|NCT01061723|365506558|FG001|Overall Study|Other than specified above|1|||
105957660|NCT01061723|365506559|FG002|Overall Study|Other than specified above|1|||
105957661|NCT01061723|365506560|FG003|Overall Study|Other than specified above|1|||
105957662|NCT01061723|365506561|FG004|Overall Study|Other than specified above|0|||
105957663|NCT01061723|365506562|FG005|Overall Study|Other than specified above|1|||
105957664|NCT00293813|365506563|FG000|Overall Study|Physician Decision|0|||
105957665|NCT00293813|365506564|FG001|Overall Study|Physician Decision|1|||
105957666|NCT00293813|365506565|FG002|Overall Study|Physician Decision|0|||
105957667|NCT00293813|365506563|FG000|Overall Study|Adverse Event|3|||
105957668|NCT00293813|365506564|FG001|Overall Study|Adverse Event|1|||
105957669|NCT00293813|365506565|FG002|Overall Study|Adverse Event|1|||
105822057|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822058|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822059|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822060|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822061|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822062|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
105822063|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
105822064|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822065|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822066|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822067|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822068|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
105822069|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822070|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822071|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822072|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822073|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822074|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822075|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822076|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822077|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822078|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822079|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105957670|NCT00293813|365506563|FG000|Overall Study|Withdrawal by Subject|7|||
105957671|NCT00293813|365506564|FG001|Overall Study|Withdrawal by Subject|4|||
105957672|NCT00293813|365506565|FG002|Overall Study|Withdrawal by Subject|4|||
105957673|NCT00293813|365506563|FG000|Overall Study|Lost to Follow-up|3|||
105957674|NCT00293813|365506564|FG001|Overall Study|Lost to Follow-up|2|||
105957675|NCT00293813|365506565|FG002|Overall Study|Lost to Follow-up|3|||
105957676|NCT00293813|365506563|FG000|Overall Study|Noncompliance|0|||
105957677|NCT00293813|365506564|FG001|Overall Study|Noncompliance|1|||
105957678|NCT00293813|365506565|FG002|Overall Study|Noncompliance|0|||
105957679|NCT03308968|365506568|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
105957680|NCT03308968|365506569|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
105957681|NCT03308968|365506570|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
105957682|NCT03308968|365506568|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
105957683|NCT03308968|365506569|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
105957684|NCT03308968|365506570|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
105957685|NCT03308968|365506568|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
105957686|NCT03308968|365506569|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
105957687|NCT03308968|365506570|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
105957688|NCT03308968|365506568|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
105957689|NCT03308968|365506569|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
105957690|NCT03308968|365506570|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
105957691|NCT03308968|365506568|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
105957692|NCT03308968|365506569|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
105957693|NCT03308968|365506570|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
105957694|NCT03308968|365506568|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
105957695|NCT03308968|365506569|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
105957696|NCT03308968|365506570|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
105957697|NCT03308968|365506568|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
105957698|NCT03308968|365506569|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
105957699|NCT03308968|365506570|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
105957700|NCT03308968|365506568|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
105957701|NCT03308968|365506569|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
105957702|NCT03308968|365506570|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
105957703|NCT03308968|365506568|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
105957704|NCT03308968|365506569|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
105957705|NCT03308968|365506570|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
105957706|NCT03308968|365506568|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
105957707|NCT03308968|365506569|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
105957708|NCT03308968|365506570|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
105957709|NCT03308968|365506568|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
105822080|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822081|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822082|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
105822083|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
106019560|NCT01499355|365734989|FG002|Double-Blind Period|Death|0|||
106019561|NCT01499355|365734990|FG003|Double-Blind Period|Death|0|||
106019562|NCT01499355|365734987|FG000|Double-Blind Period|Investigator Decision|0|||
106019563|NCT01499355|365734988|FG001|Double-Blind Period|Investigator Decision|0|||
106019564|NCT01499355|365734989|FG002|Double-Blind Period|Investigator Decision|3|||
106019565|NCT01499355|365734990|FG003|Double-Blind Period|Investigator Decision|3|||
106019566|NCT01499355|365734987|FG000|Double-Blind Period|Consent Withdrawn|0|||
106019567|NCT01499355|365734988|FG001|Double-Blind Period|Consent Withdrawn|0|||
106019568|NCT01499355|365734989|FG002|Double-Blind Period|Consent Withdrawn|1|||
106019569|NCT01499355|365734990|FG003|Double-Blind Period|Consent Withdrawn|2|||
106019570|NCT01499355|365734987|FG000|Double-Blind Period|Lost to Follow-up|0|||
106019571|NCT01499355|365734988|FG001|Double-Blind Period|Lost to Follow-up|1|||
106019572|NCT01499355|365734989|FG002|Double-Blind Period|Lost to Follow-up|0|||
106019573|NCT01499355|365734990|FG003|Double-Blind Period|Lost to Follow-up|0|||
106019574|NCT03610269|365734992|FG000|Overall Study|Physician Decision|10|||
106019575|NCT03610269|365734992|FG000|Overall Study|Protocol Violation|1|||
106019576|NCT03610269|365734992|FG000|Overall Study|Unable to draw blood|1|||
106019577|NCT03610269|365734992|FG000|Overall Study|Screen fail|4|||
106019578|NCT04411667|365734993|FG000|Overall Study|Physician Decision|1|||
106019579|NCT04411667|365734994|FG001|Overall Study|Physician Decision|0|||
106019580|NCT02817464|365734995|FG000|Overall Study|Lost to Follow-up|1|||
106019581|NCT02817464|365734996|FG001|Overall Study|Lost to Follow-up|0|||
106019582|NCT02817464|365734995|FG000|Overall Study|Discontinued early due to personal decision|1|||
105822084|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
105822085|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822086|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105822087|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
106019583|NCT02817464|365734996|FG001|Overall Study|Discontinued early due to personal decision|1|||
105822088|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
105957710|NCT03308968|365506569|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
105957711|NCT03308968|365506570|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
105957712|NCT03308968|365506568|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
105957713|NCT03308968|365506569|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
105957714|NCT03308968|365506570|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
105957715|NCT03308968|365506568|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
105957716|NCT03308968|365506569|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
105957717|NCT03308968|365506570|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
105957718|NCT03308968|365506568|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
105957719|NCT03308968|365506569|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
105957720|NCT03308968|365506570|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
105957721|NCT02140970|365506571|FG000|Overall Study|Lost to Follow-up|1|||
105957722|NCT02140970|365506572|FG001|Overall Study|Lost to Follow-up|2|||
105957723|NCT02140970|365506571|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
105957724|NCT02140970|365506572|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
105957725|NCT02140970|365506571|FG000|Overall Study|Did not meet inclusion criteria|0|||
105957726|NCT02140970|365506572|FG001|Overall Study|Did not meet inclusion criteria|1|||
105957727|NCT03650413|365506573|FG000|Overall Study|Adverse Event|1|||
105957728|NCT03650413|365506573|FG000|Overall Study|Lack of Efficacy|17|||
105957729|NCT03650413|365506573|FG000|Overall Study|Other|9|||
105957730|NCT03650413|365506573|FG000|Overall Study|Physician Decision|2|||
105957731|NCT03650413|365506573|FG000|Overall Study|Study Terminated By Sponsor|16|||
105957732|NCT03650413|365506573|FG000|Overall Study|Withdrawal by Subject|16|||
105957733|NCT01484496|365506579|FG000|Period 1|Protocol Violation|3|||
105957734|NCT01484496|365506580|FG001|Period 1|Protocol Violation|4|||
105957735|NCT01484496|365506581|FG002|Period 1|Protocol Violation|0|||
105957736|NCT01484496|365506582|FG003|Period 1|Protocol Violation|0|||
105957737|NCT01484496|365506579|FG000|Period 1|Physician Decision|5|||
105957738|NCT01484496|365506580|FG001|Period 1|Physician Decision|1|||
105957739|NCT01484496|365506581|FG002|Period 1|Physician Decision|0|||
105957740|NCT01484496|365506582|FG003|Period 1|Physician Decision|0|||
105957741|NCT01484496|365506579|FG000|Period 1|Lack of Efficacy|10|||
105957742|NCT01484496|365506580|FG001|Period 1|Lack of Efficacy|15|||
106019584|NCT00885534|365734997|FG000|Overall Study|Patient deemed ineligible|1|||
106019585|NCT01626872|365734998|FG000|Overall Study|Physician Decision|13|||
106019586|NCT01626872|365734999|FG001|Overall Study|Physician Decision|9|||
105957743|NCT01484496|365506581|FG002|Period 1|Lack of Efficacy|0|||
105957744|NCT01484496|365506582|FG003|Period 1|Lack of Efficacy|0|||
105822089|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
106019587|NCT01626872|365735000|FG002|Overall Study|Physician Decision|6|||
105957745|NCT01484496|365506579|FG000|Period 1|Adverse Event|25|||
105957746|NCT01484496|365506580|FG001|Period 1|Adverse Event|40|||
105957747|NCT01484496|365506581|FG002|Period 1|Adverse Event|0|||
106019588|NCT01626872|365734998|FG000|Overall Study|Withdrawal by Subject|19|||
106019589|NCT01626872|365734999|FG001|Overall Study|Withdrawal by Subject|27|||
106019590|NCT01626872|365735000|FG002|Overall Study|Withdrawal by Subject|8|||
106019591|NCT01626872|365734998|FG000|Overall Study|Adverse Event (including Death)|20|||
106019592|NCT01626872|365734999|FG001|Overall Study|Adverse Event (including Death)|28|||
106019593|NCT01626872|365735000|FG002|Overall Study|Adverse Event (including Death)|8|||
106019594|NCT01626872|365734998|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
106019595|NCT01626872|365734999|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
106019596|NCT01626872|365735000|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
106019597|NCT02453711|365735001|FG000|Overall Study|Withdrawal by Subject|5|||
106019598|NCT02453711|365735002|FG001|Overall Study|Withdrawal by Subject|4|||
106019599|NCT02453711|365735003|FG002|Overall Study|Withdrawal by Subject|6|||
106019600|NCT02453711|365735004|FG003|Overall Study|Withdrawal by Subject|4|||
106019601|NCT02453711|365735005|FG004|Overall Study|Withdrawal by Subject|1|||
106019602|NCT02453711|365735006|FG005|Overall Study|Withdrawal by Subject|1|||
106019603|NCT02453711|365735007|FG006|Overall Study|Withdrawal by Subject|0|||
106019604|NCT02453711|365735008|FG007|Overall Study|Withdrawal by Subject|1|||
106019605|NCT02453711|365735009|FG008|Overall Study|Withdrawal by Subject|7|||
106019606|NCT02453711|365735001|FG000|Overall Study|Lost to Follow-up|5|||
106019607|NCT02453711|365735002|FG001|Overall Study|Lost to Follow-up|3|||
106019608|NCT02453711|365735003|FG002|Overall Study|Lost to Follow-up|2|||
106019609|NCT02453711|365735004|FG003|Overall Study|Lost to Follow-up|3|||
106019610|NCT02453711|365735005|FG004|Overall Study|Lost to Follow-up|1|||
106019611|NCT02453711|365735006|FG005|Overall Study|Lost to Follow-up|5|||
106019612|NCT02453711|365735007|FG006|Overall Study|Lost to Follow-up|2|||
106019613|NCT02453711|365735008|FG007|Overall Study|Lost to Follow-up|6|||
106019614|NCT02453711|365735009|FG008|Overall Study|Lost to Follow-up|6|||
106019615|NCT02453711|365735001|FG000|Overall Study|Death|0|||
106019616|NCT02453711|365735002|FG001|Overall Study|Death|0|||
106019617|NCT02453711|365735003|FG002|Overall Study|Death|0|||
106019618|NCT02453711|365735004|FG003|Overall Study|Death|0|||
106019619|NCT02453711|365735005|FG004|Overall Study|Death|0|||
106019620|NCT02453711|365735006|FG005|Overall Study|Death|0|||
106019621|NCT02453711|365735007|FG006|Overall Study|Death|1|||
106019622|NCT02453711|365735008|FG007|Overall Study|Death|0|||
106019623|NCT02453711|365735009|FG008|Overall Study|Death|0|||
106019624|NCT02453711|365735001|FG000|Overall Study|Unclassified|1|||
106019625|NCT02453711|365735002|FG001|Overall Study|Unclassified|0|||
106019626|NCT02453711|365735003|FG002|Overall Study|Unclassified|1|||
106019627|NCT02453711|365735004|FG003|Overall Study|Unclassified|0|||
106019628|NCT02453711|365735005|FG004|Overall Study|Unclassified|0|||
106019629|NCT02453711|365735006|FG005|Overall Study|Unclassified|0|||
106019630|NCT02453711|365735007|FG006|Overall Study|Unclassified|0|||
106019631|NCT02453711|365735008|FG007|Overall Study|Unclassified|0|||
106019632|NCT02453711|365735009|FG008|Overall Study|Unclassified|0|||
106019633|NCT01273519|365735011|FG000|Overall Study|Adverse Event|3|||
106019634|NCT01273519|365735012|FG001|Overall Study|Adverse Event|0|||
106019635|NCT01273519|365735013|FG002|Overall Study|Adverse Event|0|||
106019636|NCT01273519|365735011|FG000|Overall Study|Lost to Follow-up|2|||
106019637|NCT01273519|365735012|FG001|Overall Study|Lost to Follow-up|1|||
106019638|NCT01273519|365735013|FG002|Overall Study|Lost to Follow-up|3|||
106019639|NCT01273519|365735011|FG000|Overall Study|Lack of Efficacy|8|||
106019640|NCT01273519|365735012|FG001|Overall Study|Lack of Efficacy|3|||
106019641|NCT01273519|365735013|FG002|Overall Study|Lack of Efficacy|4|||
106019642|NCT01273519|365735011|FG000|Overall Study|Other|6|||
106019643|NCT01273519|365735012|FG001|Overall Study|Other|1|||
106019644|NCT01273519|365735013|FG002|Overall Study|Other|1|||
106019645|NCT03695367|365735014|FG000|Overall Study|Missed the Day 28 visit.|1|||
106019646|NCT03695367|365735015|FG001|Overall Study|Missed the Day 28 visit.|0|||
106019647|NCT03695367|365735014|FG000|Overall Study|Lost to Follow-up|0|||
106019648|NCT03695367|365735015|FG001|Overall Study|Lost to Follow-up|1|||
106019649|NCT03695367|365735014|FG000|Overall Study|Withdrawal by Subject|0|||
106019650|NCT03695367|365735015|FG001|Overall Study|Withdrawal by Subject|1|||
106019651|NCT03695367|365735014|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
106019652|NCT03695367|365735015|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
106019653|NCT05334212|365735028|FG000|Overall Study|Study terminated prematurely|7|||
106019654|NCT01209325|365735029|FG000|Overall Study|Lost to Follow-up|24|||
106019655|NCT01209325|365735029|FG000|Overall Study|Adverse Event|1|||
106019656|NCT01209325|365735029|FG000|Overall Study|Relocated|3|||
106019657|NCT01209325|365735029|FG000|Overall Study|Refusal after starting therapy|8|||
106019658|NCT01209325|365735029|FG000|Overall Study|Protocol Violation|4|||
106019659|NCT01209325|365735029|FG000|Overall Study|Refusal prior to therapy|1|||
106019660|NCT01209325|365735029|FG000|Overall Study|Incarceration|2|||
106019661|NCT02039843|365735032|FG000|Randomization and Observation Period|Adverse Event|2|||
106019662|NCT02039843|365735033|FG001|Randomization and Observation Period|Adverse Event|0|||
106019663|NCT02039843|365735032|FG000|Randomization and Observation Period|Death|1|||
106019664|NCT02039843|365735033|FG001|Randomization and Observation Period|Death|0|||
106019665|NCT02039843|365735032|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
105822090|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822091|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822092|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822093|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822094|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822095|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822096|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822097|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822098|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822099|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822100|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822101|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822102|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822103|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822104|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
105822105|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
105822106|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822107|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822108|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822109|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822110|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
105822111|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822112|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822113|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822114|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822115|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822116|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822117|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822118|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822119|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822120|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822121|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822122|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822123|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822124|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822125|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
105822126|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
105822127|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822128|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822129|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822130|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822131|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
105822132|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822133|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822134|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822135|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822136|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822137|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822138|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822139|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822140|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822141|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822142|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822143|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822144|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822145|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822146|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
105822147|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
105822148|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822149|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822150|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822151|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822152|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
105822153|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105957748|NCT01484496|365506582|FG003|Period 1|Adverse Event|0|||
105957749|NCT01484496|365506579|FG000|Period 1|Withdrawal by Subject|15|||
106145591|NCT05323734|366193133|FG000|Overall Study|Adverse Event|5|||
106145592|NCT05323734|366193134|FG001|Overall Study|Adverse Event|2|||
106145593|NCT05323734|366193133|FG000|Overall Study|Physician Decision|1|||
105822154|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822155|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822156|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822157|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822158|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822159|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822160|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822161|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822162|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822163|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822164|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822165|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822166|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822167|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
105822168|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
105822169|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822170|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822171|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822172|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105957750|NCT01484496|365506580|FG001|Period 1|Withdrawal by Subject|12|||
105957751|NCT01484496|365506581|FG002|Period 1|Withdrawal by Subject|0|||
105957752|NCT01484496|365506582|FG003|Period 1|Withdrawal by Subject|0|||
105957753|NCT01484496|365506579|FG000|Period 1|Lost to Follow-up|2|||
105957754|NCT01484496|365506580|FG001|Period 1|Lost to Follow-up|6|||
105957755|NCT01484496|365506581|FG002|Period 1|Lost to Follow-up|0|||
105957756|NCT01484496|365506582|FG003|Period 1|Lost to Follow-up|0|||
105957757|NCT01484496|365506579|FG000|Period 1|Positive Pregnancy|1|||
105957758|NCT01484496|365506580|FG001|Period 1|Positive Pregnancy|6|||
105957759|NCT01484496|365506581|FG002|Period 1|Positive Pregnancy|0|||
105957760|NCT01484496|365506582|FG003|Period 1|Positive Pregnancy|0|||
105957761|NCT01484496|365506579|FG000|Period 1|Treatment Failure|3|||
105957762|NCT01484496|365506580|FG001|Period 1|Treatment Failure|6|||
105766478|NCT00606177|364798244|FG000|Overall Study|Progression to depressive phase|6|||
105766479|NCT00606177|364798245|FG001|Overall Study|Progression to depressive phase|1|||
105766480|NCT00606177|364798244|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
105766481|NCT00606177|364798245|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
105766482|NCT00606177|364798244|FG000|Overall Study|Change of residence or other commitments|1|||
105766483|NCT00606177|364798245|FG001|Overall Study|Change of residence or other commitments|1|||
105766484|NCT02473289|364798248|FG000|Overall Study|Adverse Event|2|||
105766485|NCT02473289|364798249|FG001|Overall Study|Adverse Event|3|||
105766486|NCT02473289|364798248|FG000|Overall Study|Lost to Follow-up|1|||
105766487|NCT02473289|364798249|FG001|Overall Study|Lost to Follow-up|1|||
105766488|NCT02473289|364798248|FG000|Overall Study|Protocol Violation|0|||
105766489|NCT02473289|364798249|FG001|Overall Study|Protocol Violation|1|||
105766490|NCT02473289|364798248|FG000|Overall Study|Withdrawal of consent|6|||
105766491|NCT02473289|364798249|FG001|Overall Study|Withdrawal of consent|7|||
105766492|NCT02473289|364798248|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
105766493|NCT02473289|364798249|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
105766494|NCT02473289|364798248|FG000|Overall Study|Other|2|||
105766495|NCT02473289|364798249|FG001|Overall Study|Other|0|||
105766496|NCT03277105|364798252|FG000|Overall Study|Death|129|||
105957763|NCT01484496|365506581|FG002|Period 1|Treatment Failure|0|||
105957764|NCT01484496|365506582|FG003|Period 1|Treatment Failure|0|||
105957765|NCT01484496|365506579|FG000|Period 1|Lack of Compliance|2|||
105957766|NCT01484496|365506580|FG001|Period 1|Lack of Compliance|1|||
105957767|NCT01484496|365506581|FG002|Period 1|Lack of Compliance|0|||
105957768|NCT01484496|365506582|FG003|Period 1|Lack of Compliance|0|||
105957769|NCT01484496|365506579|FG000|Period 1|Unable to Visit Site|0|||
105957770|NCT01484496|365506580|FG001|Period 1|Unable to Visit Site|2|||
105957771|NCT01484496|365506581|FG002|Period 1|Unable to Visit Site|0|||
105957772|NCT01484496|365506582|FG003|Period 1|Unable to Visit Site|0|||
105957773|NCT01484496|365506579|FG000|Period 2|Lack of Efficacy|0|||
105957774|NCT01484496|365506580|FG001|Period 2|Lack of Efficacy|0|||
105957775|NCT01484496|365506581|FG002|Period 2|Lack of Efficacy|1|||
105957776|NCT01484496|365506582|FG003|Period 2|Lack of Efficacy|3|||
105957777|NCT01484496|365506579|FG000|Period 2|Adverse Event|0|||
105957778|NCT01484496|365506580|FG001|Period 2|Adverse Event|0|||
105957779|NCT01484496|365506581|FG002|Period 2|Adverse Event|5|||
105957780|NCT01484496|365506582|FG003|Period 2|Adverse Event|13|||
106145594|NCT05323734|366193134|FG001|Overall Study|Physician Decision|0|||
106145595|NCT05323734|366193133|FG000|Overall Study|Lack of Efficacy|1|||
105957781|NCT01484496|365506579|FG000|Period 2|Other|0|||
105957782|NCT01484496|365506580|FG001|Period 2|Other|0|||
105957783|NCT01484496|365506581|FG002|Period 2|Other|9|||
105957784|NCT01484496|365506582|FG003|Period 2|Other|6|||
105957785|NCT00310375|365506585|FG000|Primary Reporting Phase|Adverse Event|28|||
105957786|NCT00310375|365506586|FG001|Primary Reporting Phase|Adverse Event|22|||
105957787|NCT00310375|365506587|FG002|Primary Reporting Phase|Adverse Event|0|||
105957788|NCT00310375|365506585|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
105957789|NCT00310375|365506586|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
105957790|NCT00310375|365506587|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
105957791|NCT00310375|365506585|FG000|Primary Reporting Phase|Pregnancy|2|||
105957792|NCT00310375|365506586|FG001|Primary Reporting Phase|Pregnancy|2|||
105957793|NCT00310375|365506587|FG002|Primary Reporting Phase|Pregnancy|0|||
105957794|NCT00310375|365506585|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
105957795|NCT00310375|365506586|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
105957796|NCT00310375|365506587|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
105957797|NCT00310375|365506585|FG000|Primary Reporting Phase|Protocol Violation|8|||
105957798|NCT00310375|365506586|FG001|Primary Reporting Phase|Protocol Violation|5|||
106019666|NCT02039843|365735033|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
106019667|NCT02039843|365735032|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
106019668|NCT02039843|365735033|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
106019669|NCT02039843|365735032|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
106019670|NCT02039843|365735033|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
106019671|NCT02039843|365735032|FG000|Pairing With a Study Dog|Death|1|||
106019672|NCT02039843|365735033|FG001|Pairing With a Study Dog|Death|0|||
106019673|NCT02039843|365735032|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
106019674|NCT02039843|365735033|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
106019675|NCT02039843|365735032|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
106019676|NCT02039843|365735033|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
105957799|NCT00310375|365506587|FG002|Primary Reporting Phase|Protocol Violation|0|||
105957800|NCT00310375|365506585|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
105957801|NCT00310375|365506586|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
105957802|NCT00310375|365506587|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
105957803|NCT00310375|365506585|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
105957804|NCT00310375|365506586|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
105957805|NCT00310375|365506587|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
105957806|NCT00310375|365506585|FG000|Primary Reporting Phase|Physician Decision|5|||
105957807|NCT00310375|365506586|FG001|Primary Reporting Phase|Physician Decision|3|||
105957808|NCT00310375|365506587|FG002|Primary Reporting Phase|Physician Decision|0|||
105957809|NCT00310375|365506585|FG000|Primary Reporting Phase|Request of the sponsor|2|||
105957810|NCT00310375|365506586|FG001|Primary Reporting Phase|Request of the sponsor|2|||
105957811|NCT00310375|365506587|FG002|Primary Reporting Phase|Request of the sponsor|0|||
105957812|NCT00310375|365506585|FG000|Primary Reporting Phase|Failed to return|1|||
105957813|NCT00310375|365506586|FG001|Primary Reporting Phase|Failed to return|3|||
105957814|NCT00310375|365506587|FG002|Primary Reporting Phase|Failed to return|0|||
105957815|NCT00310375|365506585|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
106019677|NCT02039843|365735032|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
106019678|NCT02039843|365735033|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
106019679|NCT01519167|365735034|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
106019680|NCT01519167|365735035|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
106019681|NCT01519167|365735034|FG000|Overall Study|Adverse Event|0|||
106019682|NCT01519167|365735035|FG001|Overall Study|Adverse Event|1|||
106019683|NCT01519167|365735034|FG000|Overall Study|Lack of Efficacy|0|||
106019684|NCT01519167|365735035|FG001|Overall Study|Lack of Efficacy|1|||
106019685|NCT01519167|365735034|FG000|Overall Study|Medical condition changes&deep sedation|0|||
106019686|NCT01519167|365735035|FG001|Overall Study|Medical condition changes&deep sedation|2|||
106019687|NCT01519167|365735034|FG000|Overall Study|Physician Decision|0|||
105766497|NCT03277105|364798253|FG001|Overall Study|Death|124|||
105766498|NCT03277105|364798252|FG000|Overall Study|Lost to Follow-up|2|||
105766499|NCT03277105|364798253|FG001|Overall Study|Lost to Follow-up|4|||
105766500|NCT03277105|364798252|FG000|Overall Study|Withdrawal by Subject|10|||
105766501|NCT03277105|364798253|FG001|Overall Study|Withdrawal by Subject|10|||
105766502|NCT03277105|364798252|FG000|Overall Study|Other|118|||
105766503|NCT03277105|364798253|FG001|Overall Study|Other|125|||
105766504|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
105766505|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
105766506|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
105766507|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
105766508|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
105766509|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
105766510|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
105766511|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
105766512|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
105766513|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
105766514|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
105766515|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
105766516|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
105766517|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
105766518|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
105957816|NCT00310375|365506586|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
105957817|NCT00310375|365506587|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
105957818|NCT00310375|365506585|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
105957819|NCT00310375|365506586|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
105957820|NCT00310375|365506587|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
105957821|NCT00310375|365506585|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
105957822|NCT00310375|365506586|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
105957823|NCT00310375|365506587|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
105957824|NCT00310375|365506585|FG000|Primary Reporting Phase|Site closure|3|||
105957825|NCT00310375|365506586|FG001|Primary Reporting Phase|Site closure|0|||
105957826|NCT00310375|365506587|FG002|Primary Reporting Phase|Site closure|0|||
105957827|NCT00310375|365506585|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
105957828|NCT00310375|365506586|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
105957829|NCT00310375|365506587|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
105957830|NCT00310375|365506585|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
105957831|NCT00310375|365506586|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
105957832|NCT00310375|365506587|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
105957833|NCT00310375|365506585|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
105957834|NCT00310375|365506586|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
105957835|NCT00310375|365506587|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
105957836|NCT00310375|365506585|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
105957837|NCT00310375|365506586|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
105957838|NCT00310375|365506587|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
105957839|NCT02168101|365506589|FG000|Overall Study|Death|2|||
105957840|NCT02168101|365506590|FG001|Overall Study|Death|2|||
105957841|NCT02168101|365506591|FG002|Overall Study|Death|1|||
105957842|NCT01973231|365506592|FG000|Overall Study|Protocol Violation|1|||
105957843|NCT01973231|365506593|FG001|Overall Study|Protocol Violation|1|||
105957844|NCT01973231|365506592|FG000|Overall Study|Lost to Follow-up|1|||
105957845|NCT01973231|365506593|FG001|Overall Study|Lost to Follow-up|1|||
105957846|NCT01973231|365506592|FG000|Overall Study|unclassified|2|||
105957847|NCT01973231|365506593|FG001|Overall Study|unclassified|1|||
105957848|NCT01973231|365506592|FG000|Overall Study|Withdrawal by Subject|7|||
105957849|NCT01973231|365506593|FG001|Overall Study|Withdrawal by Subject|9|||
105957850|NCT01485796|365506597|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
105957851|NCT01485796|365506597|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
105957852|NCT01485796|365506597|FG000|Period 2: Epoch 2|Adverse Event|3|||
105957853|NCT01485796|365506597|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
105957854|NCT01485796|365506597|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
105957855|NCT01485796|365506597|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
105957856|NCT01485796|365506597|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
105957857|NCT01485796|365506597|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
105957858|NCT04830215|365506598|FG000|Overall Study|Adverse Event|6|||
105957859|NCT04830215|365506598|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
105957860|NCT04830215|365506598|FG000|Overall Study|Withdrawal by Subject|3|||
105957861|NCT04830215|365506598|FG000|Overall Study|Protocol Deviation|1|||
105957862|NCT00211172|365506600|FG000|Overall Study|Died or lost health plan eligibility|39|||
105957863|NCT00211172|365506601|FG001|Overall Study|Died or lost health plan eligibility|32|||
105957864|NCT00770562|365506603|FG000|Overall Study|Did not take treatment|1|||
105957865|NCT00770562|365506604|FG001|Overall Study|Did not take treatment|1|||
105957866|NCT01643408|365506605|FG000|Overall Study|Adverse Event|12|||
105957867|NCT01643408|365506605|FG000|Overall Study|Other|2|||
105957868|NCT04677543|365506627|FG000|Overall Study|Withdrawal by Subject|4|||
105957869|NCT04677543|365506628|FG001|Overall Study|Withdrawal by Subject|1|||
105957870|NCT04677543|365506627|FG000|Overall Study|Physician Decision|0|||
105957871|NCT04677543|365506628|FG001|Overall Study|Physician Decision|1|||
105957872|NCT04677543|365506627|FG000|Overall Study|Adverse Event|0|||
105957873|NCT04677543|365506628|FG001|Overall Study|Adverse Event|1|||
105957874|NCT03902392|365506629|FG000|Overall Study|Lost to Follow-up|7|||
105957875|NCT03902392|365506630|FG001|Overall Study|Lost to Follow-up|7|||
105957876|NCT03799952|365506631|FG000|Overall Study|Program was too easy, discontinued|1|||
105957877|NCT03799952|365506632|FG001|Overall Study|Program was too easy, discontinued|0|||
105957878|NCT03799952|365506631|FG000|Overall Study|Lost to Follow-up|0|||
105957879|NCT03799952|365506632|FG001|Overall Study|Lost to Follow-up|2|||
105957880|NCT02595866|365506639|FG000|Overall Study|Adverse Event|2|||
106019688|NCT01519167|365735035|FG001|Overall Study|Physician Decision|1|||
106019689|NCT02541604|365735036|FG000|Overall Study|Death|6|||
106019690|NCT02541604|365735037|FG001|Overall Study|Death|5|||
106019691|NCT02541604|365735038|FG002|Overall Study|Death|7|||
106019692|NCT02541604|365735039|FG003|Overall Study|Death|2|||
106019693|NCT02541604|365735040|FG004|Overall Study|Death|9|||
106019694|NCT02541604|365735041|FG005|Overall Study|Death|8|||
106019695|NCT02541604|365735042|FG006|Overall Study|Death|9|||
106019696|NCT02541604|365735043|FG007|Overall Study|Death|9|||
106019697|NCT02541604|365735044|FG008|Overall Study|Death|3|||
106019698|NCT02541604|365735045|FG009|Overall Study|Death|4|||
106019699|NCT02541604|365735046|FG010|Overall Study|Death|2|||
106019700|NCT02541604|365735047|FG011|Overall Study|Death|3|||
106019701|NCT02541604|365735036|FG000|Overall Study|Lost to Follow-up|2|||
106019702|NCT02541604|365735037|FG001|Overall Study|Lost to Follow-up|0|||
106019703|NCT02541604|365735038|FG002|Overall Study|Lost to Follow-up|1|||
106019704|NCT02541604|365735039|FG003|Overall Study|Lost to Follow-up|0|||
106019705|NCT02541604|365735040|FG004|Overall Study|Lost to Follow-up|0|||
106019706|NCT02541604|365735041|FG005|Overall Study|Lost to Follow-up|1|||
106019707|NCT02541604|365735042|FG006|Overall Study|Lost to Follow-up|1|||
106019708|NCT02541604|365735043|FG007|Overall Study|Lost to Follow-up|0|||
106019709|NCT02541604|365735044|FG008|Overall Study|Lost to Follow-up|0|||
106019710|NCT02541604|365735045|FG009|Overall Study|Lost to Follow-up|0|||
105957881|NCT02595866|365506640|FG001|Overall Study|Adverse Event|5|||
105957882|NCT02595866|365506639|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
105957883|NCT02595866|365506640|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
105957884|NCT02595866|365506639|FG000|Overall Study|Death|0|||
105957885|NCT02595866|365506640|FG001|Overall Study|Death|1|||
105957886|NCT02595866|365506639|FG000|Overall Study|Incarceration|1|||
105957887|NCT02595866|365506640|FG001|Overall Study|Incarceration|0|||
105957888|NCT02595866|365506639|FG000|Overall Study|Lack of Efficacy|17|||
105957889|NCT02595866|365506640|FG001|Overall Study|Lack of Efficacy|7|||
105957890|NCT02595866|365506639|FG000|Overall Study|Physician Decision|4|||
105957891|NCT02595866|365506640|FG001|Overall Study|Physician Decision|3|||
105957892|NCT02595866|365506639|FG000|Overall Study|Switched to Alternative Treatment|1|||
105957893|NCT02595866|365506640|FG001|Overall Study|Switched to Alternative Treatment|0|||
105957894|NCT02595866|365506639|FG000|Overall Study|Study Terminated|0|||
105957895|NCT02595866|365506640|FG001|Overall Study|Study Terminated|4|||
105957896|NCT02595866|365506639|FG000|Overall Study|Withdrawal by Subject|6|||
105957897|NCT02595866|365506640|FG001|Overall Study|Withdrawal by Subject|1|||
105957898|NCT00778336|365506641|FG000|Index Procedure-Discharge|Death|6|||
105957899|NCT00778336|365506642|FG001|Index Procedure-Discharge|Death|3|||
105957900|NCT00778336|365506643|FG002|Index Procedure-Discharge|Death|2|||
105957901|NCT00778336|365506644|FG003|Index Procedure-Discharge|Death|0|||
106019711|NCT02541604|365735046|FG010|Overall Study|Lost to Follow-up|0|||
106019712|NCT02541604|365735047|FG011|Overall Study|Lost to Follow-up|0|||
106019713|NCT02541604|365735036|FG000|Overall Study|Withdrawal by Subject|2|||
106019714|NCT02541604|365735037|FG001|Overall Study|Withdrawal by Subject|0|||
106019715|NCT02541604|365735038|FG002|Overall Study|Withdrawal by Subject|1|||
106019716|NCT02541604|365735039|FG003|Overall Study|Withdrawal by Subject|0|||
106019717|NCT02541604|365735040|FG004|Overall Study|Withdrawal by Subject|1|||
106019718|NCT02541604|365735041|FG005|Overall Study|Withdrawal by Subject|1|||
106019719|NCT02541604|365735042|FG006|Overall Study|Withdrawal by Subject|0|||
106019720|NCT02541604|365735043|FG007|Overall Study|Withdrawal by Subject|0|||
106019721|NCT02541604|365735044|FG008|Overall Study|Withdrawal by Subject|1|||
106019722|NCT02541604|365735045|FG009|Overall Study|Withdrawal by Subject|0|||
106019723|NCT02541604|365735046|FG010|Overall Study|Withdrawal by Subject|0|||
106019724|NCT02541604|365735047|FG011|Overall Study|Withdrawal by Subject|0|||
106019725|NCT02541604|365735036|FG000|Overall Study|Study Terminated by Sponsor|1|||
106019726|NCT02541604|365735037|FG001|Overall Study|Study Terminated by Sponsor|4|||
106019727|NCT02541604|365735038|FG002|Overall Study|Study Terminated by Sponsor|2|||
106145596|NCT05323734|366193134|FG001|Overall Study|Lack of Efficacy|2|||
106145597|NCT05323734|366193133|FG000|Overall Study|Withdrawal by Subject|2|||
106145598|NCT05323734|366193134|FG001|Overall Study|Withdrawal by Subject|0|||
105957902|NCT00778336|365506641|FG000|3 Month Follow Up|Lost to Follow-up|15|||
105957903|NCT00778336|365506642|FG001|3 Month Follow Up|Lost to Follow-up|20|||
105957904|NCT00778336|365506643|FG002|3 Month Follow Up|Lost to Follow-up|3|||
105957905|NCT00778336|365506644|FG003|3 Month Follow Up|Lost to Follow-up|0|||
105957906|NCT00778336|365506641|FG000|3 Month Follow Up|Death|8|||
106019728|NCT02541604|365735039|FG003|Overall Study|Study Terminated by Sponsor|1|||
106019729|NCT02541604|365735040|FG004|Overall Study|Study Terminated by Sponsor|0|||
106019730|NCT02541604|365735041|FG005|Overall Study|Study Terminated by Sponsor|0|||
106019731|NCT02541604|365735042|FG006|Overall Study|Study Terminated by Sponsor|0|||
106019732|NCT02541604|365735043|FG007|Overall Study|Study Terminated by Sponsor|0|||
106019733|NCT02541604|365735044|FG008|Overall Study|Study Terminated by Sponsor|0|||
106019734|NCT02541604|365735045|FG009|Overall Study|Study Terminated by Sponsor|0|||
106145599|NCT05323734|366193133|FG000|Overall Study|Participant Withdrawn Due|0|||
106145600|NCT05323734|366193134|FG001|Overall Study|Participant Withdrawn Due|1|||
106019735|NCT02541604|365735046|FG010|Overall Study|Study Terminated by Sponsor|0|||
106019736|NCT02541604|365735047|FG011|Overall Study|Study Terminated by Sponsor|0|||
106019737|NCT02541604|365735036|FG000|Overall Study|Medical condition may jeopardize safety|0|||
106019738|NCT02541604|365735037|FG001|Overall Study|Medical condition may jeopardize safety|0|||
106019739|NCT02541604|365735038|FG002|Overall Study|Medical condition may jeopardize safety|0|||
106019740|NCT02541604|365735039|FG003|Overall Study|Medical condition may jeopardize safety|0|||
106019741|NCT02541604|365735040|FG004|Overall Study|Medical condition may jeopardize safety|0|||
106019742|NCT02541604|365735041|FG005|Overall Study|Medical condition may jeopardize safety|0|||
106019743|NCT02541604|365735042|FG006|Overall Study|Medical condition may jeopardize safety|0|||
106019744|NCT02541604|365735043|FG007|Overall Study|Medical condition may jeopardize safety|1|||
106019745|NCT02541604|365735044|FG008|Overall Study|Medical condition may jeopardize safety|0|||
106019746|NCT02541604|365735045|FG009|Overall Study|Medical condition may jeopardize safety|0|||
106019747|NCT02541604|365735046|FG010|Overall Study|Medical condition may jeopardize safety|0|||
106019748|NCT02541604|365735047|FG011|Overall Study|Medical condition may jeopardize safety|0|||
106019749|NCT00993148|365735048|FG000|Overall Study|Lost to Follow-up|2|||
106019750|NCT00993148|365735048|FG000|Overall Study|never initiated treatment|1|||
106019751|NCT00806819|365735051|FG000|Overall Study|progressive disease (modified RECIST )|217|||
106019752|NCT00806819|365735052|FG001|Overall Study|progressive disease (modified RECIST )|216|||
106019753|NCT00806819|365735051|FG000|Overall Study|Worsening or AE of underlying disease|18|||
106019754|NCT00806819|365735052|FG001|Overall Study|Worsening or AE of underlying disease|25|||
106019755|NCT00806819|365735051|FG000|Overall Study|Other AE|38|||
106019756|NCT00806819|365735052|FG001|Overall Study|Other AE|40|||
106019757|NCT00806819|365735051|FG000|Overall Study|Protocol Violation|9|||
106019758|NCT00806819|365735052|FG001|Overall Study|Protocol Violation|4|||
106019759|NCT00806819|365735051|FG000|Overall Study|Lost to Follow-up|1|||
106019760|NCT00806819|365735052|FG001|Overall Study|Lost to Follow-up|0|||
106019761|NCT00806819|365735051|FG000|Overall Study|Withdrawal by Subject|32|||
106019762|NCT00806819|365735052|FG001|Overall Study|Withdrawal by Subject|29|||
106019763|NCT00806819|365735051|FG000|Overall Study|Not treated|6|||
106019764|NCT00806819|365735052|FG001|Overall Study|Not treated|3|||
106019765|NCT00806819|365735051|FG000|Overall Study|Reasons other than stated above|25|||
106019766|NCT00806819|365735052|FG001|Overall Study|Reasons other than stated above|41|||
106019767|NCT04393454|365735055|FG000|Overall Study|Death|1|||
106019768|NCT04393454|365735055|FG000|Overall Study|Lost to Follow-up|1|||
106019769|NCT01704599|365735058|FG000|Overall Study|Adverse Event|1|||
106019770|NCT04237116|365735059|FG000|Overall Study|Adverse Event|0|||
106019771|NCT04237116|365735060|FG001|Overall Study|Adverse Event|1|||
106019772|NCT04237116|365735059|FG000|Overall Study|Study terminated by Sponsor|4|||
106019773|NCT04237116|365735060|FG001|Overall Study|Study terminated by Sponsor|1|||
106019774|NCT00829504|365735061|FG000|First Intervention|Adverse Event|1|||
106019775|NCT00829504|365735062|FG001|First Intervention|Adverse Event|0|||
106019776|NCT00829504|365735061|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
106019777|NCT00829504|365735062|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
106019778|NCT00829504|365735061|FG000|Second Intervention|Physician Decision|1|||
106019779|NCT00829504|365735062|FG001|Second Intervention|Physician Decision|0|||
106019780|NCT02840461|365735063|FG000|Overall Study|Adverse Event|1|||
106019781|NCT02840461|365735064|FG001|Overall Study|Adverse Event|5|||
106019782|NCT02840461|365735065|FG002|Overall Study|Adverse Event|3|||
106019783|NCT02840461|365735063|FG000|Overall Study|Lost to Follow-up|10|||
106019784|NCT02840461|365735064|FG001|Overall Study|Lost to Follow-up|7|||
106019785|NCT02840461|365735065|FG002|Overall Study|Lost to Follow-up|6|||
106019786|NCT02840461|365735063|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
106019787|NCT02840461|365735064|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
106019788|NCT02840461|365735065|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
106019789|NCT02840461|365735063|FG000|Overall Study|Protocol Violation|2|||
106019790|NCT02840461|365735064|FG001|Overall Study|Protocol Violation|3|||
106019791|NCT02840461|365735065|FG002|Overall Study|Protocol Violation|1|||
106019792|NCT02840461|365735063|FG000|Overall Study|Withdrawal by Subject|10|||
106019793|NCT02840461|365735064|FG001|Overall Study|Withdrawal by Subject|6|||
106019794|NCT02840461|365735065|FG002|Overall Study|Withdrawal by Subject|2|||
106019795|NCT02840461|365735063|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
106019796|NCT02840461|365735064|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
106019797|NCT02840461|365735065|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
106019798|NCT00599339|365735066|FG000|Overall Study|Adverse Event|79|||
106019799|NCT00599339|365735066|FG000|Overall Study|Withdrawal by Subject|137|||
106019800|NCT00599339|365735066|FG000|Overall Study|Other Reason|179|||
106019801|NCT00599339|365735066|FG000|Overall Study|Lost to Follow-up|221|||
106019802|NCT00599339|365735066|FG000|Overall Study|No valid data consent|36|||
106019803|NCT00599339|365735066|FG000|Overall Study|Study Termination Status Unknown|12|||
106019804|NCT00912197|365735067|FG000|Overall Study|Withdrawal by Subject|3|||
106019805|NCT00912197|365735068|FG001|Overall Study|Withdrawal by Subject|3|||
106019806|NCT01077050|365737045|FG000|Overall Study|Subjects signed ICF could not be located|1|||
106019807|NCT01077050|365737045|FG000|Overall Study|Screen failure|8|||
106019808|NCT01646125|365737047|FG000|Overall Study|Untreated|2|||
106019809|NCT01646125|365737048|FG001|Overall Study|Untreated|5|||
106145601|NCT04009577|366193137|FG000|Core Study|Adverse Event|1|||
105822173|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
105822174|NCT01597245|365006706|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822175|NCT01597245|365006707|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822176|NCT01597245|365006708|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105957907|NCT00778336|365506642|FG001|3 Month Follow Up|Death|3|||
105957908|NCT00778336|365506643|FG002|3 Month Follow Up|Death|2|||
105957909|NCT00778336|365506644|FG003|3 Month Follow Up|Death|0|||
105957910|NCT02131311|365506645|FG000|Overall Study|Adverse Event|2|||
105957911|NCT02131311|365506645|FG000|Overall Study|Protocol Violation|1|||
105957912|NCT02131311|365506645|FG000|Overall Study|Lost to Follow-up|1|||
105957913|NCT02623205|365506646|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
105957914|NCT02623205|365506647|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
105957915|NCT02342288|365506650|FG000|Overall Study|no protocol anesthesiologist available|3|||
105957916|NCT02342288|365506651|FG001|Overall Study|no protocol anesthesiologist available|2|||
105957917|NCT02342288|365506650|FG000|Overall Study|anesthesia leak in system|1|||
105957918|NCT02342288|365506651|FG001|Overall Study|anesthesia leak in system|0|||
105957919|NCT02342288|365506650|FG000|Overall Study|Withdrawal by Subject|1|||
105957920|NCT02342288|365506651|FG001|Overall Study|Withdrawal by Subject|0|||
105957921|NCT02342288|365506650|FG000|Overall Study|coordinator contaminated with blood|0|||
105957922|NCT02342288|365506651|FG001|Overall Study|coordinator contaminated with blood|1|||
105957923|NCT02342288|365506650|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
105957924|NCT02342288|365506651|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
105957925|NCT02342288|365506650|FG000|Overall Study|coordinator not available|0|||
105957926|NCT02342288|365506651|FG001|Overall Study|coordinator not available|2|||
105957927|NCT02720523|365506654|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
105957928|NCT02720523|365506655|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
105957929|NCT02720523|365506656|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
105957930|NCT02720523|365506657|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
105957931|NCT02720523|365506658|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
105957932|NCT02720523|365506659|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
105957933|NCT02720523|365506660|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
105957934|NCT02720523|365506654|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
105957935|NCT02720523|365506655|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105957936|NCT02720523|365506656|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105957937|NCT02720523|365506657|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105957938|NCT02720523|365506658|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105957939|NCT02720523|365506659|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105957940|NCT02720523|365506660|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105957941|NCT02720523|365506654|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
105957942|NCT02720523|365506655|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105957943|NCT02720523|365506656|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105957944|NCT02720523|365506657|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105957945|NCT02720523|365506658|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105957946|NCT02720523|365506659|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105957947|NCT02720523|365506660|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
105957948|NCT02720523|365506654|FG000|Period 1: Placebo-controlled Period|Other|0|||
105957949|NCT02720523|365506655|FG001|Period 1: Placebo-controlled Period|Other|0|||
105957950|NCT02720523|365506656|FG002|Period 1: Placebo-controlled Period|Other|1|||
105957951|NCT02720523|365506657|FG003|Period 1: Placebo-controlled Period|Other|1|||
105957952|NCT02720523|365506658|FG004|Period 1: Placebo-controlled Period|Other|0|||
105957953|NCT02720523|365506659|FG005|Period 1: Placebo-controlled Period|Other|0|||
105957954|NCT02720523|365506660|FG006|Period 1: Placebo-controlled Period|Other|0|||
105957955|NCT02720523|365506654|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
105957956|NCT02720523|365506655|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
105957957|NCT02720523|365506656|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
105957958|NCT02720523|365506657|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
106019810|NCT01646125|365737047|FG000|Overall Study|Adverse Event|2|||
106019811|NCT01646125|365737048|FG001|Overall Study|Adverse Event|1|||
106019812|NCT01646125|365737047|FG000|Overall Study|Death|1|||
106019813|NCT01646125|365737048|FG001|Overall Study|Death|1|||
106019814|NCT01646125|365737047|FG000|Overall Study|Physician Decision|1|||
105957959|NCT02720523|365506658|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
105957960|NCT02720523|365506659|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
105957961|NCT02720523|365506660|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
105957962|NCT02720523|365506654|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
105957963|NCT02720523|365506655|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
105957964|NCT02720523|365506656|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
105957965|NCT02720523|365506657|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
106019815|NCT01646125|365737048|FG001|Overall Study|Physician Decision|3|||
106019816|NCT01646125|365737047|FG000|Overall Study|Progressive disease|22|||
106019817|NCT01646125|365737048|FG001|Overall Study|Progressive disease|16|||
106019818|NCT01646125|365737047|FG000|Overall Study|Study terminated by sponsor|2|||
106019819|NCT01646125|365737048|FG001|Overall Study|Study terminated by sponsor|1|||
106019820|NCT01646125|365737047|FG000|Overall Study|Subject/Guardian decision|1|||
106019821|NCT01646125|365737048|FG001|Overall Study|Subject/Guardian decision|1|||
106019822|NCT02105662|365737049|FG000|Overall Study|Lost to Follow-up|5|||
105822177|NCT01597245|365006709|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822178|NCT01597245|365006710|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822179|NCT01597245|365006711|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822180|NCT01597245|365006712|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
106019823|NCT02105662|365737049|FG000|Overall Study|Withdrawal by Subject|1|||
106019824|NCT05462756|365737052|FG000|Treatment Period|Adverse Event|3|||
106019825|NCT05462756|365737053|FG001|Treatment Period|Adverse Event|0|||
106019826|NCT05462756|365737052|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
106019827|NCT05462756|365737053|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
106019828|NCT05462756|365737052|FG000|Treatment Period|Death|0|||
105822181|NCT01597245|365006713|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822182|NCT01597245|365006714|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822183|NCT01597245|365006715|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822184|NCT01597245|365006716|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822185|NCT01597245|365006717|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822186|NCT01597245|365006718|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822187|NCT01597245|365006719|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
105822188|NCT01597245|365006720|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822189|NCT01597245|365006721|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822190|NCT01597245|365006722|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822191|NCT01597245|365006723|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822192|NCT01597245|365006724|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822193|NCT01597245|365006725|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822194|NCT01597245|365006726|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
105822195|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822196|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822197|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822198|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822199|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822200|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822201|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822202|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822203|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822204|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822205|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822206|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822207|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822208|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
106019829|NCT05462756|365737053|FG001|Treatment Period|Death|1|||
106019830|NCT05462756|365737052|FG000|Treatment Period|Lost to Follow-up|2|||
106019831|NCT05462756|365737053|FG001|Treatment Period|Lost to Follow-up|1|||
106019832|NCT05462756|365737052|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
106019833|NCT05462756|365737053|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
106019834|NCT05462756|365737052|FG000|Treatment Period|Physician Decision|2|||
106019835|NCT05462756|365737053|FG001|Treatment Period|Physician Decision|0|||
106019836|NCT05462756|365737052|FG000|Treatment Period|Protocol Violation|0|||
106019837|NCT05462756|365737053|FG001|Treatment Period|Protocol Violation|1|||
106019838|NCT05462756|365737052|FG000|Treatment Period|Withdrawal by Subject|5|||
106019839|NCT05462756|365737053|FG001|Treatment Period|Withdrawal by Subject|12|||
106019840|NCT05462756|365737052|FG000|Follow-Up Period|Adverse Event|1|||
106019841|NCT05462756|365737053|FG001|Follow-Up Period|Adverse Event|0|||
106019842|NCT05462756|365737052|FG000|Follow-Up Period|Death|1|||
106019843|NCT05462756|365737053|FG001|Follow-Up Period|Death|0|||
106019844|NCT05462756|365737052|FG000|Follow-Up Period|Lost to Follow-up|3|||
106019845|NCT05462756|365737053|FG001|Follow-Up Period|Lost to Follow-up|1|||
106019846|NCT05462756|365737052|FG000|Follow-Up Period|Withdrawal by Subject|0|||
106019847|NCT05462756|365737053|FG001|Follow-Up Period|Withdrawal by Subject|4|||
106019848|NCT01354899|365737055|FG000|Overall Study|discharge from the hospital|2|||
105822209|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
105822210|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
106019849|NCT01354899|365737055|FG000|Overall Study|Protocol Violation|1|||
106019850|NCT01071798|365737056|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
106019851|NCT01071798|365737056|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
106019852|NCT01071798|365737056|FG000|Participants Who Received One Cycle|Patient requirement|20|||
105822211|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
105822212|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
105822213|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
105822214|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
105822215|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
105822216|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822217|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822218|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822219|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822220|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822221|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822222|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822223|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822224|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822225|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822226|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822227|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822228|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822229|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822230|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822231|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822232|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
105822233|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
105822234|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
105822235|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
105822236|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
105822237|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822238|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822239|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822240|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822241|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822242|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822243|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822244|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822245|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822246|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822247|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105957966|NCT02720523|365506658|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
105957967|NCT02720523|365506659|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
105957968|NCT02720523|365506660|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
105957969|NCT02720523|365506654|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
105957970|NCT02720523|365506655|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
105957971|NCT02720523|365506656|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
105957972|NCT02720523|365506657|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
105957973|NCT02720523|365506658|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
105957974|NCT02720523|365506659|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
105957975|NCT02720523|365506660|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
105957976|NCT02720523|365506654|FG000|Period 2: Long-term Extension Period|Other|0|||
105957977|NCT02720523|365506655|FG001|Period 2: Long-term Extension Period|Other|0|||
105957978|NCT02720523|365506656|FG002|Period 2: Long-term Extension Period|Other|0|||
105957979|NCT02720523|365506657|FG003|Period 2: Long-term Extension Period|Other|0|||
105957980|NCT02720523|365506658|FG004|Period 2: Long-term Extension Period|Other|2|||
105957981|NCT02720523|365506659|FG005|Period 2: Long-term Extension Period|Other|0|||
105957982|NCT02720523|365506660|FG006|Period 2: Long-term Extension Period|Other|3|||
105957983|NCT02063984|365506662|FG000|Overall Study|Lost to Follow-up|6|||
105957984|NCT02063984|365506663|FG001|Overall Study|Lost to Follow-up|5|||
105957985|NCT02517398|365506682|FG000|Overall Study|Death|2|||
105957986|NCT02517398|365506683|FG001|Overall Study|Death|3|||
105957987|NCT02517398|365506684|FG002|Overall Study|Death|4|||
105957988|NCT02517398|365506685|FG003|Overall Study|Death|2|||
105957989|NCT02517398|365506686|FG004|Overall Study|Death|3|||
105957990|NCT02517398|365506687|FG005|Overall Study|Death|8|||
105957991|NCT02517398|365506688|FG006|Overall Study|Death|3|||
105957992|NCT02517398|365506689|FG007|Overall Study|Death|2|||
105957993|NCT02517398|365506690|FG008|Overall Study|Death|6|||
105957994|NCT02517398|365506691|FG009|Overall Study|Death|24|||
105957995|NCT02517398|365506692|FG010|Overall Study|Death|53|||
105957996|NCT02517398|365506693|FG011|Overall Study|Death|25|||
106019853|NCT01071798|365737056|FG000|Participants Who Received One Cycle|Death|5|||
106019854|NCT01071798|365737056|FG000|Participants Who Received One Cycle|Change of therapy|6|||
106145602|NCT04009577|366193138|FG001|Core Study|Adverse Event|0|||
106145603|NCT04009577|366193139|FG002|Core Study|Adverse Event|2|||
106145604|NCT04009577|366193140|FG003|Core Study|Adverse Event|4|||
106145605|NCT04009577|366193137|FG000|Core Study|Withdrawal by Subject|0|||
106145606|NCT04009577|366193138|FG001|Core Study|Withdrawal by Subject|0|||
105822248|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822249|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822250|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822251|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822252|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822253|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
105822254|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822255|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
105822256|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
105822257|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
105822258|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822259|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822260|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822261|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822262|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822263|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822264|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822265|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822266|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822267|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822268|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822269|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822270|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822271|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822272|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105957997|NCT02517398|365506694|FG012|Overall Study|Death|73|||
105957998|NCT02517398|365506695|FG013|Overall Study|Death|29|||
105957999|NCT02517398|365506696|FG014|Overall Study|Death|26|||
105958000|NCT02517398|365506697|FG015|Overall Study|Death|23|||
105958001|NCT02517398|365506698|FG016|Overall Study|Death|26|||
105958002|NCT02517398|365506699|FG017|Overall Study|Death|25|||
105958003|NCT02517398|365506700|FG018|Overall Study|Death|22|||
105958004|NCT02517398|365506701|FG019|Overall Study|Death|7|||
105958005|NCT02517398|365506702|FG020|Overall Study|Death|26|||
105958006|NCT02517398|365506703|FG021|Overall Study|Death|30|||
105958007|NCT02517398|365506704|FG022|Overall Study|Death|20|||
105958008|NCT02517398|365506682|FG000|Overall Study|Other|0|||
105958009|NCT02517398|365506683|FG001|Overall Study|Other|0|||
105958010|NCT02517398|365506684|FG002|Overall Study|Other|0|||
105958011|NCT02517398|365506685|FG003|Overall Study|Other|1|||
105958012|NCT02517398|365506686|FG004|Overall Study|Other|0|||
105958013|NCT02517398|365506687|FG005|Overall Study|Other|0|||
105958014|NCT02517398|365506688|FG006|Overall Study|Other|0|||
105958015|NCT02517398|365506689|FG007|Overall Study|Other|0|||
105958016|NCT02517398|365506690|FG008|Overall Study|Other|0|||
105958017|NCT02517398|365506691|FG009|Overall Study|Other|1|||
105958018|NCT02517398|365506692|FG010|Overall Study|Other|0|||
105958019|NCT02517398|365506693|FG011|Overall Study|Other|0|||
105958020|NCT02517398|365506694|FG012|Overall Study|Other|0|||
105958021|NCT02517398|365506695|FG013|Overall Study|Other|1|||
105958022|NCT02517398|365506696|FG014|Overall Study|Other|0|||
105958023|NCT02517398|365506697|FG015|Overall Study|Other|1|||
105958024|NCT02517398|365506698|FG016|Overall Study|Other|1|||
105958025|NCT02517398|365506699|FG017|Overall Study|Other|0|||
105958026|NCT02517398|365506700|FG018|Overall Study|Other|0|||
105958027|NCT02517398|365506701|FG019|Overall Study|Other|1|||
105958028|NCT02517398|365506702|FG020|Overall Study|Other|0|||
105958029|NCT02517398|365506703|FG021|Overall Study|Other|0|||
105958030|NCT02517398|365506704|FG022|Overall Study|Other|0|||
105958031|NCT02517398|365506682|FG000|Overall Study|Lost to Follow-up|0|||
105958032|NCT02517398|365506683|FG001|Overall Study|Lost to Follow-up|0|||
105958033|NCT02517398|365506684|FG002|Overall Study|Lost to Follow-up|0|||
105958034|NCT02517398|365506685|FG003|Overall Study|Lost to Follow-up|0|||
105958035|NCT02517398|365506686|FG004|Overall Study|Lost to Follow-up|0|||
105958036|NCT02517398|365506687|FG005|Overall Study|Lost to Follow-up|0|||
105958037|NCT02517398|365506688|FG006|Overall Study|Lost to Follow-up|0|||
105958038|NCT02517398|365506689|FG007|Overall Study|Lost to Follow-up|0|||
105958039|NCT02517398|365506690|FG008|Overall Study|Lost to Follow-up|0|||
106019855|NCT01071798|365737056|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
106019856|NCT01071798|365737056|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
106019857|NCT01071798|365737056|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
106019858|NCT01071798|365737056|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
106019859|NCT01071798|365737056|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
106019860|NCT00641667|365737060|FG000|Overall Study|Withdrawal by Subject|1|||
106019861|NCT00641667|365737060|FG000|Overall Study|Adverse Event|1|||
106019862|NCT00641667|365737060|FG000|Overall Study|Physician Decision|1|||
106019863|NCT00641667|365737060|FG000|Overall Study|Worsening of underlying disease|3|||
106019864|NCT01235741|365737061|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
106019865|NCT01235741|365737062|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
106019866|NCT01235741|365737063|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
106019867|NCT01235741|365737061|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
106019868|NCT01235741|365737062|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
106019869|NCT01235741|365737063|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
106019870|NCT01235741|365737061|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
106019871|NCT01235741|365737062|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
106019872|NCT01235741|365737063|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
106019873|NCT01235741|365737061|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
106019874|NCT01235741|365737062|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
106019875|NCT01235741|365737063|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
105822273|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822274|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822275|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
105822276|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
105822277|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
105822278|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
105822279|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822280|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822281|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822282|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822283|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822284|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822285|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822286|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822287|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822288|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822289|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822290|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822291|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822292|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822293|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822294|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822295|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
105822296|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822297|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
105822298|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
105822299|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
105822300|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822301|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822302|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822303|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822304|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822305|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822306|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822307|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822308|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822309|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822310|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822311|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822312|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
106019876|NCT01235741|365737061|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
106019877|NCT01235741|365737062|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
105766519|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
105766520|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
105766521|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
105766522|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
105766523|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
105766524|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
105766525|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
105766526|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
105766527|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
105766528|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
105766529|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
105766530|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
105766531|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
105766532|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
105766533|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
105766534|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
105766535|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
105766536|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
105766537|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
105766538|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
105766539|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
105766540|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
105766541|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
105766542|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
105766543|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
105766544|NCT03605836|364798254|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
105766545|NCT03605836|364798255|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
105766546|NCT03605836|364798256|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
105766547|NCT03605836|364798257|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
105766548|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
105766549|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
105766550|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
105766551|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
105766552|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
105766553|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
105766554|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
105766555|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
105766556|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
105766557|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
105766558|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
105766559|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
105766560|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
105766561|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
105766562|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
105766563|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
105766564|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
105766565|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
105766566|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
105766567|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
105766568|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
105766569|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
105766570|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
105766571|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
105766572|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
105766573|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
105766574|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
105766575|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
105766576|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
105766577|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
105766578|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
105766579|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
105766580|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
105822313|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822314|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822315|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822316|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
105822317|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822318|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
105822319|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
105822320|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
105822321|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822322|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822323|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822324|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822325|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105766581|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
105766582|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
105766583|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
105766584|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
105766585|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
105766586|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
105766587|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
105766588|NCT03605836|364798254|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
105766589|NCT03605836|364798255|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
105766590|NCT03605836|364798256|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
105766591|NCT03605836|364798257|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
105766592|NCT02057068|364798258|FG000|Overall Study|Withdrawal by Subject|2|||
105766593|NCT02057068|364798259|FG001|Overall Study|Withdrawal by Subject|2|||
105766594|NCT02057068|364798258|FG000|Overall Study|Caregiver (CG) Health|0|||
105766595|NCT02057068|364798259|FG001|Overall Study|Caregiver (CG) Health|2|||
105766596|NCT02057068|364798258|FG000|Overall Study|Carepartner (CP) Health|4|||
105822326|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822327|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105766597|NCT02057068|364798259|FG001|Overall Study|Carepartner (CP) Health|2|||
105766598|NCT02057068|364798258|FG000|Overall Study|Lost to Follow-up|2|||
105766599|NCT02057068|364798259|FG001|Overall Study|Lost to Follow-up|2|||
105766600|NCT00633360|364798260|FG000|Overall Study|Lost to Follow-up|1|||
105766601|NCT00633360|364798261|FG001|Overall Study|Lost to Follow-up|1|||
105766602|NCT00633360|364798260|FG000|Overall Study|Adverse Event|3|||
105766603|NCT00633360|364798261|FG001|Overall Study|Adverse Event|1|||
105766604|NCT00633360|364798260|FG000|Overall Study|Protocol Violation|0|||
105822328|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822329|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822330|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822331|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822332|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822333|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822334|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822335|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822336|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105958040|NCT02517398|365506691|FG009|Overall Study|Lost to Follow-up|1|||
105766605|NCT00633360|364798261|FG001|Overall Study|Protocol Violation|1|||
105766606|NCT01505114|364798262|FG000|Overall Study|Withdrawal by Subject|5|||
105766607|NCT01505114|364798263|FG001|Overall Study|Withdrawal by Subject|4|||
105766608|NCT01505114|364798264|FG002|Overall Study|Withdrawal by Subject|4|||
105766609|NCT01505114|364798265|FG003|Overall Study|Withdrawal by Subject|7|||
105766610|NCT01505114|364798262|FG000|Overall Study|Death|1|||
105766611|NCT01505114|364798263|FG001|Overall Study|Death|0|||
105766612|NCT01505114|364798264|FG002|Overall Study|Death|0|||
105766613|NCT01505114|364798265|FG003|Overall Study|Death|1|||
106019878|NCT01235741|365737063|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
106019879|NCT01235741|365737061|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
106019880|NCT01235741|365737062|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
106019881|NCT01235741|365737063|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
106019882|NCT01235741|365737061|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
106019883|NCT01235741|365737062|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
106019884|NCT01235741|365737063|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
106019885|NCT01235741|365737061|FG000|Randomized to Treatment|Adverse Event|0|||
106019886|NCT01235741|365737062|FG001|Randomized to Treatment|Adverse Event|1|||
106019887|NCT01235741|365737063|FG002|Randomized to Treatment|Adverse Event|1|||
106019888|NCT01235741|365737061|FG000|Randomized to Treatment|Sponsor terminated study|0|||
106019889|NCT01235741|365737062|FG001|Randomized to Treatment|Sponsor terminated study|35|||
106019890|NCT01235741|365737063|FG002|Randomized to Treatment|Sponsor terminated study|34|||
106019891|NCT01235741|365737061|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
106019892|NCT01235741|365737062|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
106019893|NCT01235741|365737063|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
106019894|NCT01235741|365737061|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
105766614|NCT01505114|364798262|FG000|Overall Study|unable to adhere to visit schedule|3|||
105766615|NCT01505114|364798263|FG001|Overall Study|unable to adhere to visit schedule|2|||
105766616|NCT01505114|364798264|FG002|Overall Study|unable to adhere to visit schedule|3|||
105766617|NCT01505114|364798265|FG003|Overall Study|unable to adhere to visit schedule|3|||
105766618|NCT01505114|364798262|FG000|Overall Study|Lost to Follow-up|11|||
105766619|NCT01505114|364798263|FG001|Overall Study|Lost to Follow-up|5|||
105766620|NCT01505114|364798264|FG002|Overall Study|Lost to Follow-up|8|||
105766621|NCT01505114|364798265|FG003|Overall Study|Lost to Follow-up|7|||
105766622|NCT01505114|364798262|FG000|Overall Study|relocated|4|||
105766623|NCT01505114|364798263|FG001|Overall Study|relocated|2|||
105766624|NCT01505114|364798264|FG002|Overall Study|relocated|2|||
105766625|NCT01505114|364798265|FG003|Overall Study|relocated|3|||
105766626|NCT01505114|364798262|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
105766627|NCT01505114|364798263|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
105766628|NCT01505114|364798264|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
105766629|NCT01505114|364798265|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
105766630|NCT01505114|364798262|FG000|Overall Study|staff safety concerns|0|||
105766631|NCT01505114|364798263|FG001|Overall Study|staff safety concerns|0|||
105766632|NCT01505114|364798264|FG002|Overall Study|staff safety concerns|0|||
105766633|NCT01505114|364798265|FG003|Overall Study|staff safety concerns|1|||
105766634|NCT01505114|364798262|FG000|Overall Study|investigator decision|1|||
105766635|NCT01505114|364798263|FG001|Overall Study|investigator decision|0|||
105766636|NCT01505114|364798264|FG002|Overall Study|investigator decision|1|||
105766637|NCT01505114|364798265|FG003|Overall Study|investigator decision|0|||
105766638|NCT00910728|364798266|FG000|Overall Study|Lack of Efficacy|2|||
105766639|NCT00910728|364798267|FG001|Overall Study|Lack of Efficacy|3|||
105766640|NCT00910728|364798268|FG002|Overall Study|Lack of Efficacy|1|||
105766641|NCT00910728|364798269|FG003|Overall Study|Lack of Efficacy|2|||
105766642|NCT00910728|364798270|FG004|Overall Study|Lack of Efficacy|1|||
105766643|NCT00910728|364798271|FG005|Overall Study|Lack of Efficacy|0|||
105766644|NCT00910728|364798272|FG006|Overall Study|Lack of Efficacy|2|||
105766645|NCT00910728|364798273|FG007|Overall Study|Lack of Efficacy|2|||
105766646|NCT00910728|364798274|FG008|Overall Study|Lack of Efficacy|2|||
105766647|NCT00910728|364798266|FG000|Overall Study|Withdrawal by Subject|0|||
105766648|NCT00910728|364798267|FG001|Overall Study|Withdrawal by Subject|0|||
105822337|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
105822338|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822339|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822340|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
105822341|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
105822342|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822343|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822344|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766649|NCT00910728|364798268|FG002|Overall Study|Withdrawal by Subject|0|||
105822345|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822346|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822347|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822348|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822349|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822350|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766650|NCT00910728|364798269|FG003|Overall Study|Withdrawal by Subject|0|||
105766651|NCT00910728|364798270|FG004|Overall Study|Withdrawal by Subject|3|||
105766652|NCT00910728|364798271|FG005|Overall Study|Withdrawal by Subject|1|||
105766653|NCT00910728|364798272|FG006|Overall Study|Withdrawal by Subject|2|||
105822351|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766654|NCT00910728|364798273|FG007|Overall Study|Withdrawal by Subject|0|||
105766655|NCT00910728|364798274|FG008|Overall Study|Withdrawal by Subject|0|||
105766656|NCT00910728|364798266|FG000|Overall Study|(not specified)|2|||
105766657|NCT00910728|364798267|FG001|Overall Study|(not specified)|0|||
105766658|NCT00910728|364798268|FG002|Overall Study|(not specified)|1|||
105766659|NCT00910728|364798269|FG003|Overall Study|(not specified)|0|||
105766660|NCT00910728|364798270|FG004|Overall Study|(not specified)|1|||
106019895|NCT01235741|365737062|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
106019896|NCT01235741|365737063|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
106019897|NCT01235741|365737061|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
106019898|NCT01235741|365737062|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
106019899|NCT01235741|365737063|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
106019900|NCT00854113|365737064|FG000|Overall Study|Adverse Event|0|||
106019901|NCT00854113|365737065|FG001|Overall Study|Adverse Event|0|||
106019902|NCT00854113|365737066|FG002|Overall Study|Adverse Event|0|||
106019903|NCT00854113|365737067|FG003|Overall Study|Adverse Event|0|||
106019904|NCT00854113|365737068|FG004|Overall Study|Adverse Event|0|||
106019905|NCT00854113|365737069|FG005|Overall Study|Adverse Event|0|||
106019906|NCT00854113|365737070|FG006|Overall Study|Adverse Event|0|||
106019907|NCT00854113|365737071|FG007|Overall Study|Adverse Event|2|||
106019908|NCT00854113|365737072|FG008|Overall Study|Adverse Event|0|||
106019909|NCT00854113|365737073|FG009|Overall Study|Adverse Event|0|||
106019910|NCT00854113|365737074|FG010|Overall Study|Adverse Event|0|||
105766661|NCT00910728|364798271|FG005|Overall Study|(not specified)|0|||
105766662|NCT00910728|364798272|FG006|Overall Study|(not specified)|0|||
105766663|NCT00910728|364798273|FG007|Overall Study|(not specified)|0|||
105766664|NCT00910728|364798274|FG008|Overall Study|(not specified)|0|||
105766665|NCT00910728|364798266|FG000|Overall Study|Adverse Event|2|||
105766666|NCT00910728|364798267|FG001|Overall Study|Adverse Event|0|||
105766667|NCT00910728|364798268|FG002|Overall Study|Adverse Event|1|||
105766668|NCT00910728|364798269|FG003|Overall Study|Adverse Event|1|||
105766669|NCT00910728|364798270|FG004|Overall Study|Adverse Event|0|||
105766670|NCT00910728|364798271|FG005|Overall Study|Adverse Event|0|||
105766671|NCT00910728|364798272|FG006|Overall Study|Adverse Event|2|||
105766672|NCT00910728|364798273|FG007|Overall Study|Adverse Event|1|||
105766673|NCT00910728|364798274|FG008|Overall Study|Adverse Event|1|||
105766674|NCT03997760|364798275|FG000|Overall Study|Protocol Deviation|0|||
105766675|NCT03997760|364798276|FG001|Overall Study|Protocol Deviation|1|||
105766676|NCT03997760|364798277|FG002|Overall Study|Protocol Deviation|0|||
105766677|NCT03997760|364798278|FG003|Overall Study|Protocol Deviation|0|||
105766678|NCT00431496|364798279|FG000|Overall Study|Adverse Event|3|||
105766679|NCT00431496|364798279|FG000|Overall Study|Lost to Follow-up|1|||
105766680|NCT00431496|364798279|FG000|Overall Study|Withdrawal by Subject|2|||
105766681|NCT00431496|364798279|FG000|Overall Study|Protocol-specified criteria|5|||
105766682|NCT00565812|364798280|FG000|Overall Study|Death|2|||
105766683|NCT00565812|364798281|FG001|Overall Study|Death|1|||
105766684|NCT00565812|364798282|FG002|Overall Study|Death|3|||
105766685|NCT00565812|364798280|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
105766686|NCT00565812|364798281|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
105766687|NCT00565812|364798282|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
105766688|NCT00565812|364798280|FG000|Overall Study|Lost to Follow-up|10|||
105766689|NCT00565812|364798281|FG001|Overall Study|Lost to Follow-up|8|||
105766690|NCT00565812|364798282|FG002|Overall Study|Lost to Follow-up|8|||
105766691|NCT00565812|364798280|FG000|Overall Study|Withdrawal by Subject|58|||
105766692|NCT00565812|364798281|FG001|Overall Study|Withdrawal by Subject|47|||
106019911|NCT00854113|365737064|FG000|Overall Study|Withdrawal by Subject|0|||
106019912|NCT00854113|365737065|FG001|Overall Study|Withdrawal by Subject|0|||
106019913|NCT00854113|365737066|FG002|Overall Study|Withdrawal by Subject|0|||
105766693|NCT00565812|364798282|FG002|Overall Study|Withdrawal by Subject|48|||
105766694|NCT00565812|364798280|FG000|Overall Study|Work Schedule|5|||
105766695|NCT00565812|364798281|FG001|Overall Study|Work Schedule|3|||
105766696|NCT00565812|364798282|FG002|Overall Study|Work Schedule|1|||
105766697|NCT00565812|364798280|FG000|Overall Study|Protocol Violation|2|||
105766698|NCT00565812|364798281|FG001|Overall Study|Protocol Violation|6|||
105822352|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766699|NCT00565812|364798282|FG002|Overall Study|Protocol Violation|4|||
106019914|NCT00854113|365737067|FG003|Overall Study|Withdrawal by Subject|0|||
106019915|NCT00854113|365737068|FG004|Overall Study|Withdrawal by Subject|0|||
106019916|NCT00854113|365737069|FG005|Overall Study|Withdrawal by Subject|0|||
106019917|NCT00854113|365737070|FG006|Overall Study|Withdrawal by Subject|0|||
105766700|NCT00565812|364798280|FG000|Overall Study|Adverse Event|41|||
105766701|NCT00565812|364798281|FG001|Overall Study|Adverse Event|54|||
105766702|NCT00565812|364798282|FG002|Overall Study|Adverse Event|40|||
105766703|NCT00565812|364798280|FG000|Overall Study|Jury Duty|1|||
105766704|NCT00565812|364798281|FG001|Overall Study|Jury Duty|0|||
105766705|NCT00565812|364798282|FG002|Overall Study|Jury Duty|0|||
105766706|NCT00565812|364798280|FG000|Overall Study|Relocated Out of Area|5|||
106145607|NCT04009577|366193139|FG002|Core Study|Withdrawal by Subject|2|||
105822353|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822354|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822355|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822356|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822357|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822358|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
105822359|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105766707|NCT00565812|364798281|FG001|Overall Study|Relocated Out of Area|8|||
105766708|NCT00565812|364798282|FG002|Overall Study|Relocated Out of Area|9|||
105766709|NCT00565812|364798280|FG000|Overall Study|Sponsor Decision|1|||
105766710|NCT00565812|364798281|FG001|Overall Study|Sponsor Decision|5|||
105766711|NCT00565812|364798282|FG002|Overall Study|Sponsor Decision|1|||
105766712|NCT00565812|364798280|FG000|Overall Study|Domestic Reasons|7|||
105766713|NCT00565812|364798281|FG001|Overall Study|Domestic Reasons|1|||
105766714|NCT00565812|364798282|FG002|Overall Study|Domestic Reasons|3|||
105766715|NCT00565812|364798280|FG000|Overall Study|Research Site Closure|6|||
105766716|NCT00565812|364798281|FG001|Overall Study|Research Site Closure|1|||
105766717|NCT00565812|364798282|FG002|Overall Study|Research Site Closure|8|||
105766718|NCT00565812|364798280|FG000|Overall Study|Surgical Intervention|0|||
105766719|NCT00565812|364798281|FG001|Overall Study|Surgical Intervention|1|||
105766720|NCT00565812|364798282|FG002|Overall Study|Surgical Intervention|2|||
105822360|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822361|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
105822362|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
105822363|NCT01597245|365006706|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822364|NCT01597245|365006707|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822365|NCT01597245|365006708|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822366|NCT01597245|365006709|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822367|NCT01597245|365006710|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822368|NCT01597245|365006711|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822369|NCT01597245|365006712|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822370|NCT01597245|365006713|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822371|NCT01597245|365006714|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822372|NCT01597245|365006715|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822373|NCT01597245|365006716|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822374|NCT01597245|365006717|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822375|NCT01597245|365006718|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822376|NCT01597245|365006719|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822377|NCT01597245|365006720|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822378|NCT01597245|365006721|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822379|NCT01597245|365006722|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822380|NCT01597245|365006723|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822381|NCT01597245|365006724|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822382|NCT01597245|365006725|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
105822383|NCT01597245|365006726|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
105822384|NCT00857454|365008719|FG000|Overall Study|Withdrawal by Subject|2|||
105822385|NCT00857454|365008719|FG000|Overall Study|Lost to Follow-up|1|||
105822386|NCT00857454|365008719|FG000|Overall Study|Adverse Event|2|||
105822387|NCT00857454|365008719|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
105822388|NCT00857454|365008719|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
105822389|NCT00857454|365008719|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
105822390|NCT00583453|365008720|FG000|Overall Study|discontinued intervention|0|||
105822391|NCT00583453|365008721|FG001|Overall Study|discontinued intervention|2|||
105822392|NCT00365365|365008722|FG000|Overall Study|Randomized but not treated|0|||
105822393|NCT00365365|365008723|FG001|Overall Study|Randomized but not treated|2|||
105822394|NCT00365365|365008724|FG002|Overall Study|Randomized but not treated|0|||
105822395|NCT00365365|365008722|FG000|Overall Study|Poor compliance to protocol|0|||
105822396|NCT00365365|365008723|FG001|Overall Study|Poor compliance to protocol|1|||
105822397|NCT00365365|365008724|FG002|Overall Study|Poor compliance to protocol|0|||
106019918|NCT00854113|365737071|FG007|Overall Study|Withdrawal by Subject|1|||
105822398|NCT00365365|365008722|FG000|Overall Study|Lost to Follow-up|3|||
105822399|NCT00365365|365008723|FG001|Overall Study|Lost to Follow-up|3|||
105822400|NCT00365365|365008724|FG002|Overall Study|Lost to Follow-up|3|||
106019919|NCT00854113|365737072|FG008|Overall Study|Withdrawal by Subject|1|||
106019920|NCT00854113|365737073|FG009|Overall Study|Withdrawal by Subject|0|||
106019921|NCT00854113|365737074|FG010|Overall Study|Withdrawal by Subject|0|||
106019922|NCT00796419|365737076|FG000|Overall Study|Death|0|||
105766721|NCT00565812|364798280|FG000|Overall Study|Low Compliance|1|||
105766722|NCT00565812|364798281|FG001|Overall Study|Low Compliance|0|||
105766723|NCT00565812|364798282|FG002|Overall Study|Low Compliance|1|||
105766724|NCT00565812|364798280|FG000|Overall Study|Follow-up Visit Not Completed|2|||
105958041|NCT02517398|365506692|FG010|Overall Study|Lost to Follow-up|0|||
105958042|NCT02517398|365506693|FG011|Overall Study|Lost to Follow-up|2|||
105958043|NCT02517398|365506694|FG012|Overall Study|Lost to Follow-up|2|||
105958044|NCT02517398|365506695|FG013|Overall Study|Lost to Follow-up|0|||
105958045|NCT02517398|365506696|FG014|Overall Study|Lost to Follow-up|1|||
105958046|NCT02517398|365506697|FG015|Overall Study|Lost to Follow-up|1|||
105958047|NCT02517398|365506698|FG016|Overall Study|Lost to Follow-up|0|||
105958048|NCT02517398|365506699|FG017|Overall Study|Lost to Follow-up|3|||
105958049|NCT02517398|365506700|FG018|Overall Study|Lost to Follow-up|1|||
105958050|NCT02517398|365506701|FG019|Overall Study|Lost to Follow-up|0|||
105958051|NCT02517398|365506702|FG020|Overall Study|Lost to Follow-up|1|||
105958052|NCT02517398|365506703|FG021|Overall Study|Lost to Follow-up|0|||
105766725|NCT00565812|364798281|FG001|Overall Study|Follow-up Visit Not Completed|0|||
105766726|NCT00565812|364798282|FG002|Overall Study|Follow-up Visit Not Completed|1|||
105766727|NCT00565812|364798280|FG000|Overall Study|Physician Decision|2|||
105766728|NCT00565812|364798281|FG001|Overall Study|Physician Decision|0|||
105766729|NCT00565812|364798282|FG002|Overall Study|Physician Decision|0|||
105766730|NCT01448707|364798283|FG000|Overall Study|Adverse Event|3|||
105766731|NCT01448707|364798284|FG001|Overall Study|Adverse Event|1|||
105766732|NCT01448707|364798283|FG000|Overall Study|Lost to Follow-up|2|||
105766733|NCT01448707|364798284|FG001|Overall Study|Lost to Follow-up|6|||
105766734|NCT01448707|364798283|FG000|Overall Study|Withdrawal by Subject|6|||
105766735|NCT01448707|364798284|FG001|Overall Study|Withdrawal by Subject|7|||
105766736|NCT01448707|364798283|FG000|Overall Study|Other|7|||
105766737|NCT01448707|364798284|FG001|Overall Study|Other|4|||
105766738|NCT00845845|364798285|FG000|Overall Study|Lost to Follow-up|0|||
105766739|NCT00845845|364798286|FG001|Overall Study|Lost to Follow-up|4|||
105766740|NCT02033850|364798289|FG000|Overall Study|Death|1|||
105766741|NCT02033850|364798290|FG001|Overall Study|Death|0|||
105766742|NCT02033850|364798289|FG000|Overall Study|unrelated medical reason|1|||
105766743|NCT02033850|364798290|FG001|Overall Study|unrelated medical reason|1|||
105766744|NCT02623699|364798294|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766745|NCT02623699|364798295|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
105766746|NCT02623699|364798296|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766747|NCT02623699|364798297|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766748|NCT02623699|364798298|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766749|NCT02623699|364798299|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766750|NCT02623699|364798300|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766751|NCT02623699|364798301|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766752|NCT02623699|364798302|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766753|NCT02623699|364798303|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766754|NCT02623699|364798304|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766755|NCT02623699|364798305|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
105766756|NCT02623699|364798294|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766757|NCT02623699|364798295|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766758|NCT02623699|364798296|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766759|NCT02623699|364798297|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766760|NCT02623699|364798298|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766761|NCT02623699|364798299|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766762|NCT02623699|364798300|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
105766763|NCT02623699|364798301|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766764|NCT02623699|364798302|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766765|NCT02623699|364798303|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766766|NCT02623699|364798304|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766767|NCT02623699|364798305|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
105766768|NCT02623699|364798294|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766769|NCT02623699|364798295|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766770|NCT02623699|364798296|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766771|NCT02623699|364798297|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766772|NCT02623699|364798298|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766773|NCT02623699|364798299|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
105766774|NCT02623699|364798300|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766775|NCT02623699|364798301|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766776|NCT02623699|364798302|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766777|NCT02623699|364798303|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105958053|NCT02517398|365506704|FG022|Overall Study|Lost to Follow-up|2|||
106019923|NCT00796419|365737077|FG001|Overall Study|Death|1|||
105766778|NCT02623699|364798304|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766779|NCT02623699|364798305|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
105766780|NCT02623699|364798294|FG000|Part B (Up to 289 Days)|Death|0|||
105958054|NCT02517398|365506682|FG000|Overall Study|Withdrew Consent|0|||
105766781|NCT02623699|364798295|FG001|Part B (Up to 289 Days)|Death|0|||
105766782|NCT02623699|364798296|FG002|Part B (Up to 289 Days)|Death|0|||
105766783|NCT02623699|364798297|FG003|Part B (Up to 289 Days)|Death|0|||
105766784|NCT02623699|364798298|FG004|Part B (Up to 289 Days)|Death|0|||
105766785|NCT02623699|364798299|FG005|Part B (Up to 289 Days)|Death|1|||
105766786|NCT02623699|364798300|FG006|Part B (Up to 289 Days)|Death|1|||
105958055|NCT02517398|365506683|FG001|Overall Study|Withdrew Consent|0|||
105822401|NCT00365365|365008722|FG000|Overall Study|Death|1|||
105822402|NCT00365365|365008723|FG001|Overall Study|Death|3|||
105822403|NCT00365365|365008724|FG002|Overall Study|Death|0|||
105822404|NCT00365365|365008722|FG000|Overall Study|Subject's request|11|||
105822405|NCT00365365|365008723|FG001|Overall Study|Subject's request|13|||
105822406|NCT00365365|365008724|FG002|Overall Study|Subject's request|1|||
105822407|NCT00365365|365008722|FG000|Overall Study|Disease progression/relapse|9|||
105822408|NCT00365365|365008723|FG001|Overall Study|Disease progression/relapse|6|||
105822409|NCT00365365|365008724|FG002|Overall Study|Disease progression/relapse|7|||
105822410|NCT00365365|365008722|FG000|Overall Study|Adverse Event|6|||
105822411|NCT00365365|365008723|FG001|Overall Study|Adverse Event|6|||
105822412|NCT00365365|365008724|FG002|Overall Study|Adverse Event|3|||
105822413|NCT00365365|365008722|FG000|Overall Study|Moved|2|||
105822414|NCT00365365|365008723|FG001|Overall Study|Moved|0|||
105822415|NCT00365365|365008724|FG002|Overall Study|Moved|0|||
105822416|NCT00365365|365008722|FG000|Overall Study|New cancer|1|||
105822417|NCT00365365|365008723|FG001|Overall Study|New cancer|0|||
105822418|NCT00365365|365008724|FG002|Overall Study|New cancer|0|||
105822419|NCT00365365|365008722|FG000|Overall Study|Withdrew consent|1|||
105822420|NCT00365365|365008723|FG001|Overall Study|Withdrew consent|1|||
105822421|NCT00365365|365008724|FG002|Overall Study|Withdrew consent|0|||
105822422|NCT00365365|365008722|FG000|Overall Study|Second malignancy|0|||
105822423|NCT00365365|365008723|FG001|Overall Study|Second malignancy|1|||
105822424|NCT00365365|365008724|FG002|Overall Study|Second malignancy|0|||
105822425|NCT00365365|365008722|FG000|Overall Study|Patient/physician decision|0|||
105822426|NCT00365365|365008723|FG001|Overall Study|Patient/physician decision|0|||
105822427|NCT00365365|365008724|FG002|Overall Study|Patient/physician decision|1|||
105822428|NCT00984022|365008725|FG000|Overall Study|Lost to Follow-up|10|||
105822429|NCT00984022|365008726|FG001|Overall Study|Lost to Follow-up|14|||
105822430|NCT00573443|365008727|FG000|Double-Blind Phase|Lost to Follow-up|1|||
105822431|NCT00573443|365008728|FG001|Double-Blind Phase|Lost to Follow-up|3|||
105822432|NCT00573443|365008729|FG002|Double-Blind Phase|Lost to Follow-up|2|||
105822433|NCT00573443|365008727|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
105822434|NCT00573443|365008728|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
105822435|NCT00573443|365008729|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
105822436|NCT00573443|365008727|FG000|Double-Blind Phase|Adverse Event|1|||
105822437|NCT00573443|365008728|FG001|Double-Blind Phase|Adverse Event|5|||
105822438|NCT00573443|365008729|FG002|Double-Blind Phase|Adverse Event|0|||
105822439|NCT00573443|365008727|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
105822440|NCT00573443|365008728|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
105822441|NCT00573443|365008729|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
105822442|NCT00573443|365008727|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
105822443|NCT00573443|365008728|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
105822444|NCT00573443|365008729|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
105822445|NCT00573443|365008727|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
105822446|NCT00573443|365008728|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
105822447|NCT00573443|365008729|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
105822448|NCT00573443|365008727|FG000|Double-Blind Phase|Protocol Violation|0|||
105822449|NCT00573443|365008728|FG001|Double-Blind Phase|Protocol Violation|2|||
106019924|NCT01596062|365737078|FG000|Overall Study|Adverse Event|1|||
106019925|NCT01596062|365737079|FG001|Overall Study|Adverse Event|0|||
106019926|NCT01596062|365737080|FG002|Overall Study|Adverse Event|2|||
106019927|NCT01596062|365737078|FG000|Overall Study|Lack of Efficacy|0|||
105822450|NCT00573443|365008729|FG002|Double-Blind Phase|Protocol Violation|1|||
105822451|NCT00573443|365008727|FG000|Double-Blind Phase|Other|0|||
105822452|NCT00573443|365008728|FG001|Double-Blind Phase|Other|2|||
105822453|NCT00573443|365008729|FG002|Double-Blind Phase|Other|3|||
105822454|NCT00573443|365008727|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
105822455|NCT00573443|365008728|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105822456|NCT00573443|365008729|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
105822457|NCT00573443|365008727|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
105822458|NCT00573443|365008728|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
105822459|NCT00573443|365008729|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
105822460|NCT00573443|365008727|FG000|Open-Label Extension Phase|Adverse Event|3|||
106019928|NCT01596062|365737079|FG001|Overall Study|Lack of Efficacy|0|||
105822461|NCT00573443|365008728|FG001|Open-Label Extension Phase|Adverse Event|0|||
106019929|NCT01596062|365737080|FG002|Overall Study|Lack of Efficacy|1|||
106019930|NCT00145158|365737081|FG000|Overall Study|premature withdrawal|2|||
105822462|NCT00573443|365008729|FG002|Open-Label Extension Phase|Adverse Event|0|||
105822463|NCT00573443|365008727|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
105822464|NCT00573443|365008728|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
106019931|NCT00145158|365737082|FG001|Overall Study|premature withdrawal|3|||
105822465|NCT00573443|365008729|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
105822466|NCT00573443|365008727|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
105822467|NCT00573443|365008728|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
105822468|NCT00573443|365008729|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
106019932|NCT01705509|365737090|FG000|Inclusion CPET|Screen Failure|5|||
106019933|NCT01705509|365737090|FG000|Inclusion CPET|Withdrawal by Subject|2|||
106019934|NCT01705509|365737090|FG000|CPET w/ Ranexa|Screen Failure|2|||
106019935|NCT00904033|365737091|FG000|Overall Study|Withdrawal by Subject|1|||
106019936|NCT00904033|365737092|FG001|Overall Study|Withdrawal by Subject|1|||
106019937|NCT00904033|365737093|FG002|Overall Study|Withdrawal by Subject|0|||
106019938|NCT00904033|365737094|FG003|Overall Study|Withdrawal by Subject|0|||
106019939|NCT00904033|365737091|FG000|Overall Study|Physician Decision|0|||
106019940|NCT00904033|365737092|FG001|Overall Study|Physician Decision|0|||
106019941|NCT00904033|365737093|FG002|Overall Study|Physician Decision|1|||
106019942|NCT00904033|365737094|FG003|Overall Study|Physician Decision|0|||
106019943|NCT00904033|365737091|FG000|Overall Study|Unable to obtain final blood draw|0|||
106019944|NCT00904033|365737092|FG001|Overall Study|Unable to obtain final blood draw|0|||
106019945|NCT00904033|365737093|FG002|Overall Study|Unable to obtain final blood draw|0|||
106019946|NCT00904033|365737094|FG003|Overall Study|Unable to obtain final blood draw|2|||
106019947|NCT01227018|365737095|FG000|Overall Study|Disease progression|9|||
106019948|NCT01227018|365737095|FG000|Overall Study|Toxicity|2|||
106019949|NCT01227018|365737095|FG000|Overall Study|Withdrew after beginning treatment|4|||
106019950|NCT02873702|365737098|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
106019951|NCT02873702|365737099|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
106019952|NCT02873702|365737100|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
106019953|NCT02873702|365737101|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
106019954|NCT02873702|365737098|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
106019955|NCT02873702|365737099|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
106019956|NCT02873702|365737100|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
106019957|NCT02873702|365737101|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
106019958|NCT02873702|365737098|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
106019959|NCT02873702|365737099|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
106019960|NCT02873702|365737100|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
106019961|NCT02873702|365737101|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
106019962|NCT02873702|365737098|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
106019963|NCT02873702|365737099|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
106019964|NCT02873702|365737100|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
106019965|NCT02873702|365737101|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
106019966|NCT02873702|365737098|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
106019967|NCT02873702|365737099|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
106019968|NCT02873702|365737100|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
106019969|NCT02873702|365737101|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
106019970|NCT03436082|365737103|FG000|Overall Study|Did not undergo procedure|1|||
106019971|NCT03436082|365737104|FG001|Overall Study|Did not undergo procedure|0|||
106019972|NCT00499616|365737105|FG000|Overall Study|Death|1|||
106019973|NCT00499616|365737106|FG001|Overall Study|Death|5|||
106019974|NCT00499616|365737107|FG002|Overall Study|Death|3|||
106019975|NCT00499616|365737108|FG003|Overall Study|Death|1|||
106019976|NCT00499616|365737105|FG000|Overall Study|Lack of Efficacy|5|||
106019977|NCT00499616|365737106|FG001|Overall Study|Lack of Efficacy|0|||
106019978|NCT00499616|365737107|FG002|Overall Study|Lack of Efficacy|19|||
106019979|NCT00499616|365737108|FG003|Overall Study|Lack of Efficacy|0|||
106019980|NCT00499616|365737105|FG000|Overall Study|Lost to Follow-up|0|||
106019981|NCT00499616|365737106|FG001|Overall Study|Lost to Follow-up|0|||
106019982|NCT00499616|365737107|FG002|Overall Study|Lost to Follow-up|1|||
106019983|NCT00499616|365737108|FG003|Overall Study|Lost to Follow-up|0|||
106019984|NCT00499616|365737105|FG000|Overall Study|Physician Decision|6|||
106019985|NCT00499616|365737106|FG001|Overall Study|Physician Decision|16|||
106019986|NCT00499616|365737107|FG002|Overall Study|Physician Decision|9|||
106019987|NCT00499616|365737108|FG003|Overall Study|Physician Decision|0|||
106145608|NCT04009577|366193140|FG003|Core Study|Withdrawal by Subject|0|||
106145609|NCT04009577|366193137|FG000|Core Study|Other|0|||
106145610|NCT04009577|366193138|FG001|Core Study|Other|0|||
106145611|NCT04009577|366193139|FG002|Core Study|Other|0|||
106145612|NCT04009577|366193140|FG003|Core Study|Other|1|||
106145613|NCT04009577|366193137|FG000|Extension Phase|Adverse Event|0|||
106145614|NCT04009577|366193138|FG001|Extension Phase|Adverse Event|0|||
106145615|NCT04009577|366193139|FG002|Extension Phase|Adverse Event|0|||
106145616|NCT04009577|366193140|FG003|Extension Phase|Adverse Event|1|||
106145617|NCT04009577|366193137|FG000|Extension Phase|Inadequate therapeutic effect|0|||
106145618|NCT04009577|366193138|FG001|Extension Phase|Inadequate therapeutic effect|0|||
106145619|NCT04009577|366193139|FG002|Extension Phase|Inadequate therapeutic effect|1|||
106145620|NCT04009577|366193140|FG003|Extension Phase|Inadequate therapeutic effect|0|||
106145621|NCT04009577|366193137|FG000|Extension Phase|Withdrawal by Subject|0|||
106145622|NCT04009577|366193138|FG001|Extension Phase|Withdrawal by Subject|0|||
106145623|NCT04009577|366193139|FG002|Extension Phase|Withdrawal by Subject|1|||
106145624|NCT04009577|366193140|FG003|Extension Phase|Withdrawal by Subject|0|||
106145625|NCT04009577|366193137|FG000|Extension Phase|Not Treated|0|||
106145626|NCT04009577|366193138|FG001|Extension Phase|Not Treated|0|||
106145627|NCT04009577|366193139|FG002|Extension Phase|Not Treated|2|||
105822469|NCT00573443|365008727|FG000|Open-Label Extension Phase|Protocol Violation|2|||
105822470|NCT00573443|365008728|FG001|Open-Label Extension Phase|Protocol Violation|0|||
105822471|NCT00573443|365008729|FG002|Open-Label Extension Phase|Protocol Violation|0|||
105822472|NCT00573443|365008727|FG000|Open-Label Extension Phase|Other|2|||
105822473|NCT00573443|365008728|FG001|Open-Label Extension Phase|Other|0|||
105822474|NCT00573443|365008729|FG002|Open-Label Extension Phase|Other|0|||
105822475|NCT00418561|365008732|FG000|Overall Study|Participant's (guardian's) decision|0|||
105822476|NCT00418561|365008733|FG001|Overall Study|Participant's (guardian's) decision|1|||
105822477|NCT00418561|365008734|FG002|Overall Study|Participant's (guardian's) decision|0|||
105822478|NCT01693523|365008739|FG000|Overall Study|Adverse Event|2|||
105822479|NCT01693523|365008740|FG001|Overall Study|Adverse Event|1|||
105822480|NCT01693523|365008741|FG002|Overall Study|Adverse Event|0|||
105822481|NCT01693523|365008739|FG000|Overall Study|Death|0|||
105822482|NCT01693523|365008740|FG001|Overall Study|Death|1|||
105822483|NCT01693523|365008741|FG002|Overall Study|Death|1|||
105822484|NCT01693523|365008739|FG000|Overall Study|Lost to Follow-up|0|||
105822485|NCT01693523|365008740|FG001|Overall Study|Lost to Follow-up|0|||
105822486|NCT01693523|365008741|FG002|Overall Study|Lost to Follow-up|4|||
105822487|NCT01693523|365008739|FG000|Overall Study|Physician Decision|0|||
105822488|NCT01693523|365008740|FG001|Overall Study|Physician Decision|0|||
106019988|NCT00499616|365737105|FG000|Overall Study|Withdrawal by Subject|1|||
106019989|NCT00499616|365737106|FG001|Overall Study|Withdrawal by Subject|0|||
106019990|NCT00499616|365737107|FG002|Overall Study|Withdrawal by Subject|1|||
106019991|NCT00499616|365737108|FG003|Overall Study|Withdrawal by Subject|0|||
106019992|NCT00499616|365737105|FG000|Overall Study|Ineligible|1|||
106019993|NCT00499616|365737106|FG001|Overall Study|Ineligible|2|||
106019994|NCT00499616|365737107|FG002|Overall Study|Ineligible|0|||
106019995|NCT00499616|365737108|FG003|Overall Study|Ineligible|15|||
106019996|NCT00499616|365737105|FG000|Overall Study|Not evaluable|0|||
106019997|NCT00499616|365737106|FG001|Overall Study|Not evaluable|0|||
106019998|NCT00499616|365737107|FG002|Overall Study|Not evaluable|0|||
106019999|NCT00499616|365737108|FG003|Overall Study|Not evaluable|41|||
106020000|NCT00499616|365737105|FG000|Overall Study|Patient/Parent Refusal|1|||
106020001|NCT00499616|365737106|FG001|Overall Study|Patient/Parent Refusal|5|||
106020002|NCT00499616|365737107|FG002|Overall Study|Patient/Parent Refusal|3|||
106020003|NCT00499616|365737108|FG003|Overall Study|Patient/Parent Refusal|0|||
106020004|NCT01255436|365737118|FG000|Overall Study|Lost to Follow-up|178|||
106020005|NCT01255436|365737119|FG001|Overall Study|Lost to Follow-up|191|||
106020006|NCT01255436|365737118|FG000|Overall Study|Death, stroke, or MI|4|||
106020007|NCT01255436|365737119|FG001|Overall Study|Death, stroke, or MI|3|||
106020008|NCT04816669|365737120|FG000|Part 1|Adverse Event|1|||
106020009|NCT04816669|365737121|FG001|Part 1|Adverse Event|1|||
106020010|NCT04816669|365737122|FG002|Part 1|Adverse Event|0|||
106020011|NCT04816669|365737123|FG003|Part 1|Adverse Event|0|||
106020012|NCT04816669|365737120|FG000|Part 1|Lost to Follow-up|2|||
106020013|NCT04816669|365737121|FG001|Part 1|Lost to Follow-up|2|||
106020014|NCT04816669|365737122|FG002|Part 1|Lost to Follow-up|0|||
106020015|NCT04816669|365737123|FG003|Part 1|Lost to Follow-up|0|||
106020016|NCT04816669|365737120|FG000|Part 1|Protocol Violation|0|||
106020017|NCT04816669|365737121|FG001|Part 1|Protocol Violation|1|||
106020018|NCT04816669|365737122|FG002|Part 1|Protocol Violation|0|||
105822489|NCT01693523|365008741|FG002|Overall Study|Physician Decision|1|||
105822490|NCT01693523|365008739|FG000|Overall Study|Withdrawal by Subject|1|||
105822491|NCT01693523|365008740|FG001|Overall Study|Withdrawal by Subject|2|||
105822492|NCT01693523|365008741|FG002|Overall Study|Withdrawal by Subject|2|||
105822493|NCT01693523|365008739|FG000|Overall Study|Lack of compliance study medication|1|||
105822494|NCT01693523|365008740|FG001|Overall Study|Lack of compliance study medication|2|||
105822495|NCT01693523|365008741|FG002|Overall Study|Lack of compliance study medication|0|||
105958056|NCT02517398|365506684|FG002|Overall Study|Withdrew Consent|0|||
105958057|NCT02517398|365506685|FG003|Overall Study|Withdrew Consent|0|||
105958058|NCT02517398|365506686|FG004|Overall Study|Withdrew Consent|0|||
105958059|NCT02517398|365506687|FG005|Overall Study|Withdrew Consent|0|||
105958060|NCT02517398|365506688|FG006|Overall Study|Withdrew Consent|1|||
105958061|NCT02517398|365506689|FG007|Overall Study|Withdrew Consent|0|||
105958062|NCT02517398|365506690|FG008|Overall Study|Withdrew Consent|0|||
105958063|NCT02517398|365506691|FG009|Overall Study|Withdrew Consent|2|||
105958064|NCT02517398|365506692|FG010|Overall Study|Withdrew Consent|7|||
105958065|NCT02517398|365506693|FG011|Overall Study|Withdrew Consent|1|||
105958066|NCT02517398|365506694|FG012|Overall Study|Withdrew Consent|5|||
105958067|NCT02517398|365506695|FG013|Overall Study|Withdrew Consent|4|||
105958068|NCT02517398|365506696|FG014|Overall Study|Withdrew Consent|2|||
105958069|NCT02517398|365506697|FG015|Overall Study|Withdrew Consent|5|||
105958070|NCT02517398|365506698|FG016|Overall Study|Withdrew Consent|4|||
105958071|NCT02517398|365506699|FG017|Overall Study|Withdrew Consent|2|||
105958072|NCT02517398|365506700|FG018|Overall Study|Withdrew Consent|3|||
106020019|NCT04816669|365737123|FG003|Part 1|Protocol Violation|0|||
106020020|NCT04816669|365737120|FG000|Part 1|Withdrawal by Subject|1|||
106020021|NCT04816669|365737121|FG001|Part 1|Withdrawal by Subject|2|||
106020022|NCT04816669|365737122|FG002|Part 1|Withdrawal by Subject|0|||
106020023|NCT04816669|365737123|FG003|Part 1|Withdrawal by Subject|0|||
105958073|NCT02517398|365506701|FG019|Overall Study|Withdrew Consent|2|||
106020024|NCT04816669|365737120|FG000|Part 2|Other|0|||
105822496|NCT01693523|365008739|FG000|Overall Study|Chemotherapy was held|1|||
105822497|NCT01693523|365008740|FG001|Overall Study|Chemotherapy was held|2|||
105822498|NCT01693523|365008741|FG002|Overall Study|Chemotherapy was held|0|||
105822499|NCT03343535|365008742|FG000|Overall Study|Lost to Follow-up|1|||
105822500|NCT03343535|365008742|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
105822501|NCT03343535|365008742|FG000|Overall Study|Death|12|||
105822502|NCT03181594|365008743|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
105822503|NCT03181594|365008743|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
105822504|NCT03181594|365008743|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
105822505|NCT03181594|365008743|FG000|Initial Study Protocol (12-month FU)|Death|1|||
105822506|NCT03181594|365008743|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
105822507|NCT03181594|365008743|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
105822508|NCT01675765|365008744|FG000|Overall Study|Progressive disease|4|||
105822509|NCT01675765|365008745|FG001|Overall Study|Progressive disease|4|||
105822510|NCT01675765|365008744|FG000|Overall Study|Adverse Event|1|||
105822511|NCT01675765|365008745|FG001|Overall Study|Adverse Event|2|||
105822512|NCT01675765|365008744|FG000|Overall Study|Withdrawal by Subject|2|||
105822513|NCT01675765|365008745|FG001|Overall Study|Withdrawal by Subject|0|||
105822514|NCT01675765|365008744|FG000|Overall Study|Death|1|||
105822515|NCT01675765|365008745|FG001|Overall Study|Death|0|||
105822516|NCT01675765|365008744|FG000|Overall Study|Clinical progression|3|||
105822517|NCT01675765|365008745|FG001|Overall Study|Clinical progression|2|||
105822518|NCT00113386|365008757|FG000|Overall Study|Withdrawal by Subject|1|||
105822519|NCT00113386|365008758|FG001|Overall Study|Withdrawal by Subject|0|||
105822520|NCT00113386|365008757|FG000|Overall Study|Physician Decision|0|||
105822521|NCT00113386|365008758|FG001|Overall Study|Physician Decision|1|||
105822522|NCT00113386|365008757|FG000|Overall Study|Toxicity|3|||
105822523|NCT00113386|365008758|FG001|Overall Study|Toxicity|0|||
105822524|NCT00113386|365008757|FG000|Overall Study|Ineligible|1|||
105822525|NCT00113386|365008758|FG001|Overall Study|Ineligible|2|||
105822526|NCT00113386|365008757|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
105822527|NCT00113386|365008758|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
105822528|NCT00640562|365008759|FG000|Overall Study|Adverse Event|8|||
105822529|NCT00640562|365008760|FG001|Overall Study|Adverse Event|5|||
105822530|NCT00640562|365008759|FG000|Overall Study|Lack of Efficacy|1|||
105822531|NCT00640562|365008760|FG001|Overall Study|Lack of Efficacy|4|||
105822532|NCT00640562|365008759|FG000|Overall Study|Protocol Violation|2|||
105822533|NCT00640562|365008760|FG001|Overall Study|Protocol Violation|4|||
105822534|NCT00640562|365008759|FG000|Overall Study|Withdrawal by Subject|6|||
105822535|NCT00640562|365008760|FG001|Overall Study|Withdrawal by Subject|10|||
105822536|NCT00640562|365008759|FG000|Overall Study|Known risperidone intolerance|0|||
105822537|NCT00640562|365008760|FG001|Overall Study|Known risperidone intolerance|1|||
105822538|NCT00640562|365008759|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
105822539|NCT00640562|365008760|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
105822540|NCT00640562|365008759|FG000|Overall Study|Low study drug dose|0|||
105822541|NCT00640562|365008760|FG001|Overall Study|Low study drug dose|1|||
105822542|NCT00640562|365008759|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
105822543|NCT00640562|365008760|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
105822544|NCT02849457|365008761|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
105822545|NCT02849457|365008762|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
105869067|NCT01995513|365171604|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
105869068|NCT01995513|365171605|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
105869069|NCT01995513|365171602|FG000|Period 2: Double Blind Treatment|Death|0|||
105958074|NCT02517398|365506702|FG020|Overall Study|Withdrew Consent|9|||
105869070|NCT01995513|365171603|FG001|Period 2: Double Blind Treatment|Death|0|||
105869071|NCT01995513|365171604|FG002|Period 2: Double Blind Treatment|Death|0|||
105869072|NCT01995513|365171605|FG003|Period 2: Double Blind Treatment|Death|1|||
105869073|NCT01995513|365171602|FG000|Period 2: Double Blind Treatment|Other|0|||
105869074|NCT01995513|365171603|FG001|Period 2: Double Blind Treatment|Other|0|||
105869075|NCT01995513|365171604|FG002|Period 2: Double Blind Treatment|Other|3|||
105869076|NCT01995513|365171605|FG003|Period 2: Double Blind Treatment|Other|3|||
105869077|NCT01995513|365171602|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
105869078|NCT01995513|365171603|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
105869079|NCT01995513|365171604|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
105869080|NCT01995513|365171605|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
105869081|NCT01995513|365171602|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
105869082|NCT01995513|365171603|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
105869083|NCT01995513|365171604|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
105869084|NCT01995513|365171605|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
105869085|NCT01995513|365171602|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
105869086|NCT01995513|365171603|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
105869087|NCT01995513|365171604|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
106145628|NCT04009577|366193140|FG003|Extension Phase|Not Treated|0|||
105822546|NCT02849457|365008763|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
105822547|NCT02849457|365008764|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
105822548|NCT03673670|365008766|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
105822549|NCT03673670|365008767|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105822550|NCT03673670|365008768|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105822551|NCT03673670|365008769|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105958075|NCT02517398|365506703|FG021|Overall Study|Withdrew Consent|3|||
105958076|NCT02517398|365506704|FG022|Overall Study|Withdrew Consent|1|||
105958077|NCT00809926|365506705|FG000|Overall Study|Adverse Event|18|||
105958078|NCT00809926|365506706|FG001|Overall Study|Adverse Event|10|||
105958079|NCT00809926|365506705|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
105958080|NCT00809926|365506706|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
105958081|NCT00809926|365506705|FG000|Overall Study|Patient withdrew consent|8|||
105958082|NCT00809926|365506706|FG001|Overall Study|Patient withdrew consent|6|||
105958083|NCT00809926|365506705|FG000|Overall Study|Lost to Follow-up|2|||
105958084|NCT00809926|365506706|FG001|Overall Study|Lost to Follow-up|1|||
105958085|NCT00809926|365506705|FG000|Overall Study|Administrative Problems|0|||
105958086|NCT00809926|365506706|FG001|Overall Study|Administrative Problems|1|||
105958087|NCT00809926|365506705|FG000|Overall Study|Protocol deviation|0|||
105958088|NCT00809926|365506706|FG001|Overall Study|Protocol deviation|2|||
105958089|NCT00130039|365506711|FG000|Overall Study|Withdrawal by Subject|15|||
105958090|NCT00130039|365506712|FG001|Overall Study|Withdrawal by Subject|11|||
105958091|NCT00130039|365506711|FG000|Overall Study|Lost to Follow-up|3|||
105958092|NCT00130039|365506712|FG001|Overall Study|Lost to Follow-up|1|||
105958093|NCT00130039|365506711|FG000|Overall Study|Adverse Event|4|||
105958094|NCT00130039|365506712|FG001|Overall Study|Adverse Event|2|||
105958095|NCT00130039|365506711|FG000|Overall Study|Physician Decision|3|||
105958096|NCT00130039|365506712|FG001|Overall Study|Physician Decision|0|||
105958097|NCT00130039|365506711|FG000|Overall Study|clinical events without follow up MRI|5|||
105958098|NCT00130039|365506712|FG001|Overall Study|clinical events without follow up MRI|4|||
105958099|NCT00642707|365506713|FG000|Overall Study|Adverse Event|0|||
105958100|NCT00642707|365506714|FG001|Overall Study|Adverse Event|0|||
105958101|NCT00642707|365506715|FG002|Overall Study|Adverse Event|0|||
105958102|NCT00642707|365506716|FG003|Overall Study|Adverse Event|2|||
105958103|NCT00642707|365506713|FG000|Overall Study|Withdrawal by Subject|1|||
105958104|NCT00642707|365506714|FG001|Overall Study|Withdrawal by Subject|0|||
105958105|NCT00642707|365506715|FG002|Overall Study|Withdrawal by Subject|0|||
105958106|NCT00642707|365506716|FG003|Overall Study|Withdrawal by Subject|0|||
105958107|NCT02311881|365506731|FG000|Overall Study|Did not meet the study criteria|2|||
105958108|NCT02311881|365506732|FG001|Overall Study|Did not meet the study criteria|2|||
105958109|NCT02311881|365506733|FG002|Overall Study|Did not meet the study criteria|0|||
105958110|NCT02311881|365506731|FG000|Overall Study|Adverse Event|7|||
105958111|NCT02311881|365506732|FG001|Overall Study|Adverse Event|15|||
105958112|NCT02311881|365506733|FG002|Overall Study|Adverse Event|8|||
105958113|NCT02311881|365506731|FG000|Overall Study|Lost to Follow-up|3|||
105958114|NCT02311881|365506732|FG001|Overall Study|Lost to Follow-up|3|||
105958115|NCT02311881|365506733|FG002|Overall Study|Lost to Follow-up|2|||
105958116|NCT02311881|365506731|FG000|Overall Study|Protocol Violation|1|||
105958117|NCT02311881|365506732|FG001|Overall Study|Protocol Violation|2|||
105958118|NCT02311881|365506733|FG002|Overall Study|Protocol Violation|3|||
105958119|NCT02311881|365506731|FG000|Overall Study|Withdrawal of consent|14|||
105958120|NCT02311881|365506732|FG001|Overall Study|Withdrawal of consent|16|||
105958121|NCT02311881|365506733|FG002|Overall Study|Withdrawal of consent|17|||
105958122|NCT02311881|365506731|FG000|Overall Study|Other|0|||
105958123|NCT02311881|365506732|FG001|Overall Study|Other|0|||
105958124|NCT02311881|365506733|FG002|Overall Study|Other|1|||
105958125|NCT02311881|365506731|FG000|Overall Study|Lack of Efficacy|1|||
105958126|NCT02311881|365506732|FG001|Overall Study|Lack of Efficacy|2|||
105958127|NCT02311881|365506733|FG002|Overall Study|Lack of Efficacy|0|||
105958128|NCT02311881|365506731|FG000|Overall Study|Subject has border line pregnancy test|1|||
105958129|NCT02311881|365506732|FG001|Overall Study|Subject has border line pregnancy test|0|||
105958130|NCT02311881|365506733|FG002|Overall Study|Subject has border line pregnancy test|0|||
105958131|NCT02311881|365506731|FG000|Overall Study|Withdrawal by Subject|3|||
105958132|NCT02311881|365506732|FG001|Overall Study|Withdrawal by Subject|1|||
105958133|NCT02311881|365506733|FG002|Overall Study|Withdrawal by Subject|4|||
105958134|NCT02311881|365506731|FG000|Overall Study|Sponsor Decision|1|||
105958135|NCT02311881|365506732|FG001|Overall Study|Sponsor Decision|1|||
105958136|NCT02311881|365506733|FG002|Overall Study|Sponsor Decision|1|||
105958137|NCT02311881|365506731|FG000|Overall Study|Protocol Deviation|1|||
105958138|NCT02311881|365506732|FG001|Overall Study|Protocol Deviation|0|||
105958139|NCT02311881|365506733|FG002|Overall Study|Protocol Deviation|0|||
105958140|NCT02311881|365506731|FG000|Overall Study|Non-Compliance|1|||
106145629|NCT00958633|366193143|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
106145630|NCT00958633|366193144|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
105822552|NCT03673670|365008770|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105822553|NCT03673670|365008771|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
105822554|NCT03673670|365008766|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822555|NCT03673670|365008767|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822556|NCT03673670|365008768|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
105822557|NCT03673670|365008769|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822558|NCT03673670|365008770|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822559|NCT03673670|365008771|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
105822560|NCT03673670|365008766|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822561|NCT03673670|365008767|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822562|NCT03673670|365008768|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822563|NCT03673670|365008769|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822564|NCT03673670|365008770|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
105822565|NCT03673670|365008771|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
105822566|NCT03673670|365008766|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822567|NCT03673670|365008767|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822568|NCT03673670|365008768|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822569|NCT03673670|365008769|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822570|NCT03673670|365008770|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
105822571|NCT03673670|365008771|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
105822572|NCT03673670|365008766|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
105822573|NCT03673670|365008767|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
105822574|NCT03673670|365008768|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
105822575|NCT03673670|365008769|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
105822576|NCT03673670|365008770|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
106145631|NCT00958633|366193145|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
106145632|NCT00958633|366193143|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
106145633|NCT00958633|366193144|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
106145634|NCT00958633|366193145|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
106145635|NCT00958633|366193143|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
106145636|NCT00958633|366193144|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
106145637|NCT00958633|366193145|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
106145638|NCT00958633|366193143|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
106145639|NCT00958633|366193144|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
106145640|NCT00958633|366193145|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
106145641|NCT00958633|366193143|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
106145642|NCT00958633|366193144|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
106145643|NCT00958633|366193145|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
106145644|NCT00958633|366193143|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
106145645|NCT00958633|366193144|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
106145646|NCT00958633|366193145|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
106145647|NCT00958633|366193143|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
106145648|NCT00958633|366193144|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
106145649|NCT00958633|366193145|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
106145650|NCT02261467|366193146|FG000|Overall Study|Enrolled in Error|1|||
106145651|NCT02261467|366193147|FG001|Overall Study|Enrolled in Error|0|||
106145652|NCT02261467|366193146|FG000|Overall Study|Protocol Violation|0|||
106145653|NCT02261467|366193147|FG001|Overall Study|Protocol Violation|1|||
106145654|NCT02261467|366193146|FG000|Overall Study|Personal Reasons|17|||
106145655|NCT02261467|366193147|FG001|Overall Study|Personal Reasons|22|||
106145656|NCT02261467|366193146|FG000|Overall Study|Lost to Follow-up|2|||
106145657|NCT02261467|366193147|FG001|Overall Study|Lost to Follow-up|13|||
106145658|NCT02261467|366193146|FG000|Overall Study|Adverse Event|1|||
106145659|NCT02261467|366193147|FG001|Overall Study|Adverse Event|1|||
106145660|NCT00736853|366193153|FG000|Open-Label Period|Physician Decision|2|||
106145661|NCT00736853|366193154|FG001|Open-Label Period|Physician Decision|0|||
106145662|NCT00736853|366193155|FG002|Open-Label Period|Physician Decision|0|||
106145663|NCT00736853|366193153|FG000|Open-Label Period|Adverse Event|31|||
106145664|NCT00736853|366193154|FG001|Open-Label Period|Adverse Event|0|||
106145665|NCT00736853|366193155|FG002|Open-Label Period|Adverse Event|0|||
106145666|NCT00736853|366193153|FG000|Open-Label Period|Withdrawal by Subject|16|||
106145667|NCT00736853|366193154|FG001|Open-Label Period|Withdrawal by Subject|0|||
106145668|NCT00736853|366193155|FG002|Open-Label Period|Withdrawal by Subject|0|||
106145669|NCT00736853|366193153|FG000|Open-Label Period|Started but not treated|42|||
106145670|NCT00736853|366193154|FG001|Open-Label Period|Started but not treated|0|||
106145671|NCT00736853|366193155|FG002|Open-Label Period|Started but not treated|0|||
106145672|NCT00736853|366193153|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
106145673|NCT00736853|366193154|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
105958141|NCT02311881|365506732|FG001|Overall Study|Non-Compliance|0|||
105958142|NCT02311881|365506733|FG002|Overall Study|Non-Compliance|2|||
105958143|NCT02311881|365506731|FG000|Overall Study|Physician Decision|0|||
105958144|NCT02311881|365506732|FG001|Overall Study|Physician Decision|0|||
105958145|NCT02311881|365506733|FG002|Overall Study|Physician Decision|1|||
105958146|NCT02311881|365506731|FG000|Overall Study|Medical Monitor Discretion|0|||
105958147|NCT02311881|365506732|FG001|Overall Study|Medical Monitor Discretion|0|||
105958148|NCT02311881|365506733|FG002|Overall Study|Medical Monitor Discretion|1|||
105958149|NCT02311881|365506731|FG000|Overall Study|Participant taking another medication|0|||
105958150|NCT02311881|365506732|FG001|Overall Study|Participant taking another medication|0|||
105958151|NCT02311881|365506733|FG002|Overall Study|Participant taking another medication|1|||
105958152|NCT02311881|365506731|FG000|Overall Study|Serious Adverse Event|0|||
105958153|NCT02311881|365506732|FG001|Overall Study|Serious Adverse Event|1|||
105958154|NCT02311881|365506733|FG002|Overall Study|Serious Adverse Event|0|||
105766787|NCT02623699|364798301|FG007|Part B (Up to 289 Days)|Death|0|||
105958155|NCT01102491|365506736|FG000|Overall Study|Protocol Violation|11|||
105958156|NCT01102491|365506737|FG001|Overall Study|Protocol Violation|12|||
105958157|NCT00790582|365506743|FG000|Overall Study|Death|14|||
105958158|NCT00790582|365506744|FG001|Overall Study|Death|32|||
105958159|NCT00790582|365506743|FG000|Overall Study|Physician Decision|7|||
105958160|NCT00790582|365506744|FG001|Overall Study|Physician Decision|1|||
105958161|NCT00790582|365506743|FG000|Overall Study|Lost to Follow-up|3|||
105958162|NCT00790582|365506744|FG001|Overall Study|Lost to Follow-up|3|||
105958163|NCT00790582|365506743|FG000|Overall Study|Withdrawal by Subject|7|||
105958164|NCT00790582|365506744|FG001|Overall Study|Withdrawal by Subject|51|||
105958165|NCT00556439|365506747|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
105958166|NCT00556439|365506748|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
105958167|NCT00556439|365506749|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
105766788|NCT02623699|364798302|FG008|Part B (Up to 289 Days)|Death|1|||
105766789|NCT02623699|364798303|FG009|Part B (Up to 289 Days)|Death|0|||
105766790|NCT02623699|364798304|FG010|Part B (Up to 289 Days)|Death|0|||
105766791|NCT02623699|364798305|FG011|Part B (Up to 289 Days)|Death|0|||
105766792|NCT02623699|364798294|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
105766793|NCT02623699|364798295|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
105766794|NCT02623699|364798296|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
105766795|NCT02623699|364798297|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
105766796|NCT02623699|364798298|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
105766797|NCT02623699|364798299|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
105766798|NCT02623699|364798300|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
105766799|NCT02623699|364798301|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
105766800|NCT02623699|364798302|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
105766801|NCT02623699|364798303|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
105766802|NCT02623699|364798304|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
105766803|NCT02623699|364798305|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
105766804|NCT02623699|364798294|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766805|NCT02623699|364798295|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766806|NCT02623699|364798296|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766807|NCT02623699|364798297|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766808|NCT02623699|364798298|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766809|NCT02623699|364798299|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766810|NCT02623699|364798300|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766811|NCT02623699|364798301|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766812|NCT02623699|364798302|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766813|NCT02623699|364798303|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
105766814|NCT02623699|364798304|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
105766815|NCT02623699|364798305|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
105766816|NCT02623699|364798294|FG000|Part C (Up to 236 Days)|Death|0|||
105766817|NCT02623699|364798295|FG001|Part C (Up to 236 Days)|Death|0|||
105766818|NCT02623699|364798296|FG002|Part C (Up to 236 Days)|Death|0|||
105766819|NCT02623699|364798297|FG003|Part C (Up to 236 Days)|Death|0|||
105766820|NCT02623699|364798298|FG004|Part C (Up to 236 Days)|Death|0|||
105822577|NCT03673670|365008771|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
105766821|NCT02623699|364798299|FG005|Part C (Up to 236 Days)|Death|0|||
105766822|NCT02623699|364798300|FG006|Part C (Up to 236 Days)|Death|0|||
105822578|NCT03673670|365008766|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105958168|NCT00556439|365506750|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
105958169|NCT00556439|365506747|FG000|Study Entry to Week 12|Physician Decision|1|||
105958170|NCT00556439|365506748|FG001|Study Entry to Week 12|Physician Decision|0|||
105958171|NCT00556439|365506749|FG002|Study Entry to Week 12|Physician Decision|0|||
105958172|NCT00556439|365506750|FG003|Study Entry to Week 12|Physician Decision|0|||
105958173|NCT00556439|365506747|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
105958174|NCT00556439|365506748|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
105958175|NCT00556439|365506749|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
105958176|NCT00556439|365506750|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
105958177|NCT00556439|365506747|FG000|Study Entry to Week 12|Recurrent infection|1|||
105958178|NCT00556439|365506748|FG001|Study Entry to Week 12|Recurrent infection|0|||
105958179|NCT00556439|365506749|FG002|Study Entry to Week 12|Recurrent infection|0|||
105958180|NCT00556439|365506750|FG003|Study Entry to Week 12|Recurrent infection|0|||
105958181|NCT00556439|365506747|FG000|Study Entry to Week 12|Malignancy|0|||
105958182|NCT00556439|365506748|FG001|Study Entry to Week 12|Malignancy|0|||
105958183|NCT00556439|365506749|FG002|Study Entry to Week 12|Malignancy|1|||
105958184|NCT00556439|365506750|FG003|Study Entry to Week 12|Malignancy|0|||
105958185|NCT00556439|365506747|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
105958186|NCT00556439|365506748|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
105958187|NCT00556439|365506749|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
105958188|NCT00556439|365506750|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
105958189|NCT00556439|365506747|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
105958190|NCT00556439|365506748|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
105958191|NCT00556439|365506749|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
105958192|NCT00556439|365506750|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
105958193|NCT00556439|365506747|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
105958194|NCT00556439|365506748|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
105958195|NCT00556439|365506749|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
105958196|NCT00556439|365506750|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
105958197|NCT00556439|365506747|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
105958198|NCT00556439|365506748|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
105958199|NCT00556439|365506749|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
105958200|NCT00556439|365506750|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
105958201|NCT00325130|365506751|FG000|Overall Study|Lost to Follow-up|6|||
105958202|NCT00325130|365506752|FG001|Overall Study|Lost to Follow-up|14|||
105958203|NCT00325130|365506751|FG000|Overall Study|Withdrawal by Subject|12|||
105958204|NCT00325130|365506752|FG001|Overall Study|Withdrawal by Subject|14|||
105958205|NCT00325130|365506751|FG000|Overall Study|Protocol Deviation|0|||
105958206|NCT00325130|365506752|FG001|Overall Study|Protocol Deviation|1|||
105958207|NCT00325130|365506751|FG000|Overall Study|Moved|0|||
105958208|NCT00325130|365506752|FG001|Overall Study|Moved|1|||
105958209|NCT00325130|365506751|FG000|Overall Study|Patient Discontinued for Other|1|||
105958210|NCT00325130|365506752|FG001|Overall Study|Patient Discontinued for Other|0|||
105958211|NCT00326001|365506753|FG000|Overall Study|Adverse Event|4|||
105958212|NCT00326001|365506754|FG001|Overall Study|Adverse Event|5|||
105958213|NCT00326001|365506753|FG000|Overall Study|Physician Decision|3|||
105958214|NCT00326001|365506754|FG001|Overall Study|Physician Decision|3|||
105958215|NCT02931838|365506755|FG000|Overall Study|Reason not provided by investigator|1|||
105958216|NCT02931838|365506756|FG001|Overall Study|Reason not provided by investigator|0|||
105958217|NCT02931838|365506757|FG002|Overall Study|Reason not provided by investigator|1|||
105958218|NCT02931838|365506758|FG003|Overall Study|Reason not provided by investigator|0|||
105958219|NCT02931838|365506759|FG004|Overall Study|Reason not provided by investigator|0|||
105958220|NCT02931838|365506760|FG005|Overall Study|Reason not provided by investigator|0|||
105958221|NCT02931838|365506755|FG000|Overall Study|Poor/non-compliance|0|||
105958222|NCT02931838|365506756|FG001|Overall Study|Poor/non-compliance|0|||
105958223|NCT02931838|365506757|FG002|Overall Study|Poor/non-compliance|1|||
105958224|NCT02931838|365506758|FG003|Overall Study|Poor/non-compliance|0|||
105958225|NCT02931838|365506759|FG004|Overall Study|Poor/non-compliance|0|||
105958226|NCT02931838|365506760|FG005|Overall Study|Poor/non-compliance|0|||
105958227|NCT02931838|365506755|FG000|Overall Study|Lack of Efficacy|5|||
105958228|NCT02931838|365506756|FG001|Overall Study|Lack of Efficacy|4|||
105958229|NCT02931838|365506757|FG002|Overall Study|Lack of Efficacy|0|||
105958230|NCT02931838|365506758|FG003|Overall Study|Lack of Efficacy|0|||
105958231|NCT02931838|365506759|FG004|Overall Study|Lack of Efficacy|0|||
105958232|NCT02931838|365506760|FG005|Overall Study|Lack of Efficacy|1|||
105958233|NCT02931838|365506755|FG000|Overall Study|Lost to Follow-up|1|||
105958234|NCT02931838|365506756|FG001|Overall Study|Lost to Follow-up|0|||
105958235|NCT02931838|365506757|FG002|Overall Study|Lost to Follow-up|1|||
106020025|NCT04816669|365737121|FG001|Part 2|Other|0|||
106020026|NCT04816669|365737122|FG002|Part 2|Other|1|||
105958236|NCT02931838|365506758|FG003|Overall Study|Lost to Follow-up|1|||
105958237|NCT02931838|365506759|FG004|Overall Study|Lost to Follow-up|2|||
105958238|NCT02931838|365506760|FG005|Overall Study|Lost to Follow-up|0|||
105958239|NCT02931838|365506755|FG000|Overall Study|Subject request to discontinue treatment|4|||
105958240|NCT02931838|365506756|FG001|Overall Study|Subject request to discontinue treatment|3|||
105958241|NCT02931838|365506757|FG002|Overall Study|Subject request to discontinue treatment|3|||
105958242|NCT02931838|365506758|FG003|Overall Study|Subject request to discontinue treatment|0|||
106020027|NCT04816669|365737123|FG003|Part 2|Other|0|||
105766823|NCT02623699|364798301|FG007|Part C (Up to 236 Days)|Death|0|||
105766824|NCT02623699|364798302|FG008|Part C (Up to 236 Days)|Death|0|||
105766825|NCT02623699|364798303|FG009|Part C (Up to 236 Days)|Death|0|||
105766826|NCT02623699|364798304|FG010|Part C (Up to 236 Days)|Death|0|||
105766827|NCT02623699|364798305|FG011|Part C (Up to 236 Days)|Death|1|||
105766828|NCT02623699|364798294|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
105766829|NCT02623699|364798295|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
105766830|NCT02623699|364798296|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
105766831|NCT02623699|364798297|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
105766832|NCT02623699|364798298|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
105766833|NCT02623699|364798299|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
105766834|NCT02623699|364798300|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
105766835|NCT02623699|364798301|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
105766836|NCT02623699|364798302|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
105766837|NCT02623699|364798303|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
105766838|NCT02623699|364798304|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
105766839|NCT02623699|364798305|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
105766840|NCT00899678|364798306|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
105766841|NCT00899678|364798307|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
105766842|NCT00899678|364798308|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
105766843|NCT00899678|364798306|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
105766844|NCT00899678|364798307|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
105766845|NCT00899678|364798308|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
105766846|NCT00899678|364798306|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
105766847|NCT00899678|364798307|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
105766848|NCT00899678|364798308|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
105766849|NCT00899678|364798306|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
105766850|NCT00899678|364798307|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
105766851|NCT00899678|364798308|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
105766852|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
105766853|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
105766854|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
105766855|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
105766856|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
105766857|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
105766858|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
105766859|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
105766860|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
105766861|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
105766862|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
105766863|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
105766864|NCT00899678|364798306|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
105766865|NCT00899678|364798307|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
105766866|NCT00899678|364798308|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
105766867|NCT02699125|364798309|FG000|Placebo|Lost to Follow-up|2|||
105766868|NCT02699125|364798310|FG001|Placebo|Lost to Follow-up|0|||
105766869|NCT02699125|364798309|FG000|Placebo|Protocol Violation|1|||
105766870|NCT02699125|364798310|FG001|Placebo|Protocol Violation|0|||
105766871|NCT02699125|364798309|FG000|Placebo|Withdrawal by Subject|0|||
105766872|NCT02699125|364798310|FG001|Placebo|Withdrawal by Subject|4|||
105958243|NCT02931838|365506759|FG004|Overall Study|Subject request to discontinue treatment|1|||
105958244|NCT02931838|365506760|FG005|Overall Study|Subject request to discontinue treatment|0|||
105958245|NCT02931838|365506755|FG000|Overall Study|Withdrawal by Subject|1|||
105958246|NCT02931838|365506756|FG001|Overall Study|Withdrawal by Subject|2|||
105958247|NCT02931838|365506757|FG002|Overall Study|Withdrawal by Subject|0|||
105958248|NCT02931838|365506758|FG003|Overall Study|Withdrawal by Subject|1|||
105958249|NCT02931838|365506759|FG004|Overall Study|Withdrawal by Subject|0|||
105958250|NCT02931838|365506760|FG005|Overall Study|Withdrawal by Subject|0|||
105958251|NCT02931838|365506755|FG000|Overall Study|Adverse Event|2|||
105958252|NCT02931838|365506756|FG001|Overall Study|Adverse Event|1|||
105958253|NCT02931838|365506757|FG002|Overall Study|Adverse Event|2|||
105958254|NCT02931838|365506758|FG003|Overall Study|Adverse Event|1|||
105958255|NCT02931838|365506759|FG004|Overall Study|Adverse Event|3|||
105958256|NCT02931838|365506760|FG005|Overall Study|Adverse Event|1|||
105958257|NCT01027650|365506762|FG000|Overall Study|Personal Reasons|0|||
105958258|NCT01027650|365506763|FG001|Overall Study|Personal Reasons|0|||
105958259|NCT01027650|365506764|FG002|Overall Study|Personal Reasons|0|||
105958260|NCT01027650|365506765|FG003|Overall Study|Personal Reasons|0|||
105958261|NCT01027650|365506766|FG004|Overall Study|Personal Reasons|2|||
105958262|NCT01027650|365506767|FG005|Overall Study|Personal Reasons|1|||
105958263|NCT01027650|365506768|FG006|Overall Study|Personal Reasons|0|||
105958264|NCT01027650|365506769|FG007|Overall Study|Personal Reasons|0|||
105958265|NCT01027650|365506762|FG000|Overall Study|Lost to Follow-up|0|||
105958266|NCT01027650|365506763|FG001|Overall Study|Lost to Follow-up|0|||
105958267|NCT01027650|365506764|FG002|Overall Study|Lost to Follow-up|0|||
105958268|NCT01027650|365506765|FG003|Overall Study|Lost to Follow-up|0|||
105958269|NCT01027650|365506766|FG004|Overall Study|Lost to Follow-up|0|||
105958270|NCT01027650|365506767|FG005|Overall Study|Lost to Follow-up|0|||
105766873|NCT02699125|364798309|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
105766874|NCT02699125|364798310|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
105766875|NCT03148795|364798315|FG000|Overall Study|Progressive Disease|1|||
105766876|NCT02963766|364798316|FG000|Double-Blind Period|Adverse Event|1|||
105766877|NCT02963766|364798317|FG001|Double-Blind Period|Adverse Event|0|||
105766878|NCT02963766|364798318|FG002|Double-Blind Period|Adverse Event|1|||
105766879|NCT02963766|364798316|FG000|Double-Blind Period|Physician Decision|1|||
105766880|NCT02963766|364798317|FG001|Double-Blind Period|Physician Decision|0|||
105766881|NCT02963766|364798318|FG002|Double-Blind Period|Physician Decision|0|||
105766882|NCT02963766|364798316|FG000|Double-Blind Period|Withdrawal by Subject|1|||
105766883|NCT02963766|364798317|FG001|Double-Blind Period|Withdrawal by Subject|1|||
105766884|NCT02963766|364798318|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105766885|NCT02963766|364798316|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
105766886|NCT02963766|364798317|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
105766887|NCT02963766|364798318|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
105766888|NCT02963766|364798316|FG000|Double-Blind Period|Protocol Violation|1|||
105766889|NCT02963766|364798317|FG001|Double-Blind Period|Protocol Violation|0|||
105766890|NCT02963766|364798318|FG002|Double-Blind Period|Protocol Violation|0|||
105766891|NCT02963766|364798316|FG000|Double-Blind Period|Lost to Follow-up|0|||
105766892|NCT02963766|364798317|FG001|Double-Blind Period|Lost to Follow-up|1|||
105766893|NCT02963766|364798318|FG002|Double-Blind Period|Lost to Follow-up|0|||
105766894|NCT02963766|364798316|FG000|Open Label Extension (OLE)|Physician Decision|1|||
105766895|NCT02963766|364798317|FG001|Open Label Extension (OLE)|Physician Decision|2|||
105766896|NCT02963766|364798318|FG002|Open Label Extension (OLE)|Physician Decision|2|||
105766897|NCT02963766|364798316|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
105766898|NCT02963766|364798317|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
105766899|NCT02963766|364798318|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
105766900|NCT00398138|364798319|FG000|Overall Study|Adverse Event|2|||
105766901|NCT02224274|364798320|FG000|Overall Study|Death|1|||
105766902|NCT02224274|364798321|FG001|Overall Study|Death|0|||
105766903|NCT00499460|364798322|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
105766904|NCT00499460|364798323|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
105766905|NCT00499460|364798322|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
105766906|NCT00499460|364798323|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
105766907|NCT00499460|364798322|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
105766908|NCT00499460|364798323|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
105766909|NCT03418376|364798324|FG000|Overall Study|Musculoskeletal injury|1|||
105766910|NCT03418376|364798325|FG001|Overall Study|Musculoskeletal injury|2|||
105766911|NCT03418376|364798326|FG002|Overall Study|Musculoskeletal injury|1|||
105766912|NCT03418376|364798327|FG003|Overall Study|Musculoskeletal injury|0|||
105766913|NCT03418376|364798324|FG000|Overall Study|Personal reasons|0|||
105766914|NCT03418376|364798325|FG001|Overall Study|Personal reasons|2|||
105766915|NCT03418376|364798326|FG002|Overall Study|Personal reasons|2|||
105766916|NCT03418376|364798327|FG003|Overall Study|Personal reasons|1|||
105766917|NCT03418376|364798324|FG000|Overall Study|Exacerbation|0|||
105766918|NCT03418376|364798325|FG001|Overall Study|Exacerbation|1|||
105766919|NCT03418376|364798326|FG002|Overall Study|Exacerbation|0|||
105766920|NCT03418376|364798327|FG003|Overall Study|Exacerbation|0|||
105766921|NCT00807014|364798328|FG000|Overall Study|Participant Considered Disease Cured|13|||
105766922|NCT00807014|364798329|FG001|Overall Study|Participant Considered Disease Cured|2|||
105766923|NCT00807014|364798328|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
105766924|NCT00807014|364798329|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
105766925|NCT00807014|364798328|FG000|Overall Study|Protocol Violation|2|||
105766926|NCT00807014|364798329|FG001|Overall Study|Protocol Violation|8|||
105766927|NCT00807014|364798328|FG000|Overall Study|Adverse Event|0|||
105766928|NCT00807014|364798329|FG001|Overall Study|Adverse Event|2|||
105766929|NCT00807014|364798328|FG000|Overall Study|Lost to Follow-up|9|||
105766930|NCT00807014|364798329|FG001|Overall Study|Lost to Follow-up|7|||
105766931|NCT00807014|364798328|FG000|Overall Study|Recovery|1|||
105766932|NCT00807014|364798329|FG001|Overall Study|Recovery|0|||
105766933|NCT00807014|364798328|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
105766934|NCT00807014|364798329|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
105766935|NCT00814307|364798337|FG000|Overall Study|Randomized but not treated|1|||
105766936|NCT00814307|364798338|FG001|Overall Study|Randomized but not treated|0|||
105766937|NCT00814307|364798339|FG002|Overall Study|Randomized but not treated|0|||
105766938|NCT00814307|364798340|FG003|Overall Study|Randomized but not treated|0|||
105766939|NCT00814307|364798337|FG000|Overall Study|Adverse Event|3|||
105766940|NCT00814307|364798338|FG001|Overall Study|Adverse Event|9|||
105766941|NCT00814307|364798339|FG002|Overall Study|Adverse Event|3|||
105766942|NCT00814307|364798340|FG003|Overall Study|Adverse Event|2|||
105766943|NCT00814307|364798337|FG000|Overall Study|Lack of Efficacy|1|||
105766944|NCT00814307|364798338|FG001|Overall Study|Lack of Efficacy|1|||
105766945|NCT00814307|364798339|FG002|Overall Study|Lack of Efficacy|3|||
105766946|NCT00814307|364798340|FG003|Overall Study|Lack of Efficacy|4|||
105766947|NCT00814307|364798337|FG000|Overall Study|Other|1|||
105766948|NCT00814307|364798338|FG001|Overall Study|Other|2|||
105766949|NCT00814307|364798339|FG002|Overall Study|Other|0|||
105766950|NCT00814307|364798340|FG003|Overall Study|Other|1|||
105766951|NCT00814307|364798337|FG000|Overall Study|Protocol Violation|2|||
105766952|NCT00814307|364798338|FG001|Overall Study|Protocol Violation|8|||
105822579|NCT03673670|365008767|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105822580|NCT03673670|365008768|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105822581|NCT03673670|365008769|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105822582|NCT03673670|365008770|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
105822583|NCT03673670|365008771|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
105822584|NCT03673670|365008766|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822585|NCT03673670|365008767|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822586|NCT03673670|365008768|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822587|NCT03673670|365008769|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822588|NCT03673670|365008770|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
105822589|NCT03673670|365008771|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
105822590|NCT00244764|365008772|FG000|Overall Study|Adverse Event|37|||
105822591|NCT00244764|365008772|FG000|Overall Study|Lost to Follow-up|23|||
105766953|NCT00814307|364798339|FG002|Overall Study|Protocol Violation|1|||
105766954|NCT00814307|364798340|FG003|Overall Study|Protocol Violation|1|||
105766955|NCT00814307|364798337|FG000|Overall Study|Withdrawal by Subject|4|||
105766956|NCT00814307|364798338|FG001|Overall Study|Withdrawal by Subject|6|||
105766957|NCT00814307|364798339|FG002|Overall Study|Withdrawal by Subject|0|||
105766958|NCT00814307|364798340|FG003|Overall Study|Withdrawal by Subject|2|||
105766959|NCT00814307|364798337|FG000|Overall Study|Death|0|||
105766960|NCT00814307|364798338|FG001|Overall Study|Death|1|||
105766961|NCT00814307|364798339|FG002|Overall Study|Death|0|||
105766962|NCT00814307|364798340|FG003|Overall Study|Death|0|||
105766963|NCT03209362|364798349|FG000|Overall Study|Adverse Event|0|||
105766964|NCT03209362|364798350|FG001|Overall Study|Adverse Event|1|||
105822592|NCT00244764|365008772|FG000|Overall Study|Withdrawal by Subject|12|||
105822593|NCT00244764|365008772|FG000|Overall Study|Disease Progression|13|||
105822594|NCT00244764|365008772|FG000|Overall Study|Protocol Violation|2|||
105822595|NCT00244764|365008772|FG000|Overall Study|Death|1|||
105822596|NCT00244764|365008772|FG000|Overall Study|Off Study Medication for >21 Days|1|||
105822597|NCT00244764|365008772|FG000|Overall Study|Declining Performance Status|1|||
105822598|NCT00244764|365008772|FG000|Overall Study|Participant was Hospitalized until Death|1|||
105822599|NCT00244764|365008772|FG000|Overall Study|Primary Investigator Discretion|2|||
105822600|NCT00244764|365008772|FG000|Overall Study|Sponsor Terminated Study|2|||
105822601|NCT00244764|365008772|FG000|Overall Study|Developed Secondary Malignancy|1|||
105822602|NCT02911792|365008775|FG000|Overall Study|Lost to Follow-up|3|||
105822603|NCT02911792|365008776|FG001|Overall Study|Lost to Follow-up|3|||
105822604|NCT02911792|365008777|FG002|Overall Study|Lost to Follow-up|3|||
105958271|NCT01027650|365506768|FG006|Overall Study|Lost to Follow-up|1|||
105958272|NCT01027650|365506769|FG007|Overall Study|Lost to Follow-up|0|||
105958273|NCT01027650|365506762|FG000|Overall Study|Lack of Efficacy|0|||
105958274|NCT01027650|365506763|FG001|Overall Study|Lack of Efficacy|0|||
105958275|NCT01027650|365506764|FG002|Overall Study|Lack of Efficacy|0|||
105958276|NCT01027650|365506765|FG003|Overall Study|Lack of Efficacy|0|||
105958277|NCT01027650|365506766|FG004|Overall Study|Lack of Efficacy|0|||
105958278|NCT01027650|365506767|FG005|Overall Study|Lack of Efficacy|1|||
105958279|NCT01027650|365506768|FG006|Overall Study|Lack of Efficacy|0|||
105958280|NCT01027650|365506769|FG007|Overall Study|Lack of Efficacy|0|||
105958281|NCT03110029|365506770|FG000|Overall Study|Withdrawal by Subject|1|||
105958282|NCT03110029|365506771|FG001|Overall Study|Withdrawal by Subject|1|||
105958283|NCT02175277|365506772|FG000|Overall Study|Protocol-specified Criteria|1|||
105958284|NCT00600106|365508025|FG000|Overall Study|Withdrawal by Subject|1|||
105958285|NCT00600106|365508026|FG001|Overall Study|Withdrawal by Subject|1|||
105958286|NCT00460655|365508028|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
105958287|NCT00460655|365508029|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105958288|NCT00460655|365508030|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105958289|NCT00460655|365508031|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105958290|NCT00460655|365508028|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
105958291|NCT00460655|365508029|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
106020028|NCT04816669|365737120|FG000|Part 2|Withdrawal by Subject|0|||
106020029|NCT04816669|365737121|FG001|Part 2|Withdrawal by Subject|0|||
105766965|NCT03209362|364798349|FG000|Overall Study|Lost to Follow-up|0|||
105766966|NCT03209362|364798350|FG001|Overall Study|Lost to Follow-up|1|||
105822605|NCT02911792|365008778|FG003|Overall Study|Lost to Follow-up|3|||
105822606|NCT01244620|365008779|FG000|Overall Study|Study terminated|4|||
105822607|NCT01244620|365008780|FG001|Overall Study|Study terminated|4|||
105766967|NCT03209362|364798349|FG000|Overall Study|Withdrawal by Subject|2|||
106020030|NCT04816669|365737122|FG002|Part 2|Withdrawal by Subject|0|||
106020031|NCT04816669|365737123|FG003|Part 2|Withdrawal by Subject|1|||
106020032|NCT04816669|365737120|FG000|Part 2|Lost to Follow-up|0|||
106020033|NCT04816669|365737121|FG001|Part 2|Lost to Follow-up|0|||
106020034|NCT04816669|365737122|FG002|Part 2|Lost to Follow-up|1|||
106020035|NCT04816669|365737123|FG003|Part 2|Lost to Follow-up|0|||
106020036|NCT01237899|365737124|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
106020037|NCT01237899|365737125|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
106020038|NCT01237899|365737126|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
106020039|NCT01237899|365737127|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
106020040|NCT01237899|365737128|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
106020041|NCT01237899|365737129|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
106020042|NCT01237899|365737130|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
106020043|NCT01237899|365737131|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
106020044|NCT01237899|365737132|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
106020045|NCT01237899|365737133|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
106020046|NCT01237899|365737134|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
106020047|NCT03219528|365737137|FG000|Overall Study|Lost to Follow-up|5|||
106020048|NCT03219528|365737138|FG001|Overall Study|Lost to Follow-up|4|||
106020049|NCT03219528|365737137|FG000|Overall Study|Withdrawal by Subject|4|||
106020050|NCT03219528|365737138|FG001|Overall Study|Withdrawal by Subject|4|||
106020051|NCT00241839|365737139|FG000|Overall Study|Withdrawal by Subject|18|||
106020052|NCT00241839|365737140|FG001|Overall Study|Withdrawal by Subject|17|||
106020053|NCT00241839|365737139|FG000|Overall Study|Adverse Event|1|||
106020054|NCT00241839|365737140|FG001|Overall Study|Adverse Event|1|||
106020055|NCT03565497|365737150|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
106020056|NCT03565497|365737151|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
106020057|NCT03565497|365737152|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
106020058|NCT03565497|365737150|FG000|Overall Study|Lost to Follow-up|1|||
106020059|NCT03565497|365737151|FG001|Overall Study|Lost to Follow-up|1|||
106020060|NCT03565497|365737152|FG002|Overall Study|Lost to Follow-up|2|||
106020061|NCT03565497|365737150|FG000|Overall Study|Withdrawal by Subject|1|||
106020062|NCT03565497|365737151|FG001|Overall Study|Withdrawal by Subject|1|||
106020063|NCT03565497|365737152|FG002|Overall Study|Withdrawal by Subject|1|||
106020064|NCT03196349|365737155|FG000|Overall Study|Did not receive study drug|0|||
106020065|NCT03196349|365737156|FG001|Overall Study|Did not receive study drug|1|||
106020066|NCT03196349|365737157|FG002|Overall Study|Did not receive study drug|2|||
106020067|NCT03196349|365737155|FG000|Overall Study|No data entered|2|||
106020068|NCT03196349|365737156|FG001|Overall Study|No data entered|4|||
106020069|NCT03196349|365737157|FG002|Overall Study|No data entered|0|||
106020070|NCT03196349|365737155|FG000|Overall Study|Study Terminated early|15|||
106020071|NCT03196349|365737156|FG001|Overall Study|Study Terminated early|9|||
106020072|NCT03196349|365737157|FG002|Overall Study|Study Terminated early|11|||
106020073|NCT03388164|365737158|FG000|Overall Study|Withdrawal by Subject|3|||
106020074|NCT03388164|365737159|FG001|Overall Study|Withdrawal by Subject|1|||
106020075|NCT00060840|365737162|FG000|Overall Study|Change in surgical plan|2|||
106020076|NCT00060840|365737163|FG001|Overall Study|Change in surgical plan|6|||
106020077|NCT00060840|365737162|FG000|Overall Study|Death|0|||
106020078|NCT00060840|365737163|FG001|Overall Study|Death|1|||
106020079|NCT00060840|365737162|FG000|Overall Study|Withdrawal by Subject|0|||
106020080|NCT00060840|365737163|FG001|Overall Study|Withdrawal by Subject|1|||
106020081|NCT00060840|365737162|FG000|Overall Study|Subinvestigator unavailable|0|||
106020082|NCT00060840|365737163|FG001|Overall Study|Subinvestigator unavailable|1|||
106020083|NCT00060840|365737162|FG000|Overall Study|Physician Decision|1|||
106020084|NCT00060840|365737163|FG001|Overall Study|Physician Decision|0|||
106020085|NCT00060840|365737162|FG000|Overall Study|Other|1|||
106020086|NCT00060840|365737163|FG001|Overall Study|Other|0|||
106020087|NCT00976560|365737168|FG000|Overall Study|Adverse Event|5|||
106020088|NCT00976560|365737169|FG001|Overall Study|Adverse Event|5|||
106020089|NCT00976560|365737168|FG000|Overall Study|Lack of Efficacy|3|||
106020090|NCT00976560|365737169|FG001|Overall Study|Lack of Efficacy|5|||
106020091|NCT00976560|365737168|FG000|Overall Study|Protocol Violation|1|||
106020092|NCT00976560|365737169|FG001|Overall Study|Protocol Violation|0|||
106145674|NCT00736853|366193155|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
105958292|NCT00460655|365508030|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105958293|NCT00460655|365508031|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
106020093|NCT00976560|365737168|FG000|Overall Study|Lost to Follow-up|1|||
106020094|NCT00976560|365737169|FG001|Overall Study|Lost to Follow-up|0|||
106020095|NCT00976560|365737168|FG000|Overall Study|Physician Decision|2|||
105958294|NCT00460655|365508028|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
105958295|NCT00460655|365508029|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
105958296|NCT00460655|365508030|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
105958297|NCT00460655|365508031|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
105958298|NCT00460655|365508028|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105958299|NCT00460655|365508029|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
106145675|NCT00736853|366193153|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
105822608|NCT01244620|365008781|FG002|Overall Study|Study terminated|4|||
105822609|NCT01244620|365008782|FG003|Overall Study|Study terminated|4|||
105822610|NCT03872128|365008783|FG000|Overall Study|Dropped out before treatment|1|||
105822611|NCT03872128|365008784|FG001|Overall Study|Dropped out before treatment|0|||
105822612|NCT03872128|365008785|FG002|Overall Study|Dropped out before treatment|4|||
105822613|NCT03872128|365008783|FG000|Overall Study|Lost to Follow-up|2|||
105822614|NCT03872128|365008784|FG001|Overall Study|Lost to Follow-up|5|||
105822615|NCT03872128|365008785|FG002|Overall Study|Lost to Follow-up|8|||
105822616|NCT00840073|365008786|FG000|Second Intervention|Missed 72 hour blood draw|1|||
105958300|NCT00460655|365508030|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
105958301|NCT00460655|365508031|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
105958302|NCT00460655|365508028|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105958303|NCT00460655|365508029|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105958304|NCT00460655|365508030|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
105958305|NCT00460655|365508031|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
105958306|NCT00460655|365508028|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
105958307|NCT00460655|365508029|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
105958308|NCT00460655|365508030|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
105958309|NCT00460655|365508031|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
105958310|NCT02705105|365508032|FG000|Treatment|Objective Disease Progression|1|||
105958311|NCT02705105|365508033|FG001|Treatment|Objective Disease Progression|50|||
105958312|NCT02705105|365508032|FG000|Treatment|Withdrawal by Subject|3|||
105958313|NCT02705105|365508033|FG001|Treatment|Withdrawal by Subject|5|||
105958314|NCT02705105|365508032|FG000|Treatment|Adverse Event|0|||
105958315|NCT02705105|365508033|FG001|Treatment|Adverse Event|17|||
105958316|NCT02705105|365508032|FG000|Treatment|Clinical Disease Progression|0|||
105958317|NCT02705105|365508033|FG001|Treatment|Clinical Disease Progression|32|||
105958318|NCT02705105|365508032|FG000|Treatment|Physician Decision|0|||
105958319|NCT02705105|365508033|FG001|Treatment|Physician Decision|3|||
105958320|NCT02705105|365508032|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
105958321|NCT02705105|365508033|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
105958322|NCT02705105|365508032|FG000|Follow-Up|Death|3|||
105958323|NCT02705105|365508033|FG001|Follow-Up|Death|68|||
105958324|NCT02705105|365508032|FG000|Follow-Up|Withdrawal by Subject|1|||
105958325|NCT02705105|365508033|FG001|Follow-Up|Withdrawal by Subject|14|||
105958326|NCT02705105|365508032|FG000|Follow-Up|Study Terminated|0|||
105958327|NCT02705105|365508033|FG001|Follow-Up|Study Terminated|26|||
105958328|NCT02705105|365508032|FG000|Follow-Up|Discontinued per Amendment 3|0|||
105958329|NCT02705105|365508033|FG001|Follow-Up|Discontinued per Amendment 3|2|||
105958330|NCT00375427|365508034|FG000|Overall Study|Adverse Event|21|||
105958331|NCT00375427|365508035|FG001|Overall Study|Adverse Event|27|||
105958332|NCT00375427|365508034|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105958333|NCT00375427|365508035|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105958334|NCT00375427|365508034|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105958335|NCT00375427|365508035|FG001|Overall Study|Abnormal laboratory value(s)|2|||
105958336|NCT00375427|365508034|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105958337|NCT00375427|365508035|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
105958338|NCT00375427|365508034|FG000|Overall Study|Patient no longer requires study drug|3|||
105958339|NCT00375427|365508035|FG001|Overall Study|Patient no longer requires study drug|7|||
105958340|NCT00375427|365508034|FG000|Overall Study|Protocol Violation|10|||
105958341|NCT00375427|365508035|FG001|Overall Study|Protocol Violation|8|||
105958342|NCT00375427|365508034|FG000|Overall Study|Withdrawal by Subject|9|||
105958343|NCT00375427|365508035|FG001|Overall Study|Withdrawal by Subject|13|||
105958344|NCT00375427|365508034|FG000|Overall Study|Lost to Follow-up|1|||
105958345|NCT00375427|365508035|FG001|Overall Study|Lost to Follow-up|1|||
105958346|NCT00375427|365508034|FG000|Overall Study|Administrative reasons|0|||
105958347|NCT00375427|365508035|FG001|Overall Study|Administrative reasons|1|||
105958348|NCT00375427|365508034|FG000|Overall Study|Death|11|||
105958349|NCT00375427|365508035|FG001|Overall Study|Death|10|||
105958350|NCT02817594|365508041|FG000|Overall Study|Withdrawal by Subject|1|||
105958351|NCT02817594|365508041|FG000|Overall Study|Other|1|||
105958352|NCT02817594|365508041|FG000|Overall Study|Did Not Receive Treatment|1|||
105958353|NCT02229825|365508045|FG000|Overall Study|Personal Reasons|0|||
105958354|NCT02229825|365508046|FG001|Overall Study|Personal Reasons|1|||
105958355|NCT02229825|365508045|FG000|Overall Study|Refused continuing medication|7|||
105958356|NCT02229825|365508046|FG001|Overall Study|Refused continuing medication|6|||
105958357|NCT02229825|365508045|FG000|Overall Study|Lost to Follow-up|1|||
105958358|NCT02229825|365508046|FG001|Overall Study|Lost to Follow-up|2|||
105958359|NCT02229825|365508045|FG000|Overall Study|Protocol Violation|1|||
105958360|NCT02229825|365508046|FG001|Overall Study|Protocol Violation|1|||
105958361|NCT02229825|365508045|FG000|Overall Study|Lack of Efficacy|4|||
105958362|NCT02229825|365508046|FG001|Overall Study|Lack of Efficacy|10|||
105822617|NCT00840073|365008787|FG001|Second Intervention|Missed 72 hour blood draw|1|||
105822618|NCT03637764|365008788|FG000|Overall Study|Adverse Event|2|||
105958363|NCT02229825|365508045|FG000|Overall Study|Adverse Event|11|||
105958364|NCT02229825|365508046|FG001|Overall Study|Adverse Event|9|||
106020096|NCT00976560|365737169|FG001|Overall Study|Physician Decision|0|||
106020097|NCT00976560|365737168|FG000|Overall Study|Withdrawal by Subject|2|||
106020098|NCT00976560|365737169|FG001|Overall Study|Withdrawal by Subject|3|||
106020099|NCT00125164|365737172|FG000|Overall Study|Adverse Event|0|||
106020100|NCT00125164|365737173|FG001|Overall Study|Adverse Event|0|||
106020101|NCT00125164|365737174|FG002|Overall Study|Adverse Event|2|||
106020102|NCT00125164|365737175|FG003|Overall Study|Adverse Event|4|||
106020103|NCT00125164|365737172|FG000|Overall Study|Lost to Follow-up|0|||
106020104|NCT00125164|365737173|FG001|Overall Study|Lost to Follow-up|0|||
106020105|NCT00125164|365737174|FG002|Overall Study|Lost to Follow-up|1|||
106020106|NCT00125164|365737175|FG003|Overall Study|Lost to Follow-up|1|||
106020107|NCT00125164|365737172|FG000|Overall Study|Withdrawal by Subject|2|||
106020108|NCT00125164|365737173|FG001|Overall Study|Withdrawal by Subject|0|||
106020109|NCT00125164|365737174|FG002|Overall Study|Withdrawal by Subject|1|||
106020110|NCT00125164|365737175|FG003|Overall Study|Withdrawal by Subject|1|||
106020111|NCT00889720|365737176|FG000|Overall Study|Withdrawal by Subject|4|||
106020112|NCT00889720|365737176|FG000|Overall Study|Other|4|||
106020113|NCT01339052|365737177|FG000|Overall Study|Disease progression|13|||
106020114|NCT01339052|365737178|FG001|Overall Study|Disease progression|46|||
106020115|NCT01339052|365737177|FG000|Overall Study|Adverse Event|1|||
106020116|NCT01339052|365737178|FG001|Overall Study|Adverse Event|1|||
106020117|NCT01339052|365737177|FG000|Overall Study|Withdrawal by Subject|0|||
106020118|NCT01339052|365737178|FG001|Overall Study|Withdrawal by Subject|3|||
106020119|NCT01339052|365737177|FG000|Overall Study|Physician Decision|1|||
106020120|NCT01339052|365737178|FG001|Overall Study|Physician Decision|0|||
106020121|NCT03865381|365737181|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
106020122|NCT03865381|365737181|FG000|Overall Study|Withdrawal by Subject|2|||
106020123|NCT00068419|365737184|FG000|Overall Study|Adverse Event|3|||
106020124|NCT00068419|365737184|FG000|Overall Study|Lack of Efficacy|24|||
106020125|NCT00068419|365737184|FG000|Overall Study|Lost to Follow-up|1|||
106020126|NCT00068419|365737184|FG000|Overall Study|Physician Decision|7|||
106020127|NCT00068419|365737184|FG000|Overall Study|Withdrawal by Subject|14|||
106020128|NCT00068419|365737184|FG000|Overall Study|Ineligible|11|||
106020129|NCT01032889|365737185|FG000|Overall Study|Adverse Event|2|||
106020130|NCT01032889|365737186|FG001|Overall Study|Adverse Event|2|||
106020131|NCT01032889|365737187|FG002|Overall Study|Adverse Event|0|||
106020132|NCT01032889|365737185|FG000|Overall Study|Withdrawal of Consent|1|||
106020133|NCT01032889|365737186|FG001|Overall Study|Withdrawal of Consent|2|||
106020134|NCT01032889|365737187|FG002|Overall Study|Withdrawal of Consent|1|||
106020135|NCT01032889|365737185|FG000|Overall Study|Patient Request|0|||
106020136|NCT01032889|365737186|FG001|Overall Study|Patient Request|1|||
106020137|NCT01032889|365737187|FG002|Overall Study|Patient Request|0|||
106020138|NCT01032889|365737185|FG000|Overall Study|Lost to Follow-up|1|||
105822619|NCT03637764|365008789|FG001|Overall Study|Adverse Event|0|||
105822620|NCT03637764|365008790|FG002|Overall Study|Adverse Event|0|||
105822621|NCT03637764|365008791|FG003|Overall Study|Adverse Event|1|||
105822622|NCT03637764|365008788|FG000|Overall Study|Progressive Disease|23|||
105822623|NCT03637764|365008789|FG001|Overall Study|Progressive Disease|23|||
105822624|NCT03637764|365008790|FG002|Overall Study|Progressive Disease|18|||
105822625|NCT03637764|365008791|FG003|Overall Study|Progressive Disease|31|||
105822626|NCT03637764|365008788|FG000|Overall Study|Withdrawal by Subject|1|||
105822627|NCT03637764|365008789|FG001|Overall Study|Withdrawal by Subject|3|||
105822628|NCT03637764|365008790|FG002|Overall Study|Withdrawal by Subject|0|||
105822629|NCT03637764|365008791|FG003|Overall Study|Withdrawal by Subject|1|||
105822630|NCT02648438|365008792|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105822631|NCT02648438|365008793|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
105822632|NCT02648438|365008794|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105822633|NCT02648438|365008792|FG000|Overall Study|Protocol Violation|2|||
106020139|NCT01032889|365737186|FG001|Overall Study|Lost to Follow-up|1|||
106020140|NCT01032889|365737187|FG002|Overall Study|Lost to Follow-up|0|||
106020141|NCT01032889|365737185|FG000|Overall Study|Lack of Submental Fat|2|||
106020142|NCT01032889|365737186|FG001|Overall Study|Lack of Submental Fat|8|||
106020143|NCT01032889|365737187|FG002|Overall Study|Lack of Submental Fat|1|||
106020144|NCT01032889|365737185|FG000|Overall Study|Miscellaneous Reasons|2|||
106020145|NCT01032889|365737186|FG001|Overall Study|Miscellaneous Reasons|1|||
106020146|NCT01032889|365737187|FG002|Overall Study|Miscellaneous Reasons|1|||
106020147|NCT00721968|365737193|FG000|Overall Study|Lost to Follow-up|2|||
106020148|NCT00721968|365737194|FG001|Overall Study|Lost to Follow-up|0|||
106020149|NCT01064947|365737196|FG000|Overall Study|negative culture|41|||
106020150|NCT02970942|365737197|FG000|Overall Study|Death|0|||
106020151|NCT02970942|365737198|FG001|Overall Study|Death|1|||
106020152|NCT02970942|365737199|FG002|Overall Study|Death|0|||
106020153|NCT02970942|365737200|FG003|Overall Study|Death|0|||
106020154|NCT02970942|365737197|FG000|Overall Study|Lost to Follow-up|1|||
106020155|NCT02970942|365737198|FG001|Overall Study|Lost to Follow-up|0|||
106020156|NCT02970942|365737199|FG002|Overall Study|Lost to Follow-up|2|||
106020157|NCT02970942|365737200|FG003|Overall Study|Lost to Follow-up|1|||
105822634|NCT02648438|365008793|FG001|Overall Study|Protocol Violation|0|||
105822635|NCT02648438|365008794|FG002|Overall Study|Protocol Violation|0|||
105822636|NCT02648438|365008792|FG000|Overall Study|Withdrawal by Subject|1|||
105822637|NCT02648438|365008793|FG001|Overall Study|Withdrawal by Subject|1|||
105822638|NCT02648438|365008794|FG002|Overall Study|Withdrawal by Subject|0|||
105822639|NCT02760927|365008795|FG000|Overall Study|Tube Slippage from Device|1|||
105822640|NCT02105272|365008796|FG000|Overall Study|Adverse Event|1|||
105766968|NCT03209362|364798350|FG001|Overall Study|Withdrawal by Subject|0|||
105822641|NCT02105272|365008797|FG001|Overall Study|Adverse Event|2|||
105822642|NCT02105272|365008796|FG000|Overall Study|Physician Decision|0|||
105822643|NCT02105272|365008797|FG001|Overall Study|Physician Decision|1|||
105822644|NCT02105272|365008796|FG000|Overall Study|Protocol Violation|2|||
105766969|NCT03209362|364798349|FG000|Overall Study|Other|0|||
105766970|NCT03209362|364798350|FG001|Overall Study|Other|1|||
105766971|NCT00796224|364798351|FG000|Overall Study|Adverse Event|1|||
105766972|NCT00796224|364798352|FG001|Overall Study|Adverse Event|0|||
105766973|NCT00796224|364798351|FG000|Overall Study|Protocol Violation|0|||
105766974|NCT00796224|364798352|FG001|Overall Study|Protocol Violation|1|||
105766975|NCT02569398|364798353|FG000|Overall Study|Adverse Event|0|||
105766976|NCT02569398|364798354|FG001|Overall Study|Adverse Event|1|||
105766977|NCT02569398|364798355|FG002|Overall Study|Adverse Event|6|||
105766978|NCT02569398|364798353|FG000|Overall Study|Withdrawal by Subject|43|||
105766979|NCT02569398|364798354|FG001|Overall Study|Withdrawal by Subject|43|||
105766980|NCT02569398|364798355|FG002|Overall Study|Withdrawal by Subject|30|||
105766981|NCT02569398|364798353|FG000|Overall Study|Study terminated by sponsor|130|||
105766982|NCT02569398|364798354|FG001|Overall Study|Study terminated by sponsor|131|||
105766983|NCT02569398|364798355|FG002|Overall Study|Study terminated by sponsor|134|||
105766984|NCT02569398|364798353|FG000|Overall Study|Other|12|||
105766985|NCT02569398|364798354|FG001|Overall Study|Other|14|||
105766986|NCT02569398|364798355|FG002|Overall Study|Other|13|||
105766987|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
105766988|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
105766989|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Death|0|||
105766990|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Death|4|||
105766991|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
105766992|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
105766993|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
105766994|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
105766995|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
105766996|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
105766997|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
105766998|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
105766999|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
105767000|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
105767001|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Other|4|||
105822645|NCT02105272|365008797|FG001|Overall Study|Protocol Violation|0|||
105822646|NCT02105272|365008796|FG000|Overall Study|Withdrawal by Subject|2|||
105958365|NCT02229825|365508045|FG000|Overall Study|Not treated|0|||
105958366|NCT02229825|365508046|FG001|Overall Study|Not treated|1|||
105958367|NCT00040742|365508051|FG000|Overall Study|Death|0|||
105958368|NCT00040742|365508052|FG001|Overall Study|Death|0|||
105958369|NCT00040742|365508053|FG002|Overall Study|Death|1|||
105958370|NCT00040742|365508054|FG003|Overall Study|Death|0|||
105958371|NCT00040742|365508051|FG000|Overall Study|Adverse Event|15|||
105958372|NCT00040742|365508052|FG001|Overall Study|Adverse Event|16|||
105958373|NCT00040742|365508053|FG002|Overall Study|Adverse Event|21|||
105958374|NCT00040742|365508054|FG003|Overall Study|Adverse Event|9|||
105958375|NCT00040742|365508051|FG000|Overall Study|Withdrawal by Subject|7|||
105958376|NCT00040742|365508052|FG001|Overall Study|Withdrawal by Subject|15|||
105958377|NCT00040742|365508053|FG002|Overall Study|Withdrawal by Subject|10|||
105958378|NCT00040742|365508054|FG003|Overall Study|Withdrawal by Subject|13|||
105958379|NCT00040742|365508051|FG000|Overall Study|Chemotoxicity|4|||
105958380|NCT00040742|365508052|FG001|Overall Study|Chemotoxicity|3|||
105958381|NCT00040742|365508053|FG002|Overall Study|Chemotoxicity|5|||
105958382|NCT00040742|365508054|FG003|Overall Study|Chemotoxicity|2|||
105958383|NCT00040742|365508051|FG000|Overall Study|Incomplete Forms|6|||
105958384|NCT00040742|365508052|FG001|Overall Study|Incomplete Forms|10|||
105958385|NCT00040742|365508053|FG002|Overall Study|Incomplete Forms|4|||
105958386|NCT00040742|365508054|FG003|Overall Study|Incomplete Forms|5|||
105958387|NCT00040742|365508051|FG000|Overall Study|Other medical|7|||
105958388|NCT00040742|365508052|FG001|Overall Study|Other medical|5|||
105958389|NCT00040742|365508053|FG002|Overall Study|Other medical|5|||
105958390|NCT00040742|365508054|FG003|Overall Study|Other medical|5|||
105958391|NCT03726658|365508057|FG000|Overall Study|Lost to Follow-up|0|||
105958392|NCT03726658|365508058|FG001|Overall Study|Lost to Follow-up|0|||
105958393|NCT03726658|365508059|FG002|Overall Study|Lost to Follow-up|2|||
105767002|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Other|3|||
105767003|NCT03517722|364798356|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
105767004|NCT03517722|364798357|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
105767005|NCT03517722|364798356|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
105767006|NCT03517722|364798357|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
105767007|NCT03517722|364798356|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
105767008|NCT03517722|364798357|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
105767009|NCT03517722|364798356|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
105767010|NCT03517722|364798357|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
105767011|NCT03517722|364798356|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
105767012|NCT03517722|364798357|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
105767013|NCT02371980|364800366|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
105767014|NCT02371980|364800367|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
106020158|NCT02970942|365737197|FG000|Overall Study|Withdrawal by Subject|3|||
106020159|NCT02970942|365737198|FG001|Overall Study|Withdrawal by Subject|5|||
106020160|NCT02970942|365737199|FG002|Overall Study|Withdrawal by Subject|3|||
106020161|NCT02970942|365737200|FG003|Overall Study|Withdrawal by Subject|2|||
106020162|NCT02930018|365737204|FG000|Overall Study|Lost to Follow-up|1|||
106020163|NCT02930018|365737205|FG001|Overall Study|Lost to Follow-up|1|||
106020164|NCT02930018|365737204|FG000|Overall Study|Withdrawal by Subject|5|||
105767015|NCT02371980|364800368|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
105767016|NCT02371980|364800369|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
105767017|NCT02371980|364800370|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
105767018|NCT02371980|364800366|FG000|Open-label Period|Significant Protocol Deviation|19|||
105767019|NCT02371980|364800367|FG001|Open-label Period|Significant Protocol Deviation|0|||
105767020|NCT02371980|364800368|FG002|Open-label Period|Significant Protocol Deviation|0|||
105767021|NCT02371980|364800369|FG003|Open-label Period|Significant Protocol Deviation|0|||
105767022|NCT02371980|364800370|FG004|Open-label Period|Significant Protocol Deviation|0|||
105767023|NCT02371980|364800366|FG000|Open-label Period|Noncompliance with Study Drug|10|||
105767024|NCT02371980|364800367|FG001|Open-label Period|Noncompliance with Study Drug|0|||
105767025|NCT02371980|364800368|FG002|Open-label Period|Noncompliance with Study Drug|0|||
106020165|NCT02930018|365737205|FG001|Overall Study|Withdrawal by Subject|2|||
106020166|NCT02529553|365737206|FG000|Overall Study|Progressive Disease|1|||
105767026|NCT02371980|364800369|FG003|Open-label Period|Noncompliance with Study Drug|0|||
105767027|NCT02371980|364800370|FG004|Open-label Period|Noncompliance with Study Drug|0|||
106020167|NCT02529553|365737207|FG001|Overall Study|Progressive Disease|0|||
106020168|NCT02529553|365737208|FG002|Overall Study|Progressive Disease|1|||
106020169|NCT02529553|365737209|FG003|Overall Study|Progressive Disease|3|||
106020170|NCT02529553|365737210|FG004|Overall Study|Progressive Disease|2|||
106020171|NCT02529553|365737211|FG005|Overall Study|Progressive Disease|3|||
106020172|NCT02529553|365737212|FG006|Overall Study|Progressive Disease|3|||
106020173|NCT02529553|365737213|FG007|Overall Study|Progressive Disease|5|||
106020174|NCT02529553|365737214|FG008|Overall Study|Progressive Disease|3|||
106020175|NCT02529553|365737206|FG000|Overall Study|Physician Decision|0|||
106020176|NCT02529553|365737207|FG001|Overall Study|Physician Decision|1|||
106020177|NCT02529553|365737208|FG002|Overall Study|Physician Decision|0|||
106020178|NCT02529553|365737209|FG003|Overall Study|Physician Decision|0|||
106020179|NCT02529553|365737210|FG004|Overall Study|Physician Decision|1|||
106020180|NCT02529553|365737211|FG005|Overall Study|Physician Decision|0|||
106020181|NCT02529553|365737212|FG006|Overall Study|Physician Decision|0|||
106020182|NCT02529553|365737213|FG007|Overall Study|Physician Decision|0|||
106020183|NCT02529553|365737214|FG008|Overall Study|Physician Decision|0|||
106020184|NCT02529553|365737206|FG000|Overall Study|Withdrawal by Subject|0|||
106020185|NCT02529553|365737207|FG001|Overall Study|Withdrawal by Subject|0|||
106020186|NCT02529553|365737208|FG002|Overall Study|Withdrawal by Subject|0|||
106020187|NCT02529553|365737209|FG003|Overall Study|Withdrawal by Subject|0|||
106020188|NCT02529553|365737210|FG004|Overall Study|Withdrawal by Subject|0|||
106020189|NCT02529553|365737211|FG005|Overall Study|Withdrawal by Subject|1|||
106020190|NCT02529553|365737212|FG006|Overall Study|Withdrawal by Subject|0|||
106020191|NCT02529553|365737213|FG007|Overall Study|Withdrawal by Subject|1|||
106020192|NCT02529553|365737214|FG008|Overall Study|Withdrawal by Subject|0|||
106020193|NCT00702715|365738578|FG000|Overall Study|Lost to Follow-up|1|||
105767028|NCT02371980|364800366|FG000|Open-label Period|Lost to Follow-up|55|||
105767029|NCT02371980|364800367|FG001|Open-label Period|Lost to Follow-up|0|||
105767030|NCT02371980|364800368|FG002|Open-label Period|Lost to Follow-up|0|||
106020194|NCT00702715|365738579|FG001|Overall Study|Lost to Follow-up|0|||
106020195|NCT04040933|365738580|FG000|Overall Study|Protocol Violation|1|||
106020196|NCT04040933|365738580|FG000|Overall Study|Withdrawal by Subject|2|||
106020197|NCT04661579|365738592|FG000|Overall Study|Lost to Follow-up|19|||
106020198|NCT04661579|365738593|FG001|Overall Study|Lost to Follow-up|10|||
106020199|NCT04661579|365738594|FG002|Overall Study|Lost to Follow-up|2|||
106020200|NCT04661579|365738595|FG003|Overall Study|Lost to Follow-up|7|||
106020201|NCT04661579|365738596|FG004|Overall Study|Lost to Follow-up|11|||
106020202|NCT04661579|365738592|FG000|Overall Study|Physician Decision|2|||
106020203|NCT04661579|365738593|FG001|Overall Study|Physician Decision|0|||
106020204|NCT04661579|365738594|FG002|Overall Study|Physician Decision|0|||
105767031|NCT02371980|364800369|FG003|Open-label Period|Lost to Follow-up|0|||
105767032|NCT02371980|364800370|FG004|Open-label Period|Lost to Follow-up|0|||
105822647|NCT02105272|365008797|FG001|Overall Study|Withdrawal by Subject|0|||
105822648|NCT02964039|365008798|FG000|Overall Study|Medical reason unrelated to study participation|1|||
105822649|NCT02964039|365008799|FG001|Overall Study|Medical reason unrelated to study participation|0|||
105822650|NCT02964039|365008800|FG002|Overall Study|Medical reason unrelated to study participation|3|||
105822651|NCT02964039|365008798|FG000|Overall Study|Research shutdown due to pandemic|2|||
105822652|NCT02964039|365008799|FG001|Overall Study|Research shutdown due to pandemic|0|||
105822653|NCT02964039|365008800|FG002|Overall Study|Research shutdown due to pandemic|1|||
105822654|NCT02964039|365008798|FG000|Overall Study|Withdrawal by Subject|0|||
105822655|NCT02964039|365008799|FG001|Overall Study|Withdrawal by Subject|1|||
105822656|NCT02964039|365008800|FG002|Overall Study|Withdrawal by Subject|0|||
105822657|NCT02964039|365008798|FG000|Overall Study|Lost to Follow-up|1|||
105822658|NCT02964039|365008799|FG001|Overall Study|Lost to Follow-up|0|||
105822659|NCT02964039|365008800|FG002|Overall Study|Lost to Follow-up|1|||
105822660|NCT01103713|365008801|FG000|Overall Study|Lost to Follow-up|2|||
105822661|NCT01103713|365008801|FG000|Overall Study|Withdrawal by Subject|8|||
105822662|NCT01103713|365008801|FG000|Overall Study|Study terminated by sponsor|2|||
105822663|NCT01103713|365008801|FG000|Overall Study|Other|1|||
105822664|NCT01615198|365008802|FG000|Overall Study|Withdrawal by Subject|5|||
105822665|NCT01615198|365008803|FG001|Overall Study|Withdrawal by Subject|5|||
105822666|NCT01615198|365008802|FG000|Overall Study|Protocol deviation|1|||
105822667|NCT01615198|365008803|FG001|Overall Study|Protocol deviation|1|||
105822668|NCT01615198|365008802|FG000|Overall Study|Physician Decision|5|||
105822669|NCT01615198|365008803|FG001|Overall Study|Physician Decision|1|||
105822670|NCT01615198|365008802|FG000|Overall Study|Lost to Follow-up|1|||
105767033|NCT02371980|364800366|FG000|Open-label Period|Voluntary Withdrawal|91|||
105767034|NCT02371980|364800367|FG001|Open-label Period|Voluntary Withdrawal|0|||
105767035|NCT02371980|364800368|FG002|Open-label Period|Voluntary Withdrawal|0|||
105767036|NCT02371980|364800369|FG003|Open-label Period|Voluntary Withdrawal|0|||
105767037|NCT02371980|364800370|FG004|Open-label Period|Voluntary Withdrawal|0|||
105767038|NCT02371980|364800366|FG000|Open-label Period|Pregnancy|1|||
105767039|NCT02371980|364800367|FG001|Open-label Period|Pregnancy|0|||
105767040|NCT02371980|364800368|FG002|Open-label Period|Pregnancy|0|||
105767041|NCT02371980|364800369|FG003|Open-label Period|Pregnancy|0|||
105767042|NCT02371980|364800370|FG004|Open-label Period|Pregnancy|0|||
105822671|NCT01615198|365008803|FG001|Overall Study|Lost to Follow-up|1|||
105822672|NCT01615198|365008802|FG000|Overall Study|Lack of Efficacy|1|||
105822673|NCT01615198|365008803|FG001|Overall Study|Lack of Efficacy|6|||
105822674|NCT01615198|365008802|FG000|Overall Study|Adverse Event|11|||
105822675|NCT01615198|365008803|FG001|Overall Study|Adverse Event|5|||
105822676|NCT02089685|365008804|FG000|Overall Study|Adverse Event|1|||
105822677|NCT02089685|365008805|FG001|Overall Study|Adverse Event|0|||
105822678|NCT02089685|365008806|FG002|Overall Study|Adverse Event|0|||
105822679|NCT02089685|365008807|FG003|Overall Study|Adverse Event|0|||
105822680|NCT02089685|365008808|FG004|Overall Study|Adverse Event|1|||
105822681|NCT02089685|365008809|FG005|Overall Study|Adverse Event|0|||
105822682|NCT02089685|365008804|FG000|Overall Study|Clinical Progression|4|||
105958394|NCT03726658|365508060|FG003|Overall Study|Lost to Follow-up|0|||
105958395|NCT03726658|365508061|FG004|Overall Study|Lost to Follow-up|0|||
105958396|NCT03726658|365508062|FG005|Overall Study|Lost to Follow-up|1|||
105958397|NCT03726658|365508063|FG006|Overall Study|Lost to Follow-up|1|||
105958398|NCT03726658|365508057|FG000|Overall Study|Withdrawal by Subject|1|||
105958399|NCT03726658|365508058|FG001|Overall Study|Withdrawal by Subject|0|||
105958400|NCT03726658|365508059|FG002|Overall Study|Withdrawal by Subject|0|||
105958401|NCT03726658|365508060|FG003|Overall Study|Withdrawal by Subject|0|||
105958402|NCT03726658|365508061|FG004|Overall Study|Withdrawal by Subject|6|||
105958403|NCT03726658|365508062|FG005|Overall Study|Withdrawal by Subject|4|||
105958404|NCT03726658|365508063|FG006|Overall Study|Withdrawal by Subject|2|||
105958405|NCT03726658|365508057|FG000|Overall Study|Pregnancy|0|||
105822683|NCT02089685|365008805|FG001|Overall Study|Clinical Progression|0|||
105822684|NCT02089685|365008806|FG002|Overall Study|Clinical Progression|0|||
105958406|NCT03726658|365508058|FG001|Overall Study|Pregnancy|0|||
105958407|NCT03726658|365508059|FG002|Overall Study|Pregnancy|0|||
105822685|NCT02089685|365008807|FG003|Overall Study|Clinical Progression|5|||
105822686|NCT02089685|365008808|FG004|Overall Study|Clinical Progression|1|||
105822687|NCT02089685|365008809|FG005|Overall Study|Clinical Progression|2|||
105822688|NCT02089685|365008804|FG000|Overall Study|Excluded Medication|1|||
105958408|NCT03726658|365508060|FG003|Overall Study|Pregnancy|0|||
105958409|NCT03726658|365508061|FG004|Overall Study|Pregnancy|0|||
105958410|NCT03726658|365508062|FG005|Overall Study|Pregnancy|0|||
105822689|NCT02089685|365008805|FG001|Overall Study|Excluded Medication|0|||
105822690|NCT02089685|365008806|FG002|Overall Study|Excluded Medication|0|||
105958411|NCT03726658|365508063|FG006|Overall Study|Pregnancy|1|||
105958412|NCT03726658|365508057|FG000|Overall Study|Not Reported|0|||
105767043|NCT02371980|364800366|FG000|Open-label Period|Lack of Efficacy|116|||
105767044|NCT02371980|364800367|FG001|Open-label Period|Lack of Efficacy|0|||
105767045|NCT02371980|364800368|FG002|Open-label Period|Lack of Efficacy|0|||
106020205|NCT04661579|365738595|FG003|Overall Study|Physician Decision|1|||
106020206|NCT04661579|365738596|FG004|Overall Study|Physician Decision|0|||
106020207|NCT04661579|365738592|FG000|Overall Study|Withdrawal by Subject|1|||
106020208|NCT04661579|365738593|FG001|Overall Study|Withdrawal by Subject|4|||
106020209|NCT04661579|365738594|FG002|Overall Study|Withdrawal by Subject|0|||
106020210|NCT04661579|365738595|FG003|Overall Study|Withdrawal by Subject|2|||
106020211|NCT04661579|365738596|FG004|Overall Study|Withdrawal by Subject|0|||
106020212|NCT04661579|365738592|FG000|Overall Study|Death|1|||
106020213|NCT04661579|365738593|FG001|Overall Study|Death|0|||
106020214|NCT04661579|365738594|FG002|Overall Study|Death|0|||
106020215|NCT04661579|365738595|FG003|Overall Study|Death|0|||
106020216|NCT04661579|365738596|FG004|Overall Study|Death|0|||
106020217|NCT04661579|365738592|FG000|Overall Study|Other|1|||
106020218|NCT04661579|365738593|FG001|Overall Study|Other|2|||
106020219|NCT04661579|365738594|FG002|Overall Study|Other|1|||
106020220|NCT04661579|365738595|FG003|Overall Study|Other|1|||
106020221|NCT04661579|365738596|FG004|Overall Study|Other|1|||
106020222|NCT04661579|365738592|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
106020223|NCT04661579|365738593|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
106020224|NCT04661579|365738594|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
106020225|NCT04661579|365738595|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
106020226|NCT04661579|365738596|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
106020227|NCT00742235|365738599|FG000|Overall Study|Lost to Follow-up|0|||
106020228|NCT00742235|365738600|FG001|Overall Study|Lost to Follow-up|31|||
106020229|NCT02223858|365738605|FG000|Overall Study|Death|1|||
106020230|NCT02223858|365738606|FG001|Overall Study|Death|1|||
106020231|NCT02223858|365738605|FG000|Overall Study|Lost to Follow-up|6|||
106020232|NCT02223858|365738606|FG001|Overall Study|Lost to Follow-up|11|||
106020233|NCT02223858|365738605|FG000|Overall Study|Withdrawal by Subject|8|||
106020234|NCT02223858|365738606|FG001|Overall Study|Withdrawal by Subject|5|||
106020235|NCT02223858|365738605|FG000|Overall Study|Refused|9|||
106020236|NCT02223858|365738606|FG001|Overall Study|Refused|9|||
106020237|NCT04455815|365738607|FG000|Randomisation Phase|Adverse Event|1|||
106020238|NCT04455815|365738608|FG001|Randomisation Phase|Adverse Event|0|||
106020239|NCT04455815|365738607|FG000|Treatment Phase|Adverse Event|0|||
106020240|NCT04455815|365738608|FG001|Treatment Phase|Adverse Event|1|||
106020241|NCT04455815|365738607|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
106020242|NCT04455815|365738608|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
106020243|NCT04455815|365738607|FG000|Treatment Phase|Withdrawal by Subject|1|||
106020244|NCT04455815|365738608|FG001|Treatment Phase|Withdrawal by Subject|1|||
106020245|NCT03198507|365738609|FG000|Overall Study|Withdrawal by Subject|1|||
106020246|NCT03198507|365738610|FG001|Overall Study|Withdrawal by Subject|0|||
106020247|NCT01349959|365738617|FG000|Overall Study|Adverse Event|7|||
106020248|NCT01491607|365738618|FG000|Overall Study|Lost to Follow-up|7|||
106020249|NCT01491607|365738618|FG000|Overall Study|Withdrawal by Subject|3|||
106145676|NCT00736853|366193154|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
106145677|NCT00736853|366193155|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
106145678|NCT00736853|366193153|FG000|Double-Blind Period|Lack of Efficacy|0|||
106145679|NCT00736853|366193154|FG001|Double-Blind Period|Lack of Efficacy|19|||
106145680|NCT00736853|366193155|FG002|Double-Blind Period|Lack of Efficacy|42|||
106145681|NCT00736853|366193153|FG000|Double-Blind Period|Adverse Event|0|||
106145682|NCT00736853|366193154|FG001|Double-Blind Period|Adverse Event|3|||
106145683|NCT00736853|366193155|FG002|Double-Blind Period|Adverse Event|2|||
105767046|NCT02371980|364800369|FG003|Open-label Period|Lack of Efficacy|0|||
105767047|NCT02371980|364800370|FG004|Open-label Period|Lack of Efficacy|0|||
105767048|NCT02371980|364800366|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
105767049|NCT02371980|364800367|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
105767050|NCT02371980|364800368|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
105767051|NCT02371980|364800369|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
105767052|NCT02371980|364800370|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
105767053|NCT02371980|364800366|FG000|Open-label Period|Reason not Specified|9|||
105767054|NCT02371980|364800367|FG001|Open-label Period|Reason not Specified|0|||
105767055|NCT02371980|364800368|FG002|Open-label Period|Reason not Specified|0|||
105767056|NCT02371980|364800369|FG003|Open-label Period|Reason not Specified|0|||
105767057|NCT02371980|364800370|FG004|Open-label Period|Reason not Specified|0|||
105767058|NCT02371980|364800366|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
105767059|NCT02371980|364800367|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
105767060|NCT02371980|364800368|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
105767061|NCT02371980|364800369|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
105767062|NCT02371980|364800370|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
105822691|NCT02089685|365008807|FG003|Overall Study|Excluded Medication|11|||
106020250|NCT01317277|365738619|FG000|Overall Study|Lost to Follow-up|3|||
106020251|NCT01317277|365738620|FG001|Overall Study|Lost to Follow-up|1|||
106145684|NCT00736853|366193153|FG000|Double-Blind Period|Withdrawal by Subject|0|||
106145685|NCT00736853|366193154|FG001|Double-Blind Period|Withdrawal by Subject|1|||
106020252|NCT01317277|365738619|FG000|Overall Study|Lost MEMS|1|||
106020253|NCT01317277|365738620|FG001|Overall Study|Lost MEMS|1|||
106020254|NCT01317277|365738619|FG000|Overall Study|Unable to comply with intervention|1|||
106020255|NCT01317277|365738620|FG001|Overall Study|Unable to comply with intervention|0|||
106020256|NCT01317277|365738619|FG000|Overall Study|Withdrawal by Subject|1|||
106020257|NCT01317277|365738620|FG001|Overall Study|Withdrawal by Subject|0|||
106020258|NCT01317277|365738619|FG000|Overall Study|Adverse Event|1|||
106020259|NCT01317277|365738620|FG001|Overall Study|Adverse Event|0|||
106020260|NCT00774566|365738621|FG000|Overall Study|Protocol Violation|18|||
105822692|NCT02089685|365008808|FG004|Overall Study|Excluded Medication|2|||
105822693|NCT02089685|365008809|FG005|Overall Study|Excluded Medication|1|||
105822694|NCT02089685|365008804|FG000|Overall Study|Progressive disease|13|||
105822695|NCT02089685|365008805|FG001|Overall Study|Progressive disease|10|||
105822696|NCT02089685|365008806|FG002|Overall Study|Progressive disease|3|||
105822697|NCT02089685|365008807|FG003|Overall Study|Progressive disease|51|||
105822698|NCT02089685|365008808|FG004|Overall Study|Progressive disease|17|||
105822699|NCT02089685|365008809|FG005|Overall Study|Progressive disease|12|||
105822700|NCT02089685|365008804|FG000|Overall Study|Follow up ended by sponsor|2|||
105822701|NCT02089685|365008805|FG001|Overall Study|Follow up ended by sponsor|2|||
105822702|NCT02089685|365008806|FG002|Overall Study|Follow up ended by sponsor|0|||
105822703|NCT02089685|365008807|FG003|Overall Study|Follow up ended by sponsor|70|||
106020261|NCT00774566|365738622|FG001|Overall Study|Protocol Violation|15|||
106020262|NCT03860259|365738627|FG000|Overall Study|Lost to Follow-up|5|||
106020263|NCT03860259|365738628|FG001|Overall Study|Lost to Follow-up|5|||
106020264|NCT03860259|365738627|FG000|Overall Study|Protocol Violation|1|||
106020265|NCT03860259|365738628|FG001|Overall Study|Protocol Violation|0|||
106020266|NCT01075685|365738629|FG000|Overall Study|Protocol Violation|9|||
106020267|NCT01075685|365738630|FG001|Overall Study|Protocol Violation|1|||
106020268|NCT01075685|365738629|FG000|Overall Study|Withdrawal by Subject|20|||
106020269|NCT01075685|365738630|FG001|Overall Study|Withdrawal by Subject|5|||
106020270|NCT01075685|365738629|FG000|Overall Study|Lost to Follow-up|563|||
106020271|NCT01075685|365738630|FG001|Overall Study|Lost to Follow-up|220|||
106020272|NCT00811018|365738631|FG000|Overall Study|Additional Chronic Treatment|31|||
106020273|NCT00811018|365738631|FG000|Overall Study|Adverse Event|79|||
106020274|NCT00811018|365738631|FG000|Overall Study|Death|147|||
106020275|NCT00811018|365738631|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
106020276|NCT00811018|365738631|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
106020277|NCT00811018|365738631|FG000|Overall Study|Investigator Decision|57|||
106020278|NCT00811018|365738631|FG000|Overall Study|Lost to Follow-up|19|||
106020279|NCT00811018|365738631|FG000|Overall Study|Pregnancy|6|||
106020280|NCT00811018|365738631|FG000|Overall Study|Sponsor Decision|450|||
106020281|NCT00811018|365738631|FG000|Overall Study|Withdrawal by Subject|70|||
106020282|NCT00811018|365738631|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
106020283|NCT00811018|365738631|FG000|Overall Study|Other|26|||
105822704|NCT02089685|365008808|FG004|Overall Study|Follow up ended by sponsor|26|||
105822705|NCT02089685|365008809|FG005|Overall Study|Follow up ended by sponsor|26|||
105822706|NCT02089685|365008804|FG000|Overall Study|Withdrawal by Subject|0|||
105822707|NCT02089685|365008805|FG001|Overall Study|Withdrawal by Subject|2|||
105822708|NCT02089685|365008806|FG002|Overall Study|Withdrawal by Subject|0|||
105822709|NCT02089685|365008807|FG003|Overall Study|Withdrawal by Subject|8|||
106020284|NCT02858362|365738632|FG000|Overall Study|Protocol Violation|0|||
106020285|NCT02858362|365738633|FG001|Overall Study|Protocol Violation|1|||
105822710|NCT02089685|365008808|FG004|Overall Study|Withdrawal by Subject|1|||
105822711|NCT02089685|365008809|FG005|Overall Study|Withdrawal by Subject|1|||
105822712|NCT02089685|365008804|FG000|Overall Study|Status not recorded|1|||
105822713|NCT02089685|365008805|FG001|Overall Study|Status not recorded|0|||
106020286|NCT02858362|365738634|FG002|Overall Study|Protocol Violation|0|||
106020287|NCT02858362|365738632|FG000|Overall Study|Withdrawal by Subject|1|||
106020288|NCT02858362|365738633|FG001|Overall Study|Withdrawal by Subject|0|||
106020289|NCT02858362|365738634|FG002|Overall Study|Withdrawal by Subject|0|||
106020290|NCT02858362|365738632|FG000|Overall Study|Early Study Termination|0|||
106020291|NCT02858362|365738633|FG001|Overall Study|Early Study Termination|0|||
106020292|NCT02858362|365738634|FG002|Overall Study|Early Study Termination|3|||
106020293|NCT02858362|365738632|FG000|Overall Study|Lost to Follow-up|1|||
106020294|NCT02858362|365738633|FG001|Overall Study|Lost to Follow-up|0|||
106020295|NCT02858362|365738634|FG002|Overall Study|Lost to Follow-up|0|||
106020296|NCT00934362|365738635|FG000|Overall Study|Adverse Event|1|||
105822714|NCT02089685|365008806|FG002|Overall Study|Status not recorded|0|||
105822715|NCT02089685|365008807|FG003|Overall Study|Status not recorded|0|||
105822716|NCT02089685|365008808|FG004|Overall Study|Status not recorded|1|||
105822717|NCT02089685|365008809|FG005|Overall Study|Status not recorded|0|||
105822718|NCT02089685|365008804|FG000|Overall Study|Death|0|||
106020297|NCT00934362|365738636|FG001|Overall Study|Adverse Event|0|||
106020298|NCT03527732|365738637|FG000|Overall Study|Lost to Follow-up|21|||
106020299|NCT03527732|365738638|FG001|Overall Study|Lost to Follow-up|23|||
106020300|NCT03527732|365738639|FG002|Overall Study|Lost to Follow-up|80|||
106020301|NCT03527732|365738640|FG003|Overall Study|Lost to Follow-up|62|||
106020302|NCT03527732|365738641|FG004|Overall Study|Lost to Follow-up|12|||
106020303|NCT03527732|365738642|FG005|Overall Study|Lost to Follow-up|20|||
106020304|NCT04154189|365738643|FG000|Overall Study|Withdrawal by Subject|4|||
106020305|NCT04154189|365738644|FG001|Overall Study|Withdrawal by Subject|6|||
106020306|NCT04154189|365738643|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
106020307|NCT04154189|365738644|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
106020308|NCT04154189|365738643|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
106020309|NCT04154189|365738644|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
106020310|NCT04154189|365738643|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
106020311|NCT04154189|365738644|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
106020312|NCT04154189|365738643|FG000|Overall Study|Death|25|||
106020313|NCT04154189|365738644|FG001|Overall Study|Death|25|||
106020314|NCT01191762|365738647|FG000|Overall Study|Adverse Event|1|||
105822719|NCT02089685|365008805|FG001|Overall Study|Death|0|||
105822720|NCT02089685|365008806|FG002|Overall Study|Death|0|||
105822721|NCT02089685|365008807|FG003|Overall Study|Death|7|||
105822722|NCT02089685|365008808|FG004|Overall Study|Death|2|||
105822723|NCT02089685|365008809|FG005|Overall Study|Death|5|||
105822724|NCT02089685|365008804|FG000|Overall Study|Lost to Follow-up|0|||
105822725|NCT02089685|365008805|FG001|Overall Study|Lost to Follow-up|0|||
105822726|NCT02089685|365008806|FG002|Overall Study|Lost to Follow-up|0|||
105822727|NCT02089685|365008807|FG003|Overall Study|Lost to Follow-up|1|||
105822728|NCT02089685|365008808|FG004|Overall Study|Lost to Follow-up|0|||
105822729|NCT02089685|365008809|FG005|Overall Study|Lost to Follow-up|0|||
105822730|NCT02089685|365008804|FG000|Overall Study|Physician Decision|0|||
105822731|NCT02089685|365008805|FG001|Overall Study|Physician Decision|0|||
105822732|NCT02089685|365008806|FG002|Overall Study|Physician Decision|0|||
106020315|NCT01191762|365738648|FG001|Overall Study|Adverse Event|0|||
106020316|NCT01409811|365738649|FG000|Overall Study|Insurance denial|1|||
106020317|NCT02625909|365738650|FG000|Overall Study|Death|2|||
105822733|NCT02089685|365008807|FG003|Overall Study|Physician Decision|0|||
105822734|NCT02089685|365008808|FG004|Overall Study|Physician Decision|0|||
105822735|NCT02089685|365008809|FG005|Overall Study|Physician Decision|4|||
105822736|NCT02089685|365008804|FG000|Overall Study|Screen failure|1|||
105822737|NCT02089685|365008805|FG001|Overall Study|Screen failure|0|||
105822738|NCT02089685|365008806|FG002|Overall Study|Screen failure|0|||
105822739|NCT02089685|365008807|FG003|Overall Study|Screen failure|0|||
105822740|NCT02089685|365008808|FG004|Overall Study|Screen failure|0|||
105822741|NCT02089685|365008809|FG005|Overall Study|Screen failure|0|||
105822742|NCT01848938|365008814|FG000|Overall Study|Lost to Follow-up|1|||
105822743|NCT01848938|365008815|FG001|Overall Study|Lost to Follow-up|1|||
105822744|NCT01757392|365008816|FG000|Overall Study|Withdrawal by Subject|1|||
105822745|NCT01757392|365008816|FG000|Overall Study|Screen Fail|3|||
105822746|NCT04608188|365008821|FG000|Overall Study|Withdrawal by Subject|4|||
105822747|NCT04608188|365008822|FG001|Overall Study|Withdrawal by Subject|8|||
105822748|NCT00463684|365008826|FG000|Overall Study|Withdrawal by Subject|1|||
105822749|NCT00463684|365008826|FG000|Overall Study|Lost to Follow-up|3|||
105822750|NCT01929863|365008827|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
105822751|NCT01929863|365008828|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
105822752|NCT01929863|365008827|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
105822753|NCT01929863|365008828|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
105822754|NCT01929863|365008827|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
105822755|NCT01929863|365008828|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
105822756|NCT03792477|365008829|FG000|Overall Study|Adverse Event|0|||
105822757|NCT03792477|365008830|FG001|Overall Study|Adverse Event|0|||
105822758|NCT03792477|365008831|FG002|Overall Study|Adverse Event|0|||
105822759|NCT03792477|365008832|FG003|Overall Study|Adverse Event|1|||
106020318|NCT02625909|365738651|FG001|Overall Study|Death|0|||
106020319|NCT02625909|365738650|FG000|Overall Study|Lost to Follow-up|3|||
106020320|NCT02625909|365738651|FG001|Overall Study|Lost to Follow-up|5|||
106020321|NCT02625909|365738650|FG000|Overall Study|Lack of Efficacy|9|||
106020322|NCT02625909|365738651|FG001|Overall Study|Lack of Efficacy|2|||
106020323|NCT02625909|365738650|FG000|Overall Study|Reinfection|3|||
106020324|NCT02625909|365738651|FG001|Overall Study|Reinfection|2|||
106020325|NCT00067002|365738663|FG000|Overall Study|Early Death|1|||
105822760|NCT03792477|365008833|FG004|Overall Study|Adverse Event|0|||
105822761|NCT03792477|365008829|FG000|Overall Study|Lost to Follow-up|0|||
105822762|NCT03792477|365008830|FG001|Overall Study|Lost to Follow-up|0|||
106020326|NCT00067002|365738664|FG001|Overall Study|Early Death|2|||
106020327|NCT00067002|365738663|FG000|Overall Study|Delayed|1|||
105822763|NCT03792477|365008831|FG002|Overall Study|Lost to Follow-up|2|||
105822764|NCT03792477|365008832|FG003|Overall Study|Lost to Follow-up|0|||
105822765|NCT03792477|365008833|FG004|Overall Study|Lost to Follow-up|0|||
105822766|NCT03792477|365008829|FG000|Overall Study|Other|0|||
105822767|NCT03792477|365008830|FG001|Overall Study|Other|0|||
105822768|NCT03792477|365008831|FG002|Overall Study|Other|0|||
105822769|NCT03792477|365008832|FG003|Overall Study|Other|0|||
105822770|NCT03792477|365008833|FG004|Overall Study|Other|1|||
105822771|NCT00840411|365008834|FG000|First Intervention|Adverse Event|1|||
105822772|NCT00840411|365008835|FG001|First Intervention|Adverse Event|0|||
106020328|NCT00067002|365738664|FG001|Overall Study|Delayed|1|||
105822773|NCT00840411|365008834|FG000|Washout|Withdrawal by Subject|1|||
105822774|NCT00840411|365008835|FG001|Washout|Withdrawal by Subject|0|||
105822775|NCT03122457|365008836|FG000|Overall Study|Withdrawal by Subject|6|||
105822776|NCT01921062|365008837|FG000|Overall Study|Withdrawal by Subject|0|||
105822777|NCT01921062|365008838|FG001|Overall Study|Withdrawal by Subject|7|||
105822778|NCT01921062|365008837|FG000|Overall Study|Adverse Event|5|||
105822779|NCT01921062|365008838|FG001|Overall Study|Adverse Event|6|||
105822780|NCT01921062|365008837|FG000|Overall Study|Protocol Violation|0|||
105822781|NCT01921062|365008838|FG001|Overall Study|Protocol Violation|1|||
105822782|NCT01921062|365008837|FG000|Overall Study|VMIQ score > 72|4|||
105822783|NCT01921062|365008838|FG001|Overall Study|VMIQ score > 72|1|||
105822784|NCT01921062|365008837|FG000|Overall Study|Logistic error|0|||
105822785|NCT01921062|365008838|FG001|Overall Study|Logistic error|1|||
105822786|NCT01878292|365008839|FG000|Randomized|Protocol Violation|1|||
105822787|NCT01878292|365008840|FG001|Randomized|Protocol Violation|0|||
105822788|NCT01878292|365008841|FG002|Randomized|Protocol Violation|0|||
105822789|NCT01878292|365008839|FG000|Randomized|Lost to Follow-up|1|||
105822790|NCT01878292|365008840|FG001|Randomized|Lost to Follow-up|0|||
105822791|NCT01878292|365008841|FG002|Randomized|Lost to Follow-up|0|||
105822792|NCT01878292|365008839|FG000|Randomized|Adverse Event|1|||
105822793|NCT01878292|365008840|FG001|Randomized|Adverse Event|0|||
105822794|NCT01878292|365008841|FG002|Randomized|Adverse Event|0|||
105822795|NCT01878292|365008839|FG000|Double-blind Treatment Period|Other Reasons|2|||
105822796|NCT01878292|365008840|FG001|Double-blind Treatment Period|Other Reasons|0|||
105822797|NCT01878292|365008841|FG002|Double-blind Treatment Period|Other Reasons|0|||
105822798|NCT01878292|365008839|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
105822799|NCT01878292|365008840|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
105822800|NCT01878292|365008841|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
105822801|NCT01878292|365008839|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
105822802|NCT01878292|365008840|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
105822803|NCT01878292|365008841|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
105822804|NCT01878292|365008839|FG000|Double-blind Treatment Period|Protocol Violation|3|||
105822805|NCT01878292|365008840|FG001|Double-blind Treatment Period|Protocol Violation|4|||
105822806|NCT01878292|365008841|FG002|Double-blind Treatment Period|Protocol Violation|2|||
105822807|NCT01878292|365008839|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
105822808|NCT01878292|365008840|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
105822809|NCT01878292|365008841|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
105822810|NCT01878292|365008839|FG000|Double-blind Treatment Period|Adverse Event|4|||
105822811|NCT01878292|365008840|FG001|Double-blind Treatment Period|Adverse Event|9|||
105822812|NCT01878292|365008841|FG002|Double-blind Treatment Period|Adverse Event|8|||
106020329|NCT00067002|365738663|FG000|Overall Study|Graft Failure|5|||
106020330|NCT00067002|365738664|FG001|Overall Study|Graft Failure|6|||
106020331|NCT03350672|365738665|FG000|Overall Study|Withdrawal by Subject|7|||
106020332|NCT03350672|365738666|FG001|Overall Study|Withdrawal by Subject|0|||
106020333|NCT03350672|365738667|FG002|Overall Study|Withdrawal by Subject|0|||
106020334|NCT01931566|365738670|FG000|Overall Study|Randomized But Not Treated|6|||
106020335|NCT01931566|365738671|FG001|Overall Study|Randomized But Not Treated|9|||
106020336|NCT01931566|365738672|FG002|Overall Study|Randomized But Not Treated|14|||
106020337|NCT01931566|365738670|FG000|Overall Study|Adverse Event|37|||
106020338|NCT01931566|365738671|FG001|Overall Study|Adverse Event|167|||
106020339|NCT01931566|365738672|FG002|Overall Study|Adverse Event|132|||
106020340|NCT01931566|365738670|FG000|Overall Study|Major Protocol Deviation|5|||
106020341|NCT01931566|365738671|FG001|Overall Study|Major Protocol Deviation|14|||
106020342|NCT01931566|365738672|FG002|Overall Study|Major Protocol Deviation|21|||
106020343|NCT01931566|365738670|FG000|Overall Study|Lost to Follow-up|3|||
106145686|NCT00736853|366193155|FG002|Double-Blind Period|Withdrawal by Subject|4|||
106145687|NCT00736853|366193153|FG000|Double-Blind Period|Ineligible to participate the study|0|||
106145688|NCT00736853|366193154|FG001|Double-Blind Period|Ineligible to participate the study|1|||
106145689|NCT00736853|366193155|FG002|Double-Blind Period|Ineligible to participate the study|0|||
106145690|NCT01597258|366193156|FG000|Overall Study|No Drug Administration|1|||
105822813|NCT01878292|365008839|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
105822814|NCT01878292|365008840|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
105822815|NCT01878292|365008841|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
105822816|NCT00773253|365008842|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
105822817|NCT00773253|365008843|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
106020344|NCT01931566|365738671|FG001|Overall Study|Lost to Follow-up|26|||
106020345|NCT01931566|365738672|FG002|Overall Study|Lost to Follow-up|23|||
106145691|NCT01199705|366193157|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
105822818|NCT00323882|365008844|FG000|Overall Study|Adverse Event|2|||
105822819|NCT00323882|365008845|FG001|Overall Study|Adverse Event|1|||
105822820|NCT00323882|365008846|FG002|Overall Study|Adverse Event|1|||
105822821|NCT00323882|365008847|FG003|Overall Study|Adverse Event|1|||
105822822|NCT00323882|365008848|FG004|Overall Study|Adverse Event|3|||
106020346|NCT01931566|365738670|FG000|Overall Study|Voluntary Withdrawal|78|||
106145692|NCT01692730|366193158|FG000|Overall Study|Lost to Follow-up|225|||
105958413|NCT03726658|365508058|FG001|Overall Study|Not Reported|0|||
105958414|NCT03726658|365508059|FG002|Overall Study|Not Reported|0|||
105958415|NCT03726658|365508060|FG003|Overall Study|Not Reported|0|||
105958416|NCT03726658|365508061|FG004|Overall Study|Not Reported|0|||
105958417|NCT03726658|365508062|FG005|Overall Study|Not Reported|0|||
105958418|NCT03726658|365508063|FG006|Overall Study|Not Reported|1|||
105958419|NCT00090779|365508064|FG000|Step 1|Withdrawal by Subject|4|||
105958420|NCT00090779|365508065|FG001|Step 1|Withdrawal by Subject|2|||
105958421|NCT00090779|365508064|FG000|Step 1|Lost to Follow-up|3|||
105958422|NCT00090779|365508065|FG001|Step 1|Lost to Follow-up|2|||
105958423|NCT00090779|365508064|FG000|Step 1|Death|0|||
105958424|NCT00090779|365508065|FG001|Step 1|Death|2|||
105958425|NCT00090779|365508064|FG000|Step 1|Physician Decision|1|||
105958426|NCT00090779|365508065|FG001|Step 1|Physician Decision|0|||
105958427|NCT00090779|365508064|FG000|Step 1|Pregnancy|1|||
105958428|NCT00090779|365508065|FG001|Step 1|Pregnancy|0|||
105958429|NCT00090779|365508064|FG000|Step 1|Non-compliance to study requirements|0|||
105958430|NCT00090779|365508065|FG001|Step 1|Non-compliance to study requirements|1|||
105958431|NCT00090779|365508064|FG000|Step 1|Subject relocated|2|||
105958432|NCT00090779|365508065|FG001|Step 1|Subject relocated|8|||
105958433|NCT00090779|365508064|FG000|Step 2|Off study per study closure|6|||
105958434|NCT00090779|365508065|FG001|Step 2|Off study per study closure|16|||
106020347|NCT01931566|365738671|FG001|Overall Study|Voluntary Withdrawal|245|||
106020348|NCT01931566|365738672|FG002|Overall Study|Voluntary Withdrawal|225|||
105767063|NCT02371980|364800366|FG000|Double-blind Period|Significant Protocol Deviation|0|||
105767064|NCT02371980|364800367|FG001|Double-blind Period|Significant Protocol Deviation|2|||
105767065|NCT02371980|364800368|FG002|Double-blind Period|Significant Protocol Deviation|7|||
105767066|NCT02371980|364800369|FG003|Double-blind Period|Significant Protocol Deviation|3|||
105767067|NCT02371980|364800370|FG004|Double-blind Period|Significant Protocol Deviation|3|||
105767068|NCT02371980|364800366|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
105767069|NCT02371980|364800367|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
105767070|NCT02371980|364800368|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
105767071|NCT02371980|364800369|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
105767072|NCT02371980|364800370|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
105767073|NCT02371980|364800366|FG000|Double-blind Period|Lost to Follow-up|0|||
105767074|NCT02371980|364800367|FG001|Double-blind Period|Lost to Follow-up|8|||
105767075|NCT02371980|364800368|FG002|Double-blind Period|Lost to Follow-up|8|||
105767076|NCT02371980|364800369|FG003|Double-blind Period|Lost to Follow-up|6|||
105767077|NCT02371980|364800370|FG004|Double-blind Period|Lost to Follow-up|5|||
105767078|NCT02371980|364800366|FG000|Double-blind Period|Voluntary Withdrawal|0|||
105767079|NCT02371980|364800367|FG001|Double-blind Period|Voluntary Withdrawal|12|||
105767080|NCT02371980|364800368|FG002|Double-blind Period|Voluntary Withdrawal|8|||
105767081|NCT02371980|364800369|FG003|Double-blind Period|Voluntary Withdrawal|9|||
105767082|NCT02371980|364800370|FG004|Double-blind Period|Voluntary Withdrawal|11|||
105767083|NCT02371980|364800366|FG000|Double-blind Period|Relapse|0|||
105767084|NCT02371980|364800367|FG001|Double-blind Period|Relapse|50|||
105767085|NCT02371980|364800368|FG002|Double-blind Period|Relapse|25|||
105767086|NCT02371980|364800369|FG003|Double-blind Period|Relapse|25|||
105767087|NCT02371980|364800370|FG004|Double-blind Period|Relapse|26|||
105767088|NCT02371980|364800366|FG000|Double-blind Period|Reason not Specified|0|||
105767089|NCT02371980|364800367|FG001|Double-blind Period|Reason not Specified|3|||
105767090|NCT02371980|364800368|FG002|Double-blind Period|Reason not Specified|3|||
105767091|NCT02371980|364800369|FG003|Double-blind Period|Reason not Specified|2|||
105767092|NCT02371980|364800370|FG004|Double-blind Period|Reason not Specified|1|||
105767093|NCT02371980|364800366|FG000|Double-blind Period|Missing|0|||
105767094|NCT02371980|364800367|FG001|Double-blind Period|Missing|1|||
105767095|NCT02371980|364800368|FG002|Double-blind Period|Missing|0|||
105767096|NCT02371980|364800369|FG003|Double-blind Period|Missing|0|||
105767097|NCT02371980|364800370|FG004|Double-blind Period|Missing|0|||
105767098|NCT05569421|364800377|FG000|Overall Study|Withdrawal by Subject|1|||
105767099|NCT05569421|364800378|FG001|Overall Study|Withdrawal by Subject|0|||
105767100|NCT05569421|364800379|FG002|Overall Study|Withdrawal by Subject|0|||
105767101|NCT02158728|364800380|FG000|Overall Study|no procedure according to CIP done|3|||
105822823|NCT00323882|365008844|FG000|Overall Study|Disease Progression|6|||
105958435|NCT00090779|365508064|FG000|Step 2|Subject relocated|0|||
105958436|NCT00090779|365508065|FG001|Step 2|Subject relocated|1|||
105958437|NCT00090779|365508064|FG000|Step 2|Non-compliance to study requirements|0|||
105767102|NCT02158728|364800380|FG000|Overall Study|no qualified dataset|24|||
106020349|NCT01931566|365738670|FG000|Overall Study|Study Termination|289|||
105767103|NCT00524043|364800381|FG000|Overall Study|Lack of Efficacy|15|||
105958438|NCT00090779|365508065|FG001|Step 2|Non-compliance to study requirements|1|||
105958439|NCT00090779|365508064|FG000|Step 3|Initiation of ART and off extended study|3|||
105958440|NCT00090779|365508065|FG001|Step 3|Initiation of ART and off extended study|2|||
105958441|NCT00090779|365508064|FG000|Step 3|Off extended study due to study closure|4|||
105958442|NCT00090779|365508065|FG001|Step 3|Off extended study due to study closure|3|||
105958443|NCT01523743|365508066|FG000|Period 1|Adverse Event|1|||
106020350|NCT01931566|365738671|FG001|Overall Study|Study Termination|968|||
106020351|NCT01931566|365738672|FG002|Overall Study|Study Termination|1037|||
106020352|NCT01931566|365738670|FG000|Overall Study|Reason Not Specified|11|||
106020353|NCT01931566|365738671|FG001|Overall Study|Reason Not Specified|47|||
106020354|NCT01931566|365738672|FG002|Overall Study|Reason Not Specified|53|||
106020355|NCT01931566|365738670|FG000|Overall Study|Missing|0|||
106020356|NCT01931566|365738671|FG001|Overall Study|Missing|0|||
106020357|NCT01931566|365738672|FG002|Overall Study|Missing|1|||
106020358|NCT02873377|365738676|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
106020359|NCT02873377|365738677|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
106020360|NCT02873377|365738676|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
106020361|NCT02873377|365738677|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
106020362|NCT03530124|365738682|FG000|Overall Study|Withdrawal by Subject|0|||
106020363|NCT03530124|365738683|FG001|Overall Study|Withdrawal by Subject|1|||
106020364|NCT03530124|365738682|FG000|Overall Study|Protocol Violation|1|||
106020365|NCT03530124|365738683|FG001|Overall Study|Protocol Violation|0|||
106020366|NCT03530124|365738682|FG000|Overall Study|Discharged prior to study completion|1|||
106020367|NCT03530124|365738683|FG001|Overall Study|Discharged prior to study completion|0|||
106020368|NCT01583296|365738684|FG000|Overall Study|Withdrawal by Subject|11|||
106020369|NCT01583296|365738685|FG001|Overall Study|Withdrawal by Subject|10|||
106020370|NCT03179319|365738686|FG000|Overall Study|Lost to Follow-up|6|||
106020371|NCT03179319|365738687|FG001|Overall Study|Lost to Follow-up|0|||
106020372|NCT02533453|365738688|FG000|Overall Study|Adverse Event|6|||
106020373|NCT02533453|365738688|FG000|Overall Study|Protocol Violation|1|||
106020374|NCT02533453|365738688|FG000|Overall Study|Withdrawal by Subject|2|||
106020375|NCT01160822|365738699|FG000|Overall Study|Adverse Event|0|||
106020376|NCT01160822|365738700|FG001|Overall Study|Adverse Event|0|||
106020377|NCT01160822|365738701|FG002|Overall Study|Adverse Event|0|||
106020378|NCT01160822|365738702|FG003|Overall Study|Adverse Event|0|||
106020379|NCT01160822|365738703|FG004|Overall Study|Adverse Event|1|||
105767104|NCT00524043|364800382|FG001|Overall Study|Lack of Efficacy|13|||
105767105|NCT00524043|364800383|FG002|Overall Study|Lack of Efficacy|14|||
105767106|NCT00524043|364800381|FG000|Overall Study|Withdrawal by Subject|5|||
105767107|NCT00524043|364800382|FG001|Overall Study|Withdrawal by Subject|7|||
105767108|NCT00524043|364800383|FG002|Overall Study|Withdrawal by Subject|7|||
105767109|NCT00524043|364800381|FG000|Overall Study|Adverse Event|5|||
105767110|NCT00524043|364800382|FG001|Overall Study|Adverse Event|2|||
105767111|NCT00524043|364800383|FG002|Overall Study|Adverse Event|7|||
105767112|NCT00524043|364800381|FG000|Overall Study|Lost to Follow-up|3|||
105767113|NCT00524043|364800382|FG001|Overall Study|Lost to Follow-up|5|||
105767114|NCT00524043|364800383|FG002|Overall Study|Lost to Follow-up|3|||
105767115|NCT00524043|364800381|FG000|Overall Study|Various (eg, incarceration)|2|||
105767116|NCT00524043|364800382|FG001|Overall Study|Various (eg, incarceration)|1|||
105767117|NCT00524043|364800383|FG002|Overall Study|Various (eg, incarceration)|0|||
105767118|NCT03933215|364800397|FG000|Overall Study|Other|6|||
105767119|NCT03933215|364800397|FG000|Overall Study|Sponsor decision|5|||
105767120|NCT03933215|364800397|FG000|Overall Study|Protocol Violation|5|||
105767121|NCT03933215|364800397|FG000|Overall Study|Withdrawal by Subject|6|||
105767122|NCT03933215|364800397|FG000|Overall Study|Lost to Follow-up|6|||
105767123|NCT03933215|364800397|FG000|Overall Study|Enrolled but not treated|38|||
105767124|NCT04222673|364800398|FG000|Overall Study|Lost to Follow-up|5|||
105767125|NCT04097028|364800399|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
105767126|NCT04097028|364800399|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
105767127|NCT04097028|364800399|FG000|Overall Study|Disease Progression prior to Surgery|2|||
105767128|NCT04097028|364800399|FG000|Overall Study|Adverse Event prior to Surgery|1|||
105767129|NCT04072575|364800400|FG000|Overall Study|Physician Decision|1|||
105767130|NCT04072575|364800400|FG000|Overall Study|Adverse Event|7|||
105767131|NCT04072575|364800400|FG000|Overall Study|Withdrawal by Subject|14|||
105767132|NCT04072575|364800400|FG000|Overall Study|Other|2|||
105767133|NCT02244619|364800401|FG000|Overall Study|Did not receive study intervention|8|||
105767134|NCT02244619|364800402|FG001|Overall Study|Did not receive study intervention|21|||
105767135|NCT03285490|364800403|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
105767136|NCT03285490|364800404|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
105767137|NCT03285490|364800403|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
106020380|NCT01160822|365738704|FG005|Overall Study|Adverse Event|2|||
106020381|NCT01160822|365738705|FG006|Overall Study|Adverse Event|5|||
106020382|NCT01160822|365738699|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105767138|NCT03285490|364800404|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
106020383|NCT01160822|365738700|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
106020384|NCT01160822|365738701|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
106020385|NCT01160822|365738702|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
106020386|NCT01160822|365738703|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
106020387|NCT01160822|365738704|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
106020388|NCT01160822|365738705|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
106020389|NCT01160822|365738699|FG000|Overall Study|Withdrawal by Subject|0|||
106020390|NCT01160822|365738700|FG001|Overall Study|Withdrawal by Subject|0|||
106020391|NCT01160822|365738701|FG002|Overall Study|Withdrawal by Subject|0|||
106020392|NCT01160822|365738702|FG003|Overall Study|Withdrawal by Subject|0|||
106020393|NCT01160822|365738703|FG004|Overall Study|Withdrawal by Subject|0|||
106020394|NCT01160822|365738704|FG005|Overall Study|Withdrawal by Subject|0|||
105767139|NCT03745989|364800405|FG000|Overall Study|Death|3|||
105767140|NCT03745989|364800406|FG001|Overall Study|Death|7|||
105767141|NCT03745989|364800407|FG002|Overall Study|Death|4|||
105767142|NCT03745989|364800405|FG000|Overall Study|Lost to Follow-up|0|||
105767143|NCT03745989|364800406|FG001|Overall Study|Lost to Follow-up|2|||
105767144|NCT03745989|364800407|FG002|Overall Study|Lost to Follow-up|0|||
105767145|NCT03745989|364800405|FG000|Overall Study|Sponsor Decision|0|||
105767146|NCT03745989|364800406|FG001|Overall Study|Sponsor Decision|2|||
105767147|NCT03745989|364800407|FG002|Overall Study|Sponsor Decision|8|||
105767148|NCT03745989|364800405|FG000|Overall Study|Withdrawal by Subject|0|||
105767149|NCT03745989|364800406|FG001|Overall Study|Withdrawal by Subject|1|||
105767150|NCT03745989|364800407|FG002|Overall Study|Withdrawal by Subject|3|||
105767151|NCT02728206|364800408|FG000|Overall Study|Death|1|||
105767152|NCT02773368|364800412|FG000|Overall Study|Lost to Follow-up|4|||
105767153|NCT02773368|364800413|FG001|Overall Study|Lost to Follow-up|1|||
105767154|NCT02773368|364800412|FG000|Overall Study|Withdrawal by Subject|5|||
105767155|NCT02773368|364800413|FG001|Overall Study|Withdrawal by Subject|1|||
105767156|NCT02773368|364800412|FG000|Overall Study|Unclassified|1|||
105767157|NCT02773368|364800413|FG001|Overall Study|Unclassified|1|||
105767158|NCT02773368|364800412|FG000|Overall Study|Missing|0|||
105767159|NCT02773368|364800413|FG001|Overall Study|Missing|1|||
105767160|NCT01366534|364800415|FG000|Overall Study|Lost to Follow-up|1|||
105767161|NCT01366534|364800416|FG001|Overall Study|Lost to Follow-up|0|||
105767162|NCT01366534|364800417|FG002|Overall Study|Lost to Follow-up|0|||
105767163|NCT01366534|364800415|FG000|Overall Study|Migrated|1|||
105767164|NCT01366534|364800416|FG001|Overall Study|Migrated|1|||
105767165|NCT01366534|364800417|FG002|Overall Study|Migrated|0|||
105767166|NCT01366534|364800415|FG000|Overall Study|Declined challenged|0|||
105767167|NCT01366534|364800416|FG001|Overall Study|Declined challenged|1|||
105767168|NCT01366534|364800417|FG002|Overall Study|Declined challenged|0|||
105767169|NCT01929018|364800418|FG000|Overall Study|Lost to Follow-up|1|||
105767170|NCT01929018|364800419|FG001|Overall Study|Lost to Follow-up|0|||
105767171|NCT01929018|364800418|FG000|Overall Study|Hospitalization|0|||
105767172|NCT01929018|364800419|FG001|Overall Study|Hospitalization|1|||
105767173|NCT01047436|364800421|FG000|Overall Study|Protocol Violation|1|||
105767174|NCT01047436|364800422|FG001|Overall Study|Protocol Violation|0|||
105767175|NCT01678313|364800426|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
105767176|NCT01678313|364800427|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
105767177|NCT01678313|364800426|FG000|Completed the 3-month Therapy|Physician Decision|3|||
105767178|NCT01678313|364800427|FG001|Completed the 3-month Therapy|Physician Decision|4|||
105767179|NCT01678313|364800426|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
105767180|NCT01678313|364800427|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
105767181|NCT01678313|364800426|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
105767182|NCT01678313|364800427|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
105767183|NCT02635867|364800429|FG000|Overall Study|Lost to Follow-up|4|||
105767184|NCT02635867|364800430|FG001|Overall Study|Lost to Follow-up|3|||
105767185|NCT02635867|364800431|FG002|Overall Study|Lost to Follow-up|3|||
105767186|NCT02635867|364800432|FG003|Overall Study|Lost to Follow-up|4|||
105767187|NCT02635867|364800433|FG004|Overall Study|Lost to Follow-up|1|||
105767188|NCT02565576|364800434|FG000|Overall Study|abnormal lab value|2|||
105767189|NCT02565576|364800435|FG001|Overall Study|abnormal lab value|0|||
106020395|NCT01160822|365738705|FG006|Overall Study|Withdrawal by Subject|1|||
106020396|NCT01160822|365738699|FG000|Overall Study|Lost to Follow-up|0|||
105767190|NCT02565576|364800434|FG000|Overall Study|subject / guardian decision|1|||
105767191|NCT02565576|364800435|FG001|Overall Study|subject / guardian decision|3|||
105767192|NCT02565576|364800434|FG000|Overall Study|Lost to Follow-up|1|||
105767193|NCT02565576|364800435|FG001|Overall Study|Lost to Follow-up|0|||
105767194|NCT02565576|364800434|FG000|Overall Study|Death|0|||
105767195|NCT02565576|364800435|FG001|Overall Study|Death|2|||
105767196|NCT02565576|364800434|FG000|Overall Study|Adverse Event|1|||
105767197|NCT02565576|364800435|FG001|Overall Study|Adverse Event|0|||
106020397|NCT01160822|365738700|FG001|Overall Study|Lost to Follow-up|0|||
105822824|NCT00323882|365008845|FG001|Overall Study|Disease Progression|4|||
105822825|NCT00323882|365008846|FG002|Overall Study|Disease Progression|10|||
105822826|NCT00323882|365008847|FG003|Overall Study|Disease Progression|5|||
105822827|NCT00323882|365008848|FG004|Overall Study|Disease Progression|22|||
105822828|NCT00323882|365008844|FG000|Overall Study|Death|0|||
105822829|NCT00323882|365008845|FG001|Overall Study|Death|1|||
105822830|NCT00323882|365008846|FG002|Overall Study|Death|1|||
105822831|NCT00323882|365008847|FG003|Overall Study|Death|0|||
105822832|NCT00323882|365008848|FG004|Overall Study|Death|5|||
105822833|NCT00323882|365008844|FG000|Overall Study|Lost to Follow-up|0|||
105822834|NCT00323882|365008845|FG001|Overall Study|Lost to Follow-up|0|||
105822835|NCT00323882|365008846|FG002|Overall Study|Lost to Follow-up|1|||
105822836|NCT00323882|365008847|FG003|Overall Study|Lost to Follow-up|0|||
105822837|NCT00323882|365008848|FG004|Overall Study|Lost to Follow-up|1|||
105822838|NCT00323882|365008844|FG000|Overall Study|Other|0|||
105822839|NCT00323882|365008845|FG001|Overall Study|Other|0|||
105822840|NCT00323882|365008846|FG002|Overall Study|Other|0|||
105767198|NCT00424099|364800436|FG000|Overall Study|Adverse Event|0|||
105767199|NCT00424099|364800437|FG001|Overall Study|Adverse Event|1|||
105767200|NCT00424099|364800438|FG002|Overall Study|Adverse Event|1|||
105767201|NCT00424099|364800439|FG003|Overall Study|Adverse Event|0|||
105767202|NCT00424099|364800436|FG000|Overall Study|Death|0|||
105767203|NCT00424099|364800437|FG001|Overall Study|Death|1|||
105767204|NCT00424099|364800438|FG002|Overall Study|Death|0|||
105767205|NCT00424099|364800439|FG003|Overall Study|Death|0|||
105767206|NCT00424099|364800436|FG000|Overall Study|Illness|2|||
105767207|NCT00424099|364800437|FG001|Overall Study|Illness|0|||
105767208|NCT00424099|364800438|FG002|Overall Study|Illness|1|||
105767209|NCT00424099|364800439|FG003|Overall Study|Illness|4|||
105767210|NCT00424099|364800436|FG000|Overall Study|Lost to Follow-up|0|||
105767211|NCT00424099|364800437|FG001|Overall Study|Lost to Follow-up|0|||
105767212|NCT00424099|364800438|FG002|Overall Study|Lost to Follow-up|3|||
105767213|NCT00424099|364800439|FG003|Overall Study|Lost to Follow-up|0|||
105767214|NCT00424099|364800436|FG000|Overall Study|Hospitalized|1|||
105767215|NCT00424099|364800437|FG001|Overall Study|Hospitalized|2|||
105767216|NCT00424099|364800438|FG002|Overall Study|Hospitalized|1|||
105767217|NCT00424099|364800439|FG003|Overall Study|Hospitalized|3|||
105767218|NCT00424099|364800436|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
105767219|NCT00424099|364800437|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
105767220|NCT00424099|364800438|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
105767221|NCT00424099|364800439|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
105767222|NCT00424099|364800436|FG000|Overall Study|Withdrawal by Subject|1|||
105767223|NCT00424099|364800437|FG001|Overall Study|Withdrawal by Subject|9|||
105767224|NCT00424099|364800438|FG002|Overall Study|Withdrawal by Subject|4|||
105767225|NCT00424099|364800439|FG003|Overall Study|Withdrawal by Subject|6|||
105767226|NCT00424099|364800436|FG000|Overall Study|Physician Decision|0|||
105767227|NCT00424099|364800437|FG001|Overall Study|Physician Decision|0|||
105767228|NCT00424099|364800438|FG002|Overall Study|Physician Decision|1|||
105767229|NCT00424099|364800439|FG003|Overall Study|Physician Decision|0|||
105767230|NCT00424099|364800436|FG000|Overall Study|Missing|0|||
105767231|NCT00424099|364800437|FG001|Overall Study|Missing|0|||
105767232|NCT00424099|364800438|FG002|Overall Study|Missing|1|||
105767233|NCT00424099|364800439|FG003|Overall Study|Missing|0|||
105767234|NCT00796003|364800440|FG000|Overall Study|Disease Progression|2|||
105767235|NCT00796003|364800441|FG001|Overall Study|Disease Progression|13|||
105767236|NCT00796003|364800440|FG000|Overall Study|Adverse Event|1|||
105767237|NCT00796003|364800441|FG001|Overall Study|Adverse Event|7|||
105767238|NCT00796003|364800440|FG000|Overall Study|Specified organ function not met|0|||
105822841|NCT00323882|365008847|FG003|Overall Study|Other|1|||
105767239|NCT00796003|364800441|FG001|Overall Study|Specified organ function not met|1|||
105767240|NCT00796003|364800440|FG000|Overall Study|Physician Decision|0|||
105767241|NCT00796003|364800441|FG001|Overall Study|Physician Decision|4|||
105767242|NCT00796003|364800440|FG000|Overall Study|Withdrawal by Subject|0|||
105767243|NCT00796003|364800441|FG001|Overall Study|Withdrawal by Subject|1|||
105767244|NCT00796003|364800440|FG000|Overall Study|Other|0|||
105767245|NCT00796003|364800441|FG001|Overall Study|Other|1|||
105767246|NCT00796003|364800440|FG000|Overall Study|Participants Not treated|0|||
105822842|NCT00323882|365008848|FG004|Overall Study|Other|1|||
105822843|NCT00835536|365008849|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
105767247|NCT00796003|364800441|FG001|Overall Study|Participants Not treated|2|||
105822844|NCT00835536|365008850|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
105822845|NCT02911701|365008853|FG000|Overall Study|Withdrawal by Subject|2|||
105822846|NCT02911701|365008854|FG001|Overall Study|Withdrawal by Subject|4|||
105767248|NCT05179057|364800442|FG000|Overall Study|Adverse Event|3|||
105767249|NCT05179057|364800443|FG001|Overall Study|Adverse Event|2|||
105767250|NCT05179057|364800442|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
105767251|NCT05179057|364800443|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
105767252|NCT05179057|364800442|FG000|Overall Study|Study terminated|13|||
105822847|NCT02911701|365008853|FG000|Overall Study|Adverse Event|1|||
106020398|NCT01160822|365738701|FG002|Overall Study|Lost to Follow-up|0|||
106020399|NCT01160822|365738702|FG003|Overall Study|Lost to Follow-up|0|||
106020400|NCT01160822|365738703|FG004|Overall Study|Lost to Follow-up|1|||
106020401|NCT01160822|365738704|FG005|Overall Study|Lost to Follow-up|0|||
106020402|NCT01160822|365738705|FG006|Overall Study|Lost to Follow-up|0|||
106020403|NCT01160822|365738699|FG000|Overall Study|Administrative problems|0|||
106020404|NCT01160822|365738700|FG001|Overall Study|Administrative problems|0|||
106020405|NCT01160822|365738701|FG002|Overall Study|Administrative problems|0|||
106020406|NCT01160822|365738702|FG003|Overall Study|Administrative problems|0|||
106020407|NCT01160822|365738703|FG004|Overall Study|Administrative problems|1|||
106020408|NCT01160822|365738704|FG005|Overall Study|Administrative problems|0|||
106020409|NCT01160822|365738705|FG006|Overall Study|Administrative problems|0|||
106020410|NCT01160822|365738699|FG000|Overall Study|Protocol deviation|0|||
106020411|NCT01160822|365738700|FG001|Overall Study|Protocol deviation|0|||
106020412|NCT01160822|365738701|FG002|Overall Study|Protocol deviation|0|||
106020413|NCT01160822|365738702|FG003|Overall Study|Protocol deviation|0|||
106020414|NCT01160822|365738703|FG004|Overall Study|Protocol deviation|2|||
106020415|NCT01160822|365738704|FG005|Overall Study|Protocol deviation|0|||
106020416|NCT01160822|365738705|FG006|Overall Study|Protocol deviation|0|||
106020417|NCT00314795|365738706|FG000|Overall Study|Adverse Event|8|||
106020418|NCT00314795|365738706|FG000|Overall Study|Death|4|||
106020419|NCT00314795|365738706|FG000|Overall Study|Reason not Specified|3|||
106020420|NCT00314795|365738706|FG000|Overall Study|Renal Transplant|3|||
106020421|NCT00314795|365738706|FG000|Overall Study|Participants Withdrew Consent|2|||
106020422|NCT04717336|365738707|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
106020423|NCT04717336|365738708|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
106020424|NCT04717336|365738707|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
106020425|NCT04717336|365738708|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
106020426|NCT02087423|365738709|FG000|Overall Study|Withdrawal by Subject|20|||
106020427|NCT02087423|365738710|FG001|Overall Study|Withdrawal by Subject|20|||
106020428|NCT02087423|365738711|FG002|Overall Study|Withdrawal by Subject|3|||
106020429|NCT02087423|365738709|FG000|Overall Study|Death|68|||
106020430|NCT02087423|365738710|FG001|Overall Study|Death|207|||
106020431|NCT02087423|365738711|FG002|Overall Study|Death|40|||
106020432|NCT02087423|365738709|FG000|Overall Study|Lost to Follow-up|0|||
106020433|NCT02087423|365738710|FG001|Overall Study|Lost to Follow-up|2|||
106020434|NCT02087423|365738711|FG002|Overall Study|Lost to Follow-up|0|||
106020435|NCT02087423|365738709|FG000|Overall Study|Terminated from study at final DCO|23|||
106020436|NCT02087423|365738710|FG001|Overall Study|Terminated from study at final DCO|36|||
106020437|NCT02087423|365738711|FG002|Overall Study|Terminated from study at final DCO|25|||
106020438|NCT01010867|365738712|FG000|Overall Study|< 50% adherence to probiotic|1|||
106020439|NCT00884741|365738713|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
106020440|NCT00884741|365738714|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
106020441|NCT00884741|365738715|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
106020442|NCT00884741|365738716|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
106020443|NCT00884741|365738713|FG000|Step 1 Registration: Tissue Screening|Death|3|||
106020444|NCT00884741|365738714|FG001|Step 1 Registration: Tissue Screening|Death|0|||
106020445|NCT00884741|365738715|FG002|Step 1 Registration: Tissue Screening|Death|0|||
106020446|NCT00884741|365738716|FG003|Step 1 Registration: Tissue Screening|Death|0|||
106020447|NCT00884741|365738713|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
106020448|NCT00884741|365738714|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
106020449|NCT00884741|365738715|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
106020450|NCT00884741|365738716|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
106020451|NCT00884741|365738713|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
106020452|NCT00884741|365738714|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
106020453|NCT00884741|365738715|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
106020454|NCT00884741|365738716|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
106020455|NCT00884741|365738713|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
106020456|NCT00884741|365738714|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
106020457|NCT00884741|365738715|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
106020458|NCT00884741|365738716|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
106020459|NCT00884741|365738713|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
106020460|NCT00884741|365738714|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
106020461|NCT00884741|365738715|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
106020462|NCT00884741|365738716|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
106020463|NCT00884741|365738713|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
106020464|NCT00884741|365738714|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
106020465|NCT00884741|365738715|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
106020466|NCT00884741|365738716|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
106020467|NCT00884741|365738713|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
105767253|NCT05179057|364800443|FG001|Overall Study|Study terminated|7|||
105822848|NCT02911701|365008854|FG001|Overall Study|Adverse Event|0|||
105767254|NCT05179057|364800442|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
105767255|NCT05179057|364800443|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
105958444|NCT01523743|365508067|FG001|Period 1|Adverse Event|0|||
105958445|NCT01523743|365508066|FG000|Period 1|Withdrawal by Subject|6|||
105958446|NCT01523743|365508067|FG001|Period 1|Withdrawal by Subject|2|||
105958447|NCT01523743|365508066|FG000|Period 1|Lost to Follow-up|1|||
105958448|NCT01523743|365508067|FG001|Period 1|Lost to Follow-up|0|||
105958449|NCT01523743|365508066|FG000|Period 1|Lack of Efficacy|1|||
105958450|NCT01523743|365508067|FG001|Period 1|Lack of Efficacy|0|||
105958451|NCT01523743|365508066|FG000|Period 1|Felt unable to empty bladder|1|||
105958452|NCT01523743|365508067|FG001|Period 1|Felt unable to empty bladder|0|||
105958453|NCT01523743|365508066|FG000|Period 2|Withdrawal by Subject|0|||
105958454|NCT01523743|365508067|FG001|Period 2|Withdrawal by Subject|2|||
105958455|NCT01523743|365508066|FG000|Period 2|Adverse Event|1|||
105958456|NCT01523743|365508067|FG001|Period 2|Adverse Event|0|||
105958457|NCT00363142|365508068|FG000|Overall Study|Adverse Event|2|||
105958458|NCT00363142|365508069|FG001|Overall Study|Adverse Event|0|||
105958459|NCT00363142|365508068|FG000|Overall Study|Lack of Efficacy|0|||
105958460|NCT00363142|365508069|FG001|Overall Study|Lack of Efficacy|1|||
105958461|NCT00363142|365508068|FG000|Overall Study|Lost to Follow-up|1|||
105958462|NCT00363142|365508069|FG001|Overall Study|Lost to Follow-up|0|||
105958463|NCT00363142|365508068|FG000|Overall Study|Non-compliance|1|||
105958464|NCT00363142|365508069|FG001|Overall Study|Non-compliance|1|||
105958465|NCT00363142|365508068|FG000|Overall Study|Withdrawal by Subject|3|||
105958466|NCT00363142|365508069|FG001|Overall Study|Withdrawal by Subject|1|||
105958467|NCT00645840|365508075|FG000|Overall Study|Protocol Violation|3|||
105958468|NCT02923531|365508076|FG000|Overall Study|Adverse Event|4|||
105958469|NCT02923531|365508076|FG000|Overall Study|Clinical Deterioration|1|||
105958470|NCT02923531|365508076|FG000|Overall Study|Disease Progression|3|||
105958471|NCT02923531|365508076|FG000|Overall Study|Study Termination|1|||
105958472|NCT01823198|365508080|FG000|Overall Study|Physician Decision|0|||
105958473|NCT01823198|365508081|FG001|Overall Study|Physician Decision|1|||
105958474|NCT01823198|365508082|FG002|Overall Study|Physician Decision|0|||
105958475|NCT01823198|365508083|FG003|Overall Study|Physician Decision|0|||
105958476|NCT01823198|365508084|FG004|Overall Study|Physician Decision|0|||
105958477|NCT01823198|365508085|FG005|Overall Study|Physician Decision|3|||
105958478|NCT01823198|365508086|FG006|Overall Study|Physician Decision|3|||
105958479|NCT03943290|365508089|FG000|Overall Study|Sponsor Terminated Study|6|||
105958480|NCT03943290|365508090|FG001|Overall Study|Sponsor Terminated Study|1|||
105958481|NCT03943290|365508091|FG002|Overall Study|Sponsor Terminated Study|11|||
105958482|NCT03943290|365508092|FG003|Overall Study|Sponsor Terminated Study|6|||
105958483|NCT03943290|365508093|FG004|Overall Study|Sponsor Terminated Study|7|||
105958484|NCT03943290|365508094|FG005|Overall Study|Sponsor Terminated Study|6|||
105958485|NCT03943290|365508095|FG006|Overall Study|Sponsor Terminated Study|6|||
105958486|NCT03943290|365508096|FG007|Overall Study|Sponsor Terminated Study|7|||
105958487|NCT03943290|365508097|FG008|Overall Study|Sponsor Terminated Study|8|||
105958488|NCT03943290|365508089|FG000|Overall Study|Lost to Follow-up|1|||
105958489|NCT03943290|365508090|FG001|Overall Study|Lost to Follow-up|0|||
105958490|NCT03943290|365508091|FG002|Overall Study|Lost to Follow-up|1|||
105767256|NCT05179057|364800442|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
105767257|NCT05179057|364800443|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
105767258|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
105767259|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
105767260|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
105767261|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
105767262|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
105767263|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
105767264|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
105767265|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
105767266|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
105767267|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
105767268|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
105767269|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
105767270|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
105767271|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
105767272|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
105767273|NCT02417064|364800444|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
105767274|NCT02417064|364800445|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
105958491|NCT03943290|365508092|FG003|Overall Study|Lost to Follow-up|0|||
105958492|NCT03943290|365508093|FG004|Overall Study|Lost to Follow-up|0|||
105958493|NCT03943290|365508094|FG005|Overall Study|Lost to Follow-up|0|||
105958494|NCT03943290|365508095|FG006|Overall Study|Lost to Follow-up|0|||
105958495|NCT03943290|365508096|FG007|Overall Study|Lost to Follow-up|1|||
105958496|NCT03943290|365508097|FG008|Overall Study|Lost to Follow-up|0|||
106145693|NCT01692730|366193159|FG001|Overall Study|Lost to Follow-up|227|||
106020468|NCT00884741|365738714|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
106020469|NCT00884741|365738715|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
105958497|NCT03943290|365508089|FG000|Overall Study|Withdrawal by Subject|0|||
105958498|NCT03943290|365508090|FG001|Overall Study|Withdrawal by Subject|0|||
105958499|NCT03943290|365508091|FG002|Overall Study|Withdrawal by Subject|1|||
106020470|NCT00884741|365738716|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
106020471|NCT00884741|365738713|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
106020472|NCT00884741|365738714|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
106020473|NCT00884741|365738715|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
106020474|NCT00884741|365738716|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
106020475|NCT00884741|365738713|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
106020476|NCT00884741|365738714|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
106020477|NCT00884741|365738715|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
106020478|NCT00884741|365738716|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
106020479|NCT00884741|365738713|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
106020480|NCT00884741|365738714|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
106020481|NCT00884741|365738715|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
106145694|NCT01415349|366193160|FG000|Treatment Period 1|Adverse Event|0|||
106145695|NCT01415349|366193161|FG001|Treatment Period 1|Adverse Event|1|||
106145696|NCT01415349|366193160|FG000|Treatment Period 1|Withdrawal by Subject|0|||
106145697|NCT01415349|366193161|FG001|Treatment Period 1|Withdrawal by Subject|1|||
106145698|NCT01239316|366193162|FG000|Overall Study|Progression/Relapse|11|||
106145699|NCT01239316|366193162|FG000|Overall Study|Adverse Event|1|||
106145700|NCT00774852|366193165|FG000|Overall Study|Adverse Event|9|||
106145701|NCT00774852|366193166|FG001|Overall Study|Adverse Event|6|||
106145702|NCT00774852|366193165|FG000|Overall Study|Death|2|||
106145703|NCT00774852|366193166|FG001|Overall Study|Death|1|||
106145704|NCT00774852|366193165|FG000|Overall Study|Lack of Efficacy|3|||
106145705|NCT00774852|366193166|FG001|Overall Study|Lack of Efficacy|7|||
106145706|NCT00774852|366193165|FG000|Overall Study|Lost to Follow-up|9|||
106145707|NCT00774852|366193166|FG001|Overall Study|Lost to Follow-up|5|||
106145708|NCT00774852|366193165|FG000|Overall Study|Physician Decision|2|||
106145709|NCT00774852|366193166|FG001|Overall Study|Physician Decision|6|||
106145710|NCT00774852|366193165|FG000|Overall Study|Pregnancy|1|||
106145711|NCT00774852|366193166|FG001|Overall Study|Pregnancy|2|||
106145712|NCT00774852|366193165|FG000|Overall Study|Withdrawal by Subject|2|||
106145713|NCT00774852|366193166|FG001|Overall Study|Withdrawal by Subject|2|||
106145714|NCT00774852|366193165|FG000|Overall Study|Non-responder|15|||
106145715|NCT00774852|366193166|FG001|Overall Study|Non-responder|11|||
106145716|NCT00774852|366193165|FG000|Overall Study|Subject non-compliance|0|||
106145717|NCT00774852|366193166|FG001|Overall Study|Subject non-compliance|1|||
106145718|NCT00774852|366193165|FG000|Overall Study|Protocol Violation|1|||
106145719|NCT00774852|366193166|FG001|Overall Study|Protocol Violation|0|||
106145720|NCT00774852|366193165|FG000|Overall Study|Subject received prohibited medication|1|||
106145721|NCT00774852|366193166|FG001|Overall Study|Subject received prohibited medication|0|||
106145722|NCT01424397|366194392|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
105958500|NCT03943290|365508092|FG003|Overall Study|Withdrawal by Subject|0|||
105958501|NCT03943290|365508093|FG004|Overall Study|Withdrawal by Subject|0|||
105958502|NCT03943290|365508094|FG005|Overall Study|Withdrawal by Subject|0|||
105958503|NCT03943290|365508095|FG006|Overall Study|Withdrawal by Subject|0|||
105958504|NCT03943290|365508096|FG007|Overall Study|Withdrawal by Subject|0|||
105958505|NCT03943290|365508097|FG008|Overall Study|Withdrawal by Subject|0|||
105958506|NCT01737762|365508099|FG000|Overall Study|Adverse Event|2|||
105958507|NCT01737762|365508100|FG001|Overall Study|Adverse Event|2|||
105958508|NCT01737762|365508099|FG000|Overall Study|Lost to Follow-up|1|||
105958509|NCT01737762|365508100|FG001|Overall Study|Lost to Follow-up|0|||
105958510|NCT01737762|365508099|FG000|Overall Study|Withdrawal by Subject|2|||
105958511|NCT01737762|365508100|FG001|Overall Study|Withdrawal by Subject|2|||
105958512|NCT01737762|365508099|FG000|Overall Study|Progressive disease|1|||
106020482|NCT00884741|365738716|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
106020483|NCT00884741|365738713|FG000|Randomization|Protocol Violation|0|||
106020484|NCT00884741|365738714|FG001|Randomization|Protocol Violation|0|||
106145723|NCT01424397|366194393|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145724|NCT01424397|366194394|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
106145725|NCT01424397|366194395|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145726|NCT01424397|366194396|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145727|NCT01424397|366194397|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145728|NCT01424397|366194398|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145729|NCT01424397|366194399|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145730|NCT01424397|366194400|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145731|NCT01424397|366194401|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145732|NCT01424397|366194402|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145733|NCT01424397|366194403|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
106145734|NCT01185561|366194405|FG000|Overall Study|Lost to Follow-up|0|||
105958513|NCT01737762|365508100|FG001|Overall Study|Progressive disease|2|||
106020485|NCT00884741|365738715|FG002|Randomization|Protocol Violation|8|||
106020486|NCT00884741|365738716|FG003|Randomization|Protocol Violation|8|||
106020487|NCT02281383|365738719|FG000|Overall Study|Progressive Disease|1|||
106020488|NCT02281383|365738719|FG000|Overall Study|Withdrawal by Subject|6|||
106020489|NCT02281383|365738719|FG000|Overall Study|Protocol Violation|2|||
106020490|NCT02281383|365738719|FG000|Overall Study|Death|1|||
106020491|NCT02281383|365738719|FG000|Overall Study|Adverse Event|2|||
106020492|NCT00899431|365738720|FG000|Overall Study|Physician Decision|1|||
106020493|NCT00899431|365738721|FG001|Overall Study|Physician Decision|0|||
106020494|NCT00899431|365738722|FG002|Overall Study|Physician Decision|0|||
106020495|NCT01615029|365738724|FG000|Overall Study|Adverse Event|0|||
106020496|NCT01615029|365738725|FG001|Overall Study|Adverse Event|0|||
106020497|NCT01615029|365738726|FG002|Overall Study|Adverse Event|0|||
106020498|NCT01615029|365738727|FG003|Overall Study|Adverse Event|0|||
106020499|NCT01615029|365738728|FG004|Overall Study|Adverse Event|1|||
106020500|NCT01615029|365738724|FG000|Overall Study|Death|0|||
106020501|NCT01615029|365738725|FG001|Overall Study|Death|0|||
106020502|NCT01615029|365738726|FG002|Overall Study|Death|0|||
106020503|NCT01615029|365738727|FG003|Overall Study|Death|0|||
106020504|NCT01615029|365738728|FG004|Overall Study|Death|1|||
106020505|NCT01615029|365738724|FG000|Overall Study|Lost to Follow-up|0|||
106020506|NCT01615029|365738725|FG001|Overall Study|Lost to Follow-up|0|||
106020507|NCT01615029|365738726|FG002|Overall Study|Lost to Follow-up|0|||
106020508|NCT01615029|365738727|FG003|Overall Study|Lost to Follow-up|0|||
106020509|NCT01615029|365738728|FG004|Overall Study|Lost to Follow-up|1|||
106020510|NCT01615029|365738724|FG000|Overall Study|Progressive disease|2|||
106020511|NCT01615029|365738725|FG001|Overall Study|Progressive disease|1|||
106020512|NCT01615029|365738726|FG002|Overall Study|Progressive disease|1|||
106020513|NCT01615029|365738727|FG003|Overall Study|Progressive disease|1|||
106020514|NCT01615029|365738728|FG004|Overall Study|Progressive disease|5|||
106020515|NCT01615029|365738724|FG000|Overall Study|Physician Decision|0|||
106020516|NCT01615029|365738725|FG001|Overall Study|Physician Decision|0|||
106020517|NCT01615029|365738726|FG002|Overall Study|Physician Decision|0|||
106020518|NCT01615029|365738727|FG003|Overall Study|Physician Decision|0|||
106020519|NCT01615029|365738728|FG004|Overall Study|Physician Decision|1|||
106020520|NCT01615029|365738724|FG000|Overall Study|Ongoing|1|||
106020521|NCT01615029|365738725|FG001|Overall Study|Ongoing|2|||
106020522|NCT01615029|365738726|FG002|Overall Study|Ongoing|3|||
106020523|NCT01615029|365738727|FG003|Overall Study|Ongoing|2|||
106020524|NCT01615029|365738728|FG004|Overall Study|Ongoing|23|||
106020525|NCT01326104|365738729|FG000|Overall Study|progressed prior to vaccine|0|||
106020526|NCT01326104|365738730|FG001|Overall Study|progressed prior to vaccine|2|||
106020527|NCT01326104|365738729|FG000|Overall Study|unable to make vaccine|0|||
106020528|NCT01326104|365738730|FG001|Overall Study|unable to make vaccine|2|||
106020529|NCT04421027|365738731|FG000|Treatment Period|Adverse Event|5|||
106020530|NCT04421027|365738732|FG001|Treatment Period|Adverse Event|3|||
106145735|NCT01185561|366194406|FG001|Overall Study|Lost to Follow-up|4|||
106145736|NCT01185561|366194405|FG000|Overall Study|Withdrawal by Subject|2|||
106145737|NCT01185561|366194406|FG001|Overall Study|Withdrawal by Subject|8|||
106145738|NCT00071799|366194407|FG000|Overall Study|Adverse Event|19|||
106145739|NCT00071799|366194408|FG001|Overall Study|Adverse Event|10|||
106145740|NCT00071799|366194407|FG000|Overall Study|Protocol Violation|1|||
106145741|NCT00071799|366194408|FG001|Overall Study|Protocol Violation|7|||
106145742|NCT00071799|366194407|FG000|Overall Study|Lost to Follow-up|1|||
106145743|NCT00071799|366194408|FG001|Overall Study|Lost to Follow-up|1|||
106145744|NCT00071799|366194407|FG000|Overall Study|Withdrawal by Subject|15|||
106145745|NCT00071799|366194408|FG001|Overall Study|Withdrawal by Subject|37|||
106145746|NCT00071799|366194407|FG000|Overall Study|Physician Decision|0|||
106145747|NCT00071799|366194408|FG001|Overall Study|Physician Decision|2|||
106145748|NCT00071799|366194407|FG000|Overall Study|Lack of Efficacy|11|||
106145749|NCT00071799|366194408|FG001|Overall Study|Lack of Efficacy|18|||
106145750|NCT00071799|366194407|FG000|Overall Study|Disease Progression|23|||
106145751|NCT00071799|366194408|FG001|Overall Study|Disease Progression|20|||
106145752|NCT00071799|366194407|FG000|Overall Study|Different Central+Local Pathology Review|0|||
106145753|NCT00071799|366194408|FG001|Overall Study|Different Central+Local Pathology Review|1|||
106145754|NCT00071799|366194407|FG000|Overall Study|Not Documented|0|||
106145755|NCT00071799|366194408|FG001|Overall Study|Not Documented|2|||
106145756|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
105958514|NCT01737762|365508099|FG000|Overall Study|Physician Decision|1|||
105958515|NCT01737762|365508100|FG001|Overall Study|Physician Decision|1|||
105958516|NCT01737762|365508099|FG000|Overall Study|Moved from area|2|||
105958517|NCT01737762|365508100|FG001|Overall Study|Moved from area|1|||
105958518|NCT01737762|365508099|FG000|Overall Study|Trial termination|11|||
105958519|NCT01737762|365508100|FG001|Overall Study|Trial termination|9|||
105958520|NCT00881530|365508101|FG000|Overall Study|Adverse Event|5|||
105958521|NCT00881530|365508102|FG001|Overall Study|Adverse Event|1|||
105958522|NCT00881530|365508103|FG002|Overall Study|Adverse Event|1|||
105958523|NCT00881530|365508104|FG003|Overall Study|Adverse Event|4|||
106020531|NCT04421027|365738733|FG002|Treatment Period|Adverse Event|0|||
106020532|NCT04421027|365738734|FG003|Treatment Period|Adverse Event|0|||
105767275|NCT02417064|364800446|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
105767276|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
105767277|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
105767278|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
105767279|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
105767280|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
105767281|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
105767282|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
105767283|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
105767284|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
105767285|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
105767286|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
105767287|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
105767288|NCT02417064|364800444|FG000|Follow-up Phase (24 Weeks)|Other|2|||
105767289|NCT02417064|364800445|FG001|Follow-up Phase (24 Weeks)|Other|2|||
105767290|NCT02417064|364800446|FG002|Follow-up Phase (24 Weeks)|Other|3|||
105767291|NCT02136134|364800447|FG000|Overall Study|Death|170|||
105767292|NCT02136134|364800448|FG001|Overall Study|Death|148|||
105767293|NCT02136134|364800447|FG000|Overall Study|Withdrawal by Subject|19|||
105767294|NCT02136134|364800448|FG001|Overall Study|Withdrawal by Subject|10|||
105767295|NCT02136134|364800447|FG000|Overall Study|Lost to Follow-up|3|||
105767296|NCT02136134|364800448|FG001|Overall Study|Lost to Follow-up|3|||
105767297|NCT02136134|364800447|FG000|Overall Study|Uspecified|55|||
105767298|NCT02136134|364800448|FG001|Overall Study|Uspecified|90|||
105767299|NCT03345342|364800449|FG000|Open-Label Phase|Adverse Event|30|||
105767300|NCT03345342|364800450|FG001|Open-Label Phase|Adverse Event|0|||
105767301|NCT03345342|364800451|FG002|Open-Label Phase|Adverse Event|0|||
105767302|NCT03345342|364800452|FG003|Open-Label Phase|Adverse Event|0|||
105767303|NCT03345342|364800453|FG004|Open-Label Phase|Adverse Event|0|||
105958524|NCT00881530|365508105|FG004|Overall Study|Adverse Event|10|||
105958525|NCT00881530|365508106|FG005|Overall Study|Adverse Event|2|||
105958526|NCT00881530|365508101|FG000|Overall Study|Lack of Efficacy|1|||
105958527|NCT00881530|365508102|FG001|Overall Study|Lack of Efficacy|0|||
105958528|NCT00881530|365508103|FG002|Overall Study|Lack of Efficacy|0|||
105958529|NCT00881530|365508104|FG003|Overall Study|Lack of Efficacy|0|||
105958530|NCT00881530|365508105|FG004|Overall Study|Lack of Efficacy|1|||
105958531|NCT00881530|365508106|FG005|Overall Study|Lack of Efficacy|1|||
105958532|NCT00881530|365508101|FG000|Overall Study|Not compliant with the protocol|0|||
105958533|NCT00881530|365508102|FG001|Overall Study|Not compliant with the protocol|0|||
105958534|NCT00881530|365508103|FG002|Overall Study|Not compliant with the protocol|0|||
105958535|NCT00881530|365508104|FG003|Overall Study|Not compliant with the protocol|0|||
105958536|NCT00881530|365508105|FG004|Overall Study|Not compliant with the protocol|2|||
105958537|NCT00881530|365508106|FG005|Overall Study|Not compliant with the protocol|0|||
105958538|NCT00881530|365508101|FG000|Overall Study|Lost to Follow-up|0|||
105958539|NCT00881530|365508102|FG001|Overall Study|Lost to Follow-up|1|||
105958540|NCT00881530|365508103|FG002|Overall Study|Lost to Follow-up|1|||
105958541|NCT00881530|365508104|FG003|Overall Study|Lost to Follow-up|3|||
105958542|NCT00881530|365508105|FG004|Overall Study|Lost to Follow-up|1|||
105958543|NCT00881530|365508106|FG005|Overall Study|Lost to Follow-up|0|||
105958544|NCT00881530|365508101|FG000|Overall Study|Refused to continue medication|7|||
105958545|NCT00881530|365508102|FG001|Overall Study|Refused to continue medication|2|||
105958546|NCT00881530|365508103|FG002|Overall Study|Refused to continue medication|1|||
105958547|NCT00881530|365508104|FG003|Overall Study|Refused to continue medication|2|||
105958548|NCT00881530|365508105|FG004|Overall Study|Refused to continue medication|0|||
105958549|NCT00881530|365508106|FG005|Overall Study|Refused to continue medication|0|||
105958550|NCT00881530|365508101|FG000|Overall Study|Other reason not defined above|1|||
105958551|NCT00881530|365508102|FG001|Overall Study|Other reason not defined above|1|||
105958552|NCT00881530|365508103|FG002|Overall Study|Other reason not defined above|2|||
105958553|NCT00881530|365508104|FG003|Overall Study|Other reason not defined above|0|||
105958554|NCT00881530|365508105|FG004|Overall Study|Other reason not defined above|0|||
105958555|NCT00881530|365508106|FG005|Overall Study|Other reason not defined above|2|||
105958556|NCT01509846|365508107|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
105958557|NCT01509846|365508108|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
105958558|NCT01509846|365508109|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
105958559|NCT01509846|365508110|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
105958560|NCT01509846|365508111|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
105958561|NCT01509846|365508107|FG000|Received Vaccination 2|Illness|0|||
105958562|NCT01509846|365508108|FG001|Received Vaccination 2|Illness|0|||
105958563|NCT01509846|365508109|FG002|Received Vaccination 2|Illness|0|||
105958564|NCT01509846|365508110|FG003|Received Vaccination 2|Illness|0|||
105958565|NCT01509846|365508111|FG004|Received Vaccination 2|Illness|1|||
105958566|NCT01509846|365508107|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
105958567|NCT01509846|365508108|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
105767304|NCT03345342|364800449|FG000|Open-Label Phase|Death|1|||
105767305|NCT03345342|364800450|FG001|Open-Label Phase|Death|0|||
106020533|NCT04421027|365738731|FG000|Treatment Period|Death|98|||
106020534|NCT04421027|365738732|FG001|Treatment Period|Death|61|||
106020535|NCT04421027|365738733|FG002|Treatment Period|Death|0|||
106020536|NCT04421027|365738734|FG003|Treatment Period|Death|0|||
106020537|NCT04421027|365738731|FG000|Treatment Period|Lost to Follow-up|22|||
106020538|NCT04421027|365738732|FG001|Treatment Period|Lost to Follow-up|20|||
106020539|NCT04421027|365738733|FG002|Treatment Period|Lost to Follow-up|0|||
106020540|NCT04421027|365738734|FG003|Treatment Period|Lost to Follow-up|0|||
105767306|NCT03345342|364800451|FG002|Open-Label Phase|Death|0|||
105958568|NCT01509846|365508109|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
105958569|NCT01509846|365508110|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
105958570|NCT01509846|365508111|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
105958571|NCT01509846|365508107|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
105958572|NCT01509846|365508108|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
105958573|NCT01509846|365508109|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
105958574|NCT01509846|365508110|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
105958575|NCT01509846|365508111|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
105958576|NCT01509846|365508107|FG000|Received Vaccination 3|Pregnancy|0|||
105958577|NCT01509846|365508108|FG001|Received Vaccination 3|Pregnancy|0|||
105958578|NCT01509846|365508109|FG002|Received Vaccination 3|Pregnancy|0|||
105958579|NCT01509846|365508110|FG003|Received Vaccination 3|Pregnancy|1|||
105958580|NCT01509846|365508111|FG004|Received Vaccination 3|Pregnancy|0|||
105958581|NCT01509846|365508107|FG000|Received Vaccination 3|Lost to Follow-up|0|||
105958582|NCT01509846|365508108|FG001|Received Vaccination 3|Lost to Follow-up|0|||
105958583|NCT01509846|365508109|FG002|Received Vaccination 3|Lost to Follow-up|1|||
105958584|NCT01509846|365508110|FG003|Received Vaccination 3|Lost to Follow-up|0|||
105958585|NCT01509846|365508111|FG004|Received Vaccination 3|Lost to Follow-up|0|||
105958586|NCT04396795|365508113|FG000|Month 1|Lost to Follow-up|2|||
105958587|NCT04396795|365508114|FG001|Month 1|Lost to Follow-up|3|||
105958588|NCT04396795|365508113|FG000|Month 3|Lost to Follow-up|1|||
105958589|NCT04396795|365508114|FG001|Month 3|Lost to Follow-up|3|||
105958590|NCT04396795|365508113|FG000|Month 6|Lost to Follow-up|3|||
105958591|NCT04396795|365508114|FG001|Month 6|Lost to Follow-up|3|||
105958592|NCT01393899|365508115|FG000|Overall Study|Study terminated by sponsor|1|||
105958593|NCT01393899|365508116|FG001|Overall Study|Study terminated by sponsor|0|||
105958594|NCT01393899|365508117|FG002|Overall Study|Study terminated by sponsor|1|||
105958595|NCT01393899|365508115|FG000|Overall Study|Other|1|||
105958596|NCT01393899|365508116|FG001|Overall Study|Other|0|||
105958597|NCT01393899|365508117|FG002|Overall Study|Other|0|||
105958598|NCT01393899|365508115|FG000|Overall Study|Withdrawal by Subject|2|||
105958599|NCT01393899|365508116|FG001|Overall Study|Withdrawal by Subject|2|||
105958600|NCT01393899|365508117|FG002|Overall Study|Withdrawal by Subject|1|||
105958601|NCT01393899|365508115|FG000|Overall Study|Lost to Follow-up|0|||
105958602|NCT01393899|365508116|FG001|Overall Study|Lost to Follow-up|0|||
105958603|NCT01393899|365508117|FG002|Overall Study|Lost to Follow-up|1|||
105958604|NCT01393899|365508115|FG000|Overall Study|Does not meet entrance criteria|1|||
105958605|NCT01393899|365508116|FG001|Overall Study|Does not meet entrance criteria|0|||
105958606|NCT01393899|365508117|FG002|Overall Study|Does not meet entrance criteria|1|||
105958607|NCT01393899|365508115|FG000|Overall Study|Lack of Efficacy|26|||
105958608|NCT01393899|365508116|FG001|Overall Study|Lack of Efficacy|21|||
105958609|NCT01393899|365508117|FG002|Overall Study|Lack of Efficacy|16|||
105958610|NCT01393899|365508115|FG000|Overall Study|Adverse Event|1|||
105958611|NCT01393899|365508116|FG001|Overall Study|Adverse Event|5|||
105958612|NCT01393899|365508117|FG002|Overall Study|Adverse Event|3|||
105958613|NCT01162473|365508121|FG000|Overall Study|Adverse Event|2|||
105958614|NCT01162473|365508122|FG001|Overall Study|Adverse Event|1|||
105958615|NCT01162473|365508121|FG000|Overall Study|Withdrawal by Subject|0|||
105958616|NCT01162473|365508122|FG001|Overall Study|Withdrawal by Subject|4|||
105958617|NCT01001767|365508123|FG000|Overall Study|no baseline study performed|1|||
105958618|NCT01001767|365508124|FG001|Overall Study|no baseline study performed|0|||
105958619|NCT01001767|365508123|FG000|Overall Study|Protocol Violation|1|||
105958620|NCT01001767|365508124|FG001|Overall Study|Protocol Violation|0|||
105958621|NCT01001767|365508123|FG000|Overall Study|Lost to Follow-up|1|||
106020541|NCT04421027|365738731|FG000|Treatment Period|Other-Unknown|15|||
105767307|NCT03345342|364800452|FG003|Open-Label Phase|Death|0|||
105767308|NCT03345342|364800453|FG004|Open-Label Phase|Death|0|||
106020542|NCT04421027|365738732|FG001|Treatment Period|Other-Unknown|9|||
106020543|NCT04421027|365738733|FG002|Treatment Period|Other-Unknown|0|||
106020544|NCT04421027|365738734|FG003|Treatment Period|Other-Unknown|0|||
105958622|NCT01001767|365508124|FG001|Overall Study|Lost to Follow-up|0|||
105958623|NCT01001767|365508123|FG000|Overall Study|Physician Decision|1|||
105958624|NCT01001767|365508124|FG001|Overall Study|Physician Decision|0|||
105958625|NCT02520388|365508125|FG000|Overall Study|Physician Decision|1|||
105958626|NCT02520388|365508126|FG001|Overall Study|Physician Decision|0|||
105958627|NCT02520388|365508125|FG000|Overall Study|Subject or parent/guardian request|0|||
105958628|NCT02520388|365508126|FG001|Overall Study|Subject or parent/guardian request|6|||
105958629|NCT02520388|365508125|FG000|Overall Study|Adverse Event|1|||
105767309|NCT03345342|364800449|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
106020545|NCT04421027|365738731|FG000|Treatment Period|Physician Decision|1|||
106020546|NCT04421027|365738732|FG001|Treatment Period|Physician Decision|1|||
106020547|NCT04421027|365738733|FG002|Treatment Period|Physician Decision|0|||
106020548|NCT04421027|365738734|FG003|Treatment Period|Physician Decision|0|||
106020549|NCT04421027|365738731|FG000|Treatment Period|Withdrawal by Subject|7|||
106020550|NCT04421027|365738732|FG001|Treatment Period|Withdrawal by Subject|12|||
106020551|NCT04421027|365738733|FG002|Treatment Period|Withdrawal by Subject|0|||
106020552|NCT04421027|365738734|FG003|Treatment Period|Withdrawal by Subject|0|||
106020553|NCT04421027|365738731|FG000|Treatment Period|Randomized Not Dosed|9|||
106020554|NCT04421027|365738732|FG001|Treatment Period|Randomized Not Dosed|14|||
106020555|NCT04421027|365738733|FG002|Treatment Period|Randomized Not Dosed|0|||
106020556|NCT04421027|365738734|FG003|Treatment Period|Randomized Not Dosed|0|||
106020557|NCT04421027|365738731|FG000|Follow-Up Period|Adverse Event|0|||
106020558|NCT04421027|365738732|FG001|Follow-Up Period|Adverse Event|0|||
106020559|NCT04421027|365738733|FG002|Follow-Up Period|Adverse Event|0|||
106020560|NCT04421027|365738734|FG003|Follow-Up Period|Adverse Event|3|||
106020561|NCT04421027|365738731|FG000|Follow-Up Period|Death|0|||
106020562|NCT04421027|365738732|FG001|Follow-Up Period|Death|0|||
106020563|NCT04421027|365738733|FG002|Follow-Up Period|Death|16|||
106020564|NCT04421027|365738734|FG003|Follow-Up Period|Death|17|||
106020565|NCT04421027|365738731|FG000|Follow-Up Period|Lost to Follow-up|0|||
106020566|NCT04421027|365738732|FG001|Follow-Up Period|Lost to Follow-up|0|||
106020567|NCT04421027|365738733|FG002|Follow-Up Period|Lost to Follow-up|7|||
106020568|NCT04421027|365738734|FG003|Follow-Up Period|Lost to Follow-up|7|||
106020569|NCT04421027|365738731|FG000|Follow-Up Period|Protocol Deviation|0|||
106020570|NCT04421027|365738732|FG001|Follow-Up Period|Protocol Deviation|0|||
106020571|NCT04421027|365738733|FG002|Follow-Up Period|Protocol Deviation|1|||
106020572|NCT04421027|365738734|FG003|Follow-Up Period|Protocol Deviation|0|||
106020573|NCT04421027|365738731|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
106020574|NCT04421027|365738732|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
106020575|NCT04421027|365738733|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
106020576|NCT04421027|365738734|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
106020577|NCT04421027|365738731|FG000|Follow-Up Period|Left message, participant did not call back|0|||
106020578|NCT04421027|365738732|FG001|Follow-Up Period|Left message, participant did not call back|0|||
106020579|NCT04421027|365738733|FG002|Follow-Up Period|Left message, participant did not call back|0|||
106020580|NCT04421027|365738734|FG003|Follow-Up Period|Left message, participant did not call back|1|||
106020581|NCT04421027|365738731|FG000|Follow-Up Period|Participant died|0|||
106020582|NCT04421027|365738732|FG001|Follow-Up Period|Participant died|0|||
106020583|NCT04421027|365738733|FG002|Follow-Up Period|Participant died|0|||
106020584|NCT04421027|365738734|FG003|Follow-Up Period|Participant died|1|||
106020585|NCT04421027|365738731|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
106020586|NCT04421027|365738732|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
106020587|NCT04421027|365738733|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
106020588|NCT04421027|365738734|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
106020589|NCT01677377|365741351|FG000|Overall Study|Protocol Violation|1|||
106020590|NCT01677377|365741352|FG001|Overall Study|Protocol Violation|0|||
106020591|NCT01677377|365741353|FG002|Overall Study|Protocol Violation|0|||
106020592|NCT01677377|365741351|FG000|Overall Study|Lost to Follow-up|0|||
106020593|NCT01677377|365741352|FG001|Overall Study|Lost to Follow-up|1|||
106020594|NCT01677377|365741353|FG002|Overall Study|Lost to Follow-up|1|||
106020595|NCT01677377|365741351|FG000|Overall Study|Withdrawal by Subject|0|||
106020596|NCT01677377|365741352|FG001|Overall Study|Withdrawal by Subject|0|||
106020597|NCT01677377|365741353|FG002|Overall Study|Withdrawal by Subject|3|||
106020598|NCT01677377|365741351|FG000|Overall Study|Lack of Efficacy|0|||
106020599|NCT01677377|365741352|FG001|Overall Study|Lack of Efficacy|0|||
106020600|NCT01677377|365741353|FG002|Overall Study|Lack of Efficacy|1|||
106020601|NCT01677377|365741351|FG000|Overall Study|Pregnancy|0|||
106020602|NCT01677377|365741352|FG001|Overall Study|Pregnancy|0|||
106020603|NCT01677377|365741353|FG002|Overall Study|Pregnancy|1|||
106020604|NCT00807001|365741354|FG000|Overall Study|Non-compliance|0|||
106020605|NCT00807001|365741355|FG001|Overall Study|Non-compliance|1|||
106020606|NCT00807001|365741356|FG002|Overall Study|Non-compliance|0|||
106020607|NCT00807001|365741357|FG003|Overall Study|Non-compliance|0|||
106020608|NCT00807001|365741358|FG004|Overall Study|Non-compliance|0|||
106020609|NCT02840799|365741374|FG000|Phase 1|Physician Decision|1|||
106020610|NCT02840799|365741375|FG001|Phase 1|Physician Decision|3|||
106020611|NCT02840799|365741374|FG000|Phase 1|Withdrawal by Subject|4|||
106020612|NCT02840799|365741375|FG001|Phase 1|Withdrawal by Subject|0|||
106020613|NCT02840799|365741374|FG000|Phase 2 (Crossover)|Adverse Event|0|||
106020614|NCT02840799|365741375|FG001|Phase 2 (Crossover)|Adverse Event|1|||
106020615|NCT02840799|365741374|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
106020616|NCT02840799|365741375|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
106020617|NCT01069900|365741379|FG000|Overall Study|Technical problems|0|||
106145757|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
106020618|NCT01069900|365741380|FG001|Overall Study|Technical problems|1|||
105822849|NCT00830024|365008855|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105822850|NCT00830024|365008856|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105822851|NCT03134222|365008857|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
105822852|NCT03134222|365008858|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
105822853|NCT03134222|365008859|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
105822854|NCT03134222|365008860|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
105822855|NCT03134222|365008861|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
105822856|NCT03134222|365008857|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
105822857|NCT03134222|365008858|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
105822858|NCT03134222|365008859|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
105822859|NCT03134222|365008860|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
106020619|NCT01069900|365741379|FG000|Overall Study|Lost to Follow-up|7|||
106020620|NCT01069900|365741380|FG001|Overall Study|Lost to Follow-up|1|||
106020621|NCT01069900|365741379|FG000|Overall Study|Withdrawal by Subject|6|||
106020622|NCT01069900|365741380|FG001|Overall Study|Withdrawal by Subject|1|||
105822860|NCT03134222|365008861|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
105822861|NCT03134222|365008857|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
106020623|NCT01069900|365741379|FG000|Overall Study|Protocol Violation|4|||
106020624|NCT01069900|365741380|FG001|Overall Study|Protocol Violation|1|||
106020625|NCT01069900|365741379|FG000|Overall Study|Insufficient Therapeutic effect|1|||
106020626|NCT01069900|365741380|FG001|Overall Study|Insufficient Therapeutic effect|0|||
106020627|NCT03180840|365741381|FG000|Overall Study|Withdrawal by Subject|1|||
106020628|NCT01621802|365741384|FG000|Overall Study|Protocol Violation|0|||
106020629|NCT01621802|365741385|FG001|Overall Study|Protocol Violation|0|||
106020630|NCT01621802|365741386|FG002|Overall Study|Protocol Violation|0|||
106020631|NCT01621802|365741387|FG003|Overall Study|Protocol Violation|0|||
106020632|NCT01621802|365741388|FG004|Overall Study|Protocol Violation|0|||
106145758|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
106145759|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
106145760|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
106145761|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
106145762|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
106145763|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
106145764|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
106145765|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
106145766|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
106145767|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
106145768|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
106145769|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
106145770|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
106145771|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
106145772|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
106145773|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
106145774|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
106145775|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
106145776|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
106145777|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
106145778|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
106145779|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
106145780|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
106145781|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
106145782|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
106145783|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
106145784|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
106145785|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
106145786|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
106145787|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
106145788|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
106145789|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
106145790|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
106145791|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
106145792|NCT03593213|366194411|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
106145793|NCT03593213|366194412|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
106145794|NCT03593213|366194413|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
106020633|NCT01621802|365741389|FG005|Overall Study|Protocol Violation|1|||
106020634|NCT01621802|365741384|FG000|Overall Study|Withdrawal by Subject|8|||
106020635|NCT01621802|365741385|FG001|Overall Study|Withdrawal by Subject|4|||
106020636|NCT01621802|365741386|FG002|Overall Study|Withdrawal by Subject|4|||
106020637|NCT01621802|365741387|FG003|Overall Study|Withdrawal by Subject|2|||
106020638|NCT01621802|365741388|FG004|Overall Study|Withdrawal by Subject|2|||
106020639|NCT01621802|365741389|FG005|Overall Study|Withdrawal by Subject|0|||
106020640|NCT01621802|365741384|FG000|Overall Study|Migrated/moved from study area|0|||
106020641|NCT01621802|365741385|FG001|Overall Study|Migrated/moved from study area|0|||
106020642|NCT01621802|365741386|FG002|Overall Study|Migrated/moved from study area|2|||
106020643|NCT01621802|365741387|FG003|Overall Study|Migrated/moved from study area|0|||
106020644|NCT01621802|365741388|FG004|Overall Study|Migrated/moved from study area|1|||
106020645|NCT01621802|365741389|FG005|Overall Study|Migrated/moved from study area|0|||
106020646|NCT01621802|365741384|FG000|Overall Study|Others|3|||
106020647|NCT01621802|365741385|FG001|Overall Study|Others|3|||
106020648|NCT01621802|365741386|FG002|Overall Study|Others|3|||
106020649|NCT01621802|365741387|FG003|Overall Study|Others|2|||
106020650|NCT01621802|365741388|FG004|Overall Study|Others|1|||
106020651|NCT01621802|365741389|FG005|Overall Study|Others|0|||
106020652|NCT01621802|365741384|FG000|Overall Study|Lost to Follow-up|36|||
106020653|NCT01621802|365741385|FG001|Overall Study|Lost to Follow-up|16|||
106020654|NCT01621802|365741386|FG002|Overall Study|Lost to Follow-up|24|||
106020655|NCT01621802|365741387|FG003|Overall Study|Lost to Follow-up|7|||
106020656|NCT01621802|365741388|FG004|Overall Study|Lost to Follow-up|31|||
105822862|NCT03134222|365008858|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
105822863|NCT03134222|365008859|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
105822864|NCT03134222|365008860|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
105822865|NCT03134222|365008861|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
105958630|NCT02520388|365508126|FG001|Overall Study|Adverse Event|4|||
105958631|NCT02520388|365508125|FG000|Overall Study|Lost to Follow-up|3|||
105958632|NCT02520388|365508126|FG001|Overall Study|Lost to Follow-up|2|||
105958633|NCT02520388|365508125|FG000|Overall Study|Other (reason not defined)|4|||
105958634|NCT02520388|365508126|FG001|Overall Study|Other (reason not defined)|4|||
105958635|NCT04721158|365508127|FG000|Overall Study|Lost to Follow-up|4|||
105958636|NCT04721158|365508127|FG000|Overall Study|Device did not connect|1|||
105958637|NCT01437111|365508129|FG000|Overall Study|Adverse Event|2|||
105958638|NCT01437111|365508129|FG000|Overall Study|Withdrawal by Subject|4|||
105958639|NCT01437111|365508129|FG000|Overall Study|Not reported|5|||
105958640|NCT01437111|365508129|FG000|Overall Study|Physician Decision|1|||
105958641|NCT01437111|365508129|FG000|Overall Study|Lost to Follow-up|5|||
105958642|NCT01437111|365508129|FG000|Overall Study|Protocol Violation|1|||
105958643|NCT03035864|365508131|FG000|Treatment Period|Adverse Event|1|||
105958644|NCT03035864|365508132|FG001|Treatment Period|Adverse Event|0|||
105958645|NCT03035864|365508131|FG000|Treatment Period|Other|3|||
105958646|NCT03035864|365508132|FG001|Treatment Period|Other|1|||
105958647|NCT03035864|365508131|FG000|Follow-up Period|Adverse Event|1|||
105958648|NCT03035864|365508132|FG001|Follow-up Period|Adverse Event|0|||
105958649|NCT03035864|365508131|FG000|Follow-up Period|Lost to Follow-up|6|||
105958650|NCT03035864|365508132|FG001|Follow-up Period|Lost to Follow-up|2|||
105958651|NCT03035864|365508131|FG000|Follow-up Period|Physician Decision|1|||
105958652|NCT03035864|365508132|FG001|Follow-up Period|Physician Decision|0|||
105958653|NCT03035864|365508131|FG000|Follow-up Period|Other|3|||
105958654|NCT03035864|365508132|FG001|Follow-up Period|Other|2|||
105958655|NCT04188834|365508137|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
105958656|NCT00553436|365508138|FG000|Overall Study|Conversion to another procedure|1|||
105958657|NCT00577707|365508139|FG000|Overall Study|Withdrawal by Subject|3|||
105958658|NCT03299244|365508140|FG000|Overall Study|Withdrawal by Subject|34|||
105958659|NCT03299244|365508141|FG001|Overall Study|Withdrawal by Subject|29|||
105958660|NCT03299244|365508140|FG000|Overall Study|Decision by Sponsor|4|||
105958661|NCT03299244|365508141|FG001|Overall Study|Decision by Sponsor|5|||
105958662|NCT03299244|365508140|FG000|Overall Study|Death|9|||
105958663|NCT03299244|365508141|FG001|Overall Study|Death|4|||
105958664|NCT03089047|365508142|FG000|Overall Study|Lost to Follow-up|1|||
105958665|NCT03089047|365508143|FG001|Overall Study|Lost to Follow-up|0|||
105958666|NCT00429182|365508144|FG000|Overall Study|Not evaluable, Disease Progression|2|||
105958667|NCT00429182|365508144|FG000|Overall Study|Not eligible|5|||
105958668|NCT01127607|365509588|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
105958669|NCT01127607|365509589|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
105958670|NCT01127607|365509588|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
105958671|NCT01127607|365509589|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
105958672|NCT03941873|365509596|FG000|Overall Study|Death|0|||
105958673|NCT03941873|365509597|FG001|Overall Study|Death|12|||
105958674|NCT03941873|365509598|FG002|Overall Study|Death|2|||
105958675|NCT03941873|365509599|FG003|Overall Study|Death|53|||
105958676|NCT03941873|365509596|FG000|Overall Study|Withdrawal by Subject|1|||
105958677|NCT03941873|365509597|FG001|Overall Study|Withdrawal by Subject|1|||
105958678|NCT03941873|365509598|FG002|Overall Study|Withdrawal by Subject|0|||
105958679|NCT03941873|365509599|FG003|Overall Study|Withdrawal by Subject|5|||
105958680|NCT03941873|365509596|FG000|Overall Study|Lost to Follow-up|1|||
105958681|NCT03941873|365509597|FG001|Overall Study|Lost to Follow-up|2|||
105958682|NCT03941873|365509598|FG002|Overall Study|Lost to Follow-up|0|||
105958683|NCT03941873|365509599|FG003|Overall Study|Lost to Follow-up|0|||
105958684|NCT03941873|365509596|FG000|Overall Study|Sponsor Decision|0|||
105958685|NCT03941873|365509597|FG001|Overall Study|Sponsor Decision|6|||
105958686|NCT03941873|365509598|FG002|Overall Study|Sponsor Decision|0|||
105958687|NCT03941873|365509599|FG003|Overall Study|Sponsor Decision|15|||
105958688|NCT01234480|365509602|FG000|Overall Study|Pregnancy|88|||
105958689|NCT01234480|365509602|FG000|Overall Study|>36/Normal History|50|||
105958690|NCT01234480|365509602|FG000|Overall Study|Age|3|||
105958691|NCT01234480|365509602|FG000|Overall Study|HPV Vaccine History|28|||
105958692|NCT01234480|365509602|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
105958693|NCT01234480|365509602|FG000|Overall Study|Hysterectomy|2|||
105958694|NCT01234480|365509602|FG000|Overall Study|Hysterectomy post enrollment|1|||
105958695|NCT01234480|365509602|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
105958696|NCT01234480|365509602|FG000|Overall Study|Informed Consent Form Violation|30|||
105958697|NCT01234480|365509602|FG000|Overall Study|Incorrect Visit|3|||
105958698|NCT01234480|365509602|FG000|Overall Study|No Florida Lab License|20|||
105958699|NCT01234480|365509602|FG000|Overall Study|Out of Window|42|||
105958700|NCT01234480|365509602|FG000|Overall Study|Sample Processing/Storage|92|||
105958701|NCT01234480|365509602|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
105958702|NCT01234480|365509602|FG000|Overall Study|Site/Subject non-compliance|44|||
105958703|NCT01234480|365509602|FG000|Overall Study|Missing Sample|9|||
105958704|NCT03370419|365509603|FG000|Overall Study|Lost to Follow-up|16|||
105958705|NCT02522429|365509604|FG000|Overall Study|Lost to Follow-up|8|||
105958706|NCT02522429|365509604|FG000|Overall Study|Adverse Event|2|||
105958707|NCT02522429|365509604|FG000|Overall Study|Death|1|||
105958708|NCT02522429|365509604|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
105958709|NCT01734785|365509605|FG000|Open-Label Period|Adverse Event|0|||
105958710|NCT01734785|365509606|FG001|Open-Label Period|Adverse Event|0|||
105958711|NCT01734785|365509607|FG002|Open-Label Period|Adverse Event|0|||
105958712|NCT01734785|365509608|FG003|Open-Label Period|Adverse Event|9|||
105958713|NCT01734785|365509605|FG000|Open-Label Period|Lack of Efficacy|0|||
105958714|NCT01734785|365509606|FG001|Open-Label Period|Lack of Efficacy|0|||
105958715|NCT01734785|365509607|FG002|Open-Label Period|Lack of Efficacy|0|||
105958716|NCT01734785|365509608|FG003|Open-Label Period|Lack of Efficacy|1|||
105958717|NCT01734785|365509605|FG000|Open-Label Period|Protocol Violation|0|||
105958718|NCT01734785|365509606|FG001|Open-Label Period|Protocol Violation|0|||
105958719|NCT01734785|365509607|FG002|Open-Label Period|Protocol Violation|0|||
105958720|NCT01734785|365509608|FG003|Open-Label Period|Protocol Violation|13|||
105958721|NCT01734785|365509605|FG000|Open-Label Period|Lost to Follow-up|0|||
105958722|NCT01734785|365509606|FG001|Open-Label Period|Lost to Follow-up|0|||
105958723|NCT01734785|365509607|FG002|Open-Label Period|Lost to Follow-up|0|||
105958724|NCT01734785|365509608|FG003|Open-Label Period|Lost to Follow-up|14|||
105958725|NCT01734785|365509605|FG000|Open-Label Period|Withdrawal by Subject|0|||
105958726|NCT01734785|365509606|FG001|Open-Label Period|Withdrawal by Subject|0|||
105958727|NCT01734785|365509607|FG002|Open-Label Period|Withdrawal by Subject|0|||
105958728|NCT01734785|365509608|FG003|Open-Label Period|Withdrawal by Subject|12|||
105958729|NCT01734785|365509605|FG000|Open-Label Period|Other Reasons|0|||
105958730|NCT01734785|365509606|FG001|Open-Label Period|Other Reasons|0|||
105958731|NCT01734785|365509607|FG002|Open-Label Period|Other Reasons|0|||
105958732|NCT01734785|365509608|FG003|Open-Label Period|Other Reasons|224|||
105958733|NCT01734785|365509605|FG000|Double-Blind Period|Adverse Event|0|||
105958734|NCT01734785|365509606|FG001|Double-Blind Period|Adverse Event|3|||
105958735|NCT01734785|365509607|FG002|Double-Blind Period|Adverse Event|2|||
105958736|NCT01734785|365509608|FG003|Double-Blind Period|Adverse Event|0|||
105958737|NCT01734785|365509605|FG000|Double-Blind Period|Lack of Efficacy|0|||
105958738|NCT01734785|365509606|FG001|Double-Blind Period|Lack of Efficacy|1|||
105958739|NCT01734785|365509607|FG002|Double-Blind Period|Lack of Efficacy|0|||
105958740|NCT01734785|365509608|FG003|Double-Blind Period|Lack of Efficacy|0|||
105958741|NCT01734785|365509605|FG000|Double-Blind Period|Protocol Violation|0|||
105958742|NCT01734785|365509606|FG001|Double-Blind Period|Protocol Violation|1|||
105958743|NCT01734785|365509607|FG002|Double-Blind Period|Protocol Violation|1|||
105958744|NCT01734785|365509608|FG003|Double-Blind Period|Protocol Violation|0|||
105958745|NCT01734785|365509605|FG000|Double-Blind Period|Lost to Follow-up|2|||
105958746|NCT01734785|365509606|FG001|Double-Blind Period|Lost to Follow-up|4|||
105958747|NCT01734785|365509607|FG002|Double-Blind Period|Lost to Follow-up|2|||
105958748|NCT01734785|365509608|FG003|Double-Blind Period|Lost to Follow-up|0|||
105958749|NCT01734785|365509605|FG000|Double-Blind Period|Withdrawal by Subject|2|||
105958750|NCT01734785|365509606|FG001|Double-Blind Period|Withdrawal by Subject|0|||
105958751|NCT01734785|365509607|FG002|Double-Blind Period|Withdrawal by Subject|0|||
105958752|NCT01734785|365509608|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105958753|NCT01734785|365509605|FG000|Double-Blind Period|Not treated|1|||
106020657|NCT01621802|365741389|FG005|Overall Study|Lost to Follow-up|11|||
106020658|NCT00950859|365741390|FG000|Overall Study|Adverse Event|3|||
106020659|NCT00950859|365741391|FG001|Overall Study|Adverse Event|3|||
106020660|NCT00950859|365741390|FG000|Overall Study|Insufficient Viral Load Response|12|||
106020661|NCT00950859|365741391|FG001|Overall Study|Insufficient Viral Load Response|3|||
106020662|NCT00950859|365741390|FG000|Overall Study|Protocol Violation|1|||
106020663|NCT00950859|365741391|FG001|Overall Study|Protocol Violation|1|||
106020664|NCT00950859|365741390|FG000|Overall Study|Lost to Follow-up|0|||
106020665|NCT00950859|365741391|FG001|Overall Study|Lost to Follow-up|3|||
106020666|NCT04896086|365741392|FG000|Overall Study|Lost to Follow-up|0|||
106020667|NCT04896086|365741393|FG001|Overall Study|Lost to Follow-up|2|||
106020668|NCT04896086|365741394|FG002|Overall Study|Lost to Follow-up|1|||
106020669|NCT04896086|365741395|FG003|Overall Study|Lost to Follow-up|0|||
106020670|NCT04896086|365741396|FG004|Overall Study|Lost to Follow-up|0|||
106020671|NCT04896086|365741392|FG000|Overall Study|Physician Decision|0|||
106020672|NCT04896086|365741393|FG001|Overall Study|Physician Decision|1|||
106020673|NCT04896086|365741394|FG002|Overall Study|Physician Decision|0|||
106020674|NCT04896086|365741395|FG003|Overall Study|Physician Decision|0|||
106020675|NCT04896086|365741396|FG004|Overall Study|Physician Decision|0|||
106020676|NCT04896086|365741392|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
106020677|NCT04896086|365741393|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
106020678|NCT04896086|365741394|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
106020679|NCT04896086|365741395|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
106020680|NCT04896086|365741396|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
106020681|NCT04896086|365741392|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
106020682|NCT04896086|365741393|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
106020683|NCT04896086|365741394|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
106020684|NCT04896086|365741395|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
106020685|NCT04896086|365741396|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
106020686|NCT00867815|365741405|FG000|Overall Study|Lost to Follow-up|1|||
106145795|NCT03593213|366194414|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
105767310|NCT03345342|364800450|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
105767311|NCT03345342|364800451|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
105767312|NCT03345342|364800452|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
105767313|NCT03345342|364800453|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
105767314|NCT03345342|364800449|FG000|Open-Label Phase|Lack of Efficacy|6|||
105767315|NCT03345342|364800450|FG001|Open-Label Phase|Lack of Efficacy|0|||
105767316|NCT03345342|364800451|FG002|Open-Label Phase|Lack of Efficacy|0|||
105767317|NCT03345342|364800452|FG003|Open-Label Phase|Lack of Efficacy|0|||
105767318|NCT03345342|364800453|FG004|Open-Label Phase|Lack of Efficacy|0|||
105767319|NCT03345342|364800449|FG000|Open-Label Phase|Lost to Follow-up|9|||
105767320|NCT03345342|364800450|FG001|Open-Label Phase|Lost to Follow-up|0|||
105767321|NCT03345342|364800451|FG002|Open-Label Phase|Lost to Follow-up|0|||
105767322|NCT03345342|364800452|FG003|Open-Label Phase|Lost to Follow-up|0|||
105767323|NCT03345342|364800453|FG004|Open-Label Phase|Lost to Follow-up|0|||
105767324|NCT03345342|364800449|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
105767325|NCT03345342|364800450|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
105767326|NCT03345342|364800451|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
105767327|NCT03345342|364800452|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
105767328|NCT03345342|364800453|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
105767329|NCT03345342|364800449|FG000|Open-Label Phase|Physician Decision|4|||
105767330|NCT03345342|364800450|FG001|Open-Label Phase|Physician Decision|0|||
105767331|NCT03345342|364800451|FG002|Open-Label Phase|Physician Decision|0|||
105767332|NCT03345342|364800452|FG003|Open-Label Phase|Physician Decision|0|||
105767333|NCT03345342|364800453|FG004|Open-Label Phase|Physician Decision|0|||
105767334|NCT03345342|364800449|FG000|Open-Label Phase|Protocol Violation|8|||
105767335|NCT03345342|364800450|FG001|Open-Label Phase|Protocol Violation|0|||
105767336|NCT03345342|364800451|FG002|Open-Label Phase|Protocol Violation|0|||
105767337|NCT03345342|364800452|FG003|Open-Label Phase|Protocol Violation|0|||
105767338|NCT03345342|364800453|FG004|Open-Label Phase|Protocol Violation|0|||
105767339|NCT03345342|364800449|FG000|Open-Label Phase|Withdrawal by Subject|57|||
105767340|NCT03345342|364800450|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105767341|NCT03345342|364800451|FG002|Open-Label Phase|Withdrawal by Subject|0|||
105767342|NCT03345342|364800452|FG003|Open-Label Phase|Withdrawal by Subject|0|||
105767343|NCT03345342|364800453|FG004|Open-Label Phase|Withdrawal by Subject|0|||
105767344|NCT03345342|364800449|FG000|Open-Label Phase|Other|15|||
105767345|NCT03345342|364800450|FG001|Open-Label Phase|Other|0|||
105767346|NCT03345342|364800451|FG002|Open-Label Phase|Other|0|||
105767347|NCT03345342|364800452|FG003|Open-Label Phase|Other|0|||
105822866|NCT03134222|365008857|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
106145796|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
105822867|NCT03134222|365008858|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
105822868|NCT03134222|365008859|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
105822869|NCT03134222|365008860|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
105822870|NCT03134222|365008861|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
105822871|NCT03134222|365008857|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
105822872|NCT03134222|365008858|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
105822873|NCT03134222|365008859|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
105822874|NCT03134222|365008860|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
105822875|NCT03134222|365008861|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
105958754|NCT01734785|365509606|FG001|Double-Blind Period|Not treated|0|||
105958755|NCT01734785|365509607|FG002|Double-Blind Period|Not treated|0|||
105958756|NCT01734785|365509608|FG003|Double-Blind Period|Not treated|0|||
105958757|NCT01645735|365509609|FG000|Overall Study|Physician Decision|2|||
105958758|NCT01645735|365509610|FG001|Overall Study|Physician Decision|0|||
105958759|NCT01645735|365509609|FG000|Overall Study|Withdrawal by Subject|1|||
105958760|NCT01645735|365509610|FG001|Overall Study|Withdrawal by Subject|0|||
105958761|NCT01645735|365509609|FG000|Overall Study|Protocol Violation|1|||
105958762|NCT01645735|365509610|FG001|Overall Study|Protocol Violation|0|||
105958763|NCT01645735|365509609|FG000|Overall Study|Adverse Event|0|||
105958764|NCT01645735|365509610|FG001|Overall Study|Adverse Event|1|||
105958765|NCT01524224|365509613|FG000|Overall Study|Progressive Disease|1|||
105958766|NCT01524224|365509614|FG001|Overall Study|Progressive Disease|0|||
105958767|NCT01524224|365509615|FG002|Overall Study|Progressive Disease|2|||
105958768|NCT01524224|365509616|FG003|Overall Study|Progressive Disease|1|||
105958769|NCT01524224|365509617|FG004|Overall Study|Progressive Disease|2|||
105958770|NCT01524224|365509618|FG005|Overall Study|Progressive Disease|1|||
105958771|NCT01524224|365509619|FG006|Overall Study|Progressive Disease|1|||
105958772|NCT01524224|365509620|FG007|Overall Study|Progressive Disease|5|||
105958773|NCT01524224|365509613|FG000|Overall Study|Withdrawal by Subject|2|||
105958774|NCT01524224|365509614|FG001|Overall Study|Withdrawal by Subject|0|||
105958775|NCT01524224|365509615|FG002|Overall Study|Withdrawal by Subject|0|||
105958776|NCT01524224|365509616|FG003|Overall Study|Withdrawal by Subject|0|||
105958777|NCT01524224|365509617|FG004|Overall Study|Withdrawal by Subject|0|||
106020687|NCT01499277|365741408|FG000|Overall Study|Adverse Event|3|||
106020688|NCT01499277|365741409|FG001|Overall Study|Adverse Event|6|||
106020689|NCT01499277|365741408|FG000|Overall Study|Death|3|||
106020690|NCT01499277|365741409|FG001|Overall Study|Death|2|||
106020691|NCT01499277|365741408|FG000|Overall Study|Lost to Follow-up|15|||
106020692|NCT01499277|365741409|FG001|Overall Study|Lost to Follow-up|8|||
106020693|NCT01499277|365741408|FG000|Overall Study|Protocol Violation|2|||
106020694|NCT01499277|365741409|FG001|Overall Study|Protocol Violation|3|||
106020695|NCT01499277|365741408|FG000|Overall Study|Withdrawal by Subject|16|||
106020696|NCT01499277|365741409|FG001|Overall Study|Withdrawal by Subject|6|||
106020697|NCT01499277|365741408|FG000|Overall Study|Lack of therapeutic response and other|8|||
106020698|NCT01499277|365741409|FG001|Overall Study|Lack of therapeutic response and other|7|||
106020699|NCT04881942|365741410|FG000|Overall Study|Adverse Event|0|||
106020700|NCT04881942|365741411|FG001|Overall Study|Adverse Event|0|||
106020701|NCT04881942|365741412|FG002|Overall Study|Adverse Event|0|||
106020702|NCT04881942|365741413|FG003|Overall Study|Adverse Event|0|||
106020703|NCT04881942|365741414|FG004|Overall Study|Adverse Event|1|||
106020704|NCT04881942|365741410|FG000|Overall Study|Alternates|0|||
106020705|NCT04881942|365741411|FG001|Overall Study|Alternates|0|||
106020706|NCT04881942|365741412|FG002|Overall Study|Alternates|0|||
106020707|NCT04881942|365741413|FG003|Overall Study|Alternates|0|||
106020708|NCT04881942|365741414|FG004|Overall Study|Alternates|2|||
106020709|NCT04023396|365741415|FG000|Overall Study|Adverse Event|16|||
106020710|NCT04023396|365741415|FG000|Overall Study|Death|1|||
106020711|NCT04023396|365741415|FG000|Overall Study|Lost to Follow-up|1|||
106020712|NCT04023396|365741415|FG000|Overall Study|Withdrawal by Subject|14|||
106020713|NCT04023396|365741415|FG000|Overall Study|Pregnancy|4|||
106020714|NCT04023396|365741415|FG000|Overall Study|Lack of Efficacy|3|||
106020715|NCT04023396|365741415|FG000|Overall Study|Physician Decision|4|||
106020716|NCT04023396|365741415|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
106020717|NCT04730271|365741416|FG000|Overall Study|Adverse Event|0|||
106020718|NCT04730271|365741417|FG001|Overall Study|Adverse Event|2|||
106020719|NCT04730271|365741416|FG000|Overall Study|Withdrawal by Subject|1|||
106020720|NCT04730271|365741417|FG001|Overall Study|Withdrawal by Subject|1|||
106020721|NCT04730271|365741416|FG000|Overall Study|Protocol Violation|7|||
105958778|NCT01524224|365509618|FG005|Overall Study|Withdrawal by Subject|0|||
105958779|NCT01524224|365509619|FG006|Overall Study|Withdrawal by Subject|2|||
105958780|NCT01524224|365509620|FG007|Overall Study|Withdrawal by Subject|0|||
105958781|NCT01524224|365509613|FG000|Overall Study|Adverse Event|0|||
105958782|NCT01524224|365509614|FG001|Overall Study|Adverse Event|1|||
105958783|NCT01524224|365509615|FG002|Overall Study|Adverse Event|0|||
106020722|NCT04730271|365741417|FG001|Overall Study|Protocol Violation|13|||
106020723|NCT04730271|365741416|FG000|Overall Study|Lost to Follow-up|3|||
106020724|NCT04730271|365741417|FG001|Overall Study|Lost to Follow-up|3|||
106020725|NCT04730271|365741416|FG000|Overall Study|Death|1|||
106145797|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
106145798|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
106145799|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
106145800|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
106145801|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
106145802|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
106145803|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
106145804|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
106145805|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
106145806|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
106145807|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
106145808|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
106145809|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
105958784|NCT01524224|365509616|FG003|Overall Study|Adverse Event|0|||
105958785|NCT01524224|365509617|FG004|Overall Study|Adverse Event|0|||
106145810|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
106145811|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
106145812|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
106145813|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
105767348|NCT03345342|364800453|FG004|Open-Label Phase|Other|0|||
105767349|NCT03345342|364800449|FG000|Double-Blind Phase|Adverse Event|0|||
105767350|NCT03345342|364800450|FG001|Double-Blind Phase|Adverse Event|1|||
105958786|NCT01524224|365509618|FG005|Overall Study|Adverse Event|1|||
105958787|NCT01524224|365509619|FG006|Overall Study|Adverse Event|0|||
105958788|NCT01524224|365509620|FG007|Overall Study|Adverse Event|0|||
105958789|NCT01524224|365509613|FG000|Overall Study|Physician Decision|0|||
105958790|NCT01524224|365509614|FG001|Overall Study|Physician Decision|0|||
105958791|NCT01524224|365509615|FG002|Overall Study|Physician Decision|0|||
105958792|NCT01524224|365509616|FG003|Overall Study|Physician Decision|1|||
105958793|NCT01524224|365509617|FG004|Overall Study|Physician Decision|1|||
105958794|NCT01524224|365509618|FG005|Overall Study|Physician Decision|0|||
105958795|NCT01524224|365509619|FG006|Overall Study|Physician Decision|0|||
105958796|NCT01524224|365509620|FG007|Overall Study|Physician Decision|1|||
105958797|NCT01524224|365509613|FG000|Overall Study|Sponsor Decision|0|||
106020726|NCT04730271|365741417|FG001|Overall Study|Death|0|||
105767351|NCT03345342|364800451|FG002|Double-Blind Phase|Adverse Event|6|||
105767352|NCT03345342|364800452|FG003|Double-Blind Phase|Adverse Event|0|||
105767353|NCT03345342|364800453|FG004|Double-Blind Phase|Adverse Event|0|||
105767354|NCT03345342|364800449|FG000|Double-Blind Phase|Death|0|||
105767355|NCT03345342|364800450|FG001|Double-Blind Phase|Death|2|||
105767356|NCT03345342|364800451|FG002|Double-Blind Phase|Death|1|||
105767357|NCT03345342|364800452|FG003|Double-Blind Phase|Death|0|||
105767358|NCT03345342|364800453|FG004|Double-Blind Phase|Death|0|||
105767359|NCT03345342|364800449|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
105767360|NCT03345342|364800450|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
105767361|NCT03345342|364800451|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
105767362|NCT03345342|364800452|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
105767363|NCT03345342|364800453|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
105767364|NCT03345342|364800449|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105767365|NCT03345342|364800450|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105767366|NCT03345342|364800451|FG002|Double-Blind Phase|Lost to Follow-up|7|||
105767367|NCT03345342|364800452|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105767368|NCT03345342|364800453|FG004|Double-Blind Phase|Lost to Follow-up|0|||
105767369|NCT03345342|364800449|FG000|Double-Blind Phase|Physician Decision|0|||
105767370|NCT03345342|364800450|FG001|Double-Blind Phase|Physician Decision|1|||
105767371|NCT03345342|364800451|FG002|Double-Blind Phase|Physician Decision|4|||
105767372|NCT03345342|364800452|FG003|Double-Blind Phase|Physician Decision|0|||
105767373|NCT03345342|364800453|FG004|Double-Blind Phase|Physician Decision|0|||
105767374|NCT03345342|364800449|FG000|Double-Blind Phase|Protocol Violation|0|||
105767375|NCT03345342|364800450|FG001|Double-Blind Phase|Protocol Violation|0|||
105767376|NCT03345342|364800451|FG002|Double-Blind Phase|Protocol Violation|1|||
105767377|NCT03345342|364800452|FG003|Double-Blind Phase|Protocol Violation|0|||
105767378|NCT03345342|364800453|FG004|Double-Blind Phase|Protocol Violation|0|||
105767379|NCT03345342|364800449|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
105767380|NCT03345342|364800450|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
105767381|NCT03345342|364800451|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
105767382|NCT03345342|364800452|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105767383|NCT03345342|364800453|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
105958798|NCT01524224|365509614|FG001|Overall Study|Sponsor Decision|0|||
105767384|NCT03345342|364800449|FG000|Double-Blind Phase|Other|0|||
105958799|NCT01524224|365509615|FG002|Overall Study|Sponsor Decision|0|||
105958800|NCT01524224|365509616|FG003|Overall Study|Sponsor Decision|0|||
105958801|NCT01524224|365509617|FG004|Overall Study|Sponsor Decision|1|||
105822876|NCT03134222|365008857|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
105822877|NCT03134222|365008858|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
105822878|NCT03134222|365008859|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
105822879|NCT03134222|365008860|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
105822880|NCT03134222|365008861|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
105822881|NCT03134222|365008857|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
105822882|NCT03134222|365008858|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
105822883|NCT03134222|365008859|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
105822884|NCT03134222|365008860|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
105822885|NCT03134222|365008861|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
105822886|NCT03134222|365008857|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
105822887|NCT03134222|365008858|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
105822888|NCT03134222|365008859|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
105822889|NCT03134222|365008860|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
105822890|NCT03134222|365008861|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
105822891|NCT00950989|365008862|FG000|Overall Study|Death|0|||
105822892|NCT00950989|365008863|FG001|Overall Study|Death|0|||
105822893|NCT00950989|365008864|FG002|Overall Study|Death|1|||
105822894|NCT00950989|365008865|FG003|Overall Study|Death|0|||
105958802|NCT01524224|365509618|FG005|Overall Study|Sponsor Decision|0|||
105958803|NCT01524224|365509619|FG006|Overall Study|Sponsor Decision|0|||
105958804|NCT01524224|365509620|FG007|Overall Study|Sponsor Decision|0|||
105958805|NCT02819297|365509623|FG000|Overall Study|Withdrawal by Subject|25|||
105958806|NCT02819297|365509624|FG001|Overall Study|Withdrawal by Subject|13|||
105958807|NCT02819297|365509623|FG000|Overall Study|Lost to Follow-up|12|||
105958808|NCT02819297|365509624|FG001|Overall Study|Lost to Follow-up|14|||
105958809|NCT02819297|365509623|FG000|Overall Study|Adverse Event|12|||
105958810|NCT02819297|365509624|FG001|Overall Study|Adverse Event|10|||
105958811|NCT02819297|365509623|FG000|Overall Study|Physician Decision|5|||
105958812|NCT02819297|365509624|FG001|Overall Study|Physician Decision|5|||
105958813|NCT02819297|365509623|FG000|Overall Study|Lack of Efficacy|5|||
105958814|NCT02819297|365509624|FG001|Overall Study|Lack of Efficacy|8|||
105958815|NCT02819297|365509623|FG000|Overall Study|Protocol Violation|1|||
105958816|NCT02819297|365509624|FG001|Overall Study|Protocol Violation|2|||
105958817|NCT03994211|365509625|FG000|Core Phase|Adverse Event|0|||
105958818|NCT03994211|365509626|FG001|Core Phase|Adverse Event|1|||
105958819|NCT03994211|365509627|FG002|Core Phase|Adverse Event|0|||
105958820|NCT03994211|365509625|FG000|Extension Phase|Adverse Event|0|||
105958821|NCT03994211|365509626|FG001|Extension Phase|Adverse Event|0|||
105958822|NCT03994211|365509627|FG002|Extension Phase|Adverse Event|1|||
105958823|NCT03994211|365509625|FG000|Extension Phase|Physician Decision|0|||
105958824|NCT03994211|365509626|FG001|Extension Phase|Physician Decision|0|||
105958825|NCT03994211|365509627|FG002|Extension Phase|Physician Decision|1|||
105958826|NCT03994211|365509625|FG000|Extension Phase|Progressive Disease|0|||
105958827|NCT03994211|365509626|FG001|Extension Phase|Progressive Disease|0|||
105958828|NCT03994211|365509627|FG002|Extension Phase|Progressive Disease|20|||
105958829|NCT03994211|365509625|FG000|Extension Phase|Withdrawal by Subject|0|||
105958830|NCT03994211|365509626|FG001|Extension Phase|Withdrawal by Subject|0|||
105958831|NCT03994211|365509627|FG002|Extension Phase|Withdrawal by Subject|2|||
105958832|NCT02201329|365509628|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
105958833|NCT02201329|365509628|FG000|Overall Study|Withdrawal by Subject|2|||
105958834|NCT01140867|365509629|FG000|Overall Study|Adverse Event|22|||
105958835|NCT01140867|365509629|FG000|Overall Study|Lack of Efficacy|3|||
105958836|NCT01140867|365509629|FG000|Overall Study|Lost to Follow-up|2|||
105958837|NCT01140867|365509629|FG000|Overall Study|Withdrawal by Subject|1|||
105958838|NCT01140867|365509629|FG000|Overall Study|Protocol Violation|1|||
105958839|NCT01140867|365509629|FG000|Overall Study|Uncooperative patient|2|||
105958840|NCT01140867|365509629|FG000|Overall Study|Medication Noncompliance|2|||
105822895|NCT00950989|365008862|FG000|Overall Study|Administrative Decision|0|||
105822896|NCT00950989|365008863|FG001|Overall Study|Administrative Decision|1|||
105822897|NCT00950989|365008864|FG002|Overall Study|Administrative Decision|0|||
105822898|NCT00950989|365008865|FG003|Overall Study|Administrative Decision|0|||
105822899|NCT00950989|365008862|FG000|Overall Study|Disease Progression|0|||
105822900|NCT00950989|365008863|FG001|Overall Study|Disease Progression|0|||
105822901|NCT00950989|365008864|FG002|Overall Study|Disease Progression|1|||
105958841|NCT00783835|365509630|FG000|Overall Study|Adverse Event|3|||
105958842|NCT00783835|365509630|FG000|Overall Study|Medical Criteria|1|||
105958843|NCT00783835|365509630|FG000|Overall Study|Withdrawal by Subject|2|||
105958844|NCT00783835|365509630|FG000|Overall Study|Lost to Follow-up|1|||
105958845|NCT00783835|365509630|FG000|Overall Study|Participant not Adherent|3|||
105958846|NCT00690430|365509634|FG000|Core Phase|Abnormal Laboratory value|0|||
105958847|NCT00690430|365509635|FG001|Core Phase|Abnormal Laboratory value|1|||
106020727|NCT02474069|365741420|FG000|Selection Phase (SP)|Adverse Event|8|||
105822902|NCT00950989|365008865|FG003|Overall Study|Disease Progression|0|||
105822903|NCT00950989|365008862|FG000|Overall Study|Withdrawal by Subject|2|||
105822904|NCT00950989|365008863|FG001|Overall Study|Withdrawal by Subject|1|||
105822905|NCT00950989|365008864|FG002|Overall Study|Withdrawal by Subject|0|||
105822906|NCT00950989|365008865|FG003|Overall Study|Withdrawal by Subject|0|||
105822907|NCT00950989|365008862|FG000|Overall Study|Adverse Event|2|||
105822908|NCT00950989|365008863|FG001|Overall Study|Adverse Event|1|||
105822909|NCT00950989|365008864|FG002|Overall Study|Adverse Event|1|||
105822910|NCT00950989|365008865|FG003|Overall Study|Adverse Event|0|||
105822911|NCT01841554|365008870|FG000|Overall Study|Death|7|||
105822912|NCT01841554|365008870|FG000|Overall Study|No Implantation|1|||
105822913|NCT01841554|365008870|FG000|Overall Study|Discontinued Follow Up|5|||
105822914|NCT01841554|365008870|FG000|Overall Study|Study exit due to secondary intervention|6|||
105822915|NCT03804983|365008874|FG000|Overall Study|Adverse Event|0|||
105822916|NCT03804983|365008875|FG001|Overall Study|Adverse Event|1|||
105822917|NCT03804983|365008874|FG000|Overall Study|Family Obligation|1|||
105822918|NCT03804983|365008875|FG001|Overall Study|Family Obligation|0|||
105822919|NCT02152163|365008876|FG000|Overall Study|Physician Decision|12|||
105822920|NCT02152163|365008877|FG001|Overall Study|Physician Decision|13|||
105822921|NCT03123471|365008880|FG000|Placebo-controlled Phase|Adverse Event|3|||
105822922|NCT03123471|365008881|FG001|Placebo-controlled Phase|Adverse Event|8|||
105822923|NCT03123471|365008880|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
105822924|NCT03123471|365008881|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
105822925|NCT03123471|365008880|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
105822926|NCT03123471|365008881|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
105822927|NCT03123471|365008880|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
105822928|NCT03123471|365008881|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
105958848|NCT00690430|365509636|FG002|Core Phase|Abnormal Laboratory value|0|||
105958849|NCT00690430|365509634|FG000|Core Phase|Adverse Event|5|||
105958850|NCT00690430|365509635|FG001|Core Phase|Adverse Event|1|||
105958851|NCT00690430|365509636|FG002|Core Phase|Adverse Event|0|||
105958852|NCT00690430|365509634|FG000|Core Phase|Death|0|||
105958853|NCT00690430|365509635|FG001|Core Phase|Death|2|||
105958854|NCT00690430|365509636|FG002|Core Phase|Death|0|||
105958855|NCT00690430|365509634|FG000|Core Phase|Protocol Violation|1|||
105958856|NCT00690430|365509635|FG001|Core Phase|Protocol Violation|0|||
105958857|NCT00690430|365509636|FG002|Core Phase|Protocol Violation|0|||
105958858|NCT00690430|365509634|FG000|Core Phase|Withdrawal by Subject|3|||
105958859|NCT00690430|365509635|FG001|Core Phase|Withdrawal by Subject|3|||
105958860|NCT00690430|365509636|FG002|Core Phase|Withdrawal by Subject|0|||
105958861|NCT00690430|365509634|FG000|Core Phase|Subject no longer requires study drug|1|||
105958862|NCT00690430|365509635|FG001|Core Phase|Subject no longer requires study drug|0|||
105958863|NCT00690430|365509636|FG002|Core Phase|Subject no longer requires study drug|0|||
105958864|NCT00690430|365509634|FG000|Core Phase|Lack of Efficacy|8|||
105958865|NCT00690430|365509635|FG001|Core Phase|Lack of Efficacy|10|||
105958866|NCT00690430|365509636|FG002|Core Phase|Lack of Efficacy|0|||
105958867|NCT00690430|365509634|FG000|Core Phase|Administrative Problems|0|||
105958868|NCT00690430|365509635|FG001|Core Phase|Administrative Problems|1|||
105958869|NCT00690430|365509636|FG002|Core Phase|Administrative Problems|0|||
105958870|NCT00690430|365509634|FG000|Core Phase|Early Termination|0|||
105958871|NCT00690430|365509635|FG001|Core Phase|Early Termination|5|||
105958872|NCT00690430|365509636|FG002|Core Phase|Early Termination|0|||
105958873|NCT00690430|365509634|FG000|Extension Phase|Lack of Efficacy|3|||
105958874|NCT00690430|365509635|FG001|Extension Phase|Lack of Efficacy|1|||
105958875|NCT00690430|365509636|FG002|Extension Phase|Lack of Efficacy|4|||
105958876|NCT00690430|365509634|FG000|Extension Phase|Abnormal Lab Values|1|||
105958877|NCT00690430|365509635|FG001|Extension Phase|Abnormal Lab Values|0|||
105958878|NCT00690430|365509636|FG002|Extension Phase|Abnormal Lab Values|0|||
105958879|NCT00690430|365509634|FG000|Extension Phase|Abnormal test procedure results|1|||
105958880|NCT00690430|365509635|FG001|Extension Phase|Abnormal test procedure results|0|||
105958881|NCT00690430|365509636|FG002|Extension Phase|Abnormal test procedure results|0|||
105958882|NCT00690430|365509634|FG000|Extension Phase|Administrative Problems|0|||
105958883|NCT00690430|365509635|FG001|Extension Phase|Administrative Problems|1|||
105958884|NCT00690430|365509636|FG002|Extension Phase|Administrative Problems|1|||
105958885|NCT00690430|365509634|FG000|Extension Phase|Adverse Event|2|||
105958886|NCT00690430|365509635|FG001|Extension Phase|Adverse Event|1|||
105958887|NCT00690430|365509636|FG002|Extension Phase|Adverse Event|2|||
105958888|NCT00690430|365509634|FG000|Extension Phase|Death|1|||
105958889|NCT00690430|365509635|FG001|Extension Phase|Death|1|||
105958890|NCT00690430|365509636|FG002|Extension Phase|Death|1|||
106145814|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
105958891|NCT00690430|365509634|FG000|Extension Phase|Withdrawal by Subject|0|||
105822929|NCT03123471|365008880|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
105822930|NCT03123471|365008881|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
105822931|NCT03123471|365008880|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
105822932|NCT03123471|365008881|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
105958892|NCT00690430|365509635|FG001|Extension Phase|Withdrawal by Subject|0|||
105958893|NCT00690430|365509636|FG002|Extension Phase|Withdrawal by Subject|2|||
106145815|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
105822933|NCT03123471|365008880|FG000|Placebo-controlled Phase|Miscellaneous|0|||
105822934|NCT03123471|365008881|FG001|Placebo-controlled Phase|Miscellaneous|1|||
105822935|NCT03123471|365008880|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
105822936|NCT03123471|365008881|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
105822937|NCT03123471|365008880|FG000|Apremilast Extension Phase|Adverse Event|1|||
105822938|NCT03123471|365008881|FG001|Apremilast Extension Phase|Adverse Event|5|||
105822939|NCT03123471|365008880|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
105822940|NCT03123471|365008881|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
105822941|NCT03123471|365008880|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
105822942|NCT03123471|365008881|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
105822943|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
105822944|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
105822945|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
105822946|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
105822947|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
105822948|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
105822949|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
105822950|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
105822951|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
106020728|NCT02474069|365741421|FG001|Selection Phase (SP)|Adverse Event|0|||
106020729|NCT02474069|365741422|FG002|Selection Phase (SP)|Adverse Event|0|||
106020730|NCT02474069|365741420|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
106020731|NCT02474069|365741421|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
106020732|NCT02474069|365741422|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
106020733|NCT02474069|365741420|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
106020734|NCT02474069|365741421|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
106020735|NCT02474069|365741422|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
106020736|NCT02474069|365741420|FG000|Selection Phase (SP)|Physician Decision|1|||
106020737|NCT02474069|365741421|FG001|Selection Phase (SP)|Physician Decision|0|||
106020738|NCT02474069|365741422|FG002|Selection Phase (SP)|Physician Decision|0|||
106020739|NCT02474069|365741420|FG000|Selection Phase (SP)|Protocol Violation|1|||
106020740|NCT02474069|365741421|FG001|Selection Phase (SP)|Protocol Violation|0|||
106020741|NCT02474069|365741422|FG002|Selection Phase (SP)|Protocol Violation|0|||
106020742|NCT02474069|365741420|FG000|Selection Phase (SP)|No longer requires treatment|1|||
106020743|NCT02474069|365741421|FG001|Selection Phase (SP)|No longer requires treatment|0|||
106020744|NCT02474069|365741422|FG002|Selection Phase (SP)|No longer requires treatment|0|||
106020745|NCT02474069|365741420|FG000|Selection Phase (SP)|Technical Problem|1|||
106020746|NCT02474069|365741421|FG001|Selection Phase (SP)|Technical Problem|0|||
106020747|NCT02474069|365741422|FG002|Selection Phase (SP)|Technical Problem|0|||
106020748|NCT02474069|365741420|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
106020749|NCT02474069|365741421|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
106020750|NCT02474069|365741422|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
106020751|NCT02474069|365741420|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
106020752|NCT02474069|365741421|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
106020753|NCT02474069|365741422|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
106020754|NCT02474069|365741420|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
106020755|NCT02474069|365741421|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
106020756|NCT02474069|365741422|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
106020757|NCT02474069|365741420|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
106020758|NCT02474069|365741421|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
106020759|NCT02474069|365741422|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
106020760|NCT02474069|365741420|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
106020761|NCT02474069|365741421|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
106020762|NCT02474069|365741422|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
106020763|NCT02474069|365741420|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
106020764|NCT02474069|365741421|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
106020765|NCT02474069|365741422|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
106020766|NCT01623050|365741425|FG000|Overall Study|Lost to Follow-up|9|||
106020767|NCT00953056|365741429|FG000|Overall Study|Withdrew Consent|0|||
106020768|NCT00953056|365741430|FG001|Overall Study|Withdrew Consent|0|||
106020769|NCT00953056|365741431|FG002|Overall Study|Withdrew Consent|0|||
106020770|NCT00953056|365741432|FG003|Overall Study|Withdrew Consent|0|||
106020771|NCT00953056|365741433|FG004|Overall Study|Withdrew Consent|2|||
106020772|NCT00953056|365741434|FG005|Overall Study|Withdrew Consent|3|||
106020773|NCT00953056|365741429|FG000|Overall Study|Serious Adverse Event|0|||
106020774|NCT00953056|365741430|FG001|Overall Study|Serious Adverse Event|0|||
106020775|NCT00953056|365741431|FG002|Overall Study|Serious Adverse Event|0|||
106020776|NCT00953056|365741432|FG003|Overall Study|Serious Adverse Event|0|||
106020777|NCT00953056|365741433|FG004|Overall Study|Serious Adverse Event|0|||
106020778|NCT00953056|365741434|FG005|Overall Study|Serious Adverse Event|1|||
105822952|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
105822953|NCT00424047|365008882|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
106020779|NCT01598506|365741435|FG000|Overall Study|Withdrawal by Subject|2|||
106020780|NCT00035932|365741440|FG000|Overall Study|Adverse Event|10|||
105958894|NCT00690430|365509634|FG000|Extension Phase|Early Termination|10|||
105958895|NCT00690430|365509635|FG001|Extension Phase|Early Termination|1|||
105958896|NCT00690430|365509636|FG002|Extension Phase|Early Termination|3|||
105958897|NCT00763256|365509637|FG000|Overall Study|Didn't return for appointments|7|||
105958898|NCT00763256|365509638|FG001|Overall Study|Didn't return for appointments|10|||
105958899|NCT02544750|365509640|FG000|Overall Study|Physician Decision|3|||
105958900|NCT02544750|365509641|FG001|Overall Study|Physician Decision|1|||
106020781|NCT00035932|365741441|FG001|Overall Study|Adverse Event|9|||
106020782|NCT00035932|365741442|FG002|Overall Study|Adverse Event|9|||
106020783|NCT00035932|365741440|FG000|Overall Study|Death|0|||
106020784|NCT00035932|365741441|FG001|Overall Study|Death|0|||
106020785|NCT00035932|365741442|FG002|Overall Study|Death|1|||
106020786|NCT00035932|365741440|FG000|Overall Study|Disease Progression / Relapse|1|||
106020787|NCT00035932|365741441|FG001|Overall Study|Disease Progression / Relapse|1|||
106020788|NCT00035932|365741442|FG002|Overall Study|Disease Progression / Relapse|0|||
106020789|NCT00035932|365741440|FG000|Overall Study|Lost to Follow-up|4|||
106020790|NCT00035932|365741441|FG001|Overall Study|Lost to Follow-up|4|||
106020791|NCT00035932|365741442|FG002|Overall Study|Lost to Follow-up|3|||
106020792|NCT00035932|365741440|FG000|Overall Study|Noncompliance|6|||
106020793|NCT00035932|365741441|FG001|Overall Study|Noncompliance|7|||
106020794|NCT00035932|365741442|FG002|Overall Study|Noncompliance|6|||
106020795|NCT00035932|365741440|FG000|Overall Study|Protocol Violation While on Study|0|||
106020796|NCT00035932|365741441|FG001|Overall Study|Protocol Violation While on Study|1|||
106020797|NCT00035932|365741442|FG002|Overall Study|Protocol Violation While on Study|2|||
106020798|NCT00035932|365741440|FG000|Overall Study|Withdrawal by Subject|1|||
106020799|NCT00035932|365741441|FG001|Overall Study|Withdrawal by Subject|5|||
106020800|NCT00035932|365741442|FG002|Overall Study|Withdrawal by Subject|0|||
106020801|NCT00035932|365741440|FG000|Overall Study|Study Termination by Sponsor|1|||
106020802|NCT00035932|365741441|FG001|Overall Study|Study Termination by Sponsor|0|||
106020803|NCT00035932|365741442|FG002|Overall Study|Study Termination by Sponsor|0|||
106020804|NCT00035932|365741440|FG000|Overall Study|Lack of Efficacy|33|||
106020805|NCT00035932|365741441|FG001|Overall Study|Lack of Efficacy|33|||
106020806|NCT00035932|365741442|FG002|Overall Study|Lack of Efficacy|28|||
106020807|NCT01976741|365741443|FG000|Overall Study|Withdrawal by Subject|1|||
106020808|NCT01976741|365741444|FG001|Overall Study|Withdrawal by Subject|0|||
105958901|NCT02544750|365509640|FG000|Overall Study|Other reasons|69|||
105958902|NCT02544750|365509641|FG001|Overall Study|Other reasons|39|||
105958903|NCT02544750|365509640|FG000|Overall Study|Met withdrawal criteria|2|||
105958904|NCT02544750|365509641|FG001|Overall Study|Met withdrawal criteria|2|||
105958905|NCT02544750|365509640|FG000|Overall Study|Transition To Commercial Product|1|||
105958906|NCT02544750|365509641|FG001|Overall Study|Transition To Commercial Product|0|||
105958907|NCT02544750|365509640|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
105958908|NCT02544750|365509641|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
105958909|NCT02544750|365509640|FG000|Overall Study|Adverse Event|8|||
105958910|NCT02544750|365509641|FG001|Overall Study|Adverse Event|10|||
105958911|NCT02544750|365509640|FG000|Overall Study|Withdrawal by Subject|10|||
105958912|NCT02544750|365509641|FG001|Overall Study|Withdrawal by Subject|4|||
105958913|NCT02544750|365509640|FG000|Overall Study|Lost to Follow-up|1|||
105958914|NCT02544750|365509641|FG001|Overall Study|Lost to Follow-up|0|||
105958915|NCT02125838|365509642|FG000|Overall Study|Lost to Follow-up|4|||
105958916|NCT02125838|365509643|FG001|Overall Study|Lost to Follow-up|4|||
105958917|NCT00244725|365509649|FG000|Overall Study|Lost to Follow-up|3|||
105958918|NCT00244725|365509650|FG001|Overall Study|Lost to Follow-up|4|||
106020809|NCT01976741|365741445|FG002|Overall Study|Withdrawal by Subject|1|||
106020810|NCT01976741|365741446|FG003|Overall Study|Withdrawal by Subject|1|||
105767385|NCT03345342|364800450|FG001|Double-Blind Phase|Other|1|||
105767386|NCT03345342|364800451|FG002|Double-Blind Phase|Other|3|||
105767387|NCT03345342|364800452|FG003|Double-Blind Phase|Other|0|||
105767388|NCT03345342|364800453|FG004|Double-Blind Phase|Other|0|||
105767389|NCT03345342|364800449|FG000|Follow-Up Phase|Adverse Event|0|||
105767390|NCT03345342|364800450|FG001|Follow-Up Phase|Adverse Event|0|||
105767391|NCT03345342|364800451|FG002|Follow-Up Phase|Adverse Event|0|||
105767392|NCT03345342|364800452|FG003|Follow-Up Phase|Adverse Event|0|||
105767393|NCT03345342|364800453|FG004|Follow-Up Phase|Adverse Event|4|||
105767394|NCT03345342|364800449|FG000|Follow-Up Phase|Lost to Follow-up|0|||
106020811|NCT01976741|365741447|FG004|Overall Study|Withdrawal by Subject|0|||
105767395|NCT03345342|364800450|FG001|Follow-Up Phase|Lost to Follow-up|0|||
105958919|NCT00244725|365509651|FG002|Overall Study|Lost to Follow-up|9|||
105767396|NCT03345342|364800451|FG002|Follow-Up Phase|Lost to Follow-up|0|||
105767397|NCT03345342|364800452|FG003|Follow-Up Phase|Lost to Follow-up|0|||
105958920|NCT00244725|365509652|FG003|Overall Study|Lost to Follow-up|2|||
105958921|NCT00244725|365509649|FG000|Overall Study|Withdrawal by Subject|9|||
105958922|NCT00244725|365509650|FG001|Overall Study|Withdrawal by Subject|7|||
105767398|NCT03345342|364800453|FG004|Follow-Up Phase|Lost to Follow-up|6|||
105958923|NCT00244725|365509651|FG002|Overall Study|Withdrawal by Subject|7|||
106020812|NCT01976741|365741448|FG005|Overall Study|Withdrawal by Subject|0|||
106020813|NCT01976741|365741449|FG006|Overall Study|Withdrawal by Subject|1|||
106020814|NCT01976741|365741450|FG007|Overall Study|Withdrawal by Subject|4|||
106020815|NCT01976741|365741451|FG008|Overall Study|Withdrawal by Subject|0|||
106020816|NCT01976741|365741452|FG009|Overall Study|Withdrawal by Subject|0|||
106020817|NCT01976741|365741443|FG000|Overall Study|Adverse Event|0|||
106020818|NCT01976741|365741444|FG001|Overall Study|Adverse Event|0|||
106020819|NCT01976741|365741445|FG002|Overall Study|Adverse Event|2|||
106020820|NCT01976741|365741446|FG003|Overall Study|Adverse Event|0|||
106020821|NCT01976741|365741447|FG004|Overall Study|Adverse Event|0|||
106020822|NCT01976741|365741448|FG005|Overall Study|Adverse Event|0|||
106020823|NCT01976741|365741449|FG006|Overall Study|Adverse Event|3|||
106020824|NCT01976741|365741450|FG007|Overall Study|Adverse Event|8|||
106020825|NCT01976741|365741451|FG008|Overall Study|Adverse Event|1|||
106020826|NCT01976741|365741452|FG009|Overall Study|Adverse Event|4|||
106020827|NCT00670306|365741457|FG000|Overall Study|Adverse Event|8|||
106020828|NCT00670306|365741457|FG000|Overall Study|Lack of Efficacy|10|||
106020829|NCT00670306|365741457|FG000|Overall Study|Withdrawal by Subject|9|||
106020830|NCT00670306|365741457|FG000|Overall Study|Physician Decision|1|||
106020831|NCT00670306|365741457|FG000|Overall Study|Lost to Follow-up|8|||
106020832|NCT00670306|365741457|FG000|Overall Study|incl/excl criterias did not meet|19|||
106020833|NCT02637037|365741461|FG000|Overall Study|Positive drug screen at admission|1|||
106020834|NCT02637037|365741462|FG001|Overall Study|Positive drug screen at admission|0|||
106020835|NCT02637037|365741461|FG000|Overall Study|Withdrawal by Subject|2|||
106020836|NCT02637037|365741462|FG001|Overall Study|Withdrawal by Subject|1|||
106020837|NCT02637037|365741461|FG000|Overall Study|Adverse Event|1|||
106020838|NCT02637037|365741462|FG001|Overall Study|Adverse Event|0|||
106020839|NCT03339219|365741463|FG000|Overall Study|Death|12|||
106020840|NCT03339219|365741463|FG000|Overall Study|Site Terminated by Sponsor|22|||
106020841|NCT03339219|365741463|FG000|Overall Study|Withdrawal by Subject|1|||
106020842|NCT02067676|365741464|FG000|Overall Study|Withdrawal by Subject|1|||
106020843|NCT02067676|365741465|FG001|Overall Study|Withdrawal by Subject|0|||
105822954|NCT00424047|365008883|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
105822955|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Adverse Event|22|||
105822956|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Adverse Event|12|||
105822957|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Progression of disease|92|||
105822958|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Progression of disease|128|||
105822959|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
105822960|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
105822961|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
105822962|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
105822963|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Death|11|||
105822964|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Death|11|||
105822965|NCT00424047|365008882|FG000|On Study at Time of Unblinding|Other|5|||
105822966|NCT00424047|365008883|FG001|On Study at Time of Unblinding|Other|4|||
105822967|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
105822968|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
105822969|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
105822970|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
105822971|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
105822972|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
105822973|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
105822974|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
105822975|NCT00424047|365008882|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
105822976|NCT00424047|365008883|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
105822977|NCT00312897|365008884|FG000|Overall Study|Adverse Event|1|||
105822978|NCT00312897|365008885|FG001|Overall Study|Adverse Event|0|||
105822979|NCT00312897|365008884|FG000|Overall Study|Lost to Follow-up|2|||
105822980|NCT00312897|365008885|FG001|Overall Study|Lost to Follow-up|0|||
105822981|NCT00312897|365008884|FG000|Overall Study|Physician Decision|1|||
105822982|NCT00312897|365008885|FG001|Overall Study|Physician Decision|0|||
105822983|NCT00312897|365008884|FG000|Overall Study|Withdrawal by Subject|1|||
105822984|NCT00312897|365008885|FG001|Overall Study|Withdrawal by Subject|3|||
105822985|NCT00312897|365008884|FG000|Overall Study|Pregnancy|1|||
105822986|NCT00312897|365008885|FG001|Overall Study|Pregnancy|0|||
106020844|NCT02067676|365741466|FG002|Overall Study|Withdrawal by Subject|0|||
106020845|NCT02067676|365741467|FG003|Overall Study|Withdrawal by Subject|0|||
106020846|NCT02067676|365741468|FG004|Overall Study|Withdrawal by Subject|0|||
105822987|NCT00312897|365008884|FG000|Overall Study|discontinued prior to getting treatment|0|||
105822988|NCT00312897|365008885|FG001|Overall Study|discontinued prior to getting treatment|3|||
105822989|NCT01473953|365008888|FG000|Overall Study|Other|1|||
106020847|NCT02067676|365741469|FG005|Overall Study|Withdrawal by Subject|0|||
106020848|NCT00476229|365741472|FG000|Overall Study|Progressive shortness of breath|1|||
106020849|NCT00845897|365741473|FG000|Overall Study|Lost to Follow-up|1|||
106020850|NCT00845897|365741474|FG001|Overall Study|Lost to Follow-up|1|||
106020851|NCT00845897|365741475|FG002|Overall Study|Lost to Follow-up|0|||
106020852|NCT00845897|365741473|FG000|Overall Study|Withdrawal by Subject|0|||
106020853|NCT00845897|365741474|FG001|Overall Study|Withdrawal by Subject|3|||
106020854|NCT00845897|365741475|FG002|Overall Study|Withdrawal by Subject|2|||
106020855|NCT00845897|365741473|FG000|Overall Study|Ulcer did not heal|1|||
106020856|NCT00845897|365741474|FG001|Overall Study|Ulcer did not heal|0|||
106020857|NCT00845897|365741475|FG002|Overall Study|Ulcer did not heal|1|||
106020858|NCT00845897|365741473|FG000|Overall Study|Too ill to participate|0|||
106020859|NCT00845897|365741474|FG001|Overall Study|Too ill to participate|1|||
106020860|NCT00845897|365741475|FG002|Overall Study|Too ill to participate|0|||
106020861|NCT02164461|365741476|FG000|Overall Study|Adverse Event|0|||
106020862|NCT02164461|365741477|FG001|Overall Study|Adverse Event|0|||
106020863|NCT02164461|365741478|FG002|Overall Study|Adverse Event|1|||
106020864|NCT02164461|365741476|FG000|Overall Study|Disease Progression|1|||
106020865|NCT02164461|365741477|FG001|Overall Study|Disease Progression|3|||
106020866|NCT02164461|365741478|FG002|Overall Study|Disease Progression|4|||
106020867|NCT02164461|365741476|FG000|Overall Study|Withdrawal by Subject|0|||
106020868|NCT02164461|365741477|FG001|Overall Study|Withdrawal by Subject|3|||
106020869|NCT02164461|365741478|FG002|Overall Study|Withdrawal by Subject|0|||
106020870|NCT03904693|365741479|FG000|Overall Study|Death|0|||
106020871|NCT03904693|365741480|FG001|Overall Study|Death|0|||
106020872|NCT03904693|365741481|FG002|Overall Study|Death|3|||
106020873|NCT03904693|365741479|FG000|Overall Study|Physician Decision|0|||
106020874|NCT03904693|365741480|FG001|Overall Study|Physician Decision|0|||
106020875|NCT03904693|365741481|FG002|Overall Study|Physician Decision|2|||
106020876|NCT03904693|365741479|FG000|Overall Study|Withdrawal by Subject|0|||
106020877|NCT03904693|365741480|FG001|Overall Study|Withdrawal by Subject|1|||
105822990|NCT01473953|365008889|FG001|Overall Study|Other|0|||
105822991|NCT01473953|365008890|FG002|Overall Study|Other|0|||
105822992|NCT01473953|365008891|FG003|Overall Study|Other|0|||
105822993|NCT01473953|365008892|FG004|Overall Study|Other|0|||
105822994|NCT01279486|365008893|FG000|Overall Study|Lost to Follow-up|1|||
106020878|NCT03904693|365741481|FG002|Overall Study|Withdrawal by Subject|4|||
106020879|NCT01932437|365741482|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
106020880|NCT01932437|365741483|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
106020881|NCT01932437|365741484|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
106020882|NCT01932437|365741485|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
106020883|NCT01932437|365741486|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
106020884|NCT01932437|365741487|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
106020885|NCT02100696|365741488|FG000|Induction Phase|Adverse Event|0|||
106020886|NCT02100696|365741489|FG001|Induction Phase|Adverse Event|0|||
106020887|NCT02100696|365741490|FG002|Induction Phase|Adverse Event|1|||
106020888|NCT02100696|365741491|FG003|Induction Phase|Adverse Event|0|||
106020889|NCT02100696|365741492|FG004|Induction Phase|Adverse Event|0|||
106020890|NCT02100696|365741493|FG005|Induction Phase|Adverse Event|0|||
106020891|NCT02100696|365741488|FG000|Induction Phase|Lost to Follow-up|1|||
106020892|NCT02100696|365741489|FG001|Induction Phase|Lost to Follow-up|0|||
106020893|NCT02100696|365741490|FG002|Induction Phase|Lost to Follow-up|1|||
106020894|NCT02100696|365741491|FG003|Induction Phase|Lost to Follow-up|0|||
106020895|NCT02100696|365741492|FG004|Induction Phase|Lost to Follow-up|0|||
106020896|NCT02100696|365741493|FG005|Induction Phase|Lost to Follow-up|0|||
106020897|NCT02100696|365741488|FG000|Induction Phase|Protocol Violation|0|||
106020898|NCT02100696|365741489|FG001|Induction Phase|Protocol Violation|1|||
106020899|NCT02100696|365741490|FG002|Induction Phase|Protocol Violation|1|||
106020900|NCT02100696|365741491|FG003|Induction Phase|Protocol Violation|0|||
106020901|NCT02100696|365741492|FG004|Induction Phase|Protocol Violation|0|||
106020902|NCT02100696|365741493|FG005|Induction Phase|Protocol Violation|0|||
106020903|NCT02100696|365741488|FG000|Induction Phase|Withdrawal by Subject|8|||
106020904|NCT02100696|365741489|FG001|Induction Phase|Withdrawal by Subject|2|||
106020905|NCT02100696|365741490|FG002|Induction Phase|Withdrawal by Subject|13|||
105822995|NCT01404988|365008900|FG000|Overall Study|Death|2|||
105822996|NCT01404988|365008901|FG001|Overall Study|Death|0|||
105822997|NCT01404988|365008902|FG002|Overall Study|Death|2|||
106020906|NCT02100696|365741491|FG003|Induction Phase|Withdrawal by Subject|0|||
106020907|NCT02100696|365741492|FG004|Induction Phase|Withdrawal by Subject|0|||
106020908|NCT02100696|365741493|FG005|Induction Phase|Withdrawal by Subject|0|||
106020909|NCT02100696|365741488|FG000|Induction Phase|Physician Decision|1|||
106020910|NCT02100696|365741489|FG001|Induction Phase|Physician Decision|0|||
106020911|NCT02100696|365741490|FG002|Induction Phase|Physician Decision|2|||
105822998|NCT01404988|365008900|FG000|Overall Study|Adverse Event|1|||
106145816|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
106020912|NCT02100696|365741491|FG003|Induction Phase|Physician Decision|0|||
106020913|NCT02100696|365741492|FG004|Induction Phase|Physician Decision|0|||
105822999|NCT01404988|365008901|FG001|Overall Study|Adverse Event|0|||
105823000|NCT01404988|365008902|FG002|Overall Study|Adverse Event|0|||
106020914|NCT02100696|365741493|FG005|Induction Phase|Physician Decision|0|||
106145817|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
106020915|NCT02100696|365741488|FG000|Induction Phase|Multiple Reasons|5|||
105958924|NCT00244725|365509652|FG003|Overall Study|Withdrawal by Subject|8|||
105958925|NCT00244725|365509649|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
105958926|NCT00244725|365509650|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
105958927|NCT00244725|365509651|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
105958928|NCT00244725|365509652|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
105958929|NCT00244725|365509649|FG000|Overall Study|Physician Decision|3|||
105958930|NCT00244725|365509650|FG001|Overall Study|Physician Decision|0|||
105958931|NCT00244725|365509651|FG002|Overall Study|Physician Decision|1|||
105958932|NCT00244725|365509652|FG003|Overall Study|Physician Decision|2|||
105958933|NCT00244725|365509649|FG000|Overall Study|Adverse Events|3|||
105958934|NCT00244725|365509650|FG001|Overall Study|Adverse Events|1|||
105958935|NCT00244725|365509651|FG002|Overall Study|Adverse Events|4|||
105958936|NCT00244725|365509652|FG003|Overall Study|Adverse Events|4|||
105958937|NCT00244725|365509649|FG000|Overall Study|Withdrwal by participant|1|||
105958938|NCT00244725|365509650|FG001|Overall Study|Withdrwal by participant|0|||
105958939|NCT00244725|365509651|FG002|Overall Study|Withdrwal by participant|0|||
105958940|NCT00244725|365509652|FG003|Overall Study|Withdrwal by participant|1|||
105958941|NCT00244725|365509649|FG000|Overall Study|Liver function test abnormality|2|||
105958942|NCT00244725|365509650|FG001|Overall Study|Liver function test abnormality|0|||
105958943|NCT00244725|365509651|FG002|Overall Study|Liver function test abnormality|0|||
105958944|NCT00244725|365509652|FG003|Overall Study|Liver function test abnormality|1|||
105958945|NCT00244725|365509649|FG000|Overall Study|Sponsor withdrew the participant|1|||
105958946|NCT00244725|365509650|FG001|Overall Study|Sponsor withdrew the participant|0|||
105958947|NCT00244725|365509651|FG002|Overall Study|Sponsor withdrew the participant|0|||
105958948|NCT00244725|365509652|FG003|Overall Study|Sponsor withdrew the participant|1|||
105958949|NCT00244725|365509649|FG000|Overall Study|Mediciation Error|0|||
105958950|NCT00244725|365509650|FG001|Overall Study|Mediciation Error|1|||
105958951|NCT00244725|365509651|FG002|Overall Study|Mediciation Error|0|||
105958952|NCT00244725|365509652|FG003|Overall Study|Mediciation Error|0|||
105958953|NCT00244725|365509649|FG000|Overall Study|Rehab Refused to allow participantion|0|||
105958954|NCT00244725|365509650|FG001|Overall Study|Rehab Refused to allow participantion|1|||
105958955|NCT00244725|365509651|FG002|Overall Study|Rehab Refused to allow participantion|0|||
105958956|NCT00244725|365509652|FG003|Overall Study|Rehab Refused to allow participantion|0|||
105958957|NCT00244725|365509649|FG000|Overall Study|Headache|0|||
105958958|NCT00244725|365509650|FG001|Overall Study|Headache|1|||
105958959|NCT00244725|365509651|FG002|Overall Study|Headache|0|||
105958960|NCT00244725|365509652|FG003|Overall Study|Headache|0|||
105958961|NCT00244725|365509649|FG000|Overall Study|Received prohibited medication|0|||
105958962|NCT00244725|365509650|FG001|Overall Study|Received prohibited medication|1|||
105958963|NCT00244725|365509651|FG002|Overall Study|Received prohibited medication|0|||
105958964|NCT00244725|365509652|FG003|Overall Study|Received prohibited medication|1|||
105958965|NCT00244725|365509649|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
105958966|NCT00244725|365509650|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
105958967|NCT00244725|365509651|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
105958968|NCT00244725|365509652|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
105958969|NCT00244725|365509649|FG000|Overall Study|Administrative reason|0|||
105958970|NCT00244725|365509650|FG001|Overall Study|Administrative reason|0|||
105958971|NCT00244725|365509651|FG002|Overall Study|Administrative reason|1|||
105958972|NCT00244725|365509652|FG003|Overall Study|Administrative reason|0|||
105958973|NCT00244725|365509649|FG000|Overall Study|Vomit|0|||
105958974|NCT00244725|365509650|FG001|Overall Study|Vomit|0|||
105958975|NCT00244725|365509651|FG002|Overall Study|Vomit|1|||
105958976|NCT00244725|365509652|FG003|Overall Study|Vomit|0|||
105958977|NCT00244725|365509649|FG000|Overall Study|Failed to follow-up|0|||
105958978|NCT00244725|365509650|FG001|Overall Study|Failed to follow-up|0|||
105958979|NCT00244725|365509651|FG002|Overall Study|Failed to follow-up|1|||
105958980|NCT00244725|365509652|FG003|Overall Study|Failed to follow-up|1|||
105958981|NCT03472495|365509653|FG000|Overall Study|Treatment no longer indicated|1|||
105958982|NCT03472495|365509654|FG001|Overall Study|Treatment no longer indicated|2|||
105958983|NCT03472495|365509653|FG000|Overall Study|Physician Decision|0|||
105958984|NCT03472495|365509654|FG001|Overall Study|Physician Decision|2|||
105958985|NCT01144416|365509655|FG000|Intervention Period|Adverse Event|5|||
105958986|NCT01144416|365509656|FG001|Intervention Period|Adverse Event|6|||
105958987|NCT01144416|365509655|FG000|Intervention Period|Insufficient ovarian response|11|||
105958988|NCT01144416|365509656|FG001|Intervention Period|Insufficient ovarian response|17|||
105958989|NCT01144416|365509655|FG000|Intervention Period|Risk of OHSS|0|||
105958990|NCT01144416|365509656|FG001|Intervention Period|Risk of OHSS|1|||
105958991|NCT01144416|365509655|FG000|Intervention Period|Too high ovarian response|4|||
105958992|NCT01144416|365509656|FG001|Intervention Period|Too high ovarian response|2|||
106020916|NCT02100696|365741489|FG001|Induction Phase|Multiple Reasons|2|||
105958993|NCT01144416|365509655|FG000|Intervention Period|No/too few/bad oocytes|7|||
105958994|NCT01144416|365509656|FG001|Intervention Period|No/too few/bad oocytes|5|||
105958995|NCT01144416|365509655|FG000|Intervention Period|No or abnormal fertilization|25|||
105958996|NCT01144416|365509656|FG001|Intervention Period|No or abnormal fertilization|10|||
106020917|NCT02100696|365741490|FG002|Induction Phase|Multiple Reasons|8|||
105767399|NCT03345342|364800449|FG000|Follow-Up Phase|Physician Decision|0|||
105767400|NCT03345342|364800450|FG001|Follow-Up Phase|Physician Decision|0|||
105958997|NCT01144416|365509655|FG000|Intervention Period|No/too few/bad quality embryos|3|||
105958998|NCT01144416|365509656|FG001|Intervention Period|No/too few/bad quality embryos|3|||
105958999|NCT01144416|365509655|FG000|Intervention Period|Other|7|||
105959000|NCT01144416|365509656|FG001|Intervention Period|Other|5|||
105959001|NCT00124072|365509657|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
105959002|NCT00124072|365509658|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
105959003|NCT00124072|365509659|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
105959004|NCT00124072|365509660|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
105959005|NCT00124072|365509657|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
105959006|NCT00124072|365509658|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
105959007|NCT00124072|365509659|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
105959008|NCT00124072|365509660|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
105959009|NCT00124072|365509657|FG000|Overall Study|Death|499|||
105959010|NCT00124072|365509658|FG001|Overall Study|Death|484|||
105959011|NCT00124072|365509659|FG002|Overall Study|Death|471|||
105959012|NCT00124072|365509660|FG003|Overall Study|Death|480|||
105959013|NCT00995436|365509661|FG000|Overall Study|Withdrawal by Subject|2|||
105767401|NCT03345342|364800451|FG002|Follow-Up Phase|Physician Decision|0|||
105959014|NCT00995436|365509662|FG001|Overall Study|Withdrawal by Subject|5|||
105959015|NCT00995436|365509663|FG002|Overall Study|Withdrawal by Subject|0|||
105959016|NCT01107392|365509664|FG000|Overall Study|Adverse Event|2|||
105959017|NCT01107392|365509665|FG001|Overall Study|Adverse Event|0|||
105959018|NCT01107392|365509664|FG000|Overall Study|Personal Reasons|2|||
105959019|NCT01107392|365509665|FG001|Overall Study|Personal Reasons|3|||
105959020|NCT01107392|365509664|FG000|Overall Study|Administrative decision|1|||
105959021|NCT01107392|365509665|FG001|Overall Study|Administrative decision|0|||
105959022|NCT02038946|365509667|FG000|Overall Study|Death|5|||
105959023|NCT02038946|365509667|FG000|Overall Study|Withdrawal by Subject|3|||
105959024|NCT02038946|365509667|FG000|Overall Study|Lost to Follow-up|2|||
105959025|NCT02038946|365509667|FG000|Overall Study|Other reasons|2|||
105959026|NCT03519997|365509668|FG000|Overall Study|Adverse Event|4|||
105959027|NCT03519997|365509668|FG000|Overall Study|Withdrawal by Subject|2|||
105959028|NCT03519997|365509668|FG000|Overall Study|Protocol Violation|1|||
105959029|NCT03162796|365509671|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
105959030|NCT03162796|365509672|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
105959031|NCT03162796|365509673|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
105959032|NCT03162796|365509671|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
105959033|NCT03162796|365509672|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
105959034|NCT03162796|365509673|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
105959035|NCT03162796|365509671|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
105959036|NCT03162796|365509672|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
105959037|NCT03162796|365509673|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
105959038|NCT03162796|365509671|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
105959039|NCT03162796|365509672|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
105959040|NCT03162796|365509673|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
105959041|NCT03162796|365509671|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
105959042|NCT03162796|365509672|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
105959043|NCT03162796|365509673|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
105959044|NCT03162796|365509671|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
105959045|NCT03162796|365509672|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
105959046|NCT03162796|365509673|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
105959047|NCT03162796|365509671|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
105959048|NCT03162796|365509672|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
105959049|NCT03162796|365509673|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
105959050|NCT03162796|365509671|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
105959051|NCT03162796|365509672|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
105959052|NCT03162796|365509673|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
105959053|NCT03162796|365509671|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
105959054|NCT03162796|365509672|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
105959055|NCT03162796|365509673|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
106020918|NCT02100696|365741491|FG003|Induction Phase|Multiple Reasons|0|||
106145818|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
105959056|NCT03162796|365509671|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
105959057|NCT03162796|365509672|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
105959058|NCT03162796|365509673|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
105959059|NCT03162796|365509671|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
105959060|NCT03162796|365509672|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
105959061|NCT03162796|365509673|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
105767402|NCT03345342|364800452|FG003|Follow-Up Phase|Physician Decision|0|||
105767403|NCT03345342|364800453|FG004|Follow-Up Phase|Physician Decision|5|||
105767404|NCT03345342|364800449|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
105767405|NCT03345342|364800450|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
105767406|NCT03345342|364800451|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
105767407|NCT03345342|364800452|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
105767408|NCT03345342|364800453|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
105767409|NCT03345342|364800449|FG000|Follow-Up Phase|Other|0|||
105767410|NCT03345342|364800450|FG001|Follow-Up Phase|Other|0|||
105767411|NCT03345342|364800451|FG002|Follow-Up Phase|Other|0|||
105767412|NCT03345342|364800452|FG003|Follow-Up Phase|Other|3|||
105767413|NCT03345342|364800453|FG004|Follow-Up Phase|Other|1|||
105767414|NCT02437162|364800454|FG000|Overall Study|Protocol Violation|0|||
105767415|NCT02437162|364800455|FG001|Overall Study|Protocol Violation|1|||
105767416|NCT02437162|364800456|FG002|Overall Study|Protocol Violation|0|||
105767417|NCT02437162|364800454|FG000|Overall Study|Randomized but not treated|0|||
105767418|NCT02437162|364800455|FG001|Overall Study|Randomized but not treated|0|||
105767419|NCT02437162|364800456|FG002|Overall Study|Randomized but not treated|1|||
105767420|NCT02437162|364800454|FG000|Overall Study|Study discontinued by Sponsor|93|||
105767421|NCT02437162|364800455|FG001|Overall Study|Study discontinued by Sponsor|98|||
105767422|NCT02437162|364800456|FG002|Overall Study|Study discontinued by Sponsor|97|||
105767423|NCT02437162|364800454|FG000|Overall Study|Withdrawal by Subject|13|||
105767424|NCT02437162|364800455|FG001|Overall Study|Withdrawal by Subject|7|||
105767425|NCT02437162|364800456|FG002|Overall Study|Withdrawal by Subject|9|||
105767426|NCT02437162|364800454|FG000|Overall Study|Adverse Event|0|||
105767427|NCT02437162|364800455|FG001|Overall Study|Adverse Event|1|||
105767428|NCT02437162|364800456|FG002|Overall Study|Adverse Event|0|||
105767429|NCT02437162|364800454|FG000|Overall Study|Lost to Follow-up|1|||
105767430|NCT02437162|364800455|FG001|Overall Study|Lost to Follow-up|0|||
105767431|NCT02437162|364800456|FG002|Overall Study|Lost to Follow-up|1|||
105767432|NCT02437162|364800454|FG000|Overall Study|Death|0|||
105767433|NCT02437162|364800455|FG001|Overall Study|Death|1|||
105767434|NCT02437162|364800456|FG002|Overall Study|Death|0|||
105767435|NCT02437162|364800454|FG000|Overall Study|Other|0|||
105767436|NCT02437162|364800455|FG001|Overall Study|Other|0|||
105767437|NCT02437162|364800456|FG002|Overall Study|Other|1|||
105767438|NCT03981744|364800457|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
105767439|NCT03981744|364800458|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
105959062|NCT02473471|365509674|FG000|Overall Study|poor oral hygiene|2|||
105959063|NCT02473471|365509674|FG000|Overall Study|Lost to Follow-up|1|||
105959064|NCT01916824|365509679|FG000|Overall Study|Lost to Follow-up|3|||
105959065|NCT01916824|365509680|FG001|Overall Study|Lost to Follow-up|6|||
105959066|NCT01916824|365509679|FG000|Overall Study|Physician Decision|2|||
105959067|NCT01916824|365509680|FG001|Overall Study|Physician Decision|0|||
105959068|NCT01916824|365509679|FG000|Overall Study|Withdrawal by Subject|2|||
105959069|NCT01916824|365509680|FG001|Overall Study|Withdrawal by Subject|3|||
105959070|NCT00771927|365509681|FG000|Overall Study|Adverse Event|100|||
105959071|NCT00771927|365509682|FG001|Overall Study|Adverse Event|105|||
105959072|NCT00771927|365509681|FG000|Overall Study|Lack of Efficacy|70|||
105959073|NCT00771927|365509682|FG001|Overall Study|Lack of Efficacy|42|||
105959074|NCT00771927|365509681|FG000|Overall Study|Lost to Follow-up|46|||
105959075|NCT00771927|365509682|FG001|Overall Study|Lost to Follow-up|46|||
105959076|NCT00771927|365509681|FG000|Overall Study|Withdrawal by Subject|16|||
105959077|NCT00771927|365509682|FG001|Overall Study|Withdrawal by Subject|17|||
105959078|NCT00771927|365509681|FG000|Overall Study|Other reason|23|||
105959079|NCT00771927|365509682|FG001|Overall Study|Other reason|27|||
105959080|NCT00465972|365509685|FG000|Overall Study|Withdrawal by Subject|2|||
105959081|NCT00465972|365509686|FG001|Overall Study|Withdrawal by Subject|1|||
105959082|NCT00819156|365509695|FG000|Overall Study|Adverse Event|1|||
105959083|NCT00819156|365509696|FG001|Overall Study|Adverse Event|4|||
105959084|NCT00819156|365509697|FG002|Overall Study|Adverse Event|2|||
105959085|NCT00819156|365509698|FG003|Overall Study|Adverse Event|1|||
105959086|NCT00819156|365509699|FG004|Overall Study|Adverse Event|2|||
105959087|NCT00819156|365509700|FG005|Overall Study|Adverse Event|3|||
105959088|NCT00819156|365509695|FG000|Overall Study|Withdrawal by Subject|0|||
106145819|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
105767440|NCT03981744|364800459|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
105767441|NCT03981744|364800460|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
105767442|NCT03981744|364800457|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
105767443|NCT03981744|364800458|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
105767444|NCT03981744|364800459|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
105767445|NCT03981744|364800460|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
105767446|NCT03981744|364800457|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
105959089|NCT00819156|365509696|FG001|Overall Study|Withdrawal by Subject|3|||
105959090|NCT00819156|365509697|FG002|Overall Study|Withdrawal by Subject|2|||
105959091|NCT00819156|365509698|FG003|Overall Study|Withdrawal by Subject|0|||
105959092|NCT00819156|365509699|FG004|Overall Study|Withdrawal by Subject|1|||
106020919|NCT02100696|365741492|FG004|Induction Phase|Multiple Reasons|0|||
106020920|NCT02100696|365741493|FG005|Induction Phase|Multiple Reasons|0|||
106020921|NCT02100696|365741488|FG000|Maintenance Phase|Adverse Event|0|||
106020922|NCT02100696|365741489|FG001|Maintenance Phase|Adverse Event|0|||
106020923|NCT02100696|365741490|FG002|Maintenance Phase|Adverse Event|0|||
106020924|NCT02100696|365741491|FG003|Maintenance Phase|Adverse Event|0|||
106020925|NCT02100696|365741492|FG004|Maintenance Phase|Adverse Event|0|||
106020926|NCT02100696|365741493|FG005|Maintenance Phase|Adverse Event|2|||
106020927|NCT02100696|365741488|FG000|Maintenance Phase|Lost to Follow-up|0|||
106020928|NCT02100696|365741489|FG001|Maintenance Phase|Lost to Follow-up|0|||
106020929|NCT02100696|365741490|FG002|Maintenance Phase|Lost to Follow-up|0|||
106020930|NCT02100696|365741491|FG003|Maintenance Phase|Lost to Follow-up|0|||
106020931|NCT02100696|365741492|FG004|Maintenance Phase|Lost to Follow-up|1|||
106020932|NCT02100696|365741493|FG005|Maintenance Phase|Lost to Follow-up|0|||
106020933|NCT02100696|365741488|FG000|Maintenance Phase|Protocol Violation|0|||
106020934|NCT02100696|365741489|FG001|Maintenance Phase|Protocol Violation|0|||
106020935|NCT02100696|365741490|FG002|Maintenance Phase|Protocol Violation|0|||
106020936|NCT02100696|365741491|FG003|Maintenance Phase|Protocol Violation|0|||
106020937|NCT02100696|365741492|FG004|Maintenance Phase|Protocol Violation|1|||
106020938|NCT02100696|365741493|FG005|Maintenance Phase|Protocol Violation|0|||
105823001|NCT01404988|365008900|FG000|Overall Study|Withdrawal by Subject|2|||
105823002|NCT01404988|365008901|FG001|Overall Study|Withdrawal by Subject|2|||
105823003|NCT01404988|365008902|FG002|Overall Study|Withdrawal by Subject|0|||
105823004|NCT01404988|365008900|FG000|Overall Study|Lost to Follow-up|1|||
105823005|NCT01404988|365008901|FG001|Overall Study|Lost to Follow-up|2|||
105823006|NCT01404988|365008902|FG002|Overall Study|Lost to Follow-up|1|||
105823007|NCT01963728|365008907|FG000|Overall Study|Study terminated early|0|||
105823008|NCT01963728|365008908|FG001|Overall Study|Study terminated early|1|||
105823009|NCT04852978|365008911|FG000|Overall Study|Physician Decision|0|||
106020939|NCT02100696|365741488|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105823010|NCT04852978|365008912|FG001|Overall Study|Physician Decision|1|||
105823011|NCT04852978|365008913|FG002|Overall Study|Physician Decision|0|||
106020940|NCT02100696|365741489|FG001|Maintenance Phase|Withdrawal by Subject|0|||
106020941|NCT02100696|365741490|FG002|Maintenance Phase|Withdrawal by Subject|0|||
106020942|NCT02100696|365741491|FG003|Maintenance Phase|Withdrawal by Subject|1|||
106020943|NCT02100696|365741492|FG004|Maintenance Phase|Withdrawal by Subject|4|||
106020944|NCT02100696|365741493|FG005|Maintenance Phase|Withdrawal by Subject|2|||
106020945|NCT02100696|365741488|FG000|Maintenance Phase|Physician Decision|0|||
106020946|NCT02100696|365741489|FG001|Maintenance Phase|Physician Decision|0|||
106020947|NCT02100696|365741490|FG002|Maintenance Phase|Physician Decision|0|||
106145820|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
106145821|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
105823012|NCT04852978|365008914|FG003|Overall Study|Physician Decision|0|||
105823013|NCT04852978|365008915|FG004|Overall Study|Physician Decision|0|||
105823014|NCT04852978|365008916|FG005|Overall Study|Physician Decision|0|||
105823015|NCT04852978|365008917|FG006|Overall Study|Physician Decision|0|||
105823016|NCT04852978|365008918|FG007|Overall Study|Physician Decision|2|||
105823017|NCT04852978|365008919|FG008|Overall Study|Physician Decision|0|||
105823018|NCT04852978|365008911|FG000|Overall Study|Sponsor request|0|||
105959093|NCT00819156|365509700|FG005|Overall Study|Withdrawal by Subject|0|||
105959094|NCT00819156|365509695|FG000|Overall Study|Protocol Violation|1|||
105959095|NCT00819156|365509696|FG001|Overall Study|Protocol Violation|0|||
105959096|NCT00819156|365509697|FG002|Overall Study|Protocol Violation|1|||
105959097|NCT00819156|365509698|FG003|Overall Study|Protocol Violation|0|||
105959098|NCT00819156|365509699|FG004|Overall Study|Protocol Violation|0|||
105959099|NCT00819156|365509700|FG005|Overall Study|Protocol Violation|1|||
105959100|NCT00819156|365509695|FG000|Overall Study|Lost to Follow-up|0|||
105959101|NCT00819156|365509696|FG001|Overall Study|Lost to Follow-up|1|||
105959102|NCT00819156|365509697|FG002|Overall Study|Lost to Follow-up|0|||
105959103|NCT00819156|365509698|FG003|Overall Study|Lost to Follow-up|0|||
105959104|NCT00819156|365509699|FG004|Overall Study|Lost to Follow-up|0|||
105959105|NCT00819156|365509700|FG005|Overall Study|Lost to Follow-up|2|||
106020948|NCT02100696|365741491|FG003|Maintenance Phase|Physician Decision|0|||
106020949|NCT02100696|365741492|FG004|Maintenance Phase|Physician Decision|1|||
106020950|NCT02100696|365741493|FG005|Maintenance Phase|Physician Decision|0|||
106020951|NCT02100696|365741488|FG000|Maintenance Phase|Multiple Reasons|0|||
106145822|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
106145823|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
105823019|NCT04852978|365008912|FG001|Overall Study|Sponsor request|0|||
105823020|NCT04852978|365008913|FG002|Overall Study|Sponsor request|1|||
105823021|NCT04852978|365008914|FG003|Overall Study|Sponsor request|0|||
105959106|NCT00819156|365509695|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
105959107|NCT00819156|365509696|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
105959108|NCT00819156|365509697|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
106020952|NCT02100696|365741489|FG001|Maintenance Phase|Multiple Reasons|0|||
106020953|NCT02100696|365741490|FG002|Maintenance Phase|Multiple Reasons|0|||
105823022|NCT04852978|365008915|FG004|Overall Study|Sponsor request|0|||
105823023|NCT04852978|365008916|FG005|Overall Study|Sponsor request|0|||
105823024|NCT04852978|365008917|FG006|Overall Study|Sponsor request|0|||
105823025|NCT04852978|365008918|FG007|Overall Study|Sponsor request|0|||
105823026|NCT04852978|365008919|FG008|Overall Study|Sponsor request|0|||
105823027|NCT04852978|365008911|FG000|Overall Study|Death|0|||
105823028|NCT04852978|365008912|FG001|Overall Study|Death|0|||
105823029|NCT04852978|365008913|FG002|Overall Study|Death|0|||
105823030|NCT04852978|365008914|FG003|Overall Study|Death|0|||
105823031|NCT04852978|365008915|FG004|Overall Study|Death|0|||
105823032|NCT04852978|365008916|FG005|Overall Study|Death|0|||
105823033|NCT04852978|365008917|FG006|Overall Study|Death|1|||
105823034|NCT04852978|365008918|FG007|Overall Study|Death|0|||
105823035|NCT04852978|365008919|FG008|Overall Study|Death|0|||
105823036|NCT04852978|365008911|FG000|Overall Study|Lost to Follow-up|3|||
105823037|NCT04852978|365008912|FG001|Overall Study|Lost to Follow-up|2|||
105823038|NCT04852978|365008913|FG002|Overall Study|Lost to Follow-up|2|||
105823039|NCT04852978|365008914|FG003|Overall Study|Lost to Follow-up|0|||
105823040|NCT04852978|365008915|FG004|Overall Study|Lost to Follow-up|2|||
105823041|NCT04852978|365008916|FG005|Overall Study|Lost to Follow-up|4|||
105767447|NCT03981744|364800458|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
105767448|NCT03981744|364800459|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
105767449|NCT03981744|364800460|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
105767450|NCT02782104|364800461|FG000|Overall Study|Other|215|||
105823042|NCT04852978|365008917|FG006|Overall Study|Lost to Follow-up|1|||
105823043|NCT04852978|365008918|FG007|Overall Study|Lost to Follow-up|2|||
105823044|NCT04852978|365008919|FG008|Overall Study|Lost to Follow-up|2|||
105823045|NCT04852978|365008911|FG000|Overall Study|Withdrawal by Subject|4|||
105823046|NCT04852978|365008912|FG001|Overall Study|Withdrawal by Subject|2|||
105823047|NCT04852978|365008913|FG002|Overall Study|Withdrawal by Subject|2|||
105823048|NCT04852978|365008914|FG003|Overall Study|Withdrawal by Subject|1|||
105823049|NCT04852978|365008915|FG004|Overall Study|Withdrawal by Subject|5|||
105823050|NCT04852978|365008916|FG005|Overall Study|Withdrawal by Subject|3|||
105823051|NCT04852978|365008917|FG006|Overall Study|Withdrawal by Subject|2|||
105823052|NCT04852978|365008918|FG007|Overall Study|Withdrawal by Subject|2|||
105823053|NCT04852978|365008919|FG008|Overall Study|Withdrawal by Subject|1|||
105823054|NCT02068794|365010404|FG000|Overall Study|Withdrawal by Subject|0|||
105823055|NCT02068794|365010405|FG001|Overall Study|Withdrawal by Subject|1|||
105823056|NCT02068794|365010406|FG002|Overall Study|Withdrawal by Subject|2|||
105823057|NCT02068794|365010404|FG000|Overall Study|Early Progression|1|||
105823058|NCT02068794|365010405|FG001|Overall Study|Early Progression|0|||
105823059|NCT02068794|365010406|FG002|Overall Study|Early Progression|1|||
105823060|NCT02068794|365010404|FG000|Overall Study|Ineligible|0|||
105823061|NCT02068794|365010405|FG001|Overall Study|Ineligible|0|||
105823062|NCT02068794|365010406|FG002|Overall Study|Ineligible|1|||
105823063|NCT04115293|365010407|FG000|Overall Study|Adverse Event|0|||
105959109|NCT00819156|365509698|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
105767451|NCT02782104|364800461|FG000|Overall Study|Induction Day 28 Non Responder|9|||
105767452|NCT02782104|364800461|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105767453|NCT02782104|364800461|FG000|Overall Study|Death|8|||
105767454|NCT02782104|364800461|FG000|Overall Study|Pregnancy|6|||
105767455|NCT02782104|364800461|FG000|Overall Study|Withdrawal by Subject|63|||
105767456|NCT02782104|364800461|FG000|Overall Study|Protocol Violation|7|||
105767457|NCT02782104|364800461|FG000|Overall Study|Lack of Efficacy|61|||
105767458|NCT02782104|364800461|FG000|Overall Study|Lost to Follow-up|23|||
105767459|NCT02782104|364800461|FG000|Overall Study|Adverse Event|74|||
105767460|NCT03464136|364800462|FG000|Overall Study|Lost to Follow-up|5|||
105767461|NCT03464136|364800463|FG001|Overall Study|Lost to Follow-up|8|||
105767462|NCT03464136|364800462|FG000|Overall Study|Withdrawal by Subject|16|||
105767463|NCT03464136|364800463|FG001|Overall Study|Withdrawal by Subject|13|||
105767464|NCT03464136|364800462|FG000|Overall Study|Death|1|||
105767465|NCT03464136|364800463|FG001|Overall Study|Death|0|||
105767466|NCT03464136|364800462|FG000|Overall Study|Other|8|||
105767467|NCT03464136|364800463|FG001|Overall Study|Other|4|||
105767468|NCT04338321|364800464|FG000|Overall Study|Adverse Event|4|||
105767469|NCT04338321|364800465|FG001|Overall Study|Adverse Event|10|||
105767470|NCT04338321|364800464|FG000|Overall Study|Death|1|||
105767471|NCT04338321|364800465|FG001|Overall Study|Death|1|||
105767472|NCT04338321|364800464|FG000|Overall Study|Lost to Follow-up|4|||
105767473|NCT04338321|364800465|FG001|Overall Study|Lost to Follow-up|9|||
105767474|NCT04338321|364800464|FG000|Overall Study|Withdrawal by Subject|45|||
105823064|NCT04115293|365010408|FG001|Overall Study|Adverse Event|2|||
105823065|NCT04115293|365010407|FG000|Overall Study|Withdrawal by Subject|2|||
105823066|NCT04115293|365010408|FG001|Overall Study|Withdrawal by Subject|1|||
105823067|NCT04115293|365010407|FG000|Overall Study|Physician Decision|1|||
105823068|NCT04115293|365010408|FG001|Overall Study|Physician Decision|0|||
105823069|NCT04115293|365010407|FG000|Overall Study|Death|1|||
105823070|NCT04115293|365010408|FG001|Overall Study|Death|1|||
105823071|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
105823072|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
106020954|NCT02100696|365741491|FG003|Maintenance Phase|Multiple Reasons|0|||
106020955|NCT02100696|365741492|FG004|Maintenance Phase|Multiple Reasons|2|||
106020956|NCT02100696|365741493|FG005|Maintenance Phase|Multiple Reasons|1|||
106020957|NCT02357368|365741496|FG000|Overall Study|Lost to Follow-up|0|||
106020958|NCT02357368|365741497|FG001|Overall Study|Lost to Follow-up|0|||
106020959|NCT02357368|365741498|FG002|Overall Study|Lost to Follow-up|0|||
106020960|NCT02357368|365741499|FG003|Overall Study|Lost to Follow-up|1|||
106020961|NCT02357368|365741496|FG000|Overall Study|Pregnancy|3|||
106020962|NCT02357368|365741497|FG001|Overall Study|Pregnancy|2|||
106020963|NCT02357368|365741498|FG002|Overall Study|Pregnancy|0|||
106020964|NCT02357368|365741499|FG003|Overall Study|Pregnancy|0|||
106020965|NCT02357368|365741496|FG000|Overall Study|Withdrawal by Subject|3|||
106020966|NCT02357368|365741497|FG001|Overall Study|Withdrawal by Subject|1|||
106020967|NCT02357368|365741498|FG002|Overall Study|Withdrawal by Subject|1|||
106020968|NCT02357368|365741499|FG003|Overall Study|Withdrawal by Subject|2|||
106020969|NCT00048074|365741502|FG000|Overall Study|Adverse Event|46|||
106020970|NCT00048074|365741503|FG001|Overall Study|Adverse Event|41|||
106020971|NCT00048074|365741504|FG002|Overall Study|Adverse Event|53|||
106020972|NCT00048074|365741502|FG000|Overall Study|Death|3|||
106020973|NCT00048074|365741503|FG001|Overall Study|Death|3|||
106020974|NCT00048074|365741504|FG002|Overall Study|Death|2|||
106020975|NCT00048074|365741502|FG000|Overall Study|Lost to Follow-up|2|||
106020976|NCT00048074|365741503|FG001|Overall Study|Lost to Follow-up|6|||
106020977|NCT00048074|365741504|FG002|Overall Study|Lost to Follow-up|6|||
106020978|NCT00048074|365741502|FG000|Overall Study|Withdrawal by Subject|28|||
106020979|NCT00048074|365741503|FG001|Overall Study|Withdrawal by Subject|30|||
106020980|NCT00048074|365741504|FG002|Overall Study|Withdrawal by Subject|35|||
106020981|NCT00048074|365741502|FG000|Overall Study|Protocol Violation|1|||
106020982|NCT00048074|365741503|FG001|Overall Study|Protocol Violation|3|||
106020983|NCT00048074|365741504|FG002|Overall Study|Protocol Violation|0|||
106020984|NCT00048074|365741502|FG000|Overall Study|Study participation was terminated|0|||
106020985|NCT00048074|365741503|FG001|Overall Study|Study participation was terminated|1|||
106020986|NCT00048074|365741504|FG002|Overall Study|Study participation was terminated|0|||
106020987|NCT00048074|365741502|FG000|Overall Study|Husband ill|0|||
106020988|NCT00048074|365741503|FG001|Overall Study|Husband ill|1|||
106020989|NCT00048074|365741504|FG002|Overall Study|Husband ill|0|||
106020990|NCT00048074|365741502|FG000|Overall Study|Poor compliance|0|||
106020991|NCT00048074|365741503|FG001|Overall Study|Poor compliance|1|||
106020992|NCT00048074|365741504|FG002|Overall Study|Poor compliance|0|||
106020993|NCT00048074|365741502|FG000|Overall Study|Out of station|0|||
106020994|NCT00048074|365741503|FG001|Overall Study|Out of station|1|||
105959110|NCT00819156|365509699|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
105959111|NCT00819156|365509700|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
105959112|NCT00819156|365509695|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
105959113|NCT00819156|365509696|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
105959114|NCT00819156|365509697|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
105959115|NCT00819156|365509698|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
105959116|NCT00819156|365509699|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
105959117|NCT00819156|365509700|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
105959118|NCT00819156|365509695|FG000|Overall Study|Prostate-specific antigen progression|0|||
105959119|NCT00819156|365509696|FG001|Overall Study|Prostate-specific antigen progression|0|||
105959120|NCT00819156|365509697|FG002|Overall Study|Prostate-specific antigen progression|0|||
105959121|NCT00819156|365509698|FG003|Overall Study|Prostate-specific antigen progression|0|||
105959122|NCT00819156|365509699|FG004|Overall Study|Prostate-specific antigen progression|1|||
105959123|NCT00819156|365509700|FG005|Overall Study|Prostate-specific antigen progression|0|||
105959124|NCT00803595|365509701|FG000|Overall Study|Adverse Event|3|||
105959125|NCT00803595|365509702|FG001|Overall Study|Adverse Event|4|||
105959126|NCT00803595|365509703|FG002|Overall Study|Adverse Event|1|||
105959127|NCT00803595|365509701|FG000|Overall Study|Protocol Violation|7|||
105959128|NCT00803595|365509702|FG001|Overall Study|Protocol Violation|2|||
105959129|NCT00803595|365509703|FG002|Overall Study|Protocol Violation|12|||
105959130|NCT00803595|365509701|FG000|Overall Study|Withdrawal by Subject|5|||
105959131|NCT00803595|365509702|FG001|Overall Study|Withdrawal by Subject|2|||
105959132|NCT00803595|365509703|FG002|Overall Study|Withdrawal by Subject|3|||
106145824|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
106020995|NCT00048074|365741504|FG002|Overall Study|Out of station|1|||
106020996|NCT00048074|365741502|FG000|Overall Study|Social reasons|1|||
106020997|NCT00048074|365741503|FG001|Overall Study|Social reasons|0|||
106020998|NCT00048074|365741504|FG002|Overall Study|Social reasons|0|||
106020999|NCT03500224|365741507|FG000|Overall Study|Withdrawal by Subject|2|||
106021000|NCT01324401|365741508|FG000|Overall Study|Withdrawn before any treatment|0|||
105959133|NCT00984594|365509704|FG000|Overall Study|Lost to Follow-up|1|||
105959134|NCT00984594|365509705|FG001|Overall Study|Lost to Follow-up|0|||
105959135|NCT00984594|365509704|FG000|Overall Study|Withdrawal by Subject|0|||
105959136|NCT00984594|365509705|FG001|Overall Study|Withdrawal by Subject|1|||
106021001|NCT01324401|365741509|FG001|Overall Study|Withdrawn before any treatment|3|||
106021002|NCT01324401|365741508|FG000|Overall Study|Adverse Event|1|||
105767475|NCT04338321|364800465|FG001|Overall Study|Withdrawal by Subject|69|||
105767476|NCT04338321|364800464|FG000|Overall Study|Physician Decision|5|||
105767477|NCT04338321|364800465|FG001|Overall Study|Physician Decision|9|||
105767478|NCT04338321|364800464|FG000|Overall Study|Other|3|||
105767479|NCT04338321|364800465|FG001|Overall Study|Other|10|||
105767480|NCT02438787|364800466|FG000|Overall Study|Adverse Event|1|||
105767481|NCT02438787|364800467|FG001|Overall Study|Adverse Event|0|||
105767482|NCT02438787|364800468|FG002|Overall Study|Adverse Event|2|||
105767483|NCT02438787|364800466|FG000|Overall Study|Lack of Efficacy|1|||
105767484|NCT02438787|364800467|FG001|Overall Study|Lack of Efficacy|2|||
105767485|NCT02438787|364800468|FG002|Overall Study|Lack of Efficacy|0|||
105767486|NCT02438787|364800466|FG000|Overall Study|Lost to Follow-up|0|||
105767487|NCT02438787|364800467|FG001|Overall Study|Lost to Follow-up|1|||
105767488|NCT02438787|364800468|FG002|Overall Study|Lost to Follow-up|0|||
105767489|NCT02438787|364800466|FG000|Overall Study|Protocol Violation|0|||
105767490|NCT02438787|364800467|FG001|Overall Study|Protocol Violation|0|||
105767491|NCT02438787|364800468|FG002|Overall Study|Protocol Violation|1|||
105767492|NCT02438787|364800466|FG000|Overall Study|Withdrawal by Subject|15|||
105767493|NCT02438787|364800467|FG001|Overall Study|Withdrawal by Subject|7|||
105767494|NCT02438787|364800468|FG002|Overall Study|Withdrawal by Subject|10|||
105767495|NCT02438787|364800466|FG000|Overall Study|Study discontinued by sponsor|64|||
105767496|NCT02438787|364800467|FG001|Overall Study|Study discontinued by sponsor|72|||
105767497|NCT02438787|364800468|FG002|Overall Study|Study discontinued by sponsor|69|||
105767498|NCT02438787|364800466|FG000|Overall Study|Other|0|||
105767499|NCT02438787|364800467|FG001|Overall Study|Other|1|||
105767500|NCT02438787|364800468|FG002|Overall Study|Other|0|||
105767501|NCT02438787|364800466|FG000|Overall Study|Site terminated by sponsor|0|||
105767502|NCT02438787|364800467|FG001|Overall Study|Site terminated by sponsor|0|||
105767503|NCT02438787|364800468|FG002|Overall Study|Site terminated by sponsor|1|||
105767504|NCT03412565|364800469|FG000|Overall Study|Lost to Follow-up|0|||
105767505|NCT03412565|364800470|FG001|Overall Study|Lost to Follow-up|0|||
105767506|NCT03412565|364800471|FG002|Overall Study|Lost to Follow-up|1|||
105767507|NCT03412565|364800472|FG003|Overall Study|Lost to Follow-up|0|||
105767508|NCT03412565|364800469|FG000|Overall Study|Physician Decision|0|||
105767509|NCT03412565|364800470|FG001|Overall Study|Physician Decision|0|||
105767510|NCT03412565|364800471|FG002|Overall Study|Physician Decision|0|||
105767511|NCT03412565|364800472|FG003|Overall Study|Physician Decision|1|||
105767512|NCT03412565|364800469|FG000|Overall Study|Withdrawal by Subject|0|||
105767513|NCT03412565|364800470|FG001|Overall Study|Withdrawal by Subject|4|||
105767514|NCT03412565|364800471|FG002|Overall Study|Withdrawal by Subject|5|||
105767515|NCT03412565|364800472|FG003|Overall Study|Withdrawal by Subject|5|||
105767516|NCT03412565|364800469|FG000|Overall Study|Death|1|||
105767517|NCT03412565|364800470|FG001|Overall Study|Death|3|||
105767518|NCT03412565|364800471|FG002|Overall Study|Death|4|||
105767519|NCT03412565|364800472|FG003|Overall Study|Death|5|||
105767520|NCT03412565|364800469|FG000|Overall Study|Data collection ended|0|||
105767521|NCT03412565|364800470|FG001|Overall Study|Data collection ended|41|||
105767522|NCT03412565|364800471|FG002|Overall Study|Data collection ended|41|||
105767523|NCT03412565|364800472|FG003|Overall Study|Data collection ended|40|||
105767524|NCT03107793|364800473|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
105767525|NCT03107793|364800474|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
105767526|NCT03107793|364800475|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
105767527|NCT03107793|364800476|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
105959137|NCT03135431|365509707|FG000|Overall Study|Study Surgeon not available|2|||
105959138|NCT03135431|365509708|FG001|Overall Study|Study Surgeon not available|0|||
105959139|NCT02100423|365509710|FG000|Overall Study|Death|1|||
105959140|NCT02100423|365509710|FG000|Overall Study|Withdrawal by Subject|3|||
105959141|NCT02100423|365509710|FG000|Overall Study|Adverse Event|1|||
105959142|NCT02100423|365509710|FG000|Overall Study|Physician Decision|1|||
105767528|NCT03107793|364800477|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
105767529|NCT03107793|364800473|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
105767530|NCT03107793|364800474|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
105767531|NCT03107793|364800475|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
105767532|NCT03107793|364800476|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
105767533|NCT03107793|364800477|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
105767534|NCT03107793|364800473|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
105767535|NCT03107793|364800474|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
105767536|NCT03107793|364800475|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
105959143|NCT02195700|365509711|FG000|Overall Study|Protocol Violation|0|||
105767537|NCT03107793|364800476|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
105767538|NCT03107793|364800477|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
105767539|NCT03107793|364800473|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
105767540|NCT03107793|364800474|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105767541|NCT03107793|364800475|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105767542|NCT03107793|364800476|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105959144|NCT02195700|365509712|FG001|Overall Study|Protocol Violation|2|||
105959145|NCT02195700|365509711|FG000|Overall Study|Noncompliance|1|||
105767543|NCT03107793|364800477|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105767544|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105767545|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
105767546|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
105767547|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105767548|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105767549|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105767550|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
105767551|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
105767552|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105823073|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
105959146|NCT02195700|365509712|FG001|Overall Study|Noncompliance|0|||
105959147|NCT02195700|365509711|FG000|Overall Study|Adverse Event|1|||
105767553|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105767554|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
105767555|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
105767556|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
105767557|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
105767558|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
105959148|NCT02195700|365509712|FG001|Overall Study|Adverse Event|2|||
105959149|NCT02195700|365509711|FG000|Overall Study|Withdrawal by Subject|3|||
105959150|NCT02195700|365509712|FG001|Overall Study|Withdrawal by Subject|2|||
105959151|NCT02195700|365509711|FG000|Overall Study|Lost to Follow-up|1|||
105959152|NCT02195700|365509712|FG001|Overall Study|Lost to Follow-up|1|||
105959153|NCT02454530|365509713|FG000|Overall Study|Other|8|||
105959154|NCT02454530|365509714|FG001|Overall Study|Other|13|||
105959155|NCT02454530|365509713|FG000|Overall Study|Missing information|56|||
105959156|NCT02454530|365509714|FG001|Overall Study|Missing information|69|||
105959157|NCT02454530|365509713|FG000|Overall Study|Death|2|||
105959158|NCT02454530|365509714|FG001|Overall Study|Death|41|||
105959159|NCT02454530|365509713|FG000|Overall Study|Lost to Follow-up|4|||
105959160|NCT02454530|365509714|FG001|Overall Study|Lost to Follow-up|4|||
105767559|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105767560|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
105767561|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
105767562|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105767563|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105767564|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
105959161|NCT03265145|365509715|FG000|Overall Study|Protocol Violation|2|||
105959162|NCT03265145|365509716|FG001|Overall Study|Protocol Violation|0|||
105959163|NCT03265145|365509715|FG000|Overall Study|Adverse Event|1|||
106021003|NCT01324401|365741509|FG001|Overall Study|Adverse Event|3|||
106021004|NCT01708902|365741510|FG000|Overall Study|Adverse Event|3|||
106021005|NCT01708902|365741511|FG001|Overall Study|Adverse Event|4|||
106021006|NCT01708902|365741512|FG002|Overall Study|Adverse Event|9|||
106021007|NCT01708902|365741513|FG003|Overall Study|Adverse Event|2|||
106021008|NCT01708902|365741514|FG004|Overall Study|Adverse Event|7|||
106021009|NCT01708902|365741515|FG005|Overall Study|Adverse Event|3|||
106021010|NCT01708902|365741516|FG006|Overall Study|Adverse Event|5|||
106021011|NCT01708902|365741510|FG000|Overall Study|Lack of Efficacy|3|||
106021012|NCT01708902|365741511|FG001|Overall Study|Lack of Efficacy|1|||
106021013|NCT01708902|365741512|FG002|Overall Study|Lack of Efficacy|0|||
106021014|NCT01708902|365741513|FG003|Overall Study|Lack of Efficacy|0|||
106021015|NCT01708902|365741514|FG004|Overall Study|Lack of Efficacy|0|||
106021016|NCT01708902|365741515|FG005|Overall Study|Lack of Efficacy|1|||
106021017|NCT01708902|365741516|FG006|Overall Study|Lack of Efficacy|0|||
106021018|NCT01708902|365741510|FG000|Overall Study|Non compliance with protocol|0|||
106021019|NCT01708902|365741511|FG001|Overall Study|Non compliance with protocol|2|||
106021020|NCT01708902|365741512|FG002|Overall Study|Non compliance with protocol|1|||
106021021|NCT01708902|365741513|FG003|Overall Study|Non compliance with protocol|3|||
106021022|NCT01708902|365741514|FG004|Overall Study|Non compliance with protocol|0|||
106021023|NCT01708902|365741515|FG005|Overall Study|Non compliance with protocol|0|||
106021024|NCT01708902|365741516|FG006|Overall Study|Non compliance with protocol|0|||
105767565|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
105767566|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
105767567|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
105767568|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
105767569|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
105767570|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
105767571|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
105767572|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
105767573|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
105767574|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
106021025|NCT01708902|365741510|FG000|Overall Study|Lost to Follow-up|2|||
106145825|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
106145826|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
106145827|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
106145828|NCT03593213|366194411|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
106145829|NCT03593213|366194412|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
106145830|NCT03593213|366194413|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
106145831|NCT03593213|366194414|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
106145832|NCT00668863|366194415|FG000|Overall Study|Objective Progression or Relapse|42|||
106145833|NCT00668863|366194415|FG000|Overall Study|Adverse Event|13|||
106145834|NCT00668863|366194415|FG000|Overall Study|Study Terminated by Sponsor|8|||
106145835|NCT00668863|366194415|FG000|Overall Study|Global Deterioration of Health Status|4|||
106145836|NCT00668863|366194415|FG000|Overall Study|Withdrawal by Subject|1|||
106145837|NCT00668863|366194415|FG000|Overall Study|Surgery|1|||
106145838|NCT00668863|366194415|FG000|Overall Study|Subject's work scheduling problem|1|||
106145839|NCT00668863|366194415|FG000|Overall Study|Physician Decision|1|||
106145840|NCT03844269|366194416|FG000|Overall Study|Withdrawal pre-intervention|1|||
106145841|NCT03844269|366194416|FG000|Overall Study|Did not complete the intervention|2|||
106145842|NCT00439569|366194420|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
106145843|NCT00439569|366194420|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
106145844|NCT00439569|366194420|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
106145845|NCT02755116|366194421|FG000|Overall Study|surgery converted to open, pt admitted|3|||
106145846|NCT02755116|366194422|FG001|Overall Study|surgery converted to open, pt admitted|1|||
106145847|NCT02214160|366194423|FG000|Overall Study|Withdrawal by Subject|1|||
106145848|NCT02214160|366194424|FG001|Overall Study|Withdrawal by Subject|0|||
106145849|NCT02214160|366194425|FG002|Overall Study|Withdrawal by Subject|6|||
106145850|NCT02214160|366194423|FG000|Overall Study|Death|2|||
106145851|NCT02214160|366194424|FG001|Overall Study|Death|2|||
106145852|NCT02214160|366194425|FG002|Overall Study|Death|1|||
106145853|NCT02214160|366194423|FG000|Overall Study|Subject Non-Compliance|0|||
106145854|NCT02214160|366194424|FG001|Overall Study|Subject Non-Compliance|3|||
106145855|NCT02214160|366194425|FG002|Overall Study|Subject Non-Compliance|1|||
106145856|NCT02214160|366194423|FG000|Overall Study|Adverse Event|0|||
106145857|NCT02214160|366194424|FG001|Overall Study|Adverse Event|1|||
106021026|NCT01708902|365741511|FG001|Overall Study|Lost to Follow-up|1|||
106021027|NCT01708902|365741512|FG002|Overall Study|Lost to Follow-up|2|||
106021028|NCT01708902|365741513|FG003|Overall Study|Lost to Follow-up|2|||
106021029|NCT01708902|365741514|FG004|Overall Study|Lost to Follow-up|0|||
106145858|NCT02214160|366194425|FG002|Overall Study|Adverse Event|1|||
106145859|NCT02214160|366194423|FG000|Overall Study|Sponsor Decision|0|||
106145860|NCT02214160|366194424|FG001|Overall Study|Sponsor Decision|2|||
105767575|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105767576|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105767577|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105767578|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105767579|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
105767580|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
105767581|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
105767582|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
105767583|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
105767584|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
105767585|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
105767586|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
105767587|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
105767588|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
105767589|NCT03107793|364800473|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105767590|NCT03107793|364800474|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
105767591|NCT03107793|364800475|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
105767592|NCT03107793|364800476|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105767593|NCT03107793|364800477|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105767594|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
105767595|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
105767596|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
105767597|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
105767598|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
105823074|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105823075|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105823076|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105823077|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
105823078|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105823079|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
105823080|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
105823081|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105823082|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105823083|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
106021030|NCT01708902|365741515|FG005|Overall Study|Lost to Follow-up|0|||
106145861|NCT02214160|366194425|FG002|Overall Study|Sponsor Decision|0|||
106145862|NCT02214160|366194423|FG000|Overall Study|Protocol Violation|1|||
106145863|NCT02214160|366194424|FG001|Overall Study|Protocol Violation|0|||
106145864|NCT02214160|366194425|FG002|Overall Study|Protocol Violation|0|||
106145865|NCT02214160|366194423|FG000|Overall Study|Physician Decision|0|||
106145866|NCT02214160|366194424|FG001|Overall Study|Physician Decision|0|||
106145867|NCT02214160|366194425|FG002|Overall Study|Physician Decision|1|||
106145868|NCT01264679|366194426|FG000|Overall Study|Participation in Another Clinical Trial|1|||
106145869|NCT01264679|366194426|FG000|Overall Study|Physician Decision|1|||
106145870|NCT01264679|366194426|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
106145871|NCT01264679|366194426|FG000|Overall Study|Withdrawal by Subject|1|||
106145872|NCT00424645|366194431|FG000|Overall Study|Death|1|||
106145873|NCT00424645|366194432|FG001|Overall Study|Death|0|||
106145874|NCT00468052|366194434|FG000|Overall Study|Protocol Violation|7|||
106145875|NCT00468052|366194435|FG001|Overall Study|Protocol Violation|8|||
106145876|NCT00529789|366194436|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
106145877|NCT00529789|366194436|FG000|Study Period II/III|Adverse Event|3|||
106145878|NCT00529789|366194436|FG000|Study Period II/III|Lack of Efficacy|2|||
106145879|NCT00529789|366194436|FG000|Study Period II/III|Withdrawal by Subject|1|||
106145880|NCT00529789|366194436|FG000|Study Period II/III|Protocol Violation|3|||
106145881|NCT00529789|366194436|FG000|Study Period II/III|Physician Decision|3|||
106145882|NCT00529789|366194436|FG000|Study Period II/III|Lost to Follow-up|3|||
106145883|NCT00529789|366194436|FG000|Study Period IV|Parent/Caregiver Decision|1|||
106145884|NCT00529789|366194436|FG000|Study Period IV|Adverse Event|1|||
106145885|NCT00529789|366194436|FG000|Study Period IV|Lack of Efficacy|1|||
106145886|NCT00529789|366194436|FG000|Study Period IV|Lost to Follow-up|3|||
106145887|NCT01595061|366194437|FG000|Overall Study|Never Treated|3|||
106145888|NCT01595061|366194437|FG000|Overall Study|Inadequate Pathology|1|||
106145889|NCT02204982|366194440|FG000|Overall Study|Patient ineligible-medical monitor|1|||
106145890|NCT02204982|366194441|FG001|Overall Study|Patient ineligible-medical monitor|0|||
106145891|NCT02204982|366194440|FG000|Overall Study|Withdrawal by Subject|1|||
106145892|NCT02204982|366194441|FG001|Overall Study|Withdrawal by Subject|0|||
106145893|NCT02204982|366194440|FG000|Overall Study|Adverse Event|1|||
106145894|NCT02204982|366194441|FG001|Overall Study|Adverse Event|0|||
106145895|NCT02204982|366194440|FG000|Overall Study|Adverse Event and Investigator decision|1|||
105823084|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
105823085|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
105823086|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
106021031|NCT01708902|365741516|FG006|Overall Study|Lost to Follow-up|1|||
106021032|NCT01708902|365741510|FG000|Overall Study|Refused to continue trial medication|8|||
106021033|NCT01708902|365741511|FG001|Overall Study|Refused to continue trial medication|0|||
106021034|NCT01708902|365741512|FG002|Overall Study|Refused to continue trial medication|4|||
106021035|NCT01708902|365741513|FG003|Overall Study|Refused to continue trial medication|2|||
106021036|NCT01708902|365741514|FG004|Overall Study|Refused to continue trial medication|8|||
106021037|NCT01708902|365741515|FG005|Overall Study|Refused to continue trial medication|1|||
106021038|NCT01708902|365741516|FG006|Overall Study|Refused to continue trial medication|1|||
106021039|NCT01708902|365741510|FG000|Overall Study|Other Reason|1|||
106021040|NCT01708902|365741511|FG001|Overall Study|Other Reason|0|||
106021041|NCT01708902|365741512|FG002|Overall Study|Other Reason|1|||
106021042|NCT01708902|365741513|FG003|Overall Study|Other Reason|1|||
106021043|NCT01708902|365741514|FG004|Overall Study|Other Reason|1|||
106021044|NCT01708902|365741515|FG005|Overall Study|Other Reason|2|||
106021045|NCT01708902|365741516|FG006|Overall Study|Other Reason|0|||
106021046|NCT01500720|365741517|FG000|Overall Study|Randomized But Not Treated|1|||
106021047|NCT01500720|365741518|FG001|Overall Study|Randomized But Not Treated|1|||
106021048|NCT01500720|365741517|FG000|Overall Study|Other|4|||
106021049|NCT01500720|365741518|FG001|Overall Study|Other|8|||
106021050|NCT00740857|365741519|FG000|Overall Study|Withdrawal by Subject|1|||
106021051|NCT00740857|365741520|FG001|Overall Study|Withdrawal by Subject|0|||
106021052|NCT00740857|365741521|FG002|Overall Study|Withdrawal by Subject|0|||
106021053|NCT02527421|365741522|FG000|Overall Study|Withdrawal by Subject|1|||
106021054|NCT02527421|365741523|FG001|Overall Study|Withdrawal by Subject|0|||
106021055|NCT00334113|365741531|FG000|Overall Study|Lost to Follow-up|2|||
106021056|NCT00334113|365741532|FG001|Overall Study|Lost to Follow-up|2|||
106021057|NCT00334113|365741531|FG000|Overall Study|Withdrawal by Subject|0|||
106021058|NCT00334113|365741532|FG001|Overall Study|Withdrawal by Subject|1|||
106021059|NCT04189224|365741533|FG000|Period 2|Adverse Event|0|||
106021060|NCT04189224|365741534|FG001|Period 2|Adverse Event|1|||
106021061|NCT00488683|365741536|FG000|Overall Study|Withdrawal by Subject|1|||
106145896|NCT02204982|366194441|FG001|Overall Study|Adverse Event and Investigator decision|0|||
106145897|NCT02204982|366194440|FG000|Overall Study|Physician Decision|0|||
106145898|NCT02204982|366194441|FG001|Overall Study|Physician Decision|2|||
106145899|NCT02204982|366194440|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
106145900|NCT02204982|366194441|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
106145901|NCT02204982|366194440|FG000|Overall Study|Termination of Study bySponsor|0|||
106145902|NCT02204982|366194441|FG001|Overall Study|Termination of Study bySponsor|1|||
106145903|NCT00960141|366194442|FG000|Overall Study|Adverse Event|4|||
106145904|NCT00960141|366194443|FG001|Overall Study|Adverse Event|8|||
106145905|NCT00960141|366194444|FG002|Overall Study|Adverse Event|2|||
106145906|NCT00960141|366194442|FG000|Overall Study|Lack of Efficacy|3|||
106145907|NCT00960141|366194443|FG001|Overall Study|Lack of Efficacy|4|||
106145908|NCT00960141|366194444|FG002|Overall Study|Lack of Efficacy|2|||
106145909|NCT00960141|366194442|FG000|Overall Study|Lost to Follow-up|1|||
106145910|NCT00960141|366194443|FG001|Overall Study|Lost to Follow-up|0|||
106145911|NCT00960141|366194444|FG002|Overall Study|Lost to Follow-up|0|||
106145912|NCT00960141|366194442|FG000|Overall Study|Protocol Violation|1|||
106145913|NCT00960141|366194443|FG001|Overall Study|Protocol Violation|3|||
106145914|NCT00960141|366194444|FG002|Overall Study|Protocol Violation|2|||
106145915|NCT00960141|366194442|FG000|Overall Study|Withdrawal by Subject|1|||
106145916|NCT00960141|366194443|FG001|Overall Study|Withdrawal by Subject|2|||
106145917|NCT00960141|366194444|FG002|Overall Study|Withdrawal by Subject|1|||
106145918|NCT00457743|366194446|FG000|Overall Study|Adverse Event|0|||
106145919|NCT00457743|366194447|FG001|Overall Study|Adverse Event|4|||
106145920|NCT00457743|366194448|FG002|Overall Study|Adverse Event|0|||
106145921|NCT00457743|366194446|FG000|Overall Study|Lack of Efficacy|3|||
106145922|NCT00457743|366194447|FG001|Overall Study|Lack of Efficacy|23|||
106145923|NCT00457743|366194448|FG002|Overall Study|Lack of Efficacy|3|||
106145924|NCT01837966|366194449|FG000|Overall Study|Withdrawal by Subject|2|||
106145925|NCT01837966|366194450|FG001|Overall Study|Withdrawal by Subject|1|||
106145926|NCT01493778|366194456|FG000|Overall Study|Withdrawal by Subject|8|||
106145927|NCT02115139|366194459|FG000|Overall Study|Protocol Violation|1|||
106145928|NCT02115139|366194459|FG000|Overall Study|treatment discontinuation|6|||
106145929|NCT01576484|366194460|FG000|Overall Study|Adverse Event|1|||
106021062|NCT00488683|365741537|FG001|Overall Study|Withdrawal by Subject|2|||
106021063|NCT00488683|365741538|FG002|Overall Study|Withdrawal by Subject|2|||
106021064|NCT00488683|365741536|FG000|Overall Study|Lost to Follow-up|5|||
106021065|NCT00488683|365741537|FG001|Overall Study|Lost to Follow-up|3|||
106021066|NCT00488683|365741538|FG002|Overall Study|Lost to Follow-up|0|||
106021067|NCT00488683|365741536|FG000|Overall Study|Protocol Violation|5|||
106021068|NCT00488683|365741537|FG001|Overall Study|Protocol Violation|1|||
106145930|NCT01576484|366194461|FG001|Overall Study|Adverse Event|1|||
106145931|NCT01576484|366194460|FG000|Overall Study|Protocol Violation|0|||
106145932|NCT01576484|366194461|FG001|Overall Study|Protocol Violation|2|||
106145933|NCT01576484|366194460|FG000|Overall Study|Sponsor Decision|2|||
106145934|NCT01576484|366194461|FG001|Overall Study|Sponsor Decision|8|||
105959164|NCT03265145|365509716|FG001|Overall Study|Adverse Event|0|||
105959165|NCT03265145|365509715|FG000|Overall Study|Withdrawal by Subject|23|||
105959166|NCT03265145|365509716|FG001|Overall Study|Withdrawal by Subject|19|||
105959167|NCT03265145|365509715|FG000|Overall Study|Death|12|||
105959168|NCT03265145|365509716|FG001|Overall Study|Death|12|||
105959169|NCT03265145|365509715|FG000|Overall Study|Lost to Follow-up|13|||
105959170|NCT03265145|365509716|FG001|Overall Study|Lost to Follow-up|9|||
105959171|NCT03265145|365509715|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
105959172|NCT03265145|365509716|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
105959173|NCT03265145|365509715|FG000|Overall Study|Switched back to previous medication|1|||
105767599|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
105767600|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
105767601|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
105959174|NCT03265145|365509716|FG001|Overall Study|Switched back to previous medication|0|||
105959175|NCT03265145|365509715|FG000|Overall Study|Did not want to take medication|1|||
105959176|NCT03265145|365509716|FG001|Overall Study|Did not want to take medication|0|||
105959177|NCT03265145|365509715|FG000|Overall Study|Subject could not afford medication|0|||
105959178|NCT03265145|365509716|FG001|Overall Study|Subject could not afford medication|1|||
105959179|NCT03265145|365509715|FG000|Overall Study|Site closed|2|||
105959180|NCT03265145|365509716|FG001|Overall Study|Site closed|3|||
105959181|NCT03265145|365509715|FG000|Overall Study|Incorrectly randomized|16|||
105959182|NCT03265145|365509716|FG001|Overall Study|Incorrectly randomized|6|||
105959183|NCT03265145|365509715|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
105959184|NCT03265145|365509716|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
105959185|NCT03265145|365509715|FG000|Overall Study|Physician Decision|0|||
105959186|NCT03265145|365509716|FG001|Overall Study|Physician Decision|3|||
105959187|NCT03265145|365509715|FG000|Overall Study|Subject transferred to another facility|0|||
105959188|NCT03265145|365509716|FG001|Overall Study|Subject transferred to another facility|1|||
105959189|NCT00837161|365509717|FG000|Overall Study|refused hysterectomy|2|||
105959190|NCT00316706|365511369|FG000|Overall Study|Lost to Follow-up|38|||
105959191|NCT00316706|365511370|FG001|Overall Study|Lost to Follow-up|48|||
105959192|NCT00283803|365511371|FG000|Overall Study|Physician Decision|9|||
105959193|NCT00283803|365511371|FG000|Overall Study|Withdrawal by Subject|4|||
106021069|NCT00488683|365741538|FG002|Overall Study|Protocol Violation|0|||
106021070|NCT00488683|365741536|FG000|Overall Study|Unable to Classify|1|||
105767602|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
105767603|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
105767604|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
105959194|NCT03493451|365511372|FG000|Overall Study|Death|11|||
105959195|NCT03493451|365511373|FG001|Overall Study|Death|26|||
106021071|NCT00488683|365741537|FG001|Overall Study|Unable to Classify|0|||
106021072|NCT00488683|365741538|FG002|Overall Study|Unable to Classify|0|||
105767605|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
105767606|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
105959196|NCT03493451|365511374|FG002|Overall Study|Death|3|||
105959197|NCT03493451|365511372|FG000|Overall Study|Lost to Follow-up|1|||
105959198|NCT03493451|365511373|FG001|Overall Study|Lost to Follow-up|4|||
105767607|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
105767608|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
105767609|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Death|0|||
105767610|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Death|0|||
105767611|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Death|0|||
105767612|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Death|0|||
105767613|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Death|1|||
105767614|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
105767615|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
105767616|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
105767617|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
105767618|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
105767619|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
105767620|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
105767621|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
105767622|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
105767623|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
105767624|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
105959199|NCT03493451|365511374|FG002|Overall Study|Lost to Follow-up|1|||
105959200|NCT03493451|365511372|FG000|Overall Study|Withdrawal by Subject|1|||
105959201|NCT03493451|365511373|FG001|Overall Study|Withdrawal by Subject|1|||
105959202|NCT03493451|365511374|FG002|Overall Study|Withdrawal by Subject|2|||
105959203|NCT03493451|365511372|FG000|Overall Study|Progressive Disease|1|||
105959204|NCT03493451|365511373|FG001|Overall Study|Progressive Disease|0|||
105959205|NCT03493451|365511374|FG002|Overall Study|Progressive Disease|0|||
105959206|NCT03493451|365511372|FG000|Overall Study|Transferred to long term extension study|8|||
105959207|NCT03493451|365511373|FG001|Overall Study|Transferred to long term extension study|13|||
105959208|NCT03493451|365511374|FG002|Overall Study|Transferred to long term extension study|5|||
105823087|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
105959209|NCT01133756|365511376|FG000|Overall Study|Adverse Event|1|||
105959210|NCT01133756|365511377|FG001|Overall Study|Adverse Event|2|||
105959211|NCT01133756|365511378|FG002|Overall Study|Adverse Event|1|||
106021073|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
106021074|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
106021075|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
106021076|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
106021077|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
106021078|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
106021079|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
106021080|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
106021081|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
106021082|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
106021083|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
106021084|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
106021085|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
106021086|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
106021087|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
106021088|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
105767625|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
105767626|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
105767627|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
105767628|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
105767629|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
105767630|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
105767631|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
105767632|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
105767633|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
105767634|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
105767635|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
105767636|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
105767637|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
105767638|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
105767639|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Other|0|||
105767640|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Other|0|||
105767641|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Other|0|||
105767642|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Other|1|||
105767643|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Other|3|||
105767644|NCT03107793|364800473|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
105767645|NCT03107793|364800474|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
105767646|NCT03107793|364800475|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
105767647|NCT03107793|364800476|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
105767648|NCT03107793|364800477|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
105767649|NCT03097133|364800478|FG000|Overall Study|Lost to Follow-up|3|||
105767650|NCT03097133|364800479|FG001|Overall Study|Lost to Follow-up|2|||
105767651|NCT03097133|364800478|FG000|Overall Study|Withdrawal by Subject|2|||
105767652|NCT03097133|364800479|FG001|Overall Study|Withdrawal by Subject|5|||
105767653|NCT03097133|364800478|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
105767654|NCT03097133|364800479|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
105767655|NCT03097133|364800478|FG000|Overall Study|Other|3|||
105767656|NCT03097133|364800479|FG001|Overall Study|Other|2|||
105767657|NCT03097133|364800478|FG000|Overall Study|Adverse Event|1|||
105767658|NCT03097133|364800479|FG001|Overall Study|Adverse Event|0|||
105767659|NCT01989572|364800483|FG000|Overall Study|Lack of Efficacy|35|||
105767660|NCT01989572|364800484|FG001|Overall Study|Lack of Efficacy|48|||
105767661|NCT01989572|364800485|FG002|Overall Study|Lack of Efficacy|48|||
105767662|NCT01989572|364800486|FG003|Overall Study|Lack of Efficacy|43|||
105767663|NCT01989572|364800487|FG004|Overall Study|Lack of Efficacy|71|||
105767664|NCT01989572|364800488|FG005|Overall Study|Lack of Efficacy|79|||
105767665|NCT01989572|364800483|FG000|Overall Study|Adverse Event|2|||
105767666|NCT01989572|364800484|FG001|Overall Study|Adverse Event|1|||
105767667|NCT01989572|364800485|FG002|Overall Study|Adverse Event|3|||
106021089|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
106021090|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
106021091|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
106021092|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
106021093|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
106021094|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
106021095|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
106021096|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
106021097|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
106021098|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
106021099|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
105959212|NCT01133756|365511376|FG000|Overall Study|Investigator Decision|1|||
105959213|NCT01133756|365511377|FG001|Overall Study|Investigator Decision|0|||
105959214|NCT01133756|365511378|FG002|Overall Study|Investigator Decision|0|||
105959215|NCT01133756|365511376|FG000|Overall Study|Withdrawal by Subject|0|||
105959216|NCT01133756|365511377|FG001|Overall Study|Withdrawal by Subject|1|||
105959217|NCT01133756|365511378|FG002|Overall Study|Withdrawal by Subject|0|||
105959218|NCT01133756|365511376|FG000|Overall Study|Progression of Disease|0|||
105959219|NCT01133756|365511377|FG001|Overall Study|Progression of Disease|0|||
105959220|NCT01133756|365511378|FG002|Overall Study|Progression of Disease|1|||
105959221|NCT01238991|365511382|FG000|Overall Study|Adverse Event|1|||
105959222|NCT01238991|365511383|FG001|Overall Study|Adverse Event|0|||
105959223|NCT01238991|365511384|FG002|Overall Study|Adverse Event|3|||
105959224|NCT01238991|365511385|FG003|Overall Study|Adverse Event|1|||
105959225|NCT01238991|365511386|FG004|Overall Study|Adverse Event|1|||
105959226|NCT01238991|365511387|FG005|Overall Study|Adverse Event|0|||
105959227|NCT01238991|365511388|FG006|Overall Study|Adverse Event|1|||
105959228|NCT01238991|365511389|FG007|Overall Study|Adverse Event|1|||
105767668|NCT01989572|364800486|FG003|Overall Study|Adverse Event|0|||
105959229|NCT01238991|365511390|FG008|Overall Study|Adverse Event|0|||
105959230|NCT01238991|365511391|FG009|Overall Study|Adverse Event|0|||
105959231|NCT01238991|365511382|FG000|Overall Study|Death|0|||
105959232|NCT01238991|365511383|FG001|Overall Study|Death|0|||
105959233|NCT01238991|365511384|FG002|Overall Study|Death|0|||
105767669|NCT01989572|364800487|FG004|Overall Study|Adverse Event|3|||
105767670|NCT01989572|364800488|FG005|Overall Study|Adverse Event|0|||
105767671|NCT01989572|364800483|FG000|Overall Study|Death|0|||
105767672|NCT01989572|364800484|FG001|Overall Study|Death|0|||
105767673|NCT01989572|364800485|FG002|Overall Study|Death|0|||
105767674|NCT01989572|364800486|FG003|Overall Study|Death|0|||
105767675|NCT01989572|364800487|FG004|Overall Study|Death|1|||
105767676|NCT01989572|364800488|FG005|Overall Study|Death|0|||
105823088|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105823089|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
106145935|NCT01576484|366194460|FG000|Overall Study|Withdrawal by Subject|0|||
106145936|NCT01576484|366194461|FG001|Overall Study|Withdrawal by Subject|3|||
106145937|NCT01576484|366194460|FG000|Overall Study|Other|2|||
106145938|NCT01576484|366194461|FG001|Overall Study|Other|5|||
106145939|NCT01792830|366194463|FG000|Overall Study|Withdrawal by Subject|22|||
106145940|NCT01792830|366194464|FG001|Overall Study|Withdrawal by Subject|0|||
106145941|NCT01792830|366194465|FG002|Overall Study|Withdrawal by Subject|0|||
106145942|NCT01792830|366194466|FG003|Overall Study|Withdrawal by Subject|2|||
106145943|NCT01792830|366194467|FG004|Overall Study|Withdrawal by Subject|1|||
106145944|NCT01792830|366194468|FG005|Overall Study|Withdrawal by Subject|1|||
106145945|NCT01792830|366194469|FG006|Overall Study|Withdrawal by Subject|1|||
106145946|NCT01792830|366194470|FG007|Overall Study|Withdrawal by Subject|1|||
106145947|NCT01792830|366194471|FG008|Overall Study|Withdrawal by Subject|7|||
106145948|NCT01792830|366194472|FG009|Overall Study|Withdrawal by Subject|0|||
106145949|NCT01792830|366194473|FG010|Overall Study|Withdrawal by Subject|2|||
106145950|NCT01792830|366194463|FG000|Overall Study|Death|3|||
106145951|NCT01792830|366194464|FG001|Overall Study|Death|0|||
106145952|NCT01792830|366194465|FG002|Overall Study|Death|0|||
106145953|NCT01792830|366194466|FG003|Overall Study|Death|1|||
106145954|NCT01792830|366194467|FG004|Overall Study|Death|0|||
106145955|NCT01792830|366194468|FG005|Overall Study|Death|0|||
106145956|NCT01792830|366194469|FG006|Overall Study|Death|1|||
106145957|NCT01792830|366194470|FG007|Overall Study|Death|0|||
106145958|NCT01792830|366194471|FG008|Overall Study|Death|1|||
106145959|NCT01792830|366194472|FG009|Overall Study|Death|0|||
106145960|NCT01792830|366194473|FG010|Overall Study|Death|1|||
106145961|NCT01792830|366194463|FG000|Overall Study|Adverse Event|0|||
106145962|NCT01792830|366194464|FG001|Overall Study|Adverse Event|0|||
106145963|NCT01792830|366194465|FG002|Overall Study|Adverse Event|0|||
106145964|NCT01792830|366194466|FG003|Overall Study|Adverse Event|0|||
106145965|NCT01792830|366194467|FG004|Overall Study|Adverse Event|0|||
106145966|NCT01792830|366194468|FG005|Overall Study|Adverse Event|0|||
106145967|NCT01792830|366194469|FG006|Overall Study|Adverse Event|0|||
106145968|NCT01792830|366194470|FG007|Overall Study|Adverse Event|0|||
106145969|NCT01792830|366194471|FG008|Overall Study|Adverse Event|1|||
106145970|NCT01792830|366194472|FG009|Overall Study|Adverse Event|0|||
106145971|NCT01792830|366194473|FG010|Overall Study|Adverse Event|0|||
106145972|NCT04504916|366194474|FG000|Overall Study|Study terminated|7|||
106145973|NCT04504916|366194475|FG001|Overall Study|Study terminated|8|||
106145974|NCT04504916|366194474|FG000|Overall Study|Death|54|||
106145975|NCT04504916|366194475|FG001|Overall Study|Death|18|||
106145976|NCT04504916|366194474|FG000|Overall Study|Lost to Follow-up|1|||
106145977|NCT04504916|366194475|FG001|Overall Study|Lost to Follow-up|1|||
106145978|NCT04504916|366194474|FG000|Overall Study|Withdrawal by Subject|8|||
106145979|NCT04504916|366194475|FG001|Overall Study|Withdrawal by Subject|4|||
106145980|NCT04504916|366194474|FG000|Overall Study|Did not agree to follow-up|0|||
106145981|NCT04504916|366194475|FG001|Overall Study|Did not agree to follow-up|1|||
106145982|NCT01943799|366194476|FG000|Overall Study|Lost to Follow-up|0|||
106145983|NCT01943799|366194477|FG001|Overall Study|Lost to Follow-up|1|||
106145984|NCT01943799|366194478|FG002|Overall Study|Lost to Follow-up|1|||
106145985|NCT01943799|366194479|FG003|Overall Study|Lost to Follow-up|0|||
106145986|NCT01943799|366194476|FG000|Overall Study|Protocol Violation|1|||
106145987|NCT01943799|366194477|FG001|Overall Study|Protocol Violation|0|||
106145988|NCT01943799|366194478|FG002|Overall Study|Protocol Violation|0|||
106145989|NCT01943799|366194479|FG003|Overall Study|Protocol Violation|0|||
106145990|NCT01943799|366194476|FG000|Overall Study|Withdrawal by Subject|4|||
106145991|NCT01943799|366194477|FG001|Overall Study|Withdrawal by Subject|2|||
106145992|NCT01943799|366194478|FG002|Overall Study|Withdrawal by Subject|1|||
106145993|NCT01943799|366194479|FG003|Overall Study|Withdrawal by Subject|0|||
106145994|NCT00373529|366194482|FG000|Overall Study|Physician Decision|19|||
106145995|NCT00373529|366194482|FG000|Overall Study|Withdrawal by Subject|7|||
106145996|NCT00373529|366194482|FG000|Overall Study|Adverse Event|7|||
105767677|NCT01989572|364800483|FG000|Overall Study|Withdrawal by Subject|4|||
105767678|NCT01989572|364800484|FG001|Overall Study|Withdrawal by Subject|1|||
105767679|NCT01989572|364800485|FG002|Overall Study|Withdrawal by Subject|5|||
106145997|NCT00373529|366194482|FG000|Overall Study|Treatment failure|36|||
106145998|NCT00373529|366194482|FG000|Overall Study|Disease recurrence|10|||
106145999|NCT00373529|366194482|FG000|Overall Study|Death|16|||
106146000|NCT00373529|366194482|FG000|Overall Study|Need for treatment prohibited by study|1|||
106146001|NCT00373529|366194482|FG000|Overall Study|Other|8|||
105767680|NCT01989572|364800486|FG003|Overall Study|Withdrawal by Subject|1|||
105767681|NCT01989572|364800487|FG004|Overall Study|Withdrawal by Subject|12|||
105767682|NCT01989572|364800488|FG005|Overall Study|Withdrawal by Subject|4|||
105767683|NCT01989572|364800483|FG000|Overall Study|complicating disease|1|||
105767684|NCT01989572|364800484|FG001|Overall Study|complicating disease|1|||
105767685|NCT01989572|364800485|FG002|Overall Study|complicating disease|2|||
105767686|NCT01989572|364800486|FG003|Overall Study|complicating disease|0|||
105767687|NCT01989572|364800487|FG004|Overall Study|complicating disease|1|||
105767688|NCT01989572|364800488|FG005|Overall Study|complicating disease|0|||
105767689|NCT01989572|364800483|FG000|Overall Study|error|2|||
105767690|NCT01989572|364800484|FG001|Overall Study|error|1|||
105767691|NCT01989572|364800485|FG002|Overall Study|error|1|||
105767692|NCT01989572|364800486|FG003|Overall Study|error|1|||
105767693|NCT01989572|364800487|FG004|Overall Study|error|1|||
105767694|NCT01989572|364800488|FG005|Overall Study|error|1|||
105959234|NCT01238991|365511385|FG003|Overall Study|Death|1|||
105767695|NCT01989572|364800483|FG000|Overall Study|maximum dose reached|0|||
105959235|NCT01238991|365511386|FG004|Overall Study|Death|0|||
106021100|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
106021101|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
106021102|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
106021103|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
106021104|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
106146002|NCT00373529|366194482|FG000|Overall Study|Failed independent confirmation of AML|3|||
106146003|NCT00373529|366194482|FG000|Overall Study|Consent violation|1|||
106146004|NCT00630786|366194488|FG000|Overall Study|Physician Decision|0|||
106146005|NCT00630786|366194489|FG001|Overall Study|Physician Decision|0|||
106146006|NCT00630786|366194490|FG002|Overall Study|Physician Decision|1|||
106146007|NCT00630786|366194488|FG000|Overall Study|Withdrawal by Subject|0|||
106146008|NCT00630786|366194489|FG001|Overall Study|Withdrawal by Subject|1|||
106146009|NCT00630786|366194490|FG002|Overall Study|Withdrawal by Subject|1|||
106146010|NCT00630786|366194488|FG000|Overall Study|Lost to Follow-up|0|||
106146011|NCT00630786|366194489|FG001|Overall Study|Lost to Follow-up|1|||
106146012|NCT00630786|366194490|FG002|Overall Study|Lost to Follow-up|0|||
106146013|NCT00630786|366194488|FG000|Overall Study|Other|1|||
106146014|NCT00630786|366194489|FG001|Overall Study|Other|0|||
106146015|NCT00630786|366194490|FG002|Overall Study|Other|0|||
106146016|NCT01787760|366194494|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
106146017|NCT01787760|366194495|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
106146018|NCT01787760|366194496|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
106146019|NCT01787760|366194494|FG000|Overall Study|Decompensated on left exotropia|0|||
106146020|NCT01787760|366194495|FG001|Overall Study|Decompensated on left exotropia|0|||
106146021|NCT01787760|366194496|FG002|Overall Study|Decompensated on left exotropia|1|||
106146022|NCT01787760|366194494|FG000|Overall Study|Dryness|0|||
106146023|NCT01787760|366194495|FG001|Overall Study|Dryness|1|||
106146024|NCT01787760|366194496|FG002|Overall Study|Dryness|0|||
106146025|NCT01787760|366194494|FG000|Overall Study|Relocation|1|||
106146026|NCT01787760|366194495|FG001|Overall Study|Relocation|1|||
106146027|NCT01787760|366194496|FG002|Overall Study|Relocation|0|||
106146028|NCT01787760|366194494|FG000|Overall Study|Lens discomfort|3|||
106146029|NCT01787760|366194495|FG001|Overall Study|Lens discomfort|0|||
106146030|NCT01787760|366194496|FG002|Overall Study|Lens discomfort|0|||
106146031|NCT01787760|366194494|FG000|Overall Study|Lens handling difficulty|1|||
106146032|NCT01787760|366194495|FG001|Overall Study|Lens handling difficulty|2|||
106146033|NCT01787760|366194496|FG002|Overall Study|Lens handling difficulty|0|||
106146034|NCT01787760|366194494|FG000|Overall Study|Protocol Violation|6|||
106146035|NCT01787760|366194495|FG001|Overall Study|Protocol Violation|0|||
106146036|NCT01787760|366194496|FG002|Overall Study|Protocol Violation|1|||
106146037|NCT01787760|366194494|FG000|Overall Study|Withdrawal by Subject|5|||
106146038|NCT01787760|366194495|FG001|Overall Study|Withdrawal by Subject|1|||
106146039|NCT01787760|366194496|FG002|Overall Study|Withdrawal by Subject|2|||
106146040|NCT01787760|366194494|FG000|Overall Study|Lost to Follow-up|1|||
106146041|NCT01787760|366194495|FG001|Overall Study|Lost to Follow-up|0|||
106146042|NCT01787760|366194496|FG002|Overall Study|Lost to Follow-up|1|||
106146043|NCT01787760|366194494|FG000|Overall Study|Stroke|1|||
106146044|NCT01787760|366194495|FG001|Overall Study|Stroke|0|||
106146045|NCT01787760|366194496|FG002|Overall Study|Stroke|0|||
106146046|NCT01787760|366194494|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
106146047|NCT01787760|366194495|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
106146048|NCT01787760|366194496|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
106146049|NCT01787760|366194494|FG000|Overall Study|Unsatisfactory physiological response|2|||
106146050|NCT01787760|366194495|FG001|Overall Study|Unsatisfactory physiological response|4|||
106146051|NCT01787760|366194496|FG002|Overall Study|Unsatisfactory physiological response|0|||
106146052|NCT01787760|366194494|FG000|Overall Study|Unsatisfactory visual response|1|||
106146053|NCT01787760|366194495|FG001|Overall Study|Unsatisfactory visual response|1|||
106021105|NCT03818035|365741540|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
106146054|NCT01787760|366194496|FG002|Overall Study|Unsatisfactory visual response|0|||
106146055|NCT01787760|366194494|FG000|Overall Study|Near vision blur|1|||
106146056|NCT01787760|366194495|FG001|Overall Study|Near vision blur|0|||
106146057|NCT01787760|366194496|FG002|Overall Study|Near vision blur|0|||
106146058|NCT03512756|366194497|FG000|Part 1|Death|23|||
105767696|NCT01989572|364800484|FG001|Overall Study|maximum dose reached|1|||
105767697|NCT01989572|364800485|FG002|Overall Study|maximum dose reached|0|||
105767698|NCT01989572|364800486|FG003|Overall Study|maximum dose reached|0|||
105767699|NCT01989572|364800487|FG004|Overall Study|maximum dose reached|1|||
105767700|NCT01989572|364800488|FG005|Overall Study|maximum dose reached|0|||
105767701|NCT01989572|364800483|FG000|Overall Study|unknown/not specify|3|||
105767702|NCT01989572|364800484|FG001|Overall Study|unknown/not specify|4|||
106021106|NCT03818035|365741541|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
105767703|NCT01989572|364800485|FG002|Overall Study|unknown/not specify|1|||
105767704|NCT01989572|364800486|FG003|Overall Study|unknown/not specify|3|||
105767705|NCT01989572|364800487|FG004|Overall Study|unknown/not specify|3|||
105767706|NCT01989572|364800488|FG005|Overall Study|unknown/not specify|5|||
105767707|NCT01989572|364800483|FG000|Overall Study|not start protocol therapy|5|||
105767708|NCT01989572|364800484|FG001|Overall Study|not start protocol therapy|1|||
105767709|NCT01989572|364800485|FG002|Overall Study|not start protocol therapy|2|||
105767710|NCT01989572|364800486|FG003|Overall Study|not start protocol therapy|3|||
105767711|NCT01989572|364800487|FG004|Overall Study|not start protocol therapy|4|||
105767712|NCT01989572|364800488|FG005|Overall Study|not start protocol therapy|18|||
105767713|NCT01989572|364800483|FG000|Overall Study|alternative therapy|3|||
105767714|NCT01989572|364800484|FG001|Overall Study|alternative therapy|0|||
105767715|NCT01989572|364800485|FG002|Overall Study|alternative therapy|0|||
105767716|NCT01989572|364800486|FG003|Overall Study|alternative therapy|0|||
105767717|NCT01989572|364800487|FG004|Overall Study|alternative therapy|1|||
105767718|NCT01989572|364800488|FG005|Overall Study|alternative therapy|3|||
105767719|NCT00732641|364800493|FG000|Overall Study|Relapse or Progressive Disease|65|||
105767720|NCT00732641|364800494|FG001|Overall Study|Relapse or Progressive Disease|101|||
105767721|NCT00732641|364800493|FG000|Overall Study|Serious Adverse Events|12|||
105767722|NCT00732641|364800494|FG001|Overall Study|Serious Adverse Events|3|||
105767723|NCT00732641|364800493|FG000|Overall Study|Physician Decision|6|||
105767724|NCT00732641|364800494|FG001|Overall Study|Physician Decision|0|||
105767725|NCT00732641|364800493|FG000|Overall Study|Withdrawal by Subject|4|||
105767726|NCT00732641|364800494|FG001|Overall Study|Withdrawal by Subject|2|||
105767727|NCT00732641|364800493|FG000|Overall Study|Unable to Complete|1|||
105767728|NCT00732641|364800494|FG001|Overall Study|Unable to Complete|1|||
105767729|NCT00732641|364800493|FG000|Overall Study|Other|18|||
106021107|NCT03818035|365741542|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
106021108|NCT03818035|365741543|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
106146059|NCT03512756|366194498|FG001|Part 1|Death|18|||
106146060|NCT03512756|366194499|FG002|Part 1|Death|0|||
106146061|NCT03512756|366194500|FG003|Part 1|Death|0|||
106146062|NCT03512756|366194497|FG000|Part 1|Lost to Follow-up|0|||
106146063|NCT03512756|366194498|FG001|Part 1|Lost to Follow-up|3|||
106146064|NCT03512756|366194499|FG002|Part 1|Lost to Follow-up|0|||
106146065|NCT03512756|366194500|FG003|Part 1|Lost to Follow-up|0|||
106146066|NCT03512756|366194497|FG000|Part 1|Physician Decision|0|||
106146067|NCT03512756|366194498|FG001|Part 1|Physician Decision|1|||
106146068|NCT03512756|366194499|FG002|Part 1|Physician Decision|0|||
106146069|NCT03512756|366194500|FG003|Part 1|Physician Decision|0|||
106146070|NCT03512756|366194497|FG000|Part 1|Withdrawal by Subject|2|||
106146071|NCT03512756|366194498|FG001|Part 1|Withdrawal by Subject|2|||
106146072|NCT03512756|366194499|FG002|Part 1|Withdrawal by Subject|0|||
106146073|NCT03512756|366194500|FG003|Part 1|Withdrawal by Subject|0|||
106146074|NCT03512756|366194497|FG000|Part 2|Death|0|||
106146075|NCT03512756|366194498|FG001|Part 2|Death|0|||
106146076|NCT03512756|366194499|FG002|Part 2|Death|32|||
106146077|NCT03512756|366194500|FG003|Part 2|Death|21|||
106146078|NCT03512756|366194497|FG000|Part 2|Lost to Follow-up|0|||
106146079|NCT03512756|366194498|FG001|Part 2|Lost to Follow-up|0|||
106146080|NCT03512756|366194499|FG002|Part 2|Lost to Follow-up|1|||
106146081|NCT03512756|366194500|FG003|Part 2|Lost to Follow-up|0|||
106146082|NCT03512756|366194497|FG000|Part 2|Physician Decision|0|||
106146083|NCT03512756|366194498|FG001|Part 2|Physician Decision|0|||
106146084|NCT03512756|366194499|FG002|Part 2|Physician Decision|2|||
106146085|NCT03512756|366194500|FG003|Part 2|Physician Decision|4|||
106146086|NCT03512756|366194497|FG000|Part 2|Study Terminated by Sponsor|0|||
106146087|NCT03512756|366194498|FG001|Part 2|Study Terminated by Sponsor|0|||
106146088|NCT03512756|366194499|FG002|Part 2|Study Terminated by Sponsor|2|||
106146089|NCT03512756|366194500|FG003|Part 2|Study Terminated by Sponsor|6|||
106146090|NCT03512756|366194497|FG000|Part 2|Protocol Violation|0|||
106146091|NCT03512756|366194498|FG001|Part 2|Protocol Violation|0|||
106146092|NCT03512756|366194499|FG002|Part 2|Protocol Violation|1|||
106146093|NCT03512756|366194500|FG003|Part 2|Protocol Violation|0|||
105767730|NCT00732641|364800494|FG001|Overall Study|Other|5|||
106146094|NCT03512756|366194497|FG000|Part 2|Withdrawal by Subject|0|||
106146095|NCT03512756|366194498|FG001|Part 2|Withdrawal by Subject|0|||
106146096|NCT03512756|366194499|FG002|Part 2|Withdrawal by Subject|3|||
106146097|NCT03512756|366194500|FG003|Part 2|Withdrawal by Subject|9|||
106146098|NCT01353963|366194503|FG000|Overall Study|Adverse Event|2|||
106146099|NCT00933400|366194509|FG000|Overall Study|Withdrawal by Subject|21|||
106146100|NCT00933400|366194510|FG001|Overall Study|Withdrawal by Subject|1|||
106146101|NCT01041417|366194513|FG000|Overall Study|Adverse Event|5|||
105767731|NCT00732238|364800495|FG000|Overall Study|Bacteremia|4|||
105767732|NCT00732238|364800496|FG001|Overall Study|Bacteremia|1|||
105767733|NCT00732238|364800495|FG000|Overall Study|Asymptomatic bacteriuria|1|||
105767734|NCT00732238|364800496|FG001|Overall Study|Asymptomatic bacteriuria|0|||
105767735|NCT02280096|364800497|FG000|Overall Study|Pregnancy|1|||
105767736|NCT02280096|364800498|FG001|Overall Study|Pregnancy|0|||
105767737|NCT02280096|364800497|FG000|Overall Study|Functional neurological disorder|1|||
105767738|NCT02280096|364800498|FG001|Overall Study|Functional neurological disorder|0|||
105767739|NCT02280096|364800497|FG000|Overall Study|Lack of attachment|0|||
105767740|NCT02280096|364800498|FG001|Overall Study|Lack of attachment|1|||
105767747|NCT02939976|364800503|FG000|Overall Study|Lost to Follow-up|7|||
105767748|NCT02939976|364800504|FG001|Overall Study|Lost to Follow-up|1|||
105767749|NCT02939976|364800505|FG002|Overall Study|Lost to Follow-up|1|||
105767750|NCT02939976|364800506|FG003|Overall Study|Lost to Follow-up|2|||
105767751|NCT02939976|364800503|FG000|Overall Study|Withdrawal by Subject|4|||
105767752|NCT02939976|364800504|FG001|Overall Study|Withdrawal by Subject|0|||
105767753|NCT02939976|364800505|FG002|Overall Study|Withdrawal by Subject|2|||
105767754|NCT02939976|364800506|FG003|Overall Study|Withdrawal by Subject|4|||
105767755|NCT02939976|364800503|FG000|Overall Study|Due to early study closure|4|||
105767756|NCT02939976|364800504|FG001|Overall Study|Due to early study closure|3|||
105767757|NCT02939976|364800505|FG002|Overall Study|Due to early study closure|2|||
105767758|NCT02939976|364800506|FG003|Overall Study|Due to early study closure|3|||
105767759|NCT00246376|364800507|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
105767760|NCT00246376|364800508|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
105767761|NCT00246376|364800509|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
105767762|NCT00246376|364800510|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
105767763|NCT00246376|364800511|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
105823090|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105823091|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
105823092|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
105823093|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
105823094|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
105823095|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105823096|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105823097|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105823098|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
105823099|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
105823100|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823101|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823102|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
106146102|NCT01041417|366194514|FG001|Overall Study|Adverse Event|2|||
106146103|NCT01041417|366194513|FG000|Overall Study|Lost to Follow-up|1|||
106146104|NCT01041417|366194514|FG001|Overall Study|Lost to Follow-up|1|||
106146105|NCT01041417|366194513|FG000|Overall Study|Death|1|||
106146106|NCT01041417|366194514|FG001|Overall Study|Death|0|||
106146107|NCT02299375|366194515|FG000|Overall Study|Adverse Event, serious fatal|1|||
105767764|NCT00246376|364800507|FG000|Overall Study|Adverse Event|2|||
105767765|NCT00246376|364800508|FG001|Overall Study|Adverse Event|3|||
105767766|NCT00246376|364800509|FG002|Overall Study|Adverse Event|1|||
105767767|NCT00246376|364800510|FG003|Overall Study|Adverse Event|3|||
105767768|NCT00246376|364800511|FG004|Overall Study|Adverse Event|1|||
105767769|NCT00246376|364800507|FG000|Overall Study|Lost to Follow-up|2|||
105767770|NCT00246376|364800508|FG001|Overall Study|Lost to Follow-up|11|||
105767771|NCT00246376|364800509|FG002|Overall Study|Lost to Follow-up|11|||
105767772|NCT00246376|364800510|FG003|Overall Study|Lost to Follow-up|16|||
105767773|NCT00246376|364800511|FG004|Overall Study|Lost to Follow-up|13|||
105767774|NCT01872897|364800512|FG000|Overall Study|Withdrawal by Subject|1|||
105767775|NCT01872897|364800513|FG001|Overall Study|Withdrawal by Subject|0|||
105767776|NCT01116648|364800514|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
105767777|NCT01116648|364800515|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
105767778|NCT01116648|364800516|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
105767779|NCT01116648|364800517|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
105767780|NCT01116648|364800518|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
105767781|NCT01116648|364800519|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
105767782|NCT01116648|364800520|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
105767783|NCT01116648|364800521|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
105767784|NCT01116648|364800522|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
105823103|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823104|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823105|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
105823106|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823107|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823108|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
105823109|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823110|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823111|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823112|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
105823113|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823114|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823115|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
105823116|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823117|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823118|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
106021109|NCT03818035|365741540|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
106021110|NCT03818035|365741541|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
106021111|NCT03818035|365741542|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
106021112|NCT03818035|365741543|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
106021113|NCT03818035|365741540|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
106021114|NCT03818035|365741541|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
106021115|NCT03818035|365741542|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
106146108|NCT02299375|366194516|FG001|Overall Study|Adverse Event, serious fatal|3|||
106146109|NCT02299375|366194515|FG000|Overall Study|Adverse Event, non-fatal|8|||
106146110|NCT02299375|366194516|FG001|Overall Study|Adverse Event, non-fatal|9|||
106146111|NCT02299375|366194515|FG000|Overall Study|Lack of Efficacy|1|||
106146112|NCT02299375|366194516|FG001|Overall Study|Lack of Efficacy|3|||
106146113|NCT02299375|366194515|FG000|Overall Study|Protocol Violation|1|||
106146114|NCT02299375|366194516|FG001|Overall Study|Protocol Violation|3|||
106146115|NCT02299375|366194515|FG000|Overall Study|Other: Met stopping criteria|1|||
106146116|NCT02299375|366194516|FG001|Overall Study|Other: Met stopping criteria|0|||
106146117|NCT02299375|366194515|FG000|Overall Study|Other: Study closed/terminated|66|||
106146118|NCT02299375|366194516|FG001|Overall Study|Other: Study closed/terminated|55|||
106146119|NCT02299375|366194515|FG000|Overall Study|Lost to Follow-up|0|||
106146120|NCT02299375|366194516|FG001|Overall Study|Lost to Follow-up|2|||
106146121|NCT02299375|366194515|FG000|Overall Study|Physician Decision|1|||
106146122|NCT02299375|366194516|FG001|Overall Study|Physician Decision|1|||
106146123|NCT02299375|366194515|FG000|Overall Study|Withdrawal by Subject|1|||
106146124|NCT02299375|366194516|FG001|Overall Study|Withdrawal by Subject|4|||
106146127|NCT03086369|366196414|FG000|Overall Study|Lost to Follow-up|1|||
106146128|NCT03086369|366196415|FG001|Overall Study|Lost to Follow-up|0|||
106146129|NCT03086369|366196416|FG002|Overall Study|Lost to Follow-up|0|||
106146130|NCT03086369|366196417|FG003|Overall Study|Lost to Follow-up|2|||
106146131|NCT03086369|366196418|FG004|Overall Study|Lost to Follow-up|1|||
106146132|NCT03086369|366196414|FG000|Overall Study|Physician Decision|0|||
106146133|NCT03086369|366196415|FG001|Overall Study|Physician Decision|0|||
106146134|NCT03086369|366196416|FG002|Overall Study|Physician Decision|0|||
106146135|NCT03086369|366196417|FG003|Overall Study|Physician Decision|1|||
106146136|NCT03086369|366196418|FG004|Overall Study|Physician Decision|2|||
106146137|NCT03086369|366196414|FG000|Overall Study|Withdrawal by Subject|0|||
106146138|NCT03086369|366196415|FG001|Overall Study|Withdrawal by Subject|0|||
106146139|NCT03086369|366196416|FG002|Overall Study|Withdrawal by Subject|0|||
106146140|NCT03086369|366196417|FG003|Overall Study|Withdrawal by Subject|5|||
106146141|NCT03086369|366196418|FG004|Overall Study|Withdrawal by Subject|3|||
106146142|NCT03086369|366196414|FG000|Overall Study|Progressive Disease|0|||
106146143|NCT03086369|366196415|FG001|Overall Study|Progressive Disease|0|||
106146144|NCT03086369|366196416|FG002|Overall Study|Progressive Disease|0|||
106146145|NCT03086369|366196417|FG003|Overall Study|Progressive Disease|1|||
106146146|NCT03086369|366196418|FG004|Overall Study|Progressive Disease|1|||
106146147|NCT00925587|366196421|FG000|Overall Study|Protocol Specified Criteria|6|||
106146148|NCT00925587|366196422|FG001|Overall Study|Protocol Specified Criteria|6|||
106146149|NCT00925587|366196421|FG000|Overall Study|Physician Decision|4|||
106146150|NCT00925587|366196422|FG001|Overall Study|Physician Decision|1|||
106146151|NCT00925587|366196421|FG000|Overall Study|Protocol Violation|6|||
106146152|NCT00925587|366196422|FG001|Overall Study|Protocol Violation|4|||
106146153|NCT00925587|366196421|FG000|Overall Study|Withdrawal by Subject|9|||
106146154|NCT00925587|366196422|FG001|Overall Study|Withdrawal by Subject|6|||
106146155|NCT00925587|366196421|FG000|Overall Study|Death|5|||
106146156|NCT00925587|366196422|FG001|Overall Study|Death|5|||
105767785|NCT01116648|364800523|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
105767786|NCT01116648|364800524|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
105767787|NCT01116648|364800525|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
105767788|NCT01116648|364800526|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
105767789|NCT01116648|364800527|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
105767790|NCT01116648|364800528|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
105767791|NCT04159701|364800529|FG000|Period 1: Treatment Period|Pregnancy|1|||
105767792|NCT04159701|364800530|FG001|Period 1: Treatment Period|Pregnancy|0|||
105767793|NCT04159701|364800529|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
105767794|NCT04159701|364800530|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
105767795|NCT04159701|364800529|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
105767796|NCT04159701|364800530|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
105767797|NCT04159701|364800529|FG000|Washout Period|site terminated by sponsor|0|||
105767798|NCT04159701|364800530|FG001|Washout Period|site terminated by sponsor|1|||
105767799|NCT04159701|364800529|FG000|Washout Period|study terminated by sponsor|10|||
105767800|NCT04159701|364800530|FG001|Washout Period|study terminated by sponsor|3|||
105767801|NCT04159701|364800529|FG000|Washout Period|Withdrawal by Subject|1|||
105767802|NCT04159701|364800530|FG001|Washout Period|Withdrawal by Subject|0|||
105767803|NCT04159701|364800529|FG000|Washout Period|Inadvertent Enrollment|1|||
105767804|NCT04159701|364800530|FG001|Washout Period|Inadvertent Enrollment|0|||
105767805|NCT04159701|364800529|FG000|Washout Period|Miscellaneous|1|||
105767806|NCT04159701|364800530|FG001|Washout Period|Miscellaneous|0|||
105767807|NCT04159701|364800529|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
105767808|NCT04159701|364800530|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
105767809|NCT04159701|364800529|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
105767810|NCT04159701|364800530|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
105767811|NCT04159701|364800529|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
105767812|NCT04159701|364800530|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
105767813|NCT04159701|364800529|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
105767814|NCT04159701|364800530|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
105767815|NCT04159701|364800529|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
105767816|NCT04159701|364800530|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
105767817|NCT00865046|364800531|FG000|Overall Study|Lost to Follow-up|1|||
105767818|NCT00865046|364800532|FG001|Overall Study|Lost to Follow-up|4|||
105767819|NCT00865046|364800533|FG002|Overall Study|Lost to Follow-up|0|||
105767820|NCT00865046|364800531|FG000|Overall Study|Death|0|||
105767821|NCT00865046|364800532|FG001|Overall Study|Death|1|||
105767822|NCT00865046|364800533|FG002|Overall Study|Death|1|||
105767823|NCT00865046|364800531|FG000|Overall Study|Withdrawal by Subject|5|||
105767824|NCT00865046|364800532|FG001|Overall Study|Withdrawal by Subject|0|||
105767825|NCT00865046|364800533|FG002|Overall Study|Withdrawal by Subject|0|||
105767826|NCT03447821|364800534|FG000|Overall Study|Withdrawal by Subject|1|||
105767827|NCT03447821|364800535|FG001|Overall Study|Withdrawal by Subject|1|||
105767828|NCT03447821|364800536|FG002|Overall Study|Withdrawal by Subject|0|||
105767829|NCT03447821|364800534|FG000|Overall Study|Lost to Follow-up|0|||
105767830|NCT03447821|364800535|FG001|Overall Study|Lost to Follow-up|0|||
105959236|NCT01238991|365511387|FG005|Overall Study|Death|0|||
105959237|NCT01238991|365511388|FG006|Overall Study|Death|0|||
105959238|NCT01238991|365511389|FG007|Overall Study|Death|0|||
105959239|NCT01238991|365511390|FG008|Overall Study|Death|0|||
105959240|NCT01238991|365511391|FG009|Overall Study|Death|0|||
105959241|NCT01238991|365511382|FG000|Overall Study|Lack of Efficacy|0|||
105959242|NCT01238991|365511383|FG001|Overall Study|Lack of Efficacy|0|||
105959243|NCT01238991|365511384|FG002|Overall Study|Lack of Efficacy|1|||
105959244|NCT01238991|365511385|FG003|Overall Study|Lack of Efficacy|0|||
105959245|NCT01238991|365511386|FG004|Overall Study|Lack of Efficacy|0|||
105959246|NCT01238991|365511387|FG005|Overall Study|Lack of Efficacy|0|||
105959247|NCT01238991|365511388|FG006|Overall Study|Lack of Efficacy|0|||
105959248|NCT01238991|365511389|FG007|Overall Study|Lack of Efficacy|0|||
105959249|NCT01238991|365511390|FG008|Overall Study|Lack of Efficacy|1|||
105959250|NCT01238991|365511391|FG009|Overall Study|Lack of Efficacy|0|||
105959251|NCT01238991|365511382|FG000|Overall Study|Withdrawal by Subject|0|||
105959252|NCT01238991|365511383|FG001|Overall Study|Withdrawal by Subject|0|||
105959253|NCT01238991|365511384|FG002|Overall Study|Withdrawal by Subject|1|||
105959254|NCT01238991|365511385|FG003|Overall Study|Withdrawal by Subject|0|||
105959255|NCT01238991|365511386|FG004|Overall Study|Withdrawal by Subject|0|||
105959256|NCT01238991|365511387|FG005|Overall Study|Withdrawal by Subject|0|||
105959257|NCT01238991|365511388|FG006|Overall Study|Withdrawal by Subject|0|||
105959258|NCT01238991|365511389|FG007|Overall Study|Withdrawal by Subject|0|||
105959259|NCT01238991|365511390|FG008|Overall Study|Withdrawal by Subject|0|||
105959260|NCT01238991|365511391|FG009|Overall Study|Withdrawal by Subject|0|||
105959261|NCT01238991|365511382|FG000|Overall Study|Study Terminated by Sponsor|0|||
105959262|NCT01238991|365511383|FG001|Overall Study|Study Terminated by Sponsor|0|||
105959263|NCT01238991|365511384|FG002|Overall Study|Study Terminated by Sponsor|0|||
106146157|NCT00925587|366196421|FG000|Overall Study|Adverse Event|6|||
105767831|NCT03447821|364800536|FG002|Overall Study|Lost to Follow-up|1|||
105767832|NCT00329784|364800537|FG000|Overall Study|Lost to Follow-up|0|||
105767833|NCT00329784|364800538|FG001|Overall Study|Lost to Follow-up|1|||
105767834|NCT00329784|364800539|FG002|Overall Study|Lost to Follow-up|0|||
105767835|NCT00329784|364800540|FG003|Overall Study|Lost to Follow-up|0|||
105767836|NCT00329784|364800537|FG000|Overall Study|Withdrawal by Subject|4|||
105767837|NCT00329784|364800538|FG001|Overall Study|Withdrawal by Subject|2|||
105767838|NCT00329784|364800539|FG002|Overall Study|Withdrawal by Subject|0|||
105767839|NCT00329784|364800540|FG003|Overall Study|Withdrawal by Subject|0|||
105767840|NCT00329784|364800537|FG000|Overall Study|Other|1|||
105767841|NCT00329784|364800538|FG001|Overall Study|Other|2|||
105767842|NCT00329784|364800539|FG002|Overall Study|Other|0|||
105767843|NCT00329784|364800540|FG003|Overall Study|Other|0|||
105767844|NCT04362189|364800541|FG000|Overall Study|Lost to Follow-up|0|||
105767845|NCT04362189|364800542|FG001|Overall Study|Lost to Follow-up|1|||
105767846|NCT04362189|364800541|FG000|Overall Study|Withdrawal by Subject|1|||
106021116|NCT03818035|365741543|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
106021117|NCT03818035|365741540|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
106021118|NCT03818035|365741541|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
106021119|NCT03818035|365741542|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
106021120|NCT03818035|365741543|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
106021121|NCT03818035|365741540|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
106021122|NCT03818035|365741541|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
106021123|NCT03818035|365741542|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
106021124|NCT03818035|365741543|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
106021125|NCT03818035|365741540|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
106021126|NCT03818035|365741541|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
106021127|NCT03818035|365741542|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
106021128|NCT03818035|365741543|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
106021129|NCT03818035|365741540|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
106021130|NCT03818035|365741541|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
106021131|NCT03818035|365741542|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
106021132|NCT03818035|365741543|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
106021133|NCT03374202|365741544|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
106021134|NCT03374202|365741545|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
106021135|NCT03374202|365741546|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
106021136|NCT03374202|365741544|FG000|Five Year Long Term Follow Up|Death|0|||
106021137|NCT03374202|365741545|FG001|Five Year Long Term Follow Up|Death|1|||
106021138|NCT03374202|365741546|FG002|Five Year Long Term Follow Up|Death|0|||
106097353|NCT01343407|366014389|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
106097354|NCT01343407|366014390|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
106097355|NCT01343407|366014385|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
106097356|NCT01343407|366014386|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
105823119|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
105823120|NCT04242446|365010410|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
106097357|NCT01343407|366014387|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
106097358|NCT01343407|366014388|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
106097359|NCT01343407|366014389|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
106097360|NCT01343407|366014390|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
106146158|NCT00925587|366196422|FG001|Overall Study|Adverse Event|2|||
106146159|NCT00925587|366196421|FG000|Overall Study|Lost to Follow-up|0|||
106146160|NCT00925587|366196422|FG001|Overall Study|Lost to Follow-up|1|||
106146161|NCT03762668|366196423|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
106146162|NCT03762668|366196424|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
106146163|NCT00178399|366196427|FG000|Overall Study|Physician Decision|4|||
106146164|NCT00178399|366196427|FG000|Overall Study|Withdrawal by Subject|8|||
106146165|NCT00178399|366196427|FG000|Overall Study|Lost to Follow-up|1|||
106146166|NCT04425629|366196432|FG000|Overall Study|Adverse Event|0|||
106146167|NCT04425629|366196433|FG001|Overall Study|Adverse Event|0|||
106146168|NCT04425629|366196434|FG002|Overall Study|Adverse Event|0|||
106146169|NCT04425629|366196435|FG003|Overall Study|Adverse Event|0|||
106146170|NCT04425629|366196436|FG004|Overall Study|Adverse Event|1|||
106146171|NCT04425629|366196437|FG005|Overall Study|Adverse Event|0|||
106146172|NCT04425629|366196438|FG006|Overall Study|Adverse Event|0|||
106146173|NCT04425629|366196439|FG007|Overall Study|Adverse Event|0|||
106146174|NCT04425629|366196440|FG008|Overall Study|Adverse Event|0|||
106146175|NCT04425629|366196441|FG009|Overall Study|Adverse Event|3|||
106146176|NCT04425629|366196442|FG010|Overall Study|Adverse Event|2|||
106146177|NCT04425629|366196443|FG011|Overall Study|Adverse Event|1|||
106146178|NCT04425629|366196444|FG012|Overall Study|Adverse Event|1|||
106146179|NCT04425629|366196445|FG013|Overall Study|Adverse Event|0|||
106146180|NCT04425629|366196446|FG014|Overall Study|Adverse Event|0|||
106146181|NCT04425629|366196447|FG015|Overall Study|Adverse Event|0|||
105823121|NCT04242446|365010411|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
106097361|NCT03950739|366014391|FG000|Treatment Phase|Adverse Event|2|||
106146182|NCT04425629|366196448|FG016|Overall Study|Adverse Event|0|||
106146183|NCT04425629|366196449|FG017|Overall Study|Adverse Event|0|||
106146184|NCT04425629|366196450|FG018|Overall Study|Adverse Event|0|||
106146185|NCT04425629|366196432|FG000|Overall Study|Lost to Follow-up|1|||
106146186|NCT04425629|366196433|FG001|Overall Study|Lost to Follow-up|3|||
106146187|NCT04425629|366196434|FG002|Overall Study|Lost to Follow-up|1|||
106146188|NCT04425629|366196435|FG003|Overall Study|Lost to Follow-up|7|||
106146189|NCT04425629|366196436|FG004|Overall Study|Lost to Follow-up|1|||
105959264|NCT01238991|365511385|FG003|Overall Study|Study Terminated by Sponsor|0|||
105959265|NCT01238991|365511386|FG004|Overall Study|Study Terminated by Sponsor|1|||
105959266|NCT01238991|365511387|FG005|Overall Study|Study Terminated by Sponsor|0|||
105959267|NCT01238991|365511388|FG006|Overall Study|Study Terminated by Sponsor|7|||
105959268|NCT01238991|365511389|FG007|Overall Study|Study Terminated by Sponsor|4|||
105959269|NCT01238991|365511390|FG008|Overall Study|Study Terminated by Sponsor|2|||
105959270|NCT01238991|365511391|FG009|Overall Study|Study Terminated by Sponsor|2|||
105959271|NCT01238991|365511382|FG000|Overall Study|Caregiver's request|0|||
105959272|NCT01238991|365511383|FG001|Overall Study|Caregiver's request|0|||
105959273|NCT01238991|365511384|FG002|Overall Study|Caregiver's request|0|||
105959274|NCT01238991|365511385|FG003|Overall Study|Caregiver's request|0|||
106021139|NCT03207763|365743239|FG000|Overall Study|Lost to Follow-up|1|||
106021140|NCT03207763|365743240|FG001|Overall Study|Lost to Follow-up|0|||
106146190|NCT04425629|366196437|FG005|Overall Study|Lost to Follow-up|2|||
106146191|NCT04425629|366196438|FG006|Overall Study|Lost to Follow-up|1|||
106146192|NCT04425629|366196439|FG007|Overall Study|Lost to Follow-up|0|||
106146193|NCT04425629|366196440|FG008|Overall Study|Lost to Follow-up|1|||
106146194|NCT04425629|366196441|FG009|Overall Study|Lost to Follow-up|64|||
106146195|NCT04425629|366196442|FG010|Overall Study|Lost to Follow-up|70|||
106146196|NCT04425629|366196443|FG011|Overall Study|Lost to Follow-up|98|||
106146197|NCT04425629|366196444|FG012|Overall Study|Lost to Follow-up|30|||
105767847|NCT04362189|364800542|FG001|Overall Study|Withdrawal by Subject|0|||
105767848|NCT04362189|364800541|FG000|Overall Study|FDA Clinical Hold|7|||
105767849|NCT04362189|364800542|FG001|Overall Study|FDA Clinical Hold|2|||
105767850|NCT04362189|364800541|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
105767851|NCT04362189|364800542|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
105767852|NCT04362189|364800541|FG000|Overall Study|Adverse Event|0|||
105767853|NCT04362189|364800542|FG001|Overall Study|Adverse Event|2|||
105767854|NCT04362189|364800541|FG000|Overall Study|Death|4|||
105767855|NCT04362189|364800542|FG001|Overall Study|Death|1|||
105767856|NCT00841672|364800547|FG000|Overall Study|Adverse Event|7|||
105767857|NCT00841672|364800548|FG001|Overall Study|Adverse Event|16|||
105767858|NCT00841672|364800547|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105767859|NCT00841672|364800548|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105767860|NCT00841672|364800547|FG000|Overall Study|Subject withdrew consent|2|||
105767861|NCT00841672|364800548|FG001|Overall Study|Subject withdrew consent|4|||
105767862|NCT00841672|364800547|FG000|Overall Study|Lost to Follow-up|1|||
105767863|NCT00841672|364800548|FG001|Overall Study|Lost to Follow-up|1|||
105767864|NCT00841672|364800547|FG000|Overall Study|Administrative problems|9|||
105767865|NCT00841672|364800548|FG001|Overall Study|Administrative problems|9|||
105767866|NCT00841672|364800547|FG000|Overall Study|Misrandomized|1|||
105767867|NCT00841672|364800548|FG001|Overall Study|Misrandomized|0|||
105767868|NCT00841672|364800547|FG000|Overall Study|Protocol Deviation|0|||
105767869|NCT00841672|364800548|FG001|Overall Study|Protocol Deviation|1|||
105767870|NCT01927068|364800549|FG000|Overall Study|Death|37|||
105767871|NCT01927068|364800550|FG001|Overall Study|Death|3|||
105767872|NCT01927068|364800549|FG000|Overall Study|Withdrawal by Subject|50|||
105767873|NCT01927068|364800550|FG001|Overall Study|Withdrawal by Subject|3|||
105767874|NCT01927068|364800549|FG000|Overall Study|Lost to Follow-up|10|||
105767875|NCT01927068|364800550|FG001|Overall Study|Lost to Follow-up|2|||
105767876|NCT01927068|364800549|FG000|Overall Study|Physician Decision|9|||
105767877|NCT01927068|364800550|FG001|Overall Study|Physician Decision|0|||
105767878|NCT01927068|364800549|FG000|Overall Study|Missed last follow-up visit|2|||
105767879|NCT01927068|364800550|FG001|Overall Study|Missed last follow-up visit|0|||
105767880|NCT00880607|364800551|FG000|Overall Study|Physician Decision|2|||
105823122|NCT04242446|365010412|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
105823123|NCT04242446|365010413|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105767881|NCT00880607|364800552|FG001|Overall Study|Physician Decision|2|||
105767882|NCT00880607|364800551|FG000|Overall Study|Protocol Violation|2|||
105767883|NCT00880607|364800552|FG001|Overall Study|Protocol Violation|1|||
105959275|NCT01238991|365511386|FG004|Overall Study|Caregiver's request|0|||
106146198|NCT04425629|366196445|FG013|Overall Study|Lost to Follow-up|0|||
106146199|NCT04425629|366196446|FG014|Overall Study|Lost to Follow-up|5|||
105959276|NCT01238991|365511387|FG005|Overall Study|Caregiver's request|0|||
105959277|NCT01238991|365511388|FG006|Overall Study|Caregiver's request|0|||
105959278|NCT01238991|365511389|FG007|Overall Study|Caregiver's request|0|||
105823124|NCT04242446|365010414|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105959279|NCT01238991|365511390|FG008|Overall Study|Caregiver's request|1|||
105959280|NCT01238991|365511391|FG009|Overall Study|Caregiver's request|0|||
105959281|NCT01238991|365511382|FG000|Overall Study|Admission to a nursing home|1|||
105959282|NCT01238991|365511383|FG001|Overall Study|Admission to a nursing home|0|||
105959283|NCT01238991|365511384|FG002|Overall Study|Admission to a nursing home|1|||
105959284|NCT01238991|365511385|FG003|Overall Study|Admission to a nursing home|0|||
105959285|NCT01238991|365511386|FG004|Overall Study|Admission to a nursing home|0|||
105959286|NCT01238991|365511387|FG005|Overall Study|Admission to a nursing home|0|||
105959287|NCT01238991|365511388|FG006|Overall Study|Admission to a nursing home|0|||
105959288|NCT01238991|365511389|FG007|Overall Study|Admission to a nursing home|0|||
105767884|NCT00880607|364800551|FG000|Overall Study|surgery did not extend past L1 level|3|||
105767885|NCT00880607|364800552|FG001|Overall Study|surgery did not extend past L1 level|0|||
105767886|NCT02725268|364800553|FG000|Overall Study|Death|58|||
106146200|NCT04425629|366196447|FG015|Overall Study|Lost to Follow-up|4|||
106146201|NCT04425629|366196448|FG016|Overall Study|Lost to Follow-up|0|||
105959289|NCT01238991|365511390|FG008|Overall Study|Admission to a nursing home|0|||
105959290|NCT01238991|365511391|FG009|Overall Study|Admission to a nursing home|0|||
105959291|NCT02263326|365511400|FG000|Overall Study|Lost to Follow-up|1|||
105959292|NCT02263326|365511401|FG001|Overall Study|Lost to Follow-up|1|||
105959293|NCT02397915|365511402|FG000|Period 1|Protocol Violation|0|||
105959294|NCT02397915|365511403|FG001|Period 1|Protocol Violation|1|||
105959295|NCT02397915|365511404|FG002|Period 1|Protocol Violation|0|||
105959296|NCT02397915|365511405|FG003|Period 1|Protocol Violation|0|||
105959297|NCT02397915|365511402|FG000|Period 1|Physician Decision|1|||
105959298|NCT02397915|365511403|FG001|Period 1|Physician Decision|0|||
105959299|NCT02397915|365511404|FG002|Period 1|Physician Decision|0|||
105959300|NCT02397915|365511405|FG003|Period 1|Physician Decision|0|||
105959301|NCT00861757|365511407|FG000|Overall Study|Adverse Event|1|||
105959302|NCT00861757|365511408|FG001|Overall Study|Adverse Event|5|||
105959303|NCT00861757|365511409|FG002|Overall Study|Adverse Event|7|||
105959304|NCT00861757|365511410|FG003|Overall Study|Adverse Event|2|||
105959305|NCT00861757|365511407|FG000|Overall Study|Entry Criteria Not Met|1|||
105959306|NCT00861757|365511408|FG001|Overall Study|Entry Criteria Not Met|2|||
105959307|NCT00861757|365511409|FG002|Overall Study|Entry Criteria Not Met|1|||
105959308|NCT00861757|365511410|FG003|Overall Study|Entry Criteria Not Met|1|||
105959309|NCT00861757|365511407|FG000|Overall Study|Lack of Efficacy|3|||
105959310|NCT00861757|365511408|FG001|Overall Study|Lack of Efficacy|1|||
105959311|NCT00861757|365511409|FG002|Overall Study|Lack of Efficacy|0|||
105959312|NCT00861757|365511410|FG003|Overall Study|Lack of Efficacy|1|||
105959313|NCT00861757|365511407|FG000|Overall Study|Lost to Follow-up|1|||
105959314|NCT00861757|365511408|FG001|Overall Study|Lost to Follow-up|0|||
105959315|NCT00861757|365511409|FG002|Overall Study|Lost to Follow-up|1|||
106146202|NCT04425629|366196449|FG017|Overall Study|Lost to Follow-up|3|||
106146203|NCT04425629|366196450|FG018|Overall Study|Lost to Follow-up|1|||
106146204|NCT04425629|366196432|FG000|Overall Study|Subject Decision|0|||
106146205|NCT04425629|366196433|FG001|Overall Study|Subject Decision|2|||
106146206|NCT04425629|366196434|FG002|Overall Study|Subject Decision|1|||
106146207|NCT04425629|366196435|FG003|Overall Study|Subject Decision|3|||
106146208|NCT04425629|366196436|FG004|Overall Study|Subject Decision|6|||
106146209|NCT04425629|366196437|FG005|Overall Study|Subject Decision|6|||
106146210|NCT04425629|366196438|FG006|Overall Study|Subject Decision|3|||
106146211|NCT04425629|366196439|FG007|Overall Study|Subject Decision|3|||
106146212|NCT04425629|366196440|FG008|Overall Study|Subject Decision|1|||
106146213|NCT04425629|366196441|FG009|Overall Study|Subject Decision|70|||
106146214|NCT04425629|366196442|FG010|Overall Study|Subject Decision|95|||
106146215|NCT04425629|366196443|FG011|Overall Study|Subject Decision|124|||
106146216|NCT04425629|366196444|FG012|Overall Study|Subject Decision|25|||
106146217|NCT04425629|366196445|FG013|Overall Study|Subject Decision|0|||
106146218|NCT04425629|366196446|FG014|Overall Study|Subject Decision|1|||
106146219|NCT04425629|366196447|FG015|Overall Study|Subject Decision|4|||
106146220|NCT04425629|366196448|FG016|Overall Study|Subject Decision|1|||
106146221|NCT04425629|366196449|FG017|Overall Study|Subject Decision|0|||
106146222|NCT04425629|366196450|FG018|Overall Study|Subject Decision|2|||
106146223|NCT04425629|366196432|FG000|Overall Study|Death|0|||
106146224|NCT04425629|366196433|FG001|Overall Study|Death|0|||
106146225|NCT04425629|366196434|FG002|Overall Study|Death|0|||
106146226|NCT04425629|366196435|FG003|Overall Study|Death|0|||
106146227|NCT04425629|366196436|FG004|Overall Study|Death|0|||
106146228|NCT04425629|366196437|FG005|Overall Study|Death|0|||
106146229|NCT04425629|366196438|FG006|Overall Study|Death|0|||
106146230|NCT04425629|366196439|FG007|Overall Study|Death|0|||
106146231|NCT04425629|366196440|FG008|Overall Study|Death|0|||
105959316|NCT00861757|365511410|FG003|Overall Study|Lost to Follow-up|1|||
105959317|NCT00861757|365511407|FG000|Overall Study|Physician Decision|0|||
105959318|NCT00861757|365511408|FG001|Overall Study|Physician Decision|0|||
105959319|NCT00861757|365511409|FG002|Overall Study|Physician Decision|0|||
106146232|NCT04425629|366196441|FG009|Overall Study|Death|11|||
106146233|NCT04425629|366196442|FG010|Overall Study|Death|2|||
106146234|NCT04425629|366196443|FG011|Overall Study|Death|4|||
106146235|NCT04425629|366196444|FG012|Overall Study|Death|0|||
106146236|NCT04425629|366196445|FG013|Overall Study|Death|0|||
106146237|NCT04425629|366196446|FG014|Overall Study|Death|0|||
106146238|NCT04425629|366196447|FG015|Overall Study|Death|0|||
106146239|NCT04425629|366196448|FG016|Overall Study|Death|0|||
105959320|NCT00861757|365511410|FG003|Overall Study|Physician Decision|1|||
105959321|NCT00861757|365511407|FG000|Overall Study|Protocol Violation|2|||
105959322|NCT00861757|365511408|FG001|Overall Study|Protocol Violation|2|||
105959323|NCT00861757|365511409|FG002|Overall Study|Protocol Violation|4|||
105959324|NCT00861757|365511410|FG003|Overall Study|Protocol Violation|1|||
105959325|NCT00861757|365511407|FG000|Overall Study|Withdrawal by Subject|1|||
105959326|NCT00861757|365511408|FG001|Overall Study|Withdrawal by Subject|5|||
106146240|NCT04425629|366196449|FG017|Overall Study|Death|0|||
106146241|NCT04425629|366196450|FG018|Overall Study|Death|0|||
106146242|NCT04425629|366196432|FG000|Overall Study|Sponsor Request|0|||
106146243|NCT04425629|366196433|FG001|Overall Study|Sponsor Request|0|||
105959327|NCT00861757|365511409|FG002|Overall Study|Withdrawal by Subject|5|||
105959328|NCT00861757|365511410|FG003|Overall Study|Withdrawal by Subject|2|||
105959329|NCT03332173|365511414|FG000|Overall Study|Death|7|||
105959330|NCT03332173|365511414|FG000|Overall Study|Withdrawal by Subject|6|||
105959331|NCT03332173|365511414|FG000|Overall Study|Lost to Follow-up|2|||
105959332|NCT03332173|365511414|FG000|Overall Study|Transferred to long-term extension study|29|||
105959333|NCT01995526|365511415|FG000|Overall Study|Physician Decision|1|||
105959334|NCT00383331|365511416|FG000|Overall Study|Protocol Violation|0|||
105959335|NCT00383331|365511417|FG001|Overall Study|Protocol Violation|1|||
105959336|NCT03226249|365511421|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
105959337|NCT03226249|365511421|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
105959338|NCT03226249|365511421|FG000|Survival Follow-up|Patients still in follow-up.|30|||
105959339|NCT00606411|365511422|FG000|Overall Study|Adverse Event|1|||
105959340|NCT00606411|365511423|FG001|Overall Study|Adverse Event|2|||
105959341|NCT00606411|365511422|FG000|Overall Study|Lack of Adherence|1|||
105959342|NCT00606411|365511423|FG001|Overall Study|Lack of Adherence|1|||
105959343|NCT00606411|365511422|FG000|Overall Study|Lack of Efficacy|1|||
105959344|NCT00606411|365511423|FG001|Overall Study|Lack of Efficacy|1|||
105959345|NCT00606411|365511422|FG000|Overall Study|Withdrawal by Subject|2|||
105959346|NCT00606411|365511423|FG001|Overall Study|Withdrawal by Subject|0|||
105959347|NCT00606411|365511422|FG000|Overall Study|Lost to Follow-up|1|||
105959348|NCT00606411|365511423|FG001|Overall Study|Lost to Follow-up|2|||
105959349|NCT00606411|365511422|FG000|Overall Study|Move out of state|0|||
105959350|NCT00606411|365511423|FG001|Overall Study|Move out of state|1|||
105959351|NCT01390298|365511425|FG000|Overall Study|Death|1|||
105959352|NCT01390298|365511425|FG000|Overall Study|long term ICU admission|1|||
105959353|NCT01390298|365511425|FG000|Overall Study|Withdrawal by Subject|14|||
105959354|NCT01390298|365511425|FG000|Overall Study|Lost to Follow-up|7|||
105959355|NCT01390298|365511425|FG000|Overall Study|Surgery cancelled|1|||
105959356|NCT02569476|365511430|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
105959357|NCT02569476|365511430|FG000|Overall Study|Death|33|||
105959358|NCT02569476|365511430|FG000|Overall Study|Withdrawal by Subject|9|||
105959359|NCT02569476|365511430|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
106021141|NCT02605122|365743241|FG000|Overall Study|Withdrawal by Subject|4|||
106021142|NCT02605122|365743242|FG001|Overall Study|Withdrawal by Subject|1|||
106021143|NCT02605122|365743241|FG000|Overall Study|Lost to Follow-up|1|||
106146244|NCT04425629|366196434|FG002|Overall Study|Sponsor Request|0|||
106146245|NCT04425629|366196435|FG003|Overall Study|Sponsor Request|2|||
106146246|NCT04425629|366196436|FG004|Overall Study|Sponsor Request|2|||
106146247|NCT04425629|366196437|FG005|Overall Study|Sponsor Request|2|||
106146248|NCT04425629|366196438|FG006|Overall Study|Sponsor Request|1|||
106146249|NCT04425629|366196439|FG007|Overall Study|Sponsor Request|0|||
106146250|NCT04425629|366196440|FG008|Overall Study|Sponsor Request|0|||
106146251|NCT04425629|366196441|FG009|Overall Study|Sponsor Request|9|||
106146252|NCT04425629|366196442|FG010|Overall Study|Sponsor Request|9|||
106146253|NCT04425629|366196443|FG011|Overall Study|Sponsor Request|10|||
106146254|NCT04425629|366196444|FG012|Overall Study|Sponsor Request|8|||
106146255|NCT04425629|366196445|FG013|Overall Study|Sponsor Request|0|||
106021144|NCT02605122|365743242|FG001|Overall Study|Lost to Follow-up|1|||
106021145|NCT02331277|365743243|FG000|Overall Study|Withdrawal by Subject|1|||
106021146|NCT02331277|365743244|FG001|Overall Study|Withdrawal by Subject|0|||
106021147|NCT00684060|365743245|FG000|Overall Study|Lost to Follow-up|1|||
106021148|NCT00684060|365743246|FG001|Overall Study|Lost to Follow-up|0|||
106021149|NCT00684060|365743245|FG000|Overall Study|New stenosis identified|1|||
106021150|NCT00684060|365743246|FG001|Overall Study|New stenosis identified|0|||
106021151|NCT00684060|365743245|FG000|Overall Study|Unable to collect MRI|1|||
106021152|NCT00684060|365743246|FG001|Overall Study|Unable to collect MRI|2|||
106146256|NCT04425629|366196446|FG014|Overall Study|Sponsor Request|0|||
106146257|NCT04425629|366196447|FG015|Overall Study|Sponsor Request|1|||
106146258|NCT04425629|366196448|FG016|Overall Study|Sponsor Request|0|||
106146259|NCT04425629|366196449|FG017|Overall Study|Sponsor Request|0|||
105959360|NCT02569476|365511430|FG000|Overall Study|Palliative care|1|||
106021153|NCT00684060|365743245|FG000|Overall Study|Death|0|||
106021154|NCT00684060|365743246|FG001|Overall Study|Death|1|||
106021155|NCT03894813|365743253|FG000|Overall Study|Adverse Event|1|||
106146260|NCT04425629|366196450|FG018|Overall Study|Sponsor Request|0|||
106146261|NCT04425629|366196432|FG000|Overall Study|Physician Decision|0|||
106146262|NCT04425629|366196433|FG001|Overall Study|Physician Decision|0|||
106146263|NCT04425629|366196434|FG002|Overall Study|Physician Decision|0|||
106146264|NCT04425629|366196435|FG003|Overall Study|Physician Decision|0|||
105959361|NCT02569476|365511430|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
105959362|NCT02569476|365511430|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
105959363|NCT04482439|365511435|FG000|Overall Study|Lost to Follow-up|1|||
105959364|NCT04482439|365511435|FG000|Overall Study|Unrelated illness|1|||
105959365|NCT02318368|365511436|FG000|Overall Study|Withdrawal by Subject|2|||
105959366|NCT02318368|365511437|FG001|Overall Study|Withdrawal by Subject|0|||
105959367|NCT02318368|365511436|FG000|Overall Study|Study terminated by the sponsor|5|||
106021156|NCT03894813|365743254|FG001|Overall Study|Adverse Event|1|||
106021157|NCT03894813|365743253|FG000|Overall Study|Lack of Efficacy|3|||
106021158|NCT03894813|365743254|FG001|Overall Study|Lack of Efficacy|3|||
106021159|NCT03894813|365743253|FG000|Overall Study|Lost to Follow-up|1|||
106021160|NCT03894813|365743254|FG001|Overall Study|Lost to Follow-up|0|||
106021161|NCT03894813|365743253|FG000|Overall Study|Pregnancy|2|||
106021162|NCT03894813|365743254|FG001|Overall Study|Pregnancy|1|||
106021163|NCT03894813|365743253|FG000|Overall Study|Protocol Violation|3|||
106021164|NCT03894813|365743254|FG001|Overall Study|Protocol Violation|7|||
106021165|NCT03894813|365743253|FG000|Overall Study|Withdrawal by Subject|1|||
106021166|NCT03894813|365743254|FG001|Overall Study|Withdrawal by Subject|3|||
106021167|NCT03894813|365743253|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
106021168|NCT03894813|365743254|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
106021169|NCT03083873|365743257|FG000|Overall Study|Death|6|||
106021170|NCT03083873|365743258|FG001|Overall Study|Death|15|||
106021171|NCT03083873|365743259|FG002|Overall Study|Death|13|||
106021172|NCT03083873|365743260|FG003|Overall Study|Death|9|||
106021173|NCT03083873|365743261|FG004|Overall Study|Death|0|||
106021174|NCT03083873|365743257|FG000|Overall Study|Sponsor Terminated Study|0|||
105767887|NCT02725268|364800554|FG001|Overall Study|Death|59|||
105767888|NCT02725268|364800555|FG002|Overall Study|Death|30|||
105767889|NCT02725268|364800556|FG003|Overall Study|Death|16|||
106021175|NCT03083873|365743258|FG001|Overall Study|Sponsor Terminated Study|1|||
106021176|NCT03083873|365743259|FG002|Overall Study|Sponsor Terminated Study|2|||
106021177|NCT03083873|365743260|FG003|Overall Study|Sponsor Terminated Study|3|||
106021178|NCT03083873|365743261|FG004|Overall Study|Sponsor Terminated Study|0|||
106021179|NCT03083873|365743257|FG000|Overall Study|Lost to Follow-up|0|||
106021180|NCT03083873|365743258|FG001|Overall Study|Lost to Follow-up|1|||
106021181|NCT03083873|365743259|FG002|Overall Study|Lost to Follow-up|1|||
106021182|NCT03083873|365743260|FG003|Overall Study|Lost to Follow-up|0|||
106021183|NCT03083873|365743261|FG004|Overall Study|Lost to Follow-up|0|||
106021184|NCT03083873|365743257|FG000|Overall Study|Withdrawal by Subject|2|||
106021185|NCT03083873|365743258|FG001|Overall Study|Withdrawal by Subject|0|||
106021186|NCT03083873|365743259|FG002|Overall Study|Withdrawal by Subject|0|||
106021187|NCT03083873|365743260|FG003|Overall Study|Withdrawal by Subject|0|||
106021188|NCT03083873|365743261|FG004|Overall Study|Withdrawal by Subject|0|||
106021189|NCT03083873|365743257|FG000|Overall Study|Did Not Receive TIL|2|||
106021190|NCT03083873|365743258|FG001|Overall Study|Did Not Receive TIL|5|||
106021191|NCT03083873|365743259|FG002|Overall Study|Did Not Receive TIL|3|||
106021192|NCT03083873|365743260|FG003|Overall Study|Did Not Receive TIL|1|||
105767890|NCT02725268|364800553|FG000|Overall Study|Lost to Follow-up|4|||
106021193|NCT03083873|365743261|FG004|Overall Study|Did Not Receive TIL|0|||
106021194|NCT02656693|365743262|FG000|Overall Study|Pregnancy|1|||
106021195|NCT02656693|365743263|FG001|Overall Study|Pregnancy|1|||
106021196|NCT02656693|365743264|FG002|Overall Study|Pregnancy|1|||
106021197|NCT02656693|365743262|FG000|Overall Study|Bariatric surgery|0|||
105767891|NCT02725268|364800554|FG001|Overall Study|Lost to Follow-up|3|||
106021198|NCT02656693|365743263|FG001|Overall Study|Bariatric surgery|1|||
105959368|NCT02318368|365511437|FG001|Overall Study|Study terminated by the sponsor|2|||
105959369|NCT02318368|365511436|FG000|Overall Study|Death|0|||
105959370|NCT02318368|365511437|FG001|Overall Study|Death|1|||
105959371|NCT01901614|365511438|FG000|Overall Study|Adverse Event|0|||
105959372|NCT01901614|365511439|FG001|Overall Study|Adverse Event|1|||
105959373|NCT01901614|365511438|FG000|Overall Study|Lost to Follow-up|1|||
105959374|NCT01901614|365511439|FG001|Overall Study|Lost to Follow-up|0|||
105959375|NCT01901614|365511438|FG000|Overall Study|Screen Fail|1|||
105959376|NCT01901614|365511439|FG001|Overall Study|Screen Fail|0|||
105959377|NCT01534351|365511440|FG000|Overall Study|Study Terminated Early|1|||
105959378|NCT01534351|365511441|FG001|Overall Study|Study Terminated Early|0|||
105959379|NCT01534351|365511442|FG002|Overall Study|Study Terminated Early|0|||
105959380|NCT02243371|365511445|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
105959381|NCT02243371|365511446|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
105959382|NCT02243371|365511445|FG000|Overall Study|Death (unrelated)|2|||
105959383|NCT02243371|365511446|FG001|Overall Study|Death (unrelated)|4|||
105959384|NCT02243371|365511445|FG000|Overall Study|Adverse Event (unrelated)|0|||
105959385|NCT02243371|365511446|FG001|Overall Study|Adverse Event (unrelated)|1|||
105959386|NCT02243371|365511445|FG000|Overall Study|Lack of Clinical Benefit|0|||
105959387|NCT02243371|365511446|FG001|Overall Study|Lack of Clinical Benefit|1|||
105959388|NCT02243371|365511445|FG000|Overall Study|Withdrawal by Subject|0|||
105959389|NCT02243371|365511446|FG001|Overall Study|Withdrawal by Subject|2|||
105959390|NCT01369199|365511447|FG000|Overall Study|Withdrawal by Subject|1|||
105959391|NCT01369199|365511447|FG000|Overall Study|Lost to Follow-up|2|||
105959392|NCT03012828|365511450|FG000|Overall Study|Lost to Follow-up|1|||
105959393|NCT03012828|365511451|FG001|Overall Study|Lost to Follow-up|0|||
105959394|NCT03012828|365511452|FG002|Overall Study|Lost to Follow-up|1|||
105959395|NCT03012828|365511453|FG003|Overall Study|Lost to Follow-up|0|||
105959396|NCT03012828|365511454|FG004|Overall Study|Lost to Follow-up|1|||
105959397|NCT03012828|365511455|FG005|Overall Study|Lost to Follow-up|0|||
105959398|NCT03012828|365511450|FG000|Overall Study|Withdrawal by Subject|0|||
105959399|NCT03012828|365511451|FG001|Overall Study|Withdrawal by Subject|0|||
105959400|NCT03012828|365511452|FG002|Overall Study|Withdrawal by Subject|1|||
105959401|NCT03012828|365511453|FG003|Overall Study|Withdrawal by Subject|0|||
105959402|NCT03012828|365511454|FG004|Overall Study|Withdrawal by Subject|0|||
105959403|NCT03012828|365511455|FG005|Overall Study|Withdrawal by Subject|1|||
105959404|NCT03012828|365511450|FG000|Overall Study|Non-compliance with protocol|0|||
105959405|NCT03012828|365511451|FG001|Overall Study|Non-compliance with protocol|0|||
105959406|NCT03012828|365511452|FG002|Overall Study|Non-compliance with protocol|0|||
105959407|NCT03012828|365511453|FG003|Overall Study|Non-compliance with protocol|0|||
105959408|NCT03012828|365511454|FG004|Overall Study|Non-compliance with protocol|1|||
105959409|NCT03012828|365511455|FG005|Overall Study|Non-compliance with protocol|0|||
105959410|NCT03012828|365511450|FG000|Overall Study|Delay to last visit would delay DBL|0|||
105959411|NCT03012828|365511451|FG001|Overall Study|Delay to last visit would delay DBL|0|||
105959412|NCT03012828|365511452|FG002|Overall Study|Delay to last visit would delay DBL|0|||
105959413|NCT03012828|365511453|FG003|Overall Study|Delay to last visit would delay DBL|0|||
105959414|NCT03012828|365511454|FG004|Overall Study|Delay to last visit would delay DBL|0|||
105959415|NCT03012828|365511455|FG005|Overall Study|Delay to last visit would delay DBL|1|||
105959416|NCT03900728|365511456|FG000|Overall Study|No text responses|0|||
105959417|NCT03900728|365511457|FG001|Overall Study|No text responses|0|||
105959418|NCT03900728|365511458|FG002|Overall Study|No text responses|4|||
105959419|NCT02565147|365511461|FG000|Overall Study|Withdrawal by Subject|5|||
105959420|NCT02565147|365511462|FG001|Overall Study|Withdrawal by Subject|1|||
105959421|NCT02565147|365511461|FG000|Overall Study|Lost to Follow-up|0|||
105959422|NCT02565147|365511462|FG001|Overall Study|Lost to Follow-up|1|||
105959423|NCT02565147|365511461|FG000|Overall Study|Death|1|||
105959424|NCT02565147|365511462|FG001|Overall Study|Death|1|||
105959425|NCT03082677|365511467|FG000|Overall Study|Not Treated|2|||
105959426|NCT03835481|365511468|FG000|Double-blind Period|Other not stated below|0|||
105959427|NCT03835481|365511469|FG001|Double-blind Period|Other not stated below|0|||
105959428|NCT03835481|365511470|FG002|Double-blind Period|Other not stated below|0|||
105959429|NCT03835481|365511471|FG003|Double-blind Period|Other not stated below|1|||
105959430|NCT03835481|365511472|FG004|Double-blind Period|Other not stated below|1|||
105959431|NCT03835481|365511468|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
105959432|NCT03835481|365511469|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
105959433|NCT03835481|365511470|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
105959434|NCT03835481|365511471|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
105959435|NCT03835481|365511472|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
105959436|NCT03835481|365511468|FG000|Double-blind Period|Withdrawal by Subject|0|||
105823125|NCT04242446|365010415|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105823126|NCT04242446|365010416|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
105823127|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105823128|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105823129|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
105823130|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
105823131|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
105823132|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
105823133|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
105823134|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105823135|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105823136|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
105823137|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
105823138|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
105823139|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
105823140|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
105823141|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105823142|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105823143|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
105823144|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
105823145|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
105823146|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
105823147|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
105823148|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105823149|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105823150|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
105823151|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
105823152|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
105823153|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
105823154|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
105823155|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105823156|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105823157|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
105823158|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
105823159|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
106146265|NCT04425629|366196436|FG004|Overall Study|Physician Decision|0|||
106146266|NCT04425629|366196437|FG005|Overall Study|Physician Decision|0|||
106146267|NCT04425629|366196438|FG006|Overall Study|Physician Decision|0|||
106146268|NCT04425629|366196439|FG007|Overall Study|Physician Decision|0|||
106146269|NCT04425629|366196440|FG008|Overall Study|Physician Decision|0|||
106146270|NCT04425629|366196441|FG009|Overall Study|Physician Decision|4|||
106146271|NCT04425629|366196442|FG010|Overall Study|Physician Decision|3|||
106146272|NCT04425629|366196443|FG011|Overall Study|Physician Decision|5|||
106146273|NCT04425629|366196444|FG012|Overall Study|Physician Decision|1|||
106146274|NCT04425629|366196445|FG013|Overall Study|Physician Decision|0|||
106146275|NCT04425629|366196446|FG014|Overall Study|Physician Decision|0|||
106146276|NCT04425629|366196447|FG015|Overall Study|Physician Decision|1|||
106146277|NCT04425629|366196448|FG016|Overall Study|Physician Decision|0|||
106146278|NCT04425629|366196449|FG017|Overall Study|Physician Decision|0|||
106146279|NCT04425629|366196450|FG018|Overall Study|Physician Decision|0|||
106146280|NCT04425629|366196432|FG000|Overall Study|Lack of Efficacy|0|||
106146281|NCT04425629|366196433|FG001|Overall Study|Lack of Efficacy|0|||
106146282|NCT04425629|366196434|FG002|Overall Study|Lack of Efficacy|0|||
106146283|NCT04425629|366196435|FG003|Overall Study|Lack of Efficacy|0|||
106146284|NCT04425629|366196436|FG004|Overall Study|Lack of Efficacy|0|||
106146285|NCT04425629|366196437|FG005|Overall Study|Lack of Efficacy|0|||
106146286|NCT04425629|366196438|FG006|Overall Study|Lack of Efficacy|0|||
106146287|NCT04425629|366196439|FG007|Overall Study|Lack of Efficacy|0|||
106146288|NCT04425629|366196440|FG008|Overall Study|Lack of Efficacy|0|||
106146289|NCT04425629|366196441|FG009|Overall Study|Lack of Efficacy|0|||
106146290|NCT04425629|366196442|FG010|Overall Study|Lack of Efficacy|1|||
106146291|NCT04425629|366196443|FG011|Overall Study|Lack of Efficacy|0|||
106146292|NCT04425629|366196444|FG012|Overall Study|Lack of Efficacy|0|||
106146293|NCT04425629|366196445|FG013|Overall Study|Lack of Efficacy|0|||
106146294|NCT04425629|366196446|FG014|Overall Study|Lack of Efficacy|0|||
106146295|NCT04425629|366196447|FG015|Overall Study|Lack of Efficacy|0|||
106146296|NCT04425629|366196448|FG016|Overall Study|Lack of Efficacy|0|||
106146297|NCT04425629|366196449|FG017|Overall Study|Lack of Efficacy|0|||
106146298|NCT04425629|366196450|FG018|Overall Study|Lack of Efficacy|0|||
106146299|NCT00002842|366196453|FG000|Overall Study|ineligible for surgical resection|27|||
106021199|NCT02656693|365743264|FG002|Overall Study|Bariatric surgery|2|||
106021200|NCT02269267|365743265|FG000|Overall Study|Death|5|||
106021201|NCT03773796|365743266|FG000|Overall Study|Adverse Event|1|||
106021202|NCT03773796|365743266|FG000|Overall Study|Withdrawal by Subject|1|||
106021203|NCT03773796|365743266|FG000|Overall Study|Lack of Efficacy|1|||
106021204|NCT03805659|365743267|FG000|Overall Study|Withdrawal by Subject|0|||
106021205|NCT03805659|365743268|FG001|Overall Study|Withdrawal by Subject|1|||
106021206|NCT00539864|365743270|FG000|Overall Study|Lost to Follow-up|0|||
106021207|NCT00539864|365743271|FG001|Overall Study|Lost to Follow-up|1|||
106021208|NCT00539864|365743270|FG000|Overall Study|Withdrawal by Subject|1|||
106021209|NCT00539864|365743271|FG001|Overall Study|Withdrawal by Subject|1|||
106021210|NCT01250145|365743272|FG000|Overall Study|Adverse Event|2|||
106021211|NCT01250145|365743273|FG001|Overall Study|Adverse Event|1|||
106021212|NCT01250145|365743272|FG000|Overall Study|Withdrawal by Subject|0|||
106021213|NCT01250145|365743273|FG001|Overall Study|Withdrawal by Subject|4|||
106021214|NCT02273596|365743274|FG000|24-Week Treatment Period|Adverse Event|3|||
106021215|NCT02273596|365743274|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
106021216|NCT02273596|365743274|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
106021217|NCT02273596|365743274|FG000|24-Week Treatment Period|Physician Decision|1|||
106021218|NCT02273596|365743274|FG000|24-Week Treatment Period|Protocol Deviation|1|||
106021219|NCT02273596|365743274|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
106021220|NCT02273596|365743274|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
106021221|NCT02273596|365743274|FG000|Extension Period|Lost to Follow-up|1|||
106021222|NCT02273596|365743274|FG000|Extension Period|Protocol Deviation|1|||
106021223|NCT02604160|365743275|FG000|Overall Study|Protocol Violation|0|||
106021224|NCT02604160|365743276|FG001|Overall Study|Protocol Violation|1|||
106021225|NCT02604160|365743275|FG000|Overall Study|Physician Decision|0|||
106021226|NCT02604160|365743276|FG001|Overall Study|Physician Decision|1|||
106021227|NCT02139592|365743277|FG000|Overall Study|Case Report Forms Uncollected|8|||
106021228|NCT02687191|365743279|FG000|Overall Study|Death|0|||
106021229|NCT02687191|365743280|FG001|Overall Study|Death|1|||
106021230|NCT02687191|365743281|FG002|Overall Study|Death|1|||
106021231|NCT02687191|365743282|FG003|Overall Study|Death|0|||
106021232|NCT02687191|365743283|FG004|Overall Study|Death|1|||
106021233|NCT02687191|365743284|FG005|Overall Study|Death|1|||
106021234|NCT02687191|365743279|FG000|Overall Study|Withdrawal by Subject|0|||
106021235|NCT02687191|365743280|FG001|Overall Study|Withdrawal by Subject|0|||
106021236|NCT02687191|365743281|FG002|Overall Study|Withdrawal by Subject|0|||
106021237|NCT02687191|365743282|FG003|Overall Study|Withdrawal by Subject|1|||
106021238|NCT02687191|365743283|FG004|Overall Study|Withdrawal by Subject|0|||
106021239|NCT02687191|365743284|FG005|Overall Study|Withdrawal by Subject|0|||
106021240|NCT03887702|365743285|FG000|Overall Study|Study terminated|0|||
106021241|NCT03887702|365743286|FG001|Overall Study|Study terminated|0|||
106021242|NCT03887702|365743287|FG002|Overall Study|Study terminated|2|||
106021243|NCT03887702|365743288|FG003|Overall Study|Study terminated|2|||
106021244|NCT01168219|365743292|FG000|Overall Study|off study before starting treatment|2|||
106021245|NCT01168219|365743292|FG000|Overall Study|withdrew before transplant|1|||
106021246|NCT01168219|365743292|FG000|Overall Study|ineligible due to CML|2|||
106021247|NCT02600819|365743295|FG000|GEN Phase|Adverse Event|2|||
106021248|NCT02600819|365743296|FG001|GEN Phase|Adverse Event|0|||
106021249|NCT02600819|365743295|FG000|GEN Phase|Death|2|||
106021250|NCT02600819|365743296|FG001|GEN Phase|Death|0|||
106021251|NCT02600819|365743295|FG000|GEN Phase|Investigator's Discretion|4|||
106021252|NCT02600819|365743296|FG001|GEN Phase|Investigator's Discretion|0|||
106021253|NCT02600819|365743295|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
106021254|NCT02600819|365743296|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
106021255|NCT02600819|365743295|FG000|GEN Phase|Withdrew Consent|5|||
106021256|NCT02600819|365743296|FG001|GEN Phase|Withdrew Consent|0|||
106021257|NCT02600819|365743295|FG000|GEN Phase|Lost to Follow-up|2|||
106021258|NCT02600819|365743296|FG001|GEN Phase|Lost to Follow-up|0|||
106021259|NCT02736890|365743297|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
106021260|NCT02736890|365743298|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
106021261|NCT02736890|365743297|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
106021262|NCT02736890|365743298|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
105767892|NCT02725268|364800555|FG002|Overall Study|Lost to Follow-up|0|||
105767893|NCT02725268|364800556|FG003|Overall Study|Lost to Follow-up|1|||
105767894|NCT02725268|364800553|FG000|Overall Study|Site Terminated by Sponsor|0|||
105767895|NCT02725268|364800554|FG001|Overall Study|Site Terminated by Sponsor|1|||
105767896|NCT02725268|364800555|FG002|Overall Study|Site Terminated by Sponsor|0|||
106021263|NCT01027273|365743299|FG000|Overall Study|Lost to Follow-up|57|||
106021264|NCT01027273|365743300|FG001|Overall Study|Lost to Follow-up|31|||
105767897|NCT02725268|364800556|FG003|Overall Study|Site Terminated by Sponsor|0|||
106021265|NCT01027273|365743299|FG000|Overall Study|Death|2|||
106021266|NCT01027273|365743300|FG001|Overall Study|Death|2|||
106021267|NCT02563067|365743306|FG000|Overall Study|Subject/guardian decision|14|||
106021268|NCT02563067|365743307|FG001|Overall Study|Subject/guardian decision|20|||
106021269|NCT02563067|365743308|FG002|Overall Study|Subject/guardian decision|16|||
106021270|NCT02563067|365743306|FG000|Overall Study|Physician Decision|0|||
106146300|NCT01613716|366196456|FG000|Overall Study|screen failures|3|||
106146301|NCT01613716|366196456|FG000|Overall Study|Lost to Follow-up|4|||
106146302|NCT00818454|366196457|FG000|Treatment Period 1|Adverse Event|0|||
106146303|NCT00818454|366196458|FG001|Treatment Period 1|Adverse Event|1|||
106146304|NCT00818454|366196459|FG002|Treatment Period 1|Adverse Event|0|||
106146305|NCT00818454|366196460|FG003|Treatment Period 1|Adverse Event|0|||
105823160|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
105823161|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
106146306|NCT00818454|366196457|FG000|Treatment Period 1|Other|3|||
106146307|NCT00818454|366196458|FG001|Treatment Period 1|Other|0|||
106146308|NCT00818454|366196459|FG002|Treatment Period 1|Other|0|||
105767898|NCT02725268|364800553|FG000|Overall Study|Withdrawal by Subject|8|||
105767899|NCT02725268|364800554|FG001|Overall Study|Withdrawal by Subject|6|||
105767900|NCT02725268|364800555|FG002|Overall Study|Withdrawal by Subject|8|||
105767901|NCT02725268|364800556|FG003|Overall Study|Withdrawal by Subject|1|||
105767902|NCT02725268|364800553|FG000|Overall Study|Reason not Specified|2|||
105823162|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823163|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823164|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823165|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
105823166|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823167|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105823168|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
105959437|NCT03835481|365511469|FG001|Double-blind Period|Withdrawal by Subject|0|||
105959438|NCT03835481|365511470|FG002|Double-blind Period|Withdrawal by Subject|1|||
105959439|NCT03835481|365511471|FG003|Double-blind Period|Withdrawal by Subject|0|||
105767903|NCT02725268|364800554|FG001|Overall Study|Reason not Specified|1|||
105767904|NCT02725268|364800555|FG002|Overall Study|Reason not Specified|0|||
105767905|NCT02725268|364800556|FG003|Overall Study|Reason not Specified|0|||
105767906|NCT04228445|364800557|FG000|Overall Study|Lost to Follow-up|1|||
105767907|NCT04228445|364800558|FG001|Overall Study|Lost to Follow-up|1|||
105767908|NCT04228445|364800557|FG000|Overall Study|Physician Decision|1|||
105767909|NCT04228445|364800558|FG001|Overall Study|Physician Decision|2|||
105767910|NCT04228445|364800557|FG000|Overall Study|Withdrawal by Subject|0|||
105767911|NCT04228445|364800558|FG001|Overall Study|Withdrawal by Subject|1|||
105767912|NCT04228445|364800557|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
105767913|NCT04228445|364800558|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
105959440|NCT03835481|365511472|FG004|Double-blind Period|Withdrawal by Subject|5|||
105959441|NCT03835481|365511468|FG000|Double-blind Period|Lost to Follow-up|0|||
105959442|NCT03835481|365511469|FG001|Double-blind Period|Lost to Follow-up|0|||
105959443|NCT03835481|365511470|FG002|Double-blind Period|Lost to Follow-up|0|||
105959444|NCT03835481|365511471|FG003|Double-blind Period|Lost to Follow-up|1|||
105959445|NCT03835481|365511472|FG004|Double-blind Period|Lost to Follow-up|0|||
105959446|NCT03835481|365511468|FG000|Double-blind Period|Protocol Violation|0|||
105959447|NCT03835481|365511469|FG001|Double-blind Period|Protocol Violation|2|||
105959448|NCT03835481|365511470|FG002|Double-blind Period|Protocol Violation|0|||
105959449|NCT03835481|365511471|FG003|Double-blind Period|Protocol Violation|1|||
105959450|NCT03835481|365511472|FG004|Double-blind Period|Protocol Violation|0|||
105959451|NCT03835481|365511468|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
105959452|NCT03835481|365511469|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
105959453|NCT03835481|365511470|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
105959454|NCT03835481|365511471|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
105959455|NCT03835481|365511472|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
105959456|NCT03835481|365511468|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
105959457|NCT03835481|365511469|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
105959458|NCT03835481|365511470|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
105959459|NCT03835481|365511471|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
105959460|NCT03835481|365511472|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
105959461|NCT03835481|365511468|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
105959462|NCT03835481|365511469|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
105959463|NCT03835481|365511470|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
105959464|NCT03835481|365511471|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
106146309|NCT00818454|366196460|FG003|Treatment Period 1|Other|0|||
106146310|NCT00818454|366196457|FG000|Washout Period of 1 Week|Adverse Event|1|||
105767914|NCT01167153|364800559|FG000|Overall Study|Non-effective therapy|1|||
105767915|NCT01167153|364800560|FG001|Overall Study|Non-effective therapy|4|||
105767916|NCT01167153|364800559|FG000|Overall Study|AE including clinical laboratory AE|2|||
105959465|NCT03835481|365511472|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
105767917|NCT01167153|364800560|FG001|Overall Study|AE including clinical laboratory AE|8|||
105767918|NCT01167153|364800559|FG000|Overall Study|Hypotension|1|||
105767919|NCT01167153|364800560|FG001|Overall Study|Hypotension|0|||
105767920|NCT01167153|364800559|FG000|Overall Study|Lost to Follow-up|7|||
105767921|NCT01167153|364800560|FG001|Overall Study|Lost to Follow-up|9|||
105767922|NCT01167153|364800559|FG000|Overall Study|Non-compliance to concomitant medication|0|||
105767923|NCT01167153|364800560|FG001|Overall Study|Non-compliance to concomitant medication|2|||
105767924|NCT01167153|364800559|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
105767925|NCT01167153|364800560|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
105767926|NCT01167153|364800559|FG000|Overall Study|Withdrawal consent|1|||
105767927|NCT01167153|364800560|FG001|Overall Study|Withdrawal consent|1|||
105767928|NCT01167153|364800559|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
105767929|NCT01167153|364800560|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
105767930|NCT01696396|364802555|FG000|Overall Study|Withdrawal by Subject|19|||
105767931|NCT01696396|364802556|FG001|Overall Study|Withdrawal by Subject|5|||
105767932|NCT01696396|364802557|FG002|Overall Study|Withdrawal by Subject|19|||
105767933|NCT01696396|364802558|FG003|Overall Study|Withdrawal by Subject|11|||
105767934|NCT01696396|364802555|FG000|Overall Study|Decision by Sponsor|3|||
105767935|NCT01696396|364802556|FG001|Overall Study|Decision by Sponsor|1|||
105767936|NCT01696396|364802557|FG002|Overall Study|Decision by Sponsor|2|||
105767937|NCT01696396|364802558|FG003|Overall Study|Decision by Sponsor|2|||
105767938|NCT01696396|364802555|FG000|Overall Study|Lost to Follow-up|9|||
105767939|NCT01696396|364802556|FG001|Overall Study|Lost to Follow-up|1|||
105767940|NCT01696396|364802557|FG002|Overall Study|Lost to Follow-up|4|||
105767941|NCT01696396|364802558|FG003|Overall Study|Lost to Follow-up|1|||
105767942|NCT01696396|364802555|FG000|Overall Study|Death|0|||
105767943|NCT01696396|364802556|FG001|Overall Study|Death|0|||
105767944|NCT01696396|364802557|FG002|Overall Study|Death|1|||
105767945|NCT01696396|364802558|FG003|Overall Study|Death|0|||
105767946|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Death|3|||
105767947|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Death|0|||
105767948|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Death|0|||
105767949|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Death|0|||
105767950|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Death|0|||
105767951|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Death|0|||
105767952|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Death|0|||
105767953|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Death|0|||
105767954|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767955|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
105767956|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
105767957|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767958|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767959|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767960|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767961|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
105767962|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
105767963|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767964|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
105767965|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767966|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767967|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767968|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767969|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
105767970|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105959466|NCT03835481|365511468|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
105959467|NCT03835481|365511469|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
105959468|NCT03835481|365511470|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
105959469|NCT03835481|365511471|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
105959470|NCT03835481|365511472|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
105959471|NCT03835481|365511468|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
105959472|NCT03835481|365511469|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
105767971|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767972|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
105767973|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767974|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767975|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767976|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767977|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
105767978|NCT02712008|364802565|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767979|NCT02712008|364802566|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
105767980|NCT02712008|364802567|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767981|NCT02712008|364802568|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767982|NCT02712008|364802569|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767983|NCT02712008|364802570|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767984|NCT02712008|364802571|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767985|NCT02712008|364802572|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
105767986|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Adverse Event|0|||
105767987|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Adverse Event|0|||
105767988|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Adverse Event|0|||
105767989|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Adverse Event|0|||
105767990|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Adverse Event|1|||
105767991|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Adverse Event|0|||
105767992|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Adverse Event|0|||
105767993|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Adverse Event|2|||
105767994|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Death|1|||
105767995|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Death|0|||
105767996|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Death|0|||
105767997|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Death|0|||
105767998|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Death|0|||
105767999|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Death|0|||
105768000|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Death|1|||
105768001|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Death|0|||
105768002|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
105823169|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823170|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823171|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823172|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823173|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
105823174|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105823175|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
105768003|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768004|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768005|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
105768006|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768007|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768008|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
105768009|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
105768010|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Physician Decision|0|||
105768011|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Physician Decision|0|||
105768012|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Physician Decision|0|||
105768013|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Physician Decision|1|||
105768014|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Physician Decision|1|||
105768015|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Physician Decision|0|||
105768016|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Physician Decision|0|||
105823176|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823177|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823178|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823179|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823180|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
105823181|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823182|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
105823183|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823184|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823185|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823186|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823187|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
105823188|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
105823189|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
106146311|NCT00818454|366196458|FG001|Washout Period of 1 Week|Adverse Event|1|||
106146312|NCT00818454|366196459|FG002|Washout Period of 1 Week|Adverse Event|0|||
105768017|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Physician Decision|0|||
105768018|NCT02712008|364802565|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768019|NCT02712008|364802566|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768020|NCT02712008|364802567|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768021|NCT02712008|364802568|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768022|NCT02712008|364802569|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105823190|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823191|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823192|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823193|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823194|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
105823195|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823196|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
105823197|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823198|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823199|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823200|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823201|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
105823202|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823203|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
105823204|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823205|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823206|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823207|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823208|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823209|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
105823210|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
105823211|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823212|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823213|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823214|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823215|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823216|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
105823217|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
105823218|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823219|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105768023|NCT02712008|364802570|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
105768024|NCT02712008|364802571|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
105768025|NCT02712008|364802572|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
105768026|NCT00777257|364802573|FG000|Overall Study|Adverse Event|3|||
105768027|NCT00777257|364802574|FG001|Overall Study|Adverse Event|1|||
105768028|NCT00777257|364802575|FG002|Overall Study|Adverse Event|0|||
105768029|NCT00777257|364802573|FG000|Overall Study|Lost to Follow-up|3|||
105768030|NCT00777257|364802574|FG001|Overall Study|Lost to Follow-up|3|||
105768031|NCT00777257|364802575|FG002|Overall Study|Lost to Follow-up|2|||
105768032|NCT00777257|364802573|FG000|Overall Study|Protocol Violation|2|||
105768033|NCT00777257|364802574|FG001|Overall Study|Protocol Violation|2|||
105768034|NCT00777257|364802575|FG002|Overall Study|Protocol Violation|2|||
105768035|NCT00777257|364802573|FG000|Overall Study|Withdrawal by Subject|3|||
105768036|NCT00777257|364802574|FG001|Overall Study|Withdrawal by Subject|6|||
105768037|NCT00777257|364802575|FG002|Overall Study|Withdrawal by Subject|5|||
105768038|NCT01199198|364802576|FG000|Overall Study|Adverse Event|3|||
105768039|NCT01199198|364802577|FG001|Overall Study|Adverse Event|0|||
105768040|NCT01199198|364802576|FG000|Overall Study|Lost to Follow-up|1|||
105768041|NCT01199198|364802577|FG001|Overall Study|Lost to Follow-up|5|||
105823220|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823221|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823222|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823223|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
105823224|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
105959473|NCT03835481|365511470|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
105959474|NCT03835481|365511471|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
105959475|NCT03835481|365511472|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
106146313|NCT00818454|366196460|FG003|Washout Period of 1 Week|Adverse Event|0|||
106146314|NCT00818454|366196457|FG000|Washout Period of 1 Week|Protocol Violation|2|||
105768042|NCT01199198|364802576|FG000|Overall Study|Withdrawal by Subject|1|||
105768043|NCT01199198|364802577|FG001|Overall Study|Withdrawal by Subject|2|||
105768044|NCT01199198|364802576|FG000|Overall Study|ICU Transfer|1|||
105768045|NCT01199198|364802577|FG001|Overall Study|ICU Transfer|2|||
105768046|NCT01199198|364802576|FG000|Overall Study|Hospice-care transfer|1|||
105768047|NCT01199198|364802577|FG001|Overall Study|Hospice-care transfer|2|||
105768048|NCT04315298|364802578|FG000|Overall Study|Withdrawal by Subject|0|||
105768049|NCT04315298|364802579|FG001|Overall Study|Withdrawal by Subject|0|||
105768050|NCT04315298|364802580|FG002|Overall Study|Withdrawal by Subject|0|||
105768051|NCT04315298|364802581|FG003|Overall Study|Withdrawal by Subject|2|||
105768052|NCT04315298|364802582|FG004|Overall Study|Withdrawal by Subject|2|||
105768053|NCT04315298|364802583|FG005|Overall Study|Withdrawal by Subject|2|||
105768054|NCT04315298|364802584|FG006|Overall Study|Withdrawal by Subject|0|||
105768055|NCT04315298|364802585|FG007|Overall Study|Withdrawal by Subject|1|||
105768056|NCT04315298|364802586|FG008|Overall Study|Withdrawal by Subject|1|||
105768057|NCT04315298|364802587|FG009|Overall Study|Withdrawal by Subject|1|||
105768058|NCT04315298|364802588|FG010|Overall Study|Withdrawal by Subject|0|||
105768059|NCT04315298|364802589|FG011|Overall Study|Withdrawal by Subject|0|||
105768060|NCT04315298|364802590|FG012|Overall Study|Withdrawal by Subject|0|||
105768061|NCT04315298|364802591|FG013|Overall Study|Withdrawal by Subject|0|||
105768062|NCT04315298|364802592|FG014|Overall Study|Withdrawal by Subject|0|||
105768063|NCT04315298|364802593|FG015|Overall Study|Withdrawal by Subject|0|||
105768064|NCT04315298|364802594|FG016|Overall Study|Withdrawal by Subject|0|||
105768065|NCT04315298|364802595|FG017|Overall Study|Withdrawal by Subject|0|||
105768066|NCT04315298|364802596|FG018|Overall Study|Withdrawal by Subject|0|||
105768067|NCT04315298|364802578|FG000|Overall Study|Physician Decision|0|||
105768068|NCT04315298|364802579|FG001|Overall Study|Physician Decision|0|||
105768069|NCT04315298|364802580|FG002|Overall Study|Physician Decision|0|||
105768070|NCT04315298|364802581|FG003|Overall Study|Physician Decision|0|||
105768071|NCT04315298|364802582|FG004|Overall Study|Physician Decision|1|||
105768072|NCT04315298|364802583|FG005|Overall Study|Physician Decision|0|||
105768073|NCT04315298|364802584|FG006|Overall Study|Physician Decision|0|||
105768074|NCT04315298|364802585|FG007|Overall Study|Physician Decision|0|||
105768075|NCT04315298|364802586|FG008|Overall Study|Physician Decision|0|||
105768076|NCT04315298|364802587|FG009|Overall Study|Physician Decision|0|||
105768077|NCT04315298|364802588|FG010|Overall Study|Physician Decision|0|||
105768078|NCT04315298|364802589|FG011|Overall Study|Physician Decision|0|||
105768079|NCT04315298|364802590|FG012|Overall Study|Physician Decision|0|||
105768080|NCT04315298|364802591|FG013|Overall Study|Physician Decision|0|||
105768081|NCT04315298|364802592|FG014|Overall Study|Physician Decision|0|||
105768082|NCT04315298|364802593|FG015|Overall Study|Physician Decision|0|||
105768083|NCT04315298|364802594|FG016|Overall Study|Physician Decision|0|||
105768084|NCT04315298|364802595|FG017|Overall Study|Physician Decision|0|||
105768085|NCT04315298|364802596|FG018|Overall Study|Physician Decision|0|||
105768086|NCT04315298|364802578|FG000|Overall Study|Lost to Follow-up|5|||
105768087|NCT04315298|364802579|FG001|Overall Study|Lost to Follow-up|10|||
105768088|NCT04315298|364802580|FG002|Overall Study|Lost to Follow-up|6|||
105768089|NCT04315298|364802581|FG003|Overall Study|Lost to Follow-up|8|||
105768090|NCT04315298|364802582|FG004|Overall Study|Lost to Follow-up|12|||
105768091|NCT04315298|364802583|FG005|Overall Study|Lost to Follow-up|13|||
105768092|NCT04315298|364802584|FG006|Overall Study|Lost to Follow-up|9|||
105768093|NCT04315298|364802585|FG007|Overall Study|Lost to Follow-up|16|||
105768094|NCT04315298|364802586|FG008|Overall Study|Lost to Follow-up|14|||
105959476|NCT03835481|365511468|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
105959477|NCT03835481|365511469|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
105959478|NCT03835481|365511470|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
105959479|NCT03835481|365511471|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
105959480|NCT03835481|365511472|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
105959481|NCT00255723|365511474|FG000|Overall Study|Adverse Event|1|||
105959482|NCT00255723|365511475|FG001|Overall Study|Adverse Event|1|||
105959483|NCT00255723|365511474|FG000|Overall Study|Death|0|||
105959484|NCT00255723|365511475|FG001|Overall Study|Death|1|||
105959485|NCT00255723|365511474|FG000|Overall Study|Response Data Not Available|1|||
105959486|NCT00255723|365511475|FG001|Overall Study|Response Data Not Available|0|||
105959487|NCT03711370|365511477|FG000|Overall Study|Lost to Follow-up|16|||
105959488|NCT03711370|365511478|FG001|Overall Study|Lost to Follow-up|10|||
105959489|NCT03711370|365511477|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
105959490|NCT03711370|365511478|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
105959491|NCT00976716|365511479|FG000|Overall Study|Adverse Event|1|||
105959492|NCT00407602|365511480|FG000|Overall Study|Death - unrelated to device|1|||
105959493|NCT00407602|365511480|FG000|Overall Study|Device explanted|5|||
105959494|NCT00407602|365511480|FG000|Overall Study|Withdrawal by Subject|1|||
105959495|NCT03028129|365511481|FG000|Overall Study|Adverse Event|13|||
105959496|NCT03028129|365511482|FG001|Overall Study|Adverse Event|2|||
105959497|NCT03028129|365511481|FG000|Overall Study|Lost to Follow-up|50|||
105959498|NCT03028129|365511482|FG001|Overall Study|Lost to Follow-up|38|||
105768095|NCT04315298|364802587|FG009|Overall Study|Lost to Follow-up|0|||
105959499|NCT03028129|365511481|FG000|Overall Study|Physician Decision|0|||
105959500|NCT03028129|365511482|FG001|Overall Study|Physician Decision|1|||
105823225|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823226|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823227|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823228|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823229|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823230|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
105823231|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
105823232|NCT04242446|365010410|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823233|NCT04242446|365010411|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823234|NCT04242446|365010412|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105959501|NCT03028129|365511481|FG000|Overall Study|Protocol Violation|1|||
105959502|NCT03028129|365511482|FG001|Overall Study|Protocol Violation|1|||
105959503|NCT03028129|365511481|FG000|Overall Study|Withdrawal by Subject|62|||
105959504|NCT03028129|365511482|FG001|Overall Study|Withdrawal by Subject|45|||
105768096|NCT04315298|364802588|FG010|Overall Study|Lost to Follow-up|2|||
105768097|NCT04315298|364802589|FG011|Overall Study|Lost to Follow-up|1|||
105768098|NCT04315298|364802590|FG012|Overall Study|Lost to Follow-up|0|||
105768099|NCT04315298|364802591|FG013|Overall Study|Lost to Follow-up|0|||
105768100|NCT04315298|364802592|FG014|Overall Study|Lost to Follow-up|0|||
105768101|NCT04315298|364802593|FG015|Overall Study|Lost to Follow-up|2|||
105768102|NCT04315298|364802594|FG016|Overall Study|Lost to Follow-up|0|||
105768103|NCT04315298|364802595|FG017|Overall Study|Lost to Follow-up|0|||
105768104|NCT04315298|364802596|FG018|Overall Study|Lost to Follow-up|0|||
105768105|NCT04315298|364802578|FG000|Overall Study|Death|24|||
105768106|NCT04315298|364802579|FG001|Overall Study|Death|60|||
105768107|NCT04315298|364802580|FG002|Overall Study|Death|49|||
105768108|NCT04315298|364802581|FG003|Overall Study|Death|59|||
105768109|NCT04315298|364802582|FG004|Overall Study|Death|70|||
105768110|NCT04315298|364802583|FG005|Overall Study|Death|114|||
105768111|NCT04315298|364802584|FG006|Overall Study|Death|9|||
105768112|NCT04315298|364802585|FG007|Overall Study|Death|12|||
105768113|NCT04315298|364802586|FG008|Overall Study|Death|21|||
105768114|NCT04315298|364802587|FG009|Overall Study|Death|16|||
105768115|NCT04315298|364802588|FG010|Overall Study|Death|40|||
105768116|NCT04315298|364802589|FG011|Overall Study|Death|40|||
105768117|NCT04315298|364802590|FG012|Overall Study|Death|3|||
105768118|NCT04315298|364802591|FG013|Overall Study|Death|4|||
105768119|NCT04315298|364802592|FG014|Overall Study|Death|6|||
105768120|NCT04315298|364802593|FG015|Overall Study|Death|4|||
105768121|NCT04315298|364802594|FG016|Overall Study|Death|3|||
105768122|NCT04315298|364802595|FG017|Overall Study|Death|1|||
105768123|NCT04315298|364802596|FG018|Overall Study|Death|0|||
105768124|NCT01183104|364802597|FG000|Overall Study|Adverse Event|8|||
105768125|NCT01183104|364802598|FG001|Overall Study|Adverse Event|6|||
105768126|NCT01183104|364802597|FG000|Overall Study|Death|0|||
105768127|NCT01183104|364802598|FG001|Overall Study|Death|1|||
105959505|NCT01169701|365511487|FG000|Overall Study|Lost to Follow-up|1|||
105959506|NCT01169701|365511488|FG001|Overall Study|Lost to Follow-up|1|||
105959507|NCT01169701|365511487|FG000|Overall Study|Withdrawal by Subject|1|||
105959508|NCT01169701|365511488|FG001|Overall Study|Withdrawal by Subject|3|||
105959509|NCT01169701|365511487|FG000|Overall Study|Adverse Event|1|||
105959510|NCT01169701|365511488|FG001|Overall Study|Adverse Event|2|||
105959511|NCT01169701|365511487|FG000|Overall Study|Exclusion criteria|2|||
105959512|NCT01169701|365511488|FG001|Overall Study|Exclusion criteria|0|||
105959513|NCT01169701|365511487|FG000|Overall Study|Death|0|||
105959514|NCT01169701|365511488|FG001|Overall Study|Death|1|||
105959515|NCT01169701|365511487|FG000|Overall Study|Administrative problems|0|||
105959516|NCT01169701|365511488|FG001|Overall Study|Administrative problems|1|||
105959517|NCT01169701|365511487|FG000|Overall Study|Serious adverse event|0|||
105959518|NCT01169701|365511488|FG001|Overall Study|Serious adverse event|1|||
105959519|NCT01169701|365511487|FG000|Overall Study|Sponsor decision|0|||
105959520|NCT01169701|365511488|FG001|Overall Study|Sponsor decision|1|||
105959521|NCT03583359|365511489|FG000|Overall Study|Withdrawal by Subject|15|||
105959522|NCT03583359|365511490|FG001|Overall Study|Withdrawal by Subject|6|||
105959523|NCT03583359|365511489|FG000|Overall Study|Lost to Follow-up|12|||
105959524|NCT03583359|365511490|FG001|Overall Study|Lost to Follow-up|3|||
105959525|NCT03583359|365511489|FG000|Overall Study|Adverse Event|0|||
105768128|NCT01183104|364802597|FG000|Overall Study|Lost to Follow-up|14|||
105768129|NCT01183104|364802598|FG001|Overall Study|Lost to Follow-up|7|||
105768130|NCT01183104|364802597|FG000|Overall Study|Physician Decision|5|||
105768131|NCT01183104|364802598|FG001|Overall Study|Physician Decision|8|||
105768132|NCT01183104|364802597|FG000|Overall Study|Withdrawal by Subject|6|||
105768133|NCT01183104|364802598|FG001|Overall Study|Withdrawal by Subject|11|||
105768134|NCT01183104|364802597|FG000|Overall Study|Nonparticipation in Extension Study|39|||
105959526|NCT03583359|365511490|FG001|Overall Study|Adverse Event|1|||
105768135|NCT01183104|364802598|FG001|Overall Study|Nonparticipation in Extension Study|50|||
105768136|NCT01183104|364802597|FG000|Overall Study|Did not receive study drug|5|||
105959527|NCT03583359|365511489|FG000|Overall Study|Protocol Violation|0|||
105959528|NCT03583359|365511490|FG001|Overall Study|Protocol Violation|1|||
105959529|NCT03583359|365511489|FG000|Overall Study|Other|2|||
105959530|NCT03583359|365511490|FG001|Overall Study|Other|1|||
105959531|NCT00375505|365511496|FG000|Overall Study|Adverse Event|1|||
105959532|NCT00375505|365511497|FG001|Overall Study|Adverse Event|2|||
105959533|NCT03497039|365511499|FG000|Overall Study|Withdrawal by Subject|1|||
105959534|NCT03497039|365511500|FG001|Overall Study|Withdrawal by Subject|0|||
105959535|NCT03497039|365511499|FG000|Overall Study|Protocol Violation|0|||
105959536|NCT03497039|365511500|FG001|Overall Study|Protocol Violation|1|||
105959537|NCT02567799|365511501|FG000|Concurrent Chemoradiotherapy|Death|1|||
105959538|NCT02567799|365511502|FG001|Concurrent Chemoradiotherapy|Death|0|||
105959539|NCT02567799|365511503|FG002|Concurrent Chemoradiotherapy|Death|0|||
105959540|NCT02567799|365511501|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
105959541|NCT02567799|365511502|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
105959542|NCT02567799|365511503|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
105959543|NCT02567799|365511501|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
106146315|NCT00818454|366196458|FG001|Washout Period of 1 Week|Protocol Violation|0|||
106146316|NCT00818454|366196459|FG002|Washout Period of 1 Week|Protocol Violation|0|||
106146317|NCT00818454|366196460|FG003|Washout Period of 1 Week|Protocol Violation|0|||
106146318|NCT00818454|366196457|FG000|Washout Period of 1 Week|Other|1|||
106146319|NCT00818454|366196458|FG001|Washout Period of 1 Week|Other|2|||
106146320|NCT00818454|366196459|FG002|Washout Period of 1 Week|Other|0|||
106146321|NCT00818454|366196460|FG003|Washout Period of 1 Week|Other|0|||
106146322|NCT00818454|366196457|FG000|Treatment Period 2|Other|2|||
106146323|NCT00818454|366196458|FG001|Treatment Period 2|Other|1|||
106146324|NCT00818454|366196459|FG002|Treatment Period 2|Other|0|||
106146325|NCT00818454|366196460|FG003|Treatment Period 2|Other|0|||
106146326|NCT00818454|366196457|FG000|Treatment Period 3|Adverse Event|0|||
105959544|NCT02567799|365511502|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
105959545|NCT02567799|365511503|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
105959546|NCT02567799|365511501|FG000|Follow-up|Death|1|||
105959547|NCT02567799|365511502|FG001|Follow-up|Death|0|||
105959548|NCT02567799|365511503|FG002|Follow-up|Death|1|||
105959549|NCT02567799|365511501|FG000|Follow-up|Progressive Disease|1|||
105959550|NCT02567799|365511502|FG001|Follow-up|Progressive Disease|1|||
105959551|NCT02567799|365511503|FG002|Follow-up|Progressive Disease|3|||
105959552|NCT03292640|365511506|FG000|Overall Study|Withdrawal by Subject|17|||
105959553|NCT03292640|365511507|FG001|Overall Study|Withdrawal by Subject|16|||
105959554|NCT03292640|365511506|FG000|Overall Study|Adverse Event|20|||
105959555|NCT03292640|365511507|FG001|Overall Study|Adverse Event|2|||
105959556|NCT03292640|365511506|FG000|Overall Study|Lost to Follow-up|24|||
106146327|NCT00818454|366196458|FG001|Treatment Period 3|Adverse Event|0|||
105959557|NCT03292640|365511507|FG001|Overall Study|Lost to Follow-up|24|||
105959558|NCT00972517|365511509|FG000|Overall Study|Adverse Event|0|||
105959559|NCT00972517|365511510|FG001|Overall Study|Adverse Event|0|||
105959560|NCT00972517|365511511|FG002|Overall Study|Adverse Event|0|||
105959561|NCT00972517|365511512|FG003|Overall Study|Adverse Event|1|||
105959562|NCT00972517|365511513|FG004|Overall Study|Adverse Event|0|||
106146328|NCT00818454|366196459|FG002|Treatment Period 3|Adverse Event|0|||
106146329|NCT00818454|366196460|FG003|Treatment Period 3|Adverse Event|1|||
105768137|NCT01183104|364802598|FG001|Overall Study|Did not receive study drug|9|||
105768138|NCT03050307|364802599|FG000|Overall Study|Adverse Event|4|||
105768139|NCT03050307|364802600|FG001|Overall Study|Adverse Event|2|||
105768140|NCT03050307|364802599|FG000|Overall Study|Significant Protocol Deviation|0|||
105768141|NCT03050307|364802600|FG001|Overall Study|Significant Protocol Deviation|1|||
105768142|NCT03050307|364802599|FG000|Overall Study|Lost to Follow-up|0|||
105768143|NCT03050307|364802600|FG001|Overall Study|Lost to Follow-up|1|||
105768144|NCT03050307|364802599|FG000|Overall Study|Voluntary Withdrawal|3|||
105768145|NCT03050307|364802600|FG001|Overall Study|Voluntary Withdrawal|4|||
105768146|NCT03050307|364802599|FG000|Overall Study|Reason not Specified|1|||
105768147|NCT03050307|364802600|FG001|Overall Study|Reason not Specified|1|||
105768148|NCT02177786|364802601|FG000|Overall Study|Withdrew Consent|2|||
105768149|NCT02177786|364802602|FG001|Overall Study|Withdrew Consent|6|||
105768150|NCT02177786|364802603|FG002|Overall Study|Withdrew Consent|9|||
105768151|NCT02177786|364802604|FG003|Overall Study|Withdrew Consent|5|||
105768152|NCT02177786|364802601|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
105768153|NCT02177786|364802602|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
105768154|NCT02177786|364802603|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
105768155|NCT02177786|364802604|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
105768156|NCT02177786|364802601|FG000|Overall Study|Adverse Event|1|||
105768157|NCT02177786|364802602|FG001|Overall Study|Adverse Event|1|||
105768158|NCT02177786|364802603|FG002|Overall Study|Adverse Event|2|||
105768159|NCT02177786|364802604|FG003|Overall Study|Adverse Event|3|||
105768160|NCT02177786|364802601|FG000|Overall Study|Death|1|||
105768161|NCT02177786|364802602|FG001|Overall Study|Death|1|||
105768162|NCT02177786|364802603|FG002|Overall Study|Death|1|||
105768163|NCT02177786|364802604|FG003|Overall Study|Death|1|||
105768164|NCT02177786|364802601|FG000|Overall Study|Lost to Follow-up|0|||
105768165|NCT02177786|364802602|FG001|Overall Study|Lost to Follow-up|0|||
105768166|NCT02177786|364802603|FG002|Overall Study|Lost to Follow-up|2|||
105768167|NCT02177786|364802604|FG003|Overall Study|Lost to Follow-up|2|||
105768168|NCT02177786|364802601|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105768169|NCT02177786|364802602|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105768170|NCT02177786|364802603|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105768171|NCT02177786|364802604|FG003|Overall Study|Non-Compliance with Study Drug|1|||
105768172|NCT02177786|364802601|FG000|Overall Study|Protocol Violation|0|||
105768173|NCT02177786|364802602|FG001|Overall Study|Protocol Violation|0|||
105768174|NCT02177786|364802603|FG002|Overall Study|Protocol Violation|2|||
105768175|NCT02177786|364802604|FG003|Overall Study|Protocol Violation|0|||
105768176|NCT02177786|364802601|FG000|Overall Study|Progressive Disease|0|||
105768177|NCT02177786|364802602|FG001|Overall Study|Progressive Disease|1|||
105768178|NCT02177786|364802603|FG002|Overall Study|Progressive Disease|0|||
105768179|NCT02177786|364802604|FG003|Overall Study|Progressive Disease|0|||
105768180|NCT02177786|364802601|FG000|Overall Study|Missing study completion status|0|||
105768181|NCT02177786|364802602|FG001|Overall Study|Missing study completion status|1|||
105768182|NCT02177786|364802603|FG002|Overall Study|Missing study completion status|0|||
105768183|NCT02177786|364802604|FG003|Overall Study|Missing study completion status|0|||
105768184|NCT01305941|364802605|FG000|Overall Study|Adverse Event|6|||
105768185|NCT01305941|364802605|FG000|Overall Study|Clinical decline|2|||
105768186|NCT01305941|364802605|FG000|Overall Study|Withdrawal by Subject|1|||
105768187|NCT01305941|364802605|FG000|Overall Study|Death|1|||
105768188|NCT02892734|364802606|FG000|Treatment on Study|Progressive Disease|2|||
105768189|NCT02892734|364802606|FG000|Follow up for 2 Years|Death|2|||
105768190|NCT02892734|364802606|FG000|Follow up for 2 Years|Study closed early|1|||
105768191|NCT00688623|364802607|FG000|Overall Study|Adverse Event|22|||
105768192|NCT00688623|364802607|FG000|Overall Study|abnormal lab value|1|||
105768193|NCT00688623|364802607|FG000|Overall Study|Withdrawal by Subject|4|||
105959563|NCT00972517|365511514|FG005|Overall Study|Adverse Event|0|||
105959564|NCT00972517|365511509|FG000|Overall Study|Withdrawal by Subject|0|||
105959565|NCT00972517|365511510|FG001|Overall Study|Withdrawal by Subject|1|||
105959566|NCT00972517|365511511|FG002|Overall Study|Withdrawal by Subject|0|||
105959567|NCT00972517|365511512|FG003|Overall Study|Withdrawal by Subject|2|||
105959568|NCT00972517|365511513|FG004|Overall Study|Withdrawal by Subject|1|||
105959569|NCT00972517|365511514|FG005|Overall Study|Withdrawal by Subject|0|||
105768194|NCT00688623|364802607|FG000|Overall Study|Death|3|||
105768195|NCT00688623|364802607|FG000|Overall Study|disease progression|23|||
105768196|NCT00688623|364802607|FG000|Overall Study|Protocol Violation|2|||
105768197|NCT04402385|364802613|FG000|Overall Study|Withdrawal by Subject|4|||
105768198|NCT04402385|364802614|FG001|Overall Study|Withdrawal by Subject|4|||
105768199|NCT04402385|364802613|FG000|Overall Study|Lost to Follow-up|1|||
105768200|NCT04402385|364802614|FG001|Overall Study|Lost to Follow-up|1|||
105768201|NCT04402385|364802613|FG000|Overall Study|Physician Decision|0|||
106146330|NCT00414544|366196462|FG000|Overall Study|Lost to Follow-up|14|||
105768202|NCT04402385|364802614|FG001|Overall Study|Physician Decision|1|||
105768203|NCT00088595|364802615|FG000|Overall Study|Adverse Event|11|||
105768204|NCT00088595|364802615|FG000|Overall Study|Withdrawal by Subject|8|||
106146331|NCT01765543|366196464|FG000|Overall Study|Death|1|||
106146332|NCT01765543|366196464|FG000|Overall Study|Withdrawal by Subject|2|||
105768205|NCT00088595|364802615|FG000|Overall Study|Ongoing (After Core)|7|||
105768206|NCT00088595|364802615|FG000|Overall Study|New Cancer Therapy|2|||
105768207|NCT01308853|364802623|FG000|Overall Study|Adverse Event|1|||
105768208|NCT01308853|364802623|FG000|Overall Study|Lost to Follow-up|2|||
105768209|NCT01308853|364802623|FG000|Overall Study|Insertion of permanent implants|1|||
105768210|NCT05283499|364802626|FG000|Overall Study|Did not receive intervention|1|||
105768211|NCT05283499|364802627|FG001|Overall Study|Did not receive intervention|2|||
105768212|NCT02828644|364802630|FG000|Overall Study|Lost to Follow-up|23|||
105768213|NCT02828644|364802631|FG001|Overall Study|Lost to Follow-up|22|||
105768214|NCT02436915|364802632|FG000|Overall Study|Withdrawal by Subject|0|||
105768215|NCT02436915|364802633|FG001|Overall Study|Withdrawal by Subject|1|||
105768216|NCT02603172|364802636|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768217|NCT02603172|364802637|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768218|NCT02603172|364802638|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
105768219|NCT02603172|364802639|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768220|NCT02603172|364802640|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768221|NCT02603172|364802641|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768222|NCT02603172|364802642|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768223|NCT02603172|364802643|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
105768224|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
105768225|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
105823235|NCT04242446|365010413|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823236|NCT04242446|365010414|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823237|NCT04242446|365010415|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
105823238|NCT04242446|365010416|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
105823239|NCT03071575|365010417|FG000|Overall Study|Death|0|||
105823240|NCT03071575|365010418|FG001|Overall Study|Death|1|||
105823241|NCT03071575|365010417|FG000|Overall Study|Lost to Follow-up|5|||
105823242|NCT03071575|365010418|FG001|Overall Study|Lost to Follow-up|11|||
105823243|NCT03071575|365010417|FG000|Overall Study|Withdrawal by Subject|4|||
105823244|NCT03071575|365010418|FG001|Overall Study|Withdrawal by Subject|2|||
105823245|NCT00834795|365010423|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
105823246|NCT00834795|365010424|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
105823247|NCT00834795|365010423|FG000|Second Intervention|Adverse Event|1|||
105823248|NCT00834795|365010424|FG001|Second Intervention|Adverse Event|0|||
105823249|NCT03818581|365010425|FG000|Overall Study|Adverse Event|1|||
105823250|NCT03818581|365010426|FG001|Overall Study|Adverse Event|0|||
105823251|NCT03818581|365010427|FG002|Overall Study|Adverse Event|0|||
105823252|NCT03818581|365010428|FG003|Overall Study|Adverse Event|0|||
105823253|NCT03818581|365010429|FG004|Overall Study|Adverse Event|0|||
105823254|NCT03818581|365010425|FG000|Overall Study|Covid-19|2|||
105823255|NCT03818581|365010426|FG001|Overall Study|Covid-19|0|||
105823256|NCT03818581|365010427|FG002|Overall Study|Covid-19|0|||
105823257|NCT03818581|365010428|FG003|Overall Study|Covid-19|0|||
105823258|NCT03818581|365010429|FG004|Overall Study|Covid-19|1|||
105823259|NCT03818581|365010425|FG000|Overall Study|Withdrawal by Subject|0|||
105823260|NCT03818581|365010426|FG001|Overall Study|Withdrawal by Subject|0|||
105823261|NCT03818581|365010427|FG002|Overall Study|Withdrawal by Subject|0|||
105823262|NCT03818581|365010428|FG003|Overall Study|Withdrawal by Subject|0|||
105823263|NCT03818581|365010429|FG004|Overall Study|Withdrawal by Subject|1|||
105823264|NCT03818581|365010425|FG000|Overall Study|No longer met study criteria|0|||
105823265|NCT03818581|365010426|FG001|Overall Study|No longer met study criteria|0|||
105823266|NCT03818581|365010427|FG002|Overall Study|No longer met study criteria|0|||
105823267|NCT03818581|365010428|FG003|Overall Study|No longer met study criteria|0|||
105959570|NCT00851890|365511517|FG000|Overall Study|Lost to Follow-up|0|||
105959571|NCT00851890|365511518|FG001|Overall Study|Lost to Follow-up|1|||
105959572|NCT00851890|365511519|FG002|Overall Study|Lost to Follow-up|0|||
105959573|NCT00851890|365511520|FG003|Overall Study|Lost to Follow-up|1|||
105959574|NCT02015481|365511522|FG000|Overall Study|Death|1|||
105959575|NCT02222688|365513231|FG000|Overall Study|Withdrawal by Subject|0|||
105959576|NCT02222688|365513232|FG001|Overall Study|Withdrawal by Subject|0|||
105959577|NCT02222688|365513233|FG002|Overall Study|Withdrawal by Subject|0|||
105959578|NCT02222688|365513234|FG003|Overall Study|Withdrawal by Subject|2|||
105959579|NCT02222688|365513235|FG004|Overall Study|Withdrawal by Subject|1|||
105959580|NCT02222688|365513236|FG005|Overall Study|Withdrawal by Subject|0|||
106146333|NCT03454529|366196465|FG000|Overall Study|Did not receive treatment|6|||
105768226|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
105823268|NCT03818581|365010429|FG004|Overall Study|No longer met study criteria|1|||
105823269|NCT03255733|365010433|FG000|Overall Study|Lost to Follow-up|4|||
105823270|NCT01435265|365010434|FG000|Overall Study|Lost to Follow-up|0|||
105959581|NCT02222688|365513237|FG006|Overall Study|Withdrawal by Subject|1|||
105959582|NCT02222688|365513231|FG000|Overall Study|Disease progression|1|||
105768227|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
105768228|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
105768229|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
105768230|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
106021271|NCT02563067|365743307|FG001|Overall Study|Physician Decision|1|||
106021272|NCT02563067|365743308|FG002|Overall Study|Physician Decision|3|||
106021273|NCT02563067|365743306|FG000|Overall Study|Lost to Follow-up|1|||
106021274|NCT02563067|365743307|FG001|Overall Study|Lost to Follow-up|2|||
106021275|NCT02563067|365743308|FG002|Overall Study|Lost to Follow-up|0|||
106021276|NCT02563067|365743306|FG000|Overall Study|Technical problems|0|||
105768231|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
105768232|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
105768233|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
105768234|NCT02418585|364802644|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
105768235|NCT02418585|364802645|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
105768236|NCT02418585|364802644|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
105768237|NCT02418585|364802645|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
105768238|NCT02418585|364802644|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
105768239|NCT02418585|364802645|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
105768240|NCT02418585|364802644|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
105768241|NCT02418585|364802645|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
105768242|NCT02418585|364802644|FG000|Follow-up Phase (24 Weeks)|Other|3|||
105768243|NCT02418585|364802645|FG001|Follow-up Phase (24 Weeks)|Other|2|||
105768244|NCT04075396|364802646|FG000|Overall Study|Death|11|||
105768245|NCT04075396|364802647|FG001|Overall Study|Death|9|||
105768246|NCT04075396|364802646|FG000|Overall Study|Withdrawal by Subject|1|||
105768247|NCT04075396|364802647|FG001|Overall Study|Withdrawal by Subject|2|||
105768248|NCT04075396|364802646|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
105768249|NCT04075396|364802647|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
105768250|NCT04075396|364802646|FG000|Overall Study|Enrolled but not-treated|0|||
105768251|NCT04075396|364802647|FG001|Overall Study|Enrolled but not-treated|1|||
105768252|NCT00693693|364802650|FG000|Overall Study|Lost to Follow-up|1|||
105768253|NCT00693693|364802651|FG001|Overall Study|Lost to Follow-up|1|||
105768254|NCT00693693|364802652|FG002|Overall Study|Lost to Follow-up|2|||
105768255|NCT01690988|364802658|FG000|Overall Study|Withdrawal by Subject|2|||
105768256|NCT01690988|364802659|FG001|Overall Study|Withdrawal by Subject|2|||
105768257|NCT01690988|364802660|FG002|Overall Study|Withdrawal by Subject|3|||
105768258|NCT01690988|364802658|FG000|Overall Study|Physician Decision|0|||
105768259|NCT01690988|364802659|FG001|Overall Study|Physician Decision|0|||
105768260|NCT01690988|364802660|FG002|Overall Study|Physician Decision|1|||
105768261|NCT01690988|364802658|FG000|Overall Study|Operation Cancelled|1|||
105768262|NCT01690988|364802659|FG001|Overall Study|Operation Cancelled|1|||
105768263|NCT01690988|364802660|FG002|Overall Study|Operation Cancelled|0|||
105768264|NCT01690988|364802658|FG000|Overall Study|Determined ineligible|1|||
105768265|NCT01690988|364802659|FG001|Overall Study|Determined ineligible|0|||
105768266|NCT01690988|364802660|FG002|Overall Study|Determined ineligible|0|||
105768267|NCT01690988|364802658|FG000|Overall Study|Death|1|||
105768268|NCT01690988|364802659|FG001|Overall Study|Death|1|||
105768269|NCT01690988|364802660|FG002|Overall Study|Death|1|||
105768270|NCT01690988|364802658|FG000|Overall Study|Sedated|1|||
105768271|NCT01690988|364802659|FG001|Overall Study|Sedated|1|||
105768272|NCT01690988|364802660|FG002|Overall Study|Sedated|2|||
105768273|NCT00372489|364802663|FG000|Overall Study|Adverse Event|18|||
105768274|NCT00372489|364802663|FG000|Overall Study|Lack of Efficacy|1|||
105768275|NCT00372489|364802663|FG000|Overall Study|Lost to Follow-up|3|||
105768276|NCT00372489|364802663|FG000|Overall Study|Physician Decision|3|||
105768277|NCT00372489|364802663|FG000|Overall Study|Withdrawal by Subject|5|||
105768278|NCT00372489|364802663|FG000|Overall Study|Patient Relocation|2|||
105768279|NCT00372489|364802663|FG000|Overall Study|Renal transplant|6|||
105768280|NCT00372489|364802663|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
105768281|NCT00552344|364802669|FG000|Overall Study|Lack of Efficacy|55|||
105768282|NCT00552344|364802669|FG000|Overall Study|Loss of efficacy|75|||
105768283|NCT00552344|364802669|FG000|Overall Study|Lost to Follow-up|8|||
105768284|NCT00552344|364802669|FG000|Overall Study|Withdrawal by Subject|48|||
105768285|NCT00552344|364802669|FG000|Overall Study|SAE, non-fatal|6|||
105768286|NCT00552344|364802669|FG000|Overall Study|AE, non-serious non-fatal|38|||
105768287|NCT00552344|364802669|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
105768288|NCT00552344|364802669|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
105768289|NCT00552344|364802669|FG000|Overall Study|Other Reason|22|||
105768290|NCT00471276|364802670|FG000|Overall Study|Death|2|||
105768291|NCT00471276|364802670|FG000|Overall Study|Adverse Event|16|||
105768292|NCT00471276|364802670|FG000|Overall Study|Protocol Violation|1|||
105768293|NCT00471276|364802670|FG000|Overall Study|Objective progression or relapse|54|||
105823271|NCT01435265|365010435|FG001|Overall Study|Lost to Follow-up|1|||
105768294|NCT00471276|364802670|FG000|Overall Study|Global deterioration of health status|1|||
105768295|NCT00471276|364802670|FG000|Overall Study|Other|3|||
105768296|NCT00471276|364802670|FG000|Overall Study|Refused treatment|6|||
106021277|NCT02563067|365743307|FG001|Overall Study|Technical problems|1|||
105768297|NCT01594411|364802671|FG000|Overall Study|Lost to Follow-up|2|||
105768298|NCT04731922|364802672|FG000|Overall Study|Adverse Event|0|||
105768299|NCT04731922|364802673|FG001|Overall Study|Adverse Event|0|||
105768300|NCT04731922|364802674|FG002|Overall Study|Adverse Event|0|||
105768301|NCT04731922|364802675|FG003|Overall Study|Adverse Event|0|||
105768302|NCT04731922|364802676|FG004|Overall Study|Adverse Event|0|||
105768303|NCT04731922|364802677|FG005|Overall Study|Adverse Event|0|||
105768304|NCT04731922|364802678|FG006|Overall Study|Adverse Event|0|||
105768305|NCT04731922|364802679|FG007|Overall Study|Adverse Event|0|||
105768306|NCT04731922|364802680|FG008|Overall Study|Adverse Event|0|||
105768307|NCT04731922|364802681|FG009|Overall Study|Adverse Event|0|||
105768308|NCT04731922|364802682|FG010|Overall Study|Adverse Event|1|||
105768309|NCT04731922|364802683|FG011|Overall Study|Adverse Event|0|||
105768310|NCT04731922|364802684|FG012|Overall Study|Adverse Event|0|||
105768311|NCT04731922|364802685|FG013|Overall Study|Adverse Event|0|||
105768312|NCT04731922|364802686|FG014|Overall Study|Adverse Event|0|||
105768313|NCT04731922|364802687|FG015|Overall Study|Adverse Event|0|||
105768314|NCT04731922|364802688|FG016|Overall Study|Adverse Event|0|||
105768315|NCT04731922|364802672|FG000|Overall Study|Lost to Follow-up|0|||
105768316|NCT04731922|364802673|FG001|Overall Study|Lost to Follow-up|0|||
105768317|NCT04731922|364802674|FG002|Overall Study|Lost to Follow-up|0|||
105768318|NCT04731922|364802675|FG003|Overall Study|Lost to Follow-up|1|||
105768319|NCT04731922|364802676|FG004|Overall Study|Lost to Follow-up|0|||
105768320|NCT04731922|364802677|FG005|Overall Study|Lost to Follow-up|1|||
105768321|NCT04731922|364802678|FG006|Overall Study|Lost to Follow-up|0|||
105768322|NCT04731922|364802679|FG007|Overall Study|Lost to Follow-up|0|||
105768323|NCT04731922|364802680|FG008|Overall Study|Lost to Follow-up|0|||
105768324|NCT04731922|364802681|FG009|Overall Study|Lost to Follow-up|0|||
105768325|NCT04731922|364802682|FG010|Overall Study|Lost to Follow-up|0|||
105768326|NCT04731922|364802683|FG011|Overall Study|Lost to Follow-up|0|||
105768327|NCT04731922|364802684|FG012|Overall Study|Lost to Follow-up|0|||
105768328|NCT04731922|364802685|FG013|Overall Study|Lost to Follow-up|0|||
105768329|NCT04731922|364802686|FG014|Overall Study|Lost to Follow-up|0|||
105768330|NCT04731922|364802687|FG015|Overall Study|Lost to Follow-up|0|||
105768331|NCT04731922|364802688|FG016|Overall Study|Lost to Follow-up|0|||
105768332|NCT04731922|364802672|FG000|Overall Study|Withdrawal by Subject|1|||
105768333|NCT04731922|364802673|FG001|Overall Study|Withdrawal by Subject|0|||
105768334|NCT04731922|364802674|FG002|Overall Study|Withdrawal by Subject|0|||
105768335|NCT04731922|364802675|FG003|Overall Study|Withdrawal by Subject|0|||
105768336|NCT04731922|364802676|FG004|Overall Study|Withdrawal by Subject|1|||
105768337|NCT04731922|364802677|FG005|Overall Study|Withdrawal by Subject|0|||
105768338|NCT04731922|364802678|FG006|Overall Study|Withdrawal by Subject|1|||
105768339|NCT04731922|364802679|FG007|Overall Study|Withdrawal by Subject|0|||
105768340|NCT04731922|364802680|FG008|Overall Study|Withdrawal by Subject|0|||
105768341|NCT04731922|364802681|FG009|Overall Study|Withdrawal by Subject|0|||
105768342|NCT04731922|364802682|FG010|Overall Study|Withdrawal by Subject|0|||
105768343|NCT04731922|364802683|FG011|Overall Study|Withdrawal by Subject|0|||
105768344|NCT04731922|364802684|FG012|Overall Study|Withdrawal by Subject|0|||
105768345|NCT04731922|364802685|FG013|Overall Study|Withdrawal by Subject|1|||
105768346|NCT04731922|364802686|FG014|Overall Study|Withdrawal by Subject|0|||
105768347|NCT04731922|364802687|FG015|Overall Study|Withdrawal by Subject|0|||
105768348|NCT04731922|364802688|FG016|Overall Study|Withdrawal by Subject|0|||
105768349|NCT04731922|364802672|FG000|Overall Study|Other|0|||
105768350|NCT04731922|364802673|FG001|Overall Study|Other|0|||
105768351|NCT04731922|364802674|FG002|Overall Study|Other|0|||
105768352|NCT04731922|364802675|FG003|Overall Study|Other|0|||
105768353|NCT04731922|364802676|FG004|Overall Study|Other|0|||
105959583|NCT02222688|365513232|FG001|Overall Study|Disease progression|0|||
105768354|NCT04731922|364802677|FG005|Overall Study|Other|0|||
105959584|NCT02222688|365513233|FG002|Overall Study|Disease progression|0|||
105959585|NCT02222688|365513234|FG003|Overall Study|Disease progression|0|||
105959586|NCT02222688|365513235|FG004|Overall Study|Disease progression|0|||
105768355|NCT04731922|364802678|FG006|Overall Study|Other|1|||
105768356|NCT04731922|364802679|FG007|Overall Study|Other|0|||
105823272|NCT01111461|365010439|FG000|Overall Study|Adverse Event|32|||
105823273|NCT01111461|365010439|FG000|Overall Study|Participant choice|11|||
105823274|NCT01111461|365010439|FG000|Overall Study|Lost to Follow-up|1|||
105823275|NCT01111461|365010439|FG000|Overall Study|Withdrawal by Subject|1|||
105823276|NCT01111461|365010439|FG000|Overall Study|Other|6|||
105823277|NCT04278560|365010440|FG000|Overall Study|Adverse Event|1|||
105823278|NCT04278560|365010441|FG001|Overall Study|Adverse Event|2|||
105823279|NCT04278560|365010440|FG000|Overall Study|Withdrawal by Subject|0|||
105823280|NCT04278560|365010441|FG001|Overall Study|Withdrawal by Subject|1|||
105823281|NCT03616535|365010442|FG000|Overall Study|Death|2|||
105823282|NCT03616535|365010443|FG001|Overall Study|Death|0|||
105823283|NCT03616535|365010444|FG002|Overall Study|Death|0|||
105823284|NCT03616535|365010445|FG003|Overall Study|Death|1|||
105823285|NCT03616535|365010442|FG000|Overall Study|Lost to Follow-up|2|||
105823286|NCT03616535|365010443|FG001|Overall Study|Lost to Follow-up|1|||
105823287|NCT03616535|365010444|FG002|Overall Study|Lost to Follow-up|0|||
105823288|NCT03616535|365010445|FG003|Overall Study|Lost to Follow-up|2|||
105823289|NCT03616535|365010442|FG000|Overall Study|Withdrawal by Subject|1|||
105823290|NCT03616535|365010443|FG001|Overall Study|Withdrawal by Subject|2|||
105823291|NCT03616535|365010444|FG002|Overall Study|Withdrawal by Subject|5|||
105823292|NCT03616535|365010445|FG003|Overall Study|Withdrawal by Subject|1|||
105823293|NCT03616535|365010442|FG000|Overall Study|Not specified or change in eligibility|2|||
105823294|NCT03616535|365010443|FG001|Overall Study|Not specified or change in eligibility|3|||
105823295|NCT03616535|365010444|FG002|Overall Study|Not specified or change in eligibility|3|||
105823296|NCT03616535|365010445|FG003|Overall Study|Not specified or change in eligibility|1|||
105823297|NCT03935880|365010448|FG000|Overall Study|Lost to Follow-up|0|||
105823298|NCT03935880|365010449|FG001|Overall Study|Lost to Follow-up|1|||
105823299|NCT02476994|365010450|FG000|Overall Study|Based on feedback from FDA|1|||
105823300|NCT02476994|365010451|FG001|Overall Study|Based on feedback from FDA|0|||
105823301|NCT05618808|365010452|FG000|Overall Study|Withdrawal by Subject|3|||
105823302|NCT05618808|365010453|FG001|Overall Study|Withdrawal by Subject|1|||
105823303|NCT05618808|365010454|FG002|Overall Study|Withdrawal by Subject|3|||
105823304|NCT02646124|365010455|FG000|Overall Study|Lost to Follow-up|0|||
105823305|NCT02646124|365010456|FG001|Overall Study|Lost to Follow-up|2|||
105823306|NCT00905606|365010459|FG000|Period 1|Adverse Event|0|||
105823307|NCT00905606|365010460|FG001|Period 1|Adverse Event|1|||
105823308|NCT00905606|365010459|FG000|Washout|Withdrawal by Subject|1|||
105823309|NCT00905606|365010460|FG001|Washout|Withdrawal by Subject|0|||
105959587|NCT02222688|365513236|FG005|Overall Study|Disease progression|0|||
105959588|NCT02222688|365513237|FG006|Overall Study|Disease progression|0|||
105959589|NCT00294671|365513240|FG000|Overall Study|Lack of Efficacy|11|||
105959590|NCT00294671|365513241|FG001|Overall Study|Lack of Efficacy|23|||
105959591|NCT00294671|365513240|FG000|Overall Study|Liver transplant|7|||
105959592|NCT00294671|365513241|FG001|Overall Study|Liver transplant|9|||
105959593|NCT00294671|365513240|FG000|Overall Study|Drug related adverse event (AE)|4|||
105959594|NCT00294671|365513241|FG001|Overall Study|Drug related adverse event (AE)|2|||
105959595|NCT00294671|365513240|FG000|Overall Study|Non-drug related AE|3|||
105959596|NCT00294671|365513241|FG001|Overall Study|Non-drug related AE|2|||
105959597|NCT00294671|365513240|FG000|Overall Study|Lost to Follow-up|1|||
105959598|NCT00294671|365513241|FG001|Overall Study|Lost to Follow-up|3|||
105959599|NCT00294671|365513240|FG000|Overall Study|Non-compliance|1|||
105959600|NCT00294671|365513241|FG001|Overall Study|Non-compliance|0|||
105959601|NCT00294671|365513240|FG000|Overall Study|Death|0|||
105959602|NCT00294671|365513241|FG001|Overall Study|Death|1|||
105959603|NCT00958360|365513249|FG000|Overall Study|Withdrawal by Subject|3|||
105959604|NCT00958360|365513250|FG001|Overall Study|Withdrawal by Subject|1|||
105959605|NCT00958360|365513249|FG000|Overall Study|Death|6|||
105959606|NCT00958360|365513250|FG001|Overall Study|Death|7|||
105959607|NCT00958360|365513249|FG000|Overall Study|Physician Decision|2|||
105959608|NCT00958360|365513250|FG001|Overall Study|Physician Decision|1|||
105959609|NCT00958360|365513249|FG000|Overall Study|Lost to Follow-up|0|||
105959610|NCT00958360|365513250|FG001|Overall Study|Lost to Follow-up|1|||
105959611|NCT03107052|365513251|FG000|Overall Study|Adverse Event|6|||
105959612|NCT03107052|365513252|FG001|Overall Study|Adverse Event|1|||
105959613|NCT03107052|365513253|FG002|Overall Study|Adverse Event|2|||
105959614|NCT03107052|365513251|FG000|Overall Study|Withdrawal by Subject|9|||
105959615|NCT03107052|365513252|FG001|Overall Study|Withdrawal by Subject|5|||
105959616|NCT03107052|365513253|FG002|Overall Study|Withdrawal by Subject|8|||
105959617|NCT03107052|365513251|FG000|Overall Study|Protocol Violation|6|||
105959618|NCT03107052|365513252|FG001|Overall Study|Protocol Violation|0|||
105959619|NCT03107052|365513253|FG002|Overall Study|Protocol Violation|3|||
105959620|NCT03107052|365513251|FG000|Overall Study|Lost to Follow-up|4|||
105959621|NCT03107052|365513252|FG001|Overall Study|Lost to Follow-up|0|||
105823310|NCT03635320|365010461|FG000|Overall Study|not implanted the device|1|||
105823311|NCT03635320|365010462|FG001|Overall Study|not implanted the device|2|||
105823312|NCT03635320|365010461|FG000|Overall Study|Withdrawal by Subject|11|||
105823313|NCT03635320|365010462|FG001|Overall Study|Withdrawal by Subject|6|||
105823314|NCT00804856|365010463|FG000|Overall Study|Progressive Disease|3|||
105823315|NCT00804856|365010464|FG001|Overall Study|Progressive Disease|2|||
105823316|NCT00804856|365010465|FG002|Overall Study|Progressive Disease|4|||
105823317|NCT00804856|365010466|FG003|Overall Study|Progressive Disease|6|||
106146334|NCT03454529|366196465|FG000|Overall Study|Received < 80% doses|1|||
105823318|NCT00804856|365010467|FG004|Overall Study|Progressive Disease|4|||
105823319|NCT00804856|365010468|FG005|Overall Study|Progressive Disease|1|||
105823320|NCT00804856|365010469|FG006|Overall Study|Progressive Disease|8|||
105959622|NCT03107052|365513253|FG002|Overall Study|Lost to Follow-up|1|||
105959623|NCT03107052|365513251|FG000|Overall Study|Lack of Efficacy|23|||
105959624|NCT03107052|365513252|FG001|Overall Study|Lack of Efficacy|7|||
105959625|NCT03107052|365513253|FG002|Overall Study|Lack of Efficacy|4|||
105959626|NCT03107052|365513251|FG000|Overall Study|Other than specified|4|||
105959627|NCT03107052|365513252|FG001|Overall Study|Other than specified|2|||
105959628|NCT03107052|365513253|FG002|Overall Study|Other than specified|0|||
105823321|NCT00804856|365010470|FG007|Overall Study|Progressive Disease|2|||
105959629|NCT03107052|365513251|FG000|Overall Study|Study terminated due to futility|67|||
105823322|NCT00804856|365010471|FG008|Overall Study|Progressive Disease|4|||
105823323|NCT00804856|365010472|FG009|Overall Study|Progressive Disease|5|||
105823324|NCT00804856|365010473|FG010|Overall Study|Progressive Disease|12|||
105823325|NCT00804856|365010474|FG011|Overall Study|Progressive Disease|2|||
105823326|NCT00804856|365010475|FG012|Overall Study|Progressive Disease|2|||
105823327|NCT00804856|365010476|FG013|Overall Study|Progressive Disease|26|||
105823328|NCT00804856|365010477|FG014|Overall Study|Progressive Disease|20|||
105823329|NCT00804856|365010463|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823330|NCT00804856|365010464|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823331|NCT00804856|365010465|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823332|NCT00804856|365010466|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823333|NCT00804856|365010467|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105823334|NCT00804856|365010468|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823335|NCT00804856|365010469|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823336|NCT00804856|365010470|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823337|NCT00804856|365010471|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823338|NCT00804856|365010472|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823339|NCT00804856|365010473|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823340|NCT00804856|365010474|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823341|NCT00804856|365010475|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823342|NCT00804856|365010476|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
105823343|NCT00804856|365010477|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
105823344|NCT00804856|365010463|FG000|Overall Study|Other Adverse Event|1|||
105823345|NCT00804856|365010464|FG001|Overall Study|Other Adverse Event|1|||
105823346|NCT00804856|365010465|FG002|Overall Study|Other Adverse Event|1|||
105823347|NCT00804856|365010466|FG003|Overall Study|Other Adverse Event|2|||
105823348|NCT00804856|365010467|FG004|Overall Study|Other Adverse Event|2|||
105823349|NCT00804856|365010468|FG005|Overall Study|Other Adverse Event|1|||
105823350|NCT00804856|365010469|FG006|Overall Study|Other Adverse Event|3|||
105823351|NCT00804856|365010470|FG007|Overall Study|Other Adverse Event|0|||
105823352|NCT00804856|365010471|FG008|Overall Study|Other Adverse Event|0|||
105823353|NCT00804856|365010472|FG009|Overall Study|Other Adverse Event|1|||
105823354|NCT00804856|365010473|FG010|Overall Study|Other Adverse Event|5|||
105823355|NCT00804856|365010474|FG011|Overall Study|Other Adverse Event|2|||
105823356|NCT00804856|365010475|FG012|Overall Study|Other Adverse Event|0|||
105823357|NCT00804856|365010476|FG013|Overall Study|Other Adverse Event|6|||
105823358|NCT00804856|365010477|FG014|Overall Study|Other Adverse Event|13|||
105823359|NCT00804856|365010463|FG000|Overall Study|Non compliance with protocol|0|||
105823360|NCT00804856|365010464|FG001|Overall Study|Non compliance with protocol|0|||
105823361|NCT00804856|365010465|FG002|Overall Study|Non compliance with protocol|0|||
105823362|NCT00804856|365010466|FG003|Overall Study|Non compliance with protocol|0|||
105823363|NCT00804856|365010467|FG004|Overall Study|Non compliance with protocol|0|||
105823364|NCT00804856|365010468|FG005|Overall Study|Non compliance with protocol|0|||
105823365|NCT00804856|365010469|FG006|Overall Study|Non compliance with protocol|0|||
105823366|NCT00804856|365010470|FG007|Overall Study|Non compliance with protocol|0|||
105823367|NCT00804856|365010471|FG008|Overall Study|Non compliance with protocol|0|||
105823368|NCT00804856|365010472|FG009|Overall Study|Non compliance with protocol|0|||
105823369|NCT00804856|365010473|FG010|Overall Study|Non compliance with protocol|0|||
105823370|NCT00804856|365010474|FG011|Overall Study|Non compliance with protocol|0|||
105823371|NCT00804856|365010475|FG012|Overall Study|Non compliance with protocol|0|||
105823372|NCT00804856|365010476|FG013|Overall Study|Non compliance with protocol|2|||
105823373|NCT00804856|365010477|FG014|Overall Study|Non compliance with protocol|0|||
105823374|NCT00804856|365010463|FG000|Overall Study|Refused to continue medication|0|||
105823375|NCT00804856|365010464|FG001|Overall Study|Refused to continue medication|0|||
105823376|NCT00804856|365010465|FG002|Overall Study|Refused to continue medication|0|||
105823377|NCT00804856|365010466|FG003|Overall Study|Refused to continue medication|1|||
105823378|NCT00804856|365010467|FG004|Overall Study|Refused to continue medication|1|||
105823379|NCT00804856|365010468|FG005|Overall Study|Refused to continue medication|0|||
105823380|NCT00804856|365010469|FG006|Overall Study|Refused to continue medication|0|||
105823381|NCT00804856|365010470|FG007|Overall Study|Refused to continue medication|0|||
105823382|NCT00804856|365010471|FG008|Overall Study|Refused to continue medication|0|||
105823383|NCT00804856|365010472|FG009|Overall Study|Refused to continue medication|0|||
105823384|NCT00804856|365010473|FG010|Overall Study|Refused to continue medication|3|||
105959630|NCT03107052|365513252|FG001|Overall Study|Study terminated due to futility|31|||
105959631|NCT03107052|365513253|FG002|Overall Study|Study terminated due to futility|23|||
105959632|NCT03015363|365513254|FG000|Overall Study|Physician Decision|14|||
105823385|NCT00804856|365010474|FG011|Overall Study|Refused to continue medication|0|||
105823386|NCT00804856|365010475|FG012|Overall Study|Refused to continue medication|1|||
105823387|NCT00804856|365010476|FG013|Overall Study|Refused to continue medication|1|||
105823388|NCT00804856|365010477|FG014|Overall Study|Refused to continue medication|5|||
105823389|NCT00804856|365010463|FG000|Overall Study|Other reason than listed above|0|||
105959633|NCT03015363|365513254|FG000|Overall Study|Withdrawal by Subject|3|||
105959634|NCT00500357|365513255|FG000|Overall Study|Death|1|||
106021278|NCT02563067|365743308|FG002|Overall Study|Technical problems|0|||
105823390|NCT00804856|365010464|FG001|Overall Study|Other reason than listed above|0|||
105823391|NCT00804856|365010465|FG002|Overall Study|Other reason than listed above|0|||
105823392|NCT00804856|365010466|FG003|Overall Study|Other reason than listed above|0|||
105823393|NCT00804856|365010467|FG004|Overall Study|Other reason than listed above|0|||
105823394|NCT00804856|365010468|FG005|Overall Study|Other reason than listed above|1|||
105823395|NCT00804856|365010469|FG006|Overall Study|Other reason than listed above|0|||
105823396|NCT00804856|365010470|FG007|Overall Study|Other reason than listed above|0|||
105823397|NCT00804856|365010471|FG008|Overall Study|Other reason than listed above|1|||
105823398|NCT00804856|365010472|FG009|Overall Study|Other reason than listed above|0|||
105823399|NCT00804856|365010473|FG010|Overall Study|Other reason than listed above|3|||
105823400|NCT00804856|365010474|FG011|Overall Study|Other reason than listed above|1|||
105823401|NCT00804856|365010475|FG012|Overall Study|Other reason than listed above|1|||
105823402|NCT00804856|365010476|FG013|Overall Study|Other reason than listed above|10|||
105823403|NCT00804856|365010477|FG014|Overall Study|Other reason than listed above|3|||
105823404|NCT00829309|365010478|FG000|Washout: 7 Days|Protocol Violation|1|||
105823405|NCT00829309|365010479|FG001|Washout: 7 Days|Protocol Violation|0|||
105823406|NCT03107091|365010480|FG000|Overall Study|Physician Decision|1|||
105823407|NCT00455312|365010481|FG000|Overall Study|Death|0|||
105823408|NCT00455312|365010482|FG001|Overall Study|Death|1|||
105823409|NCT00834418|365010483|FG000|Overall Study|Adverse Event|0|||
105823410|NCT00834418|365010484|FG001|Overall Study|Adverse Event|2|||
105823411|NCT01705574|365010485|FG000|Double-Blind Phase|Lost to Follow-up|12|||
105823412|NCT01705574|365010486|FG001|Double-Blind Phase|Lost to Follow-up|16|||
105823413|NCT01705574|365010487|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105823414|NCT01705574|365010488|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105823415|NCT01705574|365010485|FG000|Double-Blind Phase|Adverse Event|3|||
105823416|NCT01705574|365010486|FG001|Double-Blind Phase|Adverse Event|10|||
105823417|NCT01705574|365010487|FG002|Double-Blind Phase|Adverse Event|0|||
105823418|NCT01705574|365010488|FG003|Double-Blind Phase|Adverse Event|0|||
105823419|NCT01705574|365010485|FG000|Double-Blind Phase|Withdrew Consent|8|||
105823420|NCT01705574|365010486|FG001|Double-Blind Phase|Withdrew Consent|5|||
105823421|NCT01705574|365010487|FG002|Double-Blind Phase|Withdrew Consent|0|||
105823422|NCT01705574|365010488|FG003|Double-Blind Phase|Withdrew Consent|0|||
105823423|NCT01705574|365010485|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
105823424|NCT01705574|365010486|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
105823425|NCT01705574|365010487|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
105823426|NCT01705574|365010488|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
105823427|NCT01705574|365010485|FG000|Double-Blind Phase|Pregnancy|1|||
105823428|NCT01705574|365010486|FG001|Double-Blind Phase|Pregnancy|1|||
105823429|NCT01705574|365010487|FG002|Double-Blind Phase|Pregnancy|0|||
105823430|NCT01705574|365010488|FG003|Double-Blind Phase|Pregnancy|0|||
105823431|NCT01705574|365010485|FG000|Double-Blind Phase|Protocol Violation|1|||
105823432|NCT01705574|365010486|FG001|Double-Blind Phase|Protocol Violation|0|||
105823433|NCT01705574|365010487|FG002|Double-Blind Phase|Protocol Violation|0|||
105823434|NCT01705574|365010488|FG003|Double-Blind Phase|Protocol Violation|0|||
105823435|NCT01705574|365010485|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
105823436|NCT01705574|365010486|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
105823437|NCT01705574|365010487|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
105823438|NCT01705574|365010488|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
105823439|NCT01705574|365010485|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
105823440|NCT01705574|365010486|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105823441|NCT01705574|365010487|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
105823442|NCT01705574|365010488|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
105823443|NCT01705574|365010485|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
105823444|NCT01705574|365010486|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
105823445|NCT01705574|365010487|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
105823446|NCT01705574|365010488|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
105823447|NCT01705574|365010485|FG000|Open-Label Extension Phase|Adverse Event|3|||
105823448|NCT01705574|365010486|FG001|Open-Label Extension Phase|Adverse Event|0|||
105823449|NCT01705574|365010487|FG002|Open-Label Extension Phase|Adverse Event|0|||
105823450|NCT01705574|365010488|FG003|Open-Label Extension Phase|Adverse Event|1|||
105823451|NCT01705574|365010485|FG000|Open-Label Extension Phase|Death|2|||
105823452|NCT01705574|365010486|FG001|Open-Label Extension Phase|Death|0|||
105823453|NCT01705574|365010487|FG002|Open-Label Extension Phase|Death|1|||
105823454|NCT01705574|365010488|FG003|Open-Label Extension Phase|Death|0|||
105823455|NCT01705574|365010485|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
106146335|NCT01124734|366196473|FG000|Overall Study|Disease progression|13|||
105823456|NCT01705574|365010486|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
105823457|NCT01705574|365010487|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
105823458|NCT01705574|365010488|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
105823459|NCT01705574|365010485|FG000|Open-Label Extension Phase|Physician Decision|0|||
106146336|NCT01124734|366196473|FG000|Overall Study|Adverse Event|1|||
105823460|NCT01705574|365010486|FG001|Open-Label Extension Phase|Physician Decision|0|||
105823461|NCT01705574|365010487|FG002|Open-Label Extension Phase|Physician Decision|2|||
106021279|NCT02563067|365743306|FG000|Overall Study|Lack of Efficacy|1|||
106021280|NCT02563067|365743307|FG001|Overall Study|Lack of Efficacy|0|||
106021281|NCT02563067|365743308|FG002|Overall Study|Lack of Efficacy|0|||
106021282|NCT02563067|365743306|FG000|Overall Study|Death|0|||
106021283|NCT02563067|365743307|FG001|Overall Study|Death|1|||
106021284|NCT02563067|365743308|FG002|Overall Study|Death|1|||
106021285|NCT02563067|365743306|FG000|Overall Study|Adverse Event|2|||
106021286|NCT02563067|365743307|FG001|Overall Study|Adverse Event|1|||
106021287|NCT02563067|365743308|FG002|Overall Study|Adverse Event|0|||
106021288|NCT02563067|365743306|FG000|Overall Study|Death post Treatment/safety period|1|||
106021289|NCT02563067|365743307|FG001|Overall Study|Death post Treatment/safety period|0|||
106021290|NCT02563067|365743308|FG002|Overall Study|Death post Treatment/safety period|0|||
106021291|NCT03544333|365743313|FG000|Overall Study|Withdrawal by Subject|1|||
106021292|NCT03544333|365743314|FG001|Overall Study|Withdrawal by Subject|0|||
106021293|NCT01039519|365743315|FG000|Treatment|Progressive disease|20|||
105823462|NCT01705574|365010488|FG003|Open-Label Extension Phase|Physician Decision|0|||
105823463|NCT01705574|365010485|FG000|Open-Label Extension Phase|Pregnancy|0|||
105823464|NCT01705574|365010486|FG001|Open-Label Extension Phase|Pregnancy|0|||
105823465|NCT01705574|365010487|FG002|Open-Label Extension Phase|Pregnancy|1|||
105823466|NCT01705574|365010488|FG003|Open-Label Extension Phase|Pregnancy|1|||
105823467|NCT00777023|365010489|FG000|Overall Study|Adverse Event|15|||
105823468|NCT00777023|365010490|FG001|Overall Study|Adverse Event|21|||
105823469|NCT00777023|365010491|FG002|Overall Study|Adverse Event|8|||
105823470|NCT00777023|365010489|FG000|Overall Study|Lack of Efficacy|1|||
105823471|NCT00777023|365010490|FG001|Overall Study|Lack of Efficacy|0|||
105823472|NCT00777023|365010491|FG002|Overall Study|Lack of Efficacy|14|||
105823473|NCT00777023|365010489|FG000|Overall Study|Protocol Violation|2|||
105823474|NCT00777023|365010490|FG001|Overall Study|Protocol Violation|1|||
105823475|NCT00777023|365010491|FG002|Overall Study|Protocol Violation|1|||
105823476|NCT00777023|365010489|FG000|Overall Study|Lost to Follow-up|2|||
105823477|NCT00777023|365010490|FG001|Overall Study|Lost to Follow-up|3|||
105823478|NCT00777023|365010491|FG002|Overall Study|Lost to Follow-up|3|||
105823479|NCT00777023|365010489|FG000|Overall Study|Death|0|||
105823480|NCT00777023|365010490|FG001|Overall Study|Death|1|||
105823481|NCT00777023|365010491|FG002|Overall Study|Death|0|||
105823482|NCT00777023|365010489|FG000|Overall Study|Withdrawal by Subject|7|||
105823483|NCT00777023|365010490|FG001|Overall Study|Withdrawal by Subject|7|||
105823484|NCT00777023|365010491|FG002|Overall Study|Withdrawal by Subject|8|||
105823485|NCT00777023|365010489|FG000|Overall Study|Missing data|1|||
105823486|NCT00777023|365010490|FG001|Overall Study|Missing data|1|||
105823487|NCT00777023|365010491|FG002|Overall Study|Missing data|0|||
105823488|NCT00777023|365010489|FG000|Overall Study|Reasons not specified|4|||
105823489|NCT00777023|365010490|FG001|Overall Study|Reasons not specified|4|||
105823490|NCT00777023|365010491|FG002|Overall Study|Reasons not specified|2|||
105823491|NCT00777023|365010489|FG000|Overall Study|Last dose date unknown|3|||
105823492|NCT00777023|365010490|FG001|Overall Study|Last dose date unknown|3|||
105823493|NCT00777023|365010491|FG002|Overall Study|Last dose date unknown|1|||
105823494|NCT03049748|365010492|FG000|Overall Study|Lost to Follow-up|1|||
105823495|NCT03049748|365010493|FG001|Overall Study|Lost to Follow-up|0|||
105823496|NCT03049748|365010492|FG000|Overall Study|Death|3|||
105823497|NCT03049748|365010493|FG001|Overall Study|Death|0|||
105823498|NCT03049748|365010492|FG000|Overall Study|Withdrawal by Subject|0|||
105823499|NCT03049748|365010493|FG001|Overall Study|Withdrawal by Subject|3|||
105823500|NCT03049748|365010492|FG000|Overall Study|Protocol Violation|0|||
105823501|NCT03049748|365010493|FG001|Overall Study|Protocol Violation|2|||
105823502|NCT03049748|365010492|FG000|Overall Study|Moved out of state (relocation)|0|||
105823503|NCT03049748|365010493|FG001|Overall Study|Moved out of state (relocation)|1|||
105823504|NCT02659150|365010494|FG000|Subject Enrollment|Physician Decision|3|||
105823505|NCT02659150|365010494|FG000|Subject Enrollment|Withdrawal by Subject|2|||
105823506|NCT02659150|365010494|FG000|Baseline Imaging|Withdrawal by Subject|1|||
105823507|NCT02659150|365010494|FG000|Baseline Imaging|Physician Decision|1|||
105823508|NCT02659150|365010494|FG000|Study Drug Dosing|Adverse Event|1|||
105823509|NCT03315455|365010495|FG000|Overall Study|Ongoing in the Study|13|||
105823510|NCT03315455|365010496|FG001|Overall Study|Ongoing in the Study|24|||
105823511|NCT03315455|365010497|FG002|Overall Study|Ongoing in the Study|17|||
105823512|NCT03315455|365010498|FG003|Overall Study|Ongoing in the Study|15|||
105823513|NCT03315455|365010495|FG000|Overall Study|Withdrawal by Subject|0|||
105823514|NCT03315455|365010496|FG001|Overall Study|Withdrawal by Subject|1|||
105823515|NCT03315455|365010497|FG002|Overall Study|Withdrawal by Subject|0|||
105823516|NCT03315455|365010498|FG003|Overall Study|Withdrawal by Subject|0|||
106021294|NCT01039519|365743315|FG000|Treatment|Treatment failure|2|||
106021295|NCT01039519|365743315|FG000|Treatment|Adverse Event|3|||
105823517|NCT00794963|365010501|FG000|Overall Study|Withdrawal by Subject|1|||
105823518|NCT00794963|365010502|FG001|Overall Study|Withdrawal by Subject|4|||
105823519|NCT01370317|365010508|FG000|Overall Study|Participant withdrew consent|1|||
105823520|NCT01370317|365010509|FG001|Overall Study|Participant withdrew consent|0|||
105823521|NCT01370317|365010508|FG000|Overall Study|Protocol deviation|0|||
106021296|NCT01039519|365743315|FG000|Treatment|Physician Decision|2|||
105959635|NCT00301262|365513256|FG000|Double Blind Phase (DB)|Adverse Event|1|||
105959636|NCT00301262|365513257|FG001|Double Blind Phase (DB)|Adverse Event|0|||
105959637|NCT00301262|365513256|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
105959638|NCT00301262|365513257|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
105959639|NCT00301262|365513256|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
105959640|NCT00301262|365513257|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
105959641|NCT00301262|365513256|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
105959642|NCT00301262|365513257|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
105959643|NCT00301262|365513256|FG000|Double Blind Phase (DB)|Other|1|||
105959644|NCT00301262|365513257|FG001|Double Blind Phase (DB)|Other|4|||
105959645|NCT00301262|365513256|FG000|Open Label Phase (OL)|Adverse Event|1|||
105959646|NCT00301262|365513257|FG001|Open Label Phase (OL)|Adverse Event|0|||
105959647|NCT00301262|365513256|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
105959648|NCT00301262|365513257|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
105959649|NCT00301262|365513256|FG000|Open Label Phase (OL)|Other|2|||
105959650|NCT00301262|365513257|FG001|Open Label Phase (OL)|Other|0|||
105959651|NCT01893411|365513258|FG000|Overall Study|Protocol Violation|1|||
105959652|NCT01893411|365513259|FG001|Overall Study|Protocol Violation|0|||
105959653|NCT01893411|365513260|FG002|Overall Study|Protocol Violation|0|||
105959654|NCT01893411|365513258|FG000|Overall Study|Physician Decision|1|||
105959655|NCT01893411|365513259|FG001|Overall Study|Physician Decision|1|||
105959656|NCT01893411|365513260|FG002|Overall Study|Physician Decision|2|||
105959657|NCT01893411|365513258|FG000|Overall Study|Lack of Efficacy|2|||
105959658|NCT01893411|365513259|FG001|Overall Study|Lack of Efficacy|1|||
105959659|NCT01893411|365513260|FG002|Overall Study|Lack of Efficacy|0|||
105959660|NCT01893411|365513258|FG000|Overall Study|Other|3|||
105959661|NCT01893411|365513259|FG001|Overall Study|Other|1|||
105959662|NCT01893411|365513260|FG002|Overall Study|Other|3|||
105959663|NCT01893411|365513258|FG000|Overall Study|Adverse Event|1|||
105959664|NCT01893411|365513259|FG001|Overall Study|Adverse Event|0|||
105959665|NCT01893411|365513260|FG002|Overall Study|Adverse Event|0|||
105959666|NCT01893411|365513258|FG000|Overall Study|Withdrawal by Subject|7|||
105959667|NCT01893411|365513259|FG001|Overall Study|Withdrawal by Subject|4|||
105959668|NCT01893411|365513260|FG002|Overall Study|Withdrawal by Subject|3|||
105959669|NCT01893411|365513258|FG000|Overall Study|Lost to Follow-up|2|||
105959670|NCT01893411|365513259|FG001|Overall Study|Lost to Follow-up|0|||
105959671|NCT01893411|365513260|FG002|Overall Study|Lost to Follow-up|1|||
105959672|NCT00368745|365513261|FG000|Double-blind Treatment Period|Adverse Event|6|||
105959673|NCT00368745|365513262|FG001|Double-blind Treatment Period|Adverse Event|6|||
105959674|NCT00368745|365513261|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
105959675|NCT00368745|365513262|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
105959676|NCT00368745|365513261|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
105959677|NCT00368745|365513262|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105959678|NCT00368745|365513261|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
105959679|NCT00368745|365513262|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
105959680|NCT00368745|365513261|FG000|Double-blind Treatment Period|Other|7|||
105959681|NCT00368745|365513262|FG001|Double-blind Treatment Period|Other|6|||
105959682|NCT02013778|365513265|FG000|Overall Study|Death|4|||
105959683|NCT02013778|365513265|FG000|Overall Study|Withdrawal by Subject|1|||
105959684|NCT02013778|365513265|FG000|Overall Study|Physician Decision|1|||
105959685|NCT02013778|365513265|FG000|Overall Study|Adverse Event|1|||
105959686|NCT02719691|365513266|FG000|Overall Study|Physician Decision|0|||
105959687|NCT02719691|365513267|FG001|Overall Study|Physician Decision|0|||
105959688|NCT02719691|365513268|FG002|Overall Study|Physician Decision|1|||
105959689|NCT02719691|365513269|FG003|Overall Study|Physician Decision|0|||
105959690|NCT02719691|365513270|FG004|Overall Study|Physician Decision|0|||
105959691|NCT02719691|365513271|FG005|Overall Study|Physician Decision|0|||
105959692|NCT02719691|365513272|FG006|Overall Study|Physician Decision|0|||
105959693|NCT02719691|365513266|FG000|Overall Study|Withdrawal by Subject|0|||
105959694|NCT02719691|365513267|FG001|Overall Study|Withdrawal by Subject|0|||
105959695|NCT02719691|365513268|FG002|Overall Study|Withdrawal by Subject|0|||
105959696|NCT02719691|365513269|FG003|Overall Study|Withdrawal by Subject|0|||
105959697|NCT02719691|365513270|FG004|Overall Study|Withdrawal by Subject|0|||
105959698|NCT02719691|365513271|FG005|Overall Study|Withdrawal by Subject|1|||
105959699|NCT02719691|365513272|FG006|Overall Study|Withdrawal by Subject|0|||
105959700|NCT02141633|365513273|FG000|Overall Study|Physician Decision|1|||
105959701|NCT02141633|365513274|FG001|Overall Study|Physician Decision|0|||
105959702|NCT02482298|365513275|FG000|Overall Study|Withdrawal by Subject|2|||
105959703|NCT02482298|365513276|FG001|Overall Study|Withdrawal by Subject|1|||
105959704|NCT02482298|365513277|FG002|Overall Study|Withdrawal by Subject|2|||
105959705|NCT02482298|365513275|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
105959706|NCT02482298|365513276|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
105959707|NCT02482298|365513277|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
105959708|NCT02482298|365513275|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
105959709|NCT02482298|365513276|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
105959710|NCT02482298|365513277|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
105959711|NCT02482298|365513275|FG000|Overall Study|Lost to Follow-up|0|||
105959712|NCT02482298|365513276|FG001|Overall Study|Lost to Follow-up|1|||
105959713|NCT02482298|365513277|FG002|Overall Study|Lost to Follow-up|0|||
105959714|NCT00603941|365513283|FG000|Overall Study|Disease progression|6|||
105959715|NCT00603941|365513284|FG001|Overall Study|Disease progression|7|||
105959716|NCT00603941|365513285|FG002|Overall Study|Disease progression|1|||
105959717|NCT00603941|365513283|FG000|Overall Study|Adverse Event|1|||
105959718|NCT00603941|365513284|FG001|Overall Study|Adverse Event|0|||
105959719|NCT00603941|365513285|FG002|Overall Study|Adverse Event|1|||
105959720|NCT00603941|365513283|FG000|Overall Study|Physician Decision|0|||
105959721|NCT00603941|365513284|FG001|Overall Study|Physician Decision|1|||
105959722|NCT00603941|365513285|FG002|Overall Study|Physician Decision|0|||
105959723|NCT00603941|365513283|FG000|Overall Study|Withdrawal by Subject|0|||
105959724|NCT00603941|365513284|FG001|Overall Study|Withdrawal by Subject|2|||
105959725|NCT00603941|365513285|FG002|Overall Study|Withdrawal by Subject|0|||
105959726|NCT03654040|365513286|FG000|Overall Study|Death|1|||
105959727|NCT03654040|365513287|FG001|Overall Study|Death|0|||
105959728|NCT03654040|365513286|FG000|Overall Study|Withdrawal by Subject|1|||
105959729|NCT03654040|365513287|FG001|Overall Study|Withdrawal by Subject|0|||
105959730|NCT03654040|365513286|FG000|Overall Study|Study terminated by sponsor|8|||
105959731|NCT03654040|365513287|FG001|Overall Study|Study terminated by sponsor|2|||
105959732|NCT03654040|365513286|FG000|Overall Study|Failure to initiate study therapy|2|||
105959733|NCT03654040|365513287|FG001|Overall Study|Failure to initiate study therapy|0|||
105959734|NCT03654040|365513286|FG000|Overall Study|Transplanted at another center|2|||
105959735|NCT03654040|365513287|FG001|Overall Study|Transplanted at another center|0|||
105959736|NCT03654040|365513286|FG000|Overall Study|Failure to meet eligibility criteria|14|||
105959737|NCT03654040|365513287|FG001|Overall Study|Failure to meet eligibility criteria|2|||
105959738|NCT03654040|365513286|FG000|Overall Study|No longer transplant candidate|1|||
105959739|NCT03654040|365513287|FG001|Overall Study|No longer transplant candidate|0|||
105959740|NCT03654040|365513286|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
105959741|NCT03654040|365513287|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
105959742|NCT03654040|365513286|FG000|Overall Study|Recipient ineligible|0|||
105959743|NCT03654040|365513287|FG001|Overall Study|Recipient ineligible|2|||
105959744|NCT03654040|365513286|FG000|Overall Study|Received deceased liver|0|||
106021297|NCT01039519|365743315|FG000|Survival Follow-up|Death|23|||
105768357|NCT04731922|364802680|FG008|Overall Study|Other|0|||
105768358|NCT04731922|364802681|FG009|Overall Study|Other|0|||
105768359|NCT04731922|364802682|FG010|Overall Study|Other|0|||
105768360|NCT04731922|364802683|FG011|Overall Study|Other|0|||
105768361|NCT04731922|364802684|FG012|Overall Study|Other|0|||
105768362|NCT04731922|364802685|FG013|Overall Study|Other|0|||
105768363|NCT04731922|364802686|FG014|Overall Study|Other|0|||
105768364|NCT04731922|364802687|FG015|Overall Study|Other|0|||
105768365|NCT04731922|364802688|FG016|Overall Study|Other|0|||
105768366|NCT00422903|364802691|FG000|Overall Study|Disease Progression|3|||
105768367|NCT00422903|364802692|FG001|Overall Study|Disease Progression|1|||
105768368|NCT00422903|364802691|FG000|Overall Study|Adverse Event|0|||
105768369|NCT00422903|364802692|FG001|Overall Study|Adverse Event|2|||
105768370|NCT00422903|364802691|FG000|Overall Study|Informed Consent Withdrawn|1|||
105768371|NCT00422903|364802692|FG001|Overall Study|Informed Consent Withdrawn|2|||
105768372|NCT02092324|364802693|FG000|Overall Study|Adverse Event|1|||
105768373|NCT02092324|364802693|FG000|Overall Study|Lack of Efficacy|6|||
105768374|NCT02092324|364802693|FG000|Overall Study|Proceed to Transplant|3|||
105768375|NCT02092324|364802693|FG000|Overall Study|Physician Decision|7|||
105768376|NCT02092324|364802693|FG000|Overall Study|Misdiagnosis|2|||
105768377|NCT00981682|364802694|FG000|Overall Study|Adverse Event|48|||
105768378|NCT00981682|364802694|FG000|Overall Study|Withdrawal by Subject|52|||
105768379|NCT00981682|364802694|FG000|Overall Study|Lost to Follow-up|14|||
105768380|NCT00981682|364802694|FG000|Overall Study|Lack of Efficacy|13|||
105768381|NCT00981682|364802694|FG000|Overall Study|Protocol Violation|6|||
105768382|NCT00981682|364802694|FG000|Overall Study|administrative|9|||
105768383|NCT00044213|364802695|FG000|Overall Study|Withdrawal by Subject|50|||
105768384|NCT00044213|364802696|FG001|Overall Study|Withdrawal by Subject|65|||
105768385|NCT00044213|364802697|FG002|Overall Study|Withdrawal by Subject|91|||
105768386|NCT00044213|364802698|FG003|Overall Study|Withdrawal by Subject|83|||
105768387|NCT00044213|364802695|FG000|Overall Study|Death|42|||
105768388|NCT00044213|364802696|FG001|Overall Study|Death|42|||
105768389|NCT00044213|364802697|FG002|Overall Study|Death|42|||
105768390|NCT00044213|364802698|FG003|Overall Study|Death|49|||
105768391|NCT00044213|364802695|FG000|Overall Study|Lost to Follow-up|8|||
105768392|NCT00044213|364802696|FG001|Overall Study|Lost to Follow-up|5|||
105768393|NCT00044213|364802697|FG002|Overall Study|Lost to Follow-up|5|||
105768394|NCT00044213|364802698|FG003|Overall Study|Lost to Follow-up|4|||
105823522|NCT01370317|365010509|FG001|Overall Study|Protocol deviation|1|||
105823523|NCT02909907|365010512|FG000|Overall Study|Withdrawal by Subject|0|||
105823524|NCT02909907|365010513|FG001|Overall Study|Withdrawal by Subject|1|||
105823525|NCT03247972|365010518|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
105823526|NCT03247972|365010518|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
105823527|NCT01175018|365010519|FG000|Overall Study|Adverse Event|3|||
105823528|NCT01175018|365010520|FG001|Overall Study|Adverse Event|1|||
105823529|NCT01415986|365010528|FG000|Overall Study|Lost to Follow-up|1|||
105823530|NCT04078022|365010529|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
105823531|NCT04078022|365010530|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
105823532|NCT01316055|365010536|FG000|Overall Study|Lost to Follow-up|1|||
105823533|NCT01316055|365010537|FG001|Overall Study|Lost to Follow-up|0|||
105823534|NCT01316055|365010538|FG002|Overall Study|Lost to Follow-up|0|||
105823535|NCT00003470|365010539|FG000|Overall Study|Not evaluable|6|||
105823536|NCT00251979|365010540|FG000|Overall Study|Protocol Violation|3|||
105823537|NCT00251979|365010541|FG001|Overall Study|Protocol Violation|5|||
105823538|NCT00251979|365010540|FG000|Overall Study|Adverse Event|11|||
105823539|NCT00251979|365010541|FG001|Overall Study|Adverse Event|17|||
105823540|NCT00251979|365010540|FG000|Overall Study|Withdrawal by Subject|13|||
105823541|NCT00251979|365010541|FG001|Overall Study|Withdrawal by Subject|7|||
105823542|NCT00251979|365010540|FG000|Overall Study|Lost to Follow-up|8|||
105823543|NCT00251979|365010541|FG001|Overall Study|Lost to Follow-up|6|||
105823544|NCT00251979|365010540|FG000|Overall Study|Death|3|||
105823545|NCT00251979|365010541|FG001|Overall Study|Death|5|||
105823546|NCT03273153|365010544|FG000|Overall Study|Adverse Event|1|||
105823547|NCT03273153|365010545|FG001|Overall Study|Adverse Event|2|||
105823548|NCT03273153|365010544|FG000|Overall Study|Missing|0|||
105823549|NCT03273153|365010545|FG001|Overall Study|Missing|2|||
105823550|NCT03273153|365010544|FG000|Overall Study|Other|3|||
105823551|NCT03273153|365010545|FG001|Overall Study|Other|2|||
105823552|NCT03273153|365010544|FG000|Overall Study|Symptomatic Deterioration|0|||
105823553|NCT03273153|365010545|FG001|Overall Study|Symptomatic Deterioration|1|||
105823554|NCT03273153|365010544|FG000|Overall Study|Progressive Disease|6|||
105823555|NCT03273153|365010545|FG001|Overall Study|Progressive Disease|5|||
105823556|NCT03273153|365010544|FG000|Overall Study|Physician Decision|1|||
105823557|NCT03273153|365010545|FG001|Overall Study|Physician Decision|3|||
105823558|NCT03273153|365010544|FG000|Overall Study|Study Terminated by Sponsor|112|||
105823559|NCT03273153|365010545|FG001|Overall Study|Study Terminated by Sponsor|102|||
105823560|NCT03273153|365010544|FG000|Overall Study|Withdrawal by Subject|26|||
105823561|NCT03273153|365010545|FG001|Overall Study|Withdrawal by Subject|25|||
105823562|NCT03273153|365010544|FG000|Overall Study|Protocol Deviation|3|||
105823563|NCT03273153|365010545|FG001|Overall Study|Protocol Deviation|0|||
105823564|NCT03273153|365010544|FG000|Overall Study|Lost to Follow-up|6|||
105823565|NCT03273153|365010545|FG001|Overall Study|Lost to Follow-up|11|||
105823566|NCT03273153|365010544|FG000|Overall Study|Death|66|||
105823567|NCT03273153|365010545|FG001|Overall Study|Death|69|||
105823568|NCT00268203|365010546|FG000|Overall Study|Lost to Follow-up|92|||
105823569|NCT00268203|365010546|FG000|Overall Study|Withdrawal by Subject|9|||
105823570|NCT00268203|365010546|FG000|Overall Study|Received Other NHL Therapy|7|||
105823571|NCT00268203|365010546|FG000|Overall Study|Progressive Disease|359|||
105823572|NCT00268203|365010546|FG000|Overall Study|Death|84|||
105823573|NCT00268203|365010546|FG000|Overall Study|Reason Not Specified|34|||
105823574|NCT00268203|365010546|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
105823575|NCT00796562|365010550|FG000|Overall Study|Death|49|||
105823576|NCT02957942|365010551|FG000|Overall Study|Withdrawal by Subject|0|||
105823577|NCT02957942|365010552|FG001|Overall Study|Withdrawal by Subject|1|||
105823578|NCT02957942|365010551|FG000|Overall Study|Practicing experiment protocol|0|||
105823579|NCT02957942|365010552|FG001|Overall Study|Practicing experiment protocol|6|||
105823580|NCT02316548|365012006|FG000|Overall Study|Protocol Violation|0|||
105823581|NCT02316548|365012007|FG001|Overall Study|Protocol Violation|1|||
105823582|NCT02571907|365012008|FG000|Overall Study|Death|4|||
105823583|NCT02571907|365012008|FG000|Overall Study|Lost to Follow-up|3|||
105823584|NCT02571907|365012008|FG000|Overall Study|Withdrawal by Subject|3|||
105823585|NCT06358820|365012009|FG000|Overall Study|Adverse Event|11|||
105823586|NCT06358820|365012009|FG000|Overall Study|kidney transplantation|3|||
105823587|NCT06358820|365012009|FG000|Overall Study|patient voluntary withdrawal|6|||
105823588|NCT06358820|365012009|FG000|Overall Study|Physician Decision|1|||
105823589|NCT04247282|365012012|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
105823590|NCT04247282|365012013|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
105823591|NCT04247282|365012014|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
105823592|NCT04247282|365012015|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
105823593|NCT04247282|365012012|FG000|Overall Study|Refused further treatment|0|||
105823594|NCT04247282|365012013|FG001|Overall Study|Refused further treatment|1|||
105823595|NCT04247282|365012014|FG002|Overall Study|Refused further treatment|0|||
105823596|NCT04247282|365012015|FG003|Overall Study|Refused further treatment|0|||
105823597|NCT02519348|365012016|FG000|Overall Study|Death|31|||
105823598|NCT02519348|365012017|FG001|Overall Study|Death|74|||
106021298|NCT01039519|365743315|FG000|Survival Follow-up|Sponsor decision|4|||
106021299|NCT00423917|365743324|FG000|Overall Study|Cancel|2|||
106021300|NCT00423917|365743324|FG000|Overall Study|Ineligible|1|||
106021301|NCT00243269|365743325|FG000|Overall Study|Protocol Violation|2|||
106021302|NCT00243269|365743326|FG001|Overall Study|Protocol Violation|1|||
106021303|NCT00243269|365743327|FG002|Overall Study|Protocol Violation|0|||
106021304|NCT00243269|365743328|FG003|Overall Study|Protocol Violation|1|||
106021305|NCT00243269|365743325|FG000|Overall Study|Lost to Follow-up|1|||
106021306|NCT00243269|365743326|FG001|Overall Study|Lost to Follow-up|0|||
106021307|NCT00243269|365743327|FG002|Overall Study|Lost to Follow-up|1|||
106021308|NCT00243269|365743328|FG003|Overall Study|Lost to Follow-up|3|||
106021309|NCT03085797|365743330|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
106021310|NCT03085797|365743331|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
106021311|NCT03085797|365743330|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
106021312|NCT03085797|365743331|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
106021313|NCT03085797|365743330|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
106021314|NCT03085797|365743331|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
106021315|NCT03052400|365743332|FG000|Overall Study|Lost to Follow-up|1|||
106021316|NCT03052400|365743333|FG001|Overall Study|Lost to Follow-up|0|||
106021317|NCT03052400|365743332|FG000|Overall Study|Withdrawal by Subject|0|||
106021318|NCT03052400|365743333|FG001|Overall Study|Withdrawal by Subject|1|||
106021319|NCT03926611|365743335|FG000|Overall Study|Adverse Event|0|||
106021320|NCT03926611|365743336|FG001|Overall Study|Adverse Event|0|||
106021321|NCT03926611|365743337|FG002|Overall Study|Adverse Event|0|||
106021322|NCT03926611|365743338|FG003|Overall Study|Adverse Event|3|||
106021323|NCT03926611|365743339|FG004|Overall Study|Adverse Event|1|||
106021324|NCT03926611|365743340|FG005|Overall Study|Adverse Event|3|||
106021325|NCT03926611|365743341|FG006|Overall Study|Adverse Event|0|||
106021326|NCT03926611|365743335|FG000|Overall Study|Lack of Efficacy|1|||
106021327|NCT03926611|365743336|FG001|Overall Study|Lack of Efficacy|2|||
106021328|NCT03926611|365743337|FG002|Overall Study|Lack of Efficacy|0|||
106021329|NCT03926611|365743338|FG003|Overall Study|Lack of Efficacy|0|||
106021330|NCT03926611|365743339|FG004|Overall Study|Lack of Efficacy|1|||
106021331|NCT03926611|365743340|FG005|Overall Study|Lack of Efficacy|0|||
106021332|NCT03926611|365743341|FG006|Overall Study|Lack of Efficacy|1|||
106021333|NCT03926611|365743335|FG000|Overall Study|Physician Decision|0|||
106021334|NCT03926611|365743336|FG001|Overall Study|Physician Decision|0|||
106021335|NCT03926611|365743337|FG002|Overall Study|Physician Decision|0|||
106021336|NCT03926611|365743338|FG003|Overall Study|Physician Decision|0|||
106021337|NCT03926611|365743339|FG004|Overall Study|Physician Decision|0|||
106021338|NCT03926611|365743340|FG005|Overall Study|Physician Decision|1|||
106021339|NCT03926611|365743341|FG006|Overall Study|Physician Decision|0|||
106021340|NCT03926611|365743335|FG000|Overall Study|Protocol Violation|1|||
106021341|NCT03926611|365743336|FG001|Overall Study|Protocol Violation|0|||
106021342|NCT03926611|365743337|FG002|Overall Study|Protocol Violation|0|||
106021343|NCT03926611|365743338|FG003|Overall Study|Protocol Violation|1|||
106021344|NCT03926611|365743339|FG004|Overall Study|Protocol Violation|1|||
106021345|NCT03926611|365743340|FG005|Overall Study|Protocol Violation|1|||
106021346|NCT03926611|365743341|FG006|Overall Study|Protocol Violation|1|||
106021347|NCT03926611|365743335|FG000|Overall Study|Technical problems|0|||
106021348|NCT03926611|365743336|FG001|Overall Study|Technical problems|0|||
105823599|NCT02519348|365012018|FG002|Overall Study|Death|47|||
105823600|NCT02519348|365012019|FG003|Overall Study|Death|54|||
105823601|NCT02519348|365012020|FG004|Overall Study|Death|63|||
105823602|NCT02519348|365012021|FG005|Overall Study|Death|18|||
105823603|NCT02519348|365012022|FG006|Overall Study|Death|2|||
105823604|NCT02519348|365012023|FG007|Overall Study|Death|5|||
105823605|NCT02519348|365012024|FG008|Overall Study|Death|5|||
105823606|NCT02519348|365012016|FG000|Overall Study|Withdrawal by Subject|4|||
106021349|NCT03926611|365743337|FG002|Overall Study|Technical problems|0|||
106021350|NCT03926611|365743338|FG003|Overall Study|Technical problems|0|||
106021351|NCT03926611|365743339|FG004|Overall Study|Technical problems|0|||
106021352|NCT03926611|365743340|FG005|Overall Study|Technical problems|1|||
106021353|NCT03926611|365743341|FG006|Overall Study|Technical problems|0|||
106021354|NCT03926611|365743335|FG000|Overall Study|Withdrawal by Subject|1|||
106021355|NCT03926611|365743336|FG001|Overall Study|Withdrawal by Subject|1|||
106021356|NCT03926611|365743337|FG002|Overall Study|Withdrawal by Subject|1|||
106146337|NCT01124734|366196473|FG000|Overall Study|Withdrawal by Subject|1|||
106146338|NCT01124734|366196473|FG000|Overall Study|Elected for alternative treatment|2|||
105823607|NCT02519348|365012017|FG001|Overall Study|Withdrawal by Subject|7|||
105823608|NCT02519348|365012018|FG002|Overall Study|Withdrawal by Subject|4|||
106021357|NCT03926611|365743338|FG003|Overall Study|Withdrawal by Subject|0|||
106021358|NCT03926611|365743339|FG004|Overall Study|Withdrawal by Subject|0|||
106021359|NCT03926611|365743340|FG005|Overall Study|Withdrawal by Subject|1|||
106021360|NCT03926611|365743341|FG006|Overall Study|Withdrawal by Subject|3|||
106021361|NCT03926611|365743335|FG000|Overall Study|Covid-19 pandemic|0|||
105823609|NCT02519348|365012019|FG003|Overall Study|Withdrawal by Subject|3|||
105823610|NCT02519348|365012020|FG004|Overall Study|Withdrawal by Subject|3|||
106021362|NCT03926611|365743336|FG001|Overall Study|Covid-19 pandemic|0|||
105823611|NCT02519348|365012021|FG005|Overall Study|Withdrawal by Subject|2|||
105823612|NCT02519348|365012022|FG006|Overall Study|Withdrawal by Subject|0|||
105823613|NCT02519348|365012023|FG007|Overall Study|Withdrawal by Subject|0|||
105823614|NCT02519348|365012024|FG008|Overall Study|Withdrawal by Subject|1|||
105823615|NCT02519348|365012016|FG000|Overall Study|Lost to Follow-up|0|||
105823616|NCT02519348|365012017|FG001|Overall Study|Lost to Follow-up|0|||
105823617|NCT02519348|365012018|FG002|Overall Study|Lost to Follow-up|1|||
105823618|NCT02519348|365012019|FG003|Overall Study|Lost to Follow-up|0|||
105823619|NCT02519348|365012020|FG004|Overall Study|Lost to Follow-up|2|||
105823620|NCT02519348|365012021|FG005|Overall Study|Lost to Follow-up|1|||
105823621|NCT02519348|365012022|FG006|Overall Study|Lost to Follow-up|1|||
105823622|NCT02519348|365012023|FG007|Overall Study|Lost to Follow-up|0|||
105823623|NCT02519348|365012024|FG008|Overall Study|Lost to Follow-up|0|||
105823624|NCT02519348|365012016|FG000|Overall Study|Other|0|||
105823625|NCT02519348|365012017|FG001|Overall Study|Other|3|||
105823626|NCT02519348|365012018|FG002|Overall Study|Other|0|||
105823627|NCT02519348|365012019|FG003|Overall Study|Other|0|||
105823628|NCT02519348|365012020|FG004|Overall Study|Other|1|||
105823629|NCT02519348|365012021|FG005|Overall Study|Other|0|||
105823630|NCT02519348|365012022|FG006|Overall Study|Other|0|||
105823631|NCT02519348|365012023|FG007|Overall Study|Other|0|||
105823632|NCT02519348|365012024|FG008|Overall Study|Other|0|||
105823633|NCT02519348|365012016|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
105823634|NCT02519348|365012017|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
105823635|NCT02519348|365012018|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
105823636|NCT02519348|365012019|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
105823637|NCT02519348|365012020|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
105823638|NCT02519348|365012021|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
105823639|NCT02519348|365012022|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
105823640|NCT02519348|365012023|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
105823641|NCT02519348|365012024|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
105823642|NCT00207090|365012029|FG000|Overall Study|Study drug toxicity|3|||
105823643|NCT00207090|365012029|FG000|Overall Study|Chest wall mass larger|1|||
105823644|NCT00207090|365012029|FG000|Overall Study|Disease progression/relapse|2|||
105823645|NCT00207090|365012029|FG000|Overall Study|Physician Decision|1|||
105823646|NCT00841698|365012032|FG000|First Intervention|Withdrawal by Subject|1|||
105823647|NCT00841698|365012033|FG001|First Intervention|Withdrawal by Subject|0|||
105823648|NCT00906399|365012038|FG000|Year 1|Randomized But Not Treated|0|||
105823649|NCT00906399|365012039|FG001|Year 1|Randomized But Not Treated|1|||
105823650|NCT00906399|365012040|FG002|Year 1|Randomized But Not Treated|3|||
105823651|NCT00906399|365012041|FG003|Year 1|Randomized But Not Treated|0|||
105823652|NCT00906399|365012042|FG004|Year 1|Randomized But Not Treated|0|||
105823653|NCT00906399|365012043|FG005|Year 1|Randomized But Not Treated|0|||
105823654|NCT00906399|365012044|FG006|Year 1|Randomized But Not Treated|0|||
105823655|NCT00906399|365012038|FG000|Year 1|Adverse Event|4|||
105823656|NCT00906399|365012039|FG001|Year 1|Adverse Event|22|||
105823657|NCT00906399|365012040|FG002|Year 1|Adverse Event|24|||
105823658|NCT00906399|365012041|FG003|Year 1|Adverse Event|0|||
105823659|NCT00906399|365012042|FG004|Year 1|Adverse Event|0|||
105823660|NCT00906399|365012043|FG005|Year 1|Adverse Event|0|||
105823661|NCT00906399|365012044|FG006|Year 1|Adverse Event|0|||
105823662|NCT00906399|365012038|FG000|Year 1|Lost to Follow-up|4|||
105823663|NCT00906399|365012039|FG001|Year 1|Lost to Follow-up|4|||
105823664|NCT00906399|365012040|FG002|Year 1|Lost to Follow-up|2|||
105823665|NCT00906399|365012041|FG003|Year 1|Lost to Follow-up|0|||
105823666|NCT00906399|365012042|FG004|Year 1|Lost to Follow-up|0|||
105823667|NCT00906399|365012043|FG005|Year 1|Lost to Follow-up|0|||
105823668|NCT00906399|365012044|FG006|Year 1|Lost to Follow-up|0|||
105823669|NCT00906399|365012038|FG000|Year 1|Withdrawal by Subject|30|||
105823670|NCT00906399|365012039|FG001|Year 1|Withdrawal by Subject|32|||
105823671|NCT00906399|365012040|FG002|Year 1|Withdrawal by Subject|36|||
105823672|NCT00906399|365012041|FG003|Year 1|Withdrawal by Subject|0|||
105823673|NCT00906399|365012042|FG004|Year 1|Withdrawal by Subject|0|||
105823674|NCT00906399|365012043|FG005|Year 1|Withdrawal by Subject|0|||
105823675|NCT00906399|365012044|FG006|Year 1|Withdrawal by Subject|0|||
105823676|NCT00906399|365012038|FG000|Year 1|Physician Decision|0|||
105823677|NCT00906399|365012039|FG001|Year 1|Physician Decision|1|||
105823678|NCT00906399|365012040|FG002|Year 1|Physician Decision|3|||
105823679|NCT00906399|365012041|FG003|Year 1|Physician Decision|0|||
105823680|NCT00906399|365012042|FG004|Year 1|Physician Decision|0|||
105823681|NCT00906399|365012043|FG005|Year 1|Physician Decision|0|||
105823682|NCT00906399|365012044|FG006|Year 1|Physician Decision|0|||
105823683|NCT00906399|365012038|FG000|Year 1|Death|2|||
105823684|NCT00906399|365012039|FG001|Year 1|Death|1|||
105823685|NCT00906399|365012040|FG002|Year 1|Death|1|||
105823686|NCT00906399|365012041|FG003|Year 1|Death|0|||
105823687|NCT00906399|365012042|FG004|Year 1|Death|0|||
105823688|NCT00906399|365012043|FG005|Year 1|Death|0|||
105823689|NCT00906399|365012044|FG006|Year 1|Death|0|||
105823690|NCT00906399|365012038|FG000|Year 1|Other|4|||
105823691|NCT00906399|365012039|FG001|Year 1|Other|2|||
105823692|NCT00906399|365012040|FG002|Year 1|Other|7|||
105823693|NCT00906399|365012041|FG003|Year 1|Other|0|||
105823694|NCT00906399|365012042|FG004|Year 1|Other|0|||
105823695|NCT00906399|365012043|FG005|Year 1|Other|0|||
105823696|NCT00906399|365012044|FG006|Year 1|Other|0|||
105823697|NCT00906399|365012038|FG000|Year 2|Adverse Event|0|||
105823698|NCT00906399|365012039|FG001|Year 2|Adverse Event|0|||
105823699|NCT00906399|365012040|FG002|Year 2|Adverse Event|0|||
105823700|NCT00906399|365012041|FG003|Year 2|Adverse Event|9|||
105823701|NCT00906399|365012042|FG004|Year 2|Adverse Event|8|||
105823702|NCT00906399|365012043|FG005|Year 2|Adverse Event|11|||
105823703|NCT00906399|365012044|FG006|Year 2|Adverse Event|6|||
105823704|NCT00906399|365012038|FG000|Year 2|Lost to Follow-up|0|||
105823705|NCT00906399|365012039|FG001|Year 2|Lost to Follow-up|0|||
105823706|NCT00906399|365012040|FG002|Year 2|Lost to Follow-up|0|||
105823707|NCT00906399|365012041|FG003|Year 2|Lost to Follow-up|1|||
105823708|NCT00906399|365012042|FG004|Year 2|Lost to Follow-up|4|||
105823709|NCT00906399|365012043|FG005|Year 2|Lost to Follow-up|2|||
105823710|NCT00906399|365012044|FG006|Year 2|Lost to Follow-up|4|||
105823711|NCT00906399|365012038|FG000|Year 2|Withdrawal by Subject|0|||
105823712|NCT00906399|365012039|FG001|Year 2|Withdrawal by Subject|0|||
105823713|NCT00906399|365012040|FG002|Year 2|Withdrawal by Subject|0|||
105823714|NCT00906399|365012041|FG003|Year 2|Withdrawal by Subject|17|||
105823715|NCT00906399|365012042|FG004|Year 2|Withdrawal by Subject|18|||
105823716|NCT00906399|365012043|FG005|Year 2|Withdrawal by Subject|27|||
105823717|NCT00906399|365012044|FG006|Year 2|Withdrawal by Subject|13|||
105823718|NCT00906399|365012038|FG000|Year 2|Physician Decision|0|||
105823719|NCT00906399|365012039|FG001|Year 2|Physician Decision|0|||
105823720|NCT00906399|365012040|FG002|Year 2|Physician Decision|0|||
105823721|NCT00906399|365012041|FG003|Year 2|Physician Decision|0|||
105823722|NCT00906399|365012042|FG004|Year 2|Physician Decision|2|||
105823723|NCT00906399|365012043|FG005|Year 2|Physician Decision|6|||
105823724|NCT00906399|365012044|FG006|Year 2|Physician Decision|3|||
105823725|NCT00906399|365012038|FG000|Year 2|Death|0|||
105823726|NCT00906399|365012039|FG001|Year 2|Death|0|||
105823727|NCT00906399|365012040|FG002|Year 2|Death|0|||
105823728|NCT00906399|365012041|FG003|Year 2|Death|1|||
105823729|NCT00906399|365012042|FG004|Year 2|Death|0|||
105823730|NCT00906399|365012043|FG005|Year 2|Death|0|||
105823731|NCT00906399|365012044|FG006|Year 2|Death|3|||
105823732|NCT00906399|365012038|FG000|Year 2|Other|0|||
105823733|NCT00906399|365012039|FG001|Year 2|Other|0|||
105823734|NCT00906399|365012040|FG002|Year 2|Other|0|||
105823735|NCT00906399|365012041|FG003|Year 2|Other|2|||
105823736|NCT00906399|365012042|FG004|Year 2|Other|3|||
105823737|NCT00906399|365012043|FG005|Year 2|Other|1|||
105823738|NCT00906399|365012044|FG006|Year 2|Other|0|||
105823739|NCT00185458|365012045|FG000|Contraception Phase|Adverse Event|37|||
105823740|NCT00185458|365012045|FG000|Contraception Phase|Lost to Follow-up|10|||
105823741|NCT00185458|365012045|FG000|Contraception Phase|Protocol Violation|2|||
105823742|NCT00185458|365012045|FG000|Contraception Phase|Physician Decision|2|||
105823743|NCT00185458|365012045|FG000|Contraception Phase|Withdrawal by Subject|7|||
105823744|NCT00185458|365012045|FG000|HRT Phase|Adverse Event|18|||
106021363|NCT03926611|365743337|FG002|Overall Study|Covid-19 pandemic|1|||
106021364|NCT03926611|365743338|FG003|Overall Study|Covid-19 pandemic|0|||
106021365|NCT03926611|365743339|FG004|Overall Study|Covid-19 pandemic|1|||
106021366|NCT03926611|365743340|FG005|Overall Study|Covid-19 pandemic|2|||
106021367|NCT03926611|365743341|FG006|Overall Study|Covid-19 pandemic|0|||
106021368|NCT00485134|365743342|FG000|Overall Study|Lost to Follow-up|1|||
106021369|NCT00485134|365743343|FG001|Overall Study|Lost to Follow-up|0|||
106021370|NCT00485134|365743344|FG002|Overall Study|Lost to Follow-up|0|||
106021371|NCT00485134|365743345|FG003|Overall Study|Lost to Follow-up|0|||
106021372|NCT00485134|365743346|FG004|Overall Study|Lost to Follow-up|0|||
106021373|NCT00485134|365743347|FG005|Overall Study|Lost to Follow-up|0|||
106021374|NCT00485134|365743348|FG006|Overall Study|Lost to Follow-up|0|||
106021375|NCT00485134|365743349|FG007|Overall Study|Lost to Follow-up|0|||
106021376|NCT00485134|365743342|FG000|Overall Study|Withdrawal by Subject|0|||
105823745|NCT00185458|365012045|FG000|HRT Phase|Lost to Follow-up|4|||
105823746|NCT00185458|365012045|FG000|HRT Phase|Protocol Violation|2|||
105823747|NCT00185458|365012045|FG000|HRT Phase|Withdrawal by Subject|3|||
105823748|NCT01911676|365012046|FG000|Period 1 of Study|Withdrawal by Subject|4|||
105823749|NCT01911676|365012047|FG001|Period 1 of Study|Withdrawal by Subject|2|||
106021377|NCT00485134|365743343|FG001|Overall Study|Withdrawal by Subject|1|||
106021378|NCT00485134|365743344|FG002|Overall Study|Withdrawal by Subject|0|||
105768395|NCT00422240|364802701|FG000|Overall Study|Lack of Efficacy|1|||
105768396|NCT00422240|364802702|FG001|Overall Study|Lack of Efficacy|2|||
105768397|NCT00422240|364802703|FG002|Overall Study|Lack of Efficacy|0|||
105768398|NCT00422240|364802704|FG003|Overall Study|Lack of Efficacy|1|||
105768399|NCT00422240|364802701|FG000|Overall Study|Adverse Event|11|||
105768400|NCT00422240|364802702|FG001|Overall Study|Adverse Event|4|||
105768401|NCT00422240|364802703|FG002|Overall Study|Adverse Event|5|||
105768402|NCT00422240|364802704|FG003|Overall Study|Adverse Event|2|||
105768403|NCT00422240|364802701|FG000|Overall Study|Subject request|21|||
105768404|NCT00422240|364802702|FG001|Overall Study|Subject request|17|||
105768405|NCT00422240|364802703|FG002|Overall Study|Subject request|18|||
105768406|NCT00422240|364802704|FG003|Overall Study|Subject request|30|||
105768407|NCT00422240|364802701|FG000|Overall Study|Protocol Violation|0|||
105823750|NCT01911676|365012048|FG002|Period 1 of Study|Withdrawal by Subject|1|||
105823751|NCT01911676|365012049|FG003|Period 1 of Study|Withdrawal by Subject|2|||
105823752|NCT01911676|365012046|FG000|Period 1 of Study|Physician Decision|2|||
105823753|NCT01911676|365012047|FG001|Period 1 of Study|Physician Decision|0|||
105823754|NCT01911676|365012048|FG002|Period 1 of Study|Physician Decision|0|||
105823755|NCT01911676|365012049|FG003|Period 1 of Study|Physician Decision|1|||
105823756|NCT01911676|365012046|FG000|Period 2 of Study|Physician Decision|2|||
105823757|NCT01911676|365012047|FG001|Period 2 of Study|Physician Decision|0|||
105823758|NCT01911676|365012048|FG002|Period 2 of Study|Physician Decision|0|||
105823759|NCT01911676|365012049|FG003|Period 2 of Study|Physician Decision|1|||
105823760|NCT01911676|365012046|FG000|Period 2 of Study|Lost to Follow-up|0|||
105823761|NCT01911676|365012047|FG001|Period 2 of Study|Lost to Follow-up|0|||
105823762|NCT01911676|365012048|FG002|Period 2 of Study|Lost to Follow-up|0|||
105823763|NCT01911676|365012049|FG003|Period 2 of Study|Lost to Follow-up|1|||
105823764|NCT01348789|365012050|FG000|Overall Study|Protocol Violation|2|||
105823765|NCT01348789|365012050|FG000|Overall Study|Withdrawal by Subject|2|||
105823766|NCT01566721|365012060|FG000|Treatment Period|Withdrawal by Subject|35|||
105823767|NCT01566721|365012061|FG001|Treatment Period|Withdrawal by Subject|9|||
105823768|NCT01566721|365012060|FG000|Treatment Period|Disease Progression/Recurrence|37|||
105823769|NCT01566721|365012061|FG001|Treatment Period|Disease Progression/Recurrence|13|||
105823770|NCT01566721|365012060|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
105823771|NCT01566721|365012061|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
105823772|NCT01566721|365012060|FG000|Treatment Period|Other|13|||
105823773|NCT01566721|365012061|FG001|Treatment Period|Other|2|||
105823774|NCT01566721|365012060|FG000|Treatment Period|Lack of Compliance|5|||
105823775|NCT01566721|365012061|FG001|Treatment Period|Lack of Compliance|1|||
105823776|NCT01566721|365012060|FG000|Treatment Period|Adverse Event|100|||
105823777|NCT01566721|365012061|FG001|Treatment Period|Adverse Event|30|||
105823778|NCT01566721|365012060|FG000|Treatment Period|Pregnancy|1|||
105823779|NCT01566721|365012061|FG001|Treatment Period|Pregnancy|0|||
105823780|NCT01566721|365012060|FG000|Safety Follow-up|Physician Decision|6|||
105823781|NCT01566721|365012061|FG001|Safety Follow-up|Physician Decision|4|||
105823782|NCT01566721|365012060|FG000|Safety Follow-up|Lost to Follow-up|101|||
105823783|NCT01566721|365012061|FG001|Safety Follow-up|Lost to Follow-up|48|||
105823784|NCT01566721|365012060|FG000|Safety Follow-up|Withdrawal by Subject|155|||
105823785|NCT01566721|365012061|FG001|Safety Follow-up|Withdrawal by Subject|49|||
105823786|NCT01566721|365012060|FG000|Safety Follow-up|Death|28|||
105823787|NCT01566721|365012061|FG001|Safety Follow-up|Death|4|||
105823788|NCT01566721|365012060|FG000|Safety Follow-up|Non-compliance|7|||
105823789|NCT01566721|365012061|FG001|Safety Follow-up|Non-compliance|3|||
105823790|NCT01566721|365012060|FG000|Safety Follow-up|Protocol Violation|7|||
105823791|NCT01566721|365012061|FG001|Safety Follow-up|Protocol Violation|0|||
105823792|NCT01566721|365012060|FG000|Safety Follow-up|Site closure|2|||
105823793|NCT01566721|365012061|FG001|Safety Follow-up|Site closure|3|||
105823794|NCT01566721|365012060|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
105823795|NCT01566721|365012061|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
105823796|NCT01566721|365012060|FG000|Safety Follow-up|Missing|7|||
105823797|NCT01566721|365012061|FG001|Safety Follow-up|Missing|2|||
105823798|NCT01566721|365012060|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
105823799|NCT01566721|365012061|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
105823800|NCT01566721|365012060|FG000|Safety Follow-up|Sponsor decision|1|||
105823801|NCT01566721|365012061|FG001|Safety Follow-up|Sponsor decision|0|||
105823802|NCT01566721|365012060|FG000|Safety Follow-up|Adverse Event|8|||
105823803|NCT01566721|365012061|FG001|Safety Follow-up|Adverse Event|4|||
105823804|NCT01794845|365012063|FG000|Overall Study|Withdrawal by Subject|1|||
105823805|NCT01169558|365012066|FG000|Overall Study|Disease progression|98|||
105823806|NCT01169558|365012066|FG000|Overall Study|Adverse Event|25|||
105823807|NCT01169558|365012066|FG000|Overall Study|Withdrawal of Consent|8|||
105823808|NCT01169558|365012066|FG000|Overall Study|Medical Decision|7|||
105823809|NCT01169558|365012066|FG000|Overall Study|Stable Disease|4|||
105823810|NCT01169558|365012066|FG000|Overall Study|Lost to Follow-up|4|||
105823811|NCT01169558|365012066|FG000|Overall Study|Need for Surgery|4|||
105823812|NCT01169558|365012066|FG000|Overall Study|Non-compliance|2|||
105823813|NCT01169558|365012066|FG000|Overall Study|Protocol Violation|2|||
105823814|NCT01169558|365012066|FG000|Overall Study|Partial response|2|||
105823815|NCT00429416|365012069|FG000|Overall Study|Death|1|||
105823816|NCT01456221|365012073|FG000|Overall Study|Withdrawal by Subject|56|||
105823817|NCT01456221|365012074|FG001|Overall Study|Withdrawal by Subject|49|||
105823818|NCT01456221|365012073|FG000|Overall Study|Lost to Follow-up|1|||
105823819|NCT01456221|365012074|FG001|Overall Study|Lost to Follow-up|4|||
105823820|NCT01456221|365012073|FG000|Overall Study|Received medication|3|||
105823821|NCT01456221|365012074|FG001|Overall Study|Received medication|2|||
105823822|NCT01456221|365012073|FG000|Overall Study|Incomplete data|4|||
105823823|NCT01456221|365012074|FG001|Overall Study|Incomplete data|2|||
105823824|NCT02530905|365012079|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
105823825|NCT02530905|365012080|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
105823826|NCT02530905|365012081|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
106021379|NCT00485134|365743345|FG003|Overall Study|Withdrawal by Subject|0|||
106021380|NCT00485134|365743346|FG004|Overall Study|Withdrawal by Subject|0|||
106021381|NCT00485134|365743347|FG005|Overall Study|Withdrawal by Subject|0|||
106021382|NCT00485134|365743348|FG006|Overall Study|Withdrawal by Subject|0|||
106021383|NCT00485134|365743349|FG007|Overall Study|Withdrawal by Subject|0|||
106021384|NCT00485134|365743342|FG000|Overall Study|Change in health status|0|||
106021385|NCT00485134|365743343|FG001|Overall Study|Change in health status|1|||
106021386|NCT00485134|365743344|FG002|Overall Study|Change in health status|2|||
106021387|NCT00485134|365743345|FG003|Overall Study|Change in health status|1|||
106021388|NCT00485134|365743346|FG004|Overall Study|Change in health status|0|||
106021389|NCT00485134|365743347|FG005|Overall Study|Change in health status|1|||
106021390|NCT00485134|365743348|FG006|Overall Study|Change in health status|0|||
106021391|NCT00485134|365743349|FG007|Overall Study|Change in health status|0|||
106021392|NCT00485134|365743342|FG000|Overall Study|Withdrew for adverse event|0|||
106021393|NCT00485134|365743343|FG001|Overall Study|Withdrew for adverse event|0|||
106021394|NCT00485134|365743344|FG002|Overall Study|Withdrew for adverse event|1|||
106021395|NCT00485134|365743345|FG003|Overall Study|Withdrew for adverse event|0|||
106021396|NCT00485134|365743346|FG004|Overall Study|Withdrew for adverse event|0|||
106021397|NCT00485134|365743347|FG005|Overall Study|Withdrew for adverse event|0|||
106021398|NCT00485134|365743348|FG006|Overall Study|Withdrew for adverse event|0|||
106021399|NCT00485134|365743349|FG007|Overall Study|Withdrew for adverse event|0|||
106021400|NCT00485134|365743342|FG000|Overall Study|Positive drug test|0|||
106021401|NCT00485134|365743343|FG001|Overall Study|Positive drug test|0|||
106021402|NCT00485134|365743344|FG002|Overall Study|Positive drug test|0|||
106021403|NCT00485134|365743345|FG003|Overall Study|Positive drug test|0|||
106021404|NCT00485134|365743346|FG004|Overall Study|Positive drug test|2|||
106021405|NCT00485134|365743347|FG005|Overall Study|Positive drug test|1|||
106021406|NCT00485134|365743348|FG006|Overall Study|Positive drug test|0|||
106021407|NCT00485134|365743349|FG007|Overall Study|Positive drug test|0|||
106021408|NCT00485134|365743342|FG000|Overall Study|Non-compliance|0|||
106021409|NCT00485134|365743343|FG001|Overall Study|Non-compliance|0|||
106021410|NCT00485134|365743344|FG002|Overall Study|Non-compliance|0|||
105823827|NCT06999265|365012082|FG000|Overall Study|Lost to Follow-up|1|||
105823828|NCT06999265|365012083|FG001|Overall Study|Lost to Follow-up|1|||
105823829|NCT00811655|365012085|FG000|Overall Study|Physician Decision|1|||
105823830|NCT03043872|365012086|FG000|Overall Study|Withdrawal by Subject|6|||
105823831|NCT03043872|365012087|FG001|Overall Study|Withdrawal by Subject|6|||
105823832|NCT03043872|365012088|FG002|Overall Study|Withdrawal by Subject|15|||
105823833|NCT03043872|365012086|FG000|Overall Study|Lost to Follow-up|2|||
105823834|NCT03043872|365012087|FG001|Overall Study|Lost to Follow-up|1|||
105823835|NCT03043872|365012088|FG002|Overall Study|Lost to Follow-up|1|||
105823836|NCT03043872|365012086|FG000|Overall Study|Death|270|||
105823837|NCT03043872|365012087|FG001|Overall Study|Death|269|||
105823838|NCT03043872|365012088|FG002|Overall Study|Death|296|||
105823839|NCT02430480|365012089|FG000|Overall Study|Death|1|||
105823840|NCT02430480|365012089|FG000|Overall Study|Anesthesia concerns|1|||
105823841|NCT02430480|365012089|FG000|Overall Study|Progressed on treatment|1|||
105823842|NCT04493684|365012091|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
105823843|NCT04493684|365012092|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823844|NCT04493684|365012093|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
105823845|NCT04493684|365012094|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823846|NCT04493684|365012095|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823847|NCT04493684|365012096|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
105823848|NCT04493684|365012097|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823849|NCT04493684|365012098|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823850|NCT04493684|365012099|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823851|NCT04493684|365012100|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823852|NCT04493684|365012101|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823853|NCT04493684|365012102|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823854|NCT04493684|365012103|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823855|NCT04493684|365012104|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823856|NCT04493684|365012105|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823857|NCT04493684|365012106|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823858|NCT04493684|365012107|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
105823859|NCT04493684|365012091|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
105823860|NCT04493684|365012092|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823861|NCT04493684|365012093|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823862|NCT04493684|365012094|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
106021411|NCT00485134|365743345|FG003|Overall Study|Non-compliance|0|||
106021412|NCT00485134|365743346|FG004|Overall Study|Non-compliance|1|||
106021413|NCT00485134|365743347|FG005|Overall Study|Non-compliance|2|||
106021414|NCT00485134|365743348|FG006|Overall Study|Non-compliance|2|||
105959745|NCT03654040|365513287|FG001|Overall Study|Received deceased liver|1|||
105959746|NCT00700622|365513288|FG000|Overall Study|Adverse Event|4|||
105959747|NCT00700622|365513289|FG001|Overall Study|Adverse Event|0|||
105959748|NCT00700622|365513288|FG000|Overall Study|Lost to Follow-up|0|||
105959749|NCT00700622|365513289|FG001|Overall Study|Lost to Follow-up|1|||
105959750|NCT00700622|365513288|FG000|Overall Study|Physician Decision|2|||
105959751|NCT00700622|365513289|FG001|Overall Study|Physician Decision|1|||
105959752|NCT00700622|365513288|FG000|Overall Study|Protocol Violation|0|||
105959753|NCT00700622|365513289|FG001|Overall Study|Protocol Violation|1|||
105959754|NCT00700622|365513288|FG000|Overall Study|Withdrawal by Subject|4|||
105959755|NCT00700622|365513289|FG001|Overall Study|Withdrawal by Subject|1|||
105959756|NCT00700622|365513288|FG000|Overall Study|Other|3|||
105959757|NCT00700622|365513289|FG001|Overall Study|Other|1|||
106021415|NCT00485134|365743349|FG007|Overall Study|Non-compliance|0|||
106021416|NCT00485134|365743342|FG000|Overall Study|Unable to comply with study schedule|0|||
106021417|NCT00485134|365743343|FG001|Overall Study|Unable to comply with study schedule|0|||
105823863|NCT04493684|365012095|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823864|NCT04493684|365012096|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823865|NCT04493684|365012097|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823866|NCT04493684|365012098|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823867|NCT04493684|365012099|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823868|NCT04493684|365012100|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823869|NCT04493684|365012101|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823870|NCT04493684|365012102|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823871|NCT04493684|365012103|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823872|NCT04493684|365012104|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823873|NCT04493684|365012105|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823874|NCT04493684|365012106|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823875|NCT04493684|365012107|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
105823876|NCT04493684|365012091|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823877|NCT04493684|365012092|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823878|NCT04493684|365012093|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823879|NCT04493684|365012094|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823880|NCT04493684|365012095|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823881|NCT04493684|365012096|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823882|NCT04493684|365012097|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
105823883|NCT04493684|365012098|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823884|NCT04493684|365012099|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823885|NCT04493684|365012100|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823886|NCT04493684|365012101|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823887|NCT04493684|365012102|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823888|NCT04493684|365012103|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823889|NCT04493684|365012104|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105959758|NCT05507567|365513290|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
105959759|NCT05507567|365513291|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
105959760|NCT05507567|365513292|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
105768408|NCT00422240|364802702|FG001|Overall Study|Protocol Violation|1|||
105768409|NCT00422240|364802703|FG002|Overall Study|Protocol Violation|0|||
105768410|NCT00422240|364802704|FG003|Overall Study|Protocol Violation|1|||
105768411|NCT00422240|364802701|FG000|Overall Study|Lost to Follow-up|31|||
105768412|NCT00422240|364802702|FG001|Overall Study|Lost to Follow-up|32|||
105768413|NCT00422240|364802703|FG002|Overall Study|Lost to Follow-up|19|||
105768414|NCT00422240|364802704|FG003|Overall Study|Lost to Follow-up|34|||
105768415|NCT00422240|364802701|FG000|Overall Study|Other|1|||
105768416|NCT00422240|364802702|FG001|Overall Study|Other|0|||
105768417|NCT00422240|364802703|FG002|Overall Study|Other|0|||
105768418|NCT00422240|364802704|FG003|Overall Study|Other|1|||
105768419|NCT00422240|364802701|FG000|Overall Study|Pregnancy|3|||
105768420|NCT00422240|364802702|FG001|Overall Study|Pregnancy|1|||
105768421|NCT00422240|364802703|FG002|Overall Study|Pregnancy|1|||
105768422|NCT00422240|364802704|FG003|Overall Study|Pregnancy|2|||
105768423|NCT00441012|364802705|FG000|Overall Study|Adverse Event|0|||
105768424|NCT00441012|364802706|FG001|Overall Study|Adverse Event|1|||
105768425|NCT00441012|364802705|FG000|Overall Study|Lost to Follow-up|3|||
105768426|NCT00441012|364802706|FG001|Overall Study|Lost to Follow-up|3|||
105768427|NCT00441012|364802705|FG000|Overall Study|Protocol Violation|10|||
105768428|NCT00441012|364802706|FG001|Overall Study|Protocol Violation|9|||
105768429|NCT00441012|364802705|FG000|Overall Study|Withdrawal by Subject|4|||
105768430|NCT00441012|364802706|FG001|Overall Study|Withdrawal by Subject|0|||
105823890|NCT04493684|365012105|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823891|NCT04493684|365012106|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823892|NCT04493684|365012107|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
105823893|NCT04493684|365012091|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
105823894|NCT04493684|365012092|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823895|NCT04493684|365012093|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823896|NCT04493684|365012094|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823897|NCT04493684|365012095|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823898|NCT04493684|365012096|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823899|NCT04493684|365012097|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823900|NCT04493684|365012098|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823901|NCT04493684|365012099|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823902|NCT04493684|365012100|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823903|NCT04493684|365012101|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823904|NCT04493684|365012102|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823905|NCT04493684|365012103|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823906|NCT04493684|365012104|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823907|NCT04493684|365012105|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823908|NCT04493684|365012106|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823909|NCT04493684|365012107|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
105823910|NCT04493684|365012091|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823911|NCT04493684|365012092|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823912|NCT04493684|365012093|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823913|NCT04493684|365012094|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823914|NCT04493684|365012095|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823915|NCT04493684|365012096|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
105823916|NCT04493684|365012097|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823917|NCT04493684|365012098|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823918|NCT04493684|365012099|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823919|NCT04493684|365012100|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823920|NCT04493684|365012101|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
106021418|NCT00485134|365743344|FG002|Overall Study|Unable to comply with study schedule|0|||
106021419|NCT00485134|365743345|FG003|Overall Study|Unable to comply with study schedule|0|||
106021420|NCT00485134|365743346|FG004|Overall Study|Unable to comply with study schedule|0|||
106021421|NCT00485134|365743347|FG005|Overall Study|Unable to comply with study schedule|0|||
106021422|NCT00485134|365743348|FG006|Overall Study|Unable to comply with study schedule|0|||
106021423|NCT00485134|365743349|FG007|Overall Study|Unable to comply with study schedule|1|||
106021424|NCT00485134|365743342|FG000|Overall Study|Pregnancy|0|||
106021425|NCT00485134|365743343|FG001|Overall Study|Pregnancy|0|||
106021426|NCT00485134|365743344|FG002|Overall Study|Pregnancy|0|||
106021427|NCT00485134|365743345|FG003|Overall Study|Pregnancy|0|||
106021428|NCT00485134|365743346|FG004|Overall Study|Pregnancy|0|||
106021429|NCT00485134|365743347|FG005|Overall Study|Pregnancy|0|||
106021430|NCT00485134|365743348|FG006|Overall Study|Pregnancy|1|||
106021431|NCT00485134|365743349|FG007|Overall Study|Pregnancy|0|||
106021432|NCT04050202|365743350|FG000|Overall Study|Lost to Follow-up|2|||
106021433|NCT04027608|365743351|FG000|Overall Study|Withdrawal by Subject|13|||
106021434|NCT04027608|365743352|FG001|Overall Study|Withdrawal by Subject|2|||
106021435|NCT04027608|365743351|FG000|Overall Study|Protocol Violation|2|||
106021436|NCT04027608|365743352|FG001|Overall Study|Protocol Violation|1|||
106021437|NCT04027608|365743351|FG000|Overall Study|Physician Decision|1|||
106021438|NCT04027608|365743352|FG001|Overall Study|Physician Decision|0|||
106021439|NCT04027608|365743351|FG000|Overall Study|Lost to Follow-up|20|||
106021440|NCT04027608|365743352|FG001|Overall Study|Lost to Follow-up|4|||
106021441|NCT03275350|365743355|FG000|Overall Study|Lost to Follow-up|4|||
106021442|NCT03275350|365743356|FG001|Overall Study|Lost to Follow-up|6|||
106021443|NCT03275350|365743355|FG000|Overall Study|Death|2|||
106021444|NCT03275350|365743356|FG001|Overall Study|Death|1|||
106021445|NCT03275350|365743355|FG000|Overall Study|Physician Decision|1|||
106021446|NCT03275350|365743356|FG001|Overall Study|Physician Decision|0|||
106021447|NCT03275350|365743355|FG000|Overall Study|Incarcerated|1|||
106021448|NCT03275350|365743356|FG001|Overall Study|Incarcerated|1|||
106021449|NCT00380367|365743360|FG000|Overall Study|Lost to Follow-up|1|||
106021450|NCT00380367|365743360|FG000|Overall Study|Withdrawal by Subject|1|||
106021451|NCT02194985|365743361|FG000|Overall Study|Adverse Event|1|||
106021452|NCT02194985|365743361|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
106021453|NCT02194985|365743361|FG000|Overall Study|Physician Decision|4|||
106021454|NCT02194985|365743361|FG000|Overall Study|Lost to Follow-up|1|||
106146339|NCT02423798|366196474|FG000|Overall Study|Withdrawal by Subject|3|||
106021455|NCT02194985|365743361|FG000|Overall Study|Withdrawal by Subject|2|||
106021456|NCT02561832|365743362|FG000|Overall Study|Withdrawal by Subject|1|||
105823921|NCT04493684|365012102|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823922|NCT04493684|365012103|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823923|NCT04493684|365012104|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823924|NCT04493684|365012105|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823925|NCT04493684|365012106|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823926|NCT04493684|365012107|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
105823927|NCT04493684|365012091|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823928|NCT04493684|365012092|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823929|NCT04493684|365012093|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823930|NCT04493684|365012094|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823931|NCT04493684|365012095|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823932|NCT04493684|365012096|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823933|NCT04493684|365012097|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823934|NCT04493684|365012098|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823935|NCT04493684|365012099|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823936|NCT04493684|365012100|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823937|NCT04493684|365012101|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823938|NCT04493684|365012102|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
105823939|NCT04493684|365012103|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823940|NCT04493684|365012104|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823941|NCT04493684|365012105|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105959761|NCT05507567|365513290|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
105959762|NCT05507567|365513291|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
105959763|NCT05507567|365513292|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
105959764|NCT05507567|365513290|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
105959765|NCT05507567|365513291|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
105959766|NCT05507567|365513292|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
105959767|NCT05507567|365513290|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
105959768|NCT05507567|365513291|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
105959769|NCT05507567|365513292|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
105959770|NCT00910910|365513293|FG000|Overall Study|Adverse Event|63|||
105959771|NCT00910910|365513294|FG001|Overall Study|Adverse Event|35|||
105959772|NCT00910910|365513293|FG000|Overall Study|PD without histologic change|27|||
105959773|NCT00910910|365513294|FG001|Overall Study|PD without histologic change|23|||
105959774|NCT00910910|365513293|FG000|Overall Study|PD with histologic change|0|||
105959775|NCT00910910|365513294|FG001|Overall Study|PD with histologic change|2|||
105959776|NCT00910910|365513293|FG000|Overall Study|Withdrawal by Subject|7|||
105959777|NCT00910910|365513294|FG001|Overall Study|Withdrawal by Subject|5|||
105959778|NCT00910910|365513293|FG000|Overall Study|Lost to Follow-up|2|||
105959779|NCT00910910|365513294|FG001|Overall Study|Lost to Follow-up|2|||
105959780|NCT00910910|365513293|FG000|Overall Study|Death|9|||
105959781|NCT00910910|365513294|FG001|Overall Study|Death|3|||
105959782|NCT00910910|365513293|FG000|Overall Study|Protocol Violation|2|||
105959783|NCT00910910|365513294|FG001|Overall Study|Protocol Violation|2|||
105959784|NCT00910910|365513293|FG000|Overall Study|Completed 13 cycles of treatment|0|||
105959785|NCT00910910|365513294|FG001|Overall Study|Completed 13 cycles of treatment|118|||
105959786|NCT00910910|365513293|FG000|Overall Study|Other|114|||
105959787|NCT00910910|365513294|FG001|Overall Study|Other|32|||
105959788|NCT00910910|365513293|FG000|Overall Study|Untreated before cycle 1|1|||
105959789|NCT00910910|365513294|FG001|Overall Study|Untreated before cycle 1|2|||
105959790|NCT02096952|365513300|FG000|Overall Study|Adverse Event|1|||
105959791|NCT00624468|365513302|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
105959792|NCT00624468|365513303|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
105959793|NCT00624468|365513304|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
105959794|NCT00624468|365513305|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
105959795|NCT00624468|365513302|FG000|Double-blind Period|Withdrew Prematurely|1|||
105959796|NCT00624468|365513303|FG001|Double-blind Period|Withdrew Prematurely|1|||
105959797|NCT00624468|365513304|FG002|Double-blind Period|Withdrew Prematurely|0|||
105959798|NCT00624468|365513305|FG003|Double-blind Period|Withdrew Prematurely|0|||
105959799|NCT00624468|365513302|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
105959800|NCT00624468|365513303|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
106146340|NCT01063972|366196475|FG000|Overall Study|Death|12|||
105959801|NCT00624468|365513304|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
105959802|NCT00624468|365513305|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
105959803|NCT00624468|365513302|FG000|Safety Follow-up (SFU) Period|Other|0|||
105959804|NCT00624468|365513303|FG001|Safety Follow-up (SFU) Period|Other|0|||
105959805|NCT00624468|365513304|FG002|Safety Follow-up (SFU) Period|Other|1|||
106146341|NCT01063972|366196476|FG001|Overall Study|Death|11|||
105823942|NCT04493684|365012106|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823943|NCT04493684|365012107|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
105823944|NCT04493684|365012091|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823945|NCT04493684|365012092|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823946|NCT04493684|365012093|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823947|NCT04493684|365012094|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823948|NCT04493684|365012095|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823949|NCT04493684|365012096|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823950|NCT04493684|365012097|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823951|NCT04493684|365012098|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823952|NCT04493684|365012099|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823953|NCT04493684|365012100|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823954|NCT04493684|365012101|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823955|NCT04493684|365012102|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823956|NCT04493684|365012103|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823957|NCT04493684|365012104|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823958|NCT04493684|365012105|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823959|NCT04493684|365012106|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
105823960|NCT04493684|365012107|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
105823961|NCT04493684|365012091|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823962|NCT04493684|365012092|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823963|NCT04493684|365012093|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823964|NCT04493684|365012094|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823965|NCT04493684|365012095|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823966|NCT04493684|365012096|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823967|NCT04493684|365012097|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823968|NCT04493684|365012098|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823969|NCT04493684|365012099|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823970|NCT04493684|365012100|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823971|NCT04493684|365012101|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823972|NCT04493684|365012102|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823973|NCT04493684|365012103|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823974|NCT04493684|365012104|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823975|NCT04493684|365012105|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823976|NCT04493684|365012106|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
105823977|NCT04493684|365012107|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
105823978|NCT00001703|365013083|FG000|Overall Study|progressed disease|2|||
105823979|NCT00001703|365013083|FG000|Overall Study|No evidence of disease|1|||
105823980|NCT00001703|365013083|FG000|Overall Study|recurrent disease|2|||
105823981|NCT05710718|365013088|FG000|Overall Study|Withdrawal by Subject|5|||
105823982|NCT05710718|365013089|FG001|Overall Study|Withdrawal by Subject|1|||
105823983|NCT05710718|365013088|FG000|Overall Study|Lost to Follow-up|0|||
105823984|NCT05710718|365013089|FG001|Overall Study|Lost to Follow-up|1|||
105823985|NCT05710718|365013088|FG000|Overall Study|Death|0|||
105823986|NCT05710718|365013089|FG001|Overall Study|Death|1|||
105823987|NCT04915755|365013090|FG000|Overall Study|Physician Decision|3|||
105823988|NCT04915755|365013091|FG001|Overall Study|Physician Decision|2|||
105823989|NCT04915755|365013090|FG000|Overall Study|Withdrawal by Subject|1|||
105823990|NCT04915755|365013091|FG001|Overall Study|Withdrawal by Subject|1|||
105823991|NCT04915755|365013090|FG000|Overall Study|Ongoing for PACT|3|||
105823992|NCT04915755|365013091|FG001|Overall Study|Ongoing for PACT|2|||
105823993|NCT04915755|365013090|FG000|Overall Study|Other|7|||
105823994|NCT04915755|365013091|FG001|Overall Study|Other|11|||
105823995|NCT02533258|365013092|FG000|Overall Study|Adverse Event|1|||
105823996|NCT02533258|365013092|FG000|Overall Study|Death|2|||
105823997|NCT02533258|365013092|FG000|Overall Study|Other|1|||
105823998|NCT02533258|365013092|FG000|Overall Study|Economic factor|1|||
105823999|NCT02533258|365013092|FG000|Overall Study|Progression of pleural effusion|1|||
105824000|NCT02533258|365013092|FG000|Overall Study|Lack of Efficacy|2|||
105959806|NCT00624468|365513305|FG003|Safety Follow-up (SFU) Period|Other|1|||
105959807|NCT00372619|365513306|FG000|Overall Study|Ineligible|0|||
105959808|NCT00372619|365513307|FG001|Overall Study|Ineligible|0|||
105824001|NCT03697109|365013097|FG000|Open-label (OL) Phase|Adverse Event|24|||
105824002|NCT03697109|365013098|FG001|Open-label (OL) Phase|Adverse Event|0|||
105959809|NCT00372619|365513308|FG002|Overall Study|Ineligible|0|||
105824003|NCT03697109|365013099|FG002|Open-label (OL) Phase|Adverse Event|0|||
105824004|NCT03697109|365013097|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
105824005|NCT03697109|365013098|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
105824006|NCT03697109|365013099|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
105824007|NCT03697109|365013097|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
105824008|NCT03697109|365013098|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
105824009|NCT03697109|365013099|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
105824010|NCT03697109|365013097|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
105824011|NCT03697109|365013098|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
105824012|NCT03697109|365013099|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
105824013|NCT03697109|365013097|FG000|Open-label (OL) Phase|Physician Decision|2|||
105824014|NCT03697109|365013098|FG001|Open-label (OL) Phase|Physician Decision|0|||
105824015|NCT03697109|365013099|FG002|Open-label (OL) Phase|Physician Decision|0|||
105824016|NCT03697109|365013097|FG000|Open-label (OL) Phase|Death|2|||
105824017|NCT03697109|365013098|FG001|Open-label (OL) Phase|Death|0|||
105824018|NCT03697109|365013099|FG002|Open-label (OL) Phase|Death|0|||
105824019|NCT03697109|365013097|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
105824020|NCT03697109|365013098|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
105824021|NCT03697109|365013099|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
105824022|NCT03697109|365013097|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
105824023|NCT03697109|365013098|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
105824024|NCT03697109|365013099|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
105824025|NCT03697109|365013097|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
105824026|NCT03697109|365013098|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
105824027|NCT03697109|365013099|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
105824028|NCT02096211|365013104|FG000|Overall Study|Death|2|||
105824029|NCT02096211|365013104|FG000|Overall Study|Withdrawal by Subject|8|||
105824030|NCT02096211|365013104|FG000|Overall Study|Revision of implant|7|||
105824031|NCT02096211|365013104|FG000|Overall Study|Lost to Follow-up|43|||
105824032|NCT00519194|365013108|FG000|Overall Study|Withdrawal by Subject|9|||
105824033|NCT00519194|365013108|FG000|Overall Study|Death|9|||
105824034|NCT00519194|365013108|FG000|Overall Study|Lost to Follow-up|3|||
105824035|NCT03165994|365013109|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
105824036|NCT03165994|365013109|FG000|Overall Study|Death|2|||
105824037|NCT03165994|365013109|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
105824038|NCT03165994|365013109|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
105824039|NCT03165994|365013109|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
105824040|NCT03165994|365013109|FG000|Overall Study|Miscellaneous|1|||
105824041|NCT02301975|365013110|FG000|Overall Study|Adverse Event|8|||
105824042|NCT02301975|365013111|FG001|Overall Study|Adverse Event|3|||
105824043|NCT02301975|365013112|FG002|Overall Study|Adverse Event|2|||
105824044|NCT02301975|365013110|FG000|Overall Study|Lack of Efficacy|1|||
105824045|NCT02301975|365013111|FG001|Overall Study|Lack of Efficacy|1|||
105824046|NCT02301975|365013112|FG002|Overall Study|Lack of Efficacy|1|||
105824047|NCT02301975|365013110|FG000|Overall Study|Protocol Violation|3|||
105824048|NCT02301975|365013111|FG001|Overall Study|Protocol Violation|5|||
105824049|NCT02301975|365013112|FG002|Overall Study|Protocol Violation|3|||
105824050|NCT02301975|365013110|FG000|Overall Study|Lost to Follow-up|0|||
105824051|NCT02301975|365013111|FG001|Overall Study|Lost to Follow-up|2|||
105824052|NCT02301975|365013112|FG002|Overall Study|Lost to Follow-up|2|||
105824053|NCT02301975|365013110|FG000|Overall Study|Physician Decision|4|||
105824054|NCT02301975|365013111|FG001|Overall Study|Physician Decision|2|||
105824055|NCT02301975|365013112|FG002|Overall Study|Physician Decision|3|||
105824056|NCT02301975|365013110|FG000|Overall Study|Withdrawal by Subject|15|||
105824057|NCT02301975|365013111|FG001|Overall Study|Withdrawal by Subject|12|||
105824058|NCT02301975|365013112|FG002|Overall Study|Withdrawal by Subject|11|||
105824059|NCT00440518|365013114|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
105824060|NCT00440518|365013115|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
105824061|NCT00440518|365013116|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
105824062|NCT00440518|365013114|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
105824063|NCT00440518|365013115|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
105824064|NCT00440518|365013116|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
105824065|NCT00440518|365013114|FG000|Randomized /Titration Period|Protocol Deviation|1|||
105824066|NCT00440518|365013115|FG001|Randomized /Titration Period|Protocol Deviation|0|||
105824067|NCT00440518|365013116|FG002|Randomized /Titration Period|Protocol Deviation|0|||
105824068|NCT00440518|365013114|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
105824069|NCT00440518|365013115|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
105824070|NCT00440518|365013116|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
105824071|NCT00440518|365013114|FG000|Randomized /Titration Period|Other|1|||
105824072|NCT00440518|365013115|FG001|Randomized /Titration Period|Other|0|||
105824073|NCT00440518|365013116|FG002|Randomized /Titration Period|Other|0|||
105824074|NCT00440518|365013114|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
105824075|NCT00440518|365013115|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
105824076|NCT00440518|365013116|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
105824077|NCT00440518|365013114|FG000|Randomized /Titration Period|Adverse Event|2|||
105824078|NCT00440518|365013115|FG001|Randomized /Titration Period|Adverse Event|3|||
105824079|NCT00440518|365013116|FG002|Randomized /Titration Period|Adverse Event|0|||
105824080|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
105824081|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
105824082|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
105824083|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
105824084|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
105824085|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
105824086|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
105824087|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
105824088|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
105824089|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
105824090|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
105824091|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
105824092|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
105824093|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
105824094|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
105824095|NCT00440518|365013114|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
105824096|NCT00440518|365013115|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
105824097|NCT00440518|365013116|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
105824098|NCT03733730|365013118|FG000|Overall Study|Lost to Follow-up|1|||
105824099|NCT03733730|365013119|FG001|Overall Study|Lost to Follow-up|32|||
105824100|NCT03733730|365013118|FG000|Overall Study|Other|1|||
105824101|NCT03733730|365013119|FG001|Overall Study|Other|0|||
105824102|NCT03733730|365013118|FG000|Overall Study|Adverse Event|0|||
105824103|NCT03733730|365013119|FG001|Overall Study|Adverse Event|4|||
105824104|NCT03733730|365013118|FG000|Overall Study|Death|0|||
105824105|NCT03733730|365013119|FG001|Overall Study|Death|5|||
105824106|NCT03733730|365013118|FG000|Overall Study|Withdrawal by Subject|0|||
105824107|NCT03733730|365013119|FG001|Overall Study|Withdrawal by Subject|8|||
105824108|NCT02563561|365013120|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
105824109|NCT02563561|365013121|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
105824110|NCT02563561|365013122|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
105824111|NCT02563561|365013120|FG000|Overall Study|Withdrew of Consent|1|||
105824112|NCT02563561|365013121|FG001|Overall Study|Withdrew of Consent|1|||
105824113|NCT02563561|365013122|FG002|Overall Study|Withdrew of Consent|2|||
105824114|NCT02563561|365013120|FG000|Overall Study|Lost to Follow-up|1|||
105824115|NCT02563561|365013121|FG001|Overall Study|Lost to Follow-up|1|||
105824116|NCT02563561|365013122|FG002|Overall Study|Lost to Follow-up|0|||
105824117|NCT02563561|365013120|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
105959810|NCT00372619|365513309|FG003|Overall Study|Ineligible|0|||
105959811|NCT00372619|365513310|FG004|Overall Study|Ineligible|0|||
105959812|NCT00372619|365513311|FG005|Overall Study|Ineligible|2|||
105959813|NCT00372619|365513312|FG006|Overall Study|Ineligible|0|||
105959814|NCT00372619|365513306|FG000|Overall Study|Inevaluable|0|||
105959815|NCT00372619|365513307|FG001|Overall Study|Inevaluable|0|||
105959816|NCT00372619|365513308|FG002|Overall Study|Inevaluable|0|||
105959817|NCT00372619|365513309|FG003|Overall Study|Inevaluable|0|||
105959818|NCT00372619|365513310|FG004|Overall Study|Inevaluable|0|||
105959819|NCT00372619|365513311|FG005|Overall Study|Inevaluable|1|||
105959820|NCT00372619|365513312|FG006|Overall Study|Inevaluable|0|||
105959821|NCT00066222|365513313|FG000|Overall Study|No protocol treatment received|1|||
105959822|NCT00412958|365513314|FG000|Overall Study|Withdrawal by Subject|3|||
105959823|NCT00412958|365513315|FG001|Overall Study|Withdrawal by Subject|0|||
105959824|NCT00412958|365513316|FG002|Overall Study|Withdrawal by Subject|0|||
105959825|NCT00412958|365513317|FG003|Overall Study|Withdrawal by Subject|1|||
105959826|NCT00412958|365513314|FG000|Overall Study|Adverse Event|0|||
106021457|NCT02561832|365743363|FG001|Overall Study|Withdrawal by Subject|1|||
106021458|NCT02561832|365743362|FG000|Overall Study|Adverse Event|3|||
106021459|NCT02561832|365743363|FG001|Overall Study|Adverse Event|0|||
106021460|NCT02561832|365743362|FG000|Overall Study|Disease progression|3|||
106021461|NCT02561832|365743363|FG001|Overall Study|Disease progression|3|||
106021462|NCT02280408|365743364|FG000|Overall Study|Lost to Follow-up|0|||
106021463|NCT02280408|365743365|FG001|Overall Study|Lost to Follow-up|2|||
106021464|NCT02280408|365743366|FG002|Overall Study|Lost to Follow-up|0|||
106021465|NCT02280408|365743367|FG003|Overall Study|Lost to Follow-up|0|||
105824118|NCT02563561|365013121|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
105824119|NCT02563561|365013122|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
105959827|NCT00412958|365513315|FG001|Overall Study|Adverse Event|1|||
105959828|NCT00412958|365513316|FG002|Overall Study|Adverse Event|0|||
105959829|NCT00412958|365513317|FG003|Overall Study|Adverse Event|0|||
105959830|NCT00412958|365513314|FG000|Overall Study|Lost to Follow-up|0|||
105959831|NCT00412958|365513315|FG001|Overall Study|Lost to Follow-up|1|||
106021466|NCT04380519|365743368|FG000|Overall Study|Withdrawal by Subject|4|||
105959832|NCT00412958|365513316|FG002|Overall Study|Lost to Follow-up|0|||
106021467|NCT04380519|365743369|FG001|Overall Study|Withdrawal by Subject|0|||
106021468|NCT04380519|365743370|FG002|Overall Study|Withdrawal by Subject|1|||
106021469|NCT04380519|365743368|FG000|Overall Study|Death|14|||
106021470|NCT04380519|365743369|FG001|Overall Study|Death|9|||
106021471|NCT04380519|365743370|FG002|Overall Study|Death|6|||
106021472|NCT04380519|365743368|FG000|Overall Study|Adverse Event|0|||
106021473|NCT04380519|365743369|FG001|Overall Study|Adverse Event|1|||
106021474|NCT04380519|365743370|FG002|Overall Study|Adverse Event|0|||
106021475|NCT04380519|365743368|FG000|Overall Study|relatives' decision|0|||
106021476|NCT04380519|365743369|FG001|Overall Study|relatives' decision|1|||
106021477|NCT04380519|365743370|FG002|Overall Study|relatives' decision|0|||
106021478|NCT03710083|365743371|FG000|Overall Study|Withdrawal by Subject|2|||
106021479|NCT03710083|365743371|FG000|Overall Study|Unsuccessful Procedure|1|||
106021480|NCT05300763|365743372|FG000|Overall Study|Adverse Event|0|||
106021481|NCT05300763|365743373|FG001|Overall Study|Adverse Event|1|||
106021482|NCT05300763|365743372|FG000|Overall Study|Major Protocol Deviation|1|||
106021483|NCT05300763|365743373|FG001|Overall Study|Major Protocol Deviation|0|||
106021484|NCT05300763|365743372|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
106021485|NCT05300763|365743373|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
106021486|NCT02283762|365743377|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
106021487|NCT02283762|365743378|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
106021488|NCT02283762|365743377|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
106021489|NCT02283762|365743378|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
106021490|NCT02283762|365743377|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
106021491|NCT02283762|365743378|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
106021492|NCT02283762|365743377|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
106021493|NCT02283762|365743378|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
106021494|NCT02283762|365743377|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
106021495|NCT02283762|365743378|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
105824120|NCT02563561|365013120|FG000|Overall Study|Investigator Decision|3|||
105824121|NCT02563561|365013121|FG001|Overall Study|Investigator Decision|4|||
105824122|NCT02563561|365013122|FG002|Overall Study|Investigator Decision|2|||
105824123|NCT02563561|365013120|FG000|Overall Study|Sponsor Decision|5|||
105824124|NCT02563561|365013121|FG001|Overall Study|Sponsor Decision|2|||
105824125|NCT02563561|365013122|FG002|Overall Study|Sponsor Decision|4|||
105824126|NCT02563561|365013120|FG000|Overall Study|Other|1|||
105824127|NCT02563561|365013121|FG001|Overall Study|Other|5|||
105824128|NCT02563561|365013122|FG002|Overall Study|Other|2|||
105824129|NCT01056484|365013125|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
105824130|NCT01056484|365013126|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
105824131|NCT01056484|365013125|FG000|Randomized Controlled Trial|Physician Decision|1|||
105824132|NCT01056484|365013126|FG001|Randomized Controlled Trial|Physician Decision|0|||
105824133|NCT01056484|365013125|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
105824134|NCT01056484|365013126|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
105824135|NCT06195579|365013127|FG000|Overall Study|Withdrawal by Subject|1|||
105824136|NCT00446966|365013129|FG000|Overall Study|Lost to Follow-up|10|||
105824137|NCT00446966|365013130|FG001|Overall Study|Lost to Follow-up|7|||
105824138|NCT00835575|365013131|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
105824139|NCT00835575|365013132|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
105824140|NCT01440803|365013133|FG000|Overall Study|Met study stopping rule|2|||
105824141|NCT01440803|365013134|FG001|Overall Study|Met study stopping rule|1|||
105824142|NCT01440803|365013133|FG000|Overall Study|Lost to Follow-up|0|||
105824143|NCT01440803|365013134|FG001|Overall Study|Lost to Follow-up|2|||
105824144|NCT01440803|365013133|FG000|Overall Study|Withdrawal by Subject|0|||
105824145|NCT01440803|365013134|FG001|Overall Study|Withdrawal by Subject|1|||
105824146|NCT03868891|365013135|FG000|Overall Study|Adverse Event|1|||
105824147|NCT03868891|365013136|FG001|Overall Study|Adverse Event|0|||
105824148|NCT03868891|365013135|FG000|Overall Study|Lost to Follow-up|2|||
105824149|NCT03868891|365013136|FG001|Overall Study|Lost to Follow-up|1|||
105824150|NCT03868891|365013135|FG000|Overall Study|COVID-19 Restrictions|1|||
105824151|NCT03868891|365013136|FG001|Overall Study|COVID-19 Restrictions|2|||
105824152|NCT03123094|365013137|FG000|Overall Study|Withdrawal by Subject|0|||
105824153|NCT03123094|365013138|FG001|Overall Study|Withdrawal by Subject|2|||
105824154|NCT03123094|365013139|FG002|Overall Study|Withdrawal by Subject|1|||
105824155|NCT03123094|365013140|FG003|Overall Study|Withdrawal by Subject|0|||
105824156|NCT03123094|365013141|FG004|Overall Study|Withdrawal by Subject|1|||
105824157|NCT01158118|365013142|FG000|Overall Study|Screen failure|1|||
105824158|NCT01158118|365013143|FG001|Overall Study|Screen failure|0|||
105824159|NCT01158118|365013142|FG000|Overall Study|Donor match was a screen failure|0|||
105824160|NCT01158118|365013143|FG001|Overall Study|Donor match was a screen failure|1|||
105824161|NCT01158118|365013142|FG000|Overall Study|Suffered stroke prior to transplant|0|||
106021496|NCT02283762|365743377|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
106021497|NCT02283762|365743378|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
106021498|NCT02283762|365743377|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
106021499|NCT02283762|365743378|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
105824162|NCT01158118|365013143|FG001|Overall Study|Suffered stroke prior to transplant|1|||
105824163|NCT01158118|365013142|FG000|Overall Study|Death|0|||
105824164|NCT01158118|365013143|FG001|Overall Study|Death|1|||
105824165|NCT02241551|365013144|FG000|Overall Study|Adverse Event|1|||
105824166|NCT02241551|365013145|FG001|Overall Study|Adverse Event|0|||
105824167|NCT03496623|365013146|FG000|Run-In Period (2 Weeks)|Death|1|||
105824168|NCT03496623|365013147|FG001|Run-In Period (2 Weeks)|Death|0|||
105824169|NCT03496623|365013148|FG002|Run-In Period (2 Weeks)|Death|0|||
105824170|NCT03496623|365013149|FG003|Run-In Period (2 Weeks)|Death|0|||
105824171|NCT03496623|365013150|FG004|Run-In Period (2 Weeks)|Death|0|||
105824172|NCT03496623|365013146|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
105824173|NCT03496623|365013147|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
105824174|NCT03496623|365013148|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
105824175|NCT03496623|365013149|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
106021500|NCT02283762|365743377|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
106021501|NCT02283762|365743378|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
106021502|NCT02283762|365743377|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
106021503|NCT02283762|365743378|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
106021504|NCT02283762|365743377|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
106021505|NCT02283762|365743378|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
106021506|NCT02283762|365743377|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
106021507|NCT02283762|365743378|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
106021508|NCT02283762|365743377|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
106021509|NCT02283762|365743378|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
106021510|NCT02920242|365743379|FG000|Overall Study|Withdrawal by Subject|1|||
106021511|NCT02920242|365743380|FG001|Overall Study|Withdrawal by Subject|0|||
106021512|NCT02920242|365743381|FG002|Overall Study|Withdrawal by Subject|1|||
106021513|NCT02920242|365743379|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
106021514|NCT02920242|365743380|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
106021515|NCT02920242|365743381|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
106021516|NCT01942733|365743383|FG000|Overall Study|Lost to Follow-up|1|||
106021517|NCT01942733|365743383|FG000|Overall Study|Non-compliance with IMP|1|||
106021518|NCT01942733|365743383|FG000|Overall Study|Administrative|1|||
106021519|NCT00139477|365743388|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
106021520|NCT00139477|365743389|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
106021521|NCT00139477|365743388|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
106021522|NCT00139477|365743389|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
105824176|NCT03496623|365013150|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
105824177|NCT03496623|365013146|FG000|Period 1 (12 Weeks)|Death|0|||
105824178|NCT03496623|365013147|FG001|Period 1 (12 Weeks)|Death|3|||
105824179|NCT03496623|365013148|FG002|Period 1 (12 Weeks)|Death|0|||
105824180|NCT03496623|365013149|FG003|Period 1 (12 Weeks)|Death|0|||
105824181|NCT03496623|365013150|FG004|Period 1 (12 Weeks)|Death|0|||
105824182|NCT03496623|365013146|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
105824183|NCT03496623|365013147|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
105824184|NCT03496623|365013148|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
106021523|NCT00139477|365743388|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
106097362|NCT03950739|366014391|FG000|Optional Extension Phase|Death|1|||
105768431|NCT00441012|364802705|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
105768432|NCT00441012|364802706|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
105768433|NCT01976624|364802707|FG000|Overall Study|Participants contraindicated|2|||
105768434|NCT01976624|364802707|FG000|Overall Study|Participants age less than 19 years|12|||
105768435|NCT04350372|364802708|FG000|Overall Study|Death|1|||
105768436|NCT05116683|364802709|FG000|Overall Study|Physician Decision|4|||
105768437|NCT03782376|364802712|FG000|Overall Study|Lost to Follow-up|2|||
105768438|NCT03782376|364802713|FG001|Overall Study|Lost to Follow-up|2|||
105768439|NCT03782376|364802712|FG000|Overall Study|Withdrawal by Subject|7|||
105768440|NCT03782376|364802713|FG001|Overall Study|Withdrawal by Subject|11|||
105768441|NCT03782376|364802712|FG000|Overall Study|Death|1|||
105768442|NCT03782376|364802713|FG001|Overall Study|Death|0|||
105768443|NCT03782376|364802712|FG000|Overall Study|Other|16|||
105768444|NCT03782376|364802713|FG001|Overall Study|Other|17|||
105768445|NCT03559192|364802714|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
105768446|NCT03559192|364802715|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
105768447|NCT03559192|364802716|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
105768448|NCT03559192|364802714|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
105768449|NCT03559192|364802715|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
105768450|NCT03559192|364802716|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
105768451|NCT03559192|364802714|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
105768452|NCT03559192|364802715|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
105768453|NCT03559192|364802716|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
105768454|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
105768455|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
105824185|NCT03496623|365013149|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
105824186|NCT03496623|365013150|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
105824187|NCT03496623|365013146|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105824188|NCT03496623|365013147|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
105824189|NCT03496623|365013148|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
105824190|NCT03496623|365013149|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105824191|NCT03496623|365013150|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
105824192|NCT03496623|365013146|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
105824193|NCT03496623|365013147|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
105824194|NCT03496623|365013148|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
105824195|NCT03496623|365013149|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
105824196|NCT03496623|365013150|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
105824197|NCT03496623|365013146|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105824198|NCT03496623|365013147|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105824199|NCT03496623|365013148|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
105824200|NCT03496623|365013149|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105824201|NCT03496623|365013150|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
105824202|NCT03496623|365013146|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
105824203|NCT03496623|365013147|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
105824204|NCT03496623|365013148|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
105824205|NCT03496623|365013149|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
105824206|NCT03496623|365013150|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
105824207|NCT03496623|365013146|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105824208|NCT03496623|365013147|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
105824209|NCT03496623|365013148|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105824210|NCT03496623|365013149|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105824211|NCT03496623|365013150|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
105824212|NCT01518972|365013151|FG000|Overall Study|Lost to Follow-up|2|||
105824213|NCT01518972|365013152|FG001|Overall Study|Lost to Follow-up|1|||
105824214|NCT01518972|365013151|FG000|Overall Study|Withdrawal by Subject|1|||
105824215|NCT01518972|365013152|FG001|Overall Study|Withdrawal by Subject|0|||
105824216|NCT01518972|365013151|FG000|Overall Study|Moved from area|1|||
105824217|NCT01518972|365013152|FG001|Overall Study|Moved from area|0|||
105824218|NCT01518972|365013151|FG000|Overall Study|Transportation problems|1|||
105824219|NCT01518972|365013152|FG001|Overall Study|Transportation problems|0|||
105824220|NCT01518972|365013151|FG000|Overall Study|Exclusionary medical condition|1|||
105824221|NCT01518972|365013152|FG001|Overall Study|Exclusionary medical condition|0|||
105824222|NCT01518972|365013151|FG000|Overall Study|Missed safety visits|0|||
106146342|NCT01063972|366196475|FG000|Overall Study|Incarcerated|2|||
106146343|NCT01063972|366196476|FG001|Overall Study|Incarcerated|1|||
106146344|NCT00356265|366196479|FG000|Overall Study|Withdrawal by Subject|0|||
106146345|NCT00356265|366196480|FG001|Overall Study|Withdrawal by Subject|0|||
106146346|NCT00356265|366196481|FG002|Overall Study|Withdrawal by Subject|1|||
106146347|NCT01236560|366196486|FG000|Overall Study|Adverse Event|0|||
106146348|NCT01236560|366196487|FG001|Overall Study|Adverse Event|2|||
106146349|NCT01236560|366196488|FG002|Overall Study|Adverse Event|1|||
106146350|NCT01236560|366196489|FG003|Overall Study|Adverse Event|3|||
106146351|NCT01236560|366196490|FG004|Overall Study|Adverse Event|0|||
106146352|NCT01236560|366196491|FG005|Overall Study|Adverse Event|0|||
106146353|NCT01236560|366196486|FG000|Overall Study|Death|0|||
106146354|NCT01236560|366196487|FG001|Overall Study|Death|1|||
106146355|NCT01236560|366196488|FG002|Overall Study|Death|0|||
106146356|NCT01236560|366196489|FG003|Overall Study|Death|1|||
106146357|NCT01236560|366196490|FG004|Overall Study|Death|0|||
106146358|NCT01236560|366196491|FG005|Overall Study|Death|0|||
106146359|NCT01236560|366196486|FG000|Overall Study|Lost to Follow-up|0|||
106146360|NCT01236560|366196487|FG001|Overall Study|Lost to Follow-up|1|||
106146361|NCT01236560|366196488|FG002|Overall Study|Lost to Follow-up|1|||
106146362|NCT01236560|366196489|FG003|Overall Study|Lost to Follow-up|0|||
106146363|NCT01236560|366196490|FG004|Overall Study|Lost to Follow-up|0|||
106146364|NCT01236560|366196491|FG005|Overall Study|Lost to Follow-up|0|||
105824223|NCT01518972|365013152|FG001|Overall Study|Missed safety visits|1|||
105959833|NCT00412958|365513317|FG003|Overall Study|Lost to Follow-up|0|||
106146365|NCT01236560|366196486|FG000|Overall Study|Physician Decision|0|||
106146366|NCT01236560|366196487|FG001|Overall Study|Physician Decision|1|||
106146367|NCT01236560|366196488|FG002|Overall Study|Physician Decision|8|||
106146368|NCT01236560|366196489|FG003|Overall Study|Physician Decision|0|||
106146369|NCT01236560|366196490|FG004|Overall Study|Physician Decision|0|||
106146370|NCT01236560|366196491|FG005|Overall Study|Physician Decision|0|||
105824224|NCT01518972|365013151|FG000|Overall Study|Exclusionary medication|0|||
105824225|NCT01518972|365013152|FG001|Overall Study|Exclusionary medication|1|||
105824226|NCT01518972|365013151|FG000|Overall Study|Declined medication starting on day 12|0|||
105824227|NCT01518972|365013152|FG001|Overall Study|Declined medication starting on day 12|1|||
105824228|NCT02321098|365013154|FG000|12 Weeks Treament|Lost to Follow-up|1|||
105824229|NCT02321098|365013155|FG001|12 Weeks Treament|Lost to Follow-up|1|||
106146371|NCT01236560|366196486|FG000|Overall Study|Withdrawal by Subject|0|||
106146372|NCT01236560|366196487|FG001|Overall Study|Withdrawal by Subject|0|||
106146373|NCT01236560|366196488|FG002|Overall Study|Withdrawal by Subject|1|||
106146374|NCT01236560|366196489|FG003|Overall Study|Withdrawal by Subject|2|||
106146375|NCT01236560|366196490|FG004|Overall Study|Withdrawal by Subject|0|||
106146376|NCT01236560|366196491|FG005|Overall Study|Withdrawal by Subject|0|||
106146377|NCT01236560|366196486|FG000|Overall Study|Progressive disease|5|||
106146378|NCT01236560|366196487|FG001|Overall Study|Progressive disease|19|||
106146379|NCT01236560|366196488|FG002|Overall Study|Progressive disease|9|||
106146380|NCT01236560|366196489|FG003|Overall Study|Progressive disease|16|||
106146381|NCT01236560|366196490|FG004|Overall Study|Progressive disease|0|||
106146382|NCT01236560|366196491|FG005|Overall Study|Progressive disease|0|||
106146383|NCT04590963|366196500|FG000|Overall Study|Death|118|||
106146384|NCT04590963|366196501|FG001|Overall Study|Death|59|||
106146385|NCT04590963|366196500|FG000|Overall Study|Lost to Follow-up|1|||
106146386|NCT04590963|366196501|FG001|Overall Study|Lost to Follow-up|1|||
106146387|NCT04590963|366196500|FG000|Overall Study|Progressive disease|0|||
106146388|NCT04590963|366196501|FG001|Overall Study|Progressive disease|1|||
106146389|NCT04590963|366196500|FG000|Overall Study|Study terminated by sponsor|103|||
106146390|NCT04590963|366196501|FG001|Overall Study|Study terminated by sponsor|50|||
106146391|NCT04590963|366196500|FG000|Overall Study|Withdrawal by Subject|15|||
106146392|NCT04590963|366196501|FG001|Overall Study|Withdrawal by Subject|8|||
106146393|NCT04590963|366196500|FG000|Overall Study|Ongoing at data cut-off|9|||
106146394|NCT04590963|366196501|FG001|Overall Study|Ongoing at data cut-off|4|||
106146395|NCT04590963|366196500|FG000|Overall Study|Screen failure|1|||
106146396|NCT04590963|366196501|FG001|Overall Study|Screen failure|0|||
106146397|NCT05274217|366196502|FG000|Overall Study|Study terminated.|11|||
106146398|NCT05274217|366196503|FG001|Overall Study|Study terminated.|0|||
106146399|NCT04594759|366196504|FG000|Overall Study|Lost to Follow-up|3|||
106146400|NCT03811574|366196505|FG000|Overall Study|Withdrawal by Subject|2|||
106146401|NCT03811574|366196506|FG001|Overall Study|Withdrawal by Subject|4|||
106146402|NCT03811574|366196507|FG002|Overall Study|Withdrawal by Subject|0|||
106146403|NCT01832480|366196508|FG000|Overall Study|Lost to Follow-up|33|||
106146404|NCT01832480|366196509|FG001|Overall Study|Lost to Follow-up|30|||
106146405|NCT01832480|366196508|FG000|Overall Study|Withdrawal by Subject|0|||
106146406|NCT01832480|366196509|FG001|Overall Study|Withdrawal by Subject|2|||
106146407|NCT01832480|366196508|FG000|Overall Study|post randomization ineligible|8|||
106146408|NCT01832480|366196509|FG001|Overall Study|post randomization ineligible|10|||
106146409|NCT05609032|366196510|FG000|Overall Study|Lost to Follow-up|3|||
106146410|NCT05609032|366196511|FG001|Overall Study|Lost to Follow-up|1|||
106146411|NCT05609032|366196510|FG000|Overall Study|Withdrawal by Subject|1|||
106146412|NCT05609032|366196511|FG001|Overall Study|Withdrawal by Subject|0|||
106146413|NCT04305405|366196512|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105824230|NCT02321098|365013156|FG002|12 Weeks Treament|Lost to Follow-up|0|||
105824231|NCT02321098|365013154|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
106146414|NCT04305405|366196513|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106146415|NCT02528188|366196514|FG000|Overall Study|Adverse Event|23|||
106146416|NCT02528188|366196515|FG001|Overall Study|Adverse Event|22|||
106146417|NCT02528188|366196516|FG002|Overall Study|Adverse Event|8|||
106146418|NCT02528188|366196514|FG000|Overall Study|Protocol Violation|4|||
106146419|NCT02528188|366196515|FG001|Overall Study|Protocol Violation|6|||
106146420|NCT02528188|366196516|FG002|Overall Study|Protocol Violation|4|||
105824232|NCT02321098|365013155|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
105824233|NCT02321098|365013156|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
105824234|NCT02321098|365013154|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
105824235|NCT02321098|365013155|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
105824236|NCT02321098|365013156|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
105824237|NCT02321098|365013154|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
105824238|NCT02321098|365013155|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
105824239|NCT02321098|365013156|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
105824240|NCT01788423|365013157|FG000|Overall Study|See Comments in Completed (above)|0|||
105824241|NCT01788423|365013158|FG001|Overall Study|See Comments in Completed (above)|4|||
105824242|NCT01788423|365013159|FG002|Overall Study|See Comments in Completed (above)|5|||
105824243|NCT03190915|365013160|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
105824244|NCT03190915|365013160|FG000|Overall Study|Progressive Disease|3|||
105824245|NCT05211284|365013161|FG000|Overall Study|Study Terminated|3|||
105824246|NCT05211284|365013162|FG001|Overall Study|Study Terminated|1|||
106146421|NCT02528188|366196514|FG000|Overall Study|Lack of Efficacy|19|||
106146422|NCT02528188|366196515|FG001|Overall Study|Lack of Efficacy|21|||
106146423|NCT02528188|366196516|FG002|Overall Study|Lack of Efficacy|22|||
106146424|NCT02528188|366196514|FG000|Overall Study|Withdrawal by Subject|97|||
106146425|NCT02528188|366196515|FG001|Overall Study|Withdrawal by Subject|104|||
106146426|NCT02528188|366196516|FG002|Overall Study|Withdrawal by Subject|100|||
106146427|NCT02528188|366196514|FG000|Overall Study|Lost to Follow-up|25|||
106146428|NCT02528188|366196515|FG001|Overall Study|Lost to Follow-up|21|||
106146429|NCT02528188|366196516|FG002|Overall Study|Lost to Follow-up|31|||
106146430|NCT02528188|366196514|FG000|Overall Study|Death|4|||
106146431|NCT02528188|366196515|FG001|Overall Study|Death|4|||
106146432|NCT02528188|366196516|FG002|Overall Study|Death|0|||
105824247|NCT05630885|365013163|FG000|Study Completion|Took prohibited medications|2|||
105824248|NCT05630885|365013164|FG001|Study Completion|Took prohibited medications|0|||
106146433|NCT02528188|366196514|FG000|Overall Study|Other|89|||
106146434|NCT02528188|366196515|FG001|Overall Study|Other|91|||
106146435|NCT02528188|366196516|FG002|Overall Study|Other|74|||
105824249|NCT05630885|365013163|FG000|Study Completion|Non-compliance with study drug|1|||
105824250|NCT05630885|365013164|FG001|Study Completion|Non-compliance with study drug|0|||
105824251|NCT05630885|365013163|FG000|Study Completion|Adverse Event|1|||
105824252|NCT05630885|365013164|FG001|Study Completion|Adverse Event|0|||
105824253|NCT05630885|365013163|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
105824254|NCT05630885|365013164|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
105824255|NCT05630885|365013163|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
105824256|NCT05630885|365013164|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
105824257|NCT05921903|365013168|FG000|Overall Study|Unsolicited non-SAE|0|||
105824258|NCT05921903|365013169|FG001|Overall Study|Unsolicited non-SAE|1|||
105824259|NCT05921903|365013170|FG002|Overall Study|Unsolicited non-SAE|0|||
105824260|NCT05921903|365013168|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
105824261|NCT05921903|365013169|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
105824262|NCT05921903|365013170|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
105824263|NCT05921903|365013168|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
105824264|NCT05921903|365013169|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
105824265|NCT05921903|365013170|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
105824266|NCT06539676|365013171|FG000|Overall Study|Early study termination|1|||
105824267|NCT06539676|365013172|FG001|Overall Study|Early study termination|0|||
105824268|NCT06539676|365013173|FG002|Overall Study|Early study termination|6|||
105824269|NCT01825798|365013174|FG000|Overall Study|Adverse Event|1|||
105824270|NCT01825798|365013175|FG001|Overall Study|Adverse Event|5|||
105824271|NCT01825798|365013174|FG000|Overall Study|Lost to Follow-up|1|||
105824272|NCT01825798|365013175|FG001|Overall Study|Lost to Follow-up|0|||
106146436|NCT02528188|366196514|FG000|Overall Study|Randomized but not treated|6|||
106146437|NCT02528188|366196515|FG001|Overall Study|Randomized but not treated|7|||
106146438|NCT02528188|366196516|FG002|Overall Study|Randomized but not treated|12|||
106146439|NCT01849055|366196517|FG000|Overall Study|Withdrawal by Subject|0|||
106146440|NCT01849055|366196518|FG001|Overall Study|Withdrawal by Subject|0|||
105824273|NCT01908205|365013176|FG000|Overall Study|Lost to Follow-up|2|||
105824274|NCT01908205|365013177|FG001|Overall Study|Lost to Follow-up|0|||
105824275|NCT01908205|365013176|FG000|Overall Study|Withdrawal by Subject|3|||
105824276|NCT01908205|365013177|FG001|Overall Study|Withdrawal by Subject|1|||
105824277|NCT05323396|365013182|FG000|Overall Study|Lost to Follow-up|1|||
105824278|NCT05323396|365013183|FG001|Overall Study|Lost to Follow-up|35|||
105824279|NCT05323396|365013182|FG000|Overall Study|Pregnancy|1|||
105824280|NCT05323396|365013183|FG001|Overall Study|Pregnancy|0|||
105824281|NCT02619682|365013184|FG000|Overall Study|Withdrawal by Subject|3|||
105824282|NCT02619682|365013184|FG000|Overall Study|Lack of Efficacy|8|||
105824283|NCT02619682|365013184|FG000|Overall Study|new secondary cancer|1|||
105824284|NCT02619682|365013184|FG000|Overall Study|post surgery complications|2|||
105824285|NCT01154231|365013188|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
105824286|NCT01154231|365013188|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
105824287|NCT02286739|365014428|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
105824288|NCT02286739|365014429|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
105824289|NCT02286739|365014428|FG000|Overall Study|No Verasense type documented|0|||
105824290|NCT02286739|365014429|FG001|Overall Study|No Verasense type documented|23|||
105824291|NCT02286739|365014428|FG000|Overall Study|Adverse Event|1|||
105824292|NCT02286739|365014429|FG001|Overall Study|Adverse Event|2|||
105824293|NCT02286739|365014428|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
105824294|NCT02286739|365014429|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
105824295|NCT03122535|365014434|FG000|Overall Study|Lost to Follow-up|68|||
105824296|NCT03122535|365014435|FG001|Overall Study|Lost to Follow-up|68|||
105824297|NCT03122535|365014434|FG000|Overall Study|Physician Decision|3|||
105824298|NCT03122535|365014435|FG001|Overall Study|Physician Decision|3|||
105824299|NCT03122535|365014434|FG000|Overall Study|Withdrawal by Subject|2|||
105824300|NCT03122535|365014435|FG001|Overall Study|Withdrawal by Subject|2|||
105824301|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
105824302|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
105824303|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
106146441|NCT01849055|366196519|FG002|Overall Study|Withdrawal by Subject|1|||
105824304|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
105824305|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824306|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824307|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
106146442|NCT01849055|366196520|FG003|Overall Study|Withdrawal by Subject|0|||
106146443|NCT01849055|366196521|FG004|Overall Study|Withdrawal by Subject|0|||
106146444|NCT01849055|366196522|FG005|Overall Study|Withdrawal by Subject|0|||
106146445|NCT02139943|366196527|FG000|Overall Study|Adverse Event|0|||
106146446|NCT02139943|366196528|FG001|Overall Study|Adverse Event|1|||
106146447|NCT02139943|366196529|FG002|Overall Study|Adverse Event|2|||
105824308|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824309|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824310|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824311|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824312|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824313|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824314|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
105824315|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
105824316|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
105824317|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
105824318|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
105824319|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824320|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824321|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824322|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824323|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824324|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824325|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824326|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824327|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824328|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
105824329|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
105824330|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824331|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
105824332|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824333|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824334|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824335|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824336|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824337|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824338|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824339|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824340|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824341|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824342|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
105824343|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
105824344|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
105824345|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
105824346|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824347|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824348|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824349|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824350|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824351|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824352|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824353|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824354|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824355|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824356|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
105824357|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
105824358|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824359|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
105824360|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824361|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824362|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824363|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824364|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105959834|NCT00412958|365513314|FG000|Overall Study|Death|0|||
105959835|NCT00412958|365513315|FG001|Overall Study|Death|1|||
106146448|NCT02139943|366196527|FG000|Overall Study|Lost to Follow-up|3|||
106146449|NCT02139943|366196528|FG001|Overall Study|Lost to Follow-up|2|||
105824365|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824366|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824367|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824368|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824369|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824370|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
105824371|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
105824372|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824373|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
105824374|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824375|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824376|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824377|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824378|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824379|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824380|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824381|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824382|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824383|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824384|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
105824385|NCT01695239|365014443|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
105824386|NCT01695239|365014444|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824387|NCT01695239|365014445|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824388|NCT01695239|365014446|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824389|NCT01695239|365014447|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824390|NCT01695239|365014448|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824391|NCT01695239|365014449|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824392|NCT01695239|365014450|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824393|NCT01695239|365014451|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824394|NCT01695239|365014452|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824395|NCT01695239|365014453|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824396|NCT01695239|365014454|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824397|NCT01695239|365014455|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824398|NCT01695239|365014456|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
105824399|NCT01695239|365014443|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824400|NCT01695239|365014444|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824401|NCT01695239|365014445|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824402|NCT01695239|365014446|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824403|NCT01695239|365014447|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824404|NCT01695239|365014448|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824405|NCT01695239|365014449|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824406|NCT01695239|365014450|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
105824407|NCT01695239|365014451|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824408|NCT01695239|365014452|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824409|NCT01695239|365014453|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824410|NCT01695239|365014454|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824411|NCT01695239|365014455|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824412|NCT01695239|365014456|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
105824413|NCT01695239|365014443|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824414|NCT01695239|365014444|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824415|NCT01695239|365014445|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824416|NCT01695239|365014446|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824417|NCT01695239|365014447|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824418|NCT01695239|365014448|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105959836|NCT00412958|365513316|FG002|Overall Study|Death|0|||
105959837|NCT00412958|365513317|FG003|Overall Study|Death|0|||
105959838|NCT00412958|365513314|FG000|Overall Study|Transport issue|0|||
105959839|NCT00412958|365513315|FG001|Overall Study|Transport issue|1|||
105959840|NCT00412958|365513316|FG002|Overall Study|Transport issue|0|||
105959841|NCT00412958|365513317|FG003|Overall Study|Transport issue|0|||
105959842|NCT01703091|365513320|FG000|Overall Study|Adverse Event|5|||
105959843|NCT01703091|365513321|FG001|Overall Study|Adverse Event|3|||
105959844|NCT01703091|365513320|FG000|Overall Study|Physician Decision|2|||
105959845|NCT01703091|365513321|FG001|Overall Study|Physician Decision|1|||
105959846|NCT01703091|365513320|FG000|Overall Study|Withdrawal by Subject|1|||
105959847|NCT01703091|365513321|FG001|Overall Study|Withdrawal by Subject|0|||
106146450|NCT02139943|366196529|FG002|Overall Study|Lost to Follow-up|2|||
105959848|NCT01703091|365513320|FG000|Overall Study|Sponsor Decision|1|||
105959849|NCT01703091|365513321|FG001|Overall Study|Sponsor Decision|0|||
105824419|NCT01695239|365014449|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105959850|NCT01092780|365513329|FG000|Washout Period 1|Adverse Event|0|||
105959851|NCT01092780|365513330|FG001|Washout Period 1|Adverse Event|1|||
105824420|NCT01695239|365014450|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
105824421|NCT01695239|365014451|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824422|NCT01695239|365014452|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824423|NCT01695239|365014453|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824424|NCT01695239|365014454|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824425|NCT01695239|365014455|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824426|NCT01695239|365014456|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
105824427|NCT01695239|365014443|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824428|NCT01695239|365014444|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824429|NCT01695239|365014445|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824430|NCT01695239|365014446|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824431|NCT01695239|365014447|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824432|NCT01695239|365014448|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824433|NCT01695239|365014449|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824434|NCT01695239|365014450|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
105824435|NCT01695239|365014451|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824436|NCT01695239|365014452|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824437|NCT01695239|365014453|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824438|NCT01695239|365014454|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824439|NCT01695239|365014455|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824440|NCT01695239|365014456|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
105824441|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824442|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824443|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824444|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824445|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824446|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824447|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824448|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824449|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
105824450|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
105824451|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824452|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824453|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824454|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
105824455|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
105824456|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
105824457|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
105824458|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
105824459|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
105824460|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
105824461|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
105824462|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
105824463|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
105824464|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
105824465|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
105824466|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
105824467|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
105824468|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
105824469|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824470|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824471|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824472|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824473|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824474|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824475|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824476|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824477|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
105824478|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
105824479|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824480|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824481|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824482|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
105824483|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
105824484|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
105824485|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
105824486|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
105824487|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
105824488|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
105824489|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
105824490|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
105824491|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
105824492|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
105824493|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
105824494|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
105824495|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
105824496|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
105824497|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824498|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824499|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824500|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824501|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824502|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824503|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824504|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824505|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
105824506|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
105824507|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824508|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824509|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
106146451|NCT02139943|366196527|FG000|Overall Study|Withdrawal by Subject|4|||
106146452|NCT02139943|366196528|FG001|Overall Study|Withdrawal by Subject|3|||
106146453|NCT02139943|366196529|FG002|Overall Study|Withdrawal by Subject|0|||
105824510|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
105824511|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824512|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824513|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824514|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824515|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824516|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824517|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824518|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824519|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
105824520|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
105824521|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824522|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824523|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824524|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
105824525|NCT01695239|365014443|FG000|Extension Long-Term Extension Periods|Death|0|||
105824526|NCT01695239|365014444|FG001|Extension Long-Term Extension Periods|Death|0|||
105824527|NCT01695239|365014445|FG002|Extension Long-Term Extension Periods|Death|0|||
105824528|NCT01695239|365014446|FG003|Extension Long-Term Extension Periods|Death|0|||
105824529|NCT01695239|365014447|FG004|Extension Long-Term Extension Periods|Death|0|||
105824530|NCT01695239|365014448|FG005|Extension Long-Term Extension Periods|Death|0|||
105824531|NCT01695239|365014449|FG006|Extension Long-Term Extension Periods|Death|0|||
105824532|NCT01695239|365014450|FG007|Extension Long-Term Extension Periods|Death|0|||
105824533|NCT01695239|365014451|FG008|Extension Long-Term Extension Periods|Death|1|||
105824534|NCT01695239|365014452|FG009|Extension Long-Term Extension Periods|Death|0|||
105824535|NCT01695239|365014453|FG010|Extension Long-Term Extension Periods|Death|0|||
105824536|NCT01695239|365014454|FG011|Extension Long-Term Extension Periods|Death|0|||
105824537|NCT01695239|365014455|FG012|Extension Long-Term Extension Periods|Death|0|||
105824538|NCT01695239|365014456|FG013|Extension Long-Term Extension Periods|Death|0|||
105824539|NCT01695239|365014443|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824540|NCT01695239|365014444|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824541|NCT01695239|365014445|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824542|NCT01695239|365014446|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824543|NCT01695239|365014447|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824544|NCT01695239|365014448|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824545|NCT01695239|365014449|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824546|NCT01695239|365014450|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824547|NCT01695239|365014451|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824548|NCT01695239|365014452|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824549|NCT01695239|365014453|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
105824550|NCT01695239|365014454|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
105824551|NCT01695239|365014455|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
105824552|NCT01695239|365014456|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
105824553|NCT01695239|365014443|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824554|NCT01695239|365014444|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824555|NCT01695239|365014445|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824556|NCT01695239|365014446|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824557|NCT01695239|365014447|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824558|NCT01695239|365014448|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824559|NCT01695239|365014449|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824560|NCT01695239|365014450|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824561|NCT01695239|365014451|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824562|NCT01695239|365014452|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824563|NCT01695239|365014453|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824564|NCT01695239|365014454|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105824565|NCT01695239|365014455|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
105824566|NCT01695239|365014456|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
105824567|NCT01695239|365014443|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824568|NCT01695239|365014444|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824569|NCT01695239|365014445|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824570|NCT01695239|365014446|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824571|NCT01695239|365014447|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824572|NCT01695239|365014448|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824573|NCT01695239|365014449|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824574|NCT01695239|365014450|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824575|NCT01695239|365014451|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824576|NCT01695239|365014452|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824577|NCT01695239|365014453|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824578|NCT01695239|365014454|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824579|NCT01695239|365014455|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
105824580|NCT01695239|365014456|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
105824581|NCT01695239|365014443|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824582|NCT01695239|365014444|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824583|NCT01695239|365014445|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824584|NCT01695239|365014446|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824585|NCT01695239|365014447|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824586|NCT01695239|365014448|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824587|NCT01695239|365014449|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824588|NCT01695239|365014450|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824589|NCT01695239|365014451|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824590|NCT01695239|365014452|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824591|NCT01695239|365014453|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824592|NCT01695239|365014454|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824593|NCT01695239|365014455|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
105824594|NCT01695239|365014456|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
105824595|NCT04994535|365014458|FG000|Overall Study|Lost to Follow-up|7|||
105824596|NCT04994535|365014459|FG001|Overall Study|Lost to Follow-up|7|||
105824597|NCT04994535|365014458|FG000|Overall Study|Withdrawal by Subject|10|||
105824598|NCT04994535|365014459|FG001|Overall Study|Withdrawal by Subject|7|||
105824599|NCT04994535|365014458|FG000|Overall Study|Other|1|||
105824600|NCT04994535|365014459|FG001|Overall Study|Other|1|||
105824601|NCT00604162|365014462|FG000|Overall Study|Physician Decision|3|||
105824602|NCT00604162|365014462|FG000|Overall Study|Withdrawal by Subject|1|||
105824603|NCT02682238|365014464|FG000|Overall Study|Lost to Follow-up|0|||
105824604|NCT02682238|365014465|FG001|Overall Study|Lost to Follow-up|2|||
105824605|NCT02682238|365014464|FG000|Overall Study|Withdrawal by Subject|1|||
105824606|NCT02682238|365014465|FG001|Overall Study|Withdrawal by Subject|0|||
105824607|NCT02682238|365014464|FG000|Overall Study|Adverse Event|1|||
105824608|NCT02682238|365014465|FG001|Overall Study|Adverse Event|0|||
105824609|NCT02682238|365014464|FG000|Overall Study|Non-compliance with Study Drug|1|||
105824610|NCT02682238|365014465|FG001|Overall Study|Non-compliance with Study Drug|0|||
105959852|NCT01092780|365513331|FG002|Washout Period 1|Adverse Event|0|||
105824611|NCT02682238|365014464|FG000|Overall Study|Non-compliance with Protocol|0|||
105824612|NCT02682238|365014465|FG001|Overall Study|Non-compliance with Protocol|2|||
105824613|NCT00003659|365014470|FG000|Overall Study|Withdrawal by Subject|3|||
105824614|NCT00835263|365014471|FG000|Second Intervention|Adverse Event|1|||
105824615|NCT00835263|365014472|FG001|Second Intervention|Adverse Event|0|||
105824616|NCT01913405|365014473|FG000|Overall Study|Withdrawal by Subject|1|||
105824617|NCT01913405|365014473|FG000|Overall Study|Adverse Event|1|||
105824618|NCT00466167|365014474|FG000|Overall Study|Adverse Event|8|||
105824619|NCT00466167|365014475|FG001|Overall Study|Adverse Event|8|||
105824620|NCT00466167|365014476|FG002|Overall Study|Adverse Event|7|||
105824621|NCT00466167|365014474|FG000|Overall Study|Lack of Efficacy|2|||
105824622|NCT00466167|365014475|FG001|Overall Study|Lack of Efficacy|0|||
105824623|NCT00466167|365014476|FG002|Overall Study|Lack of Efficacy|3|||
105824624|NCT00466167|365014474|FG000|Overall Study|Protocol Violation|1|||
105824625|NCT00466167|365014475|FG001|Overall Study|Protocol Violation|1|||
105824626|NCT00466167|365014476|FG002|Overall Study|Protocol Violation|2|||
105824627|NCT00466167|365014474|FG000|Overall Study|Lost to Follow-up|3|||
105824628|NCT00466167|365014475|FG001|Overall Study|Lost to Follow-up|2|||
105824629|NCT00466167|365014476|FG002|Overall Study|Lost to Follow-up|2|||
105824630|NCT00466167|365014474|FG000|Overall Study|Withdrawal by Subject|4|||
105824631|NCT00466167|365014475|FG001|Overall Study|Withdrawal by Subject|1|||
105824632|NCT00466167|365014476|FG002|Overall Study|Withdrawal by Subject|6|||
105824633|NCT00466167|365014474|FG000|Overall Study|patient did not meet inclusion criteria|1|||
105824634|NCT00466167|365014475|FG001|Overall Study|patient did not meet inclusion criteria|0|||
105824635|NCT00466167|365014476|FG002|Overall Study|patient did not meet inclusion criteria|1|||
105824636|NCT00466167|365014474|FG000|Overall Study|Not treated|1|||
105824637|NCT00466167|365014475|FG001|Overall Study|Not treated|0|||
105824638|NCT00466167|365014476|FG002|Overall Study|Not treated|0|||
105824639|NCT01535222|365014477|FG000|Overall Study|Inclusion/exclusion|0|||
105824640|NCT01535222|365014478|FG001|Overall Study|Inclusion/exclusion|0|||
105824641|NCT01535222|365014479|FG002|Overall Study|Inclusion/exclusion|1|||
105824642|NCT01535222|365014480|FG003|Overall Study|Inclusion/exclusion|0|||
105824643|NCT01535222|365014481|FG004|Overall Study|Inclusion/exclusion|0|||
105824644|NCT01535222|365014482|FG005|Overall Study|Inclusion/exclusion|0|||
105824645|NCT00935012|365014483|FG000|Overall Study|Death|19|||
105824646|NCT00935012|365014483|FG000|Overall Study|Withdrawal by Subject|3|||
105824647|NCT00935012|365014483|FG000|Overall Study|Other|5|||
105824648|NCT00935012|365014483|FG000|Overall Study|Adverse Event|2|||
105824649|NCT01442155|365014484|FG000|Overall Study|Complete remission|35|||
105824650|NCT01442155|365014484|FG000|Overall Study|Recurrence|26|||
105824651|NCT01442155|365014484|FG000|Overall Study|Adverse Event|2|||
105824652|NCT01442155|365014484|FG000|Overall Study|Lost to Follow-up|2|||
105824653|NCT03366792|365014491|FG000|Overall Study|Withdrawal by Subject|7|||
105824654|NCT03366792|365014491|FG000|Overall Study|Lost to Follow-up|2|||
105824655|NCT03366792|365014491|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
105824656|NCT03366792|365014491|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
105824657|NCT05308290|365014493|FG000|Overall Study|Death|1|||
105824658|NCT05308290|365014494|FG001|Overall Study|Death|0|||
105824659|NCT05308290|365014493|FG000|Overall Study|Lost to Follow-up|2|||
105959853|NCT01092780|365513332|FG003|Washout Period 1|Adverse Event|0|||
105959854|NCT01092780|365513329|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
105959855|NCT01092780|365513330|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
105959856|NCT01092780|365513331|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
105959857|NCT01092780|365513332|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
105959858|NCT01092780|365513329|FG000|Washout Period 2|Adverse Event|0|||
105824660|NCT05308290|365014494|FG001|Overall Study|Lost to Follow-up|1|||
105824661|NCT05308290|365014493|FG000|Overall Study|still in study followup|0|||
105824662|NCT05308290|365014494|FG001|Overall Study|still in study followup|1|||
105824663|NCT01370733|365014495|FG000|Overall Study|Withdrawal by Subject|8|||
105824664|NCT01370733|365014496|FG001|Overall Study|Withdrawal by Subject|8|||
105824665|NCT01370733|365014495|FG000|Overall Study|Lost to Follow-up|3|||
105959859|NCT01092780|365513330|FG001|Washout Period 2|Adverse Event|1|||
105959860|NCT01092780|365513331|FG002|Washout Period 2|Adverse Event|1|||
105959861|NCT01092780|365513332|FG003|Washout Period 2|Adverse Event|0|||
105959862|NCT00615719|365513334|FG000|Overall Study|Physician Decision|5|||
106146454|NCT02139943|366196527|FG000|Overall Study|Other|0|||
106146455|NCT02139943|366196528|FG001|Overall Study|Other|0|||
105824666|NCT01370733|365014496|FG001|Overall Study|Lost to Follow-up|0|||
105824667|NCT01370733|365014495|FG000|Overall Study|Adverse Event|2|||
105824668|NCT01370733|365014496|FG001|Overall Study|Adverse Event|4|||
105824669|NCT01370733|365014495|FG000|Overall Study|Lack of Efficacy|3|||
105824670|NCT01370733|365014496|FG001|Overall Study|Lack of Efficacy|5|||
105824671|NCT01370733|365014495|FG000|Overall Study|Physician Decision|0|||
105824672|NCT01370733|365014496|FG001|Overall Study|Physician Decision|2|||
105824673|NCT01370733|365014495|FG000|Overall Study|Protocol Violation|1|||
105824674|NCT01370733|365014496|FG001|Overall Study|Protocol Violation|3|||
105824675|NCT01237054|365014497|FG000|Overall Study|imaging 10C0096|1|||
105824676|NCT01983969|365014498|FG000|Overall Study|Disease Progression|0|||
105824677|NCT01983969|365014499|FG001|Overall Study|Disease Progression|1|||
105824678|NCT01983969|365014500|FG002|Overall Study|Disease Progression|0|||
105824679|NCT00436163|365014503|FG000|Overall Study|Lost to Follow-up|2|||
105824680|NCT00436163|365014503|FG000|Overall Study|Adverse Event|1|||
105959863|NCT04550832|365513337|FG000|Overall Study|Adverse Event|0|||
105959864|NCT04550832|365513338|FG001|Overall Study|Adverse Event|0|||
105959865|NCT04550832|365513339|FG002|Overall Study|Adverse Event|2|||
106146456|NCT02139943|366196529|FG002|Overall Study|Other|1|||
105824681|NCT06647173|365014509|FG000|Overall Study|Lost to Follow-up|24|||
105824682|NCT02286089|365014511|FG000|Overall Study|Ongoing in Study|1|||
105824683|NCT02286089|365014512|FG001|Overall Study|Ongoing in Study|1|||
105824684|NCT02286089|365014513|FG002|Overall Study|Ongoing in Study|4|||
105824685|NCT02286089|365014514|FG003|Overall Study|Ongoing in Study|10|||
105824686|NCT02286089|365014511|FG000|Overall Study|Withdrawal by Subject|0|||
105768456|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
105768457|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
105768458|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
105824687|NCT02286089|365014512|FG001|Overall Study|Withdrawal by Subject|0|||
105824688|NCT02286089|365014513|FG002|Overall Study|Withdrawal by Subject|2|||
105824689|NCT02286089|365014514|FG003|Overall Study|Withdrawal by Subject|2|||
105824690|NCT01248728|365014515|FG000|Overall Study|Adverse Event|1|||
105824691|NCT01248728|365014516|FG001|Overall Study|Adverse Event|1|||
105824692|NCT01248728|365014515|FG000|Overall Study|Withdrawal by Subject|2|||
105824693|NCT01248728|365014516|FG001|Overall Study|Withdrawal by Subject|1|||
105824694|NCT01248728|365014515|FG000|Overall Study|Lack of Efficacy|1|||
105824695|NCT01248728|365014516|FG001|Overall Study|Lack of Efficacy|0|||
105824696|NCT03100344|365014517|FG000|Overall Study|Adverse Event|0|||
105824697|NCT03100344|365014518|FG001|Overall Study|Adverse Event|3|||
105824698|NCT03100344|365014519|FG002|Overall Study|Adverse Event|2|||
105824699|NCT03100344|365014520|FG003|Overall Study|Adverse Event|3|||
105824700|NCT03100344|365014517|FG000|Overall Study|Lack of Efficacy|2|||
105824701|NCT03100344|365014518|FG001|Overall Study|Lack of Efficacy|0|||
105824702|NCT03100344|365014519|FG002|Overall Study|Lack of Efficacy|0|||
105824703|NCT03100344|365014520|FG003|Overall Study|Lack of Efficacy|0|||
105824704|NCT03100344|365014517|FG000|Overall Study|Protocol Violation|1|||
105824705|NCT03100344|365014518|FG001|Overall Study|Protocol Violation|0|||
105824706|NCT03100344|365014519|FG002|Overall Study|Protocol Violation|0|||
105824707|NCT03100344|365014520|FG003|Overall Study|Protocol Violation|0|||
105824708|NCT03100344|365014517|FG000|Overall Study|Withdrawal by Subject|10|||
105824709|NCT03100344|365014518|FG001|Overall Study|Withdrawal by Subject|7|||
105824710|NCT03100344|365014519|FG002|Overall Study|Withdrawal by Subject|4|||
105824711|NCT03100344|365014520|FG003|Overall Study|Withdrawal by Subject|8|||
105824712|NCT03100344|365014517|FG000|Overall Study|Lost to Follow-up|1|||
105824713|NCT03100344|365014518|FG001|Overall Study|Lost to Follow-up|1|||
105824714|NCT03100344|365014519|FG002|Overall Study|Lost to Follow-up|1|||
105824715|NCT03100344|365014520|FG003|Overall Study|Lost to Follow-up|1|||
105824716|NCT03114891|365014521|FG000|First Treatment Round|Lost to Follow-up|0|||
105824717|NCT03114891|365014522|FG001|First Treatment Round|Lost to Follow-up|1|||
105824718|NCT03114891|365014523|FG002|First Treatment Round|Lost to Follow-up|1|||
105824719|NCT03114891|365014524|FG003|First Treatment Round|Lost to Follow-up|0|||
105824720|NCT03114891|365014521|FG000|First Treatment Round|Withdrawal by Subject|0|||
105959866|NCT04550832|365513340|FG003|Overall Study|Adverse Event|0|||
105959867|NCT04550832|365513341|FG004|Overall Study|Adverse Event|1|||
105959868|NCT02674464|365513342|FG000|Overall Study|Death|10|||
105959869|NCT02674464|365513343|FG001|Overall Study|Death|21|||
105768459|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
105768460|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
105768461|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
105768462|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
105768463|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
105768464|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
105768465|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
105768466|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
105768467|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
105768468|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
105768469|NCT03559192|364802714|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
105768470|NCT03559192|364802715|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
105768471|NCT03559192|364802716|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
105768472|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
105768473|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
105768474|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
105768475|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
105768476|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
105768477|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
105768478|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
105768479|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
105768480|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
105768481|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
105768482|NCT02422186|364802717|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
105768483|NCT02422186|364802718|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
105959870|NCT02674464|365513342|FG000|Overall Study|Withdrawal by Subject|24|||
106021524|NCT00139477|365743389|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
106021525|NCT00139477|365743388|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
106021526|NCT00139477|365743389|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
105768484|NCT02422186|364802717|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
105768485|NCT02422186|364802718|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
105768486|NCT02422186|364802717|FG000|Follow-up Phase (2 Weeks)|Other|3|||
105768487|NCT02422186|364802718|FG001|Follow-up Phase (2 Weeks)|Other|0|||
105768488|NCT01627782|364802723|FG000|Overall Study|Adverse Event|1|||
105768489|NCT01627782|364802724|FG001|Overall Study|Adverse Event|2|||
105768490|NCT01627782|364802725|FG002|Overall Study|Adverse Event|0|||
105768491|NCT01627782|364802726|FG003|Overall Study|Adverse Event|1|||
105768492|NCT01627782|364802723|FG000|Overall Study|Lack of Efficacy|11|||
105768493|NCT01627782|364802724|FG001|Overall Study|Lack of Efficacy|1|||
105768494|NCT01627782|364802725|FG002|Overall Study|Lack of Efficacy|15|||
105768495|NCT01627782|364802726|FG003|Overall Study|Lack of Efficacy|2|||
105768496|NCT01627782|364802723|FG000|Overall Study|Protocol Violation|1|||
105768497|NCT01627782|364802724|FG001|Overall Study|Protocol Violation|0|||
105768498|NCT01627782|364802725|FG002|Overall Study|Protocol Violation|0|||
105768499|NCT01627782|364802726|FG003|Overall Study|Protocol Violation|0|||
105768500|NCT01627782|364802723|FG000|Overall Study|Withdrawal by Subject|2|||
105768501|NCT01627782|364802724|FG001|Overall Study|Withdrawal by Subject|1|||
105768502|NCT01627782|364802725|FG002|Overall Study|Withdrawal by Subject|0|||
105768503|NCT01627782|364802726|FG003|Overall Study|Withdrawal by Subject|0|||
105768504|NCT01627782|364802723|FG000|Overall Study|Other|0|||
105768505|NCT01627782|364802724|FG001|Overall Study|Other|2|||
105768506|NCT01627782|364802725|FG002|Overall Study|Other|0|||
105768507|NCT01627782|364802726|FG003|Overall Study|Other|3|||
105768508|NCT01627782|364802723|FG000|Overall Study|Randomized But Not Treated|1|||
105768509|NCT01627782|364802724|FG001|Overall Study|Randomized But Not Treated|0|||
105768510|NCT01627782|364802725|FG002|Overall Study|Randomized But Not Treated|0|||
105768511|NCT01627782|364802726|FG003|Overall Study|Randomized But Not Treated|0|||
105768512|NCT03573401|364802727|FG000|Overall Study|Withdrawal by Subject|2|||
105768513|NCT03573401|364802728|FG001|Overall Study|Withdrawal by Subject|0|||
105768514|NCT03573401|364802727|FG000|Overall Study|Subject non-compliance with study schedule|1|||
105768515|NCT03573401|364802728|FG001|Overall Study|Subject non-compliance with study schedule|0|||
105768516|NCT03573401|364802727|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
105768517|NCT03573401|364802728|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
105768518|NCT03573401|364802727|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
105768519|NCT03573401|364802728|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
105768520|NCT05516134|364804424|FG000|Overall Study|Lost to Follow-up|1|||
105768521|NCT05516134|364804425|FG001|Overall Study|Lost to Follow-up|0|||
105768522|NCT05516134|364804426|FG002|Overall Study|Lost to Follow-up|0|||
105768523|NCT01408732|364804427|FG000|Overall Study|Withdrawal by Subject|2|||
105768524|NCT01408732|364804428|FG001|Overall Study|Withdrawal by Subject|2|||
105768525|NCT03377452|364804429|FG000|Overall Study|Refused assessment|0|||
105768526|NCT03377452|364804430|FG001|Overall Study|Refused assessment|2|||
105768527|NCT03377452|364804429|FG000|Overall Study|Lost to Follow-up|5|||
105768528|NCT03377452|364804430|FG001|Overall Study|Lost to Follow-up|4|||
105768529|NCT02040857|364804432|FG000|Overall Study|Adverse Event|14|||
105768530|NCT02040857|364804432|FG000|Overall Study|Physician Decision|5|||
105768531|NCT02040857|364804432|FG000|Overall Study|Withdrawal by Subject|31|||
105768532|NCT02040857|364804432|FG000|Overall Study|patient non-compliance|3|||
105768533|NCT02040857|364804432|FG000|Overall Study|Lost to Follow-up|2|||
105768534|NCT02040857|364804432|FG000|Overall Study|recurrence|4|||
105768535|NCT02040857|364804432|FG000|Overall Study|ineligible|1|||
105768536|NCT03146403|364804440|FG000|Overall Study|Withdrawal by Subject|0|||
105768537|NCT03146403|364804441|FG001|Overall Study|Withdrawal by Subject|3|||
105768538|NCT03146403|364804440|FG000|Overall Study|Lost to Follow-up|2|||
105768539|NCT03146403|364804441|FG001|Overall Study|Lost to Follow-up|0|||
105768540|NCT01024920|364804445|FG000|Overall Study|Progressive disease|47|||
105768541|NCT01024920|364804446|FG001|Overall Study|Progressive disease|25|||
105768542|NCT01024920|364804445|FG000|Overall Study|Adverse Event|8|||
105768543|NCT01024920|364804446|FG001|Overall Study|Adverse Event|4|||
105768544|NCT01024920|364804445|FG000|Overall Study|Lost to Follow-up|0|||
105768545|NCT01024920|364804446|FG001|Overall Study|Lost to Follow-up|1|||
105768546|NCT01024920|364804445|FG000|Overall Study|Patient refusal to continue|4|||
105768547|NCT01024920|364804446|FG001|Overall Study|Patient refusal to continue|0|||
105768548|NCT01024920|364804445|FG000|Overall Study|Other than listed|5|||
105768549|NCT01024920|364804446|FG001|Overall Study|Other than listed|1|||
105768550|NCT01024920|364804445|FG000|Overall Study|Not treated|3|||
105768551|NCT01024920|364804446|FG001|Overall Study|Not treated|0|||
105768552|NCT01024920|364804445|FG000|Overall Study|Protocol Violation|0|||
105768553|NCT01024920|364804446|FG001|Overall Study|Protocol Violation|1|||
105768554|NCT02977507|364804448|FG000|Overall Study|Protocol Deviation|1|||
105768555|NCT02977507|364804449|FG001|Overall Study|Protocol Deviation|0|||
105768556|NCT02977507|364804448|FG000|Overall Study|Lost to Follow-up|1|||
105959871|NCT02674464|365513343|FG001|Overall Study|Withdrawal by Subject|44|||
105959872|NCT02674464|365513342|FG000|Overall Study|Lost to Follow-up|97|||
106146457|NCT02139943|366196527|FG000|Overall Study|Participant wishes to discontinue|2|||
106146458|NCT02139943|366196528|FG001|Overall Study|Participant wishes to discontinue|0|||
106146459|NCT02139943|366196529|FG002|Overall Study|Participant wishes to discontinue|0|||
106146460|NCT02139943|366196527|FG000|Overall Study|Participant in Poor Compliance|1|||
106146461|NCT02139943|366196528|FG001|Overall Study|Participant in Poor Compliance|0|||
106146462|NCT02139943|366196529|FG002|Overall Study|Participant in Poor Compliance|1|||
106146463|NCT02139943|366196527|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
106146464|NCT02139943|366196528|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
106146465|NCT02139943|366196529|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
106146466|NCT00704184|366196530|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
106146467|NCT00704184|366196531|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
106146468|NCT00704184|366196532|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
105768557|NCT02977507|364804449|FG001|Overall Study|Lost to Follow-up|0|||
105768558|NCT01098032|364804450|FG000|Overall Study|Withdrawal by Subject|1|||
105768559|NCT01098032|364804451|FG001|Overall Study|Withdrawal by Subject|1|||
105768560|NCT00481988|364804452|FG000|Overall Study|Withdrawal by Subject|1|||
105768561|NCT00481988|364804453|FG001|Overall Study|Withdrawal by Subject|1|||
105768562|NCT00654420|364804455|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
105768563|NCT00654420|364804456|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
105768564|NCT00654420|364804457|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
105768565|NCT00654420|364804458|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
105768566|NCT00654420|364804455|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
105768567|NCT00654420|364804456|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
105768568|NCT00654420|364804457|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
105768569|NCT00654420|364804458|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
105768570|NCT00654420|364804455|FG000|Phase II|Adverse Event|0|||
105768571|NCT00654420|364804456|FG001|Phase II|Adverse Event|0|||
105768572|NCT00654420|364804457|FG002|Phase II|Adverse Event|3|||
105768573|NCT00654420|364804458|FG003|Phase II|Adverse Event|3|||
105768574|NCT00654420|364804455|FG000|Phase II|Lost to Follow-up|0|||
105768575|NCT00654420|364804456|FG001|Phase II|Lost to Follow-up|0|||
105768576|NCT00654420|364804457|FG002|Phase II|Lost to Follow-up|0|||
105768577|NCT00654420|364804458|FG003|Phase II|Lost to Follow-up|1|||
105768578|NCT00654420|364804455|FG000|Phase II|Physician Decision|0|||
105768579|NCT00654420|364804456|FG001|Phase II|Physician Decision|0|||
105768580|NCT00654420|364804457|FG002|Phase II|Physician Decision|0|||
105768581|NCT00654420|364804458|FG003|Phase II|Physician Decision|4|||
105768582|NCT00654420|364804455|FG000|Phase II|Progressive Disease|0|||
105768583|NCT00654420|364804456|FG001|Phase II|Progressive Disease|0|||
105768584|NCT00654420|364804457|FG002|Phase II|Progressive Disease|29|||
105768585|NCT00654420|364804458|FG003|Phase II|Progressive Disease|29|||
105768586|NCT00654420|364804455|FG000|Phase II|Withdrawal by Subject|0|||
105768587|NCT00654420|364804456|FG001|Phase II|Withdrawal by Subject|0|||
105768588|NCT00654420|364804457|FG002|Phase II|Withdrawal by Subject|4|||
105768589|NCT00654420|364804458|FG003|Phase II|Withdrawal by Subject|1|||
105768590|NCT00654420|364804455|FG000|Phase II|Missing Disposition Record|0|||
105768591|NCT00654420|364804456|FG001|Phase II|Missing Disposition Record|0|||
105768592|NCT00654420|364804457|FG002|Phase II|Missing Disposition Record|1|||
105768593|NCT00654420|364804458|FG003|Phase II|Missing Disposition Record|0|||
105768594|NCT02252588|364804462|FG000|Overall Study|Withdrawal by Subject|4|||
105768595|NCT02252588|364804463|FG001|Overall Study|Withdrawal by Subject|0|||
105768596|NCT03039790|364804468|FG000|Overall Study|Lost to Follow-up|2|||
105768597|NCT03039790|364804469|FG001|Overall Study|Lost to Follow-up|0|||
105768598|NCT03039790|364804470|FG002|Overall Study|Lost to Follow-up|1|||
105768599|NCT03039790|364804471|FG003|Overall Study|Lost to Follow-up|1|||
105768600|NCT03039790|364804472|FG004|Overall Study|Lost to Follow-up|0|||
105768601|NCT03039790|364804473|FG005|Overall Study|Lost to Follow-up|1|||
105768602|NCT03039790|364804474|FG006|Overall Study|Lost to Follow-up|1|||
105768603|NCT03039790|364804475|FG007|Overall Study|Lost to Follow-up|1|||
105768604|NCT03039790|364804476|FG008|Overall Study|Lost to Follow-up|0|||
105768605|NCT03039790|364804477|FG009|Overall Study|Lost to Follow-up|1|||
105768606|NCT03039790|364804478|FG010|Overall Study|Lost to Follow-up|1|||
105768607|NCT03039790|364804479|FG011|Overall Study|Lost to Follow-up|0|||
105768608|NCT03039790|364804480|FG012|Overall Study|Lost to Follow-up|1|||
105768609|NCT03039790|364804481|FG013|Overall Study|Lost to Follow-up|0|||
105768610|NCT03039790|364804482|FG014|Overall Study|Lost to Follow-up|3|||
105768611|NCT03039790|364804483|FG015|Overall Study|Lost to Follow-up|1|||
105768612|NCT03039790|364804484|FG016|Overall Study|Lost to Follow-up|2|||
105768613|NCT03039790|364804485|FG017|Overall Study|Lost to Follow-up|2|||
105768614|NCT03039790|364804486|FG018|Overall Study|Lost to Follow-up|1|||
105768615|NCT03039790|364804487|FG019|Overall Study|Lost to Follow-up|3|||
105768616|NCT03039790|364804468|FG000|Overall Study|Withdrawal of Consent|1|||
105768617|NCT03039790|364804469|FG001|Overall Study|Withdrawal of Consent|0|||
106146469|NCT00704184|366196533|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
106146470|NCT00704184|366196534|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
106146471|NCT00704184|366196530|FG000|Open-Label Treatment|Adverse Event|0|||
106146472|NCT00704184|366196531|FG001|Open-Label Treatment|Adverse Event|0|||
106146473|NCT00704184|366196532|FG002|Open-Label Treatment|Adverse Event|2|||
106146474|NCT00704184|366196533|FG003|Open-Label Treatment|Adverse Event|0|||
106146475|NCT00704184|366196534|FG004|Open-Label Treatment|Adverse Event|1|||
106146476|NCT00704184|366196530|FG000|Open-Label Treatment|Lack of Efficacy|0|||
106146477|NCT00704184|366196531|FG001|Open-Label Treatment|Lack of Efficacy|2|||
106146478|NCT00704184|366196532|FG002|Open-Label Treatment|Lack of Efficacy|2|||
106146479|NCT00704184|366196533|FG003|Open-Label Treatment|Lack of Efficacy|2|||
106146480|NCT00704184|366196534|FG004|Open-Label Treatment|Lack of Efficacy|1|||
106146481|NCT00704184|366196530|FG000|Open-Label Treatment|Physician Decision|0|||
106146482|NCT00704184|366196531|FG001|Open-Label Treatment|Physician Decision|0|||
106146483|NCT00704184|366196532|FG002|Open-Label Treatment|Physician Decision|0|||
106146484|NCT00704184|366196533|FG003|Open-Label Treatment|Physician Decision|0|||
106146485|NCT00704184|366196534|FG004|Open-Label Treatment|Physician Decision|1|||
106146486|NCT00704184|366196530|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
106146487|NCT00704184|366196531|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
106146488|NCT00704184|366196532|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
106146489|NCT00704184|366196533|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
106146490|NCT00704184|366196534|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
106146491|NCT01803555|366196537|FG000|Overall Study|Adverse Event|3|||
106146492|NCT01803555|366196538|FG001|Overall Study|Adverse Event|2|||
106146493|NCT01803555|366196537|FG000|Overall Study|Withdrawal by Subject|3|||
106146494|NCT01803555|366196538|FG001|Overall Study|Withdrawal by Subject|3|||
106146495|NCT01803555|366196537|FG000|Overall Study|Non-compliance|1|||
106146496|NCT01803555|366196538|FG001|Overall Study|Non-compliance|1|||
106146497|NCT01803555|366196537|FG000|Overall Study|Protocol Violation|3|||
106146498|NCT01803555|366196538|FG001|Overall Study|Protocol Violation|5|||
106146499|NCT01803555|366196537|FG000|Overall Study|Lost to Follow-up|0|||
106146500|NCT01803555|366196538|FG001|Overall Study|Lost to Follow-up|2|||
106146501|NCT01803555|366196537|FG000|Overall Study|Other than specified|3|||
106146502|NCT01803555|366196538|FG001|Overall Study|Other than specified|5|||
106146503|NCT00203411|366196544|FG000|Follow-up|Progressive Disease|4|||
106146504|NCT03807778|366196550|FG000|Overall Study|Adverse Event|0|||
106146505|NCT03807778|366196551|FG001|Overall Study|Adverse Event|0|||
106146506|NCT03807778|366196552|FG002|Overall Study|Adverse Event|3|||
106146507|NCT03807778|366196553|FG003|Overall Study|Adverse Event|5|||
106146508|NCT03807778|366196550|FG000|Overall Study|Progressive Disease|4|||
106146509|NCT03807778|366196551|FG001|Overall Study|Progressive Disease|2|||
106146510|NCT03807778|366196552|FG002|Overall Study|Progressive Disease|8|||
106146511|NCT03807778|366196553|FG003|Overall Study|Progressive Disease|15|||
106146512|NCT03807778|366196550|FG000|Overall Study|Symptomatic Deterioration|0|||
106146513|NCT03807778|366196551|FG001|Overall Study|Symptomatic Deterioration|1|||
106146514|NCT03807778|366196552|FG002|Overall Study|Symptomatic Deterioration|0|||
106146515|NCT03807778|366196553|FG003|Overall Study|Symptomatic Deterioration|1|||
106146516|NCT03807778|366196550|FG000|Overall Study|Withdrawal by Subject|0|||
106146517|NCT03807778|366196551|FG001|Overall Study|Withdrawal by Subject|1|||
106146518|NCT03807778|366196552|FG002|Overall Study|Withdrawal by Subject|0|||
106146519|NCT03807778|366196553|FG003|Overall Study|Withdrawal by Subject|1|||
106146520|NCT03807778|366196550|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
106146521|NCT03807778|366196551|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
106146522|NCT03807778|366196552|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
106146523|NCT03807778|366196553|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
106146524|NCT01188655|366197955|FG000|Overall Study|Lack of Efficacy|1|||
106146525|NCT01188655|366197955|FG000|Overall Study|Lost to Follow-up|1|||
106146526|NCT01188655|366197955|FG000|Overall Study|Other|11|||
106146527|NCT03351075|366197956|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
106146528|NCT03351075|366197957|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
106146529|NCT03351075|366197956|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
106146530|NCT03351075|366197957|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
106146531|NCT03351075|366197956|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
106146532|NCT03351075|366197957|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
106146533|NCT03351075|366197956|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
106146534|NCT03351075|366197957|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
106146535|NCT00683696|366197958|FG000|Overall Study|Withdrawn due to study closure|337|||
106146536|NCT00683696|366197959|FG001|Overall Study|Withdrawn due to study closure|338|||
106146537|NCT00683696|366197958|FG000|Overall Study|Withdrawn prior to study closure|13|||
106146538|NCT00683696|366197959|FG001|Overall Study|Withdrawn prior to study closure|28|||
106146539|NCT00683696|366197958|FG000|Overall Study|Lost to Follow-up|5|||
106146540|NCT00683696|366197959|FG001|Overall Study|Lost to Follow-up|6|||
106146541|NCT00683696|366197958|FG000|Overall Study|Vital status follow-up only|3|||
106146542|NCT00683696|366197959|FG001|Overall Study|Vital status follow-up only|3|||
105959873|NCT02674464|365513343|FG001|Overall Study|Lost to Follow-up|92|||
105959874|NCT02674464|365513342|FG000|Overall Study|Outside survey window|6|||
105959875|NCT02674464|365513343|FG001|Overall Study|Outside survey window|3|||
105959876|NCT03928418|365513344|FG000|Overall Study|Lost to Follow-up|5|||
105959877|NCT03928418|365513345|FG001|Overall Study|Lost to Follow-up|3|||
105959878|NCT03928418|365513346|FG002|Overall Study|Lost to Follow-up|5|||
105959879|NCT03928418|365513344|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
105959880|NCT03928418|365513345|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
105959881|NCT03928418|365513346|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
105959882|NCT00470262|365513347|FG000|Overall Study|Withdrawal by Subject|2|||
105959883|NCT00470262|365513348|FG001|Overall Study|Withdrawal by Subject|0|||
106021527|NCT00139477|365743388|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
106021528|NCT00139477|365743389|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
106021529|NCT00139477|365743388|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
106021530|NCT00139477|365743389|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
106021531|NCT00139477|365743388|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
106021532|NCT00139477|365743389|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
106021533|NCT00486291|365743395|FG000|Overall Study|Adverse Event|3|||
106021534|NCT00486291|365743396|FG001|Overall Study|Adverse Event|4|||
106021535|NCT00486291|365743395|FG000|Overall Study|Lost to Follow-up|3|||
106021536|NCT00486291|365743396|FG001|Overall Study|Lost to Follow-up|7|||
106021537|NCT00486291|365743395|FG000|Overall Study|protocol non-compliance|10|||
106021538|NCT00486291|365743396|FG001|Overall Study|protocol non-compliance|15|||
106021539|NCT00486291|365743395|FG000|Overall Study|requirement for restricted medication|0|||
105824721|NCT03114891|365014522|FG001|First Treatment Round|Withdrawal by Subject|2|||
105824722|NCT03114891|365014523|FG002|First Treatment Round|Withdrawal by Subject|0|||
105824723|NCT03114891|365014524|FG003|First Treatment Round|Withdrawal by Subject|1|||
105824724|NCT03114891|365014521|FG000|3 Week Break|Lost to Follow-up|1|||
105824725|NCT03114891|365014522|FG001|3 Week Break|Lost to Follow-up|0|||
105824726|NCT03114891|365014523|FG002|3 Week Break|Lost to Follow-up|0|||
105824727|NCT03114891|365014524|FG003|3 Week Break|Lost to Follow-up|1|||
105824728|NCT03114891|365014521|FG000|3 Week Break|Withdrawal by Subject|0|||
105824729|NCT03114891|365014522|FG001|3 Week Break|Withdrawal by Subject|1|||
105824730|NCT03114891|365014523|FG002|3 Week Break|Withdrawal by Subject|0|||
105824731|NCT03114891|365014524|FG003|3 Week Break|Withdrawal by Subject|0|||
105824732|NCT03114891|365014521|FG000|Second Treatment Round|Lost to Follow-up|1|||
105824733|NCT03114891|365014522|FG001|Second Treatment Round|Lost to Follow-up|0|||
105824734|NCT03114891|365014523|FG002|Second Treatment Round|Lost to Follow-up|0|||
105824735|NCT03114891|365014524|FG003|Second Treatment Round|Lost to Follow-up|0|||
105824736|NCT03114891|365014521|FG000|Second Treatment Round|Physician Decision|1|||
105824737|NCT03114891|365014522|FG001|Second Treatment Round|Physician Decision|0|||
105824738|NCT03114891|365014523|FG002|Second Treatment Round|Physician Decision|0|||
105824739|NCT03114891|365014524|FG003|Second Treatment Round|Physician Decision|0|||
105824740|NCT00849797|365014525|FG000|First Intervention|bad veins|1|||
105824741|NCT00849797|365014526|FG001|First Intervention|bad veins|0|||
106021540|NCT00486291|365743396|FG001|Overall Study|requirement for restricted medication|3|||
106021541|NCT00126490|365743402|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
106021542|NCT00975780|365743403|FG000|Follow Up|Death|88|||
106021543|NCT00975780|365743404|FG001|Follow Up|Death|122|||
106021544|NCT00975780|365743403|FG000|Follow Up|Facility Withdrawal|7|||
106021545|NCT00975780|365743404|FG001|Follow Up|Facility Withdrawal|23|||
106021546|NCT00975780|365743403|FG000|Follow Up|Discharged from Facility|7|||
106021547|NCT00975780|365743404|FG001|Follow Up|Discharged from Facility|12|||
106021548|NCT01262820|365743414|FG000|Overall Study|Adverse Event|5|||
106021549|NCT01262820|365743414|FG000|Overall Study|Lack of Efficacy|9|||
106021550|NCT01262820|365743414|FG000|Overall Study|Drug held for 21+ days|1|||
106021551|NCT05188053|365743417|FG000|Overall Study|Lost to Follow-up|23|||
106021552|NCT05188053|365743418|FG001|Overall Study|Lost to Follow-up|30|||
106021553|NCT05188053|365743417|FG000|Overall Study|Protocol Violation|16|||
106021554|NCT05188053|365743418|FG001|Overall Study|Protocol Violation|16|||
106021555|NCT05188053|365743417|FG000|Overall Study|Physician Decision|3|||
106021556|NCT05188053|365743418|FG001|Overall Study|Physician Decision|0|||
106021557|NCT05188053|365743417|FG000|Overall Study|Withdrawal by Subject|0|||
106021558|NCT05188053|365743418|FG001|Overall Study|Withdrawal by Subject|1|||
106021559|NCT02447302|365743422|FG000|Overall Study|Physician Decision|1|||
105824742|NCT00849797|365014525|FG000|First Intervention|Adverse Event|0|||
105824743|NCT00849797|365014526|FG001|First Intervention|Adverse Event|1|||
105824744|NCT00849797|365014525|FG000|Washout: One Week|Withdrawal by Subject|0|||
105959884|NCT00787839|365513349|FG000|Overall Study|Failure to have the OGTT was most common|404|||
106021560|NCT02447302|365743423|FG001|Overall Study|Physician Decision|0|||
106021561|NCT02447302|365743424|FG002|Overall Study|Physician Decision|0|||
106021562|NCT02447302|365743422|FG000|Overall Study|Adverse Event|4|||
106021563|NCT02447302|365743423|FG001|Overall Study|Adverse Event|3|||
106021564|NCT02447302|365743424|FG002|Overall Study|Adverse Event|0|||
106146543|NCT00683696|366197958|FG000|Overall Study|Death|46|||
105824745|NCT00849797|365014526|FG001|Washout: One Week|Withdrawal by Subject|2|||
106021565|NCT02447302|365743422|FG000|Overall Study|Withdrawal by Subject|0|||
106021566|NCT02447302|365743423|FG001|Overall Study|Withdrawal by Subject|1|||
106021567|NCT02447302|365743424|FG002|Overall Study|Withdrawal by Subject|5|||
106021568|NCT02447302|365743422|FG000|Overall Study|Sponsor Decision|0|||
106021569|NCT02447302|365743423|FG001|Overall Study|Sponsor Decision|0|||
106021570|NCT02447302|365743424|FG002|Overall Study|Sponsor Decision|1|||
106021571|NCT00943072|365744749|FG000|Overall Study|Adverse Event|0|||
105959885|NCT02122146|365513354|FG000|Part 1: Dose Escalation|Death|0|||
105959886|NCT02122146|365513355|FG001|Part 1: Dose Escalation|Death|1|||
105959887|NCT02122146|365513356|FG002|Part 1: Dose Escalation|Death|1|||
105959888|NCT02122146|365513357|FG003|Part 1: Dose Escalation|Death|0|||
105959889|NCT02122146|365513358|FG004|Part 1: Dose Escalation|Death|0|||
105959890|NCT02122146|365513359|FG005|Part 1: Dose Escalation|Death|0|||
105959891|NCT02122146|365513360|FG006|Part 1: Dose Escalation|Death|0|||
105959892|NCT02122146|365513361|FG007|Part 1: Dose Escalation|Death|0|||
105959893|NCT02122146|365513354|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
105959894|NCT02122146|365513355|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
105959895|NCT02122146|365513356|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
105959896|NCT02122146|365513357|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
105959897|NCT02122146|365513358|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
105959898|NCT02122146|365513359|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
105959899|NCT02122146|365513360|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
105959900|NCT02122146|365513361|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
105959901|NCT02122146|365513354|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105959902|NCT02122146|365513355|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105959903|NCT02122146|365513356|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105959904|NCT02122146|365513357|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
105959905|NCT02122146|365513358|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105959906|NCT02122146|365513359|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105959907|NCT02122146|365513360|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105959908|NCT02122146|365513361|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
105959909|NCT02122146|365513354|FG000|Part 1: Dose Escalation|Other|1|||
105959910|NCT02122146|365513355|FG001|Part 1: Dose Escalation|Other|0|||
105959911|NCT02122146|365513356|FG002|Part 1: Dose Escalation|Other|0|||
105959912|NCT02122146|365513357|FG003|Part 1: Dose Escalation|Other|0|||
105959913|NCT02122146|365513358|FG004|Part 1: Dose Escalation|Other|0|||
105959914|NCT02122146|365513359|FG005|Part 1: Dose Escalation|Other|1|||
105959915|NCT02122146|365513360|FG006|Part 1: Dose Escalation|Other|1|||
105959916|NCT02122146|365513361|FG007|Part 1: Dose Escalation|Other|2|||
105959917|NCT02036580|365513362|FG000|Overall Study|Withdrawal by Subject|0|||
106021572|NCT00943072|365744750|FG001|Overall Study|Adverse Event|3|||
106021573|NCT00943072|365744749|FG000|Overall Study|Death|0|||
106021574|NCT00943072|365744750|FG001|Overall Study|Death|2|||
106021575|NCT00943072|365744749|FG000|Overall Study|Withdrawal by Subject|3|||
106021576|NCT00943072|365744750|FG001|Overall Study|Withdrawal by Subject|1|||
106021577|NCT00943072|365744749|FG000|Overall Study|Protocol Violation|0|||
106021578|NCT00943072|365744750|FG001|Overall Study|Protocol Violation|1|||
105824746|NCT01249651|365014527|FG000|Overall Study|Withdrawal by Subject|4|||
105824747|NCT01249651|365014527|FG000|Overall Study|Adverse Event|1|||
105824748|NCT01249651|365014527|FG000|Overall Study|Protocol Violation|1|||
105824749|NCT01249651|365014527|FG000|Overall Study|Sponsor Decision|1|||
105824750|NCT04827394|365014532|FG000|Overall Study|Physician Decision|0|||
105824751|NCT04827394|365014533|FG001|Overall Study|Physician Decision|2|||
105824752|NCT03801707|365014534|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
105824753|NCT03500094|365014535|FG000|Overall Study|Withdrawal by Subject|1|||
105824754|NCT03500094|365014535|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
105824755|NCT03500094|365014535|FG000|Overall Study|Lost to Follow-up|1|||
105824756|NCT01030133|365014538|FG000|Overall Study|failed to experience pain at level 7/10|2|||
105824757|NCT01030133|365014539|FG001|Overall Study|failed to experience pain at level 7/10|2|||
105824758|NCT00829764|365014540|FG000|First Intervention|Adverse Event|1|||
106021579|NCT00943072|365744749|FG000|Overall Study|Lost to Follow-up|1|||
105824759|NCT00829764|365014541|FG001|First Intervention|Adverse Event|0|||
105824760|NCT00829764|365014540|FG000|First Intervention|Withdrawal by Subject|1|||
105959918|NCT02036580|365513363|FG001|Overall Study|Withdrawal by Subject|1|||
105959919|NCT02036580|365513364|FG002|Overall Study|Withdrawal by Subject|0|||
105959920|NCT02036580|365513362|FG000|Overall Study|Adverse Event|1|||
105959921|NCT02036580|365513363|FG001|Overall Study|Adverse Event|0|||
105959922|NCT02036580|365513364|FG002|Overall Study|Adverse Event|0|||
106021580|NCT00943072|365744750|FG001|Overall Study|Lost to Follow-up|2|||
106021581|NCT00943072|365744749|FG000|Overall Study|Lack of Efficacy|0|||
106021582|NCT00943072|365744750|FG001|Overall Study|Lack of Efficacy|4|||
106021583|NCT00943072|365744749|FG000|Overall Study|Other|1|||
106021584|NCT00943072|365744750|FG001|Overall Study|Other|1|||
106021585|NCT00552188|365744752|FG000|Overall Study|Adverse Event|0|||
105824761|NCT00829764|365014541|FG001|First Intervention|Withdrawal by Subject|1|||
105824762|NCT04594252|365014542|FG000|Overall Study|Adverse Event|0|||
105824763|NCT04594252|365014543|FG001|Overall Study|Adverse Event|2|||
105824764|NCT05152576|365014544|FG000|Overall Study|Lost to Follow-up|3|||
105824765|NCT05152576|365014545|FG001|Overall Study|Lost to Follow-up|0|||
105824766|NCT05152576|365014546|FG002|Overall Study|Lost to Follow-up|0|||
105824767|NCT05152576|365014547|FG003|Overall Study|Lost to Follow-up|1|||
105824768|NCT05152576|365014544|FG000|Overall Study|Withdrawal by Subject|0|||
105824769|NCT05152576|365014545|FG001|Overall Study|Withdrawal by Subject|1|||
105824770|NCT05152576|365014546|FG002|Overall Study|Withdrawal by Subject|0|||
105824771|NCT05152576|365014547|FG003|Overall Study|Withdrawal by Subject|1|||
105824772|NCT05152576|365014544|FG000|Overall Study|Other|2|||
105824773|NCT05152576|365014545|FG001|Overall Study|Other|0|||
105824774|NCT05152576|365014546|FG002|Overall Study|Other|0|||
105824775|NCT05152576|365014547|FG003|Overall Study|Other|0|||
105824776|NCT00835705|365016360|FG000|First Intervention|Difficulty with vein|1|||
105824777|NCT00835705|365016361|FG001|First Intervention|Difficulty with vein|0|||
105824778|NCT00835705|365016360|FG000|Second Intervention|Difficulty with vein|1|||
105824779|NCT00835705|365016361|FG001|Second Intervention|Difficulty with vein|0|||
105824780|NCT00594035|365016362|FG000|Overall Study|Lost to Follow-up|1|||
105824781|NCT00594035|365016363|FG001|Overall Study|Lost to Follow-up|1|||
105824782|NCT00594035|365016362|FG000|Overall Study|Withdrawal by Subject|1|||
105824783|NCT00594035|365016363|FG001|Overall Study|Withdrawal by Subject|0|||
105824784|NCT00594035|365016362|FG000|Overall Study|Subject transferred to nursing home|0|||
105824785|NCT00594035|365016363|FG001|Overall Study|Subject transferred to nursing home|1|||
105824786|NCT00594035|365016362|FG000|Overall Study|Subject couldn't return due to job|0|||
105824787|NCT00594035|365016363|FG001|Overall Study|Subject couldn't return due to job|1|||
105824788|NCT00795821|365016364|FG000|Acute Treatment Phase|Adverse Event|23|||
105824789|NCT00795821|365016365|FG001|Acute Treatment Phase|Adverse Event|4|||
105824790|NCT00795821|365016364|FG000|Acute Treatment Phase|Death|1|||
105824791|NCT00795821|365016365|FG001|Acute Treatment Phase|Death|0|||
105824792|NCT00795821|365016364|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
105824793|NCT00795821|365016365|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
105824794|NCT00795821|365016364|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
105959923|NCT02998671|365513365|FG000|Period 1|Study Terminated By Sponsor|2|||
105824795|NCT00795821|365016365|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
105824796|NCT00795821|365016364|FG000|Acute Treatment Phase|Physician Decision|1|||
105824797|NCT00795821|365016365|FG001|Acute Treatment Phase|Physician Decision|1|||
106021586|NCT00552188|365744753|FG001|Overall Study|Adverse Event|2|||
106021587|NCT00552188|365744752|FG000|Overall Study|Lost to Follow-up|2|||
106021588|NCT00552188|365744753|FG001|Overall Study|Lost to Follow-up|1|||
106021589|NCT00552188|365744752|FG000|Overall Study|Withdrawal of consent|0|||
106021590|NCT00552188|365744753|FG001|Overall Study|Withdrawal of consent|1|||
106021591|NCT00552188|365744752|FG000|Overall Study|Subject returned to home country|0|||
106021592|NCT00552188|365744753|FG001|Overall Study|Subject returned to home country|1|||
105824798|NCT00795821|365016364|FG000|Acute Treatment Phase|Protocol Violation|1|||
105824799|NCT00795821|365016365|FG001|Acute Treatment Phase|Protocol Violation|2|||
105824800|NCT00795821|365016364|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
105824801|NCT00795821|365016365|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
105824802|NCT00795821|365016364|FG000|Long-term Extension Phase|Adverse Event|25|||
105824803|NCT00795821|365016365|FG001|Long-term Extension Phase|Adverse Event|32|||
105824804|NCT00795821|365016364|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
105824805|NCT00795821|365016365|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
105824806|NCT00795821|365016364|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
105824807|NCT00795821|365016365|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
105824808|NCT00795821|365016364|FG000|Long-term Extension Phase|Physician Decision|1|||
105824809|NCT00795821|365016365|FG001|Long-term Extension Phase|Physician Decision|2|||
105824810|NCT00795821|365016364|FG000|Long-term Extension Phase|Protocol Violation|3|||
105824811|NCT00795821|365016365|FG001|Long-term Extension Phase|Protocol Violation|5|||
105824812|NCT00795821|365016364|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
105824813|NCT00795821|365016365|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
105824814|NCT00795821|365016364|FG000|Taper Phase|Adverse Event|2|||
105824815|NCT00795821|365016365|FG001|Taper Phase|Adverse Event|0|||
105824816|NCT00795821|365016364|FG000|Taper Phase|Lost to Follow-up|1|||
105824817|NCT00795821|365016365|FG001|Taper Phase|Lost to Follow-up|0|||
105824818|NCT00795821|365016364|FG000|Taper Phase|Physician Decision|2|||
105824819|NCT00795821|365016365|FG001|Taper Phase|Physician Decision|0|||
105824820|NCT00795821|365016364|FG000|Taper Phase|Withdrawal by Subject|4|||
105824821|NCT00795821|365016365|FG001|Taper Phase|Withdrawal by Subject|0|||
105824822|NCT00712959|365016368|FG000|Overall Study|Protocol Violation|3|||
105824823|NCT00712959|365016369|FG001|Overall Study|Protocol Violation|1|||
105824824|NCT00712959|365016368|FG000|Overall Study|Lost to Follow-up|13|||
105824825|NCT00712959|365016369|FG001|Overall Study|Lost to Follow-up|2|||
105824826|NCT00712959|365016368|FG000|Overall Study|Withdrawal by Subject|3|||
105824827|NCT00712959|365016369|FG001|Overall Study|Withdrawal by Subject|0|||
105824828|NCT00508651|365016370|FG000|Overall Study|Lost to Follow-up|3|||
105824829|NCT00508651|365016371|FG001|Overall Study|Lost to Follow-up|1|||
105824830|NCT00508651|365016370|FG000|Overall Study|Withdrawal by Subject|1|||
105824831|NCT00508651|365016371|FG001|Overall Study|Withdrawal by Subject|1|||
105824832|NCT01531894|365016375|FG000|Overall Study|Physician Decision|8|||
105824833|NCT01531894|365016375|FG000|Overall Study|Death|1|||
105824834|NCT02125461|365016376|FG000|Overall Study|Withdrawal by Subject|30|||
105824835|NCT02125461|365016377|FG001|Overall Study|Withdrawal by Subject|16|||
105824836|NCT02125461|365016376|FG000|Overall Study|Lost to Follow-up|8|||
105824837|NCT02125461|365016377|FG001|Overall Study|Lost to Follow-up|3|||
105824838|NCT02125461|365016376|FG000|Overall Study|Death|260|||
105824839|NCT02125461|365016377|FG001|Overall Study|Death|149|||
105824840|NCT02125461|365016376|FG000|Overall Study|Missing Termination Reason|0|||
105824841|NCT02125461|365016377|FG001|Overall Study|Missing Termination Reason|1|||
105824842|NCT02888756|365016379|FG000|Analytical Treatment Interruption|Physician Decision|10|||
105824843|NCT02888756|365016380|FG001|Analytical Treatment Interruption|Physician Decision|6|||
105824844|NCT02888756|365016381|FG002|Analytical Treatment Interruption|Physician Decision|5|||
105824845|NCT01547286|365016387|FG000|Overall Study|Did not meet all eligibility criteria|1|||
105824846|NCT01547286|365016387|FG000|Overall Study|Physician Decision|1|||
105824847|NCT03502811|365016391|FG000|Overall Study|Death|157|||
105824848|NCT03502811|365016391|FG000|Overall Study|Withdrawal by Subject|105|||
105824849|NCT03502811|365016391|FG000|Overall Study|Lost to Follow-up|26|||
105824850|NCT03502811|365016391|FG000|Overall Study|No Visits (Missed)|31|||
105824851|NCT03913377|365016392|FG000|Period 1|Test Article no longer available|0|||
105824852|NCT03913377|365016393|FG001|Period 1|Test Article no longer available|1|||
105824853|NCT03913377|365016394|FG002|Period 1|Test Article no longer available|0|||
105824854|NCT03913377|365016392|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
105824855|NCT03913377|365016393|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
105824856|NCT03913377|365016394|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
105824857|NCT05239195|365016395|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
105824858|NCT05239195|365016396|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
106021593|NCT01788358|365744754|FG000|Overall Study|Other|11|||
105824859|NCT03552484|365016397|FG000|Overall Study|Death|6|||
105824860|NCT03552484|365016398|FG001|Overall Study|Death|4|||
105824861|NCT03552484|365016397|FG000|Overall Study|Lost to Follow-up|0|||
105824862|NCT03552484|365016398|FG001|Overall Study|Lost to Follow-up|16|||
105824863|NCT01204294|365016401|FG000|Overall Study|Adverse Event|2|||
105824864|NCT01204294|365016402|FG001|Overall Study|Adverse Event|6|||
106021594|NCT01788358|365744754|FG000|Overall Study|Logistical difficulties|1|||
106021595|NCT01788358|365744754|FG000|Overall Study|Lost to Follow-up|5|||
106021596|NCT01788358|365744754|FG000|Overall Study|Protocol Violation|3|||
106021597|NCT01788358|365744754|FG000|Overall Study|Withdrawal by Subject|26|||
106021598|NCT01788358|365744754|FG000|Overall Study|Lack of Efficacy|1|||
106021599|NCT01788358|365744754|FG000|Overall Study|Adverse Event|51|||
106021600|NCT02948634|365744755|FG000|Overall Study|Lack of efficacy and study suspended|10|||
106021601|NCT02948634|365744756|FG001|Overall Study|Lack of efficacy and study suspended|2|||
105824865|NCT01204294|365016403|FG002|Overall Study|Adverse Event|0|||
106021602|NCT00555061|365744758|FG000|Overall Study|Adverse Event|3|||
106021603|NCT00555061|365744758|FG000|Overall Study|Protocol Violation|1|||
106021604|NCT00555061|365744758|FG000|Overall Study|Lost to Follow-up|2|||
106021605|NCT00555061|365744758|FG000|Overall Study|Withdrawal by Subject|2|||
106021606|NCT00555061|365744758|FG000|Overall Study|Participant enrolled, but never treated|1|||
105824866|NCT01204294|365016404|FG003|Overall Study|Adverse Event|7|||
105824867|NCT01204294|365016405|FG004|Overall Study|Adverse Event|1|||
105824868|NCT01204294|365016406|FG005|Overall Study|Adverse Event|4|||
105824869|NCT01204294|365016407|FG006|Overall Study|Adverse Event|0|||
105824870|NCT01204294|365016401|FG000|Overall Study|Protocol Violation|1|||
105824871|NCT01204294|365016402|FG001|Overall Study|Protocol Violation|0|||
105824872|NCT01204294|365016403|FG002|Overall Study|Protocol Violation|2|||
105824873|NCT01204294|365016404|FG003|Overall Study|Protocol Violation|1|||
105824874|NCT01204294|365016405|FG004|Overall Study|Protocol Violation|0|||
105824875|NCT01204294|365016406|FG005|Overall Study|Protocol Violation|0|||
105824876|NCT01204294|365016407|FG006|Overall Study|Protocol Violation|0|||
105824877|NCT01204294|365016401|FG000|Overall Study|Withdrawal by Subject|0|||
105824878|NCT01204294|365016402|FG001|Overall Study|Withdrawal by Subject|2|||
105824879|NCT01204294|365016403|FG002|Overall Study|Withdrawal by Subject|2|||
105824880|NCT01204294|365016404|FG003|Overall Study|Withdrawal by Subject|1|||
106021607|NCT00970684|365744760|FG000|Overall Study|Lack of Efficacy|5|||
106021608|NCT00970684|365744760|FG000|Overall Study|Adverse Event|4|||
106021609|NCT00970684|365744760|FG000|Overall Study|Withdrawal by Subject|1|||
106021610|NCT00436345|365744761|FG000|Overall Study|ICU resident beyond follow-up period|3|||
106021611|NCT00436345|365744762|FG001|Overall Study|ICU resident beyond follow-up period|0|||
106021612|NCT00481091|365744763|FG000|Overall Study|Withdrawal by Subject|0|||
106021613|NCT00481091|365744764|FG001|Overall Study|Withdrawal by Subject|1|||
106021614|NCT00481091|365744765|FG002|Overall Study|Withdrawal by Subject|1|||
106021615|NCT00481091|365744766|FG003|Overall Study|Withdrawal by Subject|0|||
106021616|NCT00481091|365744767|FG004|Overall Study|Withdrawal by Subject|0|||
106021617|NCT00481091|365744768|FG005|Overall Study|Withdrawal by Subject|0|||
106021618|NCT00481091|365744769|FG006|Overall Study|Withdrawal by Subject|0|||
106021619|NCT00481091|365744770|FG007|Overall Study|Withdrawal by Subject|0|||
106021620|NCT00481091|365744771|FG008|Overall Study|Withdrawal by Subject|1|||
106021621|NCT00481091|365744772|FG009|Overall Study|Withdrawal by Subject|6|||
106021622|NCT00481091|365744763|FG000|Overall Study|Other, Not Specified|0|||
106021623|NCT00481091|365744764|FG001|Overall Study|Other, Not Specified|1|||
106021624|NCT00481091|365744765|FG002|Overall Study|Other, Not Specified|1|||
106021625|NCT00481091|365744766|FG003|Overall Study|Other, Not Specified|0|||
106021626|NCT00481091|365744767|FG004|Overall Study|Other, Not Specified|0|||
106021627|NCT00481091|365744768|FG005|Overall Study|Other, Not Specified|1|||
106021628|NCT00481091|365744769|FG006|Overall Study|Other, Not Specified|0|||
106021629|NCT00481091|365744770|FG007|Overall Study|Other, Not Specified|0|||
105824881|NCT01204294|365016405|FG004|Overall Study|Withdrawal by Subject|1|||
105824882|NCT01204294|365016406|FG005|Overall Study|Withdrawal by Subject|1|||
105824883|NCT01204294|365016407|FG006|Overall Study|Withdrawal by Subject|2|||
105824884|NCT01204294|365016401|FG000|Overall Study|Lack of Efficacy|0|||
105824885|NCT01204294|365016402|FG001|Overall Study|Lack of Efficacy|0|||
105824886|NCT01204294|365016403|FG002|Overall Study|Lack of Efficacy|0|||
105824887|NCT01204294|365016404|FG003|Overall Study|Lack of Efficacy|2|||
105824888|NCT01204294|365016405|FG004|Overall Study|Lack of Efficacy|0|||
105824889|NCT01204294|365016406|FG005|Overall Study|Lack of Efficacy|0|||
106021630|NCT00481091|365744771|FG008|Overall Study|Other, Not Specified|0|||
105824890|NCT01204294|365016407|FG006|Overall Study|Lack of Efficacy|0|||
105824891|NCT01204294|365016401|FG000|Overall Study|Other (house moving)|0|||
105824892|NCT01204294|365016402|FG001|Overall Study|Other (house moving)|0|||
105824893|NCT01204294|365016403|FG002|Overall Study|Other (house moving)|1|||
105824894|NCT01204294|365016404|FG003|Overall Study|Other (house moving)|0|||
105824895|NCT01204294|365016405|FG004|Overall Study|Other (house moving)|0|||
105824896|NCT01204294|365016406|FG005|Overall Study|Other (house moving)|0|||
105824897|NCT01204294|365016407|FG006|Overall Study|Other (house moving)|0|||
105824898|NCT03128723|365016408|FG000|Overall Study|Withdrawal by Subject|2|||
106021631|NCT00481091|365744772|FG009|Overall Study|Other, Not Specified|4|||
106021632|NCT00481091|365744763|FG000|Overall Study|Adverse Event|1|||
105824899|NCT00075478|365016409|FG000|Overall Study|not eligible|1|||
106021633|NCT00481091|365744764|FG001|Overall Study|Adverse Event|2|||
106021634|NCT00481091|365744765|FG002|Overall Study|Adverse Event|0|||
106021635|NCT00481091|365744766|FG003|Overall Study|Adverse Event|1|||
105824900|NCT00075478|365016410|FG001|Overall Study|not eligible|0|||
105824901|NCT00075478|365016409|FG000|Overall Study|Physician Decision|0|||
105824902|NCT00075478|365016410|FG001|Overall Study|Physician Decision|1|||
105824903|NCT02075463|365016411|FG000|Overall Study|Adverse Event|3|||
105824904|NCT02075463|365016411|FG000|Overall Study|Par. reached stopping criteria|4|||
105824905|NCT02075463|365016411|FG000|Overall Study|Withdrawal by Subject|1|||
105824906|NCT01642277|365016413|FG000|Overall Study|Adverse Event|10|||
105824907|NCT01642277|365016414|FG001|Overall Study|Adverse Event|0|||
105824908|NCT01642277|365016413|FG000|Overall Study|Physician Decision|2|||
105824909|NCT01642277|365016414|FG001|Overall Study|Physician Decision|0|||
105824910|NCT01642277|365016413|FG000|Overall Study|Protocol Violation|1|||
105824911|NCT01642277|365016414|FG001|Overall Study|Protocol Violation|0|||
105824912|NCT01642277|365016413|FG000|Overall Study|Withdrawal by Subject|11|||
105824913|NCT01642277|365016414|FG001|Overall Study|Withdrawal by Subject|0|||
105824914|NCT01444378|365016418|FG000|Overall Study|Lost to Follow-up|1|||
105824915|NCT01444378|365016418|FG000|Overall Study|Withdrawal by Subject|1|||
105824916|NCT01444378|365016418|FG000|Overall Study|Death|3|||
105824917|NCT01444378|365016418|FG000|Overall Study|Administrative Closure Of The Study|2|||
105824918|NCT01444378|365016418|FG000|Overall Study|Missed Visits|10|||
105824919|NCT04022954|365016419|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
105824920|NCT04022954|365016419|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
105824921|NCT04022954|365016419|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
105824922|NCT02558491|365016424|FG000|First Invention|Withdrawal by Subject|3|||
105824923|NCT02558491|365016425|FG001|First Invention|Withdrawal by Subject|1|||
105824924|NCT02558491|365016424|FG000|First Invention|Data collection issues|1|||
105824925|NCT02558491|365016425|FG001|First Invention|Data collection issues|0|||
105824926|NCT02558491|365016424|FG000|First Invention|Stopping criteria|0|||
105824927|NCT02558491|365016425|FG001|First Invention|Stopping criteria|1|||
105824928|NCT02558491|365016424|FG000|First Invention|Changed parameters during trial|1|||
105824929|NCT02558491|365016425|FG001|First Invention|Changed parameters during trial|0|||
105824930|NCT02558491|365016424|FG000|Second Intervention|Withdrawal by Subject|1|||
105824931|NCT02558491|365016425|FG001|Second Intervention|Withdrawal by Subject|0|||
105824932|NCT02558491|365016424|FG000|Second Intervention|Stopping Criteria|1|||
105824933|NCT02558491|365016425|FG001|Second Intervention|Stopping Criteria|0|||
105824934|NCT00834431|365016426|FG000|First Intervention|Adverse Event|0|||
105824935|NCT00834431|365016427|FG001|First Intervention|Adverse Event|1|||
105824936|NCT00834431|365016426|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
105824937|NCT00834431|365016427|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105824938|NCT03249454|365016430|FG000|Overall Study|Withdrawal by Subject|0|||
105824939|NCT03249454|365016431|FG001|Overall Study|Withdrawal by Subject|0|||
105824940|NCT03249454|365016432|FG002|Overall Study|Withdrawal by Subject|0|||
105824941|NCT03249454|365016433|FG003|Overall Study|Withdrawal by Subject|0|||
105824942|NCT03249454|365016434|FG004|Overall Study|Withdrawal by Subject|0|||
105824943|NCT03249454|365016435|FG005|Overall Study|Withdrawal by Subject|0|||
105824944|NCT03249454|365016436|FG006|Overall Study|Withdrawal by Subject|0|||
105824945|NCT03249454|365016437|FG007|Overall Study|Withdrawal by Subject|0|||
105824946|NCT03249454|365016438|FG008|Overall Study|Withdrawal by Subject|0|||
105824947|NCT03249454|365016439|FG009|Overall Study|Withdrawal by Subject|1|||
105824948|NCT03249454|365016440|FG010|Overall Study|Withdrawal by Subject|1|||
105824949|NCT00796328|365016441|FG000|Overall Study|experienced hypotension requiring tx|6|||
105824950|NCT02842853|365016444|FG000|Overall Study|Non-compliance with the protocol|3|||
105824951|NCT02842853|365016445|FG001|Overall Study|Non-compliance with the protocol|7|||
105824952|NCT02842853|365016446|FG002|Overall Study|Non-compliance with the protocol|2|||
105824953|NCT02842853|365016447|FG003|Overall Study|Non-compliance with the protocol|5|||
105824954|NCT02842853|365016444|FG000|Overall Study|Subject met exclusion criteria|0|||
105824955|NCT02842853|365016445|FG001|Overall Study|Subject met exclusion criteria|1|||
105959924|NCT02998671|365513366|FG001|Period 1|Study Terminated By Sponsor|1|||
105959925|NCT02998671|365513367|FG002|Period 1|Study Terminated By Sponsor|0|||
105959926|NCT02998671|365513368|FG003|Period 1|Study Terminated By Sponsor|0|||
105959927|NCT02998671|365513369|FG004|Period 1|Study Terminated By Sponsor|1|||
105959928|NCT02998671|365513365|FG000|Period 1|Withdrawal by Subject|1|||
105959929|NCT02998671|365513366|FG001|Period 1|Withdrawal by Subject|2|||
105824956|NCT02842853|365016446|FG002|Overall Study|Subject met exclusion criteria|0|||
105824957|NCT02842853|365016447|FG003|Overall Study|Subject met exclusion criteria|0|||
105824958|NCT02842853|365016444|FG000|Overall Study|Withdrawal by Subject|11|||
105824959|NCT02842853|365016445|FG001|Overall Study|Withdrawal by Subject|13|||
105824960|NCT02842853|365016446|FG002|Overall Study|Withdrawal by Subject|9|||
105824961|NCT02842853|365016447|FG003|Overall Study|Withdrawal by Subject|8|||
105824962|NCT02842853|365016444|FG000|Overall Study|Lost to Follow-up|9|||
105824963|NCT02842853|365016445|FG001|Overall Study|Lost to Follow-up|13|||
105824964|NCT02842853|365016446|FG002|Overall Study|Lost to Follow-up|10|||
105824965|NCT02842853|365016447|FG003|Overall Study|Lost to Follow-up|11|||
105824966|NCT03261167|365016448|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
105824967|NCT03261167|365016449|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
105824968|NCT03261167|365016448|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
105824969|NCT03261167|365016449|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
105959930|NCT02998671|365513367|FG002|Period 1|Withdrawal by Subject|0|||
105959931|NCT02998671|365513368|FG003|Period 1|Withdrawal by Subject|0|||
105959932|NCT02998671|365513369|FG004|Period 1|Withdrawal by Subject|2|||
105959933|NCT02998671|365513365|FG000|Period 1|Pregnancy|1|||
105959934|NCT02998671|365513366|FG001|Period 1|Pregnancy|0|||
105959935|NCT02998671|365513367|FG002|Period 1|Pregnancy|0|||
105959936|NCT02998671|365513368|FG003|Period 1|Pregnancy|0|||
105959937|NCT02998671|365513369|FG004|Period 1|Pregnancy|0|||
105959938|NCT02998671|365513365|FG000|Period 1|Adverse Event|0|||
105959939|NCT02998671|365513366|FG001|Period 1|Adverse Event|0|||
105959940|NCT02998671|365513367|FG002|Period 1|Adverse Event|0|||
105959941|NCT02998671|365513368|FG003|Period 1|Adverse Event|0|||
105959942|NCT02998671|365513369|FG004|Period 1|Adverse Event|1|||
105959943|NCT02998671|365513365|FG000|Period 2|Adverse Event|0|||
105959944|NCT02998671|365513366|FG001|Period 2|Adverse Event|1|||
105959945|NCT02998671|365513367|FG002|Period 2|Adverse Event|0|||
105959946|NCT02998671|365513368|FG003|Period 2|Adverse Event|0|||
105959947|NCT02998671|365513369|FG004|Period 2|Adverse Event|0|||
105959948|NCT02998671|365513365|FG000|Period 2|Study Terminated By Sponsor|3|||
105959949|NCT02998671|365513366|FG001|Period 2|Study Terminated By Sponsor|5|||
105959950|NCT02998671|365513367|FG002|Period 2|Study Terminated By Sponsor|1|||
105959951|NCT02998671|365513368|FG003|Period 2|Study Terminated By Sponsor|3|||
105959952|NCT02998671|365513369|FG004|Period 2|Study Terminated By Sponsor|0|||
105959953|NCT02998671|365513365|FG000|Period 2|Withdrawal by Subject|0|||
105959954|NCT02998671|365513366|FG001|Period 2|Withdrawal by Subject|1|||
105959955|NCT02998671|365513367|FG002|Period 2|Withdrawal by Subject|0|||
105959956|NCT02998671|365513368|FG003|Period 2|Withdrawal by Subject|0|||
105959957|NCT02998671|365513369|FG004|Period 2|Withdrawal by Subject|0|||
105959958|NCT02998671|365513365|FG000|Period 2|Lost to Follow-up|0|||
105959959|NCT02998671|365513366|FG001|Period 2|Lost to Follow-up|0|||
105959960|NCT02998671|365513367|FG002|Period 2|Lost to Follow-up|0|||
105959961|NCT02998671|365513368|FG003|Period 2|Lost to Follow-up|1|||
105959962|NCT02998671|365513369|FG004|Period 2|Lost to Follow-up|0|||
105959963|NCT02676895|365513370|FG000|Overall Study|Administrative reason|1|||
105959964|NCT02676895|365513371|FG001|Overall Study|Administrative reason|0|||
105959965|NCT02676895|365513372|FG002|Overall Study|Administrative reason|0|||
105959966|NCT02676895|365513370|FG000|Overall Study|Protocol Violation|1|||
105959967|NCT02676895|365513371|FG001|Overall Study|Protocol Violation|0|||
105959968|NCT02676895|365513372|FG002|Overall Study|Protocol Violation|0|||
105959969|NCT02676895|365513370|FG000|Overall Study|Adverse Event|0|||
105959970|NCT02676895|365513371|FG001|Overall Study|Adverse Event|3|||
105959971|NCT02676895|365513372|FG002|Overall Study|Adverse Event|1|||
106021636|NCT00481091|365744767|FG004|Overall Study|Adverse Event|1|||
106021637|NCT00481091|365744768|FG005|Overall Study|Adverse Event|1|||
106021638|NCT00481091|365744769|FG006|Overall Study|Adverse Event|2|||
106021639|NCT00481091|365744770|FG007|Overall Study|Adverse Event|1|||
106021640|NCT00481091|365744771|FG008|Overall Study|Adverse Event|1|||
106021641|NCT00481091|365744772|FG009|Overall Study|Adverse Event|6|||
106021642|NCT00481091|365744763|FG000|Overall Study|Progressive disease clinical|0|||
106021643|NCT00481091|365744764|FG001|Overall Study|Progressive disease clinical|0|||
106021644|NCT00481091|365744765|FG002|Overall Study|Progressive disease clinical|0|||
106021645|NCT00481091|365744766|FG003|Overall Study|Progressive disease clinical|0|||
106021646|NCT00481091|365744767|FG004|Overall Study|Progressive disease clinical|0|||
106021647|NCT00481091|365744768|FG005|Overall Study|Progressive disease clinical|0|||
106021648|NCT00481091|365744769|FG006|Overall Study|Progressive disease clinical|0|||
106021649|NCT00481091|365744770|FG007|Overall Study|Progressive disease clinical|0|||
106021650|NCT00481091|365744771|FG008|Overall Study|Progressive disease clinical|1|||
106021651|NCT00481091|365744772|FG009|Overall Study|Progressive disease clinical|7|||
106021652|NCT00481091|365744763|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
106021653|NCT00481091|365744764|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
106021654|NCT00481091|365744765|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105959972|NCT02676895|365513370|FG000|Overall Study|Lost to Follow-up|0|||
105959973|NCT02676895|365513371|FG001|Overall Study|Lost to Follow-up|0|||
105959974|NCT02676895|365513372|FG002|Overall Study|Lost to Follow-up|1|||
106021655|NCT00481091|365744766|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
106021656|NCT00481091|365744767|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105959975|NCT02676895|365513370|FG000|Overall Study|Withdrawal by Subject|0|||
106021657|NCT00481091|365744768|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
105959976|NCT02676895|365513371|FG001|Overall Study|Withdrawal by Subject|0|||
106021658|NCT00481091|365744769|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
105959977|NCT02676895|365513372|FG002|Overall Study|Withdrawal by Subject|1|||
105959978|NCT04222699|365513379|FG000|Overall Study|Lost to Follow-up|2|||
105959979|NCT01221753|365513384|FG000|Overall Study|Adverse Event|1|||
105959980|NCT00431444|365513385|FG000|Overall Study|Protocol Violation|1|||
105959981|NCT00431444|365513386|FG001|Overall Study|Protocol Violation|4|||
105959982|NCT00431444|365513385|FG000|Overall Study|Adverse Event|2|||
105959983|NCT00431444|365513386|FG001|Overall Study|Adverse Event|1|||
105824970|NCT03261167|365016448|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
105824971|NCT03261167|365016449|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
105824972|NCT03261167|365016448|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
105824973|NCT03261167|365016449|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
105824974|NCT03261167|365016448|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
105824975|NCT03261167|365016449|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
105824976|NCT03889639|365016450|FG000|Overall Study|Withdrawal by Subject|0|||
105824977|NCT03889639|365016451|FG001|Overall Study|Withdrawal by Subject|0|||
105824978|NCT03889639|365016452|FG002|Overall Study|Withdrawal by Subject|0|||
105824979|NCT03889639|365016453|FG003|Overall Study|Withdrawal by Subject|0|||
105824980|NCT03889639|365016454|FG004|Overall Study|Withdrawal by Subject|0|||
105824981|NCT03889639|365016455|FG005|Overall Study|Withdrawal by Subject|0|||
105824982|NCT03889639|365016456|FG006|Overall Study|Withdrawal by Subject|0|||
105824983|NCT03889639|365016457|FG007|Overall Study|Withdrawal by Subject|1|||
105824984|NCT03256695|365016460|FG000|Overall Study|Adverse Event|8|||
105824985|NCT03256695|365016460|FG000|Overall Study|Death|2|||
105824986|NCT03256695|365016460|FG000|Overall Study|Withdrawal by Subject|14|||
105824987|NCT03256695|365016460|FG000|Overall Study|Non-compliance with study drug|1|||
105824988|NCT03256695|365016460|FG000|Overall Study|Lost to Follow-up|3|||
105824989|NCT03256695|365016460|FG000|Overall Study|Lack of Efficacy|3|||
105824990|NCT03256695|365016460|FG000|Overall Study|Protocol Violation|5|||
105824991|NCT03256695|365016460|FG000|Overall Study|Other than specified|3|||
105824992|NCT03930732|365016461|FG000|Overall Study|Adverse Event|9|||
105824993|NCT03930732|365016462|FG001|Overall Study|Adverse Event|7|||
105824994|NCT03930732|365016461|FG000|Overall Study|Poor compliance to protocol|0|||
105824995|NCT03930732|365016462|FG001|Overall Study|Poor compliance to protocol|1|||
105824996|NCT03930732|365016461|FG000|Overall Study|Withdrawal by Subject|23|||
105824997|NCT03930732|365016462|FG001|Overall Study|Withdrawal by Subject|11|||
105824998|NCT03930732|365016461|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
105824999|NCT03930732|365016462|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
105825000|NCT03930732|365016461|FG000|Overall Study|Other reason not related to COVID-19|5|||
105825001|NCT03930732|365016462|FG001|Overall Study|Other reason not related to COVID-19|8|||
105825002|NCT00606281|365016467|FG000|Overall Study|Adverse Event|11|||
105825003|NCT00606281|365016468|FG001|Overall Study|Adverse Event|12|||
105825004|NCT00606281|365016467|FG000|Overall Study|Death|1|||
105825005|NCT00606281|365016468|FG001|Overall Study|Death|0|||
105825006|NCT00606281|365016467|FG000|Overall Study|Lack of Efficacy|28|||
105825007|NCT00606281|365016468|FG001|Overall Study|Lack of Efficacy|35|||
105825008|NCT00606281|365016467|FG000|Overall Study|Physician Decision|0|||
105825009|NCT00606281|365016468|FG001|Overall Study|Physician Decision|1|||
105825010|NCT00606281|365016467|FG000|Overall Study|Protocol Violation|3|||
105825011|NCT00606281|365016468|FG001|Overall Study|Protocol Violation|3|||
105825012|NCT00606281|365016467|FG000|Overall Study|Withdrawal by Subject|11|||
105825013|NCT00606281|365016468|FG001|Overall Study|Withdrawal by Subject|13|||
105825014|NCT00606281|365016467|FG000|Overall Study|Progression to depressive phase|1|||
105825015|NCT00606281|365016468|FG001|Overall Study|Progression to depressive phase|1|||
105825016|NCT00606281|365016467|FG000|Overall Study|Change of residence or other commitments|1|||
105825017|NCT00606281|365016468|FG001|Overall Study|Change of residence or other commitments|1|||
105825018|NCT03236311|365016469|FG000|Overall Study|Study terminated by sponsor|0|||
105825019|NCT03236311|365016470|FG001|Overall Study|Study terminated by sponsor|2|||
105825020|NCT03236311|365016469|FG000|Overall Study|Adverse Event|0|||
105825021|NCT03236311|365016470|FG001|Overall Study|Adverse Event|1|||
105825022|NCT00796653|365016471|FG000|Overall Study|Adverse Event|19|||
105825023|NCT00796653|365016472|FG001|Overall Study|Adverse Event|16|||
105825024|NCT00796653|365016473|FG002|Overall Study|Adverse Event|16|||
105825025|NCT00796653|365016474|FG003|Overall Study|Adverse Event|16|||
105825026|NCT00796653|365016471|FG000|Overall Study|Lost to Follow-up|2|||
105825027|NCT00796653|365016472|FG001|Overall Study|Lost to Follow-up|1|||
105825028|NCT00796653|365016473|FG002|Overall Study|Lost to Follow-up|2|||
105825029|NCT00796653|365016474|FG003|Overall Study|Lost to Follow-up|3|||
105825030|NCT00796653|365016471|FG000|Overall Study|Withdrawal by Subject|16|||
105825031|NCT00796653|365016472|FG001|Overall Study|Withdrawal by Subject|8|||
105825032|NCT00796653|365016473|FG002|Overall Study|Withdrawal by Subject|8|||
105825033|NCT00796653|365016474|FG003|Overall Study|Withdrawal by Subject|13|||
105825034|NCT00796653|365016471|FG000|Overall Study|Lack of Efficacy|8|||
105825035|NCT00796653|365016472|FG001|Overall Study|Lack of Efficacy|1|||
105825036|NCT00796653|365016473|FG002|Overall Study|Lack of Efficacy|3|||
105825037|NCT00796653|365016474|FG003|Overall Study|Lack of Efficacy|2|||
105825038|NCT00796653|365016471|FG000|Overall Study|Non compliance with protocol|2|||
105825039|NCT00796653|365016472|FG001|Overall Study|Non compliance with protocol|2|||
105825040|NCT00796653|365016473|FG002|Overall Study|Non compliance with protocol|0|||
105825041|NCT00796653|365016474|FG003|Overall Study|Non compliance with protocol|2|||
105825042|NCT00796653|365016471|FG000|Overall Study|Other reason not described above|4|||
105825043|NCT00796653|365016472|FG001|Overall Study|Other reason not described above|9|||
105825044|NCT00796653|365016473|FG002|Overall Study|Other reason not described above|7|||
105825045|NCT00796653|365016474|FG003|Overall Study|Other reason not described above|4|||
105825046|NCT02409355|365016479|FG000|Overall Study|Withdrawal by Subject|1|||
105825047|NCT02409355|365016480|FG001|Overall Study|Withdrawal by Subject|0|||
105825048|NCT02409355|365016479|FG000|Overall Study|Death|1|||
105825049|NCT02409355|365016480|FG001|Overall Study|Death|1|||
105825050|NCT02409355|365016479|FG000|Overall Study|Study terminated by Sponsor|2|||
105959984|NCT00431444|365513385|FG000|Overall Study|Withdrawal by Subject|1|||
105825051|NCT02409355|365016480|FG001|Overall Study|Study terminated by Sponsor|3|||
105825052|NCT04633564|365016481|FG000|Period 1|Adverse Event|28|||
105825053|NCT04633564|365016482|FG001|Period 1|Adverse Event|19|||
106021659|NCT00481091|365744770|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
106021660|NCT00481091|365744771|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
106021661|NCT00481091|365744772|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
106021662|NCT00481091|365744763|FG000|Overall Study|Progressive disease other|1|||
106021663|NCT00481091|365744764|FG001|Overall Study|Progressive disease other|1|||
106021664|NCT00481091|365744765|FG002|Overall Study|Progressive disease other|0|||
106021665|NCT00481091|365744766|FG003|Overall Study|Progressive disease other|1|||
106021666|NCT00481091|365744767|FG004|Overall Study|Progressive disease other|1|||
106021667|NCT00481091|365744768|FG005|Overall Study|Progressive disease other|1|||
106021668|NCT00481091|365744769|FG006|Overall Study|Progressive disease other|0|||
106021669|NCT00481091|365744770|FG007|Overall Study|Progressive disease other|2|||
106021670|NCT00481091|365744771|FG008|Overall Study|Progressive disease other|0|||
105825054|NCT04633564|365016481|FG000|Period 1|Death|8|||
105825055|NCT04633564|365016482|FG001|Period 1|Death|7|||
105825056|NCT04633564|365016481|FG000|Period 1|Lost to Follow-up|3|||
105825057|NCT04633564|365016482|FG001|Period 1|Lost to Follow-up|5|||
105825058|NCT04633564|365016481|FG000|Period 1|Physician Decision|4|||
105825059|NCT04633564|365016482|FG001|Period 1|Physician Decision|12|||
105825060|NCT04633564|365016481|FG000|Period 1|Protocol Violation|0|||
105825061|NCT04633564|365016482|FG001|Period 1|Protocol Violation|1|||
105825062|NCT04633564|365016481|FG000|Period 1|Withdrawal by Subject|10|||
105959985|NCT00431444|365513386|FG001|Overall Study|Withdrawal by Subject|1|||
105959986|NCT00431444|365513385|FG000|Overall Study|Lost to Follow-up|1|||
105959987|NCT00431444|365513386|FG001|Overall Study|Lost to Follow-up|0|||
105959988|NCT00431444|365513385|FG000|Overall Study|Administrative Problems|0|||
105959989|NCT00431444|365513386|FG001|Overall Study|Administrative Problems|1|||
105959990|NCT01262560|365513388|FG000|Overall Study|Protocol Violation|0|||
105959991|NCT01262560|365513389|FG001|Overall Study|Protocol Violation|1|||
105959992|NCT01262560|365513390|FG002|Overall Study|Protocol Violation|2|||
105959993|NCT04238481|365513391|FG000|Overall Study|Miscellaneous|0|||
105959994|NCT04238481|365513392|FG001|Overall Study|Miscellaneous|1|||
105959995|NCT04238481|365513393|FG002|Overall Study|Miscellaneous|0|||
105959996|NCT04238481|365513394|FG003|Overall Study|Miscellaneous|0|||
105959997|NCT00005947|365513395|FG000|Overall Study|Death|54|||
105959998|NCT00005947|365513396|FG001|Overall Study|Death|40|||
105959999|NCT00005947|365513395|FG000|Overall Study|Patient Refused to Continue|2|||
105960000|NCT00005947|365513396|FG001|Overall Study|Patient Refused to Continue|1|||
105960001|NCT00005947|365513395|FG000|Overall Study|Site Closure|1|||
105960002|NCT00005947|365513396|FG001|Overall Study|Site Closure|0|||
105960003|NCT02470585|365513397|FG000|Overall Study|Death|224|||
105960004|NCT02470585|365513398|FG001|Overall Study|Death|227|||
105960005|NCT02470585|365513399|FG002|Overall Study|Death|199|||
105960006|NCT02470585|365513397|FG000|Overall Study|Withdrew consent|21|||
105960007|NCT02470585|365513398|FG001|Overall Study|Withdrew consent|22|||
105960008|NCT02470585|365513399|FG002|Overall Study|Withdrew consent|31|||
105960009|NCT02470585|365513397|FG000|Overall Study|Lost to Follow-up|8|||
105960010|NCT02470585|365513398|FG001|Overall Study|Lost to Follow-up|15|||
105960011|NCT02470585|365513399|FG002|Overall Study|Lost to Follow-up|13|||
105960012|NCT02470585|365513397|FG000|Overall Study|Sponsor discontinued study|117|||
105960013|NCT02470585|365513398|FG001|Overall Study|Sponsor discontinued study|110|||
105960014|NCT02470585|365513399|FG002|Overall Study|Sponsor discontinued study|122|||
105960015|NCT02470585|365513397|FG000|Overall Study|Other, not specified|5|||
105960016|NCT02470585|365513398|FG001|Overall Study|Other, not specified|7|||
106021671|NCT00481091|365744772|FG009|Overall Study|Progressive disease other|0|||
106021672|NCT00481091|365744763|FG000|Overall Study|No reason given|0|||
105825063|NCT04633564|365016482|FG001|Period 1|Withdrawal by Subject|8|||
105825064|NCT04633564|365016481|FG000|Period 1|Progressive disease|47|||
105825065|NCT04633564|365016482|FG001|Period 1|Progressive disease|51|||
105960017|NCT02470585|365513399|FG002|Overall Study|Other, not specified|14|||
106021673|NCT00481091|365744764|FG001|Overall Study|No reason given|0|||
106021674|NCT00481091|365744765|FG002|Overall Study|No reason given|1|||
106146544|NCT00683696|366197959|FG001|Overall Study|Death|30|||
105960018|NCT02470585|365513397|FG000|Overall Study|Missing due to site non-compliance|0|||
105960019|NCT02470585|365513398|FG001|Overall Study|Missing due to site non-compliance|2|||
105825066|NCT04633564|365016481|FG000|Period 1|Terminated by Sponsor|8|||
105825067|NCT04633564|365016482|FG001|Period 1|Terminated by Sponsor|6|||
105825068|NCT04633564|365016481|FG000|Period 2|Adverse Event|3|||
105960020|NCT02470585|365513399|FG002|Overall Study|Missing due to site non-compliance|3|||
105960021|NCT05111002|365513400|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
105960022|NCT05111002|365513401|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
105960023|NCT05111002|365513400|FG000|Secondary Outcome|Lost to Follow-up|1|||
105960024|NCT05111002|365513401|FG001|Secondary Outcome|Lost to Follow-up|0|||
105960025|NCT03306433|365513402|FG000|Overall Study|Lost to Follow-up|3|||
105960026|NCT03306433|365513402|FG000|Overall Study|Patient did not have teeth extracted|1|||
105960027|NCT03306433|365513402|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
105960028|NCT03122145|365513403|FG000|Overall Study|Concurrent respiratory disease|3|||
105960029|NCT03122145|365513404|FG001|Overall Study|Concurrent respiratory disease|0|||
105960030|NCT00334737|365513407|FG000|Hospital Phase|Death|1|||
105960031|NCT00334737|365513408|FG001|Hospital Phase|Death|2|||
105960032|NCT00334737|365513409|FG002|Hospital Phase|Death|3|||
105960033|NCT00334737|365513407|FG000|Hospital Phase|Withdrawal by Subject|0|||
105960034|NCT00334737|365513408|FG001|Hospital Phase|Withdrawal by Subject|0|||
105960035|NCT00334737|365513409|FG002|Hospital Phase|Withdrawal by Subject|1|||
105960036|NCT00334737|365513407|FG000|Hospital Phase|Did not receive study drug|1|||
105960037|NCT00334737|365513408|FG001|Hospital Phase|Did not receive study drug|0|||
105960038|NCT00334737|365513409|FG002|Hospital Phase|Did not receive study drug|0|||
105960039|NCT00334737|365513407|FG000|Follow up Phase|Lost to Follow-up|5|||
105960040|NCT00334737|365513408|FG001|Follow up Phase|Lost to Follow-up|3|||
105960041|NCT00334737|365513409|FG002|Follow up Phase|Lost to Follow-up|6|||
105960042|NCT03419897|365515043|FG000|Overall Study|Death|180|||
105960043|NCT03419897|365515043|FG000|Overall Study|Lost to Follow-up|1|||
105960044|NCT03419897|365515043|FG000|Overall Study|Withdrawal by Subject|6|||
105960045|NCT03419897|365515043|FG000|Overall Study|Sponsor Decision|61|||
105960046|NCT03419897|365515043|FG000|Overall Study|Physician Decision|1|||
105960047|NCT01905943|365515044|FG000|Overall Study|Withdrawal of consent|90|||
105960048|NCT01905943|365515044|FG000|Overall Study|Lost to Follow-up|16|||
105960049|NCT01905943|365515044|FG000|Overall Study|Investigator discretion|7|||
105960050|NCT01905943|365515044|FG000|Overall Study|Death|186|||
105960051|NCT01905943|365515044|FG000|Overall Study|Adverse Event|3|||
105960052|NCT01905943|365515044|FG000|Overall Study|Other|12|||
105960053|NCT02974140|365515045|FG000|Overall Study|Adverse Event|2|||
105960054|NCT02974140|365515045|FG000|Overall Study|Lost to Follow-up|1|||
105960055|NCT02974140|365515045|FG000|Overall Study|Study Terminated by Sponsor|36|||
105960056|NCT02574078|365515046|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960057|NCT02574078|365515047|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960058|NCT02574078|365515048|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960059|NCT02574078|365515049|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960060|NCT02574078|365515050|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960061|NCT02574078|365515051|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105960062|NCT02574078|365515052|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
105960063|NCT02574078|365515053|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960064|NCT02574078|365515054|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105960065|NCT02574078|365515055|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960066|NCT02574078|365515056|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960067|NCT02574078|365515057|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960068|NCT02574078|365515058|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105960069|NCT02574078|365515046|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
105960070|NCT02574078|365515047|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
105960071|NCT02574078|365515048|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
105960072|NCT02574078|365515049|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
105960073|NCT02574078|365515050|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
105960074|NCT02574078|365515051|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
105960075|NCT02574078|365515052|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
105960076|NCT02574078|365515053|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
105960077|NCT02574078|365515054|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
105960078|NCT02574078|365515055|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
105960079|NCT02574078|365515056|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
105960080|NCT02574078|365515057|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
105960081|NCT02574078|365515058|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
105960082|NCT02574078|365515046|FG000|Pre-Treatment Period|Other reasons|0|||
105960083|NCT02574078|365515047|FG001|Pre-Treatment Period|Other reasons|0|||
105960084|NCT02574078|365515048|FG002|Pre-Treatment Period|Other reasons|0|||
105960085|NCT02574078|365515049|FG003|Pre-Treatment Period|Other reasons|0|||
105960086|NCT02574078|365515050|FG004|Pre-Treatment Period|Other reasons|0|||
105960087|NCT02574078|365515051|FG005|Pre-Treatment Period|Other reasons|0|||
105825069|NCT04633564|365016482|FG001|Period 2|Adverse Event|4|||
106146545|NCT03648762|366197963|FG000|Overall Study|Lost to Follow-up|1|||
106146546|NCT03648762|366197964|FG001|Overall Study|Lost to Follow-up|2|||
105825070|NCT04633564|365016481|FG000|Period 2|Death|0|||
105825071|NCT04633564|365016482|FG001|Period 2|Death|2|||
105825072|NCT04633564|365016481|FG000|Period 2|Lost to Follow-up|0|||
105825073|NCT04633564|365016482|FG001|Period 2|Lost to Follow-up|1|||
105825074|NCT04633564|365016481|FG000|Period 2|Physician Decision|2|||
105825075|NCT04633564|365016482|FG001|Period 2|Physician Decision|4|||
105825076|NCT04633564|365016481|FG000|Period 2|Withdrawal by Subject|5|||
105825077|NCT04633564|365016482|FG001|Period 2|Withdrawal by Subject|1|||
105825078|NCT04633564|365016481|FG000|Period 2|Progressive Disease|74|||
105825079|NCT04633564|365016482|FG001|Period 2|Progressive Disease|82|||
105825080|NCT04633564|365016481|FG000|Period 2|Terminated by Sponsor|9|||
105825081|NCT04633564|365016482|FG001|Period 2|Terminated by Sponsor|3|||
105825082|NCT01010503|365016483|FG000|Overall Study|Adverse Event|1|||
105825083|NCT01010503|365016483|FG000|Overall Study|Death|1|||
105825084|NCT02358538|365016484|FG000|Through Week 26|Adverse Event|0|||
105825085|NCT02358538|365016485|FG001|Through Week 26|Adverse Event|1|||
105825086|NCT02358538|365016486|FG002|Through Week 26|Adverse Event|1|||
105825087|NCT02358538|365016487|FG003|Through Week 26|Adverse Event|2|||
105825088|NCT02358538|365016484|FG000|Through Week 26|Lack of Efficacy|1|||
105825089|NCT02358538|365016485|FG001|Through Week 26|Lack of Efficacy|1|||
105825090|NCT02358538|365016486|FG002|Through Week 26|Lack of Efficacy|3|||
105825091|NCT02358538|365016487|FG003|Through Week 26|Lack of Efficacy|3|||
105825092|NCT02358538|365016484|FG000|Through Week 26|Withdrawal by Subject|1|||
105825093|NCT02358538|365016485|FG001|Through Week 26|Withdrawal by Subject|0|||
105825094|NCT02358538|365016486|FG002|Through Week 26|Withdrawal by Subject|0|||
105825095|NCT02358538|365016487|FG003|Through Week 26|Withdrawal by Subject|0|||
105825096|NCT02358538|365016484|FG000|Through Week 26|Non-Compliance|0|||
105825097|NCT02358538|365016485|FG001|Through Week 26|Non-Compliance|0|||
105825098|NCT02358538|365016486|FG002|Through Week 26|Non-Compliance|1|||
105825099|NCT02358538|365016487|FG003|Through Week 26|Non-Compliance|0|||
105825100|NCT02358538|365016484|FG000|Through Week 26|Family did not see benefit from IP|1|||
105825101|NCT02358538|365016485|FG001|Through Week 26|Family did not see benefit from IP|0|||
105960088|NCT02574078|365515052|FG006|Pre-Treatment Period|Other reasons|2|||
105960089|NCT02574078|365515053|FG007|Pre-Treatment Period|Other reasons|0|||
105960090|NCT02574078|365515054|FG008|Pre-Treatment Period|Other reasons|0|||
105960091|NCT02574078|365515055|FG009|Pre-Treatment Period|Other reasons|0|||
105960092|NCT02574078|365515056|FG010|Pre-Treatment Period|Other reasons|2|||
105960093|NCT02574078|365515057|FG011|Pre-Treatment Period|Other reasons|0|||
105960094|NCT02574078|365515058|FG012|Pre-Treatment Period|Other reasons|0|||
105960095|NCT02574078|365515046|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
105960096|NCT02574078|365515047|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
105960097|NCT02574078|365515048|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
105960098|NCT02574078|365515049|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
105960099|NCT02574078|365515050|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
105960100|NCT02574078|365515051|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
105960101|NCT02574078|365515052|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
105960102|NCT02574078|365515053|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
105960103|NCT02574078|365515054|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
105960104|NCT02574078|365515055|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
105960105|NCT02574078|365515056|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
105960106|NCT02574078|365515057|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
105960107|NCT02574078|365515058|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
105960108|NCT02574078|365515046|FG000|Treatment Period|Disease progression|6|||
105960109|NCT02574078|365515047|FG001|Treatment Period|Disease progression|4|||
105960110|NCT02574078|365515048|FG002|Treatment Period|Disease progression|7|||
105960111|NCT02574078|365515049|FG003|Treatment Period|Disease progression|18|||
105960112|NCT02574078|365515050|FG004|Treatment Period|Disease progression|16|||
105960113|NCT02574078|365515051|FG005|Treatment Period|Disease progression|26|||
105960114|NCT02574078|365515052|FG006|Treatment Period|Disease progression|5|||
105960115|NCT02574078|365515053|FG007|Treatment Period|Disease progression|9|||
105960116|NCT02574078|365515054|FG008|Treatment Period|Disease progression|8|||
105960117|NCT02574078|365515055|FG009|Treatment Period|Disease progression|5|||
106146547|NCT03648762|366197965|FG002|Overall Study|Lost to Follow-up|0|||
105825102|NCT02358538|365016486|FG002|Through Week 26|Family did not see benefit from IP|0|||
105825103|NCT02358538|365016487|FG003|Through Week 26|Family did not see benefit from IP|0|||
105960118|NCT02574078|365515056|FG010|Treatment Period|Disease progression|20|||
105825104|NCT02358538|365016484|FG000|52 Week Extension Period|Lack of Efficacy|0|||
105825105|NCT02358538|365016485|FG001|52 Week Extension Period|Lack of Efficacy|0|||
105960119|NCT02574078|365515057|FG011|Treatment Period|Disease progression|29|||
105960120|NCT02574078|365515058|FG012|Treatment Period|Disease progression|2|||
105960121|NCT02574078|365515046|FG000|Treatment Period|Study drug toxicity|1|||
105960122|NCT02574078|365515047|FG001|Treatment Period|Study drug toxicity|1|||
105960123|NCT02574078|365515048|FG002|Treatment Period|Study drug toxicity|0|||
105960124|NCT02574078|365515049|FG003|Treatment Period|Study drug toxicity|5|||
105960125|NCT02574078|365515050|FG004|Treatment Period|Study drug toxicity|3|||
105960126|NCT02574078|365515051|FG005|Treatment Period|Study drug toxicity|1|||
105960127|NCT02574078|365515052|FG006|Treatment Period|Study drug toxicity|2|||
105960128|NCT02574078|365515053|FG007|Treatment Period|Study drug toxicity|0|||
105960129|NCT02574078|365515054|FG008|Treatment Period|Study drug toxicity|2|||
105960130|NCT02574078|365515055|FG009|Treatment Period|Study drug toxicity|1|||
105960131|NCT02574078|365515056|FG010|Treatment Period|Study drug toxicity|16|||
105960132|NCT02574078|365515057|FG011|Treatment Period|Study drug toxicity|2|||
105960133|NCT02574078|365515058|FG012|Treatment Period|Study drug toxicity|4|||
105960134|NCT02574078|365515046|FG000|Treatment Period|Death|2|||
105960135|NCT02574078|365515047|FG001|Treatment Period|Death|0|||
105960136|NCT02574078|365515048|FG002|Treatment Period|Death|0|||
105960137|NCT02574078|365515049|FG003|Treatment Period|Death|0|||
106021675|NCT00481091|365744766|FG003|Overall Study|No reason given|1|||
106021676|NCT00481091|365744767|FG004|Overall Study|No reason given|1|||
106021677|NCT00481091|365744768|FG005|Overall Study|No reason given|0|||
106021678|NCT00481091|365744769|FG006|Overall Study|No reason given|1|||
106021679|NCT00481091|365744770|FG007|Overall Study|No reason given|1|||
106021680|NCT00481091|365744771|FG008|Overall Study|No reason given|1|||
106021681|NCT00481091|365744772|FG009|Overall Study|No reason given|4|||
106021682|NCT04294680|365744773|FG000|Overall Study|Withdrawal by Subject|2|||
106021683|NCT04294680|365744774|FG001|Overall Study|Withdrawal by Subject|1|||
106021684|NCT04294680|365744773|FG000|Overall Study|Follow-up visits completed outside of window|1|||
105825106|NCT02358538|365016486|FG002|52 Week Extension Period|Lack of Efficacy|2|||
105825107|NCT02358538|365016487|FG003|52 Week Extension Period|Lack of Efficacy|4|||
105825108|NCT01494532|365016490|FG000|Overall Study|Adverse Event|4|||
105825109|NCT01494532|365016491|FG001|Overall Study|Adverse Event|1|||
105825110|NCT01494532|365016492|FG002|Overall Study|Adverse Event|8|||
105825111|NCT01494532|365016493|FG003|Overall Study|Adverse Event|6|||
105825112|NCT01494532|365016494|FG004|Overall Study|Adverse Event|5|||
105825113|NCT01494532|365016495|FG005|Overall Study|Adverse Event|0|||
105825114|NCT01494532|365016490|FG000|Overall Study|Lack of Efficacy|0|||
106021685|NCT04294680|365744774|FG001|Overall Study|Follow-up visits completed outside of window|0|||
106021686|NCT00859456|365744777|FG000|Overall Study|Adverse Event|3|||
106021687|NCT00859456|365744777|FG000|Overall Study|Progressive disease|2|||
106021688|NCT00859456|365744777|FG000|Overall Study|Non-compliance|3|||
106021689|NCT00856518|365744778|FG000|Overall Study|Lost to Follow-up|4|||
106021690|NCT00856518|365744779|FG001|Overall Study|Lost to Follow-up|2|||
106021691|NCT00947193|365744780|FG000|Overall Study|Lost to Follow-up|1|||
106021692|NCT00947193|365744781|FG001|Overall Study|Lost to Follow-up|0|||
106021693|NCT00947193|365744780|FG000|Overall Study|Withdrawal by Subject|1|||
106021694|NCT00947193|365744781|FG001|Overall Study|Withdrawal by Subject|0|||
106021695|NCT00947193|365744780|FG000|Overall Study|Factor VIII >1%|1|||
106021696|NCT00947193|365744781|FG001|Overall Study|Factor VIII >1%|0|||
106021697|NCT04364984|365744782|FG000|Overall Study|Death|2|||
106021698|NCT04364984|365744783|FG001|Overall Study|Death|2|||
106021699|NCT04364984|365744784|FG002|Overall Study|Death|0|||
106021700|NCT00926029|365744785|FG000|Overall Study|Lost to Follow-up|2|||
106021701|NCT00926029|365744786|FG001|Overall Study|Lost to Follow-up|1|||
106021702|NCT00926029|365744787|FG002|Overall Study|Lost to Follow-up|1|||
106021703|NCT01262989|365744788|FG000|Period 1|Lost to Follow-up|1|||
106021704|NCT01262989|365744789|FG001|Period 1|Lost to Follow-up|1|||
106146548|NCT03648762|366197963|FG000|Overall Study|Withdrawal by Subject|5|||
106146549|NCT03648762|366197964|FG001|Overall Study|Withdrawal by Subject|2|||
106146550|NCT03648762|366197965|FG002|Overall Study|Withdrawal by Subject|1|||
106146551|NCT01875848|366197966|FG000|Overall Study|Withdrawal by Subject|2|||
106146552|NCT01875848|366197967|FG001|Overall Study|Withdrawal by Subject|0|||
105825115|NCT01494532|365016491|FG001|Overall Study|Lack of Efficacy|0|||
106021705|NCT01262989|365744788|FG000|Period 1|Intercurrent disease|0|||
106146553|NCT02189252|366197968|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
105825116|NCT01494532|365016492|FG002|Overall Study|Lack of Efficacy|0|||
105825117|NCT01494532|365016493|FG003|Overall Study|Lack of Efficacy|0|||
105825118|NCT01494532|365016494|FG004|Overall Study|Lack of Efficacy|2|||
105825119|NCT01494532|365016495|FG005|Overall Study|Lack of Efficacy|0|||
105825120|NCT01494532|365016490|FG000|Overall Study|Protocol deviation|2|||
105960138|NCT02574078|365515050|FG004|Treatment Period|Death|1|||
105960139|NCT02574078|365515051|FG005|Treatment Period|Death|1|||
105960140|NCT02574078|365515052|FG006|Treatment Period|Death|1|||
105960141|NCT02574078|365515053|FG007|Treatment Period|Death|1|||
105960142|NCT02574078|365515054|FG008|Treatment Period|Death|7|||
105960143|NCT02574078|365515055|FG009|Treatment Period|Death|1|||
105960144|NCT02574078|365515056|FG010|Treatment Period|Death|0|||
105960145|NCT02574078|365515057|FG011|Treatment Period|Death|2|||
106021706|NCT01262989|365744789|FG001|Period 1|Intercurrent disease|1|||
106021707|NCT01262989|365744788|FG000|Period 1|Positive answer for exclusion criteria|0|||
105825121|NCT01494532|365016491|FG001|Overall Study|Protocol deviation|1|||
105825122|NCT01494532|365016492|FG002|Overall Study|Protocol deviation|3|||
105960146|NCT02574078|365515058|FG012|Treatment Period|Death|1|||
106021708|NCT01262989|365744789|FG001|Period 1|Positive answer for exclusion criteria|1|||
106021709|NCT01262989|365744788|FG000|Period 2|Intercurrent disease|0|||
105960147|NCT02574078|365515046|FG000|Treatment Period|Adverse event unrelated to drug|0|||
105960148|NCT02574078|365515047|FG001|Treatment Period|Adverse event unrelated to drug|0|||
105960149|NCT02574078|365515048|FG002|Treatment Period|Adverse event unrelated to drug|1|||
105960150|NCT02574078|365515049|FG003|Treatment Period|Adverse event unrelated to drug|0|||
105960151|NCT02574078|365515050|FG004|Treatment Period|Adverse event unrelated to drug|2|||
105960152|NCT02574078|365515051|FG005|Treatment Period|Adverse event unrelated to drug|3|||
105960153|NCT02574078|365515052|FG006|Treatment Period|Adverse event unrelated to drug|0|||
105960154|NCT02574078|365515053|FG007|Treatment Period|Adverse event unrelated to drug|0|||
105960155|NCT02574078|365515054|FG008|Treatment Period|Adverse event unrelated to drug|1|||
105960156|NCT02574078|365515055|FG009|Treatment Period|Adverse event unrelated to drug|2|||
105960157|NCT02574078|365515056|FG010|Treatment Period|Adverse event unrelated to drug|4|||
105960158|NCT02574078|365515057|FG011|Treatment Period|Adverse event unrelated to drug|1|||
105960159|NCT02574078|365515058|FG012|Treatment Period|Adverse event unrelated to drug|0|||
105960160|NCT02574078|365515046|FG000|Treatment Period|Administrative reason by Sponsor|0|||
105960161|NCT02574078|365515047|FG001|Treatment Period|Administrative reason by Sponsor|1|||
105960162|NCT02574078|365515048|FG002|Treatment Period|Administrative reason by Sponsor|0|||
105960163|NCT02574078|365515049|FG003|Treatment Period|Administrative reason by Sponsor|0|||
105960164|NCT02574078|365515050|FG004|Treatment Period|Administrative reason by Sponsor|0|||
105960165|NCT02574078|365515051|FG005|Treatment Period|Administrative reason by Sponsor|0|||
105960166|NCT02574078|365515052|FG006|Treatment Period|Administrative reason by Sponsor|1|||
105960167|NCT02574078|365515053|FG007|Treatment Period|Administrative reason by Sponsor|0|||
105960168|NCT02574078|365515054|FG008|Treatment Period|Administrative reason by Sponsor|0|||
105960169|NCT02574078|365515055|FG009|Treatment Period|Administrative reason by Sponsor|0|||
105960170|NCT02574078|365515056|FG010|Treatment Period|Administrative reason by Sponsor|0|||
105960171|NCT02574078|365515057|FG011|Treatment Period|Administrative reason by Sponsor|0|||
105960172|NCT02574078|365515058|FG012|Treatment Period|Administrative reason by Sponsor|3|||
105960173|NCT02574078|365515046|FG000|Treatment Period|Other reasons|1|||
105960174|NCT02574078|365515047|FG001|Treatment Period|Other reasons|0|||
105960175|NCT02574078|365515048|FG002|Treatment Period|Other reasons|1|||
105960176|NCT02574078|365515049|FG003|Treatment Period|Other reasons|3|||
105960177|NCT02574078|365515050|FG004|Treatment Period|Other reasons|3|||
105960178|NCT02574078|365515051|FG005|Treatment Period|Other reasons|1|||
105960179|NCT02574078|365515052|FG006|Treatment Period|Other reasons|2|||
105960180|NCT02574078|365515053|FG007|Treatment Period|Other reasons|1|||
105960181|NCT02574078|365515054|FG008|Treatment Period|Other reasons|3|||
105960182|NCT02574078|365515055|FG009|Treatment Period|Other reasons|1|||
105960183|NCT02574078|365515056|FG010|Treatment Period|Other reasons|1|||
105960184|NCT02574078|365515057|FG011|Treatment Period|Other reasons|3|||
105960185|NCT02574078|365515058|FG012|Treatment Period|Other reasons|1|||
105960186|NCT02574078|365515046|FG000|Treatment Period|Participant request to stop drug|0|||
105960187|NCT02574078|365515047|FG001|Treatment Period|Participant request to stop drug|0|||
105960188|NCT02574078|365515048|FG002|Treatment Period|Participant request to stop drug|0|||
105960189|NCT02574078|365515049|FG003|Treatment Period|Participant request to stop drug|2|||
105960190|NCT02574078|365515050|FG004|Treatment Period|Participant request to stop drug|4|||
105960191|NCT02574078|365515051|FG005|Treatment Period|Participant request to stop drug|0|||
105960192|NCT02574078|365515052|FG006|Treatment Period|Participant request to stop drug|1|||
105960193|NCT02574078|365515053|FG007|Treatment Period|Participant request to stop drug|0|||
105960194|NCT02574078|365515054|FG008|Treatment Period|Participant request to stop drug|3|||
105960195|NCT02574078|365515055|FG009|Treatment Period|Participant request to stop drug|2|||
105960196|NCT02574078|365515056|FG010|Treatment Period|Participant request to stop drug|2|||
105960197|NCT02574078|365515057|FG011|Treatment Period|Participant request to stop drug|4|||
105960198|NCT02574078|365515058|FG012|Treatment Period|Participant request to stop drug|1|||
105960199|NCT02574078|365515046|FG000|Treatment Period|Participant withdrew consent|0|||
105960200|NCT02574078|365515047|FG001|Treatment Period|Participant withdrew consent|0|||
105960201|NCT02574078|365515048|FG002|Treatment Period|Participant withdrew consent|0|||
105960202|NCT02574078|365515049|FG003|Treatment Period|Participant withdrew consent|0|||
105960203|NCT02574078|365515050|FG004|Treatment Period|Participant withdrew consent|1|||
106146554|NCT02189252|366197969|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
106146555|NCT02189252|366197970|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
106146556|NCT02189252|366197971|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
106146557|NCT02189252|366197968|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
106146558|NCT02189252|366197969|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
106146559|NCT02189252|366197970|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
105960204|NCT02574078|365515051|FG005|Treatment Period|Participant withdrew consent|1|||
105960205|NCT02574078|365515052|FG006|Treatment Period|Participant withdrew consent|0|||
105960206|NCT02574078|365515053|FG007|Treatment Period|Participant withdrew consent|1|||
105960207|NCT02574078|365515054|FG008|Treatment Period|Participant withdrew consent|0|||
105960208|NCT02574078|365515055|FG009|Treatment Period|Participant withdrew consent|2|||
105960209|NCT02574078|365515056|FG010|Treatment Period|Participant withdrew consent|1|||
106146560|NCT02189252|366197971|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
105960210|NCT02574078|365515057|FG011|Treatment Period|Participant withdrew consent|4|||
105960211|NCT02574078|365515058|FG012|Treatment Period|Participant withdrew consent|1|||
105960212|NCT02574078|365515046|FG000|Treatment Period|Participant no longer meets criteria|0|||
105960213|NCT02574078|365515047|FG001|Treatment Period|Participant no longer meets criteria|0|||
105960214|NCT02574078|365515048|FG002|Treatment Period|Participant no longer meets criteria|0|||
105960215|NCT02574078|365515049|FG003|Treatment Period|Participant no longer meets criteria|0|||
105960216|NCT02574078|365515050|FG004|Treatment Period|Participant no longer meets criteria|1|||
105960217|NCT02574078|365515051|FG005|Treatment Period|Participant no longer meets criteria|0|||
105960218|NCT02574078|365515052|FG006|Treatment Period|Participant no longer meets criteria|0|||
105960219|NCT02574078|365515053|FG007|Treatment Period|Participant no longer meets criteria|0|||
105960220|NCT02574078|365515054|FG008|Treatment Period|Participant no longer meets criteria|0|||
105960221|NCT02574078|365515055|FG009|Treatment Period|Participant no longer meets criteria|1|||
105960222|NCT02574078|365515056|FG010|Treatment Period|Participant no longer meets criteria|1|||
105960223|NCT02574078|365515057|FG011|Treatment Period|Participant no longer meets criteria|1|||
105960224|NCT02574078|365515058|FG012|Treatment Period|Participant no longer meets criteria|0|||
105960225|NCT02574078|365515046|FG000|Treatment Period|Lost to Follow-up|0|||
105960226|NCT02574078|365515047|FG001|Treatment Period|Lost to Follow-up|0|||
105960227|NCT02574078|365515048|FG002|Treatment Period|Lost to Follow-up|0|||
105960228|NCT02574078|365515049|FG003|Treatment Period|Lost to Follow-up|0|||
106146561|NCT04603924|366197972|FG000|Overall Study|Not Dosed|2|||
106146562|NCT04603924|366197973|FG001|Overall Study|Not Dosed|1|||
106146563|NCT04603924|366197972|FG000|Overall Study|Withdrawal by Subject|6|||
106146564|NCT04603924|366197973|FG001|Overall Study|Withdrawal by Subject|6|||
105825123|NCT01494532|365016493|FG003|Overall Study|Protocol deviation|2|||
105825124|NCT01494532|365016494|FG004|Overall Study|Protocol deviation|3|||
105825125|NCT01494532|365016495|FG005|Overall Study|Protocol deviation|0|||
106146565|NCT04603924|366197972|FG000|Overall Study|Adverse Event|2|||
106146566|NCT04603924|366197973|FG001|Overall Study|Adverse Event|2|||
106146567|NCT00686855|366197977|FG000|Overall Study|Lost to Follow-up|1|||
106146568|NCT00686855|366197978|FG001|Overall Study|Lost to Follow-up|0|||
106146569|NCT00686855|366197977|FG000|Overall Study|Progressive GVHD|0|||
106146570|NCT00686855|366197978|FG001|Overall Study|Progressive GVHD|1|||
106146571|NCT01867216|366197979|FG000|Overall Study|Withdrawal by Subject|2|||
106146572|NCT01867216|366197980|FG001|Overall Study|Withdrawal by Subject|0|||
106146573|NCT01867216|366197981|FG002|Overall Study|Withdrawal by Subject|0|||
106146574|NCT01867216|366197982|FG003|Overall Study|Withdrawal by Subject|0|||
105825126|NCT01494532|365016490|FG000|Overall Study|Protocol-defined stopping criteria|0|||
105825127|NCT01494532|365016491|FG001|Overall Study|Protocol-defined stopping criteria|0|||
105825128|NCT01494532|365016492|FG002|Overall Study|Protocol-defined stopping criteria|1|||
105825129|NCT01494532|365016493|FG003|Overall Study|Protocol-defined stopping criteria|0|||
105825130|NCT01494532|365016494|FG004|Overall Study|Protocol-defined stopping criteria|0|||
105825131|NCT01494532|365016495|FG005|Overall Study|Protocol-defined stopping criteria|0|||
105825132|NCT01494532|365016490|FG000|Overall Study|Lost to Follow-up|1|||
105825133|NCT01494532|365016491|FG001|Overall Study|Lost to Follow-up|0|||
105825134|NCT01494532|365016492|FG002|Overall Study|Lost to Follow-up|0|||
105825135|NCT01494532|365016493|FG003|Overall Study|Lost to Follow-up|2|||
105825136|NCT01494532|365016494|FG004|Overall Study|Lost to Follow-up|0|||
105825137|NCT01494532|365016495|FG005|Overall Study|Lost to Follow-up|0|||
105825138|NCT01494532|365016490|FG000|Overall Study|Physician Decision|0|||
105825139|NCT01494532|365016491|FG001|Overall Study|Physician Decision|1|||
105825140|NCT01494532|365016492|FG002|Overall Study|Physician Decision|1|||
105825141|NCT01494532|365016493|FG003|Overall Study|Physician Decision|2|||
105825142|NCT01494532|365016494|FG004|Overall Study|Physician Decision|0|||
105825143|NCT01494532|365016495|FG005|Overall Study|Physician Decision|0|||
105825144|NCT01494532|365016490|FG000|Overall Study|Withdrawal by Subject|3|||
105825145|NCT01494532|365016491|FG001|Overall Study|Withdrawal by Subject|1|||
105825146|NCT01494532|365016492|FG002|Overall Study|Withdrawal by Subject|4|||
105825147|NCT01494532|365016493|FG003|Overall Study|Withdrawal by Subject|3|||
105825148|NCT01494532|365016494|FG004|Overall Study|Withdrawal by Subject|2|||
105825149|NCT01494532|365016495|FG005|Overall Study|Withdrawal by Subject|0|||
105825150|NCT00730691|365016497|FG000|Overall Study|Adverse Event|4|||
105825151|NCT00730691|365016498|FG001|Overall Study|Adverse Event|8|||
105825152|NCT00730691|365016499|FG002|Overall Study|Adverse Event|11|||
105825153|NCT00730691|365016500|FG003|Overall Study|Adverse Event|11|||
105825154|NCT00730691|365016501|FG004|Overall Study|Adverse Event|23|||
105825155|NCT00730691|365016497|FG000|Overall Study|Lack of Efficacy|4|||
105825156|NCT00730691|365016498|FG001|Overall Study|Lack of Efficacy|4|||
105960229|NCT02574078|365515050|FG004|Treatment Period|Lost to Follow-up|0|||
105825157|NCT00730691|365016499|FG002|Overall Study|Lack of Efficacy|2|||
105825158|NCT00730691|365016500|FG003|Overall Study|Lack of Efficacy|1|||
105825159|NCT00730691|365016501|FG004|Overall Study|Lack of Efficacy|1|||
105825160|NCT00730691|365016497|FG000|Overall Study|Non-compliance with Study Drug|6|||
105825161|NCT00730691|365016498|FG001|Overall Study|Non-compliance with Study Drug|1|||
105825162|NCT00730691|365016499|FG002|Overall Study|Non-compliance with Study Drug|6|||
105825163|NCT00730691|365016500|FG003|Overall Study|Non-compliance with Study Drug|3|||
105825164|NCT00730691|365016501|FG004|Overall Study|Non-compliance with Study Drug|3|||
105960230|NCT02574078|365515051|FG005|Treatment Period|Lost to Follow-up|0|||
106021710|NCT01262989|365744789|FG001|Period 2|Intercurrent disease|1|||
106021711|NCT02147561|365744790|FG000|Overall Study|Lost to Follow-up|3|||
106021712|NCT02147561|365744790|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
106021713|NCT01485172|365744791|FG000|Overall Study|Adverse Event|2|||
106021714|NCT01485172|365744792|FG001|Overall Study|Adverse Event|1|||
106021715|NCT01485172|365744793|FG002|Overall Study|Adverse Event|2|||
106021716|NCT01485172|365744794|FG003|Overall Study|Adverse Event|2|||
106021717|NCT01485172|365744795|FG004|Overall Study|Adverse Event|1|||
106021718|NCT01485172|365744796|FG005|Overall Study|Adverse Event|2|||
106021719|NCT01485172|365744791|FG000|Overall Study|Lack of Efficacy|2|||
106021720|NCT01485172|365744792|FG001|Overall Study|Lack of Efficacy|0|||
106021721|NCT01485172|365744793|FG002|Overall Study|Lack of Efficacy|0|||
106021722|NCT01485172|365744794|FG003|Overall Study|Lack of Efficacy|0|||
106021723|NCT01485172|365744795|FG004|Overall Study|Lack of Efficacy|0|||
106021724|NCT01485172|365744796|FG005|Overall Study|Lack of Efficacy|0|||
106021725|NCT01485172|365744791|FG000|Overall Study|Protocol Violation|0|||
106021726|NCT01485172|365744792|FG001|Overall Study|Protocol Violation|0|||
106021727|NCT01485172|365744793|FG002|Overall Study|Protocol Violation|4|||
106021728|NCT01485172|365744794|FG003|Overall Study|Protocol Violation|5|||
106021729|NCT01485172|365744795|FG004|Overall Study|Protocol Violation|1|||
106021730|NCT01485172|365744796|FG005|Overall Study|Protocol Violation|0|||
106021731|NCT01485172|365744791|FG000|Overall Study|Protocol defined stopping criteria|1|||
106021732|NCT01485172|365744792|FG001|Overall Study|Protocol defined stopping criteria|0|||
106021733|NCT01485172|365744793|FG002|Overall Study|Protocol defined stopping criteria|0|||
106021734|NCT01485172|365744794|FG003|Overall Study|Protocol defined stopping criteria|0|||
106021735|NCT01485172|365744795|FG004|Overall Study|Protocol defined stopping criteria|1|||
106021736|NCT01485172|365744796|FG005|Overall Study|Protocol defined stopping criteria|0|||
106021737|NCT01485172|365744791|FG000|Overall Study|Lost to Follow-up|0|||
106021738|NCT01485172|365744792|FG001|Overall Study|Lost to Follow-up|0|||
106021739|NCT01485172|365744793|FG002|Overall Study|Lost to Follow-up|1|||
106021740|NCT01485172|365744794|FG003|Overall Study|Lost to Follow-up|0|||
106021741|NCT01485172|365744795|FG004|Overall Study|Lost to Follow-up|0|||
106021742|NCT01485172|365744796|FG005|Overall Study|Lost to Follow-up|1|||
106021743|NCT01485172|365744791|FG000|Overall Study|Physician Decision|0|||
106021744|NCT01485172|365744792|FG001|Overall Study|Physician Decision|0|||
106021745|NCT01485172|365744793|FG002|Overall Study|Physician Decision|0|||
106021746|NCT01485172|365744794|FG003|Overall Study|Physician Decision|0|||
106021747|NCT01485172|365744795|FG004|Overall Study|Physician Decision|1|||
106021748|NCT01485172|365744796|FG005|Overall Study|Physician Decision|0|||
106021749|NCT01485172|365744791|FG000|Overall Study|Withdrawal by Subject|2|||
106021750|NCT01485172|365744792|FG001|Overall Study|Withdrawal by Subject|0|||
106021751|NCT01485172|365744793|FG002|Overall Study|Withdrawal by Subject|0|||
106021752|NCT01485172|365744794|FG003|Overall Study|Withdrawal by Subject|1|||
106021753|NCT01485172|365744795|FG004|Overall Study|Withdrawal by Subject|1|||
106021754|NCT01485172|365744796|FG005|Overall Study|Withdrawal by Subject|1|||
106021755|NCT00202878|365744797|FG000|Overall Study|Death|964|||
106021756|NCT00202878|365744798|FG001|Overall Study|Death|968|||
106021757|NCT00202878|365744797|FG000|Overall Study|Only Vital Status Known|357|||
106021758|NCT00202878|365744798|FG001|Overall Study|Only Vital Status Known|356|||
106021759|NCT00202878|365744797|FG000|Overall Study|Lost to Follow-up|44|||
106021760|NCT00202878|365744798|FG001|Overall Study|Lost to Follow-up|49|||
106021761|NCT00202878|365744797|FG000|Overall Study|Site Closure|39|||
106021762|NCT00202878|365744798|FG001|Overall Study|Site Closure|36|||
106021763|NCT00202878|365744797|FG000|Overall Study|Withdrawal by Subject|795|||
106021764|NCT00202878|365744798|FG001|Overall Study|Withdrawal by Subject|808|||
106021765|NCT00838513|365744802|FG000|Screening Period|Screen Failure|3|||
106021766|NCT00838513|365744802|FG000|Extension Treatment Period|Death|1|||
106021767|NCT00838513|365744802|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
106021768|NCT00441064|365744805|FG000|Overall Study|Adverse Event|1|||
106021769|NCT00441064|365744806|FG001|Overall Study|Adverse Event|0|||
105825165|NCT00730691|365016497|FG000|Overall Study|Protocol Deviations|3|||
106021770|NCT00441064|365744805|FG000|Overall Study|Abnormal laboratory values|0|||
106021771|NCT00441064|365744806|FG001|Overall Study|Abnormal laboratory values|2|||
106021772|NCT00441064|365744805|FG000|Overall Study|Abnormal test procedure results|0|||
106021773|NCT00441064|365744806|FG001|Overall Study|Abnormal test procedure results|1|||
106021774|NCT00441064|365744805|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
106021775|NCT00441064|365744806|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
106021776|NCT00441064|365744805|FG000|Overall Study|Protocol Deviation|3|||
106021777|NCT00441064|365744806|FG001|Overall Study|Protocol Deviation|2|||
106021778|NCT00441064|365744805|FG000|Overall Study|Patient withdrew consent|5|||
106021779|NCT00441064|365744806|FG001|Overall Study|Patient withdrew consent|2|||
106021780|NCT03051178|365744807|FG000|Overall Study|Withdrawal by Subject|5|||
106021781|NCT03962504|365744808|FG000|Overall Study|Other|11|||
106021782|NCT03962504|365744809|FG001|Overall Study|Other|32|||
106021783|NCT02367833|365744810|FG000|Overall Study|Withdrawal by Subject|1|||
106021784|NCT02367833|365744811|FG001|Overall Study|Withdrawal by Subject|1|||
106021785|NCT02367833|365744812|FG002|Overall Study|Withdrawal by Subject|0|||
106021786|NCT04080167|365744815|FG000|Overall Study|Lost to Follow-up-Patients|7|||
105960231|NCT02574078|365515052|FG006|Treatment Period|Lost to Follow-up|0|||
105960232|NCT02574078|365515053|FG007|Treatment Period|Lost to Follow-up|0|||
105960233|NCT02574078|365515054|FG008|Treatment Period|Lost to Follow-up|0|||
105960234|NCT02574078|365515055|FG009|Treatment Period|Lost to Follow-up|1|||
105960235|NCT02574078|365515056|FG010|Treatment Period|Lost to Follow-up|0|||
105960236|NCT02574078|365515057|FG011|Treatment Period|Lost to Follow-up|1|||
105960237|NCT02574078|365515058|FG012|Treatment Period|Lost to Follow-up|0|||
105960238|NCT02574078|365515046|FG000|Treatment Period|Maximum clinical benefit|0|||
105960239|NCT02574078|365515047|FG001|Treatment Period|Maximum clinical benefit|0|||
105960240|NCT02574078|365515048|FG002|Treatment Period|Maximum clinical benefit|0|||
105960241|NCT02574078|365515049|FG003|Treatment Period|Maximum clinical benefit|0|||
105960242|NCT02574078|365515050|FG004|Treatment Period|Maximum clinical benefit|0|||
105960243|NCT02574078|365515051|FG005|Treatment Period|Maximum clinical benefit|0|||
105960244|NCT02574078|365515052|FG006|Treatment Period|Maximum clinical benefit|0|||
105960245|NCT02574078|365515053|FG007|Treatment Period|Maximum clinical benefit|0|||
105960246|NCT02574078|365515054|FG008|Treatment Period|Maximum clinical benefit|0|||
105960247|NCT02574078|365515055|FG009|Treatment Period|Maximum clinical benefit|1|||
105960248|NCT02574078|365515056|FG010|Treatment Period|Maximum clinical benefit|0|||
106146575|NCT01867216|366197983|FG004|Overall Study|Withdrawal by Subject|1|||
106146576|NCT01867216|366197984|FG005|Overall Study|Withdrawal by Subject|0|||
106146577|NCT01867216|366197985|FG006|Overall Study|Withdrawal by Subject|1|||
105768618|NCT03039790|364804470|FG002|Overall Study|Withdrawal of Consent|0|||
105768619|NCT03039790|364804471|FG003|Overall Study|Withdrawal of Consent|1|||
105768620|NCT03039790|364804472|FG004|Overall Study|Withdrawal of Consent|0|||
105768621|NCT03039790|364804473|FG005|Overall Study|Withdrawal of Consent|0|||
105768622|NCT03039790|364804474|FG006|Overall Study|Withdrawal of Consent|0|||
105768623|NCT03039790|364804475|FG007|Overall Study|Withdrawal of Consent|0|||
105768624|NCT03039790|364804476|FG008|Overall Study|Withdrawal of Consent|0|||
105768625|NCT03039790|364804477|FG009|Overall Study|Withdrawal of Consent|1|||
105768626|NCT03039790|364804478|FG010|Overall Study|Withdrawal of Consent|0|||
105768627|NCT03039790|364804479|FG011|Overall Study|Withdrawal of Consent|0|||
105768628|NCT03039790|364804480|FG012|Overall Study|Withdrawal of Consent|2|||
105768629|NCT03039790|364804481|FG013|Overall Study|Withdrawal of Consent|0|||
105768630|NCT03039790|364804482|FG014|Overall Study|Withdrawal of Consent|1|||
105768631|NCT03039790|364804483|FG015|Overall Study|Withdrawal of Consent|5|||
105768632|NCT03039790|364804484|FG016|Overall Study|Withdrawal of Consent|3|||
105768633|NCT03039790|364804485|FG017|Overall Study|Withdrawal of Consent|0|||
105768634|NCT03039790|364804486|FG018|Overall Study|Withdrawal of Consent|2|||
105768635|NCT03039790|364804487|FG019|Overall Study|Withdrawal of Consent|5|||
105768636|NCT03039790|364804468|FG000|Overall Study|Death|0|||
105768637|NCT03039790|364804469|FG001|Overall Study|Death|0|||
105768638|NCT03039790|364804470|FG002|Overall Study|Death|0|||
105768639|NCT03039790|364804471|FG003|Overall Study|Death|0|||
105768640|NCT03039790|364804472|FG004|Overall Study|Death|0|||
105768641|NCT03039790|364804473|FG005|Overall Study|Death|0|||
105768642|NCT03039790|364804474|FG006|Overall Study|Death|0|||
105825166|NCT00730691|365016498|FG001|Overall Study|Protocol Deviations|5|||
105825167|NCT00730691|365016499|FG002|Overall Study|Protocol Deviations|3|||
105825168|NCT00730691|365016500|FG003|Overall Study|Protocol Deviations|7|||
105825169|NCT00730691|365016501|FG004|Overall Study|Protocol Deviations|5|||
105825170|NCT00730691|365016497|FG000|Overall Study|Withdrawal of Consent|7|||
105825171|NCT00730691|365016498|FG001|Overall Study|Withdrawal of Consent|9|||
105825172|NCT00730691|365016499|FG002|Overall Study|Withdrawal of Consent|3|||
105825173|NCT00730691|365016500|FG003|Overall Study|Withdrawal of Consent|6|||
105825174|NCT00730691|365016501|FG004|Overall Study|Withdrawal of Consent|3|||
105825175|NCT00730691|365016497|FG000|Overall Study|Lost to Follow-up|11|||
105825176|NCT00730691|365016498|FG001|Overall Study|Lost to Follow-up|8|||
105825177|NCT00730691|365016499|FG002|Overall Study|Lost to Follow-up|13|||
105825178|NCT00730691|365016500|FG003|Overall Study|Lost to Follow-up|15|||
105825179|NCT00730691|365016501|FG004|Overall Study|Lost to Follow-up|13|||
105825180|NCT00730691|365016497|FG000|Overall Study|Other|1|||
105825181|NCT00730691|365016498|FG001|Overall Study|Other|1|||
105825182|NCT00730691|365016499|FG002|Overall Study|Other|1|||
105825183|NCT00730691|365016500|FG003|Overall Study|Other|2|||
105825184|NCT00730691|365016501|FG004|Overall Study|Other|2|||
105825185|NCT02554890|365016502|FG000|Double-blind|Adverse Event|45|||
105825186|NCT02554890|365016503|FG001|Double-blind|Adverse Event|51|||
105825187|NCT02554890|365016502|FG000|Double-blind|Death|6|||
105825188|NCT02554890|365016503|FG001|Double-blind|Death|4|||
105960249|NCT02574078|365515057|FG011|Treatment Period|Maximum clinical benefit|0|||
105960250|NCT02574078|365515058|FG012|Treatment Period|Maximum clinical benefit|0|||
105960251|NCT03292874|365515061|FG000|Overall Study|Due to pandemic|5|||
105825189|NCT02554890|365016502|FG000|Double-blind|Protocol Violation|1|||
105825190|NCT02554890|365016503|FG001|Double-blind|Protocol Violation|1|||
105825191|NCT02554890|365016502|FG000|Double-blind|Physician Decision|4|||
105825192|NCT02554890|365016503|FG001|Double-blind|Physician Decision|3|||
105825193|NCT02554890|365016502|FG000|Double-blind|Subject/Guardian decision|21|||
105960252|NCT00161616|365515062|FG000|Overall Study|Withdrawal by Subject|6|||
105825194|NCT02554890|365016503|FG001|Double-blind|Subject/Guardian decision|16|||
105825195|NCT02554890|365016502|FG000|Double-blind|Lost to Follow-up|7|||
105825196|NCT02554890|365016503|FG001|Double-blind|Lost to Follow-up|5|||
105825197|NCT02554890|365016502|FG000|Double-blind|Technical problems|1|||
105825198|NCT02554890|365016503|FG001|Double-blind|Technical problems|0|||
105825199|NCT02554890|365016502|FG000|Double-blind|Withdrawal by Subject|5|||
105825200|NCT02554890|365016503|FG001|Double-blind|Withdrawal by Subject|6|||
105825201|NCT02554890|365016502|FG000|Double-blind|Noncompliance with study treatment|6|||
105825202|NCT02554890|365016503|FG001|Double-blind|Noncompliance with study treatment|5|||
105825203|NCT02554890|365016502|FG000|Open-label|Adverse Event|0|||
105825204|NCT02554890|365016503|FG001|Open-label|Adverse Event|30|||
105825205|NCT02554890|365016502|FG000|Open-label|Death|0|||
105825206|NCT02554890|365016503|FG001|Open-label|Death|1|||
105825207|NCT02554890|365016502|FG000|Open-label|Physician Decision|0|||
105825208|NCT02554890|365016503|FG001|Open-label|Physician Decision|1|||
105825209|NCT02554890|365016502|FG000|Open-label|Subject/Guardian decision|0|||
105825210|NCT02554890|365016503|FG001|Open-label|Subject/Guardian decision|11|||
105960253|NCT00161616|365515063|FG001|Overall Study|Withdrawal by Subject|5|||
105960254|NCT00161616|365515062|FG000|Overall Study|Physician Decision|1|||
105960255|NCT00161616|365515063|FG001|Overall Study|Physician Decision|0|||
105960256|NCT00161616|365515062|FG000|Overall Study|Death|1|||
105960257|NCT00161616|365515063|FG001|Overall Study|Death|1|||
105960258|NCT00161616|365515062|FG000|Overall Study|Lost to Follow-up|17|||
105960259|NCT00161616|365515063|FG001|Overall Study|Lost to Follow-up|13|||
105960260|NCT00161616|365515062|FG000|Overall Study|Protocol deviation|1|||
105960261|NCT00161616|365515063|FG001|Overall Study|Protocol deviation|0|||
105960262|NCT00854724|365515064|FG000|First Intervention|Withdrawal by Subject|1|||
105960263|NCT00854724|365515065|FG001|First Intervention|Withdrawal by Subject|1|||
105960264|NCT00854724|365515064|FG000|Washout|Protocol Violation|1|||
105960265|NCT00854724|365515065|FG001|Washout|Protocol Violation|0|||
105960266|NCT00854724|365515064|FG000|Washout|Withdrawal by Subject|0|||
105960267|NCT00854724|365515065|FG001|Washout|Withdrawal by Subject|1|||
105960268|NCT00854724|365515064|FG000|Second Intervention|Protocol Violation|1|||
105960269|NCT00854724|365515065|FG001|Second Intervention|Protocol Violation|0|||
105960270|NCT00854724|365515064|FG000|Second Intervention|Physician Decision|0|||
105960271|NCT00854724|365515065|FG001|Second Intervention|Physician Decision|1|||
105960272|NCT00933608|365515066|FG000|Overall Study|Adverse Event|4|||
105960273|NCT00933608|365515067|FG001|Overall Study|Adverse Event|2|||
105960274|NCT00933608|365515066|FG000|Overall Study|Physician Decision|1|||
105960275|NCT00933608|365515067|FG001|Overall Study|Physician Decision|0|||
105960276|NCT00336284|365515072|FG000|Overall Study|Death|52|||
105960277|NCT00336284|365515073|FG001|Overall Study|Death|26|||
105960278|NCT00336284|365515072|FG000|Overall Study|Lost to Follow-up|82|||
105960279|NCT00336284|365515073|FG001|Overall Study|Lost to Follow-up|61|||
105960280|NCT00336284|365515072|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
105960281|NCT00336284|365515073|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
105960282|NCT01961297|365515081|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
105960283|NCT01961297|365515082|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
105960284|NCT01521923|365515083|FG000|Overall Study|AE, serious fatal|1|||
105960285|NCT01521923|365515084|FG001|Overall Study|AE, serious fatal|0|||
105960286|NCT01521923|365515085|FG002|Overall Study|AE, serious fatal|0|||
105960287|NCT01521923|365515086|FG003|Overall Study|AE, serious fatal|0|||
105960288|NCT01521923|365515083|FG000|Overall Study|SAE, non-fatal|0|||
105960289|NCT01521923|365515084|FG001|Overall Study|SAE, non-fatal|2|||
105960290|NCT01521923|365515085|FG002|Overall Study|SAE, non-fatal|2|||
105960291|NCT01521923|365515086|FG003|Overall Study|SAE, non-fatal|0|||
105960292|NCT01521923|365515083|FG000|Overall Study|AE, non-serious, non-fatal|1|||
106146578|NCT01867216|366197979|FG000|Overall Study|Physician Decision|1|||
105825211|NCT02554890|365016502|FG000|Open-label|Lost to Follow-up|0|||
105825212|NCT02554890|365016503|FG001|Open-label|Lost to Follow-up|7|||
105825213|NCT02554890|365016502|FG000|Open-label|Technical problems|0|||
105825214|NCT02554890|365016503|FG001|Open-label|Technical problems|1|||
105825215|NCT02554890|365016502|FG000|Open-label|Withdrawal by Subject|0|||
105825216|NCT02554890|365016503|FG001|Open-label|Withdrawal by Subject|1|||
105825217|NCT03067987|365016504|FG000|Overall Study|Lost to Follow-up|7|||
105825218|NCT03067987|365016505|FG001|Overall Study|Lost to Follow-up|10|||
105960293|NCT01521923|365515084|FG001|Overall Study|AE, non-serious, non-fatal|3|||
105960294|NCT01521923|365515085|FG002|Overall Study|AE, non-serious, non-fatal|6|||
105960295|NCT01521923|365515086|FG003|Overall Study|AE, non-serious, non-fatal|2|||
105960296|NCT01521923|365515083|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
105960297|NCT01521923|365515084|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
105960298|NCT01521923|365515085|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
105825219|NCT03067987|365016504|FG000|Overall Study|Protocol Violation|1|||
105825220|NCT03067987|365016505|FG001|Overall Study|Protocol Violation|2|||
105825221|NCT03067987|365016504|FG000|Overall Study|Withdrawal by Subject|2|||
105825222|NCT03067987|365016505|FG001|Overall Study|Withdrawal by Subject|1|||
105825223|NCT00477594|365016508|FG000|Year 1 and Year 2|Adverse Event|4|||
105825224|NCT00477594|365016509|FG001|Year 1 and Year 2|Adverse Event|2|||
105960299|NCT01521923|365515086|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
105960300|NCT01521923|365515083|FG000|Overall Study|Lack of Efficacy|1|||
105960301|NCT01521923|365515084|FG001|Overall Study|Lack of Efficacy|1|||
105960302|NCT01521923|365515085|FG002|Overall Study|Lack of Efficacy|0|||
105960303|NCT01521923|365515086|FG003|Overall Study|Lack of Efficacy|0|||
105960304|NCT01521923|365515083|FG000|Overall Study|Protocol Violation|0|||
105960305|NCT01521923|365515084|FG001|Overall Study|Protocol Violation|0|||
105960306|NCT01521923|365515085|FG002|Overall Study|Protocol Violation|1|||
105960307|NCT01521923|365515086|FG003|Overall Study|Protocol Violation|0|||
105960308|NCT01521923|365515083|FG000|Overall Study|Lost to Follow-up|1|||
105960309|NCT01521923|365515084|FG001|Overall Study|Lost to Follow-up|0|||
105960310|NCT01521923|365515085|FG002|Overall Study|Lost to Follow-up|2|||
105960311|NCT01521923|365515086|FG003|Overall Study|Lost to Follow-up|1|||
105960312|NCT01521923|365515083|FG000|Overall Study|Withdrawal by Subject|1|||
105960313|NCT01521923|365515084|FG001|Overall Study|Withdrawal by Subject|1|||
105960314|NCT01521923|365515085|FG002|Overall Study|Withdrawal by Subject|1|||
105960315|NCT01521923|365515086|FG003|Overall Study|Withdrawal by Subject|2|||
105960316|NCT01521923|365515083|FG000|Overall Study|Other|2|||
105960317|NCT01521923|365515084|FG001|Overall Study|Other|1|||
105960318|NCT01521923|365515085|FG002|Overall Study|Other|3|||
105960319|NCT01521923|365515086|FG003|Overall Study|Other|6|||
105960320|NCT01521923|365515083|FG000|Overall Study|AE, captured in Period 1|0|||
105960321|NCT01521923|365515084|FG001|Overall Study|AE, captured in Period 1|1|||
105960322|NCT01521923|365515085|FG002|Overall Study|AE, captured in Period 1|0|||
105960323|NCT01521923|365515086|FG003|Overall Study|AE, captured in Period 1|1|||
105960324|NCT00391053|365515091|FG000|Overall Study|Serious Adverse Events|1|||
105960325|NCT00391053|365515092|FG001|Overall Study|Serious Adverse Events|0|||
105960326|NCT00391053|365515093|FG002|Overall Study|Serious Adverse Events|1|||
105960327|NCT00391053|365515094|FG003|Overall Study|Serious Adverse Events|4|||
105960328|NCT00391053|365515091|FG000|Overall Study|Protocol Violation|2|||
105960329|NCT00391053|365515092|FG001|Overall Study|Protocol Violation|0|||
105960330|NCT00391053|365515093|FG002|Overall Study|Protocol Violation|0|||
105960331|NCT00391053|365515094|FG003|Overall Study|Protocol Violation|0|||
105960332|NCT00391053|365515091|FG000|Overall Study|Lost to Follow-up|1|||
105960333|NCT00391053|365515092|FG001|Overall Study|Lost to Follow-up|0|||
105960334|NCT00391053|365515093|FG002|Overall Study|Lost to Follow-up|0|||
105825225|NCT00477594|365016508|FG000|Year 1 and Year 2|Physician Decision|2|||
105960335|NCT00391053|365515094|FG003|Overall Study|Lost to Follow-up|5|||
105960336|NCT00391053|365515091|FG000|Overall Study|Withdrawal by Subject|5|||
106021787|NCT04080167|365744816|FG001|Overall Study|Lost to Follow-up-Patients|14|||
106021788|NCT04080167|365744817|FG002|Overall Study|Lost to Follow-up-Patients|0|||
106021789|NCT04080167|365744815|FG000|Overall Study|Lost to Follow-up-Providers|2|||
106021790|NCT04080167|365744816|FG001|Overall Study|Lost to Follow-up-Providers|2|||
106021791|NCT04080167|365744817|FG002|Overall Study|Lost to Follow-up-Providers|0|||
106021792|NCT04080167|365744815|FG000|Overall Study|Withdrawal by Subject|1|||
106021793|NCT04080167|365744816|FG001|Overall Study|Withdrawal by Subject|2|||
106021794|NCT04080167|365744817|FG002|Overall Study|Withdrawal by Subject|0|||
106021795|NCT04080167|365744815|FG000|Overall Study|Withdrawal by Provider|0|||
106021796|NCT04080167|365744816|FG001|Overall Study|Withdrawal by Provider|0|||
106021797|NCT04080167|365744817|FG002|Overall Study|Withdrawal by Provider|4|||
106021798|NCT04080167|365744815|FG000|Overall Study|Death-Patient|2|||
106146579|NCT01867216|366197980|FG001|Overall Study|Physician Decision|0|||
106146580|NCT01867216|366197981|FG002|Overall Study|Physician Decision|0|||
105825226|NCT00477594|365016509|FG001|Year 1 and Year 2|Physician Decision|1|||
105825227|NCT00477594|365016508|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
105825228|NCT00477594|365016509|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
105825229|NCT00477594|365016508|FG000|Year 1 and Year 2|Other|1|||
105825230|NCT00477594|365016509|FG001|Year 1 and Year 2|Other|0|||
105825231|NCT00477594|365016508|FG000|Year 3|Adverse Event|1|||
105825232|NCT00477594|365016509|FG001|Year 3|Adverse Event|0|||
105825233|NCT00477594|365016508|FG000|Year 3|Withdrawal by Subject|1|||
105825234|NCT00477594|365016509|FG001|Year 3|Withdrawal by Subject|0|||
105825235|NCT00477594|365016508|FG000|Follow-up Period|Withdrawal by Subject|2|||
105825236|NCT00477594|365016509|FG001|Follow-up Period|Withdrawal by Subject|1|||
105960337|NCT00391053|365515092|FG001|Overall Study|Withdrawal by Subject|1|||
105960338|NCT00391053|365515093|FG002|Overall Study|Withdrawal by Subject|1|||
105960339|NCT00391053|365515094|FG003|Overall Study|Withdrawal by Subject|1|||
105825237|NCT00477594|365016508|FG000|Follow-up Period|Other|1|||
105825238|NCT00477594|365016509|FG001|Follow-up Period|Other|0|||
105960340|NCT05002985|365515095|FG000|Overall Study|Withdrawal by Subject|1|||
105960341|NCT00430989|365515096|FG000|Overall Study|Lost to Follow-up|2|||
105960342|NCT00430989|365515097|FG001|Overall Study|Lost to Follow-up|3|||
105960343|NCT00430989|365515096|FG000|Overall Study|Withdrawal by Subject|15|||
105825239|NCT03447353|365018201|FG000|Overall Study|Failure at Screening Visit|2|||
105825240|NCT03447353|365018201|FG000|Overall Study|Lost to Follow-up|4|||
106021799|NCT04080167|365744816|FG001|Overall Study|Death-Patient|1|||
106021800|NCT04080167|365744817|FG002|Overall Study|Death-Patient|0|||
106021801|NCT04080167|365744815|FG000|Overall Study|Hydroxyurea New Starts|0|||
106021802|NCT04080167|365744816|FG001|Overall Study|Hydroxyurea New Starts|0|||
106021803|NCT04080167|365744817|FG002|Overall Study|Hydroxyurea New Starts|1|||
105960344|NCT00430989|365515097|FG001|Overall Study|Withdrawal by Subject|14|||
105960345|NCT00430989|365515096|FG000|Overall Study|Protocol Violation|30|||
105960346|NCT00430989|365515097|FG001|Overall Study|Protocol Violation|37|||
105960347|NCT00430989|365515096|FG000|Overall Study|Not eligible|13|||
105960348|NCT00430989|365515097|FG001|Overall Study|Not eligible|6|||
105960349|NCT03782259|365515098|FG000|Overall Study|Lost to Follow-up|1|||
105960350|NCT03782259|365515099|FG001|Overall Study|Lost to Follow-up|1|||
105960351|NCT03782259|365515098|FG000|Overall Study|Moved out of state|0|||
105960352|NCT03782259|365515099|FG001|Overall Study|Moved out of state|2|||
105960353|NCT03782259|365515098|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
105960354|NCT03782259|365515099|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
105960355|NCT03782259|365515098|FG000|Overall Study|Subject discontinued intervention|1|||
105825241|NCT03447353|365018201|FG000|Overall Study|Scheduling Conflicts|3|||
105960356|NCT03782259|365515099|FG001|Overall Study|Subject discontinued intervention|0|||
105825242|NCT03447353|365018201|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
105825243|NCT02222818|365018206|FG000|Period 1|Eligibility criteria not met|0|||
105960357|NCT00590122|365515100|FG000|Overall Study|swallowed oral dissolving dose|1|||
105825244|NCT02222818|365018207|FG001|Period 1|Eligibility criteria not met|3|||
105825245|NCT04183335|365018208|FG000|Overall Study|Adverse Event|1|||
105825246|NCT04183335|365018209|FG001|Overall Study|Adverse Event|0|||
105825247|NCT04183335|365018208|FG000|Overall Study|Withdrawal by Subject|12|||
105825248|NCT04183335|365018209|FG001|Overall Study|Withdrawal by Subject|3|||
105825249|NCT01660243|365018210|FG000|Overall Study|Adverse Event|1|||
105825250|NCT01660243|365018211|FG001|Overall Study|Adverse Event|0|||
105825251|NCT01660243|365018212|FG002|Overall Study|Adverse Event|1|||
105825252|NCT01660243|365018213|FG003|Overall Study|Adverse Event|0|||
105825253|NCT01660243|365018210|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
105825254|NCT01660243|365018211|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
105825255|NCT01660243|365018212|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
105825256|NCT01660243|365018213|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
105825257|NCT01660243|365018210|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
105825258|NCT01660243|365018211|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
105825259|NCT01660243|365018212|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
105825260|NCT01660243|365018213|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
105825261|NCT01660243|365018210|FG000|Overall Study|Randomization error|0|||
105825262|NCT01660243|365018211|FG001|Overall Study|Randomization error|0|||
105825263|NCT01660243|365018212|FG002|Overall Study|Randomization error|0|||
105825264|NCT01660243|365018213|FG003|Overall Study|Randomization error|1|||
105825265|NCT01319383|365018220|FG000|Overall Study|No ex vivo or in vivo response|4|||
105825266|NCT01319383|365018221|FG001|Overall Study|No ex vivo or in vivo response|0|||
105825267|NCT01319383|365018220|FG000|Overall Study|Physician Decision|3|||
105825268|NCT01319383|365018221|FG001|Overall Study|Physician Decision|0|||
105825269|NCT01319383|365018220|FG000|Overall Study|Lack of Efficacy|5|||
105825270|NCT01319383|365018221|FG001|Overall Study|Lack of Efficacy|9|||
105825271|NCT01319383|365018220|FG000|Overall Study|No in vivo response to interval doses|0|||
105825272|NCT01319383|365018221|FG001|Overall Study|No in vivo response to interval doses|1|||
105825273|NCT01987765|365018224|FG000|Overall Study|Protocol Violation|65|||
105825274|NCT01987765|365018224|FG000|Overall Study|Lost to Follow-up|37|||
105825275|NCT00772603|365018225|FG000|Overall Study|Withdrawal by Subject|11|||
105960358|NCT00590122|365515101|FG001|Overall Study|swallowed oral dissolving dose|0|||
105960359|NCT01642901|365515102|FG000|12-month Follow-up|Withdrawal by Subject|1|||
105960360|NCT01642901|365515103|FG001|12-month Follow-up|Withdrawal by Subject|0|||
105960361|NCT05069597|365515104|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
106021804|NCT04080167|365744815|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
106021805|NCT04080167|365744816|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
106021806|NCT04080167|365744817|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
106021807|NCT02167139|365744818|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
106146581|NCT01867216|366197982|FG003|Overall Study|Physician Decision|0|||
106146582|NCT01867216|366197983|FG004|Overall Study|Physician Decision|0|||
105825276|NCT00772603|365018226|FG001|Overall Study|Withdrawal by Subject|10|||
105825277|NCT00772603|365018227|FG002|Overall Study|Withdrawal by Subject|6|||
105825278|NCT00772603|365018225|FG000|Overall Study|Adverse Event|37|||
105825279|NCT00772603|365018226|FG001|Overall Study|Adverse Event|18|||
105825280|NCT00772603|365018227|FG002|Overall Study|Adverse Event|10|||
105825281|NCT00772603|365018225|FG000|Overall Study|Subject Non-compliance|1|||
105825282|NCT00772603|365018226|FG001|Overall Study|Subject Non-compliance|6|||
105825283|NCT00772603|365018227|FG002|Overall Study|Subject Non-compliance|4|||
105825284|NCT00772603|365018225|FG000|Overall Study|Protocol Violation|0|||
105825285|NCT00772603|365018226|FG001|Overall Study|Protocol Violation|1|||
105825286|NCT00772603|365018227|FG002|Overall Study|Protocol Violation|1|||
106146583|NCT01867216|366197984|FG005|Overall Study|Physician Decision|0|||
106146584|NCT01867216|366197985|FG006|Overall Study|Physician Decision|0|||
106146585|NCT01867216|366197979|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
106146586|NCT01867216|366197980|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
106146587|NCT01867216|366197981|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
106146588|NCT01867216|366197982|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
106146589|NCT01867216|366197983|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
106146590|NCT01867216|366197984|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
106146591|NCT01867216|366197985|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
106146592|NCT02567656|366197997|FG000|Overall Study|Premature discontinuation due to PD|1|||
106146593|NCT02567656|366197998|FG001|Overall Study|Premature discontinuation due to PD|1|||
106146594|NCT02567656|366197999|FG002|Overall Study|Premature discontinuation due to PD|2|||
106146595|NCT02567656|366198000|FG003|Overall Study|Premature discontinuation due to PD|0|||
106146596|NCT02567656|366198001|FG004|Overall Study|Premature discontinuation due to PD|0|||
106146597|NCT02567656|366198002|FG005|Overall Study|Premature discontinuation due to PD|0|||
106146598|NCT01582100|366198003|FG000|Overall Study|Adverse Event|1|||
106146599|NCT01582100|366198003|FG000|Overall Study|Withdrawal by Subject|1|||
106146600|NCT01078116|366198006|FG000|Overall Study|Lost to Follow-up|17|||
106146601|NCT01078116|366198006|FG000|Overall Study|Adverse Event|5|||
106146602|NCT01078116|366198006|FG000|Overall Study|Withdrawal by Subject|8|||
106146603|NCT01078116|366198006|FG000|Overall Study|Lack of effectiveness|15|||
106146604|NCT01078116|366198006|FG000|Overall Study|Case report form not completed|3|||
106146605|NCT03644849|366198007|FG000|Overall Study|Lost to Follow-up|1|||
106146606|NCT03644849|366198008|FG001|Overall Study|Lost to Follow-up|3|||
106146607|NCT00508924|366198009|FG000|Overall Study|Protocol Violation|0|||
106146608|NCT00508924|366198010|FG001|Overall Study|Protocol Violation|0|||
106146609|NCT00508924|366198011|FG002|Overall Study|Protocol Violation|1|||
106146610|NCT00508924|366198012|FG003|Overall Study|Protocol Violation|1|||
106146611|NCT02593149|366198017|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
106146612|NCT02593149|366198018|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
106146613|NCT02593149|366198017|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
106146614|NCT02593149|366198018|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
106146615|NCT01460290|366198024|FG000|Overall Study|Adverse Event|3|||
106146616|NCT01460290|366198024|FG000|Overall Study|Elevated liver function|1|||
106146617|NCT01135511|366198025|FG000|Overall Study|Adverse Event|0|||
106146618|NCT01135511|366198026|FG001|Overall Study|Adverse Event|1|||
106146619|NCT01135511|366198027|FG002|Overall Study|Adverse Event|2|||
106146620|NCT01135511|366198028|FG003|Overall Study|Adverse Event|0|||
106146621|NCT01135511|366198029|FG004|Overall Study|Adverse Event|0|||
106146622|NCT01135511|366198030|FG005|Overall Study|Adverse Event|1|||
106146623|NCT01135511|366198031|FG006|Overall Study|Adverse Event|0|||
106146624|NCT01135511|366198032|FG007|Overall Study|Adverse Event|1|||
106146625|NCT01135511|366198033|FG008|Overall Study|Adverse Event|0|||
106146626|NCT01135511|366198025|FG000|Overall Study|Lack of Efficacy|0|||
106146627|NCT01135511|366198026|FG001|Overall Study|Lack of Efficacy|1|||
106146628|NCT01135511|366198027|FG002|Overall Study|Lack of Efficacy|1|||
106146629|NCT01135511|366198028|FG003|Overall Study|Lack of Efficacy|2|||
106146630|NCT01135511|366198029|FG004|Overall Study|Lack of Efficacy|0|||
106146631|NCT01135511|366198030|FG005|Overall Study|Lack of Efficacy|0|||
106146632|NCT01135511|366198031|FG006|Overall Study|Lack of Efficacy|0|||
106146633|NCT01135511|366198032|FG007|Overall Study|Lack of Efficacy|0|||
106146634|NCT01135511|366198033|FG008|Overall Study|Lack of Efficacy|0|||
106146635|NCT01135511|366198025|FG000|Overall Study|Protocol Violation|0|||
106146636|NCT01135511|366198026|FG001|Overall Study|Protocol Violation|0|||
106146637|NCT01135511|366198027|FG002|Overall Study|Protocol Violation|3|||
106146638|NCT01135511|366198028|FG003|Overall Study|Protocol Violation|0|||
106146639|NCT01135511|366198029|FG004|Overall Study|Protocol Violation|0|||
106146640|NCT01135511|366198030|FG005|Overall Study|Protocol Violation|0|||
106146641|NCT01135511|366198031|FG006|Overall Study|Protocol Violation|0|||
106146642|NCT01135511|366198032|FG007|Overall Study|Protocol Violation|0|||
106146643|NCT01135511|366198033|FG008|Overall Study|Protocol Violation|0|||
106146644|NCT01135511|366198025|FG000|Overall Study|Pregnancy|0|||
106146645|NCT01135511|366198026|FG001|Overall Study|Pregnancy|0|||
106146646|NCT01135511|366198027|FG002|Overall Study|Pregnancy|0|||
106146647|NCT01135511|366198028|FG003|Overall Study|Pregnancy|1|||
106146648|NCT01135511|366198029|FG004|Overall Study|Pregnancy|0|||
106146649|NCT01135511|366198030|FG005|Overall Study|Pregnancy|0|||
106146650|NCT01135511|366198031|FG006|Overall Study|Pregnancy|0|||
106146651|NCT01135511|366198032|FG007|Overall Study|Pregnancy|0|||
106146652|NCT01135511|366198033|FG008|Overall Study|Pregnancy|0|||
106146653|NCT01135511|366198025|FG000|Overall Study|could not visit the clinic|0|||
106146654|NCT01135511|366198026|FG001|Overall Study|could not visit the clinic|1|||
106146655|NCT01135511|366198027|FG002|Overall Study|could not visit the clinic|2|||
106146656|NCT01135511|366198028|FG003|Overall Study|could not visit the clinic|0|||
106146657|NCT01135511|366198029|FG004|Overall Study|could not visit the clinic|0|||
105825287|NCT00772603|365018225|FG000|Overall Study|Lost to Follow-up|1|||
105825288|NCT00772603|365018226|FG001|Overall Study|Lost to Follow-up|5|||
105825289|NCT00772603|365018227|FG002|Overall Study|Lost to Follow-up|2|||
105825290|NCT00772603|365018225|FG000|Overall Study|Physician Decision|0|||
105825291|NCT00772603|365018226|FG001|Overall Study|Physician Decision|0|||
105825292|NCT00772603|365018227|FG002|Overall Study|Physician Decision|1|||
105825293|NCT00772603|365018225|FG000|Overall Study|Other|2|||
105825294|NCT00772603|365018226|FG001|Overall Study|Other|0|||
105825295|NCT00772603|365018227|FG002|Overall Study|Other|2|||
105825296|NCT01528696|365018228|FG000|Overall Study|See detailed description|18|||
105825297|NCT01528696|365018229|FG001|Overall Study|See detailed description|19|||
105825298|NCT03600805|365018230|FG000|Overall Study|Adverse Event|2|||
105825299|NCT03600805|365018231|FG001|Overall Study|Adverse Event|1|||
105825300|NCT03600805|365018232|FG002|Overall Study|Adverse Event|1|||
105825301|NCT03600805|365018233|FG003|Overall Study|Adverse Event|7|||
105825302|NCT03600805|365018230|FG000|Overall Study|Lack of Efficacy|2|||
105825303|NCT03600805|365018231|FG001|Overall Study|Lack of Efficacy|1|||
105825304|NCT03600805|365018232|FG002|Overall Study|Lack of Efficacy|0|||
105825305|NCT03600805|365018233|FG003|Overall Study|Lack of Efficacy|0|||
105825306|NCT03600805|365018230|FG000|Overall Study|Withdrawal by Subject|1|||
105825307|NCT03600805|365018231|FG001|Overall Study|Withdrawal by Subject|0|||
105825308|NCT03600805|365018232|FG002|Overall Study|Withdrawal by Subject|0|||
105825309|NCT03600805|365018233|FG003|Overall Study|Withdrawal by Subject|1|||
105825310|NCT03600805|365018230|FG000|Overall Study|Other unspecified|14|||
105825311|NCT03600805|365018231|FG001|Overall Study|Other unspecified|6|||
105825312|NCT03600805|365018232|FG002|Overall Study|Other unspecified|7|||
105825313|NCT03600805|365018233|FG003|Overall Study|Other unspecified|11|||
105825314|NCT02545283|365018234|FG000|Overall Study|Lost to Follow-up|2|||
105825315|NCT02545283|365018235|FG001|Overall Study|Lost to Follow-up|4|||
105825316|NCT02545283|365018234|FG000|Overall Study|Withdrawal by Subject|5|||
105825317|NCT02545283|365018235|FG001|Overall Study|Withdrawal by Subject|9|||
105825318|NCT02545283|365018234|FG000|Overall Study|Death|109|||
105825319|NCT02545283|365018235|FG001|Overall Study|Death|211|||
105825320|NCT02545283|365018234|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
105825321|NCT02545283|365018235|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
105825322|NCT02545283|365018234|FG000|Overall Study|Study Terminated By Sponsor|33|||
105825323|NCT02545283|365018235|FG001|Overall Study|Study Terminated By Sponsor|71|||
105825324|NCT01564394|365018240|FG000|Overall Study|Withdrawal by Subject|6|||
105825325|NCT01564394|365018241|FG001|Overall Study|Withdrawal by Subject|10|||
105825326|NCT00443651|365018244|FG000|Overall Study|Death|1|||
105825327|NCT00443651|365018245|FG001|Overall Study|Death|5|||
105825328|NCT00443651|365018244|FG000|Overall Study|Adverse Event|5|||
105825329|NCT00443651|365018245|FG001|Overall Study|Adverse Event|6|||
105825330|NCT00443651|365018244|FG000|Overall Study|Lost to Follow-up|18|||
105825331|NCT00443651|365018245|FG001|Overall Study|Lost to Follow-up|12|||
105825332|NCT00443651|365018244|FG000|Overall Study|Patient's/Guardian's Decision|58|||
105825333|NCT00443651|365018245|FG001|Overall Study|Patient's/Guardian's Decision|30|||
105825334|NCT00443651|365018244|FG000|Overall Study|Physician Decision|13|||
105825335|NCT00443651|365018245|FG001|Overall Study|Physician Decision|4|||
105825336|NCT00443651|365018244|FG000|Overall Study|Pregnancy|0|||
106021808|NCT02167139|365744819|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
105825337|NCT00443651|365018245|FG001|Overall Study|Pregnancy|1|||
105825338|NCT03606174|365018246|FG000|Overall Study|Death|37|||
105825339|NCT03606174|365018247|FG001|Overall Study|Death|15|||
105825340|NCT03606174|365018248|FG002|Overall Study|Death|15|||
105825341|NCT03606174|365018249|FG003|Overall Study|Death|7|||
105825342|NCT03606174|365018250|FG004|Overall Study|Death|35|||
105825343|NCT03606174|365018251|FG005|Overall Study|Death|12|||
105825344|NCT03606174|365018252|FG006|Overall Study|Death|35|||
105825345|NCT03606174|365018253|FG007|Overall Study|Death|8|||
105825346|NCT03606174|365018254|FG008|Overall Study|Death|5|||
105825347|NCT03606174|365018255|FG009|Overall Study|Death|3|||
105825348|NCT03606174|365018256|FG010|Overall Study|Death|0|||
105825349|NCT03606174|365018246|FG000|Overall Study|Lost to Follow-up|0|||
105825350|NCT03606174|365018247|FG001|Overall Study|Lost to Follow-up|0|||
105825351|NCT03606174|365018248|FG002|Overall Study|Lost to Follow-up|0|||
105825352|NCT03606174|365018249|FG003|Overall Study|Lost to Follow-up|0|||
105825353|NCT03606174|365018250|FG004|Overall Study|Lost to Follow-up|1|||
105825354|NCT03606174|365018251|FG005|Overall Study|Lost to Follow-up|1|||
105825355|NCT03606174|365018252|FG006|Overall Study|Lost to Follow-up|0|||
105825356|NCT03606174|365018253|FG007|Overall Study|Lost to Follow-up|0|||
105825357|NCT03606174|365018254|FG008|Overall Study|Lost to Follow-up|0|||
105825358|NCT03606174|365018255|FG009|Overall Study|Lost to Follow-up|0|||
105825359|NCT03606174|365018256|FG010|Overall Study|Lost to Follow-up|0|||
105825360|NCT03606174|365018246|FG000|Overall Study|Withdrawal by Subject|6|||
105825361|NCT03606174|365018247|FG001|Overall Study|Withdrawal by Subject|0|||
105825362|NCT03606174|365018248|FG002|Overall Study|Withdrawal by Subject|0|||
106021809|NCT02167139|365744820|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
106021810|NCT02167139|365744821|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
106021811|NCT02167139|365744818|FG000|Randomised, Double-blind|Adverse Event|2|||
105960362|NCT05069597|365515105|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
105960363|NCT01709110|365515106|FG000|Overall Study|Adverse Event|56|||
105960364|NCT01709110|365515107|FG001|Overall Study|Adverse Event|48|||
105960365|NCT01709110|365515106|FG000|Overall Study|Death|14|||
105960366|NCT01709110|365515107|FG001|Overall Study|Death|6|||
105960367|NCT01709110|365515106|FG000|Overall Study|Lost to Follow-up|7|||
105960368|NCT01709110|365515107|FG001|Overall Study|Lost to Follow-up|5|||
105960369|NCT01709110|365515106|FG000|Overall Study|Protocol Violation|4|||
105960370|NCT01709110|365515107|FG001|Overall Study|Protocol Violation|6|||
105960371|NCT01709110|365515106|FG000|Overall Study|Withdrawal by Subject|96|||
105960372|NCT01709110|365515107|FG001|Overall Study|Withdrawal by Subject|89|||
105960373|NCT01709110|365515106|FG000|Overall Study|Physician Decision|4|||
105960374|NCT01709110|365515107|FG001|Overall Study|Physician Decision|10|||
105960375|NCT01709110|365515106|FG000|Overall Study|Sponsor Decision|2|||
105960376|NCT01709110|365515107|FG001|Overall Study|Sponsor Decision|2|||
105960377|NCT01709110|365515106|FG000|Overall Study|Lack of Efficacy|1|||
105960378|NCT01709110|365515107|FG001|Overall Study|Lack of Efficacy|1|||
105960379|NCT01709110|365515106|FG000|Overall Study|Caregiver Decision|1|||
105960380|NCT01709110|365515107|FG001|Overall Study|Caregiver Decision|1|||
105960381|NCT02120781|365515110|FG000|Overall Study|Physician Decision|2|||
105960382|NCT02120781|365515111|FG001|Overall Study|Physician Decision|0|||
105960383|NCT02120781|365515110|FG000|Overall Study|Completion not documented|2|||
105960384|NCT02120781|365515111|FG001|Overall Study|Completion not documented|1|||
105960385|NCT00485758|365515112|FG000|Overall Study|Adverse Event|102|||
105960386|NCT00485758|365515113|FG001|Overall Study|Adverse Event|31|||
105960387|NCT00485758|365515112|FG000|Overall Study|Death|0|||
105960388|NCT00485758|365515113|FG001|Overall Study|Death|1|||
105960389|NCT00485758|365515112|FG000|Overall Study|Lost to Follow-up|5|||
105960390|NCT00485758|365515113|FG001|Overall Study|Lost to Follow-up|1|||
105960391|NCT00485758|365515112|FG000|Overall Study|Physician Decision|3|||
105960392|NCT00485758|365515113|FG001|Overall Study|Physician Decision|3|||
105960393|NCT00485758|365515112|FG000|Overall Study|Protocol Violation|11|||
105960394|NCT00485758|365515113|FG001|Overall Study|Protocol Violation|2|||
105960395|NCT00485758|365515112|FG000|Overall Study|Withdrawal by Subject|32|||
105960396|NCT00485758|365515113|FG001|Overall Study|Withdrawal by Subject|27|||
105960397|NCT00485758|365515112|FG000|Overall Study|Study Terminated by Sponsor|3|||
105960398|NCT00485758|365515113|FG001|Overall Study|Study Terminated by Sponsor|0|||
105960399|NCT04556591|365515114|FG000|Overall Study|Lost to Follow-up|1|||
105960400|NCT04556591|365515115|FG001|Overall Study|Lost to Follow-up|0|||
105960401|NCT04556591|365515114|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
105960402|NCT04556591|365515115|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
105960403|NCT03462641|365515122|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
105960404|NCT03462641|365515123|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
105960405|NCT03462641|365515122|FG000|Visit 2|Withdrawal by Subject|0|||
105960406|NCT03462641|365515123|FG001|Visit 2|Withdrawal by Subject|1|||
105960407|NCT02526212|365515124|FG000|Overall Study|Incarceration|1|||
105960408|NCT02526212|365515125|FG001|Overall Study|Incarceration|0|||
105960409|NCT02526212|365515124|FG000|Overall Study|Lost to Follow-up|1|||
105960410|NCT02526212|365515125|FG001|Overall Study|Lost to Follow-up|0|||
105960411|NCT02526212|365515124|FG000|Overall Study|Death|0|||
105960412|NCT02526212|365515125|FG001|Overall Study|Death|1|||
105960413|NCT00070109|365515126|FG000|Overall Study|Death|1|||
105960414|NCT00070109|365515127|FG001|Overall Study|Death|1|||
105960415|NCT00070109|365515128|FG002|Overall Study|Death|0|||
105960416|NCT00070109|365515129|FG003|Overall Study|Death|0|||
105960417|NCT00070109|365515130|FG004|Overall Study|Death|1|||
105960418|NCT00070109|365515126|FG000|Overall Study|Lack of Efficacy|6|||
105960419|NCT00070109|365515127|FG001|Overall Study|Lack of Efficacy|4|||
105960420|NCT00070109|365515128|FG002|Overall Study|Lack of Efficacy|5|||
105960421|NCT00070109|365515129|FG003|Overall Study|Lack of Efficacy|15|||
105960422|NCT00070109|365515130|FG004|Overall Study|Lack of Efficacy|5|||
106146658|NCT01135511|366198030|FG005|Overall Study|could not visit the clinic|0|||
106146659|NCT01135511|366198031|FG006|Overall Study|could not visit the clinic|0|||
105960423|NCT00070109|365515126|FG000|Overall Study|Physician Decision|1|||
105960424|NCT00070109|365515127|FG001|Overall Study|Physician Decision|0|||
105960425|NCT00070109|365515128|FG002|Overall Study|Physician Decision|0|||
105960426|NCT00070109|365515129|FG003|Overall Study|Physician Decision|0|||
105960427|NCT00070109|365515130|FG004|Overall Study|Physician Decision|0|||
105960428|NCT00070109|365515126|FG000|Overall Study|Withdrawal by Subject|0|||
105960429|NCT00070109|365515127|FG001|Overall Study|Withdrawal by Subject|1|||
105960430|NCT00070109|365515128|FG002|Overall Study|Withdrawal by Subject|1|||
105960431|NCT00070109|365515129|FG003|Overall Study|Withdrawal by Subject|0|||
105960432|NCT00070109|365515130|FG004|Overall Study|Withdrawal by Subject|0|||
105960433|NCT00070109|365515126|FG000|Overall Study|Adverse Event|0|||
105960434|NCT00070109|365515127|FG001|Overall Study|Adverse Event|0|||
105960435|NCT00070109|365515128|FG002|Overall Study|Adverse Event|2|||
105960436|NCT00070109|365515129|FG003|Overall Study|Adverse Event|4|||
105960437|NCT00070109|365515130|FG004|Overall Study|Adverse Event|2|||
105960438|NCT00070109|365515126|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
105825363|NCT03606174|365018249|FG003|Overall Study|Withdrawal by Subject|1|||
105825364|NCT03606174|365018250|FG004|Overall Study|Withdrawal by Subject|2|||
105825365|NCT03606174|365018251|FG005|Overall Study|Withdrawal by Subject|1|||
105825366|NCT03606174|365018252|FG006|Overall Study|Withdrawal by Subject|4|||
105825367|NCT03606174|365018253|FG007|Overall Study|Withdrawal by Subject|0|||
105825368|NCT03606174|365018254|FG008|Overall Study|Withdrawal by Subject|0|||
105825369|NCT03606174|365018255|FG009|Overall Study|Withdrawal by Subject|0|||
105825370|NCT03606174|365018256|FG010|Overall Study|Withdrawal by Subject|1|||
105825371|NCT03606174|365018246|FG000|Overall Study|Study Terminated by Sponsor|5|||
105825372|NCT03606174|365018247|FG001|Overall Study|Study Terminated by Sponsor|7|||
105825373|NCT03606174|365018248|FG002|Overall Study|Study Terminated by Sponsor|3|||
105825374|NCT03606174|365018249|FG003|Overall Study|Study Terminated by Sponsor|0|||
105825375|NCT03606174|365018250|FG004|Overall Study|Study Terminated by Sponsor|11|||
105825376|NCT03606174|365018251|FG005|Overall Study|Study Terminated by Sponsor|6|||
105825377|NCT03606174|365018252|FG006|Overall Study|Study Terminated by Sponsor|12|||
105825378|NCT03606174|365018253|FG007|Overall Study|Study Terminated by Sponsor|1|||
105825379|NCT03606174|365018254|FG008|Overall Study|Study Terminated by Sponsor|3|||
105825380|NCT03606174|365018255|FG009|Overall Study|Study Terminated by Sponsor|1|||
105825381|NCT03606174|365018256|FG010|Overall Study|Study Terminated by Sponsor|2|||
105825382|NCT03606174|365018246|FG000|Overall Study|Miscellaneous|1|||
105825383|NCT03606174|365018247|FG001|Overall Study|Miscellaneous|1|||
105825384|NCT03606174|365018248|FG002|Overall Study|Miscellaneous|0|||
105825385|NCT03606174|365018249|FG003|Overall Study|Miscellaneous|1|||
105825386|NCT03606174|365018250|FG004|Overall Study|Miscellaneous|4|||
105825387|NCT03606174|365018251|FG005|Overall Study|Miscellaneous|7|||
105825388|NCT03606174|365018252|FG006|Overall Study|Miscellaneous|5|||
105825389|NCT03606174|365018253|FG007|Overall Study|Miscellaneous|0|||
105825390|NCT03606174|365018254|FG008|Overall Study|Miscellaneous|0|||
105825391|NCT03606174|365018255|FG009|Overall Study|Miscellaneous|0|||
105825392|NCT03606174|365018256|FG010|Overall Study|Miscellaneous|1|||
105825393|NCT00859521|365018257|FG000|Washout|Withdrawal by Subject|0|||
105825394|NCT00859521|365018258|FG001|Washout|Withdrawal by Subject|1|||
105825395|NCT01609257|365018259|FG000|Overall Study|Lost to Follow-up|2|||
105825396|NCT01609257|365018260|FG001|Overall Study|Lost to Follow-up|1|||
105825397|NCT01609257|365018259|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
105825398|NCT01609257|365018260|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
105825399|NCT01609257|365018259|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
105825400|NCT01609257|365018260|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
105825401|NCT03415308|365018263|FG000|Overall Study|Lost to Follow-up|0|||
105825402|NCT03415308|365018264|FG001|Overall Study|Lost to Follow-up|0|||
105825403|NCT03415308|365018265|FG002|Overall Study|Lost to Follow-up|1|||
105825404|NCT03415308|365018263|FG000|Overall Study|Scheduling Conflicts|0|||
105825405|NCT03415308|365018264|FG001|Overall Study|Scheduling Conflicts|0|||
105825406|NCT03415308|365018265|FG002|Overall Study|Scheduling Conflicts|7|||
105825407|NCT01471353|365018267|FG000|Overall Study|remain on study|3|||
105825408|NCT00736190|365018268|FG000|Overall Study|Pregnancy|1|||
105825409|NCT00736190|365018268|FG000|Overall Study|Withdrawal by Subject|1|||
105825410|NCT00736190|365018268|FG000|Overall Study|Adverse Event|1|||
105825411|NCT01896934|365018269|FG000|Overall Study|Adverse Event|1|||
105825412|NCT01896934|365018269|FG000|Overall Study|Withdrawal by Subject|1|||
105825413|NCT02197416|365018270|FG000|Overall Study|Other reasons|0|||
106021812|NCT02167139|365744819|FG001|Randomised, Double-blind|Adverse Event|9|||
106021813|NCT02167139|365744820|FG002|Randomised, Double-blind|Adverse Event|0|||
106021814|NCT02167139|365744821|FG003|Randomised, Double-blind|Adverse Event|0|||
106021815|NCT02167139|365744818|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
106021816|NCT02167139|365744819|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
106021817|NCT02167139|365744820|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
106021818|NCT02167139|365744821|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
106021819|NCT02167139|365744818|FG000|Randomised, Double-blind|Other|3|||
106021820|NCT02167139|365744819|FG001|Randomised, Double-blind|Other|0|||
106021821|NCT02167139|365744820|FG002|Randomised, Double-blind|Other|0|||
106146660|NCT01135511|366198032|FG007|Overall Study|could not visit the clinic|0|||
106146661|NCT01135511|366198033|FG008|Overall Study|could not visit the clinic|0|||
105825414|NCT02197416|365018271|FG001|Overall Study|Other reasons|2|||
105825415|NCT02197416|365018272|FG002|Overall Study|Other reasons|5|||
105825416|NCT02197416|365018270|FG000|Overall Study|Withdrawal by Subject|0|||
105825417|NCT02197416|365018271|FG001|Overall Study|Withdrawal by Subject|2|||
105825418|NCT02197416|365018272|FG002|Overall Study|Withdrawal by Subject|1|||
105825419|NCT02197416|365018270|FG000|Overall Study|Protocol Violation|1|||
105825420|NCT02197416|365018271|FG001|Overall Study|Protocol Violation|0|||
105825421|NCT02197416|365018272|FG002|Overall Study|Protocol Violation|1|||
105825422|NCT02197416|365018270|FG000|Overall Study|Adverse Event|0|||
105825423|NCT02197416|365018271|FG001|Overall Study|Adverse Event|0|||
105825424|NCT02197416|365018272|FG002|Overall Study|Adverse Event|1|||
106021822|NCT02167139|365744821|FG003|Randomised, Double-blind|Other|0|||
106021823|NCT02167139|365744818|FG000|Transition-extension|Adverse Event|2|||
106021824|NCT02167139|365744819|FG001|Transition-extension|Adverse Event|0|||
106146662|NCT01135511|366198025|FG000|Overall Study|noncompliance with study drug taken|0|||
106146663|NCT01135511|366198026|FG001|Overall Study|noncompliance with study drug taken|0|||
106146664|NCT01135511|366198027|FG002|Overall Study|noncompliance with study drug taken|0|||
106146665|NCT01135511|366198028|FG003|Overall Study|noncompliance with study drug taken|0|||
106146666|NCT01135511|366198029|FG004|Overall Study|noncompliance with study drug taken|1|||
106146667|NCT01135511|366198030|FG005|Overall Study|noncompliance with study drug taken|0|||
106146668|NCT01135511|366198031|FG006|Overall Study|noncompliance with study drug taken|0|||
106146669|NCT01135511|366198032|FG007|Overall Study|noncompliance with study drug taken|0|||
106146670|NCT01135511|366198033|FG008|Overall Study|noncompliance with study drug taken|0|||
106146671|NCT01135511|366198025|FG000|Overall Study|Withdrawal by Subject|0|||
106146672|NCT01135511|366198026|FG001|Overall Study|Withdrawal by Subject|0|||
106146673|NCT01135511|366198027|FG002|Overall Study|Withdrawal by Subject|0|||
106146674|NCT01135511|366198028|FG003|Overall Study|Withdrawal by Subject|0|||
106146675|NCT01135511|366198029|FG004|Overall Study|Withdrawal by Subject|0|||
106146676|NCT01135511|366198030|FG005|Overall Study|Withdrawal by Subject|0|||
106146677|NCT01135511|366198031|FG006|Overall Study|Withdrawal by Subject|1|||
106146678|NCT01135511|366198032|FG007|Overall Study|Withdrawal by Subject|0|||
106146679|NCT01135511|366198033|FG008|Overall Study|Withdrawal by Subject|1|||
106146680|NCT02706717|366198034|FG000|Overall Study|Withdrawal by Subject|1|||
106146681|NCT02706717|366198035|FG001|Overall Study|Withdrawal by Subject|8|||
106146682|NCT02706717|366198034|FG000|Overall Study|Lost to Follow-up|0|||
106146683|NCT02706717|366198035|FG001|Overall Study|Lost to Follow-up|1|||
106146684|NCT02706717|366198034|FG000|Overall Study|Physician Decision|0|||
106146685|NCT02706717|366198035|FG001|Overall Study|Physician Decision|1|||
106146686|NCT02706717|366198034|FG000|Overall Study|Death|0|||
106146687|NCT02706717|366198035|FG001|Overall Study|Death|1|||
106146688|NCT03737240|366198036|FG000|Overall Study|Lost to Follow-up|16|||
106146689|NCT03737240|366198037|FG001|Overall Study|Lost to Follow-up|15|||
106146690|NCT02507752|366198039|FG000|Overall Study|Adverse Event|1|||
106146691|NCT02507752|366198039|FG000|Overall Study|Protocol Violation|6|||
106146692|NCT02507752|366198039|FG000|Overall Study|Lost to Follow-up|7|||
106146693|NCT02507752|366198039|FG000|Overall Study|Infusion reaction at first infusion|1|||
105825425|NCT00488774|365018273|FG000|Overall Study|Withdrawal of consent|2|||
105825426|NCT00488774|365018274|FG001|Overall Study|Withdrawal of consent|2|||
106146694|NCT02507752|366198039|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
106146695|NCT02507752|366198039|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
105825427|NCT00488774|365018275|FG002|Overall Study|Withdrawal of consent|2|||
105825428|NCT00488774|365018276|FG003|Overall Study|Withdrawal of consent|0|||
105825429|NCT00488774|365018273|FG000|Overall Study|Other|6|||
105825430|NCT00488774|365018274|FG001|Overall Study|Other|3|||
105825431|NCT00488774|365018275|FG002|Overall Study|Other|2|||
105825432|NCT00488774|365018276|FG003|Overall Study|Other|2|||
105825433|NCT00488774|365018273|FG000|Overall Study|Lost to Follow-up|0|||
105825434|NCT00488774|365018274|FG001|Overall Study|Lost to Follow-up|0|||
105825435|NCT00488774|365018275|FG002|Overall Study|Lost to Follow-up|1|||
105960439|NCT00070109|365515127|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
105960440|NCT00070109|365515128|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
105960441|NCT00070109|365515129|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
105960442|NCT00070109|365515130|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
105960443|NCT00405392|365515134|FG000|Overall Study|Adverse Event|15|||
105960444|NCT00405392|365515135|FG001|Overall Study|Adverse Event|14|||
105960445|NCT00405392|365515134|FG000|Overall Study|Did not meet Eligibility criteria|7|||
105960446|NCT00405392|365515135|FG001|Overall Study|Did not meet Eligibility criteria|2|||
105960447|NCT00405392|365515134|FG000|Overall Study|Withdrawal by Subject|4|||
105960448|NCT00405392|365515135|FG001|Overall Study|Withdrawal by Subject|3|||
105960449|NCT00405392|365515134|FG000|Overall Study|Lost to Follow-up|1|||
105960450|NCT00405392|365515135|FG001|Overall Study|Lost to Follow-up|2|||
105960451|NCT00405392|365515134|FG000|Overall Study|Data missing|2|||
105960452|NCT00405392|365515135|FG001|Overall Study|Data missing|0|||
105960453|NCT00405392|365515134|FG000|Overall Study|Non-compliance|0|||
105960454|NCT00405392|365515135|FG001|Overall Study|Non-compliance|1|||
105960455|NCT00405392|365515134|FG000|Overall Study|Other|1|||
105960456|NCT00405392|365515135|FG001|Overall Study|Other|5|||
105960457|NCT02684617|365515136|FG000|Overall Study|Adverse Event|1|||
105960458|NCT02684617|365515137|FG001|Overall Study|Adverse Event|0|||
105960459|NCT02684617|365515138|FG002|Overall Study|Adverse Event|1|||
105960460|NCT02684617|365515136|FG000|Overall Study|Death|8|||
105960461|NCT02684617|365515137|FG001|Overall Study|Death|16|||
106146696|NCT03740009|366198040|FG000|Overall Study|Physician Decision|9|||
106146697|NCT03740009|366198040|FG000|Overall Study|Lost to Follow-up|1|||
106146698|NCT02202499|366198043|FG000|Overall Study|Cancer diagnosis|0|||
105825436|NCT00488774|365018276|FG003|Overall Study|Lost to Follow-up|1|||
105825437|NCT00673660|365018278|FG000|Overall Study|Lost to Follow-up|107|||
105960462|NCT02684617|365515138|FG002|Overall Study|Death|28|||
105960463|NCT02684617|365515136|FG000|Overall Study|Withdrawal by Subject|2|||
105960464|NCT02684617|365515137|FG001|Overall Study|Withdrawal by Subject|0|||
105960465|NCT02684617|365515138|FG002|Overall Study|Withdrawal by Subject|4|||
105825438|NCT00824291|365018279|FG000|Overall Study|Adverse Event|15|||
105825439|NCT00824291|365018280|FG001|Overall Study|Adverse Event|6|||
105825440|NCT00824291|365018279|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
105825441|NCT00824291|365018280|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
105825442|NCT00824291|365018279|FG000|Overall Study|Lost to Follow-up|11|||
105825443|NCT00824291|365018280|FG001|Overall Study|Lost to Follow-up|9|||
105825444|NCT00824291|365018279|FG000|Overall Study|Non-compliance|1|||
105825445|NCT00824291|365018280|FG001|Overall Study|Non-compliance|1|||
105825446|NCT00824291|365018279|FG000|Overall Study|Protocol Violation|4|||
105825447|NCT00824291|365018280|FG001|Overall Study|Protocol Violation|1|||
105825448|NCT00824291|365018279|FG000|Overall Study|Withdrawal by Subject|14|||
105825449|NCT00824291|365018280|FG001|Overall Study|Withdrawal by Subject|8|||
105825450|NCT00824291|365018279|FG000|Overall Study|Lack of Efficacy|7|||
105825451|NCT00824291|365018280|FG001|Overall Study|Lack of Efficacy|8|||
105825452|NCT00824291|365018279|FG000|Overall Study|Participant on prohibited medication|1|||
105825453|NCT00824291|365018280|FG001|Overall Study|Participant on prohibited medication|0|||
105825454|NCT01383486|365018281|FG000|Overall Study|Lost to Follow-up|10|||
105825455|NCT01383486|365018281|FG000|Overall Study|Incomplete information for analysis|2|||
105825456|NCT01383486|365018281|FG000|Overall Study|Did not take any product|6|||
105825457|NCT00245063|365018282|FG000|Overall Study|Adverse Event|6|||
105825458|NCT00245063|365018283|FG001|Overall Study|Adverse Event|5|||
105825459|NCT00245063|365018282|FG000|Overall Study|Death|1|||
105825460|NCT00245063|365018283|FG001|Overall Study|Death|0|||
105825461|NCT05099380|365018284|FG000|Overall Study|Subject enrolled in error|1|||
105825462|NCT05099380|365018285|FG001|Overall Study|Subject enrolled in error|0|||
105825463|NCT05099380|365018284|FG000|Overall Study|Study Procedure|1|||
105825464|NCT05099380|365018285|FG001|Overall Study|Study Procedure|0|||
105825465|NCT05099380|365018284|FG000|Overall Study|Protocol Violation|1|||
105825466|NCT05099380|365018285|FG001|Overall Study|Protocol Violation|0|||
105825467|NCT05099380|365018284|FG000|Overall Study|Adverse Event|1|||
105825468|NCT05099380|365018285|FG001|Overall Study|Adverse Event|1|||
105825469|NCT05099380|365018284|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
105825470|NCT05099380|365018285|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
105825471|NCT01839279|365018286|FG000|Overall Study|Adverse Event|4|||
105825472|NCT01839279|365018287|FG001|Overall Study|Adverse Event|1|||
105825473|NCT01839279|365018288|FG002|Overall Study|Adverse Event|1|||
105825474|NCT01839279|365018286|FG000|Overall Study|Withdrawal by Subject|4|||
105825475|NCT01839279|365018287|FG001|Overall Study|Withdrawal by Subject|1|||
105825476|NCT01839279|365018288|FG002|Overall Study|Withdrawal by Subject|1|||
105825477|NCT01839279|365018286|FG000|Overall Study|Classified as 'Other'|5|||
105825478|NCT01839279|365018287|FG001|Overall Study|Classified as 'Other'|0|||
105825479|NCT01839279|365018288|FG002|Overall Study|Classified as 'Other'|0|||
105825480|NCT01648582|365018289|FG000|Overall Study|Adverse Event|6|||
105825481|NCT01648582|365018290|FG001|Overall Study|Adverse Event|11|||
105825482|NCT01648582|365018291|FG002|Overall Study|Adverse Event|2|||
105825483|NCT01648582|365018289|FG000|Overall Study|Lost to Follow-up|9|||
105825484|NCT01648582|365018290|FG001|Overall Study|Lost to Follow-up|6|||
105825485|NCT01648582|365018291|FG002|Overall Study|Lost to Follow-up|8|||
105825486|NCT01648582|365018289|FG000|Overall Study|Protocol Violation|1|||
105825487|NCT01648582|365018290|FG001|Overall Study|Protocol Violation|2|||
105825488|NCT01648582|365018291|FG002|Overall Study|Protocol Violation|1|||
105825489|NCT01648582|365018289|FG000|Overall Study|Withdrawal by Subject|15|||
105825490|NCT01648582|365018290|FG001|Overall Study|Withdrawal by Subject|17|||
105825491|NCT01648582|365018291|FG002|Overall Study|Withdrawal by Subject|17|||
105825492|NCT01648582|365018289|FG000|Overall Study|Physician Decision|0|||
105825493|NCT01648582|365018290|FG001|Overall Study|Physician Decision|1|||
105825494|NCT01648582|365018291|FG002|Overall Study|Physician Decision|3|||
105825495|NCT01648582|365018289|FG000|Overall Study|Death|1|||
105825496|NCT01648582|365018290|FG001|Overall Study|Death|0|||
105825497|NCT01648582|365018291|FG002|Overall Study|Death|0|||
105825498|NCT01648582|365018289|FG000|Overall Study|Sponsor Decision|0|||
105825499|NCT01648582|365018290|FG001|Overall Study|Sponsor Decision|1|||
105825500|NCT01648582|365018291|FG002|Overall Study|Sponsor Decision|1|||
105825501|NCT02392195|365018292|FG000|Overall Study|Lost to Follow-up|4|||
105825502|NCT02392195|365018292|FG000|Overall Study|Withdrawal by Subject|4|||
105825503|NCT03276754|365018293|FG000|Overall Study|Withdrawal of informed consent|4|||
105825504|NCT03276754|365018293|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
105825505|NCT03276754|365018293|FG000|Overall Study|Lost to Follow-up|27|||
105825506|NCT03276754|365018293|FG000|Overall Study|No data reported at Month 24|31|||
105825507|NCT03276754|365018293|FG000|Overall Study|Death|39|||
105825508|NCT03437265|365018294|FG000|Overall Study|Protocol Violation|6|||
105825509|NCT02294786|365018297|FG000|Overall Study|Withdrawal by Subject|0|||
106021825|NCT02167139|365744820|FG002|Transition-extension|Adverse Event|2|||
106021826|NCT02167139|365744821|FG003|Transition-extension|Adverse Event|3|||
105825510|NCT02294786|365018298|FG001|Overall Study|Withdrawal by Subject|1|||
105825511|NCT02294786|365018297|FG000|Overall Study|Physician Decision|6|||
105825512|NCT02294786|365018298|FG001|Overall Study|Physician Decision|7|||
106021827|NCT02167139|365744818|FG000|Transition-extension|Withdrawal by Subject|2|||
105825513|NCT02294786|365018297|FG000|Overall Study|Lost to Follow-up|1|||
106021828|NCT02167139|365744819|FG001|Transition-extension|Withdrawal by Subject|0|||
106021829|NCT02167139|365744820|FG002|Transition-extension|Withdrawal by Subject|4|||
106021830|NCT02167139|365744821|FG003|Transition-extension|Withdrawal by Subject|1|||
106021831|NCT02167139|365744818|FG000|Transition-extension|Lack of Efficacy|0|||
105825514|NCT02294786|365018298|FG001|Overall Study|Lost to Follow-up|2|||
106021832|NCT02167139|365744819|FG001|Transition-extension|Lack of Efficacy|0|||
106021833|NCT02167139|365744820|FG002|Transition-extension|Lack of Efficacy|1|||
106021834|NCT02167139|365744821|FG003|Transition-extension|Lack of Efficacy|1|||
106021835|NCT02167139|365744818|FG000|Transition-extension|Other|1|||
106021836|NCT02167139|365744819|FG001|Transition-extension|Other|0|||
106021837|NCT02167139|365744820|FG002|Transition-extension|Other|1|||
106021838|NCT02167139|365744821|FG003|Transition-extension|Other|0|||
106021839|NCT02167139|365744818|FG000|Transition-extension|Lost to Follow-up|1|||
105825515|NCT02294786|365018297|FG000|Overall Study|Protocol Violation|1|||
105825516|NCT02294786|365018298|FG001|Overall Study|Protocol Violation|0|||
105825517|NCT02294786|365018297|FG000|Overall Study|Adverse Event|1|||
105825518|NCT02294786|365018298|FG001|Overall Study|Adverse Event|1|||
105825519|NCT02294786|365018297|FG000|Overall Study|Death|2|||
105825520|NCT02294786|365018298|FG001|Overall Study|Death|3|||
105825521|NCT01778010|365018299|FG000|Overall Study|Withdrawal by Subject|2|||
105825522|NCT01778010|365018299|FG000|Overall Study|abnormal ECG before meds|1|||
105825523|NCT01778010|365018299|FG000|Overall Study|Arrested|1|||
105825524|NCT01778010|365018299|FG000|Overall Study|rash while on placebo|1|||
105825525|NCT05041361|365018300|FG000|Overall Study|Lost to Follow-up|1|||
105825526|NCT05041361|365018301|FG001|Overall Study|Lost to Follow-up|3|||
105825527|NCT00608322|365018304|FG000|Overall Study|Death|2|||
105825528|NCT00608322|365018305|FG001|Overall Study|Death|1|||
105825529|NCT00834444|365018306|FG000|First Intervention|Adverse Event|1|||
105825530|NCT00834444|365018307|FG001|First Intervention|Adverse Event|0|||
105825531|NCT00834444|365018306|FG000|First Intervention|Intolerance to Venopuncture|0|||
105825532|NCT00834444|365018307|FG001|First Intervention|Intolerance to Venopuncture|1|||
105825533|NCT00834444|365018306|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
105825534|NCT00834444|365018307|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105825535|NCT00834444|365018306|FG000|Second Intervention|Adverse Event|1|||
105825536|NCT00834444|365018307|FG001|Second Intervention|Adverse Event|0|||
105825537|NCT05752721|365018308|FG000|Overall Study|Lost to Follow-up|22|||
105825538|NCT05752721|365018309|FG001|Overall Study|Lost to Follow-up|20|||
105825539|NCT05752721|365018308|FG000|Overall Study|Withdrawal by Subject|15|||
106021840|NCT02167139|365744819|FG001|Transition-extension|Lost to Follow-up|0|||
106021841|NCT02167139|365744820|FG002|Transition-extension|Lost to Follow-up|0|||
106021842|NCT02167139|365744821|FG003|Transition-extension|Lost to Follow-up|0|||
106021843|NCT01459497|365744829|FG000|Overall Study|Inability to meet trial constraints.|1|||
106021844|NCT01459497|365744830|FG001|Overall Study|Inability to meet trial constraints.|0|||
106021845|NCT01459497|365744829|FG000|Overall Study|Physician Decision|1|||
106146699|NCT02202499|366198044|FG001|Overall Study|Cancer diagnosis|0|||
106146700|NCT02202499|366198045|FG002|Overall Study|Cancer diagnosis|1|||
106146701|NCT02202499|366198043|FG000|Overall Study|Moved from area|0|||
106146702|NCT02202499|366198044|FG001|Overall Study|Moved from area|0|||
105825540|NCT05752721|365018309|FG001|Overall Study|Withdrawal by Subject|12|||
105825541|NCT03419403|365018310|FG000|Overall Study|Withdrawal by Subject|5|||
105825542|NCT03419403|365018311|FG001|Overall Study|Withdrawal by Subject|2|||
105825543|NCT03419403|365018312|FG002|Overall Study|Withdrawal by Subject|5|||
105825544|NCT03419403|365018313|FG003|Overall Study|Withdrawal by Subject|1|||
105825545|NCT03419403|365018310|FG000|Overall Study|Progressive disease (per protocol)|0|||
105825546|NCT03419403|365018311|FG001|Overall Study|Progressive disease (per protocol)|2|||
105825547|NCT03419403|365018312|FG002|Overall Study|Progressive disease (per protocol)|2|||
106021846|NCT01459497|365744830|FG001|Overall Study|Physician Decision|1|||
106021847|NCT01459497|365744829|FG000|Overall Study|Hospitalization.|0|||
106146703|NCT02202499|366198045|FG002|Overall Study|Moved from area|1|||
106146704|NCT02202499|366198043|FG000|Overall Study|Declined before randomization|1|||
106146705|NCT02202499|366198044|FG001|Overall Study|Declined before randomization|0|||
106146706|NCT02202499|366198045|FG002|Overall Study|Declined before randomization|0|||
106146707|NCT02202499|366198043|FG000|Overall Study|Auto accident|1|||
105825548|NCT03419403|365018313|FG003|Overall Study|Progressive disease (per protocol)|0|||
105825549|NCT03419403|365018310|FG000|Overall Study|Other, not specified|6|||
105825550|NCT03419403|365018311|FG001|Overall Study|Other, not specified|4|||
105825551|NCT03419403|365018312|FG002|Overall Study|Other, not specified|5|||
105825552|NCT03419403|365018313|FG003|Overall Study|Other, not specified|1|||
105825553|NCT03419403|365018310|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
105825554|NCT03419403|365018311|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
106021848|NCT01459497|365744830|FG001|Overall Study|Hospitalization.|3|||
106021849|NCT01459497|365744829|FG000|Overall Study|Disease progression.|0|||
106021850|NCT01459497|365744830|FG001|Overall Study|Disease progression.|1|||
106021851|NCT01063283|365744831|FG000|Cycle 1|Adverse Event|2|||
106021852|NCT01063283|365744832|FG001|Cycle 1|Adverse Event|0|||
106021853|NCT01063283|365744833|FG002|Cycle 1|Adverse Event|0|||
106021854|NCT01063283|365744831|FG000|Cycle 1|Technical failure in data collection|1|||
106021855|NCT01063283|365744832|FG001|Cycle 1|Technical failure in data collection|0|||
106021856|NCT01063283|365744833|FG002|Cycle 1|Technical failure in data collection|0|||
106021857|NCT00104520|365744834|FG000|Overall Study|Unrelated adverse event|34|||
106021858|NCT00104520|365744835|FG001|Overall Study|Unrelated adverse event|47|||
106021859|NCT00104520|365744834|FG000|Overall Study|Study drug intolerance|0|||
106021860|NCT00104520|365744835|FG001|Overall Study|Study drug intolerance|1|||
105825555|NCT03419403|365018312|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
105825556|NCT03419403|365018313|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
105825557|NCT00418145|365018320|FG000|Overall Study|study terminated|6|||
105825558|NCT04345653|365018321|FG000|Overall Study|Withdrawal by Subject|2|||
105825559|NCT00418938|365018326|FG000|Overall Study|Reimbursement|1|||
105825560|NCT00418938|365018327|FG001|Overall Study|Reimbursement|0|||
105825561|NCT00418938|365018326|FG000|Overall Study|Administrative decision|3|||
105825562|NCT00418938|365018327|FG001|Overall Study|Administrative decision|3|||
105825563|NCT00418938|365018326|FG000|Overall Study|Withdrawal by Subject|16|||
105825564|NCT00418938|365018327|FG001|Overall Study|Withdrawal by Subject|15|||
105825565|NCT00418938|365018326|FG000|Overall Study|Lost to Follow-up|1|||
105825566|NCT00418938|365018327|FG001|Overall Study|Lost to Follow-up|3|||
105825567|NCT00418938|365018326|FG000|Overall Study|Adverse Event|1|||
105825568|NCT00418938|365018327|FG001|Overall Study|Adverse Event|1|||
105825569|NCT00418938|365018326|FG000|Overall Study|On-going|1|||
105825570|NCT00418938|365018327|FG001|Overall Study|On-going|1|||
105825571|NCT00418938|365018326|FG000|Overall Study|Ineligibility Determined|1|||
105825572|NCT00418938|365018327|FG001|Overall Study|Ineligibility Determined|0|||
105825573|NCT00115063|365018330|FG000|Overall Study|Lost to Follow-up|98|||
105825574|NCT00115063|365018331|FG001|Overall Study|Lost to Follow-up|104|||
105825575|NCT00115063|365018330|FG000|Overall Study|Death|1|||
105825576|NCT00115063|365018331|FG001|Overall Study|Death|0|||
105825577|NCT00191815|365018332|FG000|Overall Study|Adverse Event|2|||
105825578|NCT00191815|365018332|FG000|Overall Study|Disease progression or relapse|24|||
105825579|NCT00191815|365018332|FG000|Overall Study|Death|2|||
105825580|NCT00191815|365018332|FG000|Overall Study|Protocol Violation|3|||
105825581|NCT00191815|365018332|FG000|Overall Study|Physician Decision|2|||
105825582|NCT00191815|365018332|FG000|Overall Study|Withdrawal by Subject|7|||
105825583|NCT03808376|365018333|FG000|Overall Study|Withdrawal by Subject|10|||
105825584|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
105825585|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
105825586|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
105825587|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
105825588|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
105825589|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
105825590|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
105825591|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
105825592|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
105825593|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
105825594|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
105825595|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
105825596|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
105825597|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
105825598|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
105825599|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
105825600|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
105825601|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
105825602|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
106021861|NCT00104520|365744834|FG000|Overall Study|Related adverse event|13|||
106021862|NCT00104520|365744835|FG001|Overall Study|Related adverse event|15|||
106021863|NCT00104520|365744834|FG000|Overall Study|Lost to Follow-up|1|||
106021864|NCT00104520|365744835|FG001|Overall Study|Lost to Follow-up|0|||
106021865|NCT00104520|365744834|FG000|Overall Study|Noncompliance|0|||
106021866|NCT00104520|365744835|FG001|Overall Study|Noncompliance|2|||
105825603|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
105825604|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
105825605|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
105825606|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
105825607|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
105960466|NCT02684617|365515136|FG000|Overall Study|Screen Failure|1|||
105960467|NCT02684617|365515137|FG001|Overall Study|Screen Failure|0|||
105960468|NCT02684617|365515138|FG002|Overall Study|Screen Failure|2|||
105960469|NCT02684617|365515136|FG000|Overall Study|Study Terminated by Sponsor|6|||
105960470|NCT02684617|365515137|FG001|Overall Study|Study Terminated by Sponsor|1|||
105960471|NCT02684617|365515138|FG002|Overall Study|Study Terminated by Sponsor|5|||
105960472|NCT00022763|365515147|FG000|Overall Study|Adverse Event|1|||
105960473|NCT00022763|365515148|FG001|Overall Study|Adverse Event|2|||
105960474|NCT00022763|365515147|FG000|Overall Study|Injection Site Reactions|0|||
105960475|NCT00022763|365515148|FG001|Overall Study|Injection Site Reactions|2|||
105960476|NCT00022763|365515147|FG000|Overall Study|Death|0|||
105960477|NCT00022763|365515148|FG001|Overall Study|Death|1|||
105960478|NCT00022763|365515147|FG000|Overall Study|Lost to Follow-up|0|||
105960479|NCT00022763|365515148|FG001|Overall Study|Lost to Follow-up|3|||
105960480|NCT00022763|365515147|FG000|Overall Study|Withdrawal by Subject|4|||
105960481|NCT00022763|365515148|FG001|Overall Study|Withdrawal by Subject|7|||
105960482|NCT00022763|365515147|FG000|Overall Study|Insufficient Therapy|1|||
106021867|NCT00104520|365744834|FG000|Overall Study|Personal/administrative|1|||
105960483|NCT00022763|365515148|FG001|Overall Study|Insufficient Therapy|0|||
105960484|NCT00022763|365515147|FG000|Overall Study|Admin|3|||
105960485|NCT00022763|365515148|FG001|Overall Study|Admin|2|||
105960486|NCT01670279|365515149|FG000|Overall Study|Adverse Event|0|||
105960487|NCT01670279|365515150|FG001|Overall Study|Adverse Event|1|||
105960488|NCT01670279|365515151|FG002|Overall Study|Adverse Event|0|||
105960489|NCT01670279|365515152|FG003|Overall Study|Adverse Event|0|||
105960490|NCT01670279|365515149|FG000|Overall Study|Physician Decision|0|||
105960491|NCT01670279|365515150|FG001|Overall Study|Physician Decision|1|||
106021868|NCT00104520|365744835|FG001|Overall Study|Personal/administrative|1|||
106021869|NCT00104520|365744834|FG000|Overall Study|Other|1|||
106021870|NCT00104520|365744835|FG001|Overall Study|Other|5|||
105825608|NCT00073307|365018344|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
105825609|NCT00073307|365018345|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
105825610|NCT00073307|365018346|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
105825611|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
105825612|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
105825613|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
105825614|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
105825615|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
105825616|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
105825617|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
105825618|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
105825619|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
105825620|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
105825621|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
105825622|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
105825623|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
105825624|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
105825625|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
105825626|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
105825627|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
105825628|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
105825629|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
105825630|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
105825631|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
105825632|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
105825633|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
105825634|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
105825635|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
105825636|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
105825637|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
105825638|NCT00073307|365018344|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
105825639|NCT00073307|365018345|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
105825640|NCT00073307|365018346|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
105825641|NCT01075516|365018347|FG000|Overall Study|Death|5|||
105825642|NCT01075516|365018348|FG001|Overall Study|Death|9|||
105825643|NCT01075516|365018347|FG000|Overall Study|Lost to Follow-up|10|||
105825644|NCT01075516|365018348|FG001|Overall Study|Lost to Follow-up|2|||
105960492|NCT01670279|365515151|FG002|Overall Study|Physician Decision|0|||
105960493|NCT01670279|365515152|FG003|Overall Study|Physician Decision|0|||
105960494|NCT01670279|365515149|FG000|Overall Study|Participant met withdrawal criteria|0|||
105960495|NCT01670279|365515150|FG001|Overall Study|Participant met withdrawal criteria|0|||
105960496|NCT01670279|365515151|FG002|Overall Study|Participant met withdrawal criteria|0|||
105960497|NCT01670279|365515152|FG003|Overall Study|Participant met withdrawal criteria|1|||
105960498|NCT02702609|365515153|FG000|Overall Study|Lost to Follow-up|8|||
105960499|NCT02702609|365515154|FG001|Overall Study|Lost to Follow-up|4|||
105960500|NCT02702609|365515153|FG000|Overall Study|Physician Decision|1|||
105960501|NCT02702609|365515154|FG001|Overall Study|Physician Decision|0|||
105960502|NCT01262638|365515155|FG000|Overall Study|Adverse Event|3|||
105960503|NCT01262638|365515156|FG001|Overall Study|Adverse Event|4|||
105960504|NCT01262638|365515157|FG002|Overall Study|Adverse Event|3|||
105960505|NCT01262638|365515158|FG003|Overall Study|Adverse Event|4|||
106021871|NCT01742286|365744836|FG000|Escalation Phase|Administrative problems|1|||
105825645|NCT01075516|365018347|FG000|Overall Study|Withdrawal by Subject|3|||
105825646|NCT01075516|365018348|FG001|Overall Study|Withdrawal by Subject|5|||
105825647|NCT00834873|365018351|FG000|First Intervention|Adverse Event|0|||
105825648|NCT00834873|365018352|FG001|First Intervention|Adverse Event|1|||
105825649|NCT00147498|365018355|FG000|Overall Study|Adverse Event|1|||
105825650|NCT00147498|365018356|FG001|Overall Study|Adverse Event|6|||
105825651|NCT00147498|365018357|FG002|Overall Study|Adverse Event|7|||
105825652|NCT00147498|365018358|FG003|Overall Study|Adverse Event|3|||
105825653|NCT00147498|365018355|FG000|Overall Study|Lack of Efficacy|1|||
105825654|NCT00147498|365018356|FG001|Overall Study|Lack of Efficacy|1|||
105825655|NCT00147498|365018357|FG002|Overall Study|Lack of Efficacy|1|||
105825656|NCT00147498|365018358|FG003|Overall Study|Lack of Efficacy|8|||
105825657|NCT00147498|365018355|FG000|Overall Study|Laboratory abnormality|0|||
105825658|NCT00147498|365018356|FG001|Overall Study|Laboratory abnormality|0|||
105825659|NCT00147498|365018357|FG002|Overall Study|Laboratory abnormality|2|||
105825660|NCT00147498|365018358|FG003|Overall Study|Laboratory abnormality|0|||
105825661|NCT00147498|365018355|FG000|Overall Study|Participant defaulted|0|||
105825662|NCT00147498|365018356|FG001|Overall Study|Participant defaulted|1|||
105825663|NCT00147498|365018357|FG002|Overall Study|Participant defaulted|4|||
105825664|NCT00147498|365018358|FG003|Overall Study|Participant defaulted|3|||
105825665|NCT00147498|365018355|FG000|Overall Study|Other|1|||
106021872|NCT01742286|365744837|FG001|Escalation Phase|Administrative problems|1|||
106021873|NCT01742286|365744838|FG002|Escalation Phase|Administrative problems|0|||
106021874|NCT01742286|365744839|FG003|Escalation Phase|Administrative problems|0|||
106021875|NCT01742286|365744840|FG004|Escalation Phase|Administrative problems|0|||
106021876|NCT01742286|365744841|FG005|Escalation Phase|Administrative problems|0|||
106021877|NCT01742286|365744842|FG006|Escalation Phase|Administrative problems|2|||
106021878|NCT01742286|365744836|FG000|Escalation Phase|Adverse Event|0|||
106021879|NCT01742286|365744837|FG001|Escalation Phase|Adverse Event|1|||
106021880|NCT01742286|365744838|FG002|Escalation Phase|Adverse Event|2|||
106021881|NCT01742286|365744839|FG003|Escalation Phase|Adverse Event|0|||
106021882|NCT01742286|365744840|FG004|Escalation Phase|Adverse Event|0|||
106021883|NCT01742286|365744841|FG005|Escalation Phase|Adverse Event|1|||
105825666|NCT00147498|365018356|FG001|Overall Study|Other|1|||
105825667|NCT00147498|365018357|FG002|Overall Study|Other|3|||
105825668|NCT00147498|365018358|FG003|Overall Study|Other|3|||
105825669|NCT01229150|365018361|FG000|Overall Study|Toxicity|2|||
105825670|NCT01229150|365018362|FG001|Overall Study|Toxicity|2|||
105825671|NCT01229150|365018363|FG002|Overall Study|Toxicity|0|||
105825672|NCT01229150|365018364|FG003|Overall Study|Toxicity|0|||
106021884|NCT01742286|365744842|FG006|Escalation Phase|Adverse Event|0|||
106021885|NCT01742286|365744836|FG000|Escalation Phase|Disease progression|3|||
106021886|NCT01742286|365744837|FG001|Escalation Phase|Disease progression|7|||
106021887|NCT01742286|365744838|FG002|Escalation Phase|Disease progression|4|||
106021888|NCT01742286|365744839|FG003|Escalation Phase|Disease progression|1|||
106021889|NCT01742286|365744840|FG004|Escalation Phase|Disease progression|4|||
106021890|NCT01742286|365744841|FG005|Escalation Phase|Disease progression|3|||
106021891|NCT01742286|365744842|FG006|Escalation Phase|Disease progression|2|||
106021892|NCT01742286|365744836|FG000|Escalation Phase|Death|0|||
106021893|NCT01742286|365744837|FG001|Escalation Phase|Death|0|||
106021894|NCT01742286|365744838|FG002|Escalation Phase|Death|0|||
106021895|NCT01742286|365744839|FG003|Escalation Phase|Death|0|||
106021896|NCT01742286|365744840|FG004|Escalation Phase|Death|0|||
106021897|NCT01742286|365744841|FG005|Escalation Phase|Death|1|||
106021898|NCT01742286|365744842|FG006|Escalation Phase|Death|0|||
106021899|NCT01742286|365744836|FG000|Escalation Phase|Physician Decision|0|||
106021900|NCT01742286|365744837|FG001|Escalation Phase|Physician Decision|3|||
106021901|NCT01742286|365744838|FG002|Escalation Phase|Physician Decision|0|||
106021902|NCT01742286|365744839|FG003|Escalation Phase|Physician Decision|1|||
106021903|NCT01742286|365744840|FG004|Escalation Phase|Physician Decision|0|||
106021904|NCT01742286|365744841|FG005|Escalation Phase|Physician Decision|0|||
106021905|NCT01742286|365744842|FG006|Escalation Phase|Physician Decision|2|||
106146708|NCT02202499|366198044|FG001|Overall Study|Auto accident|0|||
106146709|NCT02202499|366198045|FG002|Overall Study|Auto accident|0|||
106146710|NCT00535145|366198046|FG000|Phase I|Adverse Event|3|||
106146711|NCT00535145|366198046|FG000|Phase I|Lost to Follow-up|7|||
106146712|NCT00535145|366198046|FG000|Phase I|Withdrawal by Subject|6|||
106146713|NCT00535145|366198046|FG000|Phase I|(eligibility)|8|||
106146714|NCT00535145|366198046|FG000|Phase I|(protocol violation)|1|||
106146715|NCT00535145|366198046|FG000|Phase I|(PI decision)|1|||
105825673|NCT01015287|365020010|FG000|Overall Study|Death|21|||
105825674|NCT01015287|365020011|FG001|Overall Study|Death|16|||
105825675|NCT01015287|365020010|FG000|Overall Study|Adverse Event|1|||
105825676|NCT01015287|365020011|FG001|Overall Study|Adverse Event|0|||
105825677|NCT01015287|365020010|FG000|Overall Study|Sponsor Decision|3|||
105825678|NCT01015287|365020011|FG001|Overall Study|Sponsor Decision|7|||
105825679|NCT01015287|365020010|FG000|Overall Study|Physician Decision|19|||
105825680|NCT01015287|365020011|FG001|Overall Study|Physician Decision|21|||
105825681|NCT01015287|365020010|FG000|Overall Study|Withdrawal by Subject|14|||
105825682|NCT01015287|365020011|FG001|Overall Study|Withdrawal by Subject|19|||
105825683|NCT01015287|365020010|FG000|Overall Study|Entry Criteria not Met|11|||
105825684|NCT01015287|365020011|FG001|Overall Study|Entry Criteria not Met|14|||
105825685|NCT01015287|365020010|FG000|Overall Study|Lost to Follow-up|2|||
105825686|NCT01015287|365020011|FG001|Overall Study|Lost to Follow-up|1|||
105825687|NCT01015287|365020010|FG000|Overall Study|Protocol Violation|1|||
105825688|NCT01015287|365020011|FG001|Overall Study|Protocol Violation|1|||
105825689|NCT04590027|365020012|FG000|Overall Study|Lost to Follow-up|17|||
105825690|NCT04590027|365020013|FG001|Overall Study|Lost to Follow-up|14|||
105825691|NCT04590027|365020012|FG000|Overall Study|Protocol Violation|0|||
105825692|NCT04590027|365020013|FG001|Overall Study|Protocol Violation|3|||
105825693|NCT00392665|365020016|FG000|Overall Study|Death|16|||
105825694|NCT00392665|365020017|FG001|Overall Study|Death|14|||
105825695|NCT00392665|365020016|FG000|Overall Study|Lost to Follow-up|1|||
105825696|NCT00392665|365020017|FG001|Overall Study|Lost to Follow-up|1|||
105825697|NCT00840216|365020021|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
105825698|NCT00840216|365020022|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
105825699|NCT00545792|365020025|FG000|Overall Study|Withdrawal by Subject|1|||
105825700|NCT00316277|365020027|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
105825701|NCT00316277|365020028|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
105825702|NCT00316277|365020027|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
106021906|NCT01742286|365744836|FG000|Escalation Phase|Subject/guardian decision|1|||
106021907|NCT01742286|365744837|FG001|Escalation Phase|Subject/guardian decision|0|||
106146716|NCT00535145|366198046|FG000|Phase I|(diagnosis)|3|||
106146717|NCT00535145|366198046|FG000|Phase II|Adverse Event|2|||
106146718|NCT00535145|366198046|FG000|Phase II|Lack of Efficacy|1|||
106146719|NCT00535145|366198046|FG000|Phase II|Lost to Follow-up|5|||
106146720|NCT00535145|366198046|FG000|Phase II|Withdrawal by Subject|5|||
106146721|NCT00535145|366198046|FG000|Phase II|Subject non-compliance|2|||
106146722|NCT03260140|366198047|FG000|Overall Study|Death|4|||
106146723|NCT03260140|366198048|FG001|Overall Study|Death|1|||
106146724|NCT03260140|366198047|FG000|Overall Study|Withdrawal by Subject|1|||
106146725|NCT03260140|366198048|FG001|Overall Study|Withdrawal by Subject|4|||
106146726|NCT01373346|366198051|FG000|Overall Study|Death|1|||
106146727|NCT01198028|366198052|FG000|Overall Study|Adverse Event|5|||
106146728|NCT01198028|366198052|FG000|Overall Study|Death|3|||
106146729|NCT01198028|366198052|FG000|Overall Study|Physician Decision|2|||
106146730|NCT00357097|366198053|FG000|Overall Study|Did not meet inclusion criteria|5|||
106146731|NCT00357097|366198054|FG001|Overall Study|Did not meet inclusion criteria|3|||
106146732|NCT00357097|366198053|FG000|Overall Study|Adverse Event|34|||
105825703|NCT00316277|365020028|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
105960506|NCT01262638|365515155|FG000|Overall Study|Protocol Violation|1|||
105960507|NCT01262638|365515156|FG001|Overall Study|Protocol Violation|0|||
105960508|NCT01262638|365515157|FG002|Overall Study|Protocol Violation|0|||
105960509|NCT01262638|365515158|FG003|Overall Study|Protocol Violation|1|||
105960510|NCT01262638|365515155|FG000|Overall Study|Withdrawal by Subject|2|||
105960511|NCT01262638|365515156|FG001|Overall Study|Withdrawal by Subject|1|||
105960512|NCT01262638|365515157|FG002|Overall Study|Withdrawal by Subject|0|||
105960513|NCT01262638|365515158|FG003|Overall Study|Withdrawal by Subject|1|||
105960514|NCT01262638|365515155|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
105960515|NCT01262638|365515156|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
105960516|NCT01262638|365515157|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
105960517|NCT01262638|365515158|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
105960518|NCT01262638|365515155|FG000|Overall Study|Lost to Follow-up|1|||
105960519|NCT01262638|365515156|FG001|Overall Study|Lost to Follow-up|1|||
105960520|NCT01262638|365515157|FG002|Overall Study|Lost to Follow-up|1|||
105960521|NCT01262638|365515158|FG003|Overall Study|Lost to Follow-up|1|||
105960522|NCT01262638|365515155|FG000|Overall Study|Participant Went Out of Town|0|||
105960523|NCT01262638|365515156|FG001|Overall Study|Participant Went Out of Town|0|||
105960524|NCT01262638|365515157|FG002|Overall Study|Participant Went Out of Town|1|||
105960525|NCT01262638|365515158|FG003|Overall Study|Participant Went Out of Town|0|||
105960526|NCT01071252|365515159|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
105960527|NCT01071252|365515160|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
105960528|NCT01071252|365515161|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
105960529|NCT01071252|365515162|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
105960530|NCT01071252|365515163|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
105960531|NCT01071252|365515159|FG000|Overall Study|Withdrawal by Subject|8|||
105960532|NCT01071252|365515160|FG001|Overall Study|Withdrawal by Subject|2|||
105960533|NCT01071252|365515161|FG002|Overall Study|Withdrawal by Subject|1|||
105960534|NCT01071252|365515162|FG003|Overall Study|Withdrawal by Subject|2|||
105960535|NCT01071252|365515163|FG004|Overall Study|Withdrawal by Subject|3|||
105960536|NCT01071252|365515159|FG000|Overall Study|administrative problems|1|||
105960537|NCT01071252|365515160|FG001|Overall Study|administrative problems|1|||
105960538|NCT01071252|365515161|FG002|Overall Study|administrative problems|0|||
105960539|NCT01071252|365515162|FG003|Overall Study|administrative problems|2|||
105960540|NCT01071252|365515163|FG004|Overall Study|administrative problems|1|||
105960541|NCT01071252|365515159|FG000|Overall Study|Lost to Follow-up|1|||
105960542|NCT01071252|365515160|FG001|Overall Study|Lost to Follow-up|0|||
105960543|NCT01071252|365515161|FG002|Overall Study|Lost to Follow-up|1|||
105960544|NCT01071252|365515162|FG003|Overall Study|Lost to Follow-up|2|||
105960545|NCT01071252|365515163|FG004|Overall Study|Lost to Follow-up|0|||
105960546|NCT01071252|365515159|FG000|Overall Study|Adverse Event|1|||
105960547|NCT01071252|365515160|FG001|Overall Study|Adverse Event|1|||
105960548|NCT01071252|365515161|FG002|Overall Study|Adverse Event|0|||
105960549|NCT01071252|365515162|FG003|Overall Study|Adverse Event|1|||
105960550|NCT01071252|365515163|FG004|Overall Study|Adverse Event|0|||
105960551|NCT01071252|365515159|FG000|Overall Study|Death|0|||
105960552|NCT01071252|365515160|FG001|Overall Study|Death|0|||
105960553|NCT01071252|365515161|FG002|Overall Study|Death|0|||
105960554|NCT01071252|365515162|FG003|Overall Study|Death|0|||
105960555|NCT01071252|365515163|FG004|Overall Study|Death|1|||
105960556|NCT01066104|365515164|FG000|Overall Study|Adverse Event|1|||
105960557|NCT01066104|365515165|FG001|Overall Study|Adverse Event|1|||
105960558|NCT01066104|365515164|FG000|Overall Study|Protocol Violation|1|||
105960559|NCT01066104|365515165|FG001|Overall Study|Protocol Violation|0|||
105960560|NCT00271856|365515171|FG000|Overall Study|Withdrawal by Subject|1|||
105960561|NCT00271856|365515172|FG001|Overall Study|Withdrawal by Subject|7|||
105960562|NCT00271856|365515171|FG000|Overall Study|Lost to Follow-up|10|||
105960563|NCT00271856|365515172|FG001|Overall Study|Lost to Follow-up|11|||
105960564|NCT02091362|365515173|FG000|Period 1|Protocol Violation|1|||
105960565|NCT02091362|365515174|FG001|Period 1|Protocol Violation|0|||
105960566|NCT02091362|365515173|FG000|Period 1|Withdrawal by Subject|2|||
105960567|NCT02091362|365515174|FG001|Period 1|Withdrawal by Subject|3|||
106146733|NCT00357097|366198054|FG001|Overall Study|Adverse Event|6|||
106146734|NCT00357097|366198053|FG000|Overall Study|Withdrawal by Subject|8|||
106146735|NCT00357097|366198054|FG001|Overall Study|Withdrawal by Subject|7|||
106146736|NCT00357097|366198053|FG000|Overall Study|Non-compliance|1|||
106146737|NCT00357097|366198054|FG001|Overall Study|Non-compliance|2|||
106146738|NCT00357097|366198053|FG000|Overall Study|Lack of Efficacy|2|||
106146739|NCT00357097|366198054|FG001|Overall Study|Lack of Efficacy|8|||
106146740|NCT00357097|366198053|FG000|Overall Study|Met Exclusion Criteria|3|||
106146741|NCT00357097|366198054|FG001|Overall Study|Met Exclusion Criteria|1|||
106146742|NCT00357097|366198053|FG000|Overall Study|Other|1|||
106146743|NCT00357097|366198054|FG001|Overall Study|Other|1|||
106146744|NCT00357097|366198053|FG000|Overall Study|Increase of RLS Symptoms|0|||
106146745|NCT00357097|366198054|FG001|Overall Study|Increase of RLS Symptoms|1|||
106146746|NCT00529659|366198055|FG000|Overall Study|Adverse Event|8|||
106146747|NCT00529659|366198056|FG001|Overall Study|Adverse Event|7|||
106146748|NCT00529659|366198055|FG000|Overall Study|Lost to Follow-up|0|||
106146749|NCT00529659|366198056|FG001|Overall Study|Lost to Follow-up|2|||
106146750|NCT00529659|366198055|FG000|Overall Study|Physician Decision|0|||
106146751|NCT00529659|366198056|FG001|Overall Study|Physician Decision|2|||
106146752|NCT00529659|366198055|FG000|Overall Study|Protocol Violation|2|||
106146753|NCT00529659|366198056|FG001|Overall Study|Protocol Violation|6|||
106146754|NCT00529659|366198055|FG000|Overall Study|Withdrawal by Subject|1|||
106146755|NCT00529659|366198056|FG001|Overall Study|Withdrawal by Subject|6|||
106146756|NCT03062358|366198057|FG000|Overall Study|Death|220|||
106146757|NCT03062358|366198058|FG001|Overall Study|Death|127|||
106146758|NCT03062358|366198057|FG000|Overall Study|Withdrawal by Subject|2|||
106146759|NCT03062358|366198058|FG001|Overall Study|Withdrawal by Subject|1|||
106146760|NCT03062358|366198057|FG000|Overall Study|Ongoing in Trial|78|||
106146761|NCT03062358|366198058|FG001|Overall Study|Ongoing in Trial|25|||
106146762|NCT03942042|366198062|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
106146763|NCT03942042|366198063|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
106146764|NCT03942042|366198062|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
106146765|NCT03942042|366198063|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
106146766|NCT01764464|366198064|FG000|First Intervention|Withdrawal by Subject|1|||
106146767|NCT01764464|366198065|FG001|First Intervention|Withdrawal by Subject|0|||
106146768|NCT01764464|366198064|FG000|First Intervention|Lost to Follow-up|1|||
106146769|NCT01764464|366198065|FG001|First Intervention|Lost to Follow-up|0|||
106146770|NCT01764464|366198064|FG000|First Intervention|Adverse Event|0|||
106146771|NCT01764464|366198065|FG001|First Intervention|Adverse Event|2|||
106146772|NCT01764464|366198064|FG000|First Intervention|did not receive study drug|0|||
106146773|NCT01764464|366198065|FG001|First Intervention|did not receive study drug|1|||
106146774|NCT01764464|366198064|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
106146775|NCT01764464|366198065|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
106146776|NCT01551355|366198070|FG000|Overall Study|Lost to Follow-up|51|||
106146777|NCT01551355|366198071|FG001|Overall Study|Lost to Follow-up|49|||
106146778|NCT01551355|366198072|FG002|Overall Study|Lost to Follow-up|34|||
106146779|NCT01551355|366198073|FG003|Overall Study|Lost to Follow-up|24|||
106146780|NCT01551355|366198074|FG004|Overall Study|Lost to Follow-up|9|||
106146781|NCT01551355|366198075|FG005|Overall Study|Lost to Follow-up|6|||
106146782|NCT02918071|366198077|FG000|Overall Study|Withdrawal by Subject|2|||
106146783|NCT02918071|366198077|FG000|Overall Study|Lost to Follow-up|1|||
106146784|NCT03997916|366198082|FG000|Overall Study|Protocol Violation|35|||
106146785|NCT05135000|366198083|FG000|Overall Study|Adverse Event|2|||
106146786|NCT05135000|366198084|FG001|Overall Study|Adverse Event|0|||
106146787|NCT05135000|366198083|FG000|Overall Study|Lost to Follow-up|1|||
106146788|NCT05135000|366198084|FG001|Overall Study|Lost to Follow-up|0|||
106146789|NCT05135000|366198083|FG000|Overall Study|Study Terminated by Sponsor|6|||
106146790|NCT05135000|366198084|FG001|Overall Study|Study Terminated by Sponsor|3|||
106146791|NCT00840177|366198888|FG000|Overall Study|Adverse Event|5|||
106146792|NCT00840177|366198889|FG001|Overall Study|Adverse Event|1|||
106146793|NCT00840177|366198890|FG002|Overall Study|Adverse Event|1|||
106146794|NCT00840177|366198888|FG000|Overall Study|Refusal unrelated to adverse events|1|||
106146795|NCT00840177|366198889|FG001|Overall Study|Refusal unrelated to adverse events|0|||
106146796|NCT00840177|366198890|FG002|Overall Study|Refusal unrelated to adverse events|1|||
106146797|NCT00840177|366198888|FG000|Overall Study|Progression/relapse|2|||
106146798|NCT00840177|366198889|FG001|Overall Study|Progression/relapse|0|||
106146799|NCT00840177|366198890|FG002|Overall Study|Progression/relapse|0|||
106146800|NCT00840177|366198888|FG000|Overall Study|Death|4|||
106146801|NCT00840177|366198889|FG001|Overall Study|Death|5|||
106146802|NCT00840177|366198890|FG002|Overall Study|Death|5|||
106146803|NCT00840177|366198888|FG000|Overall Study|not protocol specified|6|||
106146804|NCT00840177|366198889|FG001|Overall Study|not protocol specified|3|||
106146805|NCT00840177|366198890|FG002|Overall Study|not protocol specified|0|||
106146806|NCT00840177|366198888|FG000|Overall Study|Ineligible|0|||
106146807|NCT00840177|366198889|FG001|Overall Study|Ineligible|0|||
106146808|NCT00840177|366198890|FG002|Overall Study|Ineligible|3|||
105825704|NCT00316277|365020027|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
105825705|NCT00316277|365020028|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
105825706|NCT00316277|365020027|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
105825707|NCT00316277|365020028|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
105825708|NCT00316277|365020027|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
105825709|NCT00316277|365020028|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
105825710|NCT03679598|365020029|FG000|Overall Study|Adverse Event|2|||
105825711|NCT03679598|365020030|FG001|Overall Study|Adverse Event|0|||
105960568|NCT02091362|365515173|FG000|Period 1|Lost to Follow-up|0|||
105960569|NCT02091362|365515174|FG001|Period 1|Lost to Follow-up|1|||
105960570|NCT02091362|365515173|FG000|Period 1|Adverse Event|2|||
105960571|NCT02091362|365515174|FG001|Period 1|Adverse Event|0|||
105960572|NCT02091362|365515173|FG000|Wash-out|Lost to Follow-up|1|||
105960573|NCT02091362|365515174|FG001|Wash-out|Lost to Follow-up|1|||
105960574|NCT02091362|365515173|FG000|Wash-out|Withdrawal by Subject|0|||
105960575|NCT02091362|365515174|FG001|Wash-out|Withdrawal by Subject|2|||
105960576|NCT02091362|365515173|FG000|Period 2|Adverse Event|1|||
105960577|NCT02091362|365515174|FG001|Period 2|Adverse Event|0|||
105960578|NCT02091362|365515173|FG000|Period 2|Lost to Follow-up|0|||
105960579|NCT02091362|365515174|FG001|Period 2|Lost to Follow-up|1|||
105960580|NCT02091362|365515173|FG000|Period 2|Withdrawal by Subject|1|||
105960581|NCT02091362|365515174|FG001|Period 2|Withdrawal by Subject|1|||
105960582|NCT00335738|365515177|FG000|Overall Study|Physician Decision|6|||
105960583|NCT00335738|365515178|FG001|Overall Study|Physician Decision|0|||
105960584|NCT00335738|365515177|FG000|Overall Study|Withdrawal by Subject|2|||
105960585|NCT00335738|365515178|FG001|Overall Study|Withdrawal by Subject|0|||
105960586|NCT00335738|365515177|FG000|Overall Study|Ineligible|3|||
105960587|NCT00335738|365515178|FG001|Overall Study|Ineligible|4|||
105960588|NCT03248167|365515181|FG000|Overall Study|Withdrawal by Subject|2|||
105960589|NCT03248167|365515182|FG001|Overall Study|Withdrawal by Subject|2|||
105960590|NCT03248167|365515181|FG000|Overall Study|Physician Decision|0|||
105960591|NCT03248167|365515182|FG001|Overall Study|Physician Decision|1|||
105960592|NCT03248167|365515181|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
106146809|NCT00840177|366198888|FG000|Overall Study|Did not start treatment|0|||
105960593|NCT03248167|365515182|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
105960594|NCT03248167|365515181|FG000|Overall Study|Lost to Follow-up|1|||
105960595|NCT03248167|365515182|FG001|Overall Study|Lost to Follow-up|0|||
105960596|NCT00506454|365515183|FG000|Overall Study|Withdrawal by Subject|1|||
105960597|NCT00506454|365515184|FG001|Overall Study|Withdrawal by Subject|1|||
105960598|NCT01558596|365515187|FG000|Overall Study|Withdrawal by Subject|1|||
105960599|NCT01558596|365515188|FG001|Overall Study|Withdrawal by Subject|0|||
105960600|NCT01558596|365515187|FG000|Overall Study|surgery elsewhere or cancelled|1|||
105960601|NCT01558596|365515188|FG001|Overall Study|surgery elsewhere or cancelled|1|||
105960602|NCT01558596|365515187|FG000|Overall Study|Protocol Violation|1|||
105960603|NCT01558596|365515188|FG001|Overall Study|Protocol Violation|0|||
105960604|NCT00902850|365515190|FG000|Overall Study|Physician Decision|2|||
105960605|NCT00902850|365515191|FG001|Overall Study|Physician Decision|2|||
105960606|NCT00260832|365515192|FG000|Overall Study|Adverse Event|26|||
105960607|NCT00260832|365515193|FG001|Overall Study|Adverse Event|19|||
105960608|NCT00260832|365515192|FG000|Overall Study|Progression|116|||
105960609|NCT00260832|365515193|FG001|Overall Study|Progression|96|||
105960610|NCT00260832|365515192|FG000|Overall Study|Withdrawal by Subject|15|||
106146810|NCT00840177|366198889|FG001|Overall Study|Did not start treatment|0|||
106146811|NCT00840177|366198890|FG002|Overall Study|Did not start treatment|1|||
106146812|NCT02731755|366198893|FG000|First Intervention|Withdrawal by Subject|0|||
106146813|NCT02731755|366198894|FG001|First Intervention|Withdrawal by Subject|2|||
106146814|NCT04218110|366198895|FG000|Overall Study|Withdrawal by Subject|0|||
106146815|NCT04218110|366198896|FG001|Overall Study|Withdrawal by Subject|0|||
106146816|NCT04218110|366198897|FG002|Overall Study|Withdrawal by Subject|0|||
106146817|NCT04218110|366198898|FG003|Overall Study|Withdrawal by Subject|1|||
106146818|NCT00799396|366198899|FG000|Clopidogrel Treatment|Adverse Event|6|||
106146819|NCT00799396|366198899|FG000|Clopidogrel Treatment|Physician Decision|5|||
106146820|NCT00799396|366198899|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
106146821|NCT00799396|366198899|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
105825712|NCT03605342|365020031|FG000|Overall Study|Withdrawal by Subject|9|||
105825713|NCT03605342|365020032|FG001|Overall Study|Withdrawal by Subject|7|||
105960611|NCT00260832|365515193|FG001|Overall Study|Withdrawal by Subject|17|||
105960612|NCT00260832|365515192|FG000|Overall Study|Physician Decision|15|||
105960613|NCT00260832|365515193|FG001|Overall Study|Physician Decision|9|||
105960614|NCT00260832|365515192|FG000|Overall Study|Death|43|||
105960615|NCT00260832|365515193|FG001|Overall Study|Death|62|||
105960616|NCT00260832|365515192|FG000|Overall Study|Other|10|||
105960617|NCT00260832|365515193|FG001|Overall Study|Other|7|||
105960618|NCT00260832|365515192|FG000|Overall Study|Protocol Violation|3|||
105960619|NCT00260832|365515193|FG001|Overall Study|Protocol Violation|1|||
105960620|NCT03098433|365515194|FG000|Overall Study|Withdrawal by Subject|10|||
105960621|NCT02725476|365515199|FG000|Overall Study|Physician Decision|2|||
105960622|NCT02725476|365515200|FG001|Overall Study|Physician Decision|0|||
106146822|NCT00799396|366198899|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
106146823|NCT00714714|366198900|FG000|Overall Study|Adverse Event|1|||
106146824|NCT02242487|366198901|FG000|Overall Study|Adverse Event|13|||
106146825|NCT02242487|366198902|FG001|Overall Study|Adverse Event|15|||
106146826|NCT02242487|366198901|FG000|Overall Study|Lack of Efficacy|4|||
106146827|NCT02242487|366198902|FG001|Overall Study|Lack of Efficacy|6|||
106146828|NCT02242487|366198901|FG000|Overall Study|Protocol Violation|2|||
106146829|NCT02242487|366198902|FG001|Overall Study|Protocol Violation|0|||
106146830|NCT02242487|366198901|FG000|Overall Study|Lost to Follow-up|2|||
106146831|NCT02242487|366198902|FG001|Overall Study|Lost to Follow-up|1|||
106146832|NCT02242487|366198901|FG000|Overall Study|Other - Miscellaneous|4|||
106146833|NCT02242487|366198902|FG001|Overall Study|Other - Miscellaneous|6|||
106146834|NCT02242487|366198901|FG000|Overall Study|Withdrawal by Subject|37|||
106146835|NCT02242487|366198902|FG001|Overall Study|Withdrawal by Subject|19|||
106146836|NCT02564744|366198905|FG000|Overall Study|Investigator decision|0|||
106146837|NCT02564744|366198906|FG001|Overall Study|Investigator decision|0|||
106146838|NCT02564744|366198907|FG002|Overall Study|Investigator decision|0|||
106146839|NCT02564744|366198908|FG003|Overall Study|Investigator decision|0|||
106146840|NCT02564744|366198909|FG004|Overall Study|Investigator decision|1|||
106146841|NCT02564744|366198905|FG000|Overall Study|Death|10|||
106146842|NCT02564744|366198906|FG001|Overall Study|Death|5|||
106146843|NCT02564744|366198907|FG002|Overall Study|Death|4|||
106146844|NCT02564744|366198908|FG003|Overall Study|Death|16|||
106146845|NCT02564744|366198909|FG004|Overall Study|Death|16|||
106146846|NCT02564744|366198905|FG000|Overall Study|End of study Page Missing|0|||
106146847|NCT02564744|366198906|FG001|Overall Study|End of study Page Missing|0|||
106146848|NCT02564744|366198907|FG002|Overall Study|End of study Page Missing|3|||
106146849|NCT02564744|366198908|FG003|Overall Study|End of study Page Missing|3|||
106146850|NCT02564744|366198909|FG004|Overall Study|End of study Page Missing|0|||
106146851|NCT02564744|366198905|FG000|Overall Study|Subject Withdrew Consent|1|||
106146852|NCT02564744|366198906|FG001|Overall Study|Subject Withdrew Consent|1|||
106146853|NCT02564744|366198907|FG002|Overall Study|Subject Withdrew Consent|1|||
106146854|NCT02564744|366198908|FG003|Overall Study|Subject Withdrew Consent|0|||
106146855|NCT02564744|366198909|FG004|Overall Study|Subject Withdrew Consent|2|||
106146856|NCT02564744|366198905|FG000|Overall Study|Lost to Follow-up|0|||
106146857|NCT02564744|366198906|FG001|Overall Study|Lost to Follow-up|1|||
106146858|NCT02564744|366198907|FG002|Overall Study|Lost to Follow-up|0|||
106146859|NCT02564744|366198908|FG003|Overall Study|Lost to Follow-up|0|||
106146860|NCT02564744|366198909|FG004|Overall Study|Lost to Follow-up|1|||
106146861|NCT02564744|366198905|FG000|Overall Study|Reason not specified|1|||
106146862|NCT02564744|366198906|FG001|Overall Study|Reason not specified|0|||
106146863|NCT02564744|366198907|FG002|Overall Study|Reason not specified|0|||
106146864|NCT02564744|366198908|FG003|Overall Study|Reason not specified|0|||
106146865|NCT02564744|366198909|FG004|Overall Study|Reason not specified|0|||
105825714|NCT03605342|365020031|FG000|Overall Study|Lost to Follow-up|1|||
105825715|NCT03605342|365020032|FG001|Overall Study|Lost to Follow-up|1|||
105960623|NCT02725476|365515199|FG000|Overall Study|Adverse Event|1|||
106146866|NCT02755805|366198910|FG000|Overall Study|Lost to Follow-up|1|||
106146867|NCT02755805|366198911|FG001|Overall Study|Lost to Follow-up|2|||
106146868|NCT02755805|366198910|FG000|Overall Study|Refused assessments|1|||
106146869|NCT02755805|366198911|FG001|Overall Study|Refused assessments|0|||
106146870|NCT02755805|366198910|FG000|Overall Study|Withdrawal by Subject|0|||
106146871|NCT02755805|366198911|FG001|Overall Study|Withdrawal by Subject|2|||
106146872|NCT02252042|366198912|FG000|Overall Study|Adverse Event|9|||
106146873|NCT02252042|366198913|FG001|Overall Study|Adverse Event|6|||
106146874|NCT02252042|366198912|FG000|Overall Study|Death|209|||
106146875|NCT02252042|366198913|FG001|Overall Study|Death|217|||
106146876|NCT02252042|366198912|FG000|Overall Study|Physician Decision|0|||
105960624|NCT02725476|365515200|FG001|Overall Study|Adverse Event|1|||
105960625|NCT00191945|365515201|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
105960626|NCT00191945|365515202|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
105960627|NCT00191945|365515201|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
105960628|NCT00191945|365515202|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
105960629|NCT00191945|365515201|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
105960630|NCT00191945|365515202|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
105960631|NCT00191945|365515201|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
105960632|NCT00191945|365515202|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
105960633|NCT00289289|365515207|FG000|Overall Study|Withdrawal by Subject|5|||
106021908|NCT01742286|365744838|FG002|Escalation Phase|Subject/guardian decision|0|||
106021909|NCT01742286|365744839|FG003|Escalation Phase|Subject/guardian decision|0|||
105825716|NCT01663233|365020033|FG000|Overall Study|Withdrawal by Subject|3|||
105960634|NCT00289289|365515208|FG001|Overall Study|Withdrawal by Subject|3|||
106146877|NCT02252042|366198913|FG001|Overall Study|Physician Decision|2|||
105960635|NCT00289289|365515209|FG002|Overall Study|Withdrawal by Subject|15|||
105960636|NCT00289289|365515207|FG000|Overall Study|Lost to Follow-up|1|||
105960637|NCT00289289|365515208|FG001|Overall Study|Lost to Follow-up|0|||
105960638|NCT00289289|365515209|FG002|Overall Study|Lost to Follow-up|1|||
105960639|NCT00289289|365515207|FG000|Overall Study|Death|4|||
105960640|NCT00289289|365515208|FG001|Overall Study|Death|2|||
105960641|NCT00289289|365515209|FG002|Overall Study|Death|5|||
105960642|NCT00289289|365515207|FG000|Overall Study|No implant attempted|0|||
105960643|NCT00289289|365515208|FG001|Overall Study|No implant attempted|0|||
105960644|NCT00289289|365515209|FG002|Overall Study|No implant attempted|1|||
105960645|NCT00289289|365515207|FG000|Overall Study|Physician Decision|1|||
105960646|NCT00289289|365515208|FG001|Overall Study|Physician Decision|0|||
105960647|NCT00289289|365515209|FG002|Overall Study|Physician Decision|6|||
105960648|NCT00289289|365515207|FG000|Overall Study|Non-study device implanted|2|||
105960649|NCT00289289|365515208|FG001|Overall Study|Non-study device implanted|1|||
105960650|NCT00289289|365515209|FG002|Overall Study|Non-study device implanted|3|||
105960651|NCT00289289|365515207|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
105960652|NCT00289289|365515208|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
105960653|NCT00289289|365515209|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
105960654|NCT00289289|365515207|FG000|Overall Study|Other Exit Reason|6|||
105960655|NCT00289289|365515208|FG001|Overall Study|Other Exit Reason|4|||
105960656|NCT00289289|365515209|FG002|Overall Study|Other Exit Reason|12|||
105960657|NCT01270880|365515212|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
105960658|NCT01814046|365515213|FG000|Drug Administration|Death due to complications of RSV|1|||
105960659|NCT01814046|365515214|FG001|Drug Administration|Death due to complications of RSV|0|||
105960660|NCT01814046|365515215|FG002|Drug Administration|Death due to complications of RSV|0|||
105960661|NCT02952313|365515216|FG000|Primary Endpoint|Lost to Follow-up|4|||
105960662|NCT02952313|365515216|FG000|Primary Endpoint|Withdrawal by Subject|1|||
105960663|NCT02952313|365515216|FG000|Primary Endpoint|Lack of Efficacy|1|||
105960664|NCT02952313|365515216|FG000|Primary Endpoint|Missed visit|1|||
105960665|NCT02952313|365515216|FG000|Long-term Follow-up|Lost to Follow-up|12|||
105960666|NCT02952313|365515216|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
105960667|NCT02952313|365515216|FG000|Long-term Follow-up|Lack of Efficacy|6|||
105960668|NCT02952313|365515216|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
105960669|NCT02952313|365515216|FG000|Long-term Follow-up|Physician Decision|1|||
105960670|NCT02952313|365515216|FG000|Long-term Follow-up|Death|1|||
105960671|NCT02798315|365515217|FG000|Overall Study|Failure to return|1|||
105960672|NCT01059864|365515218|FG000|Open-Label Run-In Phase|Adverse Event|7|||
105960673|NCT01059864|365515219|FG001|Open-Label Run-In Phase|Adverse Event|0|||
105960674|NCT01059864|365515220|FG002|Open-Label Run-In Phase|Adverse Event|0|||
105960675|NCT01059864|365515218|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
105960676|NCT01059864|365515219|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
105960677|NCT01059864|365515220|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
105960678|NCT01059864|365515218|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
105960679|NCT01059864|365515219|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
105960680|NCT01059864|365515220|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
105960681|NCT01059864|365515218|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
105960682|NCT01059864|365515219|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
105960683|NCT01059864|365515220|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
105960684|NCT01059864|365515218|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
105960685|NCT01059864|365515219|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
105960686|NCT01059864|365515220|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
105960687|NCT01059864|365515218|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105960688|NCT01059864|365515219|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
105960689|NCT01059864|365515220|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
105960690|NCT03281629|365515222|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
105960691|NCT03281629|365515223|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
105960692|NCT03281629|365515222|FG000|Overall Study|Death|0|||
105960693|NCT03281629|365515223|FG001|Overall Study|Death|1|||
105960694|NCT03281629|365515222|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
105960695|NCT03281629|365515223|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
105960696|NCT00948857|365517264|FG000|Overall Study|Lost to Follow-up|1|||
105960697|NCT00948857|365517265|FG001|Overall Study|Lost to Follow-up|0|||
105960698|NCT03430843|365517269|FG000|Overall Study|Death|233|||
105960699|NCT03430843|365517270|FG001|Overall Study|Death|233|||
105960700|NCT03430843|365517269|FG000|Overall Study|Sponsor Decision|17|||
105960701|NCT03430843|365517270|FG001|Overall Study|Sponsor Decision|6|||
105960702|NCT03430843|365517269|FG000|Overall Study|Withdrawal by Subject|5|||
105960703|NCT03430843|365517270|FG001|Overall Study|Withdrawal by Subject|14|||
105960704|NCT03430843|365517269|FG000|Overall Study|Lost to Follow-up|1|||
105960705|NCT03430843|365517270|FG001|Overall Study|Lost to Follow-up|3|||
105960706|NCT00617084|365517271|FG000|Overall Study|Withdrawal by Subject|5|||
105960707|NCT00617084|365517272|FG001|Overall Study|Withdrawal by Subject|7|||
105960708|NCT00617084|365517271|FG000|Overall Study|Missed 12 Months visit|16|||
105960709|NCT00617084|365517272|FG001|Overall Study|Missed 12 Months visit|19|||
105960710|NCT01188551|365517283|FG000|Overall Study|Pharmacy issues|1|||
105960711|NCT01188551|365517284|FG001|Overall Study|Pharmacy issues|0|||
105825717|NCT01663233|365020034|FG001|Overall Study|Withdrawal by Subject|2|||
105825718|NCT01663233|365020033|FG000|Overall Study|Protocol Deviation|1|||
105825719|NCT01663233|365020034|FG001|Overall Study|Protocol Deviation|4|||
105825720|NCT01663233|365020033|FG000|Overall Study|Lost to Follow-up|0|||
105825721|NCT01663233|365020034|FG001|Overall Study|Lost to Follow-up|1|||
105825722|NCT01380782|365020035|FG000|Overall Study|Adverse Event|0|||
105825723|NCT01380782|365020036|FG001|Overall Study|Adverse Event|1|||
105825724|NCT01380782|365020037|FG002|Overall Study|Adverse Event|0|||
105825725|NCT01380782|365020038|FG003|Overall Study|Adverse Event|0|||
105825726|NCT01380782|365020035|FG000|Overall Study|Death|1|||
105825727|NCT01380782|365020036|FG001|Overall Study|Death|0|||
105825728|NCT01380782|365020037|FG002|Overall Study|Death|0|||
105825729|NCT01380782|365020038|FG003|Overall Study|Death|0|||
105825730|NCT01380782|365020035|FG000|Overall Study|Lack of Efficacy|10|||
105960712|NCT01188551|365517285|FG002|Overall Study|Pharmacy issues|0|||
105960713|NCT01188551|365517286|FG003|Overall Study|Pharmacy issues|0|||
105960714|NCT04908384|365517289|FG000|Overall Study|Lost to Follow-up|4|||
105960715|NCT04908384|365517290|FG001|Overall Study|Lost to Follow-up|4|||
105960716|NCT04908384|365517291|FG002|Overall Study|Lost to Follow-up|0|||
105960717|NCT04908384|365517292|FG003|Overall Study|Lost to Follow-up|0|||
106021910|NCT01742286|365744840|FG004|Escalation Phase|Subject/guardian decision|0|||
105825731|NCT01380782|365020036|FG001|Overall Study|Lack of Efficacy|9|||
105825732|NCT01380782|365020037|FG002|Overall Study|Lack of Efficacy|10|||
105825733|NCT01380782|365020038|FG003|Overall Study|Lack of Efficacy|3|||
105960718|NCT01208324|365517293|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
105960719|NCT01208324|365517294|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
105960720|NCT01208324|365517295|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
105960721|NCT01208324|365517296|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
105960722|NCT01701362|365517297|FG000|Overall Study|Adverse events not related to study drug|1|||
105960723|NCT01701362|365517298|FG001|Overall Study|Adverse events not related to study drug|6|||
105960724|NCT01701362|365517297|FG000|Overall Study|Adverse events related to study drug|12|||
105960725|NCT01701362|365517298|FG001|Overall Study|Adverse events related to study drug|10|||
105960726|NCT01701362|365517297|FG000|Overall Study|Protocol Violation|5|||
105960727|NCT01701362|365517298|FG001|Overall Study|Protocol Violation|3|||
105960728|NCT01701362|365517297|FG000|Overall Study|No longer willing to participate|8|||
105960729|NCT01701362|365517298|FG001|Overall Study|No longer willing to participate|14|||
105960730|NCT01701362|365517297|FG000|Overall Study|Lost to Follow-up|6|||
105960731|NCT01701362|365517298|FG001|Overall Study|Lost to Follow-up|9|||
105960732|NCT01701362|365517297|FG000|Overall Study|Insufficient clinical response|6|||
105960733|NCT01701362|365517298|FG001|Overall Study|Insufficient clinical response|6|||
106021911|NCT01742286|365744841|FG005|Escalation Phase|Subject/guardian decision|0|||
106021912|NCT01742286|365744842|FG006|Escalation Phase|Subject/guardian decision|0|||
106021913|NCT01742286|365744836|FG000|Expansion Phase|Administrative problems|0|||
106021914|NCT01742286|365744837|FG001|Expansion Phase|Administrative problems|0|||
106021915|NCT01742286|365744838|FG002|Expansion Phase|Administrative problems|0|||
106021916|NCT01742286|365744839|FG003|Expansion Phase|Administrative problems|0|||
106021917|NCT01742286|365744840|FG004|Expansion Phase|Administrative problems|0|||
106021918|NCT01742286|365744841|FG005|Expansion Phase|Administrative problems|0|||
106021919|NCT01742286|365744842|FG006|Expansion Phase|Administrative problems|5|||
106021920|NCT01742286|365744836|FG000|Expansion Phase|Physician Decision|0|||
106021921|NCT01742286|365744837|FG001|Expansion Phase|Physician Decision|0|||
106021922|NCT01742286|365744838|FG002|Expansion Phase|Physician Decision|4|||
106021923|NCT01742286|365744839|FG003|Expansion Phase|Physician Decision|0|||
106021924|NCT01742286|365744840|FG004|Expansion Phase|Physician Decision|0|||
106021925|NCT01742286|365744841|FG005|Expansion Phase|Physician Decision|0|||
106021926|NCT01742286|365744842|FG006|Expansion Phase|Physician Decision|9|||
106021927|NCT01742286|365744836|FG000|Expansion Phase|Adverse Event|0|||
106021928|NCT01742286|365744837|FG001|Expansion Phase|Adverse Event|0|||
106021929|NCT01742286|365744838|FG002|Expansion Phase|Adverse Event|0|||
106021930|NCT01742286|365744839|FG003|Expansion Phase|Adverse Event|0|||
106021931|NCT01742286|365744840|FG004|Expansion Phase|Adverse Event|0|||
106021932|NCT01742286|365744841|FG005|Expansion Phase|Adverse Event|0|||
106021933|NCT01742286|365744842|FG006|Expansion Phase|Adverse Event|6|||
106021934|NCT01742286|365744836|FG000|Expansion Phase|Disease progression|0|||
106021935|NCT01742286|365744837|FG001|Expansion Phase|Disease progression|0|||
106021936|NCT01742286|365744838|FG002|Expansion Phase|Disease progression|3|||
106021937|NCT01742286|365744839|FG003|Expansion Phase|Disease progression|0|||
106021938|NCT01742286|365744840|FG004|Expansion Phase|Disease progression|0|||
106021939|NCT01742286|365744841|FG005|Expansion Phase|Disease progression|0|||
106021940|NCT01742286|365744842|FG006|Expansion Phase|Disease progression|15|||
106021941|NCT01742286|365744836|FG000|Expansion Phase|Withdrawal by Subject|0|||
106021942|NCT01742286|365744837|FG001|Expansion Phase|Withdrawal by Subject|0|||
106021943|NCT01742286|365744838|FG002|Expansion Phase|Withdrawal by Subject|0|||
106021944|NCT01742286|365744839|FG003|Expansion Phase|Withdrawal by Subject|0|||
106021945|NCT01742286|365744840|FG004|Expansion Phase|Withdrawal by Subject|0|||
106021946|NCT01742286|365744841|FG005|Expansion Phase|Withdrawal by Subject|0|||
106021947|NCT01742286|365744842|FG006|Expansion Phase|Withdrawal by Subject|1|||
106021948|NCT01233232|365744843|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
106021949|NCT01233232|365744844|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
106021950|NCT01233232|365744845|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
106021951|NCT02624986|365744846|FG000|Overall Study|Death|0|||
106021952|NCT02624986|365744847|FG001|Overall Study|Death|1|||
106021953|NCT02624986|365744848|FG002|Overall Study|Death|2|||
106021954|NCT02624986|365744849|FG003|Overall Study|Death|2|||
106021955|NCT02624986|365744850|FG004|Overall Study|Death|2|||
106021956|NCT02624986|365744851|FG005|Overall Study|Death|0|||
106021957|NCT02624986|365744852|FG006|Overall Study|Death|0|||
106021958|NCT02624986|365744853|FG007|Overall Study|Death|1|||
105960734|NCT01701362|365517297|FG000|Overall Study|Death|0|||
105960735|NCT01701362|365517298|FG001|Overall Study|Death|1|||
105960736|NCT01701362|365517297|FG000|Overall Study|Randomized but not treated|1|||
105960737|NCT01701362|365517298|FG001|Overall Study|Randomized but not treated|2|||
105960738|NCT01701362|365517297|FG000|Overall Study|Reasons other than those mentioned above|3|||
106021959|NCT02624986|365744846|FG000|Overall Study|Study Terminated by Sponsor|1|||
106021960|NCT02624986|365744847|FG001|Overall Study|Study Terminated by Sponsor|1|||
106021961|NCT02624986|365744848|FG002|Overall Study|Study Terminated by Sponsor|0|||
106021962|NCT02624986|365744849|FG003|Overall Study|Study Terminated by Sponsor|1|||
106021963|NCT02624986|365744850|FG004|Overall Study|Study Terminated by Sponsor|2|||
106021964|NCT02624986|365744851|FG005|Overall Study|Study Terminated by Sponsor|2|||
106021965|NCT02624986|365744852|FG006|Overall Study|Study Terminated by Sponsor|4|||
105960739|NCT01701362|365517298|FG001|Overall Study|Reasons other than those mentioned above|5|||
106021966|NCT02624986|365744853|FG007|Overall Study|Study Terminated by Sponsor|3|||
106021967|NCT02624986|365744846|FG000|Overall Study|Progressive Disease|0|||
106021968|NCT02624986|365744847|FG001|Overall Study|Progressive Disease|1|||
106021969|NCT02624986|365744848|FG002|Overall Study|Progressive Disease|0|||
106021970|NCT02624986|365744849|FG003|Overall Study|Progressive Disease|0|||
106021971|NCT02624986|365744850|FG004|Overall Study|Progressive Disease|0|||
106021972|NCT02624986|365744851|FG005|Overall Study|Progressive Disease|0|||
106021973|NCT02624986|365744852|FG006|Overall Study|Progressive Disease|0|||
106021974|NCT02624986|365744853|FG007|Overall Study|Progressive Disease|0|||
106021975|NCT02624986|365744846|FG000|Overall Study|Protocol Violation|1|||
106021976|NCT02624986|365744847|FG001|Overall Study|Protocol Violation|0|||
106021977|NCT02624986|365744848|FG002|Overall Study|Protocol Violation|0|||
106021978|NCT02624986|365744849|FG003|Overall Study|Protocol Violation|0|||
106021979|NCT02624986|365744850|FG004|Overall Study|Protocol Violation|0|||
106021980|NCT02624986|365744851|FG005|Overall Study|Protocol Violation|0|||
106021981|NCT02624986|365744852|FG006|Overall Study|Protocol Violation|0|||
106021982|NCT02624986|365744853|FG007|Overall Study|Protocol Violation|0|||
106021983|NCT02624986|365744846|FG000|Overall Study|Withdrawal by Subject|0|||
106021984|NCT02624986|365744847|FG001|Overall Study|Withdrawal by Subject|0|||
106021985|NCT02624986|365744848|FG002|Overall Study|Withdrawal by Subject|0|||
106021986|NCT02624986|365744849|FG003|Overall Study|Withdrawal by Subject|0|||
106021987|NCT02624986|365744850|FG004|Overall Study|Withdrawal by Subject|0|||
106021988|NCT02624986|365744851|FG005|Overall Study|Withdrawal by Subject|0|||
106021989|NCT02624986|365744852|FG006|Overall Study|Withdrawal by Subject|0|||
106021990|NCT02624986|365744853|FG007|Overall Study|Withdrawal by Subject|1|||
106021991|NCT00530816|365744858|FG000|Overall Study|Progressive Disease|16|||
106021992|NCT00530816|365744859|FG001|Overall Study|Progressive Disease|24|||
106021993|NCT00530816|365744860|FG002|Overall Study|Progressive Disease|24|||
106021994|NCT00530816|365744858|FG000|Overall Study|Adverse Event|6|||
106021995|NCT00530816|365744859|FG001|Overall Study|Adverse Event|13|||
106021996|NCT00530816|365744860|FG002|Overall Study|Adverse Event|7|||
106021997|NCT00530816|365744858|FG000|Overall Study|Other|3|||
106021998|NCT00530816|365744859|FG001|Overall Study|Other|3|||
106021999|NCT00530816|365744860|FG002|Overall Study|Other|4|||
106022000|NCT00530816|365744858|FG000|Overall Study|Withdrawal by Subject|1|||
106022001|NCT00530816|365744859|FG001|Overall Study|Withdrawal by Subject|2|||
106022002|NCT00530816|365744860|FG002|Overall Study|Withdrawal by Subject|6|||
106022003|NCT05307692|365744866|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
106022004|NCT05307692|365744867|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
106022005|NCT05307692|365744868|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
106022006|NCT05307692|365744869|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
106022007|NCT05307692|365744866|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
106022008|NCT05307692|365744867|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
106022009|NCT05307692|365744868|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
106022010|NCT05307692|365744869|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
105825734|NCT01380782|365020035|FG000|Overall Study|Physician Decision|1|||
105825735|NCT01380782|365020036|FG001|Overall Study|Physician Decision|0|||
105825736|NCT01380782|365020037|FG002|Overall Study|Physician Decision|0|||
105825737|NCT01380782|365020038|FG003|Overall Study|Physician Decision|0|||
105825738|NCT01380782|365020035|FG000|Overall Study|Withdrawal by Subject|0|||
105825739|NCT01380782|365020036|FG001|Overall Study|Withdrawal by Subject|0|||
105825740|NCT01380782|365020037|FG002|Overall Study|Withdrawal by Subject|1|||
105825741|NCT01380782|365020038|FG003|Overall Study|Withdrawal by Subject|1|||
105825742|NCT01403194|365020039|FG000|Overall Study|Screen Failure|2|||
105825743|NCT01403194|365020039|FG000|Overall Study|Lost to Follow-up|8|||
105825744|NCT03987191|365020040|FG000|Overall Study|COVID-19 related research disruption|0|||
105825745|NCT03987191|365020041|FG001|Overall Study|COVID-19 related research disruption|2|||
105825746|NCT01020474|365020042|FG000|Overall Study|Adverse Event|4|||
105825747|NCT01020474|365020043|FG001|Overall Study|Adverse Event|4|||
105825748|NCT01020474|365020042|FG000|Overall Study|Protocol Violation|0|||
105825749|NCT01020474|365020043|FG001|Overall Study|Protocol Violation|2|||
105825750|NCT01020474|365020042|FG000|Overall Study|Withdrawal by Subject|5|||
105825751|NCT01020474|365020043|FG001|Overall Study|Withdrawal by Subject|7|||
105825752|NCT01020474|365020042|FG000|Overall Study|Other Reasons|1|||
105825753|NCT01020474|365020043|FG001|Overall Study|Other Reasons|1|||
105825754|NCT01020474|365020042|FG000|Overall Study|Insufficient Clinical Response|0|||
105825755|NCT01020474|365020043|FG001|Overall Study|Insufficient Clinical Response|3|||
105825756|NCT01701063|365020044|FG000|Overall Study|Lost to Follow-up|0|||
105825757|NCT01701063|365020045|FG001|Overall Study|Lost to Follow-up|1|||
105825758|NCT01701063|365020046|FG002|Overall Study|Lost to Follow-up|0|||
105825759|NCT01701063|365020044|FG000|Overall Study|Withdrawal by Subject|0|||
105825760|NCT01701063|365020045|FG001|Overall Study|Withdrawal by Subject|0|||
105825761|NCT01701063|365020046|FG002|Overall Study|Withdrawal by Subject|1|||
105825762|NCT01701063|365020044|FG000|Overall Study|Other|0|||
105825763|NCT01701063|365020045|FG001|Overall Study|Other|0|||
105825764|NCT01701063|365020046|FG002|Overall Study|Other|1|||
105825765|NCT05387408|365020049|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
105825766|NCT03199963|365020050|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
105825767|NCT03199963|365020051|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
105825768|NCT03199963|365020050|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
105825769|NCT03199963|365020051|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
105825770|NCT03199963|365020050|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
105825771|NCT03199963|365020051|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
105825772|NCT03199963|365020050|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
105825773|NCT03199963|365020051|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
105825774|NCT03199963|365020050|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
105825775|NCT03199963|365020051|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
105825776|NCT03199963|365020050|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
105825777|NCT03199963|365020051|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
105825778|NCT03364192|365020052|FG000|Overall Study|Ineligible|10|||
105825779|NCT03364192|365020052|FG000|Overall Study|Withdrawal by Subject|5|||
105825780|NCT03364192|365020052|FG000|Overall Study|Lost to Follow-up|1|||
105825781|NCT01919112|365020055|FG000|Secondary Analysis-day 30|Death|1|||
105825782|NCT01919112|365020056|FG001|Secondary Analysis-day 30|Death|1|||
105825783|NCT01919112|365020057|FG002|Secondary Analysis-day 30|Death|1|||
105825784|NCT01919112|365020055|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
105825785|NCT01919112|365020056|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
105825786|NCT01919112|365020057|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
105825787|NCT04692155|365020060|FG000|Overall Study|Death|1|||
105825788|NCT05133180|365020061|FG000|Overall Study|Withdrawal of consent|1|||
105825789|NCT05133180|365020062|FG001|Overall Study|Withdrawal of consent|1|||
105825790|NCT05133180|365020061|FG000|Overall Study|Lost to Follow-up|1|||
105825791|NCT05133180|365020062|FG001|Overall Study|Lost to Follow-up|1|||
105825792|NCT05133180|365020061|FG000|Overall Study|Documented disease progression|0|||
105825793|NCT05133180|365020062|FG001|Overall Study|Documented disease progression|1|||
105825794|NCT03446768|365020063|FG000|Overall Study|Withdrawal by Subject|0|||
105825795|NCT03446768|365020064|FG001|Overall Study|Withdrawal by Subject|1|||
105825796|NCT00705666|365020065|FG000|Overall Study|No post-treatment questionnaire|279|||
105825797|NCT00705666|365020065|FG000|Overall Study|Withdrawal by Subject|21|||
105825798|NCT00705666|365020065|FG000|Overall Study|Physician Decision|7|||
105825799|NCT00705666|365020065|FG000|Overall Study|Lost to Follow-up|5|||
105825800|NCT00705666|365020065|FG000|Overall Study|Death|1|||
105825801|NCT00705666|365020065|FG000|Overall Study|Adverse Event|4|||
105825802|NCT00705666|365020065|FG000|Overall Study|Other|12|||
105825803|NCT00705666|365020065|FG000|Overall Study|Other|2|||
105825804|NCT00705666|365020065|FG000|Overall Study|Lack of data|3|||
105825805|NCT00705666|365020065|FG000|Overall Study|Untreated|5|||
105825806|NCT00506831|365020066|FG000|Overall Study|Death|1|||
105825807|NCT00506831|365020066|FG000|Overall Study|Withdrawal by Subject|1|||
105825808|NCT03406156|365020073|FG000|Overall Study|Death|9|||
105825809|NCT03406156|365020074|FG001|Overall Study|Death|3|||
105825810|NCT03406156|365020073|FG000|Overall Study|Withdrawal by Subject|1|||
105825811|NCT03406156|365020074|FG001|Overall Study|Withdrawal by Subject|2|||
105825812|NCT03406156|365020073|FG000|Overall Study|COVID-19 infection|1|||
105825813|NCT03406156|365020074|FG001|Overall Study|COVID-19 infection|0|||
105825814|NCT03406156|365020073|FG000|Overall Study|Non-compliance with study procedures|1|||
105825815|NCT03406156|365020074|FG001|Overall Study|Non-compliance with study procedures|1|||
105825816|NCT03406156|365020073|FG000|Overall Study|Lost to Follow-up|0|||
105960740|NCT03367403|365517304|FG000|Overall Study|Adverse Event|20|||
105960741|NCT03367403|365517305|FG001|Overall Study|Adverse Event|6|||
105960742|NCT03367403|365517306|FG002|Overall Study|Adverse Event|2|||
105960743|NCT03367403|365517304|FG000|Overall Study|Withdrawal by Subject|12|||
105960744|NCT03367403|365517305|FG001|Overall Study|Withdrawal by Subject|13|||
105960745|NCT03367403|365517306|FG002|Overall Study|Withdrawal by Subject|1|||
105960746|NCT03367403|365517304|FG000|Overall Study|Death|1|||
105960747|NCT03367403|365517305|FG001|Overall Study|Death|2|||
105960748|NCT03367403|365517306|FG002|Overall Study|Death|0|||
105960749|NCT03367403|365517304|FG000|Overall Study|Physician Decision|0|||
105960750|NCT03367403|365517305|FG001|Overall Study|Physician Decision|1|||
105960751|NCT03367403|365517306|FG002|Overall Study|Physician Decision|0|||
105960752|NCT03367403|365517304|FG000|Overall Study|Protocol Violation|1|||
105960753|NCT03367403|365517305|FG001|Overall Study|Protocol Violation|1|||
105960754|NCT03367403|365517306|FG002|Overall Study|Protocol Violation|0|||
105960755|NCT03367403|365517304|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
105960756|NCT03367403|365517305|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
105960757|NCT03367403|365517306|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
105960758|NCT03367403|365517304|FG000|Overall Study|COVID-19|3|||
105960759|NCT03367403|365517305|FG001|Overall Study|COVID-19|6|||
105960760|NCT03367403|365517306|FG002|Overall Study|COVID-19|0|||
105960761|NCT03367403|365517304|FG000|Overall Study|Abuse of Alcohol Intake|0|||
105960762|NCT03367403|365517305|FG001|Overall Study|Abuse of Alcohol Intake|1|||
106146878|NCT02252042|366198912|FG000|Overall Study|Transferred to Extension Study|7|||
106146879|NCT02252042|366198913|FG001|Overall Study|Transferred to Extension Study|1|||
106146880|NCT02252042|366198912|FG000|Overall Study|Did Not Continue on Extension Study|7|||
106146881|NCT02252042|366198913|FG001|Overall Study|Did Not Continue on Extension Study|2|||
106146882|NCT02252042|366198912|FG000|Overall Study|Withdrawal by Subject|15|||
106146883|NCT02252042|366198913|FG001|Overall Study|Withdrawal by Subject|20|||
106146884|NCT01177670|366198915|FG000|Overall Study|Study Terminated|115|||
106146885|NCT01177670|366198915|FG000|Overall Study|Physician Decision|50|||
106146886|NCT01177670|366198915|FG000|Overall Study|Withdrawal by Subject|4|||
106146887|NCT00979992|366198916|FG000|Overall Study|Ineligible - inadequate pathology|1|||
106146888|NCT00979992|366198916|FG000|Overall Study|Ineligible - wrong cell type|2|||
106146889|NCT00979992|366198916|FG000|Overall Study|Refused - Never Treated|2|||
106146890|NCT04532528|366198919|FG000|Overall Study|Adverse Event|12|||
106146891|NCT04532528|366198920|FG001|Overall Study|Adverse Event|17|||
106146892|NCT04532528|366198919|FG000|Overall Study|Withdrawal of consent|16|||
106146893|NCT04532528|366198920|FG001|Overall Study|Withdrawal of consent|17|||
106146894|NCT04532528|366198919|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
106146895|NCT04532528|366198920|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
106146896|NCT04532528|366198919|FG000|Overall Study|Lost to Follow-up|69|||
106146897|NCT04532528|366198920|FG001|Overall Study|Lost to Follow-up|68|||
106146898|NCT04532528|366198919|FG000|Overall Study|Administrative problems|12|||
106146899|NCT04532528|366198920|FG001|Overall Study|Administrative problems|14|||
106146900|NCT04532528|366198919|FG000|Overall Study|Death|3|||
106146901|NCT04532528|366198920|FG001|Overall Study|Death|3|||
106146902|NCT04532528|366198919|FG000|Overall Study|Other|38|||
106146903|NCT04532528|366198920|FG001|Overall Study|Other|46|||
106146904|NCT02594735|366198921|FG000|Overall Study|Adverse Event|1|||
106146905|NCT02969863|366198922|FG000|Overall Study|Physician Decision|1|||
106146906|NCT02969863|366198923|FG001|Overall Study|Physician Decision|0|||
106146907|NCT02969863|366198924|FG002|Overall Study|Physician Decision|0|||
106146908|NCT02969863|366198925|FG003|Overall Study|Physician Decision|0|||
106146909|NCT02969863|366198926|FG004|Overall Study|Physician Decision|0|||
106146910|NCT02969863|366198927|FG005|Overall Study|Physician Decision|0|||
106146911|NCT01236001|366198930|FG000|Overall Study|Adverse Event|5|||
106146912|NCT01236001|366198931|FG001|Overall Study|Adverse Event|14|||
106146913|NCT01236001|366198930|FG000|Overall Study|Lack of Efficacy|6|||
106146914|NCT01236001|366198931|FG001|Overall Study|Lack of Efficacy|6|||
106146915|NCT01236001|366198930|FG000|Overall Study|Lost to Follow-up|6|||
106146916|NCT01236001|366198931|FG001|Overall Study|Lost to Follow-up|1|||
106146917|NCT01236001|366198930|FG000|Overall Study|Incompliance|1|||
106146918|NCT01236001|366198931|FG001|Overall Study|Incompliance|0|||
106146919|NCT01236001|366198930|FG000|Overall Study|Planned Visit After End of Study|0|||
106146920|NCT01236001|366198931|FG001|Overall Study|Planned Visit After End of Study|1|||
106146921|NCT03074331|366198937|FG000|Overall Study|Enrolled but Not Treated|1|||
106146922|NCT03074331|366198937|FG000|Overall Study|Lost to Follow-up|5|||
106146923|NCT03074331|366198937|FG000|Overall Study|Withdrew Consent|1|||
106146924|NCT00539734|366198947|FG000|Overall Study|Protocol Violation|1|||
106146925|NCT05368831|366198948|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
106146926|NCT03887650|366198956|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
106146927|NCT03887650|366198957|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
106146928|NCT03887650|366198956|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
106146929|NCT03887650|366198957|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
106146930|NCT03887650|366198956|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
106146931|NCT03887650|366198957|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
106146932|NCT00223795|366198960|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
106146933|NCT00223795|366198961|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
106146934|NCT00223795|366198960|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
106146935|NCT00223795|366198961|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
106146936|NCT00393484|366198965|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
106146937|NCT00393484|366198966|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
105825817|NCT03406156|365020074|FG001|Overall Study|Lost to Follow-up|2|||
105825818|NCT03406156|365020073|FG000|Overall Study|Other, not specified|72|||
105825819|NCT03406156|365020074|FG001|Overall Study|Other, not specified|28|||
105825820|NCT01410227|365020075|FG000|Overall Study|Adverse Event|1|||
105825821|NCT01410227|365020076|FG001|Overall Study|Adverse Event|0|||
105825822|NCT01410227|365020077|FG002|Overall Study|Adverse Event|0|||
105825823|NCT01410227|365020078|FG003|Overall Study|Adverse Event|0|||
105825824|NCT01410227|365020075|FG000|Overall Study|Withdrawal by Subject|3|||
105825825|NCT01410227|365020076|FG001|Overall Study|Withdrawal by Subject|0|||
105825826|NCT01410227|365020077|FG002|Overall Study|Withdrawal by Subject|1|||
105825827|NCT01410227|365020078|FG003|Overall Study|Withdrawal by Subject|0|||
105825828|NCT01410227|365020075|FG000|Overall Study|Pregnancy|0|||
105825829|NCT01410227|365020076|FG001|Overall Study|Pregnancy|0|||
105960763|NCT03367403|365517306|FG002|Overall Study|Abuse of Alcohol Intake|0|||
105960764|NCT03367403|365517304|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
105960765|NCT03367403|365517305|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
105960766|NCT03367403|365517306|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
105960767|NCT01977729|365517307|FG000|Overall Study|Study terminated|1|||
105960768|NCT02836717|365517310|FG000|Test Phase|Lack of Efficacy|14|||
105960769|NCT02836717|365517311|FG001|Test Phase|Lack of Efficacy|8|||
105960770|NCT02836717|365517312|FG002|Test Phase|Lack of Efficacy|0|||
105960771|NCT02836717|365517310|FG000|Study Phase|Adverse Event|2|||
105960772|NCT02836717|365517311|FG001|Study Phase|Adverse Event|0|||
105960773|NCT02836717|365517312|FG002|Study Phase|Adverse Event|0|||
105960774|NCT02836717|365517310|FG000|Study Phase|Lack of Efficacy|8|||
105960775|NCT02836717|365517311|FG001|Study Phase|Lack of Efficacy|6|||
105960776|NCT02836717|365517312|FG002|Study Phase|Lack of Efficacy|1|||
105960777|NCT02836717|365517310|FG000|Study Phase|Withdrawal by Subject|1|||
105960778|NCT02836717|365517311|FG001|Study Phase|Withdrawal by Subject|0|||
105960779|NCT02836717|365517312|FG002|Study Phase|Withdrawal by Subject|0|||
105960780|NCT02836717|365517310|FG000|Study Phase|Death|1|||
105960781|NCT02836717|365517311|FG001|Study Phase|Death|0|||
105960782|NCT02836717|365517312|FG002|Study Phase|Death|0|||
105960783|NCT02836717|365517310|FG000|Study Phase|abdominal surgeries|2|||
105960784|NCT02836717|365517311|FG001|Study Phase|abdominal surgeries|1|||
105960785|NCT02836717|365517312|FG002|Study Phase|abdominal surgeries|0|||
105960786|NCT00935493|365517319|FG000|Overall Study|Lost to Follow-up|1|||
105960787|NCT00935493|365517320|FG001|Overall Study|Lost to Follow-up|1|||
105960788|NCT00935493|365517321|FG002|Overall Study|Lost to Follow-up|1|||
105960789|NCT00935493|365517319|FG000|Overall Study|Treatment Discontinued|0|||
105960790|NCT00935493|365517320|FG001|Overall Study|Treatment Discontinued|1|||
105960791|NCT00935493|365517321|FG002|Overall Study|Treatment Discontinued|0|||
105960792|NCT04599803|365517322|FG000|Overall Study|Withdrawal by Subject|5|||
105960793|NCT04599803|365517322|FG000|Overall Study|Lost to Follow-up|26|||
105960794|NCT02584452|365517327|FG000|Overall Study|Physician Decision|1|||
105960795|NCT02584452|365517328|FG001|Overall Study|Physician Decision|1|||
105960796|NCT02584452|365517327|FG000|Overall Study|Lost to Follow-up|1|||
105960797|NCT02584452|365517328|FG001|Overall Study|Lost to Follow-up|1|||
105960798|NCT01479764|365517329|FG000|Randomized|Adverse Event|1|||
105960799|NCT01479764|365517330|FG001|Randomized|Adverse Event|1|||
105960800|NCT01479764|365517329|FG000|Randomized|Withdrawal by Subject|1|||
105960801|NCT01479764|365517330|FG001|Randomized|Withdrawal by Subject|0|||
105960802|NCT01479764|365517329|FG000|Treated|Lost to Follow-up|0|||
105960803|NCT01479764|365517330|FG001|Treated|Lost to Follow-up|2|||
105960804|NCT01667133|365517331|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
105960805|NCT01667133|365517332|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
105960806|NCT01667133|365517333|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
105960807|NCT01667133|365517334|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
106146938|NCT00393484|366198965|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
106146939|NCT00393484|366198966|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
106146940|NCT00393484|366198965|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
106146941|NCT00393484|366198966|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
105960808|NCT01667133|365517335|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
105960809|NCT01667133|365517336|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
105960810|NCT01667133|365517337|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
105825830|NCT01410227|365020077|FG002|Overall Study|Pregnancy|0|||
105825831|NCT01410227|365020078|FG003|Overall Study|Pregnancy|1|||
105825832|NCT01410227|365020075|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
105825833|NCT01410227|365020076|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
105825834|NCT01410227|365020077|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
105960811|NCT01667133|365517338|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
105960812|NCT01667133|365517339|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
105960813|NCT01667133|365517340|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
105960814|NCT01667133|365517341|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
105960815|NCT01667133|365517342|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
105960816|NCT01667133|365517331|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
106146942|NCT00393484|366198965|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
106146943|NCT00393484|366198966|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
106146944|NCT00393484|366198965|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
106146945|NCT00393484|366198966|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
106146946|NCT00393484|366198965|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
106146947|NCT00393484|366198966|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
106146948|NCT00393484|366198965|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
106146949|NCT00393484|366198966|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
106146950|NCT00393484|366198965|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
106146951|NCT00393484|366198966|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
106146952|NCT00393484|366198965|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
106146953|NCT00393484|366198966|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
106146954|NCT00393484|366198965|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
106146955|NCT00393484|366198966|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
106146956|NCT00411216|366198969|FG000|Overall Study|Ten participants were entered into the c|0|||
106146957|NCT00411216|366198970|FG001|Overall Study|Ten participants were entered into the c|2|||
106146958|NCT01212991|366198973|FG000|Double-blind|Lost to Follow-up|8|||
106146959|NCT01212991|366198974|FG001|Double-blind|Lost to Follow-up|4|||
106146960|NCT01212991|366198975|FG002|Double-blind|Lost to Follow-up|0|||
106146961|NCT01212991|366198973|FG000|Double-blind|Death|699|||
106146962|NCT01212991|366198974|FG001|Double-blind|Death|550|||
106146963|NCT01212991|366198975|FG002|Double-blind|Death|0|||
106146964|NCT01212991|366198973|FG000|Double-blind|Withdrawal by Subject|16|||
106146965|NCT01212991|366198974|FG001|Double-blind|Withdrawal by Subject|19|||
106146966|NCT01212991|366198975|FG002|Double-blind|Withdrawal by Subject|0|||
106146967|NCT01212991|366198973|FG000|Double-blind|Other|7|||
106146968|NCT01212991|366198974|FG001|Double-blind|Other|0|||
106146969|NCT01212991|366198975|FG002|Double-blind|Other|0|||
106146970|NCT01212991|366198973|FG000|Double-blind|Sponsor decision|142|||
106146971|NCT01212991|366198974|FG001|Double-blind|Sponsor decision|38|||
106146972|NCT01212991|366198975|FG002|Double-blind|Sponsor decision|0|||
106146973|NCT01212991|366198973|FG000|Open-label|Death|0|||
106146974|NCT01212991|366198974|FG001|Open-label|Death|0|||
106146975|NCT01212991|366198975|FG002|Open-label|Death|166|||
106146976|NCT01212991|366198973|FG000|Open-label|Lost to Follow-up|0|||
106146977|NCT01212991|366198974|FG001|Open-label|Lost to Follow-up|0|||
106146978|NCT01212991|366198975|FG002|Open-label|Lost to Follow-up|5|||
106146979|NCT01212991|366198973|FG000|Open-label|Withdrawal by Subject|0|||
106146980|NCT01212991|366198974|FG001|Open-label|Withdrawal by Subject|0|||
106146981|NCT01212991|366198975|FG002|Open-label|Withdrawal by Subject|7|||
106146982|NCT01212991|366198973|FG000|Open-label|Sponsor decision|0|||
106146983|NCT01212991|366198974|FG001|Open-label|Sponsor decision|0|||
106146984|NCT01212991|366198975|FG002|Open-label|Sponsor decision|53|||
106146985|NCT01212991|366198973|FG000|Open-label|Other|0|||
106146986|NCT01212991|366198974|FG001|Open-label|Other|0|||
106146987|NCT01212991|366198975|FG002|Open-label|Other|3|||
106146988|NCT02531113|366198976|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
105825835|NCT01410227|365020078|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
105825836|NCT02699463|365020079|FG000|Overall Study|Lost to Follow-up|11|||
105825837|NCT02699463|365020080|FG001|Overall Study|Lost to Follow-up|8|||
105825838|NCT02699463|365020079|FG000|Overall Study|Withdrawal by Subject|4|||
105825839|NCT02699463|365020080|FG001|Overall Study|Withdrawal by Subject|1|||
106022011|NCT05307692|365744866|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
106022012|NCT05307692|365744867|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
106022013|NCT05307692|365744868|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
106022014|NCT05307692|365744869|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
106022015|NCT05307692|365744866|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
106022016|NCT05307692|365744867|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
106022017|NCT05307692|365744868|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
106022018|NCT05307692|365744869|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
106146989|NCT02531113|366198976|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
106146990|NCT02531113|366198976|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
106146991|NCT02531113|366198976|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
106146992|NCT02531113|366198976|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
106146993|NCT02531113|366198976|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
106146994|NCT02531113|366198976|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
106146995|NCT02531113|366198976|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
106146996|NCT00566735|366201160|FG000|Overall Study|Withdrawal by Subject|0|||
106146997|NCT00566735|366201161|FG001|Overall Study|Withdrawal by Subject|1|||
106146998|NCT00566735|366201160|FG000|Overall Study|Refused neuropsychological testing|2|||
106146999|NCT00566735|366201161|FG001|Overall Study|Refused neuropsychological testing|5|||
105825840|NCT01808651|365020081|FG000|Study Period 1|Lost to Follow-up|1|||
105825841|NCT01808651|365020082|FG001|Study Period 1|Lost to Follow-up|3|||
105825842|NCT01808651|365020083|FG002|Study Period 1|Lost to Follow-up|0|||
105960817|NCT01667133|365517332|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105825843|NCT01808651|365020081|FG000|Study Period 1|Protocol Violation|1|||
105825844|NCT01808651|365020082|FG001|Study Period 1|Protocol Violation|0|||
105825845|NCT01808651|365020083|FG002|Study Period 1|Protocol Violation|1|||
105825846|NCT01808651|365020081|FG000|Study Period 1|Physician Decision|3|||
105825847|NCT01808651|365020082|FG001|Study Period 1|Physician Decision|2|||
105825848|NCT01808651|365020083|FG002|Study Period 1|Physician Decision|0|||
105825849|NCT01808651|365020081|FG000|Study Period 1|Lack of Efficacy|2|||
105825850|NCT01808651|365020082|FG001|Study Period 1|Lack of Efficacy|1|||
105825851|NCT01808651|365020083|FG002|Study Period 1|Lack of Efficacy|0|||
105825852|NCT01808651|365020081|FG000|Study Period 1|Adverse Event|10|||
105825853|NCT01808651|365020082|FG001|Study Period 1|Adverse Event|4|||
105825854|NCT01808651|365020083|FG002|Study Period 1|Adverse Event|1|||
105825855|NCT01808651|365020081|FG000|Study Period 1|Participant Decision|9|||
105825856|NCT01808651|365020082|FG001|Study Period 1|Participant Decision|7|||
105825857|NCT01808651|365020083|FG002|Study Period 1|Participant Decision|3|||
105825858|NCT00585286|365020085|FG000|Overall Study|Lost to Follow-up|1|||
105825859|NCT02488239|365020086|FG000|Overall Study|Death|3|||
105825860|NCT02488239|365020086|FG000|Overall Study|Withdrawal by Subject|3|||
105825861|NCT02488239|365020086|FG000|Overall Study|Physician Decision|2|||
105825862|NCT02488239|365020086|FG000|Overall Study|Consent ineligible|1|||
105825863|NCT02488239|365020086|FG000|Overall Study|Did not undergo implant procedure|1|||
105825864|NCT05479058|365020092|FG000|Overall Study|Withdrawal by Subject|1|||
105825865|NCT05479058|365020093|FG001|Overall Study|Withdrawal by Subject|1|||
105825866|NCT05479058|365020092|FG000|Overall Study|Study terminated by sponsor|10|||
105825867|NCT05479058|365020093|FG001|Overall Study|Study terminated by sponsor|10|||
105825868|NCT03325881|365020094|FG000|Overall Study|Protocol Violation|0|||
105825869|NCT03325881|365020095|FG001|Overall Study|Protocol Violation|1|||
105825870|NCT03325881|365020094|FG000|Overall Study|Withdrawal by Subject|0|||
105825871|NCT03325881|365020095|FG001|Overall Study|Withdrawal by Subject|2|||
105825872|NCT03325881|365020094|FG000|Overall Study|Lack of Efficacy|2|||
105825873|NCT03325881|365020095|FG001|Overall Study|Lack of Efficacy|0|||
105825874|NCT03325881|365020094|FG000|Overall Study|Not treated|1|||
105825875|NCT03325881|365020095|FG001|Overall Study|Not treated|0|||
105825876|NCT03676634|365020096|FG000|Overall Study|Red blood cell loss|1|||
105825877|NCT03676634|365020096|FG000|Overall Study|Out-of-limit pulse|2|||
105825878|NCT01484912|365020108|FG000|Overall Study|Withdrawal by Subject|1|||
105825879|NCT01484912|365020109|FG001|Overall Study|Withdrawal by Subject|0|||
105825880|NCT01484912|365020108|FG000|Overall Study|Physician Decision|0|||
105825881|NCT01484912|365020109|FG001|Overall Study|Physician Decision|1|||
105825882|NCT02294981|365020110|FG000|Overall Study|Lost to Follow-up|1|||
105825883|NCT02213263|365020113|FG000|Overall Study|Insufficient clinical response|4|||
105825884|NCT02213263|365020114|FG001|Overall Study|Insufficient clinical response|3|||
105825885|NCT02213263|365020113|FG000|Overall Study|Lost to Follow-up|0|||
105825886|NCT02213263|365020114|FG001|Overall Study|Lost to Follow-up|1|||
105825887|NCT02213263|365020113|FG000|Overall Study|No longer willing to participate|3|||
105960818|NCT01667133|365517333|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
105960819|NCT01667133|365517334|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105960820|NCT01667133|365517335|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105960821|NCT01667133|365517336|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105960822|NCT01667133|365517337|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105960823|NCT01667133|365517338|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105960824|NCT01667133|365517339|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105960825|NCT01667133|365517340|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105960826|NCT01667133|365517341|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
105960827|NCT01667133|365517342|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
106147000|NCT00566735|366201160|FG000|Overall Study|Switched into a manic episode|0|||
105825888|NCT02213263|365020114|FG001|Overall Study|No longer willing to participate|4|||
105825889|NCT02213263|365020113|FG000|Overall Study|Progressive disease|20|||
105825890|NCT02213263|365020114|FG001|Overall Study|Progressive disease|14|||
105825891|NCT02213263|365020113|FG000|Overall Study|Protocol Violation|0|||
105825892|NCT02213263|365020114|FG001|Overall Study|Protocol Violation|1|||
105825893|NCT02213263|365020113|FG000|Overall Study|Adverse Event|1|||
105825894|NCT02213263|365020114|FG001|Overall Study|Adverse Event|3|||
105825895|NCT01188681|365020115|FG000|Overall Study|bladder cancer|0|||
105825896|NCT01188681|365020116|FG001|Overall Study|bladder cancer|0|||
105825897|NCT01188681|365020117|FG002|Overall Study|bladder cancer|1|||
105825898|NCT01188681|365020118|FG003|Overall Study|bladder cancer|0|||
105825899|NCT01188681|365020115|FG000|Overall Study|Withdrawal by Subject|0|||
105825900|NCT01188681|365020116|FG001|Overall Study|Withdrawal by Subject|0|||
105825901|NCT01188681|365020117|FG002|Overall Study|Withdrawal by Subject|0|||
105825902|NCT01188681|365020118|FG003|Overall Study|Withdrawal by Subject|1|||
105825903|NCT00263588|365020119|FG000|Overall Study|Death|54|||
105825904|NCT00263588|365020120|FG001|Overall Study|Death|90|||
105825905|NCT00263588|365020119|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
105960828|NCT01667133|365517331|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
105960829|NCT01667133|365517332|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
105960830|NCT01667133|365517333|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
105960831|NCT01667133|365517334|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
105960832|NCT01667133|365517335|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
105960833|NCT01667133|365517336|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
105960834|NCT01667133|365517337|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
105960835|NCT01667133|365517338|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
105960836|NCT01667133|365517339|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
105960837|NCT01667133|365517340|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
105960838|NCT01667133|365517341|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
105960839|NCT01667133|365517342|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
105960840|NCT01667133|365517331|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960841|NCT01667133|365517332|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960842|NCT01667133|365517333|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960843|NCT01667133|365517334|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
105960844|NCT01667133|365517335|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960845|NCT01667133|365517336|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960846|NCT01667133|365517337|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960847|NCT01667133|365517338|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960848|NCT01667133|365517339|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960849|NCT01667133|365517340|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960850|NCT01667133|365517341|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960851|NCT01667133|365517342|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
105960852|NCT01667133|365517331|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
105960853|NCT01667133|365517332|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
105960854|NCT01667133|365517333|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
105960855|NCT01667133|365517334|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
105960856|NCT01667133|365517335|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
105960857|NCT01667133|365517336|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
105960858|NCT01667133|365517337|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
105960859|NCT01667133|365517338|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
105960860|NCT01667133|365517339|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
105960861|NCT01667133|365517340|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
105960862|NCT01667133|365517341|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
105960863|NCT01667133|365517342|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
105960864|NCT01667133|365517331|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960865|NCT01667133|365517332|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960866|NCT01667133|365517333|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960867|NCT01667133|365517334|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960868|NCT01667133|365517335|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960869|NCT01667133|365517336|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960870|NCT01667133|365517337|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960871|NCT01667133|365517338|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960872|NCT01667133|365517339|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960873|NCT01667133|365517340|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
105960874|NCT01667133|365517341|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960875|NCT01667133|365517342|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
105960876|NCT01667133|365517331|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
105960877|NCT01667133|365517332|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
105960878|NCT01667133|365517333|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
105960879|NCT01667133|365517334|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
105960880|NCT01667133|365517335|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
105960881|NCT01667133|365517336|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
105960882|NCT01667133|365517337|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
105960883|NCT01667133|365517338|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
105960884|NCT01667133|365517339|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
106147001|NCT00566735|366201161|FG001|Overall Study|Switched into a manic episode|1|||
106147002|NCT01460446|366201165|FG000|Overall Study|Non-compliance|2|||
106147003|NCT01460446|366201166|FG001|Overall Study|Non-compliance|9|||
106147004|NCT01460446|366201165|FG000|Overall Study|Consent Withdrawn|0|||
106147005|NCT01460446|366201166|FG001|Overall Study|Consent Withdrawn|4|||
106147006|NCT01460446|366201165|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
106147007|NCT01460446|366201166|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
105960885|NCT01667133|365517340|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
105960886|NCT01667133|365517341|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
105960887|NCT01667133|365517342|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
105960888|NCT01667133|365517331|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960889|NCT01667133|365517332|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960890|NCT01667133|365517333|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960891|NCT01667133|365517334|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960892|NCT01667133|365517335|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960893|NCT01667133|365517336|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960894|NCT01667133|365517337|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960895|NCT01667133|365517338|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105825906|NCT00263588|365020120|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
105825907|NCT00263588|365020119|FG000|Overall Study|Lost to Follow-up|7|||
105825908|NCT00263588|365020120|FG001|Overall Study|Lost to Follow-up|10|||
105825909|NCT00263588|365020119|FG000|Overall Study|Withdrawal by Subject|3|||
105825910|NCT00263588|365020120|FG001|Overall Study|Withdrawal by Subject|4|||
105825911|NCT00263588|365020119|FG000|Overall Study|Protocol Violation|0|||
105825912|NCT00263588|365020120|FG001|Overall Study|Protocol Violation|1|||
105825913|NCT00263588|365020119|FG000|Overall Study|Investigator decision|7|||
105825914|NCT00263588|365020120|FG001|Overall Study|Investigator decision|15|||
105825915|NCT00263588|365020119|FG000|Overall Study|Sponsor terminated study|0|||
105825916|NCT00263588|365020120|FG001|Overall Study|Sponsor terminated study|1|||
105825917|NCT02890992|365020121|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825918|NCT02890992|365020122|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
105825919|NCT02890992|365020123|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825920|NCT02890992|365020124|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825921|NCT02890992|365020125|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825922|NCT02890992|365020126|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825923|NCT02890992|365020127|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825924|NCT02890992|365020128|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
105825925|NCT02890992|365020121|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825926|NCT02890992|365020122|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825927|NCT02890992|365020123|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825928|NCT02890992|365020124|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825929|NCT02890992|365020125|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825930|NCT02890992|365020126|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
105825931|NCT02890992|365020127|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
105825932|NCT02890992|365020128|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
105825933|NCT02890992|365020121|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825934|NCT02890992|365020122|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
105825935|NCT02890992|365020123|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825936|NCT02890992|365020124|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825937|NCT02890992|365020125|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825938|NCT02890992|365020126|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825939|NCT02890992|365020127|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825940|NCT02890992|365020128|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
105825941|NCT00918684|365020132|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
105825942|NCT00918684|365020132|FG000|Treatment Phase|Lack of Efficacy|6|||
105825943|NCT00918684|365020132|FG000|Treatment Phase|Lost to Follow-up|2|||
105825944|NCT00918684|365020132|FG000|Treatment Phase|Physician Decision|8|||
105825945|NCT00918684|365020132|FG000|Treatment Phase|Protocol Violation|1|||
105960896|NCT01667133|365517339|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960897|NCT01667133|365517340|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
105960898|NCT01667133|365517341|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960899|NCT01667133|365517342|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
105960900|NCT01667133|365517331|FG000|Phase 2: Dose-expansion|Death|0|||
105960901|NCT01667133|365517332|FG001|Phase 2: Dose-expansion|Death|0|||
105960902|NCT01667133|365517333|FG002|Phase 2: Dose-expansion|Death|0|||
105960903|NCT01667133|365517334|FG003|Phase 2: Dose-expansion|Death|0|||
105960904|NCT01667133|365517335|FG004|Phase 2: Dose-expansion|Death|0|||
105960905|NCT01667133|365517336|FG005|Phase 2: Dose-expansion|Death|0|||
105960906|NCT01667133|365517337|FG006|Phase 2: Dose-expansion|Death|0|||
105960907|NCT01667133|365517338|FG007|Phase 2: Dose-expansion|Death|0|||
105960908|NCT01667133|365517339|FG008|Phase 2: Dose-expansion|Death|0|||
105960909|NCT01667133|365517340|FG009|Phase 2: Dose-expansion|Death|1|||
105960910|NCT01667133|365517341|FG010|Phase 2: Dose-expansion|Death|0|||
106147008|NCT01460446|366201165|FG000|Overall Study|Surgery/Illness|1|||
106147009|NCT01460446|366201166|FG001|Overall Study|Surgery/Illness|1|||
106147010|NCT01460446|366201165|FG000|Overall Study|Pregnancy|1|||
106147011|NCT01460446|366201166|FG001|Overall Study|Pregnancy|0|||
106147012|NCT01460446|366201165|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
106147013|NCT01460446|366201166|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
106147014|NCT01318382|366201170|FG000|Overall Study|Physician Decision|2|||
106147015|NCT01318382|366201170|FG000|Overall Study|Device Malfunction|10|||
106147016|NCT01318382|366201170|FG000|Overall Study|Protocol Violation|1|||
106147017|NCT01599104|366201171|FG000|Overall Study|Withdrawal by Subject|1|||
106147018|NCT01599104|366201172|FG001|Overall Study|Withdrawal by Subject|1|||
106147019|NCT01599104|366201173|FG002|Overall Study|Withdrawal by Subject|2|||
106147020|NCT01599104|366201171|FG000|Overall Study|Technical Problems|1|||
106147021|NCT01599104|366201172|FG001|Overall Study|Technical Problems|0|||
106147022|NCT01599104|366201173|FG002|Overall Study|Technical Problems|0|||
106147023|NCT01599104|366201171|FG000|Overall Study|Physician Decision|3|||
105825946|NCT00918684|365020132|FG000|Treatment Phase|Withdrawal by Subject|8|||
105825947|NCT00909038|365020133|FG000|Overall Study|Protocol Violation|187|||
105825948|NCT00909038|365020133|FG000|Overall Study|Non-evaluable Subjects|230|||
105825949|NCT00909753|365020134|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
106022019|NCT05307692|365744866|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
106022020|NCT05307692|365744867|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
106022021|NCT05307692|365744868|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
106147024|NCT01599104|366201172|FG001|Overall Study|Physician Decision|2|||
106147025|NCT01599104|366201173|FG002|Overall Study|Physician Decision|2|||
106147026|NCT01599104|366201171|FG000|Overall Study|Non-compliance with study treatment|0|||
106147027|NCT01599104|366201172|FG001|Overall Study|Non-compliance with study treatment|1|||
106147028|NCT01599104|366201173|FG002|Overall Study|Non-compliance with study treatment|0|||
106147029|NCT01599104|366201171|FG000|Overall Study|Lack of Efficacy|4|||
106147030|NCT01599104|366201172|FG001|Overall Study|Lack of Efficacy|4|||
106147031|NCT01599104|366201173|FG002|Overall Study|Lack of Efficacy|10|||
106147032|NCT01599104|366201171|FG000|Overall Study|Adverse Event|7|||
106147033|NCT01599104|366201172|FG001|Overall Study|Adverse Event|6|||
106147034|NCT01599104|366201173|FG002|Overall Study|Adverse Event|12|||
106147035|NCT03452189|366201176|FG000|First Intervention (3 Months)|Adverse Event|1|||
106147036|NCT03452189|366201177|FG001|First Intervention (3 Months)|Adverse Event|0|||
106147037|NCT03452189|366201176|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
106147038|NCT03452189|366201177|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
106147039|NCT01308567|366201182|FG000|Overall Study|Lost to Follow-up|2|||
106147040|NCT01308567|366201183|FG001|Overall Study|Lost to Follow-up|4|||
106147041|NCT01308567|366201184|FG002|Overall Study|Lost to Follow-up|4|||
106147042|NCT00542789|366201185|FG000|Overall Study|Adverse Event|18|||
106147043|NCT00542789|366201186|FG001|Overall Study|Adverse Event|17|||
106147044|NCT00542789|366201185|FG000|Overall Study|Withdrawal by Subject|7|||
106147045|NCT00542789|366201186|FG001|Overall Study|Withdrawal by Subject|3|||
106147046|NCT00542789|366201185|FG000|Overall Study|Protocol Violation|8|||
106147047|NCT00542789|366201186|FG001|Overall Study|Protocol Violation|1|||
106147048|NCT00542789|366201185|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
106147049|NCT00542789|366201186|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
106147050|NCT01571596|366201187|FG000|Overall Study|Adverse Event|2|||
106147051|NCT01571596|366201188|FG001|Overall Study|Adverse Event|0|||
106147052|NCT01571596|366201189|FG002|Overall Study|Adverse Event|0|||
106147053|NCT01571596|366201187|FG000|Overall Study|Study Terminated by the Sponsor|0|||
106147054|NCT01571596|366201188|FG001|Overall Study|Study Terminated by the Sponsor|1|||
106147055|NCT01571596|366201189|FG002|Overall Study|Study Terminated by the Sponsor|1|||
106147056|NCT01113931|366201195|FG000|Overall Study|Adverse Event|2|||
106147057|NCT01113931|366201196|FG001|Overall Study|Adverse Event|2|||
106147058|NCT01113931|366201195|FG000|Overall Study|Physician Decision|0|||
106147059|NCT01113931|366201196|FG001|Overall Study|Physician Decision|2|||
106147060|NCT01113931|366201195|FG000|Overall Study|Lost to Follow-up|12|||
106147061|NCT01113931|366201196|FG001|Overall Study|Lost to Follow-up|9|||
106147062|NCT01113931|366201195|FG000|Overall Study|Various|2|||
106147063|NCT01113931|366201196|FG001|Overall Study|Various|4|||
106147064|NCT01113931|366201195|FG000|Overall Study|Withdrawal by Subject|3|||
106147065|NCT01113931|366201196|FG001|Overall Study|Withdrawal by Subject|0|||
106147066|NCT01149369|366201197|FG000|Overall Study|Adverse Event|6|||
106147067|NCT01149369|366201198|FG001|Overall Study|Adverse Event|3|||
106147068|NCT02767765|366201199|FG000|Overall Study|Adverse Event|4|||
106147069|NCT02767765|366201199|FG000|Overall Study|Death|1|||
106022022|NCT05307692|365744869|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
106022023|NCT05307692|365744866|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
106022024|NCT05307692|365744867|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
106022025|NCT05307692|365744868|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
106022026|NCT05307692|365744869|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
106022027|NCT05307692|365744866|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
106022028|NCT05307692|365744867|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
106022029|NCT05307692|365744868|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
106022030|NCT05307692|365744869|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
106022031|NCT05307692|365744866|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
106022032|NCT05307692|365744867|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
106022033|NCT05307692|365744868|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
106022034|NCT05307692|365744869|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
106022035|NCT05601544|365744870|FG000|Phase 2 Period 1|Adverse Event|0|||
106022036|NCT05601544|365744871|FG001|Phase 2 Period 1|Adverse Event|1|||
106022037|NCT05601544|365744872|FG002|Phase 2 Period 1|Adverse Event|0|||
106022038|NCT05601544|365744873|FG003|Phase 2 Period 1|Adverse Event|0|||
106022039|NCT05601544|365744874|FG004|Phase 2 Period 1|Adverse Event|0|||
106022040|NCT05601544|365744875|FG005|Phase 2 Period 1|Adverse Event|0|||
106022041|NCT04198714|365744878|FG000|Overall Study|Physician Decision|0|||
106022042|NCT04198714|365744879|FG001|Overall Study|Physician Decision|1|||
106022043|NCT02923921|365746707|FG000|Overall Study|Sponsor Decision|39|||
106022044|NCT02923921|365746708|FG001|Overall Study|Sponsor Decision|38|||
106022045|NCT02923921|365746707|FG000|Overall Study|Lost to Follow-up|1|||
106022046|NCT02923921|365746708|FG001|Overall Study|Lost to Follow-up|0|||
106022047|NCT02923921|365746707|FG000|Overall Study|Withdrawal by Subject|6|||
106022048|NCT02923921|365746708|FG001|Overall Study|Withdrawal by Subject|13|||
106022049|NCT02923921|365746707|FG000|Overall Study|Unknown, Not Collected|7|||
106022050|NCT02923921|365746708|FG001|Overall Study|Unknown, Not Collected|6|||
105960911|NCT01667133|365517342|FG011|Phase 2: Dose-expansion|Death|0|||
105960912|NCT01667133|365517331|FG000|Phase 2: Dose-expansion|Other|0|||
105960913|NCT01667133|365517332|FG001|Phase 2: Dose-expansion|Other|0|||
105960914|NCT01667133|365517333|FG002|Phase 2: Dose-expansion|Other|0|||
105960915|NCT01667133|365517334|FG003|Phase 2: Dose-expansion|Other|0|||
105960916|NCT01667133|365517335|FG004|Phase 2: Dose-expansion|Other|0|||
105960917|NCT01667133|365517336|FG005|Phase 2: Dose-expansion|Other|0|||
105960918|NCT01667133|365517337|FG006|Phase 2: Dose-expansion|Other|0|||
105960919|NCT01667133|365517338|FG007|Phase 2: Dose-expansion|Other|0|||
105960920|NCT01667133|365517339|FG008|Phase 2: Dose-expansion|Other|0|||
105960921|NCT01667133|365517340|FG009|Phase 2: Dose-expansion|Other|0|||
105960922|NCT01667133|365517341|FG010|Phase 2: Dose-expansion|Other|0|||
105960923|NCT01667133|365517342|FG011|Phase 2: Dose-expansion|Other|1|||
105960924|NCT03640507|365517344|FG000|Overall Study|Withdrawal by Subject|0|||
105960925|NCT03640507|365517345|FG001|Overall Study|Withdrawal by Subject|0|||
105960926|NCT03640507|365517346|FG002|Overall Study|Withdrawal by Subject|1|||
105960927|NCT03604172|365517348|FG000|Overall Study|Lost to Follow-up|1|||
105960928|NCT03604172|365517349|FG001|Overall Study|Lost to Follow-up|2|||
105960929|NCT00923351|365517357|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
105960930|NCT00923351|365517358|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
105960931|NCT00923351|365517359|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
105960932|NCT00182078|365517360|FG000|Overall Study|Withdrawal by Subject|1|||
105960933|NCT00182078|365517361|FG001|Overall Study|Withdrawal by Subject|0|||
105960934|NCT00395486|365517362|FG000|Overall Study|Adverse Event|1|||
105960935|NCT00395486|365517363|FG001|Overall Study|Adverse Event|2|||
105960936|NCT00395486|365517362|FG000|Overall Study|Withdrawal by Subject|5|||
105960937|NCT00395486|365517363|FG001|Overall Study|Withdrawal by Subject|2|||
105960938|NCT00395486|365517362|FG000|Overall Study|Lost to Follow-up|0|||
105960939|NCT00395486|365517363|FG001|Overall Study|Lost to Follow-up|1|||
105960940|NCT01030952|365517364|FG000|Overall Study|Protocol Violation|0|||
105960941|NCT01030952|365517365|FG001|Overall Study|Protocol Violation|1|||
105960942|NCT01030952|365517364|FG000|Overall Study|Informed consent withdrawal|1|||
105960943|NCT01030952|365517365|FG001|Overall Study|Informed consent withdrawal|0|||
105960944|NCT01030952|365517364|FG000|Overall Study|Lost to Follow-up|0|||
105960945|NCT01030952|365517365|FG001|Overall Study|Lost to Follow-up|1|||
105960946|NCT01030952|365517364|FG000|Overall Study|Unexplained|1|||
105960947|NCT01030952|365517365|FG001|Overall Study|Unexplained|1|||
105960948|NCT01814397|365517370|FG000|Overall Study|Adverse Event|7|||
105960949|NCT01814397|365517370|FG000|Overall Study|Withdrawal by Subject|7|||
105960950|NCT02455336|365517372|FG000|Overall Study|Withdrawal by Subject|0|||
105960951|NCT02455336|365517373|FG001|Overall Study|Withdrawal by Subject|2|||
105960952|NCT02455336|365517372|FG000|Overall Study|Adverse Event|3|||
105960953|NCT02455336|365517373|FG001|Overall Study|Adverse Event|0|||
105960954|NCT02455336|365517372|FG000|Overall Study|Non-responder to treatment|2|||
105960955|NCT02455336|365517373|FG001|Overall Study|Non-responder to treatment|0|||
105960956|NCT00391430|365517374|FG000|Overall Study|Withdrawal by Subject|3|||
105960957|NCT00391430|365517375|FG001|Overall Study|Withdrawal by Subject|0|||
105960958|NCT00391430|365517376|FG002|Overall Study|Withdrawal by Subject|12|||
105960959|NCT02467192|365517379|FG000|Overall Study|Death|1|||
105960960|NCT02467192|365517379|FG000|Overall Study|revealed to have pneumonia before|2|||
105960961|NCT03213938|365517382|FG000|Overall Study|Lost to Follow-up|4|||
105825950|NCT00909753|365020135|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
105825951|NCT00909753|365020134|FG000|Period: Second Intervention|Protocol Violation|1|||
105825952|NCT00909753|365020135|FG001|Period: Second Intervention|Protocol Violation|0|||
105825953|NCT01895335|365020138|FG000|Overall Study|Adverse Event|106|||
105825954|NCT01895335|365020138|FG000|Overall Study|Lack of Efficacy|53|||
105960962|NCT03213938|365517383|FG001|Overall Study|Lost to Follow-up|3|||
105960963|NCT03213938|365517382|FG000|Overall Study|Lack of Efficacy|1|||
105960964|NCT03213938|365517383|FG001|Overall Study|Lack of Efficacy|0|||
105960965|NCT03213938|365517382|FG000|Overall Study|Decline to participate|5|||
105960966|NCT03213938|365517383|FG001|Overall Study|Decline to participate|4|||
105960967|NCT03213938|365517382|FG000|Overall Study|Without reason|4|||
105960968|NCT03213938|365517383|FG001|Overall Study|Without reason|5|||
105825955|NCT01895335|365020138|FG000|Overall Study|Poor Compliance to Protocol|11|||
105825956|NCT01895335|365020138|FG000|Overall Study|Included But Not treated|1|||
105960969|NCT00564902|365517387|FG000|Overall Study|Withdrawal by Subject|0|||
105825957|NCT01895335|365020138|FG000|Overall Study|Other than Specified Above|44|||
105825958|NCT01906372|365020139|FG000|Overall Study|Withdrawal by Subject|2|||
105825959|NCT00847535|365020142|FG000|Overall Study|Withdrawal by Subject|2|||
105825960|NCT00847535|365020143|FG001|Overall Study|Withdrawal by Subject|1|||
105825961|NCT00847535|365020144|FG002|Overall Study|Withdrawal by Subject|1|||
105825962|NCT00847535|365020142|FG000|Overall Study|Lost to Follow-up|0|||
105825963|NCT00847535|365020143|FG001|Overall Study|Lost to Follow-up|1|||
105825964|NCT00847535|365020144|FG002|Overall Study|Lost to Follow-up|0|||
105825965|NCT01252953|365020145|FG000|Overall Study|Withdrawal by Subject|16|||
105825966|NCT01252953|365020146|FG001|Overall Study|Withdrawal by Subject|17|||
105825967|NCT01252953|365020145|FG000|Overall Study|Lost to Follow-up|22|||
105825968|NCT01252953|365020146|FG001|Overall Study|Lost to Follow-up|21|||
105825969|NCT03503318|365020157|FG000|Overall Study|Death|1|||
105825970|NCT03503318|365020158|FG001|Overall Study|Death|0|||
105825971|NCT03503318|365020159|FG002|Overall Study|Death|4|||
105825972|NCT03503318|365020157|FG000|Overall Study|Adverse Event|3|||
105825973|NCT03503318|365020158|FG001|Overall Study|Adverse Event|4|||
105825974|NCT03503318|365020159|FG002|Overall Study|Adverse Event|2|||
105825975|NCT03503318|365020157|FG000|Overall Study|Withdrawal by Subject|12|||
105825976|NCT03503318|365020158|FG001|Overall Study|Withdrawal by Subject|17|||
105960970|NCT00564902|365517388|FG001|Overall Study|Withdrawal by Subject|3|||
105960971|NCT00564902|365517389|FG002|Overall Study|Withdrawal by Subject|4|||
105960972|NCT00564902|365517387|FG000|Overall Study|Death|1|||
105960973|NCT00564902|365517388|FG001|Overall Study|Death|1|||
105960974|NCT00564902|365517389|FG002|Overall Study|Death|0|||
105960975|NCT00958347|365517390|FG000|Overall Study|Death|43|||
105960976|NCT00958347|365517390|FG000|Overall Study|Withdrawal by Subject|23|||
105960977|NCT00958347|365517390|FG000|Overall Study|Lost to Follow-up|15|||
105960978|NCT00958347|365517390|FG000|Overall Study|revision/removal|10|||
105960979|NCT00958347|365517390|FG000|Overall Study|study termination|135|||
105960980|NCT04532294|365517393|FG000|Overall Study|Withdrawal by Subject|0|||
105960981|NCT04532294|365517394|FG001|Overall Study|Withdrawal by Subject|0|||
105960982|NCT04532294|365517395|FG002|Overall Study|Withdrawal by Subject|1|||
105960983|NCT04532294|365517393|FG000|Overall Study|Participants Not Dosed|0|||
105960984|NCT04532294|365517394|FG001|Overall Study|Participants Not Dosed|0|||
105960985|NCT04532294|365517395|FG002|Overall Study|Participants Not Dosed|2|||
105960986|NCT03146663|365517396|FG000|Overall Study|Did not receive study treatment|1|||
105960987|NCT03146663|365517397|FG001|Overall Study|Did not receive study treatment|1|||
105960988|NCT00673231|365517398|FG000|Overall Study|Withdrawal by Subject|14|||
105960989|NCT00673231|365517399|FG001|Overall Study|Withdrawal by Subject|10|||
105960990|NCT00673231|365517400|FG002|Overall Study|Withdrawal by Subject|8|||
105960991|NCT00673231|365517401|FG003|Overall Study|Withdrawal by Subject|6|||
105960992|NCT00673231|365517398|FG000|Overall Study|Adverse Event|6|||
105960993|NCT00673231|365517399|FG001|Overall Study|Adverse Event|5|||
105960994|NCT00673231|365517400|FG002|Overall Study|Adverse Event|9|||
105960995|NCT00673231|365517401|FG003|Overall Study|Adverse Event|6|||
105960996|NCT00673231|365517398|FG000|Overall Study|Lost to Follow-up|1|||
105960997|NCT00673231|365517399|FG001|Overall Study|Lost to Follow-up|2|||
105960998|NCT00673231|365517400|FG002|Overall Study|Lost to Follow-up|1|||
105960999|NCT00673231|365517401|FG003|Overall Study|Lost to Follow-up|2|||
105961000|NCT00673231|365517398|FG000|Overall Study|Death|0|||
105961001|NCT00673231|365517399|FG001|Overall Study|Death|0|||
105961002|NCT00673231|365517400|FG002|Overall Study|Death|1|||
105961003|NCT00673231|365517401|FG003|Overall Study|Death|0|||
105961004|NCT00673231|365517398|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
105961005|NCT00673231|365517399|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
105961006|NCT00673231|365517400|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
105961007|NCT00673231|365517401|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
105961008|NCT01831466|365517404|FG000|Overall Study|Protocol Violation|1|||
105961009|NCT01831466|365517405|FG001|Overall Study|Protocol Violation|1|||
106147070|NCT02767765|366201199|FG000|Overall Study|Insufficient response|1|||
106147071|NCT02767765|366201199|FG000|Overall Study|Lost to Follow-up|2|||
106147072|NCT02767765|366201199|FG000|Overall Study|Investigator decision|1|||
106147073|NCT02767765|366201199|FG000|Overall Study|Non-Compliance|1|||
106147074|NCT02767765|366201199|FG000|Overall Study|Withdrawal by Subject|1|||
106147075|NCT01951170|366201201|FG000|Overall Study|Investigator decision|1|||
106147076|NCT01808339|366201204|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
106147077|NCT01808339|366201205|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
106147078|NCT01808339|366201206|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
106147079|NCT01808339|366201207|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
106147080|NCT01808339|366201208|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
105825977|NCT03503318|365020159|FG002|Overall Study|Withdrawal by Subject|16|||
105961010|NCT01831466|365517406|FG002|Overall Study|Protocol Violation|2|||
105961011|NCT01831466|365517407|FG003|Overall Study|Protocol Violation|0|||
105825978|NCT03503318|365020157|FG000|Overall Study|Protocol Violation|5|||
105825979|NCT03503318|365020158|FG001|Overall Study|Protocol Violation|0|||
105961012|NCT01831466|365517408|FG004|Overall Study|Protocol Violation|0|||
105961013|NCT01831466|365517409|FG005|Overall Study|Protocol Violation|1|||
105825980|NCT03503318|365020159|FG002|Overall Study|Protocol Violation|3|||
105825981|NCT03503318|365020157|FG000|Overall Study|Lost to Follow-up|17|||
105825982|NCT03503318|365020158|FG001|Overall Study|Lost to Follow-up|15|||
105825983|NCT03503318|365020159|FG002|Overall Study|Lost to Follow-up|12|||
105825984|NCT03503318|365020157|FG000|Overall Study|Other than specified|1|||
105825985|NCT03503318|365020158|FG001|Overall Study|Other than specified|3|||
105961014|NCT01831466|365517410|FG006|Overall Study|Protocol Violation|0|||
105961015|NCT01831466|365517411|FG007|Overall Study|Protocol Violation|0|||
105961016|NCT01831466|365517412|FG008|Overall Study|Protocol Violation|0|||
105961017|NCT01831466|365517413|FG009|Overall Study|Protocol Violation|0|||
105961018|NCT01831466|365517414|FG010|Overall Study|Protocol Violation|0|||
105961019|NCT01831466|365517415|FG011|Overall Study|Protocol Violation|0|||
105961020|NCT01831466|365517404|FG000|Overall Study|Other|2|||
106147081|NCT01808339|366201209|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
106147082|NCT01808339|366201204|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
106147083|NCT01808339|366201205|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
106147084|NCT01808339|366201206|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
106147085|NCT01808339|366201207|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
106147086|NCT01808339|366201208|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
106147087|NCT01808339|366201209|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
106147088|NCT01808339|366201204|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
106147089|NCT01808339|366201205|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
106147090|NCT01808339|366201206|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
106147091|NCT01808339|366201207|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
106147092|NCT01808339|366201208|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
106147093|NCT01808339|366201209|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
106147094|NCT01040689|366201216|FG000|Overall Study|Adverse Event|0|||
106147095|NCT01040689|366201217|FG001|Overall Study|Adverse Event|0|||
106147096|NCT01040689|366201218|FG002|Overall Study|Adverse Event|2|||
106147097|NCT01040689|366201219|FG003|Overall Study|Adverse Event|4|||
106147098|NCT01040689|366201216|FG000|Overall Study|Lack of Efficacy|0|||
106147099|NCT01040689|366201217|FG001|Overall Study|Lack of Efficacy|0|||
106147100|NCT01040689|366201218|FG002|Overall Study|Lack of Efficacy|1|||
106147101|NCT01040689|366201219|FG003|Overall Study|Lack of Efficacy|0|||
106147102|NCT01040689|366201216|FG000|Overall Study|Lost to Follow-up|1|||
106147103|NCT01040689|366201217|FG001|Overall Study|Lost to Follow-up|0|||
106147104|NCT01040689|366201218|FG002|Overall Study|Lost to Follow-up|0|||
106147105|NCT01040689|366201219|FG003|Overall Study|Lost to Follow-up|0|||
106147106|NCT01040689|366201216|FG000|Overall Study|Withdrawal by Subject|2|||
106147107|NCT01040689|366201217|FG001|Overall Study|Withdrawal by Subject|1|||
106147108|NCT01040689|366201218|FG002|Overall Study|Withdrawal by Subject|1|||
106147109|NCT01040689|366201219|FG003|Overall Study|Withdrawal by Subject|0|||
106147110|NCT01040689|366201216|FG000|Overall Study|Other reasons not listed above|0|||
106147111|NCT01040689|366201217|FG001|Overall Study|Other reasons not listed above|1|||
106147112|NCT01040689|366201218|FG002|Overall Study|Other reasons not listed above|0|||
106147113|NCT01040689|366201219|FG003|Overall Study|Other reasons not listed above|0|||
106147114|NCT00446459|366201224|FG000|8 Months|Protocol Violation|12|||
106147115|NCT00446459|366201224|FG000|12 Months|Protocol Violation|4|||
105825986|NCT03503318|365020159|FG002|Overall Study|Other than specified|3|||
105825987|NCT02139826|365020160|FG000|Overall Study|Adverse Event|1|||
105825988|NCT02055547|365020161|FG000|Overall Study|Protocol Violation|0|||
105825989|NCT02055547|365020162|FG001|Overall Study|Protocol Violation|0|||
105825990|NCT02055547|365020163|FG002|Overall Study|Protocol Violation|1|||
105825991|NCT02055547|365020164|FG003|Overall Study|Protocol Violation|0|||
105825992|NCT02055547|365020165|FG004|Overall Study|Protocol Violation|0|||
105825993|NCT02055547|365020166|FG005|Overall Study|Protocol Violation|0|||
105825994|NCT02055547|365020167|FG006|Overall Study|Protocol Violation|1|||
105825995|NCT02055547|365020168|FG007|Overall Study|Protocol Violation|0|||
105825996|NCT02055547|365020169|FG008|Overall Study|Protocol Violation|0|||
105825997|NCT02055547|365020170|FG009|Overall Study|Protocol Violation|0|||
105825998|NCT02055547|365020171|FG010|Overall Study|Protocol Violation|0|||
105825999|NCT02055547|365020172|FG011|Overall Study|Protocol Violation|0|||
105826000|NCT02055547|365020173|FG012|Overall Study|Protocol Violation|0|||
105826001|NCT02055547|365020174|FG013|Overall Study|Protocol Violation|0|||
105826002|NCT02055547|365020175|FG014|Overall Study|Protocol Violation|0|||
105826003|NCT02055547|365020176|FG015|Overall Study|Protocol Violation|0|||
105826004|NCT02055547|365020177|FG016|Overall Study|Protocol Violation|0|||
105826005|NCT02055547|365020178|FG017|Overall Study|Protocol Violation|0|||
105826006|NCT02055547|365020179|FG018|Overall Study|Protocol Violation|0|||
105826007|NCT02055547|365020161|FG000|Overall Study|Physician Decision|0|||
105826008|NCT02055547|365020162|FG001|Overall Study|Physician Decision|1|||
105826009|NCT02055547|365020163|FG002|Overall Study|Physician Decision|1|||
105826010|NCT02055547|365020164|FG003|Overall Study|Physician Decision|0|||
105826011|NCT02055547|365020165|FG004|Overall Study|Physician Decision|1|||
105961021|NCT01831466|365517405|FG001|Overall Study|Other|3|||
105961022|NCT01831466|365517406|FG002|Overall Study|Other|2|||
105961023|NCT01831466|365517407|FG003|Overall Study|Other|2|||
105961024|NCT01831466|365517408|FG004|Overall Study|Other|2|||
105961025|NCT01831466|365517409|FG005|Overall Study|Other|1|||
105961026|NCT01831466|365517410|FG006|Overall Study|Other|0|||
105961027|NCT01831466|365517411|FG007|Overall Study|Other|0|||
105826012|NCT02055547|365020166|FG005|Overall Study|Physician Decision|0|||
105826013|NCT02055547|365020167|FG006|Overall Study|Physician Decision|0|||
105961028|NCT01831466|365517412|FG008|Overall Study|Other|0|||
106022051|NCT02565784|365746717|FG000|First Treatment|Adverse Event|1|||
105826014|NCT02055547|365020168|FG007|Overall Study|Physician Decision|0|||
105826015|NCT02055547|365020169|FG008|Overall Study|Physician Decision|0|||
105826016|NCT02055547|365020170|FG009|Overall Study|Physician Decision|1|||
105826017|NCT02055547|365020171|FG010|Overall Study|Physician Decision|1|||
105826018|NCT02055547|365020172|FG011|Overall Study|Physician Decision|0|||
105826019|NCT02055547|365020173|FG012|Overall Study|Physician Decision|0|||
105961029|NCT01831466|365517413|FG009|Overall Study|Other|0|||
106147116|NCT00446459|366201224|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
106147117|NCT00774397|366201225|FG000|Overall Study|Adverse Event|1|||
106147118|NCT00774397|366201226|FG001|Overall Study|Adverse Event|3|||
106147119|NCT00774397|366201227|FG002|Overall Study|Adverse Event|16|||
106147120|NCT00774397|366201228|FG003|Overall Study|Adverse Event|8|||
106147121|NCT00774397|366201229|FG004|Overall Study|Adverse Event|8|||
106147122|NCT00774397|366201230|FG005|Overall Study|Adverse Event|3|||
106147123|NCT00774397|366201231|FG006|Overall Study|Adverse Event|16|||
106147124|NCT00774397|366201225|FG000|Overall Study|Lack of Efficacy|11|||
106147125|NCT00774397|366201226|FG001|Overall Study|Lack of Efficacy|4|||
106147126|NCT00774397|366201227|FG002|Overall Study|Lack of Efficacy|5|||
106147127|NCT00774397|366201228|FG003|Overall Study|Lack of Efficacy|3|||
106147128|NCT00774397|366201229|FG004|Overall Study|Lack of Efficacy|27|||
106147129|NCT00774397|366201230|FG005|Overall Study|Lack of Efficacy|15|||
106147130|NCT00774397|366201231|FG006|Overall Study|Lack of Efficacy|9|||
106147131|NCT00774397|366201225|FG000|Overall Study|Protocol Violation|0|||
106147132|NCT00774397|366201226|FG001|Overall Study|Protocol Violation|1|||
106147133|NCT00774397|366201227|FG002|Overall Study|Protocol Violation|3|||
106147134|NCT00774397|366201228|FG003|Overall Study|Protocol Violation|1|||
106147135|NCT00774397|366201229|FG004|Overall Study|Protocol Violation|2|||
106147136|NCT00774397|366201230|FG005|Overall Study|Protocol Violation|1|||
106147137|NCT00774397|366201231|FG006|Overall Study|Protocol Violation|0|||
106147138|NCT00774397|366201225|FG000|Overall Study|Lost to Follow-up|0|||
106147139|NCT00774397|366201226|FG001|Overall Study|Lost to Follow-up|1|||
106147140|NCT00774397|366201227|FG002|Overall Study|Lost to Follow-up|1|||
106147141|NCT00774397|366201228|FG003|Overall Study|Lost to Follow-up|1|||
106147142|NCT00774397|366201229|FG004|Overall Study|Lost to Follow-up|0|||
106147143|NCT00774397|366201230|FG005|Overall Study|Lost to Follow-up|1|||
106147144|NCT00774397|366201231|FG006|Overall Study|Lost to Follow-up|0|||
106147145|NCT00774397|366201225|FG000|Overall Study|Refused to continue trial medication|1|||
106147146|NCT00774397|366201226|FG001|Overall Study|Refused to continue trial medication|3|||
106147147|NCT00774397|366201227|FG002|Overall Study|Refused to continue trial medication|2|||
106147148|NCT00774397|366201228|FG003|Overall Study|Refused to continue trial medication|2|||
106147149|NCT00774397|366201229|FG004|Overall Study|Refused to continue trial medication|6|||
106147150|NCT00774397|366201230|FG005|Overall Study|Refused to continue trial medication|2|||
106147151|NCT00774397|366201231|FG006|Overall Study|Refused to continue trial medication|3|||
106147152|NCT00774397|366201225|FG000|Overall Study|Not treated|0|||
106147153|NCT00774397|366201226|FG001|Overall Study|Not treated|0|||
106147154|NCT00774397|366201227|FG002|Overall Study|Not treated|0|||
106147155|NCT00774397|366201228|FG003|Overall Study|Not treated|0|||
106147156|NCT00774397|366201229|FG004|Overall Study|Not treated|1|||
106147157|NCT00774397|366201230|FG005|Overall Study|Not treated|0|||
106147158|NCT00774397|366201231|FG006|Overall Study|Not treated|1|||
106147159|NCT00774397|366201225|FG000|Overall Study|Other than those stated above|1|||
106147160|NCT00774397|366201226|FG001|Overall Study|Other than those stated above|1|||
106147161|NCT00774397|366201227|FG002|Overall Study|Other than those stated above|3|||
106147162|NCT00774397|366201228|FG003|Overall Study|Other than those stated above|2|||
106147163|NCT00774397|366201229|FG004|Overall Study|Other than those stated above|2|||
106147164|NCT00774397|366201230|FG005|Overall Study|Other than those stated above|0|||
106147165|NCT00774397|366201231|FG006|Overall Study|Other than those stated above|1|||
106147166|NCT02616900|366201234|FG000|Overall Study|Lack of Efficacy|7|||
106147167|NCT02616900|366201234|FG000|Overall Study|Lost to Follow-up|2|||
106147168|NCT02616900|366201234|FG000|Overall Study|Protocol Violation|5|||
106147169|NCT02616900|366201234|FG000|Overall Study|Withdrawal by Subject|3|||
106147170|NCT02616900|366201234|FG000|Overall Study|Incomplete data|6|||
106147171|NCT02499159|366201235|FG000|Randomization|Protocol Violation|1|||
106147172|NCT02499159|366201236|FG001|Randomization|Protocol Violation|1|||
106147173|NCT02499159|366201235|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
106147174|NCT02499159|366201236|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
106147175|NCT02499159|366201235|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
106147176|NCT02499159|366201236|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
106147177|NCT02499159|366201235|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
106147178|NCT02499159|366201236|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
106147179|NCT02499159|366201235|FG000|30-Day Follow-Up Phone Call|Other|1|||
106147180|NCT02499159|366201236|FG001|30-Day Follow-Up Phone Call|Other|0|||
106147181|NCT02601820|366201237|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
106147182|NCT02601820|366201237|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
106147183|NCT02601820|366201237|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
106147184|NCT02601820|366201237|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
106147185|NCT01599793|366201238|FG000|Overall Study|Adverse Event|2|||
106147186|NCT02918279|366201247|FG000|Overall Study|Lost to Follow-up|3|||
106147187|NCT02918279|366201248|FG001|Overall Study|Lost to Follow-up|6|||
106147188|NCT02918279|366201247|FG000|Overall Study|Withdrawal by Subject|5|||
106147189|NCT02918279|366201248|FG001|Overall Study|Withdrawal by Subject|15|||
106147190|NCT02918279|366201247|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105961030|NCT01831466|365517414|FG010|Overall Study|Other|0|||
105961031|NCT01831466|365517415|FG011|Overall Study|Other|0|||
105961032|NCT01831466|365517404|FG000|Overall Study|Non-compliance with study treatment|2|||
105961033|NCT01831466|365517405|FG001|Overall Study|Non-compliance with study treatment|1|||
105961034|NCT01831466|365517406|FG002|Overall Study|Non-compliance with study treatment|1|||
105961035|NCT01831466|365517407|FG003|Overall Study|Non-compliance with study treatment|0|||
105961036|NCT01831466|365517408|FG004|Overall Study|Non-compliance with study treatment|0|||
105961037|NCT01831466|365517409|FG005|Overall Study|Non-compliance with study treatment|1|||
105961038|NCT01831466|365517410|FG006|Overall Study|Non-compliance with study treatment|0|||
105961039|NCT01831466|365517411|FG007|Overall Study|Non-compliance with study treatment|0|||
105961040|NCT01831466|365517412|FG008|Overall Study|Non-compliance with study treatment|0|||
105961041|NCT01831466|365517413|FG009|Overall Study|Non-compliance with study treatment|0|||
105961042|NCT01831466|365517414|FG010|Overall Study|Non-compliance with study treatment|0|||
105961043|NCT01831466|365517415|FG011|Overall Study|Non-compliance with study treatment|0|||
105961044|NCT01831466|365517404|FG000|Overall Study|Death|0|||
105961045|NCT01831466|365517405|FG001|Overall Study|Death|1|||
105961046|NCT01831466|365517406|FG002|Overall Study|Death|0|||
105961047|NCT01831466|365517407|FG003|Overall Study|Death|0|||
105961048|NCT01831466|365517408|FG004|Overall Study|Death|0|||
105961049|NCT01831466|365517409|FG005|Overall Study|Death|0|||
105961050|NCT01831466|365517410|FG006|Overall Study|Death|0|||
105961051|NCT01831466|365517411|FG007|Overall Study|Death|0|||
105961052|NCT01831466|365517412|FG008|Overall Study|Death|0|||
105961053|NCT01831466|365517413|FG009|Overall Study|Death|0|||
105961054|NCT01831466|365517414|FG010|Overall Study|Death|0|||
105961055|NCT01831466|365517415|FG011|Overall Study|Death|0|||
105961056|NCT01831466|365517404|FG000|Overall Study|Withdrawal by Subject|6|||
105961057|NCT01831466|365517405|FG001|Overall Study|Withdrawal by Subject|3|||
105961058|NCT01831466|365517406|FG002|Overall Study|Withdrawal by Subject|3|||
105961059|NCT01831466|365517407|FG003|Overall Study|Withdrawal by Subject|3|||
106022052|NCT02565784|365746717|FG000|First Treatment|Withdrawal by Subject|1|||
106022053|NCT02565784|365746717|FG000|Second Treatment|Withdrawal by Subject|2|||
106022054|NCT03983317|365746718|FG000|Overall Study|Physician Decision|5|||
106022055|NCT02741518|365746721|FG000|Overall Study|Withdrawal by Subject|1|||
106022056|NCT02741518|365746722|FG001|Overall Study|Withdrawal by Subject|1|||
106022057|NCT02249832|365746727|FG000|Overall Study|Withdrawal by Subject|3|||
106022058|NCT02249832|365746727|FG000|Overall Study|Lost to Follow-up|10|||
106022059|NCT01296672|365746728|FG000|Overall Study|Lost to Follow-up|73|||
106022060|NCT01296672|365746729|FG001|Overall Study|Lost to Follow-up|18|||
106022061|NCT01716052|365746730|FG000|Overall Study|Withdrawal of funding|1|||
106022062|NCT01716052|365746731|FG001|Overall Study|Withdrawal of funding|1|||
106022063|NCT03830892|365746734|FG000|Overall Study|Physician Decision|2|||
106022064|NCT03830892|365746735|FG001|Overall Study|Physician Decision|3|||
106022065|NCT03830892|365746734|FG000|Overall Study|Study terminated due to COVID|4|||
106022066|NCT03830892|365746735|FG001|Overall Study|Study terminated due to COVID|0|||
106022067|NCT03830892|365746734|FG000|Overall Study|Protocol Violation|0|||
106022068|NCT03830892|365746735|FG001|Overall Study|Protocol Violation|1|||
106022069|NCT03830892|365746734|FG000|Overall Study|Withdrawal by Subject|0|||
106022070|NCT03830892|365746735|FG001|Overall Study|Withdrawal by Subject|2|||
106022071|NCT00337675|365746736|FG000|Overall Study|Adverse Event|10|||
106022072|NCT00337675|365746737|FG001|Overall Study|Adverse Event|9|||
106022073|NCT00337675|365746738|FG002|Overall Study|Adverse Event|19|||
106022074|NCT00337675|365746736|FG000|Overall Study|Lack of Efficacy|10|||
106022075|NCT00337675|365746737|FG001|Overall Study|Lack of Efficacy|7|||
106022076|NCT00337675|365746738|FG002|Overall Study|Lack of Efficacy|9|||
106022077|NCT00337675|365746736|FG000|Overall Study|Lost to Follow-up|22|||
106022078|NCT00337675|365746737|FG001|Overall Study|Lost to Follow-up|19|||
106022079|NCT00337675|365746738|FG002|Overall Study|Lost to Follow-up|17|||
106022080|NCT00337675|365746736|FG000|Overall Study|Physician Decision|9|||
106022081|NCT00337675|365746737|FG001|Overall Study|Physician Decision|17|||
106022082|NCT00337675|365746738|FG002|Overall Study|Physician Decision|14|||
106022083|NCT00337675|365746736|FG000|Overall Study|Protocol Violation|21|||
105961060|NCT01831466|365517408|FG004|Overall Study|Withdrawal by Subject|3|||
105961061|NCT01831466|365517409|FG005|Overall Study|Withdrawal by Subject|5|||
105961062|NCT01831466|365517410|FG006|Overall Study|Withdrawal by Subject|0|||
106022084|NCT00337675|365746737|FG001|Overall Study|Protocol Violation|24|||
106022085|NCT00337675|365746738|FG002|Overall Study|Protocol Violation|19|||
106022086|NCT00337675|365746736|FG000|Overall Study|Withdrawal by Subject|25|||
105961063|NCT01831466|365517411|FG007|Overall Study|Withdrawal by Subject|0|||
105961064|NCT01831466|365517412|FG008|Overall Study|Withdrawal by Subject|0|||
105961065|NCT01831466|365517413|FG009|Overall Study|Withdrawal by Subject|1|||
105826020|NCT02055547|365020174|FG013|Overall Study|Physician Decision|0|||
105826021|NCT02055547|365020175|FG014|Overall Study|Physician Decision|0|||
105826022|NCT02055547|365020176|FG015|Overall Study|Physician Decision|0|||
105826023|NCT02055547|365020177|FG016|Overall Study|Physician Decision|0|||
105826024|NCT02055547|365020178|FG017|Overall Study|Physician Decision|0|||
105826025|NCT02055547|365020179|FG018|Overall Study|Physician Decision|0|||
105826026|NCT02055547|365020161|FG000|Overall Study|Adverse Event|0|||
105826027|NCT02055547|365020162|FG001|Overall Study|Adverse Event|0|||
105826028|NCT02055547|365020163|FG002|Overall Study|Adverse Event|0|||
105826029|NCT02055547|365020164|FG003|Overall Study|Adverse Event|0|||
105826030|NCT02055547|365020165|FG004|Overall Study|Adverse Event|0|||
105826031|NCT02055547|365020166|FG005|Overall Study|Adverse Event|0|||
105826032|NCT02055547|365020167|FG006|Overall Study|Adverse Event|1|||
105826033|NCT02055547|365020168|FG007|Overall Study|Adverse Event|0|||
105826034|NCT02055547|365020169|FG008|Overall Study|Adverse Event|1|||
105826035|NCT02055547|365020170|FG009|Overall Study|Adverse Event|0|||
105961066|NCT01831466|365517414|FG010|Overall Study|Withdrawal by Subject|0|||
105961067|NCT01831466|365517415|FG011|Overall Study|Withdrawal by Subject|1|||
105961068|NCT01831466|365517404|FG000|Overall Study|Lost to Follow-up|0|||
105961069|NCT01831466|365517405|FG001|Overall Study|Lost to Follow-up|1|||
105961070|NCT01831466|365517406|FG002|Overall Study|Lost to Follow-up|4|||
105961071|NCT01831466|365517407|FG003|Overall Study|Lost to Follow-up|2|||
105961072|NCT01831466|365517408|FG004|Overall Study|Lost to Follow-up|0|||
105961073|NCT01831466|365517409|FG005|Overall Study|Lost to Follow-up|3|||
105961074|NCT01831466|365517410|FG006|Overall Study|Lost to Follow-up|0|||
105961075|NCT01831466|365517411|FG007|Overall Study|Lost to Follow-up|0|||
105961076|NCT01831466|365517412|FG008|Overall Study|Lost to Follow-up|0|||
105961077|NCT01831466|365517413|FG009|Overall Study|Lost to Follow-up|1|||
105961078|NCT01831466|365517414|FG010|Overall Study|Lost to Follow-up|0|||
105961079|NCT01831466|365517415|FG011|Overall Study|Lost to Follow-up|1|||
105961080|NCT01831466|365517404|FG000|Overall Study|Lack of Efficacy|5|||
105961081|NCT01831466|365517405|FG001|Overall Study|Lack of Efficacy|8|||
105961082|NCT01831466|365517406|FG002|Overall Study|Lack of Efficacy|7|||
105961083|NCT01831466|365517407|FG003|Overall Study|Lack of Efficacy|6|||
105961084|NCT01831466|365517408|FG004|Overall Study|Lack of Efficacy|9|||
105961085|NCT01831466|365517409|FG005|Overall Study|Lack of Efficacy|8|||
105961086|NCT01831466|365517410|FG006|Overall Study|Lack of Efficacy|1|||
105961087|NCT01831466|365517411|FG007|Overall Study|Lack of Efficacy|1|||
106147191|NCT02918279|366201248|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106147192|NCT02918279|366201247|FG000|Overall Study|Other|3|||
106147193|NCT02918279|366201248|FG001|Overall Study|Other|1|||
106147194|NCT00309907|366201249|FG000|Overall Study|Death|4|||
106147195|NCT00309907|366201249|FG000|Overall Study|Physician Decision|1|||
106147196|NCT00309907|366201249|FG000|Overall Study|Ineligible|11|||
106147197|NCT00309907|366201249|FG000|Overall Study|Major infectious event|4|||
106147198|NCT00244855|366201250|FG000|Overall Study|Withdrawal by Subject|0|||
106147199|NCT00244855|366201251|FG001|Overall Study|Withdrawal by Subject|1|||
106147200|NCT00869258|366201252|FG000|Overall Study|Physician Decision|1|||
106147201|NCT00636207|366201253|FG000|Overall Study|Adverse Event|1|||
106147202|NCT00636207|366201254|FG001|Overall Study|Adverse Event|0|||
106147203|NCT00636207|366201255|FG002|Overall Study|Adverse Event|0|||
106147204|NCT00636207|366201256|FG003|Overall Study|Adverse Event|0|||
106147205|NCT00636207|366201257|FG004|Overall Study|Adverse Event|0|||
106147206|NCT00636207|366201258|FG005|Overall Study|Adverse Event|0|||
106147207|NCT00636207|366201259|FG006|Overall Study|Adverse Event|0|||
106147208|NCT00636207|366201253|FG000|Overall Study|Withdrawal by Subject|0|||
106147209|NCT00636207|366201254|FG001|Overall Study|Withdrawal by Subject|1|||
106147210|NCT00636207|366201255|FG002|Overall Study|Withdrawal by Subject|0|||
106147211|NCT00636207|366201256|FG003|Overall Study|Withdrawal by Subject|0|||
106147212|NCT00636207|366201257|FG004|Overall Study|Withdrawal by Subject|1|||
106147213|NCT00636207|366201258|FG005|Overall Study|Withdrawal by Subject|0|||
106147214|NCT00636207|366201259|FG006|Overall Study|Withdrawal by Subject|0|||
106147215|NCT01641198|366201262|FG000|After 12 Months of Function|Lost to Follow-up|3|||
106147216|NCT01641198|366201263|FG001|After 12 Months of Function|Lost to Follow-up|2|||
106147217|NCT01641198|366201264|FG002|After 12 Months of Function|Lost to Follow-up|2|||
106147218|NCT01641198|366201262|FG000|After 12 Months of Function|Protocol Violation|1|||
106147219|NCT01641198|366201263|FG001|After 12 Months of Function|Protocol Violation|0|||
106147220|NCT01641198|366201264|FG002|After 12 Months of Function|Protocol Violation|0|||
106147221|NCT01641198|366201262|FG000|After 12 Months of Function|Adverse Event|0|||
106147222|NCT01641198|366201263|FG001|After 12 Months of Function|Adverse Event|1|||
106147223|NCT01641198|366201264|FG002|After 12 Months of Function|Adverse Event|0|||
106147224|NCT01641198|366201262|FG000|After 24 Months of Function|Lost to Follow-up|4|||
106147225|NCT01641198|366201263|FG001|After 24 Months of Function|Lost to Follow-up|9|||
106147226|NCT01641198|366201264|FG002|After 24 Months of Function|Lost to Follow-up|6|||
106147227|NCT01641198|366201262|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
106147228|NCT01641198|366201263|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
106147229|NCT01641198|366201264|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
106147230|NCT01641198|366201262|FG000|At 15-20 Years of Function|Death|1|||
106147231|NCT01641198|366201263|FG001|At 15-20 Years of Function|Death|0|||
105768643|NCT03039790|364804475|FG007|Overall Study|Death|0|||
105961088|NCT01831466|365517412|FG008|Overall Study|Lack of Efficacy|2|||
106147232|NCT01641198|366201264|FG002|At 15-20 Years of Function|Death|1|||
106147233|NCT01075217|366201266|FG000|Overall Study|Adverse Event|1|||
106147234|NCT01075217|366201267|FG001|Overall Study|Adverse Event|1|||
106147235|NCT01075217|366201266|FG000|Overall Study|Physician Decision|1|||
106147236|NCT01075217|366201267|FG001|Overall Study|Physician Decision|0|||
106147237|NCT01068743|366201268|FG000|Period 3|Adverse Event|0|||
105961089|NCT01831466|365517413|FG009|Overall Study|Lack of Efficacy|2|||
105961090|NCT01831466|365517414|FG010|Overall Study|Lack of Efficacy|2|||
105961091|NCT01831466|365517415|FG011|Overall Study|Lack of Efficacy|0|||
105961092|NCT01831466|365517404|FG000|Overall Study|Adverse Event|0|||
105961093|NCT01831466|365517405|FG001|Overall Study|Adverse Event|0|||
105961094|NCT01831466|365517406|FG002|Overall Study|Adverse Event|4|||
105961095|NCT01831466|365517407|FG003|Overall Study|Adverse Event|6|||
105961096|NCT01831466|365517408|FG004|Overall Study|Adverse Event|3|||
105961097|NCT01831466|365517409|FG005|Overall Study|Adverse Event|7|||
105961098|NCT01831466|365517410|FG006|Overall Study|Adverse Event|0|||
105961099|NCT01831466|365517411|FG007|Overall Study|Adverse Event|1|||
105961100|NCT01831466|365517412|FG008|Overall Study|Adverse Event|1|||
105961101|NCT01831466|365517413|FG009|Overall Study|Adverse Event|1|||
105961102|NCT01831466|365517414|FG010|Overall Study|Adverse Event|0|||
105961103|NCT01831466|365517415|FG011|Overall Study|Adverse Event|2|||
105961104|NCT02146131|365517416|FG000|Overall Study|Physician Decision|61|||
105961105|NCT02146131|365517417|FG001|Overall Study|Physician Decision|56|||
105961106|NCT02218697|365517418|FG000|Overall Study|Adverse Event|0|||
105961107|NCT02218697|365517419|FG001|Overall Study|Adverse Event|2|||
105961108|NCT02218697|365517418|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
105961109|NCT02218697|365517419|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
105961110|NCT02218697|365517418|FG000|Overall Study|Withdrawal by Subject|2|||
105961111|NCT02218697|365517419|FG001|Overall Study|Withdrawal by Subject|3|||
105961112|NCT00451958|365517430|FG000|CS21A (NCT00451958)|Adverse Event|21|||
105961113|NCT00451958|365517431|FG001|CS21A (NCT00451958)|Adverse Event|34|||
105961114|NCT00451958|365517432|FG002|CS21A (NCT00451958)|Adverse Event|14|||
105961115|NCT00451958|365517433|FG003|CS21A (NCT00451958)|Adverse Event|17|||
105961116|NCT00451958|365517434|FG004|CS21A (NCT00451958)|Adverse Event|0|||
105961117|NCT00451958|365517430|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
105961118|NCT00451958|365517431|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
105961119|NCT00451958|365517432|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
105961120|NCT00451958|365517433|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
105961121|NCT00451958|365517434|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
105961122|NCT00451958|365517430|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
105961123|NCT00451958|365517431|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
105961124|NCT00451958|365517432|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
105961125|NCT00451958|365517433|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
105961126|NCT00451958|365517434|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
105961127|NCT00451958|365517430|FG000|CS21A (NCT00451958)|Physician Decision|2|||
105961128|NCT00451958|365517431|FG001|CS21A (NCT00451958)|Physician Decision|4|||
105961129|NCT00451958|365517432|FG002|CS21A (NCT00451958)|Physician Decision|4|||
105961130|NCT00451958|365517433|FG003|CS21A (NCT00451958)|Physician Decision|4|||
105961131|NCT00451958|365517434|FG004|CS21A (NCT00451958)|Physician Decision|0|||
105961132|NCT00451958|365517430|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
105961133|NCT00451958|365517431|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
105961134|NCT00451958|365517432|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
105961135|NCT00451958|365517433|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
105961136|NCT00451958|365517434|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
105961137|NCT00451958|365517430|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
105961138|NCT00451958|365517431|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
105961139|NCT00451958|365517432|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
105961140|NCT00451958|365517433|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
105961141|NCT00451958|365517434|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
105961142|NCT01170273|365517439|FG000|Overall Study|Lost to Follow-up|6|||
105961143|NCT01170273|365517440|FG001|Overall Study|Lost to Follow-up|8|||
105961144|NCT01170273|365517439|FG000|Overall Study|Protocol Violation|1|||
105961145|NCT01170273|365517440|FG001|Overall Study|Protocol Violation|0|||
105961146|NCT01170273|365517439|FG000|Overall Study|Death|1|||
105961147|NCT01170273|365517440|FG001|Overall Study|Death|0|||
105961148|NCT01170273|365517439|FG000|Overall Study|Adverse Event|0|||
105961149|NCT01170273|365517440|FG001|Overall Study|Adverse Event|1|||
105961150|NCT02220855|365519061|FG000|Overall Study|Adverse Event|8|||
105961151|NCT02220855|365519061|FG000|Overall Study|Disease Progression|5|||
105961152|NCT02220855|365519061|FG000|Overall Study|Withdrawal by Subject|1|||
105961153|NCT03280303|365519062|FG000|Overall Study|Death|505|||
105961154|NCT03280303|365519062|FG000|Overall Study|Study terminated by sponsor|383|||
106147238|NCT01068743|366201269|FG001|Period 3|Adverse Event|1|||
106147239|NCT01068743|366201270|FG002|Period 3|Adverse Event|0|||
106147240|NCT01068743|366201271|FG003|Period 3|Adverse Event|0|||
106147241|NCT00364013|366201272|FG000|Overall Study|Ineligibility determined|4|||
106147242|NCT00364013|366201273|FG001|Overall Study|Ineligibility determined|2|||
106147243|NCT00364013|366201272|FG000|Overall Study|Adverse Event|4|||
106147244|NCT00364013|366201273|FG001|Overall Study|Adverse Event|3|||
106147245|NCT00364013|366201272|FG000|Overall Study|Withdrawal by Subject|13|||
106147246|NCT00364013|366201273|FG001|Overall Study|Withdrawal by Subject|18|||
106147247|NCT00364013|366201272|FG000|Overall Study|Physician Decision|3|||
106147248|NCT00364013|366201273|FG001|Overall Study|Physician Decision|3|||
106147249|NCT00364013|366201272|FG000|Overall Study|Lost to Follow-up|10|||
106147250|NCT00364013|366201273|FG001|Overall Study|Lost to Follow-up|3|||
106147251|NCT00364013|366201272|FG000|Overall Study|Protocol-specified criteria|6|||
106147252|NCT00364013|366201273|FG001|Overall Study|Protocol-specified criteria|6|||
106147253|NCT00364013|366201272|FG000|Overall Study|Other|41|||
106147254|NCT00364013|366201273|FG001|Overall Study|Other|47|||
106147255|NCT00364013|366201272|FG000|Overall Study|Ongoing|20|||
106147256|NCT00364013|366201273|FG001|Overall Study|Ongoing|13|||
106147257|NCT00293293|366201274|FG000|Overall Study|Withdrawal by Subject|1|||
106147258|NCT00293293|366201275|FG001|Overall Study|Withdrawal by Subject|1|||
106147259|NCT00293293|366201274|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
106147260|NCT00293293|366201275|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
106147261|NCT00293293|366201274|FG000|Overall Study|Patient discontinued chemotherapy|0|||
106147262|NCT00293293|366201275|FG001|Overall Study|Patient discontinued chemotherapy|1|||
106147263|NCT01185782|366201280|FG000|Overall Study|Adverse Event|0|||
106147264|NCT01185782|366201281|FG001|Overall Study|Adverse Event|1|||
106147265|NCT01185782|366201280|FG000|Overall Study|Protocol Violation|1|||
106147266|NCT01185782|366201281|FG001|Overall Study|Protocol Violation|0|||
106147267|NCT01185782|366201280|FG000|Overall Study|Poor Response to Treatment|3|||
106147268|NCT01185782|366201281|FG001|Overall Study|Poor Response to Treatment|1|||
106147269|NCT01185782|366201280|FG000|Overall Study|Other|2|||
106147270|NCT01185782|366201281|FG001|Overall Study|Other|5|||
106147271|NCT01185782|366201280|FG000|Overall Study|Randomized but not treated|0|||
106147272|NCT01185782|366201281|FG001|Overall Study|Randomized but not treated|4|||
106147273|NCT00444600|366201282|FG000|Overall Study|Death|7|||
106147274|NCT00444600|366201283|FG001|Overall Study|Death|5|||
106147275|NCT00444600|366201284|FG002|Overall Study|Death|3|||
106147276|NCT00444600|366201285|FG003|Overall Study|Death|2|||
106147277|NCT00444600|366201282|FG000|Overall Study|Dropped|11|||
106147278|NCT00444600|366201283|FG001|Overall Study|Dropped|11|||
106147279|NCT00444600|366201284|FG002|Overall Study|Dropped|7|||
106147280|NCT00444600|366201285|FG003|Overall Study|Dropped|7|||
106147281|NCT00444600|366201282|FG000|Overall Study|Missed visit|1|||
106147282|NCT00444600|366201283|FG001|Overall Study|Missed visit|0|||
106147283|NCT00444600|366201284|FG002|Overall Study|Missed visit|0|||
106147284|NCT00444600|366201285|FG003|Overall Study|Missed visit|1|||
106147285|NCT05132478|366201286|FG000|Overall Study|did not complete survey after consent|1|||
106147286|NCT05132478|366201287|FG001|Overall Study|did not complete survey after consent|1|||
106147287|NCT05132478|366201286|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
106147288|NCT05132478|366201287|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
106147289|NCT00585533|366201288|FG000|Overall Study|objective or symptomatic progression|9|||
106147290|NCT01254188|366201289|FG000|Overall Study|Disease Progression|6|||
106147291|NCT01254188|366201289|FG000|Overall Study|Protocol Violation|6|||
106147292|NCT01254188|366201289|FG000|Overall Study|Pregnancy|2|||
106147293|NCT01254188|366201289|FG000|Overall Study|Death|4|||
106147294|NCT01254188|366201289|FG000|Overall Study|Lost to Follow-up|5|||
106147295|NCT01254188|366201289|FG000|Overall Study|Withdrawal by Subject|7|||
106147296|NCT01254188|366201289|FG000|Overall Study|Adverse Event|43|||
106147297|NCT01254188|366201289|FG000|Overall Study|per investigator discretion|20|||
106147298|NCT01061151|366201290|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
106147299|NCT01061151|366201291|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
106147300|NCT01061151|366201292|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
106147301|NCT01061151|366201293|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
106147302|NCT01061151|366201290|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
106147303|NCT01061151|366201291|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
106147304|NCT01061151|366201292|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
106147305|NCT01061151|366201293|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
106147306|NCT01061151|366201290|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
105961155|NCT03280303|365519062|FG000|Overall Study|Other|148|||
106147307|NCT01061151|366201291|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
106147308|NCT01061151|366201292|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
106147309|NCT01061151|366201293|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
105961156|NCT03280303|365519062|FG000|Overall Study|No longer willing to participate in study|101|||
105961157|NCT03280303|365519062|FG000|Overall Study|Lost to follow up|39|||
105961158|NCT03280303|365519062|FG000|Overall Study|Adverse Event|20|||
105961159|NCT00064259|365519063|FG000|Overall Study|Adverse Event|1|||
105961160|NCT00064259|365519064|FG001|Overall Study|Adverse Event|0|||
105961161|NCT00064259|365519065|FG002|Overall Study|Adverse Event|0|||
105961162|NCT00064259|365519066|FG003|Overall Study|Adverse Event|1|||
105961163|NCT01132651|365519068|FG000|Overall Study|Lost to Follow-up|1|||
105961164|NCT01132651|365519069|FG001|Overall Study|Lost to Follow-up|1|||
105961165|NCT02482428|365519075|FG000|Overall Study|Lost to Follow-up|4|||
105961166|NCT02482428|365519076|FG001|Overall Study|Lost to Follow-up|9|||
105961167|NCT02482428|365519077|FG002|Overall Study|Lost to Follow-up|1|||
105961168|NCT02482428|365519078|FG003|Overall Study|Lost to Follow-up|2|||
106147310|NCT01061151|366201290|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
106147311|NCT01061151|366201291|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
106147312|NCT01061151|366201292|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
106147313|NCT01061151|366201293|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
106147314|NCT01061151|366201290|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
106147315|NCT01061151|366201291|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
106147316|NCT01061151|366201292|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
106147317|NCT01061151|366201293|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
106147318|NCT01061151|366201290|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
106147319|NCT01061151|366201291|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
106147320|NCT01061151|366201292|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
106147321|NCT01061151|366201293|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
106147322|NCT01061151|366201290|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
106147323|NCT01061151|366201291|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
106147324|NCT01061151|366201292|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
106147325|NCT01061151|366201293|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
106147326|NCT01061151|366201290|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
106147327|NCT01061151|366201291|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
106147328|NCT01061151|366201292|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
106147329|NCT01061151|366201293|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
106147330|NCT01061151|366201290|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
106147331|NCT01061151|366201291|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
106147332|NCT01061151|366201292|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
106147333|NCT01061151|366201293|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
106147334|NCT01061151|366201290|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
106147335|NCT01061151|366201291|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
106147336|NCT01061151|366201292|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
106147337|NCT01061151|366201293|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
105961169|NCT02482428|365519079|FG004|Overall Study|Lost to Follow-up|4|||
105961170|NCT02482428|365519075|FG000|Overall Study|Physician Decision|0|||
105961171|NCT02482428|365519076|FG001|Overall Study|Physician Decision|0|||
105961172|NCT02482428|365519077|FG002|Overall Study|Physician Decision|0|||
105961173|NCT02482428|365519078|FG003|Overall Study|Physician Decision|0|||
105961174|NCT02482428|365519079|FG004|Overall Study|Physician Decision|1|||
105961175|NCT02482428|365519075|FG000|Overall Study|protocol deviation|1|||
105961176|NCT02482428|365519076|FG001|Overall Study|protocol deviation|1|||
105961177|NCT02482428|365519077|FG002|Overall Study|protocol deviation|0|||
105961178|NCT02482428|365519078|FG003|Overall Study|protocol deviation|0|||
105961179|NCT02482428|365519079|FG004|Overall Study|protocol deviation|0|||
105961180|NCT02482428|365519075|FG000|Overall Study|subject/guardian decision|4|||
105961181|NCT02482428|365519076|FG001|Overall Study|subject/guardian decision|2|||
105961182|NCT02482428|365519077|FG002|Overall Study|subject/guardian decision|0|||
105961183|NCT02482428|365519078|FG003|Overall Study|subject/guardian decision|0|||
105961184|NCT02482428|365519079|FG004|Overall Study|subject/guardian decision|2|||
105961185|NCT05935878|365519083|FG000|Overall Study|Death|1|||
105961186|NCT05935878|365519084|FG001|Overall Study|Death|2|||
105961187|NCT05935878|365519083|FG000|Overall Study|Withdrawal by Subject|5|||
105961188|NCT05935878|365519084|FG001|Overall Study|Withdrawal by Subject|5|||
105961189|NCT05935878|365519083|FG000|Overall Study|Revision of implant|1|||
105961190|NCT05935878|365519084|FG001|Overall Study|Revision of implant|1|||
105961191|NCT05935878|365519083|FG000|Overall Study|Mobile bearing dislocation|0|||
105961192|NCT05935878|365519084|FG001|Overall Study|Mobile bearing dislocation|1|||
105961193|NCT05924165|365519085|FG000|Overall Study|Physician Decision|2|||
105961194|NCT05924165|365519086|FG001|Overall Study|Physician Decision|3|||
105961195|NCT03037476|365519087|FG000|Overall Study|Lost to Follow-up|63|||
105961196|NCT03037476|365519088|FG001|Overall Study|Lost to Follow-up|46|||
105961197|NCT03053440|365519089|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
105961198|NCT03053440|365519090|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
105961199|NCT03053440|365519089|FG000|Overall Study|Death|18|||
105961200|NCT03053440|365519090|FG001|Overall Study|Death|14|||
105961201|NCT03053440|365519089|FG000|Overall Study|Withdrawal by Subject|9|||
105961202|NCT03053440|365519090|FG001|Overall Study|Withdrawal by Subject|8|||
105961203|NCT03053440|365519089|FG000|Overall Study|Lost to Follow-up|1|||
105961204|NCT03053440|365519090|FG001|Overall Study|Lost to Follow-up|0|||
105961205|NCT03053440|365519089|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
105961206|NCT03053440|365519090|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
105961207|NCT03053440|365519089|FG000|Overall Study|Physician Decision|2|||
105961208|NCT03053440|365519090|FG001|Overall Study|Physician Decision|1|||
105961209|NCT03053440|365519089|FG000|Overall Study|Participant Randomized but died before dosing|1|||
105961210|NCT03053440|365519090|FG001|Overall Study|Participant Randomized but died before dosing|0|||
106022087|NCT00337675|365746737|FG001|Overall Study|Withdrawal by Subject|25|||
106022088|NCT00337675|365746738|FG002|Overall Study|Withdrawal by Subject|19|||
106022089|NCT00337675|365746736|FG000|Overall Study|Progressive Disease|0|||
105961211|NCT02943070|365519093|FG000|Overall Study|Physician Decision|1|||
105961212|NCT02943070|365519093|FG000|Overall Study|Adverse Event|2|||
105961213|NCT02943070|365519093|FG000|Overall Study|Death|2|||
105961214|NCT02943070|365519093|FG000|Overall Study|Withdrawal by Subject|3|||
105961215|NCT02943070|365519093|FG000|Overall Study|Lost to Follow-up|4|||
105961216|NCT02943070|365519093|FG000|Overall Study|Retreatment or TURP|13|||
105961217|NCT02943070|365519093|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
105961218|NCT00570778|365519094|FG000|Overall Study|Protocol deviation|2|||
106022090|NCT00337675|365746737|FG001|Overall Study|Progressive Disease|2|||
105961219|NCT00570778|365519095|FG001|Overall Study|Protocol deviation|1|||
105961220|NCT00570778|365519096|FG002|Overall Study|Protocol deviation|2|||
105961221|NCT00570778|365519097|FG003|Overall Study|Protocol deviation|2|||
106022091|NCT00337675|365746738|FG002|Overall Study|Progressive Disease|0|||
106022092|NCT00337675|365746736|FG000|Overall Study|Trial Terminated|0|||
106022093|NCT00337675|365746737|FG001|Overall Study|Trial Terminated|0|||
106022094|NCT00337675|365746738|FG002|Overall Study|Trial Terminated|2|||
106022095|NCT04693234|365746739|FG000|Overall Study|Death|79|||
106022096|NCT04693234|365746740|FG001|Overall Study|Death|19|||
106022097|NCT04693234|365746739|FG000|Overall Study|Sponsor Ended Study|47|||
106022098|NCT04693234|365746740|FG001|Overall Study|Sponsor Ended Study|18|||
106022099|NCT04693234|365746739|FG000|Overall Study|Withdrawal by Subject|10|||
105826036|NCT02055547|365020171|FG010|Overall Study|Adverse Event|0|||
105826037|NCT02055547|365020172|FG011|Overall Study|Adverse Event|0|||
105826038|NCT02055547|365020173|FG012|Overall Study|Adverse Event|0|||
105826039|NCT02055547|365020174|FG013|Overall Study|Adverse Event|0|||
105826040|NCT02055547|365020175|FG014|Overall Study|Adverse Event|0|||
105826041|NCT02055547|365020176|FG015|Overall Study|Adverse Event|0|||
105826042|NCT02055547|365020177|FG016|Overall Study|Adverse Event|0|||
105826043|NCT02055547|365020178|FG017|Overall Study|Adverse Event|0|||
105826044|NCT02055547|365020179|FG018|Overall Study|Adverse Event|0|||
105826045|NCT02055547|365020161|FG000|Overall Study|Withdrawal by Subject|0|||
105826046|NCT02055547|365020162|FG001|Overall Study|Withdrawal by Subject|0|||
105826047|NCT02055547|365020163|FG002|Overall Study|Withdrawal by Subject|0|||
106022100|NCT04693234|365746740|FG001|Overall Study|Withdrawal by Subject|2|||
105826048|NCT02055547|365020164|FG003|Overall Study|Withdrawal by Subject|0|||
105826049|NCT02055547|365020165|FG004|Overall Study|Withdrawal by Subject|0|||
105826050|NCT02055547|365020166|FG005|Overall Study|Withdrawal by Subject|1|||
105826051|NCT02055547|365020167|FG006|Overall Study|Withdrawal by Subject|0|||
105826052|NCT02055547|365020168|FG007|Overall Study|Withdrawal by Subject|0|||
105826053|NCT02055547|365020169|FG008|Overall Study|Withdrawal by Subject|1|||
105826054|NCT02055547|365020170|FG009|Overall Study|Withdrawal by Subject|0|||
105826055|NCT02055547|365020171|FG010|Overall Study|Withdrawal by Subject|0|||
106022101|NCT04693234|365746739|FG000|Overall Study|Lost to Follow-up|2|||
105961222|NCT00570778|365519094|FG000|Overall Study|Adverse Event|0|||
105961223|NCT00570778|365519095|FG001|Overall Study|Adverse Event|1|||
105961224|NCT00570778|365519096|FG002|Overall Study|Adverse Event|4|||
105961225|NCT00570778|365519097|FG003|Overall Study|Adverse Event|1|||
105961226|NCT00570778|365519094|FG000|Overall Study|Subject withdrew consent|0|||
105961227|NCT00570778|365519095|FG001|Overall Study|Subject withdrew consent|1|||
105961228|NCT00570778|365519096|FG002|Overall Study|Subject withdrew consent|0|||
105961229|NCT00570778|365519097|FG003|Overall Study|Subject withdrew consent|1|||
105961230|NCT00570778|365519094|FG000|Overall Study|Abnormal test procedure|1|||
105961231|NCT00570778|365519095|FG001|Overall Study|Abnormal test procedure|0|||
105961232|NCT00570778|365519096|FG002|Overall Study|Abnormal test procedure|0|||
105961233|NCT00570778|365519097|FG003|Overall Study|Abnormal test procedure|0|||
105961234|NCT00570778|365519094|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105961235|NCT00570778|365519095|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105961236|NCT00570778|365519096|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
105961237|NCT00570778|365519097|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105961238|NCT00570778|365519094|FG000|Overall Study|Lost to Follow-up|0|||
105961239|NCT00570778|365519095|FG001|Overall Study|Lost to Follow-up|0|||
105961240|NCT00570778|365519096|FG002|Overall Study|Lost to Follow-up|1|||
105961241|NCT00570778|365519097|FG003|Overall Study|Lost to Follow-up|0|||
105961242|NCT00570778|365519094|FG000|Overall Study|Subject no longer requires study drug|0|||
105961243|NCT00570778|365519095|FG001|Overall Study|Subject no longer requires study drug|1|||
105961244|NCT00570778|365519096|FG002|Overall Study|Subject no longer requires study drug|0|||
105961245|NCT00570778|365519097|FG003|Overall Study|Subject no longer requires study drug|0|||
105961246|NCT00711594|365519098|FG000|Overall Study|Progressive disease|2|||
105961247|NCT00711594|365519099|FG001|Overall Study|Progressive disease|2|||
105961248|NCT00711594|365519100|FG002|Overall Study|Progressive disease|6|||
105961249|NCT00711594|365519101|FG003|Overall Study|Progressive disease|44|||
105961250|NCT00711594|365519098|FG000|Overall Study|Other Adverse Event|1|||
105961251|NCT00711594|365519099|FG001|Overall Study|Other Adverse Event|0|||
105961252|NCT00711594|365519100|FG002|Overall Study|Other Adverse Event|0|||
105961253|NCT00711594|365519101|FG003|Overall Study|Other Adverse Event|16|||
106022102|NCT04693234|365746740|FG001|Overall Study|Lost to Follow-up|1|||
106022103|NCT02675634|365746741|FG000|Test Period 1|Adverse Event|0|||
106147338|NCT01061151|366201290|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
105961254|NCT00711594|365519098|FG000|Overall Study|Withdrawal by Subject|0|||
105961255|NCT00711594|365519099|FG001|Overall Study|Withdrawal by Subject|1|||
105961256|NCT00711594|365519100|FG002|Overall Study|Withdrawal by Subject|0|||
106022104|NCT02675634|365746742|FG001|Test Period 1|Adverse Event|1|||
106147339|NCT01061151|366201291|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
106147340|NCT01061151|366201292|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
106147341|NCT01061151|366201293|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
106147342|NCT01061151|366201290|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
106147343|NCT01061151|366201291|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
106147344|NCT01061151|366201292|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
106147345|NCT01061151|366201293|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
106147346|NCT01061151|366201290|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
106147347|NCT01061151|366201291|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
106147348|NCT01061151|366201292|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
106147349|NCT01061151|366201293|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
106147350|NCT01061151|366201290|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
106147351|NCT01061151|366201291|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
106147352|NCT01061151|366201292|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
106147353|NCT01061151|366201293|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
106147354|NCT01061151|366201290|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
106147355|NCT01061151|366201291|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
106147356|NCT01061151|366201292|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
106147357|NCT01061151|366201293|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
106147358|NCT01369498|366201294|FG000|Overall Study|Lack of Efficacy|9|||
106147359|NCT01369498|366201295|FG001|Overall Study|Lack of Efficacy|9|||
106147360|NCT01369498|366201296|FG002|Overall Study|Lack of Efficacy|1|||
106147361|NCT01369498|366201297|FG003|Overall Study|Lack of Efficacy|3|||
106147362|NCT01369498|366201294|FG000|Overall Study|Adverse Event|1|||
106147363|NCT01369498|366201295|FG001|Overall Study|Adverse Event|2|||
106147364|NCT01369498|366201296|FG002|Overall Study|Adverse Event|0|||
106147365|NCT01369498|366201297|FG003|Overall Study|Adverse Event|1|||
106147366|NCT01369498|366201294|FG000|Overall Study|Withdrawal of Consent|0|||
106147367|NCT01369498|366201295|FG001|Overall Study|Withdrawal of Consent|1|||
106147368|NCT01369498|366201296|FG002|Overall Study|Withdrawal of Consent|1|||
106147369|NCT01369498|366201297|FG003|Overall Study|Withdrawal of Consent|1|||
106147370|NCT01369498|366201294|FG000|Overall Study|Death|0|||
106147371|NCT01369498|366201295|FG001|Overall Study|Death|0|||
106022105|NCT02675634|365746743|FG002|Test Period 1|Adverse Event|0|||
105961257|NCT00711594|365519101|FG003|Overall Study|Withdrawal by Subject|2|||
105961258|NCT04123093|365519110|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
105961259|NCT04123093|365519111|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
105961260|NCT04123093|365519110|FG000|Phase 2|Physician Decision|0|||
105961261|NCT04123093|365519111|FG001|Phase 2|Physician Decision|1|||
105961262|NCT04123093|365519110|FG000|Phase 2|Withdrawal by Subject|0|||
105961263|NCT04123093|365519111|FG001|Phase 2|Withdrawal by Subject|1|||
105961264|NCT00654745|365519112|FG000|Overall Study|Adverse Event|12|||
105961265|NCT00654745|365519112|FG000|Overall Study|Lost to Follow-up|7|||
105961266|NCT00654745|365519112|FG000|Overall Study|Protocol Violation|11|||
105961267|NCT00654745|365519112|FG000|Overall Study|Withdrawal by Subject|10|||
105961268|NCT00654745|365519112|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
105961269|NCT04551963|365519113|FG000|Overall Study|Physician Decision|1|||
105961270|NCT04551963|365519114|FG001|Overall Study|Physician Decision|1|||
105961271|NCT04551963|365519113|FG000|Overall Study|Death|1|||
105961272|NCT04551963|365519114|FG001|Overall Study|Death|0|||
105961273|NCT03379259|365519115|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
105961274|NCT03379259|365519116|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
105961275|NCT03379259|365519117|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
105961276|NCT03379259|365519118|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
105961277|NCT03379259|365519119|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
105961278|NCT03379259|365519120|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
105961279|NCT03379259|365519115|FG000|Overall Study|Death|0|||
105961280|NCT03379259|365519116|FG001|Overall Study|Death|1|||
105961281|NCT03379259|365519117|FG002|Overall Study|Death|2|||
105961282|NCT03379259|365519118|FG003|Overall Study|Death|1|||
105961283|NCT03379259|365519119|FG004|Overall Study|Death|4|||
105961284|NCT03379259|365519120|FG005|Overall Study|Death|2|||
105961285|NCT03379259|365519115|FG000|Overall Study|Withdrawal by Subject|0|||
105961286|NCT03379259|365519116|FG001|Overall Study|Withdrawal by Subject|0|||
105961287|NCT03379259|365519117|FG002|Overall Study|Withdrawal by Subject|1|||
105961288|NCT03379259|365519118|FG003|Overall Study|Withdrawal by Subject|0|||
105961289|NCT03379259|365519119|FG004|Overall Study|Withdrawal by Subject|2|||
105961290|NCT03379259|365519120|FG005|Overall Study|Withdrawal by Subject|0|||
105961291|NCT03379259|365519115|FG000|Overall Study|Study terminated by sponsor|0|||
105961292|NCT03379259|365519116|FG001|Overall Study|Study terminated by sponsor|0|||
105961293|NCT03379259|365519117|FG002|Overall Study|Study terminated by sponsor|0|||
105961294|NCT03379259|365519118|FG003|Overall Study|Study terminated by sponsor|1|||
105961295|NCT03379259|365519119|FG004|Overall Study|Study terminated by sponsor|1|||
105961296|NCT03379259|365519120|FG005|Overall Study|Study terminated by sponsor|4|||
105961297|NCT03379259|365519115|FG000|Overall Study|Disease progression|0|||
105961298|NCT03379259|365519116|FG001|Overall Study|Disease progression|0|||
105961299|NCT03379259|365519117|FG002|Overall Study|Disease progression|0|||
105961300|NCT03379259|365519118|FG003|Overall Study|Disease progression|1|||
105961301|NCT03379259|365519119|FG004|Overall Study|Disease progression|0|||
105961302|NCT03379259|365519120|FG005|Overall Study|Disease progression|1|||
105961303|NCT03379259|365519115|FG000|Overall Study|Lost to Follow-up|0|||
105961304|NCT03379259|365519116|FG001|Overall Study|Lost to Follow-up|0|||
105961305|NCT03379259|365519117|FG002|Overall Study|Lost to Follow-up|0|||
105961306|NCT03379259|365519118|FG003|Overall Study|Lost to Follow-up|0|||
105961307|NCT03379259|365519119|FG004|Overall Study|Lost to Follow-up|1|||
105961308|NCT03379259|365519120|FG005|Overall Study|Lost to Follow-up|0|||
105961309|NCT03379259|365519115|FG000|Overall Study|Deteriorating condition|0|||
105961310|NCT03379259|365519116|FG001|Overall Study|Deteriorating condition|0|||
105961311|NCT03379259|365519117|FG002|Overall Study|Deteriorating condition|0|||
105961312|NCT03379259|365519118|FG003|Overall Study|Deteriorating condition|0|||
105961313|NCT03379259|365519119|FG004|Overall Study|Deteriorating condition|1|||
105961314|NCT03379259|365519120|FG005|Overall Study|Deteriorating condition|0|||
105961315|NCT00984165|365519121|FG000|Overall Study|Death on study|2|||
105961316|NCT00984165|365519122|FG001|Overall Study|Death on study|0|||
105961317|NCT00984165|365519123|FG002|Overall Study|Death on study|0|||
105961318|NCT00984165|365519124|FG003|Overall Study|Death on study|0|||
105961319|NCT00984165|365519121|FG000|Overall Study|Disease progression on study|5|||
105961320|NCT00984165|365519122|FG001|Overall Study|Disease progression on study|1|||
105961321|NCT00984165|365519123|FG002|Overall Study|Disease progression on study|0|||
105961322|NCT00984165|365519124|FG003|Overall Study|Disease progression on study|0|||
105961323|NCT00984165|365519121|FG000|Overall Study|Death of recipient|0|||
105961324|NCT00984165|365519122|FG001|Overall Study|Death of recipient|0|||
105961325|NCT00984165|365519123|FG002|Overall Study|Death of recipient|0|||
105961326|NCT00984165|365519124|FG003|Overall Study|Death of recipient|1|||
105961327|NCT00984165|365519121|FG000|Overall Study|New protocol|0|||
105961328|NCT00984165|365519122|FG001|Overall Study|New protocol|0|||
105961329|NCT00984165|365519123|FG002|Overall Study|New protocol|0|||
105961330|NCT00984165|365519124|FG003|Overall Study|New protocol|1|||
105961331|NCT00984165|365519121|FG000|Overall Study|P+/donor pair removed from protocol|0|||
105961332|NCT00984165|365519122|FG001|Overall Study|P+/donor pair removed from protocol|0|||
105961333|NCT00984165|365519123|FG002|Overall Study|P+/donor pair removed from protocol|0|||
105826056|NCT02055547|365020172|FG011|Overall Study|Withdrawal by Subject|0|||
105826057|NCT02055547|365020173|FG012|Overall Study|Withdrawal by Subject|0|||
105826058|NCT02055547|365020174|FG013|Overall Study|Withdrawal by Subject|1|||
105826059|NCT02055547|365020175|FG014|Overall Study|Withdrawal by Subject|0|||
105826060|NCT02055547|365020176|FG015|Overall Study|Withdrawal by Subject|1|||
105826061|NCT02055547|365020177|FG016|Overall Study|Withdrawal by Subject|0|||
105826062|NCT02055547|365020178|FG017|Overall Study|Withdrawal by Subject|0|||
105826063|NCT02055547|365020179|FG018|Overall Study|Withdrawal by Subject|0|||
105826064|NCT02055547|365020161|FG000|Overall Study|Lost to Follow-up|0|||
105826065|NCT02055547|365020162|FG001|Overall Study|Lost to Follow-up|0|||
105826066|NCT02055547|365020163|FG002|Overall Study|Lost to Follow-up|1|||
105826067|NCT02055547|365020164|FG003|Overall Study|Lost to Follow-up|0|||
105826068|NCT02055547|365020165|FG004|Overall Study|Lost to Follow-up|0|||
105826069|NCT02055547|365020166|FG005|Overall Study|Lost to Follow-up|0|||
105826070|NCT02055547|365020167|FG006|Overall Study|Lost to Follow-up|0|||
105826071|NCT02055547|365020168|FG007|Overall Study|Lost to Follow-up|0|||
105826072|NCT02055547|365020169|FG008|Overall Study|Lost to Follow-up|0|||
106147372|NCT01369498|366201296|FG002|Overall Study|Death|1|||
106147373|NCT01369498|366201297|FG003|Overall Study|Death|0|||
106147374|NCT01369498|366201294|FG000|Overall Study|Investigator's Discretion|1|||
106147375|NCT01369498|366201295|FG001|Overall Study|Investigator's Discretion|0|||
106147376|NCT01369498|366201296|FG002|Overall Study|Investigator's Discretion|1|||
106147377|NCT01369498|366201297|FG003|Overall Study|Investigator's Discretion|3|||
106147378|NCT01369498|366201294|FG000|Overall Study|Unknown Reason|1|||
106147379|NCT01369498|366201295|FG001|Overall Study|Unknown Reason|0|||
106147380|NCT01369498|366201296|FG002|Overall Study|Unknown Reason|11|||
106147381|NCT01369498|366201297|FG003|Overall Study|Unknown Reason|6|||
106147382|NCT01369498|366201294|FG000|Overall Study|Disease Progression|0|||
106147383|NCT01369498|366201295|FG001|Overall Study|Disease Progression|0|||
106147384|NCT01369498|366201296|FG002|Overall Study|Disease Progression|0|||
106147385|NCT01369498|366201297|FG003|Overall Study|Disease Progression|1|||
106147386|NCT02988817|366201302|FG000|Overall Study|Withdrawal by Subject|1|||
106147387|NCT02988817|366201303|FG001|Overall Study|Withdrawal by Subject|0|||
106147388|NCT02988817|366201304|FG002|Overall Study|Withdrawal by Subject|0|||
106147389|NCT02988817|366201305|FG003|Overall Study|Withdrawal by Subject|1|||
106147390|NCT02988817|366201306|FG004|Overall Study|Withdrawal by Subject|3|||
106147391|NCT02988817|366201307|FG005|Overall Study|Withdrawal by Subject|1|||
106147392|NCT02988817|366201308|FG006|Overall Study|Withdrawal by Subject|2|||
106147393|NCT02988817|366201309|FG007|Overall Study|Withdrawal by Subject|1|||
106147394|NCT02988817|366201310|FG008|Overall Study|Withdrawal by Subject|1|||
106147395|NCT02988817|366201311|FG009|Overall Study|Withdrawal by Subject|1|||
106147396|NCT02988817|366201312|FG010|Overall Study|Withdrawal by Subject|1|||
106147397|NCT02988817|366201313|FG011|Overall Study|Withdrawal by Subject|12|||
106147398|NCT02988817|366201314|FG012|Overall Study|Withdrawal by Subject|6|||
106147399|NCT02988817|366201315|FG013|Overall Study|Withdrawal by Subject|6|||
106147400|NCT02988817|366201316|FG014|Overall Study|Withdrawal by Subject|4|||
106147401|NCT02988817|366201317|FG015|Overall Study|Withdrawal by Subject|5|||
106147402|NCT02988817|366201318|FG016|Overall Study|Withdrawal by Subject|4|||
106147403|NCT02988817|366201319|FG017|Overall Study|Withdrawal by Subject|11|||
106147404|NCT02988817|366201320|FG018|Overall Study|Withdrawal by Subject|4|||
106147405|NCT02988817|366201321|FG019|Overall Study|Withdrawal by Subject|2|||
106147406|NCT02988817|366201302|FG000|Overall Study|Death|0|||
106147407|NCT02988817|366201303|FG001|Overall Study|Death|1|||
106147408|NCT02988817|366201304|FG002|Overall Study|Death|3|||
106147409|NCT02988817|366201305|FG003|Overall Study|Death|1|||
106147410|NCT02988817|366201306|FG004|Overall Study|Death|6|||
106147411|NCT02988817|366201307|FG005|Overall Study|Death|10|||
106147412|NCT02988817|366201308|FG006|Overall Study|Death|1|||
106147413|NCT02988817|366201309|FG007|Overall Study|Death|2|||
106147414|NCT02988817|366201310|FG008|Overall Study|Death|1|||
106147415|NCT02988817|366201311|FG009|Overall Study|Death|5|||
106147416|NCT02988817|366201312|FG010|Overall Study|Death|1|||
106147417|NCT02988817|366201313|FG011|Overall Study|Death|8|||
106147418|NCT02988817|366201314|FG012|Overall Study|Death|9|||
106147419|NCT02988817|366201315|FG013|Overall Study|Death|17|||
106147420|NCT02988817|366201316|FG014|Overall Study|Death|18|||
106147421|NCT02988817|366201317|FG015|Overall Study|Death|30|||
106147422|NCT02988817|366201318|FG016|Overall Study|Death|17|||
106147423|NCT02988817|366201319|FG017|Overall Study|Death|38|||
106147424|NCT02988817|366201320|FG018|Overall Study|Death|14|||
106147425|NCT02988817|366201321|FG019|Overall Study|Death|16|||
106147426|NCT02988817|366201302|FG000|Overall Study|Other|0|||
105961334|NCT00984165|365519124|FG003|Overall Study|P+/donor pair removed from protocol|1|||
105961335|NCT00984165|365519121|FG000|Overall Study|removed with a pair recipient|0|||
105961336|NCT00984165|365519122|FG001|Overall Study|removed with a pair recipient|0|||
105961337|NCT00984165|365519123|FG002|Overall Study|removed with a pair recipient|0|||
105961338|NCT00984165|365519124|FG003|Overall Study|removed with a pair recipient|1|||
105961339|NCT00748618|365519125|FG000|Overall Study|Adverse Event|1|||
105961340|NCT00748618|365519126|FG001|Overall Study|Adverse Event|0|||
105961341|NCT00135330|365519131|FG000|Overall Study|Adverse Event|2|||
105961342|NCT00135330|365519132|FG001|Overall Study|Adverse Event|5|||
105961343|NCT00135330|365519133|FG002|Overall Study|Adverse Event|1|||
105961344|NCT00135330|365519131|FG000|Overall Study|Lost to Follow-up|0|||
105961345|NCT00135330|365519132|FG001|Overall Study|Lost to Follow-up|2|||
105961346|NCT00135330|365519133|FG002|Overall Study|Lost to Follow-up|3|||
105961347|NCT00135330|365519131|FG000|Overall Study|Physician Decision|1|||
105961348|NCT00135330|365519132|FG001|Overall Study|Physician Decision|1|||
105961349|NCT00135330|365519133|FG002|Overall Study|Physician Decision|0|||
105961350|NCT00135330|365519131|FG000|Overall Study|Protocol Violation|4|||
105961351|NCT00135330|365519132|FG001|Overall Study|Protocol Violation|3|||
105961352|NCT00135330|365519133|FG002|Overall Study|Protocol Violation|3|||
105961353|NCT00135330|365519131|FG000|Overall Study|Patient Decision|5|||
105961354|NCT00135330|365519132|FG001|Overall Study|Patient Decision|1|||
105961355|NCT00135330|365519133|FG002|Overall Study|Patient Decision|4|||
105961356|NCT00135330|365519131|FG000|Overall Study|Sponsor Decision|0|||
105961357|NCT00135330|365519132|FG001|Overall Study|Sponsor Decision|1|||
105961358|NCT00135330|365519133|FG002|Overall Study|Sponsor Decision|0|||
105961359|NCT00194077|365519140|FG000|Overall Study|Lack of Efficacy|22|||
105961360|NCT00194077|365519141|FG001|Overall Study|Lack of Efficacy|29|||
105961361|NCT00194077|365519140|FG000|Overall Study|Study nonadherence|1|||
105961362|NCT00194077|365519141|FG001|Overall Study|Study nonadherence|0|||
105961363|NCT00194077|365519140|FG000|Overall Study|Withdrawal by Subject|1|||
105961364|NCT00194077|365519141|FG001|Overall Study|Withdrawal by Subject|1|||
105961365|NCT05332392|365519144|FG000|Overall Study|Did not meet inclusion criteria|25|||
105961366|NCT05332392|365519144|FG000|Overall Study|Principal Investigator's decision|17|||
105961367|NCT05332392|365519144|FG000|Overall Study|Adverse Event|1|||
105961368|NCT05332392|365519144|FG000|Overall Study|Subject's decision|1|||
105961369|NCT01268046|365519145|FG000|Overall Study|Withdrawal by Subject|1|||
105961370|NCT01268046|365519146|FG001|Overall Study|Withdrawal by Subject|0|||
105961371|NCT01268046|365519147|FG002|Overall Study|Withdrawal by Subject|0|||
105961372|NCT01268046|365519148|FG003|Overall Study|Withdrawal by Subject|1|||
105961373|NCT01268046|365519145|FG000|Overall Study|Lost to Follow-up|0|||
105961374|NCT01268046|365519146|FG001|Overall Study|Lost to Follow-up|0|||
105961375|NCT01268046|365519147|FG002|Overall Study|Lost to Follow-up|1|||
105961376|NCT01268046|365519148|FG003|Overall Study|Lost to Follow-up|0|||
105961377|NCT03850093|365519153|FG000|Overall Study|Withdrawal by Subject|1|||
105961378|NCT03850093|365519154|FG001|Overall Study|Withdrawal by Subject|0|||
105961379|NCT03850093|365519155|FG002|Overall Study|Withdrawal by Subject|2|||
105961380|NCT00224120|365519156|FG000|Overall Study|Adverse Event|10|||
105961381|NCT00224120|365519157|FG001|Overall Study|Adverse Event|4|||
105961382|NCT00224120|365519156|FG000|Overall Study|Protocol Violation|1|||
105961383|NCT00224120|365519157|FG001|Overall Study|Protocol Violation|0|||
105961384|NCT00224120|365519156|FG000|Overall Study|Withdrawal by Subject|5|||
105961385|NCT00224120|365519157|FG001|Overall Study|Withdrawal by Subject|10|||
105961386|NCT00224120|365519156|FG000|Overall Study|Lack of Efficacy|0|||
105826073|NCT02055547|365020170|FG009|Overall Study|Lost to Follow-up|0|||
105826074|NCT02055547|365020171|FG010|Overall Study|Lost to Follow-up|0|||
105826075|NCT02055547|365020172|FG011|Overall Study|Lost to Follow-up|0|||
105826076|NCT02055547|365020173|FG012|Overall Study|Lost to Follow-up|0|||
105826077|NCT02055547|365020174|FG013|Overall Study|Lost to Follow-up|0|||
105826078|NCT02055547|365020175|FG014|Overall Study|Lost to Follow-up|0|||
105826079|NCT02055547|365020176|FG015|Overall Study|Lost to Follow-up|0|||
105826080|NCT02055547|365020177|FG016|Overall Study|Lost to Follow-up|0|||
105826081|NCT02055547|365020178|FG017|Overall Study|Lost to Follow-up|0|||
105826082|NCT02055547|365020179|FG018|Overall Study|Lost to Follow-up|0|||
105826083|NCT04198363|365020180|FG000|Overall Study|Adverse Event|1|||
105826084|NCT04198363|365020181|FG001|Overall Study|Adverse Event|1|||
105826085|NCT04198363|365020180|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
105826086|NCT04198363|365020181|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
105826087|NCT04198363|365020180|FG000|Overall Study|Reason not Specified|1|||
105826088|NCT04198363|365020181|FG001|Overall Study|Reason not Specified|0|||
105826089|NCT04236596|365020185|FG000|Overall Study|Withdrawal by Subject|1|||
105961387|NCT00224120|365519157|FG001|Overall Study|Lack of Efficacy|2|||
105961388|NCT00224120|365519156|FG000|Overall Study|Lost to Follow-up|2|||
105961389|NCT00224120|365519157|FG001|Overall Study|Lost to Follow-up|3|||
105961390|NCT00224120|365519156|FG000|Overall Study|Other|4|||
105961391|NCT00224120|365519157|FG001|Overall Study|Other|5|||
106147427|NCT02988817|366201303|FG001|Overall Study|Other|0|||
106147428|NCT02988817|366201304|FG002|Overall Study|Other|0|||
105961392|NCT00104416|365519158|FG000|Double-Blind Phase|Adverse Event|2|||
105961393|NCT00104416|365519159|FG001|Double-Blind Phase|Adverse Event|1|||
105961394|NCT00104416|365519160|FG002|Double-Blind Phase|Adverse Event|0|||
105961395|NCT00104416|365519161|FG003|Double-Blind Phase|Adverse Event|0|||
105961396|NCT00104416|365519162|FG004|Double-Blind Phase|Adverse Event|0|||
105961397|NCT00104416|365519158|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105961398|NCT00104416|365519159|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105961399|NCT00104416|365519160|FG002|Double-Blind Phase|Lost to Follow-up|0|||
105961400|NCT00104416|365519161|FG003|Double-Blind Phase|Lost to Follow-up|0|||
105961401|NCT00104416|365519162|FG004|Double-Blind Phase|Lost to Follow-up|0|||
105961402|NCT00104416|365519158|FG000|Double-Blind Phase|Protocol Violation|0|||
105961403|NCT00104416|365519159|FG001|Double-Blind Phase|Protocol Violation|1|||
105961404|NCT00104416|365519160|FG002|Double-Blind Phase|Protocol Violation|0|||
105961405|NCT00104416|365519161|FG003|Double-Blind Phase|Protocol Violation|0|||
105961406|NCT00104416|365519162|FG004|Double-Blind Phase|Protocol Violation|0|||
105961407|NCT00104416|365519158|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
105961408|NCT00104416|365519159|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
105961409|NCT00104416|365519160|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105961410|NCT00104416|365519161|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105961411|NCT00104416|365519162|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
105961412|NCT00104416|365519158|FG000|Double-Blind Phase|Pregnancy|1|||
105961413|NCT00104416|365519159|FG001|Double-Blind Phase|Pregnancy|0|||
105961414|NCT00104416|365519160|FG002|Double-Blind Phase|Pregnancy|0|||
105961415|NCT00104416|365519161|FG003|Double-Blind Phase|Pregnancy|0|||
105961416|NCT00104416|365519162|FG004|Double-Blind Phase|Pregnancy|0|||
105961417|NCT00104416|365519158|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
105961418|NCT00104416|365519159|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
105961419|NCT00104416|365519160|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
105961420|NCT00104416|365519161|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
105961421|NCT00104416|365519162|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
105961422|NCT00104416|365519158|FG000|Continuation Phase|Adverse Event|0|||
105961423|NCT00104416|365519159|FG001|Continuation Phase|Adverse Event|0|||
105961424|NCT00104416|365519160|FG002|Continuation Phase|Adverse Event|2|||
105961425|NCT00104416|365519161|FG003|Continuation Phase|Adverse Event|0|||
105961426|NCT00104416|365519162|FG004|Continuation Phase|Adverse Event|2|||
105961427|NCT00104416|365519158|FG000|Continuation Phase|Lost to Follow-up|0|||
105961428|NCT00104416|365519159|FG001|Continuation Phase|Lost to Follow-up|0|||
105961429|NCT00104416|365519160|FG002|Continuation Phase|Lost to Follow-up|1|||
105961430|NCT00104416|365519161|FG003|Continuation Phase|Lost to Follow-up|0|||
105961431|NCT00104416|365519162|FG004|Continuation Phase|Lost to Follow-up|1|||
105961432|NCT00104416|365519158|FG000|Continuation Phase|Withdrawal by Subject|0|||
105961433|NCT00104416|365519159|FG001|Continuation Phase|Withdrawal by Subject|0|||
105961434|NCT00104416|365519160|FG002|Continuation Phase|Withdrawal by Subject|2|||
105961435|NCT00104416|365519161|FG003|Continuation Phase|Withdrawal by Subject|1|||
105961436|NCT00104416|365519162|FG004|Continuation Phase|Withdrawal by Subject|1|||
105961437|NCT00104416|365519158|FG000|Continuation Phase|Pregnancy|0|||
105961438|NCT00104416|365519159|FG001|Continuation Phase|Pregnancy|0|||
105961439|NCT00104416|365519160|FG002|Continuation Phase|Pregnancy|1|||
105961440|NCT00104416|365519161|FG003|Continuation Phase|Pregnancy|1|||
106022106|NCT02675634|365746744|FG003|Test Period 1|Adverse Event|1|||
106022107|NCT02675634|365746745|FG004|Test Period 1|Adverse Event|0|||
106022108|NCT02675634|365746746|FG005|Test Period 1|Adverse Event|0|||
106022109|NCT02675634|365746741|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
105961441|NCT00104416|365519162|FG004|Continuation Phase|Pregnancy|0|||
105961442|NCT00104416|365519158|FG000|Continuation Phase|Non-compliance|0|||
105961443|NCT00104416|365519159|FG001|Continuation Phase|Non-compliance|0|||
105961444|NCT00104416|365519160|FG002|Continuation Phase|Non-compliance|0|||
105961445|NCT00104416|365519161|FG003|Continuation Phase|Non-compliance|0|||
105961446|NCT00104416|365519162|FG004|Continuation Phase|Non-compliance|1|||
105961447|NCT04560816|365519164|FG000|Overall Study|Withdrawal by Subject|1|||
105961448|NCT04560816|365519165|FG001|Overall Study|Withdrawal by Subject|1|||
105961449|NCT04560816|365519166|FG002|Overall Study|Withdrawal by Subject|1|||
105961450|NCT04560816|365519167|FG003|Overall Study|Withdrawal by Subject|0|||
105961451|NCT04560816|365519168|FG004|Overall Study|Withdrawal by Subject|3|||
105961452|NCT04560816|365519169|FG005|Overall Study|Withdrawal by Subject|0|||
105961453|NCT04560816|365519164|FG000|Overall Study|Lost to Follow-up|1|||
105961454|NCT04560816|365519165|FG001|Overall Study|Lost to Follow-up|0|||
105961455|NCT04560816|365519166|FG002|Overall Study|Lost to Follow-up|0|||
106022110|NCT02675634|365746742|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
105961456|NCT04560816|365519167|FG003|Overall Study|Lost to Follow-up|0|||
105961457|NCT04560816|365519168|FG004|Overall Study|Lost to Follow-up|0|||
105961458|NCT04560816|365519169|FG005|Overall Study|Lost to Follow-up|0|||
105961459|NCT04560816|365519164|FG000|Overall Study|Protocol Violation|1|||
105961460|NCT04560816|365519165|FG001|Overall Study|Protocol Violation|0|||
105961461|NCT04560816|365519166|FG002|Overall Study|Protocol Violation|0|||
105961462|NCT04560816|365519167|FG003|Overall Study|Protocol Violation|0|||
106022111|NCT02675634|365746743|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
105961463|NCT04560816|365519168|FG004|Overall Study|Protocol Violation|0|||
105961464|NCT04560816|365519169|FG005|Overall Study|Protocol Violation|0|||
105961465|NCT01532921|365519172|FG000|Overall Study|Death|3|||
105961466|NCT01532921|365519172|FG000|Overall Study|Withdrawal by Subject|2|||
105961467|NCT01532921|365519172|FG000|Overall Study|Lost to Follow-up|3|||
105961468|NCT01532921|365519172|FG000|Overall Study|Physician Decision|7|||
105961469|NCT01532921|365519172|FG000|Overall Study|Device was explanted during procedure|1|||
105961470|NCT00588237|365519175|FG000|Overall Study|Evaluable for toxicity only|3|||
105961471|NCT00588237|365519175|FG000|Overall Study|Patien not treated|1|||
105961472|NCT01147250|365519176|FG000|Overall Study|Lost to Follow-up|14|||
105961473|NCT01147250|365519177|FG001|Overall Study|Lost to Follow-up|11|||
105961474|NCT01147250|365519176|FG000|Overall Study|Withdrawal by Subject|83|||
105961475|NCT01147250|365519177|FG001|Overall Study|Withdrawal by Subject|88|||
105961476|NCT01147250|365519176|FG000|Overall Study|Site termination by sponsor|13|||
105961477|NCT01147250|365519177|FG001|Overall Study|Site termination by sponsor|5|||
106147429|NCT02988817|366201305|FG003|Overall Study|Other|1|||
106147430|NCT02988817|366201306|FG004|Overall Study|Other|1|||
105961478|NCT01147250|365519176|FG000|Overall Study|Other than specified|0|||
105961479|NCT01147250|365519177|FG001|Overall Study|Other than specified|1|||
105961480|NCT05059301|365519178|FG000|Overall Study|Adverse Event|0|||
105961481|NCT05059301|365519179|FG001|Overall Study|Adverse Event|2|||
105961482|NCT05059301|365519180|FG002|Overall Study|Adverse Event|2|||
105961483|NCT05059301|365519178|FG000|Overall Study|Lost to Follow-up|2|||
105961484|NCT05059301|365519179|FG001|Overall Study|Lost to Follow-up|3|||
105961485|NCT05059301|365519180|FG002|Overall Study|Lost to Follow-up|3|||
105961486|NCT01035463|365519183|FG000|Overall Study|Adverse Event|0|||
105961487|NCT01035463|365519184|FG001|Overall Study|Adverse Event|0|||
105961488|NCT01035463|365519185|FG002|Overall Study|Adverse Event|4|||
105961489|NCT01035463|365519186|FG003|Overall Study|Adverse Event|1|||
105961490|NCT01035463|365519187|FG004|Overall Study|Adverse Event|5|||
105961491|NCT01035463|365519188|FG005|Overall Study|Adverse Event|7|||
105961492|NCT01035463|365519183|FG000|Overall Study|Withdrawal by Subject|0|||
105961493|NCT01035463|365519184|FG001|Overall Study|Withdrawal by Subject|2|||
105961494|NCT01035463|365519185|FG002|Overall Study|Withdrawal by Subject|1|||
105961495|NCT01035463|365519186|FG003|Overall Study|Withdrawal by Subject|0|||
105961496|NCT01035463|365519187|FG004|Overall Study|Withdrawal by Subject|1|||
105961497|NCT01035463|365519188|FG005|Overall Study|Withdrawal by Subject|4|||
105961498|NCT01035463|365519183|FG000|Overall Study|Disease progression|0|||
105961499|NCT01035463|365519184|FG001|Overall Study|Disease progression|0|||
105961500|NCT01035463|365519185|FG002|Overall Study|Disease progression|0|||
106147431|NCT02988817|366201307|FG005|Overall Study|Other|0|||
106147432|NCT02988817|366201308|FG006|Overall Study|Other|0|||
105961501|NCT01035463|365519186|FG003|Overall Study|Disease progression|0|||
105961502|NCT01035463|365519187|FG004|Overall Study|Disease progression|0|||
105961503|NCT01035463|365519188|FG005|Overall Study|Disease progression|3|||
105961504|NCT01035463|365519183|FG000|Overall Study|Other Malignancy|0|||
105961505|NCT01035463|365519184|FG001|Overall Study|Other Malignancy|0|||
105961506|NCT01035463|365519185|FG002|Overall Study|Other Malignancy|0|||
105961507|NCT01035463|365519186|FG003|Overall Study|Other Malignancy|0|||
105961508|NCT01035463|365519187|FG004|Overall Study|Other Malignancy|0|||
105961509|NCT01035463|365519188|FG005|Overall Study|Other Malignancy|2|||
105961510|NCT01035463|365519183|FG000|Overall Study|Other|0|||
105961511|NCT01035463|365519184|FG001|Overall Study|Other|0|||
105961512|NCT01035463|365519185|FG002|Overall Study|Other|0|||
106147433|NCT02988817|366201309|FG007|Overall Study|Other|0|||
106147434|NCT02988817|366201310|FG008|Overall Study|Other|0|||
106147435|NCT02988817|366201311|FG009|Overall Study|Other|0|||
105961513|NCT01035463|365519186|FG003|Overall Study|Other|1|||
105961514|NCT01035463|365519187|FG004|Overall Study|Other|0|||
105961515|NCT01035463|365519188|FG005|Overall Study|Other|2|||
105961516|NCT02151903|365519191|FG000|Overall Study|Withdrawal by Subject|1|||
105961517|NCT02151903|365519192|FG001|Overall Study|Withdrawal by Subject|0|||
105961518|NCT02151903|365519191|FG000|Overall Study|Progressive disease|2|||
106147436|NCT02988817|366201312|FG010|Overall Study|Other|0|||
106147437|NCT02988817|366201313|FG011|Overall Study|Other|0|||
106147438|NCT02988817|366201314|FG012|Overall Study|Other|0|||
105826090|NCT04236596|365020185|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
105826091|NCT04236596|365020185|FG000|Overall Study|Participants did not receive implant at all|4|||
105826092|NCT02588339|365020188|FG000|Overall Study|Withdrawal by Subject|1|||
105826093|NCT02588339|365020188|FG000|Overall Study|GVHD Progression prior to treatment|2|||
105826094|NCT01958294|365021999|FG000|Overall Study|Clinical Circumstances|2|||
105826095|NCT02566850|365022000|FG000|Overall Study|Protocol Violation|1|||
105826096|NCT02057835|365022006|FG000|Overall Study|Withdrawal by Subject|0|||
105826097|NCT02057835|365022007|FG001|Overall Study|Withdrawal by Subject|2|||
105826098|NCT02057835|365022008|FG002|Overall Study|Withdrawal by Subject|0|||
105826099|NCT02057835|365022009|FG003|Overall Study|Withdrawal by Subject|0|||
105826100|NCT02057835|365022010|FG004|Overall Study|Withdrawal by Subject|0|||
105826101|NCT02057835|365022011|FG005|Overall Study|Withdrawal by Subject|0|||
105826102|NCT02057835|365022012|FG006|Overall Study|Withdrawal by Subject|0|||
105826103|NCT02057835|365022013|FG007|Overall Study|Withdrawal by Subject|0|||
105826104|NCT02057835|365022014|FG008|Overall Study|Withdrawal by Subject|0|||
105826105|NCT02057835|365022015|FG009|Overall Study|Withdrawal by Subject|0|||
105826106|NCT02267187|365022016|FG000|Overall Study|Physician Decision|2|||
105826107|NCT02267187|365022016|FG000|Overall Study|Screen fail|3|||
105826108|NCT04035187|365022017|FG000|Overall Study|Withdrawal by Subject|2|||
105826109|NCT04035187|365022018|FG001|Overall Study|Withdrawal by Subject|1|||
105826110|NCT04035187|365022019|FG002|Overall Study|Withdrawal by Subject|0|||
105826111|NCT04035187|365022020|FG003|Overall Study|Withdrawal by Subject|0|||
105826112|NCT04035187|365022017|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
105826113|NCT04035187|365022018|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
105826114|NCT04035187|365022019|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
105826115|NCT04035187|365022020|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
105826116|NCT01592240|365022023|FG000|Overall Study|Adverse Event|1|||
105826117|NCT01592240|365022024|FG001|Overall Study|Adverse Event|0|||
105826118|NCT01592240|365022025|FG002|Overall Study|Adverse Event|0|||
105826119|NCT01592240|365022026|FG003|Overall Study|Adverse Event|1|||
105826120|NCT01592240|365022027|FG004|Overall Study|Adverse Event|1|||
105826121|NCT01592240|365022028|FG005|Overall Study|Adverse Event|0|||
105826122|NCT01592240|365022029|FG006|Overall Study|Adverse Event|0|||
105826123|NCT01592240|365022023|FG000|Overall Study|Death|0|||
105826124|NCT01592240|365022024|FG001|Overall Study|Death|1|||
105826125|NCT01592240|365022025|FG002|Overall Study|Death|0|||
105826126|NCT01592240|365022026|FG003|Overall Study|Death|0|||
105826127|NCT01592240|365022027|FG004|Overall Study|Death|0|||
105826128|NCT01592240|365022028|FG005|Overall Study|Death|0|||
105826129|NCT01592240|365022029|FG006|Overall Study|Death|0|||
105826130|NCT01592240|365022023|FG000|Overall Study|Lost to Follow-up|1|||
105826131|NCT01592240|365022024|FG001|Overall Study|Lost to Follow-up|3|||
105826132|NCT01592240|365022025|FG002|Overall Study|Lost to Follow-up|1|||
105826133|NCT01592240|365022026|FG003|Overall Study|Lost to Follow-up|0|||
105826134|NCT01592240|365022027|FG004|Overall Study|Lost to Follow-up|3|||
105826135|NCT01592240|365022028|FG005|Overall Study|Lost to Follow-up|2|||
105826136|NCT01592240|365022029|FG006|Overall Study|Lost to Follow-up|0|||
105826137|NCT01592240|365022023|FG000|Overall Study|Protocol Violation|0|||
105826138|NCT01592240|365022024|FG001|Overall Study|Protocol Violation|0|||
105826139|NCT01592240|365022025|FG002|Overall Study|Protocol Violation|0|||
105826140|NCT01592240|365022026|FG003|Overall Study|Protocol Violation|0|||
105826141|NCT01592240|365022027|FG004|Overall Study|Protocol Violation|0|||
105826142|NCT01592240|365022028|FG005|Overall Study|Protocol Violation|1|||
105826143|NCT01592240|365022029|FG006|Overall Study|Protocol Violation|0|||
105826144|NCT01592240|365022023|FG000|Overall Study|Withdrawal by Subject|0|||
105826145|NCT01592240|365022024|FG001|Overall Study|Withdrawal by Subject|4|||
105826146|NCT01592240|365022025|FG002|Overall Study|Withdrawal by Subject|4|||
105826147|NCT01592240|365022026|FG003|Overall Study|Withdrawal by Subject|1|||
105826148|NCT01592240|365022027|FG004|Overall Study|Withdrawal by Subject|3|||
105826149|NCT01592240|365022028|FG005|Overall Study|Withdrawal by Subject|0|||
105826150|NCT01592240|365022029|FG006|Overall Study|Withdrawal by Subject|2|||
105826151|NCT01592240|365022023|FG000|Overall Study|Other|0|||
105826152|NCT01592240|365022024|FG001|Overall Study|Other|3|||
105826153|NCT01592240|365022025|FG002|Overall Study|Other|1|||
105826154|NCT01592240|365022026|FG003|Overall Study|Other|1|||
105826155|NCT01592240|365022027|FG004|Overall Study|Other|0|||
105826156|NCT01592240|365022028|FG005|Overall Study|Other|0|||
105826157|NCT01592240|365022029|FG006|Overall Study|Other|1|||
105826158|NCT01592240|365022023|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
105826159|NCT01592240|365022024|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
105826160|NCT01592240|365022025|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
105826161|NCT01592240|365022026|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
105826162|NCT01592240|365022027|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
105826163|NCT01592240|365022028|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
105826164|NCT01592240|365022029|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
106022112|NCT02675634|365746744|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
106022113|NCT02675634|365746745|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
106022114|NCT02675634|365746746|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
106022115|NCT02675634|365746741|FG000|Test Period 2|Lack of Efficacy|1|||
106022116|NCT02675634|365746742|FG001|Test Period 2|Lack of Efficacy|0|||
106022117|NCT02675634|365746743|FG002|Test Period 2|Lack of Efficacy|0|||
106022118|NCT02675634|365746744|FG003|Test Period 2|Lack of Efficacy|0|||
106022119|NCT02675634|365746745|FG004|Test Period 2|Lack of Efficacy|0|||
106022120|NCT02675634|365746746|FG005|Test Period 2|Lack of Efficacy|0|||
106022121|NCT02675634|365746741|FG000|Test Period 2|Adverse Event|0|||
106022122|NCT02675634|365746742|FG001|Test Period 2|Adverse Event|0|||
106022123|NCT02675634|365746743|FG002|Test Period 2|Adverse Event|0|||
106022124|NCT02675634|365746744|FG003|Test Period 2|Adverse Event|0|||
106022125|NCT02675634|365746745|FG004|Test Period 2|Adverse Event|0|||
106022126|NCT02675634|365746746|FG005|Test Period 2|Adverse Event|1|||
106022127|NCT01652534|365746747|FG000|Overall Study|Lack of Efficacy|1|||
106147439|NCT02988817|366201315|FG013|Overall Study|Other|0|||
106147440|NCT02988817|366201316|FG014|Overall Study|Other|0|||
106147441|NCT02988817|366201317|FG015|Overall Study|Other|1|||
106147442|NCT02988817|366201318|FG016|Overall Study|Other|0|||
106147443|NCT02988817|366201319|FG017|Overall Study|Other|0|||
106147444|NCT02988817|366201320|FG018|Overall Study|Other|0|||
106147445|NCT02988817|366201321|FG019|Overall Study|Other|0|||
106147446|NCT02988817|366201302|FG000|Overall Study|Lost to Follow-up|0|||
106147447|NCT02988817|366201303|FG001|Overall Study|Lost to Follow-up|0|||
106147448|NCT02988817|366201304|FG002|Overall Study|Lost to Follow-up|0|||
106147449|NCT02988817|366201305|FG003|Overall Study|Lost to Follow-up|0|||
106147450|NCT02988817|366201306|FG004|Overall Study|Lost to Follow-up|0|||
106147451|NCT02988817|366201307|FG005|Overall Study|Lost to Follow-up|0|||
106147452|NCT02988817|366201308|FG006|Overall Study|Lost to Follow-up|0|||
106147453|NCT02988817|366201309|FG007|Overall Study|Lost to Follow-up|0|||
106147454|NCT02988817|366201310|FG008|Overall Study|Lost to Follow-up|1|||
106147455|NCT02988817|366201311|FG009|Overall Study|Lost to Follow-up|0|||
106147456|NCT02988817|366201312|FG010|Overall Study|Lost to Follow-up|1|||
106147457|NCT02988817|366201313|FG011|Overall Study|Lost to Follow-up|1|||
106147458|NCT02988817|366201314|FG012|Overall Study|Lost to Follow-up|0|||
106147459|NCT02988817|366201315|FG013|Overall Study|Lost to Follow-up|0|||
106147460|NCT02988817|366201316|FG014|Overall Study|Lost to Follow-up|1|||
106147461|NCT02988817|366201317|FG015|Overall Study|Lost to Follow-up|1|||
106147462|NCT02988817|366201318|FG016|Overall Study|Lost to Follow-up|2|||
106147463|NCT02988817|366201319|FG017|Overall Study|Lost to Follow-up|3|||
106147464|NCT02988817|366201320|FG018|Overall Study|Lost to Follow-up|0|||
106147465|NCT02988817|366201321|FG019|Overall Study|Lost to Follow-up|0|||
106147466|NCT02988817|366201302|FG000|Overall Study|Sponsor decision|0|||
106147467|NCT02988817|366201303|FG001|Overall Study|Sponsor decision|0|||
106147468|NCT02988817|366201304|FG002|Overall Study|Sponsor decision|0|||
106147469|NCT02988817|366201305|FG003|Overall Study|Sponsor decision|0|||
106147470|NCT02988817|366201306|FG004|Overall Study|Sponsor decision|0|||
106147471|NCT02988817|366201307|FG005|Overall Study|Sponsor decision|0|||
106147472|NCT02988817|366201308|FG006|Overall Study|Sponsor decision|0|||
106147473|NCT02988817|366201309|FG007|Overall Study|Sponsor decision|0|||
106147474|NCT02988817|366201310|FG008|Overall Study|Sponsor decision|0|||
106147475|NCT02988817|366201311|FG009|Overall Study|Sponsor decision|0|||
106147476|NCT02988817|366201312|FG010|Overall Study|Sponsor decision|0|||
106147477|NCT02988817|366201313|FG011|Overall Study|Sponsor decision|1|||
106147478|NCT02988817|366201314|FG012|Overall Study|Sponsor decision|1|||
106147479|NCT02988817|366201315|FG013|Overall Study|Sponsor decision|2|||
106147480|NCT02988817|366201316|FG014|Overall Study|Sponsor decision|2|||
106147481|NCT02988817|366201317|FG015|Overall Study|Sponsor decision|6|||
106147482|NCT02988817|366201318|FG016|Overall Study|Sponsor decision|2|||
106147483|NCT02988817|366201319|FG017|Overall Study|Sponsor decision|3|||
106147484|NCT02988817|366201320|FG018|Overall Study|Sponsor decision|2|||
106147485|NCT02988817|366201321|FG019|Overall Study|Sponsor decision|7|||
106147486|NCT02988817|366201302|FG000|Overall Study|Physician Decision|0|||
105961519|NCT02151903|365519192|FG001|Overall Study|Progressive disease|1|||
105961520|NCT01555073|365519197|FG000|Overall Study|Lost to Follow-up|1|||
105961521|NCT01555073|365519198|FG001|Overall Study|Lost to Follow-up|2|||
105961522|NCT01555073|365519199|FG002|Overall Study|Lost to Follow-up|0|||
105961523|NCT01555073|365519200|FG003|Overall Study|Lost to Follow-up|5|||
105961524|NCT01500252|365519201|FG000|Overall Study|Death|4|||
105961525|NCT01500252|365519202|FG001|Overall Study|Death|2|||
105961526|NCT01500252|365519201|FG000|Overall Study|Lost to Follow-up|5|||
105961527|NCT01500252|365519202|FG001|Overall Study|Lost to Follow-up|4|||
105961528|NCT01355679|365519203|FG000|Overall Study|benign tumor types found at biopsy|2|||
105961529|NCT02027311|365519204|FG000|Overall Study|Protocol Violation|3|||
105961530|NCT02027311|365519205|FG001|Overall Study|Protocol Violation|2|||
105961531|NCT03423238|365519208|FG000|Overall Study|Lost to Follow-up|1|||
105961532|NCT03423238|365519209|FG001|Overall Study|Lost to Follow-up|0|||
105961533|NCT03423238|365519208|FG000|Overall Study|Withdrawal by Subject|1|||
105961534|NCT03423238|365519209|FG001|Overall Study|Withdrawal by Subject|0|||
105961535|NCT01076205|365519210|FG000|Overall Study|Adverse Drug Reaction|299|||
105961536|NCT01076205|365519210|FG000|Overall Study|Lack of Effectiveness|1423|||
105961537|NCT01076205|365519210|FG000|Overall Study|Other Reason|1075|||
105961538|NCT01076205|365519210|FG000|Overall Study|Unknown Reason|71|||
105961539|NCT01076205|365519210|FG000|Overall Study|Lost to Follow-up|3151|||
105961540|NCT02241733|365519211|FG000|Overall Study|Lost to Follow-up|9|||
105961541|NCT02241733|365519212|FG001|Overall Study|Lost to Follow-up|4|||
105961542|NCT02241733|365519211|FG000|Overall Study|Physician Decision|6|||
105961543|NCT02241733|365519212|FG001|Overall Study|Physician Decision|2|||
105961544|NCT02241733|365519211|FG000|Overall Study|Withdrawal by Subject|0|||
105961545|NCT02241733|365519212|FG001|Overall Study|Withdrawal by Subject|2|||
105961546|NCT02241733|365519211|FG000|Overall Study|Death|0|||
105961547|NCT02241733|365519212|FG001|Overall Study|Death|2|||
105961548|NCT02485639|365519219|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
105961549|NCT02485639|365519219|FG000|Overall Study|Early termination|4|||
105961550|NCT02485639|365519219|FG000|Overall Study|Withdrawal by Subject|4|||
106147487|NCT02988817|366201303|FG001|Overall Study|Physician Decision|0|||
106147488|NCT02988817|366201304|FG002|Overall Study|Physician Decision|0|||
106147489|NCT02988817|366201305|FG003|Overall Study|Physician Decision|0|||
106147490|NCT02988817|366201306|FG004|Overall Study|Physician Decision|0|||
106147491|NCT02988817|366201307|FG005|Overall Study|Physician Decision|0|||
106147492|NCT02988817|366201308|FG006|Overall Study|Physician Decision|0|||
106147493|NCT02988817|366201309|FG007|Overall Study|Physician Decision|0|||
106147494|NCT02988817|366201310|FG008|Overall Study|Physician Decision|0|||
106147495|NCT02988817|366201311|FG009|Overall Study|Physician Decision|0|||
106147496|NCT02988817|366201312|FG010|Overall Study|Physician Decision|0|||
106147497|NCT02988817|366201313|FG011|Overall Study|Physician Decision|0|||
106147498|NCT02988817|366201314|FG012|Overall Study|Physician Decision|0|||
106147499|NCT02988817|366201315|FG013|Overall Study|Physician Decision|0|||
106147500|NCT02988817|366201316|FG014|Overall Study|Physician Decision|0|||
106147501|NCT02988817|366201317|FG015|Overall Study|Physician Decision|1|||
106147502|NCT02988817|366201318|FG016|Overall Study|Physician Decision|0|||
106147503|NCT02988817|366201319|FG017|Overall Study|Physician Decision|0|||
106147504|NCT02988817|366201320|FG018|Overall Study|Physician Decision|1|||
106147505|NCT02988817|366201321|FG019|Overall Study|Physician Decision|1|||
106147506|NCT01251354|366201330|FG000|Overall Study|Adverse Event|1|||
106147507|NCT01251354|366201330|FG000|Overall Study|Investigator's Decision|1|||
106147508|NCT01251354|366201330|FG000|Overall Study|Disease Progression|4|||
106147509|NCT00089544|366202399|FG000|Overall Study|Ineligible|1|||
106147510|NCT00089544|366202400|FG001|Overall Study|Ineligible|0|||
106147511|NCT01972724|366202405|FG000|Double-Blind|Rescue Criteria Met|1|||
106147512|NCT01972724|366202406|FG001|Double-Blind|Rescue Criteria Met|0|||
106147513|NCT01972724|366202407|FG002|Double-Blind|Rescue Criteria Met|0|||
106147514|NCT01972724|366202405|FG000|Double-Blind|Adverse Event|1|||
106147515|NCT01972724|366202406|FG001|Double-Blind|Adverse Event|0|||
106147516|NCT01972724|366202407|FG002|Double-Blind|Adverse Event|0|||
106147517|NCT01972724|366202405|FG000|Double-Blind|Withdrawal of Consent|2|||
106147518|NCT01972724|366202406|FG001|Double-Blind|Withdrawal of Consent|1|||
105961551|NCT04621240|365519220|FG000|Overall Study|Withdrawal by Subject|36|||
105961552|NCT01659996|365519221|FG000|Overall Study|Protocol Violation|3|||
105961553|NCT01659996|365519222|FG001|Overall Study|Protocol Violation|3|||
105961554|NCT01659996|365519223|FG002|Overall Study|Protocol Violation|3|||
105961555|NCT01659996|365519221|FG000|Overall Study|Lost to Follow-up|1|||
105961556|NCT01659996|365519222|FG001|Overall Study|Lost to Follow-up|3|||
105961557|NCT01659996|365519223|FG002|Overall Study|Lost to Follow-up|2|||
105961558|NCT01659996|365519221|FG000|Overall Study|Adverse Event|0|||
105961559|NCT01659996|365519222|FG001|Overall Study|Adverse Event|0|||
105961560|NCT01659996|365519223|FG002|Overall Study|Adverse Event|1|||
105961561|NCT01659996|365519221|FG000|Overall Study|Withdrawal by Subject|4|||
105961562|NCT01659996|365519222|FG001|Overall Study|Withdrawal by Subject|1|||
105961563|NCT01659996|365519223|FG002|Overall Study|Withdrawal by Subject|5|||
105961564|NCT02709577|365519224|FG000|Overall Study|non-accommodating anatomy|0|||
105961565|NCT02709577|365519225|FG001|Overall Study|non-accommodating anatomy|1|||
105961566|NCT02709577|365519226|FG002|Overall Study|non-accommodating anatomy|0|||
105961567|NCT02709577|365519227|FG003|Overall Study|non-accommodating anatomy|0|||
105961568|NCT02709577|365519224|FG000|Overall Study|procedural complication|0|||
105961569|NCT02709577|365519225|FG001|Overall Study|procedural complication|1|||
105961570|NCT02709577|365519226|FG002|Overall Study|procedural complication|0|||
105961571|NCT02709577|365519227|FG003|Overall Study|procedural complication|0|||
105961572|NCT02709577|365519224|FG000|Overall Study|Withdrawal by Subject|2|||
105961573|NCT02709577|365519225|FG001|Overall Study|Withdrawal by Subject|3|||
105961574|NCT02709577|365519226|FG002|Overall Study|Withdrawal by Subject|2|||
105961575|NCT02709577|365519227|FG003|Overall Study|Withdrawal by Subject|0|||
105961576|NCT05959447|365520964|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
105961577|NCT05959447|365520965|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
105961578|NCT05959447|365520964|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
105961579|NCT05959447|365520965|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
105961580|NCT05959447|365520964|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
105961581|NCT05959447|365520965|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
105961582|NCT05959447|365520964|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
105961583|NCT05959447|365520965|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
105961584|NCT02253433|365520967|FG000|Overall Study|Unable to Contact|9|||
105961585|NCT02253433|365520968|FG001|Overall Study|Unable to Contact|16|||
105961586|NCT02253433|365520967|FG000|Overall Study|Death|1|||
105961587|NCT02253433|365520968|FG001|Overall Study|Death|1|||
105961588|NCT02253433|365520967|FG000|Overall Study|No Longer Interested|3|||
105961589|NCT02253433|365520968|FG001|Overall Study|No Longer Interested|15|||
105961590|NCT02253433|365520967|FG000|Overall Study|Out of Study Area|2|||
105961591|NCT02253433|365520968|FG001|Overall Study|Out of Study Area|7|||
105961592|NCT02253433|365520967|FG000|Overall Study|Uncomfortable with home visitors|0|||
105961593|NCT02253433|365520968|FG001|Overall Study|Uncomfortable with home visitors|3|||
105961594|NCT02253433|365520967|FG000|Overall Study|Unstable Housing/Homeless|0|||
105961595|NCT02253433|365520968|FG001|Overall Study|Unstable Housing/Homeless|7|||
106022128|NCT01652534|365746748|FG001|Overall Study|Lack of Efficacy|0|||
105961596|NCT02253433|365520967|FG000|Overall Study|Too Busy|0|||
105961597|NCT02253433|365520968|FG001|Overall Study|Too Busy|4|||
106147519|NCT01972724|366202407|FG002|Double-Blind|Withdrawal of Consent|0|||
106147520|NCT01972724|366202405|FG000|Double-Blind|Significant Protocol Deviation|5|||
106147521|NCT01972724|366202406|FG001|Double-Blind|Significant Protocol Deviation|8|||
106147522|NCT01972724|366202407|FG002|Double-Blind|Significant Protocol Deviation|0|||
106147523|NCT01972724|366202405|FG000|Open-Label|Withdrew Consent|0|||
106147524|NCT01972724|366202406|FG001|Open-Label|Withdrew Consent|0|||
106147525|NCT01972724|366202407|FG002|Open-Label|Withdrew Consent|3|||
106147526|NCT01972724|366202405|FG000|Open-Label|Significant Protocol Deviation|0|||
106147527|NCT01972724|366202406|FG001|Open-Label|Significant Protocol Deviation|0|||
106147528|NCT01972724|366202407|FG002|Open-Label|Significant Protocol Deviation|2|||
106147529|NCT00391898|366202412|FG000|Overall Study|Adverse Event|3|||
106147530|NCT00391898|366202413|FG001|Overall Study|Adverse Event|0|||
106147531|NCT00391898|366202412|FG000|Overall Study|Other|8|||
106147532|NCT00391898|366202413|FG001|Overall Study|Other|10|||
106147533|NCT01636687|366202414|FG000|Induction Period|Withdrawal by Subject|1|||
106147534|NCT01636687|366202415|FG001|Induction Period|Withdrawal by Subject|0|||
106147535|NCT01636687|366202416|FG002|Induction Period|Withdrawal by Subject|0|||
106147536|NCT01636687|366202417|FG003|Induction Period|Withdrawal by Subject|0|||
106147537|NCT01636687|366202418|FG004|Induction Period|Withdrawal by Subject|0|||
106147538|NCT01636687|366202414|FG000|Induction Period|Adverse Event|1|||
106147539|NCT01636687|366202415|FG001|Induction Period|Adverse Event|0|||
106147540|NCT01636687|366202416|FG002|Induction Period|Adverse Event|0|||
106147541|NCT01636687|366202417|FG003|Induction Period|Adverse Event|0|||
106147542|NCT01636687|366202418|FG004|Induction Period|Adverse Event|1|||
106147543|NCT01636687|366202414|FG000|Induction Period|Lack of Efficacy|0|||
106147544|NCT01636687|366202415|FG001|Induction Period|Lack of Efficacy|0|||
106147545|NCT01636687|366202416|FG002|Induction Period|Lack of Efficacy|0|||
106147546|NCT01636687|366202417|FG003|Induction Period|Lack of Efficacy|0|||
106147547|NCT01636687|366202418|FG004|Induction Period|Lack of Efficacy|1|||
106147548|NCT01636687|366202414|FG000|Induction Period|Physician Decision|1|||
106147549|NCT01636687|366202415|FG001|Induction Period|Physician Decision|0|||
106147550|NCT01636687|366202416|FG002|Induction Period|Physician Decision|0|||
106147551|NCT01636687|366202417|FG003|Induction Period|Physician Decision|0|||
106147552|NCT01636687|366202418|FG004|Induction Period|Physician Decision|0|||
106147553|NCT01636687|366202414|FG000|Maintenance Period|Withdrawal by Subject|2|||
106147554|NCT01636687|366202415|FG001|Maintenance Period|Withdrawal by Subject|0|||
106147555|NCT01636687|366202416|FG002|Maintenance Period|Withdrawal by Subject|2|||
106147556|NCT01636687|366202417|FG003|Maintenance Period|Withdrawal by Subject|0|||
106147557|NCT01636687|366202418|FG004|Maintenance Period|Withdrawal by Subject|0|||
106147558|NCT01636687|366202414|FG000|Maintenance Period|Adverse Event|1|||
106147559|NCT01636687|366202415|FG001|Maintenance Period|Adverse Event|0|||
106147560|NCT01636687|366202416|FG002|Maintenance Period|Adverse Event|0|||
106147561|NCT01636687|366202417|FG003|Maintenance Period|Adverse Event|0|||
106147562|NCT01636687|366202418|FG004|Maintenance Period|Adverse Event|0|||
106147563|NCT01636687|366202414|FG000|Maintenance Period|Lack of Efficacy|4|||
106147564|NCT01636687|366202415|FG001|Maintenance Period|Lack of Efficacy|1|||
106147565|NCT01636687|366202416|FG002|Maintenance Period|Lack of Efficacy|0|||
106147566|NCT01636687|366202417|FG003|Maintenance Period|Lack of Efficacy|0|||
106147567|NCT01636687|366202418|FG004|Maintenance Period|Lack of Efficacy|0|||
106147568|NCT01636687|366202414|FG000|Maintenance Period|Lost to Follow-up|1|||
106147569|NCT01636687|366202415|FG001|Maintenance Period|Lost to Follow-up|1|||
106147570|NCT01636687|366202416|FG002|Maintenance Period|Lost to Follow-up|0|||
106147571|NCT01636687|366202417|FG003|Maintenance Period|Lost to Follow-up|0|||
106147572|NCT01636687|366202418|FG004|Maintenance Period|Lost to Follow-up|1|||
106147573|NCT01636687|366202414|FG000|Maintenance Period|Physician Decision|0|||
106147574|NCT01636687|366202415|FG001|Maintenance Period|Physician Decision|0|||
106147575|NCT01636687|366202416|FG002|Maintenance Period|Physician Decision|0|||
106147576|NCT01636687|366202417|FG003|Maintenance Period|Physician Decision|0|||
106147577|NCT01636687|366202418|FG004|Maintenance Period|Physician Decision|1|||
105826165|NCT01205035|365022034|FG000|Overall Study|Withdrawal by Subject|1|||
105826166|NCT01205035|365022035|FG001|Overall Study|Withdrawal by Subject|0|||
105826167|NCT01205035|365022034|FG000|Overall Study|Physician Decision|1|||
105826168|NCT01205035|365022035|FG001|Overall Study|Physician Decision|0|||
105826169|NCT02663349|365022039|FG000|Overall Study|Withdrawal by Subject|6|||
105826170|NCT03246503|365022040|FG000|Overall Study|Lost to Follow-up|23|||
105826171|NCT03246503|365022040|FG000|Overall Study|Withdrawal by Subject|20|||
105826172|NCT03246503|365022040|FG000|Overall Study|Physician Decision|5|||
106147578|NCT01636687|366202414|FG000|Extension Period|technical problems|0|||
106147579|NCT01636687|366202415|FG001|Extension Period|technical problems|1|||
106147580|NCT01636687|366202416|FG002|Extension Period|technical problems|2|||
106147581|NCT01636687|366202417|FG003|Extension Period|technical problems|1|||
106147582|NCT01636687|366202418|FG004|Extension Period|technical problems|0|||
106147583|NCT01636687|366202414|FG000|Extension Period|Adverse Event|4|||
106147584|NCT01636687|366202415|FG001|Extension Period|Adverse Event|3|||
106147585|NCT01636687|366202416|FG002|Extension Period|Adverse Event|2|||
106147586|NCT01636687|366202417|FG003|Extension Period|Adverse Event|1|||
106147587|NCT01636687|366202418|FG004|Extension Period|Adverse Event|0|||
106147588|NCT01636687|366202414|FG000|Extension Period|Lack of Efficacy|7|||
106147589|NCT01636687|366202415|FG001|Extension Period|Lack of Efficacy|0|||
106147590|NCT01636687|366202416|FG002|Extension Period|Lack of Efficacy|2|||
106147591|NCT01636687|366202417|FG003|Extension Period|Lack of Efficacy|1|||
106147592|NCT01636687|366202418|FG004|Extension Period|Lack of Efficacy|0|||
106147593|NCT01636687|366202414|FG000|Extension Period|Lost to Follow-up|1|||
106147594|NCT01636687|366202415|FG001|Extension Period|Lost to Follow-up|0|||
106147595|NCT01636687|366202416|FG002|Extension Period|Lost to Follow-up|1|||
106147596|NCT01636687|366202417|FG003|Extension Period|Lost to Follow-up|0|||
106147597|NCT01636687|366202418|FG004|Extension Period|Lost to Follow-up|0|||
106147598|NCT01636687|366202414|FG000|Extension Period|Physician Decision|1|||
106147599|NCT01636687|366202415|FG001|Extension Period|Physician Decision|0|||
106147600|NCT01636687|366202416|FG002|Extension Period|Physician Decision|0|||
106147601|NCT01636687|366202417|FG003|Extension Period|Physician Decision|1|||
106147602|NCT01636687|366202418|FG004|Extension Period|Physician Decision|0|||
106147603|NCT01636687|366202414|FG000|Extension Period|study terminated by sponsor|33|||
106147604|NCT01636687|366202415|FG001|Extension Period|study terminated by sponsor|50|||
106147605|NCT01636687|366202416|FG002|Extension Period|study terminated by sponsor|17|||
106147606|NCT01636687|366202417|FG003|Extension Period|study terminated by sponsor|23|||
106147607|NCT01636687|366202418|FG004|Extension Period|study terminated by sponsor|0|||
106147608|NCT01636687|366202414|FG000|Extension Period|Withdrawal by Subject|1|||
106147609|NCT01636687|366202415|FG001|Extension Period|Withdrawal by Subject|0|||
106147610|NCT01636687|366202416|FG002|Extension Period|Withdrawal by Subject|1|||
106147611|NCT01636687|366202417|FG003|Extension Period|Withdrawal by Subject|1|||
106147612|NCT01636687|366202418|FG004|Extension Period|Withdrawal by Subject|0|||
106147613|NCT01636687|366202414|FG000|Follow-up Period|Withdrawal by Subject|1|||
106147614|NCT01636687|366202415|FG001|Follow-up Period|Withdrawal by Subject|0|||
106147615|NCT01636687|366202416|FG002|Follow-up Period|Withdrawal by Subject|0|||
106147616|NCT01636687|366202417|FG003|Follow-up Period|Withdrawal by Subject|0|||
106147617|NCT01636687|366202418|FG004|Follow-up Period|Withdrawal by Subject|1|||
106147618|NCT03950622|366202419|FG000|Overall Study|Withdrawal by Subject|1|||
106147619|NCT03950622|366202420|FG001|Overall Study|Withdrawal by Subject|0|||
106147620|NCT03950622|366202419|FG000|Overall Study|Protocol Deviation|0|||
106147621|NCT03950622|366202420|FG001|Overall Study|Protocol Deviation|1|||
106147622|NCT03950622|366202419|FG000|Overall Study|Physician Decision|1|||
106147623|NCT03950622|366202420|FG001|Overall Study|Physician Decision|0|||
106147624|NCT03950622|366202419|FG000|Overall Study|Lost to Follow-up|5|||
106147625|NCT03950622|366202420|FG001|Overall Study|Lost to Follow-up|5|||
106147626|NCT03950622|366202419|FG000|Overall Study|Death|1|||
106147627|NCT03950622|366202420|FG001|Overall Study|Death|1|||
106147628|NCT03752151|366202421|FG000|Overall Study|Withdrawal by Subject|1|||
106147629|NCT03752151|366202421|FG000|Overall Study|Protocol Violation|1|||
106147630|NCT01510717|366202425|FG000|Overall Study|Adverse Event|1|||
106147631|NCT01510717|366202426|FG001|Overall Study|Adverse Event|2|||
106147632|NCT01510717|366202425|FG000|Overall Study|Death|1|||
106147633|NCT01510717|366202426|FG001|Overall Study|Death|0|||
106147634|NCT01510717|366202425|FG000|Overall Study|Lost to Follow-up|0|||
106147635|NCT01510717|366202426|FG001|Overall Study|Lost to Follow-up|1|||
106147636|NCT01510717|366202425|FG000|Overall Study|Withdrawal by Subject|0|||
106147637|NCT01510717|366202426|FG001|Overall Study|Withdrawal by Subject|2|||
106147638|NCT03482011|366202427|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
106147639|NCT03482011|366202428|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
106147640|NCT03482011|366202429|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
106147641|NCT03482011|366202430|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
106022129|NCT00459186|365746749|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
106022130|NCT00459186|365746749|FG000|PET Imaging and Assessment|Adverse Event|3|||
106022131|NCT01587014|365746750|FG000|Overall Study|Death|2|||
106022132|NCT03801031|365746751|FG000|Overall Study|Lost to Follow-up|1|||
106022133|NCT03801031|365746752|FG001|Overall Study|Lost to Follow-up|0|||
106022134|NCT03801031|365746751|FG000|Overall Study|Unable to comply|1|||
106022135|NCT03801031|365746752|FG001|Overall Study|Unable to comply|0|||
105826173|NCT03246503|365022040|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
105826174|NCT03206749|365022041|FG000|Overall Study|Withdrawal of consent|5|||
105826175|NCT03206749|365022042|FG001|Overall Study|Withdrawal of consent|3|||
106022136|NCT03801031|365746751|FG000|Overall Study|Withdrawal by Subject|0|||
106022137|NCT03801031|365746752|FG001|Overall Study|Withdrawal by Subject|1|||
105768644|NCT03039790|364804476|FG008|Overall Study|Death|0|||
105768645|NCT03039790|364804477|FG009|Overall Study|Death|0|||
105768646|NCT03039790|364804478|FG010|Overall Study|Death|0|||
105768647|NCT03039790|364804479|FG011|Overall Study|Death|0|||
105768648|NCT03039790|364804480|FG012|Overall Study|Death|0|||
105768649|NCT03039790|364804481|FG013|Overall Study|Death|0|||
105768650|NCT03039790|364804482|FG014|Overall Study|Death|0|||
105768651|NCT03039790|364804483|FG015|Overall Study|Death|1|||
105768652|NCT03039790|364804484|FG016|Overall Study|Death|3|||
105768653|NCT03039790|364804485|FG017|Overall Study|Death|0|||
105826176|NCT03206749|365022043|FG002|Overall Study|Withdrawal of consent|6|||
105826177|NCT03206749|365022041|FG000|Overall Study|Lost to Follow-up|0|||
105826178|NCT03206749|365022042|FG001|Overall Study|Lost to Follow-up|0|||
105826179|NCT03206749|365022043|FG002|Overall Study|Lost to Follow-up|1|||
105826180|NCT01492439|365022044|FG000|Overall Study|Withdrew from RTE|4|||
105826181|NCT01492439|365022045|FG001|Overall Study|Withdrew from RTE|9|||
105826182|NCT00716625|365022046|FG000|Overall Study|Safety was not Assessable|1|||
105826183|NCT00933686|365022048|FG000|Overall Study|Protocol Violation|0|||
105826184|NCT00933686|365022049|FG001|Overall Study|Protocol Violation|1|||
105826185|NCT00933686|365022048|FG000|Overall Study|Lost to Follow-up|2|||
105826186|NCT00933686|365022049|FG001|Overall Study|Lost to Follow-up|2|||
105826187|NCT00933686|365022048|FG000|Overall Study|Withdrawal by Subject|6|||
105826188|NCT00933686|365022049|FG001|Overall Study|Withdrawal by Subject|5|||
105826189|NCT00933686|365022048|FG000|Overall Study|Adverse Event|1|||
105961598|NCT02253433|365520967|FG000|Overall Study|Medical or Other Concerns|1|||
105961599|NCT02253433|365520968|FG001|Overall Study|Medical or Other Concerns|2|||
105961600|NCT00759876|365520971|FG000|Overall Study|Sponsor terminated study early|36|||
105961601|NCT03520920|365520974|FG000|Overall Study|Death|13|||
105961602|NCT03520920|365520975|FG001|Overall Study|Death|1|||
105826190|NCT00933686|365022049|FG001|Overall Study|Adverse Event|1|||
105961603|NCT03520920|365520976|FG002|Overall Study|Death|0|||
105961604|NCT03520920|365520974|FG000|Overall Study|Withdrawal by Subject|2|||
105961605|NCT03520920|365520975|FG001|Overall Study|Withdrawal by Subject|1|||
105961606|NCT03520920|365520976|FG002|Overall Study|Withdrawal by Subject|0|||
105961607|NCT03520920|365520974|FG000|Overall Study|Study Terminated by the Sponsor|5|||
105961608|NCT03520920|365520975|FG001|Overall Study|Study Terminated by the Sponsor|14|||
105961609|NCT03520920|365520976|FG002|Overall Study|Study Terminated by the Sponsor|5|||
105961610|NCT03248531|365520977|FG000|Overall Study|Adverse Event|0|||
105961611|NCT03248531|365520978|FG001|Overall Study|Adverse Event|0|||
105961612|NCT03248531|365520979|FG002|Overall Study|Adverse Event|1|||
105961613|NCT03248531|365520977|FG000|Overall Study|Lost to Follow-up|1|||
105961614|NCT03248531|365520978|FG001|Overall Study|Lost to Follow-up|0|||
105961615|NCT03248531|365520979|FG002|Overall Study|Lost to Follow-up|5|||
105961616|NCT03248531|365520977|FG000|Overall Study|Withdrawal by Subject|3|||
105961617|NCT03248531|365520978|FG001|Overall Study|Withdrawal by Subject|3|||
105961618|NCT03248531|365520979|FG002|Overall Study|Withdrawal by Subject|2|||
105961619|NCT03248531|365520977|FG000|Overall Study|Sponsor Request|0|||
105961620|NCT03248531|365520978|FG001|Overall Study|Sponsor Request|2|||
105961621|NCT03248531|365520979|FG002|Overall Study|Sponsor Request|0|||
105961622|NCT04075513|365520980|FG000|Overall Study|Withdrawal by Subject|2|||
105961623|NCT04075513|365520981|FG001|Overall Study|Withdrawal by Subject|2|||
105961624|NCT04075513|365520980|FG000|Overall Study|Lack of Efficacy|1|||
105961625|NCT04075513|365520981|FG001|Overall Study|Lack of Efficacy|0|||
105961626|NCT04075513|365520980|FG000|Overall Study|Lost to Follow-up|4|||
105961627|NCT04075513|365520981|FG001|Overall Study|Lost to Follow-up|2|||
105961628|NCT04075513|365520980|FG000|Overall Study|Switch to insulin pump|1|||
105961629|NCT04075513|365520981|FG001|Overall Study|Switch to insulin pump|0|||
105961630|NCT02858440|365520989|FG000|Overall Study|Lost to Follow-up|3|||
105961631|NCT02858440|365520989|FG000|Overall Study|Protocol Violation|2|||
105961632|NCT02858440|365520989|FG000|Overall Study|Consent withdrawal|3|||
105961633|NCT02858440|365520989|FG000|Overall Study|Migrated/moved from study area|4|||
105961634|NCT03629223|365520990|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
105961635|NCT03629223|365520991|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
105961636|NCT03629223|365520992|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
105961637|NCT03629223|365520993|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
105961638|NCT03629223|365520994|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
105961639|NCT03629223|365520995|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
105961640|NCT03629223|365520990|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105961641|NCT03629223|365520991|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105961642|NCT03629223|365520992|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105961643|NCT03629223|365520993|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
105961644|NCT03629223|365520994|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105961645|NCT03629223|365520995|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
105961646|NCT03629223|365520990|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105961647|NCT03629223|365520991|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
105961648|NCT03629223|365520992|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105961649|NCT03629223|365520993|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105961650|NCT03629223|365520994|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105961651|NCT03629223|365520995|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
105961652|NCT03629223|365520990|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105961653|NCT03629223|365520991|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
105961654|NCT03629223|365520992|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105961655|NCT03629223|365520993|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105961656|NCT03629223|365520994|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105961657|NCT03629223|365520995|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
105961658|NCT03629223|365520990|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
105961659|NCT03629223|365520991|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105961660|NCT03629223|365520992|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105961661|NCT03629223|365520993|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105961662|NCT03629223|365520994|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105961663|NCT03629223|365520995|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
105961664|NCT04153981|365520996|FG000|Overall Study|Death|1|||
105961665|NCT04153981|365520996|FG000|Overall Study|Withdrawal by Subject|24|||
105961666|NCT04153981|365520996|FG000|Overall Study|Lost to Follow-up|1|||
105961667|NCT04153981|365520996|FG000|Overall Study|Physician Decision|1|||
105961668|NCT04153981|365520996|FG000|Overall Study|Due to Unavailable Glucometer|1|||
106022138|NCT02948088|365746753|FG000|Overall Study|Lost to Follow-up|8|||
106022139|NCT02948088|365746753|FG000|Overall Study|Death|1|||
106022140|NCT02948088|365746753|FG000|Overall Study|Withdrawal by Subject|4|||
106022141|NCT02948088|365746753|FG000|Overall Study|Other|2|||
106022142|NCT00634101|365746754|FG000|Overall Study|Study Terminated|3|||
106022143|NCT00634101|365746755|FG001|Overall Study|Study Terminated|3|||
106022144|NCT00634101|365746754|FG000|Overall Study|Lost to Follow-up|2|||
106022145|NCT00634101|365746755|FG001|Overall Study|Lost to Follow-up|0|||
106022146|NCT01077076|365746758|FG000|First Intervention|Withdrawal by Subject|1|||
106022147|NCT01077076|365746759|FG001|First Intervention|Withdrawal by Subject|0|||
106022148|NCT01077076|365746760|FG002|First Intervention|Withdrawal by Subject|0|||
106022149|NCT01077076|365746761|FG003|First Intervention|Withdrawal by Subject|0|||
106022150|NCT01077076|365746762|FG004|First Intervention|Withdrawal by Subject|0|||
106022151|NCT01077076|365746763|FG005|First Intervention|Withdrawal by Subject|0|||
106022152|NCT01077076|365746758|FG000|Third Intervention|Death in the participant's family|0|||
106022153|NCT01077076|365746759|FG001|Third Intervention|Death in the participant's family|0|||
106022154|NCT01077076|365746760|FG002|Third Intervention|Death in the participant's family|0|||
106022155|NCT01077076|365746761|FG003|Third Intervention|Death in the participant's family|0|||
106022156|NCT01077076|365746762|FG004|Third Intervention|Death in the participant's family|0|||
106022157|NCT01077076|365746763|FG005|Third Intervention|Death in the participant's family|1|||
106022158|NCT01388335|365746764|FG000|Period 1|Progressive Disease|1|||
106022159|NCT01388335|365746764|FG000|Period 2|Progressive Disease|2|||
105826191|NCT00933686|365022048|FG000|Overall Study|Physician Decision|1|||
105826192|NCT00933686|365022049|FG001|Overall Study|Physician Decision|0|||
105826193|NCT00933686|365022048|FG000|Overall Study|Failure to show up at endpoint visits|0|||
105826194|NCT00933686|365022049|FG001|Overall Study|Failure to show up at endpoint visits|2|||
105826195|NCT00927069|365022062|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
105826196|NCT00927069|365022063|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
105961669|NCT04153981|365520996|FG000|Overall Study|Covid 19|52|||
105961670|NCT04153981|365520996|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
105961671|NCT04153981|365520996|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
106022160|NCT01388335|365746764|FG000|Period 2|Sponsor Decision|1|||
106022161|NCT01388335|365746764|FG000|Safety Extension|Progressive Disease|7|||
105961672|NCT04660552|365520997|FG000|Overall Study|Withdrawal by Subject|3|||
106022162|NCT01297491|365746765|FG000|Overall Study|Adverse Event|11|||
106022163|NCT01297491|365746766|FG001|Overall Study|Adverse Event|6|||
105961673|NCT04660552|365520998|FG001|Overall Study|Withdrawal by Subject|1|||
105961674|NCT03490292|365520999|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
105961675|NCT03490292|365521000|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
105961676|NCT03490292|365520999|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
105961677|NCT03490292|365521000|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
105961678|NCT03490292|365520999|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
105961679|NCT03490292|365521000|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
105961680|NCT03490292|365520999|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
105961681|NCT03490292|365521000|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
105961682|NCT03490292|365520999|FG000|1 Year Follow Up Post Last Dose|Death|1|||
105961683|NCT03490292|365521000|FG001|1 Year Follow Up Post Last Dose|Death|1|||
105961684|NCT00904670|365521003|FG000|Open Label Phase|Withdrawal by Subject|2|||
105961685|NCT00904670|365521004|FG001|Open Label Phase|Withdrawal by Subject|0|||
105961686|NCT00904670|365521003|FG000|Open Label Phase|Adverse Event|2|||
105961687|NCT00904670|365521004|FG001|Open Label Phase|Adverse Event|0|||
105961688|NCT00904670|365521003|FG000|Open Label Phase|Lack of Efficacy|1|||
105961689|NCT00904670|365521004|FG001|Open Label Phase|Lack of Efficacy|0|||
105961690|NCT00904670|365521003|FG000|Open Label Phase|Lost to Follow-up|1|||
105961691|NCT00904670|365521004|FG001|Open Label Phase|Lost to Follow-up|0|||
105961692|NCT03768089|365521008|FG000|Part A|Lost to Follow-up|0|||
105961693|NCT03768089|365521009|FG001|Part A|Lost to Follow-up|0|||
106147642|NCT03482011|366202431|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
105961694|NCT03768089|365521010|FG002|Part A|Lost to Follow-up|0|||
105961695|NCT03768089|365521011|FG003|Part A|Lost to Follow-up|0|||
105961696|NCT03768089|365521012|FG004|Part A|Lost to Follow-up|1|||
105961697|NCT03768089|365521013|FG005|Part A|Lost to Follow-up|0|||
105961698|NCT03768089|365521014|FG006|Part A|Lost to Follow-up|0|||
105961699|NCT03768089|365521015|FG007|Part A|Lost to Follow-up|0|||
105961700|NCT03768089|365521016|FG008|Part A|Lost to Follow-up|0|||
105961701|NCT03768089|365521017|FG009|Part A|Lost to Follow-up|0|||
105961702|NCT03768089|365521018|FG010|Part A|Lost to Follow-up|0|||
105961703|NCT03768089|365521019|FG011|Part A|Lost to Follow-up|0|||
105961704|NCT03768089|365521020|FG012|Part A|Lost to Follow-up|0|||
105961705|NCT03768089|365521021|FG013|Part A|Lost to Follow-up|0|||
105961706|NCT03768089|365521022|FG014|Part A|Lost to Follow-up|0|||
105961707|NCT03768089|365521023|FG015|Part A|Lost to Follow-up|0|||
105961708|NCT03768089|365521024|FG016|Part A|Lost to Follow-up|0|||
105961709|NCT03768089|365521025|FG017|Part A|Lost to Follow-up|0|||
105961710|NCT03768089|365521008|FG000|Part C|Randomized, Never Dosed|0|||
105961711|NCT03768089|365521009|FG001|Part C|Randomized, Never Dosed|0|||
105961712|NCT03768089|365521010|FG002|Part C|Randomized, Never Dosed|0|||
105961713|NCT03768089|365521011|FG003|Part C|Randomized, Never Dosed|0|||
105961714|NCT03768089|365521012|FG004|Part C|Randomized, Never Dosed|0|||
105961715|NCT03768089|365521013|FG005|Part C|Randomized, Never Dosed|0|||
106147643|NCT03482011|366202432|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
105961716|NCT03768089|365521014|FG006|Part C|Randomized, Never Dosed|0|||
105961717|NCT03768089|365521015|FG007|Part C|Randomized, Never Dosed|0|||
105961718|NCT03768089|365521016|FG008|Part C|Randomized, Never Dosed|0|||
105961719|NCT03768089|365521017|FG009|Part C|Randomized, Never Dosed|0|||
105961720|NCT03768089|365521018|FG010|Part C|Randomized, Never Dosed|0|||
105961721|NCT03768089|365521019|FG011|Part C|Randomized, Never Dosed|0|||
105961722|NCT03768089|365521020|FG012|Part C|Randomized, Never Dosed|0|||
105961723|NCT03768089|365521021|FG013|Part C|Randomized, Never Dosed|0|||
105961724|NCT03768089|365521022|FG014|Part C|Randomized, Never Dosed|1|||
106147644|NCT03482011|366202433|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
106147645|NCT03482011|366202434|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
106147646|NCT03482011|366202427|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
106147647|NCT03482011|366202428|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
106147648|NCT03482011|366202429|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
106147649|NCT03482011|366202430|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
106147650|NCT03482011|366202431|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
106147651|NCT03482011|366202432|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
106147652|NCT03482011|366202433|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
106147653|NCT03482011|366202434|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
106147654|NCT03482011|366202427|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
106147655|NCT03482011|366202428|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
105961725|NCT03768089|365521023|FG015|Part C|Randomized, Never Dosed|0|||
105961726|NCT03768089|365521024|FG016|Part C|Randomized, Never Dosed|0|||
105961727|NCT03768089|365521025|FG017|Part C|Randomized, Never Dosed|0|||
105961728|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
105961729|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
105961730|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
105961731|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
105961732|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Death|58|||
106147656|NCT03482011|366202429|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
106147657|NCT03482011|366202430|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
105826197|NCT00927069|365022064|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
105826198|NCT00927069|365022065|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
105961733|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Death|65|||
105961734|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Adverse Event|28|||
105961735|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Adverse Event|40|||
105961736|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Disease Progression|22|||
105961737|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Disease Progression|35|||
105961738|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Other|25|||
105961739|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Other|33|||
105961740|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
105961741|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
105961742|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Noncompliance|8|||
105961743|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Noncompliance|8|||
105961744|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
105961745|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
105961746|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
105961747|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
105961748|NCT00286091|365521036|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
105961749|NCT00286091|365521037|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
105961750|NCT00286091|365521036|FG000|Open-label Treatment Phase|Physician Decision|24|||
105961751|NCT00286091|365521037|FG001|Open-label Treatment Phase|Physician Decision|21|||
105961752|NCT00286091|365521036|FG000|Open-label Treatment Phase|Adverse Event|5|||
105961753|NCT00286091|365521037|FG001|Open-label Treatment Phase|Adverse Event|16|||
105961754|NCT00286091|365521036|FG000|Open-label Treatment Phase|Other|11|||
105961755|NCT00286091|365521037|FG001|Open-label Treatment Phase|Other|11|||
105961756|NCT00286091|365521036|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
105961757|NCT00286091|365521037|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
105961758|NCT00286091|365521036|FG000|Open-label Treatment Phase|Death|10|||
105961759|NCT00286091|365521037|FG001|Open-label Treatment Phase|Death|7|||
105961760|NCT00286091|365521036|FG000|Open-label Treatment Phase|Disease Progression|9|||
106022164|NCT01297491|365746765|FG000|Overall Study|Physician Decision|3|||
106147658|NCT03482011|366202431|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
106147659|NCT03482011|366202432|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
106147660|NCT03482011|366202433|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
106147661|NCT03482011|366202434|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
106147662|NCT03482011|366202427|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
106147663|NCT03482011|366202428|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
106147664|NCT03482011|366202429|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
106147665|NCT03482011|366202430|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
106147666|NCT03482011|366202431|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
106147667|NCT03482011|366202432|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
106147668|NCT03482011|366202433|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
106147669|NCT03482011|366202434|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
106147670|NCT03482011|366202427|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
106147671|NCT03482011|366202428|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
106147672|NCT03482011|366202429|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106147673|NCT03482011|366202430|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106147674|NCT03482011|366202431|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106147675|NCT03482011|366202432|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106147676|NCT03482011|366202433|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106147677|NCT03482011|366202434|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106147678|NCT03482011|366202427|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
106147679|NCT03482011|366202428|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
106147680|NCT03482011|366202429|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
106147681|NCT03482011|366202430|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
106147682|NCT03482011|366202431|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
106147683|NCT03482011|366202432|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
106147684|NCT03482011|366202433|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
106147685|NCT03482011|366202434|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
106147686|NCT03482011|366202427|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
106147687|NCT03482011|366202428|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
106147688|NCT03482011|366202429|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
106147689|NCT03482011|366202430|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
106147690|NCT03482011|366202431|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
106147691|NCT03482011|366202432|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
106147692|NCT03482011|366202433|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
106147693|NCT03482011|366202434|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
106147694|NCT03482011|366202427|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
106147695|NCT03482011|366202428|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105961761|NCT00286091|365521037|FG001|Open-label Treatment Phase|Disease Progression|3|||
105961762|NCT00286091|365521036|FG000|Open-label Treatment Phase|Noncompliance|3|||
106147696|NCT03482011|366202429|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
106147697|NCT03482011|366202430|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
106147698|NCT03482011|366202431|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
106147699|NCT03482011|366202432|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
106147700|NCT03482011|366202433|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
106147701|NCT03482011|366202434|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
106147702|NCT03482011|366202427|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
106147703|NCT03482011|366202428|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
106147704|NCT03482011|366202429|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
105826199|NCT00927069|365022062|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
106147705|NCT03482011|366202430|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
106147706|NCT03482011|366202431|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
106147707|NCT03482011|366202432|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
105826200|NCT00927069|365022063|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
105826201|NCT00927069|365022064|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
105826202|NCT00927069|365022065|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
105826203|NCT00927069|365022062|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
105826204|NCT00927069|365022063|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
105826205|NCT00927069|365022064|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
105826206|NCT00927069|365022065|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
105826207|NCT00927069|365022062|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
105826208|NCT00927069|365022063|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
105826209|NCT00927069|365022064|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
105826210|NCT00927069|365022065|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
105826211|NCT00927069|365022062|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
105826212|NCT00927069|365022063|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
105826213|NCT00927069|365022064|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
105826214|NCT00927069|365022065|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
105826215|NCT00848536|365022068|FG000|Overall Study|Adverse Event|2|||
105826216|NCT00848536|365022069|FG001|Overall Study|Adverse Event|2|||
105826217|NCT00848536|365022068|FG000|Overall Study|Withdrawal by Subject|0|||
105826218|NCT00848536|365022069|FG001|Overall Study|Withdrawal by Subject|1|||
105826219|NCT00848536|365022068|FG000|Overall Study|Protocol Violation|0|||
105826220|NCT00848536|365022069|FG001|Overall Study|Protocol Violation|1|||
105826221|NCT00848536|365022068|FG000|Overall Study|Noncompliance|1|||
105826222|NCT00848536|365022069|FG001|Overall Study|Noncompliance|0|||
105826223|NCT00848536|365022068|FG000|Overall Study|Inadequate Control of IOP|1|||
105826224|NCT00848536|365022069|FG001|Overall Study|Inadequate Control of IOP|1|||
105826225|NCT00848536|365022068|FG000|Overall Study|Patient Moved|0|||
105826226|NCT00848536|365022069|FG001|Overall Study|Patient Moved|2|||
105826227|NCT04089553|365022072|FG000|Overall Study|Death|1|||
105826228|NCT04089553|365022073|FG001|Overall Study|Death|1|||
105826229|NCT04089553|365022072|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
105826230|NCT04089553|365022073|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
105826231|NCT04089553|365022072|FG000|Overall Study|Withdrawal by Subject|3|||
105826232|NCT04089553|365022073|FG001|Overall Study|Withdrawal by Subject|3|||
105826233|NCT04089553|365022072|FG000|Overall Study|Physician Decision|1|||
105826234|NCT04089553|365022073|FG001|Overall Study|Physician Decision|0|||
105826235|NCT04089553|365022072|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
105826236|NCT04089553|365022073|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
105961763|NCT00286091|365521037|FG001|Open-label Treatment Phase|Noncompliance|1|||
105961764|NCT00286091|365521036|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
105961765|NCT00286091|365521037|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
105961766|NCT00286091|365521036|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
105961767|NCT00286091|365521037|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
105961768|NCT00286091|365521036|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
105961769|NCT00286091|365521037|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
105961770|NCT02936869|365521038|FG000|Overall Study|Lost to Follow-up|1|||
105961771|NCT02936869|365521039|FG001|Overall Study|Lost to Follow-up|3|||
105961772|NCT02936869|365521038|FG000|Overall Study|Death|0|||
105826237|NCT04089553|365022072|FG000|Overall Study|Other|1|||
105826238|NCT04089553|365022073|FG001|Overall Study|Other|0|||
105826239|NCT04089553|365022072|FG000|Overall Study|Adverse Event|1|||
105826240|NCT04089553|365022073|FG001|Overall Study|Adverse Event|1|||
105826241|NCT01572662|365022083|FG000|Overall Study|Withdrawal by Subject|1|||
105826242|NCT01572662|365022084|FG001|Overall Study|Withdrawal by Subject|0|||
105826243|NCT01572662|365022083|FG000|Overall Study|Physician Decision|0|||
105826244|NCT01572662|365022084|FG001|Overall Study|Physician Decision|1|||
105961773|NCT02936869|365521039|FG001|Overall Study|Death|1|||
105826245|NCT00835666|365022085|FG000|Washout|Protocol Violation|1|||
105826246|NCT00835666|365022086|FG001|Washout|Protocol Violation|0|||
105826247|NCT00835666|365022085|FG000|Washout|Withdrawal by Subject|1|||
105826248|NCT00835666|365022086|FG001|Washout|Withdrawal by Subject|0|||
105826249|NCT02450539|365022091|FG000|Overall Study|Withdrawal by Subject|12|||
105826250|NCT02450539|365022092|FG001|Overall Study|Withdrawal by Subject|6|||
105826251|NCT02450539|365022091|FG000|Overall Study|Lost to Follow-up|4|||
105826252|NCT02450539|365022092|FG001|Overall Study|Lost to Follow-up|1|||
105826253|NCT00829712|365022093|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
105826254|NCT00829712|365022094|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
105826255|NCT03131895|365022096|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
105826256|NCT03131895|365022097|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
105826257|NCT03131895|365022098|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
105826258|NCT03131895|365022099|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
105826259|NCT03131895|365022096|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
105826260|NCT03131895|365022097|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
105826261|NCT03131895|365022098|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
105826262|NCT03131895|365022099|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
105826263|NCT03131895|365022096|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105826264|NCT03131895|365022097|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
105826265|NCT03131895|365022098|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105826266|NCT03131895|365022099|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
105826267|NCT03131895|365022096|FG000|Washout Period (at Least 5 Days)|Other|0|||
105826268|NCT03131895|365022097|FG001|Washout Period (at Least 5 Days)|Other|0|||
105826269|NCT03131895|365022098|FG002|Washout Period (at Least 5 Days)|Other|2|||
105826270|NCT03131895|365022099|FG003|Washout Period (at Least 5 Days)|Other|0|||
105826271|NCT03131895|365022096|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
105826272|NCT03131895|365022097|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
105826273|NCT03131895|365022098|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
105826274|NCT03131895|365022099|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
105826275|NCT03131895|365022096|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
105826276|NCT03131895|365022097|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
105826277|NCT03131895|365022098|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
105826278|NCT03131895|365022099|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
105826279|NCT02622386|365022102|FG000|First Assignment|Withdrawal by Subject|3|||
105826280|NCT02622386|365022103|FG001|First Assignment|Withdrawal by Subject|2|||
105826281|NCT02622386|365022102|FG000|Washout|Withdrawal by Subject|4|||
105826282|NCT02622386|365022103|FG001|Washout|Withdrawal by Subject|4|||
105826283|NCT02622386|365022102|FG000|Second Assignment|Withdrawal by Subject|0|||
105826284|NCT02622386|365022103|FG001|Second Assignment|Withdrawal by Subject|2|||
105826285|NCT02412852|365022105|FG000|Overall Study|Withdrawal by Subject|0|||
105826286|NCT02412852|365022106|FG001|Overall Study|Withdrawal by Subject|1|||
105826287|NCT02412852|365022107|FG002|Overall Study|Withdrawal by Subject|0|||
105826288|NCT02412852|365022108|FG003|Overall Study|Withdrawal by Subject|0|||
105826289|NCT02412852|365022105|FG000|Overall Study|Physician Decision|0|||
105826290|NCT02412852|365022106|FG001|Overall Study|Physician Decision|0|||
105826291|NCT02412852|365022107|FG002|Overall Study|Physician Decision|0|||
106022165|NCT01297491|365746766|FG001|Overall Study|Physician Decision|2|||
106022166|NCT01297491|365746765|FG000|Overall Study|Progressive disease|11|||
106022167|NCT01297491|365746766|FG001|Overall Study|Progressive disease|20|||
106022168|NCT01297491|365746765|FG000|Overall Study|Patient/Guardian decision|3|||
106022169|NCT01297491|365746766|FG001|Overall Study|Patient/Guardian decision|4|||
106022170|NCT01297491|365746765|FG000|Overall Study|Death|2|||
106022171|NCT01297491|365746766|FG001|Overall Study|Death|1|||
106022172|NCT04973436|365746767|FG000|Overall Study|Lost to Follow-up|3|||
106022173|NCT04973436|365746767|FG000|Overall Study|Withdrawal by Subject|1|||
105826292|NCT02412852|365022108|FG003|Overall Study|Physician Decision|1|||
105826293|NCT01174186|365022109|FG000|Overall Study|Lost to Follow-up|0|||
105826294|NCT01174186|365022110|FG001|Overall Study|Lost to Follow-up|1|||
105826295|NCT01174186|365022109|FG000|Overall Study|Withdrawal by Subject|0|||
105826296|NCT01174186|365022110|FG001|Overall Study|Withdrawal by Subject|2|||
105826297|NCT00484679|365022111|FG000|Overall Study|Withdrawal by Subject|3|||
105826298|NCT00402103|365022112|FG000|Overall Study|Adverse Event|60|||
105826299|NCT00402103|365022113|FG001|Overall Study|Adverse Event|7|||
105826300|NCT00402103|365022112|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105826301|NCT00402103|365022113|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105826302|NCT00402103|365022112|FG000|Overall Study|Condition no longer requires study drug|2|||
105826303|NCT00402103|365022113|FG001|Overall Study|Condition no longer requires study drug|0|||
105826304|NCT00402103|365022112|FG000|Overall Study|Protocol Deviation|8|||
105826305|NCT00402103|365022113|FG001|Overall Study|Protocol Deviation|0|||
106022174|NCT04973436|365746767|FG000|Overall Study|Death|2|||
106022175|NCT01192191|365746770|FG000|Overall Study|Adverse Event|7|||
106022176|NCT01192191|365746771|FG001|Overall Study|Adverse Event|12|||
106022177|NCT01192191|365746770|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
105826306|NCT00402103|365022112|FG000|Overall Study|Patient withdrew consent|12|||
105826307|NCT00402103|365022113|FG001|Overall Study|Patient withdrew consent|1|||
105826308|NCT00402103|365022112|FG000|Overall Study|Lost to Follow-up|6|||
105826309|NCT00402103|365022113|FG001|Overall Study|Lost to Follow-up|3|||
105826310|NCT00402103|365022112|FG000|Overall Study|Administrative problems|2|||
105826311|NCT00402103|365022113|FG001|Overall Study|Administrative problems|0|||
105826312|NCT00835692|365022114|FG000|First Intervention|Withdrawal by Subject|1|||
105826313|NCT00835692|365022115|FG001|First Intervention|Withdrawal by Subject|0|||
105826314|NCT00841542|365022116|FG000|Period 1|Adverse Event|1|||
105826315|NCT00841542|365022117|FG001|Period 1|Adverse Event|0|||
105826316|NCT03480763|365022118|FG000|Overall Study|Withdrawal by Subject|18|||
105826317|NCT03480763|365022119|FG001|Overall Study|Withdrawal by Subject|10|||
105826318|NCT03480763|365022118|FG000|Overall Study|Lost to Follow-up|4|||
105826319|NCT03480763|365022119|FG001|Overall Study|Lost to Follow-up|7|||
105826320|NCT03480763|365022118|FG000|Overall Study|non-study pneumococcal vaccine|1|||
105826321|NCT03480763|365022119|FG001|Overall Study|non-study pneumococcal vaccine|0|||
105826322|NCT03480763|365022118|FG000|Overall Study|oncological treatment|0|||
105826323|NCT03480763|365022119|FG001|Overall Study|oncological treatment|2|||
105826324|NCT03480763|365022118|FG000|Overall Study|pain with vaccination|1|||
105826325|NCT03480763|365022119|FG001|Overall Study|pain with vaccination|0|||
105826326|NCT03644550|365022122|FG000|Overall Study|Withdrawal by Subject|3|||
105826327|NCT03644550|365022122|FG000|Overall Study|Progressive disease|15|||
105826328|NCT01075282|365022123|FG000|Overall Study|Withdrawal by Subject|11|||
105826329|NCT01075282|365022124|FG001|Overall Study|Withdrawal by Subject|7|||
105826330|NCT01075282|365022125|FG002|Overall Study|Withdrawal by Subject|11|||
105826331|NCT01075282|365022123|FG000|Overall Study|Adverse Event|9|||
105826332|NCT01075282|365022124|FG001|Overall Study|Adverse Event|8|||
105826333|NCT01075282|365022125|FG002|Overall Study|Adverse Event|5|||
105826334|NCT01075282|365022123|FG000|Overall Study|Entry Criteria Not Met|3|||
105826335|NCT01075282|365022124|FG001|Overall Study|Entry Criteria Not Met|2|||
105826336|NCT01075282|365022125|FG002|Overall Study|Entry Criteria Not Met|0|||
105826337|NCT01075282|365022123|FG000|Overall Study|Lost to Follow-up|3|||
105826338|NCT01075282|365022124|FG001|Overall Study|Lost to Follow-up|3|||
105826339|NCT01075282|365022125|FG002|Overall Study|Lost to Follow-up|3|||
105826340|NCT01075282|365022123|FG000|Overall Study|Physician Decision|3|||
105826341|NCT01075282|365022124|FG001|Overall Study|Physician Decision|3|||
105826342|NCT01075282|365022125|FG002|Overall Study|Physician Decision|3|||
105826343|NCT01075282|365022123|FG000|Overall Study|Lack of Efficacy|1|||
105826344|NCT01075282|365022124|FG001|Overall Study|Lack of Efficacy|1|||
105826345|NCT01075282|365022125|FG002|Overall Study|Lack of Efficacy|0|||
105826346|NCT01075282|365022123|FG000|Overall Study|Treatment Non-compliance|1|||
105826347|NCT01075282|365022124|FG001|Overall Study|Treatment Non-compliance|2|||
105826348|NCT01075282|365022125|FG002|Overall Study|Treatment Non-compliance|2|||
105826349|NCT01075282|365022123|FG000|Overall Study|Protocol Violation|0|||
105826350|NCT01075282|365022124|FG001|Overall Study|Protocol Violation|2|||
105826351|NCT01075282|365022125|FG002|Overall Study|Protocol Violation|1|||
105826352|NCT01075282|365022123|FG000|Overall Study|Death|0|||
105826353|NCT01075282|365022124|FG001|Overall Study|Death|1|||
105826354|NCT01075282|365022125|FG002|Overall Study|Death|2|||
105826355|NCT00700739|365022126|FG000|Overall Study|Lost to Follow-up|4|||
105826356|NCT00700739|365022127|FG001|Overall Study|Lost to Follow-up|4|||
105826357|NCT00924638|365022128|FG000|Overall Study|Death|3|||
105826358|NCT00924638|365022129|FG001|Overall Study|Death|2|||
105826359|NCT00924638|365022128|FG000|Overall Study|Lost to Follow-up|1|||
105826360|NCT00924638|365022129|FG001|Overall Study|Lost to Follow-up|1|||
105826361|NCT00924638|365022128|FG000|Overall Study|Withdrawal by Subject|5|||
105826362|NCT00924638|365022129|FG001|Overall Study|Withdrawal by Subject|7|||
105826363|NCT00924638|365022128|FG000|Overall Study|Physician Decision|3|||
105826364|NCT00924638|365022129|FG001|Overall Study|Physician Decision|3|||
106147708|NCT03482011|366202433|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
106147709|NCT03482011|366202434|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
106147710|NCT03482011|366202427|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
106147711|NCT03482011|366202428|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
106147712|NCT03482011|366202429|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
106147713|NCT03482011|366202430|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
106147714|NCT03482011|366202431|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
106147715|NCT03482011|366202432|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
106147716|NCT03482011|366202433|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
106147717|NCT03482011|366202434|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
105826365|NCT03488108|365022136|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
105826366|NCT03488108|365022137|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105826367|NCT03488108|365022136|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
105826368|NCT03488108|365022137|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
105826369|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
105826370|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
105826371|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
106147718|NCT03482011|366202427|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
106147719|NCT03482011|366202428|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
106147720|NCT03482011|366202429|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
106147721|NCT03482011|366202430|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
106147722|NCT03482011|366202431|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
105826372|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
105826373|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
105826374|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
105826375|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
105826376|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
105826377|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
105826378|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
105826379|NCT01438060|365022145|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
105826380|NCT01438060|365022146|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
105826381|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
105826382|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
105826383|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
105826384|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
105826385|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
105826386|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
105826387|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
105826388|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
105826389|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
105826390|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
105826391|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
105826392|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
105826393|NCT01438060|365022145|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
105826394|NCT01438060|365022146|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
105826395|NCT01438060|365022145|FG000|On Study Beyond Week 140|Adverse Event|0|||
105826396|NCT01438060|365022146|FG001|On Study Beyond Week 140|Adverse Event|2|||
105826397|NCT01438060|365022145|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
105826398|NCT01438060|365022146|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
105826399|NCT01438060|365022145|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
105826400|NCT01438060|365022146|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
105826401|NCT01438060|365022145|FG000|On Study Beyond Week 140|Death|0|||
105826402|NCT01438060|365022146|FG001|On Study Beyond Week 140|Death|1|||
105826403|NCT01438060|365022145|FG000|On Study Beyond Week 140|Other Reason|0|||
105826404|NCT01438060|365022146|FG001|On Study Beyond Week 140|Other Reason|3|||
105826405|NCT00858780|365022147|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
105826406|NCT00858780|365022148|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
105826407|NCT00858780|365022149|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
105826408|NCT00858780|365022150|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
105826409|NCT00858780|365022151|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
105826410|NCT00858780|365022147|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
105826411|NCT00858780|365022148|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
105826412|NCT00858780|365022149|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
105826413|NCT00858780|365022150|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
105826414|NCT00858780|365022151|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
105826415|NCT00858780|365022147|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
105826416|NCT00858780|365022148|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
105826417|NCT00858780|365022149|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
105826418|NCT00858780|365022150|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
105826419|NCT00858780|365022151|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
105826420|NCT00858780|365022147|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
105826421|NCT00858780|365022148|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
105826422|NCT00858780|365022149|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
105826423|NCT00858780|365022150|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
105826424|NCT00858780|365022151|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
105826425|NCT00858780|365022147|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
105826426|NCT00858780|365022148|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
105826427|NCT00858780|365022149|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
105826428|NCT00858780|365022150|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
106147723|NCT03482011|366202432|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
106147724|NCT03482011|366202433|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
105826429|NCT00858780|365022151|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
106147725|NCT03482011|366202434|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
106147726|NCT03482011|366202427|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
105961774|NCT02936869|365521038|FG000|Overall Study|Legal Case|0|||
105961775|NCT02936869|365521039|FG001|Overall Study|Legal Case|1|||
105961776|NCT02936869|365521038|FG000|Overall Study|Protocol Violation|1|||
105961777|NCT02936869|365521039|FG001|Overall Study|Protocol Violation|0|||
105961778|NCT00851552|365521040|FG000|Overall Study|Death|2|||
105961779|NCT00851552|365521040|FG000|Overall Study|Adverse Event|1|||
105961780|NCT00851552|365521040|FG000|Overall Study|Disease Progression|4|||
105961781|NCT02689206|365521041|FG000|Overall Study|Adverse Event|0|||
105961782|NCT02689206|365521042|FG001|Overall Study|Adverse Event|0|||
105768654|NCT03039790|364804486|FG018|Overall Study|Death|2|||
105768655|NCT03039790|364804487|FG019|Overall Study|Death|0|||
105768656|NCT03039790|364804468|FG000|Overall Study|Reason, not Specified|1|||
105768657|NCT03039790|364804469|FG001|Overall Study|Reason, not Specified|0|||
105961783|NCT02689206|365521043|FG002|Overall Study|Adverse Event|1|||
105961784|NCT02689206|365521044|FG003|Overall Study|Adverse Event|0|||
105961785|NCT02689206|365521045|FG004|Overall Study|Adverse Event|2|||
105768658|NCT03039790|364804470|FG002|Overall Study|Reason, not Specified|0|||
105768659|NCT03039790|364804471|FG003|Overall Study|Reason, not Specified|0|||
105768660|NCT03039790|364804472|FG004|Overall Study|Reason, not Specified|0|||
105768661|NCT03039790|364804473|FG005|Overall Study|Reason, not Specified|0|||
105768662|NCT03039790|364804474|FG006|Overall Study|Reason, not Specified|0|||
105768663|NCT03039790|364804475|FG007|Overall Study|Reason, not Specified|0|||
105768664|NCT03039790|364804476|FG008|Overall Study|Reason, not Specified|0|||
105768665|NCT03039790|364804477|FG009|Overall Study|Reason, not Specified|0|||
105768666|NCT03039790|364804478|FG010|Overall Study|Reason, not Specified|0|||
105768667|NCT03039790|364804479|FG011|Overall Study|Reason, not Specified|0|||
105768668|NCT03039790|364804480|FG012|Overall Study|Reason, not Specified|0|||
105768669|NCT03039790|364804481|FG013|Overall Study|Reason, not Specified|0|||
105768670|NCT03039790|364804482|FG014|Overall Study|Reason, not Specified|0|||
105768671|NCT03039790|364804483|FG015|Overall Study|Reason, not Specified|0|||
105768672|NCT03039790|364804484|FG016|Overall Study|Reason, not Specified|2|||
105768673|NCT03039790|364804485|FG017|Overall Study|Reason, not Specified|0|||
105768674|NCT03039790|364804486|FG018|Overall Study|Reason, not Specified|1|||
105768675|NCT03039790|364804487|FG019|Overall Study|Reason, not Specified|0|||
105768676|NCT02465489|364804491|FG000|Overall Study|Adverse Event|5|||
105768677|NCT04599972|364804494|FG000|Overall Study|Withdrawal by Subject|6|||
105768678|NCT04599972|364804495|FG001|Overall Study|Withdrawal by Subject|1|||
105768679|NCT04599972|364804494|FG000|Overall Study|Adverse Event|1|||
105768680|NCT04599972|364804495|FG001|Overall Study|Adverse Event|1|||
105768681|NCT04599972|364804494|FG000|Overall Study|Lost to Follow-up|1|||
105768682|NCT04599972|364804495|FG001|Overall Study|Lost to Follow-up|6|||
105768683|NCT04599972|364804494|FG000|Overall Study|Protocol Violation|1|||
105768684|NCT04599972|364804495|FG001|Overall Study|Protocol Violation|0|||
105768685|NCT04599972|364804494|FG000|Overall Study|Other reason|1|||
105768686|NCT04599972|364804495|FG001|Overall Study|Other reason|0|||
105768687|NCT03342404|364804496|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
105768688|NCT03342404|364804497|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
105768689|NCT03342404|364804496|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
105768690|NCT03342404|364804497|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
105768691|NCT03342404|364804496|FG000|Blinded Treatment Phase|Adverse Event|5|||
105768692|NCT03342404|364804497|FG001|Blinded Treatment Phase|Adverse Event|4|||
105768693|NCT03342404|364804496|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
105768694|NCT03342404|364804497|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
105768695|NCT03342404|364804496|FG000|Blinded Treatment Phase|Other reasons|1|||
105768696|NCT03342404|364804497|FG001|Blinded Treatment Phase|Other reasons|0|||
105768697|NCT03342404|364804496|FG000|Blinded Treatment Phase|Physician Decision|1|||
105768698|NCT03342404|364804497|FG001|Blinded Treatment Phase|Physician Decision|0|||
105768699|NCT03342404|364804496|FG000|Blinded Treatment Phase|Death|1|||
105768700|NCT03342404|364804497|FG001|Blinded Treatment Phase|Death|0|||
105768701|NCT03342404|364804496|FG000|Open-Label Phase|Lost to Follow-up|0|||
105768702|NCT03342404|364804497|FG001|Open-Label Phase|Lost to Follow-up|1|||
105768703|NCT03342404|364804496|FG000|Open-Label Phase|Other reasons|0|||
105768704|NCT03342404|364804497|FG001|Open-Label Phase|Other reasons|1|||
105768705|NCT03342404|364804496|FG000|Open-Label Phase|Adverse Event|0|||
105768706|NCT03342404|364804497|FG001|Open-Label Phase|Adverse Event|3|||
105768707|NCT03342404|364804496|FG000|Open-Label Phase|Withdrawal by Subject|0|||
105768708|NCT03342404|364804497|FG001|Open-Label Phase|Withdrawal by Subject|6|||
105768709|NCT01855425|364804502|FG000|Overall Study|Physician Decision|20|||
105768710|NCT00638690|364804503|FG000|Overall Study|Death|655|||
105768711|NCT00638690|364804504|FG001|Overall Study|Death|335|||
105768712|NCT00638690|364804503|FG000|Overall Study|Withdrawal by Subject|22|||
105768713|NCT00638690|364804504|FG001|Overall Study|Withdrawal by Subject|5|||
105768714|NCT00638690|364804503|FG000|Overall Study|Lost to Follow-up|4|||
105768715|NCT00638690|364804504|FG001|Overall Study|Lost to Follow-up|2|||
105768716|NCT02201251|364804512|FG000|Overall Study|Adverse Event|1|||
105826430|NCT00858780|365022147|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
105826431|NCT00858780|365022148|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
105826432|NCT00858780|365022149|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
105826433|NCT00858780|365022150|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
105826434|NCT00858780|365022151|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
105826435|NCT04631562|365022154|FG000|Overall Study|Withdrawal by Subject|0|||
105826436|NCT04631562|365022155|FG001|Overall Study|Withdrawal by Subject|0|||
105826437|NCT04631562|365022156|FG002|Overall Study|Withdrawal by Subject|0|||
105826438|NCT04631562|365022157|FG003|Overall Study|Withdrawal by Subject|0|||
105826439|NCT04631562|365022158|FG004|Overall Study|Withdrawal by Subject|0|||
105961786|NCT02689206|365521041|FG000|Overall Study|Protocol Violation|1|||
105961787|NCT02689206|365521042|FG001|Overall Study|Protocol Violation|0|||
105961788|NCT02689206|365521043|FG002|Overall Study|Protocol Violation|0|||
105961789|NCT02689206|365521044|FG003|Overall Study|Protocol Violation|1|||
105961790|NCT02689206|365521045|FG004|Overall Study|Protocol Violation|2|||
105961791|NCT02689206|365521041|FG000|Overall Study|Other: Reached stopping criteria|0|||
105961792|NCT02689206|365521042|FG001|Overall Study|Other: Reached stopping criteria|1|||
105961793|NCT02689206|365521043|FG002|Overall Study|Other: Reached stopping criteria|2|||
105961794|NCT02689206|365521044|FG003|Overall Study|Other: Reached stopping criteria|3|||
105961795|NCT02689206|365521045|FG004|Overall Study|Other: Reached stopping criteria|4|||
105961796|NCT02689206|365521041|FG000|Overall Study|Physician Decision|1|||
105961797|NCT02689206|365521042|FG001|Overall Study|Physician Decision|0|||
105961798|NCT02689206|365521043|FG002|Overall Study|Physician Decision|0|||
105961799|NCT02689206|365521044|FG003|Overall Study|Physician Decision|0|||
105961800|NCT02689206|365521045|FG004|Overall Study|Physician Decision|0|||
105961801|NCT02689206|365521041|FG000|Overall Study|Withdrawal by Subject|1|||
105961802|NCT02689206|365521042|FG001|Overall Study|Withdrawal by Subject|0|||
105961803|NCT02689206|365521043|FG002|Overall Study|Withdrawal by Subject|1|||
105961804|NCT02689206|365521044|FG003|Overall Study|Withdrawal by Subject|0|||
105961805|NCT02689206|365521045|FG004|Overall Study|Withdrawal by Subject|0|||
105961806|NCT01606176|365521046|FG000|Overall Study|Adverse Event|2|||
105961807|NCT01606176|365521047|FG001|Overall Study|Adverse Event|3|||
105961808|NCT01606176|365521046|FG000|Overall Study|Disease progression|1|||
105961809|NCT01606176|365521047|FG001|Overall Study|Disease progression|0|||
105961810|NCT01606176|365521046|FG000|Overall Study|Withdrawal by Subject|1|||
105961811|NCT01606176|365521047|FG001|Overall Study|Withdrawal by Subject|0|||
105961812|NCT01832493|365521048|FG000|Overall Study|Physician Decision|2|||
105961813|NCT01832493|365521048|FG000|Overall Study|Protocol Violation|4|||
105961814|NCT01832493|365521048|FG000|Overall Study|Unable to place LV lead|2|||
105961815|NCT02993822|365521049|FG000|Overall Study|Lack of Efficacy|1|||
105961816|NCT02993822|365521050|FG001|Overall Study|Lack of Efficacy|1|||
105961817|NCT02993822|365521051|FG002|Overall Study|Lack of Efficacy|0|||
105961818|NCT02993822|365521052|FG003|Overall Study|Lack of Efficacy|0|||
105961819|NCT02993822|365521049|FG000|Overall Study|Protocol Violation|1|||
105961820|NCT02993822|365521050|FG001|Overall Study|Protocol Violation|0|||
105961821|NCT02993822|365521051|FG002|Overall Study|Protocol Violation|0|||
105961822|NCT02993822|365521052|FG003|Overall Study|Protocol Violation|0|||
105961823|NCT02993822|365521049|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
105961824|NCT02993822|365521050|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
105961825|NCT02993822|365521051|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
105961826|NCT02993822|365521052|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
105961827|NCT02993822|365521049|FG000|Overall Study|Adverse Event|3|||
105961828|NCT02993822|365521050|FG001|Overall Study|Adverse Event|1|||
105961829|NCT02993822|365521051|FG002|Overall Study|Adverse Event|7|||
105961830|NCT02993822|365521052|FG003|Overall Study|Adverse Event|0|||
105961831|NCT02993822|365521049|FG000|Overall Study|Withdrawal by Subject|4|||
105961832|NCT02993822|365521050|FG001|Overall Study|Withdrawal by Subject|2|||
105961833|NCT02993822|365521051|FG002|Overall Study|Withdrawal by Subject|2|||
105961834|NCT02993822|365521052|FG003|Overall Study|Withdrawal by Subject|3|||
105961835|NCT02993822|365521049|FG000|Overall Study|Lost to Follow-up|1|||
105961836|NCT02993822|365521050|FG001|Overall Study|Lost to Follow-up|0|||
105961837|NCT02993822|365521051|FG002|Overall Study|Lost to Follow-up|1|||
105826440|NCT04631562|365022159|FG005|Overall Study|Withdrawal by Subject|0|||
105961838|NCT02993822|365521052|FG003|Overall Study|Lost to Follow-up|0|||
105961839|NCT04154293|365521053|FG000|Overall Study|Withdrawal by Subject|2|||
105961840|NCT04154293|365521054|FG001|Overall Study|Withdrawal by Subject|3|||
105961841|NCT04154293|365521055|FG002|Overall Study|Withdrawal by Subject|1|||
105961842|NCT04154293|365521053|FG000|Overall Study|Physician Decision|0|||
105961843|NCT04154293|365521054|FG001|Overall Study|Physician Decision|0|||
105961844|NCT04154293|365521055|FG002|Overall Study|Physician Decision|1|||
105961845|NCT00861692|365521061|FG000|Overall Study|Death|6|||
105961846|NCT02907216|365521062|FG000|Overall Study|No benefit to be obtained by continuing|0|||
105961847|NCT02907216|365521063|FG001|Overall Study|No benefit to be obtained by continuing|1|||
105961848|NCT02907216|365521062|FG000|Overall Study|Withdrawal by Subject|1|||
105961849|NCT02907216|365521063|FG001|Overall Study|Withdrawal by Subject|0|||
105961850|NCT04776720|365521069|FG000|Overall Study|COVID Related|4|||
105961851|NCT04776720|365521070|FG001|Overall Study|COVID Related|2|||
105961852|NCT04776720|365521069|FG000|Overall Study|Adverse Event|2|||
105961853|NCT04776720|365521070|FG001|Overall Study|Adverse Event|0|||
105961854|NCT04776720|365521069|FG000|Overall Study|Serious Adverse Event|0|||
105961855|NCT04776720|365521070|FG001|Overall Study|Serious Adverse Event|1|||
105961856|NCT04776720|365521069|FG000|Overall Study|Too Busy|3|||
105961857|NCT04776720|365521070|FG001|Overall Study|Too Busy|1|||
105961858|NCT04776720|365521069|FG000|Overall Study|Lost to Follow-up|1|||
105961859|NCT04776720|365521070|FG001|Overall Study|Lost to Follow-up|2|||
105961860|NCT04776720|365521069|FG000|Overall Study|Family|2|||
105961861|NCT04776720|365521070|FG001|Overall Study|Family|2|||
105961862|NCT04776720|365521069|FG000|Overall Study|No remote technology access|0|||
105961863|NCT04776720|365521070|FG001|Overall Study|No remote technology access|1|||
105961864|NCT04776720|365521069|FG000|Overall Study|Withdrawal by Subject|1|||
105961865|NCT04776720|365521070|FG001|Overall Study|Withdrawal by Subject|0|||
105961866|NCT04776720|365521069|FG000|Overall Study|Cannot tolerate intervention|1|||
105961867|NCT04776720|365521070|FG001|Overall Study|Cannot tolerate intervention|0|||
105961868|NCT04776720|365521069|FG000|Overall Study|Incomplete outcome data|6|||
105961869|NCT04776720|365521070|FG001|Overall Study|Incomplete outcome data|1|||
105961870|NCT00792740|365521073|FG000|Overall Study|Disease Worsening|3|||
105961871|NCT00792740|365521074|FG001|Overall Study|Disease Worsening|2|||
105961872|NCT00792740|365521073|FG000|Overall Study|Personal Reason|1|||
105961873|NCT00792740|365521074|FG001|Overall Study|Personal Reason|0|||
105961874|NCT00792740|365521073|FG000|Overall Study|Adverse Event|1|||
105961875|NCT00792740|365521074|FG001|Overall Study|Adverse Event|3|||
105961876|NCT00792740|365521073|FG000|Overall Study|Patient's withdrawal of consent|0|||
105961877|NCT00792740|365521074|FG001|Overall Study|Patient's withdrawal of consent|1|||
105961878|NCT00792740|365521073|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
105961879|NCT00792740|365521074|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
105961880|NCT00792740|365521073|FG000|Overall Study|Other reasons|0|||
105961881|NCT00792740|365521074|FG001|Overall Study|Other reasons|1|||
105961882|NCT00703846|365521075|FG000|Overall Study|Adverse Event|8|||
105961883|NCT00703846|365521075|FG000|Overall Study|Lost to Follow-up|55|||
105961884|NCT00703846|365521075|FG000|Overall Study|Lack of Efficacy|15|||
105961885|NCT00703846|365521075|FG000|Overall Study|Noncompliance with Study Treatment|2|||
105961886|NCT00703846|365521075|FG000|Overall Study|Withdrawal by Subject|40|||
105961887|NCT00703846|365521075|FG000|Overall Study|Death|1|||
105961888|NCT00703846|365521075|FG000|Overall Study|Other|14|||
105961889|NCT00703846|365521075|FG000|Overall Study|Did Not Receive Study Drug|2|||
105961890|NCT02016716|365521078|FG000|Overall Study|Withdrawal by Subject|5|||
105961891|NCT02016716|365521079|FG001|Overall Study|Withdrawal by Subject|5|||
105961892|NCT02016716|365521080|FG002|Overall Study|Withdrawal by Subject|5|||
105961893|NCT02016716|365521078|FG000|Overall Study|Protocol-specified Criteria|0|||
105961894|NCT02016716|365521079|FG001|Overall Study|Protocol-specified Criteria|1|||
105961895|NCT02016716|365521080|FG002|Overall Study|Protocol-specified Criteria|0|||
105961896|NCT02016716|365521078|FG000|Overall Study|Lost to Follow-up|1|||
105961897|NCT02016716|365521079|FG001|Overall Study|Lost to Follow-up|2|||
105961898|NCT02016716|365521080|FG002|Overall Study|Lost to Follow-up|1|||
105961899|NCT00079391|365521081|FG000|Overall Study|Withdrawal by Subject|1|||
105961900|NCT02248649|365521082|FG000|Overall Study|Death|7|||
105961901|NCT02248649|365521083|FG001|Overall Study|Death|11|||
105961902|NCT02248649|365521082|FG000|Overall Study|Lost to Follow-up|14|||
105961903|NCT02248649|365521083|FG001|Overall Study|Lost to Follow-up|10|||
105961904|NCT01597908|365521084|FG000|Randomized Phase|Death|217|||
105961905|NCT01597908|365521085|FG001|Randomized Phase|Death|238|||
105961906|NCT01597908|365521086|FG002|Randomized Phase|Death|0|||
105961907|NCT01597908|365521084|FG000|Randomized Phase|Sponsor Decision|93|||
105961908|NCT01597908|365521085|FG001|Randomized Phase|Sponsor Decision|39|||
105961909|NCT01597908|365521086|FG002|Randomized Phase|Sponsor Decision|0|||
105961910|NCT01597908|365521084|FG000|Randomized Phase|Lost to Follow-up|9|||
105961911|NCT01597908|365521085|FG001|Randomized Phase|Lost to Follow-up|16|||
105961912|NCT01597908|365521086|FG002|Randomized Phase|Lost to Follow-up|0|||
105961913|NCT01597908|365521084|FG000|Randomized Phase|Physician Decision|6|||
105961914|NCT01597908|365521085|FG001|Randomized Phase|Physician Decision|3|||
105961915|NCT01597908|365521086|FG002|Randomized Phase|Physician Decision|0|||
105961916|NCT01597908|365521084|FG000|Randomized Phase|Withdrawal by Subject|26|||
105961917|NCT01597908|365521085|FG001|Randomized Phase|Withdrawal by Subject|22|||
105961918|NCT01597908|365521086|FG002|Randomized Phase|Withdrawal by Subject|0|||
105961919|NCT01597908|365521084|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
105961920|NCT01597908|365521085|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
105961921|NCT01597908|365521086|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
105961922|NCT01597908|365521084|FG000|Crossover Phase|Death|0|||
105961923|NCT01597908|365521085|FG001|Crossover Phase|Death|0|||
105961924|NCT01597908|365521086|FG002|Crossover Phase|Death|11|||
105961925|NCT01597908|365521084|FG000|Crossover Phase|Withdrawal by Subject|0|||
105961926|NCT01597908|365521085|FG001|Crossover Phase|Withdrawal by Subject|0|||
105961927|NCT01597908|365521086|FG002|Crossover Phase|Withdrawal by Subject|3|||
105961928|NCT01597908|365521084|FG000|Crossover Phase|Sponsor Decision|0|||
106147727|NCT03482011|366202428|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
106147728|NCT03482011|366202429|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
106147729|NCT03482011|366202430|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
106147730|NCT03482011|366202431|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
106147731|NCT03482011|366202432|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
106147732|NCT03482011|366202433|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
106147733|NCT03482011|366202434|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
106147734|NCT03482011|366202427|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
106147735|NCT03482011|366202428|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
106147736|NCT03482011|366202429|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
106147737|NCT03482011|366202430|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
106147738|NCT03482011|366202431|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
106147739|NCT03482011|366202432|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
106147740|NCT03482011|366202433|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
106147741|NCT03482011|366202434|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
106147742|NCT03482011|366202427|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
106147743|NCT03482011|366202428|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
106147744|NCT03482011|366202429|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
106147745|NCT03482011|366202430|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
106147746|NCT03482011|366202431|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
106147747|NCT03482011|366202432|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
106147748|NCT03482011|366202433|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
106147749|NCT03482011|366202434|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
106147750|NCT03482011|366202427|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
106147751|NCT03482011|366202428|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
106147752|NCT03482011|366202429|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
106147753|NCT03482011|366202430|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
106147754|NCT03482011|366202431|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
106147755|NCT03482011|366202432|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
106147756|NCT03482011|366202433|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
106147757|NCT03482011|366202434|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
106147758|NCT02538107|366202445|FG000|Overall Study|Did not receive any Mircera dose|11|||
106147759|NCT02538107|366202445|FG000|Overall Study|Missing|5|||
106147760|NCT02538107|366202445|FG000|Overall Study|Necessity of dialysis|20|||
106147761|NCT02538107|366202445|FG000|Overall Study|Administration of other ESA|11|||
106147762|NCT02538107|366202445|FG000|Overall Study|No further treatment necessary|18|||
106147763|NCT02538107|366202445|FG000|Overall Study|Withdrawal by Subject|17|||
106147764|NCT02538107|366202445|FG000|Overall Study|Death|4|||
106147765|NCT02538107|366202445|FG000|Overall Study|Administrative reason|5|||
106147766|NCT02538107|366202445|FG000|Overall Study|Adverse Event|4|||
106147767|NCT02538107|366202445|FG000|Overall Study|Surgery|1|||
106147768|NCT02538107|366202445|FG000|Overall Study|Other|7|||
106147769|NCT02538107|366202445|FG000|Overall Study|Not recorded|7|||
106147770|NCT00785512|366202446|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
106147771|NCT00785512|366202447|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
106147772|NCT00785512|366202446|FG000|Overall Study|Adverse Event|0|||
105826441|NCT04631562|365022160|FG006|Overall Study|Withdrawal by Subject|0|||
105826442|NCT04631562|365022161|FG007|Overall Study|Withdrawal by Subject|1|||
105826443|NCT04631562|365022162|FG008|Overall Study|Withdrawal by Subject|0|||
105826444|NCT04631562|365022154|FG000|Overall Study|Other|0|||
105826445|NCT04631562|365022155|FG001|Overall Study|Other|0|||
105826446|NCT04631562|365022156|FG002|Overall Study|Other|0|||
105826447|NCT04631562|365022157|FG003|Overall Study|Other|0|||
105826448|NCT04631562|365022158|FG004|Overall Study|Other|0|||
105826449|NCT04631562|365022159|FG005|Overall Study|Other|0|||
105826450|NCT04631562|365022160|FG006|Overall Study|Other|0|||
105826451|NCT04631562|365022161|FG007|Overall Study|Other|0|||
105826452|NCT04631562|365022162|FG008|Overall Study|Other|1|||
105826453|NCT04631562|365022154|FG000|Overall Study|Lost to Follow-up|0|||
105826454|NCT04631562|365022155|FG001|Overall Study|Lost to Follow-up|0|||
106147773|NCT00785512|366202447|FG001|Overall Study|Adverse Event|0|||
106147774|NCT00785512|366202446|FG000|Overall Study|Lack of Efficacy|0|||
106147775|NCT00785512|366202447|FG001|Overall Study|Lack of Efficacy|2|||
106147776|NCT00785512|366202446|FG000|Overall Study|Withdrawal by Subject|0|||
106147777|NCT00785512|366202447|FG001|Overall Study|Withdrawal by Subject|1|||
106147778|NCT00785512|366202446|FG000|Overall Study|Lost to Follow-up|3|||
106147779|NCT00785512|366202447|FG001|Overall Study|Lost to Follow-up|0|||
106147780|NCT00785512|366202446|FG000|Overall Study|Precedure Refused|0|||
106147781|NCT00785512|366202447|FG001|Overall Study|Precedure Refused|0|||
105826455|NCT04631562|365022156|FG002|Overall Study|Lost to Follow-up|0|||
105826456|NCT04631562|365022157|FG003|Overall Study|Lost to Follow-up|1|||
105826457|NCT04631562|365022158|FG004|Overall Study|Lost to Follow-up|0|||
105826458|NCT04631562|365022159|FG005|Overall Study|Lost to Follow-up|0|||
106147782|NCT00785512|366202446|FG000|Overall Study|IVRS Programing Error|0|||
105826459|NCT04631562|365022160|FG006|Overall Study|Lost to Follow-up|0|||
106147783|NCT00785512|366202447|FG001|Overall Study|IVRS Programing Error|0|||
105826460|NCT04631562|365022161|FG007|Overall Study|Lost to Follow-up|0|||
105826461|NCT04631562|365022162|FG008|Overall Study|Lost to Follow-up|0|||
105826462|NCT04631562|365022154|FG000|Overall Study|Adverse Event|0|||
105826463|NCT04631562|365022155|FG001|Overall Study|Adverse Event|0|||
105826464|NCT04631562|365022156|FG002|Overall Study|Adverse Event|0|||
105826465|NCT04631562|365022157|FG003|Overall Study|Adverse Event|0|||
105826466|NCT04631562|365022158|FG004|Overall Study|Adverse Event|0|||
105826467|NCT04631562|365022159|FG005|Overall Study|Adverse Event|0|||
105826468|NCT04631562|365022160|FG006|Overall Study|Adverse Event|1|||
105826469|NCT04631562|365022161|FG007|Overall Study|Adverse Event|0|||
105826470|NCT04631562|365022162|FG008|Overall Study|Adverse Event|0|||
105826471|NCT01190865|365022167|FG000|Overall Study|Withdrawal by Subject|1|||
105826472|NCT01190865|365022167|FG000|Overall Study|Non-compliance|2|||
105826473|NCT00829452|365022168|FG000|First Intervention|Withdrawal by Subject|0|||
105826474|NCT00829452|365022169|FG001|First Intervention|Withdrawal by Subject|1|||
105826475|NCT00829452|365022168|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
105826476|NCT00829452|365022169|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
105826477|NCT00829452|365022168|FG000|Second Intervention|Physician Decision|0|||
105826478|NCT00829452|365022169|FG001|Second Intervention|Physician Decision|1|||
105826479|NCT02436200|365022171|FG000|Overall Study|Significant outlier|1|||
105826480|NCT05098743|365022176|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
105826481|NCT05098743|365022177|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
105826482|NCT05098743|365022176|FG000|Overall Study|Lost to Follow-up|1|||
105826483|NCT05098743|365022177|FG001|Overall Study|Lost to Follow-up|2|||
105826484|NCT00838539|365022178|FG000|Overall Study|Disease Progression|2|||
105826485|NCT00838539|365022179|FG001|Overall Study|Disease Progression|4|||
105826486|NCT00838539|365022180|FG002|Overall Study|Disease Progression|3|||
105826487|NCT00838539|365022181|FG003|Overall Study|Disease Progression|2|||
105826488|NCT00838539|365022182|FG004|Overall Study|Disease Progression|4|||
105826489|NCT00838539|365022183|FG005|Overall Study|Disease Progression|2|||
105826490|NCT00838539|365022184|FG006|Overall Study|Disease Progression|3|||
105826491|NCT00838539|365022185|FG007|Overall Study|Disease Progression|4|||
105826492|NCT00838539|365022186|FG008|Overall Study|Disease Progression|4|||
105826493|NCT00838539|365022187|FG009|Overall Study|Disease Progression|5|||
105826494|NCT00838539|365022188|FG010|Overall Study|Disease Progression|1|||
105826495|NCT00838539|365022189|FG011|Overall Study|Disease Progression|4|||
105826496|NCT00838539|365022178|FG000|Overall Study|Adverse Event|1|||
105826497|NCT00838539|365022179|FG001|Overall Study|Adverse Event|1|||
105826498|NCT00838539|365022180|FG002|Overall Study|Adverse Event|1|||
105826499|NCT00838539|365022181|FG003|Overall Study|Adverse Event|1|||
105826500|NCT00838539|365022182|FG004|Overall Study|Adverse Event|2|||
105826501|NCT00838539|365022183|FG005|Overall Study|Adverse Event|1|||
105826502|NCT00838539|365022184|FG006|Overall Study|Adverse Event|0|||
105826503|NCT00838539|365022185|FG007|Overall Study|Adverse Event|2|||
105826504|NCT00838539|365022186|FG008|Overall Study|Adverse Event|0|||
105826505|NCT00838539|365022187|FG009|Overall Study|Adverse Event|1|||
105826506|NCT00838539|365022188|FG010|Overall Study|Adverse Event|2|||
105826507|NCT00838539|365022189|FG011|Overall Study|Adverse Event|0|||
105826508|NCT00838539|365022178|FG000|Overall Study|Withdrawal by Subject|0|||
105826509|NCT00838539|365022179|FG001|Overall Study|Withdrawal by Subject|1|||
105826510|NCT00838539|365022180|FG002|Overall Study|Withdrawal by Subject|0|||
105826511|NCT00838539|365022181|FG003|Overall Study|Withdrawal by Subject|0|||
105826512|NCT00838539|365022182|FG004|Overall Study|Withdrawal by Subject|0|||
105826513|NCT00838539|365022183|FG005|Overall Study|Withdrawal by Subject|0|||
105826514|NCT00838539|365022184|FG006|Overall Study|Withdrawal by Subject|0|||
105826515|NCT00838539|365022185|FG007|Overall Study|Withdrawal by Subject|0|||
105826516|NCT00838539|365022186|FG008|Overall Study|Withdrawal by Subject|0|||
105826517|NCT00838539|365022187|FG009|Overall Study|Withdrawal by Subject|1|||
105826518|NCT00838539|365022188|FG010|Overall Study|Withdrawal by Subject|2|||
105826519|NCT00838539|365022189|FG011|Overall Study|Withdrawal by Subject|0|||
105826520|NCT00838539|365022178|FG000|Overall Study|Death|0|||
105826521|NCT00838539|365022179|FG001|Overall Study|Death|0|||
106022178|NCT01192191|365746771|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
106022179|NCT01192191|365746770|FG000|Overall Study|Lost to Follow-up|0|||
105826522|NCT00838539|365022180|FG002|Overall Study|Death|0|||
105826523|NCT00838539|365022181|FG003|Overall Study|Death|0|||
105826524|NCT00838539|365022182|FG004|Overall Study|Death|0|||
105826525|NCT00838539|365022183|FG005|Overall Study|Death|0|||
105826526|NCT00838539|365022184|FG006|Overall Study|Death|1|||
105826527|NCT00838539|365022185|FG007|Overall Study|Death|0|||
105826528|NCT00838539|365022186|FG008|Overall Study|Death|0|||
105826529|NCT00838539|365022187|FG009|Overall Study|Death|0|||
105826530|NCT00838539|365022188|FG010|Overall Study|Death|0|||
105826531|NCT00838539|365022189|FG011|Overall Study|Death|0|||
105826532|NCT00838539|365022178|FG000|Overall Study|Physician Decision|0|||
105826533|NCT00838539|365022179|FG001|Overall Study|Physician Decision|0|||
105826534|NCT00838539|365022180|FG002|Overall Study|Physician Decision|0|||
105826535|NCT00838539|365022181|FG003|Overall Study|Physician Decision|0|||
105826536|NCT00838539|365022182|FG004|Overall Study|Physician Decision|0|||
105826537|NCT00838539|365022183|FG005|Overall Study|Physician Decision|0|||
105826538|NCT00838539|365022184|FG006|Overall Study|Physician Decision|0|||
105826539|NCT00838539|365022185|FG007|Overall Study|Physician Decision|0|||
105826540|NCT00838539|365022186|FG008|Overall Study|Physician Decision|1|||
105826541|NCT00838539|365022187|FG009|Overall Study|Physician Decision|0|||
105826542|NCT00838539|365022188|FG010|Overall Study|Physician Decision|0|||
105826543|NCT00838539|365022189|FG011|Overall Study|Physician Decision|0|||
105826544|NCT00838539|365022178|FG000|Overall Study|Clinical Progression|0|||
105826545|NCT00838539|365022179|FG001|Overall Study|Clinical Progression|0|||
105826546|NCT00838539|365022180|FG002|Overall Study|Clinical Progression|0|||
105826547|NCT00838539|365022181|FG003|Overall Study|Clinical Progression|0|||
105826548|NCT00838539|365022182|FG004|Overall Study|Clinical Progression|0|||
105826549|NCT00838539|365022183|FG005|Overall Study|Clinical Progression|0|||
105826550|NCT00838539|365022184|FG006|Overall Study|Clinical Progression|1|||
105826551|NCT00838539|365022185|FG007|Overall Study|Clinical Progression|0|||
105826552|NCT00838539|365022186|FG008|Overall Study|Clinical Progression|0|||
105826553|NCT00838539|365022187|FG009|Overall Study|Clinical Progression|0|||
105826554|NCT00838539|365022188|FG010|Overall Study|Clinical Progression|0|||
105826555|NCT00838539|365022189|FG011|Overall Study|Clinical Progression|0|||
105826556|NCT00838539|365022178|FG000|Overall Study|Symptomatic Deterioration|0|||
105826557|NCT00838539|365022179|FG001|Overall Study|Symptomatic Deterioration|0|||
105826558|NCT00838539|365022180|FG002|Overall Study|Symptomatic Deterioration|1|||
105826559|NCT00838539|365022181|FG003|Overall Study|Symptomatic Deterioration|1|||
105826560|NCT00838539|365022182|FG004|Overall Study|Symptomatic Deterioration|0|||
105826561|NCT00838539|365022183|FG005|Overall Study|Symptomatic Deterioration|1|||
105826562|NCT00838539|365022184|FG006|Overall Study|Symptomatic Deterioration|0|||
105826563|NCT00838539|365022185|FG007|Overall Study|Symptomatic Deterioration|0|||
105826564|NCT00838539|365022186|FG008|Overall Study|Symptomatic Deterioration|0|||
105826565|NCT00838539|365022187|FG009|Overall Study|Symptomatic Deterioration|1|||
105826566|NCT00838539|365022188|FG010|Overall Study|Symptomatic Deterioration|0|||
105826567|NCT00838539|365022189|FG011|Overall Study|Symptomatic Deterioration|0|||
105826568|NCT02635750|365024218|FG000|Part 1, Period 2|Adverse Event|1|||
105826569|NCT02635750|365024219|FG001|Part 1, Period 2|Adverse Event|0|||
105826570|NCT02635750|365024220|FG002|Part 1, Period 2|Adverse Event|0|||
105826571|NCT02642653|365024222|FG000|Overall Study|Adverse Event|2|||
105826572|NCT02642653|365024223|FG001|Overall Study|Adverse Event|0|||
105826573|NCT00830258|365024224|FG000|First Intervention|Adverse Event|1|||
105826574|NCT00830258|365024225|FG001|First Intervention|Adverse Event|0|||
105826575|NCT00830258|365024224|FG000|Washout: 7 Days|Protocol Violation|1|||
105826576|NCT00830258|365024225|FG001|Washout: 7 Days|Protocol Violation|0|||
105826577|NCT00682461|365024230|FG000|Overall Study|Adverse Event|5|||
105826578|NCT00682461|365024231|FG001|Overall Study|Adverse Event|7|||
105826579|NCT00682461|365024230|FG000|Overall Study|Lost to Follow-up|8|||
105826580|NCT00682461|365024231|FG001|Overall Study|Lost to Follow-up|5|||
105826581|NCT00682461|365024230|FG000|Overall Study|Withdrawal by Subject|12|||
105826582|NCT00682461|365024231|FG001|Overall Study|Withdrawal by Subject|19|||
105826583|NCT02875392|365024232|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
105826584|NCT02875392|365024233|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
105826585|NCT03599193|365024236|FG000|Overall Study|Adverse Event|0|||
105826586|NCT03599193|365024237|FG001|Overall Study|Adverse Event|2|||
105826587|NCT03599193|365024236|FG000|Overall Study|Withdrawal by Subject|1|||
105826588|NCT03599193|365024237|FG001|Overall Study|Withdrawal by Subject|0|||
105826589|NCT03599193|365024236|FG000|Overall Study|Protocol Violation|1|||
105826590|NCT03599193|365024237|FG001|Overall Study|Protocol Violation|0|||
105961929|NCT01597908|365521085|FG001|Crossover Phase|Sponsor Decision|0|||
105961930|NCT01597908|365521086|FG002|Crossover Phase|Sponsor Decision|20|||
105961931|NCT00281099|365521089|FG000|Overall Study|Death|46|||
105961932|NCT00281099|365521090|FG001|Overall Study|Death|57|||
105961933|NCT00281099|365521089|FG000|Overall Study|Lost to Follow-up|10|||
105961934|NCT00281099|365521090|FG001|Overall Study|Lost to Follow-up|19|||
105961935|NCT00281099|365521089|FG000|Overall Study|Withdrawal by Subject|65|||
105961936|NCT00281099|365521090|FG001|Overall Study|Withdrawal by Subject|70|||
105961937|NCT00281099|365521089|FG000|Overall Study|Physician Decision|79|||
105961938|NCT00281099|365521090|FG001|Overall Study|Physician Decision|72|||
105961939|NCT00281099|365521089|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
105961940|NCT00281099|365521090|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
105961941|NCT02628600|365521095|FG000|Overall Study|Death|2|||
105961942|NCT02628600|365521096|FG001|Overall Study|Death|1|||
105961943|NCT02628600|365521095|FG000|Overall Study|Adverse Event|3|||
105961944|NCT02628600|365521096|FG001|Overall Study|Adverse Event|20|||
105826591|NCT03599193|365024236|FG000|Overall Study|Lost to Follow-up|0|||
105826592|NCT03599193|365024237|FG001|Overall Study|Lost to Follow-up|1|||
105826593|NCT00834717|365024238|FG000|First Intervention|Adverse Event|1|||
105826594|NCT00834717|365024239|FG001|First Intervention|Adverse Event|0|||
105826595|NCT00834717|365024238|FG000|First Intervention|Withdrawal by Subject|0|||
105826596|NCT00834717|365024239|FG001|First Intervention|Withdrawal by Subject|1|||
105961945|NCT02628600|365521095|FG000|Overall Study|Protocol Violation|0|||
105826597|NCT04299087|365024240|FG000|Overall Study|Lost to Follow-up|2|||
105826598|NCT04299087|365024241|FG001|Overall Study|Lost to Follow-up|1|||
105826599|NCT03025087|365024242|FG000|Overall Study|Physician Decision|3|||
105826600|NCT03025087|365024243|FG001|Overall Study|Physician Decision|3|||
105826601|NCT03025087|365024244|FG002|Overall Study|Physician Decision|0|||
105826602|NCT03025087|365024245|FG003|Overall Study|Physician Decision|0|||
105826603|NCT03025087|365024246|FG004|Overall Study|Physician Decision|0|||
105826604|NCT03025087|365024242|FG000|Overall Study|Withdrawal by Subject|1|||
105826605|NCT03025087|365024243|FG001|Overall Study|Withdrawal by Subject|1|||
105826606|NCT03025087|365024244|FG002|Overall Study|Withdrawal by Subject|0|||
105826607|NCT03025087|365024245|FG003|Overall Study|Withdrawal by Subject|0|||
105826608|NCT03025087|365024246|FG004|Overall Study|Withdrawal by Subject|0|||
105826609|NCT03025087|365024242|FG000|Overall Study|Unable to complete MRI|2|||
105826610|NCT03025087|365024243|FG001|Overall Study|Unable to complete MRI|2|||
105826611|NCT03025087|365024244|FG002|Overall Study|Unable to complete MRI|0|||
105826612|NCT03025087|365024245|FG003|Overall Study|Unable to complete MRI|0|||
105826613|NCT03025087|365024246|FG004|Overall Study|Unable to complete MRI|0|||
105826614|NCT01116739|365024249|FG000|Overall Study|Child had 2 years of HS|110|||
105826615|NCT01116739|365024250|FG001|Overall Study|Child had 2 years of HS|128|||
105826616|NCT01116739|365024249|FG000|Overall Study|Withdrawal by Subject|6|||
105826617|NCT01116739|365024250|FG001|Overall Study|Withdrawal by Subject|0|||
105826618|NCT01116739|365024249|FG000|Overall Study|child too young|2|||
105826619|NCT01116739|365024250|FG001|Overall Study|child too young|6|||
105826620|NCT01116739|365024249|FG000|Overall Study|child not enrolled in head start|10|||
105826621|NCT01116739|365024250|FG001|Overall Study|child not enrolled in head start|2|||
105826622|NCT01116739|365024249|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
105826623|NCT01116739|365024250|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
105826624|NCT05511935|365024251|FG000|Overall Study|Lost to Follow-up|9|||
105826625|NCT05511935|365024252|FG001|Overall Study|Lost to Follow-up|27|||
105826626|NCT01376037|365024253|FG000|Overall Study|Lost to Follow-up|0|||
105826627|NCT01376037|365024254|FG001|Overall Study|Lost to Follow-up|2|||
105826628|NCT02328040|365024256|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
105826629|NCT02328040|365024257|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
105826630|NCT00660660|365024259|FG000|Overall Study|Adverse Event|1|||
105826631|NCT00660660|365024260|FG001|Overall Study|Adverse Event|0|||
105826632|NCT00660660|365024259|FG000|Overall Study|Lost to Follow-up|0|||
105826633|NCT00660660|365024260|FG001|Overall Study|Lost to Follow-up|6|||
105826634|NCT00660660|365024259|FG000|Overall Study|Lack of Efficacy|0|||
105826635|NCT00660660|365024260|FG001|Overall Study|Lack of Efficacy|2|||
105826636|NCT00660660|365024259|FG000|Overall Study|Withdrawal by Subject|3|||
105826637|NCT00660660|365024260|FG001|Overall Study|Withdrawal by Subject|0|||
105826638|NCT00660660|365024259|FG000|Overall Study|Incorrect enrollment and other|0|||
105826639|NCT00660660|365024260|FG001|Overall Study|Incorrect enrollment and other|1|||
105826640|NCT00660660|365024259|FG000|Overall Study|New medication after randomization|1|||
105826641|NCT00660660|365024260|FG001|Overall Study|New medication after randomization|0|||
105826642|NCT02832063|365024261|FG000|Overall Study|Adverse Event|2|||
105826643|NCT02832063|365024262|FG001|Overall Study|Adverse Event|1|||
105826644|NCT02832063|365024261|FG000|Overall Study|Physician Decision|5|||
105826645|NCT02832063|365024262|FG001|Overall Study|Physician Decision|7|||
105826646|NCT02832063|365024261|FG000|Overall Study|Lost to Follow-up|15|||
105826647|NCT02832063|365024262|FG001|Overall Study|Lost to Follow-up|8|||
105826648|NCT02832063|365024261|FG000|Overall Study|Withdrawal by Subject|10|||
105826649|NCT02832063|365024262|FG001|Overall Study|Withdrawal by Subject|21|||
105826650|NCT02832063|365024261|FG000|Overall Study|Other|2|||
105826651|NCT02832063|365024262|FG001|Overall Study|Other|1|||
105826652|NCT03086460|365024263|FG000|Study Participants|Lost to Follow-up|2|||
105826653|NCT03086460|365024263|FG000|Study Participants|Protocol Violation|1|||
105826654|NCT03086460|365024263|FG000|Study Participants|Withdrawal by Subject|6|||
105826655|NCT03086460|365024263|FG000|Treatment A|Lost to Follow-up|1|||
105961946|NCT02628600|365521096|FG001|Overall Study|Protocol Violation|1|||
105961947|NCT02628600|365521095|FG000|Overall Study|Lack of Efficacy|2|||
105961948|NCT02628600|365521096|FG001|Overall Study|Lack of Efficacy|0|||
105961949|NCT02628600|365521095|FG000|Overall Study|Withdrawal by Subject|13|||
105961950|NCT02628600|365521096|FG001|Overall Study|Withdrawal by Subject|8|||
105961951|NCT02628600|365521095|FG000|Overall Study|Lost to Follow-up|1|||
105826656|NCT03086460|365024263|FG000|Treatment A|Protocol Violation|1|||
105826657|NCT03086460|365024263|FG000|Treatment A|Withdrawal by Subject|2|||
105826658|NCT03086460|365024263|FG000|Treatment C|Withdrawal by Subject|2|||
105826659|NCT03086460|365024263|FG000|Treatment E|Lost to Follow-up|1|||
105826660|NCT03086460|365024263|FG000|Treatment E|Withdrawal by Subject|3|||
105826661|NCT00836472|365024276|FG000|Washout|Adverse Event|1|||
105826662|NCT00836472|365024277|FG001|Washout|Adverse Event|2|||
105826663|NCT00836472|365024276|FG000|Washout|Withdrawal by Subject|1|||
105826664|NCT00836472|365024277|FG001|Washout|Withdrawal by Subject|1|||
105826665|NCT01735994|365024278|FG000|Overall Study|Withdrawal by Subject|6|||
105826666|NCT01735994|365024279|FG001|Overall Study|Withdrawal by Subject|4|||
105826667|NCT01735994|365024278|FG000|Overall Study|Injury|2|||
105826668|NCT01735994|365024279|FG001|Overall Study|Injury|0|||
105826669|NCT01735994|365024278|FG000|Overall Study|Kicked off team|5|||
105826670|NCT01735994|365024279|FG001|Overall Study|Kicked off team|0|||
105826671|NCT01735994|365024278|FG000|Overall Study|Lost to Follow-up|50|||
105826672|NCT01735994|365024279|FG001|Overall Study|Lost to Follow-up|62|||
105826673|NCT03499353|365024280|FG000|Treatment|Adverse Event|3|||
105826674|NCT03499353|365024280|FG000|Treatment|Progressive Disease|10|||
105826675|NCT03499353|365024280|FG000|Treatment|Other|1|||
105826676|NCT03499353|365024280|FG000|Treatment|Withdrawal by Subject|2|||
105826677|NCT03499353|365024280|FG000|Long-Term Follow-up|Death|2|||
105826678|NCT03499353|365024280|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
105826679|NCT03499353|365024280|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
105826680|NCT00469898|365024284|FG000|Overall Study|Adverse Event|7|||
105826681|NCT00469898|365024284|FG000|Overall Study|Withdrawal by Subject|4|||
105826682|NCT00469898|365024284|FG000|Overall Study|Death|4|||
105826683|NCT00469898|365024284|FG000|Overall Study|Disease progression|9|||
105826684|NCT00469898|365024284|FG000|Overall Study|Decreased performance status|1|||
105826685|NCT02451696|365024286|FG000|Overall Study|Surgery postponed|1|||
105826686|NCT02451696|365024287|FG001|Overall Study|Surgery postponed|0|||
105826687|NCT00395694|365024288|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
105826688|NCT00395694|365024289|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
105826689|NCT00395694|365024288|FG000|Continuation Phase|Adverse Event|1|||
105826690|NCT00395694|365024289|FG001|Continuation Phase|Adverse Event|0|||
105826691|NCT00395694|365024288|FG000|Continuation Phase|Lack of Efficacy|12|||
105826692|NCT00395694|365024289|FG001|Continuation Phase|Lack of Efficacy|11|||
105826693|NCT00395694|365024288|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
105826694|NCT00395694|365024289|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
105826695|NCT00395694|365024288|FG000|Continuation Phase|Poor Compliance|1|||
105826696|NCT00395694|365024289|FG001|Continuation Phase|Poor Compliance|0|||
105826697|NCT00395694|365024288|FG000|Continuation Phase|Withdrawal by Subject|0|||
105826698|NCT00395694|365024289|FG001|Continuation Phase|Withdrawal by Subject|2|||
105826699|NCT02699866|365024290|FG000|Overall Study|Withdrawal by Subject|3|||
105826700|NCT02699866|365024290|FG000|Overall Study|Physician Decision|2|||
105826701|NCT02699866|365024290|FG000|Overall Study|Adverse Event|3|||
105826702|NCT01959672|365024291|FG000|Overall Study|Death|1|||
105826703|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Adverse Event|8|||
105826704|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Adverse Event|15|||
105826705|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Adverse Event|25|||
105826706|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
105826707|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
105826708|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
105826709|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
105826710|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
105826711|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
105826712|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
105826713|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
105826714|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
105826715|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
105826716|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
105826717|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
105826718|NCT01058668|365024292|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
105826719|NCT01058668|365024293|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
105826720|NCT01058668|365024294|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
105826721|NCT01175135|365024298|FG000|Overall Study|Adverse Event|2|||
105826722|NCT01175135|365024299|FG001|Overall Study|Adverse Event|5|||
105826723|NCT01175135|365024300|FG002|Overall Study|Adverse Event|3|||
105826724|NCT01175135|365024301|FG003|Overall Study|Adverse Event|4|||
105826725|NCT01175135|365024298|FG000|Overall Study|Death|1|||
105826726|NCT01175135|365024299|FG001|Overall Study|Death|0|||
105826727|NCT01175135|365024300|FG002|Overall Study|Death|0|||
105826728|NCT01175135|365024301|FG003|Overall Study|Death|0|||
105826729|NCT01175135|365024298|FG000|Overall Study|Lack of Efficacy|4|||
105826730|NCT01175135|365024299|FG001|Overall Study|Lack of Efficacy|5|||
105826731|NCT01175135|365024300|FG002|Overall Study|Lack of Efficacy|0|||
105826732|NCT01175135|365024301|FG003|Overall Study|Lack of Efficacy|5|||
105826733|NCT01175135|365024298|FG000|Overall Study|Lost to Follow-up|1|||
105826734|NCT01175135|365024299|FG001|Overall Study|Lost to Follow-up|2|||
105826735|NCT01175135|365024300|FG002|Overall Study|Lost to Follow-up|0|||
105826736|NCT01175135|365024301|FG003|Overall Study|Lost to Follow-up|0|||
105826737|NCT01175135|365024298|FG000|Overall Study|Protocol Violation|1|||
105826738|NCT01175135|365024299|FG001|Overall Study|Protocol Violation|1|||
105826739|NCT01175135|365024300|FG002|Overall Study|Protocol Violation|0|||
105826740|NCT01175135|365024301|FG003|Overall Study|Protocol Violation|0|||
105826741|NCT01175135|365024298|FG000|Overall Study|Withdrawal by Subject|4|||
105826742|NCT01175135|365024299|FG001|Overall Study|Withdrawal by Subject|8|||
105826743|NCT01175135|365024300|FG002|Overall Study|Withdrawal by Subject|5|||
105826744|NCT01175135|365024301|FG003|Overall Study|Withdrawal by Subject|5|||
105826745|NCT01175135|365024298|FG000|Overall Study|Other|3|||
105826746|NCT01175135|365024299|FG001|Overall Study|Other|1|||
105826747|NCT01175135|365024300|FG002|Overall Study|Other|3|||
105826748|NCT01175135|365024301|FG003|Overall Study|Other|0|||
105826749|NCT01175135|365024298|FG000|Overall Study|Randomized But Not Treated|0|||
105826750|NCT01175135|365024299|FG001|Overall Study|Randomized But Not Treated|0|||
105826751|NCT01175135|365024300|FG002|Overall Study|Randomized But Not Treated|1|||
105826752|NCT01175135|365024301|FG003|Overall Study|Randomized But Not Treated|0|||
105826753|NCT03428750|365024305|FG000|Overall Study|Withdrawal by Subject|11|||
105826754|NCT03428750|365024306|FG001|Overall Study|Withdrawal by Subject|10|||
105826755|NCT03428750|365024305|FG000|Overall Study|Lost to Follow-up|3|||
105826756|NCT03428750|365024306|FG001|Overall Study|Lost to Follow-up|9|||
105826757|NCT03428750|365024305|FG000|Overall Study|Adverse Event|9|||
105826758|NCT03428750|365024306|FG001|Overall Study|Adverse Event|1|||
105826759|NCT03428750|365024305|FG000|Overall Study|Protocol Violation|1|||
105826760|NCT03428750|365024306|FG001|Overall Study|Protocol Violation|0|||
105826761|NCT03428750|365024305|FG000|Overall Study|Administrative|0|||
105826762|NCT03428750|365024306|FG001|Overall Study|Administrative|1|||
105826763|NCT02554877|365024309|FG000|Overall Study|Adverse Event|2|||
105826764|NCT02554877|365024310|FG001|Overall Study|Adverse Event|0|||
105826765|NCT02554877|365024311|FG002|Overall Study|Adverse Event|0|||
105826766|NCT02554877|365024312|FG003|Overall Study|Adverse Event|1|||
105826767|NCT02554877|365024309|FG000|Overall Study|Lost to Follow-up|1|||
105826768|NCT02554877|365024310|FG001|Overall Study|Lost to Follow-up|1|||
105826769|NCT02554877|365024311|FG002|Overall Study|Lost to Follow-up|1|||
105826770|NCT02554877|365024312|FG003|Overall Study|Lost to Follow-up|2|||
105826771|NCT02554877|365024309|FG000|Overall Study|Did not meet entrance criteria|0|||
105826772|NCT02554877|365024310|FG001|Overall Study|Did not meet entrance criteria|0|||
105826773|NCT02554877|365024311|FG002|Overall Study|Did not meet entrance criteria|1|||
105826774|NCT02554877|365024312|FG003|Overall Study|Did not meet entrance criteria|0|||
105826775|NCT02554877|365024309|FG000|Overall Study|No longer met eligibility criteria|1|||
105826776|NCT02554877|365024310|FG001|Overall Study|No longer met eligibility criteria|0|||
105826777|NCT02554877|365024311|FG002|Overall Study|No longer met eligibility criteria|1|||
105826778|NCT02554877|365024312|FG003|Overall Study|No longer met eligibility criteria|1|||
105826779|NCT02554877|365024309|FG000|Overall Study|Protocol Violation|3|||
105826780|NCT02554877|365024310|FG001|Overall Study|Protocol Violation|1|||
105826781|NCT02554877|365024311|FG002|Overall Study|Protocol Violation|1|||
105826782|NCT02554877|365024312|FG003|Overall Study|Protocol Violation|0|||
105826783|NCT02554877|365024309|FG000|Overall Study|Other|1|||
105826784|NCT02554877|365024310|FG001|Overall Study|Other|3|||
105826785|NCT02554877|365024311|FG002|Overall Study|Other|0|||
105826786|NCT02554877|365024312|FG003|Overall Study|Other|3|||
105826787|NCT02554877|365024309|FG000|Overall Study|Insufficient clinical response|4|||
105826788|NCT02554877|365024310|FG001|Overall Study|Insufficient clinical response|0|||
105826789|NCT02554877|365024311|FG002|Overall Study|Insufficient clinical response|0|||
105826790|NCT02554877|365024312|FG003|Overall Study|Insufficient clinical response|0|||
105826791|NCT02554877|365024309|FG000|Overall Study|No longer willing to participate|0|||
105826792|NCT02554877|365024310|FG001|Overall Study|No longer willing to participate|2|||
105826793|NCT02554877|365024311|FG002|Overall Study|No longer willing to participate|2|||
105826794|NCT02554877|365024312|FG003|Overall Study|No longer willing to participate|0|||
105826795|NCT00274651|365024313|FG000|Overall Study|Adverse Event|6|||
105826796|NCT00274651|365024314|FG001|Overall Study|Adverse Event|3|||
105826797|NCT00274651|365024313|FG000|Overall Study|Lack of Efficacy|13|||
105826798|NCT00274651|365024314|FG001|Overall Study|Lack of Efficacy|6|||
105826799|NCT00274651|365024313|FG000|Overall Study|Death|1|||
105826800|NCT00274651|365024314|FG001|Overall Study|Death|3|||
105826801|NCT00274651|365024313|FG000|Overall Study|Withdrawal by Subject|0|||
105826802|NCT00274651|365024314|FG001|Overall Study|Withdrawal by Subject|1|||
105826803|NCT00274651|365024313|FG000|Overall Study|Physician Decision|8|||
105826804|NCT00274651|365024314|FG001|Overall Study|Physician Decision|7|||
105826805|NCT00918645|365024315|FG000|Overall Study|Withdrawal by Subject|1|||
105826806|NCT00107991|365024316|FG000|Eligibility Assessment|Disease not severe enough|7|||
105826807|NCT00107991|365024316|FG000|Eligibility Assessment|Unwilling to participate|7|||
105826808|NCT00107991|365024316|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
105826809|NCT00107991|365024316|FG000|Eligibility Assessment|Abnormal labs|2|||
105826810|NCT00107991|365024316|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
105826811|NCT00107991|365024316|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
105826812|NCT00107991|365024316|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
105826813|NCT00107991|365024316|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
105826814|NCT00107991|365024316|FG000|12 Week Treatment Period|Adverse Event|1|||
105826815|NCT00107991|365024316|FG000|12 Week Treatment Period|Protocol Violation|1|||
105826816|NCT00107991|365024316|FG000|12 Week Treatment Period|Incarcerated|1|||
105826817|NCT00107991|365024316|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
105826818|NCT04547192|365024317|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
105826819|NCT04547192|365024318|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
105826820|NCT04547192|365024319|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
105961952|NCT02628600|365521096|FG001|Overall Study|Lost to Follow-up|0|||
105961953|NCT02628600|365521095|FG000|Overall Study|Physician Decision|2|||
105961954|NCT02628600|365521096|FG001|Overall Study|Physician Decision|2|||
105961955|NCT02628600|365521095|FG000|Overall Study|Other not specified|1|||
105961956|NCT02628600|365521096|FG001|Overall Study|Other not specified|0|||
105961957|NCT03206918|365521101|FG000|Overall Study|Death|11|||
105961958|NCT03206918|365521101|FG000|Overall Study|Withdrawal by Subject|5|||
105961959|NCT03206918|365521101|FG000|Overall Study|Study terminated by sponsor|12|||
105961960|NCT03206918|365521101|FG000|Overall Study|Lost to Follow-up|3|||
105961961|NCT03206918|365521101|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
105961962|NCT01673854|365521107|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
105961963|NCT01673854|365521107|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
105961964|NCT01673854|365521107|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
105961965|NCT01673854|365521107|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
105961966|NCT01673854|365521107|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
105961967|NCT01673854|365521107|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
105961968|NCT01673854|365521107|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
105961969|NCT01673854|365521107|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
105961970|NCT01673854|365521107|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
105961971|NCT01673854|365521107|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
105961972|NCT01673854|365521107|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
105961973|NCT01673854|365521107|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
105961974|NCT00583752|365521108|FG000|Overall Study|Lost to Follow-up|5|||
105961975|NCT00583752|365521109|FG001|Overall Study|Lost to Follow-up|5|||
105961976|NCT02316353|365521110|FG000|Overall Study|Pregnancy|1|||
105961977|NCT02316353|365521111|FG001|Overall Study|Pregnancy|3|||
105961978|NCT02316353|365521110|FG000|Overall Study|Adverse Event|1|||
105961979|NCT02316353|365521111|FG001|Overall Study|Adverse Event|3|||
105961980|NCT02316353|365521110|FG000|Overall Study|Withdrawal by Subject|6|||
105961981|NCT02316353|365521111|FG001|Overall Study|Withdrawal by Subject|2|||
105961982|NCT02644096|365521112|FG000|Overall Study|Withdrawal by Subject|28|||
105961983|NCT02644096|365521113|FG001|Overall Study|Withdrawal by Subject|25|||
105961984|NCT02147197|365521117|FG000|Overall Study|Adverse Event|1|||
105961985|NCT02147197|365521118|FG001|Overall Study|Adverse Event|0|||
105961986|NCT02147197|365521119|FG002|Overall Study|Adverse Event|0|||
105961987|NCT02147197|365521117|FG000|Overall Study|Withdrawal of Consent|4|||
105961988|NCT02147197|365521118|FG001|Overall Study|Withdrawal of Consent|3|||
105961989|NCT02147197|365521119|FG002|Overall Study|Withdrawal of Consent|2|||
105961990|NCT02147197|365521117|FG000|Overall Study|Lost to Follow-up|2|||
105961991|NCT02147197|365521118|FG001|Overall Study|Lost to Follow-up|3|||
105961992|NCT02147197|365521119|FG002|Overall Study|Lost to Follow-up|1|||
105961993|NCT02147197|365521117|FG000|Overall Study|Protocol Violation|1|||
105961994|NCT02147197|365521118|FG001|Overall Study|Protocol Violation|0|||
105961995|NCT02147197|365521119|FG002|Overall Study|Protocol Violation|3|||
105961996|NCT02147197|365521117|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105961997|NCT02147197|365521118|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105961998|NCT02147197|365521119|FG002|Overall Study|Other Miscellaneous Reasons|3|||
105961999|NCT01700959|365521120|FG000|Overall Study|Adverse Event|0|||
105962000|NCT01700959|365521121|FG001|Overall Study|Adverse Event|1|||
105962001|NCT01700959|365521122|FG002|Overall Study|Adverse Event|1|||
105962002|NCT01700959|365521123|FG003|Overall Study|Adverse Event|2|||
105962003|NCT01700959|365521124|FG004|Overall Study|Adverse Event|0|||
105962004|NCT01700959|365521125|FG005|Overall Study|Adverse Event|2|||
105962005|NCT01700959|365521120|FG000|Overall Study|Withdrawal by Subject|15|||
105962006|NCT01700959|365521121|FG001|Overall Study|Withdrawal by Subject|9|||
105962007|NCT01700959|365521122|FG002|Overall Study|Withdrawal by Subject|12|||
105962008|NCT01700959|365521123|FG003|Overall Study|Withdrawal by Subject|11|||
105962009|NCT01700959|365521124|FG004|Overall Study|Withdrawal by Subject|8|||
105962010|NCT01700959|365521125|FG005|Overall Study|Withdrawal by Subject|12|||
105962011|NCT01700959|365521120|FG000|Overall Study|Ineligible|2|||
105962012|NCT01700959|365521121|FG001|Overall Study|Ineligible|1|||
105962013|NCT01700959|365521122|FG002|Overall Study|Ineligible|2|||
105962014|NCT01700959|365521123|FG003|Overall Study|Ineligible|0|||
105962015|NCT01700959|365521124|FG004|Overall Study|Ineligible|0|||
106022180|NCT01192191|365746771|FG001|Overall Study|Lost to Follow-up|1|||
105962016|NCT01700959|365521125|FG005|Overall Study|Ineligible|1|||
105962017|NCT01700959|365521120|FG000|Overall Study|Noncompliant|9|||
105962018|NCT01700959|365521121|FG001|Overall Study|Noncompliant|9|||
105962019|NCT01700959|365521122|FG002|Overall Study|Noncompliant|17|||
105962020|NCT01700959|365521123|FG003|Overall Study|Noncompliant|18|||
105962021|NCT01700959|365521124|FG004|Overall Study|Noncompliant|15|||
105962022|NCT01700959|365521125|FG005|Overall Study|Noncompliant|9|||
105962023|NCT01700959|365521120|FG000|Overall Study|Side effects|1|||
105962024|NCT01700959|365521121|FG001|Overall Study|Side effects|4|||
105962025|NCT01700959|365521122|FG002|Overall Study|Side effects|8|||
105962026|NCT01700959|365521123|FG003|Overall Study|Side effects|4|||
105826821|NCT04547192|365024320|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
105826822|NCT04547192|365024317|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
105826823|NCT04547192|365024318|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
105826824|NCT04547192|365024319|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
105826825|NCT04547192|365024320|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
105826826|NCT04547192|365024317|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
105826827|NCT04547192|365024318|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
105826828|NCT04547192|365024319|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
105826829|NCT04547192|365024320|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
105826830|NCT04547192|365024317|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
105826831|NCT04547192|365024318|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
105826832|NCT04547192|365024319|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
105826833|NCT04547192|365024320|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
105826834|NCT04547192|365024317|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
105826835|NCT04547192|365024318|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
105826836|NCT04547192|365024319|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
105826837|NCT04547192|365024320|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
105826838|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
105826839|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
105826840|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
105826841|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
105826842|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
105826843|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
105826844|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
105826845|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
105826846|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
105826847|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
105826848|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
105826849|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
105826850|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
105826851|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
105826852|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
105826853|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
105826854|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
105826855|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
105826856|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
105826857|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
105826858|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
105826859|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
105826860|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
105826861|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
105826862|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
105826863|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
105826864|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
105826865|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
105826866|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
105826867|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
105826868|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
105826869|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
105826870|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
105826871|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
105826872|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
105962027|NCT01700959|365521124|FG004|Overall Study|Side effects|4|||
105962028|NCT01700959|365521125|FG005|Overall Study|Side effects|1|||
105962029|NCT00830375|365521126|FG000|Overall Study|Lost to Follow-up|1|||
105826873|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
105826874|NCT04194801|365024321|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
105826875|NCT04194801|365024322|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
105826876|NCT04194801|365024323|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
105826877|NCT04194801|365024321|FG000|Part Ib/II End of Study|Death|2|||
105826878|NCT04194801|365024322|FG001|Part Ib/II End of Study|Death|3|||
105826879|NCT04194801|365024323|FG002|Part Ib/II End of Study|Death|3|||
105826880|NCT04194801|365024321|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
105962030|NCT04308239|365523041|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
105962031|NCT04308239|365523042|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
105962032|NCT04308239|365523041|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
105962033|NCT04308239|365523042|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
106147784|NCT00785512|366202446|FG000|Overall Study|Physician Decision|0|||
105962034|NCT04308239|365523041|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
105962035|NCT04308239|365523042|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
105962036|NCT04308239|365523041|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
105962037|NCT04308239|365523042|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
105962038|NCT02403817|365523043|FG000|Overall Study|Withdrawal by Subject|5|||
105962039|NCT02403817|365523044|FG001|Overall Study|Withdrawal by Subject|0|||
105962040|NCT01436656|365523045|FG000|Dose Escalation|Death|1|||
105962041|NCT01436656|365523046|FG001|Dose Escalation|Death|3|||
105962042|NCT01436656|365523047|FG002|Dose Escalation|Death|1|||
105962043|NCT01436656|365523048|FG003|Dose Escalation|Death|0|||
105962044|NCT01436656|365523049|FG004|Dose Escalation|Death|2|||
105962045|NCT01436656|365523050|FG005|Dose Escalation|Death|1|||
105962046|NCT01436656|365523051|FG006|Dose Escalation|Death|1|||
105962047|NCT01436656|365523052|FG007|Dose Escalation|Death|1|||
105962048|NCT01436656|365523053|FG008|Dose Escalation|Death|1|||
105962049|NCT01436656|365523054|FG009|Dose Escalation|Death|0|||
105962050|NCT01436656|365523055|FG010|Dose Escalation|Death|0|||
105962051|NCT01436656|365523056|FG011|Dose Escalation|Death|0|||
105962052|NCT01436656|365523057|FG012|Dose Escalation|Death|0|||
106147785|NCT00785512|366202447|FG001|Overall Study|Physician Decision|0|||
105826881|NCT04194801|365024322|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
105962053|NCT01436656|365523058|FG013|Dose Escalation|Death|0|||
105962054|NCT01436656|365523059|FG014|Dose Escalation|Death|0|||
105962055|NCT01436656|365523060|FG015|Dose Escalation|Death|0|||
106022181|NCT01192191|365746770|FG000|Overall Study|Withdrawal by Subject|1|||
105768717|NCT02201251|364804513|FG001|Overall Study|Adverse Event|1|||
105768718|NCT02201251|364804512|FG000|Overall Study|Protocol Violation|1|||
105768719|NCT02201251|364804513|FG001|Overall Study|Protocol Violation|0|||
105768720|NCT02201251|364804512|FG000|Overall Study|Noncompliance with Study Drug|0|||
105768721|NCT02201251|364804513|FG001|Overall Study|Noncompliance with Study Drug|1|||
105768722|NCT02201251|364804512|FG000|Overall Study|Withdrawal by Subject|2|||
105768723|NCT02201251|364804513|FG001|Overall Study|Withdrawal by Subject|1|||
105768724|NCT01819194|364804514|FG000|Overall Study|Loss of study articles|2|||
105768725|NCT00023712|364804519|FG000|Overall Study|Not platinum sensitive|1|||
105768726|NCT00023712|364804520|FG001|Overall Study|Not platinum sensitive|0|||
105768727|NCT00023712|364804519|FG000|Overall Study|Never treated|1|||
105768728|NCT00023712|364804520|FG001|Overall Study|Never treated|1|||
105768729|NCT02392468|364804521|FG000|Overall Study|Adverse Event|0|||
105768730|NCT02392468|364804522|FG001|Overall Study|Adverse Event|1|||
105768731|NCT02392468|364804523|FG002|Overall Study|Adverse Event|0|||
105768732|NCT02392468|364804524|FG003|Overall Study|Adverse Event|0|||
105768733|NCT02392468|364804525|FG004|Overall Study|Adverse Event|0|||
105768734|NCT02392468|364804526|FG005|Overall Study|Adverse Event|1|||
105768735|NCT01039428|364804527|FG000|Overall Study|Protocol Violation|1|||
105768736|NCT01039428|364804528|FG001|Overall Study|Protocol Violation|0|||
105768737|NCT01039428|364804527|FG000|Overall Study|Withdrawal by Subject|1|||
105768738|NCT01039428|364804528|FG001|Overall Study|Withdrawal by Subject|0|||
105768739|NCT01922739|364804533|FG000|Titration/Adjustment Period|Adverse Event|3|||
105768740|NCT01922739|364804533|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
105768741|NCT01922739|364804533|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
105768742|NCT01922739|364804533|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
105768743|NCT01922739|364804533|FG000|Open-label Treatment Period|Adverse Event|6|||
105768744|NCT01922739|364804533|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
105768745|NCT01922739|364804533|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
105768746|NCT01922739|364804533|FG000|Open-label Treatment Period|Protocol Violation|5|||
105768747|NCT01922739|364804533|FG000|Open-label Treatment Period|Pregnancy|1|||
105768748|NCT01922739|364804533|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
105768749|NCT01922739|364804533|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
105768750|NCT01922739|364804533|FG000|Open-label Treatment Period|Physician Decision|1|||
105768751|NCT01922739|364804533|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
105768752|NCT01624467|364804535|FG000|Overall Study|Withdrawal by Subject|2|||
105768753|NCT01624467|364804535|FG000|Overall Study|Lost to Follow-up|1|||
105768754|NCT01624467|364804535|FG000|Overall Study|Adverse Event|7|||
105768755|NCT01624467|364804535|FG000|Overall Study|Progressive Disease|19|||
105768756|NCT01624467|364804535|FG000|Overall Study|Per Sponsor Requirement|1|||
105768757|NCT01624467|364804535|FG000|Overall Study|Subject Withdrew from Treatment|1|||
105768758|NCT04498468|364804536|FG000|Overall Study|Lost to Follow-up|3|||
105768759|NCT03399786|364804539|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
105768760|NCT03399786|364804540|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105768761|NCT03399786|364804541|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105768762|NCT03399786|364804542|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
105768763|NCT03399786|364804539|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
105768764|NCT03399786|364804540|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
105962056|NCT01436656|365523061|FG016|Dose Escalation|Death|0|||
105962057|NCT01436656|365523062|FG017|Dose Escalation|Death|0|||
105962058|NCT01436656|365523045|FG000|Dose Escalation|Protocol Violation|0|||
105962059|NCT01436656|365523046|FG001|Dose Escalation|Protocol Violation|0|||
105962060|NCT01436656|365523047|FG002|Dose Escalation|Protocol Violation|0|||
105962061|NCT01436656|365523048|FG003|Dose Escalation|Protocol Violation|0|||
105962062|NCT01436656|365523049|FG004|Dose Escalation|Protocol Violation|0|||
105962063|NCT01436656|365523050|FG005|Dose Escalation|Protocol Violation|1|||
105962064|NCT01436656|365523051|FG006|Dose Escalation|Protocol Violation|0|||
105962065|NCT01436656|365523052|FG007|Dose Escalation|Protocol Violation|0|||
105962066|NCT01436656|365523053|FG008|Dose Escalation|Protocol Violation|0|||
105962067|NCT01436656|365523054|FG009|Dose Escalation|Protocol Violation|0|||
105962068|NCT01436656|365523055|FG010|Dose Escalation|Protocol Violation|0|||
105962069|NCT01436656|365523056|FG011|Dose Escalation|Protocol Violation|0|||
105962070|NCT01436656|365523057|FG012|Dose Escalation|Protocol Violation|0|||
105962071|NCT01436656|365523058|FG013|Dose Escalation|Protocol Violation|0|||
105962072|NCT01436656|365523059|FG014|Dose Escalation|Protocol Violation|0|||
105962073|NCT01436656|365523060|FG015|Dose Escalation|Protocol Violation|0|||
105962074|NCT01436656|365523061|FG016|Dose Escalation|Protocol Violation|0|||
105962075|NCT01436656|365523062|FG017|Dose Escalation|Protocol Violation|0|||
105962076|NCT01436656|365523045|FG000|Dose Escalation|Withdrawal by Subject|0|||
105962077|NCT01436656|365523046|FG001|Dose Escalation|Withdrawal by Subject|0|||
105962078|NCT01436656|365523047|FG002|Dose Escalation|Withdrawal by Subject|0|||
105962079|NCT01436656|365523048|FG003|Dose Escalation|Withdrawal by Subject|0|||
105962080|NCT01436656|365523049|FG004|Dose Escalation|Withdrawal by Subject|1|||
105962081|NCT01436656|365523050|FG005|Dose Escalation|Withdrawal by Subject|0|||
105962082|NCT01436656|365523051|FG006|Dose Escalation|Withdrawal by Subject|0|||
105962083|NCT01436656|365523052|FG007|Dose Escalation|Withdrawal by Subject|2|||
105962084|NCT01436656|365523053|FG008|Dose Escalation|Withdrawal by Subject|0|||
105962085|NCT01436656|365523054|FG009|Dose Escalation|Withdrawal by Subject|1|||
105962086|NCT01436656|365523055|FG010|Dose Escalation|Withdrawal by Subject|1|||
105962087|NCT01436656|365523056|FG011|Dose Escalation|Withdrawal by Subject|0|||
105962088|NCT01436656|365523057|FG012|Dose Escalation|Withdrawal by Subject|0|||
105962089|NCT01436656|365523058|FG013|Dose Escalation|Withdrawal by Subject|0|||
105962090|NCT01436656|365523059|FG014|Dose Escalation|Withdrawal by Subject|0|||
106022182|NCT01192191|365746771|FG001|Overall Study|Withdrawal by Subject|6|||
105826882|NCT04194801|365024323|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
106022183|NCT01047553|365746773|FG000|Overall Study|Adverse Event|10|||
106022184|NCT01047553|365746774|FG001|Overall Study|Adverse Event|5|||
106022185|NCT01047553|365746773|FG000|Overall Study|Withdrawal by Subject|4|||
106022186|NCT01047553|365746774|FG001|Overall Study|Withdrawal by Subject|2|||
106022187|NCT01047553|365746773|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
106022188|NCT01047553|365746774|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
106022189|NCT01047553|365746773|FG000|Overall Study|Lost to Follow-up|1|||
106022190|NCT01047553|365746774|FG001|Overall Study|Lost to Follow-up|0|||
106022191|NCT01047553|365746773|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
106022192|NCT01047553|365746774|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
106022193|NCT01047553|365746773|FG000|Overall Study|PI's decision|0|||
106022194|NCT01047553|365746774|FG001|Overall Study|PI's decision|1|||
106022195|NCT05343624|365746775|FG000|Overall Study|Chart review not completed|1|||
106022196|NCT00223080|365746782|FG000|Overall Study|Withdrawal by Subject|253|||
106022197|NCT00223080|365746783|FG001|Overall Study|Withdrawal by Subject|232|||
106022198|NCT00223080|365746782|FG000|Overall Study|Required contraindicated med|0|||
106022199|NCT00223080|365746783|FG001|Overall Study|Required contraindicated med|1|||
106022200|NCT00223080|365746782|FG000|Overall Study|Non-compliant|7|||
106022201|NCT00223080|365746783|FG001|Overall Study|Non-compliant|7|||
106022202|NCT00223080|365746782|FG000|Overall Study|Moved from study area|37|||
106022203|NCT00223080|365746783|FG001|Overall Study|Moved from study area|47|||
106022204|NCT00223080|365746782|FG000|Overall Study|Lost to Follow-up|259|||
106022205|NCT00223080|365746783|FG001|Overall Study|Lost to Follow-up|284|||
106022206|NCT00223080|365746782|FG000|Overall Study|Death|85|||
105962091|NCT01436656|365523060|FG015|Dose Escalation|Withdrawal by Subject|0|||
105962092|NCT01436656|365523061|FG016|Dose Escalation|Withdrawal by Subject|0|||
106022207|NCT00223080|365746783|FG001|Overall Study|Death|74|||
106022208|NCT00223080|365746782|FG000|Overall Study|Other|14|||
106022209|NCT00223080|365746783|FG001|Overall Study|Other|11|||
106022210|NCT00223080|365746782|FG000|Overall Study|Reason not provided|141|||
106022211|NCT00223080|365746783|FG001|Overall Study|Reason not provided|140|||
106022212|NCT00223080|365746782|FG000|Overall Study|Adverse Event|0|||
106147786|NCT00785512|366202446|FG000|Overall Study|Lack of compliance|0|||
106147787|NCT00785512|366202447|FG001|Overall Study|Lack of compliance|1|||
106147788|NCT00546754|366202448|FG000|Overall Study|Serious Adverse Event|1|||
105962093|NCT01436656|365523062|FG017|Dose Escalation|Withdrawal by Subject|0|||
105962094|NCT01436656|365523045|FG000|Dose Escalation|Administrative problems|0|||
105962095|NCT01436656|365523046|FG001|Dose Escalation|Administrative problems|1|||
105962096|NCT01436656|365523047|FG002|Dose Escalation|Administrative problems|0|||
105962097|NCT01436656|365523048|FG003|Dose Escalation|Administrative problems|0|||
105962098|NCT01436656|365523049|FG004|Dose Escalation|Administrative problems|0|||
105962099|NCT01436656|365523050|FG005|Dose Escalation|Administrative problems|0|||
105962100|NCT01436656|365523051|FG006|Dose Escalation|Administrative problems|0|||
105962101|NCT01436656|365523052|FG007|Dose Escalation|Administrative problems|0|||
105962102|NCT01436656|365523053|FG008|Dose Escalation|Administrative problems|0|||
105962103|NCT01436656|365523054|FG009|Dose Escalation|Administrative problems|0|||
105962104|NCT01436656|365523055|FG010|Dose Escalation|Administrative problems|0|||
105962105|NCT01436656|365523056|FG011|Dose Escalation|Administrative problems|0|||
105962106|NCT01436656|365523057|FG012|Dose Escalation|Administrative problems|0|||
105962107|NCT01436656|365523058|FG013|Dose Escalation|Administrative problems|0|||
105962108|NCT01436656|365523059|FG014|Dose Escalation|Administrative problems|0|||
105962109|NCT01436656|365523060|FG015|Dose Escalation|Administrative problems|0|||
105962110|NCT01436656|365523061|FG016|Dose Escalation|Administrative problems|0|||
105962111|NCT01436656|365523062|FG017|Dose Escalation|Administrative problems|0|||
105962112|NCT01436656|365523045|FG000|Dose Escalation|Lost to Follow-up|1|||
105962113|NCT01436656|365523046|FG001|Dose Escalation|Lost to Follow-up|0|||
105962114|NCT01436656|365523047|FG002|Dose Escalation|Lost to Follow-up|0|||
105962115|NCT01436656|365523048|FG003|Dose Escalation|Lost to Follow-up|0|||
105962116|NCT01436656|365523049|FG004|Dose Escalation|Lost to Follow-up|1|||
105962117|NCT01436656|365523050|FG005|Dose Escalation|Lost to Follow-up|0|||
105962118|NCT01436656|365523051|FG006|Dose Escalation|Lost to Follow-up|0|||
105962119|NCT01436656|365523052|FG007|Dose Escalation|Lost to Follow-up|0|||
105962120|NCT01436656|365523053|FG008|Dose Escalation|Lost to Follow-up|0|||
105962121|NCT01436656|365523054|FG009|Dose Escalation|Lost to Follow-up|0|||
105962122|NCT01436656|365523055|FG010|Dose Escalation|Lost to Follow-up|0|||
105962123|NCT01436656|365523056|FG011|Dose Escalation|Lost to Follow-up|0|||
105962124|NCT01436656|365523057|FG012|Dose Escalation|Lost to Follow-up|0|||
105962125|NCT01436656|365523058|FG013|Dose Escalation|Lost to Follow-up|0|||
105962126|NCT01436656|365523059|FG014|Dose Escalation|Lost to Follow-up|0|||
105962127|NCT01436656|365523060|FG015|Dose Escalation|Lost to Follow-up|0|||
105962128|NCT01436656|365523061|FG016|Dose Escalation|Lost to Follow-up|0|||
105962129|NCT01436656|365523062|FG017|Dose Escalation|Lost to Follow-up|0|||
105962130|NCT01436656|365523045|FG000|Dose Escalation|New anti-cancer therapy|1|||
105962131|NCT01436656|365523046|FG001|Dose Escalation|New anti-cancer therapy|0|||
105962132|NCT01436656|365523047|FG002|Dose Escalation|New anti-cancer therapy|0|||
105962133|NCT01436656|365523048|FG003|Dose Escalation|New anti-cancer therapy|0|||
105962134|NCT01436656|365523049|FG004|Dose Escalation|New anti-cancer therapy|0|||
105962135|NCT01436656|365523050|FG005|Dose Escalation|New anti-cancer therapy|0|||
105962136|NCT01436656|365523051|FG006|Dose Escalation|New anti-cancer therapy|0|||
105962137|NCT01436656|365523052|FG007|Dose Escalation|New anti-cancer therapy|0|||
105962138|NCT01436656|365523053|FG008|Dose Escalation|New anti-cancer therapy|1|||
105962139|NCT01436656|365523054|FG009|Dose Escalation|New anti-cancer therapy|1|||
105962140|NCT01436656|365523055|FG010|Dose Escalation|New anti-cancer therapy|0|||
105962141|NCT01436656|365523056|FG011|Dose Escalation|New anti-cancer therapy|0|||
105962142|NCT01436656|365523057|FG012|Dose Escalation|New anti-cancer therapy|0|||
105962143|NCT01436656|365523058|FG013|Dose Escalation|New anti-cancer therapy|0|||
105962144|NCT01436656|365523059|FG014|Dose Escalation|New anti-cancer therapy|0|||
105962145|NCT01436656|365523060|FG015|Dose Escalation|New anti-cancer therapy|0|||
105962146|NCT01436656|365523061|FG016|Dose Escalation|New anti-cancer therapy|0|||
105962147|NCT01436656|365523062|FG017|Dose Escalation|New anti-cancer therapy|0|||
105962148|NCT01436656|365523045|FG000|Dose Expansion|Adverse Event|0|||
105962149|NCT01436656|365523046|FG001|Dose Expansion|Adverse Event|0|||
105962150|NCT01436656|365523047|FG002|Dose Expansion|Adverse Event|0|||
105962151|NCT01436656|365523048|FG003|Dose Expansion|Adverse Event|0|||
105962152|NCT01436656|365523049|FG004|Dose Expansion|Adverse Event|0|||
105962153|NCT01436656|365523050|FG005|Dose Expansion|Adverse Event|0|||
105962154|NCT01436656|365523051|FG006|Dose Expansion|Adverse Event|0|||
105962155|NCT01436656|365523052|FG007|Dose Expansion|Adverse Event|0|||
105962156|NCT01436656|365523053|FG008|Dose Expansion|Adverse Event|0|||
105962157|NCT01436656|365523054|FG009|Dose Expansion|Adverse Event|0|||
105962158|NCT01436656|365523055|FG010|Dose Expansion|Adverse Event|0|||
105962159|NCT01436656|365523056|FG011|Dose Expansion|Adverse Event|1|||
106022213|NCT00223080|365746783|FG001|Overall Study|Adverse Event|1|||
106022214|NCT02598583|365746784|FG000|Extension Period|Withdrawal by Subject|1|||
106022215|NCT02598583|365746785|FG001|Extension Period|Withdrawal by Subject|0|||
106022216|NCT03237286|365746786|FG000|Overall Study|Withdrawal by Subject|1|||
106022217|NCT03237286|365746787|FG001|Overall Study|Withdrawal by Subject|0|||
106022218|NCT03237286|365746788|FG002|Overall Study|Withdrawal by Subject|2|||
105962160|NCT01436656|365523057|FG012|Dose Expansion|Adverse Event|0|||
105962161|NCT01436656|365523058|FG013|Dose Expansion|Adverse Event|0|||
105962162|NCT01436656|365523059|FG014|Dose Expansion|Adverse Event|0|||
105962163|NCT01436656|365523060|FG015|Dose Expansion|Adverse Event|0|||
105962164|NCT01436656|365523061|FG016|Dose Expansion|Adverse Event|0|||
105962165|NCT01436656|365523062|FG017|Dose Expansion|Adverse Event|0|||
105962166|NCT01436656|365523045|FG000|Dose Expansion|Withdrawal by Subject|0|||
105962167|NCT01436656|365523046|FG001|Dose Expansion|Withdrawal by Subject|0|||
105962168|NCT01436656|365523047|FG002|Dose Expansion|Withdrawal by Subject|0|||
105962169|NCT01436656|365523048|FG003|Dose Expansion|Withdrawal by Subject|0|||
105826883|NCT04194801|365024321|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
105826884|NCT04194801|365024322|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
105826885|NCT04194801|365024323|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
105826886|NCT04194801|365024321|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
105826887|NCT04194801|365024322|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
105826888|NCT04194801|365024323|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
105826889|NCT04194801|365024321|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
105826890|NCT04194801|365024322|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
105826891|NCT04194801|365024323|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
105826892|NCT01923740|365024329|FG000|Overall Study|Lost to Follow-up|4|||
105826893|NCT01923740|365024330|FG001|Overall Study|Lost to Follow-up|9|||
105826894|NCT01923740|365024329|FG000|Overall Study|Withdrawal by Subject|2|||
105826895|NCT01923740|365024330|FG001|Overall Study|Withdrawal by Subject|0|||
105826896|NCT04723693|365024331|FG000|Overall Study|Withdrawal by Subject|2|||
105826897|NCT03669861|365024332|FG000|Overall Study|Disease Flare|5|||
105826898|NCT03669861|365024332|FG000|Overall Study|Lack of Efficacy|2|||
105962170|NCT01436656|365523049|FG004|Dose Expansion|Withdrawal by Subject|0|||
105962171|NCT01436656|365523050|FG005|Dose Expansion|Withdrawal by Subject|0|||
105962172|NCT01436656|365523051|FG006|Dose Expansion|Withdrawal by Subject|0|||
105962173|NCT01436656|365523052|FG007|Dose Expansion|Withdrawal by Subject|0|||
105826899|NCT00294047|365024333|FG000|Month 48|Adverse Event|28|||
105826900|NCT00294047|365024334|FG001|Month 48|Adverse Event|13|||
105826901|NCT00294047|365024333|FG000|Month 48|Protocol Violation|4|||
105826902|NCT00294047|365024334|FG001|Month 48|Protocol Violation|4|||
105962174|NCT01436656|365523053|FG008|Dose Expansion|Withdrawal by Subject|0|||
105962175|NCT01436656|365523054|FG009|Dose Expansion|Withdrawal by Subject|0|||
105962176|NCT01436656|365523055|FG010|Dose Expansion|Withdrawal by Subject|0|||
105962177|NCT01436656|365523056|FG011|Dose Expansion|Withdrawal by Subject|1|||
105962178|NCT01436656|365523057|FG012|Dose Expansion|Withdrawal by Subject|3|||
105962179|NCT01436656|365523058|FG013|Dose Expansion|Withdrawal by Subject|1|||
105962180|NCT01436656|365523059|FG014|Dose Expansion|Withdrawal by Subject|2|||
105962181|NCT01436656|365523060|FG015|Dose Expansion|Withdrawal by Subject|0|||
105962182|NCT01436656|365523061|FG016|Dose Expansion|Withdrawal by Subject|1|||
105962183|NCT01436656|365523062|FG017|Dose Expansion|Withdrawal by Subject|1|||
105962184|NCT01436656|365523045|FG000|Dose Expansion|Death|0|||
105962185|NCT01436656|365523046|FG001|Dose Expansion|Death|0|||
105962186|NCT01436656|365523047|FG002|Dose Expansion|Death|0|||
105962187|NCT01436656|365523048|FG003|Dose Expansion|Death|0|||
105962188|NCT01436656|365523049|FG004|Dose Expansion|Death|0|||
105962189|NCT01436656|365523050|FG005|Dose Expansion|Death|0|||
106022219|NCT03237286|365746786|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
106022220|NCT03237286|365746787|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
106022221|NCT03237286|365746788|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
106022222|NCT00948441|365746789|FG000|Overall Study|no longer meet inclusion criteria|1|||
106022223|NCT00948441|365746790|FG001|Overall Study|no longer meet inclusion criteria|4|||
106022224|NCT02792829|365746791|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
106022225|NCT02792829|365746792|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
106022226|NCT02792829|365746793|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
106022227|NCT02792829|365746794|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
106022228|NCT02792829|365746795|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
106022229|NCT02792829|365746796|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
106022230|NCT02792829|365746797|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
106022231|NCT02792829|365746798|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
106022232|NCT02792829|365746791|FG000|Treatment Period 2|Adverse Event|0|||
106022233|NCT02792829|365746792|FG001|Treatment Period 2|Adverse Event|0|||
106022234|NCT02792829|365746793|FG002|Treatment Period 2|Adverse Event|0|||
106022235|NCT02792829|365746794|FG003|Treatment Period 2|Adverse Event|0|||
106022236|NCT02792829|365746795|FG004|Treatment Period 2|Adverse Event|1|||
106022237|NCT02792829|365746796|FG005|Treatment Period 2|Adverse Event|0|||
106022238|NCT02792829|365746797|FG006|Treatment Period 2|Adverse Event|1|||
106022239|NCT02792829|365746798|FG007|Treatment Period 2|Adverse Event|1|||
106147789|NCT00546754|366202449|FG001|Overall Study|Serious Adverse Event|1|||
106147790|NCT00546754|366202448|FG000|Overall Study|Adverse Event|11|||
106147791|NCT00546754|366202449|FG001|Overall Study|Adverse Event|16|||
106147792|NCT00546754|366202448|FG000|Overall Study|Lack of Efficacy|1|||
106147793|NCT00546754|366202449|FG001|Overall Study|Lack of Efficacy|1|||
106147794|NCT00546754|366202448|FG000|Overall Study|Lost to Follow-up|9|||
106147795|NCT00546754|366202449|FG001|Overall Study|Lost to Follow-up|15|||
106147796|NCT00546754|366202448|FG000|Overall Study|Protocol Violation|3|||
106147797|NCT00546754|366202449|FG001|Overall Study|Protocol Violation|0|||
106147798|NCT00546754|366202448|FG000|Overall Study|Withdrawal by Subject|6|||
106147799|NCT00546754|366202449|FG001|Overall Study|Withdrawal by Subject|7|||
106147800|NCT00546754|366202448|FG000|Overall Study|Dyspnea|1|||
106147801|NCT00546754|366202449|FG001|Overall Study|Dyspnea|0|||
106147802|NCT00546754|366202448|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
106022240|NCT02792829|365746791|FG000|Treatment Period 2|Use of proscribed medications|0|||
106022241|NCT02792829|365746792|FG001|Treatment Period 2|Use of proscribed medications|0|||
106022242|NCT02792829|365746793|FG002|Treatment Period 2|Use of proscribed medications|0|||
106022243|NCT02792829|365746794|FG003|Treatment Period 2|Use of proscribed medications|0|||
106022244|NCT02792829|365746795|FG004|Treatment Period 2|Use of proscribed medications|0|||
106022245|NCT02792829|365746796|FG005|Treatment Period 2|Use of proscribed medications|0|||
106022246|NCT02792829|365746797|FG006|Treatment Period 2|Use of proscribed medications|0|||
106022247|NCT02792829|365746798|FG007|Treatment Period 2|Use of proscribed medications|1|||
106022248|NCT00947882|365746802|FG000|Overall Study|Adverse Event|0|||
106022249|NCT00947882|365746803|FG001|Overall Study|Adverse Event|1|||
106022250|NCT00947882|365746804|FG002|Overall Study|Adverse Event|4|||
106022251|NCT00947882|365746805|FG003|Overall Study|Adverse Event|4|||
106022252|NCT00947882|365746802|FG000|Overall Study|Withdrawal by Subject|2|||
106022253|NCT00947882|365746803|FG001|Overall Study|Withdrawal by Subject|0|||
106022254|NCT00947882|365746804|FG002|Overall Study|Withdrawal by Subject|8|||
106022255|NCT00947882|365746805|FG003|Overall Study|Withdrawal by Subject|2|||
106022256|NCT00947882|365746802|FG000|Overall Study|Protocol Violation|0|||
106022257|NCT00947882|365746803|FG001|Overall Study|Protocol Violation|0|||
106022258|NCT00947882|365746804|FG002|Overall Study|Protocol Violation|1|||
106022259|NCT00947882|365746805|FG003|Overall Study|Protocol Violation|0|||
106022260|NCT00947882|365746802|FG000|Overall Study|Lost to Follow-up|0|||
106022261|NCT00947882|365746803|FG001|Overall Study|Lost to Follow-up|2|||
106022262|NCT00947882|365746804|FG002|Overall Study|Lost to Follow-up|1|||
106022263|NCT00947882|365746805|FG003|Overall Study|Lost to Follow-up|0|||
106022264|NCT00947882|365746802|FG000|Overall Study|Other/Unknown|10|||
106022265|NCT00947882|365746803|FG001|Overall Study|Other/Unknown|13|||
106022266|NCT00947882|365746804|FG002|Overall Study|Other/Unknown|3|||
106022267|NCT00947882|365746805|FG003|Overall Study|Other/Unknown|6|||
105962190|NCT01436656|365523051|FG006|Dose Expansion|Death|0|||
105962191|NCT01436656|365523052|FG007|Dose Expansion|Death|0|||
105962192|NCT01436656|365523053|FG008|Dose Expansion|Death|0|||
105962193|NCT01436656|365523054|FG009|Dose Expansion|Death|0|||
105962194|NCT01436656|365523055|FG010|Dose Expansion|Death|0|||
105962195|NCT01436656|365523056|FG011|Dose Expansion|Death|0|||
105962196|NCT01436656|365523057|FG012|Dose Expansion|Death|1|||
105962197|NCT01436656|365523058|FG013|Dose Expansion|Death|0|||
105962198|NCT01436656|365523059|FG014|Dose Expansion|Death|3|||
105962199|NCT01436656|365523060|FG015|Dose Expansion|Death|0|||
105962200|NCT01436656|365523061|FG016|Dose Expansion|Death|3|||
105962201|NCT01436656|365523062|FG017|Dose Expansion|Death|3|||
105962202|NCT01436656|365523045|FG000|Dose Expansion|Lost to Follow-up|0|||
105962203|NCT01436656|365523046|FG001|Dose Expansion|Lost to Follow-up|0|||
105962204|NCT01436656|365523047|FG002|Dose Expansion|Lost to Follow-up|0|||
105962205|NCT01436656|365523048|FG003|Dose Expansion|Lost to Follow-up|0|||
105962206|NCT01436656|365523049|FG004|Dose Expansion|Lost to Follow-up|0|||
105962207|NCT01436656|365523050|FG005|Dose Expansion|Lost to Follow-up|0|||
105962208|NCT01436656|365523051|FG006|Dose Expansion|Lost to Follow-up|0|||
105962209|NCT01436656|365523052|FG007|Dose Expansion|Lost to Follow-up|0|||
105962210|NCT01436656|365523053|FG008|Dose Expansion|Lost to Follow-up|0|||
105962211|NCT01436656|365523054|FG009|Dose Expansion|Lost to Follow-up|0|||
105962212|NCT01436656|365523055|FG010|Dose Expansion|Lost to Follow-up|0|||
105962213|NCT01436656|365523056|FG011|Dose Expansion|Lost to Follow-up|0|||
105962214|NCT01436656|365523057|FG012|Dose Expansion|Lost to Follow-up|0|||
105962215|NCT01436656|365523058|FG013|Dose Expansion|Lost to Follow-up|0|||
105962216|NCT01436656|365523059|FG014|Dose Expansion|Lost to Follow-up|0|||
105962217|NCT01436656|365523060|FG015|Dose Expansion|Lost to Follow-up|0|||
106022268|NCT00947882|365746802|FG000|Overall Study|Trial Terminated by Sponsor|62|||
105962218|NCT01436656|365523061|FG016|Dose Expansion|Lost to Follow-up|0|||
106022269|NCT00947882|365746803|FG001|Overall Study|Trial Terminated by Sponsor|61|||
106022270|NCT00947882|365746804|FG002|Overall Study|Trial Terminated by Sponsor|62|||
105962219|NCT01436656|365523062|FG017|Dose Expansion|Lost to Follow-up|3|||
106147803|NCT00546754|366202449|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
106147804|NCT00546754|366202448|FG000|Overall Study|Hip Replacement|1|||
106147805|NCT00546754|366202449|FG001|Overall Study|Hip Replacement|0|||
106147806|NCT00546754|366202448|FG000|Overall Study|Suicide|1|||
106147807|NCT00546754|366202449|FG001|Overall Study|Suicide|0|||
106147808|NCT00546754|366202448|FG000|Overall Study|Missing Cooperation|1|||
106147809|NCT00546754|366202449|FG001|Overall Study|Missing Cooperation|0|||
106147810|NCT00546754|366202448|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
106147811|NCT00546754|366202449|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
106147812|NCT00546754|366202448|FG000|Overall Study|Patient's Decision|0|||
106147813|NCT00546754|366202449|FG001|Overall Study|Patient's Decision|1|||
106147814|NCT00546754|366202448|FG000|Overall Study|Missing|14|||
106147815|NCT00546754|366202449|FG001|Overall Study|Missing|7|||
106147816|NCT00529100|366202452|FG000|Overall Study|Adverse Event|0|||
106147817|NCT00529100|366202453|FG001|Overall Study|Adverse Event|5|||
106147818|NCT00529100|366202452|FG000|Overall Study|Protocol Violation|0|||
106147819|NCT00529100|366202453|FG001|Overall Study|Protocol Violation|1|||
106147820|NCT00529100|366202452|FG000|Overall Study|Progressive Disease|0|||
106147821|NCT00529100|366202453|FG001|Overall Study|Progressive Disease|1|||
106147822|NCT00529100|366202452|FG000|Overall Study|Withdrawal by Subject|0|||
106147823|NCT00529100|366202453|FG001|Overall Study|Withdrawal by Subject|1|||
106147824|NCT00529100|366202452|FG000|Overall Study|Participant Ineligibility|0|||
106147825|NCT00529100|366202453|FG001|Overall Study|Participant Ineligibility|1|||
106147826|NCT03733119|366202454|FG000|Overall Study|Physician Decision|2|||
106147827|NCT03733119|366202455|FG001|Overall Study|Physician Decision|1|||
106147828|NCT03733119|366202454|FG000|Overall Study|ineligible to treat per protocol|0|||
106147829|NCT03733119|366202455|FG001|Overall Study|ineligible to treat per protocol|1|||
106147830|NCT01943916|366202457|FG000|Overall Study|Technically invalid images|10|||
106147831|NCT01943916|366202457|FG000|Overall Study|Enrollment Failure|23|||
106147832|NCT01943916|366202457|FG000|Overall Study|Pilot Phase exclusion|100|||
106147833|NCT01943916|366202457|FG000|Overall Study|Quality Assurance Reader Fail|130|||
106147834|NCT01943916|366202457|FG000|Overall Study|Technical Failure|39|||
106147835|NCT01943916|366202457|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
106147836|NCT01943916|366202457|FG000|Overall Study|No Truth Panel Review|38|||
106147837|NCT01943916|366202457|FG000|Overall Study|Protocol Deviation|1|||
106147838|NCT05782231|366202459|FG000|Overall Study|Withdrawal by Subject|1|||
106147839|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
106147840|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
106147841|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
106147842|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
106147843|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
106147844|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
106147845|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
106147846|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
106147847|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
106147848|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
106147849|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
106147850|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
106147851|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
106147852|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
106147853|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
106147854|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
106147855|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
106147856|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
106147857|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
106147858|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
106147859|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
106147860|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
106147861|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
106147862|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
106147863|NCT00311363|366202460|FG000|24-Week Single-Blind Treatment Period|Death|1|||
106147864|NCT00311363|366202461|FG001|24-Week Single-Blind Treatment Period|Death|0|||
106147865|NCT00311363|366202462|FG002|24-Week Single-Blind Treatment Period|Death|0|||
106147866|NCT00311363|366202460|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
106147867|NCT00311363|366202461|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
106147868|NCT00311363|366202462|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
106147869|NCT00311363|366202460|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
106147870|NCT00311363|366202461|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
106147871|NCT00311363|366202462|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
106147872|NCT00311363|366202460|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
106147873|NCT00311363|366202461|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
106147874|NCT00311363|366202462|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
106147875|NCT00311363|366202460|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
106147876|NCT00311363|366202461|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
106147877|NCT00311363|366202462|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
106147878|NCT00311363|366202460|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
106147879|NCT00311363|366202461|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
106147880|NCT00311363|366202462|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
106147881|NCT00311363|366202460|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
106147882|NCT00311363|366202461|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
106147883|NCT00311363|366202462|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
106147884|NCT03830866|366202463|FG000|Overall Study|Death|90|||
106147885|NCT03830866|366202464|FG001|Overall Study|Death|111|||
106147886|NCT03830866|366202463|FG000|Overall Study|Lost to Follow-up|7|||
106147887|NCT03830866|366202464|FG001|Overall Study|Lost to Follow-up|7|||
106147888|NCT03830866|366202463|FG000|Overall Study|Withdrawal by Subject|19|||
106147889|NCT03830866|366202464|FG001|Overall Study|Withdrawal by Subject|16|||
106147890|NCT03830866|366202463|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
106147891|NCT03830866|366202464|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
106147892|NCT03830866|366202463|FG000|Overall Study|Other|1|||
106147893|NCT03830866|366202464|FG001|Overall Study|Other|1|||
106147894|NCT02708108|366202465|FG000|Overall Study|Death|1|||
106147895|NCT02708108|366202466|FG001|Overall Study|Death|2|||
105826903|NCT00294047|365024333|FG000|Month 48|Withdrawal by Subject|111|||
105826904|NCT00294047|365024334|FG001|Month 48|Withdrawal by Subject|115|||
105826905|NCT00294047|365024333|FG000|Month 48|Lost to Follow-up|272|||
105826906|NCT00294047|365024334|FG001|Month 48|Lost to Follow-up|287|||
105826907|NCT00294047|365024333|FG000|Month 48|Other|10|||
105826908|NCT00294047|365024334|FG001|Month 48|Other|14|||
105826909|NCT00294047|365024333|FG000|Month 84|Adverse Event|4|||
105826910|NCT00294047|365024334|FG001|Month 84|Adverse Event|2|||
105826911|NCT00294047|365024333|FG000|Month 84|Protocol Violation|1|||
105826912|NCT00294047|365024334|FG001|Month 84|Protocol Violation|1|||
105826913|NCT00294047|365024333|FG000|Month 84|Withdrawal by Subject|33|||
105826914|NCT00294047|365024334|FG001|Month 84|Withdrawal by Subject|31|||
105826915|NCT00294047|365024333|FG000|Month 84|Lost to Follow-up|187|||
105826916|NCT00294047|365024334|FG001|Month 84|Lost to Follow-up|190|||
105826917|NCT00294047|365024333|FG000|Month 84|Absent Cervix|2|||
105826918|NCT00294047|365024334|FG001|Month 84|Absent Cervix|0|||
105826919|NCT00294047|365024333|FG000|Month 84|Work related reasons|4|||
105826920|NCT00294047|365024334|FG001|Month 84|Work related reasons|2|||
105826921|NCT00294047|365024333|FG000|Month 84|Center closed, subject did not transfer|1|||
105826922|NCT00294047|365024334|FG001|Month 84|Center closed, subject did not transfer|0|||
105826923|NCT00294047|365024333|FG000|Month 84|Family problems|2|||
105826924|NCT00294047|365024334|FG001|Month 84|Family problems|2|||
105826925|NCT00294047|365024333|FG000|Month 84|Lack of time|3|||
105826926|NCT00294047|365024334|FG001|Month 84|Lack of time|1|||
105826927|NCT00294047|365024333|FG000|Month 84|Personal reason|2|||
106022271|NCT00947882|365746805|FG003|Overall Study|Trial Terminated by Sponsor|70|||
106022272|NCT00329797|365746806|FG000|Overall Study|Protocol Violation|1|||
106147896|NCT02708108|366202465|FG000|Overall Study|Regimen change|1|||
105826928|NCT00294047|365024334|FG001|Month 84|Personal reason|4|||
105826929|NCT00294047|365024333|FG000|Month 84|Subject does not want male physician|1|||
105962220|NCT01436656|365523045|FG000|Dose Expansion|Disease progression|0|||
105962221|NCT01436656|365523046|FG001|Dose Expansion|Disease progression|0|||
105962222|NCT01436656|365523047|FG002|Dose Expansion|Disease progression|0|||
105962223|NCT01436656|365523048|FG003|Dose Expansion|Disease progression|0|||
105962224|NCT01436656|365523049|FG004|Dose Expansion|Disease progression|0|||
105962225|NCT01436656|365523050|FG005|Dose Expansion|Disease progression|0|||
105962226|NCT01436656|365523051|FG006|Dose Expansion|Disease progression|0|||
105962227|NCT01436656|365523052|FG007|Dose Expansion|Disease progression|0|||
105962228|NCT01436656|365523053|FG008|Dose Expansion|Disease progression|0|||
105962229|NCT01436656|365523054|FG009|Dose Expansion|Disease progression|0|||
105962230|NCT01436656|365523055|FG010|Dose Expansion|Disease progression|0|||
105962231|NCT01436656|365523056|FG011|Dose Expansion|Disease progression|3|||
105962232|NCT01436656|365523057|FG012|Dose Expansion|Disease progression|1|||
105962233|NCT01436656|365523058|FG013|Dose Expansion|Disease progression|0|||
105962234|NCT01436656|365523059|FG014|Dose Expansion|Disease progression|1|||
105962235|NCT01436656|365523060|FG015|Dose Expansion|Disease progression|0|||
105962236|NCT01436656|365523061|FG016|Dose Expansion|Disease progression|0|||
105962237|NCT01436656|365523062|FG017|Dose Expansion|Disease progression|1|||
105962238|NCT01436656|365523045|FG000|Dose Expansion|New cancer therapy|0|||
105962239|NCT01436656|365523046|FG001|Dose Expansion|New cancer therapy|0|||
105962240|NCT01436656|365523047|FG002|Dose Expansion|New cancer therapy|0|||
105962241|NCT01436656|365523048|FG003|Dose Expansion|New cancer therapy|0|||
105962242|NCT01436656|365523049|FG004|Dose Expansion|New cancer therapy|0|||
105962243|NCT01436656|365523050|FG005|Dose Expansion|New cancer therapy|0|||
105962244|NCT01436656|365523051|FG006|Dose Expansion|New cancer therapy|0|||
105962245|NCT01436656|365523052|FG007|Dose Expansion|New cancer therapy|0|||
105962246|NCT01436656|365523053|FG008|Dose Expansion|New cancer therapy|0|||
105962247|NCT01436656|365523054|FG009|Dose Expansion|New cancer therapy|0|||
105962248|NCT01436656|365523055|FG010|Dose Expansion|New cancer therapy|0|||
105962249|NCT01436656|365523056|FG011|Dose Expansion|New cancer therapy|1|||
105962250|NCT01436656|365523057|FG012|Dose Expansion|New cancer therapy|1|||
105962251|NCT01436656|365523058|FG013|Dose Expansion|New cancer therapy|0|||
105962252|NCT01436656|365523059|FG014|Dose Expansion|New cancer therapy|2|||
105962253|NCT01436656|365523060|FG015|Dose Expansion|New cancer therapy|0|||
105962254|NCT01436656|365523061|FG016|Dose Expansion|New cancer therapy|0|||
105962255|NCT01436656|365523062|FG017|Dose Expansion|New cancer therapy|0|||
105962256|NCT01498692|365523064|FG000|Overall Study|Death|4|||
105962257|NCT01498692|365523064|FG000|Overall Study|Withdrawal by Subject|1|||
105962258|NCT01498692|365523064|FG000|Overall Study|Missed 12-month visit|3|||
105962259|NCT03050450|365523065|FG000|Overall Study|Physician Decision|1|||
105962260|NCT03050450|365523066|FG001|Overall Study|Physician Decision|0|||
105962261|NCT03050450|365523067|FG002|Overall Study|Physician Decision|0|||
105962262|NCT03050450|365523068|FG003|Overall Study|Physician Decision|0|||
105962263|NCT03050450|365523069|FG004|Overall Study|Physician Decision|0|||
105962264|NCT02707965|365523071|FG000|Overall Study|Withdrawal by Subject|0|||
105962265|NCT02707965|365523072|FG001|Overall Study|Withdrawal by Subject|0|||
105826930|NCT00294047|365024334|FG001|Month 84|Subject does not want male physician|0|||
105962266|NCT02707965|365523073|FG002|Overall Study|Withdrawal by Subject|1|||
105962267|NCT02707965|365523074|FG003|Overall Study|Withdrawal by Subject|0|||
105962268|NCT02707965|365523075|FG004|Overall Study|Withdrawal by Subject|0|||
105962269|NCT02707965|365523076|FG005|Overall Study|Withdrawal by Subject|0|||
105962270|NCT02707965|365523077|FG006|Overall Study|Withdrawal by Subject|0|||
105962271|NCT02707965|365523078|FG007|Overall Study|Withdrawal by Subject|2|||
105962272|NCT02707965|365523079|FG008|Overall Study|Withdrawal by Subject|0|||
105962273|NCT02707965|365523080|FG009|Overall Study|Withdrawal by Subject|0|||
105962274|NCT02707965|365523081|FG010|Overall Study|Withdrawal by Subject|0|||
105962275|NCT02707965|365523082|FG011|Overall Study|Withdrawal by Subject|0|||
105962276|NCT02707965|365523083|FG012|Overall Study|Withdrawal by Subject|0|||
105962277|NCT02707965|365523084|FG013|Overall Study|Withdrawal by Subject|0|||
105962278|NCT02707965|365523085|FG014|Overall Study|Withdrawal by Subject|0|||
105962279|NCT02707965|365523086|FG015|Overall Study|Withdrawal by Subject|0|||
105962280|NCT02707965|365523071|FG000|Overall Study|PI decisions|0|||
105962281|NCT02707965|365523072|FG001|Overall Study|PI decisions|0|||
105962282|NCT02707965|365523073|FG002|Overall Study|PI decisions|0|||
105962283|NCT02707965|365523074|FG003|Overall Study|PI decisions|0|||
105962284|NCT02707965|365523075|FG004|Overall Study|PI decisions|0|||
105962285|NCT02707965|365523076|FG005|Overall Study|PI decisions|0|||
105962286|NCT02707965|365523077|FG006|Overall Study|PI decisions|0|||
105962287|NCT02707965|365523078|FG007|Overall Study|PI decisions|0|||
105962288|NCT02707965|365523079|FG008|Overall Study|PI decisions|0|||
105962289|NCT02707965|365523080|FG009|Overall Study|PI decisions|0|||
105962290|NCT02707965|365523081|FG010|Overall Study|PI decisions|0|||
105962291|NCT02707965|365523082|FG011|Overall Study|PI decisions|0|||
105962292|NCT02707965|365523083|FG012|Overall Study|PI decisions|0|||
105962293|NCT02707965|365523084|FG013|Overall Study|PI decisions|0|||
105962294|NCT02707965|365523085|FG014|Overall Study|PI decisions|2|||
105962295|NCT02707965|365523086|FG015|Overall Study|PI decisions|0|||
105962296|NCT02707965|365523071|FG000|Overall Study|Protocol deviation|1|||
105962297|NCT02707965|365523072|FG001|Overall Study|Protocol deviation|1|||
105962298|NCT02707965|365523073|FG002|Overall Study|Protocol deviation|0|||
105962299|NCT02707965|365523074|FG003|Overall Study|Protocol deviation|0|||
105962300|NCT02707965|365523075|FG004|Overall Study|Protocol deviation|0|||
105962301|NCT02707965|365523076|FG005|Overall Study|Protocol deviation|0|||
105962302|NCT02707965|365523077|FG006|Overall Study|Protocol deviation|0|||
105962303|NCT02707965|365523078|FG007|Overall Study|Protocol deviation|1|||
105962304|NCT02707965|365523079|FG008|Overall Study|Protocol deviation|0|||
105962305|NCT02707965|365523080|FG009|Overall Study|Protocol deviation|0|||
105962306|NCT02707965|365523081|FG010|Overall Study|Protocol deviation|0|||
105962307|NCT02707965|365523082|FG011|Overall Study|Protocol deviation|0|||
105962308|NCT02707965|365523083|FG012|Overall Study|Protocol deviation|0|||
105962309|NCT02707965|365523084|FG013|Overall Study|Protocol deviation|0|||
105962310|NCT02707965|365523085|FG014|Overall Study|Protocol deviation|0|||
105826931|NCT00294047|365024333|FG000|Month 84|Transport reimbursement delayed|0|||
105826932|NCT00294047|365024334|FG001|Month 84|Transport reimbursement delayed|1|||
105962311|NCT02707965|365523086|FG015|Overall Study|Protocol deviation|0|||
105962312|NCT00576628|365523087|FG000|Overall Study|Adverse Event|11|||
105962313|NCT00576628|365523087|FG000|Overall Study|Death|2|||
105962314|NCT00576628|365523087|FG000|Overall Study|Failure to return|1|||
105962315|NCT00576628|365523087|FG000|Overall Study|Refused Treatment|8|||
105962316|NCT00576628|365523087|FG000|Overall Study|Pregnancy|1|||
105962317|NCT00576628|365523087|FG000|Overall Study|RBC transfusion|1|||
105962318|NCT00576628|365523087|FG000|Overall Study|Progression of Kidney Disease|1|||
105962319|NCT00576628|365523087|FG000|Overall Study|Progression of Renal Failure|1|||
105962320|NCT00576628|365523087|FG000|Overall Study|The patient move into other town|1|||
105962321|NCT00576628|365523087|FG000|Overall Study|Transplantation|1|||
105962322|NCT00576628|365523087|FG000|Overall Study|Dialysis|15|||
105962323|NCT00249808|365523088|FG000|Overall Study|Other|27|||
105826933|NCT00294047|365024333|FG000|Month 84|Unable to reach study site|1|||
105826934|NCT00294047|365024334|FG001|Month 84|Unable to reach study site|0|||
105826935|NCT00294047|365024333|FG000|Month 84|Under investigation locally|1|||
105826936|NCT00294047|365024334|FG001|Month 84|Under investigation locally|0|||
105826937|NCT00294047|365024333|FG000|Month 84|Visit missed|0|||
105826938|NCT00294047|365024334|FG001|Month 84|Visit missed|1|||
105826939|NCT00294047|365024333|FG000|Month 84|No consent for Month 84 Follow-up|731|||
105826940|NCT00294047|365024334|FG001|Month 84|No consent for Month 84 Follow-up|754|||
105826941|NCT02157974|365024335|FG000|Overall Study|Withdrawal by Subject|0|||
105826942|NCT02157974|365024336|FG001|Overall Study|Withdrawal by Subject|1|||
105826943|NCT02157974|365024337|FG002|Overall Study|Withdrawal by Subject|0|||
105826944|NCT02157974|365024338|FG003|Overall Study|Withdrawal by Subject|0|||
105826945|NCT02157974|365024339|FG004|Overall Study|Withdrawal by Subject|0|||
105826946|NCT02157974|365024335|FG000|Overall Study|Screen Failure|0|||
105826947|NCT02157974|365024336|FG001|Overall Study|Screen Failure|1|||
105826948|NCT02157974|365024337|FG002|Overall Study|Screen Failure|0|||
105826949|NCT02157974|365024338|FG003|Overall Study|Screen Failure|0|||
105826950|NCT02157974|365024339|FG004|Overall Study|Screen Failure|0|||
105826951|NCT02157974|365024335|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
105826952|NCT02157974|365024336|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
105826953|NCT02157974|365024337|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
105826954|NCT02157974|365024338|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
105962324|NCT00249808|365523088|FG000|Overall Study|Protocol Violation|3|||
105962325|NCT00249808|365523088|FG000|Overall Study|Lost to Follow-up|8|||
105962326|NCT00249808|365523088|FG000|Overall Study|Adverse Event|81|||
105962327|NCT00249808|365523088|FG000|Overall Study|Lack of Efficacy|52|||
105962328|NCT00249808|365523088|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
105962329|NCT01576146|365523089|FG000|Extension Period 1|Adverse Event|2|||
105962330|NCT01576146|365523089|FG000|Extension Period 1|Death|2|||
105962331|NCT01576146|365523089|FG000|Extension Period 1|Physician Decision|2|||
105962332|NCT01576146|365523089|FG000|Extension Period 1|Withdrawal by Subject|1|||
105962333|NCT01576146|365523089|FG000|Extension Period 1|Lost to Follow-up|1|||
105962334|NCT01576146|365523089|FG000|Extension Period 1|Parathyroidectomy|1|||
105962335|NCT01576146|365523089|FG000|Extension Period 1|Renal Transplant|1|||
105962336|NCT01576146|365523089|FG000|Extension Period 2|Sponsor Decision|13|||
105962337|NCT01576146|365523089|FG000|Extension Period 2|Death|1|||
105962338|NCT01576146|365523089|FG000|Extension Period 2|Adverse Event|1|||
105962339|NCT01576146|365523089|FG000|Extension Period 2|Renal Transplant|1|||
105962340|NCT01576146|365523089|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
105962341|NCT02516982|365523090|FG000|Overall Study|Called in to antenatal appointment|32|||
105962342|NCT02516982|365523091|FG001|Overall Study|Called in to antenatal appointment|35|||
105962343|NCT02516982|365523092|FG002|Overall Study|Called in to antenatal appointment|0|||
105962344|NCT02516982|365523093|FG003|Overall Study|Called in to antenatal appointment|0|||
105962345|NCT02516982|365523090|FG000|Overall Study|Withdrawal by Subject|0|||
105962346|NCT02516982|365523091|FG001|Overall Study|Withdrawal by Subject|0|||
105962347|NCT02516982|365523092|FG002|Overall Study|Withdrawal by Subject|1|||
105962348|NCT02516982|365523093|FG003|Overall Study|Withdrawal by Subject|2|||
105962349|NCT02516982|365523090|FG000|Overall Study|Protocol Violation|0|||
105962350|NCT02516982|365523091|FG001|Overall Study|Protocol Violation|0|||
105962351|NCT02516982|365523092|FG002|Overall Study|Protocol Violation|1|||
105962352|NCT02516982|365523093|FG003|Overall Study|Protocol Violation|1|||
105962353|NCT02516982|365523090|FG000|Overall Study|Did not install the app|0|||
105962354|NCT02516982|365523091|FG001|Overall Study|Did not install the app|0|||
105962355|NCT02516982|365523092|FG002|Overall Study|Did not install the app|46|||
105962356|NCT02516982|365523093|FG003|Overall Study|Did not install the app|47|||
105962357|NCT00443872|365523094|FG000|Overall Study|Protocol Violation|7|||
105962358|NCT00443872|365523094|FG000|Overall Study|Lost to Follow-up|2|||
105962359|NCT00443872|365523094|FG000|Overall Study|Adverse Event|8|||
105962360|NCT02789345|365523095|FG000|Overall Study|Adverse Event|0|||
105962361|NCT02789345|365523096|FG001|Overall Study|Adverse Event|0|||
105962362|NCT02789345|365523097|FG002|Overall Study|Adverse Event|1|||
105962363|NCT02789345|365523095|FG000|Overall Study|Death|0|||
105962364|NCT02789345|365523096|FG001|Overall Study|Death|0|||
105962365|NCT02789345|365523097|FG002|Overall Study|Death|1|||
105962366|NCT02789345|365523095|FG000|Overall Study|Physician Decision|2|||
105962367|NCT02789345|365523096|FG001|Overall Study|Physician Decision|0|||
105962368|NCT02789345|365523097|FG002|Overall Study|Physician Decision|1|||
105962369|NCT02789345|365523095|FG000|Overall Study|Progressive Disease|1|||
105962370|NCT02789345|365523096|FG001|Overall Study|Progressive Disease|3|||
105962371|NCT02789345|365523097|FG002|Overall Study|Progressive Disease|14|||
105962372|NCT00466947|365523099|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
105962373|NCT00466947|365523100|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
105962374|NCT00466947|365523099|FG000|Study End Analysis Period|Adverse Event|35|||
105962375|NCT00466947|365523100|FG001|Study End Analysis Period|Adverse Event|43|||
105962376|NCT00466947|365523099|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
105962377|NCT00466947|365523100|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
105962378|NCT00466947|365523099|FG000|Study End Analysis Period|Physician Decision|29|||
105962379|NCT00466947|365523100|FG001|Study End Analysis Period|Physician Decision|29|||
105962380|NCT00466947|365523099|FG000|Study End Analysis Period|Protocol Violation|9|||
105962381|NCT00466947|365523100|FG001|Study End Analysis Period|Protocol Violation|17|||
105962382|NCT00466947|365523099|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
105962383|NCT00466947|365523100|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
106022273|NCT00329797|365746807|FG001|Overall Study|Protocol Violation|0|||
106022274|NCT00329797|365746806|FG000|Overall Study|Withdrawal by Subject|6|||
106022275|NCT00329797|365746807|FG001|Overall Study|Withdrawal by Subject|6|||
106022276|NCT01026324|365746808|FG000|Follow up/Survival|Withdrawal by Subject|1|||
106022277|NCT01026324|365746809|FG001|Follow up/Survival|Withdrawal by Subject|0|||
106022278|NCT01026324|365746810|FG002|Follow up/Survival|Withdrawal by Subject|0|||
106022279|NCT00711477|365746813|FG000|Overall Study|Adverse Event|3|||
106022280|NCT00711477|365746814|FG001|Overall Study|Adverse Event|1|||
106022281|NCT00711477|365746813|FG000|Overall Study|Lost to Follow-up|0|||
106022282|NCT00711477|365746814|FG001|Overall Study|Lost to Follow-up|1|||
105962384|NCT00466947|365523099|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
105962385|NCT00466947|365523100|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
105962386|NCT00466947|365523099|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
105962387|NCT00466947|365523100|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
105962388|NCT00466947|365523099|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
105962389|NCT00466947|365523100|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
105962390|NCT03470194|365523101|FG000|Overall Study|Lost to Follow-up|11|||
105962391|NCT03470194|365523102|FG001|Overall Study|Lost to Follow-up|17|||
105962392|NCT01822899|365523103|FG000|Overall Study|Adverse Event|6|||
105962393|NCT01822899|365523104|FG001|Overall Study|Adverse Event|5|||
105962394|NCT01822899|365523103|FG000|Overall Study|Lack of Efficacy|6|||
105962395|NCT01822899|365523104|FG001|Overall Study|Lack of Efficacy|3|||
105962396|NCT01822899|365523103|FG000|Overall Study|Protocol Violation|6|||
105962397|NCT01822899|365523104|FG001|Overall Study|Protocol Violation|3|||
105962398|NCT01822899|365523103|FG000|Overall Study|Lost to Follow-up|1|||
105962399|NCT01822899|365523104|FG001|Overall Study|Lost to Follow-up|0|||
105962400|NCT01822899|365523103|FG000|Overall Study|Withdrawal by Subject|5|||
105962401|NCT01822899|365523104|FG001|Overall Study|Withdrawal by Subject|7|||
105962402|NCT02314156|365523105|FG000|Overall Study|Adverse Event|1|||
105962403|NCT02314156|365523106|FG001|Overall Study|Adverse Event|0|||
105962404|NCT02314156|365523105|FG000|Overall Study|Withdrawal by Subject|1|||
105962405|NCT02314156|365523106|FG001|Overall Study|Withdrawal by Subject|0|||
105962406|NCT01309997|365523107|FG000|Overall Study|Adverse Event|1|||
105962407|NCT01309997|365523108|FG001|Overall Study|Adverse Event|0|||
105962408|NCT01309997|365523107|FG000|Overall Study|Death|1|||
105962409|NCT01309997|365523108|FG001|Overall Study|Death|3|||
105962410|NCT01309997|365523107|FG000|Overall Study|Lack of Efficacy|2|||
105962411|NCT01309997|365523108|FG001|Overall Study|Lack of Efficacy|2|||
105962412|NCT01309997|365523107|FG000|Overall Study|Withdrawal by Subject|1|||
105962413|NCT01309997|365523108|FG001|Overall Study|Withdrawal by Subject|1|||
105962414|NCT00282087|365523109|FG000|Overall Study|Death|1|||
105962415|NCT02277691|365523110|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
105962416|NCT02277691|365523110|FG000|Overall Study|Voluntary Withdrawal|7|||
105962417|NCT02277691|365523110|FG000|Overall Study|Lack of Efficacy|5|||
105962418|NCT02277691|365523110|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
105962419|NCT03818607|365523114|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
105962420|NCT03818607|365523115|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
105962421|NCT03818607|365523114|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
105962422|NCT03818607|365523115|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
105962423|NCT03818607|365523114|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
105962424|NCT03818607|365523115|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
105962425|NCT01804049|365523116|FG000|Overall Study|Adverse Event|2|||
105962426|NCT01804049|365523117|FG001|Overall Study|Adverse Event|10|||
105962427|NCT01804049|365523116|FG000|Overall Study|Lost to Follow-up|2|||
105962428|NCT01804049|365523117|FG001|Overall Study|Lost to Follow-up|1|||
105962429|NCT01804049|365523116|FG000|Overall Study|Decreased interest/personal|4|||
105962430|NCT01804049|365523117|FG001|Overall Study|Decreased interest/personal|5|||
105962431|NCT01804049|365523116|FG000|Overall Study|Other health concerns|2|||
105962432|NCT01804049|365523117|FG001|Overall Study|Other health concerns|7|||
105962433|NCT01804049|365523116|FG000|Overall Study|Moved out of area|0|||
105962434|NCT01804049|365523117|FG001|Overall Study|Moved out of area|7|||
105962435|NCT01804049|365523116|FG000|Overall Study|other MD recommended|1|||
105962436|NCT01804049|365523117|FG001|Overall Study|other MD recommended|1|||
106147897|NCT02708108|366202466|FG001|Overall Study|Regimen change|0|||
105962437|NCT01804049|365523116|FG000|Overall Study|Enrollment in dual studies|0|||
105962438|NCT01804049|365523117|FG001|Overall Study|Enrollment in dual studies|1|||
105962439|NCT01164891|365523122|FG000|Overall Study|Disease Progression|5|||
105962440|NCT01164891|365523122|FG000|Overall Study|Adverse Event|1|||
105962441|NCT00441142|365523123|FG000|Overall Study|Adverse Event|2|||
105962442|NCT00441142|365523124|FG001|Overall Study|Adverse Event|3|||
105962443|NCT00441142|365523125|FG002|Overall Study|Adverse Event|3|||
105962444|NCT00441142|365523126|FG003|Overall Study|Adverse Event|22|||
105962445|NCT00441142|365523123|FG000|Overall Study|Lack of Efficacy|3|||
105962446|NCT00441142|365523124|FG001|Overall Study|Lack of Efficacy|3|||
105962447|NCT00441142|365523125|FG002|Overall Study|Lack of Efficacy|17|||
105962448|NCT00441142|365523126|FG003|Overall Study|Lack of Efficacy|32|||
105962449|NCT00441142|365523123|FG000|Overall Study|Withdrawal by Subject|0|||
105962450|NCT00441142|365523124|FG001|Overall Study|Withdrawal by Subject|0|||
105962451|NCT00441142|365523125|FG002|Overall Study|Withdrawal by Subject|2|||
106147898|NCT02708108|366202465|FG000|Overall Study|No MRD and no imaging available|0|||
106022283|NCT00711477|365746813|FG000|Overall Study|Noncompliance|0|||
106147899|NCT02708108|366202466|FG001|Overall Study|No MRD and no imaging available|1|||
106147900|NCT00510887|366202467|FG000|Overall Study|Lost to Follow-up|1|||
106147901|NCT03764475|366202480|FG000|Overall Study|Adverse Event|11|||
106147902|NCT03764475|366202481|FG001|Overall Study|Adverse Event|2|||
106147903|NCT03764475|366202480|FG000|Overall Study|Lost to Follow-up|24|||
105826955|NCT02157974|365024339|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
105826956|NCT01590563|365024342|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
105826957|NCT01604941|365024343|FG000|Overall Study|Adverse Event|1|||
105826958|NCT01604941|365024344|FG001|Overall Study|Adverse Event|2|||
105826959|NCT01604941|365024345|FG002|Overall Study|Adverse Event|0|||
105826960|NCT01604941|365024346|FG003|Overall Study|Adverse Event|0|||
105826961|NCT01604941|365024347|FG004|Overall Study|Adverse Event|1|||
106022284|NCT00711477|365746814|FG001|Overall Study|Noncompliance|1|||
106022285|NCT01396070|365746816|FG000|Overall Study|Withdrawal by Subject|2|||
106022286|NCT01396070|365746816|FG000|Overall Study|Death|2|||
106022287|NCT01396070|365746816|FG000|Overall Study|Adverse Event|8|||
106022288|NCT01396070|365746816|FG000|Overall Study|Physician Decision|3|||
106022289|NCT01396070|365746816|FG000|Overall Study|Lack of Efficacy|4|||
106022290|NCT01561313|365746817|FG000|Overall Study|Withdrawal by Subject|1|||
106022291|NCT01561313|365746818|FG001|Overall Study|Withdrawal by Subject|0|||
106022292|NCT01561313|365746817|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
106022293|NCT01561313|365746818|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
106022294|NCT00916929|365746819|FG000|Overall Study|Lost to Follow-up|1|||
106022295|NCT00916929|365746820|FG001|Overall Study|Lost to Follow-up|3|||
106022296|NCT00916929|365746819|FG000|Overall Study|Death|5|||
106022297|NCT00916929|365746820|FG001|Overall Study|Death|10|||
106022298|NCT00916929|365746819|FG000|Overall Study|Withdrawal by Subject|1|||
106022299|NCT00916929|365746820|FG001|Overall Study|Withdrawal by Subject|5|||
106022300|NCT00916929|365746819|FG000|Overall Study|Left ventricular epicardial lead|1|||
106022301|NCT00916929|365746820|FG001|Overall Study|Left ventricular epicardial lead|2|||
106022302|NCT00916929|365746819|FG000|Overall Study|Transferred to hospice care|1|||
106022303|NCT00916929|365746820|FG001|Overall Study|Transferred to hospice care|1|||
106022304|NCT00916929|365746819|FG000|Overall Study|System explant|1|||
106022305|NCT00916929|365746820|FG001|Overall Study|System explant|0|||
106022306|NCT00916929|365746819|FG000|Overall Study|Moved to another state|0|||
106022307|NCT00916929|365746820|FG001|Overall Study|Moved to another state|1|||
106022308|NCT00916929|365746819|FG000|Overall Study|Device unable to process impedance data|0|||
106022309|NCT00916929|365746820|FG001|Overall Study|Device unable to process impedance data|7|||
106022310|NCT03037580|365746823|FG000|Overall Study|Withdrawal by Subject|3|||
106022311|NCT03037580|365746824|FG001|Overall Study|Withdrawal by Subject|0|||
106022312|NCT03037580|365746823|FG000|Overall Study|Adverse Event|1|||
106022313|NCT03037580|365746824|FG001|Overall Study|Adverse Event|0|||
105826962|NCT01604941|365024348|FG005|Overall Study|Adverse Event|5|||
105826963|NCT01604941|365024343|FG000|Overall Study|Non-compliance|1|||
105826964|NCT01604941|365024344|FG001|Overall Study|Non-compliance|0|||
105962452|NCT00441142|365523126|FG003|Overall Study|Withdrawal by Subject|10|||
105962453|NCT00441142|365523123|FG000|Overall Study|Patient still receiving active study tx|1|||
105962454|NCT00441142|365523124|FG001|Overall Study|Patient still receiving active study tx|0|||
105962455|NCT00441142|365523125|FG002|Overall Study|Patient still receiving active study tx|0|||
105962456|NCT00441142|365523126|FG003|Overall Study|Patient still receiving active study tx|2|||
106147904|NCT03764475|366202481|FG001|Overall Study|Lost to Follow-up|10|||
106147905|NCT03764475|366202480|FG000|Overall Study|Withdrawal by Subject|26|||
106147906|NCT03764475|366202481|FG001|Overall Study|Withdrawal by Subject|10|||
106147907|NCT03764475|366202480|FG000|Overall Study|Lack of Efficacy|3|||
106147908|NCT03764475|366202481|FG001|Overall Study|Lack of Efficacy|0|||
106147909|NCT03764475|366202480|FG000|Overall Study|COVID-19 Disruption|2|||
106147910|NCT03764475|366202481|FG001|Overall Study|COVID-19 Disruption|0|||
106147911|NCT05510245|366202482|FG000|Overall Study|Withdrawal by Subject|1|||
106147912|NCT05510245|366202483|FG001|Overall Study|Withdrawal by Subject|0|||
106147913|NCT05510245|366202484|FG002|Overall Study|Withdrawal by Subject|0|||
106147914|NCT00970359|366202488|FG000|Overall Study|Not Treated|4|||
106147915|NCT01565148|366202489|FG000|Overall Study|Withdrawal by Subject|1|||
106147916|NCT01565148|366202490|FG001|Overall Study|Withdrawal by Subject|1|||
106147917|NCT01565148|366202491|FG002|Overall Study|Withdrawal by Subject|1|||
106147918|NCT01565148|366202492|FG003|Overall Study|Withdrawal by Subject|2|||
106147919|NCT01565148|366202489|FG000|Overall Study|Lost to Follow-up|4|||
106147920|NCT01565148|366202490|FG001|Overall Study|Lost to Follow-up|4|||
106147921|NCT01565148|366202491|FG002|Overall Study|Lost to Follow-up|0|||
106147922|NCT01565148|366202492|FG003|Overall Study|Lost to Follow-up|3|||
106147923|NCT01565148|366202489|FG000|Overall Study|Rescue Therapy|8|||
106147924|NCT01565148|366202490|FG001|Overall Study|Rescue Therapy|5|||
106147925|NCT01565148|366202491|FG002|Overall Study|Rescue Therapy|5|||
106147926|NCT01565148|366202492|FG003|Overall Study|Rescue Therapy|8|||
106147927|NCT01565148|366202489|FG000|Overall Study|Death|0|||
106147928|NCT01565148|366202490|FG001|Overall Study|Death|0|||
106147929|NCT01565148|366202491|FG002|Overall Study|Death|1|||
106147930|NCT01565148|366202492|FG003|Overall Study|Death|0|||
106147931|NCT01565148|366202489|FG000|Overall Study|Physician Decision|2|||
106147932|NCT01565148|366202490|FG001|Overall Study|Physician Decision|5|||
106147933|NCT01565148|366202491|FG002|Overall Study|Physician Decision|0|||
106147934|NCT01565148|366202492|FG003|Overall Study|Physician Decision|0|||
106147935|NCT01759771|366202494|FG000|Overall Study|Withdrawal by Subject|1|||
106147936|NCT01759771|366202495|FG001|Overall Study|Withdrawal by Subject|1|||
106147937|NCT00068601|366202497|FG000|Overall Study|Ineligible|11|||
106147938|NCT00068601|366202498|FG001|Overall Study|Ineligible|13|||
106147939|NCT00068601|366202497|FG000|Overall Study|Not evaluable: withdrew consent|5|||
106147940|NCT00068601|366202498|FG001|Overall Study|Not evaluable: withdrew consent|4|||
106147941|NCT00068601|366202497|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
106147942|NCT00068601|366202498|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
106147943|NCT00068601|366202497|FG000|Overall Study|Death|11|||
106147944|NCT00068601|366202498|FG001|Overall Study|Death|3|||
106147945|NCT00068601|366202497|FG000|Overall Study|Lost to Follow-up|3|||
106147946|NCT00068601|366202498|FG001|Overall Study|Lost to Follow-up|2|||
106147947|NCT00068601|366202497|FG000|Overall Study|Missing primary outcome data|30|||
106147948|NCT00068601|366202498|FG001|Overall Study|Missing primary outcome data|34|||
106147949|NCT00088413|366202499|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
106147950|NCT00088413|366202500|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
106147951|NCT00088413|366202501|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
106147952|NCT00088413|366202502|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
106147953|NCT00088413|366202499|FG000|Overall Study|Adverse Events/Side Effects|0|||
106147954|NCT00088413|366202500|FG001|Overall Study|Adverse Events/Side Effects|1|||
106147955|NCT00088413|366202501|FG002|Overall Study|Adverse Events/Side Effects|1|||
106147956|NCT00088413|366202502|FG003|Overall Study|Adverse Events/Side Effects|0|||
106147957|NCT00088413|366202499|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
106147958|NCT00088413|366202500|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
106147959|NCT00088413|366202501|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
106147960|NCT00088413|366202502|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
106147961|NCT00088413|366202499|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
106147962|NCT00088413|366202500|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
106147963|NCT00088413|366202501|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
106147964|NCT00088413|366202502|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
106147965|NCT00088413|366202499|FG000|Overall Study|Death|0|||
106147966|NCT00088413|366202500|FG001|Overall Study|Death|1|||
106147967|NCT00088413|366202501|FG002|Overall Study|Death|0|||
106147968|NCT00088413|366202502|FG003|Overall Study|Death|0|||
106147969|NCT00088413|366202499|FG000|Overall Study|Progressive disease|9|||
106147970|NCT00088413|366202500|FG001|Overall Study|Progressive disease|11|||
106147971|NCT00088413|366202501|FG002|Overall Study|Progressive disease|8|||
106147972|NCT00088413|366202502|FG003|Overall Study|Progressive disease|14|||
106147973|NCT00088413|366202499|FG000|Overall Study|Other|0|||
106147974|NCT00088413|366202500|FG001|Overall Study|Other|1|||
105962457|NCT00441142|365523123|FG000|Overall Study|Physician Decision|0|||
105962458|NCT00441142|365523124|FG001|Overall Study|Physician Decision|1|||
105962459|NCT00441142|365523125|FG002|Overall Study|Physician Decision|0|||
105962460|NCT00441142|365523126|FG003|Overall Study|Physician Decision|1|||
105962461|NCT00441142|365523123|FG000|Overall Study|Death|0|||
105962462|NCT00441142|365523124|FG001|Overall Study|Death|0|||
105962463|NCT00441142|365523125|FG002|Overall Study|Death|0|||
105962464|NCT00441142|365523126|FG003|Overall Study|Death|1|||
105962465|NCT03985943|365523127|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105962466|NCT03985943|365523128|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
105826965|NCT01604941|365024345|FG002|Overall Study|Non-compliance|0|||
105826966|NCT01604941|365024346|FG003|Overall Study|Non-compliance|0|||
105826967|NCT01604941|365024347|FG004|Overall Study|Non-compliance|0|||
105826968|NCT01604941|365024348|FG005|Overall Study|Non-compliance|0|||
105826969|NCT01604941|365024343|FG000|Overall Study|Participant Decision|0|||
105826970|NCT01604941|365024344|FG001|Overall Study|Participant Decision|0|||
105826971|NCT01604941|365024345|FG002|Overall Study|Participant Decision|0|||
105826972|NCT01604941|365024346|FG003|Overall Study|Participant Decision|0|||
105826973|NCT01604941|365024347|FG004|Overall Study|Participant Decision|0|||
105826974|NCT01604941|365024348|FG005|Overall Study|Participant Decision|2|||
105826975|NCT01604941|365024343|FG000|Overall Study|Early Study Termination|9|||
105826976|NCT01604941|365024344|FG001|Overall Study|Early Study Termination|2|||
105826977|NCT01604941|365024345|FG002|Overall Study|Early Study Termination|3|||
105826978|NCT01604941|365024346|FG003|Overall Study|Early Study Termination|3|||
105826979|NCT01604941|365024347|FG004|Overall Study|Early Study Termination|0|||
105826980|NCT01604941|365024348|FG005|Overall Study|Early Study Termination|0|||
105826981|NCT02280863|365024357|FG000|Integrated Platform|Met stopping criteria|0|||
106147975|NCT00088413|366202501|FG002|Overall Study|Other|0|||
105826982|NCT02280863|365024358|FG001|Integrated Platform|Met stopping criteria|1|||
106147976|NCT00088413|366202502|FG003|Overall Study|Other|0|||
106147977|NCT00088413|366202499|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
106147978|NCT00088413|366202500|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
106147979|NCT00088413|366202501|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
106147980|NCT00088413|366202502|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
106147981|NCT03394885|366202512|FG000|Overall Study|Adverse Event|4|||
106147982|NCT03394885|366202512|FG000|Overall Study|Lack of Efficacy|1|||
106147983|NCT03394885|366202512|FG000|Overall Study|Physician Decision|1|||
106147984|NCT03394885|366202512|FG000|Overall Study|Withdrawal by Subject|8|||
106147985|NCT03394885|366202512|FG000|Overall Study|Alternative Therapy|1|||
106147986|NCT00632424|366202513|FG000|Overall Study|Disease Progression|17|||
106147987|NCT00632424|366202513|FG000|Overall Study|Study Drug Toxicity|1|||
106147988|NCT03482635|366202514|FG000|Overall Study|Lack of Efficacy|0|||
106147989|NCT03482635|366202515|FG001|Overall Study|Lack of Efficacy|0|||
106147990|NCT03482635|366202516|FG002|Overall Study|Lack of Efficacy|1|||
106147991|NCT03482635|366202517|FG003|Overall Study|Lack of Efficacy|3|||
106147992|NCT03482635|366202514|FG000|Overall Study|Adverse Event|2|||
106147993|NCT03482635|366202515|FG001|Overall Study|Adverse Event|2|||
106147994|NCT03482635|366202516|FG002|Overall Study|Adverse Event|0|||
106147995|NCT03482635|366202517|FG003|Overall Study|Adverse Event|3|||
106147996|NCT03482635|366202514|FG000|Overall Study|Withdrawal by Subject|2|||
106147997|NCT03482635|366202515|FG001|Overall Study|Withdrawal by Subject|1|||
106147998|NCT03482635|366202516|FG002|Overall Study|Withdrawal by Subject|0|||
106147999|NCT03482635|366202517|FG003|Overall Study|Withdrawal by Subject|1|||
106148000|NCT03482635|366202514|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
106148001|NCT03482635|366202515|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
106148002|NCT03482635|366202516|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
106148003|NCT03482635|366202517|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
106148004|NCT03482635|366202514|FG000|Overall Study|Not treated|0|||
106148005|NCT03482635|366202515|FG001|Overall Study|Not treated|0|||
106148006|NCT03482635|366202516|FG002|Overall Study|Not treated|0|||
106148007|NCT03482635|366202517|FG003|Overall Study|Not treated|1|||
106148008|NCT01170026|366203874|FG000|Overall Study|Lost to Follow-up|4|||
106148009|NCT01170026|366203875|FG001|Overall Study|Lost to Follow-up|2|||
106148010|NCT03783026|366203876|FG000|Treatment Phase|Adverse Event|15|||
106148011|NCT03783026|366203876|FG000|Treatment Phase|Lack of Efficacy|11|||
106148012|NCT03783026|366203876|FG000|Treatment Phase|Withdrawal by Subject|6|||
106148013|NCT03783026|366203876|FG000|Treatment Phase|Lost to Follow-up|2|||
106148014|NCT03783026|366203876|FG000|Treatment Phase|Protocol Deviation|8|||
106148015|NCT03783026|366203876|FG000|Treatment Phase|Did Not Receive Treatment|1|||
105962467|NCT03985943|365523129|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105962468|NCT03985943|365523130|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105962469|NCT03985943|365523131|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105962470|NCT03985943|365523132|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
105826983|NCT00216736|365024362|FG000|Overall Study|Lost to Follow-up|1|||
105826984|NCT00216736|365024363|FG001|Overall Study|Lost to Follow-up|1|||
105826985|NCT03158727|365024364|FG000|Overall Study|Withdrawal by Subject|2|||
105826986|NCT03158727|365024365|FG001|Overall Study|Withdrawal by Subject|6|||
105826987|NCT03158727|365024364|FG000|Overall Study|Death|11|||
105826988|NCT03158727|365024365|FG001|Overall Study|Death|12|||
105826989|NCT03158727|365024364|FG000|Overall Study|Lost to Follow-up|1|||
105826990|NCT03158727|365024365|FG001|Overall Study|Lost to Follow-up|0|||
105826991|NCT03158727|365024364|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
105826992|NCT03158727|365024365|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
105826993|NCT03158727|365024364|FG000|Overall Study|Visit 11 not done by mistake|0|||
105826994|NCT03158727|365024365|FG001|Overall Study|Visit 11 not done by mistake|1|||
105826995|NCT03158727|365024364|FG000|Overall Study|Enrolled, not treated|1|||
105826996|NCT03158727|365024365|FG001|Overall Study|Enrolled, not treated|0|||
105962471|NCT03985943|365523127|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
105962472|NCT03985943|365523128|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
105962473|NCT03985943|365523129|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105962474|NCT03985943|365523130|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105962475|NCT03985943|365523131|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105962476|NCT03985943|365523132|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105962477|NCT03985943|365523127|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
105962478|NCT03985943|365523128|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
105962479|NCT03985943|365523129|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105962480|NCT03985943|365523130|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105962481|NCT03985943|365523131|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105962482|NCT03985943|365523132|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105826997|NCT00669162|365024366|FG000|Overall Study|Withdrawal by Subject|1|||
105826998|NCT00807495|365024367|FG000|Overall Study|Adverse Event|6|||
105826999|NCT00807495|365024368|FG001|Overall Study|Adverse Event|3|||
105827000|NCT00807495|365024369|FG002|Overall Study|Adverse Event|1|||
105827001|NCT00807495|365024370|FG003|Overall Study|Adverse Event|1|||
105827002|NCT00807495|365024371|FG004|Overall Study|Adverse Event|2|||
105827003|NCT00807495|365024367|FG000|Overall Study|Withdrawal by Patient|2|||
105827004|NCT00807495|365024368|FG001|Overall Study|Withdrawal by Patient|0|||
105827005|NCT00807495|365024369|FG002|Overall Study|Withdrawal by Patient|1|||
106148016|NCT03783026|366203876|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
106148017|NCT04623008|366203877|FG000|Baseline to T2|Withdrawal by Subject|4|||
106148018|NCT04623008|366203878|FG001|Baseline to T2|Withdrawal by Subject|2|||
105827006|NCT00807495|365024370|FG003|Overall Study|Withdrawal by Patient|0|||
105827007|NCT00807495|365024371|FG004|Overall Study|Withdrawal by Patient|0|||
105827008|NCT00807495|365024367|FG000|Overall Study|Reason Not Specified|0|||
105827009|NCT00807495|365024368|FG001|Overall Study|Reason Not Specified|3|||
105827010|NCT00807495|365024369|FG002|Overall Study|Reason Not Specified|2|||
105827011|NCT00807495|365024370|FG003|Overall Study|Reason Not Specified|0|||
106148019|NCT04623008|366203877|FG000|Baseline to T3|Withdrawal by Subject|4|||
106148020|NCT04623008|366203878|FG001|Baseline to T3|Withdrawal by Subject|2|||
106148021|NCT03422276|366203879|FG000|Overall Study|Withdrawal by Subject|21|||
106148022|NCT03422276|366203880|FG001|Overall Study|Withdrawal by Subject|25|||
106148023|NCT03422276|366203881|FG002|Overall Study|Withdrawal by Subject|14|||
105827012|NCT00807495|365024371|FG004|Overall Study|Reason Not Specified|3|||
105827013|NCT01051349|365024374|FG000|Overall Study|Adverse Event|88|||
106022314|NCT03037580|365746823|FG000|Overall Study|Study Terminated by Sponsor|12|||
106022315|NCT03037580|365746824|FG001|Overall Study|Study Terminated by Sponsor|15|||
106022316|NCT03037580|365746823|FG000|Overall Study|Death|0|||
105827014|NCT01051349|365024374|FG000|Overall Study|Consent Withdrawn|54|||
105827015|NCT01051349|365024374|FG000|Overall Study|Investigator Decision|6|||
105827016|NCT01051349|365024374|FG000|Overall Study|Lost to Follow-up|6|||
105827017|NCT01051349|365024374|FG000|Overall Study|Subject non-compliance|7|||
105827018|NCT01051349|365024374|FG000|Overall Study|Reason not Specified|12|||
105827019|NCT02264977|365024385|FG000|Overall Study|Death|3|||
105827020|NCT02264977|365024385|FG000|Overall Study|Physician Decision|1|||
105827021|NCT02264977|365024385|FG000|Overall Study|Refuse to return|1|||
105827022|NCT03578809|365026355|FG000|Overall Study|Death|0|||
105827023|NCT03578809|365026356|FG001|Overall Study|Death|2|||
105827024|NCT03578809|365026357|FG002|Overall Study|Death|0|||
105827025|NCT03578809|365026358|FG003|Overall Study|Death|1|||
105827026|NCT03578809|365026355|FG000|Overall Study|Lost to Follow-up|0|||
105827027|NCT03578809|365026356|FG001|Overall Study|Lost to Follow-up|1|||
105827028|NCT03578809|365026357|FG002|Overall Study|Lost to Follow-up|0|||
105827029|NCT03578809|365026358|FG003|Overall Study|Lost to Follow-up|0|||
105827030|NCT03578809|365026355|FG000|Overall Study|Withdrawal by Subject|3|||
105827031|NCT03578809|365026356|FG001|Overall Study|Withdrawal by Subject|5|||
105827032|NCT03578809|365026357|FG002|Overall Study|Withdrawal by Subject|2|||
105827033|NCT03578809|365026358|FG003|Overall Study|Withdrawal by Subject|0|||
106022317|NCT03037580|365746824|FG001|Overall Study|Death|1|||
106148024|NCT03422276|366203882|FG003|Overall Study|Withdrawal by Subject|16|||
106148025|NCT03422276|366203879|FG000|Overall Study|Death|14|||
106148026|NCT03422276|366203880|FG001|Overall Study|Death|21|||
106148027|NCT03422276|366203881|FG002|Overall Study|Death|3|||
106148028|NCT03422276|366203882|FG003|Overall Study|Death|1|||
106148029|NCT03422276|366203879|FG000|Overall Study|Discontinued, ineligible|4|||
106148030|NCT03422276|366203880|FG001|Overall Study|Discontinued, ineligible|3|||
106148031|NCT03422276|366203881|FG002|Overall Study|Discontinued, ineligible|0|||
106148032|NCT03422276|366203882|FG003|Overall Study|Discontinued, ineligible|0|||
106148033|NCT03422276|366203879|FG000|Overall Study|Lost to Follow-up|15|||
106148034|NCT03422276|366203880|FG001|Overall Study|Lost to Follow-up|8|||
106148035|NCT03422276|366203881|FG002|Overall Study|Lost to Follow-up|13|||
106148036|NCT03422276|366203882|FG003|Overall Study|Lost to Follow-up|4|||
106148037|NCT03422276|366203879|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
106148038|NCT03422276|366203880|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
106148039|NCT03422276|366203881|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
106148040|NCT03422276|366203882|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
106148041|NCT03422276|366203879|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
106148042|NCT03422276|366203880|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
106148043|NCT03422276|366203881|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
106148044|NCT03422276|366203882|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
106148045|NCT03422276|366203879|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
106148046|NCT03422276|366203880|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
106148047|NCT03422276|366203881|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
106148048|NCT03422276|366203882|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
106148049|NCT03422276|366203879|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
106148050|NCT03422276|366203880|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
106148051|NCT03422276|366203881|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
106148052|NCT03422276|366203882|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
106148053|NCT03422276|366203879|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
106148054|NCT03422276|366203880|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
106148055|NCT03422276|366203881|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
106148056|NCT03422276|366203882|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
106148057|NCT00304031|366203886|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
106148058|NCT00304031|366203887|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
106148059|NCT00304031|366203888|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
106148060|NCT00304031|366203886|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
106148061|NCT00304031|366203887|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
106148062|NCT00304031|366203888|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
106148063|NCT00304031|366203886|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
106148064|NCT00304031|366203887|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
106148065|NCT00304031|366203888|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
106148066|NCT00304031|366203886|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
105827034|NCT03578809|365026355|FG000|Overall Study|Other|3|||
105827035|NCT03578809|365026356|FG001|Overall Study|Other|6|||
105827036|NCT03578809|365026357|FG002|Overall Study|Other|2|||
105827037|NCT03578809|365026358|FG003|Overall Study|Other|8|||
105827038|NCT01750294|365026359|FG000|Overall Study|Withdrawal by Subject|1|||
105827039|NCT01750294|365026359|FG000|Overall Study|Safety Endpoint|1|||
105827040|NCT00665925|365026360|FG000|Overall Study|Lack of Efficacy|10|||
105827041|NCT00665925|365026361|FG001|Overall Study|Lack of Efficacy|8|||
105827042|NCT00665925|365026362|FG002|Overall Study|Lack of Efficacy|9|||
105827043|NCT00665925|365026363|FG003|Overall Study|Lack of Efficacy|8|||
105827044|NCT00665925|365026360|FG000|Overall Study|Lost to Follow-up|1|||
105827045|NCT00665925|365026361|FG001|Overall Study|Lost to Follow-up|2|||
105962483|NCT03985943|365523127|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
105962484|NCT03985943|365523128|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
105962485|NCT03985943|365523129|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
105962486|NCT03985943|365523130|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
105962487|NCT03985943|365523131|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
105962488|NCT03985943|365523132|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
105962489|NCT03985943|365523127|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105962490|NCT03985943|365523128|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
105962491|NCT03985943|365523129|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105962492|NCT03985943|365523130|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105962493|NCT03985943|365523131|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105827046|NCT00665925|365026362|FG002|Overall Study|Lost to Follow-up|2|||
105827047|NCT00665925|365026363|FG003|Overall Study|Lost to Follow-up|2|||
105827048|NCT00665925|365026360|FG000|Overall Study|Withdrawal by Subject|2|||
105827049|NCT00665925|365026361|FG001|Overall Study|Withdrawal by Subject|2|||
105827050|NCT00665925|365026362|FG002|Overall Study|Withdrawal by Subject|3|||
105827051|NCT00665925|365026363|FG003|Overall Study|Withdrawal by Subject|2|||
105827052|NCT00665925|365026360|FG000|Overall Study|Physician Decision|0|||
105827053|NCT00665925|365026361|FG001|Overall Study|Physician Decision|0|||
105827054|NCT00665925|365026362|FG002|Overall Study|Physician Decision|1|||
105827055|NCT00665925|365026363|FG003|Overall Study|Physician Decision|2|||
105827056|NCT00665925|365026360|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
105827057|NCT00665925|365026361|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
105827058|NCT00665925|365026362|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
105827059|NCT00665925|365026363|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
105827060|NCT00665925|365026360|FG000|Overall Study|Adverse Event|1|||
105827061|NCT00665925|365026361|FG001|Overall Study|Adverse Event|5|||
105827062|NCT00665925|365026362|FG002|Overall Study|Adverse Event|10|||
105827063|NCT00665925|365026363|FG003|Overall Study|Adverse Event|5|||
105827064|NCT00665925|365026360|FG000|Overall Study|Enrolled by mistake|0|||
105827065|NCT00665925|365026361|FG001|Overall Study|Enrolled by mistake|0|||
105827066|NCT00665925|365026362|FG002|Overall Study|Enrolled by mistake|0|||
105827067|NCT00665925|365026363|FG003|Overall Study|Enrolled by mistake|1|||
105827068|NCT00665925|365026360|FG000|Overall Study|Due to exclusion criteria|1|||
105827069|NCT00665925|365026361|FG001|Overall Study|Due to exclusion criteria|0|||
105827070|NCT00665925|365026362|FG002|Overall Study|Due to exclusion criteria|0|||
105827071|NCT00665925|365026363|FG003|Overall Study|Due to exclusion criteria|0|||
105827072|NCT02316223|365026370|FG000|Overall Study|Lack of Efficacy|0|||
105827073|NCT02316223|365026371|FG001|Overall Study|Lack of Efficacy|1|||
105827074|NCT02316223|365026372|FG002|Overall Study|Lack of Efficacy|1|||
105827075|NCT02316223|365026370|FG000|Overall Study|Lost to Follow-up|27|||
105827076|NCT02316223|365026371|FG001|Overall Study|Lost to Follow-up|34|||
105827077|NCT02316223|365026372|FG002|Overall Study|Lost to Follow-up|36|||
105827078|NCT02316223|365026370|FG000|Overall Study|COPD Diagnosis|3|||
105827079|NCT02316223|365026371|FG001|Overall Study|COPD Diagnosis|2|||
105827080|NCT02316223|365026372|FG002|Overall Study|COPD Diagnosis|3|||
105827081|NCT02316223|365026370|FG000|Overall Study|Reside outside study area|1|||
105827082|NCT02316223|365026371|FG001|Overall Study|Reside outside study area|1|||
105827083|NCT02316223|365026372|FG002|Overall Study|Reside outside study area|1|||
105827084|NCT02316223|365026370|FG000|Overall Study|No asthma|2|||
105827085|NCT02316223|365026371|FG001|Overall Study|No asthma|0|||
105827086|NCT02316223|365026372|FG002|Overall Study|No asthma|0|||
105827087|NCT02316223|365026370|FG000|Overall Study|Discontinued by PI|11|||
106022318|NCT02442804|365746825|FG000|Overall Study|Withdrawal by Subject|0|||
105827088|NCT02316223|365026371|FG001|Overall Study|Discontinued by PI|19|||
105827089|NCT02316223|365026372|FG002|Overall Study|Discontinued by PI|3|||
105827090|NCT02255149|365026373|FG000|Overall Study|Lost to Follow-up|2|||
105827091|NCT02255149|365026373|FG000|Overall Study|Withdrawal by Subject|1|||
105827092|NCT02255149|365026373|FG000|Overall Study|Withdrawal by PI|1|||
105827093|NCT02255149|365026373|FG000|Overall Study|Implant Failure|1|||
105827094|NCT03669250|365026374|FG000|Overall Study|Adverse Event|0|||
105827095|NCT03669250|365026375|FG001|Overall Study|Adverse Event|0|||
105827096|NCT03669250|365026376|FG002|Overall Study|Adverse Event|0|||
105827097|NCT03669250|365026377|FG003|Overall Study|Adverse Event|0|||
105827098|NCT03669250|365026378|FG004|Overall Study|Adverse Event|1|||
106148067|NCT00304031|366203887|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
106148068|NCT00304031|366203888|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
106148069|NCT00304031|366203886|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
106148070|NCT00304031|366203887|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
106148071|NCT00304031|366203888|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
106148072|NCT00304031|366203886|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
106148073|NCT00304031|366203887|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
106148074|NCT00304031|366203888|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
106148075|NCT00304031|366203886|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
106148076|NCT00304031|366203887|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
106148077|NCT00304031|366203888|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
106148078|NCT00304031|366203886|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
106148079|NCT00304031|366203887|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
106148080|NCT00304031|366203888|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
106148081|NCT00304031|366203886|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
106148082|NCT00304031|366203887|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
106148083|NCT00304031|366203888|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
106148084|NCT02407249|366203898|FG000|Overall Study|Did not complete 12-month follow-up|13|||
106148085|NCT02407249|366203898|FG000|Overall Study|Not treated|13|||
106148086|NCT01391832|366203899|FG000|Overall Study|Withdrawal by Subject|21|||
106148087|NCT01391832|366203900|FG001|Overall Study|Withdrawal by Subject|22|||
106148088|NCT01391832|366203899|FG000|Overall Study|Lost to Follow-up|0|||
106148089|NCT01391832|366203900|FG001|Overall Study|Lost to Follow-up|1|||
106148090|NCT03345901|366203901|FG000|Overall Study|The study was terminated|18|||
106148091|NCT04252586|366203907|FG000|Overall Study|Withdrawal by parent/guardian|3|||
106148092|NCT04252586|366203907|FG000|Overall Study|Adverse Event|1|||
106148093|NCT04252586|366203907|FG000|Overall Study|Death|2|||
106148094|NCT04252586|366203907|FG000|Overall Study|Study terminated by sponsor|4|||
106148095|NCT04252586|366203907|FG000|Overall Study|Sponsor request|10|||
106148096|NCT04252586|366203907|FG000|Overall Study|Did not complete treatment period|1|||
106148097|NCT03050814|366203908|FG000|Overall Study|Screen failures|0|||
106148098|NCT03050814|366203909|FG001|Overall Study|Screen failures|0|||
106148099|NCT03050814|366203910|FG002|Overall Study|Screen failures|4|||
106148100|NCT01443845|366203911|FG000|Overall Study|Protocol Violation|43|||
106148101|NCT01443845|366203912|FG001|Overall Study|Protocol Violation|45|||
106148102|NCT01443845|366203911|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
106148103|NCT01443845|366203912|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
106148104|NCT01443845|366203911|FG000|Overall Study|Deterioration in pulmonary function|1|||
106148105|NCT01443845|366203912|FG001|Overall Study|Deterioration in pulmonary function|4|||
106148106|NCT01443845|366203911|FG000|Overall Study|Lack of Efficacy|10|||
106148107|NCT01443845|366203912|FG001|Overall Study|Lack of Efficacy|5|||
106148108|NCT01443845|366203911|FG000|Overall Study|Adverse Event|64|||
106148109|NCT01443845|366203912|FG001|Overall Study|Adverse Event|138|||
106148110|NCT01443845|366203911|FG000|Overall Study|Withdrawal by Subject|63|||
106148111|NCT01443845|366203912|FG001|Overall Study|Withdrawal by Subject|67|||
106148112|NCT01443845|366203911|FG000|Overall Study|Military Conflict - Site Terminated|20|||
106148113|NCT01443845|366203912|FG001|Overall Study|Military Conflict - Site Terminated|21|||
106148114|NCT01443845|366203911|FG000|Overall Study|Lost to Follow-up|9|||
106148115|NCT01443845|366203912|FG001|Overall Study|Lost to Follow-up|13|||
106148116|NCT00332241|366203913|FG000|Overall Study|Lack of Efficacy|6|||
106148117|NCT00332241|366203914|FG001|Overall Study|Lack of Efficacy|1|||
106148118|NCT00332241|366203913|FG000|Overall Study|Adverse Event|3|||
106148119|NCT00332241|366203914|FG001|Overall Study|Adverse Event|5|||
106148120|NCT00332241|366203913|FG000|Overall Study|Withdrawal by Subject|2|||
106148121|NCT00332241|366203914|FG001|Overall Study|Withdrawal by Subject|1|||
106148122|NCT00332241|366203913|FG000|Overall Study|Lost to Follow-up|4|||
106148123|NCT00332241|366203914|FG001|Overall Study|Lost to Follow-up|1|||
106148124|NCT02584829|366203915|FG000|Overall Study|Physician Decision|1|||
106148125|NCT02584829|366203916|FG001|Overall Study|Physician Decision|0|||
106148126|NCT02584829|366203915|FG000|Overall Study|Withdrawal by Subject|0|||
106148127|NCT02584829|366203916|FG001|Overall Study|Withdrawal by Subject|1|||
106148128|NCT02584829|366203915|FG000|Overall Study|Progressive Disease|0|||
106148129|NCT02584829|366203916|FG001|Overall Study|Progressive Disease|3|||
106148130|NCT00802464|366203917|FG000|Month 0 - Month 8|Adverse Event|0|||
106148131|NCT00802464|366203918|FG001|Month 0 - Month 8|Adverse Event|1|||
106148132|NCT00802464|366203919|FG002|Month 0 - Month 8|Adverse Event|1|||
106148133|NCT00802464|366203920|FG003|Month 0 - Month 8|Adverse Event|2|||
106148134|NCT00802464|366203917|FG000|Month 0 - Month 8|Protocol Violation|0|||
106148135|NCT00802464|366203918|FG001|Month 0 - Month 8|Protocol Violation|0|||
106148136|NCT00802464|366203919|FG002|Month 0 - Month 8|Protocol Violation|1|||
106148137|NCT00802464|366203920|FG003|Month 0 - Month 8|Protocol Violation|0|||
106148138|NCT00802464|366203917|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
106148139|NCT00802464|366203918|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
106148140|NCT00802464|366203919|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
105827099|NCT03669250|365026379|FG005|Overall Study|Adverse Event|0|||
105827100|NCT03669250|365026374|FG000|Overall Study|Withdrawal by Subject|0|||
105827101|NCT03669250|365026375|FG001|Overall Study|Withdrawal by Subject|1|||
105827102|NCT03669250|365026376|FG002|Overall Study|Withdrawal by Subject|0|||
105827103|NCT03669250|365026377|FG003|Overall Study|Withdrawal by Subject|1|||
105827104|NCT03669250|365026378|FG004|Overall Study|Withdrawal by Subject|0|||
105827105|NCT03669250|365026379|FG005|Overall Study|Withdrawal by Subject|0|||
105827106|NCT00081653|365026394|FG000|Overall Study|Adverse Event|23|||
105827107|NCT00081653|365026395|FG001|Overall Study|Adverse Event|17|||
105827108|NCT00081653|365026394|FG000|Overall Study|Lost to Follow-up|2|||
105827109|NCT00081653|365026395|FG001|Overall Study|Lost to Follow-up|4|||
105962494|NCT03985943|365523132|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105962495|NCT03985943|365523127|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
105962496|NCT03985943|365523128|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
105962497|NCT03985943|365523129|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
105962498|NCT03985943|365523130|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
105962499|NCT03985943|365523131|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
105962500|NCT03985943|365523132|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
105962501|NCT03985943|365523127|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105962502|NCT03985943|365523128|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
105962503|NCT03985943|365523129|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105962504|NCT03985943|365523130|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105962505|NCT03985943|365523131|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105962506|NCT03985943|365523132|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
105962507|NCT03985943|365523127|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105962508|NCT03985943|365523128|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
105962509|NCT03985943|365523129|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105962510|NCT03985943|365523130|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105962511|NCT03985943|365523131|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
105962512|NCT03985943|365523132|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
106148141|NCT00802464|366203920|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
106148142|NCT00802464|366203917|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
106148143|NCT00802464|366203918|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
106148144|NCT00802464|366203919|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
106148145|NCT00802464|366203920|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
106148146|NCT00802464|366203917|FG000|Month 0 - Month 8|Other|0|||
106148147|NCT00802464|366203918|FG001|Month 0 - Month 8|Other|0|||
106148148|NCT00802464|366203919|FG002|Month 0 - Month 8|Other|1|||
106148149|NCT00802464|366203920|FG003|Month 0 - Month 8|Other|0|||
106148150|NCT00802464|366203917|FG000|Month 8 - Month 14|Adverse Event|0|||
106148151|NCT00802464|366203918|FG001|Month 8 - Month 14|Adverse Event|1|||
106148152|NCT00802464|366203919|FG002|Month 8 - Month 14|Adverse Event|0|||
106148153|NCT00802464|366203920|FG003|Month 8 - Month 14|Adverse Event|0|||
106148154|NCT00802464|366203917|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
106148155|NCT00802464|366203918|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
106148156|NCT00802464|366203919|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
106148157|NCT00802464|366203920|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
106148158|NCT00802464|366203917|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
106148159|NCT00802464|366203918|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
106148160|NCT00802464|366203919|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
106148161|NCT00802464|366203920|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
106148162|NCT02622568|366203929|FG000|Overall Study|Lost to Follow-up|5|||
106148163|NCT02622568|366203930|FG001|Overall Study|Lost to Follow-up|5|||
106148164|NCT04723394|366203931|FG000|Overall Study|Adverse Event|0|||
106148165|NCT04723394|366203932|FG001|Overall Study|Adverse Event|3|||
106148166|NCT04723394|366203931|FG000|Overall Study|Death|8|||
106148167|NCT04723394|366203932|FG001|Overall Study|Death|8|||
106148168|NCT04723394|366203931|FG000|Overall Study|Lost to Follow-up|20|||
106148169|NCT04723394|366203932|FG001|Overall Study|Lost to Follow-up|17|||
106148170|NCT04723394|366203931|FG000|Overall Study|Physician Decision|1|||
106148171|NCT04723394|366203932|FG001|Overall Study|Physician Decision|0|||
106148172|NCT04723394|366203931|FG000|Overall Study|Withdrawal by Subject|20|||
106148173|NCT04723394|366203932|FG001|Overall Study|Withdrawal by Subject|34|||
106148174|NCT04723394|366203931|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
106148175|NCT04723394|366203932|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
106148176|NCT00858117|366203934|FG000|Treatment on Study|Adverse Event|2|||
106148177|NCT00858117|366203934|FG000|Follow up for 5 Years|Death|4|||
106148178|NCT00858117|366203934|FG000|Follow up for 5 Years|No further data collected for study|9|||
106148179|NCT00371787|366203935|FG000|Overall Study|Withdrawal by Subject|3|||
106148180|NCT00371787|366203936|FG001|Overall Study|Withdrawal by Subject|1|||
105827110|NCT00081653|365026394|FG000|Overall Study|Refused Treatment|18|||
105827111|NCT00081653|365026395|FG001|Overall Study|Refused Treatment|14|||
106022319|NCT02442804|365746826|FG001|Overall Study|Withdrawal by Subject|1|||
105827112|NCT00081653|365026394|FG000|Overall Study|Low bone mineral density|1|||
106022320|NCT02442804|365746825|FG000|Overall Study|Adverse Event|1|||
106022321|NCT02442804|365746826|FG001|Overall Study|Adverse Event|0|||
106022322|NCT02036853|365746827|FG000|Overall Study|Adverse Event|0|||
106022323|NCT02036853|365746828|FG001|Overall Study|Adverse Event|2|||
106022324|NCT02036853|365746827|FG000|Overall Study|Lack of Efficacy|0|||
106022325|NCT02036853|365746828|FG001|Overall Study|Lack of Efficacy|2|||
106022326|NCT02036853|365746827|FG000|Overall Study|Physician Decision|0|||
106022327|NCT02036853|365746828|FG001|Overall Study|Physician Decision|1|||
106022328|NCT02036853|365746827|FG000|Overall Study|Withdrawal by Subject|0|||
106022329|NCT02036853|365746828|FG001|Overall Study|Withdrawal by Subject|1|||
106022330|NCT00101452|365746833|FG000|Overall Study|Adverse Event|2|||
106022331|NCT00101452|365746834|FG001|Overall Study|Adverse Event|0|||
106022332|NCT00101452|365746835|FG002|Overall Study|Adverse Event|1|||
106022333|NCT00101452|365746833|FG000|Overall Study|Lost to Follow-up|13|||
106022334|NCT00101452|365746834|FG001|Overall Study|Lost to Follow-up|8|||
106022335|NCT00101452|365746835|FG002|Overall Study|Lost to Follow-up|14|||
106022336|NCT00101452|365746833|FG000|Overall Study|Withdrawal by Subject|10|||
106022337|NCT00101452|365746834|FG001|Overall Study|Withdrawal by Subject|14|||
106022338|NCT00101452|365746835|FG002|Overall Study|Withdrawal by Subject|9|||
106022339|NCT00101452|365746833|FG000|Overall Study|Baseline Fail|2|||
106022340|NCT00101452|365746834|FG001|Overall Study|Baseline Fail|1|||
106022341|NCT00101452|365746835|FG002|Overall Study|Baseline Fail|2|||
106022342|NCT00101452|365746833|FG000|Overall Study|Physician Decision|0|||
106022343|NCT00101452|365746834|FG001|Overall Study|Physician Decision|3|||
106022344|NCT00101452|365746835|FG002|Overall Study|Physician Decision|2|||
106022345|NCT00101452|365746833|FG000|Overall Study|Protocol Violation|2|||
106022346|NCT00101452|365746834|FG001|Overall Study|Protocol Violation|1|||
106022347|NCT00101452|365746835|FG002|Overall Study|Protocol Violation|3|||
106022348|NCT00101452|365746833|FG000|Overall Study|Other|15|||
106022349|NCT00101452|365746834|FG001|Overall Study|Other|16|||
106022350|NCT00101452|365746835|FG002|Overall Study|Other|12|||
106022351|NCT02633020|365746836|FG000|Overall Study|Adverse Event|1|||
106148181|NCT00077675|366203937|FG000|Overall Study|Adverse Event|1|||
106022352|NCT02633020|365746837|FG001|Overall Study|Adverse Event|0|||
106022353|NCT01057589|365746838|FG000|Overall Study|Disease Progression|35|||
106022354|NCT01057589|365746838|FG000|Overall Study|Adverse Event|10|||
106022355|NCT01057589|365746838|FG000|Overall Study|Physician Decision|8|||
106022356|NCT01057589|365746838|FG000|Overall Study|Withdrawal by Subject|3|||
106022357|NCT01057589|365746838|FG000|Overall Study|Sponsor Decision|1|||
106022358|NCT01057589|365746838|FG000|Overall Study|Death|8|||
106148182|NCT00077675|366203938|FG001|Overall Study|Adverse Event|2|||
106148183|NCT00077675|366203937|FG000|Overall Study|Lost to Follow-up|6|||
106148184|NCT00077675|366203938|FG001|Overall Study|Lost to Follow-up|3|||
106148185|NCT00077675|366203937|FG000|Overall Study|Withdrawal by Subject|1|||
106148186|NCT00077675|366203938|FG001|Overall Study|Withdrawal by Subject|0|||
106148187|NCT00077675|366203937|FG000|Overall Study|Other|0|||
106148188|NCT00077675|366203938|FG001|Overall Study|Other|1|||
106148189|NCT00077675|366203937|FG000|Overall Study|Never received study treatment|3|||
106148190|NCT00077675|366203938|FG001|Overall Study|Never received study treatment|3|||
106148191|NCT04425863|366203939|FG000|Overall Study|Death|0|||
106148192|NCT04425863|366203940|FG001|Overall Study|Death|0|||
106148193|NCT04425863|366203941|FG002|Overall Study|Death|1|||
106148194|NCT01854385|366203943|FG000|Pre-Treatment|Withdrawal by Subject|4|||
106148195|NCT01854385|366203943|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
106148196|NCT01854385|366203943|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
106148197|NCT01854385|366203943|FG000|Pre-Treatment|Unable to come for study visits|1|||
106148198|NCT01854385|366203943|FG000|Treatment|Lost to Follow-up|1|||
106148199|NCT00277355|366203948|FG000|Overall Study|Withdrawal by Subject|3|||
106148200|NCT00277355|366203949|FG001|Overall Study|Withdrawal by Subject|3|||
106148201|NCT00277355|366203948|FG000|Overall Study|Lost to Follow-up|2|||
106148202|NCT00277355|366203949|FG001|Overall Study|Lost to Follow-up|2|||
106148203|NCT00277355|366203948|FG000|Overall Study|Adverse Event|5|||
106148204|NCT00277355|366203949|FG001|Overall Study|Adverse Event|0|||
106148205|NCT00277355|366203948|FG000|Overall Study|Death|3|||
106148206|NCT00277355|366203949|FG001|Overall Study|Death|0|||
106148207|NCT00277355|366203948|FG000|Overall Study|Physician Decision|1|||
106148208|NCT00277355|366203949|FG001|Overall Study|Physician Decision|0|||
106148209|NCT02765100|366203950|FG000|Overall Study|subject found ineligible after baseline|1|||
106148210|NCT02765100|366203951|FG001|Overall Study|subject found ineligible after baseline|1|||
106148211|NCT02765100|366203950|FG000|Overall Study|Lost to Follow-up|0|||
106148212|NCT02765100|366203951|FG001|Overall Study|Lost to Follow-up|1|||
106148213|NCT02597920|366203957|FG000|Overall Study|Worsening of other pre-existing disease|0|||
106148214|NCT02597920|366203958|FG001|Overall Study|Worsening of other pre-existing disease|1|||
106148215|NCT02597920|366203959|FG002|Overall Study|Worsening of other pre-existing disease|0|||
106148216|NCT02597920|366203957|FG000|Overall Study|Other adverse event|20|||
106148217|NCT02597920|366203958|FG001|Overall Study|Other adverse event|30|||
106148218|NCT02597920|366203959|FG002|Overall Study|Other adverse event|0|||
106148219|NCT02597920|366203957|FG000|Overall Study|Lost to Follow-up|7|||
106148220|NCT02597920|366203958|FG001|Overall Study|Lost to Follow-up|9|||
105827113|NCT00081653|365026395|FG001|Overall Study|Low bone mineral density|0|||
105827114|NCT00081653|365026394|FG000|Overall Study|Bone loss|2|||
105827115|NCT00081653|365026395|FG001|Overall Study|Bone loss|0|||
105827116|NCT00081653|365026394|FG000|Overall Study|Participant leaving country|1|||
105827117|NCT00081653|365026395|FG001|Overall Study|Participant leaving country|0|||
105827118|NCT00081653|365026394|FG000|Overall Study|Loss of bone mass|0|||
105827119|NCT00081653|365026395|FG001|Overall Study|Loss of bone mass|2|||
105827120|NCT01117623|365026396|FG000|Overall Study|Adverse Event|0|||
105827121|NCT01117623|365026397|FG001|Overall Study|Adverse Event|2|||
105827122|NCT01117623|365026398|FG002|Overall Study|Adverse Event|4|||
105827123|NCT01117623|365026399|FG003|Overall Study|Adverse Event|0|||
105827124|NCT01117623|365026400|FG004|Overall Study|Adverse Event|2|||
105827125|NCT01117623|365026401|FG005|Overall Study|Adverse Event|0|||
105827126|NCT01117623|365026402|FG006|Overall Study|Adverse Event|0|||
105827127|NCT01117623|365026403|FG007|Overall Study|Adverse Event|2|||
105827128|NCT01117623|365026396|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
105827129|NCT01117623|365026397|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
105827130|NCT01117623|365026398|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
105827131|NCT01117623|365026399|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
106148221|NCT02597920|366203959|FG002|Overall Study|Lost to Follow-up|0|||
106148222|NCT02597920|366203957|FG000|Overall Study|Refuse to continue in the study|3|||
106148223|NCT02597920|366203958|FG001|Overall Study|Refuse to continue in the study|13|||
106148224|NCT02597920|366203959|FG002|Overall Study|Refuse to continue in the study|1|||
106148225|NCT02597920|366203957|FG000|Overall Study|Other than specified|10|||
106148226|NCT02597920|366203958|FG001|Overall Study|Other than specified|31|||
106148227|NCT02597920|366203959|FG002|Overall Study|Other than specified|5|||
106148228|NCT02597920|366203957|FG000|Overall Study|Other|1|||
106148229|NCT02597920|366203958|FG001|Overall Study|Other|0|||
106148230|NCT02597920|366203959|FG002|Overall Study|Other|0|||
106148231|NCT00642850|366203963|FG000|Overall Study|Death|7|||
106148232|NCT00642850|366203963|FG000|Overall Study|Adverse Event|2|||
106148233|NCT00642850|366203963|FG000|Overall Study|Lack of Efficacy|1|||
106148234|NCT00642850|366203963|FG000|Overall Study|Protocol Violation|2|||
106148235|NCT00642850|366203963|FG000|Overall Study|Kidney transplantation|8|||
106148236|NCT00642850|366203963|FG000|Overall Study|Blood transfusion|6|||
106148237|NCT00642850|366203963|FG000|Overall Study|Other reasons|7|||
106148238|NCT04530747|366203967|FG000|Overall Study|Withdrawal by Subject|1|||
106148239|NCT04530747|366203968|FG001|Overall Study|Withdrawal by Subject|0|||
106148240|NCT00529516|366203969|FG000|Overall Study|Adverse Event|2|||
106148241|NCT00529516|366203970|FG001|Overall Study|Adverse Event|1|||
106148242|NCT00529516|366203971|FG002|Overall Study|Adverse Event|0|||
106148243|NCT00529516|366203969|FG000|Overall Study|Withdrawal by Subject|1|||
106148244|NCT00529516|366203970|FG001|Overall Study|Withdrawal by Subject|1|||
106148245|NCT00529516|366203971|FG002|Overall Study|Withdrawal by Subject|0|||
106148246|NCT00529516|366203969|FG000|Overall Study|Lost to Follow-up|0|||
106148247|NCT00529516|366203970|FG001|Overall Study|Lost to Follow-up|0|||
106148248|NCT00529516|366203971|FG002|Overall Study|Lost to Follow-up|1|||
106148249|NCT00761605|366203974|FG000|Overall Study|Adverse Event|26|||
106148250|NCT00761605|366203974|FG000|Overall Study|Death|2|||
106148251|NCT00761605|366203974|FG000|Overall Study|Lack of Efficacy|26|||
106148252|NCT00761605|366203974|FG000|Overall Study|Lost to Follow-up|29|||
106148253|NCT00761605|366203974|FG000|Overall Study|Withdrawal by Subject|37|||
106148254|NCT00761605|366203974|FG000|Overall Study|Other|21|||
106148255|NCT01546753|366203976|FG000|Overall Study|anxiety|1|||
106148256|NCT01546753|366203977|FG001|Overall Study|anxiety|1|||
106148257|NCT01546753|366203976|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
106148258|NCT01546753|366203977|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
106148259|NCT01000480|366203979|FG000|Induction Phase|Adverse Event|2|||
106148260|NCT01000480|366203979|FG000|Induction Phase|Lost to Follow-up|1|||
106148261|NCT01000480|366203979|FG000|Induction Phase|Physician Decision|1|||
106148262|NCT01000480|366203979|FG000|Induction Phase|Entry Criteria Not Met|3|||
106148263|NCT01000480|366203979|FG000|Concurrent Therapy Phase|Adverse Event|4|||
106148264|NCT01000480|366203979|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
106148265|NCT01000480|366203979|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
106148266|NCT01000480|366203979|FG000|Concurrent Therapy Phase|Physician Decision|1|||
106148267|NCT00174382|366203984|FG000|Overall Study|Death|2|||
106148268|NCT00174382|366203984|FG000|Overall Study|Adverse Event|19|||
106148269|NCT00174382|366203984|FG000|Overall Study|Withdrawal by Subject|6|||
106148270|NCT00174382|366203984|FG000|Overall Study|Protocol Violation|3|||
106148271|NCT00174382|366203984|FG000|Overall Study|Arrived early for last visit in error|1|||
106148272|NCT00174382|366203984|FG000|Overall Study|Subject felt pill not effective enough|1|||
106148273|NCT00174382|366203984|FG000|Overall Study|Lost to Follow-up|1|||
106148274|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
106148275|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
106148276|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
106148277|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
106148278|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
106148279|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
105962513|NCT03985943|365523127|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105962514|NCT03985943|365523128|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105962515|NCT03985943|365523129|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
105962516|NCT03985943|365523130|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
105962517|NCT03985943|365523131|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
105962518|NCT03985943|365523132|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
105962519|NCT03985943|365523127|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105962520|NCT03985943|365523128|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105962521|NCT03985943|365523129|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
105962522|NCT03985943|365523130|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
105962523|NCT03985943|365523131|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
105962524|NCT03985943|365523132|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
105962525|NCT03985943|365523127|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
105962526|NCT03985943|365523128|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
105962527|NCT03985943|365523129|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
105962528|NCT03985943|365523130|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
105962529|NCT03985943|365523131|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
105962530|NCT03985943|365523132|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
105962531|NCT03985943|365523127|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105962532|NCT03985943|365523128|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105962533|NCT03985943|365523129|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105962534|NCT03985943|365523130|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105962535|NCT03985943|365523131|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105962536|NCT03985943|365523132|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105962537|NCT03985943|365523127|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
105962538|NCT03985943|365523128|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
105962539|NCT03985943|365523129|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
105962540|NCT03985943|365523130|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
105962541|NCT03985943|365523131|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
105962542|NCT03985943|365523132|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
105962543|NCT03985943|365523127|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
105962544|NCT03985943|365523128|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
105962545|NCT03985943|365523129|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
105962546|NCT03985943|365523130|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
105962547|NCT03985943|365523131|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
105827132|NCT01117623|365026400|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
105827133|NCT01117623|365026401|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
105827134|NCT01117623|365026402|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
105827135|NCT01117623|365026403|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
105962548|NCT03985943|365523132|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
105962549|NCT03985943|365523127|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
105962550|NCT03985943|365523128|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
106148280|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
106148281|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
105827136|NCT01117623|365026396|FG000|Overall Study|Withdrawal by Subject|0|||
105827137|NCT01117623|365026397|FG001|Overall Study|Withdrawal by Subject|0|||
105827138|NCT01117623|365026398|FG002|Overall Study|Withdrawal by Subject|2|||
105827139|NCT01117623|365026399|FG003|Overall Study|Withdrawal by Subject|0|||
105827140|NCT01117623|365026400|FG004|Overall Study|Withdrawal by Subject|0|||
105827141|NCT01117623|365026401|FG005|Overall Study|Withdrawal by Subject|1|||
105827142|NCT01117623|365026402|FG006|Overall Study|Withdrawal by Subject|1|||
105827143|NCT01117623|365026403|FG007|Overall Study|Withdrawal by Subject|1|||
105827144|NCT01117623|365026396|FG000|Overall Study|Non-compliance with study medication|0|||
105827145|NCT01117623|365026397|FG001|Overall Study|Non-compliance with study medication|0|||
105827146|NCT01117623|365026398|FG002|Overall Study|Non-compliance with study medication|0|||
105827147|NCT01117623|365026399|FG003|Overall Study|Non-compliance with study medication|0|||
105827148|NCT01117623|365026400|FG004|Overall Study|Non-compliance with study medication|0|||
105827149|NCT01117623|365026401|FG005|Overall Study|Non-compliance with study medication|0|||
105827150|NCT01117623|365026402|FG006|Overall Study|Non-compliance with study medication|0|||
105827151|NCT01117623|365026403|FG007|Overall Study|Non-compliance with study medication|1|||
105827152|NCT01117623|365026396|FG000|Overall Study|Invest. text: completed all planned txs|0|||
105827153|NCT01117623|365026397|FG001|Overall Study|Invest. text: completed all planned txs|0|||
105827154|NCT01117623|365026398|FG002|Overall Study|Invest. text: completed all planned txs|0|||
105827155|NCT01117623|365026399|FG003|Overall Study|Invest. text: completed all planned txs|0|||
105827156|NCT01117623|365026400|FG004|Overall Study|Invest. text: completed all planned txs|0|||
105827157|NCT01117623|365026401|FG005|Overall Study|Invest. text: completed all planned txs|1|||
105827158|NCT01117623|365026402|FG006|Overall Study|Invest. text: completed all planned txs|0|||
105827159|NCT01117623|365026403|FG007|Overall Study|Invest. text: completed all planned txs|0|||
105827160|NCT00540423|365026410|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105827161|NCT00540423|365026411|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105827162|NCT00540423|365026412|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105827163|NCT00540423|365026410|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
105827164|NCT00540423|365026411|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
105827165|NCT00540423|365026412|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
105827166|NCT01634139|365026413|FG000|Overall Study|Non compliant with protocol|1|||
105827167|NCT01634139|365026414|FG001|Overall Study|Non compliant with protocol|0|||
105827168|NCT01634139|365026415|FG002|Overall Study|Non compliant with protocol|0|||
105827169|NCT01634139|365026413|FG000|Overall Study|Consent withdrawn not due to AE|4|||
105827170|NCT01634139|365026414|FG001|Overall Study|Consent withdrawn not due to AE|3|||
105827171|NCT01634139|365026415|FG002|Overall Study|Consent withdrawn not due to AE|2|||
105827172|NCT01634139|365026413|FG000|Overall Study|Other|4|||
106148282|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
106148283|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
106148284|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
106148285|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
106148286|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
106148287|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
106148288|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
106148289|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
106148290|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
105827173|NCT01634139|365026414|FG001|Overall Study|Other|0|||
106148291|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
106148292|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
106148293|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
105962551|NCT03985943|365523129|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
105962552|NCT03985943|365523130|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
105962553|NCT03985943|365523131|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
105962554|NCT03985943|365523132|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
105962555|NCT00338286|365523133|FG000|Overall Study|Withdrawal by Subject|50|||
105962556|NCT00338286|365523134|FG001|Overall Study|Withdrawal by Subject|54|||
105962557|NCT00338286|365523133|FG000|Overall Study|Lost to Follow-up|80|||
105962558|NCT00338286|365523134|FG001|Overall Study|Lost to Follow-up|66|||
105962559|NCT00338286|365523133|FG000|Overall Study|Other|103|||
105962560|NCT00338286|365523134|FG001|Overall Study|Other|93|||
105962561|NCT04952597|365523135|FG000|Overall Study|Death|12|||
105962562|NCT04952597|365523136|FG001|Overall Study|Death|13|||
105962563|NCT04952597|365523137|FG002|Overall Study|Death|14|||
105962564|NCT04952597|365523135|FG000|Overall Study|Withdrawal by Subject|1|||
105962565|NCT04952597|365523136|FG001|Overall Study|Withdrawal by Subject|0|||
105962566|NCT04952597|365523137|FG002|Overall Study|Withdrawal by Subject|3|||
105962567|NCT04952597|365523135|FG000|Overall Study|Lost to Follow-up|0|||
105962568|NCT04952597|365523136|FG001|Overall Study|Lost to Follow-up|1|||
105962569|NCT04952597|365523137|FG002|Overall Study|Lost to Follow-up|1|||
105962570|NCT00716482|365523141|FG000|Overall Study|Lost to Follow-up|6|||
105962571|NCT00716482|365523141|FG000|Overall Study|Inadequate acquisition or analysis|50|||
105962572|NCT00716482|365523141|FG000|Overall Study|no pathology obtained|10|||
105962573|NCT00716482|365523141|FG000|Overall Study|technical/machine error|28|||
105962574|NCT00716482|365523141|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
105962575|NCT02141399|365523144|FG000|Overall Study|Adverse Event|158|||
105962576|NCT02141399|365523144|FG000|Overall Study|Lack of Efficacy|62|||
105962577|NCT02141399|365523144|FG000|Overall Study|Lost to Follow-up|151|||
105962578|NCT02141399|365523144|FG000|Overall Study|Non-compliance with study drug|18|||
105962579|NCT02141399|365523144|FG000|Overall Study|Other|45|||
105962580|NCT02141399|365523144|FG000|Overall Study|Physician Decision|17|||
105962581|NCT02141399|365523144|FG000|Overall Study|Pregnancy|3|||
105962582|NCT02141399|365523144|FG000|Overall Study|Protocol Violation|38|||
105962583|NCT02141399|365523144|FG000|Overall Study|Withdrawal by Subject|238|||
105962584|NCT02141399|365523144|FG000|Overall Study|Failure to meet eligibility criteria|14|||
105962585|NCT02550288|365523145|FG000|Overall Study|Adverse Event|0|||
105962586|NCT02550288|365523146|FG001|Overall Study|Adverse Event|1|||
105962587|NCT02550288|365523147|FG002|Overall Study|Adverse Event|0|||
105962588|NCT02550288|365523148|FG003|Overall Study|Adverse Event|0|||
105962589|NCT02550288|365523149|FG004|Overall Study|Adverse Event|0|||
105962590|NCT02550288|365523145|FG000|Overall Study|Physician Decision|0|||
105962591|NCT02550288|365523146|FG001|Overall Study|Physician Decision|0|||
105962592|NCT02550288|365523147|FG002|Overall Study|Physician Decision|0|||
105962593|NCT02550288|365523148|FG003|Overall Study|Physician Decision|1|||
105962594|NCT02550288|365523149|FG004|Overall Study|Physician Decision|0|||
105962595|NCT02550288|365523145|FG000|Overall Study|Protocol Violation|2|||
105962596|NCT02550288|365523146|FG001|Overall Study|Protocol Violation|2|||
105962597|NCT02550288|365523147|FG002|Overall Study|Protocol Violation|1|||
105962598|NCT02550288|365523148|FG003|Overall Study|Protocol Violation|0|||
105962599|NCT02550288|365523149|FG004|Overall Study|Protocol Violation|3|||
105962600|NCT02550288|365523145|FG000|Overall Study|Participant moved|0|||
105962601|NCT02550288|365523146|FG001|Overall Study|Participant moved|0|||
105962602|NCT02550288|365523147|FG002|Overall Study|Participant moved|0|||
105962603|NCT02550288|365523148|FG003|Overall Study|Participant moved|1|||
105962604|NCT02550288|365523149|FG004|Overall Study|Participant moved|0|||
106022359|NCT01057589|365746838|FG000|Overall Study|Lost to Follow-up|1|||
106022360|NCT02252939|365746839|FG000|Overall Study|Lost to Follow-up|3|||
106022361|NCT00661427|365746847|FG000|Overall Study|Adverse Event|5|||
106022362|NCT00661427|365746848|FG001|Overall Study|Adverse Event|5|||
105962605|NCT02550288|365523145|FG000|Overall Study|Withdrawal by Subject|0|||
105962606|NCT02550288|365523146|FG001|Overall Study|Withdrawal by Subject|0|||
105962607|NCT02550288|365523147|FG002|Overall Study|Withdrawal by Subject|0|||
105962608|NCT02550288|365523148|FG003|Overall Study|Withdrawal by Subject|1|||
105962609|NCT02550288|365523149|FG004|Overall Study|Withdrawal by Subject|0|||
105962610|NCT03517371|365523153|FG000|Overall Study|Adverse Event|8|||
105962611|NCT03517371|365523154|FG001|Overall Study|Adverse Event|9|||
105962612|NCT03517371|365523153|FG000|Overall Study|Lost to Follow-up|1|||
105962613|NCT03517371|365523154|FG001|Overall Study|Lost to Follow-up|2|||
105962614|NCT03517371|365523153|FG000|Overall Study|Withdrawal by Subject|4|||
105962615|NCT03517371|365523154|FG001|Overall Study|Withdrawal by Subject|4|||
105962616|NCT03517371|365523153|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
105962617|NCT03517371|365523154|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
105962618|NCT03517371|365523153|FG000|Overall Study|COVID restrictions|2|||
105962619|NCT03517371|365523154|FG001|Overall Study|COVID restrictions|0|||
105962620|NCT03517371|365523153|FG000|Overall Study|Receiving DBS Surgery|0|||
105962621|NCT03517371|365523154|FG001|Overall Study|Receiving DBS Surgery|1|||
105962622|NCT05420961|365523155|FG000|Overall Study|Withdrawal by Subject|2|||
105962623|NCT05420961|365523156|FG001|Overall Study|Withdrawal by Subject|1|||
105962624|NCT05420961|365523157|FG002|Overall Study|Withdrawal by Subject|1|||
105962625|NCT05420961|365523158|FG003|Overall Study|Withdrawal by Subject|0|||
105962626|NCT05420961|365523159|FG004|Overall Study|Withdrawal by Subject|0|||
105962627|NCT05420961|365523155|FG000|Overall Study|Lost to Follow-up|0|||
105962628|NCT05420961|365523156|FG001|Overall Study|Lost to Follow-up|0|||
105962629|NCT05420961|365523157|FG002|Overall Study|Lost to Follow-up|1|||
105962630|NCT05420961|365523158|FG003|Overall Study|Lost to Follow-up|0|||
105962631|NCT05420961|365523159|FG004|Overall Study|Lost to Follow-up|0|||
105962632|NCT05420961|365523155|FG000|Overall Study|Randomized by mistake without study treatment|0|||
105962633|NCT05420961|365523156|FG001|Overall Study|Randomized by mistake without study treatment|0|||
105962634|NCT05420961|365523157|FG002|Overall Study|Randomized by mistake without study treatment|1|||
106022363|NCT00661427|365746847|FG000|Overall Study|Patient not treated|0|||
106022364|NCT00661427|365746848|FG001|Overall Study|Patient not treated|2|||
105962635|NCT05420961|365523158|FG003|Overall Study|Randomized by mistake without study treatment|0|||
105962636|NCT05420961|365523159|FG004|Overall Study|Randomized by mistake without study treatment|1|||
105962637|NCT04283656|365523160|FG000|Overall Study|Adverse Event|1|||
105962638|NCT04283656|365523161|FG001|Overall Study|Adverse Event|0|||
105962639|NCT04283656|365523160|FG000|Overall Study|Lost to Follow-up|0|||
105962640|NCT04283656|365523161|FG001|Overall Study|Lost to Follow-up|1|||
105962641|NCT01345929|365523162|FG000|Overall Study|Withdrawal by Subject|9|||
106022365|NCT01821560|365746849|FG000|Overall Study|Lost to Follow-up|5|||
106022366|NCT01821560|365746850|FG001|Overall Study|Lost to Follow-up|5|||
106022367|NCT01821560|365746849|FG000|Overall Study|Withdrawal by Subject|1|||
106022368|NCT01821560|365746850|FG001|Overall Study|Withdrawal by Subject|1|||
106022369|NCT01821560|365746849|FG000|Overall Study|Protocol Violation|0|||
106022370|NCT01821560|365746850|FG001|Overall Study|Protocol Violation|1|||
105962642|NCT01345929|365523163|FG001|Overall Study|Withdrawal by Subject|8|||
105962643|NCT01345929|365523162|FG000|Overall Study|Lost to Follow-up|9|||
105962644|NCT01345929|365523163|FG001|Overall Study|Lost to Follow-up|9|||
105962645|NCT01345929|365523162|FG000|Overall Study|Adverse Event|0|||
105962646|NCT01345929|365523163|FG001|Overall Study|Adverse Event|1|||
105962647|NCT01345929|365523162|FG000|Overall Study|Didn't meet eligibility criteria|2|||
105962648|NCT01345929|365523163|FG001|Overall Study|Didn't meet eligibility criteria|0|||
105962649|NCT01345929|365523162|FG000|Overall Study|40,000 CFU/ML|1|||
105962650|NCT01345929|365523163|FG001|Overall Study|40,000 CFU/ML|0|||
105962651|NCT01345929|365523162|FG000|Overall Study|Patient withdrawal|0|||
105962652|NCT01345929|365523163|FG001|Overall Study|Patient withdrawal|1|||
105962653|NCT01864148|365523164|FG000|Overall Study|Other|2|||
105962654|NCT01864148|365523165|FG001|Overall Study|Other|1|||
105962655|NCT01864148|365523166|FG002|Overall Study|Other|1|||
105962656|NCT01864148|365523167|FG003|Overall Study|Other|3|||
105962657|NCT01864148|365523168|FG004|Overall Study|Other|1|||
105962658|NCT01864148|365523164|FG000|Overall Study|Death|0|||
105962659|NCT01864148|365523165|FG001|Overall Study|Death|0|||
105962660|NCT01864148|365523166|FG002|Overall Study|Death|0|||
105962661|NCT01864148|365523167|FG003|Overall Study|Death|1|||
105962662|NCT01864148|365523168|FG004|Overall Study|Death|0|||
105962663|NCT01864148|365523164|FG000|Overall Study|Investigator Decision|5|||
105962664|NCT01864148|365523165|FG001|Overall Study|Investigator Decision|0|||
105962665|NCT01864148|365523166|FG002|Overall Study|Investigator Decision|0|||
105962666|NCT01864148|365523167|FG003|Overall Study|Investigator Decision|4|||
105962667|NCT01864148|365523168|FG004|Overall Study|Investigator Decision|6|||
105962668|NCT01864148|365523164|FG000|Overall Study|Withdrawal by Subject|9|||
105962669|NCT01864148|365523165|FG001|Overall Study|Withdrawal by Subject|2|||
105962670|NCT01864148|365523166|FG002|Overall Study|Withdrawal by Subject|6|||
105962671|NCT01864148|365523167|FG003|Overall Study|Withdrawal by Subject|8|||
105962672|NCT01864148|365523168|FG004|Overall Study|Withdrawal by Subject|8|||
105962673|NCT01864148|365523164|FG000|Overall Study|Lost to Follow-up|0|||
105962674|NCT01864148|365523165|FG001|Overall Study|Lost to Follow-up|0|||
105962675|NCT01864148|365523166|FG002|Overall Study|Lost to Follow-up|0|||
105962676|NCT01864148|365523167|FG003|Overall Study|Lost to Follow-up|2|||
105962677|NCT01864148|365523168|FG004|Overall Study|Lost to Follow-up|1|||
105962678|NCT01864148|365523164|FG000|Overall Study|Adverse Event|4|||
105962679|NCT01864148|365523165|FG001|Overall Study|Adverse Event|2|||
105962680|NCT01864148|365523166|FG002|Overall Study|Adverse Event|4|||
105962681|NCT01864148|365523167|FG003|Overall Study|Adverse Event|7|||
105962682|NCT01864148|365523168|FG004|Overall Study|Adverse Event|7|||
105962683|NCT01864148|365523164|FG000|Overall Study|Not Dosed|0|||
105962684|NCT01864148|365523165|FG001|Overall Study|Not Dosed|0|||
105962685|NCT01864148|365523166|FG002|Overall Study|Not Dosed|0|||
105962686|NCT01864148|365523167|FG003|Overall Study|Not Dosed|1|||
105962687|NCT01864148|365523168|FG004|Overall Study|Not Dosed|0|||
105962688|NCT00964002|365523170|FG000|Overall Study|Protocol Violation|8|||
105962689|NCT02466425|365523171|FG000|Overall Study|Adverse Event|3|||
105962690|NCT02466425|365523172|FG001|Overall Study|Adverse Event|11|||
105962691|NCT02466425|365523171|FG000|Overall Study|Lack of Efficacy|4|||
105962692|NCT02466425|365523172|FG001|Overall Study|Lack of Efficacy|1|||
105962693|NCT02466425|365523171|FG000|Overall Study|Lost to Follow-up|3|||
105962694|NCT02466425|365523172|FG001|Overall Study|Lost to Follow-up|0|||
105962695|NCT02466425|365523171|FG000|Overall Study|Protocol Violation|1|||
105962696|NCT02466425|365523172|FG001|Overall Study|Protocol Violation|0|||
105962697|NCT02466425|365523171|FG000|Overall Study|Withdrawal by Subject|0|||
105962698|NCT02466425|365523172|FG001|Overall Study|Withdrawal by Subject|1|||
105962699|NCT02466425|365523171|FG000|Overall Study|Other|1|||
105962700|NCT02466425|365523172|FG001|Overall Study|Other|3|||
105962701|NCT02466425|365523171|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105962702|NCT02466425|365523172|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105962703|NCT01721486|365523177|FG000|Overall Study|Protocol Violation|1|||
105962704|NCT01721486|365523178|FG001|Overall Study|Protocol Violation|0|||
105962705|NCT01721486|365523177|FG000|Overall Study|Physician Decision|0|||
105962706|NCT01721486|365523178|FG001|Overall Study|Physician Decision|1|||
105962707|NCT04004221|365523185|FG000|Overall Study|Death|89|||
105962708|NCT04004221|365523185|FG000|Overall Study|Withdrawal by Subject|5|||
105962709|NCT04004221|365523185|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
105962710|NCT04004221|365523185|FG000|Overall Study|Sponsor Decision|9|||
105962711|NCT04004221|365523185|FG000|Overall Study|Participant refused to enter LTE|1|||
105962712|NCT05141175|365523186|FG000|Overall Study|Withdrawal by Subject|1|||
106022371|NCT00531427|365746853|FG000|Overall Study|Withdrawal by Subject|7|||
106022372|NCT00531427|365746854|FG001|Overall Study|Withdrawal by Subject|13|||
105962713|NCT01901289|365523188|FG000|Overall Study|Death|32|||
105962714|NCT01901289|365523188|FG000|Overall Study|Lost to Follow-up|16|||
105962715|NCT01901289|365523188|FG000|Overall Study|Withdrawal by Subject|35|||
105962716|NCT01901289|365523188|FG000|Overall Study|Other type of endpoint met|2|||
105962717|NCT00992056|365523189|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
105962718|NCT00992056|365523190|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
105962719|NCT00992056|365523189|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
105962720|NCT00992056|365523190|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
105962721|NCT00177294|365523193|FG000|Overall Study|Withdrawal by Subject|7|||
105962722|NCT00177294|365523194|FG001|Overall Study|Withdrawal by Subject|5|||
105962723|NCT03745638|365523200|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
105962724|NCT03745638|365523201|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
105962725|NCT03745638|365523202|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
105962726|NCT03745638|365523203|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105962727|NCT03745638|365523204|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105962728|NCT03745638|365523205|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105962729|NCT03745638|365523206|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105962730|NCT03745638|365523200|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
105962731|NCT03745638|365523201|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105962732|NCT03745638|365523202|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105962733|NCT03745638|365523203|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105962734|NCT03745638|365523204|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105962735|NCT03745638|365523205|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105962736|NCT03745638|365523206|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
105962737|NCT03745638|365523200|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
105962738|NCT03745638|365523201|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
105962739|NCT03745638|365523202|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
105962740|NCT03745638|365523203|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105962741|NCT03745638|365523204|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105962742|NCT03745638|365523205|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105962743|NCT03745638|365523206|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105962744|NCT03745638|365523200|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
105962745|NCT03745638|365523201|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
105962746|NCT03745638|365523202|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105962747|NCT03745638|365523203|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105962748|NCT03745638|365523204|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105962749|NCT03745638|365523205|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105962750|NCT03745638|365523206|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105962751|NCT03745638|365523200|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
105962752|NCT03745638|365523201|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105962753|NCT03745638|365523202|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105962754|NCT03745638|365523203|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105962755|NCT03745638|365523204|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105962756|NCT03745638|365523205|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105962757|NCT03745638|365523206|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
105962758|NCT03745638|365523200|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105962759|NCT03745638|365523201|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
105962760|NCT03745638|365523202|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105962761|NCT03745638|365523203|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105962762|NCT03745638|365523204|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105962763|NCT03745638|365523205|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105962764|NCT03745638|365523206|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105962765|NCT03745638|365523200|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
105962766|NCT03745638|365523201|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
105962767|NCT03745638|365523202|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
105962768|NCT03745638|365523203|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105962769|NCT03745638|365523204|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105962770|NCT03745638|365523205|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105962771|NCT03745638|365523206|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105962772|NCT03745638|365523200|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
105962773|NCT03745638|365523201|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
105962774|NCT03745638|365523202|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105962775|NCT03745638|365523203|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105962776|NCT03745638|365523204|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105962777|NCT03745638|365523205|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105962778|NCT03745638|365523206|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
105962779|NCT03745638|365523200|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105962780|NCT03745638|365523201|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105962781|NCT03745638|365523202|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105962782|NCT03745638|365523203|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105962783|NCT03745638|365523204|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105962784|NCT03745638|365523205|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
105962785|NCT03745638|365523206|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
105962786|NCT03745638|365523200|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105962787|NCT03745638|365523201|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105962788|NCT03745638|365523202|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105827174|NCT01634139|365026415|FG002|Overall Study|Other|3|||
105827175|NCT01634139|365026413|FG000|Overall Study|Lost to Follow-up|0|||
105827176|NCT01634139|365026414|FG001|Overall Study|Lost to Follow-up|2|||
105827177|NCT01634139|365026415|FG002|Overall Study|Lost to Follow-up|0|||
105827178|NCT01634139|365026413|FG000|Overall Study|Not treated|1|||
105827179|NCT01634139|365026414|FG001|Overall Study|Not treated|1|||
105827180|NCT01634139|365026415|FG002|Overall Study|Not treated|0|||
105827181|NCT02441686|365026416|FG000|Induction|Adverse Event|4|||
105827182|NCT02441686|365026416|FG000|Induction|Complicating disease|1|||
105827183|NCT02441686|365026416|FG000|Induction|Physician Decision|1|||
105827184|NCT02441686|365026416|FG000|Induction|Withdrawal by Subject|1|||
105827185|NCT02441686|365026416|FG000|Induction|Did not receive treatment|1|||
105827186|NCT02441686|365026416|FG000|Maintenance|Remaining on Treatment|23|||
105827187|NCT02441686|365026416|FG000|Maintenance|Physician Decision|1|||
105827188|NCT02441686|365026416|FG000|Maintenance|Adverse Event|3|||
105827189|NCT02441686|365026416|FG000|Maintenance|Progressive Disease|10|||
105827190|NCT02441686|365026416|FG000|Maintenance|Withdrawal by Subject|1|||
105827191|NCT01647828|365026418|FG000|Overall Study|Death|3|||
105827192|NCT01647828|365026419|FG001|Overall Study|Death|4|||
105827193|NCT01647828|365026420|FG002|Overall Study|Death|4|||
105827194|NCT01647828|365026421|FG003|Overall Study|Death|5|||
105827195|NCT01647828|365026422|FG004|Overall Study|Death|6|||
105827196|NCT01647828|365026423|FG005|Overall Study|Death|3|||
105827197|NCT01647828|365026424|FG006|Overall Study|Death|10|||
105827198|NCT01647828|365026425|FG007|Overall Study|Death|60|||
105827199|NCT01647828|365026426|FG008|Overall Study|Death|71|||
105827200|NCT01647828|365026418|FG000|Overall Study|Withdrawal by Subject|2|||
105827201|NCT01647828|365026419|FG001|Overall Study|Withdrawal by Subject|0|||
105827202|NCT01647828|365026420|FG002|Overall Study|Withdrawal by Subject|0|||
105827203|NCT01647828|365026421|FG003|Overall Study|Withdrawal by Subject|1|||
105827204|NCT01647828|365026422|FG004|Overall Study|Withdrawal by Subject|0|||
105827205|NCT01647828|365026423|FG005|Overall Study|Withdrawal by Subject|0|||
105827206|NCT01647828|365026424|FG006|Overall Study|Withdrawal by Subject|1|||
105827207|NCT01647828|365026425|FG007|Overall Study|Withdrawal by Subject|0|||
105827208|NCT01647828|365026426|FG008|Overall Study|Withdrawal by Subject|2|||
105827209|NCT01647828|365026418|FG000|Overall Study|Study terminated by Sponsor|0|||
105827210|NCT01647828|365026419|FG001|Overall Study|Study terminated by Sponsor|0|||
105827211|NCT01647828|365026420|FG002|Overall Study|Study terminated by Sponsor|0|||
105827212|NCT01647828|365026421|FG003|Overall Study|Study terminated by Sponsor|0|||
105827213|NCT01647828|365026422|FG004|Overall Study|Study terminated by Sponsor|0|||
105827214|NCT01647828|365026423|FG005|Overall Study|Study terminated by Sponsor|0|||
105827215|NCT01647828|365026424|FG006|Overall Study|Study terminated by Sponsor|1|||
105827216|NCT01647828|365026425|FG007|Overall Study|Study terminated by Sponsor|26|||
105827217|NCT01647828|365026426|FG008|Overall Study|Study terminated by Sponsor|16|||
105827218|NCT01647828|365026418|FG000|Overall Study|Lost to Follow-up|0|||
105827219|NCT01647828|365026419|FG001|Overall Study|Lost to Follow-up|0|||
105827220|NCT01647828|365026420|FG002|Overall Study|Lost to Follow-up|0|||
105827221|NCT01647828|365026421|FG003|Overall Study|Lost to Follow-up|0|||
105827222|NCT01647828|365026422|FG004|Overall Study|Lost to Follow-up|0|||
105827223|NCT01647828|365026423|FG005|Overall Study|Lost to Follow-up|0|||
105827224|NCT01647828|365026424|FG006|Overall Study|Lost to Follow-up|0|||
106148294|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
106148295|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
106148296|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
106148297|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
106148298|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
106148299|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
106148300|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
106148301|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
106148302|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
106148303|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
106148304|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
106148305|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
106148306|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
106148307|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
106148308|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
105962789|NCT03745638|365523203|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
105962790|NCT03745638|365523204|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105962791|NCT03745638|365523205|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
105962792|NCT03745638|365523206|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
105962793|NCT03745638|365523200|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105962794|NCT03745638|365523201|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105962795|NCT03745638|365523202|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105962796|NCT03745638|365523203|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
105962797|NCT03745638|365523204|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
105962798|NCT03745638|365523205|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
105962799|NCT03745638|365523206|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
105962800|NCT03745638|365523200|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105962801|NCT03745638|365523201|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105962802|NCT03745638|365523202|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105962803|NCT03745638|365523203|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105962804|NCT03745638|365523204|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
105962805|NCT03745638|365523205|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
105962806|NCT03745638|365523206|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105962807|NCT03745638|365523200|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105962808|NCT03745638|365523201|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105962809|NCT03745638|365523202|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105962810|NCT03745638|365523203|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105962811|NCT03745638|365523204|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105962812|NCT03745638|365523205|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
105962813|NCT03745638|365523206|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105962814|NCT03745638|365523200|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105962815|NCT03745638|365523201|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105962816|NCT03745638|365523202|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105962817|NCT03745638|365523203|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
105962818|NCT03745638|365523204|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
105962819|NCT03745638|365523205|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
105962820|NCT03745638|365523206|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
105962821|NCT03745638|365523200|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105962822|NCT03745638|365523201|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105962823|NCT03745638|365523202|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105962824|NCT03745638|365523203|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105962825|NCT03745638|365523204|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
105962826|NCT03745638|365523205|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
105962827|NCT03745638|365523206|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
105962828|NCT04470050|365523209|FG000|Double-blind Treatment Phase|Adverse Event|0|||
105962829|NCT04470050|365523210|FG001|Double-blind Treatment Phase|Adverse Event|0|||
105962830|NCT04470050|365523211|FG002|Double-blind Treatment Phase|Adverse Event|0|||
105962831|NCT04470050|365523212|FG003|Double-blind Treatment Phase|Adverse Event|1|||
105962832|NCT04470050|365523213|FG004|Double-blind Treatment Phase|Adverse Event|0|||
105962833|NCT04470050|365523214|FG005|Double-blind Treatment Phase|Adverse Event|0|||
105962834|NCT04470050|365523215|FG006|Double-blind Treatment Phase|Adverse Event|0|||
105962835|NCT04470050|365523209|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
106148309|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
106148310|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
106148311|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
106148312|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
105827225|NCT01647828|365026425|FG007|Overall Study|Lost to Follow-up|2|||
105827226|NCT01647828|365026426|FG008|Overall Study|Lost to Follow-up|0|||
105827227|NCT03629054|365026428|FG000|Period 2 (4 Days)|Not treated|0|||
105827228|NCT03629054|365026429|FG001|Period 2 (4 Days)|Not treated|1|||
105827229|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
105827230|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
105827231|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
105827232|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
105827233|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
105827234|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
105827235|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Death|9|||
105827236|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Death|7|||
105827237|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Death|14|||
105827238|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Death|7|||
105827239|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Death|0|||
105827240|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Death|0|||
105827241|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
105827242|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
105827243|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
105827244|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
105827245|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
105827246|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
105827247|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Other Event|49|||
105827248|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Other Event|52|||
105827249|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Other Event|41|||
105827250|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Other Event|58|||
105827251|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Other Event|0|||
105827252|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Other Event|0|||
105827253|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
105827254|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
105827255|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
105827256|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
105827257|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
105827258|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
105827259|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
105827260|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
105962836|NCT04470050|365523210|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
105962837|NCT04470050|365523211|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
105962838|NCT04470050|365523212|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
105962839|NCT04470050|365523213|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
105962840|NCT04470050|365523214|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
105962841|NCT04470050|365523215|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
105962842|NCT04470050|365523209|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
105962843|NCT04470050|365523210|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
105962844|NCT04470050|365523211|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
105962845|NCT04470050|365523212|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
105962846|NCT04470050|365523213|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
105962847|NCT04470050|365523214|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
105962848|NCT04470050|365523215|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
105962849|NCT01813058|365523217|FG000|Overall Study|Withdrawal by Subject|5|||
105962850|NCT01813058|365523218|FG001|Overall Study|Withdrawal by Subject|4|||
105962851|NCT00313144|365523219|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
105962852|NCT00313144|365523219|FG000|Overall Study|Death|7|||
105962853|NCT00313144|365523219|FG000|Overall Study|Lost to Follow-up|5|||
105962854|NCT00313144|365523219|FG000|Overall Study|Withdrawal by Subject|4|||
105962855|NCT00313144|365523219|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
105962856|NCT00313144|365523219|FG000|Overall Study|Physician Decision|4|||
105962857|NCT00313144|365523219|FG000|Overall Study|Adverse event - transient|5|||
105962858|NCT00313144|365523219|FG000|Overall Study|Liver transplant|1|||
105962859|NCT00313144|365523219|FG000|Overall Study|Insurance (homecare provider) change|1|||
105962860|NCT00313144|365523219|FG000|Overall Study|Change to different product|1|||
105962861|NCT00313144|365523219|FG000|Overall Study|Due to termination of the study|66|||
105962862|NCT01932372|365523220|FG000|Overall Study|Not meeting eligibility criteria|33|||
105962863|NCT01932372|365523221|FG001|Overall Study|Not meeting eligibility criteria|179|||
105962864|NCT05823974|365525201|FG000|Overall Study|Lost to Follow-up|0|||
105962865|NCT05823974|365525202|FG001|Overall Study|Lost to Follow-up|3|||
105962866|NCT05823974|365525203|FG002|Overall Study|Lost to Follow-up|1|||
105962867|NCT05823974|365525204|FG003|Overall Study|Lost to Follow-up|0|||
105827261|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
105962868|NCT05823974|365525205|FG004|Overall Study|Lost to Follow-up|1|||
105962869|NCT05823974|365525206|FG005|Overall Study|Lost to Follow-up|0|||
105962870|NCT05823974|365525207|FG006|Overall Study|Lost to Follow-up|1|||
105962871|NCT05823974|365525208|FG007|Overall Study|Lost to Follow-up|0|||
105962872|NCT05823974|365525209|FG008|Overall Study|Lost to Follow-up|0|||
105962873|NCT05823974|365525210|FG009|Overall Study|Lost to Follow-up|1|||
105962874|NCT05823974|365525211|FG010|Overall Study|Lost to Follow-up|1|||
105962875|NCT05823974|365525212|FG011|Overall Study|Lost to Follow-up|0|||
105962876|NCT05823974|365525213|FG012|Overall Study|Lost to Follow-up|1|||
105962877|NCT05823974|365525214|FG013|Overall Study|Lost to Follow-up|2|||
105962878|NCT05823974|365525215|FG014|Overall Study|Lost to Follow-up|1|||
105962879|NCT05823974|365525216|FG015|Overall Study|Lost to Follow-up|1|||
105962880|NCT05823974|365525217|FG016|Overall Study|Lost to Follow-up|1|||
105962881|NCT05823974|365525218|FG017|Overall Study|Lost to Follow-up|0|||
105962882|NCT05823974|365525219|FG018|Overall Study|Lost to Follow-up|0|||
105962883|NCT05823974|365525220|FG019|Overall Study|Lost to Follow-up|2|||
105962884|NCT05823974|365525221|FG020|Overall Study|Lost to Follow-up|0|||
105962885|NCT05823974|365525201|FG000|Overall Study|Physician Decision|0|||
105962886|NCT05823974|365525202|FG001|Overall Study|Physician Decision|0|||
105962887|NCT05823974|365525203|FG002|Overall Study|Physician Decision|0|||
105962888|NCT05823974|365525204|FG003|Overall Study|Physician Decision|0|||
105962889|NCT05823974|365525205|FG004|Overall Study|Physician Decision|0|||
105962890|NCT05823974|365525206|FG005|Overall Study|Physician Decision|0|||
105962891|NCT05823974|365525207|FG006|Overall Study|Physician Decision|0|||
105962892|NCT05823974|365525208|FG007|Overall Study|Physician Decision|0|||
105962893|NCT05823974|365525209|FG008|Overall Study|Physician Decision|0|||
105962894|NCT05823974|365525210|FG009|Overall Study|Physician Decision|0|||
105962895|NCT05823974|365525211|FG010|Overall Study|Physician Decision|0|||
105962896|NCT05823974|365525212|FG011|Overall Study|Physician Decision|0|||
105962897|NCT05823974|365525213|FG012|Overall Study|Physician Decision|0|||
105962898|NCT05823974|365525214|FG013|Overall Study|Physician Decision|0|||
105962899|NCT05823974|365525215|FG014|Overall Study|Physician Decision|0|||
105962900|NCT05823974|365525216|FG015|Overall Study|Physician Decision|1|||
105827262|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
105827263|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
105962901|NCT05823974|365525217|FG016|Overall Study|Physician Decision|0|||
105962902|NCT05823974|365525218|FG017|Overall Study|Physician Decision|1|||
105962903|NCT05823974|365525219|FG018|Overall Study|Physician Decision|1|||
105962904|NCT05823974|365525220|FG019|Overall Study|Physician Decision|0|||
105962905|NCT05823974|365525221|FG020|Overall Study|Physician Decision|0|||
105962906|NCT05823974|365525201|FG000|Overall Study|Withdrawal by Subject|1|||
105962907|NCT05823974|365525202|FG001|Overall Study|Withdrawal by Subject|1|||
105962908|NCT05823974|365525203|FG002|Overall Study|Withdrawal by Subject|2|||
105962909|NCT05823974|365525204|FG003|Overall Study|Withdrawal by Subject|0|||
105962910|NCT05823974|365525205|FG004|Overall Study|Withdrawal by Subject|2|||
105827264|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
105827265|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
105827266|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
105827267|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
105827268|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
105827269|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
105827270|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
105827271|NCT00205777|365026430|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
105827272|NCT00205777|365026431|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
105827273|NCT00205777|365026432|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
105827274|NCT00205777|365026433|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
105827275|NCT00205777|365026434|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
105827276|NCT00205777|365026435|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
105827277|NCT00205777|365026430|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
105827278|NCT00205777|365026431|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
105827279|NCT00205777|365026432|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
105827280|NCT00205777|365026433|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
105827281|NCT00205777|365026434|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
105827282|NCT00205777|365026435|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
105827283|NCT00205777|365026430|FG000|Completed Core Study, Entered SE I|Other Event|52|||
105827284|NCT00205777|365026431|FG001|Completed Core Study, Entered SE I|Other Event|46|||
105827285|NCT00205777|365026432|FG002|Completed Core Study, Entered SE I|Other Event|47|||
105827286|NCT00205777|365026433|FG003|Completed Core Study, Entered SE I|Other Event|50|||
105827287|NCT00205777|365026434|FG004|Completed Core Study, Entered SE I|Other Event|0|||
105827288|NCT00205777|365026435|FG005|Completed Core Study, Entered SE I|Other Event|0|||
105827289|NCT00205777|365026430|FG000|Study Extension I|Adverse Event|57|||
105827290|NCT00205777|365026431|FG001|Study Extension I|Adverse Event|0|||
105827291|NCT00205777|365026432|FG002|Study Extension I|Adverse Event|0|||
105827292|NCT00205777|365026433|FG003|Study Extension I|Adverse Event|61|||
105827293|NCT00205777|365026434|FG004|Study Extension I|Adverse Event|58|||
105827294|NCT00205777|365026435|FG005|Study Extension I|Adverse Event|0|||
105827295|NCT00205777|365026430|FG000|Study Extension I|Death|5|||
105827296|NCT00205777|365026431|FG001|Study Extension I|Death|0|||
105827297|NCT00205777|365026432|FG002|Study Extension I|Death|0|||
105827298|NCT00205777|365026433|FG003|Study Extension I|Death|1|||
105827299|NCT00205777|365026434|FG004|Study Extension I|Death|2|||
105827300|NCT00205777|365026435|FG005|Study Extension I|Death|0|||
105827301|NCT00205777|365026430|FG000|Study Extension I|Withdrawal by Subject|99|||
105827302|NCT00205777|365026431|FG001|Study Extension I|Withdrawal by Subject|0|||
105827303|NCT00205777|365026432|FG002|Study Extension I|Withdrawal by Subject|0|||
105827304|NCT00205777|365026433|FG003|Study Extension I|Withdrawal by Subject|106|||
105827305|NCT00205777|365026434|FG004|Study Extension I|Withdrawal by Subject|89|||
105827306|NCT00205777|365026435|FG005|Study Extension I|Withdrawal by Subject|0|||
105827307|NCT00205777|365026430|FG000|Study Extension I|Protocol Violation|4|||
105827308|NCT00205777|365026431|FG001|Study Extension I|Protocol Violation|0|||
105827309|NCT00205777|365026432|FG002|Study Extension I|Protocol Violation|0|||
105827310|NCT00205777|365026433|FG003|Study Extension I|Protocol Violation|8|||
105827311|NCT00205777|365026434|FG004|Study Extension I|Protocol Violation|8|||
105827312|NCT00205777|365026435|FG005|Study Extension I|Protocol Violation|0|||
105827313|NCT00205777|365026430|FG000|Study Extension I|Lack of Efficacy|0|||
105827314|NCT00205777|365026431|FG001|Study Extension I|Lack of Efficacy|0|||
105827315|NCT00205777|365026432|FG002|Study Extension I|Lack of Efficacy|0|||
105827316|NCT00205777|365026433|FG003|Study Extension I|Lack of Efficacy|1|||
105827317|NCT00205777|365026434|FG004|Study Extension I|Lack of Efficacy|2|||
105962911|NCT05823974|365525206|FG005|Overall Study|Withdrawal by Subject|3|||
105962912|NCT05823974|365525207|FG006|Overall Study|Withdrawal by Subject|1|||
105962913|NCT05823974|365525208|FG007|Overall Study|Withdrawal by Subject|1|||
105962914|NCT05823974|365525209|FG008|Overall Study|Withdrawal by Subject|2|||
105962915|NCT05823974|365525210|FG009|Overall Study|Withdrawal by Subject|1|||
105962916|NCT05823974|365525211|FG010|Overall Study|Withdrawal by Subject|1|||
105962917|NCT05823974|365525212|FG011|Overall Study|Withdrawal by Subject|0|||
105962918|NCT05823974|365525213|FG012|Overall Study|Withdrawal by Subject|0|||
105962919|NCT05823974|365525214|FG013|Overall Study|Withdrawal by Subject|1|||
105962920|NCT05823974|365525215|FG014|Overall Study|Withdrawal by Subject|1|||
105962921|NCT05823974|365525216|FG015|Overall Study|Withdrawal by Subject|3|||
105962922|NCT05823974|365525217|FG016|Overall Study|Withdrawal by Subject|0|||
105962923|NCT05823974|365525218|FG017|Overall Study|Withdrawal by Subject|2|||
105962924|NCT05823974|365525219|FG018|Overall Study|Withdrawal by Subject|2|||
105962925|NCT05823974|365525220|FG019|Overall Study|Withdrawal by Subject|0|||
105962926|NCT05823974|365525221|FG020|Overall Study|Withdrawal by Subject|1|||
105962927|NCT05823974|365525201|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962928|NCT05823974|365525202|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962929|NCT05823974|365525203|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105962930|NCT05823974|365525204|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962931|NCT05823974|365525205|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962932|NCT05823974|365525206|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105827318|NCT00205777|365026435|FG005|Study Extension I|Lack of Efficacy|0|||
105962933|NCT05823974|365525207|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962934|NCT05823974|365525208|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962935|NCT05823974|365525209|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962936|NCT05823974|365525210|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962937|NCT05823974|365525211|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962938|NCT05823974|365525212|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962939|NCT05823974|365525213|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962940|NCT05823974|365525214|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962941|NCT05823974|365525215|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105962942|NCT05823974|365525216|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962943|NCT05823974|365525217|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962944|NCT05823974|365525218|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962945|NCT05823974|365525219|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962946|NCT05823974|365525220|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962947|NCT05823974|365525221|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105962948|NCT05823974|365525201|FG000|Overall Study|Other|0|||
105962949|NCT05823974|365525202|FG001|Overall Study|Other|1|||
105962950|NCT05823974|365525203|FG002|Overall Study|Other|1|||
105962951|NCT05823974|365525204|FG003|Overall Study|Other|1|||
105962952|NCT05823974|365525205|FG004|Overall Study|Other|0|||
105962953|NCT05823974|365525206|FG005|Overall Study|Other|1|||
105962954|NCT05823974|365525207|FG006|Overall Study|Other|1|||
105962955|NCT05823974|365525208|FG007|Overall Study|Other|1|||
105962956|NCT05823974|365525209|FG008|Overall Study|Other|1|||
105962957|NCT05823974|365525210|FG009|Overall Study|Other|0|||
105962958|NCT05823974|365525211|FG010|Overall Study|Other|0|||
105962959|NCT05823974|365525212|FG011|Overall Study|Other|0|||
105962960|NCT05823974|365525213|FG012|Overall Study|Other|2|||
105962961|NCT05823974|365525214|FG013|Overall Study|Other|1|||
105962962|NCT05823974|365525215|FG014|Overall Study|Other|0|||
105962963|NCT05823974|365525216|FG015|Overall Study|Other|1|||
105962964|NCT05823974|365525217|FG016|Overall Study|Other|0|||
105962965|NCT05823974|365525218|FG017|Overall Study|Other|0|||
105962966|NCT05823974|365525219|FG018|Overall Study|Other|0|||
105962967|NCT05823974|365525220|FG019|Overall Study|Other|0|||
106148313|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
106148314|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
106148315|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
106148316|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
106148317|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
106148318|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
106148319|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
105962968|NCT05823974|365525221|FG020|Overall Study|Other|0|||
105962969|NCT03744910|365525222|FG000|Overall Study|Withdrew Consent|1|||
105962970|NCT03744910|365525223|FG001|Overall Study|Withdrew Consent|8|||
105962971|NCT03744910|365525222|FG000|Overall Study|Physician Decision|5|||
105962972|NCT03744910|365525223|FG001|Overall Study|Physician Decision|4|||
106022373|NCT00531427|365746853|FG000|Overall Study|Adverse Event|44|||
106148320|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
106148321|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
106148322|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
106148323|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
106148324|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
106148325|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
105962973|NCT03744910|365525222|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
105962974|NCT03744910|365525223|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
105962975|NCT03744910|365525222|FG000|Overall Study|Lost to Follow-up|0|||
105962976|NCT03744910|365525223|FG001|Overall Study|Lost to Follow-up|1|||
105962977|NCT03744910|365525222|FG000|Overall Study|Other-unspecified|4|||
105962978|NCT03744910|365525223|FG001|Overall Study|Other-unspecified|1|||
105962979|NCT02255435|365525224|FG000|Overall Study|Patient's Limited Time Availability|0|||
105962980|NCT02255435|365525225|FG001|Overall Study|Patient's Limited Time Availability|0|||
105962981|NCT02255435|365525226|FG002|Overall Study|Patient's Limited Time Availability|0|||
105962982|NCT02255435|365525227|FG003|Overall Study|Patient's Limited Time Availability|0|||
105962983|NCT02255435|365525228|FG004|Overall Study|Patient's Limited Time Availability|0|||
105962984|NCT02255435|365525229|FG005|Overall Study|Patient's Limited Time Availability|0|||
105962985|NCT02255435|365525230|FG006|Overall Study|Patient's Limited Time Availability|0|||
105962986|NCT02255435|365525231|FG007|Overall Study|Patient's Limited Time Availability|1|||
105962987|NCT02255435|365525232|FG008|Overall Study|Patient's Limited Time Availability|0|||
105962988|NCT02255435|365525233|FG009|Overall Study|Patient's Limited Time Availability|0|||
105962989|NCT02255435|365525224|FG000|Overall Study|Withdrawal by Subject|0|||
105962990|NCT02255435|365525225|FG001|Overall Study|Withdrawal by Subject|0|||
105962991|NCT02255435|365525226|FG002|Overall Study|Withdrawal by Subject|0|||
105962992|NCT02255435|365525227|FG003|Overall Study|Withdrawal by Subject|0|||
105962993|NCT02255435|365525228|FG004|Overall Study|Withdrawal by Subject|0|||
105962994|NCT02255435|365525229|FG005|Overall Study|Withdrawal by Subject|0|||
105962995|NCT02255435|365525230|FG006|Overall Study|Withdrawal by Subject|0|||
105962996|NCT02255435|365525231|FG007|Overall Study|Withdrawal by Subject|0|||
105962997|NCT02255435|365525232|FG008|Overall Study|Withdrawal by Subject|1|||
105962998|NCT02255435|365525233|FG009|Overall Study|Withdrawal by Subject|4|||
105962999|NCT02255435|365525224|FG000|Overall Study|Administrative reasons|0|||
105963000|NCT02255435|365525225|FG001|Overall Study|Administrative reasons|0|||
105963001|NCT02255435|365525226|FG002|Overall Study|Administrative reasons|0|||
105963002|NCT02255435|365525227|FG003|Overall Study|Administrative reasons|0|||
105963003|NCT02255435|365525228|FG004|Overall Study|Administrative reasons|0|||
105963004|NCT02255435|365525229|FG005|Overall Study|Administrative reasons|0|||
105963005|NCT02255435|365525230|FG006|Overall Study|Administrative reasons|0|||
105963006|NCT02255435|365525231|FG007|Overall Study|Administrative reasons|0|||
105827319|NCT00205777|365026430|FG000|Study Extension I|Failed to return|15|||
105827320|NCT00205777|365026431|FG001|Study Extension I|Failed to return|0|||
105827321|NCT00205777|365026432|FG002|Study Extension I|Failed to return|0|||
105827322|NCT00205777|365026433|FG003|Study Extension I|Failed to return|17|||
105827323|NCT00205777|365026434|FG004|Study Extension I|Failed to return|13|||
105827324|NCT00205777|365026435|FG005|Study Extension I|Failed to return|0|||
105827325|NCT00205777|365026430|FG000|Study Extension I|Other Event|34|||
105827326|NCT00205777|365026431|FG001|Study Extension I|Other Event|0|||
105827327|NCT00205777|365026432|FG002|Study Extension I|Other Event|0|||
105827328|NCT00205777|365026433|FG003|Study Extension I|Other Event|34|||
105963007|NCT02255435|365525232|FG008|Overall Study|Administrative reasons|0|||
105963008|NCT02255435|365525233|FG009|Overall Study|Administrative reasons|2|||
105963009|NCT05828095|365525234|FG000|Overall Study|Lost to Follow-up|1|||
105963010|NCT05828095|365525235|FG001|Overall Study|Lost to Follow-up|0|||
105963011|NCT05828095|365525234|FG000|Overall Study|Reactogenicity symptom|0|||
105963012|NCT05828095|365525235|FG001|Overall Study|Reactogenicity symptom|1|||
105963013|NCT05360966|365525236|FG000|Overall Study|Adverse Event|5|||
105963014|NCT05360966|365525237|FG001|Overall Study|Adverse Event|5|||
105963015|NCT05360966|365525236|FG000|Overall Study|Withdrawal of Consent|5|||
105963016|NCT05360966|365525237|FG001|Overall Study|Withdrawal of Consent|3|||
105963017|NCT05360966|365525236|FG000|Overall Study|Noncompliance|2|||
105963018|NCT05360966|365525237|FG001|Overall Study|Noncompliance|1|||
105963019|NCT05360966|365525236|FG000|Overall Study|Lost to Follow-up|2|||
105963020|NCT05360966|365525237|FG001|Overall Study|Lost to Follow-up|3|||
105963021|NCT05360966|365525236|FG000|Overall Study|Protocol Deviation|2|||
105963022|NCT05360966|365525237|FG001|Overall Study|Protocol Deviation|1|||
105963023|NCT05360966|365525236|FG000|Overall Study|As specified in the Clinical Study Report|1|||
105963024|NCT05360966|365525237|FG001|Overall Study|As specified in the Clinical Study Report|3|||
105963025|NCT05396014|365525238|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
105963026|NCT05396014|365525239|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963027|NCT05396014|365525240|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963028|NCT05396014|365525241|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963029|NCT05396014|365525242|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963030|NCT05396014|365525243|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963031|NCT05396014|365525244|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963032|NCT05396014|365525245|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963033|NCT05396014|365525246|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963034|NCT05396014|365525247|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963035|NCT05396014|365525248|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963036|NCT05396014|365525249|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963037|NCT05396014|365525250|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963038|NCT05396014|365525251|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
105963039|NCT05396014|365525252|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963040|NCT05396014|365525253|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963041|NCT05396014|365525254|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
106022374|NCT00531427|365746854|FG001|Overall Study|Adverse Event|30|||
106022375|NCT00531427|365746853|FG000|Overall Study|Lost to Follow-up|4|||
106022376|NCT00531427|365746854|FG001|Overall Study|Lost to Follow-up|3|||
105963042|NCT05396014|365525255|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963043|NCT05396014|365525256|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963044|NCT05396014|365525257|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
106022377|NCT00531427|365746853|FG000|Overall Study|Lack of Efficacy|14|||
106022378|NCT00531427|365746854|FG001|Overall Study|Lack of Efficacy|39|||
106022379|NCT00531427|365746853|FG000|Overall Study|Administrative|4|||
106022380|NCT00531427|365746854|FG001|Overall Study|Administrative|9|||
106022381|NCT01287741|365746858|FG000|Overall Study|Withdrawal by Subject|35|||
106022382|NCT01287741|365746859|FG001|Overall Study|Withdrawal by Subject|38|||
106022383|NCT01287741|365746858|FG000|Overall Study|Protocol Violation|2|||
106022384|NCT01287741|365746859|FG001|Overall Study|Protocol Violation|0|||
106022385|NCT01287741|365746858|FG000|Overall Study|Physician Decision|15|||
106148326|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
106148327|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
106148328|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
106148329|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
106148330|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
106148331|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
106148332|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
106148333|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
106148334|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
106148335|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
106148336|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
106148337|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
106148338|NCT03903822|366203985|FG000|Treatment Phase (6 Weeks)|Other|2|||
106148339|NCT03903822|366203986|FG001|Treatment Phase (6 Weeks)|Other|1|||
106148340|NCT03903822|366203987|FG002|Treatment Phase (6 Weeks)|Other|0|||
106148341|NCT03903822|366203988|FG003|Treatment Phase (6 Weeks)|Other|0|||
106148342|NCT03903822|366203989|FG004|Treatment Phase (6 Weeks)|Other|1|||
106148343|NCT03903822|366203990|FG005|Treatment Phase (6 Weeks)|Other|1|||
106148344|NCT03903822|366203991|FG006|Treatment Phase (6 Weeks)|Other|0|||
106148345|NCT03903822|366203992|FG007|Treatment Phase (6 Weeks)|Other|0|||
106148346|NCT03903822|366203985|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
106148347|NCT03903822|366203986|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
106148348|NCT03903822|366203987|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
106148349|NCT03903822|366203988|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
106148350|NCT03903822|366203989|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
106148351|NCT03903822|366203990|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
106148352|NCT03903822|366203991|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
106148353|NCT03903822|366203992|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
106148354|NCT03903822|366203985|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
106148355|NCT03903822|366203986|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
106148356|NCT03903822|366203987|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
106148357|NCT03903822|366203988|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
106148358|NCT03903822|366203989|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
106148359|NCT03903822|366203990|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105963045|NCT05396014|365525258|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
106148360|NCT03903822|366203991|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
105827329|NCT00205777|365026434|FG004|Study Extension I|Other Event|29|||
105827330|NCT00205777|365026435|FG005|Study Extension I|Other Event|0|||
106022386|NCT01287741|365746859|FG001|Overall Study|Physician Decision|23|||
106022387|NCT01287741|365746858|FG000|Overall Study|Non-compliance|8|||
106022388|NCT01287741|365746859|FG001|Overall Study|Non-compliance|6|||
106148361|NCT03903822|366203992|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
106148362|NCT03903822|366203985|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
106148363|NCT03903822|366203986|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
106148364|NCT03903822|366203987|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
106148365|NCT03903822|366203988|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
106148366|NCT03903822|366203989|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
106148367|NCT03903822|366203990|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
106148368|NCT03903822|366203991|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
106148369|NCT03903822|366203992|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
106148370|NCT03903822|366203985|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
106148371|NCT03903822|366203986|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
106148372|NCT03903822|366203987|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
106148373|NCT03903822|366203988|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
106148374|NCT03903822|366203989|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
106148375|NCT03903822|366203990|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
106148376|NCT03903822|366203991|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
106148377|NCT03903822|366203992|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
106148378|NCT03903822|366203985|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
106148379|NCT03903822|366203986|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
106148380|NCT03903822|366203987|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
106148381|NCT03903822|366203988|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
106148382|NCT03903822|366203989|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
106148383|NCT03903822|366203990|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
106148384|NCT03903822|366203991|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
106148385|NCT03903822|366203992|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
106148386|NCT03903822|366203985|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
106148387|NCT03903822|366203986|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
106148388|NCT03903822|366203987|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
106148389|NCT03903822|366203988|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
106148390|NCT03903822|366203989|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
106148391|NCT03903822|366203990|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
106148392|NCT03903822|366203991|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
106148393|NCT03903822|366203992|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
106148394|NCT03903822|366203985|FG000|Follow up Phase (4 Weeks)|Other|1|||
106148395|NCT03903822|366203986|FG001|Follow up Phase (4 Weeks)|Other|1|||
106148396|NCT03903822|366203987|FG002|Follow up Phase (4 Weeks)|Other|0|||
106148397|NCT03903822|366203988|FG003|Follow up Phase (4 Weeks)|Other|0|||
106148398|NCT03903822|366203989|FG004|Follow up Phase (4 Weeks)|Other|0|||
106148399|NCT03903822|366203990|FG005|Follow up Phase (4 Weeks)|Other|0|||
106148400|NCT03903822|366203991|FG006|Follow up Phase (4 Weeks)|Other|0|||
106148401|NCT03903822|366203992|FG007|Follow up Phase (4 Weeks)|Other|0|||
106148402|NCT00807937|366203995|FG000|Overall Study|Adverse Event|12|||
106022389|NCT01287741|365746858|FG000|Overall Study|Lost to Follow-up|10|||
106022390|NCT01287741|365746859|FG001|Overall Study|Lost to Follow-up|8|||
106022391|NCT01287741|365746858|FG000|Overall Study|Death|32|||
106022392|NCT01287741|365746859|FG001|Overall Study|Death|44|||
106022393|NCT01287741|365746858|FG000|Overall Study|Adverse Event|4|||
106022394|NCT01287741|365746859|FG001|Overall Study|Adverse Event|6|||
106022395|NCT01287741|365746858|FG000|Overall Study|Study terminated by Sponsor|307|||
106022396|NCT01287741|365746859|FG001|Overall Study|Study terminated by Sponsor|315|||
105827331|NCT00205777|365026430|FG000|Study Extension I|Withdrawn as per protocol|0|||
105827332|NCT00205777|365026431|FG001|Study Extension I|Withdrawn as per protocol|0|||
105827333|NCT00205777|365026432|FG002|Study Extension I|Withdrawn as per protocol|1070|||
105827334|NCT00205777|365026433|FG003|Study Extension I|Withdrawn as per protocol|0|||
105827335|NCT00205777|365026434|FG004|Study Extension I|Withdrawn as per protocol|0|||
105827336|NCT00205777|365026435|FG005|Study Extension I|Withdrawn as per protocol|0|||
105827337|NCT00205777|365026430|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
105827338|NCT00205777|365026431|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
105827339|NCT00205777|365026432|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
105827340|NCT00205777|365026433|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
105827341|NCT00205777|365026434|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
105827342|NCT00205777|365026435|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
105827343|NCT00205777|365026430|FG000|Study Extension II|Adverse Event|0|||
105827344|NCT00205777|365026431|FG001|Study Extension II|Adverse Event|0|||
105827345|NCT00205777|365026432|FG002|Study Extension II|Adverse Event|0|||
105827346|NCT00205777|365026433|FG003|Study Extension II|Adverse Event|14|||
105827347|NCT00205777|365026434|FG004|Study Extension II|Adverse Event|0|||
105827348|NCT00205777|365026435|FG005|Study Extension II|Adverse Event|30|||
105827349|NCT00205777|365026430|FG000|Study Extension II|Death|0|||
105827350|NCT00205777|365026431|FG001|Study Extension II|Death|0|||
105827351|NCT00205777|365026432|FG002|Study Extension II|Death|0|||
105827352|NCT00205777|365026433|FG003|Study Extension II|Death|2|||
105827353|NCT00205777|365026434|FG004|Study Extension II|Death|0|||
105827354|NCT00205777|365026435|FG005|Study Extension II|Death|5|||
105827355|NCT00205777|365026430|FG000|Study Extension II|Withdrawal by Subject|0|||
105827356|NCT00205777|365026431|FG001|Study Extension II|Withdrawal by Subject|0|||
105827357|NCT00205777|365026432|FG002|Study Extension II|Withdrawal by Subject|0|||
105827358|NCT00205777|365026433|FG003|Study Extension II|Withdrawal by Subject|35|||
105827359|NCT00205777|365026434|FG004|Study Extension II|Withdrawal by Subject|0|||
105827360|NCT00205777|365026435|FG005|Study Extension II|Withdrawal by Subject|59|||
105827361|NCT00205777|365026430|FG000|Study Extension II|Protocol Violation|0|||
105827362|NCT00205777|365026431|FG001|Study Extension II|Protocol Violation|0|||
105827363|NCT00205777|365026432|FG002|Study Extension II|Protocol Violation|0|||
105827364|NCT00205777|365026433|FG003|Study Extension II|Protocol Violation|1|||
105827365|NCT00205777|365026434|FG004|Study Extension II|Protocol Violation|0|||
105827366|NCT00205777|365026435|FG005|Study Extension II|Protocol Violation|10|||
105963046|NCT05396014|365525259|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963047|NCT05396014|365525260|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963048|NCT05396014|365525261|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963049|NCT05396014|365525262|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963050|NCT05396014|365525263|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963051|NCT05396014|365525264|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
105963052|NCT05396014|365525265|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963053|NCT05396014|365525266|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963054|NCT05396014|365525267|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963055|NCT05396014|365525268|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963056|NCT05396014|365525269|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963057|NCT05396014|365525270|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963058|NCT05396014|365525271|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963059|NCT05396014|365525272|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963060|NCT05396014|365525273|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105827367|NCT00205777|365026430|FG000|Study Extension II|Lack of Efficacy|0|||
105827368|NCT00205777|365026431|FG001|Study Extension II|Lack of Efficacy|0|||
105827369|NCT00205777|365026432|FG002|Study Extension II|Lack of Efficacy|0|||
105827370|NCT00205777|365026433|FG003|Study Extension II|Lack of Efficacy|0|||
105827371|NCT00205777|365026434|FG004|Study Extension II|Lack of Efficacy|0|||
105827372|NCT00205777|365026435|FG005|Study Extension II|Lack of Efficacy|1|||
105827373|NCT00205777|365026430|FG000|Study Extension II|Failed to return|0|||
105827374|NCT00205777|365026431|FG001|Study Extension II|Failed to return|0|||
105827375|NCT00205777|365026432|FG002|Study Extension II|Failed to return|0|||
105827376|NCT00205777|365026433|FG003|Study Extension II|Failed to return|14|||
105827377|NCT00205777|365026434|FG004|Study Extension II|Failed to return|0|||
105827378|NCT00205777|365026435|FG005|Study Extension II|Failed to return|26|||
105827379|NCT00205777|365026430|FG000|Study Extension II|Other Event|0|||
105827380|NCT00205777|365026431|FG001|Study Extension II|Other Event|0|||
105827381|NCT00205777|365026432|FG002|Study Extension II|Other Event|0|||
105827382|NCT00205777|365026433|FG003|Study Extension II|Other Event|12|||
105827383|NCT00205777|365026434|FG004|Study Extension II|Other Event|0|||
105827384|NCT00205777|365026435|FG005|Study Extension II|Other Event|20|||
105827385|NCT00205777|365026430|FG000|Study Extension II|Enrolled but not treated|0|||
105827386|NCT00205777|365026431|FG001|Study Extension II|Enrolled but not treated|0|||
105827387|NCT00205777|365026432|FG002|Study Extension II|Enrolled but not treated|0|||
105827388|NCT00205777|365026433|FG003|Study Extension II|Enrolled but not treated|71|||
105963061|NCT05396014|365525274|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963062|NCT05396014|365525275|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963063|NCT05396014|365525276|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105827389|NCT00205777|365026434|FG004|Study Extension II|Enrolled but not treated|0|||
105963064|NCT05396014|365525277|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
105963065|NCT05396014|365525278|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963066|NCT05396014|365525279|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963067|NCT05396014|365525280|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
105963068|NCT05396014|365525238|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
105963069|NCT05396014|365525239|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963070|NCT05396014|365525240|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963071|NCT05396014|365525241|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963072|NCT05396014|365525242|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963073|NCT05396014|365525243|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
106148403|NCT00807937|366203996|FG001|Overall Study|Adverse Event|12|||
106148404|NCT00807937|366203997|FG002|Overall Study|Adverse Event|5|||
106148405|NCT00807937|366203998|FG003|Overall Study|Adverse Event|4|||
106148406|NCT00807937|366203995|FG000|Overall Study|Protocol Violation|4|||
106148407|NCT00807937|366203996|FG001|Overall Study|Protocol Violation|5|||
106148408|NCT00807937|366203997|FG002|Overall Study|Protocol Violation|3|||
106148409|NCT00807937|366203998|FG003|Overall Study|Protocol Violation|3|||
106148410|NCT00807937|366203995|FG000|Overall Study|Withdrawal by Subject|5|||
106148411|NCT00807937|366203996|FG001|Overall Study|Withdrawal by Subject|4|||
106148412|NCT00807937|366203997|FG002|Overall Study|Withdrawal by Subject|1|||
106148413|NCT00807937|366203998|FG003|Overall Study|Withdrawal by Subject|4|||
106148414|NCT00807937|366203995|FG000|Overall Study|Lost to Follow-up|4|||
106148415|NCT00807937|366203996|FG001|Overall Study|Lost to Follow-up|0|||
106148416|NCT00807937|366203997|FG002|Overall Study|Lost to Follow-up|2|||
106148417|NCT00807937|366203998|FG003|Overall Study|Lost to Follow-up|1|||
106148418|NCT00807937|366203995|FG000|Overall Study|Lack of Efficacy|0|||
106148419|NCT00807937|366203996|FG001|Overall Study|Lack of Efficacy|0|||
106148420|NCT00807937|366203997|FG002|Overall Study|Lack of Efficacy|1|||
106148421|NCT00807937|366203998|FG003|Overall Study|Lack of Efficacy|2|||
106148422|NCT00807937|366203995|FG000|Overall Study|Intake of prohibited medicine|0|||
106148423|NCT00807937|366203996|FG001|Overall Study|Intake of prohibited medicine|0|||
106148424|NCT00807937|366203997|FG002|Overall Study|Intake of prohibited medicine|2|||
106148425|NCT00807937|366203998|FG003|Overall Study|Intake of prohibited medicine|0|||
106148426|NCT00807937|366203995|FG000|Overall Study|All other reasons (not provided)|2|||
106148427|NCT00807937|366203996|FG001|Overall Study|All other reasons (not provided)|4|||
106148428|NCT00807937|366203997|FG002|Overall Study|All other reasons (not provided)|0|||
106148429|NCT00807937|366203998|FG003|Overall Study|All other reasons (not provided)|1|||
106148430|NCT01697969|366204003|FG000|Overall Study|Did not meet inc/exc criteria|3|||
106148431|NCT01561989|366204004|FG000|Overall Study|accural target not met.|5|||
106148432|NCT01561989|366204005|FG001|Overall Study|accural target not met.|6|||
106148433|NCT05777785|366205359|FG000|Overall Study|Withdrawal by Subject|5|||
106148434|NCT05777785|366205359|FG000|Overall Study|Lost to Follow-up|1|||
106148435|NCT01823536|366205360|FG000|Overall Study|Lost to Follow-up|1|||
106148436|NCT01823536|366205361|FG001|Overall Study|Lost to Follow-up|0|||
106148437|NCT01823536|366205362|FG002|Overall Study|Lost to Follow-up|0|||
106148438|NCT01823536|366205363|FG003|Overall Study|Lost to Follow-up|1|||
106148439|NCT01823536|366205364|FG004|Overall Study|Lost to Follow-up|1|||
106148440|NCT01823536|366205365|FG005|Overall Study|Lost to Follow-up|0|||
106148441|NCT01823536|366205360|FG000|Overall Study|Protocol Violation|0|||
106148442|NCT01823536|366205361|FG001|Overall Study|Protocol Violation|1|||
106148443|NCT01823536|366205362|FG002|Overall Study|Protocol Violation|0|||
106148444|NCT01823536|366205363|FG003|Overall Study|Protocol Violation|0|||
106148445|NCT01823536|366205364|FG004|Overall Study|Protocol Violation|0|||
106148446|NCT01823536|366205365|FG005|Overall Study|Protocol Violation|0|||
106148447|NCT01823536|366205360|FG000|Overall Study|Withdrawal by Subject|1|||
106148448|NCT01823536|366205361|FG001|Overall Study|Withdrawal by Subject|1|||
106148449|NCT01823536|366205362|FG002|Overall Study|Withdrawal by Subject|0|||
106148450|NCT01823536|366205363|FG003|Overall Study|Withdrawal by Subject|0|||
106148451|NCT01823536|366205364|FG004|Overall Study|Withdrawal by Subject|0|||
106148452|NCT01823536|366205365|FG005|Overall Study|Withdrawal by Subject|0|||
106148453|NCT01823536|366205360|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
106148454|NCT01823536|366205361|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
106148455|NCT01823536|366205362|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
106148456|NCT01823536|366205363|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
106148457|NCT01823536|366205364|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
106148458|NCT01823536|366205365|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
106148459|NCT01823536|366205360|FG000|Overall Study|Met exclusion criterion No 6|0|||
106148460|NCT01823536|366205361|FG001|Overall Study|Met exclusion criterion No 6|0|||
106148461|NCT01823536|366205362|FG002|Overall Study|Met exclusion criterion No 6|0|||
106148462|NCT01823536|366205363|FG003|Overall Study|Met exclusion criterion No 6|1|||
106148463|NCT01823536|366205364|FG004|Overall Study|Met exclusion criterion No 6|0|||
106148464|NCT01823536|366205365|FG005|Overall Study|Met exclusion criterion No 6|0|||
106148465|NCT01823536|366205360|FG000|Overall Study|Subject moved out of the state|0|||
106148466|NCT01823536|366205361|FG001|Overall Study|Subject moved out of the state|0|||
106148467|NCT01823536|366205362|FG002|Overall Study|Subject moved out of the state|0|||
106148468|NCT01823536|366205363|FG003|Overall Study|Subject moved out of the state|0|||
106148469|NCT01823536|366205364|FG004|Overall Study|Subject moved out of the state|1|||
106148470|NCT01823536|366205365|FG005|Overall Study|Subject moved out of the state|0|||
106148471|NCT01622868|366205368|FG000|Overall Study|Protocol Violation|7|||
106148472|NCT01622868|366205369|FG001|Overall Study|Protocol Violation|0|||
106148473|NCT00610649|366205370|FG000|Overall Study|Adverse Event|1|||
106148474|NCT00610649|366205371|FG001|Overall Study|Adverse Event|0|||
106148475|NCT00610649|366205372|FG002|Overall Study|Adverse Event|0|||
106148476|NCT00610649|366205373|FG003|Overall Study|Adverse Event|0|||
106148477|NCT00610649|366205374|FG004|Overall Study|Adverse Event|0|||
106022397|NCT01287741|365746858|FG000|Overall Study|Progressive disease|190|||
106022398|NCT01287741|365746859|FG001|Overall Study|Progressive disease|166|||
105827390|NCT00205777|365026435|FG005|Study Extension II|Enrolled but not treated|131|||
105827391|NCT02462837|365026436|FG000|Overall Study|pt developed hives|1|||
105827392|NCT02462837|365026437|FG001|Overall Study|pt developed hives|0|||
105827393|NCT02462837|365026436|FG000|Overall Study|Withdrawal by Subject|1|||
105827394|NCT02462837|365026437|FG001|Overall Study|Withdrawal by Subject|0|||
105827395|NCT04411680|365026442|FG000|Treatment Period|Adverse Event|3|||
105827396|NCT04411680|365026443|FG001|Treatment Period|Adverse Event|0|||
105827397|NCT04411680|365026442|FG000|Treatment Period|Discharged from hospital|18|||
105827398|NCT04411680|365026443|FG001|Treatment Period|Discharged from hospital|7|||
105827399|NCT04411680|365026442|FG000|Treatment Period|Missed 1 or more doses|8|||
105827400|NCT04411680|365026443|FG001|Treatment Period|Missed 1 or more doses|0|||
105827401|NCT04411680|365026442|FG000|Treatment Period|Transferred to another hospital|0|||
105827402|NCT04411680|365026443|FG001|Treatment Period|Transferred to another hospital|1|||
105827403|NCT04411680|365026442|FG000|Follow up Period|Withdrawal by Subject|2|||
105827404|NCT04411680|365026443|FG001|Follow up Period|Withdrawal by Subject|0|||
105827405|NCT04411680|365026442|FG000|Follow up Period|Lost to Follow-up|5|||
105827406|NCT04411680|365026443|FG001|Follow up Period|Lost to Follow-up|6|||
105827407|NCT04411680|365026442|FG000|Follow up Period|Death|11|||
105827408|NCT04411680|365026443|FG001|Follow up Period|Death|8|||
105827409|NCT00748566|365026444|FG000|Overall Study|Adverse Event|49|||
105827410|NCT00748566|365026444|FG000|Overall Study|Death|1|||
105827411|NCT00748566|365026444|FG000|Overall Study|Lack of Efficacy|12|||
105827412|NCT00748566|365026444|FG000|Overall Study|Lost to Follow-up|1|||
105827413|NCT00748566|365026444|FG000|Overall Study|Protocol Violation|13|||
105827414|NCT00748566|365026444|FG000|Overall Study|Withdrawal by Subject|22|||
105827415|NCT00748566|365026444|FG000|Overall Study|Study terminated by sponsor|5|||
105827416|NCT00748566|365026444|FG000|Overall Study|Other|9|||
105827417|NCT02426918|365026448|FG000|Overall Study|Adverse Event|2|||
105827418|NCT02426918|365026449|FG001|Overall Study|Adverse Event|2|||
105827419|NCT02426918|365026450|FG002|Overall Study|Adverse Event|0|||
105827420|NCT02426918|365026448|FG000|Overall Study|Physician Decision|1|||
105827421|NCT02426918|365026449|FG001|Overall Study|Physician Decision|1|||
105827422|NCT02426918|365026450|FG002|Overall Study|Physician Decision|1|||
105827423|NCT02426918|365026448|FG000|Overall Study|Withdrawal by Subject|5|||
105827424|NCT02426918|365026449|FG001|Overall Study|Withdrawal by Subject|5|||
105827425|NCT02426918|365026450|FG002|Overall Study|Withdrawal by Subject|4|||
105827426|NCT02426918|365026448|FG000|Overall Study|Other|9|||
105827427|NCT02426918|365026449|FG001|Overall Study|Other|11|||
105827428|NCT02426918|365026450|FG002|Overall Study|Other|9|||
105827429|NCT01442376|365026451|FG000|Overall Study|Adverse Event|0|||
105827430|NCT01442376|365026452|FG001|Overall Study|Adverse Event|3|||
105827431|NCT01442376|365026453|FG002|Overall Study|Adverse Event|2|||
105827432|NCT01442376|365026451|FG000|Overall Study|Death|0|||
105827433|NCT01442376|365026452|FG001|Overall Study|Death|1|||
105827434|NCT01442376|365026453|FG002|Overall Study|Death|1|||
105827435|NCT01442376|365026451|FG000|Overall Study|Withdrawal of consent|0|||
105827436|NCT01442376|365026452|FG001|Overall Study|Withdrawal of consent|0|||
105827437|NCT01442376|365026453|FG002|Overall Study|Withdrawal of consent|1|||
105827438|NCT01442376|365026451|FG000|Overall Study|Patients not treated|2|||
105827439|NCT01442376|365026452|FG001|Overall Study|Patients not treated|3|||
105827440|NCT01442376|365026453|FG002|Overall Study|Patients not treated|1|||
105827441|NCT01442376|365026451|FG000|Overall Study|Not eligible for subsequent cycles|1|||
105827442|NCT01442376|365026452|FG001|Overall Study|Not eligible for subsequent cycles|2|||
105827443|NCT01442376|365026453|FG002|Overall Study|Not eligible for subsequent cycles|0|||
105827444|NCT00863330|365026454|FG000|Overall Study|study terminated early due to administra|6|||
105827445|NCT01297504|365026455|FG000|Overall Study|Invalid Consent|1|||
106022399|NCT01287741|365746858|FG000|Overall Study|Reason not specified|23|||
105827446|NCT01297504|365026455|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
106022400|NCT01287741|365746859|FG001|Overall Study|Reason not specified|9|||
106148478|NCT00610649|366205375|FG005|Overall Study|Adverse Event|0|||
106148479|NCT00610649|366205376|FG006|Overall Study|Adverse Event|0|||
106148480|NCT00610649|366205377|FG007|Overall Study|Adverse Event|0|||
106148481|NCT00610649|366205378|FG008|Overall Study|Adverse Event|0|||
106148482|NCT00610649|366205379|FG009|Overall Study|Adverse Event|0|||
106148483|NCT00610649|366205380|FG010|Overall Study|Adverse Event|1|||
106148484|NCT00610649|366205370|FG000|Overall Study|Family Emergency|0|||
106148485|NCT00610649|366205371|FG001|Overall Study|Family Emergency|1|||
106148486|NCT00610649|366205372|FG002|Overall Study|Family Emergency|0|||
106148487|NCT00610649|366205373|FG003|Overall Study|Family Emergency|0|||
106148488|NCT00610649|366205374|FG004|Overall Study|Family Emergency|0|||
106148489|NCT00610649|366205375|FG005|Overall Study|Family Emergency|0|||
106148490|NCT00610649|366205376|FG006|Overall Study|Family Emergency|0|||
106148491|NCT00610649|366205377|FG007|Overall Study|Family Emergency|0|||
106148492|NCT00610649|366205378|FG008|Overall Study|Family Emergency|0|||
106148493|NCT00610649|366205379|FG009|Overall Study|Family Emergency|0|||
106148494|NCT00610649|366205380|FG010|Overall Study|Family Emergency|0|||
106148495|NCT00610649|366205370|FG000|Overall Study|Withdrawal by Subject|0|||
105827447|NCT01297504|365026455|FG000|Overall Study|No Study Visits|4|||
105827448|NCT01297504|365026455|FG000|Overall Study|Death|3|||
105827449|NCT01297504|365026455|FG000|Overall Study|Lost to Follow-up|43|||
106022401|NCT05148234|365746860|FG000|Phase I|Ineligible|0|||
105827450|NCT01297504|365026455|FG000|Overall Study|Withdrawal by Subject|9|||
105827451|NCT01297504|365026455|FG000|Overall Study|Site Closure|3|||
105827452|NCT01297504|365026455|FG000|Overall Study|Protocol Violation|3|||
105827453|NCT04404725|365026456|FG000|First Intervention|Withdrawal by Subject|0|||
105827454|NCT04404725|365026457|FG001|First Intervention|Withdrawal by Subject|2|||
105827455|NCT04404725|365026456|FG000|Second Intervention|Adverse Event|1|||
105963074|NCT05396014|365525244|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105827456|NCT04404725|365026457|FG001|Second Intervention|Adverse Event|1|||
105963075|NCT05396014|365525245|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963076|NCT05396014|365525246|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963077|NCT05396014|365525247|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963078|NCT05396014|365525248|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963079|NCT05396014|365525249|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963080|NCT05396014|365525250|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963081|NCT05396014|365525251|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
105963082|NCT05396014|365525252|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963083|NCT05396014|365525253|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963084|NCT05396014|365525254|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963085|NCT05396014|365525255|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963086|NCT05396014|365525256|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963087|NCT05396014|365525257|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963088|NCT05396014|365525258|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963089|NCT05396014|365525259|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963090|NCT05396014|365525260|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963091|NCT05396014|365525261|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963092|NCT05396014|365525262|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963093|NCT05396014|365525263|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963094|NCT05396014|365525264|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
105963095|NCT05396014|365525265|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963096|NCT05396014|365525266|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963097|NCT05396014|365525267|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963098|NCT05396014|365525268|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963099|NCT05396014|365525269|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963100|NCT05396014|365525270|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963101|NCT05396014|365525271|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
106022402|NCT05148234|365746861|FG001|Phase I|Ineligible|0|||
106022403|NCT05148234|365746862|FG002|Phase I|Ineligible|0|||
106022404|NCT05148234|365746863|FG003|Phase I|Ineligible|0|||
106022405|NCT05148234|365746864|FG004|Phase I|Ineligible|0|||
106022406|NCT05148234|365746865|FG005|Phase I|Ineligible|0|||
106022407|NCT05148234|365746866|FG006|Phase I|Ineligible|0|||
106022408|NCT05148234|365746867|FG007|Phase I|Ineligible|1|||
106022409|NCT05148234|365746860|FG000|Phase I|Company closed the trial.|0|||
106022410|NCT05148234|365746861|FG001|Phase I|Company closed the trial.|1|||
106022411|NCT05148234|365746862|FG002|Phase I|Company closed the trial.|0|||
106022412|NCT05148234|365746863|FG003|Phase I|Company closed the trial.|0|||
106022413|NCT05148234|365746864|FG004|Phase I|Company closed the trial.|0|||
106022414|NCT05148234|365746865|FG005|Phase I|Company closed the trial.|0|||
106022415|NCT05148234|365746866|FG006|Phase I|Company closed the trial.|0|||
106022416|NCT05148234|365746867|FG007|Phase I|Company closed the trial.|0|||
106022417|NCT02499328|365746870|FG000|Overall Study|Withdrawal by Subject|1|||
106022418|NCT02499328|365746871|FG001|Overall Study|Withdrawal by Subject|1|||
106022419|NCT02499328|365746872|FG002|Overall Study|Withdrawal by Subject|5|||
106022420|NCT02499328|365746873|FG003|Overall Study|Withdrawal by Subject|3|||
106022421|NCT02499328|365746874|FG004|Overall Study|Withdrawal by Subject|5|||
106022422|NCT02499328|365746875|FG005|Overall Study|Withdrawal by Subject|0|||
106022423|NCT02499328|365746876|FG006|Overall Study|Withdrawal by Subject|0|||
106022424|NCT02499328|365746877|FG007|Overall Study|Withdrawal by Subject|0|||
106022425|NCT02499328|365746878|FG008|Overall Study|Withdrawal by Subject|2|||
106022426|NCT02499328|365746879|FG009|Overall Study|Withdrawal by Subject|2|||
106022427|NCT02499328|365746880|FG010|Overall Study|Withdrawal by Subject|0|||
106022428|NCT02499328|365746881|FG011|Overall Study|Withdrawal by Subject|3|||
106022429|NCT02499328|365746882|FG012|Overall Study|Withdrawal by Subject|7|||
106022430|NCT02499328|365746883|FG013|Overall Study|Withdrawal by Subject|3|||
106022431|NCT02499328|365746884|FG014|Overall Study|Withdrawal by Subject|1|||
106022432|NCT02499328|365746885|FG015|Overall Study|Withdrawal by Subject|0|||
106022433|NCT02499328|365746886|FG016|Overall Study|Withdrawal by Subject|0|||
106022434|NCT02499328|365746887|FG017|Overall Study|Withdrawal by Subject|3|||
106148496|NCT00610649|366205371|FG001|Overall Study|Withdrawal by Subject|0|||
106148497|NCT00610649|366205372|FG002|Overall Study|Withdrawal by Subject|0|||
106148498|NCT00610649|366205373|FG003|Overall Study|Withdrawal by Subject|0|||
106022435|NCT02499328|365746888|FG018|Overall Study|Withdrawal by Subject|0|||
106022436|NCT02499328|365746870|FG000|Overall Study|Lost to Follow-up|0|||
106022437|NCT02499328|365746871|FG001|Overall Study|Lost to Follow-up|1|||
106022438|NCT02499328|365746872|FG002|Overall Study|Lost to Follow-up|1|||
106022439|NCT02499328|365746873|FG003|Overall Study|Lost to Follow-up|2|||
106022440|NCT02499328|365746874|FG004|Overall Study|Lost to Follow-up|0|||
106022441|NCT02499328|365746875|FG005|Overall Study|Lost to Follow-up|0|||
106022442|NCT02499328|365746876|FG006|Overall Study|Lost to Follow-up|0|||
106148499|NCT00610649|366205374|FG004|Overall Study|Withdrawal by Subject|0|||
106148500|NCT00610649|366205375|FG005|Overall Study|Withdrawal by Subject|0|||
106148501|NCT00610649|366205376|FG006|Overall Study|Withdrawal by Subject|0|||
106148502|NCT00610649|366205377|FG007|Overall Study|Withdrawal by Subject|0|||
106148503|NCT00610649|366205378|FG008|Overall Study|Withdrawal by Subject|0|||
106148504|NCT00610649|366205379|FG009|Overall Study|Withdrawal by Subject|1|||
106148505|NCT00610649|366205380|FG010|Overall Study|Withdrawal by Subject|0|||
106148506|NCT02271854|366205390|FG000|Overall Study|Withdrawal by Subject|2|||
106148507|NCT02271854|366205390|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
106148508|NCT02271854|366205390|FG000|Overall Study|Lost to Follow-up|1|||
106148509|NCT01534494|366205391|FG000|Overall Study|Withdrawal by Subject|1|||
105827457|NCT04404725|365026456|FG000|Second Intervention|Withdrawal by Subject|0|||
105827458|NCT04404725|365026457|FG001|Second Intervention|Withdrawal by Subject|1|||
105827459|NCT03602339|365026458|FG000|Overall Study|Withdrawal by Subject|9|||
105827460|NCT03602339|365026458|FG000|Overall Study|Physician Decision|2|||
105827461|NCT03602339|365026458|FG000|Overall Study|Other reason|4|||
105827462|NCT02252016|365026459|FG000|Overall Study|Lost to Follow-up|2|||
105827463|NCT02252016|365026460|FG001|Overall Study|Lost to Follow-up|1|||
105827464|NCT02252016|365026459|FG000|Overall Study|Physician Decision|1|||
105827465|NCT02252016|365026460|FG001|Overall Study|Physician Decision|0|||
105827466|NCT02252016|365026459|FG000|Overall Study|Withdrawal by Subject|0|||
105827467|NCT02252016|365026460|FG001|Overall Study|Withdrawal by Subject|2|||
105827468|NCT02615249|365026462|FG000|Overall Study|Withdrawal by Subject|1|||
105827469|NCT00574847|365026463|FG000|Overall Study|Adverse Event|2|||
105827470|NCT00574847|365026464|FG001|Overall Study|Adverse Event|0|||
105827471|NCT00574847|365026463|FG000|Overall Study|Death|1|||
105827472|NCT00574847|365026464|FG001|Overall Study|Death|0|||
105827473|NCT00574847|365026463|FG000|Overall Study|Withdrawal by Subject|2|||
105827474|NCT00574847|365026464|FG001|Overall Study|Withdrawal by Subject|2|||
105827475|NCT00574847|365026463|FG000|Overall Study|Physician Decision|1|||
105827476|NCT00574847|365026464|FG001|Overall Study|Physician Decision|0|||
105827477|NCT00574847|365026463|FG000|Overall Study|Did not receive medication (declined)|2|||
105827478|NCT00574847|365026464|FG001|Overall Study|Did not receive medication (declined)|5|||
105827479|NCT00957021|365026467|FG000|Overall Study|Death|5|||
105827480|NCT00957021|365026467|FG000|Overall Study|Lost to Follow-up|8|||
105827481|NCT00957021|365026467|FG000|Overall Study|Withdrawal by Subject|34|||
105827482|NCT00957021|365026467|FG000|Overall Study|No 2 yr ROM data|35|||
105827483|NCT00957021|365026467|FG000|Overall Study|Revised study component by 2 yr visit|8|||
105827484|NCT00957021|365026467|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
106148510|NCT02724592|366205392|FG000|Overall Study|Lost to Follow-up|4|||
106148511|NCT02724592|366205393|FG001|Overall Study|Lost to Follow-up|1|||
106148512|NCT00402246|366205394|FG000|Overall Study|Death|62|||
106148513|NCT00402246|366205395|FG001|Overall Study|Death|58|||
105827485|NCT00957021|365026467|FG000|Overall Study|Surgery Cancelled|9|||
105827486|NCT00957021|365026467|FG000|Overall Study|Termination due to language issue|2|||
105827487|NCT00487435|365026470|FG000|Overall Study|Adverse Event|146|||
106148514|NCT00402246|366205394|FG000|Overall Study|Lost to Follow-up|20|||
105963102|NCT05396014|365525272|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963103|NCT05396014|365525273|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963104|NCT05396014|365525274|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963105|NCT05396014|365525275|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963106|NCT05396014|365525276|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963107|NCT05396014|365525277|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
105963108|NCT05396014|365525278|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963109|NCT05396014|365525279|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963110|NCT05396014|365525280|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
105963111|NCT05396014|365525238|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
105963112|NCT05396014|365525239|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963113|NCT05396014|365525240|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963114|NCT05396014|365525241|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963115|NCT05396014|365525242|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963116|NCT05396014|365525243|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963117|NCT05396014|365525244|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963118|NCT05396014|365525245|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963119|NCT05396014|365525246|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963120|NCT05396014|365525247|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963121|NCT05396014|365525248|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963122|NCT05396014|365525249|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963123|NCT05396014|365525250|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963124|NCT05396014|365525251|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
105963125|NCT05396014|365525252|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963126|NCT05396014|365525253|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963127|NCT05396014|365525254|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963128|NCT05396014|365525255|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963129|NCT05396014|365525256|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963130|NCT05396014|365525257|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963131|NCT05396014|365525258|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963132|NCT05396014|365525259|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963133|NCT05396014|365525260|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963134|NCT05396014|365525261|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963135|NCT05396014|365525262|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963136|NCT05396014|365525263|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963137|NCT05396014|365525264|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
105963138|NCT05396014|365525265|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963139|NCT05396014|365525266|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963140|NCT05396014|365525267|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963141|NCT05396014|365525268|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963142|NCT05396014|365525269|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963143|NCT05396014|365525270|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963144|NCT05396014|365525271|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963145|NCT05396014|365525272|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963146|NCT05396014|365525273|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963147|NCT05396014|365525274|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
106022443|NCT02499328|365746877|FG007|Overall Study|Lost to Follow-up|2|||
106148515|NCT00402246|366205395|FG001|Overall Study|Lost to Follow-up|28|||
106148516|NCT00402246|366205394|FG000|Overall Study|Withdrawal by Subject|72|||
106148517|NCT00402246|366205395|FG001|Overall Study|Withdrawal by Subject|87|||
106148518|NCT00402246|366205394|FG000|Overall Study|Physician Decision|24|||
106148519|NCT00402246|366205395|FG001|Overall Study|Physician Decision|26|||
106148520|NCT00402246|366205394|FG000|Overall Study|Protocol Violation|25|||
106148521|NCT00402246|366205395|FG001|Overall Study|Protocol Violation|24|||
106148522|NCT00402246|366205394|FG000|Overall Study|Missed Final Visit|1|||
106148523|NCT00402246|366205395|FG001|Overall Study|Missed Final Visit|2|||
106148524|NCT00402246|366205394|FG000|Overall Study|Insurance Issues|2|||
106148525|NCT00402246|366205395|FG001|Overall Study|Insurance Issues|1|||
106148526|NCT00402246|366205394|FG000|Overall Study|Heart Transplant|0|||
106148527|NCT00402246|366205395|FG001|Overall Study|Heart Transplant|1|||
106148528|NCT00402246|366205394|FG000|Overall Study|Patient's device explanted|6|||
106148529|NCT00402246|366205395|FG001|Overall Study|Patient's device explanted|2|||
106148530|NCT00402246|366205394|FG000|Overall Study|Center Closure|5|||
106148531|NCT00402246|366205395|FG001|Overall Study|Center Closure|3|||
106148532|NCT00402246|366205394|FG000|Overall Study|Deterioriating Condition|3|||
106148533|NCT00402246|366205395|FG001|Overall Study|Deterioriating Condition|2|||
106148534|NCT02724956|366205400|FG000|Overall Study|Physician Decision|1|||
106148535|NCT02724956|366205401|FG001|Overall Study|Physician Decision|0|||
106148536|NCT02724956|366205400|FG000|Overall Study|Lack of Efficacy|0|||
106148537|NCT02724956|366205401|FG001|Overall Study|Lack of Efficacy|1|||
106148538|NCT02724956|366205400|FG000|Overall Study|Withdrawal by Subject|0|||
106148539|NCT02724956|366205401|FG001|Overall Study|Withdrawal by Subject|1|||
106148540|NCT05262738|366205402|FG000|Overall Study|Withdrawal by Subject|1|||
106148541|NCT05262738|366205403|FG001|Overall Study|Withdrawal by Subject|0|||
106148542|NCT02932579|366205406|FG000|Overall Study|Withdrawal by Subject|4|||
106148543|NCT02932579|366205407|FG001|Overall Study|Withdrawal by Subject|1|||
106148544|NCT02652442|366205410|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
106148545|NCT00106080|366205413|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
106148546|NCT00106080|366205414|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
106148547|NCT02549170|366205417|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
106148548|NCT02549170|366205418|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
106148549|NCT02549170|366205419|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
106148550|NCT02549170|366205420|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
106148551|NCT02549170|366205421|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
106148552|NCT02549170|366205417|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
106148553|NCT02549170|366205418|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
106148554|NCT02549170|366205419|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
106148555|NCT02549170|366205420|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
106148556|NCT02549170|366205421|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
106148557|NCT02549170|366205417|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
105827488|NCT00487435|365026470|FG000|Overall Study|Death|2|||
105827489|NCT00487435|365026470|FG000|Overall Study|Lack of Efficacy|33|||
105827490|NCT00487435|365026470|FG000|Overall Study|Lost to Follow-up|54|||
105827491|NCT00487435|365026470|FG000|Overall Study|Pregnancy|2|||
105827492|NCT00487435|365026470|FG000|Overall Study|Withdrawal by Subject|132|||
106148558|NCT02549170|366205418|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
106148559|NCT02549170|366205419|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
105827493|NCT00487435|365026470|FG000|Overall Study|Resolution Of Pain|1|||
105827494|NCT00487435|365026470|FG000|Overall Study|Study Medication Non-Compliant|32|||
106148560|NCT02549170|366205420|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
106148561|NCT02549170|366205421|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
105827495|NCT00487435|365026470|FG000|Overall Study|Other|83|||
105827496|NCT00868998|365026471|FG000|Overall Study|Screen Failure|1|||
106148562|NCT03292913|366205422|FG000|Overall Study|Death|9|||
105827497|NCT00868998|365026471|FG000|Overall Study|Withdrawal by Subject|1|||
105827498|NCT00868998|365026471|FG000|Overall Study|Progression of disease|2|||
105827499|NCT00868998|365026471|FG000|Overall Study|Death|1|||
105827500|NCT01986647|365026472|FG000|Overall Study|Lost to Follow-up|4|||
105827501|NCT01986647|365026473|FG001|Overall Study|Lost to Follow-up|1|||
105827502|NCT01986647|365026474|FG002|Overall Study|Lost to Follow-up|4|||
105827503|NCT01986647|365026475|FG003|Overall Study|Lost to Follow-up|4|||
105827504|NCT01986647|365026472|FG000|Overall Study|Withdrawal by Subject|1|||
105827505|NCT01986647|365026473|FG001|Overall Study|Withdrawal by Subject|3|||
105827506|NCT01986647|365026474|FG002|Overall Study|Withdrawal by Subject|2|||
105827507|NCT01986647|365026475|FG003|Overall Study|Withdrawal by Subject|3|||
105827508|NCT01986647|365026472|FG000|Overall Study|Health|5|||
105827509|NCT01986647|365026473|FG001|Overall Study|Health|3|||
105827510|NCT01986647|365026474|FG002|Overall Study|Health|6|||
105827511|NCT01986647|365026475|FG003|Overall Study|Health|4|||
105827512|NCT01507662|365026476|FG000|Overall Study|Death|26|||
105827513|NCT01507662|365026477|FG001|Overall Study|Death|18|||
105827514|NCT01507662|365026476|FG000|Overall Study|Withdrawal by Subject|290|||
105827515|NCT01507662|365026477|FG001|Overall Study|Withdrawal by Subject|287|||
105827516|NCT01507662|365026476|FG000|Overall Study|Lost to Follow-up|498|||
105827517|NCT01507662|365026477|FG001|Overall Study|Lost to Follow-up|523|||
105827518|NCT01507662|365026476|FG000|Overall Study|Proxy interview done|2|||
105827519|NCT01507662|365026477|FG001|Overall Study|Proxy interview done|3|||
105827520|NCT02911025|365026478|FG000|Overall Study|Lost to Follow-up|3|||
105827521|NCT02272803|365026479|FG000|Overall Study|Disease progression|16|||
105827522|NCT02272803|365026480|FG001|Overall Study|Disease progression|8|||
105827523|NCT02272803|365026479|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
105827524|NCT02272803|365026480|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
105827525|NCT02272803|365026479|FG000|Overall Study|Study drug toxicity|4|||
105827526|NCT02272803|365026480|FG001|Overall Study|Study drug toxicity|9|||
105827527|NCT02272803|365026479|FG000|Overall Study|Participant request to discontinue study treatment|3|||
105963148|NCT05396014|365525275|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963149|NCT05396014|365525276|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963150|NCT05396014|365525277|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
105963151|NCT05396014|365525278|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963152|NCT05396014|365525279|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963153|NCT05396014|365525280|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
105963154|NCT05396014|365525238|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963155|NCT05396014|365525239|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963156|NCT05396014|365525240|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963157|NCT05396014|365525241|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963158|NCT05396014|365525242|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963159|NCT05396014|365525243|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963160|NCT05396014|365525244|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963161|NCT05396014|365525245|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963162|NCT05396014|365525246|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963163|NCT05396014|365525247|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963164|NCT05396014|365525248|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963165|NCT05396014|365525249|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963166|NCT05396014|365525250|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963167|NCT05396014|365525251|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963168|NCT05396014|365525252|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963169|NCT05396014|365525253|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963170|NCT05396014|365525254|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963171|NCT05396014|365525255|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963172|NCT05396014|365525256|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963173|NCT05396014|365525257|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963174|NCT05396014|365525258|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963175|NCT05396014|365525259|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963176|NCT05396014|365525260|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963177|NCT05396014|365525261|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963178|NCT05396014|365525262|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
106022444|NCT02499328|365746878|FG008|Overall Study|Lost to Follow-up|3|||
106022445|NCT02499328|365746879|FG009|Overall Study|Lost to Follow-up|0|||
106022446|NCT02499328|365746880|FG010|Overall Study|Lost to Follow-up|0|||
106022447|NCT02499328|365746881|FG011|Overall Study|Lost to Follow-up|0|||
106022448|NCT02499328|365746882|FG012|Overall Study|Lost to Follow-up|0|||
106022449|NCT02499328|365746883|FG013|Overall Study|Lost to Follow-up|0|||
106022450|NCT02499328|365746884|FG014|Overall Study|Lost to Follow-up|0|||
106022451|NCT02499328|365746885|FG015|Overall Study|Lost to Follow-up|0|||
106022452|NCT02499328|365746886|FG016|Overall Study|Lost to Follow-up|0|||
106022453|NCT02499328|365746887|FG017|Overall Study|Lost to Follow-up|0|||
106022454|NCT02499328|365746888|FG018|Overall Study|Lost to Follow-up|1|||
106022455|NCT02499328|365746870|FG000|Overall Study|Death|0|||
105827528|NCT02272803|365026480|FG001|Overall Study|Participant request to discontinue study treatment|7|||
105827529|NCT02272803|365026479|FG000|Overall Study|Maximum clinical benefit|4|||
105827530|NCT02272803|365026480|FG001|Overall Study|Maximum clinical benefit|2|||
105827531|NCT02272803|365026479|FG000|Overall Study|Poor/non-compliance|2|||
105827532|NCT02272803|365026480|FG001|Overall Study|Poor/non-compliance|2|||
105827533|NCT02272803|365026479|FG000|Overall Study|Withdrawal by Subject|2|||
105827534|NCT02272803|365026480|FG001|Overall Study|Withdrawal by Subject|1|||
105827535|NCT02272803|365026479|FG000|Overall Study|Death|0|||
105827536|NCT02272803|365026480|FG001|Overall Study|Death|1|||
105827537|NCT02272803|365026479|FG000|Overall Study|Other reasons|1|||
105827538|NCT02272803|365026480|FG001|Overall Study|Other reasons|3|||
105827539|NCT02272803|365026479|FG000|Overall Study|Administrative reason by sponsor|5|||
105827540|NCT02272803|365026480|FG001|Overall Study|Administrative reason by sponsor|4|||
105827541|NCT00725322|365026481|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
105827542|NCT00725322|365026482|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
105827543|NCT00725322|365026481|FG000|Washout (28 Days)|Protocol Violation|0|||
105827544|NCT00725322|365026482|FG001|Washout (28 Days)|Protocol Violation|1|||
105827545|NCT04474405|365028012|FG000|Overall Study|Withdrawal by Subject|0|||
105827546|NCT04474405|365028013|FG001|Overall Study|Withdrawal by Subject|0|||
105827547|NCT04474405|365028014|FG002|Overall Study|Withdrawal by Subject|1|||
105827548|NCT04474405|365028015|FG003|Overall Study|Withdrawal by Subject|0|||
105827549|NCT04474405|365028016|FG004|Overall Study|Withdrawal by Subject|1|||
105827550|NCT04474405|365028017|FG005|Overall Study|Withdrawal by Subject|0|||
105827551|NCT04474405|365028012|FG000|Overall Study|Other|0|||
105827552|NCT04474405|365028013|FG001|Overall Study|Other|0|||
105827553|NCT04474405|365028014|FG002|Overall Study|Other|0|||
105827554|NCT04474405|365028015|FG003|Overall Study|Other|0|||
105827555|NCT04474405|365028016|FG004|Overall Study|Other|3|||
105827556|NCT04474405|365028017|FG005|Overall Study|Other|0|||
105827557|NCT03599362|365028018|FG000|Overall Study|Screen Failure|3|||
105827558|NCT00635648|365028019|FG000|Overall Study|Adverse Event|12|||
105827559|NCT00635648|365028019|FG000|Overall Study|Withdrawal by Subject|9|||
105827560|NCT00635648|365028019|FG000|Overall Study|Physician Decision|4|||
105827561|NCT00635648|365028019|FG000|Overall Study|Rapid progression of baseline disease|4|||
105827562|NCT00635648|365028019|FG000|Overall Study|Use of other antifungal agent needed|1|||
105827563|NCT00635648|365028019|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
105827564|NCT00635648|365028019|FG000|Overall Study|Noncompliance with protocol|1|||
105827565|NCT00635648|365028019|FG000|Overall Study|Other reason|2|||
105827566|NCT01537887|365028020|FG000|Period 1|Physician Decision|0|||
105827567|NCT01537887|365028021|FG001|Period 1|Physician Decision|0|||
105827568|NCT01537887|365028022|FG002|Period 1|Physician Decision|0|||
105827569|NCT01537887|365028023|FG003|Period 1|Physician Decision|0|||
105827570|NCT01537887|365028024|FG004|Period 1|Physician Decision|1|||
105827571|NCT01537887|365028025|FG005|Period 1|Physician Decision|1|||
105827572|NCT01537887|365028020|FG000|Period 1|Did not receive treatment|0|||
105827573|NCT01537887|365028021|FG001|Period 1|Did not receive treatment|0|||
105827574|NCT01537887|365028022|FG002|Period 1|Did not receive treatment|1|||
105827575|NCT01537887|365028023|FG003|Period 1|Did not receive treatment|0|||
105827576|NCT01537887|365028024|FG004|Period 1|Did not receive treatment|0|||
105827577|NCT01537887|365028025|FG005|Period 1|Did not receive treatment|0|||
105827578|NCT01537887|365028020|FG000|Period 2|Withdrawal by Subject|0|||
105827579|NCT01537887|365028021|FG001|Period 2|Withdrawal by Subject|1|||
105827580|NCT01537887|365028022|FG002|Period 2|Withdrawal by Subject|0|||
105827581|NCT01537887|365028023|FG003|Period 2|Withdrawal by Subject|0|||
105827582|NCT01537887|365028024|FG004|Period 2|Withdrawal by Subject|0|||
105827583|NCT01537887|365028025|FG005|Period 2|Withdrawal by Subject|0|||
105827584|NCT01537887|365028020|FG000|Period 3|Adverse Event|0|||
105827585|NCT01537887|365028021|FG001|Period 3|Adverse Event|0|||
105827586|NCT01537887|365028022|FG002|Period 3|Adverse Event|1|||
105827587|NCT01537887|365028023|FG003|Period 3|Adverse Event|0|||
105827588|NCT01537887|365028024|FG004|Period 3|Adverse Event|0|||
105827589|NCT01537887|365028025|FG005|Period 3|Adverse Event|0|||
105827590|NCT01537887|365028020|FG000|Period 3|Withdrawal by Subject|0|||
105963179|NCT05396014|365525263|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105827591|NCT01537887|365028021|FG001|Period 3|Withdrawal by Subject|1|||
105827592|NCT01537887|365028022|FG002|Period 3|Withdrawal by Subject|0|||
105827593|NCT01537887|365028023|FG003|Period 3|Withdrawal by Subject|0|||
105827594|NCT01537887|365028024|FG004|Period 3|Withdrawal by Subject|0|||
105827595|NCT01537887|365028025|FG005|Period 3|Withdrawal by Subject|0|||
105827596|NCT01370083|365028027|FG000|Overall Study|Lost to Follow-up|2|||
105827597|NCT01370083|365028028|FG001|Overall Study|Lost to Follow-up|0|||
105827598|NCT01370083|365028027|FG000|Overall Study|Adverse Event|0|||
105827599|NCT01370083|365028028|FG001|Overall Study|Adverse Event|1|||
105827600|NCT03497130|365028032|FG000|Overall Study|Lost to Follow-up|1|||
105827601|NCT03497130|365028033|FG001|Overall Study|Lost to Follow-up|1|||
105827602|NCT04002648|365028034|FG000|Overall Study|Lost to Follow-up|2|||
105963180|NCT05396014|365525264|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
105827603|NCT04002648|365028035|FG001|Overall Study|Lost to Follow-up|0|||
105827604|NCT03358147|365028037|FG000|Overall Study|Withdrawal by Subject|13|||
105827605|NCT03358147|365028038|FG001|Overall Study|Withdrawal by Subject|19|||
105827606|NCT03358147|365028039|FG002|Overall Study|Withdrawal by Subject|16|||
105827607|NCT03358147|365028040|FG003|Overall Study|Withdrawal by Subject|10|||
105827608|NCT03358147|365028041|FG004|Overall Study|Withdrawal by Subject|5|||
105827609|NCT03358147|365028037|FG000|Overall Study|Adverse Event|3|||
105827610|NCT03358147|365028038|FG001|Overall Study|Adverse Event|9|||
105827611|NCT03358147|365028039|FG002|Overall Study|Adverse Event|7|||
105827612|NCT03358147|365028040|FG003|Overall Study|Adverse Event|5|||
105827613|NCT03358147|365028041|FG004|Overall Study|Adverse Event|2|||
105827614|NCT03358147|365028037|FG000|Overall Study|Lost to Follow-up|4|||
105827615|NCT03358147|365028038|FG001|Overall Study|Lost to Follow-up|3|||
105827616|NCT03358147|365028039|FG002|Overall Study|Lost to Follow-up|7|||
105827617|NCT03358147|365028040|FG003|Overall Study|Lost to Follow-up|6|||
105827618|NCT03358147|365028041|FG004|Overall Study|Lost to Follow-up|4|||
105827619|NCT03358147|365028037|FG000|Overall Study|Major Protocol Deviation|11|||
105827620|NCT03358147|365028038|FG001|Overall Study|Major Protocol Deviation|3|||
105827621|NCT03358147|365028039|FG002|Overall Study|Major Protocol Deviation|2|||
105827622|NCT03358147|365028040|FG003|Overall Study|Major Protocol Deviation|3|||
105827623|NCT03358147|365028041|FG004|Overall Study|Major Protocol Deviation|1|||
105827624|NCT03358147|365028037|FG000|Overall Study|Protocol specified criteria|2|||
105827625|NCT03358147|365028038|FG001|Overall Study|Protocol specified criteria|3|||
105827626|NCT03358147|365028039|FG002|Overall Study|Protocol specified criteria|0|||
105827627|NCT03358147|365028040|FG003|Overall Study|Protocol specified criteria|3|||
105827628|NCT03358147|365028041|FG004|Overall Study|Protocol specified criteria|1|||
105827629|NCT03358147|365028037|FG000|Overall Study|Physician Decision|1|||
105827630|NCT03358147|365028038|FG001|Overall Study|Physician Decision|0|||
105827631|NCT03358147|365028039|FG002|Overall Study|Physician Decision|1|||
105827632|NCT03358147|365028040|FG003|Overall Study|Physician Decision|6|||
105827633|NCT03358147|365028041|FG004|Overall Study|Physician Decision|1|||
105827634|NCT03358147|365028037|FG000|Overall Study|Administrative reasons|0|||
105827635|NCT03358147|365028038|FG001|Overall Study|Administrative reasons|1|||
105827636|NCT03358147|365028039|FG002|Overall Study|Administrative reasons|0|||
105827637|NCT03358147|365028040|FG003|Overall Study|Administrative reasons|3|||
105827638|NCT03358147|365028041|FG004|Overall Study|Administrative reasons|0|||
105827639|NCT03358147|365028037|FG000|Overall Study|Lack of Efficacy|0|||
105827640|NCT03358147|365028038|FG001|Overall Study|Lack of Efficacy|1|||
105827641|NCT03358147|365028039|FG002|Overall Study|Lack of Efficacy|1|||
105827642|NCT03358147|365028040|FG003|Overall Study|Lack of Efficacy|0|||
105827643|NCT03358147|365028041|FG004|Overall Study|Lack of Efficacy|0|||
105827644|NCT00731939|365028044|FG000|Overall Study|Adverse Event|6|||
105827645|NCT00731939|365028044|FG000|Overall Study|Lost to Follow-up|15|||
105827646|NCT00731939|365028044|FG000|Overall Study|Not implanted with study device|9|||
105827647|NCT00731939|365028044|FG000|Overall Study|Withdrawal by Subject|2|||
105827648|NCT00731939|365028044|FG000|Overall Study|Did not meet enrollment criteria|2|||
105827649|NCT02072096|365028045|FG000|Overall Study|Lack of Efficacy|18|||
105827650|NCT02072096|365028046|FG001|Overall Study|Lack of Efficacy|29|||
105827651|NCT02072096|365028045|FG000|Overall Study|Protocol Violation|7|||
105827652|NCT02072096|365028046|FG001|Overall Study|Protocol Violation|7|||
105827653|NCT02072096|365028045|FG000|Overall Study|Withdrawal by Subject|5|||
105827654|NCT02072096|365028046|FG001|Overall Study|Withdrawal by Subject|7|||
105827655|NCT02072096|365028045|FG000|Overall Study|Adverse Event|5|||
105827656|NCT02072096|365028046|FG001|Overall Study|Adverse Event|2|||
105827657|NCT02072096|365028045|FG000|Overall Study|No Reason Provided|4|||
105827658|NCT02072096|365028046|FG001|Overall Study|No Reason Provided|2|||
105827659|NCT02072096|365028045|FG000|Overall Study|Death|2|||
105827660|NCT02072096|365028046|FG001|Overall Study|Death|0|||
105827661|NCT02072096|365028045|FG000|Overall Study|Physician Decision|0|||
105827662|NCT02072096|365028046|FG001|Overall Study|Physician Decision|1|||
105827663|NCT02072096|365028045|FG000|Overall Study|Study Terminated by Sponsor|43|||
105827664|NCT02072096|365028046|FG001|Overall Study|Study Terminated by Sponsor|30|||
105827665|NCT02072096|365028045|FG000|Overall Study|Lost to Follow-up|1|||
105827666|NCT02072096|365028046|FG001|Overall Study|Lost to Follow-up|0|||
105827667|NCT02704091|365028047|FG000|Overall Study|Adverse Event|4|||
105827668|NCT02704091|365028048|FG001|Overall Study|Adverse Event|3|||
105827669|NCT02704091|365028047|FG000|Overall Study|Protocol Violation|5|||
105827670|NCT02704091|365028048|FG001|Overall Study|Protocol Violation|3|||
105827671|NCT02704091|365028047|FG000|Overall Study|Consent withdrawn|4|||
105827672|NCT02704091|365028048|FG001|Overall Study|Consent withdrawn|4|||
105827673|NCT02704091|365028047|FG000|Overall Study|Lost to Follow-up|13|||
105827674|NCT02704091|365028048|FG001|Overall Study|Lost to Follow-up|5|||
105827675|NCT02704091|365028047|FG000|Overall Study|Other|2|||
105827676|NCT02704091|365028048|FG001|Overall Study|Other|8|||
105827677|NCT03214588|365028049|FG000|Overall Study|Adverse Event|1|||
105963181|NCT05396014|365525265|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105827678|NCT03214588|365028050|FG001|Overall Study|Adverse Event|0|||
105827679|NCT03214588|365028051|FG002|Overall Study|Adverse Event|2|||
105827680|NCT03214588|365028049|FG000|Overall Study|Reason Not Specified|0|||
105827681|NCT03214588|365028050|FG001|Overall Study|Reason Not Specified|1|||
105827682|NCT03214588|365028051|FG002|Overall Study|Reason Not Specified|0|||
105827683|NCT02679729|365028054|FG000|Overall Study|Lost to Follow-up|0|||
105827684|NCT02679729|365028055|FG001|Overall Study|Lost to Follow-up|1|||
105827685|NCT02679729|365028056|FG002|Overall Study|Lost to Follow-up|0|||
105827686|NCT02679729|365028057|FG003|Overall Study|Lost to Follow-up|0|||
105827687|NCT02679729|365028058|FG004|Overall Study|Lost to Follow-up|1|||
105827688|NCT02679729|365028059|FG005|Overall Study|Lost to Follow-up|0|||
105827689|NCT02679729|365028060|FG006|Overall Study|Lost to Follow-up|0|||
105827690|NCT02679729|365028061|FG007|Overall Study|Lost to Follow-up|0|||
105827691|NCT02679729|365028062|FG008|Overall Study|Lost to Follow-up|0|||
105827692|NCT02679729|365028054|FG000|Overall Study|Participant decision|0|||
105827693|NCT02679729|365028055|FG001|Overall Study|Participant decision|1|||
105827694|NCT02679729|365028056|FG002|Overall Study|Participant decision|0|||
105827695|NCT02679729|365028057|FG003|Overall Study|Participant decision|0|||
105827696|NCT02679729|365028058|FG004|Overall Study|Participant decision|0|||
105827697|NCT02679729|365028059|FG005|Overall Study|Participant decision|0|||
105827698|NCT02679729|365028060|FG006|Overall Study|Participant decision|1|||
105827699|NCT02679729|365028061|FG007|Overall Study|Participant decision|0|||
105827700|NCT02679729|365028062|FG008|Overall Study|Participant decision|0|||
105827701|NCT01186458|365028063|FG000|Overall Study|Adverse Event|1|||
105827702|NCT04567329|365028064|FG000|Overall Study|Withdrawal by Subject|5|||
105827703|NCT04567329|365028065|FG001|Overall Study|Withdrawal by Subject|6|||
105827704|NCT04567329|365028064|FG000|Overall Study|Protocol Violation|2|||
105827705|NCT04567329|365028065|FG001|Overall Study|Protocol Violation|3|||
105827706|NCT04567329|365028064|FG000|Overall Study|Discontinued|2|||
105827707|NCT04567329|365028065|FG001|Overall Study|Discontinued|2|||
105827708|NCT04567329|365028064|FG000|Overall Study|Lost to Follow-up|0|||
105827709|NCT04567329|365028065|FG001|Overall Study|Lost to Follow-up|1|||
105827710|NCT04567329|365028064|FG000|Overall Study|Lack of Efficacy|0|||
105827711|NCT04567329|365028065|FG001|Overall Study|Lack of Efficacy|1|||
105827712|NCT02933060|365028068|FG000|Overall Study|Withdrawal by Subject|0|||
105827713|NCT02933060|365028069|FG001|Overall Study|Withdrawal by Subject|1|||
105827714|NCT05034874|365028070|FG000|Overall Study|Withdrawal by Subject|6|||
105827715|NCT05034874|365028071|FG001|Overall Study|Withdrawal by Subject|6|||
105827716|NCT05034874|365028070|FG000|Overall Study|Lost to Follow-up|18|||
105827717|NCT05034874|365028071|FG001|Overall Study|Lost to Follow-up|8|||
105827718|NCT05034874|365028070|FG000|Overall Study|Physician Decision|0|||
105827719|NCT05034874|365028071|FG001|Overall Study|Physician Decision|1|||
105827720|NCT05034874|365028070|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
105827721|NCT05034874|365028071|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
105827722|NCT00989950|365028072|FG000|Randomized Phase|Protocol Violation|1|||
105827723|NCT00989950|365028073|FG001|Randomized Phase|Protocol Violation|0|||
105827724|NCT00989950|365028074|FG002|Randomized Phase|Protocol Violation|0|||
105827725|NCT00989950|365028075|FG003|Randomized Phase|Protocol Violation|0|||
105827726|NCT00989950|365028072|FG000|Randomized Phase|Adverse Event|0|||
105827727|NCT00989950|365028073|FG001|Randomized Phase|Adverse Event|1|||
105827728|NCT00989950|365028074|FG002|Randomized Phase|Adverse Event|0|||
105827729|NCT00989950|365028075|FG003|Randomized Phase|Adverse Event|0|||
105827730|NCT00474058|365028076|FG000|Overall Study|Adverse Event|11|||
105827731|NCT00474058|365028077|FG001|Overall Study|Adverse Event|6|||
105827732|NCT00474058|365028076|FG000|Overall Study|Lack of Efficacy|0|||
105827733|NCT00474058|365028077|FG001|Overall Study|Lack of Efficacy|4|||
105827734|NCT00474058|365028076|FG000|Overall Study|Withdrawal by Subject|11|||
105827735|NCT00474058|365028077|FG001|Overall Study|Withdrawal by Subject|7|||
105827736|NCT00474058|365028076|FG000|Overall Study|Other|2|||
105827737|NCT00474058|365028077|FG001|Overall Study|Other|0|||
105827738|NCT00624286|365028078|FG000|Overall Study|Protocol Deviation|7|||
105827739|NCT00624286|365028079|FG001|Overall Study|Protocol Deviation|9|||
105827740|NCT00624286|365028078|FG000|Overall Study|Adverse Event|6|||
105827741|NCT00624286|365028079|FG001|Overall Study|Adverse Event|3|||
105827742|NCT00624286|365028078|FG000|Overall Study|Withdrawal by Subject|5|||
105827743|NCT00624286|365028079|FG001|Overall Study|Withdrawal by Subject|4|||
105827744|NCT00624286|365028078|FG000|Overall Study|Lost to Follow-up|3|||
105827745|NCT00624286|365028079|FG001|Overall Study|Lost to Follow-up|2|||
105827746|NCT00624286|365028078|FG000|Overall Study|Administrative problems|3|||
105827747|NCT00624286|365028079|FG001|Overall Study|Administrative problems|0|||
105827748|NCT00624286|365028078|FG000|Overall Study|Lack of Efficacy|1|||
105827749|NCT00624286|365028079|FG001|Overall Study|Lack of Efficacy|6|||
105827750|NCT00624286|365028078|FG000|Overall Study|Not stated|0|||
105827751|NCT00624286|365028079|FG001|Overall Study|Not stated|1|||
105827752|NCT00624286|365028078|FG000|Overall Study|Abnormal test procedure result(s)|0|||
105827753|NCT00624286|365028079|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105827754|NCT00624286|365028078|FG000|Overall Study|Death|0|||
105827755|NCT00624286|365028079|FG001|Overall Study|Death|1|||
105827756|NCT00841659|365028083|FG000|Washout: 2 Weeks|Protocol Violation|1|||
105827757|NCT00841659|365028084|FG001|Washout: 2 Weeks|Protocol Violation|0|||
105827758|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Refused|1|||
105827759|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Refused|3|||
105963182|NCT05396014|365525266|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963183|NCT05396014|365525267|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963184|NCT05396014|365525268|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963185|NCT05396014|365525269|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963186|NCT05396014|365525270|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963187|NCT05396014|365525271|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963188|NCT05396014|365525272|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963189|NCT05396014|365525273|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963190|NCT05396014|365525274|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963191|NCT05396014|365525275|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963192|NCT05396014|365525276|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963193|NCT05396014|365525277|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
105963194|NCT05396014|365525278|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
106022456|NCT02499328|365746871|FG001|Overall Study|Death|3|||
106148563|NCT03292913|366205423|FG001|Overall Study|Death|3|||
106148564|NCT03292913|366205422|FG000|Overall Study|Lost to Follow-up|49|||
106148565|NCT03292913|366205423|FG001|Overall Study|Lost to Follow-up|49|||
106148566|NCT03292913|366205422|FG000|Overall Study|Withdrawal by Subject|2|||
106148567|NCT03292913|366205423|FG001|Overall Study|Withdrawal by Subject|0|||
106148568|NCT03292913|366205422|FG000|Overall Study|Clinic closed due to COVID|22|||
106148569|NCT03292913|366205423|FG001|Overall Study|Clinic closed due to COVID|36|||
106148570|NCT01839331|366205424|FG000|Overall Study|Early Termination|3|||
106148571|NCT01839331|366205425|FG001|Overall Study|Early Termination|0|||
106148572|NCT01839331|366205426|FG002|Overall Study|Early Termination|1|||
106148573|NCT01839331|366205427|FG003|Overall Study|Early Termination|2|||
106148574|NCT01839331|366205424|FG000|Overall Study|Protocol Violation|1|||
106148575|NCT01839331|366205425|FG001|Overall Study|Protocol Violation|6|||
106148576|NCT01839331|366205426|FG002|Overall Study|Protocol Violation|4|||
106148577|NCT01839331|366205427|FG003|Overall Study|Protocol Violation|3|||
106148578|NCT03051165|366205430|FG000|Overall Study|Withdrawal by Subject|1|||
106148579|NCT03051165|366205430|FG000|Overall Study|Early termination of study|12|||
105827760|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Medical|0|||
105827761|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Medical|1|||
105827762|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
105827763|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
105827764|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
105827765|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
105827766|NCT02054715|365028085|FG000|Baseline/Follow-up 1|No Reason|0|||
105827767|NCT02054715|365028086|FG001|Baseline/Follow-up 1|No Reason|1|||
105827768|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
105827769|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
105827770|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Ineligible|3|||
105827771|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Ineligible|0|||
105827772|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Hospitalization|1|||
105827773|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Hospitalization|0|||
105827774|NCT02054715|365028085|FG000|Baseline/Follow-up 1|Changed Mind|1|||
105827775|NCT02054715|365028086|FG001|Baseline/Follow-up 1|Changed Mind|0|||
105827776|NCT02054715|365028085|FG000|Follow-up 2|Lost to Followup|3|||
105827777|NCT02054715|365028086|FG001|Follow-up 2|Lost to Followup|1|||
105827778|NCT02054715|365028085|FG000|Follow-up 2|Refused|3|||
105827779|NCT02054715|365028086|FG001|Follow-up 2|Refused|2|||
105827780|NCT02054715|365028085|FG000|Follow-up 2|Followup Not Completed|3|||
105827781|NCT02054715|365028086|FG001|Follow-up 2|Followup Not Completed|4|||
105827782|NCT02054715|365028085|FG000|Follow-up 2|Ineligible|4|||
105827783|NCT02054715|365028086|FG001|Follow-up 2|Ineligible|5|||
105827784|NCT02054715|365028085|FG000|Follow-up 2|Death|3|||
105827785|NCT02054715|365028086|FG001|Follow-up 2|Death|3|||
105827786|NCT02054715|365028085|FG000|Follow-up 2|Hospitalization|0|||
105827787|NCT02054715|365028086|FG001|Follow-up 2|Hospitalization|2|||
105827788|NCT02054715|365028085|FG000|Follow-up 2|Changed MD/Facility|0|||
105827789|NCT02054715|365028086|FG001|Follow-up 2|Changed MD/Facility|1|||
105827790|NCT02054715|365028085|FG000|Follow-up 2|Changed Mind|0|||
105827791|NCT02054715|365028086|FG001|Follow-up 2|Changed Mind|1|||
105827792|NCT02054715|365028085|FG000|Follow-up 2|No Reason|2|||
105827793|NCT02054715|365028086|FG001|Follow-up 2|No Reason|0|||
105827794|NCT02054715|365028085|FG000|Follow-up 2|Treatment Change or Delay|1|||
105827795|NCT02054715|365028086|FG001|Follow-up 2|Treatment Change or Delay|0|||
105827796|NCT03499873|365028090|FG000|Overall Study|Withdrawal by Subject|4|||
105827797|NCT03499873|365028091|FG001|Overall Study|Withdrawal by Subject|6|||
105827798|NCT03499873|365028092|FG002|Overall Study|Withdrawal by Subject|1|||
105827799|NCT03499873|365028090|FG000|Overall Study|Subjects condition worsened|0|||
105827800|NCT03499873|365028091|FG001|Overall Study|Subjects condition worsened|3|||
105827801|NCT03499873|365028092|FG002|Overall Study|Subjects condition worsened|11|||
106148580|NCT02267824|366205431|FG000|Overall Study|Pregnancy|1|||
106148581|NCT02267824|366205432|FG001|Overall Study|Pregnancy|1|||
106148582|NCT02267824|366205431|FG000|Overall Study|Lost to Follow-up|4|||
105827802|NCT03499873|365028090|FG000|Overall Study|Adverse Event|8|||
105827803|NCT03499873|365028091|FG001|Overall Study|Adverse Event|3|||
105827804|NCT03499873|365028092|FG002|Overall Study|Adverse Event|6|||
105827805|NCT03499873|365028090|FG000|Overall Study|Physician Decision|1|||
105827806|NCT03499873|365028091|FG001|Overall Study|Physician Decision|0|||
105827807|NCT03499873|365028092|FG002|Overall Study|Physician Decision|0|||
105827808|NCT03499873|365028090|FG000|Overall Study|Administrative reasons|0|||
105827809|NCT03499873|365028091|FG001|Overall Study|Administrative reasons|1|||
105827810|NCT03499873|365028092|FG002|Overall Study|Administrative reasons|0|||
105827811|NCT03499873|365028090|FG000|Overall Study|Concomitant therapy|5|||
105827812|NCT03499873|365028091|FG001|Overall Study|Concomitant therapy|4|||
105827813|NCT03499873|365028092|FG002|Overall Study|Concomitant therapy|7|||
105827814|NCT03499873|365028090|FG000|Overall Study|Miscellaneous|1|||
105827815|NCT03499873|365028091|FG001|Overall Study|Miscellaneous|2|||
105827816|NCT03499873|365028092|FG002|Overall Study|Miscellaneous|2|||
105827817|NCT03499873|365028090|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
105827818|NCT03499873|365028091|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
105827819|NCT03499873|365028092|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
105827820|NCT01964950|365028093|FG000|Overall Study|Protocol Violation|25|||
105827821|NCT03255980|365028094|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
105827822|NCT03255980|365028095|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
105827823|NCT03255980|365028096|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
105827824|NCT03255980|365028097|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
105827825|NCT03255980|365028094|FG000|Overall Study|Adverse Event|1|||
105827826|NCT03255980|365028095|FG001|Overall Study|Adverse Event|1|||
105827827|NCT03255980|365028096|FG002|Overall Study|Adverse Event|0|||
105827828|NCT03255980|365028097|FG003|Overall Study|Adverse Event|1|||
105827829|NCT03255980|365028094|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
105827830|NCT03255980|365028095|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
105827831|NCT03255980|365028096|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
105827832|NCT03255980|365028097|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
105827833|NCT03255980|365028094|FG000|Overall Study|Lost to Follow-up|1|||
105827834|NCT03255980|365028095|FG001|Overall Study|Lost to Follow-up|1|||
105827835|NCT03255980|365028096|FG002|Overall Study|Lost to Follow-up|0|||
105827836|NCT03255980|365028097|FG003|Overall Study|Lost to Follow-up|3|||
105827837|NCT03255980|365028094|FG000|Overall Study|Withdrawal by Subject|0|||
105827838|NCT03255980|365028095|FG001|Overall Study|Withdrawal by Subject|1|||
105827839|NCT03255980|365028096|FG002|Overall Study|Withdrawal by Subject|0|||
105827840|NCT03255980|365028097|FG003|Overall Study|Withdrawal by Subject|3|||
106022457|NCT02499328|365746872|FG002|Overall Study|Death|3|||
106022458|NCT02499328|365746873|FG003|Overall Study|Death|2|||
106022459|NCT02499328|365746874|FG004|Overall Study|Death|4|||
106022460|NCT02499328|365746875|FG005|Overall Study|Death|7|||
106022461|NCT02499328|365746876|FG006|Overall Study|Death|3|||
106022462|NCT02499328|365746877|FG007|Overall Study|Death|0|||
106022463|NCT02499328|365746878|FG008|Overall Study|Death|2|||
106022464|NCT02499328|365746879|FG009|Overall Study|Death|6|||
106022465|NCT02499328|365746880|FG010|Overall Study|Death|6|||
106022466|NCT02499328|365746881|FG011|Overall Study|Death|20|||
106022467|NCT02499328|365746882|FG012|Overall Study|Death|9|||
106022468|NCT02499328|365746883|FG013|Overall Study|Death|7|||
106022469|NCT02499328|365746884|FG014|Overall Study|Death|3|||
106022470|NCT02499328|365746885|FG015|Overall Study|Death|1|||
106148583|NCT02267824|366205432|FG001|Overall Study|Lost to Follow-up|0|||
106148584|NCT02267824|366205431|FG000|Overall Study|Protocol Violation|3|||
106148585|NCT02267824|366205432|FG001|Overall Study|Protocol Violation|0|||
106148586|NCT02267824|366205431|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
105827841|NCT01395017|365028098|FG000|Overall Study|Lost to Follow-up|1|||
105827842|NCT01395017|365028099|FG001|Overall Study|Lost to Follow-up|0|||
105827843|NCT01395017|365028098|FG000|Overall Study|Adverse Event|26|||
105827844|NCT01395017|365028099|FG001|Overall Study|Adverse Event|12|||
105827845|NCT01395017|365028098|FG000|Overall Study|Physician Decision|11|||
106148587|NCT02267824|366205432|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
106148588|NCT00350792|366205433|FG000|Overall Study|Adverse Event|11|||
106148589|NCT00350792|366205433|FG000|Overall Study|Death from Study Disease|1|||
106148590|NCT00350792|366205433|FG000|Overall Study|Death from Study Drug Toxicity|1|||
105827846|NCT01395017|365028099|FG001|Overall Study|Physician Decision|15|||
105827847|NCT01395017|365028098|FG000|Overall Study|Withdrawal by Subject|14|||
106022471|NCT02499328|365746886|FG016|Overall Study|Death|1|||
106022472|NCT02499328|365746887|FG017|Overall Study|Death|16|||
106022473|NCT02499328|365746888|FG018|Overall Study|Death|5|||
106022474|NCT02499328|365746870|FG000|Overall Study|"Other"|2|||
105827848|NCT01395017|365028099|FG001|Overall Study|Withdrawal by Subject|8|||
105827849|NCT01395017|365028098|FG000|Overall Study|Protocol deviation|1|||
105827850|NCT01395017|365028099|FG001|Overall Study|Protocol deviation|2|||
105827851|NCT01395017|365028098|FG000|Overall Study|Death|4|||
105827852|NCT01395017|365028099|FG001|Overall Study|Death|3|||
106022475|NCT02499328|365746871|FG001|Overall Study|"Other"|2|||
106022476|NCT02499328|365746872|FG002|Overall Study|"Other"|1|||
106022477|NCT02499328|365746873|FG003|Overall Study|"Other"|3|||
105963195|NCT05396014|365525279|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963196|NCT05396014|365525280|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
105963197|NCT05396014|365525238|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963198|NCT05396014|365525239|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963199|NCT05396014|365525240|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963200|NCT05396014|365525241|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963201|NCT05396014|365525242|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963202|NCT05396014|365525243|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963203|NCT05396014|365525244|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963204|NCT05396014|365525245|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963205|NCT05396014|365525246|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963206|NCT05396014|365525247|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963207|NCT05396014|365525248|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963208|NCT05396014|365525249|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963209|NCT05396014|365525250|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963210|NCT05396014|365525251|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
106148591|NCT00350792|366205433|FG000|Overall Study|Death Not Study Drug Related|2|||
106148592|NCT00350792|366205433|FG000|Overall Study|Protocol Violation|1|||
106148593|NCT00350792|366205433|FG000|Overall Study|Withdrawal by Subject|4|||
106148594|NCT00350792|366205433|FG000|Overall Study|Physician Decision|2|||
106148595|NCT00350792|366205433|FG000|Overall Study|Lack of Efficacy|11|||
106148596|NCT00939510|366205438|FG000|Overall Study|Withdrawal by Subject|1|||
106148597|NCT00520546|366205439|FG000|Overall Study|Withdrawal by Subject|1|||
106148598|NCT00520546|366205439|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
106148599|NCT03036813|366205440|FG000|Overall Study|Adverse Event|6|||
106148600|NCT03036813|366205441|FG001|Overall Study|Adverse Event|11|||
106148601|NCT03036813|366205442|FG002|Overall Study|Adverse Event|6|||
106148602|NCT03036813|366205440|FG000|Overall Study|Withdrawal by Subject|12|||
106148603|NCT03036813|366205441|FG001|Overall Study|Withdrawal by Subject|6|||
106148604|NCT03036813|366205442|FG002|Overall Study|Withdrawal by Subject|10|||
106148605|NCT03036813|366205440|FG000|Overall Study|Lost to Follow-up|1|||
106148606|NCT03036813|366205441|FG001|Overall Study|Lost to Follow-up|1|||
106148607|NCT03036813|366205442|FG002|Overall Study|Lost to Follow-up|0|||
106148608|NCT03036813|366205440|FG000|Overall Study|Physician Decision|2|||
106148609|NCT03036813|366205441|FG001|Overall Study|Physician Decision|1|||
106148610|NCT03036813|366205442|FG002|Overall Study|Physician Decision|1|||
106148611|NCT03036813|366205440|FG000|Overall Study|Non-Compliance|1|||
106148612|NCT03036813|366205441|FG001|Overall Study|Non-Compliance|5|||
106148613|NCT03036813|366205442|FG002|Overall Study|Non-Compliance|3|||
106148614|NCT03036813|366205440|FG000|Overall Study|Pregnancy|0|||
106148615|NCT03036813|366205441|FG001|Overall Study|Pregnancy|0|||
106148616|NCT03036813|366205442|FG002|Overall Study|Pregnancy|1|||
106148617|NCT03036813|366205440|FG000|Overall Study|Other|0|||
106148618|NCT03036813|366205441|FG001|Overall Study|Other|3|||
106148619|NCT03036813|366205442|FG002|Overall Study|Other|5|||
106148620|NCT01736215|366205443|FG000|Overall Study|Early termination of erythropoietin use|1|||
106148621|NCT01736215|366205443|FG000|Overall Study|Adverse Event|4|||
106148622|NCT01736215|366205443|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
106148623|NCT01736215|366205443|FG000|Overall Study|Insufficient data to perform analysis|8|||
105827853|NCT01395017|365028098|FG000|Overall Study|Disease progression|42|||
105827854|NCT01395017|365028099|FG001|Overall Study|Disease progression|58|||
105827855|NCT01395017|365028098|FG000|Overall Study|Sponsor discontinued study|1|||
105827856|NCT01395017|365028099|FG001|Overall Study|Sponsor discontinued study|4|||
105827857|NCT01451541|365028100|FG000|Overall Study|Adverse Event|4|||
105827858|NCT01451541|365028101|FG001|Overall Study|Adverse Event|3|||
105827859|NCT01451541|365028102|FG002|Overall Study|Adverse Event|6|||
105827860|NCT01451541|365028100|FG000|Overall Study|Lack of Efficacy|2|||
105827861|NCT01451541|365028101|FG001|Overall Study|Lack of Efficacy|0|||
105827862|NCT01451541|365028102|FG002|Overall Study|Lack of Efficacy|0|||
105827863|NCT01451541|365028100|FG000|Overall Study|Lost to Follow-up|4|||
105827864|NCT01451541|365028101|FG001|Overall Study|Lost to Follow-up|4|||
105827865|NCT01451541|365028102|FG002|Overall Study|Lost to Follow-up|7|||
105827866|NCT01451541|365028100|FG000|Overall Study|Withdrawal by Subject|15|||
106148624|NCT01061671|366205449|FG000|Overall Study|Withdrawal by Subject|16|||
106148625|NCT01061671|366205450|FG001|Overall Study|Withdrawal by Subject|20|||
106148626|NCT01061671|366205449|FG000|Overall Study|Lost to Follow-up|3|||
106148627|NCT01061671|366205450|FG001|Overall Study|Lost to Follow-up|5|||
106148628|NCT01061671|366205449|FG000|Overall Study|Death|28|||
106148629|NCT01061671|366205450|FG001|Overall Study|Death|30|||
106148630|NCT01070069|366205453|FG000|Overall Study|Death|1|||
106148631|NCT01070069|366205454|FG001|Overall Study|Death|0|||
106148632|NCT01070069|366205455|FG002|Overall Study|Death|2|||
106148633|NCT01070069|366205456|FG003|Overall Study|Death|0|||
105827867|NCT01451541|365028101|FG001|Overall Study|Withdrawal by Subject|8|||
105827868|NCT01451541|365028102|FG002|Overall Study|Withdrawal by Subject|6|||
106148634|NCT01070069|366205457|FG004|Overall Study|Death|1|||
105827869|NCT01451541|365028100|FG000|Overall Study|randomization error, noncompliance|11|||
105827870|NCT01451541|365028101|FG001|Overall Study|randomization error, noncompliance|10|||
105827871|NCT01451541|365028102|FG002|Overall Study|randomization error, noncompliance|8|||
105827872|NCT03366428|365028104|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
105827873|NCT03366428|365028104|FG000|Overall Study|Adverse Event|12|||
105827874|NCT03366428|365028104|FG000|Overall Study|Clinical progression|2|||
105827875|NCT03366428|365028104|FG000|Overall Study|Withdrawal by Subject|4|||
105827876|NCT01004510|365028105|FG000|Overall Study|Adverse Event|1|||
106148635|NCT01070069|366205453|FG000|Overall Study|Withdrawal by Subject|1|||
106148636|NCT01070069|366205454|FG001|Overall Study|Withdrawal by Subject|1|||
106148637|NCT01070069|366205455|FG002|Overall Study|Withdrawal by Subject|4|||
106148638|NCT01070069|366205456|FG003|Overall Study|Withdrawal by Subject|0|||
106148639|NCT01070069|366205457|FG004|Overall Study|Withdrawal by Subject|0|||
106148640|NCT01070069|366205453|FG000|Overall Study|Lost to Follow-up|4|||
106148641|NCT01070069|366205454|FG001|Overall Study|Lost to Follow-up|1|||
106148642|NCT01070069|366205455|FG002|Overall Study|Lost to Follow-up|0|||
106148643|NCT01070069|366205456|FG003|Overall Study|Lost to Follow-up|0|||
106148644|NCT01070069|366205457|FG004|Overall Study|Lost to Follow-up|3|||
106148645|NCT03565315|366205465|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
106148646|NCT03565315|366205466|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
106148647|NCT03565315|366205467|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
105827877|NCT03541252|365028109|FG000|Overall Study|Withdrawal by Subject|1|||
105827878|NCT03218787|365028119|FG000|Overall Study|Lost to Follow-up|12|||
105827879|NCT03218787|365028119|FG000|Overall Study|Withdrawal by Subject|72|||
105963211|NCT05396014|365525252|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963212|NCT05396014|365525253|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963213|NCT05396014|365525254|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963214|NCT05396014|365525255|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963215|NCT05396014|365525256|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963216|NCT05396014|365525257|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105827880|NCT03218787|365028119|FG000|Overall Study|Physician Decision|11|||
105827881|NCT03218787|365028119|FG000|Overall Study|Death|111|||
105827882|NCT01960296|365028120|FG000|Overall Study|Postponed surgery|1|||
105827883|NCT01960296|365028121|FG001|Overall Study|Postponed surgery|0|||
105827884|NCT01960296|365028120|FG000|Overall Study|Received different procedure|1|||
105827885|NCT01960296|365028121|FG001|Overall Study|Received different procedure|3|||
105827886|NCT02003391|365028122|FG000|Overall Study|Withdrawal by Subject|2|||
105827887|NCT02003391|365028123|FG001|Overall Study|Withdrawal by Subject|1|||
105827888|NCT02003391|365028122|FG000|Overall Study|Protocol Violation|0|||
105827889|NCT02003391|365028123|FG001|Overall Study|Protocol Violation|1|||
105827890|NCT02003391|365028122|FG000|Overall Study|Adverse Event|1|||
105827891|NCT02003391|365028123|FG001|Overall Study|Adverse Event|0|||
105827892|NCT03719040|365028124|FG000|Overall Study|Withdrawal by Subject|177|||
105827893|NCT03719040|365028124|FG000|Overall Study|Lost to Follow-up|26|||
105827894|NCT00227370|365028125|FG000|Overall Study|Withdrawal by Subject|1|||
105827895|NCT00227370|365028126|FG001|Overall Study|Withdrawal by Subject|2|||
105827896|NCT00227370|365028125|FG000|Overall Study|Death|3|||
105827897|NCT00227370|365028126|FG001|Overall Study|Death|4|||
105827898|NCT00227370|365028125|FG000|Overall Study|Adverse Event|6|||
105827899|NCT00227370|365028126|FG001|Overall Study|Adverse Event|11|||
105827900|NCT00227370|365028125|FG000|Overall Study|Physician Decision|9|||
105827901|NCT00227370|365028126|FG001|Overall Study|Physician Decision|6|||
105827902|NCT00227370|365028125|FG000|Overall Study|Other reasons|2|||
105827903|NCT00227370|365028126|FG001|Overall Study|Other reasons|1|||
105827904|NCT05315713|365028129|FG000|Overall Study|Death|5|||
105827905|NCT05315713|365028129|FG000|Overall Study|Progressive disease|1|||
105827906|NCT05315713|365028129|FG000|Overall Study|Withdrawal by Subject|1|||
105827907|NCT05315713|365028129|FG000|Overall Study|Study terminated by sponsor|1|||
105827908|NCT03961204|365028130|FG000|Overall Study|Withdrawal by Subject|2|||
105827909|NCT03961204|365028130|FG000|Overall Study|Lost to Follow-up|3|||
105827910|NCT03961204|365028130|FG000|Overall Study|Other|1|||
105827911|NCT03961204|365028130|FG000|Overall Study|Missing|1|||
105827912|NCT01120028|365028131|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
105827913|NCT01120028|365028132|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
106148648|NCT03565315|366205468|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
106148649|NCT01771731|366205469|FG000|Overall Study|Physician Decision|1|||
105827914|NCT01120028|365028133|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
105963217|NCT05396014|365525258|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105827915|NCT01120028|365028134|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
105827916|NCT01120028|365028131|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
105827917|NCT01120028|365028132|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
105827918|NCT01120028|365028133|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
105827919|NCT01120028|365028134|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
105827920|NCT01838681|365028137|FG000|Period A|Adverse Event|39|||
106022478|NCT02499328|365746874|FG004|Overall Study|"Other"|6|||
106022479|NCT02499328|365746875|FG005|Overall Study|"Other"|2|||
105827921|NCT01838681|365028138|FG001|Period A|Adverse Event|0|||
105827922|NCT01838681|365028139|FG002|Period A|Adverse Event|0|||
105827923|NCT01838681|365028140|FG003|Period A|Adverse Event|0|||
105827924|NCT01838681|365028137|FG000|Period A|Lack of Efficacy|21|||
105827925|NCT01838681|365028138|FG001|Period A|Lack of Efficacy|0|||
105827926|NCT01838681|365028139|FG002|Period A|Lack of Efficacy|0|||
105827927|NCT01838681|365028140|FG003|Period A|Lack of Efficacy|0|||
105827928|NCT01838681|365028137|FG000|Period A|Early response|148|||
105827929|NCT01838681|365028138|FG001|Period A|Early response|0|||
105827930|NCT01838681|365028139|FG002|Period A|Early response|0|||
105827931|NCT01838681|365028140|FG003|Period A|Early response|0|||
105827932|NCT01838681|365028137|FG000|Period A|Withdrawal by Subject|70|||
105827933|NCT01838681|365028138|FG001|Period A|Withdrawal by Subject|0|||
105827934|NCT01838681|365028139|FG002|Period A|Withdrawal by Subject|0|||
105827935|NCT01838681|365028140|FG003|Period A|Withdrawal by Subject|0|||
105827936|NCT01838681|365028137|FG000|Period A|Protocol Violation|16|||
105827937|NCT01838681|365028138|FG001|Period A|Protocol Violation|0|||
105827938|NCT01838681|365028139|FG002|Period A|Protocol Violation|0|||
105827939|NCT01838681|365028140|FG003|Period A|Protocol Violation|0|||
105827940|NCT01838681|365028137|FG000|Period A|Non-compliance with IMP|6|||
105827941|NCT01838681|365028138|FG001|Period A|Non-compliance with IMP|0|||
105827942|NCT01838681|365028139|FG002|Period A|Non-compliance with IMP|0|||
105827943|NCT01838681|365028140|FG003|Period A|Non-compliance with IMP|0|||
105827944|NCT01838681|365028137|FG000|Period A|Lost to Follow-up|4|||
105827945|NCT01838681|365028138|FG001|Period A|Lost to Follow-up|0|||
105827946|NCT01838681|365028139|FG002|Period A|Lost to Follow-up|0|||
105827947|NCT01838681|365028140|FG003|Period A|Lost to Follow-up|0|||
105827948|NCT01838681|365028137|FG000|Period A|Withdrawal before treatment|4|||
105827949|NCT01838681|365028138|FG001|Period A|Withdrawal before treatment|0|||
105827950|NCT01838681|365028139|FG002|Period A|Withdrawal before treatment|0|||
105827951|NCT01838681|365028140|FG003|Period A|Withdrawal before treatment|0|||
105827952|NCT01838681|365028137|FG000|Period A|Administrative or other reasons|17|||
105827953|NCT01838681|365028138|FG001|Period A|Administrative or other reasons|0|||
105827954|NCT01838681|365028139|FG002|Period A|Administrative or other reasons|0|||
105827955|NCT01838681|365028140|FG003|Period A|Administrative or other reasons|0|||
105827956|NCT01838681|365028137|FG000|Period B/A+|Adverse Event|0|||
105827957|NCT01838681|365028138|FG001|Period B/A+|Adverse Event|13|||
105827958|NCT01838681|365028139|FG002|Period B/A+|Adverse Event|27|||
105827959|NCT01838681|365028140|FG003|Period B/A+|Adverse Event|16|||
105827960|NCT01838681|365028137|FG000|Period B/A+|Lack of Efficacy|0|||
105827961|NCT01838681|365028138|FG001|Period B/A+|Lack of Efficacy|9|||
105827962|NCT01838681|365028139|FG002|Period B/A+|Lack of Efficacy|11|||
105827963|NCT01838681|365028140|FG003|Period B/A+|Lack of Efficacy|6|||
105827964|NCT01838681|365028137|FG000|Period B/A+|Withdrawal by Subject|0|||
105827965|NCT01838681|365028138|FG001|Period B/A+|Withdrawal by Subject|28|||
105827966|NCT01838681|365028139|FG002|Period B/A+|Withdrawal by Subject|35|||
105827967|NCT01838681|365028140|FG003|Period B/A+|Withdrawal by Subject|47|||
105827968|NCT01838681|365028137|FG000|Period B/A+|Protocol Violation|0|||
105827969|NCT01838681|365028138|FG001|Period B/A+|Protocol Violation|1|||
105827970|NCT01838681|365028139|FG002|Period B/A+|Protocol Violation|4|||
105827971|NCT01838681|365028140|FG003|Period B/A+|Protocol Violation|6|||
105827972|NCT01838681|365028137|FG000|Period B/A+|Non-compliance with IMP|0|||
105827973|NCT01838681|365028138|FG001|Period B/A+|Non-compliance with IMP|2|||
105827974|NCT01838681|365028139|FG002|Period B/A+|Non-compliance with IMP|3|||
105827975|NCT01838681|365028140|FG003|Period B/A+|Non-compliance with IMP|3|||
105827976|NCT01838681|365028137|FG000|Period B/A+|Lost to Follow-up|0|||
105827977|NCT01838681|365028138|FG001|Period B/A+|Lost to Follow-up|2|||
105827978|NCT01838681|365028139|FG002|Period B/A+|Lost to Follow-up|5|||
105827979|NCT01838681|365028140|FG003|Period B/A+|Lost to Follow-up|11|||
105827980|NCT01838681|365028137|FG000|Period B/A+|Withdrawal before treatment|0|||
105827981|NCT01838681|365028138|FG001|Period B/A+|Withdrawal before treatment|1|||
106022480|NCT02499328|365746876|FG006|Overall Study|"Other"|3|||
106022481|NCT02499328|365746877|FG007|Overall Study|"Other"|4|||
106022482|NCT02499328|365746878|FG008|Overall Study|"Other"|6|||
105827982|NCT01838681|365028139|FG002|Period B/A+|Withdrawal before treatment|0|||
105827983|NCT01838681|365028140|FG003|Period B/A+|Withdrawal before treatment|0|||
105827984|NCT01838681|365028137|FG000|Period B/A+|Administrative or other reasons|0|||
105827985|NCT01838681|365028138|FG001|Period B/A+|Administrative or other reasons|6|||
105827986|NCT01838681|365028139|FG002|Period B/A+|Administrative or other reasons|10|||
105827987|NCT01838681|365028140|FG003|Period B/A+|Administrative or other reasons|28|||
105827988|NCT02452463|365028143|FG000|Overall Study|Death|1|||
105827989|NCT02452463|365028144|FG001|Overall Study|Death|0|||
105827990|NCT02452463|365028145|FG002|Overall Study|Death|0|||
105827991|NCT02452463|365028143|FG000|Overall Study|Study Suspended|1|||
105827992|NCT02452463|365028144|FG001|Overall Study|Study Suspended|0|||
105827993|NCT02452463|365028145|FG002|Overall Study|Study Suspended|0|||
105827994|NCT02452463|365028143|FG000|Overall Study|Recommended by DSMB|0|||
105827995|NCT02452463|365028144|FG001|Overall Study|Recommended by DSMB|1|||
105827996|NCT02452463|365028145|FG002|Overall Study|Recommended by DSMB|0|||
105827997|NCT02452463|365028143|FG000|Overall Study|Withdrawal by Subject|0|||
105827998|NCT02452463|365028144|FG001|Overall Study|Withdrawal by Subject|1|||
105827999|NCT02452463|365028145|FG002|Overall Study|Withdrawal by Subject|0|||
105828000|NCT03867760|365028146|FG000|Overall Study|Lost to Follow-up|2|||
105828001|NCT03867760|365028147|FG001|Overall Study|Lost to Follow-up|3|||
105828002|NCT03867760|365028146|FG000|Overall Study|Withdrawal by Subject|1|||
105828003|NCT03867760|365028147|FG001|Overall Study|Withdrawal by Subject|2|||
105828004|NCT03867760|365028146|FG000|Overall Study|subject could not meet study logistics|3|||
105828005|NCT03867760|365028147|FG001|Overall Study|subject could not meet study logistics|3|||
105828006|NCT01528735|365028149|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
105828007|NCT01528735|365028150|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
105828008|NCT01528735|365028149|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
105828009|NCT01528735|365028150|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
105828010|NCT00556673|365028151|FG000|Overall Study|Protocol deviation|3|||
105828011|NCT00556673|365028152|FG001|Overall Study|Protocol deviation|2|||
105828012|NCT01401062|365028153|FG000|Overall Study|Death|9|||
105828013|NCT01401062|365028154|FG001|Overall Study|Death|7|||
105828014|NCT01401062|365028153|FG000|Overall Study|Physician Decision|1|||
105828015|NCT01401062|365028154|FG001|Overall Study|Physician Decision|0|||
105828016|NCT01401062|365028153|FG000|Overall Study|Withdrawal by Subject|1|||
105828017|NCT01401062|365028154|FG001|Overall Study|Withdrawal by Subject|1|||
105828018|NCT01131260|365028155|FG000|Overall Study|Randomization error|5|||
105828019|NCT01131260|365028156|FG001|Overall Study|Randomization error|1|||
105828020|NCT01131260|365028155|FG000|Overall Study|Declined to continue participation|8|||
105828021|NCT01131260|365028156|FG001|Overall Study|Declined to continue participation|13|||
105828022|NCT01131260|365028155|FG000|Overall Study|Physician Decision|22|||
105828023|NCT01131260|365028156|FG001|Overall Study|Physician Decision|24|||
105828024|NCT01131260|365028155|FG000|Overall Study|Technical problems|7|||
105828025|NCT01131260|365028156|FG001|Overall Study|Technical problems|6|||
105828026|NCT01131260|365028155|FG000|Overall Study|Staff error|2|||
105828027|NCT01131260|365028156|FG001|Overall Study|Staff error|1|||
105828028|NCT01131260|365028155|FG000|Overall Study|Ineligible|0|||
105828029|NCT01131260|365028156|FG001|Overall Study|Ineligible|2|||
105828030|NCT02011945|365028160|FG000|Overall Study|Participant requested to Discontinue|0|||
105828031|NCT02011945|365028161|FG001|Overall Study|Participant requested to Discontinue|1|||
105828032|NCT02011945|365028162|FG002|Overall Study|Participant requested to Discontinue|1|||
105828033|NCT02011945|365028160|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
105828034|NCT02011945|365028161|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
105828035|NCT02011945|365028162|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
105828036|NCT02011945|365028160|FG000|Overall Study|Study Drug Toxicity|0|||
105828037|NCT02011945|365028161|FG001|Overall Study|Study Drug Toxicity|0|||
105828038|NCT02011945|365028162|FG002|Overall Study|Study Drug Toxicity|1|||
105828039|NCT02011945|365028160|FG000|Overall Study|Treatment Failure|0|||
105828040|NCT02011945|365028161|FG001|Overall Study|Treatment Failure|7|||
105828041|NCT02011945|365028162|FG002|Overall Study|Treatment Failure|6|||
105828042|NCT02011945|365028160|FG000|Overall Study|No Longer Meets Study Criteria|1|||
105828043|NCT02011945|365028161|FG001|Overall Study|No Longer Meets Study Criteria|0|||
105828044|NCT02011945|365028162|FG002|Overall Study|No Longer Meets Study Criteria|0|||
105828045|NCT02011945|365028160|FG000|Overall Study|Proceeded to stem cell transplant|0|||
105828046|NCT02011945|365028161|FG001|Overall Study|Proceeded to stem cell transplant|0|||
105828047|NCT02011945|365028162|FG002|Overall Study|Proceeded to stem cell transplant|1|||
105828048|NCT02011945|365028160|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
105828049|NCT02011945|365028161|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
105828050|NCT02011945|365028162|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
105828051|NCT00679081|365028163|FG000|Overall Study|Lost to Follow-up|1|||
105828052|NCT01566435|365028164|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
105828053|NCT02286466|365028165|FG000|Overall Study|Death|1|||
105828054|NCT02286466|365028166|FG001|Overall Study|Death|3|||
105828055|NCT02286466|365028165|FG000|Overall Study|Withdrawal by Subject|5|||
105828056|NCT02286466|365028166|FG001|Overall Study|Withdrawal by Subject|2|||
105828057|NCT02286466|365028165|FG000|Overall Study|Lost to Follow-up|1|||
105828058|NCT02286466|365028166|FG001|Overall Study|Lost to Follow-up|4|||
105828059|NCT02286466|365028165|FG000|Overall Study|Declined Clinician Assessment|0|||
105828060|NCT02286466|365028166|FG001|Overall Study|Declined Clinician Assessment|1|||
105828061|NCT01912807|365028169|FG000|Overall Study|Did not meet elegibility criteria|6|||
105828062|NCT01912807|365028170|FG001|Overall Study|Did not meet elegibility criteria|4|||
105828063|NCT01912807|365028169|FG000|Overall Study|Lost to Follow-up|36|||
105828064|NCT01912807|365028170|FG001|Overall Study|Lost to Follow-up|37|||
105828065|NCT04750239|365028171|FG000|Overall Study|Withdrawal by Subject|2|||
105828066|NCT04750239|365028171|FG000|Overall Study|Trial terminated by sponsor|1|||
105828067|NCT00919711|365028172|FG000|Overall Study|Withdrawal by Subject|15|||
105828068|NCT00919711|365028173|FG001|Overall Study|Withdrawal by Subject|7|||
105828069|NCT00919711|365028172|FG000|Overall Study|Adverse Event|13|||
105828070|NCT00919711|365028173|FG001|Overall Study|Adverse Event|3|||
105828071|NCT00919711|365028172|FG000|Overall Study|Other|1|||
105828072|NCT00919711|365028173|FG001|Overall Study|Other|2|||
105828073|NCT00919711|365028172|FG000|Overall Study|Administrative Decision|0|||
105828074|NCT00919711|365028173|FG001|Overall Study|Administrative Decision|1|||
105828075|NCT00919711|365028172|FG000|Overall Study|Lost to Follow-up|2|||
105828076|NCT00919711|365028173|FG001|Overall Study|Lost to Follow-up|0|||
105828077|NCT00919711|365028172|FG000|Overall Study|Death|1|||
105828078|NCT00919711|365028173|FG001|Overall Study|Death|0|||
105828079|NCT00919711|365028172|FG000|Overall Study|Noncompliance|1|||
105828080|NCT00919711|365028173|FG001|Overall Study|Noncompliance|0|||
105828081|NCT02535923|365028179|FG000|Overall Study|Lost to Follow-up|5|||
105828082|NCT02535923|365028180|FG001|Overall Study|Lost to Follow-up|5|||
105828083|NCT02535923|365028179|FG000|Overall Study|Withdrawal by Subject|4|||
105828084|NCT02535923|365028180|FG001|Overall Study|Withdrawal by Subject|3|||
105828085|NCT01253564|365028181|FG000|Overall Study|Disease Progression|22|||
105828086|NCT01253564|365028181|FG000|Overall Study|Withdrawal by Subject|1|||
105828087|NCT01253564|365028181|FG000|Overall Study|Serious Adverse Event|1|||
105828088|NCT03694197|365028182|FG000|Overall Study|Adverse Event|9|||
105828089|NCT03694197|365028182|FG000|Overall Study|Protocol became inconvenient to participate|1|||
105828090|NCT03694197|365028182|FG000|Overall Study|Physician Decision|4|||
105828091|NCT03694197|365028182|FG000|Overall Study|Study terminated by sponsor|1350|||
105828092|NCT03694197|365028182|FG000|Overall Study|Participant moved|5|||
105828093|NCT03694197|365028182|FG000|Overall Study|Participant withdrew consent|10|||
105828094|NCT03694197|365028182|FG000|Overall Study|Related to IMP administration|1|||
105828095|NCT03694197|365028182|FG000|Overall Study|Not disclosed|5|||
105828096|NCT01952691|365030525|FG000|Overall Study|Lost to Follow-up|2|||
105828097|NCT00529763|365030526|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
105828098|NCT00529763|365030527|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
105828099|NCT00529763|365030528|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
105828100|NCT00529763|365030526|FG000|Overall Study|Death|1|||
105828101|NCT00529763|365030527|FG001|Overall Study|Death|1|||
105828102|NCT00529763|365030528|FG002|Overall Study|Death|1|||
105828103|NCT00529763|365030526|FG000|Overall Study|Disease Progression|10|||
105828104|NCT00529763|365030527|FG001|Overall Study|Disease Progression|16|||
105828105|NCT00529763|365030528|FG002|Overall Study|Disease Progression|11|||
105828106|NCT00529763|365030526|FG000|Overall Study|Lost to Follow-up|1|||
105828107|NCT00529763|365030527|FG001|Overall Study|Lost to Follow-up|2|||
105828108|NCT00529763|365030528|FG002|Overall Study|Lost to Follow-up|3|||
105828109|NCT00529763|365030526|FG000|Overall Study|Stem Cell Transplant|0|||
105828110|NCT00529763|365030527|FG001|Overall Study|Stem Cell Transplant|3|||
105828111|NCT00529763|365030528|FG002|Overall Study|Stem Cell Transplant|1|||
105828112|NCT00529763|365030526|FG000|Overall Study|Study Drug Toxicity|3|||
105828113|NCT00529763|365030527|FG001|Overall Study|Study Drug Toxicity|6|||
105828114|NCT00529763|365030528|FG002|Overall Study|Study Drug Toxicity|4|||
105828115|NCT00529763|365030526|FG000|Overall Study|Participant Withdrew Consent|2|||
105828116|NCT00529763|365030527|FG001|Overall Study|Participant Withdrew Consent|3|||
105828117|NCT00529763|365030528|FG002|Overall Study|Participant Withdrew Consent|4|||
105828118|NCT00529763|365030526|FG000|Overall Study|Other reasons|2|||
105828119|NCT00529763|365030527|FG001|Overall Study|Other reasons|0|||
105828120|NCT00529763|365030528|FG002|Overall Study|Other reasons|2|||
105828121|NCT00529763|365030526|FG000|Overall Study|Participant request to discontinue treatment|1|||
105828122|NCT00529763|365030527|FG001|Overall Study|Participant request to discontinue treatment|1|||
105828123|NCT00529763|365030528|FG002|Overall Study|Participant request to discontinue treatment|3|||
105828124|NCT02997176|365030529|FG000|Overall Study|Adverse Event|0|||
105828125|NCT02997176|365030530|FG001|Overall Study|Adverse Event|0|||
105828126|NCT02997176|365030531|FG002|Overall Study|Adverse Event|0|||
105828127|NCT02997176|365030532|FG003|Overall Study|Adverse Event|8|||
105828128|NCT02997176|365030529|FG000|Overall Study|Progressive Disease|1|||
105828129|NCT02997176|365030530|FG001|Overall Study|Progressive Disease|0|||
105828130|NCT02997176|365030531|FG002|Overall Study|Progressive Disease|1|||
105963218|NCT05396014|365525259|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963219|NCT05396014|365525260|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963220|NCT05396014|365525261|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963221|NCT05396014|365525262|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963222|NCT05396014|365525263|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963223|NCT05396014|365525264|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
105963224|NCT05396014|365525265|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105828131|NCT02997176|365030532|FG003|Overall Study|Progressive Disease|1|||
105828132|NCT02997176|365030529|FG000|Overall Study|Death|0|||
105828133|NCT02997176|365030530|FG001|Overall Study|Death|0|||
105828134|NCT02997176|365030531|FG002|Overall Study|Death|1|||
105828135|NCT02997176|365030532|FG003|Overall Study|Death|1|||
105828136|NCT02997176|365030529|FG000|Overall Study|Withdrawal by Subject|0|||
105828137|NCT02997176|365030530|FG001|Overall Study|Withdrawal by Subject|2|||
105828138|NCT02997176|365030531|FG002|Overall Study|Withdrawal by Subject|0|||
105828139|NCT02997176|365030532|FG003|Overall Study|Withdrawal by Subject|1|||
105828140|NCT02751424|365030533|FG000|Part 2|Adverse Event|0|||
105828141|NCT02751424|365030534|FG001|Part 2|Adverse Event|0|||
105828142|NCT02751424|365030535|FG002|Part 2|Adverse Event|0|||
105828143|NCT02751424|365030536|FG003|Part 2|Adverse Event|0|||
105828144|NCT02751424|365030537|FG004|Part 2|Adverse Event|0|||
105828145|NCT02751424|365030538|FG005|Part 2|Adverse Event|0|||
105828146|NCT02751424|365030539|FG006|Part 2|Adverse Event|0|||
105828147|NCT02751424|365030540|FG007|Part 2|Adverse Event|5|||
105828148|NCT02751424|365030541|FG008|Part 2|Adverse Event|0|||
105828149|NCT00985439|365030542|FG000|Overall Study|Adverse Event|0|||
105828150|NCT00985439|365030543|FG001|Overall Study|Adverse Event|0|||
105828151|NCT00985439|365030544|FG002|Overall Study|Adverse Event|1|||
105828152|NCT00985439|365030545|FG003|Overall Study|Adverse Event|0|||
105828153|NCT00367133|365030553|FG000|2 Years|Death|20|||
105828154|NCT00367133|365030554|FG001|2 Years|Death|12|||
105828155|NCT00367133|365030555|FG002|2 Years|Death|12|||
105828156|NCT00367133|365030553|FG000|2 Years|Dropped|34|||
105828157|NCT00367133|365030554|FG001|2 Years|Dropped|19|||
105828158|NCT00367133|365030555|FG002|2 Years|Dropped|33|||
105828159|NCT00367133|365030553|FG000|2 Years|Missed visit|4|||
105828160|NCT00367133|365030554|FG001|2 Years|Missed visit|5|||
105828161|NCT00367133|365030555|FG002|2 Years|Missed visit|4|||
105828162|NCT02336074|365030557|FG000|Overall Study|Adverse Event|0|||
105828163|NCT02336074|365030558|FG001|Overall Study|Adverse Event|2|||
105828164|NCT00958724|365030564|FG000|Overall Study|Disease Progression|6|||
105828165|NCT05604014|365030582|FG000|Overall Study|Lost to Follow-up|13|||
105828166|NCT01168856|365030583|FG000|Overall Study|Lost to Follow-up|4|||
105828167|NCT01168856|365030584|FG001|Overall Study|Lost to Follow-up|34|||
105828168|NCT01168856|365030583|FG000|Overall Study|Withdrawal by Subject|6|||
105828169|NCT01168856|365030584|FG001|Overall Study|Withdrawal by Subject|8|||
105828170|NCT01168856|365030583|FG000|Overall Study|Physician Decision|2|||
105828171|NCT01168856|365030584|FG001|Overall Study|Physician Decision|1|||
105828172|NCT01168856|365030583|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
105828173|NCT01168856|365030584|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
105828174|NCT01168856|365030583|FG000|Overall Study|Participant received anti-HCV treatment|1|||
105828175|NCT01168856|365030584|FG001|Overall Study|Participant received anti-HCV treatment|0|||
105828176|NCT01168856|365030583|FG000|Overall Study|Death|0|||
105828177|NCT01168856|365030584|FG001|Overall Study|Death|2|||
105828178|NCT01168856|365030583|FG000|Overall Study|Other|1|||
105828179|NCT01168856|365030584|FG001|Overall Study|Other|291|||
105828180|NCT01168856|365030583|FG000|Overall Study|Protocol Violation|4|||
105828181|NCT01168856|365030584|FG001|Overall Study|Protocol Violation|6|||
105828182|NCT01266902|365030585|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
105828183|NCT01266902|365030586|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
105828184|NCT01266902|365030587|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
105828185|NCT01266902|365030585|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
105828186|NCT01266902|365030586|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
105828187|NCT01266902|365030587|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
105828188|NCT01266902|365030585|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
105828189|NCT01266902|365030586|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
105828190|NCT01266902|365030587|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
105828191|NCT01266902|365030585|FG000|Period 1 (Main Study)|Adverse Event|3|||
105828192|NCT01266902|365030586|FG001|Period 1 (Main Study)|Adverse Event|11|||
105828193|NCT01266902|365030587|FG002|Period 1 (Main Study)|Adverse Event|0|||
105828194|NCT01266902|365030585|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
105828195|NCT01266902|365030586|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
105828196|NCT01266902|365030587|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
105828197|NCT01266902|365030585|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
105828198|NCT01266902|365030586|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
105828199|NCT01266902|365030587|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
105828200|NCT01266902|365030585|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
105828201|NCT01266902|365030586|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
105828202|NCT01266902|365030587|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
105828203|NCT01266902|365030585|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
105828204|NCT01266902|365030586|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
105828205|NCT01266902|365030587|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
105828206|NCT01266902|365030585|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
105828207|NCT01266902|365030586|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
105828208|NCT01266902|365030587|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
105828209|NCT01266902|365030585|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
105828210|NCT01266902|365030586|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
105828211|NCT01266902|365030587|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
105828212|NCT02121184|365030588|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
105828213|NCT02121184|365030589|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
105828214|NCT02121184|365030588|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
105828215|NCT02121184|365030589|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
105828216|NCT02121184|365030588|FG000|Overall Study|Emergency cesarean section required|0|||
105828217|NCT02121184|365030589|FG001|Overall Study|Emergency cesarean section required|2|||
105828218|NCT02121184|365030588|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
105869088|NCT01995513|365171605|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
105869089|NCT01995513|365171602|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
105963225|NCT05396014|365525266|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963226|NCT05396014|365525267|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963227|NCT05396014|365525268|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963228|NCT05396014|365525269|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963229|NCT05396014|365525270|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963230|NCT05396014|365525271|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963231|NCT05396014|365525272|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963232|NCT05396014|365525273|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963233|NCT05396014|365525274|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963234|NCT05396014|365525275|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963235|NCT05396014|365525276|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963236|NCT05396014|365525277|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963237|NCT05396014|365525278|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963238|NCT05396014|365525279|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963239|NCT05396014|365525280|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
105963240|NCT05396014|365525238|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963241|NCT05396014|365525239|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963242|NCT05396014|365525240|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963243|NCT05396014|365525241|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963244|NCT05396014|365525242|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963245|NCT05396014|365525243|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963246|NCT05396014|365525244|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963247|NCT05396014|365525245|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963248|NCT05396014|365525246|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963249|NCT05396014|365525247|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963250|NCT05396014|365525248|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963251|NCT05396014|365525249|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963252|NCT05396014|365525250|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963253|NCT05396014|365525251|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
105963254|NCT05396014|365525252|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963255|NCT05396014|365525253|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963256|NCT05396014|365525254|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963257|NCT05396014|365525255|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963258|NCT05396014|365525256|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963259|NCT05396014|365525257|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963260|NCT05396014|365525258|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963261|NCT05396014|365525259|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963262|NCT05396014|365525260|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963263|NCT05396014|365525261|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963264|NCT05396014|365525262|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963265|NCT05396014|365525263|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
106022483|NCT02499328|365746879|FG009|Overall Study|"Other"|16|||
105869090|NCT01995513|365171603|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
105869091|NCT01995513|365171604|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
105869092|NCT01995513|365171605|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
105869093|NCT02652949|365171606|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
105869094|NCT02652949|365171606|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
105869095|NCT02652949|365171606|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
105869096|NCT02652949|365171606|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
105869097|NCT02652949|365171606|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
105869098|NCT02652949|365171606|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
105869099|NCT02652949|365171606|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
105869100|NCT02652949|365171606|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
105869101|NCT02652949|365171606|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
105869102|NCT02652949|365171606|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
105869103|NCT02652949|365171606|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
105869104|NCT02652949|365171606|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
105869105|NCT02652949|365171606|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
105963266|NCT05396014|365525264|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963267|NCT05396014|365525265|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963268|NCT05396014|365525266|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963269|NCT05396014|365525267|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963270|NCT05396014|365525268|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963271|NCT05396014|365525269|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963272|NCT05396014|365525270|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963273|NCT05396014|365525271|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963274|NCT05396014|365525272|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963275|NCT05396014|365525273|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963276|NCT05396014|365525274|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963277|NCT05396014|365525275|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963278|NCT05396014|365525276|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963279|NCT05396014|365525277|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963280|NCT05396014|365525278|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963281|NCT05396014|365525279|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963282|NCT05396014|365525280|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
105963283|NCT05396014|365525238|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
105963284|NCT05396014|365525239|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963285|NCT05396014|365525240|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963286|NCT05396014|365525241|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963287|NCT05396014|365525242|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963288|NCT05396014|365525243|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963289|NCT05396014|365525244|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963290|NCT05396014|365525245|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963291|NCT05396014|365525246|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963292|NCT05396014|365525247|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963293|NCT05396014|365525248|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963294|NCT05396014|365525249|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963295|NCT05396014|365525250|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963296|NCT05396014|365525251|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
105963297|NCT05396014|365525252|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963298|NCT05396014|365525253|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963299|NCT05396014|365525254|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963300|NCT05396014|365525255|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963301|NCT05396014|365525256|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963302|NCT05396014|365525257|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963303|NCT05396014|365525258|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963304|NCT05396014|365525259|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963305|NCT05396014|365525260|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963306|NCT05396014|365525261|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963307|NCT05396014|365525262|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963308|NCT05396014|365525263|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963309|NCT05396014|365525264|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963310|NCT05396014|365525265|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963311|NCT05396014|365525266|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963312|NCT05396014|365525267|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963313|NCT05396014|365525268|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963314|NCT05396014|365525269|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963315|NCT05396014|365525270|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963316|NCT05396014|365525271|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963317|NCT05396014|365525272|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963318|NCT05396014|365525273|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963319|NCT05396014|365525274|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963320|NCT05396014|365525275|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963321|NCT05396014|365525276|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963322|NCT05396014|365525277|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
105963323|NCT05396014|365525278|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963324|NCT05396014|365525279|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963325|NCT05396014|365525280|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
105963326|NCT05396014|365525238|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
105963327|NCT05396014|365525239|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963328|NCT05396014|365525240|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963329|NCT05396014|365525241|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963330|NCT05396014|365525242|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963331|NCT05396014|365525243|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963332|NCT05396014|365525244|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963333|NCT05396014|365525245|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963334|NCT05396014|365525246|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963335|NCT05396014|365525247|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963336|NCT05396014|365525248|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963337|NCT05396014|365525249|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963338|NCT05396014|365525250|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963339|NCT05396014|365525251|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963340|NCT05396014|365525252|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105828219|NCT02121184|365030589|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
105828220|NCT00840203|365030590|FG000|First Intervention|Protocol Violation|1|||
105828221|NCT00840203|365030591|FG001|First Intervention|Protocol Violation|1|||
105828222|NCT00840203|365030590|FG000|Washout|Protocol Violation|1|||
105828223|NCT00840203|365030591|FG001|Washout|Protocol Violation|0|||
105828224|NCT05562011|365030600|FG000|Overall Study|Withdrawal by Subject|3|||
105828225|NCT05562011|365030600|FG000|Overall Study|Lost to Follow-up|1|||
105828226|NCT05562011|365030600|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
105828227|NCT05562011|365030600|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
105828228|NCT05562011|365030600|FG000|Overall Study|Device malfunction|13|||
105828229|NCT00387153|365030605|FG000|Overall Study|Adverse Event|1|||
105828230|NCT00387153|365030605|FG000|Overall Study|Disease Progression|3|||
105828231|NCT00387153|365030605|FG000|Overall Study|Lack of Response|4|||
105828232|NCT03073798|365030606|FG000|Overall Study|Adverse Event|1|||
105828233|NCT03073798|365030606|FG000|Overall Study|Withdrawal by Subject|1|||
105828234|NCT01945580|365030609|FG000|Overall Study|Withdrawal by Subject|13|||
105828235|NCT01945580|365030610|FG001|Overall Study|Withdrawal by Subject|35|||
105828236|NCT01945580|365030609|FG000|Overall Study|Physician Decision|3|||
105828237|NCT01945580|365030610|FG001|Overall Study|Physician Decision|2|||
105828238|NCT01945580|365030609|FG000|Overall Study|Lost to Follow-up|26|||
105828239|NCT01945580|365030610|FG001|Overall Study|Lost to Follow-up|39|||
105828240|NCT01945580|365030609|FG000|Overall Study|Death|7|||
105828241|NCT01945580|365030610|FG001|Overall Study|Death|2|||
105828242|NCT01945580|365030609|FG000|Overall Study|Patient moved out of state|0|||
105828243|NCT01945580|365030610|FG001|Overall Study|Patient moved out of state|1|||
105828244|NCT01945580|365030609|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
105828245|NCT01945580|365030610|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
105828246|NCT01945580|365030609|FG000|Overall Study|Family illness - unable to return|0|||
105828247|NCT01945580|365030610|FG001|Overall Study|Family illness - unable to return|1|||
105828248|NCT01945580|365030609|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
105828249|NCT01945580|365030610|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
105828250|NCT01945580|365030609|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
105828251|NCT01945580|365030610|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
105828252|NCT01945580|365030609|FG000|Overall Study|Noncompliance with 36 month visit|1|||
105828253|NCT01945580|365030610|FG001|Overall Study|Noncompliance with 36 month visit|0|||
105828254|NCT01945580|365030609|FG000|Overall Study|The patient moved.|1|||
105828255|NCT01945580|365030610|FG001|Overall Study|The patient moved.|0|||
105828256|NCT01945580|365030609|FG000|Overall Study|No data available|0|||
105828257|NCT01945580|365030610|FG001|Overall Study|No data available|2|||
105828258|NCT02957331|365030613|FG000|Overall Study|Protocol Violation|1|||
105828259|NCT02957331|365030614|FG001|Overall Study|Protocol Violation|0|||
105828260|NCT00101439|365030615|FG000|Period 2|Withdrawal by Subject|0|||
105828261|NCT00101439|365030616|FG001|Period 2|Withdrawal by Subject|2|||
105828262|NCT00840658|365030617|FG000|Overall Study|Death|2|||
105828263|NCT00840658|365030618|FG001|Overall Study|Death|2|||
105828264|NCT00840658|365030619|FG002|Overall Study|Death|3|||
105828265|NCT00840658|365030620|FG003|Overall Study|Death|3|||
105828266|NCT00840658|365030617|FG000|Overall Study|Lost to Follow-up|3|||
105828267|NCT00840658|365030618|FG001|Overall Study|Lost to Follow-up|1|||
105828268|NCT00840658|365030619|FG002|Overall Study|Lost to Follow-up|2|||
105828269|NCT00840658|365030620|FG003|Overall Study|Lost to Follow-up|1|||
105828270|NCT01867658|365030621|FG000|Overall Study|Withdrawal by Subject|6|||
105828271|NCT01867658|365030621|FG000|Overall Study|Death|2|||
105828272|NCT01867658|365030621|FG000|Overall Study|Subject could not be contacted|1|||
105828273|NCT03101358|365030622|FG000|Overall Study|Non-compliance with study schedule|1|||
105828274|NCT03101358|365030623|FG001|Overall Study|Non-compliance with study schedule|0|||
105828275|NCT03101358|365030624|FG002|Overall Study|Non-compliance with study schedule|0|||
105828276|NCT03101358|365030625|FG003|Overall Study|Non-compliance with study schedule|1|||
105963341|NCT05396014|365525253|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963342|NCT05396014|365525254|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963343|NCT05396014|365525255|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963344|NCT05396014|365525256|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963345|NCT05396014|365525257|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963346|NCT05396014|365525258|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963347|NCT05396014|365525259|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963348|NCT05396014|365525260|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963349|NCT05396014|365525261|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963350|NCT05396014|365525262|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963351|NCT05396014|365525263|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963352|NCT05396014|365525264|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
105828277|NCT03101358|365030622|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
105828278|NCT03101358|365030623|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
105828279|NCT03101358|365030624|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
105963353|NCT05396014|365525265|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963354|NCT05396014|365525266|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963355|NCT05396014|365525267|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963356|NCT05396014|365525268|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963357|NCT05396014|365525269|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963358|NCT05396014|365525270|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963359|NCT05396014|365525271|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963360|NCT05396014|365525272|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963361|NCT05396014|365525273|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963362|NCT05396014|365525274|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963363|NCT05396014|365525275|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963364|NCT05396014|365525276|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963365|NCT05396014|365525277|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963366|NCT05396014|365525278|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963367|NCT05396014|365525279|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963368|NCT05396014|365525280|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
105963369|NCT05396014|365525238|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963370|NCT05396014|365525239|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963371|NCT05396014|365525240|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963372|NCT05396014|365525241|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963373|NCT05396014|365525242|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963374|NCT05396014|365525243|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963375|NCT05396014|365525244|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963376|NCT05396014|365525245|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963377|NCT05396014|365525246|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963378|NCT05396014|365525247|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963379|NCT05396014|365525248|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963380|NCT05396014|365525249|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963381|NCT05396014|365525250|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963382|NCT05396014|365525251|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
105963383|NCT05396014|365525252|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963384|NCT05396014|365525253|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963385|NCT05396014|365525254|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963386|NCT05396014|365525255|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963387|NCT05396014|365525256|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963388|NCT05396014|365525257|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963389|NCT05396014|365525258|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105828280|NCT03101358|365030625|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
105828281|NCT03101358|365030622|FG000|Overall Study|Physician Decision|1|||
105828282|NCT03101358|365030623|FG001|Overall Study|Physician Decision|0|||
105828283|NCT03101358|365030624|FG002|Overall Study|Physician Decision|0|||
105828284|NCT03101358|365030625|FG003|Overall Study|Physician Decision|3|||
105828285|NCT03101358|365030622|FG000|Overall Study|Adverse Event|0|||
105828286|NCT03101358|365030623|FG001|Overall Study|Adverse Event|0|||
105963390|NCT05396014|365525259|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963391|NCT05396014|365525260|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963392|NCT05396014|365525261|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963393|NCT05396014|365525262|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963394|NCT05396014|365525263|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105828287|NCT03101358|365030624|FG002|Overall Study|Adverse Event|1|||
105828288|NCT03101358|365030625|FG003|Overall Study|Adverse Event|0|||
105963395|NCT05396014|365525264|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105828289|NCT03101358|365030622|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
105828290|NCT03101358|365030623|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
105828291|NCT03101358|365030624|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
105828292|NCT03101358|365030625|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
105828293|NCT03101358|365030622|FG000|Overall Study|Lost to Follow-up|1|||
105828294|NCT03101358|365030623|FG001|Overall Study|Lost to Follow-up|0|||
105828295|NCT03101358|365030624|FG002|Overall Study|Lost to Follow-up|0|||
105828296|NCT03101358|365030625|FG003|Overall Study|Lost to Follow-up|1|||
105828297|NCT02845336|365030630|FG000|Overall Study|Lost to Follow-up|3|||
105828298|NCT02845336|365030631|FG001|Overall Study|Lost to Follow-up|1|||
105828299|NCT02845336|365030630|FG000|Overall Study|Inability to get medication|2|||
105828300|NCT02845336|365030631|FG001|Overall Study|Inability to get medication|0|||
105828301|NCT01496118|365030632|FG000|Overall Study|Disease progression|3|||
105828302|NCT01496118|365030633|FG001|Overall Study|Disease progression|2|||
105828303|NCT01496118|365030634|FG002|Overall Study|Disease progression|3|||
105828304|NCT01496118|365030635|FG003|Overall Study|Disease progression|1|||
105828305|NCT01496118|365030636|FG004|Overall Study|Disease progression|2|||
105828306|NCT01496118|365030637|FG005|Overall Study|Disease progression|2|||
105828307|NCT01496118|365030638|FG006|Overall Study|Disease progression|14|||
105828308|NCT01496118|365030639|FG007|Overall Study|Disease progression|10|||
105828309|NCT01496118|365030632|FG000|Overall Study|Physician Decision|0|||
105828310|NCT01496118|365030633|FG001|Overall Study|Physician Decision|0|||
105828311|NCT01496118|365030634|FG002|Overall Study|Physician Decision|0|||
105828312|NCT01496118|365030635|FG003|Overall Study|Physician Decision|0|||
105828313|NCT01496118|365030636|FG004|Overall Study|Physician Decision|1|||
105828314|NCT01496118|365030637|FG005|Overall Study|Physician Decision|0|||
105828315|NCT01496118|365030638|FG006|Overall Study|Physician Decision|3|||
105828316|NCT01496118|365030639|FG007|Overall Study|Physician Decision|6|||
105828317|NCT01496118|365030632|FG000|Overall Study|Adverse Event|1|||
105828318|NCT01496118|365030633|FG001|Overall Study|Adverse Event|1|||
105828319|NCT01496118|365030634|FG002|Overall Study|Adverse Event|0|||
105828320|NCT01496118|365030635|FG003|Overall Study|Adverse Event|0|||
105828321|NCT01496118|365030636|FG004|Overall Study|Adverse Event|0|||
105828322|NCT01496118|365030637|FG005|Overall Study|Adverse Event|0|||
105828323|NCT01496118|365030638|FG006|Overall Study|Adverse Event|6|||
105828324|NCT01496118|365030639|FG007|Overall Study|Adverse Event|10|||
105828325|NCT01496118|365030632|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828326|NCT01496118|365030633|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828327|NCT01496118|365030634|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828328|NCT01496118|365030635|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828329|NCT01496118|365030636|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828330|NCT01496118|365030637|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828331|NCT01496118|365030638|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
105828332|NCT01496118|365030639|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
105828333|NCT01496118|365030632|FG000|Overall Study|Death|0|||
105828334|NCT01496118|365030633|FG001|Overall Study|Death|0|||
105828335|NCT01496118|365030634|FG002|Overall Study|Death|0|||
105828336|NCT01496118|365030635|FG003|Overall Study|Death|0|||
105828337|NCT01496118|365030636|FG004|Overall Study|Death|0|||
105828338|NCT01496118|365030637|FG005|Overall Study|Death|0|||
105828339|NCT01496118|365030638|FG006|Overall Study|Death|1|||
105828340|NCT01496118|365030639|FG007|Overall Study|Death|1|||
105828341|NCT01496118|365030632|FG000|Overall Study|Withdrawal by Subject|0|||
105828342|NCT01496118|365030633|FG001|Overall Study|Withdrawal by Subject|0|||
105828343|NCT01496118|365030634|FG002|Overall Study|Withdrawal by Subject|0|||
105828344|NCT01496118|365030635|FG003|Overall Study|Withdrawal by Subject|2|||
105828345|NCT01496118|365030636|FG004|Overall Study|Withdrawal by Subject|0|||
105828346|NCT01496118|365030637|FG005|Overall Study|Withdrawal by Subject|1|||
105828347|NCT01496118|365030638|FG006|Overall Study|Withdrawal by Subject|6|||
105828348|NCT01496118|365030639|FG007|Overall Study|Withdrawal by Subject|3|||
105828349|NCT00654186|365030652|FG000|Overall Study|Withdrawal by Subject|5|||
105828350|NCT03306277|365030654|FG000|Overall Study|Death|1|||
105828351|NCT03306277|365030654|FG000|Overall Study|Adverse Event|1|||
105828352|NCT03306277|365030654|FG000|Overall Study|Withdrawal by Subject|1|||
105828353|NCT00881751|365030655|FG000|Overall Study|Physician Decision|0|||
105828354|NCT00881751|365030656|FG001|Overall Study|Physician Decision|1|||
105828355|NCT00881751|365030655|FG000|Overall Study|Adverse Event|0|||
105828356|NCT00881751|365030656|FG001|Overall Study|Adverse Event|2|||
105828357|NCT00881751|365030655|FG000|Overall Study|Withdrawal by Subject|0|||
105828358|NCT00881751|365030656|FG001|Overall Study|Withdrawal by Subject|2|||
105828359|NCT00301964|365030657|FG000|Overall Study|Second primary|2|||
105828360|NCT00301964|365030657|FG000|Overall Study|Wrong primary|1|||
105828361|NCT00301964|365030657|FG000|Overall Study|Inadequate pathology|1|||
105828362|NCT02385708|365030658|FG000|Overall Study|Withdrawal by Subject|0|||
105963396|NCT05396014|365525265|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963397|NCT05396014|365525266|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963398|NCT05396014|365525267|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963399|NCT05396014|365525268|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963400|NCT05396014|365525269|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963401|NCT05396014|365525270|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963402|NCT05396014|365525271|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963403|NCT05396014|365525272|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963404|NCT05396014|365525273|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963405|NCT05396014|365525274|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963406|NCT05396014|365525275|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963407|NCT05396014|365525276|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963408|NCT05396014|365525277|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963409|NCT05396014|365525278|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963410|NCT05396014|365525279|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963411|NCT05396014|365525280|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
105963412|NCT05396014|365525238|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963413|NCT05396014|365525239|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963414|NCT05396014|365525240|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105828363|NCT02385708|365030659|FG001|Overall Study|Withdrawal by Subject|2|||
105963415|NCT05396014|365525241|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
105963416|NCT05396014|365525242|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963417|NCT05396014|365525243|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963418|NCT05396014|365525244|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963419|NCT05396014|365525245|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963420|NCT05396014|365525246|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
105963421|NCT05396014|365525247|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963422|NCT05396014|365525248|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963423|NCT05396014|365525249|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963424|NCT05396014|365525250|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963425|NCT05396014|365525251|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963426|NCT05396014|365525252|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963427|NCT05396014|365525253|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963428|NCT05396014|365525254|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963429|NCT05396014|365525255|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963430|NCT05396014|365525256|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963431|NCT05396014|365525257|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963432|NCT05396014|365525258|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963433|NCT05396014|365525259|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963434|NCT05396014|365525260|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963435|NCT05396014|365525261|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963436|NCT05396014|365525262|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963437|NCT05396014|365525263|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
105963438|NCT05396014|365525264|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963439|NCT05396014|365525265|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963440|NCT05396014|365525266|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963441|NCT05396014|365525267|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963442|NCT05396014|365525268|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963443|NCT05396014|365525269|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963444|NCT05396014|365525270|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963445|NCT05396014|365525271|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963446|NCT05396014|365525272|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963447|NCT05396014|365525273|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963448|NCT05396014|365525274|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963449|NCT05396014|365525275|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963450|NCT05396014|365525276|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963451|NCT05396014|365525277|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
105963452|NCT05396014|365525278|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
105963453|NCT05396014|365525279|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
105963454|NCT05396014|365525280|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
105963455|NCT05396014|365525238|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963456|NCT05396014|365525239|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963457|NCT05396014|365525240|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963458|NCT05396014|365525241|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963459|NCT05396014|365525242|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963460|NCT05396014|365525243|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105828364|NCT02385708|365030658|FG000|Overall Study|Withdrawn - surgery canceled|2|||
105828365|NCT02385708|365030659|FG001|Overall Study|Withdrawn - surgery canceled|5|||
105828366|NCT02385708|365030658|FG000|Overall Study|Investigator decision|5|||
105828367|NCT02385708|365030659|FG001|Overall Study|Investigator decision|7|||
105828368|NCT02385708|365030658|FG000|Overall Study|Protocol Violation|1|||
105828369|NCT02385708|365030659|FG001|Overall Study|Protocol Violation|1|||
105828370|NCT02471807|365030665|FG000|Overall Study|Death|14|||
105828371|NCT02471807|365030665|FG000|Overall Study|Withdrawal by Subject|2|||
105828372|NCT02471807|365030665|FG000|Overall Study|Explant|5|||
105828373|NCT02471807|365030665|FG000|Overall Study|Lost to Follow-up|1|||
105828374|NCT00672984|365030668|FG000|First Intervention|Adverse Event|5|||
105828375|NCT00672984|365030669|FG001|First Intervention|Adverse Event|0|||
105828376|NCT00672984|365030670|FG002|First Intervention|Adverse Event|0|||
105828377|NCT00672984|365030668|FG000|First Intervention|Withdrawal by Subject|1|||
105828378|NCT00672984|365030669|FG001|First Intervention|Withdrawal by Subject|2|||
105828379|NCT00672984|365030670|FG002|First Intervention|Withdrawal by Subject|2|||
105828380|NCT00672984|365030668|FG000|First Intervention|Sponsor decision|3|||
105828381|NCT00672984|365030669|FG001|First Intervention|Sponsor decision|0|||
105828382|NCT00672984|365030670|FG002|First Intervention|Sponsor decision|0|||
105828383|NCT00672984|365030668|FG000|Second Intervention|Non-compliance with facility policies|0|||
105828384|NCT00672984|365030669|FG001|Second Intervention|Non-compliance with facility policies|2|||
105828385|NCT00672984|365030670|FG002|Second Intervention|Non-compliance with facility policies|0|||
105828386|NCT00672984|365030668|FG000|Second Intervention|Withdrawal by Subject|0|||
105828387|NCT00672984|365030669|FG001|Second Intervention|Withdrawal by Subject|3|||
105828388|NCT00672984|365030670|FG002|Second Intervention|Withdrawal by Subject|0|||
105828389|NCT00672984|365030668|FG000|Second Intervention|Protocol Violation|0|||
105828390|NCT00672984|365030669|FG001|Second Intervention|Protocol Violation|1|||
105828391|NCT00672984|365030670|FG002|Second Intervention|Protocol Violation|1|||
105828392|NCT00672984|365030668|FG000|Third Intervention|Adverse Event|1|||
105828393|NCT00672984|365030669|FG001|Third Intervention|Adverse Event|0|||
105828394|NCT00672984|365030670|FG002|Third Intervention|Adverse Event|1|||
105828395|NCT00354835|365030671|FG000|Overall Study|Death|1|||
105828396|NCT00354835|365030672|FG001|Overall Study|Death|1|||
105828397|NCT00354835|365030671|FG000|Overall Study|Physician Decision|8|||
105828398|NCT00354835|365030672|FG001|Overall Study|Physician Decision|13|||
105828399|NCT00354835|365030671|FG000|Overall Study|Withdrawal by Subject|2|||
105828400|NCT00354835|365030672|FG001|Overall Study|Withdrawal by Subject|1|||
105828401|NCT00354835|365030671|FG000|Overall Study|Ineligible|17|||
105828402|NCT00354835|365030672|FG001|Overall Study|Ineligible|16|||
105828403|NCT00354835|365030671|FG000|Overall Study|Disease progression or relapse|15|||
105828404|NCT00354835|365030672|FG001|Overall Study|Disease progression or relapse|22|||
105828405|NCT00354835|365030671|FG000|Overall Study|Adverse Event|6|||
105828406|NCT00354835|365030672|FG001|Overall Study|Adverse Event|0|||
105828407|NCT00354835|365030671|FG000|Overall Study|Refusal of further therapy|3|||
105828408|NCT00354835|365030672|FG001|Overall Study|Refusal of further therapy|8|||
105828409|NCT03277248|365030680|FG000|Overall Study|Adverse Event|3|||
105828410|NCT03277248|365030681|FG001|Overall Study|Adverse Event|1|||
105828411|NCT03277248|365030680|FG000|Overall Study|Subject Withdrawal of Consent|6|||
105828412|NCT03277248|365030681|FG001|Overall Study|Subject Withdrawal of Consent|23|||
105828413|NCT03277248|365030680|FG000|Overall Study|Investigator/Sponsor Decision|2|||
105828414|NCT03277248|365030681|FG001|Overall Study|Investigator/Sponsor Decision|2|||
105828415|NCT03277248|365030680|FG000|Overall Study|Pregnancy|4|||
105828416|NCT03277248|365030681|FG001|Overall Study|Pregnancy|1|||
105828417|NCT03277248|365030680|FG000|Overall Study|Lost to Follow-up|0|||
105828418|NCT03277248|365030681|FG001|Overall Study|Lost to Follow-up|2|||
105828419|NCT03277248|365030680|FG000|Overall Study|Lack of Efficacy|0|||
105828420|NCT03277248|365030681|FG001|Overall Study|Lack of Efficacy|2|||
105828421|NCT03277248|365030680|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
105828422|NCT03277248|365030681|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
105828423|NCT01663896|365030684|FG000|Overall Study|Various reasons|43|||
105828424|NCT01046084|365030691|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
105828425|NCT01046084|365030692|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
105828426|NCT00999687|365030693|FG000|First Intervention|Withdrawal by Subject|1|||
105828427|NCT00999687|365030693|FG000|Second Intervention|Withdrawal by Subject|2|||
105828428|NCT00999687|365030693|FG000|Second Intervention|Lack of Efficacy|1|||
105828429|NCT00474188|365030696|FG000|Overall Study|Withdrawal by Subject|1|||
105828430|NCT00474188|365030696|FG000|Overall Study|Study discontinued by sponsor|5|||
105828431|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
105828432|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
105828433|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
105828434|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
105828435|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
105828436|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828437|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828438|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828439|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
105963461|NCT05396014|365525244|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963462|NCT05396014|365525245|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963463|NCT05396014|365525246|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
105963464|NCT05396014|365525247|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963465|NCT05396014|365525248|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963466|NCT05396014|365525249|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963467|NCT05396014|365525250|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963468|NCT05396014|365525251|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963469|NCT05396014|365525252|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963470|NCT05396014|365525253|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963471|NCT05396014|365525254|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963472|NCT05396014|365525255|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963473|NCT05396014|365525256|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963474|NCT05396014|365525257|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963475|NCT05396014|365525258|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963476|NCT05396014|365525259|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963477|NCT05396014|365525260|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
105963478|NCT05396014|365525261|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963479|NCT05396014|365525262|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963480|NCT05396014|365525263|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963481|NCT05396014|365525264|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963482|NCT05396014|365525265|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963483|NCT05396014|365525266|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963484|NCT05396014|365525267|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963485|NCT05396014|365525268|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963486|NCT05396014|365525269|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963487|NCT05396014|365525270|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963488|NCT05396014|365525271|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963489|NCT05396014|365525272|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963490|NCT05396014|365525273|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
105963491|NCT05396014|365525274|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963492|NCT05396014|365525275|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963493|NCT05396014|365525276|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
106022484|NCT02499328|365746880|FG010|Overall Study|"Other"|13|||
106022485|NCT02499328|365746881|FG011|Overall Study|"Other"|31|||
105828440|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828441|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828442|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828443|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828444|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828445|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828446|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828447|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828448|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828449|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828450|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828451|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828452|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828453|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828454|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828455|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828456|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
105828457|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828458|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
105828459|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828460|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828461|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828462|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828463|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828464|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828465|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828466|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828467|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828468|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
106022486|NCT02499328|365746882|FG012|Overall Study|"Other"|8|||
106022487|NCT02499328|365746883|FG013|Overall Study|"Other"|7|||
105828469|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
106022488|NCT02499328|365746884|FG014|Overall Study|"Other"|6|||
105828470|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828471|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828472|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828473|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828474|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828475|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828476|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828477|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828478|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828479|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828480|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828481|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828482|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
105828483|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828484|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
105828485|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828486|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828487|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828488|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828489|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828490|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828491|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828492|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828493|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828494|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828495|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828496|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828497|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828498|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828499|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828500|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828501|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828502|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828503|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828504|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828505|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828506|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828507|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828508|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
105828509|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
105828510|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828511|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
105828512|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
105828513|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
105828514|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828515|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828516|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828517|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828518|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828519|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828520|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828521|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828522|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828523|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828524|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828525|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828526|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828527|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828528|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828529|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828530|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828531|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828532|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828533|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828534|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
105828535|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
105828536|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
105828537|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
105828538|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
105828539|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
105828540|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
106148650|NCT01771731|366205470|FG001|Overall Study|Physician Decision|0|||
105828541|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828542|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828543|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828544|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828545|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828546|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828547|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828548|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828549|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828550|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828551|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828552|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828553|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828554|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828555|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828556|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828557|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828558|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828559|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828560|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
105828561|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|moved|0|||
105828562|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|moved|1|||
105828563|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|moved|1|||
105828564|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|moved|0|||
105828565|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|moved|0|||
105828566|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|moved|0|||
105828567|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|moved|0|||
105828568|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|moved|0|||
105828569|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|moved|0|||
105828570|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|moved|0|||
105828571|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|moved|0|||
105828572|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|moved|0|||
105828573|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|moved|0|||
105828574|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|moved|0|||
105828575|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|moved|0|||
105828576|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|moved|0|||
105828577|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|moved|0|||
105828578|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|moved|0|||
105828579|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|moved|0|||
106148651|NCT01771731|366205469|FG000|Overall Study|Protocol Violation|0|||
106148652|NCT01771731|366205470|FG001|Overall Study|Protocol Violation|1|||
106148653|NCT01771731|366205469|FG000|Overall Study|Adverse event: Pain Crisis|1|||
106148654|NCT01771731|366205470|FG001|Overall Study|Adverse event: Pain Crisis|1|||
106148655|NCT00440011|366205471|FG000|Overall Study|Adverse Event|2|||
106148656|NCT00440011|366205472|FG001|Overall Study|Adverse Event|0|||
106148657|NCT00440011|366205471|FG000|Overall Study|Lost to Follow-up|0|||
106148658|NCT00440011|366205472|FG001|Overall Study|Lost to Follow-up|2|||
105828580|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|moved|0|||
105828581|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|moved|0|||
105828582|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|moved|0|||
105828583|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|moved|0|||
105828584|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|moved|0|||
105828585|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|moved|0|||
105828586|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|moved|0|||
105828587|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828588|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828589|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828590|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
105828591|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828592|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828593|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828594|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828595|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828596|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
106148659|NCT00440011|366205471|FG000|Overall Study|Protocol Violation|1|||
106148660|NCT00440011|366205472|FG001|Overall Study|Protocol Violation|1|||
106148661|NCT00440011|366205471|FG000|Overall Study|Withdrawal by Subject|1|||
106148662|NCT00440011|366205472|FG001|Overall Study|Withdrawal by Subject|0|||
105828597|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828598|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828599|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828600|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828601|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828602|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828603|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828604|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828605|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828606|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828607|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828608|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828609|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828610|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828611|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828612|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
105828613|NCT00112437|365030697|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828614|NCT00112437|365030698|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828615|NCT00112437|365030699|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828616|NCT00112437|365030700|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828617|NCT00112437|365030701|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
105828618|NCT00112437|365030702|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828619|NCT00112437|365030703|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828620|NCT00112437|365030704|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828621|NCT00112437|365030705|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828622|NCT00112437|365030706|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828623|NCT00112437|365030707|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828624|NCT00112437|365030708|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828625|NCT00112437|365030709|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828626|NCT00112437|365030710|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828627|NCT00112437|365030711|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828628|NCT00112437|365030712|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828629|NCT00112437|365030713|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828630|NCT00112437|365030714|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828631|NCT00112437|365030715|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828632|NCT00112437|365030716|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828633|NCT00112437|365030717|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828634|NCT00112437|365030718|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828635|NCT00112437|365030719|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828636|NCT00112437|365030720|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828637|NCT00112437|365030721|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828638|NCT00112437|365030722|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
105828639|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
105828640|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
105828641|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
105828642|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
105828643|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
105828644|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
105828645|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
105828646|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
105828647|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
105828648|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
105828649|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
105828650|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
105828651|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
105828652|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
105828653|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
105828654|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
105828655|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
105828656|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
105828657|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
105828658|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
105828659|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
105828660|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
105828661|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
105828662|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
105828663|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
105828664|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
105828665|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828666|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828667|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828668|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828669|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828670|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
105828671|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
105828672|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828673|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828674|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
105828675|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828676|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828677|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828678|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828679|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828680|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828681|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828682|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828683|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828684|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828685|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828686|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828687|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828688|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828689|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828690|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
105828691|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828692|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828693|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828694|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828695|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828696|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828697|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828698|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828699|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
105828700|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828701|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828702|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828703|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828704|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828705|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828706|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828707|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828708|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828709|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828710|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828711|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828712|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828713|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828714|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828715|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828716|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
105828717|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828718|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828719|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828720|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828721|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828722|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828723|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828724|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828725|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
105828726|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828727|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828728|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828729|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828730|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828731|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
106148663|NCT02538341|366205476|FG000|Overall Study|Lost to Follow-up|51|||
105828732|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828733|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828734|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828735|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828736|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828737|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828738|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828739|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828740|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828741|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828742|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
105828743|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828744|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828745|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828746|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828747|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828748|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
105828749|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
105828750|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
105828751|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
105828752|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
105828753|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828754|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828755|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828756|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828757|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828758|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828759|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828760|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828761|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828762|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828763|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828764|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828765|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828766|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828767|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828768|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
105828769|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828770|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828771|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828772|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828773|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828774|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828775|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828776|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828777|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828778|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
105828779|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828780|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828781|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828782|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828783|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828784|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105963494|NCT05396014|365525277|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
105963495|NCT05396014|365525278|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
106148664|NCT02538341|366205477|FG001|Overall Study|Lost to Follow-up|46|||
106148665|NCT02538341|366205476|FG000|Overall Study|Withdrawal by Subject|3|||
106148666|NCT02538341|366205477|FG001|Overall Study|Withdrawal by Subject|1|||
106148667|NCT02538341|366205476|FG000|Overall Study|Death|2|||
105828785|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828786|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828787|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828788|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828789|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105963496|NCT05396014|365525279|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
105828790|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
106148668|NCT02538341|366205477|FG001|Overall Study|Death|0|||
105828791|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828792|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828793|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828794|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
105828795|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828796|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828797|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828798|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828799|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828800|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828801|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828802|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828803|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828804|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
105828805|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828806|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828807|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828808|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828809|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828810|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828811|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828812|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828813|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828814|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828815|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828816|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828817|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828818|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828819|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828820|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
105828821|NCT00112437|365030697|FG000|Year 2 (12-Month Extension)|Moved|0|||
105828822|NCT00112437|365030698|FG001|Year 2 (12-Month Extension)|Moved|0|||
105828823|NCT00112437|365030699|FG002|Year 2 (12-Month Extension)|Moved|0|||
105828824|NCT00112437|365030700|FG003|Year 2 (12-Month Extension)|Moved|0|||
105828825|NCT00112437|365030701|FG004|Year 2 (12-Month Extension)|Moved|0|||
105828826|NCT00112437|365030702|FG005|Year 2 (12-Month Extension)|Moved|0|||
105828827|NCT00112437|365030703|FG006|Year 2 (12-Month Extension)|Moved|0|||
105828828|NCT00112437|365030704|FG007|Year 2 (12-Month Extension)|Moved|0|||
105828829|NCT00112437|365030705|FG008|Year 2 (12-Month Extension)|Moved|0|||
105828830|NCT00112437|365030706|FG009|Year 2 (12-Month Extension)|Moved|1|||
105828831|NCT00112437|365030707|FG010|Year 2 (12-Month Extension)|Moved|0|||
105828832|NCT00112437|365030708|FG011|Year 2 (12-Month Extension)|Moved|0|||
105828833|NCT00112437|365030709|FG012|Year 2 (12-Month Extension)|Moved|0|||
105828834|NCT00112437|365030710|FG013|Year 2 (12-Month Extension)|Moved|0|||
105828835|NCT00112437|365030711|FG014|Year 2 (12-Month Extension)|Moved|0|||
105828836|NCT00112437|365030712|FG015|Year 2 (12-Month Extension)|Moved|0|||
105828837|NCT00112437|365030713|FG016|Year 2 (12-Month Extension)|Moved|0|||
105828838|NCT00112437|365030714|FG017|Year 2 (12-Month Extension)|Moved|0|||
105828839|NCT00112437|365030715|FG018|Year 2 (12-Month Extension)|Moved|0|||
105828840|NCT00112437|365030716|FG019|Year 2 (12-Month Extension)|Moved|0|||
105828841|NCT00112437|365030717|FG020|Year 2 (12-Month Extension)|Moved|0|||
105828842|NCT00112437|365030718|FG021|Year 2 (12-Month Extension)|Moved|0|||
105828843|NCT00112437|365030719|FG022|Year 2 (12-Month Extension)|Moved|0|||
105828844|NCT00112437|365030720|FG023|Year 2 (12-Month Extension)|Moved|0|||
105828845|NCT00112437|365030721|FG024|Year 2 (12-Month Extension)|Moved|0|||
105828846|NCT00112437|365030722|FG025|Year 2 (12-Month Extension)|Moved|0|||
105828847|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
105828848|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
105828849|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
105963497|NCT05396014|365525280|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
105963498|NCT05396014|365525238|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963499|NCT05396014|365525239|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105828850|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
105828851|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
105828852|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
105828853|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
105828854|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
105828855|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
105828856|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
105828857|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
105828858|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
105963500|NCT05396014|365525240|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105828859|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
105828860|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
105828861|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
105828862|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
105828863|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
105828864|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
105828865|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
105828866|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
105828867|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
105828868|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
105828869|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
105828870|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
105828871|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
105828872|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
105828873|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828874|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828875|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828876|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828877|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828878|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828879|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828880|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828881|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828882|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828883|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828884|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
105828885|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828886|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
105828887|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828888|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
105828889|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828890|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828891|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
105828892|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828893|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828894|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828895|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828896|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828897|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828898|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
105828899|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828900|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828901|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828902|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828903|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828904|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828905|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828906|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828907|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828908|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828909|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828910|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828911|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828912|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828913|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828914|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
105828915|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828916|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828917|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
106148669|NCT00331136|366205478|FG000|Overall Study|Adverse Event|3|||
105828918|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828919|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828920|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828921|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828922|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828923|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828924|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
105828925|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828926|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828927|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
106148670|NCT00331136|366205479|FG001|Overall Study|Adverse Event|5|||
105828928|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828929|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828930|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828931|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828932|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828933|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828934|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828935|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828936|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828937|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828938|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828939|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828940|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
105828941|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828942|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828943|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828944|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828945|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828946|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828947|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828948|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828949|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828950|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
105828951|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828952|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828953|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828954|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828955|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828956|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828957|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828958|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828959|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828960|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828961|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828962|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
105828963|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828964|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828965|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
105828966|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828967|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828968|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828969|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828970|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828971|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828972|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828973|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828974|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828975|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828976|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
105828977|NCT00112437|365030697|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828978|NCT00112437|365030698|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828979|NCT00112437|365030699|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828980|NCT00112437|365030700|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828981|NCT00112437|365030701|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828982|NCT00112437|365030702|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828983|NCT00112437|365030703|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828984|NCT00112437|365030704|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828985|NCT00112437|365030705|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828986|NCT00112437|365030706|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828987|NCT00112437|365030707|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
105828988|NCT00112437|365030708|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
105828989|NCT00112437|365030709|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828990|NCT00112437|365030710|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828991|NCT00112437|365030711|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828992|NCT00112437|365030712|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828993|NCT00112437|365030713|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105963501|NCT05396014|365525241|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963502|NCT05396014|365525242|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105828994|NCT00112437|365030714|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828995|NCT00112437|365030715|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828996|NCT00112437|365030716|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828997|NCT00112437|365030717|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828998|NCT00112437|365030718|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105828999|NCT00112437|365030719|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105829000|NCT00112437|365030720|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105829001|NCT00112437|365030721|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105829002|NCT00112437|365030722|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
105829003|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829004|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829005|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829006|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829007|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829008|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829009|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829010|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829011|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829012|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829013|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829014|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829015|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829016|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829017|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829018|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829019|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829020|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829021|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829022|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829023|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
105829024|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
105829025|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829026|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829027|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829028|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
105829029|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829030|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829031|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829032|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829033|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829034|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829035|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829036|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829037|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829038|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829039|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829040|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829041|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829042|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829043|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829044|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829045|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829046|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829047|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829048|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829049|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
105829050|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829051|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829052|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829053|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829054|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
105829055|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829056|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829057|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829058|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829059|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829060|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829061|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829062|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829063|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829064|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829065|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829066|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829067|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829068|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829069|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829070|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829071|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829072|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829073|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829074|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829075|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829076|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
105829077|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829078|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829079|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829080|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
105829081|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829082|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829083|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829084|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829085|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829086|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829087|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829088|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829089|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829090|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829091|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829092|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829093|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829094|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829095|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829096|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829097|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829098|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829099|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829100|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829101|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829102|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
105829103|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829104|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829105|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
105829106|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
106148671|NCT00331136|366205480|FG002|Overall Study|Adverse Event|0|||
105829107|NCT00112437|365030697|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829108|NCT00112437|365030698|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829109|NCT00112437|365030699|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829110|NCT00112437|365030700|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829111|NCT00112437|365030701|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829112|NCT00112437|365030702|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829113|NCT00112437|365030703|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829114|NCT00112437|365030704|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829115|NCT00112437|365030705|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829116|NCT00112437|365030706|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829117|NCT00112437|365030707|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829118|NCT00112437|365030708|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829119|NCT00112437|365030709|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829120|NCT00112437|365030710|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829121|NCT00112437|365030711|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829122|NCT00112437|365030712|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
106148672|NCT00331136|366205481|FG003|Overall Study|Adverse Event|1|||
105829123|NCT00112437|365030713|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829124|NCT00112437|365030714|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
106148673|NCT00331136|366205478|FG000|Overall Study|Withdrawal by Subject|0|||
106022489|NCT02499328|365746885|FG015|Overall Study|"Other"|0|||
106022490|NCT02499328|365746886|FG016|Overall Study|"Other"|0|||
105829125|NCT00112437|365030715|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829126|NCT00112437|365030716|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829127|NCT00112437|365030717|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
105829128|NCT00112437|365030718|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
105829129|NCT00112437|365030719|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829130|NCT00112437|365030720|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829131|NCT00112437|365030721|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829132|NCT00112437|365030722|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
105829133|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829134|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829135|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829136|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829137|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829138|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829139|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829140|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829141|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829142|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829143|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829144|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829145|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829146|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829147|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829148|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829149|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829150|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829151|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829152|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829153|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829154|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829155|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
105829156|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
105829157|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
105829158|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
105829159|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Death|0|||
105829160|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Death|0|||
105829161|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Death|0|||
105829162|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Death|0|||
105829163|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Death|0|||
105829164|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Death|0|||
105829165|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Death|0|||
105829166|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Death|0|||
105829167|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Death|0|||
105829168|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Death|0|||
105829169|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Death|0|||
105829170|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Death|0|||
105829171|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Death|0|||
105829172|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Death|0|||
105829173|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Death|0|||
105829174|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Death|0|||
105829175|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Death|0|||
105829176|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Death|0|||
105829177|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Death|0|||
105829178|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Death|0|||
105829179|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Death|0|||
105829180|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Death|0|||
105829181|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Death|0|||
105829182|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Death|2|||
105829183|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Death|0|||
105829184|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Death|0|||
105829185|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829186|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829187|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829188|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829189|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829190|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829191|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829192|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829193|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829194|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829195|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829196|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829197|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829198|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829199|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829200|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829201|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829202|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829203|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829204|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829205|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829206|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829207|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829208|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829209|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
105829210|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
105829211|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Other|0|||
105829212|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Other|0|||
105829213|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Other|0|||
105829214|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Other|0|||
105829215|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Other|0|||
105829216|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Other|0|||
105829217|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Other|0|||
105829218|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Other|0|||
105829219|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Other|0|||
105829220|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Other|0|||
105829221|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Other|0|||
105829222|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Other|0|||
105829223|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Other|0|||
105829224|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Other|0|||
105829225|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Other|0|||
105829226|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Other|0|||
105829227|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Other|0|||
105829228|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Other|0|||
105829229|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Other|0|||
105829230|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Other|0|||
105829231|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Other|0|||
105829232|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Other|0|||
105829233|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Other|0|||
105829234|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Other|0|||
105829235|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Other|1|||
105829236|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Other|0|||
105829237|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829238|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829239|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829240|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829241|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829242|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829243|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829244|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829245|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829246|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829247|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829248|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829249|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
106148674|NCT00331136|366205479|FG001|Overall Study|Withdrawal by Subject|1|||
106148675|NCT00331136|366205480|FG002|Overall Study|Withdrawal by Subject|0|||
106148676|NCT00331136|366205481|FG003|Overall Study|Withdrawal by Subject|0|||
105829250|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829251|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829252|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829253|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829254|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829255|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829256|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829257|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829258|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829259|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829260|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
105829261|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
106022491|NCT02499328|365746887|FG017|Overall Study|"Other"|34|||
105829262|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
105829263|NCT00112437|365030697|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829264|NCT00112437|365030698|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829265|NCT00112437|365030699|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829266|NCT00112437|365030700|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829267|NCT00112437|365030701|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829268|NCT00112437|365030702|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829269|NCT00112437|365030703|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829270|NCT00112437|365030704|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829271|NCT00112437|365030705|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829272|NCT00112437|365030706|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829273|NCT00112437|365030707|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829274|NCT00112437|365030708|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829275|NCT00112437|365030709|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829276|NCT00112437|365030710|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829277|NCT00112437|365030711|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829278|NCT00112437|365030712|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829279|NCT00112437|365030713|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829280|NCT00112437|365030714|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829281|NCT00112437|365030715|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829282|NCT00112437|365030716|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829283|NCT00112437|365030717|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829284|NCT00112437|365030718|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829285|NCT00112437|365030719|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
105829286|NCT00112437|365030720|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
105829287|NCT00112437|365030721|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
105829288|NCT00112437|365030722|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
105829289|NCT03614728|365030724|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
105829290|NCT03614728|365030725|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
105829291|NCT03614728|365030726|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
105829292|NCT03614728|365030727|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
105829293|NCT03614728|365030724|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
105829294|NCT03614728|365030725|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
105829295|NCT03614728|365030726|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
105829296|NCT03614728|365030727|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
105829297|NCT01691612|365030728|FG000|Overall Study|deemed ineligible after 1st visit|6|||
105829298|NCT01691612|365030728|FG000|Overall Study|Adverse Event|1|||
105829299|NCT05740098|365030729|FG000|Overall Study|Lost to Follow-up|26|||
106022492|NCT02499328|365746888|FG018|Overall Study|"Other"|43|||
106022493|NCT02499328|365746870|FG000|Overall Study|Disease Progression|0|||
106022494|NCT02499328|365746871|FG001|Overall Study|Disease Progression|0|||
105829300|NCT05740098|365030730|FG001|Overall Study|Lost to Follow-up|17|||
105829301|NCT05740098|365030731|FG002|Overall Study|Lost to Follow-up|21|||
105829302|NCT01018862|365030732|FG000|Overall Study|Adverse Event|2|||
105829303|NCT01018862|365030733|FG001|Overall Study|Adverse Event|0|||
105829304|NCT01018862|365030734|FG002|Overall Study|Adverse Event|6|||
105829305|NCT01018862|365030732|FG000|Overall Study|Lack of Efficacy|1|||
105829306|NCT01018862|365030733|FG001|Overall Study|Lack of Efficacy|0|||
105829307|NCT01018862|365030734|FG002|Overall Study|Lack of Efficacy|2|||
105829308|NCT01018862|365030732|FG000|Overall Study|Lost to Follow-up|3|||
105829309|NCT01018862|365030733|FG001|Overall Study|Lost to Follow-up|1|||
105829310|NCT01018862|365030734|FG002|Overall Study|Lost to Follow-up|0|||
105829311|NCT01018862|365030732|FG000|Overall Study|Protocol Violation|1|||
105829312|NCT01018862|365030733|FG001|Overall Study|Protocol Violation|3|||
105829313|NCT01018862|365030734|FG002|Overall Study|Protocol Violation|3|||
105829314|NCT01018862|365030732|FG000|Overall Study|Withdrawal by Subject|1|||
105829315|NCT01018862|365030733|FG001|Overall Study|Withdrawal by Subject|2|||
105829316|NCT01018862|365030734|FG002|Overall Study|Withdrawal by Subject|1|||
106022495|NCT02499328|365746872|FG002|Overall Study|Disease Progression|0|||
106022496|NCT02499328|365746873|FG003|Overall Study|Disease Progression|0|||
105829317|NCT01018862|365030732|FG000|Overall Study|administrative problems|5|||
105829318|NCT01018862|365030733|FG001|Overall Study|administrative problems|4|||
105829319|NCT01018862|365030734|FG002|Overall Study|administrative problems|4|||
105829320|NCT00798603|365032180|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
105829321|NCT00798603|365032180|FG000|Overall Study|Withdrawal by Subject|10|||
105829322|NCT00798603|365032180|FG000|Overall Study|Adverse Event|22|||
106022497|NCT02499328|365746874|FG004|Overall Study|Disease Progression|0|||
106022498|NCT02499328|365746875|FG005|Overall Study|Disease Progression|0|||
105829323|NCT00798603|365032180|FG000|Overall Study|Physician Decision|1|||
105829324|NCT00798603|365032180|FG000|Overall Study|Lack of insurance coverage|1|||
105829325|NCT01490190|365032183|FG000|Overall Study|Withdrawal by Subject|9|||
105829326|NCT01490190|365032183|FG000|Overall Study|Adverse Event|17|||
105829327|NCT01490190|365032183|FG000|Overall Study|Protocol Violation|5|||
105829328|NCT01490190|365032183|FG000|Overall Study|Lost to Follow-up|13|||
105829329|NCT01490190|365032183|FG000|Overall Study|Relocation|1|||
105829330|NCT01490190|365032183|FG000|Overall Study|Inconvenience|1|||
105829331|NCT01490190|365032183|FG000|Overall Study|Ring expulsion|2|||
105829332|NCT02664415|365032184|FG000|Overall Study|Adverse Event|1|||
105829333|NCT02664415|365032185|FG001|Overall Study|Adverse Event|0|||
105829334|NCT04408924|365032186|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
105829335|NCT04408924|365032186|FG000|Overall Study|Lost to Follow-up|3|||
105829336|NCT04408924|365032186|FG000|Overall Study|Withdrawal by Subject|5|||
105829337|NCT04408924|365032186|FG000|Overall Study|Sponsor Decision|2|||
105829338|NCT01993186|365032187|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
105829339|NCT01993186|365032188|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
105829340|NCT01993186|365032187|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
105829341|NCT01993186|365032188|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
105829342|NCT01993186|365032187|FG000|Open-Label Extension Period|Other, Not Specified|0|||
105829343|NCT01993186|365032188|FG001|Open-Label Extension Period|Other, Not Specified|1|||
105829344|NCT01993186|365032187|FG000|Open-Label Extension Period|Adverse Event|1|||
105829345|NCT01993186|365032188|FG001|Open-Label Extension Period|Adverse Event|0|||
105829346|NCT01993186|365032187|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
105829347|NCT01993186|365032188|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
105829348|NCT01993186|365032187|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
105829349|NCT01993186|365032188|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
105829350|NCT01993186|365032187|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
105829351|NCT01993186|365032188|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
105829352|NCT00084864|365032193|FG000|Overall Study|Adverse Event|1|||
105829353|NCT00084864|365032194|FG001|Overall Study|Adverse Event|0|||
105829354|NCT00084864|365032195|FG002|Overall Study|Adverse Event|0|||
105829355|NCT00084864|365032196|FG003|Overall Study|Adverse Event|0|||
105829356|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
105829357|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
105829358|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
105829359|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
105829360|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
105829361|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
105829362|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
105829363|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
105829364|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
105829365|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
105829366|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
105829367|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
105829368|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
105963503|NCT05396014|365525243|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963504|NCT05396014|365525244|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963505|NCT05396014|365525245|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963506|NCT05396014|365525246|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963507|NCT05396014|365525247|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105829369|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
105829370|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
105829371|NCT00385736|365032197|FG000|Efficacy Analysis Set - Induction|Other|0|||
105829372|NCT00385736|365032198|FG001|Efficacy Analysis Set - Induction|Other|0|||
105829373|NCT00385736|365032199|FG002|Efficacy Analysis Set - Induction|Other|1|||
105829374|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
105963508|NCT05396014|365525248|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963509|NCT05396014|365525249|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963510|NCT05396014|365525250|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105829375|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
105829376|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
105963511|NCT05396014|365525251|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
105963512|NCT05396014|365525252|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105829377|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
105829378|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
105829379|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
105829380|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
105829381|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
105829382|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
105829383|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
105829384|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
105829385|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
105829386|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
105829387|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
105829388|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
105829389|NCT00385736|365032197|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
105829390|NCT00385736|365032198|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
105829391|NCT00385736|365032199|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
105829392|NCT00385736|365032197|FG000|Safety Analysis Set|Adverse Event|23|||
105829393|NCT00385736|365032198|FG001|Safety Analysis Set|Adverse Event|15|||
105829394|NCT00385736|365032199|FG002|Safety Analysis Set|Adverse Event|23|||
105829395|NCT00385736|365032197|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
105829396|NCT00385736|365032198|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
105829397|NCT00385736|365032199|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
105829398|NCT00385736|365032197|FG000|Safety Analysis Set|Lost to Follow-up|0|||
105829399|NCT00385736|365032198|FG001|Safety Analysis Set|Lost to Follow-up|2|||
105829400|NCT00385736|365032199|FG002|Safety Analysis Set|Lost to Follow-up|2|||
105829401|NCT00385736|365032197|FG000|Safety Analysis Set|Lack of Efficacy|38|||
105829402|NCT00385736|365032198|FG001|Safety Analysis Set|Lack of Efficacy|16|||
105829403|NCT00385736|365032199|FG002|Safety Analysis Set|Lack of Efficacy|31|||
105829404|NCT00385736|365032197|FG000|Safety Analysis Set|Protocol Violation|2|||
105829405|NCT00385736|365032198|FG001|Safety Analysis Set|Protocol Violation|1|||
105829406|NCT00385736|365032199|FG002|Safety Analysis Set|Protocol Violation|6|||
105829407|NCT00385736|365032197|FG000|Safety Analysis Set|Other|1|||
105829408|NCT00385736|365032198|FG001|Safety Analysis Set|Other|4|||
105829409|NCT00385736|365032199|FG002|Safety Analysis Set|Other|4|||
105829410|NCT02727192|365032209|FG000|Overall Study|Lost to Follow-up|1|||
105829411|NCT02727192|365032210|FG001|Overall Study|Lost to Follow-up|0|||
105829412|NCT02727192|365032211|FG002|Overall Study|Lost to Follow-up|0|||
105829413|NCT00928057|365032212|FG000|Overall Study|Adverse Event|1|||
105829414|NCT00928057|365032213|FG001|Overall Study|Adverse Event|2|||
105829415|NCT00928057|365032212|FG000|Overall Study|Withdrawal by Subject|1|||
105829416|NCT00928057|365032213|FG001|Overall Study|Withdrawal by Subject|0|||
105829417|NCT00928057|365032212|FG000|Overall Study|Lost to Follow-up|0|||
105829418|NCT00928057|365032213|FG001|Overall Study|Lost to Follow-up|1|||
105829419|NCT00928057|365032212|FG000|Overall Study|Protocol Violation|0|||
105829420|NCT00928057|365032213|FG001|Overall Study|Protocol Violation|1|||
105829421|NCT05497557|365032220|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
105829422|NCT05497557|365032221|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
105829423|NCT05497557|365032222|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
105829424|NCT03387462|365032223|FG000|Overall Study|Lost to Follow-up|1|||
105829425|NCT03540160|365032226|FG000|Overall Study|Protocol Violation|1|||
105829426|NCT03540160|365032226|FG000|Overall Study|Physician Decision|8|||
105829427|NCT03540160|365032226|FG000|Overall Study|Lack of Efficacy|60|||
105829428|NCT03540160|365032226|FG000|Overall Study|Pregnancy|1|||
105829429|NCT03540160|365032226|FG000|Overall Study|Adverse Event|20|||
105829430|NCT03540160|365032226|FG000|Overall Study|Withdrawal by Subject|68|||
105829431|NCT03540160|365032226|FG000|Overall Study|COVID-19|2|||
105829432|NCT03540160|365032226|FG000|Overall Study|Study Closure|10|||
105829433|NCT03540160|365032226|FG000|Overall Study|Lost to Follow-up|18|||
105829434|NCT03540160|365032226|FG000|Overall Study|Sponsor decision|191|||
105829435|NCT01853176|365032230|FG000|Overall Study|Study terminated|4|||
105829436|NCT01853176|365032231|FG001|Overall Study|Study terminated|0|||
105829437|NCT00198133|365032232|FG000|Overall Study|Disease progression|2|||
105829438|NCT00198133|365032233|FG001|Overall Study|Disease progression|5|||
105829439|NCT00198133|365032232|FG000|Overall Study|Adverse Event|1|||
105829440|NCT00198133|365032233|FG001|Overall Study|Adverse Event|3|||
105829441|NCT00198133|365032232|FG000|Overall Study|Withdrawal by Subject|1|||
105829442|NCT00198133|365032233|FG001|Overall Study|Withdrawal by Subject|0|||
105829443|NCT00198133|365032232|FG000|Overall Study|Physician Decision|1|||
105963513|NCT05396014|365525253|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105829444|NCT00198133|365032233|FG001|Overall Study|Physician Decision|0|||
105829445|NCT01557751|365032237|FG000|Overall Study|Physician Decision|3|||
105829446|NCT02043132|365032241|FG000|Overall Study|Lost to Follow-up|1|||
105829447|NCT02043132|365032242|FG001|Overall Study|Lost to Follow-up|1|||
105829448|NCT02043132|365032241|FG000|Overall Study|screen failures|4|||
105829449|NCT02043132|365032242|FG001|Overall Study|screen failures|8|||
105829450|NCT05274763|365032249|FG000|Overall Study|Lost to Follow-up|1|||
105829451|NCT00425308|365032250|FG000|Overall Study|Adverse Event|2|||
105829452|NCT00425308|365032251|FG001|Overall Study|Adverse Event|1|||
105829453|NCT00425308|365032250|FG000|Overall Study|Withdrawal by Subject|1|||
105829454|NCT00425308|365032251|FG001|Overall Study|Withdrawal by Subject|0|||
105829455|NCT00425308|365032250|FG000|Overall Study|Death|1|||
105829456|NCT00425308|365032251|FG001|Overall Study|Death|0|||
105963514|NCT05396014|365525254|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
106022499|NCT02499328|365746876|FG006|Overall Study|Disease Progression|1|||
105829457|NCT00472212|365032252|FG000|Overall Study|Lost to Follow-up|6|||
105829458|NCT00472212|365032253|FG001|Overall Study|Lost to Follow-up|4|||
105829459|NCT01143337|365032268|FG000|Overall Study|Adverse Event|3|||
105829460|NCT01143337|365032269|FG001|Overall Study|Adverse Event|9|||
105829461|NCT01143337|365032270|FG002|Overall Study|Adverse Event|5|||
105829462|NCT01143337|365032268|FG000|Overall Study|Lack of Efficacy|6|||
105829463|NCT01143337|365032269|FG001|Overall Study|Lack of Efficacy|2|||
105829464|NCT01143337|365032270|FG002|Overall Study|Lack of Efficacy|1|||
105829465|NCT01143337|365032268|FG000|Overall Study|Protocol Violation|1|||
105829466|NCT01143337|365032269|FG001|Overall Study|Protocol Violation|0|||
105963515|NCT05396014|365525255|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963516|NCT05396014|365525256|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963517|NCT05396014|365525257|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963518|NCT05396014|365525258|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963519|NCT05396014|365525259|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963520|NCT05396014|365525260|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963521|NCT05396014|365525261|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963522|NCT05396014|365525262|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963523|NCT05396014|365525263|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963524|NCT05396014|365525264|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
105829467|NCT01143337|365032270|FG002|Overall Study|Protocol Violation|0|||
105829468|NCT01143337|365032268|FG000|Overall Study|Withdrawal by Subject|0|||
105829469|NCT01143337|365032269|FG001|Overall Study|Withdrawal by Subject|0|||
105829470|NCT01143337|365032270|FG002|Overall Study|Withdrawal by Subject|1|||
105829471|NCT01143337|365032268|FG000|Overall Study|Other reason|0|||
105829472|NCT01143337|365032269|FG001|Overall Study|Other reason|0|||
105829473|NCT01143337|365032270|FG002|Overall Study|Other reason|5|||
105829474|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
105829475|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
105829476|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
105829477|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
105829478|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
105829479|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
105829480|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
105829481|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829482|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829483|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829484|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829485|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
105829486|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
105829487|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
105829488|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
105829489|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
105829490|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
105829491|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
105829492|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
105829493|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
105829494|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
105829495|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
105829496|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
105829497|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
105829498|NCT01559363|365032277|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829499|NCT01559363|365032278|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
105829500|NCT01559363|365032279|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829501|NCT01559363|365032280|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829502|NCT01559363|365032281|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829503|NCT01559363|365032282|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
105829504|NCT01559363|365032277|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
105829505|NCT01559363|365032278|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
105829506|NCT01559363|365032279|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
105829507|NCT01559363|365032280|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
105829508|NCT01559363|365032281|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
105829509|NCT01559363|365032282|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
105829510|NCT01559363|365032277|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105963525|NCT05396014|365525265|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963526|NCT05396014|365525266|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963527|NCT05396014|365525267|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105829511|NCT01559363|365032278|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105829512|NCT01559363|365032279|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105829513|NCT01559363|365032280|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
106022500|NCT02499328|365746877|FG007|Overall Study|Disease Progression|0|||
105829514|NCT01559363|365032281|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105829515|NCT01559363|365032282|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
105829516|NCT01868243|365032283|FG000|Overall Study|Death|0|||
105829517|NCT01868243|365032284|FG001|Overall Study|Death|1|||
105829518|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
105829519|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
105829520|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
105829521|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
105829522|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
105829523|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
105829524|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
105829525|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
105829526|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
105829527|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
105829528|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
105829529|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
105829530|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
105829531|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
105829532|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
105829533|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
105829534|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
105829535|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
105829536|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
105829537|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
105829538|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
105829539|NCT02227238|365032285|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
105829540|NCT02227238|365032286|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
105829541|NCT02227238|365032287|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
105829542|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
105829543|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
105829544|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
106148677|NCT00331136|366205478|FG000|Overall Study|Lost to Follow-up|0|||
106148678|NCT00331136|366205479|FG001|Overall Study|Lost to Follow-up|1|||
106148679|NCT00331136|366205480|FG002|Overall Study|Lost to Follow-up|0|||
105829545|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
105829546|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
105829547|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
105829548|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
105829549|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
105829550|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
105829551|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
105829552|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
105829553|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
105829554|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
105829555|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
105829556|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
105829557|NCT02227238|365032285|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
105829558|NCT02227238|365032286|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
105829559|NCT02227238|365032287|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
105829560|NCT01632306|365032288|FG000|Overall Study|Protocol Violation|1|||
105829561|NCT01632306|365032289|FG001|Overall Study|Protocol Violation|0|||
105829562|NCT01632306|365032290|FG002|Overall Study|Protocol Violation|0|||
105829563|NCT00985751|365032291|FG000|Overall Study|Adverse Event|0|||
105829564|NCT00985751|365032292|FG001|Overall Study|Adverse Event|0|||
105829565|NCT00985751|365032293|FG002|Overall Study|Adverse Event|0|||
105829566|NCT00985751|365032294|FG003|Overall Study|Adverse Event|0|||
105829567|NCT00985751|365032295|FG004|Overall Study|Adverse Event|1|||
105829568|NCT00380588|365032296|FG000|Overall Study|Unequivocal Disease Progression|25|||
105829569|NCT00380588|365032297|FG001|Overall Study|Unequivocal Disease Progression|34|||
105829570|NCT00380588|365032296|FG000|Overall Study|Next Cycle Not Started|4|||
105829571|NCT00380588|365032297|FG001|Overall Study|Next Cycle Not Started|0|||
105829572|NCT00380588|365032296|FG000|Overall Study|Adverse Event|7|||
105829573|NCT00380588|365032297|FG001|Overall Study|Adverse Event|3|||
105829574|NCT00380588|365032296|FG000|Overall Study|Withdrawal by Subject|1|||
106148680|NCT00331136|366205481|FG003|Overall Study|Lost to Follow-up|0|||
105829575|NCT00380588|365032297|FG001|Overall Study|Withdrawal by Subject|3|||
105829576|NCT00380588|365032296|FG000|Overall Study|Physician Decision|2|||
105829577|NCT00380588|365032297|FG001|Overall Study|Physician Decision|0|||
106148681|NCT00331136|366205478|FG000|Overall Study|Protocol Violation|1|||
106148682|NCT00331136|366205479|FG001|Overall Study|Protocol Violation|0|||
105829578|NCT01483820|365032298|FG000|Overall Study|Lack of Efficacy|6|||
105829579|NCT01483820|365032298|FG000|Overall Study|Adverse Event|1|||
105829580|NCT01483820|365032298|FG000|Overall Study|Death|1|||
105829581|NCT03498560|365032299|FG000|Overall Study|Found Ineligible|2|||
105829582|NCT03498560|365032299|FG000|Overall Study|Withdrawal by Subject|14|||
105829583|NCT03498560|365032299|FG000|Overall Study|Lost to Follow-up|4|||
105829584|NCT03498560|365032299|FG000|Overall Study|Death|1|||
105829585|NCT00867360|365032300|FG000|Overall Study|Withdrawal by Subject|1|||
105829586|NCT00867360|365032301|FG001|Overall Study|Withdrawal by Subject|0|||
105829587|NCT00867360|365032300|FG000|Overall Study|Physician Decision|0|||
105829588|NCT00867360|365032301|FG001|Overall Study|Physician Decision|1|||
105829589|NCT00842309|365032304|FG000|Overall Study|Withdrawal by Subject|3|||
105829590|NCT00842309|365032305|FG001|Overall Study|Withdrawal by Subject|1|||
105829591|NCT00533507|365032306|FG000|Overall Study|Withdrawal by Subject|1|||
105829592|NCT01576705|365032307|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
105829593|NCT01576705|365032308|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
105829594|NCT01576705|365032309|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
105829595|NCT01576705|365032310|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
105829596|NCT01576705|365032307|FG000|Overall Study|invalid ICF|0|||
105829597|NCT01576705|365032308|FG001|Overall Study|invalid ICF|1|||
105829598|NCT01576705|365032309|FG002|Overall Study|invalid ICF|0|||
105829599|NCT01576705|365032310|FG003|Overall Study|invalid ICF|0|||
105829600|NCT03573544|365032311|FG000|Overall Study|Adverse Event|0|||
105829601|NCT03573544|365032312|FG001|Overall Study|Adverse Event|0|||
105829602|NCT03573544|365032313|FG002|Overall Study|Adverse Event|0|||
105829603|NCT03573544|365032314|FG003|Overall Study|Adverse Event|3|||
105829604|NCT03573544|365032315|FG004|Overall Study|Adverse Event|1|||
105829605|NCT03573544|365032316|FG005|Overall Study|Adverse Event|0|||
105829606|NCT03573544|365032317|FG006|Overall Study|Adverse Event|2|||
105829607|NCT03573544|365032318|FG007|Overall Study|Adverse Event|0|||
105829608|NCT03573544|365032311|FG000|Overall Study|Physician Decision|0|||
105829609|NCT03573544|365032312|FG001|Overall Study|Physician Decision|0|||
105829610|NCT03573544|365032313|FG002|Overall Study|Physician Decision|0|||
105829611|NCT03573544|365032314|FG003|Overall Study|Physician Decision|0|||
105829612|NCT03573544|365032315|FG004|Overall Study|Physician Decision|0|||
105829613|NCT03573544|365032316|FG005|Overall Study|Physician Decision|0|||
105829614|NCT03573544|365032317|FG006|Overall Study|Physician Decision|1|||
105829615|NCT03573544|365032318|FG007|Overall Study|Physician Decision|0|||
105829616|NCT03573544|365032311|FG000|Overall Study|Withdrawal by Subject|2|||
105829617|NCT03573544|365032312|FG001|Overall Study|Withdrawal by Subject|0|||
105829618|NCT03573544|365032313|FG002|Overall Study|Withdrawal by Subject|0|||
105829619|NCT03573544|365032314|FG003|Overall Study|Withdrawal by Subject|1|||
105829620|NCT03573544|365032315|FG004|Overall Study|Withdrawal by Subject|1|||
105829621|NCT03573544|365032316|FG005|Overall Study|Withdrawal by Subject|1|||
105829622|NCT03573544|365032317|FG006|Overall Study|Withdrawal by Subject|0|||
105829623|NCT03573544|365032318|FG007|Overall Study|Withdrawal by Subject|1|||
105829624|NCT03573544|365032311|FG000|Overall Study|Disease progression|3|||
105829625|NCT03573544|365032312|FG001|Overall Study|Disease progression|3|||
105829626|NCT03573544|365032313|FG002|Overall Study|Disease progression|6|||
105829627|NCT03573544|365032314|FG003|Overall Study|Disease progression|4|||
105829628|NCT03573544|365032315|FG004|Overall Study|Disease progression|5|||
105829629|NCT03573544|365032316|FG005|Overall Study|Disease progression|7|||
105829630|NCT03573544|365032317|FG006|Overall Study|Disease progression|6|||
105829631|NCT03573544|365032318|FG007|Overall Study|Disease progression|7|||
105829632|NCT00757172|365032322|FG000|Overall Study|Withdrawal by Subject|4|||
105829633|NCT00757172|365032322|FG000|Overall Study|Physician Decision|3|||
105829634|NCT00757172|365032322|FG000|Overall Study|Progression|4|||
105829635|NCT03555695|365032323|FG000|Overall Study|Withdrawal by Subject|1|||
105829636|NCT03555695|365032323|FG000|Overall Study|Lost to Follow-up|1|||
105829637|NCT03555695|365032323|FG000|Overall Study|appendicitis (unrelated)|1|||
105829638|NCT03555695|365032323|FG000|Overall Study|pre-existing sciatica|1|||
105829639|NCT01426854|365032324|FG000|Overall Study|Adverse Event|1|||
105829640|NCT01426854|365032325|FG001|Overall Study|Adverse Event|5|||
106148683|NCT00331136|366205480|FG002|Overall Study|Protocol Violation|0|||
106148684|NCT00331136|366205481|FG003|Overall Study|Protocol Violation|0|||
105829641|NCT01426854|365032324|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
105829642|NCT01426854|365032325|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
105829643|NCT01426854|365032324|FG000|Overall Study|Lost to Follow-up|3|||
105829644|NCT01426854|365032325|FG001|Overall Study|Lost to Follow-up|0|||
105829645|NCT01426854|365032324|FG000|Overall Study|Noncompliance|0|||
105829646|NCT01426854|365032325|FG001|Overall Study|Noncompliance|1|||
105829647|NCT01426854|365032324|FG000|Overall Study|Treatment Failure|0|||
105829648|NCT01426854|365032325|FG001|Overall Study|Treatment Failure|16|||
105829649|NCT01426854|365032324|FG000|Overall Study|Protocol Deviation|0|||
105829650|NCT01426854|365032325|FG001|Overall Study|Protocol Deviation|1|||
105829651|NCT01426854|365032324|FG000|Overall Study|Other|3|||
105829652|NCT01426854|365032325|FG001|Overall Study|Other|2|||
105829653|NCT01942135|365032330|FG000|Overall Study|Adverse Event|21|||
106148685|NCT00331136|366205478|FG000|Overall Study|Not treated|1|||
105829654|NCT01942135|365032331|FG001|Overall Study|Adverse Event|7|||
105829655|NCT01942135|365032330|FG000|Overall Study|Global Deterioration of Health Status|9|||
105829656|NCT01942135|365032331|FG001|Overall Study|Global Deterioration of Health Status|6|||
105829657|NCT01942135|365032330|FG000|Overall Study|Randomized Not Treated|2|||
105829658|NCT01942135|365032331|FG001|Overall Study|Randomized Not Treated|2|||
105829659|NCT01942135|365032330|FG000|Overall Study|Death|2|||
105829660|NCT01942135|365032331|FG001|Overall Study|Death|1|||
105829661|NCT01942135|365032330|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
105829662|NCT01942135|365032331|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
105829663|NCT01942135|365032330|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
105829664|NCT01942135|365032331|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
105829665|NCT01942135|365032330|FG000|Overall Study|Withdrawal by Subject|4|||
105829666|NCT01942135|365032331|FG001|Overall Study|Withdrawal by Subject|3|||
105829667|NCT01942135|365032330|FG000|Overall Study|Protocol Violation|1|||
105829668|NCT01942135|365032331|FG001|Overall Study|Protocol Violation|0|||
105829669|NCT01942135|365032330|FG000|Overall Study|Other|19|||
105829670|NCT01942135|365032331|FG001|Overall Study|Other|4|||
105829671|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
105829672|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
105829673|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
105829674|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
105829675|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
105829676|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
105829677|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
105829678|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
105829679|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
105829680|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
105829681|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
105829682|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
105829683|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
105829684|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
105829685|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
105829686|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
105829687|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
105829688|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
105829689|NCT00950300|365032332|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
105829690|NCT00950300|365032333|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
105829691|NCT00950300|365032332|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
105829692|NCT00950300|365032333|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
105829693|NCT00950300|365032332|FG000|TFFU Period|Death|4|||
105829694|NCT00950300|365032333|FG001|TFFU Period|Death|1|||
105829695|NCT00950300|365032332|FG000|TFFU Period|Refused Treatment|10|||
105829696|NCT00950300|365032333|FG001|TFFU Period|Refused Treatment|11|||
105829697|NCT00950300|365032332|FG000|TFFU Period|Failure to Return|16|||
105829698|NCT00950300|365032333|FG001|TFFU Period|Failure to Return|16|||
105829699|NCT00950300|365032332|FG000|TFFU Period|Recurrence of Disease|63|||
105829700|NCT00950300|365032333|FG001|TFFU Period|Recurrence of Disease|72|||
105829701|NCT00950300|365032332|FG000|TFFU Period|Other|4|||
105829702|NCT00950300|365032333|FG001|TFFU Period|Other|3|||
105829703|NCT00950300|365032332|FG000|SFU Period|Death|44|||
105829704|NCT00950300|365032333|FG001|SFU Period|Death|42|||
105829705|NCT00950300|365032332|FG000|SFU Period|Lost to Follow-up|30|||
105829706|NCT00950300|365032333|FG001|SFU Period|Lost to Follow-up|28|||
105829707|NCT00950300|365032332|FG000|SFU Period|Withdrawal by Subject|4|||
105829708|NCT00950300|365032333|FG001|SFU Period|Withdrawal by Subject|8|||
105829709|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
105829710|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105829711|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105829712|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105829713|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105829714|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
105963528|NCT05396014|365525268|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963529|NCT05396014|365525269|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963530|NCT05396014|365525270|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105829715|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
105829716|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105963531|NCT05396014|365525271|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963532|NCT05396014|365525272|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
105829717|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105963533|NCT05396014|365525273|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
106148686|NCT00331136|366205479|FG001|Overall Study|Not treated|0|||
106148687|NCT00331136|366205480|FG002|Overall Study|Not treated|0|||
106148688|NCT00331136|366205481|FG003|Overall Study|Not treated|0|||
106148689|NCT00419341|366205482|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
106148690|NCT00419341|366205482|FG000|Wash in/Wash Out Period|Adverse Event|2|||
106148691|NCT00419341|366205482|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
106148692|NCT00419341|366205482|FG000|Efficacy Period|Withdrawal by Subject|6|||
106148693|NCT00419341|366205482|FG000|Efficacy Period|Protocol Violation|1|||
106148694|NCT00419341|366205482|FG000|Efficacy Period|Lost to Follow-up|1|||
106148695|NCT00419341|366205482|FG000|Efficacy Period|Non-compliance|1|||
106148696|NCT00419341|366205482|FG000|Efficacy Period|Termination of study site|1|||
106148697|NCT04200365|366205483|FG000|Overall Study|Adverse Event|2|||
106148698|NCT04200365|366205483|FG000|Overall Study|Progressive Disease|4|||
106148699|NCT04200365|366205483|FG000|Overall Study|Lack of Efficacy|1|||
105829718|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105829719|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105829720|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
105829721|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
105829722|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829723|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829724|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829725|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829726|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
105829727|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
105829728|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829729|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829730|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829731|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829732|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
105829733|NCT00902538|365032334|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
105829734|NCT00902538|365032335|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829735|NCT00902538|365032336|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829736|NCT00902538|365032337|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829737|NCT00902538|365032338|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829738|NCT00902538|365032339|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
105829739|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
105829740|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
105829741|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
105829742|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
105829743|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
105829744|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
105829745|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
105829746|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
105829747|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
105829748|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
105829749|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
105829750|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
105829751|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
105829752|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
105829753|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
105829754|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
105829755|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
105829756|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
105829757|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
105829758|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
105829759|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
105829760|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
105829761|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
105829762|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
105829763|NCT00902538|365032334|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
105829764|NCT00902538|365032335|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
105829765|NCT00902538|365032336|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
105829766|NCT00902538|365032337|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
105829767|NCT00902538|365032338|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
106148700|NCT04200365|366205483|FG000|Overall Study|Study Closure|4|||
106148701|NCT04128319|366205485|FG000|Overall Study|Death|3|||
105829768|NCT00902538|365032339|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
105829769|NCT00902538|365032334|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
105829770|NCT00902538|365032335|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
105829771|NCT00902538|365032336|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
105829772|NCT00902538|365032337|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
105829773|NCT00902538|365032338|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
105829774|NCT00902538|365032339|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
105829775|NCT00902538|365032334|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829776|NCT00902538|365032335|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
105829777|NCT00902538|365032336|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829778|NCT00902538|365032337|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829779|NCT00902538|365032338|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829780|NCT00902538|365032339|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
105829781|NCT00902538|365032334|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105963534|NCT05396014|365525274|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963535|NCT05396014|365525275|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963536|NCT05396014|365525276|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963537|NCT05396014|365525277|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963538|NCT05396014|365525278|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963539|NCT05396014|365525279|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
105963540|NCT05396014|365525280|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
105963541|NCT05396014|365525238|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963542|NCT05396014|365525239|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963543|NCT05396014|365525240|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963544|NCT05396014|365525241|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963545|NCT05396014|365525242|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963546|NCT05396014|365525243|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963547|NCT05396014|365525244|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963548|NCT05396014|365525245|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963549|NCT05396014|365525246|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963550|NCT05396014|365525247|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963551|NCT05396014|365525248|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963552|NCT05396014|365525249|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963553|NCT05396014|365525250|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963554|NCT05396014|365525251|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963555|NCT05396014|365525252|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963556|NCT05396014|365525253|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963557|NCT05396014|365525254|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963558|NCT05396014|365525255|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963559|NCT05396014|365525256|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
106022501|NCT02499328|365746878|FG008|Overall Study|Disease Progression|1|||
106022502|NCT02499328|365746879|FG009|Overall Study|Disease Progression|0|||
106148702|NCT01499199|366205486|FG000|Overall Study|Adverse Event|1|||
106022503|NCT02499328|365746880|FG010|Overall Study|Disease Progression|1|||
106022504|NCT02499328|365746881|FG011|Overall Study|Disease Progression|0|||
106022505|NCT02499328|365746882|FG012|Overall Study|Disease Progression|0|||
106022506|NCT02499328|365746883|FG013|Overall Study|Disease Progression|0|||
106022507|NCT02499328|365746884|FG014|Overall Study|Disease Progression|0|||
106022508|NCT02499328|365746885|FG015|Overall Study|Disease Progression|0|||
106022509|NCT02499328|365746886|FG016|Overall Study|Disease Progression|0|||
106022510|NCT02499328|365746887|FG017|Overall Study|Disease Progression|2|||
106022511|NCT02499328|365746888|FG018|Overall Study|Disease Progression|0|||
106022512|NCT02499328|365746870|FG000|Overall Study|Adverse Event|1|||
106022513|NCT02499328|365746871|FG001|Overall Study|Adverse Event|0|||
106022514|NCT02499328|365746872|FG002|Overall Study|Adverse Event|0|||
106022515|NCT02499328|365746873|FG003|Overall Study|Adverse Event|1|||
106022516|NCT02499328|365746874|FG004|Overall Study|Adverse Event|0|||
106022517|NCT02499328|365746875|FG005|Overall Study|Adverse Event|0|||
106022518|NCT02499328|365746876|FG006|Overall Study|Adverse Event|0|||
106148703|NCT01499199|366205486|FG000|Overall Study|Lack of Efficacy|1|||
106148704|NCT02692417|366205487|FG000|Overall Study|Withdrawal by Subject|5|||
106148705|NCT02692417|366205488|FG001|Overall Study|Withdrawal by Subject|1|||
106148706|NCT02692417|366205487|FG000|Overall Study|Adverse Event|1|||
106148707|NCT02692417|366205488|FG001|Overall Study|Adverse Event|0|||
106148708|NCT01199575|366205491|FG000|Overall Study|Withdrawal by Subject|5|||
106022519|NCT02499328|365746877|FG007|Overall Study|Adverse Event|0|||
106148709|NCT04732338|366205498|FG000|Overall Study|Lost to Follow-up|3|||
106148710|NCT04732338|366205499|FG001|Overall Study|Lost to Follow-up|3|||
106022520|NCT02499328|365746878|FG008|Overall Study|Adverse Event|0|||
106148711|NCT00716859|366205505|FG000|Overall Study|Adverse Event|4|||
106148712|NCT00716859|366205506|FG001|Overall Study|Adverse Event|1|||
106148713|NCT00716859|366205505|FG000|Overall Study|Lack of Efficacy|3|||
106148714|NCT00716859|366205506|FG001|Overall Study|Lack of Efficacy|0|||
106148715|NCT00716859|366205505|FG000|Overall Study|Withdrawal by Subject|1|||
106148716|NCT00716859|366205506|FG001|Overall Study|Withdrawal by Subject|3|||
106148717|NCT00716859|366205505|FG000|Overall Study|Not treated|1|||
106148718|NCT00716859|366205506|FG001|Overall Study|Not treated|1|||
106148719|NCT03101371|366205509|FG000|Overall Study|Physician Decision|0|||
106148720|NCT03101371|366205510|FG001|Overall Study|Physician Decision|1|||
106148721|NCT03101371|366205509|FG000|Overall Study|Lost to Follow-up|1|||
106148722|NCT03101371|366205510|FG001|Overall Study|Lost to Follow-up|4|||
106148723|NCT03101371|366205509|FG000|Overall Study|Did not meet eligibility criteria|2|||
106148724|NCT03101371|366205510|FG001|Overall Study|Did not meet eligibility criteria|1|||
106148725|NCT02769858|366205517|FG000|Overall Study|Withdrawal by Subject|2|||
106148726|NCT04411056|366206848|FG000|Overall Study|surgery cancelled|1|||
106148727|NCT04411056|366206849|FG001|Overall Study|surgery cancelled|0|||
106148728|NCT04411056|366206848|FG000|Overall Study|Equipment problem during intubation|0|||
106148729|NCT04411056|366206849|FG001|Overall Study|Equipment problem during intubation|1|||
106148730|NCT03889925|366206852|FG000|Overall Study|Lost to Follow-up|11|||
106148731|NCT03889925|366206853|FG001|Overall Study|Lost to Follow-up|10|||
106148732|NCT04817670|366206854|FG000|Overall Study|Withdrawal by Subject|1|||
106148733|NCT04817670|366206855|FG001|Overall Study|Withdrawal by Subject|0|||
106148734|NCT04817670|366206856|FG002|Overall Study|Withdrawal by Subject|0|||
106148735|NCT04817670|366206857|FG003|Overall Study|Withdrawal by Subject|0|||
105829782|NCT00902538|365032335|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
105829783|NCT00902538|365032336|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105829784|NCT00902538|365032337|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105829785|NCT00902538|365032338|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105829786|NCT00902538|365032339|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
105829787|NCT00902538|365032334|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829788|NCT00902538|365032335|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
105829789|NCT00902538|365032336|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829790|NCT00902538|365032337|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829791|NCT00902538|365032338|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829792|NCT00902538|365032339|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
105829793|NCT00902538|365032334|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
105829794|NCT00902538|365032335|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
105829795|NCT00902538|365032336|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
105829796|NCT00902538|365032337|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
105829797|NCT00902538|365032338|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
105829798|NCT00902538|365032339|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
105829799|NCT00902538|365032334|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
105829800|NCT00902538|365032335|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
105829801|NCT00902538|365032336|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
105829802|NCT00902538|365032337|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
105829803|NCT00902538|365032338|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
105829804|NCT00902538|365032339|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
105829805|NCT00902538|365032334|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829806|NCT00902538|365032335|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829807|NCT00902538|365032336|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829808|NCT00902538|365032337|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
105829809|NCT00902538|365032338|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829810|NCT00902538|365032339|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
105829811|NCT03531827|365032340|FG000|Overall Study|Adverse Event|2|||
105829812|NCT03531827|365032341|FG001|Overall Study|Adverse Event|0|||
105829813|NCT03531827|365032340|FG000|Overall Study|Progressive disease|1|||
105829814|NCT03531827|365032341|FG001|Overall Study|Progressive disease|0|||
105829815|NCT01717040|365032342|FG000|Overall Study|Lost to Follow-up|2|||
105829816|NCT01717040|365032343|FG001|Overall Study|Lost to Follow-up|3|||
105829817|NCT01717040|365032342|FG000|Overall Study|Lack of Efficacy|1|||
105829818|NCT01717040|365032343|FG001|Overall Study|Lack of Efficacy|1|||
105829819|NCT01717040|365032342|FG000|Overall Study|Adverse Event|1|||
105829820|NCT01717040|365032343|FG001|Overall Study|Adverse Event|0|||
105829821|NCT01717040|365032342|FG000|Overall Study|Required Medication Change|0|||
105829822|NCT01717040|365032343|FG001|Overall Study|Required Medication Change|1|||
106148736|NCT04817670|366206858|FG004|Overall Study|Withdrawal by Subject|0|||
105829823|NCT01717040|365032342|FG000|Overall Study|New Substance Use Disorder|1|||
105829824|NCT01717040|365032343|FG001|Overall Study|New Substance Use Disorder|0|||
106148737|NCT04817670|366206854|FG000|Overall Study|Lost to Follow-up|0|||
106148738|NCT04817670|366206855|FG001|Overall Study|Lost to Follow-up|0|||
106148739|NCT04817670|366206856|FG002|Overall Study|Lost to Follow-up|1|||
106148740|NCT04817670|366206857|FG003|Overall Study|Lost to Follow-up|0|||
106148741|NCT04817670|366206858|FG004|Overall Study|Lost to Follow-up|0|||
106148742|NCT02411084|366206861|FG000|Overall Study|Lack of Efficacy|6|||
106148743|NCT02411084|366206862|FG001|Overall Study|Lack of Efficacy|3|||
106148744|NCT02411084|366206861|FG000|Overall Study|Death|5|||
106148745|NCT02411084|366206862|FG001|Overall Study|Death|4|||
106148746|NCT02411084|366206861|FG000|Overall Study|Adverse Event|2|||
106148747|NCT02411084|366206862|FG001|Overall Study|Adverse Event|1|||
106148748|NCT02411084|366206861|FG000|Overall Study|Other reasons|0|||
106148749|NCT02411084|366206862|FG001|Overall Study|Other reasons|5|||
106148750|NCT03990649|366206870|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
105963560|NCT05396014|365525257|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963561|NCT05396014|365525258|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963562|NCT05396014|365525259|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963563|NCT05396014|365525260|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963564|NCT05396014|365525261|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105829825|NCT03684928|365032344|FG000|First Intervention|Lost to Follow-up|0|||
105829826|NCT03684928|365032345|FG001|First Intervention|Lost to Follow-up|1|||
105829827|NCT03684928|365032344|FG000|First Intervention|Withdrawal by Subject|0|||
105829828|NCT03684928|365032345|FG001|First Intervention|Withdrawal by Subject|2|||
105829829|NCT03684928|365032344|FG000|Second Intervention|Soft Tissue Injury|1|||
105829830|NCT03684928|365032345|FG001|Second Intervention|Soft Tissue Injury|0|||
105869106|NCT02652949|365171606|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
105869107|NCT02652949|365171606|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
105869108|NCT02652949|365171606|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
105869109|NCT02652949|365171606|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
105869110|NCT01232452|365171611|FG000|Overall Study|Adverse Event|17|||
105869111|NCT01232452|365171612|FG001|Overall Study|Adverse Event|15|||
105869112|NCT01232452|365171611|FG000|Overall Study|Withdrawal by Subject|11|||
105869113|NCT01232452|365171612|FG001|Overall Study|Withdrawal by Subject|8|||
105869114|NCT01232452|365171611|FG000|Overall Study|Physician Decision|8|||
105869115|NCT01232452|365171612|FG001|Overall Study|Physician Decision|12|||
105869116|NCT01232452|365171611|FG000|Overall Study|Protocol entry criterion not met|0|||
105869117|NCT01232452|365171612|FG001|Overall Study|Protocol entry criterion not met|2|||
105869118|NCT01232452|365171611|FG000|Overall Study|Sponsor Decision|3|||
105869119|NCT01232452|365171612|FG001|Overall Study|Sponsor Decision|1|||
105869120|NCT01232452|365171611|FG000|Overall Study|Protocol Violation|0|||
105869121|NCT01232452|365171612|FG001|Overall Study|Protocol Violation|1|||
105869122|NCT04108299|365171617|FG000|Overall Study|Not interested in participating|2|||
105869123|NCT04108299|365171618|FG001|Overall Study|Not interested in participating|1|||
105869124|NCT04108299|365171619|FG002|Overall Study|Not interested in participating|2|||
105869125|NCT04108299|365171620|FG003|Overall Study|Not interested in participating|1|||
105869126|NCT00247676|365171621|FG000|Overall Study|Death|5|||
105869127|NCT00247676|365171621|FG000|Overall Study|Adverse Event|11|||
105869128|NCT00247676|365171621|FG000|Overall Study|Lack of Efficacy|15|||
105869129|NCT00247676|365171621|FG000|Overall Study|Other|3|||
105869130|NCT00247676|365171621|FG000|Overall Study|Withdrawal by Subject|2|||
105869131|NCT05024747|365171622|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
105869132|NCT05024747|365171623|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
105869133|NCT05024747|365171622|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
105869134|NCT05024747|365171623|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
105869135|NCT05024747|365171622|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
105869136|NCT05024747|365171623|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
105869137|NCT00662649|365171624|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
105869138|NCT00662649|365171625|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
105869139|NCT00662649|365171626|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
105869140|NCT00662649|365171627|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
105869141|NCT00662649|365171628|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
105869142|NCT00662649|365171624|FG000|Core Study (24 Months)|Adverse Event|22|||
105963565|NCT05396014|365525262|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963566|NCT05396014|365525263|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963567|NCT05396014|365525264|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
105963568|NCT05396014|365525265|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963569|NCT05396014|365525266|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963570|NCT05396014|365525267|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963571|NCT05396014|365525268|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105869143|NCT00662649|365171625|FG001|Core Study (24 Months)|Adverse Event|13|||
105869144|NCT00662649|365171626|FG002|Core Study (24 Months)|Adverse Event|18|||
105869145|NCT00662649|365171627|FG003|Core Study (24 Months)|Adverse Event|0|||
105869146|NCT00662649|365171628|FG004|Core Study (24 Months)|Adverse Event|0|||
105869147|NCT00662649|365171624|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
105869148|NCT00662649|365171625|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
106148751|NCT03990649|366206871|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
106148752|NCT03990649|366206872|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
105829831|NCT00452348|365033948|FG000|Overall Study|Adverse Event|6|||
105829832|NCT00452348|365033949|FG001|Overall Study|Adverse Event|9|||
105829833|NCT00452348|365033948|FG000|Overall Study|Lack of Efficacy|10|||
105829834|NCT00452348|365033949|FG001|Overall Study|Lack of Efficacy|9|||
105829835|NCT00452348|365033948|FG000|Overall Study|Lost to Follow-up|14|||
105829836|NCT00452348|365033949|FG001|Overall Study|Lost to Follow-up|8|||
105829837|NCT00452348|365033948|FG000|Overall Study|Protocol Violation|22|||
105829838|NCT00452348|365033949|FG001|Overall Study|Protocol Violation|28|||
105829839|NCT00452348|365033948|FG000|Overall Study|Withdrawal by Subject|18|||
105829840|NCT00452348|365033949|FG001|Overall Study|Withdrawal by Subject|21|||
105829841|NCT00452348|365033948|FG000|Overall Study|Other|9|||
105829842|NCT00452348|365033949|FG001|Overall Study|Other|9|||
105829843|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Subject request|8|||
105829844|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Subject request|11|||
105829845|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
105829846|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
105829847|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
105829848|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
105829849|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
105829850|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
105829851|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
105829852|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
105829853|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
106022521|NCT02499328|365746879|FG009|Overall Study|Adverse Event|0|||
106022522|NCT02499328|365746880|FG010|Overall Study|Adverse Event|0|||
106022523|NCT02499328|365746881|FG011|Overall Study|Adverse Event|0|||
106022524|NCT02499328|365746882|FG012|Overall Study|Adverse Event|1|||
106022525|NCT02499328|365746883|FG013|Overall Study|Adverse Event|0|||
106022526|NCT02499328|365746884|FG014|Overall Study|Adverse Event|0|||
106022527|NCT02499328|365746885|FG015|Overall Study|Adverse Event|0|||
106022528|NCT02499328|365746886|FG016|Overall Study|Adverse Event|0|||
106022529|NCT02499328|365746887|FG017|Overall Study|Adverse Event|0|||
106022530|NCT02499328|365746888|FG018|Overall Study|Adverse Event|0|||
106022531|NCT03751657|365748560|FG000|Overall Study|Physician Decision|0|||
106022532|NCT03751657|365748561|FG001|Overall Study|Physician Decision|1|||
106022533|NCT03751657|365748560|FG000|Overall Study|Withdrawal by Subject|1|||
106022534|NCT03751657|365748561|FG001|Overall Study|Withdrawal by Subject|1|||
106022535|NCT03751657|365748560|FG000|Overall Study|Lost to Follow-up|2|||
106022536|NCT03751657|365748561|FG001|Overall Study|Lost to Follow-up|1|||
106022537|NCT03079102|365748562|FG000|Overall Study|Physician Decision|0|||
106022538|NCT03079102|365748563|FG001|Overall Study|Physician Decision|1|||
106022539|NCT02175199|365748572|FG000|Overall Study|Withdrawal by Subject|1|||
106022540|NCT02175199|365748573|FG001|Overall Study|Withdrawal by Subject|5|||
106022541|NCT02175199|365748572|FG000|Overall Study|Randomized in Error|1|||
106022542|NCT02175199|365748573|FG001|Overall Study|Randomized in Error|0|||
106022543|NCT02175199|365748572|FG000|Overall Study|Sponsor Decision|1|||
106022544|NCT02175199|365748573|FG001|Overall Study|Sponsor Decision|0|||
106022545|NCT01193257|365748578|FG000|Overall Study|Death|202|||
106022546|NCT01193257|365748579|FG001|Overall Study|Death|391|||
106022547|NCT01193257|365748578|FG000|Overall Study|Study termination by sponsor|0|||
106022548|NCT01193257|365748579|FG001|Overall Study|Study termination by sponsor|3|||
106022549|NCT01193257|365748578|FG000|Overall Study|Withdrawal by Subject|26|||
106022550|NCT01193257|365748579|FG001|Overall Study|Withdrawal by Subject|86|||
106022551|NCT01193257|365748578|FG000|Overall Study|Lost to Follow-up|2|||
106022552|NCT01193257|365748579|FG001|Overall Study|Lost to Follow-up|3|||
106022553|NCT01193257|365748578|FG000|Overall Study|Unblinded due to futility|135|||
106022554|NCT01193257|365748579|FG001|Overall Study|Unblinded due to futility|251|||
106022555|NCT00375609|365748580|FG000|Overall Study|Did not receive treatment|1|||
106022556|NCT00375609|365748581|FG001|Overall Study|Did not receive treatment|0|||
106022557|NCT00375609|365748582|FG002|Overall Study|Did not receive treatment|0|||
106022558|NCT00375609|365748580|FG000|Overall Study|Adverse Event|0|||
106022559|NCT00375609|365748581|FG001|Overall Study|Adverse Event|3|||
106022560|NCT00375609|365748582|FG002|Overall Study|Adverse Event|0|||
106022561|NCT00375609|365748580|FG000|Overall Study|Lost to Follow-up|1|||
106022562|NCT00375609|365748581|FG001|Overall Study|Lost to Follow-up|0|||
105829854|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
105829855|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Death|1|||
105829856|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Death|0|||
106022563|NCT00375609|365748582|FG002|Overall Study|Lost to Follow-up|0|||
106022564|NCT00375609|365748580|FG000|Overall Study|Physician Decision|0|||
106022565|NCT00375609|365748581|FG001|Overall Study|Physician Decision|0|||
106022566|NCT00375609|365748582|FG002|Overall Study|Physician Decision|1|||
106022567|NCT00375609|365748580|FG000|Overall Study|Withdrawal by Subject|1|||
106022568|NCT00375609|365748581|FG001|Overall Study|Withdrawal by Subject|4|||
106022569|NCT00375609|365748582|FG002|Overall Study|Withdrawal by Subject|0|||
106022570|NCT00375609|365748580|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
106022571|NCT00375609|365748581|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
106022572|NCT00375609|365748582|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
106022573|NCT00792571|365748583|FG000|Overall Study|Death|1|||
106022574|NCT00792571|365748583|FG000|Overall Study|Adverse Event|4|||
106022575|NCT00792571|365748583|FG000|Overall Study|Withdrawal by Subject|1|||
106022576|NCT00792571|365748583|FG000|Overall Study|Other|4|||
106022577|NCT01754727|365748584|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
106022578|NCT01715857|365748585|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
106022579|NCT00505778|365748586|FG000|Overall Study|Adverse Event|2|||
106022580|NCT00505778|365748587|FG001|Overall Study|Adverse Event|7|||
106022581|NCT00505778|365748586|FG000|Overall Study|Physician Decision|8|||
106022582|NCT00505778|365748587|FG001|Overall Study|Physician Decision|14|||
106022583|NCT00505778|365748586|FG000|Overall Study|Lost to Follow-up|17|||
106022584|NCT00505778|365748587|FG001|Overall Study|Lost to Follow-up|23|||
106022585|NCT00505778|365748586|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
106022586|NCT00505778|365748587|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
106148753|NCT03990649|366206870|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
106022587|NCT00505778|365748586|FG000|Overall Study|Protocol Violation|7|||
106022588|NCT00505778|365748587|FG001|Overall Study|Protocol Violation|9|||
105829857|NCT00521586|365033950|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
105829858|NCT00521586|365033951|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
105829859|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
105829860|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
105829861|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
105829862|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
105829863|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
105829864|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
105829865|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
105829866|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
105829867|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
105829868|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
105829869|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
106022589|NCT00505778|365748586|FG000|Overall Study|Withdrawal by Subject|29|||
106022590|NCT00505778|365748587|FG001|Overall Study|Withdrawal by Subject|14|||
106022591|NCT00505778|365748586|FG000|Overall Study|Relapse|65|||
106022592|NCT00505778|365748587|FG001|Overall Study|Relapse|65|||
106022593|NCT00505778|365748586|FG000|Overall Study|Took No Study Drug|2|||
106022594|NCT00505778|365748587|FG001|Overall Study|Took No Study Drug|2|||
106148754|NCT03990649|366206871|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
105829870|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
105829871|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
105829872|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
105829873|NCT00521586|365033950|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
105829874|NCT00521586|365033951|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
105829875|NCT00521586|365033950|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
105829876|NCT00521586|365033951|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
105829877|NCT00521586|365033950|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
105829878|NCT00521586|365033951|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
105829879|NCT00521586|365033950|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
105829880|NCT00521586|365033951|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
105829881|NCT03234907|365033952|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
105829882|NCT03234907|365033953|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
105829883|NCT03234907|365033954|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
105829884|NCT03234907|365033955|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
105829885|NCT03234907|365033956|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
105829886|NCT03234907|365033957|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
105829887|NCT03234907|365033952|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
106022595|NCT03790696|365748588|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
106022596|NCT03790696|365748589|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
106022597|NCT01149148|365748590|FG000|Overall Study|Lost to Follow-up|1|||
106022598|NCT01149148|365748591|FG001|Overall Study|Lost to Follow-up|2|||
106022599|NCT01149148|365748590|FG000|Overall Study|Death|1|||
106022600|NCT01149148|365748591|FG001|Overall Study|Death|0|||
106022601|NCT01330108|365748592|FG000|Overall Study|Withdrawal by Subject|4|||
105829888|NCT03234907|365033953|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
105829889|NCT03234907|365033954|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
105829890|NCT03234907|365033955|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
105829891|NCT03234907|365033956|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
105829892|NCT03234907|365033957|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
105829893|NCT03234907|365033952|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
105829894|NCT03234907|365033953|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829895|NCT03234907|365033954|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829896|NCT03234907|365033955|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829897|NCT03234907|365033956|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829898|NCT03234907|365033957|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
105829899|NCT03234907|365033952|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
105829900|NCT03234907|365033953|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
105829901|NCT03234907|365033954|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
105829902|NCT03234907|365033955|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
105829903|NCT03234907|365033956|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
105829904|NCT03234907|365033957|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
105829905|NCT03234907|365033952|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
105829906|NCT03234907|365033953|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
105829907|NCT03234907|365033954|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
105829908|NCT03234907|365033955|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
105829909|NCT03234907|365033956|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
105829910|NCT03234907|365033957|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
105829911|NCT03234907|365033952|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
105829912|NCT03234907|365033953|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
105829913|NCT03234907|365033954|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
105829914|NCT03234907|365033955|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
105829915|NCT03234907|365033956|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
105829916|NCT03234907|365033957|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
105829917|NCT03234907|365033952|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
105829918|NCT03234907|365033953|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
105829919|NCT03234907|365033954|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
105829920|NCT03234907|365033955|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
105829921|NCT03234907|365033956|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
105829922|NCT03234907|365033957|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
105829923|NCT02583048|365033965|FG000|Overall Study|Withdrawal by Subject|0|||
105829924|NCT02583048|365033966|FG001|Overall Study|Withdrawal by Subject|1|||
105829925|NCT02583048|365033967|FG002|Overall Study|Withdrawal by Subject|0|||
105829926|NCT02583048|365033965|FG000|Overall Study|Failed to meet eligibility criterion|0|||
105829927|NCT02583048|365033966|FG001|Overall Study|Failed to meet eligibility criterion|0|||
105829928|NCT02583048|365033967|FG002|Overall Study|Failed to meet eligibility criterion|1|||
105829929|NCT00414726|365033972|FG000|Overall Study|Withdrawal by Subject|0|||
105829930|NCT00414726|365033973|FG001|Overall Study|Withdrawal by Subject|1|||
105829931|NCT02107196|365033974|FG000|12-week Treatment Period|Adverse Event|6|||
105829932|NCT02107196|365033975|FG001|12-week Treatment Period|Adverse Event|3|||
105829933|NCT02107196|365033974|FG000|12-week Treatment Period|Lack of Efficacy|2|||
105829934|NCT02107196|365033975|FG001|12-week Treatment Period|Lack of Efficacy|1|||
105829935|NCT02107196|365033974|FG000|12-week Treatment Period|Lost to Follow-up|3|||
105829936|NCT02107196|365033975|FG001|12-week Treatment Period|Lost to Follow-up|6|||
105829937|NCT02107196|365033974|FG000|12-week Treatment Period|Physician Decision|0|||
105829938|NCT02107196|365033975|FG001|12-week Treatment Period|Physician Decision|1|||
105829939|NCT02107196|365033974|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
105829940|NCT02107196|365033975|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
105829941|NCT02107196|365033974|FG000|12-week Treatment Period|Protocol Violation|7|||
105829942|NCT02107196|365033975|FG001|12-week Treatment Period|Protocol Violation|8|||
105829943|NCT02107196|365033974|FG000|12-week Treatment Period|Reason Missing|11|||
105963572|NCT05396014|365525269|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963573|NCT05396014|365525270|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963574|NCT05396014|365525271|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105829944|NCT02107196|365033975|FG001|12-week Treatment Period|Reason Missing|8|||
105829945|NCT02107196|365033974|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
105829946|NCT02107196|365033975|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
105829947|NCT02107196|365033974|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
105829948|NCT02107196|365033975|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105963575|NCT05396014|365525272|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963576|NCT05396014|365525273|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105829949|NCT02107196|365033974|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
105829950|NCT02107196|365033975|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
105829951|NCT02107196|365033974|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
105829952|NCT02107196|365033975|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
105829953|NCT00516295|365033976|FG000|Overall Study|Lack of Efficacy|2|||
105829954|NCT00516295|365033977|FG001|Overall Study|Lack of Efficacy|0|||
105829955|NCT00516295|365033978|FG002|Overall Study|Lack of Efficacy|0|||
105829956|NCT00516295|365033976|FG000|Overall Study|Ineligible|1|||
105829957|NCT00516295|365033977|FG001|Overall Study|Ineligible|0|||
105829958|NCT00516295|365033978|FG002|Overall Study|Ineligible|0|||
105829959|NCT02034513|365033979|FG000|Overall Study|Adverse Event|11|||
105829960|NCT02034513|365033980|FG001|Overall Study|Adverse Event|10|||
105829961|NCT02034513|365033979|FG000|Overall Study|Lack of Efficacy|0|||
105829962|NCT02034513|365033980|FG001|Overall Study|Lack of Efficacy|1|||
105829963|NCT02034513|365033979|FG000|Overall Study|Lost to Follow-up|6|||
105829964|NCT02034513|365033980|FG001|Overall Study|Lost to Follow-up|7|||
105829965|NCT02034513|365033979|FG000|Overall Study|Pregnancy|0|||
105829966|NCT02034513|365033980|FG001|Overall Study|Pregnancy|3|||
105829967|NCT02034513|365033979|FG000|Overall Study|Protocol Violation|7|||
105829968|NCT02034513|365033980|FG001|Overall Study|Protocol Violation|10|||
105829969|NCT02034513|365033979|FG000|Overall Study|Withdrawal by Subject|25|||
105829970|NCT02034513|365033980|FG001|Overall Study|Withdrawal by Subject|25|||
105829971|NCT02034513|365033979|FG000|Overall Study|Unclassified|0|||
105829972|NCT02034513|365033980|FG001|Overall Study|Unclassified|1|||
105829973|NCT01151280|365033981|FG000|Overall Study|Adverse Event|1|||
105829974|NCT01151280|365033981|FG000|Overall Study|Lack of Efficacy|3|||
105829975|NCT01243151|365033984|FG000|Overall Study|Adverse Event|0|||
105829976|NCT01243151|365033985|FG001|Overall Study|Adverse Event|1|||
105829977|NCT01243151|365033986|FG002|Overall Study|Adverse Event|0|||
105829978|NCT01243151|365033987|FG003|Overall Study|Adverse Event|0|||
105829979|NCT01243151|365033988|FG004|Overall Study|Adverse Event|0|||
105829980|NCT01243151|365033984|FG000|Overall Study|Protocol Violation|0|||
105829981|NCT01243151|365033985|FG001|Overall Study|Protocol Violation|0|||
105829982|NCT01243151|365033986|FG002|Overall Study|Protocol Violation|1|||
105829983|NCT01243151|365033987|FG003|Overall Study|Protocol Violation|0|||
105829984|NCT01243151|365033988|FG004|Overall Study|Protocol Violation|0|||
105829985|NCT01243151|365033984|FG000|Overall Study|Other|0|||
105829986|NCT01243151|365033985|FG001|Overall Study|Other|0|||
105829987|NCT01243151|365033986|FG002|Overall Study|Other|0|||
105829988|NCT01243151|365033987|FG003|Overall Study|Other|1|||
105829989|NCT01243151|365033988|FG004|Overall Study|Other|0|||
105829990|NCT01243151|365033984|FG000|Overall Study|Randomized but not treated|0|||
105829991|NCT01243151|365033985|FG001|Overall Study|Randomized but not treated|0|||
105829992|NCT01243151|365033986|FG002|Overall Study|Randomized but not treated|0|||
105829993|NCT01243151|365033987|FG003|Overall Study|Randomized but not treated|1|||
105829994|NCT01243151|365033988|FG004|Overall Study|Randomized but not treated|0|||
105829995|NCT00757705|365033989|FG000|Overall Study|Adverse Event|19|||
105829996|NCT00757705|365033989|FG000|Overall Study|Lost to Follow-up|16|||
105829997|NCT00757705|365033989|FG000|Overall Study|Withdrawal by Subject|25|||
105829998|NCT00757705|365033989|FG000|Overall Study|Insufficient Response|26|||
105829999|NCT00757705|365033989|FG000|Overall Study|Ineligible to continue|8|||
105830000|NCT00757705|365033989|FG000|Overall Study|Non-compliant|9|||
105830001|NCT00757705|365033989|FG000|Overall Study|Other|18|||
105830002|NCT02308241|365033991|FG000|Overall Study|Withdrawal by Subject|3|||
105830003|NCT00659815|365033992|FG000|Overall Study|Study related symptoms and complaints|2|||
105830004|NCT00659815|365033993|FG001|Overall Study|Study related symptoms and complaints|1|||
105830005|NCT00659815|365033992|FG000|Overall Study|Inability to maintain wearing schedule|1|||
105830006|NCT00659815|365033993|FG001|Overall Study|Inability to maintain wearing schedule|2|||
105830007|NCT00659815|365033992|FG000|Overall Study|Withdrawal by Subject|1|||
105830008|NCT00659815|365033993|FG001|Overall Study|Withdrawal by Subject|1|||
105830009|NCT02651987|365033994|FG000|Overall Study|Adverse Event|2|||
105830010|NCT02651987|365033995|FG001|Overall Study|Adverse Event|2|||
105830011|NCT02651987|365033994|FG000|Overall Study|Consent Withdrawn|2|||
105830012|NCT02651987|365033995|FG001|Overall Study|Consent Withdrawn|0|||
105830013|NCT02651987|365033994|FG000|Overall Study|Local PD|0|||
105830014|NCT02651987|365033995|FG001|Overall Study|Local PD|2|||
105830015|NCT02651987|365033994|FG000|Overall Study|Investigator Decision|1|||
105830016|NCT02651987|365033995|FG001|Overall Study|Investigator Decision|1|||
105830017|NCT00691704|365033996|FG000|Induction Therapy|Disease Progression|1|||
105830018|NCT00691704|365033996|FG000|Induction Therapy|Active Hepatitis|1|||
105830019|NCT00691704|365033996|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
105830020|NCT00691704|365033996|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
105830021|NCT00691704|365033996|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
105830022|NCT05061992|365033999|FG000|Overall Study|Excess bowel movements|1|||
105830023|NCT05061992|365034000|FG001|Overall Study|Excess bowel movements|0|||
105830024|NCT05061992|365033999|FG000|Overall Study|Complications of Medical Care|1|||
105830025|NCT05061992|365034000|FG001|Overall Study|Complications of Medical Care|0|||
106148755|NCT03990649|366206872|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
106148756|NCT03990649|366206870|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
106148757|NCT03990649|366206871|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
106148758|NCT03990649|366206872|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
106148759|NCT03990649|366206870|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
106148760|NCT03990649|366206871|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
106148761|NCT03990649|366206872|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
105963577|NCT05396014|365525274|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963578|NCT05396014|365525275|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963579|NCT05396014|365525276|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963580|NCT05396014|365525277|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
106148762|NCT03990649|366206870|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
106148763|NCT03990649|366206871|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
106148764|NCT03990649|366206872|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
106148765|NCT03990649|366206870|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
106148766|NCT03990649|366206871|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
106148767|NCT03990649|366206872|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
106148768|NCT03990649|366206870|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
106148769|NCT03990649|366206871|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
106148770|NCT03990649|366206872|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
106148771|NCT00232180|366206873|FG000|Double-blind (DB) Phase|Death|186|||
105830026|NCT05061992|365033999|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
105830027|NCT05061992|365034000|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
105830028|NCT05061992|365033999|FG000|Overall Study|Withdrawal by Subject|0|||
105830029|NCT05061992|365034000|FG001|Overall Study|Withdrawal by Subject|1|||
105830030|NCT04523480|365034001|FG000|Overall Study|Lost to Follow-up|30|||
105830031|NCT04523480|365034002|FG001|Overall Study|Lost to Follow-up|35|||
105830032|NCT04523480|365034003|FG002|Overall Study|Lost to Follow-up|0|||
105830033|NCT00397254|365034015|FG000|Overall Study|Lost to Follow-up|2|||
105830034|NCT00397254|365034016|FG001|Overall Study|Lost to Follow-up|2|||
105830035|NCT03827395|365034018|FG000|Overall Study|Lost to Follow-up|1|||
105830036|NCT03827395|365034019|FG001|Overall Study|Lost to Follow-up|0|||
105830037|NCT03827395|365034018|FG000|Overall Study|Protocol Violation|1|||
105830038|NCT03827395|365034019|FG001|Overall Study|Protocol Violation|0|||
105830039|NCT03827395|365034018|FG000|Overall Study|Became ineligible after enrollment|1|||
105830040|NCT03827395|365034019|FG001|Overall Study|Became ineligible after enrollment|2|||
105830041|NCT02420353|365034020|FG000|Overall Study|Withdrawal by Subject|0|||
105830042|NCT02420353|365034021|FG001|Overall Study|Withdrawal by Subject|1|||
105830043|NCT00875524|365034024|FG000|Overall Study|Serious adverse event|0|||
105830044|NCT00875524|365034025|FG001|Overall Study|Serious adverse event|1|||
105830045|NCT00875524|365034024|FG000|Overall Study|Protocol Violation|4|||
105830046|NCT00875524|365034025|FG001|Overall Study|Protocol Violation|0|||
105830047|NCT00875524|365034024|FG000|Overall Study|Lost to Follow-up|1|||
105830048|NCT00875524|365034025|FG001|Overall Study|Lost to Follow-up|0|||
105830049|NCT00875524|365034024|FG000|Overall Study|Withdrawal by Subject|3|||
105830050|NCT00875524|365034025|FG001|Overall Study|Withdrawal by Subject|5|||
105963581|NCT05396014|365525278|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963582|NCT05396014|365525279|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963583|NCT05396014|365525280|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
105963584|NCT04683029|365525283|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
105963585|NCT04683029|365525284|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
105963586|NCT04683029|365525285|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
105963587|NCT04683029|365525286|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
105963588|NCT04683029|365525283|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
105963589|NCT04683029|365525284|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
105963590|NCT04683029|365525285|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
105963591|NCT04683029|365525286|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
105963592|NCT04683029|365525283|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
105963593|NCT04683029|365525284|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
105830051|NCT01859598|365034033|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
105963594|NCT04683029|365525285|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
105963595|NCT04683029|365525286|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
105963596|NCT04299308|365525287|FG000|Overall Study|Withdrawal by Subject|1|||
105830052|NCT01968551|365034034|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
105830053|NCT01968551|365034035|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
105830054|NCT01968551|365034036|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
105830055|NCT01968551|365034034|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
105830056|NCT01968551|365034035|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
105830057|NCT01968551|365034036|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
105830058|NCT01968551|365034034|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
105830059|NCT01968551|365034035|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
105963597|NCT04299308|365525288|FG001|Overall Study|Withdrawal by Subject|0|||
105963598|NCT04299308|365525287|FG000|Overall Study|issue with PET image (1)|1|||
105830060|NCT01968551|365034036|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
105830061|NCT01968551|365034034|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
105830062|NCT01968551|365034035|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
105830063|NCT01968551|365034036|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
105830064|NCT01968551|365034034|FG000|Extension Phase|Adverse Event|0|||
105830065|NCT01968551|365034035|FG001|Extension Phase|Adverse Event|0|||
105830066|NCT01968551|365034036|FG002|Extension Phase|Adverse Event|2|||
105830067|NCT01968551|365034034|FG000|Extension Phase|Death|0|||
105830068|NCT01968551|365034035|FG001|Extension Phase|Death|1|||
105830069|NCT01968551|365034036|FG002|Extension Phase|Death|0|||
105830070|NCT01968551|365034034|FG000|Extension Phase|Withdrew Consent|0|||
105830071|NCT01968551|365034035|FG001|Extension Phase|Withdrew Consent|0|||
105830072|NCT01968551|365034036|FG002|Extension Phase|Withdrew Consent|1|||
105830073|NCT01968551|365034034|FG000|Extension Phase|Lost to Follow-up|1|||
105830074|NCT01968551|365034035|FG001|Extension Phase|Lost to Follow-up|0|||
105830075|NCT01968551|365034036|FG002|Extension Phase|Lost to Follow-up|1|||
105830076|NCT00645853|365034037|FG000|Overall Study|Adverse Event|18|||
105830077|NCT00645853|365034038|FG001|Overall Study|Adverse Event|7|||
105830078|NCT00645853|365034037|FG000|Overall Study|AZ study closure in Hungary|60|||
105830079|NCT00645853|365034038|FG001|Overall Study|AZ study closure in Hungary|40|||
105830080|NCT00645853|365034037|FG000|Overall Study|Withdrawal by Subject|5|||
105830081|NCT00645853|365034038|FG001|Overall Study|Withdrawal by Subject|2|||
105830082|NCT00645853|365034037|FG000|Overall Study|Protocol Violation|0|||
105830083|NCT00645853|365034038|FG001|Overall Study|Protocol Violation|2|||
105830084|NCT00645853|365034037|FG000|Overall Study|Discontinuation criteria|2|||
105830085|NCT00645853|365034038|FG001|Overall Study|Discontinuation criteria|2|||
105830086|NCT00645853|365034037|FG000|Overall Study|recall of ICF, planned operation, death|7|||
105830087|NCT00645853|365034038|FG001|Overall Study|recall of ICF, planned operation, death|4|||
105830088|NCT00819169|365034039|FG000|Overall Study|Withdrawal by Subject|2|||
105830089|NCT00819169|365034040|FG001|Overall Study|Withdrawal by Subject|0|||
105830090|NCT00819169|365034041|FG002|Overall Study|Withdrawal by Subject|0|||
105830091|NCT00819169|365034042|FG003|Overall Study|Withdrawal by Subject|1|||
105830092|NCT00819169|365034043|FG004|Overall Study|Withdrawal by Subject|1|||
105830093|NCT00819169|365034044|FG005|Overall Study|Withdrawal by Subject|1|||
105830094|NCT00819169|365034045|FG006|Overall Study|Withdrawal by Subject|5|||
105830095|NCT00819169|365034046|FG007|Overall Study|Withdrawal by Subject|1|||
105830096|NCT00819169|365034047|FG008|Overall Study|Withdrawal by Subject|4|||
105830097|NCT00819169|365034039|FG000|Overall Study|Lost to Follow-up|0|||
105830098|NCT00819169|365034040|FG001|Overall Study|Lost to Follow-up|2|||
105830099|NCT00819169|365034041|FG002|Overall Study|Lost to Follow-up|0|||
105830100|NCT00819169|365034042|FG003|Overall Study|Lost to Follow-up|1|||
105830101|NCT00819169|365034043|FG004|Overall Study|Lost to Follow-up|0|||
105830102|NCT00819169|365034044|FG005|Overall Study|Lost to Follow-up|6|||
105830103|NCT00819169|365034045|FG006|Overall Study|Lost to Follow-up|2|||
105830104|NCT00819169|365034046|FG007|Overall Study|Lost to Follow-up|2|||
105830105|NCT00819169|365034047|FG008|Overall Study|Lost to Follow-up|1|||
105830106|NCT00819169|365034039|FG000|Overall Study|Death|1|||
105830107|NCT00819169|365034040|FG001|Overall Study|Death|1|||
105830108|NCT00819169|365034041|FG002|Overall Study|Death|3|||
105830109|NCT00819169|365034042|FG003|Overall Study|Death|8|||
105830110|NCT00819169|365034043|FG004|Overall Study|Death|5|||
105830111|NCT00819169|365034044|FG005|Overall Study|Death|7|||
105830112|NCT00819169|365034045|FG006|Overall Study|Death|9|||
105830113|NCT00819169|365034046|FG007|Overall Study|Death|4|||
105830114|NCT00819169|365034047|FG008|Overall Study|Death|7|||
105830115|NCT00819169|365034039|FG000|Overall Study|Ineligibility determined|0|||
105830116|NCT00819169|365034040|FG001|Overall Study|Ineligibility determined|0|||
105830117|NCT00819169|365034041|FG002|Overall Study|Ineligibility determined|0|||
105830118|NCT00819169|365034042|FG003|Overall Study|Ineligibility determined|2|||
105830119|NCT00819169|365034043|FG004|Overall Study|Ineligibility determined|0|||
105830120|NCT00819169|365034044|FG005|Overall Study|Ineligibility determined|0|||
105830121|NCT00819169|365034045|FG006|Overall Study|Ineligibility determined|0|||
105830122|NCT00819169|365034046|FG007|Overall Study|Ineligibility determined|0|||
105830123|NCT00819169|365034047|FG008|Overall Study|Ineligibility determined|1|||
105830124|NCT00819169|365034039|FG000|Overall Study|Adverse Event|0|||
105830125|NCT00819169|365034040|FG001|Overall Study|Adverse Event|0|||
105830126|NCT00819169|365034041|FG002|Overall Study|Adverse Event|0|||
105830127|NCT00819169|365034042|FG003|Overall Study|Adverse Event|0|||
105830128|NCT00819169|365034043|FG004|Overall Study|Adverse Event|1|||
105830129|NCT00819169|365034044|FG005|Overall Study|Adverse Event|0|||
105830130|NCT00819169|365034045|FG006|Overall Study|Adverse Event|0|||
105830131|NCT00819169|365034046|FG007|Overall Study|Adverse Event|0|||
105830132|NCT00819169|365034047|FG008|Overall Study|Adverse Event|0|||
105830133|NCT00819169|365034039|FG000|Overall Study|Administrative Decision|0|||
105830134|NCT00819169|365034040|FG001|Overall Study|Administrative Decision|0|||
105830135|NCT00819169|365034041|FG002|Overall Study|Administrative Decision|0|||
105830136|NCT00819169|365034042|FG003|Overall Study|Administrative Decision|0|||
105830137|NCT00819169|365034043|FG004|Overall Study|Administrative Decision|1|||
105830138|NCT00819169|365034044|FG005|Overall Study|Administrative Decision|2|||
105830139|NCT00819169|365034045|FG006|Overall Study|Administrative Decision|0|||
105830140|NCT00819169|365034046|FG007|Overall Study|Administrative Decision|2|||
105830141|NCT00819169|365034047|FG008|Overall Study|Administrative Decision|0|||
105830142|NCT04060251|365034058|FG000|Overall Study|Study terminated due to low enrollment.|7|||
105830143|NCT04060251|365034059|FG001|Overall Study|Study terminated due to low enrollment.|5|||
105830144|NCT04060251|365034060|FG002|Overall Study|Study terminated due to low enrollment.|7|||
105830145|NCT04060251|365034058|FG000|Overall Study|Adverse Event|1|||
105830146|NCT04060251|365034059|FG001|Overall Study|Adverse Event|1|||
105830147|NCT04060251|365034060|FG002|Overall Study|Adverse Event|0|||
105830148|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
105830149|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
105830150|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
105830151|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
105830152|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
105830153|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
105830154|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
105830155|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
105830156|NCT01087502|365034062|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
105830157|NCT01087502|365034063|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
105830158|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
105830159|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
105830160|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
105830161|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
105830162|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
105830163|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
105830164|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
105830165|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
105830166|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
105830167|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
105830168|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
105830169|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
105830170|NCT01087502|365034062|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
105830171|NCT01087502|365034063|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
105830172|NCT01728116|365034064|FG000|Overall Study|Sponsor Terminated Study|106|||
105830173|NCT01728116|365034065|FG001|Overall Study|Sponsor Terminated Study|35|||
105830174|NCT01728116|365034064|FG000|Overall Study|Withdrawal by Subject|16|||
105830175|NCT01728116|365034065|FG001|Overall Study|Withdrawal by Subject|9|||
105830176|NCT01728116|365034064|FG000|Overall Study|Adverse Event|13|||
105830177|NCT01728116|365034065|FG001|Overall Study|Adverse Event|0|||
105830178|NCT01728116|365034064|FG000|Overall Study|Procedure/device failure|7|||
105830179|NCT01728116|365034065|FG001|Overall Study|Procedure/device failure|0|||
105830180|NCT01728116|365034064|FG000|Overall Study|Lost to Follow-up|9|||
105830181|NCT01728116|365034065|FG001|Overall Study|Lost to Follow-up|2|||
105830182|NCT01728116|365034064|FG000|Overall Study|Physician Decision|2|||
105830183|NCT01728116|365034065|FG001|Overall Study|Physician Decision|0|||
105830184|NCT01728116|365034064|FG000|Overall Study|Subject Non-Compliance|2|||
105830185|NCT01728116|365034065|FG001|Overall Study|Subject Non-Compliance|0|||
105830186|NCT01728116|365034064|FG000|Overall Study|Inter-current finding at procedure|1|||
105830187|NCT01728116|365034065|FG001|Overall Study|Inter-current finding at procedure|0|||
105830188|NCT01728116|365034064|FG000|Overall Study|Incorrectly enrolled in Study|0|||
105963599|NCT04299308|365525288|FG001|Overall Study|issue with PET image (1)|0|||
105963600|NCT04075292|365525291|FG000|Overall Study|Withdrawal by Subject|1|||
105963601|NCT04075292|365525292|FG001|Overall Study|Withdrawal by Subject|9|||
105963602|NCT04075292|365525291|FG000|Overall Study|Death|2|||
105963603|NCT04075292|365525292|FG001|Overall Study|Death|5|||
105963604|NCT04075292|365525291|FG000|Overall Study|Remained on study at time of DCO|74|||
105963605|NCT04075292|365525292|FG001|Overall Study|Remained on study at time of DCO|64|||
105963606|NCT01696994|365525295|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
105830189|NCT01728116|365034065|FG001|Overall Study|Incorrectly enrolled in Study|1|||
105830190|NCT01728116|365034064|FG000|Overall Study|various not noted previously|5|||
105830191|NCT01728116|365034065|FG001|Overall Study|various not noted previously|0|||
105830192|NCT01559116|365034067|FG000|Overall Study|Adverse Event|10|||
105963607|NCT01696994|365525296|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
105963608|NCT01696994|365525295|FG000|Overall Study|Died Before Randomization|1|||
105830193|NCT01559116|365034067|FG000|Overall Study|Lack of Efficacy|1|||
105830194|NCT01559116|365034067|FG000|Overall Study|Lost to Follow-up|1|||
105830195|NCT01559116|365034067|FG000|Overall Study|Protocol Violation|1|||
105830196|NCT01559116|365034067|FG000|Overall Study|Withdrawal by Subject|4|||
105830197|NCT01559116|365034067|FG000|Overall Study|other than stated above|9|||
105830198|NCT01151618|365034068|FG000|Overall Study|Adverse Event|2|||
105830199|NCT01151618|365034068|FG000|Overall Study|Withdrawal by Subject|7|||
105830200|NCT00562718|365034069|FG000|Overall Study|Death|1|||
105830201|NCT00562718|365034069|FG000|Overall Study|Withdrawal by Subject|3|||
105830202|NCT00562718|365034069|FG000|Overall Study|Adverse Event|4|||
105830203|NCT00562718|365034069|FG000|Overall Study|Lack of Efficacy|2|||
105830204|NCT00562718|365034069|FG000|Overall Study|not stated|1|||
105830205|NCT04025021|365034070|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
105830206|NCT04025021|365034071|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
105830207|NCT03966911|365034072|FG000|Overall Study|Adverse Event|1|||
105830208|NCT03966911|365034073|FG001|Overall Study|Adverse Event|1|||
105830209|NCT03966911|365034072|FG000|Overall Study|Withdrawal by Subject|8|||
105830210|NCT03966911|365034073|FG001|Overall Study|Withdrawal by Subject|2|||
105830211|NCT03966911|365034072|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
105830212|NCT03966911|365034073|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
105830213|NCT02905435|365034078|FG000|Overall Study|Death|2|||
105830214|NCT02905435|365034078|FG000|Overall Study|Physician Decision|1|||
105830215|NCT02905435|365034078|FG000|Overall Study|Lost to Follow-up|4|||
105830216|NCT03259165|365034083|FG000|Overall Study|COVID 19 pandemic|1|||
105830217|NCT03259165|365034084|FG001|Overall Study|COVID 19 pandemic|1|||
105830218|NCT00903877|365034085|FG000|Overall Study|Did not meet study criteria|33|||
105830219|NCT00903877|365034085|FG000|Overall Study|Withdrawal by Subject|3|||
105830220|NCT00903877|365034085|FG000|Overall Study|Adverse Event|2|||
105830221|NCT00903877|365034085|FG000|Overall Study|Lost to Follow-up|1|||
105830222|NCT00903877|365034085|FG000|Overall Study|Participation put on hold|4|||
105830223|NCT00840879|365034090|FG000|Second Intervention|Withdrawal by Subject|1|||
105830224|NCT00840879|365034091|FG001|Second Intervention|Withdrawal by Subject|0|||
105830225|NCT00828321|365035430|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
105830226|NCT00828321|365035431|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
105830227|NCT00828321|365035430|FG000|Second Intervention|Protocol Violation|0|||
105830228|NCT00828321|365035431|FG001|Second Intervention|Protocol Violation|1|||
105830229|NCT00642993|365035432|FG000|Overall Study|Adverse Event|85|||
105830230|NCT00642993|365035433|FG001|Overall Study|Adverse Event|4|||
105830231|NCT00642993|365035432|FG000|Overall Study|Lost to Follow-up|8|||
105830232|NCT00642993|365035433|FG001|Overall Study|Lost to Follow-up|4|||
105830233|NCT00642993|365035432|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
105830234|NCT00642993|365035433|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
105830235|NCT00642993|365035432|FG000|Overall Study|Protocol Violation|1|||
105830236|NCT00642993|365035433|FG001|Overall Study|Protocol Violation|4|||
105830237|NCT00642993|365035432|FG000|Overall Study|Did not meet protocol eligibility|0|||
105830238|NCT00642993|365035433|FG001|Overall Study|Did not meet protocol eligibility|1|||
105830239|NCT00642993|365035432|FG000|Overall Study|Administrative|1|||
105830240|NCT00642993|365035433|FG001|Overall Study|Administrative|0|||
105830241|NCT01624233|365035434|FG000|Period 2 - Induction|Adverse Event|1|||
105830242|NCT01624233|365035434|FG000|Period 3 - Maintenance|Adverse Event|2|||
105830243|NCT01624233|365035434|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
105830244|NCT01624233|365035434|FG000|Period 3 - Maintenance|Physician Decision|2|||
105830245|NCT01624233|365035434|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
105830246|NCT01624233|365035434|FG000|Period 4 - Drug Free Period|Relapsed|61|||
105830247|NCT01624233|365035434|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
105830248|NCT01624233|365035434|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
105830249|NCT01624233|365035434|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
106148772|NCT00232180|366206874|FG001|Double-blind (DB) Phase|Death|222|||
105830250|NCT01624233|365035434|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
105830251|NCT01624233|365035434|FG000|Period 6: Follow-up|Adverse Event|3|||
105830252|NCT01624233|365035434|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
105830253|NCT01624233|365035434|FG000|Period 6: Follow-up|Physician Decision|1|||
106148773|NCT00232180|366206875|FG002|Double-blind (DB) Phase|Death|0|||
106148774|NCT00232180|366206873|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
106148775|NCT00232180|366206874|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
106148776|NCT00232180|366206875|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
105830254|NCT01624233|365035434|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
105830255|NCT00373256|365035438|FG000|Overall Study|Adverse Event (AE)|1|||
105830256|NCT00373256|365035439|FG001|Overall Study|Adverse Event (AE)|5|||
105830257|NCT00373256|365035438|FG000|Overall Study|Lost to Follow-up|2|||
105830258|NCT00373256|365035439|FG001|Overall Study|Lost to Follow-up|1|||
105830259|NCT00373256|365035438|FG000|Overall Study|Death|9|||
105830260|NCT00373256|365035439|FG001|Overall Study|Death|8|||
105830261|NCT00373256|365035438|FG000|Overall Study|Objective Progression or Relapse|111|||
105830262|NCT00373256|365035439|FG001|Overall Study|Objective Progression or Relapse|104|||
106148777|NCT00232180|366206873|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
105963609|NCT01696994|365525296|FG001|Overall Study|Died Before Randomization|2|||
105963610|NCT01696994|365525295|FG000|Overall Study|Died Before ASU (Control)|73|||
105963611|NCT01696994|365525296|FG001|Overall Study|Died Before ASU (Control)|0|||
105963612|NCT01696994|365525295|FG000|Overall Study|No Ovaries at Baseline|4807|||
105963613|NCT01696994|365525296|FG001|Overall Study|No Ovaries at Baseline|4851|||
105963614|NCT01696994|365525295|FG000|Overall Study|Refused ASU (Control)|311|||
105963615|NCT01696994|365525296|FG001|Overall Study|Refused ASU (Control)|0|||
105963616|NCT01696994|365525295|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
105963617|NCT01696994|365525296|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
105963618|NCT06004895|365525297|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
105963619|NCT06004895|365525297|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
105963620|NCT00878254|365525298|FG000|Overall Study|Physician Decision|1|||
105963621|NCT00878254|365525298|FG000|Overall Study|Death|1|||
105963622|NCT00878254|365525298|FG000|Overall Study|Withdrawal by Subject|1|||
105963623|NCT02854436|365525299|FG000|Overall Study|Adverse Event|1|||
105963624|NCT02854436|365525299|FG000|Overall Study|Death|208|||
105963625|NCT02854436|365525299|FG000|Overall Study|Lost to Follow-up|5|||
105963626|NCT02854436|365525299|FG000|Overall Study|Withdrawal by Subject|24|||
105963627|NCT02854436|365525299|FG000|Overall Study|Other|45|||
105963628|NCT02854436|365525299|FG000|Overall Study|Physician Decision|6|||
105963629|NCT03636893|365525300|FG000|Overall Study|Death|0|||
105963630|NCT03636893|365525301|FG001|Overall Study|Death|1|||
105963631|NCT03636893|365525300|FG000|Overall Study|Protocol Violation|0|||
105963632|NCT03636893|365525301|FG001|Overall Study|Protocol Violation|3|||
105963633|NCT03636893|365525300|FG000|Overall Study|Withdrawal by Subject|1|||
105963634|NCT03636893|365525301|FG001|Overall Study|Withdrawal by Subject|2|||
105963635|NCT03636893|365525300|FG000|Overall Study|Refusal to surgery|4|||
105963636|NCT03636893|365525301|FG001|Overall Study|Refusal to surgery|3|||
105963637|NCT03636893|365525300|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
105963638|NCT03636893|365525301|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
105963639|NCT03636893|365525300|FG000|Overall Study|Adverse Event|1|||
105963640|NCT03636893|365525301|FG001|Overall Study|Adverse Event|1|||
105963641|NCT04908865|365525302|FG000|Overall Study|Adverse Event|2|||
105963642|NCT04908865|365525302|FG000|Overall Study|Lack of Efficacy|5|||
105963643|NCT04908865|365525302|FG000|Overall Study|Lost to Follow-up|1|||
105963644|NCT05312697|365525303|FG000|Overall Study|Sponsor Terminated Trial|2|||
105963645|NCT01970241|365525304|FG000|Overall Study|Withdrawal by Subject|2|||
105963646|NCT01970241|365525305|FG001|Overall Study|Withdrawal by Subject|0|||
105963647|NCT01970241|365525304|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
105963648|NCT01970241|365525305|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
105963649|NCT01104545|365525306|FG000|Overall Study|Adverse Event|0|||
105963650|NCT01104545|365525307|FG001|Overall Study|Adverse Event|1|||
105963651|NCT01104545|365525308|FG002|Overall Study|Adverse Event|2|||
105963652|NCT03585764|365525311|FG000|Overall Study|Death|3|||
105963653|NCT03585764|365525312|FG001|Overall Study|Death|2|||
105963654|NCT03585764|365525313|FG002|Overall Study|Death|3|||
105963655|NCT03585764|365525314|FG003|Overall Study|Death|0|||
105963656|NCT03585764|365525311|FG000|Overall Study|Lost to Follow-up|0|||
105963657|NCT03585764|365525312|FG001|Overall Study|Lost to Follow-up|1|||
105963658|NCT03585764|365525313|FG002|Overall Study|Lost to Follow-up|0|||
105963659|NCT03585764|365525314|FG003|Overall Study|Lost to Follow-up|0|||
105963660|NCT03585764|365525311|FG000|Overall Study|Physician Decision|0|||
105963661|NCT03585764|365525312|FG001|Overall Study|Physician Decision|0|||
105963662|NCT03585764|365525313|FG002|Overall Study|Physician Decision|2|||
105963663|NCT03585764|365525314|FG003|Overall Study|Physician Decision|0|||
105963664|NCT01536561|365525316|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
106022602|NCT01175083|365748593|FG000|Primary Epoch|Withdrawal by Subject|0|||
106022603|NCT01175083|365748594|FG001|Primary Epoch|Withdrawal by Subject|0|||
106022604|NCT01175083|365748595|FG002|Primary Epoch|Withdrawal by Subject|0|||
106022605|NCT01175083|365748596|FG003|Primary Epoch|Withdrawal by Subject|0|||
106022606|NCT01175083|365748597|FG004|Primary Epoch|Withdrawal by Subject|0|||
106022607|NCT01175083|365748598|FG005|Primary Epoch|Withdrawal by Subject|2|||
105963665|NCT01536561|365525316|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
105963666|NCT01536561|365525316|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
105963667|NCT01536561|365525316|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
105963668|NCT01536561|365525316|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
105963669|NCT01536561|365525316|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
105963670|NCT01732510|365525317|FG000|Overall Study|Adverse Event|0|||
105963671|NCT01732510|365525318|FG001|Overall Study|Adverse Event|1|||
105963672|NCT01732510|365525319|FG002|Overall Study|Adverse Event|1|||
105963673|NCT01732510|365525320|FG003|Overall Study|Adverse Event|0|||
105963674|NCT01732510|365525321|FG004|Overall Study|Adverse Event|0|||
105963675|NCT01732510|365525322|FG005|Overall Study|Adverse Event|0|||
105963676|NCT01732510|365525323|FG006|Overall Study|Adverse Event|1|||
105963677|NCT01732510|365525317|FG000|Overall Study|Protocol Violation|0|||
106022608|NCT01175083|365748593|FG000|Primary Epoch|Lost to Follow-up|0|||
105830263|NCT00373256|365035438|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
105830264|NCT00373256|365035439|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
105830265|NCT00373256|365035438|FG000|Overall Study|Other|73|||
105830266|NCT00373256|365035439|FG001|Overall Study|Other|107|||
105830267|NCT00373256|365035438|FG000|Overall Study|Protocol Violation|0|||
105830268|NCT00373256|365035439|FG001|Overall Study|Protocol Violation|2|||
105830269|NCT00373256|365035438|FG000|Overall Study|Study Terminated by Sponsor|41|||
105830270|NCT00373256|365035439|FG001|Overall Study|Study Terminated by Sponsor|13|||
105830271|NCT02986139|365035440|FG000|Overall Study|Sponsor Decision|1|||
105830272|NCT02986139|365035441|FG001|Overall Study|Sponsor Decision|2|||
105830273|NCT02986139|365035440|FG000|Overall Study|Withdrawal by Subject|0|||
105830274|NCT02986139|365035441|FG001|Overall Study|Withdrawal by Subject|1|||
105830275|NCT02986139|365035440|FG000|Overall Study|Lost to Follow-up|0|||
105830276|NCT02986139|365035441|FG001|Overall Study|Lost to Follow-up|1|||
105830277|NCT00735696|365035444|FG000|Overall Study|Withdrawal by Subject|1|||
105830278|NCT00735696|365035444|FG000|Overall Study|Enrolled but never Treated|1|||
105830279|NCT00874822|365035445|FG000|Overall Study|excluded by criteria|8|||
105830280|NCT02627963|365035446|FG000|Overall Study|Randomized but not treated|2|||
105830281|NCT02627963|365035447|FG001|Overall Study|Randomized but not treated|6|||
105830282|NCT03807440|365035451|FG000|Overall Study|No documentation of index date 2|320|||
105830283|NCT03807440|365035451|FG000|Overall Study|No informed consent for index date 2|117|||
105830284|NCT01024855|365035454|FG000|Overall Study|Inclusion/exclusion criteria|1|||
105830285|NCT02372006|365035455|FG000|Overall Study|Progressive disease|8|||
105830286|NCT02372006|365035456|FG001|Overall Study|Progressive disease|7|||
105830287|NCT02372006|365035457|FG002|Overall Study|Progressive disease|34|||
105830288|NCT02372006|365035455|FG000|Overall Study|Dose limiting toxicity|0|||
105830289|NCT02372006|365035456|FG001|Overall Study|Dose limiting toxicity|1|||
105830290|NCT02372006|365035457|FG002|Overall Study|Dose limiting toxicity|0|||
105830291|NCT02372006|365035455|FG000|Overall Study|Adverse Event|0|||
105830292|NCT02372006|365035456|FG001|Overall Study|Adverse Event|0|||
105830293|NCT02372006|365035457|FG002|Overall Study|Adverse Event|3|||
105830294|NCT02372006|365035455|FG000|Overall Study|Withdrawal by Subject|0|||
105830295|NCT02372006|365035456|FG001|Overall Study|Withdrawal by Subject|1|||
105830296|NCT02372006|365035457|FG002|Overall Study|Withdrawal by Subject|1|||
105830297|NCT02372006|365035455|FG000|Overall Study|Other reason for not completing|0|||
105830298|NCT02372006|365035456|FG001|Overall Study|Other reason for not completing|0|||
105830299|NCT02372006|365035457|FG002|Overall Study|Other reason for not completing|1|||
105830300|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Death|0|||
105830301|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Death|1|||
105830302|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
105830303|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
105830304|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
105830305|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
105830306|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
105830307|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
105830308|NCT01717313|365035461|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
105830309|NCT01717313|365035462|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
105830310|NCT01717313|365035461|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
105830311|NCT01717313|365035462|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
105830312|NCT01717313|365035461|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
105830313|NCT01717313|365035462|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
105830314|NCT01717313|365035461|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
105830315|NCT01717313|365035462|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
105830316|NCT01717313|365035461|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
105830317|NCT01717313|365035462|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
105830318|NCT01567527|365035463|FG000|Conversion Phase.|Protocol deviation|3|||
105830319|NCT01567527|365035464|FG001|Conversion Phase.|Protocol deviation|0|||
105830320|NCT01567527|365035465|FG002|Conversion Phase.|Protocol deviation|0|||
105830321|NCT01567527|365035466|FG003|Conversion Phase.|Protocol deviation|0|||
105830322|NCT01567527|365035467|FG004|Conversion Phase.|Protocol deviation|0|||
105830323|NCT01567527|365035463|FG000|Conversion Phase.|Met withdrawal criteria|10|||
105830324|NCT01567527|365035464|FG001|Conversion Phase.|Met withdrawal criteria|0|||
105830325|NCT01567527|365035465|FG002|Conversion Phase.|Met withdrawal criteria|0|||
105830326|NCT01567527|365035466|FG003|Conversion Phase.|Met withdrawal criteria|0|||
105830327|NCT01567527|365035467|FG004|Conversion Phase.|Met withdrawal criteria|0|||
105830328|NCT01567527|365035463|FG000|Conversion Phase.|Withdrawal by Subject|32|||
105830329|NCT01567527|365035464|FG001|Conversion Phase.|Withdrawal by Subject|0|||
105830330|NCT01567527|365035465|FG002|Conversion Phase.|Withdrawal by Subject|0|||
105830331|NCT01567527|365035466|FG003|Conversion Phase.|Withdrawal by Subject|0|||
105830332|NCT01567527|365035467|FG004|Conversion Phase.|Withdrawal by Subject|0|||
105830333|NCT01567527|365035463|FG000|Conversion Phase.|Lost to Follow-up|16|||
105830334|NCT01567527|365035464|FG001|Conversion Phase.|Lost to Follow-up|0|||
105830335|NCT01567527|365035465|FG002|Conversion Phase.|Lost to Follow-up|0|||
105963678|NCT01732510|365525318|FG001|Overall Study|Protocol Violation|0|||
105963679|NCT01732510|365525319|FG002|Overall Study|Protocol Violation|0|||
105963680|NCT01732510|365525320|FG003|Overall Study|Protocol Violation|1|||
105963681|NCT01732510|365525321|FG004|Overall Study|Protocol Violation|0|||
105963682|NCT01732510|365525322|FG005|Overall Study|Protocol Violation|0|||
105830336|NCT01567527|365035466|FG003|Conversion Phase.|Lost to Follow-up|0|||
105830337|NCT01567527|365035467|FG004|Conversion Phase.|Lost to Follow-up|0|||
105830338|NCT01567527|365035463|FG000|Conversion Phase.|Lack of Efficacy|2|||
105830339|NCT01567527|365035464|FG001|Conversion Phase.|Lack of Efficacy|0|||
105830340|NCT01567527|365035465|FG002|Conversion Phase.|Lack of Efficacy|0|||
105830341|NCT01567527|365035466|FG003|Conversion Phase.|Lack of Efficacy|0|||
105830342|NCT01567527|365035467|FG004|Conversion Phase.|Lack of Efficacy|0|||
105830343|NCT01567527|365035463|FG000|Conversion Phase.|Adverse Event|33|||
105830344|NCT01567527|365035464|FG001|Conversion Phase.|Adverse Event|0|||
105830345|NCT01567527|365035465|FG002|Conversion Phase.|Adverse Event|0|||
105830346|NCT01567527|365035466|FG003|Conversion Phase.|Adverse Event|0|||
105830347|NCT01567527|365035467|FG004|Conversion Phase.|Adverse Event|0|||
105830348|NCT01567527|365035463|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
105830349|NCT01567527|365035464|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
105830350|NCT01567527|365035465|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
105830351|NCT01567527|365035466|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
105830352|NCT01567527|365035467|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
105830353|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
105830354|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
105830355|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
105830356|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
105830357|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
105830358|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
105830359|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
105830360|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
105830361|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
105830362|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
105830363|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
105830364|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
105830365|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
105830366|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
105830367|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
105830368|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
105830369|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
105830370|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
105830371|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
105830372|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
105830373|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
105830374|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
105830375|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
105830376|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
105830377|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
105830378|NCT01567527|365035463|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
105830379|NCT01567527|365035464|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
105830380|NCT01567527|365035465|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
105963683|NCT01732510|365525323|FG006|Overall Study|Protocol Violation|0|||
105963684|NCT01732510|365525317|FG000|Overall Study|Withdrawal by Subject|1|||
105830381|NCT01567527|365035466|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
105830382|NCT01567527|365035467|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
105830383|NCT01567527|365035463|FG000|IM Depot Stabilization.|Protocol deviation|0|||
105830384|NCT01567527|365035464|FG001|IM Depot Stabilization.|Protocol deviation|0|||
105830385|NCT01567527|365035465|FG002|IM Depot Stabilization.|Protocol deviation|5|||
105830386|NCT01567527|365035466|FG003|IM Depot Stabilization.|Protocol deviation|0|||
105830387|NCT01567527|365035467|FG004|IM Depot Stabilization.|Protocol deviation|0|||
105830388|NCT01567527|365035463|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
105830389|NCT01567527|365035464|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
105830390|NCT01567527|365035465|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
105830391|NCT01567527|365035466|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
105830392|NCT01567527|365035467|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
105830393|NCT01567527|365035463|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
105830394|NCT01567527|365035464|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
106148778|NCT00232180|366206874|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
105830395|NCT01567527|365035465|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
105963685|NCT01732510|365525318|FG001|Overall Study|Withdrawal by Subject|3|||
106148779|NCT00232180|366206875|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
106148780|NCT00232180|366206873|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
106148781|NCT00232180|366206874|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
105830396|NCT01567527|365035466|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
105830397|NCT01567527|365035467|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
105830398|NCT01567527|365035463|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
105830399|NCT01567527|365035464|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
105830400|NCT01567527|365035465|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
105830401|NCT01567527|365035466|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
105830402|NCT01567527|365035467|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
105830403|NCT01567527|365035463|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
105830404|NCT01567527|365035464|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
105830405|NCT01567527|365035465|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
105830406|NCT01567527|365035466|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
105830407|NCT01567527|365035467|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
105830408|NCT01567527|365035463|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
105830409|NCT01567527|365035464|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
105830410|NCT01567527|365035465|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
105830411|NCT01567527|365035466|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
105830412|NCT01567527|365035467|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
105830413|NCT01567527|365035463|FG000|IM Depot Stabilization.|Adverse Event|0|||
105830414|NCT01567527|365035464|FG001|IM Depot Stabilization.|Adverse Event|0|||
105830415|NCT01567527|365035465|FG002|IM Depot Stabilization.|Adverse Event|37|||
105830416|NCT01567527|365035466|FG003|IM Depot Stabilization.|Adverse Event|0|||
105830417|NCT01567527|365035467|FG004|IM Depot Stabilization.|Adverse Event|0|||
105830418|NCT01567527|365035463|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
105830419|NCT01567527|365035464|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
105830420|NCT01567527|365035465|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
105830421|NCT01567527|365035466|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
105830422|NCT01567527|365035467|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
105830423|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
105830424|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
105830425|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
105830426|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
105830427|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
105830428|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
105830429|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
105830430|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
105830431|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
105830432|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
105830433|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
105830434|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
105830435|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
105830436|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
105830437|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
105830438|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
105830439|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
105830440|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
105830441|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
105830442|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
105830443|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105830444|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105830445|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
105830446|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
105830447|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
105830448|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
105830449|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
105830450|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
106148782|NCT00232180|366206875|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
106148783|NCT00232180|366206873|FG000|Double-blind (DB) Phase|Adverse Event|83|||
106148784|NCT00232180|366206874|FG001|Double-blind (DB) Phase|Adverse Event|100|||
105830451|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
105830452|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
105830453|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
106022609|NCT01175083|365748594|FG001|Primary Epoch|Lost to Follow-up|0|||
105830454|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
105830455|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
105830456|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
105830457|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
105830458|NCT01567527|365035463|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105830459|NCT01567527|365035464|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105830460|NCT01567527|365035465|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
105830461|NCT01567527|365035466|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
105830462|NCT01567527|365035467|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
105830463|NCT01958476|365035470|FG000|Overall Study|Parent requested exclusion from analysis|1|||
105830464|NCT01958476|365035471|FG001|Overall Study|Parent requested exclusion from analysis|0|||
105830465|NCT02004691|365035472|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
105830466|NCT02004691|365035473|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
105830467|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
105830468|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
105830469|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
105830470|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
105830471|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
105830472|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
105830473|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
105830474|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
105830475|NCT02004691|365035472|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
105830476|NCT02004691|365035473|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
105830477|NCT00884390|365035475|FG000|Overall Study|Adverse Event|0|||
105830478|NCT00884390|365035476|FG001|Overall Study|Adverse Event|1|||
105830479|NCT00884390|365035475|FG000|Overall Study|Lost to Follow-up|0|||
105830480|NCT00884390|365035476|FG001|Overall Study|Lost to Follow-up|1|||
105830481|NCT00884390|365035475|FG000|Overall Study|Physician Decision|2|||
105830482|NCT00884390|365035476|FG001|Overall Study|Physician Decision|1|||
105830483|NCT00884390|365035475|FG000|Overall Study|Protocol Violation|4|||
105830484|NCT00884390|365035476|FG001|Overall Study|Protocol Violation|1|||
105830485|NCT00884390|365035475|FG000|Overall Study|Withdrawal by Subject|4|||
105830486|NCT00884390|365035476|FG001|Overall Study|Withdrawal by Subject|1|||
105830487|NCT00884390|365035475|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
105830488|NCT00884390|365035476|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
105830489|NCT00884390|365035475|FG000|Overall Study|Other|11|||
105830490|NCT00884390|365035476|FG001|Overall Study|Other|1|||
105830491|NCT00751023|365035479|FG000|Overall Study|Lost to Follow-up|11|||
105830492|NCT00751023|365035480|FG001|Overall Study|Lost to Follow-up|7|||
105830493|NCT02623218|365035481|FG000|Overall Study|Lost to Follow-up|0|||
105830494|NCT02623218|365035482|FG001|Overall Study|Lost to Follow-up|1|||
105830495|NCT02623218|365035483|FG002|Overall Study|Lost to Follow-up|0|||
105830496|NCT02623218|365035484|FG003|Overall Study|Lost to Follow-up|0|||
105830497|NCT02623218|365035485|FG004|Overall Study|Lost to Follow-up|0|||
105830498|NCT00702507|365035486|FG000|Initial Treatment Phase|Adverse Event|2|||
105830499|NCT00702507|365035486|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
105830500|NCT00702507|365035486|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
105963686|NCT01732510|365525319|FG002|Overall Study|Withdrawal by Subject|2|||
105963687|NCT01732510|365525320|FG003|Overall Study|Withdrawal by Subject|1|||
105963688|NCT01732510|365525321|FG004|Overall Study|Withdrawal by Subject|5|||
105830501|NCT00702507|365035486|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
105830502|NCT00702507|365035486|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
105830503|NCT00702507|365035486|FG000|Follow-up Phase|Protocol Violation|2|||
105830504|NCT00702507|365035486|FG000|Follow-up Phase|Lost to Follow-up|23|||
105830505|NCT00702507|365035486|FG000|Follow-up Phase|Late Enrollment|1|||
105830506|NCT05412121|365035493|FG000|Overall Study|Withdrawal by Subject|4|||
105830507|NCT05412121|365035493|FG000|Overall Study|Physician Decision|1|||
105830508|NCT05412121|365035493|FG000|Overall Study|Lost to Follow-up|5|||
105830509|NCT02670551|365035497|FG000|Overall Study|Adverse Event|4|||
105830510|NCT02670551|365035498|FG001|Overall Study|Adverse Event|7|||
105830511|NCT02670551|365035499|FG002|Overall Study|Adverse Event|9|||
105830512|NCT02670551|365035497|FG000|Overall Study|Lack of Efficacy|2|||
105830513|NCT02670551|365035498|FG001|Overall Study|Lack of Efficacy|0|||
105830514|NCT02670551|365035499|FG002|Overall Study|Lack of Efficacy|3|||
105830515|NCT02670551|365035497|FG000|Overall Study|Withdrawal of Consent|6|||
105830516|NCT02670551|365035498|FG001|Overall Study|Withdrawal of Consent|3|||
105830517|NCT02670551|365035499|FG002|Overall Study|Withdrawal of Consent|8|||
105830518|NCT02670551|365035497|FG000|Overall Study|Lost to Follow-up|5|||
105830519|NCT02670551|365035498|FG001|Overall Study|Lost to Follow-up|7|||
105830520|NCT02670551|365035499|FG002|Overall Study|Lost to Follow-up|6|||
105830521|NCT02670551|365035497|FG000|Overall Study|Protocol Violation|1|||
105830522|NCT02670551|365035498|FG001|Overall Study|Protocol Violation|0|||
105830523|NCT02670551|365035499|FG002|Overall Study|Protocol Violation|0|||
105830524|NCT02670551|365035497|FG000|Overall Study|Noncompliance with study drug|3|||
105830525|NCT02670551|365035498|FG001|Overall Study|Noncompliance with study drug|3|||
105830526|NCT02670551|365035499|FG002|Overall Study|Noncompliance with study drug|2|||
105830527|NCT02670551|365035497|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105830528|NCT02670551|365035498|FG001|Overall Study|Other Miscellaneous Reasons|3|||
105830529|NCT02670551|365035499|FG002|Overall Study|Other Miscellaneous Reasons|3|||
105830530|NCT02670551|365035497|FG000|Overall Study|Did Not Receive Treatment|5|||
105830531|NCT02670551|365035498|FG001|Overall Study|Did Not Receive Treatment|3|||
105830532|NCT02670551|365035499|FG002|Overall Study|Did Not Receive Treatment|0|||
105830533|NCT01971645|365035502|FG000|Overall Study|Adverse Event|1|||
105830534|NCT01971645|365035503|FG001|Overall Study|Adverse Event|0|||
105830535|NCT01971645|365035504|FG002|Overall Study|Adverse Event|0|||
105830536|NCT01971645|365035502|FG000|Overall Study|Lost to Follow-up|1|||
105830537|NCT01971645|365035503|FG001|Overall Study|Lost to Follow-up|0|||
105830538|NCT01971645|365035504|FG002|Overall Study|Lost to Follow-up|1|||
105830539|NCT01971645|365035502|FG000|Overall Study|Protocol Violation|0|||
105830540|NCT01971645|365035503|FG001|Overall Study|Protocol Violation|0|||
105830541|NCT01971645|365035504|FG002|Overall Study|Protocol Violation|1|||
105830542|NCT01962298|365035505|FG000|Overall Study|Protocol Violation|1|||
105830543|NCT01962298|365035506|FG001|Overall Study|Protocol Violation|0|||
105830544|NCT01962298|365035507|FG002|Overall Study|Protocol Violation|1|||
105830545|NCT01962298|365035508|FG003|Overall Study|Protocol Violation|1|||
105830546|NCT01962298|365035509|FG004|Overall Study|Protocol Violation|0|||
105830547|NCT01962298|365035505|FG000|Overall Study|Data quality insufficient|2|||
105830548|NCT01962298|365035506|FG001|Overall Study|Data quality insufficient|0|||
105830549|NCT01962298|365035507|FG002|Overall Study|Data quality insufficient|3|||
105830550|NCT01962298|365035508|FG003|Overall Study|Data quality insufficient|1|||
105830551|NCT01962298|365035509|FG004|Overall Study|Data quality insufficient|4|||
105830552|NCT01962298|365035505|FG000|Overall Study|Insufficient data|0|||
105830553|NCT01962298|365035506|FG001|Overall Study|Insufficient data|2|||
105830554|NCT01962298|365035507|FG002|Overall Study|Insufficient data|1|||
105830555|NCT01962298|365035508|FG003|Overall Study|Insufficient data|0|||
105830556|NCT01962298|365035509|FG004|Overall Study|Insufficient data|1|||
105830557|NCT01962298|365035505|FG000|Overall Study|Incorrect data recorded|0|||
105830558|NCT01962298|365035506|FG001|Overall Study|Incorrect data recorded|1|||
105830559|NCT01962298|365035507|FG002|Overall Study|Incorrect data recorded|0|||
105830560|NCT01962298|365035508|FG003|Overall Study|Incorrect data recorded|0|||
105830561|NCT01962298|365035509|FG004|Overall Study|Incorrect data recorded|0|||
105830562|NCT01962298|365035505|FG000|Overall Study|Physician Decision|0|||
105830563|NCT01962298|365035506|FG001|Overall Study|Physician Decision|1|||
105830564|NCT01962298|365035507|FG002|Overall Study|Physician Decision|0|||
105830565|NCT01962298|365035508|FG003|Overall Study|Physician Decision|0|||
105830566|NCT01962298|365035509|FG004|Overall Study|Physician Decision|1|||
105830567|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
105830568|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
105830569|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
105830570|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
105830571|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Death|3|||
105830572|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Death|1|||
105830573|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
105830574|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
105830575|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
105830576|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
105830577|NCT00537095|365035510|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
105963689|NCT01732510|365525322|FG005|Overall Study|Withdrawal by Subject|0|||
105963690|NCT01732510|365525323|FG006|Overall Study|Withdrawal by Subject|1|||
105963691|NCT01732510|365525317|FG000|Overall Study|Lost to Follow-up|0|||
105963692|NCT01732510|365525318|FG001|Overall Study|Lost to Follow-up|0|||
105963693|NCT01732510|365525319|FG002|Overall Study|Lost to Follow-up|1|||
105963694|NCT01732510|365525320|FG003|Overall Study|Lost to Follow-up|1|||
105963695|NCT01732510|365525321|FG004|Overall Study|Lost to Follow-up|0|||
105963696|NCT01732510|365525322|FG005|Overall Study|Lost to Follow-up|1|||
106148785|NCT00232180|366206875|FG002|Double-blind (DB) Phase|Adverse Event|0|||
106148786|NCT00232180|366206873|FG000|Double-blind (DB) Phase|Other|70|||
105830578|NCT00537095|365035511|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
105830579|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Adverse Event|2|||
105830580|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Adverse Event|11|||
105830581|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
105830582|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
105830583|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Death|2|||
105830584|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Death|2|||
105830585|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
105963697|NCT01732510|365525323|FG006|Overall Study|Lost to Follow-up|0|||
105830586|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
105830587|NCT00537095|365035510|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
105830588|NCT00537095|365035511|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
105830589|NCT03727139|365035512|FG000|Overall Study|Protocol Violation|60|||
105830590|NCT00566722|365035513|FG000|Overall Study|Adverse Event|0|||
105830591|NCT00566722|365035514|FG001|Overall Study|Adverse Event|1|||
105830592|NCT00566722|365035515|FG002|Overall Study|Adverse Event|0|||
105830593|NCT00566722|365035513|FG000|Overall Study|Withdrawal by Subject|0|||
105830594|NCT00566722|365035514|FG001|Overall Study|Withdrawal by Subject|0|||
105830595|NCT00566722|365035515|FG002|Overall Study|Withdrawal by Subject|1|||
105830596|NCT00566722|365035513|FG000|Overall Study|Lost to Follow-up|1|||
105830597|NCT00566722|365035514|FG001|Overall Study|Lost to Follow-up|1|||
105830598|NCT00566722|365035515|FG002|Overall Study|Lost to Follow-up|1|||
105830599|NCT00566722|365035513|FG000|Overall Study|Lack of Efficacy|1|||
105830600|NCT00566722|365035514|FG001|Overall Study|Lack of Efficacy|2|||
105830601|NCT00566722|365035515|FG002|Overall Study|Lack of Efficacy|4|||
105830602|NCT00566722|365035513|FG000|Overall Study|Did not meet exclusion criteria|0|||
105830603|NCT00566722|365035514|FG001|Overall Study|Did not meet exclusion criteria|0|||
105830604|NCT00566722|365035515|FG002|Overall Study|Did not meet exclusion criteria|2|||
105830605|NCT00566722|365035513|FG000|Overall Study|Serious adverse event|0|||
105830606|NCT00566722|365035514|FG001|Overall Study|Serious adverse event|1|||
105830607|NCT00566722|365035515|FG002|Overall Study|Serious adverse event|0|||
105830608|NCT00566722|365035513|FG000|Overall Study|Noncompliant with drug administration|0|||
105830609|NCT00566722|365035514|FG001|Overall Study|Noncompliant with drug administration|0|||
105830610|NCT00566722|365035515|FG002|Overall Study|Noncompliant with drug administration|1|||
105830611|NCT03105297|365035516|FG000|Baseline Phase (Day 1)|Other|21|||
105830612|NCT03105297|365035516|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
105830613|NCT03105297|365035516|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
105830614|NCT05065619|365035517|FG000|Up to Day 42|Lost to Follow-up|1|||
105830615|NCT05065619|365035518|FG001|Up to Day 42|Lost to Follow-up|0|||
105830616|NCT05065619|365035517|FG000|Up to Day 42|Withdrawal by Subject|1|||
105830617|NCT05065619|365035518|FG001|Up to Day 42|Withdrawal by Subject|0|||
105830618|NCT05065619|365035517|FG000|After Day 43|Lost to Follow-up|1|||
105830619|NCT05065619|365035518|FG001|After Day 43|Lost to Follow-up|0|||
105830620|NCT05065619|365035517|FG000|After Day 43|Physician Decision|3|||
105830621|NCT05065619|365035518|FG001|After Day 43|Physician Decision|0|||
105830622|NCT05065619|365035517|FG000|After Day 43|Withdrawal by Subject|1|||
105830623|NCT05065619|365035518|FG001|After Day 43|Withdrawal by Subject|2|||
105830624|NCT05065619|365035517|FG000|After Day 43|Public vaccination|6|||
105830625|NCT05065619|365035518|FG001|After Day 43|Public vaccination|8|||
105830626|NCT05065619|365035517|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
105830627|NCT05065619|365035518|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
105830628|NCT05065619|365035517|FG000|After Day 43|Study Terminated by Sponsor|88|||
105830629|NCT05065619|365035518|FG001|After Day 43|Study Terminated by Sponsor|16|||
105830630|NCT00835081|365035522|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
105830631|NCT00835081|365035523|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
105830632|NCT00421304|365035524|FG000|Overall Study|Lost to Follow-up|5|||
105830633|NCT00421304|365035525|FG001|Overall Study|Lost to Follow-up|2|||
105830634|NCT00421304|365035526|FG002|Overall Study|Lost to Follow-up|5|||
105830635|NCT00421304|365035524|FG000|Overall Study|Withdrawal by Subject|2|||
105830636|NCT00421304|365035525|FG001|Overall Study|Withdrawal by Subject|2|||
105830637|NCT00421304|365035526|FG002|Overall Study|Withdrawal by Subject|2|||
105830638|NCT00421304|365035524|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
105830639|NCT00421304|365035525|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
105830640|NCT00421304|365035526|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
105830641|NCT00421304|365035524|FG000|Overall Study|Did not attend Day 360 visit|0|||
105830642|NCT00421304|365035525|FG001|Overall Study|Did not attend Day 360 visit|0|||
105830643|NCT00421304|365035526|FG002|Overall Study|Did not attend Day 360 visit|1|||
105830644|NCT01968031|365035529|FG000|Overall Study|Adverse Event|13|||
105830645|NCT01968031|365035530|FG001|Overall Study|Adverse Event|10|||
105830646|NCT01968031|365035531|FG002|Overall Study|Adverse Event|22|||
105830647|NCT01968031|365035529|FG000|Overall Study|Withdrawal by Subject|3|||
105830648|NCT01968031|365035530|FG001|Overall Study|Withdrawal by Subject|7|||
105830649|NCT01968031|365035531|FG002|Overall Study|Withdrawal by Subject|3|||
105830650|NCT01968031|365035529|FG000|Overall Study|Did not meet entry criteria|1|||
105830651|NCT01968031|365035530|FG001|Overall Study|Did not meet entry criteria|1|||
105830652|NCT01968031|365035531|FG002|Overall Study|Did not meet entry criteria|1|||
105830653|NCT01968031|365035529|FG000|Overall Study|Noncompliance|0|||
105830654|NCT01968031|365035530|FG001|Overall Study|Noncompliance|0|||
105963698|NCT01732510|365525317|FG000|Overall Study|Physician Decision|0|||
105963699|NCT01732510|365525318|FG001|Overall Study|Physician Decision|1|||
105830655|NCT01968031|365035531|FG002|Overall Study|Noncompliance|2|||
105830656|NCT01968031|365035529|FG000|Overall Study|Failed inclusion criteria|0|||
105830657|NCT01968031|365035530|FG001|Overall Study|Failed inclusion criteria|2|||
105830658|NCT01968031|365035531|FG002|Overall Study|Failed inclusion criteria|0|||
105830659|NCT01968031|365035529|FG000|Overall Study|Death|0|||
105830660|NCT01968031|365035530|FG001|Overall Study|Death|0|||
105830661|NCT01968031|365035531|FG002|Overall Study|Death|1|||
105830662|NCT01968031|365035529|FG000|Overall Study|Prohibited concomitant medication|1|||
105830663|NCT01968031|365035530|FG001|Overall Study|Prohibited concomitant medication|0|||
105830664|NCT01968031|365035531|FG002|Overall Study|Prohibited concomitant medication|0|||
105830665|NCT00685334|365035537|FG000|Overall Study|Withdrawal by Subject|5|||
105830666|NCT00685334|365035538|FG001|Overall Study|Withdrawal by Subject|6|||
105830667|NCT00685334|365035537|FG000|Overall Study|Lost to Follow-up|4|||
105830668|NCT00685334|365035538|FG001|Overall Study|Lost to Follow-up|0|||
105830669|NCT00685334|365035537|FG000|Overall Study|Chose to enter hospital|1|||
105830670|NCT00685334|365035538|FG001|Overall Study|Chose to enter hospital|1|||
105830671|NCT01891357|365035539|FG000|Overall Study|Protocol Violation|3|||
105830672|NCT00874276|365035540|FG000|Overall Study|Withdrawal by Subject|1|||
105830673|NCT00874276|365035541|FG001|Overall Study|Withdrawal by Subject|1|||
105830674|NCT01520987|365037091|FG000|Overall Study|Withdrawal by Subject|1|||
105830675|NCT01520987|365037092|FG001|Overall Study|Withdrawal by Subject|0|||
105830676|NCT01520987|365037093|FG002|Overall Study|Withdrawal by Subject|0|||
105830677|NCT01520987|365037094|FG003|Overall Study|Withdrawal by Subject|0|||
105830678|NCT01520987|365037095|FG004|Overall Study|Withdrawal by Subject|0|||
105830679|NCT01520987|365037096|FG005|Overall Study|Withdrawal by Subject|1|||
105830680|NCT01520987|365037097|FG006|Overall Study|Withdrawal by Subject|0|||
105830681|NCT01520987|365037098|FG007|Overall Study|Withdrawal by Subject|0|||
105830682|NCT01691430|365037099|FG000|Overall Study|Death|17|||
106022610|NCT01175083|365748595|FG002|Primary Epoch|Lost to Follow-up|0|||
105830683|NCT01691430|365037100|FG001|Overall Study|Death|16|||
105830684|NCT01691430|365037099|FG000|Overall Study|Withdrawal by Subject|5|||
105830685|NCT01691430|365037100|FG001|Overall Study|Withdrawal by Subject|1|||
105830686|NCT01691430|365037099|FG000|Overall Study|Lost to Follow-up|0|||
105830687|NCT01691430|365037100|FG001|Overall Study|Lost to Follow-up|3|||
105830688|NCT01109849|365037103|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
105830689|NCT01109849|365037104|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
105830690|NCT01109849|365037105|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
105830691|NCT01109849|365037106|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
105830692|NCT01109849|365037107|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
105830693|NCT01109849|365037103|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
105830694|NCT01109849|365037104|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
105830695|NCT01109849|365037105|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
105830696|NCT01109849|365037106|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
105830697|NCT01109849|365037107|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
105830698|NCT01109849|365037103|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
105830699|NCT01109849|365037104|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
105830700|NCT01109849|365037105|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
105830701|NCT01109849|365037106|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
105830702|NCT01109849|365037107|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
105830703|NCT01109849|365037103|FG000|Initial Randomization: ADHD Treatment|move away|2|||
105830704|NCT01109849|365037104|FG001|Initial Randomization: ADHD Treatment|move away|7|||
105830705|NCT01109849|365037105|FG002|Initial Randomization: ADHD Treatment|move away|0|||
105830706|NCT01109849|365037106|FG003|Initial Randomization: ADHD Treatment|move away|0|||
105830707|NCT01109849|365037107|FG004|Initial Randomization: ADHD Treatment|move away|0|||
105830708|NCT01109849|365037103|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
105830709|NCT01109849|365037104|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
105830710|NCT01109849|365037105|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
105830711|NCT01109849|365037106|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
105830712|NCT01109849|365037107|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
105830713|NCT01109849|365037103|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
105830714|NCT01109849|365037104|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
105830715|NCT01109849|365037105|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
105830716|NCT01109849|365037106|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
105830717|NCT01109849|365037107|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
105830718|NCT05776901|365037108|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
105830719|NCT03119662|365037116|FG000|Overall Study|Withdrawal by Subject|0|||
105830720|NCT03119662|365037117|FG001|Overall Study|Withdrawal by Subject|1|||
105830721|NCT01630616|365037124|FG000|Overall Study|Adverse Event|0|||
105830722|NCT01630616|365037125|FG001|Overall Study|Adverse Event|0|||
106022611|NCT01175083|365748596|FG003|Primary Epoch|Lost to Follow-up|0|||
106022612|NCT01175083|365748597|FG004|Primary Epoch|Lost to Follow-up|0|||
105830723|NCT01630616|365037126|FG002|Overall Study|Adverse Event|0|||
105830724|NCT01630616|365037127|FG003|Overall Study|Adverse Event|1|||
105830725|NCT01630616|365037128|FG004|Overall Study|Adverse Event|0|||
105830726|NCT01630616|365037129|FG005|Overall Study|Adverse Event|0|||
105963700|NCT01732510|365525319|FG002|Overall Study|Physician Decision|0|||
105963701|NCT01732510|365525320|FG003|Overall Study|Physician Decision|0|||
105963702|NCT01732510|365525321|FG004|Overall Study|Physician Decision|0|||
105963703|NCT01732510|365525322|FG005|Overall Study|Physician Decision|0|||
105963704|NCT01732510|365525323|FG006|Overall Study|Physician Decision|0|||
105963705|NCT01732510|365525317|FG000|Overall Study|Pregnancy|0|||
105963706|NCT01732510|365525318|FG001|Overall Study|Pregnancy|0|||
105963707|NCT01732510|365525319|FG002|Overall Study|Pregnancy|0|||
105963708|NCT01732510|365525320|FG003|Overall Study|Pregnancy|1|||
105963709|NCT01732510|365525321|FG004|Overall Study|Pregnancy|0|||
105963710|NCT01732510|365525322|FG005|Overall Study|Pregnancy|0|||
105963711|NCT01732510|365525323|FG006|Overall Study|Pregnancy|0|||
105963712|NCT01732510|365525317|FG000|Overall Study|Study Terminated By Sponsor|0|||
105963713|NCT01732510|365525318|FG001|Overall Study|Study Terminated By Sponsor|0|||
105963714|NCT01732510|365525319|FG002|Overall Study|Study Terminated By Sponsor|0|||
105963715|NCT01732510|365525320|FG003|Overall Study|Study Terminated By Sponsor|1|||
105963716|NCT01732510|365525321|FG004|Overall Study|Study Terminated By Sponsor|0|||
105963717|NCT01732510|365525322|FG005|Overall Study|Study Terminated By Sponsor|12|||
105963718|NCT01732510|365525323|FG006|Overall Study|Study Terminated By Sponsor|6|||
105963719|NCT01208961|365525324|FG000|High-Fat Period III|Protocol Violation|1|||
105963720|NCT01208961|365525325|FG001|High-Fat Period III|Protocol Violation|0|||
105963721|NCT01939977|365525326|FG000|Overall Study|Adverse Event|4|||
105963722|NCT01939977|365525327|FG001|Overall Study|Adverse Event|3|||
105963723|NCT01939977|365525326|FG000|Overall Study|Lack of Efficacy|3|||
105963724|NCT01939977|365525327|FG001|Overall Study|Lack of Efficacy|0|||
105963725|NCT01939977|365525326|FG000|Overall Study|Physician Decision|1|||
105963726|NCT01939977|365525327|FG001|Overall Study|Physician Decision|1|||
105963727|NCT01939977|365525326|FG000|Overall Study|Withdrawal by Subject|0|||
105963728|NCT01939977|365525327|FG001|Overall Study|Withdrawal by Subject|2|||
105963729|NCT01939977|365525326|FG000|Overall Study|Did not meet inclusion criteria|1|||
105963730|NCT01939977|365525327|FG001|Overall Study|Did not meet inclusion criteria|0|||
105963731|NCT01939977|365525326|FG000|Overall Study|Did not receive study medication|0|||
105963732|NCT01939977|365525327|FG001|Overall Study|Did not receive study medication|1|||
105963733|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
105963734|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
105963735|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
105963736|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
105963737|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
105963738|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
105963739|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
105963740|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
105963741|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
105963742|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
105963743|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
105963744|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
105963745|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
105963746|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
105963747|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
105963748|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
105830727|NCT01630616|365037124|FG000|Overall Study|Withdrawal by Subject|0|||
105830728|NCT01630616|365037125|FG001|Overall Study|Withdrawal by Subject|0|||
105830729|NCT01630616|365037126|FG002|Overall Study|Withdrawal by Subject|0|||
105830730|NCT01630616|365037127|FG003|Overall Study|Withdrawal by Subject|2|||
105830731|NCT01630616|365037128|FG004|Overall Study|Withdrawal by Subject|0|||
105830732|NCT01630616|365037129|FG005|Overall Study|Withdrawal by Subject|0|||
105830733|NCT00856349|365037131|FG000|Overall Study|Death|418|||
105830734|NCT00856349|365037131|FG000|Overall Study|Withdrawal by Subject|116|||
105830735|NCT00856349|365037131|FG000|Overall Study|Lost to Follow-up|91|||
105830736|NCT00856349|365037131|FG000|Overall Study|Protocol Violation|38|||
105830737|NCT00856349|365037131|FG000|Overall Study|Physician Decision|13|||
105830738|NCT00856349|365037131|FG000|Overall Study|Subject relocation|104|||
105830739|NCT00856349|365037131|FG000|Overall Study|Device explant|33|||
105830740|NCT00856349|365037131|FG000|Overall Study|Site closure|78|||
105963749|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
105963750|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
105963751|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
106148787|NCT00232180|366206874|FG001|Double-blind (DB) Phase|Other|75|||
105963752|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
105963753|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
105963754|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
106148788|NCT00232180|366206875|FG002|Double-blind (DB) Phase|Other|0|||
106148789|NCT00232180|366206873|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
106148790|NCT00232180|366206874|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
105830741|NCT00856349|365037131|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
105830742|NCT02725515|365037132|FG000|Overall Study|Refused infusion (no study treatment)|1|||
105830743|NCT02725515|365037133|FG001|Overall Study|Refused infusion (no study treatment)|0|||
105830744|NCT02725515|365037132|FG000|Overall Study|Loss of Improvement per Protocol|14|||
105830745|NCT02725515|365037133|FG001|Overall Study|Loss of Improvement per Protocol|25|||
105830746|NCT02725515|365037132|FG000|Overall Study|Withdrawal by Subject|2|||
105830747|NCT02725515|365037133|FG001|Overall Study|Withdrawal by Subject|1|||
105830748|NCT02725515|365037132|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105830749|NCT02725515|365037133|FG001|Overall Study|Non-Compliance With Study Drug|3|||
105830750|NCT02725515|365037132|FG000|Overall Study|Lost to Follow-up|1|||
105830751|NCT02725515|365037133|FG001|Overall Study|Lost to Follow-up|1|||
105830752|NCT02725515|365037132|FG000|Overall Study|Adverse Event|7|||
105830753|NCT02725515|365037133|FG001|Overall Study|Adverse Event|2|||
105830754|NCT02725515|365037132|FG000|Overall Study|No Documented Disease Improvement|0|||
105830755|NCT02725515|365037133|FG001|Overall Study|No Documented Disease Improvement|1|||
105830756|NCT02725515|365037132|FG000|Overall Study|Completed Study Under Original Protocol|0|||
105830757|NCT02725515|365037133|FG001|Overall Study|Completed Study Under Original Protocol|1|||
105830758|NCT02725515|365037132|FG000|Overall Study|Lack of Response|0|||
105830759|NCT02725515|365037133|FG001|Overall Study|Lack of Response|1|||
105830760|NCT02313558|365037135|FG000|Overall Study|Withdrawal by Subject|2|||
105830761|NCT02313558|365037136|FG001|Overall Study|Withdrawal by Subject|0|||
105830762|NCT02313558|365037135|FG000|Overall Study|Lost to Follow-up|4|||
105830763|NCT02313558|365037136|FG001|Overall Study|Lost to Follow-up|4|||
105830764|NCT00874549|365037137|FG000|Overall Study|Adverse Event|0|||
105830765|NCT00874549|365037138|FG001|Overall Study|Adverse Event|0|||
105830766|NCT00874549|365037139|FG002|Overall Study|Adverse Event|1|||
105830767|NCT00874549|365037140|FG003|Overall Study|Adverse Event|0|||
105830768|NCT00874549|365037137|FG000|Overall Study|Protocol Violation|1|||
105830769|NCT00874549|365037138|FG001|Overall Study|Protocol Violation|0|||
105830770|NCT00874549|365037139|FG002|Overall Study|Protocol Violation|2|||
105830771|NCT00874549|365037140|FG003|Overall Study|Protocol Violation|1|||
105830772|NCT00874549|365037137|FG000|Overall Study|Lost to Follow-up|0|||
105830773|NCT00874549|365037138|FG001|Overall Study|Lost to Follow-up|0|||
105830774|NCT00874549|365037139|FG002|Overall Study|Lost to Follow-up|1|||
105830775|NCT00874549|365037140|FG003|Overall Study|Lost to Follow-up|0|||
105830776|NCT00874549|365037137|FG000|Overall Study|Withdrawal by Subject|0|||
105830777|NCT00874549|365037138|FG001|Overall Study|Withdrawal by Subject|1|||
105830778|NCT00874549|365037139|FG002|Overall Study|Withdrawal by Subject|0|||
105830779|NCT00874549|365037140|FG003|Overall Study|Withdrawal by Subject|1|||
105830780|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
105830781|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
105830782|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
105830783|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
105830784|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
105830785|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
105830786|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
105830787|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
105830788|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
105830789|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
105830790|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
105830791|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
105830792|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
105963755|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
105963756|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
105963757|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
105963758|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
105963759|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
105963760|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
105963761|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
105963762|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
105963763|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
105963764|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
105963765|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
105963766|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
105963767|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
105963768|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
105963769|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
105963770|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
105963771|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
105963772|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
105830793|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
105830794|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
105830795|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
105830796|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
105830797|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
105830798|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
105830799|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
105830800|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
105830801|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
105830802|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
105830803|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
105830804|NCT01710358|365037143|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
105830805|NCT01710358|365037144|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
105830806|NCT01710358|365037145|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
105830807|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
105830808|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
105830809|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
105830810|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
105830811|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
105963773|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
105963774|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
105963775|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
105963776|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
105963777|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
105963778|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
105963779|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
105963780|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
105963781|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
105963782|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
105963783|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
105963784|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
105963785|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
105963786|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
105963787|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
105963788|NCT04951622|365525332|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
105963789|NCT04951622|365525333|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
105963790|NCT04951622|365525334|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
105963791|NCT04951622|365525335|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
105963792|NCT04951622|365525336|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
105963793|NCT04951622|365525332|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
105963794|NCT04951622|365525333|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
105963795|NCT04951622|365525334|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
105963796|NCT04951622|365525335|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
105963797|NCT04951622|365525336|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
105963798|NCT04951622|365525332|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
105963799|NCT04951622|365525333|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
105963800|NCT04951622|365525334|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
105963801|NCT04951622|365525335|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
105963802|NCT04951622|365525336|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
105963803|NCT04951622|365525332|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
105963804|NCT04951622|365525333|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
105963805|NCT04951622|365525334|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
105963806|NCT04951622|365525335|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
105963807|NCT04951622|365525336|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
105963808|NCT04951622|365525332|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
105963809|NCT04951622|365525333|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
105963810|NCT04951622|365525334|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
105963811|NCT04951622|365525335|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
105963812|NCT04951622|365525336|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
105963813|NCT04951622|365525332|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
105963814|NCT04951622|365525333|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
105963815|NCT04951622|365525334|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
105963816|NCT04951622|365525335|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
106148791|NCT00232180|366206875|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
106148792|NCT00232180|366206873|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
105830812|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
105830813|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
105830814|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
105830815|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
105830816|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
105830817|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
105830818|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
105830819|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
105830820|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
105830821|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
105830822|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
105830823|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
105830824|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
105830825|NCT01710358|365037143|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
105830826|NCT01710358|365037144|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
105830827|NCT01710358|365037145|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
105830828|NCT01710358|365037143|FG000|Rescue Period|Adverse Event|0|||
105830829|NCT01710358|365037144|FG001|Rescue Period|Adverse Event|15|||
105830830|NCT01710358|365037145|FG002|Rescue Period|Adverse Event|0|||
105830831|NCT01710358|365037143|FG000|Rescue Period|Death|0|||
105830832|NCT01710358|365037144|FG001|Rescue Period|Death|1|||
105830833|NCT01710358|365037145|FG002|Rescue Period|Death|0|||
105830834|NCT01710358|365037143|FG000|Rescue Period|Lack of Efficacy|0|||
105830835|NCT01710358|365037144|FG001|Rescue Period|Lack of Efficacy|7|||
105830836|NCT01710358|365037145|FG002|Rescue Period|Lack of Efficacy|0|||
105830837|NCT01710358|365037143|FG000|Rescue Period|Withdrawal by Subject|0|||
105830838|NCT01710358|365037144|FG001|Rescue Period|Withdrawal by Subject|8|||
105830839|NCT01710358|365037145|FG002|Rescue Period|Withdrawal by Subject|0|||
105830840|NCT02906917|365037151|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
105830841|NCT02906917|365037152|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
105830842|NCT02906917|365037151|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
105830843|NCT02906917|365037152|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
105830844|NCT02906917|365037151|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
105830845|NCT02906917|365037152|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
105830846|NCT02906917|365037151|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
105830847|NCT02906917|365037152|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
105830848|NCT02906917|365037151|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
105830849|NCT02906917|365037152|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
105830850|NCT02906917|365037151|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
105830851|NCT02906917|365037152|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
105830852|NCT02906917|365037151|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
105830853|NCT02906917|365037152|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
105830854|NCT02906917|365037151|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
105830855|NCT02906917|365037152|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
105830856|NCT00210639|365037153|FG000|Overall Study|Lost to Follow-up|37|||
105830857|NCT00210639|365037154|FG001|Overall Study|Lost to Follow-up|29|||
105830858|NCT00210639|365037153|FG000|Overall Study|Withdrawal by Subject|8|||
105830859|NCT00210639|365037154|FG001|Overall Study|Withdrawal by Subject|1|||
105830860|NCT00210639|365037153|FG000|Overall Study|Other|18|||
105830861|NCT00210639|365037154|FG001|Overall Study|Other|12|||
105830862|NCT03707587|365037157|FG000|Overall Study|Death|0|||
105830863|NCT03707587|365037158|FG001|Overall Study|Death|1|||
105830864|NCT02854800|365037159|FG000|Overall Study|Protocol Violation|16|||
105830865|NCT02854800|365037160|FG001|Overall Study|Protocol Violation|11|||
105830866|NCT02854800|365037161|FG002|Overall Study|Protocol Violation|3|||
105830867|NCT02854800|365037159|FG000|Overall Study|Withdrawal by Subject|4|||
105830868|NCT02854800|365037160|FG001|Overall Study|Withdrawal by Subject|2|||
105830869|NCT02854800|365037161|FG002|Overall Study|Withdrawal by Subject|3|||
106022613|NCT01175083|365748598|FG005|Primary Epoch|Lost to Follow-up|1|||
106022614|NCT01175083|365748593|FG000|Booster Epoch|Death|0|||
106022615|NCT01175083|365748594|FG001|Booster Epoch|Death|0|||
106022616|NCT01175083|365748595|FG002|Booster Epoch|Death|1|||
106022617|NCT01175083|365748596|FG003|Booster Epoch|Death|0|||
106022618|NCT01175083|365748597|FG004|Booster Epoch|Death|0|||
106022619|NCT01175083|365748598|FG005|Booster Epoch|Death|0|||
106022620|NCT01175083|365748593|FG000|Booster Epoch|Withdrawal by Subject|0|||
106022621|NCT01175083|365748594|FG001|Booster Epoch|Withdrawal by Subject|0|||
106022622|NCT01175083|365748595|FG002|Booster Epoch|Withdrawal by Subject|0|||
106022623|NCT01175083|365748596|FG003|Booster Epoch|Withdrawal by Subject|1|||
105830870|NCT04442503|365037162|FG000|Overall Study|Adverse Event|1|||
105830871|NCT04442503|365037163|FG001|Overall Study|Adverse Event|1|||
106022624|NCT01175083|365748597|FG004|Booster Epoch|Withdrawal by Subject|0|||
106022625|NCT01175083|365748598|FG005|Booster Epoch|Withdrawal by Subject|0|||
106022626|NCT01652469|365748599|FG000|Overall Study|Withdrawal by Subject|1|||
106022627|NCT01652469|365748600|FG001|Overall Study|Withdrawal by Subject|4|||
105830872|NCT04442503|365037162|FG000|Overall Study|Lost to Follow-up|8|||
105830873|NCT04442503|365037163|FG001|Overall Study|Lost to Follow-up|6|||
105830874|NCT04442503|365037162|FG000|Overall Study|Physician Decision|0|||
105830875|NCT04442503|365037163|FG001|Overall Study|Physician Decision|2|||
105830876|NCT04442503|365037162|FG000|Overall Study|Withdrawal by Subject|3|||
105830877|NCT04442503|365037163|FG001|Overall Study|Withdrawal by Subject|4|||
105830878|NCT04442503|365037162|FG000|Overall Study|Reason not Specified|0|||
105830879|NCT04442503|365037163|FG001|Overall Study|Reason not Specified|1|||
105830880|NCT04442503|365037162|FG000|Overall Study|Randomized but not Treated|3|||
105830881|NCT04442503|365037163|FG001|Overall Study|Randomized but not Treated|1|||
105830882|NCT00503867|365037166|FG000|Overall Study|Lost to Follow-up|1|||
105830883|NCT00503867|365037166|FG000|Overall Study|Adverse Event|1|||
105830884|NCT00323258|365037168|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
105830885|NCT00323258|365037169|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
105830886|NCT00323258|365037168|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
105830887|NCT00323258|365037169|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
105963817|NCT04951622|365525336|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
105963818|NCT04951622|365525332|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
106022628|NCT01652469|365748599|FG000|Overall Study|Lost to Follow-up|0|||
106022629|NCT01652469|365748600|FG001|Overall Study|Lost to Follow-up|2|||
106022630|NCT01386970|365748601|FG000|Overall Study|Withdrawal by Subject|0|||
106022631|NCT01386970|365748602|FG001|Overall Study|Withdrawal by Subject|1|||
106022632|NCT01386970|365748601|FG000|Overall Study|Adverse Event|4|||
106022633|NCT01386970|365748602|FG001|Overall Study|Adverse Event|1|||
106022634|NCT01731938|365748603|FG000|Preliminary Part I|Withdrawal by Subject|2|||
106022635|NCT01731938|365748604|FG001|Preliminary Part I|Withdrawal by Subject|2|||
106022636|NCT01731938|365748603|FG000|Preliminary Part I|Physician Decision|1|||
106022637|NCT01731938|365748604|FG001|Preliminary Part I|Physician Decision|0|||
106022638|NCT01731938|365748603|FG000|Preliminary Part I|Lost to Follow-up|0|||
106022639|NCT01731938|365748604|FG001|Preliminary Part I|Lost to Follow-up|3|||
106022640|NCT01731938|365748603|FG000|Preliminary Part I|Missed Week 6 visit|0|||
106022641|NCT01731938|365748604|FG001|Preliminary Part I|Missed Week 6 visit|3|||
106022642|NCT01731938|365748603|FG000|Primary Part II|Withdrawal by Subject|5|||
106022643|NCT01731938|365748604|FG001|Primary Part II|Withdrawal by Subject|4|||
106022644|NCT01731938|365748603|FG000|Primary Part II|Lost to Follow-up|4|||
106022645|NCT01731938|365748604|FG001|Primary Part II|Lost to Follow-up|5|||
106022646|NCT01731938|365748603|FG000|Primary Part II|Death|2|||
106022647|NCT01731938|365748604|FG001|Primary Part II|Death|1|||
106022648|NCT01731938|365748603|FG000|Primary Part II|Missed Week 6 visit|2|||
106022649|NCT01731938|365748604|FG001|Primary Part II|Missed Week 6 visit|3|||
106022650|NCT01049009|365748605|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
106022651|NCT01049009|365748606|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
106022652|NCT01049009|365748605|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106022653|NCT01049009|365748606|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
106022654|NCT01049009|365748605|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
106022655|NCT01049009|365748606|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
106022656|NCT01049009|365748605|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
106022657|NCT01049009|365748606|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
106022658|NCT02350478|365748607|FG000|Overall Study|Lost to Follow-up|5|||
106022659|NCT02350478|365748608|FG001|Overall Study|Lost to Follow-up|1|||
106022660|NCT00578292|365748621|FG000|Overall Study|Death|1|||
106022661|NCT00578292|365748621|FG000|Overall Study|Graft failure|2|||
106022662|NCT02888119|365748626|FG000|Overall Study|Lost to Follow-up|5|||
106022663|NCT02888119|365748627|FG001|Overall Study|Lost to Follow-up|4|||
106022664|NCT02888119|365748628|FG002|Overall Study|Lost to Follow-up|0|||
106022665|NCT04849559|365748632|FG000|Overall Study|Withdrawal by Subject|2|||
105963819|NCT04951622|365525333|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
105963820|NCT04951622|365525334|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
105963821|NCT04951622|365525335|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
105963822|NCT04951622|365525336|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
105963823|NCT04951622|365525332|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
105963824|NCT04951622|365525333|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
105830888|NCT00323258|365037168|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
105963825|NCT04951622|365525334|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
105963826|NCT04951622|365525335|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
106022666|NCT04849559|365748633|FG001|Overall Study|Withdrawal by Subject|1|||
106022667|NCT02105961|365748635|FG000|Overall Study|Adverse Event|18|||
106022668|NCT02105961|365748636|FG001|Overall Study|Adverse Event|7|||
106022669|NCT02105961|365748637|FG002|Overall Study|Adverse Event|13|||
106022670|NCT02105961|365748635|FG000|Overall Study|Lack of Efficacy|3|||
106022671|NCT02105961|365748636|FG001|Overall Study|Lack of Efficacy|0|||
106022672|NCT02105961|365748637|FG002|Overall Study|Lack of Efficacy|3|||
106022673|NCT02105961|365748635|FG000|Overall Study|Lost to Follow-up|2|||
106022674|NCT02105961|365748636|FG001|Overall Study|Lost to Follow-up|0|||
106022675|NCT02105961|365748637|FG002|Overall Study|Lost to Follow-up|1|||
105830889|NCT00323258|365037169|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
105830890|NCT00323258|365037168|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
105830891|NCT00323258|365037169|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
105830892|NCT00323258|365037168|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
105830893|NCT00323258|365037169|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
105830894|NCT00323258|365037168|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
105830895|NCT00323258|365037169|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
105830896|NCT00323258|365037168|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
105830897|NCT00323258|365037169|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
105830898|NCT05616728|365037173|FG000|Overall Study|Lost to Follow-up|0|||
105830899|NCT05616728|365037174|FG001|Overall Study|Lost to Follow-up|0|||
105830900|NCT05616728|365037175|FG002|Overall Study|Lost to Follow-up|1|||
105830901|NCT05616728|365037173|FG000|Overall Study|Withdrawal by Subject|1|||
105830902|NCT05616728|365037174|FG001|Overall Study|Withdrawal by Subject|1|||
105830903|NCT05616728|365037175|FG002|Overall Study|Withdrawal by Subject|0|||
105830904|NCT05616728|365037173|FG000|Overall Study|Physician Decision|1|||
105830905|NCT05616728|365037174|FG001|Overall Study|Physician Decision|1|||
105830906|NCT05616728|365037175|FG002|Overall Study|Physician Decision|1|||
105830907|NCT05616728|365037173|FG000|Overall Study|Other|0|||
105830908|NCT05616728|365037174|FG001|Overall Study|Other|2|||
105830909|NCT05616728|365037175|FG002|Overall Study|Other|0|||
105830910|NCT00577655|365037176|FG000|Overall Study|Patient Request|0|||
105830911|NCT00577655|365037177|FG001|Overall Study|Patient Request|2|||
105830912|NCT00577655|365037176|FG000|Overall Study|Protocol Violation|0|||
105830913|NCT00577655|365037177|FG001|Overall Study|Protocol Violation|1|||
105830914|NCT00577655|365037176|FG000|Overall Study|Lost to Follow-up|1|||
105830915|NCT00577655|365037177|FG001|Overall Study|Lost to Follow-up|1|||
105830916|NCT01055834|365037178|FG000|Treatment Period I|Adverse Event|1|||
105830917|NCT01055834|365037179|FG001|Treatment Period I|Adverse Event|0|||
105830918|NCT01370863|365037180|FG000|Overall Study|Adverse Event|1|||
105830919|NCT01370863|365037181|FG001|Overall Study|Adverse Event|1|||
105830920|NCT01370863|365037180|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
105830921|NCT01370863|365037181|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
105830922|NCT01370863|365037180|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
105830923|NCT01370863|365037181|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
105830924|NCT04133311|365037185|FG000|Period 1 Double Masked Treatment Period|Death|1|||
105830925|NCT04133311|365037186|FG001|Period 1 Double Masked Treatment Period|Death|0|||
105830926|NCT04133311|365037187|FG002|Period 1 Double Masked Treatment Period|Death|0|||
105830927|NCT04133311|365037188|FG003|Period 1 Double Masked Treatment Period|Death|0|||
105830928|NCT04133311|365037185|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
105830929|NCT04133311|365037186|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
105830930|NCT04133311|365037187|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
105830931|NCT04133311|365037188|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
105830932|NCT04133311|365037185|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
105830933|NCT04133311|365037186|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
105830934|NCT04133311|365037187|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
105830935|NCT04133311|365037188|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
105830936|NCT04133311|365037185|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
105830937|NCT04133311|365037186|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
105830938|NCT04133311|365037187|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
105963827|NCT04951622|365525336|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
105963828|NCT04951622|365525332|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
105963829|NCT04951622|365525333|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
105963830|NCT04951622|365525334|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
105963831|NCT04951622|365525335|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
105963832|NCT04951622|365525336|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
105963833|NCT04552288|365525337|FG000|Overall Study|Death|3|||
105963834|NCT04552288|365525337|FG000|Overall Study|Lost to Follow-up|6|||
105963835|NCT04552288|365525337|FG000|Overall Study|Physician Decision|3|||
105963836|NCT04552288|365525337|FG000|Overall Study|Protocol Violation|9|||
105963837|NCT04552288|365525337|FG000|Overall Study|Withdrawal by Subject|6|||
105963838|NCT04552288|365525337|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
105963839|NCT03497676|365525338|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
105963840|NCT03497676|365525339|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
105963841|NCT03497676|365525340|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
105830939|NCT04133311|365037188|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
105963842|NCT03497676|365525341|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
105963843|NCT03497676|365525338|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
105963844|NCT03497676|365525339|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
105963845|NCT03497676|365525340|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
105963846|NCT03497676|365525341|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
105963847|NCT03497676|365525338|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
105963848|NCT03497676|365525339|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
105963849|NCT03497676|365525340|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
105963850|NCT03497676|365525341|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
105963851|NCT03497676|365525338|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
105963852|NCT03497676|365525339|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
105963853|NCT03497676|365525340|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
105963854|NCT03497676|365525341|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
105963855|NCT03497676|365525338|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
105963856|NCT03497676|365525339|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
105963857|NCT03497676|365525340|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
105963858|NCT03497676|365525341|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
105963859|NCT03497676|365525338|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
105963860|NCT03497676|365525339|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
105963861|NCT03497676|365525340|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
105963862|NCT03497676|365525341|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
105963863|NCT03497676|365525338|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
105963864|NCT03497676|365525339|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
105830940|NCT04133311|365037185|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
105830941|NCT04133311|365037186|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
105830942|NCT04133311|365037187|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
105830943|NCT04133311|365037188|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
105830944|NCT04133311|365037185|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
105830945|NCT04133311|365037186|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
105830946|NCT04133311|365037187|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
105830947|NCT04133311|365037188|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
105830948|NCT04133311|365037185|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
105830949|NCT04133311|365037186|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
105830950|NCT04133311|365037187|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
105830951|NCT04133311|365037188|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
105830952|NCT04133311|365037185|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
105830953|NCT04133311|365037186|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
105830954|NCT04133311|365037187|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
105830955|NCT04133311|365037188|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
105830956|NCT00728754|365037193|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
105830957|NCT00728754|365037194|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
105830958|NCT00728754|365037193|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
105830959|NCT00728754|365037194|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
105830960|NCT00728754|365037193|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
105830961|NCT00728754|365037194|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
105830962|NCT01926119|365037195|FG000|Overall Study|Withdrawal by Subject|1|||
105830963|NCT00573313|365037196|FG000|Overall Study|Protocol Violation|5|||
105830964|NCT00573313|365037197|FG001|Overall Study|Protocol Violation|0|||
105830965|NCT00573313|365037198|FG002|Overall Study|Protocol Violation|6|||
105830966|NCT00573313|365037199|FG003|Overall Study|Protocol Violation|0|||
105830967|NCT00406393|365037200|FG000|Overall Study|Did not undergo transplantation|2|||
105830968|NCT00406393|365037201|FG001|Overall Study|Did not undergo transplantation|1|||
105830969|NCT02611362|365037210|FG000|Overall Study|Withdrawal by Subject|7|||
105830970|NCT02611362|365037211|FG001|Overall Study|Withdrawal by Subject|2|||
105830971|NCT02611362|365037210|FG000|Overall Study|Lost to Follow-up|2|||
105830972|NCT02611362|365037211|FG001|Overall Study|Lost to Follow-up|4|||
105830973|NCT02046122|365037212|FG000|Overall Study|Physician Decision|8|||
105830974|NCT02046122|365037212|FG000|Overall Study|Withdrawal by Subject|1|||
105963865|NCT03497676|365525340|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
105963866|NCT03497676|365525341|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
105830975|NCT01653704|365037213|FG000|Overall Study|Technical failure during recording|1|||
105830976|NCT01653704|365037214|FG001|Overall Study|Technical failure during recording|1|||
105830977|NCT01653704|365037213|FG000|Overall Study|Performance not reflective of training|1|||
105830978|NCT01653704|365037214|FG001|Overall Study|Performance not reflective of training|0|||
105830979|NCT02705716|365037217|FG000|Overall Study|Adverse Event|0|||
105830980|NCT02705716|365037218|FG001|Overall Study|Adverse Event|1|||
105830981|NCT02705716|365037217|FG000|Overall Study|Protocol Violation|3|||
105830982|NCT02705716|365037218|FG001|Overall Study|Protocol Violation|0|||
105830983|NCT02705716|365037217|FG000|Overall Study|Withdrawal of Consent|1|||
105830984|NCT02705716|365037218|FG001|Overall Study|Withdrawal of Consent|1|||
105830985|NCT01196390|365037219|FG000|Overall Study|Protocol Violation|4|||
105830986|NCT01196390|365037220|FG001|Overall Study|Protocol Violation|5|||
105830987|NCT01532908|365037221|FG000|Overall Study|Not Transplanted|1|||
105830988|NCT01532908|365037222|FG001|Overall Study|Not Transplanted|0|||
105830989|NCT00467597|365037225|FG000|Overall Study|Withdrawal by Subject|2|||
105830990|NCT00467597|365037226|FG001|Overall Study|Withdrawal by Subject|0|||
105830991|NCT01949532|365037235|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
105830992|NCT01949532|365037236|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
105830993|NCT05665387|365037237|FG000|Overall Study|Withdrawal by Subject|1|||
105830994|NCT05665387|365037238|FG001|Overall Study|Withdrawal by Subject|0|||
105830995|NCT05665387|365037239|FG002|Overall Study|Withdrawal by Subject|1|||
105830996|NCT00379353|365037240|FG000|Overall Study|Hospitalization|3|||
105830997|NCT00379353|365037241|FG001|Overall Study|Hospitalization|3|||
105963867|NCT03497676|365525338|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
105963868|NCT03497676|365525339|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
105963869|NCT03497676|365525340|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
105963870|NCT03497676|365525341|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
106148793|NCT00232180|366206874|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
106148794|NCT00232180|366206875|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
106148795|NCT00232180|366206873|FG000|Open Label Phase|Death|0|||
106148796|NCT00232180|366206874|FG001|Open Label Phase|Death|0|||
106148797|NCT00232180|366206875|FG002|Open Label Phase|Death|48|||
106148798|NCT00232180|366206873|FG000|Open Label Phase|Lost to Follow-up|0|||
106148799|NCT00232180|366206874|FG001|Open Label Phase|Lost to Follow-up|0|||
106148800|NCT00232180|366206875|FG002|Open Label Phase|Lost to Follow-up|5|||
106148801|NCT00232180|366206873|FG000|Open Label Phase|Protocol Violation|0|||
106148802|NCT00232180|366206874|FG001|Open Label Phase|Protocol Violation|0|||
106148803|NCT00232180|366206875|FG002|Open Label Phase|Protocol Violation|3|||
106148804|NCT00232180|366206873|FG000|Open Label Phase|Study terminated by sponsor|0|||
106148805|NCT00232180|366206874|FG001|Open Label Phase|Study terminated by sponsor|0|||
106148806|NCT00232180|366206875|FG002|Open Label Phase|Study terminated by sponsor|3|||
106148807|NCT00232180|366206873|FG000|Open Label Phase|Withdrawal by Subject|0|||
106148808|NCT00232180|366206874|FG001|Open Label Phase|Withdrawal by Subject|0|||
106148809|NCT00232180|366206875|FG002|Open Label Phase|Withdrawal by Subject|37|||
106148810|NCT00232180|366206873|FG000|Open Label Phase|Other|0|||
106148811|NCT00232180|366206874|FG001|Open Label Phase|Other|0|||
105830998|NCT00379353|365037240|FG000|Overall Study|Withdrawal by Subject|5|||
105963871|NCT01917929|365525342|FG000|Overall Study|Death|8|||
105963872|NCT01917929|365525342|FG000|Overall Study|Lost to Follow-up|19|||
105963873|NCT01917929|365525342|FG000|Overall Study|Withdrawal by Subject|33|||
105963874|NCT01917929|365525342|FG000|Overall Study|Adverse Event|6|||
105963875|NCT01917929|365525342|FG000|Overall Study|Investigative Site Terminated|35|||
105963876|NCT01917929|365525342|FG000|Overall Study|Censored because study device not implanted|6|||
105963877|NCT01917929|365525342|FG000|Overall Study|Censored because surgery not performed|3|||
105963878|NCT01917929|365525342|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
105963879|NCT01917929|365525342|FG000|Overall Study|Sponsor terminated study|175|||
105963880|NCT05285644|365525343|FG000|Overall Study|Adverse Event|3|||
105963881|NCT05285644|365525344|FG001|Overall Study|Adverse Event|3|||
105963882|NCT05285644|365525343|FG000|Overall Study|Withdrawal of Consent|2|||
105963883|NCT05285644|365525344|FG001|Overall Study|Withdrawal of Consent|5|||
105963884|NCT05285644|365525343|FG000|Overall Study|Noncompliance|0|||
105963885|NCT05285644|365525344|FG001|Overall Study|Noncompliance|4|||
105963886|NCT05285644|365525343|FG000|Overall Study|Lost to Follow-up|4|||
105963887|NCT05285644|365525344|FG001|Overall Study|Lost to Follow-up|6|||
105963888|NCT05285644|365525343|FG000|Overall Study|Disallowed Concurrent Medication|1|||
105963889|NCT05285644|365525344|FG001|Overall Study|Disallowed Concurrent Medication|1|||
105963890|NCT05285644|365525343|FG000|Overall Study|Investigator Decision|2|||
105963891|NCT05285644|365525344|FG001|Overall Study|Investigator Decision|0|||
105963892|NCT05285644|365525343|FG000|Overall Study|Protocol Deviation|1|||
105963893|NCT05285644|365525344|FG001|Overall Study|Protocol Deviation|0|||
105963894|NCT05285644|365525343|FG000|Overall Study|As specified in the Clinical Study Report|7|||
106022676|NCT02105961|365748635|FG000|Overall Study|Physician Decision|3|||
106148812|NCT00232180|366206875|FG002|Open Label Phase|Other|16|||
106148813|NCT00232180|366206873|FG000|Open Label Phase|Adverse Event|0|||
105830999|NCT00379353|365037241|FG001|Overall Study|Withdrawal by Subject|2|||
105831000|NCT00379353|365037240|FG000|Overall Study|Death|1|||
105831001|NCT00379353|365037241|FG001|Overall Study|Death|0|||
105831002|NCT00379353|365037240|FG000|Overall Study|Cardiac Tamponade|1|||
105831003|NCT00379353|365037241|FG001|Overall Study|Cardiac Tamponade|0|||
105831004|NCT00379353|365037240|FG000|Overall Study|Non-compliance|1|||
105831005|NCT00379353|365037241|FG001|Overall Study|Non-compliance|0|||
105831006|NCT00379353|365037240|FG000|Overall Study|Conflicting drug treatment|0|||
106148814|NCT00232180|366206874|FG001|Open Label Phase|Adverse Event|0|||
106148815|NCT00232180|366206875|FG002|Open Label Phase|Adverse Event|25|||
105831007|NCT00379353|365037241|FG001|Overall Study|Conflicting drug treatment|1|||
105831008|NCT03732833|365037242|FG000|Overall Study|Adverse Event|0|||
105831009|NCT03732833|365037243|FG001|Overall Study|Adverse Event|3|||
105831010|NCT03732833|365037244|FG002|Overall Study|Adverse Event|1|||
105831011|NCT03732833|365037242|FG000|Overall Study|Withdrawal by Subject|11|||
105831012|NCT03732833|365037243|FG001|Overall Study|Withdrawal by Subject|13|||
105831013|NCT03732833|365037244|FG002|Overall Study|Withdrawal by Subject|8|||
105831014|NCT03732833|365037242|FG000|Overall Study|Lost to Follow-up|3|||
105831015|NCT03732833|365037243|FG001|Overall Study|Lost to Follow-up|5|||
105831016|NCT03732833|365037244|FG002|Overall Study|Lost to Follow-up|4|||
105831017|NCT03732833|365037242|FG000|Overall Study|Pregnancy|0|||
105831018|NCT03732833|365037243|FG001|Overall Study|Pregnancy|2|||
105831019|NCT03732833|365037244|FG002|Overall Study|Pregnancy|0|||
105831020|NCT03732833|365037242|FG000|Overall Study|Physician Decision|2|||
105831021|NCT03732833|365037243|FG001|Overall Study|Physician Decision|3|||
105831022|NCT03732833|365037244|FG002|Overall Study|Physician Decision|1|||
105831023|NCT03732833|365037242|FG000|Overall Study|Covid-19 related and other reasons|2|||
105831024|NCT03732833|365037243|FG001|Overall Study|Covid-19 related and other reasons|7|||
105831025|NCT03732833|365037244|FG002|Overall Study|Covid-19 related and other reasons|3|||
105831026|NCT04320745|365037245|FG000|Overall Study|Adverse Event|26|||
105831027|NCT04320745|365037245|FG000|Overall Study|Withdrawal by Subject|4|||
105831028|NCT04320745|365037245|FG000|Overall Study|Lost to Follow-up|12|||
105831029|NCT04320745|365037245|FG000|Overall Study|Protocol Deviation|2|||
105831030|NCT04320745|365037245|FG000|Overall Study|Non-compliance With Study Drug|2|||
105831031|NCT04320745|365037245|FG000|Overall Study|Reason Not Specified|1|||
105831032|NCT00021541|365037246|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
105831033|NCT00021541|365037247|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
105831034|NCT00021541|365037246|FG000|Period 1-First Treatment|Adverse Event|2|||
105831035|NCT00021541|365037247|FG001|Period 1-First Treatment|Adverse Event|1|||
105831036|NCT00021541|365037246|FG000|Period 1-First Treatment|non-adherence|3|||
105831037|NCT00021541|365037247|FG001|Period 1-First Treatment|non-adherence|0|||
105831038|NCT00021541|365037246|FG000|Period 1-First Treatment|Death|1|||
105831039|NCT00021541|365037247|FG001|Period 1-First Treatment|Death|0|||
105831040|NCT00021541|365037246|FG000|Period 1-First Treatment|Pts that did not progress|2|||
105831041|NCT00021541|365037247|FG001|Period 1-First Treatment|Pts that did not progress|2|||
105831042|NCT00021541|365037246|FG000|Period 1-First Treatment|Ineligible|0|||
105831043|NCT00021541|365037247|FG001|Period 1-First Treatment|Ineligible|2|||
105831044|NCT00021541|365037246|FG000|Period 2-crossover|refused phase B|2|||
105831045|NCT00021541|365037247|FG001|Period 2-crossover|refused phase B|2|||
105831046|NCT00021541|365037246|FG000|Period 2-crossover|Withdrawal by Subject|3|||
105831047|NCT00021541|365037247|FG001|Period 2-crossover|Withdrawal by Subject|4|||
105831048|NCT00021541|365037246|FG000|Period 2-crossover|Adverse Event|2|||
105831049|NCT00021541|365037247|FG001|Period 2-crossover|Adverse Event|2|||
105831050|NCT00021541|365037246|FG000|Period 2-crossover|non-adherence|1|||
105831051|NCT00021541|365037247|FG001|Period 2-crossover|non-adherence|0|||
105831052|NCT00021541|365037246|FG000|Period 2-crossover|Pts that did not progress|2|||
105831053|NCT00021541|365037247|FG001|Period 2-crossover|Pts that did not progress|3|||
105831054|NCT01874535|365037248|FG000|Overall Study|Lost to Follow-up|10|||
105831055|NCT01874535|365037249|FG001|Overall Study|Lost to Follow-up|9|||
105831056|NCT01874535|365037248|FG000|Overall Study|incomplete symptom resolution|45|||
105831057|NCT01874535|365037249|FG001|Overall Study|incomplete symptom resolution|35|||
105831058|NCT02611323|365037250|FG000|Overall Study|Death|3|||
105831059|NCT02611323|365037251|FG001|Overall Study|Death|1|||
105831060|NCT02611323|365037252|FG002|Overall Study|Death|0|||
105831061|NCT02611323|365037253|FG003|Overall Study|Death|0|||
105831062|NCT02611323|365037254|FG004|Overall Study|Death|1|||
105831063|NCT02611323|365037255|FG005|Overall Study|Death|1|||
105831064|NCT02611323|365037256|FG006|Overall Study|Death|8|||
105831065|NCT02611323|365037257|FG007|Overall Study|Death|0|||
105831066|NCT02611323|365037258|FG008|Overall Study|Death|4|||
105831067|NCT02611323|365037259|FG009|Overall Study|Death|6|||
105831068|NCT02611323|365037260|FG010|Overall Study|Death|26|||
105831069|NCT02611323|365037250|FG000|Overall Study|Lost to Follow-up|1|||
105831070|NCT02611323|365037251|FG001|Overall Study|Lost to Follow-up|0|||
105831071|NCT02611323|365037252|FG002|Overall Study|Lost to Follow-up|0|||
105963895|NCT05285644|365525344|FG001|Overall Study|As specified in the Clinical Study Report|3|||
105963896|NCT04295759|365525345|FG000|Overall Study|Lack of Efficacy|9|||
105831072|NCT02611323|365037253|FG003|Overall Study|Lost to Follow-up|0|||
105963897|NCT04295759|365525345|FG000|Overall Study|Death|1|||
105963898|NCT04295759|365525345|FG000|Overall Study|Withdrawal by Subject|2|||
105831073|NCT02611323|365037254|FG004|Overall Study|Lost to Follow-up|0|||
105831074|NCT02611323|365037255|FG005|Overall Study|Lost to Follow-up|0|||
105831075|NCT02611323|365037256|FG006|Overall Study|Lost to Follow-up|3|||
105831076|NCT02611323|365037257|FG007|Overall Study|Lost to Follow-up|0|||
105831077|NCT02611323|365037258|FG008|Overall Study|Lost to Follow-up|0|||
105831078|NCT02611323|365037259|FG009|Overall Study|Lost to Follow-up|0|||
105831079|NCT02611323|365037260|FG010|Overall Study|Lost to Follow-up|2|||
105831080|NCT02611323|365037250|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831081|NCT02611323|365037251|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831082|NCT02611323|365037252|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831083|NCT02611323|365037253|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831084|NCT02611323|365037254|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831085|NCT02611323|365037255|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831086|NCT02611323|365037256|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831087|NCT02611323|365037257|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831088|NCT02611323|365037258|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831089|NCT02611323|365037259|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
105831090|NCT02611323|365037260|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
105831091|NCT02611323|365037250|FG000|Overall Study|Progressive Disease|0|||
105831092|NCT02611323|365037251|FG001|Overall Study|Progressive Disease|0|||
105831093|NCT02611323|365037252|FG002|Overall Study|Progressive Disease|0|||
105831094|NCT02611323|365037253|FG003|Overall Study|Progressive Disease|0|||
105831095|NCT02611323|365037254|FG004|Overall Study|Progressive Disease|0|||
105831096|NCT02611323|365037255|FG005|Overall Study|Progressive Disease|0|||
105831097|NCT02611323|365037256|FG006|Overall Study|Progressive Disease|0|||
105831098|NCT02611323|365037257|FG007|Overall Study|Progressive Disease|0|||
105831099|NCT02611323|365037258|FG008|Overall Study|Progressive Disease|0|||
105831100|NCT02611323|365037259|FG009|Overall Study|Progressive Disease|0|||
105831101|NCT02611323|365037260|FG010|Overall Study|Progressive Disease|1|||
105831102|NCT02611323|365037250|FG000|Overall Study|Withdrawal by Subject|1|||
105831103|NCT02611323|365037251|FG001|Overall Study|Withdrawal by Subject|0|||
105831104|NCT02611323|365037252|FG002|Overall Study|Withdrawal by Subject|0|||
105831105|NCT02611323|365037253|FG003|Overall Study|Withdrawal by Subject|0|||
105831106|NCT02611323|365037254|FG004|Overall Study|Withdrawal by Subject|0|||
105831107|NCT02611323|365037255|FG005|Overall Study|Withdrawal by Subject|0|||
105831108|NCT02611323|365037256|FG006|Overall Study|Withdrawal by Subject|0|||
105831109|NCT02611323|365037257|FG007|Overall Study|Withdrawal by Subject|1|||
105831110|NCT02611323|365037258|FG008|Overall Study|Withdrawal by Subject|0|||
105831111|NCT02611323|365037259|FG009|Overall Study|Withdrawal by Subject|1|||
105831112|NCT02611323|365037260|FG010|Overall Study|Withdrawal by Subject|0|||
105831113|NCT00858403|365037261|FG000|Overall Study|Withdrawal by Subject|1|||
105831114|NCT00858403|365037261|FG000|Overall Study|Death|3|||
105831115|NCT00858403|365037261|FG000|Overall Study|Disease Progression|1|||
105831116|NCT02597049|365037262|FG000|Overall Study|Lost to Follow-up|0|||
105831117|NCT02597049|365037263|FG001|Overall Study|Lost to Follow-up|3|||
105831118|NCT02597049|365037264|FG002|Overall Study|Lost to Follow-up|2|||
105831119|NCT02597049|365037262|FG000|Overall Study|Withdrawal by Subject|2|||
105831120|NCT02597049|365037263|FG001|Overall Study|Withdrawal by Subject|2|||
105831121|NCT02597049|365037264|FG002|Overall Study|Withdrawal by Subject|1|||
105831122|NCT02597049|365037262|FG000|Overall Study|Adverse Event|2|||
105831123|NCT02597049|365037263|FG001|Overall Study|Adverse Event|0|||
105831124|NCT02597049|365037264|FG002|Overall Study|Adverse Event|0|||
105831125|NCT02597049|365037262|FG000|Overall Study|Death|2|||
105831126|NCT02597049|365037263|FG001|Overall Study|Death|0|||
105831127|NCT02597049|365037264|FG002|Overall Study|Death|0|||
105831128|NCT02597049|365037262|FG000|Overall Study|Noncompliant with Study Visits|1|||
105831129|NCT02597049|365037263|FG001|Overall Study|Noncompliant with Study Visits|0|||
105831130|NCT02597049|365037264|FG002|Overall Study|Noncompliant with Study Visits|0|||
105831131|NCT01215721|365037267|FG000|Overall Study|Adverse Event|2|||
105831132|NCT00243347|365037269|FG000|Overall Study|Lack of Efficacy|4|||
105831133|NCT00243347|365037269|FG000|Overall Study|Adverse Event|2|||
105831134|NCT00243347|365037269|FG000|Overall Study|Death|1|||
105831135|NCT00243347|365037269|FG000|Overall Study|Withdrawal by Subject|5|||
105831136|NCT00243347|365037269|FG000|Overall Study|Condition worsened|7|||
105831137|NCT00199901|365038907|FG000|Overall Study|Protocol Violation|2|||
105831138|NCT00199901|365038908|FG001|Overall Study|Protocol Violation|0|||
105831139|NCT00199901|365038907|FG000|Overall Study|Withdrawal by Subject|1|||
105963899|NCT04295759|365525345|FG000|Overall Study|Deemed ineligible|1|||
105963900|NCT01696981|365525346|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
105963901|NCT01696981|365525347|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
105963902|NCT01696981|365525346|FG000|Overall Study|Died Before Randomization|3|||
105963903|NCT01696981|365525347|FG001|Overall Study|Died Before Randomization|8|||
105963904|NCT01696981|365525346|FG000|Overall Study|Died Before ASU (Control)|278|||
105963905|NCT01696981|365525347|FG001|Overall Study|Died Before ASU (Control)|0|||
105963906|NCT01696981|365525346|FG000|Overall Study|Refused ASU (Control)|920|||
105963907|NCT01696981|365525347|FG001|Overall Study|Refused ASU (Control)|0|||
105963908|NCT01696981|365525346|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
105963909|NCT01696981|365525347|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
105963910|NCT04113018|365525352|FG000|Overall Study|Death|2|||
105831140|NCT00199901|365038908|FG001|Overall Study|Withdrawal by Subject|0|||
105831141|NCT00199901|365038907|FG000|Overall Study|Progressive Disease|24|||
105831142|NCT00199901|365038908|FG001|Overall Study|Progressive Disease|24|||
105963911|NCT04113018|365525352|FG000|Overall Study|Lost to Follow-up|1|||
105831143|NCT04729101|365038911|FG000|Overall Study|Adverse Event|1|||
105831144|NCT04729101|365038912|FG001|Overall Study|Adverse Event|0|||
105831145|NCT04729101|365038911|FG000|Overall Study|Physician Decision|1|||
105831146|NCT04729101|365038912|FG001|Overall Study|Physician Decision|0|||
105831147|NCT04729101|365038911|FG000|Overall Study|Withdrawal by Subject|1|||
105831148|NCT04729101|365038912|FG001|Overall Study|Withdrawal by Subject|0|||
105831149|NCT03969641|365038915|FG000|Overall Study|Lost to Follow-up|5|||
105831150|NCT03969641|365038916|FG001|Overall Study|Lost to Follow-up|3|||
105831151|NCT03969641|365038915|FG000|Overall Study|Withdrawal by Subject|1|||
105831152|NCT03969641|365038916|FG001|Overall Study|Withdrawal by Subject|2|||
105831153|NCT03969641|365038915|FG000|Overall Study|Found to be ineligible|1|||
105831154|NCT03969641|365038916|FG001|Overall Study|Found to be ineligible|1|||
105831155|NCT03969641|365038915|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
105831156|NCT03969641|365038916|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
105831157|NCT03969641|365038915|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
105831158|NCT03969641|365038916|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
105831159|NCT03969641|365038915|FG000|Overall Study|Elective termination|0|||
105831160|NCT03969641|365038916|FG001|Overall Study|Elective termination|1|||
105831161|NCT00762411|365038917|FG000|Initial Treatment|Death|7|||
105831162|NCT00762411|365038918|FG001|Initial Treatment|Death|6|||
105831163|NCT00762411|365038917|FG000|Initial Treatment|Adverse Event|132|||
105831164|NCT00762411|365038918|FG001|Initial Treatment|Adverse Event|40|||
105831165|NCT00762411|365038917|FG000|Initial Treatment|Protocol Violation|4|||
105831166|NCT00762411|365038918|FG001|Initial Treatment|Protocol Violation|1|||
105831167|NCT00762411|365038917|FG000|Initial Treatment|Withdrawal by Subject|65|||
105831168|NCT00762411|365038918|FG001|Initial Treatment|Withdrawal by Subject|52|||
105831169|NCT00762411|365038917|FG000|Initial Treatment|Physician Decision|1|||
105831170|NCT00762411|365038918|FG001|Initial Treatment|Physician Decision|0|||
105831171|NCT00762411|365038917|FG000|Initial Treatment|Sponsor Decision|293|||
105831172|NCT00762411|365038918|FG001|Initial Treatment|Sponsor Decision|401|||
105831173|NCT00762411|365038917|FG000|Initial Treatment|Lost to Follow-up|5|||
105831174|NCT00762411|365038918|FG001|Initial Treatment|Lost to Follow-up|0|||
105831175|NCT00762411|365038917|FG000|Initial Treatment|Caregiver Decision|21|||
105831176|NCT00762411|365038918|FG001|Initial Treatment|Caregiver Decision|16|||
105831177|NCT00762411|365038917|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
105831178|NCT00762411|365038918|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
105831179|NCT00762411|365038917|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
105831180|NCT00762411|365038918|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
105831181|NCT00762411|365038917|FG000|Delayed Start|Adverse Event|0|||
105831182|NCT00762411|365038918|FG001|Delayed Start|Adverse Event|4|||
105831183|NCT00762411|365038917|FG000|Delayed Start|Protocol Violation|0|||
105831184|NCT00762411|365038918|FG001|Delayed Start|Protocol Violation|1|||
105831185|NCT00762411|365038917|FG000|Delayed Start|Sponsor Decision|16|||
105831186|NCT00762411|365038918|FG001|Delayed Start|Sponsor Decision|20|||
105831187|NCT00762411|365038917|FG000|Delayed Start|Caregiver Decision|1|||
105831188|NCT00762411|365038918|FG001|Delayed Start|Caregiver Decision|1|||
105831189|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
105831190|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
105831191|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
105831192|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
105831193|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
105831194|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
105831195|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
105831196|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
105831197|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
105963912|NCT04113018|365525352|FG000|Overall Study|Still On Study (on study treatment)|24|||
106148816|NCT00232180|366206873|FG000|Open Label Phase|Laboratory abnormality|0|||
106148817|NCT00232180|366206874|FG001|Open Label Phase|Laboratory abnormality|0|||
105831198|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
105831199|NCT00762411|365038917|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
105831200|NCT00762411|365038918|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
105831201|NCT01541215|365038919|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
105831202|NCT01541215|365038920|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
105831203|NCT01541215|365038919|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
105831204|NCT01541215|365038920|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
105831205|NCT01541215|365038919|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
105831206|NCT01541215|365038920|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
105831207|NCT01541215|365038919|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
105831208|NCT01541215|365038920|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
105831209|NCT01541215|365038919|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
105831210|NCT01541215|365038920|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
105831211|NCT01541215|365038919|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
105831212|NCT01541215|365038920|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
105831213|NCT02302716|365038923|FG000|Overall Study|Adverse Event|1|||
106148818|NCT00232180|366206875|FG002|Open Label Phase|Laboratory abnormality|10|||
105831214|NCT02302716|365038924|FG001|Overall Study|Adverse Event|1|||
105831215|NCT02302716|365038923|FG000|Overall Study|Death|0|||
105831216|NCT02302716|365038924|FG001|Overall Study|Death|1|||
105831217|NCT02302716|365038923|FG000|Overall Study|Lack of Efficacy|0|||
105831218|NCT02302716|365038924|FG001|Overall Study|Lack of Efficacy|1|||
105831219|NCT02302716|365038923|FG000|Overall Study|Lost to Follow-up|2|||
105831220|NCT02302716|365038924|FG001|Overall Study|Lost to Follow-up|4|||
105831221|NCT02302716|365038923|FG000|Overall Study|Physician Decision|3|||
105831222|NCT02302716|365038924|FG001|Overall Study|Physician Decision|4|||
105831223|NCT02302716|365038923|FG000|Overall Study|Withdrawal by Subject|13|||
105831224|NCT02302716|365038924|FG001|Overall Study|Withdrawal by Subject|7|||
105831225|NCT02302716|365038923|FG000|Overall Study|Protocol Violation|0|||
105831226|NCT02302716|365038924|FG001|Overall Study|Protocol Violation|1|||
105831227|NCT02817828|365038930|FG000|Overall Study|Lost to Follow-up|41|||
105831228|NCT02817828|365038930|FG000|Overall Study|Adverse event not related to bleeding|104|||
105831229|NCT02817828|365038930|FG000|Overall Study|Adverse event related to bleeding|53|||
105831230|NCT02817828|365038930|FG000|Overall Study|Protocol Violation|11|||
105831231|NCT02817828|365038930|FG000|Overall Study|Pregnancy|7|||
105831232|NCT02817828|365038930|FG000|Overall Study|Pregnancy wish|15|||
105831233|NCT02817828|365038930|FG000|Overall Study|Withdrawal by Subject|78|||
105831234|NCT02817828|365038930|FG000|Overall Study|Other|26|||
105831235|NCT00486434|365038931|FG000|Overall Study|Withdrawal by Subject|34|||
105831236|NCT00486434|365038932|FG001|Overall Study|Withdrawal by Subject|39|||
105831237|NCT00486434|365038931|FG000|Overall Study|Adverse Event|118|||
105831238|NCT00486434|365038932|FG001|Overall Study|Adverse Event|44|||
105831239|NCT00486434|365038931|FG000|Overall Study|Protocol Violation|22|||
105831240|NCT00486434|365038932|FG001|Overall Study|Protocol Violation|21|||
105831241|NCT00486434|365038931|FG000|Overall Study|Lack of Efficacy|12|||
105831242|NCT00486434|365038932|FG001|Overall Study|Lack of Efficacy|19|||
105831243|NCT00486434|365038931|FG000|Overall Study|Lost to Follow-up|2|||
105831244|NCT00486434|365038932|FG001|Overall Study|Lost to Follow-up|3|||
105831245|NCT00486434|365038931|FG000|Overall Study|Death|1|||
105831246|NCT00486434|365038932|FG001|Overall Study|Death|2|||
105831247|NCT00486434|365038931|FG000|Overall Study|Personal reasons|5|||
105831248|NCT00486434|365038932|FG001|Overall Study|Personal reasons|6|||
105831249|NCT04661202|365038933|FG000|Overall Study|Withdrawal by Subject|1|||
105831250|NCT04661202|365038934|FG001|Overall Study|Withdrawal by Subject|1|||
105831251|NCT04661202|365038933|FG000|Overall Study|Lack of Efficacy|2|||
105831252|NCT04661202|365038934|FG001|Overall Study|Lack of Efficacy|0|||
105831253|NCT02578641|365038935|FG000|Overall Study|Adverse Event|5|||
105831254|NCT02578641|365038936|FG001|Overall Study|Adverse Event|15|||
105831255|NCT02578641|365038935|FG000|Overall Study|Death|16|||
105831256|NCT02578641|365038936|FG001|Overall Study|Death|8|||
105831257|NCT02578641|365038935|FG000|Overall Study|Lost to Follow-up|0|||
105831258|NCT02578641|365038936|FG001|Overall Study|Lost to Follow-up|1|||
105831259|NCT02578641|365038935|FG000|Overall Study|Withdrawal by Subject|14|||
105831260|NCT02578641|365038936|FG001|Overall Study|Withdrawal by Subject|7|||
106022677|NCT02105961|365748636|FG001|Overall Study|Physician Decision|3|||
106022678|NCT02105961|365748637|FG002|Overall Study|Physician Decision|2|||
106022679|NCT02105961|365748635|FG000|Overall Study|Withdrawal by Subject|15|||
106022680|NCT02105961|365748636|FG001|Overall Study|Withdrawal by Subject|7|||
106022681|NCT02105961|365748637|FG002|Overall Study|Withdrawal by Subject|11|||
106022682|NCT02813577|365748638|FG000|Overall Study|Study terminated|4|||
106022683|NCT04413617|365748639|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
106022684|NCT04413617|365748640|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
106022685|NCT04413617|365748641|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
106022686|NCT04413617|365748642|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
106022687|NCT04413617|365748643|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
106022688|NCT04413617|365748639|FG000|Overall Study|Protocol Violation|0|||
106022689|NCT04413617|365748640|FG001|Overall Study|Protocol Violation|1|||
106022690|NCT04413617|365748641|FG002|Overall Study|Protocol Violation|0|||
106022691|NCT04413617|365748642|FG003|Overall Study|Protocol Violation|0|||
106022692|NCT04413617|365748643|FG004|Overall Study|Protocol Violation|1|||
106022693|NCT04413617|365748639|FG000|Overall Study|Lack of Efficacy|2|||
105831261|NCT02578641|365038935|FG000|Overall Study|Progressive Disease|69|||
105831262|NCT02578641|365038936|FG001|Overall Study|Progressive Disease|21|||
105831263|NCT02578641|365038935|FG000|Overall Study|No Study Drug|2|||
105831264|NCT02578641|365038936|FG001|Overall Study|No Study Drug|0|||
105831265|NCT02578641|365038935|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
105831266|NCT02578641|365038936|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
105831267|NCT02578641|365038935|FG000|Overall Study|Non-compliance with Study Schedule|1|||
105831268|NCT02578641|365038936|FG001|Overall Study|Non-compliance with Study Schedule|0|||
105831269|NCT02578641|365038935|FG000|Overall Study|Other|1|||
106022694|NCT04413617|365748640|FG001|Overall Study|Lack of Efficacy|0|||
105831270|NCT02578641|365038936|FG001|Overall Study|Other|10|||
105831271|NCT02578641|365038935|FG000|Overall Study|Not treated|1|||
105831272|NCT02578641|365038936|FG001|Overall Study|Not treated|4|||
105831273|NCT04158687|365038938|FG000|Overall Study|Adverse Event|2|||
105831274|NCT04158687|365038939|FG001|Overall Study|Adverse Event|3|||
105831275|NCT04158687|365038940|FG002|Overall Study|Adverse Event|0|||
105831276|NCT04158687|365038941|FG003|Overall Study|Adverse Event|3|||
105831277|NCT04158687|365038938|FG000|Overall Study|Lost to Follow-up|5|||
105831278|NCT04158687|365038939|FG001|Overall Study|Lost to Follow-up|12|||
105831279|NCT04158687|365038940|FG002|Overall Study|Lost to Follow-up|4|||
105831280|NCT04158687|365038941|FG003|Overall Study|Lost to Follow-up|5|||
106148819|NCT00232180|366206873|FG000|Open Label Phase|Randomized but not treated|0|||
106148820|NCT00232180|366206874|FG001|Open Label Phase|Randomized but not treated|0|||
106148821|NCT00232180|366206875|FG002|Open Label Phase|Randomized but not treated|1|||
106148822|NCT02748317|366206876|FG000|Overall Study|Withdrawal by Subject|14|||
106148823|NCT02748317|366206876|FG000|Overall Study|Lost to Follow-up|8|||
106148824|NCT02748317|366206876|FG000|Overall Study|Death|1|||
106148825|NCT00505934|366206877|FG000|Overall Study|Adverse Event|1|||
106148826|NCT00505934|366206877|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
106148827|NCT00505934|366206877|FG000|Overall Study|Other: IV dose needed to be changed|1|||
106148828|NCT02374463|366206891|FG000|Overall Study|Withdrawal by Subject|3|||
106148829|NCT02374463|366206892|FG001|Overall Study|Withdrawal by Subject|3|||
106148830|NCT01414738|366206901|FG000|Overall Study|Death|26|||
106148831|NCT01414738|366206901|FG000|Overall Study|Refused testing|5|||
106148832|NCT01414738|366206901|FG000|Overall Study|Lost to Follow-up|2|||
106148833|NCT01414738|366206901|FG000|Overall Study|Refused, disease progression|8|||
106148834|NCT01414738|366206901|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
106148835|NCT01266122|366206902|FG000|Overall Study|Lost to Follow-up|6|||
106148836|NCT01266122|366206903|FG001|Overall Study|Lost to Follow-up|6|||
106148837|NCT00421889|366206904|FG000|Overall Study|Adverse Event|1|||
106148838|NCT00421889|366206905|FG001|Overall Study|Adverse Event|0|||
106148839|NCT00421889|366206906|FG002|Overall Study|Adverse Event|1|||
105831281|NCT04158687|365038938|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
105831282|NCT04158687|365038939|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
105831283|NCT04158687|365038940|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
105831284|NCT04158687|365038941|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
105831285|NCT04158687|365038938|FG000|Overall Study|Non-Compliance with Study Medication|2|||
105831286|NCT04158687|365038939|FG001|Overall Study|Non-Compliance with Study Medication|2|||
105831287|NCT04158687|365038940|FG002|Overall Study|Non-Compliance with Study Medication|3|||
105831288|NCT04158687|365038941|FG003|Overall Study|Non-Compliance with Study Medication|0|||
105831289|NCT04158687|365038938|FG000|Overall Study|Investigator Decision|0|||
105831290|NCT04158687|365038939|FG001|Overall Study|Investigator Decision|0|||
105831291|NCT04158687|365038940|FG002|Overall Study|Investigator Decision|2|||
105831292|NCT04158687|365038941|FG003|Overall Study|Investigator Decision|0|||
105831293|NCT04158687|365038938|FG000|Overall Study|Protocol Violation|0|||
105831294|NCT04158687|365038939|FG001|Overall Study|Protocol Violation|2|||
105831295|NCT04158687|365038940|FG002|Overall Study|Protocol Violation|1|||
105831296|NCT04158687|365038941|FG003|Overall Study|Protocol Violation|0|||
105831297|NCT04158687|365038938|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
105831298|NCT04158687|365038939|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
105831299|NCT04158687|365038940|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
105831300|NCT04158687|365038941|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
105831301|NCT04158687|365038938|FG000|Overall Study|Reason not Specified|3|||
105831302|NCT04158687|365038939|FG001|Overall Study|Reason not Specified|2|||
105831303|NCT04158687|365038940|FG002|Overall Study|Reason not Specified|4|||
105831304|NCT04158687|365038941|FG003|Overall Study|Reason not Specified|4|||
105831305|NCT02694536|365038944|FG000|Overall Study|Progressive Disease|40|||
105831306|NCT02694536|365038944|FG000|Overall Study|Lost to Follow-up|1|||
105831307|NCT02694536|365038944|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
105831308|NCT02694536|365038944|FG000|Overall Study|Withdrawal by Subject|8|||
105831309|NCT02694536|365038944|FG000|Overall Study|Death|8|||
105831310|NCT02694536|365038944|FG000|Overall Study|Other|22|||
105831311|NCT01824576|365038949|FG000|Overall Study|Device deficiency|2|||
105831312|NCT00045162|365038950|FG000|Overall Study|Ineligible|12|||
105831313|NCT00045162|365038951|FG001|Overall Study|Ineligible|8|||
105831314|NCT00045162|365038950|FG000|Overall Study|Not treated|7|||
105831315|NCT00045162|365038951|FG001|Overall Study|Not treated|2|||
105831316|NCT00045162|365038950|FG000|Overall Study|Adverse Event|55|||
105831317|NCT00045162|365038951|FG001|Overall Study|Adverse Event|50|||
105831318|NCT00045162|365038950|FG000|Overall Study|Lack of Efficacy|32|||
105831319|NCT00045162|365038951|FG001|Overall Study|Lack of Efficacy|29|||
105831320|NCT00045162|365038950|FG000|Overall Study|Death|10|||
105831321|NCT00045162|365038951|FG001|Overall Study|Death|10|||
105831322|NCT00045162|365038950|FG000|Overall Study|Withdrawal by Subject|5|||
105831323|NCT00045162|365038951|FG001|Overall Study|Withdrawal by Subject|3|||
106022695|NCT04413617|365748641|FG002|Overall Study|Lack of Efficacy|2|||
106148840|NCT00421889|366206907|FG003|Overall Study|Adverse Event|1|||
106148841|NCT00421889|366206908|FG004|Overall Study|Adverse Event|1|||
106148842|NCT00421889|366206909|FG005|Overall Study|Adverse Event|4|||
106148843|NCT00421889|366206910|FG006|Overall Study|Adverse Event|1|||
106148844|NCT00421889|366206911|FG007|Overall Study|Adverse Event|0|||
105831324|NCT00045162|365038950|FG000|Overall Study|Other|21|||
105831325|NCT00045162|365038951|FG001|Overall Study|Other|16|||
105831326|NCT01044433|365038952|FG000|Overall Study|Lost to Follow-up|3|||
105831327|NCT01044433|365038952|FG000|Overall Study|Withdrawal by Subject|3|||
105831328|NCT00714051|365038961|FG000|Overall Study|Withdrawal by Subject|1|||
105831329|NCT00714051|365038962|FG001|Overall Study|Withdrawal by Subject|0|||
105831330|NCT00714051|365038961|FG000|Overall Study|Death|0|||
105831331|NCT00714051|365038962|FG001|Overall Study|Death|1|||
105831332|NCT01390948|365038964|FG000|Overall Study|End of Study|1|||
105831333|NCT01390948|365038965|FG001|Overall Study|End of Study|0|||
105831334|NCT01390948|365038966|FG002|Overall Study|End of Study|0|||
105831335|NCT01390948|365038964|FG000|Overall Study|Withdrew consent|2|||
105831336|NCT01390948|365038965|FG001|Overall Study|Withdrew consent|2|||
105831337|NCT01390948|365038966|FG002|Overall Study|Withdrew consent|0|||
105831338|NCT01390948|365038964|FG000|Overall Study|Progressive Disease|2|||
105831339|NCT01390948|365038965|FG001|Overall Study|Progressive Disease|5|||
105831340|NCT01390948|365038966|FG002|Overall Study|Progressive Disease|0|||
105831341|NCT01390948|365038964|FG000|Overall Study|Death during follow-up|10|||
105831342|NCT01390948|365038965|FG001|Overall Study|Death during follow-up|11|||
105831343|NCT01390948|365038966|FG002|Overall Study|Death during follow-up|1|||
105831344|NCT05692154|365038967|FG000|Overall Study|Adverse Event|0|||
105831345|NCT05692154|365038968|FG001|Overall Study|Adverse Event|1|||
105831346|NCT03250117|365038969|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
105869149|NCT00662649|365171626|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
105869150|NCT00662649|365171627|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
105869151|NCT00662649|365171628|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
105869152|NCT00662649|365171624|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
105869153|NCT00662649|365171625|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
105869154|NCT00662649|365171626|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
105869155|NCT00662649|365171627|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
105869156|NCT00662649|365171628|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
105869157|NCT00662649|365171624|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
105869158|NCT00662649|365171625|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
105869159|NCT00662649|365171626|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
105869160|NCT00662649|365171627|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
105869161|NCT00662649|365171628|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
105869162|NCT00662649|365171624|FG000|Core Study (24 Months)|Protocol Violation|5|||
105869163|NCT00662649|365171625|FG001|Core Study (24 Months)|Protocol Violation|5|||
105869164|NCT00662649|365171626|FG002|Core Study (24 Months)|Protocol Violation|4|||
105869165|NCT00662649|365171627|FG003|Core Study (24 Months)|Protocol Violation|0|||
105869166|NCT00662649|365171628|FG004|Core Study (24 Months)|Protocol Violation|0|||
105869167|NCT00662649|365171624|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
105869168|NCT00662649|365171625|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
105869169|NCT00662649|365171626|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
105869170|NCT00662649|365171627|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
105869171|NCT00662649|365171628|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
105869172|NCT00662649|365171624|FG000|Core Study (24 Months)|Death|1|||
105869173|NCT00662649|365171625|FG001|Core Study (24 Months)|Death|0|||
105869174|NCT00662649|365171626|FG002|Core Study (24 Months)|Death|2|||
105869175|NCT00662649|365171627|FG003|Core Study (24 Months)|Death|0|||
105869176|NCT00662649|365171628|FG004|Core Study (24 Months)|Death|0|||
105869177|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
105869178|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
105869179|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
105869180|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
105869181|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
105869182|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
105869183|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
105869184|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
105869185|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
105869186|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
105869187|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
105869188|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
105869189|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
105869190|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
105869191|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
105869192|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
105869193|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
105869194|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
105963913|NCT04113018|365525352|FG000|Overall Study|Still On Study (in follow up)|12|||
105963914|NCT04576455|365525353|FG000|Overall Study|Ongoing in the Study|48|||
105963915|NCT04576455|365525354|FG001|Overall Study|Ongoing in the Study|58|||
105963916|NCT04576455|365525353|FG000|Overall Study|Death|83|||
105963917|NCT04576455|365525354|FG001|Overall Study|Death|77|||
105963918|NCT04576455|365525353|FG000|Overall Study|Lost to Follow-up|4|||
105963919|NCT04576455|365525354|FG001|Overall Study|Lost to Follow-up|5|||
105963920|NCT04576455|365525353|FG000|Overall Study|Withdrawal by Subject|16|||
105963921|NCT04576455|365525354|FG001|Overall Study|Withdrawal by Subject|12|||
105963922|NCT04380753|365525355|FG000|Overall Study|Participants continuing study|4|||
105963923|NCT04380753|365525355|FG000|Overall Study|Death|2|||
105963924|NCT02095873|365525356|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
105963925|NCT02095873|365525357|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
105963926|NCT02095873|365525356|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
105963927|NCT02095873|365525357|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
105963928|NCT02095873|365525356|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
105963929|NCT02095873|365525357|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
105963930|NCT03989349|365525360|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
105963931|NCT03989349|365525361|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105963932|NCT03989349|365525362|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105963933|NCT03989349|365525363|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105963934|NCT03989349|365525364|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105963935|NCT03989349|365525365|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
105963936|NCT03989349|365525360|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
105963937|NCT03989349|365525361|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
105963938|NCT03989349|365525362|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105963939|NCT03989349|365525363|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105963940|NCT03989349|365525364|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105963941|NCT03989349|365525365|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
105963942|NCT03989349|365525360|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
105963943|NCT03989349|365525361|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
105963944|NCT03989349|365525362|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
105963945|NCT03989349|365525363|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
105963946|NCT03989349|365525364|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
105963947|NCT03989349|365525365|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
105963948|NCT03989349|365525360|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
105963949|NCT03989349|365525361|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
105963950|NCT03989349|365525362|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105963951|NCT03989349|365525363|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105963952|NCT03989349|365525364|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105963953|NCT03989349|365525365|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
105963954|NCT03989349|365525360|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
105963955|NCT03989349|365525361|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
105963956|NCT03989349|365525362|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
105963957|NCT03989349|365525363|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
105963958|NCT03989349|365525364|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
105963959|NCT03989349|365525365|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
105963960|NCT03989349|365525360|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
105963961|NCT03989349|365525361|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105963962|NCT03989349|365525362|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105963963|NCT03989349|365525363|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105963964|NCT03989349|365525364|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105963965|NCT03989349|365525365|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
105963966|NCT03989349|365525360|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
105963967|NCT03989349|365525361|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
105963968|NCT03989349|365525362|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
105963969|NCT03989349|365525363|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
105963970|NCT03989349|365525364|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
105963971|NCT03989349|365525365|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
105963972|NCT03989349|365525360|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105963973|NCT03989349|365525361|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
105963974|NCT03989349|365525362|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
106148845|NCT00421889|366206912|FG008|Overall Study|Adverse Event|2|||
106148846|NCT00421889|366206904|FG000|Overall Study|Withdrawal by Subject|1|||
105963975|NCT03989349|365525363|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
105963976|NCT03989349|365525364|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
105963977|NCT03989349|365525365|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
105831347|NCT03250117|365038970|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
105831348|NCT03250117|365038971|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
105831349|NCT03250117|365038972|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
105963978|NCT03989349|365525360|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105963979|NCT03989349|365525361|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
105963980|NCT03989349|365525362|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
105963981|NCT03989349|365525363|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
105963982|NCT03989349|365525364|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
105963983|NCT03989349|365525365|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
105831350|NCT01073631|365038973|FG000|Overall Study|Death|82|||
105831351|NCT01073631|365038973|FG000|Overall Study|Adverse Event|24|||
105831352|NCT01073631|365038973|FG000|Overall Study|Other|63|||
105831353|NCT00860262|365038976|FG000|Overall Study|Adverse Event|9|||
105831354|NCT00860262|365038977|FG001|Overall Study|Adverse Event|6|||
105831355|NCT00860262|365038978|FG002|Overall Study|Adverse Event|7|||
105831356|NCT00860262|365038976|FG000|Overall Study|Protocol Violation|0|||
105831357|NCT00860262|365038977|FG001|Overall Study|Protocol Violation|1|||
105831358|NCT00860262|365038978|FG002|Overall Study|Protocol Violation|0|||
105831359|NCT00860262|365038976|FG000|Overall Study|Lost to Follow-up|2|||
105831360|NCT00860262|365038977|FG001|Overall Study|Lost to Follow-up|0|||
105831361|NCT00860262|365038978|FG002|Overall Study|Lost to Follow-up|1|||
105831362|NCT00860262|365038976|FG000|Overall Study|Withdrawal by Subject|4|||
105831363|NCT00860262|365038977|FG001|Overall Study|Withdrawal by Subject|8|||
105831364|NCT00860262|365038978|FG002|Overall Study|Withdrawal by Subject|6|||
105831365|NCT00860262|365038976|FG000|Overall Study|Lack of Efficacy|0|||
105831366|NCT00860262|365038977|FG001|Overall Study|Lack of Efficacy|4|||
105831367|NCT00860262|365038978|FG002|Overall Study|Lack of Efficacy|3|||
105831368|NCT00860262|365038976|FG000|Overall Study|Other|5|||
105831369|NCT00860262|365038977|FG001|Overall Study|Other|3|||
105831370|NCT00860262|365038978|FG002|Overall Study|Other|1|||
105831371|NCT01971554|365038983|FG000|Overall Study|Lost to Follow-up|1|||
105831372|NCT01971554|365038984|FG001|Overall Study|Lost to Follow-up|0|||
105831373|NCT01971554|365038985|FG002|Overall Study|Lost to Follow-up|0|||
105831374|NCT01971554|365038986|FG003|Overall Study|Lost to Follow-up|0|||
105831375|NCT00494013|365038987|FG000|Overall Study|Adverse Event|0|||
105831376|NCT00494013|365038988|FG001|Overall Study|Adverse Event|1|||
105831377|NCT00494013|365038987|FG000|Overall Study|Entry Criteria Not Met|1|||
105831378|NCT00494013|365038988|FG001|Overall Study|Entry Criteria Not Met|4|||
105831379|NCT00494013|365038987|FG000|Overall Study|Lost to Follow-up|5|||
105831380|NCT00494013|365038988|FG001|Overall Study|Lost to Follow-up|6|||
105831381|NCT00494013|365038987|FG000|Overall Study|Physician Decision|3|||
105831382|NCT00494013|365038988|FG001|Overall Study|Physician Decision|5|||
105831383|NCT00494013|365038987|FG000|Overall Study|Protocol Violation|8|||
105831384|NCT00494013|365038988|FG001|Overall Study|Protocol Violation|5|||
105831385|NCT00494013|365038987|FG000|Overall Study|Withdrawal by Subject|13|||
105831386|NCT00494013|365038988|FG001|Overall Study|Withdrawal by Subject|14|||
105831387|NCT00494013|365038987|FG000|Overall Study|Sponsor Decision|0|||
105831388|NCT00494013|365038988|FG001|Overall Study|Sponsor Decision|1|||
105831389|NCT04194151|365038989|FG000|Overall Study|Physician Decision|1|||
105831390|NCT04194151|365038990|FG001|Overall Study|Physician Decision|1|||
105831391|NCT04194151|365038991|FG002|Overall Study|Physician Decision|1|||
105831392|NCT04194151|365038992|FG003|Overall Study|Physician Decision|1|||
105831393|NCT04194151|365038993|FG004|Overall Study|Physician Decision|0|||
105831394|NCT04194151|365038994|FG005|Overall Study|Physician Decision|1|||
105831395|NCT04194151|365038989|FG000|Overall Study|Monitorization problem|0|||
105831396|NCT04194151|365038990|FG001|Overall Study|Monitorization problem|1|||
106022696|NCT04413617|365748642|FG003|Overall Study|Lack of Efficacy|1|||
105831397|NCT04194151|365038991|FG002|Overall Study|Monitorization problem|0|||
105831398|NCT04194151|365038992|FG003|Overall Study|Monitorization problem|0|||
105831399|NCT04194151|365038993|FG004|Overall Study|Monitorization problem|0|||
105831400|NCT04194151|365038994|FG005|Overall Study|Monitorization problem|0|||
105831401|NCT00593827|365038995|FG000|Overall Study|On Active Treatment/Pending|0|||
105831402|NCT00593827|365038996|FG001|Overall Study|On Active Treatment/Pending|2|||
105831403|NCT01499043|365038997|FG000|Overall Study|Progressive disease (radiographic)|2|||
105831404|NCT01499043|365038997|FG000|Overall Study|Progressive disease (clinical)|1|||
105831405|NCT01499043|365038997|FG000|Overall Study|Withdrawal by Subject|2|||
105831406|NCT01499043|365038997|FG000|Overall Study|Adverse Event|1|||
105831407|NCT04203823|365038998|FG000|Overall Study|Withdrawal by Subject|2|||
105831408|NCT04203823|365038999|FG001|Overall Study|Withdrawal by Subject|2|||
105831409|NCT04203823|365038998|FG000|Overall Study|Adverse Event|1|||
105831410|NCT04203823|365038999|FG001|Overall Study|Adverse Event|1|||
105831411|NCT04203823|365038998|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105831412|NCT04203823|365038999|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
105963984|NCT03989349|365525360|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105963985|NCT03989349|365525361|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
105963986|NCT03989349|365525362|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
105963987|NCT03989349|365525363|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
105963988|NCT03989349|365525364|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
105963989|NCT03989349|365525365|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
105963990|NCT03989349|365525360|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105963991|NCT03989349|365525361|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105963992|NCT03989349|365525362|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
105963993|NCT03989349|365525363|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105963994|NCT03989349|365525364|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
105963995|NCT03989349|365525365|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
105963996|NCT03989349|365525360|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105963997|NCT03989349|365525361|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105963998|NCT03989349|365525362|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
105963999|NCT03989349|365525363|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
105964000|NCT03989349|365525364|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
105964001|NCT03989349|365525365|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
105964002|NCT03989349|365525360|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
105964003|NCT03989349|365525361|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
105964004|NCT03989349|365525362|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
105964005|NCT03989349|365525363|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
105964006|NCT03989349|365525364|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
105964007|NCT03989349|365525365|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
105964008|NCT03989349|365525360|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
105964009|NCT03989349|365525361|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
105964010|NCT03989349|365525362|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
105964011|NCT03989349|365525363|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
105964012|NCT03989349|365525364|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
105831413|NCT01598896|365039001|FG000|Overall Study|Withdrawal by Subject|0|||
105831414|NCT01598896|365039002|FG001|Overall Study|Withdrawal by Subject|1|||
106022697|NCT04413617|365748643|FG004|Overall Study|Lack of Efficacy|0|||
106022698|NCT04413617|365748639|FG000|Overall Study|Withdrawal by Subject|3|||
106022699|NCT04413617|365748640|FG001|Overall Study|Withdrawal by Subject|4|||
106022700|NCT04413617|365748641|FG002|Overall Study|Withdrawal by Subject|2|||
106022701|NCT04413617|365748642|FG003|Overall Study|Withdrawal by Subject|5|||
106022702|NCT04413617|365748643|FG004|Overall Study|Withdrawal by Subject|3|||
105831415|NCT01598896|365039001|FG000|Overall Study|Lack of Efficacy|0|||
105831416|NCT01598896|365039002|FG001|Overall Study|Lack of Efficacy|1|||
105831417|NCT00438633|365039003|FG000|Overall Study|Withdrawal by Subject|1|||
105831418|NCT00438633|365039004|FG001|Overall Study|Withdrawal by Subject|0|||
105831419|NCT00438633|365039003|FG000|Overall Study|Lost to Follow-up|15|||
105831420|NCT00438633|365039004|FG001|Overall Study|Lost to Follow-up|17|||
105831421|NCT03193021|365039005|FG000|Overall Study|Lost to Follow-up|1|||
105831422|NCT03193021|365039006|FG001|Overall Study|Lost to Follow-up|1|||
105831423|NCT03196284|365039009|FG000|Main Part|Withdrawal by Subject|0|||
105831424|NCT03196284|365039010|FG001|Main Part|Withdrawal by Subject|1|||
105831425|NCT03196284|365039011|FG002|Main Part|Withdrawal by Subject|0|||
105831426|NCT03196284|365039009|FG000|Extension Part|Lack of Efficacy|0|||
105831427|NCT03196284|365039010|FG001|Extension Part|Lack of Efficacy|0|||
105831428|NCT03196284|365039011|FG002|Extension Part|Lack of Efficacy|1|||
105831429|NCT03196284|365039009|FG000|Extension Part|Withdrawal by Subject|0|||
105831430|NCT03196284|365039010|FG001|Extension Part|Withdrawal by Subject|0|||
105831431|NCT03196284|365039011|FG002|Extension Part|Withdrawal by Subject|1|||
105831432|NCT03196284|365039009|FG000|Extension Part|Physician Decision|0|||
105831433|NCT03196284|365039010|FG001|Extension Part|Physician Decision|0|||
105831434|NCT03196284|365039011|FG002|Extension Part|Physician Decision|1|||
105831435|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
106022703|NCT04413617|365748639|FG000|Overall Study|Death|1|||
106022704|NCT04413617|365748640|FG001|Overall Study|Death|0|||
105831436|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
105831437|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
106022705|NCT04413617|365748641|FG002|Overall Study|Death|0|||
105831438|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
105831439|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
105831440|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
105831441|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
105831442|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
105831443|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
105831444|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
105831445|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
105831446|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
105831447|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
105831448|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
105831449|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
105831450|NCT01139762|365039012|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
105831451|NCT01139762|365039013|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
105831452|NCT01139762|365039014|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
105831453|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
105831454|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
105831455|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
105831456|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Death|0|||
105831457|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Death|1|||
105831458|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Death|1|||
105831459|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
105831460|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
105831461|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
105831462|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
105831463|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
105831464|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
105831465|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
105831466|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
105831467|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
105831468|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
105831469|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
105831470|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
105831471|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
105831472|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
105831473|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
105831474|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
105831475|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
105831476|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
105831477|NCT01139762|365039012|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
105831478|NCT01139762|365039013|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
105831479|NCT01139762|365039014|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
105831480|NCT01675596|365039015|FG000|Overall Study|Death|6|||
105831481|NCT01675596|365039015|FG000|Overall Study|Exit with other reason|1|||
105831482|NCT01675596|365039015|FG000|Overall Study|Missed Visit|1|||
105831483|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Adverse Event|8|||
105831484|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Adverse Event|5|||
105831485|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Adverse Event|9|||
105831486|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Adverse Event|0|||
105831487|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Adverse Event|0|||
105831488|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Adverse Event|0|||
105831489|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
105831490|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
105831491|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
105831492|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
105831493|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
105831494|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
105831495|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
105831496|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
105831497|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
105831498|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
105831499|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
105831500|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
105831501|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Physician Decision|4|||
105831502|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Physician Decision|0|||
105831503|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Physician Decision|2|||
105831504|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Physician Decision|0|||
105831505|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Physician Decision|0|||
106022706|NCT04413617|365748642|FG003|Overall Study|Death|0|||
106022707|NCT04413617|365748643|FG004|Overall Study|Death|0|||
106022708|NCT04413617|365748639|FG000|Overall Study|Adverse Event|1|||
106022709|NCT04413617|365748640|FG001|Overall Study|Adverse Event|0|||
105831506|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Physician Decision|0|||
106022710|NCT04413617|365748641|FG002|Overall Study|Adverse Event|0|||
106022711|NCT04413617|365748642|FG003|Overall Study|Adverse Event|1|||
105964013|NCT03989349|365525365|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
105831507|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Pregnancy|1|||
105831508|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Pregnancy|2|||
105831509|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Pregnancy|0|||
105831510|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Pregnancy|0|||
105831511|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Pregnancy|0|||
105831512|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Pregnancy|0|||
105831513|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
105831514|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
105831515|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
105831516|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
105831517|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
105831518|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
105831519|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
105831520|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831521|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831522|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831523|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831524|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
105831525|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
105831526|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
105831527|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
105831528|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
105831529|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
105831530|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
105831531|NCT02614196|365039016|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
105831532|NCT02614196|365039017|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
105831533|NCT02614196|365039018|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
105831534|NCT02614196|365039019|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
105831535|NCT02614196|365039020|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
105831536|NCT02614196|365039021|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
105831537|NCT02614196|365039016|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
105831538|NCT02614196|365039017|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
105831539|NCT02614196|365039018|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
105831540|NCT02614196|365039019|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
105831541|NCT02614196|365039020|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
105964014|NCT03823287|365525370|FG000|Overall Study|Withdrawal by Subject|25|||
105964015|NCT03823287|365525371|FG001|Overall Study|Withdrawal by Subject|17|||
105964016|NCT03823287|365525370|FG000|Overall Study|Death|13|||
105964017|NCT03823287|365525371|FG001|Overall Study|Death|7|||
105964018|NCT03823287|365525370|FG000|Overall Study|Lost to Follow-up|7|||
105964019|NCT03823287|365525371|FG001|Overall Study|Lost to Follow-up|8|||
105964020|NCT03823287|365525370|FG000|Overall Study|Adverse Event|6|||
105964021|NCT03823287|365525371|FG001|Overall Study|Adverse Event|8|||
105964022|NCT03823287|365525370|FG000|Overall Study|Physician Decision|5|||
105964023|NCT03823287|365525371|FG001|Overall Study|Physician Decision|2|||
105964024|NCT03823287|365525370|FG000|Overall Study|Lack of Efficacy|2|||
105964025|NCT03823287|365525371|FG001|Overall Study|Lack of Efficacy|0|||
105964026|NCT03823287|365525370|FG000|Overall Study|Other|2|||
105964027|NCT03823287|365525371|FG001|Overall Study|Other|4|||
105964028|NCT01221623|365525372|FG000|Overall Study|Withdrawal by Subject|19|||
105964029|NCT01221623|365525373|FG001|Overall Study|Withdrawal by Subject|8|||
105964030|NCT01221623|365525372|FG000|Overall Study|Lost to Follow-up|7|||
105964031|NCT01221623|365525373|FG001|Overall Study|Lost to Follow-up|1|||
105964032|NCT01221623|365525372|FG000|Overall Study|Adverse Event|6|||
105964033|NCT01221623|365525373|FG001|Overall Study|Adverse Event|3|||
105964034|NCT01221623|365525372|FG000|Overall Study|Death|1|||
105831542|NCT02614196|365039021|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
105831543|NCT02614196|365039016|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
105831544|NCT02614196|365039017|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
105831545|NCT02614196|365039018|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
105831546|NCT02614196|365039019|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
105964035|NCT01221623|365525373|FG001|Overall Study|Death|0|||
105964036|NCT01221623|365525372|FG000|Overall Study|Other|5|||
105964037|NCT01221623|365525373|FG001|Overall Study|Other|2|||
105964038|NCT06899737|365525374|FG000|Overall Study|Lost to Follow-up|19|||
105964039|NCT06899737|365525375|FG001|Overall Study|Lost to Follow-up|7|||
105831547|NCT02614196|365039020|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
105964040|NCT02744612|365527131|FG000|Overall Study|Withdrawal by Subject|0|||
105964041|NCT02744612|365527132|FG001|Overall Study|Withdrawal by Subject|2|||
105964042|NCT03522246|365527133|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
105964043|NCT03522246|365527134|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
105964044|NCT03522246|365527135|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
105831548|NCT02614196|365039021|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
105831549|NCT02614196|365039016|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
105831550|NCT02614196|365039017|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
105831551|NCT02614196|365039018|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
105964045|NCT03522246|365527136|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
105831552|NCT02614196|365039019|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
105831553|NCT02614196|365039020|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
105831554|NCT02614196|365039021|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
105831555|NCT02614196|365039016|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
105964046|NCT03522246|365527137|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
105964047|NCT01696968|365527138|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
105964048|NCT01696968|365527139|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
105964049|NCT01696968|365527138|FG000|Overall Study|Died Before Randomization|3|||
105964050|NCT01696968|365527139|FG001|Overall Study|Died Before Randomization|8|||
105964051|NCT01696968|365527138|FG000|Overall Study|Died Before ASU (Control)|278|||
105964052|NCT01696968|365527139|FG001|Overall Study|Died Before ASU (Control)|0|||
105964053|NCT01696968|365527138|FG000|Overall Study|Refused ASU (Control)|920|||
105964054|NCT01696968|365527139|FG001|Overall Study|Refused ASU (Control)|0|||
105964055|NCT01696968|365527138|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
105964056|NCT01696968|365527139|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
105964057|NCT01314118|365527142|FG000|Overall Study|Adverse Event|9|||
105964058|NCT01314118|365527142|FG000|Overall Study|Progressive disease|27|||
105964059|NCT01314118|365527142|FG000|Overall Study|Physician Decision|11|||
105964060|NCT01314118|365527142|FG000|Overall Study|Death|4|||
105964061|NCT01314118|365527142|FG000|Overall Study|Protocol Violation|5|||
105964062|NCT01314118|365527142|FG000|Overall Study|Withdrawal by Subject|11|||
105964063|NCT01314118|365527142|FG000|Overall Study|Other|2|||
105964064|NCT01314118|365527142|FG000|Overall Study|Ongoing|62|||
105964065|NCT02150057|365527143|FG000|Overall Study|Lost to Follow-up|6|||
105964066|NCT02150057|365527144|FG001|Overall Study|Lost to Follow-up|4|||
105964067|NCT03814746|365527145|FG000|Overall Study|Participant decision|9|||
105964068|NCT03814746|365527146|FG001|Overall Study|Participant decision|6|||
105964069|NCT03814746|365527147|FG002|Overall Study|Participant decision|15|||
105964070|NCT03814746|365527145|FG000|Overall Study|Physician Decision|2|||
105964071|NCT03814746|365527146|FG001|Overall Study|Physician Decision|2|||
105964072|NCT03814746|365527147|FG002|Overall Study|Physician Decision|4|||
105964073|NCT03814746|365527145|FG000|Overall Study|Death|2|||
105964074|NCT03814746|365527146|FG001|Overall Study|Death|2|||
105964075|NCT03814746|365527147|FG002|Overall Study|Death|2|||
105964076|NCT03814746|365527145|FG000|Overall Study|Adverse Event|2|||
105964077|NCT03814746|365527146|FG001|Overall Study|Adverse Event|2|||
105964078|NCT03814746|365527147|FG002|Overall Study|Adverse Event|1|||
105964079|NCT03814746|365527145|FG000|Overall Study|Lost to Follow-up|2|||
105964080|NCT03814746|365527146|FG001|Overall Study|Lost to Follow-up|1|||
105964081|NCT03814746|365527147|FG002|Overall Study|Lost to Follow-up|2|||
105964082|NCT03814746|365527145|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105964083|NCT03814746|365527146|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105964084|NCT03814746|365527147|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105964085|NCT03814746|365527145|FG000|Overall Study|Pregnancy|0|||
105964086|NCT03814746|365527146|FG001|Overall Study|Pregnancy|1|||
105964087|NCT03814746|365527147|FG002|Overall Study|Pregnancy|1|||
105964088|NCT03814746|365527145|FG000|Overall Study|Protocol Violation|1|||
105964089|NCT03814746|365527146|FG001|Overall Study|Protocol Violation|0|||
105964090|NCT03814746|365527147|FG002|Overall Study|Protocol Violation|0|||
106022712|NCT04413617|365748643|FG004|Overall Study|Adverse Event|1|||
105831556|NCT02614196|365039017|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
105831557|NCT02614196|365039018|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
105831558|NCT02614196|365039019|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
105831559|NCT02614196|365039020|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
105964091|NCT03458910|365527148|FG000|Overall Study|Withdrawal by Subject|7|||
105964092|NCT03458910|365527149|FG001|Overall Study|Withdrawal by Subject|8|||
105964093|NCT03458910|365527150|FG002|Overall Study|Withdrawal by Subject|6|||
105964094|NCT03458910|365527151|FG003|Overall Study|Withdrawal by Subject|4|||
105964095|NCT03458910|365527148|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
105964096|NCT03458910|365527149|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
105964097|NCT03458910|365527150|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
105964098|NCT03458910|365527151|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
105964099|NCT04995419|365527152|FG000|Overall Study|Withdrawal by Subject|3|||
105964100|NCT04995419|365527152|FG000|Overall Study|Progressive Disease|19|||
105964101|NCT04995419|365527152|FG000|Overall Study|Adverse Event|2|||
105964102|NCT04995419|365527152|FG000|Overall Study|Ongoing|16|||
105964103|NCT00758069|365527155|FG000|Overall Study|Lack of Efficacy|0|||
105964104|NCT00758069|365527156|FG001|Overall Study|Lack of Efficacy|0|||
105964105|NCT00758069|365527157|FG002|Overall Study|Lack of Efficacy|1|||
106022713|NCT04413617|365748639|FG000|Overall Study|COVID-19|0|||
106022714|NCT04413617|365748640|FG001|Overall Study|COVID-19|1|||
105831560|NCT02614196|365039021|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
105831561|NCT00642811|365039022|FG000|Overall Study|Adverse Event|2|||
105831562|NCT00642811|365039023|FG001|Overall Study|Adverse Event|3|||
105831563|NCT00642811|365039024|FG002|Overall Study|Adverse Event|0|||
105831564|NCT00642811|365039025|FG003|Overall Study|Adverse Event|0|||
105831565|NCT00642811|365039026|FG004|Overall Study|Adverse Event|0|||
105831566|NCT00642811|365039027|FG005|Overall Study|Adverse Event|1|||
105831567|NCT00642811|365039022|FG000|Overall Study|Developement of discontinuation criteria|0|||
105831568|NCT00642811|365039023|FG001|Overall Study|Developement of discontinuation criteria|0|||
105831569|NCT00642811|365039024|FG002|Overall Study|Developement of discontinuation criteria|0|||
105831570|NCT00642811|365039025|FG003|Overall Study|Developement of discontinuation criteria|0|||
105831571|NCT00642811|365039026|FG004|Overall Study|Developement of discontinuation criteria|1|||
105831572|NCT00642811|365039027|FG005|Overall Study|Developement of discontinuation criteria|0|||
105831573|NCT00642811|365039022|FG000|Overall Study|Severe Non-compliance to protocol|1|||
105831574|NCT00642811|365039023|FG001|Overall Study|Severe Non-compliance to protocol|0|||
105831575|NCT00642811|365039024|FG002|Overall Study|Severe Non-compliance to protocol|0|||
105831576|NCT00642811|365039025|FG003|Overall Study|Severe Non-compliance to protocol|0|||
105831577|NCT00642811|365039026|FG004|Overall Study|Severe Non-compliance to protocol|0|||
105831578|NCT00642811|365039027|FG005|Overall Study|Severe Non-compliance to protocol|0|||
105831579|NCT00642811|365039022|FG000|Overall Study|Other|0|||
105831580|NCT00642811|365039023|FG001|Overall Study|Other|1|||
105831581|NCT00642811|365039024|FG002|Overall Study|Other|0|||
105831582|NCT00642811|365039025|FG003|Overall Study|Other|1|||
105831583|NCT00642811|365039026|FG004|Overall Study|Other|0|||
105831584|NCT00642811|365039027|FG005|Overall Study|Other|0|||
105831585|NCT00087529|365039028|FG000|Overall Study|Death|1|||
105831586|NCT00087529|365039029|FG001|Overall Study|Death|0|||
105831587|NCT00087529|365039028|FG000|Overall Study|Adverse Event|0|||
105831588|NCT00087529|365039029|FG001|Overall Study|Adverse Event|8|||
105831589|NCT00087529|365039028|FG000|Overall Study|Pregnancy|0|||
105831590|NCT00087529|365039029|FG001|Overall Study|Pregnancy|1|||
105831591|NCT00087529|365039028|FG000|Overall Study|Lost to Follow-up|2|||
105831592|NCT00087529|365039029|FG001|Overall Study|Lost to Follow-up|3|||
105831593|NCT00087529|365039028|FG000|Overall Study|Participant Decision|14|||
105831594|NCT00087529|365039029|FG001|Overall Study|Participant Decision|37|||
105831595|NCT00087529|365039028|FG000|Overall Study|Physician Decision|4|||
105831596|NCT00087529|365039029|FG001|Overall Study|Physician Decision|8|||
105831597|NCT00087529|365039028|FG000|Overall Study|Initiation of Excluded Therapy|0|||
105831598|NCT00087529|365039029|FG001|Overall Study|Initiation of Excluded Therapy|1|||
105831599|NCT00087529|365039028|FG000|Overall Study|Participant Noncompliance|0|||
105831600|NCT00087529|365039029|FG001|Overall Study|Participant Noncompliance|1|||
105831601|NCT00087529|365039028|FG000|Overall Study|Disease Progression|5|||
105831602|NCT00087529|365039029|FG001|Overall Study|Disease Progression|4|||
105831603|NCT00087529|365039028|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
105831604|NCT00087529|365039029|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
105831605|NCT04553406|365039030|FG000|Overall Study|Study Discontinuation|0|||
105831606|NCT04553406|365039031|FG001|Overall Study|Study Discontinuation|1|||
105831607|NCT01539239|365039032|FG000|Overall Study|Death|5|||
105831608|NCT01539239|365039033|FG001|Overall Study|Death|5|||
105831609|NCT01539239|365039032|FG000|Overall Study|Lost to Follow-up|7|||
105831610|NCT01539239|365039033|FG001|Overall Study|Lost to Follow-up|12|||
105831611|NCT01223027|365039037|FG000|Overall Study|Adverse Event|20|||
105831612|NCT01223027|365039038|FG001|Overall Study|Adverse Event|10|||
105831613|NCT01223027|365039037|FG000|Overall Study|Death|42|||
105831614|NCT01223027|365039038|FG001|Overall Study|Death|42|||
105831615|NCT01223027|365039037|FG000|Overall Study|Lost to Follow-up|2|||
105831616|NCT01223027|365039038|FG001|Overall Study|Lost to Follow-up|1|||
105964106|NCT00758069|365527155|FG000|Overall Study|Incorrect Study Drug|1|||
105964107|NCT00758069|365527156|FG001|Overall Study|Incorrect Study Drug|0|||
105964108|NCT00758069|365527157|FG002|Overall Study|Incorrect Study Drug|0|||
105831617|NCT01223027|365039037|FG000|Overall Study|Physician Decision|4|||
105831618|NCT01223027|365039038|FG001|Overall Study|Physician Decision|8|||
105831619|NCT01223027|365039037|FG000|Overall Study|Progressive Disease|167|||
105831620|NCT01223027|365039038|FG001|Overall Study|Progressive Disease|183|||
105831621|NCT01223027|365039037|FG000|Overall Study|Protocol Violation|2|||
105831622|NCT01223027|365039038|FG001|Overall Study|Protocol Violation|1|||
105831623|NCT01223027|365039037|FG000|Overall Study|Subject/guardian decicion|18|||
105831624|NCT01223027|365039038|FG001|Overall Study|Subject/guardian decicion|16|||
105831625|NCT01223027|365039037|FG000|Overall Study|New therapy for study indication|17|||
105831626|NCT01223027|365039038|FG001|Overall Study|New therapy for study indication|8|||
105831627|NCT01223027|365039037|FG000|Overall Study|Study terminated by sponsor|2|||
105964109|NCT02846389|365527160|FG000|Overall Study|Withdrawal by Subject|1|||
105831628|NCT01223027|365039038|FG001|Overall Study|Study terminated by sponsor|8|||
105831629|NCT01992094|365039040|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
105831630|NCT01992094|365039041|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
105831631|NCT01992094|365039042|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
105964110|NCT02846389|365527161|FG001|Overall Study|Withdrawal by Subject|1|||
105831632|NCT01992094|365039040|FG000|Overall Study|Adverse Event|1|||
105831633|NCT01992094|365039041|FG001|Overall Study|Adverse Event|0|||
105831634|NCT01992094|365039042|FG002|Overall Study|Adverse Event|0|||
105831635|NCT01992094|365039040|FG000|Overall Study|Death|5|||
105964111|NCT00853242|365527164|FG000|Overall Study|Adverse Event|0|||
105964112|NCT00853242|365527165|FG001|Overall Study|Adverse Event|1|||
105964113|NCT00853242|365527166|FG002|Overall Study|Adverse Event|1|||
105964114|NCT00853242|365527167|FG003|Overall Study|Adverse Event|0|||
105964115|NCT00853242|365527168|FG004|Overall Study|Adverse Event|3|||
105964116|NCT00853242|365527169|FG005|Overall Study|Adverse Event|1|||
105831636|NCT01992094|365039041|FG001|Overall Study|Death|5|||
105831637|NCT01992094|365039042|FG002|Overall Study|Death|2|||
105831638|NCT01992094|365039040|FG000|Overall Study|Lost to Follow-up|26|||
105831639|NCT01992094|365039041|FG001|Overall Study|Lost to Follow-up|9|||
105831640|NCT01992094|365039042|FG002|Overall Study|Lost to Follow-up|13|||
105831641|NCT01992094|365039040|FG000|Overall Study|OTHER|4|||
105831642|NCT01992094|365039041|FG001|Overall Study|OTHER|0|||
105831643|NCT01992094|365039042|FG002|Overall Study|OTHER|0|||
105831644|NCT01992094|365039040|FG000|Overall Study|Protocol Violation|1|||
105831645|NCT01992094|365039041|FG001|Overall Study|Protocol Violation|0|||
105831646|NCT01992094|365039042|FG002|Overall Study|Protocol Violation|1|||
105831647|NCT01992094|365039040|FG000|Overall Study|Withdrawal by Subject|7|||
105831648|NCT01992094|365039041|FG001|Overall Study|Withdrawal by Subject|3|||
105831649|NCT01992094|365039042|FG002|Overall Study|Withdrawal by Subject|4|||
105831650|NCT04428645|365039043|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
105831651|NCT03201003|365039044|FG000|Overall Study|Adverse Event|14|||
105831652|NCT03201003|365039045|FG001|Overall Study|Adverse Event|1|||
105831653|NCT03201003|365039044|FG000|Overall Study|Other reasons|5|||
105831654|NCT03201003|365039045|FG001|Overall Study|Other reasons|1|||
105831655|NCT03201003|365039044|FG000|Overall Study|Withdrawal by Subject|4|||
105831656|NCT03201003|365039045|FG001|Overall Study|Withdrawal by Subject|1|||
105831657|NCT03201003|365039044|FG000|Overall Study|Lost to Follow-up|2|||
105831658|NCT03201003|365039045|FG001|Overall Study|Lost to Follow-up|0|||
105831659|NCT03201003|365039044|FG000|Overall Study|Protocol Violation|1|||
105831660|NCT03201003|365039045|FG001|Overall Study|Protocol Violation|0|||
105831661|NCT00834613|365039046|FG000|First Intervention|Protocol Violation|1|||
105831662|NCT00834613|365039047|FG001|First Intervention|Protocol Violation|0|||
105831663|NCT00663234|365039048|FG000|Overall Study|Not willing to adhere to requirements|1|||
105831664|NCT01709903|365039049|FG000|Overall Study|administrative problems|2|||
105831665|NCT01709903|365039050|FG001|Overall Study|administrative problems|6|||
105831666|NCT01709903|365039049|FG000|Overall Study|Abnormal test procedure results|1|||
105831667|NCT01709903|365039050|FG001|Overall Study|Abnormal test procedure results|0|||
105831668|NCT01709903|365039049|FG000|Overall Study|In ability to use device|1|||
105831669|NCT01709903|365039050|FG001|Overall Study|In ability to use device|1|||
105831670|NCT01709903|365039049|FG000|Overall Study|no longer needed study drug|0|||
105831671|NCT01709903|365039050|FG001|Overall Study|no longer needed study drug|1|||
105831672|NCT01709903|365039049|FG000|Overall Study|Lost to Follow-up|0|||
105831673|NCT01709903|365039050|FG001|Overall Study|Lost to Follow-up|2|||
105831674|NCT01709903|365039049|FG000|Overall Study|Death|2|||
105831675|NCT01709903|365039050|FG001|Overall Study|Death|0|||
105831676|NCT01709903|365039049|FG000|Overall Study|Protocol Violation|3|||
105831677|NCT01709903|365039050|FG001|Overall Study|Protocol Violation|2|||
105831678|NCT01709903|365039049|FG000|Overall Study|Lack of Efficacy|3|||
105831679|NCT01709903|365039050|FG001|Overall Study|Lack of Efficacy|3|||
105964117|NCT00853242|365527170|FG006|Overall Study|Adverse Event|1|||
105964118|NCT00853242|365527164|FG000|Overall Study|Noncompliant|0|||
105964119|NCT00853242|365527165|FG001|Overall Study|Noncompliant|0|||
105964120|NCT00853242|365527166|FG002|Overall Study|Noncompliant|0|||
105964121|NCT00853242|365527167|FG003|Overall Study|Noncompliant|0|||
105964122|NCT00853242|365527168|FG004|Overall Study|Noncompliant|1|||
105831680|NCT01709903|365039049|FG000|Overall Study|Withdrawal by Subject|6|||
105831681|NCT01709903|365039050|FG001|Overall Study|Withdrawal by Subject|6|||
105831682|NCT01709903|365039049|FG000|Overall Study|Adverse Event|11|||
105831683|NCT01709903|365039050|FG001|Overall Study|Adverse Event|18|||
105831684|NCT02061280|365039051|FG000|Overall Study|Protocol Violation|12|||
105831685|NCT02061280|365039052|FG001|Overall Study|Protocol Violation|8|||
105831686|NCT02061280|365039051|FG000|Overall Study|moved out of state|0|||
105831687|NCT02061280|365039052|FG001|Overall Study|moved out of state|1|||
105831688|NCT02061280|365039051|FG000|Overall Study|Withdrawal by Subject|1|||
105831689|NCT02061280|365039052|FG001|Overall Study|Withdrawal by Subject|2|||
105831690|NCT02061280|365039051|FG000|Overall Study|Lost to Follow-up|5|||
105831691|NCT02061280|365039052|FG001|Overall Study|Lost to Follow-up|1|||
105964123|NCT00853242|365527169|FG005|Overall Study|Noncompliant|0|||
105964124|NCT00853242|365527170|FG006|Overall Study|Noncompliant|0|||
105831692|NCT02473393|365040870|FG000|Overall Study|Adverse Event|0|||
105831693|NCT02473393|365040871|FG001|Overall Study|Adverse Event|0|||
105831694|NCT02473393|365040872|FG002|Overall Study|Adverse Event|1|||
105831695|NCT02473393|365040873|FG003|Overall Study|Adverse Event|0|||
105964125|NCT00853242|365527164|FG000|Overall Study|Withdrawal by Subject|1|||
105831696|NCT02473393|365040870|FG000|Overall Study|Withdrawal by Subject|0|||
105831697|NCT02473393|365040871|FG001|Overall Study|Withdrawal by Subject|0|||
105831698|NCT02473393|365040872|FG002|Overall Study|Withdrawal by Subject|1|||
105831699|NCT02473393|365040873|FG003|Overall Study|Withdrawal by Subject|1|||
105831700|NCT00640393|365040874|FG000|Part 1|Lost to Follow-up|2|||
105831701|NCT00640393|365040875|FG001|Part 1|Lost to Follow-up|0|||
105831702|NCT00640393|365040876|FG002|Part 1|Lost to Follow-up|0|||
105831703|NCT00640393|365040874|FG000|Part 1|Withdrawal by Subject|3|||
105831704|NCT00640393|365040875|FG001|Part 1|Withdrawal by Subject|0|||
105831705|NCT00640393|365040876|FG002|Part 1|Withdrawal by Subject|0|||
105831706|NCT00640393|365040874|FG000|Randomization|Withdrawn per protocol|17|||
105831707|NCT00640393|365040875|FG001|Randomization|Withdrawn per protocol|0|||
105831708|NCT00640393|365040876|FG002|Randomization|Withdrawn per protocol|0|||
105831709|NCT00640393|365040874|FG000|Randomization|Never randomized by site|2|||
105831710|NCT00640393|365040875|FG001|Randomization|Never randomized by site|0|||
105831711|NCT00640393|365040876|FG002|Randomization|Never randomized by site|0|||
105831712|NCT00640393|365040874|FG000|Part 2|Lost to Follow-up|0|||
105831713|NCT00640393|365040875|FG001|Part 2|Lost to Follow-up|2|||
105831714|NCT00640393|365040876|FG002|Part 2|Lost to Follow-up|2|||
105831715|NCT00640393|365040874|FG000|Part 2|Withdrawal by Subject|0|||
105831716|NCT00640393|365040875|FG001|Part 2|Withdrawal by Subject|6|||
105831717|NCT00640393|365040876|FG002|Part 2|Withdrawal by Subject|1|||
105831718|NCT00640393|365040874|FG000|Part 2|Non-adherence|0|||
105831719|NCT00640393|365040875|FG001|Part 2|Non-adherence|1|||
105831720|NCT00640393|365040876|FG002|Part 2|Non-adherence|0|||
105831721|NCT00640393|365040874|FG000|Part 2|Adverse Event|0|||
105831722|NCT00640393|365040875|FG001|Part 2|Adverse Event|1|||
105831723|NCT00640393|365040876|FG002|Part 2|Adverse Event|0|||
105831724|NCT04406194|365040878|FG000|Period 1|Withdrawal by Subject|0|||
105831725|NCT04406194|365040879|FG001|Period 1|Withdrawal by Subject|1|||
105831726|NCT04102345|365040886|FG000|Overall Study|Withdrawal by Subject|1|||
105831727|NCT04102345|365040887|FG001|Overall Study|Withdrawal by Subject|0|||
105831728|NCT02419573|365040888|FG000|Overall Study|Lost to Follow-up|3|||
105831729|NCT02419573|365040889|FG001|Overall Study|Lost to Follow-up|0|||
105831730|NCT02419573|365040888|FG000|Overall Study|Withdrawal by Subject|1|||
105831731|NCT02419573|365040889|FG001|Overall Study|Withdrawal by Subject|0|||
105831732|NCT01513239|365040903|FG000|Period 1: Main Phase|Adverse Event|1|||
105831733|NCT01513239|365040904|FG001|Period 1: Main Phase|Adverse Event|1|||
105831734|NCT01513239|365040905|FG002|Period 1: Main Phase|Adverse Event|2|||
105831735|NCT01513239|365040906|FG003|Period 1: Main Phase|Adverse Event|0|||
105831736|NCT01513239|365040907|FG004|Period 1: Main Phase|Adverse Event|0|||
105831737|NCT01513239|365040908|FG005|Period 1: Main Phase|Adverse Event|0|||
105831738|NCT01513239|365040903|FG000|Period 1: Main Phase|Death|29|||
105831739|NCT01513239|365040904|FG001|Period 1: Main Phase|Death|22|||
105831740|NCT01513239|365040905|FG002|Period 1: Main Phase|Death|32|||
105831741|NCT01513239|365040906|FG003|Period 1: Main Phase|Death|0|||
105831742|NCT01513239|365040907|FG004|Period 1: Main Phase|Death|0|||
105831743|NCT01513239|365040908|FG005|Period 1: Main Phase|Death|0|||
105831744|NCT01513239|365040903|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
105831745|NCT01513239|365040904|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
105831746|NCT01513239|365040905|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
105831747|NCT01513239|365040906|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
105831748|NCT01513239|365040907|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
105831749|NCT01513239|365040908|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
105831750|NCT01513239|365040903|FG000|Period 1: Main Phase|Physician Decision|4|||
105831751|NCT01513239|365040904|FG001|Period 1: Main Phase|Physician Decision|4|||
105831752|NCT01513239|365040905|FG002|Period 1: Main Phase|Physician Decision|4|||
105831753|NCT01513239|365040906|FG003|Period 1: Main Phase|Physician Decision|0|||
105831754|NCT01513239|365040907|FG004|Period 1: Main Phase|Physician Decision|0|||
105831755|NCT01513239|365040908|FG005|Period 1: Main Phase|Physician Decision|0|||
105831756|NCT01513239|365040903|FG000|Period 1: Main Phase|Protocol Violation|2|||
105831757|NCT01513239|365040904|FG001|Period 1: Main Phase|Protocol Violation|2|||
105831758|NCT01513239|365040905|FG002|Period 1: Main Phase|Protocol Violation|2|||
105831759|NCT01513239|365040906|FG003|Period 1: Main Phase|Protocol Violation|0|||
105964126|NCT00853242|365527165|FG001|Overall Study|Withdrawal by Subject|2|||
105964127|NCT00853242|365527166|FG002|Overall Study|Withdrawal by Subject|0|||
105964128|NCT00853242|365527167|FG003|Overall Study|Withdrawal by Subject|4|||
105964129|NCT00853242|365527168|FG004|Overall Study|Withdrawal by Subject|0|||
105964130|NCT00853242|365527169|FG005|Overall Study|Withdrawal by Subject|0|||
105964131|NCT00853242|365527170|FG006|Overall Study|Withdrawal by Subject|2|||
105831760|NCT01513239|365040907|FG004|Period 1: Main Phase|Protocol Violation|0|||
105831761|NCT01513239|365040908|FG005|Period 1: Main Phase|Protocol Violation|0|||
105831762|NCT01513239|365040903|FG000|Period 1: Main Phase|Technical Problems|1|||
105831763|NCT01513239|365040904|FG001|Period 1: Main Phase|Technical Problems|2|||
105831764|NCT01513239|365040905|FG002|Period 1: Main Phase|Technical Problems|0|||
105831765|NCT01513239|365040906|FG003|Period 1: Main Phase|Technical Problems|0|||
105831766|NCT01513239|365040907|FG004|Period 1: Main Phase|Technical Problems|0|||
105831767|NCT01513239|365040908|FG005|Period 1: Main Phase|Technical Problems|0|||
105831768|NCT01513239|365040903|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
105831769|NCT01513239|365040904|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
105831770|NCT01513239|365040905|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
105831771|NCT01513239|365040906|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
105831772|NCT01513239|365040907|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
105831773|NCT01513239|365040908|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
105831774|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
105831775|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
105831776|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
105831777|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
105831778|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
105831779|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
105831780|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Death|0|||
105831781|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Death|0|||
105831782|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Death|0|||
105831783|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Death|2|||
105831784|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Death|5|||
105831785|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Death|2|||
105831786|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
105831787|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
105831788|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
105831789|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
105831790|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
105831791|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
105831792|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831793|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831794|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831795|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
105831796|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831797|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
105831798|NCT01513239|365040903|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
105831799|NCT01513239|365040904|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
105831800|NCT01513239|365040905|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
105831801|NCT01513239|365040906|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
105831802|NCT01513239|365040907|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
105831803|NCT01513239|365040908|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
105831804|NCT00396162|365040909|FG000|Overall Study|Withdrawal by Subject|2|||
105831805|NCT00396162|365040910|FG001|Overall Study|Withdrawal by Subject|3|||
105831806|NCT03167606|365040913|FG000|Overall Study|Lost to Follow-up|73|||
105831807|NCT03167606|365040914|FG001|Overall Study|Lost to Follow-up|64|||
105831808|NCT03167606|365040913|FG000|Overall Study|Withdrawal by Subject|6|||
105831809|NCT03167606|365040914|FG001|Overall Study|Withdrawal by Subject|5|||
105831810|NCT03167606|365040913|FG000|Overall Study|Withdrawal by Investigator|0|||
105831811|NCT03167606|365040914|FG001|Overall Study|Withdrawal by Investigator|2|||
105831812|NCT00059332|365040915|FG000|Overall Study|Withdrawal by Subject|2|||
105831813|NCT00059332|365040916|FG001|Overall Study|Withdrawal by Subject|1|||
105831814|NCT00059332|365040915|FG000|Overall Study|Lost to Follow-up|1|||
105831815|NCT00059332|365040916|FG001|Overall Study|Lost to Follow-up|1|||
105831816|NCT01741545|365040917|FG000|Treatment Period|Lack of Efficacy|0|||
105964132|NCT00853242|365527164|FG000|Overall Study|Other|2|||
105964133|NCT00853242|365527165|FG001|Overall Study|Other|0|||
105964134|NCT00853242|365527166|FG002|Overall Study|Other|2|||
105831817|NCT01741545|365040918|FG001|Treatment Period|Lack of Efficacy|1|||
105831818|NCT01741545|365040917|FG000|Treatment Period|Adverse event, non-fatal|1|||
105831819|NCT01741545|365040918|FG001|Treatment Period|Adverse event, non-fatal|3|||
105831820|NCT01741545|365040917|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
105831821|NCT01741545|365040918|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
105831822|NCT01741545|365040917|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
105831823|NCT01741545|365040918|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
105831824|NCT01456962|365040919|FG000|Overall Study|Lost to Follow-up|2|||
105831825|NCT01456962|365040920|FG001|Overall Study|Lost to Follow-up|1|||
105831826|NCT01911429|365040921|FG000|Overall Study|Adverse Event|5|||
105831827|NCT01911429|365040922|FG001|Overall Study|Adverse Event|3|||
105831828|NCT01911429|365040923|FG002|Overall Study|Adverse Event|9|||
105964135|NCT00853242|365527167|FG003|Overall Study|Other|0|||
105964136|NCT00853242|365527168|FG004|Overall Study|Other|0|||
105831829|NCT01911429|365040921|FG000|Overall Study|Lack of Efficacy|1|||
105831830|NCT01911429|365040922|FG001|Overall Study|Lack of Efficacy|2|||
105964137|NCT00853242|365527169|FG005|Overall Study|Other|1|||
105831831|NCT01911429|365040923|FG002|Overall Study|Lack of Efficacy|4|||
105831832|NCT01911429|365040921|FG000|Overall Study|Lost to Follow-up|0|||
105831833|NCT01911429|365040922|FG001|Overall Study|Lost to Follow-up|0|||
105964138|NCT00853242|365527170|FG006|Overall Study|Other|2|||
105831834|NCT01911429|365040923|FG002|Overall Study|Lost to Follow-up|1|||
105831835|NCT01911429|365040921|FG000|Overall Study|Protocol Violation|0|||
105831836|NCT01911429|365040922|FG001|Overall Study|Protocol Violation|0|||
105831837|NCT01911429|365040923|FG002|Overall Study|Protocol Violation|1|||
105831838|NCT01911429|365040921|FG000|Overall Study|Withdrawal by Subject|5|||
105831839|NCT01911429|365040922|FG001|Overall Study|Withdrawal by Subject|5|||
105831840|NCT01911429|365040923|FG002|Overall Study|Withdrawal by Subject|4|||
105831841|NCT01911429|365040921|FG000|Overall Study|Accidental randomization|0|||
105831842|NCT01911429|365040922|FG001|Overall Study|Accidental randomization|0|||
105831843|NCT01911429|365040923|FG002|Overall Study|Accidental randomization|1|||
105831844|NCT01911429|365040921|FG000|Overall Study|subject left study|1|||
105831845|NCT01911429|365040922|FG001|Overall Study|subject left study|0|||
105831846|NCT01911429|365040923|FG002|Overall Study|subject left study|0|||
105831847|NCT00413049|365040927|FG000|Overall Study|Adverse Event|10|||
105831848|NCT00413049|365040928|FG001|Overall Study|Adverse Event|8|||
105831849|NCT00413049|365040927|FG000|Overall Study|Withdrawal by Subject|7|||
105831850|NCT00413049|365040928|FG001|Overall Study|Withdrawal by Subject|5|||
105831851|NCT00413049|365040927|FG000|Overall Study|Lost to Follow-up|2|||
105831852|NCT00413049|365040928|FG001|Overall Study|Lost to Follow-up|3|||
105831853|NCT00413049|365040927|FG000|Overall Study|Protocol Violation|3|||
105831854|NCT00413049|365040928|FG001|Overall Study|Protocol Violation|1|||
105831855|NCT00413049|365040927|FG000|Overall Study|Subject no longer requires study drug|0|||
105831856|NCT00413049|365040928|FG001|Overall Study|Subject no longer requires study drug|1|||
105831857|NCT00413049|365040927|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105831858|NCT00413049|365040928|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105831859|NCT00413049|365040927|FG000|Overall Study|Lack of Efficacy|1|||
105831860|NCT00413049|365040928|FG001|Overall Study|Lack of Efficacy|0|||
105831861|NCT01460628|365040929|FG000|Overall Study|Adverse Event|3|||
105831862|NCT01460628|365040929|FG000|Overall Study|Withdrawal by Subject|2|||
105831863|NCT02587143|365040930|FG000|Overall Study|Adverse Event|1|||
105831864|NCT02587143|365040931|FG001|Overall Study|Adverse Event|0|||
105831865|NCT01664039|365040933|FG000|Overall Study|Adverse Event|3|||
105831866|NCT01664039|365040934|FG001|Overall Study|Adverse Event|4|||
105831867|NCT01664039|365040933|FG000|Overall Study|Lost to Follow-up|1|||
105831868|NCT01664039|365040934|FG001|Overall Study|Lost to Follow-up|1|||
105831869|NCT01664039|365040933|FG000|Overall Study|Withdrawal by Subject|1|||
105831870|NCT01664039|365040934|FG001|Overall Study|Withdrawal by Subject|3|||
105831871|NCT01664039|365040933|FG000|Overall Study|Noncompliance|1|||
105831872|NCT01664039|365040934|FG001|Overall Study|Noncompliance|1|||
105831873|NCT03314857|365040935|FG000|Overall Study|Death|4|||
105831874|NCT03314857|365040935|FG000|Overall Study|Physician Decision|1|||
105831875|NCT02167594|365040937|FG000|Overall Study|Withdrawal by Subject|2|||
105831876|NCT02167594|365040938|FG001|Overall Study|Withdrawal by Subject|0|||
105831877|NCT02167594|365040939|FG002|Overall Study|Withdrawal by Subject|0|||
105831878|NCT02167594|365040937|FG000|Overall Study|Death|0|||
105831879|NCT02167594|365040938|FG001|Overall Study|Death|1|||
105831880|NCT02167594|365040939|FG002|Overall Study|Death|0|||
105831881|NCT04281472|365040947|FG000|Stage A|Lack of Efficacy|8|||
105831882|NCT04281472|365040948|FG001|Stage A|Lack of Efficacy|0|||
105831883|NCT04281472|365040949|FG002|Stage A|Lack of Efficacy|0|||
105831884|NCT04281472|365040947|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
105831885|NCT04281472|365040948|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
105831886|NCT04281472|365040949|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
105831887|NCT04281472|365040947|FG000|Stage A|Adverse Event|20|||
105831888|NCT04281472|365040948|FG001|Stage A|Adverse Event|0|||
105831889|NCT04281472|365040949|FG002|Stage A|Adverse Event|0|||
105831890|NCT04281472|365040947|FG000|Stage A|Death|1|||
105831891|NCT04281472|365040948|FG001|Stage A|Death|0|||
105831892|NCT04281472|365040949|FG002|Stage A|Death|0|||
105831893|NCT04281472|365040947|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
105831894|NCT04281472|365040948|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
105831895|NCT04281472|365040949|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
105964139|NCT01296711|365527171|FG000|Overall Study|Adverse Event|3|||
105964140|NCT01296711|365527172|FG001|Overall Study|Adverse Event|1|||
105964141|NCT01296711|365527173|FG002|Overall Study|Adverse Event|4|||
105964142|NCT01296711|365527174|FG003|Overall Study|Adverse Event|3|||
105831896|NCT04281472|365040947|FG000|Stage A|Lost to Follow-up|2|||
105831897|NCT04281472|365040948|FG001|Stage A|Lost to Follow-up|0|||
105831898|NCT04281472|365040949|FG002|Stage A|Lost to Follow-up|0|||
105831899|NCT04281472|365040947|FG000|Stage A|Non-compliance with study drug|1|||
105831900|NCT04281472|365040948|FG001|Stage A|Non-compliance with study drug|0|||
105831901|NCT04281472|365040949|FG002|Stage A|Non-compliance with study drug|0|||
105831902|NCT04281472|365040947|FG000|Stage A|Physician Decision|1|||
105831903|NCT04281472|365040948|FG001|Stage A|Physician Decision|0|||
105831904|NCT04281472|365040949|FG002|Stage A|Physician Decision|0|||
105964143|NCT01296711|365527175|FG004|Overall Study|Adverse Event|1|||
105964144|NCT01296711|365527176|FG005|Overall Study|Adverse Event|6|||
105964145|NCT01296711|365527177|FG006|Overall Study|Adverse Event|11|||
105831905|NCT04281472|365040947|FG000|Stage A|Prohibited medications|2|||
105831906|NCT04281472|365040948|FG001|Stage A|Prohibited medications|0|||
105831907|NCT04281472|365040949|FG002|Stage A|Prohibited medications|0|||
105831908|NCT04281472|365040947|FG000|Stage A|Withdrawal by Subject|11|||
105831909|NCT04281472|365040948|FG001|Stage A|Withdrawal by Subject|0|||
105831910|NCT04281472|365040949|FG002|Stage A|Withdrawal by Subject|0|||
105831911|NCT04281472|365040947|FG000|Stage A|Other|5|||
105831912|NCT04281472|365040948|FG001|Stage A|Other|0|||
105831913|NCT04281472|365040949|FG002|Stage A|Other|0|||
105831914|NCT04281472|365040947|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
105831915|NCT04281472|365040948|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
105831916|NCT04281472|365040949|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
105831917|NCT04281472|365040947|FG000|Stage B|Adverse Event|0|||
105831918|NCT04281472|365040948|FG001|Stage B|Adverse Event|3|||
105831919|NCT04281472|365040949|FG002|Stage B|Adverse Event|0|||
105831920|NCT04281472|365040947|FG000|Stage B|Death|0|||
105831921|NCT04281472|365040948|FG001|Stage B|Death|0|||
105831922|NCT04281472|365040949|FG002|Stage B|Death|1|||
105831923|NCT04281472|365040947|FG000|Stage B|Lack of Efficacy|0|||
105831924|NCT04281472|365040948|FG001|Stage B|Lack of Efficacy|0|||
105831925|NCT04281472|365040949|FG002|Stage B|Lack of Efficacy|1|||
105831926|NCT04281472|365040947|FG000|Stage B|Lost to Follow-up|0|||
105831927|NCT04281472|365040948|FG001|Stage B|Lost to Follow-up|0|||
105831928|NCT04281472|365040949|FG002|Stage B|Lost to Follow-up|2|||
105831929|NCT04281472|365040947|FG000|Stage B|Prohibited medications|0|||
105831930|NCT04281472|365040948|FG001|Stage B|Prohibited medications|2|||
105831931|NCT04281472|365040949|FG002|Stage B|Prohibited medications|1|||
105831932|NCT04281472|365040947|FG000|Stage B|Protocol Violation|0|||
105831933|NCT04281472|365040948|FG001|Stage B|Protocol Violation|1|||
105831934|NCT04281472|365040949|FG002|Stage B|Protocol Violation|1|||
105831935|NCT04281472|365040947|FG000|Stage B|Sponsor decision|0|||
105831936|NCT04281472|365040948|FG001|Stage B|Sponsor decision|0|||
105831937|NCT04281472|365040949|FG002|Stage B|Sponsor decision|1|||
105831938|NCT04281472|365040947|FG000|Stage B|Withdrawal by Subject|0|||
105831939|NCT04281472|365040948|FG001|Stage B|Withdrawal by Subject|3|||
105831940|NCT04281472|365040949|FG002|Stage B|Withdrawal by Subject|3|||
105831941|NCT04281472|365040947|FG000|Stage B|Other|0|||
105831942|NCT04281472|365040948|FG001|Stage B|Other|3|||
105831943|NCT04281472|365040949|FG002|Stage B|Other|0|||
105831944|NCT05278858|365040950|FG000|Overall Study|Withdrawal by Subject|1|||
105831945|NCT02640235|365040951|FG000|Overall Study|Withdrawal by Subject|7|||
105964146|NCT01296711|365527178|FG007|Overall Study|Adverse Event|3|||
105964147|NCT01296711|365527171|FG000|Overall Study|Lack of Efficacy|1|||
105964148|NCT01296711|365527172|FG001|Overall Study|Lack of Efficacy|4|||
105964149|NCT01296711|365527173|FG002|Overall Study|Lack of Efficacy|1|||
105964150|NCT01296711|365527174|FG003|Overall Study|Lack of Efficacy|1|||
105964151|NCT01296711|365527175|FG004|Overall Study|Lack of Efficacy|1|||
105964152|NCT01296711|365527176|FG005|Overall Study|Lack of Efficacy|0|||
105964153|NCT01296711|365527177|FG006|Overall Study|Lack of Efficacy|2|||
105964154|NCT01296711|365527178|FG007|Overall Study|Lack of Efficacy|3|||
105964155|NCT01296711|365527171|FG000|Overall Study|Lost to Follow-up|0|||
105964156|NCT01296711|365527172|FG001|Overall Study|Lost to Follow-up|0|||
105964157|NCT01296711|365527173|FG002|Overall Study|Lost to Follow-up|1|||
105964158|NCT01296711|365527174|FG003|Overall Study|Lost to Follow-up|1|||
105964159|NCT01296711|365527175|FG004|Overall Study|Lost to Follow-up|2|||
105964160|NCT01296711|365527176|FG005|Overall Study|Lost to Follow-up|0|||
105964161|NCT01296711|365527177|FG006|Overall Study|Lost to Follow-up|4|||
105964162|NCT01296711|365527178|FG007|Overall Study|Lost to Follow-up|2|||
105964163|NCT01296711|365527171|FG000|Overall Study|Protocol Violation|0|||
105964164|NCT01296711|365527172|FG001|Overall Study|Protocol Violation|0|||
105964165|NCT01296711|365527173|FG002|Overall Study|Protocol Violation|0|||
105964166|NCT01296711|365527174|FG003|Overall Study|Protocol Violation|1|||
105964167|NCT01296711|365527175|FG004|Overall Study|Protocol Violation|1|||
105964168|NCT01296711|365527176|FG005|Overall Study|Protocol Violation|0|||
105964169|NCT01296711|365527177|FG006|Overall Study|Protocol Violation|0|||
105964170|NCT01296711|365527178|FG007|Overall Study|Protocol Violation|0|||
105964171|NCT01296711|365527171|FG000|Overall Study|Withdrawal by Subject|4|||
105964172|NCT01296711|365527172|FG001|Overall Study|Withdrawal by Subject|2|||
105964173|NCT01296711|365527173|FG002|Overall Study|Withdrawal by Subject|2|||
105964174|NCT01296711|365527174|FG003|Overall Study|Withdrawal by Subject|1|||
105964175|NCT01296711|365527175|FG004|Overall Study|Withdrawal by Subject|1|||
105964176|NCT01296711|365527176|FG005|Overall Study|Withdrawal by Subject|1|||
105964177|NCT01296711|365527177|FG006|Overall Study|Withdrawal by Subject|2|||
105964178|NCT01296711|365527178|FG007|Overall Study|Withdrawal by Subject|1|||
105964179|NCT01296711|365527171|FG000|Overall Study|Study termination|8|||
105964180|NCT01296711|365527172|FG001|Overall Study|Study termination|1|||
105964181|NCT01296711|365527173|FG002|Overall Study|Study termination|5|||
105964182|NCT01296711|365527174|FG003|Overall Study|Study termination|4|||
105831946|NCT02640235|365040952|FG001|Overall Study|Withdrawal by Subject|6|||
105831947|NCT02640235|365040951|FG000|Overall Study|Lost to Follow-up|4|||
105831948|NCT02640235|365040952|FG001|Overall Study|Lost to Follow-up|3|||
105831949|NCT02640235|365040951|FG000|Overall Study|Death|2|||
105831950|NCT02640235|365040952|FG001|Overall Study|Death|3|||
105831951|NCT02640235|365040951|FG000|Overall Study|Other|1|||
105831952|NCT02640235|365040952|FG001|Overall Study|Other|2|||
105831953|NCT00152451|365040953|FG000|Overall Study|Adverse Event|4|||
105831954|NCT04697173|365040956|FG000|Overall Study|Withdrawal by Subject|34|||
105831955|NCT04697173|365040957|FG001|Overall Study|Withdrawal by Subject|38|||
105831956|NCT04608448|365040958|FG000|Overall Study|Withdrawal by Subject|1|||
105831957|NCT04608448|365040958|FG000|Overall Study|Adverse Event|1|||
105831958|NCT00674128|365040961|FG000|Overall Study|Withdrawal by Subject|25|||
105831959|NCT00674128|365040962|FG001|Overall Study|Withdrawal by Subject|23|||
105831960|NCT05004649|365040971|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
105831961|NCT05004649|365040971|FG000|Overall Study|Lost to Follow-up|1|||
105831962|NCT05004649|365040971|FG000|Overall Study|Withdrawal by Subject|2|||
105964183|NCT01296711|365527175|FG004|Overall Study|Study termination|4|||
105831963|NCT05004649|365040971|FG000|Overall Study|COVID-19|1|||
105831964|NCT03504085|365040973|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
105831965|NCT03504085|365040974|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
105831966|NCT03504085|365040973|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
105831967|NCT03504085|365040974|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
105831968|NCT02761915|365040975|FG000|Overall Study|Death|3|||
105831969|NCT02761915|365040976|FG001|Overall Study|Death|1|||
105831970|NCT02761915|365040977|FG002|Overall Study|Death|1|||
105831971|NCT02761915|365040978|FG003|Overall Study|Death|1|||
105831972|NCT02761915|365040979|FG004|Overall Study|Death|0|||
105831973|NCT02761915|365040980|FG005|Overall Study|Death|1|||
105831974|NCT02761915|365040975|FG000|Overall Study|Withdrawal by Subject|1|||
105831975|NCT02761915|365040976|FG001|Overall Study|Withdrawal by Subject|0|||
105831976|NCT02761915|365040977|FG002|Overall Study|Withdrawal by Subject|0|||
105831977|NCT02761915|365040978|FG003|Overall Study|Withdrawal by Subject|0|||
105831978|NCT02761915|365040979|FG004|Overall Study|Withdrawal by Subject|1|||
105831979|NCT02761915|365040980|FG005|Overall Study|Withdrawal by Subject|2|||
105831980|NCT02761915|365040975|FG000|Overall Study|Disease Progression|0|||
105831981|NCT02761915|365040976|FG001|Overall Study|Disease Progression|0|||
105831982|NCT02761915|365040977|FG002|Overall Study|Disease Progression|0|||
105831983|NCT02761915|365040978|FG003|Overall Study|Disease Progression|2|||
105831984|NCT02761915|365040979|FG004|Overall Study|Disease Progression|2|||
105831985|NCT02761915|365040980|FG005|Overall Study|Disease Progression|2|||
105831986|NCT01617096|365040992|FG000|Overall Study|Withdrawal by Subject|96|||
105831987|NCT01617096|365040993|FG001|Overall Study|Withdrawal by Subject|81|||
105831988|NCT01617096|365040992|FG000|Overall Study|Lost to Follow-up|37|||
105831989|NCT01617096|365040993|FG001|Overall Study|Lost to Follow-up|32|||
105831990|NCT01617096|365040992|FG000|Overall Study|Physician Decision|10|||
105831991|NCT01617096|365040993|FG001|Overall Study|Physician Decision|18|||
105831992|NCT01617096|365040992|FG000|Overall Study|Death|4|||
105831993|NCT01617096|365040993|FG001|Overall Study|Death|3|||
105831994|NCT01617096|365040992|FG000|Overall Study|Other|1|||
105831995|NCT01617096|365040993|FG001|Overall Study|Other|3|||
105831996|NCT04473326|365040994|FG000|Overall Study|Death|0|||
105831997|NCT04473326|365040995|FG001|Overall Study|Death|1|||
105831998|NCT04473326|365040994|FG000|Overall Study|Withdrawal by Subject|1|||
105831999|NCT04473326|365040995|FG001|Overall Study|Withdrawal by Subject|2|||
105832000|NCT02229084|365040996|FG000|Overall Study|Adverse Event|1|||
105832001|NCT02229084|365040997|FG001|Overall Study|Adverse Event|0|||
105832002|NCT02229084|365040998|FG002|Overall Study|Adverse Event|0|||
105832003|NCT02229084|365040999|FG003|Overall Study|Adverse Event|0|||
105832004|NCT02229084|365041000|FG004|Overall Study|Adverse Event|0|||
105832005|NCT02229084|365041001|FG005|Overall Study|Adverse Event|0|||
105832006|NCT02229084|365041002|FG006|Overall Study|Adverse Event|0|||
105832007|NCT02229084|365040996|FG000|Overall Study|Lost to Follow-up|0|||
105832008|NCT02229084|365040997|FG001|Overall Study|Lost to Follow-up|0|||
105832009|NCT02229084|365040998|FG002|Overall Study|Lost to Follow-up|1|||
105964184|NCT01296711|365527176|FG005|Overall Study|Study termination|4|||
105832010|NCT02229084|365040999|FG003|Overall Study|Lost to Follow-up|1|||
105832011|NCT02229084|365041000|FG004|Overall Study|Lost to Follow-up|0|||
105832012|NCT02229084|365041001|FG005|Overall Study|Lost to Follow-up|0|||
105964185|NCT01296711|365527177|FG006|Overall Study|Study termination|8|||
105964186|NCT01296711|365527178|FG007|Overall Study|Study termination|10|||
105832013|NCT02229084|365041002|FG006|Overall Study|Lost to Follow-up|1|||
105832014|NCT02229084|365040996|FG000|Overall Study|Physician Decision|0|||
105832015|NCT02229084|365040997|FG001|Overall Study|Physician Decision|0|||
105832016|NCT02229084|365040998|FG002|Overall Study|Physician Decision|0|||
105832017|NCT02229084|365040999|FG003|Overall Study|Physician Decision|1|||
105964187|NCT01296711|365527171|FG000|Overall Study|Continued elevated liver enzymes|0|||
105964188|NCT01296711|365527172|FG001|Overall Study|Continued elevated liver enzymes|0|||
105964189|NCT01296711|365527173|FG002|Overall Study|Continued elevated liver enzymes|0|||
105832018|NCT02229084|365041000|FG004|Overall Study|Physician Decision|3|||
105832019|NCT02229084|365041001|FG005|Overall Study|Physician Decision|0|||
105832020|NCT02229084|365041002|FG006|Overall Study|Physician Decision|1|||
105832021|NCT02229084|365040996|FG000|Overall Study|Withdrawal by Subject|0|||
105964190|NCT01296711|365527174|FG003|Overall Study|Continued elevated liver enzymes|1|||
105964191|NCT01296711|365527175|FG004|Overall Study|Continued elevated liver enzymes|0|||
105964192|NCT01296711|365527176|FG005|Overall Study|Continued elevated liver enzymes|0|||
105964193|NCT01296711|365527177|FG006|Overall Study|Continued elevated liver enzymes|0|||
105964194|NCT01296711|365527178|FG007|Overall Study|Continued elevated liver enzymes|0|||
105964195|NCT01296711|365527171|FG000|Overall Study|Methotrexate discontinued|0|||
105964196|NCT01296711|365527172|FG001|Overall Study|Methotrexate discontinued|0|||
105832022|NCT02229084|365040997|FG001|Overall Study|Withdrawal by Subject|0|||
105832023|NCT02229084|365040998|FG002|Overall Study|Withdrawal by Subject|1|||
105832024|NCT02229084|365040999|FG003|Overall Study|Withdrawal by Subject|0|||
105832025|NCT02229084|365041000|FG004|Overall Study|Withdrawal by Subject|1|||
105832026|NCT02229084|365041001|FG005|Overall Study|Withdrawal by Subject|1|||
105832027|NCT02229084|365041002|FG006|Overall Study|Withdrawal by Subject|1|||
105832028|NCT02229084|365040996|FG000|Overall Study|Death|0|||
105832029|NCT02229084|365040997|FG001|Overall Study|Death|0|||
105832030|NCT02229084|365040998|FG002|Overall Study|Death|0|||
105832031|NCT02229084|365040999|FG003|Overall Study|Death|0|||
105832032|NCT02229084|365041000|FG004|Overall Study|Death|0|||
105964197|NCT01296711|365527173|FG002|Overall Study|Methotrexate discontinued|0|||
105964198|NCT01296711|365527174|FG003|Overall Study|Methotrexate discontinued|1|||
105964199|NCT01296711|365527175|FG004|Overall Study|Methotrexate discontinued|0|||
105964200|NCT01296711|365527176|FG005|Overall Study|Methotrexate discontinued|0|||
105964201|NCT01296711|365527177|FG006|Overall Study|Methotrexate discontinued|0|||
105964202|NCT01296711|365527178|FG007|Overall Study|Methotrexate discontinued|0|||
105832033|NCT02229084|365041001|FG005|Overall Study|Death|0|||
105832034|NCT02229084|365041002|FG006|Overall Study|Death|1|||
105964203|NCT01296711|365527171|FG000|Overall Study|Investigator discretion|0|||
105964204|NCT01296711|365527172|FG001|Overall Study|Investigator discretion|0|||
105964205|NCT01296711|365527173|FG002|Overall Study|Investigator discretion|0|||
105964206|NCT01296711|365527174|FG003|Overall Study|Investigator discretion|0|||
105964207|NCT01296711|365527175|FG004|Overall Study|Investigator discretion|0|||
105964208|NCT01296711|365527176|FG005|Overall Study|Investigator discretion|0|||
105964209|NCT01296711|365527177|FG006|Overall Study|Investigator discretion|1|||
105964210|NCT01296711|365527178|FG007|Overall Study|Investigator discretion|0|||
105964211|NCT01296711|365527171|FG000|Overall Study|Other|0|||
105964212|NCT01296711|365527172|FG001|Overall Study|Other|0|||
105964213|NCT01296711|365527173|FG002|Overall Study|Other|0|||
105964214|NCT01296711|365527174|FG003|Overall Study|Other|0|||
105964215|NCT01296711|365527175|FG004|Overall Study|Other|0|||
105964216|NCT01296711|365527176|FG005|Overall Study|Other|0|||
105832035|NCT01344018|365041003|FG000|Overall Study|Death|22|||
105832036|NCT01344018|365041004|FG001|Overall Study|Death|25|||
105964217|NCT01296711|365527177|FG006|Overall Study|Other|1|||
106022715|NCT04413617|365748641|FG002|Overall Study|COVID-19|0|||
106022716|NCT04413617|365748642|FG003|Overall Study|COVID-19|0|||
106022717|NCT04413617|365748643|FG004|Overall Study|COVID-19|0|||
106022718|NCT00312195|365748644|FG000|Overall Study|Adverse Event|4|||
106022719|NCT00312195|365748645|FG001|Overall Study|Adverse Event|6|||
106022720|NCT00312195|365748644|FG000|Overall Study|Lost to Follow-up|1|||
106022721|NCT00312195|365748645|FG001|Overall Study|Lost to Follow-up|0|||
106022722|NCT00312195|365748644|FG000|Overall Study|Protocol Violation|1|||
106022723|NCT00312195|365748645|FG001|Overall Study|Protocol Violation|0|||
106022724|NCT02657408|365748646|FG000|Overall Study|Adverse Event|3|||
106022725|NCT02657408|365748647|FG001|Overall Study|Adverse Event|7|||
106022726|NCT00344487|365748649|FG000|Overall Study|immunologic failure|1|||
106022727|NCT02504216|365748651|FG000|Overall Study|Lost to Follow-up|3|||
106022728|NCT02504216|365748652|FG001|Overall Study|Lost to Follow-up|3|||
106022729|NCT02504216|365748651|FG000|Overall Study|Withdrawal by Subject|8|||
106022730|NCT02504216|365748652|FG001|Overall Study|Withdrawal by Subject|12|||
106022731|NCT00862082|365748653|FG000|Overall Study|Sponsor decision to terminate the study|5|||
106022732|NCT00862082|365748654|FG001|Overall Study|Sponsor decision to terminate the study|0|||
105964218|NCT01296711|365527178|FG007|Overall Study|Other|0|||
105964219|NCT01296711|365527171|FG000|Overall Study|Required restricted steroid injections|0|||
105964220|NCT01296711|365527172|FG001|Overall Study|Required restricted steroid injections|0|||
105964221|NCT01296711|365527173|FG002|Overall Study|Required restricted steroid injections|0|||
105832037|NCT01344018|365041003|FG000|Overall Study|Lost to Follow-up|4|||
105832038|NCT01344018|365041004|FG001|Overall Study|Lost to Follow-up|7|||
105964222|NCT01296711|365527174|FG003|Overall Study|Required restricted steroid injections|0|||
105964223|NCT01296711|365527175|FG004|Overall Study|Required restricted steroid injections|0|||
105964224|NCT01296711|365527176|FG005|Overall Study|Required restricted steroid injections|0|||
106022733|NCT00862082|365748653|FG000|Overall Study|Withdrawal by Subject|0|||
106022734|NCT00862082|365748654|FG001|Overall Study|Withdrawal by Subject|1|||
105832039|NCT02096705|365041011|FG000|Treatment|Adverse Event|6|||
105832040|NCT02096705|365041012|FG001|Treatment|Adverse Event|3|||
105964225|NCT01296711|365527177|FG006|Overall Study|Required restricted steroid injections|1|||
105964226|NCT01296711|365527178|FG007|Overall Study|Required restricted steroid injections|0|||
105832041|NCT02096705|365041011|FG000|Treatment|Subject request to discontinue treatment|1|||
105832042|NCT02096705|365041012|FG001|Treatment|Subject request to discontinue treatment|1|||
105832043|NCT02096705|365041011|FG000|Treatment|Withdrawal by Subject|1|||
105832044|NCT02096705|365041012|FG001|Treatment|Withdrawal by Subject|0|||
105832045|NCT02096705|365041011|FG000|Treatment|Other|1|||
105832046|NCT02096705|365041012|FG001|Treatment|Other|1|||
105832047|NCT02096705|365041011|FG000|Follow-up|Withdrawal by Subject|1|||
105832048|NCT02096705|365041012|FG001|Follow-up|Withdrawal by Subject|0|||
105832049|NCT02096705|365041011|FG000|Follow-up|Adverse Event|2|||
105832050|NCT02096705|365041012|FG001|Follow-up|Adverse Event|2|||
105832051|NCT02096705|365041011|FG000|Follow-up|Subjects not reporting status|1|||
105832052|NCT02096705|365041012|FG001|Follow-up|Subjects not reporting status|2|||
105832053|NCT01097694|365041013|FG000|Overall Study|Adverse Event|5|||
105832054|NCT01097694|365041014|FG001|Overall Study|Adverse Event|0|||
105832055|NCT01097694|365041013|FG000|Overall Study|Lost to Follow-up|0|||
105832056|NCT01097694|365041014|FG001|Overall Study|Lost to Follow-up|3|||
105832057|NCT01097694|365041013|FG000|Overall Study|Withdrawal by Subject|3|||
105832058|NCT01097694|365041014|FG001|Overall Study|Withdrawal by Subject|1|||
105832059|NCT02858037|365041017|FG000|Overall Study|Death|1|||
105832060|NCT02858037|365041017|FG000|Overall Study|Withdrawal by Subject|18|||
105832061|NCT02858037|365041017|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
105832062|NCT02858037|365041017|FG000|Overall Study|Lost to Follow-up|3|||
105832063|NCT02858037|365041017|FG000|Overall Study|Other|4|||
105832064|NCT01670097|365041018|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
105832065|NCT01670097|365041019|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
105832066|NCT01670097|365041018|FG000|Overall Study|Study burden|1|||
105832067|NCT01670097|365041019|FG001|Overall Study|Study burden|0|||
105832068|NCT01670097|365041018|FG000|Overall Study|COPD exacerbation|0|||
105832069|NCT01670097|365041019|FG001|Overall Study|COPD exacerbation|1|||
105832070|NCT01670097|365041018|FG000|Overall Study|Neutropenia|0|||
105832071|NCT01670097|365041019|FG001|Overall Study|Neutropenia|1|||
105832072|NCT01670097|365041018|FG000|Overall Study|Clinical deterioration|0|||
105832073|NCT01670097|365041019|FG001|Overall Study|Clinical deterioration|1|||
105832074|NCT01670097|365041018|FG000|Overall Study|Disease progression|0|||
105832075|NCT01670097|365041019|FG001|Overall Study|Disease progression|1|||
105832076|NCT00697827|365041020|FG000|Overall Study|enrolled but not treated|2|||
105832077|NCT00697827|365041021|FG001|Overall Study|enrolled but not treated|1|||
105832078|NCT02166606|365041026|FG000|Overall Study|Adverse Event|3|||
105832079|NCT02166606|365041026|FG000|Overall Study|Death|31|||
105832080|NCT02166606|365041026|FG000|Overall Study|Protocol Violation|7|||
105832081|NCT02166606|365041026|FG000|Overall Study|Lost to Follow-up|30|||
105832082|NCT02166606|365041026|FG000|Overall Study|Withdrawal by Subject|1|||
105832083|NCT02166606|365041026|FG000|Overall Study|Physician Decision|1|||
105832084|NCT02166606|365041026|FG000|Overall Study|Device upgrade|1|||
105832085|NCT02166606|365041026|FG000|Overall Study|Enrolled after End of Enrollment|4|||
105964227|NCT01296711|365527171|FG000|Overall Study|Ongoing missed appointments|0|||
105964228|NCT01296711|365527172|FG001|Overall Study|Ongoing missed appointments|0|||
105964229|NCT01296711|365527173|FG002|Overall Study|Ongoing missed appointments|0|||
105964230|NCT01296711|365527174|FG003|Overall Study|Ongoing missed appointments|0|||
105964231|NCT01296711|365527175|FG004|Overall Study|Ongoing missed appointments|0|||
105964232|NCT01296711|365527176|FG005|Overall Study|Ongoing missed appointments|0|||
105964233|NCT01296711|365527177|FG006|Overall Study|Ongoing missed appointments|1|||
105964234|NCT01296711|365527178|FG007|Overall Study|Ongoing missed appointments|0|||
105964235|NCT01296711|365527171|FG000|Overall Study|Failure to comply with visits|0|||
105964236|NCT01296711|365527172|FG001|Overall Study|Failure to comply with visits|0|||
105964237|NCT01296711|365527173|FG002|Overall Study|Failure to comply with visits|0|||
106148847|NCT00421889|366206905|FG001|Overall Study|Withdrawal by Subject|3|||
106148848|NCT00421889|366206906|FG002|Overall Study|Withdrawal by Subject|0|||
106148849|NCT00421889|366206907|FG003|Overall Study|Withdrawal by Subject|0|||
106148850|NCT00421889|366206908|FG004|Overall Study|Withdrawal by Subject|2|||
106148851|NCT00421889|366206909|FG005|Overall Study|Withdrawal by Subject|0|||
106148852|NCT00421889|366206910|FG006|Overall Study|Withdrawal by Subject|0|||
106148853|NCT00421889|366206911|FG007|Overall Study|Withdrawal by Subject|0|||
106148854|NCT00421889|366206912|FG008|Overall Study|Withdrawal by Subject|0|||
105832086|NCT02311894|365041029|FG000|Overall Study|Discontinued in error|1|||
105964238|NCT01296711|365527174|FG003|Overall Study|Failure to comply with visits|0|||
105964239|NCT01296711|365527175|FG004|Overall Study|Failure to comply with visits|0|||
105964240|NCT01296711|365527176|FG005|Overall Study|Failure to comply with visits|0|||
105964241|NCT01296711|365527177|FG006|Overall Study|Failure to comply with visits|0|||
105964242|NCT01296711|365527178|FG007|Overall Study|Failure to comply with visits|1|||
105832087|NCT02311894|365041029|FG000|Overall Study|Lost to Follow-up|1|||
105832088|NCT02311894|365041029|FG000|Overall Study|Adverse Event|1|||
105832089|NCT02311894|365041029|FG000|Overall Study|Withdrawal by Subject|1|||
105832090|NCT02472639|365041030|FG000|Overall Study|Physician Decision|4|||
105832091|NCT02472639|365041031|FG001|Overall Study|Physician Decision|3|||
105832092|NCT01726803|365041032|FG000|Overall Study|Lost to Follow-up|6|||
106148855|NCT00421889|366206904|FG000|Overall Study|Death|0|||
106148856|NCT00421889|366206905|FG001|Overall Study|Death|0|||
106148857|NCT00421889|366206906|FG002|Overall Study|Death|0|||
106148858|NCT00421889|366206907|FG003|Overall Study|Death|0|||
106148859|NCT00421889|366206908|FG004|Overall Study|Death|1|||
106148860|NCT00421889|366206909|FG005|Overall Study|Death|1|||
106148861|NCT00421889|366206910|FG006|Overall Study|Death|0|||
106148862|NCT00421889|366206911|FG007|Overall Study|Death|0|||
106148863|NCT00421889|366206912|FG008|Overall Study|Death|0|||
106148864|NCT00421889|366206904|FG000|Overall Study|Progressive disease|3|||
106148865|NCT00421889|366206905|FG001|Overall Study|Progressive disease|2|||
105832093|NCT01726803|365041033|FG001|Overall Study|Lost to Follow-up|1|||
105832094|NCT01726803|365041032|FG000|Overall Study|Withdrawal by Subject|1|||
105832095|NCT01726803|365041033|FG001|Overall Study|Withdrawal by Subject|0|||
105832096|NCT01751087|365041035|FG000|Overall Study|Withdrawal by Subject|1|||
105832097|NCT01751087|365041036|FG001|Overall Study|Withdrawal by Subject|0|||
105832098|NCT01751087|365041037|FG002|Overall Study|Withdrawal by Subject|0|||
105832099|NCT01751087|365041035|FG000|Overall Study|Physician Decision|0|||
105832100|NCT01751087|365041036|FG001|Overall Study|Physician Decision|0|||
105832101|NCT01751087|365041037|FG002|Overall Study|Physician Decision|1|||
105832102|NCT00724958|365041046|FG000|Overall Study|Adverse Event|28|||
105832103|NCT00724958|365041046|FG000|Overall Study|Loss of Response|40|||
105832104|NCT00724958|365041046|FG000|Overall Study|No Response|18|||
105832105|NCT00724958|365041046|FG000|Overall Study|Remission|7|||
105832106|NCT00724958|365041046|FG000|Overall Study|Other Reason|76|||
105832107|NCT00724958|365041046|FG000|Overall Study|No documentation for end of therapy|13|||
105832108|NCT03247686|365042658|FG000|Overall Study|Withdrawal by Subject|1|||
105832109|NCT03247686|365042659|FG001|Overall Study|Withdrawal by Subject|2|||
105832110|NCT01894230|365042660|FG000|Overall Study|Lost to Follow-up|2|||
105832111|NCT01894230|365042661|FG001|Overall Study|Lost to Follow-up|2|||
105832112|NCT01894230|365042660|FG000|Overall Study|Withdrawal by Subject|4|||
105832113|NCT01894230|365042661|FG001|Overall Study|Withdrawal by Subject|4|||
105832114|NCT01894230|365042660|FG000|Overall Study|Non-adherent|0|||
105832115|NCT01894230|365042661|FG001|Overall Study|Non-adherent|1|||
105832116|NCT01894230|365042660|FG000|Overall Study|Death|1|||
105832117|NCT01894230|365042661|FG001|Overall Study|Death|0|||
105832118|NCT01098851|365042669|FG000|Overall Study|Equipment failure|1|||
105832119|NCT01098851|365042670|FG001|Overall Study|Equipment failure|0|||
105832120|NCT02435433|365042671|FG000|Overall Study|Withdrawal by Subject|2|||
105832121|NCT02435433|365042672|FG001|Overall Study|Withdrawal by Subject|3|||
105832122|NCT02435433|365042673|FG002|Overall Study|Withdrawal by Subject|1|||
105832123|NCT02435433|365042674|FG003|Overall Study|Withdrawal by Subject|0|||
105832124|NCT02435433|365042675|FG004|Overall Study|Withdrawal by Subject|0|||
105832125|NCT02435433|365042671|FG000|Overall Study|Lost to Follow-up|2|||
105832126|NCT02435433|365042672|FG001|Overall Study|Lost to Follow-up|2|||
105832127|NCT02435433|365042673|FG002|Overall Study|Lost to Follow-up|4|||
105832128|NCT02435433|365042674|FG003|Overall Study|Lost to Follow-up|1|||
105832129|NCT02435433|365042675|FG004|Overall Study|Lost to Follow-up|0|||
105832130|NCT02218541|365042676|FG000|Overall Study|Lost to Follow-up|2|||
105832131|NCT02218541|365042677|FG001|Overall Study|Lost to Follow-up|1|||
105832132|NCT02218541|365042676|FG000|Overall Study|Implant Failure|4|||
105832133|NCT02218541|365042677|FG001|Overall Study|Implant Failure|1|||
105832134|NCT00544167|365042678|FG000|Overall Study|Adverse Event|21|||
105832135|NCT00544167|365042678|FG000|Overall Study|Physician Decision|8|||
105832136|NCT01944722|365042682|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
105832137|NCT01944722|365042682|FG000|Overall Study|Specimen Shipping Issues|34|||
106022735|NCT00452361|365748655|FG000|Overall Study|Adverse Event|8|||
106022736|NCT00452361|365748656|FG001|Overall Study|Adverse Event|0|||
106022737|NCT00452361|365748655|FG000|Overall Study|Withdrawal by Subject|0|||
106022738|NCT00452361|365748656|FG001|Overall Study|Withdrawal by Subject|1|||
106022739|NCT00452361|365748655|FG000|Overall Study|Premature termination|13|||
106022740|NCT00452361|365748656|FG001|Overall Study|Premature termination|9|||
105832138|NCT01944722|365042682|FG000|Overall Study|Improper Storage/Transport|5|||
105832139|NCT01944722|365042682|FG000|Overall Study|Insufficient Volume for Test|1|||
105832140|NCT01944722|365042682|FG000|Overall Study|Missing Specimens|3|||
105832141|NCT01944722|365042682|FG000|Overall Study|Specimens Mislabeled|2|||
105832142|NCT01944722|365042682|FG000|Overall Study|Withdrawal by Subject|8|||
105832143|NCT01944722|365042682|FG000|Overall Study|NILM Subjects <30 years old|8106|||
105832144|NCT01944722|365042682|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
105832145|NCT01944722|365042682|FG000|Overall Study|>ASCUS Cytology|1122|||
105832146|NCT02340780|365042689|FG000|Overall Study|Ineligible|1|||
105832147|NCT01149057|365042690|FG000|Overall Study|Lack of Efficacy|16|||
106022741|NCT00776919|365748657|FG000|Overall Study|Withdrawal by Subject|16|||
106022742|NCT00776919|365748658|FG001|Overall Study|Withdrawal by Subject|14|||
105832148|NCT01149057|365042690|FG000|Overall Study|Adverse Event|13|||
105832149|NCT01149057|365042690|FG000|Overall Study|Withdrawal by Subject|9|||
105832150|NCT01149057|365042690|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
105832151|NCT01149057|365042690|FG000|Overall Study|B Cell Depletion|4|||
106022743|NCT00776919|365748659|FG002|Overall Study|Withdrawal by Subject|15|||
106148866|NCT00421889|366206906|FG002|Overall Study|Progressive disease|2|||
106148867|NCT00421889|366206907|FG003|Overall Study|Progressive disease|3|||
105832152|NCT01149057|365042690|FG000|Overall Study|Participant Non-Compliance|2|||
105964243|NCT01296711|365527171|FG000|Overall Study|Patient decision due to transport|0|||
105964244|NCT01296711|365527172|FG001|Overall Study|Patient decision due to transport|0|||
105964245|NCT01296711|365527173|FG002|Overall Study|Patient decision due to transport|0|||
105964246|NCT01296711|365527174|FG003|Overall Study|Patient decision due to transport|0|||
105964247|NCT01296711|365527175|FG004|Overall Study|Patient decision due to transport|0|||
105964248|NCT01296711|365527176|FG005|Overall Study|Patient decision due to transport|0|||
105964249|NCT01296711|365527177|FG006|Overall Study|Patient decision due to transport|0|||
105964250|NCT01296711|365527178|FG007|Overall Study|Patient decision due to transport|1|||
105964251|NCT03249909|365527179|FG000|Overall Study|Withdrawal by Subject|3|||
105964252|NCT03249909|365527180|FG001|Overall Study|Withdrawal by Subject|0|||
105964253|NCT03249909|365527181|FG002|Overall Study|Withdrawal by Subject|0|||
105964254|NCT03249909|365527179|FG000|Overall Study|Adverse Event|3|||
105964255|NCT03249909|365527180|FG001|Overall Study|Adverse Event|0|||
105964256|NCT03249909|365527181|FG002|Overall Study|Adverse Event|0|||
105964257|NCT03249909|365527179|FG000|Overall Study|Lost to Follow-up|0|||
105964258|NCT03249909|365527180|FG001|Overall Study|Lost to Follow-up|1|||
106022744|NCT00776919|365748660|FG003|Overall Study|Withdrawal by Subject|26|||
106022745|NCT00776919|365748657|FG000|Overall Study|Lost to Follow-up|8|||
106022746|NCT00776919|365748658|FG001|Overall Study|Lost to Follow-up|12|||
105832153|NCT01149057|365042690|FG000|Overall Study|Lost to Follow-up|1|||
105832154|NCT01149057|365042690|FG000|Overall Study|High Parathyroid Hormone Value|1|||
105832155|NCT01149057|365042690|FG000|Overall Study|Other|6|||
105832156|NCT02654145|365042691|FG000|Overall Study|Lack of Efficacy|1|||
105832157|NCT02654145|365042691|FG000|Overall Study|Protocol Violation|1|||
105832158|NCT02654145|365042691|FG000|Overall Study|Withdrawal by Subject|5|||
105832159|NCT00009945|365042692|FG000|Overall Study|no follow up data|7|||
105832160|NCT00009945|365042693|FG001|Overall Study|no follow up data|5|||
105832161|NCT01943435|365042694|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
106022747|NCT00776919|365748659|FG002|Overall Study|Lost to Follow-up|11|||
106022748|NCT00776919|365748660|FG003|Overall Study|Lost to Follow-up|8|||
106022749|NCT00776919|365748657|FG000|Overall Study|Adverse Event|1|||
106022750|NCT00776919|365748658|FG001|Overall Study|Adverse Event|0|||
106022751|NCT00776919|365748659|FG002|Overall Study|Adverse Event|2|||
106022752|NCT00776919|365748660|FG003|Overall Study|Adverse Event|2|||
106022753|NCT00776919|365748657|FG000|Overall Study|Protocol Violation|1|||
106022754|NCT00776919|365748658|FG001|Overall Study|Protocol Violation|2|||
106022755|NCT00776919|365748659|FG002|Overall Study|Protocol Violation|0|||
106022756|NCT00776919|365748660|FG003|Overall Study|Protocol Violation|1|||
106022757|NCT00776919|365748657|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
106022758|NCT00776919|365748658|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
106022759|NCT00776919|365748659|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
106022760|NCT00776919|365748660|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
106022761|NCT04530136|365748663|FG000|Overall Study|Lost to Follow-up|2|||
106022762|NCT04530136|365748664|FG001|Overall Study|Lost to Follow-up|3|||
106022763|NCT04530136|365748663|FG000|Overall Study|Withdrawal by Subject|1|||
106022764|NCT04530136|365748664|FG001|Overall Study|Withdrawal by Subject|0|||
106022765|NCT04530136|365748663|FG000|Overall Study|Death|0|||
106022766|NCT04530136|365748664|FG001|Overall Study|Death|1|||
106022767|NCT01309282|365748665|FG000|Overall Study|Lost to Follow-up|1|||
106022768|NCT00499590|365748668|FG000|Overall Study|Study Terminated|112|||
106022769|NCT00499590|365748669|FG001|Overall Study|Study Terminated|112|||
106022770|NCT00499590|365748670|FG002|Overall Study|Study Terminated|112|||
106022771|NCT00499590|365748668|FG000|Overall Study|Not treated|1|||
106022772|NCT00499590|365748669|FG001|Overall Study|Not treated|0|||
106022773|NCT00499590|365748670|FG002|Overall Study|Not treated|1|||
106022774|NCT01668589|365748671|FG000|Overall Study|Lost to Follow-up|29|||
106022775|NCT01668589|365748672|FG001|Overall Study|Lost to Follow-up|37|||
106022776|NCT01668589|365748673|FG002|Overall Study|Lost to Follow-up|15|||
106022777|NCT01668589|365748674|FG003|Overall Study|Lost to Follow-up|5|||
106022778|NCT01668589|365748671|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
106022779|NCT01668589|365748672|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
105832162|NCT01943435|365042695|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
105832163|NCT01943435|365042696|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
105832164|NCT01943435|365042694|FG000|Intervention Period|Withdrawal by Subject|3|||
105832165|NCT01943435|365042695|FG001|Intervention Period|Withdrawal by Subject|3|||
105964259|NCT03249909|365527181|FG002|Overall Study|Lost to Follow-up|0|||
105964260|NCT02763566|365527182|FG000|Overall Study|Lost to Follow-up|1|||
106022780|NCT01668589|365748673|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
106022781|NCT01668589|365748674|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
106022782|NCT01668589|365748671|FG000|Overall Study|Death|12|||
106022783|NCT01668589|365748672|FG001|Overall Study|Death|3|||
106022784|NCT01668589|365748673|FG002|Overall Study|Death|2|||
106022785|NCT01668589|365748674|FG003|Overall Study|Death|11|||
106022786|NCT01668589|365748671|FG000|Overall Study|Other|44|||
106022787|NCT01668589|365748672|FG001|Overall Study|Other|10|||
106022788|NCT01668589|365748673|FG002|Overall Study|Other|7|||
106022789|NCT01668589|365748674|FG003|Overall Study|Other|15|||
105832166|NCT01943435|365042696|FG002|Intervention Period|Withdrawal by Subject|4|||
105832167|NCT01943435|365042694|FG000|2 Month Follow up|Lost to Follow-up|2|||
105832168|NCT01943435|365042695|FG001|2 Month Follow up|Lost to Follow-up|3|||
105832169|NCT01943435|365042696|FG002|2 Month Follow up|Lost to Follow-up|0|||
105832170|NCT01943435|365042694|FG000|6 Month Follow up|Lost to Follow-up|12|||
105832171|NCT01943435|365042695|FG001|6 Month Follow up|Lost to Follow-up|7|||
105832172|NCT01943435|365042696|FG002|6 Month Follow up|Lost to Follow-up|15|||
105832173|NCT00295490|365042697|FG000|Overall Study|Protocol Violation|0|||
105832174|NCT00295490|365042698|FG001|Overall Study|Protocol Violation|0|||
105832175|NCT00295490|365042699|FG002|Overall Study|Protocol Violation|3|||
105832176|NCT00295490|365042700|FG003|Overall Study|Protocol Violation|3|||
105832177|NCT00295490|365042697|FG000|Overall Study|Withdrawal by Subject|0|||
105832178|NCT00295490|365042698|FG001|Overall Study|Withdrawal by Subject|2|||
105832179|NCT00295490|365042699|FG002|Overall Study|Withdrawal by Subject|0|||
105832180|NCT00295490|365042700|FG003|Overall Study|Withdrawal by Subject|1|||
105832181|NCT00295490|365042697|FG000|Overall Study|Lost to Follow-up|0|||
105832182|NCT00295490|365042698|FG001|Overall Study|Lost to Follow-up|0|||
105832183|NCT00295490|365042699|FG002|Overall Study|Lost to Follow-up|1|||
105832184|NCT00295490|365042700|FG003|Overall Study|Lost to Follow-up|0|||
105832185|NCT00295490|365042697|FG000|Overall Study|Adverse Event|1|||
105832186|NCT00295490|365042698|FG001|Overall Study|Adverse Event|0|||
105832187|NCT00295490|365042699|FG002|Overall Study|Adverse Event|0|||
105832188|NCT00295490|365042700|FG003|Overall Study|Adverse Event|0|||
105832189|NCT00295490|365042697|FG000|Overall Study|Other|0|||
105832190|NCT00295490|365042698|FG001|Overall Study|Other|2|||
105832191|NCT00295490|365042699|FG002|Overall Study|Other|0|||
105964261|NCT02763566|365527183|FG001|Overall Study|Lost to Follow-up|4|||
105964262|NCT02763566|365527184|FG002|Overall Study|Lost to Follow-up|0|||
105964263|NCT02763566|365527185|FG003|Overall Study|Lost to Follow-up|1|||
105964264|NCT02763566|365527182|FG000|Overall Study|On study treatment at study conclusion|114|||
105964265|NCT02763566|365527183|FG001|Overall Study|On study treatment at study conclusion|34|||
105964266|NCT02763566|365527184|FG002|Overall Study|On study treatment at study conclusion|54|||
105964267|NCT02763566|365527185|FG003|Overall Study|On study treatment at study conclusion|13|||
105964268|NCT02763566|365527182|FG000|Overall Study|Withdrawal by Subject|3|||
105964269|NCT02763566|365527183|FG001|Overall Study|Withdrawal by Subject|1|||
105964270|NCT02763566|365527184|FG002|Overall Study|Withdrawal by Subject|0|||
105964271|NCT02763566|365527185|FG003|Overall Study|Withdrawal by Subject|0|||
105964272|NCT03631199|365527186|FG000|Overall Study|Progressive disease|9|||
105964273|NCT03631199|365527187|FG001|Overall Study|Progressive disease|5|||
105964274|NCT03631199|365527188|FG002|Overall Study|Progressive disease|5|||
105964275|NCT03631199|365527189|FG003|Overall Study|Progressive disease|149|||
105964276|NCT03631199|365527190|FG004|Overall Study|Progressive disease|148|||
105964277|NCT03631199|365527186|FG000|Overall Study|Physician Decision|0|||
105964278|NCT03631199|365527187|FG001|Overall Study|Physician Decision|2|||
105964279|NCT03631199|365527188|FG002|Overall Study|Physician Decision|3|||
105964280|NCT03631199|365527189|FG003|Overall Study|Physician Decision|19|||
105964281|NCT03631199|365527190|FG004|Overall Study|Physician Decision|13|||
105964282|NCT03631199|365527186|FG000|Overall Study|Adverse Event|1|||
105964283|NCT03631199|365527187|FG001|Overall Study|Adverse Event|1|||
105964284|NCT03631199|365527188|FG002|Overall Study|Adverse Event|0|||
105964285|NCT03631199|365527189|FG003|Overall Study|Adverse Event|28|||
105964286|NCT03631199|365527190|FG004|Overall Study|Adverse Event|29|||
105964287|NCT03631199|365527186|FG000|Overall Study|Death|0|||
105964288|NCT03631199|365527187|FG001|Overall Study|Death|1|||
105964289|NCT03631199|365527188|FG002|Overall Study|Death|0|||
105964290|NCT03631199|365527189|FG003|Overall Study|Death|35|||
105964291|NCT03631199|365527190|FG004|Overall Study|Death|48|||
105964292|NCT03631199|365527186|FG000|Overall Study|Subject decision|0|||
105964293|NCT03631199|365527187|FG001|Overall Study|Subject decision|1|||
105964294|NCT03631199|365527188|FG002|Overall Study|Subject decision|0|||
105964295|NCT03631199|365527189|FG003|Overall Study|Subject decision|12|||
105964296|NCT03631199|365527190|FG004|Overall Study|Subject decision|12|||
105964297|NCT03631199|365527186|FG000|Overall Study|No treated|0|||
105964298|NCT03631199|365527187|FG001|Overall Study|No treated|0|||
105964299|NCT03631199|365527188|FG002|Overall Study|No treated|0|||
105964300|NCT03631199|365527189|FG003|Overall Study|No treated|0|||
105964301|NCT03631199|365527190|FG004|Overall Study|No treated|1|||
105964302|NCT03631199|365527186|FG000|Overall Study|Treatment ongoing|0|||
105832192|NCT00295490|365042700|FG003|Overall Study|Other|1|||
105832193|NCT01597791|365042701|FG000|Overall Study|Physician Decision|2|||
105832194|NCT01597791|365042702|FG001|Overall Study|Physician Decision|1|||
105832195|NCT01597791|365042701|FG000|Overall Study|Cesarean Section|6|||
105832196|NCT01597791|365042702|FG001|Overall Study|Cesarean Section|7|||
105832197|NCT01597791|365042701|FG000|Overall Study|Subject withdrawal|0|||
105964303|NCT03631199|365527187|FG001|Overall Study|Treatment ongoing|1|||
105964304|NCT03631199|365527188|FG002|Overall Study|Treatment ongoing|1|||
105964305|NCT03631199|365527189|FG003|Overall Study|Treatment ongoing|76|||
105964306|NCT03631199|365527190|FG004|Overall Study|Treatment ongoing|71|||
105964307|NCT03631199|365527186|FG000|Overall Study|Guardian decision|0|||
105964308|NCT03631199|365527187|FG001|Overall Study|Guardian decision|0|||
105964309|NCT03631199|365527188|FG002|Overall Study|Guardian decision|0|||
105964310|NCT03631199|365527189|FG003|Overall Study|Guardian decision|1|||
105964311|NCT03631199|365527190|FG004|Overall Study|Guardian decision|1|||
105964312|NCT00002540|365527191|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
105964313|NCT00002540|365527192|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
105964314|NCT00002540|365527191|FG000|Overall Study|Died Before Randomization|2|||
105964315|NCT00002540|365527192|FG001|Overall Study|Died Before Randomization|6|||
105964316|NCT00002540|365527191|FG000|Overall Study|Died Before ASU (Control)|202|||
105964317|NCT00002540|365527192|FG001|Overall Study|Died Before ASU (Control)|0|||
105964318|NCT00002540|365527191|FG000|Overall Study|Refused ASU (Control)|597|||
105964319|NCT00002540|365527192|FG001|Overall Study|Refused ASU (Control)|0|||
105964320|NCT00002540|365527191|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
105964321|NCT00002540|365527192|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
105964322|NCT00582712|365527196|FG000|Overall Study|Adverse Event|1|||
105964323|NCT00582712|365527196|FG000|Overall Study|Lack of Efficacy|1|||
105964324|NCT00582712|365527196|FG000|Overall Study|Withdrawal by Subject|1|||
105964325|NCT00582712|365527196|FG000|Overall Study|Complicating disease requiring treatment|1|||
105964326|NCT02443116|365527200|FG000|Part 1|Adverse Event|2|||
105964327|NCT02443116|365527201|FG001|Part 1|Adverse Event|3|||
105964328|NCT02443116|365527202|FG002|Part 1|Adverse Event|0|||
105964329|NCT02443116|365527203|FG003|Part 1|Adverse Event|0|||
105964330|NCT02443116|365527204|FG004|Part 1|Adverse Event|0|||
105832198|NCT01597791|365042702|FG001|Overall Study|Subject withdrawal|1|||
105964331|NCT02443116|365527205|FG005|Part 1|Adverse Event|0|||
105964332|NCT02443116|365527206|FG006|Part 1|Adverse Event|0|||
105964333|NCT02443116|365527207|FG007|Part 1|Adverse Event|0|||
105964334|NCT02443116|365527208|FG008|Part 1|Adverse Event|0|||
105964335|NCT02443116|365527200|FG000|Part 1|Withdrew informed consent|0|||
105964336|NCT02443116|365527201|FG001|Part 1|Withdrew informed consent|1|||
106148868|NCT00421889|366206908|FG004|Overall Study|Progressive disease|2|||
106148869|NCT00421889|366206909|FG005|Overall Study|Progressive disease|21|||
106148870|NCT00421889|366206910|FG006|Overall Study|Progressive disease|3|||
105964337|NCT02443116|365527202|FG002|Part 1|Withdrew informed consent|0|||
105964338|NCT02443116|365527203|FG003|Part 1|Withdrew informed consent|0|||
105964339|NCT02443116|365527204|FG004|Part 1|Withdrew informed consent|0|||
105964340|NCT02443116|365527205|FG005|Part 1|Withdrew informed consent|0|||
105964341|NCT02443116|365527206|FG006|Part 1|Withdrew informed consent|0|||
105964342|NCT02443116|365527207|FG007|Part 1|Withdrew informed consent|0|||
105964343|NCT02443116|365527208|FG008|Part 1|Withdrew informed consent|0|||
105964344|NCT02443116|365527200|FG000|Part 1|Lost to Follow-up|0|||
105964345|NCT02443116|365527201|FG001|Part 1|Lost to Follow-up|0|||
105964346|NCT02443116|365527202|FG002|Part 1|Lost to Follow-up|2|||
105964347|NCT02443116|365527203|FG003|Part 1|Lost to Follow-up|0|||
105964348|NCT02443116|365527204|FG004|Part 1|Lost to Follow-up|0|||
105964349|NCT02443116|365527205|FG005|Part 1|Lost to Follow-up|0|||
105832199|NCT01597791|365042701|FG000|Overall Study|Protocol Violation|0|||
105832200|NCT01597791|365042702|FG001|Overall Study|Protocol Violation|1|||
105832201|NCT01155531|365042703|FG000|Overall Study|Adverse Event|0|||
105832202|NCT01155531|365042704|FG001|Overall Study|Adverse Event|0|||
105832203|NCT01155531|365042705|FG002|Overall Study|Adverse Event|1|||
105832204|NCT01155531|365042706|FG003|Overall Study|Adverse Event|0|||
105832205|NCT01155531|365042703|FG000|Overall Study|Lost to Follow-up|0|||
105832206|NCT01155531|365042704|FG001|Overall Study|Lost to Follow-up|0|||
105832207|NCT01155531|365042705|FG002|Overall Study|Lost to Follow-up|0|||
105832208|NCT01155531|365042706|FG003|Overall Study|Lost to Follow-up|1|||
105832209|NCT01155531|365042703|FG000|Overall Study|Withdrawal by Subject|1|||
105832210|NCT01155531|365042704|FG001|Overall Study|Withdrawal by Subject|0|||
105832211|NCT01155531|365042705|FG002|Overall Study|Withdrawal by Subject|1|||
105964350|NCT02443116|365527206|FG006|Part 1|Lost to Follow-up|0|||
105964351|NCT02443116|365527207|FG007|Part 1|Lost to Follow-up|0|||
105964352|NCT02443116|365527208|FG008|Part 1|Lost to Follow-up|0|||
106148871|NCT00421889|366206911|FG007|Overall Study|Progressive disease|1|||
105832212|NCT01155531|365042706|FG003|Overall Study|Withdrawal by Subject|0|||
105832213|NCT00354159|365042707|FG000|Randomized Study Period|Withdrawal by Subject|5|||
105964353|NCT02443116|365527200|FG000|Part 1|Participant moved out of state|0|||
105964354|NCT02443116|365527201|FG001|Part 1|Participant moved out of state|0|||
105964355|NCT02443116|365527202|FG002|Part 1|Participant moved out of state|1|||
105964356|NCT02443116|365527203|FG003|Part 1|Participant moved out of state|0|||
105964357|NCT02443116|365527204|FG004|Part 1|Participant moved out of state|0|||
105964358|NCT02443116|365527205|FG005|Part 1|Participant moved out of state|0|||
105964359|NCT02443116|365527206|FG006|Part 1|Participant moved out of state|0|||
105964360|NCT02443116|365527207|FG007|Part 1|Participant moved out of state|0|||
105832214|NCT00354159|365042708|FG001|Randomized Study Period|Withdrawal by Subject|3|||
105832215|NCT00354159|365042707|FG000|Randomized Study Period|Physician Decision|6|||
105832216|NCT00354159|365042708|FG001|Randomized Study Period|Physician Decision|10|||
105964361|NCT02443116|365527208|FG008|Part 1|Participant moved out of state|0|||
105964362|NCT02443116|365527200|FG000|Part 1|Participant enrolled in another clinical trial|0|||
106148872|NCT00421889|366206912|FG008|Overall Study|Progressive disease|5|||
105832217|NCT00354159|365042707|FG000|Randomized Study Period|Lost to Follow-up|4|||
105832218|NCT00354159|365042708|FG001|Randomized Study Period|Lost to Follow-up|0|||
105832219|NCT00354159|365042707|FG000|Randomized Study Period|Death|7|||
105832220|NCT00354159|365042708|FG001|Randomized Study Period|Death|9|||
105832221|NCT00354159|365042707|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
105832222|NCT00354159|365042708|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
105832223|NCT00354159|365042707|FG000|Long-term Follow-up|Physician Decision|127|||
105832224|NCT00354159|365042708|FG001|Long-term Follow-up|Physician Decision|122|||
105832225|NCT00354159|365042707|FG000|Long-term Follow-up|Lost to Follow-up|1|||
105832226|NCT00354159|365042708|FG001|Long-term Follow-up|Lost to Follow-up|0|||
105832227|NCT00354159|365042707|FG000|Long-term Follow-up|Death|14|||
105832228|NCT00354159|365042708|FG001|Long-term Follow-up|Death|11|||
105832229|NCT00354159|365042707|FG000|Long-term Follow-up|Study Closed|29|||
105832230|NCT00354159|365042708|FG001|Long-term Follow-up|Study Closed|34|||
105832231|NCT05070754|365042717|FG000|Overall Study|Withdrawal by Subject|0|||
105832232|NCT05070754|365042718|FG001|Overall Study|Withdrawal by Subject|0|||
105832233|NCT05070754|365042719|FG002|Overall Study|Withdrawal by Subject|0|||
105832234|NCT05070754|365042720|FG003|Overall Study|Withdrawal by Subject|1|||
105832235|NCT05070754|365042717|FG000|Overall Study|Protocol Violation|0|||
105832236|NCT05070754|365042718|FG001|Overall Study|Protocol Violation|0|||
105832237|NCT05070754|365042719|FG002|Overall Study|Protocol Violation|0|||
105832238|NCT05070754|365042720|FG003|Overall Study|Protocol Violation|1|||
105832239|NCT04535986|365042721|FG000|Overall Study|Death|4|||
105832240|NCT04535986|365042722|FG001|Overall Study|Death|5|||
105832241|NCT04535986|365042721|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
105832242|NCT04535986|365042722|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
105832243|NCT04535986|365042721|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
105832244|NCT04535986|365042722|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
105832245|NCT04535986|365042721|FG000|Overall Study|Adverse Event|10|||
105832246|NCT04535986|365042722|FG001|Overall Study|Adverse Event|1|||
105832247|NCT04535986|365042721|FG000|Overall Study|Lack of Efficacy|3|||
105832248|NCT04535986|365042722|FG001|Overall Study|Lack of Efficacy|2|||
105832249|NCT04535986|365042721|FG000|Overall Study|Investigator discretion|3|||
105832250|NCT04535986|365042722|FG001|Overall Study|Investigator discretion|0|||
105832251|NCT04535986|365042721|FG000|Overall Study|Withdrawal by Subject|32|||
105832252|NCT04535986|365042722|FG001|Overall Study|Withdrawal by Subject|14|||
105832253|NCT04535986|365042721|FG000|Overall Study|Lost to Follow-up|5|||
105832254|NCT04535986|365042722|FG001|Overall Study|Lost to Follow-up|3|||
105832255|NCT04535986|365042721|FG000|Overall Study|Other|7|||
105832256|NCT04535986|365042722|FG001|Overall Study|Other|3|||
105832257|NCT00252564|365042725|FG000|Overall Study|Adverse Event|17|||
105832258|NCT00252564|365042726|FG001|Overall Study|Adverse Event|13|||
105832259|NCT00252564|365042725|FG000|Overall Study|Unrelated Complication|2|||
105832260|NCT00252564|365042726|FG001|Overall Study|Unrelated Complication|1|||
105832261|NCT00252564|365042725|FG000|Overall Study|Disease Progression|14|||
105832262|NCT00252564|365042726|FG001|Overall Study|Disease Progression|20|||
105832263|NCT00252564|365042725|FG000|Overall Study|Death|0|||
105832264|NCT00252564|365042726|FG001|Overall Study|Death|3|||
105832265|NCT00252564|365042725|FG000|Overall Study|Physician Decision|1|||
105832266|NCT00252564|365042726|FG001|Overall Study|Physician Decision|0|||
105832267|NCT00252564|365042725|FG000|Overall Study|Lost to Follow-up|1|||
105832268|NCT00252564|365042726|FG001|Overall Study|Lost to Follow-up|0|||
105832269|NCT00252564|365042725|FG000|Overall Study|Patient Request|4|||
105832270|NCT00252564|365042726|FG001|Overall Study|Patient Request|5|||
105832271|NCT00252564|365042725|FG000|Overall Study|Withdrawal by Subject|0|||
105832272|NCT00252564|365042726|FG001|Overall Study|Withdrawal by Subject|2|||
105832273|NCT01745094|365042727|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
105832274|NCT01745094|365042728|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
105832275|NCT01745094|365042729|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
105832276|NCT01745094|365042730|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
105832277|NCT01745094|365042727|FG000|Overall Study|Adverse Event|0|||
105832278|NCT01745094|365042728|FG001|Overall Study|Adverse Event|0|||
105832279|NCT01745094|365042729|FG002|Overall Study|Adverse Event|3|||
105832280|NCT01745094|365042730|FG003|Overall Study|Adverse Event|0|||
105832281|NCT01745094|365042727|FG000|Overall Study|Withdrawal by Subject|2|||
105832282|NCT01745094|365042728|FG001|Overall Study|Withdrawal by Subject|0|||
105832283|NCT01745094|365042729|FG002|Overall Study|Withdrawal by Subject|1|||
105832284|NCT01745094|365042730|FG003|Overall Study|Withdrawal by Subject|2|||
105832285|NCT01745094|365042727|FG000|Overall Study|Protocol Violation|1|||
105832286|NCT01745094|365042728|FG001|Overall Study|Protocol Violation|0|||
105832287|NCT01745094|365042729|FG002|Overall Study|Protocol Violation|3|||
105832288|NCT01745094|365042730|FG003|Overall Study|Protocol Violation|1|||
105832289|NCT01745094|365042727|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
105832290|NCT01745094|365042728|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
105832291|NCT01745094|365042729|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
105832292|NCT01745094|365042730|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
105832293|NCT01745094|365042727|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
105964363|NCT02443116|365527201|FG001|Part 1|Participant enrolled in another clinical trial|0|||
105964364|NCT02443116|365527202|FG002|Part 1|Participant enrolled in another clinical trial|1|||
105964365|NCT02443116|365527203|FG003|Part 1|Participant enrolled in another clinical trial|0|||
105964366|NCT02443116|365527204|FG004|Part 1|Participant enrolled in another clinical trial|0|||
105964367|NCT02443116|365527205|FG005|Part 1|Participant enrolled in another clinical trial|0|||
105964368|NCT02443116|365527206|FG006|Part 1|Participant enrolled in another clinical trial|0|||
105964369|NCT02443116|365527207|FG007|Part 1|Participant enrolled in another clinical trial|0|||
105964370|NCT02443116|365527208|FG008|Part 1|Participant enrolled in another clinical trial|0|||
105964371|NCT02443116|365527200|FG000|Part 2|Adverse Event|0|||
105832294|NCT01745094|365042728|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
105832295|NCT01745094|365042729|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
105832296|NCT01745094|365042730|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
105832297|NCT01745094|365042727|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
105832298|NCT01745094|365042728|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
105832299|NCT01745094|365042729|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
105832300|NCT01745094|365042730|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
105832301|NCT01993940|365042731|FG000|Overall Study|Adverse Event|16|||
105832302|NCT01993940|365042732|FG001|Overall Study|Adverse Event|11|||
105832303|NCT01993940|365042731|FG000|Overall Study|Withdrawal by Subject|15|||
105832304|NCT01993940|365042732|FG001|Overall Study|Withdrawal by Subject|19|||
105832305|NCT01993940|365042731|FG000|Overall Study|Lost to Follow-up|2|||
105832306|NCT01993940|365042732|FG001|Overall Study|Lost to Follow-up|5|||
105832307|NCT01993940|365042731|FG000|Overall Study|Protocol Violation|5|||
105832308|NCT01993940|365042732|FG001|Overall Study|Protocol Violation|8|||
105832309|NCT01993940|365042731|FG000|Overall Study|Death|1|||
105832310|NCT01993940|365042732|FG001|Overall Study|Death|0|||
105832311|NCT01993940|365042731|FG000|Overall Study|Other - Miscellaneous|1|||
105832312|NCT01993940|365042732|FG001|Overall Study|Other - Miscellaneous|1|||
105832313|NCT02308696|365042738|FG000|Overall Study|Lost to Follow-up|28|||
105832314|NCT02308696|365042739|FG001|Overall Study|Lost to Follow-up|21|||
105832315|NCT02308696|365042738|FG000|Overall Study|Death|8|||
105832316|NCT02308696|365042739|FG001|Overall Study|Death|4|||
105832317|NCT02308696|365042738|FG000|Overall Study|Moved to a Higher Level of Care|17|||
105832318|NCT02308696|365042739|FG001|Overall Study|Moved to a Higher Level of Care|6|||
105832319|NCT01211262|365042740|FG000|Overall Study|Progressive Disease|18|||
105832320|NCT01211262|365042741|FG001|Overall Study|Progressive Disease|9|||
105832321|NCT01211262|365042740|FG000|Overall Study|Adverse Event|4|||
105832322|NCT01211262|365042741|FG001|Overall Study|Adverse Event|0|||
105832323|NCT01211262|365042740|FG000|Overall Study|Withdrawal of Consent|1|||
105832324|NCT01211262|365042741|FG001|Overall Study|Withdrawal of Consent|0|||
105832325|NCT01211262|365042740|FG000|Overall Study|Other|0|||
105832326|NCT01211262|365042741|FG001|Overall Study|Other|1|||
105832327|NCT01277510|365042742|FG000|Double-blind Phase|Non-compliance|0|||
105832328|NCT01277510|365042743|FG001|Double-blind Phase|Non-compliance|1|||
105832329|NCT01277510|365042742|FG000|Double-blind Phase|Adverse Event|1|||
105832330|NCT01277510|365042743|FG001|Double-blind Phase|Adverse Event|0|||
105832331|NCT01277510|365042742|FG000|Double-blind Phase|Withdrawal by Subject|2|||
105832332|NCT01277510|365042743|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105832333|NCT01277510|365042742|FG000|Double-blind Phase|Administrative decision|7|||
105832334|NCT01277510|365042743|FG001|Double-blind Phase|Administrative decision|9|||
105832335|NCT01277510|365042742|FG000|Double-blind Phase|Death|0|||
105832336|NCT01277510|365042743|FG001|Double-blind Phase|Death|1|||
105832337|NCT01277510|365042742|FG000|Double-blind Phase|Protocol-specified criteria|2|||
105832338|NCT01277510|365042743|FG001|Double-blind Phase|Protocol-specified criteria|6|||
105832339|NCT01277510|365042742|FG000|Double-blind Phase|Other|1|||
105832340|NCT01277510|365042743|FG001|Double-blind Phase|Other|1|||
105832341|NCT01277510|365042742|FG000|Open-label Phase|Administrative decision|4|||
105832342|NCT01277510|365042743|FG001|Open-label Phase|Administrative decision|3|||
105832343|NCT01277510|365042742|FG000|Open-label Phase|Protocol-specified criteria|1|||
105832344|NCT01277510|365042743|FG001|Open-label Phase|Protocol-specified criteria|0|||
105832345|NCT01277510|365042742|FG000|Open-label Phase|Never received investigational product|2|||
105964372|NCT02443116|365527201|FG001|Part 2|Adverse Event|0|||
105964373|NCT02443116|365527202|FG002|Part 2|Adverse Event|0|||
105964374|NCT02443116|365527203|FG003|Part 2|Adverse Event|0|||
105964375|NCT02443116|365527204|FG004|Part 2|Adverse Event|1|||
105964376|NCT02443116|365527205|FG005|Part 2|Adverse Event|1|||
105964377|NCT02443116|365527206|FG006|Part 2|Adverse Event|2|||
105964378|NCT02443116|365527207|FG007|Part 2|Adverse Event|0|||
105832346|NCT01277510|365042743|FG001|Open-label Phase|Never received investigational product|0|||
105832347|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
105832348|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
105832349|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
105832350|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
105832351|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
105964379|NCT02443116|365527208|FG008|Part 2|Adverse Event|0|||
105964380|NCT02443116|365527200|FG000|Part 2|Withdrew informed consent|0|||
105832352|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
105832353|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
105832354|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
105832355|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
105832356|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
105832357|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
105832358|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
105832359|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
105832360|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
105832361|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
105832362|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
105832363|NCT01685008|365042744|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
105832364|NCT01685008|365042745|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
105832365|NCT01685008|365042746|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
105832366|NCT01685008|365042747|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
105832367|NCT04476277|365042748|FG000|Overall Study|Withdrawal by Subject|0|||
105832368|NCT04476277|365042749|FG001|Overall Study|Withdrawal by Subject|0|||
105832369|NCT04476277|365042750|FG002|Overall Study|Withdrawal by Subject|1|||
105832370|NCT04476277|365042751|FG003|Overall Study|Withdrawal by Subject|0|||
105832371|NCT03980522|365042760|FG000|Treatment Period|Adverse Event|1|||
105832372|NCT03980522|365042761|FG001|Treatment Period|Adverse Event|0|||
105832373|NCT03980522|365042762|FG002|Treatment Period|Adverse Event|0|||
105832374|NCT03980522|365042763|FG003|Treatment Period|Adverse Event|0|||
105832375|NCT03980522|365042764|FG004|Treatment Period|Adverse Event|0|||
105832376|NCT02896296|365042765|FG000|Overall Study|Adverse Event|1|||
105832377|NCT02896296|365042765|FG000|Overall Study|Lost to Follow-up|19|||
105832378|NCT02896296|365042765|FG000|Overall Study|Pregnancy|1|||
105832379|NCT02896296|365042765|FG000|Overall Study|Physician Decision|2|||
105832380|NCT02896296|365042765|FG000|Overall Study|Withdrawal by Subject|10|||
105832381|NCT02896296|365042765|FG000|Overall Study|Site closing|7|||
105832382|NCT02896296|365042765|FG000|Overall Study|Incarceration|1|||
105832383|NCT02896296|365042765|FG000|Overall Study|Relocation|1|||
105832384|NCT00939523|365042771|FG000|Overall Study|Lack of Efficacy|1|||
105832385|NCT00939523|365042771|FG000|Overall Study|Physician Decision|2|||
105832386|NCT00024258|365042772|FG000|Overall Study|Withdrawal by Subject|1|||
105832387|NCT00024258|365042772|FG000|Overall Study|Disease Progression|8|||
105832388|NCT01050764|365042773|FG000|Overall Study|Death, before HSCT|1|||
105832389|NCT01050764|365042773|FG000|Overall Study|Donor mobilization failure, death|1|||
105832390|NCT01050764|365042773|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
105832391|NCT02416934|365042785|FG000|Overall Study|given steroids|1|||
105832392|NCT02416934|365042786|FG001|Overall Study|given steroids|2|||
105832393|NCT02416934|365042785|FG000|Overall Study|Lost to Follow-up|0|||
105832394|NCT02416934|365042786|FG001|Overall Study|Lost to Follow-up|2|||
105832395|NCT02416934|365042785|FG000|Overall Study|Withdrawal by Subject|1|||
105832396|NCT02416934|365042786|FG001|Overall Study|Withdrawal by Subject|0|||
105964381|NCT02443116|365527201|FG001|Part 2|Withdrew informed consent|0|||
105964382|NCT02443116|365527202|FG002|Part 2|Withdrew informed consent|0|||
105964383|NCT02443116|365527203|FG003|Part 2|Withdrew informed consent|0|||
105964384|NCT02443116|365527204|FG004|Part 2|Withdrew informed consent|0|||
105964385|NCT02443116|365527205|FG005|Part 2|Withdrew informed consent|1|||
105964386|NCT02443116|365527206|FG006|Part 2|Withdrew informed consent|1|||
105964387|NCT02443116|365527207|FG007|Part 2|Withdrew informed consent|0|||
105964388|NCT02443116|365527208|FG008|Part 2|Withdrew informed consent|0|||
105964389|NCT02443116|365527200|FG000|Part 2|Inability to comply with protocol|0|||
105964390|NCT02443116|365527201|FG001|Part 2|Inability to comply with protocol|0|||
105964391|NCT02443116|365527202|FG002|Part 2|Inability to comply with protocol|0|||
105964392|NCT02443116|365527203|FG003|Part 2|Inability to comply with protocol|1|||
105964393|NCT02443116|365527204|FG004|Part 2|Inability to comply with protocol|0|||
105964394|NCT02443116|365527205|FG005|Part 2|Inability to comply with protocol|0|||
105964395|NCT02443116|365527206|FG006|Part 2|Inability to comply with protocol|0|||
105964396|NCT02443116|365527207|FG007|Part 2|Inability to comply with protocol|0|||
105832397|NCT02416934|365042785|FG000|Overall Study|recruited during continuing renewal proc|0|||
105832398|NCT02416934|365042786|FG001|Overall Study|recruited during continuing renewal proc|1|||
105832399|NCT02416934|365042785|FG000|Overall Study|Protocol Violation|0|||
105832400|NCT02416934|365042786|FG001|Overall Study|Protocol Violation|1|||
105832401|NCT02416934|365042785|FG000|Overall Study|surgery started late|0|||
105832402|NCT02416934|365042786|FG001|Overall Study|surgery started late|1|||
105832403|NCT02416934|365042785|FG000|Overall Study|re-operation|1|||
105964397|NCT02443116|365527208|FG008|Part 2|Inability to comply with protocol|0|||
105964398|NCT02443116|365527200|FG000|Part 2|Lost to Follow-up|0|||
105964399|NCT02443116|365527201|FG001|Part 2|Lost to Follow-up|0|||
105964400|NCT02443116|365527202|FG002|Part 2|Lost to Follow-up|0|||
105832404|NCT02416934|365042786|FG001|Overall Study|re-operation|0|||
105832405|NCT00124618|365042788|FG000|Overall Study|Ineligible|1|||
105832406|NCT02387762|365042789|FG000|Overall Study|Withdrawal by Subject|1|||
105832407|NCT02387762|365042790|FG001|Overall Study|Withdrawal by Subject|0|||
105832408|NCT03370510|365042794|FG000|Overall Study|COVID-19|2|||
105832409|NCT03370510|365042795|FG001|Overall Study|COVID-19|0|||
105832410|NCT04388787|365042796|FG000|Blinded Period|Patient could not follow instructions|1|||
105832411|NCT04388787|365042796|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
105832412|NCT03108820|365042797|FG000|Overall Study|Lost to Follow-up|30|||
105832413|NCT03108820|365042798|FG001|Overall Study|Lost to Follow-up|28|||
105832414|NCT03108820|365042797|FG000|Overall Study|Withdrawal by Subject|32|||
105832415|NCT03108820|365042798|FG001|Overall Study|Withdrawal by Subject|24|||
105832416|NCT03108820|365042797|FG000|Overall Study|Death|6|||
105832417|NCT03108820|365042798|FG001|Overall Study|Death|11|||
105832418|NCT00688844|365042801|FG000|Overall Study|Lost to Follow-up|10|||
105832419|NCT01374451|365042802|FG000|Overall Study|Administrative problems|1|||
105832420|NCT01374451|365042803|FG001|Overall Study|Administrative problems|0|||
105832421|NCT03493919|365042806|FG000|Overall Study|Other|2|||
105832422|NCT03493919|365042807|FG001|Overall Study|Other|0|||
105832423|NCT03493919|365042808|FG002|Overall Study|Other|1|||
105832424|NCT03493919|365042809|FG003|Overall Study|Other|0|||
105832425|NCT03493919|365042806|FG000|Overall Study|Withdrawal by Subject|9|||
105832426|NCT03493919|365042807|FG001|Overall Study|Withdrawal by Subject|3|||
105832427|NCT03493919|365042808|FG002|Overall Study|Withdrawal by Subject|1|||
105832428|NCT03493919|365042809|FG003|Overall Study|Withdrawal by Subject|1|||
105832429|NCT03493919|365042806|FG000|Overall Study|Lost to Follow-up|5|||
105832430|NCT03493919|365042807|FG001|Overall Study|Lost to Follow-up|0|||
105832431|NCT03493919|365042808|FG002|Overall Study|Lost to Follow-up|0|||
105832432|NCT03493919|365042809|FG003|Overall Study|Lost to Follow-up|3|||
105832433|NCT03493919|365042806|FG000|Overall Study|Adverse Event|0|||
105832434|NCT03493919|365042807|FG001|Overall Study|Adverse Event|1|||
105832435|NCT03493919|365042808|FG002|Overall Study|Adverse Event|0|||
105832436|NCT03493919|365042809|FG003|Overall Study|Adverse Event|0|||
105832437|NCT00697619|365042810|FG000|Overall Study|Lack of Efficacy|2|||
105832438|NCT00697619|365042811|FG001|Overall Study|Lack of Efficacy|2|||
105832439|NCT00697619|365042810|FG000|Overall Study|Adverse Event|4|||
105832440|NCT00697619|365042811|FG001|Overall Study|Adverse Event|6|||
105832441|NCT00640341|365044668|FG000|Overall Study|Adverse Event|0|||
105832442|NCT00640341|365044669|FG001|Overall Study|Adverse Event|0|||
105832443|NCT00640341|365044670|FG002|Overall Study|Adverse Event|1|||
105832444|NCT00640341|365044668|FG000|Overall Study|Positive Slit Lamp Findings|0|||
105832445|NCT00640341|365044669|FG001|Overall Study|Positive Slit Lamp Findings|0|||
105832446|NCT00640341|365044670|FG002|Overall Study|Positive Slit Lamp Findings|1|||
105832447|NCT00640341|365044668|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
105832448|NCT00640341|365044669|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
105832449|NCT00640341|365044670|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
105832450|NCT00640341|365044668|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
105832451|NCT00640341|365044669|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
105832452|NCT00640341|365044670|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
105832453|NCT00640341|365044668|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
105832454|NCT00640341|365044669|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
105832455|NCT00640341|365044670|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
105832456|NCT00640341|365044668|FG000|Overall Study|Lost to Follow-up|2|||
105832457|NCT00640341|365044669|FG001|Overall Study|Lost to Follow-up|0|||
105832458|NCT00640341|365044670|FG002|Overall Study|Lost to Follow-up|0|||
105832459|NCT00640341|365044668|FG000|Overall Study|Withdrawal by Subject|4|||
105832460|NCT00640341|365044669|FG001|Overall Study|Withdrawal by Subject|0|||
105832461|NCT00640341|365044670|FG002|Overall Study|Withdrawal by Subject|1|||
105832462|NCT00640341|365044668|FG000|Overall Study|Unacceptable Lens Movement|1|||
105832463|NCT00640341|365044669|FG001|Overall Study|Unacceptable Lens Movement|0|||
105832464|NCT00640341|365044670|FG002|Overall Study|Unacceptable Lens Movement|0|||
105832465|NCT00640341|365044668|FG000|Overall Study|Poor fit/Uncomfortable|4|||
105832466|NCT00640341|365044669|FG001|Overall Study|Poor fit/Uncomfortable|0|||
105832467|NCT00640341|365044670|FG002|Overall Study|Poor fit/Uncomfortable|0|||
105832468|NCT00640341|365044668|FG000|Overall Study|Ineligable at Baseline|5|||
105832469|NCT00640341|365044669|FG001|Overall Study|Ineligable at Baseline|3|||
105832470|NCT00640341|365044670|FG002|Overall Study|Ineligable at Baseline|2|||
105832471|NCT00640341|365044668|FG000|Overall Study|Adverse event and positive slit lamp|1|||
105832472|NCT00640341|365044669|FG001|Overall Study|Adverse event and positive slit lamp|0|||
105832473|NCT00640341|365044670|FG002|Overall Study|Adverse event and positive slit lamp|0|||
105832474|NCT04573309|365044674|FG000|Overall Study|Protocol Violation|1|||
105832475|NCT04573309|365044675|FG001|Overall Study|Protocol Violation|0|||
105832476|NCT00660387|365044676|FG000|Overall Study|Adverse Event|1|||
105832477|NCT00660387|365044677|FG001|Overall Study|Adverse Event|2|||
105832478|NCT00660387|365044676|FG000|Overall Study|Lack of Efficacy|0|||
105832479|NCT00660387|365044677|FG001|Overall Study|Lack of Efficacy|1|||
105832480|NCT00660387|365044676|FG000|Overall Study|Protocol Violation|1|||
105832481|NCT00660387|365044677|FG001|Overall Study|Protocol Violation|0|||
105832482|NCT00557245|365044681|FG000|Overall Study|Lost to Follow-up|7|||
105832483|NCT00557245|365044682|FG001|Overall Study|Lost to Follow-up|8|||
105964401|NCT02443116|365527203|FG003|Part 2|Lost to Follow-up|1|||
105832484|NCT00557245|365044683|FG002|Overall Study|Lost to Follow-up|10|||
105832485|NCT00557245|365044681|FG000|Overall Study|Ineligible|5|||
105832486|NCT00557245|365044682|FG001|Overall Study|Ineligible|4|||
105832487|NCT00557245|365044683|FG002|Overall Study|Ineligible|2|||
105832488|NCT04364854|365044684|FG000|Overall Study|Withdrawal by Subject|1|||
105832489|NCT04364854|365044685|FG001|Overall Study|Withdrawal by Subject|0|||
105832490|NCT04364854|365044686|FG002|Overall Study|Withdrawal by Subject|1|||
105832491|NCT04364854|365044687|FG003|Overall Study|Withdrawal by Subject|3|||
105832492|NCT04364854|365044684|FG000|Overall Study|Death|1|||
105832493|NCT04364854|365044685|FG001|Overall Study|Death|0|||
105832494|NCT04364854|365044686|FG002|Overall Study|Death|0|||
105832495|NCT04364854|365044687|FG003|Overall Study|Death|0|||
105832496|NCT04364854|365044684|FG000|Overall Study|Lost to Follow-up|0|||
105832497|NCT04364854|365044685|FG001|Overall Study|Lost to Follow-up|0|||
105832498|NCT04364854|365044686|FG002|Overall Study|Lost to Follow-up|0|||
105832499|NCT04364854|365044687|FG003|Overall Study|Lost to Follow-up|1|||
105832500|NCT01453153|365044690|FG000|Overall Study|Physician Decision|0|||
105832501|NCT01453153|365044691|FG001|Overall Study|Physician Decision|0|||
105832502|NCT01453153|365044692|FG002|Overall Study|Physician Decision|1|||
105832503|NCT01453153|365044690|FG000|Overall Study|Progressive Disease|3|||
105832504|NCT01453153|365044691|FG001|Overall Study|Progressive Disease|2|||
105832505|NCT01453153|365044692|FG002|Overall Study|Progressive Disease|16|||
105832506|NCT01453153|365044690|FG000|Overall Study|Withdrawal by Subject|0|||
105832507|NCT01453153|365044691|FG001|Overall Study|Withdrawal by Subject|1|||
105832508|NCT01453153|365044692|FG002|Overall Study|Withdrawal by Subject|2|||
105832509|NCT01453153|365044690|FG000|Overall Study|Adverse Event|1|||
105832510|NCT01453153|365044691|FG001|Overall Study|Adverse Event|1|||
105832511|NCT01453153|365044692|FG002|Overall Study|Adverse Event|1|||
105832512|NCT00960154|365044694|FG000|Overall Study|Study termination|25|||
105832513|NCT00960154|365044695|FG001|Overall Study|Study termination|25|||
105832514|NCT00522041|365044698|FG000|Overall Study|Adverse Event|9|||
105832515|NCT00522041|365044699|FG001|Overall Study|Adverse Event|3|||
105832516|NCT00522041|365044698|FG000|Overall Study|Protocol Violation|2|||
105832517|NCT00522041|365044699|FG001|Overall Study|Protocol Violation|0|||
105832518|NCT00522041|365044698|FG000|Overall Study|Lost to Follow-up|1|||
105964402|NCT02443116|365527204|FG004|Part 2|Lost to Follow-up|0|||
105964403|NCT02443116|365527205|FG005|Part 2|Lost to Follow-up|0|||
105964404|NCT02443116|365527206|FG006|Part 2|Lost to Follow-up|0|||
105964405|NCT02443116|365527207|FG007|Part 2|Lost to Follow-up|0|||
105964406|NCT02443116|365527208|FG008|Part 2|Lost to Follow-up|0|||
105832519|NCT00522041|365044699|FG001|Overall Study|Lost to Follow-up|4|||
105832520|NCT00522041|365044698|FG000|Overall Study|Voluntary withdrawal|5|||
105964407|NCT02443116|365527200|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105964408|NCT02443116|365527201|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105964409|NCT02443116|365527202|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105964410|NCT02443116|365527203|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105964411|NCT02443116|365527204|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105964412|NCT02443116|365527205|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
105964413|NCT02443116|365527206|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105964414|NCT02443116|365527207|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105964415|NCT02443116|365527208|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
105964416|NCT02443116|365527200|FG000|Part 3|Adverse Event|0|||
105964417|NCT02443116|365527201|FG001|Part 3|Adverse Event|0|||
105964418|NCT02443116|365527202|FG002|Part 3|Adverse Event|0|||
105964419|NCT02443116|365527203|FG003|Part 3|Adverse Event|0|||
105964420|NCT02443116|365527204|FG004|Part 3|Adverse Event|0|||
105964421|NCT02443116|365527205|FG005|Part 3|Adverse Event|0|||
105964422|NCT02443116|365527206|FG006|Part 3|Adverse Event|0|||
105964423|NCT02443116|365527207|FG007|Part 3|Adverse Event|0|||
105964424|NCT02443116|365527208|FG008|Part 3|Adverse Event|1|||
105964425|NCT02443116|365527200|FG000|Part 3|Withdrew informed consent|0|||
105964426|NCT02443116|365527201|FG001|Part 3|Withdrew informed consent|0|||
105964427|NCT02443116|365527202|FG002|Part 3|Withdrew informed consent|0|||
105964428|NCT02443116|365527203|FG003|Part 3|Withdrew informed consent|0|||
105964429|NCT02443116|365527204|FG004|Part 3|Withdrew informed consent|0|||
105832521|NCT00522041|365044699|FG001|Overall Study|Voluntary withdrawal|4|||
105832522|NCT00522041|365044698|FG000|Overall Study|Did not receive treatment|0|||
105832523|NCT00522041|365044699|FG001|Overall Study|Did not receive treatment|1|||
105832524|NCT00288704|365044700|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
105832525|NCT00288704|365044701|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
105832526|NCT00288704|365044702|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
105832527|NCT00288704|365044700|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
105832528|NCT00288704|365044701|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
105832529|NCT00288704|365044702|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
105964430|NCT02443116|365527205|FG005|Part 3|Withdrew informed consent|0|||
105832530|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
105832531|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
105964431|NCT02443116|365527206|FG006|Part 3|Withdrew informed consent|0|||
105964432|NCT02443116|365527207|FG007|Part 3|Withdrew informed consent|3|||
105964433|NCT02443116|365527208|FG008|Part 3|Withdrew informed consent|2|||
105964434|NCT02443116|365527200|FG000|Part 3|Lost to Follow-up|0|||
105964435|NCT02443116|365527201|FG001|Part 3|Lost to Follow-up|0|||
105964436|NCT02443116|365527202|FG002|Part 3|Lost to Follow-up|0|||
105964437|NCT02443116|365527203|FG003|Part 3|Lost to Follow-up|0|||
105964438|NCT02443116|365527204|FG004|Part 3|Lost to Follow-up|0|||
105964439|NCT02443116|365527205|FG005|Part 3|Lost to Follow-up|0|||
105964440|NCT02443116|365527206|FG006|Part 3|Lost to Follow-up|0|||
105964441|NCT02443116|365527207|FG007|Part 3|Lost to Follow-up|1|||
105964442|NCT02443116|365527208|FG008|Part 3|Lost to Follow-up|2|||
105964443|NCT01854775|365527211|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
105964444|NCT01854775|365527212|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
105964445|NCT01854775|365527213|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
105964446|NCT01854775|365527211|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
105964447|NCT01854775|365527212|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
105964448|NCT01854775|365527213|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
105964449|NCT01854775|365527211|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
105964450|NCT01854775|365527212|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
105964451|NCT01854775|365527213|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
105832532|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
105832533|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
105832534|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
105832535|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
105832536|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
105832537|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
105832538|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
105832539|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
105832540|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
105832541|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
105832542|NCT00288704|365044700|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
105832543|NCT00288704|365044701|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
105832544|NCT00288704|365044702|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
105832545|NCT01802216|365044703|FG000|4 Month Visit|Participant did not show to visit|3|||
105832546|NCT01802216|365044704|FG001|4 Month Visit|Participant did not show to visit|4|||
105832547|NCT01802216|365044703|FG000|8 Month Visit|Participant did not show to visit|3|||
105832548|NCT01802216|365044704|FG001|8 Month Visit|Participant did not show to visit|5|||
105832549|NCT01802216|365044703|FG000|12 Month Visit|Participant did not show to visit|3|||
105832550|NCT01802216|365044704|FG001|12 Month Visit|Participant did not show to visit|4|||
105832551|NCT04982445|365044707|FG000|Overall Study|Protocol Violation|1|||
105832552|NCT04982445|365044707|FG000|Overall Study|Withdrawal by Subject|4|||
105832553|NCT04982445|365044707|FG000|Overall Study|Lost to Follow-up|1|||
105832554|NCT02483416|365044708|FG000|Overall Study|Other reason|0|||
105832555|NCT02483416|365044709|FG001|Overall Study|Other reason|1|||
105832556|NCT02483416|365044708|FG000|Overall Study|Treatment stop|3|||
105832557|NCT02483416|365044709|FG001|Overall Study|Treatment stop|0|||
105832558|NCT03885934|365044714|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
105832559|NCT03885934|365044715|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
105832560|NCT03885934|365044716|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
105832561|NCT03885934|365044717|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
105832562|NCT03885934|365044718|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
105832563|NCT03885934|365044719|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
105832564|NCT00881569|365044722|FG000|Overall Study|Disease progression|1|||
105964452|NCT01854775|365527211|FG000|Extension Phase|Pregnancy|3|||
105964453|NCT01854775|365527212|FG001|Extension Phase|Pregnancy|0|||
105964454|NCT01854775|365527213|FG002|Extension Phase|Pregnancy|0|||
105964455|NCT01854775|365527211|FG000|Extension Phase|Investigator's Discretion|1|||
105964456|NCT01854775|365527212|FG001|Extension Phase|Investigator's Discretion|0|||
105964457|NCT01854775|365527213|FG002|Extension Phase|Investigator's Discretion|0|||
105964458|NCT01854775|365527211|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
105964459|NCT01854775|365527212|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
105964460|NCT01854775|365527213|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
105832565|NCT00881569|365044723|FG001|Overall Study|Disease progression|1|||
105832566|NCT00640926|365044724|FG000|Overall Study|Adverse Event|2|||
105832567|NCT00640926|365044725|FG001|Overall Study|Adverse Event|3|||
105832568|NCT00640926|365044726|FG002|Overall Study|Adverse Event|2|||
105832569|NCT00640926|365044724|FG000|Overall Study|Lack of Efficacy|0|||
105964461|NCT01854775|365527211|FG000|Extension Phase|Lost to Follow-up|2|||
105964462|NCT01854775|365527212|FG001|Extension Phase|Lost to Follow-up|0|||
105964463|NCT01854775|365527213|FG002|Extension Phase|Lost to Follow-up|0|||
105832570|NCT00640926|365044725|FG001|Overall Study|Lack of Efficacy|2|||
105832571|NCT00640926|365044726|FG002|Overall Study|Lack of Efficacy|1|||
105832572|NCT00640926|365044724|FG000|Overall Study|Protocol Violation|2|||
105832573|NCT00640926|365044725|FG001|Overall Study|Protocol Violation|0|||
105832574|NCT00640926|365044726|FG002|Overall Study|Protocol Violation|2|||
105832575|NCT00640926|365044724|FG000|Overall Study|Lost to Follow-up|3|||
105832576|NCT00640926|365044725|FG001|Overall Study|Lost to Follow-up|1|||
105832577|NCT00640926|365044726|FG002|Overall Study|Lost to Follow-up|2|||
105832578|NCT00640926|365044724|FG000|Overall Study|Withdrawal by Subject|1|||
105832579|NCT00640926|365044725|FG001|Overall Study|Withdrawal by Subject|0|||
105832580|NCT00640926|365044726|FG002|Overall Study|Withdrawal by Subject|1|||
105832581|NCT04892147|365044730|FG000|Overall Study|Withdrawal by Subject|2|||
105832582|NCT04892147|365044731|FG001|Overall Study|Withdrawal by Subject|0|||
105832583|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
105832584|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
105832585|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
105832586|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
105832587|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
105832588|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
105832589|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
105832590|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
105832591|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
105832592|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
105832593|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
105832594|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
105832595|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
105832596|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
105832597|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
105832598|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
105832599|NCT01067521|365044733|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
105832600|NCT01067521|365044734|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
105832601|NCT01067521|365044733|FG000|Open-Label Period|Death|3|||
105832602|NCT01067521|365044734|FG001|Open-Label Period|Death|1|||
105832603|NCT01067521|365044733|FG000|Open-Label Period|Adverse Event|30|||
105832604|NCT01067521|365044734|FG001|Open-Label Period|Adverse Event|28|||
105832605|NCT01067521|365044733|FG000|Open-Label Period|Withdrawal by Subject|160|||
105832606|NCT01067521|365044734|FG001|Open-Label Period|Withdrawal by Subject|88|||
105832607|NCT01067521|365044733|FG000|Open-Label Period|Physician Decision|13|||
105832608|NCT01067521|365044734|FG001|Open-Label Period|Physician Decision|11|||
105832609|NCT01067521|365044733|FG000|Open-Label Period|Non-compliance with study drug|5|||
105832610|NCT01067521|365044734|FG001|Open-Label Period|Non-compliance with study drug|0|||
105832611|NCT01067521|365044733|FG000|Open-Label Period|Protocol Violation|3|||
105832612|NCT01067521|365044734|FG001|Open-Label Period|Protocol Violation|0|||
105832613|NCT01067521|365044733|FG000|Open-Label Period|Pregnancy|14|||
105832614|NCT01067521|365044734|FG001|Open-Label Period|Pregnancy|8|||
105832615|NCT01067521|365044733|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
105832616|NCT01067521|365044734|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
105832617|NCT01067521|365044733|FG000|Open-Label Period|Lost to Follow-up|21|||
105832618|NCT01067521|365044734|FG001|Open-Label Period|Lost to Follow-up|20|||
105832619|NCT01547728|365044738|FG000|Overall Study|Change in procedure and equipment|1|||
105832620|NCT01547728|365044738|FG000|Overall Study|Drug not ready for subject|1|||
105832621|NCT01547728|365044738|FG000|Overall Study|Screen failure|39|||
105964464|NCT01854775|365527211|FG000|Extension Phase|Still on Study|32|||
105964465|NCT01854775|365527212|FG001|Extension Phase|Still on Study|47|||
105964466|NCT01854775|365527213|FG002|Extension Phase|Still on Study|18|||
105964467|NCT05596734|365527214|FG000|Substudy A|Withdrawal by Subject|1|||
105964468|NCT05596734|365527215|FG001|Substudy A|Withdrawal by Subject|0|||
105964469|NCT05596734|365527216|FG002|Substudy A|Withdrawal by Subject|0|||
105964470|NCT05596734|365527217|FG003|Substudy A|Withdrawal by Subject|0|||
105964471|NCT05596734|365527218|FG004|Substudy A|Withdrawal by Subject|0|||
105964472|NCT05596734|365527219|FG005|Substudy A|Withdrawal by Subject|0|||
105964473|NCT05596734|365527220|FG006|Substudy A|Withdrawal by Subject|1|||
105832622|NCT03828539|365044739|FG000|Overall Study|Adverse Event|3|||
105964474|NCT05596734|365527221|FG007|Substudy A|Withdrawal by Subject|0|||
105964475|NCT05596734|365527222|FG008|Substudy A|Withdrawal by Subject|0|||
105832623|NCT03828539|365044740|FG001|Overall Study|Adverse Event|12|||
105832624|NCT03828539|365044739|FG000|Overall Study|Patient's/guardian's decision|3|||
105832625|NCT03828539|365044740|FG001|Overall Study|Patient's/guardian's decision|5|||
105832626|NCT03828539|365044739|FG000|Overall Study|Lost to Follow-up|4|||
105832627|NCT03828539|365044740|FG001|Overall Study|Lost to Follow-up|2|||
105964476|NCT05596734|365527223|FG009|Substudy A|Withdrawal by Subject|0|||
105964477|NCT05596734|365527224|FG010|Substudy A|Withdrawal by Subject|0|||
105832628|NCT03828539|365044739|FG000|Overall Study|Protocol Violation|3|||
105964478|NCT05596734|365527225|FG011|Substudy A|Withdrawal by Subject|0|||
105832629|NCT03828539|365044740|FG001|Overall Study|Protocol Violation|2|||
105832630|NCT03828539|365044739|FG000|Overall Study|Withdrawal of informed consent|2|||
105832631|NCT03828539|365044740|FG001|Overall Study|Withdrawal of informed consent|1|||
105832632|NCT03828539|365044739|FG000|Overall Study|New therapy for study indication|1|||
105832633|NCT03828539|365044740|FG001|Overall Study|New therapy for study indication|0|||
105832634|NCT00057941|365044741|FG000|Overall Study|Death|1|||
105832635|NCT00057941|365044742|FG001|Overall Study|Death|2|||
105832636|NCT00057941|365044741|FG000|Overall Study|Adverse Event|7|||
105832637|NCT00057941|365044742|FG001|Overall Study|Adverse Event|9|||
105832638|NCT00057941|365044741|FG000|Overall Study|Lack of Efficacy|54|||
105832639|NCT00057941|365044742|FG001|Overall Study|Lack of Efficacy|53|||
105832640|NCT00057941|365044741|FG000|Overall Study|Withdrawal by Subject|6|||
105832641|NCT00057941|365044742|FG001|Overall Study|Withdrawal by Subject|1|||
105832642|NCT00057941|365044741|FG000|Overall Study|still on treatment|3|||
105832643|NCT00057941|365044742|FG001|Overall Study|still on treatment|1|||
105832644|NCT00057941|365044741|FG000|Overall Study|insurance, symptomatic deterioration|1|||
105832645|NCT00057941|365044742|FG001|Overall Study|insurance, symptomatic deterioration|3|||
105832646|NCT00057941|365044741|FG000|Overall Study|Ineligible|2|||
105832647|NCT00057941|365044742|FG001|Overall Study|Ineligible|5|||
105832648|NCT02616380|365044743|FG000|Overall Study|Lost to Follow-up|1|||
105832649|NCT02616380|365044743|FG000|Overall Study|Other|2|||
105832650|NCT02760433|365044744|FG000|Overall Study|Lost to Follow-up|1|||
105832651|NCT02760433|365044745|FG001|Overall Study|Lost to Follow-up|0|||
105832652|NCT02760433|365044746|FG002|Overall Study|Lost to Follow-up|1|||
105832653|NCT02760433|365044747|FG003|Overall Study|Lost to Follow-up|0|||
105832654|NCT02760433|365044748|FG004|Overall Study|Lost to Follow-up|0|||
105832655|NCT02760433|365044744|FG000|Overall Study|Withdrawal by Subject|23|||
105832656|NCT02760433|365044745|FG001|Overall Study|Withdrawal by Subject|9|||
105832657|NCT02760433|365044746|FG002|Overall Study|Withdrawal by Subject|0|||
105832658|NCT02760433|365044747|FG003|Overall Study|Withdrawal by Subject|2|||
105832659|NCT02760433|365044748|FG004|Overall Study|Withdrawal by Subject|9|||
105832660|NCT02760433|365044744|FG000|Overall Study|Lack of Response At Week 14|0|||
105832661|NCT02760433|365044745|FG001|Overall Study|Lack of Response At Week 14|0|||
105832662|NCT02760433|365044746|FG002|Overall Study|Lack of Response At Week 14|0|||
105832663|NCT02760433|365044747|FG003|Overall Study|Lack of Response At Week 14|0|||
105832664|NCT02760433|365044748|FG004|Overall Study|Lack of Response At Week 14|1|||
105832665|NCT02760433|365044744|FG000|Overall Study|Subject refused to continue the study|1|||
105832666|NCT02760433|365044745|FG001|Overall Study|Subject refused to continue the study|0|||
105832667|NCT02760433|365044746|FG002|Overall Study|Subject refused to continue the study|0|||
105832668|NCT02760433|365044747|FG003|Overall Study|Subject refused to continue the study|0|||
105832669|NCT02760433|365044748|FG004|Overall Study|Subject refused to continue the study|0|||
105832670|NCT02760433|365044744|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
105832671|NCT02760433|365044745|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
105832672|NCT02760433|365044746|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
105832673|NCT02760433|365044747|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
105832674|NCT02760433|365044748|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
105832675|NCT02760433|365044744|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
105832676|NCT02760433|365044745|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
105832677|NCT02760433|365044746|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
105832678|NCT02760433|365044747|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
105964479|NCT05596734|365527226|FG012|Substudy A|Withdrawal by Subject|0|||
105964480|NCT05596734|365527227|FG013|Substudy A|Withdrawal by Subject|0|||
105964481|NCT05596734|365527228|FG014|Substudy A|Withdrawal by Subject|0|||
105964482|NCT05596734|365527229|FG015|Substudy A|Withdrawal by Subject|0|||
105832679|NCT02760433|365044748|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
105832680|NCT00766493|365044749|FG000|30 Days Post-Procedure|Discontinued|7|||
105832681|NCT00766493|365044749|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
105832682|NCT00766493|365044749|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
105832683|NCT03407729|365044750|FG000|Overall Study|Lost to Follow-up|2|||
105832684|NCT03407729|365044751|FG001|Overall Study|Lost to Follow-up|0|||
105832685|NCT03407729|365044750|FG000|Overall Study|Unable to schedule|0|||
105832686|NCT03407729|365044751|FG001|Overall Study|Unable to schedule|3|||
105832687|NCT02914457|365044754|FG000|Overall Study|Withdrawal by Subject|1|||
105832688|NCT02914457|365044754|FG000|Overall Study|Physician Decision|1|||
105832689|NCT02914457|365044754|FG000|Overall Study|No veins available for lead placement|1|||
105832690|NCT02914457|365044754|FG000|Overall Study|Electrical instability of patient|1|||
105832691|NCT02914457|365044754|FG000|Overall Study|ECG acquisition error due to sweating|1|||
105964483|NCT05596734|365527230|FG016|Substudy A|Withdrawal by Subject|0|||
105832692|NCT02914457|365044754|FG000|Overall Study|Protocol Violation|1|||
105964484|NCT05596734|365527231|FG017|Substudy A|Withdrawal by Subject|0|||
105964485|NCT05596734|365527232|FG018|Substudy A|Withdrawal by Subject|0|||
105832693|NCT02943096|365044755|FG000|Overall Study|Lack of Efficacy|0|||
105832694|NCT02943096|365044756|FG001|Overall Study|Lack of Efficacy|1|||
105832695|NCT04142658|365044757|FG000|Overall Study|Death|2|||
105832696|NCT04142658|365044758|FG001|Overall Study|Death|1|||
105832697|NCT04142658|365044757|FG000|Overall Study|Lost to Follow-up|4|||
105832698|NCT04142658|365044758|FG001|Overall Study|Lost to Follow-up|13|||
105832699|NCT04142658|365044757|FG000|Overall Study|Withdrawal by Subject|9|||
105832700|NCT04142658|365044758|FG001|Overall Study|Withdrawal by Subject|16|||
105832701|NCT03950674|365044759|FG000|Overall Study|Death|16|||
105832702|NCT03950674|365044760|FG001|Overall Study|Death|15|||
105832703|NCT03950674|365044759|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
105832704|NCT03950674|365044760|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
105832705|NCT02174276|365044761|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
105832706|NCT02174276|365044762|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
105832707|NCT02174276|365044763|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
105832708|NCT02174276|365044764|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
105832709|NCT02174276|365044761|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
105832710|NCT02174276|365044762|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
105832711|NCT02174276|365044763|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
105832712|NCT02174276|365044764|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
105832713|NCT02174276|365044761|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
105832714|NCT02174276|365044762|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
105832715|NCT02174276|365044763|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
105832716|NCT02174276|365044764|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
105832717|NCT02174276|365044761|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
105832718|NCT02174276|365044762|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
105832719|NCT02174276|365044763|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
105832720|NCT02174276|365044764|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
105832721|NCT02174276|365044761|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
105832722|NCT02174276|365044762|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
105832723|NCT02174276|365044763|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
105832724|NCT02174276|365044764|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
105832725|NCT02174276|365044761|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
105832726|NCT02174276|365044762|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
105832727|NCT02174276|365044763|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
105832728|NCT02174276|365044764|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
105832729|NCT02119936|365044767|FG000|Overall Study|Lost to Follow-up|10|||
105832730|NCT00570128|365044768|FG000|Overall Study|Adverse Event|1|||
105832731|NCT00570128|365044769|FG001|Overall Study|Adverse Event|0|||
105832732|NCT00570128|365044768|FG000|Overall Study|Lost to Follow-up|1|||
105832733|NCT00570128|365044769|FG001|Overall Study|Lost to Follow-up|0|||
105832734|NCT00570128|365044768|FG000|Overall Study|Withdrawal by Subject|2|||
105832735|NCT00570128|365044769|FG001|Overall Study|Withdrawal by Subject|0|||
105832736|NCT00609154|365044770|FG000|Overall Study|Protocol Violation|1|||
105832737|NCT00609154|365044771|FG001|Overall Study|Protocol Violation|2|||
105832738|NCT00609154|365044770|FG000|Overall Study|Unable to establish IV access|0|||
105832739|NCT00609154|365044771|FG001|Overall Study|Unable to establish IV access|4|||
105832740|NCT00609154|365044770|FG000|Overall Study|Adverse Event|0|||
105832741|NCT00609154|365044771|FG001|Overall Study|Adverse Event|2|||
105832742|NCT01898598|365044772|FG000|Overall Study|Adverse Event|1|||
105832743|NCT01898598|365044773|FG001|Overall Study|Adverse Event|0|||
105832744|NCT01898598|365044772|FG000|Overall Study|Withdrawal by Subject|3|||
105832745|NCT01898598|365044773|FG001|Overall Study|Withdrawal by Subject|0|||
105832746|NCT01898598|365044772|FG000|Overall Study|Lost to Follow-up|0|||
105832747|NCT01898598|365044773|FG001|Overall Study|Lost to Follow-up|1|||
105832748|NCT01898598|365044772|FG000|Overall Study|Other|0|||
105832749|NCT01898598|365044773|FG001|Overall Study|Other|1|||
105964486|NCT05596734|365527233|FG019|Substudy A|Withdrawal by Subject|0|||
105832750|NCT01499160|365044776|FG000|Overall Study|Adverse Event|1|||
105832751|NCT01499160|365044776|FG000|Overall Study|Withdrawal by Subject|1|||
105832752|NCT03868631|365044781|FG000|Baseline to Week 6|Adverse Event|0|||
105832753|NCT03868631|365044782|FG001|Baseline to Week 6|Adverse Event|3|||
105832754|NCT03868631|365044781|FG000|Baseline to Week 6|Protocol Violation|1|||
105832755|NCT03868631|365044782|FG001|Baseline to Week 6|Protocol Violation|1|||
105832756|NCT03868631|365044781|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
105832757|NCT03868631|365044782|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
105832758|NCT03868631|365044781|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
105832759|NCT03868631|365044782|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
105832760|NCT03868631|365044781|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
105832761|NCT03868631|365044782|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
105832762|NCT03868631|365044781|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
105832763|NCT03868631|365044782|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
105832764|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
105832765|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
105832766|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
105832767|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
105832768|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
105832769|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
105832770|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
105832771|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
105832772|NCT03448692|365044783|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
105832773|NCT03448692|365044784|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
105832774|NCT01077258|365044786|FG000|Overall Study|Lost to Follow-up|1390|||
105832775|NCT01077258|365044786|FG000|Overall Study|Adverse drug reaction|218|||
105832776|NCT01077258|365044786|FG000|Overall Study|Lack of Efficacy|663|||
105832777|NCT01077258|365044786|FG000|Overall Study|Clinical remission|37|||
105832778|NCT01077258|365044786|FG000|Overall Study|Other reasons|260|||
105832779|NCT00726895|365044790|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105832780|NCT00726895|365044791|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105832781|NCT04194008|365044796|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
105832782|NCT04194008|365044796|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
105832783|NCT04194008|365044796|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
105832784|NCT04194008|365044796|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
105832785|NCT04194008|365044796|FG000|Treatment Phase With Nerivio|Missing data|4|||
105832786|NCT04194008|365044796|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
105832787|NCT01785615|365044797|FG000|Dietary Phase|Lost to Follow-up|0|||
105832788|NCT01785615|365044798|FG001|Dietary Phase|Lost to Follow-up|0|||
105832789|NCT01785615|365044799|FG002|Dietary Phase|Lost to Follow-up|0|||
105832790|NCT01785615|365044800|FG003|Dietary Phase|Lost to Follow-up|24|||
105832791|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
105832792|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
105832793|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
105832794|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
105832795|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
105832796|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
105832797|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
105832798|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
105832799|NCT00982228|365044803|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
105832800|NCT00982228|365044804|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
105832801|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
105832802|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
105832803|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
105832804|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
105832805|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
105832806|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
105832807|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
105832808|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
105832809|NCT00982228|365044803|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
105832810|NCT00982228|365044804|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
105832811|NCT01929681|365044805|FG000|Overall Study|Withdrawal by Subject|1|||
105832812|NCT01929681|365044806|FG001|Overall Study|Withdrawal by Subject|0|||
105832813|NCT01929681|365044805|FG000|Overall Study|Physician Decision|1|||
105832814|NCT01929681|365044806|FG001|Overall Study|Physician Decision|1|||
105832815|NCT02218216|365044807|FG000|Overall Study|Study terminated before completed|6|||
105832816|NCT02218216|365044808|FG001|Overall Study|Study terminated before completed|0|||
105832817|NCT02218216|365044809|FG002|Overall Study|Study terminated before completed|0|||
105832818|NCT01596127|365044810|FG000|Overall Study|Patient Ineligible|1|||
105832819|NCT00772148|365044812|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
105832820|NCT00772148|365044813|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
105832821|NCT00772148|365044812|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
105832822|NCT00772148|365044813|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
105832823|NCT00772148|365044812|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
105964487|NCT05596734|365527234|FG020|Substudy A|Withdrawal by Subject|0|||
105964488|NCT05596734|365527235|FG021|Substudy A|Withdrawal by Subject|0|||
105964489|NCT05596734|365527236|FG022|Substudy A|Withdrawal by Subject|0|||
105964490|NCT05596734|365527237|FG023|Substudy A|Withdrawal by Subject|0|||
105964491|NCT05596734|365527214|FG000|Substudy A|Lost to Follow-up|1|||
105964492|NCT05596734|365527215|FG001|Substudy A|Lost to Follow-up|0|||
105964493|NCT05596734|365527216|FG002|Substudy A|Lost to Follow-up|1|||
105964494|NCT05596734|365527217|FG003|Substudy A|Lost to Follow-up|0|||
105964495|NCT05596734|365527218|FG004|Substudy A|Lost to Follow-up|0|||
105832824|NCT00772148|365044813|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
105832825|NCT00772148|365044812|FG000|Maintenance Phase (Week 52)|Death|2|||
105832826|NCT00772148|365044813|FG001|Maintenance Phase (Week 52)|Death|2|||
105964496|NCT05596734|365527219|FG005|Substudy A|Lost to Follow-up|0|||
105832827|NCT00772148|365044812|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
105832828|NCT00772148|365044813|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
105832829|NCT00772148|365044812|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
105832830|NCT00772148|365044813|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
105832831|NCT00772148|365044812|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
105832832|NCT00772148|365044813|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
105832833|NCT01562613|365044814|FG000|Overall Study|Lost to Follow-up|2|||
105832834|NCT01562613|365044814|FG000|Overall Study|Withdrawal by Subject|2|||
105832835|NCT00633022|365044815|FG000|Overall Study|Adverse Event|1|||
105832836|NCT00633022|365044816|FG001|Overall Study|Adverse Event|0|||
105832837|NCT00633022|365044817|FG002|Overall Study|Adverse Event|5|||
105832838|NCT00633022|365044815|FG000|Overall Study|Physician Decision|0|||
105832839|NCT00633022|365044816|FG001|Overall Study|Physician Decision|1|||
105832840|NCT00633022|365044817|FG002|Overall Study|Physician Decision|0|||
105832841|NCT03573336|365044819|FG000|Overall Study|Study terminated|2|||
105832842|NCT03573336|365044820|FG001|Overall Study|Study terminated|4|||
105832843|NCT03573336|365044821|FG002|Overall Study|Study terminated|2|||
105832844|NCT01525628|365044822|FG000|Overall Study|Adverse Event|1|||
105832845|NCT01525628|365044823|FG001|Overall Study|Adverse Event|1|||
105832846|NCT01525628|365044824|FG002|Overall Study|Adverse Event|2|||
105832847|NCT01525628|365044825|FG003|Overall Study|Adverse Event|0|||
105832848|NCT01525628|365044826|FG004|Overall Study|Adverse Event|1|||
105832849|NCT01525628|365044822|FG000|Overall Study|Lack of Efficacy|0|||
105832850|NCT01525628|365044823|FG001|Overall Study|Lack of Efficacy|2|||
105832851|NCT01525628|365044824|FG002|Overall Study|Lack of Efficacy|2|||
105832852|NCT01525628|365044825|FG003|Overall Study|Lack of Efficacy|1|||
105832853|NCT01525628|365044826|FG004|Overall Study|Lack of Efficacy|2|||
105832854|NCT01525628|365044822|FG000|Overall Study|Protocol Violation|0|||
105832855|NCT01525628|365044823|FG001|Overall Study|Protocol Violation|0|||
105832856|NCT01525628|365044824|FG002|Overall Study|Protocol Violation|1|||
105832857|NCT01525628|365044825|FG003|Overall Study|Protocol Violation|0|||
105832858|NCT01525628|365044826|FG004|Overall Study|Protocol Violation|0|||
105832859|NCT01525628|365044822|FG000|Overall Study|Lost to Follow-up|1|||
105832860|NCT01525628|365044823|FG001|Overall Study|Lost to Follow-up|1|||
105832861|NCT01525628|365044824|FG002|Overall Study|Lost to Follow-up|0|||
105832862|NCT01525628|365044825|FG003|Overall Study|Lost to Follow-up|0|||
105832863|NCT01525628|365044826|FG004|Overall Study|Lost to Follow-up|0|||
105832864|NCT01525628|365044822|FG000|Overall Study|Withdrawal by Subject|0|||
105832865|NCT01525628|365044823|FG001|Overall Study|Withdrawal by Subject|1|||
105832866|NCT01525628|365044824|FG002|Overall Study|Withdrawal by Subject|0|||
105832867|NCT01525628|365044825|FG003|Overall Study|Withdrawal by Subject|0|||
105832868|NCT01525628|365044826|FG004|Overall Study|Withdrawal by Subject|0|||
105832869|NCT01525628|365044822|FG000|Overall Study|Other reason not defined above|0|||
105832870|NCT01525628|365044823|FG001|Overall Study|Other reason not defined above|0|||
105832871|NCT01525628|365044824|FG002|Overall Study|Other reason not defined above|0|||
105832872|NCT01525628|365044825|FG003|Overall Study|Other reason not defined above|3|||
105832873|NCT01525628|365044826|FG004|Overall Study|Other reason not defined above|0|||
105832874|NCT02614898|365044827|FG000|Overall Study|Participated until study termination|10|||
105832875|NCT02614898|365044828|FG001|Overall Study|Participated until study termination|26|||
105832876|NCT02614898|365044827|FG000|Overall Study|Lost to Follow-up|0|||
105832877|NCT02614898|365044828|FG001|Overall Study|Lost to Follow-up|2|||
105832878|NCT02614898|365044827|FG000|Overall Study|Physician Decision|1|||
105832879|NCT02614898|365044828|FG001|Overall Study|Physician Decision|8|||
105832880|NCT02614898|365044827|FG000|Overall Study|Study Terminated by Sponsor|3|||
105832881|NCT02614898|365044828|FG001|Overall Study|Study Terminated by Sponsor|0|||
105832882|NCT02614898|365044827|FG000|Overall Study|Withdrawal by Subject|0|||
105832883|NCT02614898|365044828|FG001|Overall Study|Withdrawal by Subject|2|||
105832884|NCT02614898|365044827|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105832885|NCT02614898|365044828|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105832886|NCT02614898|365044827|FG000|Overall Study|Other-Additional Information Unavailable|0|||
105832887|NCT02614898|365044828|FG001|Overall Study|Other-Additional Information Unavailable|11|||
105832888|NCT02614898|365044827|FG000|Overall Study|Missing|0|||
105832889|NCT02614898|365044828|FG001|Overall Study|Missing|1|||
105832890|NCT00239005|365044829|FG000|Overall Study|Adverse Event|6|||
105832891|NCT00239005|365044830|FG001|Overall Study|Adverse Event|6|||
105832892|NCT00239005|365044829|FG000|Overall Study|Withdrawal by Subject|3|||
105832893|NCT00239005|365044830|FG001|Overall Study|Withdrawal by Subject|4|||
105964497|NCT05596734|365527220|FG006|Substudy A|Lost to Follow-up|0|||
105964498|NCT05596734|365527221|FG007|Substudy A|Lost to Follow-up|0|||
105964499|NCT05596734|365527222|FG008|Substudy A|Lost to Follow-up|0|||
105832894|NCT00239005|365044829|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
105964500|NCT05596734|365527223|FG009|Substudy A|Lost to Follow-up|0|||
105964501|NCT05596734|365527224|FG010|Substudy A|Lost to Follow-up|0|||
105964502|NCT05596734|365527225|FG011|Substudy A|Lost to Follow-up|0|||
105964503|NCT05596734|365527226|FG012|Substudy A|Lost to Follow-up|0|||
105964504|NCT05596734|365527227|FG013|Substudy A|Lost to Follow-up|0|||
105964505|NCT05596734|365527228|FG014|Substudy A|Lost to Follow-up|0|||
105964506|NCT05596734|365527229|FG015|Substudy A|Lost to Follow-up|0|||
105964507|NCT05596734|365527230|FG016|Substudy A|Lost to Follow-up|0|||
105964508|NCT05596734|365527231|FG017|Substudy A|Lost to Follow-up|0|||
105964509|NCT05596734|365527232|FG018|Substudy A|Lost to Follow-up|0|||
105964510|NCT05596734|365527233|FG019|Substudy A|Lost to Follow-up|0|||
105964511|NCT05596734|365527234|FG020|Substudy A|Lost to Follow-up|0|||
105964512|NCT05596734|365527235|FG021|Substudy A|Lost to Follow-up|0|||
105964513|NCT05596734|365527236|FG022|Substudy A|Lost to Follow-up|0|||
105964514|NCT05596734|365527237|FG023|Substudy A|Lost to Follow-up|0|||
105964515|NCT05596734|365527214|FG000|Substudy B|Withdrawal by Subject|0|||
105964516|NCT05596734|365527215|FG001|Substudy B|Withdrawal by Subject|0|||
105964517|NCT05596734|365527216|FG002|Substudy B|Withdrawal by Subject|0|||
105964518|NCT05596734|365527217|FG003|Substudy B|Withdrawal by Subject|0|||
105964519|NCT05596734|365527218|FG004|Substudy B|Withdrawal by Subject|0|||
105964520|NCT05596734|365527219|FG005|Substudy B|Withdrawal by Subject|0|||
105964521|NCT05596734|365527220|FG006|Substudy B|Withdrawal by Subject|0|||
105964522|NCT05596734|365527221|FG007|Substudy B|Withdrawal by Subject|0|||
105964523|NCT05596734|365527222|FG008|Substudy B|Withdrawal by Subject|0|||
105964524|NCT05596734|365527223|FG009|Substudy B|Withdrawal by Subject|0|||
105964525|NCT05596734|365527224|FG010|Substudy B|Withdrawal by Subject|0|||
105964526|NCT05596734|365527225|FG011|Substudy B|Withdrawal by Subject|0|||
105964527|NCT05596734|365527226|FG012|Substudy B|Withdrawal by Subject|1|||
105964528|NCT05596734|365527227|FG013|Substudy B|Withdrawal by Subject|0|||
105964529|NCT05596734|365527228|FG014|Substudy B|Withdrawal by Subject|1|||
105964530|NCT05596734|365527229|FG015|Substudy B|Withdrawal by Subject|2|||
105964531|NCT05596734|365527230|FG016|Substudy B|Withdrawal by Subject|2|||
105964532|NCT05596734|365527231|FG017|Substudy B|Withdrawal by Subject|1|||
105964533|NCT05596734|365527232|FG018|Substudy B|Withdrawal by Subject|2|||
106022790|NCT02873429|365748675|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
106022791|NCT02873429|365748676|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
106022792|NCT02873429|365748675|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
106022793|NCT02873429|365748676|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
106022794|NCT02873429|365748675|FG000|16 Weeks|Lost to Follow-up|3|||
106022795|NCT02873429|365748676|FG001|16 Weeks|Lost to Follow-up|0|||
106022796|NCT01388985|365748677|FG000|Overall Study|Death|0|||
106022797|NCT01388985|365748678|FG001|Overall Study|Death|1|||
106022798|NCT01388985|365748677|FG000|Overall Study|Lost to Follow-up|30|||
106022799|NCT01388985|365748678|FG001|Overall Study|Lost to Follow-up|30|||
106022800|NCT01388985|365748677|FG000|Overall Study|Withdrawal by Subject|13|||
106022801|NCT01388985|365748678|FG001|Overall Study|Withdrawal by Subject|4|||
106022802|NCT01388985|365748677|FG000|Overall Study|Subject unavailable|1|||
106022803|NCT01388985|365748678|FG001|Overall Study|Subject unavailable|1|||
106022804|NCT01388985|365748677|FG000|Overall Study|Other (no reason)|0|||
106022805|NCT01388985|365748678|FG001|Overall Study|Other (no reason)|1|||
106022806|NCT01388985|365748677|FG000|Overall Study|Error of nurse|5|||
106022807|NCT01388985|365748678|FG001|Overall Study|Error of nurse|1|||
106022808|NCT00853567|365748681|FG000|Overall Study|Study prematurely terminated|71|||
106022809|NCT02055118|365748682|FG000|Overall Study|Withdrawal by Subject|0|||
106022810|NCT02055118|365748683|FG001|Overall Study|Withdrawal by Subject|2|||
106022811|NCT02055118|365748684|FG002|Overall Study|Withdrawal by Subject|0|||
106022812|NCT01001325|365748685|FG000|Overall Study|Lost to Follow-up|16|||
106022813|NCT01001325|365748686|FG001|Overall Study|Lost to Follow-up|10|||
106022814|NCT01001325|365748685|FG000|Overall Study|Protocol Violation|2|||
106022815|NCT01001325|365748686|FG001|Overall Study|Protocol Violation|0|||
106022816|NCT01584440|365748687|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
106022817|NCT01584440|365748688|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
106022818|NCT01584440|365748689|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
106022819|NCT01584440|365748690|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
106022820|NCT01584440|365748691|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
106022821|NCT01584440|365748687|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
106022822|NCT01584440|365748688|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
106022823|NCT01584440|365748689|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
106022824|NCT01584440|365748690|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
106022825|NCT01584440|365748691|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
106148873|NCT00421889|366206904|FG000|Overall Study|Patient/Investigator request|0|||
105964534|NCT05596734|365527233|FG019|Substudy B|Withdrawal by Subject|0|||
105964535|NCT05596734|365527234|FG020|Substudy B|Withdrawal by Subject|0|||
105964536|NCT05596734|365527235|FG021|Substudy B|Withdrawal by Subject|0|||
105964537|NCT05596734|365527236|FG022|Substudy B|Withdrawal by Subject|0|||
105964538|NCT05596734|365527237|FG023|Substudy B|Withdrawal by Subject|1|||
105964539|NCT05596734|365527214|FG000|Substudy B|Physician Decision|0|||
106022826|NCT01584440|365748687|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
106022827|NCT01584440|365748688|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
106022828|NCT01584440|365748689|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
106022829|NCT01584440|365748690|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
106022830|NCT01584440|365748691|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
106022831|NCT01584440|365748687|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
106022832|NCT01584440|365748688|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
105832895|NCT00239005|365044830|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
105832896|NCT00239005|365044829|FG000|Overall Study|Protocol Violation|1|||
105832897|NCT00239005|365044830|FG001|Overall Study|Protocol Violation|0|||
105832898|NCT00239005|365044829|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
105832899|NCT00239005|365044830|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
105832900|NCT00239005|365044829|FG000|Overall Study|Lost to Follow-up|0|||
105832901|NCT00239005|365044830|FG001|Overall Study|Lost to Follow-up|1|||
105832902|NCT03382041|365044831|FG000|Overall Study|Consent Form Lost|2|||
105832903|NCT03382041|365044832|FG001|Overall Study|Consent Form Lost|1|||
105832904|NCT03382041|365044831|FG000|Overall Study|Withdrawal by Subject|1|||
105832905|NCT03382041|365044832|FG001|Overall Study|Withdrawal by Subject|4|||
105832906|NCT03382041|365044831|FG000|Overall Study|Lost to Follow-up|1|||
105832907|NCT03382041|365044832|FG001|Overall Study|Lost to Follow-up|4|||
105832908|NCT00787605|365044833|FG000|Overall Study|Administrative Problems|3|||
105832909|NCT00787605|365044834|FG001|Overall Study|Administrative Problems|0|||
105832910|NCT00787605|365044833|FG000|Overall Study|Adverse Event|14|||
105832911|NCT00787605|365044834|FG001|Overall Study|Adverse Event|25|||
105832912|NCT00787605|365044833|FG000|Overall Study|Lost to Follow-up|3|||
105832913|NCT00787605|365044834|FG001|Overall Study|Lost to Follow-up|6|||
105832914|NCT00787605|365044833|FG000|Overall Study|Protocol Violation|7|||
105832915|NCT00787605|365044834|FG001|Overall Study|Protocol Violation|3|||
105832916|NCT00787605|365044833|FG000|Overall Study|Withdrawal by Subject|6|||
105832917|NCT00787605|365044834|FG001|Overall Study|Withdrawal by Subject|13|||
105832918|NCT00787605|365044833|FG000|Overall Study|Lack of Efficacy|13|||
105832919|NCT00787605|365044834|FG001|Overall Study|Lack of Efficacy|9|||
105832920|NCT04640194|365044840|FG000|Overall Study|Adverse Event|3|||
105832921|NCT04640194|365044841|FG001|Overall Study|Adverse Event|7|||
105832922|NCT04640194|365044842|FG002|Overall Study|Adverse Event|0|||
105832923|NCT04640194|365044843|FG003|Overall Study|Adverse Event|5|||
105964540|NCT05596734|365527215|FG001|Substudy B|Physician Decision|0|||
105964541|NCT05596734|365527216|FG002|Substudy B|Physician Decision|0|||
105964542|NCT05596734|365527217|FG003|Substudy B|Physician Decision|0|||
105964543|NCT05596734|365527218|FG004|Substudy B|Physician Decision|0|||
105964544|NCT05596734|365527219|FG005|Substudy B|Physician Decision|0|||
105964545|NCT05596734|365527220|FG006|Substudy B|Physician Decision|0|||
105964546|NCT05596734|365527221|FG007|Substudy B|Physician Decision|0|||
106022833|NCT01584440|365748689|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
106022834|NCT01584440|365748690|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
106022835|NCT01584440|365748691|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
106022836|NCT01584440|365748687|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
106022837|NCT01584440|365748688|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
106022838|NCT01584440|365748689|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
106022839|NCT01584440|365748690|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
106022840|NCT01584440|365748691|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
106022841|NCT01584440|365748687|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
106022842|NCT01584440|365748688|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
106022843|NCT01584440|365748689|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
106022844|NCT01584440|365748690|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
106022845|NCT01584440|365748691|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
106022846|NCT01584440|365748687|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
106022847|NCT01584440|365748688|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
106022848|NCT01584440|365748689|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
106022849|NCT01584440|365748690|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
106022850|NCT01584440|365748691|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
106022851|NCT01584440|365748687|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
106022852|NCT01584440|365748688|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
106022853|NCT01584440|365748689|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
106022854|NCT01584440|365748690|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
106022855|NCT01584440|365748691|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
106022856|NCT01584440|365748687|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
106148874|NCT00421889|366206905|FG001|Overall Study|Patient/Investigator request|0|||
106148875|NCT00421889|366206906|FG002|Overall Study|Patient/Investigator request|0|||
106148876|NCT00421889|366206907|FG003|Overall Study|Patient/Investigator request|0|||
105832924|NCT04640194|365044844|FG004|Overall Study|Adverse Event|0|||
105832925|NCT04640194|365044845|FG005|Overall Study|Adverse Event|4|||
105964547|NCT05596734|365527222|FG008|Substudy B|Physician Decision|0|||
106148877|NCT00421889|366206908|FG004|Overall Study|Patient/Investigator request|0|||
106148878|NCT00421889|366206909|FG005|Overall Study|Patient/Investigator request|9|||
105832926|NCT04640194|365044846|FG006|Overall Study|Adverse Event|0|||
105832927|NCT04640194|365044840|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
105832928|NCT04640194|365044841|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
105832929|NCT04640194|365044842|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
105964548|NCT05596734|365527223|FG009|Substudy B|Physician Decision|0|||
106022857|NCT01584440|365748688|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
106022858|NCT01584440|365748689|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
106148879|NCT00421889|366206910|FG006|Overall Study|Patient/Investigator request|0|||
105832930|NCT04640194|365044843|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
105832931|NCT04640194|365044844|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
105832932|NCT04640194|365044845|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
105832933|NCT04640194|365044846|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
105832934|NCT04640194|365044840|FG000|Overall Study|fibrinogen level too low|0|||
106148880|NCT00421889|366206911|FG007|Overall Study|Patient/Investigator request|1|||
106148881|NCT00421889|366206912|FG008|Overall Study|Patient/Investigator request|3|||
106148882|NCT00421889|366206904|FG000|Overall Study|Lost to Follow-up|0|||
106148883|NCT00421889|366206905|FG001|Overall Study|Lost to Follow-up|0|||
106148884|NCT00421889|366206906|FG002|Overall Study|Lost to Follow-up|0|||
106148885|NCT00421889|366206907|FG003|Overall Study|Lost to Follow-up|0|||
106148886|NCT00421889|366206908|FG004|Overall Study|Lost to Follow-up|0|||
106148887|NCT00421889|366206909|FG005|Overall Study|Lost to Follow-up|0|||
106148888|NCT00421889|366206910|FG006|Overall Study|Lost to Follow-up|0|||
106148889|NCT00421889|366206911|FG007|Overall Study|Lost to Follow-up|0|||
106148890|NCT00421889|366206912|FG008|Overall Study|Lost to Follow-up|1|||
106148891|NCT00978042|366206913|FG000|Initial Treatment Period|Treated in Error|0|||
106148892|NCT00978042|366206914|FG001|Initial Treatment Period|Treated in Error|3|||
106148893|NCT00978042|366206913|FG000|Initial Treatment Period|Ineligibility|1|||
106148894|NCT00978042|366206914|FG001|Initial Treatment Period|Ineligibility|0|||
105964549|NCT05596734|365527224|FG010|Substudy B|Physician Decision|0|||
105964550|NCT05596734|365527225|FG011|Substudy B|Physician Decision|0|||
105964551|NCT05596734|365527226|FG012|Substudy B|Physician Decision|0|||
105964552|NCT05596734|365527227|FG013|Substudy B|Physician Decision|0|||
105964553|NCT05596734|365527228|FG014|Substudy B|Physician Decision|0|||
105964554|NCT05596734|365527229|FG015|Substudy B|Physician Decision|1|||
105964555|NCT05596734|365527230|FG016|Substudy B|Physician Decision|0|||
105964556|NCT05596734|365527231|FG017|Substudy B|Physician Decision|0|||
105964557|NCT05596734|365527232|FG018|Substudy B|Physician Decision|0|||
105964558|NCT05596734|365527233|FG019|Substudy B|Physician Decision|0|||
105964559|NCT05596734|365527234|FG020|Substudy B|Physician Decision|0|||
105964560|NCT05596734|365527235|FG021|Substudy B|Physician Decision|0|||
105964561|NCT05596734|365527236|FG022|Substudy B|Physician Decision|0|||
105964562|NCT05596734|365527237|FG023|Substudy B|Physician Decision|0|||
105964563|NCT05596734|365527214|FG000|Substudy B|Lost to Follow-up|0|||
105964564|NCT05596734|365527215|FG001|Substudy B|Lost to Follow-up|0|||
105964565|NCT05596734|365527216|FG002|Substudy B|Lost to Follow-up|0|||
105964566|NCT05596734|365527217|FG003|Substudy B|Lost to Follow-up|0|||
105964567|NCT05596734|365527218|FG004|Substudy B|Lost to Follow-up|0|||
105964568|NCT05596734|365527219|FG005|Substudy B|Lost to Follow-up|0|||
105964569|NCT05596734|365527220|FG006|Substudy B|Lost to Follow-up|0|||
105964570|NCT05596734|365527221|FG007|Substudy B|Lost to Follow-up|0|||
105964571|NCT05596734|365527222|FG008|Substudy B|Lost to Follow-up|0|||
105964572|NCT05596734|365527223|FG009|Substudy B|Lost to Follow-up|0|||
105964573|NCT05596734|365527224|FG010|Substudy B|Lost to Follow-up|0|||
105964574|NCT05596734|365527225|FG011|Substudy B|Lost to Follow-up|0|||
105964575|NCT05596734|365527226|FG012|Substudy B|Lost to Follow-up|1|||
105964576|NCT05596734|365527227|FG013|Substudy B|Lost to Follow-up|0|||
105964577|NCT05596734|365527228|FG014|Substudy B|Lost to Follow-up|1|||
105964578|NCT05596734|365527229|FG015|Substudy B|Lost to Follow-up|1|||
105964579|NCT05596734|365527230|FG016|Substudy B|Lost to Follow-up|0|||
105964580|NCT05596734|365527231|FG017|Substudy B|Lost to Follow-up|0|||
105964581|NCT05596734|365527232|FG018|Substudy B|Lost to Follow-up|0|||
105964582|NCT05596734|365527233|FG019|Substudy B|Lost to Follow-up|0|||
105964583|NCT05596734|365527234|FG020|Substudy B|Lost to Follow-up|0|||
105964584|NCT05596734|365527235|FG021|Substudy B|Lost to Follow-up|0|||
105964585|NCT05596734|365527236|FG022|Substudy B|Lost to Follow-up|0|||
105964586|NCT05596734|365527237|FG023|Substudy B|Lost to Follow-up|0|||
105964587|NCT02059499|365527238|FG000|Upto Week 20|Lost to Follow-up|2|||
105964588|NCT02059499|365527239|FG001|Upto Week 20|Lost to Follow-up|6|||
105964589|NCT02059499|365527240|FG002|Upto Week 20|Lost to Follow-up|0|||
105964590|NCT02059499|365527238|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
105964591|NCT02059499|365527239|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
105964592|NCT02059499|365527240|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
105964593|NCT02059499|365527238|FG000|Upto Week 20|Withdrawal by Subject|1|||
105964594|NCT02059499|365527239|FG001|Upto Week 20|Withdrawal by Subject|1|||
105964595|NCT02059499|365527240|FG002|Upto Week 20|Withdrawal by Subject|0|||
105964596|NCT02059499|365527238|FG000|Upto Week 20|No treatment per protocol criteria|0|||
105964597|NCT02059499|365527239|FG001|Upto Week 20|No treatment per protocol criteria|0|||
105964598|NCT02059499|365527240|FG002|Upto Week 20|No treatment per protocol criteria|5|||
105964599|NCT02059499|365527238|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
105964600|NCT02059499|365527239|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
105964601|NCT02059499|365527240|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
105964602|NCT02059499|365527238|FG000|Post-week 20|Lost to Follow-up|0|||
105964603|NCT02059499|365527239|FG001|Post-week 20|Lost to Follow-up|2|||
105964604|NCT02059499|365527240|FG002|Post-week 20|Lost to Follow-up|0|||
105964605|NCT02059499|365527238|FG000|Post-week 20|Withdrawal by Subject|0|||
106148895|NCT00978042|366206913|FG000|Initial Treatment Period|Lost to Follow-up|21|||
106148896|NCT00978042|366206914|FG001|Initial Treatment Period|Lost to Follow-up|3|||
106148897|NCT00978042|366206913|FG000|Initial Treatment Period|Adverse Event|2|||
106148898|NCT00978042|366206914|FG001|Initial Treatment Period|Adverse Event|0|||
106148899|NCT00978042|366206913|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
106148900|NCT00978042|366206914|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
106148901|NCT00978042|366206913|FG000|Initial Treatment Period|Consent withdrawn|22|||
106148902|NCT00978042|366206914|FG001|Initial Treatment Period|Consent withdrawn|9|||
106148903|NCT00978042|366206913|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
106148904|NCT00978042|366206914|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
106148905|NCT02379819|366206915|FG000|Overall Study|Withdrawal by Subject|10|||
106148906|NCT02379819|366206915|FG000|Overall Study|Death|2|||
106148907|NCT02379819|366206915|FG000|Overall Study|Lack of Efficacy|1|||
106148908|NCT02379819|366206915|FG000|Overall Study|Lost to Follow-up|1|||
105832935|NCT04640194|365044841|FG001|Overall Study|fibrinogen level too low|0|||
105964606|NCT02059499|365527239|FG001|Post-week 20|Withdrawal by Subject|1|||
105964607|NCT02059499|365527240|FG002|Post-week 20|Withdrawal by Subject|0|||
106148909|NCT04056624|366206916|FG000|Overall Study|Withdrawal by Subject|0|||
105832936|NCT04640194|365044842|FG002|Overall Study|fibrinogen level too low|0|||
105832937|NCT04640194|365044843|FG003|Overall Study|fibrinogen level too low|1|||
105832938|NCT04640194|365044844|FG004|Overall Study|fibrinogen level too low|0|||
105832939|NCT04640194|365044845|FG005|Overall Study|fibrinogen level too low|0|||
105832940|NCT04640194|365044846|FG006|Overall Study|fibrinogen level too low|0|||
105832941|NCT04640194|365044840|FG000|Overall Study|mild bleeding|0|||
105832942|NCT04640194|365044841|FG001|Overall Study|mild bleeding|0|||
105832943|NCT04640194|365044842|FG002|Overall Study|mild bleeding|0|||
105832944|NCT04640194|365044843|FG003|Overall Study|mild bleeding|1|||
105832945|NCT04640194|365044844|FG004|Overall Study|mild bleeding|0|||
105832946|NCT04640194|365044845|FG005|Overall Study|mild bleeding|0|||
105832947|NCT04640194|365044846|FG006|Overall Study|mild bleeding|0|||
105832948|NCT04640194|365044840|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832949|NCT04640194|365044841|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
105832950|NCT04640194|365044842|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832951|NCT04640194|365044843|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832952|NCT04640194|365044844|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832953|NCT04640194|365044845|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832954|NCT04640194|365044846|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
105832955|NCT04773600|365044851|FG000|Overall Study|Withdrawal by Subject|15|||
105832956|NCT04773600|365044852|FG001|Overall Study|Withdrawal by Subject|9|||
105832957|NCT04773600|365044851|FG000|Overall Study|Lost to Follow-up|10|||
105832958|NCT04773600|365044852|FG001|Overall Study|Lost to Follow-up|6|||
105832959|NCT04773600|365044851|FG000|Overall Study|Adverse Event|8|||
105832960|NCT04773600|365044852|FG001|Overall Study|Adverse Event|2|||
105832961|NCT04773600|365044851|FG000|Overall Study|Lack of Efficacy|2|||
105832962|NCT04773600|365044852|FG001|Overall Study|Lack of Efficacy|3|||
105832963|NCT04773600|365044851|FG000|Overall Study|Noncompliance|2|||
105832964|NCT04773600|365044852|FG001|Overall Study|Noncompliance|0|||
105832965|NCT04773600|365044851|FG000|Overall Study|Protocol Violation|2|||
105832966|NCT04773600|365044852|FG001|Overall Study|Protocol Violation|0|||
105832967|NCT04773600|365044851|FG000|Overall Study|Physician Decision|0|||
105832968|NCT04773600|365044852|FG001|Overall Study|Physician Decision|1|||
105832969|NCT04773600|365044851|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
105832970|NCT04773600|365044852|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
106148910|NCT04056624|366206917|FG001|Overall Study|Withdrawal by Subject|0|||
106148911|NCT04056624|366206918|FG002|Overall Study|Withdrawal by Subject|1|||
105832971|NCT04773600|365044851|FG000|Overall Study|Emergency Travel Out of Country|1|||
105832972|NCT04773600|365044852|FG001|Overall Study|Emergency Travel Out of Country|0|||
105832973|NCT03506633|365046411|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
105832974|NCT03506633|365046412|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
105832975|NCT00258856|365046413|FG000|Overall Study|Lost to Follow-up|1|||
105832976|NCT00258856|365046414|FG001|Overall Study|Lost to Follow-up|0|||
105832977|NCT00258856|365046415|FG002|Overall Study|Lost to Follow-up|2|||
105832978|NCT00258856|365046416|FG003|Overall Study|Lost to Follow-up|0|||
105832979|NCT00258856|365046413|FG000|Overall Study|Non-compliance|2|||
105832980|NCT00258856|365046414|FG001|Overall Study|Non-compliance|0|||
105832981|NCT00258856|365046415|FG002|Overall Study|Non-compliance|0|||
105832982|NCT00258856|365046416|FG003|Overall Study|Non-compliance|1|||
105832983|NCT02005562|365046417|FG000|Overall Study|Death|2|||
105832984|NCT02005562|365046418|FG001|Overall Study|Death|2|||
105832985|NCT02005562|365046417|FG000|Overall Study|Graft loss|7|||
105832986|NCT02005562|365046418|FG001|Overall Study|Graft loss|6|||
105964608|NCT02059499|365527238|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
105964609|NCT02059499|365527239|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
105832987|NCT02005562|365046417|FG000|Overall Study|Withdrawal by Subject|2|||
105832988|NCT02005562|365046418|FG001|Overall Study|Withdrawal by Subject|2|||
105832989|NCT02005562|365046417|FG000|Overall Study|No transplant|1|||
105832990|NCT02005562|365046418|FG001|Overall Study|No transplant|4|||
105832991|NCT02005562|365046417|FG000|Overall Study|Physician Decision|0|||
105964610|NCT02059499|365527240|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
105964611|NCT01892722|365527241|FG000|Overall Study|Protocol deviation|0|||
105964612|NCT01892722|365527242|FG001|Overall Study|Protocol deviation|1|||
105964613|NCT01892722|365527241|FG000|Overall Study|Administrative problems|0|||
105964614|NCT01892722|365527242|FG001|Overall Study|Administrative problems|1|||
105964615|NCT01892722|365527241|FG000|Overall Study|Patient/guardian decision|0|||
105964616|NCT01892722|365527242|FG001|Overall Study|Patient/guardian decision|2|||
105964617|NCT01892722|365527241|FG000|Overall Study|Physician Decision|1|||
105964618|NCT01892722|365527242|FG001|Overall Study|Physician Decision|2|||
105964619|NCT01892722|365527241|FG000|Overall Study|Adverse Event|3|||
105964620|NCT01892722|365527242|FG001|Overall Study|Adverse Event|2|||
105964621|NCT01892722|365527241|FG000|Overall Study|Lack of Efficacy|0|||
105964622|NCT01892722|365527242|FG001|Overall Study|Lack of Efficacy|7|||
105964623|NCT01892722|365527241|FG000|Overall Study|Withdrawal by Subject|3|||
105964624|NCT01892722|365527242|FG001|Overall Study|Withdrawal by Subject|5|||
105964625|NCT05356910|365527243|FG000|Overall Study|Lost to Follow-up|10|||
105964626|NCT05356910|365527244|FG001|Overall Study|Lost to Follow-up|19|||
105964627|NCT05356910|365527245|FG002|Overall Study|Lost to Follow-up|0|||
105964628|NCT05356910|365527246|FG003|Overall Study|Lost to Follow-up|0|||
106148912|NCT04056624|366206916|FG000|Overall Study|Protocol Violation|1|||
105832992|NCT02005562|365046418|FG001|Overall Study|Physician Decision|1|||
105832993|NCT02219009|365046421|FG000|Overall Study|Withdrawal by Subject|5|||
105832994|NCT02219009|365046422|FG001|Overall Study|Withdrawal by Subject|1|||
105832995|NCT02219009|365046421|FG000|Overall Study|Adverse Event|2|||
105832996|NCT02219009|365046422|FG001|Overall Study|Adverse Event|4|||
105964629|NCT05356910|365527243|FG000|Overall Study|Withdrawal by Subject|4|||
106148913|NCT04056624|366206917|FG001|Overall Study|Protocol Violation|2|||
106148914|NCT04056624|366206918|FG002|Overall Study|Protocol Violation|0|||
106148915|NCT00703820|366206921|FG000|Overall Study|Adverse Event|12|||
106148916|NCT00703820|366206922|FG001|Overall Study|Adverse Event|17|||
106148917|NCT00703820|366206921|FG000|Overall Study|Death|5|||
106148918|NCT00703820|366206922|FG001|Overall Study|Death|0|||
106148919|NCT00703820|366206921|FG000|Overall Study|Lack of Efficacy|11|||
106148920|NCT00703820|366206922|FG001|Overall Study|Lack of Efficacy|11|||
105964630|NCT05356910|365527244|FG001|Overall Study|Withdrawal by Subject|2|||
105964631|NCT05356910|365527245|FG002|Overall Study|Withdrawal by Subject|0|||
105964632|NCT05356910|365527246|FG003|Overall Study|Withdrawal by Subject|0|||
105964633|NCT03451851|365527250|FG000|PCP: Week 0 -16|Adverse Event|1|||
105964634|NCT03451851|365527251|FG001|PCP: Week 0 -16|Adverse Event|0|||
105964635|NCT03451851|365527252|FG002|PCP: Week 0 -16|Adverse Event|0|||
105964636|NCT03451851|365527253|FG003|PCP: Week 0 -16|Adverse Event|0|||
105964637|NCT03451851|365527254|FG004|PCP: Week 0 -16|Adverse Event|0|||
105964638|NCT03451851|365527255|FG005|PCP: Week 0 -16|Adverse Event|0|||
105964639|NCT03451851|365527256|FG006|PCP: Week 0 -16|Adverse Event|1|||
105964640|NCT03451851|365527257|FG007|PCP: Week 0 -16|Adverse Event|0|||
105964641|NCT03451851|365527250|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
105964642|NCT03451851|365527251|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
105964643|NCT03451851|365527252|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
105964644|NCT03451851|365527253|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
105964645|NCT03451851|365527254|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
105964646|NCT03451851|365527255|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
105964647|NCT03451851|365527256|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
106148921|NCT00703820|366206921|FG000|Overall Study|Received non-protocol therapy|1|||
106148922|NCT00703820|366206922|FG001|Overall Study|Received non-protocol therapy|0|||
105832997|NCT02219009|365046421|FG000|Overall Study|Lost to Follow-up|2|||
105832998|NCT02219009|365046422|FG001|Overall Study|Lost to Follow-up|2|||
105832999|NCT02219009|365046421|FG000|Overall Study|Protocol deviation|1|||
105833000|NCT02219009|365046422|FG001|Overall Study|Protocol deviation|0|||
105833001|NCT02219009|365046421|FG000|Overall Study|Physician Decision|0|||
105833002|NCT02219009|365046422|FG001|Overall Study|Physician Decision|1|||
105833003|NCT02488109|365046423|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
105833004|NCT02488109|365046424|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
105833005|NCT02488109|365046423|FG000|12-month Follow-Up|Lost to Follow-up|4|||
105833006|NCT02488109|365046424|FG001|12-month Follow-Up|Lost to Follow-up|7|||
105833007|NCT03086135|365046427|FG000|Overall Study|Adverse Event|1|||
105833008|NCT03086135|365046427|FG000|Overall Study|Lost to Follow-up|2|||
105833009|NCT02966340|365046430|FG000|Overall Study|Adverse Event|0|||
105833010|NCT02966340|365046431|FG001|Overall Study|Adverse Event|1|||
105833011|NCT02966340|365046430|FG000|Overall Study|Lost to Follow-up|0|||
105833012|NCT02966340|365046431|FG001|Overall Study|Lost to Follow-up|1|||
105833013|NCT02966340|365046430|FG000|Overall Study|Withdrawal by Subject|1|||
105833014|NCT02966340|365046431|FG001|Overall Study|Withdrawal by Subject|0|||
105833015|NCT02966340|365046430|FG000|Overall Study|data acquisition error|1|||
105833016|NCT02966340|365046431|FG001|Overall Study|data acquisition error|0|||
105833017|NCT02966340|365046430|FG000|Overall Study|startle non-responder|1|||
105833018|NCT02966340|365046431|FG001|Overall Study|startle non-responder|1|||
105833019|NCT02259348|365046432|FG000|Overall Study|Donors|6|||
105833020|NCT02259348|365046432|FG000|Overall Study|Death|4|||
105833021|NCT04211766|365046433|FG000|Overall Study|Withdrawal by Subject|5|||
105833022|NCT04211766|365046434|FG001|Overall Study|Withdrawal by Subject|1|||
105833023|NCT02710214|365046435|FG000|Overall Study|Lost to Follow-up|1|||
105833024|NCT02710214|365046436|FG001|Overall Study|Lost to Follow-up|0|||
105833025|NCT02710214|365046435|FG000|Overall Study|Lack of Efficacy|0|||
105833026|NCT02710214|365046436|FG001|Overall Study|Lack of Efficacy|1|||
105833027|NCT02710214|365046435|FG000|Overall Study|Death|0|||
105833028|NCT02710214|365046436|FG001|Overall Study|Death|1|||
105833029|NCT01120899|365046445|FG000|Overall Study|Withdrawal by Subject|3|||
105833030|NCT03686215|365046446|FG000|Overall Study|Adverse Event|0|||
105833031|NCT03686215|365046447|FG001|Overall Study|Adverse Event|0|||
105833032|NCT03686215|365046448|FG002|Overall Study|Adverse Event|7|||
105833033|NCT03686215|365046446|FG000|Overall Study|Physician Decision|0|||
105833034|NCT03686215|365046447|FG001|Overall Study|Physician Decision|0|||
105833035|NCT03686215|365046448|FG002|Overall Study|Physician Decision|1|||
105833036|NCT03686215|365046446|FG000|Overall Study|Protocol Violation|0|||
105833037|NCT03686215|365046447|FG001|Overall Study|Protocol Violation|0|||
105833038|NCT03686215|365046448|FG002|Overall Study|Protocol Violation|4|||
105833039|NCT03686215|365046446|FG000|Overall Study|Device issue|1|||
105833040|NCT03686215|365046447|FG001|Overall Study|Device issue|0|||
105833041|NCT03686215|365046448|FG002|Overall Study|Device issue|2|||
105833042|NCT01188226|365046454|FG000|Overall Study|Withdrawal by Subject|4|||
105833043|NCT00202839|365046455|FG000|Overall Study|Adverse Event|1|||
105833044|NCT00202839|365046456|FG001|Overall Study|Adverse Event|5|||
105833045|NCT00202839|365046455|FG000|Overall Study|Physician Decision|12|||
105833046|NCT00202839|365046456|FG001|Overall Study|Physician Decision|0|||
105833047|NCT00202839|365046455|FG000|Overall Study|Withdrawal by Subject|6|||
105833048|NCT00202839|365046456|FG001|Overall Study|Withdrawal by Subject|2|||
105833049|NCT00202839|365046455|FG000|Overall Study|Protocol Violation|2|||
105833050|NCT00202839|365046456|FG001|Overall Study|Protocol Violation|1|||
105833051|NCT00202839|365046455|FG000|Overall Study|Lost to Follow-up|3|||
105833052|NCT00202839|365046456|FG001|Overall Study|Lost to Follow-up|2|||
105833053|NCT01662024|365046457|FG000|Overall Study|Pregnancy|2|||
105833054|NCT01662024|365046457|FG000|Overall Study|Withdrawal by Subject|3|||
105833055|NCT04980456|365046458|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
105833056|NCT04980456|365046459|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
105833057|NCT04980456|365046458|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
105833058|NCT04980456|365046459|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
105833059|NCT04980456|365046458|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
105833060|NCT04980456|365046459|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
105833061|NCT04980456|365046458|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
105833062|NCT04980456|365046459|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
105833063|NCT04832971|365046460|FG000|Overall Study|Death|1|||
105833064|NCT04832971|365046461|FG001|Overall Study|Death|0|||
105833065|NCT04832971|365046462|FG002|Overall Study|Death|0|||
105833066|NCT04832971|365046463|FG003|Overall Study|Death|0|||
105833067|NCT04832971|365046460|FG000|Overall Study|Lost to Follow-up|1|||
105833068|NCT04832971|365046461|FG001|Overall Study|Lost to Follow-up|1|||
105833069|NCT04832971|365046462|FG002|Overall Study|Lost to Follow-up|1|||
105833070|NCT04832971|365046463|FG003|Overall Study|Lost to Follow-up|0|||
105833071|NCT04832971|365046460|FG000|Overall Study|Withdrawal by Subject|1|||
106022859|NCT01584440|365748690|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
105833072|NCT04832971|365046461|FG001|Overall Study|Withdrawal by Subject|3|||
105833073|NCT04832971|365046462|FG002|Overall Study|Withdrawal by Subject|2|||
105833074|NCT04832971|365046463|FG003|Overall Study|Withdrawal by Subject|2|||
105833075|NCT04832971|365046460|FG000|Overall Study|Other, Not Specified|0|||
105833076|NCT04832971|365046461|FG001|Overall Study|Other, Not Specified|0|||
105833077|NCT04832971|365046462|FG002|Overall Study|Other, Not Specified|1|||
105833078|NCT04832971|365046463|FG003|Overall Study|Other, Not Specified|0|||
105833079|NCT04768296|365046464|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
105833080|NCT04768296|365046465|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
105833081|NCT03035890|365046470|FG000|Overall Study|Death|1|||
105833082|NCT01579006|365046471|FG000|Overall Study|Lack of Efficacy|10|||
105833083|NCT01579006|365046471|FG000|Overall Study|Adverse Event|13|||
105833084|NCT01579006|365046471|FG000|Overall Study|Withdrawal by Subject|5|||
105833085|NCT01579006|365046471|FG000|Overall Study|Non-compliance|3|||
105833086|NCT01579006|365046471|FG000|Overall Study|Due to participant's health fund|1|||
105833087|NCT01579006|365046471|FG000|Overall Study|Scheduled surgery|1|||
105833088|NCT02998541|365046472|FG000|Overall Study|Adverse Event|4|||
105833089|NCT02998541|365046473|FG001|Overall Study|Adverse Event|5|||
105833090|NCT02998541|365046474|FG002|Overall Study|Adverse Event|1|||
105833091|NCT02998541|365046472|FG000|Overall Study|Protocol Violation|1|||
105833092|NCT02998541|365046473|FG001|Overall Study|Protocol Violation|0|||
105833093|NCT02998541|365046474|FG002|Overall Study|Protocol Violation|0|||
105833094|NCT02998541|365046472|FG000|Overall Study|Withdrawal by Subject|3|||
105833095|NCT02998541|365046473|FG001|Overall Study|Withdrawal by Subject|1|||
105833096|NCT02998541|365046474|FG002|Overall Study|Withdrawal by Subject|0|||
105833097|NCT02998541|365046472|FG000|Overall Study|Lost to Follow-up|0|||
105833098|NCT02998541|365046473|FG001|Overall Study|Lost to Follow-up|3|||
105833099|NCT02998541|365046474|FG002|Overall Study|Lost to Follow-up|1|||
105833100|NCT02998541|365046472|FG000|Overall Study|Physician Decision|0|||
105833101|NCT02998541|365046473|FG001|Overall Study|Physician Decision|0|||
105833102|NCT02998541|365046474|FG002|Overall Study|Physician Decision|3|||
105833103|NCT02998541|365046472|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105833104|NCT02998541|365046473|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105833105|NCT02998541|365046474|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
105833106|NCT00487695|365046477|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
105833107|NCT00487695|365046478|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
105833108|NCT00487695|365046477|FG000|First Procedure|active wheezing (did not have procedure)|1|||
105833109|NCT00487695|365046478|FG001|First Procedure|active wheezing (did not have procedure)|0|||
105833110|NCT00487695|365046477|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
105833111|NCT00487695|365046478|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
105833112|NCT00487695|365046477|FG000|Second Procedure|active wheezing|0|||
105833113|NCT00487695|365046478|FG001|Second Procedure|active wheezing|1|||
105833114|NCT00487695|365046477|FG000|Second Procedure|Withdrawal by Subject|1|||
105833115|NCT00487695|365046478|FG001|Second Procedure|Withdrawal by Subject|2|||
105833116|NCT02786953|365046481|FG000|Overall Study|Withdrawal by Subject|3|||
105833117|NCT02786953|365046482|FG001|Overall Study|Withdrawal by Subject|0|||
105833118|NCT02786953|365046481|FG000|Overall Study|Physician Decision|0|||
105833119|NCT02786953|365046482|FG001|Overall Study|Physician Decision|1|||
105833120|NCT00177164|365046483|FG000|Overall Study|Protocol Violation|0|||
105833121|NCT00177164|365046484|FG001|Overall Study|Protocol Violation|7|||
105833122|NCT00177164|365046483|FG000|Overall Study|Lost to Follow-up|4|||
105833123|NCT00177164|365046484|FG001|Overall Study|Lost to Follow-up|5|||
105833124|NCT00177164|365046483|FG000|Overall Study|increase in alcohol and drug use|1|||
105833125|NCT00177164|365046484|FG001|Overall Study|increase in alcohol and drug use|2|||
105833126|NCT00177164|365046483|FG000|Overall Study|Adverse Event|1|||
105833127|NCT00177164|365046484|FG001|Overall Study|Adverse Event|0|||
105833128|NCT00177164|365046483|FG000|Overall Study|discharge from hospital|1|||
105833129|NCT00177164|365046484|FG001|Overall Study|discharge from hospital|0|||
105833130|NCT00177164|365046483|FG000|Overall Study|Lack of Efficacy|2|||
105833131|NCT00177164|365046484|FG001|Overall Study|Lack of Efficacy|1|||
105833132|NCT00177164|365046483|FG000|Overall Study|Pregnancy|0|||
105833133|NCT00177164|365046484|FG001|Overall Study|Pregnancy|1|||
105833134|NCT00965757|365046485|FG000|Double-blind Phase|Progression of concomitant disease|1|||
105833135|NCT00965757|365046486|FG001|Double-blind Phase|Progression of concomitant disease|2|||
105833136|NCT00965757|365046487|FG002|Double-blind Phase|Progression of concomitant disease|0|||
105833137|NCT00965757|365046488|FG003|Double-blind Phase|Progression of concomitant disease|0|||
105833138|NCT00965757|365046485|FG000|Double-blind Phase|Adverse drug reaction|2|||
105833139|NCT00965757|365046486|FG001|Double-blind Phase|Adverse drug reaction|1|||
105833140|NCT00965757|365046487|FG002|Double-blind Phase|Adverse drug reaction|0|||
105833141|NCT00965757|365046488|FG003|Double-blind Phase|Adverse drug reaction|0|||
105833142|NCT00965757|365046485|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
105833143|NCT00965757|365046486|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
105833144|NCT00965757|365046487|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
105833145|NCT00965757|365046488|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
105833146|NCT00965757|365046485|FG000|Double-blind Phase|Lack of Efficacy|7|||
105833147|NCT00965757|365046486|FG001|Double-blind Phase|Lack of Efficacy|11|||
105833148|NCT00965757|365046487|FG002|Double-blind Phase|Lack of Efficacy|0|||
105833149|NCT00965757|365046488|FG003|Double-blind Phase|Lack of Efficacy|0|||
105833150|NCT00965757|365046485|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
105833151|NCT00965757|365046486|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
105833152|NCT00965757|365046487|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
105833153|NCT00965757|365046488|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
105833154|NCT00965757|365046485|FG000|Double-blind Phase|Lost to Follow-up|0|||
105833155|NCT00965757|365046486|FG001|Double-blind Phase|Lost to Follow-up|1|||
105833156|NCT00965757|365046487|FG002|Double-blind Phase|Lost to Follow-up|0|||
105833157|NCT00965757|365046488|FG003|Double-blind Phase|Lost to Follow-up|0|||
105833158|NCT00965757|365046485|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
105833159|NCT00965757|365046486|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
105833160|NCT00965757|365046487|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
105833161|NCT00965757|365046488|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
105833162|NCT00965757|365046485|FG000|Double-blind Phase|Other|1|||
105833163|NCT00965757|365046486|FG001|Double-blind Phase|Other|0|||
105833164|NCT00965757|365046487|FG002|Double-blind Phase|Other|0|||
105833165|NCT00965757|365046488|FG003|Double-blind Phase|Other|0|||
105833166|NCT00965757|365046485|FG000|Extension Phase|Progression of concomitant disease|0|||
105833167|NCT00965757|365046486|FG001|Extension Phase|Progression of concomitant disease|0|||
105833168|NCT00965757|365046487|FG002|Extension Phase|Progression of concomitant disease|4|||
105833169|NCT00965757|365046488|FG003|Extension Phase|Progression of concomitant disease|2|||
105833170|NCT00965757|365046485|FG000|Extension Phase|Adverse drug reaction|0|||
105833171|NCT00965757|365046486|FG001|Extension Phase|Adverse drug reaction|0|||
105833172|NCT00965757|365046487|FG002|Extension Phase|Adverse drug reaction|6|||
105833173|NCT00965757|365046488|FG003|Extension Phase|Adverse drug reaction|3|||
105833174|NCT00965757|365046485|FG000|Extension Phase|Abnormal Laboratory Value|0|||
105833175|NCT00965757|365046486|FG001|Extension Phase|Abnormal Laboratory Value|0|||
105833176|NCT00965757|365046487|FG002|Extension Phase|Abnormal Laboratory Value|6|||
105833177|NCT00965757|365046488|FG003|Extension Phase|Abnormal Laboratory Value|1|||
105833178|NCT00965757|365046485|FG000|Extension Phase|Lack of Efficacy|0|||
105833179|NCT00965757|365046486|FG001|Extension Phase|Lack of Efficacy|0|||
105833180|NCT00965757|365046487|FG002|Extension Phase|Lack of Efficacy|8|||
105833181|NCT00965757|365046488|FG003|Extension Phase|Lack of Efficacy|12|||
105833182|NCT00965757|365046485|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
105833183|NCT00965757|365046486|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
105833184|NCT00965757|365046487|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
105833185|NCT00965757|365046488|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
105833186|NCT00965757|365046485|FG000|Extension Phase|Lost to Follow-up|0|||
105833187|NCT00965757|365046486|FG001|Extension Phase|Lost to Follow-up|0|||
105833188|NCT00965757|365046487|FG002|Extension Phase|Lost to Follow-up|0|||
105833189|NCT00965757|365046488|FG003|Extension Phase|Lost to Follow-up|1|||
105833190|NCT00965757|365046485|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
105833191|NCT00965757|365046486|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
105833192|NCT00965757|365046487|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
105833193|NCT00965757|365046488|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
105833194|NCT00965757|365046485|FG000|Extension Phase|Protocol Violation|0|||
105833195|NCT00965757|365046486|FG001|Extension Phase|Protocol Violation|0|||
105833196|NCT00965757|365046487|FG002|Extension Phase|Protocol Violation|0|||
105833197|NCT00965757|365046488|FG003|Extension Phase|Protocol Violation|1|||
105833198|NCT00965757|365046485|FG000|Extension Phase|Other|0|||
105833199|NCT00965757|365046486|FG001|Extension Phase|Other|0|||
105833200|NCT00965757|365046487|FG002|Extension Phase|Other|2|||
105833201|NCT00965757|365046488|FG003|Extension Phase|Other|1|||
105833202|NCT02451358|365046489|FG000|Overall Study|Withdrawal by Subject|1|||
105833203|NCT02451358|365046490|FG001|Overall Study|Withdrawal by Subject|1|||
105833204|NCT02451358|365046491|FG002|Overall Study|Withdrawal by Subject|0|||
105833205|NCT02451358|365046492|FG003|Overall Study|Withdrawal by Subject|0|||
105833206|NCT02451358|365046489|FG000|Overall Study|Protocol Violation|0|||
105833207|NCT02451358|365046490|FG001|Overall Study|Protocol Violation|1|||
105833208|NCT02451358|365046491|FG002|Overall Study|Protocol Violation|1|||
105833209|NCT02451358|365046492|FG003|Overall Study|Protocol Violation|0|||
105833210|NCT01698554|365046494|FG000|Overall Study|Adverse Event|2|||
105833211|NCT01698554|365046495|FG001|Overall Study|Adverse Event|5|||
105833212|NCT01698554|365046496|FG002|Overall Study|Adverse Event|0|||
105833213|NCT01698554|365046497|FG003|Overall Study|Adverse Event|1|||
105833214|NCT01698554|365046494|FG000|Overall Study|Lost to Follow-up|1|||
105833215|NCT01698554|365046495|FG001|Overall Study|Lost to Follow-up|0|||
105833216|NCT01698554|365046496|FG002|Overall Study|Lost to Follow-up|0|||
105833217|NCT01698554|365046497|FG003|Overall Study|Lost to Follow-up|0|||
105833218|NCT01698554|365046494|FG000|Overall Study|Personal Reasons|0|||
105833219|NCT01698554|365046495|FG001|Overall Study|Personal Reasons|5|||
105833220|NCT01698554|365046496|FG002|Overall Study|Personal Reasons|1|||
105833221|NCT01698554|365046497|FG003|Overall Study|Personal Reasons|1|||
105833222|NCT01698554|365046494|FG000|Overall Study|Protocol Violation|2|||
105833223|NCT01698554|365046495|FG001|Overall Study|Protocol Violation|0|||
105833224|NCT01698554|365046496|FG002|Overall Study|Protocol Violation|1|||
105833225|NCT01698554|365046497|FG003|Overall Study|Protocol Violation|0|||
105833226|NCT01698554|365046494|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105833227|NCT01698554|365046495|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105833228|NCT01698554|365046496|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105833229|NCT01698554|365046497|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105833230|NCT01398787|365046500|FG000|Overall Study|Adverse Event|1|||
105833231|NCT03141151|365046501|FG000|Overall Study|Lost to Follow-up|3|||
105833232|NCT03141151|365046502|FG001|Overall Study|Lost to Follow-up|2|||
105833233|NCT03141151|365046501|FG000|Overall Study|Withdrawal by Subject|3|||
105964648|NCT03451851|365527257|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
105964649|NCT03451851|365527250|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105964650|NCT03451851|365527251|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105964651|NCT03451851|365527252|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
105964652|NCT03451851|365527253|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105964653|NCT03451851|365527254|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105964654|NCT03451851|365527255|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105964655|NCT03451851|365527256|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105964656|NCT03451851|365527257|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
105964657|NCT03451851|365527250|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105964658|NCT03451851|365527251|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105964659|NCT03451851|365527252|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105964660|NCT03451851|365527253|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105964661|NCT03451851|365527254|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
105964662|NCT03451851|365527255|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
105964663|NCT03451851|365527256|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105964664|NCT03451851|365527257|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
105964665|NCT03451851|365527250|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105964666|NCT03451851|365527251|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105964667|NCT03451851|365527252|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105964668|NCT03451851|365527253|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105964669|NCT03451851|365527254|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
105964670|NCT03451851|365527255|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105964671|NCT03451851|365527256|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105964672|NCT03451851|365527257|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
105964673|NCT03451851|365527250|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105964674|NCT03451851|365527251|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105964675|NCT03451851|365527252|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105964676|NCT03451851|365527253|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105964677|NCT03451851|365527254|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
105964678|NCT03451851|365527255|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105964679|NCT03451851|365527256|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105964680|NCT03451851|365527257|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
105964681|NCT02954406|365530145|FG000|Overall Study|Adverse Event|0|||
105964682|NCT02954406|365530146|FG001|Overall Study|Adverse Event|1|||
105964683|NCT02954406|365530147|FG002|Overall Study|Adverse Event|0|||
105964684|NCT02954406|365530148|FG003|Overall Study|Adverse Event|0|||
105964685|NCT02954406|365530149|FG004|Overall Study|Adverse Event|1|||
105964686|NCT02954406|365530150|FG005|Overall Study|Adverse Event|0|||
105964687|NCT02954406|365530151|FG006|Overall Study|Adverse Event|0|||
105964688|NCT02954406|365530152|FG007|Overall Study|Adverse Event|0|||
105964689|NCT02954406|365530153|FG008|Overall Study|Adverse Event|1|||
105964690|NCT02954406|365530154|FG009|Overall Study|Adverse Event|1|||
105964691|NCT02954406|365530155|FG010|Overall Study|Adverse Event|0|||
105964692|NCT02954406|365530145|FG000|Overall Study|Progressive Disease|3|||
106148923|NCT00703820|366206921|FG000|Overall Study|Physician Decision|4|||
105833234|NCT03141151|365046502|FG001|Overall Study|Withdrawal by Subject|2|||
105833235|NCT04561115|365046503|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
105833236|NCT04561115|365046504|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
105833237|NCT04561115|365046503|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
105833238|NCT04561115|365046504|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
105833239|NCT04561115|365046503|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
105833240|NCT04561115|365046504|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
105833241|NCT04610580|365046505|FG000|Two-way Crossover Period|Adverse Event|1|||
105833242|NCT04610580|365046506|FG001|Two-way Crossover Period|Adverse Event|0|||
105833243|NCT04610580|365046507|FG002|Two-way Crossover Period|Adverse Event|0|||
106148924|NCT00703820|366206922|FG001|Overall Study|Physician Decision|5|||
106148925|NCT00703820|366206921|FG000|Overall Study|Withdrawal by Subject|2|||
106148926|NCT00703820|366206922|FG001|Overall Study|Withdrawal by Subject|1|||
105833244|NCT04610580|365046508|FG003|Two-way Crossover Period|Adverse Event|0|||
105833245|NCT04610580|365046509|FG004|Two-way Crossover Period|Adverse Event|0|||
106148927|NCT02092116|366206926|FG000|Overall Study|Withdrawal by Subject|0|||
106148928|NCT02092116|366206927|FG001|Overall Study|Withdrawal by Subject|3|||
106148929|NCT02092116|366206926|FG000|Overall Study|Adverse Event|0|||
106148930|NCT02092116|366206927|FG001|Overall Study|Adverse Event|1|||
106148931|NCT03531840|366206928|FG000|Overall Study|Death on study|3|||
105833246|NCT04610580|365046510|FG005|Two-way Crossover Period|Adverse Event|0|||
105833247|NCT04610580|365046505|FG000|Two-way Crossover Period|Physician Decision|1|||
105833248|NCT04610580|365046506|FG001|Two-way Crossover Period|Physician Decision|0|||
105833249|NCT04610580|365046507|FG002|Two-way Crossover Period|Physician Decision|0|||
105833250|NCT04610580|365046508|FG003|Two-way Crossover Period|Physician Decision|0|||
105833251|NCT04610580|365046509|FG004|Two-way Crossover Period|Physician Decision|0|||
105833252|NCT04610580|365046510|FG005|Two-way Crossover Period|Physician Decision|0|||
105833253|NCT04610580|365046505|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
105833254|NCT04610580|365046506|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
105833255|NCT04610580|365046507|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
105833256|NCT04610580|365046508|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
105833257|NCT04610580|365046509|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
105833258|NCT04610580|365046510|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
105833259|NCT04610580|365046505|FG000|Two-way Crossover Period|Other than specified|0|||
105833260|NCT04610580|365046506|FG001|Two-way Crossover Period|Other than specified|1|||
105833261|NCT04610580|365046507|FG002|Two-way Crossover Period|Other than specified|0|||
105833262|NCT04610580|365046508|FG003|Two-way Crossover Period|Other than specified|0|||
105833263|NCT04610580|365046509|FG004|Two-way Crossover Period|Other than specified|0|||
105833264|NCT04610580|365046510|FG005|Two-way Crossover Period|Other than specified|0|||
105833265|NCT04610580|365046505|FG000|Washout Before Extension Period|Other than specified|0|||
105833266|NCT04610580|365046506|FG001|Washout Before Extension Period|Other than specified|1|||
105833267|NCT04610580|365046507|FG002|Washout Before Extension Period|Other than specified|0|||
105833268|NCT04610580|365046508|FG003|Washout Before Extension Period|Other than specified|0|||
105833269|NCT04610580|365046509|FG004|Washout Before Extension Period|Other than specified|0|||
105833270|NCT04610580|365046510|FG005|Washout Before Extension Period|Other than specified|0|||
105833271|NCT04610580|365046505|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
105833272|NCT04610580|365046506|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
105833273|NCT04610580|365046507|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
105833274|NCT04610580|365046508|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
105833275|NCT04610580|365046509|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
105833276|NCT04610580|365046510|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
105833277|NCT04610580|365046505|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833278|NCT04610580|365046506|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833279|NCT04610580|365046507|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833280|NCT04610580|365046508|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833281|NCT04610580|365046509|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
105833282|NCT04610580|365046510|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
105833283|NCT03922750|365046519|FG000|Overall Study|Unclassified|0|||
105833284|NCT03922750|365046520|FG001|Overall Study|Unclassified|0|||
105833285|NCT03922750|365046521|FG002|Overall Study|Unclassified|1|||
105833286|NCT03922750|365046519|FG000|Overall Study|Adverse Event|0|||
105833287|NCT03922750|365046520|FG001|Overall Study|Adverse Event|1|||
105833288|NCT03922750|365046521|FG002|Overall Study|Adverse Event|0|||
105833289|NCT02985398|365046522|FG000|Overall Study|Adverse Event|1|||
105833290|NCT02985398|365046522|FG000|Overall Study|Lost to Follow-up|4|||
105833291|NCT02985398|365046522|FG000|Overall Study|Withdrawal by Subject|8|||
105833292|NCT02985398|365046522|FG000|Overall Study|Study Burden|9|||
105833293|NCT00668395|365046525|FG000|Overall Study|Withdrawal by Subject|4|||
105833294|NCT00668395|365046526|FG001|Overall Study|Withdrawal by Subject|4|||
105833295|NCT00668395|365046527|FG002|Overall Study|Withdrawal by Subject|1|||
105833296|NCT00668395|365046525|FG000|Overall Study|Adverse Event|1|||
105833297|NCT00668395|365046526|FG001|Overall Study|Adverse Event|1|||
105833298|NCT00668395|365046527|FG002|Overall Study|Adverse Event|0|||
105833299|NCT00668395|365046525|FG000|Overall Study|Physician Decision|1|||
105833300|NCT00668395|365046526|FG001|Overall Study|Physician Decision|1|||
105833301|NCT00668395|365046527|FG002|Overall Study|Physician Decision|0|||
105833302|NCT04164758|365046528|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
105833303|NCT04164758|365046529|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
105833304|NCT04164758|365046530|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
105833305|NCT04164758|365046528|FG000|Overall Study|Adverse Event|0|||
105833306|NCT04164758|365046529|FG001|Overall Study|Adverse Event|1|||
105833307|NCT04164758|365046530|FG002|Overall Study|Adverse Event|0|||
105833308|NCT00283842|365046531|FG000|Overall Study|Adverse Event|8|||
105833309|NCT00283842|365046532|FG001|Overall Study|Adverse Event|7|||
105833310|NCT00283842|365046533|FG002|Overall Study|Adverse Event|21|||
105833311|NCT00283842|365046534|FG003|Overall Study|Adverse Event|21|||
105833312|NCT00283842|365046535|FG004|Overall Study|Adverse Event|5|||
105833313|NCT00283842|365046531|FG000|Overall Study|Protocol Violation|1|||
105833314|NCT00283842|365046532|FG001|Overall Study|Protocol Violation|5|||
105833315|NCT00283842|365046533|FG002|Overall Study|Protocol Violation|4|||
105833316|NCT00283842|365046534|FG003|Overall Study|Protocol Violation|0|||
105833317|NCT00283842|365046535|FG004|Overall Study|Protocol Violation|0|||
105833318|NCT00283842|365046531|FG000|Overall Study|Protocol deviation|0|||
105833319|NCT00283842|365046532|FG001|Overall Study|Protocol deviation|0|||
105833320|NCT00283842|365046533|FG002|Overall Study|Protocol deviation|0|||
105833321|NCT00283842|365046534|FG003|Overall Study|Protocol deviation|0|||
105833322|NCT00283842|365046535|FG004|Overall Study|Protocol deviation|2|||
105833323|NCT00283842|365046531|FG000|Overall Study|Withdrawal by Subject|2|||
105833324|NCT00283842|365046532|FG001|Overall Study|Withdrawal by Subject|1|||
105833325|NCT00283842|365046533|FG002|Overall Study|Withdrawal by Subject|1|||
105833326|NCT00283842|365046534|FG003|Overall Study|Withdrawal by Subject|5|||
105833327|NCT00283842|365046535|FG004|Overall Study|Withdrawal by Subject|4|||
105833328|NCT00283842|365046531|FG000|Overall Study|Lack of Efficacy|1|||
105833329|NCT00283842|365046532|FG001|Overall Study|Lack of Efficacy|3|||
105833330|NCT00283842|365046533|FG002|Overall Study|Lack of Efficacy|1|||
105833331|NCT00283842|365046534|FG003|Overall Study|Lack of Efficacy|0|||
105833332|NCT00283842|365046535|FG004|Overall Study|Lack of Efficacy|3|||
105833333|NCT00283842|365046531|FG000|Overall Study|Lost to Follow-up|0|||
105833334|NCT00283842|365046532|FG001|Overall Study|Lost to Follow-up|2|||
105833335|NCT00283842|365046533|FG002|Overall Study|Lost to Follow-up|4|||
105833336|NCT00283842|365046534|FG003|Overall Study|Lost to Follow-up|1|||
105833337|NCT00283842|365046535|FG004|Overall Study|Lost to Follow-up|1|||
105833338|NCT00550147|365046538|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
105833339|NCT00550147|365046538|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
105833340|NCT00550147|365046538|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
105833341|NCT00550147|365046538|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
105833342|NCT00550147|365046538|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
105833343|NCT01824498|365046539|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
105833344|NCT01824498|365046540|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
105833345|NCT01824498|365046541|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
105833346|NCT01824498|365046542|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
105833347|NCT01824498|365046543|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
105833348|NCT01824498|365046544|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
105833349|NCT02448563|365046546|FG000|Overall Study|Lost to Follow-up|16|||
105833350|NCT02448563|365046547|FG001|Overall Study|Lost to Follow-up|10|||
105833351|NCT02448563|365046546|FG000|Overall Study|Withdrawal by Subject|0|||
105833352|NCT02448563|365046547|FG001|Overall Study|Withdrawal by Subject|1|||
105833353|NCT04049097|365046552|FG000|Overall Study|Adverse Event|18|||
105833354|NCT04049097|365046552|FG000|Overall Study|Death|2|||
105833355|NCT04049097|365046552|FG000|Overall Study|Lost to Follow-up|1|||
105833356|NCT04049097|365046552|FG000|Overall Study|Physician Decision|2|||
105833357|NCT04049097|365046552|FG000|Overall Study|Withdrawal by Subject|9|||
105833358|NCT04049097|365046552|FG000|Overall Study|Protocol Violation|2|||
105833359|NCT04049097|365046552|FG000|Overall Study|Other|1|||
105833360|NCT04049097|365046552|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
105833361|NCT00715676|365046553|FG000|Overall Study|Adverse Event|3|||
105833362|NCT00715676|365046554|FG001|Overall Study|Adverse Event|5|||
105833363|NCT00715676|365046555|FG002|Overall Study|Adverse Event|21|||
105833364|NCT00715676|365046553|FG000|Overall Study|Withdrawal by Subject|1|||
105833365|NCT00715676|365046554|FG001|Overall Study|Withdrawal by Subject|3|||
105833366|NCT00715676|365046555|FG002|Overall Study|Withdrawal by Subject|8|||
105833367|NCT00715676|365046553|FG000|Overall Study|Lost to Follow-up|1|||
105833368|NCT00715676|365046554|FG001|Overall Study|Lost to Follow-up|2|||
105833369|NCT00715676|365046555|FG002|Overall Study|Lost to Follow-up|1|||
105833370|NCT00715676|365046553|FG000|Overall Study|Terminated by Sponsor|1|||
105833371|NCT00715676|365046554|FG001|Overall Study|Terminated by Sponsor|0|||
105833372|NCT00715676|365046555|FG002|Overall Study|Terminated by Sponsor|0|||
105833373|NCT00715676|365046553|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
105833374|NCT00715676|365046554|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
105833375|NCT00715676|365046555|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
105833376|NCT00715676|365046553|FG000|Overall Study|Use of Exclusionary Medication|0|||
105833377|NCT00715676|365046554|FG001|Overall Study|Use of Exclusionary Medication|0|||
105833378|NCT00715676|365046555|FG002|Overall Study|Use of Exclusionary Medication|1|||
105833379|NCT00715676|365046553|FG000|Overall Study|Elevated Blood Glucose|0|||
105833380|NCT00715676|365046554|FG001|Overall Study|Elevated Blood Glucose|1|||
105833381|NCT00715676|365046555|FG002|Overall Study|Elevated Blood Glucose|0|||
105833382|NCT01320722|365046556|FG000|Overall Study|Did not Receive Intervention|3|||
105833383|NCT01320722|365046557|FG001|Overall Study|Did not Receive Intervention|2|||
105833384|NCT01320722|365046558|FG002|Overall Study|Did not Receive Intervention|1|||
105833385|NCT01320722|365046559|FG003|Overall Study|Did not Receive Intervention|1|||
105833386|NCT01320722|365046560|FG004|Overall Study|Did not Receive Intervention|2|||
105833387|NCT01320722|365046556|FG000|Overall Study|Lost to Follow-up|0|||
105833388|NCT01320722|365046557|FG001|Overall Study|Lost to Follow-up|1|||
105833389|NCT01320722|365046558|FG002|Overall Study|Lost to Follow-up|0|||
105833390|NCT01320722|365046559|FG003|Overall Study|Lost to Follow-up|1|||
105833391|NCT01320722|365046560|FG004|Overall Study|Lost to Follow-up|3|||
105833392|NCT01320722|365046556|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
105833393|NCT01320722|365046557|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
105833394|NCT01320722|365046558|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
105964693|NCT02954406|365530146|FG001|Overall Study|Progressive Disease|4|||
105964694|NCT02954406|365530147|FG002|Overall Study|Progressive Disease|3|||
105964695|NCT02954406|365530148|FG003|Overall Study|Progressive Disease|4|||
105964696|NCT02954406|365530149|FG004|Overall Study|Progressive Disease|3|||
105964697|NCT02954406|365530150|FG005|Overall Study|Progressive Disease|3|||
105964698|NCT02954406|365530151|FG006|Overall Study|Progressive Disease|2|||
105964699|NCT02954406|365530152|FG007|Overall Study|Progressive Disease|2|||
105964700|NCT02954406|365530153|FG008|Overall Study|Progressive Disease|1|||
105964701|NCT02954406|365530154|FG009|Overall Study|Progressive Disease|1|||
105964702|NCT02954406|365530155|FG010|Overall Study|Progressive Disease|0|||
105964703|NCT02954406|365530145|FG000|Overall Study|Symptomatic Deterioration|0|||
105964704|NCT02954406|365530146|FG001|Overall Study|Symptomatic Deterioration|1|||
105964705|NCT02954406|365530147|FG002|Overall Study|Symptomatic Deterioration|0|||
105964706|NCT02954406|365530148|FG003|Overall Study|Symptomatic Deterioration|0|||
105964707|NCT02954406|365530149|FG004|Overall Study|Symptomatic Deterioration|0|||
105964708|NCT02954406|365530150|FG005|Overall Study|Symptomatic Deterioration|0|||
105964709|NCT02954406|365530151|FG006|Overall Study|Symptomatic Deterioration|0|||
105964710|NCT02954406|365530152|FG007|Overall Study|Symptomatic Deterioration|0|||
105964711|NCT02954406|365530153|FG008|Overall Study|Symptomatic Deterioration|0|||
105964712|NCT02954406|365530154|FG009|Overall Study|Symptomatic Deterioration|0|||
105964713|NCT02954406|365530155|FG010|Overall Study|Symptomatic Deterioration|0|||
105964714|NCT02954406|365530145|FG000|Overall Study|Death|0|||
105964715|NCT02954406|365530146|FG001|Overall Study|Death|0|||
105964716|NCT02954406|365530147|FG002|Overall Study|Death|0|||
105964717|NCT02954406|365530148|FG003|Overall Study|Death|0|||
105833395|NCT01320722|365046559|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
105833396|NCT01320722|365046560|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
105833397|NCT01320722|365046556|FG000|Overall Study|Participant Developed a Rash|0|||
105833398|NCT01320722|365046557|FG001|Overall Study|Participant Developed a Rash|0|||
105833399|NCT01320722|365046558|FG002|Overall Study|Participant Developed a Rash|2|||
105833400|NCT01320722|365046559|FG003|Overall Study|Participant Developed a Rash|1|||
105833401|NCT01320722|365046560|FG004|Overall Study|Participant Developed a Rash|1|||
105833402|NCT01320722|365046556|FG000|Overall Study|Non-compliant with Medication|0|||
105833403|NCT01320722|365046557|FG001|Overall Study|Non-compliant with Medication|0|||
105833404|NCT01320722|365046558|FG002|Overall Study|Non-compliant with Medication|1|||
105833405|NCT01320722|365046559|FG003|Overall Study|Non-compliant with Medication|0|||
105833406|NCT01320722|365046560|FG004|Overall Study|Non-compliant with Medication|0|||
105833407|NCT01320722|365046556|FG000|Overall Study|Adverse Event|0|||
105833408|NCT01320722|365046557|FG001|Overall Study|Adverse Event|0|||
105833409|NCT01320722|365046558|FG002|Overall Study|Adverse Event|3|||
105833410|NCT01320722|365046559|FG003|Overall Study|Adverse Event|6|||
105833411|NCT01320722|365046560|FG004|Overall Study|Adverse Event|0|||
105833412|NCT01320722|365046556|FG000|Overall Study|Not Compliant with Study Procedures|0|||
105833413|NCT01320722|365046557|FG001|Overall Study|Not Compliant with Study Procedures|0|||
105833414|NCT01320722|365046558|FG002|Overall Study|Not Compliant with Study Procedures|0|||
105833415|NCT01320722|365046559|FG003|Overall Study|Not Compliant with Study Procedures|4|||
105833416|NCT01320722|365046560|FG004|Overall Study|Not Compliant with Study Procedures|0|||
105833417|NCT01320722|365046556|FG000|Overall Study|Pregnancy|0|||
105833418|NCT01320722|365046557|FG001|Overall Study|Pregnancy|0|||
105833419|NCT01320722|365046558|FG002|Overall Study|Pregnancy|0|||
105833420|NCT01320722|365046559|FG003|Overall Study|Pregnancy|1|||
105833421|NCT01320722|365046560|FG004|Overall Study|Pregnancy|0|||
105833422|NCT01320722|365046556|FG000|Overall Study|Started an Exclusionary Medication|0|||
105833423|NCT01320722|365046557|FG001|Overall Study|Started an Exclusionary Medication|0|||
105833424|NCT01320722|365046558|FG002|Overall Study|Started an Exclusionary Medication|0|||
105833425|NCT01320722|365046559|FG003|Overall Study|Started an Exclusionary Medication|0|||
105833426|NCT01320722|365046560|FG004|Overall Study|Started an Exclusionary Medication|1|||
105964718|NCT02954406|365530149|FG004|Overall Study|Death|1|||
105964719|NCT02954406|365530150|FG005|Overall Study|Death|0|||
105964720|NCT02954406|365530151|FG006|Overall Study|Death|0|||
105964721|NCT02954406|365530152|FG007|Overall Study|Death|0|||
105964722|NCT02954406|365530153|FG008|Overall Study|Death|1|||
105964723|NCT02954406|365530154|FG009|Overall Study|Death|1|||
105964724|NCT02954406|365530155|FG010|Overall Study|Death|0|||
105964725|NCT02954406|365530145|FG000|Overall Study|Reason Not Specified|0|||
105833427|NCT01320722|365046556|FG000|Overall Study|Withdrew due to Health Condition|0|||
105833428|NCT01320722|365046557|FG001|Overall Study|Withdrew due to Health Condition|0|||
105833429|NCT01320722|365046558|FG002|Overall Study|Withdrew due to Health Condition|0|||
105833430|NCT01320722|365046559|FG003|Overall Study|Withdrew due to Health Condition|0|||
105833431|NCT01320722|365046560|FG004|Overall Study|Withdrew due to Health Condition|1|||
105833432|NCT01899053|365046562|FG000|Overall Study|Progressive Disease|4|||
105833433|NCT01899053|365046563|FG001|Overall Study|Progressive Disease|0|||
105964726|NCT02954406|365530146|FG001|Overall Study|Reason Not Specified|0|||
105964727|NCT02954406|365530147|FG002|Overall Study|Reason Not Specified|3|||
105964728|NCT02954406|365530148|FG003|Overall Study|Reason Not Specified|2|||
105964729|NCT02954406|365530149|FG004|Overall Study|Reason Not Specified|2|||
105964730|NCT02954406|365530150|FG005|Overall Study|Reason Not Specified|0|||
105964731|NCT02954406|365530151|FG006|Overall Study|Reason Not Specified|1|||
105964732|NCT02954406|365530152|FG007|Overall Study|Reason Not Specified|0|||
105964733|NCT02954406|365530153|FG008|Overall Study|Reason Not Specified|1|||
105964734|NCT02954406|365530154|FG009|Overall Study|Reason Not Specified|0|||
105964735|NCT02954406|365530155|FG010|Overall Study|Reason Not Specified|0|||
105964736|NCT00814580|365530156|FG000|Overall Study|Adverse Event|6|||
105964737|NCT00814580|365530157|FG001|Overall Study|Adverse Event|15|||
105964738|NCT00814580|365530156|FG000|Overall Study|Lack of Efficacy|18|||
105964739|NCT00814580|365530157|FG001|Overall Study|Lack of Efficacy|25|||
105964740|NCT00814580|365530156|FG000|Overall Study|Protocol Violation|2|||
105964741|NCT00814580|365530157|FG001|Overall Study|Protocol Violation|0|||
105964742|NCT00814580|365530156|FG000|Overall Study|Withdrawal by Subject|2|||
105964743|NCT00814580|365530157|FG001|Overall Study|Withdrawal by Subject|2|||
105964744|NCT00814580|365530156|FG000|Overall Study|Other|1|||
105964745|NCT00814580|365530157|FG001|Overall Study|Other|3|||
105964746|NCT00814580|365530156|FG000|Overall Study|Did Not Take Drug|2|||
105964747|NCT00814580|365530157|FG001|Overall Study|Did Not Take Drug|2|||
105964748|NCT02582814|365530158|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105964749|NCT02582814|365530159|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105964750|NCT02582814|365530158|FG000|Overall Study|Withdrawal by Subject|4|||
105964751|NCT02582814|365530159|FG001|Overall Study|Withdrawal by Subject|3|||
105964752|NCT02582814|365530158|FG000|Overall Study|Adverse Event|4|||
105964753|NCT02582814|365530159|FG001|Overall Study|Adverse Event|4|||
105964754|NCT01558115|365530163|FG000|Overall Study|Withdrawal by Subject|3|||
105964755|NCT01558115|365530163|FG000|Overall Study|Study closed due to poor enrollment|4|||
105964756|NCT00880269|365530164|FG000|Overall Study|Protocol Violation|1|||
105964757|NCT00880269|365530165|FG001|Overall Study|Protocol Violation|0|||
105964758|NCT00880269|365530164|FG000|Overall Study|Disease Progression|13|||
105964759|NCT00880269|365530165|FG001|Overall Study|Disease Progression|11|||
105964760|NCT00880269|365530164|FG000|Overall Study|New Cancer Therapy|1|||
105964761|NCT00880269|365530165|FG001|Overall Study|New Cancer Therapy|0|||
105964762|NCT00880269|365530164|FG000|Overall Study|Death|4|||
105964763|NCT00880269|365530165|FG001|Overall Study|Death|2|||
105964764|NCT00880269|365530164|FG000|Overall Study|Lost to Follow-up|0|||
105964765|NCT00880269|365530165|FG001|Overall Study|Lost to Follow-up|1|||
105964766|NCT00880269|365530164|FG000|Overall Study|Withdrawal by Subject|3|||
105964767|NCT00880269|365530165|FG001|Overall Study|Withdrawal by Subject|4|||
105964768|NCT00880269|365530164|FG000|Overall Study|Adverse Event|10|||
105964769|NCT00880269|365530165|FG001|Overall Study|Adverse Event|9|||
105964770|NCT00316225|365530172|FG000|Overall Study|Adverse Event|2|||
105964771|NCT00316225|365530172|FG000|Overall Study|Physician Decision|3|||
105964772|NCT00316225|365530172|FG000|Overall Study|Progressive Disease|15|||
105964773|NCT00316225|365530172|FG000|Overall Study|Withdrawal by Subject|3|||
105964774|NCT00316225|365530172|FG000|Overall Study|Death|2|||
105964775|NCT01811485|365530174|FG000|Overall Study|Adverse Event|1|||
105964776|NCT01811485|365530175|FG001|Overall Study|Adverse Event|3|||
105964777|NCT01811485|365530176|FG002|Overall Study|Adverse Event|2|||
105964778|NCT01811485|365530174|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105964779|NCT01811485|365530175|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105964780|NCT01811485|365530176|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
105964781|NCT01811485|365530174|FG000|Overall Study|Administrative problems|1|||
105964782|NCT01811485|365530175|FG001|Overall Study|Administrative problems|0|||
105964783|NCT01811485|365530176|FG002|Overall Study|Administrative problems|0|||
105964784|NCT01811485|365530174|FG000|Overall Study|Protocol Deviation|0|||
105964785|NCT01811485|365530175|FG001|Overall Study|Protocol Deviation|1|||
105964786|NCT01811485|365530176|FG002|Overall Study|Protocol Deviation|0|||
105964787|NCT03645421|365530177|FG000|Overall Study|Adverse Event|0|||
105964788|NCT03645421|365530178|FG001|Overall Study|Adverse Event|0|||
105964789|NCT03645421|365530179|FG002|Overall Study|Adverse Event|4|||
105964790|NCT03645421|365530180|FG003|Overall Study|Adverse Event|1|||
105964791|NCT03645421|365530177|FG000|Overall Study|Withdrawal by patient|0|||
105964792|NCT03645421|365530178|FG001|Overall Study|Withdrawal by patient|0|||
105964793|NCT03645421|365530179|FG002|Overall Study|Withdrawal by patient|0|||
105964794|NCT03645421|365530180|FG003|Overall Study|Withdrawal by patient|3|||
105964795|NCT03645421|365530177|FG000|Overall Study|Study specific withdrawal criteria|0|||
105964796|NCT03645421|365530178|FG001|Overall Study|Study specific withdrawal criteria|0|||
105964797|NCT03645421|365530179|FG002|Overall Study|Study specific withdrawal criteria|1|||
105964798|NCT03645421|365530180|FG003|Overall Study|Study specific withdrawal criteria|0|||
105964799|NCT03654404|365530181|FG000|Overall Study|Death|1|||
105964800|NCT03654404|365530181|FG000|Overall Study|Lost to Follow-up|2|||
105964801|NCT03654404|365530181|FG000|Overall Study|Withdrawal by Subject|5|||
105964802|NCT02003638|365530191|FG000|Overall Study|Withdrawal by Subject|1|||
106148932|NCT03531840|366206929|FG001|Overall Study|Death on study|2|||
106148933|NCT03531840|366206930|FG002|Overall Study|Death on study|1|||
106148934|NCT03531840|366206931|FG003|Overall Study|Death on study|2|||
105833434|NCT01899053|365046564|FG002|Overall Study|Progressive Disease|3|||
105833435|NCT01899053|365046565|FG003|Overall Study|Progressive Disease|0|||
105833436|NCT01899053|365046566|FG004|Overall Study|Progressive Disease|3|||
105833437|NCT01899053|365046567|FG005|Overall Study|Progressive Disease|1|||
105833438|NCT01899053|365046568|FG006|Overall Study|Progressive Disease|1|||
105833439|NCT01899053|365046569|FG007|Overall Study|Progressive Disease|1|||
105833440|NCT01899053|365046570|FG008|Overall Study|Progressive Disease|4|||
105833441|NCT01899053|365046571|FG009|Overall Study|Progressive Disease|3|||
105833442|NCT01899053|365046572|FG010|Overall Study|Progressive Disease|12|||
105833443|NCT01899053|365046573|FG011|Overall Study|Progressive Disease|5|||
105833444|NCT01899053|365046574|FG012|Overall Study|Progressive Disease|8|||
105833445|NCT01899053|365046575|FG013|Overall Study|Progressive Disease|17|||
105833446|NCT01899053|365046562|FG000|Overall Study|Adverse Event|1|||
105833447|NCT01899053|365046563|FG001|Overall Study|Adverse Event|1|||
105833448|NCT01899053|365046564|FG002|Overall Study|Adverse Event|1|||
105833449|NCT01899053|365046565|FG003|Overall Study|Adverse Event|3|||
105833450|NCT01899053|365046566|FG004|Overall Study|Adverse Event|1|||
105833451|NCT01899053|365046567|FG005|Overall Study|Adverse Event|1|||
105833452|NCT01899053|365046568|FG006|Overall Study|Adverse Event|1|||
105833453|NCT01899053|365046569|FG007|Overall Study|Adverse Event|0|||
105833454|NCT01899053|365046570|FG008|Overall Study|Adverse Event|2|||
105833455|NCT01899053|365046571|FG009|Overall Study|Adverse Event|0|||
105833456|NCT01899053|365046572|FG010|Overall Study|Adverse Event|3|||
105833457|NCT01899053|365046573|FG011|Overall Study|Adverse Event|1|||
105833458|NCT01899053|365046574|FG012|Overall Study|Adverse Event|2|||
105833459|NCT01899053|365046575|FG013|Overall Study|Adverse Event|2|||
105833460|NCT01899053|365046562|FG000|Overall Study|Reason Not Specified|0|||
105833461|NCT01899053|365046563|FG001|Overall Study|Reason Not Specified|0|||
105833462|NCT01899053|365046564|FG002|Overall Study|Reason Not Specified|0|||
105833463|NCT01899053|365046565|FG003|Overall Study|Reason Not Specified|0|||
105833464|NCT01899053|365046566|FG004|Overall Study|Reason Not Specified|0|||
105833465|NCT01899053|365046567|FG005|Overall Study|Reason Not Specified|0|||
105833466|NCT01899053|365046568|FG006|Overall Study|Reason Not Specified|1|||
105833467|NCT01899053|365046569|FG007|Overall Study|Reason Not Specified|0|||
105833468|NCT01899053|365046570|FG008|Overall Study|Reason Not Specified|0|||
105833469|NCT01899053|365046571|FG009|Overall Study|Reason Not Specified|0|||
105833470|NCT01899053|365046572|FG010|Overall Study|Reason Not Specified|0|||
105833471|NCT01899053|365046573|FG011|Overall Study|Reason Not Specified|0|||
105833472|NCT01899053|365046574|FG012|Overall Study|Reason Not Specified|1|||
105833473|NCT01899053|365046575|FG013|Overall Study|Reason Not Specified|0|||
105833474|NCT01899053|365046562|FG000|Overall Study|Withdrawal by Subject|1|||
105833475|NCT01899053|365046563|FG001|Overall Study|Withdrawal by Subject|1|||
105833476|NCT01899053|365046564|FG002|Overall Study|Withdrawal by Subject|2|||
105833477|NCT01899053|365046565|FG003|Overall Study|Withdrawal by Subject|0|||
105833478|NCT01899053|365046566|FG004|Overall Study|Withdrawal by Subject|2|||
105833479|NCT01899053|365046567|FG005|Overall Study|Withdrawal by Subject|0|||
105833480|NCT01899053|365046568|FG006|Overall Study|Withdrawal by Subject|0|||
105833481|NCT01899053|365046569|FG007|Overall Study|Withdrawal by Subject|1|||
105833482|NCT01899053|365046570|FG008|Overall Study|Withdrawal by Subject|0|||
105833483|NCT01899053|365046571|FG009|Overall Study|Withdrawal by Subject|0|||
105833484|NCT01899053|365046572|FG010|Overall Study|Withdrawal by Subject|0|||
105833485|NCT01899053|365046573|FG011|Overall Study|Withdrawal by Subject|0|||
105964803|NCT02003638|365530192|FG001|Overall Study|Withdrawal by Subject|0|||
105964804|NCT03215758|365530193|FG000|Overall Study|Technical Problems|1|||
105964805|NCT03215758|365530194|FG001|Overall Study|Technical Problems|0|||
105964806|NCT03215758|365530193|FG000|Overall Study|Protocol deviation|0|||
105964807|NCT03215758|365530194|FG001|Overall Study|Protocol deviation|1|||
105964808|NCT03215758|365530193|FG000|Overall Study|Physician Decision|0|||
105964809|NCT03215758|365530194|FG001|Overall Study|Physician Decision|1|||
105964810|NCT03215758|365530193|FG000|Overall Study|Death|0|||
105964811|NCT03215758|365530194|FG001|Overall Study|Death|1|||
105964812|NCT03215758|365530193|FG000|Overall Study|Adverse Event|1|||
106148935|NCT03531840|366206928|FG000|Overall Study|Death during follow up|2|||
106148936|NCT03531840|366206929|FG001|Overall Study|Death during follow up|3|||
105833486|NCT01899053|365046574|FG012|Overall Study|Withdrawal by Subject|1|||
105833487|NCT01899053|365046575|FG013|Overall Study|Withdrawal by Subject|1|||
105833488|NCT01899053|365046562|FG000|Overall Study|Protocol Violation|0|||
105833489|NCT01899053|365046563|FG001|Overall Study|Protocol Violation|0|||
105833490|NCT01899053|365046564|FG002|Overall Study|Protocol Violation|1|||
105833491|NCT01899053|365046565|FG003|Overall Study|Protocol Violation|0|||
105833492|NCT01899053|365046566|FG004|Overall Study|Protocol Violation|0|||
105833493|NCT01899053|365046567|FG005|Overall Study|Protocol Violation|0|||
105833494|NCT01899053|365046568|FG006|Overall Study|Protocol Violation|0|||
105833495|NCT01899053|365046569|FG007|Overall Study|Protocol Violation|0|||
105964813|NCT03215758|365530194|FG001|Overall Study|Adverse Event|2|||
105964814|NCT03215758|365530193|FG000|Overall Study|Subject/Guardian Decision|3|||
106148937|NCT03531840|366206930|FG002|Overall Study|Death during follow up|4|||
105833496|NCT01899053|365046570|FG008|Overall Study|Protocol Violation|0|||
105833497|NCT01899053|365046571|FG009|Overall Study|Protocol Violation|0|||
105833498|NCT01899053|365046572|FG010|Overall Study|Protocol Violation|0|||
105833499|NCT01899053|365046573|FG011|Overall Study|Protocol Violation|0|||
105833500|NCT01899053|365046574|FG012|Overall Study|Protocol Violation|0|||
105833501|NCT01899053|365046575|FG013|Overall Study|Protocol Violation|0|||
105833502|NCT01899053|365046562|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
105833503|NCT01899053|365046563|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
105833504|NCT01899053|365046564|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833505|NCT01899053|365046565|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833506|NCT01899053|365046566|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833507|NCT01899053|365046567|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833508|NCT01899053|365046568|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833509|NCT01899053|365046569|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833510|NCT01899053|365046570|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833511|NCT01899053|365046571|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833512|NCT01899053|365046572|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
105833513|NCT01899053|365046573|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833514|NCT01899053|365046574|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833515|NCT01899053|365046575|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
105833516|NCT01899053|365046562|FG000|Overall Study|Symptomatic Deterioration|0|||
105833517|NCT01899053|365046563|FG001|Overall Study|Symptomatic Deterioration|0|||
105833518|NCT01899053|365046564|FG002|Overall Study|Symptomatic Deterioration|0|||
105833519|NCT01899053|365046565|FG003|Overall Study|Symptomatic Deterioration|0|||
105833520|NCT01899053|365046566|FG004|Overall Study|Symptomatic Deterioration|0|||
105833521|NCT01899053|365046567|FG005|Overall Study|Symptomatic Deterioration|1|||
105833522|NCT01899053|365046568|FG006|Overall Study|Symptomatic Deterioration|0|||
105833523|NCT01899053|365046569|FG007|Overall Study|Symptomatic Deterioration|1|||
105833524|NCT01899053|365046570|FG008|Overall Study|Symptomatic Deterioration|0|||
105833525|NCT01899053|365046571|FG009|Overall Study|Symptomatic Deterioration|0|||
105833526|NCT01899053|365046572|FG010|Overall Study|Symptomatic Deterioration|0|||
105833527|NCT01899053|365046573|FG011|Overall Study|Symptomatic Deterioration|1|||
105833528|NCT01899053|365046574|FG012|Overall Study|Symptomatic Deterioration|2|||
105833529|NCT01899053|365046575|FG013|Overall Study|Symptomatic Deterioration|0|||
105833530|NCT01341405|365046576|FG000|Overall Study|Adverse Event|0|||
105833531|NCT01341405|365046577|FG001|Overall Study|Adverse Event|1|||
105833532|NCT01341405|365046578|FG002|Overall Study|Adverse Event|1|||
105833533|NCT01341405|365046576|FG000|Overall Study|Withdrawal by Subject|3|||
105833534|NCT01341405|365046577|FG001|Overall Study|Withdrawal by Subject|2|||
105833535|NCT01341405|365046578|FG002|Overall Study|Withdrawal by Subject|1|||
105833536|NCT00826241|365046579|FG000|Overall Study|Withdrawal from Follow-up|1|||
105833537|NCT00826241|365046579|FG000|Overall Study|Withdrew consent|2|||
105833538|NCT00826241|365046579|FG000|Overall Study|Death|4|||
105833539|NCT00826241|365046579|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
105833540|NCT00826241|365046579|FG000|Overall Study|Non-compliance|1|||
105833541|NCT00826241|365046579|FG000|Overall Study|Progression of disease|1|||
105833542|NCT00826241|365046579|FG000|Overall Study|Patient refused follow-up|3|||
105833543|NCT00826241|365046579|FG000|Overall Study|Lost to Follow-up|9|||
105833544|NCT00826241|365046579|FG000|Overall Study|Could not obtain records|1|||
105833545|NCT00826241|365046579|FG000|Overall Study|Screen failure|2|||
105833546|NCT00826241|365046579|FG000|Overall Study|Pt unable to proceed to registration|1|||
105833547|NCT00826241|365046579|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
105833548|NCT02300987|365048598|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
105833549|NCT02300987|365048599|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
105833550|NCT02300987|365048598|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
105833551|NCT02300987|365048599|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
105833552|NCT02300987|365048598|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
105833553|NCT02300987|365048599|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
105833554|NCT02300987|365048598|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
105833555|NCT02300987|365048599|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
105964815|NCT03215758|365530194|FG001|Overall Study|Subject/Guardian Decision|3|||
105964816|NCT04115748|365530195|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
105964817|NCT04115748|365530196|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
105833556|NCT02300987|365048598|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
105833557|NCT02300987|365048599|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
105833558|NCT04264819|365048600|FG000|Overall Study|Physician Decision|19|||
105833559|NCT04264819|365048600|FG000|Overall Study|Adverse Event|12|||
105833560|NCT04264819|365048600|FG000|Overall Study|Withdrawal by Subject|11|||
105833561|NCT04264819|365048600|FG000|Overall Study|Lost to Follow-up|2|||
105833562|NCT04264819|365048600|FG000|Overall Study|Death|2|||
105833563|NCT00754052|365048601|FG000|Overall Study|Study terminated by Sponsor|5|||
105833564|NCT00754052|365048602|FG001|Overall Study|Study terminated by Sponsor|3|||
105833565|NCT01680016|365048603|FG000|Overall Study|Adverse Event|0|||
105833566|NCT01680016|365048604|FG001|Overall Study|Adverse Event|0|||
105833567|NCT01680016|365048605|FG002|Overall Study|Adverse Event|1|||
105833568|NCT01680016|365048606|FG003|Overall Study|Adverse Event|4|||
105833569|NCT01680016|365048603|FG000|Overall Study|The Subject went out of The Trial|1|||
105833570|NCT01680016|365048604|FG001|Overall Study|The Subject went out of The Trial|0|||
105833571|NCT01680016|365048605|FG002|Overall Study|The Subject went out of The Trial|3|||
105833572|NCT01680016|365048606|FG003|Overall Study|The Subject went out of The Trial|0|||
105833573|NCT01680016|365048603|FG000|Overall Study|Protocol Violation|0|||
105833574|NCT01680016|365048604|FG001|Overall Study|Protocol Violation|1|||
105833575|NCT01680016|365048605|FG002|Overall Study|Protocol Violation|0|||
105833576|NCT01680016|365048606|FG003|Overall Study|Protocol Violation|0|||
105833577|NCT01680016|365048603|FG000|Overall Study|Withdrawal by Subject|5|||
105833578|NCT01680016|365048604|FG001|Overall Study|Withdrawal by Subject|7|||
105833579|NCT01680016|365048605|FG002|Overall Study|Withdrawal by Subject|1|||
105833580|NCT01680016|365048606|FG003|Overall Study|Withdrawal by Subject|1|||
105833581|NCT02846883|365048609|FG000|Overall Study|Death|0|||
105833582|NCT02846883|365048610|FG001|Overall Study|Death|1|||
105833583|NCT02846883|365048611|FG002|Overall Study|Death|1|||
105833584|NCT02846883|365048609|FG000|Overall Study|Lost to Follow-up|0|||
105833585|NCT02846883|365048610|FG001|Overall Study|Lost to Follow-up|0|||
105833586|NCT02846883|365048611|FG002|Overall Study|Lost to Follow-up|1|||
105833587|NCT02846883|365048609|FG000|Overall Study|Withdrawal by Subject|1|||
105833588|NCT02846883|365048610|FG001|Overall Study|Withdrawal by Subject|0|||
105833589|NCT02846883|365048611|FG002|Overall Study|Withdrawal by Subject|0|||
105833590|NCT02846883|365048609|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
105833591|NCT02846883|365048610|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
105833592|NCT02846883|365048611|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
105833593|NCT02846883|365048609|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
105964818|NCT04115748|365530197|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
105964819|NCT04115748|365530198|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
105964820|NCT04115748|365530199|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105964821|NCT04115748|365530200|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105964822|NCT04115748|365530201|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105964823|NCT04115748|365530202|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105964824|NCT04115748|365530203|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105964825|NCT04115748|365530204|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
105964826|NCT04115748|365530195|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964827|NCT04115748|365530196|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964828|NCT04115748|365530197|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964829|NCT04115748|365530198|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
105964830|NCT04115748|365530199|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964831|NCT04115748|365530200|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964832|NCT04115748|365530201|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964833|NCT04115748|365530202|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964834|NCT04115748|365530203|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964835|NCT04115748|365530204|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
105964836|NCT04115748|365530195|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
105964837|NCT04115748|365530196|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
105964838|NCT04115748|365530197|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
105964839|NCT04115748|365530198|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
105964840|NCT04115748|365530199|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
105964841|NCT04115748|365530200|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
105964842|NCT04115748|365530201|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
105964843|NCT04115748|365530202|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
105964844|NCT04115748|365530203|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
105964845|NCT04115748|365530204|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
105964846|NCT04115748|365530195|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105964847|NCT04115748|365530196|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105964848|NCT04115748|365530197|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
106148938|NCT03531840|366206931|FG003|Overall Study|Death during follow up|1|||
106148939|NCT03451721|366206934|FG000|Overall Study|Death|1|||
106148940|NCT01985334|366206935|FG000|Overall Study|Administrative problems|1|||
106148941|NCT01985334|366206936|FG001|Overall Study|Administrative problems|1|||
106148942|NCT01985334|366206937|FG002|Overall Study|Administrative problems|0|||
106148943|NCT01985334|366206938|FG003|Overall Study|Administrative problems|2|||
106148944|NCT01985334|366206939|FG004|Overall Study|Administrative problems|0|||
106148945|NCT01985334|366206940|FG005|Overall Study|Administrative problems|1|||
106148946|NCT01985334|366206941|FG006|Overall Study|Administrative problems|1|||
105833594|NCT02846883|365048610|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
105833595|NCT02846883|365048611|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
105964849|NCT04115748|365530198|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105964850|NCT04115748|365530199|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105964851|NCT04115748|365530200|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105964852|NCT04115748|365530201|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105964853|NCT04115748|365530202|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105964854|NCT04115748|365530203|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
105964855|NCT04115748|365530204|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
105964856|NCT01200407|365530205|FG000|Overall Study|Lost to Follow-up|56|||
105964857|NCT01200407|365530205|FG000|Overall Study|Adverse Event|3|||
105964858|NCT01200407|365530205|FG000|Overall Study|Withdrawal by Subject|4|||
105964859|NCT01200407|365530205|FG000|Overall Study|Other|19|||
105964860|NCT00473668|365530206|FG000|Overall Study|Withdrawal by Subject|0|||
105964861|NCT00473668|365530207|FG001|Overall Study|Withdrawal by Subject|2|||
105964862|NCT00473668|365530208|FG002|Overall Study|Withdrawal by Subject|0|||
105964863|NCT00473668|365530206|FG000|Overall Study|Migrated/moved from study area|3|||
105964864|NCT00473668|365530207|FG001|Overall Study|Migrated/moved from study area|2|||
105964865|NCT00473668|365530208|FG002|Overall Study|Migrated/moved from study area|0|||
105964866|NCT00473668|365530206|FG000|Overall Study|Lost to Follow-up|0|||
105964867|NCT00473668|365530207|FG001|Overall Study|Lost to Follow-up|4|||
105964868|NCT00473668|365530208|FG002|Overall Study|Lost to Follow-up|6|||
105964869|NCT00473668|365530206|FG000|Overall Study|Other|2|||
105964870|NCT00473668|365530207|FG001|Overall Study|Other|3|||
105964871|NCT00473668|365530208|FG002|Overall Study|Other|4|||
105964872|NCT00334815|365530209|FG000|Overall Study|Adverse Event|3|||
106022860|NCT01584440|365748691|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
106022861|NCT03304249|365748695|FG000|Overall Study|Lost to Follow-up|8|||
106022862|NCT03304249|365748696|FG001|Overall Study|Lost to Follow-up|10|||
106022863|NCT03304249|365748695|FG000|Overall Study|Withdrawal by Subject|12|||
106022864|NCT03304249|365748696|FG001|Overall Study|Withdrawal by Subject|2|||
106022865|NCT03304249|365748695|FG000|Overall Study|Moved Out of District|4|||
106022866|NCT03304249|365748696|FG001|Overall Study|Moved Out of District|2|||
106022867|NCT01253577|365748697|FG000|Overall Study|Lost to Follow-up|3|||
106022868|NCT02509026|365748698|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
106022869|NCT02509026|365748698|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
106022870|NCT02509026|365748698|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
106022871|NCT02509026|365748698|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
106022872|NCT02509026|365748698|FG000|Induction Period (24 Weeks)|Other|2|||
106022873|NCT02509026|365748698|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
106022874|NCT02509026|365748698|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
106022875|NCT02509026|365748698|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
106022876|NCT02509026|365748698|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
106022877|NCT02509026|365748698|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
106022878|NCT02509026|365748698|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
106022879|NCT02509026|365748698|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
106022880|NCT02509026|365748698|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
106022881|NCT01165216|365748699|FG000|Overall Study|Adverse Event|6|||
106022882|NCT01165216|365748700|FG001|Overall Study|Adverse Event|3|||
106022883|NCT01165216|365748699|FG000|Overall Study|Withdrawal by Subject|1|||
106022884|NCT01165216|365748700|FG001|Overall Study|Withdrawal by Subject|1|||
106022885|NCT01165216|365748699|FG000|Overall Study|Disease progression|1|||
106022886|NCT01165216|365748700|FG001|Overall Study|Disease progression|3|||
106022887|NCT02626624|365748708|FG000|Overall Study|Adverse Event|1|||
106022888|NCT02626624|365748708|FG000|Overall Study|Lost to Follow-up|3|||
106022889|NCT02626624|365748708|FG000|Overall Study|Protocol Violation|4|||
106022890|NCT02626624|365748708|FG000|Overall Study|Death|2|||
106022891|NCT05141448|365748709|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
106022892|NCT05141448|365748710|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
106022893|NCT05141448|365748711|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
106022894|NCT05141448|365748712|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
106022895|NCT05141448|365748713|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
106022896|NCT05141448|365748714|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
106022897|NCT05141448|365748709|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
106022898|NCT05141448|365748710|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
106022899|NCT05141448|365748711|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
106022900|NCT05141448|365748712|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
106022901|NCT05141448|365748713|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
105964873|NCT00334815|365530210|FG001|Overall Study|Adverse Event|2|||
105964874|NCT00334815|365530209|FG000|Overall Study|Death|0|||
105964875|NCT00334815|365530210|FG001|Overall Study|Death|2|||
105964876|NCT00334815|365530209|FG000|Overall Study|Progression|1|||
105964877|NCT00334815|365530210|FG001|Overall Study|Progression|0|||
105964878|NCT00334815|365530209|FG000|Overall Study|ineligible|1|||
106148947|NCT01985334|366206942|FG007|Overall Study|Administrative problems|3|||
106148948|NCT01985334|366206935|FG000|Overall Study|Death|1|||
106148949|NCT01985334|366206936|FG001|Overall Study|Death|0|||
106148950|NCT01985334|366206937|FG002|Overall Study|Death|0|||
106148951|NCT01985334|366206938|FG003|Overall Study|Death|3|||
106148952|NCT01985334|366206939|FG004|Overall Study|Death|0|||
106148953|NCT01985334|366206940|FG005|Overall Study|Death|0|||
106148954|NCT01985334|366206941|FG006|Overall Study|Death|1|||
106148955|NCT01985334|366206942|FG007|Overall Study|Death|2|||
106148956|NCT01985334|366206935|FG000|Overall Study|Worsening of disease|0|||
106148957|NCT01985334|366206936|FG001|Overall Study|Worsening of disease|0|||
106148958|NCT01985334|366206937|FG002|Overall Study|Worsening of disease|0|||
106148959|NCT01985334|366206938|FG003|Overall Study|Worsening of disease|1|||
106148960|NCT01985334|366206939|FG004|Overall Study|Worsening of disease|0|||
106148961|NCT01985334|366206940|FG005|Overall Study|Worsening of disease|3|||
106148962|NCT01985334|366206941|FG006|Overall Study|Worsening of disease|0|||
106148963|NCT01985334|366206942|FG007|Overall Study|Worsening of disease|1|||
106148964|NCT01985334|366206935|FG000|Overall Study|Other|2|||
106148965|NCT01985334|366206936|FG001|Overall Study|Other|9|||
106148966|NCT01985334|366206937|FG002|Overall Study|Other|7|||
106148967|NCT01985334|366206938|FG003|Overall Study|Other|17|||
106148968|NCT01985334|366206939|FG004|Overall Study|Other|4|||
106148969|NCT01985334|366206940|FG005|Overall Study|Other|8|||
106148970|NCT01985334|366206941|FG006|Overall Study|Other|4|||
106148971|NCT01985334|366206942|FG007|Overall Study|Other|7|||
106148972|NCT01985334|366206935|FG000|Overall Study|Protocol deviation|6|||
106148973|NCT01985334|366206936|FG001|Overall Study|Protocol deviation|31|||
106148974|NCT01985334|366206937|FG002|Overall Study|Protocol deviation|25|||
106148975|NCT01985334|366206938|FG003|Overall Study|Protocol deviation|84|||
106148976|NCT01985334|366206939|FG004|Overall Study|Protocol deviation|17|||
106148977|NCT01985334|366206940|FG005|Overall Study|Protocol deviation|47|||
106148978|NCT01985334|366206941|FG006|Overall Study|Protocol deviation|15|||
106148979|NCT01985334|366206942|FG007|Overall Study|Protocol deviation|42|||
106148980|NCT01985334|366206935|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
106148981|NCT01985334|366206936|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
106148982|NCT01985334|366206937|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
106148983|NCT01985334|366206938|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
106148984|NCT01985334|366206939|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
106148985|NCT01985334|366206940|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
106148986|NCT01985334|366206941|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
106148987|NCT01985334|366206942|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
106148988|NCT01985334|366206935|FG000|Overall Study|Subject withdrawal of consent|3|||
106148989|NCT01985334|366206936|FG001|Overall Study|Subject withdrawal of consent|6|||
106148990|NCT01985334|366206937|FG002|Overall Study|Subject withdrawal of consent|2|||
106148991|NCT01985334|366206938|FG003|Overall Study|Subject withdrawal of consent|28|||
106148992|NCT01985334|366206939|FG004|Overall Study|Subject withdrawal of consent|4|||
106148993|NCT01985334|366206940|FG005|Overall Study|Subject withdrawal of consent|19|||
106148994|NCT01985334|366206941|FG006|Overall Study|Subject withdrawal of consent|0|||
106148995|NCT01985334|366206942|FG007|Overall Study|Subject withdrawal of consent|20|||
106148996|NCT01985334|366206935|FG000|Overall Study|Adverse Event|0|||
105833596|NCT05393271|365048618|FG000|Overall Study|Physician Decision|0|||
105833597|NCT05393271|365048619|FG001|Overall Study|Physician Decision|0|||
105833598|NCT05393271|365048620|FG002|Overall Study|Physician Decision|0|||
105833599|NCT05393271|365048621|FG003|Overall Study|Physician Decision|0|||
105833600|NCT05393271|365048622|FG004|Overall Study|Physician Decision|0|||
105833601|NCT05393271|365048623|FG005|Overall Study|Physician Decision|0|||
105833602|NCT05393271|365048624|FG006|Overall Study|Physician Decision|1|||
105833603|NCT05393271|365048625|FG007|Overall Study|Physician Decision|0|||
105833604|NCT05393271|365048626|FG008|Overall Study|Physician Decision|0|||
105833605|NCT05393271|365048627|FG009|Overall Study|Physician Decision|0|||
105833606|NCT05393271|365048628|FG010|Overall Study|Physician Decision|0|||
105833607|NCT02943993|365048629|FG000|Overall Study|Withdrawal by Subject|52|||
106148997|NCT01985334|366206936|FG001|Overall Study|Adverse Event|8|||
106148998|NCT01985334|366206937|FG002|Overall Study|Adverse Event|2|||
105833608|NCT02943993|365048629|FG000|Overall Study|Transfer to another institution|6|||
106148999|NCT01985334|366206938|FG003|Overall Study|Adverse Event|26|||
106149000|NCT01985334|366206939|FG004|Overall Study|Adverse Event|3|||
105833609|NCT02943993|365048629|FG000|Overall Study|Lost to Follow-up|135|||
105833610|NCT02943993|365048629|FG000|Overall Study|Death|98|||
105964879|NCT00334815|365530210|FG001|Overall Study|ineligible|1|||
106149001|NCT01985334|366206940|FG005|Overall Study|Adverse Event|18|||
106149002|NCT01985334|366206941|FG006|Overall Study|Adverse Event|3|||
106149003|NCT01985334|366206942|FG007|Overall Study|Adverse Event|15|||
105833611|NCT02943993|365048629|FG000|Overall Study|Other reason for premature termination|32|||
105964880|NCT00334815|365530209|FG000|Overall Study|patient refused treatment|0|||
105964881|NCT00334815|365530210|FG001|Overall Study|patient refused treatment|1|||
105964882|NCT00334815|365530209|FG000|Overall Study|Physician Decision|2|||
105964883|NCT00334815|365530210|FG001|Overall Study|Physician Decision|4|||
105964884|NCT02226562|365530211|FG000|Overall Study|Lost to Follow-up|0|||
105964885|NCT02226562|365530212|FG001|Overall Study|Lost to Follow-up|1|||
105964886|NCT00438360|365530215|FG000|Overall Study|Adverse Event|6|||
105964887|NCT00438360|365530216|FG001|Overall Study|Adverse Event|1|||
105964888|NCT00438360|365530215|FG000|Overall Study|Lack of Efficacy|42|||
105964889|NCT00438360|365530216|FG001|Overall Study|Lack of Efficacy|27|||
105964890|NCT00438360|365530215|FG000|Overall Study|Other|24|||
105964891|NCT00438360|365530216|FG001|Overall Study|Other|15|||
105964892|NCT02752633|365530217|FG000|Overall Study|Withdrawal by Subject|1|||
105964893|NCT02957747|365530218|FG000|Overall Study|Withdrawal by Subject|0|||
105833612|NCT02943993|365048629|FG000|Overall Study|Missing reason for termination|7|||
105964894|NCT02957747|365530219|FG001|Overall Study|Withdrawal by Subject|3|||
105964895|NCT02957747|365530218|FG000|Overall Study|Lost to Follow-up|10|||
105964896|NCT02957747|365530219|FG001|Overall Study|Lost to Follow-up|5|||
105964897|NCT03497975|365530220|FG000|Overall Study|Withdrew Consent|34|||
105964898|NCT03497975|365530221|FG001|Overall Study|Withdrew Consent|35|||
105964899|NCT03497975|365530220|FG000|Overall Study|Lost to Follow-up|7|||
105964900|NCT03497975|365530221|FG001|Overall Study|Lost to Follow-up|7|||
105964901|NCT03497975|365530220|FG000|Overall Study|Physician Decision|4|||
105964902|NCT03497975|365530221|FG001|Overall Study|Physician Decision|5|||
105964903|NCT03497975|365530220|FG000|Overall Study|Discontinued|42|||
105964904|NCT03497975|365530221|FG001|Overall Study|Discontinued|39|||
105964905|NCT03497975|365530220|FG000|Overall Study|Reason Not Specified|15|||
105964906|NCT03497975|365530221|FG001|Overall Study|Reason Not Specified|14|||
105964907|NCT05286658|365530223|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
105964908|NCT05286658|365530223|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
105964909|NCT00610857|365530227|FG000|Overall Study|Not evaluable for response|2|||
105964910|NCT00842153|365530228|FG000|Overall Study|Adverse Event|0|||
105964911|NCT00842153|365530229|FG001|Overall Study|Adverse Event|1|||
105964912|NCT00842153|365530228|FG000|Overall Study|Lost to Follow-up|1|||
105964913|NCT00842153|365530229|FG001|Overall Study|Lost to Follow-up|2|||
105964914|NCT00054327|365530236|FG000|Overall Study|Engraftment failure|1|||
105964915|NCT00054327|365530237|FG001|Overall Study|Engraftment failure|0|||
105964916|NCT00054327|365530238|FG002|Overall Study|Engraftment failure|0|||
105964917|NCT00054327|365530239|FG003|Overall Study|Engraftment failure|0|||
105964918|NCT00054327|365530240|FG004|Overall Study|Engraftment failure|0|||
105964919|NCT00054327|365530241|FG005|Overall Study|Engraftment failure|0|||
105964920|NCT00613327|365530242|FG000|Overall Study|Adverse Event|38|||
105964921|NCT00613327|365530242|FG000|Overall Study|Lost to Follow-up|8|||
105964922|NCT00613327|365530242|FG000|Overall Study|Withdrawal by Subject|6|||
105964923|NCT00613327|365530242|FG000|Overall Study|Protocol Violation|2|||
105964924|NCT00613327|365530242|FG000|Overall Study|Other|47|||
105964925|NCT00700882|365530243|FG000|Overall Study|Never received treatment|6|||
105833613|NCT04968925|365048633|FG000|Phase I- Period 1|COVID-19 related|0|||
105833614|NCT04968925|365048634|FG001|Phase I- Period 1|COVID-19 related|1|||
105833615|NCT04968925|365048635|FG002|Phase I- Period 1|COVID-19 related|0|||
105833616|NCT04968925|365048636|FG003|Phase I- Period 1|COVID-19 related|0|||
105833617|NCT04968925|365048633|FG000|Phase I- Period 1|Subject enrolled in error|1|||
105833618|NCT04968925|365048634|FG001|Phase I- Period 1|Subject enrolled in error|1|||
105833619|NCT04968925|365048635|FG002|Phase I- Period 1|Subject enrolled in error|0|||
105833620|NCT04968925|365048636|FG003|Phase I- Period 1|Subject enrolled in error|0|||
105833621|NCT04968925|365048633|FG000|Phase II- Period 1|COVID-19 Related|0|||
105833622|NCT04968925|365048634|FG001|Phase II- Period 1|COVID-19 Related|0|||
105833623|NCT04968925|365048635|FG002|Phase II- Period 1|COVID-19 Related|6|||
105833624|NCT04968925|365048636|FG003|Phase II- Period 1|COVID-19 Related|6|||
105833625|NCT04968925|365048633|FG000|Phase II- Period 1|Subject enrolled in error|0|||
105833626|NCT04968925|365048634|FG001|Phase II- Period 1|Subject enrolled in error|0|||
105833627|NCT04968925|365048635|FG002|Phase II- Period 1|Subject enrolled in error|1|||
105833628|NCT04968925|365048636|FG003|Phase II- Period 1|Subject enrolled in error|0|||
105833629|NCT04968925|365048633|FG000|Phase II -Period 2|COVID-19 related|0|||
105964926|NCT00700882|365530243|FG000|Overall Study|Ineligible|2|||
105964927|NCT00700882|365530243|FG000|Overall Study|No KIT mutation|51|||
105964928|NCT00361231|365530249|FG000|Overall Study|Physician Decision|3|||
105964929|NCT00361231|365530249|FG000|Overall Study|Symptomatic deterioration|5|||
105964930|NCT00361231|365530249|FG000|Overall Study|Radiographic disease progression|16|||
105964931|NCT00361231|365530249|FG000|Overall Study|Withdrawal by Subject|4|||
105964932|NCT00361231|365530249|FG000|Overall Study|Adverse Event|6|||
105833630|NCT04968925|365048634|FG001|Phase II -Period 2|COVID-19 related|0|||
105833631|NCT04968925|365048635|FG002|Phase II -Period 2|COVID-19 related|4|||
105833632|NCT04968925|365048636|FG003|Phase II -Period 2|COVID-19 related|3|||
105833633|NCT04968925|365048633|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
105833634|NCT04968925|365048634|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
105833635|NCT04968925|365048635|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
105833636|NCT04968925|365048636|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
105833637|NCT01119625|365048637|FG000|Overall Study|Lost to Follow-up|1|||
105833638|NCT01119625|365048638|FG001|Overall Study|Lost to Follow-up|2|||
105833639|NCT01119625|365048637|FG000|Overall Study|Withdrawal by Subject|2|||
105833640|NCT01119625|365048638|FG001|Overall Study|Withdrawal by Subject|1|||
105833641|NCT01119625|365048637|FG000|Overall Study|Other|0|||
105833642|NCT01119625|365048638|FG001|Overall Study|Other|1|||
105833643|NCT00876265|365048639|FG000|Overall Study|Miscellaneous reasons|4|||
105833644|NCT00876265|365048639|FG000|Overall Study|Lost to Follow-up|6|||
105833645|NCT00876265|365048639|FG000|Overall Study|Withdrawal by Subject|2|||
105833646|NCT01721772|365048640|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
105833647|NCT01721772|365048641|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
105833648|NCT01721772|365048640|FG000|Pre-Treatment|Poor/non-compliance|0|||
105833649|NCT01721772|365048641|FG001|Pre-Treatment|Poor/non-compliance|1|||
105833650|NCT01721772|365048640|FG000|Pre-Treatment|Participant withdrew consent|0|||
105833651|NCT01721772|365048641|FG001|Pre-Treatment|Participant withdrew consent|1|||
105833652|NCT01721772|365048640|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
105833653|NCT01721772|365048641|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
105833654|NCT01721772|365048640|FG000|Treatment|Disease progression|119|||
105833655|NCT01721772|365048641|FG001|Treatment|Disease progression|168|||
105833656|NCT01721772|365048640|FG000|Treatment|Study drug toxicity|19|||
105833657|NCT01721772|365048641|FG001|Treatment|Study drug toxicity|10|||
105833658|NCT01721772|365048640|FG000|Treatment|Adverse event unrelated to study drug|7|||
105833659|NCT01721772|365048641|FG001|Treatment|Adverse event unrelated to study drug|7|||
105833660|NCT01721772|365048640|FG000|Treatment|Maximum clinical benefit|16|||
105833661|NCT01721772|365048641|FG001|Treatment|Maximum clinical benefit|4|||
105833662|NCT01721772|365048640|FG000|Treatment|Other|19|||
105833663|NCT01721772|365048641|FG001|Treatment|Other|2|||
105833664|NCT01721772|365048640|FG000|Treatment|Participant withdrew consent|2|||
105833665|NCT01721772|365048641|FG001|Treatment|Participant withdrew consent|5|||
105833666|NCT01721772|365048640|FG000|Treatment|Participant request to discontinue study treatment|21|||
105833667|NCT01721772|365048641|FG001|Treatment|Participant request to discontinue study treatment|8|||
105833668|NCT01721772|365048640|FG000|Treatment|Death|1|||
105833669|NCT01721772|365048641|FG001|Treatment|Death|0|||
105833670|NCT01721772|365048640|FG000|Treatment|Not reported|1|||
105833671|NCT01721772|365048641|FG001|Treatment|Not reported|0|||
105833672|NCT01721772|365048640|FG000|Treatment|Poor/non-compliance|1|||
105833673|NCT01721772|365048641|FG001|Treatment|Poor/non-compliance|0|||
105833674|NCT01721772|365048640|FG000|Treatment|Lost to Follow-up|0|||
105833675|NCT01721772|365048641|FG001|Treatment|Lost to Follow-up|1|||
105833676|NCT02754492|365048642|FG000|Overall Study|Protocol Violation|2|||
105833677|NCT02754492|365048643|FG001|Overall Study|Protocol Violation|2|||
105833678|NCT02754492|365048644|FG002|Overall Study|Protocol Violation|0|||
105833679|NCT02754492|365048645|FG003|Overall Study|Protocol Violation|1|||
105833680|NCT02754492|365048642|FG000|Overall Study|Withdrawal by Subject|2|||
105833681|NCT02754492|365048643|FG001|Overall Study|Withdrawal by Subject|0|||
105833682|NCT02754492|365048644|FG002|Overall Study|Withdrawal by Subject|0|||
105833683|NCT02754492|365048645|FG003|Overall Study|Withdrawal by Subject|0|||
106022902|NCT05141448|365748714|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
106149004|NCT01985334|366206935|FG000|Overall Study|Other|4|||
106149005|NCT01985334|366206936|FG001|Overall Study|Other|2|||
106149006|NCT01985334|366206937|FG002|Overall Study|Other|3|||
106149007|NCT01985334|366206938|FG003|Overall Study|Other|10|||
105833684|NCT02754492|365048642|FG000|Overall Study|Equipment malfuntion|0|||
105833685|NCT02754492|365048643|FG001|Overall Study|Equipment malfuntion|0|||
105833686|NCT02754492|365048644|FG002|Overall Study|Equipment malfuntion|2|||
105833687|NCT02754492|365048645|FG003|Overall Study|Equipment malfuntion|5|||
105833688|NCT02754492|365048642|FG000|Overall Study|Adverse Event|0|||
105833689|NCT02754492|365048643|FG001|Overall Study|Adverse Event|0|||
105833690|NCT02754492|365048644|FG002|Overall Study|Adverse Event|0|||
105833691|NCT02754492|365048645|FG003|Overall Study|Adverse Event|13|||
105833692|NCT02754492|365048642|FG000|Overall Study|Venous access issues not resulting in AE|0|||
106149008|NCT01985334|366206939|FG004|Overall Study|Other|1|||
105833693|NCT02754492|365048643|FG001|Overall Study|Venous access issues not resulting in AE|0|||
105833694|NCT02754492|365048644|FG002|Overall Study|Venous access issues not resulting in AE|0|||
105833695|NCT02754492|365048645|FG003|Overall Study|Venous access issues not resulting in AE|4|||
105833696|NCT02327325|365048646|FG000|Overall Study|Withdrawal by Subject|1|||
105833697|NCT02327325|365048647|FG001|Overall Study|Withdrawal by Subject|4|||
105833698|NCT02327325|365048648|FG002|Overall Study|Withdrawal by Subject|4|||
105833699|NCT02327325|365048646|FG000|Overall Study|Excluded by Study Team|0|||
105833700|NCT02327325|365048647|FG001|Overall Study|Excluded by Study Team|0|||
105833701|NCT02327325|365048648|FG002|Overall Study|Excluded by Study Team|1|||
106149009|NCT01985334|366206940|FG005|Overall Study|Other|6|||
106149010|NCT01985334|366206941|FG006|Overall Study|Other|2|||
106022903|NCT05141448|365748709|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
106022904|NCT05141448|365748710|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
106022905|NCT05141448|365748711|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
106022906|NCT05141448|365748712|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
106022907|NCT05141448|365748713|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
106022908|NCT05141448|365748714|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
106022909|NCT05141448|365748709|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
106022910|NCT05141448|365748710|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
106022911|NCT05141448|365748711|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
106022912|NCT05141448|365748712|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
106022913|NCT05141448|365748713|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
106022914|NCT05141448|365748714|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
106022915|NCT05141448|365748709|FG000|Period 2|COVID-19 Related|0|||
106022916|NCT05141448|365748710|FG001|Period 2|COVID-19 Related|0|||
106022917|NCT05141448|365748711|FG002|Period 2|COVID-19 Related|0|||
106022918|NCT05141448|365748712|FG003|Period 2|COVID-19 Related|1|||
106022919|NCT05141448|365748713|FG004|Period 2|COVID-19 Related|0|||
106022920|NCT05141448|365748714|FG005|Period 2|COVID-19 Related|1|||
106022921|NCT05141448|365748709|FG000|3|Covid-19 related|2|||
106022922|NCT05141448|365748710|FG001|3|Covid-19 related|0|||
106022923|NCT05141448|365748711|FG002|3|Covid-19 related|0|||
106022924|NCT05141448|365748712|FG003|3|Covid-19 related|0|||
106022925|NCT05141448|365748713|FG004|3|Covid-19 related|0|||
106022926|NCT05141448|365748714|FG005|3|Covid-19 related|1|||
106022927|NCT05141448|365748709|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
106022928|NCT05141448|365748710|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
106022929|NCT05141448|365748711|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
106022930|NCT05141448|365748712|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
106022931|NCT05141448|365748713|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
106022932|NCT05141448|365748714|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
106022933|NCT01006291|365750258|FG000|Overall Study|Adverse Event|2|||
106022934|NCT01006291|365750259|FG001|Overall Study|Adverse Event|1|||
106022935|NCT01006291|365750260|FG002|Overall Study|Adverse Event|2|||
106022936|NCT01006291|365750258|FG000|Overall Study|Lack of Efficacy|2|||
106022937|NCT01006291|365750259|FG001|Overall Study|Lack of Efficacy|2|||
106022938|NCT01006291|365750260|FG002|Overall Study|Lack of Efficacy|1|||
106022939|NCT01006291|365750258|FG000|Overall Study|Protocol Violation|3|||
106022940|NCT01006291|365750259|FG001|Overall Study|Protocol Violation|3|||
106022941|NCT01006291|365750260|FG002|Overall Study|Protocol Violation|3|||
106022942|NCT01006291|365750258|FG000|Overall Study|Withdrawal criteria|5|||
106022943|NCT01006291|365750259|FG001|Overall Study|Withdrawal criteria|4|||
106022944|NCT01006291|365750260|FG002|Overall Study|Withdrawal criteria|4|||
106022945|NCT01006291|365750258|FG000|Overall Study|Other|14|||
106022946|NCT01006291|365750259|FG001|Overall Study|Other|14|||
106022947|NCT01006291|365750260|FG002|Overall Study|Other|17|||
106022948|NCT00479687|365750261|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
106022949|NCT00479687|365750262|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
106022950|NCT00479687|365750263|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
106022951|NCT00479687|365750261|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
106022952|NCT00479687|365750262|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
106022953|NCT00479687|365750263|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
106022954|NCT00479687|365750261|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
106022955|NCT00479687|365750262|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
106022956|NCT00479687|365750263|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
106022957|NCT00479687|365750261|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
106022958|NCT00479687|365750262|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
106022959|NCT00479687|365750263|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
106022960|NCT00479687|365750261|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
106022961|NCT00479687|365750262|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
106022962|NCT00479687|365750263|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
106022963|NCT00479687|365750261|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
106022964|NCT00479687|365750262|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
106022965|NCT00479687|365750263|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
106022966|NCT00479687|365750261|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
106022967|NCT00479687|365750262|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
106022968|NCT00479687|365750263|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
106022969|NCT00479687|365750261|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
106149011|NCT01985334|366206942|FG007|Overall Study|Other|2|||
106022970|NCT00479687|365750262|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
106022971|NCT00479687|365750263|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
106149012|NCT01985334|366206935|FG000|Overall Study|Medication non-compliance|0|||
105964933|NCT04731298|365530262|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
105964934|NCT04731298|365530263|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
105964935|NCT03718884|365530273|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
105964936|NCT03718884|365530274|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
105964937|NCT03718884|365530273|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
105964938|NCT03718884|365530274|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
105964939|NCT03594747|365530282|FG000|Overall Study|Death|78|||
105964940|NCT03594747|365530283|FG001|Overall Study|Death|86|||
105964941|NCT03594747|365530284|FG002|Overall Study|Death|87|||
105964942|NCT03594747|365530282|FG000|Overall Study|Withdrawal by Subject|5|||
105964943|NCT03594747|365530283|FG001|Overall Study|Withdrawal by Subject|2|||
105964944|NCT03594747|365530284|FG002|Overall Study|Withdrawal by Subject|11|||
105964945|NCT03594747|365530282|FG000|Overall Study|Lost to Follow-up|4|||
105964946|NCT03594747|365530283|FG001|Overall Study|Lost to Follow-up|1|||
105964947|NCT03594747|365530284|FG002|Overall Study|Lost to Follow-up|1|||
105964948|NCT03594747|365530282|FG000|Overall Study|Physician Decision|0|||
105964949|NCT03594747|365530283|FG001|Overall Study|Physician Decision|1|||
105964950|NCT03594747|365530284|FG002|Overall Study|Physician Decision|0|||
105964951|NCT03594747|365530282|FG000|Overall Study|Sponsor decision|23|||
105964952|NCT03594747|365530283|FG001|Overall Study|Sponsor decision|17|||
105833702|NCT01408888|365048649|FG000|First Intervention|Adverse Event|0|||
105833703|NCT01408888|365048650|FG001|First Intervention|Adverse Event|1|||
105833704|NCT01408888|365048649|FG000|First Intervention|Withdrawal by Subject|0|||
105833705|NCT01408888|365048650|FG001|First Intervention|Withdrawal by Subject|2|||
105833706|NCT01408888|365048649|FG000|Second Intervention|Withdrawal by Subject|1|||
105833707|NCT01408888|365048650|FG001|Second Intervention|Withdrawal by Subject|0|||
105833708|NCT01408888|365048649|FG000|Second Intervention|Adverse Event|1|||
105833709|NCT01408888|365048650|FG001|Second Intervention|Adverse Event|0|||
105833710|NCT01957150|365048651|FG000|Overall Study|Adverse Event|23|||
105833711|NCT01957150|365048652|FG001|Overall Study|Adverse Event|20|||
105833712|NCT01957150|365048651|FG000|Overall Study|Withdrawal by Subject|13|||
105833713|NCT01957150|365048652|FG001|Overall Study|Withdrawal by Subject|17|||
105833714|NCT01957150|365048651|FG000|Overall Study|Physician Decision|3|||
105833715|NCT01957150|365048652|FG001|Overall Study|Physician Decision|6|||
105833716|NCT01957150|365048651|FG000|Overall Study|Lost to Follow-up|4|||
105833717|NCT01957150|365048652|FG001|Overall Study|Lost to Follow-up|4|||
105833718|NCT01957150|365048651|FG000|Overall Study|Protocol Violation|1|||
105833719|NCT01957150|365048652|FG001|Overall Study|Protocol Violation|0|||
105833720|NCT01957150|365048651|FG000|Overall Study|Lack of Efficacy|11|||
105833721|NCT01957150|365048652|FG001|Overall Study|Lack of Efficacy|11|||
105833722|NCT02416180|365048659|FG000|Overall Study|Withdrawal by Subject|1|||
105833723|NCT02179190|365048660|FG000|Enrollment|Exit Prior to Device Attempt|11|||
105833724|NCT02179190|365048660|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
105833725|NCT02179190|365048660|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
105833726|NCT02179190|365048660|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
105833727|NCT02179190|365048660|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
105833728|NCT02179190|365048660|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
105833729|NCT02377349|365048662|FG000|Overall Study|Serious Adverse Event|1|||
105833730|NCT02377349|365048663|FG001|Overall Study|Serious Adverse Event|0|||
105833731|NCT02377349|365048662|FG000|Overall Study|Protocol Violation|3|||
105833732|NCT02377349|365048663|FG001|Overall Study|Protocol Violation|2|||
105964953|NCT03594747|365530284|FG002|Overall Study|Sponsor decision|16|||
105964954|NCT03594747|365530282|FG000|Overall Study|Did not meet inclusion criteria|0|||
105964955|NCT03594747|365530283|FG001|Overall Study|Did not meet inclusion criteria|0|||
105964956|NCT03594747|365530284|FG002|Overall Study|Did not meet inclusion criteria|1|||
105964957|NCT03594747|365530282|FG000|Overall Study|Transfer to long term extension study|10|||
105964958|NCT03594747|365530283|FG001|Overall Study|Transfer to long term extension study|12|||
105964959|NCT03594747|365530284|FG002|Overall Study|Transfer to long term extension study|5|||
105833733|NCT02377349|365048662|FG000|Overall Study|Withdrawal by Subject|5|||
105833734|NCT02377349|365048663|FG001|Overall Study|Withdrawal by Subject|3|||
105833735|NCT02377349|365048662|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
105833736|NCT02377349|365048663|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
105833737|NCT02377349|365048662|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
105833738|NCT02377349|365048663|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
105833739|NCT02377349|365048662|FG000|Overall Study|Other|0|||
105964960|NCT04382586|365530285|FG000|Overall Study|Death|3|||
105964961|NCT04382586|365530286|FG001|Overall Study|Death|4|||
105964962|NCT04382586|365530285|FG000|Overall Study|Lost to Follow-up|11|||
105964963|NCT04382586|365530286|FG001|Overall Study|Lost to Follow-up|8|||
105964964|NCT04382586|365530285|FG000|Overall Study|Withdrawal by Subject|3|||
105833740|NCT02377349|365048663|FG001|Overall Study|Other|1|||
105833741|NCT04010227|365048664|FG000|Overall Study|Death|1|||
105833742|NCT04010227|365048665|FG001|Overall Study|Death|2|||
105833743|NCT04010227|365048664|FG000|Overall Study|Medical Reasons|4|||
105833744|NCT04010227|365048665|FG001|Overall Study|Medical Reasons|3|||
105964965|NCT04382586|365530286|FG001|Overall Study|Withdrawal by Subject|1|||
106149013|NCT01985334|366206936|FG001|Overall Study|Medication non-compliance|4|||
106149014|NCT01985334|366206937|FG002|Overall Study|Medication non-compliance|1|||
105833745|NCT04010227|365048664|FG000|Overall Study|Withdrawal by Subject|2|||
105833746|NCT04010227|365048665|FG001|Overall Study|Withdrawal by Subject|0|||
105833747|NCT04010227|365048664|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
105833748|NCT04010227|365048665|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
105833749|NCT01841073|365048670|FG000|Overall Study|Adverse Event|1|||
105833750|NCT01841073|365048671|FG001|Overall Study|Adverse Event|1|||
105833751|NCT01841073|365048670|FG000|Overall Study|Physician Decision|1|||
105833752|NCT01841073|365048671|FG001|Overall Study|Physician Decision|0|||
105833753|NCT01841073|365048670|FG000|Overall Study|Lost to Follow-up|0|||
105833754|NCT01841073|365048671|FG001|Overall Study|Lost to Follow-up|2|||
105833755|NCT00046839|365048672|FG000|Overall Study|Ineligible / No protocol treatment|0|||
105833756|NCT00046839|365048673|FG001|Overall Study|Ineligible / No protocol treatment|2|||
105833757|NCT00046839|365048672|FG000|Overall Study|Withdrawal of consent|1|||
105833758|NCT00046839|365048673|FG001|Overall Study|Withdrawal of consent|0|||
105833759|NCT01970592|365048675|FG000|Overall Study|Withdrawal by Subject|4|||
105833760|NCT01970592|365048675|FG000|Overall Study|Physician Decision|1|||
105833761|NCT01970592|365048675|FG000|Overall Study|Adverse Event|1|||
105833762|NCT05263505|365048678|FG000|Overall Study|Adverse Event|0|||
105833763|NCT05263505|365048679|FG001|Overall Study|Adverse Event|1|||
105833764|NCT00965731|365048681|FG000|Overall Study|Death|0|||
105833765|NCT00965731|365048682|FG001|Overall Study|Death|4|||
105833766|NCT00965731|365048681|FG000|Overall Study|Withdrawal by Subject|0|||
105833767|NCT00965731|365048682|FG001|Overall Study|Withdrawal by Subject|1|||
105833768|NCT00965731|365048681|FG000|Overall Study|Other|7|||
105833769|NCT00965731|365048682|FG001|Overall Study|Other|15|||
105833770|NCT01098539|365048685|FG000|Overall Study|Adverse Event|26|||
105833771|NCT01098539|365048686|FG001|Overall Study|Adverse Event|26|||
105833772|NCT01098539|365048685|FG000|Overall Study|Protocol Violation|1|||
105833773|NCT01098539|365048686|FG001|Overall Study|Protocol Violation|4|||
105833774|NCT01098539|365048685|FG000|Overall Study|Noncompliance|3|||
105833775|NCT01098539|365048686|FG001|Overall Study|Noncompliance|5|||
105833776|NCT01098539|365048685|FG000|Overall Study|Lost to Follow-up|4|||
105833777|NCT01098539|365048686|FG001|Overall Study|Lost to Follow-up|4|||
105833778|NCT01098539|365048685|FG000|Overall Study|Withdrawal by Subject|12|||
105833779|NCT01098539|365048686|FG001|Overall Study|Withdrawal by Subject|26|||
105833780|NCT01098539|365048685|FG000|Overall Study|Physician Decision|5|||
105833781|NCT01098539|365048686|FG001|Overall Study|Physician Decision|3|||
105833782|NCT03843125|365048687|FG000|Overall Study|Adverse Event|17|||
105833783|NCT03843125|365048688|FG001|Overall Study|Adverse Event|13|||
105833784|NCT03843125|365048689|FG002|Overall Study|Adverse Event|5|||
105833785|NCT03843125|365048690|FG003|Overall Study|Adverse Event|9|||
105833786|NCT03843125|365048687|FG000|Overall Study|Death|0|||
105833787|NCT03843125|365048688|FG001|Overall Study|Death|6|||
105833788|NCT03843125|365048689|FG002|Overall Study|Death|2|||
105833789|NCT03843125|365048690|FG003|Overall Study|Death|0|||
105833790|NCT03843125|365048687|FG000|Overall Study|Lack of Efficacy|14|||
105833791|NCT03843125|365048688|FG001|Overall Study|Lack of Efficacy|11|||
105833792|NCT03843125|365048689|FG002|Overall Study|Lack of Efficacy|9|||
105833793|NCT03843125|365048690|FG003|Overall Study|Lack of Efficacy|4|||
105833794|NCT03843125|365048687|FG000|Overall Study|Lost to Follow-up|3|||
105833795|NCT03843125|365048688|FG001|Overall Study|Lost to Follow-up|4|||
105833796|NCT03843125|365048689|FG002|Overall Study|Lost to Follow-up|0|||
105833797|NCT03843125|365048690|FG003|Overall Study|Lost to Follow-up|2|||
105833798|NCT03843125|365048687|FG000|Overall Study|Other|12|||
105833799|NCT03843125|365048688|FG001|Overall Study|Other|14|||
105833800|NCT03843125|365048689|FG002|Overall Study|Other|3|||
105833801|NCT03843125|365048690|FG003|Overall Study|Other|4|||
105833802|NCT03843125|365048687|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
105833803|NCT03843125|365048688|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
105833804|NCT03843125|365048689|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
105833805|NCT03843125|365048690|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
105833806|NCT03843125|365048687|FG000|Overall Study|Study Terminated by Sponsor|318|||
105833807|NCT03843125|365048688|FG001|Overall Study|Study Terminated by Sponsor|318|||
105833808|NCT03843125|365048689|FG002|Overall Study|Study Terminated by Sponsor|163|||
105833809|NCT03843125|365048690|FG003|Overall Study|Study Terminated by Sponsor|163|||
105833810|NCT03843125|365048687|FG000|Overall Study|Withdrawal by Subject|23|||
105833811|NCT03843125|365048688|FG001|Overall Study|Withdrawal by Subject|12|||
105833812|NCT03843125|365048689|FG002|Overall Study|Withdrawal by Subject|6|||
105833813|NCT03843125|365048690|FG003|Overall Study|Withdrawal by Subject|9|||
105833814|NCT03843125|365048687|FG000|Overall Study|Missing data|0|||
105833815|NCT03843125|365048688|FG001|Overall Study|Missing data|1|||
105833816|NCT03843125|365048689|FG002|Overall Study|Missing data|1|||
105833817|NCT03843125|365048690|FG003|Overall Study|Missing data|0|||
105833818|NCT01292837|365048694|FG000|Overall Study|Adverse Event|1|||
105833819|NCT01292837|365048694|FG000|Overall Study|Further treatment determined|1|||
105833820|NCT02661022|365048703|FG000|Overall Study|Withdrawal by Subject|3|||
106149015|NCT01985334|366206938|FG003|Overall Study|Medication non-compliance|6|||
105833821|NCT02661022|365048704|FG001|Overall Study|Withdrawal by Subject|0|||
105833822|NCT02661022|365048703|FG000|Overall Study|Adverse Event|1|||
105833823|NCT02661022|365048704|FG001|Overall Study|Adverse Event|1|||
105833824|NCT02661022|365048703|FG000|Overall Study|Physician Decision|1|||
105833825|NCT02661022|365048704|FG001|Overall Study|Physician Decision|0|||
105833826|NCT02661022|365048703|FG000|Overall Study|Progressive Disease|2|||
105833827|NCT02661022|365048704|FG001|Overall Study|Progressive Disease|1|||
105833828|NCT00830167|365048705|FG000|Overall Study|Lack of Efficacy|26|||
105833829|NCT00830167|365048706|FG001|Overall Study|Lack of Efficacy|10|||
105833830|NCT00830167|365048705|FG000|Overall Study|Adverse Event|8|||
105833831|NCT00830167|365048706|FG001|Overall Study|Adverse Event|24|||
105833832|NCT00830167|365048705|FG000|Overall Study|Not meeting entrance criteria|2|||
105833833|NCT00830167|365048706|FG001|Overall Study|Not meeting entrance criteria|5|||
105833834|NCT00830167|365048705|FG000|Overall Study|Withdrawal by Subject|2|||
105833835|NCT00830167|365048706|FG001|Overall Study|Withdrawal by Subject|0|||
105833836|NCT00830167|365048705|FG000|Overall Study|Lost to Follow-up|0|||
105833837|NCT00830167|365048706|FG001|Overall Study|Lost to Follow-up|1|||
105833838|NCT00830167|365048705|FG000|Overall Study|Protocol Violation|0|||
105833839|NCT00830167|365048706|FG001|Overall Study|Protocol Violation|1|||
105833840|NCT00830167|365048705|FG000|Overall Study|Other|2|||
105833841|NCT00830167|365048706|FG001|Overall Study|Other|2|||
105833842|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
105833843|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
105833844|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
105833845|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
105833846|NCT02224053|365048707|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
105833847|NCT03833427|365048710|FG000|Overall Study|Death|4|||
105833848|NCT03833427|365048711|FG001|Overall Study|Death|2|||
105833849|NCT03833427|365048712|FG002|Overall Study|Death|9|||
105833850|NCT03833427|365048713|FG003|Overall Study|Death|11|||
105833851|NCT03833427|365048714|FG004|Overall Study|Death|0|||
105833852|NCT03833427|365048715|FG005|Overall Study|Death|0|||
105833853|NCT03833427|365048716|FG006|Overall Study|Death|0|||
105833854|NCT03833427|365048710|FG000|Overall Study|Withdrawal by Subject|0|||
105833855|NCT03833427|365048711|FG001|Overall Study|Withdrawal by Subject|1|||
105833856|NCT03833427|365048712|FG002|Overall Study|Withdrawal by Subject|1|||
105833857|NCT03833427|365048713|FG003|Overall Study|Withdrawal by Subject|0|||
105833858|NCT03833427|365048714|FG004|Overall Study|Withdrawal by Subject|0|||
105833859|NCT03833427|365048715|FG005|Overall Study|Withdrawal by Subject|0|||
105833860|NCT03833427|365048716|FG006|Overall Study|Withdrawal by Subject|0|||
105833861|NCT03833427|365048710|FG000|Overall Study|Sponsor Decision|0|||
105833862|NCT03833427|365048711|FG001|Overall Study|Sponsor Decision|0|||
105833863|NCT03833427|365048712|FG002|Overall Study|Sponsor Decision|1|||
105833864|NCT03833427|365048713|FG003|Overall Study|Sponsor Decision|3|||
105833865|NCT03833427|365048714|FG004|Overall Study|Sponsor Decision|0|||
105833866|NCT03833427|365048715|FG005|Overall Study|Sponsor Decision|0|||
105833867|NCT03833427|365048716|FG006|Overall Study|Sponsor Decision|0|||
105833868|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
105833869|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
105833870|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
105833871|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
105833872|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
105833873|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
105833874|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
105833875|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
105833876|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
105833877|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
105833878|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
105833879|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
105833880|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
106149016|NCT01985334|366206939|FG004|Overall Study|Medication non-compliance|2|||
105833881|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
105833882|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
105833883|NCT02250651|365048721|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
105833884|NCT02250651|365048722|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
105833885|NCT02250651|365048723|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
106149017|NCT01985334|366206940|FG005|Overall Study|Medication non-compliance|3|||
106149018|NCT01985334|366206941|FG006|Overall Study|Medication non-compliance|1|||
106149019|NCT01985334|366206942|FG007|Overall Study|Medication non-compliance|3|||
105833886|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
105833887|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
105833888|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
105833889|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
106149020|NCT01985334|366206935|FG000|Overall Study|Use of prohibited treatment|1|||
106149021|NCT01985334|366206936|FG001|Overall Study|Use of prohibited treatment|4|||
106149022|NCT01985334|366206937|FG002|Overall Study|Use of prohibited treatment|1|||
106149023|NCT01985334|366206938|FG003|Overall Study|Use of prohibited treatment|2|||
106149024|NCT01985334|366206939|FG004|Overall Study|Use of prohibited treatment|1|||
106149025|NCT01985334|366206940|FG005|Overall Study|Use of prohibited treatment|6|||
106149026|NCT01985334|366206941|FG006|Overall Study|Use of prohibited treatment|2|||
106149027|NCT01985334|366206942|FG007|Overall Study|Use of prohibited treatment|0|||
106149028|NCT01985334|366206935|FG000|Overall Study|Investigator decision|0|||
106149029|NCT01985334|366206936|FG001|Overall Study|Investigator decision|3|||
106149030|NCT01985334|366206937|FG002|Overall Study|Investigator decision|0|||
106149031|NCT01985334|366206938|FG003|Overall Study|Investigator decision|7|||
106149032|NCT01985334|366206939|FG004|Overall Study|Investigator decision|1|||
106149033|NCT01985334|366206940|FG005|Overall Study|Investigator decision|1|||
106149034|NCT01985334|366206941|FG006|Overall Study|Investigator decision|0|||
106149035|NCT01985334|366206942|FG007|Overall Study|Investigator decision|4|||
106149036|NCT01985334|366206935|FG000|Overall Study|Lost to Follow-up|0|||
106149037|NCT01985334|366206936|FG001|Overall Study|Lost to Follow-up|2|||
106149038|NCT01985334|366206937|FG002|Overall Study|Lost to Follow-up|0|||
106149039|NCT01985334|366206938|FG003|Overall Study|Lost to Follow-up|3|||
106149040|NCT01985334|366206939|FG004|Overall Study|Lost to Follow-up|1|||
106149041|NCT01985334|366206940|FG005|Overall Study|Lost to Follow-up|4|||
106149042|NCT01985334|366206941|FG006|Overall Study|Lost to Follow-up|0|||
106149043|NCT01985334|366206942|FG007|Overall Study|Lost to Follow-up|3|||
106149044|NCT00914589|366206943|FG000|Overall Study|Adverse Event|1|||
106022972|NCT00479687|365750261|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
106022973|NCT00479687|365750262|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
106022974|NCT00479687|365750263|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
106022975|NCT01243242|365750264|FG000|Overall Study|Adverse Event|1|||
106022976|NCT01243242|365750265|FG001|Overall Study|Adverse Event|1|||
106022977|NCT01243242|365750264|FG000|Overall Study|Withdrawal by Subject|1|||
106149045|NCT00914589|366206944|FG001|Overall Study|Adverse Event|0|||
106149046|NCT00914589|366206945|FG002|Overall Study|Adverse Event|1|||
106149047|NCT00914589|366206943|FG000|Overall Study|Protocol Violation|8|||
106022978|NCT01243242|365750265|FG001|Overall Study|Withdrawal by Subject|1|||
106022979|NCT01243242|365750264|FG000|Overall Study|Physician Decision|0|||
106022980|NCT01243242|365750265|FG001|Overall Study|Physician Decision|1|||
106022981|NCT01243242|365750264|FG000|Overall Study|sponsor decision|0|||
106022982|NCT01243242|365750265|FG001|Overall Study|sponsor decision|1|||
106022983|NCT01243242|365750264|FG000|Overall Study|non compliance|1|||
106022984|NCT01243242|365750265|FG001|Overall Study|non compliance|0|||
106022985|NCT02260180|365750266|FG000|Overall Study|Adverse Event|2|||
106022986|NCT02260180|365750267|FG001|Overall Study|Adverse Event|0|||
106022987|NCT02260180|365750268|FG002|Overall Study|Adverse Event|1|||
106022988|NCT02891070|365750273|FG000|Overall Study|Adverse Event|1|||
106022989|NCT02891070|365750274|FG001|Overall Study|Adverse Event|0|||
106022990|NCT02891070|365750273|FG000|Overall Study|Physician Decision|0|||
106022991|NCT02891070|365750274|FG001|Overall Study|Physician Decision|1|||
106022992|NCT02891070|365750273|FG000|Overall Study|Lost to Follow-up|4|||
106022993|NCT02891070|365750274|FG001|Overall Study|Lost to Follow-up|4|||
106149048|NCT00914589|366206944|FG001|Overall Study|Protocol Violation|6|||
106149049|NCT00914589|366206945|FG002|Overall Study|Protocol Violation|3|||
106149050|NCT00914589|366206943|FG000|Overall Study|unclassified|16|||
106149051|NCT00914589|366206944|FG001|Overall Study|unclassified|9|||
106149052|NCT00914589|366206945|FG002|Overall Study|unclassified|7|||
106149053|NCT00914589|366206943|FG000|Overall Study|Death|0|||
106149054|NCT00914589|366206944|FG001|Overall Study|Death|1|||
106022994|NCT02891070|365750273|FG000|Overall Study|Other|1|||
106022995|NCT02891070|365750274|FG001|Overall Study|Other|0|||
106022996|NCT02891070|365750273|FG000|Overall Study|Protocol Violation|0|||
106022997|NCT02891070|365750274|FG001|Overall Study|Protocol Violation|1|||
106149055|NCT00914589|366206945|FG002|Overall Study|Death|1|||
106022998|NCT02891070|365750273|FG000|Overall Study|Withdrawal by Subject|1|||
106149056|NCT01290341|366206946|FG000|Overall Study|Protocol Violation|7|||
106149057|NCT01290341|366206947|FG001|Overall Study|Protocol Violation|3|||
106149058|NCT01290341|366206946|FG000|Overall Study|Adverse Event|1|||
105833890|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
105833891|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
105833892|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
105833893|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
105833894|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
105833895|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
105833896|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
105833897|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
105833898|NCT02250651|365048721|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
105833899|NCT02250651|365048722|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
105833900|NCT02250651|365048723|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
105833901|NCT02250651|365048721|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
105833902|NCT02250651|365048722|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
105833903|NCT02250651|365048723|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
105833904|NCT02250651|365048721|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
105833905|NCT02250651|365048722|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
105833906|NCT02250651|365048723|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
105833907|NCT02250651|365048721|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
105833908|NCT02250651|365048722|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
105833909|NCT02250651|365048723|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
105833910|NCT02250651|365048721|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
105833911|NCT02250651|365048722|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
105833912|NCT02250651|365048723|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
105833913|NCT01438476|365048724|FG000|Overall Study|Protocol Violation|1|||
105833914|NCT01438476|365048725|FG001|Overall Study|Protocol Violation|0|||
105833915|NCT01438476|365048724|FG000|Overall Study|Withdrawal by Subject|1|||
105833916|NCT01438476|365048725|FG001|Overall Study|Withdrawal by Subject|0|||
105833917|NCT01438476|365048724|FG000|Overall Study|No Surgery- Disease|8|||
105833918|NCT01438476|365048725|FG001|Overall Study|No Surgery- Disease|10|||
105833919|NCT01438476|365048724|FG000|Overall Study|Communication barrier|0|||
105833920|NCT01438476|365048725|FG001|Overall Study|Communication barrier|1|||
105833921|NCT03310619|365048726|FG000|Pre-Treatment Period|Death|1|||
105833922|NCT03310619|365048727|FG001|Pre-Treatment Period|Death|0|||
105833923|NCT03310619|365048728|FG002|Pre-Treatment Period|Death|0|||
105833924|NCT03310619|365048729|FG003|Pre-Treatment Period|Death|0|||
105833925|NCT03310619|365048730|FG004|Pre-Treatment Period|Death|1|||
105833926|NCT03310619|365048731|FG005|Pre-Treatment Period|Death|0|||
105833927|NCT03310619|365048732|FG006|Pre-Treatment Period|Death|0|||
105833928|NCT03310619|365048733|FG007|Pre-Treatment Period|Death|0|||
105833929|NCT03310619|365048726|FG000|Pre-Treatment Period|Other reasons|2|||
105833930|NCT03310619|365048727|FG001|Pre-Treatment Period|Other reasons|1|||
105833931|NCT03310619|365048728|FG002|Pre-Treatment Period|Other reasons|2|||
105833932|NCT03310619|365048729|FG003|Pre-Treatment Period|Other reasons|0|||
105833933|NCT03310619|365048730|FG004|Pre-Treatment Period|Other reasons|0|||
105833934|NCT03310619|365048731|FG005|Pre-Treatment Period|Other reasons|0|||
105833935|NCT03310619|365048732|FG006|Pre-Treatment Period|Other reasons|2|||
105833936|NCT03310619|365048733|FG007|Pre-Treatment Period|Other reasons|0|||
105833937|NCT03310619|365048726|FG000|Treatment Period|Death|1|||
105833938|NCT03310619|365048727|FG001|Treatment Period|Death|2|||
105833939|NCT03310619|365048728|FG002|Treatment Period|Death|0|||
105833940|NCT03310619|365048729|FG003|Treatment Period|Death|0|||
105833941|NCT03310619|365048730|FG004|Treatment Period|Death|1|||
105833942|NCT03310619|365048731|FG005|Treatment Period|Death|0|||
105833943|NCT03310619|365048732|FG006|Treatment Period|Death|2|||
105833944|NCT03310619|365048733|FG007|Treatment Period|Death|0|||
105833945|NCT03310619|365048726|FG000|Treatment Period|Adverse Event|0|||
105833946|NCT03310619|365048727|FG001|Treatment Period|Adverse Event|1|||
105833947|NCT03310619|365048728|FG002|Treatment Period|Adverse Event|4|||
105833948|NCT03310619|365048729|FG003|Treatment Period|Adverse Event|1|||
105964966|NCT04382586|365530285|FG000|Overall Study|Physician Decision|0|||
105833949|NCT03310619|365048730|FG004|Treatment Period|Adverse Event|0|||
105833950|NCT03310619|365048731|FG005|Treatment Period|Adverse Event|0|||
105833951|NCT03310619|365048732|FG006|Treatment Period|Adverse Event|0|||
105833952|NCT03310619|365048733|FG007|Treatment Period|Adverse Event|0|||
105833953|NCT03310619|365048726|FG000|Treatment Period|Withdrawal by participant|0|||
105833954|NCT03310619|365048727|FG001|Treatment Period|Withdrawal by participant|0|||
105833955|NCT03310619|365048728|FG002|Treatment Period|Withdrawal by participant|1|||
105833956|NCT03310619|365048729|FG003|Treatment Period|Withdrawal by participant|0|||
105833957|NCT03310619|365048730|FG004|Treatment Period|Withdrawal by participant|0|||
105833958|NCT03310619|365048731|FG005|Treatment Period|Withdrawal by participant|0|||
105833959|NCT03310619|365048732|FG006|Treatment Period|Withdrawal by participant|0|||
105833960|NCT03310619|365048733|FG007|Treatment Period|Withdrawal by participant|0|||
105833961|NCT03310619|365048726|FG000|Treatment Period|Lost to Follow-up|0|||
105833962|NCT03310619|365048727|FG001|Treatment Period|Lost to Follow-up|0|||
105833963|NCT03310619|365048728|FG002|Treatment Period|Lost to Follow-up|0|||
105833964|NCT03310619|365048729|FG003|Treatment Period|Lost to Follow-up|0|||
105833965|NCT03310619|365048730|FG004|Treatment Period|Lost to Follow-up|0|||
105833966|NCT03310619|365048731|FG005|Treatment Period|Lost to Follow-up|0|||
105833967|NCT03310619|365048732|FG006|Treatment Period|Lost to Follow-up|0|||
105833968|NCT03310619|365048733|FG007|Treatment Period|Lost to Follow-up|1|||
105833969|NCT03310619|365048726|FG000|Treatment Period|Study terminated by sponsor|0|||
105833970|NCT03310619|365048727|FG001|Treatment Period|Study terminated by sponsor|0|||
105833971|NCT03310619|365048728|FG002|Treatment Period|Study terminated by sponsor|0|||
105833972|NCT03310619|365048729|FG003|Treatment Period|Study terminated by sponsor|0|||
105833973|NCT03310619|365048730|FG004|Treatment Period|Study terminated by sponsor|0|||
105833974|NCT03310619|365048731|FG005|Treatment Period|Study terminated by sponsor|0|||
105833975|NCT03310619|365048732|FG006|Treatment Period|Study terminated by sponsor|0|||
105833976|NCT03310619|365048733|FG007|Treatment Period|Study terminated by sponsor|1|||
105833977|NCT03310619|365048726|FG000|Treatment Period|Physician Decision|0|||
105833978|NCT03310619|365048727|FG001|Treatment Period|Physician Decision|0|||
105833979|NCT03310619|365048728|FG002|Treatment Period|Physician Decision|0|||
105833980|NCT03310619|365048729|FG003|Treatment Period|Physician Decision|0|||
105833981|NCT03310619|365048730|FG004|Treatment Period|Physician Decision|3|||
105833982|NCT03310619|365048731|FG005|Treatment Period|Physician Decision|0|||
105833983|NCT03310619|365048732|FG006|Treatment Period|Physician Decision|0|||
105833984|NCT03310619|365048733|FG007|Treatment Period|Physician Decision|0|||
105833985|NCT03310619|365048726|FG000|Treatment Period|Other reasons|1|||
105833986|NCT03310619|365048727|FG001|Treatment Period|Other reasons|0|||
105833987|NCT03310619|365048728|FG002|Treatment Period|Other reasons|2|||
105833988|NCT03310619|365048729|FG003|Treatment Period|Other reasons|0|||
105833989|NCT03310619|365048730|FG004|Treatment Period|Other reasons|0|||
105833990|NCT03310619|365048731|FG005|Treatment Period|Other reasons|0|||
105833991|NCT03310619|365048732|FG006|Treatment Period|Other reasons|0|||
105833992|NCT03310619|365048733|FG007|Treatment Period|Other reasons|0|||
106149059|NCT01290341|366206947|FG001|Overall Study|Adverse Event|0|||
106149060|NCT01290341|366206946|FG000|Overall Study|Lost to Follow-up|21|||
106149061|NCT01290341|366206947|FG001|Overall Study|Lost to Follow-up|10|||
105833993|NCT04979858|365048734|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
105833994|NCT04979858|365048735|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
105833995|NCT04974580|365048736|FG000|Overall Study|Lost to Follow-up|33|||
105833996|NCT04974580|365048737|FG001|Overall Study|Lost to Follow-up|39|||
105833997|NCT04974580|365048738|FG002|Overall Study|Lost to Follow-up|30|||
105833998|NCT04974580|365048739|FG003|Overall Study|Lost to Follow-up|29|||
105833999|NCT00398073|365048742|FG000|Overall Study|Withdrawal by Subject|1|||
105834000|NCT00398073|365048743|FG001|Overall Study|Withdrawal by Subject|0|||
105964967|NCT04382586|365530286|FG001|Overall Study|Physician Decision|3|||
105964968|NCT03335150|365530288|FG000|Overall Study|Withdrawal by Subject|10|||
105964969|NCT03335150|365530289|FG001|Overall Study|Withdrawal by Subject|4|||
105964970|NCT03335150|365530288|FG000|Overall Study|Adverse Event|0|||
105964971|NCT03335150|365530289|FG001|Overall Study|Adverse Event|1|||
105964972|NCT00349349|365530290|FG000|Overall Study|Adverse Event|5|||
105964973|NCT00349349|365530291|FG001|Overall Study|Adverse Event|6|||
105964974|NCT00349349|365530292|FG002|Overall Study|Adverse Event|2|||
105964975|NCT00349349|365530290|FG000|Overall Study|Withdrawal by Subject|5|||
105964976|NCT00349349|365530291|FG001|Overall Study|Withdrawal by Subject|2|||
105964977|NCT00349349|365530292|FG002|Overall Study|Withdrawal by Subject|1|||
105964978|NCT00349349|365530290|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
105834001|NCT00879684|365048747|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
105834002|NCT00879684|365048748|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
105834003|NCT00879684|365048749|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
105834004|NCT00879684|365048750|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
105834005|NCT00879684|365048751|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
105834006|NCT00879684|365048752|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
105964979|NCT00349349|365530291|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
105834007|NCT00879684|365048753|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
105964980|NCT00349349|365530292|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
105834008|NCT00879684|365048747|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
105834009|NCT00879684|365048748|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
105834010|NCT00879684|365048749|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
105834011|NCT00879684|365048750|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
105834012|NCT00879684|365048751|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
105834013|NCT00879684|365048752|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
105834014|NCT00879684|365048753|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
105834015|NCT00879684|365048747|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834016|NCT00879684|365048748|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834017|NCT00879684|365048749|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
105834018|NCT00879684|365048750|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
105834019|NCT00879684|365048751|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834020|NCT00879684|365048752|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834021|NCT00879684|365048753|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
105834022|NCT00879684|365048747|FG000|Stage 1: Dose Escalation|Death|0|||
105834023|NCT00879684|365048748|FG001|Stage 1: Dose Escalation|Death|0|||
105834024|NCT00879684|365048749|FG002|Stage 1: Dose Escalation|Death|1|||
105834025|NCT00879684|365048750|FG003|Stage 1: Dose Escalation|Death|0|||
105834026|NCT00879684|365048751|FG004|Stage 1: Dose Escalation|Death|0|||
105834027|NCT00879684|365048752|FG005|Stage 1: Dose Escalation|Death|0|||
105834028|NCT00879684|365048753|FG006|Stage 1: Dose Escalation|Death|0|||
105834029|NCT00879684|365048747|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834030|NCT00879684|365048748|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834031|NCT00879684|365048749|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834032|NCT00879684|365048750|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834033|NCT00879684|365048751|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834034|NCT00879684|365048752|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
105834035|NCT00879684|365048753|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
105834036|NCT00879684|365048747|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834037|NCT00879684|365048748|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834038|NCT00879684|365048749|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834039|NCT00879684|365048750|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834040|NCT00879684|365048751|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834041|NCT00879684|365048752|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
105834042|NCT00879684|365048753|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
105834043|NCT00879684|365048747|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834044|NCT00879684|365048748|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834045|NCT00879684|365048749|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834046|NCT00879684|365048750|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834047|NCT00879684|365048751|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834048|NCT00879684|365048752|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
105834049|NCT00879684|365048753|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
105834050|NCT01160640|365048754|FG000|Overall Study|Physician Decision|3|||
105834051|NCT01160640|365048755|FG001|Overall Study|Physician Decision|3|||
105834052|NCT01160640|365048754|FG000|Overall Study|Incarceration|1|||
105834053|NCT01160640|365048755|FG001|Overall Study|Incarceration|0|||
105834054|NCT01160640|365048754|FG000|Overall Study|Withdrawal by Subject|0|||
105834055|NCT01160640|365048755|FG001|Overall Study|Withdrawal by Subject|3|||
105834056|NCT01148225|365048764|FG000|Overall Study|Other|185|||
105834057|NCT04148287|365048765|FG000|Overall Study|Death|2|||
105834058|NCT02490800|365048766|FG000|Overall Study|Adverse Event|0|||
105834059|NCT02490800|365048767|FG001|Overall Study|Adverse Event|0|||
105834060|NCT02490800|365048768|FG002|Overall Study|Adverse Event|0|||
105834061|NCT02490800|365048769|FG003|Overall Study|Adverse Event|2|||
105834062|NCT02490800|365048770|FG004|Overall Study|Adverse Event|3|||
105834063|NCT02490800|365048771|FG005|Overall Study|Adverse Event|2|||
105834064|NCT02490800|365048772|FG006|Overall Study|Adverse Event|0|||
105834065|NCT02490800|365048773|FG007|Overall Study|Adverse Event|0|||
105834066|NCT02490800|365048774|FG008|Overall Study|Adverse Event|0|||
105834067|NCT02490800|365048775|FG009|Overall Study|Adverse Event|0|||
105834068|NCT02490800|365048776|FG010|Overall Study|Adverse Event|0|||
105834069|NCT02490800|365048777|FG011|Overall Study|Adverse Event|2|||
105834070|NCT02490800|365048778|FG012|Overall Study|Adverse Event|2|||
105834071|NCT02490800|365048766|FG000|Overall Study|Withdrawal by Subject|0|||
105834072|NCT02490800|365048767|FG001|Overall Study|Withdrawal by Subject|0|||
105834073|NCT02490800|365048768|FG002|Overall Study|Withdrawal by Subject|0|||
105834074|NCT02490800|365048769|FG003|Overall Study|Withdrawal by Subject|1|||
105834075|NCT02490800|365048770|FG004|Overall Study|Withdrawal by Subject|0|||
105834076|NCT02490800|365048771|FG005|Overall Study|Withdrawal by Subject|0|||
105834077|NCT02490800|365048772|FG006|Overall Study|Withdrawal by Subject|0|||
105834078|NCT02490800|365048773|FG007|Overall Study|Withdrawal by Subject|0|||
105834079|NCT02490800|365048774|FG008|Overall Study|Withdrawal by Subject|1|||
105834080|NCT02490800|365048775|FG009|Overall Study|Withdrawal by Subject|0|||
105834081|NCT02490800|365048776|FG010|Overall Study|Withdrawal by Subject|0|||
105834082|NCT02490800|365048777|FG011|Overall Study|Withdrawal by Subject|0|||
105834083|NCT02490800|365048778|FG012|Overall Study|Withdrawal by Subject|0|||
105834084|NCT02490800|365048766|FG000|Overall Study|Progressive disease|3|||
105834085|NCT02490800|365048767|FG001|Overall Study|Progressive disease|3|||
105834086|NCT02490800|365048768|FG002|Overall Study|Progressive disease|3|||
105834087|NCT02490800|365048769|FG003|Overall Study|Progressive disease|4|||
105834088|NCT02490800|365048770|FG004|Overall Study|Progressive disease|4|||
105834089|NCT02490800|365048771|FG005|Overall Study|Progressive disease|1|||
105834090|NCT02490800|365048772|FG006|Overall Study|Progressive disease|4|||
105834091|NCT02490800|365048773|FG007|Overall Study|Progressive disease|3|||
105834092|NCT02490800|365048774|FG008|Overall Study|Progressive disease|6|||
105834093|NCT02490800|365048775|FG009|Overall Study|Progressive disease|2|||
105834094|NCT02490800|365048776|FG010|Overall Study|Progressive disease|7|||
105834095|NCT02490800|365048777|FG011|Overall Study|Progressive disease|1|||
105834096|NCT02490800|365048778|FG012|Overall Study|Progressive disease|10|||
105834097|NCT02490800|365048766|FG000|Overall Study|Patient enrolled in post-trial access|0|||
105834098|NCT02490800|365048767|FG001|Overall Study|Patient enrolled in post-trial access|0|||
105834099|NCT02490800|365048768|FG002|Overall Study|Patient enrolled in post-trial access|0|||
105834100|NCT02490800|365048769|FG003|Overall Study|Patient enrolled in post-trial access|0|||
105834101|NCT02490800|365048770|FG004|Overall Study|Patient enrolled in post-trial access|0|||
105834102|NCT02490800|365048771|FG005|Overall Study|Patient enrolled in post-trial access|0|||
105834103|NCT02490800|365048772|FG006|Overall Study|Patient enrolled in post-trial access|0|||
105834104|NCT02490800|365048773|FG007|Overall Study|Patient enrolled in post-trial access|0|||
105834105|NCT02490800|365048774|FG008|Overall Study|Patient enrolled in post-trial access|0|||
105834106|NCT02490800|365048775|FG009|Overall Study|Patient enrolled in post-trial access|1|||
105834107|NCT02490800|365048776|FG010|Overall Study|Patient enrolled in post-trial access|1|||
105834108|NCT02490800|365048777|FG011|Overall Study|Patient enrolled in post-trial access|0|||
105834109|NCT02490800|365048778|FG012|Overall Study|Patient enrolled in post-trial access|6|||
105834110|NCT01214239|365048779|FG000|Overall Study|Adverse Event|3|||
105834111|NCT01214239|365048780|FG001|Overall Study|Adverse Event|4|||
105834112|NCT01214239|365048779|FG000|Overall Study|Protocol Violation|2|||
105834113|NCT01214239|365048780|FG001|Overall Study|Protocol Violation|1|||
105834114|NCT01214239|365048779|FG000|Overall Study|Lost to Follow-up|1|||
105834115|NCT01214239|365048780|FG001|Overall Study|Lost to Follow-up|1|||
105834116|NCT01214239|365048779|FG000|Overall Study|Withdrawal by Subject|4|||
105834117|NCT01214239|365048780|FG001|Overall Study|Withdrawal by Subject|9|||
105834118|NCT01214239|365048779|FG000|Overall Study|Lack of Efficacy|1|||
105834119|NCT01214239|365048780|FG001|Overall Study|Lack of Efficacy|2|||
105834120|NCT01214239|365048779|FG000|Overall Study|patient's private reason|1|||
105834121|NCT01214239|365048780|FG001|Overall Study|patient's private reason|1|||
105834122|NCT01049581|365048781|FG000|Overall Study|Lost to Follow-up|2|||
105834123|NCT01049581|365048782|FG001|Overall Study|Lost to Follow-up|1|||
105834124|NCT02625974|365048786|FG000|Part 1|Lost to Follow-up|9|||
105834125|NCT02625974|365048787|FG001|Part 1|Lost to Follow-up|3|||
105834126|NCT02625974|365048786|FG000|Part 2|Lost to Follow-up|4|||
105834127|NCT02625974|365048787|FG001|Part 2|Lost to Follow-up|6|||
105834128|NCT02625974|365048786|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
105834129|NCT02625974|365048787|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
105834130|NCT05068284|365048792|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
105834131|NCT05068284|365048793|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
105834132|NCT05068284|365048794|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834133|NCT05068284|365048795|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834134|NCT05068284|365048796|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834135|NCT05068284|365048797|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834136|NCT05068284|365048798|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834137|NCT05068284|365048799|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
105834138|NCT05068284|365048792|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834139|NCT05068284|365048793|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834140|NCT05068284|365048794|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
105834141|NCT05068284|365048795|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834142|NCT05068284|365048796|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834143|NCT05068284|365048797|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834144|NCT05068284|365048798|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834145|NCT05068284|365048799|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
105834146|NCT05068284|365048792|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
105834147|NCT05068284|365048793|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
105834148|NCT05068284|365048794|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
105834149|NCT05068284|365048795|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
105834150|NCT05068284|365048796|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
106149062|NCT01290341|366206946|FG000|Overall Study|Withdrawal by Subject|19|||
106149063|NCT01290341|366206947|FG001|Overall Study|Withdrawal by Subject|5|||
106149064|NCT01290341|366206946|FG000|Overall Study|Negative baseline culture and others|44|||
106149065|NCT01290341|366206947|FG001|Overall Study|Negative baseline culture and others|11|||
106149066|NCT03988023|366206951|FG000|Overall Study|Non-compliance|3|||
106149067|NCT03988023|366206952|FG001|Overall Study|Non-compliance|0|||
106149068|NCT03988023|366206951|FG000|Overall Study|Withdrawal by Subject|39|||
106149069|NCT03988023|366206952|FG001|Overall Study|Withdrawal by Subject|37|||
106149070|NCT03988023|366206951|FG000|Overall Study|Adverse Event|0|||
106149071|NCT03988023|366206952|FG001|Overall Study|Adverse Event|2|||
106149072|NCT03988023|366206951|FG000|Overall Study|Physician Decision|0|||
106149073|NCT03988023|366206952|FG001|Overall Study|Physician Decision|1|||
106149074|NCT03988023|366206951|FG000|Overall Study|Lost to Follow-up|5|||
106149075|NCT03988023|366206952|FG001|Overall Study|Lost to Follow-up|8|||
106149076|NCT03988023|366206951|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
106149077|NCT03988023|366206952|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
106149078|NCT03988023|366206951|FG000|Overall Study|Lack of Efficacy|3|||
106149079|NCT03988023|366206952|FG001|Overall Study|Lack of Efficacy|1|||
106149080|NCT03988023|366206951|FG000|Overall Study|COVID-19 pandemic|225|||
106149081|NCT03988023|366206952|FG001|Overall Study|COVID-19 pandemic|227|||
106149082|NCT02101281|366206953|FG000|Overall Study|Adverse Event|0|||
106149083|NCT02101281|366206954|FG001|Overall Study|Adverse Event|1|||
106149084|NCT03403413|366206955|FG000|Overall Study|Lack of Efficacy|2|||
106149085|NCT02374307|366206958|FG000|3-months Follow-up|Lost to Follow-up|1|||
106149086|NCT02374307|366206959|FG001|3-months Follow-up|Lost to Follow-up|2|||
105834151|NCT05068284|365048797|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
105834152|NCT05068284|365048798|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
105834153|NCT05068284|365048799|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
105834154|NCT05068284|365048792|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834155|NCT05068284|365048793|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834156|NCT05068284|365048794|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
105834157|NCT05068284|365048795|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834158|NCT05068284|365048796|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
105834159|NCT05068284|365048797|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834160|NCT05068284|365048798|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834161|NCT05068284|365048799|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
105834162|NCT05068284|365048792|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834163|NCT05068284|365048793|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834164|NCT05068284|365048794|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834165|NCT05068284|365048795|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
105834166|NCT05068284|365048796|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834167|NCT05068284|365048797|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105964981|NCT00349349|365530290|FG000|Overall Study|Death|13|||
105964982|NCT00349349|365530291|FG001|Overall Study|Death|10|||
106149087|NCT02374307|366206958|FG000|3-months Follow-up|Withdrawal by Subject|1|||
106149088|NCT02374307|366206959|FG001|3-months Follow-up|Withdrawal by Subject|4|||
106149089|NCT02374307|366206958|FG000|3-months Follow-up|Death|1|||
106149090|NCT02374307|366206959|FG001|3-months Follow-up|Death|2|||
106149091|NCT02374307|366206958|FG000|3-months Follow-up|Missed first follow-up|5|||
106149092|NCT02374307|366206959|FG001|3-months Follow-up|Missed first follow-up|1|||
106149093|NCT02374307|366206958|FG000|6-months Follow-up|Lost to Follow-up|1|||
105964983|NCT00349349|365530292|FG002|Overall Study|Death|1|||
105964984|NCT00349349|365530290|FG000|Overall Study|Other Treatment Selected|2|||
105964985|NCT00349349|365530291|FG001|Overall Study|Other Treatment Selected|0|||
105964986|NCT00349349|365530292|FG002|Overall Study|Other Treatment Selected|0|||
105964987|NCT00349349|365530290|FG000|Overall Study|Participant Reduced General Condition|0|||
105964988|NCT00349349|365530291|FG001|Overall Study|Participant Reduced General Condition|1|||
105964989|NCT00349349|365530292|FG002|Overall Study|Participant Reduced General Condition|0|||
105964990|NCT00349349|365530290|FG000|Overall Study|Physician Decision|1|||
105964991|NCT00349349|365530291|FG001|Overall Study|Physician Decision|2|||
105964992|NCT00349349|365530292|FG002|Overall Study|Physician Decision|1|||
105964993|NCT00349349|365530290|FG000|Overall Study|No Response|0|||
105964994|NCT00349349|365530291|FG001|Overall Study|No Response|3|||
105964995|NCT00349349|365530292|FG002|Overall Study|No Response|0|||
105964996|NCT00349349|365530290|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
105964997|NCT00349349|365530291|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
105964998|NCT00349349|365530292|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
105964999|NCT02097719|365530294|FG000|Overall Study|Subject Withdrew Consent|1|||
105965000|NCT02097719|365530295|FG001|Overall Study|Subject Withdrew Consent|0|||
105965001|NCT02097719|365530294|FG000|Overall Study|Lost to Follow-up|0|||
106149094|NCT02374307|366206959|FG001|6-months Follow-up|Lost to Follow-up|2|||
105834168|NCT05068284|365048798|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
105834169|NCT05068284|365048799|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
106022999|NCT02891070|365750274|FG001|Overall Study|Withdrawal by Subject|2|||
106023000|NCT02891070|365750273|FG000|Overall Study|Death|3|||
106023001|NCT02891070|365750274|FG001|Overall Study|Death|0|||
106023002|NCT03539549|365750279|FG000|Overall Study|Adverse Event|12|||
106023003|NCT03539549|365750279|FG000|Overall Study|Lost to Follow-up|1|||
106023004|NCT03539549|365750279|FG000|Overall Study|Death|2|||
106023005|NCT03539549|365750279|FG000|Overall Study|Progressive Disease|1|||
106023006|NCT03539549|365750279|FG000|Overall Study|Reason not Specified|1|||
106023007|NCT02405442|365750280|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
106023008|NCT02405442|365750281|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
106023009|NCT02405442|365750282|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
106023010|NCT02405442|365750283|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
106023011|NCT02405442|365750280|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
106023012|NCT02405442|365750281|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
106023013|NCT02405442|365750282|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
106023014|NCT02405442|365750283|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
106023015|NCT02405442|365750280|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
106023016|NCT02405442|365750281|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
106023017|NCT02405442|365750282|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
106023018|NCT02405442|365750283|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
106023019|NCT02405442|365750280|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
106023020|NCT02405442|365750281|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
106023021|NCT02405442|365750282|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
106023022|NCT02405442|365750283|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
106023023|NCT02405442|365750280|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
106023024|NCT02405442|365750281|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
106023025|NCT02405442|365750282|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
106023026|NCT02405442|365750283|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
106023027|NCT02405442|365750280|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
106023028|NCT02405442|365750281|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
106023029|NCT02405442|365750282|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
106023030|NCT02405442|365750283|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
106023031|NCT02405442|365750280|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
106023032|NCT02405442|365750281|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
106023033|NCT02405442|365750282|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
106023034|NCT02405442|365750283|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
106023035|NCT02405442|365750280|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
106023036|NCT02405442|365750281|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
106023037|NCT02405442|365750282|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
106023038|NCT02405442|365750283|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
106023039|NCT02405442|365750280|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
106023040|NCT02405442|365750281|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
106023041|NCT02405442|365750282|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
106023042|NCT02405442|365750283|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
106023043|NCT02405442|365750280|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
106023044|NCT02405442|365750281|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
106023045|NCT02405442|365750282|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
106023046|NCT02405442|365750283|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
106023047|NCT02405442|365750280|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
106023048|NCT02405442|365750281|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
106023049|NCT02405442|365750282|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
106023050|NCT02405442|365750283|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
106023051|NCT02405442|365750280|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
106023052|NCT02405442|365750281|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
106023053|NCT02405442|365750282|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
106023054|NCT02405442|365750283|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
106023055|NCT02405442|365750280|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
106023056|NCT02405442|365750281|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
106023057|NCT02405442|365750282|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
106149095|NCT02374307|366206958|FG000|6-months Follow-up|Death|2|||
105834170|NCT05068284|365048792|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
106023058|NCT02405442|365750283|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
106149096|NCT02374307|366206959|FG001|6-months Follow-up|Death|1|||
106149097|NCT02374307|366206958|FG000|6-months Follow-up|Withdrawal by Subject|0|||
106149098|NCT02374307|366206959|FG001|6-months Follow-up|Withdrawal by Subject|3|||
106149099|NCT00999167|366206962|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
106149100|NCT00999167|366206963|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
106149101|NCT00999167|366206964|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
106149102|NCT00999167|366206962|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
106149103|NCT00999167|366206963|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
106149104|NCT00999167|366206964|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
106149105|NCT00999167|366206962|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
106149106|NCT00999167|366206963|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
106149107|NCT00999167|366206964|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
106149108|NCT00999167|366206962|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
106149109|NCT00999167|366206963|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
105834171|NCT05068284|365048793|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105834172|NCT05068284|365048794|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
105834173|NCT05068284|365048795|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
105834174|NCT05068284|365048796|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105834175|NCT05068284|365048797|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105834176|NCT05068284|365048798|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
106149110|NCT00999167|366206964|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
106149111|NCT00999167|366206962|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
106149112|NCT00999167|366206963|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
105834177|NCT05068284|365048799|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
105834178|NCT05068284|365048792|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834179|NCT05068284|365048793|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834180|NCT05068284|365048794|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
105834181|NCT05068284|365048795|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834182|NCT05068284|365048796|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834183|NCT05068284|365048797|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834184|NCT05068284|365048798|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834185|NCT05068284|365048799|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
105834186|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
105834187|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834188|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834189|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834190|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834191|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834192|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834193|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
105834194|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
105834195|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834196|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834197|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834198|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834199|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
105834200|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
105834201|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
105834202|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
105834203|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834204|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834205|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834206|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834207|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834208|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
105834209|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
105834210|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
105834211|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834212|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834213|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834214|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834215|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834216|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834217|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
105834218|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
105834219|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834220|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834221|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105965002|NCT02097719|365530295|FG001|Overall Study|Lost to Follow-up|1|||
105965003|NCT02097719|365530294|FG000|Overall Study|Adverse Event|2|||
105965004|NCT02097719|365530295|FG001|Overall Study|Adverse Event|0|||
105965005|NCT03028415|365530296|FG000|Overall Study|Lost to Follow-up|6|||
105965006|NCT03028415|365530297|FG001|Overall Study|Lost to Follow-up|3|||
105965007|NCT03028415|365530296|FG000|Overall Study|Withdrawal by Subject|1|||
105965008|NCT03028415|365530297|FG001|Overall Study|Withdrawal by Subject|0|||
105965009|NCT03028415|365530296|FG000|Overall Study|Discontinued due to COVID-19|1|||
105965010|NCT03028415|365530297|FG001|Overall Study|Discontinued due to COVID-19|0|||
105965011|NCT01946529|365530303|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
105965012|NCT01946529|365530304|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
105965013|NCT01946529|365530305|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
105965014|NCT01946529|365530303|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
105965015|NCT01946529|365530304|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
105965016|NCT01946529|365530305|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
105965017|NCT00980538|365530306|FG000|Overall Study|Lost to Follow-up|20|||
105965018|NCT00980538|365530306|FG000|Overall Study|Sponsor's Decision|4|||
105965019|NCT00980538|365530306|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
105965020|NCT00980538|365530306|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
105965021|NCT00980538|365530306|FG000|Overall Study|Switch to Commercially Available Medication|25|||
105965022|NCT00980538|365530306|FG000|Overall Study|Participant Non-Compliant|9|||
105965023|NCT00980538|365530306|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
105965024|NCT00980538|365530306|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
105965025|NCT00980538|365530306|FG000|Overall Study|Other|60|||
105965026|NCT00980538|365530306|FG000|Overall Study|Other|1|||
106023059|NCT02405442|365750280|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
106023060|NCT02405442|365750281|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
106023061|NCT02405442|365750282|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
106023062|NCT02405442|365750283|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
106023063|NCT02078960|365750285|FG000|Treatment Period|Other|0|||
106023064|NCT02078960|365750286|FG001|Treatment Period|Other|0|||
106023065|NCT02078960|365750287|FG002|Treatment Period|Other|1|||
106023066|NCT02078960|365750285|FG000|Treatment Period|Lack of Efficacy|0|||
106023067|NCT02078960|365750286|FG001|Treatment Period|Lack of Efficacy|1|||
106023068|NCT02078960|365750287|FG002|Treatment Period|Lack of Efficacy|0|||
106023069|NCT02078960|365750285|FG000|Treatment Period|Disease progression - accelerated phase|0|||
106023070|NCT02078960|365750286|FG001|Treatment Period|Disease progression - accelerated phase|1|||
106023071|NCT02078960|365750287|FG002|Treatment Period|Disease progression - accelerated phase|0|||
106023072|NCT02078960|365750285|FG000|Treatment Period|Disease progression - blast phase|1|||
106023073|NCT02078960|365750286|FG001|Treatment Period|Disease progression - blast phase|0|||
106023074|NCT02078960|365750287|FG002|Treatment Period|Disease progression - blast phase|0|||
106023075|NCT02078960|365750285|FG000|Treatment Period|Withdrawal by Subject|0|||
106023076|NCT02078960|365750286|FG001|Treatment Period|Withdrawal by Subject|1|||
106023077|NCT02078960|365750287|FG002|Treatment Period|Withdrawal by Subject|1|||
106023078|NCT02078960|365750285|FG000|Treatment Period|Adverse Event|1|||
106023079|NCT02078960|365750286|FG001|Treatment Period|Adverse Event|0|||
106023080|NCT02078960|365750287|FG002|Treatment Period|Adverse Event|0|||
106023081|NCT02078960|365750285|FG000|Treatment Period|Death|0|||
106023082|NCT02078960|365750286|FG001|Treatment Period|Death|0|||
106023083|NCT02078960|365750287|FG002|Treatment Period|Death|1|||
106149113|NCT00999167|366206964|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
105965027|NCT01108731|365530307|FG000|Overall Study|Withdrawal by Subject|1|||
105965028|NCT01108731|365530308|FG001|Overall Study|Withdrawal by Subject|1|||
105965029|NCT01108731|365530307|FG000|Overall Study|Adverse Event|3|||
105965030|NCT01108731|365530308|FG001|Overall Study|Adverse Event|3|||
105965031|NCT03802630|365530309|FG000|Overall Study|Study terminated by sponsor|130|||
105965032|NCT03802630|365530310|FG001|Overall Study|Study terminated by sponsor|134|||
105965033|NCT03802630|365530309|FG000|Overall Study|Subject decision|16|||
106023084|NCT02078960|365750285|FG000|Follow-up Period|Death|2|||
106023085|NCT02078960|365750286|FG001|Follow-up Period|Death|0|||
106023086|NCT02078960|365750287|FG002|Follow-up Period|Death|0|||
106023087|NCT02078960|365750285|FG000|Follow-up Period|Lost to Follow-up|0|||
106023088|NCT02078960|365750286|FG001|Follow-up Period|Lost to Follow-up|1|||
105965034|NCT03802630|365530310|FG001|Overall Study|Subject decision|9|||
105965035|NCT03802630|365530309|FG000|Overall Study|Adverse Event|3|||
105965036|NCT03802630|365530310|FG001|Overall Study|Adverse Event|1|||
105965037|NCT03802630|365530309|FG000|Overall Study|Lost to Follow-up|2|||
105965038|NCT03802630|365530310|FG001|Overall Study|Lost to Follow-up|2|||
105965039|NCT03802630|365530309|FG000|Overall Study|Physician Decision|2|||
105965040|NCT03802630|365530310|FG001|Overall Study|Physician Decision|0|||
105965041|NCT03802630|365530309|FG000|Overall Study|Death|0|||
105965042|NCT03802630|365530310|FG001|Overall Study|Death|2|||
105965043|NCT01063062|365530311|FG000|Overall Study|Patient withdrew consent|0|||
105965044|NCT01063062|365530312|FG001|Overall Study|Patient withdrew consent|1|||
105965045|NCT01063062|365530311|FG000|Overall Study|Adverse Event|2|||
105965046|NCT01063062|365530312|FG001|Overall Study|Adverse Event|4|||
105965047|NCT01063062|365530311|FG000|Overall Study|Protocol Violation|5|||
105965048|NCT01063062|365530312|FG001|Overall Study|Protocol Violation|4|||
105965049|NCT01063062|365530311|FG000|Overall Study|Investigator's request|1|||
105965050|NCT01063062|365530312|FG001|Overall Study|Investigator's request|0|||
105965051|NCT01063062|365530311|FG000|Overall Study|Lost to Follow-up|0|||
105965052|NCT01063062|365530312|FG001|Overall Study|Lost to Follow-up|2|||
105965053|NCT01063062|365530311|FG000|Overall Study|Miscellaneous reason|0|||
105965054|NCT01063062|365530312|FG001|Overall Study|Miscellaneous reason|1|||
105965055|NCT04601532|365530313|FG000|Overall Study|Lost to Follow-up|1|||
105965056|NCT04601532|365530314|FG001|Overall Study|Lost to Follow-up|2|||
105965057|NCT04601532|365530313|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
105965058|NCT04601532|365530314|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
105965059|NCT02597452|365530315|FG000|Overall Study|testing incomplete|30|||
105965060|NCT01352221|365530316|FG000|Double-blind Phase|Adverse Event|6|||
105965061|NCT01352221|365530317|FG001|Double-blind Phase|Adverse Event|4|||
105965062|NCT01352221|365530318|FG002|Double-blind Phase|Adverse Event|0|||
105965063|NCT01352221|365530319|FG003|Double-blind Phase|Adverse Event|0|||
105965064|NCT01352221|365530316|FG000|Double-blind Phase|Withdrawal by Subject|3|||
105965065|NCT01352221|365530317|FG001|Double-blind Phase|Withdrawal by Subject|5|||
105965066|NCT01352221|365530318|FG002|Double-blind Phase|Withdrawal by Subject|0|||
105965067|NCT01352221|365530319|FG003|Double-blind Phase|Withdrawal by Subject|0|||
105965068|NCT01352221|365530316|FG000|Double-blind Phase|Lost to Follow-up|0|||
105965069|NCT01352221|365530317|FG001|Double-blind Phase|Lost to Follow-up|1|||
105965070|NCT01352221|365530318|FG002|Double-blind Phase|Lost to Follow-up|0|||
105965071|NCT01352221|365530319|FG003|Double-blind Phase|Lost to Follow-up|0|||
105965072|NCT01352221|365530316|FG000|Double-blind Phase|Protocol Violation|0|||
105965073|NCT01352221|365530317|FG001|Double-blind Phase|Protocol Violation|1|||
105965074|NCT01352221|365530318|FG002|Double-blind Phase|Protocol Violation|0|||
105965075|NCT01352221|365530319|FG003|Double-blind Phase|Protocol Violation|0|||
105965076|NCT01352221|365530316|FG000|Open-label Phase|Physician Decision|0|||
105965077|NCT01352221|365530317|FG001|Open-label Phase|Physician Decision|0|||
105965078|NCT01352221|365530318|FG002|Open-label Phase|Physician Decision|2|||
105965079|NCT01352221|365530319|FG003|Open-label Phase|Physician Decision|1|||
105965080|NCT01352221|365530316|FG000|Open-label Phase|Pregnancy|0|||
105965081|NCT01352221|365530317|FG001|Open-label Phase|Pregnancy|0|||
105965082|NCT01352221|365530318|FG002|Open-label Phase|Pregnancy|1|||
105965083|NCT01352221|365530319|FG003|Open-label Phase|Pregnancy|0|||
105965084|NCT01352221|365530316|FG000|Open-label Phase|Adverse Event|0|||
105965085|NCT01352221|365530317|FG001|Open-label Phase|Adverse Event|0|||
105965086|NCT01352221|365530318|FG002|Open-label Phase|Adverse Event|8|||
105965087|NCT01352221|365530319|FG003|Open-label Phase|Adverse Event|4|||
105965088|NCT01352221|365530316|FG000|Open-label Phase|Withdrawal by Subject|0|||
105965089|NCT01352221|365530317|FG001|Open-label Phase|Withdrawal by Subject|0|||
105965090|NCT01352221|365530318|FG002|Open-label Phase|Withdrawal by Subject|1|||
105965091|NCT01352221|365530319|FG003|Open-label Phase|Withdrawal by Subject|6|||
105965092|NCT01352221|365530316|FG000|Open-label Phase|Worsening of IBD|0|||
105965093|NCT01352221|365530317|FG001|Open-label Phase|Worsening of IBD|0|||
105965094|NCT01352221|365530318|FG002|Open-label Phase|Worsening of IBD|1|||
105965095|NCT01352221|365530319|FG003|Open-label Phase|Worsening of IBD|0|||
105965096|NCT02566785|365530320|FG000|Overall Study|Lost to Follow-up|0|||
105965097|NCT02566785|365530321|FG001|Overall Study|Lost to Follow-up|2|||
105965098|NCT02566785|365530320|FG000|Overall Study|Worsening condition|1|||
105965099|NCT02566785|365530321|FG001|Overall Study|Worsening condition|1|||
105965100|NCT03108521|365530322|FG000|Overall Study|Lost to Follow-up|3|||
105965101|NCT03108521|365530323|FG001|Overall Study|Lost to Follow-up|0|||
105965102|NCT03108521|365530322|FG000|Overall Study|Lack of Efficacy|2|||
105965103|NCT03108521|365530323|FG001|Overall Study|Lack of Efficacy|0|||
105965104|NCT03108521|365530322|FG000|Overall Study|Physician Decision|4|||
105965105|NCT03108521|365530323|FG001|Overall Study|Physician Decision|0|||
105965106|NCT03108521|365530322|FG000|Overall Study|Adverse Event|3|||
105965107|NCT03108521|365530323|FG001|Overall Study|Adverse Event|0|||
105965108|NCT00875485|365532194|FG000|Challenge Dose Epoch|Pregnancy|1|||
105965109|NCT00875485|365532195|FG001|Challenge Dose Epoch|Pregnancy|0|||
105965110|NCT02712983|365532196|FG000|Treatment Phase|Adverse Event|3|||
105965111|NCT02712983|365532197|FG001|Treatment Phase|Adverse Event|1|||
105965112|NCT02712983|365532198|FG002|Treatment Phase|Adverse Event|1|||
105965113|NCT02712983|365532199|FG003|Treatment Phase|Adverse Event|4|||
105965114|NCT02712983|365532200|FG004|Treatment Phase|Adverse Event|3|||
105965115|NCT02712983|365532201|FG005|Treatment Phase|Adverse Event|0|||
105965116|NCT02712983|365532202|FG006|Treatment Phase|Adverse Event|6|||
105965117|NCT02712983|365532203|FG007|Treatment Phase|Adverse Event|6|||
105965118|NCT02712983|365532204|FG008|Treatment Phase|Adverse Event|1|||
105965119|NCT02712983|365532196|FG000|Treatment Phase|Protocol Deviation|0|||
105965120|NCT02712983|365532197|FG001|Treatment Phase|Protocol Deviation|0|||
105965121|NCT02712983|365532198|FG002|Treatment Phase|Protocol Deviation|0|||
105834222|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834223|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834224|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105834225|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
105965122|NCT02712983|365532199|FG003|Treatment Phase|Protocol Deviation|2|||
105965123|NCT02712983|365532200|FG004|Treatment Phase|Protocol Deviation|0|||
105965124|NCT02712983|365532201|FG005|Treatment Phase|Protocol Deviation|0|||
105965125|NCT02712983|365532202|FG006|Treatment Phase|Protocol Deviation|1|||
105965126|NCT02712983|365532203|FG007|Treatment Phase|Protocol Deviation|0|||
105965127|NCT02712983|365532204|FG008|Treatment Phase|Protocol Deviation|0|||
105965128|NCT02712983|365532196|FG000|Treatment Phase|Technical Problems|0|||
105965129|NCT02712983|365532197|FG001|Treatment Phase|Technical Problems|0|||
105965130|NCT02712983|365532198|FG002|Treatment Phase|Technical Problems|0|||
105965131|NCT02712983|365532199|FG003|Treatment Phase|Technical Problems|0|||
105965132|NCT02712983|365532200|FG004|Treatment Phase|Technical Problems|0|||
105965133|NCT02712983|365532201|FG005|Treatment Phase|Technical Problems|0|||
105965134|NCT02712983|365532202|FG006|Treatment Phase|Technical Problems|1|||
105965135|NCT02712983|365532203|FG007|Treatment Phase|Technical Problems|0|||
105965136|NCT02712983|365532204|FG008|Treatment Phase|Technical Problems|0|||
105965137|NCT02712983|365532196|FG000|Treatment Phase|Physician Decision|0|||
105965138|NCT02712983|365532197|FG001|Treatment Phase|Physician Decision|0|||
105965139|NCT02712983|365532198|FG002|Treatment Phase|Physician Decision|0|||
105965140|NCT02712983|365532199|FG003|Treatment Phase|Physician Decision|0|||
105965141|NCT02712983|365532200|FG004|Treatment Phase|Physician Decision|0|||
105965142|NCT02712983|365532201|FG005|Treatment Phase|Physician Decision|0|||
105965143|NCT02712983|365532202|FG006|Treatment Phase|Physician Decision|0|||
105965144|NCT02712983|365532203|FG007|Treatment Phase|Physician Decision|1|||
105965145|NCT02712983|365532204|FG008|Treatment Phase|Physician Decision|1|||
105965146|NCT02712983|365532196|FG000|Treatment Phase|Subject Decision|2|||
105965147|NCT02712983|365532197|FG001|Treatment Phase|Subject Decision|0|||
105965148|NCT02712983|365532198|FG002|Treatment Phase|Subject Decision|0|||
105965149|NCT02712983|365532199|FG003|Treatment Phase|Subject Decision|2|||
105965150|NCT02712983|365532200|FG004|Treatment Phase|Subject Decision|1|||
105965151|NCT02712983|365532201|FG005|Treatment Phase|Subject Decision|0|||
105965152|NCT02712983|365532202|FG006|Treatment Phase|Subject Decision|1|||
105965153|NCT02712983|365532203|FG007|Treatment Phase|Subject Decision|2|||
105965154|NCT02712983|365532204|FG008|Treatment Phase|Subject Decision|0|||
105965155|NCT02712983|365532196|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105965156|NCT02712983|365532197|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
105965157|NCT02712983|365532198|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105965158|NCT02712983|365532199|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105965159|NCT02712983|365532200|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105965160|NCT02712983|365532201|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105965161|NCT02712983|365532202|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
105965162|NCT02712983|365532203|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
105965163|NCT02712983|365532204|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
105965164|NCT02712983|365532196|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105965165|NCT02712983|365532197|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105965166|NCT02712983|365532198|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105965167|NCT02712983|365532199|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
105965168|NCT02712983|365532200|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105965169|NCT02712983|365532201|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105965170|NCT02712983|365532202|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105965171|NCT02712983|365532203|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105965172|NCT02712983|365532204|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
105965173|NCT02712983|365532196|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105965174|NCT02712983|365532197|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105965175|NCT02712983|365532198|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105965176|NCT02712983|365532199|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105965177|NCT02712983|365532200|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
106023089|NCT02078960|365750287|FG002|Follow-up Period|Lost to Follow-up|0|||
105834226|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
105834227|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
105834228|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
105834229|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
105834230|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
105834231|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
105834232|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
105834233|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
105834234|NCT05068284|365048792|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834235|NCT05068284|365048793|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834236|NCT05068284|365048794|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834237|NCT05068284|365048795|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834238|NCT05068284|365048796|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834239|NCT05068284|365048797|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834240|NCT05068284|365048798|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
105834241|NCT05068284|365048799|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
105965178|NCT02712983|365532201|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
105965179|NCT02712983|365532202|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
105965180|NCT02712983|365532203|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
105965181|NCT02712983|365532204|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
105834246|NCT00274625|365050176|FG000|Overall Study|Lost to Follow-up|46|||
105834247|NCT00274625|365050177|FG001|Overall Study|Lost to Follow-up|54|||
105834248|NCT00274625|365050176|FG000|Overall Study|Excluded from analysis|14|||
105834249|NCT00274625|365050177|FG001|Overall Study|Excluded from analysis|8|||
105834250|NCT01023061|365050178|FG000|Overall Study|Withdrawal prior to treatment|2|||
105834251|NCT01622660|365050179|FG000|Overall Study|Adverse Event|1|||
105834252|NCT04812548|365050180|FG000|Overall Study|Adverse Event|2|||
105834253|NCT04812548|365050181|FG001|Overall Study|Adverse Event|7|||
105834254|NCT04812548|365050180|FG000|Overall Study|HSCT Planned|2|||
105834255|NCT04812548|365050181|FG001|Overall Study|HSCT Planned|3|||
105834256|NCT04812548|365050180|FG000|Overall Study|Progressive Disease|0|||
105834257|NCT04812548|365050181|FG001|Overall Study|Progressive Disease|2|||
105834258|NCT04812548|365050180|FG000|Overall Study|Death|0|||
105834259|NCT04812548|365050181|FG001|Overall Study|Death|1|||
105834260|NCT04812548|365050180|FG000|Overall Study|Post Study Access to Treatment|0|||
105834261|NCT04812548|365050181|FG001|Overall Study|Post Study Access to Treatment|1|||
105834262|NCT04812548|365050180|FG000|Overall Study|Withdrawal by Subject|0|||
105834263|NCT04812548|365050181|FG001|Overall Study|Withdrawal by Subject|1|||
105834264|NCT04812548|365050180|FG000|Overall Study|Physician Decision|1|||
105834265|NCT04812548|365050181|FG001|Overall Study|Physician Decision|0|||
105834266|NCT01754376|365050183|FG000|Overall Study|Adverse Event|1|||
105834267|NCT01754376|365050183|FG000|Overall Study|Lack of Efficacy|2|||
105834268|NCT04590781|365050184|FG000|Overall Study|Death|0|||
105834269|NCT04590781|365050185|FG001|Overall Study|Death|2|||
105834270|NCT04590781|365050184|FG000|Overall Study|Withdrawal by Subject|2|||
105834271|NCT04590781|365050185|FG001|Overall Study|Withdrawal by Subject|0|||
105834272|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
105834273|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
105965182|NCT01271010|365532205|FG000|Overall Study|Reason not specified|11|||
105965183|NCT01271010|365532205|FG000|Overall Study|Start of new CLL therapy|1|||
105965184|NCT01271010|365532205|FG000|Overall Study|Protocol Violation|1|||
105965185|NCT01271010|365532205|FG000|Overall Study|Death|2|||
105965186|NCT01271010|365532205|FG000|Overall Study|Progression and relapse of disease|1|||
105965187|NCT01271010|365532205|FG000|Overall Study|Withdrawal by Subject|18|||
105965188|NCT01271010|365532205|FG000|Overall Study|Disease progression|27|||
105965189|NCT01945216|365532206|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
105965190|NCT01945216|365532206|FG000|Overall Study|Protocol Violation|42|||
105965191|NCT01945216|365532206|FG000|Overall Study|CRF not assured by investigators|5|||
105965192|NCT03062280|365532208|FG000|Overall Study|Adverse Event|1|||
105965193|NCT03062280|365532208|FG000|Overall Study|Death|1|||
106149114|NCT00999167|366206962|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
106149115|NCT00999167|366206963|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
105834274|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
105834275|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105965194|NCT03062280|365532208|FG000|Overall Study|Fertility Treatment|2|||
105965195|NCT03062280|365532208|FG000|Overall Study|Physician Decision|2|||
105965196|NCT03062280|365532208|FG000|Overall Study|Pregnancy|5|||
105965197|NCT03062280|365532208|FG000|Overall Study|Withdrawal by Subject|11|||
105965198|NCT05258890|365532215|FG000|Overall Study|Patient withdrawal|6|||
105965199|NCT05258890|365532216|FG001|Overall Study|Patient withdrawal|7|||
105965200|NCT05258890|365532215|FG000|Overall Study|Patient lost to follow-up|10|||
106149116|NCT00999167|366206964|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
105834276|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105834277|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105834278|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105834279|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
105834280|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
105834281|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834282|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834283|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834284|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834285|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834286|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834287|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
105834288|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105834289|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834290|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
105834291|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834292|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834293|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834294|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834295|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
105834296|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
105834297|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834298|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834299|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834300|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834301|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834302|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834303|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
105834304|NCT04556734|365050186|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834305|NCT04556734|365050187|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834306|NCT04556734|365050188|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
105834307|NCT04556734|365050189|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834308|NCT04556734|365050190|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834309|NCT04556734|365050191|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834310|NCT04556734|365050192|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834311|NCT04556734|365050193|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
105834312|NCT04556734|365050186|FG000|OLE Period (28 Weeks)|Not reported|0|||
105834313|NCT04556734|365050187|FG001|OLE Period (28 Weeks)|Not reported|0|||
105834314|NCT04556734|365050188|FG002|OLE Period (28 Weeks)|Not reported|0|||
105834315|NCT04556734|365050189|FG003|OLE Period (28 Weeks)|Not reported|0|||
105834316|NCT04556734|365050190|FG004|OLE Period (28 Weeks)|Not reported|0|||
105834317|NCT04556734|365050191|FG005|OLE Period (28 Weeks)|Not reported|1|||
105834318|NCT04556734|365050192|FG006|OLE Period (28 Weeks)|Not reported|0|||
105834319|NCT04556734|365050193|FG007|OLE Period (28 Weeks)|Not reported|0|||
105834320|NCT04556734|365050186|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834321|NCT04556734|365050187|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834322|NCT04556734|365050188|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834323|NCT04556734|365050189|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834324|NCT04556734|365050190|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834325|NCT04556734|365050191|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105834326|NCT04556734|365050192|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
105965201|NCT05258890|365532216|FG001|Overall Study|Patient lost to follow-up|3|||
105965202|NCT05258890|365532215|FG000|Overall Study|Social network member withdrawal|1|||
105965203|NCT05258890|365532216|FG001|Overall Study|Social network member withdrawal|0|||
105965204|NCT05258890|365532215|FG000|Overall Study|Social network member lost to follow-up|5|||
105965205|NCT05258890|365532216|FG001|Overall Study|Social network member lost to follow-up|0|||
106149117|NCT00999167|366206962|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
106149118|NCT00999167|366206963|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
106149119|NCT00999167|366206964|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
106149120|NCT00999167|366206962|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
106149121|NCT00999167|366206963|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
105834327|NCT04556734|365050193|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
105834328|NCT04556734|365050186|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
105834329|NCT04556734|365050187|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
105834330|NCT04556734|365050188|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
105834331|NCT04556734|365050189|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
105834332|NCT04556734|365050190|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
105834333|NCT04556734|365050191|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
105834334|NCT04556734|365050192|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
105834335|NCT04556734|365050193|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
105965206|NCT02920528|365532219|FG000|Overall Study|Incomplete Data|1|||
105965207|NCT02920528|365532220|FG001|Overall Study|Incomplete Data|1|||
105965208|NCT02920528|365532221|FG002|Overall Study|Incomplete Data|1|||
105965209|NCT02920528|365532219|FG000|Overall Study|Adverse Event|0|||
105965210|NCT02920528|365532220|FG001|Overall Study|Adverse Event|0|||
105965211|NCT02920528|365532221|FG002|Overall Study|Adverse Event|3|||
105965212|NCT02920528|365532219|FG000|Overall Study|Did not meet inclusion criteria|2|||
105965213|NCT02920528|365532220|FG001|Overall Study|Did not meet inclusion criteria|0|||
105965214|NCT02920528|365532221|FG002|Overall Study|Did not meet inclusion criteria|1|||
105965215|NCT00809835|365532222|FG000|Overall Study|Lost to Follow-up|7|||
105965216|NCT00809835|365532223|FG001|Overall Study|Lost to Follow-up|6|||
105965217|NCT00809835|365532224|FG002|Overall Study|Lost to Follow-up|10|||
105965218|NCT00809835|365532225|FG003|Overall Study|Lost to Follow-up|2|||
105965219|NCT00809835|365532222|FG000|Overall Study|Withdrawal by Subject|1|||
105965220|NCT00809835|365532223|FG001|Overall Study|Withdrawal by Subject|1|||
105965221|NCT00809835|365532224|FG002|Overall Study|Withdrawal by Subject|1|||
105965222|NCT00809835|365532225|FG003|Overall Study|Withdrawal by Subject|0|||
105965223|NCT02547038|365532226|FG000|Overall Study|Lost to Follow-up|3|||
105965224|NCT02547038|365532227|FG001|Overall Study|Lost to Follow-up|2|||
105965225|NCT00516893|365532228|FG000|Overall Study|Lost to Follow-up|4|||
105965226|NCT00516893|365532228|FG000|Overall Study|Adverse Event|3|||
105965227|NCT00516893|365532228|FG000|Overall Study|Withdrawal by Subject|2|||
105965228|NCT00516893|365532228|FG000|Overall Study|Noncompliance|2|||
105965229|NCT00516893|365532228|FG000|Overall Study|Death|1|||
105965230|NCT00516893|365532228|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
105965231|NCT00516893|365532228|FG000|Overall Study|Relocated|1|||
105965232|NCT00516893|365532228|FG000|Overall Study|Pregnancy|1|||
105965233|NCT00516893|365532228|FG000|Overall Study|Received Medication From Another Study|1|||
105965234|NCT05659719|365532235|FG000|Overall Study|At sponsor's request|0|||
105965235|NCT05659719|365532236|FG001|Overall Study|At sponsor's request|0|||
105965236|NCT05659719|365532237|FG002|Overall Study|At sponsor's request|0|||
105965237|NCT05659719|365532238|FG003|Overall Study|At sponsor's request|95|||
105965238|NCT05659719|365532235|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
105965239|NCT05659719|365532236|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
105965240|NCT05659719|365532237|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
105965241|NCT05659719|365532238|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
105965242|NCT05659719|365532235|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
105965243|NCT05659719|365532236|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
105965244|NCT05659719|365532237|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
105965245|NCT05659719|365532238|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
105965246|NCT05659719|365532235|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
105965247|NCT05659719|365532236|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
105965248|NCT05659719|365532237|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
105965249|NCT05659719|365532238|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
105965250|NCT05659719|365532235|FG000|Overall Study|Lost to Follow-up|0|||
105965251|NCT05659719|365532236|FG001|Overall Study|Lost to Follow-up|0|||
105965252|NCT05659719|365532237|FG002|Overall Study|Lost to Follow-up|0|||
105965253|NCT05659719|365532238|FG003|Overall Study|Lost to Follow-up|2|||
105965254|NCT05659719|365532235|FG000|Overall Study|Moved to another observational study|0|||
105965255|NCT05659719|365532236|FG001|Overall Study|Moved to another observational study|0|||
105965256|NCT05659719|365532237|FG002|Overall Study|Moved to another observational study|0|||
105965257|NCT05659719|365532238|FG003|Overall Study|Moved to another observational study|1|||
105965258|NCT05659719|365532235|FG000|Overall Study|The child was enrolled in an interventional study|0|||
106023090|NCT04335136|365750296|FG000|Overall Study|Death|8|||
106023091|NCT04335136|365750297|FG001|Overall Study|Death|4|||
106023092|NCT04335136|365750296|FG000|Overall Study|Lost to Follow-up|2|||
106023093|NCT04335136|365750297|FG001|Overall Study|Lost to Follow-up|0|||
106023094|NCT04335136|365750296|FG000|Overall Study|Protocol Violation|1|||
106023095|NCT04335136|365750297|FG001|Overall Study|Protocol Violation|0|||
105965259|NCT05659719|365532236|FG001|Overall Study|The child was enrolled in an interventional study|0|||
105965260|NCT05659719|365532237|FG002|Overall Study|The child was enrolled in an interventional study|0|||
105965261|NCT05659719|365532238|FG003|Overall Study|The child was enrolled in an interventional study|55|||
105965262|NCT05659719|365532235|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
105965263|NCT05659719|365532236|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
105965264|NCT05659719|365532237|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
105965265|NCT05659719|365532238|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
106023096|NCT04335136|365750296|FG000|Overall Study|Withdrawal by Subject|1|||
106023097|NCT04335136|365750297|FG001|Overall Study|Withdrawal by Subject|1|||
106149122|NCT00999167|366206964|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
106149123|NCT02554786|366206965|FG000|Overall Study|Subject/guardian decision|29|||
106149124|NCT02554786|366206966|FG001|Overall Study|Subject/guardian decision|17|||
106149125|NCT02554786|366206967|FG002|Overall Study|Subject/guardian decision|18|||
106149126|NCT02554786|366206968|FG003|Overall Study|Subject/guardian decision|30|||
106149127|NCT02554786|366206969|FG004|Overall Study|Subject/guardian decision|20|||
106149128|NCT02554786|366206965|FG000|Overall Study|Lost to Follow-up|4|||
105834336|NCT04556734|365050186|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105834337|NCT04556734|365050187|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105834338|NCT04556734|365050188|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105834339|NCT04556734|365050189|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
105834340|NCT04556734|365050190|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
105834341|NCT04556734|365050191|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
105834342|NCT04556734|365050192|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
105834343|NCT04556734|365050193|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
105834344|NCT02658019|365050200|FG000|Overall Study|Adverse Event|1|||
105834345|NCT02722616|365050201|FG000|Overall Study|Sponsor closed study after one month|2|||
105834346|NCT02722616|365050202|FG001|Overall Study|Sponsor closed study after one month|0|||
105834347|NCT02722616|365050203|FG002|Overall Study|Sponsor closed study after one month|0|||
105834348|NCT00820599|365050206|FG000|Overall Study|Death|129|||
105834349|NCT00820599|365050206|FG000|Overall Study|Withdrawal by Subject|2|||
105834350|NCT02485158|365050207|FG000|Overall Study|Withdrawal by Subject|3|||
105834351|NCT02485158|365050207|FG000|Overall Study|expected drug side effect|1|||
105834352|NCT00442351|365050208|FG000|Overall Study|Administrative|6|||
105834353|NCT00442351|365050209|FG001|Overall Study|Administrative|5|||
105834354|NCT00442351|365050208|FG000|Overall Study|Did not meet protocol eligibility|1|||
105834355|NCT00442351|365050209|FG001|Overall Study|Did not meet protocol eligibility|0|||
105834356|NCT00442351|365050208|FG000|Overall Study|Other|0|||
106023098|NCT04335136|365750296|FG000|Overall Study|Health-threatening condition|0|||
106023099|NCT04335136|365750297|FG001|Overall Study|Health-threatening condition|1|||
106023100|NCT04335136|365750296|FG000|Overall Study|Adverse Event|0|||
106023101|NCT04335136|365750297|FG001|Overall Study|Adverse Event|1|||
106023102|NCT04335136|365750296|FG000|Overall Study|Erroneously randomized|2|||
106023103|NCT04335136|365750297|FG001|Overall Study|Erroneously randomized|0|||
106023104|NCT01396447|365750298|FG000|Overall Study|Did Not Receive Treatment|3|||
106023105|NCT01396447|365750299|FG001|Overall Study|Did Not Receive Treatment|2|||
106023106|NCT01396447|365750300|FG002|Overall Study|Did Not Receive Treatment|1|||
106023107|NCT01396447|365750301|FG003|Overall Study|Did Not Receive Treatment|0|||
106023108|NCT01396447|365750298|FG000|Overall Study|Adverse Event|15|||
106023109|NCT01396447|365750299|FG001|Overall Study|Adverse Event|12|||
106023110|NCT01396447|365750300|FG002|Overall Study|Adverse Event|12|||
106023111|NCT01396447|365750301|FG003|Overall Study|Adverse Event|17|||
106149129|NCT02554786|366206966|FG001|Overall Study|Lost to Follow-up|3|||
106149130|NCT02554786|366206967|FG002|Overall Study|Lost to Follow-up|4|||
106149131|NCT02554786|366206968|FG003|Overall Study|Lost to Follow-up|2|||
106149132|NCT02554786|366206969|FG004|Overall Study|Lost to Follow-up|2|||
106149133|NCT02554786|366206965|FG000|Overall Study|Protocol deviation|1|||
106149134|NCT02554786|366206966|FG001|Overall Study|Protocol deviation|3|||
106149135|NCT02554786|366206967|FG002|Overall Study|Protocol deviation|3|||
106149136|NCT02554786|366206968|FG003|Overall Study|Protocol deviation|4|||
106149137|NCT02554786|366206969|FG004|Overall Study|Protocol deviation|2|||
106149138|NCT02554786|366206965|FG000|Overall Study|Technical problems|1|||
106149139|NCT02554786|366206966|FG001|Overall Study|Technical problems|1|||
106149140|NCT02554786|366206967|FG002|Overall Study|Technical problems|0|||
106149141|NCT02554786|366206968|FG003|Overall Study|Technical problems|2|||
106149142|NCT02554786|366206969|FG004|Overall Study|Technical problems|1|||
106149143|NCT02554786|366206965|FG000|Overall Study|Adverse Event|0|||
106149144|NCT02554786|366206966|FG001|Overall Study|Adverse Event|0|||
106149145|NCT02554786|366206967|FG002|Overall Study|Adverse Event|0|||
106149146|NCT02554786|366206968|FG003|Overall Study|Adverse Event|0|||
106149147|NCT02554786|366206969|FG004|Overall Study|Adverse Event|2|||
106149148|NCT02554786|366206965|FG000|Overall Study|Death|0|||
105834357|NCT00442351|365050209|FG001|Overall Study|Other|1|||
105834358|NCT03087786|365050210|FG000|Overall Study|Withdrawal by Subject|2|||
105834359|NCT03087786|365050211|FG001|Overall Study|Withdrawal by Subject|0|||
106149149|NCT02554786|366206966|FG001|Overall Study|Death|0|||
105834360|NCT01813435|365050212|FG000|Overall Study|did not finish experimental regimen|1902|||
105834361|NCT01813435|365050213|FG001|Overall Study|did not finish experimental regimen|770|||
105834362|NCT01813435|365050212|FG000|Overall Study|Lost to Follow-up|268|||
105834363|NCT01813435|365050213|FG001|Overall Study|Lost to Follow-up|237|||
105834364|NCT03243396|365050214|FG000|Overall Study|Lost to Follow-up|2|||
105834365|NCT03243396|365050215|FG001|Overall Study|Lost to Follow-up|3|||
106023112|NCT01396447|365750298|FG000|Overall Study|Insufficient Therapeutic Response|5|||
106023113|NCT01396447|365750299|FG001|Overall Study|Insufficient Therapeutic Response|5|||
106023114|NCT01396447|365750300|FG002|Overall Study|Insufficient Therapeutic Response|2|||
106023115|NCT01396447|365750301|FG003|Overall Study|Insufficient Therapeutic Response|4|||
105965266|NCT05659719|365532235|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
105965267|NCT05659719|365532236|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
105965268|NCT05659719|365532237|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
105965269|NCT05659719|365532238|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
105965270|NCT01681186|365532239|FG000|Washout Period From Second Intervention|Adverse Event|0|||
105965271|NCT01681186|365532240|FG001|Washout Period From Second Intervention|Adverse Event|0|||
105965272|NCT01681186|365532241|FG002|Washout Period From Second Intervention|Adverse Event|0|||
105965273|NCT01681186|365532242|FG003|Washout Period From Second Intervention|Adverse Event|0|||
105965274|NCT01681186|365532243|FG004|Washout Period From Second Intervention|Adverse Event|0|||
105965275|NCT01681186|365532244|FG005|Washout Period From Second Intervention|Adverse Event|0|||
105965276|NCT01681186|365532245|FG006|Washout Period From Second Intervention|Adverse Event|1|||
105965277|NCT01681186|365532246|FG007|Washout Period From Second Intervention|Adverse Event|0|||
105965278|NCT01681186|365532239|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
105965279|NCT01681186|365532240|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
105965280|NCT01681186|365532241|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
105965281|NCT01681186|365532242|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
105965282|NCT01681186|365532243|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
105965283|NCT01681186|365532244|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
105965284|NCT01681186|365532245|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
105965285|NCT01681186|365532246|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
105965286|NCT01681186|365532239|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
105965287|NCT01681186|365532240|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
105965288|NCT01681186|365532241|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
105965289|NCT01681186|365532242|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
105965290|NCT01681186|365532243|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
105965291|NCT01681186|365532244|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
106023116|NCT01396447|365750298|FG000|Overall Study|Protocol Violation|5|||
106023117|NCT01396447|365750299|FG001|Overall Study|Protocol Violation|2|||
105965292|NCT01681186|365532245|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
105965293|NCT01681186|365532246|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
105965294|NCT01681186|365532239|FG000|Fourth Intervention|Protocol Violation|0|||
105965295|NCT01681186|365532240|FG001|Fourth Intervention|Protocol Violation|0|||
106023118|NCT01396447|365750300|FG002|Overall Study|Protocol Violation|3|||
105834366|NCT03243396|365050216|FG002|Overall Study|Lost to Follow-up|15|||
105834367|NCT03243396|365050217|FG003|Overall Study|Lost to Follow-up|8|||
106023119|NCT01396447|365750301|FG003|Overall Study|Protocol Violation|7|||
106023120|NCT01396447|365750298|FG000|Overall Study|Withdrawal of Consent|11|||
106023121|NCT01396447|365750299|FG001|Overall Study|Withdrawal of Consent|9|||
106023122|NCT01396447|365750300|FG002|Overall Study|Withdrawal of Consent|4|||
106023123|NCT01396447|365750301|FG003|Overall Study|Withdrawal of Consent|15|||
106023124|NCT01396447|365750298|FG000|Overall Study|Lost to Follow-up|4|||
106023125|NCT01396447|365750299|FG001|Overall Study|Lost to Follow-up|8|||
106023126|NCT01396447|365750300|FG002|Overall Study|Lost to Follow-up|7|||
106023127|NCT01396447|365750301|FG003|Overall Study|Lost to Follow-up|9|||
106023128|NCT01396447|365750298|FG000|Overall Study|Other Miscellaneous Reasons|0|||
106023129|NCT01396447|365750299|FG001|Overall Study|Other Miscellaneous Reasons|2|||
106023130|NCT01396447|365750300|FG002|Overall Study|Other Miscellaneous Reasons|1|||
106023131|NCT01396447|365750301|FG003|Overall Study|Other Miscellaneous Reasons|0|||
106023132|NCT02597478|365750308|FG000|Overall Study|Withdrawal by Subject|2|||
106023133|NCT02597478|365750309|FG001|Overall Study|Withdrawal by Subject|0|||
106023134|NCT02597478|365750308|FG000|Overall Study|Change of opioid dose|1|||
106023135|NCT02597478|365750309|FG001|Overall Study|Change of opioid dose|0|||
106023136|NCT02597478|365750308|FG000|Overall Study|Insufficient exertional dyspnea|0|||
106023137|NCT02597478|365750309|FG001|Overall Study|Insufficient exertional dyspnea|1|||
106023138|NCT00796978|365750310|FG000|Overall Study|Cardiac adverse event|5|||
106023139|NCT00796978|365750310|FG000|Overall Study|Adverse Event|4|||
106023140|NCT00796978|365750310|FG000|Overall Study|Withdrawal by Subject|3|||
106023141|NCT02364336|365750311|FG000|Overall Study|Adverse Event|0|||
106023142|NCT02364336|365750312|FG001|Overall Study|Adverse Event|1|||
106023143|NCT01092546|365750314|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
106023144|NCT00771953|365750315|FG000|Overall Study|Adverse Event|5|||
106023145|NCT00771953|365750316|FG001|Overall Study|Adverse Event|3|||
106023146|NCT00771953|365750315|FG000|Overall Study|Death|2|||
106023147|NCT00771953|365750316|FG001|Overall Study|Death|2|||
106023148|NCT00771953|365750315|FG000|Overall Study|Progression before active Tx|1|||
106023149|NCT00771953|365750316|FG001|Overall Study|Progression before active Tx|2|||
106023150|NCT00771953|365750315|FG000|Overall Study|Sponsor decision|1|||
106023151|NCT00771953|365750316|FG001|Overall Study|Sponsor decision|0|||
106023152|NCT00771953|365750315|FG000|Overall Study|Other complicating disease|1|||
106023153|NCT00771953|365750316|FG001|Overall Study|Other complicating disease|0|||
105834368|NCT03243396|365050218|FG004|Overall Study|Lost to Follow-up|1|||
105834369|NCT03243396|365050219|FG005|Overall Study|Lost to Follow-up|4|||
105834370|NCT03243396|365050220|FG006|Overall Study|Lost to Follow-up|9|||
105834371|NCT03687242|365050221|FG000|Overall Study|Adverse Event|1|||
105834372|NCT00377156|365050224|FG000|Overall Study|Death|23|||
105834373|NCT00377156|365050225|FG001|Overall Study|Death|19|||
105834374|NCT00377156|365050224|FG000|Overall Study|Withdrawal by Subject|16|||
105834375|NCT00377156|365050225|FG001|Overall Study|Withdrawal by Subject|24|||
105834376|NCT00377156|365050224|FG000|Overall Study|Had follow-up <90 d|3|||
105834377|NCT00377156|365050225|FG001|Overall Study|Had follow-up <90 d|6|||
105834378|NCT00377156|365050224|FG000|Overall Study|Cancellation|1|||
105834379|NCT00377156|365050225|FG001|Overall Study|Cancellation|0|||
106023154|NCT00771953|365750315|FG000|Overall Study|Withdrawal by Subject|0|||
106023155|NCT00771953|365750316|FG001|Overall Study|Withdrawal by Subject|3|||
106023156|NCT01086358|365750317|FG000|First Intervention|Lost to Follow-up|9|||
106023157|NCT01086358|365750318|FG001|First Intervention|Lost to Follow-up|4|||
106023158|NCT01086358|365750317|FG000|First Intervention|Withdrawal by Subject|0|||
106023159|NCT01086358|365750318|FG001|First Intervention|Withdrawal by Subject|1|||
106023160|NCT01086358|365750317|FG000|Second Intervention|Lost to Follow-up|4|||
105834380|NCT00377156|365050224|FG000|Overall Study|Refused testing|0|||
105965296|NCT01681186|365532241|FG002|Fourth Intervention|Protocol Violation|0|||
105965297|NCT01681186|365532242|FG003|Fourth Intervention|Protocol Violation|0|||
105965298|NCT01681186|365532243|FG004|Fourth Intervention|Protocol Violation|0|||
105965299|NCT01681186|365532244|FG005|Fourth Intervention|Protocol Violation|0|||
105965300|NCT01681186|365532245|FG006|Fourth Intervention|Protocol Violation|0|||
105965301|NCT01681186|365532246|FG007|Fourth Intervention|Protocol Violation|1|||
105834381|NCT00377156|365050225|FG001|Overall Study|Refused testing|1|||
105965302|NCT02290691|365532253|FG000|Overall Study|Noncompliance|0|||
105965303|NCT02290691|365532254|FG001|Overall Study|Noncompliance|1|||
105965304|NCT02290691|365532253|FG000|Overall Study|Withdrawal by Subject|1|||
105965305|NCT02290691|365532254|FG001|Overall Study|Withdrawal by Subject|1|||
105965306|NCT02290691|365532253|FG000|Overall Study|Lost to Follow-up|7|||
105965307|NCT02290691|365532254|FG001|Overall Study|Lost to Follow-up|7|||
105965308|NCT03530995|365532256|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
105965309|NCT03530995|365532257|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
105965310|NCT03530995|365532256|FG000|Part 1 Period 3|Protocol Violation|1|||
105965311|NCT03530995|365532257|FG001|Part 1 Period 3|Protocol Violation|0|||
105965312|NCT03530995|365532256|FG000|Part 1 Period 4|Physician Decision|1|||
105965313|NCT03530995|365532257|FG001|Part 1 Period 4|Physician Decision|0|||
105965314|NCT03530995|365532256|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
105965315|NCT03530995|365532257|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
105965316|NCT00218634|365532264|FG000|Overall Study|Lost to Follow-up|8|||
105965317|NCT00218634|365532265|FG001|Overall Study|Lost to Follow-up|15|||
105965318|NCT04848220|365532270|FG000|Overall Study|Unable to proceed to study procedure|0|||
105965319|NCT04848220|365532271|FG001|Overall Study|Unable to proceed to study procedure|1|||
105965320|NCT04848220|365532272|FG002|Overall Study|Unable to proceed to study procedure|0|||
105965321|NCT04848220|365532270|FG000|Overall Study|Fractional flow not significant|0|||
105965322|NCT04848220|365532271|FG001|Overall Study|Fractional flow not significant|1|||
105965323|NCT04848220|365532272|FG002|Overall Study|Fractional flow not significant|0|||
105965324|NCT01986231|365532273|FG000|Overall Study|Adverse Event|1|||
105965325|NCT02923830|365532274|FG000|Overall Study|Physician Decision|13|||
105965326|NCT02923830|365532275|FG001|Overall Study|Physician Decision|15|||
105965327|NCT00837265|365532278|FG000|Pilot Phase|Withdrawal by Subject|0|||
105965328|NCT00837265|365532279|FG001|Pilot Phase|Withdrawal by Subject|2|||
105965329|NCT00837265|365532280|FG002|Pilot Phase|Withdrawal by Subject|3|||
105965330|NCT00837265|365532281|FG003|Pilot Phase|Withdrawal by Subject|2|||
105965331|NCT00837265|365532282|FG004|Pilot Phase|Withdrawal by Subject|0|||
105965332|NCT00837265|365532283|FG005|Pilot Phase|Withdrawal by Subject|0|||
105965333|NCT00837265|365532284|FG006|Pilot Phase|Withdrawal by Subject|0|||
105965334|NCT00837265|365532278|FG000|Pilot Phase|Decision of the investigator|2|||
105965335|NCT00837265|365532279|FG001|Pilot Phase|Decision of the investigator|1|||
105965336|NCT00837265|365532280|FG002|Pilot Phase|Decision of the investigator|0|||
105965337|NCT00837265|365532281|FG003|Pilot Phase|Decision of the investigator|0|||
105965338|NCT00837265|365532282|FG004|Pilot Phase|Decision of the investigator|0|||
105965339|NCT00837265|365532283|FG005|Pilot Phase|Decision of the investigator|0|||
105965340|NCT00837265|365532284|FG006|Pilot Phase|Decision of the investigator|0|||
105965341|NCT00837265|365532278|FG000|Pilot Phase|Adverse Event|1|||
105965342|NCT00837265|365532279|FG001|Pilot Phase|Adverse Event|0|||
105965343|NCT00837265|365532280|FG002|Pilot Phase|Adverse Event|0|||
105965344|NCT00837265|365532281|FG003|Pilot Phase|Adverse Event|0|||
105965345|NCT00837265|365532282|FG004|Pilot Phase|Adverse Event|0|||
105965346|NCT00837265|365532283|FG005|Pilot Phase|Adverse Event|0|||
105965347|NCT00837265|365532284|FG006|Pilot Phase|Adverse Event|0|||
105965348|NCT00837265|365532278|FG000|Pilot Phase|Disease progression|0|||
105965349|NCT00837265|365532279|FG001|Pilot Phase|Disease progression|0|||
105965350|NCT00837265|365532280|FG002|Pilot Phase|Disease progression|0|||
105965351|NCT00837265|365532281|FG003|Pilot Phase|Disease progression|1|||
105965352|NCT00837265|365532282|FG004|Pilot Phase|Disease progression|0|||
105965353|NCT00837265|365532283|FG005|Pilot Phase|Disease progression|0|||
105965354|NCT00837265|365532284|FG006|Pilot Phase|Disease progression|0|||
105965355|NCT00837265|365532278|FG000|Pilot Phase|Participant left the city|0|||
105965356|NCT00837265|365532279|FG001|Pilot Phase|Participant left the city|0|||
105965357|NCT00837265|365532280|FG002|Pilot Phase|Participant left the city|0|||
105965358|NCT00837265|365532281|FG003|Pilot Phase|Participant left the city|1|||
105965359|NCT00837265|365532282|FG004|Pilot Phase|Participant left the city|0|||
105965360|NCT00837265|365532283|FG005|Pilot Phase|Participant left the city|0|||
105965361|NCT00837265|365532284|FG006|Pilot Phase|Participant left the city|0|||
105965362|NCT00837265|365532278|FG000|Main Phase|Withdrawal by Subject|0|||
105965363|NCT00837265|365532279|FG001|Main Phase|Withdrawal by Subject|0|||
105965364|NCT00837265|365532280|FG002|Main Phase|Withdrawal by Subject|0|||
105965365|NCT00837265|365532281|FG003|Main Phase|Withdrawal by Subject|0|||
105965366|NCT00837265|365532282|FG004|Main Phase|Withdrawal by Subject|4|||
105965367|NCT00837265|365532283|FG005|Main Phase|Withdrawal by Subject|2|||
105965368|NCT00837265|365532284|FG006|Main Phase|Withdrawal by Subject|1|||
105965369|NCT00837265|365532278|FG000|Main Phase|Decision of the investigator|0|||
106023161|NCT01086358|365750318|FG001|Second Intervention|Lost to Follow-up|4|||
106023162|NCT01667419|365750319|FG000|Overall Study|Reason Not Specified|1|||
106023163|NCT01667419|365750320|FG001|Overall Study|Reason Not Specified|0|||
106023164|NCT01667419|365750321|FG002|Overall Study|Reason Not Specified|0|||
105965370|NCT00837265|365532279|FG001|Main Phase|Decision of the investigator|0|||
105965371|NCT00837265|365532280|FG002|Main Phase|Decision of the investigator|0|||
105965372|NCT00837265|365532281|FG003|Main Phase|Decision of the investigator|0|||
105965373|NCT00837265|365532282|FG004|Main Phase|Decision of the investigator|0|||
105965374|NCT00837265|365532283|FG005|Main Phase|Decision of the investigator|2|||
105965375|NCT00837265|365532284|FG006|Main Phase|Decision of the investigator|1|||
105965376|NCT00837265|365532278|FG000|Main Phase|Adverse Event|0|||
105965377|NCT00837265|365532279|FG001|Main Phase|Adverse Event|0|||
105965378|NCT00837265|365532280|FG002|Main Phase|Adverse Event|0|||
105834382|NCT00377156|365050224|FG000|Overall Study|Ineligible|0|||
105965379|NCT00837265|365532281|FG003|Main Phase|Adverse Event|0|||
105965380|NCT00837265|365532282|FG004|Main Phase|Adverse Event|0|||
105965381|NCT00837265|365532283|FG005|Main Phase|Adverse Event|1|||
106149150|NCT02554786|366206967|FG002|Overall Study|Death|0|||
105834383|NCT00377156|365050225|FG001|Overall Study|Ineligible|1|||
105834384|NCT00377156|365050224|FG000|Overall Study|Disability or language problem|0|||
105834385|NCT00377156|365050225|FG001|Overall Study|Disability or language problem|1|||
105834386|NCT00377156|365050224|FG000|Overall Study|Other|5|||
105834387|NCT00377156|365050225|FG001|Overall Study|Other|2|||
105834388|NCT00799708|365050226|FG000|Overall Study|non-compliance|1|||
105834389|NCT00799708|365050227|FG001|Overall Study|non-compliance|0|||
105834390|NCT00799708|365050228|FG002|Overall Study|non-compliance|0|||
105834391|NCT00880334|365050229|FG000|Randomized Phase|Physician Decision|1|||
105834392|NCT00880334|365050230|FG001|Randomized Phase|Physician Decision|0|||
105834393|NCT00880334|365050229|FG000|Randomized Phase|Withdrawal by Subject|2|||
105834394|NCT00880334|365050230|FG001|Randomized Phase|Withdrawal by Subject|1|||
105834395|NCT00880334|365050229|FG000|Randomized Phase|Inadequate Labs|1|||
105834396|NCT00880334|365050230|FG001|Randomized Phase|Inadequate Labs|1|||
105834397|NCT00880334|365050229|FG000|Randomized Phase|Brain Metastasis|0|||
105834398|NCT00880334|365050230|FG001|Randomized Phase|Brain Metastasis|1|||
105834399|NCT00880334|365050229|FG000|Randomized Phase|Crossover Participants|0|||
105834400|NCT00880334|365050230|FG001|Randomized Phase|Crossover Participants|37|||
105834401|NCT03343639|365050231|FG000|Overall Study|Withdrawal by Subject|10|||
105834402|NCT03343639|365050232|FG001|Overall Study|Withdrawal by Subject|6|||
105834403|NCT03343639|365050231|FG000|Overall Study|Lost to Follow-up|4|||
105834404|NCT03343639|365050232|FG001|Overall Study|Lost to Follow-up|5|||
105834405|NCT03343639|365050231|FG000|Overall Study|Protocol Violation|0|||
105834406|NCT03343639|365050232|FG001|Overall Study|Protocol Violation|1|||
105834407|NCT02697617|365050238|FG000|Overall Study|Withdrawal by Subject|0|||
105834408|NCT02697617|365050239|FG001|Overall Study|Withdrawal by Subject|2|||
105834409|NCT02697617|365050238|FG000|Overall Study|Pregnancy|1|||
105834410|NCT02697617|365050239|FG001|Overall Study|Pregnancy|0|||
105834411|NCT02274558|365050242|FG000|Overall Study|Adverse Event|2|||
105834412|NCT02274558|365050243|FG001|Overall Study|Adverse Event|4|||
105834413|NCT02274558|365050244|FG002|Overall Study|Adverse Event|2|||
105965382|NCT00837265|365532284|FG006|Main Phase|Adverse Event|0|||
105965383|NCT00837265|365532278|FG000|Main Phase|Death|0|||
105965384|NCT00837265|365532279|FG001|Main Phase|Death|0|||
105965385|NCT00837265|365532280|FG002|Main Phase|Death|0|||
105965386|NCT00837265|365532281|FG003|Main Phase|Death|0|||
106023165|NCT01667419|365750322|FG003|Overall Study|Reason Not Specified|0|||
105965387|NCT00837265|365532282|FG004|Main Phase|Death|2|||
105965388|NCT00837265|365532283|FG005|Main Phase|Death|0|||
105965389|NCT00837265|365532284|FG006|Main Phase|Death|1|||
105965390|NCT00837265|365532278|FG000|Main Phase|Lost to Follow-up|0|||
105834414|NCT02274558|365050242|FG000|Overall Study|Non-compliance|2|||
105965391|NCT00837265|365532279|FG001|Main Phase|Lost to Follow-up|0|||
106023166|NCT01667419|365750319|FG000|Overall Study|Withdrawal by Subject|16|||
105834415|NCT02274558|365050243|FG001|Overall Study|Non-compliance|1|||
105834416|NCT02274558|365050244|FG002|Overall Study|Non-compliance|0|||
105834417|NCT02274558|365050242|FG000|Overall Study|Withdrawal by Subject|1|||
105834418|NCT02274558|365050243|FG001|Overall Study|Withdrawal by Subject|5|||
105834419|NCT02274558|365050244|FG002|Overall Study|Withdrawal by Subject|4|||
105965392|NCT00837265|365532280|FG002|Main Phase|Lost to Follow-up|0|||
105965393|NCT00837265|365532281|FG003|Main Phase|Lost to Follow-up|0|||
105965394|NCT00837265|365532282|FG004|Main Phase|Lost to Follow-up|1|||
105965395|NCT00837265|365532283|FG005|Main Phase|Lost to Follow-up|0|||
106023167|NCT01667419|365750320|FG001|Overall Study|Withdrawal by Subject|8|||
105834420|NCT02274558|365050242|FG000|Overall Study|Death|0|||
105834421|NCT02274558|365050243|FG001|Overall Study|Death|0|||
105834422|NCT02274558|365050244|FG002|Overall Study|Death|1|||
105834423|NCT02274558|365050242|FG000|Overall Study|Lost to Follow-up|2|||
105834424|NCT02274558|365050243|FG001|Overall Study|Lost to Follow-up|1|||
105834425|NCT02274558|365050244|FG002|Overall Study|Lost to Follow-up|1|||
105834426|NCT02274558|365050242|FG000|Overall Study|Physician Decision|0|||
105834427|NCT02274558|365050243|FG001|Overall Study|Physician Decision|2|||
105834428|NCT02274558|365050244|FG002|Overall Study|Physician Decision|1|||
105834429|NCT02655224|365050245|FG000|Overall Study|Adverse Event|1|||
105834430|NCT02655224|365050246|FG001|Overall Study|Adverse Event|1|||
105834431|NCT01257581|365050247|FG000|Overall Study|Early Termination|3|||
105834432|NCT01257581|365050248|FG001|Overall Study|Early Termination|1|||
105834433|NCT01257581|365050249|FG002|Overall Study|Early Termination|2|||
105834434|NCT01257581|365050247|FG000|Overall Study|Death|2|||
105834435|NCT01257581|365050248|FG001|Overall Study|Death|2|||
105834436|NCT01257581|365050249|FG002|Overall Study|Death|4|||
105834437|NCT01157234|365050250|FG000|Overall Study|Withdrawal by Subject|1|||
105834438|NCT01157234|365050251|FG001|Overall Study|Withdrawal by Subject|0|||
105834439|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
105834440|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
105834441|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
105834442|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
105834443|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
105834444|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
105834445|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
105834446|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
105834447|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
105834448|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
105834449|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
105834450|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
105834451|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
105834452|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
105834453|NCT04592419|365050252|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
105834454|NCT04592419|365050253|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
105834455|NCT04592419|365050252|FG000|Open-Label Extension Period|Adverse Event|1|||
105834456|NCT04592419|365050253|FG001|Open-Label Extension Period|Adverse Event|2|||
105834457|NCT04592419|365050252|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
105834458|NCT04592419|365050253|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
105834459|NCT04592419|365050252|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
105834460|NCT04592419|365050253|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
105834461|NCT04592419|365050252|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
105834462|NCT04592419|365050253|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
105834463|NCT04592419|365050252|FG000|Open-Label Extension Period|Sponsor Request|73|||
105834464|NCT04592419|365050253|FG001|Open-Label Extension Period|Sponsor Request|84|||
105834465|NCT01765270|365050260|FG000|Overall Study|Physician Decision|1|||
105834466|NCT01765270|365050261|FG001|Overall Study|Physician Decision|0|||
105834467|NCT01765270|365050260|FG000|Overall Study|Withdrawal by Subject|0|||
105834468|NCT01765270|365050261|FG001|Overall Study|Withdrawal by Subject|1|||
105834469|NCT00517192|365050262|FG000|Overall Study|Adverse Event|1|||
105834470|NCT00517192|365050263|FG001|Overall Study|Adverse Event|1|||
105834471|NCT00517192|365050262|FG000|Overall Study|Lost to Follow-up|1|||
105834472|NCT00517192|365050263|FG001|Overall Study|Lost to Follow-up|1|||
105834473|NCT00517192|365050262|FG000|Overall Study|Withdrawal by Subject|1|||
105834474|NCT00517192|365050263|FG001|Overall Study|Withdrawal by Subject|0|||
105834475|NCT00517192|365050262|FG000|Overall Study|Early termination of the trial|16|||
105834476|NCT00517192|365050263|FG001|Overall Study|Early termination of the trial|18|||
105834477|NCT02733627|365050271|FG000|Overall Study|Adverse Event|0|||
105834478|NCT02733627|365050272|FG001|Overall Study|Adverse Event|1|||
105834479|NCT02733627|365050273|FG002|Overall Study|Adverse Event|1|||
105834480|NCT02733627|365050274|FG003|Overall Study|Adverse Event|0|||
105834481|NCT02733627|365050271|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
105834482|NCT02733627|365050272|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
105834483|NCT02733627|365050273|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
105834484|NCT02733627|365050274|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
105834485|NCT02246764|365050275|FG000|Overall Study|Adverse Event|15|||
105834486|NCT02246764|365050276|FG001|Overall Study|Adverse Event|29|||
105834487|NCT02246764|365050277|FG002|Overall Study|Adverse Event|1|||
105834488|NCT02246764|365050275|FG000|Overall Study|Withdrawal by Subject|0|||
105834489|NCT02246764|365050276|FG001|Overall Study|Withdrawal by Subject|0|||
105834490|NCT02246764|365050277|FG002|Overall Study|Withdrawal by Subject|1|||
105834491|NCT02246764|365050275|FG000|Overall Study|Disallowed Concomitant Medication|1|||
105834492|NCT02246764|365050276|FG001|Overall Study|Disallowed Concomitant Medication|0|||
105834493|NCT02246764|365050277|FG002|Overall Study|Disallowed Concomitant Medication|0|||
105834494|NCT02246764|365050275|FG000|Overall Study|Physician Decision|0|||
105834495|NCT02246764|365050276|FG001|Overall Study|Physician Decision|2|||
105834496|NCT02246764|365050277|FG002|Overall Study|Physician Decision|1|||
105834497|NCT02246764|365050275|FG000|Overall Study|Protocol Violation|2|||
105834498|NCT02246764|365050276|FG001|Overall Study|Protocol Violation|1|||
105834499|NCT02246764|365050277|FG002|Overall Study|Protocol Violation|1|||
105834500|NCT00183196|365050278|FG000|Overall Study|Withdrawal by Subject|18|||
105965396|NCT00837265|365532284|FG006|Main Phase|Lost to Follow-up|0|||
105965397|NCT00837265|365532278|FG000|Main Phase|Principal investigator resignation|0|||
105965398|NCT00837265|365532279|FG001|Main Phase|Principal investigator resignation|0|||
105965399|NCT00837265|365532280|FG002|Main Phase|Principal investigator resignation|0|||
105965400|NCT00837265|365532281|FG003|Main Phase|Principal investigator resignation|0|||
105965401|NCT00837265|365532282|FG004|Main Phase|Principal investigator resignation|2|||
105965402|NCT00837265|365532283|FG005|Main Phase|Principal investigator resignation|0|||
105965403|NCT00837265|365532284|FG006|Main Phase|Principal investigator resignation|0|||
105965404|NCT00837265|365532278|FG000|Main Phase|Participant's personal reason|0|||
105965405|NCT00837265|365532279|FG001|Main Phase|Participant's personal reason|0|||
105834501|NCT00183196|365050279|FG001|Overall Study|Withdrawal by Subject|11|||
105834502|NCT00183196|365050280|FG002|Overall Study|Withdrawal by Subject|13|||
105834503|NCT00183196|365050278|FG000|Overall Study|Adverse Event|1|||
105834504|NCT00183196|365050279|FG001|Overall Study|Adverse Event|2|||
105834505|NCT00183196|365050280|FG002|Overall Study|Adverse Event|2|||
105834506|NCT00183196|365050278|FG000|Overall Study|Legal event|1|||
105834507|NCT00183196|365050279|FG001|Overall Study|Legal event|1|||
105834508|NCT00183196|365050280|FG002|Overall Study|Legal event|1|||
105834509|NCT00183196|365050278|FG000|Overall Study|Required more intensive care|0|||
105834510|NCT00183196|365050279|FG001|Overall Study|Required more intensive care|1|||
105834511|NCT00183196|365050280|FG002|Overall Study|Required more intensive care|2|||
105834512|NCT00695110|365050286|FG000|Treatment Period 1|Adverse Event|1|||
105834513|NCT00695110|365050286|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105834514|NCT00695110|365050286|FG000|Treatment Period 3|Withdrawal by Subject|1|||
105834515|NCT00695110|365050286|FG000|Treatment Period 4|Adverse Event|1|||
105834516|NCT00348816|365050289|FG000|Overall Study|Noncompliance with radiation treatment|1|||
105834517|NCT02161549|365050290|FG000|Overall Study|Physician Decision|6|||
105834518|NCT02161549|365050291|FG001|Overall Study|Physician Decision|2|||
105834519|NCT03433703|365050292|FG000|Overall Study|Study terminated by Sponsor|2|||
105834520|NCT02637141|365050297|FG000|Overall Study|Adverse Event|1|||
105834521|NCT02637141|365050298|FG001|Overall Study|Adverse Event|1|||
105834522|NCT02637141|365050299|FG002|Overall Study|Adverse Event|0|||
105834523|NCT02637141|365050297|FG000|Overall Study|Withdrawal by Subject|1|||
105834524|NCT02637141|365050298|FG001|Overall Study|Withdrawal by Subject|1|||
105834525|NCT02637141|365050299|FG002|Overall Study|Withdrawal by Subject|1|||
105834526|NCT00743145|365050305|FG000|Overall Study|Withdrawal by Subject|1|||
105834527|NCT00743145|365050305|FG000|Overall Study|Adverse Event|2|||
105834528|NCT00743145|365050305|FG000|Overall Study|Pregnancy|1|||
105834529|NCT01583530|365050306|FG000|Overall Study|Adverse Event|0|||
105834530|NCT01583530|365050307|FG001|Overall Study|Adverse Event|0|||
105834531|NCT01583530|365050308|FG002|Overall Study|Adverse Event|0|||
105834532|NCT01583530|365050309|FG003|Overall Study|Adverse Event|0|||
105834533|NCT01583530|365050310|FG004|Overall Study|Adverse Event|0|||
105834534|NCT01583530|365050311|FG005|Overall Study|Adverse Event|1|||
105834535|NCT01583530|365050306|FG000|Overall Study|Withdrawal by Subject|0|||
105834536|NCT01583530|365050307|FG001|Overall Study|Withdrawal by Subject|3|||
105834537|NCT01583530|365050308|FG002|Overall Study|Withdrawal by Subject|0|||
105965406|NCT00837265|365532280|FG002|Main Phase|Participant's personal reason|0|||
105965407|NCT00837265|365532281|FG003|Main Phase|Participant's personal reason|0|||
105834538|NCT01583530|365050309|FG003|Overall Study|Withdrawal by Subject|1|||
105834539|NCT01583530|365050310|FG004|Overall Study|Withdrawal by Subject|1|||
105834540|NCT01583530|365050311|FG005|Overall Study|Withdrawal by Subject|2|||
105834541|NCT01583530|365050306|FG000|Overall Study|Lost to Follow-up|0|||
105834542|NCT01583530|365050307|FG001|Overall Study|Lost to Follow-up|0|||
105834543|NCT01583530|365050308|FG002|Overall Study|Lost to Follow-up|0|||
105834544|NCT01583530|365050309|FG003|Overall Study|Lost to Follow-up|0|||
105834545|NCT01583530|365050310|FG004|Overall Study|Lost to Follow-up|3|||
105834546|NCT01583530|365050311|FG005|Overall Study|Lost to Follow-up|0|||
105834547|NCT01583530|365050306|FG000|Overall Study|Lack of compliance|0|||
105834548|NCT01583530|365050307|FG001|Overall Study|Lack of compliance|0|||
105834549|NCT01583530|365050308|FG002|Overall Study|Lack of compliance|0|||
105834550|NCT01583530|365050309|FG003|Overall Study|Lack of compliance|0|||
105965408|NCT00837265|365532282|FG004|Main Phase|Participant's personal reason|1|||
105965409|NCT00837265|365532283|FG005|Main Phase|Participant's personal reason|0|||
105965410|NCT00837265|365532284|FG006|Main Phase|Participant's personal reason|0|||
105834551|NCT01583530|365050310|FG004|Overall Study|Lack of compliance|1|||
105834552|NCT01583530|365050311|FG005|Overall Study|Lack of compliance|0|||
105834553|NCT03414034|365050312|FG000|Overall Study|Adverse Event|6|||
105834554|NCT03414034|365050313|FG001|Overall Study|Adverse Event|1|||
105834555|NCT03414034|365050314|FG002|Overall Study|Adverse Event|1|||
105834556|NCT03414034|365050312|FG000|Overall Study|Death|0|||
105834557|NCT03414034|365050313|FG001|Overall Study|Death|0|||
105834558|NCT03414034|365050314|FG002|Overall Study|Death|1|||
105834559|NCT03414034|365050312|FG000|Overall Study|Non-compliance With Study Drug|0|||
105834560|NCT03414034|365050313|FG001|Overall Study|Non-compliance With Study Drug|0|||
105834561|NCT03414034|365050314|FG002|Overall Study|Non-compliance With Study Drug|1|||
105834562|NCT03414034|365050312|FG000|Overall Study|Physician Decision|1|||
105834563|NCT03414034|365050313|FG001|Overall Study|Physician Decision|3|||
105834564|NCT03414034|365050314|FG002|Overall Study|Physician Decision|2|||
105834565|NCT03414034|365050312|FG000|Overall Study|Withdrawal of Informed Consent|2|||
105834566|NCT03414034|365050313|FG001|Overall Study|Withdrawal of Informed Consent|1|||
105834567|NCT03414034|365050314|FG002|Overall Study|Withdrawal of Informed Consent|4|||
105834568|NCT03414034|365050312|FG000|Overall Study|Progressive Disease|15|||
105834569|NCT03414034|365050313|FG001|Overall Study|Progressive Disease|15|||
105834570|NCT03414034|365050314|FG002|Overall Study|Progressive Disease|17|||
105834571|NCT03414034|365050312|FG000|Overall Study|Miscellaneous|0|||
105834572|NCT03414034|365050313|FG001|Overall Study|Miscellaneous|0|||
105834573|NCT03414034|365050314|FG002|Overall Study|Miscellaneous|2|||
105834574|NCT02351167|365050316|FG000|Overall Study|Withdrawal by Subject|19|||
105834575|NCT02351167|365050317|FG001|Overall Study|Withdrawal by Subject|18|||
105834576|NCT02351167|365050318|FG002|Overall Study|Withdrawal by Subject|21|||
105834577|NCT01332968|365050319|FG000|Induction Period|Adverse Event|23|||
105834578|NCT01332968|365050320|FG001|Induction Period|Adverse Event|26|||
105834579|NCT01332968|365050321|FG002|Induction Period|Adverse Event|0|||
105834580|NCT01332968|365050322|FG003|Induction Period|Adverse Event|0|||
105834581|NCT01332968|365050323|FG004|Induction Period|Adverse Event|0|||
105834582|NCT01332968|365050324|FG005|Induction Period|Adverse Event|0|||
105834583|NCT01332968|365050325|FG006|Induction Period|Adverse Event|0|||
105834584|NCT01332968|365050326|FG007|Induction Period|Adverse Event|0|||
105834585|NCT01332968|365050319|FG000|Induction Period|Death|1|||
105834586|NCT01332968|365050320|FG001|Induction Period|Death|4|||
105834587|NCT01332968|365050321|FG002|Induction Period|Death|0|||
105834588|NCT01332968|365050322|FG003|Induction Period|Death|0|||
105834589|NCT01332968|365050323|FG004|Induction Period|Death|0|||
105834590|NCT01332968|365050324|FG005|Induction Period|Death|0|||
105834591|NCT01332968|365050325|FG006|Induction Period|Death|0|||
105834592|NCT01332968|365050326|FG007|Induction Period|Death|0|||
105834593|NCT01332968|365050319|FG000|Induction Period|Non-compliance|1|||
105834594|NCT01332968|365050320|FG001|Induction Period|Non-compliance|0|||
105965411|NCT00623233|365532285|FG000|Overall Study|Adverse Event|10|||
105965412|NCT00623233|365532285|FG000|Overall Study|Physician Decision|10|||
105965413|NCT00623233|365532285|FG000|Overall Study|Lost to Follow-up|1|||
105965414|NCT00623233|365532285|FG000|Overall Study|Withdrawal by Subject|3|||
105965415|NCT01751906|365532292|FG000|Overall Study|Lost to Follow-up|151|||
105965416|NCT01751906|365532293|FG001|Overall Study|Lost to Follow-up|68|||
105965417|NCT01751906|365532292|FG000|Overall Study|Withdrawal by Subject|22|||
105965418|NCT01751906|365532293|FG001|Overall Study|Withdrawal by Subject|18|||
105965419|NCT01751906|365532292|FG000|Overall Study|Physician Decision|5|||
105965420|NCT01751906|365532293|FG001|Overall Study|Physician Decision|2|||
105965421|NCT01751906|365532292|FG000|Overall Study|Death|84|||
105965422|NCT01751906|365532293|FG001|Overall Study|Death|43|||
105965423|NCT01751906|365532292|FG000|Overall Study|Denied on premises for follow-up by law|1|||
105965424|NCT01751906|365532293|FG001|Overall Study|Denied on premises for follow-up by law|0|||
105965425|NCT01110330|365532296|FG000|Overall Study|Adverse Event|0|||
105965426|NCT01110330|365532297|FG001|Overall Study|Adverse Event|4|||
105965427|NCT01110330|365532298|FG002|Overall Study|Adverse Event|3|||
105834595|NCT01332968|365050321|FG002|Induction Period|Non-compliance|0|||
105834596|NCT01332968|365050322|FG003|Induction Period|Non-compliance|0|||
105965428|NCT01110330|365532296|FG000|Overall Study|Lack of Efficacy|3|||
105834597|NCT01332968|365050323|FG004|Induction Period|Non-compliance|0|||
105834598|NCT01332968|365050324|FG005|Induction Period|Non-compliance|0|||
106023168|NCT01667419|365750321|FG002|Overall Study|Withdrawal by Subject|9|||
106023169|NCT01667419|365750322|FG003|Overall Study|Withdrawal by Subject|8|||
105834599|NCT01332968|365050325|FG006|Induction Period|Non-compliance|0|||
105834600|NCT01332968|365050326|FG007|Induction Period|Non-compliance|0|||
105965429|NCT01110330|365532297|FG001|Overall Study|Lack of Efficacy|1|||
105965430|NCT01110330|365532298|FG002|Overall Study|Lack of Efficacy|1|||
105965431|NCT01110330|365532296|FG000|Overall Study|Lost to Follow-up|9|||
105834601|NCT01332968|365050319|FG000|Induction Period|Other|2|||
105834602|NCT01332968|365050320|FG001|Induction Period|Other|2|||
105834603|NCT01332968|365050321|FG002|Induction Period|Other|0|||
105834604|NCT01332968|365050322|FG003|Induction Period|Other|0|||
105834605|NCT01332968|365050323|FG004|Induction Period|Other|0|||
105834606|NCT01332968|365050324|FG005|Induction Period|Other|0|||
105965432|NCT01110330|365532297|FG001|Overall Study|Lost to Follow-up|10|||
106023170|NCT01667419|365750319|FG000|Overall Study|Non-compliance|0|||
105834607|NCT01332968|365050325|FG006|Induction Period|Other|0|||
105834608|NCT01332968|365050326|FG007|Induction Period|Other|0|||
105834609|NCT01332968|365050319|FG000|Induction Period|Physician Decision|6|||
105834610|NCT01332968|365050320|FG001|Induction Period|Physician Decision|1|||
105834611|NCT01332968|365050321|FG002|Induction Period|Physician Decision|0|||
105834612|NCT01332968|365050322|FG003|Induction Period|Physician Decision|0|||
105834613|NCT01332968|365050323|FG004|Induction Period|Physician Decision|0|||
105834614|NCT01332968|365050324|FG005|Induction Period|Physician Decision|0|||
105834615|NCT01332968|365050325|FG006|Induction Period|Physician Decision|0|||
105834616|NCT01332968|365050326|FG007|Induction Period|Physician Decision|0|||
105834617|NCT01332968|365050319|FG000|Induction Period|Progressive Disease|15|||
105834618|NCT01332968|365050320|FG001|Induction Period|Progressive Disease|7|||
105834619|NCT01332968|365050321|FG002|Induction Period|Progressive Disease|0|||
105834620|NCT01332968|365050322|FG003|Induction Period|Progressive Disease|0|||
105834621|NCT01332968|365050323|FG004|Induction Period|Progressive Disease|0|||
105834622|NCT01332968|365050324|FG005|Induction Period|Progressive Disease|0|||
105834623|NCT01332968|365050325|FG006|Induction Period|Progressive Disease|0|||
105834624|NCT01332968|365050326|FG007|Induction Period|Progressive Disease|0|||
105834625|NCT01332968|365050319|FG000|Induction Period|Protocol Violation|3|||
105834626|NCT01332968|365050320|FG001|Induction Period|Protocol Violation|4|||
105834627|NCT01332968|365050321|FG002|Induction Period|Protocol Violation|0|||
105834628|NCT01332968|365050322|FG003|Induction Period|Protocol Violation|0|||
105834629|NCT01332968|365050323|FG004|Induction Period|Protocol Violation|0|||
105834630|NCT01332968|365050324|FG005|Induction Period|Protocol Violation|0|||
105834631|NCT01332968|365050325|FG006|Induction Period|Protocol Violation|0|||
105834632|NCT01332968|365050326|FG007|Induction Period|Protocol Violation|0|||
105834633|NCT01332968|365050319|FG000|Induction Period|Withdrawal by Subject|3|||
105834634|NCT01332968|365050320|FG001|Induction Period|Withdrawal by Subject|5|||
105834635|NCT01332968|365050321|FG002|Induction Period|Withdrawal by Subject|0|||
105834636|NCT01332968|365050322|FG003|Induction Period|Withdrawal by Subject|0|||
105834637|NCT01332968|365050323|FG004|Induction Period|Withdrawal by Subject|0|||
105834638|NCT01332968|365050324|FG005|Induction Period|Withdrawal by Subject|0|||
105834639|NCT01332968|365050325|FG006|Induction Period|Withdrawal by Subject|0|||
105834640|NCT01332968|365050326|FG007|Induction Period|Withdrawal by Subject|0|||
105834641|NCT01332968|365050319|FG000|Induction Period|Randomised but not treated|4|||
105834642|NCT01332968|365050320|FG001|Induction Period|Randomised but not treated|7|||
105834643|NCT01332968|365050321|FG002|Induction Period|Randomised but not treated|0|||
105834644|NCT01332968|365050322|FG003|Induction Period|Randomised but not treated|0|||
105834645|NCT01332968|365050323|FG004|Induction Period|Randomised but not treated|0|||
105834646|NCT01332968|365050324|FG005|Induction Period|Randomised but not treated|0|||
105834647|NCT01332968|365050325|FG006|Induction Period|Randomised but not treated|0|||
105834648|NCT01332968|365050326|FG007|Induction Period|Randomised but not treated|0|||
105834649|NCT01332968|365050319|FG000|Maintenance/Observation Period|Adverse Event|0|||
105834650|NCT01332968|365050320|FG001|Maintenance/Observation Period|Adverse Event|0|||
105834651|NCT01332968|365050321|FG002|Maintenance/Observation Period|Adverse Event|53|||
105834652|NCT01332968|365050322|FG003|Maintenance/Observation Period|Adverse Event|66|||
105834653|NCT01332968|365050323|FG004|Maintenance/Observation Period|Adverse Event|0|||
105834654|NCT01332968|365050324|FG005|Maintenance/Observation Period|Adverse Event|0|||
105834655|NCT01332968|365050325|FG006|Maintenance/Observation Period|Adverse Event|0|||
105834656|NCT01332968|365050326|FG007|Maintenance/Observation Period|Adverse Event|0|||
105834657|NCT01332968|365050319|FG000|Maintenance/Observation Period|Death|0|||
105834658|NCT01332968|365050320|FG001|Maintenance/Observation Period|Death|0|||
105834659|NCT01332968|365050321|FG002|Maintenance/Observation Period|Death|5|||
105834660|NCT01332968|365050322|FG003|Maintenance/Observation Period|Death|6|||
105834661|NCT01332968|365050323|FG004|Maintenance/Observation Period|Death|0|||
105834662|NCT01332968|365050324|FG005|Maintenance/Observation Period|Death|0|||
105834663|NCT01332968|365050325|FG006|Maintenance/Observation Period|Death|0|||
105834664|NCT01332968|365050326|FG007|Maintenance/Observation Period|Death|0|||
105834665|NCT01332968|365050319|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
105834666|NCT01332968|365050320|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
105834667|NCT01332968|365050321|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
105834668|NCT01332968|365050322|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
105834669|NCT01332968|365050323|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
105834670|NCT01332968|365050324|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
105834671|NCT01332968|365050325|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
105834672|NCT01332968|365050326|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
105834673|NCT01332968|365050319|FG000|Maintenance/Observation Period|Non-compliance|0|||
105834674|NCT01332968|365050320|FG001|Maintenance/Observation Period|Non-compliance|0|||
105834675|NCT01332968|365050321|FG002|Maintenance/Observation Period|Non-compliance|4|||
105834676|NCT01332968|365050322|FG003|Maintenance/Observation Period|Non-compliance|3|||
105834677|NCT01332968|365050323|FG004|Maintenance/Observation Period|Non-compliance|0|||
105834678|NCT01332968|365050324|FG005|Maintenance/Observation Period|Non-compliance|0|||
105834679|NCT01332968|365050325|FG006|Maintenance/Observation Period|Non-compliance|0|||
105834680|NCT01332968|365050326|FG007|Maintenance/Observation Period|Non-compliance|0|||
105834681|NCT01332968|365050319|FG000|Maintenance/Observation Period|Other|0|||
105834682|NCT01332968|365050320|FG001|Maintenance/Observation Period|Other|0|||
105834683|NCT01332968|365050321|FG002|Maintenance/Observation Period|Other|4|||
105834684|NCT01332968|365050322|FG003|Maintenance/Observation Period|Other|7|||
105834685|NCT01332968|365050323|FG004|Maintenance/Observation Period|Other|0|||
105834686|NCT01332968|365050324|FG005|Maintenance/Observation Period|Other|0|||
105834687|NCT01332968|365050325|FG006|Maintenance/Observation Period|Other|0|||
105834688|NCT01332968|365050326|FG007|Maintenance/Observation Period|Other|0|||
105834689|NCT01332968|365050319|FG000|Maintenance/Observation Period|Physician Decision|0|||
105834690|NCT01332968|365050320|FG001|Maintenance/Observation Period|Physician Decision|0|||
105834691|NCT01332968|365050321|FG002|Maintenance/Observation Period|Physician Decision|14|||
105834692|NCT01332968|365050322|FG003|Maintenance/Observation Period|Physician Decision|19|||
105834693|NCT01332968|365050323|FG004|Maintenance/Observation Period|Physician Decision|0|||
105834694|NCT01332968|365050324|FG005|Maintenance/Observation Period|Physician Decision|1|||
105834695|NCT01332968|365050325|FG006|Maintenance/Observation Period|Physician Decision|0|||
105834696|NCT01332968|365050326|FG007|Maintenance/Observation Period|Physician Decision|0|||
105834697|NCT01332968|365050319|FG000|Maintenance/Observation Period|Progressive Disease|0|||
105834698|NCT01332968|365050320|FG001|Maintenance/Observation Period|Progressive Disease|0|||
105834699|NCT01332968|365050321|FG002|Maintenance/Observation Period|Progressive Disease|72|||
105834700|NCT01332968|365050322|FG003|Maintenance/Observation Period|Progressive Disease|40|||
105834701|NCT01332968|365050323|FG004|Maintenance/Observation Period|Progressive Disease|0|||
105834702|NCT01332968|365050324|FG005|Maintenance/Observation Period|Progressive Disease|0|||
105834703|NCT01332968|365050325|FG006|Maintenance/Observation Period|Progressive Disease|0|||
105834704|NCT01332968|365050326|FG007|Maintenance/Observation Period|Progressive Disease|0|||
105834705|NCT01332968|365050319|FG000|Maintenance/Observation Period|Protocol Violation|0|||
105834706|NCT01332968|365050320|FG001|Maintenance/Observation Period|Protocol Violation|0|||
105834707|NCT01332968|365050321|FG002|Maintenance/Observation Period|Protocol Violation|1|||
105834708|NCT01332968|365050322|FG003|Maintenance/Observation Period|Protocol Violation|1|||
105834709|NCT01332968|365050323|FG004|Maintenance/Observation Period|Protocol Violation|0|||
105834710|NCT01332968|365050324|FG005|Maintenance/Observation Period|Protocol Violation|0|||
105834711|NCT01332968|365050325|FG006|Maintenance/Observation Period|Protocol Violation|0|||
105834712|NCT01332968|365050326|FG007|Maintenance/Observation Period|Protocol Violation|0|||
105834713|NCT01332968|365050319|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834714|NCT01332968|365050320|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834715|NCT01332968|365050321|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
105834716|NCT01332968|365050322|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
105834717|NCT01332968|365050323|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834718|NCT01332968|365050324|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834719|NCT01332968|365050325|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834720|NCT01332968|365050326|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
105834721|NCT01332968|365050319|FG000|Follow-Up Period|Adverse Event|0|||
105834722|NCT01332968|365050320|FG001|Follow-Up Period|Adverse Event|0|||
105834723|NCT01332968|365050321|FG002|Follow-Up Period|Adverse Event|0|||
105834724|NCT01332968|365050322|FG003|Follow-Up Period|Adverse Event|0|||
105834725|NCT01332968|365050323|FG004|Follow-Up Period|Adverse Event|0|||
105834726|NCT01332968|365050324|FG005|Follow-Up Period|Adverse Event|0|||
105834727|NCT01332968|365050325|FG006|Follow-Up Period|Adverse Event|0|||
105834728|NCT01332968|365050326|FG007|Follow-Up Period|Adverse Event|4|||
105834729|NCT01332968|365050319|FG000|Follow-Up Period|Death|0|||
105834730|NCT01332968|365050320|FG001|Follow-Up Period|Death|0|||
105834731|NCT01332968|365050321|FG002|Follow-Up Period|Death|0|||
105834732|NCT01332968|365050322|FG003|Follow-Up Period|Death|0|||
105834733|NCT01332968|365050323|FG004|Follow-Up Period|Death|0|||
105834734|NCT01332968|365050324|FG005|Follow-Up Period|Death|0|||
105834735|NCT01332968|365050325|FG006|Follow-Up Period|Death|27|||
106149151|NCT02554786|366206968|FG003|Overall Study|Death|1|||
106149152|NCT02554786|366206969|FG004|Overall Study|Death|0|||
106149153|NCT02554786|366206965|FG000|Overall Study|Non-compliance with study treatment|0|||
106149154|NCT02554786|366206966|FG001|Overall Study|Non-compliance with study treatment|1|||
106149155|NCT02554786|366206967|FG002|Overall Study|Non-compliance with study treatment|1|||
106149156|NCT02554786|366206968|FG003|Overall Study|Non-compliance with study treatment|0|||
106149157|NCT02554786|366206969|FG004|Overall Study|Non-compliance with study treatment|1|||
106149158|NCT02554786|366206965|FG000|Overall Study|Physician Decision|0|||
105834736|NCT01332968|365050326|FG007|Follow-Up Period|Death|30|||
106023171|NCT01667419|365750320|FG001|Overall Study|Non-compliance|0|||
106149159|NCT02554786|366206966|FG001|Overall Study|Physician Decision|1|||
105834737|NCT01332968|365050319|FG000|Follow-Up Period|Lost to Follow-up|0|||
105834738|NCT01332968|365050320|FG001|Follow-Up Period|Lost to Follow-up|0|||
105834739|NCT01332968|365050321|FG002|Follow-Up Period|Lost to Follow-up|0|||
105834740|NCT01332968|365050322|FG003|Follow-Up Period|Lost to Follow-up|0|||
105834741|NCT01332968|365050323|FG004|Follow-Up Period|Lost to Follow-up|0|||
105834742|NCT01332968|365050324|FG005|Follow-Up Period|Lost to Follow-up|0|||
105834743|NCT01332968|365050325|FG006|Follow-Up Period|Lost to Follow-up|11|||
105834744|NCT01332968|365050326|FG007|Follow-Up Period|Lost to Follow-up|15|||
105834745|NCT01332968|365050319|FG000|Follow-Up Period|Non-compliance|0|||
105834746|NCT01332968|365050320|FG001|Follow-Up Period|Non-compliance|0|||
105834747|NCT01332968|365050321|FG002|Follow-Up Period|Non-compliance|0|||
105834748|NCT01332968|365050322|FG003|Follow-Up Period|Non-compliance|0|||
105834749|NCT01332968|365050323|FG004|Follow-Up Period|Non-compliance|0|||
105834750|NCT01332968|365050324|FG005|Follow-Up Period|Non-compliance|0|||
105834751|NCT01332968|365050325|FG006|Follow-Up Period|Non-compliance|4|||
105834752|NCT01332968|365050326|FG007|Follow-Up Period|Non-compliance|9|||
105834753|NCT01332968|365050319|FG000|Follow-Up Period|Other|0|||
105834754|NCT01332968|365050320|FG001|Follow-Up Period|Other|0|||
105834755|NCT01332968|365050321|FG002|Follow-Up Period|Other|0|||
105834756|NCT01332968|365050322|FG003|Follow-Up Period|Other|0|||
105834757|NCT01332968|365050323|FG004|Follow-Up Period|Other|0|||
105834758|NCT01332968|365050324|FG005|Follow-Up Period|Other|0|||
105834759|NCT01332968|365050325|FG006|Follow-Up Period|Other|18|||
105834760|NCT01332968|365050326|FG007|Follow-Up Period|Other|21|||
105834761|NCT01332968|365050319|FG000|Follow-Up Period|Physician Decision|0|||
105834762|NCT01332968|365050320|FG001|Follow-Up Period|Physician Decision|0|||
105834763|NCT01332968|365050321|FG002|Follow-Up Period|Physician Decision|0|||
105834764|NCT01332968|365050322|FG003|Follow-Up Period|Physician Decision|0|||
105834765|NCT01332968|365050323|FG004|Follow-Up Period|Physician Decision|0|||
106023172|NCT01667419|365750321|FG002|Overall Study|Non-compliance|0|||
106023173|NCT01667419|365750322|FG003|Overall Study|Non-compliance|1|||
106023174|NCT01667419|365750319|FG000|Overall Study|Protocol Violation|1|||
106023175|NCT01667419|365750320|FG001|Overall Study|Protocol Violation|0|||
106023176|NCT01667419|365750321|FG002|Overall Study|Protocol Violation|0|||
106023177|NCT01667419|365750322|FG003|Overall Study|Protocol Violation|0|||
106023178|NCT01667419|365750319|FG000|Overall Study|Lost to Follow-up|7|||
105834766|NCT01332968|365050324|FG005|Follow-Up Period|Physician Decision|0|||
105834767|NCT01332968|365050325|FG006|Follow-Up Period|Physician Decision|12|||
105834768|NCT01332968|365050326|FG007|Follow-Up Period|Physician Decision|15|||
105834769|NCT01332968|365050319|FG000|Follow-Up Period|Progressive Disease|0|||
105834770|NCT01332968|365050320|FG001|Follow-Up Period|Progressive Disease|0|||
105834771|NCT01332968|365050321|FG002|Follow-Up Period|Progressive Disease|0|||
105834772|NCT01332968|365050322|FG003|Follow-Up Period|Progressive Disease|0|||
105834773|NCT01332968|365050323|FG004|Follow-Up Period|Progressive Disease|0|||
105834774|NCT01332968|365050324|FG005|Follow-Up Period|Progressive Disease|0|||
105834775|NCT01332968|365050325|FG006|Follow-Up Period|Progressive Disease|126|||
106023179|NCT01667419|365750320|FG001|Overall Study|Lost to Follow-up|6|||
106023180|NCT01667419|365750321|FG002|Overall Study|Lost to Follow-up|2|||
105834776|NCT01332968|365050326|FG007|Follow-Up Period|Progressive Disease|106|||
105834777|NCT01332968|365050319|FG000|Follow-Up Period|Protocol Violation|0|||
105834778|NCT01332968|365050320|FG001|Follow-Up Period|Protocol Violation|0|||
105834779|NCT01332968|365050321|FG002|Follow-Up Period|Protocol Violation|0|||
105834780|NCT01332968|365050322|FG003|Follow-Up Period|Protocol Violation|0|||
105834781|NCT01332968|365050323|FG004|Follow-Up Period|Protocol Violation|0|||
105834782|NCT01332968|365050324|FG005|Follow-Up Period|Protocol Violation|0|||
105834783|NCT01332968|365050325|FG006|Follow-Up Period|Protocol Violation|1|||
105834784|NCT01332968|365050326|FG007|Follow-Up Period|Protocol Violation|0|||
105834785|NCT01332968|365050319|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105834786|NCT01332968|365050320|FG001|Follow-Up Period|Withdrawal by Subject|0|||
105834787|NCT01332968|365050321|FG002|Follow-Up Period|Withdrawal by Subject|0|||
105834788|NCT01332968|365050322|FG003|Follow-Up Period|Withdrawal by Subject|0|||
105834789|NCT01332968|365050323|FG004|Follow-Up Period|Withdrawal by Subject|0|||
105834790|NCT01332968|365050324|FG005|Follow-Up Period|Withdrawal by Subject|0|||
105834791|NCT01332968|365050325|FG006|Follow-Up Period|Withdrawal by Subject|29|||
105834792|NCT01332968|365050326|FG007|Follow-Up Period|Withdrawal by Subject|32|||
105834793|NCT01332968|365050319|FG000|Follow-Up Period|No reason provided|0|||
105834794|NCT01332968|365050320|FG001|Follow-Up Period|No reason provided|0|||
105834795|NCT01332968|365050321|FG002|Follow-Up Period|No reason provided|0|||
105834796|NCT01332968|365050322|FG003|Follow-Up Period|No reason provided|0|||
105834797|NCT01332968|365050323|FG004|Follow-Up Period|No reason provided|0|||
105834798|NCT01332968|365050324|FG005|Follow-Up Period|No reason provided|0|||
105834799|NCT01332968|365050325|FG006|Follow-Up Period|No reason provided|2|||
105834800|NCT01332968|365050326|FG007|Follow-Up Period|No reason provided|3|||
105834801|NCT00515216|365050327|FG000|Overall Study|Withdrawal by Subject|1|||
105834802|NCT01450800|365050328|FG000|Overall Study|Protocol Violation|1|||
105834803|NCT01450800|365050329|FG001|Overall Study|Protocol Violation|3|||
105834804|NCT04106817|365050330|FG000|Overall Study|Lost to Follow-up|1|||
105834805|NCT04106817|365050331|FG001|Overall Study|Lost to Follow-up|0|||
105834806|NCT04106817|365050332|FG002|Overall Study|Lost to Follow-up|0|||
105834807|NCT02460835|365051861|FG000|Overall Study|Disease progression prior to treatment|3|||
105834808|NCT02460835|365051861|FG000|Overall Study|Unable to complete planning scans|2|||
105834809|NCT02460835|365051861|FG000|Overall Study|Decrease in performance status|1|||
105834810|NCT02460835|365051861|FG000|Overall Study|Withdrawal by Subject|3|||
105834811|NCT02460835|365051861|FG000|Overall Study|Underwent fractionated RT|10|||
105834812|NCT02460835|365051861|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
105834813|NCT04129944|365051864|FG000|Overall Study|Death|0|||
105834814|NCT04129944|365051865|FG001|Overall Study|Death|0|||
105834815|NCT04129944|365051866|FG002|Overall Study|Death|0|||
105834816|NCT04129944|365051867|FG003|Overall Study|Death|1|||
105834817|NCT04129944|365051864|FG000|Overall Study|Lost to Follow-up|1|||
105834818|NCT04129944|365051865|FG001|Overall Study|Lost to Follow-up|0|||
105834819|NCT04129944|365051866|FG002|Overall Study|Lost to Follow-up|0|||
105834820|NCT04129944|365051867|FG003|Overall Study|Lost to Follow-up|0|||
105834821|NCT04129944|365051864|FG000|Overall Study|Withdrawal by Subject|1|||
105834822|NCT04129944|365051865|FG001|Overall Study|Withdrawal by Subject|0|||
105834823|NCT04129944|365051866|FG002|Overall Study|Withdrawal by Subject|1|||
105834824|NCT04129944|365051867|FG003|Overall Study|Withdrawal by Subject|2|||
105834825|NCT00493792|365051870|FG000|Overall Study|Death|55|||
105834826|NCT00493792|365051871|FG001|Overall Study|Death|50|||
105834827|NCT00493792|365051870|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
105834828|NCT00493792|365051871|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
105834829|NCT03008005|365051874|FG000|Overall Study|Physician Decision|1|||
105834830|NCT03008005|365051875|FG001|Overall Study|Physician Decision|0|||
105834831|NCT03008005|365051876|FG002|Overall Study|Physician Decision|0|||
105834832|NCT03008005|365051874|FG000|Overall Study|Withdrawal by Subject|1|||
105834833|NCT03008005|365051875|FG001|Overall Study|Withdrawal by Subject|0|||
105834834|NCT03008005|365051876|FG002|Overall Study|Withdrawal by Subject|0|||
105834835|NCT03008005|365051874|FG000|Overall Study|Ineligible|0|||
105834836|NCT03008005|365051875|FG001|Overall Study|Ineligible|1|||
105834837|NCT03008005|365051876|FG002|Overall Study|Ineligible|0|||
105834838|NCT01628549|365051877|FG000|Overall Study|Adverse Event|1|||
105834839|NCT01628549|365051878|FG001|Overall Study|Adverse Event|1|||
105834840|NCT01628549|365051879|FG002|Overall Study|Adverse Event|0|||
105834841|NCT01628549|365051880|FG003|Overall Study|Adverse Event|4|||
105834842|NCT01628549|365051877|FG000|Overall Study|Lost to Follow-up|3|||
105834843|NCT01628549|365051878|FG001|Overall Study|Lost to Follow-up|4|||
105834844|NCT01628549|365051879|FG002|Overall Study|Lost to Follow-up|3|||
105834845|NCT01628549|365051880|FG003|Overall Study|Lost to Follow-up|3|||
105834846|NCT01628549|365051877|FG000|Overall Study|Withdrawal by Subject|3|||
105834847|NCT01628549|365051878|FG001|Overall Study|Withdrawal by Subject|4|||
105834848|NCT01628549|365051879|FG002|Overall Study|Withdrawal by Subject|4|||
105834849|NCT01628549|365051880|FG003|Overall Study|Withdrawal by Subject|1|||
105834850|NCT01628549|365051877|FG000|Overall Study|Protocol Violation|2|||
105834851|NCT01628549|365051878|FG001|Overall Study|Protocol Violation|1|||
105834852|NCT01628549|365051879|FG002|Overall Study|Protocol Violation|1|||
105834853|NCT01628549|365051880|FG003|Overall Study|Protocol Violation|0|||
105834854|NCT01628549|365051877|FG000|Overall Study|withdrawn for noncompliance|0|||
105834855|NCT01628549|365051878|FG001|Overall Study|withdrawn for noncompliance|2|||
105834856|NCT01628549|365051879|FG002|Overall Study|withdrawn for noncompliance|1|||
106149160|NCT02554786|366206967|FG002|Overall Study|Physician Decision|4|||
106149161|NCT02554786|366206968|FG003|Overall Study|Physician Decision|1|||
106149162|NCT02554786|366206969|FG004|Overall Study|Physician Decision|1|||
106149163|NCT02554786|366206965|FG000|Overall Study|Pregnancy|0|||
105834857|NCT01628549|365051880|FG003|Overall Study|withdrawn for noncompliance|0|||
105834858|NCT01628549|365051877|FG000|Overall Study|abnormal laboratory test results|0|||
105834859|NCT01628549|365051878|FG001|Overall Study|abnormal laboratory test results|0|||
105834860|NCT01628549|365051879|FG002|Overall Study|abnormal laboratory test results|1|||
105834861|NCT01628549|365051880|FG003|Overall Study|abnormal laboratory test results|0|||
105834862|NCT01628549|365051877|FG000|Overall Study|positive pregnancy test|0|||
105834863|NCT01628549|365051878|FG001|Overall Study|positive pregnancy test|0|||
105834864|NCT01628549|365051879|FG002|Overall Study|positive pregnancy test|0|||
105834865|NCT01628549|365051880|FG003|Overall Study|positive pregnancy test|1|||
105834866|NCT03480022|365051885|FG000|Overall Study|Pregnancy|2|||
105834867|NCT03480022|365051886|FG001|Overall Study|Pregnancy|0|||
105834868|NCT03480022|365051885|FG000|Overall Study|Adverse Event|6|||
105834869|NCT03480022|365051886|FG001|Overall Study|Adverse Event|0|||
105834870|NCT03480022|365051885|FG000|Overall Study|Lack of Efficacy|0|||
105834871|NCT03480022|365051886|FG001|Overall Study|Lack of Efficacy|2|||
105834872|NCT03480022|365051885|FG000|Overall Study|Physician Decision|0|||
105834873|NCT03480022|365051886|FG001|Overall Study|Physician Decision|1|||
105834874|NCT03480022|365051885|FG000|Overall Study|Withdrawal by Subject|2|||
105834875|NCT03480022|365051886|FG001|Overall Study|Withdrawal by Subject|0|||
105834876|NCT03480022|365051885|FG000|Overall Study|Medication concerns|1|||
105834877|NCT03480022|365051886|FG001|Overall Study|Medication concerns|0|||
105834878|NCT03480022|365051885|FG000|Overall Study|Family member COVID exposure|0|||
105834879|NCT03480022|365051886|FG001|Overall Study|Family member COVID exposure|1|||
105834880|NCT02050321|365051891|FG000|Overall Study|Withdrawal by Subject|1|||
105834881|NCT02050321|365051891|FG000|Overall Study|Adverse Event|1|||
105834882|NCT04768114|365051892|FG000|Overall Study|Lost to Follow-up|5|||
105834883|NCT04768114|365051893|FG001|Overall Study|Lost to Follow-up|10|||
105834884|NCT04768114|365051892|FG000|Overall Study|Withdrawal by Subject|0|||
105834885|NCT04768114|365051893|FG001|Overall Study|Withdrawal by Subject|1|||
105834886|NCT00113919|365051894|FG000|Overall Study|Physician Decision|8|||
105834887|NCT00113919|365051894|FG000|Overall Study|Death|6|||
105834888|NCT02005276|365051895|FG000|Overall Study|No longer interested|5|||
105834889|NCT02005276|365051896|FG001|Overall Study|No longer interested|2|||
105834890|NCT02005276|365051897|FG002|Overall Study|No longer interested|3|||
105834891|NCT02005276|365051898|FG003|Overall Study|No longer interested|3|||
105834892|NCT01963260|365051899|FG000|Overall Study|Withdrawal by Subject|2|||
105834893|NCT01963260|365051900|FG001|Overall Study|Withdrawal by Subject|0|||
105834894|NCT01963260|365051901|FG002|Overall Study|Withdrawal by Subject|0|||
105834895|NCT01963260|365051902|FG003|Overall Study|Withdrawal by Subject|1|||
105834896|NCT01963260|365051903|FG004|Overall Study|Withdrawal by Subject|2|||
105834897|NCT01963260|365051904|FG005|Overall Study|Withdrawal by Subject|0|||
105834898|NCT01963260|365051905|FG006|Overall Study|Withdrawal by Subject|0|||
105834899|NCT01963260|365051906|FG007|Overall Study|Withdrawal by Subject|0|||
105834900|NCT01963260|365051907|FG008|Overall Study|Withdrawal by Subject|0|||
105834901|NCT01963260|365051908|FG009|Overall Study|Withdrawal by Subject|0|||
105834902|NCT00530348|365051909|FG000|Overall Study|Adverse Event|5|||
106149164|NCT02554786|366206966|FG001|Overall Study|Pregnancy|0|||
106149165|NCT02554786|366206967|FG002|Overall Study|Pregnancy|0|||
106149166|NCT02554786|366206968|FG003|Overall Study|Pregnancy|1|||
106149167|NCT02554786|366206969|FG004|Overall Study|Pregnancy|1|||
106149168|NCT03684044|366206970|FG000|Overall Study|Adverse Event|3|||
106149169|NCT03684044|366206971|FG001|Overall Study|Adverse Event|0|||
106149170|NCT03684044|366206970|FG000|Overall Study|Death|4|||
106149171|NCT03684044|366206971|FG001|Overall Study|Death|7|||
106149172|NCT03684044|366206970|FG000|Overall Study|Lost to Follow-up|3|||
105834903|NCT00530348|365051910|FG001|Overall Study|Adverse Event|1|||
105834904|NCT00530348|365051909|FG000|Overall Study|Death|0|||
105834905|NCT00530348|365051910|FG001|Overall Study|Death|1|||
105834906|NCT00530348|365051909|FG000|Overall Study|Lack of Efficacy|2|||
105834907|NCT00530348|365051910|FG001|Overall Study|Lack of Efficacy|0|||
105834908|NCT00530348|365051909|FG000|Overall Study|Lost to Follow-up|0|||
105834909|NCT00530348|365051910|FG001|Overall Study|Lost to Follow-up|2|||
105834910|NCT00530348|365051909|FG000|Overall Study|Physician Decision|1|||
105834911|NCT00530348|365051910|FG001|Overall Study|Physician Decision|2|||
105834912|NCT00530348|365051909|FG000|Overall Study|Pregnancy|1|||
105834913|NCT00530348|365051910|FG001|Overall Study|Pregnancy|0|||
105834914|NCT00530348|365051909|FG000|Overall Study|Withdrawal by Subject|12|||
105834915|NCT00530348|365051910|FG001|Overall Study|Withdrawal by Subject|12|||
105834916|NCT00530348|365051909|FG000|Overall Study|Randomised in error|1|||
105834917|NCT00530348|365051910|FG001|Overall Study|Randomised in error|0|||
105834918|NCT00530348|365051909|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
106149173|NCT03684044|366206971|FG001|Overall Study|Lost to Follow-up|2|||
105834919|NCT00530348|365051910|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
105834920|NCT00372996|365051911|FG000|Overall Study|Death|11|||
105834921|NCT00372996|365051912|FG001|Overall Study|Death|4|||
105834922|NCT00372996|365051913|FG002|Overall Study|Death|8|||
105834923|NCT00372996|365051914|FG003|Overall Study|Death|7|||
105834924|NCT00372996|365051911|FG000|Overall Study|Lost to Follow-up|0|||
105834925|NCT00372996|365051912|FG001|Overall Study|Lost to Follow-up|2|||
105834926|NCT00372996|365051913|FG002|Overall Study|Lost to Follow-up|0|||
105834927|NCT00372996|365051914|FG003|Overall Study|Lost to Follow-up|1|||
105834928|NCT00372996|365051911|FG000|Overall Study|Withdrawal by Subject|12|||
105834929|NCT00372996|365051912|FG001|Overall Study|Withdrawal by Subject|6|||
105834930|NCT00372996|365051913|FG002|Overall Study|Withdrawal by Subject|9|||
105834931|NCT00372996|365051914|FG003|Overall Study|Withdrawal by Subject|5|||
105834932|NCT00372996|365051911|FG000|Overall Study|Study Terminated by Sponsor|4|||
105834933|NCT00372996|365051912|FG001|Overall Study|Study Terminated by Sponsor|0|||
105834934|NCT00372996|365051913|FG002|Overall Study|Study Terminated by Sponsor|4|||
105834935|NCT00372996|365051914|FG003|Overall Study|Study Terminated by Sponsor|0|||
105834936|NCT00372996|365051911|FG000|Overall Study|Other|10|||
105834937|NCT00372996|365051912|FG001|Overall Study|Other|2|||
105834938|NCT00372996|365051913|FG002|Overall Study|Other|7|||
105834939|NCT00372996|365051914|FG003|Overall Study|Other|7|||
105834940|NCT01091363|365051915|FG000|Overall Study|Withdrawal by Subject|11|||
105834941|NCT01091363|365051916|FG001|Overall Study|Withdrawal by Subject|15|||
105965433|NCT01110330|365532298|FG002|Overall Study|Lost to Follow-up|15|||
105965434|NCT01110330|365532296|FG000|Overall Study|Physician Decision|0|||
105965435|NCT01110330|365532297|FG001|Overall Study|Physician Decision|1|||
105965436|NCT01110330|365532298|FG002|Overall Study|Physician Decision|0|||
105965437|NCT01110330|365532296|FG000|Overall Study|Protocol Violation|2|||
105965438|NCT01110330|365532297|FG001|Overall Study|Protocol Violation|0|||
105965439|NCT01110330|365532298|FG002|Overall Study|Protocol Violation|4|||
105965440|NCT01110330|365532296|FG000|Overall Study|Withdrawal by Subject|0|||
105965441|NCT01110330|365532297|FG001|Overall Study|Withdrawal by Subject|6|||
105965442|NCT01110330|365532298|FG002|Overall Study|Withdrawal by Subject|2|||
105965443|NCT01110330|365532296|FG000|Overall Study|Other|1|||
105965444|NCT01110330|365532297|FG001|Overall Study|Other|1|||
105965445|NCT01110330|365532298|FG002|Overall Study|Other|1|||
105965446|NCT05791565|365532308|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
105965447|NCT05791565|365532309|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
105965448|NCT04644276|365532310|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
105965449|NCT04644276|365532311|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
105965450|NCT04644276|365532312|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
105965451|NCT02388165|365532315|FG000|Overall Study|Study terminated by sponsor|5|||
105965452|NCT02388165|365532316|FG001|Overall Study|Study terminated by sponsor|5|||
105965453|NCT02388165|365532315|FG000|Overall Study|Other|11|||
105965454|NCT02388165|365532316|FG001|Overall Study|Other|13|||
105965455|NCT02388165|365532315|FG000|Overall Study|No longer meet eligibility criteria|40|||
105965456|NCT02388165|365532316|FG001|Overall Study|No longer meet eligibility criteria|43|||
105965457|NCT02388165|365532315|FG000|Overall Study|Withdrawal of consent|31|||
105965458|NCT02388165|365532316|FG001|Overall Study|Withdrawal of consent|32|||
105965459|NCT02388165|365532315|FG000|Overall Study|Lost to Follow-up|19|||
105965460|NCT02388165|365532316|FG001|Overall Study|Lost to Follow-up|20|||
105965461|NCT02388165|365532315|FG000|Overall Study|Death|13|||
105965462|NCT02388165|365532316|FG001|Overall Study|Death|10|||
105965463|NCT02388165|365532315|FG000|Overall Study|Adverse Event|3|||
105965464|NCT02388165|365532316|FG001|Overall Study|Adverse Event|5|||
105965465|NCT02388165|365532315|FG000|Overall Study|Did not meet entrance criteria|5|||
105965466|NCT02388165|365532316|FG001|Overall Study|Did not meet entrance criteria|2|||
105965467|NCT04729972|365532317|FG000|Overall Study|Adverse Event|1|||
105965468|NCT01951586|365532325|FG000|Overall Study|Death|61|||
105965469|NCT01951586|365532326|FG001|Overall Study|Death|120|||
106023181|NCT01667419|365750322|FG003|Overall Study|Lost to Follow-up|4|||
105834942|NCT01091363|365051915|FG000|Overall Study|Lost to Follow-up|2|||
105834943|NCT01091363|365051916|FG001|Overall Study|Lost to Follow-up|2|||
105965470|NCT01951586|365532325|FG000|Overall Study|Withdrawal by Subject|8|||
105965471|NCT01951586|365532326|FG001|Overall Study|Withdrawal by Subject|17|||
105965472|NCT01951586|365532325|FG000|Overall Study|Lost to Follow-up|0|||
105965473|NCT01951586|365532326|FG001|Overall Study|Lost to Follow-up|1|||
105834944|NCT03419962|365051919|FG000|Overall Study|Change to other medication|1|||
105965474|NCT01951586|365532325|FG000|Overall Study|Sponsor Decision|9|||
105965475|NCT01951586|365532326|FG001|Overall Study|Sponsor Decision|10|||
105965476|NCT01667224|365532328|FG000|Overall Study|Withdrawal by Subject|3|||
105965477|NCT01667224|365532329|FG001|Overall Study|Withdrawal by Subject|1|||
105965478|NCT01667224|365532328|FG000|Overall Study|Protocol Violation|1|||
105834945|NCT03419962|365051919|FG000|Overall Study|Refusal of continuing with trial drug|1|||
105834946|NCT03419962|365051919|FG000|Overall Study|Lost to Follow-up|3|||
105834947|NCT03419962|365051919|FG000|Overall Study|Difficulty in inhaling the doses|1|||
105834948|NCT03419962|365051919|FG000|Overall Study|Missing completion data|31|||
105834949|NCT01781234|365051922|FG000|Overall Study|Adverse Event|2|||
105834950|NCT01781234|365051923|FG001|Overall Study|Adverse Event|0|||
105834951|NCT01781234|365051922|FG000|Overall Study|Protocol Violation|3|||
105834952|NCT01781234|365051923|FG001|Overall Study|Protocol Violation|0|||
105834953|NCT01781234|365051922|FG000|Overall Study|Withdrawal by Subject|4|||
105834954|NCT01781234|365051923|FG001|Overall Study|Withdrawal by Subject|3|||
105834955|NCT00721955|365051924|FG000|Overall Study|Adverse Event|0|||
105834956|NCT00721955|365051925|FG001|Overall Study|Adverse Event|0|||
105834957|NCT00721955|365051926|FG002|Overall Study|Adverse Event|2|||
105834958|NCT03439085|365051927|FG000|Overall Study|Death|2|||
105834959|NCT03439085|365051927|FG000|Overall Study|Screen Failure|20|||
105834960|NCT01863433|365051928|FG000|Overall Study|Protocol Violation|1|||
105834961|NCT01206439|365051930|FG000|Overall Study|subject did not meet inclusion criteria|1|||
105834962|NCT05889039|365051931|FG000|Overall Study|error in completing survey|0|||
105834963|NCT05889039|365051932|FG001|Overall Study|error in completing survey|2|||
105834964|NCT05889039|365051933|FG002|Overall Study|error in completing survey|0|||
105834965|NCT05889039|365051934|FG003|Overall Study|error in completing survey|0|||
105834966|NCT05889039|365051931|FG000|Overall Study|Lost to Follow-up|4|||
105834967|NCT05889039|365051932|FG001|Overall Study|Lost to Follow-up|0|||
105834968|NCT05889039|365051933|FG002|Overall Study|Lost to Follow-up|0|||
105834969|NCT05889039|365051934|FG003|Overall Study|Lost to Follow-up|0|||
105834970|NCT00725764|365051937|FG000|Overall Study|Withdrawal by Subject|2|||
105834971|NCT00725764|365051937|FG000|Overall Study|Physician Decision|1|||
105834972|NCT00725764|365051937|FG000|Overall Study|Progressive Disease|7|||
105834973|NCT00725764|365051937|FG000|Overall Study|Lost to Follow-up|1|||
105834974|NCT00725764|365051937|FG000|Overall Study|Death|1|||
105834975|NCT00725764|365051937|FG000|Overall Study|Participant non compliant with protocol|1|||
106023182|NCT01667419|365750319|FG000|Overall Study|Death|18|||
106023183|NCT01667419|365750320|FG001|Overall Study|Death|33|||
106023184|NCT01667419|365750321|FG002|Overall Study|Death|25|||
106023185|NCT01667419|365750322|FG003|Overall Study|Death|26|||
106023186|NCT01941186|365750323|FG000|Follow-up|Lost to Follow-up|1|||
106023187|NCT01941186|365750324|FG001|Follow-up|Lost to Follow-up|0|||
106023188|NCT01092117|365750325|FG000|Index Procedure to 1 Month|Death|1|||
106023189|NCT01092117|365750325|FG000|1 Month|Death|1|||
106023190|NCT01092117|365750325|FG000|1 Month|Withdrawal by Subject|1|||
106023191|NCT01092117|365750325|FG000|1 Month|Lost to Follow-up|1|||
106023192|NCT01092117|365750325|FG000|6 Months|Death|2|||
106023193|NCT01092117|365750325|FG000|6 Months|Withdrawal by Subject|3|||
106023194|NCT01092117|365750325|FG000|12 Month|Death|11|||
106023195|NCT01092117|365750325|FG000|12 Month|Withdrawal by Subject|2|||
106023196|NCT01092117|365750325|FG000|12 Month|Lost to Follow-up|1|||
106023197|NCT01092117|365750325|FG000|Year 2|Death|5|||
106023198|NCT01092117|365750325|FG000|Year 2|Withdrawal by Subject|4|||
106023199|NCT01092117|365750325|FG000|Year 2|Lost to Follow-up|1|||
106023200|NCT01092117|365750325|FG000|Year 3|Death|7|||
106023201|NCT01092117|365750325|FG000|Year 3|Withdrawal by Subject|9|||
106023202|NCT01092117|365750325|FG000|Year 3|Lost to Follow-up|3|||
106023203|NCT01092117|365750325|FG000|Year 4|Death|8|||
106023204|NCT01092117|365750325|FG000|Year 4|Withdrawal by Subject|4|||
106023205|NCT01092117|365750325|FG000|Year 4|Lost to Follow-up|4|||
106023206|NCT01068600|365750326|FG000|Overall Study|Withdrawal by Subject|5|||
106023207|NCT01068600|365750327|FG001|Overall Study|Withdrawal by Subject|6|||
106023208|NCT01068600|365750326|FG000|Overall Study|Adverse Event|3|||
106023209|NCT01068600|365750327|FG001|Overall Study|Adverse Event|3|||
106023210|NCT01068600|365750326|FG000|Overall Study|Abnormal laboratory value(s)|1|||
106023211|NCT01068600|365750327|FG001|Overall Study|Abnormal laboratory value(s)|0|||
106023212|NCT01068600|365750326|FG000|Overall Study|Lost to Follow-up|1|||
106023213|NCT01068600|365750327|FG001|Overall Study|Lost to Follow-up|2|||
106023214|NCT01068600|365750326|FG000|Overall Study|Protocol deviation|1|||
106023215|NCT01068600|365750327|FG001|Overall Study|Protocol deviation|1|||
105834976|NCT00725764|365051937|FG000|Overall Study|Decline in performance status|1|||
105834977|NCT02972515|365051938|FG000|Overall Study|Lost to Follow-up|78|||
105834978|NCT04531527|365051939|FG000|Overall Study|Found to be Ineligible|3|||
105834979|NCT03428945|365051955|FG000|Overall Study|Lost to Follow-up|5|||
105834980|NCT03428945|365051956|FG001|Overall Study|Lost to Follow-up|3|||
105834981|NCT03428945|365051955|FG000|Overall Study|Withdrawal by Subject|10|||
105834982|NCT03428945|365051956|FG001|Overall Study|Withdrawal by Subject|10|||
105834983|NCT02522780|365051961|FG000|Overall Study|Consent withdrawn by subject|5|||
105834984|NCT02522780|365051962|FG001|Overall Study|Consent withdrawn by subject|7|||
106023216|NCT01068600|365750326|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
106023217|NCT01068600|365750327|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
106023218|NCT01068600|365750326|FG000|Overall Study|Administrative problems|0|||
106023219|NCT01068600|365750327|FG001|Overall Study|Administrative problems|1|||
106023220|NCT02644109|365750328|FG000|Overall Study|Adverse Event|0|||
106023221|NCT02644109|365750329|FG001|Overall Study|Adverse Event|4|||
106023222|NCT04173494|365750330|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
106023223|NCT04173494|365750331|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
106023224|NCT04173494|365750330|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
105834985|NCT02522780|365051961|FG000|Overall Study|Protocol deviation|1|||
105834986|NCT02522780|365051962|FG001|Overall Study|Protocol deviation|3|||
105834987|NCT02522780|365051961|FG000|Overall Study|Subject refused endoscopic procedure|0|||
105834988|NCT02522780|365051962|FG001|Overall Study|Subject refused endoscopic procedure|1|||
105834989|NCT02522780|365051961|FG000|Overall Study|Adverse event, non-fatal|11|||
105834990|NCT02522780|365051962|FG001|Overall Study|Adverse event, non-fatal|16|||
105834991|NCT02058160|365051963|FG000|Overall Study|Randomized but not treated|2|||
105834992|NCT02058160|365051964|FG001|Overall Study|Randomized but not treated|4|||
105834993|NCT02058160|365051963|FG000|Overall Study|Poor compliance to protocol|4|||
105834994|NCT02058160|365051964|FG001|Overall Study|Poor compliance to protocol|1|||
105834995|NCT02058160|365051963|FG000|Overall Study|Adverse Event|12|||
105834996|NCT02058160|365051964|FG001|Overall Study|Adverse Event|3|||
105834997|NCT02058160|365051963|FG000|Overall Study|Lost to Follow-up|1|||
105834998|NCT02058160|365051964|FG001|Overall Study|Lost to Follow-up|0|||
105834999|NCT02058160|365051963|FG000|Overall Study|Other than specified above|12|||
105835000|NCT02058160|365051964|FG001|Overall Study|Other than specified above|6|||
105835001|NCT01203917|365051967|FG000|Overall Study|Death|29|||
105835002|NCT01203917|365051967|FG000|Overall Study|Lost to Follow-up|2|||
105835003|NCT01203917|365051967|FG000|Overall Study|Withdrawal by Subject|3|||
105835004|NCT01203917|365051967|FG000|Overall Study|Due to objective disease progression|1|||
105835005|NCT01203917|365051967|FG000|Overall Study|Due to EGFR M+I patient|1|||
105835006|NCT02427399|365051968|FG000|Overall Study|Protocol Violation|14|||
105835007|NCT02427399|365051969|FG001|Overall Study|Protocol Violation|16|||
105835008|NCT02427399|365051970|FG002|Overall Study|Protocol Violation|12|||
105835009|NCT02427399|365051971|FG003|Overall Study|Protocol Violation|18|||
105835010|NCT02427399|365051972|FG004|Overall Study|Protocol Violation|15|||
105835011|NCT01115933|365051973|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
105835012|NCT00926367|365051974|FG000|Overall Study|Withdrawal by Subject|0|||
105835013|NCT00926367|365051975|FG001|Overall Study|Withdrawal by Subject|1|||
105835014|NCT00926367|365051974|FG000|Overall Study|Lost to Follow-up|1|||
105835015|NCT00926367|365051975|FG001|Overall Study|Lost to Follow-up|0|||
105835016|NCT00926367|365051974|FG000|Overall Study|Skin Irritation|1|||
105835017|NCT00926367|365051975|FG001|Overall Study|Skin Irritation|2|||
105835018|NCT03294317|365051976|FG000|Overall Study|Physician Decision|1|||
105835019|NCT03294317|365051976|FG000|Overall Study|Withdrawal by Subject|6|||
105835020|NCT03294317|365051976|FG000|Overall Study|Lost to Follow-up|1|||
105835021|NCT03294317|365051976|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
105835022|NCT03294317|365051976|FG000|Overall Study|Failed HB lead implant|8|||
105835023|NCT03294317|365051976|FG000|Overall Study|Received CRT instead|1|||
105835024|NCT03294317|365051976|FG000|Overall Study|Exited after lead revision|2|||
105835025|NCT01266603|365051977|FG000|Overall Study|Adverse Event|1|||
105835026|NCT01266603|365051977|FG000|Overall Study|Lack of Efficacy|14|||
105835027|NCT01266603|365051977|FG000|Overall Study|Withdrawal by Subject|1|||
105835028|NCT01266603|365051977|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
105835029|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
105835030|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
105835031|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
105835032|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
105835033|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
105835034|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
105835035|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
105835036|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
105835037|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
105835038|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Other|1|||
105835039|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Other|4|||
105835040|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Other|5|||
105835041|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
105835042|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
105835043|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
105835044|NCT02725411|365051978|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
105835045|NCT02725411|365051979|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
105835046|NCT02725411|365051980|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
105835047|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
105835048|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
105835049|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
105835050|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
105835051|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
105835052|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
105835053|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
105835054|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
105835055|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
105835056|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Other|1|||
105835057|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Other|4|||
105835058|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Other|2|||
105835059|NCT02725411|365051978|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
105835060|NCT02725411|365051979|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
105835061|NCT02725411|365051980|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
105835062|NCT02786927|365051981|FG000|Overall Study|Adverse Event|1|||
105835063|NCT02786927|365051981|FG000|Overall Study|Protocol Violation|4|||
105835064|NCT01685216|365051982|FG000|Overall Study|Did not receive study drug|1|||
105835065|NCT02911935|365051985|FG000|Overall Study|Lost to Follow-up|5|||
105835066|NCT02911935|365051986|FG001|Overall Study|Lost to Follow-up|7|||
105835067|NCT00756717|365051987|FG000|Overall Study|Withdrawal by Subject|2|||
105835068|NCT00685750|365051988|FG000|Overall Study|Tumor sampling failure|0|||
105835069|NCT00685750|365051989|FG001|Overall Study|Tumor sampling failure|0|||
105835070|NCT00685750|365051990|FG002|Overall Study|Tumor sampling failure|1|||
105835071|NCT00685750|365051991|FG003|Overall Study|Tumor sampling failure|0|||
105835072|NCT00685750|365051992|FG004|Overall Study|Tumor sampling failure|0|||
105835073|NCT00685750|365051993|FG005|Overall Study|Tumor sampling failure|0|||
105835074|NCT00685750|365051994|FG006|Overall Study|Tumor sampling failure|0|||
105835075|NCT00685750|365051988|FG000|Overall Study|Patient didn't receive the treatment|0|||
105835076|NCT00685750|365051989|FG001|Overall Study|Patient didn't receive the treatment|0|||
105835077|NCT00685750|365051990|FG002|Overall Study|Patient didn't receive the treatment|0|||
105835078|NCT00685750|365051991|FG003|Overall Study|Patient didn't receive the treatment|0|||
105835079|NCT00685750|365051992|FG004|Overall Study|Patient didn't receive the treatment|0|||
105835080|NCT00685750|365051993|FG005|Overall Study|Patient didn't receive the treatment|0|||
105835081|NCT00685750|365051994|FG006|Overall Study|Patient didn't receive the treatment|1|||
105835082|NCT00685750|365051988|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105835083|NCT00685750|365051989|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105835084|NCT00685750|365051990|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105835085|NCT00685750|365051991|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
105835086|NCT00685750|365051992|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
105835087|NCT00685750|365051993|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
105835088|NCT00685750|365051994|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
105835089|NCT02654015|365051995|FG000|Overall Study|Death|12|||
105835090|NCT02654015|365051995|FG000|Overall Study|Lost to Follow-up|3|||
105835091|NCT01896505|365051996|FG000|Overall Study|Adverse Event|1|||
105835092|NCT01896505|365051997|FG001|Overall Study|Adverse Event|0|||
105835093|NCT01896505|365051998|FG002|Overall Study|Adverse Event|2|||
105835094|NCT01896505|365051999|FG003|Overall Study|Adverse Event|1|||
105835095|NCT01896505|365052000|FG004|Overall Study|Adverse Event|1|||
105835096|NCT01896505|365052001|FG005|Overall Study|Adverse Event|0|||
105835097|NCT01896505|365051996|FG000|Overall Study|Physician Decision|1|||
105835098|NCT01896505|365051997|FG001|Overall Study|Physician Decision|3|||
105835099|NCT01896505|365051998|FG002|Overall Study|Physician Decision|2|||
105835100|NCT01896505|365051999|FG003|Overall Study|Physician Decision|0|||
105835101|NCT01896505|365052000|FG004|Overall Study|Physician Decision|0|||
105835102|NCT01896505|365052001|FG005|Overall Study|Physician Decision|1|||
105835103|NCT01896505|365051996|FG000|Overall Study|Withdrawal by Subject|1|||
105835104|NCT01896505|365051997|FG001|Overall Study|Withdrawal by Subject|0|||
105835105|NCT01896505|365051998|FG002|Overall Study|Withdrawal by Subject|3|||
105835106|NCT01896505|365051999|FG003|Overall Study|Withdrawal by Subject|1|||
105835107|NCT01896505|365052000|FG004|Overall Study|Withdrawal by Subject|0|||
105835108|NCT01896505|365052001|FG005|Overall Study|Withdrawal by Subject|0|||
105835109|NCT01896505|365051996|FG000|Overall Study|Disease Progression|7|||
105835110|NCT01896505|365051997|FG001|Overall Study|Disease Progression|5|||
105835111|NCT01896505|365051998|FG002|Overall Study|Disease Progression|8|||
105835112|NCT01896505|365051999|FG003|Overall Study|Disease Progression|4|||
105965479|NCT01667224|365532329|FG001|Overall Study|Protocol Violation|1|||
105965480|NCT01474772|365532332|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
105835113|NCT01896505|365052000|FG004|Overall Study|Disease Progression|4|||
105835114|NCT01896505|365052001|FG005|Overall Study|Disease Progression|4|||
105835115|NCT01896505|365051996|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
105835116|NCT01896505|365051997|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
105965481|NCT01474772|365532333|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
105965482|NCT01474772|365532332|FG000|Period 1|AE not Related to Study Drug|1|||
105965483|NCT01474772|365532333|FG001|Period 1|AE not Related to Study Drug|0|||
105965484|NCT01474772|365532332|FG000|Period 1|Withdrawal by Subject|3|||
105835117|NCT01896505|365051998|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
105835118|NCT01896505|365051999|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
105835119|NCT01896505|365052000|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
105835120|NCT01896505|365052001|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
105835121|NCT01896505|365051996|FG000|Overall Study|Intercurrent illness|0|||
105835122|NCT01896505|365051997|FG001|Overall Study|Intercurrent illness|1|||
105965485|NCT01474772|365532333|FG001|Period 1|Withdrawal by Subject|1|||
105965486|NCT01474772|365532332|FG000|Period 1|Lost to Follow-up|1|||
105965487|NCT01474772|365532333|FG001|Period 1|Lost to Follow-up|0|||
105965488|NCT01474772|365532332|FG000|Period 1|Reason not Specified|1|||
105835123|NCT01896505|365051998|FG002|Overall Study|Intercurrent illness|0|||
105835124|NCT01896505|365051999|FG003|Overall Study|Intercurrent illness|0|||
105835125|NCT01896505|365052000|FG004|Overall Study|Intercurrent illness|0|||
105835126|NCT01896505|365052001|FG005|Overall Study|Intercurrent illness|0|||
105835127|NCT01896505|365051996|FG000|Overall Study|Death|0|||
105835128|NCT01896505|365051997|FG001|Overall Study|Death|0|||
105835129|NCT01896505|365051998|FG002|Overall Study|Death|1|||
105835130|NCT01896505|365051999|FG003|Overall Study|Death|1|||
105835131|NCT01896505|365052000|FG004|Overall Study|Death|0|||
105835132|NCT01896505|365052001|FG005|Overall Study|Death|1|||
105835133|NCT00250705|365052004|FG000|Overall Study|Lack of Efficacy|2|||
105835134|NCT00889252|365052008|FG000|Overall Study|Adverse Event|2|||
105835135|NCT00889252|365052009|FG001|Overall Study|Adverse Event|4|||
105835136|NCT00889252|365052008|FG000|Overall Study|Withdrawal by Subject|3|||
105835137|NCT00889252|365052009|FG001|Overall Study|Withdrawal by Subject|0|||
105835138|NCT00889252|365052008|FG000|Overall Study|Protocol Violation|2|||
105835139|NCT00889252|365052009|FG001|Overall Study|Protocol Violation|0|||
105835140|NCT01020526|365052010|FG000|Overall Study|Withdrawal by Subject|5|||
105835141|NCT01020526|365052010|FG000|Overall Study|Other reasons|3|||
105835142|NCT01020526|365052010|FG000|Overall Study|Insufficient clinical response|3|||
105835143|NCT01020526|365052010|FG000|Overall Study|Lost to Follow-up|1|||
105835144|NCT01020526|365052010|FG000|Overall Study|Adverse Event|2|||
105835145|NCT00420095|365052016|FG000|Overall Study|Adverse Event|1|||
105835146|NCT00420095|365052017|FG001|Overall Study|Adverse Event|0|||
105835147|NCT00420095|365052016|FG000|Overall Study|Protocol Violation|1|||
105835148|NCT00420095|365052017|FG001|Overall Study|Protocol Violation|1|||
105835149|NCT00420095|365052016|FG000|Overall Study|Lost to Follow-up|1|||
105835150|NCT00420095|365052017|FG001|Overall Study|Lost to Follow-up|0|||
105835151|NCT01378962|365052018|FG000|Overall Study|Death|14|||
105835152|NCT01378962|365052018|FG000|Overall Study|Lost to Follow-up|1|||
105835153|NCT01378962|365052018|FG000|Overall Study|Other|2|||
105835154|NCT02129062|365053681|FG000|Overall Study|Death|1|||
105835155|NCT02129062|365053681|FG000|Overall Study|Disease Progression|2|||
105835156|NCT02940522|365053682|FG000|Overall Study|Lost to Follow-up|1|||
105835157|NCT02940522|365053683|FG001|Overall Study|Lost to Follow-up|2|||
105835158|NCT02940522|365053682|FG000|Overall Study|Withdrawal by Subject|1|||
105835159|NCT02940522|365053683|FG001|Overall Study|Withdrawal by Subject|0|||
105835160|NCT00559637|365053684|FG000|Overall Study|Adverse Event|22|||
105835161|NCT00559637|365053684|FG000|Overall Study|Withdrawal by Subject|4|||
105835162|NCT00559637|365053684|FG000|Overall Study|Protocol Violation|6|||
105835163|NCT00559637|365053684|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
105835164|NCT00559637|365053684|FG000|Overall Study|Failure to return|6|||
105835165|NCT00559637|365053684|FG000|Overall Study|Insufficient response|3|||
105835166|NCT00559637|365053684|FG000|Overall Study|Started requiring dialysis after month 7|2|||
105835167|NCT00559637|365053684|FG000|Overall Study|Suspected lung cancer|1|||
105835168|NCT00559637|365053684|FG000|Overall Study|Participation in another study|1|||
105835169|NCT00559637|365053684|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
105835170|NCT00559637|365053684|FG000|Overall Study|Change of center|1|||
105835171|NCT00559637|365053684|FG000|Overall Study|Change of home|1|||
105835172|NCT00559637|365053684|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
105835173|NCT02832167|365053685|FG000|Treatment Period 1|Disease progression|90|||
105835174|NCT02832167|365053685|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
105835175|NCT02832167|365053685|FG000|Treatment Period 1|Death|2|||
105835176|NCT02832167|365053685|FG000|Treatment Period 1|Study Drug Toxicity|6|||
105835177|NCT02832167|365053685|FG000|Treatment Period 1|Participant request to discontinue|9|||
105835178|NCT02832167|365053685|FG000|Treatment Period 1|No longer meet study criteria|1|||
105835179|NCT02832167|365053685|FG000|Treatment Period 1|Participant withdrew consent|3|||
105835180|NCT02832167|365053685|FG000|Treatment Period 1|Other reasons|6|||
105835181|NCT02832167|365053685|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
105835182|NCT02832167|365053685|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
105835183|NCT02832167|365053685|FG000|Transition From Period 1 to Period 2|Death|2|||
105965489|NCT01474772|365532333|FG001|Period 1|Reason not Specified|1|||
105965490|NCT01474772|365532332|FG000|Washout|AE not Related to Study Drug|2|||
105835184|NCT02832167|365053685|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
105965491|NCT01474772|365532333|FG001|Washout|AE not Related to Study Drug|0|||
105965492|NCT01474772|365532332|FG000|Washout|Withdrawal by Subject|1|||
105835185|NCT02832167|365053685|FG000|Treatment Period 2|Disease progression|69|||
105835186|NCT02832167|365053685|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
105835187|NCT02832167|365053685|FG000|Treatment Period 2|Maximum clinical benefit|1|||
105835188|NCT02832167|365053685|FG000|Treatment Period 2|Study Drug Toxicity|5|||
105835189|NCT02832167|365053685|FG000|Treatment Period 2|Participant request to discontinue|2|||
105835190|NCT02832167|365053685|FG000|Treatment Period 2|Participant withdrew consent|3|||
105835191|NCT02832167|365053685|FG000|Treatment Period 2|Other reasons|3|||
105835192|NCT00685035|365053686|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
105965493|NCT01474772|365532333|FG001|Washout|Withdrawal by Subject|0|||
106149174|NCT03684044|366206970|FG000|Overall Study|Patient Not Available|0|||
106149175|NCT03684044|366206971|FG001|Overall Study|Patient Not Available|2|||
105835193|NCT00685035|365053687|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
105835194|NCT01235715|365053688|FG000|Overall Study|Physician Decision|0|||
105835195|NCT01235715|365053689|FG001|Overall Study|Physician Decision|2|||
105835196|NCT00687739|365053697|FG000|Overall Study|Lost to Follow-up|2|||
105835197|NCT00687739|365053698|FG001|Overall Study|Lost to Follow-up|2|||
105835198|NCT00687739|365053699|FG002|Overall Study|Lost to Follow-up|1|||
105835199|NCT00687739|365053700|FG003|Overall Study|Lost to Follow-up|2|||
105835200|NCT00687739|365053697|FG000|Overall Study|Adverse Event|0|||
105835201|NCT00687739|365053698|FG001|Overall Study|Adverse Event|1|||
105835202|NCT00687739|365053699|FG002|Overall Study|Adverse Event|1|||
105835203|NCT00687739|365053700|FG003|Overall Study|Adverse Event|0|||
105835204|NCT01190930|365053702|FG000|Induction|Adverse Event|17|||
105835205|NCT01190930|365053703|FG001|Induction|Adverse Event|0|||
105835206|NCT01190930|365053704|FG002|Induction|Adverse Event|0|||
105835207|NCT01190930|365053705|FG003|Induction|Adverse Event|0|||
105835208|NCT01190930|365053706|FG004|Induction|Adverse Event|0|||
105835209|NCT01190930|365053707|FG005|Induction|Adverse Event|0|||
105835210|NCT01190930|365053708|FG006|Induction|Adverse Event|0|||
105835211|NCT01190930|365053709|FG007|Induction|Adverse Event|0|||
106023225|NCT04173494|365750331|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
106023226|NCT04173494|365750330|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
106023227|NCT04173494|365750331|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
106023228|NCT04173494|365750330|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
106023229|NCT04173494|365750331|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
106023230|NCT04173494|365750330|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
105835212|NCT01190930|365053710|FG008|Induction|Adverse Event|0|||
105835213|NCT01190930|365053711|FG009|Induction|Adverse Event|0|||
105835214|NCT01190930|365053702|FG000|Induction|Death|34|||
105835215|NCT01190930|365053703|FG001|Induction|Death|0|||
105835216|NCT01190930|365053704|FG002|Induction|Death|0|||
105835217|NCT01190930|365053705|FG003|Induction|Death|0|||
105835218|NCT01190930|365053706|FG004|Induction|Death|0|||
105835219|NCT01190930|365053707|FG005|Induction|Death|0|||
105835220|NCT01190930|365053708|FG006|Induction|Death|0|||
105835221|NCT01190930|365053709|FG007|Induction|Death|0|||
105835222|NCT01190930|365053710|FG008|Induction|Death|0|||
105835223|NCT01190930|365053711|FG009|Induction|Death|0|||
105835224|NCT01190930|365053702|FG000|Induction|Lost to Follow-up|1|||
105835225|NCT01190930|365053703|FG001|Induction|Lost to Follow-up|0|||
105835226|NCT01190930|365053704|FG002|Induction|Lost to Follow-up|0|||
105835227|NCT01190930|365053705|FG003|Induction|Lost to Follow-up|0|||
105835228|NCT01190930|365053706|FG004|Induction|Lost to Follow-up|0|||
105835229|NCT01190930|365053707|FG005|Induction|Lost to Follow-up|0|||
105835230|NCT01190930|365053708|FG006|Induction|Lost to Follow-up|0|||
105835231|NCT01190930|365053709|FG007|Induction|Lost to Follow-up|0|||
105835232|NCT01190930|365053710|FG008|Induction|Lost to Follow-up|0|||
105835233|NCT01190930|365053711|FG009|Induction|Lost to Follow-up|0|||
105835234|NCT01190930|365053702|FG000|Induction|Physician Decision|125|||
105835235|NCT01190930|365053703|FG001|Induction|Physician Decision|3|||
105835236|NCT01190930|365053704|FG002|Induction|Physician Decision|0|||
105835237|NCT01190930|365053705|FG003|Induction|Physician Decision|0|||
105835238|NCT01190930|365053706|FG004|Induction|Physician Decision|0|||
105835239|NCT01190930|365053707|FG005|Induction|Physician Decision|0|||
105835240|NCT01190930|365053708|FG006|Induction|Physician Decision|0|||
106023231|NCT04173494|365750331|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
106023232|NCT04173494|365750330|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
106023233|NCT04173494|365750331|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
106023234|NCT04173494|365750330|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
105835241|NCT01190930|365053709|FG007|Induction|Physician Decision|0|||
105835242|NCT01190930|365053710|FG008|Induction|Physician Decision|0|||
105835243|NCT01190930|365053711|FG009|Induction|Physician Decision|0|||
105835244|NCT01190930|365053702|FG000|Induction|Withdrawal by Subject|9|||
106023235|NCT04173494|365750331|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
105835245|NCT01190930|365053703|FG001|Induction|Withdrawal by Subject|0|||
105835246|NCT01190930|365053704|FG002|Induction|Withdrawal by Subject|0|||
106023236|NCT04173494|365750330|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
105835247|NCT01190930|365053705|FG003|Induction|Withdrawal by Subject|0|||
105835248|NCT01190930|365053706|FG004|Induction|Withdrawal by Subject|0|||
105835249|NCT01190930|365053707|FG005|Induction|Withdrawal by Subject|0|||
106149176|NCT03684044|366206970|FG000|Overall Study|Physician Decision|1|||
105835250|NCT01190930|365053708|FG006|Induction|Withdrawal by Subject|0|||
105835251|NCT01190930|365053709|FG007|Induction|Withdrawal by Subject|0|||
105835252|NCT01190930|365053710|FG008|Induction|Withdrawal by Subject|0|||
105835253|NCT01190930|365053711|FG009|Induction|Withdrawal by Subject|0|||
105835254|NCT01190930|365053702|FG000|Induction|Refusal|235|||
105835255|NCT01190930|365053703|FG001|Induction|Refusal|0|||
105835256|NCT01190930|365053704|FG002|Induction|Refusal|0|||
105835257|NCT01190930|365053705|FG003|Induction|Refusal|0|||
105835258|NCT01190930|365053706|FG004|Induction|Refusal|0|||
105835259|NCT01190930|365053707|FG005|Induction|Refusal|0|||
105835260|NCT01190930|365053708|FG006|Induction|Refusal|0|||
105835261|NCT01190930|365053709|FG007|Induction|Refusal|0|||
105835262|NCT01190930|365053710|FG008|Induction|Refusal|0|||
105835263|NCT01190930|365053711|FG009|Induction|Refusal|0|||
105835264|NCT01190930|365053702|FG000|Induction|Inevaluable|23|||
105835265|NCT01190930|365053703|FG001|Induction|Inevaluable|1|||
105835266|NCT01190930|365053704|FG002|Induction|Inevaluable|0|||
105835267|NCT01190930|365053705|FG003|Induction|Inevaluable|0|||
105835268|NCT01190930|365053706|FG004|Induction|Inevaluable|0|||
105835269|NCT01190930|365053707|FG005|Induction|Inevaluable|0|||
105835270|NCT01190930|365053708|FG006|Induction|Inevaluable|0|||
105835271|NCT01190930|365053709|FG007|Induction|Inevaluable|0|||
105835272|NCT01190930|365053710|FG008|Induction|Inevaluable|0|||
105835273|NCT01190930|365053711|FG009|Induction|Inevaluable|0|||
105835274|NCT01190930|365053702|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
105835275|NCT01190930|365053703|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835276|NCT01190930|365053704|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835277|NCT01190930|365053705|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835278|NCT01190930|365053706|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835279|NCT01190930|365053707|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835280|NCT01190930|365053708|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835281|NCT01190930|365053709|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835282|NCT01190930|365053710|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835283|NCT01190930|365053711|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
105835284|NCT01190930|365053702|FG000|Induction|High Risk Downs|80|||
105835285|NCT01190930|365053703|FG001|Induction|High Risk Downs|0|||
105835286|NCT01190930|365053704|FG002|Induction|High Risk Downs|0|||
105835287|NCT01190930|365053705|FG003|Induction|High Risk Downs|0|||
105835288|NCT01190930|365053706|FG004|Induction|High Risk Downs|0|||
105835289|NCT01190930|365053707|FG005|Induction|High Risk Downs|0|||
105835290|NCT01190930|365053708|FG006|Induction|High Risk Downs|0|||
105835291|NCT01190930|365053709|FG007|Induction|High Risk Downs|0|||
105835292|NCT01190930|365053710|FG008|Induction|High Risk Downs|0|||
105835293|NCT01190930|365053711|FG009|Induction|High Risk Downs|0|||
105835294|NCT01190930|365053702|FG000|Induction|Enrollment onto another COG Protocol|1|||
105835295|NCT01190930|365053703|FG001|Induction|Enrollment onto another COG Protocol|0|||
105835296|NCT01190930|365053704|FG002|Induction|Enrollment onto another COG Protocol|0|||
105835297|NCT01190930|365053705|FG003|Induction|Enrollment onto another COG Protocol|0|||
105835298|NCT01190930|365053706|FG004|Induction|Enrollment onto another COG Protocol|0|||
105835299|NCT01190930|365053707|FG005|Induction|Enrollment onto another COG Protocol|0|||
105835300|NCT01190930|365053708|FG006|Induction|Enrollment onto another COG Protocol|0|||
105835301|NCT01190930|365053709|FG007|Induction|Enrollment onto another COG Protocol|0|||
105835302|NCT01190930|365053710|FG008|Induction|Enrollment onto another COG Protocol|0|||
105835303|NCT01190930|365053711|FG009|Induction|Enrollment onto another COG Protocol|0|||
105835304|NCT01190930|365053702|FG000|Induction|Average Risk|1847|||
105965494|NCT01474772|365532332|FG000|Washout|Lost to Follow-up|0|||
105965495|NCT01474772|365532333|FG001|Washout|Lost to Follow-up|1|||
105835305|NCT01190930|365053703|FG001|Induction|Average Risk|0|||
105835306|NCT01190930|365053704|FG002|Induction|Average Risk|0|||
105835307|NCT01190930|365053705|FG003|Induction|Average Risk|0|||
105835308|NCT01190930|365053706|FG004|Induction|Average Risk|0|||
105835309|NCT01190930|365053707|FG005|Induction|Average Risk|0|||
105835310|NCT01190930|365053708|FG006|Induction|Average Risk|0|||
105835311|NCT01190930|365053709|FG007|Induction|Average Risk|0|||
105835312|NCT01190930|365053710|FG008|Induction|Average Risk|0|||
105835313|NCT01190930|365053711|FG009|Induction|Average Risk|0|||
105835314|NCT01190930|365053702|FG000|Induction|High Risk|1227|||
105835315|NCT01190930|365053703|FG001|Induction|High Risk|0|||
105965496|NCT01474772|365532332|FG000|Washout|Reason not Specified|0|||
106149177|NCT03684044|366206971|FG001|Overall Study|Physician Decision|0|||
106149178|NCT03684044|366206970|FG000|Overall Study|Withdrawal by Subject|11|||
106149179|NCT03684044|366206971|FG001|Overall Study|Withdrawal by Subject|9|||
106149180|NCT03703336|366206972|FG000|Overall Study|Parent withdrew consent|29|||
105835316|NCT01190930|365053704|FG002|Induction|High Risk|0|||
105835317|NCT01190930|365053705|FG003|Induction|High Risk|0|||
105965497|NCT01474772|365532333|FG001|Washout|Reason not Specified|1|||
105835318|NCT01190930|365053706|FG004|Induction|High Risk|0|||
105835319|NCT01190930|365053707|FG005|Induction|High Risk|0|||
105835320|NCT01190930|365053708|FG006|Induction|High Risk|0|||
105835321|NCT01190930|365053709|FG007|Induction|High Risk|0|||
105835322|NCT01190930|365053710|FG008|Induction|High Risk|0|||
105835323|NCT01190930|365053711|FG009|Induction|High Risk|0|||
105835324|NCT01190930|365053702|FG000|Induction|Low Risk|443|||
105835325|NCT01190930|365053703|FG001|Induction|Low Risk|0|||
105965498|NCT01474772|365532332|FG000|Period 2|Death|0|||
106149181|NCT03703336|366206973|FG001|Overall Study|Parent withdrew consent|8|||
106149182|NCT03703336|366206972|FG000|Overall Study|Migration|3|||
105835326|NCT01190930|365053704|FG002|Induction|Low Risk|0|||
105835327|NCT01190930|365053705|FG003|Induction|Low Risk|0|||
105835328|NCT01190930|365053706|FG004|Induction|Low Risk|0|||
105835329|NCT01190930|365053707|FG005|Induction|Low Risk|0|||
105965499|NCT01474772|365532333|FG001|Period 2|Death|1|||
105835330|NCT01190930|365053708|FG006|Induction|Low Risk|0|||
105835331|NCT01190930|365053709|FG007|Induction|Low Risk|0|||
105835332|NCT01190930|365053710|FG008|Induction|Low Risk|0|||
105835333|NCT01190930|365053711|FG009|Induction|Low Risk|0|||
105835334|NCT01190930|365053702|FG000|Induction|Very High Risk|1012|||
105835335|NCT01190930|365053703|FG001|Induction|Very High Risk|0|||
105835336|NCT01190930|365053704|FG002|Induction|Very High Risk|0|||
105835337|NCT01190930|365053705|FG003|Induction|Very High Risk|0|||
105835338|NCT01190930|365053706|FG004|Induction|Very High Risk|0|||
105835339|NCT01190930|365053707|FG005|Induction|Very High Risk|0|||
105835340|NCT01190930|365053708|FG006|Induction|Very High Risk|0|||
105835341|NCT01190930|365053709|FG007|Induction|Very High Risk|0|||
105835342|NCT01190930|365053710|FG008|Induction|Very High Risk|0|||
105835343|NCT01190930|365053711|FG009|Induction|Very High Risk|0|||
105835344|NCT01190930|365053702|FG000|Induction|Philadelphia chromosome-positive|99|||
105835345|NCT01190930|365053703|FG001|Induction|Philadelphia chromosome-positive|0|||
105835346|NCT01190930|365053704|FG002|Induction|Philadelphia chromosome-positive|0|||
105835347|NCT01190930|365053705|FG003|Induction|Philadelphia chromosome-positive|0|||
105835348|NCT01190930|365053706|FG004|Induction|Philadelphia chromosome-positive|0|||
105835349|NCT01190930|365053707|FG005|Induction|Philadelphia chromosome-positive|0|||
105835350|NCT01190930|365053708|FG006|Induction|Philadelphia chromosome-positive|0|||
105835351|NCT01190930|365053709|FG007|Induction|Philadelphia chromosome-positive|0|||
105835352|NCT01190930|365053710|FG008|Induction|Philadelphia chromosome-positive|0|||
105835353|NCT01190930|365053711|FG009|Induction|Philadelphia chromosome-positive|0|||
105835354|NCT01190930|365053702|FG000|Induction|Incomplete Induction data|63|||
105835355|NCT01190930|365053703|FG001|Induction|Incomplete Induction data|0|||
105835356|NCT01190930|365053704|FG002|Induction|Incomplete Induction data|0|||
105835357|NCT01190930|365053705|FG003|Induction|Incomplete Induction data|0|||
105835358|NCT01190930|365053706|FG004|Induction|Incomplete Induction data|0|||
105835359|NCT01190930|365053707|FG005|Induction|Incomplete Induction data|0|||
105835360|NCT01190930|365053708|FG006|Induction|Incomplete Induction data|0|||
105835361|NCT01190930|365053709|FG007|Induction|Incomplete Induction data|0|||
105835362|NCT01190930|365053710|FG008|Induction|Incomplete Induction data|0|||
105835363|NCT01190930|365053711|FG009|Induction|Incomplete Induction data|0|||
105835364|NCT01190930|365053702|FG000|Induction|Progressive disease|0|||
105835365|NCT01190930|365053703|FG001|Induction|Progressive disease|1|||
105835366|NCT01190930|365053704|FG002|Induction|Progressive disease|0|||
105835367|NCT01190930|365053705|FG003|Induction|Progressive disease|0|||
105835368|NCT01190930|365053706|FG004|Induction|Progressive disease|0|||
105835369|NCT01190930|365053707|FG005|Induction|Progressive disease|0|||
105835370|NCT01190930|365053708|FG006|Induction|Progressive disease|0|||
105835371|NCT01190930|365053709|FG007|Induction|Progressive disease|0|||
105835372|NCT01190930|365053710|FG008|Induction|Progressive disease|0|||
105835373|NCT01190930|365053711|FG009|Induction|Progressive disease|0|||
105835374|NCT01190930|365053702|FG000|Induction|No treatment|3|||
105835375|NCT01190930|365053703|FG001|Induction|No treatment|0|||
105835376|NCT01190930|365053704|FG002|Induction|No treatment|0|||
105835377|NCT01190930|365053705|FG003|Induction|No treatment|0|||
105835378|NCT01190930|365053706|FG004|Induction|No treatment|0|||
105835379|NCT01190930|365053707|FG005|Induction|No treatment|0|||
105835380|NCT01190930|365053708|FG006|Induction|No treatment|0|||
105835381|NCT01190930|365053709|FG007|Induction|No treatment|0|||
105835382|NCT01190930|365053710|FG008|Induction|No treatment|0|||
105835383|NCT01190930|365053711|FG009|Induction|No treatment|0|||
105835384|NCT01190930|365053702|FG000|Induction|Ineligible|69|||
105835385|NCT01190930|365053703|FG001|Induction|Ineligible|4|||
105835386|NCT01190930|365053704|FG002|Induction|Ineligible|0|||
105835387|NCT01190930|365053705|FG003|Induction|Ineligible|0|||
105835388|NCT01190930|365053706|FG004|Induction|Ineligible|0|||
105835389|NCT01190930|365053707|FG005|Induction|Ineligible|0|||
105835390|NCT01190930|365053708|FG006|Induction|Ineligible|0|||
105835391|NCT01190930|365053709|FG007|Induction|Ineligible|0|||
106149183|NCT03703336|366206973|FG001|Overall Study|Migration|3|||
106149184|NCT03703336|366206972|FG000|Overall Study|Protocol Violation|3|||
105835392|NCT01190930|365053710|FG008|Induction|Ineligible|0|||
105835393|NCT01190930|365053711|FG009|Induction|Ineligible|0|||
105835394|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
105835395|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
105835396|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
105835397|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
105835398|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
105835399|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
105835400|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
105835401|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
105835402|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
106149185|NCT03703336|366206973|FG001|Overall Study|Protocol Violation|1|||
106149186|NCT03703336|366206972|FG000|Overall Study|Physician Decision|2|||
105835403|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
105835404|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Death|0|||
105835405|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Death|0|||
105835406|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Death|8|||
105835407|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Death|4|||
105835408|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Death|0|||
105835409|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Death|0|||
105835410|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Death|0|||
105835411|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Death|0|||
105835412|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Death|0|||
105835413|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Death|0|||
105835414|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
105835415|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
105835416|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
105835417|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
105835418|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
105835419|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
105835420|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
105835421|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
105835422|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
105835423|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
105835424|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835425|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
105835426|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
105835427|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
105835428|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835429|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835430|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835431|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835432|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835433|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
105835434|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Refusal|0|||
105835435|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Refusal|2|||
105835436|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Refusal|694|||
105835437|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Refusal|4|||
105835438|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Refusal|0|||
105835439|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Refusal|3|||
105835440|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Refusal|0|||
105835441|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Refusal|0|||
105835442|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Refusal|0|||
105835443|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Refusal|0|||
105835444|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
105835445|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
105835446|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
105835447|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
105835448|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
105835449|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
105835450|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
105835451|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
105835452|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
105835453|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
105835454|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835455|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
105835456|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835457|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835458|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835459|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835460|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835461|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835462|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835463|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
105835464|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
105835465|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
105835466|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
105835467|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
105835468|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
105835469|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
106023237|NCT04173494|365750331|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
105835470|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
105835471|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
105835472|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
105835473|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
105965500|NCT01474772|365532332|FG000|Period 2|AE Related to Study Drug|0|||
105965501|NCT01474772|365532333|FG001|Period 2|AE Related to Study Drug|1|||
105965502|NCT01474772|365532332|FG000|Period 2|AE not Related to Study Drug|4|||
105835474|NCT01190930|365053702|FG000|Post Induction Pre-Maintenance|Relapse|0|||
105835475|NCT01190930|365053703|FG001|Post Induction Pre-Maintenance|Relapse|0|||
105835476|NCT01190930|365053704|FG002|Post Induction Pre-Maintenance|Relapse|1|||
105835477|NCT01190930|365053705|FG003|Post Induction Pre-Maintenance|Relapse|0|||
105835478|NCT01190930|365053706|FG004|Post Induction Pre-Maintenance|Relapse|0|||
105835479|NCT01190930|365053707|FG005|Post Induction Pre-Maintenance|Relapse|0|||
105835480|NCT01190930|365053708|FG006|Post Induction Pre-Maintenance|Relapse|0|||
105835481|NCT01190930|365053709|FG007|Post Induction Pre-Maintenance|Relapse|0|||
105835482|NCT01190930|365053710|FG008|Post Induction Pre-Maintenance|Relapse|0|||
105835483|NCT01190930|365053711|FG009|Post Induction Pre-Maintenance|Relapse|0|||
105835484|NCT01190930|365053702|FG000|Maintenance|Adverse Event|0|||
105835485|NCT01190930|365053703|FG001|Maintenance|Adverse Event|0|||
105835486|NCT01190930|365053704|FG002|Maintenance|Adverse Event|0|||
105835487|NCT01190930|365053705|FG003|Maintenance|Adverse Event|0|||
105835488|NCT01190930|365053706|FG004|Maintenance|Adverse Event|0|||
105835489|NCT01190930|365053707|FG005|Maintenance|Adverse Event|1|||
105835490|NCT01190930|365053708|FG006|Maintenance|Adverse Event|1|||
105835491|NCT01190930|365053709|FG007|Maintenance|Adverse Event|3|||
105835492|NCT01190930|365053710|FG008|Maintenance|Adverse Event|3|||
105835493|NCT01190930|365053711|FG009|Maintenance|Adverse Event|0|||
105835494|NCT01190930|365053702|FG000|Maintenance|Death|0|||
105835495|NCT01190930|365053703|FG001|Maintenance|Death|0|||
105835496|NCT01190930|365053704|FG002|Maintenance|Death|0|||
105835497|NCT01190930|365053705|FG003|Maintenance|Death|1|||
105835498|NCT01190930|365053706|FG004|Maintenance|Death|0|||
105835499|NCT01190930|365053707|FG005|Maintenance|Death|0|||
105835500|NCT01190930|365053708|FG006|Maintenance|Death|2|||
105835501|NCT01190930|365053709|FG007|Maintenance|Death|2|||
105835502|NCT01190930|365053710|FG008|Maintenance|Death|2|||
105835503|NCT01190930|365053711|FG009|Maintenance|Death|2|||
105835504|NCT01190930|365053702|FG000|Maintenance|Lost to Follow-up|0|||
105835505|NCT01190930|365053703|FG001|Maintenance|Lost to Follow-up|0|||
105835506|NCT01190930|365053704|FG002|Maintenance|Lost to Follow-up|0|||
105835507|NCT01190930|365053705|FG003|Maintenance|Lost to Follow-up|0|||
105835508|NCT01190930|365053706|FG004|Maintenance|Lost to Follow-up|0|||
105835509|NCT01190930|365053707|FG005|Maintenance|Lost to Follow-up|0|||
105835510|NCT01190930|365053708|FG006|Maintenance|Lost to Follow-up|1|||
105835511|NCT01190930|365053709|FG007|Maintenance|Lost to Follow-up|1|||
105835512|NCT01190930|365053710|FG008|Maintenance|Lost to Follow-up|1|||
105835513|NCT01190930|365053711|FG009|Maintenance|Lost to Follow-up|0|||
105835514|NCT01190930|365053702|FG000|Maintenance|Physician Decision|0|||
105835515|NCT01190930|365053703|FG001|Maintenance|Physician Decision|1|||
105835516|NCT01190930|365053704|FG002|Maintenance|Physician Decision|0|||
105835517|NCT01190930|365053705|FG003|Maintenance|Physician Decision|5|||
105835518|NCT01190930|365053706|FG004|Maintenance|Physician Decision|9|||
105835519|NCT01190930|365053707|FG005|Maintenance|Physician Decision|4|||
105835520|NCT01190930|365053708|FG006|Maintenance|Physician Decision|8|||
105835521|NCT01190930|365053709|FG007|Maintenance|Physician Decision|8|||
105835522|NCT01190930|365053710|FG008|Maintenance|Physician Decision|10|||
105835523|NCT01190930|365053711|FG009|Maintenance|Physician Decision|17|||
105835524|NCT01190930|365053702|FG000|Maintenance|Withdrawal by Subject|0|||
105835525|NCT01190930|365053703|FG001|Maintenance|Withdrawal by Subject|0|||
105965503|NCT01474772|365532333|FG001|Period 2|AE not Related to Study Drug|1|||
105965504|NCT01474772|365532332|FG000|Period 2|Lack of Efficacy|1|||
105965505|NCT01474772|365532333|FG001|Period 2|Lack of Efficacy|0|||
105965506|NCT01474772|365532332|FG000|Period 2|Withdrawal by Subject|3|||
105965507|NCT01474772|365532333|FG001|Period 2|Withdrawal by Subject|4|||
106023238|NCT04173494|365750330|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
106023239|NCT04173494|365750331|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
106023240|NCT04173494|365750330|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
106149187|NCT03703336|366206973|FG001|Overall Study|Physician Decision|0|||
105835526|NCT01190930|365053704|FG002|Maintenance|Withdrawal by Subject|0|||
105965508|NCT01474772|365532332|FG000|Period 2|Lost to Follow-up|1|||
105965509|NCT01474772|365532333|FG001|Period 2|Lost to Follow-up|1|||
106149188|NCT03703336|366206972|FG000|Overall Study|Adverse Event|0|||
105835527|NCT01190930|365053705|FG003|Maintenance|Withdrawal by Subject|0|||
105835528|NCT01190930|365053706|FG004|Maintenance|Withdrawal by Subject|0|||
105835529|NCT01190930|365053707|FG005|Maintenance|Withdrawal by Subject|0|||
105835530|NCT01190930|365053708|FG006|Maintenance|Withdrawal by Subject|2|||
105835531|NCT01190930|365053709|FG007|Maintenance|Withdrawal by Subject|1|||
105835532|NCT01190930|365053710|FG008|Maintenance|Withdrawal by Subject|4|||
105965510|NCT01474772|365532332|FG000|Period 2|Reason not Specified|0|||
105965511|NCT01474772|365532333|FG001|Period 2|Reason not Specified|2|||
105835533|NCT01190930|365053711|FG009|Maintenance|Withdrawal by Subject|1|||
105835534|NCT01190930|365053702|FG000|Maintenance|Refusal|0|||
105835535|NCT01190930|365053703|FG001|Maintenance|Refusal|1|||
105835536|NCT01190930|365053704|FG002|Maintenance|Refusal|0|||
105835537|NCT01190930|365053705|FG003|Maintenance|Refusal|2|||
105835538|NCT01190930|365053706|FG004|Maintenance|Refusal|0|||
105835539|NCT01190930|365053707|FG005|Maintenance|Refusal|4|||
105835540|NCT01190930|365053708|FG006|Maintenance|Refusal|5|||
105835541|NCT01190930|365053709|FG007|Maintenance|Refusal|17|||
105835542|NCT01190930|365053710|FG008|Maintenance|Refusal|13|||
105835543|NCT01190930|365053711|FG009|Maintenance|Refusal|6|||
105835544|NCT01190930|365053702|FG000|Maintenance|second malignant neoplasm|0|||
105835545|NCT01190930|365053703|FG001|Maintenance|second malignant neoplasm|0|||
105835546|NCT01190930|365053704|FG002|Maintenance|second malignant neoplasm|0|||
105835547|NCT01190930|365053705|FG003|Maintenance|second malignant neoplasm|1|||
105835548|NCT01190930|365053706|FG004|Maintenance|second malignant neoplasm|0|||
105835549|NCT01190930|365053707|FG005|Maintenance|second malignant neoplasm|1|||
105835550|NCT01190930|365053708|FG006|Maintenance|second malignant neoplasm|0|||
105835551|NCT01190930|365053709|FG007|Maintenance|second malignant neoplasm|0|||
105835552|NCT01190930|365053710|FG008|Maintenance|second malignant neoplasm|1|||
105835553|NCT01190930|365053711|FG009|Maintenance|second malignant neoplasm|0|||
105835554|NCT01190930|365053702|FG000|Maintenance|Inevaluable|0|||
105835555|NCT01190930|365053703|FG001|Maintenance|Inevaluable|0|||
105835556|NCT01190930|365053704|FG002|Maintenance|Inevaluable|0|||
105835557|NCT01190930|365053705|FG003|Maintenance|Inevaluable|0|||
105835558|NCT01190930|365053706|FG004|Maintenance|Inevaluable|0|||
105835559|NCT01190930|365053707|FG005|Maintenance|Inevaluable|1|||
105835560|NCT01190930|365053708|FG006|Maintenance|Inevaluable|1|||
105835561|NCT01190930|365053709|FG007|Maintenance|Inevaluable|1|||
105835562|NCT01190930|365053710|FG008|Maintenance|Inevaluable|0|||
105835563|NCT01190930|365053711|FG009|Maintenance|Inevaluable|0|||
105835564|NCT01190930|365053702|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
105835565|NCT01190930|365053703|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
105835566|NCT01190930|365053704|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
105835567|NCT01190930|365053705|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
105835568|NCT01190930|365053706|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
105835569|NCT01190930|365053707|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
105835570|NCT01190930|365053708|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
105835571|NCT01190930|365053709|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
105835572|NCT01190930|365053710|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
105835573|NCT01190930|365053711|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
105835574|NCT01190930|365053702|FG000|Maintenance|Relapse|0|||
105835575|NCT01190930|365053703|FG001|Maintenance|Relapse|0|||
105835576|NCT01190930|365053704|FG002|Maintenance|Relapse|0|||
105835577|NCT01190930|365053705|FG003|Maintenance|Relapse|2|||
105835578|NCT01190930|365053706|FG004|Maintenance|Relapse|0|||
105835579|NCT01190930|365053707|FG005|Maintenance|Relapse|1|||
105835580|NCT01190930|365053708|FG006|Maintenance|Relapse|6|||
105835581|NCT01190930|365053709|FG007|Maintenance|Relapse|13|||
105835582|NCT01190930|365053710|FG008|Maintenance|Relapse|11|||
105835583|NCT01190930|365053711|FG009|Maintenance|Relapse|11|||
105835584|NCT01190930|365053702|FG000|Maintenance|Still on therapy|0|||
106023241|NCT04173494|365750331|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
106023242|NCT04173494|365750330|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
106023243|NCT04173494|365750331|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
106023244|NCT04173494|365750330|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
106023245|NCT04173494|365750331|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
106023246|NCT04173494|365750330|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
106023247|NCT04173494|365750331|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
106023248|NCT04173494|365750330|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
106023249|NCT04173494|365750331|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
106023250|NCT04173494|365750330|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
106023251|NCT04173494|365750331|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
106023252|NCT04173494|365750330|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
106023253|NCT04173494|365750331|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
105835585|NCT01190930|365053703|FG001|Maintenance|Still on therapy|8|||
105835586|NCT01190930|365053704|FG002|Maintenance|Still on therapy|0|||
105835587|NCT01190930|365053705|FG003|Maintenance|Still on therapy|29|||
105835588|NCT01190930|365053706|FG004|Maintenance|Still on therapy|0|||
105835589|NCT01190930|365053707|FG005|Maintenance|Still on therapy|0|||
105835590|NCT01190930|365053708|FG006|Maintenance|Still on therapy|0|||
105835591|NCT01190930|365053709|FG007|Maintenance|Still on therapy|0|||
105835592|NCT01190930|365053710|FG008|Maintenance|Still on therapy|0|||
105835593|NCT01190930|365053711|FG009|Maintenance|Still on therapy|0|||
105835594|NCT02340962|365053714|FG000|Overall Study|Lost to Follow-up|1|||
105835595|NCT02340962|365053715|FG001|Overall Study|Lost to Follow-up|0|||
105835596|NCT01186016|365053716|FG000|Overall Study|Withdrawal by Subject|46|||
105835597|NCT01186016|365053717|FG001|Overall Study|Withdrawal by Subject|29|||
105835598|NCT00160524|365053718|FG000|Overall Study|Adverse Event|119|||
105835599|NCT00160524|365053718|FG000|Overall Study|Adverse Event and Other|94|||
105835600|NCT00160524|365053718|FG000|Overall Study|Protocol Violation|16|||
105835601|NCT00160524|365053718|FG000|Overall Study|Protocol Violation and Other|2|||
105835602|NCT00160524|365053718|FG000|Overall Study|Withdrawal by Subject|141|||
105835603|NCT00160524|365053718|FG000|Overall Study|Withdrawal by Subject and Other|17|||
105835604|NCT00160524|365053718|FG000|Overall Study|Physician Decision|27|||
105835605|NCT00160524|365053718|FG000|Overall Study|Physician Decision and Other|6|||
105835606|NCT00160524|365053718|FG000|Overall Study|Lost to Follow-up|13|||
105835607|NCT00160524|365053718|FG000|Overall Study|Lost to Follow-up and Other|1|||
105835608|NCT00160524|365053718|FG000|Overall Study|Lack of Efficacy|21|||
105835609|NCT00160524|365053718|FG000|Overall Study|Lack of Efficacy and Other|1|||
105835610|NCT00160524|365053718|FG000|Overall Study|Other|20|||
105835611|NCT03750695|365053720|FG000|Overall Study|Lost to Follow-up|0|||
105835612|NCT03750695|365053721|FG001|Overall Study|Lost to Follow-up|1|||
105835613|NCT02151149|365053722|FG000|Treatment Period|Death|2|||
105835614|NCT02151149|365053723|FG001|Treatment Period|Death|3|||
105835615|NCT02151149|365053722|FG000|Treatment Period|Adverse Event|17|||
105835616|NCT02151149|365053723|FG001|Treatment Period|Adverse Event|14|||
105835617|NCT02151149|365053722|FG000|Treatment Period|Progressive Disease|25|||
105835618|NCT02151149|365053723|FG001|Treatment Period|Progressive Disease|24|||
105835619|NCT02151149|365053722|FG000|Treatment Period|Symptomatic Deterioration|2|||
105835620|NCT02151149|365053723|FG001|Treatment Period|Symptomatic Deterioration|10|||
105835621|NCT02151149|365053722|FG000|Treatment Period|Withdrawal by Subject|13|||
105835622|NCT02151149|365053723|FG001|Treatment Period|Withdrawal by Subject|11|||
105835623|NCT02151149|365053722|FG000|Treatment Period|Miscellaneous|8|||
105835624|NCT02151149|365053723|FG001|Treatment Period|Miscellaneous|7|||
105835625|NCT02151149|365053722|FG000|Treatment Period|Participants randomized but not treated|3|||
105835626|NCT02151149|365053723|FG001|Treatment Period|Participants randomized but not treated|2|||
105835627|NCT02151149|365053722|FG000|Follow-Up Period|Lost to Follow-up|2|||
105835628|NCT02151149|365053723|FG001|Follow-Up Period|Lost to Follow-up|3|||
105835629|NCT02151149|365053722|FG000|Follow-Up Period|Death|37|||
105835630|NCT02151149|365053723|FG001|Follow-Up Period|Death|34|||
105835631|NCT03173560|365053724|FG000|Overall Study|Death|70|||
105835632|NCT03173560|365053725|FG001|Overall Study|Death|60|||
105835633|NCT03173560|365053724|FG000|Overall Study|Lost to Follow-up|1|||
105835634|NCT03173560|365053725|FG001|Overall Study|Lost to Follow-up|4|||
105835635|NCT03173560|365053724|FG000|Overall Study|Withdrawal by Subject|10|||
105835636|NCT03173560|365053725|FG001|Overall Study|Withdrawal by Subject|5|||
105835637|NCT03173560|365053724|FG000|Overall Study|Other|0|||
105835638|NCT03173560|365053725|FG001|Overall Study|Other|1|||
105835639|NCT02289820|365053730|FG000|Overall Study|Withdrawal by Subject|2|||
105835640|NCT02289820|365053731|FG001|Overall Study|Withdrawal by Subject|1|||
105835641|NCT02289820|365053732|FG002|Overall Study|Withdrawal by Subject|2|||
105835642|NCT02289820|365053733|FG003|Overall Study|Withdrawal by Subject|1|||
105835643|NCT02289820|365053734|FG004|Overall Study|Withdrawal by Subject|0|||
105835644|NCT02289820|365053735|FG005|Overall Study|Withdrawal by Subject|0|||
105835645|NCT02289820|365053736|FG006|Overall Study|Withdrawal by Subject|1|||
105835646|NCT02289820|365053730|FG000|Overall Study|Death|0|||
105835647|NCT02289820|365053731|FG001|Overall Study|Death|0|||
105835648|NCT02289820|365053732|FG002|Overall Study|Death|1|||
105835649|NCT02289820|365053733|FG003|Overall Study|Death|0|||
105835650|NCT02289820|365053734|FG004|Overall Study|Death|0|||
105835651|NCT02289820|365053735|FG005|Overall Study|Death|0|||
105835652|NCT02289820|365053736|FG006|Overall Study|Death|0|||
105835653|NCT02289820|365053730|FG000|Overall Study|Lost to Follow-up|0|||
105835654|NCT02289820|365053731|FG001|Overall Study|Lost to Follow-up|0|||
105835655|NCT02289820|365053732|FG002|Overall Study|Lost to Follow-up|3|||
105835656|NCT02289820|365053733|FG003|Overall Study|Lost to Follow-up|1|||
105835657|NCT02289820|365053734|FG004|Overall Study|Lost to Follow-up|0|||
105835658|NCT02289820|365053735|FG005|Overall Study|Lost to Follow-up|1|||
105835659|NCT02289820|365053736|FG006|Overall Study|Lost to Follow-up|1|||
105835660|NCT02289820|365053730|FG000|Overall Study|withdrawal of consent|0|||
105835661|NCT02289820|365053731|FG001|Overall Study|withdrawal of consent|1|||
105835662|NCT02289820|365053732|FG002|Overall Study|withdrawal of consent|0|||
105835663|NCT02289820|365053733|FG003|Overall Study|withdrawal of consent|0|||
105835664|NCT02289820|365053734|FG004|Overall Study|withdrawal of consent|0|||
105835665|NCT02289820|365053735|FG005|Overall Study|withdrawal of consent|0|||
105835666|NCT02289820|365053736|FG006|Overall Study|withdrawal of consent|0|||
105835667|NCT01517867|365053740|FG000|Overall Study|never started treatment|29|||
105835668|NCT01517867|365053741|FG001|Overall Study|never started treatment|32|||
105835669|NCT01517867|365053740|FG000|Overall Study|Withdrawal by Subject|34|||
105835670|NCT01517867|365053741|FG001|Overall Study|Withdrawal by Subject|30|||
105835671|NCT01517867|365053740|FG000|Overall Study|Still in treatment at study end|0|||
105835672|NCT01517867|365053741|FG001|Overall Study|Still in treatment at study end|3|||
105835673|NCT01294449|365053749|FG000|Overall Study|Death|11|||
105835674|NCT01294449|365053750|FG001|Overall Study|Death|12|||
105835675|NCT01294449|365053749|FG000|Overall Study|Withdrawal by Subject|1|||
105835676|NCT01294449|365053750|FG001|Overall Study|Withdrawal by Subject|3|||
105835677|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
105835678|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
106149189|NCT03703336|366206973|FG001|Overall Study|Adverse Event|2|||
106149190|NCT03703336|366206972|FG000|Overall Study|Lost to Follow-up|1|||
106149191|NCT03703336|366206973|FG001|Overall Study|Lost to Follow-up|0|||
106149192|NCT01248936|366206980|FG000|Overall Study|Sponsor Decision|259|||
106149193|NCT01248936|366206980|FG000|Overall Study|Progression of Disease|50|||
106149194|NCT01248936|366206980|FG000|Overall Study|Death|26|||
106149195|NCT01248936|366206980|FG000|Overall Study|Withdrawal of Consent|20|||
106149196|NCT01248936|366206980|FG000|Overall Study|Adverse Event|8|||
106149197|NCT01248936|366206980|FG000|Overall Study|Lost to Follow-up|7|||
106149198|NCT01248936|366206980|FG000|Overall Study|Refused Treatment|1|||
106149199|NCT01248936|366206980|FG000|Overall Study|Other reason|3|||
106149200|NCT03485950|366206981|FG000|Overall Study|Adverse Event|1|||
106149201|NCT03485950|366206982|FG001|Overall Study|Adverse Event|0|||
106149202|NCT03485950|366206981|FG000|Overall Study|Death|3|||
106149203|NCT03485950|366206982|FG001|Overall Study|Death|2|||
106149204|NCT03485950|366206981|FG000|Overall Study|Withdrawal by Subject|3|||
106149205|NCT03485950|366206982|FG001|Overall Study|Withdrawal by Subject|0|||
106149206|NCT01925339|366206990|FG000|Overall Study|Adverse Event|2|||
106149207|NCT01925339|366206991|FG001|Overall Study|Adverse Event|0|||
106149208|NCT01538719|366206992|FG000|Overall Study|Lost to Follow-up|2|||
106149209|NCT01538719|366206993|FG001|Overall Study|Lost to Follow-up|0|||
106149210|NCT04048382|366206994|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
106149211|NCT04048382|366206995|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
106149212|NCT04048382|366206994|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
106149213|NCT04048382|366206995|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
106149214|NCT04048382|366206994|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
105835679|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
105835680|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
105835681|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
105835682|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
105835683|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
106149215|NCT04048382|366206995|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
105835684|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
105835685|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
105835686|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
105835687|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
105835688|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
105835689|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
105835690|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
105835691|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
105835692|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
105835693|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
105835694|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
105835695|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
105835696|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
105835697|NCT02418754|365053753|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
105835698|NCT02418754|365053754|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
105835699|NCT02418754|365053755|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
105835700|NCT02418754|365053756|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
105835701|NCT02418754|365053757|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
105835702|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
105835703|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
105835704|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
105835705|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
105835706|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
105835707|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
105835708|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
105835709|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
105835710|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
105835711|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
105835712|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
105835713|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
105835714|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
105835715|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
105835716|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
106149216|NCT01205048|366206997|FG000|Overall Study|Withdrawal by Subject|14|||
106149217|NCT01205048|366206997|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
106149218|NCT01205048|366206997|FG000|Overall Study|Lost to Follow-up|4|||
106149219|NCT01205048|366206997|FG000|Overall Study|Other|2|||
106149220|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
106149221|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
106149222|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
106149223|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
105835717|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
105835718|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
105835719|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
105835720|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
105835721|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
105835722|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
105835723|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
105835724|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
105835725|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
105835726|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
105835727|NCT02418754|365053753|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
105835728|NCT02418754|365053754|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
105835729|NCT02418754|365053755|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
105835730|NCT02418754|365053756|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
105835731|NCT02418754|365053757|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
105835732|NCT02063217|365053759|FG000|Overall Study|Withdrawal by Subject|1|||
105835733|NCT02063217|365053760|FG001|Overall Study|Withdrawal by Subject|0|||
105835734|NCT02063217|365053761|FG002|Overall Study|Withdrawal by Subject|0|||
105835735|NCT01833169|365053762|FG000|Overall Study|Disease Progression|99|||
105835736|NCT01833169|365053762|FG000|Overall Study|Adverse Event|33|||
105835737|NCT01833169|365053762|FG000|Overall Study|Withdrawal by Subject|9|||
105835738|NCT01833169|365053762|FG000|Overall Study|Death|3|||
105835739|NCT01833169|365053762|FG000|Overall Study|Physician Decision|2|||
105835740|NCT00127166|365053763|FG000|Period I|Protocol Violation|0|||
105835741|NCT00127166|365053764|FG001|Period I|Protocol Violation|2|||
105835742|NCT00127166|365053763|FG000|Period I|Withdrawal by Subject|2|||
105835743|NCT00127166|365053764|FG001|Period I|Withdrawal by Subject|0|||
105835744|NCT00127166|365053763|FG000|Period I|Patient did not meet inclusion criteria|1|||
105835745|NCT00127166|365053764|FG001|Period I|Patient did not meet inclusion criteria|0|||
105835746|NCT00127166|365053763|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
105835747|NCT00127166|365053764|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
105835748|NCT00127166|365053763|FG000|Period II|Withdrawal by Subject|2|||
105835749|NCT00127166|365053764|FG001|Period II|Withdrawal by Subject|0|||
105835750|NCT00127166|365053763|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
105835751|NCT00127166|365053764|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
105835752|NCT00105157|365053765|FG000|Double-Blind (DB)|Never Treated|1|||
105835753|NCT00105157|365053766|FG001|Double-Blind (DB)|Never Treated|0|||
105835754|NCT00105157|365053767|FG002|Double-Blind (DB)|Never Treated|0|||
105835755|NCT00105157|365053768|FG003|Double-Blind (DB)|Never Treated|0|||
105835756|NCT00105157|365053765|FG000|Double-Blind (DB)|Adverse Event|2|||
105835757|NCT00105157|365053766|FG001|Double-Blind (DB)|Adverse Event|0|||
105835758|NCT00105157|365053767|FG002|Double-Blind (DB)|Adverse Event|1|||
105835759|NCT00105157|365053768|FG003|Double-Blind (DB)|Adverse Event|1|||
105835760|NCT00105157|365053765|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
105835761|NCT00105157|365053766|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
105835762|NCT00105157|365053767|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
105835763|NCT00105157|365053768|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
105835764|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Adverse Event|3|||
105835765|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Adverse Event|1|||
105965512|NCT01474772|365532332|FG000|Follow-up|AE not Related to Study Drug|0|||
105965513|NCT01474772|365532333|FG001|Follow-up|AE not Related to Study Drug|1|||
105965514|NCT03286543|365532334|FG000|Consented|Screen failure before randomization|2|||
105965515|NCT03286543|365532335|FG001|Consented|Screen failure before randomization|0|||
105965516|NCT03286543|365532336|FG002|Consented|Screen failure before randomization|0|||
105965517|NCT03286543|365532334|FG000|Consented|Screen failure before enrollment|4|||
105965518|NCT03286543|365532335|FG001|Consented|Screen failure before enrollment|0|||
105965519|NCT03286543|365532336|FG002|Consented|Screen failure before enrollment|0|||
105965520|NCT03286543|365532334|FG000|Consented|TKA cancelled after enrollment|1|||
105965521|NCT03286543|365532335|FG001|Consented|TKA cancelled after enrollment|0|||
105965522|NCT03286543|365532336|FG002|Consented|TKA cancelled after enrollment|0|||
105965523|NCT03286543|365532334|FG000|Consented|Withdrawn from study|12|||
105965524|NCT03286543|365532335|FG001|Consented|Withdrawn from study|0|||
105965525|NCT03286543|365532336|FG002|Consented|Withdrawn from study|0|||
105965526|NCT03286543|365532334|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
105965527|NCT03286543|365532335|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
105965528|NCT03286543|365532336|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
105835766|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Adverse Event|0|||
105965529|NCT03286543|365532334|FG000|Study Enrollment|Withdrawn from study|0|||
105965530|NCT03286543|365532335|FG001|Study Enrollment|Withdrawn from study|6|||
105965531|NCT03286543|365532336|FG002|Study Enrollment|Withdrawn from study|6|||
105835767|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Adverse Event|0|||
105835768|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
105835769|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
105835770|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
105835771|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
105835772|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
105835773|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
105835774|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
105835775|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
105835776|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
105835777|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
105835778|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
105835779|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
105835780|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
105835781|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
105835782|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
105835783|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
105835784|NCT00105157|365053765|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
105835785|NCT00105157|365053766|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
105835786|NCT00105157|365053767|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
105835787|NCT00105157|365053768|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
105835788|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
105835789|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
105835790|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
105835791|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
105835792|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
105835793|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
105835794|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
105965532|NCT01463696|365532337|FG000|Overall Study|Adverse Event|0|||
105965533|NCT01463696|365532338|FG001|Overall Study|Adverse Event|1|||
105965534|NCT01463696|365532339|FG002|Overall Study|Adverse Event|0|||
105965535|NCT01463696|365532340|FG003|Overall Study|Adverse Event|2|||
105965536|NCT01463696|365532341|FG004|Overall Study|Adverse Event|0|||
105965537|NCT01463696|365532342|FG005|Overall Study|Adverse Event|1|||
105965538|NCT01463696|365532343|FG006|Overall Study|Adverse Event|3|||
105965539|NCT01463696|365532344|FG007|Overall Study|Adverse Event|2|||
105965540|NCT01463696|365532337|FG000|Overall Study|Lost to Follow-up|0|||
105965541|NCT01463696|365532338|FG001|Overall Study|Lost to Follow-up|0|||
105965542|NCT01463696|365532339|FG002|Overall Study|Lost to Follow-up|1|||
105965543|NCT01463696|365532340|FG003|Overall Study|Lost to Follow-up|0|||
105965544|NCT01463696|365532341|FG004|Overall Study|Lost to Follow-up|0|||
105965545|NCT01463696|365532342|FG005|Overall Study|Lost to Follow-up|0|||
105965546|NCT01463696|365532343|FG006|Overall Study|Lost to Follow-up|0|||
105965547|NCT01463696|365532344|FG007|Overall Study|Lost to Follow-up|0|||
105965548|NCT01463696|365532337|FG000|Overall Study|Progressive Disease|0|||
105965549|NCT01463696|365532338|FG001|Overall Study|Progressive Disease|1|||
105965550|NCT01463696|365532339|FG002|Overall Study|Progressive Disease|0|||
105965551|NCT01463696|365532340|FG003|Overall Study|Progressive Disease|1|||
105965552|NCT01463696|365532341|FG004|Overall Study|Progressive Disease|0|||
105965553|NCT01463696|365532342|FG005|Overall Study|Progressive Disease|1|||
105965554|NCT01463696|365532343|FG006|Overall Study|Progressive Disease|4|||
105965555|NCT01463696|365532344|FG007|Overall Study|Progressive Disease|2|||
105965556|NCT01463696|365532337|FG000|Overall Study|Withdrawal by Subject|0|||
105965557|NCT01463696|365532338|FG001|Overall Study|Withdrawal by Subject|0|||
105965558|NCT01463696|365532339|FG002|Overall Study|Withdrawal by Subject|0|||
105965559|NCT01463696|365532340|FG003|Overall Study|Withdrawal by Subject|1|||
105965560|NCT01463696|365532341|FG004|Overall Study|Withdrawal by Subject|1|||
105965561|NCT01463696|365532342|FG005|Overall Study|Withdrawal by Subject|1|||
105965562|NCT01463696|365532343|FG006|Overall Study|Withdrawal by Subject|2|||
105965563|NCT01463696|365532344|FG007|Overall Study|Withdrawal by Subject|0|||
105965564|NCT01463696|365532337|FG000|Overall Study|Not Treated|0|||
105965565|NCT01463696|365532338|FG001|Overall Study|Not Treated|0|||
105965566|NCT01463696|365532339|FG002|Overall Study|Not Treated|0|||
105965567|NCT01463696|365532340|FG003|Overall Study|Not Treated|0|||
105965568|NCT01463696|365532341|FG004|Overall Study|Not Treated|0|||
105965569|NCT01463696|365532342|FG005|Overall Study|Not Treated|0|||
105965570|NCT01463696|365532343|FG006|Overall Study|Not Treated|1|||
105965571|NCT01463696|365532344|FG007|Overall Study|Not Treated|0|||
105965572|NCT01450696|365532345|FG000|Overall Study|Never Treated|1|||
105965573|NCT01450696|365532346|FG001|Overall Study|Never Treated|1|||
105965574|NCT01450696|365532345|FG000|Overall Study|Death|77|||
105965575|NCT01450696|365532346|FG001|Overall Study|Death|84|||
105965576|NCT01450696|365532345|FG000|Overall Study|Lost to Follow-up|3|||
105965577|NCT01450696|365532346|FG001|Overall Study|Lost to Follow-up|3|||
105835795|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
105835796|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
105835797|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
105835798|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
105835799|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
105835800|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
105835801|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
105835802|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
105835803|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
105835804|NCT00105157|365053765|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
105835805|NCT00105157|365053766|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
105965578|NCT01450696|365532345|FG000|Overall Study|Non-Compliance|1|||
105965579|NCT01450696|365532346|FG001|Overall Study|Non-Compliance|0|||
105965580|NCT01450696|365532345|FG000|Overall Study|Withdrawal by Subject|13|||
105965581|NCT01450696|365532346|FG001|Overall Study|Withdrawal by Subject|2|||
105965582|NCT01450696|365532345|FG000|Overall Study|Study Terminated by Sponsor|53|||
105965583|NCT01450696|365532346|FG001|Overall Study|Study Terminated by Sponsor|58|||
105965584|NCT00967694|365532347|FG000|Overall Study|Withdrawal by Subject|6|||
105965585|NCT02321319|365532348|FG000|Overall Study|Product discontinued|5|||
105965586|NCT02249091|365532349|FG000|Overall Study|Lack of Efficacy|8|||
105965587|NCT02249091|365532350|FG001|Overall Study|Lack of Efficacy|3|||
105965588|NCT02249091|365532349|FG000|Overall Study|Physician Decision|4|||
105965589|NCT02249091|365532350|FG001|Overall Study|Physician Decision|1|||
105965590|NCT02249091|365532349|FG000|Overall Study|Withdrawal by Subject|2|||
105965591|NCT02249091|365532350|FG001|Overall Study|Withdrawal by Subject|2|||
105965592|NCT02249091|365532349|FG000|Overall Study|Death|3|||
105965593|NCT02249091|365532350|FG001|Overall Study|Death|4|||
105965594|NCT02249091|365532349|FG000|Overall Study|Adverse Event|1|||
105965595|NCT02249091|365532350|FG001|Overall Study|Adverse Event|0|||
105965596|NCT02249091|365532349|FG000|Overall Study|Stable disease with following SCT|0|||
105965597|NCT02249091|365532350|FG001|Overall Study|Stable disease with following SCT|1|||
105965598|NCT02249091|365532349|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
105965599|NCT02249091|365532350|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
105965600|NCT02249091|365532349|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
105965601|NCT02249091|365532350|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
105965602|NCT02249091|365532349|FG000|Overall Study|Refractory AML|1|||
105965603|NCT02249091|365532350|FG001|Overall Study|Refractory AML|1|||
105965604|NCT00433966|365532351|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
105965605|NCT00433966|365532352|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
105965606|NCT00433966|365532353|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
105965607|NCT00433966|365532354|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
105965608|NCT00433966|365532351|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
105965609|NCT00433966|365532352|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
105965610|NCT00433966|365532353|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
105965611|NCT00433966|365532354|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
105965612|NCT00433966|365532351|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
105965613|NCT00433966|365532352|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
105965614|NCT00433966|365532353|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
105965615|NCT00433966|365532354|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
105965616|NCT00433966|365532351|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
105965617|NCT00433966|365532352|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
105965618|NCT00433966|365532353|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
105965619|NCT00433966|365532354|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
105965620|NCT00433966|365532351|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
105965621|NCT00433966|365532352|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
105965622|NCT00433966|365532353|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
105965623|NCT00433966|365532354|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
105965624|NCT03905265|365532356|FG000|Overall Study|Withdrawal by Subject|1|||
105965625|NCT03905265|365532357|FG001|Overall Study|Withdrawal by Subject|1|||
105965626|NCT03905265|365532358|FG002|Overall Study|Withdrawal by Subject|0|||
105965627|NCT03905265|365532359|FG003|Overall Study|Withdrawal by Subject|0|||
105965628|NCT01265563|365532360|FG000|Overall Study|Withdrawal by Subject|0|||
105965629|NCT01265563|365532361|FG001|Overall Study|Withdrawal by Subject|1|||
105965630|NCT01265563|365532362|FG002|Overall Study|Withdrawal by Subject|1|||
105965631|NCT01265563|365532363|FG003|Overall Study|Withdrawal by Subject|0|||
105965632|NCT01265563|365532364|FG004|Overall Study|Withdrawal by Subject|2|||
105965633|NCT00606034|365532369|FG000|Overall Study|incarceration|1|||
105965634|NCT00632827|365532372|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
105965635|NCT00632827|365532372|FG000|Overall Study|Death|2|||
106149224|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
106149225|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
106149226|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
106149227|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
106149228|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
106149229|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
106149230|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
106149231|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
106149232|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
106149233|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
106149234|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
106149235|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
106149236|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
106149237|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
106149238|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
106149239|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
106149240|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
106149241|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
106149242|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
106149243|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
106149244|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
106149245|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
106149246|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
106149247|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
106149248|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
106149249|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
106149250|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
106149251|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
106149252|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
106149253|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
106149254|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
106149255|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
106149256|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
106149257|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
106149258|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
106149259|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
106149260|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
106149261|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
106149262|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
105835806|NCT00105157|365053767|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
105835807|NCT00105157|365053768|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
105835808|NCT00708682|365053769|FG000|Infant Series|Adverse Event|1|||
105835809|NCT00708682|365053769|FG000|Infant Series|Lost to Follow-up|4|||
105835810|NCT00708682|365053769|FG000|Infant Series|Protocol Violation|1|||
105835811|NCT00708682|365053769|FG000|Infant Series|Parent/legal guardian request|6|||
105835812|NCT00708682|365053769|FG000|Infant Series|Failed to return|2|||
105835813|NCT00708682|365053769|FG000|Infant Series|Other|19|||
106023254|NCT04195893|365750332|FG000|Second Intervention|Withdrawal by Subject|1|||
106023255|NCT04195893|365750333|FG001|Second Intervention|Withdrawal by Subject|0|||
106023256|NCT01519869|365750334|FG000|Overall Study|Lost to Follow-up|1|||
106023257|NCT03023813|365750335|FG000|Overall Study|Lost to Follow-up|1|||
106023258|NCT03023813|365750336|FG001|Overall Study|Lost to Follow-up|2|||
106023259|NCT03023813|365750337|FG002|Overall Study|Lost to Follow-up|0|||
106023260|NCT01802073|365750340|FG000|Overall Study|Lost to Follow-up|0|||
105835814|NCT00708682|365053769|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
106023261|NCT01802073|365750341|FG001|Overall Study|Lost to Follow-up|1|||
106023262|NCT01802073|365750340|FG000|Overall Study|Non-compliant|4|||
106023263|NCT01802073|365750341|FG001|Overall Study|Non-compliant|2|||
106023264|NCT01802073|365750340|FG000|Overall Study|Withdrawal by Subject|1|||
106023265|NCT01802073|365750341|FG001|Overall Study|Withdrawal by Subject|1|||
106023266|NCT01802073|365750340|FG000|Overall Study|Physician Decision|0|||
106023267|NCT01802073|365750341|FG001|Overall Study|Physician Decision|7|||
106023268|NCT04075734|365750342|FG000|Overall Study|Lost to Follow-up|1|||
106023269|NCT04075734|365750343|FG001|Overall Study|Lost to Follow-up|1|||
106023270|NCT04075734|365750344|FG002|Overall Study|Lost to Follow-up|0|||
106023271|NCT04075734|365750342|FG000|Overall Study|Withdrawal by Subject|3|||
106023272|NCT04075734|365750343|FG001|Overall Study|Withdrawal by Subject|0|||
105835815|NCT00708682|365053769|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
105835816|NCT00708682|365053769|FG000|Toddler Dose|Lost to Follow-up|3|||
105965636|NCT00632827|365532372|FG000|Overall Study|Adverse Event|5|||
105965637|NCT00632827|365532372|FG000|Overall Study|Lost to Follow-up|1|||
105965638|NCT01257230|365532373|FG000|Overall Study|Not Treated|0|||
105965639|NCT01257230|365532374|FG001|Overall Study|Not Treated|0|||
105965640|NCT01257230|365532375|FG002|Overall Study|Not Treated|1|||
105965641|NCT01257230|365532373|FG000|Overall Study|Adverse Event|2|||
105965642|NCT01257230|365532374|FG001|Overall Study|Adverse Event|0|||
105965643|NCT01257230|365532375|FG002|Overall Study|Adverse Event|0|||
105965644|NCT01257230|365532373|FG000|Overall Study|Lack of Efficacy|0|||
105965645|NCT01257230|365532374|FG001|Overall Study|Lack of Efficacy|1|||
105965646|NCT01257230|365532375|FG002|Overall Study|Lack of Efficacy|0|||
105965647|NCT01257230|365532373|FG000|Overall Study|Protocol Violation|3|||
105965648|NCT01257230|365532374|FG001|Overall Study|Protocol Violation|0|||
105965649|NCT01257230|365532375|FG002|Overall Study|Protocol Violation|1|||
105965650|NCT01257230|365532373|FG000|Overall Study|Withdrawal by Subject|0|||
105965651|NCT01257230|365532374|FG001|Overall Study|Withdrawal by Subject|4|||
105965652|NCT01257230|365532375|FG002|Overall Study|Withdrawal by Subject|1|||
105965653|NCT01257230|365532373|FG000|Overall Study|Other reason not defined above|1|||
105965654|NCT01257230|365532374|FG001|Overall Study|Other reason not defined above|5|||
105965655|NCT01257230|365532375|FG002|Overall Study|Other reason not defined above|3|||
105965656|NCT00675441|365532376|FG000|Overall Study|Withdrawal by Subject|2|||
105965657|NCT00675441|365532376|FG000|Overall Study|Death|1|||
105965658|NCT01581021|365532377|FG000|Overall Study|Lost to Follow-up|4|||
105965659|NCT01581021|365532378|FG001|Overall Study|Lost to Follow-up|6|||
105965660|NCT01581021|365532377|FG000|Overall Study|More than 2 hooks in thoracic|3|||
105965661|NCT01581021|365532378|FG001|Overall Study|More than 2 hooks in thoracic|0|||
105965662|NCT01581021|365532377|FG000|Overall Study|Neuromuscular|2|||
105965663|NCT01581021|365532378|FG001|Overall Study|Neuromuscular|1|||
105965664|NCT01581021|365532377|FG000|Overall Study|Not Randomized|1|||
105965665|NCT01581021|365532378|FG001|Overall Study|Not Randomized|2|||
105965666|NCT01581021|365532377|FG000|Overall Study|Lenke 6 Classification|0|||
105965667|NCT01581021|365532378|FG001|Overall Study|Lenke 6 Classification|1|||
105965668|NCT01581021|365532377|FG000|Overall Study|Lack of Efficacy|0|||
105965669|NCT01581021|365532378|FG001|Overall Study|Lack of Efficacy|1|||
105965670|NCT00782171|365533760|FG000|Overall Study|Lost to Follow-up|2|||
105965671|NCT00782171|365533761|FG001|Overall Study|Lost to Follow-up|2|||
105965672|NCT00782171|365533760|FG000|Overall Study|Withdrawal by Subject|2|||
105965673|NCT00782171|365533761|FG001|Overall Study|Withdrawal by Subject|1|||
105965674|NCT00782171|365533760|FG000|Overall Study|complications|3|||
105965675|NCT00782171|365533761|FG001|Overall Study|complications|1|||
105965676|NCT00782171|365533760|FG000|Overall Study|others|7|||
105965677|NCT00782171|365533761|FG001|Overall Study|others|9|||
105965678|NCT00782171|365533760|FG000|Overall Study|not eligible|8|||
105965679|NCT00782171|365533761|FG001|Overall Study|not eligible|6|||
105965680|NCT04493424|365533769|FG000|Overall Study|Termination of the trial by the sponsor|89|||
105965681|NCT04493424|365533769|FG000|Overall Study|Withdrawal by Subject|9|||
105965682|NCT04493424|365533769|FG000|Overall Study|Lost to Follow-up|2|||
105965683|NCT04493424|365533769|FG000|Overall Study|Lack of Efficacy|3|||
105965684|NCT04493424|365533769|FG000|Overall Study|Adverse Event|5|||
105965685|NCT01340625|365533770|FG000|First Intervention|Adverse Event|1|||
105965686|NCT01340625|365533771|FG001|First Intervention|Adverse Event|0|||
105965687|NCT01340625|365533770|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
105965688|NCT01340625|365533771|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
105965689|NCT00734604|365533774|FG000|Overall Study|Adverse Event|0|||
105965690|NCT00734604|365533775|FG001|Overall Study|Adverse Event|2|||
105965691|NCT00734604|365533776|FG002|Overall Study|Adverse Event|0|||
105965692|NCT00734604|365533777|FG003|Overall Study|Adverse Event|2|||
105965693|NCT00734604|365533778|FG004|Overall Study|Adverse Event|1|||
105965694|NCT00734604|365533779|FG005|Overall Study|Adverse Event|1|||
105965695|NCT00734604|365533774|FG000|Overall Study|Serious Adverse Event|1|||
105965696|NCT00734604|365533775|FG001|Overall Study|Serious Adverse Event|0|||
105965697|NCT00734604|365533776|FG002|Overall Study|Serious Adverse Event|1|||
105965698|NCT00734604|365533777|FG003|Overall Study|Serious Adverse Event|2|||
105965699|NCT00734604|365533778|FG004|Overall Study|Serious Adverse Event|0|||
105965700|NCT00734604|365533779|FG005|Overall Study|Serious Adverse Event|1|||
105965701|NCT00734604|365533774|FG000|Overall Study|Lost to Follow-up|1|||
105965702|NCT00734604|365533775|FG001|Overall Study|Lost to Follow-up|2|||
105965703|NCT00734604|365533776|FG002|Overall Study|Lost to Follow-up|2|||
105965704|NCT00734604|365533777|FG003|Overall Study|Lost to Follow-up|4|||
105965705|NCT00734604|365533778|FG004|Overall Study|Lost to Follow-up|2|||
105965706|NCT00734604|365533779|FG005|Overall Study|Lost to Follow-up|3|||
105965707|NCT00734604|365533774|FG000|Overall Study|Physician Decision|0|||
105965708|NCT00734604|365533775|FG001|Overall Study|Physician Decision|1|||
105965709|NCT00734604|365533776|FG002|Overall Study|Physician Decision|1|||
105965710|NCT00734604|365533777|FG003|Overall Study|Physician Decision|0|||
105965711|NCT00734604|365533778|FG004|Overall Study|Physician Decision|0|||
105965712|NCT00734604|365533779|FG005|Overall Study|Physician Decision|0|||
105965713|NCT00734604|365533774|FG000|Overall Study|Protocol Violation|0|||
106023273|NCT04075734|365750344|FG002|Overall Study|Withdrawal by Subject|0|||
106023274|NCT00393861|365750345|FG000|Overall Study|Adverse Event|2|||
106023275|NCT00393861|365750345|FG000|Overall Study|Disease Progression|24|||
106023276|NCT00918736|365750349|FG000|Overall Study|Withdrawal by Subject|4|||
106023277|NCT01474018|365750350|FG000|Overall Study|Lost to Follow-up|0|||
106023278|NCT01474018|365750351|FG001|Overall Study|Lost to Follow-up|1|||
106023279|NCT01474018|365750350|FG000|Overall Study|Withdrawal by Subject|0|||
106023280|NCT01474018|365750351|FG001|Overall Study|Withdrawal by Subject|2|||
106023281|NCT01137604|365750352|FG000|Overall Study|Adverse Event|3|||
106023282|NCT01137604|365750353|FG001|Overall Study|Adverse Event|6|||
105835817|NCT00708682|365053769|FG000|Toddler Dose|Failed to Return|4|||
105835818|NCT02212457|365053774|FG000|Overall Study|Adverse Event|1|||
105835819|NCT02212457|365053775|FG001|Overall Study|Adverse Event|2|||
105835820|NCT02212457|365053776|FG002|Overall Study|Adverse Event|2|||
105835821|NCT02212457|365053777|FG003|Overall Study|Adverse Event|2|||
105835822|NCT02212457|365053778|FG004|Overall Study|Adverse Event|0|||
105835823|NCT02212457|365053779|FG005|Overall Study|Adverse Event|1|||
105835824|NCT02212457|365053774|FG000|Overall Study|Withdrawal by Subject|8|||
105835825|NCT02212457|365053775|FG001|Overall Study|Withdrawal by Subject|10|||
105835826|NCT02212457|365053776|FG002|Overall Study|Withdrawal by Subject|8|||
105835827|NCT02212457|365053777|FG003|Overall Study|Withdrawal by Subject|6|||
105835828|NCT02212457|365053778|FG004|Overall Study|Withdrawal by Subject|5|||
106023283|NCT01137604|365750354|FG002|Overall Study|Adverse Event|9|||
106023284|NCT01137604|365750355|FG003|Overall Study|Adverse Event|9|||
106023285|NCT01137604|365750352|FG000|Overall Study|Participant Choice|0|||
106023286|NCT01137604|365750353|FG001|Overall Study|Participant Choice|2|||
106023287|NCT01137604|365750354|FG002|Overall Study|Participant Choice|2|||
105835829|NCT02212457|365053779|FG005|Overall Study|Withdrawal by Subject|4|||
105835830|NCT02212457|365053774|FG000|Overall Study|Lost to Follow-up|6|||
105835831|NCT02212457|365053775|FG001|Overall Study|Lost to Follow-up|7|||
105835832|NCT02212457|365053776|FG002|Overall Study|Lost to Follow-up|4|||
105835833|NCT02212457|365053777|FG003|Overall Study|Lost to Follow-up|1|||
105835834|NCT02212457|365053778|FG004|Overall Study|Lost to Follow-up|8|||
105835835|NCT02212457|365053779|FG005|Overall Study|Lost to Follow-up|4|||
105835836|NCT02212457|365053774|FG000|Overall Study|Protocol Violation|2|||
105835837|NCT02212457|365053775|FG001|Overall Study|Protocol Violation|1|||
105965714|NCT00734604|365533775|FG001|Overall Study|Protocol Violation|2|||
105965715|NCT00734604|365533776|FG002|Overall Study|Protocol Violation|0|||
105965716|NCT00734604|365533777|FG003|Overall Study|Protocol Violation|0|||
105965717|NCT00734604|365533778|FG004|Overall Study|Protocol Violation|1|||
105965718|NCT00734604|365533779|FG005|Overall Study|Protocol Violation|0|||
105965719|NCT00734604|365533774|FG000|Overall Study|Sponsor Decision|1|||
105965720|NCT00734604|365533775|FG001|Overall Study|Sponsor Decision|2|||
105965721|NCT00734604|365533776|FG002|Overall Study|Sponsor Decision|1|||
105965722|NCT00734604|365533777|FG003|Overall Study|Sponsor Decision|0|||
105965723|NCT00734604|365533778|FG004|Overall Study|Sponsor Decision|2|||
105965724|NCT00734604|365533779|FG005|Overall Study|Sponsor Decision|0|||
105965725|NCT00734604|365533774|FG000|Overall Study|Withdrawal by Subject|0|||
105965726|NCT00734604|365533775|FG001|Overall Study|Withdrawal by Subject|2|||
105965727|NCT00734604|365533776|FG002|Overall Study|Withdrawal by Subject|0|||
105965728|NCT00734604|365533777|FG003|Overall Study|Withdrawal by Subject|1|||
105965729|NCT00734604|365533778|FG004|Overall Study|Withdrawal by Subject|2|||
105965730|NCT00734604|365533779|FG005|Overall Study|Withdrawal by Subject|1|||
105965731|NCT00734604|365533774|FG000|Overall Study|Lack of Efficacy|0|||
105965732|NCT00734604|365533775|FG001|Overall Study|Lack of Efficacy|1|||
105965733|NCT00734604|365533776|FG002|Overall Study|Lack of Efficacy|1|||
105965734|NCT00734604|365533777|FG003|Overall Study|Lack of Efficacy|0|||
105965735|NCT00734604|365533778|FG004|Overall Study|Lack of Efficacy|0|||
105965736|NCT00734604|365533779|FG005|Overall Study|Lack of Efficacy|0|||
105965737|NCT05243745|365533780|FG000|Overall Study|Withdrawal by Subject|0|||
105965738|NCT05243745|365533781|FG001|Overall Study|Withdrawal by Subject|0|||
105965739|NCT05243745|365533782|FG002|Overall Study|Withdrawal by Subject|0|||
105965740|NCT05243745|365533783|FG003|Overall Study|Withdrawal by Subject|1|||
105965741|NCT05243745|365533780|FG000|Overall Study|Unable to Attend Visit 6|0|||
106023288|NCT01137604|365750355|FG003|Overall Study|Participant Choice|0|||
106023289|NCT01137604|365750352|FG000|Overall Study|Withdrawal of consent|0|||
106023290|NCT01137604|365750353|FG001|Overall Study|Withdrawal of consent|0|||
106023291|NCT01137604|365750354|FG002|Overall Study|Withdrawal of consent|0|||
106149263|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
106149264|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
105835838|NCT02212457|365053776|FG002|Overall Study|Protocol Violation|0|||
105835839|NCT02212457|365053777|FG003|Overall Study|Protocol Violation|1|||
105835840|NCT02212457|365053778|FG004|Overall Study|Protocol Violation|2|||
105835841|NCT02212457|365053779|FG005|Overall Study|Protocol Violation|3|||
105835842|NCT02212457|365053774|FG000|Overall Study|Other|2|||
105835843|NCT02212457|365053775|FG001|Overall Study|Other|1|||
105965742|NCT05243745|365533781|FG001|Overall Study|Unable to Attend Visit 6|0|||
105965743|NCT05243745|365533782|FG002|Overall Study|Unable to Attend Visit 6|1|||
105965744|NCT05243745|365533783|FG003|Overall Study|Unable to Attend Visit 6|0|||
105835844|NCT02212457|365053776|FG002|Overall Study|Other|2|||
105835845|NCT02212457|365053777|FG003|Overall Study|Other|1|||
105835846|NCT02212457|365053778|FG004|Overall Study|Other|0|||
105835847|NCT02212457|365053779|FG005|Overall Study|Other|1|||
105835848|NCT00393705|365053780|FG000|Overall Study|Adverse Event|0|||
105835849|NCT00393705|365053781|FG001|Overall Study|Adverse Event|2|||
105835850|NCT00393705|365053780|FG000|Overall Study|Death|0|||
105835851|NCT00393705|365053781|FG001|Overall Study|Death|1|||
105835852|NCT00393705|365053780|FG000|Overall Study|Lost to Follow-up|2|||
105835853|NCT00393705|365053781|FG001|Overall Study|Lost to Follow-up|2|||
105835854|NCT00393705|365053780|FG000|Overall Study|Entry Criteria Not Met|10|||
105835855|NCT00393705|365053781|FG001|Overall Study|Entry Criteria Not Met|10|||
105835856|NCT00393705|365053780|FG000|Overall Study|Protocol Violation|4|||
105835857|NCT00393705|365053781|FG001|Overall Study|Protocol Violation|3|||
105835858|NCT00393705|365053780|FG000|Overall Study|Withdrawal by Subject|5|||
105835859|NCT00393705|365053781|FG001|Overall Study|Withdrawal by Subject|3|||
105965745|NCT00176488|365533784|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
105965746|NCT00459875|365533785|FG000|Overall Study|Ineligible participant|1|||
105965747|NCT00459875|365533785|FG000|Overall Study|Adverse Event|2|||
105965748|NCT02557100|365533794|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
105965749|NCT02557100|365533795|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
105965750|NCT02557100|365533796|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
105965751|NCT02557100|365533794|FG000|Single Blind Treatment Period|Death|0|||
105965752|NCT02557100|365533795|FG001|Single Blind Treatment Period|Death|1|||
105965753|NCT02557100|365533796|FG002|Single Blind Treatment Period|Death|0|||
105965754|NCT02557100|365533794|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
105965755|NCT02557100|365533795|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
106023292|NCT01137604|365750355|FG003|Overall Study|Withdrawal of consent|2|||
106023293|NCT01137604|365750352|FG000|Overall Study|Clinical progression/deterioration|1|||
105835860|NCT00393705|365053780|FG000|Overall Study|Physician Decision|2|||
105835861|NCT00393705|365053781|FG001|Overall Study|Physician Decision|2|||
105835862|NCT01120691|365053782|FG000|Overall Study|Adverse Event|59|||
105835863|NCT01120691|365053783|FG001|Overall Study|Adverse Event|67|||
105835864|NCT01120691|365053784|FG002|Overall Study|Adverse Event|47|||
105835865|NCT01120691|365053782|FG000|Overall Study|Subject withdrew consent|33|||
105835866|NCT01120691|365053783|FG001|Overall Study|Subject withdrew consent|50|||
105835867|NCT01120691|365053784|FG002|Overall Study|Subject withdrew consent|44|||
105835868|NCT01120691|365053782|FG000|Overall Study|Death|21|||
105835869|NCT01120691|365053783|FG001|Overall Study|Death|22|||
105835870|NCT01120691|365053784|FG002|Overall Study|Death|24|||
105835871|NCT01120691|365053782|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
105835872|NCT01120691|365053783|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
105835873|NCT01120691|365053784|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
105835874|NCT01120691|365053782|FG000|Overall Study|Administrative problems|15|||
105835875|NCT01120691|365053783|FG001|Overall Study|Administrative problems|8|||
105835876|NCT01120691|365053784|FG002|Overall Study|Administrative problems|9|||
105835877|NCT01120691|365053782|FG000|Overall Study|Protocol deviation|13|||
105835878|NCT01120691|365053783|FG001|Overall Study|Protocol deviation|12|||
105835879|NCT01120691|365053784|FG002|Overall Study|Protocol deviation|12|||
105835880|NCT01120691|365053782|FG000|Overall Study|Lost to Follow-up|5|||
105835881|NCT01120691|365053783|FG001|Overall Study|Lost to Follow-up|6|||
105835882|NCT01120691|365053784|FG002|Overall Study|Lost to Follow-up|4|||
105835883|NCT01120691|365053782|FG000|Overall Study|Abnormal test procedure result(s)|3|||
105835884|NCT01120691|365053783|FG001|Overall Study|Abnormal test procedure result(s)|2|||
105835885|NCT01120691|365053784|FG002|Overall Study|Abnormal test procedure result(s)|1|||
105835886|NCT01120691|365053782|FG000|Overall Study|Patient's inability to use the device|3|||
105835887|NCT01120691|365053783|FG001|Overall Study|Patient's inability to use the device|1|||
105835888|NCT01120691|365053784|FG002|Overall Study|Patient's inability to use the device|0|||
105835889|NCT01120691|365053782|FG000|Overall Study|Abnormal laboratory value(s)|1|||
105835890|NCT01120691|365053783|FG001|Overall Study|Abnormal laboratory value(s)|3|||
105835891|NCT01120691|365053784|FG002|Overall Study|Abnormal laboratory value(s)|4|||
105965756|NCT02557100|365533796|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
105965757|NCT02557100|365533794|FG000|Single Blind Treatment Period|Adverse Event|0|||
106023294|NCT01137604|365750353|FG001|Overall Study|Clinical progression/deterioration|2|||
106023295|NCT01137604|365750354|FG002|Overall Study|Clinical progression/deterioration|2|||
106149265|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
106149266|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105835892|NCT02030535|365053785|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
105835893|NCT03185741|365053792|FG000|Baseline|Withdrawal by Subject|1|||
105835894|NCT03185741|365053793|FG001|Baseline|Withdrawal by Subject|3|||
105835895|NCT03185741|365053794|FG002|Baseline|Withdrawal by Subject|2|||
105835896|NCT03185741|365053792|FG000|Baseline|Lost to Follow-up|1|||
105835897|NCT03185741|365053793|FG001|Baseline|Lost to Follow-up|2|||
105835898|NCT03185741|365053794|FG002|Baseline|Lost to Follow-up|3|||
105965758|NCT02557100|365533795|FG001|Single Blind Treatment Period|Adverse Event|1|||
105965759|NCT02557100|365533796|FG002|Single Blind Treatment Period|Adverse Event|0|||
106149267|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
106149268|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
106149269|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105835899|NCT03185741|365053792|FG000|3Month|Death|1|||
105835900|NCT03185741|365053793|FG001|3Month|Death|1|||
106149270|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105835901|NCT03185741|365053794|FG002|3Month|Death|2|||
105835902|NCT03185741|365053792|FG000|3Month|Withdrawal by Subject|1|||
105835903|NCT03185741|365053793|FG001|3Month|Withdrawal by Subject|5|||
105835904|NCT03185741|365053794|FG002|3Month|Withdrawal by Subject|1|||
105835905|NCT03185741|365053792|FG000|3Month|Lost to Follow-up|7|||
105835906|NCT03185741|365053793|FG001|3Month|Lost to Follow-up|9|||
105835907|NCT03185741|365053794|FG002|3Month|Lost to Follow-up|8|||
105835908|NCT03185741|365053792|FG000|3Month|Unavailable for 3Month|11|||
105835909|NCT03185741|365053793|FG001|3Month|Unavailable for 3Month|10|||
105835910|NCT03185741|365053794|FG002|3Month|Unavailable for 3Month|11|||
106149271|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
106149272|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105835911|NCT03185741|365053792|FG000|3Month|Protocol Violation|0|||
105835912|NCT03185741|365053793|FG001|3Month|Protocol Violation|0|||
105835913|NCT03185741|365053794|FG002|3Month|Protocol Violation|3|||
105835914|NCT03185741|365053792|FG000|6Month|Death|1|||
105835915|NCT03185741|365053793|FG001|6Month|Death|1|||
105835916|NCT03185741|365053794|FG002|6Month|Death|2|||
105835917|NCT03185741|365053792|FG000|6Month|Withdrawal by Subject|2|||
105835918|NCT03185741|365053793|FG001|6Month|Withdrawal by Subject|3|||
105835919|NCT03185741|365053794|FG002|6Month|Withdrawal by Subject|1|||
105835920|NCT03185741|365053792|FG000|6Month|Lost to Follow-up|16|||
105835921|NCT03185741|365053793|FG001|6Month|Lost to Follow-up|15|||
105835922|NCT03185741|365053794|FG002|6Month|Lost to Follow-up|16|||
105835923|NCT01588548|365053795|FG000|Overall Study|Withdrawal by Subject|0|||
105835924|NCT01588548|365053796|FG001|Overall Study|Withdrawal by Subject|1|||
105835925|NCT01588548|365053797|FG002|Overall Study|Withdrawal by Subject|1|||
105835926|NCT01588548|365053798|FG003|Overall Study|Withdrawal by Subject|1|||
105835927|NCT01588548|365053799|FG004|Overall Study|Withdrawal by Subject|2|||
105835928|NCT01588548|365053800|FG005|Overall Study|Withdrawal by Subject|3|||
105835929|NCT01588548|365053795|FG000|Overall Study|Adverse Event|0|||
105835930|NCT01588548|365053796|FG001|Overall Study|Adverse Event|0|||
105835931|NCT01588548|365053797|FG002|Overall Study|Adverse Event|1|||
105835932|NCT01588548|365053798|FG003|Overall Study|Adverse Event|2|||
105835933|NCT01588548|365053799|FG004|Overall Study|Adverse Event|1|||
105835934|NCT01588548|365053800|FG005|Overall Study|Adverse Event|0|||
105835935|NCT01588548|365053795|FG000|Overall Study|Condition Under Investigation Worsened|3|||
105835936|NCT01588548|365053796|FG001|Overall Study|Condition Under Investigation Worsened|6|||
105835937|NCT01588548|365053797|FG002|Overall Study|Condition Under Investigation Worsened|4|||
105835938|NCT01588548|365053798|FG003|Overall Study|Condition Under Investigation Worsened|4|||
105835939|NCT01588548|365053799|FG004|Overall Study|Condition Under Investigation Worsened|3|||
105835940|NCT01588548|365053800|FG005|Overall Study|Condition Under Investigation Worsened|3|||
105835941|NCT00089973|365053805|FG000|Overall Study|Adverse Event|3|||
105835942|NCT00089973|365053805|FG000|Overall Study|Withdrawal by Subject|1|||
105835943|NCT00089973|365053805|FG000|Overall Study|Disease progression|45|||
105835944|NCT00089973|365053805|FG000|Overall Study|Death|1|||
105835945|NCT01634854|365053806|FG000|Overall Study|Cesarean delivery|2|||
105965760|NCT02557100|365533794|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
105965761|NCT02557100|365533795|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
105965762|NCT02557100|365533796|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
105965763|NCT02557100|365533794|FG000|Cumulative Abatacept Period|Other Reasons|0|||
105965764|NCT02557100|365533795|FG001|Cumulative Abatacept Period|Other Reasons|0|||
105965765|NCT02557100|365533796|FG002|Cumulative Abatacept Period|Other Reasons|1|||
105965766|NCT02557100|365533794|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
105965767|NCT02557100|365533795|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
105965768|NCT02557100|365533796|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
105965769|NCT02557100|365533794|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
105965770|NCT02557100|365533795|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
105965771|NCT02557100|365533796|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
105965772|NCT00394251|365533797|FG000|Overall Study|Adverse Event|7|||
105965773|NCT00394251|365533798|FG001|Overall Study|Adverse Event|5|||
106023296|NCT01137604|365750355|FG003|Overall Study|Clinical progression/deterioration|0|||
105835946|NCT01634854|365053807|FG001|Overall Study|Cesarean delivery|7|||
105835947|NCT00654641|365053808|FG000|Overall Study|Lost to Follow-up|2|||
105835948|NCT00654641|365053809|FG001|Overall Study|Lost to Follow-up|3|||
105835949|NCT01337596|365053810|FG000|Overall Study|Withdrawal by Subject|0|||
105835950|NCT01337596|365053811|FG001|Overall Study|Withdrawal by Subject|0|||
105835951|NCT01337596|365053812|FG002|Overall Study|Withdrawal by Subject|0|||
105835952|NCT01337596|365053813|FG003|Overall Study|Withdrawal by Subject|0|||
105965774|NCT00394251|365533797|FG000|Overall Study|Unacceptable Toxicity|20|||
106149273|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
105835953|NCT01337596|365053814|FG004|Overall Study|Withdrawal by Subject|2|||
105835954|NCT01337596|365053815|FG005|Overall Study|Withdrawal by Subject|0|||
105835955|NCT01337596|365053816|FG006|Overall Study|Withdrawal by Subject|0|||
105835956|NCT01337596|365053817|FG007|Overall Study|Withdrawal by Subject|0|||
105835957|NCT01337596|365053818|FG008|Overall Study|Withdrawal by Subject|0|||
105835958|NCT03365791|365053819|FG000|Overall Study|Adverse Event|5|||
105835959|NCT03365791|365053819|FG000|Overall Study|Death|1|||
105835960|NCT03365791|365053819|FG000|Overall Study|Lost to Follow-up|1|||
105835961|NCT03365791|365053819|FG000|Overall Study|Physician Decision|9|||
105835962|NCT03365791|365053819|FG000|Overall Study|Progressive disease|51|||
105835963|NCT03365791|365053819|FG000|Overall Study|Subject/guardian decision|5|||
105835964|NCT01362296|365053820|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
105835965|NCT01362296|365053821|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
105835966|NCT01362296|365053822|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
105835967|NCT01362296|365053823|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
105835968|NCT01362296|365053820|FG000|Randomized Phase (RP)|Physician Decision|1|||
105835969|NCT01362296|365053821|FG001|Randomized Phase (RP)|Physician Decision|9|||
105835970|NCT01362296|365053822|FG002|Randomized Phase (RP)|Physician Decision|0|||
105835971|NCT01362296|365053823|FG003|Randomized Phase (RP)|Physician Decision|0|||
105835972|NCT01362296|365053820|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
105835973|NCT01362296|365053821|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
105835974|NCT01362296|365053822|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
105835975|NCT01362296|365053823|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
105835976|NCT01362296|365053820|FG000|Randomized Phase (RP)|Adverse Event|20|||
105835977|NCT01362296|365053821|FG001|Randomized Phase (RP)|Adverse Event|4|||
105835978|NCT01362296|365053822|FG002|Randomized Phase (RP)|Adverse Event|0|||
105835979|NCT01362296|365053823|FG003|Randomized Phase (RP)|Adverse Event|0|||
105835980|NCT01362296|365053820|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
105835981|NCT01362296|365053821|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
105835982|NCT01362296|365053822|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
105835983|NCT01362296|365053823|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
105835984|NCT01362296|365053820|FG000|Crossover Phase|PD including Death due to PD|0|||
105835985|NCT01362296|365053821|FG001|Crossover Phase|PD including Death due to PD|0|||
105835986|NCT01362296|365053822|FG002|Crossover Phase|PD including Death due to PD|16|||
105835987|NCT01362296|365053823|FG003|Crossover Phase|PD including Death due to PD|1|||
105835988|NCT01362296|365053820|FG000|Crossover Phase|Withdrawal by Subject|0|||
105835989|NCT01362296|365053821|FG001|Crossover Phase|Withdrawal by Subject|0|||
105835990|NCT01362296|365053822|FG002|Crossover Phase|Withdrawal by Subject|2|||
105835991|NCT01362296|365053823|FG003|Crossover Phase|Withdrawal by Subject|1|||
105835992|NCT01362296|365053820|FG000|Crossover Phase|Adverse Event|0|||
105835993|NCT01362296|365053821|FG001|Crossover Phase|Adverse Event|0|||
105835994|NCT01362296|365053822|FG002|Crossover Phase|Adverse Event|4|||
105835995|NCT01362296|365053823|FG003|Crossover Phase|Adverse Event|0|||
105835996|NCT01362296|365053820|FG000|Crossover Phase|Study Closed/Terminated|0|||
105835997|NCT01362296|365053821|FG001|Crossover Phase|Study Closed/Terminated|0|||
105835998|NCT01362296|365053822|FG002|Crossover Phase|Study Closed/Terminated|1|||
105835999|NCT01362296|365053823|FG003|Crossover Phase|Study Closed/Terminated|0|||
105836000|NCT03693950|365053824|FG000|Overall Study|Withdrawal by Subject|1|||
105836001|NCT03693950|365053825|FG001|Overall Study|Withdrawal by Subject|0|||
105836002|NCT01475487|365053826|FG000|Overall Study|had to leave early for personal reasons|2|||
105836003|NCT01475487|365053827|FG001|Overall Study|had to leave early for personal reasons|1|||
105836004|NCT01321697|365053832|FG000|Overall Study|Study Terminated|7|||
105836005|NCT00857818|365053833|FG000|Overall Study|Lack of Efficacy|1|||
105836006|NCT00857818|365053834|FG001|Overall Study|Lack of Efficacy|0|||
105836007|NCT00857818|365053833|FG000|Overall Study|Adverse Event|3|||
105836008|NCT00857818|365053834|FG001|Overall Study|Adverse Event|0|||
105836009|NCT00857818|365053833|FG000|Overall Study|Withdrawal by Subject|0|||
105836010|NCT00857818|365053834|FG001|Overall Study|Withdrawal by Subject|4|||
105836011|NCT00857818|365053833|FG000|Overall Study|Sponsor terminated study|6|||
105836012|NCT00857818|365053834|FG001|Overall Study|Sponsor terminated study|4|||
105836013|NCT00857818|365053833|FG000|Overall Study|Investigator decision|1|||
105836014|NCT00857818|365053834|FG001|Overall Study|Investigator decision|0|||
105965775|NCT00394251|365533798|FG001|Overall Study|Unacceptable Toxicity|18|||
105965776|NCT00394251|365533797|FG000|Overall Study|Physician Decision|1|||
105965777|NCT00394251|365533798|FG001|Overall Study|Physician Decision|1|||
105965778|NCT00394251|365533797|FG000|Overall Study|Protocol Violation|0|||
105965779|NCT00394251|365533798|FG001|Overall Study|Protocol Violation|1|||
105965780|NCT00394251|365533797|FG000|Overall Study|Withdrawal by Subject|7|||
105836015|NCT00434590|365053835|FG000|Overall Study|Administrative problems|5|||
105836016|NCT00434590|365053836|FG001|Overall Study|Administrative problems|5|||
105836017|NCT02028455|365053837|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836018|NCT02028455|365053838|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105965781|NCT00394251|365533798|FG001|Overall Study|Withdrawal by Subject|11|||
105965782|NCT00394251|365533797|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
106023297|NCT00573144|365750356|FG000|Overall Study|Withdrawal by Subject|2|||
106023298|NCT00573144|365750357|FG001|Overall Study|Withdrawal by Subject|3|||
106023299|NCT03735667|365750364|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
106023300|NCT03735667|365750365|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
106023301|NCT03735667|365750366|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
106023302|NCT03735667|365750364|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
105965783|NCT00394251|365533798|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
105965784|NCT03206970|365533799|FG000|Overall Study|Death|21|||
105965785|NCT03206970|365533799|FG000|Overall Study|Withdrawal by Subject|13|||
105965786|NCT03206970|365533799|FG000|Overall Study|Lost to Follow-up|3|||
105965787|NCT03206970|365533799|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
105965788|NCT01814878|365533800|FG000|Overall Study|Adverse Event|16|||
105965789|NCT01814878|365533801|FG001|Overall Study|Adverse Event|5|||
105965790|NCT01814878|365533800|FG000|Overall Study|Withdrawal by Subject|20|||
105965791|NCT01814878|365533801|FG001|Overall Study|Withdrawal by Subject|16|||
106023303|NCT03735667|365750365|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
105836019|NCT02028455|365053839|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836020|NCT02028455|365053840|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836021|NCT02028455|365053841|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836022|NCT02028455|365053842|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
105836023|NCT02028455|365053843|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
105836024|NCT02028455|365053844|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
105836025|NCT02028455|365053837|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
105836026|NCT02028455|365053838|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
105836027|NCT02028455|365053839|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
105836028|NCT02028455|365053840|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
105836029|NCT02028455|365053841|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
105836030|NCT02028455|365053842|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
105836031|NCT02028455|365053843|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
105836032|NCT02028455|365053844|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
105836033|NCT02028455|365053837|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836034|NCT02028455|365053838|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836035|NCT02028455|365053839|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836036|NCT02028455|365053840|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836037|NCT02028455|365053841|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836038|NCT02028455|365053842|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
105836039|NCT02028455|365053843|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
105836040|NCT02028455|365053844|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
105836041|NCT02028455|365053837|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
105836042|NCT02028455|365053838|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
105836043|NCT02028455|365053839|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
105836044|NCT02028455|365053840|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
105836045|NCT02028455|365053841|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
105836046|NCT02028455|365053842|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
105836047|NCT02028455|365053843|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
105836048|NCT02028455|365053844|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
105836049|NCT05135273|365054977|FG000|Overall Study|Recruited into the army|0|||
105836050|NCT05135273|365054978|FG001|Overall Study|Recruited into the army|0|||
105836051|NCT05135273|365054979|FG002|Overall Study|Recruited into the army|0|||
105836052|NCT05135273|365054980|FG003|Overall Study|Recruited into the army|0|||
105836053|NCT05135273|365054981|FG004|Overall Study|Recruited into the army|1|||
105836054|NCT05135273|365054982|FG005|Overall Study|Recruited into the army|0|||
105836055|NCT05135273|365054983|FG006|Overall Study|Recruited into the army|0|||
105836056|NCT05135273|365054984|FG007|Overall Study|Recruited into the army|0|||
105836057|NCT05135273|365054977|FG000|Overall Study|Moved away from study site|0|||
105836058|NCT05135273|365054978|FG001|Overall Study|Moved away from study site|0|||
105836059|NCT05135273|365054979|FG002|Overall Study|Moved away from study site|0|||
105836060|NCT05135273|365054980|FG003|Overall Study|Moved away from study site|0|||
105836061|NCT05135273|365054981|FG004|Overall Study|Moved away from study site|0|||
105836062|NCT05135273|365054982|FG005|Overall Study|Moved away from study site|1|||
106023304|NCT03735667|365750366|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
106023305|NCT03735667|365750364|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
106149274|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149275|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
106149276|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105836063|NCT05135273|365054983|FG006|Overall Study|Moved away from study site|1|||
105836064|NCT05135273|365054984|FG007|Overall Study|Moved away from study site|0|||
105836065|NCT05135273|365054977|FG000|Overall Study|Travel|0|||
105836066|NCT05135273|365054978|FG001|Overall Study|Travel|0|||
105836067|NCT05135273|365054979|FG002|Overall Study|Travel|0|||
105836068|NCT05135273|365054980|FG003|Overall Study|Travel|0|||
105836069|NCT05135273|365054981|FG004|Overall Study|Travel|0|||
105836070|NCT05135273|365054982|FG005|Overall Study|Travel|0|||
105836071|NCT05135273|365054983|FG006|Overall Study|Travel|0|||
105836072|NCT05135273|365054984|FG007|Overall Study|Travel|1|||
105836073|NCT01958060|365054989|FG000|Overall Study|Not treated|2|||
105836074|NCT01958060|365054990|FG001|Overall Study|Not treated|0|||
105836075|NCT01958060|365054991|FG002|Overall Study|Not treated|0|||
105836076|NCT01958060|365054992|FG003|Overall Study|Not treated|0|||
105836077|NCT01958060|365054993|FG004|Overall Study|Not treated|1|||
105836078|NCT01958060|365054994|FG005|Overall Study|Not treated|0|||
105836079|NCT01705717|365054997|FG000|Overall Study|Adverse Event|2|||
105836080|NCT01705717|365054998|FG001|Overall Study|Adverse Event|2|||
105836081|NCT01705717|365054997|FG000|Overall Study|Lack of Efficacy|0|||
105836082|NCT01705717|365054998|FG001|Overall Study|Lack of Efficacy|1|||
105836083|NCT01705717|365054997|FG000|Overall Study|Other|0|||
105836084|NCT01705717|365054998|FG001|Overall Study|Other|2|||
105836085|NCT02031237|365055002|FG000|Overall Study|Death|1|||
105836086|NCT02031237|365055003|FG001|Overall Study|Death|5|||
105836087|NCT02031237|365055004|FG002|Overall Study|Death|0|||
105836088|NCT02031237|365055002|FG000|Overall Study|Physician Decision|0|||
105836089|NCT02031237|365055003|FG001|Overall Study|Physician Decision|1|||
105836090|NCT02031237|365055004|FG002|Overall Study|Physician Decision|0|||
105836091|NCT02031237|365055002|FG000|Overall Study|Withdrawal by Subject|2|||
105836092|NCT02031237|365055003|FG001|Overall Study|Withdrawal by Subject|2|||
105836093|NCT02031237|365055004|FG002|Overall Study|Withdrawal by Subject|0|||
105836094|NCT02031237|365055002|FG000|Overall Study|Protocol Violation|2|||
105836095|NCT02031237|365055003|FG001|Overall Study|Protocol Violation|6|||
105836096|NCT02031237|365055004|FG002|Overall Study|Protocol Violation|0|||
105836097|NCT02031237|365055002|FG000|Overall Study|Alternate Treatment Given|0|||
105836098|NCT02031237|365055003|FG001|Overall Study|Alternate Treatment Given|0|||
105836099|NCT02031237|365055004|FG002|Overall Study|Alternate Treatment Given|3|||
105836100|NCT00927251|365055005|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
105836101|NCT05996198|365055008|FG000|Overall Study|Withdrawal by Subject|1|||
105836102|NCT05996198|365055009|FG001|Overall Study|Withdrawal by Subject|0|||
105836103|NCT00835796|365055010|FG000|First Intervention|Withdrawal by Subject|0|||
105836104|NCT00835796|365055011|FG001|First Intervention|Withdrawal by Subject|1|||
105836105|NCT00396630|365055012|FG000|Overall Study|Lost to Follow-up|1|||
105836106|NCT00396630|365055013|FG001|Overall Study|Lost to Follow-up|1|||
105836107|NCT00396630|365055012|FG000|Overall Study|Withdrawal by Subject|1|||
105836108|NCT00396630|365055013|FG001|Overall Study|Withdrawal by Subject|1|||
105836109|NCT00396630|365055012|FG000|Overall Study|Not vaccinated at Visit 3|3|||
105836110|NCT00396630|365055013|FG001|Overall Study|Not vaccinated at Visit 3|3|||
105836111|NCT04542694|365055014|FG000|Overall Study|The need for prohibited therapy|2|||
105836112|NCT04542694|365055015|FG001|Overall Study|The need for prohibited therapy|0|||
105836113|NCT04542694|365055014|FG000|Overall Study|Adverse Event|1|||
105836114|NCT04542694|365055015|FG001|Overall Study|Adverse Event|0|||
105836115|NCT04542694|365055014|FG000|Overall Study|Protocol Violation|1|||
105836116|NCT04542694|365055015|FG001|Overall Study|Protocol Violation|0|||
105836117|NCT00996437|365055016|FG000|Overall Study|Death|1|||
105836118|NCT00996437|365055017|FG001|Overall Study|Death|0|||
105836119|NCT00996437|365055016|FG000|Overall Study|Dropped|2|||
105836120|NCT00996437|365055017|FG001|Overall Study|Dropped|2|||
105836121|NCT00996437|365055016|FG000|Overall Study|Missed|2|||
105836122|NCT00996437|365055017|FG001|Overall Study|Missed|5|||
105836123|NCT01755975|365055018|FG000|Overall Study|Adverse Event|0|||
105836124|NCT01755975|365055019|FG001|Overall Study|Adverse Event|0|||
105836125|NCT01755975|365055020|FG002|Overall Study|Adverse Event|1|||
105836126|NCT01755975|365055021|FG003|Overall Study|Adverse Event|0|||
105836127|NCT01755975|365055022|FG004|Overall Study|Adverse Event|2|||
105836128|NCT04412057|365055023|FG000|Overall Study|Death|3|||
105836129|NCT04412057|365055024|FG001|Overall Study|Death|7|||
105836130|NCT04412057|365055023|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
105836131|NCT04412057|365055024|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
105836132|NCT02104817|365055025|FG000|Overall Study|Death|363|||
105836133|NCT02104817|365055026|FG001|Overall Study|Death|330|||
105836134|NCT02104817|365055025|FG000|Overall Study|Lost to Follow-up|3|||
105836135|NCT02104817|365055026|FG001|Overall Study|Lost to Follow-up|2|||
105836136|NCT02104817|365055025|FG000|Overall Study|Protocol Violation|0|||
105836137|NCT02104817|365055026|FG001|Overall Study|Protocol Violation|1|||
105836138|NCT02104817|365055025|FG000|Overall Study|Study terminated by sponsor|5854|||
105836139|NCT02104817|365055026|FG001|Overall Study|Study terminated by sponsor|5901|||
105836140|NCT02104817|365055025|FG000|Overall Study|Withdrawal by Subject|111|||
105836141|NCT02104817|365055026|FG001|Overall Study|Withdrawal by Subject|78|||
105836142|NCT02104817|365055025|FG000|Overall Study|Other reasons|128|||
105836143|NCT02104817|365055026|FG001|Overall Study|Other reasons|135|||
105836144|NCT03223909|365055035|FG000|Overall Study|Protocol Violation|48|||
105836145|NCT03223909|365055036|FG001|Overall Study|Protocol Violation|45|||
105836146|NCT03223909|365055037|FG002|Overall Study|Protocol Violation|16|||
105836147|NCT04886063|365055040|FG000|Overall Study|Adverse Event|50|||
105836148|NCT04886063|365055040|FG000|Overall Study|Lack of Efficacy|31|||
105836149|NCT04886063|365055040|FG000|Overall Study|Withdrawal by Subject|45|||
105836150|NCT04886063|365055040|FG000|Overall Study|Physician Decision|3|||
105836151|NCT04886063|365055040|FG000|Overall Study|Protocol Violation|3|||
105836152|NCT04886063|365055040|FG000|Overall Study|Site closure|4|||
105836153|NCT04886063|365055040|FG000|Overall Study|Nursing home replacement|3|||
105836154|NCT04886063|365055040|FG000|Overall Study|Lost to Follow-up|5|||
105836155|NCT04886063|365055040|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
105836156|NCT04886063|365055040|FG000|Overall Study|>1 reason|20|||
105836157|NCT01055886|365055045|FG000|Overall Study|Withdrawal by Subject|4|||
105836158|NCT01055886|365055046|FG001|Overall Study|Withdrawal by Subject|9|||
105836159|NCT01055886|365055045|FG000|Overall Study|Lost to Follow-up|1|||
105836160|NCT01055886|365055046|FG001|Overall Study|Lost to Follow-up|1|||
105836161|NCT01055886|365055045|FG000|Overall Study|Withdrawal by PI|0|||
105836162|NCT01055886|365055046|FG001|Overall Study|Withdrawal by PI|1|||
105836163|NCT02359864|365055048|FG000|Overall Study|Withdrawal by Subject|1|||
105836164|NCT02359864|365055049|FG001|Overall Study|Withdrawal by Subject|0|||
105836165|NCT04254809|365055053|FG000|Overall Study|Lost to Follow-up|5|||
105836166|NCT04254809|365055054|FG001|Overall Study|Lost to Follow-up|10|||
105836167|NCT04480307|365055055|FG000|Overall Study|Withdrawal by Subject|0|||
105836168|NCT04480307|365055056|FG001|Overall Study|Withdrawal by Subject|1|||
105836169|NCT04480307|365055057|FG002|Overall Study|Withdrawal by Subject|0|||
105836170|NCT04480307|365055058|FG003|Overall Study|Withdrawal by Subject|0|||
105836171|NCT04480307|365055055|FG000|Overall Study|Adverse Event|0|||
105836172|NCT04480307|365055056|FG001|Overall Study|Adverse Event|0|||
105836173|NCT04480307|365055057|FG002|Overall Study|Adverse Event|0|||
105836174|NCT04480307|365055058|FG003|Overall Study|Adverse Event|1|||
105836175|NCT01928615|365055059|FG000|Overall Study|Study Terminated by Sponsor|2|||
105836176|NCT01881737|365055062|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
105836177|NCT01881737|365055062|FG000|Overall Study|Withdrawal by Subject|1|||
105836178|NCT01881737|365055062|FG000|Overall Study|Worsening of baseline behavior|1|||
105836179|NCT03496298|365055063|FG000|Overall Study|Adverse Event|49|||
105836180|NCT03496298|365055064|FG001|Overall Study|Adverse Event|68|||
105836181|NCT03496298|365055065|FG002|Overall Study|Adverse Event|79|||
105836182|NCT03496298|365055063|FG000|Overall Study|Study terminated by Sponsor|1050|||
105836183|NCT03496298|365055064|FG001|Overall Study|Study terminated by Sponsor|1063|||
105836184|NCT03496298|365055065|FG002|Overall Study|Study terminated by Sponsor|1071|||
105836185|NCT03496298|365055063|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
105836186|NCT03496298|365055064|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
105836187|NCT03496298|365055065|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
105836188|NCT03496298|365055063|FG000|Overall Study|Withdrawal by Subject|176|||
105836189|NCT03496298|365055064|FG001|Overall Study|Withdrawal by Subject|154|||
105836190|NCT03496298|365055065|FG002|Overall Study|Withdrawal by Subject|151|||
105836191|NCT03496298|365055063|FG000|Overall Study|Other|29|||
105836192|NCT03496298|365055064|FG001|Overall Study|Other|20|||
105836193|NCT03496298|365055065|FG002|Overall Study|Other|23|||
105836194|NCT03496298|365055063|FG000|Overall Study|Randomized and not treated|1|||
105836195|NCT03496298|365055064|FG001|Overall Study|Randomized and not treated|1|||
105836196|NCT03496298|365055065|FG002|Overall Study|Randomized and not treated|1|||
105836197|NCT02608476|365055068|FG000|Overall Study|Withdrawal by Subject|30|||
105836198|NCT02608476|365055069|FG001|Overall Study|Withdrawal by Subject|37|||
105836199|NCT02608476|365055068|FG000|Overall Study|Lost to Follow-up|24|||
105836200|NCT02608476|365055069|FG001|Overall Study|Lost to Follow-up|24|||
105836201|NCT02608476|365055068|FG000|Overall Study|Adverse Event|2|||
105836202|NCT02608476|365055069|FG001|Overall Study|Adverse Event|8|||
105836203|NCT02608476|365055068|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
105836204|NCT02608476|365055069|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
106149277|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105836205|NCT02608476|365055068|FG000|Overall Study|Noncompliance with treatment|1|||
105836206|NCT02608476|365055069|FG001|Overall Study|Noncompliance with treatment|5|||
105836207|NCT02608476|365055068|FG000|Overall Study|Lack of Efficacy|3|||
105836208|NCT02608476|365055069|FG001|Overall Study|Lack of Efficacy|1|||
105836209|NCT02608476|365055068|FG000|Overall Study|Other|0|||
105836210|NCT02608476|365055069|FG001|Overall Study|Other|1|||
106023306|NCT03735667|365750365|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
105836211|NCT02608476|365055068|FG000|Overall Study|Physician Decision|1|||
105836212|NCT02608476|365055069|FG001|Overall Study|Physician Decision|0|||
105836213|NCT02608476|365055068|FG000|Overall Study|Pregnancy|0|||
105836214|NCT02608476|365055069|FG001|Overall Study|Pregnancy|1|||
105836215|NCT02608476|365055068|FG000|Overall Study|Progressive disease|1|||
105836216|NCT02608476|365055069|FG001|Overall Study|Progressive disease|0|||
105836217|NCT02795676|365055070|FG000|Overall Study|Adverse Event|2|||
105836218|NCT02795676|365055071|FG001|Overall Study|Adverse Event|0|||
105836219|NCT02795676|365055070|FG000|Overall Study|Withdrawal by Subject|3|||
105836220|NCT02795676|365055071|FG001|Overall Study|Withdrawal by Subject|1|||
105836221|NCT01264835|365055072|FG000|Overall Study|Lost to Follow-up|1|||
105836222|NCT02260635|365055073|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
105836223|NCT02260635|365055074|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
105836224|NCT02260635|365055073|FG000|Open-Label Extension|Study Termination|25|||
105836225|NCT02260635|365055074|FG001|Open-Label Extension|Study Termination|25|||
105836226|NCT02260635|365055073|FG000|Open-Label Extension|Withdrawal by Subject|1|||
105836227|NCT02260635|365055074|FG001|Open-Label Extension|Withdrawal by Subject|0|||
105836228|NCT00152516|365055075|FG000|Overall Study|Adverse Event|18|||
105836229|NCT00152516|365055075|FG000|Overall Study|Lack and Loss of Efficacy|30|||
105836230|NCT00152516|365055075|FG000|Overall Study|Lost to Follow-up|5|||
105836231|NCT00152516|365055075|FG000|Overall Study|Withdrawal by Subject|8|||
105836232|NCT00152516|365055075|FG000|Overall Study|Protocol Violation|3|||
105836233|NCT00152516|365055075|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
105836234|NCT00152516|365055075|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
105836235|NCT00152516|365055075|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
105836236|NCT00152516|365055075|FG000|Overall Study|Other: Non-Compliance|2|||
105836237|NCT00152516|365055075|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
105836238|NCT00152516|365055075|FG000|Overall Study|Other: Moved Out Of State|1|||
105836239|NCT00152516|365055075|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
105836240|NCT00152516|365055075|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
105836241|NCT00360490|365055076|FG000|Overall Study|Adverse Event|4|||
105836242|NCT00360490|365055077|FG001|Overall Study|Adverse Event|2|||
105836243|NCT00360490|365055076|FG000|Overall Study|Lost to Follow-up|2|||
105836244|NCT00360490|365055077|FG001|Overall Study|Lost to Follow-up|1|||
105836245|NCT00360490|365055076|FG000|Overall Study|Physician Decision|2|||
105836246|NCT00360490|365055077|FG001|Overall Study|Physician Decision|1|||
105836247|NCT00360490|365055076|FG000|Overall Study|Protocol Violation|0|||
105836248|NCT00360490|365055077|FG001|Overall Study|Protocol Violation|4|||
105836249|NCT00360490|365055076|FG000|Overall Study|Withdrawal by Subject|1|||
105836250|NCT00360490|365055077|FG001|Overall Study|Withdrawal by Subject|3|||
105836251|NCT00605176|365055080|FG000|Overall Study|Adverse Event|2|||
105836252|NCT00605176|365055081|FG001|Overall Study|Adverse Event|1|||
105836253|NCT00605176|365055082|FG002|Overall Study|Adverse Event|3|||
105836254|NCT00605176|365055080|FG000|Overall Study|Withdrawal by Subject|4|||
105836255|NCT00605176|365055081|FG001|Overall Study|Withdrawal by Subject|2|||
105836256|NCT00605176|365055082|FG002|Overall Study|Withdrawal by Subject|4|||
105836257|NCT00605176|365055080|FG000|Overall Study|Lost to Follow-up|2|||
105836258|NCT00605176|365055081|FG001|Overall Study|Lost to Follow-up|2|||
105836259|NCT00605176|365055082|FG002|Overall Study|Lost to Follow-up|1|||
105836260|NCT00605176|365055080|FG000|Overall Study|Non-complicance with study procedures|1|||
105836261|NCT00605176|365055081|FG001|Overall Study|Non-complicance with study procedures|0|||
105836262|NCT00605176|365055082|FG002|Overall Study|Non-complicance with study procedures|0|||
105836263|NCT00605176|365055080|FG000|Overall Study|Use of concomitant therapy|1|||
105836264|NCT00605176|365055081|FG001|Overall Study|Use of concomitant therapy|0|||
105836265|NCT00605176|365055082|FG002|Overall Study|Use of concomitant therapy|1|||
105836266|NCT00605176|365055080|FG000|Overall Study|Other (not due to AE)|1|||
105836267|NCT00605176|365055081|FG001|Overall Study|Other (not due to AE)|1|||
105836268|NCT00605176|365055082|FG002|Overall Study|Other (not due to AE)|0|||
105836269|NCT01256060|365055087|FG000|Overall Study|Lost to Follow-up|0|||
105836270|NCT01256060|365055088|FG001|Overall Study|Lost to Follow-up|1|||
105836271|NCT01256060|365055089|FG002|Overall Study|Lost to Follow-up|0|||
105836272|NCT01256060|365055090|FG003|Overall Study|Lost to Follow-up|0|||
105836273|NCT00603512|365055095|FG000|Overall Study|Adverse Event|0|||
105836274|NCT00603512|365055096|FG001|Overall Study|Adverse Event|2|||
105836275|NCT00603512|365055097|FG002|Overall Study|Adverse Event|4|||
105836276|NCT00603512|365055098|FG003|Overall Study|Adverse Event|4|||
105836277|NCT00603512|365055099|FG004|Overall Study|Adverse Event|2|||
105836278|NCT00603512|365055095|FG000|Overall Study|Lack of Efficacy|0|||
105836279|NCT00603512|365055096|FG001|Overall Study|Lack of Efficacy|1|||
105836280|NCT00603512|365055097|FG002|Overall Study|Lack of Efficacy|0|||
105836281|NCT00603512|365055098|FG003|Overall Study|Lack of Efficacy|0|||
105836282|NCT00603512|365055099|FG004|Overall Study|Lack of Efficacy|1|||
105836283|NCT00603512|365055095|FG000|Overall Study|Other|2|||
105836284|NCT00603512|365055096|FG001|Overall Study|Other|1|||
105836285|NCT00603512|365055097|FG002|Overall Study|Other|0|||
105836286|NCT00603512|365055098|FG003|Overall Study|Other|1|||
105836287|NCT00603512|365055099|FG004|Overall Study|Other|1|||
105836288|NCT00603512|365055095|FG000|Overall Study|Withdrawal by Subject|0|||
105836289|NCT00603512|365055096|FG001|Overall Study|Withdrawal by Subject|0|||
105836290|NCT00603512|365055097|FG002|Overall Study|Withdrawal by Subject|0|||
105836291|NCT00603512|365055098|FG003|Overall Study|Withdrawal by Subject|0|||
105836292|NCT00603512|365055099|FG004|Overall Study|Withdrawal by Subject|1|||
105836293|NCT00603512|365055095|FG000|Overall Study|Randomized but not treated|0|||
105836294|NCT00603512|365055096|FG001|Overall Study|Randomized but not treated|1|||
105836295|NCT00603512|365055097|FG002|Overall Study|Randomized but not treated|1|||
105836296|NCT00603512|365055098|FG003|Overall Study|Randomized but not treated|2|||
105836297|NCT00603512|365055099|FG004|Overall Study|Randomized but not treated|0|||
105836298|NCT02297841|365056875|FG000|Overall Study|Withdrawal by Subject|1|||
105836299|NCT02297841|365056875|FG000|Overall Study|Protocol Violation|7|||
105836300|NCT03429049|365056876|FG000|Overall Study|Adverse Event|2|||
105836301|NCT03429049|365056877|FG001|Overall Study|Adverse Event|3|||
105836302|NCT03429049|365056876|FG000|Overall Study|Death|0|||
105836303|NCT03429049|365056877|FG001|Overall Study|Death|1|||
105836304|NCT03429049|365056876|FG000|Overall Study|Lack of Efficacy|4|||
105836305|NCT03429049|365056877|FG001|Overall Study|Lack of Efficacy|2|||
105836306|NCT03429049|365056876|FG000|Overall Study|Lost to Follow-up|9|||
105836307|NCT03429049|365056877|FG001|Overall Study|Lost to Follow-up|8|||
105836308|NCT03429049|365056876|FG000|Overall Study|Physician Decision|1|||
105836309|NCT03429049|365056877|FG001|Overall Study|Physician Decision|0|||
105836310|NCT03429049|365056876|FG000|Overall Study|Protocol Violation|3|||
105836311|NCT03429049|365056877|FG001|Overall Study|Protocol Violation|0|||
105836312|NCT03429049|365056876|FG000|Overall Study|Sponsor Decision|2|||
105836313|NCT03429049|365056877|FG001|Overall Study|Sponsor Decision|0|||
105836314|NCT03429049|365056876|FG000|Overall Study|Withdrawal by Subject|4|||
105836315|NCT03429049|365056877|FG001|Overall Study|Withdrawal by Subject|20|||
105836316|NCT03429049|365056876|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
105836317|NCT03429049|365056877|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
105836318|NCT01841060|365056878|FG000|Overall Study|Protocol Violation|10|||
105836319|NCT01872715|365056882|FG000|Overall Study|Adverse Event|1|||
105836320|NCT01872715|365056882|FG000|Overall Study|Protocol Violation|1|||
105836321|NCT01872715|365056882|FG000|Overall Study|Withdrawal by Subject|2|||
105836322|NCT00683592|365056883|FG000|Overall Study|Adverse Event|12|||
105836323|NCT00683592|365056884|FG001|Overall Study|Adverse Event|4|||
105836324|NCT00683592|365056883|FG000|Overall Study|Withdrawal by Subject|11|||
105836325|NCT00683592|365056884|FG001|Overall Study|Withdrawal by Subject|11|||
105836326|NCT00683592|365056883|FG000|Overall Study|Lost to Follow-up|17|||
105836327|NCT00683592|365056884|FG001|Overall Study|Lost to Follow-up|17|||
105836328|NCT00683592|365056883|FG000|Overall Study|Lack of Efficacy|3|||
105836329|NCT00683592|365056884|FG001|Overall Study|Lack of Efficacy|7|||
105836330|NCT00683592|365056883|FG000|Overall Study|Physician Decision|0|||
105836331|NCT00683592|365056884|FG001|Overall Study|Physician Decision|1|||
105836332|NCT00683592|365056883|FG000|Overall Study|Non-compliance|3|||
105836333|NCT00683592|365056884|FG001|Overall Study|Non-compliance|5|||
105836334|NCT00683592|365056883|FG000|Overall Study|Other|1|||
105836335|NCT00683592|365056884|FG001|Overall Study|Other|1|||
105836336|NCT05258630|365056885|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
105836337|NCT05258630|365056886|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
105836338|NCT05258630|365056885|FG000|Overall Study|Lost to Follow-up|0|||
105836339|NCT05258630|365056886|FG001|Overall Study|Lost to Follow-up|2|||
105836340|NCT01848210|365056896|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
105836341|NCT01848210|365056897|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
105836342|NCT01848210|365056896|FG000|Overall Study|Lost to Follow-up|24|||
105836343|NCT01848210|365056897|FG001|Overall Study|Lost to Follow-up|12|||
105836344|NCT01848210|365056896|FG000|Overall Study|Protocol Violation|3|||
105836345|NCT01848210|365056897|FG001|Overall Study|Protocol Violation|5|||
105836346|NCT01848210|365056896|FG000|Overall Study|Use of Forbidden Drugs|9|||
105836347|NCT01848210|365056897|FG001|Overall Study|Use of Forbidden Drugs|10|||
105836348|NCT01848210|365056896|FG000|Overall Study|Impedition Condition|5|||
105836349|NCT01848210|365056897|FG001|Overall Study|Impedition Condition|9|||
105836350|NCT01848210|365056896|FG000|Overall Study|Adverse Event|7|||
105836351|NCT01848210|365056897|FG001|Overall Study|Adverse Event|9|||
105836352|NCT01848210|365056896|FG000|Overall Study|Discontinuation Criterion|5|||
105836353|NCT01848210|365056897|FG001|Overall Study|Discontinuation Criterion|7|||
105836354|NCT01848210|365056896|FG000|Overall Study|Hypesensitivity|1|||
105836355|NCT01848210|365056897|FG001|Overall Study|Hypesensitivity|0|||
105836356|NCT01848210|365056896|FG000|Overall Study|Hepatic Function Alteration|4|||
105836357|NCT01848210|365056897|FG001|Overall Study|Hepatic Function Alteration|0|||
105836358|NCT01848210|365056896|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
105836359|NCT01848210|365056897|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
105836360|NCT01848210|365056896|FG000|Overall Study|Administrative|1|||
105836361|NCT01848210|365056897|FG001|Overall Study|Administrative|0|||
105836362|NCT00381849|365056898|FG000|Wash Out|Withdrawal by Subject|0|||
105836363|NCT00381849|365056899|FG001|Wash Out|Withdrawal by Subject|1|||
105836364|NCT00651183|365056902|FG000|Overall Study|Lack of Efficacy|1|||
105836365|NCT00651183|365056903|FG001|Overall Study|Lack of Efficacy|0|||
105836366|NCT00651183|365056902|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
105836367|NCT00651183|365056903|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
105836368|NCT00651183|365056902|FG000|Overall Study|Tolerability insufficient|5|||
105836369|NCT00651183|365056903|FG001|Overall Study|Tolerability insufficient|2|||
105836370|NCT00651183|365056902|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
105836371|NCT00651183|365056903|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
105836372|NCT00651183|365056902|FG000|Overall Study|Withdrawal by Subject|6|||
105836373|NCT00651183|365056903|FG001|Overall Study|Withdrawal by Subject|3|||
105836374|NCT00651183|365056902|FG000|Overall Study|Lost to Follow-up|3|||
105836375|NCT00651183|365056903|FG001|Overall Study|Lost to Follow-up|1|||
105836376|NCT00651183|365056902|FG000|Overall Study|Other reasons|4|||
105836377|NCT00651183|365056903|FG001|Overall Study|Other reasons|2|||
105836378|NCT00651183|365056902|FG000|Overall Study|missing|1|||
105836379|NCT00651183|365056903|FG001|Overall Study|missing|0|||
105836380|NCT02576717|365056905|FG000|Overall Study|Other Reasons|16|||
105836381|NCT02576717|365056906|FG001|Overall Study|Other Reasons|18|||
105836382|NCT02576717|365056907|FG002|Overall Study|Other Reasons|15|||
105836383|NCT02576717|365056905|FG000|Overall Study|Covid-19 Pandemic|0|||
105836384|NCT02576717|365056906|FG001|Overall Study|Covid-19 Pandemic|1|||
105836385|NCT02576717|365056907|FG002|Overall Study|Covid-19 Pandemic|1|||
105836386|NCT02576717|365056905|FG000|Overall Study|Sponsor Decision|0|||
105836387|NCT02576717|365056906|FG001|Overall Study|Sponsor Decision|0|||
105836388|NCT02576717|365056907|FG002|Overall Study|Sponsor Decision|1|||
105836389|NCT02576717|365056905|FG000|Overall Study|Physician Decision|3|||
105836390|NCT02576717|365056906|FG001|Overall Study|Physician Decision|8|||
105836391|NCT02576717|365056907|FG002|Overall Study|Physician Decision|9|||
105836392|NCT02576717|365056905|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
105836393|NCT02576717|365056906|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
105836394|NCT02576717|365056907|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
105836395|NCT02576717|365056905|FG000|Overall Study|Death|3|||
105836396|NCT02576717|365056906|FG001|Overall Study|Death|5|||
105836397|NCT02576717|365056907|FG002|Overall Study|Death|3|||
105836398|NCT02576717|365056905|FG000|Overall Study|Lost to Follow-up|9|||
105836399|NCT02576717|365056906|FG001|Overall Study|Lost to Follow-up|10|||
105836400|NCT02576717|365056907|FG002|Overall Study|Lost to Follow-up|19|||
105836401|NCT02576717|365056905|FG000|Overall Study|Protocol Violation|4|||
105836402|NCT02576717|365056906|FG001|Overall Study|Protocol Violation|0|||
105836403|NCT02576717|365056907|FG002|Overall Study|Protocol Violation|5|||
105836404|NCT02576717|365056905|FG000|Overall Study|Lack of Efficacy|24|||
105836405|NCT02576717|365056906|FG001|Overall Study|Lack of Efficacy|28|||
105836406|NCT02576717|365056907|FG002|Overall Study|Lack of Efficacy|20|||
105836407|NCT02576717|365056905|FG000|Overall Study|Adverse Event|26|||
105836408|NCT02576717|365056906|FG001|Overall Study|Adverse Event|32|||
105836409|NCT02576717|365056907|FG002|Overall Study|Adverse Event|26|||
105836410|NCT00969124|365056908|FG000|Overall Study|Protocol Violation|2|||
105836411|NCT00969124|365056908|FG000|Overall Study|Inadequate bowel preparation|15|||
105836412|NCT00969124|365056908|FG000|Overall Study|Inability to reach cecum|9|||
105836413|NCT00969124|365056908|FG000|Overall Study|Previously unrecognized disease|3|||
105836414|NCT00969124|365056908|FG000|Overall Study|Technical error|1|||
105836415|NCT00763555|365056913|FG000|Overall Study|Adverse Event|2|||
105836416|NCT00763555|365056914|FG001|Overall Study|Adverse Event|1|||
105836417|NCT00763555|365056913|FG000|Overall Study|Withdrawal by Subject|2|||
105836418|NCT00763555|365056914|FG001|Overall Study|Withdrawal by Subject|6|||
105836419|NCT00763555|365056913|FG000|Overall Study|Lost to Follow-up|0|||
105836420|NCT00763555|365056914|FG001|Overall Study|Lost to Follow-up|3|||
105836421|NCT01729026|365056915|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
105836422|NCT01729026|365056916|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
105836423|NCT01729026|365056915|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
105836424|NCT01729026|365056916|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
105836425|NCT02575339|365056917|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
105836426|NCT02575339|365056918|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
105836427|NCT02575339|365056919|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
105836428|NCT02575339|365056917|FG000|Study Treatment|Disease Progression|5|||
105836429|NCT02575339|365056918|FG001|Study Treatment|Disease Progression|2|||
105836430|NCT02575339|365056919|FG002|Study Treatment|Disease Progression|0|||
105836431|NCT02575339|365056917|FG000|Study Treatment|Adverse Event|1|||
105836432|NCT02575339|365056918|FG001|Study Treatment|Adverse Event|2|||
105836433|NCT02575339|365056919|FG002|Study Treatment|Adverse Event|0|||
105836434|NCT02575339|365056917|FG000|Follow up|Death|6|||
105836435|NCT02575339|365056918|FG001|Follow up|Death|2|||
105836436|NCT02575339|365056919|FG002|Follow up|Death|0|||
105836437|NCT02575339|365056917|FG000|Follow up|Study Terminated|0|||
105836438|NCT02575339|365056918|FG001|Follow up|Study Terminated|2|||
105836439|NCT02575339|365056919|FG002|Follow up|Study Terminated|0|||
105836440|NCT02575339|365056917|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
105836441|NCT02575339|365056918|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
105836442|NCT02575339|365056919|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
105836443|NCT04633642|365056920|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
105836444|NCT04633642|365056921|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
105836445|NCT04675775|365056922|FG000|Overall Study|Withdrawal by Subject|7|||
105836446|NCT00434837|365056929|FG000|Overall Study|Lost to Follow-up|20|||
105836447|NCT00434837|365056930|FG001|Overall Study|Lost to Follow-up|23|||
105836448|NCT00434837|365056931|FG002|Overall Study|Lost to Follow-up|30|||
105836449|NCT03023137|365056932|FG000|Overall Study|Multiple pregnancy|2|||
105836450|NCT03023137|365056933|FG001|Overall Study|Multiple pregnancy|4|||
105836451|NCT03023137|365056932|FG000|Overall Study|Lost to Follow-up|1|||
105836452|NCT03023137|365056933|FG001|Overall Study|Lost to Follow-up|1|||
105836453|NCT03023137|365056932|FG000|Overall Study|Protocol Violation|0|||
105836454|NCT03023137|365056933|FG001|Overall Study|Protocol Violation|4|||
105836455|NCT03023137|365056932|FG000|Overall Study|Lost the baby in a car accident|1|||
105836456|NCT03023137|365056933|FG001|Overall Study|Lost the baby in a car accident|0|||
105836457|NCT01086969|365056938|FG000|Overall Study|Withdrawal by Subject|1|||
105836458|NCT01086969|365056939|FG001|Overall Study|Withdrawal by Subject|2|||
105836459|NCT01086969|365056940|FG002|Overall Study|Withdrawal by Subject|0|||
105836460|NCT03847974|365056945|FG000|Overall Study|relocated out of region|3|||
105836461|NCT03847974|365056945|FG000|Overall Study|Withdrawal by Subject|2|||
105836462|NCT03847974|365056945|FG000|Overall Study|Adverse Event|1|||
105836463|NCT02466386|365056956|FG000|Overall Study|Adverse Event|5|||
105836464|NCT02466386|365056956|FG000|Overall Study|Protocol Violation|2|||
105836465|NCT02466386|365056956|FG000|Overall Study|Withdrawal by Subject|14|||
105836466|NCT02466386|365056956|FG000|Overall Study|Lost to Follow-up|5|||
105836467|NCT02466386|365056956|FG000|Overall Study|Lack of Efficacy|8|||
105836468|NCT02466386|365056956|FG000|Overall Study|Other|10|||
105965792|NCT01814878|365533800|FG000|Overall Study|Protocol Violation|5|||
105965793|NCT01814878|365533801|FG001|Overall Study|Protocol Violation|5|||
105836469|NCT05317195|365056957|FG000|Randomization|Withdrawal by Subject|1|||
105836470|NCT05317195|365056957|FG000|Randomization|Discontinued|6|||
105836471|NCT05317195|365056957|FG000|Admission|Withdrawal by Subject|2|||
105836472|NCT00220727|365056970|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
105836473|NCT00220727|365056971|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
105836474|NCT05103657|365056972|FG000|Overall Study|Other reasons than listed|9|||
105836475|NCT05103657|365056973|FG001|Overall Study|Other reasons than listed|8|||
105836476|NCT05103657|365056972|FG000|Overall Study|Protocol deviation|2|||
105836477|NCT05103657|365056973|FG001|Overall Study|Protocol deviation|2|||
105836478|NCT05103657|365056972|FG000|Overall Study|No reason available|5|||
105965794|NCT01814878|365533800|FG000|Overall Study|Physician Decision|3|||
105965795|NCT01814878|365533801|FG001|Overall Study|Physician Decision|1|||
105836479|NCT05103657|365056973|FG001|Overall Study|No reason available|4|||
105836480|NCT05103657|365056972|FG000|Overall Study|Burden of study procedures|3|||
105965796|NCT01814878|365533800|FG000|Overall Study|Screening failure (drop-out)|0|||
105965797|NCT01814878|365533801|FG001|Overall Study|Screening failure (drop-out)|3|||
105965798|NCT01814878|365533800|FG000|Overall Study|Other|2|||
105965799|NCT01814878|365533801|FG001|Overall Study|Other|0|||
105965800|NCT01289353|365533802|FG000|Overall Study|Lost to Follow-up|2|||
105965801|NCT03299881|365533803|FG000|Overall Study|Study Termination|17|||
105965802|NCT03299881|365533804|FG001|Overall Study|Study Termination|13|||
105965803|NCT00223808|365533805|FG000|Overall Study|<5 hrs therapy before discharge|3|||
105965804|NCT00223808|365533806|FG001|Overall Study|<5 hrs therapy before discharge|5|||
105965805|NCT00223808|365533807|FG002|Overall Study|<5 hrs therapy before discharge|5|||
105965806|NCT03195660|365533808|FG000|Overall Study|The study was terminated|2|||
105965807|NCT06422364|365533809|FG000|Overall Study|Withdrawn due to study closure|0|||
105965808|NCT06422364|365533810|FG001|Overall Study|Withdrawn due to study closure|2|||
105965809|NCT05730335|365533812|FG000|Overall Study|Lost to Follow-up|8|||
105965810|NCT05730335|365533812|FG000|Overall Study|Withdrawal by Subject|6|||
106023307|NCT03735667|365750366|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
106023308|NCT03735667|365750364|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
106023309|NCT03735667|365750365|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
106023310|NCT03735667|365750366|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
106023311|NCT03735667|365750364|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
106023312|NCT03735667|365750365|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
106023313|NCT03735667|365750366|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
106023314|NCT03735667|365750364|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
105836481|NCT05103657|365056973|FG001|Overall Study|Burden of study procedures|1|||
105836482|NCT05103657|365056972|FG000|Overall Study|Perceived lack of efficacy|1|||
106023315|NCT03735667|365750365|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
106023316|NCT03735667|365750366|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
106023317|NCT03735667|365750364|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
106023318|NCT03735667|365750365|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
106023319|NCT03735667|365750366|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
106023320|NCT03735667|365750364|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
106023321|NCT03735667|365750365|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
106023322|NCT03735667|365750366|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
105836483|NCT05103657|365056973|FG001|Overall Study|Perceived lack of efficacy|1|||
105836484|NCT05103657|365056972|FG000|Overall Study|Adverse Event|6|||
105836485|NCT05103657|365056973|FG001|Overall Study|Adverse Event|14|||
105836486|NCT05103657|365056972|FG000|Overall Study|Not Treated|1|||
105836487|NCT05103657|365056973|FG001|Overall Study|Not Treated|1|||
105836488|NCT00585312|365056984|FG000|Overall Study|Adverse Event|3|||
105836489|NCT00585312|365056985|FG001|Overall Study|Adverse Event|0|||
105836490|NCT00585312|365056984|FG000|Overall Study|Lack of Efficacy|6|||
105836491|NCT00585312|365056985|FG001|Overall Study|Lack of Efficacy|11|||
105836492|NCT00585312|365056984|FG000|Overall Study|Lost to Follow-up|1|||
105836493|NCT00585312|365056985|FG001|Overall Study|Lost to Follow-up|1|||
105836494|NCT00585312|365056984|FG000|Overall Study|Reason not specified|2|||
105836495|NCT00585312|365056985|FG001|Overall Study|Reason not specified|0|||
105836496|NCT00585312|365056984|FG000|Overall Study|Withdrawal by Subject|5|||
105836497|NCT00585312|365056985|FG001|Overall Study|Withdrawal by Subject|1|||
105836498|NCT00585312|365056984|FG000|Overall Study|Study terminated by the sponsor|34|||
105836499|NCT00585312|365056985|FG001|Overall Study|Study terminated by the sponsor|31|||
105836500|NCT03919695|365056991|FG000|3-month Follow-up|Death|1|||
105836501|NCT03919695|365056992|FG001|3-month Follow-up|Death|1|||
105836502|NCT03919695|365056991|FG000|3-month Follow-up|unable to contact|0|||
105836503|NCT03919695|365056992|FG001|3-month Follow-up|unable to contact|3|||
105836504|NCT03919695|365056991|FG000|3-month Follow-up|in prison|0|||
105836505|NCT03919695|365056992|FG001|3-month Follow-up|in prison|1|||
105965811|NCT03070171|365533815|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
105965812|NCT03070171|365533816|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
105965813|NCT03070171|365533815|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
105965814|NCT03070171|365533816|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
105965815|NCT01471028|365533817|FG000|VTI-208|Adverse Event|39|||
105965816|NCT01471028|365533818|FG001|VTI-208|Adverse Event|41|||
105965817|NCT01471028|365533817|FG000|VTI-208|Withdrawal by Subject|0|||
105965818|NCT01471028|365533818|FG001|VTI-208|Withdrawal by Subject|2|||
105965819|NCT01471028|365533817|FG000|VTI-208|Lost to Follow-up|1|||
105965820|NCT01471028|365533818|FG001|VTI-208|Lost to Follow-up|1|||
105965821|NCT01471028|365533817|FG000|VTI-208E|Death|7|||
105965822|NCT01471028|365533818|FG001|VTI-208E|Death|10|||
105965823|NCT01471028|365533817|FG000|VTI-208E|Withdrawal by Subject|1|||
105965824|NCT01471028|365533818|FG001|VTI-208E|Withdrawal by Subject|0|||
105965825|NCT01471028|365533817|FG000|VTI-208E|Lost to Follow-up|0|||
105965826|NCT01471028|365533818|FG001|VTI-208E|Lost to Follow-up|2|||
105965827|NCT05411822|365533819|FG000|Overall Study|Withdrawal by Subject|2|||
105965828|NCT05411822|365533820|FG001|Overall Study|Withdrawal by Subject|1|||
105965829|NCT01866111|365533824|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
105965830|NCT01866111|365533825|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
105965831|NCT01866111|365533826|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
105965832|NCT01866111|365533827|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
105965833|NCT01866111|365533824|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
105965834|NCT01866111|365533825|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
105965835|NCT01866111|365533826|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
105965836|NCT01866111|365533827|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
105965837|NCT01866111|365533824|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
105965838|NCT01866111|365533825|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
105965839|NCT01866111|365533826|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
105965840|NCT01866111|365533827|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
105965841|NCT01866111|365533824|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
105965842|NCT01866111|365533825|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
105965843|NCT01866111|365533826|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
105965844|NCT01866111|365533827|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
105965845|NCT01866111|365533824|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
105965846|NCT01866111|365533825|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
105965847|NCT01866111|365533826|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
105965848|NCT01866111|365533827|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
105965849|NCT01866111|365533824|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
105965850|NCT01866111|365533825|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
105965851|NCT01866111|365533826|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
105965852|NCT01866111|365533827|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
105965853|NCT01866111|365533824|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
105965854|NCT01866111|365533825|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
105965855|NCT01866111|365533826|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
105965856|NCT01866111|365533827|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
105836506|NCT03919695|365056991|FG000|6-month Follow-up|Death|0|||
105836507|NCT03919695|365056992|FG001|6-month Follow-up|Death|1|||
105836508|NCT03919695|365056991|FG000|6-month Follow-up|Lost to Follow-up|1|||
105836509|NCT03919695|365056992|FG001|6-month Follow-up|Lost to Follow-up|2|||
105836510|NCT03919695|365056991|FG000|6-month Follow-up|in prison|0|||
105836511|NCT03919695|365056992|FG001|6-month Follow-up|in prison|2|||
105965857|NCT01866111|365533824|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
105836512|NCT03919695|365056991|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
105836513|NCT03919695|365056992|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
106149278|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149279|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149280|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149281|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149282|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149283|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105836514|NCT03919695|365056991|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
105836515|NCT03919695|365056992|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
105836516|NCT03635983|365056993|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
105836517|NCT03635983|365056994|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
105836518|NCT03635983|365056993|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105836519|NCT03635983|365056994|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105836520|NCT03635983|365056993|FG000|Pre-Treatment Period|Other reasons|0|||
105836521|NCT03635983|365056994|FG001|Pre-Treatment Period|Other reasons|1|||
105836522|NCT03635983|365056993|FG000|Pre-Treatment Period|Disease Progression|0|||
105836523|NCT03635983|365056994|FG001|Pre-Treatment Period|Disease Progression|1|||
105836524|NCT03635983|365056993|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
105836525|NCT03635983|365056994|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
105836526|NCT03635983|365056993|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
105836527|NCT03635983|365056994|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
105836528|NCT03635983|365056993|FG000|Treatment Period|Withdrawal by Subject|3|||
105836529|NCT03635983|365056994|FG001|Treatment Period|Withdrawal by Subject|5|||
105836530|NCT03635983|365056993|FG000|Treatment Period|Death|3|||
105836531|NCT03635983|365056994|FG001|Treatment Period|Death|5|||
105836532|NCT03635983|365056993|FG000|Treatment Period|Poor/Non-compliance|2|||
105836533|NCT03635983|365056994|FG001|Treatment Period|Poor/Non-compliance|1|||
105836534|NCT03635983|365056993|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
105836535|NCT03635983|365056994|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
105836536|NCT03635983|365056993|FG000|Treatment Period|Other reasons|7|||
105836537|NCT03635983|365056994|FG001|Treatment Period|Other reasons|4|||
105836538|NCT03635983|365056993|FG000|Treatment Period|Disease progression|230|||
105836539|NCT03635983|365056994|FG001|Treatment Period|Disease progression|201|||
105836540|NCT03635983|365056993|FG000|Treatment Period|Study drug toxicity|35|||
105836541|NCT03635983|365056994|FG001|Treatment Period|Study drug toxicity|36|||
105836542|NCT03635983|365056993|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
105836543|NCT03635983|365056994|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
105836544|NCT03635983|365056993|FG000|Treatment Period|Maximum clinical benefit|3|||
105836545|NCT03635983|365056994|FG001|Treatment Period|Maximum clinical benefit|5|||
105836546|NCT03635983|365056993|FG000|Treatment Period|Administrative reason by the sponsor|1|||
105836547|NCT03635983|365056994|FG001|Treatment Period|Administrative reason by the sponsor|2|||
105836548|NCT03635983|365056993|FG000|Treatment Period|Lost to Follow-up|0|||
105836549|NCT03635983|365056994|FG001|Treatment Period|Lost to Follow-up|1|||
105836550|NCT04531982|365056996|FG000|Overall Study|Withdrawal by Subject|10|||
105836551|NCT04531982|365056997|FG001|Overall Study|Withdrawal by Subject|11|||
105836552|NCT04531982|365056996|FG000|Overall Study|Adverse Event|6|||
105836553|NCT04531982|365056997|FG001|Overall Study|Adverse Event|14|||
105836554|NCT04531982|365056996|FG000|Overall Study|Protocol Violation|6|||
105836555|NCT04531982|365056997|FG001|Overall Study|Protocol Violation|9|||
105836556|NCT04531982|365056996|FG000|Overall Study|Non-compliance with study drug|3|||
105836557|NCT04531982|365056997|FG001|Overall Study|Non-compliance with study drug|2|||
105836558|NCT04531982|365056996|FG000|Overall Study|Use of prohibited medication|2|||
105836559|NCT04531982|365056997|FG001|Overall Study|Use of prohibited medication|0|||
105836560|NCT04531982|365056996|FG000|Overall Study|Lost to Follow-up|0|||
105836561|NCT04531982|365056997|FG001|Overall Study|Lost to Follow-up|1|||
105836562|NCT04531982|365056996|FG000|Overall Study|Geopolitical conflict|2|||
105965858|NCT01866111|365533825|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
105965859|NCT01866111|365533826|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
105965860|NCT01866111|365533827|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
106149284|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105836563|NCT04531982|365056997|FG001|Overall Study|Geopolitical conflict|0|||
105836564|NCT04531982|365056996|FG000|Overall Study|Lack of Efficacy|3|||
105836565|NCT04531982|365056997|FG001|Overall Study|Lack of Efficacy|1|||
105836566|NCT01688882|365056998|FG000|Overall Study|Adverse Event|1|||
105836567|NCT01688882|365056999|FG001|Overall Study|Adverse Event|0|||
105836568|NCT01688882|365056998|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105836569|NCT01688882|365056999|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105836570|NCT01688882|365056998|FG000|Overall Study|Administrative problems|1|||
105836571|NCT01688882|365056999|FG001|Overall Study|Administrative problems|0|||
105836572|NCT03259789|365057000|FG000|Overall Study|Adverse Event|3|||
105836573|NCT03259789|365057001|FG001|Overall Study|Adverse Event|2|||
105836574|NCT03259789|365057002|FG002|Overall Study|Adverse Event|1|||
105836575|NCT03259789|365057000|FG000|Overall Study|Withdrawal by Subject|9|||
105836576|NCT03259789|365057001|FG001|Overall Study|Withdrawal by Subject|5|||
105836577|NCT03259789|365057002|FG002|Overall Study|Withdrawal by Subject|1|||
105836578|NCT03259789|365057000|FG000|Overall Study|Lost to Follow-up|5|||
105836579|NCT03259789|365057001|FG001|Overall Study|Lost to Follow-up|9|||
105836580|NCT03259789|365057002|FG002|Overall Study|Lost to Follow-up|4|||
105836581|NCT03259789|365057000|FG000|Overall Study|Physician Decision|0|||
105836582|NCT03259789|365057001|FG001|Overall Study|Physician Decision|1|||
105836583|NCT03259789|365057002|FG002|Overall Study|Physician Decision|0|||
105836584|NCT01235442|365057004|FG000|Overall Study|Lost to Follow-up|12|||
105836585|NCT01235442|365057005|FG001|Overall Study|Lost to Follow-up|10|||
105836586|NCT01235442|365057004|FG000|Overall Study|Death|0|||
105836587|NCT01235442|365057005|FG001|Overall Study|Death|2|||
105836588|NCT01235442|365057004|FG000|Overall Study|Pregnancy|1|||
105836589|NCT01235442|365057005|FG001|Overall Study|Pregnancy|1|||
105836590|NCT01235442|365057004|FG000|Overall Study|Ineligibility determined|5|||
105836591|NCT01235442|365057005|FG001|Overall Study|Ineligibility determined|4|||
105836592|NCT01235442|365057004|FG000|Overall Study|Protocol Violation|3|||
105836593|NCT01235442|365057005|FG001|Overall Study|Protocol Violation|3|||
105836594|NCT01235442|365057004|FG000|Overall Study|Adverse Event|4|||
105836595|NCT01235442|365057005|FG001|Overall Study|Adverse Event|6|||
105836596|NCT01235442|365057004|FG000|Overall Study|Withdrawal by Subject|15|||
105836597|NCT01235442|365057005|FG001|Overall Study|Withdrawal by Subject|9|||
105836598|NCT01235442|365057004|FG000|Overall Study|Lack of Efficacy|1|||
105836599|NCT01235442|365057005|FG001|Overall Study|Lack of Efficacy|3|||
105836600|NCT01235442|365057004|FG000|Overall Study|Noncompliance|1|||
105836601|NCT01235442|365057005|FG001|Overall Study|Noncompliance|2|||
105836602|NCT01235442|365057004|FG000|Overall Study|Administrative decision|1|||
105836603|NCT01235442|365057005|FG001|Overall Study|Administrative decision|2|||
105836604|NCT01235442|365057004|FG000|Overall Study|Other unspecified|1|||
105836605|NCT01235442|365057005|FG001|Overall Study|Other unspecified|2|||
105836606|NCT04291508|365057006|FG000|Overall Study|Withdrawal by Subject|1|||
105836607|NCT04291508|365057007|FG001|Overall Study|Withdrawal by Subject|0|||
105836608|NCT04291508|365057008|FG002|Overall Study|Withdrawal by Subject|1|||
105836609|NCT04291508|365057009|FG003|Overall Study|Withdrawal by Subject|0|||
105836610|NCT04291508|365057006|FG000|Overall Study|lost to follow up|4|||
105836611|NCT04291508|365057007|FG001|Overall Study|lost to follow up|0|||
105836612|NCT04291508|365057008|FG002|Overall Study|lost to follow up|1|||
105836613|NCT04291508|365057009|FG003|Overall Study|lost to follow up|0|||
105836614|NCT01701973|365057010|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836615|NCT01701973|365057011|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
105836616|NCT01701973|365057012|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836617|NCT01701973|365057013|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836618|NCT01701973|365057014|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836619|NCT01701973|365057015|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836620|NCT01701973|365057016|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836621|NCT01701973|365057017|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
105836622|NCT03566238|365057018|FG000|Overall Study|Adverse Event|0|||
105836623|NCT03566238|365057019|FG001|Overall Study|Adverse Event|1|||
105836624|NCT03566238|365057020|FG002|Overall Study|Adverse Event|0|||
105836625|NCT03566238|365057018|FG000|Overall Study|Lack of Efficacy|4|||
105836626|NCT03566238|365057019|FG001|Overall Study|Lack of Efficacy|2|||
105836627|NCT03566238|365057020|FG002|Overall Study|Lack of Efficacy|5|||
105836628|NCT03566238|365057018|FG000|Overall Study|Other|1|||
105836629|NCT03566238|365057019|FG001|Overall Study|Other|0|||
105836630|NCT03566238|365057020|FG002|Overall Study|Other|0|||
105836631|NCT04449341|365057023|FG000|Overall Study|Protocol Violation|1|||
105836632|NCT04449341|365057024|FG001|Overall Study|Protocol Violation|0|||
105836633|NCT04499482|365057025|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
105836634|NCT04314843|365057026|FG000|Overall Study|Death|2|||
105836635|NCT04314843|365057027|FG001|Overall Study|Death|2|||
105836636|NCT04314843|365057026|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
105836637|NCT04314843|365057027|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
105836638|NCT00551616|365057029|FG000|Overall Study|Lost to Follow-up|48|||
105836639|NCT00551616|365057030|FG001|Overall Study|Lost to Follow-up|40|||
105836640|NCT01263561|365057031|FG000|Overall Study|Death|1|||
105836641|NCT01263561|365057032|FG001|Overall Study|Death|2|||
105836642|NCT04203667|365057033|FG000|Overall Study|Withdrawal by Subject|1|||
105836643|NCT04203667|365057033|FG000|Overall Study|Lost to Follow-up|1|||
105836644|NCT04203667|365057033|FG000|Overall Study|Death|1|||
105836645|NCT04203667|365057033|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
105836646|NCT03942211|365057034|FG000|Overall Study|Death|1|||
105836647|NCT03942211|365057035|FG001|Overall Study|Death|0|||
105836648|NCT03942211|365057034|FG000|Overall Study|Study terminated by sponsor|5|||
105836649|NCT03942211|365057035|FG001|Overall Study|Study terminated by sponsor|3|||
105836650|NCT03942211|365057034|FG000|Overall Study|Adverse Event|0|||
105836651|NCT03942211|365057035|FG001|Overall Study|Adverse Event|1|||
105836652|NCT02169336|365057038|FG000|Overall Study|Lack of Efficacy|1|||
105836653|NCT02169336|365057039|FG001|Overall Study|Lack of Efficacy|1|||
105836654|NCT02169336|365057040|FG002|Overall Study|Lack of Efficacy|0|||
105836655|NCT02169336|365057038|FG000|Overall Study|Adverse Event|2|||
105836656|NCT02169336|365057039|FG001|Overall Study|Adverse Event|3|||
105836657|NCT02169336|365057040|FG002|Overall Study|Adverse Event|1|||
105836658|NCT02169336|365057038|FG000|Overall Study|Withdrawal by Subject|1|||
105836659|NCT02169336|365057039|FG001|Overall Study|Withdrawal by Subject|0|||
105836660|NCT02169336|365057040|FG002|Overall Study|Withdrawal by Subject|0|||
105836661|NCT02169336|365057038|FG000|Overall Study|Physician Decision|0|||
105836662|NCT02169336|365057039|FG001|Overall Study|Physician Decision|0|||
105836663|NCT02169336|365057040|FG002|Overall Study|Physician Decision|1|||
105836664|NCT02169336|365057038|FG000|Overall Study|Subject declined to continue dosing|0|||
105836665|NCT02169336|365057039|FG001|Overall Study|Subject declined to continue dosing|0|||
105836666|NCT02169336|365057040|FG002|Overall Study|Subject declined to continue dosing|1|||
105836667|NCT01396421|365057041|FG000|Overall Study|Lost to Follow-up|0|||
105836668|NCT01396421|365057042|FG001|Overall Study|Lost to Follow-up|0|||
105836669|NCT01396421|365057043|FG002|Overall Study|Lost to Follow-up|0|||
105836670|NCT01396421|365057044|FG003|Overall Study|Lost to Follow-up|1|||
105836671|NCT01396421|365057041|FG000|Overall Study|Adverse Event|17|||
105836672|NCT01396421|365057042|FG001|Overall Study|Adverse Event|15|||
105836673|NCT01396421|365057043|FG002|Overall Study|Adverse Event|12|||
105836674|NCT01396421|365057044|FG003|Overall Study|Adverse Event|32|||
105836675|NCT01396421|365057041|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
105836676|NCT01396421|365057042|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
105836677|NCT01396421|365057043|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
105836678|NCT01396421|365057044|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
105836679|NCT01396421|365057041|FG000|Overall Study|Physician Decision|1|||
105836680|NCT01396421|365057042|FG001|Overall Study|Physician Decision|1|||
105836681|NCT01396421|365057043|FG002|Overall Study|Physician Decision|0|||
105836682|NCT01396421|365057044|FG003|Overall Study|Physician Decision|3|||
105836683|NCT01396421|365057041|FG000|Overall Study|Withdrawal by Subject|31|||
105836684|NCT01396421|365057042|FG001|Overall Study|Withdrawal by Subject|24|||
105836685|NCT01396421|365057043|FG002|Overall Study|Withdrawal by Subject|13|||
105836686|NCT01396421|365057044|FG003|Overall Study|Withdrawal by Subject|21|||
105836687|NCT01396421|365057041|FG000|Overall Study|Protocol Deviation|2|||
105836688|NCT01396421|365057042|FG001|Overall Study|Protocol Deviation|1|||
105836689|NCT01396421|365057043|FG002|Overall Study|Protocol Deviation|1|||
105836690|NCT01396421|365057044|FG003|Overall Study|Protocol Deviation|0|||
105836691|NCT01396421|365057041|FG000|Overall Study|Lack of Efficacy|7|||
105836692|NCT01396421|365057042|FG001|Overall Study|Lack of Efficacy|17|||
105836693|NCT01396421|365057043|FG002|Overall Study|Lack of Efficacy|7|||
105836694|NCT01396421|365057044|FG003|Overall Study|Lack of Efficacy|18|||
105836695|NCT01977456|365057051|FG000|Overall Study|Death|5|||
105836696|NCT01142661|365057052|FG000|Overall Study|Adverse Event|2|||
105836697|NCT01142661|365057052|FG000|Overall Study|Withdrawal by Subject|1|||
105836698|NCT01142661|365057052|FG000|Overall Study|Physician Decision|1|||
105836699|NCT02293460|365058771|FG000|Overall Study|Protocol Violation|1|||
105836700|NCT02293460|365058771|FG000|Overall Study|Lack of Efficacy|2|||
105836701|NCT02293460|365058771|FG000|Overall Study|Adverse Event|2|||
105836702|NCT02293460|365058771|FG000|Overall Study|Withdrawal by Subject|1|||
105836703|NCT00500318|365058772|FG000|Overall Study|Adverse Event|3|||
105836704|NCT00500318|365058773|FG001|Overall Study|Adverse Event|8|||
105836705|NCT00500318|365058772|FG000|Overall Study|Protocol Violation|1|||
105836706|NCT00500318|365058773|FG001|Overall Study|Protocol Violation|3|||
105836707|NCT00500318|365058772|FG000|Overall Study|Withdrawal by Subject|1|||
105836708|NCT00500318|365058773|FG001|Overall Study|Withdrawal by Subject|2|||
105836709|NCT00500318|365058772|FG000|Overall Study|Lack of Efficacy|0|||
106149285|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
106149286|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
106149287|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105836710|NCT00500318|365058773|FG001|Overall Study|Lack of Efficacy|3|||
105836711|NCT00500318|365058772|FG000|Overall Study|Other Reason|0|||
105836712|NCT00500318|365058773|FG001|Overall Study|Other Reason|1|||
105836713|NCT01074008|365058774|FG000|Overall Study|Adverse Event|0|||
105836714|NCT01074008|365058775|FG001|Overall Study|Adverse Event|1|||
105836715|NCT01074008|365058776|FG002|Overall Study|Adverse Event|0|||
105836716|NCT01074008|365058777|FG003|Overall Study|Adverse Event|0|||
105836717|NCT01074008|365058778|FG004|Overall Study|Adverse Event|0|||
105836718|NCT01074008|365058779|FG005|Overall Study|Adverse Event|0|||
105836719|NCT01074008|365058780|FG006|Overall Study|Adverse Event|0|||
105836720|NCT01074008|365058781|FG007|Overall Study|Adverse Event|0|||
105836721|NCT01074008|365058782|FG008|Overall Study|Adverse Event|0|||
105836722|NCT01074008|365058774|FG000|Overall Study|Withdrawal by Subject|1|||
105836723|NCT01074008|365058775|FG001|Overall Study|Withdrawal by Subject|1|||
105836724|NCT01074008|365058776|FG002|Overall Study|Withdrawal by Subject|1|||
105836725|NCT01074008|365058777|FG003|Overall Study|Withdrawal by Subject|0|||
105836726|NCT01074008|365058778|FG004|Overall Study|Withdrawal by Subject|1|||
105836727|NCT01074008|365058779|FG005|Overall Study|Withdrawal by Subject|0|||
105836728|NCT01074008|365058780|FG006|Overall Study|Withdrawal by Subject|0|||
105836729|NCT01074008|365058781|FG007|Overall Study|Withdrawal by Subject|0|||
105836730|NCT01074008|365058782|FG008|Overall Study|Withdrawal by Subject|0|||
105836731|NCT01074008|365058774|FG000|Overall Study|Lost to Follow-up|0|||
105836732|NCT01074008|365058775|FG001|Overall Study|Lost to Follow-up|1|||
105836733|NCT01074008|365058776|FG002|Overall Study|Lost to Follow-up|1|||
105836734|NCT01074008|365058777|FG003|Overall Study|Lost to Follow-up|1|||
105836735|NCT01074008|365058778|FG004|Overall Study|Lost to Follow-up|1|||
105836736|NCT01074008|365058779|FG005|Overall Study|Lost to Follow-up|0|||
105836737|NCT01074008|365058780|FG006|Overall Study|Lost to Follow-up|1|||
105836738|NCT01074008|365058781|FG007|Overall Study|Lost to Follow-up|0|||
105836739|NCT01074008|365058782|FG008|Overall Study|Lost to Follow-up|4|||
105836740|NCT00224484|365058785|FG000|Overall Study|Serious Adverse Event|1|||
105836741|NCT00224484|365058786|FG001|Overall Study|Serious Adverse Event|1|||
105836742|NCT00224484|365058787|FG002|Overall Study|Serious Adverse Event|0|||
105836743|NCT00224484|365058785|FG000|Overall Study|Non-Serious Adverse Event|5|||
105836744|NCT00224484|365058786|FG001|Overall Study|Non-Serious Adverse Event|7|||
105836745|NCT00224484|365058787|FG002|Overall Study|Non-Serious Adverse Event|3|||
105836746|NCT00224484|365058785|FG000|Overall Study|Protocol Violation|2|||
105836747|NCT00224484|365058786|FG001|Overall Study|Protocol Violation|2|||
105836748|NCT00224484|365058787|FG002|Overall Study|Protocol Violation|0|||
105836749|NCT00224484|365058785|FG000|Overall Study|Withdrawal by Subject|49|||
105836750|NCT00224484|365058786|FG001|Overall Study|Withdrawal by Subject|18|||
105836751|NCT00224484|365058787|FG002|Overall Study|Withdrawal by Subject|16|||
105836752|NCT00224484|365058785|FG000|Overall Study|Migrated/moved from study area|18|||
105836753|NCT00224484|365058786|FG001|Overall Study|Migrated/moved from study area|5|||
105836754|NCT00224484|365058787|FG002|Overall Study|Migrated/moved from study area|5|||
105836755|NCT00224484|365058785|FG000|Overall Study|Lost to Follow-up|66|||
105836756|NCT00224484|365058786|FG001|Overall Study|Lost to Follow-up|28|||
105836757|NCT00224484|365058787|FG002|Overall Study|Lost to Follow-up|36|||
105836758|NCT00224484|365058785|FG000|Overall Study|Reason not specified|5|||
105836759|NCT00224484|365058786|FG001|Overall Study|Reason not specified|4|||
105836760|NCT00224484|365058787|FG002|Overall Study|Reason not specified|2|||
105836761|NCT02805309|365058788|FG000|Overall Study|Lost to Follow-up|2|||
105836762|NCT02805309|365058789|FG001|Overall Study|Lost to Follow-up|2|||
105836763|NCT02805309|365058790|FG002|Overall Study|Lost to Follow-up|2|||
105836764|NCT02805309|365058788|FG000|Overall Study|Post-Randomization Exclusion|0|||
105836765|NCT02805309|365058789|FG001|Overall Study|Post-Randomization Exclusion|2|||
105836766|NCT02805309|365058790|FG002|Overall Study|Post-Randomization Exclusion|1|||
105836767|NCT00108628|365058798|FG000|Overall Study|Withdrawal by Subject|17|||
105836768|NCT00108628|365058799|FG001|Overall Study|Withdrawal by Subject|9|||
105836769|NCT00108628|365058798|FG000|Overall Study|Lack of Efficacy|2|||
105836770|NCT00108628|365058799|FG001|Overall Study|Lack of Efficacy|1|||
105836771|NCT00108628|365058798|FG000|Overall Study|Death|1|||
105836772|NCT00108628|365058799|FG001|Overall Study|Death|0|||
105836773|NCT01350934|365058800|FG000|Base Study|Adverse Event|6|||
105836774|NCT01350934|365058801|FG001|Base Study|Adverse Event|0|||
105836775|NCT01350934|365058800|FG000|Base Study|Lost to Follow-up|1|||
105836776|NCT01350934|365058801|FG001|Base Study|Lost to Follow-up|0|||
105836777|NCT01350934|365058800|FG000|Base Study|Protocol Violation|1|||
105836778|NCT01350934|365058801|FG001|Base Study|Protocol Violation|1|||
105836779|NCT01350934|365058800|FG000|Base Study|Withdrawal by Subject|1|||
105836780|NCT01350934|365058801|FG001|Base Study|Withdrawal by Subject|2|||
105836781|NCT01350934|365058800|FG000|Base Study|Non-Compliance With Study Drug|2|||
105836782|NCT01350934|365058801|FG001|Base Study|Non-Compliance With Study Drug|0|||
105836783|NCT01350934|365058800|FG000|Extension Study|Adverse Event|2|||
105836784|NCT01350934|365058801|FG001|Extension Study|Adverse Event|1|||
105836785|NCT01350934|365058800|FG000|Extension Study|Lost to Follow-up|2|||
105836786|NCT01350934|365058801|FG001|Extension Study|Lost to Follow-up|0|||
106149288|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
105836787|NCT01350934|365058800|FG000|Extension Study|Protocol Violation|1|||
105836788|NCT01350934|365058801|FG001|Extension Study|Protocol Violation|1|||
105836789|NCT01350934|365058800|FG000|Extension Study|Lack of Efficacy|0|||
105836790|NCT01350934|365058801|FG001|Extension Study|Lack of Efficacy|1|||
105836791|NCT01350934|365058800|FG000|Extension Study|Withdrawal by Subject|0|||
105836792|NCT01350934|365058801|FG001|Extension Study|Withdrawal by Subject|1|||
105836793|NCT03547635|365058804|FG000|Overall Study|Adverse Event|5|||
105836794|NCT03547635|365058805|FG001|Overall Study|Adverse Event|2|||
105836795|NCT03547635|365058806|FG002|Overall Study|Adverse Event|3|||
105836796|NCT03547635|365058804|FG000|Overall Study|Lost to Follow-up|1|||
105836797|NCT03547635|365058805|FG001|Overall Study|Lost to Follow-up|3|||
105836798|NCT03547635|365058806|FG002|Overall Study|Lost to Follow-up|4|||
105836799|NCT03547635|365058804|FG000|Overall Study|Withdrawal by Subject|1|||
105836800|NCT03547635|365058805|FG001|Overall Study|Withdrawal by Subject|0|||
105836801|NCT03547635|365058806|FG002|Overall Study|Withdrawal by Subject|0|||
105836802|NCT03547635|365058804|FG000|Overall Study|Withdrawal By PI|0|||
105836803|NCT03547635|365058805|FG001|Overall Study|Withdrawal By PI|1|||
105836804|NCT03547635|365058806|FG002|Overall Study|Withdrawal By PI|0|||
105836805|NCT03547635|365058804|FG000|Overall Study|Withdrawal by Sponsor|0|||
105836806|NCT03547635|365058805|FG001|Overall Study|Withdrawal by Sponsor|0|||
105836807|NCT03547635|365058806|FG002|Overall Study|Withdrawal by Sponsor|1|||
105836808|NCT03547635|365058804|FG000|Overall Study|Errant Randomization before Treatment|0|||
105836809|NCT03547635|365058805|FG001|Overall Study|Errant Randomization before Treatment|1|||
105836810|NCT03547635|365058806|FG002|Overall Study|Errant Randomization before Treatment|0|||
105836811|NCT03547635|365058804|FG000|Overall Study|Withdrawal by Subject|1|||
105836812|NCT03547635|365058805|FG001|Overall Study|Withdrawal by Subject|0|||
105836813|NCT03547635|365058806|FG002|Overall Study|Withdrawal by Subject|0|||
105836814|NCT01011335|365058807|FG000|Overall Study|Lost to Follow-up|0|||
105836815|NCT01011335|365058808|FG001|Overall Study|Lost to Follow-up|0|||
105836816|NCT01011335|365058809|FG002|Overall Study|Lost to Follow-up|1|||
105836817|NCT01011335|365058810|FG003|Overall Study|Lost to Follow-up|1|||
105836818|NCT01011335|365058811|FG004|Overall Study|Lost to Follow-up|1|||
105836819|NCT01011335|365058812|FG005|Overall Study|Lost to Follow-up|1|||
105836820|NCT01011335|365058813|FG006|Overall Study|Lost to Follow-up|2|||
105836821|NCT01011335|365058814|FG007|Overall Study|Lost to Follow-up|2|||
105836822|NCT01011335|365058815|FG008|Overall Study|Lost to Follow-up|1|||
105836823|NCT01011335|365058816|FG009|Overall Study|Lost to Follow-up|0|||
105836824|NCT01011335|365058817|FG010|Overall Study|Lost to Follow-up|0|||
105836825|NCT01011335|365058818|FG011|Overall Study|Lost to Follow-up|1|||
105836826|NCT01011335|365058819|FG012|Overall Study|Lost to Follow-up|2|||
105836827|NCT01011335|365058807|FG000|Overall Study|Protocol Violation|0|||
105836828|NCT01011335|365058808|FG001|Overall Study|Protocol Violation|1|||
105836829|NCT01011335|365058809|FG002|Overall Study|Protocol Violation|0|||
105836830|NCT01011335|365058810|FG003|Overall Study|Protocol Violation|0|||
105836831|NCT01011335|365058811|FG004|Overall Study|Protocol Violation|0|||
105836832|NCT01011335|365058812|FG005|Overall Study|Protocol Violation|0|||
105836833|NCT01011335|365058813|FG006|Overall Study|Protocol Violation|0|||
105836834|NCT01011335|365058814|FG007|Overall Study|Protocol Violation|0|||
105836835|NCT01011335|365058815|FG008|Overall Study|Protocol Violation|0|||
105836836|NCT01011335|365058816|FG009|Overall Study|Protocol Violation|0|||
105836837|NCT01011335|365058817|FG010|Overall Study|Protocol Violation|0|||
105836838|NCT01011335|365058818|FG011|Overall Study|Protocol Violation|0|||
105836839|NCT01011335|365058819|FG012|Overall Study|Protocol Violation|0|||
105836840|NCT01011335|365058807|FG000|Overall Study|Moved/deployed or no booster|1|||
105836841|NCT01011335|365058808|FG001|Overall Study|Moved/deployed or no booster|0|||
105836842|NCT01011335|365058809|FG002|Overall Study|Moved/deployed or no booster|0|||
105836843|NCT01011335|365058810|FG003|Overall Study|Moved/deployed or no booster|1|||
105836844|NCT01011335|365058811|FG004|Overall Study|Moved/deployed or no booster|0|||
105836845|NCT01011335|365058812|FG005|Overall Study|Moved/deployed or no booster|0|||
105836846|NCT01011335|365058813|FG006|Overall Study|Moved/deployed or no booster|1|||
105836847|NCT01011335|365058814|FG007|Overall Study|Moved/deployed or no booster|0|||
105836848|NCT01011335|365058815|FG008|Overall Study|Moved/deployed or no booster|1|||
105836849|NCT01011335|365058816|FG009|Overall Study|Moved/deployed or no booster|0|||
105836850|NCT01011335|365058817|FG010|Overall Study|Moved/deployed or no booster|2|||
105836851|NCT01011335|365058818|FG011|Overall Study|Moved/deployed or no booster|0|||
105836852|NCT01011335|365058819|FG012|Overall Study|Moved/deployed or no booster|0|||
105836853|NCT01011335|365058807|FG000|Overall Study|Adverse Event|0|||
105965861|NCT01866111|365533824|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
105965862|NCT01866111|365533825|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
105965863|NCT01866111|365533826|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
105965864|NCT01866111|365533827|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
105965865|NCT01866111|365533824|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
105965866|NCT01866111|365533825|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
105965867|NCT01866111|365533826|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
105965868|NCT01866111|365533827|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
106023323|NCT03735667|365750364|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
106023324|NCT03735667|365750365|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
106023325|NCT03735667|365750366|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
106023326|NCT03735667|365750364|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
105836854|NCT01011335|365058808|FG001|Overall Study|Adverse Event|0|||
105836855|NCT01011335|365058809|FG002|Overall Study|Adverse Event|0|||
105836856|NCT01011335|365058810|FG003|Overall Study|Adverse Event|0|||
105836857|NCT01011335|365058811|FG004|Overall Study|Adverse Event|0|||
105836858|NCT01011335|365058812|FG005|Overall Study|Adverse Event|0|||
105836859|NCT01011335|365058813|FG006|Overall Study|Adverse Event|0|||
105836860|NCT01011335|365058814|FG007|Overall Study|Adverse Event|0|||
105836861|NCT01011335|365058815|FG008|Overall Study|Adverse Event|0|||
105836862|NCT01011335|365058816|FG009|Overall Study|Adverse Event|0|||
105836863|NCT01011335|365058817|FG010|Overall Study|Adverse Event|4|||
105836864|NCT01011335|365058818|FG011|Overall Study|Adverse Event|0|||
105836865|NCT01011335|365058819|FG012|Overall Study|Adverse Event|1|||
106023327|NCT03735667|365750365|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
106023328|NCT03735667|365750366|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
105836866|NCT01636934|365058822|FG000|Overall Study|Withdrawal by Subject|3|||
105836867|NCT01636934|365058823|FG001|Overall Study|Withdrawal by Subject|2|||
105836868|NCT01636934|365058822|FG000|Overall Study|Chemo cancel|1|||
105836869|NCT01636934|365058823|FG001|Overall Study|Chemo cancel|0|||
105836870|NCT01636934|365058822|FG000|Overall Study|Too ill to continue|1|||
105836871|NCT01636934|365058823|FG001|Overall Study|Too ill to continue|0|||
105836872|NCT01636934|365058822|FG000|Overall Study|Never started study medication|1|||
105836873|NCT01636934|365058823|FG001|Overall Study|Never started study medication|1|||
105836874|NCT02415387|365058833|FG000|Overall Study|Withdrawal by Subject|6|||
105836875|NCT02415387|365058834|FG001|Overall Study|Withdrawal by Subject|1|||
105836876|NCT02415387|365058833|FG000|Overall Study|blood draw problem|0|||
105836877|NCT02415387|365058834|FG001|Overall Study|blood draw problem|1|||
105836878|NCT02415387|365058833|FG000|Overall Study|Protocol Violation|1|||
105836879|NCT02415387|365058834|FG001|Overall Study|Protocol Violation|0|||
105836880|NCT02447887|365058837|FG000|Overall Study|Study was terminated|3|||
105836881|NCT01765751|365058838|FG000|Overall Study|Lost to Follow-up|0|||
105836882|NCT01765751|365058839|FG001|Overall Study|Lost to Follow-up|2|||
105836883|NCT01765751|365058840|FG002|Overall Study|Lost to Follow-up|1|||
105836884|NCT00653159|365058841|FG000|Overall Study|Adverse Event|4|||
105836885|NCT00653159|365058842|FG001|Overall Study|Adverse Event|1|||
105836886|NCT00653159|365058841|FG000|Overall Study|Lost to Follow-up|1|||
105836887|NCT00653159|365058842|FG001|Overall Study|Lost to Follow-up|2|||
105836888|NCT00412737|365058843|FG000|Overall Study|Death|1|||
105836889|NCT00412737|365058844|FG001|Overall Study|Death|0|||
105836890|NCT00412737|365058843|FG000|Overall Study|Adverse Event|3|||
105836891|NCT00412737|365058844|FG001|Overall Study|Adverse Event|2|||
105836892|NCT00412737|365058843|FG000|Overall Study|Refused Treatment|6|||
105836893|NCT00412737|365058844|FG001|Overall Study|Refused Treatment|2|||
105836894|NCT00412737|365058843|FG000|Overall Study|Failure to Return|6|||
105836895|NCT00412737|365058844|FG001|Overall Study|Failure to Return|2|||
105836896|NCT00979212|365058845|FG000|Overall Study|Protocol Violation|1|||
105836897|NCT00979212|365058846|FG001|Overall Study|Protocol Violation|8|||
105836898|NCT00979212|365058845|FG000|Overall Study|No protocol therapy received|1|||
105836899|NCT00979212|365058846|FG001|Overall Study|No protocol therapy received|0|||
105836900|NCT01801917|365058848|FG000|Period 1 - Randomized|Adverse Event|1|||
105836901|NCT01801917|365058849|FG001|Period 1 - Randomized|Adverse Event|0|||
105836902|NCT01801917|365058850|FG002|Period 1 - Randomized|Adverse Event|1|||
105836903|NCT01801917|365058851|FG003|Period 1 - Randomized|Adverse Event|0|||
105836904|NCT01924364|365058852|FG000|Overall Study|Physician Decision|3|||
105836905|NCT04307849|365058853|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
105836906|NCT04307849|365058854|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
105836907|NCT04307849|365058855|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
105836908|NCT04307849|365058856|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
105836909|NCT04307849|365058857|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
105836910|NCT04307849|365058858|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
105836911|NCT04307849|365058853|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836912|NCT04307849|365058854|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836913|NCT04307849|365058855|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
105836914|NCT04307849|365058856|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836915|NCT04307849|365058857|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836916|NCT04307849|365058858|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
105836917|NCT04307849|365058853|FG000|Overall Study|Family member did not want them to continue|0|||
105836918|NCT04307849|365058854|FG001|Overall Study|Family member did not want them to continue|0|||
105836919|NCT04307849|365058855|FG002|Overall Study|Family member did not want them to continue|1|||
106023329|NCT03735667|365750364|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
106023330|NCT03735667|365750365|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
106023331|NCT03735667|365750366|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
106023332|NCT03735667|365750364|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
106023333|NCT03735667|365750365|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
106023334|NCT03735667|365750366|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
106023335|NCT01120717|365750367|FG000|Overall Study|Withdrawal by Subject|11|||
105836920|NCT04307849|365058856|FG003|Overall Study|Family member did not want them to continue|0|||
105836921|NCT04307849|365058857|FG004|Overall Study|Family member did not want them to continue|0|||
105836922|NCT04307849|365058858|FG005|Overall Study|Family member did not want them to continue|0|||
105836923|NCT04307849|365058853|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
105836924|NCT04307849|365058854|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
105836925|NCT04307849|365058855|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
106023336|NCT01120717|365750368|FG001|Overall Study|Withdrawal by Subject|6|||
106023337|NCT01120717|365750367|FG000|Overall Study|Adverse Event|10|||
105836926|NCT04307849|365058856|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
105836927|NCT04307849|365058857|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
105836928|NCT04307849|365058858|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
105836929|NCT00265785|365058861|FG000|Overall Study|Adverse Event|4|||
105836930|NCT00265785|365058861|FG000|Overall Study|Withdrawal by Subject|3|||
105836931|NCT00265785|365058861|FG000|Overall Study|Progression/Relapse|15|||
105836932|NCT00265785|365058861|FG000|Overall Study|Not protocol specified|2|||
105836933|NCT00265785|365058861|FG000|Overall Study|Ineligible|1|||
105836934|NCT00265785|365058861|FG000|Overall Study|Did not receive protocol treatment|2|||
105836935|NCT04253236|365058864|FG000|Overall Study|Adverse Event|1|||
105836936|NCT04253236|365058865|FG001|Overall Study|Adverse Event|0|||
105836937|NCT04253236|365058864|FG000|Overall Study|Safety Concerns|1|||
105836938|NCT04253236|365058865|FG001|Overall Study|Safety Concerns|0|||
105836939|NCT04253236|365058864|FG000|Overall Study|Study Terminated by Sponsor|1|||
105836940|NCT04253236|365058865|FG001|Overall Study|Study Terminated by Sponsor|0|||
105836941|NCT00587431|365058868|FG000|Overall Study|Adverse Event|1|||
105836942|NCT00587431|365058869|FG001|Overall Study|Adverse Event|0|||
105836943|NCT00587431|365058868|FG000|Overall Study|Withdrawal by Subject|0|||
105836944|NCT00587431|365058869|FG001|Overall Study|Withdrawal by Subject|1|||
105836945|NCT05467982|365058870|FG000|Overall Study|Death|0|||
105836946|NCT05467982|365058871|FG001|Overall Study|Death|1|||
105836947|NCT05467982|365058870|FG000|Overall Study|Lost to Follow-up|3|||
105836948|NCT05467982|365058871|FG001|Overall Study|Lost to Follow-up|1|||
105836949|NCT00613730|365058872|FG000|Overall Study|Disease progression|2|||
105836950|NCT00613730|365058872|FG000|Overall Study|Administrative decision|1|||
105836951|NCT00569777|365058873|FG000|Overall Study|Withdrawal by Subject|4|||
105836952|NCT00569777|365058874|FG001|Overall Study|Withdrawal by Subject|0|||
105836953|NCT00569777|365058873|FG000|Overall Study|Adverse Event|3|||
105836954|NCT00569777|365058874|FG001|Overall Study|Adverse Event|0|||
105836955|NCT00569777|365058873|FG000|Overall Study|Lost to Follow-up|1|||
105836956|NCT00569777|365058874|FG001|Overall Study|Lost to Follow-up|0|||
105836957|NCT00569777|365058873|FG000|Overall Study|scheduled eye surgery|0|||
105836958|NCT00569777|365058874|FG001|Overall Study|scheduled eye surgery|1|||
105836959|NCT00569777|365058873|FG000|Overall Study|did not meet exclusion criteria|1|||
105836960|NCT00569777|365058874|FG001|Overall Study|did not meet exclusion criteria|2|||
105836961|NCT00569777|365058873|FG000|Overall Study|pregnant|1|||
105836962|NCT00569777|365058874|FG001|Overall Study|pregnant|0|||
105836963|NCT05766787|365058875|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
105836964|NCT05766787|365058876|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
105836965|NCT05766787|365058875|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
105836966|NCT05766787|365058876|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
105836967|NCT05766787|365058875|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
105836968|NCT05766787|365058876|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
105836969|NCT01117987|365058877|FG000|Overall Study|Protocol deviation|0|||
105836970|NCT01117987|365058878|FG001|Overall Study|Protocol deviation|1|||
105836971|NCT01117987|365058877|FG000|Overall Study|Subject no longer requires study drug|1|||
105836972|NCT01117987|365058878|FG001|Overall Study|Subject no longer requires study drug|0|||
105836973|NCT01117987|365058877|FG000|Overall Study|Lost to Follow-up|1|||
105836974|NCT01117987|365058878|FG001|Overall Study|Lost to Follow-up|1|||
105836975|NCT01117987|365058877|FG000|Overall Study|Abnormal test procedure result|2|||
105836976|NCT01117987|365058878|FG001|Overall Study|Abnormal test procedure result|0|||
105836977|NCT01117987|365058877|FG000|Overall Study|Lack of Efficacy|3|||
105836978|NCT01117987|365058878|FG001|Overall Study|Lack of Efficacy|4|||
105836979|NCT01117987|365058877|FG000|Overall Study|Death|5|||
105836980|NCT01117987|365058878|FG001|Overall Study|Death|10|||
105836981|NCT01117987|365058877|FG000|Overall Study|Withdrawal by Subject|5|||
105836982|NCT01117987|365058878|FG001|Overall Study|Withdrawal by Subject|10|||
105965869|NCT01866111|365533824|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
105965870|NCT01866111|365533825|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
105965871|NCT01866111|365533826|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
105965872|NCT01866111|365533827|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
105965873|NCT01866111|365533824|FG000|Open-label Extension Study YKP3089C017|Death|1|||
105836983|NCT01117987|365058877|FG000|Overall Study|Adverse Event|19|||
105836984|NCT01117987|365058878|FG001|Overall Study|Adverse Event|26|||
105836985|NCT01117987|365058877|FG000|Overall Study|Administrative problems|25|||
105836986|NCT01117987|365058878|FG001|Overall Study|Administrative problems|22|||
105836987|NCT00292227|365058880|FG000|Patch Period|Adverse Event|1|||
105836988|NCT00292227|365058881|FG001|Patch Period|Adverse Event|0|||
105836989|NCT00292227|365058882|FG002|Patch Period|Adverse Event|2|||
105836990|NCT00292227|365058880|FG000|Patch Period|Withdrawal by Subject|0|||
105836991|NCT00292227|365058881|FG001|Patch Period|Withdrawal by Subject|0|||
105836992|NCT00292227|365058882|FG002|Patch Period|Withdrawal by Subject|1|||
105836993|NCT01835548|365058884|FG000|Dose Optimization Period|Adverse Event|0|||
105836994|NCT01835548|365058885|FG001|Dose Optimization Period|Adverse Event|0|||
105836995|NCT01835548|365058886|FG002|Dose Optimization Period|Adverse Event|1|||
105836996|NCT01835548|365058884|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
105836997|NCT01835548|365058885|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
105836998|NCT01835548|365058886|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
105836999|NCT01835548|365058884|FG000|Double-Blind Treatment Period|Adverse Event|0|||
105837000|NCT01835548|365058885|FG001|Double-Blind Treatment Period|Adverse Event|1|||
105837001|NCT01835548|365058886|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105837002|NCT01835548|365058884|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105837003|NCT01835548|365058885|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
105837004|NCT01835548|365058886|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
105837005|NCT01169038|365058887|FG000|Overall Study|Death|1|||
105837006|NCT01169038|365058887|FG000|Overall Study|Adverse Event|5|||
105837007|NCT01169038|365058887|FG000|Overall Study|Required antibiotic administration|1|||
105837008|NCT01488448|365058888|FG000|Overall Study|Withdrawal by Subject|3|||
105837009|NCT01488448|365058889|FG001|Overall Study|Withdrawal by Subject|1|||
105837010|NCT01488448|365058888|FG000|Overall Study|Adverse Event|9|||
105837011|NCT01488448|365058889|FG001|Overall Study|Adverse Event|4|||
105837012|NCT01488448|365058888|FG000|Overall Study|Physician Decision|4|||
105837013|NCT01488448|365058889|FG001|Overall Study|Physician Decision|9|||
105837014|NCT01488448|365058888|FG000|Overall Study|Protocol Violation|4|||
105837015|NCT01488448|365058889|FG001|Overall Study|Protocol Violation|3|||
105837016|NCT00537017|365058890|FG000|Treatment Phase|Adverse Event|19|||
105837017|NCT00537017|365058890|FG000|Treatment Phase|Withdrawal by Subject|13|||
105837018|NCT00537017|365058890|FG000|Treatment Phase|Protocol Violation|2|||
105837019|NCT00537017|365058890|FG000|Follow-up Phase|Withdrawal by Subject|9|||
105837020|NCT03257254|365058891|FG000|Overall Study|Withdrawal by Subject|7|||
105837021|NCT03257254|365058891|FG000|Overall Study|Lost to Follow-up|9|||
105837022|NCT03257254|365058891|FG000|Overall Study|Study discontinued by sponsor|5|||
105837023|NCT03234608|365058892|FG000|Overall Study|Lost to Follow-up|23|||
105837024|NCT03234608|365058893|FG001|Overall Study|Lost to Follow-up|21|||
105837025|NCT02329431|365058894|FG000|Overall Study|Lost to Follow-up|20|||
105837026|NCT02329431|365058895|FG001|Overall Study|Lost to Follow-up|13|||
105837027|NCT03168906|365058896|FG000|Overall Study|Lack of Efficacy|6|||
105837028|NCT03168906|365058897|FG001|Overall Study|Lack of Efficacy|6|||
105837029|NCT02219308|365058900|FG000|Overall Study|Withdrawal by Subject|1|||
105837030|NCT02219308|365058901|FG001|Overall Study|Withdrawal by Subject|2|||
105837031|NCT01557582|365058902|FG000|Overall Study|Protocol Violation|4|||
105837032|NCT01557582|365058902|FG000|Overall Study|Operator error|2|||
105837033|NCT03840382|365058903|FG000|Overall Study|Lost to Follow-up|11|||
105837034|NCT03203642|365058905|FG000|Overall Study|Adverse Event|3|||
105837035|NCT03203642|365058906|FG001|Overall Study|Adverse Event|1|||
105837036|NCT03203642|365058905|FG000|Overall Study|Withdrawal by Subject|6|||
105837037|NCT03203642|365058906|FG001|Overall Study|Withdrawal by Subject|6|||
105837038|NCT03203642|365058905|FG000|Overall Study|Lost to Follow-up|2|||
105837039|NCT03203642|365058906|FG001|Overall Study|Lost to Follow-up|1|||
105837040|NCT03203642|365058905|FG000|Overall Study|Termination of the study by sponsor|1|||
105837041|NCT03203642|365058906|FG001|Overall Study|Termination of the study by sponsor|1|||
105837042|NCT03203642|365058905|FG000|Overall Study|Participant moved|0|||
105837043|NCT03203642|365058906|FG001|Overall Study|Participant moved|1|||
105837044|NCT03203642|365058905|FG000|Overall Study|Investigator's decision|3|||
105837045|NCT03203642|365058906|FG001|Overall Study|Investigator's decision|0|||
105837046|NCT03203642|365058905|FG000|Overall Study|Other than above specified|0|||
105837047|NCT03203642|365058906|FG001|Overall Study|Other than above specified|1|||
105837048|NCT02413294|365058907|FG000|Overall Study|Withdrawal by Subject|1|||
105837049|NCT03303417|365060322|FG000|Overall Study|Withdrawal by Subject|1|||
105837050|NCT03303417|365060323|FG001|Overall Study|Withdrawal by Subject|1|||
105837051|NCT00784979|365060334|FG000|Overall Study|incomplete data|6|||
105837052|NCT00631007|365060336|FG000|Overall Study|Adverse Event|0|||
105837053|NCT00631007|365060337|FG001|Overall Study|Adverse Event|2|||
105837054|NCT00631007|365060338|FG002|Overall Study|Adverse Event|0|||
105837055|NCT00631007|365060339|FG003|Overall Study|Adverse Event|2|||
105837056|NCT00631007|365060340|FG004|Overall Study|Adverse Event|3|||
105837057|NCT00631007|365060341|FG005|Overall Study|Adverse Event|2|||
105837058|NCT00631007|365060336|FG000|Overall Study|Lost to Follow-up|2|||
105837059|NCT00631007|365060337|FG001|Overall Study|Lost to Follow-up|1|||
105837060|NCT00631007|365060338|FG002|Overall Study|Lost to Follow-up|2|||
105837061|NCT00631007|365060339|FG003|Overall Study|Lost to Follow-up|4|||
105837062|NCT00631007|365060340|FG004|Overall Study|Lost to Follow-up|5|||
105837063|NCT00631007|365060341|FG005|Overall Study|Lost to Follow-up|3|||
105837064|NCT00631007|365060336|FG000|Overall Study|Physician Decision|1|||
105837065|NCT00631007|365060337|FG001|Overall Study|Physician Decision|0|||
105837066|NCT00631007|365060338|FG002|Overall Study|Physician Decision|1|||
105837067|NCT00631007|365060339|FG003|Overall Study|Physician Decision|0|||
105837068|NCT00631007|365060340|FG004|Overall Study|Physician Decision|0|||
105837069|NCT00631007|365060341|FG005|Overall Study|Physician Decision|2|||
105837070|NCT00631007|365060336|FG000|Overall Study|Persistent Hyperglycemia|2|||
105837071|NCT00631007|365060337|FG001|Overall Study|Persistent Hyperglycemia|2|||
105837072|NCT00631007|365060338|FG002|Overall Study|Persistent Hyperglycemia|5|||
105837073|NCT00631007|365060339|FG003|Overall Study|Persistent Hyperglycemia|1|||
105837074|NCT00631007|365060340|FG004|Overall Study|Persistent Hyperglycemia|2|||
105837075|NCT00631007|365060341|FG005|Overall Study|Persistent Hyperglycemia|5|||
105837076|NCT00631007|365060336|FG000|Overall Study|Withdrawal by Subject|4|||
105837077|NCT00631007|365060337|FG001|Overall Study|Withdrawal by Subject|5|||
105837078|NCT00631007|365060338|FG002|Overall Study|Withdrawal by Subject|2|||
105837079|NCT00631007|365060339|FG003|Overall Study|Withdrawal by Subject|2|||
105837080|NCT00631007|365060340|FG004|Overall Study|Withdrawal by Subject|1|||
105837081|NCT00631007|365060341|FG005|Overall Study|Withdrawal by Subject|3|||
105837082|NCT00631007|365060336|FG000|Overall Study|Other|2|||
105837083|NCT00631007|365060337|FG001|Overall Study|Other|1|||
105837084|NCT00631007|365060338|FG002|Overall Study|Other|0|||
105837085|NCT00631007|365060339|FG003|Overall Study|Other|0|||
105837086|NCT00631007|365060340|FG004|Overall Study|Other|1|||
105837087|NCT00631007|365060341|FG005|Overall Study|Other|0|||
105837088|NCT02674633|365060342|FG000|Overall Study|Lost to Follow-up|3|||
105837089|NCT02674633|365060343|FG001|Overall Study|Lost to Follow-up|2|||
105837090|NCT02674633|365060342|FG000|Overall Study|Physician Decision|1|||
105837091|NCT02674633|365060343|FG001|Overall Study|Physician Decision|0|||
105837092|NCT02674633|365060342|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
105837093|NCT02674633|365060343|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105837094|NCT00683787|365060344|FG000|Overall Study|Progression|3|||
105837095|NCT00683787|365060345|FG001|Overall Study|Progression|3|||
105837096|NCT00683787|365060346|FG002|Overall Study|Progression|0|||
105837097|NCT00683787|365060344|FG000|Overall Study|Adverse Event|0|||
105837098|NCT00683787|365060345|FG001|Overall Study|Adverse Event|0|||
105837099|NCT00683787|365060346|FG002|Overall Study|Adverse Event|2|||
105837100|NCT04167618|365060347|FG000|Overall Study|Trial terminated by sponsor|1|||
105837101|NCT04167618|365060348|FG001|Overall Study|Trial terminated by sponsor|1|||
105837102|NCT00460109|365060349|FG000|Overall Study|Death|1|||
105837103|NCT01363011|365060355|FG000|Main Study|Adverse Event|2|||
105837104|NCT01363011|365060356|FG001|Main Study|Adverse Event|3|||
105837105|NCT01363011|365060355|FG000|Main Study|Investigator's Discretion|1|||
105837106|NCT01363011|365060356|FG001|Main Study|Investigator's Discretion|1|||
105837107|NCT01363011|365060355|FG000|Main Study|Withdrew Consent|1|||
105837108|NCT01363011|365060356|FG001|Main Study|Withdrew Consent|4|||
105837109|NCT01363011|365060355|FG000|Main Study|Protocol Violation|0|||
105837110|NCT01363011|365060356|FG001|Main Study|Protocol Violation|1|||
105837111|NCT01363011|365060355|FG000|Extension Phase|Adverse Event|1|||
105837112|NCT01363011|365060356|FG001|Extension Phase|Adverse Event|1|||
105837113|NCT01363011|365060355|FG000|Extension Phase|Lack of Efficacy|0|||
105837114|NCT01363011|365060356|FG001|Extension Phase|Lack of Efficacy|1|||
105837115|NCT01363011|365060355|FG000|Extension Phase|Investigator's Discretion|2|||
105837116|NCT01363011|365060356|FG001|Extension Phase|Investigator's Discretion|2|||
105837117|NCT01363011|365060355|FG000|Extension Phase|Withdrew Consent|0|||
105837118|NCT01363011|365060356|FG001|Extension Phase|Withdrew Consent|1|||
105837119|NCT01363011|365060355|FG000|Extension Phase|Lost to Follow-up|0|||
105837120|NCT01363011|365060356|FG001|Extension Phase|Lost to Follow-up|2|||
105837121|NCT01363011|365060355|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
105837122|NCT01363011|365060356|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
105837123|NCT00399893|365060357|FG000|Overall Study|Withdrawal by Subject|1|||
105837124|NCT00399893|365060358|FG001|Overall Study|Withdrawal by Subject|0|||
105837125|NCT03653026|365060359|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
105837126|NCT03653026|365060360|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
105837127|NCT03653026|365060361|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
105837128|NCT03653026|365060362|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
105837129|NCT03653026|365060359|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
105837130|NCT03653026|365060360|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
106023338|NCT01120717|365750368|FG001|Overall Study|Adverse Event|6|||
106023339|NCT01120717|365750367|FG000|Overall Study|Protocol Deviation|2|||
106023340|NCT01120717|365750368|FG001|Overall Study|Protocol Deviation|5|||
105837131|NCT03653026|365060361|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105837132|NCT03653026|365060362|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
105837133|NCT03653026|365060359|FG000|Part 1: Placebo-controlled Period|Other|0|||
105837134|NCT03653026|365060360|FG001|Part 1: Placebo-controlled Period|Other|3|||
105837135|NCT03653026|365060361|FG002|Part 1: Placebo-controlled Period|Other|0|||
105837136|NCT03653026|365060362|FG003|Part 1: Placebo-controlled Period|Other|0|||
105837137|NCT03653026|365060359|FG000|Part 2: Open-label Extension|Adverse Event|0|||
105837138|NCT03653026|365060360|FG001|Part 2: Open-label Extension|Adverse Event|0|||
105837139|NCT03653026|365060361|FG002|Part 2: Open-label Extension|Adverse Event|1|||
105837140|NCT03653026|365060362|FG003|Part 2: Open-label Extension|Adverse Event|1|||
105837141|NCT03653026|365060359|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
105837142|NCT03653026|365060360|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
106023341|NCT01120717|365750367|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105837143|NCT03653026|365060361|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
105837144|NCT03653026|365060362|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
105837145|NCT03653026|365060359|FG000|Part 2: Open-label Extension|Other|0|||
105837146|NCT03653026|365060360|FG001|Part 2: Open-label Extension|Other|0|||
105837147|NCT03653026|365060361|FG002|Part 2: Open-label Extension|Other|1|||
105837148|NCT03653026|365060362|FG003|Part 2: Open-label Extension|Other|2|||
105837149|NCT02457819|365060365|FG000|Overall Study|reason not given|8|||
105837150|NCT02457819|365060365|FG000|Overall Study|Withdrawal by Subject|24|||
105837151|NCT02457819|365060365|FG000|Overall Study|Protocol Violation|1|||
105837152|NCT02457819|365060365|FG000|Overall Study|non compliance with study drug|4|||
105837153|NCT02457819|365060365|FG000|Overall Study|Lost to Follow-up|10|||
105837154|NCT02457819|365060365|FG000|Overall Study|Lack of Efficacy|19|||
105837155|NCT02457819|365060365|FG000|Overall Study|Adverse Event|33|||
105837156|NCT03330236|365060366|FG000|Overall Study|Death|2|||
105837157|NCT03330236|365060367|FG001|Overall Study|Death|1|||
105837158|NCT03330236|365060366|FG000|Overall Study|Withdrawal by Subject|2|||
105837159|NCT03330236|365060367|FG001|Overall Study|Withdrawal by Subject|4|||
105837160|NCT03330236|365060366|FG000|Overall Study|Lost to Follow-up|0|||
105837161|NCT03330236|365060367|FG001|Overall Study|Lost to Follow-up|2|||
105837162|NCT03330236|365060366|FG000|Overall Study|Physician Decision|2|||
105837163|NCT03330236|365060367|FG001|Overall Study|Physician Decision|0|||
105837164|NCT03330236|365060366|FG000|Overall Study|Protocol Violation|4|||
105837165|NCT03330236|365060367|FG001|Overall Study|Protocol Violation|3|||
105837166|NCT03330236|365060366|FG000|Overall Study|SedLine malfunction/blinding|19|||
105837167|NCT03330236|365060367|FG001|Overall Study|SedLine malfunction/blinding|14|||
105837168|NCT03330236|365060366|FG000|Overall Study|Volatile anesthetics used|11|||
105837169|NCT03330236|365060367|FG001|Overall Study|Volatile anesthetics used|8|||
105837170|NCT03330236|365060366|FG000|Overall Study|Surgery aborted/converted to open|60|||
105837171|NCT03330236|365060367|FG001|Overall Study|Surgery aborted/converted to open|52|||
105837172|NCT01901848|365060369|FG000|Randomized and Treated|Lost to Follow-up|3|||
105837173|NCT01901848|365060370|FG001|Randomized and Treated|Lost to Follow-up|6|||
105837174|NCT01901848|365060369|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
105837175|NCT01901848|365060370|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
105837176|NCT04823130|365060371|FG000|Overall Study|Withdrawal by Subject|2|||
105837177|NCT04823130|365060372|FG001|Overall Study|Withdrawal by Subject|3|||
105837178|NCT04823130|365060371|FG000|Overall Study|Failure to meet inclusion criteria|6|||
105837179|NCT04823130|365060372|FG001|Overall Study|Failure to meet inclusion criteria|4|||
105837180|NCT04823130|365060371|FG000|Overall Study|Other-unspecified|1|||
105837181|NCT04823130|365060372|FG001|Overall Study|Other-unspecified|0|||
105837182|NCT02488824|365060373|FG000|Overall Study|Adverse Event|1|||
105837183|NCT02488824|365060374|FG001|Overall Study|Adverse Event|1|||
105837184|NCT02356211|365060375|FG000|Overall Study|Withdrawal by Subject|2|||
105837185|NCT02356211|365060376|FG001|Overall Study|Withdrawal by Subject|2|||
105837186|NCT02356211|365060375|FG000|Overall Study|ineligible|1|||
105837187|NCT02356211|365060376|FG001|Overall Study|ineligible|8|||
105837188|NCT02510261|365060379|FG000|Overall Study|Adverse Event|5|||
105837189|NCT02510261|365060380|FG001|Overall Study|Adverse Event|8|||
105837190|NCT02510261|365060381|FG002|Overall Study|Adverse Event|0|||
105837191|NCT02510261|365060379|FG000|Overall Study|Physician Decision|1|||
105837192|NCT02510261|365060380|FG001|Overall Study|Physician Decision|5|||
105837193|NCT02510261|365060381|FG002|Overall Study|Physician Decision|0|||
105837194|NCT02510261|365060379|FG000|Overall Study|Death|19|||
105837195|NCT02510261|365060380|FG001|Overall Study|Death|19|||
105837196|NCT02510261|365060381|FG002|Overall Study|Death|0|||
105837197|NCT02510261|365060379|FG000|Overall Study|Withdrawal by Subject|3|||
105837198|NCT02510261|365060380|FG001|Overall Study|Withdrawal by Subject|10|||
105837199|NCT02510261|365060381|FG002|Overall Study|Withdrawal by Subject|3|||
106023342|NCT01120717|365750368|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
106023343|NCT01120717|365750367|FG000|Overall Study|Lost to Follow-up|2|||
106023344|NCT01120717|365750368|FG001|Overall Study|Lost to Follow-up|3|||
106023345|NCT01120717|365750367|FG000|Overall Study|Death|3|||
106023346|NCT01120717|365750368|FG001|Overall Study|Death|1|||
106023347|NCT01120717|365750367|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
106023348|NCT01120717|365750368|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
105837200|NCT00108082|365060382|FG000|Overall Study|Adverse Event|14|||
105837201|NCT00108082|365060383|FG001|Overall Study|Adverse Event|12|||
105837202|NCT00108082|365060384|FG002|Overall Study|Adverse Event|17|||
105837203|NCT00108082|365060382|FG000|Overall Study|Lost to Follow-up|6|||
105837204|NCT00108082|365060383|FG001|Overall Study|Lost to Follow-up|3|||
105837205|NCT00108082|365060384|FG002|Overall Study|Lost to Follow-up|7|||
105837206|NCT00108082|365060382|FG000|Overall Study|Consent Withdrawn|3|||
105837207|NCT00108082|365060383|FG001|Overall Study|Consent Withdrawn|3|||
106023349|NCT04535453|365750369|FG000|Overall Study|Death|0|||
106023350|NCT04535453|365750370|FG001|Overall Study|Death|1|||
106023351|NCT04535453|365750371|FG002|Overall Study|Death|0|||
106023352|NCT04535453|365750372|FG003|Overall Study|Death|0|||
105837208|NCT00108082|365060384|FG002|Overall Study|Consent Withdrawn|5|||
105837209|NCT00108082|365060382|FG000|Overall Study|Protocol Violation|1|||
106023353|NCT04535453|365750373|FG004|Overall Study|Death|0|||
106023354|NCT04535453|365750374|FG005|Overall Study|Death|0|||
106023355|NCT04535453|365750375|FG006|Overall Study|Death|0|||
106023356|NCT04535453|365750376|FG007|Overall Study|Death|0|||
106023357|NCT04535453|365750377|FG008|Overall Study|Death|0|||
106023358|NCT04535453|365750378|FG009|Overall Study|Death|0|||
106023359|NCT04535453|365750379|FG010|Overall Study|Death|0|||
106023360|NCT04535453|365750380|FG011|Overall Study|Death|0|||
106023361|NCT04535453|365750369|FG000|Overall Study|Lost to Follow-up|1|||
106023362|NCT04535453|365750370|FG001|Overall Study|Lost to Follow-up|1|||
106023363|NCT04535453|365750371|FG002|Overall Study|Lost to Follow-up|1|||
106023364|NCT04535453|365750372|FG003|Overall Study|Lost to Follow-up|0|||
106023365|NCT04535453|365750373|FG004|Overall Study|Lost to Follow-up|3|||
106023366|NCT04535453|365750374|FG005|Overall Study|Lost to Follow-up|1|||
106023367|NCT04535453|365750375|FG006|Overall Study|Lost to Follow-up|0|||
106023368|NCT04535453|365750376|FG007|Overall Study|Lost to Follow-up|0|||
106023369|NCT04535453|365750377|FG008|Overall Study|Lost to Follow-up|1|||
106023370|NCT04535453|365750378|FG009|Overall Study|Lost to Follow-up|1|||
106023371|NCT04535453|365750379|FG010|Overall Study|Lost to Follow-up|0|||
106023372|NCT04535453|365750380|FG011|Overall Study|Lost to Follow-up|0|||
106023373|NCT04535453|365750369|FG000|Overall Study|Physician Decision|0|||
106023374|NCT04535453|365750370|FG001|Overall Study|Physician Decision|0|||
106023375|NCT04535453|365750371|FG002|Overall Study|Physician Decision|0|||
106023376|NCT04535453|365750372|FG003|Overall Study|Physician Decision|1|||
106023377|NCT04535453|365750373|FG004|Overall Study|Physician Decision|0|||
106023378|NCT04535453|365750374|FG005|Overall Study|Physician Decision|0|||
106023379|NCT04535453|365750375|FG006|Overall Study|Physician Decision|0|||
106023380|NCT04535453|365750376|FG007|Overall Study|Physician Decision|0|||
106023381|NCT04535453|365750377|FG008|Overall Study|Physician Decision|0|||
106023382|NCT04535453|365750378|FG009|Overall Study|Physician Decision|0|||
106023383|NCT04535453|365750379|FG010|Overall Study|Physician Decision|0|||
106023384|NCT04535453|365750380|FG011|Overall Study|Physician Decision|0|||
106023385|NCT04535453|365750369|FG000|Overall Study|Withdrawal by Subject|3|||
106023386|NCT04535453|365750370|FG001|Overall Study|Withdrawal by Subject|6|||
106023387|NCT04535453|365750371|FG002|Overall Study|Withdrawal by Subject|3|||
106023388|NCT04535453|365750372|FG003|Overall Study|Withdrawal by Subject|3|||
106023389|NCT04535453|365750373|FG004|Overall Study|Withdrawal by Subject|2|||
106023390|NCT04535453|365750374|FG005|Overall Study|Withdrawal by Subject|1|||
106023391|NCT04535453|365750375|FG006|Overall Study|Withdrawal by Subject|1|||
106023392|NCT04535453|365750376|FG007|Overall Study|Withdrawal by Subject|1|||
106023393|NCT04535453|365750377|FG008|Overall Study|Withdrawal by Subject|1|||
106023394|NCT04535453|365750378|FG009|Overall Study|Withdrawal by Subject|1|||
105837210|NCT00108082|365060383|FG001|Overall Study|Protocol Violation|2|||
105837211|NCT00108082|365060384|FG002|Overall Study|Protocol Violation|0|||
105837212|NCT00108082|365060382|FG000|Overall Study|Lack of Efficacy|3|||
105837213|NCT00108082|365060383|FG001|Overall Study|Lack of Efficacy|1|||
105837214|NCT00108082|365060384|FG002|Overall Study|Lack of Efficacy|2|||
105837215|NCT00108082|365060382|FG000|Overall Study|Amendment 4: > Month 12|5|||
105837216|NCT00108082|365060383|FG001|Overall Study|Amendment 4: > Month 12|7|||
105837217|NCT00108082|365060384|FG002|Overall Study|Amendment 4: > Month 12|5|||
105837218|NCT00108082|365060382|FG000|Overall Study|Woman of Child-bearing Potential|2|||
105837219|NCT00108082|365060383|FG001|Overall Study|Woman of Child-bearing Potential|0|||
105837220|NCT00108082|365060384|FG002|Overall Study|Woman of Child-bearing Potential|2|||
105837221|NCT00108082|365060382|FG000|Overall Study|Incorrectly Randomized|0|||
106023395|NCT04535453|365750379|FG010|Overall Study|Withdrawal by Subject|0|||
106023396|NCT04535453|365750380|FG011|Overall Study|Withdrawal by Subject|1|||
106023397|NCT04535453|365750369|FG000|Overall Study|Other|0|||
106023398|NCT04535453|365750370|FG001|Overall Study|Other|0|||
106023399|NCT04535453|365750371|FG002|Overall Study|Other|1|||
106023400|NCT04535453|365750372|FG003|Overall Study|Other|0|||
106023401|NCT04535453|365750373|FG004|Overall Study|Other|1|||
105837222|NCT00108082|365060383|FG001|Overall Study|Incorrectly Randomized|0|||
105837223|NCT00108082|365060384|FG002|Overall Study|Incorrectly Randomized|2|||
105837224|NCT00108082|365060382|FG000|Overall Study|Non-compliance|1|||
105837225|NCT00108082|365060383|FG001|Overall Study|Non-compliance|0|||
105837226|NCT00108082|365060384|FG002|Overall Study|Non-compliance|2|||
105837227|NCT00108082|365060382|FG000|Overall Study|Stopped Study Medication|0|||
105837228|NCT00108082|365060383|FG001|Overall Study|Stopped Study Medication|0|||
105837229|NCT00108082|365060384|FG002|Overall Study|Stopped Study Medication|1|||
105837230|NCT00108082|365060382|FG000|Overall Study|Site Closed Study|0|||
105837231|NCT00108082|365060383|FG001|Overall Study|Site Closed Study|2|||
105837232|NCT00108082|365060384|FG002|Overall Study|Site Closed Study|0|||
105837233|NCT00108082|365060382|FG000|Overall Study|Protocol Amendment|0|||
105837234|NCT00108082|365060383|FG001|Overall Study|Protocol Amendment|1|||
105837235|NCT00108082|365060384|FG002|Overall Study|Protocol Amendment|0|||
105837236|NCT00108082|365060382|FG000|Overall Study|Study Medication Not Tapered|0|||
105837237|NCT00108082|365060383|FG001|Overall Study|Study Medication Not Tapered|1|||
106023402|NCT04535453|365750374|FG005|Overall Study|Other|0|||
106023403|NCT04535453|365750375|FG006|Overall Study|Other|1|||
106023404|NCT04535453|365750376|FG007|Overall Study|Other|1|||
105837238|NCT00108082|365060384|FG002|Overall Study|Study Medication Not Tapered|0|||
105837239|NCT00108082|365060382|FG000|Overall Study|Subject Left Site Location|1|||
105837240|NCT00108082|365060383|FG001|Overall Study|Subject Left Site Location|0|||
105837241|NCT00108082|365060384|FG002|Overall Study|Subject Left Site Location|0|||
105837242|NCT00108082|365060382|FG000|Overall Study|Investigator Not at Site|1|||
105837243|NCT00108082|365060383|FG001|Overall Study|Investigator Not at Site|0|||
105837244|NCT00108082|365060384|FG002|Overall Study|Investigator Not at Site|0|||
105837245|NCT00108082|365060382|FG000|Overall Study|Blood Pressure Not Controlled|1|||
105837246|NCT00108082|365060383|FG001|Overall Study|Blood Pressure Not Controlled|0|||
105837247|NCT00108082|365060384|FG002|Overall Study|Blood Pressure Not Controlled|0|||
105837248|NCT01270620|365060386|FG000|Overall Study|Withdrawal by Subject|1|||
105837249|NCT01270620|365060387|FG001|Overall Study|Withdrawal by Subject|3|||
105965874|NCT01866111|365533825|FG001|Open-label Extension Study YKP3089C017|Death|1|||
105965875|NCT01866111|365533826|FG002|Open-label Extension Study YKP3089C017|Death|3|||
105965876|NCT01866111|365533827|FG003|Open-label Extension Study YKP3089C017|Death|2|||
105965877|NCT01866111|365533824|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
105965878|NCT01866111|365533825|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
105965879|NCT01866111|365533826|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
105965880|NCT01866111|365533827|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
105965881|NCT01866111|365533824|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
105965882|NCT01866111|365533825|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
105965883|NCT01866111|365533826|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
105965884|NCT01866111|365533827|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
105965885|NCT01866111|365533824|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
105965886|NCT01866111|365533825|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
105965887|NCT01866111|365533826|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
105965888|NCT01866111|365533827|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
105965889|NCT03268954|365533828|FG000|Overall Study|Ongoing|23|||
105965890|NCT03268954|365533829|FG001|Overall Study|Ongoing|31|||
105965891|NCT03268954|365533828|FG000|Overall Study|Adverse Event|53|||
105965892|NCT03268954|365533829|FG001|Overall Study|Adverse Event|62|||
105965893|NCT03268954|365533828|FG000|Overall Study|Withdrawal by Subject|25|||
105965894|NCT03268954|365533829|FG001|Overall Study|Withdrawal by Subject|16|||
105965895|NCT03268954|365533828|FG000|Overall Study|Progressive Disease|61|||
105965896|NCT03268954|365533829|FG001|Overall Study|Progressive Disease|48|||
105965897|NCT03268954|365533828|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
105965898|NCT03268954|365533829|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
105965899|NCT03268954|365533828|FG000|Overall Study|Reason not Specified|40|||
105965900|NCT03268954|365533829|FG001|Overall Study|Reason not Specified|40|||
105965901|NCT02684058|365533830|FG000|Treatment Period|Progressive disease|4|||
105965902|NCT02684058|365533831|FG001|Treatment Period|Progressive disease|10|||
105965903|NCT02684058|365533832|FG002|Treatment Period|Progressive disease|19|||
105965904|NCT02684058|365533830|FG000|Treatment Period|Adverse Event|3|||
105965905|NCT02684058|365533831|FG001|Treatment Period|Adverse Event|8|||
105965906|NCT02684058|365533832|FG002|Treatment Period|Adverse Event|1|||
105965907|NCT02684058|365533830|FG000|Treatment Period|Physician Decision|5|||
105965908|NCT02684058|365533831|FG001|Treatment Period|Physician Decision|1|||
105965909|NCT02684058|365533832|FG002|Treatment Period|Physician Decision|2|||
105965910|NCT02684058|365533830|FG000|Treatment Period|New therapy for study indication|1|||
105965911|NCT02684058|365533831|FG001|Treatment Period|New therapy for study indication|0|||
105965912|NCT02684058|365533832|FG002|Treatment Period|New therapy for study indication|0|||
105965913|NCT02684058|365533830|FG000|Treatment Period|Protocol deviation|0|||
105965914|NCT02684058|365533831|FG001|Treatment Period|Protocol deviation|1|||
105965915|NCT02684058|365533832|FG002|Treatment Period|Protocol deviation|0|||
105965916|NCT02684058|365533830|FG000|Treatment Period|Subject/guardian decision|4|||
105965917|NCT02684058|365533831|FG001|Treatment Period|Subject/guardian decision|3|||
105965918|NCT02684058|365533832|FG002|Treatment Period|Subject/guardian decision|0|||
105965919|NCT02684058|365533830|FG000|Treatment Period|Death|0|||
105965920|NCT02684058|365533831|FG001|Treatment Period|Death|0|||
105965921|NCT02684058|365533832|FG002|Treatment Period|Death|2|||
106023405|NCT04535453|365750377|FG008|Overall Study|Other|1|||
106023406|NCT04535453|365750378|FG009|Overall Study|Other|0|||
106023407|NCT04535453|365750379|FG010|Overall Study|Other|0|||
106023408|NCT04535453|365750380|FG011|Overall Study|Other|0|||
106023409|NCT01387542|365750381|FG000|Overall Study|Adverse Event|3|||
106023410|NCT01387542|365750381|FG000|Overall Study|Withdrawal by Subject|1|||
106023411|NCT01387542|365750381|FG000|Overall Study|Changed diagnosis|1|||
105965922|NCT02684058|365533830|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105965923|NCT02684058|365533831|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
106023412|NCT01387542|365750381|FG000|Overall Study|Insufficient response|1|||
105837250|NCT00848042|365060400|FG000|Overall Study|Death|1|||
105837251|NCT00848042|365060401|FG001|Overall Study|Death|2|||
105837252|NCT00848042|365060402|FG002|Overall Study|Death|0|||
105837253|NCT00848042|365060400|FG000|Overall Study|Other Therapy|3|||
105837254|NCT00848042|365060401|FG001|Overall Study|Other Therapy|0|||
105837255|NCT00848042|365060402|FG002|Overall Study|Other Therapy|0|||
105837256|NCT01049412|365060404|FG000|Period I|Withdrawal by Subject|4|||
105837257|NCT01049412|365060405|FG001|Period I|Withdrawal by Subject|6|||
105837258|NCT01049412|365060404|FG000|Period I|Lost to Follow-up|2|||
105837259|NCT01049412|365060405|FG001|Period I|Lost to Follow-up|2|||
105837260|NCT01049412|365060404|FG000|Period I|Physician Decision|0|||
105837261|NCT01049412|365060405|FG001|Period I|Physician Decision|3|||
105837262|NCT01049412|365060404|FG000|Period I|Protocol Violation|1|||
105837263|NCT01049412|365060405|FG001|Period I|Protocol Violation|2|||
105837264|NCT01049412|365060404|FG000|Period I|Adverse Event|1|||
105837265|NCT01049412|365060405|FG001|Period I|Adverse Event|0|||
105837266|NCT01049412|365060404|FG000|Period II|Withdrawal by Subject|2|||
105837267|NCT01049412|365060405|FG001|Period II|Withdrawal by Subject|3|||
105837268|NCT01049412|365060404|FG000|Period II|Adverse Event|1|||
105837269|NCT01049412|365060405|FG001|Period II|Adverse Event|0|||
105837270|NCT01049412|365060404|FG000|Period II|Lost to Follow-up|1|||
105837271|NCT01049412|365060405|FG001|Period II|Lost to Follow-up|0|||
105837272|NCT00112294|365060406|FG000|Overall Study|Still on study|5|||
105837273|NCT00112294|365060407|FG001|Overall Study|Still on study|0|||
105837274|NCT05966090|365060408|FG000|Overall Study|Lost to Follow-up|6|||
105837275|NCT05966090|365060409|FG001|Overall Study|Lost to Follow-up|6|||
105837276|NCT05966090|365060408|FG000|Overall Study|Adverse Event|1|||
105837277|NCT05966090|365060409|FG001|Overall Study|Adverse Event|1|||
105837278|NCT05966090|365060408|FG000|Overall Study|Withdrawal by Subject|1|||
105837279|NCT05966090|365060409|FG001|Overall Study|Withdrawal by Subject|1|||
105965924|NCT02684058|365533832|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
105965925|NCT02684058|365533830|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
105965926|NCT02684058|365533831|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
105965927|NCT02684058|365533832|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
105965928|NCT02684058|365533830|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
105965929|NCT02684058|365533831|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
105965930|NCT02684058|365533832|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
105965931|NCT02684058|365533830|FG000|Post-treatment Efficacy Follow-up|Death|0|||
105965932|NCT02684058|365533831|FG001|Post-treatment Efficacy Follow-up|Death|0|||
105965933|NCT02684058|365533832|FG002|Post-treatment Efficacy Follow-up|Death|3|||
105965934|NCT02684058|365533830|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
105965935|NCT02684058|365533831|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
105965936|NCT02684058|365533832|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
105965937|NCT02684058|365533830|FG000|Post-treatment Survival Follow-up|Death|0|||
105965938|NCT02684058|365533831|FG001|Post-treatment Survival Follow-up|Death|0|||
105965939|NCT02684058|365533832|FG002|Post-treatment Survival Follow-up|Death|7|||
105965940|NCT02684058|365533830|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
105965941|NCT02684058|365533831|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
105965942|NCT02684058|365533832|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
105965943|NCT02684058|365533830|FG000|Crossover Treatment Period|Progressive disease|0|||
105965944|NCT02684058|365533831|FG001|Crossover Treatment Period|Progressive disease|1|||
105965945|NCT02684058|365533832|FG002|Crossover Treatment Period|Progressive disease|0|||
105965946|NCT02524275|365533833|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
105965947|NCT04283994|365533845|FG000|Overall Study|Death|11|||
105965948|NCT04283994|365533846|FG001|Overall Study|Death|20|||
105965949|NCT04283994|365533847|FG002|Overall Study|Death|11|||
105965950|NCT04283994|365533848|FG003|Overall Study|Death|0|||
105965951|NCT04283994|365533849|FG004|Overall Study|Death|0|||
105965952|NCT04283994|365533850|FG005|Overall Study|Death|0|||
105965953|NCT04283994|365533851|FG006|Overall Study|Death|0|||
105965954|NCT04283994|365533845|FG000|Overall Study|Withdrawal by Subject|16|||
105965955|NCT04283994|365533846|FG001|Overall Study|Withdrawal by Subject|4|||
105965956|NCT04283994|365533847|FG002|Overall Study|Withdrawal by Subject|6|||
105965957|NCT04283994|365533848|FG003|Overall Study|Withdrawal by Subject|1|||
105965958|NCT04283994|365533849|FG004|Overall Study|Withdrawal by Subject|0|||
105965959|NCT04283994|365533850|FG005|Overall Study|Withdrawal by Subject|1|||
105965960|NCT04283994|365533851|FG006|Overall Study|Withdrawal by Subject|0|||
105965961|NCT00211757|365533852|FG000|Overall Study|Withdrawal by Subject|1|||
105965962|NCT00211757|365533853|FG001|Overall Study|Withdrawal by Subject|1|||
105837280|NCT05966090|365060408|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105837281|NCT05966090|365060409|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
105837282|NCT05966090|365060408|FG000|Overall Study|Other|1|||
105837283|NCT05966090|365060409|FG001|Overall Study|Other|1|||
105837284|NCT01142908|365060410|FG000|Overall Study|Lost to Follow-up|19|||
105965963|NCT00211757|365533852|FG000|Overall Study|Lack of Efficacy|0|||
105965964|NCT00211757|365533853|FG001|Overall Study|Lack of Efficacy|1|||
105965965|NCT03479541|365533857|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
105837285|NCT01142908|365060411|FG001|Overall Study|Lost to Follow-up|13|||
106023413|NCT01387542|365750381|FG000|Overall Study|Non-compliant|1|||
106023414|NCT01387542|365750381|FG000|Overall Study|Lost to Follow-up|1|||
106023415|NCT00335764|365750383|FG000|Overall Study|wrong histology|1|||
106023416|NCT00335764|365750384|FG001|Overall Study|wrong histology|0|||
106149289|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
106149290|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
106149291|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
106149292|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
106149293|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
106149294|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
106149295|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
106149296|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
106149297|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
106149298|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
106149299|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
106149300|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
106149301|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
106149302|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
106149303|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105837286|NCT01142908|365060410|FG000|Overall Study|Death|1|||
105837287|NCT01142908|365060411|FG001|Overall Study|Death|4|||
105837288|NCT01142908|365060410|FG000|Overall Study|Excluded - did not meet criteria|9|||
105837289|NCT01142908|365060411|FG001|Overall Study|Excluded - did not meet criteria|5|||
105837290|NCT01142908|365060410|FG000|Overall Study|Withdrawal by Subject|3|||
105837291|NCT01142908|365060411|FG001|Overall Study|Withdrawal by Subject|0|||
106023417|NCT00335764|365750385|FG002|Overall Study|wrong histology|0|||
106023418|NCT00335764|365750386|FG003|Overall Study|wrong histology|0|||
106023419|NCT00335764|365750387|FG004|Overall Study|wrong histology|1|||
106023420|NCT05661851|365750389|FG000|Overall Study|Protocol Violation|1|||
106023421|NCT05661851|365750390|FG001|Overall Study|Protocol Violation|1|||
106023422|NCT05661851|365750389|FG000|Overall Study|Covid-19 Related|3|||
106023423|NCT05661851|365750390|FG001|Overall Study|Covid-19 Related|4|||
106023424|NCT05661851|365750389|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
106023425|NCT05661851|365750390|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
106023426|NCT05661851|365750389|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
106023427|NCT05661851|365750390|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
106023428|NCT00145977|365750391|FG000|Overall Study|Lack of Efficacy|0|||
106023429|NCT00145977|365750392|FG001|Overall Study|Lack of Efficacy|4|||
106023430|NCT00145977|365750391|FG000|Overall Study|Lost to Follow-up|1|||
106023431|NCT00145977|365750392|FG001|Overall Study|Lost to Follow-up|0|||
106023432|NCT00145977|365750391|FG000|Overall Study|Withdrawal by Subject|1|||
106023433|NCT00145977|365750392|FG001|Overall Study|Withdrawal by Subject|0|||
106023434|NCT00782834|365750396|FG000|Treatment Phase|fibrous tumor not GIST|1|||
106023435|NCT04629066|365750398|FG000|Overall Study|Lost to Follow-up|3|||
106023436|NCT04629066|365750399|FG001|Overall Study|Lost to Follow-up|2|||
106023437|NCT01497366|365750400|FG000|Overall Study|Virologic failure|2|||
106023438|NCT01497366|365750401|FG001|Overall Study|Virologic failure|50|||
106023439|NCT01497366|365750400|FG000|Overall Study|Lost to Follow-up|11|||
105837292|NCT00035555|365060416|FG000|Overall Study|Adverse Event|5|||
105837293|NCT00035555|365060417|FG001|Overall Study|Adverse Event|8|||
105837294|NCT00035555|365060418|FG002|Overall Study|Adverse Event|9|||
105837295|NCT00035555|365060416|FG000|Overall Study|Allograft loss|1|||
105837296|NCT00035555|365060417|FG001|Overall Study|Allograft loss|1|||
105837297|NCT00035555|365060418|FG002|Overall Study|Allograft loss|2|||
105837298|NCT00035555|365060416|FG000|Overall Study|Death|0|||
105837299|NCT00035555|365060417|FG001|Overall Study|Death|0|||
105837300|NCT00035555|365060418|FG002|Overall Study|Death|2|||
105837301|NCT00035555|365060416|FG000|Overall Study|Lost to Follow-up|0|||
105837302|NCT00035555|365060417|FG001|Overall Study|Lost to Follow-up|0|||
105837303|NCT00035555|365060418|FG002|Overall Study|Lost to Follow-up|1|||
105837304|NCT00035555|365060416|FG000|Overall Study|Noncompliance|0|||
106023440|NCT01497366|365750401|FG001|Overall Study|Lost to Follow-up|10|||
106023441|NCT01497366|365750400|FG000|Overall Study|Withdrawal by Subject|6|||
106023442|NCT01497366|365750401|FG001|Overall Study|Withdrawal by Subject|6|||
106023443|NCT01497366|365750400|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
106023444|NCT01497366|365750401|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
105837305|NCT00035555|365060417|FG001|Overall Study|Noncompliance|1|||
105837306|NCT00035555|365060418|FG002|Overall Study|Noncompliance|1|||
105837307|NCT00035555|365060416|FG000|Overall Study|Prohibited medication|1|||
106023445|NCT01497366|365750400|FG000|Overall Study|Other|5|||
105837308|NCT00035555|365060417|FG001|Overall Study|Prohibited medication|1|||
105837309|NCT00035555|365060418|FG002|Overall Study|Prohibited medication|0|||
105837310|NCT00035555|365060416|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
105837311|NCT00035555|365060417|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
105837312|NCT00035555|365060418|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
105837313|NCT00035555|365060416|FG000|Overall Study|Withdrawal by Subject|2|||
105837314|NCT00035555|365060417|FG001|Overall Study|Withdrawal by Subject|0|||
105837315|NCT00035555|365060418|FG002|Overall Study|Withdrawal by Subject|2|||
105837316|NCT00035555|365060416|FG000|Overall Study|Investigator deemed not a good candidate|0|||
105837317|NCT00035555|365060417|FG001|Overall Study|Investigator deemed not a good candidate|0|||
105837318|NCT00035555|365060418|FG002|Overall Study|Investigator deemed not a good candidate|1|||
105837319|NCT00035555|365060416|FG000|Overall Study|Received cyclosporin in error|0|||
105837320|NCT00035555|365060417|FG001|Overall Study|Received cyclosporin in error|0|||
105837321|NCT00035555|365060418|FG002|Overall Study|Received cyclosporin in error|1|||
105837322|NCT00309985|365060427|FG000|Overall Study|Disease progression|12|||
105837323|NCT00309985|365060428|FG001|Overall Study|Disease progression|0|||
105837324|NCT00309985|365060427|FG000|Overall Study|Adverse Event|30|||
105837325|NCT00309985|365060428|FG001|Overall Study|Adverse Event|0|||
105837326|NCT00309985|365060427|FG000|Overall Study|Death|2|||
105837327|NCT00309985|365060428|FG001|Overall Study|Death|0|||
105837328|NCT00309985|365060427|FG000|Overall Study|Withdrawal by Subject|5|||
105837329|NCT00309985|365060428|FG001|Overall Study|Withdrawal by Subject|1|||
105837330|NCT00309985|365060427|FG000|Overall Study|Physician Decision|3|||
105837331|NCT00309985|365060428|FG001|Overall Study|Physician Decision|0|||
105837332|NCT00309985|365060427|FG000|Overall Study|Never started treatment|7|||
105837333|NCT00309985|365060428|FG001|Overall Study|Never started treatment|0|||
105837334|NCT00309985|365060427|FG000|Overall Study|Complicating disease|1|||
105837335|NCT00309985|365060428|FG001|Overall Study|Complicating disease|0|||
105837336|NCT00309985|365060427|FG000|Overall Study|Non-compliance|1|||
105837337|NCT00309985|365060428|FG001|Overall Study|Non-compliance|0|||
105837338|NCT00309985|365060427|FG000|Overall Study|Chemotherapy discontinued only|1|||
105837339|NCT00309985|365060428|FG001|Overall Study|Chemotherapy discontinued only|0|||
105837340|NCT04205162|365060439|FG000|Overall Study|Lost to Follow-up|1|||
105837341|NCT04205162|365060440|FG001|Overall Study|Lost to Follow-up|0|||
105837342|NCT04205162|365060439|FG000|Overall Study|Withdrawal by Subject|2|||
105837343|NCT04205162|365060440|FG001|Overall Study|Withdrawal by Subject|0|||
105837344|NCT04205162|365060439|FG000|Overall Study|University closure due to COVID-19|1|||
105837345|NCT04205162|365060440|FG001|Overall Study|University closure due to COVID-19|0|||
105837346|NCT01011556|365060444|FG000|Overall Study|Adverse Event|1|||
105837347|NCT01011556|365060445|FG001|Overall Study|Adverse Event|3|||
105837348|NCT01011556|365060446|FG002|Overall Study|Adverse Event|2|||
105837349|NCT01011556|365060447|FG003|Overall Study|Adverse Event|1|||
105837350|NCT01011556|365060444|FG000|Overall Study|Lost to Follow-up|1|||
105837351|NCT01011556|365060445|FG001|Overall Study|Lost to Follow-up|0|||
105837352|NCT01011556|365060446|FG002|Overall Study|Lost to Follow-up|0|||
105837353|NCT01011556|365060447|FG003|Overall Study|Lost to Follow-up|0|||
105837354|NCT01011556|365060444|FG000|Overall Study|Physician Decision|1|||
105837355|NCT01011556|365060445|FG001|Overall Study|Physician Decision|0|||
105837356|NCT01011556|365060446|FG002|Overall Study|Physician Decision|0|||
105837357|NCT01011556|365060447|FG003|Overall Study|Physician Decision|1|||
105837358|NCT01011556|365060444|FG000|Overall Study|Protocol Violation|0|||
105837359|NCT01011556|365060445|FG001|Overall Study|Protocol Violation|1|||
105837360|NCT01011556|365060446|FG002|Overall Study|Protocol Violation|0|||
105837361|NCT01011556|365060447|FG003|Overall Study|Protocol Violation|0|||
105837362|NCT01011556|365060444|FG000|Overall Study|Withdrawal by Subject|1|||
105837363|NCT01011556|365060445|FG001|Overall Study|Withdrawal by Subject|2|||
105837364|NCT01011556|365060446|FG002|Overall Study|Withdrawal by Subject|4|||
105837365|NCT01011556|365060447|FG003|Overall Study|Withdrawal by Subject|4|||
105837366|NCT01011556|365060444|FG000|Overall Study|Sponsor decision|0|||
105837367|NCT01011556|365060445|FG001|Overall Study|Sponsor decision|1|||
105837368|NCT01011556|365060446|FG002|Overall Study|Sponsor decision|1|||
105837369|NCT01011556|365060447|FG003|Overall Study|Sponsor decision|2|||
105837370|NCT01011556|365060444|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
105837371|NCT01011556|365060445|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
105837372|NCT01011556|365060446|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
105837373|NCT01011556|365060447|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
105837374|NCT01098110|365060451|FG000|Overall Study|Withdrawal by Subject|14|||
105837375|NCT01098110|365060452|FG001|Overall Study|Withdrawal by Subject|24|||
105837376|NCT01098110|365060453|FG002|Overall Study|Withdrawal by Subject|19|||
105837377|NCT01098110|365060451|FG000|Overall Study|Adverse Event|30|||
105837378|NCT01098110|365060452|FG001|Overall Study|Adverse Event|32|||
105837379|NCT01098110|365060453|FG002|Overall Study|Adverse Event|43|||
105837380|NCT01098110|365060451|FG000|Overall Study|Lack of Efficacy|13|||
105837381|NCT01098110|365060452|FG001|Overall Study|Lack of Efficacy|9|||
105837382|NCT01098110|365060453|FG002|Overall Study|Lack of Efficacy|27|||
105837383|NCT01098110|365060451|FG000|Overall Study|Other|4|||
105837384|NCT01098110|365060452|FG001|Overall Study|Other|7|||
105837385|NCT01098110|365060453|FG002|Overall Study|Other|5|||
105837386|NCT01098110|365060451|FG000|Overall Study|Untreated|1|||
105837387|NCT01098110|365060452|FG001|Overall Study|Untreated|1|||
105837388|NCT01098110|365060453|FG002|Overall Study|Untreated|0|||
105837389|NCT02147587|365060454|FG000|Overall Study|Adverse Event|9|||
105837390|NCT02147587|365060455|FG001|Overall Study|Adverse Event|4|||
105837391|NCT02147587|365060454|FG000|Overall Study|Lack of Efficacy|2|||
105837392|NCT02147587|365060455|FG001|Overall Study|Lack of Efficacy|1|||
105837393|NCT01355302|365060456|FG000|Phase 1b|Death|4|||
105837394|NCT01355302|365060457|FG001|Phase 1b|Death|0|||
105837395|NCT01355302|365060458|FG002|Phase 1b|Death|0|||
105837396|NCT01355302|365060456|FG000|Phase 1b|Study terminated by sponsor|2|||
105837397|NCT01355302|365060457|FG001|Phase 1b|Study terminated by sponsor|0|||
105837398|NCT01355302|365060458|FG002|Phase 1b|Study terminated by sponsor|0|||
105837399|NCT00779402|365060459|FG000|Treatment Phase 1|Disease Progression|1|||
105837400|NCT00779402|365060460|FG001|Treatment Phase 1|Disease Progression|0|||
105837401|NCT00779402|365060459|FG000|Treatment Phase 1|Adverse Event|2|||
105837402|NCT00779402|365060460|FG001|Treatment Phase 1|Adverse Event|0|||
105837403|NCT00779402|365060459|FG000|Treatment Phase 1|Protocol Violation|1|||
105837404|NCT00779402|365060460|FG001|Treatment Phase 1|Protocol Violation|0|||
105837405|NCT00779402|365060459|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
105837406|NCT00779402|365060460|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
105837407|NCT00779402|365060459|FG000|Treatment Phase 1|Lost to Follow-up|0|||
105837408|NCT00779402|365060460|FG001|Treatment Phase 1|Lost to Follow-up|1|||
105837409|NCT00779402|365060459|FG000|Treatment Phase 1|Death|0|||
105837410|NCT00779402|365060460|FG001|Treatment Phase 1|Death|1|||
105965966|NCT03479541|365533858|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
105965967|NCT03479541|365533859|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
105965968|NCT03479541|365533860|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
105965969|NCT03479541|365533857|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
105965970|NCT03479541|365533858|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
105965971|NCT03479541|365533859|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
105965972|NCT03479541|365533860|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
105965973|NCT03479541|365533857|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
105965974|NCT03479541|365533858|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
105965975|NCT03479541|365533859|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
105965976|NCT03479541|365533860|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
105965977|NCT03479541|365533857|FG000|Home Monitoring|Lost to Follow-up|0|||
105965978|NCT03479541|365533858|FG001|Home Monitoring|Lost to Follow-up|0|||
105837411|NCT00779402|365060459|FG000|Treatment Phase 1|Intercurrent Illness|1|||
105837412|NCT00779402|365060460|FG001|Treatment Phase 1|Intercurrent Illness|1|||
105837413|NCT00779402|365060459|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
105837414|NCT00779402|365060460|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
105837415|NCT00779402|365060459|FG000|Treatment Phase 1|Other|4|||
105837416|NCT00779402|365060460|FG001|Treatment Phase 1|Other|2|||
105837417|NCT00779402|365060459|FG000|Treatment Phase 1|Closure of Study|3|||
105837418|NCT00779402|365060460|FG001|Treatment Phase 1|Closure of Study|2|||
105837419|NCT00779402|365060459|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
105837420|NCT00779402|365060460|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
105837421|NCT00779402|365060459|FG000|Surveillance Phase|Protocol Violation|0|||
105837422|NCT00779402|365060460|FG001|Surveillance Phase|Protocol Violation|1|||
105837423|NCT00779402|365060459|FG000|Surveillance Phase|Patient refused to continue|22|||
105837424|NCT00779402|365060460|FG001|Surveillance Phase|Patient refused to continue|14|||
105965979|NCT03479541|365533859|FG002|Home Monitoring|Lost to Follow-up|8|||
105837425|NCT00779402|365060459|FG000|Surveillance Phase|Lost to Follow-up|2|||
105965980|NCT03479541|365533860|FG003|Home Monitoring|Lost to Follow-up|12|||
105965981|NCT03479541|365533857|FG000|Home Monitoring|Withdrawal by Subject|0|||
105965982|NCT03479541|365533858|FG001|Home Monitoring|Withdrawal by Subject|0|||
105965983|NCT03479541|365533859|FG002|Home Monitoring|Withdrawal by Subject|17|||
105965984|NCT03479541|365533860|FG003|Home Monitoring|Withdrawal by Subject|30|||
105965985|NCT03479541|365533857|FG000|Home Monitoring|Early Termination - PI Decision|0|||
105837426|NCT00779402|365060460|FG001|Surveillance Phase|Lost to Follow-up|1|||
105837427|NCT00779402|365060459|FG000|Surveillance Phase|Death|0|||
105837428|NCT00779402|365060460|FG001|Surveillance Phase|Death|1|||
105965986|NCT03479541|365533858|FG001|Home Monitoring|Early Termination - PI Decision|0|||
105965987|NCT03479541|365533859|FG002|Home Monitoring|Early Termination - PI Decision|4|||
105965988|NCT03479541|365533860|FG003|Home Monitoring|Early Termination - PI Decision|6|||
105837429|NCT00779402|365060459|FG000|Surveillance Phase|Intercurrent Illness|2|||
105965989|NCT00780143|365533862|FG000|Overall Study|Progressive disease|1|||
105965990|NCT00780143|365533862|FG000|Overall Study|Toxicity|1|||
105837430|NCT00779402|365060460|FG001|Surveillance Phase|Intercurrent Illness|0|||
105837431|NCT00779402|365060459|FG000|Surveillance Phase|Other|5|||
105837432|NCT00779402|365060460|FG001|Surveillance Phase|Other|5|||
105837433|NCT00779402|365060459|FG000|Surveillance Phase|Withdrawal by Subject|4|||
105837434|NCT00779402|365060460|FG001|Surveillance Phase|Withdrawal by Subject|1|||
105837435|NCT00779402|365060459|FG000|Surveillance Phase|Closure of study|5|||
105837436|NCT00779402|365060460|FG001|Surveillance Phase|Closure of study|6|||
105837437|NCT00779402|365060459|FG000|Surveillance Phase|Completed Protocol Visits|3|||
105837438|NCT00779402|365060460|FG001|Surveillance Phase|Completed Protocol Visits|2|||
105837439|NCT00779402|365060459|FG000|Long-term Follow-up|Patient refused to continue|2|||
105837440|NCT00779402|365060460|FG001|Long-term Follow-up|Patient refused to continue|0|||
105837441|NCT00779402|365060459|FG000|Long-term Follow-up|Other|5|||
105837442|NCT00779402|365060460|FG001|Long-term Follow-up|Other|0|||
105837443|NCT00779402|365060459|FG000|Long-term Follow-up|Closure of Study|8|||
105837444|NCT00779402|365060460|FG001|Long-term Follow-up|Closure of Study|4|||
105837445|NCT00779402|365060459|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
105837446|NCT00779402|365060460|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
105837447|NCT04994431|365060462|FG000|Overall Study|Adverse Event|1|||
105837448|NCT04994431|365060463|FG001|Overall Study|Adverse Event|0|||
105837449|NCT04364763|365060464|FG000|Overall Study|Death|1|||
105837450|NCT04364763|365060465|FG001|Overall Study|Death|2|||
105837451|NCT04364763|365060464|FG000|Overall Study|Lost to Follow-up|1|||
105837452|NCT04364763|365060465|FG001|Overall Study|Lost to Follow-up|0|||
105837453|NCT01386125|365060466|FG000|Overall Study|Lost to Follow-up|3|||
105837454|NCT01386125|365060467|FG001|Overall Study|Lost to Follow-up|9|||
105837455|NCT01386125|365060466|FG000|Overall Study|Physician Decision|0|||
105837456|NCT01386125|365060467|FG001|Overall Study|Physician Decision|1|||
105837457|NCT01386125|365060466|FG000|Overall Study|Protocol Violation|5|||
105837458|NCT01386125|365060467|FG001|Overall Study|Protocol Violation|7|||
105837459|NCT01386125|365060466|FG000|Overall Study|Disease Progress|1|||
105837460|NCT01386125|365060467|FG001|Overall Study|Disease Progress|2|||
105837461|NCT01386125|365060466|FG000|Overall Study|Withdrawal by Subject|13|||
105837462|NCT01386125|365060467|FG001|Overall Study|Withdrawal by Subject|12|||
105837463|NCT01386125|365060466|FG000|Overall Study|Adverse Event|2|||
105837464|NCT01386125|365060467|FG001|Overall Study|Adverse Event|5|||
105837465|NCT01386125|365060466|FG000|Overall Study|Lack of Efficacy|0|||
105837466|NCT01386125|365060467|FG001|Overall Study|Lack of Efficacy|1|||
105837467|NCT01386125|365060466|FG000|Overall Study|Participant Leaving Country|1|||
105837468|NCT01386125|365060467|FG001|Overall Study|Participant Leaving Country|0|||
105837469|NCT01849458|365060468|FG000|Overall Study|Lost to Follow-up|4|||
105837470|NCT00090753|365060470|FG000|First Treatment Period|Adverse Event|20|||
105837471|NCT00090753|365060471|FG001|First Treatment Period|Adverse Event|8|||
105837472|NCT00090753|365060470|FG000|First Treatment Period|Death|88|||
105837473|NCT00090753|365060471|FG001|First Treatment Period|Death|62|||
105837474|NCT00090753|365060470|FG000|First Treatment Period|Lack of Efficacy|2|||
105837475|NCT00090753|365060471|FG001|First Treatment Period|Lack of Efficacy|1|||
105837476|NCT00090753|365060470|FG000|First Treatment Period|Refused Treatment|32|||
105837477|NCT00090753|365060471|FG001|First Treatment Period|Refused Treatment|25|||
105837478|NCT00090753|365060470|FG000|First Treatment Period|Lost to Follow-up|4|||
105837479|NCT00090753|365060471|FG001|First Treatment Period|Lost to Follow-up|4|||
105837480|NCT00090753|365060470|FG000|First Treatment Period|Renal Transplant|70|||
105837481|NCT00090753|365060471|FG001|First Treatment Period|Renal Transplant|50|||
105837482|NCT00090753|365060470|FG000|First Treatment Period|Mircera Commercialization|1|||
105837483|NCT00090753|365060471|FG001|First Treatment Period|Mircera Commercialization|0|||
105837484|NCT00090753|365060470|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
105837485|NCT00090753|365060471|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
105837486|NCT00090753|365060470|FG000|Extended Treatment Period|Adverse Event|11|||
105837487|NCT00090753|365060471|FG001|Extended Treatment Period|Adverse Event|0|||
105837488|NCT00090753|365060470|FG000|Extended Treatment Period|Death|58|||
105837489|NCT00090753|365060471|FG001|Extended Treatment Period|Death|30|||
105837490|NCT00090753|365060470|FG000|Extended Treatment Period|Lack of Efficacy|1|||
105837491|NCT00090753|365060471|FG001|Extended Treatment Period|Lack of Efficacy|0|||
105837492|NCT00090753|365060470|FG000|Extended Treatment Period|Refused Treatment|18|||
105837493|NCT00090753|365060471|FG001|Extended Treatment Period|Refused Treatment|12|||
105837494|NCT00090753|365060470|FG000|Extended Treatment Period|Lost to Follow-up|3|||
105965991|NCT00780143|365533862|FG000|Overall Study|Adverse Event|1|||
105837495|NCT00090753|365060471|FG001|Extended Treatment Period|Lost to Follow-up|1|||
105965992|NCT00082368|365533867|FG000|Overall Study|Not treated-pt had poor IV access|1|||
105837496|NCT00090753|365060470|FG000|Extended Treatment Period|Renal Transplant|15|||
105837497|NCT00090753|365060471|FG001|Extended Treatment Period|Renal Transplant|12|||
105837498|NCT00090753|365060470|FG000|Extended Treatment Period|Mircera Commercialization|188|||
105837499|NCT00090753|365060471|FG001|Extended Treatment Period|Mircera Commercialization|93|||
105837500|NCT00090753|365060470|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
105837501|NCT00090753|365060471|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
105837502|NCT02175368|365060474|FG000|Overall Study|Lost to Follow-up|1|||
105837503|NCT02839798|365062201|FG000|Overall Study|Withdrawal by Subject|2|||
105837504|NCT00676650|365062202|FG000|Overall Study|Death|45|||
105965993|NCT03559517|365533868|FG000|Overall Study|Withdrawal by Subject|1|||
105837505|NCT00676650|365062203|FG001|Overall Study|Death|14|||
105837506|NCT00676650|365062202|FG000|Overall Study|Adverse Event|159|||
105837507|NCT00676650|365062203|FG001|Overall Study|Adverse Event|21|||
106023446|NCT01497366|365750401|FG001|Overall Study|Other|0|||
105837508|NCT00676650|365062202|FG000|Overall Study|Global deterioration of health status|66|||
105837509|NCT00676650|365062203|FG001|Overall Study|Global deterioration of health status|31|||
105965994|NCT03559517|365533869|FG001|Overall Study|Withdrawal by Subject|0|||
105965995|NCT03559517|365533870|FG002|Overall Study|Withdrawal by Subject|0|||
105965996|NCT00107900|365533871|FG000|Overall Study|Adverse Event|3|||
105965997|NCT00107900|365533872|FG001|Overall Study|Adverse Event|2|||
105837510|NCT00676650|365062202|FG000|Overall Study|Lost to Follow-up|0|||
105837511|NCT00676650|365062203|FG001|Overall Study|Lost to Follow-up|1|||
105837512|NCT00676650|365062202|FG000|Overall Study|Objective progression or relapse|189|||
105837513|NCT00676650|365062203|FG001|Overall Study|Objective progression or relapse|140|||
105837514|NCT00676650|365062202|FG000|Overall Study|Other|14|||
105837515|NCT00676650|365062203|FG001|Overall Study|Other|10|||
105837516|NCT00676650|365062202|FG000|Overall Study|Protocol Violation|3|||
105837517|NCT00676650|365062203|FG001|Overall Study|Protocol Violation|1|||
105837518|NCT00676650|365062202|FG000|Overall Study|Study terminated by sponsor|57|||
105837519|NCT00676650|365062203|FG001|Overall Study|Study terminated by sponsor|43|||
105837520|NCT00676650|365062202|FG000|Overall Study|Withdrawal by Subject|48|||
105837521|NCT00676650|365062203|FG001|Overall Study|Withdrawal by Subject|24|||
105837522|NCT00676650|365062202|FG000|Overall Study|Randomized but not treated|3|||
105837523|NCT00676650|365062203|FG001|Overall Study|Randomized but not treated|4|||
105837524|NCT00109837|365062204|FG000|Overall Study|Adverse Event|2|||
105837525|NCT00109837|365062204|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
105837526|NCT00109837|365062204|FG000|Overall Study|Death|1|||
105837527|NCT00109837|365062204|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
105837528|NCT00109837|365062204|FG000|Overall Study|Not treated|1|||
105837529|NCT00109837|365062204|FG000|Overall Study|Ineligible|1|||
105837530|NCT03431337|365062205|FG000|Overall Study|Lost to Follow-up|21|||
105837531|NCT03431337|365062206|FG001|Overall Study|Lost to Follow-up|19|||
105837532|NCT03431337|365062205|FG000|Overall Study|Withdrawal by Subject|8|||
105837533|NCT03431337|365062206|FG001|Overall Study|Withdrawal by Subject|3|||
105837534|NCT00329160|365062207|FG000|Overall Study|Adverse Event|27|||
105837535|NCT00329160|365062207|FG000|Overall Study|Withdrawal by Subject|13|||
105837536|NCT00329160|365062207|FG000|Overall Study|Protocol Violation|2|||
105837537|NCT00329160|365062207|FG000|Overall Study|Did not Receive Study Drug|1|||
105837538|NCT00329160|365062207|FG000|Overall Study|Incomplete IVUS|45|||
105837539|NCT04501094|365062208|FG000|Overall Study|Death (unrelated to research)|1|||
105837540|NCT04501094|365062209|FG001|Overall Study|Death (unrelated to research)|0|||
105837541|NCT00063258|365062210|FG000|Overall Study|Physician Decision|2|||
105837542|NCT00063258|365062211|FG001|Overall Study|Physician Decision|0|||
105837543|NCT00063258|365062210|FG000|Overall Study|Lack of Efficacy|2|||
105837544|NCT00063258|365062211|FG001|Overall Study|Lack of Efficacy|0|||
105837545|NCT02426541|365062214|FG000|Overall Study|Protocol Violation|1|||
105837546|NCT02426541|365062215|FG001|Overall Study|Protocol Violation|0|||
105837547|NCT00894933|365062216|FG000|Overall Study|Lost to Follow-up|2|||
105837548|NCT00894933|365062216|FG000|Overall Study|Cancelled Procedure|1|||
105837549|NCT00894933|365062216|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
105837550|NCT04241133|365062217|FG000|Overall Study|COVID19 Precautions|14|||
105837551|NCT04241133|365062218|FG001|Overall Study|COVID19 Precautions|34|||
105837552|NCT02994394|365062219|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837553|NCT02994394|365062220|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837554|NCT02994394|365062221|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
105837555|NCT02994394|365062222|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837556|NCT02994394|365062223|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837557|NCT02994394|365062224|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
105837558|NCT02994394|365062219|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
105837559|NCT02994394|365062220|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
105837560|NCT02994394|365062221|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
105837561|NCT02994394|365062222|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
105837562|NCT02994394|365062223|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
105965998|NCT00107900|365533873|FG002|Overall Study|Adverse Event|10|||
105965999|NCT00107900|365533874|FG003|Overall Study|Adverse Event|3|||
105966000|NCT00107900|365533875|FG004|Overall Study|Adverse Event|5|||
105837563|NCT02994394|365062224|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
105837564|NCT03619876|365062225|FG000|Overall Study|Withdrawal by Subject|1|||
105837565|NCT03619876|365062226|FG001|Overall Study|Withdrawal by Subject|2|||
105837566|NCT03619876|365062225|FG000|Overall Study|Withdrawal due to incidental finding|0|||
105966001|NCT00107900|365533876|FG005|Overall Study|Adverse Event|3|||
105837567|NCT03619876|365062226|FG001|Overall Study|Withdrawal due to incidental finding|2|||
105837568|NCT01546519|365062229|FG000|Overall Study|Adverse Event|0|||
105837569|NCT01546519|365062230|FG001|Overall Study|Adverse Event|0|||
105837570|NCT01546519|365062231|FG002|Overall Study|Adverse Event|1|||
105966002|NCT00107900|365533871|FG000|Overall Study|Death|0|||
105837571|NCT01546519|365062232|FG003|Overall Study|Adverse Event|1|||
105837572|NCT01546519|365062229|FG000|Overall Study|Death|0|||
105837573|NCT01546519|365062230|FG001|Overall Study|Death|1|||
105837574|NCT01546519|365062231|FG002|Overall Study|Death|3|||
105837575|NCT01546519|365062232|FG003|Overall Study|Death|1|||
105966003|NCT00107900|365533872|FG001|Overall Study|Death|0|||
105966004|NCT00107900|365533873|FG002|Overall Study|Death|0|||
105837576|NCT01546519|365062229|FG000|Overall Study|related to disease progression|2|||
105837577|NCT01546519|365062230|FG001|Overall Study|related to disease progression|2|||
105837578|NCT01546519|365062231|FG002|Overall Study|related to disease progression|2|||
105837579|NCT01546519|365062232|FG003|Overall Study|related to disease progression|1|||
105837580|NCT01546519|365062229|FG000|Overall Study|Physician Decision|6|||
105837581|NCT01546519|365062230|FG001|Overall Study|Physician Decision|5|||
105837582|NCT01546519|365062231|FG002|Overall Study|Physician Decision|2|||
105837583|NCT01546519|365062232|FG003|Overall Study|Physician Decision|3|||
105837584|NCT01546519|365062229|FG000|Overall Study|Withdrawal by Subject|1|||
105837585|NCT01546519|365062230|FG001|Overall Study|Withdrawal by Subject|0|||
105837586|NCT01546519|365062231|FG002|Overall Study|Withdrawal by Subject|0|||
105837587|NCT01546519|365062232|FG003|Overall Study|Withdrawal by Subject|0|||
105837588|NCT02531594|365062233|FG000|Overall Study|Withdrawal by Subject|7|||
105837589|NCT02531594|365062234|FG001|Overall Study|Withdrawal by Subject|8|||
105837590|NCT00732160|365062238|FG000|Overall Study|Adverse Event|1|||
105837591|NCT00732160|365062239|FG001|Overall Study|Adverse Event|0|||
105837592|NCT00732160|365062240|FG002|Overall Study|Adverse Event|1|||
105837593|NCT00732160|365062241|FG003|Overall Study|Adverse Event|1|||
105837594|NCT00732160|365062238|FG000|Overall Study|scheduling|4|||
105837595|NCT00732160|365062239|FG001|Overall Study|scheduling|4|||
105837596|NCT00732160|365062240|FG002|Overall Study|scheduling|2|||
105837597|NCT00732160|365062241|FG003|Overall Study|scheduling|1|||
105837598|NCT04660032|365062246|FG000|Overall Study|Protocol Violation|1|||
105837599|NCT04660032|365062247|FG001|Overall Study|Protocol Violation|1|||
105837600|NCT01609582|365062256|FG000|Overall Study|Adverse Event|20|||
105837601|NCT01609582|365062257|FG001|Overall Study|Adverse Event|18|||
105837602|NCT01609582|365062256|FG000|Overall Study|Lost to Follow-up|10|||
105837603|NCT01609582|365062257|FG001|Overall Study|Lost to Follow-up|10|||
105837604|NCT01609582|365062256|FG000|Overall Study|Withdrawal by Subject|21|||
105837605|NCT01609582|365062257|FG001|Overall Study|Withdrawal by Subject|15|||
105837606|NCT01609582|365062256|FG000|Overall Study|Study Terminated by Sponsor|1543|||
105837607|NCT01609582|365062257|FG001|Overall Study|Study Terminated by Sponsor|1548|||
105837608|NCT01609582|365062256|FG000|Overall Study|Other|9|||
105837609|NCT01609582|365062257|FG001|Overall Study|Other|10|||
105837610|NCT01609582|365062256|FG000|Overall Study|Randomized, but not treated|0|||
105837611|NCT01609582|365062257|FG001|Overall Study|Randomized, but not treated|3|||
105837612|NCT01808248|365062258|FG000|Overall Study|Lack of Efficacy|3|||
105837613|NCT01808248|365062258|FG000|Overall Study|Withdrawal by Subject|1|||
105837614|NCT01808248|365062258|FG000|Overall Study|Lost to Follow-up|1|||
105837615|NCT04220775|365062259|FG000|Overall Study|Adverse Event|1|||
105837616|NCT04220775|365062260|FG001|Overall Study|Adverse Event|0|||
105837617|NCT04220775|365062259|FG000|Overall Study|Disease Progression|1|||
105837618|NCT04220775|365062260|FG001|Overall Study|Disease Progression|0|||
105837619|NCT00436917|365062261|FG000|Overall Study|Withdrawal by Subject|13|||
105837620|NCT00436917|365062261|FG000|Overall Study|Adverse Event|2|||
105837621|NCT00436917|365062261|FG000|Overall Study|Physician Decision|1|||
105837622|NCT00436917|365062261|FG000|Overall Study|Death|1|||
105837623|NCT00436917|365062261|FG000|Overall Study|Lost to Follow-up|1|||
105837624|NCT00436917|365062261|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
105837625|NCT00436917|365062261|FG000|Overall Study|Increased creatinine|1|||
105837626|NCT00436917|365062261|FG000|Overall Study|Personal conflicts of patient|1|||
105837627|NCT00808509|365062262|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
105837628|NCT00808509|365062263|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
105837629|NCT00808509|365062262|FG000|Randomized Phase|Reduced methotrexate dose|1|||
105837630|NCT00808509|365062263|FG001|Randomized Phase|Reduced methotrexate dose|2|||
105837631|NCT00808509|365062262|FG000|Randomized Phase|Patient refused rescue therapy|0|||
105837632|NCT00808509|365062263|FG001|Randomized Phase|Patient refused rescue therapy|3|||
105837633|NCT00559364|365062268|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
105837634|NCT00559364|365062269|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
105837635|NCT04126343|365062270|FG000|Overall Study|Adverse Event|0|||
105837636|NCT04126343|365062271|FG001|Overall Study|Adverse Event|0|||
105837637|NCT04126343|365062272|FG002|Overall Study|Adverse Event|0|||
105837638|NCT04126343|365062273|FG003|Overall Study|Adverse Event|0|||
105837639|NCT04126343|365062274|FG004|Overall Study|Adverse Event|0|||
105837640|NCT04126343|365062275|FG005|Overall Study|Adverse Event|1|||
105837641|NCT04126343|365062270|FG000|Overall Study|Withdrawal by Subject|0|||
105966005|NCT00107900|365533874|FG003|Overall Study|Death|0|||
105837642|NCT04126343|365062271|FG001|Overall Study|Withdrawal by Subject|0|||
105837643|NCT04126343|365062272|FG002|Overall Study|Withdrawal by Subject|0|||
105966006|NCT00107900|365533875|FG004|Overall Study|Death|1|||
105837644|NCT04126343|365062273|FG003|Overall Study|Withdrawal by Subject|1|||
105837645|NCT04126343|365062274|FG004|Overall Study|Withdrawal by Subject|0|||
105837646|NCT04126343|365062275|FG005|Overall Study|Withdrawal by Subject|0|||
105837647|NCT04126343|365062270|FG000|Overall Study|Related to COVID-19 pandemic|3|||
105966007|NCT00107900|365533876|FG005|Overall Study|Death|0|||
105837648|NCT04126343|365062271|FG001|Overall Study|Related to COVID-19 pandemic|4|||
105966008|NCT00107900|365533871|FG000|Overall Study|Lost to Follow-up|4|||
105837649|NCT04126343|365062272|FG002|Overall Study|Related to COVID-19 pandemic|3|||
105837650|NCT04126343|365062273|FG003|Overall Study|Related to COVID-19 pandemic|3|||
105837651|NCT04126343|365062274|FG004|Overall Study|Related to COVID-19 pandemic|3|||
105837652|NCT04126343|365062275|FG005|Overall Study|Related to COVID-19 pandemic|3|||
105837653|NCT00129116|365062278|FG000|Primary Phase|Lost to Follow-up|1|||
105837654|NCT00129116|365062279|FG001|Primary Phase|Lost to Follow-up|1|||
105837655|NCT00129116|365062280|FG002|Primary Phase|Lost to Follow-up|0|||
105837656|NCT00129116|365062281|FG003|Primary Phase|Lost to Follow-up|1|||
105837657|NCT00129116|365062282|FG004|Primary Phase|Lost to Follow-up|1|||
105837658|NCT00129116|365062278|FG000|Primary Phase|Protocol Violation|0|||
105837659|NCT00129116|365062279|FG001|Primary Phase|Protocol Violation|1|||
105837660|NCT00129116|365062280|FG002|Primary Phase|Protocol Violation|0|||
105837661|NCT00129116|365062281|FG003|Primary Phase|Protocol Violation|0|||
105837662|NCT00129116|365062282|FG004|Primary Phase|Protocol Violation|0|||
105837663|NCT00129116|365062278|FG000|Primary Phase|Adverse Event|1|||
105837664|NCT00129116|365062279|FG001|Primary Phase|Adverse Event|1|||
105837665|NCT00129116|365062280|FG002|Primary Phase|Adverse Event|0|||
105837666|NCT00129116|365062281|FG003|Primary Phase|Adverse Event|0|||
105837667|NCT00129116|365062282|FG004|Primary Phase|Adverse Event|0|||
105837668|NCT00129116|365062278|FG000|Primary Phase|Withdrawal by Subject|0|||
105837669|NCT00129116|365062279|FG001|Primary Phase|Withdrawal by Subject|1|||
105837670|NCT00129116|365062280|FG002|Primary Phase|Withdrawal by Subject|0|||
105837671|NCT00129116|365062281|FG003|Primary Phase|Withdrawal by Subject|0|||
105837672|NCT00129116|365062282|FG004|Primary Phase|Withdrawal by Subject|0|||
105837673|NCT00129116|365062278|FG000|Primary Phase|Other|0|||
105837674|NCT00129116|365062279|FG001|Primary Phase|Other|0|||
105837675|NCT00129116|365062280|FG002|Primary Phase|Other|1|||
105837676|NCT00129116|365062281|FG003|Primary Phase|Other|0|||
105837677|NCT00129116|365062282|FG004|Primary Phase|Other|0|||
105837678|NCT00129116|365062278|FG000|Booster Phase|Lost to Follow-up|2|||
105837679|NCT00129116|365062279|FG001|Booster Phase|Lost to Follow-up|0|||
105837680|NCT00129116|365062280|FG002|Booster Phase|Lost to Follow-up|0|||
105837681|NCT00129116|365062281|FG003|Booster Phase|Lost to Follow-up|0|||
105837682|NCT00129116|365062282|FG004|Booster Phase|Lost to Follow-up|1|||
105837683|NCT00388037|365062284|FG000|Overall Study|Protocol Violation|1|||
105837684|NCT02941523|365062287|FG000|Monotherapy|Withdrawal by Subject|0|||
105837685|NCT02941523|365062288|FG001|Monotherapy|Withdrawal by Subject|1|||
105837686|NCT02941523|365062287|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
105837687|NCT02941523|365062288|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
105837688|NCT02941523|365062287|FG000|Carboplatin Combination Therapy|Death|1|||
105837689|NCT02941523|365062288|FG001|Carboplatin Combination Therapy|Death|2|||
105837690|NCT02941523|365062287|FG000|Carboplatin Combination Therapy|Disease progression|2|||
105837691|NCT02941523|365062288|FG001|Carboplatin Combination Therapy|Disease progression|0|||
105837692|NCT02941523|365062287|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
105837693|NCT02941523|365062288|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
105837694|NCT04330157|365062289|FG000|Overall Study|Protocol Violation|4|||
105837695|NCT04330157|365062289|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
105837696|NCT00869440|365062290|FG000|Overall Study|Withdrawal by Subject|1|||
105837697|NCT00869440|365062291|FG001|Overall Study|Withdrawal by Subject|0|||
105837698|NCT00869440|365062292|FG002|Overall Study|Withdrawal by Subject|0|||
105837699|NCT00869440|365062293|FG003|Overall Study|Withdrawal by Subject|0|||
105837700|NCT00869440|365062290|FG000|Overall Study|Physician Decision|1|||
105837701|NCT00869440|365062291|FG001|Overall Study|Physician Decision|1|||
105837702|NCT00869440|365062292|FG002|Overall Study|Physician Decision|0|||
105837703|NCT00869440|365062293|FG003|Overall Study|Physician Decision|0|||
105837704|NCT00373425|365062295|FG000|Overall Study|Relapse of NSCLC|116|||
105966009|NCT00107900|365533872|FG001|Overall Study|Lost to Follow-up|1|||
105966010|NCT00107900|365533873|FG002|Overall Study|Lost to Follow-up|3|||
105837705|NCT00373425|365062296|FG001|Overall Study|Relapse of NSCLC|104|||
105837706|NCT00373425|365062297|FG002|Overall Study|Relapse of NSCLC|19|||
105837707|NCT00373425|365062298|FG003|Overall Study|Relapse of NSCLC|2|||
105837708|NCT00373425|365062299|FG004|Overall Study|Relapse of NSCLC|26|||
105837709|NCT00373425|365062295|FG000|Overall Study|Adverse Event|191|||
105966011|NCT00107900|365533874|FG003|Overall Study|Lost to Follow-up|2|||
105966012|NCT00107900|365533875|FG004|Overall Study|Lost to Follow-up|5|||
105837710|NCT00373425|365062296|FG001|Overall Study|Adverse Event|22|||
105837711|NCT00373425|365062297|FG002|Overall Study|Adverse Event|59|||
105837712|NCT00373425|365062298|FG003|Overall Study|Adverse Event|0|||
105837713|NCT00373425|365062299|FG004|Overall Study|Adverse Event|34|||
105837714|NCT00373425|365062295|FG000|Overall Study|Patient request|35|||
105837715|NCT00373425|365062296|FG001|Overall Study|Patient request|18|||
105837716|NCT00373425|365062297|FG002|Overall Study|Patient request|43|||
105837717|NCT00373425|365062298|FG003|Overall Study|Patient request|6|||
105837718|NCT00373425|365062299|FG004|Overall Study|Patient request|7|||
105837719|NCT00373425|365062295|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
105837720|NCT00373425|365062296|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
105837721|NCT00373425|365062297|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
105966013|NCT00107900|365533876|FG005|Overall Study|Lost to Follow-up|5|||
105837722|NCT00373425|365062298|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
105837723|NCT00373425|365062299|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
105837724|NCT00373425|365062295|FG000|Overall Study|Death|7|||
105837725|NCT00373425|365062296|FG001|Overall Study|Death|0|||
105837726|NCT00373425|365062297|FG002|Overall Study|Death|3|||
105837727|NCT00373425|365062298|FG003|Overall Study|Death|1|||
105837728|NCT00373425|365062299|FG004|Overall Study|Death|0|||
105837729|NCT02808819|365062300|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
105837730|NCT02808819|365062301|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
105837731|NCT02808819|365062300|FG000|Overall Study|Withdrawal by Subject|10|||
105837732|NCT02808819|365062301|FG001|Overall Study|Withdrawal by Subject|13|||
105837733|NCT02808819|365062300|FG000|Overall Study|Site terminated by sponsor|2|||
105837734|NCT02808819|365062301|FG001|Overall Study|Site terminated by sponsor|0|||
105837735|NCT02808819|365062300|FG000|Overall Study|Pregnancy|1|||
105837736|NCT02808819|365062301|FG001|Overall Study|Pregnancy|0|||
105837737|NCT02808819|365062300|FG000|Overall Study|Lost to Follow-up|1|||
105837738|NCT02808819|365062301|FG001|Overall Study|Lost to Follow-up|6|||
105837739|NCT02808819|365062300|FG000|Overall Study|Protocol Violation|0|||
105837740|NCT02808819|365062301|FG001|Overall Study|Protocol Violation|1|||
105837741|NCT02808819|365062300|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
105837742|NCT02808819|365062301|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
105837743|NCT02808819|365062300|FG000|Overall Study|Death|1|||
105837744|NCT02808819|365062301|FG001|Overall Study|Death|0|||
105837745|NCT02808819|365062300|FG000|Overall Study|Adverse Event|3|||
105837746|NCT02808819|365062301|FG001|Overall Study|Adverse Event|4|||
105837747|NCT01083680|365062302|FG000|Overall Study|Lost to Follow-up|2758|||
105837748|NCT01083680|365062302|FG000|Overall Study|Withdrawal by Subject|1086|||
105837749|NCT03546647|365062303|FG000|Overall Study|Adverse Event|1|||
105837750|NCT03546647|365062304|FG001|Overall Study|Adverse Event|0|||
105837751|NCT01183884|365062305|FG000|Overall Study|Progressive Disease|26|||
105837752|NCT01183884|365062305|FG000|Overall Study|Adverse Event|3|||
105837753|NCT01183884|365062305|FG000|Overall Study|Withdrawal by Subject|1|||
105837754|NCT01183884|365062305|FG000|Overall Study|Other Complicating Disease|3|||
105837755|NCT01183884|365062305|FG000|Overall Study|Not Treated|1|||
105837756|NCT01183884|365062305|FG000|Overall Study|Other|4|||
105837757|NCT02260258|365062306|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
105837758|NCT02260258|365062307|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
105837759|NCT03689894|365062312|FG000|Overall Study|Adverse Event|1|||
105837760|NCT01644149|365062321|FG000|Overall Study|Withdrawal by Subject|1|||
105837761|NCT01644149|365062322|FG001|Overall Study|Withdrawal by Subject|0|||
105837762|NCT01644149|365062321|FG000|Overall Study|Lost to Follow-up|3|||
105837763|NCT01644149|365062322|FG001|Overall Study|Lost to Follow-up|1|||
105837764|NCT04718129|365062323|FG000|Overall Study|Lost to Follow-up|6|||
105837765|NCT04718129|365062324|FG001|Overall Study|Lost to Follow-up|7|||
105837766|NCT04405739|365062327|FG000|Overall Study|Adverse Event|0|||
105837767|NCT04405739|365062328|FG001|Overall Study|Adverse Event|1|||
105837768|NCT04405739|365062329|FG002|Overall Study|Adverse Event|0|||
105837769|NCT04405739|365062330|FG003|Overall Study|Adverse Event|0|||
105837770|NCT04405739|365062327|FG000|Overall Study|Lost to Follow-up|0|||
105837771|NCT04405739|365062328|FG001|Overall Study|Lost to Follow-up|2|||
105837772|NCT04405739|365062329|FG002|Overall Study|Lost to Follow-up|1|||
105837773|NCT04405739|365062330|FG003|Overall Study|Lost to Follow-up|3|||
105837774|NCT04405739|365062327|FG000|Overall Study|Withdrawal by Subject|0|||
105837775|NCT04405739|365062328|FG001|Overall Study|Withdrawal by Subject|2|||
105837776|NCT04405739|365062329|FG002|Overall Study|Withdrawal by Subject|1|||
105837777|NCT04405739|365062330|FG003|Overall Study|Withdrawal by Subject|1|||
105837778|NCT04405739|365062327|FG000|Overall Study|Death|0|||
105837779|NCT04405739|365062328|FG001|Overall Study|Death|0|||
105837780|NCT04405739|365062329|FG002|Overall Study|Death|1|||
105837781|NCT04405739|365062330|FG003|Overall Study|Death|0|||
105837782|NCT04405739|365062327|FG000|Overall Study|Transferred to rehab|0|||
105837783|NCT04405739|365062328|FG001|Overall Study|Transferred to rehab|0|||
105837784|NCT04405739|365062329|FG002|Overall Study|Transferred to rehab|0|||
105837785|NCT04405739|365062330|FG003|Overall Study|Transferred to rehab|1|||
105837786|NCT04405739|365062327|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
105837787|NCT04405739|365062328|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
105837788|NCT04405739|365062329|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
105837789|NCT04405739|365062330|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
105837790|NCT01436643|365062331|FG000|2-week Pre-treatment|Abnormal test result|0|||
105837791|NCT01436643|365062332|FG001|2-week Pre-treatment|Abnormal test result|0|||
105837792|NCT01436643|365062333|FG002|2-week Pre-treatment|Abnormal test result|0|||
105837793|NCT01436643|365062334|FG003|2-week Pre-treatment|Abnormal test result|1|||
105837794|NCT01436643|365062331|FG000|2-week Pre-treatment|Adverse Event|0|||
105837795|NCT01436643|365062332|FG001|2-week Pre-treatment|Adverse Event|0|||
105837796|NCT01436643|365062333|FG002|2-week Pre-treatment|Adverse Event|0|||
105837797|NCT01436643|365062334|FG003|2-week Pre-treatment|Adverse Event|5|||
105837798|NCT01436643|365062331|FG000|2-week Pre-treatment|Protocol Violation|0|||
106023447|NCT01497366|365750400|FG000|Overall Study|Death|1|||
105837799|NCT01436643|365062332|FG001|2-week Pre-treatment|Protocol Violation|0|||
105837800|NCT01436643|365062333|FG002|2-week Pre-treatment|Protocol Violation|0|||
106023448|NCT01497366|365750401|FG001|Overall Study|Death|1|||
106023449|NCT01497366|365750400|FG000|Overall Study|Randomized but not treated|7|||
106023450|NCT01497366|365750401|FG001|Overall Study|Randomized but not treated|21|||
106023451|NCT00282308|365750402|FG000|Treatment Period|Lost to Follow-up|1|||
106023452|NCT00282308|365750403|FG001|Treatment Period|Lost to Follow-up|0|||
106023453|NCT00282308|365750404|FG002|Treatment Period|Lost to Follow-up|0|||
106023454|NCT00282308|365750402|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
106023455|NCT00282308|365750403|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
105837801|NCT01436643|365062334|FG003|2-week Pre-treatment|Protocol Violation|4|||
105837802|NCT01436643|365062331|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
105837803|NCT01436643|365062332|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
105837804|NCT01436643|365062333|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
105837805|NCT01436643|365062334|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
105837806|NCT01436643|365062331|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
105837807|NCT01436643|365062332|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
105837808|NCT01436643|365062333|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
105837809|NCT01436643|365062334|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
105837810|NCT01436643|365062331|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
105837811|NCT01436643|365062332|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
105837812|NCT01436643|365062333|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
105837813|NCT01436643|365062334|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
105837814|NCT03718117|365062335|FG000|Overall Study|Death|12|||
105837815|NCT03718117|365062336|FG001|Overall Study|Death|11|||
105837816|NCT03718117|365062337|FG002|Overall Study|Death|0|||
105837817|NCT03718117|365062335|FG000|Overall Study|Other|0|||
105837818|NCT03718117|365062336|FG001|Overall Study|Other|1|||
105837819|NCT03718117|365062337|FG002|Overall Study|Other|0|||
105837820|NCT03718117|365062335|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
105837821|NCT03718117|365062336|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
105837822|NCT03718117|365062337|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
105837823|NCT03718117|365062335|FG000|Overall Study|Participant not met eligibility criteria|0|||
105837824|NCT03718117|365062336|FG001|Overall Study|Participant not met eligibility criteria|0|||
105837825|NCT03718117|365062337|FG002|Overall Study|Participant not met eligibility criteria|2|||
105837826|NCT03069417|365062338|FG000|Overall Study|Lost to Follow-up|2|||
105837827|NCT03069417|365062339|FG001|Overall Study|Lost to Follow-up|0|||
105837828|NCT03069417|365062338|FG000|Overall Study|Reason Unknown|4|||
105837829|NCT03069417|365062339|FG001|Overall Study|Reason Unknown|7|||
105837830|NCT00206102|365062342|FG000|Overall Study|Adverse Event|119|||
105837831|NCT00206102|365062343|FG001|Overall Study|Adverse Event|82|||
105837832|NCT00206102|365062342|FG000|Overall Study|Protocol Violation|0|||
105837833|NCT00206102|365062343|FG001|Overall Study|Protocol Violation|2|||
105837834|NCT00206102|365062342|FG000|Overall Study|Lack of therapeutic response|16|||
105837835|NCT00206102|365062343|FG001|Overall Study|Lack of therapeutic response|11|||
105837836|NCT00206102|365062342|FG000|Overall Study|Lost to Follow-up|95|||
105837837|NCT00206102|365062343|FG001|Overall Study|Lost to Follow-up|66|||
105837838|NCT00206102|365062342|FG000|Overall Study|Withdrawal by Subject|118|||
105837839|NCT00206102|365062343|FG001|Overall Study|Withdrawal by Subject|101|||
105837840|NCT00206102|365062342|FG000|Overall Study|Study-specific discontinuation criteria|18|||
105837841|NCT00206102|365062343|FG001|Overall Study|Study-specific discontinuation criteria|17|||
105837842|NCT00206102|365062342|FG000|Overall Study|None of those categories|42|||
105837843|NCT00206102|365062343|FG001|Overall Study|None of those categories|36|||
105837844|NCT04230876|365062347|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
105837845|NCT04230876|365062348|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
105837846|NCT00810602|365062349|FG000|Overall Study|Withdrawal by Subject|8|||
105837847|NCT00810602|365062350|FG001|Overall Study|Withdrawal by Subject|3|||
105837848|NCT04149535|365062353|FG000|Overall Study|Death|11|||
105837849|NCT04149535|365062354|FG001|Overall Study|Death|7|||
105837850|NCT04149535|365062353|FG000|Overall Study|Physician Decision|10|||
105837851|NCT04149535|365062354|FG001|Overall Study|Physician Decision|4|||
105837852|NCT04149535|365062353|FG000|Overall Study|Withdrawal by Subject|6|||
106023456|NCT00282308|365750404|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
106149304|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105837853|NCT04149535|365062354|FG001|Overall Study|Withdrawal by Subject|7|||
105837854|NCT04149535|365062353|FG000|Overall Study|Not described|2|||
105837855|NCT04149535|365062354|FG001|Overall Study|Not described|0|||
105837856|NCT02875028|365062355|FG000|Washout Period|Withdrawal by Subject|0|||
105837857|NCT02875028|365062356|FG001|Washout Period|Withdrawal by Subject|1|||
105837858|NCT03036839|365064405|FG000|Overall Study|Adverse Event|0|||
105837859|NCT03036839|365064406|FG001|Overall Study|Adverse Event|0|||
105837860|NCT03036839|365064407|FG002|Overall Study|Adverse Event|1|||
105837861|NCT03036839|365064405|FG000|Overall Study|Death|3|||
105837862|NCT03036839|365064406|FG001|Overall Study|Death|0|||
105966014|NCT00107900|365533871|FG000|Overall Study|Protocol Violation|1|||
105966015|NCT00107900|365533872|FG001|Overall Study|Protocol Violation|0|||
105966016|NCT00107900|365533873|FG002|Overall Study|Protocol Violation|5|||
105966017|NCT00107900|365533874|FG003|Overall Study|Protocol Violation|5|||
105966018|NCT00107900|365533875|FG004|Overall Study|Protocol Violation|7|||
105966019|NCT00107900|365533876|FG005|Overall Study|Protocol Violation|0|||
105966020|NCT00107900|365533871|FG000|Overall Study|Withdrawal by Subject|1|||
105966021|NCT00107900|365533872|FG001|Overall Study|Withdrawal by Subject|0|||
105966022|NCT00107900|365533873|FG002|Overall Study|Withdrawal by Subject|5|||
105966023|NCT00107900|365533874|FG003|Overall Study|Withdrawal by Subject|0|||
105966024|NCT00107900|365533875|FG004|Overall Study|Withdrawal by Subject|1|||
105966025|NCT00107900|365533876|FG005|Overall Study|Withdrawal by Subject|1|||
105966026|NCT00107900|365533871|FG000|Overall Study|Administrative Reasons|1|||
105966027|NCT00107900|365533872|FG001|Overall Study|Administrative Reasons|0|||
105966028|NCT00107900|365533873|FG002|Overall Study|Administrative Reasons|2|||
105966029|NCT00107900|365533874|FG003|Overall Study|Administrative Reasons|2|||
105966030|NCT00107900|365533875|FG004|Overall Study|Administrative Reasons|2|||
105966031|NCT00107900|365533876|FG005|Overall Study|Administrative Reasons|0|||
105966032|NCT01846299|365533877|FG000|Overall Study|Physician Decision|4|||
105966033|NCT01846299|365533878|FG001|Overall Study|Physician Decision|2|||
105966034|NCT01846299|365533877|FG000|Overall Study|Protocol deviation|1|||
105966035|NCT01846299|365533878|FG001|Overall Study|Protocol deviation|0|||
105966036|NCT01846299|365533877|FG000|Overall Study|Death|1|||
105966037|NCT01846299|365533878|FG001|Overall Study|Death|2|||
105966038|NCT01846299|365533877|FG000|Overall Study|Lost to Follow-up|3|||
105966039|NCT01846299|365533878|FG001|Overall Study|Lost to Follow-up|0|||
105966040|NCT01846299|365533877|FG000|Overall Study|Withdrawal by Subject|1|||
105966041|NCT01846299|365533878|FG001|Overall Study|Withdrawal by Subject|6|||
105966042|NCT01846299|365533877|FG000|Overall Study|Adverse Event|2|||
105966043|NCT01846299|365533878|FG001|Overall Study|Adverse Event|0|||
105966044|NCT04091581|365533881|FG000|Overall Study|Lost to Follow-up|0|||
105966045|NCT04091581|365533882|FG001|Overall Study|Lost to Follow-up|1|||
105966046|NCT01331837|365533883|FG000|Overall Study|Death|30|||
105966047|NCT01331837|365533884|FG001|Overall Study|Death|34|||
105966048|NCT01331837|365533883|FG000|Overall Study|Lost to Follow-up|3|||
105966049|NCT01331837|365533884|FG001|Overall Study|Lost to Follow-up|1|||
105966050|NCT01331837|365533883|FG000|Overall Study|Info not recorded|10|||
105966051|NCT01331837|365533884|FG001|Overall Study|Info not recorded|16|||
105966052|NCT01331837|365533883|FG000|Overall Study|Withdrawal by Subject|13|||
105966053|NCT01331837|365533884|FG001|Overall Study|Withdrawal by Subject|16|||
105966054|NCT02013206|365535585|FG000|Overall Study|Progressive disease (PD)|14|||
105966055|NCT02013206|365535586|FG001|Overall Study|Progressive disease (PD)|17|||
105966056|NCT02013206|365535585|FG000|Overall Study|Symptomatic deterioration|3|||
105966057|NCT02013206|365535586|FG001|Overall Study|Symptomatic deterioration|1|||
105966058|NCT02013206|365535585|FG000|Overall Study|Adverse Event|1|||
105966059|NCT02013206|365535586|FG001|Overall Study|Adverse Event|0|||
105966060|NCT02013206|365535585|FG000|Overall Study|Patient refusal|2|||
105966061|NCT02013206|365535586|FG001|Overall Study|Patient refusal|0|||
105966062|NCT02013206|365535585|FG000|Overall Study|Patient non-compliance|1|||
105966063|NCT02013206|365535586|FG001|Overall Study|Patient non-compliance|0|||
105966064|NCT02013206|365535585|FG000|Overall Study|Death|1|||
105966065|NCT02013206|365535586|FG001|Overall Study|Death|2|||
105966066|NCT02013206|365535585|FG000|Overall Study|Other reasons off treatment|5|||
105966067|NCT02013206|365535586|FG001|Overall Study|Other reasons off treatment|2|||
106023457|NCT00282308|365750402|FG000|Treatment Period|Adverse Event|0|||
106023458|NCT00282308|365750403|FG001|Treatment Period|Adverse Event|2|||
106023459|NCT00282308|365750404|FG002|Treatment Period|Adverse Event|0|||
106023460|NCT00282308|365750402|FG000|Treatment Period|Not Treated with Study Drug|1|||
106023461|NCT00282308|365750403|FG001|Treatment Period|Not Treated with Study Drug|0|||
106023462|NCT00282308|365750404|FG002|Treatment Period|Not Treated with Study Drug|0|||
106023463|NCT00282308|365750402|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
106023464|NCT00282308|365750403|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
106023465|NCT00282308|365750404|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
106023466|NCT00282308|365750402|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
105966068|NCT00327015|365535601|FG000|Overall Study|Lack of Efficacy|18|||
105966069|NCT00327015|365535602|FG001|Overall Study|Lack of Efficacy|18|||
105966070|NCT00327015|365535603|FG002|Overall Study|Lack of Efficacy|35|||
105966071|NCT00327015|365535604|FG003|Overall Study|Lack of Efficacy|29|||
106023467|NCT00282308|365750403|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
105966072|NCT00327015|365535601|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
105966073|NCT00327015|365535602|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
105966074|NCT00327015|365535603|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
105966075|NCT00327015|365535604|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
105966076|NCT00327015|365535601|FG000|Overall Study|Lost to Follow-up|22|||
105966077|NCT00327015|365535602|FG001|Overall Study|Lost to Follow-up|23|||
105966078|NCT00327015|365535603|FG002|Overall Study|Lost to Follow-up|29|||
105966079|NCT00327015|365535604|FG003|Overall Study|Lost to Follow-up|22|||
105837863|NCT03036839|365064407|FG002|Overall Study|Death|3|||
105837864|NCT03036839|365064405|FG000|Overall Study|Withdrew Consent|0|||
105837865|NCT03036839|365064406|FG001|Overall Study|Withdrew Consent|0|||
105837866|NCT03036839|365064407|FG002|Overall Study|Withdrew Consent|1|||
105837867|NCT03042468|365064409|FG000|Overall Study|Death|0|||
105837868|NCT03042468|365064410|FG001|Overall Study|Death|1|||
105837869|NCT03042468|365064411|FG002|Overall Study|Death|1|||
105837870|NCT03042468|365064412|FG003|Overall Study|Death|0|||
105837871|NCT03042468|365064413|FG004|Overall Study|Death|0|||
105837872|NCT03042468|365064414|FG005|Overall Study|Death|0|||
105837873|NCT03042468|365064409|FG000|Overall Study|Withdrawal by Subject|0|||
105837874|NCT03042468|365064410|FG001|Overall Study|Withdrawal by Subject|0|||
105837875|NCT03042468|365064411|FG002|Overall Study|Withdrawal by Subject|0|||
105837876|NCT03042468|365064412|FG003|Overall Study|Withdrawal by Subject|0|||
105837877|NCT03042468|365064413|FG004|Overall Study|Withdrawal by Subject|0|||
105837878|NCT03042468|365064414|FG005|Overall Study|Withdrawal by Subject|1|||
105837879|NCT03042468|365064409|FG000|Overall Study|Lost to Follow-up|0|||
105837880|NCT03042468|365064410|FG001|Overall Study|Lost to Follow-up|0|||
105837881|NCT03042468|365064411|FG002|Overall Study|Lost to Follow-up|0|||
105837882|NCT03042468|365064412|FG003|Overall Study|Lost to Follow-up|0|||
105837883|NCT03042468|365064413|FG004|Overall Study|Lost to Follow-up|1|||
105837884|NCT03042468|365064414|FG005|Overall Study|Lost to Follow-up|1|||
105837885|NCT01064531|365064416|FG000|Overall Study|Lost to Follow-up|0|||
105837886|NCT01064531|365064417|FG001|Overall Study|Lost to Follow-up|2|||
105837887|NCT01064531|365064416|FG000|Overall Study|Physician Decision|0|||
105837888|NCT01064531|365064417|FG001|Overall Study|Physician Decision|1|||
105837889|NCT01064531|365064416|FG000|Overall Study|Withdrawal by Subject|2|||
105837890|NCT01064531|365064417|FG001|Overall Study|Withdrawal by Subject|2|||
105837891|NCT01064531|365064416|FG000|Overall Study|Revision due to femoral stem loosening|1|||
105837892|NCT01064531|365064417|FG001|Overall Study|Revision due to femoral stem loosening|0|||
105837893|NCT01064531|365064416|FG000|Overall Study|Revision due to dislocation|0|||
105837894|NCT01064531|365064417|FG001|Overall Study|Revision due to dislocation|1|||
105837895|NCT01064531|365064416|FG000|Overall Study|Death|0|||
105837896|NCT01064531|365064417|FG001|Overall Study|Death|1|||
105837897|NCT00298740|365064418|FG000|Overall Study|Lack of Efficacy|6|||
105837898|NCT00298740|365064418|FG000|Overall Study|Withdrawal by Subject|3|||
105837899|NCT03449199|365064422|FG000|Overall Study|Lost to Follow-up|1|||
105837900|NCT03449199|365064423|FG001|Overall Study|Lost to Follow-up|1|||
105837901|NCT03449199|365064424|FG002|Overall Study|Lost to Follow-up|0|||
105837902|NCT03449199|365064422|FG000|Overall Study|Protocol Deviation|0|||
105837903|NCT03449199|365064423|FG001|Overall Study|Protocol Deviation|0|||
105837904|NCT03449199|365064424|FG002|Overall Study|Protocol Deviation|1|||
105837905|NCT03449199|365064422|FG000|Overall Study|Withdrawal by Subject|0|||
105837906|NCT03449199|365064423|FG001|Overall Study|Withdrawal by Subject|0|||
105837907|NCT03449199|365064424|FG002|Overall Study|Withdrawal by Subject|1|||
105837908|NCT01091103|365064425|FG000|Overall Study|Adverse Event|1|||
105837909|NCT01091103|365064425|FG000|Overall Study|Progressive Disease|3|||
105837910|NCT00684567|365064427|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
105837911|NCT00684567|365064427|FG000|Monotherapy Period|Adverse Event|2|||
105966080|NCT00327015|365535601|FG000|Overall Study|Adverse Event|14|||
105966081|NCT00327015|365535602|FG001|Overall Study|Adverse Event|10|||
105966082|NCT00327015|365535603|FG002|Overall Study|Adverse Event|14|||
105966083|NCT00327015|365535604|FG003|Overall Study|Adverse Event|14|||
105966084|NCT00327015|365535601|FG000|Overall Study|Subject no longer meets study criteria|4|||
105966085|NCT00327015|365535602|FG001|Overall Study|Subject no longer meets study criteria|2|||
105966086|NCT00327015|365535603|FG002|Overall Study|Subject no longer meets study criteria|8|||
105966087|NCT00327015|365535604|FG003|Overall Study|Subject no longer meets study criteria|7|||
105966088|NCT00327015|365535601|FG000|Overall Study|Poor/Noncompliance|11|||
105837912|NCT00684567|365064427|FG000|Monotherapy Period|Death|1|||
105837913|NCT00684567|365064427|FG000|Monotherapy Period|Progression of primary disease|11|||
105837914|NCT03136406|365064430|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
105837915|NCT00988208|365064436|FG000|Overall Study|Adverse Event|71|||
105837916|NCT00988208|365064437|FG001|Overall Study|Adverse Event|122|||
105837917|NCT00988208|365064436|FG000|Overall Study|Disease Progression|103|||
105837918|NCT00988208|365064437|FG001|Overall Study|Disease Progression|89|||
105837919|NCT00988208|365064436|FG000|Overall Study|Withdrawal by Subject|50|||
105837920|NCT00988208|365064437|FG001|Overall Study|Withdrawal by Subject|57|||
105837921|NCT00988208|365064436|FG000|Overall Study|Death|9|||
105837922|NCT00988208|365064437|FG001|Overall Study|Death|15|||
105837923|NCT00988208|365064436|FG000|Overall Study|Lost to Follow-up|2|||
105837924|NCT00988208|365064437|FG001|Overall Study|Lost to Follow-up|3|||
105837925|NCT00988208|365064436|FG000|Overall Study|Protocol Violation|9|||
105837926|NCT00988208|365064437|FG001|Overall Study|Protocol Violation|2|||
105837927|NCT00988208|365064436|FG000|Overall Study|Sponsor Decision|102|||
105837928|NCT00988208|365064437|FG001|Overall Study|Sponsor Decision|78|||
105837929|NCT00988208|365064436|FG000|Overall Study|Clinical Progression|17|||
105837930|NCT00988208|365064437|FG001|Overall Study|Clinical Progression|16|||
105837931|NCT00988208|365064436|FG000|Overall Study|Biochemical Progression|21|||
105837932|NCT00988208|365064437|FG001|Overall Study|Biochemical Progression|7|||
105837933|NCT00988208|365064436|FG000|Overall Study|Clinical Deterioration|7|||
105837934|NCT00988208|365064437|FG001|Overall Study|Clinical Deterioration|14|||
105837935|NCT00988208|365064436|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
105837936|NCT00988208|365064437|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
105837937|NCT00988208|365064436|FG000|Overall Study|Other|8|||
105837938|NCT00988208|365064437|FG001|Overall Study|Other|3|||
105966089|NCT00327015|365535602|FG001|Overall Study|Poor/Noncompliance|8|||
105966090|NCT00327015|365535603|FG002|Overall Study|Poor/Noncompliance|4|||
105966091|NCT00327015|365535604|FG003|Overall Study|Poor/Noncompliance|5|||
105966092|NCT00327015|365535601|FG000|Overall Study|Physician Decision|0|||
105966093|NCT00327015|365535602|FG001|Overall Study|Physician Decision|1|||
105966094|NCT00327015|365535603|FG002|Overall Study|Physician Decision|3|||
105966095|NCT00327015|365535604|FG003|Overall Study|Physician Decision|2|||
105966096|NCT00327015|365535601|FG000|Overall Study|Death|1|||
105966097|NCT00327015|365535602|FG001|Overall Study|Death|2|||
105966098|NCT00327015|365535603|FG002|Overall Study|Death|2|||
105966099|NCT00327015|365535604|FG003|Overall Study|Death|3|||
105966100|NCT00327015|365535601|FG000|Overall Study|Pregnancy|0|||
105966101|NCT00327015|365535602|FG001|Overall Study|Pregnancy|2|||
105966102|NCT00327015|365535603|FG002|Overall Study|Pregnancy|1|||
105966103|NCT00327015|365535604|FG003|Overall Study|Pregnancy|1|||
105966104|NCT00327015|365535601|FG000|Overall Study|Administrative Reason by Sponsor|1|||
105966105|NCT00327015|365535602|FG001|Overall Study|Administrative Reason by Sponsor|2|||
105966106|NCT00327015|365535603|FG002|Overall Study|Administrative Reason by Sponsor|2|||
105966107|NCT00327015|365535604|FG003|Overall Study|Administrative Reason by Sponsor|1|||
105966108|NCT01406938|365535605|FG000|Induction Period|Subject/guardian decision|6|||
105966109|NCT01406938|365535606|FG001|Induction Period|Subject/guardian decision|8|||
105966110|NCT01406938|365535607|FG002|Induction Period|Subject/guardian decision|0|||
105966111|NCT01406938|365535608|FG003|Induction Period|Subject/guardian decision|0|||
105966112|NCT01406938|365535609|FG004|Induction Period|Subject/guardian decision|0|||
105966113|NCT01406938|365535610|FG005|Induction Period|Subject/guardian decision|0|||
105966114|NCT01406938|365535605|FG000|Induction Period|Protocol deviation|1|||
105966115|NCT01406938|365535606|FG001|Induction Period|Protocol deviation|0|||
105966116|NCT01406938|365535607|FG002|Induction Period|Protocol deviation|0|||
105966117|NCT01406938|365535608|FG003|Induction Period|Protocol deviation|0|||
105966118|NCT01406938|365535609|FG004|Induction Period|Protocol deviation|0|||
105966119|NCT01406938|365535610|FG005|Induction Period|Protocol deviation|0|||
105966120|NCT01406938|365535605|FG000|Induction Period|Adverse Event|8|||
105966121|NCT01406938|365535606|FG001|Induction Period|Adverse Event|9|||
105966122|NCT01406938|365535607|FG002|Induction Period|Adverse Event|0|||
105966123|NCT01406938|365535608|FG003|Induction Period|Adverse Event|0|||
105966124|NCT01406938|365535609|FG004|Induction Period|Adverse Event|0|||
105966125|NCT01406938|365535610|FG005|Induction Period|Adverse Event|0|||
105966126|NCT01406938|365535605|FG000|Induction Period|Lack of Efficacy|1|||
105966127|NCT01406938|365535606|FG001|Induction Period|Lack of Efficacy|0|||
105966128|NCT01406938|365535607|FG002|Induction Period|Lack of Efficacy|0|||
105966129|NCT01406938|365535608|FG003|Induction Period|Lack of Efficacy|0|||
105966130|NCT01406938|365535609|FG004|Induction Period|Lack of Efficacy|0|||
105966131|NCT01406938|365535610|FG005|Induction Period|Lack of Efficacy|0|||
105966132|NCT01406938|365535605|FG000|Induction Period|Lost to Follow-up|2|||
105966133|NCT01406938|365535606|FG001|Induction Period|Lost to Follow-up|3|||
105966134|NCT01406938|365535607|FG002|Induction Period|Lost to Follow-up|0|||
105837939|NCT01796964|365064438|FG000|Overall Study|Adverse Event|1|||
105837940|NCT01796964|365064439|FG001|Overall Study|Adverse Event|1|||
105837941|NCT01796964|365064438|FG000|Overall Study|Death|1|||
105966135|NCT01406938|365535608|FG003|Induction Period|Lost to Follow-up|0|||
105966136|NCT01406938|365535609|FG004|Induction Period|Lost to Follow-up|0|||
105966137|NCT01406938|365535610|FG005|Induction Period|Lost to Follow-up|0|||
105966138|NCT01406938|365535605|FG000|Maintenance Period|Adverse Event|0|||
105966139|NCT01406938|365535606|FG001|Maintenance Period|Adverse Event|0|||
105966140|NCT01406938|365535607|FG002|Maintenance Period|Adverse Event|2|||
105837942|NCT01796964|365064439|FG001|Overall Study|Death|0|||
105837943|NCT01796964|365064438|FG000|Overall Study|Protocol Violation|0|||
105966141|NCT01406938|365535608|FG003|Maintenance Period|Adverse Event|8|||
105966142|NCT01406938|365535609|FG004|Maintenance Period|Adverse Event|4|||
105966143|NCT01406938|365535610|FG005|Maintenance Period|Adverse Event|2|||
105966144|NCT01406938|365535605|FG000|Maintenance Period|Death|0|||
105966145|NCT01406938|365535606|FG001|Maintenance Period|Death|0|||
105966146|NCT01406938|365535607|FG002|Maintenance Period|Death|0|||
105837944|NCT01796964|365064439|FG001|Overall Study|Protocol Violation|1|||
105837945|NCT01796964|365064438|FG000|Overall Study|Withdrawal by Subject|1|||
105837946|NCT01796964|365064439|FG001|Overall Study|Withdrawal by Subject|1|||
105837947|NCT00611884|365064440|FG000|Overall Study|Adverse Event|1|||
105837948|NCT00611884|365064441|FG001|Overall Study|Adverse Event|0|||
105837949|NCT00611884|365064442|FG002|Overall Study|Adverse Event|0|||
105837950|NCT00611884|365064443|FG003|Overall Study|Adverse Event|1|||
105837951|NCT00611884|365064440|FG000|Overall Study|Non-Compliance|1|||
105837952|NCT00611884|365064441|FG001|Overall Study|Non-Compliance|4|||
105837953|NCT00611884|365064442|FG002|Overall Study|Non-Compliance|2|||
105837954|NCT00611884|365064443|FG003|Overall Study|Non-Compliance|2|||
105837955|NCT00611884|365064440|FG000|Overall Study|Lack of Efficacy|0|||
105837956|NCT00611884|365064441|FG001|Overall Study|Lack of Efficacy|1|||
105837957|NCT00611884|365064442|FG002|Overall Study|Lack of Efficacy|0|||
105837958|NCT00611884|365064443|FG003|Overall Study|Lack of Efficacy|0|||
105837959|NCT00611884|365064440|FG000|Overall Study|Unclassified|7|||
105837960|NCT00611884|365064441|FG001|Overall Study|Unclassified|4|||
105837961|NCT00611884|365064442|FG002|Overall Study|Unclassified|2|||
105837962|NCT00611884|365064443|FG003|Overall Study|Unclassified|3|||
105837963|NCT01201759|365064444|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
105837964|NCT01201759|365064445|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
105837965|NCT01201759|365064444|FG000|Visit 3 - Washout|Adverse Event|0|||
105837966|NCT01201759|365064445|FG001|Visit 3 - Washout|Adverse Event|3|||
105837967|NCT01201759|365064444|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
105837968|NCT01201759|365064445|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
105837969|NCT01201759|365064444|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
105837970|NCT01201759|365064445|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
105837971|NCT00981799|365064446|FG000|Overall Study|Adverse Event|1|||
105837972|NCT00981799|365064447|FG001|Overall Study|Adverse Event|1|||
105837973|NCT00981799|365064448|FG002|Overall Study|Adverse Event|0|||
105837974|NCT00981799|365064449|FG003|Overall Study|Adverse Event|0|||
105837975|NCT01844531|365064452|FG000|Overall Study|Withdrawal by Subject|0|||
105837976|NCT01844531|365064453|FG001|Overall Study|Withdrawal by Subject|1|||
105837977|NCT01844531|365064454|FG002|Overall Study|Withdrawal by Subject|0|||
105837978|NCT01844531|365064455|FG003|Overall Study|Withdrawal by Subject|0|||
105837979|NCT00906373|365064456|FG000|Overall Study|Withdrawal by Subject|0|||
105837980|NCT00906373|365064457|FG001|Overall Study|Withdrawal by Subject|5|||
105837981|NCT00906373|365064456|FG000|Overall Study|Other|0|||
105837982|NCT00906373|365064457|FG001|Overall Study|Other|1|||
105837983|NCT00906373|365064456|FG000|Overall Study|Still on treatment at cutoff date|0|||
105837984|NCT00906373|365064457|FG001|Overall Study|Still on treatment at cutoff date|2|||
105837985|NCT01597479|365064458|FG000|Overall Study|Protocol Violation|1|||
105837986|NCT01597479|365064459|FG001|Overall Study|Protocol Violation|0|||
105837987|NCT01597479|365064458|FG000|Overall Study|Lost to Follow-up|1|||
105837988|NCT01597479|365064459|FG001|Overall Study|Lost to Follow-up|0|||
105837989|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
105837990|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
105837991|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
105837992|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
105837993|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
105837994|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
105837995|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
105837996|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
105837997|NCT01045707|365064462|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
105837998|NCT01045707|365064463|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
105837999|NCT01045707|365064462|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
105838000|NCT01045707|365064463|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
105838001|NCT01045707|365064462|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
105838002|NCT01045707|365064463|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
105838003|NCT01045707|365064462|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
105838004|NCT01045707|365064463|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
105838005|NCT01045707|365064462|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
105838006|NCT01045707|365064463|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
105838007|NCT00317642|365064476|FG000|Overall Study|Not Received Either Study Drug|1|||
105838008|NCT00317642|365064477|FG001|Overall Study|Not Received Either Study Drug|3|||
105838009|NCT00317642|365064476|FG000|Overall Study|Physician Decision|15|||
105838010|NCT00317642|365064477|FG001|Overall Study|Physician Decision|7|||
105838011|NCT00317642|365064476|FG000|Overall Study|Participant declined treatment|14|||
105838012|NCT00317642|365064477|FG001|Overall Study|Participant declined treatment|3|||
105838013|NCT00317642|365064476|FG000|Overall Study|Adverse Event|17|||
105838014|NCT00317642|365064477|FG001|Overall Study|Adverse Event|5|||
105838015|NCT00317642|365064476|FG000|Overall Study|Treatment Failure|56|||
106023468|NCT00282308|365750404|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
106023469|NCT00282308|365750402|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
106023470|NCT00282308|365750403|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
105838016|NCT00317642|365064477|FG001|Overall Study|Treatment Failure|102|||
105838017|NCT00317642|365064476|FG000|Overall Study|Disease Recurrence|1|||
105838018|NCT00317642|365064477|FG001|Overall Study|Disease Recurrence|2|||
105838019|NCT00317642|365064476|FG000|Overall Study|Death|14|||
105838020|NCT00317642|365064477|FG001|Overall Study|Death|7|||
105838021|NCT00317642|365064476|FG000|Overall Study|Not Continue to Consolidation|2|||
105838022|NCT00317642|365064477|FG001|Overall Study|Not Continue to Consolidation|0|||
105838023|NCT00317642|365064476|FG000|Overall Study|Withdrawal by Subject|0|||
105838024|NCT00317642|365064477|FG001|Overall Study|Withdrawal by Subject|1|||
105838025|NCT00317642|365064476|FG000|Overall Study|Referred For Transplantation|1|||
105838026|NCT00317642|365064477|FG001|Overall Study|Referred For Transplantation|0|||
105838027|NCT00317642|365064476|FG000|Overall Study|AML Not Centrally Confirmed|1|||
105838028|NCT00317642|365064477|FG001|Overall Study|AML Not Centrally Confirmed|5|||
105838029|NCT04317599|365064478|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
105838030|NCT04317599|365064478|FG000|Overall Study|treatment outside standard of care|4|||
105838031|NCT00809965|365064479|FG000|Overall Study|Death|194|||
105838032|NCT00809965|365064480|FG001|Overall Study|Death|147|||
105838033|NCT00809965|365064481|FG002|Overall Study|Death|196|||
105838034|NCT00809965|365064479|FG000|Overall Study|Lost to Follow-up|17|||
105838035|NCT00809965|365064480|FG001|Overall Study|Lost to Follow-up|10|||
105838036|NCT00809965|365064481|FG002|Overall Study|Lost to Follow-up|18|||
105838037|NCT00809965|365064479|FG000|Overall Study|Withdrawal by Subject|405|||
105838038|NCT00809965|365064480|FG001|Overall Study|Withdrawal by Subject|448|||
105838039|NCT00809965|365064481|FG002|Overall Study|Withdrawal by Subject|441|||
105838040|NCT00809965|365064479|FG000|Overall Study|Other Reason|167|||
105838041|NCT00809965|365064480|FG001|Overall Study|Other Reason|170|||
105838042|NCT00809965|365064481|FG002|Overall Study|Other Reason|189|||
105838043|NCT02315066|365064482|FG000|Overall Study|Lost to Follow-up|0|||
105838044|NCT02315066|365064483|FG001|Overall Study|Lost to Follow-up|1|||
105838045|NCT02315066|365064484|FG002|Overall Study|Lost to Follow-up|1|||
105838046|NCT02315066|365064485|FG003|Overall Study|Lost to Follow-up|0|||
105838047|NCT02315066|365064486|FG004|Overall Study|Lost to Follow-up|1|||
105838048|NCT02315066|365064487|FG005|Overall Study|Lost to Follow-up|0|||
105838049|NCT02315066|365064488|FG006|Overall Study|Lost to Follow-up|2|||
105838050|NCT02315066|365064489|FG007|Overall Study|Lost to Follow-up|1|||
105838051|NCT02315066|365064490|FG008|Overall Study|Lost to Follow-up|0|||
105838052|NCT02315066|365064491|FG009|Overall Study|Lost to Follow-up|0|||
105838053|NCT02315066|365064492|FG010|Overall Study|Lost to Follow-up|1|||
105838054|NCT02315066|365064493|FG011|Overall Study|Lost to Follow-up|2|||
105838055|NCT02315066|365064494|FG012|Overall Study|Lost to Follow-up|0|||
105838056|NCT02315066|365064495|FG013|Overall Study|Lost to Follow-up|4|||
105838057|NCT02315066|365064482|FG000|Overall Study|Death|2|||
105838058|NCT02315066|365064483|FG001|Overall Study|Death|7|||
105838059|NCT02315066|365064484|FG002|Overall Study|Death|6|||
105838060|NCT02315066|365064485|FG003|Overall Study|Death|11|||
105838061|NCT02315066|365064486|FG004|Overall Study|Death|10|||
105838062|NCT02315066|365064487|FG005|Overall Study|Death|3|||
105838063|NCT02315066|365064488|FG006|Overall Study|Death|9|||
105838064|NCT02315066|365064489|FG007|Overall Study|Death|9|||
105838065|NCT02315066|365064490|FG008|Overall Study|Death|10|||
105838066|NCT02315066|365064491|FG009|Overall Study|Death|8|||
105838067|NCT02315066|365064492|FG010|Overall Study|Death|10|||
105838068|NCT02315066|365064493|FG011|Overall Study|Death|7|||
105838069|NCT02315066|365064494|FG012|Overall Study|Death|8|||
105838070|NCT02315066|365064495|FG013|Overall Study|Death|21|||
105838071|NCT02315066|365064482|FG000|Overall Study|Other|0|||
105838072|NCT02315066|365064483|FG001|Overall Study|Other|0|||
105838073|NCT02315066|365064484|FG002|Overall Study|Other|0|||
105838074|NCT02315066|365064485|FG003|Overall Study|Other|0|||
105838075|NCT02315066|365064486|FG004|Overall Study|Other|0|||
105838076|NCT02315066|365064487|FG005|Overall Study|Other|0|||
105838077|NCT02315066|365064488|FG006|Overall Study|Other|0|||
105838078|NCT02315066|365064489|FG007|Overall Study|Other|1|||
105838079|NCT02315066|365064490|FG008|Overall Study|Other|1|||
105838080|NCT02315066|365064491|FG009|Overall Study|Other|2|||
105838081|NCT02315066|365064492|FG010|Overall Study|Other|0|||
105838082|NCT02315066|365064493|FG011|Overall Study|Other|0|||
105838083|NCT02315066|365064494|FG012|Overall Study|Other|0|||
106149305|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105838084|NCT02315066|365064495|FG013|Overall Study|Other|0|||
105838085|NCT02315066|365064482|FG000|Overall Study|Subject refused further follow-up|0|||
105838086|NCT02315066|365064483|FG001|Overall Study|Subject refused further follow-up|2|||
105838087|NCT02315066|365064484|FG002|Overall Study|Subject refused further follow-up|2|||
105838088|NCT02315066|365064485|FG003|Overall Study|Subject refused further follow-up|0|||
105838089|NCT02315066|365064486|FG004|Overall Study|Subject refused further follow-up|0|||
105838090|NCT02315066|365064487|FG005|Overall Study|Subject refused further follow-up|0|||
105966147|NCT01406938|365535608|FG003|Maintenance Period|Death|0|||
105966148|NCT01406938|365535609|FG004|Maintenance Period|Death|1|||
105966149|NCT01406938|365535610|FG005|Maintenance Period|Death|0|||
105966150|NCT01406938|365535605|FG000|Maintenance Period|Subject/guardian decision|0|||
105966151|NCT01406938|365535606|FG001|Maintenance Period|Subject/guardian decision|0|||
105966152|NCT01406938|365535607|FG002|Maintenance Period|Subject/guardian decision|11|||
105966153|NCT01406938|365535608|FG003|Maintenance Period|Subject/guardian decision|7|||
105966154|NCT01406938|365535609|FG004|Maintenance Period|Subject/guardian decision|10|||
105966155|NCT01406938|365535610|FG005|Maintenance Period|Subject/guardian decision|7|||
105966156|NCT01406938|365535605|FG000|Maintenance Period|Protocol Violation|0|||
105966157|NCT01406938|365535606|FG001|Maintenance Period|Protocol Violation|0|||
105966158|NCT01406938|365535607|FG002|Maintenance Period|Protocol Violation|2|||
105966159|NCT01406938|365535608|FG003|Maintenance Period|Protocol Violation|2|||
105966160|NCT01406938|365535609|FG004|Maintenance Period|Protocol Violation|2|||
105966161|NCT01406938|365535610|FG005|Maintenance Period|Protocol Violation|2|||
105966162|NCT01406938|365535605|FG000|Maintenance Period|Pregnancy|0|||
105966163|NCT01406938|365535606|FG001|Maintenance Period|Pregnancy|0|||
105966164|NCT01406938|365535607|FG002|Maintenance Period|Pregnancy|0|||
105966165|NCT01406938|365535608|FG003|Maintenance Period|Pregnancy|0|||
105966166|NCT01406938|365535609|FG004|Maintenance Period|Pregnancy|1|||
105966167|NCT01406938|365535610|FG005|Maintenance Period|Pregnancy|0|||
105966168|NCT01406938|365535605|FG000|Maintenance Period|Lost to Follow-up|0|||
105966169|NCT01406938|365535606|FG001|Maintenance Period|Lost to Follow-up|0|||
105966170|NCT01406938|365535607|FG002|Maintenance Period|Lost to Follow-up|0|||
105966171|NCT01406938|365535608|FG003|Maintenance Period|Lost to Follow-up|0|||
105966172|NCT01406938|365535609|FG004|Maintenance Period|Lost to Follow-up|4|||
105966173|NCT01406938|365535610|FG005|Maintenance Period|Lost to Follow-up|0|||
105966174|NCT01406938|365535605|FG000|Maintenance Period|Lack of Efficacy|0|||
105966175|NCT01406938|365535606|FG001|Maintenance Period|Lack of Efficacy|0|||
105966176|NCT01406938|365535607|FG002|Maintenance Period|Lack of Efficacy|2|||
105966177|NCT01406938|365535608|FG003|Maintenance Period|Lack of Efficacy|1|||
105966178|NCT01406938|365535609|FG004|Maintenance Period|Lack of Efficacy|3|||
105966179|NCT01406938|365535610|FG005|Maintenance Period|Lack of Efficacy|5|||
105966180|NCT01406938|365535605|FG000|Follow up|Lack of Efficacy|3|||
105966181|NCT01406938|365535606|FG001|Follow up|Lack of Efficacy|2|||
105966182|NCT01406938|365535607|FG002|Follow up|Lack of Efficacy|1|||
105966183|NCT01406938|365535608|FG003|Follow up|Lack of Efficacy|0|||
105966184|NCT01406938|365535609|FG004|Follow up|Lack of Efficacy|0|||
105966185|NCT01406938|365535610|FG005|Follow up|Lack of Efficacy|0|||
105966186|NCT01406938|365535605|FG000|Follow up|Patient/guardian decision|4|||
105966187|NCT01406938|365535606|FG001|Follow up|Patient/guardian decision|2|||
105966188|NCT01406938|365535607|FG002|Follow up|Patient/guardian decision|4|||
105966189|NCT01406938|365535608|FG003|Follow up|Patient/guardian decision|2|||
105966190|NCT01406938|365535609|FG004|Follow up|Patient/guardian decision|4|||
105966191|NCT01406938|365535610|FG005|Follow up|Patient/guardian decision|1|||
105966192|NCT01406938|365535605|FG000|Follow up|Protocol Violation|0|||
105966193|NCT01406938|365535606|FG001|Follow up|Protocol Violation|0|||
105966194|NCT01406938|365535607|FG002|Follow up|Protocol Violation|1|||
105966195|NCT01406938|365535608|FG003|Follow up|Protocol Violation|0|||
105966196|NCT01406938|365535609|FG004|Follow up|Protocol Violation|0|||
105966197|NCT01406938|365535610|FG005|Follow up|Protocol Violation|0|||
105966198|NCT01406938|365535605|FG000|Follow up|Physician Decision|0|||
105966199|NCT01406938|365535606|FG001|Follow up|Physician Decision|0|||
105966200|NCT01406938|365535607|FG002|Follow up|Physician Decision|2|||
105966201|NCT01406938|365535608|FG003|Follow up|Physician Decision|0|||
105966202|NCT01406938|365535609|FG004|Follow up|Physician Decision|3|||
105966203|NCT01406938|365535610|FG005|Follow up|Physician Decision|1|||
105966204|NCT01406938|365535605|FG000|Follow up|Lost to Follow-up|1|||
105966205|NCT01406938|365535606|FG001|Follow up|Lost to Follow-up|1|||
105966206|NCT01406938|365535607|FG002|Follow up|Lost to Follow-up|0|||
105966207|NCT01406938|365535608|FG003|Follow up|Lost to Follow-up|1|||
105966208|NCT01406938|365535609|FG004|Follow up|Lost to Follow-up|2|||
105966209|NCT01406938|365535610|FG005|Follow up|Lost to Follow-up|1|||
105966210|NCT01549886|365535613|FG000|Overall Study|Sponsor's decision|2|||
105966211|NCT01549886|365535614|FG001|Overall Study|Sponsor's decision|3|||
105966212|NCT03576066|365535615|FG000|Overall Study|Noncompliance with study drug|0|||
105966213|NCT03576066|365535616|FG001|Overall Study|Noncompliance with study drug|1|||
105966214|NCT00006164|365535617|FG000|Overall Study|Withdrew or lost to follow-up|70|||
105966215|NCT00006164|365535618|FG001|Overall Study|Withdrew or lost to follow-up|81|||
105966216|NCT00633074|365535619|FG000|Overall Study|Adverse Event|1|||
105966217|NCT00633074|365535620|FG001|Overall Study|Adverse Event|0|||
105966218|NCT04484649|365535621|FG000|Overall Study|Lost to Follow-up|2|||
105966219|NCT04484649|365535622|FG001|Overall Study|Lost to Follow-up|1|||
105966220|NCT04484649|365535621|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
105966221|NCT04484649|365535622|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
105966222|NCT03883165|365535625|FG000|Overall Study|Withdrawal by Subject|4|||
105966223|NCT03883165|365535626|FG001|Overall Study|Withdrawal by Subject|3|||
105966224|NCT00425698|365535627|FG000|Overall Study|Adverse Event|3|||
105966225|NCT00425698|365535628|FG001|Overall Study|Adverse Event|1|||
105966226|NCT00425698|365535627|FG000|Overall Study|Withdrawal by Subject|0|||
105966227|NCT00425698|365535628|FG001|Overall Study|Withdrawal by Subject|1|||
105966228|NCT02570152|365535629|FG000|Overall Study|Protocol Violation|2|||
105966229|NCT02570152|365535629|FG000|Overall Study|Migrated/moved from study area|13|||
105966230|NCT01126268|365535632|FG000|Overall Study|Adverse Event|1|||
105966231|NCT01205061|365535633|FG000|Overall Study|Adverse Event|4|||
105966232|NCT01205061|365535633|FG000|Overall Study|Withdrawal by Subject|11|||
105966233|NCT01205061|365535633|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
105966234|NCT01205061|365535633|FG000|Overall Study|Lost to Follow-up|9|||
105966235|NCT01205061|365535633|FG000|Overall Study|Other|1|||
105966236|NCT00765037|365535634|FG000|Overall Study|Lost to Follow-up|5|||
105966237|NCT00765037|365535634|FG000|Overall Study|Adverse Event|1|||
105966238|NCT04026009|365535639|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105966239|NCT04026009|365535640|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105966240|NCT04026009|365535641|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
105966241|NCT04026009|365535642|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
105966242|NCT04026009|365535643|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
105966243|NCT04026009|365535639|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
105966244|NCT04026009|365535640|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
105966245|NCT04026009|365535641|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
105966246|NCT04026009|365535642|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
105966247|NCT04026009|365535643|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
105966248|NCT01988662|365535644|FG000|Overall Study|Subject/guardian decision|1|||
105966249|NCT01988662|365535645|FG001|Overall Study|Subject/guardian decision|1|||
106023471|NCT00282308|365750404|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
106023472|NCT00282308|365750402|FG000|Safety Follow-up Period|Adverse Event|0|||
106023473|NCT00282308|365750403|FG001|Safety Follow-up Period|Adverse Event|0|||
106023474|NCT00282308|365750404|FG002|Safety Follow-up Period|Adverse Event|1|||
106023475|NCT00282308|365750402|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
106023476|NCT00282308|365750403|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
106023477|NCT00282308|365750404|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
106023478|NCT00282308|365750402|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
106023479|NCT00282308|365750403|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
106023480|NCT00282308|365750404|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
106023481|NCT00282308|365750402|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
106023482|NCT00282308|365750403|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
105966250|NCT01988662|365535644|FG000|Overall Study|Adverse Event|3|||
105966251|NCT01988662|365535645|FG001|Overall Study|Adverse Event|1|||
105966252|NCT01177553|365535646|FG000|Overall Study|babies not yet 6 months of age|1|||
105966253|NCT01177553|365535647|FG001|Overall Study|babies not yet 6 months of age|0|||
105966254|NCT04752566|365535660|FG000|Overall Study|Protocol Violation|0|||
105966255|NCT04752566|365535661|FG001|Overall Study|Protocol Violation|1|||
105966256|NCT04752566|365535660|FG000|Overall Study|Death|1|||
105966257|NCT04752566|365535661|FG001|Overall Study|Death|0|||
105966258|NCT04752566|365535660|FG000|Overall Study|Adverse Event|1|||
105966259|NCT04752566|365535661|FG001|Overall Study|Adverse Event|0|||
105966260|NCT04752566|365535660|FG000|Overall Study|Withdrawal by Subject|2|||
105966261|NCT04752566|365535661|FG001|Overall Study|Withdrawal by Subject|0|||
105966262|NCT04752566|365535660|FG000|Overall Study|Physician Decision|1|||
105966263|NCT04752566|365535661|FG001|Overall Study|Physician Decision|1|||
105966264|NCT03831191|365535662|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
105966265|NCT03831191|365535663|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
105966266|NCT03831191|365535664|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
106023483|NCT00282308|365750404|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
106023484|NCT00530504|365750406|FG000|Overall Study|Death|54|||
106023485|NCT00530504|365750406|FG000|Overall Study|Lost to Follow-up|26|||
105966267|NCT03831191|365535665|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
105966268|NCT03831191|365535666|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
105966269|NCT03831191|365535667|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
106023486|NCT00530504|365750406|FG000|Overall Study|Withdrawal by Subject|39|||
106023487|NCT00530504|365750406|FG000|Overall Study|Exited study due to other reasons|33|||
106023488|NCT00006289|365750407|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
106023489|NCT00006289|365750408|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
105966270|NCT03831191|365535668|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
105966271|NCT03831191|365535669|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
105966272|NCT03831191|365535670|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
105966273|NCT03831191|365535671|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
105966274|NCT03831191|365535672|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
106023490|NCT00006289|365750407|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
105838091|NCT02315066|365064488|FG006|Overall Study|Subject refused further follow-up|2|||
105838092|NCT02315066|365064489|FG007|Overall Study|Subject refused further follow-up|3|||
105838093|NCT02315066|365064490|FG008|Overall Study|Subject refused further follow-up|0|||
106023491|NCT00006289|365750408|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
106023492|NCT04359901|365750409|FG000|Overall Study|Withdrawal by Subject|0|||
106023493|NCT04359901|365750410|FG001|Overall Study|Withdrawal by Subject|1|||
106023494|NCT04359901|365750409|FG000|Overall Study|Death|6|||
106023495|NCT04359901|365750410|FG001|Overall Study|Death|2|||
106023496|NCT02872285|365750411|FG000|Overall Study|Withdrawal by Subject|2|||
106023497|NCT02872285|365750412|FG001|Overall Study|Withdrawal by Subject|0|||
106023498|NCT02872285|365750411|FG000|Overall Study|Lost to Follow-up|2|||
106023499|NCT02872285|365750412|FG001|Overall Study|Lost to Follow-up|2|||
106023500|NCT02872285|365750411|FG000|Overall Study|Discontinued due to back surgery|1|||
106023501|NCT02872285|365750412|FG001|Overall Study|Discontinued due to back surgery|0|||
106023502|NCT02660983|365750413|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
106023503|NCT02660983|365750414|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
106023504|NCT02660983|365750413|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
106023505|NCT02660983|365750414|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
106023506|NCT02660983|365750413|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
105838094|NCT02315066|365064491|FG009|Overall Study|Subject refused further follow-up|1|||
105838095|NCT02315066|365064492|FG010|Overall Study|Subject refused further follow-up|1|||
105838096|NCT02315066|365064493|FG011|Overall Study|Subject refused further follow-up|2|||
105838097|NCT02315066|365064494|FG012|Overall Study|Subject refused further follow-up|2|||
105838098|NCT02315066|365064495|FG013|Overall Study|Subject refused further follow-up|4|||
105838099|NCT02315066|365064482|FG000|Overall Study|Study ongoing at date of cut-off|0|||
105838100|NCT02315066|365064483|FG001|Overall Study|Study ongoing at date of cut-off|0|||
105838101|NCT02315066|365064484|FG002|Overall Study|Study ongoing at date of cut-off|0|||
105838102|NCT02315066|365064485|FG003|Overall Study|Study ongoing at date of cut-off|0|||
105838103|NCT02315066|365064486|FG004|Overall Study|Study ongoing at date of cut-off|0|||
105838104|NCT02315066|365064487|FG005|Overall Study|Study ongoing at date of cut-off|0|||
105838105|NCT02315066|365064488|FG006|Overall Study|Study ongoing at date of cut-off|0|||
105838106|NCT02315066|365064489|FG007|Overall Study|Study ongoing at date of cut-off|0|||
105838107|NCT02315066|365064490|FG008|Overall Study|Study ongoing at date of cut-off|0|||
105838108|NCT02315066|365064491|FG009|Overall Study|Study ongoing at date of cut-off|0|||
105838109|NCT02315066|365064492|FG010|Overall Study|Study ongoing at date of cut-off|0|||
105838110|NCT02315066|365064493|FG011|Overall Study|Study ongoing at date of cut-off|0|||
105838111|NCT02315066|365064494|FG012|Overall Study|Study ongoing at date of cut-off|0|||
105838112|NCT02315066|365064495|FG013|Overall Study|Study ongoing at date of cut-off|1|||
105838113|NCT03180801|365064496|FG000|Overall Study|Physician Decision|3|||
105838114|NCT03180801|365064497|FG001|Overall Study|Physician Decision|3|||
105838115|NCT03180801|365064498|FG002|Overall Study|Physician Decision|1|||
105838116|NCT03180801|365064496|FG000|Overall Study|Non-compliance|1|||
105838117|NCT03180801|365064497|FG001|Overall Study|Non-compliance|4|||
105838118|NCT03180801|365064498|FG002|Overall Study|Non-compliance|0|||
105838119|NCT03180801|365064496|FG000|Overall Study|Inoculation Target Reached|1|||
105838120|NCT03180801|365064497|FG001|Overall Study|Inoculation Target Reached|1|||
105838121|NCT03180801|365064498|FG002|Overall Study|Inoculation Target Reached|3|||
105838122|NCT03180801|365064496|FG000|Overall Study|Adverse Event|1|||
105838123|NCT03180801|365064497|FG001|Overall Study|Adverse Event|0|||
105838124|NCT03180801|365064498|FG002|Overall Study|Adverse Event|2|||
105838125|NCT03180801|365064496|FG000|Overall Study|Withdrawal by Subject|2|||
105838126|NCT03180801|365064497|FG001|Overall Study|Withdrawal by Subject|2|||
105838127|NCT03180801|365064498|FG002|Overall Study|Withdrawal by Subject|1|||
105838128|NCT03180801|365064496|FG000|Overall Study|Lost to Follow-up|0|||
105838129|NCT03180801|365064497|FG001|Overall Study|Lost to Follow-up|2|||
105838130|NCT03180801|365064498|FG002|Overall Study|Lost to Follow-up|3|||
105838131|NCT02618382|365064499|FG000|Overall Study|Physician Decision|1|||
105838132|NCT02618382|365064499|FG000|Overall Study|Withdrawal by Subject|1|||
106023507|NCT02660983|365750414|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
106023508|NCT02660983|365750413|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
106023509|NCT02660983|365750414|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
106023510|NCT02660983|365750413|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
106023511|NCT02660983|365750414|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
106023512|NCT02660983|365750413|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
105838133|NCT02618382|365064499|FG000|Overall Study|Protocol Violation|1|||
105838134|NCT01999894|365064500|FG000|Overall Study|Adverse Event|9|||
105838135|NCT01999894|365064500|FG000|Overall Study|Lack of Efficacy|5|||
105838136|NCT01999894|365064500|FG000|Overall Study|Protocol Violation|1|||
106023513|NCT02660983|365750414|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
105838137|NCT01999894|365064500|FG000|Overall Study|Withdrawal by Subject|7|||
105966275|NCT03831191|365535673|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
105966276|NCT03831191|365535674|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
105966277|NCT03831191|365535675|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
105966278|NCT03831191|365535676|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
105966279|NCT03831191|365535662|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
105966280|NCT03831191|365535663|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
105966281|NCT03831191|365535664|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966282|NCT03831191|365535665|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966283|NCT03831191|365535666|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966284|NCT03831191|365535667|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966285|NCT03831191|365535668|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
106023514|NCT02660983|365750413|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
106023515|NCT02660983|365750414|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
106023516|NCT01675167|365750415|FG000|Open-label Titration Phase|Adverse Event|81|||
106023517|NCT01675167|365750416|FG001|Open-label Titration Phase|Adverse Event|0|||
106023518|NCT01675167|365750417|FG002|Open-label Titration Phase|Adverse Event|0|||
106023519|NCT01675167|365750415|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
106023520|NCT01675167|365750416|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
106023521|NCT01675167|365750417|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
106023522|NCT01675167|365750415|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
106023523|NCT01675167|365750416|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
106023524|NCT01675167|365750417|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
106023525|NCT01675167|365750415|FG000|Open-label Titration Phase|Protocol Violation|43|||
106023526|NCT01675167|365750416|FG001|Open-label Titration Phase|Protocol Violation|0|||
106023527|NCT01675167|365750417|FG002|Open-label Titration Phase|Protocol Violation|0|||
106023528|NCT01675167|365750415|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
106023529|NCT01675167|365750416|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
106023530|NCT01675167|365750417|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
106023531|NCT01675167|365750415|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
106023532|NCT01675167|365750416|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
106023533|NCT01675167|365750417|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
106023534|NCT01675167|365750415|FG000|Open-label Titration Phase|Other|55|||
106023535|NCT01675167|365750416|FG001|Open-label Titration Phase|Other|0|||
106023536|NCT01675167|365750417|FG002|Open-label Titration Phase|Other|0|||
106023537|NCT01675167|365750415|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
106023538|NCT01675167|365750416|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
106023539|NCT01675167|365750417|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
106023540|NCT01675167|365750415|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
106023541|NCT01675167|365750416|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
106023542|NCT01675167|365750417|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
106023543|NCT01675167|365750415|FG000|Double-blind Treatment Phase|Adverse Event|0|||
105838138|NCT01999894|365064500|FG000|Overall Study|Lost to Follow-up|10|||
105838139|NCT01999894|365064500|FG000|Overall Study|Other Reason|3|||
105838140|NCT01999894|365064500|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
105838141|NCT00263887|365064502|FG000|Overall Study|Withdrawal by Subject|1|||
105838142|NCT00263887|365064503|FG001|Overall Study|Withdrawal by Subject|1|||
105838143|NCT00263887|365064502|FG000|Overall Study|Lung transplantation|1|||
105838144|NCT00263887|365064503|FG001|Overall Study|Lung transplantation|2|||
105838145|NCT00263887|365064502|FG000|Overall Study|Too ill to attend visit|1|||
105838146|NCT00263887|365064503|FG001|Overall Study|Too ill to attend visit|0|||
105838147|NCT00263887|365064502|FG000|Overall Study|Adverse Event|0|||
105838148|NCT00263887|365064503|FG001|Overall Study|Adverse Event|2|||
105838149|NCT00263887|365064502|FG000|Overall Study|Disease progression|0|||
105838150|NCT00263887|365064503|FG001|Overall Study|Disease progression|1|||
105838151|NCT00263887|365064502|FG000|Overall Study|Lack of Efficacy|0|||
105838152|NCT00263887|365064503|FG001|Overall Study|Lack of Efficacy|1|||
105838153|NCT00676494|365064513|FG000|Overall Study|Missed Visit|8|||
105838154|NCT00676494|365064513|FG000|Overall Study|Withdrawal by Subject|6|||
105838155|NCT01466036|365064516|FG000|Overall Study|Death|1|||
106023544|NCT01675167|365750416|FG001|Double-blind Treatment Phase|Adverse Event|5|||
106023545|NCT01675167|365750417|FG002|Double-blind Treatment Phase|Adverse Event|13|||
106023546|NCT01675167|365750415|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
106149306|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
106149307|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105838156|NCT01466036|365064517|FG001|Overall Study|Death|1|||
105838157|NCT01466036|365064516|FG000|Overall Study|Physician Decision|0|||
105838158|NCT01466036|365064517|FG001|Overall Study|Physician Decision|4|||
106023547|NCT01675167|365750416|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
106149308|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
105838159|NCT01466036|365064516|FG000|Overall Study|Adverse Event|2|||
105838160|NCT01466036|365064517|FG001|Overall Study|Adverse Event|6|||
105838161|NCT01466036|365064516|FG000|Overall Study|Withdrawal by Subject|2|||
105838162|NCT01466036|365064517|FG001|Overall Study|Withdrawal by Subject|8|||
105838163|NCT01466036|365064516|FG000|Overall Study|progression/relapse|14|||
105838164|NCT01466036|365064517|FG001|Overall Study|progression/relapse|21|||
105838165|NCT01466036|365064516|FG000|Overall Study|prolonged treatment delay|1|||
105838166|NCT01466036|365064517|FG001|Overall Study|prolonged treatment delay|1|||
105838167|NCT00819767|365064518|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105838168|NCT00819767|365064519|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105838169|NCT00983476|365064520|FG000|Overall Study|Did not receive intervention|17|||
105838170|NCT00983476|365064521|FG001|Overall Study|Did not receive intervention|22|||
105838171|NCT00983476|365064522|FG002|Overall Study|Did not receive intervention|0|||
105838172|NCT00761176|365064523|FG000|Overall Study|Death|1|||
105838173|NCT00761176|365064524|FG001|Overall Study|Death|0|||
105838174|NCT00761176|365064523|FG000|Overall Study|Withdrawal by Subject|1|||
105838175|NCT00761176|365064524|FG001|Overall Study|Withdrawal by Subject|1|||
105838176|NCT02020967|365064526|FG000|Overall Study|Withdrawal by Subject|51|||
105838177|NCT01857206|365064528|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
105838178|NCT01857206|365064529|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
105838179|NCT01857206|365064528|FG000|Overall Study|Lost to Follow-up|9|||
105838180|NCT01857206|365064529|FG001|Overall Study|Lost to Follow-up|6|||
105838181|NCT01857206|365064528|FG000|Overall Study|Unclassified|3|||
105838182|NCT01857206|365064529|FG001|Overall Study|Unclassified|3|||
105838183|NCT01857206|365064528|FG000|Overall Study|Withdrawal by Subject|1|||
105838184|NCT01857206|365064529|FG001|Overall Study|Withdrawal by Subject|0|||
105838185|NCT00476593|365064530|FG000|Overall Study|Lost to Follow-up|10|||
105838186|NCT00476593|365064531|FG001|Overall Study|Lost to Follow-up|2|||
105838187|NCT00476593|365064532|FG002|Overall Study|Lost to Follow-up|8|||
105838188|NCT00476593|365064533|FG003|Overall Study|Lost to Follow-up|22|||
105838189|NCT03430011|365064534|FG000|Pre-Treatment|Death|1|||
105838190|NCT03430011|365064535|FG001|Pre-Treatment|Death|0|||
105838191|NCT03430011|365064536|FG002|Pre-Treatment|Death|0|||
105838192|NCT03430011|365064537|FG003|Pre-Treatment|Death|0|||
105838193|NCT03430011|365064538|FG004|Pre-Treatment|Death|1|||
105838194|NCT03430011|365064539|FG005|Pre-Treatment|Death|0|||
105838195|NCT03430011|365064540|FG006|Pre-Treatment|Death|1|||
105838196|NCT03430011|365064541|FG007|Pre-Treatment|Death|0|||
105838197|NCT03430011|365064534|FG000|Pre-Treatment|Screen Fail|0|||
105838198|NCT03430011|365064535|FG001|Pre-Treatment|Screen Fail|0|||
105838199|NCT03430011|365064536|FG002|Pre-Treatment|Screen Fail|0|||
105838200|NCT03430011|365064537|FG003|Pre-Treatment|Screen Fail|0|||
105838201|NCT03430011|365064538|FG004|Pre-Treatment|Screen Fail|1|||
105838202|NCT03430011|365064539|FG005|Pre-Treatment|Screen Fail|0|||
105838203|NCT03430011|365064540|FG006|Pre-Treatment|Screen Fail|0|||
105838204|NCT03430011|365064541|FG007|Pre-Treatment|Screen Fail|0|||
105838205|NCT03430011|365064534|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838206|NCT03430011|365064535|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838207|NCT03430011|365064536|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
105838208|NCT03430011|365064537|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838209|NCT03430011|365064538|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838210|NCT03430011|365064539|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838211|NCT03430011|365064540|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838212|NCT03430011|365064541|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
105838213|NCT03430011|365064534|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
105838214|NCT03430011|365064535|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
105838215|NCT03430011|365064536|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
105838216|NCT03430011|365064537|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
105838217|NCT03430011|365064538|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
105838218|NCT03430011|365064539|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
105838219|NCT03430011|365064540|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
105838220|NCT03430011|365064541|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
105838221|NCT03430011|365064534|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
105838222|NCT03430011|365064535|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
105838223|NCT03430011|365064536|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
105838224|NCT03430011|365064537|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
105838225|NCT03430011|365064538|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
105838226|NCT03430011|365064539|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
105838227|NCT03430011|365064540|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
105838228|NCT03430011|365064541|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
105838229|NCT03430011|365064534|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
105838230|NCT03430011|365064535|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
105838231|NCT03430011|365064536|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
105838232|NCT03430011|365064537|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
105838233|NCT03430011|365064538|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
105838234|NCT03430011|365064539|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
105966286|NCT03831191|365535669|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966287|NCT03831191|365535670|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105838235|NCT03430011|365064540|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
105838236|NCT03430011|365064541|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
105838237|NCT03430011|365064534|FG000|JCARH125 Treatment|Death|4|||
105838238|NCT03430011|365064535|FG001|JCARH125 Treatment|Death|19|||
105838239|NCT03430011|365064536|FG002|JCARH125 Treatment|Death|10|||
105838240|NCT03430011|365064537|FG003|JCARH125 Treatment|Death|8|||
105838241|NCT03430011|365064538|FG004|JCARH125 Treatment|Death|5|||
105838242|NCT03430011|365064539|FG005|JCARH125 Treatment|Death|3|||
105838243|NCT03430011|365064540|FG006|JCARH125 Treatment|Death|4|||
105838244|NCT03430011|365064541|FG007|JCARH125 Treatment|Death|2|||
105838245|NCT03430011|365064534|FG000|JCARH125 Treatment|Other reasons|1|||
105838246|NCT03430011|365064535|FG001|JCARH125 Treatment|Other reasons|0|||
105838247|NCT03430011|365064536|FG002|JCARH125 Treatment|Other reasons|4|||
105838248|NCT03430011|365064537|FG003|JCARH125 Treatment|Other reasons|2|||
105838249|NCT03430011|365064538|FG004|JCARH125 Treatment|Other reasons|2|||
105838250|NCT03430011|365064539|FG005|JCARH125 Treatment|Other reasons|1|||
105838251|NCT03430011|365064540|FG006|JCARH125 Treatment|Other reasons|3|||
105838252|NCT03430011|365064541|FG007|JCARH125 Treatment|Other reasons|2|||
105838253|NCT00575380|365064542|FG000|Overall Study|Withdrawal by Subject|1|||
105838254|NCT00575380|365064543|FG001|Overall Study|Withdrawal by Subject|0|||
105838255|NCT00575380|365064542|FG000|Overall Study|Adverse Event|0|||
105838256|NCT00575380|365064543|FG001|Overall Study|Adverse Event|1|||
105838257|NCT00575380|365064542|FG000|Overall Study|Various|0|||
105838258|NCT00575380|365064543|FG001|Overall Study|Various|2|||
105838259|NCT03712124|365064553|FG000|Overall Study|Protocol Violation|1|||
105838260|NCT03712124|365064554|FG001|Overall Study|Protocol Violation|0|||
105838261|NCT01731886|365064555|FG000|Overall Study|Death|1|||
105838262|NCT01731886|365064556|FG001|Overall Study|Death|0|||
105838263|NCT01731886|365064555|FG000|Overall Study|Never started treatment|0|||
105838264|NCT01731886|365064556|FG001|Overall Study|Never started treatment|1|||
105838265|NCT01731886|365064555|FG000|Overall Study|Non-compliant|1|||
105838266|NCT01731886|365064556|FG001|Overall Study|Non-compliant|0|||
105838267|NCT00271024|365064557|FG000|Overall Study|Lost Interest|3|||
105838268|NCT00271024|365064558|FG001|Overall Study|Lost Interest|4|||
105838269|NCT00271024|365064559|FG002|Overall Study|Lost Interest|2|||
105838270|NCT00271024|365064560|FG003|Overall Study|Lost Interest|3|||
105838271|NCT00271024|365064557|FG000|Overall Study|Unknown/Unspecified|11|||
105838272|NCT00271024|365064558|FG001|Overall Study|Unknown/Unspecified|11|||
105838273|NCT00271024|365064559|FG002|Overall Study|Unknown/Unspecified|8|||
105838274|NCT00271024|365064560|FG003|Overall Study|Unknown/Unspecified|4|||
105838275|NCT00271024|365064557|FG000|Overall Study|Protocol Violation|1|||
105838276|NCT00271024|365064558|FG001|Overall Study|Protocol Violation|6|||
105838277|NCT00271024|365064559|FG002|Overall Study|Protocol Violation|5|||
105838278|NCT00271024|365064560|FG003|Overall Study|Protocol Violation|11|||
105838279|NCT00271024|365064557|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
105838280|NCT00271024|365064558|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
105838281|NCT00271024|365064559|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
105838282|NCT00271024|365064560|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
105838283|NCT00271024|365064557|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
105838284|NCT00271024|365064558|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
105838285|NCT00271024|365064559|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
105838286|NCT00271024|365064560|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
105838287|NCT02105701|365064564|FG000|Overall Study|Lost to Follow-up|1|||
105838288|NCT02105701|365064565|FG001|Overall Study|Lost to Follow-up|0|||
105838289|NCT02105701|365064566|FG002|Overall Study|Lost to Follow-up|2|||
105838290|NCT02105701|365064567|FG003|Overall Study|Lost to Follow-up|1|||
105838291|NCT02105701|365064564|FG000|Overall Study|Protocol Violation|0|||
105838292|NCT02105701|365064565|FG001|Overall Study|Protocol Violation|0|||
105838293|NCT02105701|365064566|FG002|Overall Study|Protocol Violation|1|||
105838294|NCT02105701|365064567|FG003|Overall Study|Protocol Violation|0|||
105838295|NCT02105701|365064564|FG000|Overall Study|Withdrawal by Subject|2|||
105838296|NCT02105701|365064565|FG001|Overall Study|Withdrawal by Subject|1|||
105838297|NCT02105701|365064566|FG002|Overall Study|Withdrawal by Subject|0|||
105838298|NCT02105701|365064567|FG003|Overall Study|Withdrawal by Subject|1|||
105838299|NCT02105701|365064564|FG000|Overall Study|Death|1|||
105838300|NCT02105701|365064565|FG001|Overall Study|Death|0|||
105838301|NCT02105701|365064566|FG002|Overall Study|Death|0|||
105838302|NCT02105701|365064567|FG003|Overall Study|Death|0|||
105838303|NCT03078478|365064568|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
105838304|NCT03078478|365064569|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
105838305|NCT03078478|365064568|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
105838306|NCT03078478|365064569|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
105838307|NCT03078478|365064568|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
105838308|NCT03078478|365064569|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
105838309|NCT03078478|365064568|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
105838310|NCT03078478|365064569|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
105838311|NCT03078478|365064568|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
105838312|NCT03078478|365064569|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
105838313|NCT03078478|365064568|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
105838314|NCT03078478|365064569|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
105838315|NCT03078478|365064568|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
105838316|NCT03078478|365064569|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
105838317|NCT03078478|365064568|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
105838318|NCT03078478|365064569|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
105838319|NCT02459418|365066222|FG000|Overall Study|Exclusion Criteria|4|||
105838320|NCT02459418|365066223|FG001|Overall Study|Exclusion Criteria|0|||
105838321|NCT02459418|365066222|FG000|Overall Study|Protocol Violation|0|||
105838322|NCT02459418|365066223|FG001|Overall Study|Protocol Violation|2|||
105838323|NCT02459418|365066222|FG000|Overall Study|Physician Decision|0|||
105838324|NCT02459418|365066223|FG001|Overall Study|Physician Decision|2|||
105838325|NCT02459418|365066222|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
105838326|NCT02459418|365066223|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
105838327|NCT02459418|365066222|FG000|Overall Study|Adverse Event|0|||
105838328|NCT02459418|365066223|FG001|Overall Study|Adverse Event|1|||
105838329|NCT02459418|365066222|FG000|Overall Study|Withdrawal by Subject|1|||
105838330|NCT02459418|365066223|FG001|Overall Study|Withdrawal by Subject|1|||
105838331|NCT02459418|365066222|FG000|Overall Study|Elevated Creatine Kinase|1|||
105838332|NCT02459418|365066223|FG001|Overall Study|Elevated Creatine Kinase|0|||
105838333|NCT02459418|365066222|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
105838334|NCT02459418|365066223|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
105838335|NCT01989676|365066224|FG000|Overall Study|Death|52|||
105838336|NCT01989676|365066225|FG001|Overall Study|Death|60|||
105838337|NCT01989676|365066224|FG000|Overall Study|Protocol Violation|2|||
105838338|NCT01989676|365066225|FG001|Overall Study|Protocol Violation|1|||
105838339|NCT01989676|365066224|FG000|Overall Study|Lost to Follow-up|8|||
105838340|NCT01989676|365066225|FG001|Overall Study|Lost to Follow-up|18|||
105838341|NCT01989676|365066224|FG000|Overall Study|No longer willing to participate in study|26|||
105838342|NCT01989676|365066225|FG001|Overall Study|No longer willing to participate in study|26|||
105838343|NCT01989676|365066224|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
105838344|NCT01989676|365066225|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
105838345|NCT01989676|365066224|FG000|Overall Study|Other|4|||
105838346|NCT01989676|365066225|FG001|Overall Study|Other|3|||
105838347|NCT03941834|365066226|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
105838348|NCT03941834|365066227|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
105838349|NCT03941834|365066228|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
105838350|NCT03941834|365066226|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
105838351|NCT03941834|365066227|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
105838352|NCT03941834|365066228|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
105838353|NCT03941834|365066226|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
105838354|NCT03941834|365066227|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
105838355|NCT03941834|365066228|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
105838356|NCT03941834|365066226|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
105838357|NCT03941834|365066227|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
105838358|NCT03941834|365066228|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
105838359|NCT03941834|365066226|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
105838360|NCT03941834|365066227|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
105838361|NCT03941834|365066228|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
105838362|NCT03941834|365066226|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
105838363|NCT03941834|365066227|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
105838364|NCT03941834|365066228|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
105838365|NCT02788513|365066233|FG000|Overall Study|Withdrawal by Subject|3|||
105838366|NCT02788513|365066234|FG001|Overall Study|Withdrawal by Subject|0|||
105838367|NCT02788513|365066235|FG002|Overall Study|Withdrawal by Subject|2|||
105838368|NCT02788513|365066236|FG003|Overall Study|Withdrawal by Subject|3|||
105838369|NCT02788513|365066237|FG004|Overall Study|Withdrawal by Subject|1|||
105838370|NCT02788513|365066233|FG000|Overall Study|Lost to Follow-up|1|||
105838371|NCT02788513|365066234|FG001|Overall Study|Lost to Follow-up|0|||
105838372|NCT02788513|365066235|FG002|Overall Study|Lost to Follow-up|0|||
105838373|NCT02788513|365066236|FG003|Overall Study|Lost to Follow-up|0|||
105838374|NCT02788513|365066237|FG004|Overall Study|Lost to Follow-up|1|||
105838375|NCT02788513|365066233|FG000|Overall Study|Adverse Event|5|||
105838376|NCT02788513|365066234|FG001|Overall Study|Adverse Event|8|||
105838377|NCT02788513|365066235|FG002|Overall Study|Adverse Event|4|||
105838378|NCT02788513|365066236|FG003|Overall Study|Adverse Event|2|||
105838379|NCT02788513|365066237|FG004|Overall Study|Adverse Event|2|||
105838380|NCT02788513|365066233|FG000|Overall Study|Protocol Violation|0|||
105838381|NCT02788513|365066234|FG001|Overall Study|Protocol Violation|0|||
105838382|NCT02788513|365066235|FG002|Overall Study|Protocol Violation|1|||
106149309|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
106149310|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
105838383|NCT02788513|365066236|FG003|Overall Study|Protocol Violation|1|||
105838384|NCT02788513|365066237|FG004|Overall Study|Protocol Violation|0|||
105838385|NCT02788513|365066233|FG000|Overall Study|Subject decided to stop taking treatment|0|||
105966288|NCT03831191|365535671|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966289|NCT03831191|365535672|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966290|NCT03831191|365535673|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966291|NCT03831191|365535674|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966292|NCT03831191|365535675|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966293|NCT03831191|365535676|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
105966294|NCT03831191|365535662|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
105966295|NCT03831191|365535663|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
105966296|NCT03831191|365535664|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
105966297|NCT03831191|365535665|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
105966298|NCT03831191|365535666|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
105966299|NCT03831191|365535667|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
105966300|NCT03831191|365535668|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
105966301|NCT03831191|365535669|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
105966302|NCT03831191|365535670|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
105966303|NCT03831191|365535671|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
105966304|NCT03831191|365535672|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
105966305|NCT03831191|365535673|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
105966306|NCT03831191|365535674|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
105966307|NCT03831191|365535675|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
105966308|NCT03831191|365535676|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
105966309|NCT03831191|365535662|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
105966310|NCT03831191|365535663|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
105966311|NCT03831191|365535664|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
105966312|NCT03831191|365535665|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
105966313|NCT03831191|365535666|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
105966314|NCT03831191|365535667|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
105966315|NCT03831191|365535668|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
105966316|NCT03831191|365535669|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
105966317|NCT03831191|365535670|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
105966318|NCT03831191|365535671|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
105966319|NCT03831191|365535672|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
105966320|NCT03831191|365535673|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
105966321|NCT03831191|365535674|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
105966322|NCT03831191|365535675|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
105966323|NCT03831191|365535676|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
105966324|NCT03831191|365535662|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
105966325|NCT03831191|365535663|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
105966326|NCT03831191|365535664|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
105966327|NCT03831191|365535665|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
105966328|NCT03831191|365535666|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966329|NCT03831191|365535667|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966330|NCT03831191|365535668|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966331|NCT03831191|365535669|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966332|NCT03831191|365535670|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966333|NCT03831191|365535671|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966334|NCT03831191|365535672|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966335|NCT03831191|365535673|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966336|NCT03831191|365535674|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966337|NCT03831191|365535675|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966338|NCT03831191|365535676|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
105966339|NCT03831191|365535662|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
105966340|NCT03831191|365535663|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
105966341|NCT03831191|365535664|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
105966342|NCT03831191|365535665|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
105966343|NCT03831191|365535666|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966344|NCT03831191|365535667|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966345|NCT03831191|365535668|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966346|NCT03831191|365535669|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966347|NCT03831191|365535670|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966348|NCT03831191|365535671|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966349|NCT03831191|365535672|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966350|NCT03831191|365535673|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966351|NCT03831191|365535674|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966352|NCT03831191|365535675|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966353|NCT03831191|365535676|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
105966354|NCT03831191|365535662|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966355|NCT03831191|365535663|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966356|NCT03831191|365535664|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966357|NCT03831191|365535665|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
105838386|NCT02788513|365066234|FG001|Overall Study|Subject decided to stop taking treatment|0|||
105838387|NCT02788513|365066235|FG002|Overall Study|Subject decided to stop taking treatment|1|||
105838388|NCT02788513|365066236|FG003|Overall Study|Subject decided to stop taking treatment|0|||
105838389|NCT02788513|365066237|FG004|Overall Study|Subject decided to stop taking treatment|0|||
105838390|NCT02788513|365066233|FG000|Overall Study|Decision by the study team|0|||
105838391|NCT02788513|365066234|FG001|Overall Study|Decision by the study team|0|||
105838392|NCT02788513|365066235|FG002|Overall Study|Decision by the study team|0|||
105838393|NCT02788513|365066236|FG003|Overall Study|Decision by the study team|0|||
105838394|NCT02788513|365066237|FG004|Overall Study|Decision by the study team|1|||
105838395|NCT02012452|365066238|FG000|Overall Study|Lost to Follow-up|2|||
105838396|NCT02012452|365066239|FG001|Overall Study|Lost to Follow-up|1|||
105838397|NCT02012452|365066238|FG000|Overall Study|Withdrawal by Subject|4|||
105838398|NCT02012452|365066239|FG001|Overall Study|Withdrawal by Subject|0|||
105838399|NCT02938442|365066240|FG000|Overall Study|Death|0|||
105838400|NCT02938442|365066241|FG001|Overall Study|Death|1|||
105838401|NCT02938442|365066240|FG000|Overall Study|Lost to Follow-up|0|||
105838402|NCT02938442|365066241|FG001|Overall Study|Lost to Follow-up|1|||
105838403|NCT02938442|365066240|FG000|Overall Study|Physician Decision|0|||
105838404|NCT02938442|365066241|FG001|Overall Study|Physician Decision|1|||
105838405|NCT02938442|365066240|FG000|Overall Study|Withdrawal by Subject|2|||
105838406|NCT02938442|365066241|FG001|Overall Study|Withdrawal by Subject|0|||
105838407|NCT04403399|365066242|FG000|Period 2|Physician Decision|0|||
105838408|NCT04403399|365066243|FG001|Period 2|Physician Decision|1|||
105838409|NCT02014441|365066244|FG000|Overall Study|Withdrawal by Subject|12|||
105838410|NCT00802178|365066245|FG000|Overall Study|Lack of Efficacy|36|||
105838411|NCT00802178|365066245|FG000|Overall Study|Insufficient tolerability (IT)|17|||
105838412|NCT00802178|365066245|FG000|Overall Study|Withdrawal by Subject|18|||
105838413|NCT00802178|365066245|FG000|Overall Study|Other|32|||
105838414|NCT00802178|365066245|FG000|Overall Study|Lack of efficacy and patient wish|1|||
105838415|NCT00802178|365066245|FG000|Overall Study|IT and patient wish|8|||
105838416|NCT00802178|365066245|FG000|Overall Study|Patients wish and other reason|1|||
105838417|NCT01606228|365066246|FG000|Overall Study|Lost to Follow-up|20|||
105838418|NCT01606228|365066246|FG000|Overall Study|Withdrawal by Subject|3|||
105838419|NCT01606228|365066246|FG000|Overall Study|Non-compliant|3|||
105838420|NCT01606228|365066246|FG000|Overall Study|Lack of Efficacy|2|||
105838421|NCT01606228|365066246|FG000|Overall Study|Adverse Event|1|||
105838422|NCT00546910|365066247|FG000|Overall Study|Adverse Event|2|||
105838423|NCT00546910|365066248|FG001|Overall Study|Adverse Event|3|||
105838424|NCT00546910|365066247|FG000|Overall Study|Lack of Efficacy|5|||
105838425|NCT00546910|365066248|FG001|Overall Study|Lack of Efficacy|7|||
105838426|NCT00546910|365066247|FG000|Overall Study|Physician Decision|0|||
105838427|NCT00546910|365066248|FG001|Overall Study|Physician Decision|1|||
105838428|NCT00546910|365066247|FG000|Overall Study|Withdrawal by Subject|2|||
105838429|NCT00546910|365066248|FG001|Overall Study|Withdrawal by Subject|0|||
105838430|NCT01933919|365066250|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
105838431|NCT01933919|365066251|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
105838432|NCT01933919|365066250|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
106023548|NCT01675167|365750417|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
106023549|NCT01675167|365750415|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
106149311|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105838433|NCT01933919|365066251|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
105838434|NCT01933919|365066250|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
105838435|NCT01933919|365066251|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
105838436|NCT01933919|365066250|FG000|Open-label Long-term Phase|Adverse Event|2|||
105838437|NCT01933919|365066251|FG001|Open-label Long-term Phase|Adverse Event|0|||
105838438|NCT01933919|365066250|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
105838439|NCT01933919|365066251|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
105838440|NCT01933919|365066250|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
105838441|NCT01933919|365066251|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
105838442|NCT01933919|365066250|FG000|Open-label Long-term Phase|Other|1|||
105838443|NCT01933919|365066251|FG001|Open-label Long-term Phase|Other|2|||
105838444|NCT01961882|365066252|FG000|Overall Study|Adverse Event|3|||
105838445|NCT01961882|365066253|FG001|Overall Study|Adverse Event|2|||
105838446|NCT01961882|365066252|FG000|Overall Study|Physician Decision|1|||
105838447|NCT01961882|365066253|FG001|Overall Study|Physician Decision|0|||
105838448|NCT01961882|365066252|FG000|Overall Study|Withdrawal by Subject|4|||
105838449|NCT01961882|365066253|FG001|Overall Study|Withdrawal by Subject|1|||
105838450|NCT01961882|365066252|FG000|Overall Study|Relapse of AML|39|||
105838451|NCT01961882|365066253|FG001|Overall Study|Relapse of AML|37|||
105838452|NCT01961882|365066252|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
105838453|NCT01961882|365066253|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
105838454|NCT01961882|365066252|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
105838455|NCT01961882|365066253|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
105838456|NCT00991510|365066254|FG000|Period I (Days 1-14)|Adverse Event|1|||
105838457|NCT00991510|365066255|FG001|Period I (Days 1-14)|Adverse Event|0|||
105838458|NCT00991510|365066254|FG000|Period III (Days 29-112)|Adverse Event|1|||
105838459|NCT00991510|365066255|FG001|Period III (Days 29-112)|Adverse Event|1|||
105838460|NCT00852917|365066262|FG000|Overall Study|Adverse Event|13|||
105838461|NCT00852917|365066263|FG001|Overall Study|Adverse Event|20|||
105838462|NCT00852917|365066264|FG002|Overall Study|Adverse Event|35|||
105838463|NCT00852917|365066265|FG003|Overall Study|Adverse Event|17|||
105838464|NCT00852917|365066262|FG000|Overall Study|Lack of Efficacy|21|||
105838465|NCT00852917|365066263|FG001|Overall Study|Lack of Efficacy|11|||
105838466|NCT00852917|365066264|FG002|Overall Study|Lack of Efficacy|11|||
105838467|NCT00852917|365066265|FG003|Overall Study|Lack of Efficacy|47|||
105838468|NCT00852917|365066262|FG000|Overall Study|Withdrawal by Subject|4|||
105838469|NCT00852917|365066263|FG001|Overall Study|Withdrawal by Subject|8|||
105838470|NCT00852917|365066264|FG002|Overall Study|Withdrawal by Subject|10|||
105838471|NCT00852917|365066265|FG003|Overall Study|Withdrawal by Subject|9|||
105838472|NCT00852917|365066262|FG000|Overall Study|Physician Decision|6|||
105838473|NCT00852917|365066263|FG001|Overall Study|Physician Decision|7|||
105838474|NCT00852917|365066264|FG002|Overall Study|Physician Decision|2|||
105838475|NCT00852917|365066265|FG003|Overall Study|Physician Decision|19|||
105838476|NCT00852917|365066262|FG000|Overall Study|Death|0|||
105838477|NCT00852917|365066263|FG001|Overall Study|Death|0|||
105838478|NCT00852917|365066264|FG002|Overall Study|Death|0|||
105838479|NCT00852917|365066265|FG003|Overall Study|Death|1|||
105838480|NCT03710590|365066266|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
105838481|NCT03710590|365066267|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
105838482|NCT01976728|365066269|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
105838483|NCT01976728|365066270|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
105838484|NCT01976728|365066271|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
105838485|NCT01976728|365066272|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
105838486|NCT02443324|365066274|FG000|Overall Study|Death|4|||
105838487|NCT02443324|365066275|FG001|Overall Study|Death|1|||
105838488|NCT02443324|365066276|FG002|Overall Study|Death|0|||
105838489|NCT02443324|365066277|FG003|Overall Study|Death|3|||
105838490|NCT02443324|365066278|FG004|Overall Study|Death|1|||
105838491|NCT02443324|365066279|FG005|Overall Study|Death|3|||
105838492|NCT02443324|365066280|FG006|Overall Study|Death|2|||
105838493|NCT02443324|365066274|FG000|Overall Study|Lost to Follow-up|0|||
105838494|NCT02443324|365066275|FG001|Overall Study|Lost to Follow-up|0|||
105838495|NCT02443324|365066276|FG002|Overall Study|Lost to Follow-up|0|||
105838496|NCT02443324|365066277|FG003|Overall Study|Lost to Follow-up|1|||
105838497|NCT02443324|365066278|FG004|Overall Study|Lost to Follow-up|0|||
105838498|NCT02443324|365066279|FG005|Overall Study|Lost to Follow-up|1|||
105838499|NCT02443324|365066280|FG006|Overall Study|Lost to Follow-up|0|||
105838500|NCT02443324|365066274|FG000|Overall Study|Physician Decision|0|||
105838501|NCT02443324|365066275|FG001|Overall Study|Physician Decision|3|||
105838502|NCT02443324|365066276|FG002|Overall Study|Physician Decision|5|||
105838503|NCT02443324|365066277|FG003|Overall Study|Physician Decision|1|||
105838504|NCT02443324|365066278|FG004|Overall Study|Physician Decision|1|||
105838505|NCT02443324|365066279|FG005|Overall Study|Physician Decision|0|||
105838506|NCT02443324|365066280|FG006|Overall Study|Physician Decision|2|||
105838507|NCT02443324|365066274|FG000|Overall Study|Progressive Disease|20|||
105838508|NCT02443324|365066275|FG001|Overall Study|Progressive Disease|20|||
105838509|NCT02443324|365066276|FG002|Overall Study|Progressive Disease|13|||
105838510|NCT02443324|365066277|FG003|Overall Study|Progressive Disease|10|||
105838511|NCT02443324|365066278|FG004|Overall Study|Progressive Disease|13|||
105838512|NCT02443324|365066279|FG005|Overall Study|Progressive Disease|17|||
105838513|NCT02443324|365066280|FG006|Overall Study|Progressive Disease|10|||
105838514|NCT02443324|365066274|FG000|Overall Study|Withdrawal by Subject|0|||
105838515|NCT02443324|365066275|FG001|Overall Study|Withdrawal by Subject|0|||
105838516|NCT02443324|365066276|FG002|Overall Study|Withdrawal by Subject|3|||
105838517|NCT02443324|365066277|FG003|Overall Study|Withdrawal by Subject|1|||
105838518|NCT02443324|365066278|FG004|Overall Study|Withdrawal by Subject|1|||
105838519|NCT02443324|365066279|FG005|Overall Study|Withdrawal by Subject|0|||
105838520|NCT02443324|365066280|FG006|Overall Study|Withdrawal by Subject|1|||
105838521|NCT02443324|365066274|FG000|Overall Study|Adverse Event|0|||
105838522|NCT02443324|365066275|FG001|Overall Study|Adverse Event|1|||
105838523|NCT02443324|365066276|FG002|Overall Study|Adverse Event|3|||
105838524|NCT02443324|365066277|FG003|Overall Study|Adverse Event|0|||
105838525|NCT02443324|365066278|FG004|Overall Study|Adverse Event|4|||
105838526|NCT02443324|365066279|FG005|Overall Study|Adverse Event|3|||
105838527|NCT02443324|365066280|FG006|Overall Study|Adverse Event|3|||
105838528|NCT02443324|365066274|FG000|Overall Study|Enrolled but Never Treated|0|||
105838529|NCT02443324|365066275|FG001|Overall Study|Enrolled but Never Treated|0|||
105838530|NCT02443324|365066276|FG002|Overall Study|Enrolled but Never Treated|1|||
105838531|NCT02443324|365066277|FG003|Overall Study|Enrolled but Never Treated|0|||
105838532|NCT02443324|365066278|FG004|Overall Study|Enrolled but Never Treated|1|||
105838533|NCT02443324|365066279|FG005|Overall Study|Enrolled but Never Treated|0|||
105838534|NCT02443324|365066280|FG006|Overall Study|Enrolled but Never Treated|1|||
105838535|NCT04025684|365066281|FG000|Overall Study|Withdrawal by Subject|1|||
105838536|NCT04025684|365066282|FG001|Overall Study|Withdrawal by Subject|1|||
105838537|NCT04025684|365066283|FG002|Overall Study|Withdrawal by Subject|0|||
105838538|NCT04025684|365066284|FG003|Overall Study|Withdrawal by Subject|0|||
105838539|NCT04025684|365066281|FG000|Overall Study|Multiple reasons|1|||
105838540|NCT04025684|365066282|FG001|Overall Study|Multiple reasons|3|||
105838541|NCT04025684|365066283|FG002|Overall Study|Multiple reasons|0|||
105838542|NCT04025684|365066284|FG003|Overall Study|Multiple reasons|1|||
105838543|NCT02744755|365066287|FG000|Study Period 1|Protocol Violation|2|||
105838544|NCT02744755|365066288|FG001|Study Period 1|Protocol Violation|1|||
105838545|NCT02744755|365066287|FG000|Study Period 1|not defined|0|||
105838546|NCT02744755|365066288|FG001|Study Period 1|not defined|1|||
105838547|NCT02744755|365066287|FG000|Study Period 1|Pregnancy|1|||
105838548|NCT02744755|365066288|FG001|Study Period 1|Pregnancy|0|||
105838549|NCT02744755|365066287|FG000|Study Period 1|Adverse Event|1|||
105838550|NCT02744755|365066288|FG001|Study Period 1|Adverse Event|1|||
105838551|NCT02744755|365066287|FG000|Study Period 1|Lost to Follow-up|1|||
105838552|NCT02744755|365066288|FG001|Study Period 1|Lost to Follow-up|1|||
105838553|NCT02744755|365066287|FG000|Study Period 1|Lack of Efficacy|1|||
105838554|NCT02744755|365066288|FG001|Study Period 1|Lack of Efficacy|0|||
105838555|NCT02744755|365066287|FG000|Study Period 1|Withdrawal by Subject|8|||
105838556|NCT02744755|365066288|FG001|Study Period 1|Withdrawal by Subject|4|||
105838557|NCT02744755|365066287|FG000|Study Period 2|Adverse Event|5|||
105838558|NCT02744755|365066288|FG001|Study Period 2|Adverse Event|0|||
105838559|NCT02744755|365066287|FG000|Study Period 2|Protocol Violation|1|||
105838560|NCT02744755|365066288|FG001|Study Period 2|Protocol Violation|0|||
105838561|NCT02744755|365066287|FG000|Study Period 2|not defined|3|||
105838562|NCT02744755|365066288|FG001|Study Period 2|not defined|2|||
105838563|NCT02744755|365066287|FG000|Study Period 2|Lost to Follow-up|0|||
105838564|NCT02744755|365066288|FG001|Study Period 2|Lost to Follow-up|2|||
105838565|NCT02744755|365066287|FG000|Study Period 2|Withdrawal by Subject|2|||
105838566|NCT02744755|365066288|FG001|Study Period 2|Withdrawal by Subject|2|||
105838567|NCT02744755|365066287|FG000|Study Period 2|Lack of Efficacy|3|||
105838568|NCT02744755|365066288|FG001|Study Period 2|Lack of Efficacy|2|||
105838569|NCT01239472|365066290|FG000|Overall Study|Withdrawal by Subject|5|||
105838570|NCT01239472|365066291|FG001|Overall Study|Withdrawal by Subject|1|||
105838571|NCT01239472|365066290|FG000|Overall Study|Adverse Event|0|||
105838572|NCT01239472|365066291|FG001|Overall Study|Adverse Event|1|||
105838573|NCT01239472|365066290|FG000|Overall Study|Lack of Efficacy|0|||
105838574|NCT01239472|365066291|FG001|Overall Study|Lack of Efficacy|1|||
105838575|NCT02780167|365066292|FG000|Overall Study|Adverse Event|9|||
105838576|NCT02780167|365066293|FG001|Overall Study|Adverse Event|8|||
105838577|NCT02780167|365066294|FG002|Overall Study|Adverse Event|8|||
105838578|NCT02780167|365066295|FG003|Overall Study|Adverse Event|12|||
105838579|NCT02780167|365066296|FG004|Overall Study|Adverse Event|8|||
105838580|NCT02780167|365066292|FG000|Overall Study|Lack of Efficacy|6|||
105838581|NCT02780167|365066293|FG001|Overall Study|Lack of Efficacy|5|||
105838582|NCT02780167|365066294|FG002|Overall Study|Lack of Efficacy|6|||
105838583|NCT02780167|365066295|FG003|Overall Study|Lack of Efficacy|1|||
105838584|NCT02780167|365066296|FG004|Overall Study|Lack of Efficacy|0|||
105838585|NCT02780167|365066292|FG000|Overall Study|Lost to Follow-up|2|||
105838586|NCT02780167|365066293|FG001|Overall Study|Lost to Follow-up|0|||
105838587|NCT02780167|365066294|FG002|Overall Study|Lost to Follow-up|1|||
105838588|NCT02780167|365066295|FG003|Overall Study|Lost to Follow-up|0|||
105838589|NCT02780167|365066296|FG004|Overall Study|Lost to Follow-up|0|||
105838590|NCT02780167|365066292|FG000|Overall Study|Does not meet entrance criteria|0|||
105838591|NCT02780167|365066293|FG001|Overall Study|Does not meet entrance criteria|0|||
105838592|NCT02780167|365066294|FG002|Overall Study|Does not meet entrance criteria|1|||
105838593|NCT02780167|365066295|FG003|Overall Study|Does not meet entrance criteria|0|||
105838594|NCT02780167|365066296|FG004|Overall Study|Does not meet entrance criteria|0|||
105838595|NCT02780167|365066292|FG000|Overall Study|No longer meets eligibility criteria|0|||
105838596|NCT02780167|365066293|FG001|Overall Study|No longer meets eligibility criteria|0|||
105838597|NCT02780167|365066294|FG002|Overall Study|No longer meets eligibility criteria|0|||
105966358|NCT03831191|365535666|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
105838598|NCT02780167|365066295|FG003|Overall Study|No longer meets eligibility criteria|1|||
105838599|NCT02780167|365066296|FG004|Overall Study|No longer meets eligibility criteria|1|||
105838600|NCT02780167|365066292|FG000|Overall Study|Protocol Violation|5|||
105838601|NCT02780167|365066293|FG001|Overall Study|Protocol Violation|5|||
105838602|NCT02780167|365066294|FG002|Overall Study|Protocol Violation|1|||
105838603|NCT02780167|365066295|FG003|Overall Study|Protocol Violation|1|||
105838604|NCT02780167|365066296|FG004|Overall Study|Protocol Violation|2|||
105838605|NCT02780167|365066292|FG000|Overall Study|Withdrawal by Subject|6|||
105838606|NCT02780167|365066293|FG001|Overall Study|Withdrawal by Subject|4|||
105838607|NCT02780167|365066294|FG002|Overall Study|Withdrawal by Subject|4|||
105838608|NCT02780167|365066295|FG003|Overall Study|Withdrawal by Subject|3|||
105838609|NCT02780167|365066296|FG004|Overall Study|Withdrawal by Subject|4|||
105838610|NCT02780167|365066292|FG000|Overall Study|Other|0|||
105838611|NCT02780167|365066293|FG001|Overall Study|Other|0|||
105838612|NCT02780167|365066294|FG002|Overall Study|Other|3|||
105838613|NCT02780167|365066295|FG003|Overall Study|Other|1|||
105838614|NCT02780167|365066296|FG004|Overall Study|Other|2|||
105838615|NCT02916693|365066297|FG000|Overall Study|Lost to Follow-up|7|||
105838616|NCT01223235|365066298|FG000|Overall Study|Withdrawal by Subject|1|||
105838617|NCT03235479|365066301|FG000|Overall Study|Lost to Follow-up|8|||
105838618|NCT03235479|365066302|FG001|Overall Study|Lost to Follow-up|11|||
105838619|NCT03235479|365066301|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
105838620|NCT03235479|365066302|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
105838621|NCT03235479|365066301|FG000|Overall Study|Pregnancy|1|||
105838622|NCT03235479|365066302|FG001|Overall Study|Pregnancy|0|||
105838623|NCT03235479|365066301|FG000|Overall Study|Protocol Deviation|1|||
105838624|NCT03235479|365066302|FG001|Overall Study|Protocol Deviation|3|||
105838625|NCT03235479|365066301|FG000|Overall Study|Technical Problems|3|||
105838626|NCT03235479|365066302|FG001|Overall Study|Technical Problems|2|||
105838627|NCT03235479|365066301|FG000|Overall Study|Withdrawal by Subject|2|||
105838628|NCT03235479|365066302|FG001|Overall Study|Withdrawal by Subject|2|||
105838629|NCT03235479|365066301|FG000|Overall Study|Other Reasons|3|||
105838630|NCT03235479|365066302|FG001|Overall Study|Other Reasons|5|||
105838631|NCT02001051|365066303|FG000|Overall Study|Deemed not eligible following enrollment|0|||
105838632|NCT02001051|365066304|FG001|Overall Study|Deemed not eligible following enrollment|1|||
105838633|NCT00529217|365066306|FG000|Overall Study|Lack of Efficacy|2|||
105966359|NCT03831191|365535667|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966360|NCT03831191|365535668|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966361|NCT03831191|365535669|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966362|NCT03831191|365535670|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966363|NCT03831191|365535671|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966364|NCT03831191|365535672|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966365|NCT03831191|365535673|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966366|NCT03831191|365535674|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966367|NCT03831191|365535675|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966368|NCT03831191|365535676|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
105966369|NCT03831191|365535662|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
105966370|NCT03831191|365535663|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
105966371|NCT03831191|365535664|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
105966372|NCT03831191|365535665|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
105966373|NCT03831191|365535666|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
105966374|NCT03831191|365535667|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
105966375|NCT03831191|365535668|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
105966376|NCT03831191|365535669|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
105966377|NCT03831191|365535670|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
105966378|NCT03831191|365535671|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
105966379|NCT03831191|365535672|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
105966380|NCT03831191|365535673|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
105966381|NCT03831191|365535674|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
105966382|NCT03831191|365535675|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
105966383|NCT03831191|365535676|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
105966384|NCT03831191|365535662|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966385|NCT03831191|365535663|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966386|NCT03831191|365535664|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966387|NCT03831191|365535665|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966388|NCT03831191|365535666|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966389|NCT03831191|365535667|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966390|NCT03831191|365535668|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966391|NCT03831191|365535669|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966392|NCT03831191|365535670|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966393|NCT03831191|365535671|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966394|NCT03831191|365535672|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966395|NCT03831191|365535673|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966396|NCT03831191|365535674|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966397|NCT03831191|365535675|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105966398|NCT03831191|365535676|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
105966399|NCT03831191|365535662|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966400|NCT03831191|365535663|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966401|NCT03831191|365535664|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966402|NCT03831191|365535665|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966403|NCT03831191|365535666|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966404|NCT03831191|365535667|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966405|NCT03831191|365535668|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105838634|NCT00529217|365066306|FG000|Overall Study|Unable to adhere to study schedule|2|||
105838635|NCT01790113|365066307|FG000|Overall Study|Adverse Event|2|||
105838636|NCT01790113|365066308|FG001|Overall Study|Adverse Event|7|||
105838637|NCT01790113|365066307|FG000|Overall Study|Study ended due to FDA clearance|1|||
105838638|NCT01790113|365066308|FG001|Overall Study|Study ended due to FDA clearance|68|||
105838639|NCT01519947|365066309|FG000|Overall Study|Death|0|||
105838640|NCT01519947|365066310|FG001|Overall Study|Death|0|||
105838641|NCT01519947|365066311|FG002|Overall Study|Death|0|||
105838642|NCT01519947|365066312|FG003|Overall Study|Death|1|||
105838643|NCT01519947|365066309|FG000|Overall Study|Protocol Violation|0|||
105838644|NCT01519947|365066310|FG001|Overall Study|Protocol Violation|0|||
105838645|NCT01519947|365066311|FG002|Overall Study|Protocol Violation|2|||
105838646|NCT01519947|365066312|FG003|Overall Study|Protocol Violation|1|||
105838647|NCT01519947|365066309|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
105838648|NCT01519947|365066310|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
105838649|NCT01519947|365066311|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
105838650|NCT01519947|365066312|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
105838651|NCT01519947|365066309|FG000|Overall Study|Development of Anemia|0|||
105838652|NCT01519947|365066310|FG001|Overall Study|Development of Anemia|1|||
105838653|NCT01519947|365066311|FG002|Overall Study|Development of Anemia|0|||
105838654|NCT01519947|365066312|FG003|Overall Study|Development of Anemia|1|||
105838655|NCT01519947|365066309|FG000|Overall Study|Blood Transfusion|0|||
105838656|NCT01519947|365066310|FG001|Overall Study|Blood Transfusion|1|||
105838657|NCT01519947|365066311|FG002|Overall Study|Blood Transfusion|1|||
105838658|NCT01519947|365066312|FG003|Overall Study|Blood Transfusion|0|||
105838659|NCT01519947|365066309|FG000|Overall Study|Withdrawal by Subject|0|||
105838660|NCT01519947|365066310|FG001|Overall Study|Withdrawal by Subject|1|||
105838661|NCT01519947|365066311|FG002|Overall Study|Withdrawal by Subject|0|||
105838662|NCT01519947|365066312|FG003|Overall Study|Withdrawal by Subject|1|||
105838663|NCT01519947|365066309|FG000|Overall Study|Lost to Follow-up|0|||
105838664|NCT01519947|365066310|FG001|Overall Study|Lost to Follow-up|0|||
105838665|NCT01519947|365066311|FG002|Overall Study|Lost to Follow-up|3|||
105838666|NCT01519947|365066312|FG003|Overall Study|Lost to Follow-up|2|||
105838667|NCT01519947|365066309|FG000|Overall Study|Poor Response|1|||
105838668|NCT01519947|365066310|FG001|Overall Study|Poor Response|0|||
105838669|NCT01519947|365066311|FG002|Overall Study|Poor Response|0|||
105838670|NCT01519947|365066312|FG003|Overall Study|Poor Response|1|||
105838671|NCT01519947|365066309|FG000|Overall Study|Adverse Event|1|||
105838672|NCT01519947|365066310|FG001|Overall Study|Adverse Event|0|||
105838673|NCT01519947|365066311|FG002|Overall Study|Adverse Event|1|||
105838674|NCT01519947|365066312|FG003|Overall Study|Adverse Event|1|||
105838675|NCT02274948|365066313|FG000|Overall Study|Lost to Follow-up|28|||
105838676|NCT02274948|365066314|FG001|Overall Study|Lost to Follow-up|25|||
105838677|NCT02274948|365066313|FG000|Overall Study|Withdrawal by Subject|64|||
105838678|NCT02274948|365066314|FG001|Overall Study|Withdrawal by Subject|58|||
105838679|NCT02274948|365066313|FG000|Overall Study|Stopped on family Practitioner advice|2|||
105838680|NCT02274948|365066314|FG001|Overall Study|Stopped on family Practitioner advice|5|||
105838681|NCT02274948|365066313|FG000|Overall Study|Left the area|4|||
105838682|NCT02274948|365066314|FG001|Overall Study|Left the area|3|||
105838683|NCT00707434|365066315|FG000|Overall Study|Adverse Event|1|||
105838684|NCT00931463|365066324|FG000|Overall Study|Death|8|||
105838685|NCT00931463|365066325|FG001|Overall Study|Death|4|||
105838686|NCT00931463|365066324|FG000|Overall Study|Withdrawal by Subject|5|||
105838687|NCT00931463|365066325|FG001|Overall Study|Withdrawal by Subject|0|||
105838688|NCT00931463|365066324|FG000|Overall Study|Lost to Follow-up|4|||
105838689|NCT00931463|365066325|FG001|Overall Study|Lost to Follow-up|1|||
105838690|NCT02169791|365066326|FG000|Overall Study|Death|6|||
105838691|NCT02169791|365066326|FG000|Overall Study|patient withdrew consent|1|||
105838692|NCT01009515|365066329|FG000|Overall Study|Withdrawal by Subject|3|||
105838693|NCT02539368|365066336|FG000|Overall Study|Death|4|||
105838694|NCT02539368|365066337|FG001|Overall Study|Death|2|||
105838695|NCT02539368|365066338|FG002|Overall Study|Death|1|||
105838696|NCT02539368|365066339|FG003|Overall Study|Death|0|||
105838697|NCT02539368|365066340|FG004|Overall Study|Death|0|||
105838698|NCT02539368|365066336|FG000|Overall Study|Withdrawal by Subject|44|||
105838699|NCT02539368|365066337|FG001|Overall Study|Withdrawal by Subject|35|||
106023550|NCT01675167|365750416|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
105838700|NCT02539368|365066338|FG002|Overall Study|Withdrawal by Subject|9|||
105838701|NCT02539368|365066339|FG003|Overall Study|Withdrawal by Subject|1|||
105838702|NCT02539368|365066340|FG004|Overall Study|Withdrawal by Subject|3|||
105838703|NCT02539368|365066336|FG000|Overall Study|Physician Decision|49|||
105838704|NCT02539368|365066337|FG001|Overall Study|Physician Decision|15|||
105838705|NCT02539368|365066338|FG002|Overall Study|Physician Decision|7|||
105838706|NCT02539368|365066339|FG003|Overall Study|Physician Decision|0|||
105838707|NCT02539368|365066340|FG004|Overall Study|Physician Decision|2|||
105838708|NCT02539368|365066336|FG000|Overall Study|Lost to Follow-up|96|||
105838709|NCT02539368|365066337|FG001|Overall Study|Lost to Follow-up|21|||
105838710|NCT02539368|365066338|FG002|Overall Study|Lost to Follow-up|16|||
105838711|NCT02539368|365066339|FG003|Overall Study|Lost to Follow-up|4|||
105838712|NCT02539368|365066340|FG004|Overall Study|Lost to Follow-up|3|||
105838713|NCT02539368|365066336|FG000|Overall Study|Adverse Event|44|||
105838714|NCT02539368|365066337|FG001|Overall Study|Adverse Event|5|||
105838715|NCT02539368|365066338|FG002|Overall Study|Adverse Event|9|||
105838716|NCT02539368|365066339|FG003|Overall Study|Adverse Event|0|||
105838717|NCT02539368|365066340|FG004|Overall Study|Adverse Event|3|||
105838718|NCT02539368|365066336|FG000|Overall Study|Participant Non-compliant|13|||
105838719|NCT02539368|365066337|FG001|Overall Study|Participant Non-compliant|2|||
105838720|NCT02539368|365066338|FG002|Overall Study|Participant Non-compliant|1|||
105838721|NCT02539368|365066339|FG003|Overall Study|Participant Non-compliant|1|||
105838722|NCT02539368|365066340|FG004|Overall Study|Participant Non-compliant|0|||
105838723|NCT02539368|365066336|FG000|Overall Study|Other|145|||
105838724|NCT02539368|365066337|FG001|Overall Study|Other|18|||
105838725|NCT02539368|365066338|FG002|Overall Study|Other|24|||
105838726|NCT02539368|365066339|FG003|Overall Study|Other|1|||
105838727|NCT02539368|365066340|FG004|Overall Study|Other|3|||
105838728|NCT02539368|365066336|FG000|Overall Study|Missing|10|||
105838729|NCT02539368|365066337|FG001|Overall Study|Missing|3|||
105838730|NCT02539368|365066338|FG002|Overall Study|Missing|0|||
105838731|NCT02539368|365066339|FG003|Overall Study|Missing|0|||
105838732|NCT02539368|365066340|FG004|Overall Study|Missing|0|||
105838733|NCT01899326|365066342|FG000|Overall Study|Withdrawal by Subject|1|||
105838734|NCT01899326|365066342|FG000|Overall Study|Adverse Event|2|||
105838735|NCT01899326|365066342|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
105838736|NCT02752802|365066345|FG000|Overall Study|Contrast Volume Not Collected|1|||
105838737|NCT02752802|365066346|FG001|Overall Study|Contrast Volume Not Collected|0|||
105838738|NCT00588731|365066347|FG000|Overall Study|Withdrawal by Subject|3|||
105838739|NCT00588731|365066348|FG001|Overall Study|Withdrawal by Subject|2|||
105838740|NCT00171340|365066349|FG000|Overall Study|Adverse Event|46|||
105838741|NCT00171340|365066350|FG001|Overall Study|Adverse Event|42|||
105838742|NCT00171340|365066349|FG000|Overall Study|Lack of Efficacy|29|||
105838743|NCT00171340|365066350|FG001|Overall Study|Lack of Efficacy|41|||
105838744|NCT00171340|365066349|FG000|Overall Study|Protocol Violation|7|||
105838745|NCT00171340|365066350|FG001|Overall Study|Protocol Violation|8|||
105838746|NCT00171340|365066349|FG000|Overall Study|Withdrawal by Subject|22|||
105838747|NCT00171340|365066350|FG001|Overall Study|Withdrawal by Subject|19|||
105838748|NCT00171340|365066349|FG000|Overall Study|Lost to Follow-up|0|||
105966406|NCT03831191|365535669|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966407|NCT03831191|365535670|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966408|NCT03831191|365535671|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966409|NCT03831191|365535672|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966410|NCT03831191|365535673|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966411|NCT03831191|365535674|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966412|NCT03831191|365535675|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105966413|NCT03831191|365535676|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
105966414|NCT01126437|365535680|FG000|Overall Study|Not treated|11|||
105966415|NCT01126437|365535681|FG001|Overall Study|Not treated|18|||
105966416|NCT01126437|365535682|FG002|Overall Study|Not treated|19|||
105966417|NCT01126437|365535680|FG000|Overall Study|Sites with data irregularities/fraud|6|||
105966418|NCT01126437|365535681|FG001|Overall Study|Sites with data irregularities/fraud|6|||
105966419|NCT01126437|365535682|FG002|Overall Study|Sites with data irregularities/fraud|7|||
105966420|NCT01126437|365535680|FG000|Overall Study|Adverse Event|602|||
105966421|NCT01126437|365535681|FG001|Overall Study|Adverse Event|606|||
105966422|NCT01126437|365535682|FG002|Overall Study|Adverse Event|635|||
105966423|NCT01126437|365535680|FG000|Overall Study|Lack of Efficacy|65|||
105966424|NCT01126437|365535681|FG001|Overall Study|Lack of Efficacy|60|||
105966425|NCT01126437|365535682|FG002|Overall Study|Lack of Efficacy|59|||
105966426|NCT01126437|365535680|FG000|Overall Study|Protocol Violation|64|||
105966427|NCT01126437|365535681|FG001|Overall Study|Protocol Violation|66|||
105838749|NCT00171340|365066350|FG001|Overall Study|Lost to Follow-up|5|||
105838750|NCT00171340|365066349|FG000|Overall Study|Abnormal Laboratory Results|2|||
105838751|NCT00171340|365066350|FG001|Overall Study|Abnormal Laboratory Results|0|||
105838752|NCT00171340|365066349|FG000|Overall Study|Abnormal Test Procedure Results|6|||
105838753|NCT00171340|365066350|FG001|Overall Study|Abnormal Test Procedure Results|11|||
105838754|NCT00171340|365066349|FG000|Overall Study|No Longer Required Study Drug|1|||
105966428|NCT01126437|365535682|FG002|Overall Study|Protocol Violation|41|||
105966429|NCT01126437|365535680|FG000|Overall Study|Lost to Follow-up|52|||
105966430|NCT01126437|365535681|FG001|Overall Study|Lost to Follow-up|63|||
105966431|NCT01126437|365535682|FG002|Overall Study|Lost to Follow-up|55|||
105966432|NCT01126437|365535680|FG000|Overall Study|Withdrawal by Subject|331|||
105838755|NCT00171340|365066350|FG001|Overall Study|No Longer Required Study Drug|1|||
105838756|NCT00171340|365066349|FG000|Overall Study|Administrative Problems|5|||
105838757|NCT00171340|365066350|FG001|Overall Study|Administrative Problems|2|||
105838758|NCT00171340|365066349|FG000|Overall Study|Death|6|||
105838759|NCT00171340|365066350|FG001|Overall Study|Death|6|||
105838760|NCT00063882|365066355|FG000|Overall Study|Protocol Violation|3|||
105838761|NCT00063882|365066356|FG001|Overall Study|Protocol Violation|3|||
105966433|NCT01126437|365535681|FG001|Overall Study|Withdrawal by Subject|335|||
105966434|NCT01126437|365535682|FG002|Overall Study|Withdrawal by Subject|319|||
105838762|NCT00063882|365066355|FG000|Overall Study|Withdrawal by Subject|2|||
105838763|NCT00063882|365066356|FG001|Overall Study|Withdrawal by Subject|1|||
105838764|NCT03314662|365066359|FG000|Overall Study|Withdrawal by Subject|1|||
105838765|NCT03314662|365066360|FG001|Overall Study|Withdrawal by Subject|1|||
105838766|NCT03314662|365066361|FG002|Overall Study|Withdrawal by Subject|1|||
105838767|NCT03314662|365066359|FG000|Overall Study|Lost to Follow-up|5|||
105838768|NCT03314662|365066360|FG001|Overall Study|Lost to Follow-up|4|||
105838769|NCT03314662|365066361|FG002|Overall Study|Lost to Follow-up|4|||
105838770|NCT03314662|365066359|FG000|Overall Study|Death|2|||
105838771|NCT03314662|365066360|FG001|Overall Study|Death|0|||
105838772|NCT03314662|365066361|FG002|Overall Study|Death|0|||
105838773|NCT01117766|365066362|FG000|First Intervention|Adverse Event|0|||
105838774|NCT01117766|365066363|FG001|First Intervention|Adverse Event|1|||
105838775|NCT01117766|365066362|FG000|First Intervention|Protocol Violation|1|||
105838776|NCT01117766|365066363|FG001|First Intervention|Protocol Violation|0|||
105838777|NCT01117766|365066362|FG000|Washout Period|Protocol Violation|0|||
105838778|NCT01117766|365066363|FG001|Washout Period|Protocol Violation|2|||
105838779|NCT01117766|365066362|FG000|Second Intervention|Lost to Follow-up|1|||
105838780|NCT01117766|365066363|FG001|Second Intervention|Lost to Follow-up|0|||
105838781|NCT01117766|365066362|FG000|Second Intervention|Other|1|||
105838782|NCT01117766|365066363|FG001|Second Intervention|Other|2|||
105838783|NCT01117766|365066362|FG000|Second Intervention|Adverse Event|0|||
105838784|NCT01117766|365066363|FG001|Second Intervention|Adverse Event|2|||
105838785|NCT01117766|365066362|FG000|Second Intervention|Withdrawal by Subject|0|||
105838786|NCT01117766|365066363|FG001|Second Intervention|Withdrawal by Subject|1|||
105838787|NCT00438659|365066364|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
105838788|NCT00438659|365066365|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
105838789|NCT00438659|365066364|FG000|Overall Study|Cancel|5|||
105838790|NCT00438659|365066365|FG001|Overall Study|Cancel|2|||
105838791|NCT01115855|365067670|FG000|Overall Study|Adverse Event|16|||
105838792|NCT01115855|365067671|FG001|Overall Study|Adverse Event|18|||
105838793|NCT01115855|365067670|FG000|Overall Study|Death|6|||
105838794|NCT01115855|365067671|FG001|Overall Study|Death|5|||
105838795|NCT01115855|365067670|FG000|Overall Study|Lab Abnormality|1|||
105838796|NCT01115855|365067671|FG001|Overall Study|Lab Abnormality|1|||
105838797|NCT01115855|365067670|FG000|Overall Study|Protocol Violation|0|||
105838798|NCT01115855|365067671|FG001|Overall Study|Protocol Violation|1|||
105838799|NCT01115855|365067670|FG000|Overall Study|Withdrawal by Subject|5|||
105838800|NCT01115855|365067671|FG001|Overall Study|Withdrawal by Subject|5|||
105838801|NCT01115855|365067670|FG000|Overall Study|Other|8|||
105838802|NCT01115855|365067671|FG001|Overall Study|Other|6|||
105838803|NCT00114231|365067674|FG000|Overall Study|No consent|2|||
105838804|NCT00114231|365067675|FG001|Overall Study|No consent|0|||
105838805|NCT00114231|365067674|FG000|Overall Study|QARC requirement not met|1|||
105838806|NCT00114231|365067675|FG001|Overall Study|QARC requirement not met|0|||
105838807|NCT00114231|365067674|FG000|Overall Study|Suspected metastatic disease|1|||
105838808|NCT00114231|365067675|FG001|Overall Study|Suspected metastatic disease|0|||
105838809|NCT00114231|365067674|FG000|Overall Study|No adenocarcinoma|1|||
105838810|NCT00114231|365067675|FG001|Overall Study|No adenocarcinoma|0|||
105838811|NCT00114231|365067674|FG000|Overall Study|Low creatinine clearance|0|||
105838812|NCT00114231|365067675|FG001|Overall Study|Low creatinine clearance|1|||
105838813|NCT00114231|365067674|FG000|Overall Study|Tumor size > 4cm|1|||
105838814|NCT00114231|365067675|FG001|Overall Study|Tumor size > 4cm|0|||
105966435|NCT01126437|365535680|FG000|Overall Study|Other reason not specified|210|||
105966436|NCT01126437|365535681|FG001|Overall Study|Other reason not specified|176|||
105966437|NCT01126437|365535682|FG002|Overall Study|Other reason not specified|178|||
105966438|NCT04826094|365535683|FG000|Overall Study|Lost to Follow-up|2|||
105966439|NCT04826094|365535684|FG001|Overall Study|Lost to Follow-up|1|||
105838815|NCT00114231|365067674|FG000|Overall Study|Tumor fixed on digital exam|0|||
105838816|NCT00114231|365067675|FG001|Overall Study|Tumor fixed on digital exam|1|||
105838817|NCT00114231|365067674|FG000|Overall Study|No Absolute Neutrophil Count|2|||
105838818|NCT00114231|365067675|FG001|Overall Study|No Absolute Neutrophil Count|0|||
105966440|NCT04826094|365535685|FG002|Overall Study|Lost to Follow-up|0|||
105966441|NCT04826094|365535686|FG003|Overall Study|Lost to Follow-up|0|||
105966442|NCT04826094|365535687|FG004|Overall Study|Lost to Follow-up|1|||
105966443|NCT04826094|365535688|FG005|Overall Study|Lost to Follow-up|3|||
105966444|NCT04826094|365535689|FG006|Overall Study|Lost to Follow-up|1|||
105838819|NCT00114231|365067674|FG000|Overall Study|Biopsy done after registration|1|||
105838820|NCT00114231|365067675|FG001|Overall Study|Biopsy done after registration|0|||
105838821|NCT01563237|365067678|FG000|Overall Study|Lost to Follow-up|6|||
105838822|NCT01563237|365067679|FG001|Overall Study|Lost to Follow-up|0|||
105838823|NCT01563237|365067678|FG000|Overall Study|Withdrawal by Subject|1|||
105838824|NCT01563237|365067679|FG001|Overall Study|Withdrawal by Subject|0|||
105838825|NCT01563237|365067678|FG000|Overall Study|Adverse Event|1|||
105838826|NCT01563237|365067679|FG001|Overall Study|Adverse Event|0|||
105838827|NCT01563237|365067678|FG000|Overall Study|Medical Reasons|1|||
105966445|NCT04826094|365535690|FG007|Overall Study|Lost to Follow-up|1|||
105838828|NCT01563237|365067679|FG001|Overall Study|Medical Reasons|0|||
105838829|NCT01563237|365067678|FG000|Overall Study|Death|1|||
105838830|NCT01563237|365067679|FG001|Overall Study|Death|0|||
105838831|NCT02668822|365067680|FG000|Overall Study|Protocol Violation|2|||
105838832|NCT02668822|365067681|FG001|Overall Study|Protocol Violation|0|||
105838833|NCT02668822|365067680|FG000|Overall Study|Study Terminated by Sponsor|7|||
105838834|NCT02668822|365067681|FG001|Overall Study|Study Terminated by Sponsor|9|||
105838835|NCT02000531|365067682|FG000|Overall Study|Lost to Follow-up|1|||
105838836|NCT02000531|365067683|FG001|Overall Study|Lost to Follow-up|0|||
105838837|NCT02000531|365067682|FG000|Overall Study|Discontinued due to data cut-off|3|||
105838838|NCT02000531|365067683|FG001|Overall Study|Discontinued due to data cut-off|8|||
105838839|NCT00337428|365067687|FG000|Overall Study|Withdrawal by Subject|1|||
105838840|NCT00337428|365067688|FG001|Overall Study|Withdrawal by Subject|2|||
105838841|NCT00337428|365067687|FG000|Overall Study|Lack of Time|1|||
105838842|NCT00337428|365067688|FG001|Overall Study|Lack of Time|1|||
105838843|NCT00337428|365067687|FG000|Overall Study|Unwilling to Continue|1|||
105838844|NCT00337428|365067688|FG001|Overall Study|Unwilling to Continue|0|||
105838845|NCT00337428|365067687|FG000|Overall Study|Anorexia|1|||
105838846|NCT00337428|365067688|FG001|Overall Study|Anorexia|0|||
105838847|NCT03756883|365067689|FG000|Overall Study|Adverse Event|2|||
105838848|NCT03756883|365067690|FG001|Overall Study|Adverse Event|2|||
105838849|NCT03756883|365067691|FG002|Overall Study|Adverse Event|2|||
105838850|NCT03756883|365067689|FG000|Overall Study|Lack of Efficacy|0|||
105838851|NCT03756883|365067690|FG001|Overall Study|Lack of Efficacy|1|||
105838852|NCT03756883|365067691|FG002|Overall Study|Lack of Efficacy|2|||
105838853|NCT03756883|365067689|FG000|Overall Study|Lost to Follow-up|3|||
105838854|NCT03756883|365067690|FG001|Overall Study|Lost to Follow-up|3|||
105838855|NCT03756883|365067691|FG002|Overall Study|Lost to Follow-up|0|||
105838856|NCT03756883|365067689|FG000|Overall Study|Protocol Violation|2|||
105838857|NCT03756883|365067690|FG001|Overall Study|Protocol Violation|0|||
105838858|NCT03756883|365067691|FG002|Overall Study|Protocol Violation|1|||
105838859|NCT03756883|365067689|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
105838860|NCT03756883|365067690|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
105838861|NCT03756883|365067691|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
105838862|NCT03756883|365067689|FG000|Overall Study|Withdrawal by Subject|4|||
105838863|NCT03756883|365067690|FG001|Overall Study|Withdrawal by Subject|1|||
105838864|NCT03756883|365067691|FG002|Overall Study|Withdrawal by Subject|0|||
105838865|NCT03756883|365067689|FG000|Overall Study|Other Reasons|2|||
105838866|NCT03756883|365067690|FG001|Overall Study|Other Reasons|4|||
105838867|NCT03756883|365067691|FG002|Overall Study|Other Reasons|0|||
105838868|NCT01470417|365067692|FG000|Overall Study|Disease progression|0|||
105838869|NCT01470417|365067693|FG001|Overall Study|Disease progression|2|||
105838870|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
105838871|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
105838872|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
105838873|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
105838874|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
105838875|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
105838876|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105838877|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105838878|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
105838879|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
105838880|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
105838881|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
105838882|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
105838883|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
105838884|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
105838885|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
105838886|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Death|2|||
105838887|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Death|1|||
106023551|NCT01675167|365750417|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
105838888|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Death|0|||
105838889|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Death|0|||
105838890|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
105838891|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
105838892|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
105838893|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
105838894|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
105838895|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
105838896|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
105838897|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
105838898|NCT03110380|365067696|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
105838899|NCT03110380|365067697|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
105838900|NCT03110380|365067698|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
105838901|NCT03110380|365067699|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
105838902|NCT03110380|365067696|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
105838903|NCT03110380|365067697|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
105838904|NCT03110380|365067698|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
105838905|NCT03110380|365067699|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
105838906|NCT03110380|365067696|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
105838907|NCT03110380|365067697|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
105838908|NCT03110380|365067698|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
105838909|NCT03110380|365067699|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
105838910|NCT03110380|365067696|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
105838911|NCT03110380|365067697|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
105838912|NCT03110380|365067698|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
105838913|NCT03110380|365067699|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
105838914|NCT00693225|365067700|FG000|Overall Study|Lost to Follow-up|1|||
105838915|NCT00693225|365067701|FG001|Overall Study|Lost to Follow-up|2|||
105838916|NCT00693225|365067700|FG000|Overall Study|Adverse Event|1|||
105838917|NCT00693225|365067701|FG001|Overall Study|Adverse Event|3|||
105838918|NCT01315028|365067702|FG000|Overall Study|Lost to Follow-up|1|||
105838919|NCT01315028|365067703|FG001|Overall Study|Lost to Follow-up|0|||
105838920|NCT01315028|365067702|FG000|Overall Study|Death|0|||
105838921|NCT01315028|365067703|FG001|Overall Study|Death|1|||
105838922|NCT00985231|365067708|FG000|Overall Study|ineligible|1|||
105838923|NCT00985231|365067709|FG001|Overall Study|ineligible|0|||
105838924|NCT00985231|365067708|FG000|Overall Study|Protocol Violation|1|||
105838925|NCT00985231|365067709|FG001|Overall Study|Protocol Violation|0|||
105838926|NCT00985231|365067708|FG000|Overall Study|Withdrawal by Subject|1|||
105838927|NCT00985231|365067709|FG001|Overall Study|Withdrawal by Subject|0|||
105838928|NCT00985231|365067708|FG000|Overall Study|Lost to Follow-up|0|||
105838929|NCT00985231|365067709|FG001|Overall Study|Lost to Follow-up|1|||
105838930|NCT00985231|365067708|FG000|Overall Study|Study related symptoms & complaints|0|||
105838931|NCT00985231|365067709|FG001|Overall Study|Study related symptoms & complaints|2|||
105838932|NCT01740791|365067710|FG000|Overall Study|Randomized but never treated|5|||
105838933|NCT01740791|365067711|FG001|Overall Study|Randomized but never treated|3|||
105838934|NCT01740791|365067712|FG002|Overall Study|Randomized but never treated|2|||
105838935|NCT01740791|365067713|FG003|Overall Study|Randomized but never treated|2|||
105838936|NCT01740791|365067714|FG004|Overall Study|Randomized but never treated|1|||
105838937|NCT01740791|365067715|FG005|Overall Study|Randomized but never treated|3|||
105838938|NCT01740791|365067710|FG000|Overall Study|Lost to Follow-up|2|||
105838939|NCT01740791|365067711|FG001|Overall Study|Lost to Follow-up|0|||
105838940|NCT01740791|365067712|FG002|Overall Study|Lost to Follow-up|2|||
105838941|NCT01740791|365067713|FG003|Overall Study|Lost to Follow-up|3|||
105838942|NCT01740791|365067714|FG004|Overall Study|Lost to Follow-up|2|||
105838943|NCT01740791|365067715|FG005|Overall Study|Lost to Follow-up|3|||
105838944|NCT01740791|365067710|FG000|Overall Study|Withdrew Consent|4|||
105838945|NCT01740791|365067711|FG001|Overall Study|Withdrew Consent|0|||
105838946|NCT01740791|365067712|FG002|Overall Study|Withdrew Consent|1|||
105838947|NCT01740791|365067713|FG003|Overall Study|Withdrew Consent|2|||
105838948|NCT01740791|365067714|FG004|Overall Study|Withdrew Consent|0|||
105838949|NCT01740791|365067715|FG005|Overall Study|Withdrew Consent|3|||
105838950|NCT01740791|365067710|FG000|Overall Study|Investigator's discretion|1|||
105838951|NCT01740791|365067711|FG001|Overall Study|Investigator's discretion|0|||
105838952|NCT01740791|365067712|FG002|Overall Study|Investigator's discretion|1|||
105838953|NCT01740791|365067713|FG003|Overall Study|Investigator's discretion|0|||
105838954|NCT01740791|365067714|FG004|Overall Study|Investigator's discretion|0|||
105838955|NCT01740791|365067715|FG005|Overall Study|Investigator's discretion|1|||
105838956|NCT01740791|365067710|FG000|Overall Study|Adverse Event|0|||
105838957|NCT01740791|365067711|FG001|Overall Study|Adverse Event|0|||
105838958|NCT01740791|365067712|FG002|Overall Study|Adverse Event|0|||
105838959|NCT01740791|365067713|FG003|Overall Study|Adverse Event|0|||
105838960|NCT01740791|365067714|FG004|Overall Study|Adverse Event|0|||
105838961|NCT01740791|365067715|FG005|Overall Study|Adverse Event|1|||
105838962|NCT01463982|365067716|FG000|Overall Study|Withdrawal by Subject|0|||
105838963|NCT01463982|365067717|FG001|Overall Study|Withdrawal by Subject|1|||
105838964|NCT01463982|365067718|FG002|Overall Study|Withdrawal by Subject|1|||
105838965|NCT01463982|365067719|FG003|Overall Study|Withdrawal by Subject|0|||
105838966|NCT01463982|365067716|FG000|Overall Study|Treatment delay over 5 week|0|||
105838967|NCT01463982|365067717|FG001|Overall Study|Treatment delay over 5 week|0|||
105838968|NCT01463982|365067718|FG002|Overall Study|Treatment delay over 5 week|1|||
105838969|NCT01463982|365067719|FG003|Overall Study|Treatment delay over 5 week|0|||
106149312|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
106149313|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
106149314|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
106149315|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
106149316|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105838970|NCT03170869|365067724|FG000|Overall Study|Protocol Violation|5|||
105838971|NCT03170869|365067724|FG000|Overall Study|Early study termination|3|||
105838972|NCT02762994|365067726|FG000|Overall Study|Withdrawal by Subject|0|||
105838973|NCT02762994|365067727|FG001|Overall Study|Withdrawal by Subject|1|||
105838974|NCT02762994|365067728|FG002|Overall Study|Withdrawal by Subject|2|||
105838975|NCT02762994|365067729|FG003|Overall Study|Withdrawal by Subject|0|||
105838976|NCT02762994|365067726|FG000|Overall Study|Protocol Violation|1|||
105838977|NCT02762994|365067727|FG001|Overall Study|Protocol Violation|0|||
105838978|NCT02762994|365067728|FG002|Overall Study|Protocol Violation|0|||
105838979|NCT02762994|365067729|FG003|Overall Study|Protocol Violation|2|||
105838980|NCT03507686|365067730|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
105838981|NCT03507686|365067731|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
105838982|NCT03507686|365067730|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
105838983|NCT03507686|365067731|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
105838984|NCT03507686|365067730|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
105838985|NCT03507686|365067731|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
105838986|NCT03507686|365067730|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
105838987|NCT03507686|365067731|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
105838988|NCT03507686|365067730|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
105838989|NCT03507686|365067731|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
105838990|NCT03507686|365067730|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
105838991|NCT03507686|365067731|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
105838992|NCT02508116|365067734|FG000|Overall Study|Lost to Follow-up|2|||
105838993|NCT02508116|365067735|FG001|Overall Study|Lost to Follow-up|3|||
105838994|NCT02508116|365067734|FG000|Overall Study|Withdrawal by Subject|3|||
105838995|NCT02508116|365067735|FG001|Overall Study|Withdrawal by Subject|2|||
105838996|NCT02508116|365067734|FG000|Overall Study|Protocol Violation|1|||
105838997|NCT02508116|365067735|FG001|Overall Study|Protocol Violation|2|||
105838998|NCT02508116|365067734|FG000|Overall Study|Physician Decision|2|||
105838999|NCT02508116|365067735|FG001|Overall Study|Physician Decision|0|||
105839000|NCT00109850|365067736|FG000|Overall Study|Adverse Event|1|||
105839001|NCT00109850|365067736|FG000|Overall Study|Death|2|||
105839002|NCT00109850|365067736|FG000|Overall Study|Ineligible|1|||
105839003|NCT04234464|365067737|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
105839004|NCT04234464|365067738|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
105839005|NCT00983528|365067739|FG000|Overall Study|Death|4|||
105839006|NCT00983528|365067739|FG000|Overall Study|Lost to Follow-up|1|||
105839007|NCT00983528|365067739|FG000|Overall Study|Study Terminated|1|||
105839008|NCT00084799|365067740|FG000|Overall Study|Disease Progression|1|||
105839009|NCT00084799|365067741|FG001|Overall Study|Disease Progression|0|||
105839010|NCT00330460|365067746|FG000|Overall Study|Physician Decision|1|||
105839011|NCT00330460|365067747|FG001|Overall Study|Physician Decision|0|||
105839012|NCT00330460|365067746|FG000|Overall Study|Adverse Event|10|||
105839013|NCT00330460|365067747|FG001|Overall Study|Adverse Event|8|||
105839014|NCT00330460|365067746|FG000|Overall Study|Withdrawal by Subject|18|||
105839015|NCT00330460|365067747|FG001|Overall Study|Withdrawal by Subject|17|||
105839016|NCT00330460|365067746|FG000|Overall Study|Death|1|||
105839017|NCT00330460|365067747|FG001|Overall Study|Death|1|||
105839018|NCT00330460|365067746|FG000|Overall Study|Ineligibility determined|1|||
105839019|NCT00330460|365067747|FG001|Overall Study|Ineligibility determined|3|||
105839020|NCT00330460|365067746|FG000|Overall Study|Lost to Follow-up|8|||
105839021|NCT00330460|365067747|FG001|Overall Study|Lost to Follow-up|3|||
105839022|NCT00330460|365067746|FG000|Overall Study|Noncompliance|2|||
106149317|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
105839023|NCT00330460|365067747|FG001|Overall Study|Noncompliance|1|||
105839024|NCT00330460|365067746|FG000|Overall Study|Other|1|||
105839025|NCT00330460|365067747|FG001|Overall Study|Other|0|||
105839026|NCT01857973|365067748|FG000|Overall Study|Subject did not meet required BG range|3|||
105839027|NCT01857973|365067748|FG000|Overall Study|drop out after 3 failed attempts|1|||
105839028|NCT01857973|365067748|FG000|Overall Study|Physician Decision|1|||
105839029|NCT02663882|365067749|FG000|Overall Study|Lost to Follow-up|4|||
105839030|NCT02663882|365067750|FG001|Overall Study|Lost to Follow-up|2|||
105839031|NCT00602537|365067753|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
105839032|NCT00602537|365067754|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
105839033|NCT00602537|365067753|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
105839034|NCT00602537|365067754|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
105966446|NCT04826094|365535683|FG000|Overall Study|Participant withdrew consent|1|||
105966447|NCT04826094|365535684|FG001|Overall Study|Participant withdrew consent|0|||
105966448|NCT04826094|365535685|FG002|Overall Study|Participant withdrew consent|0|||
105966449|NCT04826094|365535686|FG003|Overall Study|Participant withdrew consent|1|||
105966450|NCT04826094|365535687|FG004|Overall Study|Participant withdrew consent|1|||
105966451|NCT04826094|365535688|FG005|Overall Study|Participant withdrew consent|1|||
105966452|NCT04826094|365535689|FG006|Overall Study|Participant withdrew consent|0|||
105966453|NCT04826094|365535690|FG007|Overall Study|Participant withdrew consent|1|||
105966454|NCT04826094|365535683|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
105966455|NCT04826094|365535684|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
105966456|NCT04826094|365535685|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
105966457|NCT04826094|365535686|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
105966458|NCT04826094|365535687|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
105966459|NCT04826094|365535688|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
105966460|NCT04826094|365535689|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
105966461|NCT04826094|365535690|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
105966462|NCT04826094|365535683|FG000|Overall Study|Withdrawn by Investigator|0|||
105966463|NCT04826094|365535684|FG001|Overall Study|Withdrawn by Investigator|0|||
105966464|NCT04826094|365535685|FG002|Overall Study|Withdrawn by Investigator|0|||
105966465|NCT04826094|365535686|FG003|Overall Study|Withdrawn by Investigator|0|||
106149318|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
106149319|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149320|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
106149321|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
105966466|NCT04826094|365535687|FG004|Overall Study|Withdrawn by Investigator|0|||
105966467|NCT04826094|365535688|FG005|Overall Study|Withdrawn by Investigator|1|||
105966468|NCT04826094|365535689|FG006|Overall Study|Withdrawn by Investigator|0|||
105966469|NCT04826094|365535690|FG007|Overall Study|Withdrawn by Investigator|1|||
105966470|NCT04826094|365535683|FG000|Overall Study|Other: Moved from area|1|||
105966471|NCT04826094|365535684|FG001|Overall Study|Other: Moved from area|1|||
105966472|NCT04826094|365535685|FG002|Overall Study|Other: Moved from area|1|||
106023552|NCT01675167|365750415|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
106023553|NCT01675167|365750416|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
106023554|NCT01675167|365750417|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
106023555|NCT01675167|365750415|FG000|Double-blind Treatment Phase|Other|0|||
106023556|NCT01675167|365750416|FG001|Double-blind Treatment Phase|Other|7|||
106023557|NCT01675167|365750417|FG002|Double-blind Treatment Phase|Other|5|||
106023558|NCT01525225|365750423|FG000|Enrollment|No longer met study criteria|1|||
106023559|NCT01525225|365750423|FG000|Enrollment|Other|1|||
106023560|NCT02102204|365751759|FG000|Overall Study|Withdrawal by Subject|137|||
106023561|NCT02102204|365751759|FG000|Overall Study|Death|92|||
106023562|NCT02102204|365751759|FG000|Overall Study|Lost to Follow-up|65|||
106023563|NCT02102204|365751759|FG000|Overall Study|Sponsor Decision|5|||
106023564|NCT02102204|365751759|FG000|Overall Study|Ongoing|5|||
106023565|NCT00295880|365751760|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
106023566|NCT00295880|365751760|FG000|Overall Study|Unit randomization did not occur|1|||
106023567|NCT00122980|365751761|FG000|Overall Study|Death|0|||
106023568|NCT00122980|365751762|FG001|Overall Study|Death|1|||
106023569|NCT00122980|365751761|FG000|Overall Study|Physician Decision|2|||
106023570|NCT00122980|365751762|FG001|Overall Study|Physician Decision|0|||
106023571|NCT00122980|365751761|FG000|Overall Study|Protocol Violation|5|||
106023572|NCT00122980|365751762|FG001|Overall Study|Protocol Violation|1|||
106023573|NCT00122980|365751761|FG000|Overall Study|Withdrawal by Subject|2|||
106023574|NCT00122980|365751762|FG001|Overall Study|Withdrawal by Subject|3|||
106023575|NCT00122980|365751761|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
106023576|NCT00122980|365751762|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
105966473|NCT04826094|365535686|FG003|Overall Study|Other: Moved from area|0|||
105966474|NCT04826094|365535687|FG004|Overall Study|Other: Moved from area|0|||
105966475|NCT04826094|365535688|FG005|Overall Study|Other: Moved from area|0|||
106023577|NCT00122980|365751761|FG000|Overall Study|Study termination|27|||
106149322|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149323|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105966476|NCT04826094|365535689|FG006|Overall Study|Other: Moved from area|0|||
105966477|NCT04826094|365535690|FG007|Overall Study|Other: Moved from area|0|||
105966478|NCT04826094|365535683|FG000|Overall Study|Other: Declined|0|||
105966479|NCT04826094|365535684|FG001|Overall Study|Other: Declined|0|||
105966480|NCT04826094|365535685|FG002|Overall Study|Other: Declined|0|||
105966481|NCT04826094|365535686|FG003|Overall Study|Other: Declined|0|||
105966482|NCT04826094|365535687|FG004|Overall Study|Other: Declined|1|||
106023578|NCT00122980|365751762|FG001|Overall Study|Study termination|35|||
106023579|NCT01675544|365751770|FG000|Overall Study|Withdrawal by Subject|2|||
106023580|NCT00476008|365751774|FG000|Overall Study|Adverse Event|4|||
106023581|NCT00476008|365751775|FG001|Overall Study|Adverse Event|4|||
105966483|NCT04826094|365535688|FG005|Overall Study|Other: Declined|0|||
105966484|NCT04826094|365535689|FG006|Overall Study|Other: Declined|0|||
105966485|NCT04826094|365535690|FG007|Overall Study|Other: Declined|0|||
105966486|NCT04826094|365535683|FG000|Overall Study|Other: Vaccine not administered|0|||
105966487|NCT04826094|365535684|FG001|Overall Study|Other: Vaccine not administered|0|||
105966488|NCT04826094|365535685|FG002|Overall Study|Other: Vaccine not administered|1|||
105966489|NCT04826094|365535686|FG003|Overall Study|Other: Vaccine not administered|0|||
105966490|NCT04826094|365535687|FG004|Overall Study|Other: Vaccine not administered|0|||
105966491|NCT04826094|365535688|FG005|Overall Study|Other: Vaccine not administered|1|||
105966492|NCT04826094|365535689|FG006|Overall Study|Other: Vaccine not administered|1|||
105966493|NCT04826094|365535690|FG007|Overall Study|Other: Vaccine not administered|3|||
105966494|NCT04445519|365535691|FG000|Overall Study|Due to adaptive design|3|||
105966495|NCT04445519|365535692|FG001|Overall Study|Due to adaptive design|0|||
105966496|NCT04445519|365535693|FG002|Overall Study|Due to adaptive design|0|||
105966497|NCT04445519|365535691|FG000|Overall Study|Lost to Follow-up|0|||
105966498|NCT04445519|365535692|FG001|Overall Study|Lost to Follow-up|1|||
105966499|NCT04445519|365535693|FG002|Overall Study|Lost to Follow-up|4|||
106023582|NCT00476008|365751774|FG000|Overall Study|Placebo concerns|2|||
106023583|NCT00476008|365751775|FG001|Overall Study|Placebo concerns|2|||
106023584|NCT00476008|365751774|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
106023585|NCT00476008|365751775|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
105839035|NCT00602537|365067753|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
105839036|NCT00602537|365067754|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
105839037|NCT00602537|365067753|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
105839038|NCT00602537|365067754|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
105839039|NCT00602537|365067753|FG000|Follow Up Study Comparison|Adverse Event|1|||
105839040|NCT00602537|365067754|FG001|Follow Up Study Comparison|Adverse Event|0|||
105839041|NCT00602537|365067753|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
105839042|NCT00602537|365067754|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
105839043|NCT00602537|365067753|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
105839044|NCT00602537|365067754|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
105839045|NCT02412722|365067761|FG000|Overall Study|Adverse Event|0|||
105839046|NCT02412722|365067762|FG001|Overall Study|Adverse Event|2|||
105839047|NCT02412722|365067763|FG002|Overall Study|Adverse Event|0|||
105839048|NCT02412722|365067764|FG003|Overall Study|Adverse Event|3|||
105839049|NCT02412722|365067765|FG004|Overall Study|Adverse Event|0|||
105839050|NCT02412722|365067766|FG005|Overall Study|Adverse Event|3|||
105839051|NCT02412722|365067761|FG000|Overall Study|Progressive Disease|6|||
105839052|NCT02412722|365067762|FG001|Overall Study|Progressive Disease|4|||
105839053|NCT02412722|365067763|FG002|Overall Study|Progressive Disease|4|||
105839054|NCT02412722|365067764|FG003|Overall Study|Progressive Disease|9|||
105839055|NCT02412722|365067765|FG004|Overall Study|Progressive Disease|3|||
105839056|NCT02412722|365067766|FG005|Overall Study|Progressive Disease|3|||
105839057|NCT02412722|365067761|FG000|Overall Study|Withdrawal by Subject|2|||
105839058|NCT02412722|365067762|FG001|Overall Study|Withdrawal by Subject|0|||
105839059|NCT02412722|365067763|FG002|Overall Study|Withdrawal by Subject|1|||
105839060|NCT02412722|365067764|FG003|Overall Study|Withdrawal by Subject|2|||
105839061|NCT02412722|365067765|FG004|Overall Study|Withdrawal by Subject|1|||
105839062|NCT02412722|365067766|FG005|Overall Study|Withdrawal by Subject|1|||
105839063|NCT02412722|365067761|FG000|Overall Study|Lost to Follow-up|0|||
105839064|NCT02412722|365067762|FG001|Overall Study|Lost to Follow-up|0|||
105839065|NCT02412722|365067763|FG002|Overall Study|Lost to Follow-up|0|||
105839066|NCT02412722|365067764|FG003|Overall Study|Lost to Follow-up|0|||
105839067|NCT02412722|365067765|FG004|Overall Study|Lost to Follow-up|1|||
105839068|NCT02412722|365067766|FG005|Overall Study|Lost to Follow-up|0|||
105839069|NCT02412722|365067761|FG000|Overall Study|Received drug in run-in and discontinued|0|||
105839070|NCT02412722|365067762|FG001|Overall Study|Received drug in run-in and discontinued|2|||
105839071|NCT02412722|365067763|FG002|Overall Study|Received drug in run-in and discontinued|0|||
105839072|NCT02412722|365067764|FG003|Overall Study|Received drug in run-in and discontinued|0|||
105839073|NCT02412722|365067765|FG004|Overall Study|Received drug in run-in and discontinued|0|||
105839074|NCT02412722|365067766|FG005|Overall Study|Received drug in run-in and discontinued|0|||
105839075|NCT02412722|365067761|FG000|Overall Study|Reason not Specified|3|||
105839076|NCT02412722|365067762|FG001|Overall Study|Reason not Specified|0|||
106023586|NCT00476008|365751774|FG000|Overall Study|Withdrawal by Subject|0|||
105839077|NCT02412722|365067763|FG002|Overall Study|Reason not Specified|2|||
105839078|NCT02412722|365067764|FG003|Overall Study|Reason not Specified|1|||
105839079|NCT02412722|365067765|FG004|Overall Study|Reason not Specified|2|||
105966500|NCT04445519|365535691|FG000|Overall Study|Sponsor or IRB Decision|0|||
105966501|NCT04445519|365535692|FG001|Overall Study|Sponsor or IRB Decision|1|||
105966502|NCT04445519|365535693|FG002|Overall Study|Sponsor or IRB Decision|2|||
106023587|NCT00476008|365751775|FG001|Overall Study|Withdrawal by Subject|1|||
106023588|NCT00476008|365751774|FG000|Overall Study|Death|1|||
105839080|NCT02412722|365067766|FG005|Overall Study|Reason not Specified|6|||
105839081|NCT03558139|365067772|FG000|Overall Study|Consent Withdrawn|1|||
105839082|NCT03558139|365067773|FG001|Overall Study|Consent Withdrawn|1|||
105839083|NCT03558139|365067774|FG002|Overall Study|Consent Withdrawn|4|||
105839084|NCT03558139|365067772|FG000|Overall Study|Death|5|||
105839085|NCT03558139|365067773|FG001|Overall Study|Death|3|||
105839086|NCT03558139|365067774|FG002|Overall Study|Death|8|||
105839087|NCT03558139|365067772|FG000|Overall Study|Lost to Follow-up|0|||
105839088|NCT03558139|365067773|FG001|Overall Study|Lost to Follow-up|0|||
105839089|NCT03558139|365067774|FG002|Overall Study|Lost to Follow-up|3|||
105839090|NCT03558139|365067772|FG000|Overall Study|Study Ended Per Protocol|0|||
105839091|NCT03558139|365067773|FG001|Overall Study|Study Ended Per Protocol|3|||
105839092|NCT03558139|365067774|FG002|Overall Study|Study Ended Per Protocol|6|||
105839093|NCT03573817|365067775|FG000|Overall Study|Adverse Event|0|||
105839094|NCT03573817|365067776|FG001|Overall Study|Adverse Event|2|||
105839095|NCT03573817|365067775|FG000|Overall Study|Protocol Violation|0|||
105839096|NCT03573817|365067776|FG001|Overall Study|Protocol Violation|1|||
105839097|NCT03573817|365067775|FG000|Overall Study|Withdrawal by Subject|1|||
105839098|NCT03573817|365067776|FG001|Overall Study|Withdrawal by Subject|1|||
105839099|NCT02339740|365067777|FG000|Overall Study|Death|1|||
105839100|NCT02339740|365067778|FG001|Overall Study|Death|0|||
105839101|NCT02339740|365067777|FG000|Overall Study|Physician Decision|0|||
105839102|NCT02339740|365067778|FG001|Overall Study|Physician Decision|2|||
105839103|NCT02339740|365067777|FG000|Overall Study|Withdrawal by Subject|5|||
105839104|NCT02339740|365067778|FG001|Overall Study|Withdrawal by Subject|1|||
105839105|NCT02339740|365067777|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
105839106|NCT02339740|365067778|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
105839107|NCT00104247|365067779|FG000|Overall Study|Withdrawal by Subject|1|||
105839108|NCT00104247|365067780|FG001|Overall Study|Withdrawal by Subject|0|||
105839109|NCT00104247|365067779|FG000|Overall Study|Noncompliant with dosing|0|||
105839110|NCT00104247|365067780|FG001|Overall Study|Noncompliant with dosing|1|||
105839111|NCT02056652|365067784|FG000|Overall Study|Withdrawal by Subject|1|||
105839112|NCT02056652|365067785|FG001|Overall Study|Withdrawal by Subject|0|||
105839113|NCT02056652|365067784|FG000|Overall Study|Lost to Follow-up|0|||
105839114|NCT02056652|365067785|FG001|Overall Study|Lost to Follow-up|3|||
105839115|NCT00402025|365067786|FG000|Overall Study|Adverse Event|0|||
105839116|NCT00402025|365067787|FG001|Overall Study|Adverse Event|0|||
105839117|NCT00402025|365067788|FG002|Overall Study|Adverse Event|2|||
105839118|NCT00402025|365067786|FG000|Overall Study|Death|0|||
105839119|NCT00402025|365067787|FG001|Overall Study|Death|1|||
105839120|NCT00402025|365067788|FG002|Overall Study|Death|5|||
105839121|NCT00402025|365067786|FG000|Overall Study|Disease Progression|1|||
105839122|NCT00402025|365067787|FG001|Overall Study|Disease Progression|1|||
105839123|NCT00402025|365067788|FG002|Overall Study|Disease Progression|2|||
105839124|NCT00402025|365067786|FG000|Overall Study|Physician Decision|1|||
105839125|NCT00402025|365067787|FG001|Overall Study|Physician Decision|1|||
105839126|NCT00402025|365067788|FG002|Overall Study|Physician Decision|0|||
105839127|NCT00402025|365067786|FG000|Overall Study|Participant Decision|0|||
105839128|NCT00402025|365067787|FG001|Overall Study|Participant Decision|0|||
105839129|NCT00402025|365067788|FG002|Overall Study|Participant Decision|1|||
105839130|NCT01917968|365067790|FG000|Overall Study|Death|3|||
105839131|NCT01917968|365067791|FG001|Overall Study|Death|2|||
105839132|NCT01917968|365067790|FG000|Overall Study|Lost to Follow-up|21|||
105839133|NCT01917968|365067791|FG001|Overall Study|Lost to Follow-up|39|||
105839134|NCT01917968|365067790|FG000|Overall Study|Physician Decision|1|||
105839135|NCT01917968|365067791|FG001|Overall Study|Physician Decision|2|||
105839136|NCT01917968|365067790|FG000|Overall Study|Withdrawal by Subject|20|||
105839137|NCT01917968|365067791|FG001|Overall Study|Withdrawal by Subject|35|||
105839138|NCT01917968|365067790|FG000|Overall Study|Subject Relocation|5|||
105839139|NCT01917968|365067791|FG001|Overall Study|Subject Relocation|1|||
105839140|NCT01917968|365067790|FG000|Overall Study|36M Missed Visit|3|||
105839141|NCT01917968|365067791|FG001|Overall Study|36M Missed Visit|2|||
105839142|NCT01917968|365067790|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
106023589|NCT00476008|365751775|FG001|Overall Study|Death|0|||
105839143|NCT01917968|365067791|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
105839144|NCT01917968|365067790|FG000|Overall Study|Change in Family Circumstances|0|||
105839145|NCT01917968|365067791|FG001|Overall Study|Change in Family Circumstances|1|||
105839146|NCT01917968|365067790|FG000|Overall Study|No Data Available|0|||
105839147|NCT01917968|365067791|FG001|Overall Study|No Data Available|2|||
105839148|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
105839149|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
105839150|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
105839151|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
105839152|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
105839153|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
105839154|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
105839155|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
105839156|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
105839157|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
105839158|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
105839159|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
105839160|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
105839161|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
105839162|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
105839163|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
105839164|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
105839165|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
105839166|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
105839167|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
105839168|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
105839169|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
105839170|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
105839171|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
105839172|NCT01435928|365067792|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
105839173|NCT01435928|365067793|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
105839174|NCT01435928|365067794|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
105839175|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
105839176|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
105839177|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
105839178|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
105839179|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
105839180|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
105839181|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
105839182|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
105839183|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
105839184|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
105839185|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
105839186|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
105839187|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
105839188|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
105839189|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
105839190|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
105839191|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
105839192|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
105839193|NCT01435928|365067792|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
105839194|NCT01435928|365067793|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
105839195|NCT01435928|365067794|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
105839196|NCT04034355|365067806|FG000|Overall Study|Study terminated by Sponsor|10|||
105839197|NCT04034355|365067807|FG001|Overall Study|Study terminated by Sponsor|17|||
105839198|NCT04034355|365067806|FG000|Overall Study|Withdrawal by Subject|12|||
105839199|NCT04034355|365067807|FG001|Overall Study|Withdrawal by Subject|11|||
105839200|NCT04034355|365067806|FG000|Overall Study|Site terminated by Sponsor|4|||
105839201|NCT04034355|365067807|FG001|Overall Study|Site terminated by Sponsor|5|||
105839202|NCT04034355|365067806|FG000|Overall Study|Adverse Event|2|||
105839203|NCT04034355|365067807|FG001|Overall Study|Adverse Event|0|||
105839204|NCT04034355|365067806|FG000|Overall Study|Death|1|||
105839205|NCT04034355|365067807|FG001|Overall Study|Death|1|||
105839206|NCT04034355|365067806|FG000|Overall Study|Not reported|2|||
105839207|NCT04034355|365067807|FG001|Overall Study|Not reported|0|||
105839208|NCT04034355|365067806|FG000|Overall Study|Lost to Follow-up|1|||
105839209|NCT04034355|365067807|FG001|Overall Study|Lost to Follow-up|0|||
105839210|NCT04034355|365067806|FG000|Overall Study|Physician Decision|1|||
105839211|NCT04034355|365067807|FG001|Overall Study|Physician Decision|0|||
105839212|NCT04034355|365067806|FG000|Overall Study|Protocol Violation|0|||
105839213|NCT04034355|365067807|FG001|Overall Study|Protocol Violation|1|||
105839214|NCT04034355|365067806|FG000|Overall Study|Progressive disease|1|||
105839215|NCT04034355|365067807|FG001|Overall Study|Progressive disease|0|||
105839216|NCT01923311|365069956|FG000|Overall Study|Pregnancy|1|||
105839217|NCT01923311|365069957|FG001|Overall Study|Pregnancy|0|||
105839218|NCT01923311|365069956|FG000|Overall Study|Investigator's Discretion|1|||
105839219|NCT01923311|365069957|FG001|Overall Study|Investigator's Discretion|0|||
105839220|NCT01923311|365069956|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105839221|NCT01923311|365069957|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105839222|NCT01923311|365069956|FG000|Overall Study|Withdrew Consent|1|||
105839223|NCT01923311|365069957|FG001|Overall Study|Withdrew Consent|0|||
105839224|NCT01923311|365069956|FG000|Overall Study|Study Terminated by Sponsor|12|||
105839225|NCT01923311|365069957|FG001|Overall Study|Study Terminated by Sponsor|0|||
105839226|NCT03180528|365069962|FG000|Overall Study|Adverse Event|1|||
105839227|NCT03180528|365069962|FG000|Overall Study|Withdrawal by Subject|1|||
105839228|NCT03180528|365069962|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
105839229|NCT04703855|365069963|FG000|Overall Study|Heart Transplant|1|||
106023590|NCT00724711|365751781|FG000|Overall Study|Adverse Event|7|||
106023591|NCT00724711|365751782|FG001|Overall Study|Adverse Event|3|||
106023592|NCT00724711|365751781|FG000|Overall Study|Pregnancy|0|||
105839230|NCT00401245|365069967|FG000|Double Blind Titration Phase|Adverse Event|3|||
105839231|NCT00401245|365069968|FG001|Double Blind Titration Phase|Adverse Event|2|||
105839232|NCT00401245|365069969|FG002|Double Blind Titration Phase|Adverse Event|5|||
105839233|NCT00401245|365069970|FG003|Double Blind Titration Phase|Adverse Event|12|||
105839234|NCT00401245|365069971|FG004|Double Blind Titration Phase|Adverse Event|0|||
105839235|NCT00401245|365069972|FG005|Double Blind Titration Phase|Adverse Event|0|||
105839236|NCT00401245|365069973|FG006|Double Blind Titration Phase|Adverse Event|0|||
105839237|NCT00401245|365069974|FG007|Double Blind Titration Phase|Adverse Event|0|||
105839238|NCT00401245|365069967|FG000|Double Blind Titration Phase|Other|0|||
105839239|NCT00401245|365069968|FG001|Double Blind Titration Phase|Other|0|||
105839240|NCT00401245|365069969|FG002|Double Blind Titration Phase|Other|1|||
105839241|NCT00401245|365069970|FG003|Double Blind Titration Phase|Other|0|||
105839242|NCT00401245|365069971|FG004|Double Blind Titration Phase|Other|0|||
105839243|NCT00401245|365069972|FG005|Double Blind Titration Phase|Other|0|||
105839244|NCT00401245|365069973|FG006|Double Blind Titration Phase|Other|0|||
105839245|NCT00401245|365069974|FG007|Double Blind Titration Phase|Other|0|||
105839246|NCT00401245|365069967|FG000|Double Blind Titration Phase|Protocol Violation|0|||
105839247|NCT00401245|365069968|FG001|Double Blind Titration Phase|Protocol Violation|0|||
105839248|NCT00401245|365069969|FG002|Double Blind Titration Phase|Protocol Violation|0|||
105839249|NCT00401245|365069970|FG003|Double Blind Titration Phase|Protocol Violation|1|||
105839250|NCT00401245|365069971|FG004|Double Blind Titration Phase|Protocol Violation|0|||
105839251|NCT00401245|365069972|FG005|Double Blind Titration Phase|Protocol Violation|0|||
105839252|NCT00401245|365069973|FG006|Double Blind Titration Phase|Protocol Violation|0|||
105839253|NCT00401245|365069974|FG007|Double Blind Titration Phase|Protocol Violation|0|||
105839254|NCT00401245|365069967|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
105839255|NCT00401245|365069968|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
105839256|NCT00401245|365069969|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839257|NCT00401245|365069970|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
105839258|NCT00401245|365069971|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839259|NCT00401245|365069972|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839260|NCT00401245|365069973|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839261|NCT00401245|365069974|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
105839262|NCT00401245|365069967|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839263|NCT00401245|365069968|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
105839264|NCT00401245|365069969|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839265|NCT00401245|365069970|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
105839266|NCT00401245|365069971|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839267|NCT00401245|365069972|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839268|NCT00401245|365069973|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839269|NCT00401245|365069974|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
105839270|NCT00401245|365069967|FG000|Open Label Phase|Adverse Event|5|||
105839271|NCT00401245|365069968|FG001|Open Label Phase|Adverse Event|14|||
105839272|NCT00401245|365069969|FG002|Open Label Phase|Adverse Event|6|||
105839273|NCT00401245|365069970|FG003|Open Label Phase|Adverse Event|7|||
105839274|NCT00401245|365069971|FG004|Open Label Phase|Adverse Event|0|||
105839275|NCT00401245|365069972|FG005|Open Label Phase|Adverse Event|0|||
105839276|NCT00401245|365069973|FG006|Open Label Phase|Adverse Event|0|||
105839277|NCT00401245|365069974|FG007|Open Label Phase|Adverse Event|0|||
105839278|NCT00401245|365069967|FG000|Open Label Phase|Lost to Follow-up|5|||
105839279|NCT00401245|365069968|FG001|Open Label Phase|Lost to Follow-up|7|||
105839280|NCT00401245|365069969|FG002|Open Label Phase|Lost to Follow-up|5|||
105839281|NCT00401245|365069970|FG003|Open Label Phase|Lost to Follow-up|4|||
105839282|NCT00401245|365069971|FG004|Open Label Phase|Lost to Follow-up|0|||
105839283|NCT00401245|365069972|FG005|Open Label Phase|Lost to Follow-up|0|||
105839284|NCT00401245|365069973|FG006|Open Label Phase|Lost to Follow-up|0|||
105839285|NCT00401245|365069974|FG007|Open Label Phase|Lost to Follow-up|0|||
106023593|NCT00724711|365751782|FG001|Overall Study|Pregnancy|1|||
106023594|NCT00724711|365751781|FG000|Overall Study|Lack of Efficacy|0|||
106023595|NCT00724711|365751782|FG001|Overall Study|Lack of Efficacy|1|||
106023596|NCT00724711|365751781|FG000|Overall Study|Physician Decision|0|||
106023597|NCT00724711|365751782|FG001|Overall Study|Physician Decision|3|||
106023598|NCT00724711|365751781|FG000|Overall Study|Withdrawal by Subject|5|||
106023599|NCT00724711|365751782|FG001|Overall Study|Withdrawal by Subject|4|||
105839286|NCT00401245|365069967|FG000|Open Label Phase|Other|4|||
105839287|NCT00401245|365069968|FG001|Open Label Phase|Other|8|||
105839288|NCT00401245|365069969|FG002|Open Label Phase|Other|7|||
105839289|NCT00401245|365069970|FG003|Open Label Phase|Other|8|||
105839290|NCT00401245|365069971|FG004|Open Label Phase|Other|0|||
105839291|NCT00401245|365069972|FG005|Open Label Phase|Other|0|||
106023600|NCT00724711|365751781|FG000|Overall Study|Lost to Follow-up|4|||
105966503|NCT04445519|365535691|FG000|Overall Study|Withdrawal by Subject|0|||
105966504|NCT04445519|365535692|FG001|Overall Study|Withdrawal by Subject|3|||
105966505|NCT04445519|365535693|FG002|Overall Study|Withdrawal by Subject|3|||
105966506|NCT04445519|365535691|FG000|Overall Study|Adverse Event|0|||
105966507|NCT04445519|365535692|FG001|Overall Study|Adverse Event|8|||
105839292|NCT00401245|365069973|FG006|Open Label Phase|Other|0|||
105839293|NCT00401245|365069974|FG007|Open Label Phase|Other|0|||
105839294|NCT00401245|365069967|FG000|Open Label Phase|Protocol Violation|0|||
105839295|NCT00401245|365069968|FG001|Open Label Phase|Protocol Violation|1|||
105839296|NCT00401245|365069969|FG002|Open Label Phase|Protocol Violation|0|||
105839297|NCT00401245|365069970|FG003|Open Label Phase|Protocol Violation|1|||
105839298|NCT00401245|365069971|FG004|Open Label Phase|Protocol Violation|0|||
105839299|NCT00401245|365069972|FG005|Open Label Phase|Protocol Violation|0|||
105839300|NCT00401245|365069973|FG006|Open Label Phase|Protocol Violation|0|||
105839301|NCT00401245|365069974|FG007|Open Label Phase|Protocol Violation|0|||
105839302|NCT00401245|365069967|FG000|Open Label Phase|Withdrawal by Subject|3|||
105839303|NCT00401245|365069968|FG001|Open Label Phase|Withdrawal by Subject|3|||
105839304|NCT00401245|365069969|FG002|Open Label Phase|Withdrawal by Subject|2|||
105839305|NCT00401245|365069970|FG003|Open Label Phase|Withdrawal by Subject|1|||
105839306|NCT00401245|365069971|FG004|Open Label Phase|Withdrawal by Subject|0|||
105839307|NCT00401245|365069972|FG005|Open Label Phase|Withdrawal by Subject|0|||
105839308|NCT00401245|365069973|FG006|Open Label Phase|Withdrawal by Subject|0|||
105839309|NCT00401245|365069974|FG007|Open Label Phase|Withdrawal by Subject|0|||
105839310|NCT00401245|365069967|FG000|Open Label Phase|Lack of Efficacy|4|||
105839311|NCT00401245|365069968|FG001|Open Label Phase|Lack of Efficacy|2|||
105839312|NCT00401245|365069969|FG002|Open Label Phase|Lack of Efficacy|3|||
105839313|NCT00401245|365069970|FG003|Open Label Phase|Lack of Efficacy|0|||
105839314|NCT00401245|365069971|FG004|Open Label Phase|Lack of Efficacy|0|||
105839315|NCT00401245|365069972|FG005|Open Label Phase|Lack of Efficacy|0|||
105839316|NCT00401245|365069973|FG006|Open Label Phase|Lack of Efficacy|0|||
105839317|NCT00401245|365069974|FG007|Open Label Phase|Lack of Efficacy|0|||
105839318|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Adverse Event|0|||
105839319|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Adverse Event|0|||
105839320|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Adverse Event|0|||
105839321|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Adverse Event|0|||
105839322|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Adverse Event|1|||
105839323|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Adverse Event|1|||
105839324|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Adverse Event|2|||
105839325|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Adverse Event|4|||
105839326|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Investigator request|0|||
105839327|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Investigator request|0|||
105839328|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Investigator request|0|||
105839329|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Investigator request|0|||
105966508|NCT04445519|365535693|FG002|Overall Study|Adverse Event|6|||
105966509|NCT04445519|365535691|FG000|Overall Study|Other Reason|0|||
105966510|NCT04445519|365535692|FG001|Overall Study|Other Reason|1|||
105966511|NCT04445519|365535693|FG002|Overall Study|Other Reason|1|||
105966512|NCT04445519|365535691|FG000|Overall Study|Protocol Violation|0|||
105966513|NCT04445519|365535692|FG001|Overall Study|Protocol Violation|0|||
105966514|NCT04445519|365535693|FG002|Overall Study|Protocol Violation|1|||
105966515|NCT03931382|365535694|FG000|Overall Study|Equipment malfunction|2|||
105966516|NCT03931382|365535695|FG001|Overall Study|Equipment malfunction|0|||
105966517|NCT03931382|365535696|FG002|Overall Study|Equipment malfunction|2|||
105966518|NCT03931382|365535694|FG000|Overall Study|Withdrawal by Subject|0|||
105966519|NCT03931382|365535695|FG001|Overall Study|Withdrawal by Subject|1|||
105966520|NCT03931382|365535696|FG002|Overall Study|Withdrawal by Subject|0|||
105966521|NCT00939029|365535699|FG000|Overall Study|Withdrawal by Subject|3|||
105966522|NCT00939029|365535700|FG001|Overall Study|Withdrawal by Subject|7|||
105966523|NCT00939029|365535699|FG000|Overall Study|Lost to Follow-up|3|||
105966524|NCT00939029|365535700|FG001|Overall Study|Lost to Follow-up|4|||
105966525|NCT00939029|365535699|FG000|Overall Study|Adverse Event|0|||
105966526|NCT00939029|365535700|FG001|Overall Study|Adverse Event|1|||
105966527|NCT01272037|365535701|FG000|Overall Study|Death|25|||
105966528|NCT01272037|365535702|FG001|Overall Study|Death|28|||
105966529|NCT01272037|365535701|FG000|Overall Study|Adverse Event|12|||
105966530|NCT01272037|365535702|FG001|Overall Study|Adverse Event|7|||
105966531|NCT01272037|365535701|FG000|Overall Study|Withdrawal by Subject|175|||
105966532|NCT01272037|365535702|FG001|Overall Study|Withdrawal by Subject|93|||
105839330|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Investigator request|0|||
105966533|NCT01272037|365535701|FG000|Overall Study|Disease progression|70|||
105966534|NCT01272037|365535702|FG001|Overall Study|Disease progression|111|||
105966535|NCT01272037|365535701|FG000|Overall Study|Other reason|42|||
105839331|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Investigator request|0|||
105839332|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Investigator request|0|||
105839333|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Investigator request|1|||
105966536|NCT01272037|365535702|FG001|Overall Study|Other reason|41|||
105966537|NCT01272037|365535701|FG000|Overall Study|Delinquent data|24|||
105966538|NCT01272037|365535702|FG001|Overall Study|Delinquent data|19|||
105966539|NCT01272037|365535701|FG000|Overall Study|Reason under review|33|||
105966540|NCT01272037|365535702|FG001|Overall Study|Reason under review|29|||
105966541|NCT01272037|365535701|FG000|Overall Study|On treatment|626|||
105966542|NCT01272037|365535702|FG001|Overall Study|On treatment|632|||
105966543|NCT02487654|365535703|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
105966544|NCT02487654|365535704|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
105966545|NCT02487654|365535703|FG000|Overall Study|Withdrawal by Subject|3|||
105966546|NCT02487654|365535704|FG001|Overall Study|Withdrawal by Subject|7|||
105966547|NCT06359028|365535705|FG000|Overall Study|Adverse Event|1|||
105966548|NCT06359028|365535706|FG001|Overall Study|Adverse Event|0|||
105966549|NCT06359028|365535705|FG000|Overall Study|Withdrawal by Subject|1|||
105966550|NCT06359028|365535706|FG001|Overall Study|Withdrawal by Subject|0|||
105966551|NCT00920387|365535709|FG000|Stage 1|Adverse Event|1|||
105966552|NCT00920387|365535710|FG001|Stage 1|Adverse Event|0|||
105966553|NCT00920387|365535711|FG002|Stage 1|Adverse Event|0|||
105966554|NCT06099223|365535713|FG000|Overall Study|Preoperative surveys missed|0|||
105966555|NCT06099223|365535714|FG001|Overall Study|Preoperative surveys missed|1|||
105966556|NCT02791516|365535715|FG000|Overall Study|Withdrawal by Subject|1|||
105966557|NCT02791516|365535716|FG001|Overall Study|Withdrawal by Subject|1|||
105966558|NCT01439971|365535717|FG000|Overall Study|Required number in cohort dosed|0|||
105966559|NCT01439971|365535718|FG001|Overall Study|Required number in cohort dosed|1|||
105966560|NCT01439971|365535719|FG002|Overall Study|Required number in cohort dosed|2|||
105966561|NCT01439971|365535720|FG003|Overall Study|Required number in cohort dosed|0|||
105966562|NCT01439971|365535721|FG004|Overall Study|Required number in cohort dosed|1|||
105966563|NCT00661726|365535730|FG000|Overall Study|Adverse Event|1|||
105966564|NCT02461290|365535731|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
105966565|NCT02461290|365535731|FG000|Overall Study|Lost to Follow-up|3|||
105966566|NCT00526656|365535732|FG000|Overall Study|Death|1|||
105966567|NCT00526656|365535732|FG000|Overall Study|Refused surgery|1|||
105966568|NCT03315793|365535734|FG000|Overall Study|Adverse Event|4|||
105966569|NCT03315793|365535735|FG001|Overall Study|Adverse Event|2|||
105966570|NCT03315793|365535734|FG000|Overall Study|Protocol Deviation|1|||
105966571|NCT03315793|365535735|FG001|Overall Study|Protocol Deviation|0|||
105966572|NCT03315793|365535734|FG000|Overall Study|Difficult for regular visit|0|||
105966573|NCT03315793|365535735|FG001|Overall Study|Difficult for regular visit|1|||
105966574|NCT03724981|365537690|FG000|First Device|Protocol Violation|1|||
105966575|NCT03724981|365537691|FG001|First Device|Protocol Violation|1|||
105966576|NCT01631747|365537692|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
105966577|NCT01631747|365537693|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
105966578|NCT01631747|365537692|FG000|Live Birth|Pregnancy Termination|1|||
105966579|NCT01631747|365537693|FG001|Live Birth|Pregnancy Termination|0|||
105966580|NCT01631747|365537692|FG000|Live Birth|MIscarriage|2|||
105966581|NCT01631747|365537693|FG001|Live Birth|MIscarriage|0|||
105966582|NCT01631747|365537692|FG000|Live Birth|Stillbirth|1|||
105966583|NCT01631747|365537693|FG001|Live Birth|Stillbirth|1|||
105966584|NCT01631747|365537692|FG000|One Year Infant Outcomes|Patient Refused|13|||
105966585|NCT01631747|365537693|FG001|One Year Infant Outcomes|Patient Refused|9|||
105966586|NCT01456195|365537694|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
105966587|NCT01456195|365537695|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
105966588|NCT01456195|365537696|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
105966589|NCT01456195|365537694|FG000|Overall Study|Lost to Follow-up|3|||
105966590|NCT01456195|365537695|FG001|Overall Study|Lost to Follow-up|1|||
105966591|NCT01456195|365537696|FG002|Overall Study|Lost to Follow-up|3|||
106023601|NCT00724711|365751782|FG001|Overall Study|Lost to Follow-up|5|||
106023602|NCT00724711|365751781|FG000|Overall Study|Protocol Violation|1|||
106023603|NCT00724711|365751782|FG001|Overall Study|Protocol Violation|0|||
105966592|NCT01456195|365537694|FG000|Overall Study|Voluntary Withdrawal|5|||
105966593|NCT01456195|365537695|FG001|Overall Study|Voluntary Withdrawal|3|||
105966594|NCT01456195|365537696|FG002|Overall Study|Voluntary Withdrawal|7|||
105966595|NCT01456195|365537694|FG000|Overall Study|Lack of Efficacy|0|||
105966596|NCT01456195|365537695|FG001|Overall Study|Lack of Efficacy|1|||
105966597|NCT01456195|365537696|FG002|Overall Study|Lack of Efficacy|0|||
106023604|NCT05367492|365751784|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
106023605|NCT05367492|365751785|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
106023606|NCT05367492|365751786|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
105966598|NCT01456195|365537694|FG000|Overall Study|Other Reasons|2|||
105966599|NCT01456195|365537695|FG001|Overall Study|Other Reasons|1|||
105966600|NCT01456195|365537696|FG002|Overall Study|Other Reasons|3|||
106149324|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105839334|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Other|0|||
106149325|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105966601|NCT02109432|365537697|FG000|Overall Study|Withdrawal by Subject|1|||
105966602|NCT05897242|365537707|FG000|Overall Study|Lost to Follow-up|6|||
105966603|NCT05897242|365537708|FG001|Overall Study|Lost to Follow-up|1|||
105966604|NCT05897242|365537707|FG000|Overall Study|Incomplete|1|||
105839335|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Other|0|||
105839336|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Other|0|||
105839337|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Other|0|||
105839338|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Other|1|||
105966605|NCT05897242|365537708|FG001|Overall Study|Incomplete|0|||
105966606|NCT05897242|365537707|FG000|Overall Study|Withdrawal by Subject|1|||
105966607|NCT05897242|365537708|FG001|Overall Study|Withdrawal by Subject|0|||
105966608|NCT03596047|365537709|FG000|Overall Study|Withdrawal by Subject|7|||
105966609|NCT03596047|365537710|FG001|Overall Study|Withdrawal by Subject|4|||
105966610|NCT03596047|365537709|FG000|Overall Study|Lost to Follow-up|0|||
105966611|NCT03596047|365537710|FG001|Overall Study|Lost to Follow-up|2|||
105966612|NCT05160415|365537711|FG000|Overall Study|Withdrawal by Subject|3|||
105966613|NCT00978380|365537713|FG000|Overall Study|Protocol Violation|2|||
106023607|NCT05367492|365751784|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
106023608|NCT05367492|365751785|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
106023609|NCT05367492|365751786|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
106023610|NCT05367492|365751784|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
106023611|NCT05367492|365751785|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
106023612|NCT05367492|365751786|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
106023613|NCT05367492|365751784|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
106023614|NCT05367492|365751785|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
106023615|NCT05367492|365751786|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
106023616|NCT01088048|365751787|FG000|Overall Study|Adverse Event|7|||
106023617|NCT01088048|365751788|FG001|Overall Study|Adverse Event|9|||
106023618|NCT01088048|365751789|FG002|Overall Study|Adverse Event|7|||
106023619|NCT01088048|365751790|FG003|Overall Study|Adverse Event|5|||
106023620|NCT01088048|365751791|FG004|Overall Study|Adverse Event|6|||
106023621|NCT01088048|365751792|FG005|Overall Study|Adverse Event|3|||
106023622|NCT01088048|365751793|FG006|Overall Study|Adverse Event|3|||
106023623|NCT01088048|365751794|FG007|Overall Study|Adverse Event|0|||
106023624|NCT01088048|365751795|FG008|Overall Study|Adverse Event|2|||
106023625|NCT01088048|365751796|FG009|Overall Study|Adverse Event|2|||
106023626|NCT01088048|365751787|FG000|Overall Study|Withdrew Consent|1|||
106023627|NCT01088048|365751788|FG001|Overall Study|Withdrew Consent|1|||
106023628|NCT01088048|365751789|FG002|Overall Study|Withdrew Consent|1|||
106023629|NCT01088048|365751790|FG003|Overall Study|Withdrew Consent|1|||
106023630|NCT01088048|365751791|FG004|Overall Study|Withdrew Consent|2|||
106023631|NCT01088048|365751792|FG005|Overall Study|Withdrew Consent|1|||
106023632|NCT01088048|365751793|FG006|Overall Study|Withdrew Consent|0|||
106023633|NCT01088048|365751794|FG007|Overall Study|Withdrew Consent|2|||
106023634|NCT01088048|365751795|FG008|Overall Study|Withdrew Consent|2|||
106023635|NCT01088048|365751796|FG009|Overall Study|Withdrew Consent|1|||
106023636|NCT01088048|365751787|FG000|Overall Study|Concomitant Medication Prohibited|1|||
106023637|NCT01088048|365751788|FG001|Overall Study|Concomitant Medication Prohibited|0|||
106023638|NCT01088048|365751789|FG002|Overall Study|Concomitant Medication Prohibited|0|||
106023639|NCT01088048|365751790|FG003|Overall Study|Concomitant Medication Prohibited|0|||
106023640|NCT01088048|365751791|FG004|Overall Study|Concomitant Medication Prohibited|0|||
106023641|NCT01088048|365751792|FG005|Overall Study|Concomitant Medication Prohibited|0|||
106023642|NCT01088048|365751793|FG006|Overall Study|Concomitant Medication Prohibited|0|||
106023643|NCT01088048|365751794|FG007|Overall Study|Concomitant Medication Prohibited|0|||
106023644|NCT01088048|365751795|FG008|Overall Study|Concomitant Medication Prohibited|0|||
105839339|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Other|0|||
105839340|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Other|2|||
105839341|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Other|2|||
105839342|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839343|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839344|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839345|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839346|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
105839347|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
105839348|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
105839349|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
105839350|NCT00401245|365069967|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839351|NCT00401245|365069968|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839352|NCT00401245|365069969|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839353|NCT00401245|365069970|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839354|NCT00401245|365069971|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839355|NCT00401245|365069972|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
105839356|NCT00401245|365069973|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839357|NCT00401245|365069974|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
105839358|NCT01560819|365069977|FG000|Overall Study|Physician Decision|1|||
105839359|NCT01560819|365069978|FG001|Overall Study|Physician Decision|0|||
106023645|NCT01088048|365751796|FG009|Overall Study|Concomitant Medication Prohibited|0|||
106023646|NCT01088048|365751787|FG000|Overall Study|Investigator Request|2|||
105966614|NCT00978380|365537713|FG000|Overall Study|Withdrawal criteria|9|||
105966615|NCT00978380|365537713|FG000|Overall Study|Unclassified|8|||
105966616|NCT01443364|365537714|FG000|Overall Study|Lack of Efficacy|14|||
105966617|NCT01443364|365537714|FG000|Overall Study|Lost to Follow-up|3|||
105966618|NCT01443364|365537714|FG000|Overall Study|Withdrawal by Subject|5|||
105966619|NCT01443364|365537714|FG000|Overall Study|Other Reason|4|||
105966620|NCT01443364|365537714|FG000|Overall Study|SAE, non-fatal|6|||
105966621|NCT01443364|365537714|FG000|Overall Study|AE, non-serious non-fatal|8|||
105966622|NCT01443364|365537714|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105966623|NCT00559845|365537715|FG000|Overall Study|Withdrew Consent|1|||
105966624|NCT00559845|365537715|FG000|Overall Study|Disease Progression|1|||
105966625|NCT00559845|365537715|FG000|Overall Study|Adverse Event|3|||
106023647|NCT01088048|365751788|FG001|Overall Study|Investigator Request|2|||
105839360|NCT01619579|365069979|FG000|Overall Study|Withdrawal by Subject|0|||
105839361|NCT01619579|365069980|FG001|Overall Study|Withdrawal by Subject|3|||
105839362|NCT02344745|365069981|FG000|Overall Study|Data collection sheets were lost|2|||
105839363|NCT02344745|365069982|FG001|Overall Study|Data collection sheets were lost|0|||
105839364|NCT02124902|365069983|FG000|Overall Study|Adverse Event|7|||
105839365|NCT02124902|365069984|FG001|Overall Study|Adverse Event|2|||
105839366|NCT02124902|365069983|FG000|Overall Study|Went to alternative treatment|4|||
105839367|NCT02124902|365069984|FG001|Overall Study|Went to alternative treatment|0|||
105839368|NCT02124902|365069983|FG000|Overall Study|Withdrawal by Subject|2|||
105839369|NCT02124902|365069984|FG001|Overall Study|Withdrawal by Subject|1|||
105839370|NCT02124902|365069983|FG000|Overall Study|Physician Decision|2|||
105839371|NCT02124902|365069984|FG001|Overall Study|Physician Decision|0|||
105839372|NCT02124902|365069983|FG000|Overall Study|Not eligible|1|||
105839373|NCT02124902|365069984|FG001|Overall Study|Not eligible|0|||
105839374|NCT02124902|365069983|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
105839375|NCT02124902|365069984|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
105839376|NCT01937351|365069985|FG000|Overall Study|Withdrawal by Subject|4|||
105839377|NCT01937351|365069986|FG001|Overall Study|Withdrawal by Subject|2|||
105839378|NCT01937351|365069985|FG000|Overall Study|Death|1|||
105839379|NCT01937351|365069986|FG001|Overall Study|Death|0|||
105839380|NCT01937351|365069985|FG000|Overall Study|Not treated w device, per protocol fail|4|||
105839381|NCT01937351|365069986|FG001|Overall Study|Not treated w device, per protocol fail|0|||
105839382|NCT01961687|365069987|FG000|Overall Study|Lost to Follow-up|19|||
105839383|NCT01961687|365069987|FG000|Overall Study|Re-operation|17|||
106023648|NCT01088048|365751789|FG002|Overall Study|Investigator Request|0|||
106023649|NCT01088048|365751790|FG003|Overall Study|Investigator Request|0|||
106149326|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
106149327|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
105839384|NCT01961687|365069987|FG000|Overall Study|Death|7|||
105839385|NCT01961687|365069987|FG000|Overall Study|Withdrawal by Subject|6|||
105839386|NCT01961687|365069987|FG000|Overall Study|Adverse Event|6|||
105839387|NCT01961687|365069987|FG000|Overall Study|Moved to area without study site|2|||
105839388|NCT01961687|365069987|FG000|Overall Study|Sponsor decision|2|||
105839389|NCT01961687|365069987|FG000|Overall Study|Physician Decision|1|||
105839390|NCT01961687|365069987|FG000|Overall Study|Unable to meet follow-up requirements|1|||
105839391|NCT02688387|365069990|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839392|NCT02688387|365069991|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839393|NCT02688387|365069992|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
105839394|NCT02688387|365069993|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839395|NCT02688387|365069994|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839396|NCT02688387|365069995|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839397|NCT02688387|365069996|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839398|NCT02688387|365069997|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839399|NCT02688387|365069998|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839400|NCT02688387|365069999|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839401|NCT02688387|365070000|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839402|NCT02688387|365070001|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839403|NCT02688387|365070002|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839404|NCT02688387|365070003|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839405|NCT02688387|365070004|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839406|NCT02688387|365070005|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839407|NCT02688387|365070006|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839408|NCT02688387|365070007|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839409|NCT02688387|365070008|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839410|NCT02688387|365070009|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839411|NCT02688387|365070010|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839412|NCT02688387|365070011|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
105839413|NCT02688387|365069990|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839414|NCT02688387|365069991|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105966626|NCT00559845|365537715|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
105966627|NCT00559845|365537715|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
105839415|NCT02688387|365069992|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839416|NCT02688387|365069993|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
105839417|NCT02688387|365069994|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839418|NCT02688387|365069995|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839419|NCT02688387|365069996|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839420|NCT02688387|365069997|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839421|NCT02688387|365069998|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839422|NCT02688387|365069999|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839423|NCT02688387|365070000|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839424|NCT02688387|365070001|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839425|NCT02688387|365070002|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839426|NCT02688387|365070003|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839427|NCT02688387|365070004|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839428|NCT02688387|365070005|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839429|NCT02688387|365070006|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839430|NCT02688387|365070007|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839431|NCT02688387|365070008|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839432|NCT02688387|365070009|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839433|NCT02688387|365070010|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839434|NCT02688387|365070011|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839435|NCT02688387|365069990|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839436|NCT02688387|365069991|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
105839437|NCT02688387|365069992|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839438|NCT02688387|365069993|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839439|NCT02688387|365069994|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839440|NCT02688387|365069995|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839441|NCT02688387|365069996|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839442|NCT02688387|365069997|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839443|NCT02688387|365069998|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839444|NCT02688387|365069999|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839445|NCT02688387|365070000|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839446|NCT02688387|365070001|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839447|NCT02688387|365070002|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839448|NCT02688387|365070003|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839449|NCT02688387|365070004|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839450|NCT02688387|365070005|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839451|NCT02688387|365070006|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839452|NCT02688387|365070007|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839453|NCT02688387|365070008|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839454|NCT02688387|365070009|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839455|NCT02688387|365070010|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839456|NCT02688387|365070011|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
105839457|NCT02688387|365069990|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839458|NCT02688387|365069991|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839459|NCT02688387|365069992|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
105839460|NCT02688387|365069993|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839461|NCT02688387|365069994|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
105839462|NCT02688387|365069995|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839463|NCT02688387|365069996|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839464|NCT02688387|365069997|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839465|NCT02688387|365069998|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105966628|NCT00510718|365537716|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
105966629|NCT00510718|365537717|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
105966630|NCT00510718|365537716|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
105966631|NCT00510718|365537717|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
105966632|NCT00510718|365537716|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
105966633|NCT00510718|365537717|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
105966634|NCT00510718|365537716|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
105966635|NCT00510718|365537717|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
105966636|NCT00510718|365537716|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
106023650|NCT01088048|365751791|FG004|Overall Study|Investigator Request|3|||
106023651|NCT01088048|365751792|FG005|Overall Study|Investigator Request|1|||
105966637|NCT00510718|365537717|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
105966638|NCT00510718|365537716|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
105966639|NCT00510718|365537717|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
105966640|NCT00962741|365537722|FG000|Overall Study|Failed to return|3|||
105966641|NCT00962741|365537722|FG000|Overall Study|Lost to Follow-up|2|||
105966642|NCT00962741|365537722|FG000|Overall Study|Withdrawal by Subject|1|||
105966643|NCT00962741|365537722|FG000|Overall Study|Lack of Efficacy|1|||
105966644|NCT00962741|365537722|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
105839466|NCT02688387|365069999|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105966645|NCT00365105|365537723|FG000|Overall Study|Protocol Violation|5|||
105839467|NCT02688387|365070000|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839468|NCT02688387|365070001|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839469|NCT02688387|365070002|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839470|NCT02688387|365070003|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839471|NCT02688387|365070004|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839472|NCT02688387|365070005|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839473|NCT02688387|365070006|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839474|NCT02688387|365070007|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839475|NCT02688387|365070008|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839476|NCT02688387|365070009|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839477|NCT02688387|365070010|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839478|NCT02688387|365070011|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
105839479|NCT02688387|365069990|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
105839480|NCT02688387|365069991|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839481|NCT02688387|365069992|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839482|NCT02688387|365069993|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839483|NCT02688387|365069994|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839484|NCT02688387|365069995|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839485|NCT02688387|365069996|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839486|NCT02688387|365069997|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839487|NCT02688387|365069998|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839488|NCT02688387|365069999|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839489|NCT02688387|365070000|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839490|NCT02688387|365070001|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839491|NCT02688387|365070002|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839492|NCT02688387|365070003|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839493|NCT02688387|365070004|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839494|NCT02688387|365070005|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839495|NCT02688387|365070006|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839496|NCT02688387|365070007|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839497|NCT02688387|365070008|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839498|NCT02688387|365070009|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839499|NCT02688387|365070010|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839500|NCT02688387|365070011|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
105839501|NCT02688387|365069990|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839502|NCT02688387|365069991|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839503|NCT02688387|365069992|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839504|NCT02688387|365069993|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839505|NCT02688387|365069994|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839506|NCT02688387|365069995|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839507|NCT02688387|365069996|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839508|NCT02688387|365069997|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839509|NCT02688387|365069998|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105966646|NCT00365105|365537724|FG001|Overall Study|Protocol Violation|8|||
105966647|NCT05260073|365537725|FG000|Overall Study|Physician Decision|1|||
105966648|NCT05260073|365537725|FG000|Overall Study|Withdrawal by Subject|6|||
105966649|NCT05260073|365537725|FG000|Overall Study|Lost to Follow-up|14|||
105966650|NCT01843673|365537728|FG000|Overall Study|Lack of Efficacy|2|||
105966651|NCT01843673|365537728|FG000|Overall Study|Withdrawal by Subject|4|||
105966652|NCT00960011|365537731|FG000|Overall Study|Death|5|||
105966653|NCT00960011|365537732|FG001|Overall Study|Death|0|||
105966654|NCT00960011|365537731|FG000|Overall Study|Lost to Follow-up|6|||
105966655|NCT00960011|365537732|FG001|Overall Study|Lost to Follow-up|2|||
105966656|NCT00313313|365537733|FG000|Overall Study|Lack of Efficacy|14|||
106023652|NCT01088048|365751793|FG006|Overall Study|Investigator Request|1|||
106023653|NCT01088048|365751794|FG007|Overall Study|Investigator Request|0|||
105839510|NCT02688387|365069999|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839511|NCT02688387|365070000|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
105839512|NCT02688387|365070001|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839513|NCT02688387|365070002|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839514|NCT02688387|365070003|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839515|NCT02688387|365070004|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839516|NCT02688387|365070005|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839517|NCT02688387|365070006|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839518|NCT02688387|365070007|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839519|NCT02688387|365070008|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839520|NCT02688387|365070009|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839521|NCT02688387|365070010|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839522|NCT02688387|365070011|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
105839523|NCT02688387|365069990|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839524|NCT02688387|365069991|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839525|NCT02688387|365069992|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
106149328|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
106149329|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
106149330|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
106149331|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
106149332|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
106149333|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
106149334|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
106149335|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
106149336|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
106149337|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105839526|NCT02688387|365069993|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839527|NCT02688387|365069994|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839528|NCT02688387|365069995|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839529|NCT02688387|365069996|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839530|NCT02688387|365069997|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839531|NCT02688387|365069998|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839532|NCT02688387|365069999|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839533|NCT02688387|365070000|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839534|NCT02688387|365070001|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
106149338|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
105839535|NCT02688387|365070002|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839536|NCT02688387|365070003|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839537|NCT02688387|365070004|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
105839538|NCT02688387|365070005|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839539|NCT02688387|365070006|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839540|NCT02688387|365070007|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839541|NCT02688387|365070008|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839542|NCT02688387|365070009|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839543|NCT02688387|365070010|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839544|NCT02688387|365070011|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
105839545|NCT02688387|365069990|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839546|NCT02688387|365069991|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839547|NCT02688387|365069992|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839548|NCT02688387|365069993|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839549|NCT02688387|365069994|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839550|NCT02688387|365069995|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839551|NCT02688387|365069996|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839552|NCT02688387|365069997|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839553|NCT02688387|365069998|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839554|NCT02688387|365069999|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839555|NCT02688387|365070000|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839556|NCT02688387|365070001|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839557|NCT02688387|365070002|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839558|NCT02688387|365070003|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105966657|NCT00313313|365537734|FG001|Overall Study|Lack of Efficacy|9|||
105839559|NCT02688387|365070004|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839560|NCT02688387|365070005|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839561|NCT02688387|365070006|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839562|NCT02688387|365070007|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839563|NCT02688387|365070008|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839564|NCT02688387|365070009|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839565|NCT02688387|365070010|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
105839566|NCT02688387|365070011|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
105839567|NCT02688387|365069990|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839568|NCT02688387|365069991|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839569|NCT02688387|365069992|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839570|NCT02688387|365069993|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839571|NCT02688387|365069994|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839572|NCT02688387|365069995|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839573|NCT02688387|365069996|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839574|NCT02688387|365069997|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839575|NCT02688387|365069998|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839576|NCT02688387|365069999|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839577|NCT02688387|365070000|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839578|NCT02688387|365070001|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839579|NCT02688387|365070002|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839580|NCT02688387|365070003|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839581|NCT02688387|365070004|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839582|NCT02688387|365070005|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839583|NCT02688387|365070006|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839584|NCT02688387|365070007|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839585|NCT02688387|365070008|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
105839586|NCT02688387|365070009|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839587|NCT02688387|365070010|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
105839588|NCT02688387|365070011|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
105839589|NCT02688387|365069990|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839590|NCT02688387|365069991|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839591|NCT02688387|365069992|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839592|NCT02688387|365069993|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839593|NCT02688387|365069994|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839594|NCT02688387|365069995|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839595|NCT02688387|365069996|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839596|NCT02688387|365069997|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839597|NCT02688387|365069998|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839598|NCT02688387|365069999|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839599|NCT02688387|365070000|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839600|NCT02688387|365070001|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839601|NCT02688387|365070002|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839602|NCT02688387|365070003|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839603|NCT02688387|365070004|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839604|NCT02688387|365070005|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839605|NCT02688387|365070006|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839606|NCT02688387|365070007|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839607|NCT02688387|365070008|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839608|NCT02688387|365070009|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
105839609|NCT02688387|365070010|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839610|NCT02688387|365070011|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
105839611|NCT01467479|365070014|FG000|Overall Study|No Study Medication|1|||
105839612|NCT01467479|365070015|FG001|Overall Study|No Study Medication|0|||
105839613|NCT01467479|365070016|FG002|Overall Study|No Study Medication|2|||
106023654|NCT01088048|365751795|FG008|Overall Study|Investigator Request|0|||
106023655|NCT01088048|365751796|FG009|Overall Study|Investigator Request|0|||
106023656|NCT01088048|365751787|FG000|Overall Study|Patient Non-compliance|0|||
106023657|NCT01088048|365751788|FG001|Overall Study|Patient Non-compliance|1|||
106023658|NCT01088048|365751789|FG002|Overall Study|Patient Non-compliance|0|||
106023659|NCT01088048|365751790|FG003|Overall Study|Patient Non-compliance|0|||
106023660|NCT01088048|365751791|FG004|Overall Study|Patient Non-compliance|0|||
106023661|NCT01088048|365751792|FG005|Overall Study|Patient Non-compliance|0|||
106023662|NCT01088048|365751793|FG006|Overall Study|Patient Non-compliance|0|||
106023663|NCT01088048|365751794|FG007|Overall Study|Patient Non-compliance|0|||
106023664|NCT01088048|365751795|FG008|Overall Study|Patient Non-compliance|0|||
105839614|NCT01467479|365070014|FG000|Overall Study|Adverse Event|1|||
105839615|NCT01467479|365070015|FG001|Overall Study|Adverse Event|2|||
105839616|NCT01467479|365070016|FG002|Overall Study|Adverse Event|0|||
105839617|NCT01467479|365070014|FG000|Overall Study|Death|0|||
106023665|NCT01088048|365751796|FG009|Overall Study|Patient Non-compliance|0|||
106023666|NCT01088048|365751787|FG000|Overall Study|Disease Progression|7|||
106023667|NCT01088048|365751788|FG001|Overall Study|Disease Progression|4|||
106023668|NCT01088048|365751789|FG002|Overall Study|Disease Progression|3|||
106023669|NCT01088048|365751790|FG003|Overall Study|Disease Progression|5|||
106023670|NCT01088048|365751791|FG004|Overall Study|Disease Progression|3|||
106023671|NCT01088048|365751792|FG005|Overall Study|Disease Progression|3|||
106149339|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
105839618|NCT01467479|365070015|FG001|Overall Study|Death|0|||
105839619|NCT01467479|365070016|FG002|Overall Study|Death|1|||
105839620|NCT01467479|365070014|FG000|Overall Study|Lost to Follow-up|2|||
105839621|NCT01467479|365070015|FG001|Overall Study|Lost to Follow-up|5|||
105839622|NCT01467479|365070016|FG002|Overall Study|Lost to Follow-up|3|||
105839623|NCT01467479|365070014|FG000|Overall Study|Withdrawal of Consent|3|||
105839624|NCT01467479|365070015|FG001|Overall Study|Withdrawal of Consent|7|||
105839625|NCT01467479|365070016|FG002|Overall Study|Withdrawal of Consent|7|||
105839626|NCT01467479|365070014|FG000|Overall Study|Study Terminated by Sponsor|1|||
105839627|NCT01467479|365070015|FG001|Overall Study|Study Terminated by Sponsor|3|||
105839628|NCT01467479|365070016|FG002|Overall Study|Study Terminated by Sponsor|3|||
105839629|NCT01467479|365070014|FG000|Overall Study|Other|1|||
105839630|NCT01467479|365070015|FG001|Overall Study|Other|0|||
105839631|NCT01467479|365070016|FG002|Overall Study|Other|0|||
105839632|NCT04100096|365070027|FG000|Overall Study|Adverse Event|19|||
105839633|NCT04100096|365070028|FG001|Overall Study|Adverse Event|7|||
105839634|NCT04100096|365070027|FG000|Overall Study|Lack of Efficacy|0|||
105839635|NCT04100096|365070028|FG001|Overall Study|Lack of Efficacy|1|||
105839636|NCT04100096|365070027|FG000|Overall Study|Lost to Follow-up|13|||
105839637|NCT04100096|365070028|FG001|Overall Study|Lost to Follow-up|11|||
105839638|NCT04100096|365070027|FG000|Overall Study|Non-Compliance With Study Drug|1|||
105839639|NCT04100096|365070028|FG001|Overall Study|Non-Compliance With Study Drug|3|||
105839640|NCT04100096|365070027|FG000|Overall Study|Protocol Deviation|1|||
105839641|NCT04100096|365070028|FG001|Overall Study|Protocol Deviation|1|||
105839642|NCT04100096|365070027|FG000|Overall Study|Withdrawal by Participant|13|||
105839643|NCT04100096|365070028|FG001|Overall Study|Withdrawal by Participant|15|||
105839644|NCT00831233|365070030|FG000|Overall Study|Adverse Event|0|||
105839645|NCT00831233|365070031|FG001|Overall Study|Adverse Event|1|||
105839646|NCT00831233|365070030|FG000|Overall Study|Protocol Violation|1|||
105839647|NCT00831233|365070031|FG001|Overall Study|Protocol Violation|0|||
105839648|NCT00831233|365070030|FG000|Overall Study|Selection Criteria Not Met|2|||
105839649|NCT00831233|365070031|FG001|Overall Study|Selection Criteria Not Met|0|||
105839650|NCT02284347|365070032|FG000|Overall Study|Lost to Follow-up|2|||
105839651|NCT02284347|365070032|FG000|Overall Study|Withdrawn prior to treatment|1|||
105839652|NCT01684215|365070034|FG000|Phase 1, Part 1|Adverse Event|1|||
105839653|NCT01684215|365070035|FG001|Phase 1, Part 1|Adverse Event|0|||
105839654|NCT01684215|365070036|FG002|Phase 1, Part 1|Adverse Event|0|||
105839655|NCT01684215|365070037|FG003|Phase 1, Part 1|Adverse Event|0|||
105839656|NCT01684215|365070034|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
105839657|NCT01684215|365070035|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
105839658|NCT01684215|365070036|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
105839659|NCT01684215|365070037|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
105839660|NCT01684215|365070034|FG000|Phase 1, Part 2|Adverse Event|0|||
105839661|NCT01684215|365070035|FG001|Phase 1, Part 2|Adverse Event|0|||
105839662|NCT01684215|365070036|FG002|Phase 1, Part 2|Adverse Event|1|||
105839663|NCT01684215|365070037|FG003|Phase 1, Part 2|Adverse Event|0|||
105839664|NCT01684215|365070034|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
105839665|NCT01684215|365070035|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
105839666|NCT01684215|365070036|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
105839667|NCT01684215|365070037|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
105839668|NCT01684215|365070034|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
105839669|NCT01684215|365070035|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
105839670|NCT01684215|365070036|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
105839671|NCT01684215|365070037|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
105839672|NCT01684215|365070034|FG000|Phase 2|Death|0|||
105839673|NCT01684215|365070035|FG001|Phase 2|Death|0|||
105839674|NCT01684215|365070036|FG002|Phase 2|Death|0|||
105839675|NCT01684215|365070037|FG003|Phase 2|Death|8|||
105839676|NCT01684215|365070034|FG000|Phase 2|Study terminated by sponsor|0|||
105839677|NCT01684215|365070035|FG001|Phase 2|Study terminated by sponsor|0|||
105839678|NCT01684215|365070036|FG002|Phase 2|Study terminated by sponsor|0|||
105839679|NCT01684215|365070037|FG003|Phase 2|Study terminated by sponsor|30|||
105839680|NCT01684215|365070034|FG000|Phase 2|Enrolled but not treated|0|||
105839681|NCT01684215|365070035|FG001|Phase 2|Enrolled but not treated|0|||
105839682|NCT01684215|365070036|FG002|Phase 2|Enrolled but not treated|0|||
105839683|NCT01684215|365070037|FG003|Phase 2|Enrolled but not treated|1|||
105839684|NCT01684215|365070034|FG000|Phase 2|Lost to Follow-up|0|||
105839685|NCT01684215|365070035|FG001|Phase 2|Lost to Follow-up|0|||
105839686|NCT01684215|365070036|FG002|Phase 2|Lost to Follow-up|0|||
105839687|NCT01684215|365070037|FG003|Phase 2|Lost to Follow-up|4|||
105839688|NCT00407745|365070038|FG000|Overall Study|Lack of Efficacy|1|||
105839689|NCT00407745|365070039|FG001|Overall Study|Lack of Efficacy|2|||
105839690|NCT00407745|365070038|FG000|Overall Study|Withdrawal by Subject|3|||
106023672|NCT01088048|365751793|FG006|Overall Study|Disease Progression|2|||
105839691|NCT00407745|365070039|FG001|Overall Study|Withdrawal by Subject|3|||
105839692|NCT00407745|365070038|FG000|Overall Study|Protocol Violation|5|||
105839693|NCT00407745|365070039|FG001|Overall Study|Protocol Violation|3|||
105839694|NCT00407745|365070038|FG000|Overall Study|Adverse Event|8|||
105839695|NCT00407745|365070039|FG001|Overall Study|Adverse Event|8|||
105839696|NCT00407745|365070038|FG000|Overall Study|Other|2|||
105839697|NCT00407745|365070039|FG001|Overall Study|Other|0|||
105839698|NCT00407745|365070038|FG000|Overall Study|Randomized, unknown if treated|0|||
105839699|NCT00407745|365070039|FG001|Overall Study|Randomized, unknown if treated|1|||
105839700|NCT01552369|365070040|FG000|Overall Study|Did not consent to extended follow up|8|||
105839701|NCT01552369|365070041|FG001|Overall Study|Did not consent to extended follow up|9|||
105839702|NCT02211014|365070042|FG000|Overall Study|Adverse Event|0|||
105839703|NCT02211014|365070043|FG001|Overall Study|Adverse Event|2|||
105839704|NCT02211014|365070042|FG000|Overall Study|Physician Decision|1|||
105839705|NCT02211014|365070043|FG001|Overall Study|Physician Decision|2|||
105839706|NCT02211014|365070042|FG000|Overall Study|Started another cancer therapy|1|||
105839707|NCT02211014|365070043|FG001|Overall Study|Started another cancer therapy|0|||
105839708|NCT02211014|365070042|FG000|Overall Study|Withdrawal by Subject|0|||
105839709|NCT02211014|365070043|FG001|Overall Study|Withdrawal by Subject|1|||
105839710|NCT02211014|365070042|FG000|Overall Study|In agreement with patient, no benefit|0|||
105839711|NCT02211014|365070043|FG001|Overall Study|In agreement with patient, no benefit|1|||
105839712|NCT00966381|365070044|FG000|Overall Study|Withdrawal by Subject|2|||
105839713|NCT00966381|365070045|FG001|Overall Study|Withdrawal by Subject|2|||
105839714|NCT01915940|365070046|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
105839715|NCT01915940|365070047|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
105839716|NCT01915940|365070048|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
105839717|NCT01915940|365070046|FG000|Treatment Period|Decision of Participant|0|||
105839718|NCT01915940|365070047|FG001|Treatment Period|Decision of Participant|1|||
105839719|NCT01915940|365070048|FG002|Treatment Period|Decision of Participant|3|||
105839720|NCT01915940|365070046|FG000|Treatment Period|Adverse Event|0|||
105839721|NCT01915940|365070047|FG001|Treatment Period|Adverse Event|9|||
105839722|NCT01915940|365070048|FG002|Treatment Period|Adverse Event|1|||
105839723|NCT01915940|365070046|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
105839724|NCT01915940|365070047|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
105839725|NCT01915940|365070048|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
105839726|NCT01124695|365070051|FG000|Overall Study|Disease progression|77|||
105839727|NCT01124695|365070051|FG000|Overall Study|Adverse Event|11|||
105839728|NCT01124695|365070051|FG000|Overall Study|Death|1|||
105839729|NCT01124695|365070051|FG000|Overall Study|Withdrawal by Subject|7|||
105839730|NCT01124695|365070051|FG000|Overall Study|Physician Decision|3|||
105839731|NCT01124695|365070051|FG000|Overall Study|Alternative therapy|9|||
105839732|NCT01124695|365070051|FG000|Overall Study|No documentation that patient went off treatment|4|||
105839733|NCT01124695|365070051|FG000|Overall Study|Ineligible|9|||
105839734|NCT01124695|365070051|FG000|Overall Study|Ineligible and never start treatment|2|||
105839735|NCT00097786|365070057|FG000|Overall Study|lost to follow-up for all-cause death|296|||
105839736|NCT00097786|365070058|FG001|Overall Study|lost to follow-up for all-cause death|292|||
105839737|NCT00097786|365070059|FG002|Overall Study|lost to follow-up for all-cause death|313|||
105839738|NCT00097786|365070060|FG003|Overall Study|lost to follow-up for all-cause death|310|||
105839739|NCT02940730|365070061|FG000|Intervention 2|Physician Decision|7|||
105839740|NCT02940730|365070062|FG001|Intervention 2|Physician Decision|0|||
105839741|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
105839742|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
105839743|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
105839744|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
105839745|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
105839746|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
105839747|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
105966658|NCT00313313|365537735|FG002|Overall Study|Lack of Efficacy|20|||
105966659|NCT00313313|365537733|FG000|Overall Study|Withdrawal of consent by subject|18|||
105966660|NCT00313313|365537734|FG001|Overall Study|Withdrawal of consent by subject|17|||
105966661|NCT00313313|365537735|FG002|Overall Study|Withdrawal of consent by subject|31|||
105966662|NCT00313313|365537733|FG000|Overall Study|Lost to Follow-up|10|||
105966663|NCT00313313|365537734|FG001|Overall Study|Lost to Follow-up|7|||
105839748|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
105839749|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
105839750|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
105839751|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
105839752|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
105839753|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
105839754|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
105966664|NCT00313313|365537735|FG002|Overall Study|Lost to Follow-up|9|||
106149340|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
106149341|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
106149342|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
106149343|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
106149344|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
106149345|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
106149346|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105839755|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
105839756|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
105839757|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
105839758|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
105839759|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
105839760|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
105839761|NCT02960438|365070063|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
105839762|NCT02960438|365070064|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
105839763|NCT02960438|365070065|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
105839764|NCT02960438|365070066|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
105839765|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
105839766|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
105839767|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
105839768|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
105839769|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
105839770|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
105839771|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
105839772|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
105839773|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
105839774|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
105839775|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
105839776|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
105839777|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
105839778|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
105839779|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
105839780|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
105839781|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
105839782|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
105839783|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
105839784|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
105839785|NCT02960438|365070063|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
105839786|NCT02960438|365070064|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
105839787|NCT02960438|365070065|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
105839788|NCT02960438|365070066|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
105839789|NCT01522950|365070070|FG000|Overall Study|Withdrawal by Subject|3|||
105839790|NCT01522950|365070071|FG001|Overall Study|Withdrawal by Subject|2|||
105839791|NCT01522950|365070072|FG002|Overall Study|Withdrawal by Subject|1|||
105839792|NCT01522950|365070070|FG000|Overall Study|Adverse Event|3|||
105839793|NCT01522950|365070071|FG001|Overall Study|Adverse Event|1|||
105839794|NCT01522950|365070072|FG002|Overall Study|Adverse Event|1|||
105839795|NCT01522950|365070070|FG000|Overall Study|Protocol Violation|0|||
105839796|NCT01522950|365070071|FG001|Overall Study|Protocol Violation|0|||
105839797|NCT01522950|365070072|FG002|Overall Study|Protocol Violation|2|||
105839798|NCT01522950|365070070|FG000|Overall Study|Death|0|||
105839799|NCT01522950|365070071|FG001|Overall Study|Death|1|||
105839800|NCT01522950|365070072|FG002|Overall Study|Death|1|||
105839801|NCT01522950|365070070|FG000|Overall Study|Study Medication Sensitivity|0|||
105839802|NCT01522950|365070071|FG001|Overall Study|Study Medication Sensitivity|1|||
105839803|NCT01522950|365070072|FG002|Overall Study|Study Medication Sensitivity|0|||
105839804|NCT01647711|365070077|FG000|Overall Study|Progressive disease|6|||
105839805|NCT01647711|365070078|FG001|Overall Study|Progressive disease|2|||
105839806|NCT01647711|365070079|FG002|Overall Study|Progressive disease|6|||
105839807|NCT01647711|365070080|FG003|Overall Study|Progressive disease|8|||
105839808|NCT01647711|365070081|FG004|Overall Study|Progressive disease|2|||
105839809|NCT01647711|365070077|FG000|Overall Study|Other adverse event|0|||
105839810|NCT01647711|365070078|FG001|Overall Study|Other adverse event|0|||
105839811|NCT01647711|365070079|FG002|Overall Study|Other adverse event|2|||
105839812|NCT01647711|365070080|FG003|Overall Study|Other adverse event|0|||
105839813|NCT01647711|365070081|FG004|Overall Study|Other adverse event|2|||
105839814|NCT01647711|365070077|FG000|Overall Study|Protocol Violation|0|||
105839815|NCT01647711|365070078|FG001|Overall Study|Protocol Violation|0|||
105839816|NCT01647711|365070079|FG002|Overall Study|Protocol Violation|0|||
105966665|NCT00313313|365537733|FG000|Overall Study|Adverse Event|15|||
105966666|NCT00313313|365537734|FG001|Overall Study|Adverse Event|16|||
105966667|NCT00313313|365537735|FG002|Overall Study|Adverse Event|12|||
105966668|NCT00313313|365537733|FG000|Overall Study|Physician Decision|2|||
105966669|NCT00313313|365537734|FG001|Overall Study|Physician Decision|6|||
105966670|NCT00313313|365537735|FG002|Overall Study|Physician Decision|4|||
105966671|NCT00313313|365537733|FG000|Overall Study|Poor/Noncompliance|3|||
105966672|NCT00313313|365537734|FG001|Overall Study|Poor/Noncompliance|6|||
105966673|NCT00313313|365537735|FG002|Overall Study|Poor/Noncompliance|2|||
105966674|NCT00313313|365537733|FG000|Overall Study|Pregnancy|1|||
105966675|NCT00313313|365537734|FG001|Overall Study|Pregnancy|2|||
105966676|NCT00313313|365537735|FG002|Overall Study|Pregnancy|0|||
105966677|NCT00313313|365537733|FG000|Overall Study|Death|0|||
105966678|NCT00313313|365537734|FG001|Overall Study|Death|0|||
105966679|NCT00313313|365537735|FG002|Overall Study|Death|2|||
105966680|NCT00313313|365537733|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
105966681|NCT00313313|365537734|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
105966682|NCT00313313|365537735|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
105966683|NCT06003777|365537736|FG000|Period 1|Adverse Event|0|||
105966684|NCT06003777|365537737|FG001|Period 1|Adverse Event|0|||
105966685|NCT06003777|365537738|FG002|Period 1|Adverse Event|1|||
105966686|NCT06003777|365537739|FG003|Period 1|Adverse Event|0|||
105966687|NCT06003777|365537740|FG004|Period 1|Adverse Event|0|||
105966688|NCT06003777|365537741|FG005|Period 1|Adverse Event|0|||
105839817|NCT01647711|365070080|FG003|Overall Study|Protocol Violation|0|||
105839818|NCT01647711|365070081|FG004|Overall Study|Protocol Violation|1|||
105839819|NCT01647711|365070077|FG000|Overall Study|Refused to continue taking medication|0|||
105839820|NCT01647711|365070078|FG001|Overall Study|Refused to continue taking medication|0|||
105839821|NCT01647711|365070079|FG002|Overall Study|Refused to continue taking medication|0|||
105839822|NCT01647711|365070080|FG003|Overall Study|Refused to continue taking medication|2|||
105839823|NCT01647711|365070081|FG004|Overall Study|Refused to continue taking medication|1|||
105839824|NCT01647711|365070077|FG000|Overall Study|Other reason not defined|0|||
105839825|NCT01647711|365070078|FG001|Overall Study|Other reason not defined|1|||
105839826|NCT01647711|365070079|FG002|Overall Study|Other reason not defined|1|||
105839827|NCT01647711|365070080|FG003|Overall Study|Other reason not defined|1|||
105839828|NCT01647711|365070081|FG004|Overall Study|Other reason not defined|0|||
105839829|NCT02999984|365070086|FG000|Overall Study|Treatment Failure|1|||
105839830|NCT04019054|365070090|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
105839831|NCT04019054|365070091|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
105839832|NCT04019054|365070090|FG000|Overall Study|Withdrawal by Subject|3|||
105839833|NCT04019054|365070091|FG001|Overall Study|Withdrawal by Subject|1|||
105839834|NCT02013531|365070098|FG000|Overall Study|Lost to Follow-up|3|||
105839835|NCT02013531|365070098|FG000|Overall Study|Met Withdrawal Criteria|1|||
105839836|NCT02013531|365070098|FG000|Overall Study|Withdrawal by Subject|1|||
105839837|NCT03554317|365070099|FG000|Overall Study|Withdrawal by Subject|1|||
105839838|NCT03554317|365070099|FG000|Overall Study|PSA Progression|3|||
105839839|NCT03554317|365070099|FG000|Overall Study|Radiographic Progression|4|||
105839840|NCT02400476|365070100|FG000|Overall Study|Adverse Event|57|||
105839841|NCT02400476|365070101|FG001|Overall Study|Adverse Event|10|||
105839842|NCT02400476|365070102|FG002|Overall Study|Adverse Event|22|||
105839843|NCT02400476|365070103|FG003|Overall Study|Adverse Event|19|||
105839844|NCT02400476|365070104|FG004|Overall Study|Adverse Event|5|||
105839845|NCT02400476|365070105|FG005|Overall Study|Adverse Event|8|||
105839846|NCT02400476|365070100|FG000|Overall Study|Withdrawal by Subject|4|||
105839847|NCT02400476|365070101|FG001|Overall Study|Withdrawal by Subject|1|||
105839848|NCT02400476|365070102|FG002|Overall Study|Withdrawal by Subject|12|||
105839849|NCT02400476|365070103|FG003|Overall Study|Withdrawal by Subject|7|||
105839850|NCT02400476|365070104|FG004|Overall Study|Withdrawal by Subject|5|||
105839851|NCT02400476|365070105|FG005|Overall Study|Withdrawal by Subject|5|||
105839852|NCT02400476|365070100|FG000|Overall Study|Lost to Follow-up|0|||
105839853|NCT02400476|365070101|FG001|Overall Study|Lost to Follow-up|0|||
105839854|NCT02400476|365070102|FG002|Overall Study|Lost to Follow-up|0|||
105839855|NCT02400476|365070103|FG003|Overall Study|Lost to Follow-up|1|||
105966689|NCT06003777|365537742|FG006|Period 1|Adverse Event|0|||
105966690|NCT06003777|365537743|FG007|Period 1|Adverse Event|0|||
105966691|NCT06003777|365537744|FG008|Period 1|Adverse Event|0|||
105966692|NCT06003777|365537745|FG009|Period 1|Adverse Event|0|||
105966693|NCT06003777|365537746|FG010|Period 1|Adverse Event|0|||
105839856|NCT02400476|365070104|FG004|Overall Study|Lost to Follow-up|3|||
105966694|NCT06003777|365537747|FG011|Period 1|Adverse Event|0|||
105966695|NCT06003777|365537736|FG000|Period 1|Withdrawal by Subject|0|||
105966696|NCT06003777|365537737|FG001|Period 1|Withdrawal by Subject|0|||
105966697|NCT06003777|365537738|FG002|Period 1|Withdrawal by Subject|0|||
105966698|NCT06003777|365537739|FG003|Period 1|Withdrawal by Subject|0|||
105966699|NCT06003777|365537740|FG004|Period 1|Withdrawal by Subject|1|||
105839857|NCT02400476|365070105|FG005|Overall Study|Lost to Follow-up|1|||
105966700|NCT06003777|365537741|FG005|Period 1|Withdrawal by Subject|0|||
105966701|NCT06003777|365537742|FG006|Period 1|Withdrawal by Subject|0|||
105966702|NCT06003777|365537743|FG007|Period 1|Withdrawal by Subject|0|||
105966703|NCT06003777|365537744|FG008|Period 1|Withdrawal by Subject|0|||
105966704|NCT06003777|365537745|FG009|Period 1|Withdrawal by Subject|0|||
105966705|NCT06003777|365537746|FG010|Period 1|Withdrawal by Subject|0|||
105966706|NCT06003777|365537747|FG011|Period 1|Withdrawal by Subject|0|||
105966707|NCT06003777|365537736|FG000|Period 2|Withdrawal by Subject|0|||
105966708|NCT06003777|365537737|FG001|Period 2|Withdrawal by Subject|0|||
105966709|NCT06003777|365537738|FG002|Period 2|Withdrawal by Subject|0|||
105966710|NCT06003777|365537739|FG003|Period 2|Withdrawal by Subject|0|||
105966711|NCT06003777|365537740|FG004|Period 2|Withdrawal by Subject|0|||
105966712|NCT06003777|365537741|FG005|Period 2|Withdrawal by Subject|0|||
105966713|NCT06003777|365537742|FG006|Period 2|Withdrawal by Subject|0|||
105966714|NCT06003777|365537743|FG007|Period 2|Withdrawal by Subject|0|||
105966715|NCT06003777|365537744|FG008|Period 2|Withdrawal by Subject|1|||
105966716|NCT06003777|365537745|FG009|Period 2|Withdrawal by Subject|0|||
105966717|NCT06003777|365537746|FG010|Period 2|Withdrawal by Subject|0|||
105966718|NCT06003777|365537747|FG011|Period 2|Withdrawal by Subject|0|||
105966719|NCT06003777|365537736|FG000|Period 3|Adverse Event|0|||
106023673|NCT01088048|365751794|FG007|Overall Study|Disease Progression|1|||
106023674|NCT01088048|365751795|FG008|Overall Study|Disease Progression|0|||
106023675|NCT01088048|365751796|FG009|Overall Study|Disease Progression|0|||
105839858|NCT02400476|365070100|FG000|Overall Study|Physician Decision|0|||
105839859|NCT02400476|365070101|FG001|Overall Study|Physician Decision|0|||
105839860|NCT02400476|365070102|FG002|Overall Study|Physician Decision|1|||
105839861|NCT02400476|365070103|FG003|Overall Study|Physician Decision|1|||
105839862|NCT02400476|365070104|FG004|Overall Study|Physician Decision|0|||
105839863|NCT02400476|365070105|FG005|Overall Study|Physician Decision|1|||
105839864|NCT02400476|365070100|FG000|Overall Study|Other, Disease Progression|0|||
105839865|NCT02400476|365070101|FG001|Overall Study|Other, Disease Progression|1|||
105839866|NCT02400476|365070102|FG002|Overall Study|Other, Disease Progression|2|||
105839867|NCT02400476|365070103|FG003|Overall Study|Other, Disease Progression|1|||
105839868|NCT02400476|365070104|FG004|Overall Study|Other, Disease Progression|2|||
105839869|NCT02400476|365070105|FG005|Overall Study|Other, Disease Progression|1|||
105839870|NCT02400476|365070100|FG000|Overall Study|Other, Decreased Quality of Life|0|||
105839871|NCT02400476|365070101|FG001|Overall Study|Other, Decreased Quality of Life|0|||
105839872|NCT02400476|365070102|FG002|Overall Study|Other, Decreased Quality of Life|2|||
105839873|NCT02400476|365070103|FG003|Overall Study|Other, Decreased Quality of Life|0|||
105839874|NCT02400476|365070104|FG004|Overall Study|Other, Decreased Quality of Life|0|||
105839875|NCT02400476|365070105|FG005|Overall Study|Other, Decreased Quality of Life|0|||
105839876|NCT02400476|365070100|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
105839877|NCT02400476|365070101|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
105839878|NCT02400476|365070102|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
105839879|NCT02400476|365070103|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
105839880|NCT02400476|365070104|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
105839881|NCT02400476|365070105|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
105839882|NCT02487082|365070106|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
105839883|NCT02487082|365070107|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
105839884|NCT02487082|365070106|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
105839885|NCT02487082|365070107|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
105839886|NCT00003531|365070110|FG000|Overall Study|Not evaluable|10|||
105839887|NCT00346164|365070113|FG000|Overall Study|Adverse Event|0|||
105839888|NCT00346164|365070114|FG001|Overall Study|Adverse Event|0|||
105839889|NCT00346164|365070115|FG002|Overall Study|Adverse Event|0|||
105839890|NCT00346164|365070116|FG003|Overall Study|Adverse Event|1|||
105839891|NCT00346164|365070113|FG000|Overall Study|Lack of Efficacy|0|||
105839892|NCT00346164|365070114|FG001|Overall Study|Lack of Efficacy|1|||
105839893|NCT00346164|365070115|FG002|Overall Study|Lack of Efficacy|7|||
105839894|NCT00346164|365070116|FG003|Overall Study|Lack of Efficacy|25|||
105839895|NCT00346164|365070113|FG000|Overall Study|Physician Decision|0|||
105839896|NCT00346164|365070114|FG001|Overall Study|Physician Decision|1|||
105839897|NCT00346164|365070115|FG002|Overall Study|Physician Decision|2|||
105839898|NCT00346164|365070116|FG003|Overall Study|Physician Decision|27|||
105839899|NCT00346164|365070113|FG000|Overall Study|Protocol Violation|6|||
105966720|NCT06003777|365537737|FG001|Period 3|Adverse Event|0|||
105966721|NCT06003777|365537738|FG002|Period 3|Adverse Event|0|||
105966722|NCT06003777|365537739|FG003|Period 3|Adverse Event|0|||
105966723|NCT06003777|365537740|FG004|Period 3|Adverse Event|0|||
105966724|NCT06003777|365537741|FG005|Period 3|Adverse Event|0|||
105966725|NCT06003777|365537742|FG006|Period 3|Adverse Event|1|||
106023676|NCT01088048|365751787|FG000|Overall Study|Death|1|||
105839900|NCT00346164|365070114|FG001|Overall Study|Protocol Violation|2|||
106023677|NCT01088048|365751788|FG001|Overall Study|Death|5|||
105839901|NCT00346164|365070115|FG002|Overall Study|Protocol Violation|10|||
105966726|NCT06003777|365537743|FG007|Period 3|Adverse Event|0|||
105966727|NCT06003777|365537744|FG008|Period 3|Adverse Event|0|||
105966728|NCT06003777|365537745|FG009|Period 3|Adverse Event|0|||
105966729|NCT06003777|365537746|FG010|Period 3|Adverse Event|0|||
106023678|NCT01088048|365751789|FG002|Overall Study|Death|3|||
105839902|NCT00346164|365070116|FG003|Overall Study|Protocol Violation|4|||
105839903|NCT00346164|365070113|FG000|Overall Study|Withdrawal by Subject|0|||
105839904|NCT00346164|365070114|FG001|Overall Study|Withdrawal by Subject|0|||
105839905|NCT00346164|365070115|FG002|Overall Study|Withdrawal by Subject|2|||
105839906|NCT00346164|365070116|FG003|Overall Study|Withdrawal by Subject|0|||
105839907|NCT00346164|365070113|FG000|Overall Study|Ineligible|11|||
105839908|NCT00346164|365070114|FG001|Overall Study|Ineligible|2|||
105839909|NCT00346164|365070115|FG002|Overall Study|Ineligible|2|||
105839910|NCT00346164|365070116|FG003|Overall Study|Ineligible|23|||
105839911|NCT00346164|365070113|FG000|Overall Study|Refusal of further protocol therapy|0|||
105839912|NCT00346164|365070114|FG001|Overall Study|Refusal of further protocol therapy|1|||
105839913|NCT00346164|365070115|FG002|Overall Study|Refusal of further protocol therapy|3|||
105839914|NCT00346164|365070116|FG003|Overall Study|Refusal of further protocol therapy|15|||
105839915|NCT00346164|365070113|FG000|Overall Study|Inability to start week 16 tx on time|0|||
105839916|NCT00346164|365070114|FG001|Overall Study|Inability to start week 16 tx on time|0|||
105839917|NCT00346164|365070115|FG002|Overall Study|Inability to start week 16 tx on time|0|||
105839918|NCT00346164|365070116|FG003|Overall Study|Inability to start week 16 tx on time|11|||
105839919|NCT03297294|365070117|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
105839920|NCT03297294|365070118|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
105839921|NCT03297294|365070119|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105839922|NCT03297294|365070120|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105839923|NCT03297294|365070121|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
105839924|NCT03297294|365070117|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
105839925|NCT03297294|365070118|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
105839926|NCT03297294|365070119|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105839927|NCT03297294|365070120|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105839928|NCT03297294|365070121|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
105839929|NCT03297294|365070117|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
105839930|NCT03297294|365070118|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
105839931|NCT03297294|365070119|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105839932|NCT03297294|365070120|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105839933|NCT03297294|365070121|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
105839934|NCT03297294|365070117|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
105839935|NCT03297294|365070118|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
105839936|NCT03297294|365070119|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105839937|NCT03297294|365070120|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105839938|NCT03297294|365070121|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
105839939|NCT03297294|365070117|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
105839940|NCT03297294|365070118|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
105839941|NCT03297294|365070119|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
105839942|NCT03297294|365070120|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
105839943|NCT03297294|365070121|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
105839944|NCT01198873|365070122|FG000|Overall Study|Adverse Event|4|||
105839945|NCT01198873|365070123|FG001|Overall Study|Adverse Event|7|||
105839946|NCT01198873|365070122|FG000|Overall Study|Study closure|29|||
105966730|NCT06003777|365537747|FG011|Period 3|Adverse Event|0|||
105966731|NCT06003777|365537736|FG000|Period 4|No longer met eligibility criteria|0|||
105966732|NCT06003777|365537737|FG001|Period 4|No longer met eligibility criteria|0|||
105966733|NCT06003777|365537738|FG002|Period 4|No longer met eligibility criteria|1|||
105966734|NCT06003777|365537739|FG003|Period 4|No longer met eligibility criteria|0|||
105966735|NCT06003777|365537740|FG004|Period 4|No longer met eligibility criteria|0|||
105966736|NCT06003777|365537741|FG005|Period 4|No longer met eligibility criteria|0|||
105966737|NCT06003777|365537742|FG006|Period 4|No longer met eligibility criteria|0|||
105966738|NCT06003777|365537743|FG007|Period 4|No longer met eligibility criteria|0|||
105966739|NCT06003777|365537744|FG008|Period 4|No longer met eligibility criteria|0|||
105966740|NCT06003777|365537745|FG009|Period 4|No longer met eligibility criteria|0|||
105966741|NCT06003777|365537746|FG010|Period 4|No longer met eligibility criteria|0|||
105966742|NCT06003777|365537747|FG011|Period 4|No longer met eligibility criteria|0|||
105966743|NCT06003777|365537736|FG000|Period 4|Withdrawal by Subject|0|||
106149347|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
106149348|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
106149349|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
106149350|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
106149351|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
106149352|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
106149353|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
106149354|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
105966744|NCT06003777|365537737|FG001|Period 4|Withdrawal by Subject|1|||
106023679|NCT01088048|365751790|FG003|Overall Study|Death|3|||
106149355|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105839947|NCT01198873|365070123|FG001|Overall Study|Study closure|23|||
105839948|NCT01198873|365070122|FG000|Overall Study|Other than above|4|||
105839949|NCT01198873|365070123|FG001|Overall Study|Other than above|2|||
105839950|NCT02820740|365070124|FG000|Overall Study|Did not have procedure|2|||
105839951|NCT00562120|365070128|FG000|First Intervention Period|Adverse Event|1|||
105839952|NCT00562120|365070129|FG001|First Intervention Period|Adverse Event|0|||
105839953|NCT00562120|365070130|FG002|First Intervention Period|Adverse Event|0|||
105839954|NCT00562120|365070131|FG003|First Intervention Period|Adverse Event|0|||
105839955|NCT00562120|365070128|FG000|First Intervention Period|Randomized but not Treated|1|||
105839956|NCT00562120|365070129|FG001|First Intervention Period|Randomized but not Treated|0|||
105839957|NCT00562120|365070130|FG002|First Intervention Period|Randomized but not Treated|0|||
105839958|NCT00562120|365070131|FG003|First Intervention Period|Randomized but not Treated|0|||
105839959|NCT04232540|365070132|FG000|Overall Study|Lost to Follow-up|1|||
105839960|NCT04232540|365070133|FG001|Overall Study|Lost to Follow-up|0|||
105839961|NCT03450629|365070134|FG000|Overall Study|Adverse Event|15|||
105839962|NCT03450629|365070135|FG001|Overall Study|Adverse Event|14|||
105839963|NCT03450629|365070134|FG000|Overall Study|Physician Decision|2|||
105839964|NCT03450629|365070135|FG001|Overall Study|Physician Decision|2|||
105839965|NCT03450629|365070134|FG000|Overall Study|Lack of Efficacy|2|||
105839966|NCT03450629|365070135|FG001|Overall Study|Lack of Efficacy|0|||
105839967|NCT03450629|365070134|FG000|Overall Study|Lost to Follow-up|4|||
105839968|NCT03450629|365070135|FG001|Overall Study|Lost to Follow-up|2|||
105839969|NCT03450629|365070134|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
105839970|NCT03450629|365070135|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
105839971|NCT03450629|365070134|FG000|Overall Study|Non-Compliance With Study Drug|2|||
105839972|NCT03450629|365070135|FG001|Overall Study|Non-Compliance With Study Drug|1|||
105839973|NCT03450629|365070134|FG000|Overall Study|Protocol Violation|11|||
105839974|NCT03450629|365070135|FG001|Overall Study|Protocol Violation|8|||
105839975|NCT03450629|365070134|FG000|Overall Study|Withdrawal by Subject|12|||
105839976|NCT03450629|365070135|FG001|Overall Study|Withdrawal by Subject|6|||
105839977|NCT03366194|365070139|FG000|Overall Study|Lost to Follow-up|2|||
105839978|NCT00987831|365070146|FG000|Overall Study|Never flared in 12 months|1|||
105839979|NCT00987831|365070147|FG001|Overall Study|Never flared in 12 months|0|||
105839980|NCT00987831|365070148|FG002|Overall Study|Never flared in 12 months|0|||
105839981|NCT00987831|365070146|FG000|Overall Study|Lost to Follow-up|0|||
105839982|NCT00987831|365070147|FG001|Overall Study|Lost to Follow-up|3|||
105839983|NCT00987831|365070148|FG002|Overall Study|Lost to Follow-up|0|||
105839984|NCT03253094|365070149|FG000|Overall Study|Adverse Event|2|||
105839985|NCT03253094|365070150|FG001|Overall Study|Adverse Event|0|||
105839986|NCT03253094|365070151|FG002|Overall Study|Adverse Event|0|||
105839987|NCT03253094|365070152|FG003|Overall Study|Adverse Event|0|||
105839988|NCT03253094|365070153|FG004|Overall Study|Adverse Event|0|||
105839989|NCT03253094|365070154|FG005|Overall Study|Adverse Event|0|||
105839990|NCT03253094|365070149|FG000|Overall Study|Lack of Efficacy|0|||
105839991|NCT03253094|365070150|FG001|Overall Study|Lack of Efficacy|0|||
105839992|NCT03253094|365070151|FG002|Overall Study|Lack of Efficacy|2|||
105839993|NCT03253094|365070152|FG003|Overall Study|Lack of Efficacy|1|||
105839994|NCT03253094|365070153|FG004|Overall Study|Lack of Efficacy|2|||
105839995|NCT03253094|365070154|FG005|Overall Study|Lack of Efficacy|1|||
105839996|NCT03253094|365070149|FG000|Overall Study|Lost to Follow-up|0|||
105839997|NCT03253094|365070150|FG001|Overall Study|Lost to Follow-up|0|||
105839998|NCT03253094|365070151|FG002|Overall Study|Lost to Follow-up|1|||
105839999|NCT03253094|365070152|FG003|Overall Study|Lost to Follow-up|1|||
105840000|NCT03253094|365070153|FG004|Overall Study|Lost to Follow-up|0|||
105840001|NCT03253094|365070154|FG005|Overall Study|Lost to Follow-up|1|||
105840002|NCT03253094|365070149|FG000|Overall Study|Physician Decision|1|||
105840003|NCT03253094|365070150|FG001|Overall Study|Physician Decision|0|||
105840004|NCT03253094|365070151|FG002|Overall Study|Physician Decision|0|||
105840005|NCT03253094|365070152|FG003|Overall Study|Physician Decision|1|||
105966745|NCT06003777|365537738|FG002|Period 4|Withdrawal by Subject|0|||
105840006|NCT03253094|365070153|FG004|Overall Study|Physician Decision|0|||
105966746|NCT06003777|365537739|FG003|Period 4|Withdrawal by Subject|0|||
105966747|NCT06003777|365537740|FG004|Period 4|Withdrawal by Subject|0|||
105840007|NCT03253094|365070154|FG005|Overall Study|Physician Decision|2|||
105840008|NCT03253094|365070149|FG000|Overall Study|Withdrawal by Subject|1|||
105840009|NCT03253094|365070150|FG001|Overall Study|Withdrawal by Subject|2|||
105966748|NCT06003777|365537741|FG005|Period 4|Withdrawal by Subject|0|||
105840010|NCT03253094|365070151|FG002|Overall Study|Withdrawal by Subject|1|||
105840011|NCT03253094|365070152|FG003|Overall Study|Withdrawal by Subject|0|||
105840012|NCT03253094|365070153|FG004|Overall Study|Withdrawal by Subject|3|||
105840013|NCT03253094|365070154|FG005|Overall Study|Withdrawal by Subject|0|||
105966749|NCT06003777|365537742|FG006|Period 4|Withdrawal by Subject|0|||
105966750|NCT06003777|365537743|FG007|Period 4|Withdrawal by Subject|0|||
105840014|NCT03253094|365070149|FG000|Overall Study|Other|0|||
105840015|NCT03253094|365070150|FG001|Overall Study|Other|1|||
105840016|NCT03253094|365070151|FG002|Overall Study|Other|2|||
105840017|NCT03253094|365070152|FG003|Overall Study|Other|1|||
105966751|NCT06003777|365537744|FG008|Period 4|Withdrawal by Subject|0|||
105840018|NCT03253094|365070153|FG004|Overall Study|Other|0|||
105840019|NCT03253094|365070154|FG005|Overall Study|Other|0|||
105840020|NCT02339090|365070155|FG000|Overall Study|Adverse Event|1|||
105840021|NCT02339090|365070156|FG001|Overall Study|Adverse Event|0|||
105840022|NCT02339090|365070155|FG000|Overall Study|Lost to Follow-up|0|||
105840023|NCT02339090|365070156|FG001|Overall Study|Lost to Follow-up|1|||
105840024|NCT02339090|365070155|FG000|Overall Study|Non-compliance With Study Drug|0|||
105840025|NCT02339090|365070156|FG001|Overall Study|Non-compliance With Study Drug|1|||
105840026|NCT02339090|365070155|FG000|Overall Study|Withdrawal by Subject|2|||
105840027|NCT02339090|365070156|FG001|Overall Study|Withdrawal by Subject|1|||
105840028|NCT02339090|365070155|FG000|Overall Study|Poor Growth|3|||
105840029|NCT02339090|365070156|FG001|Overall Study|Poor Growth|0|||
105840030|NCT02339090|365070155|FG000|Overall Study|Randomized but not treated|0|||
105840031|NCT02339090|365070156|FG001|Overall Study|Randomized but not treated|2|||
105840032|NCT02792218|365070157|FG000|Overall Study|Patient/guardian decision|15|||
105840033|NCT02792218|365070158|FG001|Overall Study|Patient/guardian decision|42|||
105840034|NCT02792218|365070157|FG000|Overall Study|Adverse Event|15|||
105840035|NCT02792218|365070158|FG001|Overall Study|Adverse Event|14|||
105840036|NCT02792218|365070157|FG000|Overall Study|Lost to Follow-up|10|||
105840037|NCT02792218|365070158|FG001|Overall Study|Lost to Follow-up|5|||
105840038|NCT02792218|365070157|FG000|Overall Study|Lack of Efficacy|1|||
105840039|NCT02792218|365070158|FG001|Overall Study|Lack of Efficacy|12|||
105840040|NCT02792218|365070157|FG000|Overall Study|Physician Decision|4|||
105840041|NCT02792218|365070158|FG001|Overall Study|Physician Decision|4|||
105840042|NCT02792218|365070157|FG000|Overall Study|Protocol deviation|3|||
105840043|NCT02792218|365070158|FG001|Overall Study|Protocol deviation|2|||
105840044|NCT02792218|365070157|FG000|Overall Study|New therapy for study indication|0|||
105840045|NCT02792218|365070158|FG001|Overall Study|New therapy for study indication|1|||
105840046|NCT02792218|365070157|FG000|Overall Study|Non-compliance with study treatment|0|||
105840047|NCT02792218|365070158|FG001|Overall Study|Non-compliance with study treatment|1|||
105840048|NCT02792218|365070157|FG000|Overall Study|Pregnancy|1|||
105840049|NCT02792218|365070158|FG001|Overall Study|Pregnancy|0|||
105840050|NCT00442546|365070159|FG000|Overall Study|Adverse Event|11|||
105840051|NCT00442546|365070160|FG001|Overall Study|Adverse Event|17|||
105840052|NCT00442546|365070161|FG002|Overall Study|Adverse Event|13|||
105840053|NCT00442546|365070159|FG000|Overall Study|Lost to Follow-up|1|||
105840054|NCT00442546|365070160|FG001|Overall Study|Lost to Follow-up|2|||
105840055|NCT00442546|365070161|FG002|Overall Study|Lost to Follow-up|1|||
105840056|NCT00442546|365070159|FG000|Overall Study|Other|4|||
105840057|NCT00442546|365070160|FG001|Overall Study|Other|9|||
105840058|NCT00442546|365070161|FG002|Overall Study|Other|6|||
105840059|NCT00442546|365070159|FG000|Overall Study|Withdrawal by Subject|5|||
105840060|NCT00442546|365070160|FG001|Overall Study|Withdrawal by Subject|5|||
105840061|NCT00442546|365070161|FG002|Overall Study|Withdrawal by Subject|7|||
105840062|NCT00442546|365070159|FG000|Overall Study|Randomized But Not Treated|5|||
105840063|NCT00442546|365070160|FG001|Overall Study|Randomized But Not Treated|4|||
105840064|NCT00442546|365070161|FG002|Overall Study|Randomized But Not Treated|6|||
105840065|NCT02843659|365070162|FG000|Overall Study|Subject Withdrew Consent|0|||
105840066|NCT02843659|365070163|FG001|Overall Study|Subject Withdrew Consent|0|||
105840067|NCT02843659|365070164|FG002|Overall Study|Subject Withdrew Consent|1|||
105840068|NCT02843659|365070162|FG000|Overall Study|Administrative Reason by Sponsor|4|||
105840069|NCT02843659|365070163|FG001|Overall Study|Administrative Reason by Sponsor|5|||
105840070|NCT02843659|365070164|FG002|Overall Study|Administrative Reason by Sponsor|4|||
105840071|NCT02843659|365070162|FG000|Overall Study|Adverse Event|0|||
105840072|NCT02843659|365070163|FG001|Overall Study|Adverse Event|1|||
105840073|NCT02843659|365070164|FG002|Overall Study|Adverse Event|0|||
105840074|NCT00955721|365070165|FG000|Overall Study|Physician Decision|1|||
105840075|NCT00955721|365070166|FG001|Overall Study|Physician Decision|0|||
105840076|NCT00955721|365070165|FG000|Overall Study|Death|1|||
105966752|NCT06003777|365537745|FG009|Period 4|Withdrawal by Subject|0|||
105966753|NCT06003777|365537746|FG010|Period 4|Withdrawal by Subject|0|||
105840077|NCT00955721|365070166|FG001|Overall Study|Death|0|||
105840078|NCT00955721|365070165|FG000|Overall Study|Withdrawal by Subject|1|||
105840079|NCT00955721|365070166|FG001|Overall Study|Withdrawal by Subject|0|||
105840080|NCT01253317|365070178|FG000|Overall Study|Adverse Event|2|||
105840081|NCT00749411|365070181|FG000|Overall Study|Adverse Event|0|||
105840082|NCT00749411|365070182|FG001|Overall Study|Adverse Event|2|||
105840083|NCT00749411|365070181|FG000|Overall Study|Lack of Efficacy|0|||
105840084|NCT00749411|365070182|FG001|Overall Study|Lack of Efficacy|1|||
105840085|NCT00749411|365070181|FG000|Overall Study|Protocol Violation|1|||
105840086|NCT00749411|365070182|FG001|Overall Study|Protocol Violation|1|||
105840087|NCT00749411|365070181|FG000|Overall Study|Protocol-defined stopping criteria|0|||
105840088|NCT00749411|365070182|FG001|Overall Study|Protocol-defined stopping criteria|1|||
105840089|NCT03183141|365070183|FG000|Overall Study|Withdrawal by Subject|2|||
105966754|NCT06003777|365537747|FG011|Period 4|Withdrawal by Subject|0|||
105840090|NCT03183141|365070184|FG001|Overall Study|Withdrawal by Subject|4|||
105840091|NCT03183141|365070183|FG000|Overall Study|Death|0|||
105840092|NCT03183141|365070184|FG001|Overall Study|Death|8|||
105840093|NCT02190279|365071485|FG000|Overall Study|Withdrawal consent|1|||
105966755|NCT05319600|365537748|FG000|Overall Study|Withdrawal by Subject|1|||
105966756|NCT05319600|365537749|FG001|Overall Study|Withdrawal by Subject|0|||
105966757|NCT05319600|365537748|FG000|Overall Study|Lost to Follow-up|0|||
105966758|NCT05319600|365537749|FG001|Overall Study|Lost to Follow-up|4|||
105966759|NCT04590404|365537750|FG000|Overall Study|Death|16|||
105966760|NCT04590404|365537751|FG001|Overall Study|Death|17|||
105966761|NCT04590404|365537750|FG000|Overall Study|Withdrawal by Subject|7|||
105966762|NCT04590404|365537751|FG001|Overall Study|Withdrawal by Subject|2|||
105966763|NCT03525600|365537752|FG000|Overall Study|Adverse Event|9|||
105966764|NCT03525600|365537753|FG001|Overall Study|Adverse Event|6|||
105966765|NCT03525600|365537754|FG002|Overall Study|Adverse Event|5|||
105966766|NCT03525600|365537755|FG003|Overall Study|Adverse Event|3|||
105966767|NCT03525600|365537752|FG000|Overall Study|Lost to Follow-up|2|||
105966768|NCT03525600|365537753|FG001|Overall Study|Lost to Follow-up|4|||
105966769|NCT03525600|365537754|FG002|Overall Study|Lost to Follow-up|4|||
105966770|NCT03525600|365537755|FG003|Overall Study|Lost to Follow-up|0|||
105966771|NCT03525600|365537752|FG000|Overall Study|Physician Decision|1|||
105966772|NCT03525600|365537753|FG001|Overall Study|Physician Decision|0|||
105966773|NCT03525600|365537754|FG002|Overall Study|Physician Decision|2|||
105966774|NCT03525600|365537755|FG003|Overall Study|Physician Decision|0|||
105966775|NCT03525600|365537752|FG000|Overall Study|Consent withdrawal|36|||
105966776|NCT03525600|365537753|FG001|Overall Study|Consent withdrawal|20|||
105966777|NCT03525600|365537754|FG002|Overall Study|Consent withdrawal|6|||
105966778|NCT03525600|365537755|FG003|Overall Study|Consent withdrawal|13|||
105966779|NCT03525600|365537752|FG000|Overall Study|Death|7|||
105966780|NCT03525600|365537753|FG001|Overall Study|Death|6|||
105966781|NCT03525600|365537754|FG002|Overall Study|Death|4|||
105966782|NCT03525600|365537755|FG003|Overall Study|Death|3|||
105966783|NCT03525600|365537752|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
105966784|NCT03525600|365537753|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
105966785|NCT03525600|365537754|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
105840094|NCT02190279|365071486|FG001|Overall Study|Withdrawal consent|0|||
105840095|NCT02190279|365071487|FG002|Overall Study|Withdrawal consent|1|||
105840096|NCT02190279|365071485|FG000|Overall Study|Lost to Follow-up|2|||
105840097|NCT02190279|365071486|FG001|Overall Study|Lost to Follow-up|0|||
105840098|NCT02190279|365071487|FG002|Overall Study|Lost to Follow-up|0|||
105840099|NCT02190279|365071485|FG000|Overall Study|Refused further treatment|0|||
105840100|NCT02190279|365071486|FG001|Overall Study|Refused further treatment|0|||
105840101|NCT02190279|365071487|FG002|Overall Study|Refused further treatment|1|||
105840102|NCT02190279|365071485|FG000|Overall Study|Screening failure|0|||
105840103|NCT02190279|365071486|FG001|Overall Study|Screening failure|0|||
105840104|NCT02190279|365071487|FG002|Overall Study|Screening failure|1|||
105840105|NCT04039919|365071492|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105840106|NCT04039919|365071493|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105840107|NCT04039919|365071494|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105840108|NCT04039919|365071495|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105840109|NCT04039919|365071496|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105840110|NCT04039919|365071492|FG000|Treatment Period 1|Sponsor's decision|0|||
105840111|NCT04039919|365071493|FG001|Treatment Period 1|Sponsor's decision|0|||
105840112|NCT04039919|365071494|FG002|Treatment Period 1|Sponsor's decision|0|||
105840113|NCT04039919|365071495|FG003|Treatment Period 1|Sponsor's decision|0|||
105840114|NCT04039919|365071496|FG004|Treatment Period 1|Sponsor's decision|16|||
105840115|NCT04039919|365071492|FG000|Treatment Period 5|Withdrawal by Subject|1|||
105840116|NCT04039919|365071493|FG001|Treatment Period 5|Withdrawal by Subject|0|||
105840117|NCT04039919|365071494|FG002|Treatment Period 5|Withdrawal by Subject|0|||
105840118|NCT04039919|365071495|FG003|Treatment Period 5|Withdrawal by Subject|0|||
105840119|NCT04039919|365071496|FG004|Treatment Period 5|Withdrawal by Subject|0|||
105966786|NCT03525600|365537755|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
105966787|NCT03525600|365537752|FG000|Overall Study|Other|0|||
106023680|NCT01088048|365751791|FG004|Overall Study|Death|1|||
105840120|NCT00983918|365071501|FG000|Overall Study|conversion to open cholecystectomy|0|||
105840121|NCT00983918|365071502|FG001|Overall Study|conversion to open cholecystectomy|2|||
105840122|NCT00983918|365071503|FG002|Overall Study|conversion to open cholecystectomy|2|||
105840123|NCT00983918|365071504|FG003|Overall Study|conversion to open cholecystectomy|2|||
105840124|NCT05132569|365071505|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
105840125|NCT05132569|365071506|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
105840126|NCT05132569|365071505|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
105840127|NCT05132569|365071506|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
105966788|NCT03525600|365537753|FG001|Overall Study|Other|1|||
106023681|NCT01088048|365751792|FG005|Overall Study|Death|3|||
105966789|NCT03525600|365537754|FG002|Overall Study|Other|0|||
105966790|NCT03525600|365537755|FG003|Overall Study|Other|0|||
105966791|NCT01694121|365537756|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
105966792|NCT01694121|365537757|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
105966793|NCT03403361|365537758|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
105966794|NCT05129449|365537763|FG000|Overall Study|Protocol Violation|1|||
105966795|NCT00656058|365537765|FG000|Overall Study|Withdrawal by Subject|2|||
105966796|NCT00656058|365537765|FG000|Overall Study|Withdrawal by Subject|4|||
105966797|NCT00616018|365537766|FG000|Overall Study|Protocol Violation|3|||
105966798|NCT00350870|365537768|FG000|Overall Study|Withdrawal by Subject|21|||
105966799|NCT00350870|365537769|FG001|Overall Study|Withdrawal by Subject|17|||
105966800|NCT00350870|365537770|FG002|Overall Study|Withdrawal by Subject|15|||
105966801|NCT00350870|365537771|FG003|Overall Study|Withdrawal by Subject|14|||
105966802|NCT00350870|365537768|FG000|Overall Study|Physician Decision|1|||
105966803|NCT00350870|365537769|FG001|Overall Study|Physician Decision|0|||
105966804|NCT00350870|365537770|FG002|Overall Study|Physician Decision|1|||
105966805|NCT00350870|365537771|FG003|Overall Study|Physician Decision|1|||
105966806|NCT04700540|365537772|FG000|Overall Study|Withdrawal by Subject|12|||
105966807|NCT04700540|365537773|FG001|Overall Study|Withdrawal by Subject|8|||
105966808|NCT04700540|365537772|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
105966809|NCT04700540|365537773|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
105966810|NCT05248997|365537774|FG000|Overall Study|Lost to Follow-up|1|||
105966811|NCT05248997|365537775|FG001|Overall Study|Lost to Follow-up|1|||
105966812|NCT05248997|365537774|FG000|Overall Study|Randomized but not treated|32|||
105966813|NCT05248997|365537775|FG001|Overall Study|Randomized but not treated|25|||
105966814|NCT02265536|365537776|FG000|Overall Study|Adverse Event|1|||
105966815|NCT02265536|365537777|FG001|Overall Study|Adverse Event|0|||
105966816|NCT02265536|365537778|FG002|Overall Study|Adverse Event|0|||
105966817|NCT02265536|365537779|FG003|Overall Study|Adverse Event|0|||
105966818|NCT02265536|365537780|FG004|Overall Study|Adverse Event|1|||
105966819|NCT02265536|365537781|FG005|Overall Study|Adverse Event|0|||
105966820|NCT02265536|365537776|FG000|Overall Study|Physician Decision|0|||
105966821|NCT02265536|365537777|FG001|Overall Study|Physician Decision|0|||
105966822|NCT02265536|365537778|FG002|Overall Study|Physician Decision|0|||
105966823|NCT02265536|365537779|FG003|Overall Study|Physician Decision|0|||
105966824|NCT02265536|365537780|FG004|Overall Study|Physician Decision|2|||
105966825|NCT02265536|365537781|FG005|Overall Study|Physician Decision|0|||
105966826|NCT02265536|365537776|FG000|Overall Study|Withdrawal by Subject|0|||
105966827|NCT02265536|365537777|FG001|Overall Study|Withdrawal by Subject|3|||
105966828|NCT02265536|365537778|FG002|Overall Study|Withdrawal by Subject|0|||
105966829|NCT02265536|365537779|FG003|Overall Study|Withdrawal by Subject|0|||
105966830|NCT02265536|365537780|FG004|Overall Study|Withdrawal by Subject|0|||
105966831|NCT02265536|365537781|FG005|Overall Study|Withdrawal by Subject|0|||
105966832|NCT04730635|365537785|FG000|Overall Study|Lost to Follow-up|1|||
105966833|NCT04730635|365537786|FG001|Overall Study|Lost to Follow-up|0|||
105966834|NCT04730635|365537785|FG000|Overall Study|Withdrawal by Subject|0|||
105966835|NCT04730635|365537786|FG001|Overall Study|Withdrawal by Subject|1|||
105966836|NCT01974206|365537789|FG000|Overall Study|Did Not Take Study Drug|0|||
105966837|NCT01974206|365537790|FG001|Overall Study|Did Not Take Study Drug|1|||
105966838|NCT01974206|365537789|FG000|Overall Study|Physician Decision|1|||
105966839|NCT01974206|365537790|FG001|Overall Study|Physician Decision|0|||
105966840|NCT01974206|365537789|FG000|Overall Study|Withdrawal by Subject|3|||
105966841|NCT01974206|365537790|FG001|Overall Study|Withdrawal by Subject|0|||
105966842|NCT01974206|365537789|FG000|Overall Study|Lost to Follow-up|1|||
105966843|NCT01974206|365537790|FG001|Overall Study|Lost to Follow-up|0|||
105966844|NCT01974206|365537789|FG000|Overall Study|Death|1|||
105966845|NCT01974206|365537790|FG001|Overall Study|Death|0|||
105966846|NCT05005013|365537795|FG000|Overall Study|Withdrawal by Subject|5|||
105966847|NCT05005013|365537796|FG001|Overall Study|Withdrawal by Subject|1|||
105966848|NCT05005013|365537795|FG000|Overall Study|Lost to Follow-up|3|||
105966849|NCT05005013|365537796|FG001|Overall Study|Lost to Follow-up|1|||
105966850|NCT05005013|365537795|FG000|Overall Study|Ineligibility|1|||
105966851|NCT05005013|365537796|FG001|Overall Study|Ineligibility|1|||
105966852|NCT01202188|365537800|FG000|Overall Study|Protocol deviation|14|||
106023682|NCT01088048|365751793|FG006|Overall Study|Death|0|||
106023683|NCT01088048|365751794|FG007|Overall Study|Death|0|||
106023684|NCT01088048|365751795|FG008|Overall Study|Death|3|||
105966853|NCT01202188|365537801|FG001|Overall Study|Protocol deviation|8|||
105966854|NCT01202188|365537802|FG002|Overall Study|Protocol deviation|12|||
105966855|NCT01202188|365537803|FG003|Overall Study|Protocol deviation|10|||
105966856|NCT01202188|365537804|FG004|Overall Study|Protocol deviation|11|||
106023685|NCT01088048|365751796|FG009|Overall Study|Death|1|||
106023686|NCT01088048|365751787|FG000|Overall Study|Other|3|||
105966857|NCT01202188|365537800|FG000|Overall Study|Subject withdrew consent|12|||
105966858|NCT01202188|365537801|FG001|Overall Study|Subject withdrew consent|13|||
105966859|NCT01202188|365537802|FG002|Overall Study|Subject withdrew consent|22|||
105966860|NCT01202188|365537803|FG003|Overall Study|Subject withdrew consent|11|||
105966861|NCT01202188|365537804|FG004|Overall Study|Subject withdrew consent|13|||
105966862|NCT01202188|365537800|FG000|Overall Study|Adverse Event|5|||
106023687|NCT01088048|365751788|FG001|Overall Study|Other|5|||
105966863|NCT01202188|365537801|FG001|Overall Study|Adverse Event|23|||
105966864|NCT01202188|365537802|FG002|Overall Study|Adverse Event|13|||
105966865|NCT01202188|365537803|FG003|Overall Study|Adverse Event|10|||
106023688|NCT01088048|365751789|FG002|Overall Study|Other|0|||
105966866|NCT01202188|365537804|FG004|Overall Study|Adverse Event|10|||
105966867|NCT01202188|365537800|FG000|Overall Study|Administrative problems|3|||
105966868|NCT01202188|365537801|FG001|Overall Study|Administrative problems|2|||
105966869|NCT01202188|365537802|FG002|Overall Study|Administrative problems|1|||
105966870|NCT01202188|365537803|FG003|Overall Study|Administrative problems|1|||
105966871|NCT01202188|365537804|FG004|Overall Study|Administrative problems|2|||
105966872|NCT01202188|365537800|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105966873|NCT01202188|365537801|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105966874|NCT01202188|365537802|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105966875|NCT01202188|365537803|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
105966876|NCT01202188|365537804|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
105966877|NCT01202188|365537800|FG000|Overall Study|Lost to Follow-up|1|||
105966878|NCT01202188|365537801|FG001|Overall Study|Lost to Follow-up|1|||
105966879|NCT01202188|365537802|FG002|Overall Study|Lost to Follow-up|0|||
105966880|NCT01202188|365537803|FG003|Overall Study|Lost to Follow-up|4|||
105966881|NCT01202188|365537804|FG004|Overall Study|Lost to Follow-up|1|||
105966882|NCT01202188|365537800|FG000|Overall Study|Death|1|||
105966883|NCT01202188|365537801|FG001|Overall Study|Death|1|||
105966884|NCT01202188|365537802|FG002|Overall Study|Death|1|||
105966885|NCT01202188|365537803|FG003|Overall Study|Death|1|||
105966886|NCT01202188|365537804|FG004|Overall Study|Death|0|||
105966887|NCT01202188|365537800|FG000|Overall Study|Abnormal test procedure result (s)|0|||
105966888|NCT01202188|365537801|FG001|Overall Study|Abnormal test procedure result (s)|0|||
105966889|NCT01202188|365537802|FG002|Overall Study|Abnormal test procedure result (s)|2|||
105966890|NCT01202188|365537803|FG003|Overall Study|Abnormal test procedure result (s)|0|||
105966891|NCT01202188|365537804|FG004|Overall Study|Abnormal test procedure result (s)|0|||
105966892|NCT03763656|365537807|FG000|Overall Study|Physician Decision|1|||
105966893|NCT03763656|365537807|FG000|Overall Study|Protocol Violation|1|||
105966894|NCT03763656|365537807|FG000|Overall Study|Withdrawal by Subject|7|||
105966895|NCT00487942|365537808|FG000|Overall Study|Adverse Event|1|||
105966896|NCT00487942|365537809|FG001|Overall Study|Adverse Event|1|||
105966897|NCT00487942|365537810|FG002|Overall Study|Adverse Event|1|||
105966898|NCT00487942|365537811|FG003|Overall Study|Adverse Event|1|||
105966899|NCT00487942|365537808|FG000|Overall Study|Lost to Follow-up|1|||
105966900|NCT00487942|365537809|FG001|Overall Study|Lost to Follow-up|0|||
105966901|NCT00487942|365537810|FG002|Overall Study|Lost to Follow-up|0|||
105966902|NCT00487942|365537811|FG003|Overall Study|Lost to Follow-up|1|||
105966903|NCT00487942|365537808|FG000|Overall Study|Protocol Violation|1|||
105966904|NCT00487942|365537809|FG001|Overall Study|Protocol Violation|1|||
105966905|NCT00487942|365537810|FG002|Overall Study|Protocol Violation|0|||
105966906|NCT00487942|365537811|FG003|Overall Study|Protocol Violation|0|||
105966907|NCT00487942|365537808|FG000|Overall Study|Withdrawal by Subject|0|||
105966908|NCT00487942|365537809|FG001|Overall Study|Withdrawal by Subject|1|||
106023689|NCT01088048|365751790|FG003|Overall Study|Other|0|||
106023690|NCT01088048|365751791|FG004|Overall Study|Other|2|||
106023691|NCT01088048|365751792|FG005|Overall Study|Other|0|||
106023692|NCT01088048|365751793|FG006|Overall Study|Other|0|||
106023693|NCT01088048|365751794|FG007|Overall Study|Other|2|||
106023694|NCT01088048|365751795|FG008|Overall Study|Other|0|||
106023695|NCT01088048|365751796|FG009|Overall Study|Other|0|||
105966909|NCT00487942|365537810|FG002|Overall Study|Withdrawal by Subject|2|||
105966910|NCT00487942|365537811|FG003|Overall Study|Withdrawal by Subject|0|||
105966911|NCT01638013|365537812|FG000|Overall Study|Adverse Event|36|||
105966912|NCT01638013|365537813|FG001|Overall Study|Adverse Event|29|||
105966913|NCT01638013|365537814|FG002|Overall Study|Adverse Event|48|||
105966914|NCT01638013|365537812|FG000|Overall Study|Lack of Efficacy|39|||
105966915|NCT01638013|365537813|FG001|Overall Study|Lack of Efficacy|11|||
105966916|NCT01638013|365537814|FG002|Overall Study|Lack of Efficacy|14|||
105966917|NCT01638013|365537812|FG000|Overall Study|Protocol Violation|10|||
105966918|NCT01638013|365537813|FG001|Overall Study|Protocol Violation|7|||
105966919|NCT01638013|365537814|FG002|Overall Study|Protocol Violation|11|||
105966920|NCT01638013|365537812|FG000|Overall Study|Met discontinuation criteria|4|||
105966921|NCT01638013|365537813|FG001|Overall Study|Met discontinuation criteria|0|||
105966922|NCT01638013|365537814|FG002|Overall Study|Met discontinuation criteria|7|||
105966923|NCT01638013|365537812|FG000|Overall Study|Subject Lost to Follow up|1|||
105966924|NCT01638013|365537813|FG001|Overall Study|Subject Lost to Follow up|0|||
105966925|NCT01638013|365537814|FG002|Overall Study|Subject Lost to Follow up|1|||
105966926|NCT01638013|365537812|FG000|Overall Study|Miscellaneous|25|||
106023696|NCT01837823|365751801|FG000|Overall Study|Lost to Follow-up|6|||
106023697|NCT01874340|365751802|FG000|Overall Study|Study terminated by Sponsor|6|||
105966927|NCT01638013|365537813|FG001|Overall Study|Miscellaneous|19|||
105966928|NCT01638013|365537814|FG002|Overall Study|Miscellaneous|23|||
106023698|NCT01874340|365751803|FG001|Overall Study|Study terminated by Sponsor|8|||
106023699|NCT01874340|365751804|FG002|Overall Study|Study terminated by Sponsor|8|||
105966929|NCT01638013|365537812|FG000|Overall Study|Withdrawal of Consent|16|||
105966930|NCT01638013|365537813|FG001|Overall Study|Withdrawal of Consent|12|||
105966931|NCT01638013|365537814|FG002|Overall Study|Withdrawal of Consent|16|||
105966932|NCT01638013|365537812|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
105840128|NCT05132569|365071505|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
105840129|NCT05132569|365071506|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
105840130|NCT01197417|365071507|FG000|Overall Study|Physician Decision|3|||
105840131|NCT01197417|365071508|FG001|Overall Study|Physician Decision|2|||
105840132|NCT01197417|365071507|FG000|Overall Study|Withdrawal by Subject|2|||
105840133|NCT01197417|365071508|FG001|Overall Study|Withdrawal by Subject|4|||
105840134|NCT01197417|365071507|FG000|Overall Study|Site miscommunication|0|||
105840135|NCT01197417|365071508|FG001|Overall Study|Site miscommunication|1|||
105840136|NCT01197417|365071507|FG000|Overall Study|Subject transferred to intensive care|0|||
105840137|NCT01197417|365071508|FG001|Overall Study|Subject transferred to intensive care|1|||
105840138|NCT01197417|365071507|FG000|Overall Study|Not consented in time to receive drug|0|||
105840139|NCT01197417|365071508|FG001|Overall Study|Not consented in time to receive drug|1|||
105840140|NCT01197417|365071507|FG000|Overall Study|Hypotension|1|||
105840141|NCT01197417|365071508|FG001|Overall Study|Hypotension|2|||
105840142|NCT01197417|365071507|FG000|Overall Study|Found to be ineligible|2|||
105840143|NCT01197417|365071508|FG001|Overall Study|Found to be ineligible|5|||
105840144|NCT01197417|365071507|FG000|Overall Study|No 25-hour magnesium level|0|||
105840145|NCT01197417|365071508|FG001|Overall Study|No 25-hour magnesium level|2|||
105840146|NCT00977548|365071509|FG000|Overall Study|Ineligible|4|||
105840147|NCT00977548|365071509|FG000|Overall Study|Adverse Event|8|||
105840148|NCT00977548|365071509|FG000|Overall Study|Withdrawal by Subject|1|||
105840149|NCT04142242|365071511|FG000|Stage I|Non-compliance with the protocol|1|||
105840150|NCT04142242|365071512|FG001|Stage I|Non-compliance with the protocol|0|||
105840151|NCT04142242|365071513|FG002|Stage I|Non-compliance with the protocol|0|||
105840152|NCT04142242|365071514|FG003|Stage I|Non-compliance with the protocol|0|||
105840153|NCT04142242|365071515|FG004|Stage I|Non-compliance with the protocol|0|||
105840154|NCT04142242|365071516|FG005|Stage I|Non-compliance with the protocol|1|||
105840155|NCT04142242|365071511|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840156|NCT04142242|365071512|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
105840157|NCT04142242|365071513|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840158|NCT04142242|365071514|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840159|NCT04142242|365071515|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840160|NCT04142242|365071516|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
105840161|NCT04142242|365071511|FG000|Stage II|Non-compliance with the protocol|0|||
105840162|NCT04142242|365071512|FG001|Stage II|Non-compliance with the protocol|0|||
105840163|NCT04142242|365071513|FG002|Stage II|Non-compliance with the protocol|0|||
105840164|NCT04142242|365071514|FG003|Stage II|Non-compliance with the protocol|2|||
105840165|NCT04142242|365071515|FG004|Stage II|Non-compliance with the protocol|0|||
105840166|NCT04142242|365071516|FG005|Stage II|Non-compliance with the protocol|0|||
105840167|NCT04142242|365071511|FG000|Stage II|Lost to Follow-up|0|||
105840168|NCT04142242|365071512|FG001|Stage II|Lost to Follow-up|0|||
105840169|NCT04142242|365071513|FG002|Stage II|Lost to Follow-up|1|||
105840170|NCT04142242|365071514|FG003|Stage II|Lost to Follow-up|2|||
105840171|NCT04142242|365071515|FG004|Stage II|Lost to Follow-up|0|||
105840172|NCT04142242|365071516|FG005|Stage II|Lost to Follow-up|0|||
105840173|NCT04142242|365071511|FG000|Stage II|Withdrawal by Subject|0|||
105840174|NCT04142242|365071512|FG001|Stage II|Withdrawal by Subject|0|||
105840175|NCT04142242|365071513|FG002|Stage II|Withdrawal by Subject|5|||
105840176|NCT04142242|365071514|FG003|Stage II|Withdrawal by Subject|9|||
105840177|NCT04142242|365071515|FG004|Stage II|Withdrawal by Subject|0|||
105840178|NCT04142242|365071516|FG005|Stage II|Withdrawal by Subject|0|||
105840179|NCT02070757|365071517|FG000|Overall Study|Adverse Event|107|||
105840180|NCT02070757|365071518|FG001|Overall Study|Adverse Event|99|||
105840181|NCT02070757|365071517|FG000|Overall Study|Lost to Follow-up|7|||
105840182|NCT02070757|365071518|FG001|Overall Study|Lost to Follow-up|4|||
105840183|NCT02070757|365071517|FG000|Overall Study|Protocol Violation|0|||
105840184|NCT02070757|365071518|FG001|Overall Study|Protocol Violation|4|||
105840185|NCT02070757|365071517|FG000|Overall Study|Withdrawal by Subject|1|||
105840186|NCT02070757|365071518|FG001|Overall Study|Withdrawal by Subject|3|||
105840187|NCT02070757|365071517|FG000|Overall Study|Investigator Decision|0|||
105840188|NCT02070757|365071518|FG001|Overall Study|Investigator Decision|2|||
105840189|NCT02070757|365071517|FG000|Overall Study|Discharged from Study Hospital|2|||
105840190|NCT02070757|365071518|FG001|Overall Study|Discharged from Study Hospital|2|||
105840191|NCT01546922|365071519|FG000|First Period of 10 Weeks|Protocol Violation|3|||
105840192|NCT01546922|365071520|FG001|First Period of 10 Weeks|Protocol Violation|1|||
105966933|NCT01638013|365537813|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
105966934|NCT01638013|365537814|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
105987410|NCT03495102|365614448|FG000|Overall Study|Participant was in Rehabilitation|1|||
105987411|NCT03495102|365614449|FG001|Overall Study|Participant was in Rehabilitation|0|||
105840193|NCT01546922|365071519|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
105840194|NCT01546922|365071520|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
105840195|NCT01546922|365071519|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
105840196|NCT01546922|365071520|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
105987412|NCT03495102|365614450|FG002|Overall Study|Participant was in Rehabilitation|0|||
105966935|NCT00790868|365539814|FG000|Overall Study|Withdrawal by Subject|4|||
105966936|NCT00790868|365539815|FG001|Overall Study|Withdrawal by Subject|5|||
105966937|NCT00790868|365539814|FG000|Overall Study|Lost to Follow-up|2|||
105966938|NCT00790868|365539815|FG001|Overall Study|Lost to Follow-up|12|||
105966939|NCT01380535|365539816|FG000|Overall Study|Adverse Event|3|||
105966940|NCT01380535|365539817|FG001|Overall Study|Adverse Event|3|||
105966941|NCT01380535|365539816|FG000|Overall Study|Death|3|||
105966942|NCT01380535|365539817|FG001|Overall Study|Death|0|||
105966943|NCT01380535|365539816|FG000|Overall Study|Study site closed|0|||
105966944|NCT01380535|365539817|FG001|Overall Study|Study site closed|5|||
105966945|NCT01380535|365539816|FG000|Overall Study|Withdrawal by Subject|1|||
105966946|NCT01380535|365539817|FG001|Overall Study|Withdrawal by Subject|2|||
105966947|NCT01380535|365539816|FG000|Overall Study|Protocol Violation|0|||
105966948|NCT01380535|365539817|FG001|Overall Study|Protocol Violation|2|||
105966949|NCT01380535|365539816|FG000|Overall Study|Lack of Efficacy|0|||
105966950|NCT01380535|365539817|FG001|Overall Study|Lack of Efficacy|3|||
105966951|NCT01579565|365539818|FG000|Randomized|Adverse Event|1|||
105966952|NCT01579565|365539819|FG001|Randomized|Adverse Event|3|||
105966953|NCT01579565|365539818|FG000|Randomized|Withdrawal by Subject|3|||
105966954|NCT01579565|365539819|FG001|Randomized|Withdrawal by Subject|0|||
105966955|NCT01579565|365539818|FG000|Randomized|inadequate preoperative pupil dilation|0|||
105966956|NCT01579565|365539819|FG001|Randomized|inadequate preoperative pupil dilation|1|||
105966957|NCT01579565|365539818|FG000|Randomized|prohibited preoperative eating|1|||
105966958|NCT01579565|365539819|FG001|Randomized|prohibited preoperative eating|0|||
105966959|NCT01579565|365539818|FG000|Randomized|prohibited preoperative medication|0|||
105966960|NCT01579565|365539819|FG001|Randomized|prohibited preoperative medication|1|||
105966961|NCT01579565|365539818|FG000|Treated|Physician Decision|0|||
105966962|NCT01579565|365539819|FG001|Treated|Physician Decision|1|||
105966963|NCT01579565|365539818|FG000|Treated|Lost to Follow-up|2|||
105966964|NCT01579565|365539819|FG001|Treated|Lost to Follow-up|1|||
105966965|NCT01579565|365539818|FG000|Treated|declined to return for final visit|0|||
105966966|NCT01579565|365539819|FG001|Treated|declined to return for final visit|1|||
105966967|NCT02867813|365539820|FG000|Overall Study|Withdrawal by Subject|57|||
105966968|NCT02867813|365539821|FG001|Overall Study|Withdrawal by Subject|56|||
105966969|NCT02867813|365539820|FG000|Overall Study|Decision by Sponsor|7|||
105966970|NCT02867813|365539821|FG001|Overall Study|Decision by Sponsor|7|||
105966971|NCT02867813|365539820|FG000|Overall Study|Lost to Follow-up|91|||
105966972|NCT02867813|365539821|FG001|Overall Study|Lost to Follow-up|78|||
105966973|NCT02867813|365539820|FG000|Overall Study|Missing|2|||
105966974|NCT02867813|365539821|FG001|Overall Study|Missing|1|||
105966975|NCT02867813|365539820|FG000|Overall Study|Death|294|||
105966976|NCT02867813|365539821|FG001|Overall Study|Death|268|||
105966977|NCT02791191|365539823|FG000|Overall Study|Adverse Event|2|||
105966978|NCT02791191|365539824|FG001|Overall Study|Adverse Event|4|||
105966979|NCT02791191|365539825|FG002|Overall Study|Adverse Event|5|||
105966980|NCT02791191|365539823|FG000|Overall Study|Lack of Efficacy|0|||
105966981|NCT02791191|365539824|FG001|Overall Study|Lack of Efficacy|1|||
105966982|NCT02791191|365539825|FG002|Overall Study|Lack of Efficacy|0|||
105966983|NCT02791191|365539823|FG000|Overall Study|Study Drug Non-Compliance|0|||
105966984|NCT02791191|365539824|FG001|Overall Study|Study Drug Non-Compliance|2|||
105966985|NCT02791191|365539825|FG002|Overall Study|Study Drug Non-Compliance|0|||
105966986|NCT02791191|365539823|FG000|Overall Study|Site Closed by Sponsor|1|||
105966987|NCT02791191|365539824|FG001|Overall Study|Site Closed by Sponsor|1|||
105966988|NCT02791191|365539825|FG002|Overall Study|Site Closed by Sponsor|3|||
105966989|NCT02791191|365539823|FG000|Overall Study|Progressive Disease|1|||
105966990|NCT02791191|365539824|FG001|Overall Study|Progressive Disease|0|||
105966991|NCT02791191|365539825|FG002|Overall Study|Progressive Disease|0|||
105966992|NCT02791191|365539823|FG000|Overall Study|Study Terminated by Sponsor|29|||
105966993|NCT02791191|365539824|FG001|Overall Study|Study Terminated by Sponsor|101|||
105966994|NCT02791191|365539825|FG002|Overall Study|Study Terminated by Sponsor|109|||
105966995|NCT02791191|365539823|FG000|Overall Study|Withdrawal by Subject|3|||
105966996|NCT02791191|365539824|FG001|Overall Study|Withdrawal by Subject|1|||
105966997|NCT02791191|365539825|FG002|Overall Study|Withdrawal by Subject|3|||
105966998|NCT02791191|365539823|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
105966999|NCT02791191|365539824|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
105967000|NCT02791191|365539825|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
105967001|NCT01691014|365539828|FG000|Overall Study|Premature Termination|1|||
105967002|NCT01691014|365539829|FG001|Overall Study|Premature Termination|6|||
105967003|NCT01691014|365539830|FG002|Overall Study|Premature Termination|0|||
105967004|NCT01691014|365539831|FG003|Overall Study|Premature Termination|3|||
105967005|NCT01691014|365539828|FG000|Overall Study|Other|0|||
105967006|NCT01691014|365539829|FG001|Overall Study|Other|0|||
105967007|NCT01691014|365539830|FG002|Overall Study|Other|2|||
105967008|NCT01691014|365539831|FG003|Overall Study|Other|0|||
105967009|NCT01691014|365539828|FG000|Overall Study|Withdrawal by Subject|0|||
105967010|NCT01691014|365539829|FG001|Overall Study|Withdrawal by Subject|1|||
105967011|NCT01691014|365539830|FG002|Overall Study|Withdrawal by Subject|1|||
106023700|NCT01874340|365751805|FG003|Overall Study|Study terminated by Sponsor|4|||
106023701|NCT01874340|365751802|FG000|Overall Study|Withdrawal by Subject|0|||
105967012|NCT01691014|365539831|FG003|Overall Study|Withdrawal by Subject|1|||
105967013|NCT01691014|365539828|FG000|Overall Study|Adverse Event|0|||
105967014|NCT01691014|365539829|FG001|Overall Study|Adverse Event|5|||
105967015|NCT01691014|365539830|FG002|Overall Study|Adverse Event|1|||
105967016|NCT01691014|365539831|FG003|Overall Study|Adverse Event|1|||
105967017|NCT01691014|365539828|FG000|Overall Study|Lack of Efficacy|2|||
105967018|NCT01691014|365539829|FG001|Overall Study|Lack of Efficacy|3|||
105967019|NCT01691014|365539830|FG002|Overall Study|Lack of Efficacy|7|||
105967020|NCT01691014|365539831|FG003|Overall Study|Lack of Efficacy|0|||
105967021|NCT03372551|365539832|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
105967022|NCT03372551|365539833|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
105967023|NCT04439539|365539834|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
105967024|NCT04439539|365539835|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
105967025|NCT04439539|365539836|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
105967026|NCT04439539|365539834|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
105967027|NCT04439539|365539835|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
105967028|NCT04439539|365539836|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
105967029|NCT04439539|365539834|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
105967030|NCT04439539|365539835|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
105967031|NCT04439539|365539836|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
105967032|NCT02578680|365539839|FG000|Overall Study|Death|329|||
105967033|NCT02578680|365539840|FG001|Overall Study|Death|181|||
105967034|NCT02578680|365539839|FG000|Overall Study|Lost to Follow-up|3|||
105967035|NCT02578680|365539840|FG001|Overall Study|Lost to Follow-up|1|||
105967036|NCT02578680|365539839|FG000|Overall Study|Physician Decision|0|||
105967037|NCT02578680|365539840|FG001|Overall Study|Physician Decision|1|||
105967038|NCT02578680|365539839|FG000|Overall Study|Protocol Violation|1|||
105967039|NCT02578680|365539840|FG001|Overall Study|Protocol Violation|1|||
105967040|NCT02578680|365539839|FG000|Overall Study|Sponsor Decision|64|||
105967041|NCT02578680|365539840|FG001|Overall Study|Sponsor Decision|13|||
105967042|NCT02578680|365539839|FG000|Overall Study|Withdrawal by Subject|13|||
105967043|NCT02578680|365539840|FG001|Overall Study|Withdrawal by Subject|9|||
105967044|NCT03116828|365539841|FG000|Overall Study|Adverse Event|1|||
105967045|NCT03116828|365539842|FG001|Overall Study|Adverse Event|10|||
106023702|NCT01874340|365751803|FG001|Overall Study|Withdrawal by Subject|0|||
106023703|NCT01874340|365751804|FG002|Overall Study|Withdrawal by Subject|0|||
106023704|NCT01874340|365751805|FG003|Overall Study|Withdrawal by Subject|1|||
106023705|NCT00724867|365751809|FG000|Overall Study|Adverse Event|25|||
106023706|NCT00724867|365751809|FG000|Overall Study|Lack of Efficacy|14|||
106023707|NCT00724867|365751809|FG000|Overall Study|Lost to Follow-up|12|||
106023708|NCT00724867|365751809|FG000|Overall Study|Non-compliance with study drug|6|||
106023709|NCT00724867|365751809|FG000|Overall Study|Physician Decision|17|||
106023710|NCT00724867|365751809|FG000|Overall Study|Protocol Violation|1|||
106023711|NCT00724867|365751809|FG000|Overall Study|Withdrawal by Subject|31|||
106023712|NCT00724867|365751809|FG000|Overall Study|Sponsor decision to end study|14|||
106023713|NCT00724867|365751809|FG000|Overall Study|Subject incarcerated|1|||
106023714|NCT00724867|365751809|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
106023715|NCT00724867|365751809|FG000|Overall Study|Subject moved out of state|1|||
106023716|NCT00724867|365751809|FG000|Overall Study|Elected to exit due to site closure|2|||
106023717|NCT02881567|365751811|FG000|Overall Study|Adverse Event|1|||
106023718|NCT02881567|365751811|FG000|Overall Study|Lost to Follow-up|3|||
106023719|NCT02881567|365751811|FG000|Overall Study|Consent withdrawn|1|||
106023720|NCT02881567|365751811|FG000|Overall Study|Investigator decision|1|||
106023721|NCT02881567|365751811|FG000|Overall Study|Study terminated by sponsor|9|||
106023722|NCT02881567|365751811|FG000|Overall Study|Reason not Specified|3|||
106023723|NCT02864862|365751812|FG000|Overall Study|Lost to Follow-up|1|||
106023724|NCT02864862|365751813|FG001|Overall Study|Lost to Follow-up|0|||
106023725|NCT02864862|365751814|FG002|Overall Study|Lost to Follow-up|1|||
106023726|NCT02864862|365751812|FG000|Overall Study|Protocol Violation|0|||
106023727|NCT02864862|365751813|FG001|Overall Study|Protocol Violation|0|||
106023728|NCT02864862|365751814|FG002|Overall Study|Protocol Violation|1|||
105967046|NCT03116828|365539841|FG000|Overall Study|Withdrawal by Subject|4|||
105967047|NCT03116828|365539842|FG001|Overall Study|Withdrawal by Subject|8|||
106023729|NCT00975689|365751815|FG000|Overall Study|Adverse Event|0|||
106023730|NCT00975689|365751816|FG001|Overall Study|Adverse Event|3|||
106023731|NCT00975689|365751815|FG000|Overall Study|Withdrawal by Subject|1|||
106023732|NCT00975689|365751816|FG001|Overall Study|Withdrawal by Subject|0|||
106023733|NCT00975689|365751815|FG000|Overall Study|Physician Decision|1|||
105967048|NCT03116828|365539841|FG000|Overall Study|OTHER|3|||
105967049|NCT03116828|365539842|FG001|Overall Study|OTHER|3|||
105967050|NCT01519791|365539845|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
105967051|NCT01519791|365539846|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
105840197|NCT01546922|365071519|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
105840198|NCT01546922|365071520|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
105840199|NCT01546922|365071519|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
105840200|NCT01546922|365071520|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
105840201|NCT01613378|365071523|FG000|Overall Study|Lack of Efficacy|13|||
105840202|NCT01613378|365071523|FG000|Overall Study|Adverse Event|11|||
105840203|NCT01613378|365071523|FG000|Overall Study|Withdrawal by Subject|8|||
105840204|NCT01613378|365071523|FG000|Overall Study|Death|2|||
105840205|NCT01613378|365071523|FG000|Overall Study|Lost to Follow-up|1|||
105840206|NCT01613378|365071523|FG000|Overall Study|Other Reason|4|||
105840207|NCT00794417|365071524|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
105840208|NCT00794417|365071525|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
105840209|NCT00794417|365071526|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
105840210|NCT00794417|365071527|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
105840211|NCT00794417|365071524|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
105840212|NCT00794417|365071525|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
105840213|NCT00794417|365071526|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
105840214|NCT00794417|365071527|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
105840215|NCT00794417|365071524|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
105840216|NCT00794417|365071525|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
105840217|NCT00794417|365071526|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
105840218|NCT00794417|365071527|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
105840219|NCT00794417|365071524|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
105840220|NCT00794417|365071525|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
105840221|NCT00794417|365071526|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
105840222|NCT00794417|365071527|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
105840223|NCT00794417|365071524|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
105840224|NCT00794417|365071525|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
105840225|NCT00794417|365071526|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
105840226|NCT00794417|365071527|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
105840227|NCT00794417|365071524|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
105840228|NCT00794417|365071525|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
105840229|NCT00794417|365071526|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
105840230|NCT00794417|365071527|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
105840231|NCT01042535|365071528|FG000|Overall Study|disease progression prior to treatment|3|||
105840232|NCT01042535|365071528|FG000|Overall Study|disease progression during treatment|3|||
105840233|NCT01042535|365071528|FG000|Overall Study|complications from other disease|2|||
105840234|NCT01345318|365071529|FG000|Overall Study|Adverse Event|16|||
105840235|NCT01345318|365071529|FG000|Overall Study|Lack of Efficacy|17|||
105840236|NCT01345318|365071529|FG000|Overall Study|Lost to Follow-up|2|||
105840237|NCT01345318|365071529|FG000|Overall Study|Protocol Violation|1|||
105840238|NCT01345318|365071529|FG000|Overall Study|Withdrawal by Subject|41|||
105840239|NCT01345318|365071529|FG000|Overall Study|Other|3|||
105840240|NCT01546142|365071532|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
105840241|NCT01546142|365071533|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
105840242|NCT01546142|365071532|FG000|Overall Study|Subject Noncompliance|1|||
105840243|NCT01546142|365071533|FG001|Overall Study|Subject Noncompliance|1|||
105840244|NCT01546142|365071532|FG000|Overall Study|Adverse Event|6|||
105840245|NCT01546142|365071533|FG001|Overall Study|Adverse Event|3|||
105840246|NCT01546142|365071532|FG000|Overall Study|Lost to Follow-up|20|||
105840247|NCT01546142|365071533|FG001|Overall Study|Lost to Follow-up|15|||
105840248|NCT01546142|365071532|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
105840249|NCT01546142|365071533|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
105840250|NCT01546142|365071532|FG000|Overall Study|Subject Randomized but Not Treated|1|||
105840251|NCT01546142|365071533|FG001|Overall Study|Subject Randomized but Not Treated|0|||
105840252|NCT01213836|365071534|FG000|Period 1, First Intervention|Adverse Event|2|||
105840253|NCT01213836|365071535|FG001|Period 1, First Intervention|Adverse Event|1|||
105840254|NCT01213836|365071534|FG000|Period 1, First Intervention|Protocol Violation|0|||
105840255|NCT01213836|365071535|FG001|Period 1, First Intervention|Protocol Violation|1|||
105967052|NCT01519791|365539845|FG000|Overall Study|Protocol Violation|6|||
105967053|NCT01519791|365539846|FG001|Overall Study|Protocol Violation|19|||
105840256|NCT01213836|365071534|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
105840257|NCT01213836|365071535|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
105840258|NCT00255151|365071536|FG000|Overall Study|Adverse Event|10|||
105840259|NCT00255151|365071537|FG001|Overall Study|Adverse Event|6|||
105840260|NCT00255151|365071538|FG002|Overall Study|Adverse Event|9|||
105840261|NCT00255151|365071536|FG000|Overall Study|Lost to Follow-up|4|||
105840262|NCT00255151|365071537|FG001|Overall Study|Lost to Follow-up|3|||
105840263|NCT00255151|365071538|FG002|Overall Study|Lost to Follow-up|4|||
105840264|NCT00255151|365071536|FG000|Overall Study|Withdrawal by Subject|18|||
105967054|NCT01519791|365539845|FG000|Overall Study|Other Reason|87|||
106023734|NCT00975689|365751816|FG001|Overall Study|Physician Decision|0|||
106023735|NCT01402102|365751817|FG000|Overall Study|Protocol Violation|1|||
106023736|NCT01402102|365751818|FG001|Overall Study|Protocol Violation|0|||
106023737|NCT01402102|365751817|FG000|Overall Study|Insufficiency of compliance|1|||
106023738|NCT01402102|365751818|FG001|Overall Study|Insufficiency of compliance|1|||
106023739|NCT01402102|365751817|FG000|Overall Study|Withdrawal by Subject|0|||
106023740|NCT01402102|365751818|FG001|Overall Study|Withdrawal by Subject|2|||
106023741|NCT01256190|365751820|FG000|Overall Study|Lost to Follow-up|2|||
106023742|NCT01256190|365751821|FG001|Overall Study|Lost to Follow-up|0|||
106023743|NCT02834793|365751822|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
106023744|NCT02834793|365751823|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
106023745|NCT02834793|365751824|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
106023746|NCT02834793|365751825|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
106023747|NCT02834793|365751822|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
106023748|NCT02834793|365751823|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
106023749|NCT02834793|365751824|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
106023750|NCT02834793|365751825|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
106023751|NCT02834793|365751822|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
106023752|NCT02834793|365751823|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
106023753|NCT02834793|365751824|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
106023754|NCT02834793|365751825|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
106023755|NCT02834793|365751822|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
106023756|NCT02834793|365751823|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
106023757|NCT02834793|365751824|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
106023758|NCT02834793|365751825|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
106023759|NCT02834793|365751822|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
106023760|NCT02834793|365751823|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
106023761|NCT02834793|365751824|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
105840265|NCT00255151|365071537|FG001|Overall Study|Withdrawal by Subject|17|||
105840266|NCT00255151|365071538|FG002|Overall Study|Withdrawal by Subject|8|||
105840267|NCT00255151|365071536|FG000|Overall Study|Noncompliance|0|||
105840268|NCT00255151|365071537|FG001|Overall Study|Noncompliance|1|||
105840269|NCT00255151|365071538|FG002|Overall Study|Noncompliance|2|||
105840270|NCT00255151|365071536|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
105840271|NCT00255151|365071537|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
105840272|NCT00255151|365071538|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
105840273|NCT00255151|365071536|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
105840274|NCT00255151|365071537|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
105840275|NCT00255151|365071538|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
105840276|NCT00255151|365071536|FG000|Overall Study|Possible Barrett's Esophagus|1|||
105840277|NCT00255151|365071537|FG001|Overall Study|Possible Barrett's Esophagus|3|||
105840278|NCT00255151|365071538|FG002|Overall Study|Possible Barrett's Esophagus|8|||
105840279|NCT00255151|365071536|FG000|Overall Study|Esophageal Stricture|0|||
105840280|NCT00255151|365071537|FG001|Overall Study|Esophageal Stricture|0|||
105840281|NCT00255151|365071538|FG002|Overall Study|Esophageal Stricture|1|||
105840282|NCT00255151|365071536|FG000|Overall Study|Therapeutic Failure|11|||
105840283|NCT00255151|365071537|FG001|Overall Study|Therapeutic Failure|2|||
105840284|NCT00255151|365071538|FG002|Overall Study|Therapeutic Failure|3|||
105840285|NCT03438539|365071544|FG000|Overall Study|Lost to Follow-up|8|||
105840286|NCT03438539|365071545|FG001|Overall Study|Lost to Follow-up|4|||
105840287|NCT03438539|365071546|FG002|Overall Study|Lost to Follow-up|10|||
105840288|NCT03438539|365071547|FG003|Overall Study|Lost to Follow-up|9|||
105840289|NCT03438539|365071548|FG004|Overall Study|Lost to Follow-up|3|||
105840290|NCT03438539|365071549|FG005|Overall Study|Lost to Follow-up|8|||
105840291|NCT02065713|365071550|FG000|Overall Study|Adverse Event|0|||
105840292|NCT02065713|365071551|FG001|Overall Study|Adverse Event|1|||
105840293|NCT02065713|365071550|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105840294|NCT02065713|365071551|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
105840295|NCT01005329|365071554|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
105840296|NCT00483548|365071555|FG000|Overall Study|Randomized; not treated with study drug|1|||
105840297|NCT00483548|365071556|FG001|Overall Study|Randomized; not treated with study drug|3|||
105840298|NCT00483548|365071555|FG000|Overall Study|Adverse Event|25|||
105840299|NCT00483548|365071556|FG001|Overall Study|Adverse Event|14|||
105840300|NCT00483548|365071555|FG000|Overall Study|Laboratory abnormality|1|||
106023762|NCT02834793|365751825|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
106023763|NCT02834793|365751822|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
106023764|NCT02834793|365751823|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
106023765|NCT02834793|365751824|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
105840301|NCT00483548|365071556|FG001|Overall Study|Laboratory abnormality|2|||
105840302|NCT00483548|365071555|FG000|Overall Study|Lack of Efficacy|4|||
105967055|NCT01519791|365539846|FG001|Overall Study|Other Reason|222|||
105967056|NCT01519791|365539845|FG000|Overall Study|subjects randomized in error|2|||
105967057|NCT01519791|365539846|FG001|Overall Study|subjects randomized in error|0|||
105967058|NCT01519791|365539845|FG000|Overall Study|Lack of Efficacy|16|||
105967059|NCT01519791|365539846|FG001|Overall Study|Lack of Efficacy|20|||
105967060|NCT01519791|365539845|FG000|Overall Study|SAE, non-fatal|6|||
105967061|NCT01519791|365539846|FG001|Overall Study|SAE, non-fatal|22|||
105967062|NCT01519791|365539845|FG000|Overall Study|AE, serious fatal|0|||
105967063|NCT01519791|365539846|FG001|Overall Study|AE, serious fatal|1|||
105967064|NCT01519791|365539845|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
105967065|NCT01519791|365539846|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
105967066|NCT01519791|365539845|FG000|Overall Study|AE, non-serious non-fatal|12|||
105967067|NCT01519791|365539846|FG001|Overall Study|AE, non-serious non-fatal|31|||
105967068|NCT01519791|365539845|FG000|Overall Study|Withdrawal by Subject|15|||
105967069|NCT01519791|365539846|FG001|Overall Study|Withdrawal by Subject|37|||
105967070|NCT01519791|365539845|FG000|Overall Study|Lost to Follow-up|6|||
105967071|NCT01519791|365539846|FG001|Overall Study|Lost to Follow-up|14|||
105967072|NCT00664560|365539847|FG000|Overall Study|Adverse Event|19|||
105967073|NCT00664560|365539848|FG001|Overall Study|Adverse Event|16|||
105967074|NCT00664560|365539849|FG002|Overall Study|Adverse Event|7|||
105967075|NCT00664560|365539847|FG000|Overall Study|Withdrawal by Subject|9|||
105967076|NCT00664560|365539848|FG001|Overall Study|Withdrawal by Subject|13|||
105967077|NCT00664560|365539849|FG002|Overall Study|Withdrawal by Subject|7|||
105967078|NCT00664560|365539847|FG000|Overall Study|Lost to Follow-up|0|||
105967079|NCT00664560|365539848|FG001|Overall Study|Lost to Follow-up|2|||
105967080|NCT00664560|365539849|FG002|Overall Study|Lost to Follow-up|0|||
105967081|NCT00664560|365539847|FG000|Overall Study|Other|11|||
105967082|NCT00664560|365539848|FG001|Overall Study|Other|4|||
105967083|NCT00664560|365539849|FG002|Overall Study|Other|5|||
105967084|NCT03350035|365539850|FG000|Overall Study|Lack of Efficacy|2|||
105967085|NCT03350035|365539851|FG001|Overall Study|Lack of Efficacy|0|||
105967086|NCT03350035|365539852|FG002|Overall Study|Lack of Efficacy|0|||
105967087|NCT03350035|365539850|FG000|Overall Study|Subject discharged to hospice|0|||
105967088|NCT03350035|365539851|FG001|Overall Study|Subject discharged to hospice|0|||
105967089|NCT03350035|365539852|FG002|Overall Study|Subject discharged to hospice|1|||
105967090|NCT01545934|365539853|FG000|Overall Study|Withdrawal by Subject|4|||
105967091|NCT01545934|365539854|FG001|Overall Study|Withdrawal by Subject|3|||
105967092|NCT01545934|365539853|FG000|Overall Study|Lost to Follow-up|1|||
105967093|NCT01545934|365539854|FG001|Overall Study|Lost to Follow-up|0|||
105967094|NCT01610557|365539855|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
105967095|NCT01610557|365539856|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
105967096|NCT01610557|365539857|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
105967097|NCT01610557|365539858|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
105967098|NCT01610557|365539859|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
105967099|NCT01610557|365539855|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
105967100|NCT01610557|365539856|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
105967101|NCT01610557|365539857|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
105967102|NCT01610557|365539858|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
105967103|NCT01610557|365539859|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
105967104|NCT00713349|365539862|FG000|Overall Study|Protocol Violation|1|||
105967105|NCT03764631|365539863|FG000|Overall Study|Personal Reasons|3|||
105967106|NCT03764631|365539864|FG001|Overall Study|Personal Reasons|2|||
106023766|NCT02834793|365751825|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
106023767|NCT02834793|365751822|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
106023768|NCT02834793|365751823|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
106023769|NCT02834793|365751824|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
106023770|NCT02834793|365751825|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
106023771|NCT02834793|365751822|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
106023772|NCT02834793|365751823|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
106023773|NCT02834793|365751824|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
106023774|NCT02834793|365751825|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
106023775|NCT02834793|365751822|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
106023776|NCT02834793|365751823|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
106023777|NCT02834793|365751824|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
105967107|NCT03764631|365539863|FG000|Overall Study|Switching Therapy|3|||
105967108|NCT03764631|365539864|FG001|Overall Study|Switching Therapy|3|||
105967109|NCT03764631|365539863|FG000|Overall Study|Adverse Event|0|||
105967110|NCT03764631|365539864|FG001|Overall Study|Adverse Event|1|||
105967111|NCT03764631|365539863|FG000|Overall Study|Lost to Follow-up|33|||
105967112|NCT03764631|365539864|FG001|Overall Study|Lost to Follow-up|41|||
105967113|NCT03764631|365539863|FG000|Overall Study|No data as study site was closed|2|||
105967114|NCT03764631|365539864|FG001|Overall Study|No data as study site was closed|6|||
105967115|NCT00519376|365539865|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967116|NCT00519376|365539866|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967117|NCT00519376|365539867|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967118|NCT00519376|365539868|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967119|NCT00519376|365539869|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967120|NCT00519376|365539870|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967121|NCT00519376|365539871|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967122|NCT00519376|365539872|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967123|NCT00519376|365539873|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967124|NCT00519376|365539874|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967125|NCT00519376|365539875|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967126|NCT00519376|365539876|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967127|NCT00519376|365539877|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
105967128|NCT00519376|365539878|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967129|NCT00519376|365539879|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967130|NCT00519376|365539880|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
105967131|NCT00519376|365539865|FG000|Treatment Period 4|Lost to Follow-up|0|||
105967132|NCT00519376|365539866|FG001|Treatment Period 4|Lost to Follow-up|0|||
105967133|NCT00519376|365539867|FG002|Treatment Period 4|Lost to Follow-up|1|||
105967134|NCT00519376|365539868|FG003|Treatment Period 4|Lost to Follow-up|0|||
105967135|NCT00519376|365539869|FG004|Treatment Period 4|Lost to Follow-up|0|||
105967136|NCT00519376|365539870|FG005|Treatment Period 4|Lost to Follow-up|0|||
105967137|NCT00519376|365539871|FG006|Treatment Period 4|Lost to Follow-up|0|||
105967138|NCT00519376|365539872|FG007|Treatment Period 4|Lost to Follow-up|0|||
105967139|NCT00519376|365539873|FG008|Treatment Period 4|Lost to Follow-up|0|||
105967140|NCT00519376|365539874|FG009|Treatment Period 4|Lost to Follow-up|0|||
105967141|NCT00519376|365539875|FG010|Treatment Period 4|Lost to Follow-up|0|||
105967142|NCT00519376|365539876|FG011|Treatment Period 4|Lost to Follow-up|0|||
105967143|NCT00519376|365539877|FG012|Treatment Period 4|Lost to Follow-up|0|||
105967144|NCT00519376|365539878|FG013|Treatment Period 4|Lost to Follow-up|0|||
105967145|NCT00519376|365539879|FG014|Treatment Period 4|Lost to Follow-up|0|||
105967146|NCT00519376|365539880|FG015|Treatment Period 4|Lost to Follow-up|0|||
105967147|NCT00245050|365539884|FG000|Overall Study|Adverse Event|3|||
105967148|NCT00245050|365539885|FG001|Overall Study|Adverse Event|2|||
105967149|NCT00695955|365539889|FG000|Cohort 1|Adverse Event|26|||
105967150|NCT00695955|365539889|FG000|Cohort 1|Protocol Violation|2|||
105967151|NCT00695955|365539889|FG000|Cohort 1|Lost to Follow-up|30|||
105967152|NCT00695955|365539889|FG000|Cohort 1|Withdrawal by Subject|25|||
105967153|NCT00695955|365539889|FG000|Cohort 1|Lack of Efficacy|3|||
105967154|NCT00695955|365539889|FG000|Cohort 1|Other|16|||
105967155|NCT00695955|365539889|FG000|Cohort 2|Adverse Event|24|||
105967156|NCT00695955|365539889|FG000|Cohort 2|Protocol Violation|5|||
105967157|NCT00695955|365539889|FG000|Cohort 2|Lost to Follow-up|38|||
105967158|NCT00695955|365539889|FG000|Cohort 2|Withdrawal by Subject|28|||
105967159|NCT00695955|365539889|FG000|Cohort 2|Lack of Efficacy|4|||
105967160|NCT00695955|365539889|FG000|Cohort 2|Other|5|||
105967161|NCT01972308|365539890|FG000|Overall Study|Withdrawal by Subject|0|||
105967162|NCT01972308|365539891|FG001|Overall Study|Withdrawal by Subject|1|||
105967163|NCT01972308|365539890|FG000|Overall Study|Lost to Follow-up|4|||
105967164|NCT01972308|365539891|FG001|Overall Study|Lost to Follow-up|6|||
105967165|NCT01972308|365539890|FG000|Overall Study|Death|4|||
105967166|NCT01972308|365539891|FG001|Overall Study|Death|1|||
105967167|NCT03655054|365539894|FG000|Overall Study|Lost to Follow-up|1|||
105967168|NCT04537208|365539898|FG000|Overall Study|Adverse Event|0|||
105967169|NCT04537208|365539899|FG001|Overall Study|Adverse Event|0|||
105967170|NCT04537208|365539900|FG002|Overall Study|Adverse Event|0|||
105967171|NCT04537208|365539901|FG003|Overall Study|Adverse Event|0|||
105967172|NCT04537208|365539902|FG004|Overall Study|Adverse Event|0|||
105967173|NCT04537208|365539903|FG005|Overall Study|Adverse Event|0|||
105967174|NCT04537208|365539904|FG006|Overall Study|Adverse Event|0|||
105967175|NCT04537208|365539905|FG007|Overall Study|Adverse Event|0|||
105967176|NCT04537208|365539906|FG008|Overall Study|Adverse Event|1|||
105967177|NCT04537208|365539907|FG009|Overall Study|Adverse Event|0|||
106023778|NCT02834793|365751825|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
106023779|NCT02834793|365751822|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
106023780|NCT02834793|365751823|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
105967178|NCT04537208|365539908|FG010|Overall Study|Adverse Event|0|||
105967179|NCT04537208|365539898|FG000|Overall Study|Protocol deviation|0|||
105967180|NCT04537208|365539899|FG001|Overall Study|Protocol deviation|0|||
106023781|NCT02834793|365751824|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
105967181|NCT04537208|365539900|FG002|Overall Study|Protocol deviation|2|||
105967182|NCT04537208|365539901|FG003|Overall Study|Protocol deviation|0|||
106023782|NCT02834793|365751825|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
106023783|NCT02834793|365751822|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
105967183|NCT04537208|365539902|FG004|Overall Study|Protocol deviation|0|||
105967184|NCT04537208|365539903|FG005|Overall Study|Protocol deviation|2|||
105967185|NCT04537208|365539904|FG006|Overall Study|Protocol deviation|4|||
105967186|NCT04537208|365539905|FG007|Overall Study|Protocol deviation|0|||
105840303|NCT00483548|365071556|FG001|Overall Study|Lack of Efficacy|8|||
105967187|NCT04537208|365539906|FG008|Overall Study|Protocol deviation|1|||
105967188|NCT04537208|365539907|FG009|Overall Study|Protocol deviation|0|||
105967189|NCT04537208|365539908|FG010|Overall Study|Protocol deviation|2|||
105967190|NCT04537208|365539898|FG000|Overall Study|Withdrawal by Subject|4|||
105967191|NCT04537208|365539899|FG001|Overall Study|Withdrawal by Subject|2|||
105967192|NCT04537208|365539900|FG002|Overall Study|Withdrawal by Subject|1|||
105967193|NCT04537208|365539901|FG003|Overall Study|Withdrawal by Subject|3|||
105967194|NCT04537208|365539902|FG004|Overall Study|Withdrawal by Subject|5|||
105967195|NCT04537208|365539903|FG005|Overall Study|Withdrawal by Subject|1|||
105967196|NCT04537208|365539904|FG006|Overall Study|Withdrawal by Subject|6|||
105967197|NCT04537208|365539905|FG007|Overall Study|Withdrawal by Subject|1|||
105967198|NCT04537208|365539906|FG008|Overall Study|Withdrawal by Subject|7|||
105967199|NCT04537208|365539907|FG009|Overall Study|Withdrawal by Subject|2|||
106023784|NCT02834793|365751823|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
106023785|NCT02834793|365751824|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
106023786|NCT02834793|365751825|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
106023787|NCT02834793|365751822|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
106023788|NCT02834793|365751823|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
106023789|NCT02834793|365751824|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
106023790|NCT02834793|365751825|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
106023791|NCT02834793|365751822|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
106023792|NCT02834793|365751823|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
106023793|NCT02834793|365751824|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
106023794|NCT02834793|365751825|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
106023795|NCT02834793|365751822|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
106023796|NCT02834793|365751823|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
106023797|NCT02834793|365751824|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
106023798|NCT02834793|365751825|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
106023799|NCT02834793|365751822|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
106023800|NCT02834793|365751823|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
106023801|NCT02834793|365751824|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
106023802|NCT02834793|365751825|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
106023803|NCT00905645|365751826|FG000|Overall Study|Death (not device related)|10|||
106023804|NCT00905645|365751827|FG001|Overall Study|Death (not device related)|4|||
106023805|NCT00905645|365751828|FG002|Overall Study|Death (not device related)|15|||
106023806|NCT00905645|365751829|FG003|Overall Study|Death (not device related)|8|||
106023807|NCT00905645|365751826|FG000|Overall Study|Explantation of study device(s)|78|||
106023808|NCT00905645|365751827|FG001|Overall Study|Explantation of study device(s)|47|||
106023809|NCT00905645|365751828|FG002|Overall Study|Explantation of study device(s)|28|||
106023810|NCT00905645|365751829|FG003|Overall Study|Explantation of study device(s)|21|||
106023811|NCT00905645|365751826|FG000|Overall Study|Subject Request|41|||
106023812|NCT00905645|365751827|FG001|Overall Study|Subject Request|17|||
106023813|NCT00905645|365751828|FG002|Overall Study|Subject Request|13|||
106023814|NCT00905645|365751829|FG003|Overall Study|Subject Request|11|||
106023815|NCT00905645|365751826|FG000|Overall Study|Lost to Follow-up|299|||
106023816|NCT00905645|365751827|FG001|Overall Study|Lost to Follow-up|103|||
106023817|NCT00905645|365751828|FG002|Overall Study|Lost to Follow-up|51|||
106023818|NCT00905645|365751829|FG003|Overall Study|Lost to Follow-up|12|||
106023819|NCT04931888|365751830|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
106023820|NCT04931888|365751831|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
106023821|NCT04931888|365751832|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
106023822|NCT04931888|365751833|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
106023823|NCT02779556|365751834|FG000|Baseline|Partial baseline interview completed|1|||
106023824|NCT02779556|365751835|FG001|Baseline|Partial baseline interview completed|0|||
106023825|NCT02779556|365751834|FG000|3 Months|Lost to Follow-up|40|||
106023826|NCT02779556|365751835|FG001|3 Months|Lost to Follow-up|29|||
106023827|NCT02779556|365751834|FG000|3 Months|Missed 3 month clinic visit|27|||
106149356|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
106149357|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
106149358|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
106149359|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
106023828|NCT02779556|365751835|FG001|3 Months|Missed 3 month clinic visit|19|||
106149360|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105840304|NCT00483548|365071555|FG000|Overall Study|Protocol Violation|11|||
106023829|NCT02779556|365751834|FG000|6 Month|Lost to Follow-up|33|||
106023830|NCT02779556|365751835|FG001|6 Month|Lost to Follow-up|39|||
106023831|NCT02779556|365751834|FG000|6 Month HbA1c|No value collected during window|69|||
106023832|NCT02779556|365751835|FG001|6 Month HbA1c|No value collected during window|50|||
105840305|NCT00483548|365071556|FG001|Overall Study|Protocol Violation|7|||
105840306|NCT00483548|365071555|FG000|Overall Study|Pregnancy|1|||
105840307|NCT00483548|365071556|FG001|Overall Study|Pregnancy|0|||
105840308|NCT00483548|365071555|FG000|Overall Study|Protocol required discontinuation|6|||
105840309|NCT00483548|365071556|FG001|Overall Study|Protocol required discontinuation|6|||
105840310|NCT00483548|365071555|FG000|Overall Study|Unable to comply with protocol schedule|1|||
105840311|NCT00483548|365071556|FG001|Overall Study|Unable to comply with protocol schedule|0|||
105840312|NCT00483548|365071555|FG000|Overall Study|Non-compliance with medication|2|||
105840313|NCT00483548|365071556|FG001|Overall Study|Non-compliance with medication|0|||
105840314|NCT00483548|365071555|FG000|Overall Study|Lost to Follow-up|3|||
105840315|NCT00483548|365071556|FG001|Overall Study|Lost to Follow-up|4|||
105840316|NCT00483548|365071555|FG000|Overall Study|Withdrawal by Subject|5|||
105840317|NCT00483548|365071556|FG001|Overall Study|Withdrawal by Subject|2|||
105840318|NCT00892281|365071561|FG000|Overall Study|Adverse Event|65|||
105840319|NCT00892281|365071562|FG001|Overall Study|Adverse Event|8|||
105840320|NCT00892281|365071561|FG000|Overall Study|Lost to Follow-up|81|||
105840321|NCT00892281|365071562|FG001|Overall Study|Lost to Follow-up|8|||
105840322|NCT00892281|365071561|FG000|Overall Study|Pregnancy|1|||
105840323|NCT00892281|365071562|FG001|Overall Study|Pregnancy|0|||
105840324|NCT00892281|365071561|FG000|Overall Study|Protocol Violation|7|||
105840325|NCT00892281|365071562|FG001|Overall Study|Protocol Violation|2|||
105840326|NCT00892281|365071561|FG000|Overall Study|Withdrawal by Subject|86|||
105840327|NCT00892281|365071562|FG001|Overall Study|Withdrawal by Subject|14|||
105840328|NCT00892281|365071561|FG000|Overall Study|Subject failed to return for final visit|2|||
105840329|NCT00892281|365071562|FG001|Overall Study|Subject failed to return for final visit|0|||
105840330|NCT00892281|365071561|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
105840331|NCT00892281|365071562|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
105840332|NCT00892281|365071561|FG000|Overall Study|Final visit completed 4 weeks late|0|||
105840333|NCT00892281|365071562|FG001|Overall Study|Final visit completed 4 weeks late|1|||
105840334|NCT00892281|365071561|FG000|Overall Study|Subject completed day after study closed|1|||
105840335|NCT00892281|365071562|FG001|Overall Study|Subject completed day after study closed|0|||
105840336|NCT00892281|365071561|FG000|Overall Study|Family emergency|1|||
105840337|NCT00892281|365071562|FG001|Overall Study|Family emergency|0|||
105840338|NCT00892281|365071561|FG000|Overall Study|Last visit not done - death in family|1|||
105840339|NCT00892281|365071562|FG001|Overall Study|Last visit not done - death in family|0|||
105840340|NCT00892281|365071561|FG000|Overall Study|Did not meet incl/excl criteria|1|||
105840341|NCT00892281|365071562|FG001|Overall Study|Did not meet incl/excl criteria|0|||
105840342|NCT00892281|365071561|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
105840343|NCT00892281|365071562|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
105840344|NCT00892281|365071561|FG000|Overall Study|Unable to redeem the drug voucher|1|||
105840345|NCT00892281|365071562|FG001|Overall Study|Unable to redeem the drug voucher|0|||
105840346|NCT00892281|365071561|FG000|Overall Study|Subject not good candidate for study|1|||
105840347|NCT00892281|365071562|FG001|Overall Study|Subject not good candidate for study|0|||
105840348|NCT00892281|365071561|FG000|Overall Study|Subject did not return for any visits|1|||
105840349|NCT00892281|365071562|FG001|Overall Study|Subject did not return for any visits|0|||
105840350|NCT00892281|365071561|FG000|Overall Study|Subject missed several visits/lost meds|1|||
105840351|NCT00892281|365071562|FG001|Overall Study|Subject missed several visits/lost meds|0|||
105840352|NCT00892281|365071561|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
105840353|NCT00892281|365071562|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
105840354|NCT00892281|365071561|FG000|Overall Study|Scheduled for knee replacement|0|||
105840355|NCT00892281|365071562|FG001|Overall Study|Scheduled for knee replacement|1|||
105840356|NCT00892281|365071561|FG000|Overall Study|PI complained of inadequate compensation|3|||
105840357|NCT00892281|365071562|FG001|Overall Study|PI complained of inadequate compensation|0|||
105840358|NCT00892281|365071561|FG000|Overall Study|Subject lost interest in program|0|||
105840359|NCT00892281|365071562|FG001|Overall Study|Subject lost interest in program|1|||
105840360|NCT00892281|365071561|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
105840361|NCT00892281|365071562|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
105840362|NCT00892281|365071561|FG000|Overall Study|Death in family|1|||
105840363|NCT00892281|365071562|FG001|Overall Study|Death in family|0|||
105840364|NCT00892281|365071561|FG000|Overall Study|Lack of efficacy of study product|2|||
105840365|NCT00892281|365071562|FG001|Overall Study|Lack of efficacy of study product|0|||
105840366|NCT00892281|365071561|FG000|Overall Study|Subject not seen by PI at final visit|1|||
105840367|NCT00892281|365071562|FG001|Overall Study|Subject not seen by PI at final visit|0|||
105967200|NCT04537208|365539908|FG010|Overall Study|Withdrawal by Subject|4|||
105967201|NCT04537208|365539898|FG000|Overall Study|Lost to Follow-up|4|||
105840368|NCT00892281|365071561|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
105840369|NCT00892281|365071562|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
105840370|NCT00892281|365071561|FG000|Overall Study|Missed multiple visits|1|||
105840371|NCT00892281|365071562|FG001|Overall Study|Missed multiple visits|0|||
105840372|NCT00892281|365071561|FG000|Overall Study|Missed visits rescheduled out of window|1|||
105967202|NCT04537208|365539899|FG001|Overall Study|Lost to Follow-up|1|||
105967203|NCT04537208|365539900|FG002|Overall Study|Lost to Follow-up|3|||
105840373|NCT00892281|365071562|FG001|Overall Study|Missed visits rescheduled out of window|0|||
105840374|NCT00892281|365071561|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
105840375|NCT00892281|365071562|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
105840376|NCT00892281|365071561|FG000|Overall Study|Subject had history of drug abuse|1|||
105840377|NCT00892281|365071562|FG001|Overall Study|Subject had history of drug abuse|0|||
105840378|NCT00892281|365071561|FG000|Overall Study|Rash on hand|1|||
105840379|NCT00892281|365071562|FG001|Overall Study|Rash on hand|0|||
105840380|NCT00892281|365071561|FG000|Overall Study|Visit 4 date out of window|1|||
105840381|NCT00892281|365071562|FG001|Overall Study|Visit 4 date out of window|0|||
105840382|NCT02694549|365071563|FG000|Overall Study|screen failures|2|||
105840383|NCT01534078|365071566|FG000|Overall Study|Death|1|||
105840384|NCT01534078|365071566|FG000|Overall Study|Withdrawal by Subject|1|||
105840385|NCT00089076|365071577|FG000|Overall Study|Alternate Therapy|1|||
105840386|NCT00089076|365071577|FG000|Overall Study|Withdrawal by Subject|2|||
105840387|NCT00089076|365071577|FG000|Overall Study|Progression|7|||
105840388|NCT01501110|365071580|FG000|Overall Study|Death|0|||
105840389|NCT01501110|365071581|FG001|Overall Study|Death|1|||
105840390|NCT02462486|365071582|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
105840391|NCT02462486|365071583|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
105840392|NCT02462486|365071584|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
105840393|NCT02462486|365071582|FG000|Overall Study|Adverse Event|53|||
105840394|NCT02462486|365071583|FG001|Overall Study|Adverse Event|48|||
105840395|NCT02462486|365071584|FG002|Overall Study|Adverse Event|21|||
105840396|NCT02462486|365071582|FG000|Overall Study|Lack of Efficacy|6|||
105840397|NCT02462486|365071583|FG001|Overall Study|Lack of Efficacy|12|||
105840398|NCT02462486|365071584|FG002|Overall Study|Lack of Efficacy|3|||
105840399|NCT02462486|365071582|FG000|Overall Study|Lost to Follow-up|3|||
105840400|NCT02462486|365071583|FG001|Overall Study|Lost to Follow-up|4|||
105840401|NCT02462486|365071584|FG002|Overall Study|Lost to Follow-up|2|||
105840402|NCT02462486|365071582|FG000|Overall Study|Withdrawal by Subject|25|||
105840403|NCT02462486|365071583|FG001|Overall Study|Withdrawal by Subject|22|||
105840404|NCT02462486|365071584|FG002|Overall Study|Withdrawal by Subject|19|||
105840405|NCT02462486|365071582|FG000|Overall Study|Protocol Violation|3|||
105840406|NCT02462486|365071583|FG001|Overall Study|Protocol Violation|1|||
105840407|NCT02462486|365071584|FG002|Overall Study|Protocol Violation|1|||
105840408|NCT02462486|365071582|FG000|Overall Study|Reason not Specified|3|||
105840409|NCT02462486|365071583|FG001|Overall Study|Reason not Specified|4|||
105840410|NCT02462486|365071584|FG002|Overall Study|Reason not Specified|3|||
105840411|NCT01483625|365071585|FG000|Overall Study|Adverse Event|1|||
105840412|NCT01483625|365071586|FG001|Overall Study|Adverse Event|1|||
105840413|NCT01483625|365071585|FG000|Overall Study|Refused to continue medication|2|||
105840414|NCT01483625|365071586|FG001|Overall Study|Refused to continue medication|1|||
105840415|NCT01483625|365071585|FG000|Overall Study|Due to other reason|1|||
105840416|NCT01483625|365071586|FG001|Overall Study|Due to other reason|0|||
105840417|NCT02280187|365071587|FG000|Overall Study|Lost to Follow-up|218|||
105840418|NCT02094261|365071588|FG000|Overall Study|Death|24|||
105840419|NCT02094261|365071588|FG000|Overall Study|Lost to Follow-up|1|||
105840420|NCT02094261|365071588|FG000|Overall Study|Withdrawal by Subject|4|||
105840421|NCT02094261|365071588|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
105840422|NCT00251316|365071591|FG000|Overall Study|Physician Decision|2|||
105840423|NCT00251316|365071592|FG001|Overall Study|Physician Decision|3|||
105840424|NCT02039063|365071594|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
105840425|NCT02039063|365071595|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
105840426|NCT02039063|365071596|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
105840427|NCT02039063|365071597|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
105840428|NCT02039063|365071594|FG000|Treatment Phase|Progression of disease|0|||
105840429|NCT02039063|365071595|FG001|Treatment Phase|Progression of disease|0|||
105840430|NCT02039063|365071596|FG002|Treatment Phase|Progression of disease|1|||
105840431|NCT02039063|365071597|FG003|Treatment Phase|Progression of disease|1|||
106023833|NCT02779556|365751834|FG000|12 Month HbA1c|No value collected during window|138|||
106023834|NCT02779556|365751835|FG001|12 Month HbA1c|No value collected during window|102|||
106023835|NCT00622440|365751836|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
106023836|NCT00622440|365751837|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
106023837|NCT00622440|365751836|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
105840432|NCT02039063|365071594|FG000|Extension Phase|Inadequate therapeutic effect|0|||
105840433|NCT02039063|365071595|FG001|Extension Phase|Inadequate therapeutic effect|1|||
105840434|NCT02039063|365071596|FG002|Extension Phase|Inadequate therapeutic effect|2|||
105840435|NCT02039063|365071597|FG003|Extension Phase|Inadequate therapeutic effect|0|||
105840436|NCT02039063|365071594|FG000|Extension Phase|Progression of disease|0|||
105840437|NCT02039063|365071595|FG001|Extension Phase|Progression of disease|0|||
105840438|NCT02039063|365071596|FG002|Extension Phase|Progression of disease|0|||
105840439|NCT02039063|365071597|FG003|Extension Phase|Progression of disease|1|||
105840440|NCT02039063|365071594|FG000|Extension Phase|Adverse Event|0|||
105840441|NCT02039063|365071595|FG001|Extension Phase|Adverse Event|0|||
105840442|NCT02039063|365071596|FG002|Extension Phase|Adverse Event|1|||
105967204|NCT04537208|365539901|FG003|Overall Study|Lost to Follow-up|4|||
105967205|NCT04537208|365539902|FG004|Overall Study|Lost to Follow-up|3|||
105967206|NCT04537208|365539903|FG005|Overall Study|Lost to Follow-up|2|||
105967207|NCT04537208|365539904|FG006|Overall Study|Lost to Follow-up|3|||
105967208|NCT04537208|365539905|FG007|Overall Study|Lost to Follow-up|2|||
105967209|NCT04537208|365539906|FG008|Overall Study|Lost to Follow-up|7|||
105967210|NCT04537208|365539907|FG009|Overall Study|Lost to Follow-up|2|||
105967211|NCT04537208|365539908|FG010|Overall Study|Lost to Follow-up|2|||
105840443|NCT02039063|365071597|FG003|Extension Phase|Adverse Event|0|||
105840444|NCT00467831|365071598|FG000|Overall Study|Death|2|||
105840445|NCT00467831|365071598|FG000|Overall Study|Withdrawal by Subject|1|||
105840446|NCT00612677|365071599|FG000|Overall Study|study closed before treatment started|1|||
105840447|NCT03139240|365071600|FG000|Overall Study|Lost to Follow-up|0|||
105840448|NCT03139240|365071601|FG001|Overall Study|Lost to Follow-up|1|||
105840449|NCT03139240|365071602|FG002|Overall Study|Lost to Follow-up|1|||
105840450|NCT03139240|365071603|FG003|Overall Study|Lost to Follow-up|0|||
105840451|NCT03417830|365071605|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
105840452|NCT03417830|365071606|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
105840453|NCT00823199|365071607|FG000|Overall Study|Withdrawal by Subject|2|||
105840454|NCT01825837|365071608|FG000|PART I|Withdrawal by Subject|0|||
105840455|NCT01825837|365071609|FG001|PART I|Withdrawal by Subject|0|||
105840456|NCT01825837|365071610|FG002|PART I|Withdrawal by Subject|0|||
105840457|NCT01825837|365071611|FG003|PART I|Withdrawal by Subject|6|||
105840458|NCT01825837|365071608|FG000|PART I|Patient non-compliance|0|||
105840459|NCT01825837|365071609|FG001|PART I|Patient non-compliance|0|||
105840460|NCT01825837|365071610|FG002|PART I|Patient non-compliance|0|||
105840461|NCT01825837|365071611|FG003|PART I|Patient non-compliance|1|||
105840462|NCT01825837|365071608|FG000|PART I|Treatment failure|0|||
105840463|NCT01825837|365071609|FG001|PART I|Treatment failure|0|||
105840464|NCT01825837|365071610|FG002|PART I|Treatment failure|0|||
105840465|NCT01825837|365071611|FG003|PART I|Treatment failure|7|||
105840466|NCT01825837|365071608|FG000|PART I|reason unspecified|0|||
105840467|NCT01825837|365071609|FG001|PART I|reason unspecified|0|||
105840468|NCT01825837|365071610|FG002|PART I|reason unspecified|0|||
105840469|NCT01825837|365071611|FG003|PART I|reason unspecified|3|||
105840470|NCT01825837|365071608|FG000|PART II|Withdrawal by Subject|3|||
105840471|NCT01825837|365071609|FG001|PART II|Withdrawal by Subject|3|||
105840472|NCT01825837|365071610|FG002|PART II|Withdrawal by Subject|7|||
105840473|NCT01825837|365071611|FG003|PART II|Withdrawal by Subject|0|||
105840474|NCT01825837|365071608|FG000|PART II|Patient non-compliance|5|||
105840475|NCT01825837|365071609|FG001|PART II|Patient non-compliance|2|||
105840476|NCT01825837|365071610|FG002|PART II|Patient non-compliance|4|||
105840477|NCT01825837|365071611|FG003|PART II|Patient non-compliance|0|||
105840478|NCT01825837|365071608|FG000|PART II|Adverse Event|3|||
105840479|NCT01825837|365071609|FG001|PART II|Adverse Event|3|||
105840480|NCT01825837|365071610|FG002|PART II|Adverse Event|1|||
105840481|NCT01825837|365071611|FG003|PART II|Adverse Event|0|||
105840482|NCT01825837|365071608|FG000|PART II|Treatment failure|6|||
105840483|NCT01825837|365071609|FG001|PART II|Treatment failure|4|||
105840484|NCT01825837|365071610|FG002|PART II|Treatment failure|5|||
105840485|NCT01825837|365071611|FG003|PART II|Treatment failure|0|||
105840486|NCT01825837|365071608|FG000|PART II|reason unspecified|2|||
105840487|NCT01825837|365071609|FG001|PART II|reason unspecified|2|||
105840488|NCT01825837|365071610|FG002|PART II|reason unspecified|2|||
105840489|NCT01825837|365071611|FG003|PART II|reason unspecified|0|||
105840490|NCT00645944|365071614|FG000|Randomized|Withdrawal by Subject|1|||
105840491|NCT00645944|365071615|FG001|Randomized|Withdrawal by Subject|2|||
105840492|NCT00645944|365071614|FG000|Received Medication|Adverse Event|2|||
105840493|NCT00645944|365071615|FG001|Received Medication|Adverse Event|1|||
105840494|NCT00645944|365071614|FG000|Received Medication|Withdrawal by Subject|1|||
105840495|NCT00645944|365071615|FG001|Received Medication|Withdrawal by Subject|1|||
105967212|NCT02256384|365539915|FG000|Overall Study|Withdrawal by Subject|12|||
105840496|NCT00645944|365071614|FG000|Received Medication|Lost to Follow-up|1|||
105840497|NCT00645944|365071615|FG001|Received Medication|Lost to Follow-up|0|||
105840498|NCT00645944|365071614|FG000|Received Medication|Protocol Violation|2|||
105840499|NCT00645944|365071615|FG001|Received Medication|Protocol Violation|1|||
105840500|NCT04117945|365071618|FG000|Overall Study|Death|1|||
105840501|NCT04117945|365071619|FG001|Overall Study|Death|0|||
105840502|NCT04117945|365071618|FG000|Overall Study|Withdrawal by Subject|3|||
105840503|NCT04117945|365071619|FG001|Overall Study|Withdrawal by Subject|1|||
105840504|NCT04117945|365071618|FG000|Overall Study|Disease Progression|0|||
105967213|NCT02256384|365539915|FG000|Overall Study|Equipment not capturing data|2|||
105967214|NCT03888235|365539916|FG000|Overall Study|Lost to Follow-up|1|||
105840505|NCT04117945|365071619|FG001|Overall Study|Disease Progression|2|||
105840506|NCT04117945|365071618|FG000|Overall Study|Ineligible|8|||
105840507|NCT04117945|365071619|FG001|Overall Study|Ineligible|7|||
105840508|NCT02093923|365071620|FG000|Overall Study|Lost to Follow-up|0|||
105840509|NCT02093923|365071621|FG001|Overall Study|Lost to Follow-up|0|||
105840510|NCT02093923|365071622|FG002|Overall Study|Lost to Follow-up|0|||
105840511|NCT02093923|365071623|FG003|Overall Study|Lost to Follow-up|1|||
105840512|NCT02093923|365071624|FG004|Overall Study|Lost to Follow-up|0|||
105840513|NCT02093923|365071620|FG000|Overall Study|Screen failure after randomization|0|||
105840514|NCT02093923|365071621|FG001|Overall Study|Screen failure after randomization|0|||
105840515|NCT02093923|365071622|FG002|Overall Study|Screen failure after randomization|0|||
105840516|NCT02093923|365071623|FG003|Overall Study|Screen failure after randomization|1|||
105840517|NCT02093923|365071624|FG004|Overall Study|Screen failure after randomization|0|||
105840518|NCT01662362|365071625|FG000|Overall Study|Lost to Follow-up|38|||
105840519|NCT01181531|365071626|FG000|Overall Study|Other|17|||
105840520|NCT01181531|365071627|FG001|Overall Study|Other|12|||
105840521|NCT01181531|365071626|FG000|Overall Study|Partial consent by subject withdrawn|0|||
105840522|NCT01181531|365071627|FG001|Overall Study|Partial consent by subject withdrawn|1|||
105840523|NCT01181531|365071626|FG000|Overall Study|Physician Decision|3|||
105840524|NCT01181531|365071627|FG001|Overall Study|Physician Decision|1|||
105840525|NCT01181531|365071626|FG000|Overall Study|Noncompliance|2|||
105840526|NCT01181531|365071627|FG001|Overall Study|Noncompliance|2|||
105840527|NCT01181531|365071626|FG000|Overall Study|Ineligibility determined|1|||
105840528|NCT01181531|365071627|FG001|Overall Study|Ineligibility determined|2|||
105840529|NCT01181531|365071626|FG000|Overall Study|Protocol Specified Criteria|15|||
105840530|NCT01181531|365071627|FG001|Overall Study|Protocol Specified Criteria|8|||
105840531|NCT01181531|365071626|FG000|Overall Study|Pregnancy|0|||
105840532|NCT01181531|365071627|FG001|Overall Study|Pregnancy|1|||
105840533|NCT01181531|365071626|FG000|Overall Study|Withdrawal by Subject|8|||
105840534|NCT01181531|365071627|FG001|Overall Study|Withdrawal by Subject|7|||
105840535|NCT01181531|365071626|FG000|Overall Study|Protocol Violation|6|||
105840536|NCT01181531|365071627|FG001|Overall Study|Protocol Violation|6|||
105840537|NCT01181531|365071626|FG000|Overall Study|Death|9|||
105840538|NCT01181531|365071627|FG001|Overall Study|Death|12|||
105840539|NCT01181531|365071626|FG000|Overall Study|Adverse Event|0|||
105840540|NCT01181531|365071627|FG001|Overall Study|Adverse Event|1|||
105840541|NCT02756637|365071630|FG000|Overall Study|Not eligible for initial SWOG study|10|||
105840542|NCT02756637|365071631|FG001|Overall Study|Not eligible for initial SWOG study|10|||
105840543|NCT02756637|365071630|FG000|Overall Study|No available NLR value|44|||
105840544|NCT02756637|365071631|FG001|Overall Study|No available NLR value|44|||
105840545|NCT02756637|365071630|FG000|Overall Study|Did not complete curative therapy|33|||
105840546|NCT02756637|365071631|FG001|Overall Study|Did not complete curative therapy|0|||
105840547|NCT01220609|365073683|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
105840548|NCT01220609|365073683|FG000|Overall Study|Ineligible- Wrong cell type|1|||
105840549|NCT01220609|365073683|FG000|Overall Study|Ineligible-Never treated|1|||
105840550|NCT02225665|365073686|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
105840551|NCT02225665|365073687|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
105840552|NCT02225665|365073686|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
105840553|NCT02225665|365073687|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
105840554|NCT02973321|365073688|FG000|Overall Study|Other than specified|0|||
105840555|NCT02973321|365073689|FG001|Overall Study|Other than specified|5|||
105840556|NCT02973321|365073690|FG002|Overall Study|Other than specified|3|||
105840557|NCT02973321|365073691|FG003|Overall Study|Other than specified|3|||
105840558|NCT02973321|365073692|FG004|Overall Study|Other than specified|1|||
105840559|NCT02973321|365073688|FG000|Overall Study|Lack of Efficacy|0|||
105840560|NCT02973321|365073689|FG001|Overall Study|Lack of Efficacy|0|||
105840561|NCT02973321|365073690|FG002|Overall Study|Lack of Efficacy|0|||
105840562|NCT02973321|365073691|FG003|Overall Study|Lack of Efficacy|0|||
105840563|NCT02973321|365073692|FG004|Overall Study|Lack of Efficacy|1|||
105840564|NCT02973321|365073688|FG000|Overall Study|Adverse Event|1|||
105840565|NCT02973321|365073689|FG001|Overall Study|Adverse Event|10|||
105840566|NCT02973321|365073690|FG002|Overall Study|Adverse Event|11|||
105840567|NCT02973321|365073691|FG003|Overall Study|Adverse Event|13|||
105840568|NCT02973321|365073692|FG004|Overall Study|Adverse Event|3|||
105840569|NCT01714739|365073694|FG000|Overall Study|Disease progression|3|||
105840570|NCT01714739|365073695|FG001|Overall Study|Disease progression|5|||
105840571|NCT01714739|365073696|FG002|Overall Study|Disease progression|5|||
105840572|NCT01714739|365073697|FG003|Overall Study|Disease progression|204|||
105840573|NCT01714739|365073698|FG004|Overall Study|Disease progression|1|||
105840574|NCT01714739|365073699|FG005|Overall Study|Disease progression|3|||
105840575|NCT01714739|365073700|FG006|Overall Study|Disease progression|5|||
105840576|NCT01714739|365073694|FG000|Overall Study|Study drug toxicity|1|||
105967215|NCT03888235|365539917|FG001|Overall Study|Lost to Follow-up|1|||
105967216|NCT03888235|365539918|FG002|Overall Study|Lost to Follow-up|0|||
105967217|NCT01054560|365539922|FG000|Overall Study|Death|10|||
105967218|NCT01054560|365539923|FG001|Overall Study|Death|21|||
105840577|NCT01714739|365073695|FG001|Overall Study|Study drug toxicity|1|||
105840578|NCT01714739|365073696|FG002|Overall Study|Study drug toxicity|1|||
105840579|NCT01714739|365073697|FG003|Overall Study|Study drug toxicity|15|||
105967219|NCT01054560|365539922|FG000|Overall Study|Lost to Follow-up|2|||
105967220|NCT01054560|365539923|FG001|Overall Study|Lost to Follow-up|5|||
105840580|NCT01714739|365073698|FG004|Overall Study|Study drug toxicity|0|||
105840581|NCT01714739|365073699|FG005|Overall Study|Study drug toxicity|0|||
105840582|NCT01714739|365073700|FG006|Overall Study|Study drug toxicity|5|||
105840583|NCT01714739|365073694|FG000|Overall Study|Death|0|||
105840584|NCT01714739|365073695|FG001|Overall Study|Death|0|||
105840585|NCT01714739|365073696|FG002|Overall Study|Death|0|||
105967221|NCT01054560|365539922|FG000|Overall Study|Withdrawal by Subject|0|||
105967222|NCT01054560|365539923|FG001|Overall Study|Withdrawal by Subject|2|||
105967223|NCT01054560|365539922|FG000|Overall Study|Physician Decision|1|||
105967224|NCT01054560|365539923|FG001|Overall Study|Physician Decision|0|||
105967225|NCT04154605|365539929|FG000|Overall Study|Procedure Canceled|1|||
105967226|NCT04154605|365539930|FG001|Overall Study|Procedure Canceled|1|||
105840586|NCT01714739|365073697|FG003|Overall Study|Death|1|||
105840587|NCT01714739|365073698|FG004|Overall Study|Death|0|||
105840588|NCT01714739|365073699|FG005|Overall Study|Death|0|||
105840589|NCT01714739|365073700|FG006|Overall Study|Death|0|||
105840590|NCT01714739|365073694|FG000|Overall Study|Adverse Event unrelated to drug|0|||
105840591|NCT01714739|365073695|FG001|Overall Study|Adverse Event unrelated to drug|0|||
105840592|NCT01714739|365073696|FG002|Overall Study|Adverse Event unrelated to drug|3|||
105840593|NCT01714739|365073697|FG003|Overall Study|Adverse Event unrelated to drug|21|||
105840594|NCT01714739|365073698|FG004|Overall Study|Adverse Event unrelated to drug|0|||
105840595|NCT01714739|365073699|FG005|Overall Study|Adverse Event unrelated to drug|0|||
105840596|NCT01714739|365073700|FG006|Overall Study|Adverse Event unrelated to drug|0|||
105840597|NCT01714739|365073694|FG000|Overall Study|Participant request to stop therapy|0|||
105840598|NCT01714739|365073695|FG001|Overall Study|Participant request to stop therapy|1|||
105840599|NCT01714739|365073696|FG002|Overall Study|Participant request to stop therapy|0|||
105840600|NCT01714739|365073697|FG003|Overall Study|Participant request to stop therapy|6|||
105840601|NCT01714739|365073698|FG004|Overall Study|Participant request to stop therapy|0|||
105840602|NCT01714739|365073699|FG005|Overall Study|Participant request to stop therapy|0|||
105840603|NCT01714739|365073700|FG006|Overall Study|Participant request to stop therapy|0|||
105840604|NCT01714739|365073694|FG000|Overall Study|Participant withdrew consent|0|||
105840605|NCT01714739|365073695|FG001|Overall Study|Participant withdrew consent|1|||
105840606|NCT01714739|365073696|FG002|Overall Study|Participant withdrew consent|0|||
105840607|NCT01714739|365073697|FG003|Overall Study|Participant withdrew consent|8|||
105840608|NCT01714739|365073698|FG004|Overall Study|Participant withdrew consent|0|||
105840609|NCT01714739|365073699|FG005|Overall Study|Participant withdrew consent|0|||
105840610|NCT01714739|365073700|FG006|Overall Study|Participant withdrew consent|0|||
105840611|NCT01714739|365073694|FG000|Overall Study|Lost to Follow-up|0|||
105840612|NCT01714739|365073695|FG001|Overall Study|Lost to Follow-up|0|||
105840613|NCT01714739|365073696|FG002|Overall Study|Lost to Follow-up|0|||
105840614|NCT01714739|365073697|FG003|Overall Study|Lost to Follow-up|1|||
105840615|NCT01714739|365073698|FG004|Overall Study|Lost to Follow-up|0|||
105840616|NCT01714739|365073699|FG005|Overall Study|Lost to Follow-up|0|||
105840617|NCT01714739|365073700|FG006|Overall Study|Lost to Follow-up|0|||
105840618|NCT01714739|365073694|FG000|Overall Study|Maximum clinical benefit|0|||
105840619|NCT01714739|365073695|FG001|Overall Study|Maximum clinical benefit|1|||
105840620|NCT01714739|365073696|FG002|Overall Study|Maximum clinical benefit|1|||
105840621|NCT01714739|365073697|FG003|Overall Study|Maximum clinical benefit|3|||
105840622|NCT01714739|365073698|FG004|Overall Study|Maximum clinical benefit|0|||
105840623|NCT01714739|365073699|FG005|Overall Study|Maximum clinical benefit|0|||
105840624|NCT01714739|365073700|FG006|Overall Study|Maximum clinical benefit|0|||
105840625|NCT01714739|365073694|FG000|Overall Study|Poor/non-comliance|0|||
105840626|NCT01714739|365073695|FG001|Overall Study|Poor/non-comliance|1|||
105840627|NCT01714739|365073696|FG002|Overall Study|Poor/non-comliance|0|||
105840628|NCT01714739|365073697|FG003|Overall Study|Poor/non-comliance|1|||
105840629|NCT01714739|365073698|FG004|Overall Study|Poor/non-comliance|0|||
105840630|NCT01714739|365073699|FG005|Overall Study|Poor/non-comliance|0|||
105840631|NCT01714739|365073700|FG006|Overall Study|Poor/non-comliance|0|||
105840632|NCT01714739|365073694|FG000|Overall Study|No longer meets study criteria|0|||
105840633|NCT01714739|365073695|FG001|Overall Study|No longer meets study criteria|0|||
105840634|NCT01714739|365073696|FG002|Overall Study|No longer meets study criteria|0|||
105840635|NCT01714739|365073697|FG003|Overall Study|No longer meets study criteria|1|||
105840636|NCT01714739|365073698|FG004|Overall Study|No longer meets study criteria|0|||
105840637|NCT01714739|365073699|FG005|Overall Study|No longer meets study criteria|0|||
106149361|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105840638|NCT01714739|365073700|FG006|Overall Study|No longer meets study criteria|0|||
105840639|NCT01714739|365073694|FG000|Overall Study|Other reason|0|||
105840640|NCT01714739|365073695|FG001|Overall Study|Other reason|0|||
105840641|NCT01714739|365073696|FG002|Overall Study|Other reason|0|||
105840642|NCT01714739|365073697|FG003|Overall Study|Other reason|3|||
105840643|NCT01714739|365073698|FG004|Overall Study|Other reason|1|||
105840644|NCT01714739|365073699|FG005|Overall Study|Other reason|0|||
105840645|NCT01714739|365073700|FG006|Overall Study|Other reason|0|||
105840646|NCT01175473|365073702|FG000|Overall Study|Adverse Event|2|||
105840647|NCT01175473|365073703|FG001|Overall Study|Adverse Event|2|||
105840648|NCT02674386|365073704|FG000|Overall Study|Lost to Follow-up|0|||
105840649|NCT02674386|365073705|FG001|Overall Study|Lost to Follow-up|1|||
105840650|NCT02674386|365073706|FG002|Overall Study|Lost to Follow-up|1|||
105840651|NCT02674386|365073704|FG000|Overall Study|Withdrawal by Subject|0|||
106149362|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
105840652|NCT02674386|365073705|FG001|Overall Study|Withdrawal by Subject|4|||
105840653|NCT02674386|365073706|FG002|Overall Study|Withdrawal by Subject|0|||
106023838|NCT00622440|365751837|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
106023839|NCT00622440|365751836|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
106023840|NCT00622440|365751837|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
106023841|NCT00622440|365751836|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
106023842|NCT00622440|365751837|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
106023843|NCT03110770|365751841|FG000|Overall Study|Death|1|||
106023844|NCT03110770|365751842|FG001|Overall Study|Death|0|||
106023845|NCT03110770|365751843|FG002|Overall Study|Death|0|||
106023846|NCT03110770|365751844|FG003|Overall Study|Death|1|||
106023847|NCT03110770|365751845|FG004|Overall Study|Death|0|||
106023848|NCT03110770|365751841|FG000|Overall Study|Enrolled but did not receive product|0|||
106023849|NCT03110770|365751842|FG001|Overall Study|Enrolled but did not receive product|0|||
106149363|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
106149364|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105840654|NCT02674386|365073704|FG000|Overall Study|Other|0|||
105840655|NCT02674386|365073705|FG001|Overall Study|Other|1|||
105840656|NCT02674386|365073706|FG002|Overall Study|Other|0|||
105840657|NCT02674386|365073704|FG000|Overall Study|Enrolled but not evaluated|0|||
105840658|NCT02674386|365073705|FG001|Overall Study|Enrolled but not evaluated|4|||
105840659|NCT02674386|365073706|FG002|Overall Study|Enrolled but not evaluated|0|||
105840660|NCT01439724|365073707|FG000|Overall Study|missing consultation|9|||
105840661|NCT01439724|365073708|FG001|Overall Study|missing consultation|8|||
105840662|NCT02310763|365073716|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
105840663|NCT02310763|365073717|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
105840664|NCT02310763|365073718|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
105840665|NCT02310763|365073716|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
105840666|NCT02310763|365073717|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
105840667|NCT02310763|365073718|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
105840668|NCT02310763|365073716|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
105840669|NCT02310763|365073717|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
105840670|NCT02310763|365073718|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
105840671|NCT02310763|365073716|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
105840672|NCT02310763|365073717|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
105840673|NCT02310763|365073718|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
105840674|NCT02310763|365073716|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
105840675|NCT02310763|365073717|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
105840676|NCT02310763|365073718|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
105840677|NCT01040793|365073721|FG000|Overall Study|Adverse Event|5|||
105840678|NCT01040793|365073722|FG001|Overall Study|Adverse Event|3|||
105840679|NCT01040793|365073723|FG002|Overall Study|Adverse Event|0|||
105840680|NCT01040793|365073724|FG003|Overall Study|Adverse Event|2|||
105840681|NCT01040793|365073725|FG004|Overall Study|Adverse Event|2|||
105840682|NCT01040793|365073726|FG005|Overall Study|Adverse Event|1|||
105840683|NCT01040793|365073721|FG000|Overall Study|Protocol Violation|1|||
105840684|NCT01040793|365073722|FG001|Overall Study|Protocol Violation|1|||
105840685|NCT01040793|365073723|FG002|Overall Study|Protocol Violation|1|||
105840686|NCT01040793|365073724|FG003|Overall Study|Protocol Violation|0|||
105840687|NCT01040793|365073725|FG004|Overall Study|Protocol Violation|1|||
105840688|NCT01040793|365073726|FG005|Overall Study|Protocol Violation|0|||
105840689|NCT01040793|365073721|FG000|Overall Study|Lost to Follow-up|0|||
105840690|NCT01040793|365073722|FG001|Overall Study|Lost to Follow-up|1|||
105840691|NCT01040793|365073723|FG002|Overall Study|Lost to Follow-up|1|||
106023850|NCT03110770|365751843|FG002|Overall Study|Enrolled but did not receive product|0|||
106023851|NCT03110770|365751844|FG003|Overall Study|Enrolled but did not receive product|8|||
106149365|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105840692|NCT01040793|365073724|FG003|Overall Study|Lost to Follow-up|0|||
105840693|NCT01040793|365073725|FG004|Overall Study|Lost to Follow-up|0|||
105840694|NCT01040793|365073726|FG005|Overall Study|Lost to Follow-up|0|||
105840695|NCT01040793|365073721|FG000|Overall Study|Withdrawal by Subject|0|||
105840696|NCT01040793|365073722|FG001|Overall Study|Withdrawal by Subject|0|||
105840697|NCT01040793|365073723|FG002|Overall Study|Withdrawal by Subject|0|||
105840698|NCT01040793|365073724|FG003|Overall Study|Withdrawal by Subject|2|||
105840699|NCT01040793|365073725|FG004|Overall Study|Withdrawal by Subject|0|||
105840700|NCT01040793|365073726|FG005|Overall Study|Withdrawal by Subject|0|||
105840701|NCT01040793|365073721|FG000|Overall Study|Other reasons not listed above|0|||
105840702|NCT01040793|365073722|FG001|Overall Study|Other reasons not listed above|0|||
105840703|NCT01040793|365073723|FG002|Overall Study|Other reasons not listed above|1|||
105840704|NCT01040793|365073724|FG003|Overall Study|Other reasons not listed above|0|||
105840705|NCT01040793|365073725|FG004|Overall Study|Other reasons not listed above|1|||
105840706|NCT01040793|365073726|FG005|Overall Study|Other reasons not listed above|0|||
105840707|NCT01998243|365073731|FG000|Overall Study|Pregnancy|0|||
105840708|NCT01998243|365073732|FG001|Overall Study|Pregnancy|1|||
105840709|NCT01998243|365073731|FG000|Overall Study|Protocol Violation|5|||
105840710|NCT01998243|365073732|FG001|Overall Study|Protocol Violation|2|||
105840711|NCT01998243|365073731|FG000|Overall Study|Withdrawal by Subject|3|||
105840712|NCT01998243|365073732|FG001|Overall Study|Withdrawal by Subject|4|||
105840713|NCT01056640|365073734|FG000|Overall Study|Withdrawal by Subject|11|||
105840714|NCT01056640|365073735|FG001|Overall Study|Withdrawal by Subject|8|||
105840715|NCT01056640|365073734|FG000|Overall Study|Death|15|||
105840716|NCT01056640|365073735|FG001|Overall Study|Death|4|||
105840717|NCT00268892|365073736|FG000|Overall Study|Adverse Event|14|||
105840718|NCT00268892|365073737|FG001|Overall Study|Adverse Event|17|||
105840719|NCT00268892|365073738|FG002|Overall Study|Adverse Event|20|||
105840720|NCT00268892|365073736|FG000|Overall Study|Lack of Efficacy|1|||
105840721|NCT00268892|365073737|FG001|Overall Study|Lack of Efficacy|3|||
105840722|NCT00268892|365073738|FG002|Overall Study|Lack of Efficacy|0|||
105840723|NCT00268892|365073736|FG000|Overall Study|Withdrawal by Subject|14|||
105840724|NCT00268892|365073737|FG001|Overall Study|Withdrawal by Subject|15|||
105840725|NCT00268892|365073738|FG002|Overall Study|Withdrawal by Subject|13|||
105840726|NCT00268892|365073736|FG000|Overall Study|Physician Decision|0|||
105840727|NCT00268892|365073737|FG001|Overall Study|Physician Decision|1|||
105840728|NCT00268892|365073738|FG002|Overall Study|Physician Decision|0|||
105840729|NCT00268892|365073736|FG000|Overall Study|Lost to Follow-up|5|||
105840730|NCT00268892|365073737|FG001|Overall Study|Lost to Follow-up|2|||
105840731|NCT00268892|365073738|FG002|Overall Study|Lost to Follow-up|4|||
105840732|NCT00268892|365073736|FG000|Overall Study|Protocol Violation|0|||
105840733|NCT00268892|365073737|FG001|Overall Study|Protocol Violation|1|||
105840734|NCT00268892|365073738|FG002|Overall Study|Protocol Violation|0|||
105840735|NCT00268892|365073736|FG000|Overall Study|Disease Progression|1|||
105840736|NCT00268892|365073737|FG001|Overall Study|Disease Progression|1|||
105840737|NCT00268892|365073738|FG002|Overall Study|Disease Progression|0|||
105840738|NCT00268892|365073736|FG000|Overall Study|Trial Site Closed|4|||
105840739|NCT00268892|365073737|FG001|Overall Study|Trial Site Closed|2|||
105840740|NCT00268892|365073738|FG002|Overall Study|Trial Site Closed|2|||
105840741|NCT04569786|365073745|FG000|Overall Study|Lost to Follow-up|1|||
105840742|NCT04569786|365073746|FG001|Overall Study|Lost to Follow-up|0|||
105840743|NCT04569786|365073747|FG002|Overall Study|Lost to Follow-up|4|||
105840744|NCT04569786|365073748|FG003|Overall Study|Lost to Follow-up|1|||
105840745|NCT04569786|365073749|FG004|Overall Study|Lost to Follow-up|0|||
105840746|NCT04569786|365073745|FG000|Overall Study|Withdrawal by Subject|0|||
105840747|NCT04569786|365073746|FG001|Overall Study|Withdrawal by Subject|0|||
105840748|NCT04569786|365073747|FG002|Overall Study|Withdrawal by Subject|0|||
105840749|NCT04569786|365073748|FG003|Overall Study|Withdrawal by Subject|5|||
105840750|NCT04569786|365073749|FG004|Overall Study|Withdrawal by Subject|1|||
105840751|NCT04569786|365073745|FG000|Overall Study|Physician Decision|0|||
105840752|NCT04569786|365073746|FG001|Overall Study|Physician Decision|0|||
105840753|NCT04569786|365073747|FG002|Overall Study|Physician Decision|0|||
105840754|NCT04569786|365073748|FG003|Overall Study|Physician Decision|1|||
105840755|NCT04569786|365073749|FG004|Overall Study|Physician Decision|0|||
105840756|NCT01640184|365073750|FG000|Overall Study|Death|1|||
105840757|NCT01640184|365073751|FG001|Overall Study|Death|0|||
105840758|NCT01640184|365073752|FG002|Overall Study|Death|0|||
105840759|NCT01640184|365073750|FG000|Overall Study|Lost to Follow-up|4|||
105840760|NCT01640184|365073751|FG001|Overall Study|Lost to Follow-up|1|||
105840761|NCT01640184|365073752|FG002|Overall Study|Lost to Follow-up|0|||
105840762|NCT01640184|365073750|FG000|Overall Study|Physician Decision|3|||
105840763|NCT01640184|365073751|FG001|Overall Study|Physician Decision|0|||
105840764|NCT01640184|365073752|FG002|Overall Study|Physician Decision|0|||
105840765|NCT01640184|365073750|FG000|Overall Study|Withdrawal by Subject|0|||
105840766|NCT01640184|365073751|FG001|Overall Study|Withdrawal by Subject|1|||
105840767|NCT01640184|365073752|FG002|Overall Study|Withdrawal by Subject|1|||
105840768|NCT01640184|365073750|FG000|Overall Study|Protocol Violation|0|||
105840769|NCT01640184|365073751|FG001|Overall Study|Protocol Violation|0|||
105840770|NCT01640184|365073752|FG002|Overall Study|Protocol Violation|1|||
105840771|NCT01202877|365073753|FG000|Overall Study|Disease Progression|0|||
105840772|NCT01202877|365073754|FG001|Overall Study|Disease Progression|1|||
105840773|NCT01202877|365073755|FG002|Overall Study|Disease Progression|2|||
105840774|NCT01202877|365073753|FG000|Overall Study|Adverse Event|0|||
105840775|NCT01202877|365073754|FG001|Overall Study|Adverse Event|0|||
105840776|NCT01202877|365073755|FG002|Overall Study|Adverse Event|2|||
105840777|NCT01202877|365073753|FG000|Overall Study|Withdrawal by Subject|0|||
105840778|NCT01202877|365073754|FG001|Overall Study|Withdrawal by Subject|0|||
105840779|NCT01202877|365073755|FG002|Overall Study|Withdrawal by Subject|1|||
105840780|NCT01202877|365073753|FG000|Overall Study|Death|0|||
105840781|NCT01202877|365073754|FG001|Overall Study|Death|0|||
105840782|NCT01202877|365073755|FG002|Overall Study|Death|1|||
105840783|NCT01351350|365073756|FG000|Overall Study|Disease Progression|5|||
105840784|NCT01351350|365073757|FG001|Overall Study|Disease Progression|13|||
105840785|NCT01351350|365073758|FG002|Overall Study|Disease Progression|6|||
105840786|NCT01351350|365073759|FG003|Overall Study|Disease Progression|8|||
105840787|NCT01351350|365073760|FG004|Overall Study|Disease Progression|5|||
105840788|NCT01351350|365073756|FG000|Overall Study|Adverse Event|1|||
105840789|NCT01351350|365073757|FG001|Overall Study|Adverse Event|10|||
105840790|NCT01351350|365073758|FG002|Overall Study|Adverse Event|1|||
105840791|NCT01351350|365073759|FG003|Overall Study|Adverse Event|2|||
105840792|NCT01351350|365073760|FG004|Overall Study|Adverse Event|0|||
105840793|NCT01351350|365073756|FG000|Overall Study|Participant Decision|2|||
105840794|NCT01351350|365073757|FG001|Overall Study|Participant Decision|6|||
105840795|NCT01351350|365073758|FG002|Overall Study|Participant Decision|3|||
105840796|NCT01351350|365073759|FG003|Overall Study|Participant Decision|3|||
105840797|NCT01351350|365073760|FG004|Overall Study|Participant Decision|2|||
105840798|NCT01351350|365073756|FG000|Overall Study|Enrolled but not Treated|0|||
105840799|NCT01351350|365073757|FG001|Overall Study|Enrolled but not Treated|0|||
105840800|NCT01351350|365073758|FG002|Overall Study|Enrolled but not Treated|1|||
105840801|NCT01351350|365073759|FG003|Overall Study|Enrolled but not Treated|0|||
105840802|NCT01351350|365073760|FG004|Overall Study|Enrolled but not Treated|0|||
105840803|NCT01684878|365073768|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
105840804|NCT01684878|365073769|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
105840805|NCT01684878|365073770|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
105840806|NCT01684878|365073771|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
105840807|NCT01684878|365073768|FG000|Part 1: Safety Run in Phase|Death|15|||
105840808|NCT01684878|365073769|FG001|Part 1: Safety Run in Phase|Death|20|||
105840809|NCT01684878|365073770|FG002|Part 1: Safety Run in Phase|Death|0|||
105840810|NCT01684878|365073771|FG003|Part 1: Safety Run in Phase|Death|0|||
105840811|NCT01684878|365073768|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
105840812|NCT01684878|365073769|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
105840813|NCT01684878|365073770|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
105840814|NCT01684878|365073771|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
105840815|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
105840816|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
105840817|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
105840818|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
105840819|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
105840820|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
105840821|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
105840822|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
105840823|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Death|0|||
105840824|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Death|0|||
105967227|NCT04154605|365539929|FG000|Overall Study|Missed follow up|1|||
105967228|NCT04154605|365539930|FG001|Overall Study|Missed follow up|1|||
105967229|NCT04154605|365539929|FG000|Overall Study|Withdrawal by Subject|1|||
105967230|NCT04154605|365539930|FG001|Overall Study|Withdrawal by Subject|0|||
105967231|NCT01453205|365539937|FG000|Overall Study|Lost to Follow-up|3|||
105967232|NCT01453205|365539938|FG001|Overall Study|Lost to Follow-up|0|||
105967233|NCT01453205|365539939|FG002|Overall Study|Lost to Follow-up|1|||
105967234|NCT01453205|365539937|FG000|Overall Study|Withdrawal by Subject|8|||
105967235|NCT01453205|365539938|FG001|Overall Study|Withdrawal by Subject|3|||
105967236|NCT01453205|365539939|FG002|Overall Study|Withdrawal by Subject|0|||
105967237|NCT01453205|365539937|FG000|Overall Study|Death|24|||
105967238|NCT01453205|365539938|FG001|Overall Study|Death|22|||
105967239|NCT01453205|365539939|FG002|Overall Study|Death|18|||
105967240|NCT01453205|365539937|FG000|Overall Study|Other|45|||
105967241|NCT01453205|365539938|FG001|Overall Study|Other|27|||
105967242|NCT01453205|365539939|FG002|Overall Study|Other|35|||
105967243|NCT02602275|365539952|FG000|Day 1|Physician Decision|0|||
105967244|NCT02602275|365539953|FG001|Day 1|Physician Decision|1|||
105967245|NCT04262882|365539954|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
105840825|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Death|62|||
105840826|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Death|68|||
105840827|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
105967246|NCT04262882|365539955|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
105967247|NCT04262882|365539954|FG000|Overall Study|Lost to Follow-up|1|||
105840828|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
105840829|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
105967248|NCT04262882|365539955|FG001|Overall Study|Lost to Follow-up|0|||
105840830|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
105840831|NCT01684878|365073768|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
105840832|NCT01684878|365073769|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
105840833|NCT01684878|365073770|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
105840834|NCT01684878|365073771|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
105840835|NCT04647383|365073772|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
105840836|NCT04647383|365073773|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
105840837|NCT04647383|365073774|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
105840838|NCT04647383|365073775|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
105840839|NCT00775528|365073776|FG000|Overall Study|Protocol Violation|1|||
105840840|NCT02692482|365073777|FG000|Overall Study|Death|2|||
105840841|NCT02692482|365073778|FG001|Overall Study|Death|2|||
105840842|NCT02692482|365073777|FG000|Overall Study|Withdrawal by Subject|1|||
105840843|NCT02692482|365073778|FG001|Overall Study|Withdrawal by Subject|2|||
105840844|NCT02492841|365073779|FG000|Overall Study|Lost to Follow-up|34|||
105840845|NCT02492841|365073780|FG001|Overall Study|Lost to Follow-up|31|||
105840846|NCT02492841|365073781|FG002|Overall Study|Lost to Follow-up|35|||
105840847|NCT00479388|365073789|FG000|Overall Study|Adverse Event|90|||
105840848|NCT00479388|365073790|FG001|Overall Study|Adverse Event|45|||
105840849|NCT00479388|365073789|FG000|Overall Study|Lost to Follow-up|0|||
105840850|NCT00479388|365073790|FG001|Overall Study|Lost to Follow-up|2|||
105840851|NCT00479388|365073789|FG000|Overall Study|Protocol Violation|10|||
105840852|NCT00479388|365073790|FG001|Overall Study|Protocol Violation|9|||
105840853|NCT00479388|365073789|FG000|Overall Study|Withdrawal by Subject|32|||
105840854|NCT00479388|365073790|FG001|Overall Study|Withdrawal by Subject|17|||
105840855|NCT01876368|365073791|FG000|Overall Study|Adverse Event|2|||
105840856|NCT01876368|365073792|FG001|Overall Study|Adverse Event|5|||
105840857|NCT01876368|365073791|FG000|Overall Study|Lack of Efficacy|1|||
105840858|NCT01876368|365073792|FG001|Overall Study|Lack of Efficacy|0|||
105840859|NCT01876368|365073791|FG000|Overall Study|Lost to Follow-up|0|||
105840860|NCT01876368|365073792|FG001|Overall Study|Lost to Follow-up|1|||
105840861|NCT01876368|365073791|FG000|Overall Study|Non-compliance with study treatment|0|||
105840862|NCT01876368|365073792|FG001|Overall Study|Non-compliance with study treatment|1|||
105840863|NCT01876368|365073791|FG000|Overall Study|Physician Decision|0|||
105840864|NCT01876368|365073792|FG001|Overall Study|Physician Decision|2|||
105840865|NCT01876368|365073791|FG000|Overall Study|Protocol deviation|3|||
105840866|NCT01876368|365073792|FG001|Overall Study|Protocol deviation|3|||
105840867|NCT01876368|365073791|FG000|Overall Study|Subject/guardian decision|3|||
105840868|NCT01876368|365073792|FG001|Overall Study|Subject/guardian decision|1|||
105840869|NCT04099641|365073793|FG000|Overall Study|Death|46|||
105840870|NCT04099641|365073794|FG001|Overall Study|Death|12|||
105840871|NCT04099641|365073793|FG000|Overall Study|Lost to Follow-up|1|||
105840872|NCT04099641|365073794|FG001|Overall Study|Lost to Follow-up|0|||
105840873|NCT04099641|365073793|FG000|Overall Study|Withdrawal by Subject|2|||
105840874|NCT04099641|365073794|FG001|Overall Study|Withdrawal by Subject|0|||
105840875|NCT00895037|365073795|FG000|Overall Study|Death|0|||
105840876|NCT00895037|365073796|FG001|Overall Study|Death|2|||
105840877|NCT00895037|365073797|FG002|Overall Study|Death|1|||
105840878|NCT02096588|365073800|FG000|Overall Study|Lack of Efficacy|2|||
105840879|NCT02096588|365073801|FG001|Overall Study|Lack of Efficacy|0|||
105840880|NCT02096588|365073800|FG000|Overall Study|Withdrawal by Subject|0|||
105840881|NCT02096588|365073801|FG001|Overall Study|Withdrawal by Subject|1|||
105840882|NCT01192399|365073804|FG000|Overall Study|Lack of Efficacy|2|||
105840883|NCT01930175|365073805|FG000|Core Study|Lost to Follow-up|0|||
105840884|NCT01930175|365073806|FG001|Core Study|Lost to Follow-up|1|||
105840885|NCT01930175|365073807|FG002|Core Study|Lost to Follow-up|0|||
105840886|NCT01930175|365073805|FG000|Core Study|Adverse Event|0|||
105840887|NCT01930175|365073806|FG001|Core Study|Adverse Event|0|||
105840888|NCT01930175|365073807|FG002|Core Study|Adverse Event|1|||
105840889|NCT01867606|365073811|FG000|Overall Study|Withdrawal by Subject|10|||
105840890|NCT01867606|365073812|FG001|Overall Study|Withdrawal by Subject|14|||
105840891|NCT01867606|365073811|FG000|Overall Study|Protocol Violation|0|||
105840892|NCT01867606|365073812|FG001|Overall Study|Protocol Violation|1|||
105840893|NCT00440115|365073814|FG000|Overall Study|Death|7|||
105840894|NCT00440115|365073815|FG001|Overall Study|Death|9|||
105840895|NCT00440115|365073816|FG002|Overall Study|Death|5|||
105840896|NCT00440115|365073814|FG000|Overall Study|Incarceration|0|||
105840897|NCT00440115|365073815|FG001|Overall Study|Incarceration|2|||
105967249|NCT06107803|365539960|FG000|Overall Study|Adverse Event|1|||
105967250|NCT06107803|365539960|FG000|Overall Study|Withdrawal by Subject|2|||
105967251|NCT06107803|365539960|FG000|Overall Study|Protocol Violation|1|||
105840898|NCT00440115|365073816|FG002|Overall Study|Incarceration|1|||
105840899|NCT02244424|365073819|FG000|Overall Study|Lost to Follow-up|20|||
105840900|NCT02244424|365073820|FG001|Overall Study|Lost to Follow-up|10|||
105840901|NCT02148445|365073823|FG000|Overall Study|Death|1|||
105840902|NCT02148445|365073824|FG001|Overall Study|Death|3|||
105840903|NCT03438006|365073826|FG000|Overall Study|Adverse Event|1|||
105840904|NCT03438006|365073826|FG000|Overall Study|Lost to Follow-up|67|||
105840905|NCT03438006|365073826|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
105840906|NCT03438006|365073826|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
105840907|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
105840908|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840909|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105987413|NCT00666224|365614458|FG000|Double-Blind|Adverse Event|15|||
106023852|NCT03110770|365751845|FG004|Overall Study|Enrolled but did not receive product|7|||
106023853|NCT03110770|365751841|FG000|Overall Study|Lost to Follow-up|0|||
106023854|NCT03110770|365751842|FG001|Overall Study|Lost to Follow-up|0|||
106023855|NCT03110770|365751843|FG002|Overall Study|Lost to Follow-up|0|||
106023856|NCT03110770|365751844|FG003|Overall Study|Lost to Follow-up|53|||
106023857|NCT03110770|365751845|FG004|Overall Study|Lost to Follow-up|45|||
106023858|NCT03110770|365751841|FG000|Overall Study|Investigator Decision|0|||
106023859|NCT03110770|365751842|FG001|Overall Study|Investigator Decision|0|||
106023860|NCT03110770|365751843|FG002|Overall Study|Investigator Decision|0|||
106023861|NCT03110770|365751844|FG003|Overall Study|Investigator Decision|5|||
106023862|NCT03110770|365751845|FG004|Overall Study|Investigator Decision|3|||
106023863|NCT03110770|365751841|FG000|Overall Study|Withdrawal by Subject|0|||
106023864|NCT03110770|365751842|FG001|Overall Study|Withdrawal by Subject|0|||
106023865|NCT03110770|365751843|FG002|Overall Study|Withdrawal by Subject|0|||
106023866|NCT03110770|365751844|FG003|Overall Study|Withdrawal by Subject|24|||
106023867|NCT03110770|365751845|FG004|Overall Study|Withdrawal by Subject|24|||
105967252|NCT03099174|365539962|FG000|Overall Study|Withdrawal by Subject|0|||
105967253|NCT03099174|365539963|FG001|Overall Study|Withdrawal by Subject|0|||
105967254|NCT03099174|365539964|FG002|Overall Study|Withdrawal by Subject|1|||
105967255|NCT03099174|365539965|FG003|Overall Study|Withdrawal by Subject|0|||
105967256|NCT03099174|365539966|FG004|Overall Study|Withdrawal by Subject|2|||
105967257|NCT03099174|365539967|FG005|Overall Study|Withdrawal by Subject|2|||
105967258|NCT03099174|365539968|FG006|Overall Study|Withdrawal by Subject|1|||
105967259|NCT03099174|365539969|FG007|Overall Study|Withdrawal by Subject|4|||
105967260|NCT03099174|365539962|FG000|Overall Study|Adverse Event|0|||
105967261|NCT03099174|365539963|FG001|Overall Study|Adverse Event|1|||
105967262|NCT03099174|365539964|FG002|Overall Study|Adverse Event|1|||
105967263|NCT03099174|365539965|FG003|Overall Study|Adverse Event|2|||
105967264|NCT03099174|365539966|FG004|Overall Study|Adverse Event|5|||
105967265|NCT03099174|365539967|FG005|Overall Study|Adverse Event|3|||
105967266|NCT03099174|365539968|FG006|Overall Study|Adverse Event|6|||
106023868|NCT03110770|365751841|FG000|Overall Study|Moved from area|5|||
106023869|NCT03110770|365751842|FG001|Overall Study|Moved from area|0|||
106023870|NCT03110770|365751843|FG002|Overall Study|Moved from area|2|||
106023871|NCT03110770|365751844|FG003|Overall Study|Moved from area|42|||
106023872|NCT03110770|365751845|FG004|Overall Study|Moved from area|43|||
106023873|NCT03110770|365751841|FG000|Overall Study|Illness/Injury unrelated to product|0|||
106023874|NCT03110770|365751842|FG001|Overall Study|Illness/Injury unrelated to product|0|||
106023875|NCT03110770|365751843|FG002|Overall Study|Illness/Injury unrelated to product|0|||
106023876|NCT03110770|365751844|FG003|Overall Study|Illness/Injury unrelated to product|0|||
106023877|NCT03110770|365751845|FG004|Overall Study|Illness/Injury unrelated to product|1|||
106023878|NCT02471612|365751846|FG000|Overall Study|Lost to Follow-up|2|||
106023879|NCT03615040|365751849|FG000|Overall Study|Withdrawal by Subject|2|||
106023880|NCT03615040|365751850|FG001|Overall Study|Withdrawal by Subject|1|||
105967267|NCT03099174|365539969|FG007|Overall Study|Adverse Event|4|||
105967268|NCT03099174|365539962|FG000|Overall Study|Other than listed|6|||
105967269|NCT03099174|365539963|FG001|Overall Study|Other than listed|6|||
105967270|NCT03099174|365539964|FG002|Overall Study|Other than listed|5|||
105967271|NCT03099174|365539965|FG003|Overall Study|Other than listed|6|||
105967272|NCT03099174|365539966|FG004|Overall Study|Other than listed|19|||
106023881|NCT03615040|365751849|FG000|Overall Study|Physician Decision|2|||
105967273|NCT03099174|365539967|FG005|Overall Study|Other than listed|10|||
105967274|NCT03099174|365539968|FG006|Overall Study|Other than listed|26|||
105967275|NCT03099174|365539969|FG007|Overall Study|Other than listed|23|||
105967276|NCT02378298|365539970|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
105967277|NCT02378298|365539971|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
106023882|NCT03615040|365751850|FG001|Overall Study|Physician Decision|2|||
105967278|NCT02378298|365539972|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
106023883|NCT03615040|365751849|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
105967279|NCT02378298|365539970|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
105967280|NCT02378298|365539971|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
105967281|NCT02378298|365539972|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
105967282|NCT02378298|365539970|FG000|Surveillance (19-68 Weeks)|Death|1|||
105967283|NCT02378298|365539971|FG001|Surveillance (19-68 Weeks)|Death|0|||
105967284|NCT02378298|365539972|FG002|Surveillance (19-68 Weeks)|Death|0|||
105967285|NCT04934800|365539973|FG000|Overall Study|Other|1|||
105967286|NCT04934800|365539973|FG000|Overall Study|Withdrawal by Subject|5|||
105967287|NCT04934800|365539973|FG000|Overall Study|Lack of Efficacy|1|||
105967288|NCT04934800|365539973|FG000|Overall Study|Adverse Event|9|||
106023884|NCT03615040|365751850|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
106023885|NCT03615040|365751849|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
106023886|NCT03615040|365751850|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
106023887|NCT03615040|365751849|FG000|Overall Study|Death|0|||
106023888|NCT03615040|365751850|FG001|Overall Study|Death|2|||
106023889|NCT01776307|365751851|FG000|Overall Study|Not dosed|0|||
106023890|NCT01776307|365751852|FG001|Overall Study|Not dosed|0|||
106023891|NCT01776307|365751853|FG002|Overall Study|Not dosed|1|||
106023892|NCT03462511|365751856|FG000|Overall Study|Withdrawal by Subject|2|||
106023893|NCT03462511|365751857|FG001|Overall Study|Withdrawal by Subject|3|||
106023894|NCT01015638|365751863|FG000|Overall Study|Withdrawal by Subject|1|||
106023895|NCT01015638|365751864|FG001|Overall Study|Withdrawal by Subject|0|||
106023896|NCT04450381|365751867|FG000|Overall Study|Protocol Violation|4|||
106023897|NCT04450381|365751867|FG000|Overall Study|Wrong device setting|2|||
106023898|NCT00324961|365751868|FG000|Overall Study|Adverse Event|5|||
106023899|NCT00324961|365751868|FG000|Overall Study|Consent Withdrawn|11|||
106023900|NCT00324961|365751868|FG000|Overall Study|Lost to Follow-up|22|||
106023901|NCT00324961|365751868|FG000|Overall Study|Protocol Violation|3|||
106023902|NCT00324961|365751868|FG000|Overall Study|Other|2|||
106023903|NCT00566696|365751870|FG000|Overall Study|Met Exclusion Criteria|2|||
106023904|NCT00566696|365751870|FG000|Overall Study|Muromonab not available|1|||
106149366|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
106149367|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
106149368|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
106149369|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
106149370|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
106149371|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
106149372|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
105840910|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840911|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
106023905|NCT00566696|365751870|FG000|Overall Study|Health Status Change|1|||
106023906|NCT00566696|365751870|FG000|Overall Study|Physician Decision|1|||
106023907|NCT00566696|365751870|FG000|Overall Study|Non-Patient Donors|37|||
106023908|NCT01276054|365751875|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
106023909|NCT01276054|365751876|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
106023910|NCT00635999|365751877|FG000|Overall Study|Withdrawal by Subject|4|||
106023911|NCT00635999|365751878|FG001|Overall Study|Withdrawal by Subject|2|||
106023912|NCT00635999|365751879|FG002|Overall Study|Withdrawal by Subject|1|||
106023913|NCT01456897|365751880|FG000|Overall Study|Adverse Event|19|||
106023914|NCT01456897|365751881|FG001|Overall Study|Adverse Event|22|||
106023915|NCT01456897|365751880|FG000|Overall Study|Protocol Violation|3|||
106023916|NCT01456897|365751881|FG001|Overall Study|Protocol Violation|4|||
106023917|NCT01456897|365751880|FG000|Overall Study|Physician Decision|5|||
106023918|NCT01456897|365751881|FG001|Overall Study|Physician Decision|3|||
106023919|NCT01456897|365751880|FG000|Overall Study|Withdrawal by Subject|44|||
106023920|NCT01456897|365751881|FG001|Overall Study|Withdrawal by Subject|17|||
106023921|NCT01456897|365751880|FG000|Overall Study|Lack of Efficacy|4|||
106023922|NCT01456897|365751881|FG001|Overall Study|Lack of Efficacy|11|||
106023923|NCT04254913|365751887|FG000|Overall Study|Adverse Event|1|||
106023924|NCT01396057|365751888|FG000|Overall Study|Adverse Event|2|||
106023925|NCT01396057|365751889|FG001|Overall Study|Adverse Event|6|||
106023926|NCT01396057|365751888|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106023927|NCT01396057|365751889|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
106023928|NCT01396057|365751888|FG000|Overall Study|Protocol deviation|4|||
106023929|NCT01396057|365751889|FG001|Overall Study|Protocol deviation|4|||
106023930|NCT01396057|365751888|FG000|Overall Study|Consent withdrawn|3|||
106023931|NCT01396057|365751889|FG001|Overall Study|Consent withdrawn|2|||
106023932|NCT02695420|365751890|FG000|Overall Study|Death|0|||
106023933|NCT02695420|365751891|FG001|Overall Study|Death|1|||
106023934|NCT02695420|365751892|FG002|Overall Study|Death|0|||
106023935|NCT02695420|365751893|FG003|Overall Study|Death|0|||
106149373|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
106149374|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105840912|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840913|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840914|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840915|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
105840916|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
105840917|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
106023936|NCT02762370|365751894|FG000|Overall Study|Protocol Violation|1|||
106023937|NCT02762370|365751895|FG001|Overall Study|Protocol Violation|0|||
106023938|NCT01536392|365751898|FG000|Overall Study|Adverse Event|2|||
106023939|NCT01536392|365751899|FG001|Overall Study|Adverse Event|2|||
106023940|NCT01536392|365751898|FG000|Overall Study|Physician Decision|2|||
106023941|NCT01536392|365751899|FG001|Overall Study|Physician Decision|3|||
106023942|NCT01536392|365751898|FG000|Overall Study|Withdrawal by Subject|3|||
106023943|NCT01536392|365751899|FG001|Overall Study|Withdrawal by Subject|6|||
106023944|NCT01536392|365751898|FG000|Overall Study|Non Compliance|3|||
106023945|NCT01536392|365751899|FG001|Overall Study|Non Compliance|4|||
105967289|NCT04934800|365539973|FG000|Overall Study|Lost to Follow-up|5|||
105967290|NCT04934800|365539973|FG000|Overall Study|Enrolled but not treated|1|||
105967291|NCT05463744|365539978|FG000|Treatment Period|Withdrawal by Subject|19|||
105967292|NCT05463744|365539979|FG001|Treatment Period|Withdrawal by Subject|16|||
105967293|NCT05463744|365539978|FG000|Treatment Period|Adverse Event|4|||
105967294|NCT05463744|365539979|FG001|Treatment Period|Adverse Event|4|||
105967295|NCT05463744|365539978|FG000|Treatment Period|Pregnancy|0|||
105967296|NCT05463744|365539979|FG001|Treatment Period|Pregnancy|3|||
105967297|NCT05463744|365539978|FG000|Treatment Period|Lost to Follow-up|1|||
105967298|NCT05463744|365539979|FG001|Treatment Period|Lost to Follow-up|3|||
105967299|NCT05463744|365539978|FG000|Treatment Period|Inadvertent enrollment|2|||
105967300|NCT05463744|365539979|FG001|Treatment Period|Inadvertent enrollment|1|||
105967301|NCT05463744|365539978|FG000|Treatment Period|Death|0|||
105967302|NCT05463744|365539979|FG001|Treatment Period|Death|1|||
105967303|NCT05463744|365539978|FG000|Treatment Period|Non-compliance with Study Drug|1|||
105967304|NCT05463744|365539979|FG001|Treatment Period|Non-compliance with Study Drug|0|||
105967305|NCT05463744|365539978|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
105967306|NCT05463744|365539979|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
105967307|NCT05463744|365539978|FG000|Treatment Period|Physician Decision|0|||
105967308|NCT05463744|365539979|FG001|Treatment Period|Physician Decision|1|||
105967309|NCT05463744|365539978|FG000|Follow-Up Period|Withdrawal by Subject|3|||
105967310|NCT05463744|365539979|FG001|Follow-Up Period|Withdrawal by Subject|1|||
105967311|NCT05463744|365539978|FG000|Follow-Up Period|Lost to Follow-up|1|||
105967312|NCT05463744|365539979|FG001|Follow-Up Period|Lost to Follow-up|1|||
105967313|NCT03551665|365539982|FG000|Overall Study|Lost to Follow-up|11|||
105967314|NCT03551665|365539983|FG001|Overall Study|Lost to Follow-up|2|||
105967315|NCT02640625|365541810|FG000|Overall Study|Adverse Event|1|||
105967316|NCT01559259|365541819|FG000|Overall Study|Withdrawal by Subject|0|||
105967317|NCT01559259|365541820|FG001|Overall Study|Withdrawal by Subject|0|||
105967318|NCT01559259|365541821|FG002|Overall Study|Withdrawal by Subject|0|||
105967319|NCT01559259|365541822|FG003|Overall Study|Withdrawal by Subject|1|||
105967320|NCT01559259|365541823|FG004|Overall Study|Withdrawal by Subject|0|||
105967321|NCT01559259|365541819|FG000|Overall Study|Adverse Event|0|||
105967322|NCT01559259|365541820|FG001|Overall Study|Adverse Event|1|||
106023946|NCT01536392|365751898|FG000|Overall Study|Completed therapy early|3|||
106023947|NCT01536392|365751899|FG001|Overall Study|Completed therapy early|0|||
105840918|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840919|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840920|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840921|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840922|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840923|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840924|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
105840925|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
105840926|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840927|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840928|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840929|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840930|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840931|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840932|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840933|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
105840934|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
105840935|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840936|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840937|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840938|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840939|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105967323|NCT01559259|365541821|FG002|Overall Study|Adverse Event|1|||
106023948|NCT02954172|365751900|FG000|Overall Study|Protocol Violation|3|||
106023949|NCT02954172|365751901|FG001|Overall Study|Protocol Violation|0|||
105840940|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840941|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105967324|NCT01559259|365541822|FG003|Overall Study|Adverse Event|0|||
105967325|NCT01559259|365541823|FG004|Overall Study|Adverse Event|0|||
105967326|NCT01995669|365541824|FG000|Overall Study|Progression|2|||
105967327|NCT01995669|365541825|FG001|Overall Study|Progression|1|||
105967328|NCT01995669|365541826|FG002|Overall Study|Progression|1|||
105967329|NCT01995669|365541827|FG003|Overall Study|Progression|13|||
105967330|NCT01995669|365541824|FG000|Overall Study|Adverse Event|0|||
105967331|NCT01995669|365541825|FG001|Overall Study|Adverse Event|0|||
106023950|NCT02954172|365751900|FG000|Overall Study|allergic reaction|2|||
106023951|NCT02954172|365751901|FG001|Overall Study|allergic reaction|1|||
106023952|NCT02954172|365751900|FG000|Overall Study|non-measurable lesions at baseline|1|||
106023953|NCT02954172|365751901|FG001|Overall Study|non-measurable lesions at baseline|2|||
105840942|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
105840943|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
105840944|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840945|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840946|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840947|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840948|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840949|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840950|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840951|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
105840952|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
105840953|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840954|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840955|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840956|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840957|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840958|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840959|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840960|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
105840961|NCT00739973|365073837|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
105840962|NCT00739973|365073838|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840963|NCT00739973|365073839|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840964|NCT00739973|365073840|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840965|NCT00739973|365073841|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840966|NCT00739973|365073842|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840967|NCT00739973|365073843|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840968|NCT00739973|365073844|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840969|NCT00739973|365073845|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
105840970|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
105840971|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
105840972|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
105840973|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
105840974|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
105840975|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
105840976|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
105840977|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
105840978|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
105840979|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840980|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840981|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840982|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840983|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
105840984|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840985|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840986|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
105840987|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
105840988|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
105840989|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
105840990|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
106023954|NCT02745080|365751902|FG000|Overall Study|Adverse Event|13|||
106023955|NCT02745080|365751903|FG001|Overall Study|Adverse Event|21|||
106023956|NCT02745080|365751902|FG000|Overall Study|Lack of Efficacy|11|||
105840991|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840992|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840993|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840994|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840995|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
106023957|NCT02745080|365751903|FG001|Overall Study|Lack of Efficacy|23|||
106023958|NCT02745080|365751902|FG000|Overall Study|Lost to Follow-up|3|||
106023959|NCT02745080|365751903|FG001|Overall Study|Lost to Follow-up|3|||
105840996|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
105840997|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
105840998|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
105840999|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
105841000|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
105841001|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
105841002|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
105841003|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
105841004|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
105841005|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
105841006|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841007|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841008|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
105841009|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841010|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841011|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841012|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841013|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841014|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
105841015|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841016|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
105841017|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841018|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
105841019|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841020|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841021|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
105841022|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
105841023|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
105841024|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
105841025|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
105841026|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
105841027|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
105841028|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
105841029|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
105841030|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
105967332|NCT01995669|365541826|FG002|Overall Study|Adverse Event|0|||
105967333|NCT01995669|365541827|FG003|Overall Study|Adverse Event|3|||
105967334|NCT01995669|365541824|FG000|Overall Study|Death|0|||
105967335|NCT01995669|365541825|FG001|Overall Study|Death|0|||
105967336|NCT01995669|365541826|FG002|Overall Study|Death|0|||
105967337|NCT01995669|365541827|FG003|Overall Study|Death|6|||
105967338|NCT01995669|365541824|FG000|Overall Study|Withdrawal by Subject|0|||
105967339|NCT01995669|365541825|FG001|Overall Study|Withdrawal by Subject|0|||
105967340|NCT01995669|365541826|FG002|Overall Study|Withdrawal by Subject|0|||
105967341|NCT01995669|365541827|FG003|Overall Study|Withdrawal by Subject|6|||
105967342|NCT01995669|365541824|FG000|Overall Study|Insurance Expired|0|||
105967343|NCT01995669|365541825|FG001|Overall Study|Insurance Expired|0|||
105967344|NCT01995669|365541826|FG002|Overall Study|Insurance Expired|0|||
105967345|NCT01995669|365541827|FG003|Overall Study|Insurance Expired|1|||
105967346|NCT00066703|365541828|FG000|Overall Study|Adverse Event|80|||
105967347|NCT00066703|365541829|FG001|Overall Study|Adverse Event|111|||
105967348|NCT00066703|365541828|FG000|Overall Study|Death|3|||
105967349|NCT00066703|365541829|FG001|Overall Study|Death|0|||
105967350|NCT00066703|365541828|FG000|Overall Study|Lack of Efficacy|114|||
105967351|NCT00066703|365541829|FG001|Overall Study|Lack of Efficacy|69|||
105967352|NCT00066703|365541828|FG000|Overall Study|Lost to Follow-up|31|||
105967353|NCT00066703|365541829|FG001|Overall Study|Lost to Follow-up|28|||
105967354|NCT00066703|365541828|FG000|Overall Study|Withdrawal by Subject|38|||
105967355|NCT00066703|365541829|FG001|Overall Study|Withdrawal by Subject|63|||
105967356|NCT00066703|365541828|FG000|Overall Study|Treatment ongoing|346|||
105967357|NCT00066703|365541829|FG001|Overall Study|Treatment ongoing|311|||
105967358|NCT05425732|365541830|FG000|Overall Study|Death|4|||
105967359|NCT05425732|365541831|FG001|Overall Study|Death|2|||
106023960|NCT02745080|365751902|FG000|Overall Study|Physician Decision|3|||
105967360|NCT05425732|365541832|FG002|Overall Study|Death|0|||
105967361|NCT05425732|365541833|FG003|Overall Study|Death|0|||
105967362|NCT05425732|365541830|FG000|Overall Study|Lost to Follow-up|10|||
105967363|NCT05425732|365541831|FG001|Overall Study|Lost to Follow-up|15|||
105967364|NCT05425732|365541832|FG002|Overall Study|Lost to Follow-up|5|||
105967365|NCT05425732|365541833|FG003|Overall Study|Lost to Follow-up|3|||
105967366|NCT05425732|365541830|FG000|Overall Study|Physician Decision|0|||
105967367|NCT05425732|365541831|FG001|Overall Study|Physician Decision|2|||
105967368|NCT05425732|365541832|FG002|Overall Study|Physician Decision|0|||
105967369|NCT05425732|365541833|FG003|Overall Study|Physician Decision|0|||
105967370|NCT05425732|365541830|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105967371|NCT05425732|365541831|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
105967372|NCT05425732|365541832|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105967373|NCT05425732|365541833|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105967374|NCT05425732|365541830|FG000|Overall Study|Withdrawal by Subject|4|||
105967375|NCT05425732|365541831|FG001|Overall Study|Withdrawal by Subject|8|||
105967376|NCT05425732|365541832|FG002|Overall Study|Withdrawal by Subject|1|||
105967377|NCT05425732|365541833|FG003|Overall Study|Withdrawal by Subject|1|||
105967378|NCT05425732|365541830|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
105967379|NCT05425732|365541831|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
105967380|NCT05425732|365541832|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
105967381|NCT05425732|365541833|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
105967382|NCT03727646|365541834|FG000|Overall Study|Adverse Event|1|||
105967383|NCT03727646|365541835|FG001|Overall Study|Adverse Event|0|||
105967384|NCT04753658|365541836|FG000|Overall Study|Progressive disease|7|||
105967385|NCT04753658|365541836|FG000|Overall Study|Other|7|||
105967386|NCT04753658|365541836|FG000|Overall Study|Adverse Event|1|||
105967387|NCT00306293|365541838|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
105967388|NCT00306293|365541839|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
105967389|NCT00306293|365541838|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
105967390|NCT00306293|365541839|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
105967391|NCT00306293|365541838|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
105967392|NCT00306293|365541839|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
105967393|NCT00306293|365541838|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
105967394|NCT00306293|365541839|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
105967395|NCT00306293|365541838|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
105967396|NCT00306293|365541839|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
105967397|NCT00306293|365541838|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
105967398|NCT00306293|365541839|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
105967399|NCT00306293|365541838|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
105967400|NCT00306293|365541839|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
105967401|NCT00306293|365541838|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
105967402|NCT00306293|365541839|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
105967403|NCT00185380|365541840|FG000|Overall Study|Adverse Event|41|||
105967404|NCT00185380|365541841|FG001|Overall Study|Adverse Event|43|||
105967405|NCT00185380|365541842|FG002|Overall Study|Adverse Event|48|||
105967406|NCT00185380|365541840|FG000|Overall Study|Lost to Follow-up|0|||
105967407|NCT00185380|365541841|FG001|Overall Study|Lost to Follow-up|4|||
105967408|NCT00185380|365541842|FG002|Overall Study|Lost to Follow-up|3|||
105967409|NCT00185380|365541840|FG000|Overall Study|Pregnancy|1|||
105967410|NCT00185380|365541841|FG001|Overall Study|Pregnancy|4|||
105967411|NCT00185380|365541842|FG002|Overall Study|Pregnancy|0|||
105967412|NCT00185380|365541840|FG000|Overall Study|Protocol Violation|2|||
105967413|NCT00185380|365541841|FG001|Overall Study|Protocol Violation|2|||
105967414|NCT00185380|365541842|FG002|Overall Study|Protocol Violation|1|||
105967415|NCT00185380|365541840|FG000|Overall Study|Withdrawal by Subject|1|||
105967416|NCT00185380|365541841|FG001|Overall Study|Withdrawal by Subject|2|||
105967417|NCT00185380|365541842|FG002|Overall Study|Withdrawal by Subject|0|||
105967418|NCT00185380|365541840|FG000|Overall Study|Failed insertion|1|||
105967419|NCT00185380|365541841|FG001|Overall Study|Failed insertion|1|||
105967420|NCT00185380|365541842|FG002|Overall Study|Failed insertion|2|||
105967421|NCT00185380|365541840|FG000|Overall Study|Planned pregnancy|9|||
105967422|NCT00185380|365541841|FG001|Overall Study|Planned pregnancy|12|||
106023961|NCT02745080|365751903|FG001|Overall Study|Physician Decision|0|||
106023962|NCT02745080|365751902|FG000|Overall Study|Protocol Violation|3|||
106023963|NCT02745080|365751903|FG001|Overall Study|Protocol Violation|1|||
106023964|NCT02745080|365751902|FG000|Overall Study|Withdrawal by Subject|22|||
106023965|NCT02745080|365751903|FG001|Overall Study|Withdrawal by Subject|41|||
105967423|NCT00185380|365541842|FG002|Overall Study|Planned pregnancy|12|||
105967424|NCT00185380|365541840|FG000|Overall Study|No need for contraception|3|||
105967425|NCT00185380|365541841|FG001|Overall Study|No need for contraception|3|||
105967426|NCT00185380|365541842|FG002|Overall Study|No need for contraception|3|||
105967427|NCT00185380|365541840|FG000|Overall Study|Could not attend visits|2|||
105967428|NCT00185380|365541841|FG001|Overall Study|Could not attend visits|0|||
105967429|NCT00185380|365541842|FG002|Overall Study|Could not attend visits|4|||
105967430|NCT00185380|365541840|FG000|Overall Study|personal reason|6|||
106023966|NCT04002908|365751904|FG000|Overall Study|Death|41|||
105841031|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
105841032|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
105841033|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841034|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841035|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841036|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105967431|NCT00185380|365541841|FG001|Overall Study|personal reason|1|||
105967432|NCT00185380|365541842|FG002|Overall Study|personal reason|1|||
105967433|NCT02998203|365541844|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
105967434|NCT02998203|365541845|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
105967435|NCT02998203|365541844|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
105967436|NCT02998203|365541845|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
105967437|NCT02589665|365541846|FG000|Induction Period|Did not receive drug|0|||
105967438|NCT02589665|365541847|FG001|Induction Period|Did not receive drug|0|||
105967439|NCT02589665|365541848|FG002|Induction Period|Did not receive drug|0|||
105967440|NCT02589665|365541849|FG003|Induction Period|Did not receive drug|1|||
105967441|NCT02589665|365541850|FG004|Induction Period|Did not receive drug|0|||
105967442|NCT02589665|365541851|FG005|Induction Period|Did not receive drug|0|||
105967443|NCT02589665|365541852|FG006|Induction Period|Did not receive drug|0|||
105967444|NCT02589665|365541853|FG007|Induction Period|Did not receive drug|0|||
105967445|NCT02589665|365541854|FG008|Induction Period|Did not receive drug|0|||
105967446|NCT02589665|365541855|FG009|Induction Period|Did not receive drug|0|||
105967447|NCT02589665|365541846|FG000|Induction Period|Adverse Event|3|||
105967448|NCT02589665|365541847|FG001|Induction Period|Adverse Event|0|||
105967449|NCT02589665|365541848|FG002|Induction Period|Adverse Event|2|||
105967450|NCT02589665|365541849|FG003|Induction Period|Adverse Event|2|||
105967451|NCT02589665|365541850|FG004|Induction Period|Adverse Event|0|||
105967452|NCT02589665|365541851|FG005|Induction Period|Adverse Event|0|||
105967453|NCT02589665|365541852|FG006|Induction Period|Adverse Event|0|||
105967454|NCT02589665|365541853|FG007|Induction Period|Adverse Event|0|||
105967455|NCT02589665|365541854|FG008|Induction Period|Adverse Event|0|||
105967456|NCT02589665|365541855|FG009|Induction Period|Adverse Event|0|||
105967457|NCT02589665|365541846|FG000|Induction Period|Withdrawal by Subject|0|||
105967458|NCT02589665|365541847|FG001|Induction Period|Withdrawal by Subject|1|||
105967459|NCT02589665|365541848|FG002|Induction Period|Withdrawal by Subject|0|||
105967460|NCT02589665|365541849|FG003|Induction Period|Withdrawal by Subject|1|||
105967461|NCT02589665|365541850|FG004|Induction Period|Withdrawal by Subject|0|||
105967462|NCT02589665|365541851|FG005|Induction Period|Withdrawal by Subject|0|||
105967463|NCT02589665|365541852|FG006|Induction Period|Withdrawal by Subject|0|||
105967464|NCT02589665|365541853|FG007|Induction Period|Withdrawal by Subject|0|||
105967465|NCT02589665|365541854|FG008|Induction Period|Withdrawal by Subject|0|||
105967466|NCT02589665|365541855|FG009|Induction Period|Withdrawal by Subject|0|||
105967467|NCT02589665|365541846|FG000|Induction Period|Protocol Violation|0|||
105967468|NCT02589665|365541847|FG001|Induction Period|Protocol Violation|1|||
105967469|NCT02589665|365541848|FG002|Induction Period|Protocol Violation|0|||
105967470|NCT02589665|365541849|FG003|Induction Period|Protocol Violation|0|||
105967471|NCT02589665|365541850|FG004|Induction Period|Protocol Violation|0|||
105967472|NCT02589665|365541851|FG005|Induction Period|Protocol Violation|0|||
105967473|NCT02589665|365541852|FG006|Induction Period|Protocol Violation|0|||
105967474|NCT02589665|365541853|FG007|Induction Period|Protocol Violation|0|||
105967475|NCT02589665|365541854|FG008|Induction Period|Protocol Violation|0|||
105967476|NCT02589665|365541855|FG009|Induction Period|Protocol Violation|0|||
105967477|NCT02589665|365541846|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967478|NCT02589665|365541847|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967479|NCT02589665|365541848|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967480|NCT02589665|365541849|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967481|NCT02589665|365541850|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
105967482|NCT02589665|365541851|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
105967483|NCT02589665|365541852|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
105967484|NCT02589665|365541853|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967485|NCT02589665|365541854|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967486|NCT02589665|365541855|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967487|NCT02589665|365541846|FG000|Maintenance Period|Withdrawal by Subject|0|||
105967488|NCT02589665|365541847|FG001|Maintenance Period|Withdrawal by Subject|0|||
105967489|NCT02589665|365541848|FG002|Maintenance Period|Withdrawal by Subject|0|||
105841037|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105967490|NCT02589665|365541849|FG003|Maintenance Period|Withdrawal by Subject|0|||
105967491|NCT02589665|365541850|FG004|Maintenance Period|Withdrawal by Subject|4|||
105967492|NCT02589665|365541851|FG005|Maintenance Period|Withdrawal by Subject|2|||
105967493|NCT02589665|365541852|FG006|Maintenance Period|Withdrawal by Subject|4|||
105967494|NCT02589665|365541853|FG007|Maintenance Period|Withdrawal by Subject|0|||
105841038|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841039|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
105841040|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841041|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
105841042|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
105841043|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
105841044|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
105841045|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
105841046|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
105841047|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
105841048|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
105841049|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
105841050|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
105841051|NCT00739973|365073837|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841052|NCT00739973|365073838|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
105841053|NCT00739973|365073839|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841054|NCT00739973|365073840|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841055|NCT00739973|365073841|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841056|NCT00739973|365073842|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841057|NCT00739973|365073843|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
105841058|NCT00739973|365073844|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841059|NCT00739973|365073845|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
105841060|NCT02737592|365073847|FG000|Overall Study|Withdrawal by Subject|1|||
105841061|NCT00576303|365073849|FG000|Dose Titration Period|Early withdrawal|17|||
105841062|NCT00576303|365073849|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
105841063|NCT00576303|365073849|FG000|Long Term Safety Period|Early withdrawal|16|||
105841064|NCT00824369|365073853|FG000|Overall Study|Nolonger willing to participate in study|1|||
105841065|NCT00824369|365073854|FG001|Overall Study|Nolonger willing to participate in study|0|||
105841066|NCT00824369|365073855|FG002|Overall Study|Nolonger willing to participate in study|1|||
105841067|NCT00824369|365073856|FG003|Overall Study|Nolonger willing to participate in study|2|||
105841068|NCT00824369|365073857|FG004|Overall Study|Nolonger willing to participate in study|0|||
105841069|NCT00824369|365073858|FG005|Overall Study|Nolonger willing to participate in study|1|||
105841070|NCT00824369|365073853|FG000|Overall Study|Lost to Follow-up|0|||
105841071|NCT00824369|365073854|FG001|Overall Study|Lost to Follow-up|0|||
105841072|NCT00824369|365073855|FG002|Overall Study|Lost to Follow-up|0|||
105841073|NCT00824369|365073856|FG003|Overall Study|Lost to Follow-up|0|||
105841074|NCT00824369|365073857|FG004|Overall Study|Lost to Follow-up|1|||
105841075|NCT00824369|365073858|FG005|Overall Study|Lost to Follow-up|0|||
105841076|NCT00248170|365073859|FG000|Overall Study|Withdrawal by Subject|71|||
105841077|NCT00248170|365073860|FG001|Overall Study|Withdrawal by Subject|79|||
105841078|NCT00248170|365073859|FG000|Overall Study|Protocol Violation|35|||
105841079|NCT00248170|365073860|FG001|Overall Study|Protocol Violation|30|||
105841080|NCT00248170|365073859|FG000|Overall Study|Lost to Follow-up|28|||
105841081|NCT00248170|365073860|FG001|Overall Study|Lost to Follow-up|35|||
105841082|NCT00248170|365073859|FG000|Overall Study|Disease progression|196|||
105841083|NCT00248170|365073860|FG001|Overall Study|Disease progression|216|||
105841084|NCT00248170|365073859|FG000|Overall Study|Death|28|||
105841085|NCT00248170|365073860|FG001|Overall Study|Death|47|||
105841086|NCT00248170|365073859|FG000|Overall Study|Adverse Event|311|||
105841087|NCT00248170|365073860|FG001|Overall Study|Adverse Event|296|||
105841088|NCT00248170|365073859|FG000|Overall Study|Administrative problems|22|||
105841089|NCT00248170|365073860|FG001|Overall Study|Administrative problems|25|||
105841090|NCT00248170|365073859|FG000|Overall Study|Abnormal test procedure(s) result|49|||
105841091|NCT00248170|365073860|FG001|Overall Study|Abnormal test procedure(s) result|61|||
105841092|NCT00248170|365073859|FG000|Overall Study|Abnormal laboratory values|4|||
105841093|NCT00248170|365073860|FG001|Overall Study|Abnormal laboratory values|0|||
105841094|NCT00248170|365073859|FG000|Overall Study|Protocol deviation|17|||
105841095|NCT00248170|365073860|FG001|Overall Study|Protocol deviation|19|||
105841096|NCT03123783|365073865|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841097|NCT03123783|365073866|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
105841098|NCT03123783|365073867|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105967495|NCT02589665|365541854|FG008|Maintenance Period|Withdrawal by Subject|0|||
105967496|NCT02589665|365541855|FG009|Maintenance Period|Withdrawal by Subject|0|||
105967497|NCT02589665|365541846|FG000|Maintenance Period|Lack of Efficacy|0|||
105841099|NCT03123783|365073868|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841100|NCT03123783|365073869|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841101|NCT03123783|365073870|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841102|NCT03123783|365073871|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
105841103|NCT03123783|365073865|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
106149375|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
105841104|NCT03123783|365073866|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
105841105|NCT03123783|365073867|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
105841106|NCT03123783|365073868|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
105841107|NCT03123783|365073869|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
105841108|NCT03123783|365073870|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
105841109|NCT03123783|365073871|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
105841110|NCT03123783|365073865|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
105841111|NCT03123783|365073866|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
105841112|NCT03123783|365073867|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
105841113|NCT03123783|365073868|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
105841114|NCT03123783|365073869|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
105841115|NCT03123783|365073870|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
105841116|NCT03123783|365073871|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
105841117|NCT03123783|365073865|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841118|NCT03123783|365073866|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841119|NCT03123783|365073867|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841120|NCT03123783|365073868|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841121|NCT03123783|365073869|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
105841122|NCT03123783|365073870|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841123|NCT03123783|365073871|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
105841124|NCT01507090|365073877|FG000|Overall Study|incomplete dataset|18|||
105841125|NCT00952276|365073880|FG000|Overall Study|Withdrawal by Subject|1|||
105841126|NCT00952276|365073881|FG001|Overall Study|Withdrawal by Subject|0|||
105841127|NCT00952276|365073882|FG002|Overall Study|Withdrawal by Subject|0|||
105841128|NCT00952276|365073883|FG003|Overall Study|Withdrawal by Subject|1|||
105841129|NCT00952276|365073884|FG004|Overall Study|Withdrawal by Subject|0|||
105841130|NCT02985879|365073885|FG000|Overall Study|Adverse Event|7|||
105841131|NCT02985879|365073886|FG001|Overall Study|Adverse Event|9|||
105841132|NCT02985879|365073887|FG002|Overall Study|Adverse Event|7|||
105841133|NCT02985879|365073885|FG000|Overall Study|Withdrew consent|6|||
105841134|NCT02985879|365073886|FG001|Overall Study|Withdrew consent|8|||
105841135|NCT02985879|365073887|FG002|Overall Study|Withdrew consent|10|||
105841136|NCT02985879|365073885|FG000|Overall Study|Lost to Follow-up|1|||
105841137|NCT02985879|365073886|FG001|Overall Study|Lost to Follow-up|0|||
105841138|NCT02985879|365073887|FG002|Overall Study|Lost to Follow-up|2|||
105841139|NCT02985879|365073885|FG000|Overall Study|Other, not specified|62|||
105841140|NCT02985879|365073886|FG001|Overall Study|Other, not specified|58|||
105841141|NCT02985879|365073887|FG002|Overall Study|Other, not specified|58|||
105841142|NCT04086641|365075196|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
105841143|NCT04086641|365075197|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
105841144|NCT04776746|365075200|FG000|Overall Study|Study terminated by sponsor|61|||
105841145|NCT04776746|365075200|FG000|Overall Study|Adverse Event|5|||
105841146|NCT04776746|365075200|FG000|Overall Study|Death|4|||
105841147|NCT04776746|365075200|FG000|Overall Study|Lack of Efficacy|3|||
105967498|NCT02589665|365541847|FG001|Maintenance Period|Lack of Efficacy|0|||
105967499|NCT02589665|365541848|FG002|Maintenance Period|Lack of Efficacy|0|||
105967500|NCT02589665|365541849|FG003|Maintenance Period|Lack of Efficacy|0|||
105967501|NCT02589665|365541850|FG004|Maintenance Period|Lack of Efficacy|2|||
105967502|NCT02589665|365541851|FG005|Maintenance Period|Lack of Efficacy|1|||
105967503|NCT02589665|365541852|FG006|Maintenance Period|Lack of Efficacy|0|||
105841148|NCT04776746|365075200|FG000|Overall Study|Noncompliance with study drug|2|||
105841149|NCT04776746|365075200|FG000|Overall Study|Not related to COVID-19|2|||
105841150|NCT01652729|365075201|FG000|Overall Study|Withdrawal by Subject|14|||
105841151|NCT01652729|365075202|FG001|Overall Study|Withdrawal by Subject|7|||
105841152|NCT01652729|365075203|FG002|Overall Study|Withdrawal by Subject|7|||
105841153|NCT01652729|365075201|FG000|Overall Study|Adverse Event|4|||
105841154|NCT01652729|365075202|FG001|Overall Study|Adverse Event|0|||
105841155|NCT01652729|365075203|FG002|Overall Study|Adverse Event|3|||
105841156|NCT01652729|365075201|FG000|Overall Study|Physician Decision|1|||
105841157|NCT01652729|365075202|FG001|Overall Study|Physician Decision|0|||
105841158|NCT01652729|365075203|FG002|Overall Study|Physician Decision|1|||
105841159|NCT01652729|365075201|FG000|Overall Study|Protocol Violation|1|||
105841160|NCT01652729|365075202|FG001|Overall Study|Protocol Violation|0|||
105841161|NCT01652729|365075203|FG002|Overall Study|Protocol Violation|0|||
105841162|NCT01652729|365075201|FG000|Overall Study|Lost to Follow-up|6|||
105841163|NCT01652729|365075202|FG001|Overall Study|Lost to Follow-up|6|||
105967504|NCT02589665|365541853|FG007|Maintenance Period|Lack of Efficacy|0|||
105967505|NCT02589665|365541854|FG008|Maintenance Period|Lack of Efficacy|0|||
105967506|NCT02589665|365541855|FG009|Maintenance Period|Lack of Efficacy|0|||
105967507|NCT02589665|365541846|FG000|Maintenance Period|Adverse Event|0|||
105967508|NCT02589665|365541847|FG001|Maintenance Period|Adverse Event|0|||
105967509|NCT02589665|365541848|FG002|Maintenance Period|Adverse Event|0|||
105967510|NCT02589665|365541849|FG003|Maintenance Period|Adverse Event|0|||
105967511|NCT02589665|365541850|FG004|Maintenance Period|Adverse Event|0|||
105967512|NCT02589665|365541851|FG005|Maintenance Period|Adverse Event|0|||
105967513|NCT02589665|365541852|FG006|Maintenance Period|Adverse Event|2|||
105967514|NCT02589665|365541853|FG007|Maintenance Period|Adverse Event|0|||
105967515|NCT02589665|365541854|FG008|Maintenance Period|Adverse Event|0|||
105967516|NCT02589665|365541855|FG009|Maintenance Period|Adverse Event|0|||
105967517|NCT02589665|365541846|FG000|Maintenance Period|Lost to Follow-up|0|||
105967518|NCT02589665|365541847|FG001|Maintenance Period|Lost to Follow-up|0|||
105967519|NCT02589665|365541848|FG002|Maintenance Period|Lost to Follow-up|0|||
105967520|NCT02589665|365541849|FG003|Maintenance Period|Lost to Follow-up|0|||
105967521|NCT02589665|365541850|FG004|Maintenance Period|Lost to Follow-up|0|||
105967522|NCT02589665|365541851|FG005|Maintenance Period|Lost to Follow-up|1|||
105967523|NCT02589665|365541852|FG006|Maintenance Period|Lost to Follow-up|0|||
105967524|NCT02589665|365541853|FG007|Maintenance Period|Lost to Follow-up|0|||
105967525|NCT02589665|365541854|FG008|Maintenance Period|Lost to Follow-up|0|||
105967526|NCT02589665|365541855|FG009|Maintenance Period|Lost to Follow-up|0|||
105967527|NCT02589665|365541846|FG000|Maintenance Period|Physician Decision|0|||
105967528|NCT02589665|365541847|FG001|Maintenance Period|Physician Decision|0|||
105967529|NCT02589665|365541848|FG002|Maintenance Period|Physician Decision|0|||
105967530|NCT02589665|365541849|FG003|Maintenance Period|Physician Decision|0|||
105967531|NCT02589665|365541850|FG004|Maintenance Period|Physician Decision|0|||
105967532|NCT02589665|365541851|FG005|Maintenance Period|Physician Decision|1|||
105967533|NCT02589665|365541852|FG006|Maintenance Period|Physician Decision|0|||
105967534|NCT02589665|365541853|FG007|Maintenance Period|Physician Decision|0|||
105967535|NCT02589665|365541854|FG008|Maintenance Period|Physician Decision|0|||
105967536|NCT02589665|365541855|FG009|Maintenance Period|Physician Decision|0|||
105967537|NCT02589665|365541846|FG000|Maintenance Period|Reason Not Collected|0|||
105967538|NCT02589665|365541847|FG001|Maintenance Period|Reason Not Collected|0|||
105967539|NCT02589665|365541848|FG002|Maintenance Period|Reason Not Collected|0|||
105967540|NCT02589665|365541849|FG003|Maintenance Period|Reason Not Collected|0|||
105967541|NCT02589665|365541850|FG004|Maintenance Period|Reason Not Collected|0|||
105967542|NCT02589665|365541851|FG005|Maintenance Period|Reason Not Collected|1|||
105967543|NCT02589665|365541852|FG006|Maintenance Period|Reason Not Collected|1|||
105967544|NCT02589665|365541853|FG007|Maintenance Period|Reason Not Collected|0|||
105967545|NCT02589665|365541854|FG008|Maintenance Period|Reason Not Collected|0|||
105967546|NCT02589665|365541855|FG009|Maintenance Period|Reason Not Collected|0|||
105967547|NCT02589665|365541846|FG000|Induction Extension Period|Adverse Event|0|||
105967548|NCT02589665|365541847|FG001|Induction Extension Period|Adverse Event|0|||
105967549|NCT02589665|365541848|FG002|Induction Extension Period|Adverse Event|0|||
105967550|NCT02589665|365541849|FG003|Induction Extension Period|Adverse Event|0|||
105967551|NCT02589665|365541850|FG004|Induction Extension Period|Adverse Event|0|||
105967552|NCT02589665|365541851|FG005|Induction Extension Period|Adverse Event|0|||
105967553|NCT02589665|365541852|FG006|Induction Extension Period|Adverse Event|0|||
105967554|NCT02589665|365541853|FG007|Induction Extension Period|Adverse Event|0|||
105967555|NCT02589665|365541854|FG008|Induction Extension Period|Adverse Event|4|||
105967556|NCT02589665|365541855|FG009|Induction Extension Period|Adverse Event|0|||
105967557|NCT02589665|365541846|FG000|Induction Extension Period|Lack of Efficacy|0|||
105967558|NCT02589665|365541847|FG001|Induction Extension Period|Lack of Efficacy|0|||
105967559|NCT02589665|365541848|FG002|Induction Extension Period|Lack of Efficacy|0|||
105967560|NCT02589665|365541849|FG003|Induction Extension Period|Lack of Efficacy|0|||
105967561|NCT02589665|365541850|FG004|Induction Extension Period|Lack of Efficacy|0|||
105967562|NCT02589665|365541851|FG005|Induction Extension Period|Lack of Efficacy|0|||
105967563|NCT02589665|365541852|FG006|Induction Extension Period|Lack of Efficacy|0|||
105967564|NCT02589665|365541853|FG007|Induction Extension Period|Lack of Efficacy|0|||
105967565|NCT02589665|365541854|FG008|Induction Extension Period|Lack of Efficacy|3|||
105967566|NCT02589665|365541855|FG009|Induction Extension Period|Lack of Efficacy|0|||
105967567|NCT02589665|365541846|FG000|Induction Extension Period|Withdrawal by Subject|0|||
105967568|NCT02589665|365541847|FG001|Induction Extension Period|Withdrawal by Subject|0|||
105967569|NCT02589665|365541848|FG002|Induction Extension Period|Withdrawal by Subject|0|||
106023967|NCT04002908|365751905|FG001|Overall Study|Death|0|||
106023968|NCT04002908|365751906|FG002|Overall Study|Death|0|||
106023969|NCT04002908|365751907|FG003|Overall Study|Death|0|||
106023970|NCT04002908|365751904|FG000|Overall Study|Withdrawal by Subject|112|||
106023971|NCT04002908|365751905|FG001|Overall Study|Withdrawal by Subject|0|||
106023972|NCT04002908|365751906|FG002|Overall Study|Withdrawal by Subject|0|||
106023973|NCT04002908|365751907|FG003|Overall Study|Withdrawal by Subject|0|||
106023974|NCT04002908|365751904|FG000|Overall Study|Lost to Follow-up|72|||
106149376|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
105967570|NCT02589665|365541849|FG003|Induction Extension Period|Withdrawal by Subject|0|||
106023975|NCT04002908|365751905|FG001|Overall Study|Lost to Follow-up|0|||
106023976|NCT04002908|365751906|FG002|Overall Study|Lost to Follow-up|0|||
105841164|NCT01652729|365075203|FG002|Overall Study|Lost to Follow-up|3|||
105841165|NCT01652729|365075201|FG000|Overall Study|Administrative|1|||
105841166|NCT01652729|365075202|FG001|Overall Study|Administrative|0|||
105841167|NCT01652729|365075203|FG002|Overall Study|Administrative|0|||
105841168|NCT00126126|365075204|FG000|Overall Study|Lost to Follow-up|0|||
105841169|NCT00126126|365075205|FG001|Overall Study|Lost to Follow-up|2|||
105841170|NCT02459665|365075206|FG000|Overall Study|Withdrawal by Subject|0|||
105841171|NCT02459665|365075207|FG001|Overall Study|Withdrawal by Subject|1|||
105841172|NCT02459665|365075208|FG002|Overall Study|Withdrawal by Subject|1|||
105841173|NCT02459665|365075209|FG003|Overall Study|Withdrawal by Subject|2|||
105841174|NCT01567826|365075210|FG000|Overall Study|Lost to Follow-up|3|||
105841175|NCT01567826|365075211|FG001|Overall Study|Lost to Follow-up|2|||
105841176|NCT04364737|365075212|FG000|Overall Study|Withdrawal by Subject|4|||
105841177|NCT04364737|365075213|FG001|Overall Study|Withdrawal by Subject|9|||
105841178|NCT04364737|365075212|FG000|Overall Study|Lost to Follow-up|1|||
105841179|NCT04364737|365075213|FG001|Overall Study|Lost to Follow-up|1|||
105841180|NCT00868296|365075214|FG000|Overall Study|Adverse Event|0|||
105841181|NCT00868296|365075215|FG001|Overall Study|Adverse Event|2|||
105841182|NCT00868296|365075214|FG000|Overall Study|Withdrawal by Subject|0|||
105841183|NCT00868296|365075215|FG001|Overall Study|Withdrawal by Subject|1|||
105841184|NCT01280617|365075220|FG000|Overall Study|Adverse Event|0|||
105841185|NCT01280617|365075221|FG001|Overall Study|Adverse Event|1|||
105841186|NCT01311557|365075222|FG000|Overall Study|Serious adverse event|0|||
105841187|NCT01311557|365075223|FG001|Overall Study|Serious adverse event|1|||
105841188|NCT01311557|365075222|FG000|Overall Study|Protocol Violation|4|||
105841189|NCT01311557|365075223|FG001|Overall Study|Protocol Violation|2|||
105841190|NCT01311557|365075222|FG000|Overall Study|Lost to Follow-up|0|||
105841191|NCT01311557|365075223|FG001|Overall Study|Lost to Follow-up|1|||
105841192|NCT01311557|365075222|FG000|Overall Study|Withdrawal by Subject|1|||
105841193|NCT01311557|365075223|FG001|Overall Study|Withdrawal by Subject|2|||
105841194|NCT02418455|365075224|FG000|48-Week Treatment Period|Other- Not Specified|1|||
105841195|NCT02418455|365075224|FG000|Continuation Period|Sponsor Decision|7|||
105841196|NCT02457611|365075225|FG000|Overall Study|Lost to Follow-up|3|||
105841197|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
105841198|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
105841199|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
105841200|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
105841201|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
105841202|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
105841203|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
105841204|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
105841205|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
105841206|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
105841207|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
105841208|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
105841209|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
105841210|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
105841211|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
105841212|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
105841213|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
105967571|NCT02589665|365541850|FG004|Induction Extension Period|Withdrawal by Subject|0|||
105967572|NCT02589665|365541851|FG005|Induction Extension Period|Withdrawal by Subject|0|||
105967573|NCT02589665|365541852|FG006|Induction Extension Period|Withdrawal by Subject|0|||
105967574|NCT02589665|365541853|FG007|Induction Extension Period|Withdrawal by Subject|2|||
105967575|NCT02589665|365541854|FG008|Induction Extension Period|Withdrawal by Subject|3|||
105967576|NCT02589665|365541855|FG009|Induction Extension Period|Withdrawal by Subject|0|||
105967577|NCT02589665|365541846|FG000|Induction Extension Period|Physician Decision|0|||
105967578|NCT02589665|365541847|FG001|Induction Extension Period|Physician Decision|0|||
105967579|NCT02589665|365541848|FG002|Induction Extension Period|Physician Decision|0|||
105967580|NCT02589665|365541849|FG003|Induction Extension Period|Physician Decision|0|||
105967581|NCT02589665|365541850|FG004|Induction Extension Period|Physician Decision|0|||
105967582|NCT02589665|365541851|FG005|Induction Extension Period|Physician Decision|0|||
105967583|NCT02589665|365541852|FG006|Induction Extension Period|Physician Decision|0|||
105841214|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
105841215|NCT00384293|365075226|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
105841216|NCT00384293|365075227|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
105841217|NCT00384293|365075228|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
105841218|NCT00384293|365075226|FG000|Post-randomization Period|Adverse Event|0|||
105841219|NCT00384293|365075227|FG001|Post-randomization Period|Adverse Event|23|||
105967584|NCT02589665|365541853|FG007|Induction Extension Period|Physician Decision|0|||
106149377|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
106149378|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
106149379|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
106149380|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
106149381|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
106149382|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
106149383|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
106149384|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
106149385|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
106149386|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
106149387|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
106149388|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
106149389|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
106149390|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
106149391|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
106149392|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
106149393|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
106149394|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
106149395|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
106149396|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
106149397|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
106149398|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
106149399|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
106149400|NCT03598790|366209105|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
106149401|NCT03598790|366209106|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
106149402|NCT03598790|366209107|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
106149403|NCT03598790|366209108|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
106149404|NCT03598790|366209109|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
106149405|NCT03598790|366209110|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
106149406|NCT03598790|366209111|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
105841220|NCT00384293|365075228|FG002|Post-randomization Period|Adverse Event|7|||
105841221|NCT00384293|365075226|FG000|Post-randomization Period|Lost to Follow-up|0|||
105841222|NCT00384293|365075227|FG001|Post-randomization Period|Lost to Follow-up|2|||
105841223|NCT00384293|365075228|FG002|Post-randomization Period|Lost to Follow-up|1|||
105841224|NCT00384293|365075226|FG000|Post-randomization Period|Protocol Violation|0|||
105841225|NCT00384293|365075227|FG001|Post-randomization Period|Protocol Violation|1|||
105841226|NCT00384293|365075228|FG002|Post-randomization Period|Protocol Violation|0|||
105841227|NCT00384293|365075226|FG000|Post-randomization Period|Withdrawal by Subject|0|||
105841228|NCT00384293|365075227|FG001|Post-randomization Period|Withdrawal by Subject|8|||
105841229|NCT00384293|365075228|FG002|Post-randomization Period|Withdrawal by Subject|6|||
105841230|NCT00384293|365075226|FG000|Post-randomization Period|Trial Termination|0|||
105841231|NCT00384293|365075227|FG001|Post-randomization Period|Trial Termination|180|||
105841232|NCT00384293|365075228|FG002|Post-randomization Period|Trial Termination|204|||
105841233|NCT00384293|365075226|FG000|Post-randomization Period|Patient Randomized in Error|0|||
105841234|NCT00384293|365075227|FG001|Post-randomization Period|Patient Randomized in Error|0|||
105841235|NCT00384293|365075228|FG002|Post-randomization Period|Patient Randomized in Error|1|||
105841236|NCT00194792|365075235|FG000|Overall Study|Withdrawal by Subject|1|||
105841237|NCT00493454|365075236|FG000|Overall Study|Withdrawal by Subject|1|||
105841238|NCT03585959|365075237|FG000|Overall Study|Physician Decision|1|||
105841239|NCT03585959|365075237|FG000|Overall Study|Unsuccessful Procedure|2|||
105841240|NCT03920280|365075238|FG000|Overall Study|Adverse Event|2|||
105841241|NCT03920280|365075239|FG001|Overall Study|Adverse Event|3|||
105841242|NCT03920280|365075238|FG000|Overall Study|Lost to Follow-up|0|||
105841243|NCT03920280|365075239|FG001|Overall Study|Lost to Follow-up|1|||
105841244|NCT03920280|365075238|FG000|Overall Study|Withdrawal by Subject|1|||
105841245|NCT03920280|365075239|FG001|Overall Study|Withdrawal by Subject|1|||
105841246|NCT03920280|365075238|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
105841247|NCT03920280|365075239|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
105841248|NCT01557920|365075240|FG000|Overall Study|Withdrawal by Subject|2|||
105841249|NCT01557920|365075241|FG001|Overall Study|Withdrawal by Subject|3|||
105841250|NCT01557920|365075240|FG000|Overall Study|Lack of Efficacy|1|||
105841251|NCT01557920|365075241|FG001|Overall Study|Lack of Efficacy|0|||
105841252|NCT05444543|365075251|FG000|Overall Study|Withdrawal by Subject|1|||
105841253|NCT05444543|365075252|FG001|Overall Study|Withdrawal by Subject|0|||
105841254|NCT05444543|365075251|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
105841255|NCT05444543|365075252|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
105841256|NCT05444543|365075251|FG000|Overall Study|Adverse Event|0|||
105841257|NCT05444543|365075252|FG001|Overall Study|Adverse Event|1|||
105841258|NCT05444543|365075251|FG000|Overall Study|Family relocating at a distance from study site|0|||
105841259|NCT05444543|365075252|FG001|Overall Study|Family relocating at a distance from study site|1|||
105841260|NCT01261624|365075253|FG000|Week 0 to Week 12|Disease Progression|1|||
105841261|NCT01261624|365075254|FG001|Week 0 to Week 12|Disease Progression|1|||
105841262|NCT01261624|365075253|FG000|Week 0 to Week 12|Insufficient Response|0|||
105841263|NCT01261624|365075254|FG001|Week 0 to Week 12|Insufficient Response|2|||
105841264|NCT01261624|365075253|FG000|Week 13 to Week 24|Insufficient Response|0|||
105841265|NCT01261624|365075254|FG001|Week 13 to Week 24|Insufficient Response|1|||
105841266|NCT01134627|365075261|FG000|Overall Study|Adverse Event|47|||
105841267|NCT01134627|365075262|FG001|Overall Study|Adverse Event|31|||
105841268|NCT01134627|365075261|FG000|Overall Study|Lost to Follow-up|1|||
105841269|NCT01134627|365075262|FG001|Overall Study|Lost to Follow-up|2|||
105841270|NCT01134627|365075261|FG000|Overall Study|Protocol Violation|3|||
105841271|NCT01134627|365075262|FG001|Overall Study|Protocol Violation|5|||
105841272|NCT01134627|365075261|FG000|Overall Study|Lack of Efficacy|2|||
105841273|NCT01134627|365075262|FG001|Overall Study|Lack of Efficacy|12|||
105841274|NCT01134627|365075261|FG000|Overall Study|Withdrawal by Subject|4|||
105841275|NCT01134627|365075262|FG001|Overall Study|Withdrawal by Subject|3|||
105841276|NCT01134627|365075261|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
105841277|NCT01134627|365075262|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
105841278|NCT01134627|365075261|FG000|Overall Study|Other|11|||
105841279|NCT01134627|365075262|FG001|Overall Study|Other|14|||
105841280|NCT01719562|365075263|FG000|Overall Study|Lost to Follow-up|1|||
105841281|NCT01719562|365075264|FG001|Overall Study|Lost to Follow-up|0|||
105841282|NCT01719562|365075263|FG000|Overall Study|Death|1|||
105841283|NCT01719562|365075264|FG001|Overall Study|Death|0|||
105841284|NCT01719562|365075263|FG000|Overall Study|New cancer diagnosis|1|||
105841285|NCT01719562|365075264|FG001|Overall Study|New cancer diagnosis|0|||
105841286|NCT00396331|365075267|FG000|Overall Study|Failed to mobilize - no transplant|8|||
105841287|NCT00396331|365075267|FG000|Overall Study|Did not go on to transplant|5|||
105841288|NCT00396331|365075267|FG000|Overall Study|Lost to Follow-up|3|||
105841289|NCT00396331|365075267|FG000|Overall Study|Death|16|||
105841290|NCT01884688|365075268|FG000|Overall Study|Screen Failure|2|||
105841291|NCT01955044|365075272|FG000|Overall Study|Death|1|||
105841292|NCT01955044|365075273|FG001|Overall Study|Death|1|||
105841293|NCT01955044|365075274|FG002|Overall Study|Death|0|||
105841294|NCT02563769|365075275|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
105841295|NCT02563769|365075276|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
105841296|NCT02563769|365075277|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
105841297|NCT02953678|365075278|FG000|Overall Study|Adverse Event|20|||
105841298|NCT02953678|365075278|FG000|Overall Study|Death|7|||
105841299|NCT02953678|365075278|FG000|Overall Study|Physician Decision|23|||
105841300|NCT02953678|365075278|FG000|Overall Study|Progressive Disease of GVHD|7|||
105841301|NCT02953678|365075278|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
105841302|NCT02953678|365075278|FG000|Overall Study|Withdrawal by participant|3|||
105841303|NCT02953678|365075278|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
105841304|NCT02953678|365075278|FG000|Overall Study|Participants were transferred to commercial product.|3|||
105841305|NCT00605917|365075290|FG000|Overall Study|Protocol Violation|79|||
105841306|NCT00890552|365075291|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
105841307|NCT00890552|365075291|FG000|On-treatment|Early prog disease/ death|10|||
105841308|NCT00767520|365075293|FG000|Overall Study|Participants still on treatment|11|||
105841309|NCT00767520|365075294|FG001|Overall Study|Participants still on treatment|15|||
105841310|NCT00767520|365075293|FG000|Overall Study|Randomized in error and Never treated|0|||
105841311|NCT00767520|365075294|FG001|Overall Study|Randomized in error and Never treated|2|||
105841312|NCT04965389|365075295|FG000|Overall Study|Other reasons|1|||
105841313|NCT04965389|365075296|FG001|Overall Study|Other reasons|0|||
105841314|NCT04965389|365075297|FG002|Overall Study|Other reasons|0|||
105841315|NCT04965389|365075298|FG003|Overall Study|Other reasons|0|||
105841316|NCT04965389|365075295|FG000|Overall Study|Participant withdrew consent|0|||
105841317|NCT04965389|365075296|FG001|Overall Study|Participant withdrew consent|1|||
105841318|NCT04965389|365075297|FG002|Overall Study|Participant withdrew consent|0|||
105841319|NCT04965389|365075298|FG003|Overall Study|Participant withdrew consent|0|||
105841320|NCT04965389|365075295|FG000|Overall Study|Poor/Non-compliance|0|||
105987414|NCT00666224|365614459|FG001|Double-Blind|Adverse Event|5|||
105841321|NCT04965389|365075296|FG001|Overall Study|Poor/Non-compliance|1|||
105841322|NCT04965389|365075297|FG002|Overall Study|Poor/Non-compliance|0|||
105841323|NCT04965389|365075298|FG003|Overall Study|Poor/Non-compliance|0|||
105841324|NCT02377921|365075301|FG000|Overall Study|Subject non-compliance|1|||
105841325|NCT02377921|365075302|FG001|Overall Study|Subject non-compliance|1|||
106023977|NCT04002908|365751907|FG003|Overall Study|Lost to Follow-up|0|||
106023978|NCT04002908|365751904|FG000|Overall Study|Infant died, so mother withdrawn|34|||
106023979|NCT04002908|365751905|FG001|Overall Study|Infant died, so mother withdrawn|0|||
106023980|NCT04002908|365751906|FG002|Overall Study|Infant died, so mother withdrawn|0|||
106023981|NCT04002908|365751907|FG003|Overall Study|Infant died, so mother withdrawn|0|||
106023982|NCT01865552|365754447|FG000|Period 1|Adverse Event|1|||
106023983|NCT01865552|365754448|FG001|Period 1|Adverse Event|0|||
106023984|NCT01865552|365754449|FG002|Period 1|Adverse Event|0|||
106023985|NCT01865552|365754450|FG003|Period 1|Adverse Event|1|||
106023986|NCT01865552|365754451|FG004|Period 1|Adverse Event|1|||
106023987|NCT01865552|365754452|FG005|Period 1|Adverse Event|1|||
106023988|NCT01865552|365754447|FG000|Period 1|Pathological lab|0|||
106023989|NCT01865552|365754448|FG001|Period 1|Pathological lab|0|||
106023990|NCT01865552|365754449|FG002|Period 1|Pathological lab|0|||
106023991|NCT01865552|365754450|FG003|Period 1|Pathological lab|0|||
106023992|NCT01865552|365754451|FG004|Period 1|Pathological lab|1|||
106023993|NCT01865552|365754452|FG005|Period 1|Pathological lab|0|||
106023994|NCT01865552|365754447|FG000|Period 1|Other|0|||
106023995|NCT01865552|365754448|FG001|Period 1|Other|0|||
106023996|NCT01865552|365754449|FG002|Period 1|Other|0|||
106023997|NCT01865552|365754450|FG003|Period 1|Other|0|||
106023998|NCT01865552|365754451|FG004|Period 1|Other|1|||
106023999|NCT01865552|365754452|FG005|Period 1|Other|0|||
106024000|NCT00843284|365754453|FG000|Overall Study|Adverse Event|39|||
106024001|NCT00843284|365754453|FG000|Overall Study|Lack of Efficacy|5|||
106024002|NCT00843284|365754453|FG000|Overall Study|Lost to Follow-up|11|||
106024003|NCT00843284|365754453|FG000|Overall Study|Other|10|||
106024004|NCT00843284|365754453|FG000|Overall Study|Withdrawal by Subject|4|||
106024005|NCT00843284|365754453|FG000|Overall Study|Death|3|||
106024006|NCT01474239|365754454|FG000|Overall Study|Disease Progression|37|||
105841326|NCT02443545|365075303|FG000|Overall Study|Adverse Event|1|||
105841327|NCT02443545|365075304|FG001|Overall Study|Adverse Event|1|||
105841328|NCT02443545|365075303|FG000|Overall Study|Lost to Follow-up|0|||
105841329|NCT02443545|365075304|FG001|Overall Study|Lost to Follow-up|2|||
105841330|NCT02443545|365075303|FG000|Overall Study|Physician Decision|3|||
105841331|NCT02443545|365075304|FG001|Overall Study|Physician Decision|0|||
105841332|NCT02443545|365075303|FG000|Overall Study|Protocol Violation|8|||
105841333|NCT02443545|365075304|FG001|Overall Study|Protocol Violation|1|||
105841334|NCT02443545|365075303|FG000|Overall Study|Pregnancy|1|||
105841335|NCT02443545|365075304|FG001|Overall Study|Pregnancy|1|||
105841336|NCT02443545|365075303|FG000|Overall Study|Withdrawal by Subject|6|||
105841337|NCT02443545|365075304|FG001|Overall Study|Withdrawal by Subject|3|||
105841338|NCT02443545|365075303|FG000|Overall Study|Termination of study|20|||
105841339|NCT02443545|365075304|FG001|Overall Study|Termination of study|11|||
105841340|NCT00724373|365075305|FG000|Overall Study|Adverse Event|41|||
105841341|NCT00724373|365075305|FG000|Overall Study|Lack of Efficacy|82|||
105841342|NCT00724373|365075305|FG000|Overall Study|Lost to Follow-up|7|||
105841343|NCT00724373|365075305|FG000|Overall Study|Non-compliance|2|||
105841344|NCT00724373|365075305|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
105841345|NCT00724373|365075305|FG000|Overall Study|Participant moved away|1|||
105987415|NCT00666224|365614458|FG000|Double-Blind|Lost to Follow-up|2|||
105987416|NCT00666224|365614459|FG001|Double-Blind|Lost to Follow-up|2|||
105987417|NCT00666224|365614458|FG000|Double-Blind|Withdrawal by Subject|18|||
105987418|NCT00666224|365614459|FG001|Double-Blind|Withdrawal by Subject|14|||
105987419|NCT00666224|365614458|FG000|Double-Blind|Physician Decision|0|||
105987420|NCT00666224|365614459|FG001|Double-Blind|Physician Decision|3|||
105987421|NCT00666224|365614458|FG000|Double-Blind|Sponsor decision|1|||
105987422|NCT00666224|365614459|FG001|Double-Blind|Sponsor decision|0|||
105987423|NCT00666224|365614458|FG000|Double-Blind|Pregnancy|3|||
105987424|NCT00666224|365614459|FG001|Double-Blind|Pregnancy|2|||
105987425|NCT00666224|365614458|FG000|Double-Blind|Noncompliance|1|||
105987426|NCT00666224|365614459|FG001|Double-Blind|Noncompliance|0|||
105987427|NCT00666224|365614458|FG000|Double-Blind|Death|1|||
105987428|NCT00666224|365614459|FG001|Double-Blind|Death|0|||
105987429|NCT00666224|365614458|FG000|Double-Blind|Undefined/Unknown|4|||
105987430|NCT00666224|365614459|FG001|Double-Blind|Undefined/Unknown|1|||
105987431|NCT00666224|365614458|FG000|Open-Label|Adverse Event|8|||
105987432|NCT00666224|365614459|FG001|Open-Label|Adverse Event|43|||
105987433|NCT00666224|365614458|FG000|Open-Label|Lost to Follow-up|4|||
105987434|NCT00666224|365614459|FG001|Open-Label|Lost to Follow-up|5|||
105987435|NCT00666224|365614458|FG000|Open-Label|Withdrawal by Subject|12|||
105987436|NCT00666224|365614459|FG001|Open-Label|Withdrawal by Subject|25|||
105987437|NCT00666224|365614458|FG000|Open-Label|Physician Decision|7|||
105987438|NCT00666224|365614459|FG001|Open-Label|Physician Decision|5|||
105987439|NCT00666224|365614458|FG000|Open-Label|Pregnancy|1|||
105987440|NCT00666224|365614459|FG001|Open-Label|Pregnancy|5|||
105987441|NCT00666224|365614458|FG000|Open-Label|Noncompliance|2|||
105987442|NCT00666224|365614459|FG001|Open-Label|Noncompliance|1|||
105987443|NCT00666224|365614458|FG000|Open-Label|Undefined/Unknown|1|||
105987444|NCT00666224|365614459|FG001|Open-Label|Undefined/Unknown|1|||
105987445|NCT02814175|365614460|FG000|Part 1|Adverse Event|2|||
105987446|NCT02814175|365614461|FG001|Part 1|Adverse Event|3|||
105841346|NCT00724373|365075305|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
105967585|NCT02589665|365541854|FG008|Induction Extension Period|Physician Decision|1|||
105967586|NCT02589665|365541855|FG009|Induction Extension Period|Physician Decision|0|||
105967587|NCT02589665|365541846|FG000|Induction Extension Period|Reason Not Collected|0|||
105967588|NCT02589665|365541847|FG001|Induction Extension Period|Reason Not Collected|0|||
105967589|NCT02589665|365541848|FG002|Induction Extension Period|Reason Not Collected|0|||
105967590|NCT02589665|365541849|FG003|Induction Extension Period|Reason Not Collected|0|||
105967591|NCT02589665|365541850|FG004|Induction Extension Period|Reason Not Collected|0|||
105967592|NCT02589665|365541851|FG005|Induction Extension Period|Reason Not Collected|0|||
105967593|NCT02589665|365541852|FG006|Induction Extension Period|Reason Not Collected|0|||
105967594|NCT02589665|365541853|FG007|Induction Extension Period|Reason Not Collected|0|||
105967595|NCT02589665|365541854|FG008|Induction Extension Period|Reason Not Collected|1|||
105967596|NCT02589665|365541855|FG009|Induction Extension Period|Reason Not Collected|0|||
105967597|NCT02589665|365541846|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967598|NCT02589665|365541847|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967599|NCT02589665|365541848|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967600|NCT02589665|365541849|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967601|NCT02589665|365541850|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967602|NCT02589665|365541851|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967603|NCT02589665|365541852|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967604|NCT02589665|365541853|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967605|NCT02589665|365541854|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
105967606|NCT02589665|365541855|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
105967607|NCT02589665|365541846|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
105967608|NCT02589665|365541847|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
105967609|NCT02589665|365541848|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
105967610|NCT02589665|365541849|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
105967611|NCT02589665|365541850|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
105967612|NCT02589665|365541851|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
105967613|NCT02589665|365541852|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
105967614|NCT02589665|365541853|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
105967615|NCT02589665|365541854|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
105967616|NCT02589665|365541855|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
105967617|NCT02589665|365541846|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
105841347|NCT00724373|365075305|FG000|Overall Study|Only to have 24 week regimen|1|||
105841348|NCT00724373|365075305|FG000|Overall Study|Viral Relapse|1|||
105841349|NCT00724373|365075305|FG000|Overall Study|Acute HCV infection|1|||
105841350|NCT00724373|365075305|FG000|Overall Study|Drug Relapse|1|||
105841351|NCT00724373|365075305|FG000|Overall Study|Tolerability|23|||
105967618|NCT02589665|365541847|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
105967619|NCT02589665|365541848|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
105967620|NCT02589665|365541849|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
105967621|NCT02589665|365541850|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
105967622|NCT02589665|365541851|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
105967623|NCT02589665|365541852|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
105967624|NCT02589665|365541853|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
105841352|NCT01610063|365075308|FG000|Overall Study|Lost to Follow-up|42|||
105841353|NCT01610063|365075309|FG001|Overall Study|Lost to Follow-up|20|||
105841354|NCT03043560|365075310|FG000|Overall Study|Discontinued Intervention|1|||
105841355|NCT03043560|365075311|FG001|Overall Study|Discontinued Intervention|2|||
105841356|NCT03043560|365075310|FG000|Overall Study|Lost to Follow-up|0|||
105841357|NCT03043560|365075311|FG001|Overall Study|Lost to Follow-up|1|||
105841358|NCT01425528|365075312|FG000|Overall Study|Withdrawal by Subject|1|||
105841359|NCT01425528|365075313|FG001|Overall Study|Withdrawal by Subject|1|||
105841360|NCT01118117|365075314|FG000|Overall Study|Death|8|||
106024007|NCT01474239|365754455|FG001|Overall Study|Disease Progression|25|||
106024008|NCT01474239|365754454|FG000|Overall Study|Adverse Event|12|||
106024009|NCT01474239|365754455|FG001|Overall Study|Adverse Event|3|||
106024010|NCT01474239|365754454|FG000|Overall Study|Withdrawal by Subject|1|||
106024011|NCT01474239|365754455|FG001|Overall Study|Withdrawal by Subject|2|||
106024012|NCT01474239|365754454|FG000|Overall Study|Death|1|||
106024013|NCT01474239|365754455|FG001|Overall Study|Death|1|||
106024014|NCT01474239|365754454|FG000|Overall Study|Clinical Disease Progression|7|||
106024015|NCT01474239|365754455|FG001|Overall Study|Clinical Disease Progression|1|||
106024016|NCT01474239|365754454|FG000|Overall Study|Withdrawal for Economic Reason|1|||
106024017|NCT01474239|365754455|FG001|Overall Study|Withdrawal for Economic Reason|0|||
106024018|NCT01761162|365754458|FG000|Overall Study|Withdrawal by Subject|3|||
106024019|NCT01349049|365754465|FG000|Overall Study|Disease progression|3|||
106024020|NCT01349049|365754466|FG001|Overall Study|Disease progression|5|||
106024021|NCT01349049|365754467|FG002|Overall Study|Disease progression|3|||
106024022|NCT01349049|365754468|FG003|Overall Study|Disease progression|2|||
106024023|NCT01349049|365754469|FG004|Overall Study|Disease progression|2|||
106024024|NCT01349049|365754470|FG005|Overall Study|Disease progression|2|||
106024025|NCT01349049|365754471|FG006|Overall Study|Disease progression|3|||
106024026|NCT01349049|365754472|FG007|Overall Study|Disease progression|2|||
106024027|NCT01349049|365754473|FG008|Overall Study|Disease progression|33|||
106024028|NCT01349049|365754465|FG000|Overall Study|Adverse Event|0|||
106024029|NCT01349049|365754466|FG001|Overall Study|Adverse Event|1|||
106024030|NCT01349049|365754467|FG002|Overall Study|Adverse Event|0|||
106024031|NCT01349049|365754468|FG003|Overall Study|Adverse Event|0|||
106024032|NCT01349049|365754469|FG004|Overall Study|Adverse Event|0|||
106024033|NCT01349049|365754470|FG005|Overall Study|Adverse Event|3|||
106024034|NCT01349049|365754471|FG006|Overall Study|Adverse Event|1|||
106024035|NCT01349049|365754472|FG007|Overall Study|Adverse Event|0|||
106024036|NCT01349049|365754473|FG008|Overall Study|Adverse Event|4|||
106024037|NCT01349049|365754465|FG000|Overall Study|Physician Decision|0|||
106024038|NCT01349049|365754466|FG001|Overall Study|Physician Decision|1|||
106024039|NCT01349049|365754467|FG002|Overall Study|Physician Decision|0|||
106024040|NCT01349049|365754468|FG003|Overall Study|Physician Decision|0|||
106024041|NCT01349049|365754469|FG004|Overall Study|Physician Decision|0|||
106024042|NCT01349049|365754470|FG005|Overall Study|Physician Decision|0|||
106024043|NCT01349049|365754471|FG006|Overall Study|Physician Decision|0|||
106024044|NCT01349049|365754472|FG007|Overall Study|Physician Decision|0|||
106024045|NCT01349049|365754473|FG008|Overall Study|Physician Decision|2|||
105841361|NCT01118117|365075315|FG001|Overall Study|Death|0|||
105841362|NCT01118117|365075314|FG000|Overall Study|Lost to Follow-up|6|||
105841363|NCT01118117|365075315|FG001|Overall Study|Lost to Follow-up|0|||
105841364|NCT01118117|365075314|FG000|Overall Study|Missed 12 Month Visit|7|||
105841365|NCT01118117|365075315|FG001|Overall Study|Missed 12 Month Visit|0|||
105841366|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
105841367|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
105841368|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
105841369|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
105841370|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
105841371|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
105841372|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
105841373|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
105841374|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
105841375|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
106024046|NCT01349049|365754465|FG000|Overall Study|Protocol Violation|0|||
106024047|NCT01349049|365754466|FG001|Overall Study|Protocol Violation|0|||
106149407|NCT03598790|366209112|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
106149408|NCT03598790|366209113|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
106024048|NCT01349049|365754467|FG002|Overall Study|Protocol Violation|0|||
106024049|NCT01349049|365754468|FG003|Overall Study|Protocol Violation|0|||
106024050|NCT01349049|365754469|FG004|Overall Study|Protocol Violation|0|||
106149409|NCT03598790|366209105|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105841376|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
105841377|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
105841378|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Death|0|||
106024051|NCT01349049|365754470|FG005|Overall Study|Protocol Violation|0|||
106024052|NCT01349049|365754471|FG006|Overall Study|Protocol Violation|0|||
106024053|NCT01349049|365754472|FG007|Overall Study|Protocol Violation|0|||
106024054|NCT01349049|365754473|FG008|Overall Study|Protocol Violation|1|||
106024055|NCT01349049|365754465|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
106024056|NCT01349049|365754466|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
106024057|NCT01349049|365754467|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
105967625|NCT02589665|365541854|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
105967626|NCT02589665|365541855|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
105967627|NCT02589665|365541846|FG000|Maintenance Extension Period|Adverse Event|0|||
105967628|NCT02589665|365541847|FG001|Maintenance Extension Period|Adverse Event|0|||
105967629|NCT02589665|365541848|FG002|Maintenance Extension Period|Adverse Event|0|||
105967630|NCT02589665|365541849|FG003|Maintenance Extension Period|Adverse Event|0|||
105841379|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Death|1|||
105841380|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Death|0|||
105841381|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Death|0|||
105841382|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
105841383|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
105841384|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
105841385|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
105841386|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
105841387|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
105841388|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
105841389|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
105841390|NCT00545688|365075319|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
105841391|NCT00545688|365075320|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
105841392|NCT00545688|365075321|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
105841393|NCT00545688|365075322|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
105841394|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Disease Progression|3|||
105841395|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Disease Progression|3|||
105841396|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Disease Progression|0|||
105841397|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Disease Progression|7|||
105841398|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
105841399|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
105841400|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
105841401|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
105841402|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
105841403|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
105841404|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
105841405|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
105841406|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Adverse Event|0|||
105841407|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Adverse Event|3|||
105967631|NCT02589665|365541850|FG004|Maintenance Extension Period|Adverse Event|0|||
105967632|NCT02589665|365541851|FG005|Maintenance Extension Period|Adverse Event|0|||
105967633|NCT02589665|365541852|FG006|Maintenance Extension Period|Adverse Event|0|||
105967634|NCT02589665|365541853|FG007|Maintenance Extension Period|Adverse Event|0|||
105967635|NCT02589665|365541854|FG008|Maintenance Extension Period|Adverse Event|0|||
105967636|NCT02589665|365541855|FG009|Maintenance Extension Period|Adverse Event|2|||
105967637|NCT02589665|365541846|FG000|Maintenance Extension Period|Non-responder|0|||
105967638|NCT02589665|365541847|FG001|Maintenance Extension Period|Non-responder|0|||
105967639|NCT02589665|365541848|FG002|Maintenance Extension Period|Non-responder|0|||
105967640|NCT02589665|365541849|FG003|Maintenance Extension Period|Non-responder|0|||
105967641|NCT02589665|365541850|FG004|Maintenance Extension Period|Non-responder|0|||
105967642|NCT02589665|365541851|FG005|Maintenance Extension Period|Non-responder|0|||
105967643|NCT02589665|365541852|FG006|Maintenance Extension Period|Non-responder|0|||
105967644|NCT02589665|365541853|FG007|Maintenance Extension Period|Non-responder|0|||
105967645|NCT02589665|365541854|FG008|Maintenance Extension Period|Non-responder|0|||
105967646|NCT02589665|365541855|FG009|Maintenance Extension Period|Non-responder|1|||
105967647|NCT02199314|365541858|FG000|Overall Study|Withdrawal by Subject|6|||
105967648|NCT02199314|365541858|FG000|Overall Study|Physician Decision|10|||
105967649|NCT03842969|365541859|FG000|Overall Study|Participant declined follow-up visit|0|||
105967650|NCT03842969|365541860|FG001|Overall Study|Participant declined follow-up visit|1|||
105967651|NCT03842969|365541861|FG002|Overall Study|Participant declined follow-up visit|0|||
105967652|NCT03842969|365541859|FG000|Overall Study|Sponsor's decision|12|||
105967653|NCT03842969|365541860|FG001|Overall Study|Sponsor's decision|99|||
105967654|NCT03842969|365541861|FG002|Overall Study|Sponsor's decision|61|||
105967655|NCT03842969|365541859|FG000|Overall Study|Pregnancy|0|||
105967656|NCT03842969|365541860|FG001|Overall Study|Pregnancy|0|||
105967657|NCT03842969|365541861|FG002|Overall Study|Pregnancy|1|||
105967658|NCT03842969|365541859|FG000|Overall Study|Death|1|||
105967659|NCT03842969|365541860|FG001|Overall Study|Death|0|||
105967660|NCT03842969|365541861|FG002|Overall Study|Death|1|||
105967661|NCT03842969|365541859|FG000|Overall Study|Withdrawal by Subject|3|||
105967662|NCT03842969|365541860|FG001|Overall Study|Withdrawal by Subject|30|||
105967663|NCT03842969|365541861|FG002|Overall Study|Withdrawal by Subject|18|||
105967664|NCT03842969|365541859|FG000|Overall Study|Protocol Violation|1|||
106024058|NCT01349049|365754468|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
105841408|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Adverse Event|2|||
105841409|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Adverse Event|2|||
106024059|NCT01349049|365754469|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
106024060|NCT01349049|365754470|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
106024061|NCT01349049|365754471|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
106024062|NCT01349049|365754472|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
106024063|NCT01349049|365754473|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
106024064|NCT01349049|365754465|FG000|Overall Study|Other|0|||
106024065|NCT01349049|365754466|FG001|Overall Study|Other|0|||
106024066|NCT01349049|365754467|FG002|Overall Study|Other|0|||
106024067|NCT01349049|365754468|FG003|Overall Study|Other|0|||
106024068|NCT01349049|365754469|FG004|Overall Study|Other|0|||
106024069|NCT01349049|365754470|FG005|Overall Study|Other|1|||
105841410|NCT00545688|365075319|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
105841411|NCT00545688|365075320|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
105841412|NCT00545688|365075321|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
105841413|NCT00545688|365075322|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
105841414|NCT00545688|365075319|FG000|Follow-Up Period|Death|4|||
105841415|NCT00545688|365075320|FG001|Follow-Up Period|Death|2|||
105841416|NCT00545688|365075321|FG002|Follow-Up Period|Death|2|||
105841417|NCT00545688|365075322|FG003|Follow-Up Period|Death|6|||
105841418|NCT00545688|365075319|FG000|Follow-Up Period|Disease Progression|6|||
105841419|NCT00545688|365075320|FG001|Follow-Up Period|Disease Progression|5|||
105841420|NCT00545688|365075321|FG002|Follow-Up Period|Disease Progression|9|||
105841421|NCT00545688|365075322|FG003|Follow-Up Period|Disease Progression|9|||
105841422|NCT00545688|365075319|FG000|Follow-Up Period|Refused Treatment|6|||
105841423|NCT00545688|365075320|FG001|Follow-Up Period|Refused Treatment|2|||
105841424|NCT00545688|365075321|FG002|Follow-Up Period|Refused Treatment|0|||
105841425|NCT00545688|365075322|FG003|Follow-Up Period|Refused Treatment|2|||
105841426|NCT00545688|365075319|FG000|Follow-Up Period|Lost to Follow-up|3|||
105841427|NCT00545688|365075320|FG001|Follow-Up Period|Lost to Follow-up|3|||
105841428|NCT00545688|365075321|FG002|Follow-Up Period|Lost to Follow-up|3|||
105841429|NCT00545688|365075322|FG003|Follow-Up Period|Lost to Follow-up|1|||
105841430|NCT00545688|365075319|FG000|Follow-Up Period|Unspecified Reason|2|||
105841431|NCT00545688|365075320|FG001|Follow-Up Period|Unspecified Reason|5|||
105841432|NCT00545688|365075321|FG002|Follow-Up Period|Unspecified Reason|6|||
105841433|NCT00545688|365075322|FG003|Follow-Up Period|Unspecified Reason|8|||
105841434|NCT00545688|365075319|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
105841435|NCT00545688|365075320|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
105841436|NCT00545688|365075321|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
105841437|NCT00545688|365075322|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
105841438|NCT02858726|365075325|FG000|Overall Study|Adverse Event|4|||
105841439|NCT02858726|365075326|FG001|Overall Study|Adverse Event|4|||
105841440|NCT02858726|365075327|FG002|Overall Study|Adverse Event|9|||
105841441|NCT02858726|365075328|FG003|Overall Study|Adverse Event|1|||
105841442|NCT02858726|365075325|FG000|Overall Study|Physician Decision|0|||
105841443|NCT02858726|365075326|FG001|Overall Study|Physician Decision|0|||
105841444|NCT02858726|365075327|FG002|Overall Study|Physician Decision|1|||
105841445|NCT02858726|365075328|FG003|Overall Study|Physician Decision|0|||
105841446|NCT02858726|365075325|FG000|Overall Study|Protocol Violation|0|||
105841447|NCT02858726|365075326|FG001|Overall Study|Protocol Violation|0|||
105841448|NCT02858726|365075327|FG002|Overall Study|Protocol Violation|0|||
105841449|NCT02858726|365075328|FG003|Overall Study|Protocol Violation|1|||
105841450|NCT02858726|365075325|FG000|Overall Study|Study Terminated by Sponsor|0|||
105841451|NCT02858726|365075326|FG001|Overall Study|Study Terminated by Sponsor|0|||
105841452|NCT02858726|365075327|FG002|Overall Study|Study Terminated by Sponsor|0|||
105841453|NCT02858726|365075328|FG003|Overall Study|Study Terminated by Sponsor|1|||
105841454|NCT02858726|365075325|FG000|Overall Study|Withdrawal by Subject|1|||
105841455|NCT02858726|365075326|FG001|Overall Study|Withdrawal by Subject|2|||
105841456|NCT02858726|365075327|FG002|Overall Study|Withdrawal by Subject|1|||
105841457|NCT02858726|365075328|FG003|Overall Study|Withdrawal by Subject|0|||
105841458|NCT02858726|365075325|FG000|Overall Study|Noncompliance|0|||
105841459|NCT02858726|365075326|FG001|Overall Study|Noncompliance|1|||
105841460|NCT02858726|365075327|FG002|Overall Study|Noncompliance|0|||
105841461|NCT02858726|365075328|FG003|Overall Study|Noncompliance|0|||
106024070|NCT01349049|365754471|FG006|Overall Study|Other|0|||
106024071|NCT01349049|365754472|FG007|Overall Study|Other|0|||
105841462|NCT00233987|365075329|FG000|Overall Study|Withdrawal by Subject|1|||
105841463|NCT00233987|365075329|FG000|Overall Study|Lack of Efficacy|2|||
105841464|NCT00233987|365075329|FG000|Overall Study|Reason Under Review|1|||
106024072|NCT01349049|365754473|FG008|Overall Study|Other|4|||
106024073|NCT01349049|365754465|FG000|Overall Study|Death|0|||
106024074|NCT01349049|365754466|FG001|Overall Study|Death|0|||
105841465|NCT00233987|365075329|FG000|Overall Study|Other - Not Protocol Specified|5|||
105841466|NCT00233987|365075329|FG000|Overall Study|Eligible but No Treatment Received|2|||
105841467|NCT00233987|365075329|FG000|Overall Study|Ineligible|4|||
105841468|NCT03581188|365077565|FG000|Overall Study|Inclusion criteria not met|3|||
105841469|NCT03581188|365077566|FG001|Overall Study|Inclusion criteria not met|2|||
105841470|NCT03581188|365077565|FG000|Overall Study|Lost to Follow-up|5|||
106024075|NCT01349049|365754467|FG002|Overall Study|Death|0|||
105841471|NCT03581188|365077566|FG001|Overall Study|Lost to Follow-up|5|||
105841472|NCT03581188|365077565|FG000|Overall Study|Discontinued intervention|11|||
105841473|NCT03581188|365077566|FG001|Overall Study|Discontinued intervention|8|||
105841474|NCT04974619|365077569|FG000|Overall Study|Lost to Follow-up|0|||
105841475|NCT04974619|365077570|FG001|Overall Study|Lost to Follow-up|0|||
105841476|NCT04974619|365077571|FG002|Overall Study|Lost to Follow-up|1|||
105841477|NCT04974619|365077569|FG000|Overall Study|Withdrawal by Subject|0|||
105841478|NCT04974619|365077570|FG001|Overall Study|Withdrawal by Subject|0|||
105841479|NCT04974619|365077571|FG002|Overall Study|Withdrawal by Subject|1|||
105841480|NCT04974619|365077569|FG000|Overall Study|Protocol Violation|0|||
105841481|NCT04974619|365077570|FG001|Overall Study|Protocol Violation|1|||
105841482|NCT04974619|365077571|FG002|Overall Study|Protocol Violation|0|||
105841483|NCT01010126|365077580|FG000|Overall Study|Withdrawal by Subject|1|||
105841484|NCT01010126|365077581|FG001|Overall Study|Withdrawal by Subject|0|||
105841485|NCT01010126|365077582|FG002|Overall Study|Withdrawal by Subject|1|||
105841486|NCT01010126|365077583|FG003|Overall Study|Withdrawal by Subject|0|||
105841487|NCT01010126|365077584|FG004|Overall Study|Withdrawal by Subject|3|||
105841488|NCT01010126|365077585|FG005|Overall Study|Withdrawal by Subject|0|||
105841489|NCT01730040|365077595|FG000|Overall Study|Randomized but not treated|0|||
105841490|NCT01730040|365077596|FG001|Overall Study|Randomized but not treated|0|||
105841491|NCT01730040|365077597|FG002|Overall Study|Randomized but not treated|0|||
105841492|NCT01730040|365077598|FG003|Overall Study|Randomized but not treated|0|||
105841493|NCT01730040|365077599|FG004|Overall Study|Randomized but not treated|0|||
105841494|NCT01730040|365077600|FG005|Overall Study|Randomized but not treated|1|||
105841495|NCT01730040|365077601|FG006|Overall Study|Randomized but not treated|0|||
105841496|NCT01730040|365077595|FG000|Overall Study|Subject moved|0|||
105841497|NCT01730040|365077596|FG001|Overall Study|Subject moved|0|||
105841498|NCT01730040|365077597|FG002|Overall Study|Subject moved|1|||
105841499|NCT01730040|365077598|FG003|Overall Study|Subject moved|0|||
105841500|NCT01730040|365077599|FG004|Overall Study|Subject moved|0|||
105841501|NCT01730040|365077600|FG005|Overall Study|Subject moved|0|||
105841502|NCT01730040|365077601|FG006|Overall Study|Subject moved|1|||
105841503|NCT01730040|365077595|FG000|Overall Study|Physician Decision|0|||
105841504|NCT01730040|365077596|FG001|Overall Study|Physician Decision|0|||
105841505|NCT01730040|365077597|FG002|Overall Study|Physician Decision|0|||
105841506|NCT01730040|365077598|FG003|Overall Study|Physician Decision|0|||
105841507|NCT01730040|365077599|FG004|Overall Study|Physician Decision|0|||
105841508|NCT01730040|365077600|FG005|Overall Study|Physician Decision|1|||
105841509|NCT01730040|365077601|FG006|Overall Study|Physician Decision|1|||
105841510|NCT01730040|365077595|FG000|Overall Study|Other than specified|7|||
105841511|NCT01730040|365077596|FG001|Overall Study|Other than specified|8|||
105841512|NCT01730040|365077597|FG002|Overall Study|Other than specified|5|||
105841513|NCT01730040|365077598|FG003|Overall Study|Other than specified|5|||
105841514|NCT01730040|365077599|FG004|Overall Study|Other than specified|5|||
105841515|NCT01730040|365077600|FG005|Overall Study|Other than specified|4|||
105841516|NCT01730040|365077601|FG006|Overall Study|Other than specified|4|||
105841517|NCT01730040|365077595|FG000|Overall Study|Adverse Event|4|||
105841518|NCT01730040|365077596|FG001|Overall Study|Adverse Event|3|||
105841519|NCT01730040|365077597|FG002|Overall Study|Adverse Event|5|||
105841520|NCT01730040|365077598|FG003|Overall Study|Adverse Event|3|||
105841521|NCT01730040|365077599|FG004|Overall Study|Adverse Event|1|||
105841522|NCT01730040|365077600|FG005|Overall Study|Adverse Event|1|||
105841523|NCT01730040|365077601|FG006|Overall Study|Adverse Event|2|||
105841524|NCT01730040|365077595|FG000|Overall Study|Poor compliance to protocol|2|||
105841525|NCT01730040|365077596|FG001|Overall Study|Poor compliance to protocol|4|||
105841526|NCT01730040|365077597|FG002|Overall Study|Poor compliance to protocol|0|||
105841527|NCT01730040|365077598|FG003|Overall Study|Poor compliance to protocol|0|||
105841528|NCT01730040|365077599|FG004|Overall Study|Poor compliance to protocol|0|||
105841529|NCT01730040|365077600|FG005|Overall Study|Poor compliance to protocol|0|||
105841530|NCT01730040|365077601|FG006|Overall Study|Poor compliance to protocol|1|||
105841531|NCT01301482|365077604|FG000|Overall Study|Withdrawal by Subject|1|||
105841532|NCT01647958|365077605|FG000|Initial Study|Lost to Follow-up|2|||
105841533|NCT01647958|365077606|FG001|Initial Study|Lost to Follow-up|3|||
105841534|NCT01647958|365077605|FG000|Continuation Phase|treatment received during Overall Study|39|||
105841535|NCT01647958|365077606|FG001|Continuation Phase|treatment received during Overall Study|0|||
105841536|NCT01647958|365077605|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
105967665|NCT03842969|365541860|FG001|Overall Study|Protocol Violation|1|||
105967666|NCT03842969|365541861|FG002|Overall Study|Protocol Violation|0|||
105841537|NCT01647958|365077606|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
105841538|NCT00480324|365077609|FG000|Overall Study|Adverse Event|1|||
105841539|NCT00480324|365077610|FG001|Overall Study|Adverse Event|1|||
105841540|NCT00480324|365077609|FG000|Overall Study|Protocol Violation|0|||
105841541|NCT00480324|365077610|FG001|Overall Study|Protocol Violation|1|||
105841542|NCT00480324|365077609|FG000|Overall Study|Withdrawal by Subject|14|||
105841543|NCT00480324|365077610|FG001|Overall Study|Withdrawal by Subject|5|||
105841544|NCT00480324|365077609|FG000|Overall Study|Lost to Follow-up|17|||
105841545|NCT00480324|365077610|FG001|Overall Study|Lost to Follow-up|8|||
105967667|NCT03842969|365541859|FG000|Overall Study|Physician Decision|0|||
105967668|NCT03842969|365541860|FG001|Overall Study|Physician Decision|3|||
105967669|NCT03842969|365541861|FG002|Overall Study|Physician Decision|0|||
105967670|NCT03842969|365541859|FG000|Overall Study|Lost to Follow-up|0|||
105967671|NCT03842969|365541860|FG001|Overall Study|Lost to Follow-up|2|||
105967672|NCT03842969|365541861|FG002|Overall Study|Lost to Follow-up|0|||
105967673|NCT03842969|365541859|FG000|Overall Study|Adverse Event|0|||
105967674|NCT03842969|365541860|FG001|Overall Study|Adverse Event|2|||
105967675|NCT03842969|365541861|FG002|Overall Study|Adverse Event|0|||
105967676|NCT04187144|365541862|FG000|Overall Study|Lost to Follow-up|12|||
105967677|NCT04187144|365541863|FG001|Overall Study|Lost to Follow-up|11|||
105967678|NCT04187144|365541862|FG000|Overall Study|Withdrawal by Subject|20|||
105967679|NCT04187144|365541863|FG001|Overall Study|Withdrawal by Subject|18|||
105967680|NCT04187144|365541862|FG000|Overall Study|Adverse Event|19|||
105967681|NCT04187144|365541863|FG001|Overall Study|Adverse Event|4|||
105967682|NCT04187144|365541862|FG000|Overall Study|Physician Decision|5|||
105967683|NCT04187144|365541863|FG001|Overall Study|Physician Decision|3|||
105967684|NCT04187144|365541862|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
105967685|NCT04187144|365541863|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
105967686|NCT04187144|365541862|FG000|Overall Study|Protocol Deviation|1|||
105967687|NCT04187144|365541863|FG001|Overall Study|Protocol Deviation|4|||
105967688|NCT02650804|365541864|FG000|Overall Study|Adverse Event|3|||
105967689|NCT02650804|365541865|FG001|Overall Study|Adverse Event|2|||
105967690|NCT02650804|365541864|FG000|Overall Study|Death|1|||
105967691|NCT02650804|365541865|FG001|Overall Study|Death|2|||
105967692|NCT02650804|365541864|FG000|Overall Study|Progressive Disease|7|||
105967693|NCT02650804|365541865|FG001|Overall Study|Progressive Disease|10|||
105967694|NCT02650804|365541864|FG000|Overall Study|Physician Decision|0|||
105967695|NCT02650804|365541865|FG001|Overall Study|Physician Decision|2|||
105967696|NCT02650804|365541864|FG000|Overall Study|Withdrawal by Subject|1|||
105967697|NCT02650804|365541865|FG001|Overall Study|Withdrawal by Subject|4|||
105967698|NCT02650804|365541864|FG000|Overall Study|Symptomatic deterioration|5|||
105967699|NCT02650804|365541865|FG001|Overall Study|Symptomatic deterioration|7|||
105967700|NCT02650804|365541864|FG000|Overall Study|Protocol Violation|0|||
105967701|NCT02650804|365541865|FG001|Overall Study|Protocol Violation|1|||
105967702|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Adverse Event|76|||
105967703|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Adverse Event|0|||
105967704|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Adverse Event|0|||
105967705|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Death|3|||
105967706|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Death|0|||
105967707|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Death|0|||
105967708|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
105967709|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
105967710|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
105967711|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Physician Decision|9|||
105967712|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Physician Decision|0|||
105967713|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Physician Decision|0|||
105967714|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
105967715|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
105967716|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
105967717|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Disease progression|45|||
105967718|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Disease progression|0|||
105967719|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Disease progression|0|||
105967720|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
105967721|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
105967722|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
105967723|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
105967724|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
105967725|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
105967726|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
105967727|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
105967728|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
105967729|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
105967730|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
105967731|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
105967732|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
105967733|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
105967734|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
105967735|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
105967736|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
105987447|NCT02814175|365614462|FG002|Part 1|Adverse Event|0|||
105987448|NCT02814175|365614463|FG003|Part 1|Adverse Event|0|||
105987449|NCT02814175|365614464|FG004|Part 1|Adverse Event|0|||
106024076|NCT01349049|365754468|FG003|Overall Study|Death|0|||
106024077|NCT01349049|365754469|FG004|Overall Study|Death|0|||
106024078|NCT01349049|365754470|FG005|Overall Study|Death|0|||
106024079|NCT01349049|365754471|FG006|Overall Study|Death|0|||
106024080|NCT01349049|365754472|FG007|Overall Study|Death|1|||
106024081|NCT01349049|365754473|FG008|Overall Study|Death|5|||
106024082|NCT01349049|365754465|FG000|Overall Study|Non-compliance|0|||
106024083|NCT01349049|365754466|FG001|Overall Study|Non-compliance|0|||
106024084|NCT01349049|365754467|FG002|Overall Study|Non-compliance|0|||
106024085|NCT01349049|365754468|FG003|Overall Study|Non-compliance|1|||
106024086|NCT01349049|365754469|FG004|Overall Study|Non-compliance|0|||
106024087|NCT01349049|365754470|FG005|Overall Study|Non-compliance|0|||
106024088|NCT01349049|365754471|FG006|Overall Study|Non-compliance|0|||
106024089|NCT01349049|365754472|FG007|Overall Study|Non-compliance|0|||
105841546|NCT00480324|365077609|FG000|Overall Study|Subject's mother pregnant|0|||
105841547|NCT00480324|365077610|FG001|Overall Study|Subject's mother pregnant|1|||
105841548|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
105841549|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
105841550|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
105841551|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
105841552|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
105841553|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
105841554|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
105841555|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
105841556|NCT03785145|365077611|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
105841557|NCT03785145|365077612|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
105841558|NCT03785145|365077611|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
105841559|NCT03785145|365077612|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
105841560|NCT03785145|365077611|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
105841561|NCT03785145|365077612|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
105841562|NCT03785145|365077611|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
105841563|NCT03785145|365077612|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
105841564|NCT03785145|365077611|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
105841565|NCT03785145|365077612|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
105841566|NCT03785145|365077611|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
105841567|NCT03785145|365077612|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
105841568|NCT03785145|365077611|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
105841569|NCT03785145|365077612|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
105841570|NCT03686150|365077620|FG000|Overall Study|Withdrawal by Subject|1|||
105841571|NCT03686150|365077621|FG001|Overall Study|Withdrawal by Subject|1|||
105841572|NCT03686150|365077622|FG002|Overall Study|Withdrawal by Subject|1|||
105841573|NCT03686150|365077623|FG003|Overall Study|Withdrawal by Subject|0|||
105841574|NCT03686150|365077624|FG004|Overall Study|Withdrawal by Subject|1|||
105841575|NCT03686150|365077625|FG005|Overall Study|Withdrawal by Subject|2|||
105841576|NCT03686150|365077620|FG000|Overall Study|Physician Decision|1|||
105841577|NCT03686150|365077621|FG001|Overall Study|Physician Decision|0|||
105841578|NCT03686150|365077622|FG002|Overall Study|Physician Decision|0|||
105841579|NCT03686150|365077623|FG003|Overall Study|Physician Decision|0|||
105841580|NCT03686150|365077624|FG004|Overall Study|Physician Decision|0|||
105841581|NCT03686150|365077625|FG005|Overall Study|Physician Decision|1|||
105841582|NCT03686150|365077620|FG000|Overall Study|Lost to Follow-up|0|||
105841583|NCT03686150|365077621|FG001|Overall Study|Lost to Follow-up|1|||
105841584|NCT03686150|365077622|FG002|Overall Study|Lost to Follow-up|0|||
105841585|NCT03686150|365077623|FG003|Overall Study|Lost to Follow-up|0|||
105841586|NCT03686150|365077624|FG004|Overall Study|Lost to Follow-up|0|||
105841587|NCT03686150|365077625|FG005|Overall Study|Lost to Follow-up|0|||
105841588|NCT00614926|365077626|FG000|Overall Study|Burden of travel|1|||
105841589|NCT00614926|365077627|FG001|Overall Study|Burden of travel|0|||
105841590|NCT00614926|365077626|FG000|Overall Study|Adverse Event|3|||
105841591|NCT00614926|365077627|FG001|Overall Study|Adverse Event|0|||
105841592|NCT01207440|365077628|FG000|Overall Study|Adverse Event|46|||
105841593|NCT01207440|365077629|FG001|Overall Study|Adverse Event|11|||
106024090|NCT01349049|365754473|FG008|Overall Study|Non-compliance|0|||
106024091|NCT01349049|365754465|FG000|Overall Study|Withdrawal by Subject|0|||
106149410|NCT03598790|366209106|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106149411|NCT03598790|366209107|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106149412|NCT03598790|366209108|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
106149413|NCT03598790|366209109|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
105841594|NCT01207440|365077630|FG002|Overall Study|Adverse Event|7|||
105841595|NCT01207440|365077631|FG003|Overall Study|Adverse Event|2|||
105841596|NCT01207440|365077632|FG004|Overall Study|Adverse Event|6|||
106024092|NCT01349049|365754466|FG001|Overall Study|Withdrawal by Subject|0|||
106149414|NCT03598790|366209110|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
105841597|NCT01207440|365077633|FG005|Overall Study|Adverse Event|6|||
105967737|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
105841598|NCT01207440|365077634|FG006|Overall Study|Adverse Event|2|||
105841599|NCT01207440|365077628|FG000|Overall Study|Death|6|||
105841600|NCT01207440|365077629|FG001|Overall Study|Death|3|||
105841601|NCT01207440|365077630|FG002|Overall Study|Death|2|||
105841602|NCT01207440|365077631|FG003|Overall Study|Death|2|||
105841603|NCT01207440|365077632|FG004|Overall Study|Death|7|||
105841604|NCT01207440|365077633|FG005|Overall Study|Death|5|||
105841605|NCT01207440|365077634|FG006|Overall Study|Death|1|||
105841606|NCT01207440|365077628|FG000|Overall Study|Lack of Efficacy|13|||
105841607|NCT01207440|365077629|FG001|Overall Study|Lack of Efficacy|2|||
105841608|NCT01207440|365077630|FG002|Overall Study|Lack of Efficacy|5|||
105841609|NCT01207440|365077631|FG003|Overall Study|Lack of Efficacy|1|||
105841610|NCT01207440|365077632|FG004|Overall Study|Lack of Efficacy|2|||
105841611|NCT01207440|365077633|FG005|Overall Study|Lack of Efficacy|3|||
105841612|NCT01207440|365077634|FG006|Overall Study|Lack of Efficacy|0|||
105841613|NCT01207440|365077628|FG000|Overall Study|Lost to Follow-up|0|||
105841614|NCT01207440|365077629|FG001|Overall Study|Lost to Follow-up|0|||
105841615|NCT01207440|365077630|FG002|Overall Study|Lost to Follow-up|2|||
105841616|NCT01207440|365077631|FG003|Overall Study|Lost to Follow-up|1|||
105841617|NCT01207440|365077632|FG004|Overall Study|Lost to Follow-up|0|||
105841618|NCT01207440|365077633|FG005|Overall Study|Lost to Follow-up|0|||
105841619|NCT01207440|365077634|FG006|Overall Study|Lost to Follow-up|0|||
105841620|NCT01207440|365077628|FG000|Overall Study|Non-compliance with Study Drug|3|||
105841621|NCT01207440|365077629|FG001|Overall Study|Non-compliance with Study Drug|0|||
105841622|NCT01207440|365077630|FG002|Overall Study|Non-compliance with Study Drug|1|||
105841623|NCT01207440|365077631|FG003|Overall Study|Non-compliance with Study Drug|0|||
105841624|NCT01207440|365077632|FG004|Overall Study|Non-compliance with Study Drug|0|||
105841625|NCT01207440|365077633|FG005|Overall Study|Non-compliance with Study Drug|0|||
105841626|NCT01207440|365077634|FG006|Overall Study|Non-compliance with Study Drug|0|||
105841627|NCT01207440|365077628|FG000|Overall Study|Physician Decision|6|||
105841628|NCT01207440|365077629|FG001|Overall Study|Physician Decision|5|||
105841629|NCT01207440|365077630|FG002|Overall Study|Physician Decision|5|||
105841630|NCT01207440|365077631|FG003|Overall Study|Physician Decision|0|||
105841631|NCT01207440|365077632|FG004|Overall Study|Physician Decision|1|||
105841632|NCT01207440|365077633|FG005|Overall Study|Physician Decision|0|||
105841633|NCT01207440|365077634|FG006|Overall Study|Physician Decision|0|||
105841634|NCT01207440|365077628|FG000|Overall Study|Progressive Disease|19|||
105841635|NCT01207440|365077629|FG001|Overall Study|Progressive Disease|10|||
105841636|NCT01207440|365077630|FG002|Overall Study|Progressive Disease|19|||
105841637|NCT01207440|365077631|FG003|Overall Study|Progressive Disease|7|||
105841638|NCT01207440|365077632|FG004|Overall Study|Progressive Disease|23|||
105841639|NCT01207440|365077633|FG005|Overall Study|Progressive Disease|27|||
105841640|NCT01207440|365077634|FG006|Overall Study|Progressive Disease|0|||
105841641|NCT01207440|365077628|FG000|Overall Study|Protocol Violation|2|||
105841642|NCT01207440|365077629|FG001|Overall Study|Protocol Violation|0|||
105841643|NCT01207440|365077630|FG002|Overall Study|Protocol Violation|0|||
105841644|NCT01207440|365077631|FG003|Overall Study|Protocol Violation|0|||
105841645|NCT01207440|365077632|FG004|Overall Study|Protocol Violation|0|||
105841646|NCT01207440|365077633|FG005|Overall Study|Protocol Violation|0|||
105841647|NCT01207440|365077634|FG006|Overall Study|Protocol Violation|0|||
105841648|NCT01207440|365077628|FG000|Overall Study|Site Terminated by Sponsor|69|||
105841649|NCT01207440|365077629|FG001|Overall Study|Site Terminated by Sponsor|19|||
105841650|NCT01207440|365077630|FG002|Overall Study|Site Terminated by Sponsor|12|||
105841651|NCT01207440|365077631|FG003|Overall Study|Site Terminated by Sponsor|2|||
105841652|NCT01207440|365077632|FG004|Overall Study|Site Terminated by Sponsor|3|||
105841653|NCT01207440|365077633|FG005|Overall Study|Site Terminated by Sponsor|0|||
105841654|NCT01207440|365077634|FG006|Overall Study|Site Terminated by Sponsor|2|||
105841655|NCT01207440|365077628|FG000|Overall Study|Withdrawal by Subject|29|||
105841656|NCT01207440|365077629|FG001|Overall Study|Withdrawal by Subject|4|||
105841657|NCT01207440|365077630|FG002|Overall Study|Withdrawal by Subject|5|||
105841658|NCT01207440|365077631|FG003|Overall Study|Withdrawal by Subject|3|||
105841659|NCT01207440|365077632|FG004|Overall Study|Withdrawal by Subject|2|||
105841660|NCT01207440|365077633|FG005|Overall Study|Withdrawal by Subject|2|||
105967738|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
105967739|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
105967740|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
105841661|NCT01207440|365077634|FG006|Overall Study|Withdrawal by Subject|0|||
105841662|NCT01207440|365077628|FG000|Overall Study|Reason Not Specified|10|||
105967741|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
105841663|NCT01207440|365077629|FG001|Overall Study|Reason Not Specified|10|||
105841664|NCT01207440|365077630|FG002|Overall Study|Reason Not Specified|7|||
105841665|NCT01207440|365077631|FG003|Overall Study|Reason Not Specified|0|||
105841666|NCT01207440|365077632|FG004|Overall Study|Reason Not Specified|4|||
105841667|NCT01207440|365077633|FG005|Overall Study|Reason Not Specified|3|||
105841668|NCT01207440|365077634|FG006|Overall Study|Reason Not Specified|0|||
105841669|NCT01316419|365077638|FG000|Overall Study|Not treated|103|||
105967742|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
105967743|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
105967744|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
105967745|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
105967746|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
105967747|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Promotor request|1|||
105967748|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Promotor request|0|||
105967749|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Promotor request|0|||
105967750|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
105967751|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
105967752|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
105967753|NCT01461928|365541867|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
105967754|NCT01461928|365541868|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
105967755|NCT01461928|365541869|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
105967756|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Death|3|||
105967757|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Death|0|||
105967758|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Death|0|||
105967759|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
105967760|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
105967761|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
105967762|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
105967763|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
105967764|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
105967765|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Diseases progression|91|||
105967766|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Diseases progression|0|||
105967767|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Diseases progression|0|||
105967768|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Adverse Event|70|||
105967769|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Adverse Event|0|||
105967770|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Adverse Event|0|||
105967771|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Physician Decision|9|||
105967772|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Physician Decision|0|||
105967773|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Physician Decision|0|||
105967774|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
105967775|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
105967776|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
105967777|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
105967778|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
105967779|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
105967780|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
105967781|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
105967782|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
105967783|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Not compliant|1|||
105967784|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Not compliant|0|||
105967785|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Not compliant|0|||
105967786|NCT01461928|365541867|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
105967787|NCT01461928|365541868|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
105967788|NCT01461928|365541869|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
105967789|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Adverse Event|0|||
105967790|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Adverse Event|2|||
105967791|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Adverse Event|0|||
105967792|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Death|0|||
105967793|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Death|10|||
105967794|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Death|8|||
105967795|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Physician Decision|0|||
105967796|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Physician Decision|0|||
105967797|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Physician Decision|4|||
105967798|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
105967799|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
105967800|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
105967801|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Moved to another town|0|||
105967802|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Moved to another town|1|||
105967803|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Moved to another town|0|||
105967804|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Disease progression|0|||
105967805|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Disease progression|0|||
106024093|NCT01349049|365754467|FG002|Overall Study|Withdrawal by Subject|0|||
106024094|NCT01349049|365754468|FG003|Overall Study|Withdrawal by Subject|0|||
106024095|NCT01349049|365754469|FG004|Overall Study|Withdrawal by Subject|0|||
106024096|NCT01349049|365754470|FG005|Overall Study|Withdrawal by Subject|0|||
105967806|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Disease progression|3|||
105967807|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
105967808|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
105967809|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
105967810|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
105967811|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
105967812|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
105967813|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
105967814|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
105967815|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
105967816|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
105967817|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
105967818|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
105967819|NCT01461928|365541867|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
105967820|NCT01461928|365541868|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
105967821|NCT01461928|365541869|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
105967822|NCT00733291|365541874|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
105967823|NCT00733291|365541875|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
105967824|NCT00733291|365541876|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
105967825|NCT00733291|365541877|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
105967826|NCT02242435|365541878|FG000|Overall Study|Lost to Follow-up|3|||
105967827|NCT02242435|365541879|FG001|Overall Study|Lost to Follow-up|4|||
105967828|NCT02242435|365541878|FG000|Overall Study|Adverse Event|3|||
105967829|NCT02242435|365541879|FG001|Overall Study|Adverse Event|2|||
105967830|NCT02242435|365541878|FG000|Overall Study|Withdrawal by Subject|13|||
105967831|NCT02242435|365541879|FG001|Overall Study|Withdrawal by Subject|8|||
105967832|NCT02242435|365541878|FG000|Overall Study|Death|0|||
105967833|NCT02242435|365541879|FG001|Overall Study|Death|1|||
105967834|NCT02242435|365541878|FG000|Overall Study|Protocol Violation|1|||
105967835|NCT02242435|365541879|FG001|Overall Study|Protocol Violation|0|||
105967836|NCT02242435|365541878|FG000|Overall Study|Physician Decision|0|||
105967837|NCT02242435|365541879|FG001|Overall Study|Physician Decision|1|||
105967838|NCT03095027|365541888|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
105967839|NCT03095027|365541889|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
105967840|NCT00489424|365541891|FG000|Overall Study|Adverse Event|3|||
105967841|NCT00489424|365541892|FG001|Overall Study|Adverse Event|3|||
105967842|NCT00489424|365541893|FG002|Overall Study|Adverse Event|4|||
105967843|NCT00489424|365541891|FG000|Overall Study|Lack of Efficacy|1|||
105967844|NCT00489424|365541892|FG001|Overall Study|Lack of Efficacy|0|||
105967845|NCT00489424|365541893|FG002|Overall Study|Lack of Efficacy|0|||
105967846|NCT00489424|365541891|FG000|Overall Study|Administrative problems|0|||
105967847|NCT00489424|365541892|FG001|Overall Study|Administrative problems|2|||
105967848|NCT00489424|365541893|FG002|Overall Study|Administrative problems|1|||
105967849|NCT00705250|365541894|FG000|Overall Study|Withdrawal by Subject|1|||
105967850|NCT00705250|365541894|FG000|Overall Study|Patient died in car accident|1|||
105967851|NCT02974855|365541899|FG000|Overall Study|Adverse Event|0|||
105967852|NCT02974855|365541900|FG001|Overall Study|Adverse Event|1|||
105967853|NCT02974855|365541901|FG002|Overall Study|Adverse Event|0|||
105967854|NCT02974855|365541902|FG003|Overall Study|Adverse Event|1|||
105967855|NCT01681069|365541903|FG000|Overall Study|Withdrawal by Subject|4|||
105967856|NCT01681069|365541904|FG001|Overall Study|Withdrawal by Subject|5|||
105967857|NCT01681069|365541903|FG000|Overall Study|Protocol Violation|1|||
105967858|NCT01681069|365541904|FG001|Overall Study|Protocol Violation|1|||
105967859|NCT01681069|365541903|FG000|Overall Study|Adverse Event|0|||
105967860|NCT01681069|365541904|FG001|Overall Study|Adverse Event|1|||
105967861|NCT00923975|365541905|FG000|Overall Study|Did not meet inclusion criteria|1|||
105967862|NCT01032291|365541913|FG000|Safety Lead-in|Adverse Event|1|||
105967863|NCT01032291|365541914|FG001|Safety Lead-in|Adverse Event|0|||
105967864|NCT01032291|365541915|FG002|Safety Lead-in|Adverse Event|0|||
105967865|NCT01032291|365541913|FG000|Safety Lead-in|Death|1|||
105967866|NCT01032291|365541914|FG001|Safety Lead-in|Death|0|||
105967867|NCT01032291|365541915|FG002|Safety Lead-in|Death|0|||
105967868|NCT01032291|365541913|FG000|Proof of Concept|Adverse Event|0|||
105967869|NCT01032291|365541914|FG001|Proof of Concept|Adverse Event|5|||
105967870|NCT01032291|365541915|FG002|Proof of Concept|Adverse Event|1|||
105967871|NCT01032291|365541913|FG000|Proof of Concept|Death|0|||
105967872|NCT01032291|365541914|FG001|Proof of Concept|Death|1|||
105967873|NCT01032291|365541915|FG002|Proof of Concept|Death|2|||
105967874|NCT01032291|365541913|FG000|Proof of Concept|Lack of Efficacy|0|||
105967875|NCT01032291|365541914|FG001|Proof of Concept|Lack of Efficacy|1|||
105967876|NCT01032291|365541915|FG002|Proof of Concept|Lack of Efficacy|0|||
105967877|NCT01032291|365541913|FG000|Proof of Concept|Never Received Study Drug|0|||
105967878|NCT01032291|365541914|FG001|Proof of Concept|Never Received Study Drug|1|||
105967879|NCT01032291|365541915|FG002|Proof of Concept|Never Received Study Drug|0|||
105841670|NCT01316419|365077638|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
105841671|NCT01316419|365077638|FG000|Overall Study|Lost to Follow-up|19|||
105841672|NCT03341000|365077641|FG000|Overall Study|Adverse Event|1|||
105841673|NCT00754013|365077642|FG000|Overall Study|Lost to Follow-up|1|||
105841674|NCT00754013|365077643|FG001|Overall Study|Lost to Follow-up|1|||
105841675|NCT00754013|365077642|FG000|Overall Study|didn't return after study termed|3|||
105841676|NCT00754013|365077643|FG001|Overall Study|didn't return after study termed|4|||
105841677|NCT02310789|365077644|FG000|Overall Study|Adverse Event|1|||
105841678|NCT00792623|365077646|FG000|Overall Study|Adverse Event|2|||
105841679|NCT00792623|365077646|FG000|Overall Study|Withdrawal by Subject|5|||
105841680|NCT00107042|365077647|FG000|Overall Study|Lost to Follow-up|9|||
105841681|NCT00107042|365077648|FG001|Overall Study|Lost to Follow-up|7|||
105841682|NCT00107042|365077647|FG000|Overall Study|Withdrawal by Subject|6|||
105841683|NCT00107042|365077648|FG001|Overall Study|Withdrawal by Subject|1|||
105841684|NCT00107042|365077647|FG000|Overall Study|Moved out of area|5|||
105841685|NCT00107042|365077648|FG001|Overall Study|Moved out of area|3|||
105841686|NCT00107042|365077647|FG000|Overall Study|Pregnancy|1|||
105841687|NCT00107042|365077648|FG001|Overall Study|Pregnancy|1|||
105841688|NCT00107042|365077647|FG000|Overall Study|Inadvertent enrollment|0|||
105841689|NCT00107042|365077648|FG001|Overall Study|Inadvertent enrollment|1|||
105841690|NCT00107042|365077647|FG000|Overall Study|vaccinated outside window|1|||
105841691|NCT00107042|365077648|FG001|Overall Study|vaccinated outside window|1|||
105841692|NCT00107042|365077647|FG000|Overall Study|Disallowed medications|0|||
105841693|NCT00107042|365077648|FG001|Overall Study|Disallowed medications|2|||
105841694|NCT03919448|365077649|FG000|Overall Study|Withdrawal by Subject|1|||
105841695|NCT03919448|365077650|FG001|Overall Study|Withdrawal by Subject|0|||
105841696|NCT03919448|365077651|FG002|Overall Study|Withdrawal by Subject|0|||
105841697|NCT04213209|365077652|FG000|Overall Study|Protocol Violation|1|||
105841698|NCT04213209|365077653|FG001|Overall Study|Protocol Violation|0|||
105841699|NCT04213209|365077654|FG002|Overall Study|Protocol Violation|0|||
105841700|NCT04213209|365077655|FG003|Overall Study|Protocol Violation|0|||
105841701|NCT04213209|365077656|FG004|Overall Study|Protocol Violation|0|||
105841702|NCT04213209|365077657|FG005|Overall Study|Protocol Violation|0|||
105841703|NCT02776553|365077664|FG000|Overall Study|Lost to Follow-up|1|||
105841704|NCT02776553|365077665|FG001|Overall Study|Lost to Follow-up|0|||
105841705|NCT02776553|365077664|FG000|Overall Study|got liver transplant|1|||
105841706|NCT02776553|365077665|FG001|Overall Study|got liver transplant|2|||
105841707|NCT02776553|365077664|FG000|Overall Study|had other surgery|1|||
105841708|NCT02776553|365077665|FG001|Overall Study|had other surgery|0|||
105841709|NCT02776553|365077664|FG000|Overall Study|Protocol Violation|0|||
105841710|NCT02776553|365077665|FG001|Overall Study|Protocol Violation|1|||
105841711|NCT03827018|365077668|FG000|Overall Study|Adverse Event|1|||
105841712|NCT03827018|365077669|FG001|Overall Study|Adverse Event|0|||
105841713|NCT03827018|365077668|FG000|Overall Study|Withdrawal by Subject|2|||
105841714|NCT03827018|365077669|FG001|Overall Study|Withdrawal by Subject|2|||
105841715|NCT03827018|365077668|FG000|Overall Study|Lack of Efficacy|0|||
105841716|NCT03827018|365077669|FG001|Overall Study|Lack of Efficacy|1|||
105841717|NCT01803269|365077674|FG000|Overall Study|Withdrawal by Subject|3|||
105841718|NCT01803269|365077675|FG001|Overall Study|Withdrawal by Subject|0|||
105841719|NCT01803269|365077676|FG002|Overall Study|Withdrawal by Subject|0|||
105841720|NCT01435031|365077680|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
105841721|NCT01435031|365077680|FG000|ITT at 1 Month|Death|1|||
105841722|NCT01435031|365077680|FG000|ITT at 1 Month|Lost to Follow-up|4|||
105841723|NCT01435031|365077680|FG000|ITT at 6 Months|Death|2|||
105841724|NCT01435031|365077680|FG000|ITT at 6 Months|Lost to Follow-up|3|||
105841725|NCT01435031|365077680|FG000|ITT at 1 Year|Death|1|||
105841726|NCT01435031|365077680|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
105841727|NCT01435031|365077680|FG000|ITT at 1 Year|Lost to Follow-up|6|||
105841728|NCT01435031|365077680|FG000|ITT at 2 Years|Death|7|||
105841729|NCT01435031|365077680|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
105841730|NCT01435031|365077680|FG000|ITT at 2 Years|Lost to Follow-up|4|||
105841731|NCT01435031|365077680|FG000|ITT at 3 Years|Death|5|||
105841732|NCT01435031|365077680|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
106149415|NCT03598790|366209111|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106149416|NCT03598790|366209112|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105841733|NCT01435031|365077680|FG000|ITT at 3 Years|Lost to Follow-up|4|||
105841734|NCT01435031|365077680|FG000|ITT at 4 Years|Death|4|||
106149417|NCT03598790|366209113|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
105841735|NCT01435031|365077680|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
105841736|NCT01435031|365077680|FG000|ITT at 4 Years|Lost to Follow-up|1|||
105841737|NCT02927834|365077681|FG000|Overall Study|Lost to Follow-up|1|||
105841738|NCT02927834|365077682|FG001|Overall Study|Lost to Follow-up|2|||
105841739|NCT02927834|365077683|FG002|Overall Study|Lost to Follow-up|2|||
105841740|NCT03812991|365077684|FG000|Overall Study|Lost to Follow-up|3|||
105841741|NCT03812991|365077685|FG001|Overall Study|Lost to Follow-up|1|||
105841742|NCT04798482|365077697|FG000|Overall Study|Physician Decision|1|||
105841743|NCT04798482|365077697|FG000|Overall Study|Lost eligibility|1|||
105841744|NCT04349631|365077698|FG000|Overall Study|Lost to Follow-up|3|||
105841745|NCT04349631|365077698|FG000|Overall Study|Withdrawal by Subject|7|||
105967880|NCT02449889|365541916|FG000|Overall Study|Adverse Event|1|||
105967881|NCT02449889|365541917|FG001|Overall Study|Adverse Event|2|||
105967882|NCT02449889|365541918|FG002|Overall Study|Adverse Event|0|||
105967883|NCT02449889|365541916|FG000|Overall Study|Protocol Violation|0|||
105967884|NCT02449889|365541917|FG001|Overall Study|Protocol Violation|4|||
105967885|NCT02449889|365541918|FG002|Overall Study|Protocol Violation|1|||
105967886|NCT00758264|365541919|FG000|Active Phase|Withdrawal by Subject|0|||
105967887|NCT00758264|365541920|FG001|Active Phase|Withdrawal by Subject|0|||
105967888|NCT00758264|365541921|FG002|Active Phase|Withdrawal by Subject|1|||
105967889|NCT00758264|365541919|FG000|Active Phase|Lost to Follow-up|1|||
105967890|NCT00758264|365541920|FG001|Active Phase|Lost to Follow-up|0|||
105967891|NCT00758264|365541921|FG002|Active Phase|Lost to Follow-up|0|||
105967892|NCT00758264|365541919|FG000|Active Phase|Other|0|||
105967893|NCT00758264|365541920|FG001|Active Phase|Other|0|||
105967894|NCT00758264|365541921|FG002|Active Phase|Other|4|||
105967895|NCT03425006|365541922|FG000|Overall Study|Withdrawal by Subject|1|||
105967896|NCT03425006|365541922|FG000|Overall Study|Physician Decision|1|||
105967897|NCT03425006|365541922|FG000|Overall Study|Death|1|||
105967898|NCT01498575|365541923|FG000|Overall Sample|Withdrawal by Subject|60|||
105967899|NCT01498575|365541924|FG001|Overall Sample|Withdrawal by Subject|14|||
105967900|NCT01498575|365541923|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
105967901|NCT01498575|365541924|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
105967902|NCT01498575|365541923|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
105967903|NCT01498575|365541924|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
105967904|NCT02300558|365541926|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
105967905|NCT02300558|365541926|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
105967906|NCT02300558|365541926|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
105967907|NCT02300558|365541926|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
105967908|NCT01562314|365541937|FG000|Overall Study|Adverse Event|10|||
105967909|NCT01562314|365541938|FG001|Overall Study|Adverse Event|5|||
105967910|NCT01562314|365541937|FG000|Overall Study|Met Withdrawal Criteria|3|||
105967911|NCT01562314|365541938|FG001|Overall Study|Met Withdrawal Criteria|2|||
105967912|NCT01562314|365541937|FG000|Overall Study|Withdrawal by Subject|0|||
105967913|NCT01562314|365541938|FG001|Overall Study|Withdrawal by Subject|1|||
105967914|NCT02851797|365541939|FG000|Overall Study|Withdrawal by Subject|4|||
105967915|NCT02851797|365541940|FG001|Overall Study|Withdrawal by Subject|2|||
105967916|NCT02851797|365541939|FG000|Overall Study|Adverse Event|3|||
105967917|NCT02851797|365541940|FG001|Overall Study|Adverse Event|0|||
105967918|NCT00543803|365541942|FG000|Overall Study|Adverse Event|14|||
105967919|NCT00543803|365541942|FG000|Overall Study|Lack of Efficacy|22|||
105967920|NCT00543803|365541942|FG000|Overall Study|Lost to Follow-up|20|||
105967921|NCT00543803|365541942|FG000|Overall Study|Other|86|||
105967922|NCT04154345|365541952|FG000|Overall Study|Covid-19 pandemic|4|||
105967923|NCT00516906|365541956|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
105967924|NCT00516906|365541957|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
105967925|NCT00157196|365541960|FG000|Overall Study|Ongoing at data cut-off|9|||
105967926|NCT04210245|365541961|FG000|Overall Study|Adverse Event|0|||
105967927|NCT04210245|365541962|FG001|Overall Study|Adverse Event|3|||
105967928|NCT04210245|365541963|FG002|Overall Study|Adverse Event|6|||
105967929|NCT04210245|365541964|FG003|Overall Study|Adverse Event|0|||
105967930|NCT04210245|365541961|FG000|Overall Study|Withdrawal by Subject|0|||
105967931|NCT04210245|365541962|FG001|Overall Study|Withdrawal by Subject|1|||
105967932|NCT04210245|365541963|FG002|Overall Study|Withdrawal by Subject|4|||
105967933|NCT04210245|365541964|FG003|Overall Study|Withdrawal by Subject|4|||
105967934|NCT04210245|365541961|FG000|Overall Study|Lost to Follow-up|0|||
105967935|NCT04210245|365541962|FG001|Overall Study|Lost to Follow-up|1|||
105967936|NCT04210245|365541963|FG002|Overall Study|Lost to Follow-up|1|||
105967937|NCT04210245|365541964|FG003|Overall Study|Lost to Follow-up|1|||
105967938|NCT04210245|365541961|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
105967939|NCT04210245|365541962|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
105967940|NCT04210245|365541963|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
105967941|NCT04210245|365541964|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
105967942|NCT03941964|365541965|FG000|Overall Study|Adverse Event|1|||
105967943|NCT03941964|365541966|FG001|Overall Study|Adverse Event|8|||
105967944|NCT03941964|365541965|FG000|Overall Study|Progressive disease|7|||
105967945|NCT03941964|365541966|FG001|Overall Study|Progressive disease|3|||
105967946|NCT03941964|365541965|FG000|Overall Study|Lack of Efficacy|0|||
105967947|NCT03941964|365541966|FG001|Overall Study|Lack of Efficacy|1|||
105967948|NCT03941964|365541965|FG000|Overall Study|Death|3|||
105967949|NCT03941964|365541966|FG001|Overall Study|Death|1|||
105967950|NCT03941964|365541965|FG000|Overall Study|Withdrew consent|1|||
105967951|NCT03941964|365541966|FG001|Overall Study|Withdrew consent|3|||
105967952|NCT03941964|365541965|FG000|Overall Study|Physician Decision|9|||
105967953|NCT03941964|365541966|FG001|Overall Study|Physician Decision|2|||
105841746|NCT01258101|365077701|FG000|Overall Study|Adverse Event|5|||
105841747|NCT01258101|365077702|FG001|Overall Study|Adverse Event|6|||
105841748|NCT01258101|365077703|FG002|Overall Study|Adverse Event|0|||
105841749|NCT01258101|365077704|FG003|Overall Study|Adverse Event|0|||
105841750|NCT01258101|365077701|FG000|Overall Study|Extra exclusion criterion amended|2|||
105841751|NCT01258101|365077702|FG001|Overall Study|Extra exclusion criterion amended|1|||
105841752|NCT01258101|365077703|FG002|Overall Study|Extra exclusion criterion amended|1|||
105841753|NCT01258101|365077704|FG003|Overall Study|Extra exclusion criterion amended|1|||
105841754|NCT01258101|365077701|FG000|Overall Study|Informed consent has been withdrawn|2|||
105841755|NCT01258101|365077702|FG001|Overall Study|Informed consent has been withdrawn|2|||
105841756|NCT01258101|365077703|FG002|Overall Study|Informed consent has been withdrawn|1|||
105841757|NCT01258101|365077704|FG003|Overall Study|Informed consent has been withdrawn|1|||
105841758|NCT01258101|365077701|FG000|Overall Study|Patient is not able to attend visits|8|||
105841759|NCT01258101|365077702|FG001|Overall Study|Patient is not able to attend visits|9|||
105841760|NCT01258101|365077703|FG002|Overall Study|Patient is not able to attend visits|7|||
105841761|NCT01258101|365077704|FG003|Overall Study|Patient is not able to attend visits|6|||
105841762|NCT01258101|365077701|FG000|Overall Study|Patient´s compliance|4|||
105841763|NCT01258101|365077702|FG001|Overall Study|Patient´s compliance|3|||
105841764|NCT01258101|365077703|FG002|Overall Study|Patient´s compliance|1|||
105841765|NCT01258101|365077704|FG003|Overall Study|Patient´s compliance|2|||
105967954|NCT03941964|365541965|FG000|Overall Study|Other, not specified|2|||
105967955|NCT03941964|365541966|FG001|Overall Study|Other, not specified|1|||
105967956|NCT01802580|365541970|FG000|Overall Study|Physician Decision|1|||
105967957|NCT01802580|365541971|FG001|Overall Study|Physician Decision|0|||
105967958|NCT01802580|365541970|FG000|Overall Study|Protocol Violation|2|||
105967959|NCT01802580|365541971|FG001|Overall Study|Protocol Violation|0|||
105967960|NCT01802580|365541970|FG000|Overall Study|Withdrawal by Subject|5|||
105967961|NCT01802580|365541971|FG001|Overall Study|Withdrawal by Subject|6|||
105967962|NCT01802580|365541970|FG000|Overall Study|Other|1|||
105967963|NCT01802580|365541971|FG001|Overall Study|Other|3|||
105967964|NCT01802580|365541970|FG000|Overall Study|Lack of Efficacy|0|||
105967965|NCT01802580|365541971|FG001|Overall Study|Lack of Efficacy|2|||
105967966|NCT03255967|365541972|FG000|Overall Study|Adverse Event|26|||
105967967|NCT03255967|365541973|FG001|Overall Study|Adverse Event|30|||
105967968|NCT03255967|365541972|FG000|Overall Study|Withdrawal by Subject|6|||
105967969|NCT03255967|365541973|FG001|Overall Study|Withdrawal by Subject|6|||
105967970|NCT03255967|365541972|FG000|Overall Study|Schedule conflict|6|||
105967971|NCT03255967|365541973|FG001|Overall Study|Schedule conflict|4|||
105967972|NCT03255967|365541972|FG000|Overall Study|POA did not sign consent form|2|||
105967973|NCT03255967|365541973|FG001|Overall Study|POA did not sign consent form|0|||
105967974|NCT00443053|365541974|FG000|Overall Study|Adverse Event|2|||
105967975|NCT00443053|365541975|FG001|Overall Study|Adverse Event|1|||
105967976|NCT00443053|365541974|FG000|Overall Study|Withdrawal by Subject|9|||
105967977|NCT00443053|365541975|FG001|Overall Study|Withdrawal by Subject|18|||
105967978|NCT00443053|365541974|FG000|Overall Study|Lost to Follow-up|4|||
105967979|NCT00443053|365541975|FG001|Overall Study|Lost to Follow-up|5|||
105967980|NCT00443053|365541974|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
105967981|NCT00443053|365541975|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
105967982|NCT00443053|365541974|FG000|Overall Study|Noncompliance|2|||
105967983|NCT00443053|365541975|FG001|Overall Study|Noncompliance|1|||
105967984|NCT00443053|365541974|FG000|Overall Study|Other|3|||
105967985|NCT00443053|365541975|FG001|Overall Study|Other|4|||
105967986|NCT00443053|365541974|FG000|Overall Study|Physician Decision|0|||
105967987|NCT00443053|365541975|FG001|Overall Study|Physician Decision|4|||
105967988|NCT00778258|365541976|FG000|Overall Study|Adverse Event|1|||
105967989|NCT00778258|365541977|FG001|Overall Study|Adverse Event|0|||
105967990|NCT00778258|365541978|FG002|Overall Study|Adverse Event|0|||
105967991|NCT00778258|365541979|FG003|Overall Study|Adverse Event|0|||
105967992|NCT00778258|365541980|FG004|Overall Study|Adverse Event|0|||
105967993|NCT00778258|365541981|FG005|Overall Study|Adverse Event|1|||
105967994|NCT00778258|365541982|FG006|Overall Study|Adverse Event|0|||
106024097|NCT01349049|365754471|FG006|Overall Study|Withdrawal by Subject|0|||
106024098|NCT01349049|365754472|FG007|Overall Study|Withdrawal by Subject|0|||
105841766|NCT01258101|365077701|FG000|Overall Study|Lost to Follow-up|5|||
105841767|NCT01258101|365077702|FG001|Overall Study|Lost to Follow-up|5|||
105841768|NCT01258101|365077703|FG002|Overall Study|Lost to Follow-up|0|||
105967995|NCT00778258|365541983|FG007|Overall Study|Adverse Event|0|||
106149418|NCT03598790|366209105|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105967996|NCT00778258|365541984|FG008|Overall Study|Adverse Event|0|||
105967997|NCT00778258|365541976|FG000|Overall Study|Lost to Follow-up|0|||
105841769|NCT01258101|365077704|FG003|Overall Study|Lost to Follow-up|6|||
105841770|NCT01258101|365077701|FG000|Overall Study|PCR positive at week 24|0|||
105967998|NCT00778258|365541977|FG001|Overall Study|Lost to Follow-up|0|||
105967999|NCT00778258|365541978|FG002|Overall Study|Lost to Follow-up|2|||
105968000|NCT00778258|365541979|FG003|Overall Study|Lost to Follow-up|0|||
105968001|NCT00778258|365541980|FG004|Overall Study|Lost to Follow-up|0|||
105968002|NCT00778258|365541981|FG005|Overall Study|Lost to Follow-up|3|||
105968003|NCT00778258|365541982|FG006|Overall Study|Lost to Follow-up|2|||
105968004|NCT00778258|365541983|FG007|Overall Study|Lost to Follow-up|2|||
105968005|NCT00778258|365541984|FG008|Overall Study|Lost to Follow-up|0|||
105968006|NCT00778258|365541976|FG000|Overall Study|Withdrawal by Subject|6|||
105968007|NCT00778258|365541977|FG001|Overall Study|Withdrawal by Subject|2|||
105968008|NCT00778258|365541978|FG002|Overall Study|Withdrawal by Subject|8|||
105968009|NCT00778258|365541979|FG003|Overall Study|Withdrawal by Subject|2|||
105968010|NCT00778258|365541980|FG004|Overall Study|Withdrawal by Subject|0|||
105968011|NCT00778258|365541981|FG005|Overall Study|Withdrawal by Subject|6|||
105968012|NCT00778258|365541982|FG006|Overall Study|Withdrawal by Subject|12|||
105968013|NCT00778258|365541983|FG007|Overall Study|Withdrawal by Subject|12|||
105968014|NCT00778258|365541984|FG008|Overall Study|Withdrawal by Subject|4|||
105968015|NCT00778258|365541976|FG000|Overall Study|New Contraindication|0|||
105968016|NCT00778258|365541977|FG001|Overall Study|New Contraindication|0|||
105968017|NCT00778258|365541978|FG002|Overall Study|New Contraindication|0|||
105968018|NCT00778258|365541979|FG003|Overall Study|New Contraindication|0|||
105968019|NCT00778258|365541980|FG004|Overall Study|New Contraindication|0|||
105968020|NCT00778258|365541981|FG005|Overall Study|New Contraindication|0|||
105968021|NCT00778258|365541982|FG006|Overall Study|New Contraindication|0|||
105968022|NCT00778258|365541983|FG007|Overall Study|New Contraindication|1|||
105968023|NCT00778258|365541984|FG008|Overall Study|New Contraindication|0|||
105968024|NCT00778258|365541976|FG000|Overall Study|Non-compliance|0|||
105968025|NCT00778258|365541977|FG001|Overall Study|Non-compliance|0|||
105968026|NCT00778258|365541978|FG002|Overall Study|Non-compliance|0|||
105968027|NCT00778258|365541979|FG003|Overall Study|Non-compliance|1|||
105968028|NCT00778258|365541980|FG004|Overall Study|Non-compliance|0|||
105968029|NCT00778258|365541981|FG005|Overall Study|Non-compliance|0|||
105968030|NCT00778258|365541982|FG006|Overall Study|Non-compliance|0|||
105968031|NCT00778258|365541983|FG007|Overall Study|Non-compliance|0|||
105968032|NCT00778258|365541984|FG008|Overall Study|Non-compliance|0|||
105968033|NCT00778258|365541976|FG000|Overall Study|Other|0|||
105968034|NCT00778258|365541977|FG001|Overall Study|Other|0|||
105968035|NCT00778258|365541978|FG002|Overall Study|Other|0|||
105968036|NCT00778258|365541979|FG003|Overall Study|Other|0|||
105968037|NCT00778258|365541980|FG004|Overall Study|Other|0|||
105968038|NCT00778258|365541981|FG005|Overall Study|Other|0|||
105968039|NCT00778258|365541982|FG006|Overall Study|Other|1|||
105968040|NCT00778258|365541983|FG007|Overall Study|Other|0|||
105968041|NCT00778258|365541984|FG008|Overall Study|Other|0|||
105968042|NCT02438384|365541987|FG000|Overall Study|Lost to Follow-up|8|||
105968043|NCT02438384|365541988|FG001|Overall Study|Lost to Follow-up|6|||
105968044|NCT02438384|365541989|FG002|Overall Study|Lost to Follow-up|4|||
105968045|NCT03319953|365541990|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
105968046|NCT03319953|365541991|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
105968047|NCT03319953|365541992|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
105968048|NCT03319953|365541993|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
105968049|NCT03319953|365541990|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
105968050|NCT03319953|365541991|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
105968051|NCT03319953|365541992|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
105968052|NCT03319953|365541993|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
105968053|NCT03285958|365543610|FG000|Overall Study|Lost to Follow-up|1|||
105968054|NCT03285958|365543611|FG001|Overall Study|Lost to Follow-up|1|||
105968055|NCT03285958|365543610|FG000|Overall Study|Withdrawal by Subject|1|||
105968056|NCT03285958|365543611|FG001|Overall Study|Withdrawal by Subject|0|||
105968057|NCT03285958|365543610|FG000|Overall Study|Not able to attend required orientation|3|||
105968058|NCT03285958|365543611|FG001|Overall Study|Not able to attend required orientation|0|||
105968059|NCT03100539|365543612|FG000|Overall Study|Lost to Follow-up|60|||
105968060|NCT03100539|365543613|FG001|Overall Study|Lost to Follow-up|54|||
105968061|NCT03100539|365543614|FG002|Overall Study|Lost to Follow-up|17|||
105968062|NCT03100539|365543612|FG000|Overall Study|Uncollected|8|||
105968063|NCT03100539|365543613|FG001|Overall Study|Uncollected|8|||
105968064|NCT03100539|365543614|FG002|Overall Study|Uncollected|0|||
105968065|NCT03100539|365543612|FG000|Overall Study|Ally Health|0|||
105968066|NCT03100539|365543613|FG001|Overall Study|Ally Health|0|||
105968067|NCT03100539|365543614|FG002|Overall Study|Ally Health|3|||
105968068|NCT03100539|365543612|FG000|Overall Study|Disinterest|0|||
105968069|NCT03100539|365543613|FG001|Overall Study|Disinterest|0|||
105968070|NCT03100539|365543614|FG002|Overall Study|Disinterest|22|||
105968071|NCT03100539|365543612|FG000|Overall Study|Veteran Health|0|||
105968072|NCT03100539|365543613|FG001|Overall Study|Veteran Health|0|||
105968073|NCT03100539|365543614|FG002|Overall Study|Veteran Health|8|||
105968074|NCT03100539|365543612|FG000|Overall Study|Moved|0|||
105968075|NCT03100539|365543613|FG001|Overall Study|Moved|0|||
105968076|NCT03100539|365543614|FG002|Overall Study|Moved|1|||
105968077|NCT03100539|365543612|FG000|Overall Study|Scheduling Conflicts|0|||
105968078|NCT03100539|365543613|FG001|Overall Study|Scheduling Conflicts|0|||
105968079|NCT03100539|365543614|FG002|Overall Study|Scheduling Conflicts|12|||
105968080|NCT00882583|365543618|FG000|Overall Study|Physician Decision|1|||
105968081|NCT00882583|365543619|FG001|Overall Study|Physician Decision|0|||
105841771|NCT01258101|365077702|FG001|Overall Study|PCR positive at week 24|0|||
105841772|NCT01258101|365077703|FG002|Overall Study|PCR positive at week 24|0|||
105841773|NCT01258101|365077704|FG003|Overall Study|PCR positive at week 24|1|||
105841774|NCT01258101|365077701|FG000|Overall Study|Other reason|7|||
105841775|NCT01258101|365077702|FG001|Overall Study|Other reason|8|||
105841776|NCT01258101|365077703|FG002|Overall Study|Other reason|1|||
105841777|NCT01258101|365077704|FG003|Overall Study|Other reason|8|||
105841778|NCT00303667|365077705|FG000|Overall Study|Death|0|||
105841779|NCT00303667|365077706|FG001|Overall Study|Death|4|||
105841780|NCT01807117|365077707|FG000|Overall Study|Physician Decision|2|||
105841781|NCT01807117|365077707|FG000|Overall Study|Disease diagnosis not a study disease|1|||
105841782|NCT01029392|365077708|FG000|Overall Study|Withdrawal by Subject|18|||
105841783|NCT01029392|365077709|FG001|Overall Study|Withdrawal by Subject|11|||
105841784|NCT01029392|365077708|FG000|Overall Study|Physician Decision|2|||
105841785|NCT01029392|365077709|FG001|Overall Study|Physician Decision|0|||
105841786|NCT01103479|365077710|FG000|Overall Study|Up to date with CRC screening|1|||
105841787|NCT01103479|365077711|FG001|Overall Study|Up to date with CRC screening|9|||
105841788|NCT01103479|365077712|FG002|Overall Study|Up to date with CRC screening|12|||
105841789|NCT01103479|365077710|FG000|Overall Study|Family history of CRC|1|||
105841790|NCT01103479|365077711|FG001|Overall Study|Family history of CRC|0|||
105841791|NCT01103479|365077712|FG002|Overall Study|Family history of CRC|2|||
105841792|NCT01103479|365077710|FG000|Overall Study|Active cancer|1|||
105841793|NCT01103479|365077711|FG001|Overall Study|Active cancer|0|||
105841794|NCT01103479|365077712|FG002|Overall Study|Active cancer|0|||
105841795|NCT01103479|365077710|FG000|Overall Study|Saw non-study physician|2|||
105841796|NCT01103479|365077711|FG001|Overall Study|Saw non-study physician|0|||
105841797|NCT01103479|365077712|FG002|Overall Study|Saw non-study physician|0|||
105841798|NCT01534637|365077713|FG000|Overall Study|Physician Decision|3|||
105841799|NCT01534637|365077713|FG000|Overall Study|Lack of Efficacy|3|||
105841800|NCT01534637|365077713|FG000|Overall Study|Withdrawal by Subject|1|||
105841801|NCT01534637|365077713|FG000|Overall Study|Adverse Event|1|||
105841802|NCT01534637|365077713|FG000|Overall Study|Liver Mets before treatment|1|||
105841803|NCT00834899|365077714|FG000|Overall Study|Withdrawal by Subject|1|||
105841804|NCT00834899|365077715|FG001|Overall Study|Withdrawal by Subject|1|||
105841805|NCT02709486|365077719|FG000|Overall Study|Adverse Event|2|||
105841806|NCT02709486|365077720|FG001|Overall Study|Adverse Event|5|||
105841807|NCT02709486|365077721|FG002|Overall Study|Adverse Event|3|||
105841808|NCT02709486|365077719|FG000|Overall Study|Death|0|||
105841809|NCT02709486|365077720|FG001|Overall Study|Death|0|||
105841810|NCT02709486|365077721|FG002|Overall Study|Death|2|||
105841811|NCT02709486|365077719|FG000|Overall Study|Insufficient clinical response|7|||
105841812|NCT02709486|365077720|FG001|Overall Study|Insufficient clinical response|3|||
105841813|NCT02709486|365077721|FG002|Overall Study|Insufficient clinical response|3|||
105841814|NCT02709486|365077719|FG000|Overall Study|Lost to Follow-up|3|||
105841815|NCT02709486|365077720|FG001|Overall Study|Lost to Follow-up|2|||
105841816|NCT02709486|365077721|FG002|Overall Study|Lost to Follow-up|2|||
105841817|NCT02709486|365077719|FG000|Overall Study|Other|0|||
105841818|NCT02709486|365077720|FG001|Overall Study|Other|2|||
105841819|NCT02709486|365077721|FG002|Overall Study|Other|3|||
105841820|NCT02709486|365077719|FG000|Overall Study|Withdrawal by Subject|32|||
105841821|NCT02709486|365077720|FG001|Overall Study|Withdrawal by Subject|22|||
105841822|NCT02709486|365077721|FG002|Overall Study|Withdrawal by Subject|32|||
105841823|NCT03903159|365077725|FG000|Overall Study|Discharged with Staff Approval|2|||
105841824|NCT03903159|365077725|FG000|Overall Study|Discharged at Staff Request|2|||
105841825|NCT03903159|365077725|FG000|Overall Study|Discharged Against Staff Advice|1|||
105841826|NCT00720226|365077730|FG000|Overall Study|Withdrawal by Subject|7|||
105841827|NCT00720226|365077731|FG001|Overall Study|Withdrawal by Subject|4|||
105841828|NCT00536484|365077733|FG000|Overall Study|Adverse Event|21|||
105841829|NCT00536484|365077734|FG001|Overall Study|Adverse Event|34|||
105841830|NCT00536484|365077733|FG000|Overall Study|Withdrawal by Subject|11|||
105841831|NCT00536484|365077734|FG001|Overall Study|Withdrawal by Subject|11|||
105841832|NCT00536484|365077733|FG000|Overall Study|Lost to Follow-up|8|||
105841833|NCT00536484|365077734|FG001|Overall Study|Lost to Follow-up|6|||
105968082|NCT00882583|365543618|FG000|Overall Study|Adverse Event|0|||
105968083|NCT00882583|365543619|FG001|Overall Study|Adverse Event|1|||
105968084|NCT02596958|365543620|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
105968085|NCT02596958|365543620|FG000|Overall Study|Cancer Progression|441|||
105968086|NCT02596958|365543620|FG000|Overall Study|Death From Cancer|112|||
105968087|NCT02596958|365543620|FG000|Overall Study|Death From Other Cause|33|||
105968088|NCT02596958|365543620|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
105968089|NCT02596958|365543620|FG000|Overall Study|Administrative Reasons/Other|231|||
105968090|NCT02596958|365543620|FG000|Overall Study|Lost to Follow-up|33|||
105968091|NCT02596958|365543620|FG000|Overall Study|Missing|32|||
105968092|NCT02596958|365543620|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
105968093|NCT01044745|365543621|FG000|Overall Study|Ineiligible|2|||
105968094|NCT01892436|365543624|FG000|Overall Study|Withdrawal by Subject|8|||
105968095|NCT01892436|365543625|FG001|Overall Study|Withdrawal by Subject|15|||
105968096|NCT01892436|365543626|FG002|Overall Study|Withdrawal by Subject|4|||
105968097|NCT01892436|365543627|FG003|Overall Study|Withdrawal by Subject|4|||
105968098|NCT01892436|365543624|FG000|Overall Study|Death|1|||
105968099|NCT01892436|365543625|FG001|Overall Study|Death|1|||
105968100|NCT01892436|365543626|FG002|Overall Study|Death|0|||
105968101|NCT01892436|365543627|FG003|Overall Study|Death|0|||
105968102|NCT01892436|365543624|FG000|Overall Study|Physician Decision|2|||
105968103|NCT01892436|365543625|FG001|Overall Study|Physician Decision|1|||
105968104|NCT01892436|365543626|FG002|Overall Study|Physician Decision|0|||
105968105|NCT01892436|365543627|FG003|Overall Study|Physician Decision|1|||
105968106|NCT01892436|365543624|FG000|Overall Study|Pregnancy|0|||
105968107|NCT01892436|365543625|FG001|Overall Study|Pregnancy|2|||
105968108|NCT01892436|365543626|FG002|Overall Study|Pregnancy|1|||
105968109|NCT01892436|365543627|FG003|Overall Study|Pregnancy|0|||
105968110|NCT01892436|365543624|FG000|Overall Study|Technical problems|2|||
105968111|NCT01892436|365543625|FG001|Overall Study|Technical problems|1|||
105968112|NCT01892436|365543626|FG002|Overall Study|Technical problems|1|||
105968113|NCT01892436|365543627|FG003|Overall Study|Technical problems|1|||
105968114|NCT01892436|365543624|FG000|Overall Study|Lack of Efficacy|1|||
105968115|NCT01892436|365543625|FG001|Overall Study|Lack of Efficacy|2|||
105968116|NCT01892436|365543626|FG002|Overall Study|Lack of Efficacy|2|||
105968117|NCT01892436|365543627|FG003|Overall Study|Lack of Efficacy|2|||
105968118|NCT01892436|365543624|FG000|Overall Study|Lost to Follow-up|1|||
105968119|NCT01892436|365543625|FG001|Overall Study|Lost to Follow-up|1|||
105968120|NCT01892436|365543626|FG002|Overall Study|Lost to Follow-up|1|||
105968121|NCT01892436|365543627|FG003|Overall Study|Lost to Follow-up|3|||
105968122|NCT01892436|365543624|FG000|Overall Study|non-compliance with treatment|1|||
105968123|NCT01892436|365543625|FG001|Overall Study|non-compliance with treatment|0|||
105968124|NCT01892436|365543626|FG002|Overall Study|non-compliance with treatment|0|||
105968125|NCT01892436|365543627|FG003|Overall Study|non-compliance with treatment|0|||
105968126|NCT01892436|365543624|FG000|Overall Study|Adverse Event|7|||
105968127|NCT01892436|365543625|FG001|Overall Study|Adverse Event|6|||
105968128|NCT01892436|365543626|FG002|Overall Study|Adverse Event|2|||
105968129|NCT01892436|365543627|FG003|Overall Study|Adverse Event|3|||
105968130|NCT03895086|365543630|FG000|Overall Study|Early termination study|1|||
105968131|NCT03895086|365543631|FG001|Overall Study|Early termination study|0|||
105968132|NCT02759107|365543633|FG000|Overall Study|Adverse Event|0|||
105968133|NCT02759107|365543634|FG001|Overall Study|Adverse Event|0|||
105968134|NCT02759107|365543635|FG002|Overall Study|Adverse Event|0|||
105968135|NCT02759107|365543636|FG003|Overall Study|Adverse Event|0|||
105968136|NCT02759107|365543637|FG004|Overall Study|Adverse Event|0|||
105968137|NCT02759107|365543638|FG005|Overall Study|Adverse Event|0|||
105968138|NCT02759107|365543639|FG006|Overall Study|Adverse Event|0|||
105968139|NCT02759107|365543640|FG007|Overall Study|Adverse Event|0|||
105968140|NCT02759107|365543641|FG008|Overall Study|Adverse Event|0|||
105968141|NCT02759107|365543642|FG009|Overall Study|Adverse Event|0|||
105968142|NCT02759107|365543643|FG010|Overall Study|Adverse Event|0|||
105968143|NCT02759107|365543644|FG011|Overall Study|Adverse Event|0|||
105968144|NCT02759107|365543645|FG012|Overall Study|Adverse Event|2|||
105841834|NCT00536484|365077733|FG000|Overall Study|Lack of Efficacy|16|||
105841835|NCT00536484|365077734|FG001|Overall Study|Lack of Efficacy|5|||
105841836|NCT00536484|365077733|FG000|Overall Study|Other|4|||
105841837|NCT00536484|365077734|FG001|Overall Study|Other|0|||
105841838|NCT00706355|365077735|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
105841839|NCT00706355|365077736|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
105841840|NCT00706355|365077737|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
105841841|NCT00706355|365077738|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
105841842|NCT00706355|365077735|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
105841843|NCT00706355|365077736|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
105841844|NCT00706355|365077737|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
105841845|NCT00706355|365077738|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
105841846|NCT00706355|365077735|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
105841847|NCT00706355|365077736|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
105841848|NCT00706355|365077737|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
105841849|NCT00706355|365077738|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
105841850|NCT00706355|365077735|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
105841851|NCT00706355|365077736|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
105841852|NCT00706355|365077737|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
105841853|NCT00706355|365077738|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
105841854|NCT00706355|365077735|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
105968145|NCT02759107|365543646|FG013|Overall Study|Adverse Event|0|||
105968146|NCT02759107|365543647|FG014|Overall Study|Adverse Event|0|||
105968147|NCT02759107|365543648|FG015|Overall Study|Adverse Event|1|||
105968148|NCT02759107|365543649|FG016|Overall Study|Adverse Event|0|||
105968149|NCT02759107|365543650|FG017|Overall Study|Adverse Event|2|||
105968150|NCT02759107|365543633|FG000|Overall Study|Scheduling Conflict|0|||
105968151|NCT02759107|365543634|FG001|Overall Study|Scheduling Conflict|0|||
105968152|NCT02759107|365543635|FG002|Overall Study|Scheduling Conflict|0|||
105968153|NCT02759107|365543636|FG003|Overall Study|Scheduling Conflict|0|||
105968154|NCT02759107|365543637|FG004|Overall Study|Scheduling Conflict|0|||
105968155|NCT02759107|365543638|FG005|Overall Study|Scheduling Conflict|0|||
105968156|NCT02759107|365543639|FG006|Overall Study|Scheduling Conflict|0|||
105968157|NCT02759107|365543640|FG007|Overall Study|Scheduling Conflict|0|||
105968158|NCT02759107|365543641|FG008|Overall Study|Scheduling Conflict|0|||
105968159|NCT02759107|365543642|FG009|Overall Study|Scheduling Conflict|1|||
105968160|NCT02759107|365543643|FG010|Overall Study|Scheduling Conflict|0|||
105968161|NCT02759107|365543644|FG011|Overall Study|Scheduling Conflict|0|||
105968162|NCT02759107|365543645|FG012|Overall Study|Scheduling Conflict|0|||
105968163|NCT02759107|365543646|FG013|Overall Study|Scheduling Conflict|0|||
105968164|NCT02759107|365543647|FG014|Overall Study|Scheduling Conflict|0|||
105968165|NCT02759107|365543648|FG015|Overall Study|Scheduling Conflict|0|||
105968166|NCT02759107|365543649|FG016|Overall Study|Scheduling Conflict|0|||
105968167|NCT02759107|365543650|FG017|Overall Study|Scheduling Conflict|0|||
105968168|NCT01089413|365543654|FG000|Overall Study|Lost to Follow-up|1|||
105968169|NCT01089413|365543654|FG000|Overall Study|Progressive Disease|93|||
105968170|NCT01089413|365543654|FG000|Overall Study|Participant Withdrew Consent|1|||
105968171|NCT01089413|365543654|FG000|Overall Study|Unacceptable Toxicity|12|||
105968172|NCT01089413|365543654|FG000|Overall Study|Death|10|||
105968173|NCT01089413|365543654|FG000|Overall Study|Metastasectomy|13|||
105968174|NCT01089413|365543654|FG000|Overall Study|Other|71|||
105968175|NCT02513485|365543658|FG000|Overall Study|Adverse Event|1|||
105968176|NCT02513485|365543659|FG001|Overall Study|Adverse Event|0|||
105968177|NCT02039219|365543669|FG000|Treatment|Withdrawal by Subject|1|||
105968178|NCT02039219|365543670|FG001|Treatment|Withdrawal by Subject|0|||
105968179|NCT02039219|365543669|FG000|Treatment|Adverse Event|0|||
105968180|NCT02039219|365543670|FG001|Treatment|Adverse Event|1|||
105968181|NCT02039219|365543669|FG000|Treatment|Physician Decision|1|||
105968182|NCT02039219|365543670|FG001|Treatment|Physician Decision|0|||
105968183|NCT02039219|365543669|FG000|Treatment|Lost to Follow-up|0|||
105968184|NCT02039219|365543670|FG001|Treatment|Lost to Follow-up|1|||
105968185|NCT02039219|365543669|FG000|Treatment|Protocol Violation|1|||
105968186|NCT02039219|365543670|FG001|Treatment|Protocol Violation|0|||
105968187|NCT02039219|365543669|FG000|Treatment|Death|1|||
105968188|NCT02039219|365543670|FG001|Treatment|Death|0|||
105968189|NCT02039219|365543669|FG000|Follow up|Adverse Event|0|||
105968190|NCT02039219|365543670|FG001|Follow up|Adverse Event|1|||
105968191|NCT00129701|365543671|FG000|Overall Study|Withdrawal by Subject|33|||
105968192|NCT02750345|365543672|FG000|Intervention 1|Adverse Event|0|||
105968193|NCT02750345|365543673|FG001|Intervention 1|Adverse Event|0|||
105968194|NCT02750345|365543674|FG002|Intervention 1|Adverse Event|0|||
105968195|NCT02750345|365543675|FG003|Intervention 1|Adverse Event|0|||
105968196|NCT02750345|365543676|FG004|Intervention 1|Adverse Event|1|||
105968197|NCT02750345|365543677|FG005|Intervention 1|Adverse Event|0|||
105968198|NCT02650128|365543678|FG000|Overall Study|Death|2|||
105968199|NCT00191724|365543681|FG000|Overall Study|Adverse Event|0|||
105968200|NCT00191724|365543682|FG001|Overall Study|Adverse Event|0|||
105968201|NCT00191724|365543683|FG002|Overall Study|Adverse Event|1|||
105968202|NCT00191724|365543684|FG003|Overall Study|Adverse Event|0|||
105968203|NCT00191724|365543685|FG004|Overall Study|Adverse Event|0|||
105968204|NCT00191724|365543681|FG000|Overall Study|Lost to Follow-up|1|||
105968205|NCT00191724|365543682|FG001|Overall Study|Lost to Follow-up|1|||
105968206|NCT00191724|365543683|FG002|Overall Study|Lost to Follow-up|0|||
105968207|NCT00191724|365543684|FG003|Overall Study|Lost to Follow-up|2|||
106024099|NCT01349049|365754473|FG008|Overall Study|Withdrawal by Subject|6|||
106149419|NCT03598790|366209106|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105968208|NCT00191724|365543685|FG004|Overall Study|Lost to Follow-up|3|||
105968209|NCT00191724|365543681|FG000|Overall Study|Withdrawal by Subject|0|||
105968210|NCT00191724|365543682|FG001|Overall Study|Withdrawal by Subject|0|||
105968211|NCT00191724|365543683|FG002|Overall Study|Withdrawal by Subject|0|||
105968212|NCT00191724|365543684|FG003|Overall Study|Withdrawal by Subject|1|||
105968213|NCT00191724|365543685|FG004|Overall Study|Withdrawal by Subject|0|||
105968214|NCT00608023|365543686|FG000|Overall Study|Withdrawal by Subject|8|||
105968215|NCT00608023|365543687|FG001|Overall Study|Withdrawal by Subject|10|||
105968216|NCT00608023|365543688|FG002|Overall Study|Withdrawal by Subject|7|||
105968217|NCT00608023|365543686|FG000|Overall Study|Adverse Event|1|||
105968218|NCT00608023|365543687|FG001|Overall Study|Adverse Event|4|||
105968219|NCT00608023|365543688|FG002|Overall Study|Adverse Event|5|||
105968220|NCT00608023|365543686|FG000|Overall Study|Lost to Follow-up|2|||
105968221|NCT00608023|365543687|FG001|Overall Study|Lost to Follow-up|2|||
105968222|NCT00608023|365543688|FG002|Overall Study|Lost to Follow-up|1|||
105968223|NCT00608023|365543686|FG000|Overall Study|Protocol Violation|1|||
105968224|NCT00608023|365543687|FG001|Overall Study|Protocol Violation|3|||
105968225|NCT00608023|365543688|FG002|Overall Study|Protocol Violation|1|||
105968226|NCT00608023|365543686|FG000|Overall Study|Unknown reason|0|||
105968227|NCT00608023|365543687|FG001|Overall Study|Unknown reason|3|||
105968228|NCT00608023|365543688|FG002|Overall Study|Unknown reason|0|||
105968229|NCT00152477|365543702|FG000|Chemotherapy Period|Adverse Event|9|||
105968230|NCT00152477|365543703|FG001|Chemotherapy Period|Adverse Event|4|||
105968231|NCT00152477|365543704|FG002|Chemotherapy Period|Adverse Event|5|||
105968232|NCT00152477|365543702|FG000|Chemotherapy Period|Death|1|||
105968233|NCT00152477|365543703|FG001|Chemotherapy Period|Death|3|||
105968234|NCT00152477|365543704|FG002|Chemotherapy Period|Death|3|||
105968235|NCT00152477|365543702|FG000|Chemotherapy Period|Lack of Efficacy|4|||
105968236|NCT00152477|365543703|FG001|Chemotherapy Period|Lack of Efficacy|5|||
105968237|NCT00152477|365543704|FG002|Chemotherapy Period|Lack of Efficacy|6|||
105968238|NCT00152477|365543702|FG000|Chemotherapy Period|Lost to Follow-up|1|||
105968239|NCT00152477|365543703|FG001|Chemotherapy Period|Lost to Follow-up|0|||
105968240|NCT00152477|365543704|FG002|Chemotherapy Period|Lost to Follow-up|1|||
105968241|NCT00152477|365543702|FG000|Chemotherapy Period|Protocol Violation|1|||
105968242|NCT00152477|365543703|FG001|Chemotherapy Period|Protocol Violation|1|||
105968243|NCT00152477|365543704|FG002|Chemotherapy Period|Protocol Violation|0|||
105968244|NCT00152477|365543702|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
105968245|NCT00152477|365543703|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
105968246|NCT00152477|365543704|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
105968247|NCT00152477|365543702|FG000|Chemotherapy Period|Progression of Disease|6|||
105968248|NCT00152477|365543703|FG001|Chemotherapy Period|Progression of Disease|8|||
105968249|NCT00152477|365543704|FG002|Chemotherapy Period|Progression of Disease|4|||
105968250|NCT00152477|365543702|FG000|Chemotherapy Period|Investigator decision|0|||
105968251|NCT00152477|365543703|FG001|Chemotherapy Period|Investigator decision|0|||
105968252|NCT00152477|365543704|FG002|Chemotherapy Period|Investigator decision|1|||
105968253|NCT00152477|365543702|FG000|Chemotherapy Period|Patient condition worsened|1|||
105968254|NCT00152477|365543703|FG001|Chemotherapy Period|Patient condition worsened|0|||
105968255|NCT00152477|365543704|FG002|Chemotherapy Period|Patient condition worsened|0|||
105968256|NCT00152477|365543702|FG000|Monotherapy Period|Adverse Event|1|||
105968257|NCT00152477|365543703|FG001|Monotherapy Period|Adverse Event|0|||
105968258|NCT00152477|365543704|FG002|Monotherapy Period|Adverse Event|5|||
105968259|NCT00152477|365543702|FG000|Monotherapy Period|Death|2|||
105968260|NCT00152477|365543703|FG001|Monotherapy Period|Death|0|||
105968261|NCT00152477|365543704|FG002|Monotherapy Period|Death|1|||
105968262|NCT00152477|365543702|FG000|Monotherapy Period|Lack of Efficacy|7|||
105968263|NCT00152477|365543703|FG001|Monotherapy Period|Lack of Efficacy|16|||
105968264|NCT00152477|365543704|FG002|Monotherapy Period|Lack of Efficacy|10|||
105968265|NCT00152477|365543702|FG000|Monotherapy Period|Protocol Violation|0|||
105968266|NCT00152477|365543703|FG001|Monotherapy Period|Protocol Violation|1|||
105968267|NCT00152477|365543704|FG002|Monotherapy Period|Protocol Violation|0|||
105968268|NCT00152477|365543702|FG000|Monotherapy Period|Withdrawal by Subject|0|||
105968269|NCT00152477|365543703|FG001|Monotherapy Period|Withdrawal by Subject|0|||
105968270|NCT00152477|365543704|FG002|Monotherapy Period|Withdrawal by Subject|4|||
105968271|NCT00152477|365543702|FG000|Monotherapy Period|Progression of Disease|5|||
105968272|NCT00152477|365543703|FG001|Monotherapy Period|Progression of Disease|11|||
105968273|NCT00152477|365543704|FG002|Monotherapy Period|Progression of Disease|12|||
105968274|NCT00152477|365543702|FG000|Monotherapy Period|Patient decision|0|||
105968275|NCT00152477|365543703|FG001|Monotherapy Period|Patient decision|1|||
105968276|NCT00152477|365543704|FG002|Monotherapy Period|Patient decision|1|||
105968277|NCT00152477|365543702|FG000|Monotherapy Period|Study personel decision|0|||
105968278|NCT00152477|365543703|FG001|Monotherapy Period|Study personel decision|0|||
105968279|NCT00152477|365543704|FG002|Monotherapy Period|Study personel decision|1|||
105968280|NCT03275246|365543711|FG000|Overall Study|Protocol Violation|5|||
105968281|NCT03275246|365543711|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
105968282|NCT05526781|365543714|FG000|Overall Study|Lost to Follow-up|1|||
105968283|NCT01801436|365543715|FG000|Overall Study|Withdrawal by Subject|3|||
105968284|NCT01801436|365543715|FG000|Overall Study|Adverse Event|2|||
105968285|NCT01801436|365543715|FG000|Overall Study|Progressive disease|4|||
105968286|NCT03632993|365543716|FG000|Overall Study|Withdrawal by Subject|1|||
105968287|NCT03632993|365543717|FG001|Overall Study|Withdrawal by Subject|0|||
105968288|NCT03632993|365543718|FG002|Overall Study|Withdrawal by Subject|0|||
105968289|NCT03632993|365543719|FG003|Overall Study|Withdrawal by Subject|0|||
105968290|NCT03632993|365543720|FG004|Overall Study|Withdrawal by Subject|0|||
105968291|NCT03632993|365543721|FG005|Overall Study|Withdrawal by Subject|0|||
105968292|NCT03632993|365543722|FG006|Overall Study|Withdrawal by Subject|0|||
105968293|NCT03632993|365543723|FG007|Overall Study|Withdrawal by Subject|0|||
105968294|NCT03632993|365543724|FG008|Overall Study|Withdrawal by Subject|0|||
105968295|NCT03632993|365543725|FG009|Overall Study|Withdrawal by Subject|1|||
105968296|NCT03632993|365543716|FG000|Overall Study|Protocol Non-compliance|0|||
105968297|NCT03632993|365543717|FG001|Overall Study|Protocol Non-compliance|1|||
105968298|NCT03632993|365543718|FG002|Overall Study|Protocol Non-compliance|0|||
105968299|NCT03632993|365543719|FG003|Overall Study|Protocol Non-compliance|0|||
105968300|NCT03632993|365543720|FG004|Overall Study|Protocol Non-compliance|0|||
105968301|NCT03632993|365543721|FG005|Overall Study|Protocol Non-compliance|0|||
105968302|NCT03632993|365543722|FG006|Overall Study|Protocol Non-compliance|0|||
105968303|NCT03632993|365543723|FG007|Overall Study|Protocol Non-compliance|0|||
105968304|NCT03632993|365543724|FG008|Overall Study|Protocol Non-compliance|0|||
105968305|NCT03632993|365543725|FG009|Overall Study|Protocol Non-compliance|0|||
105968306|NCT03632993|365543716|FG000|Overall Study|Lost to Follow-up|0|||
105968307|NCT03632993|365543717|FG001|Overall Study|Lost to Follow-up|0|||
105968308|NCT03632993|365543718|FG002|Overall Study|Lost to Follow-up|0|||
105968309|NCT03632993|365543719|FG003|Overall Study|Lost to Follow-up|0|||
105968310|NCT03632993|365543720|FG004|Overall Study|Lost to Follow-up|0|||
105968311|NCT03632993|365543721|FG005|Overall Study|Lost to Follow-up|1|||
105968312|NCT03632993|365543722|FG006|Overall Study|Lost to Follow-up|0|||
105968313|NCT03632993|365543723|FG007|Overall Study|Lost to Follow-up|1|||
105968314|NCT03632993|365543724|FG008|Overall Study|Lost to Follow-up|0|||
105968315|NCT03632993|365543725|FG009|Overall Study|Lost to Follow-up|0|||
106024100|NCT01643772|365754478|FG000|Overall Study|Protocol Violation|0|||
106024101|NCT01643772|365754479|FG001|Overall Study|Protocol Violation|0|||
106024102|NCT01643772|365754480|FG002|Overall Study|Protocol Violation|0|||
106024103|NCT01643772|365754481|FG003|Overall Study|Protocol Violation|1|||
106024104|NCT01643772|365754478|FG000|Overall Study|Adverse Event|0|||
106024105|NCT01643772|365754479|FG001|Overall Study|Adverse Event|0|||
106024106|NCT01643772|365754480|FG002|Overall Study|Adverse Event|0|||
106024107|NCT01643772|365754481|FG003|Overall Study|Adverse Event|1|||
106024108|NCT01945710|365754483|FG000|Overall Study|Progressive Disease|5|||
106024109|NCT01945710|365754484|FG001|Overall Study|Progressive Disease|4|||
106024110|NCT01945710|365754485|FG002|Overall Study|Progressive Disease|3|||
106024111|NCT01945710|365754486|FG003|Overall Study|Progressive Disease|2|||
106024112|NCT01945710|365754487|FG004|Overall Study|Progressive Disease|7|||
106024113|NCT01945710|365754488|FG005|Overall Study|Progressive Disease|3|||
106024114|NCT01945710|365754489|FG006|Overall Study|Progressive Disease|19|||
106024115|NCT01945710|365754483|FG000|Overall Study|Adverse Event|0|||
106024116|NCT01945710|365754484|FG001|Overall Study|Adverse Event|1|||
106024117|NCT01945710|365754485|FG002|Overall Study|Adverse Event|0|||
106024118|NCT01945710|365754486|FG003|Overall Study|Adverse Event|0|||
106024119|NCT01945710|365754487|FG004|Overall Study|Adverse Event|0|||
106024120|NCT01945710|365754488|FG005|Overall Study|Adverse Event|0|||
106024121|NCT01945710|365754489|FG006|Overall Study|Adverse Event|0|||
106024122|NCT01945710|365754483|FG000|Overall Study|Other|2|||
106024123|NCT01945710|365754484|FG001|Overall Study|Other|0|||
106024124|NCT01945710|365754485|FG002|Overall Study|Other|3|||
106024125|NCT01945710|365754486|FG003|Overall Study|Other|1|||
106024126|NCT01945710|365754487|FG004|Overall Study|Other|1|||
106024127|NCT01945710|365754488|FG005|Overall Study|Other|0|||
106024128|NCT01945710|365754489|FG006|Overall Study|Other|4|||
106024129|NCT01945710|365754483|FG000|Overall Study|Withdrawal by Subject|0|||
106024130|NCT01945710|365754484|FG001|Overall Study|Withdrawal by Subject|1|||
106024131|NCT01945710|365754485|FG002|Overall Study|Withdrawal by Subject|1|||
106024132|NCT01945710|365754486|FG003|Overall Study|Withdrawal by Subject|0|||
106024133|NCT01945710|365754487|FG004|Overall Study|Withdrawal by Subject|1|||
106024134|NCT01945710|365754488|FG005|Overall Study|Withdrawal by Subject|0|||
106024135|NCT01945710|365754489|FG006|Overall Study|Withdrawal by Subject|0|||
106024136|NCT00588861|365754490|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
106024137|NCT00588861|365754491|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
106024138|NCT00588861|365754490|FG000|6 Months|Patients did not return for follow-up|98|||
106024139|NCT00588861|365754491|FG001|6 Months|Patients did not return for follow-up|73|||
106024140|NCT00588861|365754490|FG000|1 Year|Patients did not return for follow-up|89|||
106024141|NCT00588861|365754491|FG001|1 Year|Patients did not return for follow-up|82|||
106024142|NCT00588861|365754490|FG000|2 Years|Patients did not return for follow-up|92|||
106024143|NCT00588861|365754491|FG001|2 Years|Patients did not return for follow-up|87|||
106024144|NCT00588861|365754490|FG000|4 Years|Patients did not return for follow-up|91|||
106024145|NCT00588861|365754491|FG001|4 Years|Patients did not return for follow-up|103|||
106024146|NCT00588861|365754490|FG000|6 Years|Patients did not return for follow-up|104|||
106024147|NCT00588861|365754491|FG001|6 Years|Patients did not return for follow-up|109|||
106024148|NCT00588861|365754490|FG000|8 Years|Patients did not return for follow-up|105|||
106024149|NCT00588861|365754491|FG001|8 Years|Patients did not return for follow-up|114|||
106024150|NCT00588861|365754490|FG000|10 Years|Incomplete due to study termination|107|||
105968316|NCT03632993|365543716|FG000|Overall Study|Adverse Event|0|||
105968317|NCT03632993|365543717|FG001|Overall Study|Adverse Event|0|||
106024151|NCT00588861|365754491|FG001|10 Years|Incomplete due to study termination|114|||
106024152|NCT02730195|365754492|FG000|Overall Study|Withdrawal by Subject|1|||
106024153|NCT01368562|365754493|FG000|Overall Study|Adverse Event|1|||
106024154|NCT01368562|365754493|FG000|Overall Study|Disease progression|1|||
106024155|NCT01368562|365754493|FG000|Overall Study|Lost to Follow-up|1|||
106024156|NCT01368562|365754493|FG000|Overall Study|Death|6|||
106149420|NCT03598790|366209107|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
106024157|NCT01368562|365754493|FG000|Overall Study|Unresponsive to treatment|5|||
106149421|NCT03598790|366209108|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
106149422|NCT03598790|366209109|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105968318|NCT03632993|365543718|FG002|Overall Study|Adverse Event|0|||
105968319|NCT03632993|365543719|FG003|Overall Study|Adverse Event|0|||
105968320|NCT03632993|365543720|FG004|Overall Study|Adverse Event|0|||
105968321|NCT03632993|365543721|FG005|Overall Study|Adverse Event|1|||
105968322|NCT03632993|365543722|FG006|Overall Study|Adverse Event|0|||
105968323|NCT03632993|365543723|FG007|Overall Study|Adverse Event|1|||
105968324|NCT03632993|365543724|FG008|Overall Study|Adverse Event|0|||
105968325|NCT03632993|365543725|FG009|Overall Study|Adverse Event|0|||
105968326|NCT02743949|365543728|FG000|Overall Study|Adverse Event|0|||
105968327|NCT02743949|365543729|FG001|Overall Study|Adverse Event|0|||
105968328|NCT02743949|365543730|FG002|Overall Study|Adverse Event|2|||
105968329|NCT02743949|365543728|FG000|Overall Study|Significant Protocol Deviation|2|||
105968330|NCT02743949|365543729|FG001|Overall Study|Significant Protocol Deviation|0|||
105968331|NCT02743949|365543730|FG002|Overall Study|Significant Protocol Deviation|1|||
105968332|NCT02743949|365543728|FG000|Overall Study|Voluntary Withdrawal|2|||
105968333|NCT02743949|365543729|FG001|Overall Study|Voluntary Withdrawal|1|||
105968334|NCT02743949|365543730|FG002|Overall Study|Voluntary Withdrawal|0|||
105968335|NCT01885208|365543733|FG000|Overall Study|Unclassified|32|||
105968336|NCT01885208|365543734|FG001|Overall Study|Unclassified|38|||
105968337|NCT00920218|365543735|FG000|Overall Study|Serious Adverse Event|2|||
105968338|NCT00920218|365543736|FG001|Overall Study|Serious Adverse Event|0|||
105968339|NCT00920218|365543737|FG002|Overall Study|Serious Adverse Event|2|||
105968340|NCT00920218|365543738|FG003|Overall Study|Serious Adverse Event|1|||
105968341|NCT00920218|365543735|FG000|Overall Study|Withdrawal by Subject|0|||
105968342|NCT00920218|365543736|FG001|Overall Study|Withdrawal by Subject|3|||
105968343|NCT00920218|365543737|FG002|Overall Study|Withdrawal by Subject|2|||
105968344|NCT00920218|365543738|FG003|Overall Study|Withdrawal by Subject|0|||
105968345|NCT00920218|365543735|FG000|Overall Study|Migrated/moved from study area|0|||
105968346|NCT00920218|365543736|FG001|Overall Study|Migrated/moved from study area|0|||
106149423|NCT03598790|366209110|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
106149424|NCT03598790|366209111|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
106149425|NCT03598790|366209112|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105968347|NCT00920218|365543737|FG002|Overall Study|Migrated/moved from study area|1|||
105968348|NCT00920218|365543738|FG003|Overall Study|Migrated/moved from study area|0|||
105968349|NCT00920218|365543735|FG000|Overall Study|Lost to Follow-up|0|||
105968350|NCT00920218|365543736|FG001|Overall Study|Lost to Follow-up|1|||
105968351|NCT00920218|365543737|FG002|Overall Study|Lost to Follow-up|0|||
105968352|NCT00920218|365543738|FG003|Overall Study|Lost to Follow-up|3|||
105968353|NCT00920218|365543735|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
105968354|NCT00920218|365543736|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
105968355|NCT00920218|365543737|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
105968356|NCT00920218|365543738|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
105968357|NCT00920218|365543735|FG000|Overall Study|Other|0|||
105968358|NCT00920218|365543736|FG001|Overall Study|Other|0|||
105968359|NCT00920218|365543737|FG002|Overall Study|Other|1|||
105968360|NCT00920218|365543738|FG003|Overall Study|Other|0|||
105968361|NCT01328535|365543740|FG000|Overall Study|Ineligible|1|||
105968362|NCT01005316|365543741|FG000|Overall Study|Adverse Event|0|||
105968363|NCT01005316|365543742|FG001|Overall Study|Adverse Event|0|||
105968364|NCT01005316|365543743|FG002|Overall Study|Adverse Event|0|||
105968365|NCT01005316|365543744|FG003|Overall Study|Adverse Event|1|||
105968366|NCT01005316|365543741|FG000|Overall Study|Death|20|||
105968367|NCT01005316|365543742|FG001|Overall Study|Death|5|||
105968368|NCT01005316|365543743|FG002|Overall Study|Death|1|||
105968369|NCT01005316|365543744|FG003|Overall Study|Death|15|||
105968370|NCT01005316|365543741|FG000|Overall Study|Study Termination|5|||
105968371|NCT01005316|365543742|FG001|Overall Study|Study Termination|63|||
105968372|NCT01005316|365543743|FG002|Overall Study|Study Termination|9|||
105968373|NCT01005316|365543744|FG003|Overall Study|Study Termination|85|||
105968374|NCT01005316|365543741|FG000|Overall Study|Lost to Follow-up|1|||
105968375|NCT01005316|365543742|FG001|Overall Study|Lost to Follow-up|3|||
105968376|NCT01005316|365543743|FG002|Overall Study|Lost to Follow-up|0|||
105968377|NCT01005316|365543744|FG003|Overall Study|Lost to Follow-up|2|||
105968378|NCT01005316|365543741|FG000|Overall Study|Physician Decision|6|||
105968379|NCT01005316|365543742|FG001|Overall Study|Physician Decision|0|||
105968380|NCT01005316|365543743|FG002|Overall Study|Physician Decision|0|||
105968381|NCT01005316|365543744|FG003|Overall Study|Physician Decision|0|||
105968382|NCT01005316|365543741|FG000|Overall Study|Sponsor Decision|6|||
105968383|NCT01005316|365543742|FG001|Overall Study|Sponsor Decision|3|||
106149426|NCT03598790|366209113|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
105968384|NCT01005316|365543743|FG002|Overall Study|Sponsor Decision|0|||
105968385|NCT01005316|365543744|FG003|Overall Study|Sponsor Decision|0|||
105968386|NCT01005316|365543741|FG000|Overall Study|Withdrawal by Subject|1|||
105968387|NCT01005316|365543742|FG001|Overall Study|Withdrawal by Subject|1|||
105968388|NCT01005316|365543743|FG002|Overall Study|Withdrawal by Subject|0|||
105968389|NCT01005316|365543744|FG003|Overall Study|Withdrawal by Subject|2|||
105968390|NCT01005316|365543741|FG000|Overall Study|Consented to Another Study|2|||
105968391|NCT01005316|365543742|FG001|Overall Study|Consented to Another Study|0|||
105968392|NCT01005316|365543743|FG002|Overall Study|Consented to Another Study|0|||
105968393|NCT01005316|365543744|FG003|Overall Study|Consented to Another Study|0|||
105968394|NCT01005316|365543741|FG000|Overall Study|Delisted|8|||
105968395|NCT01005316|365543742|FG001|Overall Study|Delisted|0|||
105968396|NCT01005316|365543743|FG002|Overall Study|Delisted|0|||
105968397|NCT01005316|365543744|FG003|Overall Study|Delisted|0|||
105968398|NCT01005316|365543741|FG000|Overall Study|Transferred Care|1|||
105968399|NCT01005316|365543742|FG001|Overall Study|Transferred Care|0|||
105968400|NCT01005316|365543743|FG002|Overall Study|Transferred Care|1|||
105968401|NCT01005316|365543744|FG003|Overall Study|Transferred Care|3|||
105968402|NCT01005316|365543741|FG000|Overall Study|Retransplanted|0|||
105968403|NCT01005316|365543742|FG001|Overall Study|Retransplanted|1|||
105968404|NCT01005316|365543743|FG002|Overall Study|Retransplanted|0|||
105968405|NCT01005316|365543744|FG003|Overall Study|Retransplanted|0|||
105968406|NCT04417218|365543745|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
105968407|NCT04417218|365543746|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
105968408|NCT03224507|365543747|FG000|Overall Study|Death|3|||
105968409|NCT03224507|365543748|FG001|Overall Study|Death|0|||
105968410|NCT03224507|365543747|FG000|Overall Study|Lack of Efficacy|6|||
105968411|NCT03224507|365543748|FG001|Overall Study|Lack of Efficacy|0|||
105968412|NCT03224507|365543747|FG000|Overall Study|Withdrawal by Subject|6|||
105968413|NCT03224507|365543748|FG001|Overall Study|Withdrawal by Subject|0|||
105968414|NCT00873041|365543749|FG000|Core Study|Adverse Event|2|||
105968415|NCT00873041|365543750|FG001|Core Study|Adverse Event|3|||
105968416|NCT00873041|365543751|FG002|Core Study|Adverse Event|1|||
105968417|NCT00873041|365543749|FG000|Core Study|Withdrawal by Subject|1|||
105968418|NCT00873041|365543750|FG001|Core Study|Withdrawal by Subject|2|||
105968419|NCT00873041|365543751|FG002|Core Study|Withdrawal by Subject|2|||
105968420|NCT00873041|365543749|FG000|Core Study|Lost to Follow-up|3|||
105968421|NCT00873041|365543750|FG001|Core Study|Lost to Follow-up|1|||
105968422|NCT00873041|365543751|FG002|Core Study|Lost to Follow-up|0|||
105968423|NCT00873041|365543749|FG000|Core Study|Abnormal laboratory value|0|||
105968424|NCT00873041|365543750|FG001|Core Study|Abnormal laboratory value|0|||
105968425|NCT00873041|365543751|FG002|Core Study|Abnormal laboratory value|1|||
105968426|NCT00873041|365543749|FG000|Core Study|Protocol deviation|1|||
105968427|NCT00873041|365543750|FG001|Core Study|Protocol deviation|0|||
105968428|NCT00873041|365543751|FG002|Core Study|Protocol deviation|1|||
105968429|NCT00873041|365543749|FG000|Extension Study|Adverse Event|1|||
105968430|NCT00873041|365543750|FG001|Extension Study|Adverse Event|0|||
105968431|NCT00873041|365543751|FG002|Extension Study|Adverse Event|1|||
105968432|NCT00873041|365543749|FG000|Extension Study|Administrative reasons|0|||
105968433|NCT00873041|365543750|FG001|Extension Study|Administrative reasons|0|||
105968434|NCT00873041|365543751|FG002|Extension Study|Administrative reasons|1|||
105968435|NCT04295681|365543752|FG000|Overall Study|Eligibility error|1|||
105968436|NCT04295681|365543753|FG001|Overall Study|Eligibility error|3|||
105968437|NCT02135029|365543754|FG000|Overall Study|Adverse Event|2|||
105968438|NCT02135029|365543755|FG001|Overall Study|Adverse Event|2|||
105968439|NCT02135029|365543756|FG002|Overall Study|Adverse Event|2|||
105968440|NCT02135029|365543754|FG000|Overall Study|Lost to Follow-up|0|||
105968441|NCT02135029|365543755|FG001|Overall Study|Lost to Follow-up|1|||
105968442|NCT02135029|365543756|FG002|Overall Study|Lost to Follow-up|0|||
106149427|NCT03598790|366209105|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106149428|NCT03598790|366209106|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105968443|NCT02135029|365543754|FG000|Overall Study|Withdrawal by Subject|2|||
105968444|NCT02135029|365543755|FG001|Overall Study|Withdrawal by Subject|0|||
105968445|NCT02135029|365543756|FG002|Overall Study|Withdrawal by Subject|1|||
105968446|NCT02135029|365543754|FG000|Overall Study|Other|0|||
105968447|NCT02135029|365543755|FG001|Overall Study|Other|1|||
105968448|NCT02135029|365543756|FG002|Overall Study|Other|0|||
105968449|NCT02135029|365543754|FG000|Overall Study|Death|0|||
105968450|NCT02135029|365543755|FG001|Overall Study|Death|1|||
105968451|NCT02135029|365543756|FG002|Overall Study|Death|0|||
105968452|NCT03466099|365543759|FG000|Overall Study|Adverse Event|1|||
105968453|NCT03466099|365543760|FG001|Overall Study|Adverse Event|1|||
105968454|NCT03466099|365543761|FG002|Overall Study|Adverse Event|1|||
105968455|NCT03466099|365543759|FG000|Overall Study|Withdrawal by Subject|2|||
105968456|NCT03466099|365543760|FG001|Overall Study|Withdrawal by Subject|3|||
105968457|NCT03466099|365543761|FG002|Overall Study|Withdrawal by Subject|1|||
105968458|NCT03466099|365543759|FG000|Overall Study|Use of rescue medication|8|||
105968459|NCT03466099|365543760|FG001|Overall Study|Use of rescue medication|9|||
105968460|NCT03466099|365543761|FG002|Overall Study|Use of rescue medication|13|||
105968461|NCT03466099|365543759|FG000|Overall Study|Rescued without meeting criteria|4|||
105968462|NCT03466099|365543760|FG001|Overall Study|Rescued without meeting criteria|1|||
105968463|NCT03466099|365543761|FG002|Overall Study|Rescued without meeting criteria|1|||
105968464|NCT03466099|365543759|FG000|Overall Study|Subject compliance|2|||
105968465|NCT03466099|365543760|FG001|Overall Study|Subject compliance|0|||
105968466|NCT03466099|365543761|FG002|Overall Study|Subject compliance|0|||
105968467|NCT03466099|365543759|FG000|Overall Study|Worsening disease|0|||
105968468|NCT03466099|365543760|FG001|Overall Study|Worsening disease|0|||
105968469|NCT03466099|365543761|FG002|Overall Study|Worsening disease|1|||
106149429|NCT03598790|366209107|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105968470|NCT01923363|365543764|FG000|Overall Study|Protocol Violation|1|||
105968471|NCT02247011|365543765|FG000|Overall Study|Poor quality of radiological results|125|||
105968472|NCT02152371|365543766|FG000|Overall Study|Adverse Event|6|||
105968473|NCT02152371|365543767|FG001|Overall Study|Adverse Event|2|||
105968474|NCT02152371|365543766|FG000|Overall Study|Withdrawal by Subject|3|||
105968475|NCT02152371|365543767|FG001|Overall Study|Withdrawal by Subject|7|||
105968476|NCT02152371|365543766|FG000|Overall Study|Protocol Violation|2|||
105968477|NCT02152371|365543767|FG001|Overall Study|Protocol Violation|3|||
105968478|NCT02152371|365543766|FG000|Overall Study|Lost to Follow-up|1|||
105968479|NCT02152371|365543767|FG001|Overall Study|Lost to Follow-up|0|||
105968480|NCT02152371|365543766|FG000|Overall Study|Lack of Efficacy|0|||
105968481|NCT02152371|365543767|FG001|Overall Study|Lack of Efficacy|1|||
105968482|NCT02152371|365543766|FG000|Overall Study|Physician Decision|0|||
105968483|NCT02152371|365543767|FG001|Overall Study|Physician Decision|2|||
105968484|NCT02152371|365543766|FG000|Overall Study|Reason Not Given|0|||
105968485|NCT02152371|365543767|FG001|Overall Study|Reason Not Given|1|||
105968486|NCT03194568|365543770|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
105968487|NCT03515551|365543773|FG000|Overall Study|Death|4|||
105968488|NCT03515551|365543774|FG001|Overall Study|Death|1|||
105968489|NCT03515551|365543775|FG002|Overall Study|Death|2|||
105968490|NCT03515551|365543776|FG003|Overall Study|Death|2|||
105968491|NCT03515551|365543777|FG004|Overall Study|Death|2|||
105968492|NCT03515551|365543778|FG005|Overall Study|Death|4|||
105968493|NCT03515551|365543779|FG006|Overall Study|Death|1|||
105968494|NCT03515551|365543773|FG000|Overall Study|Lost to Follow-up|0|||
105968495|NCT03515551|365543774|FG001|Overall Study|Lost to Follow-up|0|||
105968496|NCT03515551|365543775|FG002|Overall Study|Lost to Follow-up|1|||
105968497|NCT03515551|365543776|FG003|Overall Study|Lost to Follow-up|0|||
105968498|NCT03515551|365543777|FG004|Overall Study|Lost to Follow-up|0|||
105968499|NCT03515551|365543778|FG005|Overall Study|Lost to Follow-up|0|||
105968500|NCT03515551|365543779|FG006|Overall Study|Lost to Follow-up|0|||
105968501|NCT03515551|365543773|FG000|Overall Study|Withdrawal by Subject|0|||
105968502|NCT03515551|365543774|FG001|Overall Study|Withdrawal by Subject|1|||
105968503|NCT03515551|365543775|FG002|Overall Study|Withdrawal by Subject|0|||
105968504|NCT03515551|365543776|FG003|Overall Study|Withdrawal by Subject|0|||
105968505|NCT03515551|365543777|FG004|Overall Study|Withdrawal by Subject|0|||
105968506|NCT03515551|365543778|FG005|Overall Study|Withdrawal by Subject|0|||
105968507|NCT03515551|365543779|FG006|Overall Study|Withdrawal by Subject|1|||
105968508|NCT03515551|365543773|FG000|Overall Study|Study ended by sponsor|0|||
105968509|NCT03515551|365543774|FG001|Overall Study|Study ended by sponsor|0|||
105968510|NCT03515551|365543775|FG002|Overall Study|Study ended by sponsor|2|||
105968511|NCT03515551|365543776|FG003|Overall Study|Study ended by sponsor|1|||
105968512|NCT03515551|365543777|FG004|Overall Study|Study ended by sponsor|3|||
105968513|NCT03515551|365543778|FG005|Overall Study|Study ended by sponsor|0|||
105968514|NCT03515551|365543779|FG006|Overall Study|Study ended by sponsor|3|||
105968515|NCT03515551|365543773|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105968516|NCT03515551|365543774|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
105968517|NCT03515551|365543775|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105968518|NCT03515551|365543776|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105968519|NCT03515551|365543777|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105968520|NCT03515551|365543778|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105968521|NCT03515551|365543779|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
105968522|NCT01301066|365543780|FG000|Overall Study|Lost to Follow-up|5|||
105968523|NCT01301066|365543781|FG001|Overall Study|Lost to Follow-up|11|||
105968524|NCT01301066|365543780|FG000|Overall Study|Protocol Violation|8|||
105968525|NCT01301066|365543781|FG001|Overall Study|Protocol Violation|7|||
105968526|NCT01301066|365543780|FG000|Overall Study|Withdrawal by Subject|4|||
105968527|NCT01301066|365543781|FG001|Overall Study|Withdrawal by Subject|9|||
105968528|NCT01301066|365543780|FG000|Overall Study|Adverse Event|6|||
105968529|NCT01301066|365543781|FG001|Overall Study|Adverse Event|6|||
105968530|NCT01301066|365543780|FG000|Overall Study|Sponsor Decision|2|||
105968531|NCT01301066|365543781|FG001|Overall Study|Sponsor Decision|1|||
105968532|NCT01301066|365543780|FG000|Overall Study|Physician Decision|0|||
105968533|NCT01301066|365543781|FG001|Overall Study|Physician Decision|1|||
105968534|NCT01301066|365543780|FG000|Overall Study|Other|2|||
105968535|NCT01301066|365543781|FG001|Overall Study|Other|0|||
105968536|NCT01252186|365543782|FG000|Overall Study|Adverse Event|9|||
105968537|NCT01252186|365543783|FG001|Overall Study|Adverse Event|6|||
105968538|NCT01252186|365543784|FG002|Overall Study|Adverse Event|8|||
105968539|NCT01252186|365543782|FG000|Overall Study|Withdrawal by Subject|2|||
105968540|NCT01252186|365543783|FG001|Overall Study|Withdrawal by Subject|5|||
105968541|NCT01252186|365543784|FG002|Overall Study|Withdrawal by Subject|2|||
105968542|NCT01252186|365543782|FG000|Overall Study|Physician Decision|0|||
105968543|NCT01252186|365543783|FG001|Overall Study|Physician Decision|0|||
105968544|NCT01252186|365543784|FG002|Overall Study|Physician Decision|1|||
105968545|NCT01252186|365543782|FG000|Overall Study|Non-compliance|0|||
105968546|NCT01252186|365543783|FG001|Overall Study|Non-compliance|3|||
105968547|NCT01252186|365543784|FG002|Overall Study|Non-compliance|4|||
105968548|NCT01252186|365543782|FG000|Overall Study|Protocol Violation|0|||
105968549|NCT01252186|365543783|FG001|Overall Study|Protocol Violation|0|||
105968550|NCT01252186|365543784|FG002|Overall Study|Protocol Violation|1|||
106149430|NCT03598790|366209108|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
105841855|NCT00706355|365077736|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
105841856|NCT00706355|365077737|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
105841857|NCT00706355|365077738|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
105841858|NCT00706355|365077735|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
105841859|NCT00706355|365077736|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
105841860|NCT00706355|365077737|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
105841861|NCT00706355|365077738|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
105841862|NCT00706355|365077735|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
105841863|NCT00706355|365077736|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
105841864|NCT00706355|365077737|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
105841865|NCT00706355|365077738|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
105841866|NCT00706355|365077735|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
105841867|NCT00706355|365077736|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
105841868|NCT00706355|365077737|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
105841869|NCT00706355|365077738|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
105841870|NCT00706355|365077735|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
105841871|NCT00706355|365077736|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
105841872|NCT00706355|365077737|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
105841873|NCT00706355|365077738|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
105841874|NCT02549573|365077739|FG000|Overall Study|Withdrawal by Subject|0|||
105841875|NCT02549573|365077740|FG001|Overall Study|Withdrawal by Subject|2|||
105841876|NCT02549573|365077739|FG000|Overall Study|Protocol Violation|0|||
105841877|NCT02549573|365077740|FG001|Overall Study|Protocol Violation|1|||
105841878|NCT01660022|365077741|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
105841879|NCT01660022|365077742|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
105841880|NCT01660022|365077743|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
105841881|NCT01660022|365077744|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
105841882|NCT01660022|365077745|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
105841883|NCT01660022|365077746|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
105841884|NCT01660022|365077741|FG000|First Sequence (7 Days)|Adverse Event|0|||
105841885|NCT01660022|365077742|FG001|First Sequence (7 Days)|Adverse Event|0|||
105841886|NCT01660022|365077743|FG002|First Sequence (7 Days)|Adverse Event|0|||
105841887|NCT01660022|365077744|FG003|First Sequence (7 Days)|Adverse Event|0|||
105841888|NCT01660022|365077745|FG004|First Sequence (7 Days)|Adverse Event|1|||
105841889|NCT01660022|365077746|FG005|First Sequence (7 Days)|Adverse Event|3|||
105841890|NCT01660022|365077741|FG000|First Sequence (7 Days)|Protocol Violation|0|||
105841891|NCT01660022|365077742|FG001|First Sequence (7 Days)|Protocol Violation|0|||
105841892|NCT01660022|365077743|FG002|First Sequence (7 Days)|Protocol Violation|0|||
105841893|NCT01660022|365077744|FG003|First Sequence (7 Days)|Protocol Violation|0|||
105841894|NCT01660022|365077745|FG004|First Sequence (7 Days)|Protocol Violation|0|||
105841895|NCT01660022|365077746|FG005|First Sequence (7 Days)|Protocol Violation|1|||
105841896|NCT03064438|365078940|FG000|Overall Study|Lost to Follow-up|1|||
105841897|NCT03064438|365078941|FG001|Overall Study|Lost to Follow-up|0|||
105968551|NCT01252186|365543782|FG000|Overall Study|Pregnancy|2|||
105968552|NCT01252186|365543783|FG001|Overall Study|Pregnancy|2|||
105968553|NCT01252186|365543784|FG002|Overall Study|Pregnancy|0|||
105968554|NCT01252186|365543782|FG000|Overall Study|Sponsor Request|2|||
105968555|NCT01252186|365543783|FG001|Overall Study|Sponsor Request|1|||
105968556|NCT01252186|365543784|FG002|Overall Study|Sponsor Request|0|||
105968557|NCT01252186|365543782|FG000|Overall Study|Lost to Follow-up|10|||
105968558|NCT01252186|365543783|FG001|Overall Study|Lost to Follow-up|10|||
105968559|NCT01252186|365543784|FG002|Overall Study|Lost to Follow-up|11|||
105968560|NCT01252186|365543782|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
105968561|NCT01252186|365543783|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
105968562|NCT01252186|365543784|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
105968563|NCT00322452|365543785|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105968564|NCT00322452|365543786|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105968565|NCT00322452|365543785|FG000|Overall Study|Lost to Follow-up|5|||
105968566|NCT00322452|365543786|FG001|Overall Study|Lost to Follow-up|2|||
105968567|NCT00322452|365543785|FG000|Overall Study|Withdrawal by Subject|19|||
105968568|NCT00322452|365543786|FG001|Overall Study|Withdrawal by Subject|46|||
105968569|NCT00322452|365543785|FG000|Overall Study|Death|223|||
105968570|NCT00322452|365543786|FG001|Overall Study|Death|227|||
105968571|NCT00350272|365543787|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
105841898|NCT03064438|365078940|FG000|Overall Study|Withdrawal by Subject|0|||
105841899|NCT03064438|365078941|FG001|Overall Study|Withdrawal by Subject|1|||
105968572|NCT00350272|365543788|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
105968573|NCT00350272|365543787|FG000|Blinded 12-Week Treatment|Death|1|||
105968574|NCT00350272|365543788|FG001|Blinded 12-Week Treatment|Death|0|||
105968575|NCT00350272|365543787|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
105968576|NCT00350272|365543788|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
105841900|NCT00595335|365078942|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
105841901|NCT00595335|365078943|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
105841902|NCT00595335|365078942|FG000|Baseline to Six Months|Disease Progression|1|||
105841903|NCT00595335|365078943|FG001|Baseline to Six Months|Disease Progression|1|||
105841904|NCT00595335|365078942|FG000|Baseline to Six Months|Adverse Event|1|||
105841905|NCT00595335|365078943|FG001|Baseline to Six Months|Adverse Event|0|||
105841906|NCT00595335|365078942|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
105841907|NCT00595335|365078943|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
105841908|NCT00595335|365078942|FG000|Six Months to Twelve Months|Disease Progression|1|||
105841909|NCT00595335|365078943|FG001|Six Months to Twelve Months|Disease Progression|0|||
105841910|NCT00493779|365078948|FG000|Overall Study|Logistical issue at site|1|||
105841911|NCT00544817|365078949|FG000|Combined Modality|Lack of Efficacy|2|||
105841912|NCT00544817|365078949|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
105841913|NCT00544817|365078949|FG000|Combined Modality|Adverse Event|2|||
105841914|NCT00544817|365078949|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
105841915|NCT00544817|365078949|FG000|No Treatment Interval|Lack of Efficacy|8|||
105841916|NCT00544817|365078949|FG000|No Treatment Interval|Physician Decision|3|||
105841917|NCT00544817|365078949|FG000|No Treatment Interval|Adverse Event|1|||
105841918|NCT00544817|365078949|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
105841919|NCT00544817|365078949|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
105841920|NCT00544817|365078949|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
105841921|NCT01131299|365078950|FG000|Overall Study|Withdrawal by Subject|4|||
105841922|NCT01131299|365078951|FG001|Overall Study|Withdrawal by Subject|7|||
105841923|NCT01885182|365078952|FG000|Overall Study|Adverse Event|11|||
105841924|NCT01885182|365078953|FG001|Overall Study|Adverse Event|13|||
105841925|NCT01885182|365078952|FG000|Overall Study|Withdrawal by Subject|13|||
105841926|NCT01885182|365078953|FG001|Overall Study|Withdrawal by Subject|6|||
105841927|NCT01885182|365078952|FG000|Overall Study|Lost to Follow-up|2|||
105841928|NCT01885182|365078953|FG001|Overall Study|Lost to Follow-up|2|||
105841929|NCT01885182|365078952|FG000|Overall Study|Lack of Efficacy|8|||
105841930|NCT01885182|365078953|FG001|Overall Study|Lack of Efficacy|1|||
105841931|NCT01592721|365078954|FG000|Long-term Follow-up|Death|1|||
105841932|NCT01432574|365078957|FG000|Overall Study|Moved|2|||
105841933|NCT01432574|365078957|FG000|Overall Study|Not interested|1|||
105841934|NCT01475253|365078966|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
105841935|NCT01475253|365078967|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
105841936|NCT01475253|365078968|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
105841937|NCT01475253|365078969|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
105841938|NCT01475253|365078966|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
105841939|NCT01475253|365078967|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
105841940|NCT01475253|365078968|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
105841941|NCT01475253|365078969|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
105841942|NCT03135899|365078970|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841943|NCT03135899|365078971|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841944|NCT03135899|365078972|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841945|NCT03135899|365078973|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841946|NCT03135899|365078974|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841947|NCT03135899|365078975|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841948|NCT03135899|365078976|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
105841949|NCT03135899|365078977|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
105841950|NCT03135899|365078970|FG000|Overall Study|Withdrawal by Subject|0|||
105841951|NCT03135899|365078971|FG001|Overall Study|Withdrawal by Subject|0|||
105841952|NCT03135899|365078972|FG002|Overall Study|Withdrawal by Subject|0|||
105841953|NCT03135899|365078973|FG003|Overall Study|Withdrawal by Subject|0|||
105841954|NCT03135899|365078974|FG004|Overall Study|Withdrawal by Subject|0|||
105841955|NCT03135899|365078975|FG005|Overall Study|Withdrawal by Subject|2|||
105968577|NCT00350272|365543787|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
105968578|NCT00350272|365543788|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
105968579|NCT00350272|365543787|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
105968580|NCT00350272|365543788|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
105968581|NCT00350272|365543787|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
105968582|NCT00350272|365543788|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
105968583|NCT00350272|365543787|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
105968584|NCT00350272|365543788|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
105968585|NCT00350272|365543787|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
105841956|NCT03135899|365078976|FG006|Overall Study|Withdrawal by Subject|0|||
105841957|NCT03135899|365078977|FG007|Overall Study|Withdrawal by Subject|0|||
105968586|NCT00350272|365543788|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
105968587|NCT00350272|365543787|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
105841958|NCT01559935|365078978|FG000|Car Phase|Toxicity|4|||
105841959|NCT01559935|365078978|FG000|Car Phase|Death|1|||
105841960|NCT01559935|365078978|FG000|Car Phase|Lack of Efficacy|2|||
105841961|NCT01559935|365078978|FG000|Car Phase|Lost to Follow-up|1|||
105841962|NCT01559935|365078978|FG000|Car Phase|Physician Decision|1|||
105841963|NCT01559935|365078978|FG000|Car Phase|Withdrawal by Subject|2|||
105841964|NCT01559935|365078978|FG000|Car Phase|Per protocol|1|||
105841965|NCT01559935|365078978|FG000|Car Phase|Insurance|1|||
105841966|NCT01559935|365078978|FG000|Car Phase|non-compliance|1|||
105841967|NCT01559935|365078978|FG000|BiRD Phase|Toxicity|1|||
105841968|NCT01559935|365078978|FG000|BiRD Phase|Lack of Efficacy|1|||
105841969|NCT01559935|365078978|FG000|BiRD Phase|Withdrawal by Subject|2|||
105841970|NCT01559935|365078978|FG000|Maintenance Phase|Remains on study|28|||
105841971|NCT01559935|365078978|FG000|Maintenance Phase|Toxicity|1|||
105841972|NCT01559935|365078978|FG000|Maintenance Phase|Lack of Efficacy|18|||
105841973|NCT01559935|365078978|FG000|Maintenance Phase|Withdrawal by Subject|5|||
105841974|NCT01559935|365078978|FG000|Maintenance Phase|Non-compliance|2|||
105841975|NCT01685073|365078979|FG000|Overall Study|Lost to Follow-up|6|||
105841976|NCT01685073|365078980|FG001|Overall Study|Lost to Follow-up|8|||
105841977|NCT01685073|365078979|FG000|Overall Study|Withdrawal by Subject|24|||
105841978|NCT01685073|365078980|FG001|Overall Study|Withdrawal by Subject|24|||
105841979|NCT02075606|365078993|FG000|Overall Study|Adverse Event|5|||
105841980|NCT02075606|365078993|FG000|Overall Study|Withdrawal by Subject|1|||
105841981|NCT02075606|365078993|FG000|Overall Study|Death|1|||
105841982|NCT02075606|365078993|FG000|Overall Study|Investigator's decision|1|||
105841983|NCT02075606|365078993|FG000|Overall Study|Symptom management|1|||
105841984|NCT02075606|365078993|FG000|Overall Study|Increasing Symptoms|1|||
105841985|NCT02751827|365078994|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
105841986|NCT02751827|365078995|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
105841987|NCT02751827|365078996|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
105841988|NCT03847194|365078997|FG000|Overall Study|Lost to Follow-up|2|||
105841989|NCT03847194|365078998|FG001|Overall Study|Lost to Follow-up|5|||
105841990|NCT03847194|365078997|FG000|Overall Study|Withdrawal by Subject|1|||
105841991|NCT03847194|365078998|FG001|Overall Study|Withdrawal by Subject|2|||
105841992|NCT03847194|365078997|FG000|Overall Study|Death|0|||
105841993|NCT03847194|365078998|FG001|Overall Study|Death|1|||
105841994|NCT00508027|365078999|FG000|Dose Level 1|Lost to Follow-up|4|||
105841995|NCT00508027|365078999|FG000|Dose Level 1|Withdrawal by Subject|2|||
105841996|NCT00508027|365078999|FG000|Dose Level 1|Physician Decision|2|||
105841997|NCT00508027|365078999|FG000|Dose Level 2|Lost to Follow-up|2|||
105841998|NCT00508027|365078999|FG000|Dose Level 2|Withdrawal by Subject|2|||
105841999|NCT03877926|365079000|FG000|Overall Study|Adverse Event|1|||
105842000|NCT03877926|365079001|FG001|Overall Study|Adverse Event|0|||
105842001|NCT03877926|365079002|FG002|Overall Study|Adverse Event|0|||
105842002|NCT03877926|365079003|FG003|Overall Study|Adverse Event|0|||
105842003|NCT03877926|365079000|FG000|Overall Study|Death|2|||
105842004|NCT03877926|365079001|FG001|Overall Study|Death|2|||
105842005|NCT03877926|365079002|FG002|Overall Study|Death|2|||
105842006|NCT03877926|365079003|FG003|Overall Study|Death|0|||
105842007|NCT03877926|365079000|FG000|Overall Study|Lost to Follow-up|41|||
105842008|NCT03877926|365079001|FG001|Overall Study|Lost to Follow-up|52|||
105842009|NCT03877926|365079002|FG002|Overall Study|Lost to Follow-up|45|||
105842010|NCT03877926|365079003|FG003|Overall Study|Lost to Follow-up|17|||
105842011|NCT03877926|365079000|FG000|Overall Study|Physician Decision|2|||
105842012|NCT03877926|365079001|FG001|Overall Study|Physician Decision|0|||
105842013|NCT03877926|365079002|FG002|Overall Study|Physician Decision|2|||
105968588|NCT00350272|365543788|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
105968589|NCT00350272|365543787|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
105968590|NCT00350272|365543788|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
105968591|NCT00350272|365543787|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
105968592|NCT00350272|365543788|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
105968593|NCT01795495|365543790|FG000|Overall Study|Protocol Violation|1|||
105968594|NCT01795495|365543791|FG001|Overall Study|Protocol Violation|0|||
105842014|NCT03877926|365079003|FG003|Overall Study|Physician Decision|0|||
105842015|NCT03877926|365079000|FG000|Overall Study|Withdrawal by Subject|18|||
105842016|NCT03877926|365079001|FG001|Overall Study|Withdrawal by Subject|21|||
105842017|NCT03877926|365079002|FG002|Overall Study|Withdrawal by Subject|12|||
105842018|NCT03877926|365079003|FG003|Overall Study|Withdrawal by Subject|4|||
105842019|NCT03877926|365079000|FG000|Overall Study|Other - Various|4|||
105842020|NCT03877926|365079001|FG001|Overall Study|Other - Various|1|||
105842021|NCT03877926|365079002|FG002|Overall Study|Other - Various|1|||
105968595|NCT01795495|365543792|FG002|Overall Study|Protocol Violation|1|||
105842022|NCT03877926|365079003|FG003|Overall Study|Other - Various|0|||
105842023|NCT03877926|365079000|FG000|Overall Study|Not Treated|3|||
105842024|NCT03877926|365079001|FG001|Overall Study|Not Treated|1|||
105842025|NCT03877926|365079002|FG002|Overall Study|Not Treated|1|||
105842026|NCT03877926|365079003|FG003|Overall Study|Not Treated|0|||
105842027|NCT00537199|365079008|FG000|Overall Study|Study Terminated|1|||
105842028|NCT03891329|365079009|FG000|Overall Study|Death|5|||
105842029|NCT03891329|365079009|FG000|Overall Study|Lost to Follow-up|4|||
105842030|NCT03891329|365079009|FG000|Overall Study|Physician Decision|4|||
105842031|NCT03891329|365079009|FG000|Overall Study|Device explanted|3|||
105968596|NCT01795495|365543790|FG000|Overall Study|Physician Decision|0|||
105968597|NCT01795495|365543791|FG001|Overall Study|Physician Decision|0|||
105968598|NCT01795495|365543792|FG002|Overall Study|Physician Decision|1|||
105968599|NCT01962987|365545369|FG000|Overall Study|Adverse Event|4|||
105968600|NCT01962987|365545370|FG001|Overall Study|Adverse Event|4|||
105968601|NCT01962987|365545371|FG002|Overall Study|Adverse Event|0|||
105968602|NCT01962987|365545369|FG000|Overall Study|Lost to Follow-up|0|||
105968603|NCT01962987|365545370|FG001|Overall Study|Lost to Follow-up|0|||
105968604|NCT01962987|365545371|FG002|Overall Study|Lost to Follow-up|1|||
105968605|NCT01962987|365545369|FG000|Overall Study|Non compliance with dosing requirements|4|||
105968606|NCT01962987|365545370|FG001|Overall Study|Non compliance with dosing requirements|2|||
105968607|NCT01962987|365545371|FG002|Overall Study|Non compliance with dosing requirements|0|||
105968608|NCT01962987|365545369|FG000|Overall Study|Miscellaneous|1|||
105968609|NCT01962987|365545370|FG001|Overall Study|Miscellaneous|9|||
105968610|NCT01962987|365545371|FG002|Overall Study|Miscellaneous|2|||
105968611|NCT01962987|365545369|FG000|Overall Study|Restricted medication|5|||
105968612|NCT01962987|365545370|FG001|Overall Study|Restricted medication|1|||
105968613|NCT01962987|365545371|FG002|Overall Study|Restricted medication|1|||
105968614|NCT01962987|365545369|FG000|Overall Study|Serious Adverse Event|1|||
105968615|NCT01962987|365545370|FG001|Overall Study|Serious Adverse Event|0|||
105968616|NCT01962987|365545371|FG002|Overall Study|Serious Adverse Event|0|||
105968617|NCT01962987|365545369|FG000|Overall Study|Withdrawal by Subject|11|||
105968618|NCT01962987|365545370|FG001|Overall Study|Withdrawal by Subject|10|||
105968619|NCT01962987|365545371|FG002|Overall Study|Withdrawal by Subject|6|||
105968620|NCT01962987|365545369|FG000|Overall Study|Randomized in Error|4|||
105968621|NCT01962987|365545370|FG001|Overall Study|Randomized in Error|2|||
105968622|NCT01962987|365545371|FG002|Overall Study|Randomized in Error|2|||
105968623|NCT00420004|365545378|FG000|Overall Study|Adverse Event|4|||
105968624|NCT00420004|365545379|FG001|Overall Study|Adverse Event|1|||
105968625|NCT00420004|365545380|FG002|Overall Study|Adverse Event|1|||
105968626|NCT00420004|365545378|FG000|Overall Study|Lack of Efficacy|5|||
105968627|NCT00420004|365545379|FG001|Overall Study|Lack of Efficacy|4|||
105968628|NCT00420004|365545380|FG002|Overall Study|Lack of Efficacy|1|||
105968629|NCT00420004|365545378|FG000|Overall Study|Lost to Follow-up|31|||
105968630|NCT00420004|365545379|FG001|Overall Study|Lost to Follow-up|12|||
105968631|NCT00420004|365545380|FG002|Overall Study|Lost to Follow-up|10|||
105968632|NCT00420004|365545378|FG000|Overall Study|Entry Criteria Not Met|0|||
105968633|NCT00420004|365545379|FG001|Overall Study|Entry Criteria Not Met|1|||
105968634|NCT00420004|365545380|FG002|Overall Study|Entry Criteria Not Met|0|||
105968635|NCT00420004|365545378|FG000|Overall Study|Physician Decision|14|||
105968636|NCT00420004|365545379|FG001|Overall Study|Physician Decision|4|||
105968637|NCT00420004|365545380|FG002|Overall Study|Physician Decision|2|||
105968638|NCT00420004|365545378|FG000|Overall Study|Protocol Violation|5|||
105968639|NCT00420004|365545379|FG001|Overall Study|Protocol Violation|4|||
105968640|NCT00420004|365545380|FG002|Overall Study|Protocol Violation|3|||
105968641|NCT00420004|365545378|FG000|Overall Study|Withdrawal by Subject|67|||
105968642|NCT00420004|365545379|FG001|Overall Study|Withdrawal by Subject|42|||
105968643|NCT00420004|365545380|FG002|Overall Study|Withdrawal by Subject|14|||
105968644|NCT00420004|365545378|FG000|Overall Study|Sponsor Decision|3|||
105968645|NCT00420004|365545379|FG001|Overall Study|Sponsor Decision|3|||
105968646|NCT00420004|365545380|FG002|Overall Study|Sponsor Decision|1|||
105968647|NCT01468207|365545381|FG000|Treatment Period 1|Adverse Event|1|||
105968648|NCT01468207|365545382|FG001|Treatment Period 1|Adverse Event|0|||
105968649|NCT01468207|365545383|FG002|Treatment Period 1|Adverse Event|0|||
105842032|NCT03891329|365079009|FG000|Overall Study|No study device implanted|3|||
105842033|NCT00941720|365079013|FG000|Overall Study|Withdrawal by Subject|1|||
105842034|NCT00941720|365079013|FG000|Overall Study|Insurance denied participation|11|||
105842035|NCT00941720|365079013|FG000|Overall Study|ineligible|2|||
105968650|NCT01468207|365545384|FG003|Treatment Period 1|Adverse Event|0|||
105968651|NCT01468207|365545385|FG004|Treatment Period 1|Adverse Event|0|||
105968652|NCT01468207|365545386|FG005|Treatment Period 1|Adverse Event|0|||
105968653|NCT01468207|365545381|FG000|Treatment Period 1|Protocol Violation|1|||
105968654|NCT01468207|365545382|FG001|Treatment Period 1|Protocol Violation|1|||
105968655|NCT01468207|365545383|FG002|Treatment Period 1|Protocol Violation|0|||
105968656|NCT01468207|365545384|FG003|Treatment Period 1|Protocol Violation|0|||
105968657|NCT01468207|365545385|FG004|Treatment Period 1|Protocol Violation|0|||
105968658|NCT01468207|365545386|FG005|Treatment Period 1|Protocol Violation|0|||
105968659|NCT01468207|365545381|FG000|Treatment Period 1|Withdrawal by Subject|5|||
105968660|NCT01468207|365545382|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105968661|NCT01468207|365545383|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105968662|NCT01468207|365545384|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105968663|NCT01468207|365545385|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105968664|NCT01468207|365545386|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105968665|NCT01468207|365545381|FG000|Treatment Period 1|Lost to Follow-up|2|||
105968666|NCT01468207|365545382|FG001|Treatment Period 1|Lost to Follow-up|1|||
105968667|NCT01468207|365545383|FG002|Treatment Period 1|Lost to Follow-up|0|||
105968668|NCT01468207|365545384|FG003|Treatment Period 1|Lost to Follow-up|0|||
105968669|NCT01468207|365545385|FG004|Treatment Period 1|Lost to Follow-up|0|||
105968670|NCT01468207|365545386|FG005|Treatment Period 1|Lost to Follow-up|0|||
105968671|NCT01468207|365545381|FG000|Treatment Period 1|Other|0|||
105968672|NCT01468207|365545382|FG001|Treatment Period 1|Other|2|||
105968673|NCT01468207|365545383|FG002|Treatment Period 1|Other|0|||
105968674|NCT01468207|365545384|FG003|Treatment Period 1|Other|0|||
105968675|NCT01468207|365545385|FG004|Treatment Period 1|Other|0|||
105968676|NCT01468207|365545386|FG005|Treatment Period 1|Other|0|||
105968677|NCT01468207|365545381|FG000|Treatment Period 2|Adverse Event|0|||
105968678|NCT01468207|365545382|FG001|Treatment Period 2|Adverse Event|0|||
105968679|NCT01468207|365545383|FG002|Treatment Period 2|Adverse Event|6|||
105968680|NCT01468207|365545384|FG003|Treatment Period 2|Adverse Event|1|||
105968681|NCT01468207|365545385|FG004|Treatment Period 2|Adverse Event|2|||
105968682|NCT01468207|365545386|FG005|Treatment Period 2|Adverse Event|1|||
105968683|NCT01468207|365545381|FG000|Treatment Period 2|Lack of Efficacy|0|||
105968684|NCT01468207|365545382|FG001|Treatment Period 2|Lack of Efficacy|0|||
105968685|NCT01468207|365545383|FG002|Treatment Period 2|Lack of Efficacy|1|||
105968686|NCT01468207|365545384|FG003|Treatment Period 2|Lack of Efficacy|1|||
105968687|NCT01468207|365545385|FG004|Treatment Period 2|Lack of Efficacy|0|||
105968688|NCT01468207|365545386|FG005|Treatment Period 2|Lack of Efficacy|2|||
105968689|NCT01468207|365545381|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105968690|NCT01468207|365545382|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105968691|NCT01468207|365545383|FG002|Treatment Period 2|Withdrawal by Subject|5|||
105968692|NCT01468207|365545384|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105968693|NCT01468207|365545385|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105968694|NCT01468207|365545386|FG005|Treatment Period 2|Withdrawal by Subject|2|||
105968695|NCT01468207|365545381|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
105968696|NCT01468207|365545382|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
105968697|NCT01468207|365545383|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
105968698|NCT01468207|365545384|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
105968699|NCT01468207|365545385|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
105968700|NCT01468207|365545386|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
105968701|NCT01468207|365545381|FG000|Treatment Period 2|Lost to Follow-up|0|||
105968702|NCT01468207|365545382|FG001|Treatment Period 2|Lost to Follow-up|0|||
105968703|NCT01468207|365545383|FG002|Treatment Period 2|Lost to Follow-up|5|||
105968704|NCT01468207|365545384|FG003|Treatment Period 2|Lost to Follow-up|1|||
105968705|NCT01468207|365545385|FG004|Treatment Period 2|Lost to Follow-up|0|||
105968706|NCT01468207|365545386|FG005|Treatment Period 2|Lost to Follow-up|0|||
105968707|NCT01468207|365545381|FG000|Treatment Period 2|Other|0|||
105968708|NCT01468207|365545382|FG001|Treatment Period 2|Other|0|||
105968709|NCT01468207|365545383|FG002|Treatment Period 2|Other|5|||
105968710|NCT01468207|365545384|FG003|Treatment Period 2|Other|1|||
105968711|NCT01468207|365545385|FG004|Treatment Period 2|Other|1|||
105968712|NCT01468207|365545386|FG005|Treatment Period 2|Other|2|||
105968713|NCT00591149|365545387|FG000|Overall Study|Adverse Event|4|||
105968714|NCT00591149|365545387|FG000|Overall Study|Withdrawal by Subject|1|||
105968715|NCT00470093|365545388|FG000|Overall Study|Adverse Event|2|||
105968716|NCT04569136|365545398|FG000|Overall Study|Lost to Follow-up|2|||
105968717|NCT04569136|365545399|FG001|Overall Study|Lost to Follow-up|0|||
105968718|NCT04569136|365545400|FG002|Overall Study|Lost to Follow-up|1|||
105968719|NCT01466660|365545401|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
105968720|NCT01466660|365545402|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
105968721|NCT01466660|365545401|FG000|Overall Study|Worsening of underlying cancer disease|5|||
105968722|NCT01466660|365545402|FG001|Overall Study|Worsening of underlying cancer disease|2|||
105968723|NCT01466660|365545401|FG000|Overall Study|Other adverse event|19|||
105968724|NCT01466660|365545402|FG001|Overall Study|Other adverse event|18|||
105968725|NCT01466660|365545401|FG000|Overall Study|Protocol Violation|2|||
105968726|NCT01466660|365545402|FG001|Overall Study|Protocol Violation|1|||
105968727|NCT01466660|365545401|FG000|Overall Study|Refused continuation of trial medication|4|||
105968728|NCT01466660|365545402|FG001|Overall Study|Refused continuation of trial medication|3|||
105968729|NCT01466660|365545401|FG000|Overall Study|Other reason not defined above|10|||
105968730|NCT01466660|365545402|FG001|Overall Study|Other reason not defined above|8|||
105968731|NCT00730041|365545404|FG000|Overall Study|Lost to Follow-up|0|||
105968732|NCT00730041|365545405|FG001|Overall Study|Lost to Follow-up|2|||
105968733|NCT02301546|365545408|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
105968734|NCT02301546|365545409|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
105968735|NCT02301546|365545408|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
105968736|NCT02301546|365545409|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
105968737|NCT02301546|365545408|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
105968738|NCT02301546|365545409|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
105968739|NCT02301546|365545408|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
105968740|NCT02301546|365545409|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
105968741|NCT02301546|365545408|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
105968742|NCT02301546|365545409|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
105968743|NCT02301546|365545408|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
105987450|NCT02814175|365614465|FG005|Part 1|Adverse Event|0|||
105842036|NCT00904748|365079014|FG000|Overall Study|Withdrawal by Subject|1|||
105842037|NCT00904748|365079015|FG001|Overall Study|Withdrawal by Subject|1|||
105842038|NCT00904748|365079016|FG002|Overall Study|Withdrawal by Subject|1|||
105842039|NCT00904748|365079017|FG003|Overall Study|Withdrawal by Subject|2|||
105842040|NCT00904748|365079018|FG004|Overall Study|Withdrawal by Subject|0|||
105842041|NCT00904748|365079019|FG005|Overall Study|Withdrawal by Subject|0|||
105842042|NCT00904748|365079014|FG000|Overall Study|Adverse Event|0|||
105842043|NCT00904748|365079015|FG001|Overall Study|Adverse Event|0|||
105842044|NCT00904748|365079016|FG002|Overall Study|Adverse Event|0|||
105842045|NCT00904748|365079017|FG003|Overall Study|Adverse Event|0|||
105842046|NCT00904748|365079018|FG004|Overall Study|Adverse Event|1|||
105842047|NCT00904748|365079019|FG005|Overall Study|Adverse Event|0|||
105842048|NCT00350402|365079020|FG000|Overall Study|Lost to Follow-up|1|||
105842049|NCT00350402|365079021|FG001|Overall Study|Lost to Follow-up|1|||
105842050|NCT00690482|365079024|FG000|Overall Study|Adverse Event|2|||
105842051|NCT00690482|365079025|FG001|Overall Study|Adverse Event|1|||
105842052|NCT00690482|365079024|FG000|Overall Study|Incorrect enrolment|0|||
105842053|NCT00690482|365079025|FG001|Overall Study|Incorrect enrolment|1|||
105842054|NCT00690482|365079024|FG000|Overall Study|Study-specific discontinuation criteria|1|||
105842055|NCT00690482|365079025|FG001|Overall Study|Study-specific discontinuation criteria|0|||
105842056|NCT00690482|365079024|FG000|Overall Study|Intake of prohibited medicine|1|||
105842057|NCT00690482|365079025|FG001|Overall Study|Intake of prohibited medicine|0|||
105842058|NCT00690482|365079024|FG000|Overall Study|withdrew consent at rand.day|0|||
105842059|NCT00690482|365079025|FG001|Overall Study|withdrew consent at rand.day|1|||
105842060|NCT01020799|365079029|FG000|Overall Study|Adverse Event|4|||
105842061|NCT01020799|365079030|FG001|Overall Study|Adverse Event|3|||
105842062|NCT01020799|365079031|FG002|Overall Study|Adverse Event|2|||
105842063|NCT01020799|365079029|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
105842064|NCT01020799|365079030|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
105842065|NCT01020799|365079031|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
105842066|NCT01020799|365079029|FG000|Overall Study|Protocol Violation|3|||
105842067|NCT01020799|365079030|FG001|Overall Study|Protocol Violation|2|||
105842068|NCT01020799|365079031|FG002|Overall Study|Protocol Violation|0|||
105842069|NCT01020799|365079029|FG000|Overall Study|Withdrawal by Subject|2|||
105842070|NCT01020799|365079030|FG001|Overall Study|Withdrawal by Subject|2|||
105842071|NCT01020799|365079031|FG002|Overall Study|Withdrawal by Subject|3|||
105842072|NCT01020799|365079029|FG000|Overall Study|Lost to Follow-up|6|||
105842073|NCT01020799|365079030|FG001|Overall Study|Lost to Follow-up|4|||
105842074|NCT01020799|365079031|FG002|Overall Study|Lost to Follow-up|2|||
105842075|NCT02697773|365079032|FG000|Overall Study|Adverse Event|2|||
105842076|NCT02697773|365079033|FG001|Overall Study|Adverse Event|1|||
105842077|NCT02697773|365079034|FG002|Overall Study|Adverse Event|2|||
105842078|NCT02697773|365079032|FG000|Overall Study|Death|0|||
105842079|NCT02697773|365079033|FG001|Overall Study|Death|0|||
105842080|NCT02697773|365079034|FG002|Overall Study|Death|2|||
105842081|NCT02697773|365079032|FG000|Overall Study|Lack of Efficacy|4|||
105842082|NCT02697773|365079033|FG001|Overall Study|Lack of Efficacy|6|||
105842083|NCT02697773|365079034|FG002|Overall Study|Lack of Efficacy|6|||
105842084|NCT02697773|365079032|FG000|Overall Study|Lost to Follow-up|5|||
105842085|NCT02697773|365079033|FG001|Overall Study|Lost to Follow-up|5|||
105842086|NCT02697773|365079034|FG002|Overall Study|Lost to Follow-up|7|||
105842087|NCT02697773|365079032|FG000|Overall Study|Other|15|||
105842088|NCT02697773|365079033|FG001|Overall Study|Other|11|||
105842089|NCT02697773|365079034|FG002|Overall Study|Other|10|||
105842090|NCT02697773|365079032|FG000|Overall Study|Protocol Violation|1|||
105842091|NCT02697773|365079033|FG001|Overall Study|Protocol Violation|1|||
105842092|NCT02697773|365079034|FG002|Overall Study|Protocol Violation|0|||
105842093|NCT02697773|365079032|FG000|Overall Study|Withdrawal by Subject|10|||
105842094|NCT02697773|365079033|FG001|Overall Study|Withdrawal by Subject|13|||
105842095|NCT02697773|365079034|FG002|Overall Study|Withdrawal by Subject|13|||
105842096|NCT02697773|365079032|FG000|Overall Study|Randomized but not treated|1|||
105842097|NCT02697773|365079033|FG001|Overall Study|Randomized but not treated|1|||
105842098|NCT02697773|365079034|FG002|Overall Study|Randomized but not treated|0|||
105842099|NCT02939950|365079035|FG000|Overall Study|Lost to Follow-up|13|||
105842100|NCT02939950|365079036|FG001|Overall Study|Lost to Follow-up|16|||
105842101|NCT02939950|365079035|FG000|Overall Study|Positive slit lamp findings|0|||
105842102|NCT02939950|365079036|FG001|Overall Study|Positive slit lamp findings|1|||
105842103|NCT02939950|365079035|FG000|Overall Study|Chalazion upper lid|0|||
105842104|NCT02939950|365079036|FG001|Overall Study|Chalazion upper lid|1|||
105842105|NCT02939950|365079035|FG000|Overall Study|Lack of motivation|0|||
105842106|NCT02939950|365079036|FG001|Overall Study|Lack of motivation|2|||
105842107|NCT02939950|365079035|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
105842108|NCT02939950|365079036|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
105842109|NCT02939950|365079035|FG000|Overall Study|Military orders|1|||
105842110|NCT02939950|365079036|FG001|Overall Study|Military orders|0|||
105842111|NCT02939950|365079035|FG000|Overall Study|Participant Relocated|5|||
105842112|NCT02939950|365079036|FG001|Overall Study|Participant Relocated|3|||
106024158|NCT01368562|365754493|FG000|Overall Study|Other|3|||
106024159|NCT01368562|365754493|FG000|Overall Study|Other than specified|2|||
106024160|NCT03860818|365754494|FG000|Overall Study|Death|144|||
106024161|NCT03860818|365754495|FG001|Overall Study|Death|195|||
106024162|NCT03860818|365754494|FG000|Overall Study|Graft Loss|32|||
106024163|NCT03860818|365754495|FG001|Overall Study|Graft Loss|45|||
106024164|NCT03126344|365754496|FG000|Overall Study|Lost to Follow-up|0|||
106024165|NCT03126344|365754497|FG001|Overall Study|Lost to Follow-up|0|||
106024166|NCT03126344|365754498|FG002|Overall Study|Lost to Follow-up|5|||
106024167|NCT02810444|365754499|FG000|Overall Study|Screen Failures|14|||
106024168|NCT02810444|365754499|FG000|Overall Study|Withdrawal by Subject|4|||
106024169|NCT02810444|365754499|FG000|Overall Study|Adverse Event|3|||
106024170|NCT01139008|365754500|FG000|Overall Study|Withdrawal by Subject|5|||
106024171|NCT01139008|365754500|FG000|Overall Study|Non-compliant, lost product|1|||
106024172|NCT02785770|365754503|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
106024173|NCT02785770|365754504|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
106024174|NCT02785770|365754505|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
106024175|NCT02785770|365754506|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
106024176|NCT02785770|365754503|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
106024177|NCT02785770|365754504|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
106024178|NCT02785770|365754505|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
106024179|NCT02785770|365754506|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
106024180|NCT02785770|365754503|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
106024181|NCT02785770|365754504|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
106024182|NCT02785770|365754505|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
106024183|NCT02785770|365754506|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
106024184|NCT02338882|365754512|FG000|Overall Study|Death|1|||
106024185|NCT02338882|365754513|FG001|Overall Study|Death|0|||
105842113|NCT02939950|365079035|FG000|Overall Study|Study related symptoms|8|||
106024186|NCT02338882|365754512|FG000|Overall Study|Lost to Follow-up|6|||
106024187|NCT02338882|365754513|FG001|Overall Study|Lost to Follow-up|3|||
106024188|NCT04518995|365754516|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
106024189|NCT04518995|365754517|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
106024190|NCT04518995|365754518|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
106024191|NCT04518995|365754516|FG000|Overall Study|Lack of Efficacy|2|||
106024192|NCT04518995|365754517|FG001|Overall Study|Lack of Efficacy|1|||
106024193|NCT04518995|365754518|FG002|Overall Study|Lack of Efficacy|0|||
106024194|NCT04518995|365754516|FG000|Overall Study|Non-compliance With Study Drug|0|||
106024195|NCT04518995|365754517|FG001|Overall Study|Non-compliance With Study Drug|3|||
106024196|NCT04518995|365754518|FG002|Overall Study|Non-compliance With Study Drug|2|||
106024197|NCT04518995|365754516|FG000|Overall Study|Pregnancy|0|||
106024198|NCT04518995|365754517|FG001|Overall Study|Pregnancy|0|||
106024199|NCT04518995|365754518|FG002|Overall Study|Pregnancy|1|||
106024200|NCT04518995|365754516|FG000|Overall Study|Protocol Violation|2|||
106024201|NCT04518995|365754517|FG001|Overall Study|Protocol Violation|0|||
105842114|NCT02939950|365079036|FG001|Overall Study|Study related symptoms|8|||
105842115|NCT02939950|365079035|FG000|Overall Study|Unacceptable lens movement|2|||
105842116|NCT02939950|365079036|FG001|Overall Study|Unacceptable lens movement|0|||
105842117|NCT02939950|365079035|FG000|Overall Study|Protocol Violation|6|||
105842118|NCT02939950|365079036|FG001|Overall Study|Protocol Violation|3|||
105842119|NCT02939950|365079035|FG000|Overall Study|Physician Decision|2|||
105842120|NCT02939950|365079036|FG001|Overall Study|Physician Decision|0|||
105842121|NCT02939950|365079035|FG000|Overall Study|Pregnancy|6|||
105842122|NCT02939950|365079036|FG001|Overall Study|Pregnancy|7|||
105842123|NCT02939950|365079035|FG000|Overall Study|Withdrawal by Subject|12|||
105842124|NCT02939950|365079036|FG001|Overall Study|Withdrawal by Subject|28|||
105842125|NCT02939950|365079035|FG000|Overall Study|Adverse Event|7|||
105842126|NCT02939950|365079036|FG001|Overall Study|Adverse Event|3|||
105842127|NCT02939950|365079035|FG000|Overall Study|Randomized, not dispensed|1|||
105842128|NCT02939950|365079036|FG001|Overall Study|Randomized, not dispensed|0|||
105842129|NCT02939950|365079035|FG000|Overall Study|Ineligible at Baseline|2|||
105842130|NCT02939950|365079036|FG001|Overall Study|Ineligible at Baseline|8|||
105842131|NCT01382251|365079040|FG000|Overall Study|Surgeries cancelled or delayed|16|||
105842132|NCT01382251|365079041|FG001|Overall Study|Surgeries cancelled or delayed|16|||
106024202|NCT04518995|365754518|FG002|Overall Study|Protocol Violation|1|||
106024203|NCT04518995|365754516|FG000|Overall Study|Reason not Specified|4|||
106024204|NCT04518995|365754517|FG001|Overall Study|Reason not Specified|11|||
106024205|NCT04518995|365754518|FG002|Overall Study|Reason not Specified|2|||
106024206|NCT04518995|365754516|FG000|Overall Study|Lost to Follow-up|1|||
106024207|NCT04518995|365754517|FG001|Overall Study|Lost to Follow-up|10|||
106024208|NCT04518995|365754518|FG002|Overall Study|Lost to Follow-up|6|||
106024209|NCT02248675|365754519|FG000|Overall Study|Lost to Follow-up|3|||
106024210|NCT02248675|365754520|FG001|Overall Study|Lost to Follow-up|1|||
105842133|NCT01382251|365079040|FG000|Overall Study|Lost to Follow-up|4|||
105842134|NCT01382251|365079041|FG001|Overall Study|Lost to Follow-up|4|||
106024211|NCT00669409|365754528|FG000|Part 2|Withdrawal by Subject|0|||
105968744|NCT02301546|365545409|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
105968745|NCT02301546|365545408|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
105968746|NCT02301546|365545409|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
105968747|NCT04085458|365545410|FG000|Overall Study|Other|1|||
105968748|NCT04085458|365545410|FG000|Overall Study|Withdrawal by Subject|2|||
105968749|NCT04085458|365545410|FG000|Overall Study|Adverse Event|2|||
105968750|NCT02447250|365545411|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
105968751|NCT02447250|365545411|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
105968752|NCT02447250|365545411|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
105968753|NCT01973387|365545412|FG000|Overall Study|Adverse Event|14|||
105968754|NCT01973387|365545413|FG001|Overall Study|Adverse Event|4|||
105968755|NCT01973387|365545412|FG000|Overall Study|Withdrawal by Subject|7|||
105968756|NCT01973387|365545413|FG001|Overall Study|Withdrawal by Subject|4|||
105968757|NCT01973387|365545412|FG000|Overall Study|Study terminated by sponsor|63|||
105968758|NCT01973387|365545413|FG001|Overall Study|Study terminated by sponsor|0|||
105968759|NCT01973387|365545412|FG000|Overall Study|Progressive disease or relapse|16|||
105968760|NCT01973387|365545413|FG001|Overall Study|Progressive disease or relapse|5|||
105968761|NCT01973387|365545412|FG000|Overall Study|Death|4|||
105968762|NCT01973387|365545413|FG001|Overall Study|Death|3|||
105968763|NCT01973387|365545412|FG000|Overall Study|Randomized, not treated|2|||
105968764|NCT01973387|365545413|FG001|Overall Study|Randomized, not treated|2|||
105968765|NCT00888329|365545418|FG000|Overall Study|Physician Decision|6|||
105968766|NCT00888329|365545419|FG001|Overall Study|Physician Decision|9|||
105968767|NCT00778375|365545420|FG000|Overall Study|Ineligible|3|||
105968768|NCT01106651|365545421|FG000|Overall Study|Adverse Event|17|||
105968769|NCT01106651|365545422|FG001|Overall Study|Adverse Event|9|||
105968770|NCT01106651|365545423|FG002|Overall Study|Adverse Event|23|||
105968771|NCT01106651|365545421|FG000|Overall Study|Lost to Follow-up|8|||
105968772|NCT01106651|365545422|FG001|Overall Study|Lost to Follow-up|2|||
105968773|NCT01106651|365545423|FG002|Overall Study|Lost to Follow-up|6|||
105968774|NCT01106651|365545421|FG000|Overall Study|Physician Decision|4|||
105968775|NCT01106651|365545422|FG001|Overall Study|Physician Decision|3|||
105968776|NCT01106651|365545423|FG002|Overall Study|Physician Decision|1|||
105968777|NCT01106651|365545421|FG000|Overall Study|Protocol Violation|1|||
105968778|NCT01106651|365545422|FG001|Overall Study|Protocol Violation|2|||
105968779|NCT01106651|365545423|FG002|Overall Study|Protocol Violation|1|||
105968780|NCT01106651|365545421|FG000|Overall Study|Withdrawal by Subject|14|||
105968781|NCT01106651|365545422|FG001|Overall Study|Withdrawal by Subject|7|||
105968782|NCT01106651|365545423|FG002|Overall Study|Withdrawal by Subject|4|||
105968783|NCT01106651|365545421|FG000|Overall Study|Noncompliance with study drug|1|||
105968784|NCT01106651|365545422|FG001|Overall Study|Noncompliance with study drug|0|||
105968785|NCT01106651|365545423|FG002|Overall Study|Noncompliance with study drug|2|||
105968786|NCT01106651|365545421|FG000|Overall Study|Other|34|||
105968787|NCT01106651|365545422|FG001|Overall Study|Other|31|||
105968788|NCT01106651|365545423|FG002|Overall Study|Other|21|||
105968789|NCT01106651|365545421|FG000|Overall Study|Death|0|||
105968790|NCT01106651|365545422|FG001|Overall Study|Death|3|||
105968791|NCT01106651|365545423|FG002|Overall Study|Death|0|||
105968792|NCT01425359|365545424|FG000|Overall Study|Randomized but Not Treated|2|||
105968793|NCT01425359|365545425|FG001|Overall Study|Randomized but Not Treated|3|||
105968794|NCT01425359|365545424|FG000|Overall Study|Adverse Event|9|||
105968795|NCT01425359|365545425|FG001|Overall Study|Adverse Event|8|||
105968796|NCT01425359|365545424|FG000|Overall Study|Revascularization|0|||
105968797|NCT01425359|365545425|FG001|Overall Study|Revascularization|1|||
105968798|NCT01425359|365545424|FG000|Overall Study|Death|0|||
105968799|NCT01425359|365545425|FG001|Overall Study|Death|1|||
105968800|NCT01425359|365545424|FG000|Overall Study|Unsatisfactory Response|1|||
105968801|NCT01425359|365545425|FG001|Overall Study|Unsatisfactory Response|0|||
105968802|NCT01425359|365545424|FG000|Overall Study|Protocol Violation|1|||
105968803|NCT01425359|365545425|FG001|Overall Study|Protocol Violation|2|||
105968804|NCT01425359|365545424|FG000|Overall Study|Subject Withdrew Consent|1|||
105968805|NCT01425359|365545425|FG001|Overall Study|Subject Withdrew Consent|2|||
105968806|NCT01425359|365545424|FG000|Overall Study|Investigator's Discretion|2|||
105968807|NCT01425359|365545425|FG001|Overall Study|Investigator's Discretion|0|||
105968808|NCT01425359|365545424|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
105968809|NCT01425359|365545425|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
105968810|NCT00075946|365545428|FG000|Overall Study|Path ineligible: undetermined histology|0|||
105968811|NCT00075946|365545429|FG001|Overall Study|Path ineligible: undetermined histology|0|||
105968812|NCT00075946|365545430|FG002|Overall Study|Path ineligible: undetermined histology|0|||
105968813|NCT00075946|365545431|FG003|Overall Study|Path ineligible: undetermined histology|0|||
105968814|NCT00075946|365545432|FG004|Overall Study|Path ineligible: undetermined histology|6|||
105968815|NCT00075946|365545428|FG000|Overall Study|Did not achieve response after induction|0|||
105968816|NCT00075946|365545429|FG001|Overall Study|Did not achieve response after induction|0|||
105968817|NCT00075946|365545430|FG002|Overall Study|Did not achieve response after induction|0|||
105968818|NCT00075946|365545431|FG003|Overall Study|Did not achieve response after induction|0|||
105968819|NCT00075946|365545432|FG004|Overall Study|Did not achieve response after induction|182|||
105842135|NCT01382251|365079040|FG000|Overall Study|Contacted after study closed|1|||
105842136|NCT01382251|365079041|FG001|Overall Study|Contacted after study closed|1|||
105842137|NCT02746627|365079043|FG000|Overall Study|Withdrawal by Subject|1|||
105842138|NCT02746627|365079044|FG001|Overall Study|Withdrawal by Subject|1|||
105842139|NCT02746627|365079045|FG002|Overall Study|Withdrawal by Subject|1|||
105842140|NCT02181296|365079046|FG000|Overall Study|Lost to Follow-up|7|||
105842141|NCT02181296|365079047|FG001|Overall Study|Lost to Follow-up|6|||
105842142|NCT03166124|365079048|FG000|Treatment Period 1|Adverse Event|0|||
105842143|NCT03166124|365079049|FG001|Treatment Period 1|Adverse Event|0|||
105842144|NCT03166124|365079050|FG002|Treatment Period 1|Adverse Event|1|||
105842145|NCT03166124|365079051|FG003|Treatment Period 1|Adverse Event|0|||
105842146|NCT03166124|365079048|FG000|Wash-out Period|Withdrawal by Subject|0|||
105842147|NCT03166124|365079049|FG001|Wash-out Period|Withdrawal by Subject|1|||
105842148|NCT03166124|365079050|FG002|Wash-out Period|Withdrawal by Subject|0|||
105842149|NCT03166124|365079051|FG003|Wash-out Period|Withdrawal by Subject|1|||
105842150|NCT03166124|365079048|FG000|Wash-out Period|Adverse Event|0|||
105842151|NCT03166124|365079049|FG001|Wash-out Period|Adverse Event|1|||
105842152|NCT03166124|365079050|FG002|Wash-out Period|Adverse Event|1|||
105842153|NCT03166124|365079051|FG003|Wash-out Period|Adverse Event|0|||
105842154|NCT03351231|365079054|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
105842155|NCT03351231|365079054|FG000|Combination Therapy Period|Disease progression|2|||
105842156|NCT03351231|365079054|FG000|Combination Therapy Period|Study drug toxicity|1|||
105842157|NCT03351231|365079054|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
105842158|NCT03351231|365079054|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
105842159|NCT03351231|365079054|FG000|Safety Follow-Up Period|Other reason|2|||
105842160|NCT02148913|365080660|FG000|Overall Study|Death|0|||
105842161|NCT02148913|365080661|FG001|Overall Study|Death|1|||
105842162|NCT02148913|365080662|FG002|Overall Study|Death|0|||
105842163|NCT02148913|365080663|FG003|Overall Study|Death|0|||
105842164|NCT01272921|365080666|FG000|Overall Study|Protocol Violation|2|||
105842165|NCT01272921|365080667|FG001|Overall Study|Protocol Violation|1|||
105842166|NCT01132664|365080668|FG000|Phase lb|Adverse Event|0|||
105842167|NCT01132664|365080669|FG001|Phase lb|Adverse Event|1|||
106149431|NCT03598790|366209109|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106149432|NCT03598790|366209110|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106149433|NCT03598790|366209111|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106149434|NCT03598790|366209112|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105842168|NCT01132664|365080670|FG002|Phase lb|Adverse Event|0|||
105842169|NCT01132664|365080671|FG003|Phase lb|Adverse Event|0|||
105842170|NCT01132664|365080672|FG004|Phase lb|Adverse Event|0|||
105842171|NCT01132664|365080668|FG000|Phase lb|Withdrawal by Subject|1|||
105842172|NCT01132664|365080669|FG001|Phase lb|Withdrawal by Subject|2|||
105842173|NCT01132664|365080670|FG002|Phase lb|Withdrawal by Subject|0|||
105842174|NCT01132664|365080671|FG003|Phase lb|Withdrawal by Subject|0|||
105842175|NCT01132664|365080672|FG004|Phase lb|Withdrawal by Subject|0|||
105842176|NCT01132664|365080668|FG000|Phase lb|Disease Progression|4|||
105842177|NCT01132664|365080669|FG001|Phase lb|Disease Progression|9|||
105842178|NCT01132664|365080670|FG002|Phase lb|Disease Progression|0|||
105968820|NCT00075946|365545428|FG000|Overall Study|Incorrectly randomized (no response)|5|||
105968821|NCT00075946|365545429|FG001|Overall Study|Incorrectly randomized (no response)|5|||
105968822|NCT00075946|365545430|FG002|Overall Study|Incorrectly randomized (no response)|5|||
105968823|NCT00075946|365545431|FG003|Overall Study|Incorrectly randomized (no response)|1|||
105968824|NCT00075946|365545432|FG004|Overall Study|Incorrectly randomized (no response)|0|||
105968825|NCT00075946|365545428|FG000|Overall Study|Adverse Event|2|||
105968826|NCT00075946|365545429|FG001|Overall Study|Adverse Event|10|||
105968827|NCT00075946|365545430|FG002|Overall Study|Adverse Event|0|||
105968828|NCT00075946|365545431|FG003|Overall Study|Adverse Event|2|||
105968829|NCT00075946|365545432|FG004|Overall Study|Adverse Event|0|||
105968830|NCT00075946|365545428|FG000|Overall Study|Death|0|||
105968831|NCT00075946|365545429|FG001|Overall Study|Death|1|||
105968832|NCT00075946|365545430|FG002|Overall Study|Death|0|||
105968833|NCT00075946|365545431|FG003|Overall Study|Death|0|||
105968834|NCT00075946|365545432|FG004|Overall Study|Death|0|||
105968835|NCT00075946|365545428|FG000|Overall Study|Withdrawal by Subject|23|||
105968836|NCT00075946|365545429|FG001|Overall Study|Withdrawal by Subject|58|||
105842179|NCT01132664|365080671|FG003|Phase lb|Disease Progression|0|||
105842180|NCT01132664|365080672|FG004|Phase lb|Disease Progression|0|||
105842181|NCT01132664|365080668|FG000|Phase ll|Death|0|||
105842182|NCT01132664|365080669|FG001|Phase ll|Death|0|||
105842183|NCT01132664|365080670|FG002|Phase ll|Death|2|||
105842184|NCT01132664|365080671|FG003|Phase ll|Death|0|||
105842185|NCT01132664|365080672|FG004|Phase ll|Death|0|||
105842186|NCT01132664|365080668|FG000|Phase ll|Adverse Event|0|||
105842187|NCT01132664|365080669|FG001|Phase ll|Adverse Event|0|||
105842188|NCT01132664|365080670|FG002|Phase ll|Adverse Event|10|||
105842189|NCT01132664|365080671|FG003|Phase ll|Adverse Event|0|||
105842190|NCT01132664|365080672|FG004|Phase ll|Adverse Event|0|||
105842191|NCT01132664|365080668|FG000|Phase ll|Withdrawal by Subject|0|||
105842192|NCT01132664|365080669|FG001|Phase ll|Withdrawal by Subject|0|||
105842193|NCT01132664|365080670|FG002|Phase ll|Withdrawal by Subject|3|||
105842194|NCT01132664|365080671|FG003|Phase ll|Withdrawal by Subject|0|||
105842195|NCT01132664|365080672|FG004|Phase ll|Withdrawal by Subject|0|||
105842196|NCT01132664|365080668|FG000|Phase ll|Disease progression|0|||
105842197|NCT01132664|365080669|FG001|Phase ll|Disease progression|0|||
105842198|NCT01132664|365080670|FG002|Phase ll|Disease progression|35|||
105842199|NCT01132664|365080671|FG003|Phase ll|Disease progression|0|||
105842200|NCT01132664|365080672|FG004|Phase ll|Disease progression|0|||
105842201|NCT01132664|365080668|FG000|BM Cohort|Disease progression|0|||
105842202|NCT01132664|365080669|FG001|BM Cohort|Disease progression|0|||
105842203|NCT01132664|365080670|FG002|BM Cohort|Disease progression|0|||
105842204|NCT01132664|365080671|FG003|BM Cohort|Disease progression|3|||
105842205|NCT01132664|365080672|FG004|BM Cohort|Disease progression|4|||
105842206|NCT01132664|365080668|FG000|BM Cohort|Adverse Event|0|||
105842207|NCT01132664|365080669|FG001|BM Cohort|Adverse Event|0|||
105842208|NCT01132664|365080670|FG002|BM Cohort|Adverse Event|0|||
105842209|NCT01132664|365080671|FG003|BM Cohort|Adverse Event|0|||
105842210|NCT01132664|365080672|FG004|BM Cohort|Adverse Event|1|||
105842211|NCT01132664|365080668|FG000|BM Cohort|Withdrawal by Subject|0|||
105842212|NCT01132664|365080669|FG001|BM Cohort|Withdrawal by Subject|0|||
105842213|NCT01132664|365080670|FG002|BM Cohort|Withdrawal by Subject|0|||
105842214|NCT01132664|365080671|FG003|BM Cohort|Withdrawal by Subject|0|||
105842215|NCT01132664|365080672|FG004|BM Cohort|Withdrawal by Subject|1|||
105842216|NCT00865098|365080674|FG000|Overall Study|Progressive disease|1|||
105842217|NCT00573170|365080683|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
105842218|NCT00573170|365080684|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
105842219|NCT00573170|365080685|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
105842220|NCT00573170|365080686|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
105842221|NCT00573170|365080687|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
105842222|NCT00573170|365080688|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
105842223|NCT00573170|365080683|FG000|First Washout Period|Adverse Event|1|||
105842224|NCT00573170|365080684|FG001|First Washout Period|Adverse Event|1|||
105842225|NCT00573170|365080685|FG002|First Washout Period|Adverse Event|0|||
105842226|NCT00573170|365080686|FG003|First Washout Period|Adverse Event|0|||
105842227|NCT00573170|365080687|FG004|First Washout Period|Adverse Event|0|||
105842228|NCT00573170|365080688|FG005|First Washout Period|Adverse Event|1|||
105842229|NCT00573170|365080683|FG000|First Washout Period|Lack of Efficacy|0|||
105842230|NCT00573170|365080684|FG001|First Washout Period|Lack of Efficacy|0|||
105842231|NCT00573170|365080685|FG002|First Washout Period|Lack of Efficacy|0|||
105842232|NCT00573170|365080686|FG003|First Washout Period|Lack of Efficacy|0|||
105842233|NCT00573170|365080687|FG004|First Washout Period|Lack of Efficacy|0|||
105842234|NCT00573170|365080688|FG005|First Washout Period|Lack of Efficacy|1|||
105842235|NCT00573170|365080683|FG000|First Washout Period|Lost to Follow-up|1|||
105842236|NCT00573170|365080684|FG001|First Washout Period|Lost to Follow-up|1|||
105842237|NCT00573170|365080685|FG002|First Washout Period|Lost to Follow-up|0|||
105842238|NCT00573170|365080686|FG003|First Washout Period|Lost to Follow-up|2|||
105842239|NCT00573170|365080687|FG004|First Washout Period|Lost to Follow-up|0|||
105842240|NCT00573170|365080688|FG005|First Washout Period|Lost to Follow-up|2|||
105842241|NCT00573170|365080683|FG000|First Washout Period|Withdrawal by Subject|2|||
105842242|NCT00573170|365080684|FG001|First Washout Period|Withdrawal by Subject|0|||
105842243|NCT00573170|365080685|FG002|First Washout Period|Withdrawal by Subject|0|||
105842244|NCT00573170|365080686|FG003|First Washout Period|Withdrawal by Subject|2|||
105842245|NCT00573170|365080687|FG004|First Washout Period|Withdrawal by Subject|3|||
105842246|NCT00573170|365080688|FG005|First Washout Period|Withdrawal by Subject|3|||
105842247|NCT00573170|365080683|FG000|First Washout Period|Other|4|||
105842248|NCT00573170|365080684|FG001|First Washout Period|Other|0|||
105842249|NCT00573170|365080685|FG002|First Washout Period|Other|1|||
105842250|NCT00573170|365080686|FG003|First Washout Period|Other|1|||
105842251|NCT00573170|365080687|FG004|First Washout Period|Other|0|||
105842252|NCT00573170|365080688|FG005|First Washout Period|Other|0|||
105842253|NCT00573170|365080683|FG000|Second Washout Period|Adverse Event|1|||
105842254|NCT00573170|365080684|FG001|Second Washout Period|Adverse Event|0|||
105842255|NCT00573170|365080685|FG002|Second Washout Period|Adverse Event|0|||
105842256|NCT00573170|365080686|FG003|Second Washout Period|Adverse Event|0|||
105842257|NCT00573170|365080687|FG004|Second Washout Period|Adverse Event|1|||
105842258|NCT00573170|365080688|FG005|Second Washout Period|Adverse Event|0|||
105842259|NCT00573170|365080683|FG000|Second Washout Period|Protocol Violation|2|||
105842260|NCT00573170|365080684|FG001|Second Washout Period|Protocol Violation|1|||
105842261|NCT00573170|365080685|FG002|Second Washout Period|Protocol Violation|1|||
105842262|NCT00573170|365080686|FG003|Second Washout Period|Protocol Violation|0|||
105842263|NCT00573170|365080687|FG004|Second Washout Period|Protocol Violation|0|||
105842264|NCT00573170|365080688|FG005|Second Washout Period|Protocol Violation|0|||
105842265|NCT00573170|365080683|FG000|Second Washout Period|Withdrawal by Subject|1|||
105842266|NCT00573170|365080684|FG001|Second Washout Period|Withdrawal by Subject|1|||
105842267|NCT00573170|365080685|FG002|Second Washout Period|Withdrawal by Subject|2|||
105842268|NCT00573170|365080686|FG003|Second Washout Period|Withdrawal by Subject|0|||
105987451|NCT02814175|365614460|FG000|Part 1|Withdrawal Consent|8|||
105968837|NCT00075946|365545430|FG002|Overall Study|Withdrawal by Subject|4|||
105968838|NCT00075946|365545431|FG003|Overall Study|Withdrawal by Subject|9|||
105968839|NCT00075946|365545432|FG004|Overall Study|Withdrawal by Subject|0|||
105968840|NCT00075946|365545428|FG000|Overall Study|Alternative therapy|16|||
105968841|NCT00075946|365545429|FG001|Overall Study|Alternative therapy|2|||
105968842|NCT00075946|365545430|FG002|Overall Study|Alternative therapy|5|||
105968843|NCT00075946|365545431|FG003|Overall Study|Alternative therapy|0|||
105968844|NCT00075946|365545432|FG004|Overall Study|Alternative therapy|0|||
105968845|NCT00075946|365545428|FG000|Overall Study|Other complicating disease|7|||
105968846|NCT00075946|365545429|FG001|Overall Study|Other complicating disease|13|||
105968847|NCT00075946|365545430|FG002|Overall Study|Other complicating disease|1|||
105968848|NCT00075946|365545431|FG003|Overall Study|Other complicating disease|4|||
105968849|NCT00075946|365545432|FG004|Overall Study|Other complicating disease|0|||
105968850|NCT00075946|365545428|FG000|Overall Study|No response to retreatment|23|||
105968851|NCT00075946|365545429|FG001|Overall Study|No response to retreatment|0|||
105968852|NCT00075946|365545430|FG002|Overall Study|No response to retreatment|2|||
105968853|NCT00075946|365545431|FG003|Overall Study|No response to retreatment|0|||
105968854|NCT00075946|365545432|FG004|Overall Study|No response to retreatment|0|||
105968855|NCT00075946|365545428|FG000|Overall Study|Time to progression less than 6 months|15|||
105968856|NCT00075946|365545429|FG001|Overall Study|Time to progression less than 6 months|30|||
105968857|NCT00075946|365545430|FG002|Overall Study|Time to progression less than 6 months|8|||
105968858|NCT00075946|365545431|FG003|Overall Study|Time to progression less than 6 months|3|||
105968859|NCT00075946|365545432|FG004|Overall Study|Time to progression less than 6 months|0|||
105968860|NCT00075946|365545428|FG000|Overall Study|Other|57|||
105968861|NCT00075946|365545429|FG001|Overall Study|Other|32|||
105968862|NCT00075946|365545430|FG002|Overall Study|Other|3|||
105968863|NCT00075946|365545431|FG003|Overall Study|Other|11|||
105968864|NCT00075946|365545432|FG004|Overall Study|Other|0|||
105968865|NCT01229254|365545435|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
105968866|NCT01229254|365545436|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
105968867|NCT01229254|365545437|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
105968868|NCT01229254|365545435|FG000|Overall Study|Adverse Event|4|||
105968869|NCT01229254|365545436|FG001|Overall Study|Adverse Event|5|||
105968870|NCT01229254|365545437|FG002|Overall Study|Adverse Event|3|||
105968871|NCT01229254|365545435|FG000|Overall Study|Lost to Follow-up|3|||
105968872|NCT01229254|365545436|FG001|Overall Study|Lost to Follow-up|0|||
105968873|NCT01229254|365545437|FG002|Overall Study|Lost to Follow-up|1|||
105968874|NCT01229254|365545435|FG000|Overall Study|Physician Decision|0|||
105968875|NCT01229254|365545436|FG001|Overall Study|Physician Decision|3|||
105968876|NCT01229254|365545437|FG002|Overall Study|Physician Decision|0|||
105968877|NCT01229254|365545435|FG000|Overall Study|Protocol Violation|4|||
105968878|NCT01229254|365545436|FG001|Overall Study|Protocol Violation|6|||
105968879|NCT01229254|365545437|FG002|Overall Study|Protocol Violation|5|||
105968880|NCT01229254|365545435|FG000|Overall Study|Withdrawal by Subject|1|||
105968881|NCT01229254|365545436|FG001|Overall Study|Withdrawal by Subject|0|||
105968882|NCT01229254|365545437|FG002|Overall Study|Withdrawal by Subject|1|||
105968883|NCT01229254|365545435|FG000|Overall Study|Non-compliance with Study Drug|0|||
105968884|NCT01229254|365545436|FG001|Overall Study|Non-compliance with Study Drug|1|||
105968885|NCT01229254|365545437|FG002|Overall Study|Non-compliance with Study Drug|1|||
105968886|NCT00344318|365545438|FG000|Overall Study|Adverse Event|0|||
105968887|NCT00344318|365545439|FG001|Overall Study|Adverse Event|3|||
105968888|NCT00344318|365545440|FG002|Overall Study|Adverse Event|0|||
105968889|NCT00344318|365545441|FG003|Overall Study|Adverse Event|1|||
105968890|NCT00344318|365545438|FG000|Overall Study|Withdrawal by Subject|2|||
105968891|NCT00344318|365545439|FG001|Overall Study|Withdrawal by Subject|2|||
105968892|NCT00344318|365545440|FG002|Overall Study|Withdrawal by Subject|0|||
105968893|NCT00344318|365545441|FG003|Overall Study|Withdrawal by Subject|2|||
105968894|NCT00344318|365545438|FG000|Overall Study|Lost to Follow-up|2|||
105968895|NCT00344318|365545439|FG001|Overall Study|Lost to Follow-up|0|||
105968896|NCT00344318|365545440|FG002|Overall Study|Lost to Follow-up|1|||
105968897|NCT00344318|365545441|FG003|Overall Study|Lost to Follow-up|0|||
105968898|NCT03832322|365545442|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
105968899|NCT03832322|365545443|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
105968900|NCT00244933|365545447|FG000|Overall Study|Not response evaluable|2|||
105968901|NCT03359785|365545450|FG000|Overall Study|Protocol Violation|0|||
105968902|NCT03359785|365545451|FG001|Overall Study|Protocol Violation|1|||
105968903|NCT03359785|365545452|FG002|Overall Study|Protocol Violation|0|||
105968904|NCT03359785|365545453|FG003|Overall Study|Protocol Violation|0|||
105968905|NCT03359785|365545450|FG000|Overall Study|Early study termination due to study pause|0|||
105968906|NCT03359785|365545451|FG001|Overall Study|Early study termination due to study pause|0|||
105968907|NCT03359785|365545452|FG002|Overall Study|Early study termination due to study pause|2|||
105968908|NCT03359785|365545453|FG003|Overall Study|Early study termination due to study pause|0|||
105968909|NCT03359785|365545450|FG000|Overall Study|Withdrawal by Subject|2|||
105968910|NCT03359785|365545451|FG001|Overall Study|Withdrawal by Subject|2|||
105968911|NCT03359785|365545452|FG002|Overall Study|Withdrawal by Subject|0|||
105968912|NCT03359785|365545453|FG003|Overall Study|Withdrawal by Subject|0|||
105968913|NCT03136497|365545454|FG000|Overall Study|Screen Failure|1|||
105968914|NCT03136497|365545455|FG001|Overall Study|Screen Failure|0|||
105968915|NCT03136497|365545456|FG002|Overall Study|Screen Failure|0|||
105968916|NCT01639339|365545460|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
105968917|NCT01639339|365545461|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
105968918|NCT01639339|365545460|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
105968919|NCT01639339|365545461|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
105968920|NCT01639339|365545460|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
105968921|NCT01639339|365545461|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
105968922|NCT01639339|365545460|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
105968923|NCT01639339|365545461|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
105968924|NCT01639339|365545460|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
105968925|NCT01639339|365545461|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
105968926|NCT01639339|365545460|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
105968927|NCT01639339|365545461|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
105968928|NCT01639339|365545460|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
105968929|NCT01639339|365545461|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
105968930|NCT01639339|365545460|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
105968931|NCT01639339|365545461|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
105968932|NCT01639339|365545460|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
105968933|NCT01639339|365545461|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
105968934|NCT01639339|365545460|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
105968935|NCT01639339|365545461|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
105968936|NCT00349921|365545462|FG000|First Spinal Injection|Physician Decision|1|||
105968937|NCT00349921|365545463|FG001|First Spinal Injection|Physician Decision|0|||
105968938|NCT00349921|365545464|FG002|First Spinal Injection|Physician Decision|0|||
105968939|NCT00349921|365545465|FG003|First Spinal Injection|Physician Decision|0|||
105968940|NCT00349921|365545462|FG000|First Spinal Injection|Adverse Event|0|||
105968941|NCT00349921|365545463|FG001|First Spinal Injection|Adverse Event|0|||
105968942|NCT00349921|365545464|FG002|First Spinal Injection|Adverse Event|1|||
105968943|NCT00349921|365545465|FG003|First Spinal Injection|Adverse Event|0|||
105968944|NCT03022097|365545467|FG000|Overall Study|Adverse Event|3|||
105968945|NCT03022097|365545468|FG001|Overall Study|Adverse Event|4|||
105968946|NCT03022097|365545469|FG002|Overall Study|Adverse Event|1|||
105968947|NCT03022097|365545470|FG003|Overall Study|Adverse Event|3|||
105968948|NCT03022097|365545467|FG000|Overall Study|Progressive Disease|2|||
105968949|NCT03022097|365545468|FG001|Overall Study|Progressive Disease|0|||
106149435|NCT03598790|366209113|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
105968950|NCT03022097|365545469|FG002|Overall Study|Progressive Disease|5|||
105968951|NCT03022097|365545470|FG003|Overall Study|Progressive Disease|2|||
105968952|NCT03022097|365545467|FG000|Overall Study|Lack of Efficacy|0|||
105968953|NCT03022097|365545468|FG001|Overall Study|Lack of Efficacy|0|||
105968954|NCT03022097|365545469|FG002|Overall Study|Lack of Efficacy|3|||
105968955|NCT03022097|365545470|FG003|Overall Study|Lack of Efficacy|3|||
105968956|NCT03022097|365545467|FG000|Overall Study|Protocol Violation|1|||
105968957|NCT03022097|365545468|FG001|Overall Study|Protocol Violation|0|||
105968958|NCT03022097|365545469|FG002|Overall Study|Protocol Violation|1|||
105968959|NCT03022097|365545470|FG003|Overall Study|Protocol Violation|0|||
105968960|NCT03022097|365545467|FG000|Overall Study|Withdrawal by Subject|11|||
105968961|NCT03022097|365545468|FG001|Overall Study|Withdrawal by Subject|13|||
105968962|NCT03022097|365545469|FG002|Overall Study|Withdrawal by Subject|15|||
105968963|NCT03022097|365545470|FG003|Overall Study|Withdrawal by Subject|21|||
105968964|NCT03022097|365545467|FG000|Overall Study|Lost to Follow-up|0|||
105968965|NCT03022097|365545468|FG001|Overall Study|Lost to Follow-up|0|||
105968966|NCT03022097|365545469|FG002|Overall Study|Lost to Follow-up|1|||
105968967|NCT03022097|365545470|FG003|Overall Study|Lost to Follow-up|1|||
105968968|NCT03022097|365545467|FG000|Overall Study|Other|4|||
105968969|NCT03022097|365545468|FG001|Overall Study|Other|1|||
105968970|NCT03022097|365545469|FG002|Overall Study|Other|6|||
105968971|NCT03022097|365545470|FG003|Overall Study|Other|4|||
105968972|NCT03022097|365545467|FG000|Overall Study|Due to COVID-19 pandemic|0|||
105968973|NCT03022097|365545468|FG001|Overall Study|Due to COVID-19 pandemic|1|||
105968974|NCT03022097|365545469|FG002|Overall Study|Due to COVID-19 pandemic|0|||
105968975|NCT03022097|365545470|FG003|Overall Study|Due to COVID-19 pandemic|0|||
105968976|NCT01451931|365545473|FG000|Overall Study|Lost to Follow-up|17|||
105968977|NCT01451931|365545474|FG001|Overall Study|Lost to Follow-up|36|||
105968978|NCT01451931|365545475|FG002|Overall Study|Lost to Follow-up|21|||
105968979|NCT01451931|365545473|FG000|Overall Study|Withdrawal by Subject|16|||
105968980|NCT01451931|365545474|FG001|Overall Study|Withdrawal by Subject|22|||
105968981|NCT01451931|365545475|FG002|Overall Study|Withdrawal by Subject|22|||
105968982|NCT00503581|365545478|FG000|Overall Study|Study closed|3|||
105842269|NCT00573170|365080687|FG004|Second Washout Period|Withdrawal by Subject|1|||
105968983|NCT00503581|365545479|FG001|Overall Study|Study closed|4|||
105968984|NCT00503581|365545480|FG002|Overall Study|Study closed|2|||
105968985|NCT04376684|365545481|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
105968986|NCT04376684|365545482|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
105968987|NCT04376684|365545483|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
105968988|NCT04376684|365545484|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
105968989|NCT04376684|365545481|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
105968990|NCT04376684|365545482|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
105968991|NCT04376684|365545483|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
105968992|NCT04376684|365545484|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
105968993|NCT04376684|365545481|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
105968994|NCT04376684|365545482|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
105968995|NCT04376684|365545483|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
105968996|NCT04376684|365545484|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
105968997|NCT04376684|365545481|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
105968998|NCT04376684|365545482|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
105968999|NCT04376684|365545483|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
105969000|NCT04376684|365545484|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
105969001|NCT04376684|365545481|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
105969002|NCT04376684|365545482|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
105969003|NCT04376684|365545483|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
105969004|NCT04376684|365545484|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
105969005|NCT04376684|365545481|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
105969006|NCT04376684|365545482|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
105969007|NCT04376684|365545483|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
105842270|NCT00573170|365080688|FG005|Second Washout Period|Withdrawal by Subject|0|||
105842271|NCT00573170|365080683|FG000|Second Washout Period|Lost to Follow-up|0|||
105842272|NCT00573170|365080684|FG001|Second Washout Period|Lost to Follow-up|0|||
105842273|NCT00573170|365080685|FG002|Second Washout Period|Lost to Follow-up|0|||
105842274|NCT00573170|365080686|FG003|Second Washout Period|Lost to Follow-up|1|||
105842275|NCT00573170|365080687|FG004|Second Washout Period|Lost to Follow-up|0|||
105842276|NCT00573170|365080688|FG005|Second Washout Period|Lost to Follow-up|0|||
105842277|NCT00573170|365080683|FG000|Second Washout Period|Other|1|||
105842278|NCT00573170|365080684|FG001|Second Washout Period|Other|2|||
105842279|NCT00573170|365080685|FG002|Second Washout Period|Other|1|||
105842280|NCT00573170|365080686|FG003|Second Washout Period|Other|4|||
105842281|NCT00573170|365080687|FG004|Second Washout Period|Other|6|||
105842282|NCT00573170|365080688|FG005|Second Washout Period|Other|2|||
105842283|NCT00573170|365080683|FG000|Third Treatment Period|Withdrawal by Subject|1|||
105842284|NCT00573170|365080684|FG001|Third Treatment Period|Withdrawal by Subject|0|||
105842285|NCT00573170|365080685|FG002|Third Treatment Period|Withdrawal by Subject|0|||
105842286|NCT00573170|365080686|FG003|Third Treatment Period|Withdrawal by Subject|0|||
105842287|NCT00573170|365080687|FG004|Third Treatment Period|Withdrawal by Subject|0|||
105842288|NCT00573170|365080688|FG005|Third Treatment Period|Withdrawal by Subject|0|||
105842289|NCT00573170|365080683|FG000|Third Treatment Period|Lost to Follow-up|0|||
105842290|NCT00573170|365080684|FG001|Third Treatment Period|Lost to Follow-up|0|||
105842291|NCT00573170|365080685|FG002|Third Treatment Period|Lost to Follow-up|0|||
105842292|NCT00573170|365080686|FG003|Third Treatment Period|Lost to Follow-up|0|||
105842293|NCT00573170|365080687|FG004|Third Treatment Period|Lost to Follow-up|0|||
105842294|NCT00573170|365080688|FG005|Third Treatment Period|Lost to Follow-up|2|||
105842295|NCT00918463|365080690|FG000|Overall Study|Death|1|||
105842296|NCT00918463|365080690|FG000|Overall Study|Lack of Efficacy|1|||
105842297|NCT01715896|365080695|FG000|Overall Study|Lost to Follow-up|0|||
105842298|NCT01715896|365080696|FG001|Overall Study|Lost to Follow-up|2|||
105842299|NCT01715896|365080695|FG000|Overall Study|Withdrawal by Subject|1|||
105842300|NCT01715896|365080696|FG001|Overall Study|Withdrawal by Subject|4|||
105842301|NCT01715896|365080695|FG000|Overall Study|Other|2|||
105842302|NCT01715896|365080696|FG001|Overall Study|Other|5|||
105842303|NCT01045993|365080699|FG000|Overall Study|Treated-later found eligibility not met|0|||
105842304|NCT01045993|365080700|FG001|Overall Study|Treated-later found eligibility not met|1|||
105842305|NCT01045993|365080701|FG002|Overall Study|Treated-later found eligibility not met|0|||
105842306|NCT01045993|365080702|FG003|Overall Study|Treated-later found eligibility not met|0|||
105842307|NCT00685802|365080709|FG000|Washout Period of 7 Days|Protocol Violation|2|||
105842308|NCT00685802|365080710|FG001|Washout Period of 7 Days|Protocol Violation|0|||
105969008|NCT04376684|365545484|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
105969009|NCT04376684|365545481|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
105969010|NCT04376684|365545482|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
105969011|NCT04376684|365545483|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
105969012|NCT04376684|365545484|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
105969013|NCT03219034|365545494|FG000|Overall Study|Lost to Follow-up|9|||
105842309|NCT00685802|365080709|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
105842310|NCT00685802|365080710|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
105842311|NCT01048502|365080711|FG000|Overall Study|Lost to Follow-up|2|||
105842312|NCT01048502|365080712|FG001|Overall Study|Lost to Follow-up|0|||
105842313|NCT01048502|365080713|FG002|Overall Study|Lost to Follow-up|0|||
105842314|NCT01048502|365080714|FG003|Overall Study|Lost to Follow-up|0|||
105842315|NCT01048502|365080711|FG000|Overall Study|Adverse Event|1|||
105842316|NCT01048502|365080712|FG001|Overall Study|Adverse Event|0|||
105842317|NCT01048502|365080713|FG002|Overall Study|Adverse Event|0|||
105842318|NCT01048502|365080714|FG003|Overall Study|Adverse Event|0|||
105842319|NCT01048502|365080711|FG000|Overall Study|Withdrawal by Subject|1|||
105842320|NCT01048502|365080712|FG001|Overall Study|Withdrawal by Subject|4|||
105842321|NCT01048502|365080713|FG002|Overall Study|Withdrawal by Subject|5|||
105842322|NCT01048502|365080714|FG003|Overall Study|Withdrawal by Subject|3|||
105842323|NCT01048502|365080711|FG000|Overall Study|Physician Decision|0|||
105842324|NCT01048502|365080712|FG001|Overall Study|Physician Decision|3|||
105842325|NCT01048502|365080713|FG002|Overall Study|Physician Decision|0|||
105842326|NCT01048502|365080714|FG003|Overall Study|Physician Decision|1|||
105842327|NCT03336242|365080718|FG000|Overall Study|Adverse Event|0|||
105969014|NCT03219034|365545495|FG001|Overall Study|Lost to Follow-up|13|||
105842328|NCT03336242|365080719|FG001|Overall Study|Adverse Event|1|||
105842329|NCT02100319|365080720|FG000|Overall Study|Case Report Forms Uncollected|11|||
105842330|NCT02100319|365080720|FG000|Overall Study|Protocol Deviation|5|||
105842331|NCT02224573|365080722|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
105969015|NCT03219034|365545494|FG000|Overall Study|Additional dental work needed|1|||
105969016|NCT03219034|365545495|FG001|Overall Study|Additional dental work needed|0|||
105969017|NCT03219034|365545494|FG000|Overall Study|UPPP Surgery|1|||
105969018|NCT03219034|365545495|FG001|Overall Study|UPPP Surgery|0|||
105969019|NCT03219034|365545494|FG000|Overall Study|Dental sensitivity|0|||
105969020|NCT03219034|365545495|FG001|Overall Study|Dental sensitivity|1|||
105969021|NCT03219034|365545494|FG000|Overall Study|Death in family|0|||
105969022|NCT03219034|365545495|FG001|Overall Study|Death in family|1|||
105969023|NCT00118846|365545496|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
105969024|NCT00118846|365545497|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
105969025|NCT00118846|365545496|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
105969026|NCT00118846|365545497|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
105969027|NCT00118846|365545496|FG000|Overall Study|Physician Decision|1|||
105969028|NCT00118846|365545497|FG001|Overall Study|Physician Decision|0|||
105969029|NCT00118846|365545496|FG000|Overall Study|Medical condition|2|||
105969030|NCT00118846|365545497|FG001|Overall Study|Medical condition|2|||
105969031|NCT00118846|365545496|FG000|Overall Study|Lost to Follow-up|0|||
105969032|NCT00118846|365545497|FG001|Overall Study|Lost to Follow-up|2|||
105969033|NCT00118846|365545496|FG000|Overall Study|Personal reason|4|||
105969034|NCT00118846|365545497|FG001|Overall Study|Personal reason|5|||
105969035|NCT00457821|365545501|FG000|Part 2|Withdrawal by Subject|0|||
105969036|NCT00457821|365545502|FG001|Part 2|Withdrawal by Subject|0|||
105969037|NCT00457821|365545503|FG002|Part 2|Withdrawal by Subject|0|||
105969038|NCT00457821|365545504|FG003|Part 2|Withdrawal by Subject|0|||
105969039|NCT00457821|365545505|FG004|Part 2|Withdrawal by Subject|0|||
105969040|NCT00457821|365545506|FG005|Part 2|Withdrawal by Subject|0|||
105969041|NCT00457821|365545507|FG006|Part 2|Withdrawal by Subject|0|||
105969042|NCT00457821|365545508|FG007|Part 2|Withdrawal by Subject|1|||
105969043|NCT00578877|365545509|FG000|Overall Study|Lost to Follow-up|8|||
105969044|NCT00578877|365545510|FG001|Overall Study|Lost to Follow-up|10|||
105969045|NCT00578877|365545509|FG000|Overall Study|early discontinue|61|||
105969046|NCT00578877|365545510|FG001|Overall Study|early discontinue|101|||
105969047|NCT00578877|365545509|FG000|Overall Study|did not provide follow-up data|12|||
105969048|NCT00578877|365545510|FG001|Overall Study|did not provide follow-up data|17|||
105969049|NCT02438683|365545511|FG000|Overall Study|Adverse Event|1|||
105969050|NCT02438683|365545512|FG001|Overall Study|Adverse Event|0|||
105969051|NCT02438683|365545513|FG002|Overall Study|Adverse Event|0|||
105969052|NCT02438683|365545514|FG003|Overall Study|Adverse Event|0|||
105969053|NCT02438683|365545515|FG004|Overall Study|Adverse Event|0|||
105969054|NCT02438683|365545516|FG005|Overall Study|Adverse Event|0|||
105969055|NCT00721578|365545519|FG000|Overall Study|Death|1|||
105969056|NCT00721578|365545520|FG001|Overall Study|Death|1|||
106024212|NCT00669409|365754529|FG001|Part 2|Withdrawal by Subject|0|||
106024213|NCT00669409|365754530|FG002|Part 2|Withdrawal by Subject|0|||
105842332|NCT02224573|365080723|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
105969057|NCT00721578|365545519|FG000|Overall Study|Withdrawal by Subject|1|||
105969058|NCT00721578|365545520|FG001|Overall Study|Withdrawal by Subject|1|||
105969059|NCT01330628|365545521|FG000|Overall Study|Death|2|||
105969060|NCT01330628|365545522|FG001|Overall Study|Death|3|||
105969061|NCT01330628|365545521|FG000|Overall Study|Lost to Follow-up|5|||
105969062|NCT01330628|365545522|FG001|Overall Study|Lost to Follow-up|6|||
105969063|NCT01330628|365545521|FG000|Overall Study|Adverse Event|44|||
105969064|NCT01330628|365545522|FG001|Overall Study|Adverse Event|25|||
105842333|NCT02224573|365080722|FG000|Treatment Phase|Started on Other IMP|1|||
105842334|NCT02224573|365080723|FG001|Treatment Phase|Started on Other IMP|0|||
105842335|NCT02224573|365080722|FG000|Treatment Phase|Participant Discontinued IMP|0|||
106024214|NCT00669409|365754531|FG003|Part 2|Withdrawal by Subject|0|||
106024215|NCT00669409|365754532|FG004|Part 2|Withdrawal by Subject|0|||
105969065|NCT01330628|365545521|FG000|Overall Study|Withdrawn|18|||
105969066|NCT01330628|365545522|FG001|Overall Study|Withdrawn|6|||
105969067|NCT01330628|365545521|FG000|Overall Study|Didn't receive study treatment|1|||
105969068|NCT01330628|365545522|FG001|Overall Study|Didn't receive study treatment|0|||
105969069|NCT00511433|365547658|FG000|Overall Study|Adverse Event|5|||
105969070|NCT00511433|365547659|FG001|Overall Study|Adverse Event|0|||
105969071|NCT00511433|365547658|FG000|Overall Study|Other Reason|1|||
105969072|NCT00511433|365547659|FG001|Overall Study|Other Reason|1|||
105969073|NCT02908685|365547660|FG000|Part 1 OLE|Withdrawal by Subject|0|||
105969074|NCT02908685|365547661|FG001|Part 1 OLE|Withdrawal by Subject|0|||
105969075|NCT02908685|365547662|FG002|Part 1 OLE|Withdrawal by Subject|0|||
105969076|NCT02908685|365547663|FG003|Part 1 OLE|Withdrawal by Subject|0|||
105969077|NCT02908685|365547664|FG004|Part 1 OLE|Withdrawal by Subject|0|||
105969078|NCT02908685|365547665|FG005|Part 1 OLE|Withdrawal by Subject|0|||
105969079|NCT02908685|365547666|FG006|Part 1 OLE|Withdrawal by Subject|0|||
105969080|NCT02908685|365547667|FG007|Part 1 OLE|Withdrawal by Subject|0|||
105969081|NCT02908685|365547668|FG008|Part 1 OLE|Withdrawal by Subject|0|||
105969082|NCT02908685|365547669|FG009|Part 1 OLE|Withdrawal by Subject|0|||
105969083|NCT02908685|365547670|FG010|Part 1 OLE|Withdrawal by Subject|2|||
105969084|NCT02908685|365547671|FG011|Part 1 OLE|Withdrawal by Subject|1|||
105969085|NCT02908685|365547672|FG012|Part 1 OLE|Withdrawal by Subject|0|||
105969086|NCT02908685|365547673|FG013|Part 1 OLE|Withdrawal by Subject|0|||
105969087|NCT02908685|365547660|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969088|NCT02908685|365547661|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969089|NCT02908685|365547662|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969090|NCT02908685|365547663|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969091|NCT02908685|365547664|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969092|NCT02908685|365547665|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969093|NCT02908685|365547666|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969094|NCT02908685|365547667|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969095|NCT02908685|365547668|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969096|NCT02908685|365547669|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969097|NCT02908685|365547670|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969098|NCT02908685|365547671|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
105969099|NCT02908685|365547672|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
105969100|NCT02908685|365547673|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
105969101|NCT02908685|365547660|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969102|NCT02908685|365547661|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969103|NCT02908685|365547662|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969104|NCT02908685|365547663|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969105|NCT02908685|365547664|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969106|NCT02908685|365547665|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969107|NCT02908685|365547666|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969108|NCT02908685|365547667|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969109|NCT02908685|365547668|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969110|NCT02908685|365547669|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969111|NCT02908685|365547670|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969112|NCT02908685|365547671|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969113|NCT02908685|365547672|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
105969114|NCT02908685|365547673|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
105969115|NCT02908685|365547660|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969116|NCT02908685|365547661|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969117|NCT02908685|365547662|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969118|NCT02908685|365547663|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969119|NCT02908685|365547664|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969120|NCT02908685|365547665|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969121|NCT02908685|365547666|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969122|NCT02908685|365547667|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969123|NCT02908685|365547668|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969124|NCT02908685|365547669|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969125|NCT02908685|365547670|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969126|NCT02908685|365547671|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969127|NCT02908685|365547672|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
105969128|NCT02908685|365547673|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
105969129|NCT02908685|365547660|FG000|Part 2 OLE: > Month 24|Death|0|||
105969130|NCT02908685|365547661|FG001|Part 2 OLE: > Month 24|Death|0|||
105969131|NCT02908685|365547662|FG002|Part 2 OLE: > Month 24|Death|0|||
105969132|NCT02908685|365547663|FG003|Part 2 OLE: > Month 24|Death|0|||
105969133|NCT02908685|365547664|FG004|Part 2 OLE: > Month 24|Death|0|||
105969134|NCT02908685|365547665|FG005|Part 2 OLE: > Month 24|Death|0|||
105969135|NCT02908685|365547666|FG006|Part 2 OLE: > Month 24|Death|0|||
105842336|NCT02224573|365080723|FG001|Treatment Phase|Participant Discontinued IMP|1|||
105842337|NCT02224573|365080722|FG000|Treatment Phase|Lack of Efficacy|15|||
105842338|NCT02224573|365080723|FG001|Treatment Phase|Lack of Efficacy|8|||
105842339|NCT02224573|365080722|FG000|Treatment Phase|Began Commercial Product|1|||
105842340|NCT02224573|365080723|FG001|Treatment Phase|Began Commercial Product|0|||
105842341|NCT02224573|365080722|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
105842342|NCT02224573|365080723|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
105842343|NCT02224573|365080722|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
105842344|NCT02224573|365080723|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
105842345|NCT02224573|365080722|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
105842346|NCT02224573|365080723|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
105842347|NCT02224573|365080722|FG000|Treatment Phase|Continued Compassionate Use|1|||
105842348|NCT02224573|365080723|FG001|Treatment Phase|Continued Compassionate Use|0|||
105842349|NCT02224573|365080722|FG000|Treatment Phase|Lack of Efficiency|2|||
105842350|NCT02224573|365080723|FG001|Treatment Phase|Lack of Efficiency|1|||
105842351|NCT02224573|365080722|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
105842352|NCT02224573|365080723|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
105842353|NCT02224573|365080722|FG000|Treatment Phase|Participant Moved|2|||
105969136|NCT02908685|365547667|FG007|Part 2 OLE: > Month 24|Death|0|||
105969137|NCT02908685|365547668|FG008|Part 2 OLE: > Month 24|Death|0|||
105969138|NCT02908685|365547669|FG009|Part 2 OLE: > Month 24|Death|0|||
105969139|NCT02908685|365547670|FG010|Part 2 OLE: > Month 24|Death|0|||
105969140|NCT02908685|365547671|FG011|Part 2 OLE: > Month 24|Death|0|||
105969141|NCT02908685|365547672|FG012|Part 2 OLE: > Month 24|Death|1|||
105969142|NCT02908685|365547673|FG013|Part 2 OLE: > Month 24|Death|0|||
105969143|NCT02908685|365547660|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
105969144|NCT02908685|365547661|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
105969145|NCT02908685|365547662|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
105969146|NCT02908685|365547663|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
105969147|NCT02908685|365547664|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
105969148|NCT02908685|365547665|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
105969149|NCT02908685|365547666|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
105969150|NCT02908685|365547667|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
105969151|NCT02908685|365547668|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
105969152|NCT02908685|365547669|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
105969153|NCT02908685|365547670|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
105969154|NCT02908685|365547671|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
105969155|NCT02908685|365547672|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
105969156|NCT02908685|365547673|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
105969157|NCT02908685|365547660|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969158|NCT02908685|365547661|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969159|NCT02908685|365547662|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969160|NCT02908685|365547663|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969161|NCT02908685|365547664|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969162|NCT02908685|365547665|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969163|NCT02908685|365547666|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969164|NCT02908685|365547667|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969165|NCT02908685|365547668|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969166|NCT02908685|365547669|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969167|NCT02908685|365547670|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969168|NCT02908685|365547671|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
105969169|NCT02908685|365547672|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
105969170|NCT02908685|365547673|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
105969171|NCT00197145|365547674|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
105969172|NCT00197145|365547675|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
105969173|NCT00197145|365547674|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
105969174|NCT00197145|365547675|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
105969175|NCT00197145|365547674|FG000|Period 1: Randomized Treatment Phase|Other|2|||
105969176|NCT00197145|365547675|FG001|Period 1: Randomized Treatment Phase|Other|2|||
105969177|NCT00197145|365547674|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
105969178|NCT00197145|365547675|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
105969179|NCT00197145|365547674|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
105969180|NCT00197145|365547675|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
105969181|NCT00197145|365547674|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
105969182|NCT00197145|365547675|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
105969183|NCT00197145|365547674|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
105969184|NCT00197145|365547675|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
105969185|NCT00197145|365547674|FG000|Period 2 : Open Label Phase|Other|1|||
105969186|NCT00197145|365547675|FG001|Period 2 : Open Label Phase|Other|0|||
105969187|NCT01740089|365547676|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
106024216|NCT00669409|365754533|FG005|Part 2|Withdrawal by Subject|0|||
106024217|NCT00669409|365754534|FG006|Part 2|Withdrawal by Subject|0|||
106024218|NCT00669409|365754535|FG007|Part 2|Withdrawal by Subject|0|||
106024219|NCT00669409|365754536|FG008|Part 2|Withdrawal by Subject|0|||
106024220|NCT00669409|365754537|FG009|Part 2|Withdrawal by Subject|1|||
106024221|NCT00669409|365754538|FG010|Part 2|Withdrawal by Subject|0|||
106024222|NCT00942994|365754541|FG000|Overall Study|Adverse Event|7|||
106024223|NCT00942994|365754542|FG001|Overall Study|Adverse Event|4|||
106024224|NCT00942994|365754541|FG000|Overall Study|Abnormal laboratory value(s)|1|||
106024225|NCT00942994|365754542|FG001|Overall Study|Abnormal laboratory value(s)|0|||
106024226|NCT00942994|365754541|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
106024227|NCT00942994|365754542|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
106024228|NCT00942994|365754541|FG000|Overall Study|Patient withdrew consent|5|||
106024229|NCT00942994|365754542|FG001|Overall Study|Patient withdrew consent|8|||
106024230|NCT00942994|365754541|FG000|Overall Study|Lost to Follow-up|1|||
106024231|NCT00942994|365754542|FG001|Overall Study|Lost to Follow-up|4|||
106024232|NCT00942994|365754541|FG000|Overall Study|Protocol deviation|1|||
106024233|NCT00942994|365754542|FG001|Overall Study|Protocol deviation|2|||
106024234|NCT03583385|365754543|FG000|Treatment Period 1|Withdrawal by Subject|1|||
106024235|NCT03583385|365754544|FG001|Treatment Period 1|Withdrawal by Subject|1|||
106024236|NCT03583385|365754543|FG000|Treatment Period 2|Adverse Event|1|||
106024237|NCT03583385|365754544|FG001|Treatment Period 2|Adverse Event|0|||
106024238|NCT00387790|365754547|FG000|Overall Study|Adverse Event|5|||
106024239|NCT00387790|365754547|FG000|Overall Study|Lack of Efficacy|2|||
106024240|NCT00387790|365754547|FG000|Overall Study|Physician Decision|2|||
106024241|NCT00387790|365754547|FG000|Overall Study|Withdrawal by Subject|3|||
106024242|NCT00387790|365754547|FG000|Overall Study|Ineligible for study|2|||
106024243|NCT00545272|365754548|FG000|Overall Study|Protocol deviation|0|||
106024244|NCT00545272|365754549|FG001|Overall Study|Protocol deviation|1|||
106024245|NCT00545272|365754550|FG002|Overall Study|Protocol deviation|0|||
106024246|NCT00545272|365754551|FG003|Overall Study|Protocol deviation|1|||
106024247|NCT00545272|365754552|FG004|Overall Study|Protocol deviation|0|||
106024248|NCT00545272|365754553|FG005|Overall Study|Protocol deviation|1|||
106024249|NCT00545272|365754548|FG000|Overall Study|Adverse Event|0|||
106024250|NCT00545272|365754549|FG001|Overall Study|Adverse Event|0|||
106024251|NCT00545272|365754550|FG002|Overall Study|Adverse Event|1|||
106024252|NCT00545272|365754551|FG003|Overall Study|Adverse Event|0|||
106024253|NCT00545272|365754552|FG004|Overall Study|Adverse Event|0|||
106024254|NCT00545272|365754553|FG005|Overall Study|Adverse Event|1|||
106024255|NCT00545272|365754548|FG000|Overall Study|Abnormal laboratory value(s)|0|||
106024256|NCT00545272|365754549|FG001|Overall Study|Abnormal laboratory value(s)|0|||
106024257|NCT00545272|365754550|FG002|Overall Study|Abnormal laboratory value(s)|0|||
106024258|NCT00545272|365754551|FG003|Overall Study|Abnormal laboratory value(s)|0|||
106024259|NCT00545272|365754552|FG004|Overall Study|Abnormal laboratory value(s)|0|||
106024260|NCT00545272|365754553|FG005|Overall Study|Abnormal laboratory value(s)|1|||
106024261|NCT00545272|365754548|FG000|Overall Study|Abnormal test procedure result(s)|0|||
106024262|NCT00545272|365754549|FG001|Overall Study|Abnormal test procedure result(s)|0|||
106024263|NCT00545272|365754550|FG002|Overall Study|Abnormal test procedure result(s)|0|||
106024264|NCT00545272|365754551|FG003|Overall Study|Abnormal test procedure result(s)|0|||
106024265|NCT00545272|365754552|FG004|Overall Study|Abnormal test procedure result(s)|1|||
106024266|NCT00545272|365754553|FG005|Overall Study|Abnormal test procedure result(s)|0|||
106024267|NCT00545272|365754548|FG000|Overall Study|Lost to Follow-up|0|||
106024268|NCT00545272|365754549|FG001|Overall Study|Lost to Follow-up|0|||
106024269|NCT00545272|365754550|FG002|Overall Study|Lost to Follow-up|0|||
106149436|NCT03598790|366209105|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
106024270|NCT00545272|365754551|FG003|Overall Study|Lost to Follow-up|0|||
106024271|NCT00545272|365754552|FG004|Overall Study|Lost to Follow-up|1|||
106024272|NCT00545272|365754553|FG005|Overall Study|Lost to Follow-up|0|||
106024273|NCT04491604|365754554|FG000|Overall Study|Withdrawal by Subject|3|||
106024274|NCT02934503|365754555|FG000|Overall Study|progression of disease|3|||
106024275|NCT02934503|365754555|FG000|Overall Study|Withdrawal by Subject|1|||
106024276|NCT02314637|365754556|FG000|Overall Study|Adverse Event|4|||
106024277|NCT02314637|365754557|FG001|Overall Study|Adverse Event|8|||
106024278|NCT02314637|365754556|FG000|Overall Study|Lack of Efficacy|1|||
106024279|NCT02314637|365754557|FG001|Overall Study|Lack of Efficacy|0|||
106024280|NCT02314637|365754556|FG000|Overall Study|Physician Decision|5|||
106024281|NCT02314637|365754557|FG001|Overall Study|Physician Decision|2|||
106024282|NCT02314637|365754556|FG000|Overall Study|Withdrawal by Subject|5|||
106024283|NCT02314637|365754557|FG001|Overall Study|Withdrawal by Subject|4|||
106024284|NCT02314637|365754556|FG000|Overall Study|Other Reason|1|||
106024285|NCT02314637|365754557|FG001|Overall Study|Other Reason|0|||
106024286|NCT00475306|365754558|FG000|Overall Study|Protocol Violation|1|||
106149437|NCT03598790|366209106|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
106149438|NCT03598790|366209107|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
106149439|NCT03598790|366209108|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
106149440|NCT03598790|366209109|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
105842354|NCT02224573|365080723|FG001|Treatment Phase|Participant Moved|0|||
105842355|NCT02224573|365080722|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
105842356|NCT02224573|365080723|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
105842357|NCT02224573|365080722|FG000|Treatment Phase|Refused Medication|1|||
105842358|NCT02224573|365080723|FG001|Treatment Phase|Refused Medication|1|||
105842359|NCT02224573|365080722|FG000|Treatment Phase|Adverse Event|26|||
105842360|NCT02224573|365080723|FG001|Treatment Phase|Adverse Event|38|||
105842361|NCT02224573|365080722|FG000|Treatment Phase|Placed in Group Home|0|||
105842362|NCT02224573|365080723|FG001|Treatment Phase|Placed in Group Home|1|||
105842363|NCT02224573|365080722|FG000|Treatment Phase|Pursued Other Trials|1|||
105842364|NCT02224573|365080723|FG001|Treatment Phase|Pursued Other Trials|0|||
105842365|NCT02224573|365080722|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
105842366|NCT02224573|365080723|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
105842367|NCT02224573|365080722|FG000|Treatment Phase|Lost to Follow-up|2|||
105842368|NCT02224573|365080723|FG001|Treatment Phase|Lost to Follow-up|1|||
105842369|NCT02224573|365080722|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
105842370|NCT02224573|365080723|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
105842371|NCT02224573|365080722|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
105842372|NCT02224573|365080723|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
105842373|NCT02224573|365080722|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
105842374|NCT02224573|365080723|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
105842375|NCT02224573|365080722|FG000|Taper Phase|Adverse Event|1|||
105969188|NCT01740089|365547677|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
105969189|NCT01740089|365547678|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
105969190|NCT01740089|365547676|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
105969191|NCT01740089|365547677|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
105969192|NCT01740089|365547678|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
105842376|NCT02224573|365080723|FG001|Taper Phase|Adverse Event|1|||
105842377|NCT01138826|365080724|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
105842378|NCT01138826|365080725|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
105842379|NCT01138826|365080726|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
105842380|NCT01138826|365080727|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
105842381|NCT01138826|365080728|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
105842382|NCT01138826|365080729|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
105842383|NCT01333072|365080730|FG000|Overall Study|Lost to Follow-up|3|||
105842384|NCT01333072|365080731|FG001|Overall Study|Lost to Follow-up|0|||
105842385|NCT01333072|365080730|FG000|Overall Study|Adverse Event|2|||
105842386|NCT01333072|365080731|FG001|Overall Study|Adverse Event|4|||
105842387|NCT01333072|365080730|FG000|Overall Study|Physician Decision|1|||
105842388|NCT01333072|365080731|FG001|Overall Study|Physician Decision|0|||
105969193|NCT01740089|365547676|FG000|After 12 Weeks|Lack of Efficacy|3|||
105969194|NCT01740089|365547677|FG001|After 12 Weeks|Lack of Efficacy|1|||
105969195|NCT01740089|365547678|FG002|After 12 Weeks|Lack of Efficacy|4|||
105969196|NCT01740089|365547676|FG000|After 12 Weeks|Adverse Event|2|||
105969197|NCT01740089|365547677|FG001|After 12 Weeks|Adverse Event|0|||
105969198|NCT01740089|365547678|FG002|After 12 Weeks|Adverse Event|5|||
105969199|NCT01740089|365547676|FG000|After 12 Weeks|Protocol Violation|1|||
105969200|NCT01740089|365547677|FG001|After 12 Weeks|Protocol Violation|1|||
105969201|NCT01740089|365547678|FG002|After 12 Weeks|Protocol Violation|1|||
105969202|NCT01740089|365547676|FG000|After 12 Weeks|Withdrawal by Subject|1|||
105969203|NCT01740089|365547677|FG001|After 12 Weeks|Withdrawal by Subject|1|||
105969204|NCT01740089|365547678|FG002|After 12 Weeks|Withdrawal by Subject|1|||
105969205|NCT01448824|365547679|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105969206|NCT01448824|365547680|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105969207|NCT01448824|365547681|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105969208|NCT01448824|365547682|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105969209|NCT01448824|365547683|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105969210|NCT01448824|365547684|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105969211|NCT01448824|365547685|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
105969212|NCT01448824|365547686|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
105969213|NCT01448824|365547679|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105969214|NCT01448824|365547680|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105969215|NCT01448824|365547681|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105969216|NCT01448824|365547682|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
105842389|NCT03451006|365080735|FG000|Overall Study|Withdrawal by Subject|2|||
105842390|NCT03451006|365080736|FG001|Overall Study|Withdrawal by Subject|2|||
105842391|NCT00949988|365080737|FG000|Overall Study|Withdrawal by Subject|3|||
105842392|NCT03649412|365080738|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
105842393|NCT03649412|365080739|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
105842394|NCT03649412|365080738|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
105842395|NCT03649412|365080739|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
105842396|NCT03649412|365080738|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
105969217|NCT01448824|365547683|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
105969218|NCT01448824|365547684|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
105969219|NCT01448824|365547685|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105969220|NCT01448824|365547686|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
105969221|NCT01448824|365547679|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105987452|NCT02814175|365614461|FG001|Part 1|Withdrawal Consent|1|||
105842397|NCT03649412|365080739|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
105842398|NCT03649412|365080738|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
105842399|NCT03649412|365080739|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
105842400|NCT03649412|365080738|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
105842401|NCT03649412|365080739|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
105842402|NCT03649412|365080738|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
105842403|NCT03649412|365080739|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
105842404|NCT00865514|365080740|FG000|Overall Study|Infusion cost exceeded funding|2|||
105842405|NCT04668274|365080741|FG000|Part 1 Study Period 1|Adverse Event|3|||
105842406|NCT04668274|365080742|FG001|Part 1 Study Period 1|Adverse Event|0|||
105842407|NCT04668274|365080743|FG002|Part 1 Study Period 1|Adverse Event|0|||
105842408|NCT04668274|365080744|FG003|Part 1 Study Period 1|Adverse Event|0|||
105842409|NCT04668274|365080741|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
105842410|NCT04668274|365080742|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
105842411|NCT04668274|365080743|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
105842412|NCT04668274|365080744|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
105842413|NCT04668274|365080741|FG000|Part 1 Study Period 2|Other|0|||
105842414|NCT04668274|365080742|FG001|Part 1 Study Period 2|Other|1|||
105842415|NCT04668274|365080743|FG002|Part 1 Study Period 2|Other|0|||
105842416|NCT04668274|365080744|FG003|Part 1 Study Period 2|Other|0|||
105842417|NCT04668274|365080741|FG000|Part 1 Study Period 3|Adverse Event|0|||
105842418|NCT04668274|365080742|FG001|Part 1 Study Period 3|Adverse Event|0|||
105842419|NCT04668274|365080743|FG002|Part 1 Study Period 3|Adverse Event|1|||
105842420|NCT04668274|365080744|FG003|Part 1 Study Period 3|Adverse Event|0|||
105842421|NCT04668274|365080741|FG000|Part 1 Study Period 3|Other|0|||
105842422|NCT04668274|365080742|FG001|Part 1 Study Period 3|Other|0|||
105842423|NCT04668274|365080743|FG002|Part 1 Study Period 3|Other|2|||
105842424|NCT04668274|365080744|FG003|Part 1 Study Period 3|Other|0|||
105842425|NCT04668274|365080741|FG000|Part 2 Study Period 4|Other|0|||
105842426|NCT04668274|365080742|FG001|Part 2 Study Period 4|Other|0|||
105842427|NCT04668274|365080743|FG002|Part 2 Study Period 4|Other|0|||
105842428|NCT04668274|365080744|FG003|Part 2 Study Period 4|Other|1|||
105842429|NCT02408120|365080747|FG000|Overall Study|Withdrawal by Subject|0|||
105842430|NCT02408120|365080748|FG001|Overall Study|Withdrawal by Subject|1|||
105842431|NCT02408120|365080747|FG000|Overall Study|Treatment Refusal|1|||
105842432|NCT02408120|365080748|FG001|Overall Study|Treatment Refusal|0|||
105842433|NCT02408120|365080747|FG000|Overall Study|Received Steroids|1|||
105842434|NCT02408120|365080748|FG001|Overall Study|Received Steroids|1|||
105842435|NCT02408120|365080747|FG000|Overall Study|Discharged same day|1|||
105842436|NCT02408120|365080748|FG001|Overall Study|Discharged same day|1|||
105842437|NCT02408120|365080747|FG000|Overall Study|Did not receive insulin|1|||
105842438|NCT02408120|365080748|FG001|Overall Study|Did not receive insulin|2|||
105842439|NCT00351351|365080749|FG000|Overall Study|surgical access pbs; device issues|9|||
105842440|NCT00351351|365080750|FG001|Overall Study|surgical access pbs; device issues|4|||
105842441|NCT01341587|365080751|FG000|Overall Study|Lost to Follow-up|2|||
105842442|NCT01341587|365080752|FG001|Overall Study|Lost to Follow-up|0|||
105842443|NCT01341587|365080751|FG000|Overall Study|stopped using the meters|2|||
105842444|NCT01341587|365080752|FG001|Overall Study|stopped using the meters|10|||
105842445|NCT00939627|365080757|FG000|Overall Study|Disease Progression|16|||
105842446|NCT00939627|365080758|FG001|Overall Study|Disease Progression|12|||
105842447|NCT00939627|365080759|FG002|Overall Study|Disease Progression|0|||
105842448|NCT00939627|365080757|FG000|Overall Study|Adverse Event|6|||
105842449|NCT00939627|365080758|FG001|Overall Study|Adverse Event|7|||
105842450|NCT00939627|365080759|FG002|Overall Study|Adverse Event|0|||
105842451|NCT00939627|365080757|FG000|Overall Study|Death|0|||
105842452|NCT00939627|365080758|FG001|Overall Study|Death|2|||
105842453|NCT00939627|365080759|FG002|Overall Study|Death|0|||
105842454|NCT00939627|365080757|FG000|Overall Study|Withdrawal by Subject|2|||
105842455|NCT00939627|365080758|FG001|Overall Study|Withdrawal by Subject|4|||
105842456|NCT00939627|365080759|FG002|Overall Study|Withdrawal by Subject|0|||
105842457|NCT00939627|365080757|FG000|Overall Study|Other complicating disease|1|||
105842458|NCT00939627|365080758|FG001|Overall Study|Other complicating disease|1|||
105842459|NCT00939627|365080759|FG002|Overall Study|Other complicating disease|0|||
105842460|NCT00939627|365080757|FG000|Overall Study|Not compliant|2|||
105842461|NCT00939627|365080758|FG001|Overall Study|Not compliant|0|||
105842462|NCT00939627|365080759|FG002|Overall Study|Not compliant|0|||
105842463|NCT00939627|365080757|FG000|Overall Study|No off-tx reason given|0|||
105842464|NCT00939627|365080758|FG001|Overall Study|No off-tx reason given|2|||
105842465|NCT00939627|365080759|FG002|Overall Study|No off-tx reason given|0|||
105969222|NCT01448824|365547680|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105969223|NCT01448824|365547681|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105969224|NCT01448824|365547682|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105969225|NCT01448824|365547683|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105969226|NCT01448824|365547684|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
105969227|NCT01448824|365547685|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105969228|NCT01448824|365547686|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
105969229|NCT01448824|365547679|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
105969230|NCT01448824|365547680|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
105969231|NCT01448824|365547681|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
105969232|NCT01448824|365547682|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
105969233|NCT01448824|365547683|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
105969234|NCT01448824|365547684|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
105969235|NCT01448824|365547685|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
105969236|NCT01448824|365547686|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
105969237|NCT01448824|365547679|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105969238|NCT01448824|365547680|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105969239|NCT01448824|365547681|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105969240|NCT01448824|365547682|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105969241|NCT01448824|365547683|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105969242|NCT01448824|365547684|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105969243|NCT01448824|365547685|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
105969244|NCT01448824|365547686|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
105969245|NCT01448824|365547679|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105969246|NCT01448824|365547680|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105969247|NCT01448824|365547681|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105969248|NCT01448824|365547682|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105969249|NCT01448824|365547683|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105969250|NCT01448824|365547684|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105969251|NCT01448824|365547685|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
105969252|NCT01448824|365547686|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
105969253|NCT01448824|365547679|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105969254|NCT01448824|365547680|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105969255|NCT01448824|365547681|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105969256|NCT01448824|365547682|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105969257|NCT01448824|365547683|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105969258|NCT01448824|365547684|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105969259|NCT01448824|365547685|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
105969260|NCT01448824|365547686|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
105969261|NCT01448824|365547679|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105969262|NCT01448824|365547680|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105969263|NCT01448824|365547681|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105969264|NCT01448824|365547682|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105842466|NCT00124462|365080760|FG000|Overall Study|Lost to Follow-up|3|||
105842467|NCT00124462|365080761|FG001|Overall Study|Lost to Follow-up|3|||
105842468|NCT00124462|365080760|FG000|Overall Study|Physician Decision|3|||
105842469|NCT00124462|365080761|FG001|Overall Study|Physician Decision|4|||
105842470|NCT00124462|365080760|FG000|Overall Study|Withdrawal by Subject|4|||
105842471|NCT00124462|365080761|FG001|Overall Study|Withdrawal by Subject|5|||
105842472|NCT00124462|365080760|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
105842473|NCT00124462|365080761|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
105842474|NCT01832402|365080766|FG000|Overall Study|Lost to Follow-up|2|||
105842475|NCT01832402|365080767|FG001|Overall Study|Lost to Follow-up|0|||
105842476|NCT01832402|365080766|FG000|Overall Study|Withdrawal by Subject|3|||
105842477|NCT01832402|365080767|FG001|Overall Study|Withdrawal by Subject|3|||
105842478|NCT01832402|365080766|FG000|Overall Study|Declining Performance status|2|||
105842479|NCT01832402|365080767|FG001|Overall Study|Declining Performance status|1|||
105842480|NCT00860743|365080768|FG000|Overall Study|Withdrawal by Subject|3|||
105842481|NCT00860743|365080769|FG001|Overall Study|Withdrawal by Subject|0|||
105842482|NCT01682148|365080770|FG000|Overall Study|Withdrawal by Subject|2|||
105842483|NCT01682148|365080771|FG001|Overall Study|Withdrawal by Subject|0|||
105969265|NCT01448824|365547683|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105842484|NCT01682148|365080770|FG000|Overall Study|Lost to Follow-up|1|||
105842485|NCT01682148|365080771|FG001|Overall Study|Lost to Follow-up|2|||
105842486|NCT01682148|365080770|FG000|Overall Study|Protocol Violation|1|||
105842487|NCT01682148|365080771|FG001|Overall Study|Protocol Violation|1|||
105969266|NCT01448824|365547684|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105842488|NCT02087176|365080772|FG000|Overall Study|Withdrawal by Subject|1|||
105842489|NCT02087176|365080772|FG000|Overall Study|Death|10|||
105842490|NCT02087176|365080772|FG000|Overall Study|Censored|19|||
105842491|NCT02087176|365080772|FG000|Overall Study|Study Terminated by Sponsor|2|||
105842492|NCT00873119|365080773|FG000|Overall Study|Patient request|4|||
105842493|NCT00873119|365080774|FG001|Overall Study|Patient request|2|||
105842494|NCT00873119|365080773|FG000|Overall Study|Adverse Event|8|||
105842495|NCT00873119|365080774|FG001|Overall Study|Adverse Event|0|||
105842496|NCT00873119|365080773|FG000|Overall Study|Progressive disease|26|||
105842497|NCT00873119|365080774|FG001|Overall Study|Progressive disease|18|||
105842498|NCT00873119|365080773|FG000|Overall Study|Death|2|||
105842499|NCT00873119|365080774|FG001|Overall Study|Death|1|||
105842500|NCT00873119|365080773|FG000|Overall Study|Other|2|||
105842501|NCT00873119|365080774|FG001|Overall Study|Other|5|||
105842502|NCT00873119|365080773|FG000|Overall Study|Not treated|2|||
105842503|NCT00873119|365080774|FG001|Overall Study|Not treated|0|||
105842504|NCT03648879|365080775|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
105842505|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
105842506|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
105842507|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
105842508|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
105842509|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
105842510|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
105842511|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
105842512|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
105842513|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
105842514|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
105842515|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
105842516|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
105842517|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
105842518|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
105842519|NCT04740931|365080776|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
105842520|NCT04740931|365080777|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
105842521|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
105842522|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
105842523|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
105842524|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
105842525|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
105842526|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
105842527|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
105842528|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
105842529|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
105842530|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
105842531|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
105842532|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
105842533|NCT04740931|365080776|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
105842534|NCT04740931|365080777|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
105842535|NCT00958126|365080783|FG000|Overall Study|Serious Adverse Event|0|||
105842536|NCT00958126|365080784|FG001|Overall Study|Serious Adverse Event|2|||
105842537|NCT00958126|365080785|FG002|Overall Study|Serious Adverse Event|0|||
105842538|NCT00958126|365080786|FG003|Overall Study|Serious Adverse Event|0|||
105842539|NCT00958126|365080787|FG004|Overall Study|Serious Adverse Event|0|||
105842540|NCT00958126|365080788|FG005|Overall Study|Serious Adverse Event|0|||
105842541|NCT00958126|365080789|FG006|Overall Study|Serious Adverse Event|1|||
105842542|NCT00958126|365080790|FG007|Overall Study|Serious Adverse Event|0|||
105842543|NCT00958126|365080783|FG000|Overall Study|Withdrawal by Subject|0|||
105842544|NCT00958126|365080784|FG001|Overall Study|Withdrawal by Subject|2|||
105842545|NCT00958126|365080785|FG002|Overall Study|Withdrawal by Subject|0|||
105969267|NCT01448824|365547685|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
105969268|NCT01448824|365547686|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
105969269|NCT02370537|365547689|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
105969270|NCT02370537|365547690|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
105969271|NCT02370537|365547691|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
105969272|NCT02370537|365547689|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
105969273|NCT02370537|365547690|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
105969274|NCT02370537|365547691|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
105969275|NCT02370537|365547689|FG000|Part B|Not randomised to receive treatment|1|||
105969276|NCT02370537|365547690|FG001|Part B|Not randomised to receive treatment|2|||
105969277|NCT02370537|365547691|FG002|Part B|Not randomised to receive treatment|259|||
106149441|NCT03598790|366209110|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
105842546|NCT00958126|365080786|FG003|Overall Study|Withdrawal by Subject|0|||
105842547|NCT00958126|365080787|FG004|Overall Study|Withdrawal by Subject|0|||
106149442|NCT03598790|366209111|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
106149443|NCT03598790|366209112|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
106149444|NCT03598790|366209113|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
106149445|NCT03598790|366209105|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
106149446|NCT03598790|366209106|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105842548|NCT00958126|365080788|FG005|Overall Study|Withdrawal by Subject|0|||
105842549|NCT00958126|365080789|FG006|Overall Study|Withdrawal by Subject|0|||
105842550|NCT00958126|365080790|FG007|Overall Study|Withdrawal by Subject|0|||
105842551|NCT00958126|365080783|FG000|Overall Study|Moved away from study area|0|||
105842552|NCT00958126|365080784|FG001|Overall Study|Moved away from study area|0|||
105842553|NCT00958126|365080785|FG002|Overall Study|Moved away from study area|1|||
105842554|NCT00958126|365080786|FG003|Overall Study|Moved away from study area|1|||
105842555|NCT00958126|365080787|FG004|Overall Study|Moved away from study area|0|||
105842556|NCT00958126|365080788|FG005|Overall Study|Moved away from study area|0|||
105842557|NCT00958126|365080789|FG006|Overall Study|Moved away from study area|0|||
105842558|NCT00958126|365080790|FG007|Overall Study|Moved away from study area|0|||
105842559|NCT00958126|365080783|FG000|Overall Study|Lost to Follow-up|1|||
105842560|NCT00958126|365080784|FG001|Overall Study|Lost to Follow-up|5|||
105842561|NCT00958126|365080785|FG002|Overall Study|Lost to Follow-up|9|||
105842562|NCT00958126|365080786|FG003|Overall Study|Lost to Follow-up|8|||
105842563|NCT00958126|365080787|FG004|Overall Study|Lost to Follow-up|0|||
105842564|NCT00958126|365080788|FG005|Overall Study|Lost to Follow-up|0|||
105842565|NCT00958126|365080789|FG006|Overall Study|Lost to Follow-up|0|||
105842566|NCT00958126|365080790|FG007|Overall Study|Lost to Follow-up|0|||
105842567|NCT00958126|365080783|FG000|Overall Study|Sponsor/Investigator decision|0|||
105842568|NCT00958126|365080784|FG001|Overall Study|Sponsor/Investigator decision|0|||
105842569|NCT00958126|365080785|FG002|Overall Study|Sponsor/Investigator decision|0|||
105842570|NCT00958126|365080786|FG003|Overall Study|Sponsor/Investigator decision|1|||
105842571|NCT00958126|365080787|FG004|Overall Study|Sponsor/Investigator decision|0|||
105842572|NCT00958126|365080788|FG005|Overall Study|Sponsor/Investigator decision|0|||
105842573|NCT00958126|365080789|FG006|Overall Study|Sponsor/Investigator decision|0|||
105842574|NCT00958126|365080790|FG007|Overall Study|Sponsor/Investigator decision|0|||
105842575|NCT00958126|365080783|FG000|Overall Study|Other Reason|0|||
105842576|NCT00958126|365080784|FG001|Overall Study|Other Reason|0|||
105842577|NCT00958126|365080785|FG002|Overall Study|Other Reason|0|||
105842578|NCT00958126|365080786|FG003|Overall Study|Other Reason|1|||
105842579|NCT00958126|365080787|FG004|Overall Study|Other Reason|0|||
105842580|NCT00958126|365080788|FG005|Overall Study|Other Reason|1|||
105842581|NCT00958126|365080789|FG006|Overall Study|Other Reason|0|||
105842582|NCT00958126|365080790|FG007|Overall Study|Other Reason|0|||
105842583|NCT01506908|365080791|FG000|Overall Study|Adverse Event|1|||
105842584|NCT01506908|365080792|FG001|Overall Study|Adverse Event|0|||
105842585|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
105842586|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
105842587|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
105842588|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
105842589|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
105842590|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
105842591|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
105842592|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
105842593|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
105842594|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
105842595|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
105842596|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
105842597|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
105842598|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
105842599|NCT02510014|365080793|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
105842600|NCT02510014|365080794|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
105842601|NCT02510014|365080793|FG000|Treatment Period|Adverse Event|11|||
105842602|NCT02510014|365080794|FG001|Treatment Period|Adverse Event|4|||
106149447|NCT03598790|366209107|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105842603|NCT02510014|365080793|FG000|Treatment Period|Withdrawal symptoms|3|||
105842604|NCT02510014|365080794|FG001|Treatment Period|Withdrawal symptoms|0|||
105842605|NCT02510014|365080793|FG000|Treatment Period|Lost to Follow-up|80|||
105842606|NCT02510014|365080794|FG001|Treatment Period|Lost to Follow-up|19|||
105842607|NCT02510014|365080793|FG000|Treatment Period|Physician Decision|5|||
105842608|NCT02510014|365080794|FG001|Treatment Period|Physician Decision|0|||
105842609|NCT02510014|365080793|FG000|Treatment Period|Withdrawal by Subject|67|||
105842610|NCT02510014|365080794|FG001|Treatment Period|Withdrawal by Subject|24|||
105842611|NCT02510014|365080793|FG000|Treatment Period|Withdrawn by the investigator|7|||
105842612|NCT02510014|365080794|FG001|Treatment Period|Withdrawn by the investigator|1|||
105842613|NCT02510014|365080793|FG000|Treatment Period|Protocol Violation|4|||
105969278|NCT02370537|365547689|FG000|Part B|Withdrawal by Subject|0|||
105969279|NCT02370537|365547690|FG001|Part B|Withdrawal by Subject|1|||
105969280|NCT02370537|365547691|FG002|Part B|Withdrawal by Subject|0|||
105969281|NCT01952665|365547692|FG000|Overall Study|Physician Decision|3|||
105969282|NCT01952665|365547693|FG001|Overall Study|Physician Decision|2|||
105969283|NCT01952665|365547692|FG000|Overall Study|Lost to Follow-up|1|||
105969284|NCT01952665|365547693|FG001|Overall Study|Lost to Follow-up|2|||
105969285|NCT01952665|365547692|FG000|Overall Study|Adverse Event|2|||
105969286|NCT01952665|365547693|FG001|Overall Study|Adverse Event|1|||
105969287|NCT01952665|365547692|FG000|Overall Study|Protocol Violation|0|||
105969288|NCT01952665|365547693|FG001|Overall Study|Protocol Violation|1|||
105969289|NCT01537081|365547694|FG000|Overall Study|Adverse Event|5|||
105969290|NCT01537081|365547695|FG001|Overall Study|Adverse Event|2|||
105969291|NCT01537081|365547696|FG002|Overall Study|Adverse Event|2|||
105969292|NCT01537081|365547694|FG000|Overall Study|Lack of Efficacy|2|||
105969293|NCT01537081|365547695|FG001|Overall Study|Lack of Efficacy|1|||
105969294|NCT01537081|365547696|FG002|Overall Study|Lack of Efficacy|0|||
105969295|NCT01537081|365547694|FG000|Overall Study|Lost to Follow-up|17|||
105969296|NCT01537081|365547695|FG001|Overall Study|Lost to Follow-up|15|||
105969297|NCT01537081|365547696|FG002|Overall Study|Lost to Follow-up|9|||
105969298|NCT01537081|365547694|FG000|Overall Study|Protocol Violation|3|||
105969299|NCT01537081|365547695|FG001|Overall Study|Protocol Violation|2|||
105969300|NCT01537081|365547696|FG002|Overall Study|Protocol Violation|2|||
105969301|NCT01537081|365547694|FG000|Overall Study|Withdrawal by Subject|6|||
105969302|NCT01537081|365547695|FG001|Overall Study|Withdrawal by Subject|11|||
105969303|NCT01537081|365547696|FG002|Overall Study|Withdrawal by Subject|3|||
105969304|NCT01537081|365547694|FG000|Overall Study|Physician Decision|5|||
105969305|NCT01537081|365547695|FG001|Overall Study|Physician Decision|6|||
105969306|NCT01537081|365547696|FG002|Overall Study|Physician Decision|0|||
105969307|NCT01537081|365547694|FG000|Overall Study|Sponsor decision|0|||
105969308|NCT01537081|365547695|FG001|Overall Study|Sponsor decision|1|||
105969309|NCT01537081|365547696|FG002|Overall Study|Sponsor decision|0|||
105969310|NCT01537081|365547694|FG000|Overall Study|Assigned but never dosed|1|||
105969311|NCT01537081|365547695|FG001|Overall Study|Assigned but never dosed|0|||
105969312|NCT01537081|365547696|FG002|Overall Study|Assigned but never dosed|0|||
105969313|NCT01463111|365547697|FG000|Overall Study|Withdrawal by Subject|2|||
105969314|NCT01463111|365547697|FG000|Overall Study|Lost to Follow-up|5|||
105969315|NCT01463111|365547697|FG000|Overall Study|Physician Decision|2|||
105969316|NCT01159171|365547699|FG000|Overall Study|Adverse Event|11|||
105969317|NCT01159171|365547699|FG000|Overall Study|Progression of Disease|28|||
105969318|NCT01159171|365547699|FG000|Overall Study|Protocol Violation|1|||
105969319|NCT01159171|365547699|FG000|Overall Study|Need for Surgery|5|||
105969320|NCT01159171|365547699|FG000|Overall Study|Medical Decision|4|||
105969321|NCT01159171|365547699|FG000|Overall Study|Death|1|||
105969322|NCT02264665|365547701|FG000|Overall Study|Other|0|||
105969323|NCT02264665|365547702|FG001|Overall Study|Other|0|||
105969324|NCT02264665|365547703|FG002|Overall Study|Other|3|||
105969325|NCT02264665|365547704|FG003|Overall Study|Other|0|||
106149448|NCT03598790|366209108|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
106149449|NCT03598790|366209109|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105969326|NCT02264665|365547705|FG004|Overall Study|Other|0|||
105969327|NCT02264665|365547706|FG005|Overall Study|Other|0|||
105969328|NCT02264665|365547707|FG006|Overall Study|Other|0|||
105969329|NCT02264665|365547701|FG000|Overall Study|Death|9|||
105969330|NCT02264665|365547702|FG001|Overall Study|Death|8|||
105969331|NCT02264665|365547703|FG002|Overall Study|Death|13|||
105969332|NCT02264665|365547704|FG003|Overall Study|Death|5|||
105969333|NCT02264665|365547705|FG004|Overall Study|Death|0|||
105969334|NCT02264665|365547706|FG005|Overall Study|Death|0|||
105969335|NCT02264665|365547707|FG006|Overall Study|Death|1|||
106024287|NCT00475306|365754559|FG001|Overall Study|Protocol Violation|1|||
106149450|NCT03598790|366209110|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
106149451|NCT03598790|366209111|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
106149452|NCT03598790|366209112|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
106149453|NCT03598790|366209113|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
105969336|NCT02264665|365547701|FG000|Overall Study|Lost to Follow-up|1|||
105969337|NCT02264665|365547702|FG001|Overall Study|Lost to Follow-up|0|||
105969338|NCT02264665|365547703|FG002|Overall Study|Lost to Follow-up|2|||
105969339|NCT02264665|365547704|FG003|Overall Study|Lost to Follow-up|1|||
105969340|NCT02264665|365547705|FG004|Overall Study|Lost to Follow-up|0|||
105969341|NCT02264665|365547706|FG005|Overall Study|Lost to Follow-up|0|||
105969342|NCT02264665|365547707|FG006|Overall Study|Lost to Follow-up|0|||
105969343|NCT02264665|365547701|FG000|Overall Study|Participant decision|0|||
105969344|NCT02264665|365547702|FG001|Overall Study|Participant decision|0|||
105969345|NCT02264665|365547703|FG002|Overall Study|Participant decision|0|||
105969346|NCT02264665|365547704|FG003|Overall Study|Participant decision|1|||
105969347|NCT02264665|365547705|FG004|Overall Study|Participant decision|0|||
106024288|NCT00475306|365754560|FG002|Overall Study|Protocol Violation|0|||
105969348|NCT02264665|365547706|FG005|Overall Study|Participant decision|0|||
105969349|NCT02264665|365547707|FG006|Overall Study|Participant decision|0|||
105969350|NCT02264665|365547701|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
105969351|NCT02264665|365547702|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
105969352|NCT02264665|365547703|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
105969353|NCT02264665|365547704|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
105969354|NCT02264665|365547705|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
105969355|NCT02264665|365547706|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
105969356|NCT02264665|365547707|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
105969357|NCT02264665|365547701|FG000|Overall Study|Data Missing|0|||
105969358|NCT02264665|365547702|FG001|Overall Study|Data Missing|0|||
105969359|NCT02264665|365547703|FG002|Overall Study|Data Missing|1|||
105969360|NCT02264665|365547704|FG003|Overall Study|Data Missing|0|||
105969361|NCT02264665|365547705|FG004|Overall Study|Data Missing|0|||
105969362|NCT02264665|365547706|FG005|Overall Study|Data Missing|0|||
105969363|NCT02264665|365547707|FG006|Overall Study|Data Missing|0|||
105969364|NCT05312632|365547711|FG000|Overall Study|Adverse Event|12|||
105969365|NCT05312632|365547711|FG000|Overall Study|Withdrawal by Subject|10|||
105969366|NCT05312632|365547711|FG000|Overall Study|Lack of Efficacy|4|||
105969367|NCT05312632|365547711|FG000|Overall Study|Non-compliance with study procedures|9|||
105842614|NCT02510014|365080794|FG001|Treatment Period|Protocol Violation|4|||
105842615|NCT02510014|365080793|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
105842616|NCT02510014|365080794|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
105842617|NCT01949116|365080806|FG000|Overall Study|Death|2|||
105842618|NCT01949116|365080807|FG001|Overall Study|Death|0|||
105842619|NCT01949116|365080806|FG000|Overall Study|Lost to Follow-up|1|||
105842620|NCT01949116|365080807|FG001|Overall Study|Lost to Follow-up|3|||
105842621|NCT01949116|365080806|FG000|Overall Study|Withdrawal by Subject|5|||
105842622|NCT01949116|365080807|FG001|Overall Study|Withdrawal by Subject|3|||
105842623|NCT03407118|365080808|FG000|Period 2|Withdrawal by Subject|1|||
105842624|NCT03407118|365080809|FG001|Period 2|Withdrawal by Subject|0|||
105842625|NCT01855048|365080812|FG000|Overall Study|Withdrawal by Subject|0|||
105842626|NCT01855048|365080813|FG001|Overall Study|Withdrawal by Subject|1|||
105842627|NCT01855048|365080814|FG002|Overall Study|Withdrawal by Subject|0|||
105842628|NCT01855048|365080815|FG003|Overall Study|Withdrawal by Subject|0|||
105842629|NCT01855048|365080816|FG004|Overall Study|Withdrawal by Subject|1|||
105842630|NCT01855048|365080817|FG005|Overall Study|Withdrawal by Subject|0|||
105842631|NCT00925301|365080818|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
105842632|NCT00925301|365080819|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
105842633|NCT00925301|365080820|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
105842634|NCT00925301|365080821|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
105842635|NCT00925301|365080818|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
105842636|NCT00925301|365080819|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
105842637|NCT00925301|365080820|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
105842638|NCT00925301|365080821|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
105842639|NCT00925301|365080818|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
105842640|NCT00925301|365080819|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
105842641|NCT00925301|365080820|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
105842642|NCT00925301|365080821|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
105842643|NCT00925301|365080818|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
105842644|NCT00925301|365080819|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
105842645|NCT00925301|365080820|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
105842646|NCT00925301|365080821|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
105842647|NCT00925301|365080818|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
105842648|NCT00925301|365080819|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
105842649|NCT00925301|365080820|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
105842650|NCT00925301|365080821|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
105842651|NCT00925301|365080818|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
105842652|NCT00925301|365080819|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
105842653|NCT00925301|365080820|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
105842654|NCT00925301|365080821|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
105842655|NCT00925301|365080818|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
105969368|NCT05312632|365547711|FG000|Overall Study|Other|4|||
105969369|NCT05289271|365547712|FG000|Overall Study|Mistakenly allocated, untreated|1|||
105969370|NCT05289271|365547713|FG001|Overall Study|Mistakenly allocated, untreated|0|||
105969371|NCT02516098|365547720|FG000|Period 1|Protocol Violation|1|||
105969372|NCT02516098|365547721|FG001|Period 1|Protocol Violation|0|||
105969373|NCT02516098|365547720|FG000|Washout After Period 1|Adverse Event|0|||
105969374|NCT02516098|365547721|FG001|Washout After Period 1|Adverse Event|1|||
105969375|NCT02516098|365547720|FG000|Period 2|Withdrawal by Subject|0|||
105969376|NCT02516098|365547721|FG001|Period 2|Withdrawal by Subject|1|||
105969377|NCT01734395|365547722|FG000|Overall Study|Other|65|||
106024289|NCT00475306|365754561|FG003|Overall Study|Protocol Violation|1|||
106024290|NCT01536067|365754562|FG000|Overall Study|Disease Progression|1|||
106024291|NCT03120351|365754563|FG000|Overall Study|Physician Decision|1|||
106024292|NCT03120351|365754564|FG001|Overall Study|Physician Decision|1|||
106024293|NCT01305577|365754565|FG000|Overall Study|Adverse Event|2|||
106024294|NCT01305577|365754566|FG001|Overall Study|Adverse Event|2|||
106024295|NCT01305577|365754567|FG002|Overall Study|Adverse Event|1|||
105969378|NCT01734395|365547722|FG000|Overall Study|Lost to Follow-up|287|||
105969379|NCT01734395|365547722|FG000|Overall Study|Lack of Efficacy|5|||
105969380|NCT01734395|365547722|FG000|Overall Study|Adverse Event|40|||
105969381|NCT01734395|365547722|FG000|Overall Study|Withdrawal by Subject|10|||
105969382|NCT01734395|365547722|FG000|Overall Study|Missing the reasons for not completed|3|||
105969383|NCT01007435|365547723|FG000|Overall Study|Adverse Event|16|||
105969384|NCT01007435|365547724|FG001|Overall Study|Adverse Event|25|||
105969385|NCT01007435|365547725|FG002|Overall Study|Adverse Event|47|||
105969386|NCT01007435|365547726|FG003|Overall Study|Adverse Event|31|||
105969387|NCT01007435|365547723|FG000|Overall Study|Death|2|||
105969388|NCT01007435|365547724|FG001|Overall Study|Death|4|||
105969389|NCT01007435|365547725|FG002|Overall Study|Death|2|||
105969390|NCT01007435|365547726|FG003|Overall Study|Death|1|||
105969391|NCT01007435|365547723|FG000|Overall Study|Insufficient Therapeutic Response|21|||
105969392|NCT01007435|365547724|FG001|Overall Study|Insufficient Therapeutic Response|7|||
105969393|NCT01007435|365547725|FG002|Overall Study|Insufficient Therapeutic Response|2|||
105969394|NCT01007435|365547726|FG003|Overall Study|Insufficient Therapeutic Response|9|||
105969395|NCT01007435|365547723|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
105969396|NCT01007435|365547724|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
105969397|NCT01007435|365547725|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
105969398|NCT01007435|365547726|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
105969399|NCT01007435|365547723|FG000|Overall Study|Other Protocol Violation|2|||
105969400|NCT01007435|365547724|FG001|Overall Study|Other Protocol Violation|0|||
105969401|NCT01007435|365547725|FG002|Overall Study|Other Protocol Violation|1|||
105969402|NCT01007435|365547726|FG003|Overall Study|Other Protocol Violation|0|||
105969403|NCT01007435|365547723|FG000|Overall Study|Refused Treatment|13|||
105969404|NCT01007435|365547724|FG001|Overall Study|Refused Treatment|13|||
105969405|NCT01007435|365547725|FG002|Overall Study|Refused Treatment|5|||
105969406|NCT01007435|365547726|FG003|Overall Study|Refused Treatment|8|||
105969407|NCT01007435|365547723|FG000|Overall Study|Failure to Return|5|||
105969408|NCT01007435|365547724|FG001|Overall Study|Failure to Return|4|||
105969409|NCT01007435|365547725|FG002|Overall Study|Failure to Return|3|||
105969410|NCT01007435|365547726|FG003|Overall Study|Failure to Return|6|||
105969411|NCT01007435|365547723|FG000|Overall Study|Reason not Specified|1|||
105969412|NCT01007435|365547724|FG001|Overall Study|Reason not Specified|1|||
105969413|NCT01007435|365547725|FG002|Overall Study|Reason not Specified|2|||
105969414|NCT01007435|365547726|FG003|Overall Study|Reason not Specified|1|||
106024296|NCT01305577|365754565|FG000|Overall Study|Withdrawal by Subject|7|||
106024297|NCT01305577|365754566|FG001|Overall Study|Withdrawal by Subject|5|||
106024298|NCT01305577|365754567|FG002|Overall Study|Withdrawal by Subject|6|||
106024299|NCT01305577|365754565|FG000|Overall Study|Lost to Follow-up|4|||
106024300|NCT01305577|365754566|FG001|Overall Study|Lost to Follow-up|3|||
106024301|NCT01305577|365754567|FG002|Overall Study|Lost to Follow-up|2|||
105969415|NCT00322023|365547727|FG000|Overall Study|various|0|||
105969416|NCT00322023|365547728|FG001|Overall Study|various|2|||
105969417|NCT00322023|365547729|FG002|Overall Study|various|6|||
105969418|NCT01846663|365547732|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
105969419|NCT01846663|365547733|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
105969420|NCT01846663|365547732|FG000|Overall Study|Withdrawal by Subject|1|||
105969421|NCT01846663|365547733|FG001|Overall Study|Withdrawal by Subject|0|||
105969422|NCT01846663|365547732|FG000|Overall Study|Adverse Event|1|||
105969423|NCT01846663|365547733|FG001|Overall Study|Adverse Event|2|||
105969424|NCT03077438|365547739|FG000|Overall Study|Protocol Violation|3|||
105969425|NCT03077438|365547740|FG001|Overall Study|Protocol Violation|5|||
105969426|NCT03077438|365547739|FG000|Overall Study|Withdrawal by Subject|3|||
105969427|NCT03077438|365547740|FG001|Overall Study|Withdrawal by Subject|6|||
105969428|NCT03077438|365547739|FG000|Overall Study|Lost to Follow-up|6|||
105969429|NCT03077438|365547740|FG001|Overall Study|Lost to Follow-up|3|||
105969430|NCT00813865|365547745|FG000|Overall Study|Failure to Respond|3|||
105969431|NCT00813865|365547745|FG000|Overall Study|Lost to Follow-up|3|||
105969432|NCT00813865|365547745|FG000|Overall Study|Withdrawal by Subject|1|||
105969433|NCT01626118|365547747|FG000|Overall Study|Lack of Efficacy|1|||
106024302|NCT01305577|365754565|FG000|Overall Study|Protocol Deviation|0|||
106024303|NCT01305577|365754566|FG001|Overall Study|Protocol Deviation|1|||
106024304|NCT01305577|365754567|FG002|Overall Study|Protocol Deviation|1|||
106024305|NCT02136069|365754568|FG000|Overall Study|UC flare-up|1|||
106024306|NCT02136069|365754569|FG001|Overall Study|UC flare-up|0|||
106024307|NCT02136069|365754568|FG000|Overall Study|Adverse Event|6|||
106024308|NCT02136069|365754569|FG001|Overall Study|Adverse Event|8|||
106024309|NCT02136069|365754568|FG000|Overall Study|Death|0|||
106024310|NCT02136069|365754569|FG001|Overall Study|Death|1|||
106024311|NCT02136069|365754568|FG000|Overall Study|Lack of Efficacy|10|||
105842656|NCT00925301|365080819|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
105842657|NCT00925301|365080820|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
105842658|NCT00925301|365080821|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
105842659|NCT00613834|365080822|FG000|Overall Study|Withdrawal by Subject|0|||
105842660|NCT00613834|365080823|FG001|Overall Study|Withdrawal by Subject|3|||
105842661|NCT05626803|365082391|FG000|Overall Study|Lost to Follow-up|0|||
105842662|NCT05626803|365082392|FG001|Overall Study|Lost to Follow-up|1|||
105842663|NCT05626803|365082393|FG002|Overall Study|Lost to Follow-up|0|||
105842664|NCT05626803|365082394|FG003|Overall Study|Lost to Follow-up|0|||
105842665|NCT01000610|365082397|FG000|Overall Study|Adverse Event|1|||
105842666|NCT01000610|365082397|FG000|Overall Study|Lost to Follow-up|4|||
105842667|NCT01000610|365082397|FG000|Overall Study|Treatment failure|1|||
105842668|NCT02631876|365082404|FG000|Overall Study|Death|96|||
105842669|NCT02631876|365082405|FG001|Overall Study|Death|50|||
105842670|NCT02631876|365082404|FG000|Overall Study|Investigator's discretion|1|||
105842671|NCT02631876|365082405|FG001|Overall Study|Investigator's discretion|0|||
105842672|NCT02631876|365082404|FG000|Overall Study|Lost to Follow-up|2|||
105842673|NCT02631876|365082405|FG001|Overall Study|Lost to Follow-up|0|||
105842674|NCT02631876|365082404|FG000|Overall Study|Withdrawal by Subject|16|||
105842675|NCT02631876|365082405|FG001|Overall Study|Withdrawal by Subject|9|||
105842676|NCT02631876|365082404|FG000|Overall Study|Other than specified|4|||
105842677|NCT02631876|365082405|FG001|Overall Study|Other than specified|4|||
105842678|NCT02658487|365082406|FG000|Overall Study|Death|2|||
105842679|NCT02658487|365082406|FG000|Overall Study|Disease progression|10|||
105842680|NCT02658487|365082406|FG000|Overall Study|Alternative therapy|1|||
105842681|NCT02658487|365082406|FG000|Overall Study|Adverse Event|1|||
105842682|NCT02658487|365082406|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
105842683|NCT02658487|365082406|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
105842684|NCT00784134|365082407|FG000|Overall Study|Lost to Follow-up|3|||
105842685|NCT00784134|365082408|FG001|Overall Study|Lost to Follow-up|6|||
105842686|NCT01408563|365082414|FG000|Overall Study|Ineligible after consent/ registration|2|||
105842687|NCT02516410|365082415|FG000|Overall Study|Adverse Event|0|||
105842688|NCT02516410|365082416|FG001|Overall Study|Adverse Event|1|||
105842689|NCT02516410|365082415|FG000|Overall Study|Withdrawal by Subject|0|||
105842690|NCT02516410|365082416|FG001|Overall Study|Withdrawal by Subject|1|||
105842691|NCT03250299|365082418|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
105842692|NCT03250299|365082419|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
105842693|NCT03250299|365082420|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
105842694|NCT03250299|365082421|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
105842695|NCT03250299|365082422|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
105842696|NCT03250299|365082418|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
105842697|NCT03250299|365082419|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
105842698|NCT03250299|365082420|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
105842699|NCT03250299|365082421|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
105842700|NCT03250299|365082422|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
105842701|NCT03250299|365082418|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
105842702|NCT03250299|365082419|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
105842703|NCT03250299|365082420|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
105842704|NCT03250299|365082421|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
105842705|NCT03250299|365082422|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
105842706|NCT03250299|365082418|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
105842707|NCT03250299|365082419|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
105842708|NCT03250299|365082420|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
105842709|NCT03250299|365082421|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
105842710|NCT03250299|365082422|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
105842711|NCT03346070|365082423|FG000|Overall Study|Death|0|||
105842712|NCT03346070|365082424|FG001|Overall Study|Death|0|||
105842713|NCT03346070|365082425|FG002|Overall Study|Death|0|||
105842714|NCT03346070|365082426|FG003|Overall Study|Death|0|||
105842715|NCT03346070|365082427|FG004|Overall Study|Death|1|||
105842716|NCT03346070|365082423|FG000|Overall Study|Lost to Follow-up|0|||
105842717|NCT03346070|365082424|FG001|Overall Study|Lost to Follow-up|1|||
105842718|NCT03346070|365082425|FG002|Overall Study|Lost to Follow-up|2|||
105842719|NCT03346070|365082426|FG003|Overall Study|Lost to Follow-up|0|||
105842720|NCT03346070|365082427|FG004|Overall Study|Lost to Follow-up|0|||
105842721|NCT03346070|365082423|FG000|Overall Study|Physician Decision|0|||
105842722|NCT03346070|365082424|FG001|Overall Study|Physician Decision|0|||
105969434|NCT01626118|365547748|FG001|Overall Study|Lack of Efficacy|0|||
105969435|NCT01626118|365547749|FG002|Overall Study|Lack of Efficacy|1|||
105842723|NCT03346070|365082425|FG002|Overall Study|Physician Decision|0|||
105842724|NCT03346070|365082426|FG003|Overall Study|Physician Decision|1|||
105842725|NCT03346070|365082427|FG004|Overall Study|Physician Decision|1|||
105969436|NCT01626118|365547750|FG003|Overall Study|Lack of Efficacy|3|||
105842726|NCT03346070|365082423|FG000|Overall Study|Withdrawal by Subject|1|||
105842727|NCT03346070|365082424|FG001|Overall Study|Withdrawal by Subject|0|||
105842728|NCT03346070|365082425|FG002|Overall Study|Withdrawal by Subject|0|||
105842729|NCT03346070|365082426|FG003|Overall Study|Withdrawal by Subject|1|||
106024312|NCT02136069|365754569|FG001|Overall Study|Lack of Efficacy|4|||
106024313|NCT02136069|365754568|FG000|Overall Study|Lost to Follow-up|1|||
106024314|NCT02136069|365754569|FG001|Overall Study|Lost to Follow-up|0|||
106024315|NCT02136069|365754568|FG000|Overall Study|Non-Compliance|1|||
106024316|NCT02136069|365754569|FG001|Overall Study|Non-Compliance|0|||
106024317|NCT02136069|365754568|FG000|Overall Study|Physician Decision|5|||
106024318|NCT02136069|365754569|FG001|Overall Study|Physician Decision|4|||
106024319|NCT02136069|365754568|FG000|Overall Study|Withdrawal by Subject|10|||
106024320|NCT02136069|365754569|FG001|Overall Study|Withdrawal by Subject|11|||
106024321|NCT01767142|365754570|FG000|Overall Study|Lost to Follow-up|3|||
106024322|NCT02722304|365754571|FG000|Overall Study|Study Terminated by Sponsor|1|||
106024323|NCT02722304|365754572|FG001|Overall Study|Study Terminated by Sponsor|0|||
106024324|NCT02722304|365754573|FG002|Overall Study|Study Terminated by Sponsor|2|||
106024325|NCT02722304|365754574|FG003|Overall Study|Study Terminated by Sponsor|1|||
106024326|NCT02722304|365754575|FG004|Overall Study|Study Terminated by Sponsor|1|||
106024327|NCT02722304|365754571|FG000|Overall Study|Other|0|||
106024328|NCT02722304|365754572|FG001|Overall Study|Other|0|||
106024329|NCT02722304|365754573|FG002|Overall Study|Other|0|||
106024330|NCT02722304|365754574|FG003|Overall Study|Other|1|||
106024331|NCT02722304|365754575|FG004|Overall Study|Other|1|||
106024332|NCT00435045|365754576|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
106024333|NCT00435045|365754577|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
106024334|NCT00435045|365754576|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
106024335|NCT00435045|365754577|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
106024336|NCT00435045|365754576|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
106024337|NCT00435045|365754577|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
106024338|NCT00435045|365754576|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
106024339|NCT00435045|365754577|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
106024340|NCT00435045|365754576|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
106024341|NCT00435045|365754577|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
106024342|NCT00435045|365754576|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
106024343|NCT00435045|365754577|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
106024344|NCT00435045|365754576|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
106024345|NCT00435045|365754577|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
105969437|NCT01626118|365547747|FG000|Overall Study|Lost to Follow-up|1|||
105969438|NCT01626118|365547748|FG001|Overall Study|Lost to Follow-up|0|||
105969439|NCT01626118|365547749|FG002|Overall Study|Lost to Follow-up|0|||
105969440|NCT01626118|365547750|FG003|Overall Study|Lost to Follow-up|0|||
105969441|NCT01626118|365547747|FG000|Overall Study|Adverse Event|0|||
105969442|NCT01626118|365547748|FG001|Overall Study|Adverse Event|1|||
105969443|NCT01626118|365547749|FG002|Overall Study|Adverse Event|1|||
105969444|NCT01626118|365547750|FG003|Overall Study|Adverse Event|0|||
105969445|NCT01626118|365547747|FG000|Overall Study|Investigator Decision|0|||
105969446|NCT01626118|365547748|FG001|Overall Study|Investigator Decision|1|||
105969447|NCT01626118|365547749|FG002|Overall Study|Investigator Decision|0|||
105969448|NCT01626118|365547750|FG003|Overall Study|Investigator Decision|0|||
105969449|NCT03575065|365547753|FG000|Overall Study|Death|31|||
105969450|NCT03575065|365547754|FG001|Overall Study|Death|12|||
105969451|NCT03575065|365547753|FG000|Overall Study|Sponsor's Decision|28|||
105969452|NCT03575065|365547754|FG001|Overall Study|Sponsor's Decision|13|||
105969453|NCT03575065|365547753|FG000|Overall Study|Withdrawal by Subject|2|||
105969454|NCT03575065|365547754|FG001|Overall Study|Withdrawal by Subject|1|||
106024346|NCT00435045|365754576|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
106024347|NCT00435045|365754577|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
106024348|NCT00435045|365754576|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
106024349|NCT00435045|365754577|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
106024350|NCT00435045|365754576|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
106024351|NCT00435045|365754577|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
106149454|NCT03215927|366209114|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
106149455|NCT03215927|366209115|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
105969455|NCT03575065|365547753|FG000|Overall Study|Lost to Follow-up|1|||
105969456|NCT03575065|365547754|FG001|Overall Study|Lost to Follow-up|0|||
105969457|NCT01421303|365547759|FG000|Overall Study|Lost to Follow-up|13|||
105969458|NCT01421303|365547759|FG000|Overall Study|Non compliance with study procedure|1|||
105969459|NCT01421303|365547759|FG000|Overall Study|Other|7|||
105969460|NCT01421303|365547759|FG000|Overall Study|Withdrawal by Subject|1|||
105969461|NCT03172325|365547763|FG000|Overall Study|Adverse Event|2|||
105969462|NCT03172325|365547764|FG001|Overall Study|Adverse Event|3|||
106024352|NCT00435045|365754576|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
106024353|NCT00435045|365754577|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
106024354|NCT01018810|365754578|FG000|Overall Study|Withdrawal by Subject|0|||
106024355|NCT01018810|365754579|FG001|Overall Study|Withdrawal by Subject|1|||
106024356|NCT01018810|365754580|FG002|Overall Study|Withdrawal by Subject|0|||
106024357|NCT01018810|365754581|FG003|Overall Study|Withdrawal by Subject|0|||
106024358|NCT01018810|365754582|FG004|Overall Study|Withdrawal by Subject|0|||
105969463|NCT03172325|365547763|FG000|Overall Study|Positive PPD|1|||
105969464|NCT03172325|365547764|FG001|Overall Study|Positive PPD|0|||
105969465|NCT03172325|365547763|FG000|Overall Study|Poor Compliance|1|||
105969466|NCT03172325|365547764|FG001|Overall Study|Poor Compliance|1|||
105969467|NCT02120300|365547767|FG000|Overall Study|Enrolled but Never Treated|2|||
105969468|NCT02120300|365547768|FG001|Overall Study|Enrolled but Never Treated|0|||
105969469|NCT02120300|365547769|FG002|Overall Study|Enrolled but Never Treated|0|||
105969470|NCT02120300|365547770|FG003|Overall Study|Enrolled but Never Treated|0|||
105969471|NCT02120300|365547767|FG000|Overall Study|Lack of Efficacy|0|||
105969472|NCT02120300|365547768|FG001|Overall Study|Lack of Efficacy|0|||
105969473|NCT02120300|365547769|FG002|Overall Study|Lack of Efficacy|0|||
105969474|NCT02120300|365547770|FG003|Overall Study|Lack of Efficacy|1|||
106024359|NCT01018810|365754578|FG000|Overall Study|Sponsor Decision|2|||
106024360|NCT01018810|365754579|FG001|Overall Study|Sponsor Decision|0|||
106024361|NCT01018810|365754580|FG002|Overall Study|Sponsor Decision|1|||
106024362|NCT01018810|365754581|FG003|Overall Study|Sponsor Decision|1|||
106024363|NCT01018810|365754582|FG004|Overall Study|Sponsor Decision|1|||
106024364|NCT04145219|365754583|FG000|Overall Study|Adverse Event|18|||
106024365|NCT04145219|365754584|FG001|Overall Study|Adverse Event|6|||
106024366|NCT04145219|365754583|FG000|Overall Study|Lost to Follow-up|2|||
106024367|NCT04145219|365754584|FG001|Overall Study|Lost to Follow-up|3|||
106024368|NCT04145219|365754583|FG000|Overall Study|Physician Decision|0|||
106024369|NCT04145219|365754584|FG001|Overall Study|Physician Decision|2|||
106024370|NCT04145219|365754583|FG000|Overall Study|Withdrawal by Subject|12|||
106024371|NCT04145219|365754584|FG001|Overall Study|Withdrawal by Subject|8|||
106024372|NCT04145219|365754583|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
106024373|NCT04145219|365754584|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
106024374|NCT01640314|365754585|FG000|Overall Study|Protocol Violation|0|||
106024375|NCT01640314|365754586|FG001|Overall Study|Protocol Violation|1|||
106024376|NCT02872935|365754588|FG000|Overall Study|Other|0|||
106024377|NCT02872935|365754589|FG001|Overall Study|Other|1|||
106024378|NCT00706342|365754594|FG000|Overall Study|Adverse Event|3|||
106024379|NCT00706342|365754594|FG000|Overall Study|Not responding to treatment|2|||
106024380|NCT00706342|365754594|FG000|Overall Study|Withdrawn due to failure to respond|1|||
106024381|NCT00706342|365754594|FG000|Overall Study|Death|1|||
106024382|NCT00706342|365754594|FG000|Overall Study|Withdrew from the study on his own.|1|||
106024383|NCT00706342|365754594|FG000|Overall Study|Investigator discretion|2|||
106024384|NCT00706342|365754594|FG000|Overall Study|Non-responder Week 12|1|||
106024385|NCT00706342|365754594|FG000|Overall Study|Ongoing|6|||
106024386|NCT00706342|365754594|FG000|Overall Study|WIthdrawal of consent|1|||
106024387|NCT00910299|365754596|FG000|Overall Study|Withdrawal by Subject|16|||
106024388|NCT00910299|365754597|FG001|Overall Study|Withdrawal by Subject|13|||
106024389|NCT00910299|365754596|FG000|Overall Study|Sponsor Decision|58|||
106024390|NCT00910299|365754597|FG001|Overall Study|Sponsor Decision|60|||
106024391|NCT00910299|365754596|FG000|Overall Study|Didn't receive any study drug|2|||
106024392|NCT00910299|365754597|FG001|Overall Study|Didn't receive any study drug|1|||
106024393|NCT01798849|365754598|FG000|Overall Study|Physician Decision|0|||
106024394|NCT01798849|365754599|FG001|Overall Study|Physician Decision|0|||
106024395|NCT01798849|365754600|FG002|Overall Study|Physician Decision|1|||
106024396|NCT02878798|365754601|FG000|Overall Study|Withdrawal by Subject|5|||
106024397|NCT02878798|365754602|FG001|Overall Study|Withdrawal by Subject|4|||
106024398|NCT02878798|365754601|FG000|Overall Study|Lost to Follow-up|2|||
106024399|NCT02878798|365754602|FG001|Overall Study|Lost to Follow-up|2|||
106024400|NCT02878798|365754601|FG000|Overall Study|Protocol Violation|0|||
106024401|NCT02878798|365754602|FG001|Overall Study|Protocol Violation|1|||
106024402|NCT01134705|365754603|FG000|Overall Study|Adverse Event|1|||
106024403|NCT01134705|365754604|FG001|Overall Study|Adverse Event|7|||
106024404|NCT01134705|365754603|FG000|Overall Study|Withdrawal by Subject|6|||
106024405|NCT01134705|365754604|FG001|Overall Study|Withdrawal by Subject|6|||
106149456|NCT03215927|366209114|FG000|Open Label Extension|Adverse Event|1|||
106149457|NCT03215927|366209115|FG001|Open Label Extension|Adverse Event|0|||
106149458|NCT03215927|366209114|FG000|Open Label Extension|Lack of Efficacy|1|||
106149459|NCT03215927|366209115|FG001|Open Label Extension|Lack of Efficacy|0|||
106149460|NCT03215927|366209114|FG000|Open Label Extension|Death|0|||
105969475|NCT02120300|365547767|FG000|Overall Study|Lost to Follow-up|1|||
105969476|NCT02120300|365547768|FG001|Overall Study|Lost to Follow-up|0|||
106024406|NCT01134705|365754603|FG000|Overall Study|Pregnancy|1|||
106024407|NCT01134705|365754604|FG001|Overall Study|Pregnancy|0|||
105969477|NCT02120300|365547769|FG002|Overall Study|Lost to Follow-up|0|||
105969478|NCT02120300|365547770|FG003|Overall Study|Lost to Follow-up|0|||
105969479|NCT00712725|365547771|FG000|Overall Study|Adverse Event|1|||
105969480|NCT00712725|365547772|FG001|Overall Study|Adverse Event|0|||
105969481|NCT00712725|365547773|FG002|Overall Study|Adverse Event|0|||
105969482|NCT00712725|365547774|FG003|Overall Study|Adverse Event|1|||
106024408|NCT01134705|365754603|FG000|Overall Study|Lost to Follow-up|5|||
106024409|NCT01134705|365754604|FG001|Overall Study|Lost to Follow-up|2|||
106024410|NCT01134705|365754603|FG000|Overall Study|Protocol Violation|1|||
106024411|NCT01134705|365754604|FG001|Overall Study|Protocol Violation|1|||
106149461|NCT03215927|366209115|FG001|Open Label Extension|Death|1|||
105842730|NCT03346070|365082427|FG004|Overall Study|Withdrawal by Subject|0|||
105842731|NCT03346070|365082423|FG000|Overall Study|Study medication not received as planned|2|||
105842732|NCT03346070|365082424|FG001|Overall Study|Study medication not received as planned|3|||
105842733|NCT03346070|365082425|FG002|Overall Study|Study medication not received as planned|2|||
105842734|NCT03346070|365082426|FG003|Overall Study|Study medication not received as planned|3|||
105842735|NCT03346070|365082427|FG004|Overall Study|Study medication not received as planned|2|||
105842736|NCT03346070|365082423|FG000|Overall Study|Screen Failure|0|||
105842737|NCT03346070|365082424|FG001|Overall Study|Screen Failure|0|||
105842738|NCT03346070|365082425|FG002|Overall Study|Screen Failure|0|||
105842739|NCT03346070|365082426|FG003|Overall Study|Screen Failure|1|||
105842740|NCT03346070|365082427|FG004|Overall Study|Screen Failure|1|||
105842741|NCT02813421|365082428|FG000|Overall Study|Withdrawal by Subject|1|||
105842742|NCT02813421|365082429|FG001|Overall Study|Withdrawal by Subject|2|||
105842743|NCT02813421|365082428|FG000|Overall Study|Lost to Follow-up|1|||
105842744|NCT02813421|365082429|FG001|Overall Study|Lost to Follow-up|1|||
105842745|NCT05142566|365082430|FG000|Overall Study|Protocol Violation|1|||
105842746|NCT04146363|365082439|FG000|Induction Period|Adverse Event|1|||
105842747|NCT04146363|365082440|FG001|Induction Period|Adverse Event|2|||
105842748|NCT04146363|365082441|FG002|Induction Period|Adverse Event|0|||
105842749|NCT04146363|365082442|FG003|Induction Period|Adverse Event|0|||
105842750|NCT04146363|365082443|FG004|Induction Period|Adverse Event|0|||
105842751|NCT04146363|365082444|FG005|Induction Period|Adverse Event|0|||
105842752|NCT04146363|365082445|FG006|Induction Period|Adverse Event|0|||
105842753|NCT04146363|365082446|FG007|Induction Period|Adverse Event|0|||
105842754|NCT04146363|365082447|FG008|Induction Period|Adverse Event|0|||
105842755|NCT04146363|365082448|FG009|Induction Period|Adverse Event|0|||
105842756|NCT04146363|365082449|FG010|Induction Period|Adverse Event|0|||
105842757|NCT04146363|365082439|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
105842758|NCT04146363|365082440|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
105842759|NCT04146363|365082441|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
105842760|NCT04146363|365082442|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
105842761|NCT04146363|365082443|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
105842762|NCT04146363|365082444|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
105842763|NCT04146363|365082445|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
105842764|NCT04146363|365082446|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
105842765|NCT04146363|365082447|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
105842766|NCT04146363|365082448|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
105842767|NCT04146363|365082449|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
105842768|NCT04146363|365082439|FG000|Induction Period|Lack of Efficacy|7|||
105842769|NCT04146363|365082440|FG001|Induction Period|Lack of Efficacy|2|||
105842770|NCT04146363|365082441|FG002|Induction Period|Lack of Efficacy|0|||
105842771|NCT04146363|365082442|FG003|Induction Period|Lack of Efficacy|0|||
105842772|NCT04146363|365082443|FG004|Induction Period|Lack of Efficacy|0|||
105842773|NCT04146363|365082444|FG005|Induction Period|Lack of Efficacy|0|||
105842774|NCT04146363|365082445|FG006|Induction Period|Lack of Efficacy|0|||
105842775|NCT04146363|365082446|FG007|Induction Period|Lack of Efficacy|0|||
105842776|NCT04146363|365082447|FG008|Induction Period|Lack of Efficacy|0|||
105842777|NCT04146363|365082448|FG009|Induction Period|Lack of Efficacy|0|||
105842778|NCT04146363|365082449|FG010|Induction Period|Lack of Efficacy|0|||
105842779|NCT04146363|365082439|FG000|Induction Period|Lost to Follow-up|1|||
105842780|NCT04146363|365082440|FG001|Induction Period|Lost to Follow-up|4|||
105842781|NCT04146363|365082441|FG002|Induction Period|Lost to Follow-up|0|||
105842782|NCT04146363|365082442|FG003|Induction Period|Lost to Follow-up|0|||
105842783|NCT04146363|365082443|FG004|Induction Period|Lost to Follow-up|0|||
105842784|NCT04146363|365082444|FG005|Induction Period|Lost to Follow-up|0|||
105842785|NCT04146363|365082445|FG006|Induction Period|Lost to Follow-up|0|||
105842786|NCT04146363|365082446|FG007|Induction Period|Lost to Follow-up|0|||
105842787|NCT04146363|365082447|FG008|Induction Period|Lost to Follow-up|0|||
105842788|NCT04146363|365082448|FG009|Induction Period|Lost to Follow-up|0|||
105842789|NCT04146363|365082449|FG010|Induction Period|Lost to Follow-up|0|||
105842790|NCT04146363|365082439|FG000|Induction Period|Positive quantiferon test|0|||
105842791|NCT04146363|365082440|FG001|Induction Period|Positive quantiferon test|1|||
105842792|NCT04146363|365082441|FG002|Induction Period|Positive quantiferon test|0|||
105842793|NCT04146363|365082442|FG003|Induction Period|Positive quantiferon test|0|||
105842794|NCT04146363|365082443|FG004|Induction Period|Positive quantiferon test|0|||
105842795|NCT04146363|365082444|FG005|Induction Period|Positive quantiferon test|0|||
106024412|NCT01134705|365754603|FG000|Overall Study|Other|1|||
105842796|NCT04146363|365082445|FG006|Induction Period|Positive quantiferon test|0|||
105842797|NCT04146363|365082446|FG007|Induction Period|Positive quantiferon test|0|||
105842798|NCT04146363|365082447|FG008|Induction Period|Positive quantiferon test|0|||
105842799|NCT04146363|365082448|FG009|Induction Period|Positive quantiferon test|0|||
105842800|NCT04146363|365082449|FG010|Induction Period|Positive quantiferon test|0|||
105842801|NCT04146363|365082439|FG000|Induction Period|Protocol Deviation|5|||
105842802|NCT04146363|365082440|FG001|Induction Period|Protocol Deviation|6|||
106024413|NCT01134705|365754604|FG001|Overall Study|Other|6|||
106024414|NCT01994889|365754605|FG000|Overall Study|Adverse Event|5|||
106149462|NCT03785782|366209116|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
105842803|NCT04146363|365082441|FG002|Induction Period|Protocol Deviation|0|||
105842804|NCT04146363|365082442|FG003|Induction Period|Protocol Deviation|0|||
105842805|NCT04146363|365082443|FG004|Induction Period|Protocol Deviation|0|||
105842806|NCT04146363|365082444|FG005|Induction Period|Protocol Deviation|0|||
105842807|NCT04146363|365082445|FG006|Induction Period|Protocol Deviation|0|||
105842808|NCT04146363|365082446|FG007|Induction Period|Protocol Deviation|0|||
105842809|NCT04146363|365082447|FG008|Induction Period|Protocol Deviation|0|||
105842810|NCT04146363|365082448|FG009|Induction Period|Protocol Deviation|0|||
105842811|NCT04146363|365082449|FG010|Induction Period|Protocol Deviation|0|||
105842812|NCT04146363|365082439|FG000|Induction Period|Withdrawal by Subject|6|||
105842813|NCT04146363|365082440|FG001|Induction Period|Withdrawal by Subject|3|||
105842814|NCT04146363|365082441|FG002|Induction Period|Withdrawal by Subject|0|||
105842815|NCT04146363|365082442|FG003|Induction Period|Withdrawal by Subject|0|||
105842816|NCT04146363|365082443|FG004|Induction Period|Withdrawal by Subject|0|||
105842817|NCT04146363|365082444|FG005|Induction Period|Withdrawal by Subject|0|||
105842818|NCT04146363|365082445|FG006|Induction Period|Withdrawal by Subject|0|||
105842819|NCT04146363|365082446|FG007|Induction Period|Withdrawal by Subject|0|||
105842820|NCT04146363|365082447|FG008|Induction Period|Withdrawal by Subject|0|||
105842821|NCT04146363|365082448|FG009|Induction Period|Withdrawal by Subject|0|||
105842822|NCT04146363|365082449|FG010|Induction Period|Withdrawal by Subject|0|||
105842823|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842824|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842825|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842826|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842827|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842828|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842829|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
105842830|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
105842831|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842832|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842833|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
105842834|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842835|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842836|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842837|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842838|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842839|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842840|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842841|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
105842842|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842843|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842844|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
105842845|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842846|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842847|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842848|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842849|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842850|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842851|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
105842852|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
105842853|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842854|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842855|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
105842856|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842857|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842858|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
105842859|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842860|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842861|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
105842862|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842863|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842864|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842865|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842866|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
105842867|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842868|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
106149463|NCT03785782|366209117|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
105842869|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842870|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842871|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
105842872|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
105842873|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
105842874|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
105842875|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842876|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842877|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
105842878|NCT04146363|365082439|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842879|NCT04146363|365082440|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105969483|NCT00712725|365547775|FG004|Overall Study|Adverse Event|0|||
105969484|NCT00712725|365547776|FG005|Overall Study|Adverse Event|0|||
105969485|NCT00712725|365547777|FG006|Overall Study|Adverse Event|0|||
105969486|NCT00712725|365547778|FG007|Overall Study|Adverse Event|0|||
105969487|NCT00712725|365547771|FG000|Overall Study|Lost to Follow-up|3|||
105969488|NCT00712725|365547772|FG001|Overall Study|Lost to Follow-up|2|||
105969489|NCT00712725|365547773|FG002|Overall Study|Lost to Follow-up|1|||
105969490|NCT00712725|365547774|FG003|Overall Study|Lost to Follow-up|1|||
105969491|NCT00712725|365547775|FG004|Overall Study|Lost to Follow-up|2|||
105969492|NCT00712725|365547776|FG005|Overall Study|Lost to Follow-up|2|||
105969493|NCT00712725|365547777|FG006|Overall Study|Lost to Follow-up|3|||
105969494|NCT00712725|365547778|FG007|Overall Study|Lost to Follow-up|1|||
105969495|NCT00712725|365547771|FG000|Overall Study|Physician Decision|2|||
105969496|NCT00712725|365547772|FG001|Overall Study|Physician Decision|0|||
105969497|NCT00712725|365547773|FG002|Overall Study|Physician Decision|0|||
105969498|NCT00712725|365547774|FG003|Overall Study|Physician Decision|0|||
105969499|NCT00712725|365547775|FG004|Overall Study|Physician Decision|1|||
105969500|NCT00712725|365547776|FG005|Overall Study|Physician Decision|0|||
105969501|NCT00712725|365547777|FG006|Overall Study|Physician Decision|2|||
105969502|NCT00712725|365547778|FG007|Overall Study|Physician Decision|0|||
105969503|NCT00712725|365547771|FG000|Overall Study|Pregnancy|0|||
105969504|NCT00712725|365547772|FG001|Overall Study|Pregnancy|1|||
105969505|NCT00712725|365547773|FG002|Overall Study|Pregnancy|0|||
105969506|NCT00712725|365547774|FG003|Overall Study|Pregnancy|0|||
105969507|NCT00712725|365547775|FG004|Overall Study|Pregnancy|1|||
105969508|NCT00712725|365547776|FG005|Overall Study|Pregnancy|0|||
105969509|NCT00712725|365547777|FG006|Overall Study|Pregnancy|2|||
105969510|NCT00712725|365547778|FG007|Overall Study|Pregnancy|0|||
105969511|NCT00712725|365547771|FG000|Overall Study|Protocol Violation|2|||
105969512|NCT00712725|365547772|FG001|Overall Study|Protocol Violation|0|||
105969513|NCT00712725|365547773|FG002|Overall Study|Protocol Violation|1|||
105969514|NCT00712725|365547774|FG003|Overall Study|Protocol Violation|3|||
105969515|NCT00712725|365547775|FG004|Overall Study|Protocol Violation|2|||
105969516|NCT00712725|365547776|FG005|Overall Study|Protocol Violation|0|||
105969517|NCT00712725|365547777|FG006|Overall Study|Protocol Violation|1|||
105969518|NCT00712725|365547778|FG007|Overall Study|Protocol Violation|1|||
105969519|NCT00712725|365547771|FG000|Overall Study|Withdrawal by Subject|2|||
105969520|NCT00712725|365547772|FG001|Overall Study|Withdrawal by Subject|1|||
105969521|NCT00712725|365547773|FG002|Overall Study|Withdrawal by Subject|1|||
105969522|NCT00712725|365547774|FG003|Overall Study|Withdrawal by Subject|2|||
105969523|NCT00712725|365547775|FG004|Overall Study|Withdrawal by Subject|1|||
105969524|NCT00712725|365547776|FG005|Overall Study|Withdrawal by Subject|1|||
105969525|NCT00712725|365547777|FG006|Overall Study|Withdrawal by Subject|1|||
105969526|NCT00712725|365547778|FG007|Overall Study|Withdrawal by Subject|2|||
105969527|NCT00712725|365547771|FG000|Overall Study|Lack of Qualifying Event|16|||
105842880|NCT04146363|365082441|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
105842881|NCT04146363|365082442|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842882|NCT04146363|365082443|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105969528|NCT00712725|365547772|FG001|Overall Study|Lack of Qualifying Event|2|||
105969529|NCT00712725|365547773|FG002|Overall Study|Lack of Qualifying Event|6|||
105969530|NCT00712725|365547774|FG003|Overall Study|Lack of Qualifying Event|8|||
105969531|NCT00712725|365547775|FG004|Overall Study|Lack of Qualifying Event|11|||
105969532|NCT00712725|365547776|FG005|Overall Study|Lack of Qualifying Event|13|||
105969533|NCT00712725|365547777|FG006|Overall Study|Lack of Qualifying Event|11|||
105969534|NCT00712725|365547778|FG007|Overall Study|Lack of Qualifying Event|6|||
105969535|NCT00712725|365547771|FG000|Overall Study|Protocol Specified Criteria|3|||
105969536|NCT00712725|365547772|FG001|Overall Study|Protocol Specified Criteria|0|||
105969537|NCT00712725|365547773|FG002|Overall Study|Protocol Specified Criteria|1|||
105969538|NCT00712725|365547774|FG003|Overall Study|Protocol Specified Criteria|2|||
105969539|NCT00712725|365547775|FG004|Overall Study|Protocol Specified Criteria|1|||
105969540|NCT00712725|365547776|FG005|Overall Study|Protocol Specified Criteria|0|||
105969541|NCT00712725|365547777|FG006|Overall Study|Protocol Specified Criteria|2|||
105969542|NCT00712725|365547778|FG007|Overall Study|Protocol Specified Criteria|1|||
105969543|NCT02680041|365547779|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
105969544|NCT02680041|365547779|FG000|Overall Study|Lost to Follow-up|2|||
105969545|NCT00521599|365547780|FG000|Overall Study|Adverse Event|5|||
105969546|NCT00521599|365547781|FG001|Overall Study|Adverse Event|7|||
105969547|NCT00521599|365547782|FG002|Overall Study|Adverse Event|6|||
105969548|NCT00521599|365547780|FG000|Overall Study|Treatment Failure|8|||
105969549|NCT00521599|365547781|FG001|Overall Study|Treatment Failure|9|||
105969550|NCT00521599|365547782|FG002|Overall Study|Treatment Failure|22|||
105969551|NCT00521599|365547780|FG000|Overall Study|Lost to Follow-up|2|||
105969552|NCT00521599|365547781|FG001|Overall Study|Lost to Follow-up|1|||
105969553|NCT00521599|365547782|FG002|Overall Study|Lost to Follow-up|2|||
105969554|NCT00521599|365547780|FG000|Overall Study|Withdrawal by Subject|3|||
105969555|NCT00521599|365547781|FG001|Overall Study|Withdrawal by Subject|5|||
105842883|NCT04146363|365082444|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
105842884|NCT04146363|365082445|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
105842885|NCT04146363|365082446|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
105842886|NCT04146363|365082447|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842887|NCT04146363|365082448|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842888|NCT04146363|365082449|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
105842889|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842890|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842891|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842892|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842893|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842894|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842895|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842896|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842897|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
105842898|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
105842899|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
105842900|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842901|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842902|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842903|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842904|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842905|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842906|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842907|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
105842908|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
105842909|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
105842910|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
105842911|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842912|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842913|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842914|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842915|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842916|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842917|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842918|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842919|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
105842920|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
105842921|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
105842922|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842923|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842924|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842925|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842926|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842927|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
105969556|NCT00521599|365547782|FG002|Overall Study|Withdrawal by Subject|1|||
105969557|NCT00521599|365547780|FG000|Overall Study|Withdrawal by subject treatment related|3|||
105969558|NCT00521599|365547781|FG001|Overall Study|Withdrawal by subject treatment related|1|||
105969559|NCT00521599|365547782|FG002|Overall Study|Withdrawal by subject treatment related|2|||
105969560|NCT00521599|365547780|FG000|Overall Study|Protocol Violation|2|||
105969561|NCT00521599|365547781|FG001|Overall Study|Protocol Violation|4|||
105969562|NCT00521599|365547782|FG002|Overall Study|Protocol Violation|2|||
105969563|NCT00521599|365547780|FG000|Overall Study|Did not meet protocol eligibility|2|||
105969564|NCT00521599|365547781|FG001|Overall Study|Did not meet protocol eligibility|2|||
105969565|NCT00521599|365547782|FG002|Overall Study|Did not meet protocol eligibility|1|||
105969566|NCT00290771|365547786|FG000|Overall Study|Disease progression|95|||
105969567|NCT00290771|365547787|FG001|Overall Study|Disease progression|73|||
105969568|NCT00290771|365547786|FG000|Overall Study|Death|11|||
105969569|NCT00290771|365547787|FG001|Overall Study|Death|10|||
106024415|NCT01994889|365754606|FG001|Overall Study|Adverse Event|12|||
106024416|NCT01994889|365754607|FG002|Overall Study|Adverse Event|11|||
106024417|NCT01994889|365754605|FG000|Overall Study|Cardiac Device Implantation|0|||
106024418|NCT01994889|365754606|FG001|Overall Study|Cardiac Device Implantation|2|||
106024419|NCT01994889|365754607|FG002|Overall Study|Cardiac Device Implantation|0|||
106024420|NCT01994889|365754605|FG000|Overall Study|Organ Transplantation|1|||
106024421|NCT01994889|365754606|FG001|Overall Study|Organ Transplantation|5|||
106024422|NCT01994889|365754607|FG002|Overall Study|Organ Transplantation|5|||
106024423|NCT01994889|365754605|FG000|Overall Study|No longer willing to participate|8|||
106024424|NCT01994889|365754606|FG001|Overall Study|No longer willing to participate|17|||
105969570|NCT00290771|365547786|FG000|Overall Study|Adverse Event|12|||
105969571|NCT00290771|365547787|FG001|Overall Study|Adverse Event|6|||
105969572|NCT00290771|365547786|FG000|Overall Study|Withdrawal by Subject|5|||
105969573|NCT00290771|365547787|FG001|Overall Study|Withdrawal by Subject|6|||
105969574|NCT00290771|365547786|FG000|Overall Study|Administrative problems|2|||
105969575|NCT00290771|365547787|FG001|Overall Study|Administrative problems|1|||
105969576|NCT00290771|365547786|FG000|Overall Study|Protocol Violation|2|||
105969577|NCT00290771|365547787|FG001|Overall Study|Protocol Violation|0|||
105969578|NCT00290771|365547786|FG000|Overall Study|Lost to Follow-up|0|||
105969579|NCT00290771|365547787|FG001|Overall Study|Lost to Follow-up|1|||
105969580|NCT00515294|365547791|FG000|Overall Study|Lost to Follow-up|3|||
105969581|NCT00515294|365547792|FG001|Overall Study|Lost to Follow-up|2|||
105969582|NCT00515294|365547793|FG002|Overall Study|Lost to Follow-up|3|||
105969583|NCT00515294|365547794|FG003|Overall Study|Lost to Follow-up|1|||
105969584|NCT00515294|365547791|FG000|Overall Study|Driver simulator problems|1|||
105969585|NCT00515294|365547792|FG001|Overall Study|Driver simulator problems|1|||
105969586|NCT00515294|365547793|FG002|Overall Study|Driver simulator problems|1|||
105969587|NCT00515294|365547794|FG003|Overall Study|Driver simulator problems|3|||
105969588|NCT00515294|365547791|FG000|Overall Study|Caffeine amount inaccurate|5|||
105969589|NCT00515294|365547792|FG001|Overall Study|Caffeine amount inaccurate|0|||
105969590|NCT00515294|365547793|FG002|Overall Study|Caffeine amount inaccurate|7|||
105969591|NCT00515294|365547794|FG003|Overall Study|Caffeine amount inaccurate|0|||
105969592|NCT00503776|365547798|FG000|Overall Study|Withdrawal by Subject|1|||
105969593|NCT00503776|365547799|FG001|Overall Study|Withdrawal by Subject|0|||
105969594|NCT00503776|365547800|FG002|Overall Study|Withdrawal by Subject|1|||
105969595|NCT00503776|365547801|FG003|Overall Study|Withdrawal by Subject|1|||
105969596|NCT00503776|365547798|FG000|Overall Study|Physician Decision|0|||
105969597|NCT00503776|365547799|FG001|Overall Study|Physician Decision|0|||
105969598|NCT00503776|365547800|FG002|Overall Study|Physician Decision|1|||
105969599|NCT00503776|365547801|FG003|Overall Study|Physician Decision|1|||
105969600|NCT02379988|365547802|FG000|Overall Study|Not eligible|1|||
105969601|NCT00107315|365547803|FG000|Overall Study|Disease Progression|9|||
105969602|NCT00107315|365547803|FG000|Overall Study|Adverse Event|4|||
105969603|NCT00107315|365547803|FG000|Overall Study|Withdrawal by Subject|2|||
105969604|NCT03650803|365547814|FG000|Overall Study|Lost to Follow-up|6|||
105969605|NCT02308163|365547815|FG000|Overall Study|Not fulfill eligible criteria|1|||
105969606|NCT02308163|365547816|FG001|Overall Study|Not fulfill eligible criteria|2|||
105969607|NCT02308163|365547817|FG002|Overall Study|Not fulfill eligible criteria|0|||
105969608|NCT02308163|365547818|FG003|Overall Study|Not fulfill eligible criteria|1|||
106024425|NCT01994889|365754607|FG002|Overall Study|No longer willing to participate|37|||
106149464|NCT03785782|366209116|FG000|Overall Study|Withdrawal by Subject|1|||
106149465|NCT03785782|366209117|FG001|Overall Study|Withdrawal by Subject|1|||
106149466|NCT03785782|366209116|FG000|Overall Study|insufficient image quality.|3|||
106149467|NCT03785782|366209117|FG001|Overall Study|insufficient image quality.|0|||
106149468|NCT05568615|366209118|FG000|Overall Study|Death|1|||
105969609|NCT02308163|365547819|FG004|Overall Study|Not fulfill eligible criteria|1|||
105969610|NCT02308163|365547815|FG000|Overall Study|Adverse Event|9|||
105969611|NCT02308163|365547816|FG001|Overall Study|Adverse Event|5|||
105969612|NCT02308163|365547817|FG002|Overall Study|Adverse Event|2|||
105969613|NCT02308163|365547818|FG003|Overall Study|Adverse Event|2|||
105969614|NCT02308163|365547819|FG004|Overall Study|Adverse Event|11|||
105969615|NCT02308163|365547815|FG000|Overall Study|Lack of Efficacy|11|||
105969616|NCT02308163|365547816|FG001|Overall Study|Lack of Efficacy|3|||
105969617|NCT02308163|365547817|FG002|Overall Study|Lack of Efficacy|8|||
106024426|NCT01994889|365754605|FG000|Overall Study|Lost to Follow-up|0|||
106024427|NCT01994889|365754606|FG001|Overall Study|Lost to Follow-up|1|||
106024428|NCT01994889|365754607|FG002|Overall Study|Lost to Follow-up|0|||
106024429|NCT01994889|365754605|FG000|Overall Study|Protocol Violation|0|||
106149469|NCT05568615|366209118|FG000|Overall Study|Physician Decision|1|||
106149470|NCT03779048|366209119|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
105969618|NCT02308163|365547818|FG003|Overall Study|Lack of Efficacy|4|||
105969619|NCT02308163|365547819|FG004|Overall Study|Lack of Efficacy|6|||
105969620|NCT02308163|365547815|FG000|Overall Study|Withdrawal of consent|2|||
105969621|NCT02308163|365547816|FG001|Overall Study|Withdrawal of consent|3|||
105969622|NCT02308163|365547817|FG002|Overall Study|Withdrawal of consent|0|||
105969623|NCT02308163|365547818|FG003|Overall Study|Withdrawal of consent|2|||
105969624|NCT02308163|365547819|FG004|Overall Study|Withdrawal of consent|6|||
105969625|NCT02308163|365547815|FG000|Overall Study|Protocol Violation|3|||
105969626|NCT02308163|365547816|FG001|Overall Study|Protocol Violation|3|||
105969627|NCT02308163|365547817|FG002|Overall Study|Protocol Violation|3|||
105969628|NCT02308163|365547818|FG003|Overall Study|Protocol Violation|2|||
105969629|NCT02308163|365547819|FG004|Overall Study|Protocol Violation|5|||
105969630|NCT02308163|365547815|FG000|Overall Study|Lab data met discontinuation criteria|3|||
105969631|NCT02308163|365547816|FG001|Overall Study|Lab data met discontinuation criteria|0|||
105969632|NCT02308163|365547817|FG002|Overall Study|Lab data met discontinuation criteria|0|||
105969633|NCT02308163|365547818|FG003|Overall Study|Lab data met discontinuation criteria|2|||
105969634|NCT02308163|365547819|FG004|Overall Study|Lab data met discontinuation criteria|0|||
105969635|NCT02308163|365547815|FG000|Overall Study|Miscellaneous|2|||
105969636|NCT02308163|365547816|FG001|Overall Study|Miscellaneous|2|||
105969637|NCT02308163|365547817|FG002|Overall Study|Miscellaneous|1|||
105969638|NCT02308163|365547818|FG003|Overall Study|Miscellaneous|0|||
105969639|NCT02308163|365547819|FG004|Overall Study|Miscellaneous|5|||
105969640|NCT01357161|365547830|FG000|Part 1 (Open Label Run-in)|Death|5|||
105969641|NCT01357161|365547831|FG001|Part 1 (Open Label Run-in)|Death|0|||
105969642|NCT01357161|365547832|FG002|Part 1 (Open Label Run-in)|Death|0|||
105969643|NCT01357161|365547830|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
105969644|NCT01357161|365547831|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
105969645|NCT01357161|365547832|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
105969646|NCT01357161|365547830|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
105969647|NCT01357161|365547831|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
105969648|NCT01357161|365547832|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
105969649|NCT01357161|365547830|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
105969650|NCT01357161|365547831|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
105969651|NCT01357161|365547832|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
105969652|NCT01357161|365547830|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
105969653|NCT01357161|365547831|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
105969654|NCT01357161|365547832|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
105969655|NCT01357161|365547830|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
105969656|NCT01357161|365547831|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
105969657|NCT01357161|365547832|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
105969658|NCT01357161|365547830|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
105969659|NCT01357161|365547831|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
105969660|NCT01357161|365547832|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
105969661|NCT01357161|365547830|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
105969662|NCT01357161|365547831|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
105969663|NCT01357161|365547832|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
105969664|NCT01357161|365547830|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
105969665|NCT01357161|365547831|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
105969666|NCT01357161|365547832|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
105969667|NCT01357161|365547830|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
105969668|NCT01357161|365547831|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
105969669|NCT01357161|365547832|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
105969670|NCT01357161|365547830|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
105969671|NCT01357161|365547831|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
106024430|NCT01994889|365754606|FG001|Overall Study|Protocol Violation|1|||
106024431|NCT01994889|365754607|FG002|Overall Study|Protocol Violation|1|||
106024432|NCT01994889|365754605|FG000|Overall Study|Death|14|||
106024433|NCT01994889|365754606|FG001|Overall Study|Death|25|||
106024434|NCT01994889|365754607|FG002|Overall Study|Death|38|||
106024435|NCT02152956|365754609|FG000|Overall Study|Adverse Event|0|||
106024436|NCT02152956|365754610|FG001|Overall Study|Adverse Event|0|||
106024437|NCT02152956|365754611|FG002|Overall Study|Adverse Event|0|||
106024438|NCT02152956|365754612|FG003|Overall Study|Adverse Event|0|||
105969672|NCT01357161|365547832|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
105969673|NCT02910401|365547833|FG000|Overall Study|Study closure Study closure|0|||
105969674|NCT02910401|365547834|FG001|Overall Study|Study closure Study closure|0|||
105969675|NCT02910401|365547835|FG002|Overall Study|Study closure Study closure|2|||
105969676|NCT02910401|365547833|FG000|Overall Study|Physician Decision|1|||
105969677|NCT02910401|365547834|FG001|Overall Study|Physician Decision|0|||
105969678|NCT02910401|365547835|FG002|Overall Study|Physician Decision|0|||
105969679|NCT03300024|365547837|FG000|Overall Study|Physician Decision|4|||
105969680|NCT03300024|365547838|FG001|Overall Study|Physician Decision|6|||
105969681|NCT00098748|365547839|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
105969682|NCT00098748|365547840|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
105969683|NCT00098748|365547841|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
105969684|NCT00098748|365547839|FG000|Received Study Treatment|Death|2|||
105969685|NCT00098748|365547840|FG001|Received Study Treatment|Death|1|||
106024439|NCT02152956|365754613|FG004|Overall Study|Adverse Event|0|||
106024440|NCT02152956|365754614|FG005|Overall Study|Adverse Event|0|||
106024441|NCT02152956|365754615|FG006|Overall Study|Adverse Event|0|||
105969686|NCT00098748|365547841|FG002|Received Study Treatment|Death|2|||
105969687|NCT00098748|365547839|FG000|Received Study Treatment|Adverse Event|1|||
105969688|NCT00098748|365547840|FG001|Received Study Treatment|Adverse Event|2|||
106024442|NCT02152956|365754616|FG007|Overall Study|Adverse Event|0|||
105969689|NCT00098748|365547841|FG002|Received Study Treatment|Adverse Event|5|||
105969690|NCT00098748|365547839|FG000|Received Study Treatment|Lack of Efficacy|40|||
105969691|NCT00098748|365547840|FG001|Received Study Treatment|Lack of Efficacy|27|||
105969692|NCT00098748|365547841|FG002|Received Study Treatment|Lack of Efficacy|27|||
105969693|NCT00098748|365547839|FG000|Received Study Treatment|Other|2|||
105969694|NCT00098748|365547840|FG001|Received Study Treatment|Other|2|||
105969695|NCT00098748|365547841|FG002|Received Study Treatment|Other|6|||
105969696|NCT00098748|365547839|FG000|Received Study Treatment|Subject defaulted|3|||
105969697|NCT00098748|365547840|FG001|Received Study Treatment|Subject defaulted|4|||
105969698|NCT00098748|365547841|FG002|Received Study Treatment|Subject defaulted|4|||
105969699|NCT00098748|365547839|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
106024443|NCT02152956|365754617|FG008|Overall Study|Adverse Event|0|||
106024444|NCT02152956|365754618|FG009|Overall Study|Adverse Event|0|||
106024445|NCT02152956|365754619|FG010|Overall Study|Adverse Event|0|||
106024446|NCT02152956|365754620|FG011|Overall Study|Adverse Event|4|||
106024447|NCT02152956|365754621|FG012|Overall Study|Adverse Event|0|||
106024448|NCT02152956|365754609|FG000|Overall Study|Death|0|||
105969700|NCT00098748|365547840|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
105969701|NCT00098748|365547841|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
105969702|NCT00098748|365547839|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
105969703|NCT00098748|365547840|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
105969704|NCT00098748|365547841|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
105969705|NCT00098748|365547839|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
105969706|NCT00098748|365547840|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
105969707|NCT00098748|365547841|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
106024449|NCT02152956|365754610|FG001|Overall Study|Death|3|||
106024450|NCT02152956|365754611|FG002|Overall Study|Death|3|||
106024451|NCT02152956|365754612|FG003|Overall Study|Death|4|||
105842928|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842929|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842930|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
105842931|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
105842932|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
105842933|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842934|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842935|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842936|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842937|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842938|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842939|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842940|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
105842941|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
105842942|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
105842943|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
105842944|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842945|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842946|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842947|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842948|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842949|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842950|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842951|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842952|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842953|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
105842954|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
105842955|NCT04146363|365082439|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842956|NCT04146363|365082440|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842957|NCT04146363|365082441|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842958|NCT04146363|365082442|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842959|NCT04146363|365082443|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105969708|NCT00098748|365547839|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
105969709|NCT00098748|365547840|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
105969710|NCT00098748|365547841|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
106024452|NCT02152956|365754613|FG004|Overall Study|Death|1|||
106024453|NCT02152956|365754614|FG005|Overall Study|Death|2|||
106024454|NCT02152956|365754615|FG006|Overall Study|Death|6|||
106024455|NCT02152956|365754616|FG007|Overall Study|Death|6|||
105969711|NCT00098748|365547839|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
105969712|NCT00098748|365547840|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
105969713|NCT00098748|365547841|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
105969714|NCT01560637|365547842|FG000|Overall Study|Adverse Event|63|||
105969715|NCT01560637|365547842|FG000|Overall Study|Death|69|||
105969716|NCT01560637|365547842|FG000|Overall Study|Lost to Follow-up|8|||
105969717|NCT01560637|365547842|FG000|Overall Study|Protocol Violation|8|||
105969718|NCT01560637|365547842|FG000|Overall Study|Withdrawal by Subject|24|||
105969719|NCT01560637|365547842|FG000|Overall Study|Progressive Disease|20|||
105969720|NCT01560637|365547842|FG000|Overall Study|Other Reason Not Specified|6|||
105969721|NCT01170065|365547843|FG000|Overall Study|Adverse Event|17|||
105969722|NCT01170065|365547844|FG001|Overall Study|Adverse Event|50|||
105969723|NCT01170065|365547845|FG002|Overall Study|Adverse Event|10|||
105969724|NCT01170065|365547843|FG000|Overall Study|Lost to Follow-up|1|||
105969725|NCT01170065|365547844|FG001|Overall Study|Lost to Follow-up|4|||
105969726|NCT01170065|365547845|FG002|Overall Study|Lost to Follow-up|1|||
105969727|NCT01170065|365547843|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
105969728|NCT01170065|365547844|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
105969729|NCT01170065|365547845|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
105969730|NCT01170065|365547843|FG000|Overall Study|Reason other than specified|3|||
105969731|NCT01170065|365547844|FG001|Overall Study|Reason other than specified|8|||
105969732|NCT01170065|365547845|FG002|Overall Study|Reason other than specified|3|||
105969733|NCT01170065|365547843|FG000|Overall Study|Ongoing after planned observation time|5|||
105969734|NCT01170065|365547844|FG001|Overall Study|Ongoing after planned observation time|26|||
105969735|NCT01170065|365547845|FG002|Overall Study|Ongoing after planned observation time|10|||
105969736|NCT02226198|365549714|FG000|Lead-in Phase|Protocol Violation|1|||
105969737|NCT02226198|365549715|FG001|Lead-in Phase|Protocol Violation|0|||
105969738|NCT02226198|365549716|FG002|Lead-in Phase|Protocol Violation|0|||
105969739|NCT02226198|365549714|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
105969740|NCT02226198|365549715|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
105969741|NCT02226198|365549716|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
105969742|NCT00496483|365549717|FG000|Overall Study|Not dosed|9|||
105969743|NCT00496483|365549717|FG000|Overall Study|Adverse Event|2|||
105969744|NCT00496483|365549717|FG000|Overall Study|Lack of Efficacy|1|||
105969745|NCT01145352|365549718|FG000|Overall Study|Found to have been registered twice|6|||
105969746|NCT01145352|365549718|FG000|Overall Study|Treated before marketing approval|4|||
105969747|NCT01145352|365549718|FG000|Overall Study|Syringe formulation was used|1|||
105969748|NCT02526524|365549721|FG000|Overall Study|Withdrawal by Subject|3|||
105969749|NCT02526524|365549722|FG001|Overall Study|Withdrawal by Subject|3|||
105969750|NCT02526524|365549723|FG002|Overall Study|Withdrawal by Subject|6|||
105969751|NCT02526524|365549724|FG003|Overall Study|Withdrawal by Subject|1|||
105969752|NCT02526524|365549725|FG004|Overall Study|Withdrawal by Subject|9|||
105969753|NCT02526524|365549726|FG005|Overall Study|Withdrawal by Subject|5|||
105969754|NCT02526524|365549721|FG000|Overall Study|Adverse Event|3|||
105969755|NCT02526524|365549722|FG001|Overall Study|Adverse Event|2|||
105969756|NCT02526524|365549723|FG002|Overall Study|Adverse Event|4|||
105969757|NCT02526524|365549724|FG003|Overall Study|Adverse Event|2|||
105969758|NCT02526524|365549725|FG004|Overall Study|Adverse Event|6|||
105969759|NCT02526524|365549726|FG005|Overall Study|Adverse Event|8|||
105969760|NCT02526524|365549721|FG000|Overall Study|Lost to Follow-up|2|||
105969761|NCT02526524|365549722|FG001|Overall Study|Lost to Follow-up|3|||
105969762|NCT02526524|365549723|FG002|Overall Study|Lost to Follow-up|8|||
105969763|NCT02526524|365549724|FG003|Overall Study|Lost to Follow-up|1|||
105969764|NCT02526524|365549725|FG004|Overall Study|Lost to Follow-up|2|||
105969765|NCT02526524|365549726|FG005|Overall Study|Lost to Follow-up|5|||
105969766|NCT02526524|365549721|FG000|Overall Study|Protocol Violation|3|||
105969767|NCT02526524|365549722|FG001|Overall Study|Protocol Violation|1|||
105969768|NCT02526524|365549723|FG002|Overall Study|Protocol Violation|5|||
105969769|NCT02526524|365549724|FG003|Overall Study|Protocol Violation|3|||
105969770|NCT02526524|365549725|FG004|Overall Study|Protocol Violation|4|||
105969771|NCT02526524|365549726|FG005|Overall Study|Protocol Violation|3|||
105969772|NCT02526524|365549721|FG000|Overall Study|Loss of Glucose Control|0|||
105969773|NCT02526524|365549722|FG001|Overall Study|Loss of Glucose Control|0|||
105969774|NCT02526524|365549723|FG002|Overall Study|Loss of Glucose Control|3|||
105969775|NCT02526524|365549724|FG003|Overall Study|Loss of Glucose Control|0|||
105969776|NCT02526524|365549725|FG004|Overall Study|Loss of Glucose Control|2|||
105969777|NCT02526524|365549726|FG005|Overall Study|Loss of Glucose Control|0|||
105969778|NCT02526524|365549721|FG000|Overall Study|Physician Decision|0|||
105969779|NCT02526524|365549722|FG001|Overall Study|Physician Decision|0|||
105969780|NCT02526524|365549723|FG002|Overall Study|Physician Decision|0|||
105969781|NCT02526524|365549724|FG003|Overall Study|Physician Decision|0|||
105969782|NCT02526524|365549725|FG004|Overall Study|Physician Decision|1|||
105969783|NCT02526524|365549726|FG005|Overall Study|Physician Decision|0|||
105969784|NCT02526524|365549721|FG000|Overall Study|Sponsor Decision|1|||
105969785|NCT02526524|365549722|FG001|Overall Study|Sponsor Decision|0|||
105969786|NCT02526524|365549723|FG002|Overall Study|Sponsor Decision|0|||
105969787|NCT02526524|365549724|FG003|Overall Study|Sponsor Decision|0|||
105969788|NCT02526524|365549725|FG004|Overall Study|Sponsor Decision|0|||
105969789|NCT02526524|365549726|FG005|Overall Study|Sponsor Decision|0|||
105969790|NCT03389555|365549727|FG000|Overall Study|Protocol Violation|1|||
105969791|NCT03389555|365549728|FG001|Overall Study|Protocol Violation|3|||
105969792|NCT03389555|365549727|FG000|Overall Study|Death|1|||
105969793|NCT03389555|365549728|FG001|Overall Study|Death|0|||
105969794|NCT03327220|365549731|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
105969795|NCT03327220|365549732|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
105969796|NCT03327220|365549731|FG000|Overall Study|Investigator Decision|2|||
105969797|NCT03327220|365549732|FG001|Overall Study|Investigator Decision|0|||
105969798|NCT03327220|365549731|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
105969799|NCT03327220|365549732|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
105969800|NCT03327220|365549731|FG000|Overall Study|Fungal infection|1|||
105969801|NCT03327220|365549732|FG001|Overall Study|Fungal infection|0|||
105969802|NCT03327220|365549731|FG000|Overall Study|Discharged to Rehabilitation|0|||
105969803|NCT03327220|365549732|FG001|Overall Study|Discharged to Rehabilitation|1|||
105969804|NCT03327220|365549731|FG000|Overall Study|Missing|1|||
105969805|NCT03327220|365549732|FG001|Overall Study|Missing|0|||
105969806|NCT00523705|365549733|FG000|Overall Study|No time for study.|0|||
105969807|NCT00523705|365549734|FG001|Overall Study|No time for study.|1|||
105969808|NCT00368836|365549735|FG000|Phase II|Screen Failure|1|||
105969809|NCT00368836|365549735|FG000|Phase II|Withdrawal by Subject|1|||
105969810|NCT00368836|365549735|FG000|Phase II|unable to collect blood and/or breath|17|||
105969811|NCT00368836|365549735|FG000|Phase II|Protocol Violation|2|||
105969812|NCT01239381|365549736|FG000|Overall Study|Protocol Violation|1|||
105969813|NCT01239381|365549736|FG000|Overall Study|Withdrawal by Subject|1|||
105969814|NCT01345591|365549744|FG000|Overall Study|Lost to Follow-up|1|||
105969815|NCT00847665|365549745|FG000|Overall Study|Withdrawal by Subject|1|||
105969816|NCT00847665|365549746|FG001|Overall Study|Withdrawal by Subject|0|||
105969817|NCT00585546|365549753|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
105969818|NCT00585546|365549753|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
105969819|NCT02323126|365549760|FG000|Overall Study|Patient / guardian decision|0|||
105969820|NCT02323126|365549761|FG001|Overall Study|Patient / guardian decision|1|||
105969821|NCT02323126|365549762|FG002|Overall Study|Patient / guardian decision|2|||
105969822|NCT02323126|365549760|FG000|Overall Study|Progressive disease|14|||
105969823|NCT02323126|365549761|FG001|Overall Study|Progressive disease|8|||
105969824|NCT02323126|365549762|FG002|Overall Study|Progressive disease|14|||
105969825|NCT02323126|365549760|FG000|Overall Study|Physician Decision|0|||
105969826|NCT02323126|365549761|FG001|Overall Study|Physician Decision|1|||
105969827|NCT02323126|365549762|FG002|Overall Study|Physician Decision|3|||
105969828|NCT02323126|365549760|FG000|Overall Study|Death|1|||
105969829|NCT02323126|365549761|FG001|Overall Study|Death|1|||
105969830|NCT02323126|365549762|FG002|Overall Study|Death|4|||
105969831|NCT02323126|365549760|FG000|Overall Study|Adverse Event|3|||
105969832|NCT02323126|365549761|FG001|Overall Study|Adverse Event|5|||
105969833|NCT02323126|365549762|FG002|Overall Study|Adverse Event|7|||
105969834|NCT03333252|365549765|FG000|Overall Study|Adverse Event|10|||
105969835|NCT03333252|365549766|FG001|Overall Study|Adverse Event|6|||
105969836|NCT03333252|365549767|FG002|Overall Study|Adverse Event|5|||
105969837|NCT03333252|365549768|FG003|Overall Study|Adverse Event|2|||
105969838|NCT03333252|365549765|FG000|Overall Study|Death|1|||
105969839|NCT03333252|365549766|FG001|Overall Study|Death|3|||
105969840|NCT03333252|365549767|FG002|Overall Study|Death|0|||
105969841|NCT03333252|365549768|FG003|Overall Study|Death|0|||
105969842|NCT03333252|365549765|FG000|Overall Study|Lack of Efficacy|8|||
105969843|NCT03333252|365549766|FG001|Overall Study|Lack of Efficacy|4|||
105969844|NCT03333252|365549767|FG002|Overall Study|Lack of Efficacy|0|||
105969845|NCT03333252|365549768|FG003|Overall Study|Lack of Efficacy|7|||
105969846|NCT03333252|365549765|FG000|Overall Study|Lost to Follow-up|0|||
106024456|NCT02152956|365754617|FG008|Overall Study|Death|4|||
105969847|NCT03333252|365549766|FG001|Overall Study|Lost to Follow-up|5|||
105969848|NCT03333252|365549767|FG002|Overall Study|Lost to Follow-up|9|||
105969849|NCT03333252|365549768|FG003|Overall Study|Lost to Follow-up|3|||
105969850|NCT03333252|365549765|FG000|Overall Study|Withdrawal by Subject|14|||
105969851|NCT03333252|365549766|FG001|Overall Study|Withdrawal by Subject|24|||
105969852|NCT03333252|365549767|FG002|Overall Study|Withdrawal by Subject|11|||
105969853|NCT03333252|365549768|FG003|Overall Study|Withdrawal by Subject|17|||
105969854|NCT01685801|365549772|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
105969855|NCT01685801|365549773|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
105969856|NCT01685801|365549774|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
105969857|NCT01685801|365549775|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
105969858|NCT01685801|365549772|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
105969859|NCT01685801|365549773|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
105969860|NCT01685801|365549774|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
105969861|NCT01685801|365549775|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
105969862|NCT00113399|365549776|FG000|Overall Study|Death|1|||
105969863|NCT00113399|365549777|FG001|Overall Study|Death|1|||
105842960|NCT04146363|365082444|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842961|NCT04146363|365082445|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842962|NCT04146363|365082446|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842963|NCT04146363|365082447|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842964|NCT04146363|365082448|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
105842965|NCT04146363|365082449|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
105842966|NCT02914236|365082456|FG000|Overall Study|Lost to Follow-up|1|||
105842967|NCT02676284|365082463|FG000|Overall Study|Withdrawal by Subject|1|||
105842968|NCT01221090|365082464|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
105842969|NCT01221090|365082465|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
105842970|NCT01221090|365082466|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
105842971|NCT01221090|365082467|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
105842972|NCT01221090|365082464|FG000|Overall Study|Withdrawal by Subject|0|||
105842973|NCT01221090|365082465|FG001|Overall Study|Withdrawal by Subject|22|||
105842974|NCT01221090|365082466|FG002|Overall Study|Withdrawal by Subject|27|||
105842975|NCT01221090|365082467|FG003|Overall Study|Withdrawal by Subject|2|||
105842976|NCT00708708|365082468|FG000|Overall Study|Another therapy instead of Enbrel|141|||
105842977|NCT00708708|365082468|FG000|Overall Study|Lost to Follow-up|52|||
105842978|NCT00708708|365082468|FG000|Overall Study|Withdrawal by Subject|51|||
105842979|NCT00708708|365082468|FG000|Overall Study|Intolerance|42|||
105842980|NCT00708708|365082468|FG000|Overall Study|Another therapy along with Enbrel|15|||
105842981|NCT00708708|365082468|FG000|Overall Study|Other unspecified|11|||
105842982|NCT00708708|365082468|FG000|Overall Study|Good effectiveness|9|||
105842983|NCT00708708|365082468|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
105842984|NCT00708708|365082468|FG000|Overall Study|Administrative reasons|7|||
105842985|NCT00708708|365082468|FG000|Overall Study|Lack of effectiveness|4|||
105842986|NCT00708708|365082468|FG000|Overall Study|Lack of compliance|3|||
105842987|NCT00708708|365082468|FG000|Overall Study|Pregnancy|3|||
105842988|NCT00708708|365082468|FG000|Overall Study|Adverse Event|3|||
105842989|NCT00708708|365082468|FG000|Overall Study|Missing values|392|||
105842990|NCT00440466|365082472|FG000|Overall Study|Death|3|||
105842991|NCT00440466|365082473|FG001|Overall Study|Death|2|||
105842992|NCT00440466|365082474|FG002|Overall Study|Death|9|||
105842993|NCT00440466|365082472|FG000|Overall Study|Adverse Event|3|||
105842994|NCT00440466|365082473|FG001|Overall Study|Adverse Event|4|||
105842995|NCT00440466|365082474|FG002|Overall Study|Adverse Event|11|||
105842996|NCT00440466|365082472|FG000|Overall Study|Lost to Follow-up|1|||
105842997|NCT00440466|365082473|FG001|Overall Study|Lost to Follow-up|0|||
105842998|NCT00440466|365082474|FG002|Overall Study|Lost to Follow-up|2|||
105842999|NCT00440466|365082472|FG000|Overall Study|Physician Decision|2|||
105843000|NCT00440466|365082473|FG001|Overall Study|Physician Decision|0|||
105843001|NCT00440466|365082474|FG002|Overall Study|Physician Decision|1|||
105843002|NCT00440466|365082472|FG000|Overall Study|Protocol Violation|2|||
105843003|NCT00440466|365082473|FG001|Overall Study|Protocol Violation|0|||
105843004|NCT00440466|365082474|FG002|Overall Study|Protocol Violation|4|||
105843005|NCT00440466|365082472|FG000|Overall Study|Withdrawal by Subject|2|||
105843006|NCT00440466|365082473|FG001|Overall Study|Withdrawal by Subject|5|||
105843007|NCT00440466|365082474|FG002|Overall Study|Withdrawal by Subject|9|||
105843008|NCT00440466|365082472|FG000|Overall Study|Began Dialysis|0|||
105843009|NCT00440466|365082473|FG001|Overall Study|Began Dialysis|0|||
105843010|NCT00440466|365082474|FG002|Overall Study|Began Dialysis|1|||
105969864|NCT00113399|365549776|FG000|Overall Study|Withdrawal by Subject|1|||
105969865|NCT00113399|365549777|FG001|Overall Study|Withdrawal by Subject|2|||
105969866|NCT00113399|365549776|FG000|Overall Study|Complete Response|0|||
105969867|NCT00113399|365549777|FG001|Overall Study|Complete Response|1|||
105969868|NCT00113399|365549776|FG000|Overall Study|Other|0|||
105969869|NCT00113399|365549777|FG001|Overall Study|Other|1|||
105969870|NCT00396136|365549778|FG000|Overall Study|Death|43|||
105969871|NCT00396136|365549778|FG000|Overall Study|Withdrawal by Subject|59|||
105969872|NCT00396136|365549778|FG000|Overall Study|Lost to Follow-up|15|||
105969873|NCT00396136|365549778|FG000|Overall Study|Study device explanted|8|||
105843011|NCT00440466|365082472|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
105843012|NCT00440466|365082473|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
105843013|NCT00440466|365082474|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
105843014|NCT00880087|365082475|FG000|Overall Study|Lost to Follow-up|0|||
105843015|NCT00880087|365082476|FG001|Overall Study|Lost to Follow-up|2|||
105843016|NCT01286558|365082479|FG000|Overall Study|Adverse Event|1|||
105843017|NCT01286558|365082480|FG001|Overall Study|Adverse Event|1|||
105843018|NCT01286558|365082479|FG000|Overall Study|Withdrawal by Subject|0|||
105843019|NCT01286558|365082480|FG001|Overall Study|Withdrawal by Subject|1|||
105969874|NCT04686084|365549780|FG000|Overall Study|Lost to Follow-up|1|||
105969875|NCT01779856|365549781|FG000|Overall Study|Withdrawal by Subject|15|||
105843020|NCT00418522|365082487|FG000|Overall Study|Adverse Event|7|||
105843021|NCT00418522|365082488|FG001|Overall Study|Adverse Event|1|||
105843022|NCT00418522|365082487|FG000|Overall Study|Lack of Efficacy|1|||
105969876|NCT01779856|365549781|FG000|Overall Study|Death|3|||
105969877|NCT01779856|365549781|FG000|Overall Study|Physician Decision|1|||
105843023|NCT00418522|365082488|FG001|Overall Study|Lack of Efficacy|3|||
105843024|NCT00418522|365082487|FG000|Overall Study|Lost to Follow-up|10|||
105843025|NCT00418522|365082488|FG001|Overall Study|Lost to Follow-up|4|||
105843026|NCT00418522|365082487|FG000|Overall Study|Withdrawal by Subject|31|||
105843027|NCT00418522|365082488|FG001|Overall Study|Withdrawal by Subject|7|||
105843028|NCT00418522|365082487|FG000|Overall Study|Other|27|||
105843029|NCT00418522|365082488|FG001|Overall Study|Other|23|||
105843030|NCT00418522|365082487|FG000|Overall Study|Randomized but did not receive treatment|7|||
105843031|NCT00418522|365082488|FG001|Overall Study|Randomized but did not receive treatment|4|||
105843032|NCT02695719|365082490|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
105843033|NCT02695719|365082491|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
105843034|NCT02695719|365082490|FG000|Overall Study|Significant Protocol Deviation|0|||
105843035|NCT02695719|365082491|FG001|Overall Study|Significant Protocol Deviation|1|||
105843036|NCT02695719|365082490|FG000|Overall Study|Voluntary Withdrawal|1|||
105843037|NCT02695719|365082491|FG001|Overall Study|Voluntary Withdrawal|0|||
105843038|NCT02129647|365082498|FG000|Overall Study|Adverse Event|2|||
105843039|NCT02129647|365082498|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
105843040|NCT01117337|365082499|FG000|Overall Study|Lost to Follow-up|4|||
105843041|NCT01117337|365082500|FG001|Overall Study|Lost to Follow-up|0|||
105843042|NCT01231373|365082504|FG000|Overall Study|Withdrew consent prior to randomization|2|||
105843043|NCT01231373|365082505|FG001|Overall Study|Withdrew consent prior to randomization|1|||
105843044|NCT01231373|365082506|FG002|Overall Study|Withdrew consent prior to randomization|0|||
105843045|NCT01231373|365082507|FG003|Overall Study|Withdrew consent prior to randomization|0|||
105843046|NCT01231373|365082504|FG000|Overall Study|Lost to Follow-up|0|||
105843047|NCT01231373|365082505|FG001|Overall Study|Lost to Follow-up|0|||
105843048|NCT01231373|365082506|FG002|Overall Study|Lost to Follow-up|0|||
105843049|NCT01231373|365082507|FG003|Overall Study|Lost to Follow-up|1|||
105843050|NCT01231373|365082504|FG000|Overall Study|Withdrew Consent|1|||
105843051|NCT01231373|365082505|FG001|Overall Study|Withdrew Consent|0|||
105843052|NCT01231373|365082506|FG002|Overall Study|Withdrew Consent|0|||
105843053|NCT01231373|365082507|FG003|Overall Study|Withdrew Consent|0|||
105843054|NCT00614822|365082512|FG000|Overall Study|Adverse Event|3|||
105843055|NCT00102687|365082515|FG000|Initial Period|Withdrawal by Subject|6|||
105843056|NCT00102687|365082516|FG001|Initial Period|Withdrawal by Subject|3|||
105843057|NCT00102687|365082517|FG002|Initial Period|Withdrawal by Subject|5|||
105843058|NCT00102687|365082518|FG003|Initial Period|Withdrawal by Subject|0|||
105843059|NCT00102687|365082519|FG004|Initial Period|Withdrawal by Subject|0|||
105843060|NCT00102687|365082515|FG000|Initial Period|Adverse Event|4|||
105843061|NCT00102687|365082516|FG001|Initial Period|Adverse Event|7|||
105843062|NCT00102687|365082517|FG002|Initial Period|Adverse Event|9|||
105843063|NCT00102687|365082518|FG003|Initial Period|Adverse Event|0|||
105843064|NCT00102687|365082519|FG004|Initial Period|Adverse Event|0|||
105843065|NCT00102687|365082515|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
105843066|NCT00102687|365082516|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
105843067|NCT00102687|365082517|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
105843068|NCT00102687|365082518|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
105843069|NCT00102687|365082519|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
105843070|NCT00102687|365082515|FG000|Initial Period|Protocol Violation|0|||
105843071|NCT00102687|365082516|FG001|Initial Period|Protocol Violation|0|||
105843072|NCT00102687|365082517|FG002|Initial Period|Protocol Violation|2|||
105843073|NCT00102687|365082518|FG003|Initial Period|Protocol Violation|0|||
105843074|NCT00102687|365082519|FG004|Initial Period|Protocol Violation|0|||
105843075|NCT00102687|365082515|FG000|Initial Period|Physician Decision|2|||
105843076|NCT00102687|365082516|FG001|Initial Period|Physician Decision|9|||
105843077|NCT00102687|365082517|FG002|Initial Period|Physician Decision|6|||
105843078|NCT00102687|365082518|FG003|Initial Period|Physician Decision|0|||
105969878|NCT01779856|365549781|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
105843079|NCT00102687|365082519|FG004|Initial Period|Physician Decision|0|||
105843080|NCT00102687|365082515|FG000|Initial Period|Sponsor's decision|0|||
105843081|NCT00102687|365082516|FG001|Initial Period|Sponsor's decision|1|||
105843082|NCT00102687|365082517|FG002|Initial Period|Sponsor's decision|1|||
105843083|NCT00102687|365082518|FG003|Initial Period|Sponsor's decision|0|||
105843084|NCT00102687|365082519|FG004|Initial Period|Sponsor's decision|0|||
105843085|NCT00102687|365082515|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
105843086|NCT00102687|365082516|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
105843087|NCT00102687|365082517|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
105843088|NCT00102687|365082518|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
105843089|NCT00102687|365082519|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
105843090|NCT00102687|365082515|FG000|Initial Period|Death|1|||
105843091|NCT00102687|365082516|FG001|Initial Period|Death|1|||
105843092|NCT00102687|365082517|FG002|Initial Period|Death|1|||
105843093|NCT00102687|365082518|FG003|Initial Period|Death|0|||
105843094|NCT00102687|365082519|FG004|Initial Period|Death|0|||
105843095|NCT00102687|365082515|FG000|Maintenance Period|Withdrawal by Subject|4|||
105843096|NCT00102687|365082516|FG001|Maintenance Period|Withdrawal by Subject|0|||
105843097|NCT00102687|365082517|FG002|Maintenance Period|Withdrawal by Subject|2|||
105843098|NCT00102687|365082518|FG003|Maintenance Period|Withdrawal by Subject|3|||
105843099|NCT00102687|365082519|FG004|Maintenance Period|Withdrawal by Subject|1|||
105843100|NCT00102687|365082515|FG000|Maintenance Period|Adverse Event|1|||
105843101|NCT00102687|365082516|FG001|Maintenance Period|Adverse Event|0|||
105843102|NCT00102687|365082517|FG002|Maintenance Period|Adverse Event|0|||
105843103|NCT00102687|365082518|FG003|Maintenance Period|Adverse Event|1|||
105843104|NCT00102687|365082519|FG004|Maintenance Period|Adverse Event|3|||
105843105|NCT00102687|365082515|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
105843106|NCT00102687|365082516|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
105843107|NCT00102687|365082517|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
105843108|NCT00102687|365082518|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
105843109|NCT00102687|365082519|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
105843110|NCT00102687|365082515|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
105843111|NCT00102687|365082516|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
105843112|NCT00102687|365082517|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
105843113|NCT00102687|365082518|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
105843114|NCT00102687|365082519|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
105843115|NCT00102687|365082515|FG000|Maintenance Period|Death|0|||
105843116|NCT00102687|365082516|FG001|Maintenance Period|Death|0|||
105843117|NCT00102687|365082517|FG002|Maintenance Period|Death|0|||
105843118|NCT00102687|365082518|FG003|Maintenance Period|Death|1|||
105843119|NCT00102687|365082519|FG004|Maintenance Period|Death|1|||
105843120|NCT00102687|365082515|FG000|Maintenance Period|Physician Decision|1|||
105843121|NCT00102687|365082516|FG001|Maintenance Period|Physician Decision|2|||
105843122|NCT00102687|365082517|FG002|Maintenance Period|Physician Decision|3|||
105843123|NCT00102687|365082518|FG003|Maintenance Period|Physician Decision|0|||
105843124|NCT00102687|365082519|FG004|Maintenance Period|Physician Decision|4|||
105843125|NCT02865395|365082524|FG000|Overall Study|Physician Decision|6|||
105969879|NCT01779856|365549781|FG000|Overall Study|Delays in scheduling implant|1|||
105969880|NCT01779856|365549781|FG000|Overall Study|Subject ineligible for Implant|2|||
105969881|NCT01535599|365549782|FG000|Overall Study|Adverse Event|6|||
105969882|NCT01535599|365549783|FG001|Overall Study|Adverse Event|15|||
105969883|NCT01535599|365549782|FG000|Overall Study|Lost to Follow-up|3|||
105969884|NCT01535599|365549783|FG001|Overall Study|Lost to Follow-up|4|||
105969885|NCT01535599|365549782|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
105969886|NCT01535599|365549783|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
105969887|NCT01535599|365549782|FG000|Overall Study|Treatment Failure|33|||
105969888|NCT01535599|365549783|FG001|Overall Study|Treatment Failure|66|||
105969889|NCT01535599|365549782|FG000|Overall Study|BL Culture + for Group A Strep|0|||
105969890|NCT01535599|365549783|FG001|Overall Study|BL Culture + for Group A Strep|1|||
105969891|NCT01535599|365549782|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
105969892|NCT01535599|365549783|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
105969893|NCT01535599|365549782|FG000|Overall Study|Randomized in Error|2|||
105969894|NCT01535599|365549783|FG001|Overall Study|Randomized in Error|4|||
105969895|NCT01535599|365549782|FG000|Overall Study|Did not use product|1|||
105969896|NCT01535599|365549783|FG001|Overall Study|Did not use product|0|||
105969897|NCT01535599|365549782|FG000|Overall Study|Other|1|||
105969898|NCT01535599|365549783|FG001|Overall Study|Other|0|||
105969899|NCT01535599|365549782|FG000|Overall Study|Stopped medication|0|||
105969900|NCT01535599|365549783|FG001|Overall Study|Stopped medication|1|||
105969901|NCT01535599|365549782|FG000|Overall Study|Noncompliance|0|||
105969902|NCT01535599|365549783|FG001|Overall Study|Noncompliance|1|||
105969903|NCT03350256|365549784|FG000|Overall Study|Inclusion/exclusion violation|4|||
105969904|NCT03350256|365549784|FG000|Overall Study|Recommended for other therapies|2|||
105969905|NCT03350256|365549784|FG000|Overall Study|Protocol Violation|3|||
105969906|NCT03350256|365549784|FG000|Overall Study|Non compliance|2|||
105969907|NCT03350256|365549784|FG000|Overall Study|Denial by insurance|1|||
105969908|NCT03350256|365549784|FG000|Overall Study|Adverse Event|2|||
105969909|NCT03350256|365549784|FG000|Overall Study|Trial failure|12|||
105969910|NCT03350256|365549784|FG000|Overall Study|Did not proceed to permanent implant|3|||
105969911|NCT03350256|365549784|FG000|Overall Study|Withdrawal by Subject|3|||
105969912|NCT03350256|365549784|FG000|Overall Study|Subject moving out of state|1|||
105969913|NCT03350256|365549784|FG000|Overall Study|Lost to Follow-up|1|||
105969914|NCT03350256|365549784|FG000|Overall Study|Lack of Efficacy|2|||
105969915|NCT03622112|365549789|FG000|Overall Study|Withdrawal by Subject|6|||
105969916|NCT03622112|365549790|FG001|Overall Study|Withdrawal by Subject|2|||
105969917|NCT03622112|365549791|FG002|Overall Study|Withdrawal by Subject|4|||
105843126|NCT02865395|365082525|FG001|Overall Study|Physician Decision|10|||
105969918|NCT03622112|365549792|FG003|Overall Study|Withdrawal by Subject|2|||
105969919|NCT03622112|365549793|FG004|Overall Study|Withdrawal by Subject|1|||
105969920|NCT03622112|365549794|FG005|Overall Study|Withdrawal by Subject|2|||
105969921|NCT03622112|365549795|FG006|Overall Study|Withdrawal by Subject|2|||
105969922|NCT03622112|365549789|FG000|Overall Study|Death|0|||
105969923|NCT03622112|365549790|FG001|Overall Study|Death|0|||
105969924|NCT03622112|365549791|FG002|Overall Study|Death|0|||
105969925|NCT03622112|365549792|FG003|Overall Study|Death|1|||
105843127|NCT02865395|365082526|FG002|Overall Study|Physician Decision|7|||
105843128|NCT02363439|365082528|FG000|Overall Study|Lack of Efficacy|4|||
105843129|NCT01875471|365082530|FG000|Overall Study|Adverse Event|0|||
105843130|NCT01875471|365082531|FG001|Overall Study|Adverse Event|1|||
105843131|NCT01875471|365082530|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
105843132|NCT01875471|365082531|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
105843133|NCT02610816|365082534|FG000|Phase 1|Withdrawal by Subject|2|||
105843134|NCT02610816|365082535|FG001|Phase 1|Withdrawal by Subject|6|||
105843135|NCT02610816|365082536|FG002|Phase 1|Withdrawal by Subject|0|||
105843136|NCT02610816|365082537|FG003|Phase 1|Withdrawal by Subject|0|||
105843137|NCT02610816|365082534|FG000|Phase 1|Lost to Follow-up|2|||
105843138|NCT02610816|365082535|FG001|Phase 1|Lost to Follow-up|1|||
105843139|NCT02610816|365082536|FG002|Phase 1|Lost to Follow-up|0|||
105843140|NCT02610816|365082537|FG003|Phase 1|Lost to Follow-up|0|||
105843141|NCT02610816|365082534|FG000|Phase 1|Physician Decision|0|||
105843142|NCT02610816|365082535|FG001|Phase 1|Physician Decision|1|||
105843143|NCT02610816|365082536|FG002|Phase 1|Physician Decision|0|||
105843144|NCT02610816|365082537|FG003|Phase 1|Physician Decision|0|||
105843145|NCT02610816|365082534|FG000|Phase 2|Withdrawal by Subject|0|||
105843146|NCT02610816|365082535|FG001|Phase 2|Withdrawal by Subject|0|||
105843147|NCT02610816|365082536|FG002|Phase 2|Withdrawal by Subject|9|||
105843148|NCT02610816|365082537|FG003|Phase 2|Withdrawal by Subject|3|||
105843149|NCT02610816|365082534|FG000|Phase 2|Lost to Follow-up|0|||
105843150|NCT02610816|365082535|FG001|Phase 2|Lost to Follow-up|0|||
105843151|NCT02610816|365082536|FG002|Phase 2|Lost to Follow-up|2|||
105843152|NCT02610816|365082537|FG003|Phase 2|Lost to Follow-up|0|||
105843153|NCT02610816|365082534|FG000|Phase 2|Physician Decision|0|||
105843154|NCT02610816|365082535|FG001|Phase 2|Physician Decision|0|||
105843155|NCT02610816|365082536|FG002|Phase 2|Physician Decision|0|||
105843156|NCT02610816|365082537|FG003|Phase 2|Physician Decision|2|||
105843157|NCT02610816|365082534|FG000|Phase 2|Pregnancy|0|||
105843158|NCT02610816|365082535|FG001|Phase 2|Pregnancy|0|||
105843159|NCT02610816|365082536|FG002|Phase 2|Pregnancy|0|||
105843160|NCT02610816|365082537|FG003|Phase 2|Pregnancy|1|||
105843161|NCT02691741|365082538|FG000|Overall Study|Adverse Event|0|||
105843162|NCT02691741|365082539|FG001|Overall Study|Adverse Event|2|||
105843163|NCT02691741|365082538|FG000|Overall Study|Lost to Follow-up|1|||
105969926|NCT03622112|365549793|FG004|Overall Study|Death|0|||
105969927|NCT03622112|365549794|FG005|Overall Study|Death|0|||
105969928|NCT03622112|365549795|FG006|Overall Study|Death|0|||
105969929|NCT03622112|365549789|FG000|Overall Study|Lost to Follow-up|1|||
105969930|NCT03622112|365549790|FG001|Overall Study|Lost to Follow-up|1|||
105969931|NCT03622112|365549791|FG002|Overall Study|Lost to Follow-up|0|||
105969932|NCT03622112|365549792|FG003|Overall Study|Lost to Follow-up|0|||
105969933|NCT03622112|365549793|FG004|Overall Study|Lost to Follow-up|0|||
105969934|NCT03622112|365549794|FG005|Overall Study|Lost to Follow-up|0|||
105969935|NCT03622112|365549795|FG006|Overall Study|Lost to Follow-up|0|||
105969936|NCT03622112|365549789|FG000|Overall Study|Study-specific withdrawal criteria|10|||
105969937|NCT03622112|365549790|FG001|Overall Study|Study-specific withdrawal criteria|8|||
105969938|NCT03622112|365549791|FG002|Overall Study|Study-specific withdrawal criteria|7|||
105969939|NCT03622112|365549792|FG003|Overall Study|Study-specific withdrawal criteria|6|||
105969940|NCT03622112|365549793|FG004|Overall Study|Study-specific withdrawal criteria|4|||
105969941|NCT03622112|365549794|FG005|Overall Study|Study-specific withdrawal criteria|18|||
105969942|NCT03622112|365549795|FG006|Overall Study|Study-specific withdrawal criteria|4|||
105969943|NCT03622112|365549789|FG000|Overall Study|Protocol Violation|2|||
105969944|NCT03622112|365549790|FG001|Overall Study|Protocol Violation|0|||
105969945|NCT03622112|365549791|FG002|Overall Study|Protocol Violation|1|||
105969946|NCT03622112|365549792|FG003|Overall Study|Protocol Violation|1|||
105969947|NCT03622112|365549793|FG004|Overall Study|Protocol Violation|0|||
105969948|NCT03622112|365549794|FG005|Overall Study|Protocol Violation|0|||
105969949|NCT03622112|365549795|FG006|Overall Study|Protocol Violation|0|||
105969950|NCT03622112|365549789|FG000|Overall Study|Adverse Event|6|||
105969951|NCT03622112|365549790|FG001|Overall Study|Adverse Event|8|||
105969952|NCT03622112|365549791|FG002|Overall Study|Adverse Event|4|||
105969953|NCT03622112|365549792|FG003|Overall Study|Adverse Event|11|||
105969954|NCT03622112|365549793|FG004|Overall Study|Adverse Event|4|||
105843164|NCT02691741|365082539|FG001|Overall Study|Lost to Follow-up|0|||
105843165|NCT02691741|365082538|FG000|Overall Study|Physician Decision|0|||
105843166|NCT02691741|365082539|FG001|Overall Study|Physician Decision|1|||
105843167|NCT02691741|365082538|FG000|Overall Study|Withdrawal by Subject|0|||
105843168|NCT02691741|365082539|FG001|Overall Study|Withdrawal by Subject|4|||
105843169|NCT02243293|365082540|FG000|Overall Study|Adverse Event|1|||
105843170|NCT02243293|365082541|FG001|Overall Study|Adverse Event|0|||
105843171|NCT02243293|365082542|FG002|Overall Study|Adverse Event|0|||
105843172|NCT02243293|365082543|FG003|Overall Study|Adverse Event|0|||
105843173|NCT02243293|365082544|FG004|Overall Study|Adverse Event|0|||
105969955|NCT03622112|365549794|FG005|Overall Study|Adverse Event|20|||
105969956|NCT03622112|365549795|FG006|Overall Study|Adverse Event|2|||
105969957|NCT03622112|365549789|FG000|Overall Study|Reason not specified|0|||
105969958|NCT03622112|365549790|FG001|Overall Study|Reason not specified|1|||
105969959|NCT03622112|365549791|FG002|Overall Study|Reason not specified|0|||
105843174|NCT02243293|365082545|FG005|Overall Study|Adverse Event|0|||
105843175|NCT02243293|365082546|FG006|Overall Study|Adverse Event|0|||
105843176|NCT02243293|365082547|FG007|Overall Study|Adverse Event|0|||
105843177|NCT02243293|365082548|FG008|Overall Study|Adverse Event|0|||
105843178|NCT02243293|365082549|FG009|Overall Study|Adverse Event|0|||
105843179|NCT02243293|365082550|FG010|Overall Study|Adverse Event|0|||
105843180|NCT02243293|365082551|FG011|Overall Study|Adverse Event|0|||
105843181|NCT02243293|365082552|FG012|Overall Study|Adverse Event|0|||
105843182|NCT02243293|365082553|FG013|Overall Study|Adverse Event|0|||
105843183|NCT02243293|365082554|FG014|Overall Study|Adverse Event|0|||
105843184|NCT02243293|365082555|FG015|Overall Study|Adverse Event|1|||
105843185|NCT02243293|365082556|FG016|Overall Study|Adverse Event|0|||
105843186|NCT02243293|365082557|FG017|Overall Study|Adverse Event|0|||
105843187|NCT02243293|365082558|FG018|Overall Study|Adverse Event|0|||
105843188|NCT02243293|365082559|FG019|Overall Study|Adverse Event|0|||
105843189|NCT02243293|365082560|FG020|Overall Study|Adverse Event|1|||
105843190|NCT02243293|365082561|FG021|Overall Study|Adverse Event|0|||
105843191|NCT02243293|365082540|FG000|Overall Study|Withdrawal by Subject|1|||
105843192|NCT02243293|365082541|FG001|Overall Study|Withdrawal by Subject|0|||
105843193|NCT02243293|365082542|FG002|Overall Study|Withdrawal by Subject|0|||
105843194|NCT02243293|365082543|FG003|Overall Study|Withdrawal by Subject|0|||
105843195|NCT02243293|365082544|FG004|Overall Study|Withdrawal by Subject|0|||
105843196|NCT02243293|365082545|FG005|Overall Study|Withdrawal by Subject|0|||
105843197|NCT02243293|365082546|FG006|Overall Study|Withdrawal by Subject|0|||
105843198|NCT02243293|365082547|FG007|Overall Study|Withdrawal by Subject|0|||
105843199|NCT02243293|365082548|FG008|Overall Study|Withdrawal by Subject|0|||
105843200|NCT02243293|365082549|FG009|Overall Study|Withdrawal by Subject|1|||
105843201|NCT02243293|365082550|FG010|Overall Study|Withdrawal by Subject|0|||
105843202|NCT02243293|365082551|FG011|Overall Study|Withdrawal by Subject|1|||
105843203|NCT02243293|365082552|FG012|Overall Study|Withdrawal by Subject|0|||
105843204|NCT02243293|365082553|FG013|Overall Study|Withdrawal by Subject|0|||
105843205|NCT02243293|365082554|FG014|Overall Study|Withdrawal by Subject|0|||
105843206|NCT02243293|365082555|FG015|Overall Study|Withdrawal by Subject|0|||
105843207|NCT02243293|365082556|FG016|Overall Study|Withdrawal by Subject|0|||
105843208|NCT02243293|365082557|FG017|Overall Study|Withdrawal by Subject|0|||
105843209|NCT02243293|365082558|FG018|Overall Study|Withdrawal by Subject|0|||
105843210|NCT02243293|365082559|FG019|Overall Study|Withdrawal by Subject|0|||
105843211|NCT02243293|365082560|FG020|Overall Study|Withdrawal by Subject|0|||
105843212|NCT02243293|365082561|FG021|Overall Study|Withdrawal by Subject|1|||
105843213|NCT02243293|365082540|FG000|Overall Study|Lost to Follow-up|0|||
105843214|NCT02243293|365082541|FG001|Overall Study|Lost to Follow-up|1|||
105843215|NCT02243293|365082542|FG002|Overall Study|Lost to Follow-up|1|||
105843216|NCT02243293|365082543|FG003|Overall Study|Lost to Follow-up|1|||
105843217|NCT02243293|365082544|FG004|Overall Study|Lost to Follow-up|0|||
105843218|NCT02243293|365082545|FG005|Overall Study|Lost to Follow-up|0|||
105843219|NCT02243293|365082546|FG006|Overall Study|Lost to Follow-up|3|||
105843220|NCT02243293|365082547|FG007|Overall Study|Lost to Follow-up|0|||
105843221|NCT02243293|365082548|FG008|Overall Study|Lost to Follow-up|0|||
105843222|NCT02243293|365082549|FG009|Overall Study|Lost to Follow-up|0|||
105843223|NCT02243293|365082550|FG010|Overall Study|Lost to Follow-up|0|||
105843224|NCT02243293|365082551|FG011|Overall Study|Lost to Follow-up|2|||
105843225|NCT02243293|365082552|FG012|Overall Study|Lost to Follow-up|0|||
105843226|NCT02243293|365082553|FG013|Overall Study|Lost to Follow-up|0|||
105843227|NCT02243293|365082554|FG014|Overall Study|Lost to Follow-up|0|||
105843228|NCT02243293|365082555|FG015|Overall Study|Lost to Follow-up|0|||
105843229|NCT02243293|365082556|FG016|Overall Study|Lost to Follow-up|3|||
105843230|NCT02243293|365082557|FG017|Overall Study|Lost to Follow-up|1|||
105843231|NCT02243293|365082558|FG018|Overall Study|Lost to Follow-up|0|||
105843232|NCT02243293|365082559|FG019|Overall Study|Lost to Follow-up|0|||
105843233|NCT02243293|365082560|FG020|Overall Study|Lost to Follow-up|1|||
105843234|NCT02243293|365082561|FG021|Overall Study|Lost to Follow-up|2|||
105843235|NCT02243293|365082540|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
105843236|NCT02243293|365082541|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
105843237|NCT02243293|365082542|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
105843238|NCT02243293|365082543|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
105843239|NCT02243293|365082544|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
105843240|NCT02243293|365082545|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
105843241|NCT02243293|365082546|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
105843242|NCT02243293|365082547|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
105843243|NCT02243293|365082548|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
105843244|NCT02243293|365082549|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
105843245|NCT02243293|365082550|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
105843246|NCT02243293|365082551|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
105843247|NCT02243293|365082552|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
105843248|NCT02243293|365082553|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
105843249|NCT02243293|365082554|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
105843250|NCT02243293|365082555|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
105843251|NCT02243293|365082556|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
105843252|NCT02243293|365082557|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
105843253|NCT02243293|365082558|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
105843254|NCT02243293|365082559|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
105969960|NCT03622112|365549792|FG003|Overall Study|Reason not specified|1|||
105969961|NCT03622112|365549793|FG004|Overall Study|Reason not specified|1|||
105969962|NCT03622112|365549794|FG005|Overall Study|Reason not specified|2|||
105969963|NCT03622112|365549795|FG006|Overall Study|Reason not specified|1|||
105969964|NCT01165320|365549796|FG000|Overall Study|Clinical adverse experience|2|||
105969965|NCT01165320|365549797|FG001|Overall Study|Clinical adverse experience|1|||
105969966|NCT01165320|365549798|FG002|Overall Study|Clinical adverse experience|0|||
105969967|NCT01165320|365549796|FG000|Overall Study|Laboratory adverse experience|1|||
105969968|NCT01165320|365549797|FG001|Overall Study|Laboratory adverse experience|0|||
105969969|NCT01165320|365549798|FG002|Overall Study|Laboratory adverse experience|0|||
105969970|NCT01165320|365549796|FG000|Overall Study|Lack of Efficacy|0|||
105969971|NCT01165320|365549797|FG001|Overall Study|Lack of Efficacy|2|||
105969972|NCT01165320|365549798|FG002|Overall Study|Lack of Efficacy|0|||
105969973|NCT01165320|365549796|FG000|Overall Study|Reason unknown|0|||
105969974|NCT01165320|365549797|FG001|Overall Study|Reason unknown|1|||
105969975|NCT01165320|365549798|FG002|Overall Study|Reason unknown|0|||
105969976|NCT03305419|365549799|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105969977|NCT03305419|365549800|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
105969978|NCT03305419|365549801|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105969979|NCT03305419|365549802|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105969980|NCT03305419|365549803|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105969981|NCT03305419|365549804|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105969982|NCT03305419|365549805|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105969983|NCT03305419|365549806|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
105969984|NCT03305419|365549799|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
105969985|NCT03305419|365549800|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105969986|NCT03305419|365549801|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105969987|NCT03305419|365549802|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105969988|NCT03305419|365549803|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105969989|NCT03305419|365549804|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105969990|NCT03305419|365549805|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105969991|NCT03305419|365549806|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
105969992|NCT03305419|365549799|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
105969993|NCT03305419|365549800|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105969994|NCT03305419|365549801|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105969995|NCT03305419|365549802|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105969996|NCT03305419|365549803|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105969997|NCT03305419|365549804|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105969998|NCT03305419|365549805|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105969999|NCT03305419|365549806|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
105970000|NCT03305419|365549799|FG000|Part B (14 Days)|Adverse Event|0|||
105970001|NCT03305419|365549800|FG001|Part B (14 Days)|Adverse Event|0|||
105970002|NCT03305419|365549801|FG002|Part B (14 Days)|Adverse Event|0|||
105970003|NCT03305419|365549802|FG003|Part B (14 Days)|Adverse Event|0|||
105970004|NCT03305419|365549803|FG004|Part B (14 Days)|Adverse Event|1|||
105970005|NCT03305419|365549804|FG005|Part B (14 Days)|Adverse Event|2|||
105970006|NCT03305419|365549805|FG006|Part B (14 Days)|Adverse Event|4|||
105970007|NCT03305419|365549806|FG007|Part B (14 Days)|Adverse Event|0|||
105970008|NCT03305419|365549799|FG000|Part B (14 Days)|Physician Decision|0|||
105970009|NCT03305419|365549800|FG001|Part B (14 Days)|Physician Decision|0|||
105970010|NCT03305419|365549801|FG002|Part B (14 Days)|Physician Decision|0|||
105970011|NCT03305419|365549802|FG003|Part B (14 Days)|Physician Decision|0|||
105970012|NCT03305419|365549803|FG004|Part B (14 Days)|Physician Decision|2|||
105970013|NCT03305419|365549804|FG005|Part B (14 Days)|Physician Decision|8|||
105970014|NCT03305419|365549805|FG006|Part B (14 Days)|Physician Decision|1|||
105970015|NCT03305419|365549806|FG007|Part B (14 Days)|Physician Decision|0|||
105970016|NCT02231892|365549812|FG000|Overall Study|Lost to Follow-up|1|||
105970017|NCT02231892|365549813|FG001|Overall Study|Lost to Follow-up|0|||
105970018|NCT02231892|365549814|FG002|Overall Study|Lost to Follow-up|3|||
105970019|NCT02231892|365549812|FG000|Overall Study|Withdrawal by Subject|4|||
105970020|NCT02231892|365549813|FG001|Overall Study|Withdrawal by Subject|3|||
105970021|NCT02231892|365549814|FG002|Overall Study|Withdrawal by Subject|15|||
105970022|NCT02231892|365549812|FG000|Overall Study|Physician Decision|0|||
105843255|NCT02243293|365082560|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
105843256|NCT02243293|365082561|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
105970023|NCT02231892|365549813|FG001|Overall Study|Physician Decision|2|||
105970024|NCT02231892|365549814|FG002|Overall Study|Physician Decision|4|||
105970025|NCT02231892|365549812|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
106024457|NCT02152956|365754618|FG009|Overall Study|Death|5|||
106024458|NCT02152956|365754619|FG010|Overall Study|Death|3|||
106024459|NCT02152956|365754620|FG011|Overall Study|Death|143|||
106024460|NCT02152956|365754621|FG012|Overall Study|Death|12|||
106024461|NCT02152956|365754609|FG000|Overall Study|Lost to Follow-up|0|||
106024462|NCT02152956|365754610|FG001|Overall Study|Lost to Follow-up|1|||
106024463|NCT02152956|365754611|FG002|Overall Study|Lost to Follow-up|0|||
106024464|NCT02152956|365754612|FG003|Overall Study|Lost to Follow-up|0|||
106024465|NCT02152956|365754613|FG004|Overall Study|Lost to Follow-up|0|||
106024466|NCT02152956|365754614|FG005|Overall Study|Lost to Follow-up|0|||
106024467|NCT02152956|365754615|FG006|Overall Study|Lost to Follow-up|0|||
106024468|NCT02152956|365754616|FG007|Overall Study|Lost to Follow-up|0|||
106024469|NCT02152956|365754617|FG008|Overall Study|Lost to Follow-up|0|||
106024470|NCT02152956|365754618|FG009|Overall Study|Lost to Follow-up|0|||
106024471|NCT02152956|365754619|FG010|Overall Study|Lost to Follow-up|0|||
106024472|NCT02152956|365754620|FG011|Overall Study|Lost to Follow-up|3|||
106024473|NCT02152956|365754621|FG012|Overall Study|Lost to Follow-up|0|||
106024474|NCT02152956|365754609|FG000|Overall Study|Withdrawal by Subject|1|||
106024475|NCT02152956|365754610|FG001|Overall Study|Withdrawal by Subject|0|||
106024476|NCT02152956|365754611|FG002|Overall Study|Withdrawal by Subject|1|||
106024477|NCT02152956|365754612|FG003|Overall Study|Withdrawal by Subject|0|||
106024478|NCT02152956|365754613|FG004|Overall Study|Withdrawal by Subject|2|||
106024479|NCT02152956|365754614|FG005|Overall Study|Withdrawal by Subject|2|||
106024480|NCT02152956|365754615|FG006|Overall Study|Withdrawal by Subject|0|||
106024481|NCT02152956|365754616|FG007|Overall Study|Withdrawal by Subject|0|||
106024482|NCT02152956|365754617|FG008|Overall Study|Withdrawal by Subject|1|||
106024483|NCT02152956|365754618|FG009|Overall Study|Withdrawal by Subject|0|||
106024484|NCT02152956|365754619|FG010|Overall Study|Withdrawal by Subject|0|||
106024485|NCT02152956|365754620|FG011|Overall Study|Withdrawal by Subject|4|||
106024486|NCT02152956|365754621|FG012|Overall Study|Withdrawal by Subject|0|||
106024487|NCT02152956|365754609|FG000|Overall Study|Physician Decision|0|||
106024488|NCT02152956|365754610|FG001|Overall Study|Physician Decision|0|||
106024489|NCT02152956|365754611|FG002|Overall Study|Physician Decision|0|||
106024490|NCT02152956|365754612|FG003|Overall Study|Physician Decision|0|||
106024491|NCT02152956|365754613|FG004|Overall Study|Physician Decision|0|||
105843257|NCT02243293|365082540|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
105843258|NCT02243293|365082541|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
105843259|NCT02243293|365082542|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
105843260|NCT02243293|365082543|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
105843261|NCT02243293|365082544|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
105843262|NCT02243293|365082545|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
105843263|NCT02243293|365082546|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
105843264|NCT02243293|365082547|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
105843265|NCT02243293|365082548|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
105843266|NCT02243293|365082549|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
105843267|NCT02243293|365082550|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
105843268|NCT02243293|365082551|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
106024492|NCT02152956|365754614|FG005|Overall Study|Physician Decision|0|||
106024493|NCT02152956|365754615|FG006|Overall Study|Physician Decision|0|||
105843269|NCT02243293|365082552|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
105843270|NCT02243293|365082553|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
105843271|NCT02243293|365082554|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
105843272|NCT02243293|365082555|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
105843273|NCT02243293|365082556|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
105843274|NCT02243293|365082557|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
105843275|NCT02243293|365082558|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
105843276|NCT02243293|365082559|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
105843277|NCT02243293|365082560|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
105843278|NCT02243293|365082561|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
105843279|NCT01688726|365082562|FG000|Overall Study|Adverse Event|1|||
105843280|NCT01688726|365082563|FG001|Overall Study|Adverse Event|0|||
105843281|NCT01688726|365082562|FG000|Overall Study|Relocated abroad|0|||
105843282|NCT01688726|365082563|FG001|Overall Study|Relocated abroad|1|||
105843283|NCT00710749|365082565|FG000|First Intervention|Withdrawal by Subject|1|||
105843284|NCT00710749|365082566|FG001|First Intervention|Withdrawal by Subject|0|||
106024494|NCT02152956|365754616|FG007|Overall Study|Physician Decision|0|||
106024495|NCT02152956|365754617|FG008|Overall Study|Physician Decision|0|||
106024496|NCT02152956|365754618|FG009|Overall Study|Physician Decision|0|||
105843285|NCT04678817|365084171|FG000|Overall Study|Lost to Follow-up|28|||
105843286|NCT04678817|365084172|FG001|Overall Study|Lost to Follow-up|0|||
106024497|NCT02152956|365754619|FG010|Overall Study|Physician Decision|0|||
106024498|NCT02152956|365754620|FG011|Overall Study|Physician Decision|1|||
106024499|NCT02152956|365754621|FG012|Overall Study|Physician Decision|0|||
106024500|NCT02152956|365754609|FG000|Overall Study|Study terminated by sponsor|0|||
106024501|NCT02152956|365754610|FG001|Overall Study|Study terminated by sponsor|0|||
106024502|NCT02152956|365754611|FG002|Overall Study|Study terminated by sponsor|0|||
106024503|NCT02152956|365754612|FG003|Overall Study|Study terminated by sponsor|0|||
106024504|NCT02152956|365754613|FG004|Overall Study|Study terminated by sponsor|0|||
106024505|NCT02152956|365754614|FG005|Overall Study|Study terminated by sponsor|0|||
106024506|NCT02152956|365754615|FG006|Overall Study|Study terminated by sponsor|0|||
106024507|NCT02152956|365754616|FG007|Overall Study|Study terminated by sponsor|0|||
106024508|NCT02152956|365754617|FG008|Overall Study|Study terminated by sponsor|0|||
106024509|NCT02152956|365754618|FG009|Overall Study|Study terminated by sponsor|0|||
106024510|NCT02152956|365754619|FG010|Overall Study|Study terminated by sponsor|0|||
106024511|NCT02152956|365754620|FG011|Overall Study|Study terminated by sponsor|29|||
106024512|NCT02152956|365754621|FG012|Overall Study|Study terminated by sponsor|0|||
106024513|NCT02152956|365754609|FG000|Overall Study|progressive disease|0|||
106024514|NCT02152956|365754610|FG001|Overall Study|progressive disease|0|||
106024515|NCT02152956|365754611|FG002|Overall Study|progressive disease|0|||
106024516|NCT02152956|365754612|FG003|Overall Study|progressive disease|0|||
106024517|NCT02152956|365754613|FG004|Overall Study|progressive disease|0|||
106024518|NCT02152956|365754614|FG005|Overall Study|progressive disease|0|||
106024519|NCT02152956|365754615|FG006|Overall Study|progressive disease|0|||
106024520|NCT02152956|365754616|FG007|Overall Study|progressive disease|0|||
106024521|NCT02152956|365754617|FG008|Overall Study|progressive disease|1|||
106024522|NCT02152956|365754618|FG009|Overall Study|progressive disease|0|||
106024523|NCT02152956|365754619|FG010|Overall Study|progressive disease|0|||
106024524|NCT02152956|365754620|FG011|Overall Study|progressive disease|1|||
106024525|NCT02152956|365754621|FG012|Overall Study|progressive disease|0|||
106024526|NCT00612807|365754622|FG000|Overall Study|Withdrawal by Subject|2|||
106024527|NCT00612807|365754623|FG001|Overall Study|Withdrawal by Subject|0|||
106024528|NCT01215097|365754624|FG000|Overall Study|Adverse Event|1|||
106024529|NCT01215097|365754625|FG001|Overall Study|Adverse Event|3|||
106024530|NCT01215097|365754624|FG000|Overall Study|Protocol Violation|0|||
106024531|NCT01215097|365754625|FG001|Overall Study|Protocol Violation|2|||
106024532|NCT01215097|365754624|FG000|Overall Study|Lost to Follow-up|2|||
106024533|NCT01215097|365754625|FG001|Overall Study|Lost to Follow-up|0|||
106024534|NCT01215097|365754624|FG000|Overall Study|Withdrawal by Subject|6|||
106024535|NCT01215097|365754625|FG001|Overall Study|Withdrawal by Subject|3|||
106024536|NCT01215097|365754624|FG000|Overall Study|Lack of Efficacy|0|||
106024537|NCT01215097|365754625|FG001|Overall Study|Lack of Efficacy|3|||
106024538|NCT01215097|365754624|FG000|Overall Study|patient's refusal to come|2|||
106024539|NCT01215097|365754625|FG001|Overall Study|patient's refusal to come|2|||
106024540|NCT01215097|365754624|FG000|Overall Study|patient's private reason|1|||
106024541|NCT01215097|365754625|FG001|Overall Study|patient's private reason|1|||
106024542|NCT01818752|365754626|FG000|Overall Study|Adverse Event|64|||
106024543|NCT01818752|365754627|FG001|Overall Study|Adverse Event|74|||
106024544|NCT01818752|365754626|FG000|Overall Study|Death|14|||
106024545|NCT01818752|365754627|FG001|Overall Study|Death|18|||
106024546|NCT01818752|365754626|FG000|Overall Study|Non-compliance|16|||
106024547|NCT01818752|365754627|FG001|Overall Study|Non-compliance|20|||
106024548|NCT01818752|365754626|FG000|Overall Study|Withdrawal by Subject|15|||
106024549|NCT01818752|365754627|FG001|Overall Study|Withdrawal by Subject|14|||
106024550|NCT01818752|365754626|FG000|Overall Study|Physician Decision|9|||
106024551|NCT01818752|365754627|FG001|Overall Study|Physician Decision|8|||
106024552|NCT01818752|365754626|FG000|Overall Study|Disease Progression|54|||
106024553|NCT01818752|365754627|FG001|Overall Study|Disease Progression|48|||
106024554|NCT01818752|365754626|FG000|Overall Study|Other|7|||
106024555|NCT01818752|365754627|FG001|Overall Study|Other|8|||
106024556|NCT01818752|365754626|FG000|Overall Study|Continuing Treatment|1|||
106024557|NCT01818752|365754627|FG001|Overall Study|Continuing Treatment|4|||
106024558|NCT01818752|365754626|FG000|Overall Study|Randomized but not Dosed|7|||
106024559|NCT01818752|365754627|FG001|Overall Study|Randomized but not Dosed|4|||
106024560|NCT02228980|365754628|FG000|Overall Study|Adverse Event|14|||
106149471|NCT03779048|366209120|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
106149472|NCT03779048|366209121|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
106149473|NCT03779048|366209119|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
106024561|NCT02228980|365754629|FG001|Overall Study|Adverse Event|0|||
106024562|NCT02228980|365754630|FG002|Overall Study|Adverse Event|0|||
106024563|NCT02228980|365754631|FG003|Overall Study|Adverse Event|0|||
106024564|NCT02228980|365754628|FG000|Overall Study|Protocol Violation|7|||
106024565|NCT02228980|365754629|FG001|Overall Study|Protocol Violation|0|||
106024566|NCT02228980|365754630|FG002|Overall Study|Protocol Violation|0|||
106024567|NCT02228980|365754631|FG003|Overall Study|Protocol Violation|0|||
106024568|NCT02228980|365754628|FG000|Overall Study|Withdrawal by Subject|3|||
106024569|NCT02228980|365754629|FG001|Overall Study|Withdrawal by Subject|3|||
106024570|NCT02228980|365754630|FG002|Overall Study|Withdrawal by Subject|2|||
106024571|NCT02228980|365754631|FG003|Overall Study|Withdrawal by Subject|3|||
106024572|NCT04270370|365754632|FG000|Overall Study|Lost to Follow-up|1|||
106024573|NCT04270370|365754633|FG001|Overall Study|Lost to Follow-up|0|||
106024574|NCT04270370|365754634|FG002|Overall Study|Lost to Follow-up|0|||
106024575|NCT04270370|365754635|FG003|Overall Study|Lost to Follow-up|0|||
106024576|NCT04270370|365754636|FG004|Overall Study|Lost to Follow-up|0|||
106024577|NCT04270370|365754637|FG005|Overall Study|Lost to Follow-up|0|||
106024578|NCT04270370|365754638|FG006|Overall Study|Lost to Follow-up|0|||
105970026|NCT02231892|365549813|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
105970027|NCT02231892|365549814|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
105970028|NCT02231892|365549812|FG000|Overall Study|Participant motor threshold was >83%|0|||
105970029|NCT02231892|365549813|FG001|Overall Study|Participant motor threshold was >83%|0|||
105970030|NCT02231892|365549814|FG002|Overall Study|Participant motor threshold was >83%|9|||
105970031|NCT02231892|365549812|FG000|Overall Study|Could not find motor threshold|2|||
105970032|NCT02231892|365549813|FG001|Overall Study|Could not find motor threshold|0|||
105970033|NCT02231892|365549814|FG002|Overall Study|Could not find motor threshold|1|||
105970034|NCT02231892|365549812|FG000|Overall Study|Could not find reliable motor hotspot|0|||
105970035|NCT02231892|365549813|FG001|Overall Study|Could not find reliable motor hotspot|0|||
105970036|NCT02231892|365549814|FG002|Overall Study|Could not find reliable motor hotspot|1|||
105970037|NCT00791479|365549823|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105970038|NCT00791479|365549824|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
106024579|NCT04270370|365754639|FG007|Overall Study|Lost to Follow-up|0|||
105970039|NCT00791479|365549825|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105970040|NCT00791479|365549826|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105970041|NCT00791479|365549827|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
105970042|NCT00791479|365549828|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
105970043|NCT00791479|365549823|FG000|Overall Study|Adverse Event|0|||
105970044|NCT00791479|365549824|FG001|Overall Study|Adverse Event|1|||
105970045|NCT00791479|365549825|FG002|Overall Study|Adverse Event|0|||
105970046|NCT00791479|365549826|FG003|Overall Study|Adverse Event|2|||
105970047|NCT00791479|365549827|FG004|Overall Study|Adverse Event|0|||
105970048|NCT00791479|365549828|FG005|Overall Study|Adverse Event|1|||
105970049|NCT00791479|365549823|FG000|Overall Study|Lost to Follow-up|0|||
105970050|NCT00791479|365549824|FG001|Overall Study|Lost to Follow-up|1|||
105970051|NCT00791479|365549825|FG002|Overall Study|Lost to Follow-up|0|||
105970052|NCT00791479|365549826|FG003|Overall Study|Lost to Follow-up|0|||
105970053|NCT00791479|365549827|FG004|Overall Study|Lost to Follow-up|0|||
105970054|NCT00791479|365549828|FG005|Overall Study|Lost to Follow-up|1|||
105970055|NCT00791479|365549823|FG000|Overall Study|Protocol Violation|2|||
105970056|NCT00791479|365549824|FG001|Overall Study|Protocol Violation|1|||
105970057|NCT00791479|365549825|FG002|Overall Study|Protocol Violation|0|||
105970058|NCT00791479|365549826|FG003|Overall Study|Protocol Violation|1|||
105970059|NCT00791479|365549827|FG004|Overall Study|Protocol Violation|0|||
105970060|NCT00791479|365549828|FG005|Overall Study|Protocol Violation|0|||
105970061|NCT00791479|365549823|FG000|Overall Study|Withdrawal by Subject|0|||
105970062|NCT00791479|365549824|FG001|Overall Study|Withdrawal by Subject|0|||
105970063|NCT00791479|365549825|FG002|Overall Study|Withdrawal by Subject|0|||
105970064|NCT00791479|365549826|FG003|Overall Study|Withdrawal by Subject|1|||
105970065|NCT00791479|365549827|FG004|Overall Study|Withdrawal by Subject|0|||
105970066|NCT00791479|365549828|FG005|Overall Study|Withdrawal by Subject|1|||
105970067|NCT02186652|365549829|FG000|Overall Study|Lost to Follow-up|2|||
105970068|NCT02186652|365549830|FG001|Overall Study|Lost to Follow-up|0|||
105970069|NCT00744978|365549831|FG000|Period 1|Lost to Follow-up|1|||
105970070|NCT00744978|365549832|FG001|Period 1|Lost to Follow-up|0|||
105970071|NCT00744978|365549831|FG000|Period 1|Withdrawal by Subject|0|||
105970072|NCT00744978|365549832|FG001|Period 1|Withdrawal by Subject|2|||
105970073|NCT00744978|365549831|FG000|Period 1|Other|0|||
105970074|NCT00744978|365549832|FG001|Period 1|Other|2|||
105970075|NCT00744978|365549831|FG000|Period 1|Adverse Event|4|||
105970076|NCT00744978|365549832|FG001|Period 1|Adverse Event|0|||
105970077|NCT00744978|365549831|FG000|Period 1|Randomized but not Treated|1|||
105970078|NCT00744978|365549832|FG001|Period 1|Randomized but not Treated|1|||
105970079|NCT00744978|365549831|FG000|Period 2|Adverse Event|0|||
105970080|NCT00744978|365549832|FG001|Period 2|Adverse Event|1|||
105970081|NCT00866047|365549833|FG000|Treatment Period|Progressive disease|13|||
105970082|NCT00866047|365549833|FG000|Treatment Period|Adverse Event|16|||
105970083|NCT00866047|365549833|FG000|Treatment Period|Physician Decision|14|||
105970084|NCT00866047|365549833|FG000|Treatment Period|Withdrawal by Subject|5|||
105970085|NCT00866047|365549833|FG000|Follow-up Period|Lost to Follow-up|5|||
106024580|NCT04270370|365754640|FG008|Overall Study|Lost to Follow-up|1|||
106024581|NCT04270370|365754641|FG009|Overall Study|Lost to Follow-up|0|||
106024582|NCT04270370|365754642|FG010|Overall Study|Lost to Follow-up|0|||
106024583|NCT04270370|365754643|FG011|Overall Study|Lost to Follow-up|0|||
105970086|NCT02928029|365549834|FG000|Overall Study|Withdrawal by Subject|0|||
105970087|NCT02928029|365549835|FG001|Overall Study|Withdrawal by Subject|1|||
105970088|NCT02928029|365549834|FG000|Overall Study|Radiological progression|1|||
105970089|NCT02928029|365549835|FG001|Overall Study|Radiological progression|0|||
105970090|NCT02928029|365549834|FG000|Overall Study|Clinical progression|1|||
105970091|NCT02928029|365549835|FG001|Overall Study|Clinical progression|2|||
105970092|NCT02928029|365549834|FG000|Overall Study|AE not related to clinical progression|1|||
106024584|NCT01324141|365754644|FG000|Overall Study|Declined to participate before treatment started|1|||
106024585|NCT01324141|365754644|FG000|Overall Study|Disease progression on study|1|||
106024586|NCT00750152|365754645|FG000|Overall Study|Adverse Event|2|||
106024587|NCT00750152|365754646|FG001|Overall Study|Adverse Event|1|||
106024588|NCT00750152|365754645|FG000|Overall Study|Lost to Follow-up|8|||
106024589|NCT00750152|365754646|FG001|Overall Study|Lost to Follow-up|13|||
106024590|NCT00750152|365754645|FG000|Overall Study|Withdrawal by Subject|3|||
106024591|NCT00750152|365754646|FG001|Overall Study|Withdrawal by Subject|3|||
106024592|NCT00750152|365754645|FG000|Overall Study|Physician Decision|1|||
106024593|NCT00750152|365754646|FG001|Overall Study|Physician Decision|1|||
105843287|NCT04678817|365084173|FG002|Overall Study|Lost to Follow-up|0|||
105843288|NCT00493246|365084174|FG000|Overall Study|Withdrawal by Subject|0|||
105843289|NCT00493246|365084175|FG001|Overall Study|Withdrawal by Subject|0|||
105843290|NCT00493246|365084176|FG002|Overall Study|Withdrawal by Subject|0|||
105843291|NCT00493246|365084177|FG003|Overall Study|Withdrawal by Subject|0|||
105843292|NCT00493246|365084178|FG004|Overall Study|Withdrawal by Subject|1|||
105843293|NCT00493246|365084179|FG005|Overall Study|Withdrawal by Subject|0|||
105843294|NCT00493246|365084180|FG006|Overall Study|Withdrawal by Subject|0|||
105843295|NCT00493246|365084181|FG007|Overall Study|Withdrawal by Subject|0|||
105843296|NCT00493246|365084174|FG000|Overall Study|No access to draw blood|0|||
105843297|NCT00493246|365084175|FG001|Overall Study|No access to draw blood|0|||
105843298|NCT00493246|365084176|FG002|Overall Study|No access to draw blood|0|||
105843299|NCT00493246|365084177|FG003|Overall Study|No access to draw blood|0|||
105843300|NCT00493246|365084178|FG004|Overall Study|No access to draw blood|0|||
105843301|NCT00493246|365084179|FG005|Overall Study|No access to draw blood|1|||
105843302|NCT00493246|365084180|FG006|Overall Study|No access to draw blood|0|||
105843303|NCT00493246|365084181|FG007|Overall Study|No access to draw blood|0|||
105843304|NCT00493246|365084174|FG000|Overall Study|Lost to Follow-up|0|||
105843305|NCT00493246|365084175|FG001|Overall Study|Lost to Follow-up|0|||
105843306|NCT00493246|365084176|FG002|Overall Study|Lost to Follow-up|0|||
105843307|NCT00493246|365084177|FG003|Overall Study|Lost to Follow-up|0|||
105843308|NCT00493246|365084178|FG004|Overall Study|Lost to Follow-up|0|||
105843309|NCT00493246|365084179|FG005|Overall Study|Lost to Follow-up|0|||
105843310|NCT00493246|365084180|FG006|Overall Study|Lost to Follow-up|1|||
105843311|NCT00493246|365084181|FG007|Overall Study|Lost to Follow-up|0|||
105843312|NCT00706095|365084182|FG000|Overall Study|Progressive Disease|4|||
105843313|NCT00706095|365084183|FG001|Overall Study|Progressive Disease|5|||
105843314|NCT00706095|365084184|FG002|Overall Study|Progressive Disease|3|||
105843315|NCT00706095|365084182|FG000|Overall Study|Clinical Progression|1|||
105843316|NCT00706095|365084183|FG001|Overall Study|Clinical Progression|2|||
105843317|NCT00706095|365084184|FG002|Overall Study|Clinical Progression|2|||
105843318|NCT00706095|365084182|FG000|Overall Study|Withdrawal by Subject|1|||
105843319|NCT00706095|365084183|FG001|Overall Study|Withdrawal by Subject|0|||
105843320|NCT00706095|365084184|FG002|Overall Study|Withdrawal by Subject|0|||
105843321|NCT04109313|365084185|FG000|Overall Study|Pregnancy|1|||
105843322|NCT04109313|365084185|FG000|Overall Study|Adverse Event|11|||
105843323|NCT04109313|365084185|FG000|Overall Study|Lack of Efficacy|11|||
105843324|NCT04109313|365084185|FG000|Overall Study|Lost to Follow-up|1|||
105843325|NCT04109313|365084185|FG000|Overall Study|Physician Decision|2|||
105843326|NCT04109313|365084185|FG000|Overall Study|Subject Decision|13|||
105843327|NCT04109313|365084185|FG000|Overall Study|Covid-19 situation|2|||
105843328|NCT00655850|365084186|FG000|Overall Study|Death|2|||
105843329|NCT00655850|365084186|FG000|Overall Study|Withdrawal by Subject|1|||
105843330|NCT00140413|365084187|FG000|Overall Study|Lost to Follow-up|1|||
105843331|NCT00140413|365084188|FG001|Overall Study|Lost to Follow-up|0|||
105843332|NCT00140413|365084187|FG000|Overall Study|Withdrawal by Subject|2|||
105970093|NCT02928029|365549835|FG001|Overall Study|AE not related to clinical progression|1|||
105970094|NCT01610713|365549838|FG000|Overall Study|Adverse Event|3|||
105970095|NCT01610713|365549839|FG001|Overall Study|Adverse Event|0|||
105970096|NCT01610713|365549838|FG000|Overall Study|Lack of Efficacy|1|||
105970097|NCT01610713|365549839|FG001|Overall Study|Lack of Efficacy|0|||
105970098|NCT01610713|365549838|FG000|Overall Study|low mood and poor motivation|1|||
105970099|NCT01610713|365549839|FG001|Overall Study|low mood and poor motivation|0|||
105970100|NCT01610713|365549838|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
105970101|NCT01610713|365549839|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
105970102|NCT01610713|365549838|FG000|Overall Study|Lost to Follow-up|0|||
105970103|NCT01610713|365549839|FG001|Overall Study|Lost to Follow-up|1|||
105970104|NCT03703817|365549842|FG000|Overall Study|Not meeting eligibility criteria|7|||
105970105|NCT03703817|365549843|FG001|Overall Study|Not meeting eligibility criteria|4|||
105843333|NCT00140413|365084188|FG001|Overall Study|Withdrawal by Subject|0|||
105843334|NCT00099268|365084193|FG000|Overall Study|Withdrawal by Subject|46|||
105843335|NCT00099268|365084194|FG001|Overall Study|Withdrawal by Subject|28|||
105843336|NCT00099268|365084193|FG000|Overall Study|Adverse Event|19|||
105843337|NCT00099268|365084194|FG001|Overall Study|Adverse Event|19|||
105843338|NCT00099268|365084193|FG000|Overall Study|Protocol Violation|9|||
105843339|NCT00099268|365084194|FG001|Overall Study|Protocol Violation|8|||
105843340|NCT00099268|365084193|FG000|Overall Study|Lost to Follow-up|6|||
105843341|NCT00099268|365084194|FG001|Overall Study|Lost to Follow-up|4|||
105843342|NCT00099268|365084193|FG000|Overall Study|Lack of Efficacy|5|||
106024594|NCT00750152|365754645|FG000|Overall Study|Non-compliance|0|||
106024595|NCT00750152|365754646|FG001|Overall Study|Non-compliance|1|||
106024596|NCT00750152|365754645|FG000|Overall Study|Termination by sponsor|1|||
106024597|NCT00750152|365754646|FG001|Overall Study|Termination by sponsor|0|||
106024598|NCT00750152|365754645|FG000|Overall Study|Other|7|||
106024599|NCT00750152|365754646|FG001|Overall Study|Other|8|||
106024600|NCT00715910|365754655|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
106024601|NCT00715910|365754656|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
106024602|NCT00715910|365754657|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
106024603|NCT00715910|365754658|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
106024604|NCT00715910|365754659|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
106024605|NCT00715910|365754660|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
106024606|NCT00715910|365754655|FG000|Booster and ESFU Phase|Other|0|||
106024607|NCT00715910|365754656|FG001|Booster and ESFU Phase|Other|0|||
106024608|NCT00715910|365754657|FG002|Booster and ESFU Phase|Other|0|||
106024609|NCT00715910|365754658|FG003|Booster and ESFU Phase|Other|5|||
106024610|NCT00715910|365754659|FG004|Booster and ESFU Phase|Other|1|||
106024611|NCT00715910|365754660|FG005|Booster and ESFU Phase|Other|0|||
106024612|NCT01097005|365754669|FG000|Overall Study|Case Report Form not collected|18|||
106024613|NCT01097005|365754669|FG000|Overall Study|Subjects cannot visit the hospital|1|||
106024614|NCT01097005|365754669|FG000|Overall Study|Poor medication compliance|1|||
106024615|NCT01097005|365754669|FG000|Overall Study|No examination data available|244|||
106024616|NCT01097005|365754669|FG000|Overall Study|Deviation from exclusion criteria|37|||
106024617|NCT01097005|365754669|FG000|Overall Study|Adverse Event|14|||
106024618|NCT01097005|365754669|FG000|Overall Study|Discontinuance by complication|50|||
106024619|NCT03425253|365754672|FG000|Overall Study|Adverse Event|2|||
106024620|NCT03425253|365754672|FG000|Overall Study|Lost to Follow-up|3|||
106024621|NCT03425253|365754672|FG000|Overall Study|Withdrew Consent|6|||
106024622|NCT03425253|365754672|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
106024623|NCT03844945|365756535|FG000|Overall Study|Adverse Event|1|||
106024624|NCT03844945|365756536|FG001|Overall Study|Adverse Event|1|||
106024625|NCT03844945|365756537|FG002|Overall Study|Adverse Event|4|||
106024626|NCT03844945|365756538|FG003|Overall Study|Adverse Event|0|||
106024627|NCT03844945|365756535|FG000|Overall Study|Withdrawal by Subject|0|||
106024628|NCT03844945|365756536|FG001|Overall Study|Withdrawal by Subject|0|||
106024629|NCT03844945|365756537|FG002|Overall Study|Withdrawal by Subject|1|||
106024630|NCT03844945|365756538|FG003|Overall Study|Withdrawal by Subject|0|||
106024631|NCT03844945|365756535|FG000|Overall Study|Lack of Efficacy|0|||
106024632|NCT03844945|365756536|FG001|Overall Study|Lack of Efficacy|0|||
106024633|NCT03844945|365756537|FG002|Overall Study|Lack of Efficacy|0|||
106024634|NCT03844945|365756538|FG003|Overall Study|Lack of Efficacy|1|||
106024635|NCT02160899|365756543|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
106024636|NCT02160899|365756544|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
106024637|NCT02160899|365756545|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
105843343|NCT00099268|365084194|FG001|Overall Study|Lack of Efficacy|18|||
105843344|NCT00099268|365084193|FG000|Overall Study|Administrative problems|4|||
105843345|NCT00099268|365084194|FG001|Overall Study|Administrative problems|4|||
105843346|NCT00099268|365084193|FG000|Overall Study|Death|3|||
105843347|NCT00099268|365084194|FG001|Overall Study|Death|1|||
105843348|NCT01360866|365084195|FG000|Overall Study|Lost to Follow-up|11|||
105843349|NCT01360866|365084196|FG001|Overall Study|Lost to Follow-up|28|||
105843350|NCT01360866|365084197|FG002|Overall Study|Lost to Follow-up|41|||
105843351|NCT01360866|365084198|FG003|Overall Study|Lost to Follow-up|0|||
105843352|NCT01360866|365084195|FG000|Overall Study|Adverse Event|56|||
105843353|NCT01360866|365084196|FG001|Overall Study|Adverse Event|61|||
105843354|NCT01360866|365084197|FG002|Overall Study|Adverse Event|134|||
105843355|NCT01360866|365084198|FG003|Overall Study|Adverse Event|6|||
106024638|NCT02160899|365756546|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
106024639|NCT02160899|365756547|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
106024640|NCT02160899|365756548|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
106024641|NCT04129151|365756549|FG000|Overall Study|Adverse Event|1|||
105843356|NCT01360866|365084195|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
105843357|NCT01360866|365084196|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
105843358|NCT01360866|365084197|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
105843359|NCT01360866|365084198|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
105843360|NCT01360866|365084195|FG000|Overall Study|Withdrawn by Investigator|9|||
105843361|NCT01360866|365084196|FG001|Overall Study|Withdrawn by Investigator|8|||
105843362|NCT01360866|365084197|FG002|Overall Study|Withdrawn by Investigator|31|||
105843363|NCT01360866|365084198|FG003|Overall Study|Withdrawn by Investigator|2|||
105843364|NCT01360866|365084195|FG000|Overall Study|Withdrawal by participant|79|||
105843365|NCT01360866|365084196|FG001|Overall Study|Withdrawal by participant|89|||
105843366|NCT01360866|365084197|FG002|Overall Study|Withdrawal by participant|168|||
105843367|NCT01360866|365084198|FG003|Overall Study|Withdrawal by participant|8|||
105843368|NCT01360866|365084195|FG000|Overall Study|Protocol Deviation|25|||
106024642|NCT04129151|365756549|FG000|Overall Study|Disease Progression|7|||
106024643|NCT04129151|365756549|FG000|Overall Study|Study closure|1|||
106024644|NCT02051933|365756552|FG000|Overall Study|Physician Decision|0|||
106024645|NCT02051933|365756553|FG001|Overall Study|Physician Decision|1|||
106024646|NCT00798759|365756554|FG000|Overall Study|Adverse Event|3|||
106024647|NCT00798759|365756555|FG001|Overall Study|Adverse Event|3|||
106024648|NCT00798759|365756554|FG000|Overall Study|Lost to Follow-up|1|||
106024649|NCT00798759|365756555|FG001|Overall Study|Lost to Follow-up|1|||
105970106|NCT02778555|365549844|FG000|Overall Study|Withdrawal by Subject|55|||
105970107|NCT02778555|365549845|FG001|Overall Study|Withdrawal by Subject|32|||
105970108|NCT02778555|365549846|FG002|Overall Study|Withdrawal by Subject|107|||
105970109|NCT02509039|365549847|FG000|Overall Study|Adverse Event|0|||
105970110|NCT02509039|365549848|FG001|Overall Study|Adverse Event|1|||
105970111|NCT02509039|365549849|FG002|Overall Study|Adverse Event|1|||
105970112|NCT02509039|365549850|FG003|Overall Study|Adverse Event|1|||
105970113|NCT02509039|365549847|FG000|Overall Study|Withdrawal by Subject|0|||
105970114|NCT02509039|365549848|FG001|Overall Study|Withdrawal by Subject|0|||
105970115|NCT02509039|365549849|FG002|Overall Study|Withdrawal by Subject|1|||
105970116|NCT02509039|365549850|FG003|Overall Study|Withdrawal by Subject|0|||
105970117|NCT02509039|365549847|FG000|Overall Study|Progressive disease|2|||
105970118|NCT02509039|365549848|FG001|Overall Study|Progressive disease|2|||
105970119|NCT02509039|365549849|FG002|Overall Study|Progressive disease|1|||
105970120|NCT02509039|365549850|FG003|Overall Study|Progressive disease|5|||
105970121|NCT02509039|365549847|FG000|Overall Study|Study terminated by Sponsor|1|||
105970122|NCT02509039|365549848|FG001|Overall Study|Study terminated by Sponsor|0|||
105970123|NCT02509039|365549849|FG002|Overall Study|Study terminated by Sponsor|0|||
105970124|NCT02509039|365549850|FG003|Overall Study|Study terminated by Sponsor|0|||
105970125|NCT04659174|365549854|FG000|Overall Study|Sponsor decision to discontinue study|0|||
105970126|NCT04659174|365549855|FG001|Overall Study|Sponsor decision to discontinue study|2|||
106024650|NCT00798759|365756554|FG000|Overall Study|Protocol Violation|4|||
106024651|NCT00798759|365756555|FG001|Overall Study|Protocol Violation|8|||
106024652|NCT00798759|365756554|FG000|Overall Study|Other|0|||
106024653|NCT00798759|365756555|FG001|Overall Study|Other|1|||
106024654|NCT00095940|365756556|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
106024655|NCT00095940|365756557|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
106024656|NCT00095940|365756558|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
106024657|NCT00095940|365756559|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
106024658|NCT00095940|365756560|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
106024659|NCT00095940|365756561|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
106024660|NCT00095940|365756562|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
106024661|NCT00095940|365756563|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
106024662|NCT00095940|365756564|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
106024663|NCT00095940|365756556|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
106024664|NCT00095940|365756557|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
106024665|NCT00095940|365756558|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
106024666|NCT00095940|365756559|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
106024667|NCT00095940|365756560|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
106024668|NCT00095940|365756561|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
106024669|NCT00095940|365756562|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
106024670|NCT00095940|365756563|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
106024671|NCT00095940|365756564|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
106024672|NCT00095940|365756556|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
106024673|NCT00095940|365756557|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
106024674|NCT00095940|365756558|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
106024675|NCT00095940|365756559|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
106024676|NCT00095940|365756560|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
106024677|NCT00095940|365756561|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
106024678|NCT00095940|365756562|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
106024679|NCT00095940|365756563|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
106024680|NCT00095940|365756564|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
106024681|NCT00373113|365756566|FG000|Overall Study|Death|1|||
106024682|NCT00373113|365756567|FG001|Overall Study|Death|7|||
106024683|NCT00373113|365756566|FG000|Overall Study|Adverse Event|38|||
105970127|NCT04659174|365549854|FG000|Overall Study|Lost to Follow-up|9|||
105970128|NCT04659174|365549855|FG001|Overall Study|Lost to Follow-up|11|||
106024684|NCT00373113|365756567|FG001|Overall Study|Adverse Event|24|||
105970129|NCT04659174|365549854|FG000|Overall Study|Adverse Event|8|||
105970130|NCT04659174|365549855|FG001|Overall Study|Adverse Event|5|||
106024685|NCT00373113|365756566|FG000|Overall Study|Study terminated by sponsor|9|||
106024686|NCT00373113|365756567|FG001|Overall Study|Study terminated by sponsor|1|||
106024687|NCT00373113|365756566|FG000|Overall Study|Global deterioration of health status|10|||
106024688|NCT00373113|365756567|FG001|Overall Study|Global deterioration of health status|7|||
106024689|NCT00373113|365756566|FG000|Overall Study|Lost to Follow-up|1|||
106024690|NCT00373113|365756567|FG001|Overall Study|Lost to Follow-up|3|||
106024691|NCT00373113|365756566|FG000|Overall Study|Objective progression or relapse|150|||
105970131|NCT04659174|365549854|FG000|Overall Study|Withdrawal by Subject|17|||
105970132|NCT04659174|365549855|FG001|Overall Study|Withdrawal by Subject|33|||
105970133|NCT04659174|365549854|FG000|Overall Study|Progressive disease|0|||
105970134|NCT04659174|365549855|FG001|Overall Study|Progressive disease|2|||
105970135|NCT04659174|365549854|FG000|Overall Study|Other reasons|0|||
105970136|NCT04659174|365549855|FG001|Overall Study|Other reasons|2|||
105970137|NCT04659174|365549854|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
105970138|NCT04659174|365549855|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
105970139|NCT04659174|365549854|FG000|Overall Study|Alcohol or illegal drug use|0|||
105970140|NCT04659174|365549855|FG001|Overall Study|Alcohol or illegal drug use|3|||
105970141|NCT04659174|365549854|FG000|Overall Study|Violation of entry criteria|1|||
105970142|NCT04659174|365549855|FG001|Overall Study|Violation of entry criteria|0|||
105970143|NCT04659174|365549854|FG000|Overall Study|Death|0|||
105970144|NCT04659174|365549855|FG001|Overall Study|Death|1|||
105970145|NCT03276026|365549856|FG000|Overall Study|Protocol Violation|1|||
105970146|NCT03276026|365549857|FG001|Overall Study|Protocol Violation|0|||
105970147|NCT02901054|365549861|FG000|Overall Study|Physician Decision|1|||
105970148|NCT02901054|365549861|FG000|Overall Study|Withdrawal by Subject|3|||
105970149|NCT04049266|365549862|FG000|Overall Study|Adverse Event|16|||
105970150|NCT04049266|365549863|FG001|Overall Study|Adverse Event|9|||
105970151|NCT04049266|365549862|FG000|Overall Study|Non-compliance with study drug|0|||
105970152|NCT04049266|365549863|FG001|Overall Study|Non-compliance with study drug|3|||
105970153|NCT04049266|365549862|FG000|Overall Study|Withdrawal by Subject|6|||
105970154|NCT04049266|365549863|FG001|Overall Study|Withdrawal by Subject|10|||
105970155|NCT04049266|365549862|FG000|Overall Study|Lost to Follow-up|2|||
105970156|NCT04049266|365549863|FG001|Overall Study|Lost to Follow-up|2|||
105970157|NCT04049266|365549862|FG000|Overall Study|Progressive disease|11|||
105970158|NCT04049266|365549863|FG001|Overall Study|Progressive disease|2|||
105970159|NCT04049266|365549862|FG000|Overall Study|Physician Decision|1|||
105970160|NCT04049266|365549863|FG001|Overall Study|Physician Decision|0|||
105970161|NCT04049266|365549862|FG000|Overall Study|Patient moved out of state|1|||
105970162|NCT04049266|365549863|FG001|Overall Study|Patient moved out of state|0|||
105970163|NCT01534260|365549864|FG000|Overall Study|Adverse Event|1|||
105970164|NCT01534260|365549865|FG001|Overall Study|Adverse Event|8|||
105970165|NCT01534260|365549864|FG000|Overall Study|Death|2|||
105970166|NCT01534260|365549865|FG001|Overall Study|Death|0|||
105970167|NCT01534260|365549864|FG000|Overall Study|Lack of Efficacy|1|||
105970168|NCT01534260|365549865|FG001|Overall Study|Lack of Efficacy|1|||
105970169|NCT01534260|365549864|FG000|Overall Study|Withdrawal by Subject|1|||
105970170|NCT01534260|365549865|FG001|Overall Study|Withdrawal by Subject|3|||
105970171|NCT01534260|365549864|FG000|Overall Study|Disease Progression|8|||
105970172|NCT01534260|365549865|FG001|Overall Study|Disease Progression|6|||
105970173|NCT01534260|365549864|FG000|Overall Study|Physician Decision|3|||
105970174|NCT01534260|365549865|FG001|Overall Study|Physician Decision|1|||
105970175|NCT01534260|365549864|FG000|Overall Study|No treatment, per protocol|0|||
105970176|NCT01534260|365549865|FG001|Overall Study|No treatment, per protocol|1|||
105970177|NCT01703208|365549866|FG000|Overall Study|Death|61|||
105970178|NCT01703208|365549867|FG001|Overall Study|Death|48|||
105970179|NCT01703208|365549866|FG000|Overall Study|Lack of Efficacy|1|||
105970180|NCT01703208|365549867|FG001|Overall Study|Lack of Efficacy|2|||
105970181|NCT01703208|365549866|FG000|Overall Study|Lost to Follow-up|68|||
105970182|NCT01703208|365549867|FG001|Overall Study|Lost to Follow-up|62|||
105970183|NCT01703208|365549866|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105970184|NCT01703208|365549867|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105970185|NCT01703208|365549866|FG000|Overall Study|Excluded Medication|1|||
105970186|NCT01703208|365549867|FG001|Overall Study|Excluded Medication|2|||
105970187|NCT01703208|365549866|FG000|Overall Study|Site Discontinued Study Participation|23|||
105970188|NCT01703208|365549867|FG001|Overall Study|Site Discontinued Study Participation|27|||
105970189|NCT01703208|365549866|FG000|Overall Study|Physician Decision|11|||
105970190|NCT01703208|365549867|FG001|Overall Study|Physician Decision|13|||
105970191|NCT01703208|365549866|FG000|Overall Study|Progressive disease|2|||
105970192|NCT01703208|365549867|FG001|Overall Study|Progressive disease|2|||
105970193|NCT01703208|365549866|FG000|Overall Study|Protocol Violation|1|||
105970194|NCT01703208|365549867|FG001|Overall Study|Protocol Violation|1|||
105970195|NCT01703208|365549866|FG000|Overall Study|Study Terminated by Sponsor|1710|||
105970196|NCT01703208|365549867|FG001|Overall Study|Study Terminated by Sponsor|1716|||
105970197|NCT01703208|365549866|FG000|Overall Study|Withdrawal by Subject|205|||
106024692|NCT00373113|365756567|FG001|Overall Study|Objective progression or relapse|169|||
105970198|NCT01703208|365549867|FG001|Overall Study|Withdrawal by Subject|209|||
105970199|NCT01703208|365549866|FG000|Overall Study|Adverse Event|14|||
106024693|NCT00373113|365756566|FG000|Overall Study|Other|14|||
105970200|NCT01703208|365549867|FG001|Overall Study|Adverse Event|19|||
105970201|NCT01703208|365549866|FG000|Overall Study|Technical Problems|0|||
105970202|NCT01703208|365549867|FG001|Overall Study|Technical Problems|1|||
105970203|NCT01703208|365549866|FG000|Overall Study|Protocol Deviation|2|||
105970204|NCT01703208|365549867|FG001|Overall Study|Protocol Deviation|0|||
105970205|NCT02359045|365549870|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
105843369|NCT01360866|365084196|FG001|Overall Study|Protocol Deviation|33|||
105843370|NCT01360866|365084197|FG002|Overall Study|Protocol Deviation|61|||
105843371|NCT01360866|365084198|FG003|Overall Study|Protocol Deviation|2|||
105843372|NCT01360866|365084195|FG000|Overall Study|Lack of Efficacy|30|||
105843373|NCT01360866|365084196|FG001|Overall Study|Lack of Efficacy|40|||
105843374|NCT01360866|365084197|FG002|Overall Study|Lack of Efficacy|30|||
105843375|NCT01360866|365084198|FG003|Overall Study|Lack of Efficacy|4|||
105843376|NCT03702049|365084202|FG000|Overall Study|Lost to Follow-up|4|||
105843377|NCT03702049|365084202|FG000|Overall Study|Physician Decision|1|||
105843378|NCT05016622|365084203|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
105843379|NCT05016622|365084203|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
105843380|NCT03197558|365084204|FG000|Overall Study|Tubes not placed|1|||
105843381|NCT01014624|365084207|FG000|Overall Study|Adverse Event|0|||
105843382|NCT01014624|365084208|FG001|Overall Study|Adverse Event|1|||
105843383|NCT01014624|365084207|FG000|Overall Study|Protocol Violation|1|||
105843384|NCT01014624|365084208|FG001|Overall Study|Protocol Violation|0|||
105843385|NCT01014624|365084207|FG000|Overall Study|Withdrawal by Subject|1|||
105843386|NCT01014624|365084208|FG001|Overall Study|Withdrawal by Subject|0|||
105843387|NCT02954159|365084211|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
105843388|NCT02954159|365084212|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
105843389|NCT02954159|365084211|FG000|Overall Study|Withdrawal by Subject|0|||
105843390|NCT02954159|365084212|FG001|Overall Study|Withdrawal by Subject|1|||
105843391|NCT00986570|365084214|FG000|Overall Study|Lost to Follow-up|6|||
105843392|NCT00986570|365084214|FG000|Overall Study|Potential bias for objective assessment|1|||
105843393|NCT03575871|365084221|FG000|Overall Study|Adverse Event|5|||
105843394|NCT03575871|365084222|FG001|Overall Study|Adverse Event|5|||
105843395|NCT03575871|365084223|FG002|Overall Study|Adverse Event|8|||
105843396|NCT03575871|365084221|FG000|Overall Study|Death|1|||
105843397|NCT03575871|365084222|FG001|Overall Study|Death|0|||
105843398|NCT03575871|365084223|FG002|Overall Study|Death|0|||
105843399|NCT03575871|365084221|FG000|Overall Study|Lack of Efficacy|5|||
105843400|NCT03575871|365084222|FG001|Overall Study|Lack of Efficacy|4|||
105843401|NCT03575871|365084223|FG002|Overall Study|Lack of Efficacy|7|||
105843402|NCT03575871|365084221|FG000|Overall Study|Lost to Follow-up|1|||
105843403|NCT03575871|365084222|FG001|Overall Study|Lost to Follow-up|1|||
105843404|NCT03575871|365084223|FG002|Overall Study|Lost to Follow-up|1|||
105843405|NCT03575871|365084221|FG000|Overall Study|Protocol Deviation|1|||
105843406|NCT03575871|365084222|FG001|Overall Study|Protocol Deviation|1|||
105843407|NCT03575871|365084223|FG002|Overall Study|Protocol Deviation|1|||
105843408|NCT03575871|365084221|FG000|Overall Study|Withdrawal by Subject|6|||
105843409|NCT03575871|365084222|FG001|Overall Study|Withdrawal by Subject|1|||
105843410|NCT03575871|365084223|FG002|Overall Study|Withdrawal by Subject|9|||
105843411|NCT03575871|365084221|FG000|Overall Study|Other than specified|2|||
105843412|NCT03575871|365084222|FG001|Overall Study|Other than specified|2|||
105843413|NCT03575871|365084223|FG002|Overall Study|Other than specified|0|||
105843414|NCT05506358|365084224|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
105843415|NCT05506358|365084225|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
105843416|NCT05506358|365084226|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
105843417|NCT05506358|365084227|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
105843418|NCT05506358|365084228|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
105843419|NCT05506358|365084224|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
105843420|NCT05506358|365084225|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
105843421|NCT05506358|365084226|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
105843422|NCT05506358|365084227|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
105843423|NCT05506358|365084228|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
105843424|NCT05506358|365084224|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
105843425|NCT05506358|365084225|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
105843426|NCT05506358|365084226|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
105843427|NCT05506358|365084227|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
105843428|NCT05506358|365084228|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
105843429|NCT05506358|365084224|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
105970206|NCT02359045|365549871|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
105843430|NCT05506358|365084225|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
105843431|NCT05506358|365084226|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
105843432|NCT05506358|365084227|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
105843433|NCT05506358|365084228|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
105970207|NCT02359045|365549870|FG000|Overall Study|Lost to Follow-up|1|||
105970208|NCT02359045|365549871|FG001|Overall Study|Lost to Follow-up|1|||
105843434|NCT05506358|365084224|FG000|Overall Study|HbE trait|0|||
105843435|NCT05506358|365084225|FG001|Overall Study|HbE trait|0|||
105970209|NCT02359045|365549870|FG000|Overall Study|Adverse Event|0|||
105970210|NCT02359045|365549871|FG001|Overall Study|Adverse Event|1|||
105970211|NCT02099344|365549872|FG000|Overall Study|Physician Decision|1|||
105970212|NCT02099344|365549873|FG001|Overall Study|Physician Decision|0|||
105970213|NCT00404755|365549879|FG000|Phase I (Bupropion)|Adverse Event|3|||
105970214|NCT00404755|365549879|FG000|Phase I (Bupropion)|Other|1|||
105970215|NCT00404755|365549879|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
105970216|NCT01967823|365551191|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
105970217|NCT02456636|365551195|FG000|Overall Study|Death|0|||
105970218|NCT02456636|365551196|FG001|Overall Study|Death|3|||
105970219|NCT02456636|365551197|FG002|Overall Study|Death|0|||
105970220|NCT02456636|365551195|FG000|Overall Study|Pregnancy|1|||
105970221|NCT02456636|365551196|FG001|Overall Study|Pregnancy|3|||
105970222|NCT02456636|365551197|FG002|Overall Study|Pregnancy|5|||
105970223|NCT02456636|365551195|FG000|Overall Study|Physician Decision|4|||
105970224|NCT02456636|365551196|FG001|Overall Study|Physician Decision|5|||
105970225|NCT02456636|365551197|FG002|Overall Study|Physician Decision|4|||
105970226|NCT02456636|365551195|FG000|Overall Study|Withdrawal by Subject|13|||
105970227|NCT02456636|365551196|FG001|Overall Study|Withdrawal by Subject|14|||
105970228|NCT02456636|365551197|FG002|Overall Study|Withdrawal by Subject|16|||
105970229|NCT02456636|365551195|FG000|Overall Study|Lost to Follow-up|50|||
105970230|NCT02456636|365551196|FG001|Overall Study|Lost to Follow-up|44|||
105970231|NCT02456636|365551197|FG002|Overall Study|Lost to Follow-up|50|||
105970232|NCT00413894|365551198|FG000|Overall Study|Withdrawal by Subject|10|||
105970233|NCT00413894|365551198|FG000|Overall Study|Administrative Reasons|1|||
105970234|NCT00413894|365551198|FG000|Overall Study|Hb <10 grams/deciliter|12|||
105970235|NCT00413894|365551198|FG000|Overall Study|Adverse Event|28|||
105970236|NCT00413894|365551198|FG000|Overall Study|Protocol Violation|11|||
105970237|NCT00413894|365551198|FG000|Overall Study|Other|18|||
105970238|NCT04225676|365551199|FG000|Overall Study|Physician Decision|1|||
105970239|NCT04225676|365551199|FG000|Overall Study|Lack of Efficacy|1|||
105970240|NCT04225676|365551199|FG000|Overall Study|Study terminated by sponsor|3|||
105970241|NCT03245736|365551200|FG000|Overall Study|Adverse Event|1|||
105970242|NCT03245736|365551200|FG000|Overall Study|Progressive Disease|4|||
105970243|NCT01942161|365551201|FG000|Overall Study|Adverse Event|1|||
105970244|NCT01942161|365551202|FG001|Overall Study|Adverse Event|2|||
105970245|NCT01942161|365551203|FG002|Overall Study|Adverse Event|5|||
105970246|NCT01942161|365551201|FG000|Overall Study|Physician Decision|3|||
105970247|NCT01942161|365551202|FG001|Overall Study|Physician Decision|1|||
105970248|NCT01942161|365551203|FG002|Overall Study|Physician Decision|0|||
105970249|NCT01942161|365551201|FG000|Overall Study|Protocol Violation|1|||
105970250|NCT01942161|365551202|FG001|Overall Study|Protocol Violation|0|||
105970251|NCT01942161|365551203|FG002|Overall Study|Protocol Violation|0|||
105970252|NCT01942161|365551201|FG000|Overall Study|Withdrawal by Subject|3|||
105970253|NCT01942161|365551202|FG001|Overall Study|Withdrawal by Subject|3|||
105970254|NCT01942161|365551203|FG002|Overall Study|Withdrawal by Subject|1|||
105970255|NCT02379221|365551204|FG000|Overall Study|Lost to Follow-up|1|||
105970256|NCT02019108|365551205|FG000|Overall Study|Lost to Follow-up|5|||
105970257|NCT02019108|365551206|FG001|Overall Study|Lost to Follow-up|7|||
105970258|NCT02688088|365551208|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
105970259|NCT02688088|365551209|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
105970260|NCT02688088|365551210|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
105970261|NCT02688088|365551211|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
105970262|NCT02688088|365551212|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
105970263|NCT02688088|365551208|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
105970264|NCT02688088|365551209|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
105970265|NCT02688088|365551210|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
105970266|NCT02688088|365551211|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
105970267|NCT02688088|365551212|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
105970268|NCT02688088|365551208|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
105970269|NCT02688088|365551209|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
105970270|NCT02688088|365551210|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
105970271|NCT02688088|365551211|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
105970272|NCT02688088|365551212|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
105970273|NCT02688088|365551208|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
105970274|NCT02688088|365551209|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
105970275|NCT02688088|365551210|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
105970276|NCT02688088|365551211|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
105970277|NCT02688088|365551212|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
105970278|NCT02688088|365551208|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
105970279|NCT02688088|365551209|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
105970280|NCT02688088|365551210|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
105970281|NCT02688088|365551211|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
105970282|NCT02688088|365551212|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
106149474|NCT03779048|366209120|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
105843436|NCT05506358|365084226|FG002|Overall Study|HbE trait|0|||
105843437|NCT05506358|365084227|FG003|Overall Study|HbE trait|1|||
105843438|NCT05506358|365084228|FG004|Overall Study|HbE trait|0|||
105843439|NCT00804141|365084232|FG000|Overall Study|Adverse Event|157|||
105843440|NCT00804141|365084232|FG000|Overall Study|Death|4|||
105843441|NCT00804141|365084232|FG000|Overall Study|Failed to return|96|||
105843442|NCT00804141|365084232|FG000|Overall Study|Investigator request|8|||
105843443|NCT00804141|365084232|FG000|Overall Study|Protocol Violation|85|||
105843444|NCT00804141|365084232|FG000|Overall Study|Withdrawal by Subject|131|||
105843445|NCT00804141|365084232|FG000|Overall Study|Lack of Efficacy|46|||
105843446|NCT00804141|365084232|FG000|Overall Study|Other than specified|30|||
105843447|NCT00804141|365084232|FG000|Overall Study|Enrolled but not treated|6|||
105843448|NCT00608517|365084233|FG000|Overall Study|Death|1|||
105843449|NCT00608517|365084234|FG001|Overall Study|Death|0|||
105843450|NCT00608517|365084235|FG002|Overall Study|Death|0|||
105843451|NCT02791893|365084236|FG000|Blinded Phase|Lost to Follow-up|2|||
105843452|NCT02791893|365084237|FG001|Blinded Phase|Lost to Follow-up|2|||
105843453|NCT02791893|365084236|FG000|Blinded Phase|Withdrawal by Subject|1|||
105843454|NCT02791893|365084237|FG001|Blinded Phase|Withdrawal by Subject|2|||
105843455|NCT02791893|365084236|FG000|Open Label Phase|Lost to Follow-up|3|||
105843456|NCT02791893|365084237|FG001|Open Label Phase|Lost to Follow-up|0|||
105843457|NCT02791893|365084236|FG000|Open Label Phase|Withdrawal by Subject|0|||
105843458|NCT02791893|365084237|FG001|Open Label Phase|Withdrawal by Subject|2|||
105843459|NCT01833533|365084238|FG000|Overall Study|Adverse Event|0|||
105843460|NCT01833533|365084239|FG001|Overall Study|Adverse Event|1|||
105843461|NCT01833533|365084238|FG000|Overall Study|Lost to Follow-up|4|||
105843462|NCT01833533|365084239|FG001|Overall Study|Lost to Follow-up|9|||
105843463|NCT01833533|365084238|FG000|Overall Study|To Enter an Extension Study|0|||
105843464|NCT01833533|365084239|FG001|Overall Study|To Enter an Extension Study|4|||
105843465|NCT01833533|365084238|FG000|Overall Study|Other|2|||
105843466|NCT01833533|365084239|FG001|Overall Study|Other|7|||
105843467|NCT01173471|365084240|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105843468|NCT01173471|365084241|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105843469|NCT01173471|365084242|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105843470|NCT01173471|365084243|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
105843471|NCT01173471|365084240|FG000|Overall Study|Condition under investigation worsened|2|||
105843472|NCT01173471|365084241|FG001|Overall Study|Condition under investigation worsened|0|||
105843473|NCT01173471|365084242|FG002|Overall Study|Condition under investigation worsened|0|||
105843474|NCT01173471|365084243|FG003|Overall Study|Condition under investigation worsened|0|||
105843475|NCT01173471|365084240|FG000|Overall Study|Lost to Follow-up|0|||
105843476|NCT01173471|365084241|FG001|Overall Study|Lost to Follow-up|0|||
105843477|NCT01173471|365084242|FG002|Overall Study|Lost to Follow-up|1|||
105843478|NCT01173471|365084243|FG003|Overall Study|Lost to Follow-up|0|||
105843479|NCT01173471|365084240|FG000|Overall Study|Reason given as Other|0|||
105843480|NCT01173471|365084241|FG001|Overall Study|Reason given as Other|0|||
105843481|NCT01173471|365084242|FG002|Overall Study|Reason given as Other|1|||
105843482|NCT01173471|365084243|FG003|Overall Study|Reason given as Other|0|||
105843483|NCT00572039|365084244|FG000|Overall Study|Withdrawal by Subject|9|||
105843484|NCT00572039|365084245|FG001|Overall Study|Withdrawal by Subject|6|||
105843485|NCT00572039|365084244|FG000|Overall Study|Death|2|||
105843486|NCT00572039|365084245|FG001|Overall Study|Death|3|||
105843487|NCT00572039|365084244|FG000|Overall Study|Ill|5|||
105843488|NCT00572039|365084245|FG001|Overall Study|Ill|1|||
105843489|NCT00171301|365084246|FG000|Overall Study|Death|1|||
105843490|NCT00171301|365084247|FG001|Overall Study|Death|2|||
105843491|NCT00171301|365084246|FG000|Overall Study|Adverse Event|1|||
105843492|NCT00171301|365084247|FG001|Overall Study|Adverse Event|2|||
105843493|NCT00171301|365084246|FG000|Overall Study|Lost to Follow-up|6|||
105843494|NCT00171301|365084247|FG001|Overall Study|Lost to Follow-up|2|||
105843495|NCT00171301|365084246|FG000|Overall Study|Protocol Violation|0|||
105843496|NCT00171301|365084247|FG001|Overall Study|Protocol Violation|2|||
105843497|NCT00171301|365084246|FG000|Overall Study|Withdrawal by Subject|0|||
105843498|NCT00171301|365084247|FG001|Overall Study|Withdrawal by Subject|1|||
105843499|NCT03463993|365084253|FG000|Overall Study|Lost to Follow-up|7|||
105843500|NCT03463993|365084254|FG001|Overall Study|Lost to Follow-up|8|||
105843501|NCT03463993|365084253|FG000|Overall Study|Withdrawal by Subject|2|||
105843502|NCT03463993|365084254|FG001|Overall Study|Withdrawal by Subject|0|||
105843503|NCT03463993|365084253|FG000|Overall Study|Protocol Violation|4|||
105843504|NCT03463993|365084254|FG001|Overall Study|Protocol Violation|1|||
105843505|NCT03463993|365084253|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
105843506|NCT03463993|365084254|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
105843507|NCT03463993|365084253|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
105843508|NCT03463993|365084254|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
105843509|NCT05206448|365084255|FG000|Overall Study|Lost to Follow-up|2|||
105843510|NCT05206448|365084256|FG001|Overall Study|Lost to Follow-up|2|||
105843511|NCT05206448|365084255|FG000|Overall Study|Withdrawal by Subject|2|||
105970283|NCT02688088|365551208|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
105970284|NCT02688088|365551209|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
105970285|NCT02688088|365551210|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
105970286|NCT02688088|365551211|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
105970287|NCT02688088|365551212|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
105970288|NCT02688088|365551208|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
105970289|NCT02688088|365551209|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
105970290|NCT02688088|365551210|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
105970291|NCT02688088|365551211|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
105970292|NCT02688088|365551212|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
105970293|NCT02688088|365551208|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
105970294|NCT02688088|365551209|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
105970295|NCT02688088|365551210|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
105970296|NCT02688088|365551211|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
105970297|NCT02688088|365551212|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
105970298|NCT02688088|365551208|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
105970299|NCT02688088|365551209|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
105970300|NCT02688088|365551210|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
105970301|NCT02688088|365551211|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
105970302|NCT02688088|365551212|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
105970303|NCT01728077|365551215|FG000|Overall Study|Lack of Efficacy|3|||
105970304|NCT01728077|365551216|FG001|Overall Study|Lack of Efficacy|1|||
105970305|NCT01728077|365551215|FG000|Overall Study|Lost to Follow-up|1|||
105970306|NCT01728077|365551216|FG001|Overall Study|Lost to Follow-up|0|||
105970307|NCT01728077|365551215|FG000|Overall Study|Subject choice|2|||
105970308|NCT01728077|365551216|FG001|Overall Study|Subject choice|3|||
105970309|NCT01728077|365551215|FG000|Overall Study|Death|0|||
105970310|NCT01728077|365551216|FG001|Overall Study|Death|1|||
105970311|NCT01728077|365551215|FG000|Overall Study|Patient moving|1|||
105970312|NCT01728077|365551216|FG001|Overall Study|Patient moving|0|||
105970313|NCT01728077|365551215|FG000|Overall Study|Non compliance|1|||
105970314|NCT01728077|365551216|FG001|Overall Study|Non compliance|0|||
105970315|NCT02442310|365551217|FG000|Overall Study|Adverse Event|2|||
105970316|NCT02442310|365551217|FG000|Overall Study|Withdrawal by Subject|1|||
105970317|NCT00688324|365551218|FG000|Overall Study|Withdrawal by Subject|2|||
105970318|NCT00688324|365551218|FG000|Overall Study|Physician Decision|5|||
105970319|NCT00688324|365551218|FG000|Overall Study|Lost to Follow-up|1|||
105970320|NCT03176472|365551219|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
105970321|NCT03176472|365551220|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
105970322|NCT03176472|365551219|FG000|Double Blind Treatment Period|Adverse Event|0|||
105970323|NCT03176472|365551220|FG001|Double Blind Treatment Period|Adverse Event|5|||
105970324|NCT03176472|365551219|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
105970325|NCT03176472|365551220|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105970326|NCT03176472|365551219|FG000|Double Blind Treatment Period|Physician Decision|0|||
105970327|NCT03176472|365551220|FG001|Double Blind Treatment Period|Physician Decision|1|||
105970328|NCT03176472|365551219|FG000|Double Blind Treatment Period|Protocol Violation|1|||
105970329|NCT03176472|365551220|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105970330|NCT03176472|365551219|FG000|Double Blind Treatment Period|Not Provided|1|||
105970331|NCT03176472|365551220|FG001|Double Blind Treatment Period|Not Provided|0|||
105970332|NCT03176472|365551219|FG000|Open Label Extension|Withdrawal by Subject|3|||
105970333|NCT03176472|365551220|FG001|Open Label Extension|Withdrawal by Subject|4|||
105970334|NCT03176472|365551219|FG000|Open Label Extension|Adverse Event|2|||
105970335|NCT03176472|365551220|FG001|Open Label Extension|Adverse Event|4|||
105970336|NCT03176472|365551219|FG000|Open Label Extension|Lost to Follow-up|1|||
105970337|NCT03176472|365551220|FG001|Open Label Extension|Lost to Follow-up|2|||
105970338|NCT03176472|365551219|FG000|Open Label Extension|Protocol Violation|0|||
105970339|NCT03176472|365551220|FG001|Open Label Extension|Protocol Violation|1|||
105970340|NCT03176472|365551219|FG000|Open Label Extension|Not Provided|2|||
105970341|NCT03176472|365551220|FG001|Open Label Extension|Not Provided|1|||
105970342|NCT00596154|365551221|FG000|Overall Study|Not Evaluable|2|||
105970343|NCT00624585|365551225|FG000|Overall Study|Death|3|||
105970344|NCT00624585|365551225|FG000|Overall Study|Disease Progression|6|||
105970345|NCT00624585|365551225|FG000|Overall Study|Adverse Event|3|||
105970346|NCT01190475|365551226|FG000|Overall Study|Withdrawal by Subject|0|||
105970347|NCT01190475|365551227|FG001|Overall Study|Withdrawal by Subject|0|||
105987453|NCT02814175|365614462|FG002|Part 1|Withdrawal Consent|0|||
105843512|NCT05206448|365084256|FG001|Overall Study|Withdrawal by Subject|0|||
105843513|NCT05206448|365084255|FG000|Overall Study|found ineligible after randomization|1|||
105843514|NCT05206448|365084256|FG001|Overall Study|found ineligible after randomization|1|||
105843515|NCT05206448|365084255|FG000|Overall Study|unable to complete study due to personal constraints|1|||
105843516|NCT05206448|365084256|FG001|Overall Study|unable to complete study due to personal constraints|0|||
105843517|NCT05206448|365084255|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
105843518|NCT05206448|365084256|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
105843519|NCT00754442|365084260|FG000|Overall Study|Withdrawal by Subject|5|||
105843520|NCT00754442|365084261|FG001|Overall Study|Withdrawal by Subject|3|||
105843521|NCT01557842|365084262|FG000|Overall Study|Lost to Follow-up|0|||
105843522|NCT01557842|365084263|FG001|Overall Study|Lost to Follow-up|1|||
105843523|NCT01557842|365084262|FG000|Overall Study|Death|1|||
105843524|NCT01557842|365084263|FG001|Overall Study|Death|0|||
105843525|NCT01557842|365084262|FG000|Overall Study|Lack of Efficacy|0|||
105843526|NCT01557842|365084263|FG001|Overall Study|Lack of Efficacy|1|||
105843527|NCT01557842|365084262|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
105843528|NCT01557842|365084263|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
105843529|NCT01557842|365084262|FG000|Overall Study|Study Terminated by Sponsor|3|||
105843530|NCT01557842|365084263|FG001|Overall Study|Study Terminated by Sponsor|4|||
105843531|NCT01557842|365084262|FG000|Overall Study|Not Ablated|2|||
105843532|NCT01557842|365084263|FG001|Overall Study|Not Ablated|0|||
105843533|NCT02025010|365084264|FG000|Overall Study|Symptomatic or radiographic progression|36|||
105843534|NCT02025010|365084264|FG000|Overall Study|Adverse Event|6|||
105843535|NCT02025010|365084264|FG000|Overall Study|Physician Decision|7|||
105843536|NCT02025010|365084264|FG000|Overall Study|Withdrawal by Subject|3|||
105843537|NCT02025010|365084264|FG000|Overall Study|Intercurrent illness|3|||
105843538|NCT02025010|365084264|FG000|Overall Study|Patients still on treatment|3|||
105843539|NCT02025010|365084264|FG000|Overall Study|Never initiate the treatment|2|||
105843540|NCT03005067|365084265|FG000|Overall Study|Withdrawal by Subject|3|||
105843541|NCT03005067|365084266|FG001|Overall Study|Withdrawal by Subject|2|||
105843542|NCT03005067|365084265|FG000|Overall Study|Adverse Event|4|||
105843543|NCT03005067|365084266|FG001|Overall Study|Adverse Event|3|||
105843544|NCT03005067|365084265|FG000|Overall Study|Other (reason not specified)|3|||
105970348|NCT01190475|365551228|FG002|Overall Study|Withdrawal by Subject|1|||
105970349|NCT03960580|365551229|FG000|Overall Study|Adverse Event|2|||
105970350|NCT03960580|365551230|FG001|Overall Study|Adverse Event|1|||
105970351|NCT03960580|365551231|FG002|Overall Study|Adverse Event|1|||
105970352|NCT03960580|365551229|FG000|Overall Study|Lost to Follow-up|1|||
105970353|NCT03960580|365551230|FG001|Overall Study|Lost to Follow-up|0|||
105970354|NCT03960580|365551231|FG002|Overall Study|Lost to Follow-up|0|||
105970355|NCT03960580|365551229|FG000|Overall Study|Lack of Efficacy|2|||
105970356|NCT03960580|365551230|FG001|Overall Study|Lack of Efficacy|1|||
105970357|NCT03960580|365551231|FG002|Overall Study|Lack of Efficacy|0|||
105970358|NCT03960580|365551229|FG000|Overall Study|Protocol Violation|0|||
105970359|NCT03960580|365551230|FG001|Overall Study|Protocol Violation|0|||
105970360|NCT03960580|365551231|FG002|Overall Study|Protocol Violation|1|||
105970361|NCT03960580|365551229|FG000|Overall Study|Withdrawal by Subject|1|||
105970362|NCT03960580|365551230|FG001|Overall Study|Withdrawal by Subject|1|||
105970363|NCT03960580|365551231|FG002|Overall Study|Withdrawal by Subject|1|||
105970364|NCT03960580|365551229|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
105970365|NCT03960580|365551230|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
105970366|NCT03960580|365551231|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
105970367|NCT00666588|365551234|FG000|Overall Study|ineligible|2|||
105970368|NCT00666588|365551235|FG001|Overall Study|ineligible|0|||
105970369|NCT00666588|365551236|FG002|Overall Study|ineligible|0|||
105970370|NCT00666588|365551237|FG003|Overall Study|ineligible|2|||
105843545|NCT03005067|365084266|FG001|Overall Study|Other (reason not specified)|1|||
105843546|NCT03005067|365084265|FG000|Overall Study|Protocol Violation|0|||
105843547|NCT03005067|365084266|FG001|Overall Study|Protocol Violation|1|||
105970371|NCT00666588|365551234|FG000|Overall Study|inevaluable|2|||
105970372|NCT00666588|365551235|FG001|Overall Study|inevaluable|0|||
105970373|NCT00666588|365551236|FG002|Overall Study|inevaluable|0|||
105970374|NCT00666588|365551237|FG003|Overall Study|inevaluable|0|||
105970375|NCT04043234|365551238|FG000|Overall Study|Lost to Follow-up|1|||
105843548|NCT00619359|365084267|FG000|Overall Study|Adverse Event|32|||
105843549|NCT00619359|365084268|FG001|Overall Study|Adverse Event|36|||
105843550|NCT00619359|365084267|FG000|Overall Study|Lost to Follow-up|12|||
105843551|NCT00619359|365084268|FG001|Overall Study|Lost to Follow-up|16|||
105843552|NCT00619359|365084267|FG000|Overall Study|Physician Decision|0|||
105843553|NCT00619359|365084268|FG001|Overall Study|Physician Decision|7|||
105843554|NCT00619359|365084267|FG000|Overall Study|Protocol Violation|1|||
105843555|NCT00619359|365084268|FG001|Overall Study|Protocol Violation|1|||
105843556|NCT00619359|365084267|FG000|Overall Study|Withdrawal by Subject|19|||
105843557|NCT00619359|365084268|FG001|Overall Study|Withdrawal by Subject|20|||
105843558|NCT00619359|365084267|FG000|Overall Study|Progressive Disease|3|||
105843559|NCT00619359|365084268|FG001|Overall Study|Progressive Disease|1|||
105843560|NCT01661881|365084271|FG000|Overall Study|Disease Progression|1|||
105843561|NCT01929395|365084278|FG000|Overall Study|Did not complete - non-related toxicity|1|||
105843562|NCT01929395|365084279|FG001|Overall Study|Did not complete - non-related toxicity|0|||
105843563|NCT01929395|365084280|FG002|Overall Study|Did not complete - non-related toxicity|0|||
105843564|NCT01929395|365084278|FG000|Overall Study|Withdrawal by Subject|0|||
105843565|NCT01929395|365084279|FG001|Overall Study|Withdrawal by Subject|1|||
105843566|NCT01929395|365084280|FG002|Overall Study|Withdrawal by Subject|0|||
105843567|NCT01929395|365084278|FG000|Overall Study|Screen Fail|0|||
105843568|NCT01929395|365084279|FG001|Overall Study|Screen Fail|0|||
105843569|NCT01929395|365084280|FG002|Overall Study|Screen Fail|1|||
105843570|NCT02547766|365084281|FG000|Overall Study|Withdrawal by Subject|1|||
105843571|NCT00103038|365084284|FG000|Overall Study|Withdrawal by Subject|8|||
105843572|NCT00103038|365084284|FG000|Overall Study|Screen failure|3|||
105843573|NCT00103038|365084284|FG000|Overall Study|Death|1|||
105843574|NCT00103038|365084284|FG000|Overall Study|Physician Decision|1|||
105843575|NCT03604341|365084285|FG000|Overall Study|Withdrawal by Subject|1|||
105843576|NCT03604341|365084286|FG001|Overall Study|Withdrawal by Subject|1|||
105843577|NCT03604341|365084285|FG000|Overall Study|Adverse Event|1|||
105843578|NCT03604341|365084286|FG001|Overall Study|Adverse Event|0|||
105843579|NCT03604341|365084285|FG000|Overall Study|Protocol Violation|0|||
105843580|NCT03604341|365084286|FG001|Overall Study|Protocol Violation|1|||
105843581|NCT00484419|365084287|FG000|Overall Study|Adverse Event|3|||
105843582|NCT00484419|365084288|FG001|Overall Study|Adverse Event|0|||
105843583|NCT00484419|365084289|FG002|Overall Study|Adverse Event|0|||
105843584|NCT00484419|365084287|FG000|Overall Study|Lost to Follow-up|1|||
105843585|NCT00484419|365084288|FG001|Overall Study|Lost to Follow-up|0|||
105843586|NCT00484419|365084289|FG002|Overall Study|Lost to Follow-up|2|||
105843587|NCT00484419|365084287|FG000|Overall Study|Withdrawal by Subject|3|||
105843588|NCT00484419|365084288|FG001|Overall Study|Withdrawal by Subject|1|||
105843589|NCT00484419|365084289|FG002|Overall Study|Withdrawal by Subject|1|||
105843590|NCT00484419|365084287|FG000|Overall Study|subject met discontinuation criteria|2|||
105843591|NCT00484419|365084288|FG001|Overall Study|subject met discontinuation criteria|2|||
105843592|NCT00484419|365084289|FG002|Overall Study|subject met discontinuation criteria|4|||
105843593|NCT00484419|365084287|FG000|Overall Study|required restricted medication|1|||
105843594|NCT00484419|365084288|FG001|Overall Study|required restricted medication|0|||
105843595|NCT00484419|365084289|FG002|Overall Study|required restricted medication|1|||
105843596|NCT00484419|365084287|FG000|Overall Study|Physician Decision|1|||
105843597|NCT00484419|365084288|FG001|Overall Study|Physician Decision|1|||
105843598|NCT00484419|365084289|FG002|Overall Study|Physician Decision|1|||
105843599|NCT00484419|365084287|FG000|Overall Study|subject unable to receive medication|1|||
105843600|NCT00484419|365084288|FG001|Overall Study|subject unable to receive medication|0|||
105843601|NCT00484419|365084289|FG002|Overall Study|subject unable to receive medication|0|||
105843602|NCT00484419|365084287|FG000|Overall Study|subject relocated|0|||
105843603|NCT00484419|365084288|FG001|Overall Study|subject relocated|1|||
105843604|NCT00484419|365084289|FG002|Overall Study|subject relocated|0|||
105843605|NCT00484419|365084287|FG000|Overall Study|sponsor decision, randomized in error|0|||
105843606|NCT00484419|365084288|FG001|Overall Study|sponsor decision, randomized in error|0|||
105843607|NCT00484419|365084289|FG002|Overall Study|sponsor decision, randomized in error|2|||
105843608|NCT00355472|365084294|FG000|Overall Study|Physician Decision|1|||
105843609|NCT02010255|365084297|FG000|Overall Study|Death|0|||
105843610|NCT02010255|365084298|FG001|Overall Study|Death|1|||
105843611|NCT02010255|365084299|FG002|Overall Study|Death|4|||
105843612|NCT02010255|365084300|FG003|Overall Study|Death|4|||
105970376|NCT04043234|365551238|FG000|Overall Study|Withdrawal by Subject|1|||
105970377|NCT00385944|365551239|FG000|1st Maintenance Dose Period|Physician Decision|1|||
105970378|NCT00385944|365551240|FG001|1st Maintenance Dose Period|Physician Decision|0|||
105970379|NCT00385944|365551241|FG002|1st Maintenance Dose Period|Physician Decision|0|||
105970380|NCT00385944|365551239|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
105843613|NCT02010255|365084301|FG004|Overall Study|Death|2|||
105843614|NCT02010255|365084302|FG005|Overall Study|Death|0|||
105843615|NCT02010255|365084303|FG006|Overall Study|Death|1|||
105843616|NCT02010255|365084304|FG007|Overall Study|Death|1|||
105843617|NCT02010255|365084305|FG008|Overall Study|Death|1|||
105843618|NCT02010255|365084306|FG009|Overall Study|Death|0|||
105843619|NCT02010255|365084307|FG010|Overall Study|Death|1|||
105843620|NCT02010255|365084308|FG011|Overall Study|Death|1|||
105843621|NCT02010255|365084309|FG012|Overall Study|Death|0|||
105843622|NCT02010255|365084310|FG013|Overall Study|Death|0|||
105843623|NCT02010255|365084297|FG000|Overall Study|Lack of Efficacy|4|||
105843624|NCT02010255|365084298|FG001|Overall Study|Lack of Efficacy|1|||
105843625|NCT02010255|365084299|FG002|Overall Study|Lack of Efficacy|2|||
105843626|NCT02010255|365084300|FG003|Overall Study|Lack of Efficacy|1|||
105843627|NCT02010255|365084301|FG004|Overall Study|Lack of Efficacy|1|||
105843628|NCT02010255|365084302|FG005|Overall Study|Lack of Efficacy|0|||
105843629|NCT02010255|365084303|FG006|Overall Study|Lack of Efficacy|0|||
105843630|NCT02010255|365084304|FG007|Overall Study|Lack of Efficacy|0|||
105843631|NCT02010255|365084305|FG008|Overall Study|Lack of Efficacy|0|||
105843632|NCT02010255|365084306|FG009|Overall Study|Lack of Efficacy|0|||
105843633|NCT02010255|365084307|FG010|Overall Study|Lack of Efficacy|1|||
105843634|NCT02010255|365084308|FG011|Overall Study|Lack of Efficacy|0|||
105843635|NCT02010255|365084309|FG012|Overall Study|Lack of Efficacy|0|||
105843636|NCT02010255|365084310|FG013|Overall Study|Lack of Efficacy|0|||
105843637|NCT02010255|365084297|FG000|Overall Study|Withdrew Consent|1|||
105843638|NCT02010255|365084298|FG001|Overall Study|Withdrew Consent|0|||
105843639|NCT02010255|365084299|FG002|Overall Study|Withdrew Consent|0|||
105843640|NCT02010255|365084300|FG003|Overall Study|Withdrew Consent|1|||
105843641|NCT02010255|365084301|FG004|Overall Study|Withdrew Consent|0|||
105843642|NCT02010255|365084302|FG005|Overall Study|Withdrew Consent|0|||
105843643|NCT02010255|365084303|FG006|Overall Study|Withdrew Consent|0|||
105843644|NCT02010255|365084304|FG007|Overall Study|Withdrew Consent|0|||
105843645|NCT02010255|365084305|FG008|Overall Study|Withdrew Consent|0|||
105843646|NCT02010255|365084306|FG009|Overall Study|Withdrew Consent|0|||
105843647|NCT02010255|365084307|FG010|Overall Study|Withdrew Consent|0|||
105843648|NCT02010255|365084308|FG011|Overall Study|Withdrew Consent|0|||
105843649|NCT02010255|365084309|FG012|Overall Study|Withdrew Consent|0|||
105843650|NCT02010255|365084310|FG013|Overall Study|Withdrew Consent|0|||
105843651|NCT02010255|365084297|FG000|Overall Study|Adverse Event|1|||
105843652|NCT02010255|365084298|FG001|Overall Study|Adverse Event|0|||
105843653|NCT02010255|365084299|FG002|Overall Study|Adverse Event|0|||
105843654|NCT02010255|365084300|FG003|Overall Study|Adverse Event|0|||
105843655|NCT02010255|365084301|FG004|Overall Study|Adverse Event|0|||
105843656|NCT02010255|365084302|FG005|Overall Study|Adverse Event|0|||
105843657|NCT02010255|365084303|FG006|Overall Study|Adverse Event|0|||
105843658|NCT02010255|365084304|FG007|Overall Study|Adverse Event|0|||
105843659|NCT02010255|365084305|FG008|Overall Study|Adverse Event|0|||
105843660|NCT02010255|365084306|FG009|Overall Study|Adverse Event|0|||
105843661|NCT02010255|365084307|FG010|Overall Study|Adverse Event|0|||
105843662|NCT02010255|365084308|FG011|Overall Study|Adverse Event|0|||
105843663|NCT02010255|365084309|FG012|Overall Study|Adverse Event|0|||
105843664|NCT02010255|365084310|FG013|Overall Study|Adverse Event|0|||
105843665|NCT02010255|365084297|FG000|Overall Study|Lost to Follow-up|0|||
105843666|NCT02010255|365084298|FG001|Overall Study|Lost to Follow-up|0|||
105843667|NCT02010255|365084299|FG002|Overall Study|Lost to Follow-up|1|||
105843668|NCT02010255|365084300|FG003|Overall Study|Lost to Follow-up|0|||
105843669|NCT02010255|365084301|FG004|Overall Study|Lost to Follow-up|1|||
105843670|NCT02010255|365084302|FG005|Overall Study|Lost to Follow-up|0|||
105843671|NCT02010255|365084303|FG006|Overall Study|Lost to Follow-up|0|||
105843672|NCT02010255|365084304|FG007|Overall Study|Lost to Follow-up|0|||
105843673|NCT02010255|365084305|FG008|Overall Study|Lost to Follow-up|0|||
105843674|NCT02010255|365084306|FG009|Overall Study|Lost to Follow-up|0|||
105843675|NCT02010255|365084307|FG010|Overall Study|Lost to Follow-up|0|||
105843676|NCT02010255|365084308|FG011|Overall Study|Lost to Follow-up|0|||
105843677|NCT02010255|365084309|FG012|Overall Study|Lost to Follow-up|0|||
105843678|NCT02010255|365084310|FG013|Overall Study|Lost to Follow-up|0|||
105843679|NCT02010255|365084297|FG000|Overall Study|Randomized but Not Treated|0|||
105843680|NCT02010255|365084298|FG001|Overall Study|Randomized but Not Treated|0|||
105843681|NCT02010255|365084299|FG002|Overall Study|Randomized but Not Treated|0|||
105843682|NCT02010255|365084300|FG003|Overall Study|Randomized but Not Treated|0|||
105843683|NCT02010255|365084301|FG004|Overall Study|Randomized but Not Treated|0|||
105843684|NCT02010255|365084302|FG005|Overall Study|Randomized but Not Treated|0|||
105843685|NCT02010255|365084303|FG006|Overall Study|Randomized but Not Treated|0|||
105843686|NCT02010255|365084304|FG007|Overall Study|Randomized but Not Treated|0|||
105843687|NCT02010255|365084305|FG008|Overall Study|Randomized but Not Treated|0|||
105843688|NCT02010255|365084306|FG009|Overall Study|Randomized but Not Treated|0|||
105843689|NCT02010255|365084307|FG010|Overall Study|Randomized but Not Treated|0|||
105843690|NCT02010255|365084308|FG011|Overall Study|Randomized but Not Treated|0|||
105843691|NCT02010255|365084309|FG012|Overall Study|Randomized but Not Treated|0|||
105843692|NCT02010255|365084310|FG013|Overall Study|Randomized but Not Treated|1|||
105843693|NCT01144403|365084311|FG000|Overall Study|Lost to Follow-up|3|||
105843694|NCT01144403|365084311|FG000|Overall Study|Death|1|||
105843695|NCT01144403|365084311|FG000|Overall Study|Adverse Event|1|||
105843696|NCT03176784|365084312|FG000|Overall Study|Lost to Follow-up|77|||
105843697|NCT03176784|365084313|FG001|Overall Study|Lost to Follow-up|79|||
106149475|NCT03779048|366209121|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
105843698|NCT03176784|365084314|FG002|Overall Study|Lost to Follow-up|79|||
105843699|NCT03176784|365084315|FG003|Overall Study|Lost to Follow-up|49|||
105843700|NCT03176784|365084312|FG000|Overall Study|Withdrawal by Subject|28|||
105843701|NCT03176784|365084313|FG001|Overall Study|Withdrawal by Subject|34|||
105843702|NCT03176784|365084314|FG002|Overall Study|Withdrawal by Subject|34|||
105843703|NCT03176784|365084315|FG003|Overall Study|Withdrawal by Subject|21|||
105843704|NCT01010750|365084318|FG000|Second Intervention|Adverse Event|0|||
105843705|NCT01010750|365084319|FG001|Second Intervention|Adverse Event|1|||
105843706|NCT01010750|365084320|FG002|Second Intervention|Adverse Event|0|||
105843707|NCT01010750|365084321|FG003|Second Intervention|Adverse Event|0|||
105843708|NCT01010750|365084322|FG004|Second Intervention|Adverse Event|0|||
105843709|NCT01010750|365084323|FG005|Second Intervention|Adverse Event|0|||
105843710|NCT00094094|365084333|FG000|Overall Study|Death|2|||
105843711|NCT00094094|365084333|FG000|Overall Study|Lack of Efficacy|23|||
105843712|NCT00094094|365084333|FG000|Overall Study|Adverse Event|7|||
105843713|NCT01663727|365084334|FG000|Overall Study|Death|161|||
105843714|NCT01663727|365084335|FG001|Overall Study|Death|155|||
105843715|NCT01663727|365084334|FG000|Overall Study|Lost to Follow-up|10|||
105843716|NCT01663727|365084335|FG001|Overall Study|Lost to Follow-up|8|||
105843717|NCT01663727|365084334|FG000|Overall Study|Withdrawal by Subject|18|||
105843718|NCT01663727|365084335|FG001|Overall Study|Withdrawal by Subject|25|||
105843719|NCT01663727|365084334|FG000|Overall Study|Study Terminated|51|||
105843720|NCT01663727|365084335|FG001|Overall Study|Study Terminated|50|||
105843721|NCT01663727|365084334|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
105843722|NCT01663727|365084335|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
105843723|NCT01663727|365084334|FG000|Overall Study|Withdrawal prior to dosing.|1|||
106149476|NCT03779048|366209119|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
106149477|NCT03779048|366209120|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
106149478|NCT03779048|366209121|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
106149479|NCT05938413|366209129|FG000|Overall Study|Lost to Follow-up|1|||
106149480|NCT05938413|366209130|FG001|Overall Study|Lost to Follow-up|7|||
106149481|NCT05938413|366209129|FG000|Overall Study|Withdrawal by Subject|1|||
106149482|NCT05938413|366209130|FG001|Overall Study|Withdrawal by Subject|1|||
106149483|NCT04250883|366209133|FG000|Overall Study|Lost to Follow-up|1|||
106149484|NCT04250883|366209134|FG001|Overall Study|Lost to Follow-up|0|||
105970381|NCT00385944|365551240|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
105970382|NCT00385944|365551241|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
105970383|NCT00385944|365551239|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
105970384|NCT00385944|365551240|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
105970385|NCT00385944|365551241|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
105970386|NCT00385944|365551239|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
106149485|NCT04588259|366209135|FG000|Run-in Period|Run-in failure|0|||
106149486|NCT04588259|366209136|FG001|Run-in Period|Run-in failure|23|||
106149487|NCT04588259|366209135|FG000|Run-in Period|Withdrawn before randomisation|0|||
106149488|NCT04588259|366209136|FG001|Run-in Period|Withdrawn before randomisation|8|||
106149489|NCT04588259|366209135|FG000|Treatment Period|Withdrawal by Subject|6|||
106149490|NCT04588259|366209136|FG001|Treatment Period|Withdrawal by Subject|6|||
106149491|NCT04188379|366209140|FG000|Overall Study|Withdrawal by Subject|10|||
106149492|NCT04188379|366209141|FG001|Overall Study|Withdrawal by Subject|3|||
106149493|NCT04188379|366209140|FG000|Overall Study|Physician Decision|0|||
106149494|NCT04188379|366209141|FG001|Overall Study|Physician Decision|1|||
106149495|NCT04188379|366209140|FG000|Overall Study|Adverse Event|3|||
106149496|NCT04188379|366209141|FG001|Overall Study|Adverse Event|1|||
106149497|NCT04188379|366209140|FG000|Overall Study|Pregnancy|1|||
106149498|NCT04188379|366209141|FG001|Overall Study|Pregnancy|0|||
106149499|NCT04188379|366209140|FG000|Overall Study|Lack of Efficacy|8|||
105970387|NCT00385944|365551240|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
105970388|NCT00385944|365551241|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
106149500|NCT04188379|366209141|FG001|Overall Study|Lack of Efficacy|5|||
106149501|NCT04188379|366209140|FG000|Overall Study|Other|0|||
106149502|NCT04188379|366209141|FG001|Overall Study|Other|3|||
106149503|NCT00722046|366209142|FG000|Overall Study|Adverse Event|0|||
106149504|NCT00722046|366209143|FG001|Overall Study|Adverse Event|1|||
106149505|NCT00722046|366209144|FG002|Overall Study|Adverse Event|2|||
106149506|NCT00722046|366209145|FG003|Overall Study|Adverse Event|1|||
106149507|NCT00722046|366209146|FG004|Overall Study|Adverse Event|2|||
106149508|NCT00722046|366209147|FG005|Overall Study|Adverse Event|1|||
106149509|NCT00722046|366209148|FG006|Overall Study|Adverse Event|0|||
106149510|NCT00722046|366209142|FG000|Overall Study|Death|0|||
106149511|NCT00722046|366209143|FG001|Overall Study|Death|1|||
106149512|NCT00722046|366209144|FG002|Overall Study|Death|0|||
106149513|NCT00722046|366209145|FG003|Overall Study|Death|0|||
106149514|NCT00722046|366209146|FG004|Overall Study|Death|0|||
106149515|NCT00722046|366209147|FG005|Overall Study|Death|0|||
105843724|NCT01663727|365084335|FG001|Overall Study|Withdrawal prior to dosing.|0|||
105843725|NCT02522403|365086659|FG000|Overall Study|Lost to Follow-up|2|||
105843726|NCT02522403|365086660|FG001|Overall Study|Lost to Follow-up|2|||
106149516|NCT00722046|366209148|FG006|Overall Study|Death|2|||
106149517|NCT00722046|366209142|FG000|Overall Study|Protocol Violation|1|||
106149518|NCT00722046|366209143|FG001|Overall Study|Protocol Violation|0|||
106149519|NCT00722046|366209144|FG002|Overall Study|Protocol Violation|0|||
106149520|NCT00722046|366209145|FG003|Overall Study|Protocol Violation|0|||
106149521|NCT00722046|366209146|FG004|Overall Study|Protocol Violation|0|||
106149522|NCT00722046|366209147|FG005|Overall Study|Protocol Violation|1|||
106149523|NCT00722046|366209148|FG006|Overall Study|Protocol Violation|0|||
106149524|NCT00722046|366209142|FG000|Overall Study|Withdrawal by Subject|3|||
106149525|NCT00722046|366209143|FG001|Overall Study|Withdrawal by Subject|3|||
106149526|NCT00722046|366209144|FG002|Overall Study|Withdrawal by Subject|4|||
106149527|NCT00722046|366209145|FG003|Overall Study|Withdrawal by Subject|4|||
106149528|NCT00722046|366209146|FG004|Overall Study|Withdrawal by Subject|4|||
106149529|NCT00722046|366209147|FG005|Overall Study|Withdrawal by Subject|7|||
106149530|NCT00722046|366209148|FG006|Overall Study|Withdrawal by Subject|3|||
106149531|NCT00722046|366209142|FG000|Overall Study|Randomized, but not treated|1|||
106149532|NCT00722046|366209143|FG001|Overall Study|Randomized, but not treated|1|||
106149533|NCT00722046|366209144|FG002|Overall Study|Randomized, but not treated|0|||
106149534|NCT00722046|366209145|FG003|Overall Study|Randomized, but not treated|2|||
106149535|NCT00722046|366209146|FG004|Overall Study|Randomized, but not treated|0|||
106149536|NCT00722046|366209147|FG005|Overall Study|Randomized, but not treated|0|||
106149537|NCT00722046|366209148|FG006|Overall Study|Randomized, but not treated|0|||
106149538|NCT00722046|366209142|FG000|Overall Study|Other|0|||
106149539|NCT00722046|366209143|FG001|Overall Study|Other|0|||
106149540|NCT00722046|366209144|FG002|Overall Study|Other|1|||
106149541|NCT00722046|366209145|FG003|Overall Study|Other|1|||
106149542|NCT00722046|366209146|FG004|Overall Study|Other|3|||
106149543|NCT00722046|366209147|FG005|Overall Study|Other|2|||
106149544|NCT00722046|366209148|FG006|Overall Study|Other|1|||
106149545|NCT05773313|366209151|FG000|Overall Study|Lost to Follow-up|3|||
106149546|NCT04259450|366209152|FG000|Overall Study|Adverse event/ Toxicity|0|||
106149547|NCT04259450|366209153|FG001|Overall Study|Adverse event/ Toxicity|3|||
106149548|NCT04259450|366209154|FG002|Overall Study|Adverse event/ Toxicity|0|||
106149549|NCT04259450|366209155|FG003|Overall Study|Adverse event/ Toxicity|1|||
106149550|NCT04259450|366209156|FG004|Overall Study|Adverse event/ Toxicity|0|||
106149551|NCT04259450|366209157|FG005|Overall Study|Adverse event/ Toxicity|0|||
106149552|NCT04259450|366209158|FG006|Overall Study|Adverse event/ Toxicity|0|||
106149553|NCT04259450|366209159|FG007|Overall Study|Adverse event/ Toxicity|1|||
106149554|NCT04259450|366209160|FG008|Overall Study|Adverse event/ Toxicity|0|||
106149555|NCT04259450|366209161|FG009|Overall Study|Adverse event/ Toxicity|3|||
106149556|NCT04259450|366209152|FG000|Overall Study|Disease progression|2|||
106149557|NCT04259450|366209153|FG001|Overall Study|Disease progression|3|||
106149558|NCT04259450|366209154|FG002|Overall Study|Disease progression|4|||
106149559|NCT04259450|366209155|FG003|Overall Study|Disease progression|4|||
106149560|NCT04259450|366209156|FG004|Overall Study|Disease progression|6|||
106149561|NCT04259450|366209157|FG005|Overall Study|Disease progression|6|||
106149562|NCT04259450|366209158|FG006|Overall Study|Disease progression|6|||
106149563|NCT04259450|366209159|FG007|Overall Study|Disease progression|15|||
106149564|NCT04259450|366209160|FG008|Overall Study|Disease progression|6|||
106149565|NCT04259450|366209161|FG009|Overall Study|Disease progression|18|||
106149566|NCT04259450|366209152|FG000|Overall Study|Death|0|||
106149567|NCT04259450|366209153|FG001|Overall Study|Death|0|||
106149568|NCT04259450|366209154|FG002|Overall Study|Death|0|||
106149569|NCT04259450|366209155|FG003|Overall Study|Death|0|||
106149570|NCT04259450|366209156|FG004|Overall Study|Death|0|||
106149571|NCT04259450|366209157|FG005|Overall Study|Death|0|||
106149572|NCT04259450|366209158|FG006|Overall Study|Death|0|||
106149573|NCT04259450|366209159|FG007|Overall Study|Death|1|||
106149574|NCT04259450|366209160|FG008|Overall Study|Death|1|||
106149575|NCT04259450|366209161|FG009|Overall Study|Death|0|||
106149576|NCT04259450|366209152|FG000|Overall Study|Withdrawal by Subject|0|||
106149577|NCT04259450|366209153|FG001|Overall Study|Withdrawal by Subject|0|||
106149578|NCT04259450|366209154|FG002|Overall Study|Withdrawal by Subject|0|||
106149579|NCT04259450|366209155|FG003|Overall Study|Withdrawal by Subject|0|||
106149580|NCT04259450|366209156|FG004|Overall Study|Withdrawal by Subject|0|||
106149581|NCT04259450|366209157|FG005|Overall Study|Withdrawal by Subject|0|||
106149582|NCT04259450|366209158|FG006|Overall Study|Withdrawal by Subject|0|||
106149583|NCT04259450|366209159|FG007|Overall Study|Withdrawal by Subject|1|||
106149584|NCT04259450|366209160|FG008|Overall Study|Withdrawal by Subject|0|||
106149585|NCT04259450|366209161|FG009|Overall Study|Withdrawal by Subject|0|||
106149586|NCT04259450|366209152|FG000|Overall Study|Other than listed|0|||
106149587|NCT04259450|366209153|FG001|Overall Study|Other than listed|0|||
106149588|NCT04259450|366209154|FG002|Overall Study|Other than listed|0|||
106149589|NCT04259450|366209155|FG003|Overall Study|Other than listed|0|||
106149590|NCT04259450|366209156|FG004|Overall Study|Other than listed|0|||
106149591|NCT04259450|366209157|FG005|Overall Study|Other than listed|0|||
106149592|NCT04259450|366209158|FG006|Overall Study|Other than listed|0|||
106149593|NCT04259450|366209159|FG007|Overall Study|Other than listed|1|||
106149594|NCT04259450|366209160|FG008|Overall Study|Other than listed|1|||
106149595|NCT04259450|366209161|FG009|Overall Study|Other than listed|2|||
105970389|NCT00889603|365551242|FG000|Overall Study|Adverse Event|7|||
105970390|NCT00889603|365551242|FG000|Overall Study|Death|3|||
105970391|NCT00889603|365551242|FG000|Overall Study|Lost to Follow-up|19|||
105970392|NCT00889603|365551242|FG000|Overall Study|No longer willing to participant in stud|4|||
105970393|NCT00889603|365551242|FG000|Overall Study|Other|4|||
105970394|NCT05427539|365551245|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
105970395|NCT05427539|365551246|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
105970396|NCT05427539|365551245|FG000|Period 1|Withdrawal by Subject|1|||
105970397|NCT05427539|365551246|FG001|Period 1|Withdrawal by Subject|0|||
105970398|NCT02839720|365551247|FG000|Overall Study|Adverse Event|2|||
105970399|NCT02839720|365551247|FG000|Overall Study|Non-compliance|2|||
105970400|NCT02839720|365551247|FG000|Overall Study|Intercurrent Illness|1|||
105970401|NCT02839720|365551247|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
105970402|NCT01349322|365551250|FG000|Overall Study|Protocol Violation|45|||
105970403|NCT01349322|365551251|FG001|Overall Study|Protocol Violation|47|||
105970404|NCT01271712|365551252|FG000|Double Blind Treatment|Death|2|||
105970405|NCT01271712|365551253|FG001|Double Blind Treatment|Death|0|||
105970406|NCT01271712|365551252|FG000|Double Blind Treatment|Lack of Efficacy|1|||
105970407|NCT01271712|365551253|FG001|Double Blind Treatment|Lack of Efficacy|0|||
105970408|NCT01271712|365551252|FG000|Double Blind Treatment|Adverse Event|9|||
105970409|NCT01271712|365551253|FG001|Double Blind Treatment|Adverse Event|4|||
105970410|NCT01271712|365551252|FG000|Double Blind Treatment|Progressive disease|23|||
105843727|NCT02522403|365086659|FG000|Overall Study|Withdrawal by Subject|2|||
105843728|NCT02522403|365086660|FG001|Overall Study|Withdrawal by Subject|4|||
105843729|NCT00856973|365086661|FG000|Overall Study|Adverse Event|5|||
105843730|NCT00856973|365086662|FG001|Overall Study|Adverse Event|5|||
105843731|NCT00856973|365086663|FG002|Overall Study|Adverse Event|3|||
105843732|NCT00856973|365086661|FG000|Overall Study|Lost to Follow-up|6|||
105970411|NCT01271712|365551253|FG001|Double Blind Treatment|Progressive disease|3|||
105970412|NCT01271712|365551252|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
105970413|NCT01271712|365551253|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
105970414|NCT01271712|365551252|FG000|Double Blind Treatment|Non compliance with study drug|2|||
105970415|NCT01271712|365551253|FG001|Double Blind Treatment|Non compliance with study drug|0|||
105970416|NCT01271712|365551252|FG000|Double Blind Treatment|receive no study drug|1|||
105970417|NCT01271712|365551253|FG001|Double Blind Treatment|receive no study drug|0|||
105970418|NCT01271712|365551252|FG000|Open Label Treatment|Death|6|||
105970419|NCT01271712|365551253|FG001|Open Label Treatment|Death|5|||
105970420|NCT01271712|365551252|FG000|Open Label Treatment|Withdrawal by Subject|6|||
105970421|NCT01271712|365551253|FG001|Open Label Treatment|Withdrawal by Subject|11|||
105970422|NCT01271712|365551252|FG000|Open Label Treatment|Physician Decision|2|||
105970423|NCT01271712|365551253|FG001|Open Label Treatment|Physician Decision|0|||
105970424|NCT01271712|365551252|FG000|Open Label Treatment|Adverse Event|14|||
105970425|NCT01271712|365551253|FG001|Open Label Treatment|Adverse Event|8|||
105970426|NCT01271712|365551252|FG000|Open Label Treatment|Progressive disease|59|||
105970427|NCT01271712|365551253|FG001|Open Label Treatment|Progressive disease|32|||
105970428|NCT01271712|365551252|FG000|Open Label Treatment|transferred to rollover study|1|||
105970429|NCT01271712|365551253|FG001|Open Label Treatment|transferred to rollover study|0|||
105970430|NCT01271712|365551252|FG000|Open Label Treatment|Non-compliance with study drug|1|||
105970431|NCT01271712|365551253|FG001|Open Label Treatment|Non-compliance with study drug|0|||
105970432|NCT01271712|365551252|FG000|Open Label Treatment|Protocol Violation|0|||
105970433|NCT01271712|365551253|FG001|Open Label Treatment|Protocol Violation|1|||
105970434|NCT01271712|365551252|FG000|Open Label Treatment|Switching to other therapy|2|||
105970435|NCT01271712|365551253|FG001|Open Label Treatment|Switching to other therapy|1|||
105970436|NCT01271712|365551252|FG000|Safety Follow-up|Death|11|||
105970437|NCT01271712|365551253|FG001|Safety Follow-up|Death|7|||
105970438|NCT01271712|365551252|FG000|Safety Follow-up|Withdrawal by Subject|4|||
105970439|NCT01271712|365551253|FG001|Safety Follow-up|Withdrawal by Subject|2|||
105970440|NCT01271712|365551252|FG000|Safety Follow-up|Protocol Violation|1|||
105970441|NCT01271712|365551253|FG001|Safety Follow-up|Protocol Violation|1|||
105970442|NCT01271712|365551252|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
105970443|NCT01271712|365551253|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
105970444|NCT01271712|365551252|FG000|Safety Follow-up|No follow-up|1|||
105970445|NCT01271712|365551253|FG001|Safety Follow-up|No follow-up|1|||
105970446|NCT01271712|365551252|FG000|Safety Follow-up|Progressive disease|1|||
105970447|NCT01271712|365551253|FG001|Safety Follow-up|Progressive disease|0|||
105970448|NCT01271712|365551252|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
105970449|NCT01271712|365551253|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
105970450|NCT05593913|365551254|FG000|Overall Study|Insufficient image quality|39|||
105970451|NCT04470908|365551255|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
105970452|NCT00724854|365551258|FG000|Overall Study|Lack of Efficacy|187|||
105970453|NCT00724854|365551259|FG001|Overall Study|Lack of Efficacy|13|||
105970454|NCT00724854|365551258|FG000|Overall Study|Lost to Follow-up|87|||
105970455|NCT00724854|365551259|FG001|Overall Study|Lost to Follow-up|10|||
105970456|NCT00724854|365551258|FG000|Overall Study|Adverse Event|62|||
105970457|NCT00724854|365551259|FG001|Overall Study|Adverse Event|4|||
105970458|NCT00724854|365551258|FG000|Overall Study|Other|42|||
105970459|NCT00724854|365551259|FG001|Overall Study|Other|3|||
105970460|NCT00724854|365551258|FG000|Overall Study|Death|11|||
105970461|NCT00724854|365551259|FG001|Overall Study|Death|0|||
105970462|NCT00724854|365551258|FG000|Overall Study|Change of treatment|7|||
105970463|NCT00724854|365551259|FG001|Overall Study|Change of treatment|0|||
105970464|NCT00724854|365551258|FG000|Overall Study|Withdrawal by Subject|5|||
105970465|NCT00724854|365551259|FG001|Overall Study|Withdrawal by Subject|0|||
105970466|NCT00724854|365551258|FG000|Overall Study|Adverse event + lack of efficacy|2|||
105970467|NCT00724854|365551259|FG001|Overall Study|Adverse event + lack of efficacy|1|||
105970468|NCT00096226|365551260|FG000|Overall Study|Ineligible|2|||
105970469|NCT00096226|365551260|FG000|Overall Study|Protocol treatment not started|1|||
105970470|NCT05479097|365551264|FG000|Overall Study|Withdrawal by Subject|2|||
106024694|NCT00373113|365756567|FG001|Overall Study|Other|17|||
106024695|NCT00373113|365756566|FG000|Overall Study|Protocol Violation|5|||
106024696|NCT00373113|365756567|FG001|Overall Study|Protocol Violation|1|||
106024697|NCT00373113|365756566|FG000|Overall Study|Withdrawal by Subject|10|||
106024698|NCT00373113|365756567|FG001|Overall Study|Withdrawal by Subject|15|||
106024699|NCT04248491|365756568|FG000|Overall Study|Lost to Follow-up|1|||
106024700|NCT04248491|365756569|FG001|Overall Study|Lost to Follow-up|0|||
106024701|NCT00444678|365756576|FG000|Overall Study|Toxicity|11|||
106024702|NCT00444678|365756576|FG000|Overall Study|Disease Progression|12|||
106024703|NCT00444678|365756576|FG000|Overall Study|Death|3|||
105970471|NCT04003207|365551267|FG000|Overall Study|Protocol Violation|1|||
105970472|NCT02979093|365551271|FG000|First Scan Session|Scanning data problems|1|||
105970473|NCT02979093|365551272|FG001|First Scan Session|Scanning data problems|2|||
106024704|NCT00444678|365756576|FG000|Overall Study|Physician Decision|3|||
106024705|NCT00444678|365756576|FG000|Overall Study|Withdrawal by Subject|2|||
106024706|NCT00606905|365756577|FG000|Overall Study|No Pregnancy|9|||
105970474|NCT02979093|365551273|FG002|First Scan Session|Scanning data problems|2|||
105970475|NCT02979093|365551274|FG003|First Scan Session|Scanning data problems|0|||
105970476|NCT02979093|365551271|FG000|Second Scan Session|Scanning data problems|3|||
106024707|NCT00606905|365756578|FG001|Overall Study|No Pregnancy|6|||
106024708|NCT00606905|365756577|FG000|Overall Study|Non-Index Pregnancy|1|||
106024709|NCT00606905|365756578|FG001|Overall Study|Non-Index Pregnancy|4|||
105843733|NCT00856973|365086662|FG001|Overall Study|Lost to Follow-up|3|||
105843734|NCT00856973|365086663|FG002|Overall Study|Lost to Follow-up|5|||
105843735|NCT00856973|365086661|FG000|Overall Study|Physician Decision|0|||
105843736|NCT00856973|365086662|FG001|Overall Study|Physician Decision|3|||
105843737|NCT00856973|365086663|FG002|Overall Study|Physician Decision|1|||
105843738|NCT00856973|365086661|FG000|Overall Study|Protocol Violation|1|||
105843739|NCT00856973|365086662|FG001|Overall Study|Protocol Violation|2|||
105843740|NCT00856973|365086663|FG002|Overall Study|Protocol Violation|1|||
105843741|NCT00856973|365086661|FG000|Overall Study|Withdrawal by Subject|13|||
105843742|NCT00856973|365086662|FG001|Overall Study|Withdrawal by Subject|16|||
105843743|NCT00856973|365086663|FG002|Overall Study|Withdrawal by Subject|15|||
105843744|NCT00856973|365086661|FG000|Overall Study|Other|11|||
105843745|NCT00856973|365086662|FG001|Overall Study|Other|12|||
105843746|NCT00856973|365086663|FG002|Overall Study|Other|13|||
105843747|NCT00380692|365086665|FG000|Study Period II - Double Blind|Adverse Event|1|||
105843748|NCT00380692|365086666|FG001|Study Period II - Double Blind|Adverse Event|0|||
105843749|NCT00380692|365086665|FG000|Study Period II - Double Blind|Protocol Violation|2|||
105843750|NCT00380692|365086666|FG001|Study Period II - Double Blind|Protocol Violation|2|||
105843751|NCT00380692|365086665|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
105843752|NCT00380692|365086666|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
105843753|NCT00380692|365086665|FG000|Study Period II - Double Blind|Physician Decision|0|||
105843754|NCT00380692|365086666|FG001|Study Period II - Double Blind|Physician Decision|1|||
105843755|NCT00380692|365086665|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
105843756|NCT00380692|365086666|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
105843757|NCT00380692|365086665|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
105843758|NCT00380692|365086666|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
105843759|NCT00380692|365086665|FG000|Study Period III - Open Label|Adverse Event|5|||
105843760|NCT00380692|365086666|FG001|Study Period III - Open Label|Adverse Event|3|||
105843761|NCT00380692|365086665|FG000|Study Period III - Open Label|Protocol Violation|0|||
105843762|NCT00380692|365086666|FG001|Study Period III - Open Label|Protocol Violation|0|||
105843763|NCT00380692|365086665|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
105843764|NCT00380692|365086666|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
105843765|NCT00380692|365086665|FG000|Study Period III - Open Label|Physician Decision|0|||
105843766|NCT00380692|365086666|FG001|Study Period III - Open Label|Physician Decision|3|||
105843767|NCT00380692|365086665|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
105843768|NCT00380692|365086666|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
105843769|NCT00380692|365086665|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
105843770|NCT00380692|365086666|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
105843771|NCT02698865|365086667|FG000|Overall Study|Other|11|||
105843772|NCT02698865|365086668|FG001|Overall Study|Other|11|||
105843773|NCT02698865|365086667|FG000|Overall Study|Withdrawal by Subject|20|||
105843774|NCT02698865|365086668|FG001|Overall Study|Withdrawal by Subject|16|||
105843775|NCT02698865|365086667|FG000|Overall Study|Physician Decision|0|||
105843776|NCT02698865|365086668|FG001|Overall Study|Physician Decision|4|||
105843777|NCT02698865|365086667|FG000|Overall Study|Lost to Follow-up|4|||
105843778|NCT02698865|365086668|FG001|Overall Study|Lost to Follow-up|2|||
105843779|NCT00856830|365086669|FG000|Irinotecan & Bendamustine|Death|0|||
105843780|NCT00856830|365086670|FG001|Irinotecan & Bendamustine|Death|0|||
105843781|NCT00856830|365086671|FG002|Irinotecan & Bendamustine|Death|0|||
105843782|NCT00856830|365086672|FG003|Irinotecan & Bendamustine|Death|2|||
105843783|NCT00856830|365086669|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
105843784|NCT00856830|365086670|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
105843785|NCT00856830|365086671|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
105843786|NCT00856830|365086672|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
105843787|NCT03768726|365086673|FG000|Treatment Phase|Adverse Event|2|||
105843788|NCT03768726|365086674|FG001|Treatment Phase|Adverse Event|2|||
105843789|NCT03768726|365086673|FG000|Treatment Phase|Lost to Follow-up|1|||
105843790|NCT03768726|365086674|FG001|Treatment Phase|Lost to Follow-up|0|||
105843791|NCT03768726|365086673|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
105843792|NCT03768726|365086674|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
105843793|NCT03768726|365086673|FG000|Treatment Phase|Withdrawal by Subject|3|||
105843794|NCT03768726|365086674|FG001|Treatment Phase|Withdrawal by Subject|1|||
105843795|NCT03768726|365086673|FG000|Follow-Up|Adverse Event|2|||
105843796|NCT03768726|365086674|FG001|Follow-Up|Adverse Event|2|||
105843797|NCT03768726|365086673|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
105843798|NCT03768726|365086674|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
105843799|NCT03768726|365086673|FG000|Follow-Up|Withdrawal by Subject|2|||
105843800|NCT03768726|365086674|FG001|Follow-Up|Withdrawal by Subject|0|||
105843801|NCT03768726|365086673|FG000|Follow-Up|Other|1|||
105843802|NCT03768726|365086674|FG001|Follow-Up|Other|0|||
106149596|NCT05137236|366209162|FG000|Part A|Other than Specified|1|||
105843803|NCT01787279|365086675|FG000|Overall Study|Lost to Follow-up|2|||
105843804|NCT01787279|365086675|FG000|Overall Study|Lack of Efficacy|1|||
105843805|NCT01659736|365086677|FG000|Treatment Period|Adverse Event|1|||
105843806|NCT01659736|365086678|FG001|Treatment Period|Adverse Event|1|||
105843807|NCT01659736|365086677|FG000|Treatment Period|Protocol Violation|3|||
105843808|NCT01659736|365086678|FG001|Treatment Period|Protocol Violation|1|||
105843809|NCT01659736|365086677|FG000|Treatment Period|Withdrawal by Subject|1|||
105843810|NCT01659736|365086678|FG001|Treatment Period|Withdrawal by Subject|0|||
105843811|NCT01659736|365086677|FG000|3-month Follow-up|Lost to Follow-up|0|||
105843812|NCT01659736|365086678|FG001|3-month Follow-up|Lost to Follow-up|1|||
105843813|NCT02006628|365086679|FG000|Overall Study|Adverse Event|1|||
105843814|NCT02006628|365086680|FG001|Overall Study|Adverse Event|1|||
105843815|NCT02006628|365086679|FG000|Overall Study|Withdrawal by Subject|2|||
105843816|NCT02006628|365086680|FG001|Overall Study|Withdrawal by Subject|1|||
105843817|NCT03578237|365086683|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
105843818|NCT03578237|365086684|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
105843819|NCT00252174|365086685|FG000|Overall Study|Withdrawal by Subject|0|||
105843820|NCT00252174|365086686|FG001|Overall Study|Withdrawal by Subject|1|||
105843821|NCT00252174|365086687|FG002|Overall Study|Withdrawal by Subject|0|||
106149597|NCT05137236|366209163|FG001|Part A|Other than Specified|0|||
106149598|NCT05137236|366209164|FG002|Part A|Other than Specified|0|||
106149599|NCT05137236|366209165|FG003|Part A|Other than Specified|0|||
106149600|NCT05137236|366209166|FG004|Part A|Other than Specified|0|||
106149601|NCT05137236|366209167|FG005|Part A|Other than Specified|0|||
106149602|NCT05137236|366209168|FG006|Part A|Other than Specified|0|||
106149603|NCT05137236|366209169|FG007|Part A|Other than Specified|0|||
106149604|NCT05137236|366209162|FG000|Part A|Withdrawal by Subject|0|||
106149605|NCT05137236|366209163|FG001|Part A|Withdrawal by Subject|4|||
106149606|NCT05137236|366209164|FG002|Part A|Withdrawal by Subject|1|||
106149607|NCT05137236|366209165|FG003|Part A|Withdrawal by Subject|1|||
106149608|NCT05137236|366209166|FG004|Part A|Withdrawal by Subject|3|||
106149609|NCT05137236|366209167|FG005|Part A|Withdrawal by Subject|2|||
106149610|NCT05137236|366209168|FG006|Part A|Withdrawal by Subject|0|||
106149611|NCT05137236|366209169|FG007|Part A|Withdrawal by Subject|0|||
106149612|NCT05137236|366209162|FG000|Part A|Lost to Follow-up|5|||
105843822|NCT02546362|365086688|FG000|4-week Treatment Period|Lost to Follow-up|1|||
105843823|NCT02546362|365086688|FG000|4-week Treatment Period|Change in medication|2|||
105843824|NCT02546362|365086688|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
105843825|NCT02546362|365086688|FG000|12-week Treatment Period|Lost to Follow-up|2|||
105843826|NCT02546362|365086688|FG000|12-week Treatment Period|Change in medication|1|||
105843827|NCT01478828|365086689|FG000|Overall Study|Adverse Event|1|||
105843828|NCT00296491|365086690|FG000|Overall Study|Low Pollen Counts|18|||
105843829|NCT00296491|365086691|FG001|Overall Study|Low Pollen Counts|26|||
105843830|NCT00296491|365086692|FG002|Overall Study|Low Pollen Counts|25|||
105843831|NCT00296491|365086693|FG003|Overall Study|Low Pollen Counts|16|||
105843832|NCT00296491|365086690|FG000|Overall Study|Protocol Violation|4|||
105843833|NCT00296491|365086691|FG001|Overall Study|Protocol Violation|6|||
105843834|NCT00296491|365086692|FG002|Overall Study|Protocol Violation|2|||
105843835|NCT00296491|365086693|FG003|Overall Study|Protocol Violation|3|||
105843836|NCT00296491|365086690|FG000|Overall Study|Adverse Event|1|||
105843837|NCT00296491|365086691|FG001|Overall Study|Adverse Event|3|||
105843838|NCT00296491|365086692|FG002|Overall Study|Adverse Event|1|||
105843839|NCT00296491|365086693|FG003|Overall Study|Adverse Event|4|||
105843840|NCT00296491|365086690|FG000|Overall Study|Withdrawn due to Asthma|0|||
105843841|NCT00296491|365086691|FG001|Overall Study|Withdrawn due to Asthma|0|||
105843842|NCT00296491|365086692|FG002|Overall Study|Withdrawn due to Asthma|0|||
105843843|NCT00296491|365086693|FG003|Overall Study|Withdrawn due to Asthma|4|||
105843844|NCT00296491|365086690|FG000|Overall Study|Withdrawal by Subject|7|||
105843845|NCT00296491|365086691|FG001|Overall Study|Withdrawal by Subject|3|||
105843846|NCT00296491|365086692|FG002|Overall Study|Withdrawal by Subject|3|||
105843847|NCT00296491|365086693|FG003|Overall Study|Withdrawal by Subject|2|||
105843848|NCT00296491|365086690|FG000|Overall Study|Non-Compliance|12|||
105843849|NCT00296491|365086691|FG001|Overall Study|Non-Compliance|13|||
105843850|NCT00296491|365086692|FG002|Overall Study|Non-Compliance|10|||
105843851|NCT00296491|365086693|FG003|Overall Study|Non-Compliance|14|||
105843852|NCT00296491|365086690|FG000|Overall Study|Lost to Follow-up|0|||
105843853|NCT00296491|365086691|FG001|Overall Study|Lost to Follow-up|2|||
105843854|NCT00296491|365086692|FG002|Overall Study|Lost to Follow-up|2|||
106149613|NCT05137236|366209163|FG001|Part A|Lost to Follow-up|7|||
106149614|NCT05137236|366209164|FG002|Part A|Lost to Follow-up|1|||
106149615|NCT05137236|366209165|FG003|Part A|Lost to Follow-up|3|||
106149616|NCT05137236|366209166|FG004|Part A|Lost to Follow-up|3|||
105843855|NCT00296491|365086693|FG003|Overall Study|Lost to Follow-up|0|||
105843856|NCT01300052|365086694|FG000|Overall Study|Adverse Event|3|||
105843857|NCT01300052|365086695|FG001|Overall Study|Adverse Event|0|||
105843858|NCT01300052|365086694|FG000|Overall Study|Withdrawal by Subject|2|||
105843859|NCT01300052|365086695|FG001|Overall Study|Withdrawal by Subject|2|||
105843860|NCT01300052|365086694|FG000|Overall Study|Protocol Violation|1|||
106149617|NCT05137236|366209167|FG005|Part A|Lost to Follow-up|8|||
106149618|NCT05137236|366209168|FG006|Part A|Lost to Follow-up|0|||
106149619|NCT05137236|366209169|FG007|Part A|Lost to Follow-up|0|||
105970477|NCT02979093|365551272|FG001|Second Scan Session|Scanning data problems|0|||
105970478|NCT02979093|365551273|FG002|Second Scan Session|Scanning data problems|1|||
105970479|NCT02979093|365551274|FG003|Second Scan Session|Scanning data problems|3|||
105970480|NCT04173260|365551275|FG000|Overall Study|Early termination|4|||
105970481|NCT01096368|365551278|FG000|Overall Study|Death|0|||
105970482|NCT01096368|365551279|FG001|Overall Study|Death|1|||
105970483|NCT01096368|365551280|FG002|Overall Study|Death|0|||
105970484|NCT01096368|365551281|FG003|Overall Study|Death|0|||
105970485|NCT01096368|365551282|FG004|Overall Study|Death|0|||
105970486|NCT01096368|365551278|FG000|Overall Study|Physician Decision|0|||
105970487|NCT01096368|365551279|FG001|Overall Study|Physician Decision|13|||
105970488|NCT01096368|365551280|FG002|Overall Study|Physician Decision|2|||
105970489|NCT01096368|365551281|FG003|Overall Study|Physician Decision|4|||
105970490|NCT01096368|365551282|FG004|Overall Study|Physician Decision|6|||
105970491|NCT01096368|365551278|FG000|Overall Study|Withdrawal by Subject|0|||
105970492|NCT01096368|365551279|FG001|Overall Study|Withdrawal by Subject|52|||
105970493|NCT01096368|365551280|FG002|Overall Study|Withdrawal by Subject|0|||
105970494|NCT01096368|365551281|FG003|Overall Study|Withdrawal by Subject|10|||
105970495|NCT01096368|365551282|FG004|Overall Study|Withdrawal by Subject|14|||
105970496|NCT01096368|365551278|FG000|Overall Study|Ineligible|0|||
105970497|NCT01096368|365551279|FG001|Overall Study|Ineligible|3|||
105970498|NCT01096368|365551280|FG002|Overall Study|Ineligible|2|||
105843861|NCT01300052|365086695|FG001|Overall Study|Protocol Violation|1|||
105843862|NCT00775606|365086698|FG000|Overall Study|Study sponsor terminated funding|3|||
105843863|NCT00775606|365086699|FG001|Overall Study|Study sponsor terminated funding|0|||
105843864|NCT02278718|365086700|FG000|Overall Study|Adverse Event|1|||
105843865|NCT02278718|365086701|FG001|Overall Study|Adverse Event|0|||
105843866|NCT02278718|365086700|FG000|Overall Study|Lost to Follow-up|2|||
105843867|NCT02278718|365086701|FG001|Overall Study|Lost to Follow-up|4|||
105843868|NCT02278718|365086700|FG000|Overall Study|Withdrawal by Subject|1|||
105843869|NCT02278718|365086701|FG001|Overall Study|Withdrawal by Subject|4|||
105843870|NCT02278718|365086700|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
105843871|NCT02278718|365086701|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
105843872|NCT02278718|365086700|FG000|Overall Study|Missing|0|||
105843873|NCT02278718|365086701|FG001|Overall Study|Missing|1|||
105843874|NCT01546649|365086702|FG000|Overall Study|Adverse Event|4|||
105843875|NCT01546649|365086703|FG001|Overall Study|Adverse Event|5|||
105843876|NCT01546649|365086702|FG000|Overall Study|Protocol Violation|1|||
105843877|NCT01546649|365086703|FG001|Overall Study|Protocol Violation|0|||
105843878|NCT01546649|365086702|FG000|Overall Study|Lack of Efficacy|1|||
105843879|NCT01546649|365086703|FG001|Overall Study|Lack of Efficacy|0|||
105843880|NCT01546649|365086702|FG000|Overall Study|Recurrence|1|||
105843881|NCT01546649|365086703|FG001|Overall Study|Recurrence|1|||
105843882|NCT01546649|365086702|FG000|Overall Study|Discovery of secondary cancer|0|||
105843883|NCT01546649|365086703|FG001|Overall Study|Discovery of secondary cancer|1|||
105843884|NCT01546649|365086702|FG000|Overall Study|Withdrawal by Subject|1|||
105843885|NCT01546649|365086703|FG001|Overall Study|Withdrawal by Subject|2|||
105843886|NCT04440449|365086704|FG000|Overall Study|Lost to Follow-up|2|||
105843887|NCT04440449|365086705|FG001|Overall Study|Lost to Follow-up|0|||
105843888|NCT05212883|365086706|FG000|Overall Study|Invalid test result|125|||
105970499|NCT01096368|365551281|FG003|Overall Study|Ineligible|0|||
105970500|NCT01096368|365551282|FG004|Overall Study|Ineligible|25|||
105970501|NCT01096368|365551278|FG000|Overall Study|Did not start treatment|0|||
105970502|NCT01096368|365551279|FG001|Overall Study|Did not start treatment|4|||
105970503|NCT01096368|365551280|FG002|Overall Study|Did not start treatment|4|||
105970504|NCT01096368|365551281|FG003|Overall Study|Did not start treatment|0|||
105970505|NCT01096368|365551282|FG004|Overall Study|Did not start treatment|0|||
105970506|NCT01096368|365551278|FG000|Overall Study|Progressive disease|0|||
105970507|NCT01096368|365551279|FG001|Overall Study|Progressive disease|6|||
105970508|NCT01096368|365551280|FG002|Overall Study|Progressive disease|0|||
105970509|NCT01096368|365551281|FG003|Overall Study|Progressive disease|10|||
105843889|NCT02502734|365086707|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
105843890|NCT02502734|365086708|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
105843891|NCT02502734|365086707|FG000|Washout Period|Adverse Event|1|||
105843892|NCT02502734|365086708|FG001|Washout Period|Adverse Event|0|||
105843893|NCT00897949|365086711|FG000|Overall Study|Adverse Event|1|||
105843894|NCT00897949|365086712|FG001|Overall Study|Adverse Event|1|||
105970510|NCT01096368|365551282|FG004|Overall Study|Progressive disease|3|||
105970511|NCT01096368|365551278|FG000|Overall Study|Other|0|||
105843895|NCT00897949|365086713|FG002|Overall Study|Adverse Event|0|||
105970512|NCT01096368|365551279|FG001|Overall Study|Other|0|||
105970513|NCT01096368|365551280|FG002|Overall Study|Other|1|||
105843896|NCT00897949|365086711|FG000|Overall Study|Lost to Follow-up|0|||
105843897|NCT00897949|365086712|FG001|Overall Study|Lost to Follow-up|2|||
105843898|NCT00897949|365086713|FG002|Overall Study|Lost to Follow-up|1|||
105843899|NCT00897949|365086711|FG000|Overall Study|Protocol Violation|6|||
105843900|NCT00897949|365086712|FG001|Overall Study|Protocol Violation|3|||
105843901|NCT00897949|365086713|FG002|Overall Study|Protocol Violation|1|||
105970514|NCT01096368|365551281|FG003|Overall Study|Other|0|||
105843902|NCT00897949|365086711|FG000|Overall Study|Withdrawal by Subject|1|||
105843903|NCT00897949|365086712|FG001|Overall Study|Withdrawal by Subject|2|||
105843904|NCT00897949|365086713|FG002|Overall Study|Withdrawal by Subject|0|||
105843905|NCT00897949|365086711|FG000|Overall Study|Patient Uncoorperative|0|||
105843906|NCT00897949|365086712|FG001|Overall Study|Patient Uncoorperative|2|||
106149620|NCT05137236|366209162|FG000|Part B|Withdrawal by Subject|0|||
106149621|NCT05137236|366209163|FG001|Part B|Withdrawal by Subject|0|||
106149622|NCT05137236|366209164|FG002|Part B|Withdrawal by Subject|0|||
106149623|NCT05137236|366209165|FG003|Part B|Withdrawal by Subject|0|||
106149624|NCT05137236|366209166|FG004|Part B|Withdrawal by Subject|0|||
106149625|NCT05137236|366209167|FG005|Part B|Withdrawal by Subject|0|||
106149626|NCT05137236|366209168|FG006|Part B|Withdrawal by Subject|0|||
105843907|NCT00897949|365086713|FG002|Overall Study|Patient Uncoorperative|1|||
105843908|NCT00897949|365086711|FG000|Overall Study|Lost to Follow-up|30|||
105843909|NCT00897949|365086712|FG001|Overall Study|Lost to Follow-up|23|||
106149627|NCT05137236|366209169|FG007|Part B|Withdrawal by Subject|2|||
105843910|NCT00897949|365086713|FG002|Overall Study|Lost to Follow-up|17|||
105843911|NCT00897949|365086711|FG000|Overall Study|Withdrawal by Subject|24|||
105843912|NCT00897949|365086712|FG001|Overall Study|Withdrawal by Subject|31|||
105843913|NCT00897949|365086713|FG002|Overall Study|Withdrawal by Subject|17|||
105843914|NCT00897949|365086711|FG000|Overall Study|Abnormal Prestudy Labs|2|||
105843915|NCT00897949|365086712|FG001|Overall Study|Abnormal Prestudy Labs|3|||
105843916|NCT00897949|365086713|FG002|Overall Study|Abnormal Prestudy Labs|4|||
105843917|NCT00897949|365086711|FG000|Overall Study|Abnormal Baseline ECG|2|||
105843918|NCT00897949|365086712|FG001|Overall Study|Abnormal Baseline ECG|2|||
105843919|NCT00897949|365086713|FG002|Overall Study|Abnormal Baseline ECG|4|||
105843920|NCT00897949|365086711|FG000|Overall Study|Need for Concom. Med.|0|||
105843921|NCT00897949|365086712|FG001|Overall Study|Need for Concom. Med.|1|||
105843922|NCT00897949|365086713|FG002|Overall Study|Need for Concom. Med.|1|||
105843923|NCT00897949|365086711|FG000|Overall Study|Lack of Migraine Attack|29|||
105843924|NCT00897949|365086712|FG001|Overall Study|Lack of Migraine Attack|30|||
105843925|NCT00897949|365086713|FG002|Overall Study|Lack of Migraine Attack|19|||
105843926|NCT00897949|365086711|FG000|Overall Study|Did not take study drug|9|||
105843927|NCT00897949|365086712|FG001|Overall Study|Did not take study drug|3|||
105843928|NCT00897949|365086713|FG002|Overall Study|Did not take study drug|4|||
105843929|NCT01763918|365086714|FG000|Overall Study|Withdrawal by Subject|2|||
105843930|NCT01763918|365086715|FG001|Overall Study|Withdrawal by Subject|1|||
105843931|NCT01763918|365086716|FG002|Overall Study|Withdrawal by Subject|1|||
105843932|NCT01763918|365086717|FG003|Overall Study|Withdrawal by Subject|2|||
105843933|NCT01763918|365086714|FG000|Overall Study|Sponsor Decision|4|||
105843934|NCT01763918|365086715|FG001|Overall Study|Sponsor Decision|0|||
105843935|NCT01763918|365086716|FG002|Overall Study|Sponsor Decision|9|||
105843936|NCT01763918|365086717|FG003|Overall Study|Sponsor Decision|0|||
105843937|NCT01553747|365086718|FG000|Overall Study|Protocol Violation|0|||
105843938|NCT01553747|365086719|FG001|Overall Study|Protocol Violation|2|||
105843939|NCT01553747|365086720|FG002|Overall Study|Protocol Violation|0|||
105843940|NCT01553747|365086718|FG000|Overall Study|Voluntarily withdrew|70|||
105843941|NCT01553747|365086719|FG001|Overall Study|Voluntarily withdrew|66|||
105843942|NCT01553747|365086720|FG002|Overall Study|Voluntarily withdrew|74|||
105843943|NCT01553747|365086718|FG000|Overall Study|Adverse event or SAE|32|||
105843944|NCT01553747|365086719|FG001|Overall Study|Adverse event or SAE|28|||
105843945|NCT01553747|365086720|FG002|Overall Study|Adverse event or SAE|19|||
105843946|NCT01553747|365086718|FG000|Overall Study|Physician decision: other|10|||
105843947|NCT01553747|365086719|FG001|Overall Study|Physician decision: other|8|||
105843948|NCT01553747|365086720|FG002|Overall Study|Physician decision: other|7|||
105843949|NCT01553747|365086718|FG000|Overall Study|Lost to Follow-up|11|||
105843950|NCT01553747|365086719|FG001|Overall Study|Lost to Follow-up|5|||
105843951|NCT01553747|365086720|FG002|Overall Study|Lost to Follow-up|6|||
105843952|NCT01553747|365086718|FG000|Overall Study|Sponsor decision, specify|7|||
105843953|NCT01553747|365086719|FG001|Overall Study|Sponsor decision, specify|5|||
105843954|NCT01553747|365086720|FG002|Overall Study|Sponsor decision, specify|0|||
105843955|NCT01553747|365086718|FG000|Overall Study|Physician decision: lack of efficacy|1|||
105843956|NCT01553747|365086719|FG001|Overall Study|Physician decision: lack of efficacy|5|||
105843957|NCT01553747|365086720|FG002|Overall Study|Physician decision: lack of efficacy|3|||
105843958|NCT03095118|365086724|FG000|Overall Study|Adverse Event|1|||
105843959|NCT03095118|365086724|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
105843960|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
105843961|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
105843962|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
105843963|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
105843964|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
105843965|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
105843966|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
105843967|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
106149628|NCT05137236|366209162|FG000|Part B|Lost to Follow-up|0|||
106149629|NCT05137236|366209163|FG001|Part B|Lost to Follow-up|0|||
106149630|NCT05137236|366209164|FG002|Part B|Lost to Follow-up|0|||
105843968|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
105843969|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
105843970|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
105843971|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
105843972|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105843973|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105843974|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
105843975|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
105843976|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
105843977|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
105843978|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
105843979|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
105843980|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
105843981|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
105843982|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
105843983|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
105843984|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
105843985|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
105843986|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
105843987|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
105843988|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Death|0|||
105843989|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Death|1|||
105843990|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Death|0|||
105843991|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Death|0|||
105843992|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
105843993|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
105843994|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
105843995|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
105843996|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
105843997|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
105843998|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
105843999|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
105844000|NCT02990806|365086731|FG000|Stage 1 (22 Weeks)|Other|1|||
105844001|NCT02990806|365086732|FG001|Stage 1 (22 Weeks)|Other|3|||
105844002|NCT02990806|365086733|FG002|Stage 1 (22 Weeks)|Other|0|||
105844003|NCT02990806|365086734|FG003|Stage 1 (22 Weeks)|Other|0|||
105844004|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
105844005|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
105844006|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
105844007|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
105844008|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Death|1|||
105844009|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Death|0|||
105844010|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Death|0|||
105844011|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Death|0|||
105844012|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
105844013|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
105844014|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
105844015|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
105844016|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
105844017|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
105844018|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
105844019|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
105844020|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
105844021|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
105844022|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
105844023|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
105844024|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
105844025|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
105970515|NCT01096368|365551282|FG004|Overall Study|Other|0|||
105970516|NCT01096368|365551278|FG000|Overall Study|Treated with institutional review|0|||
105970517|NCT01096368|365551279|FG001|Overall Study|Treated with institutional review|0|||
105970518|NCT01096368|365551280|FG002|Overall Study|Treated with institutional review|0|||
105970519|NCT01096368|365551281|FG003|Overall Study|Treated with institutional review|0|||
105970520|NCT01096368|365551282|FG004|Overall Study|Treated with institutional review|1|||
105970521|NCT03070223|365551283|FG000|Overall Study|Lost to Follow-up|34|||
105844026|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
105844027|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
105844028|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105844029|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
105844030|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
105970522|NCT03070223|365551284|FG001|Overall Study|Lost to Follow-up|27|||
105970523|NCT03070223|365551283|FG000|Overall Study|Withdrawal by Subject|12|||
105970524|NCT03070223|365551284|FG001|Overall Study|Withdrawal by Subject|22|||
105970525|NCT03070223|365551283|FG000|Overall Study|Protocol Violation|0|||
105970526|NCT03070223|365551284|FG001|Overall Study|Protocol Violation|1|||
105970527|NCT04644237|365551285|FG000|Overall Study|Death|3|||
105970528|NCT04644237|365551286|FG001|Overall Study|Death|2|||
105970529|NCT04644237|365551285|FG000|Overall Study|Adverse Event|15|||
105970530|NCT04644237|365551286|FG001|Overall Study|Adverse Event|12|||
105970531|NCT04644237|365551285|FG000|Overall Study|Progressive Disease|47|||
105970532|NCT04644237|365551286|FG001|Overall Study|Progressive Disease|19|||
105970533|NCT04644237|365551285|FG000|Overall Study|Clinical Progression|4|||
105970534|NCT04644237|365551286|FG001|Overall Study|Clinical Progression|1|||
105970535|NCT04644237|365551285|FG000|Overall Study|Withdrawal by Subject|1|||
105970536|NCT04644237|365551286|FG001|Overall Study|Withdrawal by Subject|2|||
105970537|NCT04644237|365551285|FG000|Overall Study|Physician Decision|3|||
105844031|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
105844032|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
105844033|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
105844034|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
105844035|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
105844036|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
105970538|NCT04644237|365551286|FG001|Overall Study|Physician Decision|0|||
105970539|NCT04644237|365551285|FG000|Overall Study|Other|1|||
105970540|NCT04644237|365551286|FG001|Overall Study|Other|0|||
105970541|NCT04644237|365551285|FG000|Overall Study|Randomized but not Treated|1|||
105970542|NCT04644237|365551286|FG001|Overall Study|Randomized but not Treated|0|||
105970543|NCT02118766|365551287|FG000|Overall Study|Adverse Event|7|||
105970544|NCT02118766|365551288|FG001|Overall Study|Adverse Event|2|||
105970545|NCT02118766|365551287|FG000|Overall Study|Withdrawal by Subject|3|||
105970546|NCT02118766|365551288|FG001|Overall Study|Withdrawal by Subject|6|||
105844037|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
105844038|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
105844039|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
105844040|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
105844041|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
105844042|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
105844043|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
105844044|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
105844045|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
105844046|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
105844047|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
105844048|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Other|3|||
105844049|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Other|0|||
105844050|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Other|4|||
105844051|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Other|1|||
105844052|NCT02990806|365086731|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
105844053|NCT02990806|365086732|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
105844054|NCT02990806|365086733|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
105844055|NCT02990806|365086734|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
105844056|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
105844057|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
105844058|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
105844059|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
105844060|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
105844061|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
105844062|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
105844063|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
105844064|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105844065|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
105844066|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105844067|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
105844068|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
105844069|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
105844070|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
105970547|NCT02118766|365551287|FG000|Overall Study|Lost to Follow-up|5|||
105970548|NCT02118766|365551288|FG001|Overall Study|Lost to Follow-up|4|||
105970549|NCT02118766|365551287|FG000|Overall Study|Withdrawal by parent/guardian|12|||
105970550|NCT02118766|365551288|FG001|Overall Study|Withdrawal by parent/guardian|18|||
105970551|NCT02118766|365551287|FG000|Overall Study|Other|3|||
106149631|NCT05137236|366209165|FG003|Part B|Lost to Follow-up|0|||
106149632|NCT05137236|366209166|FG004|Part B|Lost to Follow-up|0|||
106149633|NCT05137236|366209167|FG005|Part B|Lost to Follow-up|0|||
105970552|NCT02118766|365551288|FG001|Overall Study|Other|1|||
105970553|NCT01691105|365551289|FG000|1 Month Follow-up|Lost to Follow-up|41|||
105970554|NCT01691105|365551290|FG001|1 Month Follow-up|Lost to Follow-up|38|||
105970555|NCT01691105|365551289|FG000|1 Month Follow-up|Death|2|||
105970556|NCT01691105|365551290|FG001|1 Month Follow-up|Death|3|||
105970557|NCT01691105|365551289|FG000|6 Month Follow-up|Lost to Follow-up|39|||
105970558|NCT01691105|365551290|FG001|6 Month Follow-up|Lost to Follow-up|58|||
105970559|NCT01691105|365551289|FG000|6 Month Follow-up|Death|13|||
105970560|NCT01691105|365551290|FG001|6 Month Follow-up|Death|13|||
105970561|NCT01691105|365551289|FG000|12 Month Follow-up|Lost to Follow-up|50|||
105970562|NCT01691105|365551290|FG001|12 Month Follow-up|Lost to Follow-up|71|||
105970563|NCT01691105|365551289|FG000|12 Month Follow-up|Death|22|||
105970564|NCT01691105|365551290|FG001|12 Month Follow-up|Death|30|||
105970565|NCT01691105|365551289|FG000|12 Month Biochemical Verification|Death|22|||
105970566|NCT01691105|365551290|FG001|12 Month Biochemical Verification|Death|30|||
105970567|NCT01691105|365551289|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
105970568|NCT01691105|365551290|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
105970569|NCT01691105|365551289|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
105970570|NCT01691105|365551290|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
105970571|NCT00541866|365551291|FG000|Overall Study|Adverse Event|3|||
105970572|NCT00541866|365551292|FG001|Overall Study|Adverse Event|0|||
105970573|NCT00541866|365551293|FG002|Overall Study|Adverse Event|0|||
105970574|NCT00541866|365551294|FG003|Overall Study|Adverse Event|0|||
105970575|NCT00541866|365551295|FG004|Overall Study|Adverse Event|0|||
105970576|NCT00541866|365551291|FG000|Overall Study|Death|1|||
105970577|NCT00541866|365551292|FG001|Overall Study|Death|0|||
105970578|NCT00541866|365551293|FG002|Overall Study|Death|0|||
105970579|NCT00541866|365551294|FG003|Overall Study|Death|0|||
105970580|NCT00541866|365551295|FG004|Overall Study|Death|0|||
105970581|NCT00541866|365551291|FG000|Overall Study|Lack of Efficacy|19|||
105970582|NCT00541866|365551292|FG001|Overall Study|Lack of Efficacy|15|||
105970583|NCT00541866|365551293|FG002|Overall Study|Lack of Efficacy|10|||
105970584|NCT00541866|365551294|FG003|Overall Study|Lack of Efficacy|12|||
105970585|NCT00541866|365551295|FG004|Overall Study|Lack of Efficacy|14|||
105970586|NCT00541866|365551291|FG000|Overall Study|Not Reported or Other|11|||
105970587|NCT00541866|365551292|FG001|Overall Study|Not Reported or Other|3|||
105970588|NCT00541866|365551293|FG002|Overall Study|Not Reported or Other|3|||
105970589|NCT00541866|365551294|FG003|Overall Study|Not Reported or Other|3|||
105970590|NCT00541866|365551295|FG004|Overall Study|Not Reported or Other|1|||
105970591|NCT00541866|365551291|FG000|Overall Study|Physician Decision|0|||
105970592|NCT00541866|365551292|FG001|Overall Study|Physician Decision|0|||
105970593|NCT00541866|365551293|FG002|Overall Study|Physician Decision|2|||
105970594|NCT00541866|365551294|FG003|Overall Study|Physician Decision|1|||
105970595|NCT00541866|365551295|FG004|Overall Study|Physician Decision|0|||
105970596|NCT00957944|365551296|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
105970597|NCT00957944|365551297|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
105970598|NCT01468233|365551298|FG000|Treatment Period 1|Adverse Event|5|||
105970599|NCT01468233|365551299|FG001|Treatment Period 1|Adverse Event|3|||
105970600|NCT01468233|365551300|FG002|Treatment Period 1|Adverse Event|0|||
105970601|NCT01468233|365551301|FG003|Treatment Period 1|Adverse Event|0|||
105970602|NCT01468233|365551302|FG004|Treatment Period 1|Adverse Event|0|||
105970603|NCT01468233|365551303|FG005|Treatment Period 1|Adverse Event|0|||
105970604|NCT01468233|365551298|FG000|Treatment Period 1|Withdrawal by Subject|3|||
105970605|NCT01468233|365551299|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105970606|NCT01468233|365551300|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105970607|NCT01468233|365551301|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105970608|NCT01468233|365551302|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105970609|NCT01468233|365551303|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105970610|NCT01468233|365551298|FG000|Treatment Period 1|Lost to Follow-up|3|||
105970611|NCT01468233|365551299|FG001|Treatment Period 1|Lost to Follow-up|0|||
105970612|NCT01468233|365551300|FG002|Treatment Period 1|Lost to Follow-up|0|||
105970613|NCT01468233|365551301|FG003|Treatment Period 1|Lost to Follow-up|0|||
105970614|NCT01468233|365551302|FG004|Treatment Period 1|Lost to Follow-up|0|||
105970615|NCT01468233|365551303|FG005|Treatment Period 1|Lost to Follow-up|0|||
105970616|NCT01468233|365551298|FG000|Treatment Period 1|Other|1|||
105844071|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
105844072|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
105844073|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
105970617|NCT01468233|365551299|FG001|Treatment Period 1|Other|1|||
105970618|NCT01468233|365551300|FG002|Treatment Period 1|Other|0|||
105970619|NCT01468233|365551301|FG003|Treatment Period 1|Other|0|||
105970620|NCT01468233|365551302|FG004|Treatment Period 1|Other|0|||
105970621|NCT01468233|365551303|FG005|Treatment Period 1|Other|0|||
105970622|NCT01468233|365551298|FG000|Treatment Period 2|Adverse Event|0|||
105970623|NCT01468233|365551299|FG001|Treatment Period 2|Adverse Event|0|||
105970624|NCT01468233|365551300|FG002|Treatment Period 2|Adverse Event|3|||
105970625|NCT01468233|365551301|FG003|Treatment Period 2|Adverse Event|0|||
105970626|NCT01468233|365551302|FG004|Treatment Period 2|Adverse Event|2|||
105844074|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
105844075|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
105844076|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
105844077|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
105844078|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
105844079|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
105970627|NCT01468233|365551303|FG005|Treatment Period 2|Adverse Event|1|||
105970628|NCT01468233|365551298|FG000|Treatment Period 2|Lack of Efficacy|0|||
105970629|NCT01468233|365551299|FG001|Treatment Period 2|Lack of Efficacy|0|||
105970630|NCT01468233|365551300|FG002|Treatment Period 2|Lack of Efficacy|9|||
105970631|NCT01468233|365551301|FG003|Treatment Period 2|Lack of Efficacy|2|||
105970632|NCT01468233|365551302|FG004|Treatment Period 2|Lack of Efficacy|0|||
105970633|NCT01468233|365551303|FG005|Treatment Period 2|Lack of Efficacy|1|||
105970634|NCT01468233|365551298|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105970635|NCT01468233|365551299|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105970636|NCT01468233|365551300|FG002|Treatment Period 2|Withdrawal by Subject|9|||
105970637|NCT01468233|365551301|FG003|Treatment Period 2|Withdrawal by Subject|1|||
105970638|NCT01468233|365551302|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105970639|NCT01468233|365551303|FG005|Treatment Period 2|Withdrawal by Subject|1|||
105970640|NCT01468233|365551298|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
105970641|NCT01468233|365551299|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
105970642|NCT01468233|365551300|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
105970643|NCT01468233|365551301|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
105970644|NCT01468233|365551302|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
105970645|NCT01468233|365551303|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
105970646|NCT01468233|365551298|FG000|Treatment Period 2|Lost to Follow-up|0|||
105970647|NCT01468233|365551299|FG001|Treatment Period 2|Lost to Follow-up|0|||
105970648|NCT01468233|365551300|FG002|Treatment Period 2|Lost to Follow-up|3|||
105970649|NCT01468233|365551301|FG003|Treatment Period 2|Lost to Follow-up|0|||
105970650|NCT01468233|365551302|FG004|Treatment Period 2|Lost to Follow-up|2|||
105970651|NCT01468233|365551303|FG005|Treatment Period 2|Lost to Follow-up|0|||
105970652|NCT01468233|365551298|FG000|Treatment Period 2|Other|0|||
105970653|NCT01468233|365551299|FG001|Treatment Period 2|Other|0|||
105970654|NCT01468233|365551300|FG002|Treatment Period 2|Other|3|||
105970655|NCT01468233|365551301|FG003|Treatment Period 2|Other|0|||
105970656|NCT01468233|365551302|FG004|Treatment Period 2|Other|1|||
105970657|NCT01468233|365551303|FG005|Treatment Period 2|Other|0|||
105970658|NCT01482169|365551304|FG000|Overall Study|Physician Decision|2|||
105844080|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
105970659|NCT00522418|365551305|FG000|Overall Study|Local IRB Consent Violation|5|||
105970660|NCT00522418|365551306|FG001|Overall Study|Local IRB Consent Violation|5|||
105970661|NCT00522418|365551305|FG000|Overall Study|Early Study Termination|46|||
105970662|NCT00522418|365551306|FG001|Overall Study|Early Study Termination|47|||
105970663|NCT00522418|365551305|FG000|Overall Study|Noncompliance|2|||
105970664|NCT00522418|365551306|FG001|Overall Study|Noncompliance|2|||
105970665|NCT00522418|365551305|FG000|Overall Study|Reason Not Specified|3|||
105970666|NCT00522418|365551306|FG001|Overall Study|Reason Not Specified|1|||
105970667|NCT00522418|365551305|FG000|Overall Study|Consent Withdraw|1|||
105970668|NCT00522418|365551306|FG001|Overall Study|Consent Withdraw|2|||
105970669|NCT00522418|365551305|FG000|Overall Study|Lack of Efficacy|0|||
105970670|NCT00522418|365551306|FG001|Overall Study|Lack of Efficacy|1|||
105970671|NCT01574157|365551307|FG000|Overall Study|Withdrawal by Subject|4|||
105970672|NCT01574157|365551308|FG001|Overall Study|Withdrawal by Subject|5|||
105970673|NCT01574157|365551307|FG000|Overall Study|Lost to Follow-up|0|||
105970674|NCT01574157|365551308|FG001|Overall Study|Lost to Follow-up|3|||
105970675|NCT05151445|365551316|FG000|Overall Study|Withdrawal by Subject|3|||
105844081|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
105844082|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
105844083|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
105970676|NCT01288612|365552803|FG000|Overall Study|Unable to contact|11|||
105970677|NCT01288612|365552804|FG001|Overall Study|Unable to contact|16|||
105970678|NCT01288612|365552805|FG002|Overall Study|Unable to contact|20|||
105970679|NCT01288612|365552803|FG000|Overall Study|Declined|78|||
105970680|NCT01288612|365552804|FG001|Overall Study|Declined|63|||
105970681|NCT01288612|365552805|FG002|Overall Study|Declined|62|||
105970682|NCT01288612|365552803|FG000|Overall Study|Unable to intubate|0|||
105844084|NCT02990806|365086731|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
105844085|NCT02990806|365086732|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
106024710|NCT00606905|365756577|FG000|Overall Study|Withdrew|5|||
106024711|NCT00606905|365756578|FG001|Overall Study|Withdrew|5|||
105844086|NCT02990806|365086733|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
105970683|NCT01288612|365552804|FG001|Overall Study|Unable to intubate|3|||
105970684|NCT01288612|365552805|FG002|Overall Study|Unable to intubate|0|||
105970685|NCT00871923|365552806|FG000|Overall Study|Death|1|||
105844087|NCT02990806|365086734|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
105844088|NCT00977431|365086735|FG000|Overall Study|Other than listed|1|||
105844089|NCT00977431|365086736|FG001|Overall Study|Other than listed|0|||
105844090|NCT00977431|365086737|FG002|Overall Study|Other than listed|0|||
105844091|NCT00977431|365086738|FG003|Overall Study|Other than listed|0|||
105844092|NCT00977431|365086739|FG004|Overall Study|Other than listed|2|||
105844093|NCT00977431|365086735|FG000|Overall Study|Protocol Violation|0|||
105844094|NCT00977431|365086736|FG001|Overall Study|Protocol Violation|0|||
105844095|NCT00977431|365086737|FG002|Overall Study|Protocol Violation|1|||
105844096|NCT00977431|365086738|FG003|Overall Study|Protocol Violation|0|||
105844097|NCT00977431|365086739|FG004|Overall Study|Protocol Violation|0|||
105844098|NCT00977431|365086735|FG000|Overall Study|Adverse Event|3|||
105844099|NCT00977431|365086736|FG001|Overall Study|Adverse Event|0|||
105844100|NCT00977431|365086737|FG002|Overall Study|Adverse Event|4|||
105844101|NCT00977431|365086738|FG003|Overall Study|Adverse Event|0|||
105844102|NCT00977431|365086739|FG004|Overall Study|Adverse Event|6|||
105844103|NCT00977431|365086735|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
105844104|NCT00977431|365086736|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
105844105|NCT00977431|365086737|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
105844106|NCT00977431|365086738|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
105844107|NCT00977431|365086739|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
105844108|NCT00977431|365086735|FG000|Overall Study|Progressive disease|2|||
105844109|NCT00977431|365086736|FG001|Overall Study|Progressive disease|6|||
105844110|NCT00977431|365086737|FG002|Overall Study|Progressive disease|1|||
105844111|NCT00977431|365086738|FG003|Overall Study|Progressive disease|3|||
105844112|NCT00977431|365086739|FG004|Overall Study|Progressive disease|5|||
105844113|NCT03739138|365086742|FG000|Overall Study|Death|0|||
105844114|NCT03739138|365086743|FG001|Overall Study|Death|7|||
105844115|NCT03739138|365086744|FG002|Overall Study|Death|4|||
105844116|NCT03739138|365086745|FG003|Overall Study|Death|13|||
105844117|NCT03739138|365086746|FG004|Overall Study|Death|0|||
105844118|NCT03739138|365086742|FG000|Overall Study|Lost to Follow-up|0|||
105844119|NCT03739138|365086743|FG001|Overall Study|Lost to Follow-up|0|||
105844120|NCT03739138|365086744|FG002|Overall Study|Lost to Follow-up|1|||
105844121|NCT03739138|365086745|FG003|Overall Study|Lost to Follow-up|0|||
105844122|NCT03739138|365086746|FG004|Overall Study|Lost to Follow-up|0|||
105844123|NCT03739138|365086742|FG000|Overall Study|Study Terminated By Sponsor|0|||
105844124|NCT03739138|365086743|FG001|Overall Study|Study Terminated By Sponsor|0|||
105844125|NCT03739138|365086744|FG002|Overall Study|Study Terminated By Sponsor|0|||
105844126|NCT03739138|365086745|FG003|Overall Study|Study Terminated By Sponsor|4|||
105844127|NCT03739138|365086746|FG004|Overall Study|Study Terminated By Sponsor|0|||
105844128|NCT03739138|365086742|FG000|Overall Study|Withdrawal by Subject|0|||
105844129|NCT03739138|365086743|FG001|Overall Study|Withdrawal by Subject|0|||
105844130|NCT03739138|365086744|FG002|Overall Study|Withdrawal by Subject|0|||
105844131|NCT03739138|365086745|FG003|Overall Study|Withdrawal by Subject|1|||
105844132|NCT03739138|365086746|FG004|Overall Study|Withdrawal by Subject|0|||
105844133|NCT02654587|365086747|FG000|Overall Study|patient alive at end of study|22|||
105844134|NCT02654587|365086748|FG001|Overall Study|patient alive at end of study|8|||
105844135|NCT02654587|365086747|FG000|Overall Study|Withdrawal by Subject|1|||
105844136|NCT02654587|365086748|FG001|Overall Study|Withdrawal by Subject|7|||
105844137|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
105844138|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
105844139|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
105844140|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
105844141|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
105844142|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
105844143|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
105844144|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
105844145|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
105844146|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
105844147|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Subject decision|1|||
105844148|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Subject decision|1|||
105844149|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
105844150|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
105844151|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
105844152|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
105844153|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
105844154|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
105844155|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
105844156|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
105844157|NCT00518882|365086753|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
105844158|NCT00518882|365086754|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
105844159|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
105844160|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
105844161|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
105844162|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
105844163|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
105844164|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
105844165|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
105844166|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
105844167|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
105844168|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
105844169|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
105844170|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
105844171|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
105844172|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
105844173|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
105844174|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
105844175|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
105844176|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
105844177|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
105844178|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
105844179|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
105844180|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
105844181|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
105844182|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
105844183|NCT00518882|365086753|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
105844184|NCT00518882|365086754|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
105844185|NCT00680186|365086755|FG000|Overall Study|Adverse Event|47|||
105844186|NCT00680186|365086756|FG001|Overall Study|Adverse Event|44|||
105844187|NCT00680186|365086755|FG000|Overall Study|Protocol Violation|31|||
105844188|NCT00680186|365086756|FG001|Overall Study|Protocol Violation|26|||
105844189|NCT00680186|365086755|FG000|Overall Study|Lost to Follow-up|11|||
105844190|NCT00680186|365086756|FG001|Overall Study|Lost to Follow-up|6|||
105844191|NCT00680186|365086755|FG000|Overall Study|Withdrawal by Subject|32|||
105844192|NCT00680186|365086756|FG001|Overall Study|Withdrawal by Subject|39|||
105844193|NCT00680186|365086755|FG000|Overall Study|Other|4|||
105844194|NCT00680186|365086756|FG001|Overall Study|Other|1|||
105844195|NCT03395639|365086757|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
105844196|NCT03395639|365086758|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
105844197|NCT03395639|365086759|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
105844198|NCT03395639|365086757|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
105844199|NCT03395639|365086758|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
105844200|NCT03395639|365086759|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
105844201|NCT03395639|365086757|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
105844202|NCT03395639|365086758|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
105844203|NCT03395639|365086759|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
105844204|NCT03395639|365086757|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
105844205|NCT03395639|365086758|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
105844206|NCT03395639|365086759|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
105844207|NCT03395639|365086757|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
105844208|NCT03395639|365086758|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
105844209|NCT03395639|365086759|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
105844210|NCT00285584|365086763|FG000|Month 3|Lost to Follow-up|3|||
105844211|NCT00285584|365086764|FG001|Month 3|Lost to Follow-up|3|||
105844212|NCT00285584|365086763|FG000|Month 3|Withdrawal by Subject|1|||
105844213|NCT00285584|365086764|FG001|Month 3|Withdrawal by Subject|0|||
105844214|NCT00285584|365086763|FG000|Month 6|Lost to Follow-up|0|||
105844215|NCT00285584|365086764|FG001|Month 6|Lost to Follow-up|1|||
105844216|NCT00567476|365086765|FG000|Overall Study|Adverse Event|2|||
105844217|NCT00567476|365086766|FG001|Overall Study|Adverse Event|0|||
105844218|NCT00567476|365086765|FG000|Overall Study|Pregnancy|1|||
105844219|NCT00567476|365086766|FG001|Overall Study|Pregnancy|0|||
105844220|NCT00567476|365086765|FG000|Overall Study|Protocol Violation|4|||
105844221|NCT00567476|365086766|FG001|Overall Study|Protocol Violation|1|||
105844222|NCT00567476|365086765|FG000|Overall Study|Lost to Follow-up|0|||
105844223|NCT00567476|365086766|FG001|Overall Study|Lost to Follow-up|1|||
105844224|NCT00567476|365086765|FG000|Overall Study|Administrative issues|1|||
105844225|NCT00567476|365086766|FG001|Overall Study|Administrative issues|0|||
105844226|NCT00567476|365086765|FG000|Overall Study|Medical Decision|0|||
105844227|NCT00567476|365086766|FG001|Overall Study|Medical Decision|1|||
105844228|NCT00567476|365086765|FG000|Overall Study|Non-adherence to protocol|0|||
105844229|NCT00567476|365086766|FG001|Overall Study|Non-adherence to protocol|1|||
106024712|NCT01727024|365756598|FG000|Period 1|Lost to Follow-up|1|||
106024713|NCT01727024|365756599|FG001|Period 1|Lost to Follow-up|1|||
106024714|NCT01727024|365756598|FG000|Period 1|Withdrawal by Subject|2|||
105970686|NCT00871923|365552806|FG000|Overall Study|Withdrawal by Subject|1|||
105970687|NCT02982018|365552807|FG000|Overall Study|Incorrect Lens Dispensed|1|||
105970688|NCT02982018|365552808|FG001|Overall Study|Incorrect Lens Dispensed|0|||
105970689|NCT02982018|365552807|FG000|Overall Study|Protocol Violation|1|||
105970690|NCT02982018|365552808|FG001|Overall Study|Protocol Violation|1|||
105844230|NCT04403763|365086767|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
105844231|NCT04403763|365086768|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
105844232|NCT04403763|365086769|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844233|NCT04403763|365086770|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844234|NCT04403763|365086771|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844235|NCT04403763|365086772|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844236|NCT04403763|365086773|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
105844237|NCT04403763|365086767|FG000|Stage 1|Early termination due to PK tube failure|0|||
105844238|NCT04403763|365086768|FG001|Stage 1|Early termination due to PK tube failure|0|||
105844239|NCT04403763|365086769|FG002|Stage 1|Early termination due to PK tube failure|1|||
105844240|NCT04403763|365086770|FG003|Stage 1|Early termination due to PK tube failure|0|||
105844241|NCT04403763|365086771|FG004|Stage 1|Early termination due to PK tube failure|0|||
105844242|NCT04403763|365086772|FG005|Stage 1|Early termination due to PK tube failure|0|||
105844243|NCT04403763|365086773|FG006|Stage 1|Early termination due to PK tube failure|0|||
105844244|NCT04403763|365086767|FG000|Stage 2A|Adverse Event|0|||
105844245|NCT04403763|365086768|FG001|Stage 2A|Adverse Event|0|||
105844246|NCT04403763|365086769|FG002|Stage 2A|Adverse Event|0|||
105844247|NCT04403763|365086770|FG003|Stage 2A|Adverse Event|0|||
105844248|NCT04403763|365086771|FG004|Stage 2A|Adverse Event|0|||
105844249|NCT04403763|365086772|FG005|Stage 2A|Adverse Event|0|||
105844250|NCT04403763|365086773|FG006|Stage 2A|Adverse Event|1|||
105844251|NCT01376310|365086774|FG000|Overall Study|Study closed/terminated|1|||
105844252|NCT01376310|365086775|FG001|Overall Study|Study closed/terminated|2|||
105844253|NCT01376310|365086774|FG000|Overall Study|Withdrawal by Subject|8|||
105844254|NCT01376310|365086775|FG001|Overall Study|Withdrawal by Subject|2|||
105844255|NCT01376310|365086774|FG000|Overall Study|Physician Decision|26|||
105844256|NCT01376310|365086775|FG001|Overall Study|Physician Decision|7|||
105844257|NCT01376310|365086774|FG000|Overall Study|Lost to Follow-up|1|||
105844258|NCT01376310|365086775|FG001|Overall Study|Lost to Follow-up|0|||
105844259|NCT01523587|365086777|FG000|Overall Study|Other than listed|5|||
105844260|NCT01523587|365086778|FG001|Overall Study|Other than listed|5|||
105844261|NCT01523587|365086777|FG000|Overall Study|Worsening of underlying cancer disease|19|||
105844262|NCT01523587|365086778|FG001|Overall Study|Worsening of underlying cancer disease|34|||
105844263|NCT01523587|365086777|FG000|Overall Study|Adverse Event|68|||
105844264|NCT01523587|365086778|FG001|Overall Study|Adverse Event|52|||
105844265|NCT01523587|365086777|FG000|Overall Study|Protocol Violation|5|||
105844266|NCT01523587|365086778|FG001|Overall Study|Protocol Violation|3|||
105844267|NCT01523587|365086777|FG000|Overall Study|Lost to Follow-up|2|||
105844268|NCT01523587|365086778|FG001|Overall Study|Lost to Follow-up|2|||
105844269|NCT01523587|365086777|FG000|Overall Study|Withdrawal by Subject|28|||
105844270|NCT01523587|365086778|FG001|Overall Study|Withdrawal by Subject|20|||
105844271|NCT01523587|365086777|FG000|Overall Study|Withdrew due to Progressive disease|265|||
105844272|NCT01523587|365086778|FG001|Overall Study|Withdrew due to Progressive disease|279|||
105844273|NCT01523587|365086777|FG000|Overall Study|Randomised but bot treated|6|||
105844274|NCT01523587|365086778|FG001|Overall Study|Randomised but bot treated|2|||
105844275|NCT02903238|365086779|FG000|Overall Study|Lost to Follow-up|4|||
105970691|NCT02982018|365552807|FG000|Overall Study|Adverse Event|1|||
105970692|NCT02982018|365552808|FG001|Overall Study|Adverse Event|1|||
105970693|NCT02982018|365552807|FG000|Overall Study|Lens Discomfort|2|||
105970694|NCT02982018|365552808|FG001|Overall Study|Lens Discomfort|0|||
105970695|NCT02982018|365552807|FG000|Overall Study|Withdrawal by Subject|0|||
105970696|NCT02982018|365552808|FG001|Overall Study|Withdrawal by Subject|1|||
105970697|NCT00132691|365552812|FG000|Overall Study|Lost to Follow-up|5|||
105970698|NCT00132691|365552813|FG001|Overall Study|Lost to Follow-up|8|||
105970699|NCT00132691|365552812|FG000|Overall Study|Missed 2-year visit|4|||
105970700|NCT00132691|365552813|FG001|Overall Study|Missed 2-year visit|4|||
105970701|NCT00132691|365552812|FG000|Overall Study|Death|2|||
105970702|NCT00132691|365552813|FG001|Overall Study|Death|0|||
105970703|NCT01739933|365552814|FG000|Overall Study|Death|89|||
106024715|NCT01727024|365756599|FG001|Period 1|Withdrawal by Subject|3|||
105970704|NCT01739933|365552815|FG001|Overall Study|Death|86|||
106024716|NCT05194579|365756602|FG000|Overall Study|Lost to Follow-up|2|||
105844276|NCT01298778|365086782|FG000|Overall Study|Lost to Follow-up|2|||
105844277|NCT01298778|365086783|FG001|Overall Study|Lost to Follow-up|3|||
105844278|NCT01298778|365086782|FG000|Overall Study|Incorrect use of VAS|1|||
105844279|NCT01298778|365086783|FG001|Overall Study|Incorrect use of VAS|0|||
105844280|NCT01298778|365086782|FG000|Overall Study|Withdrawal by Subject|0|||
105844281|NCT01298778|365086783|FG001|Overall Study|Withdrawal by Subject|1|||
105844282|NCT01298778|365086782|FG000|Overall Study|Protocol Violation|0|||
105970705|NCT01739933|365552814|FG000|Overall Study|Withdrawal by Subject|10|||
105970706|NCT01739933|365552815|FG001|Overall Study|Withdrawal by Subject|8|||
106024717|NCT05194579|365756603|FG001|Overall Study|Lost to Follow-up|3|||
105844283|NCT01298778|365086783|FG001|Overall Study|Protocol Violation|1|||
105844284|NCT01298778|365086782|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
105844285|NCT01298778|365086783|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
105844286|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
105844287|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
105844288|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
105844289|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
105844290|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
105844291|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
105844292|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
105844293|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
105844294|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
105844295|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
105844296|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
105844297|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
105844298|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
105844299|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
105844300|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
105844301|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
105844302|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
105844303|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
105844304|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
105844305|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
105844306|NCT00700817|365086784|FG000|Week 0-26 (Main Period)|Unclassified|14|||
105844307|NCT00700817|365086785|FG001|Week 0-26 (Main Period)|Unclassified|4|||
105844308|NCT00700817|365086786|FG002|Week 0-26 (Main Period)|Unclassified|8|||
105844309|NCT00700817|365086787|FG003|Week 0-26 (Main Period)|Unclassified|0|||
105844310|NCT00700817|365086788|FG004|Week 0-26 (Main Period)|Unclassified|0|||
105844311|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
105844312|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
105844313|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
105844314|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
105844315|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
105844316|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
105844317|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
105844318|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
105844319|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
105844320|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
105844321|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
105844322|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
105844323|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
105844324|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
105844325|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
105844326|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
105844327|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
105844328|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
105844329|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
105844330|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
105844331|NCT00700817|365086784|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
105844332|NCT00700817|365086785|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
105844333|NCT00700817|365086786|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
105844334|NCT00700817|365086787|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
105844335|NCT00700817|365086788|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
105844336|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
105844337|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
105844338|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
105844339|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
105844340|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
105844341|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
105844342|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
105844343|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
105844344|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
105844345|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
105844346|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
105844347|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
105844348|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
105844349|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
105844350|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
105844351|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
105844352|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
105844353|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
105844354|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
105844355|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
105844356|NCT00700817|365086784|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
105844357|NCT00700817|365086785|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
105844358|NCT00700817|365086786|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
105844359|NCT00700817|365086787|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
105844360|NCT00700817|365086788|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
105844361|NCT02777918|365086789|FG000|Overall Study|Medical reasons|1|||
105844362|NCT02777918|365086790|FG001|Overall Study|Medical reasons|2|||
105844363|NCT02777918|365086789|FG000|Overall Study|Too busy / stressed|1|||
105844364|NCT02777918|365086790|FG001|Overall Study|Too busy / stressed|1|||
105844365|NCT02777918|365086789|FG000|Overall Study|Withdrawal by Subject|1|||
105844366|NCT02777918|365086790|FG001|Overall Study|Withdrawal by Subject|1|||
105844367|NCT00058214|365086791|FG000|Overall Study|Adverse Event|1|||
105844368|NCT02924376|365086798|FG000|Overall Study|Progressive Disease|4|||
105844369|NCT02924376|365086799|FG001|Overall Study|Progressive Disease|0|||
105844370|NCT02924376|365086800|FG002|Overall Study|Progressive Disease|1|||
105844371|NCT02924376|365086801|FG003|Overall Study|Progressive Disease|0|||
106024718|NCT05194579|365756602|FG000|Overall Study|Withdrawal by Subject|3|||
105970707|NCT01739933|365552814|FG000|Overall Study|Lost to Follow-up|3|||
105970708|NCT01739933|365552815|FG001|Overall Study|Lost to Follow-up|10|||
105970709|NCT01739933|365552814|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
105970710|NCT01739933|365552815|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
105970711|NCT04098367|365552816|FG000|Overall Study|Adverse Event|0|||
105970712|NCT04098367|365552817|FG001|Overall Study|Adverse Event|0|||
105970713|NCT04098367|365552818|FG002|Overall Study|Adverse Event|1|||
105970714|NCT04098367|365552816|FG000|Overall Study|Lost to Follow-up|1|||
105970715|NCT04098367|365552817|FG001|Overall Study|Lost to Follow-up|5|||
105970716|NCT04098367|365552818|FG002|Overall Study|Lost to Follow-up|2|||
105970717|NCT04098367|365552816|FG000|Overall Study|Withdrawal by Subject|0|||
105970718|NCT04098367|365552817|FG001|Overall Study|Withdrawal by Subject|0|||
105970719|NCT04098367|365552818|FG002|Overall Study|Withdrawal by Subject|1|||
105970720|NCT04098367|365552816|FG000|Overall Study|Sick . Could not attend visit|1|||
105970721|NCT04098367|365552817|FG001|Overall Study|Sick . Could not attend visit|0|||
105970722|NCT04098367|365552818|FG002|Overall Study|Sick . Could not attend visit|0|||
105970723|NCT01231321|365552826|FG000|Overall Study|Adverse Event|3|||
105970724|NCT01231321|365552826|FG000|Overall Study|Lack of Efficacy|2|||
105970725|NCT04021524|365552827|FG000|Overall Study|Change in surgical intervention|0|||
105970726|NCT04021524|365552828|FG001|Overall Study|Change in surgical intervention|1|||
105970727|NCT05275010|365552829|FG000|Overall Study|Reason Not Specified|4|||
105970728|NCT05275010|365552830|FG001|Overall Study|Reason Not Specified|1|||
105970729|NCT05275010|365552829|FG000|Overall Study|Withdrawal by Subject|1|||
105844372|NCT02924376|365086798|FG000|Overall Study|Death|73|||
105970730|NCT05275010|365552830|FG001|Overall Study|Withdrawal by Subject|0|||
105970731|NCT05275010|365552829|FG000|Overall Study|Lost to Follow-up|0|||
105970732|NCT05275010|365552830|FG001|Overall Study|Lost to Follow-up|1|||
105970733|NCT01921218|365552833|FG000|Overall Study|Death|2|||
105970734|NCT01921218|365552834|FG001|Overall Study|Death|1|||
105970735|NCT01921218|365552833|FG000|Overall Study|Withdrawal by Subject|0|||
105970736|NCT01921218|365552834|FG001|Overall Study|Withdrawal by Subject|2|||
105970737|NCT01921218|365552833|FG000|Overall Study|Kidney transplant|1|||
105970738|NCT01921218|365552834|FG001|Overall Study|Kidney transplant|1|||
105970739|NCT02545517|365552835|FG000|Overall Study|Death|2|||
105970740|NCT02545517|365552836|FG001|Overall Study|Death|2|||
105970741|NCT02545517|365552837|FG002|Overall Study|Death|1|||
105970742|NCT02545517|365552835|FG000|Overall Study|Lost to Follow-up|14|||
105970743|NCT02545517|365552836|FG001|Overall Study|Lost to Follow-up|13|||
105970744|NCT02545517|365552837|FG002|Overall Study|Lost to Follow-up|17|||
105970745|NCT02545517|365552835|FG000|Overall Study|Protocol Violation|0|||
105970746|NCT02545517|365552836|FG001|Overall Study|Protocol Violation|1|||
105970747|NCT02545517|365552837|FG002|Overall Study|Protocol Violation|1|||
105970748|NCT02545517|365552835|FG000|Overall Study|Withdrawal by Subject|5|||
105970749|NCT02545517|365552836|FG001|Overall Study|Withdrawal by Subject|8|||
105970750|NCT02545517|365552837|FG002|Overall Study|Withdrawal by Subject|9|||
105970751|NCT02545517|365552835|FG000|Overall Study|Administrative reason|5|||
105844373|NCT02924376|365086799|FG001|Overall Study|Death|18|||
105844374|NCT02924376|365086800|FG002|Overall Study|Death|15|||
105844375|NCT02924376|365086801|FG003|Overall Study|Death|2|||
105844376|NCT02924376|365086798|FG000|Overall Study|Lost to Follow-up|3|||
105844377|NCT02924376|365086799|FG001|Overall Study|Lost to Follow-up|0|||
105844378|NCT02924376|365086800|FG002|Overall Study|Lost to Follow-up|0|||
105844379|NCT02924376|365086801|FG003|Overall Study|Lost to Follow-up|0|||
105844380|NCT02924376|365086798|FG000|Overall Study|Study Terminated by Sponsor|19|||
105844381|NCT02924376|365086799|FG001|Overall Study|Study Terminated by Sponsor|0|||
105844382|NCT02924376|365086800|FG002|Overall Study|Study Terminated by Sponsor|0|||
105844383|NCT02924376|365086801|FG003|Overall Study|Study Terminated by Sponsor|0|||
105844384|NCT02924376|365086798|FG000|Overall Study|Physician Decision|1|||
105844385|NCT02924376|365086799|FG001|Overall Study|Physician Decision|0|||
105844386|NCT02924376|365086800|FG002|Overall Study|Physician Decision|0|||
105844387|NCT02924376|365086801|FG003|Overall Study|Physician Decision|0|||
105844388|NCT02924376|365086798|FG000|Overall Study|Withdrawal by Subject|7|||
105844389|NCT02924376|365086799|FG001|Overall Study|Withdrawal by Subject|2|||
105970752|NCT02545517|365552836|FG001|Overall Study|Administrative reason|6|||
105970753|NCT02545517|365552837|FG002|Overall Study|Administrative reason|10|||
105970754|NCT02545517|365552835|FG000|Overall Study|Other|2|||
105970755|NCT02545517|365552836|FG001|Overall Study|Other|4|||
105970756|NCT02545517|365552837|FG002|Overall Study|Other|3|||
105970757|NCT00006046|365552838|FG000|Overall Study|Adverse Event|3|||
106024719|NCT05194579|365756603|FG001|Overall Study|Withdrawal by Subject|4|||
105844390|NCT02924376|365086800|FG002|Overall Study|Withdrawal by Subject|1|||
105844391|NCT02924376|365086801|FG003|Overall Study|Withdrawal by Subject|0|||
105844392|NCT02924376|365086798|FG000|Overall Study|Rolled Over to Another Study|1|||
105844393|NCT02924376|365086799|FG001|Overall Study|Rolled Over to Another Study|0|||
105970758|NCT00006046|365552839|FG001|Overall Study|Adverse Event|0|||
105970759|NCT00006046|365552840|FG002|Overall Study|Adverse Event|0|||
105970760|NCT00006046|365552841|FG003|Overall Study|Adverse Event|0|||
105970761|NCT00006046|365552842|FG004|Overall Study|Adverse Event|0|||
105970762|NCT00006046|365552838|FG000|Overall Study|Disease Progression|2|||
105970763|NCT00006046|365552839|FG001|Overall Study|Disease Progression|0|||
105970764|NCT00006046|365552840|FG002|Overall Study|Disease Progression|0|||
105970765|NCT00006046|365552841|FG003|Overall Study|Disease Progression|0|||
105970766|NCT00006046|365552842|FG004|Overall Study|Disease Progression|0|||
105970767|NCT03361189|365552845|FG000|Overall Study|Received heart transplant|1|||
105970768|NCT03361189|365552846|FG001|Overall Study|Received heart transplant|0|||
105970769|NCT03361189|365552845|FG000|Overall Study|Pacemake replacement|0|||
105970770|NCT03361189|365552846|FG001|Overall Study|Pacemake replacement|1|||
105970771|NCT00590824|365552850|FG000|Overall Study|Disease could not be resected|0|||
105970772|NCT00590824|365552851|FG001|Overall Study|Disease could not be resected|2|||
105970773|NCT00590824|365552852|FG002|Overall Study|Disease could not be resected|1|||
105970774|NCT00590824|365552853|FG003|Overall Study|Disease could not be resected|0|||
105970775|NCT00590824|365552850|FG000|Overall Study|Adverse Event|0|||
105970776|NCT00590824|365552851|FG001|Overall Study|Adverse Event|0|||
105970777|NCT00590824|365552852|FG002|Overall Study|Adverse Event|0|||
105970778|NCT00590824|365552853|FG003|Overall Study|Adverse Event|1|||
105970779|NCT01155466|365552854|FG000|Overall Study|Adverse Event|13|||
105970780|NCT01155466|365552855|FG001|Overall Study|Adverse Event|15|||
105970781|NCT01155466|365552856|FG002|Overall Study|Adverse Event|6|||
105970782|NCT01155466|365552857|FG003|Overall Study|Adverse Event|17|||
105970783|NCT01155466|365552858|FG004|Overall Study|Adverse Event|18|||
105970784|NCT01155466|365552854|FG000|Overall Study|Lost to Follow-up|0|||
105970785|NCT01155466|365552855|FG001|Overall Study|Lost to Follow-up|0|||
105970786|NCT01155466|365552856|FG002|Overall Study|Lost to Follow-up|0|||
105970787|NCT01155466|365552857|FG003|Overall Study|Lost to Follow-up|0|||
105970788|NCT01155466|365552858|FG004|Overall Study|Lost to Follow-up|2|||
105970789|NCT01155466|365552854|FG000|Overall Study|Withdrawal by Subject|7|||
105970790|NCT01155466|365552855|FG001|Overall Study|Withdrawal by Subject|5|||
105970791|NCT01155466|365552856|FG002|Overall Study|Withdrawal by Subject|9|||
105970792|NCT01155466|365552857|FG003|Overall Study|Withdrawal by Subject|4|||
105970793|NCT01155466|365552858|FG004|Overall Study|Withdrawal by Subject|4|||
105970794|NCT01155466|365552854|FG000|Overall Study|Protocol Violation|0|||
105970795|NCT01155466|365552855|FG001|Overall Study|Protocol Violation|0|||
105970796|NCT01155466|365552856|FG002|Overall Study|Protocol Violation|2|||
105970797|NCT01155466|365552857|FG003|Overall Study|Protocol Violation|0|||
105970798|NCT01155466|365552858|FG004|Overall Study|Protocol Violation|1|||
105970799|NCT01155466|365552854|FG000|Overall Study|Administrative|0|||
105970800|NCT01155466|365552855|FG001|Overall Study|Administrative|3|||
105970801|NCT01155466|365552856|FG002|Overall Study|Administrative|0|||
105970802|NCT01155466|365552857|FG003|Overall Study|Administrative|0|||
105970803|NCT01155466|365552858|FG004|Overall Study|Administrative|0|||
105970804|NCT01155466|365552854|FG000|Overall Study|Randomized not treated|2|||
105970805|NCT01155466|365552855|FG001|Overall Study|Randomized not treated|2|||
105970806|NCT01155466|365552856|FG002|Overall Study|Randomized not treated|3|||
105970807|NCT01155466|365552857|FG003|Overall Study|Randomized not treated|0|||
105970808|NCT01155466|365552858|FG004|Overall Study|Randomized not treated|2|||
105970809|NCT01895543|365552859|FG000|Overall Study|Withdrawal by Subject|43|||
105970810|NCT01895543|365552859|FG000|Overall Study|Lost to Follow-up|25|||
105970811|NCT01895543|365552859|FG000|Overall Study|Adverse Event|28|||
105970812|NCT01895543|365552859|FG000|Overall Study|Subject's substantial non-compliance|6|||
105970813|NCT01895543|365552859|FG000|Overall Study|Protocol Violation|1|||
105970814|NCT01895543|365552859|FG000|Overall Study|Physician Decision|2|||
105970815|NCT01895543|365552859|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
105970816|NCT00557310|365552861|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
105970817|NCT00557310|365552861|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
105970818|NCT00557310|365552861|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
105970819|NCT00557310|365552861|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
105970820|NCT00557310|365552861|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
105970821|NCT00557310|365552861|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
105970822|NCT02649218|365552866|FG000|Overall Study|Adverse Event|8|||
105970823|NCT02649218|365552866|FG000|Overall Study|Lack of Efficacy|8|||
105970824|NCT02649218|365552866|FG000|Overall Study|Pregnancy|3|||
106024720|NCT05194579|365756602|FG000|Overall Study|Refused further study procedures|0|||
106024721|NCT05194579|365756603|FG001|Overall Study|Refused further study procedures|1|||
105844394|NCT02924376|365086800|FG002|Overall Study|Rolled Over to Another Study|0|||
105970825|NCT02649218|365552866|FG000|Overall Study|Protocol Violation|3|||
105970826|NCT02649218|365552866|FG000|Overall Study|Physician Decision|1|||
106024722|NCT05194579|365756602|FG000|Overall Study|Protocol deviation|1|||
105844395|NCT02924376|365086801|FG003|Overall Study|Rolled Over to Another Study|0|||
105970827|NCT02649218|365552866|FG000|Overall Study|Withdrawal by Subject|2|||
105970828|NCT05145322|365552867|FG000|Overall Study|Lost to Follow-up|4|||
105970829|NCT05145322|365552868|FG001|Overall Study|Lost to Follow-up|5|||
105970830|NCT04584346|365552869|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
105970831|NCT04584346|365552870|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
105970832|NCT04239222|365552871|FG000|Baseline|Withdrawal by Subject|0|||
105970833|NCT04239222|365552872|FG001|Baseline|Withdrawal by Subject|0|||
105970834|NCT04239222|365552873|FG002|Baseline|Withdrawal by Subject|1|||
105970835|NCT04239222|365552874|FG003|Baseline|Withdrawal by Subject|1|||
105970836|NCT04239222|365552871|FG000|First Foot Assignment|Withdrawal by Subject|0|||
105970837|NCT04239222|365552872|FG001|First Foot Assignment|Withdrawal by Subject|0|||
105970838|NCT04239222|365552873|FG002|First Foot Assignment|Withdrawal by Subject|1|||
105970839|NCT04239222|365552874|FG003|First Foot Assignment|Withdrawal by Subject|0|||
105970840|NCT04239222|365552871|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
105970841|NCT04239222|365552872|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
105970842|NCT04239222|365552873|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
105970843|NCT04239222|365552874|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
105970844|NCT00090233|365552880|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
105970845|NCT00090233|365552881|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
105970846|NCT00090233|365552880|FG000|Overall Study|Adverse Event|214|||
105970847|NCT00090233|365552881|FG001|Overall Study|Adverse Event|198|||
105970848|NCT00090233|365552880|FG000|Overall Study|Lost to Follow-up|68|||
105970849|NCT00090233|365552881|FG001|Overall Study|Lost to Follow-up|95|||
105970850|NCT00090233|365552880|FG000|Overall Study|Protocol Violation|960|||
105970851|NCT00090233|365552881|FG001|Overall Study|Protocol Violation|1022|||
105970852|NCT00090233|365552880|FG000|Overall Study|Withdrawal by Subject|182|||
105970853|NCT00090233|365552881|FG001|Overall Study|Withdrawal by Subject|211|||
105970854|NCT00090233|365552880|FG000|Overall Study|Moved|203|||
105970855|NCT00090233|365552881|FG001|Overall Study|Moved|189|||
105970856|NCT00090233|365552880|FG000|Overall Study|Other|1211|||
105970857|NCT00090233|365552881|FG001|Overall Study|Other|1160|||
105970858|NCT00090233|365552880|FG000|Overall Study|Data not available at data cut-off point|1552|||
105970859|NCT00090233|365552881|FG001|Overall Study|Data not available at data cut-off point|1563|||
105970860|NCT04863248|365552882|FG000|Overall Study|Sponsor Terminated|4|||
105970861|NCT04863248|365552883|FG001|Overall Study|Sponsor Terminated|1|||
105970862|NCT04863248|365552882|FG000|Overall Study|Death|0|||
105970863|NCT04863248|365552883|FG001|Overall Study|Death|1|||
105970864|NCT04863248|365552882|FG000|Overall Study|Withdrawal by Subject|0|||
105970865|NCT04863248|365552883|FG001|Overall Study|Withdrawal by Subject|1|||
105970866|NCT01779869|365552884|FG000|Overall Study|Physician Decision|2|||
105970867|NCT02136680|365552889|FG000|Overall Study|No Longer Interested|1|||
105970868|NCT02136680|365552890|FG001|Overall Study|No Longer Interested|1|||
105970869|NCT02136680|365552889|FG000|Overall Study|No longer receiving care at clinic|3|||
105970870|NCT02136680|365552890|FG001|Overall Study|No longer receiving care at clinic|5|||
105970871|NCT02136680|365552889|FG000|Overall Study|Moved away|5|||
105970872|NCT02136680|365552890|FG001|Overall Study|Moved away|4|||
105970873|NCT02136680|365552889|FG000|Overall Study|Unable to schedule|17|||
105970874|NCT02136680|365552890|FG001|Overall Study|Unable to schedule|16|||
105970875|NCT02136680|365552889|FG000|Overall Study|Study ended before interview due|6|||
105970876|NCT02136680|365552890|FG001|Overall Study|Study ended before interview due|3|||
105970877|NCT01632241|365552891|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
105970878|NCT01632241|365552892|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
105970879|NCT01632241|365552891|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
105970880|NCT01632241|365552892|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
105970881|NCT01632241|365552891|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
105970882|NCT01632241|365552892|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
106024723|NCT05194579|365756603|FG001|Overall Study|Protocol deviation|0|||
105844396|NCT00733369|365086802|FG000|Overall Study|Lost to Follow-up|2|||
105844397|NCT00733369|365086803|FG001|Overall Study|Lost to Follow-up|1|||
105844398|NCT00733369|365086802|FG000|Overall Study|Adverse Event|4|||
105844399|NCT00733369|365086803|FG001|Overall Study|Adverse Event|4|||
105844400|NCT00733369|365086802|FG000|Overall Study|Protocol Violation|4|||
105844401|NCT00733369|365086803|FG001|Overall Study|Protocol Violation|4|||
105844402|NCT03401073|365086804|FG000|Overall Study|Lost to Follow-up|1|||
105844403|NCT03401073|365086805|FG001|Overall Study|Lost to Follow-up|2|||
105844404|NCT02556307|365086811|FG000|Overall Study|Premature treatment interruption|11|||
105844405|NCT02556307|365086811|FG000|Overall Study|Lost to Follow-up|36|||
105844406|NCT02556307|365086811|FG000|Overall Study|Change to triple therapy|4|||
105844407|NCT02556307|365086811|FG000|Overall Study|Enrolled but not treated|2|||
105844408|NCT02139124|365086813|FG000|Overall Study|Adverse Event|2|||
105970883|NCT01632241|365552891|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
105970884|NCT01632241|365552892|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
105970885|NCT01632241|365552891|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
105970886|NCT01632241|365552892|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
105970887|NCT01632241|365552891|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
105970888|NCT01632241|365552892|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
105970889|NCT01632241|365552891|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
105970890|NCT01632241|365552892|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
106024724|NCT03890666|365756608|FG000|Overall Study|Withdrawal by Subject|0|||
105844409|NCT02139124|365086814|FG001|Overall Study|Adverse Event|0|||
106024725|NCT03890666|365756609|FG001|Overall Study|Withdrawal by Subject|1|||
105844410|NCT02139124|365086815|FG002|Overall Study|Adverse Event|1|||
105844411|NCT02139124|365086816|FG003|Overall Study|Adverse Event|2|||
105844412|NCT02139124|365086817|FG004|Overall Study|Adverse Event|5|||
105844413|NCT02139124|365086813|FG000|Overall Study|Withdrawal by Subject|2|||
105844414|NCT02139124|365086814|FG001|Overall Study|Withdrawal by Subject|2|||
105844415|NCT02139124|365086815|FG002|Overall Study|Withdrawal by Subject|2|||
105844416|NCT02139124|365086816|FG003|Overall Study|Withdrawal by Subject|2|||
105844417|NCT02139124|365086817|FG004|Overall Study|Withdrawal by Subject|3|||
105844418|NCT02139124|365086813|FG000|Overall Study|Protocol Violation|0|||
105844419|NCT02139124|365086814|FG001|Overall Study|Protocol Violation|0|||
105844420|NCT02139124|365086815|FG002|Overall Study|Protocol Violation|0|||
105844421|NCT02139124|365086816|FG003|Overall Study|Protocol Violation|1|||
105844422|NCT02139124|365086817|FG004|Overall Study|Protocol Violation|1|||
105844423|NCT02139124|365086813|FG000|Overall Study|non-compliant|1|||
105844424|NCT02139124|365086814|FG001|Overall Study|non-compliant|0|||
105844425|NCT02139124|365086815|FG002|Overall Study|non-compliant|0|||
105844426|NCT02139124|365086816|FG003|Overall Study|non-compliant|2|||
105844427|NCT02139124|365086817|FG004|Overall Study|non-compliant|0|||
105844428|NCT02139124|365086813|FG000|Overall Study|incarceration|0|||
105844429|NCT02139124|365086814|FG001|Overall Study|incarceration|0|||
105844430|NCT02139124|365086815|FG002|Overall Study|incarceration|1|||
105844431|NCT02139124|365086816|FG003|Overall Study|incarceration|0|||
105844432|NCT02139124|365086817|FG004|Overall Study|incarceration|0|||
105844433|NCT02139124|365086813|FG000|Overall Study|subject moved|1|||
105844434|NCT02139124|365086814|FG001|Overall Study|subject moved|0|||
105844435|NCT02139124|365086815|FG002|Overall Study|subject moved|0|||
105844436|NCT02139124|365086816|FG003|Overall Study|subject moved|0|||
105844437|NCT02139124|365086817|FG004|Overall Study|subject moved|0|||
105970891|NCT01632241|365552891|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
105970892|NCT01632241|365552892|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
105970893|NCT01632241|365552891|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
105970894|NCT01632241|365552892|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
105970895|NCT01632241|365552891|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
105970896|NCT01632241|365552892|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
105970897|NCT01632241|365552891|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
105970898|NCT01632241|365552892|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
105970899|NCT01632241|365552891|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
105970900|NCT01632241|365552892|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
105970901|NCT01632241|365552891|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
105970902|NCT01632241|365552892|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
105970903|NCT01632241|365552891|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
105970904|NCT01632241|365552892|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
105970905|NCT00027378|365552893|FG000|Overall Study|Physician Decision|0|||
105970906|NCT00027378|365552894|FG001|Overall Study|Physician Decision|3|||
105970907|NCT05605691|365552895|FG000|Overall Study|Lost to Follow-up|1|||
105970908|NCT04926831|365552896|FG000|Overall Study|Withdrawal by Subject|2|||
105970909|NCT04926831|365552896|FG000|Overall Study|Adverse Event|2|||
105970910|NCT04669262|365552897|FG000|Overall Study|Withdrawal by Subject|0|||
105970911|NCT04669262|365552898|FG001|Overall Study|Withdrawal by Subject|0|||
105970912|NCT04669262|365552899|FG002|Overall Study|Withdrawal by Subject|0|||
105970913|NCT04669262|365552900|FG003|Overall Study|Withdrawal by Subject|1|||
105970914|NCT04669262|365552897|FG000|Overall Study|Randomized but Not Treated|0|||
105970915|NCT04669262|365552898|FG001|Overall Study|Randomized but Not Treated|1|||
105970916|NCT04669262|365552899|FG002|Overall Study|Randomized but Not Treated|0|||
105970917|NCT04669262|365552900|FG003|Overall Study|Randomized but Not Treated|0|||
105970918|NCT02298179|365552901|FG000|Overall Study|Lost to Follow-up|0|||
105970919|NCT02298179|365552902|FG001|Overall Study|Lost to Follow-up|0|||
105970920|NCT02298179|365552903|FG002|Overall Study|Lost to Follow-up|1|||
105970921|NCT02298179|365552904|FG003|Overall Study|Lost to Follow-up|0|||
105970922|NCT02298179|365552905|FG004|Overall Study|Lost to Follow-up|0|||
105844438|NCT02139124|365086813|FG000|Overall Study|Lost to Follow-up|3|||
105970923|NCT02298179|365552906|FG005|Overall Study|Lost to Follow-up|0|||
105970924|NCT02298179|365552907|FG006|Overall Study|Lost to Follow-up|0|||
105970925|NCT02298179|365552908|FG007|Overall Study|Lost to Follow-up|1|||
105970926|NCT02298179|365552909|FG008|Overall Study|Lost to Follow-up|0|||
105844439|NCT02139124|365086814|FG001|Overall Study|Lost to Follow-up|2|||
105844440|NCT02139124|365086815|FG002|Overall Study|Lost to Follow-up|0|||
105844441|NCT02139124|365086816|FG003|Overall Study|Lost to Follow-up|5|||
105844442|NCT02139124|365086817|FG004|Overall Study|Lost to Follow-up|4|||
105970927|NCT02298179|365552910|FG009|Overall Study|Lost to Follow-up|0|||
105970928|NCT02298179|365552911|FG010|Overall Study|Lost to Follow-up|0|||
105844443|NCT00854373|365086818|FG000|Overall Study|Withdrawal by Subject|1|||
105844444|NCT00854373|365086819|FG001|Overall Study|Withdrawal by Subject|3|||
105970929|NCT02298179|365552912|FG011|Overall Study|Lost to Follow-up|0|||
106149634|NCT05137236|366209168|FG006|Part B|Lost to Follow-up|5|||
106149635|NCT05137236|366209169|FG007|Part B|Lost to Follow-up|5|||
105844445|NCT00854373|365086818|FG000|Overall Study|Forgot to take study drug|1|||
105844446|NCT00854373|365086819|FG001|Overall Study|Forgot to take study drug|1|||
105844447|NCT00842530|365086820|FG000|Overall Study|Serious adverse event|0|||
105844448|NCT00842530|365086821|FG001|Overall Study|Serious adverse event|6|||
105844449|NCT00842530|365086820|FG000|Overall Study|Other adverse event|6|||
105844450|NCT00842530|365086821|FG001|Overall Study|Other adverse event|1|||
105844451|NCT00842530|365086820|FG000|Overall Study|Protocol Violation|32|||
105844452|NCT00842530|365086821|FG001|Overall Study|Protocol Violation|14|||
105844453|NCT00842530|365086820|FG000|Overall Study|Lost to Follow-up|6|||
105844454|NCT00842530|365086821|FG001|Overall Study|Lost to Follow-up|8|||
105844455|NCT00842530|365086820|FG000|Overall Study|Withdrawal by Subject|73|||
105844456|NCT00842530|365086821|FG001|Overall Study|Withdrawal by Subject|28|||
105844457|NCT00706992|365086829|FG000|Overall Study|Study termination|5|||
105844458|NCT00706992|365086830|FG001|Overall Study|Study termination|5|||
105844459|NCT00706992|365086831|FG002|Overall Study|Study termination|6|||
105844460|NCT00706992|365086832|FG003|Overall Study|Study termination|2|||
105844461|NCT00706992|365086833|FG004|Overall Study|Study termination|3|||
105844462|NCT00706992|365086834|FG005|Overall Study|Study termination|2|||
105844463|NCT00706992|365086835|FG006|Overall Study|Study termination|3|||
105844464|NCT00706992|365086829|FG000|Overall Study|Disease progression before treatment|0|||
105844465|NCT00706992|365086830|FG001|Overall Study|Disease progression before treatment|0|||
105844466|NCT00706992|365086831|FG002|Overall Study|Disease progression before treatment|0|||
105844467|NCT00706992|365086832|FG003|Overall Study|Disease progression before treatment|0|||
105844468|NCT00706992|365086833|FG004|Overall Study|Disease progression before treatment|1|||
105844469|NCT00706992|365086834|FG005|Overall Study|Disease progression before treatment|0|||
105844470|NCT00706992|365086835|FG006|Overall Study|Disease progression before treatment|0|||
105844471|NCT00518622|365086836|FG000|Overall Study|Lost to Follow-up|0|||
105844472|NCT00518622|365086837|FG001|Overall Study|Lost to Follow-up|0|||
105844473|NCT00518622|365086838|FG002|Overall Study|Lost to Follow-up|1|||
105844474|NCT00518622|365086839|FG003|Overall Study|Lost to Follow-up|0|||
105844475|NCT00518622|365086840|FG004|Overall Study|Lost to Follow-up|0|||
105844476|NCT00518622|365086841|FG005|Overall Study|Lost to Follow-up|0|||
105844477|NCT00518622|365086842|FG006|Overall Study|Lost to Follow-up|0|||
105844478|NCT00518622|365086843|FG007|Overall Study|Lost to Follow-up|0|||
105844479|NCT00518622|365086836|FG000|Overall Study|Study medication taken incorrectly|0|||
105844480|NCT00518622|365086837|FG001|Overall Study|Study medication taken incorrectly|1|||
105844481|NCT00518622|365086838|FG002|Overall Study|Study medication taken incorrectly|0|||
105844482|NCT00518622|365086839|FG003|Overall Study|Study medication taken incorrectly|0|||
105844483|NCT00518622|365086840|FG004|Overall Study|Study medication taken incorrectly|0|||
105844484|NCT00518622|365086841|FG005|Overall Study|Study medication taken incorrectly|0|||
105844485|NCT00518622|365086842|FG006|Overall Study|Study medication taken incorrectly|0|||
105844486|NCT00518622|365086843|FG007|Overall Study|Study medication taken incorrectly|0|||
105844487|NCT03499119|365086844|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
105844488|NCT03499119|365086845|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
105844489|NCT03499119|365086846|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
105844490|NCT03499119|365086847|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
105844491|NCT03499119|365086844|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
105844492|NCT03499119|365086845|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
105844493|NCT03499119|365086846|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
105844494|NCT03499119|365086847|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
105844495|NCT03499119|365086844|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
105844496|NCT03499119|365086845|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
105844497|NCT03499119|365086846|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
105844498|NCT03499119|365086847|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
105844499|NCT03499119|365086844|FG000|Optional Extension Phase|Lost to Follow-up|0|||
105844500|NCT03499119|365086845|FG001|Optional Extension Phase|Lost to Follow-up|0|||
105844501|NCT03499119|365086846|FG002|Optional Extension Phase|Lost to Follow-up|0|||
105844502|NCT03499119|365086847|FG003|Optional Extension Phase|Lost to Follow-up|1|||
105844503|NCT03499119|365086844|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
105844504|NCT03499119|365086845|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
105844505|NCT03499119|365086846|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
105844506|NCT03499119|365086847|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
105844507|NCT03499119|365086844|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
105844508|NCT03499119|365086845|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
105844509|NCT03499119|365086846|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
105844510|NCT03499119|365086847|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
105844511|NCT04553913|365086848|FG000|Overall Study|patient's block resolved prior to PACU|1|||
105844512|NCT04553913|365086848|FG000|Overall Study|did not use the device properly|5|||
105970930|NCT02701777|365552913|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
105844513|NCT04495283|365088769|FG000|Overall Study|Physician Decision|0|||
105844514|NCT04495283|365088770|FG001|Overall Study|Physician Decision|0|||
105844515|NCT04495283|365088771|FG002|Overall Study|Physician Decision|1|||
105844516|NCT04495283|365088769|FG000|Overall Study|Withdrawal by Subject|0|||
105987454|NCT02814175|365614463|FG003|Part 1|Withdrawal Consent|0|||
106149636|NCT05137236|366209162|FG000|Part B|Death|0|||
106149637|NCT05137236|366209163|FG001|Part B|Death|0|||
106149638|NCT05137236|366209164|FG002|Part B|Death|0|||
106149639|NCT05137236|366209165|FG003|Part B|Death|0|||
106149640|NCT05137236|366209166|FG004|Part B|Death|0|||
106149641|NCT05137236|366209167|FG005|Part B|Death|0|||
106149642|NCT05137236|366209168|FG006|Part B|Death|0|||
105844517|NCT04495283|365088770|FG001|Overall Study|Withdrawal by Subject|1|||
105844518|NCT04495283|365088771|FG002|Overall Study|Withdrawal by Subject|1|||
105844519|NCT04495283|365088769|FG000|Overall Study|Other|1|||
105844520|NCT04495283|365088770|FG001|Overall Study|Other|0|||
105844521|NCT04495283|365088771|FG002|Overall Study|Other|1|||
105844522|NCT04718194|365088774|FG000|Overall Study|Withdrawal by Subject|3|||
105844523|NCT04718194|365088775|FG001|Overall Study|Withdrawal by Subject|0|||
105844524|NCT04718194|365088774|FG000|Overall Study|Lost to Follow-up|3|||
105844525|NCT04718194|365088775|FG001|Overall Study|Lost to Follow-up|0|||
105844526|NCT02246439|365088776|FG000|Overall Study|Adverse Event|3|||
105844527|NCT02246439|365088777|FG001|Overall Study|Adverse Event|0|||
105844528|NCT02246439|365088776|FG000|Overall Study|Lost to Follow-up|7|||
105844529|NCT02246439|365088777|FG001|Overall Study|Lost to Follow-up|5|||
105844530|NCT02246439|365088776|FG000|Overall Study|Protocol Violation|0|||
105844531|NCT02246439|365088777|FG001|Overall Study|Protocol Violation|2|||
105844532|NCT02246439|365088776|FG000|Overall Study|Physician Decision|0|||
105844533|NCT02246439|365088777|FG001|Overall Study|Physician Decision|1|||
105844534|NCT02246439|365088776|FG000|Overall Study|Unkonwn|1|||
105844535|NCT02246439|365088777|FG001|Overall Study|Unkonwn|3|||
105844536|NCT02246439|365088776|FG000|Overall Study|Withdrawal by Subject|1|||
105844537|NCT02246439|365088777|FG001|Overall Study|Withdrawal by Subject|0|||
105970931|NCT02701777|365552914|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
105970932|NCT02701777|365552915|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
105970933|NCT02701777|365552916|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
105970934|NCT02701777|365552913|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
105970935|NCT02701777|365552914|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
105970936|NCT02701777|365552915|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
105970937|NCT02701777|365552916|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
105970938|NCT00737568|365552921|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
105970939|NCT00737568|365552922|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
105970940|NCT00737568|365552921|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
105970941|NCT00737568|365552922|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
105970942|NCT00737568|365552921|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
105970943|NCT00737568|365552922|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
105970944|NCT00737568|365552921|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
105970945|NCT00737568|365552922|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
105970946|NCT00737568|365552921|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
105970947|NCT00737568|365552922|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
105970948|NCT00737568|365552921|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
105970949|NCT00737568|365552922|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
105970950|NCT00737568|365552921|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
105970951|NCT00737568|365552922|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
105970952|NCT00737568|365552921|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
105970953|NCT00737568|365552922|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
105970954|NCT00737568|365552921|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
105970955|NCT00737568|365552922|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
105970956|NCT01457014|365552923|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
105970957|NCT01457014|365552924|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
105970958|NCT01457014|365552925|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
105970959|NCT01457014|365552926|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
105970960|NCT01457014|365552923|FG000|First Night|Withdrawal by Subject|3|||
105844538|NCT00743509|365088785|FG000|Overall Study|Withdrawal by Subject|2|||
105844539|NCT01386684|365088786|FG000|Overall Study|Lost to Follow-up|51|||
105844540|NCT01386684|365088786|FG000|Overall Study|Other|51|||
105970961|NCT01457014|365552924|FG001|First Night|Withdrawal by Subject|0|||
105970962|NCT01457014|365552925|FG002|First Night|Withdrawal by Subject|0|||
105970963|NCT01457014|365552926|FG003|First Night|Withdrawal by Subject|0|||
105970964|NCT00294645|365552927|FG000|Overall Study|Death|10|||
105970965|NCT00294645|365552928|FG001|Overall Study|Death|18|||
105970966|NCT00294645|365552927|FG000|Overall Study|Lost to Follow-up|1|||
105970967|NCT00294645|365552928|FG001|Overall Study|Lost to Follow-up|10|||
106149643|NCT05137236|366209169|FG007|Part B|Death|2|||
106149644|NCT00434304|366209170|FG000|Overall Study|Adverse Event|14|||
106149645|NCT00434304|366209170|FG000|Overall Study|Lack of Efficacy|2|||
105844541|NCT01386684|365088786|FG000|Overall Study|Death|47|||
105844542|NCT01386684|365088786|FG000|Overall Study|Withdrawal of Consent|44|||
105844543|NCT01386684|365088786|FG000|Overall Study|Alternative Therapy Required|37|||
105970968|NCT00294645|365552927|FG000|Overall Study|Withdrawal by Subject|18|||
105970969|NCT00294645|365552928|FG001|Overall Study|Withdrawal by Subject|34|||
105970970|NCT00294645|365552927|FG000|Overall Study|Physician Decision|15|||
105970971|NCT00294645|365552928|FG001|Overall Study|Physician Decision|20|||
105970972|NCT00294645|365552927|FG000|Overall Study|Other|4|||
105970973|NCT00294645|365552928|FG001|Overall Study|Other|10|||
105970974|NCT00428220|365554884|FG000|Overall Study|Participant died|8|||
105970975|NCT00428220|365554884|FG000|Overall Study|Global deterioration of health status|7|||
105970976|NCT00428220|365554884|FG000|Overall Study|Lost to Follow-up|4|||
105970977|NCT00428220|365554884|FG000|Overall Study|Objective progression or relapse|123|||
105970978|NCT00428220|365554884|FG000|Overall Study|Participant refused continued treatment|7|||
105970979|NCT00428220|365554884|FG000|Overall Study|Adverse Event|51|||
105970980|NCT00428220|365554884|FG000|Overall Study|Other|23|||
105970981|NCT00983515|365554885|FG000|Ritonavir Alone|liver panel out of range|6|||
105970982|NCT00983515|365554885|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
105970983|NCT01730339|365554888|FG000|Overall Study|Withdrawal by Subject|3|||
105970984|NCT01730339|365554889|FG001|Overall Study|Withdrawal by Subject|2|||
105970985|NCT01730339|365554888|FG000|Overall Study|Lost to Follow-up|1|||
105970986|NCT01730339|365554889|FG001|Overall Study|Lost to Follow-up|1|||
105970987|NCT01730339|365554888|FG000|Overall Study|Un-specified|1|||
105970988|NCT01730339|365554889|FG001|Overall Study|Un-specified|0|||
105970989|NCT04143217|365554892|FG000|Overall Study|Withdrawal by Subject|42|||
105970990|NCT04143217|365554892|FG000|Overall Study|Adverse Event|29|||
105970991|NCT04143217|365554892|FG000|Overall Study|Lost to Follow-up|29|||
105970992|NCT04143217|365554892|FG000|Overall Study|Lack of Efficacy|15|||
105970993|NCT04143217|365554892|FG000|Overall Study|Physician Decision|1|||
105844544|NCT01386684|365088786|FG000|Overall Study|Disease Progression|28|||
105970994|NCT04143217|365554892|FG000|Overall Study|Non-Compliance With Study Drug|6|||
105970995|NCT04143217|365554892|FG000|Overall Study|Other, Multiple Categories|11|||
105970996|NCT00539513|365554893|FG000|Overall Study|Withdrawal by Subject|2|||
105970997|NCT00539513|365554894|FG001|Overall Study|Withdrawal by Subject|1|||
105970998|NCT00539513|365554893|FG000|Overall Study|Lost to Follow-up|0|||
105970999|NCT00539513|365554894|FG001|Overall Study|Lost to Follow-up|1|||
105971000|NCT00316693|365554895|FG000|Overall Study|Adverse Event|6|||
105971001|NCT00316693|365554896|FG001|Overall Study|Adverse Event|1|||
105971002|NCT00316693|365554895|FG000|Overall Study|Protocol Violation|1|||
105971003|NCT00316693|365554896|FG001|Overall Study|Protocol Violation|0|||
105971004|NCT00316693|365554895|FG000|Overall Study|Withdrawal by Subject|6|||
105971005|NCT00316693|365554896|FG001|Overall Study|Withdrawal by Subject|6|||
105971006|NCT00316693|365554895|FG000|Overall Study|Lost to Follow-up|26|||
105971007|NCT00316693|365554896|FG001|Overall Study|Lost to Follow-up|34|||
105971008|NCT00316693|365554895|FG000|Overall Study|Other|38|||
105971009|NCT00316693|365554896|FG001|Overall Study|Other|44|||
105844545|NCT01386684|365088786|FG000|Overall Study|Adverse Event|20|||
105844546|NCT01386684|365088786|FG000|Overall Study|Noncompliance|8|||
105844547|NCT01386684|365088786|FG000|Overall Study|Protocol Violation|4|||
105844548|NCT01386684|365088786|FG000|Overall Study|Missing|3|||
105844549|NCT00094458|365088787|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
105844550|NCT00094458|365088788|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
105844551|NCT00094458|365088789|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
105844552|NCT00094458|365088790|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
105844553|NCT00094458|365088791|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
105844554|NCT00094458|365088792|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
105844555|NCT00094458|365088787|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
105844556|NCT00094458|365088788|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
105844557|NCT00094458|365088789|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
105844558|NCT00094458|365088790|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
105844559|NCT00094458|365088791|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
105844560|NCT00094458|365088792|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
105844561|NCT00094458|365088787|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
105844562|NCT00094458|365088788|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
105844563|NCT00094458|365088789|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
105844564|NCT00094458|365088790|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
105844565|NCT00094458|365088791|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
105844566|NCT00094458|365088792|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
105844567|NCT00094458|365088787|FG000|Main Study: Through Week 30|Adverse Event|38|||
105844568|NCT00094458|365088788|FG001|Main Study: Through Week 30|Adverse Event|20|||
105844569|NCT00094458|365088789|FG002|Main Study: Through Week 30|Adverse Event|28|||
105844570|NCT00094458|365088790|FG003|Main Study: Through Week 30|Adverse Event|0|||
105971010|NCT03002818|365554897|FG000|Overall Study|Decision of the investigator|1|||
105971011|NCT01328041|365554899|FG000|Overall Study|Adverse Event|7|||
105971012|NCT01328041|365554899|FG000|Overall Study|Lack of Efficacy|27|||
105971013|NCT01328041|365554899|FG000|Overall Study|Protocol Violation|7|||
105971014|NCT01328041|365554899|FG000|Overall Study|Lost to Follow-up|7|||
105971015|NCT01328041|365554899|FG000|Overall Study|Physician Decision|2|||
105971016|NCT01328041|365554899|FG000|Overall Study|Withdrawal by Subject|7|||
105844571|NCT00094458|365088791|FG004|Main Study: Through Week 30|Adverse Event|0|||
105844572|NCT00094458|365088792|FG005|Main Study: Through Week 30|Adverse Event|0|||
105844573|NCT00094458|365088787|FG000|Main Study: Through Week 30|Death|1|||
105844574|NCT00094458|365088788|FG001|Main Study: Through Week 30|Death|0|||
105844575|NCT00094458|365088789|FG002|Main Study: Through Week 30|Death|0|||
105844576|NCT00094458|365088790|FG003|Main Study: Through Week 30|Death|0|||
105844577|NCT00094458|365088791|FG004|Main Study: Through Week 30|Death|0|||
105844578|NCT00094458|365088792|FG005|Main Study: Through Week 30|Death|0|||
105844579|NCT00094458|365088787|FG000|Main Study: Through Week 30|Other|19|||
105844580|NCT00094458|365088788|FG001|Main Study: Through Week 30|Other|16|||
105844581|NCT00094458|365088789|FG002|Main Study: Through Week 30|Other|9|||
105844582|NCT00094458|365088790|FG003|Main Study: Through Week 30|Other|0|||
105844583|NCT00094458|365088791|FG004|Main Study: Through Week 30|Other|0|||
105844584|NCT00094458|365088792|FG005|Main Study: Through Week 30|Other|0|||
105844585|NCT00094458|365088787|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
105844586|NCT00094458|365088788|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
105844587|NCT00094458|365088789|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
105844588|NCT00094458|365088790|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
105844589|NCT00094458|365088791|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
105844590|NCT00094458|365088792|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
105844591|NCT00094458|365088787|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
105844592|NCT00094458|365088788|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
105844593|NCT00094458|365088789|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
105844594|NCT00094458|365088790|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
105844595|NCT00094458|365088791|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
105844596|NCT00094458|365088792|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
105844597|NCT00094458|365088787|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
105844598|NCT00094458|365088788|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
105844599|NCT00094458|365088789|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
105844600|NCT00094458|365088790|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
105844601|NCT00094458|365088791|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
105844602|NCT00094458|365088792|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
105844603|NCT00094458|365088787|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
105844604|NCT00094458|365088788|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
105844605|NCT00094458|365088789|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
105844606|NCT00094458|365088790|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
105844607|NCT00094458|365088791|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
105844608|NCT00094458|365088792|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
105844609|NCT00094458|365088787|FG000|OLE: Open-Label Extension|Adverse Event|0|||
105844610|NCT00094458|365088788|FG001|OLE: Open-Label Extension|Adverse Event|0|||
105844611|NCT00094458|365088789|FG002|OLE: Open-Label Extension|Adverse Event|0|||
105844612|NCT00094458|365088790|FG003|OLE: Open-Label Extension|Adverse Event|0|||
105844613|NCT00094458|365088791|FG004|OLE: Open-Label Extension|Adverse Event|3|||
105844614|NCT00094458|365088792|FG005|OLE: Open-Label Extension|Adverse Event|4|||
105844615|NCT00094458|365088787|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
105844616|NCT00094458|365088788|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
105844617|NCT00094458|365088789|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
105844618|NCT00094458|365088790|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
105844619|NCT00094458|365088791|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
105844620|NCT00094458|365088792|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
105844621|NCT00094458|365088787|FG000|OLE: Open-Label Extension|Patient decision|0|||
105844622|NCT00094458|365088788|FG001|OLE: Open-Label Extension|Patient decision|0|||
105844623|NCT00094458|365088789|FG002|OLE: Open-Label Extension|Patient decision|0|||
105844624|NCT00094458|365088790|FG003|OLE: Open-Label Extension|Patient decision|0|||
105844625|NCT00094458|365088791|FG004|OLE: Open-Label Extension|Patient decision|1|||
105844626|NCT00094458|365088792|FG005|OLE: Open-Label Extension|Patient decision|0|||
105844627|NCT02119286|365088793|FG000|Overall Study|Adverse Event|9|||
105844628|NCT02119286|365088794|FG001|Overall Study|Adverse Event|7|||
105844629|NCT02119286|365088795|FG002|Overall Study|Adverse Event|2|||
105844630|NCT02119286|365088793|FG000|Overall Study|Lack of Efficacy|11|||
105844631|NCT02119286|365088794|FG001|Overall Study|Lack of Efficacy|3|||
106024726|NCT03890666|365756608|FG000|Overall Study|Protocol deviation|1|||
106149646|NCT00434304|366209170|FG000|Overall Study|Withdrawal by Subject|4|||
105844632|NCT02119286|365088795|FG002|Overall Study|Lack of Efficacy|4|||
105844633|NCT02119286|365088793|FG000|Overall Study|Lost to Follow-up|2|||
105844634|NCT02119286|365088794|FG001|Overall Study|Lost to Follow-up|0|||
105844635|NCT02119286|365088795|FG002|Overall Study|Lost to Follow-up|1|||
105844636|NCT02119286|365088793|FG000|Overall Study|Withdrawal by Subject|4|||
106149647|NCT00431834|366209173|FG000|Overall Study|Withdrawal by Subject|7|||
105844637|NCT02119286|365088794|FG001|Overall Study|Withdrawal by Subject|1|||
106024727|NCT03890666|365756609|FG001|Overall Study|Protocol deviation|4|||
106024728|NCT03890666|365756608|FG000|Overall Study|Lost to Follow-up|2|||
105971017|NCT03283098|365554900|FG000|Overall Study|Withdrawal by Subject|0|||
105971018|NCT03283098|365554901|FG001|Overall Study|Withdrawal by Subject|1|||
105971019|NCT01606787|365554902|FG000|Overall Study|Withdrawal by Subject|4|||
105971020|NCT01606787|365554903|FG001|Overall Study|Withdrawal by Subject|5|||
105971021|NCT01606787|365554902|FG000|Overall Study|Surgery canceled|0|||
105971022|NCT01606787|365554903|FG001|Overall Study|Surgery canceled|2|||
105971023|NCT00347438|365554922|FG000|Overall Study|Withdrawal by Subject|1|||
105971024|NCT00347438|365554922|FG000|Overall Study|Physician Decision|1|||
105971025|NCT03920293|365554923|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
105971026|NCT03920293|365554924|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
105971027|NCT03920293|365554923|FG000|Randomized-Controlled Period|Physician Decision|1|||
105971028|NCT03920293|365554924|FG001|Randomized-Controlled Period|Physician Decision|2|||
105971029|NCT03920293|365554923|FG000|Randomized-Controlled Period|Adverse Event|0|||
105971030|NCT03920293|365554924|FG001|Randomized-Controlled Period|Adverse Event|2|||
105971031|NCT03920293|365554923|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
105971032|NCT03920293|365554924|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
105971033|NCT03920293|365554923|FG000|Randomized-Controlled Period|Death|2|||
105971034|NCT03920293|365554924|FG001|Randomized-Controlled Period|Death|0|||
105971035|NCT03920293|365554923|FG000|Randomized-Controlled Period|Protocol Violation|1|||
105971036|NCT03920293|365554924|FG001|Randomized-Controlled Period|Protocol Violation|0|||
105971037|NCT03920293|365554923|FG000|Randomized-Controlled Period|Noncompliance|1|||
105971038|NCT03920293|365554924|FG001|Randomized-Controlled Period|Noncompliance|0|||
105971039|NCT03920293|365554923|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
105971040|NCT03920293|365554924|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
105971041|NCT03920293|365554923|FG000|Open- Label Extension Period|Death|3|||
105971042|NCT03920293|365554924|FG001|Open- Label Extension Period|Death|3|||
105971043|NCT03920293|365554923|FG000|Open- Label Extension Period|Physician Decision|5|||
105971044|NCT03920293|365554924|FG001|Open- Label Extension Period|Physician Decision|3|||
105971045|NCT03920293|365554923|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
105971046|NCT03920293|365554924|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
105971047|NCT00693017|365554925|FG000|Overall Study|Sponsor Decision|2|||
105971048|NCT00693017|365554926|FG001|Overall Study|Sponsor Decision|1|||
105971049|NCT00693017|365554925|FG000|Overall Study|Death|0|||
105971050|NCT00693017|365554926|FG001|Overall Study|Death|1|||
105971051|NCT01082874|365554927|FG000|Overall Study|Lost to Follow-up|10|||
105971052|NCT01082874|365554928|FG001|Overall Study|Lost to Follow-up|10|||
105971053|NCT01082874|365554929|FG002|Overall Study|Lost to Follow-up|6|||
105971054|NCT01082874|365554930|FG003|Overall Study|Lost to Follow-up|10|||
105971055|NCT01082874|365554927|FG000|Overall Study|Withdrawal by Subject|1|||
105971056|NCT01082874|365554928|FG001|Overall Study|Withdrawal by Subject|2|||
105971057|NCT01082874|365554929|FG002|Overall Study|Withdrawal by Subject|5|||
105971058|NCT01082874|365554930|FG003|Overall Study|Withdrawal by Subject|3|||
105971059|NCT00090142|365554935|FG000|Treatment Period I|Lost to Follow-up|1|||
106024729|NCT03890666|365756609|FG001|Overall Study|Lost to Follow-up|5|||
106024730|NCT03890666|365756608|FG000|Overall Study|Other than specified|1|||
106024731|NCT03890666|365756609|FG001|Overall Study|Other than specified|8|||
106024732|NCT02925416|365756610|FG000|Overall Study|Adverse Event|2|||
106024733|NCT02925416|365756611|FG001|Overall Study|Adverse Event|0|||
106024734|NCT01639729|365756612|FG000|Overall Study|Withdrawal by Subject|1|||
106024735|NCT01639729|365756613|FG001|Overall Study|Withdrawal by Subject|0|||
106024736|NCT01639729|365756614|FG002|Overall Study|Withdrawal by Subject|1|||
106024737|NCT01639729|365756615|FG003|Overall Study|Withdrawal by Subject|1|||
106024738|NCT01639729|365756616|FG004|Overall Study|Withdrawal by Subject|0|||
106024739|NCT01639729|365756617|FG005|Overall Study|Withdrawal by Subject|0|||
106024740|NCT03052426|365756620|FG000|Overall Study|Withdrawal by Subject|0|||
106024741|NCT03052426|365756621|FG001|Overall Study|Withdrawal by Subject|1|||
106024742|NCT03052426|365756622|FG002|Overall Study|Withdrawal by Subject|0|||
106024743|NCT03052426|365756620|FG000|Overall Study|Lost to Follow-up|2|||
106024744|NCT03052426|365756621|FG001|Overall Study|Lost to Follow-up|0|||
106024745|NCT03052426|365756622|FG002|Overall Study|Lost to Follow-up|1|||
106024746|NCT03083990|365756623|FG000|Overall Study|Adverse Event|1|||
106024747|NCT03083990|365756624|FG001|Overall Study|Adverse Event|0|||
106024748|NCT00984620|365756625|FG000|Overall Study|Adverse Event|5|||
105971060|NCT00090142|365554936|FG001|Treatment Period I|Lost to Follow-up|2|||
105971061|NCT00090142|365554935|FG000|Treatment Period I|Protocol Violation|2|||
105971062|NCT00090142|365554936|FG001|Treatment Period I|Protocol Violation|0|||
105971063|NCT00090142|365554935|FG000|Treatment Period I|Withdrawal by Subject|2|||
106024749|NCT00984620|365756626|FG001|Overall Study|Adverse Event|5|||
106024750|NCT00984620|365756625|FG000|Overall Study|Lost to Follow-up|1|||
106024751|NCT00984620|365756626|FG001|Overall Study|Lost to Follow-up|1|||
105971064|NCT00090142|365554936|FG001|Treatment Period I|Withdrawal by Subject|0|||
106024752|NCT00984620|365756625|FG000|Overall Study|Withdrawal by Subject|0|||
106024753|NCT00984620|365756626|FG001|Overall Study|Withdrawal by Subject|2|||
106024754|NCT00984620|365756625|FG000|Overall Study|reason other than listed above|0|||
105844638|NCT02119286|365088795|FG002|Overall Study|Withdrawal by Subject|0|||
105844639|NCT03856593|365088800|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
105844640|NCT03856593|365088801|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
105844641|NCT04179019|365088802|FG000|Overall Study|Lost to Follow-up|2|||
105844642|NCT04179019|365088802|FG000|Overall Study|Physician Decision|2|||
105844643|NCT04179019|365088802|FG000|Overall Study|Withdrawal by Subject|5|||
105844644|NCT04179019|365088802|FG000|Overall Study|Adverse Event|4|||
105844645|NCT02083926|365088803|FG000|Overall Study|Withdrawal by Subject|1|||
105844646|NCT02083926|365088804|FG001|Overall Study|Withdrawal by Subject|0|||
105844647|NCT03438227|365088807|FG000|Overall Study|Withdrawal by Subject|10|||
105844648|NCT03438227|365088808|FG001|Overall Study|Withdrawal by Subject|5|||
105844649|NCT02093221|365088811|FG000|Overall Study|Adverse Event|1|||
105844650|NCT02093221|365088812|FG001|Overall Study|Adverse Event|0|||
105844651|NCT02093221|365088813|FG002|Overall Study|Adverse Event|0|||
105844652|NCT02093221|365088814|FG003|Overall Study|Adverse Event|0|||
105844653|NCT02093221|365088815|FG004|Overall Study|Adverse Event|0|||
105844654|NCT02093221|365088811|FG000|Overall Study|Withdrawal by Subject|1|||
105844655|NCT02093221|365088812|FG001|Overall Study|Withdrawal by Subject|1|||
105844656|NCT02093221|365088813|FG002|Overall Study|Withdrawal by Subject|4|||
105844657|NCT02093221|365088814|FG003|Overall Study|Withdrawal by Subject|1|||
105844658|NCT02093221|365088815|FG004|Overall Study|Withdrawal by Subject|1|||
105844659|NCT02093221|365088811|FG000|Overall Study|Lost to Follow-up|2|||
105844660|NCT02093221|365088812|FG001|Overall Study|Lost to Follow-up|0|||
105844661|NCT02093221|365088813|FG002|Overall Study|Lost to Follow-up|1|||
105844662|NCT02093221|365088814|FG003|Overall Study|Lost to Follow-up|1|||
105844663|NCT02093221|365088815|FG004|Overall Study|Lost to Follow-up|0|||
105971065|NCT00090142|365554935|FG000|Treatment Period I|Other|0|||
105971066|NCT00090142|365554936|FG001|Treatment Period I|Other|1|||
105971067|NCT00090142|365554935|FG000|Treatment Period II|Other|1|||
105971068|NCT00090142|365554936|FG001|Treatment Period II|Other|0|||
105971069|NCT00354107|365554937|FG000|Overall Study|Adverse Event|2|||
105971070|NCT00354107|365554937|FG000|Overall Study|Physician Decision|2|||
105971071|NCT00354107|365554937|FG000|Overall Study|Withdrawal by Subject|1|||
105971072|NCT02754141|365554941|FG000|Overall Study|Disease progression|11|||
105971073|NCT02754141|365554942|FG001|Overall Study|Disease progression|7|||
105971074|NCT02754141|365554943|FG002|Overall Study|Disease progression|8|||
105971075|NCT02754141|365554944|FG003|Overall Study|Disease progression|5|||
105971076|NCT02754141|365554945|FG004|Overall Study|Disease progression|7|||
105971077|NCT02754141|365554946|FG005|Overall Study|Disease progression|7|||
105971078|NCT02754141|365554947|FG006|Overall Study|Disease progression|7|||
105971079|NCT02754141|365554948|FG007|Overall Study|Disease progression|6|||
105971080|NCT02754141|365554949|FG008|Overall Study|Disease progression|11|||
105971081|NCT02754141|365554950|FG009|Overall Study|Disease progression|16|||
105971082|NCT02754141|365554951|FG010|Overall Study|Disease progression|18|||
105971083|NCT02754141|365554952|FG011|Overall Study|Disease progression|13|||
105971084|NCT02754141|365554953|FG012|Overall Study|Disease progression|10|||
105971085|NCT02754141|365554954|FG013|Overall Study|Disease progression|12|||
105971086|NCT02754141|365554955|FG014|Overall Study|Disease progression|12|||
105971087|NCT02754141|365554956|FG015|Overall Study|Disease progression|14|||
105971088|NCT02754141|365554957|FG016|Overall Study|Disease progression|0|||
105971089|NCT02754141|365554958|FG017|Overall Study|Disease progression|1|||
105971090|NCT02754141|365554941|FG000|Overall Study|Study drug toxicity|1|||
105971091|NCT02754141|365554942|FG001|Overall Study|Study drug toxicity|1|||
105971092|NCT02754141|365554943|FG002|Overall Study|Study drug toxicity|0|||
105971093|NCT02754141|365554944|FG003|Overall Study|Study drug toxicity|0|||
105971094|NCT02754141|365554945|FG004|Overall Study|Study drug toxicity|0|||
105971095|NCT02754141|365554946|FG005|Overall Study|Study drug toxicity|0|||
105971096|NCT02754141|365554947|FG006|Overall Study|Study drug toxicity|0|||
105971097|NCT02754141|365554948|FG007|Overall Study|Study drug toxicity|0|||
105971098|NCT02754141|365554949|FG008|Overall Study|Study drug toxicity|0|||
105971099|NCT02754141|365554950|FG009|Overall Study|Study drug toxicity|0|||
105971100|NCT02754141|365554951|FG010|Overall Study|Study drug toxicity|2|||
105971101|NCT02754141|365554952|FG011|Overall Study|Study drug toxicity|1|||
105971102|NCT02754141|365554953|FG012|Overall Study|Study drug toxicity|1|||
105844664|NCT02093221|365088811|FG000|Overall Study|Death|0|||
105844665|NCT02093221|365088812|FG001|Overall Study|Death|1|||
105844666|NCT02093221|365088813|FG002|Overall Study|Death|0|||
105844667|NCT02093221|365088814|FG003|Overall Study|Death|0|||
105844668|NCT02093221|365088815|FG004|Overall Study|Death|0|||
105844669|NCT02093221|365088811|FG000|Overall Study|Protocol Violation|0|||
105844670|NCT02093221|365088812|FG001|Overall Study|Protocol Violation|1|||
105844671|NCT02093221|365088813|FG002|Overall Study|Protocol Violation|0|||
105971103|NCT02754141|365554954|FG013|Overall Study|Study drug toxicity|0|||
105971104|NCT02754141|365554955|FG014|Overall Study|Study drug toxicity|0|||
105971105|NCT02754141|365554956|FG015|Overall Study|Study drug toxicity|0|||
105971106|NCT02754141|365554957|FG016|Overall Study|Study drug toxicity|0|||
105971107|NCT02754141|365554958|FG017|Overall Study|Study drug toxicity|0|||
105971108|NCT02754141|365554941|FG000|Overall Study|AE unrelated to study drug|1|||
105971109|NCT02754141|365554942|FG001|Overall Study|AE unrelated to study drug|1|||
105844672|NCT02093221|365088814|FG003|Overall Study|Protocol Violation|0|||
105844673|NCT02093221|365088815|FG004|Overall Study|Protocol Violation|0|||
105844674|NCT02093221|365088811|FG000|Overall Study|Study termination|6|||
105844675|NCT02093221|365088812|FG001|Overall Study|Study termination|5|||
105844676|NCT02093221|365088813|FG002|Overall Study|Study termination|4|||
105844677|NCT02093221|365088814|FG003|Overall Study|Study termination|6|||
105844678|NCT02093221|365088815|FG004|Overall Study|Study termination|7|||
105844679|NCT03465436|365088816|FG000|Period 1|Protocol Violation|0|||
105844680|NCT03465436|365088817|FG001|Period 1|Protocol Violation|0|||
105844681|NCT03465436|365088818|FG002|Period 1|Protocol Violation|1|||
105844682|NCT03465436|365088819|FG003|Period 1|Protocol Violation|0|||
105844683|NCT03465436|365088816|FG000|Period 2|Protocol Violation|0|||
105844684|NCT03465436|365088817|FG001|Period 2|Protocol Violation|1|||
105844685|NCT03465436|365088818|FG002|Period 2|Protocol Violation|0|||
105844686|NCT03465436|365088819|FG003|Period 2|Protocol Violation|0|||
105844687|NCT03465436|365088816|FG000|Period 3|Protocol Violation|1|||
105844688|NCT03465436|365088817|FG001|Period 3|Protocol Violation|1|||
105844689|NCT03465436|365088818|FG002|Period 3|Protocol Violation|0|||
105844690|NCT03465436|365088819|FG003|Period 3|Protocol Violation|0|||
105844691|NCT03465436|365088816|FG000|Period 4|Protocol Violation|0|||
105844692|NCT03465436|365088817|FG001|Period 4|Protocol Violation|0|||
105844693|NCT03465436|365088818|FG002|Period 4|Protocol Violation|1|||
105844694|NCT03465436|365088819|FG003|Period 4|Protocol Violation|0|||
105844695|NCT03852459|365088820|FG000|Overall Study|Adverse Event|2|||
105844696|NCT03852459|365088821|FG001|Overall Study|Adverse Event|2|||
105844697|NCT03852459|365088820|FG000|Overall Study|Withdrawal by Subject|1|||
105844698|NCT03852459|365088821|FG001|Overall Study|Withdrawal by Subject|1|||
105844699|NCT00049842|365088822|FG000|Treatment Phase|Adverse Event|47|||
105844700|NCT00049842|365088823|FG001|Treatment Phase|Adverse Event|12|||
105844701|NCT00049842|365088822|FG000|Treatment Phase|Withdrawal by Subject|35|||
105844702|NCT00049842|365088823|FG001|Treatment Phase|Withdrawal by Subject|46|||
105844703|NCT00049842|365088822|FG000|Treatment Phase|Non-compliance with protocol|7|||
105844704|NCT00049842|365088823|FG001|Treatment Phase|Non-compliance with protocol|8|||
105844705|NCT00049842|365088822|FG000|Treatment Phase|Lost to Follow-up|4|||
105844706|NCT00049842|365088823|FG001|Treatment Phase|Lost to Follow-up|8|||
105844707|NCT00049842|365088822|FG000|Treatment Phase|Administrative|0|||
105844708|NCT00049842|365088823|FG001|Treatment Phase|Administrative|3|||
105844709|NCT00049842|365088822|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
105844710|NCT00049842|365088823|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
105844711|NCT00049842|365088822|FG000|Follow-up Phase|Adverse Event|6|||
105844712|NCT00049842|365088823|FG001|Follow-up Phase|Adverse Event|1|||
105844713|NCT00049842|365088822|FG000|Follow-up Phase|Other|1|||
105844714|NCT00049842|365088823|FG001|Follow-up Phase|Other|4|||
105844715|NCT01813071|365088824|FG000|Overall Study|Protocol Violation|0|||
105844716|NCT01813071|365088825|FG001|Overall Study|Protocol Violation|0|||
105844717|NCT01813071|365088826|FG002|Overall Study|Protocol Violation|0|||
105844718|NCT01813071|365088827|FG003|Overall Study|Protocol Violation|0|||
105844719|NCT01813071|365088828|FG004|Overall Study|Protocol Violation|1|||
105844720|NCT01813071|365088829|FG005|Overall Study|Protocol Violation|4|||
105844721|NCT01813071|365088830|FG006|Overall Study|Protocol Violation|2|||
105844722|NCT01813071|365088831|FG007|Overall Study|Protocol Violation|4|||
105844723|NCT01813071|365088832|FG008|Overall Study|Protocol Violation|2|||
105844724|NCT01813071|365088824|FG000|Overall Study|Withdrawal by Subject|0|||
105844725|NCT01813071|365088825|FG001|Overall Study|Withdrawal by Subject|0|||
105844726|NCT01813071|365088826|FG002|Overall Study|Withdrawal by Subject|0|||
105844727|NCT01813071|365088827|FG003|Overall Study|Withdrawal by Subject|0|||
105844728|NCT01813071|365088828|FG004|Overall Study|Withdrawal by Subject|0|||
105844729|NCT01813071|365088829|FG005|Overall Study|Withdrawal by Subject|1|||
105844730|NCT01813071|365088830|FG006|Overall Study|Withdrawal by Subject|0|||
105971110|NCT02754141|365554943|FG002|Overall Study|AE unrelated to study drug|0|||
105971111|NCT02754141|365554944|FG003|Overall Study|AE unrelated to study drug|1|||
105971112|NCT02754141|365554945|FG004|Overall Study|AE unrelated to study drug|3|||
105971113|NCT02754141|365554946|FG005|Overall Study|AE unrelated to study drug|2|||
105971114|NCT02754141|365554947|FG006|Overall Study|AE unrelated to study drug|1|||
105971115|NCT02754141|365554948|FG007|Overall Study|AE unrelated to study drug|0|||
105971116|NCT02754141|365554949|FG008|Overall Study|AE unrelated to study drug|0|||
105844731|NCT01813071|365088831|FG007|Overall Study|Withdrawal by Subject|0|||
105844732|NCT01813071|365088832|FG008|Overall Study|Withdrawal by Subject|0|||
105844733|NCT01813071|365088824|FG000|Overall Study|Adverse Event|0|||
105844734|NCT01813071|365088825|FG001|Overall Study|Adverse Event|0|||
105844735|NCT01813071|365088826|FG002|Overall Study|Adverse Event|0|||
105844736|NCT01813071|365088827|FG003|Overall Study|Adverse Event|0|||
105971117|NCT02754141|365554950|FG009|Overall Study|AE unrelated to study drug|0|||
105971118|NCT02754141|365554951|FG010|Overall Study|AE unrelated to study drug|0|||
106149648|NCT00431834|366209173|FG000|Overall Study|Death|3|||
105844737|NCT01813071|365088828|FG004|Overall Study|Adverse Event|0|||
105844738|NCT01813071|365088829|FG005|Overall Study|Adverse Event|1|||
105844739|NCT01813071|365088830|FG006|Overall Study|Adverse Event|0|||
105844740|NCT01813071|365088831|FG007|Overall Study|Adverse Event|0|||
105971119|NCT02754141|365554952|FG011|Overall Study|AE unrelated to study drug|0|||
105971120|NCT02754141|365554953|FG012|Overall Study|AE unrelated to study drug|0|||
105971121|NCT02754141|365554954|FG013|Overall Study|AE unrelated to study drug|0|||
105971122|NCT02754141|365554955|FG014|Overall Study|AE unrelated to study drug|0|||
105971123|NCT02754141|365554956|FG015|Overall Study|AE unrelated to study drug|0|||
105971124|NCT02754141|365554957|FG016|Overall Study|AE unrelated to study drug|0|||
105971125|NCT02754141|365554958|FG017|Overall Study|AE unrelated to study drug|0|||
105971126|NCT02754141|365554941|FG000|Overall Study|Request to discontinue|0|||
105971127|NCT02754141|365554942|FG001|Overall Study|Request to discontinue|0|||
105971128|NCT02754141|365554943|FG002|Overall Study|Request to discontinue|0|||
105971129|NCT02754141|365554944|FG003|Overall Study|Request to discontinue|0|||
105971130|NCT02754141|365554945|FG004|Overall Study|Request to discontinue|0|||
105971131|NCT02754141|365554946|FG005|Overall Study|Request to discontinue|0|||
105971132|NCT02754141|365554947|FG006|Overall Study|Request to discontinue|0|||
105971133|NCT02754141|365554948|FG007|Overall Study|Request to discontinue|0|||
105971134|NCT02754141|365554949|FG008|Overall Study|Request to discontinue|1|||
105971135|NCT02754141|365554950|FG009|Overall Study|Request to discontinue|0|||
105971136|NCT02754141|365554951|FG010|Overall Study|Request to discontinue|0|||
105971137|NCT02754141|365554952|FG011|Overall Study|Request to discontinue|0|||
105971138|NCT02754141|365554953|FG012|Overall Study|Request to discontinue|0|||
105971139|NCT02754141|365554954|FG013|Overall Study|Request to discontinue|1|||
105971140|NCT02754141|365554955|FG014|Overall Study|Request to discontinue|1|||
105971141|NCT02754141|365554956|FG015|Overall Study|Request to discontinue|0|||
105971142|NCT02754141|365554957|FG016|Overall Study|Request to discontinue|0|||
105971143|NCT02754141|365554958|FG017|Overall Study|Request to discontinue|0|||
105971144|NCT02754141|365554941|FG000|Overall Study|Withdrew consent|0|||
105971145|NCT02754141|365554942|FG001|Overall Study|Withdrew consent|0|||
105971146|NCT02754141|365554943|FG002|Overall Study|Withdrew consent|0|||
105971147|NCT02754141|365554944|FG003|Overall Study|Withdrew consent|0|||
105971148|NCT02754141|365554945|FG004|Overall Study|Withdrew consent|0|||
105971149|NCT02754141|365554946|FG005|Overall Study|Withdrew consent|0|||
105971150|NCT02754141|365554947|FG006|Overall Study|Withdrew consent|0|||
105971151|NCT02754141|365554948|FG007|Overall Study|Withdrew consent|0|||
105971152|NCT02754141|365554949|FG008|Overall Study|Withdrew consent|0|||
105971153|NCT02754141|365554950|FG009|Overall Study|Withdrew consent|1|||
105971154|NCT02754141|365554951|FG010|Overall Study|Withdrew consent|0|||
105971155|NCT02754141|365554952|FG011|Overall Study|Withdrew consent|0|||
105971156|NCT02754141|365554953|FG012|Overall Study|Withdrew consent|0|||
105971157|NCT02754141|365554954|FG013|Overall Study|Withdrew consent|0|||
105971158|NCT02754141|365554955|FG014|Overall Study|Withdrew consent|0|||
105971159|NCT02754141|365554956|FG015|Overall Study|Withdrew consent|0|||
105971160|NCT02754141|365554957|FG016|Overall Study|Withdrew consent|0|||
105971161|NCT02754141|365554958|FG017|Overall Study|Withdrew consent|0|||
105971162|NCT02754141|365554941|FG000|Overall Study|Maximum clinical benefit|0|||
105971163|NCT02754141|365554942|FG001|Overall Study|Maximum clinical benefit|0|||
105971164|NCT02754141|365554943|FG002|Overall Study|Maximum clinical benefit|0|||
105971165|NCT02754141|365554944|FG003|Overall Study|Maximum clinical benefit|1|||
105971166|NCT02754141|365554945|FG004|Overall Study|Maximum clinical benefit|0|||
105971167|NCT02754141|365554946|FG005|Overall Study|Maximum clinical benefit|0|||
105971168|NCT02754141|365554947|FG006|Overall Study|Maximum clinical benefit|0|||
105971169|NCT02754141|365554948|FG007|Overall Study|Maximum clinical benefit|0|||
105971170|NCT02754141|365554949|FG008|Overall Study|Maximum clinical benefit|0|||
105971171|NCT02754141|365554950|FG009|Overall Study|Maximum clinical benefit|0|||
105971172|NCT02754141|365554951|FG010|Overall Study|Maximum clinical benefit|0|||
105971173|NCT02754141|365554952|FG011|Overall Study|Maximum clinical benefit|0|||
105971174|NCT02754141|365554953|FG012|Overall Study|Maximum clinical benefit|0|||
105971175|NCT02754141|365554954|FG013|Overall Study|Maximum clinical benefit|0|||
105971176|NCT02754141|365554955|FG014|Overall Study|Maximum clinical benefit|0|||
105971177|NCT02754141|365554956|FG015|Overall Study|Maximum clinical benefit|0|||
105971178|NCT02754141|365554957|FG016|Overall Study|Maximum clinical benefit|0|||
105971179|NCT02754141|365554958|FG017|Overall Study|Maximum clinical benefit|0|||
105971180|NCT02754141|365554941|FG000|Overall Study|No longer meets study criteria|0|||
105971181|NCT02754141|365554942|FG001|Overall Study|No longer meets study criteria|0|||
105971182|NCT02754141|365554943|FG002|Overall Study|No longer meets study criteria|0|||
106024755|NCT00984620|365756626|FG001|Overall Study|reason other than listed above|4|||
106024756|NCT02424578|365756627|FG000|Overall Study|Withdrawal by Subject|0|||
106024757|NCT02424578|365756628|FG001|Overall Study|Withdrawal by Subject|1|||
106024758|NCT01419197|365756629|FG000|Overall Study|Death|247|||
106024759|NCT01419197|365756630|FG001|Overall Study|Death|122|||
106024760|NCT01419197|365756629|FG000|Overall Study|Physician Decision|4|||
106024761|NCT01419197|365756630|FG001|Overall Study|Physician Decision|4|||
106024762|NCT01419197|365756629|FG000|Overall Study|Non-compliance|3|||
105971183|NCT02754141|365554944|FG003|Overall Study|No longer meets study criteria|1|||
105971184|NCT02754141|365554945|FG004|Overall Study|No longer meets study criteria|0|||
105971185|NCT02754141|365554946|FG005|Overall Study|No longer meets study criteria|0|||
105971186|NCT02754141|365554947|FG006|Overall Study|No longer meets study criteria|0|||
105844741|NCT01813071|365088832|FG008|Overall Study|Adverse Event|0|||
105844742|NCT01813071|365088824|FG000|Overall Study|Physician Decision|0|||
105844743|NCT01813071|365088825|FG001|Overall Study|Physician Decision|0|||
105844744|NCT01813071|365088826|FG002|Overall Study|Physician Decision|0|||
105844745|NCT01813071|365088827|FG003|Overall Study|Physician Decision|0|||
105844746|NCT01813071|365088828|FG004|Overall Study|Physician Decision|0|||
105844747|NCT01813071|365088829|FG005|Overall Study|Physician Decision|0|||
105844748|NCT01813071|365088830|FG006|Overall Study|Physician Decision|1|||
105844749|NCT01813071|365088831|FG007|Overall Study|Physician Decision|0|||
105844750|NCT01813071|365088832|FG008|Overall Study|Physician Decision|0|||
105844751|NCT01813071|365088824|FG000|Overall Study|Met inc/exc criteria|0|||
105844752|NCT01813071|365088825|FG001|Overall Study|Met inc/exc criteria|0|||
105844753|NCT01813071|365088826|FG002|Overall Study|Met inc/exc criteria|0|||
105844754|NCT01813071|365088827|FG003|Overall Study|Met inc/exc criteria|0|||
105844755|NCT01813071|365088828|FG004|Overall Study|Met inc/exc criteria|0|||
105844756|NCT01813071|365088829|FG005|Overall Study|Met inc/exc criteria|1|||
105844757|NCT01813071|365088830|FG006|Overall Study|Met inc/exc criteria|0|||
105844758|NCT01813071|365088831|FG007|Overall Study|Met inc/exc criteria|1|||
105844759|NCT01813071|365088832|FG008|Overall Study|Met inc/exc criteria|1|||
105844760|NCT02442271|365088833|FG000|Overall Study|Adverse Event|1|||
105844761|NCT02442271|365088833|FG000|Overall Study|Withdrew Consent|1|||
105844762|NCT02442271|365088833|FG000|Overall Study|Lost to Follow-up|1|||
105844763|NCT02442271|365088833|FG000|Overall Study|Other|1|||
105844764|NCT00831623|365088835|FG000|Overall Study|Withdrawal by Subject|9|||
105844765|NCT00831623|365088835|FG000|Overall Study|Lost to Follow-up|1|||
105844766|NCT00831623|365088835|FG000|Overall Study|Not 2 years post-treatment|12|||
105844767|NCT01564459|365088836|FG000|Run-In|Adverse Event|7|||
105844768|NCT01564459|365088837|FG001|Run-In|Adverse Event|0|||
105844769|NCT01564459|365088838|FG002|Run-In|Adverse Event|0|||
105844770|NCT01564459|365088836|FG000|Run-In|Lost to Follow-up|1|||
105844771|NCT01564459|365088837|FG001|Run-In|Lost to Follow-up|0|||
105844772|NCT01564459|365088838|FG002|Run-In|Lost to Follow-up|0|||
105844773|NCT01564459|365088836|FG000|Run-In|Non-compliance with study drug|2|||
105844774|NCT01564459|365088837|FG001|Run-In|Non-compliance with study drug|0|||
105844775|NCT01564459|365088838|FG002|Run-In|Non-compliance with study drug|0|||
105844776|NCT01564459|365088836|FG000|Run-In|Protocol Violation|1|||
105844777|NCT01564459|365088837|FG001|Run-In|Protocol Violation|0|||
105844778|NCT01564459|365088838|FG002|Run-In|Protocol Violation|0|||
105844779|NCT01564459|365088836|FG000|Run-In|Withdrawal by Subject|1|||
105844780|NCT01564459|365088837|FG001|Run-In|Withdrawal by Subject|0|||
105844781|NCT01564459|365088838|FG002|Run-In|Withdrawal by Subject|0|||
105844782|NCT01564459|365088836|FG000|Double-blind Treatment|Adverse Event|0|||
105844783|NCT01564459|365088837|FG001|Double-blind Treatment|Adverse Event|0|||
105844784|NCT01564459|365088838|FG002|Double-blind Treatment|Adverse Event|1|||
105844785|NCT03629028|365088841|FG000|Overall Study|Lost to Follow-up|26|||
105844786|NCT03629028|365088842|FG001|Overall Study|Lost to Follow-up|23|||
105844787|NCT03629028|365088841|FG000|Overall Study|Pregnancy|4|||
105844788|NCT03629028|365088842|FG001|Overall Study|Pregnancy|2|||
105844789|NCT03629028|365088841|FG000|Overall Study|intolerance to examination|2|||
105844790|NCT03629028|365088842|FG001|Overall Study|intolerance to examination|0|||
105844791|NCT02427984|365088843|FG000|Overall Study|Lost to Follow-up|13|||
105844792|NCT02427984|365088844|FG001|Overall Study|Lost to Follow-up|5|||
105844793|NCT02427984|365088845|FG002|Overall Study|Lost to Follow-up|18|||
105844794|NCT03545191|365088846|FG000|Overall Study|Death|1|||
105844795|NCT03545191|365088847|FG001|Overall Study|Death|0|||
105844796|NCT03545191|365088848|FG002|Overall Study|Death|0|||
105844797|NCT03545191|365088846|FG000|Overall Study|Adverse Event|4|||
105844798|NCT03545191|365088847|FG001|Overall Study|Adverse Event|2|||
105844799|NCT03545191|365088848|FG002|Overall Study|Adverse Event|7|||
105844800|NCT03545191|365088846|FG000|Overall Study|Other reasons|3|||
105844801|NCT03545191|365088847|FG001|Overall Study|Other reasons|11|||
105844802|NCT03545191|365088848|FG002|Overall Study|Other reasons|8|||
105844803|NCT03545191|365088846|FG000|Overall Study|Withdrawal by Subject|13|||
105844804|NCT03545191|365088847|FG001|Overall Study|Withdrawal by Subject|10|||
105844805|NCT03545191|365088848|FG002|Overall Study|Withdrawal by Subject|12|||
105844806|NCT03545191|365088846|FG000|Overall Study|Lost to Follow-up|1|||
105844807|NCT03545191|365088847|FG001|Overall Study|Lost to Follow-up|2|||
105971187|NCT02754141|365554948|FG007|Overall Study|No longer meets study criteria|0|||
105971188|NCT02754141|365554949|FG008|Overall Study|No longer meets study criteria|0|||
105844808|NCT03545191|365088848|FG002|Overall Study|Lost to Follow-up|3|||
105844809|NCT01491035|365088856|FG000|Overall Study|Lost to Follow-up|0|||
105844810|NCT01491035|365088857|FG001|Overall Study|Lost to Follow-up|0|||
105844811|NCT01491035|365088858|FG002|Overall Study|Lost to Follow-up|0|||
105844812|NCT01491035|365088859|FG003|Overall Study|Lost to Follow-up|0|||
105844813|NCT01491035|365088860|FG004|Overall Study|Lost to Follow-up|1|||
105844814|NCT01491035|365088861|FG005|Overall Study|Lost to Follow-up|0|||
105844815|NCT01491035|365088862|FG006|Overall Study|Lost to Follow-up|0|||
105844816|NCT01491035|365088863|FG007|Overall Study|Lost to Follow-up|0|||
105844817|NCT00532935|365088867|FG000|Overall Study|Adverse Event|11|||
105844818|NCT00532935|365088868|FG001|Overall Study|Adverse Event|12|||
105971189|NCT02754141|365554950|FG009|Overall Study|No longer meets study criteria|0|||
105971190|NCT02754141|365554951|FG010|Overall Study|No longer meets study criteria|0|||
105971191|NCT02754141|365554952|FG011|Overall Study|No longer meets study criteria|0|||
105971192|NCT02754141|365554953|FG012|Overall Study|No longer meets study criteria|0|||
105971193|NCT02754141|365554954|FG013|Overall Study|No longer meets study criteria|0|||
105971194|NCT02754141|365554955|FG014|Overall Study|No longer meets study criteria|0|||
105971195|NCT02754141|365554956|FG015|Overall Study|No longer meets study criteria|0|||
105971196|NCT02754141|365554957|FG016|Overall Study|No longer meets study criteria|0|||
105971197|NCT02754141|365554958|FG017|Overall Study|No longer meets study criteria|0|||
105971198|NCT02754141|365554941|FG000|Overall Study|Other reasons|0|||
105971199|NCT02754141|365554942|FG001|Overall Study|Other reasons|0|||
105971200|NCT02754141|365554943|FG002|Overall Study|Other reasons|0|||
105971201|NCT02754141|365554944|FG003|Overall Study|Other reasons|0|||
105971202|NCT02754141|365554945|FG004|Overall Study|Other reasons|0|||
105971203|NCT02754141|365554946|FG005|Overall Study|Other reasons|0|||
105971204|NCT02754141|365554947|FG006|Overall Study|Other reasons|0|||
105971205|NCT02754141|365554948|FG007|Overall Study|Other reasons|1|||
105971206|NCT02754141|365554949|FG008|Overall Study|Other reasons|0|||
105971207|NCT02754141|365554950|FG009|Overall Study|Other reasons|0|||
105971208|NCT02754141|365554951|FG010|Overall Study|Other reasons|0|||
105971209|NCT02754141|365554952|FG011|Overall Study|Other reasons|0|||
105971210|NCT02754141|365554953|FG012|Overall Study|Other reasons|2|||
105971211|NCT02754141|365554954|FG013|Overall Study|Other reasons|0|||
105971212|NCT02754141|365554955|FG014|Overall Study|Other reasons|0|||
105971213|NCT02754141|365554956|FG015|Overall Study|Other reasons|0|||
105971214|NCT02754141|365554957|FG016|Overall Study|Other reasons|0|||
105971215|NCT02754141|365554958|FG017|Overall Study|Other reasons|0|||
105971216|NCT02754141|365554941|FG000|Overall Study|Completed treatment as per protocol|0|||
105971217|NCT02754141|365554942|FG001|Overall Study|Completed treatment as per protocol|1|||
105971218|NCT02754141|365554943|FG002|Overall Study|Completed treatment as per protocol|0|||
105971219|NCT02754141|365554944|FG003|Overall Study|Completed treatment as per protocol|0|||
105971220|NCT02754141|365554945|FG004|Overall Study|Completed treatment as per protocol|0|||
105971221|NCT02754141|365554946|FG005|Overall Study|Completed treatment as per protocol|0|||
105971222|NCT02754141|365554947|FG006|Overall Study|Completed treatment as per protocol|0|||
105971223|NCT02754141|365554948|FG007|Overall Study|Completed treatment as per protocol|0|||
105971224|NCT02754141|365554949|FG008|Overall Study|Completed treatment as per protocol|0|||
105971225|NCT02754141|365554950|FG009|Overall Study|Completed treatment as per protocol|0|||
105971226|NCT02754141|365554951|FG010|Overall Study|Completed treatment as per protocol|0|||
105971227|NCT02754141|365554952|FG011|Overall Study|Completed treatment as per protocol|0|||
105971228|NCT02754141|365554953|FG012|Overall Study|Completed treatment as per protocol|1|||
105971229|NCT02754141|365554954|FG013|Overall Study|Completed treatment as per protocol|0|||
105971230|NCT02754141|365554955|FG014|Overall Study|Completed treatment as per protocol|0|||
105971231|NCT02754141|365554956|FG015|Overall Study|Completed treatment as per protocol|0|||
105971232|NCT02754141|365554957|FG016|Overall Study|Completed treatment as per protocol|0|||
105971233|NCT02754141|365554958|FG017|Overall Study|Completed treatment as per protocol|0|||
105971234|NCT02754141|365554941|FG000|Overall Study|Not completing monotherapy|0|||
105971235|NCT02754141|365554942|FG001|Overall Study|Not completing monotherapy|0|||
105971236|NCT02754141|365554943|FG002|Overall Study|Not completing monotherapy|0|||
105971237|NCT02754141|365554944|FG003|Overall Study|Not completing monotherapy|0|||
105971238|NCT02754141|365554945|FG004|Overall Study|Not completing monotherapy|0|||
105971239|NCT02754141|365554946|FG005|Overall Study|Not completing monotherapy|0|||
105971240|NCT02754141|365554947|FG006|Overall Study|Not completing monotherapy|0|||
105971241|NCT02754141|365554948|FG007|Overall Study|Not completing monotherapy|0|||
105971242|NCT02754141|365554949|FG008|Overall Study|Not completing monotherapy|0|||
105971243|NCT02754141|365554950|FG009|Overall Study|Not completing monotherapy|0|||
105971244|NCT02754141|365554951|FG010|Overall Study|Not completing monotherapy|0|||
105971245|NCT02754141|365554952|FG011|Overall Study|Not completing monotherapy|0|||
105971246|NCT02754141|365554953|FG012|Overall Study|Not completing monotherapy|0|||
105971247|NCT02754141|365554954|FG013|Overall Study|Not completing monotherapy|1|||
106149649|NCT00431834|366209173|FG000|Overall Study|Missed Endpoint Visit|2|||
105971248|NCT02754141|365554955|FG014|Overall Study|Not completing monotherapy|0|||
105971249|NCT02754141|365554956|FG015|Overall Study|Not completing monotherapy|0|||
105971250|NCT02754141|365554957|FG016|Overall Study|Not completing monotherapy|0|||
105971251|NCT02754141|365554958|FG017|Overall Study|Not completing monotherapy|0|||
105971252|NCT03344549|365554959|FG000|Overall Study|Withdrawal by Subject|3|||
105971253|NCT03344549|365554960|FG001|Overall Study|Withdrawal by Subject|2|||
105971254|NCT03344549|365554959|FG000|Overall Study|Dialysis|2|||
105971255|NCT03344549|365554960|FG001|Overall Study|Dialysis|0|||
105971256|NCT03344549|365554959|FG000|Overall Study|Cancer|1|||
105971257|NCT03344549|365554960|FG001|Overall Study|Cancer|0|||
105971258|NCT03344549|365554959|FG000|Overall Study|Lack of electronic device|1|||
105971259|NCT03344549|365554960|FG001|Overall Study|Lack of electronic device|0|||
105971260|NCT03344549|365554959|FG000|Overall Study|Transportation difficulty|0|||
105971261|NCT03344549|365554960|FG001|Overall Study|Transportation difficulty|13|||
106149650|NCT00431834|366209173|FG000|Overall Study|Lost to Follow-up|1|||
105844819|NCT00532935|365088867|FG000|Overall Study|Lack of Efficacy|0|||
105844820|NCT00532935|365088868|FG001|Overall Study|Lack of Efficacy|3|||
105844821|NCT00532935|365088867|FG000|Overall Study|Lost to Follow-up|10|||
105844822|NCT00532935|365088868|FG001|Overall Study|Lost to Follow-up|6|||
105844823|NCT00532935|365088867|FG000|Overall Study|Physician Decision|4|||
105844824|NCT00532935|365088868|FG001|Overall Study|Physician Decision|5|||
105844825|NCT00532935|365088867|FG000|Overall Study|Pregnancy|1|||
105844826|NCT00532935|365088868|FG001|Overall Study|Pregnancy|0|||
105844827|NCT00532935|365088867|FG000|Overall Study|Protocol Violation|4|||
105844828|NCT00532935|365088868|FG001|Overall Study|Protocol Violation|2|||
105844829|NCT00532935|365088867|FG000|Overall Study|Withdrawal by Subject|10|||
105844830|NCT00532935|365088868|FG001|Overall Study|Withdrawal by Subject|9|||
105844831|NCT00532935|365088867|FG000|Overall Study|Protocol Specific Criteria|11|||
105844832|NCT00532935|365088868|FG001|Overall Study|Protocol Specific Criteria|15|||
105844833|NCT02149121|365088872|FG000|Main Study Period|Lack of Efficacy|2|||
105844834|NCT02149121|365088873|FG001|Main Study Period|Lack of Efficacy|2|||
105844835|NCT02149121|365088874|FG002|Main Study Period|Lack of Efficacy|1|||
105844836|NCT02149121|365088875|FG003|Main Study Period|Lack of Efficacy|0|||
105844837|NCT02149121|365088876|FG004|Main Study Period|Lack of Efficacy|0|||
105844838|NCT02149121|365088877|FG005|Main Study Period|Lack of Efficacy|0|||
105844839|NCT02149121|365088878|FG006|Main Study Period|Lack of Efficacy|0|||
105844840|NCT02149121|365088872|FG000|Main Study Period|Withdrawal by Subject|9|||
105844841|NCT02149121|365088873|FG001|Main Study Period|Withdrawal by Subject|5|||
105844842|NCT02149121|365088874|FG002|Main Study Period|Withdrawal by Subject|1|||
105844843|NCT02149121|365088875|FG003|Main Study Period|Withdrawal by Subject|0|||
105844844|NCT02149121|365088876|FG004|Main Study Period|Withdrawal by Subject|0|||
105844845|NCT02149121|365088877|FG005|Main Study Period|Withdrawal by Subject|0|||
105844846|NCT02149121|365088878|FG006|Main Study Period|Withdrawal by Subject|0|||
105844847|NCT02149121|365088872|FG000|Main Study Period|Adverse Event|2|||
105844848|NCT02149121|365088873|FG001|Main Study Period|Adverse Event|5|||
105844849|NCT02149121|365088874|FG002|Main Study Period|Adverse Event|1|||
105844850|NCT02149121|365088875|FG003|Main Study Period|Adverse Event|0|||
105844851|NCT02149121|365088876|FG004|Main Study Period|Adverse Event|0|||
105844852|NCT02149121|365088877|FG005|Main Study Period|Adverse Event|0|||
105844853|NCT02149121|365088878|FG006|Main Study Period|Adverse Event|0|||
105844854|NCT02149121|365088872|FG000|Main Study Period|Protocol Violation|2|||
105844855|NCT02149121|365088873|FG001|Main Study Period|Protocol Violation|0|||
105844856|NCT02149121|365088874|FG002|Main Study Period|Protocol Violation|0|||
105844857|NCT02149121|365088875|FG003|Main Study Period|Protocol Violation|0|||
105844858|NCT02149121|365088876|FG004|Main Study Period|Protocol Violation|0|||
105844859|NCT02149121|365088877|FG005|Main Study Period|Protocol Violation|0|||
105844860|NCT02149121|365088878|FG006|Main Study Period|Protocol Violation|0|||
105844861|NCT02149121|365088872|FG000|Main Study Period|Lost to Follow-up|2|||
105844862|NCT02149121|365088873|FG001|Main Study Period|Lost to Follow-up|1|||
105844863|NCT02149121|365088874|FG002|Main Study Period|Lost to Follow-up|0|||
105844864|NCT02149121|365088875|FG003|Main Study Period|Lost to Follow-up|0|||
105844865|NCT02149121|365088876|FG004|Main Study Period|Lost to Follow-up|0|||
105844866|NCT02149121|365088877|FG005|Main Study Period|Lost to Follow-up|0|||
105844867|NCT02149121|365088878|FG006|Main Study Period|Lost to Follow-up|0|||
105844868|NCT02149121|365088872|FG000|Main Study Period|Death|1|||
105844869|NCT02149121|365088873|FG001|Main Study Period|Death|0|||
105844870|NCT02149121|365088874|FG002|Main Study Period|Death|0|||
105844871|NCT02149121|365088875|FG003|Main Study Period|Death|0|||
105844872|NCT02149121|365088876|FG004|Main Study Period|Death|0|||
105844873|NCT02149121|365088877|FG005|Main Study Period|Death|0|||
105844874|NCT02149121|365088878|FG006|Main Study Period|Death|0|||
105844875|NCT02149121|365088872|FG000|Main Study Period|Physician Decision|1|||
105844876|NCT02149121|365088873|FG001|Main Study Period|Physician Decision|0|||
106024763|NCT01419197|365756630|FG001|Overall Study|Non-compliance|1|||
105844877|NCT02149121|365088874|FG002|Main Study Period|Physician Decision|0|||
105844878|NCT02149121|365088875|FG003|Main Study Period|Physician Decision|0|||
105844879|NCT02149121|365088876|FG004|Main Study Period|Physician Decision|0|||
105844880|NCT02149121|365088877|FG005|Main Study Period|Physician Decision|0|||
105844881|NCT02149121|365088878|FG006|Main Study Period|Physician Decision|0|||
105844882|NCT02149121|365088872|FG000|Main Study Period|Developed any malignancy|0|||
105844883|NCT02149121|365088873|FG001|Main Study Period|Developed any malignancy|1|||
105844884|NCT02149121|365088874|FG002|Main Study Period|Developed any malignancy|1|||
105844885|NCT02149121|365088875|FG003|Main Study Period|Developed any malignancy|0|||
105844886|NCT02149121|365088876|FG004|Main Study Period|Developed any malignancy|0|||
105844887|NCT02149121|365088877|FG005|Main Study Period|Developed any malignancy|0|||
105844888|NCT02149121|365088878|FG006|Main Study Period|Developed any malignancy|0|||
105844889|NCT02149121|365088872|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
105844890|NCT02149121|365088873|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
105844891|NCT02149121|365088874|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
105844892|NCT02149121|365088875|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
105844893|NCT02149121|365088876|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
105844894|NCT02149121|365088877|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
105844895|NCT02149121|365088878|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
105844896|NCT02149121|365088872|FG000|Main Study Period|Disease progression|0|||
105844897|NCT02149121|365088873|FG001|Main Study Period|Disease progression|1|||
105971262|NCT00676520|365554961|FG000|Overall Study|Withdrawal by Subject|163|||
105971263|NCT00676520|365554961|FG000|Overall Study|Lost to Follow-up|162|||
105971264|NCT00676520|365554961|FG000|Overall Study|Death|159|||
105971265|NCT00676520|365554961|FG000|Overall Study|Physician Decision|20|||
105971266|NCT00676520|365554961|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
105971267|NCT00676520|365554961|FG000|Overall Study|Other Reason|18|||
105971268|NCT02210689|365554965|FG000|Overall Study|Withdrawal by Subject|7|||
105971269|NCT02210689|365554966|FG001|Overall Study|Withdrawal by Subject|4|||
105971270|NCT02210689|365554967|FG002|Overall Study|Withdrawal by Subject|2|||
105844898|NCT02149121|365088874|FG002|Main Study Period|Disease progression|0|||
105971271|NCT02210689|365554965|FG000|Overall Study|Adverse Event|0|||
105971272|NCT02210689|365554966|FG001|Overall Study|Adverse Event|1|||
105971273|NCT02210689|365554967|FG002|Overall Study|Adverse Event|0|||
105971274|NCT02210689|365554965|FG000|Overall Study|Protocol Violation|1|||
105971275|NCT02210689|365554966|FG001|Overall Study|Protocol Violation|0|||
105971276|NCT02210689|365554967|FG002|Overall Study|Protocol Violation|0|||
105971277|NCT02210689|365554965|FG000|Overall Study|Lost to Follow-up|11|||
105971278|NCT02210689|365554966|FG001|Overall Study|Lost to Follow-up|9|||
105971279|NCT02210689|365554967|FG002|Overall Study|Lost to Follow-up|5|||
105971280|NCT02210689|365554965|FG000|Overall Study|Pregnancy|0|||
105971281|NCT02210689|365554966|FG001|Overall Study|Pregnancy|1|||
105971282|NCT02210689|365554967|FG002|Overall Study|Pregnancy|0|||
105971283|NCT02210689|365554965|FG000|Overall Study|Lack of Efficacy|0|||
105971284|NCT02210689|365554966|FG001|Overall Study|Lack of Efficacy|1|||
105971285|NCT02210689|365554967|FG002|Overall Study|Lack of Efficacy|5|||
105971286|NCT02210689|365554965|FG000|Overall Study|Prohibited medication|2|||
105971287|NCT02210689|365554966|FG001|Overall Study|Prohibited medication|8|||
105971288|NCT02210689|365554967|FG002|Overall Study|Prohibited medication|1|||
105971289|NCT02210689|365554965|FG000|Overall Study|Negative Nugent score at baseline|6|||
105971290|NCT02210689|365554966|FG001|Overall Study|Negative Nugent score at baseline|2|||
105971291|NCT02210689|365554967|FG002|Overall Study|Negative Nugent score at baseline|2|||
105971292|NCT02210689|365554965|FG000|Overall Study|Other|25|||
105971293|NCT02210689|365554966|FG001|Overall Study|Other|21|||
105971294|NCT02210689|365554967|FG002|Overall Study|Other|8|||
105971295|NCT01778049|365554976|FG000|Open Label Treatment Period|Adverse Event|5|||
105971296|NCT01778049|365554977|FG001|Open Label Treatment Period|Adverse Event|15|||
105971297|NCT01778049|365554978|FG002|Open Label Treatment Period|Adverse Event|0|||
105971298|NCT01778049|365554979|FG003|Open Label Treatment Period|Adverse Event|0|||
105971299|NCT01778049|365554980|FG004|Open Label Treatment Period|Adverse Event|0|||
105971300|NCT01778049|365554981|FG005|Open Label Treatment Period|Adverse Event|0|||
105971301|NCT01778049|365554976|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
105971302|NCT01778049|365554977|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
105844899|NCT02149121|365088875|FG003|Main Study Period|Disease progression|0|||
105844900|NCT02149121|365088876|FG004|Main Study Period|Disease progression|0|||
105844901|NCT02149121|365088877|FG005|Main Study Period|Disease progression|0|||
105844902|NCT02149121|365088878|FG006|Main Study Period|Disease progression|0|||
105971303|NCT01778049|365554978|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
105971304|NCT01778049|365554979|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
105971305|NCT01778049|365554980|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
105971306|NCT01778049|365554981|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
105971307|NCT01778049|365554976|FG000|Open Label Treatment Period|Protocol Violation|5|||
105971308|NCT01778049|365554977|FG001|Open Label Treatment Period|Protocol Violation|5|||
105971309|NCT01778049|365554978|FG002|Open Label Treatment Period|Protocol Violation|0|||
105971310|NCT01778049|365554979|FG003|Open Label Treatment Period|Protocol Violation|0|||
105971311|NCT01778049|365554980|FG004|Open Label Treatment Period|Protocol Violation|0|||
105971312|NCT01778049|365554981|FG005|Open Label Treatment Period|Protocol Violation|0|||
105971313|NCT01778049|365554976|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
105971314|NCT01778049|365554977|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
105971315|NCT01778049|365554978|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
105971316|NCT01778049|365554979|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
106149651|NCT04512482|366209174|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
106149652|NCT04512482|366209175|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
105971317|NCT01778049|365554980|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
105971318|NCT01778049|365554981|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
105971319|NCT01778049|365554976|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
106149653|NCT04711135|366209178|FG000|Overall Study|Physician Decision|0|||
106149654|NCT04711135|366209179|FG001|Overall Study|Physician Decision|1|||
106149655|NCT04711135|366209178|FG000|Overall Study|Ongoing treatment|0|||
106149656|NCT04711135|366209179|FG001|Overall Study|Ongoing treatment|1|||
105971320|NCT01778049|365554977|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
105844903|NCT02149121|365088872|FG000|Extension Study Period|Withdrawal by Subject|0|||
105971321|NCT01778049|365554978|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
105971322|NCT01778049|365554979|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
105971323|NCT01778049|365554980|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
105971324|NCT01778049|365554981|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
105971325|NCT01778049|365554976|FG000|Open Label Treatment Period|Not treated|2|||
105971326|NCT01778049|365554977|FG001|Open Label Treatment Period|Not treated|1|||
105971327|NCT01778049|365554978|FG002|Open Label Treatment Period|Not treated|0|||
105971328|NCT01778049|365554979|FG003|Open Label Treatment Period|Not treated|0|||
105971329|NCT01778049|365554980|FG004|Open Label Treatment Period|Not treated|0|||
105971330|NCT01778049|365554981|FG005|Open Label Treatment Period|Not treated|0|||
105971331|NCT01778049|365554976|FG000|Open Label Treatment Period|Other reason not defined above|77|||
105971332|NCT01778049|365554977|FG001|Open Label Treatment Period|Other reason not defined above|94|||
105971333|NCT01778049|365554978|FG002|Open Label Treatment Period|Other reason not defined above|0|||
105971334|NCT01778049|365554979|FG003|Open Label Treatment Period|Other reason not defined above|0|||
105971335|NCT01778049|365554980|FG004|Open Label Treatment Period|Other reason not defined above|0|||
105971336|NCT01778049|365554981|FG005|Open Label Treatment Period|Other reason not defined above|0|||
105971337|NCT01778049|365554976|FG000|Double Blind Treatment Period|Adverse Event|0|||
105971338|NCT01778049|365554977|FG001|Double Blind Treatment Period|Adverse Event|0|||
105971339|NCT01778049|365554978|FG002|Double Blind Treatment Period|Adverse Event|4|||
105971340|NCT01778049|365554979|FG003|Double Blind Treatment Period|Adverse Event|5|||
105971341|NCT01778049|365554980|FG004|Double Blind Treatment Period|Adverse Event|3|||
105971342|NCT01778049|365554981|FG005|Double Blind Treatment Period|Adverse Event|2|||
105971343|NCT01778049|365554976|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
105971344|NCT01778049|365554977|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
105971345|NCT01778049|365554978|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
105971346|NCT01778049|365554979|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
105971347|NCT01778049|365554980|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
105971348|NCT01778049|365554981|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
105971349|NCT01778049|365554976|FG000|Double Blind Treatment Period|Protocol Violation|0|||
105971350|NCT01778049|365554977|FG001|Double Blind Treatment Period|Protocol Violation|0|||
105971351|NCT01778049|365554978|FG002|Double Blind Treatment Period|Protocol Violation|2|||
105971352|NCT01778049|365554979|FG003|Double Blind Treatment Period|Protocol Violation|0|||
105971353|NCT01778049|365554980|FG004|Double Blind Treatment Period|Protocol Violation|0|||
105971354|NCT01778049|365554981|FG005|Double Blind Treatment Period|Protocol Violation|0|||
105971355|NCT01778049|365554976|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
105971356|NCT01778049|365554977|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
105971357|NCT01778049|365554978|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
105971358|NCT01778049|365554979|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
105971359|NCT01778049|365554980|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
105971360|NCT01778049|365554981|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
105971361|NCT01778049|365554976|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
105971362|NCT01778049|365554977|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
105971363|NCT01778049|365554978|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
105971364|NCT01778049|365554979|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
105971365|NCT01778049|365554980|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
105971366|NCT01778049|365554981|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
105971367|NCT01778049|365554976|FG000|Double Blind Treatment Period|Not treated|0|||
105844904|NCT02149121|365088873|FG001|Extension Study Period|Withdrawal by Subject|0|||
105844905|NCT02149121|365088874|FG002|Extension Study Period|Withdrawal by Subject|0|||
105844906|NCT02149121|365088875|FG003|Extension Study Period|Withdrawal by Subject|1|||
105844907|NCT02149121|365088876|FG004|Extension Study Period|Withdrawal by Subject|0|||
105844908|NCT02149121|365088877|FG005|Extension Study Period|Withdrawal by Subject|2|||
105844909|NCT02149121|365088878|FG006|Extension Study Period|Withdrawal by Subject|0|||
105844910|NCT00766831|365088889|FG000|Overall Study|Withdrawal by Subject|4|||
105844911|NCT00766831|365088889|FG000|Overall Study|Lost to Follow-up|3|||
105844912|NCT00766831|365088889|FG000|Overall Study|Adverse Event|20|||
105844913|NCT00766831|365088889|FG000|Overall Study|Protocol Violation|15|||
105844914|NCT00766831|365088889|FG000|Overall Study|Physician Decision|5|||
105844915|NCT00766831|365088889|FG000|Overall Study|Withdrawal of consent|26|||
105844916|NCT00766831|365088889|FG000|Overall Study|Non cooperation by participants|14|||
105844917|NCT00766831|365088889|FG000|Overall Study|Other|28|||
105844918|NCT02220725|365088890|FG000|Overall Study|Lost to Follow-up|0|||
105844919|NCT02220725|365088891|FG001|Overall Study|Lost to Follow-up|0|||
105844920|NCT02220725|365088892|FG002|Overall Study|Lost to Follow-up|0|||
105844921|NCT02220725|365088893|FG003|Overall Study|Lost to Follow-up|1|||
105844922|NCT02220725|365088890|FG000|Overall Study|Withdrawal by Subject|0|||
105844923|NCT02220725|365088891|FG001|Overall Study|Withdrawal by Subject|0|||
105844924|NCT02220725|365088892|FG002|Overall Study|Withdrawal by Subject|0|||
105844925|NCT02220725|365088893|FG003|Overall Study|Withdrawal by Subject|1|||
105971368|NCT01778049|365554977|FG001|Double Blind Treatment Period|Not treated|0|||
105971369|NCT01778049|365554978|FG002|Double Blind Treatment Period|Not treated|0|||
105844926|NCT00788593|365088894|FG000|Placebo Run-in Phase|Adverse Event|2|||
105844927|NCT00788593|365088895|FG001|Placebo Run-in Phase|Adverse Event|0|||
105844928|NCT00788593|365088896|FG002|Placebo Run-in Phase|Adverse Event|0|||
105844929|NCT00788593|365088894|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
105844930|NCT00788593|365088895|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
105844931|NCT00788593|365088896|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
105844932|NCT00788593|365088894|FG000|Placebo Run-in Phase|Protocol Violation|2|||
105844933|NCT00788593|365088895|FG001|Placebo Run-in Phase|Protocol Violation|0|||
105844934|NCT00788593|365088896|FG002|Placebo Run-in Phase|Protocol Violation|0|||
105844935|NCT00788593|365088894|FG000|First Intervention Period|Adverse Event|0|||
105844936|NCT00788593|365088895|FG001|First Intervention Period|Adverse Event|1|||
105844937|NCT00788593|365088896|FG002|First Intervention Period|Adverse Event|0|||
105844938|NCT00788593|365088894|FG000|Second Intervention Period|Lost to Follow-up|0|||
105844939|NCT00788593|365088895|FG001|Second Intervention Period|Lost to Follow-up|1|||
105844940|NCT00788593|365088896|FG002|Second Intervention Period|Lost to Follow-up|0|||
105844941|NCT00788593|365088894|FG000|Second Intervention Period|Other|0|||
105844942|NCT00788593|365088895|FG001|Second Intervention Period|Other|0|||
105844943|NCT00788593|365088896|FG002|Second Intervention Period|Other|1|||
105844944|NCT00515034|365088897|FG000|Overall Study|Adverse Event|2|||
105844945|NCT00515034|365088898|FG001|Overall Study|Adverse Event|0|||
105844946|NCT00515034|365088899|FG002|Overall Study|Adverse Event|1|||
105844947|NCT00515034|365088900|FG003|Overall Study|Adverse Event|0|||
105844948|NCT00515034|365088897|FG000|Overall Study|Death|4|||
105844949|NCT00515034|365088898|FG001|Overall Study|Death|2|||
105844950|NCT00515034|365088899|FG002|Overall Study|Death|1|||
105844951|NCT00515034|365088900|FG003|Overall Study|Death|3|||
105844952|NCT00515034|365088897|FG000|Overall Study|Withdrawal by Subject|1|||
105844953|NCT00515034|365088898|FG001|Overall Study|Withdrawal by Subject|0|||
105844954|NCT00515034|365088899|FG002|Overall Study|Withdrawal by Subject|3|||
105844955|NCT00515034|365088900|FG003|Overall Study|Withdrawal by Subject|0|||
105844956|NCT00515034|365088897|FG000|Overall Study|Physician Decision|0|||
105844957|NCT00515034|365088898|FG001|Overall Study|Physician Decision|0|||
105844958|NCT00515034|365088899|FG002|Overall Study|Physician Decision|1|||
105844959|NCT00515034|365088900|FG003|Overall Study|Physician Decision|1|||
105844960|NCT00515034|365088897|FG000|Overall Study|Other|1|||
105844961|NCT00515034|365088898|FG001|Overall Study|Other|0|||
105844962|NCT00515034|365088899|FG002|Overall Study|Other|2|||
105844963|NCT00515034|365088900|FG003|Overall Study|Other|1|||
105844964|NCT01392326|365088903|FG000|Overall Study|Death|2|||
105844965|NCT01392326|365088904|FG001|Overall Study|Death|0|||
105844966|NCT01392326|365088905|FG002|Overall Study|Death|0|||
105844967|NCT01392326|365088903|FG000|Overall Study|Withdrawal by Subject|12|||
105844968|NCT01392326|365088904|FG001|Overall Study|Withdrawal by Subject|11|||
105844969|NCT01392326|365088905|FG002|Overall Study|Withdrawal by Subject|15|||
105844970|NCT01392326|365088903|FG000|Overall Study|Protocol Violation|2|||
105971370|NCT01778049|365554979|FG003|Double Blind Treatment Period|Not treated|2|||
105971371|NCT01778049|365554980|FG004|Double Blind Treatment Period|Not treated|2|||
105971372|NCT01778049|365554981|FG005|Double Blind Treatment Period|Not treated|0|||
105971373|NCT01778049|365554976|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
105844971|NCT01392326|365088904|FG001|Overall Study|Protocol Violation|0|||
105844972|NCT01392326|365088905|FG002|Overall Study|Protocol Violation|0|||
105844973|NCT01392326|365088903|FG000|Overall Study|Pregnancy|0|||
105844974|NCT01392326|365088904|FG001|Overall Study|Pregnancy|0|||
105844975|NCT01392326|365088905|FG002|Overall Study|Pregnancy|1|||
105844976|NCT01392326|365088903|FG000|Overall Study|Physician Decision|7|||
105844977|NCT01392326|365088904|FG001|Overall Study|Physician Decision|5|||
105844978|NCT01392326|365088905|FG002|Overall Study|Physician Decision|2|||
105844979|NCT01392326|365088903|FG000|Overall Study|Lost to Follow-up|1|||
105844980|NCT01392326|365088904|FG001|Overall Study|Lost to Follow-up|3|||
105971374|NCT01778049|365554977|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
105971375|NCT01778049|365554978|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
105971376|NCT01778049|365554979|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
106149657|NCT04149002|366209182|FG000|Overall Study|Lost to Follow-up|1|||
106149658|NCT04149002|366209183|FG001|Overall Study|Lost to Follow-up|0|||
106149659|NCT04149002|366209182|FG000|Overall Study|Withdrawal by Subject|1|||
106149660|NCT04149002|366209183|FG001|Overall Study|Withdrawal by Subject|0|||
105844981|NCT01392326|365088905|FG002|Overall Study|Lost to Follow-up|4|||
105844982|NCT01392326|365088903|FG000|Overall Study|Lack of Efficacy|14|||
105844983|NCT01392326|365088904|FG001|Overall Study|Lack of Efficacy|10|||
105844984|NCT01392326|365088905|FG002|Overall Study|Lack of Efficacy|15|||
105844985|NCT01392326|365088903|FG000|Overall Study|Adverse Event|9|||
105844986|NCT01392326|365088904|FG001|Overall Study|Adverse Event|6|||
105844987|NCT01392326|365088905|FG002|Overall Study|Adverse Event|11|||
105844988|NCT02340221|365088910|FG000|Overall Study|Death|100|||
105844989|NCT02340221|365088911|FG001|Overall Study|Death|197|||
105844990|NCT02340221|365088910|FG000|Overall Study|Withdrawal by Participant|24|||
105844991|NCT02340221|365088911|FG001|Overall Study|Withdrawal by Participant|37|||
105844992|NCT02340221|365088910|FG000|Overall Study|Lost to Follow-up|4|||
105844993|NCT02340221|365088911|FG001|Overall Study|Lost to Follow-up|15|||
105844994|NCT02340221|365088910|FG000|Overall Study|Reason Not Specified|85|||
105844995|NCT02340221|365088911|FG001|Overall Study|Reason Not Specified|165|||
105844996|NCT02340221|365088910|FG000|Overall Study|Study Terminated by Sponsor|1|||
105844997|NCT02340221|365088911|FG001|Overall Study|Study Terminated by Sponsor|3|||
105844998|NCT00588640|365088912|FG000|Overall Study|Physician Decision|1|||
105844999|NCT00588640|365088912|FG000|Overall Study|Ineligible Patient|1|||
105845000|NCT00103402|365088913|FG000|Overall Study|Adverse Event|3|||
105845001|NCT00103402|365088914|FG001|Overall Study|Adverse Event|4|||
105845002|NCT00103402|365088913|FG000|Overall Study|Lost to Follow-up|8|||
105845003|NCT00103402|365088914|FG001|Overall Study|Lost to Follow-up|7|||
105845004|NCT00103402|365088913|FG000|Overall Study|Dissatisfied/No longer interested|6|||
105845005|NCT00103402|365088914|FG001|Overall Study|Dissatisfied/No longer interested|6|||
105845006|NCT00103402|365088913|FG000|Overall Study|Personal constraints/Other|5|||
105845007|NCT00103402|365088914|FG001|Overall Study|Personal constraints/Other|0|||
105845008|NCT01393730|365088915|FG000|Overall Study|Withdrawal by Subject|3|||
105845009|NCT01393730|365088915|FG000|Overall Study|Other|2|||
105845010|NCT01393730|365088915|FG000|Overall Study|Adverse Event|1|||
105845011|NCT01297322|365088916|FG000|Overall Study|Lost to Follow-up|1|||
105845012|NCT01297322|365088917|FG001|Overall Study|Lost to Follow-up|0|||
105845013|NCT01297322|365088916|FG000|Overall Study|Withdrawal by Subject|0|||
105845014|NCT01297322|365088917|FG001|Overall Study|Withdrawal by Subject|1|||
105845015|NCT01297322|365088916|FG000|Overall Study|Protocol Violation|0|||
105845016|NCT01297322|365088917|FG001|Overall Study|Protocol Violation|3|||
105845017|NCT01111019|365088918|FG000|Overall Study|Withdrew Prematurely|2|||
105845018|NCT01111019|365088918|FG000|Overall Study|Other|1|||
105845019|NCT01583218|365088921|FG000|Overall Study|Withdrawal by Subject|43|||
105845020|NCT01583218|365088922|FG001|Overall Study|Withdrawal by Subject|29|||
105845021|NCT01583218|365088921|FG000|Overall Study|Death|206|||
105845022|NCT01583218|365088922|FG001|Overall Study|Death|211|||
105845023|NCT01583218|365088921|FG000|Overall Study|Lost to Follow-up|11|||
105845024|NCT01583218|365088922|FG001|Overall Study|Lost to Follow-up|17|||
105845025|NCT01583218|365088921|FG000|Overall Study|Adverse event or serious adverse event|3|||
105845026|NCT01583218|365088922|FG001|Overall Study|Adverse event or serious adverse event|3|||
105845027|NCT01583218|365088921|FG000|Overall Study|Patient /Family decision|3|||
105845028|NCT01583218|365088922|FG001|Overall Study|Patient /Family decision|0|||
105845029|NCT01583218|365088921|FG000|Overall Study|Cannot contact patient directly|1|||
105845030|NCT01583218|365088922|FG001|Overall Study|Cannot contact patient directly|2|||
105845031|NCT01583218|365088921|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
105845032|NCT01583218|365088922|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
105845033|NCT01583218|365088921|FG000|Overall Study|Patient did not wish to attend visits|0|||
105845034|NCT01583218|365088922|FG001|Overall Study|Patient did not wish to attend visits|1|||
105845035|NCT01583218|365088921|FG000|Overall Study|Patient randomized but not dosed|17|||
105845036|NCT01583218|365088922|FG001|Overall Study|Patient randomized but not dosed|16|||
105845037|NCT01583218|365088921|FG000|Overall Study|Patient was assessed via phone in person|1|||
105845038|NCT01583218|365088922|FG001|Overall Study|Patient was assessed via phone in person|0|||
105845039|NCT01583218|365088921|FG000|Overall Study|Patient deemed ineligible after random|2|||
105845040|NCT01583218|365088922|FG001|Overall Study|Patient deemed ineligible after random|0|||
105845041|NCT01583218|365088921|FG000|Overall Study|Patient was early terminated from study|0|||
105845042|NCT01583218|365088922|FG001|Overall Study|Patient was early terminated from study|1|||
105845043|NCT01583218|365088921|FG000|Overall Study|Patient was randomized due to mistake|1|||
105845044|NCT01583218|365088922|FG001|Overall Study|Patient was randomized due to mistake|0|||
105845045|NCT01583218|365088921|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
105845046|NCT01583218|365088922|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
105845047|NCT01583218|365088921|FG000|Overall Study|Withdraw of consent on day of random|1|||
105845048|NCT01583218|365088922|FG001|Overall Study|Withdraw of consent on day of random|0|||
105845049|NCT01334710|365088925|FG000|Overall Study|Trial was terminated|3|||
105845050|NCT01902628|365088926|FG000|Overall Study|Withdrawal of participant's consent|7|||
105845051|NCT01902628|365088926|FG000|Overall Study|Adverse Event|41|||
105845052|NCT01902628|365088926|FG000|Overall Study|Lost to Follow-up|35|||
105845053|NCT03861481|365090746|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
105845054|NCT03861481|365090747|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
105845055|NCT03861481|365090746|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
105845056|NCT03861481|365090747|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
105845057|NCT03861481|365090746|FG000|Overall Study|Relapse|1|||
105845058|NCT03861481|365090747|FG001|Overall Study|Relapse|0|||
105845059|NCT03861481|365090746|FG000|Overall Study|Withdrawal by Subject|0|||
105845060|NCT03861481|365090747|FG001|Overall Study|Withdrawal by Subject|1|||
105845061|NCT03861481|365090746|FG000|Overall Study|Lack of Efficacy|4|||
105845062|NCT03861481|365090747|FG001|Overall Study|Lack of Efficacy|5|||
105971377|NCT01778049|365554980|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
105971378|NCT01778049|365554981|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
105971379|NCT03773133|365554982|FG000|Overall Study|Screen Failure|8|||
105971380|NCT03943550|365554983|FG000|Overall Study|Adverse Event|0|||
105971381|NCT03943550|365554984|FG001|Overall Study|Adverse Event|0|||
105971382|NCT03943550|365554985|FG002|Overall Study|Adverse Event|1|||
105971383|NCT03943550|365554983|FG000|Overall Study|Lost to Follow-up|0|||
105971384|NCT03943550|365554984|FG001|Overall Study|Lost to Follow-up|0|||
105971385|NCT03943550|365554985|FG002|Overall Study|Lost to Follow-up|1|||
105971386|NCT03943550|365554983|FG000|Overall Study|Progressive Disease|0|||
105971387|NCT03943550|365554984|FG001|Overall Study|Progressive Disease|0|||
105971388|NCT03943550|365554985|FG002|Overall Study|Progressive Disease|2|||
105971389|NCT03943550|365554983|FG000|Overall Study|Participant Moved Out of the Country|0|||
105971390|NCT03943550|365554984|FG001|Overall Study|Participant Moved Out of the Country|1|||
105971391|NCT03943550|365554985|FG002|Overall Study|Participant Moved Out of the Country|0|||
105971392|NCT00223977|365554986|FG000|Overall Study|Adverse Event|7|||
105971393|NCT00223977|365554987|FG001|Overall Study|Adverse Event|10|||
105971394|NCT00223977|365554988|FG002|Overall Study|Adverse Event|0|||
105971395|NCT00223977|365554986|FG000|Overall Study|Protocol Violation|0|||
105971396|NCT00223977|365554987|FG001|Overall Study|Protocol Violation|0|||
105971397|NCT00223977|365554988|FG002|Overall Study|Protocol Violation|1|||
105971398|NCT00223977|365554986|FG000|Overall Study|Withdrawal by Subject|1|||
105971399|NCT00223977|365554987|FG001|Overall Study|Withdrawal by Subject|1|||
105971400|NCT00223977|365554988|FG002|Overall Study|Withdrawal by Subject|2|||
105971401|NCT00223977|365554986|FG000|Overall Study|Other|1|||
105971402|NCT00223977|365554987|FG001|Overall Study|Other|0|||
105971403|NCT00223977|365554988|FG002|Overall Study|Other|0|||
105971404|NCT00367744|365554990|FG000|Overall Study|Lost to Follow-up|4|||
105971405|NCT00367744|365554991|FG001|Overall Study|Lost to Follow-up|5|||
105971406|NCT03664674|365554993|FG000|Overall Study|Adverse Event|1|||
105971407|NCT03664674|365554994|FG001|Overall Study|Adverse Event|1|||
105971408|NCT03664674|365554993|FG000|Overall Study|Physician Decision|0|||
105971409|NCT03664674|365554994|FG001|Overall Study|Physician Decision|1|||
105971410|NCT03664674|365554993|FG000|Overall Study|Withdrawal by Subject|2|||
105971411|NCT03664674|365554994|FG001|Overall Study|Withdrawal by Subject|0|||
105971412|NCT02174523|365554996|FG000|Overall Study|Withdrawal by Subject|1|||
105971413|NCT02174523|365554997|FG001|Overall Study|Withdrawal by Subject|0|||
105971414|NCT03894969|365555008|FG000|Overall Study|Adverse Event|0|||
105971415|NCT03894969|365555009|FG001|Overall Study|Adverse Event|2|||
105971416|NCT03894969|365555010|FG002|Overall Study|Adverse Event|0|||
105971417|NCT03894969|365555011|FG003|Overall Study|Adverse Event|1|||
105971418|NCT03894969|365555012|FG004|Overall Study|Adverse Event|2|||
105971419|NCT03894969|365555008|FG000|Overall Study|Lost to Follow-up|3|||
106024764|NCT01419197|365756629|FG000|Overall Study|Withdrawal by Subject|33|||
106024765|NCT01419197|365756630|FG001|Overall Study|Withdrawal by Subject|32|||
105845063|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
105845064|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
105845065|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
105845066|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
105845067|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
105845068|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
105845069|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
105845070|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
105845071|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
105845072|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
105845073|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
105971420|NCT03894969|365555009|FG001|Overall Study|Lost to Follow-up|1|||
105971421|NCT03894969|365555010|FG002|Overall Study|Lost to Follow-up|1|||
105971422|NCT03894969|365555011|FG003|Overall Study|Lost to Follow-up|0|||
105971423|NCT03894969|365555012|FG004|Overall Study|Lost to Follow-up|0|||
105971424|NCT03894969|365555008|FG000|Overall Study|Withdrawal by Subject|2|||
105845074|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
105845075|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
105845076|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
105845077|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
105845078|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
105845079|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
105845080|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
105845081|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
105845082|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845083|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845084|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845085|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845086|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
105845087|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
105845088|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
105845089|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
105845090|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
105845091|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
105845092|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
105845093|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
105845094|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
105845095|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
105845096|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
105845097|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
105845098|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
105845099|NCT00773734|365090748|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
105845100|NCT00773734|365090749|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
105845101|NCT00773734|365090750|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
105845102|NCT00773734|365090751|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
105845103|NCT00773734|365090752|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
105845104|NCT00773734|365090753|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
105845105|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
105845106|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
105845107|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
105845108|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
105845109|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
105845110|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
105845111|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
105845112|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
105845113|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
105845114|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
105845115|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
105845116|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
105845117|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
105845118|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
105845119|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
105845120|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
105845121|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
105845122|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
105845123|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
105845124|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
105845125|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
105845126|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
105845127|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
105845128|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
105845129|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
105845130|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
105845131|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
105845132|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
105845133|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
105845134|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
105845135|NCT00773734|365090748|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
105845136|NCT00773734|365090749|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
105845137|NCT00773734|365090750|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
105987455|NCT02814175|365614464|FG004|Part 1|Withdrawal Consent|0|||
105971425|NCT03894969|365555009|FG001|Overall Study|Withdrawal by Subject|1|||
105971426|NCT03894969|365555010|FG002|Overall Study|Withdrawal by Subject|3|||
105971427|NCT03894969|365555011|FG003|Overall Study|Withdrawal by Subject|4|||
105971428|NCT03894969|365555012|FG004|Overall Study|Withdrawal by Subject|8|||
105971429|NCT03894969|365555008|FG000|Overall Study|Other|0|||
105971430|NCT03894969|365555009|FG001|Overall Study|Other|0|||
105971431|NCT03894969|365555010|FG002|Overall Study|Other|0|||
105971432|NCT03894969|365555011|FG003|Overall Study|Other|0|||
105971433|NCT03894969|365555012|FG004|Overall Study|Other|3|||
105971434|NCT03894969|365555008|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
105971435|NCT03894969|365555009|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
105971436|NCT03894969|365555010|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
105971437|NCT03894969|365555011|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
105971438|NCT03894969|365555012|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
105971439|NCT03894969|365555008|FG000|Overall Study|Solicited Adverse Event|0|||
105971440|NCT03894969|365555009|FG001|Overall Study|Solicited Adverse Event|1|||
105971441|NCT03894969|365555010|FG002|Overall Study|Solicited Adverse Event|0|||
105971442|NCT03894969|365555011|FG003|Overall Study|Solicited Adverse Event|0|||
105971443|NCT03894969|365555012|FG004|Overall Study|Solicited Adverse Event|0|||
105971444|NCT00468676|365555013|FG000|Overall Study|Lost to Follow-up|14|||
105971445|NCT00468676|365555014|FG001|Overall Study|Lost to Follow-up|11|||
105971446|NCT00468676|365555013|FG000|Overall Study|Death|2|||
105971447|NCT00468676|365555014|FG001|Overall Study|Death|1|||
105971448|NCT00790647|365555027|FG000|Overall Study|Adverse Event|1|||
105971449|NCT02437409|365555028|FG000|Overall Study|Withdrawal by Subject|3|||
105971450|NCT02437409|365555028|FG000|Overall Study|Screening failure|12|||
105971451|NCT01944098|365555029|FG000|Overall Study|Physician Decision|1|||
105971452|NCT01944098|365555030|FG001|Overall Study|Physician Decision|0|||
105971453|NCT05032690|365555031|FG000|Period 1|Adverse Event|0|||
105845138|NCT00773734|365090751|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
105845139|NCT00773734|365090752|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
105845140|NCT00773734|365090753|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
105845141|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
105845142|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
105845143|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
105845144|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
105845145|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
105845146|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
105845147|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
105845148|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
105845149|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
105845150|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
105845151|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
105845152|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
105845153|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
105845154|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
105845155|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
105845156|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
105845157|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
105845158|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
105845159|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
105845160|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
105845161|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
105845162|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
105845163|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
105845164|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
105845165|NCT00773734|365090748|FG000|Extension: Active Treatment Week 24-52|Other|0|||
105845166|NCT00773734|365090749|FG001|Extension: Active Treatment Week 24-52|Other|0|||
105845167|NCT00773734|365090750|FG002|Extension: Active Treatment Week 24-52|Other|1|||
105845168|NCT00773734|365090751|FG003|Extension: Active Treatment Week 24-52|Other|2|||
105845169|NCT00773734|365090752|FG004|Extension: Active Treatment Week 24-52|Other|0|||
105845170|NCT00773734|365090753|FG005|Extension: Active Treatment Week 24-52|Other|1|||
105845171|NCT00773734|365090748|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105845172|NCT00773734|365090749|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105845173|NCT00773734|365090750|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105845174|NCT00773734|365090751|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
105845175|NCT00773734|365090752|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105971454|NCT05032690|365555032|FG001|Period 1|Adverse Event|1|||
105971455|NCT05032690|365555033|FG002|Period 1|Adverse Event|0|||
105971456|NCT05032690|365555034|FG003|Period 1|Adverse Event|0|||
105971457|NCT05032690|365555031|FG000|Period 1|Withdrawal by Subject|1|||
105971458|NCT05032690|365555032|FG001|Period 1|Withdrawal by Subject|0|||
105845176|NCT00773734|365090753|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
105845177|NCT00773734|365090748|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
105845178|NCT00773734|365090749|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
105845179|NCT00773734|365090750|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
105845180|NCT00773734|365090751|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
105845181|NCT00773734|365090752|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
105845182|NCT00773734|365090753|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
105845183|NCT00773734|365090748|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
105845184|NCT00773734|365090749|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
105845185|NCT00773734|365090750|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
105845186|NCT00773734|365090751|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
105845187|NCT00773734|365090752|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
105845188|NCT00773734|365090753|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
105845189|NCT00773734|365090748|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
105845190|NCT00773734|365090749|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
105845191|NCT00773734|365090750|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
105845192|NCT00773734|365090751|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
105845193|NCT00773734|365090752|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
105845194|NCT00773734|365090753|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
105845195|NCT02054130|365090754|FG000|Overall Study|Withdrawal by Subject|4|||
105845196|NCT02054130|365090755|FG001|Overall Study|Withdrawal by Subject|4|||
105845197|NCT02054130|365090756|FG002|Overall Study|Withdrawal by Subject|7|||
105845198|NCT02054130|365090757|FG003|Overall Study|Withdrawal by Subject|10|||
105845199|NCT02054130|365090754|FG000|Overall Study|Death|0|||
105845200|NCT02054130|365090755|FG001|Overall Study|Death|1|||
105845201|NCT02054130|365090756|FG002|Overall Study|Death|0|||
105845202|NCT02054130|365090757|FG003|Overall Study|Death|0|||
105845203|NCT02054130|365090754|FG000|Overall Study|Lost to Follow-up|0|||
105845204|NCT02054130|365090755|FG001|Overall Study|Lost to Follow-up|0|||
105845205|NCT02054130|365090756|FG002|Overall Study|Lost to Follow-up|1|||
105845206|NCT02054130|365090757|FG003|Overall Study|Lost to Follow-up|2|||
105845207|NCT02054130|365090754|FG000|Overall Study|Missed dose|4|||
105845208|NCT02054130|365090755|FG001|Overall Study|Missed dose|6|||
105845209|NCT02054130|365090756|FG002|Overall Study|Missed dose|7|||
105845210|NCT02054130|365090757|FG003|Overall Study|Missed dose|10|||
105845211|NCT01304693|365090760|FG000|Overall Study|Adverse Event|0|||
105845212|NCT01304693|365090761|FG001|Overall Study|Adverse Event|0|||
105971459|NCT05032690|365555033|FG002|Period 1|Withdrawal by Subject|0|||
105845213|NCT01304693|365090762|FG002|Overall Study|Adverse Event|0|||
105845214|NCT01304693|365090763|FG003|Overall Study|Adverse Event|0|||
105845215|NCT01304693|365090764|FG004|Overall Study|Adverse Event|1|||
105845216|NCT01304693|365090760|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
105845217|NCT01304693|365090761|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
105845218|NCT01304693|365090762|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
105845219|NCT01304693|365090763|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
105971460|NCT05032690|365555034|FG003|Period 1|Withdrawal by Subject|0|||
105971461|NCT05032690|365555031|FG000|Period 1|No longer meets eligibility criteria|0|||
105971462|NCT05032690|365555032|FG001|Period 1|No longer meets eligibility criteria|1|||
105971463|NCT05032690|365555033|FG002|Period 1|No longer meets eligibility criteria|0|||
106024766|NCT01419197|365756629|FG000|Overall Study|Study Completed by Sponsor|103|||
106024767|NCT01419197|365756630|FG001|Overall Study|Study Completed by Sponsor|34|||
106024768|NCT01419197|365756629|FG000|Overall Study|Reason Not Specified|0|||
105845220|NCT01304693|365090764|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
105845221|NCT02581163|365090776|FG000|Overall Study|Failure to return|15|||
106024769|NCT01419197|365756630|FG001|Overall Study|Reason Not Specified|1|||
105845222|NCT02581163|365090776|FG000|Overall Study|Insufficient virological response|3|||
105971464|NCT05032690|365555034|FG003|Period 1|No longer meets eligibility criteria|0|||
105971465|NCT05032690|365555031|FG000|Period 2|Adverse Event|1|||
105971466|NCT05032690|365555032|FG001|Period 2|Adverse Event|0|||
105971467|NCT05032690|365555033|FG002|Period 2|Adverse Event|0|||
105971468|NCT05032690|365555034|FG003|Period 2|Adverse Event|0|||
105971469|NCT05032690|365555031|FG000|Period 2|Withdrawal by Subject|0|||
105971470|NCT05032690|365555032|FG001|Period 2|Withdrawal by Subject|1|||
105971471|NCT05032690|365555033|FG002|Period 2|Withdrawal by Subject|0|||
105971472|NCT05032690|365555034|FG003|Period 2|Withdrawal by Subject|0|||
105845223|NCT02581163|365090776|FG000|Overall Study|Withdrew consent|1|||
105845224|NCT02581163|365090776|FG000|Overall Study|Death|1|||
106024770|NCT01419197|365756629|FG000|Overall Study|Lost to Follow-up|14|||
105845225|NCT02581163|365090776|FG000|Overall Study|Other, not specified|9|||
105845226|NCT03438396|365090777|FG000|Overall Study|Reason Not Specified|9|||
105845227|NCT03438396|365090777|FG000|Overall Study|Withdrawal by Subject|5|||
106024771|NCT01419197|365756630|FG001|Overall Study|Lost to Follow-up|4|||
106024772|NCT01781299|365756631|FG000|Overall Study|Withdrawal by Subject|0|||
105845228|NCT03438396|365090777|FG000|Overall Study|Lost to Follow-up|2|||
105845229|NCT03438396|365090777|FG000|Overall Study|Death|85|||
105845230|NCT03438396|365090777|FG000|Overall Study|Not treated|1|||
105971473|NCT05032690|365555031|FG000|Period 2|No longer meets eligibility criteria|0|||
105971474|NCT05032690|365555032|FG001|Period 2|No longer meets eligibility criteria|1|||
105971475|NCT05032690|365555033|FG002|Period 2|No longer meets eligibility criteria|0|||
105971476|NCT05032690|365555034|FG003|Period 2|No longer meets eligibility criteria|0|||
105971477|NCT05032690|365555031|FG000|Period 3|Adverse Event|0|||
105971478|NCT05032690|365555032|FG001|Period 3|Adverse Event|1|||
105971479|NCT05032690|365555033|FG002|Period 3|Adverse Event|0|||
105971480|NCT05032690|365555034|FG003|Period 3|Adverse Event|0|||
105971481|NCT00951080|365555035|FG000|Overall Study|Adverse Event|3|||
105971482|NCT00951080|365555036|FG001|Overall Study|Adverse Event|3|||
106149661|NCT00396084|366209189|FG000|Overall Study|Adverse Event|0|||
106149662|NCT00396084|366209190|FG001|Overall Study|Adverse Event|0|||
106149663|NCT00396084|366209191|FG002|Overall Study|Adverse Event|0|||
106149664|NCT00396084|366209192|FG003|Overall Study|Adverse Event|0|||
106149665|NCT00396084|366209193|FG004|Overall Study|Adverse Event|1|||
106149666|NCT00396084|366209194|FG005|Overall Study|Adverse Event|2|||
106149667|NCT00396084|366209189|FG000|Overall Study|Withdrawal by Subject|0|||
106149668|NCT00396084|366209190|FG001|Overall Study|Withdrawal by Subject|0|||
106149669|NCT00396084|366209191|FG002|Overall Study|Withdrawal by Subject|0|||
106149670|NCT00396084|366209192|FG003|Overall Study|Withdrawal by Subject|1|||
106149671|NCT00396084|366209193|FG004|Overall Study|Withdrawal by Subject|0|||
106149672|NCT00396084|366209194|FG005|Overall Study|Withdrawal by Subject|0|||
106149673|NCT03447249|366209196|FG000|Overall Study|Adverse Event|1|||
106149674|NCT03447249|366209197|FG001|Overall Study|Adverse Event|0|||
106149675|NCT03447249|366209196|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
106149676|NCT03447249|366209197|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
106149677|NCT03447249|366209196|FG000|Overall Study|Other|3|||
106149678|NCT03447249|366209197|FG001|Overall Study|Other|0|||
106149679|NCT00988858|366209198|FG000|Overall Study|Adverse Event|7|||
105845231|NCT01388166|365090778|FG000|Overall Study|Adverse Event|16|||
105845232|NCT01388166|365090778|FG000|Overall Study|Lost to Follow-up|30|||
105845233|NCT01388166|365090778|FG000|Overall Study|Others than specified above|13|||
105845234|NCT01744093|365090782|FG000|Overall Study|Withdrawal by Subject|6|||
105845235|NCT01744093|365090783|FG001|Overall Study|Withdrawal by Subject|1|||
105845236|NCT02751359|365090788|FG000|Overall Study|Lost to Follow-up|1|||
105971483|NCT00951080|365555035|FG000|Overall Study|Lost to Follow-up|0|||
105971484|NCT00951080|365555036|FG001|Overall Study|Lost to Follow-up|1|||
106149680|NCT00988858|366209198|FG000|Overall Study|Death|1|||
106149681|NCT00988858|366209198|FG000|Overall Study|Physician Decision|1|||
106149682|NCT00988858|366209198|FG000|Overall Study|Sponsor Decision|1|||
105845237|NCT00103311|365090789|FG000|Overall Study|Lost to Follow-up|1|||
105845238|NCT00103311|365090790|FG001|Overall Study|Lost to Follow-up|0|||
105845239|NCT00103311|365090789|FG000|Overall Study|Withdrawal by Subject|2|||
105845240|NCT00103311|365090790|FG001|Overall Study|Withdrawal by Subject|1|||
105845241|NCT00103311|365090789|FG000|Overall Study|Adverse Event|1|||
105845242|NCT00103311|365090790|FG001|Overall Study|Adverse Event|0|||
105845243|NCT02400671|365090791|FG000|Overall Study|Death|5|||
105845244|NCT02400671|365090792|FG001|Overall Study|Death|3|||
105845245|NCT02400671|365090793|FG002|Overall Study|Death|4|||
105845246|NCT02400671|365090791|FG000|Overall Study|Lost to Follow-up|20|||
105845247|NCT02400671|365090792|FG001|Overall Study|Lost to Follow-up|27|||
105845248|NCT02400671|365090793|FG002|Overall Study|Lost to Follow-up|24|||
105845249|NCT02400671|365090791|FG000|Overall Study|Withdrawal by Subject|2|||
105845250|NCT02400671|365090792|FG001|Overall Study|Withdrawal by Subject|2|||
105845251|NCT02400671|365090793|FG002|Overall Study|Withdrawal by Subject|0|||
105845252|NCT00158756|365090794|FG000|Overall Study|Withdrawal by Subject|5|||
105845253|NCT00158756|365090795|FG001|Overall Study|Withdrawal by Subject|0|||
105845254|NCT00158756|365090796|FG002|Overall Study|Withdrawal by Subject|6|||
105845255|NCT00158756|365090797|FG003|Overall Study|Withdrawal by Subject|1|||
105845256|NCT00158756|365090798|FG004|Overall Study|Withdrawal by Subject|3|||
105845257|NCT00158756|365090794|FG000|Overall Study|Adverse Event|0|||
105845258|NCT00158756|365090795|FG001|Overall Study|Adverse Event|0|||
105845259|NCT00158756|365090796|FG002|Overall Study|Adverse Event|1|||
105845260|NCT00158756|365090797|FG003|Overall Study|Adverse Event|0|||
105845261|NCT00158756|365090798|FG004|Overall Study|Adverse Event|0|||
105845262|NCT00158756|365090794|FG000|Overall Study|Serious adverse event|0|||
105845263|NCT00158756|365090795|FG001|Overall Study|Serious adverse event|0|||
105845264|NCT00158756|365090796|FG002|Overall Study|Serious adverse event|1|||
105845265|NCT00158756|365090797|FG003|Overall Study|Serious adverse event|0|||
105845266|NCT00158756|365090798|FG004|Overall Study|Serious adverse event|0|||
105845267|NCT00262041|365090799|FG000|Overall Study|Withdrawal by Subject|0|||
105845268|NCT00262041|365090800|FG001|Overall Study|Withdrawal by Subject|3|||
105845269|NCT00262041|365090801|FG002|Overall Study|Withdrawal by Subject|1|||
106149683|NCT00609336|366209202|FG000|Overall Study|Protocol Violation|3|||
105845270|NCT00262041|365090799|FG000|Overall Study|Lost to Follow-up|1|||
105845271|NCT00262041|365090800|FG001|Overall Study|Lost to Follow-up|1|||
105845272|NCT00262041|365090801|FG002|Overall Study|Lost to Follow-up|5|||
105845273|NCT00262041|365090799|FG000|Overall Study|Unable to classify|1|||
105971485|NCT00951080|365555035|FG000|Overall Study|Physician Decision|4|||
105845274|NCT00262041|365090800|FG001|Overall Study|Unable to classify|0|||
105845275|NCT00262041|365090801|FG002|Overall Study|Unable to classify|0|||
105845276|NCT02488330|365090804|FG000|Overall Study|Adverse Event|1|||
105845277|NCT02488330|365090804|FG000|Overall Study|Physician Decision|2|||
105845278|NCT02488330|365090804|FG000|Overall Study|Death|2|||
105845279|NCT02488330|365090804|FG000|Overall Study|Disease Progression|3|||
105845280|NCT02488330|365090804|FG000|Overall Study|Study Termination by Sponsor|4|||
105845281|NCT03052322|365090805|FG000|Overall Study|Other un-specified|1|||
105845282|NCT03052322|365090806|FG001|Overall Study|Other un-specified|2|||
105845283|NCT03052322|365090805|FG000|Overall Study|Withdrawal by Subject|10|||
105845284|NCT03052322|365090806|FG001|Overall Study|Withdrawal by Subject|9|||
105845285|NCT03052322|365090805|FG000|Overall Study|Death|0|||
105845286|NCT03052322|365090806|FG001|Overall Study|Death|2|||
105845287|NCT03052322|365090805|FG000|Overall Study|Lack of Efficacy|1|||
105845288|NCT03052322|365090806|FG001|Overall Study|Lack of Efficacy|2|||
105845289|NCT03052322|365090805|FG000|Overall Study|Protocol Violation|1|||
105845290|NCT03052322|365090806|FG001|Overall Study|Protocol Violation|0|||
105845291|NCT03052322|365090805|FG000|Overall Study|Lost to Follow-up|2|||
105845292|NCT03052322|365090806|FG001|Overall Study|Lost to Follow-up|4|||
105845293|NCT03052322|365090805|FG000|Overall Study|Adverse Event|6|||
105845294|NCT03052322|365090806|FG001|Overall Study|Adverse Event|13|||
105845295|NCT02493777|365090807|FG000|Overall Study|Lost to Follow-up|0|||
105845296|NCT02493777|365090808|FG001|Overall Study|Lost to Follow-up|1|||
105845297|NCT02370914|365090815|FG000|Overall Study|Protocol Violation|2|||
105845298|NCT03212794|365090816|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
105845299|NCT03212794|365090817|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
105845300|NCT03212794|365090816|FG000|Overall Study|Lost to Follow-up|5|||
105845301|NCT03212794|365090817|FG001|Overall Study|Lost to Follow-up|6|||
105845302|NCT03212794|365090816|FG000|Overall Study|Incarcerated; unable to participate|2|||
105845303|NCT03212794|365090817|FG001|Overall Study|Incarcerated; unable to participate|0|||
105845304|NCT03212794|365090816|FG000|Overall Study|Withdrawal by Subject|1|||
105845305|NCT03212794|365090817|FG001|Overall Study|Withdrawal by Subject|0|||
105845306|NCT03212794|365090816|FG000|Overall Study|Death|0|||
105845307|NCT03212794|365090817|FG001|Overall Study|Death|1|||
105845308|NCT03212794|365090816|FG000|Overall Study|Found to be ineligible after allocation|0|||
105845309|NCT03212794|365090817|FG001|Overall Study|Found to be ineligible after allocation|1|||
105845310|NCT03212794|365090816|FG000|Overall Study|Relocated out of area|2|||
105845311|NCT03212794|365090817|FG001|Overall Study|Relocated out of area|0|||
105845312|NCT01370213|365090818|FG000|Overall Study|Early Death|1|||
105845313|NCT01370213|365090819|FG001|Overall Study|Early Death|0|||
105845314|NCT01370213|365090820|FG002|Overall Study|Early Death|0|||
105845315|NCT01370213|365090818|FG000|Overall Study|Not evaluable|0|||
105845316|NCT01370213|365090819|FG001|Overall Study|Not evaluable|2|||
105845317|NCT01370213|365090820|FG002|Overall Study|Not evaluable|0|||
105845318|NCT02470091|365090822|FG000|Overall Study|Withdrawal by Subject|1|||
105845319|NCT02470091|365090823|FG001|Overall Study|Withdrawal by Subject|0|||
105845320|NCT02470091|365090822|FG000|Overall Study|Ineligible|0|||
105845321|NCT02470091|365090823|FG001|Overall Study|Ineligible|2|||
105845322|NCT00606502|365090824|FG000|Randomization|Randomized but not treated|3|||
105845323|NCT00606502|365090825|FG001|Randomization|Randomized but not treated|0|||
105845324|NCT00606502|365090824|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
105845325|NCT00606502|365090825|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
105845326|NCT01470612|365090829|FG000|Overall Study|Adverse Event|20|||
105845327|NCT01470612|365090830|FG001|Overall Study|Adverse Event|80|||
105845328|NCT01470612|365090829|FG000|Overall Study|Death|0|||
105845329|NCT01470612|365090830|FG001|Overall Study|Death|1|||
105845330|NCT01470612|365090829|FG000|Overall Study|Lack of Efficacy|20|||
105845331|NCT01470612|365090830|FG001|Overall Study|Lack of Efficacy|326|||
105845332|NCT01470612|365090829|FG000|Overall Study|Lost to Follow-up|2|||
105845333|NCT01470612|365090830|FG001|Overall Study|Lost to Follow-up|5|||
105845334|NCT01470612|365090829|FG000|Overall Study|Did not meet entrance criteria|0|||
105845335|NCT01470612|365090830|FG001|Overall Study|Did not meet entrance criteria|1|||
105971486|NCT00951080|365555036|FG001|Overall Study|Physician Decision|1|||
105845336|NCT01470612|365090829|FG000|Overall Study|Pregnancy|2|||
105845337|NCT01470612|365090830|FG001|Overall Study|Pregnancy|10|||
105845338|NCT01470612|365090829|FG000|Overall Study|Protocol Violation|2|||
105845339|NCT01470612|365090830|FG001|Overall Study|Protocol Violation|7|||
105845340|NCT01470612|365090829|FG000|Overall Study|Withdrawal by Subject|24|||
105845341|NCT01470612|365090830|FG001|Overall Study|Withdrawal by Subject|79|||
105845342|NCT01470612|365090829|FG000|Overall Study|Other|14|||
105845343|NCT01470612|365090830|FG001|Overall Study|Other|156|||
106149684|NCT00609336|366209202|FG000|Overall Study|Death|1|||
105845344|NCT02595008|365090838|FG000|Overall Study|Enrolled In Error|1|||
105845345|NCT02595008|365090839|FG001|Overall Study|Enrolled In Error|0|||
105845346|NCT00384176|365090845|FG000|Overall Study|Death|239|||
105845347|NCT00384176|365090846|FG001|Overall Study|Death|247|||
105845348|NCT00384176|365090847|FG002|Overall Study|Death|105|||
105845349|NCT00384176|365090845|FG000|Overall Study|Withdrawal by Subject|52|||
105845350|NCT00384176|365090846|FG001|Overall Study|Withdrawal by Subject|48|||
105845351|NCT00384176|365090847|FG002|Overall Study|Withdrawal by Subject|22|||
105845352|NCT00384176|365090845|FG000|Overall Study|Lost to Follow-up|16|||
105845353|NCT00384176|365090846|FG001|Overall Study|Lost to Follow-up|18|||
105971487|NCT00951080|365555035|FG000|Overall Study|Other|19|||
105971488|NCT00951080|365555036|FG001|Overall Study|Other|22|||
105971489|NCT01960998|365555037|FG000|Overall Study|Lost to Follow-up|3|||
105971490|NCT01960998|365555038|FG001|Overall Study|Lost to Follow-up|7|||
105971491|NCT01960998|365555037|FG000|Overall Study|Death|0|||
105971492|NCT01960998|365555038|FG001|Overall Study|Death|1|||
105971493|NCT01960998|365555037|FG000|Overall Study|Withdrawal by Subject|8|||
105971494|NCT01960998|365555038|FG001|Overall Study|Withdrawal by Subject|2|||
105971495|NCT01960998|365555037|FG000|Overall Study|lost computer access|0|||
106149685|NCT00609336|366209202|FG000|Overall Study|LA or Met at Surgery|9|||
106149686|NCT02238483|366209203|FG000|Overall Study|Withdrawal by Subject|2|||
106149687|NCT02238483|366209204|FG001|Overall Study|Withdrawal by Subject|7|||
106149688|NCT02238483|366209203|FG000|Overall Study|Lost to Follow-up|1|||
105971496|NCT01960998|365555038|FG001|Overall Study|lost computer access|1|||
105971497|NCT01713283|365555041|FG000|Overall Study|Lack of Efficacy|10|||
105971498|NCT01713283|365555042|FG001|Overall Study|Lack of Efficacy|2|||
105971499|NCT01713283|365555041|FG000|Overall Study|Lost to Follow-up|1|||
106149689|NCT02238483|366209204|FG001|Overall Study|Lost to Follow-up|1|||
106149690|NCT02238483|366209203|FG000|Overall Study|Protocol Violation|1|||
106149691|NCT02238483|366209204|FG001|Overall Study|Protocol Violation|2|||
106149692|NCT02238483|366209203|FG000|Overall Study|Death|1|||
105845354|NCT00384176|365090847|FG002|Overall Study|Lost to Follow-up|4|||
105845355|NCT00384176|365090845|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
105845356|NCT00384176|365090846|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
105845357|NCT00384176|365090847|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
105845358|NCT00384176|365090845|FG000|Overall Study|Longer QTC as Visit 1|1|||
105845359|NCT00384176|365090846|FG001|Overall Study|Longer QTC as Visit 1|0|||
105845360|NCT00384176|365090847|FG002|Overall Study|Longer QTC as Visit 1|0|||
105845361|NCT00384176|365090845|FG000|Overall Study|Toxicity of treatment|1|||
105845362|NCT00384176|365090846|FG001|Overall Study|Toxicity of treatment|0|||
105845363|NCT00384176|365090847|FG002|Overall Study|Toxicity of treatment|0|||
105845364|NCT00384176|365090845|FG000|Overall Study|Did not receive study treatment|0|||
105845365|NCT00384176|365090846|FG001|Overall Study|Did not receive study treatment|1|||
105845366|NCT00384176|365090847|FG002|Overall Study|Did not receive study treatment|1|||
105845367|NCT00384176|365090845|FG000|Overall Study|Physician Decision|0|||
105845368|NCT00384176|365090846|FG001|Overall Study|Physician Decision|2|||
105845369|NCT00384176|365090847|FG002|Overall Study|Physician Decision|0|||
105845370|NCT00384176|365090845|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
105845371|NCT00384176|365090846|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
105845372|NCT00384176|365090847|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
105845373|NCT03078582|365090848|FG000|Overall Study|Adverse Event|0|||
105845374|NCT03078582|365090849|FG001|Overall Study|Adverse Event|8|||
105845375|NCT02458092|365090850|FG000|Overall Study|Withdrawal by Subject|1|||
105845376|NCT02458092|365090851|FG001|Overall Study|Withdrawal by Subject|0|||
105845377|NCT01843348|365090852|FG000|Overall Study|Withdrawal by Subject|4|||
105845378|NCT01843348|365090853|FG001|Overall Study|Withdrawal by Subject|16|||
105845379|NCT01843348|365090854|FG002|Overall Study|Withdrawal by Subject|18|||
105845380|NCT01843348|365090852|FG000|Overall Study|Lost to Follow-up|5|||
105845381|NCT01843348|365090853|FG001|Overall Study|Lost to Follow-up|4|||
105845382|NCT01843348|365090854|FG002|Overall Study|Lost to Follow-up|2|||
105845383|NCT01843348|365090852|FG000|Overall Study|Death|5|||
105845384|NCT01843348|365090853|FG001|Overall Study|Death|3|||
105845385|NCT01843348|365090854|FG002|Overall Study|Death|4|||
105845386|NCT01843348|365090852|FG000|Overall Study|Graft loss/retransplantation|5|||
105845387|NCT01843348|365090853|FG001|Overall Study|Graft loss/retransplantation|8|||
105845388|NCT01843348|365090854|FG002|Overall Study|Graft loss/retransplantation|11|||
105845389|NCT01843348|365090852|FG000|Overall Study|Various reasons|4|||
105845390|NCT01843348|365090853|FG001|Overall Study|Various reasons|9|||
105845391|NCT01843348|365090854|FG002|Overall Study|Various reasons|6|||
105845392|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
105845393|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
106149693|NCT02238483|366209204|FG001|Overall Study|Death|0|||
105845394|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
105845395|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
105845396|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
105845397|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
105845398|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
105845399|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
105845400|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
105971500|NCT01713283|365555042|FG001|Overall Study|Lost to Follow-up|1|||
105971501|NCT00789581|365556757|FG000|AC Therapy|Adverse Event|2|||
105971502|NCT00789581|365556758|FG001|AC Therapy|Adverse Event|3|||
105971503|NCT00789581|365556757|FG000|AC Therapy|Withdrawal by Subject|4|||
105971504|NCT00789581|365556758|FG001|AC Therapy|Withdrawal by Subject|7|||
105971505|NCT00789581|365556757|FG000|AC Therapy|Disease recurrence|3|||
105971506|NCT00789581|365556758|FG001|AC Therapy|Disease recurrence|1|||
105971507|NCT00789581|365556757|FG000|AC Therapy|Intercurrent Illness|1|||
105971508|NCT00789581|365556758|FG001|AC Therapy|Intercurrent Illness|0|||
105971509|NCT00789581|365556757|FG000|AC Therapy|Never Treated|1|||
105971510|NCT00789581|365556758|FG001|AC Therapy|Never Treated|4|||
105971511|NCT00789581|365556757|FG000|AC Therapy|Other|0|||
105971512|NCT00789581|365556758|FG001|AC Therapy|Other|2|||
105971513|NCT00789581|365556757|FG000|Adjuvant Therapy|Never treated|2|||
105971514|NCT00789581|365556758|FG001|Adjuvant Therapy|Never treated|2|||
105971515|NCT00789581|365556757|FG000|Adjuvant Therapy|Adverse Event|20|||
105971516|NCT00789581|365556758|FG001|Adjuvant Therapy|Adverse Event|44|||
105971517|NCT00789581|365556757|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
105971518|NCT00789581|365556758|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
105971519|NCT00789581|365556757|FG000|Adjuvant Therapy|Disease recurrence|2|||
105971520|NCT00789581|365556758|FG001|Adjuvant Therapy|Disease recurrence|1|||
105971521|NCT00789581|365556757|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
105971522|NCT00789581|365556758|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
105971523|NCT00789581|365556757|FG000|Adjuvant Therapy|Protocol Violation|1|||
105971524|NCT00789581|365556758|FG001|Adjuvant Therapy|Protocol Violation|1|||
105971525|NCT00789581|365556757|FG000|Adjuvant Therapy|Other|0|||
105971526|NCT00789581|365556758|FG001|Adjuvant Therapy|Other|1|||
105971527|NCT01257568|365556765|FG000|Overall Study|Lost to Follow-up|2|||
105971528|NCT01257568|365556765|FG000|Overall Study|Withdrawal by Subject|6|||
105971529|NCT01257568|365556765|FG000|Overall Study|Terminated|1|||
105971530|NCT01257568|365556765|FG000|Overall Study|Component Revision|24|||
105971531|NCT03392883|365556768|FG000|Overall Study|Lost to Follow-up|122|||
105971532|NCT03392883|365556769|FG001|Overall Study|Lost to Follow-up|13|||
105971533|NCT03392883|365556770|FG002|Overall Study|Lost to Follow-up|9|||
105971534|NCT03392883|365556768|FG000|Overall Study|Death|4|||
105971535|NCT03392883|365556769|FG001|Overall Study|Death|0|||
105971536|NCT03392883|365556770|FG002|Overall Study|Death|0|||
105971537|NCT03392883|365556768|FG000|Overall Study|Lack of Efficacy|29|||
105971538|NCT03392883|365556769|FG001|Overall Study|Lack of Efficacy|0|||
105971539|NCT03392883|365556770|FG002|Overall Study|Lack of Efficacy|0|||
105971540|NCT03392883|365556768|FG000|Overall Study|Withdrawal by Subject|180|||
105971541|NCT03392883|365556769|FG001|Overall Study|Withdrawal by Subject|0|||
105971542|NCT03392883|365556770|FG002|Overall Study|Withdrawal by Subject|0|||
105971543|NCT03392883|365556768|FG000|Overall Study|Adverse Event|1|||
105971544|NCT03392883|365556769|FG001|Overall Study|Adverse Event|0|||
105971545|NCT03392883|365556770|FG002|Overall Study|Adverse Event|0|||
105971546|NCT02251717|365556771|FG000|Overall Study|Adverse Event|0|||
105971547|NCT02251717|365556772|FG001|Overall Study|Adverse Event|1|||
105971548|NCT02251717|365556771|FG000|Overall Study|Withdrew Consent|1|||
105971549|NCT02251717|365556772|FG001|Overall Study|Withdrew Consent|0|||
105971550|NCT00908115|365556782|FG000|Overall Study|Other|14|||
105971551|NCT00445939|365556783|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
105971552|NCT00445939|365556784|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
105971553|NCT00445939|365556785|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
105971554|NCT00445939|365556786|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
105971555|NCT00445939|365556783|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
105971556|NCT00445939|365556784|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
105971557|NCT00445939|365556785|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
105971558|NCT00445939|365556786|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
105971559|NCT00489736|365556787|FG000|Overall Study|Lack of Efficacy|53|||
105971560|NCT00489736|365556788|FG001|Overall Study|Lack of Efficacy|14|||
105971561|NCT00489736|365556787|FG000|Overall Study|Adverse Event|32|||
105971562|NCT00489736|365556788|FG001|Overall Study|Adverse Event|45|||
105971563|NCT00489736|365556787|FG000|Overall Study|Poor compliance|6|||
105971564|NCT00489736|365556788|FG001|Overall Study|Poor compliance|2|||
105971565|NCT00489736|365556787|FG000|Overall Study|Not coded/ Not pre-specified|5|||
105971566|NCT00489736|365556788|FG001|Overall Study|Not coded/ Not pre-specified|8|||
105971567|NCT01691885|365556790|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
105971568|NCT01691885|365556791|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
105971569|NCT01691885|365556790|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
105971570|NCT01691885|365556791|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
105971571|NCT02075047|365556804|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
105971572|NCT02075047|365556805|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
105971573|NCT02075047|365556804|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
105971574|NCT02075047|365556805|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
105971575|NCT02075047|365556804|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
105971576|NCT02075047|365556805|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
105971577|NCT02075047|365556804|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
105971578|NCT02075047|365556805|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
105971579|NCT02075047|365556804|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
105971580|NCT02075047|365556805|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
105845401|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
105845402|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
105845403|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
105845404|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
105845405|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
105845406|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
105845407|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
105845408|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
105845409|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
105845410|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
105845411|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
105845412|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
105845413|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
105845414|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
105845415|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
105845416|NCT01421342|365092340|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
105845417|NCT01421342|365092341|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
105845418|NCT01421342|365092342|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
105845419|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
105845420|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
105845421|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
105845422|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
105845423|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
105845424|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
105845425|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
105845426|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
105845427|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
105845428|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
105845429|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
105845430|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
105845431|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
105845432|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
105845433|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
105845434|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
105845435|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
105845436|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
105845437|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
105845438|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
105845439|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
105845440|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
105845441|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
105845442|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
105845443|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
105845444|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
105845445|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
105845446|NCT01421342|365092340|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
105971581|NCT02075047|365556804|FG000|Treatment Phase (4 Weeks)|Other|1|||
105971582|NCT02075047|365556805|FG001|Treatment Phase (4 Weeks)|Other|1|||
105971583|NCT02075047|365556804|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
105971584|NCT02075047|365556805|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
105971585|NCT02075047|365556804|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
105971586|NCT02075047|365556805|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
105971587|NCT02075047|365556804|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
105971588|NCT02075047|365556805|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
105971589|NCT02075047|365556804|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
105971590|NCT02075047|365556805|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
105971591|NCT02075047|365556804|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
105971592|NCT02075047|365556805|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
105971593|NCT02075047|365556804|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
105971594|NCT02075047|365556805|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
105971595|NCT02075047|365556804|FG000|Follow up Phase (5 Weeks)|Other|1|||
105971596|NCT02075047|365556805|FG001|Follow up Phase (5 Weeks)|Other|2|||
105971597|NCT02075047|365556804|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
105971598|NCT02075047|365556805|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
105971599|NCT00823212|365556806|FG000|Overall Study|Death|8|||
105971600|NCT00823212|365556807|FG001|Overall Study|Death|10|||
105971601|NCT00823212|365556806|FG000|Overall Study|Withdrawal by Subject|6|||
105845447|NCT01421342|365092341|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
105845448|NCT01421342|365092342|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
105845449|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
105845450|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
105845451|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
105845452|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
105845453|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
105845454|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
105845455|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
105845456|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
105845457|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
105845458|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
105971602|NCT00823212|365556807|FG001|Overall Study|Withdrawal by Subject|1|||
105971603|NCT00823212|365556806|FG000|Overall Study|Incarcerated|0|||
105971604|NCT00823212|365556807|FG001|Overall Study|Incarcerated|1|||
105971605|NCT00823212|365556806|FG000|Overall Study|Missed 12-month visit|21|||
105971606|NCT00823212|365556807|FG001|Overall Study|Missed 12-month visit|21|||
105971607|NCT03770728|365556808|FG000|Overall Study|Adverse Event|1|||
105971608|NCT03770728|365556809|FG001|Overall Study|Adverse Event|0|||
105971609|NCT03770728|365556810|FG002|Overall Study|Adverse Event|1|||
105971610|NCT03770728|365556811|FG003|Overall Study|Adverse Event|0|||
105971611|NCT03770728|365556808|FG000|Overall Study|Poor compliance to protocol|0|||
105971612|NCT03770728|365556809|FG001|Overall Study|Poor compliance to protocol|0|||
105971613|NCT03770728|365556810|FG002|Overall Study|Poor compliance to protocol|1|||
105971614|NCT03770728|365556811|FG003|Overall Study|Poor compliance to protocol|0|||
105971615|NCT03770728|365556808|FG000|Overall Study|Withdrawal by Subject|13|||
105971616|NCT03770728|365556809|FG001|Overall Study|Withdrawal by Subject|8|||
105971617|NCT03770728|365556810|FG002|Overall Study|Withdrawal by Subject|9|||
105971618|NCT03770728|365556811|FG003|Overall Study|Withdrawal by Subject|13|||
105971619|NCT03770728|365556808|FG000|Overall Study|Other than specified|24|||
105971620|NCT03770728|365556809|FG001|Overall Study|Other than specified|23|||
105971621|NCT03770728|365556810|FG002|Overall Study|Other than specified|21|||
105971622|NCT03770728|365556811|FG003|Overall Study|Other than specified|22|||
105971623|NCT02324205|365556812|FG000|Overall Study|Withdrawal by Subject|37|||
105971624|NCT03006458|365556819|FG000|First Intervention|Unsatisfied Vision|0|||
105845459|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
105845460|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
105845461|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
105845462|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
105845463|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
105845464|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
105845465|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
105845466|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
105845467|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
105845468|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
105845469|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
105845470|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
105845471|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
105845472|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
105845473|NCT01421342|365092340|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
105845474|NCT01421342|365092341|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
105845475|NCT01421342|365092342|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
105845476|NCT03921151|365092345|FG000|Overall Study|Withdrawal by Subject|11|||
105845477|NCT03921151|365092346|FG001|Overall Study|Withdrawal by Subject|16|||
105845478|NCT01429051|365092347|FG000|Titration Phase|Death|1|||
105971625|NCT03006458|365556820|FG001|First Intervention|Unsatisfied Vision|3|||
105971626|NCT00855933|365556821|FG000|Overall Study|Withdrawal by Subject|0|||
105971627|NCT00855933|365556822|FG001|Overall Study|Withdrawal by Subject|1|||
105971628|NCT02851407|365556823|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105971629|NCT02851407|365556824|FG001|Overall Study|Withdrawal by parent/guardian|7|||
105971630|NCT02851407|365556823|FG000|Overall Study|Protocol deviation|0|||
105971631|NCT02851407|365556824|FG001|Overall Study|Protocol deviation|1|||
105971632|NCT02851407|365556823|FG000|Overall Study|Transferred to another hospital to continue|1|||
105971633|NCT02851407|365556824|FG001|Overall Study|Transferred to another hospital to continue|0|||
106149694|NCT02238483|366209203|FG000|Overall Study|Adverse Event|7|||
106149695|NCT02238483|366209204|FG001|Overall Study|Adverse Event|3|||
106149696|NCT02238483|366209203|FG000|Overall Study|Withdrawn due to physician decision|1|||
106149697|NCT02238483|366209204|FG001|Overall Study|Withdrawn due to physician decision|0|||
106149698|NCT02238483|366209203|FG000|Overall Study|Completion status not recorded|1|||
105845479|NCT01429051|365092347|FG000|Titration Phase|Withdrawal by Subject|7|||
105845480|NCT01429051|365092347|FG000|Titration Phase|Physician Decision|1|||
105845481|NCT01429051|365092347|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
105845482|NCT01429051|365092347|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
105845483|NCT01429051|365092347|FG000|Efficacy Phase|Adverse Event|1|||
105845484|NCT01429051|365092347|FG000|Efficacy Phase|Death|1|||
105845485|NCT01429051|365092347|FG000|Tolerability Phase|Death|5|||
105845486|NCT01429051|365092347|FG000|Tolerability Phase|Adverse Event|2|||
105845487|NCT01429051|365092347|FG000|Tolerability Phase|Withdrawal by Subject|5|||
105845488|NCT01429051|365092347|FG000|Tolerability Phase|Physician Decision|1|||
105845489|NCT01429051|365092347|FG000|Tolerability Phase|Other|2|||
105845490|NCT01206816|365092352|FG000|Overall Study|Protocol Violation|0|||
105845491|NCT01206816|365092353|FG001|Overall Study|Protocol Violation|0|||
105845492|NCT01206816|365092354|FG002|Overall Study|Protocol Violation|1|||
105845493|NCT01206816|365092355|FG003|Overall Study|Protocol Violation|0|||
105845494|NCT01206816|365092356|FG004|Overall Study|Protocol Violation|0|||
105845495|NCT01206816|365092357|FG005|Overall Study|Protocol Violation|0|||
105845496|NCT01206816|365092358|FG006|Overall Study|Protocol Violation|0|||
105845497|NCT01206816|365092352|FG000|Overall Study|Withdrawal by Subject|0|||
105845498|NCT01206816|365092353|FG001|Overall Study|Withdrawal by Subject|0|||
105845499|NCT01206816|365092354|FG002|Overall Study|Withdrawal by Subject|1|||
105845500|NCT01206816|365092355|FG003|Overall Study|Withdrawal by Subject|0|||
105845501|NCT01206816|365092356|FG004|Overall Study|Withdrawal by Subject|0|||
105845502|NCT01206816|365092357|FG005|Overall Study|Withdrawal by Subject|0|||
105845503|NCT01206816|365092358|FG006|Overall Study|Withdrawal by Subject|0|||
105845504|NCT01206816|365092352|FG000|Overall Study|Progressive disease|3|||
105845505|NCT01206816|365092353|FG001|Overall Study|Progressive disease|3|||
105845506|NCT01206816|365092354|FG002|Overall Study|Progressive disease|13|||
105845507|NCT01206816|365092355|FG003|Overall Study|Progressive disease|3|||
105845508|NCT01206816|365092356|FG004|Overall Study|Progressive disease|3|||
105845509|NCT01206816|365092357|FG005|Overall Study|Progressive disease|16|||
105845510|NCT01206816|365092358|FG006|Overall Study|Progressive disease|3|||
105845511|NCT01206816|365092352|FG000|Overall Study|Other AE|0|||
105845512|NCT01206816|365092353|FG001|Overall Study|Other AE|0|||
105845513|NCT01206816|365092354|FG002|Overall Study|Other AE|4|||
105845514|NCT01206816|365092355|FG003|Overall Study|Other AE|0|||
105845515|NCT01206816|365092356|FG004|Overall Study|Other AE|0|||
105845516|NCT01206816|365092357|FG005|Overall Study|Other AE|3|||
105845517|NCT01206816|365092358|FG006|Overall Study|Other AE|2|||
105845518|NCT01206816|365092352|FG000|Overall Study|other than stated above|0|||
105845519|NCT01206816|365092353|FG001|Overall Study|other than stated above|0|||
105845520|NCT01206816|365092354|FG002|Overall Study|other than stated above|1|||
105845521|NCT01206816|365092355|FG003|Overall Study|other than stated above|0|||
105845522|NCT01206816|365092356|FG004|Overall Study|other than stated above|0|||
105845523|NCT01206816|365092357|FG005|Overall Study|other than stated above|0|||
105845524|NCT01206816|365092358|FG006|Overall Study|other than stated above|1|||
105845525|NCT03760250|365092359|FG000|Overall Study|Withdrawal by Subject|1|||
105845526|NCT03760250|365092359|FG000|Overall Study|Physician Decision|1|||
105845527|NCT03733210|365092360|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
105845528|NCT03733210|365092361|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
105845529|NCT02621034|365092362|FG000|Overall Study|Lost to Follow-up|3|||
105845530|NCT02621034|365092363|FG001|Overall Study|Lost to Follow-up|2|||
105845531|NCT02621034|365092364|FG002|Overall Study|Lost to Follow-up|5|||
105845532|NCT01939496|365092365|FG000|Overall Study|Adverse Event|2|||
105845533|NCT01939496|365092366|FG001|Overall Study|Adverse Event|0|||
105845534|NCT01939496|365092367|FG002|Overall Study|Adverse Event|0|||
105845535|NCT01939496|365092365|FG000|Overall Study|Lost to Follow-up|1|||
105845536|NCT01939496|365092366|FG001|Overall Study|Lost to Follow-up|1|||
105845537|NCT01939496|365092367|FG002|Overall Study|Lost to Follow-up|0|||
105845538|NCT01939496|365092365|FG000|Overall Study|Physician Decision|1|||
105845539|NCT01939496|365092366|FG001|Overall Study|Physician Decision|0|||
105845540|NCT01939496|365092367|FG002|Overall Study|Physician Decision|0|||
105845541|NCT01939496|365092365|FG000|Overall Study|Protocol Violation|3|||
105845542|NCT01939496|365092366|FG001|Overall Study|Protocol Violation|0|||
105845543|NCT01939496|365092367|FG002|Overall Study|Protocol Violation|0|||
105845544|NCT01939496|365092365|FG000|Overall Study|Withdrawal by Subject|0|||
105845545|NCT01939496|365092366|FG001|Overall Study|Withdrawal by Subject|1|||
105845546|NCT01939496|365092367|FG002|Overall Study|Withdrawal by Subject|1|||
105845547|NCT01939496|365092365|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
105845548|NCT01939496|365092366|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
106149699|NCT02238483|366209204|FG001|Overall Study|Completion status not recorded|1|||
105845549|NCT01939496|365092367|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
105845550|NCT01939496|365092365|FG000|Overall Study|Other|2|||
105845551|NCT01939496|365092366|FG001|Overall Study|Other|0|||
105845552|NCT01939496|365092367|FG002|Overall Study|Other|1|||
105845553|NCT03251963|365092368|FG000|Overall Study|inappropriate Xa level timing|6|||
105845554|NCT03251963|365092369|FG001|Overall Study|inappropriate Xa level timing|3|||
105845555|NCT03251963|365092368|FG000|Overall Study|no peak Xa level drawn|2|||
105971634|NCT02851407|365556823|FG000|Overall Study|Other Death|30|||
105971635|NCT02851407|365556824|FG001|Overall Study|Other Death|20|||
105971636|NCT02851407|365556823|FG000|Overall Study|Adverse event, serious fatal|6|||
105971637|NCT02851407|365556824|FG001|Overall Study|Adverse event, serious fatal|8|||
105971638|NCT02851407|365556823|FG000|Overall Study|Consent withdrawn by participant|5|||
105971639|NCT02851407|365556824|FG001|Overall Study|Consent withdrawn by participant|3|||
105971640|NCT02851407|365556823|FG000|Overall Study|Screen failure|2|||
105971641|NCT02851407|365556824|FG001|Overall Study|Screen failure|1|||
105971642|NCT02851407|365556823|FG000|Overall Study|Disease relapse|9|||
105971643|NCT02851407|365556824|FG001|Overall Study|Disease relapse|6|||
105971644|NCT02851407|365556823|FG000|Overall Study|Physician Decision|7|||
105845556|NCT03251963|365092369|FG001|Overall Study|no peak Xa level drawn|0|||
105845557|NCT03251963|365092368|FG000|Overall Study|bled prior to Xa level|1|||
105845558|NCT03251963|365092369|FG001|Overall Study|bled prior to Xa level|2|||
105845559|NCT01705236|365092370|FG000|Overall Study|Lost to Follow-up|1|||
105845560|NCT01705236|365092370|FG000|Overall Study|Administrative problems|2|||
105845561|NCT01705236|365092370|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
105845562|NCT01705236|365092370|FG000|Overall Study|Protocol Violation|3|||
105845563|NCT01705236|365092370|FG000|Overall Study|Abnormal test procedure result(s)|4|||
105845564|NCT01705236|365092370|FG000|Overall Study|Abnormal laboratory value(s)|4|||
105845565|NCT01705236|365092370|FG000|Overall Study|Withdrawal by Subject|5|||
105845566|NCT01705236|365092370|FG000|Overall Study|Adverse Event|5|||
105845567|NCT03028740|365092371|FG000|Overall Study|Did not Receive Study Drug|4|||
105845568|NCT03028740|365092372|FG001|Overall Study|Did not Receive Study Drug|5|||
105845569|NCT03028740|365092371|FG000|Overall Study|Adverse Event|8|||
105845570|NCT03028740|365092372|FG001|Overall Study|Adverse Event|26|||
105845571|NCT03028740|365092371|FG000|Overall Study|Lack of Efficacy|0|||
105845572|NCT03028740|365092372|FG001|Overall Study|Lack of Efficacy|1|||
105845573|NCT03028740|365092371|FG000|Overall Study|Withdrawal by Subject|48|||
105971645|NCT02851407|365556824|FG001|Overall Study|Physician Decision|6|||
105971646|NCT02851407|365556823|FG000|Overall Study|Transferred to hospital closer to home|0|||
105971647|NCT02851407|365556824|FG001|Overall Study|Transferred to hospital closer to home|1|||
105971648|NCT02851407|365556823|FG000|Overall Study|Enrolled in an investigational study|0|||
105971649|NCT02851407|365556824|FG001|Overall Study|Enrolled in an investigational study|1|||
105971650|NCT02851407|365556823|FG000|Overall Study|Early recovery|1|||
105971651|NCT02851407|365556824|FG001|Overall Study|Early recovery|0|||
105971652|NCT02851407|365556823|FG000|Overall Study|Adverse event, non-fatal|7|||
105971653|NCT02851407|365556824|FG001|Overall Study|Adverse event, non-fatal|5|||
105971654|NCT02851407|365556823|FG000|Overall Study|Lost to Follow-up|0|||
105971655|NCT02851407|365556824|FG001|Overall Study|Lost to Follow-up|2|||
105971656|NCT00835640|365556830|FG000|Second Intervention|Protocol Violation|1|||
105971657|NCT00835640|365556831|FG001|Second Intervention|Protocol Violation|0|||
105971658|NCT00812006|365556832|FG000|Overall Study|Lost to Follow-up|0|||
105971659|NCT00812006|365556833|FG001|Overall Study|Lost to Follow-up|0|||
105971660|NCT00812006|365556834|FG002|Overall Study|Lost to Follow-up|2|||
105971661|NCT00812006|365556832|FG000|Overall Study|Physician Decision|0|||
105971662|NCT00812006|365556833|FG001|Overall Study|Physician Decision|0|||
105971663|NCT00812006|365556834|FG002|Overall Study|Physician Decision|1|||
105971664|NCT00812006|365556832|FG000|Overall Study|Withdrawal by Subject|2|||
105971665|NCT00812006|365556833|FG001|Overall Study|Withdrawal by Subject|1|||
105971666|NCT00812006|365556834|FG002|Overall Study|Withdrawal by Subject|1|||
105971667|NCT00812006|365556832|FG000|Overall Study|Lack of Qualifying Event|4|||
105971668|NCT00812006|365556833|FG001|Overall Study|Lack of Qualifying Event|2|||
105971669|NCT00812006|365556834|FG002|Overall Study|Lack of Qualifying Event|2|||
105971670|NCT01824823|365556835|FG000|Overall Study|Lack of Efficacy|1|||
105971671|NCT01824823|365556836|FG001|Overall Study|Lack of Efficacy|1|||
105845574|NCT03028740|365092372|FG001|Overall Study|Withdrawal by Subject|101|||
105845575|NCT03028740|365092371|FG000|Overall Study|Lost to Follow-up|30|||
105845576|NCT03028740|365092372|FG001|Overall Study|Lost to Follow-up|54|||
105845577|NCT03028740|365092371|FG000|Overall Study|Physician Decision|4|||
105845578|NCT03028740|365092372|FG001|Overall Study|Physician Decision|11|||
105845579|NCT03028740|365092371|FG000|Overall Study|Protocol Violation|4|||
105845580|NCT03028740|365092372|FG001|Overall Study|Protocol Violation|8|||
105971672|NCT01824823|365556835|FG000|Overall Study|Off-treatment reason not submitted|1|||
105971673|NCT01824823|365556836|FG001|Overall Study|Off-treatment reason not submitted|0|||
105971674|NCT03263923|365556837|FG000|Overall Study|Withdrawal by Subject|10|||
105971675|NCT03263923|365556838|FG001|Overall Study|Withdrawal by Subject|8|||
106149700|NCT02238483|366209203|FG000|Overall Study|Illness in family member|1|||
106149701|NCT02238483|366209204|FG001|Overall Study|Illness in family member|0|||
106149702|NCT02574455|366209205|FG000|Overall Study|Death|197|||
105845581|NCT03028740|365092371|FG000|Overall Study|Non-compliance with Study Drug|0|||
105971676|NCT03263923|365556837|FG000|Overall Study|Lost to Follow-up|15|||
105845582|NCT03028740|365092372|FG001|Overall Study|Non-compliance with Study Drug|2|||
105845583|NCT03028740|365092371|FG000|Overall Study|Study Terminated by Sponsor|467|||
105845584|NCT03028740|365092372|FG001|Overall Study|Study Terminated by Sponsor|917|||
105845585|NCT03028740|365092371|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
105845586|NCT03028740|365092372|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
105845587|NCT03028740|365092371|FG000|Overall Study|Reason not Specified|1|||
105845588|NCT03028740|365092372|FG001|Overall Study|Reason not Specified|5|||
105845589|NCT00186888|365092374|FG000|Overall Study|Toxicity|0|||
105845590|NCT00186888|365092375|FG001|Overall Study|Toxicity|1|||
105845591|NCT00186888|365092376|FG002|Overall Study|Toxicity|0|||
105845592|NCT00186888|365092374|FG000|Overall Study|Relapse or progression of disease|4|||
105845593|NCT00186888|365092375|FG001|Overall Study|Relapse or progression of disease|2|||
105845594|NCT00186888|365092376|FG002|Overall Study|Relapse or progression of disease|0|||
105845595|NCT00289874|365092377|FG000|Overall Study|Adverse Event|1|||
105845596|NCT00289874|365092378|FG001|Overall Study|Adverse Event|5|||
105845597|NCT00289874|365092377|FG000|Overall Study|Lost to Follow-up|1|||
105845598|NCT00289874|365092378|FG001|Overall Study|Lost to Follow-up|1|||
105845599|NCT00289874|365092377|FG000|Overall Study|Protocol Violation|3|||
105845600|NCT00289874|365092378|FG001|Overall Study|Protocol Violation|2|||
105845601|NCT00289874|365092377|FG000|Overall Study|Did not meet eligibility|1|||
105845602|NCT00289874|365092378|FG001|Overall Study|Did not meet eligibility|0|||
105845603|NCT00136318|365092381|FG000|Overall Study|Adverse Event|5|||
105845604|NCT00136318|365092382|FG001|Overall Study|Adverse Event|5|||
105845605|NCT00136318|365092381|FG000|Overall Study|Withdrawal by Subject|2|||
105845606|NCT00136318|365092382|FG001|Overall Study|Withdrawal by Subject|2|||
105845607|NCT01615263|365092383|FG000|Overall Study|Post-randomization exclusion|0|||
105845608|NCT01615263|365092384|FG001|Overall Study|Post-randomization exclusion|2|||
105845609|NCT01829113|365092385|FG000|Overall Study|Disease Progression|37|||
105845610|NCT01829113|365092386|FG001|Overall Study|Disease Progression|48|||
105845611|NCT01829113|365092385|FG000|Overall Study|Adverse Event|14|||
105845612|NCT01829113|365092386|FG001|Overall Study|Adverse Event|10|||
105845613|NCT01829113|365092385|FG000|Overall Study|Withdrawal by Subject|17|||
105845614|NCT01829113|365092386|FG001|Overall Study|Withdrawal by Subject|10|||
105845615|NCT01829113|365092385|FG000|Overall Study|Death|4|||
105845616|NCT01829113|365092386|FG001|Overall Study|Death|6|||
105845617|NCT01829113|365092385|FG000|Overall Study|Sponsor Decision|1|||
105845618|NCT01829113|365092386|FG001|Overall Study|Sponsor Decision|1|||
105845619|NCT01829113|365092385|FG000|Overall Study|No Study Treatment Received|3|||
105845620|NCT01829113|365092386|FG001|Overall Study|No Study Treatment Received|2|||
105845621|NCT01829113|365092385|FG000|Overall Study|Physician Decision|1|||
105845622|NCT01829113|365092386|FG001|Overall Study|Physician Decision|1|||
105845623|NCT00942331|365092395|FG000|Overall Study|Did not start treatment|15|||
105845624|NCT00942331|365092396|FG001|Overall Study|Did not start treatment|22|||
105845625|NCT00466726|365092398|FG000|Overall Study|Not evaluable for response|14|||
105845626|NCT02696031|365092399|FG000|Up to Week 24|Adverse Event|2|||
105845627|NCT02696031|365092400|FG001|Up to Week 24|Adverse Event|4|||
105845628|NCT02696031|365092401|FG002|Up to Week 24|Adverse Event|2|||
105845629|NCT02696031|365092402|FG003|Up to Week 24|Adverse Event|0|||
105845630|NCT02696031|365092403|FG004|Up to Week 24|Adverse Event|0|||
105845631|NCT02696031|365092404|FG005|Up to Week 24|Adverse Event|0|||
105845632|NCT02696031|365092399|FG000|Up to Week 24|Lack of Efficacy|2|||
105845633|NCT02696031|365092400|FG001|Up to Week 24|Lack of Efficacy|1|||
105845634|NCT02696031|365092401|FG002|Up to Week 24|Lack of Efficacy|2|||
105845635|NCT02696031|365092402|FG003|Up to Week 24|Lack of Efficacy|0|||
105845636|NCT02696031|365092403|FG004|Up to Week 24|Lack of Efficacy|0|||
105845637|NCT02696031|365092404|FG005|Up to Week 24|Lack of Efficacy|0|||
105845638|NCT02696031|365092399|FG000|Up to Week 24|Lost to Follow-up|0|||
105845639|NCT02696031|365092400|FG001|Up to Week 24|Lost to Follow-up|1|||
105845640|NCT02696031|365092401|FG002|Up to Week 24|Lost to Follow-up|1|||
105845641|NCT02696031|365092402|FG003|Up to Week 24|Lost to Follow-up|0|||
105845642|NCT02696031|365092403|FG004|Up to Week 24|Lost to Follow-up|0|||
105845643|NCT02696031|365092404|FG005|Up to Week 24|Lost to Follow-up|0|||
105845644|NCT02696031|365092399|FG000|Up to Week 24|Physician Decision|1|||
105845645|NCT02696031|365092400|FG001|Up to Week 24|Physician Decision|0|||
105845646|NCT02696031|365092401|FG002|Up to Week 24|Physician Decision|1|||
105845647|NCT02696031|365092402|FG003|Up to Week 24|Physician Decision|0|||
105845648|NCT02696031|365092403|FG004|Up to Week 24|Physician Decision|0|||
105845649|NCT02696031|365092404|FG005|Up to Week 24|Physician Decision|0|||
105845650|NCT02696031|365092399|FG000|Up to Week 24|Protocol Violation|1|||
105845651|NCT02696031|365092400|FG001|Up to Week 24|Protocol Violation|0|||
105845652|NCT02696031|365092401|FG002|Up to Week 24|Protocol Violation|0|||
105845653|NCT02696031|365092402|FG003|Up to Week 24|Protocol Violation|0|||
105845654|NCT02696031|365092403|FG004|Up to Week 24|Protocol Violation|0|||
105845655|NCT02696031|365092404|FG005|Up to Week 24|Protocol Violation|0|||
105845656|NCT02696031|365092399|FG000|Up to Week 24|Withdrawal by Subject|4|||
105845657|NCT02696031|365092400|FG001|Up to Week 24|Withdrawal by Subject|1|||
105845658|NCT02696031|365092401|FG002|Up to Week 24|Withdrawal by Subject|5|||
105845659|NCT02696031|365092402|FG003|Up to Week 24|Withdrawal by Subject|0|||
105845660|NCT02696031|365092403|FG004|Up to Week 24|Withdrawal by Subject|0|||
105845661|NCT02696031|365092404|FG005|Up to Week 24|Withdrawal by Subject|0|||
105845662|NCT02696031|365092399|FG000|Up to Week 52|Adverse Event|4|||
105845663|NCT02696031|365092400|FG001|Up to Week 52|Adverse Event|5|||
105845664|NCT02696031|365092401|FG002|Up to Week 52|Adverse Event|3|||
105845665|NCT02696031|365092402|FG003|Up to Week 52|Adverse Event|0|||
105845666|NCT02696031|365092403|FG004|Up to Week 52|Adverse Event|0|||
105845667|NCT02696031|365092404|FG005|Up to Week 52|Adverse Event|0|||
105845668|NCT02696031|365092399|FG000|Up to Week 52|Lack of Efficacy|10|||
105845669|NCT02696031|365092400|FG001|Up to Week 52|Lack of Efficacy|7|||
105845670|NCT02696031|365092401|FG002|Up to Week 52|Lack of Efficacy|11|||
105845671|NCT02696031|365092402|FG003|Up to Week 52|Lack of Efficacy|0|||
105845672|NCT02696031|365092403|FG004|Up to Week 52|Lack of Efficacy|0|||
105845673|NCT02696031|365092404|FG005|Up to Week 52|Lack of Efficacy|0|||
105845674|NCT02696031|365092399|FG000|Up to Week 52|Lost to Follow-up|1|||
105845675|NCT02696031|365092400|FG001|Up to Week 52|Lost to Follow-up|1|||
105845676|NCT02696031|365092401|FG002|Up to Week 52|Lost to Follow-up|1|||
105845677|NCT02696031|365092402|FG003|Up to Week 52|Lost to Follow-up|0|||
105845678|NCT02696031|365092403|FG004|Up to Week 52|Lost to Follow-up|0|||
105845679|NCT02696031|365092404|FG005|Up to Week 52|Lost to Follow-up|0|||
105845680|NCT02696031|365092399|FG000|Up to Week 52|Physician Decision|1|||
105845681|NCT02696031|365092400|FG001|Up to Week 52|Physician Decision|1|||
105845682|NCT02696031|365092401|FG002|Up to Week 52|Physician Decision|2|||
105845683|NCT02696031|365092402|FG003|Up to Week 52|Physician Decision|0|||
105845684|NCT02696031|365092403|FG004|Up to Week 52|Physician Decision|0|||
105845685|NCT02696031|365092404|FG005|Up to Week 52|Physician Decision|0|||
105845686|NCT02696031|365092399|FG000|Up to Week 52|Pregnancy|0|||
105845687|NCT02696031|365092400|FG001|Up to Week 52|Pregnancy|2|||
105845688|NCT02696031|365092401|FG002|Up to Week 52|Pregnancy|0|||
105845689|NCT02696031|365092402|FG003|Up to Week 52|Pregnancy|0|||
105845690|NCT02696031|365092403|FG004|Up to Week 52|Pregnancy|0|||
105845691|NCT02696031|365092404|FG005|Up to Week 52|Pregnancy|0|||
105845692|NCT02696031|365092399|FG000|Up to Week 52|Protocol Violation|1|||
105845693|NCT02696031|365092400|FG001|Up to Week 52|Protocol Violation|0|||
105845694|NCT02696031|365092401|FG002|Up to Week 52|Protocol Violation|0|||
105845695|NCT02696031|365092402|FG003|Up to Week 52|Protocol Violation|0|||
105845696|NCT02696031|365092403|FG004|Up to Week 52|Protocol Violation|0|||
105845697|NCT02696031|365092404|FG005|Up to Week 52|Protocol Violation|0|||
105845698|NCT02696031|365092399|FG000|Up to Week 52|Withdrawal by Subject|12|||
105845699|NCT02696031|365092400|FG001|Up to Week 52|Withdrawal by Subject|3|||
105845700|NCT02696031|365092401|FG002|Up to Week 52|Withdrawal by Subject|9|||
105845701|NCT02696031|365092402|FG003|Up to Week 52|Withdrawal by Subject|0|||
105845702|NCT02696031|365092403|FG004|Up to Week 52|Withdrawal by Subject|0|||
105845703|NCT02696031|365092404|FG005|Up to Week 52|Withdrawal by Subject|0|||
105845704|NCT02696031|365092399|FG000|Up to Week 104|Pregnancy|0|||
105845705|NCT02696031|365092400|FG001|Up to Week 104|Pregnancy|2|||
105845706|NCT02696031|365092401|FG002|Up to Week 104|Pregnancy|1|||
105845707|NCT02696031|365092402|FG003|Up to Week 104|Pregnancy|0|||
105845708|NCT02696031|365092403|FG004|Up to Week 104|Pregnancy|0|||
105845709|NCT02696031|365092404|FG005|Up to Week 104|Pregnancy|0|||
105845710|NCT02696031|365092399|FG000|Up to Week 104|Withdrawal by Subject|15|||
105845711|NCT02696031|365092400|FG001|Up to Week 104|Withdrawal by Subject|10|||
105845712|NCT02696031|365092401|FG002|Up to Week 104|Withdrawal by Subject|16|||
105845713|NCT02696031|365092402|FG003|Up to Week 104|Withdrawal by Subject|0|||
105845714|NCT02696031|365092403|FG004|Up to Week 104|Withdrawal by Subject|0|||
105845715|NCT02696031|365092404|FG005|Up to Week 104|Withdrawal by Subject|0|||
105845716|NCT02696031|365092399|FG000|Up to Week 104|Protocol Violation|1|||
105845717|NCT02696031|365092400|FG001|Up to Week 104|Protocol Violation|0|||
105845718|NCT02696031|365092401|FG002|Up to Week 104|Protocol Violation|0|||
105845719|NCT02696031|365092402|FG003|Up to Week 104|Protocol Violation|0|||
105845720|NCT02696031|365092403|FG004|Up to Week 104|Protocol Violation|0|||
105845721|NCT02696031|365092404|FG005|Up to Week 104|Protocol Violation|0|||
105845722|NCT02696031|365092399|FG000|Up to Week 104|Physician Decision|1|||
106024773|NCT01781299|365756632|FG001|Overall Study|Withdrawal by Subject|1|||
106024774|NCT00653939|365756637|FG000|Overall Study|Adverse Event|1|||
106024775|NCT00653939|365756638|FG001|Overall Study|Adverse Event|3|||
106024776|NCT00653939|365756637|FG000|Overall Study|Withdrawal by Subject|3|||
106024777|NCT00653939|365756638|FG001|Overall Study|Withdrawal by Subject|3|||
106024778|NCT00653939|365756637|FG000|Overall Study|Physician Decision|4|||
106024779|NCT00653939|365756638|FG001|Overall Study|Physician Decision|0|||
106024780|NCT00653939|365756637|FG000|Overall Study|Disease Progression|2|||
106149703|NCT02574455|366209206|FG001|Overall Study|Death|210|||
106149704|NCT02574455|366209205|FG000|Overall Study|Withdrawal of Consent|11|||
106149705|NCT02574455|366209206|FG001|Overall Study|Withdrawal of Consent|28|||
106149706|NCT02574455|366209205|FG000|Overall Study|Lost to Follow-up|4|||
106149707|NCT02574455|366209206|FG001|Overall Study|Lost to Follow-up|4|||
106149708|NCT02574455|366209205|FG000|Overall Study|Sponsor's Decision|55|||
105845723|NCT02696031|365092400|FG001|Up to Week 104|Physician Decision|2|||
105845724|NCT02696031|365092401|FG002|Up to Week 104|Physician Decision|3|||
105845725|NCT02696031|365092402|FG003|Up to Week 104|Physician Decision|0|||
105845726|NCT02696031|365092403|FG004|Up to Week 104|Physician Decision|0|||
105845727|NCT02696031|365092404|FG005|Up to Week 104|Physician Decision|0|||
105845728|NCT02696031|365092399|FG000|Up to Week 104|Lost to Follow-up|2|||
105845729|NCT02696031|365092400|FG001|Up to Week 104|Lost to Follow-up|3|||
105845730|NCT02696031|365092401|FG002|Up to Week 104|Lost to Follow-up|1|||
106024781|NCT00653939|365756638|FG001|Overall Study|Disease Progression|3|||
105845731|NCT02696031|365092402|FG003|Up to Week 104|Lost to Follow-up|0|||
105845732|NCT02696031|365092403|FG004|Up to Week 104|Lost to Follow-up|0|||
105845733|NCT02696031|365092404|FG005|Up to Week 104|Lost to Follow-up|0|||
105845734|NCT02696031|365092399|FG000|Up to Week 104|Lack of Efficacy|13|||
105845735|NCT02696031|365092400|FG001|Up to Week 104|Lack of Efficacy|12|||
105845736|NCT02696031|365092401|FG002|Up to Week 104|Lack of Efficacy|11|||
105845737|NCT02696031|365092402|FG003|Up to Week 104|Lack of Efficacy|0|||
105845738|NCT02696031|365092403|FG004|Up to Week 104|Lack of Efficacy|0|||
105845739|NCT02696031|365092404|FG005|Up to Week 104|Lack of Efficacy|0|||
105845740|NCT02696031|365092399|FG000|Up to Week 104|Adverse Event|7|||
105845741|NCT02696031|365092400|FG001|Up to Week 104|Adverse Event|11|||
105845742|NCT02696031|365092401|FG002|Up to Week 104|Adverse Event|5|||
105845743|NCT02696031|365092402|FG003|Up to Week 104|Adverse Event|0|||
105845744|NCT02696031|365092403|FG004|Up to Week 104|Adverse Event|0|||
105845745|NCT02696031|365092404|FG005|Up to Week 104|Adverse Event|0|||
105845746|NCT02696031|365092399|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845747|NCT02696031|365092400|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
105845748|NCT02696031|365092401|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845749|NCT02696031|365092402|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845750|NCT02696031|365092403|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845751|NCT02696031|365092404|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
105845752|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
105845753|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
105845754|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
105845755|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
105845756|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
105845757|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
105845758|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
105845759|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
105845760|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
105845761|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
105845762|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
105845763|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
105845764|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845765|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845766|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845767|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
105845768|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845769|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
105845770|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845771|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845772|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845773|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845774|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
105845775|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
105845776|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
105845777|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
105845778|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
105845779|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
105845780|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
105845781|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
105845782|NCT02696031|365092399|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
105845783|NCT02696031|365092400|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
105845784|NCT02696031|365092401|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
105845785|NCT02696031|365092402|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
105845786|NCT02696031|365092403|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
105845787|NCT02696031|365092404|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
105845788|NCT01901874|365092407|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
105845789|NCT01901874|365092407|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
105845790|NCT01901874|365092407|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
105845791|NCT01901874|365092407|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
105845792|NCT01901874|365092407|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
105845793|NCT01901874|365092407|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
105845794|NCT03978091|365092408|FG000|Overall Study|Lost to Follow-up|0|||
106149709|NCT02574455|366209206|FG001|Overall Study|Sponsor's Decision|20|||
105845795|NCT03978091|365092409|FG001|Overall Study|Lost to Follow-up|0|||
105845796|NCT03978091|365092410|FG002|Overall Study|Lost to Follow-up|1|||
106149710|NCT00390299|366209212|FG000|Overall Study|Cancellation|1|||
106149711|NCT00390299|366209213|FG001|Overall Study|Cancellation|0|||
105845797|NCT03978091|365092411|FG003|Overall Study|Lost to Follow-up|0|||
105845798|NCT03978091|365092412|FG004|Overall Study|Lost to Follow-up|0|||
105845799|NCT03978091|365092413|FG005|Overall Study|Lost to Follow-up|0|||
106149712|NCT00390299|366209214|FG002|Overall Study|Cancellation|0|||
105971677|NCT03263923|365556838|FG001|Overall Study|Lost to Follow-up|13|||
105971678|NCT00580034|365556842|FG000|Overall Study|Toxicity|10|||
105845800|NCT03978091|365092408|FG000|Overall Study|Withdrawal by Subject|0|||
105845801|NCT03978091|365092409|FG001|Overall Study|Withdrawal by Subject|0|||
105845802|NCT03978091|365092410|FG002|Overall Study|Withdrawal by Subject|0|||
105845803|NCT03978091|365092411|FG003|Overall Study|Withdrawal by Subject|1|||
105845804|NCT03978091|365092412|FG004|Overall Study|Withdrawal by Subject|1|||
105845805|NCT03978091|365092413|FG005|Overall Study|Withdrawal by Subject|0|||
105845806|NCT02039414|365092420|FG000|Overall Study|Delivered|1|||
105845807|NCT02039414|365092421|FG001|Overall Study|Delivered|1|||
105845808|NCT02039414|365092420|FG000|Overall Study|Lost to Follow-up|2|||
105845809|NCT02039414|365092421|FG001|Overall Study|Lost to Follow-up|0|||
105845810|NCT02039414|365092420|FG000|Overall Study|Protocol Violation|3|||
105845811|NCT02039414|365092421|FG001|Overall Study|Protocol Violation|1|||
105845812|NCT02972502|365092426|FG000|Overall Study|Lost to Follow-up|3|||
105845813|NCT02972502|365092427|FG001|Overall Study|Lost to Follow-up|1|||
105971679|NCT00580034|365556843|FG001|Overall Study|Toxicity|0|||
105971680|NCT01939002|365556844|FG000|Overall Study|Adverse Event|13|||
105971681|NCT01939002|365556845|FG001|Overall Study|Adverse Event|13|||
105971682|NCT01939002|365556844|FG000|Overall Study|Withdrawal by Subject|5|||
105845814|NCT02972502|365092426|FG000|Overall Study|Withdrawal by Subject|1|||
105845815|NCT02972502|365092427|FG001|Overall Study|Withdrawal by Subject|1|||
105845816|NCT00257920|365092430|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
105845817|NCT00257920|365092431|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
105845818|NCT00257920|365092430|FG000|Period: Second Intervention|Other|2|||
105845819|NCT00257920|365092431|FG001|Period: Second Intervention|Other|1|||
105845820|NCT03977701|365092434|FG000|Overall Study|COVID-19 pandemic|0|||
105845821|NCT03977701|365092435|FG001|Overall Study|COVID-19 pandemic|0|||
105845822|NCT03977701|365092436|FG002|Overall Study|COVID-19 pandemic|0|||
105845823|NCT03977701|365092437|FG003|Overall Study|COVID-19 pandemic|0|||
105845824|NCT03977701|365092438|FG004|Overall Study|COVID-19 pandemic|0|||
105845825|NCT03977701|365092439|FG005|Overall Study|COVID-19 pandemic|1|||
105845826|NCT03977701|365092440|FG006|Overall Study|COVID-19 pandemic|0|||
105845827|NCT03977701|365092441|FG007|Overall Study|COVID-19 pandemic|1|||
105845828|NCT03977701|365092442|FG008|Overall Study|COVID-19 pandemic|0|||
105845829|NCT03977701|365092443|FG009|Overall Study|COVID-19 pandemic|0|||
105845830|NCT01347866|365092444|FG000|Overall Study|Death|0|||
105845831|NCT01347866|365092445|FG001|Overall Study|Death|0|||
105845832|NCT01347866|365092446|FG002|Overall Study|Death|0|||
105845833|NCT01347866|365092447|FG003|Overall Study|Death|1|||
105845834|NCT01347866|365092448|FG004|Overall Study|Death|2|||
105845835|NCT01347866|365092449|FG005|Overall Study|Death|2|||
106149713|NCT00390299|366209215|FG003|Overall Study|Cancellation|0|||
106149714|NCT00390299|366209216|FG004|Overall Study|Cancellation|0|||
105971683|NCT01939002|365556845|FG001|Overall Study|Withdrawal by Subject|3|||
105971684|NCT01939002|365556844|FG000|Overall Study|Other|1|||
105971685|NCT01939002|365556845|FG001|Overall Study|Other|2|||
105971686|NCT03305081|365556849|FG000|Overall Study|Lost to Follow-up|10|||
105971687|NCT03305081|365556850|FG001|Overall Study|Lost to Follow-up|15|||
105971688|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
105845836|NCT01347866|365092450|FG006|Overall Study|Death|1|||
105845837|NCT01347866|365092451|FG007|Overall Study|Death|0|||
105845838|NCT01347866|365092452|FG008|Overall Study|Death|4|||
106149715|NCT01388361|366209220|FG000|Overall Study|Adverse Event|0|||
106149716|NCT01388361|366209221|FG001|Overall Study|Adverse Event|5|||
105845839|NCT01347866|365092453|FG009|Overall Study|Death|1|||
105971689|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
106149717|NCT01388361|366209222|FG002|Overall Study|Adverse Event|1|||
106149718|NCT01388361|366209220|FG000|Overall Study|Protocol Violation|0|||
105845840|NCT01347866|365092454|FG010|Overall Study|Death|3|||
105845841|NCT01347866|365092455|FG011|Overall Study|Death|1|||
105845842|NCT01347866|365092456|FG012|Overall Study|Death|2|||
105971690|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Death|0|||
105971691|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Death|0|||
105987456|NCT02814175|365614465|FG005|Part 1|Withdrawal Consent|0|||
105987457|NCT02814175|365614460|FG000|Part 1|Lost to Follow-up|1|||
105845843|NCT01347866|365092457|FG013|Overall Study|Death|0|||
105845844|NCT01347866|365092458|FG014|Overall Study|Death|0|||
105845845|NCT01347866|365092459|FG015|Overall Study|Death|1|||
105845846|NCT01347866|365092460|FG016|Overall Study|Death|0|||
105845847|NCT01347866|365092444|FG000|Overall Study|Lost to Follow-up|0|||
105845848|NCT01347866|365092445|FG001|Overall Study|Lost to Follow-up|0|||
105987458|NCT02814175|365614461|FG001|Part 1|Lost to Follow-up|0|||
105845849|NCT01347866|365092446|FG002|Overall Study|Lost to Follow-up|0|||
105845850|NCT01347866|365092447|FG003|Overall Study|Lost to Follow-up|0|||
105845851|NCT01347866|365092448|FG004|Overall Study|Lost to Follow-up|0|||
105845852|NCT01347866|365092449|FG005|Overall Study|Lost to Follow-up|0|||
105845853|NCT01347866|365092450|FG006|Overall Study|Lost to Follow-up|0|||
105845854|NCT01347866|365092451|FG007|Overall Study|Lost to Follow-up|1|||
105845855|NCT01347866|365092452|FG008|Overall Study|Lost to Follow-up|1|||
105845856|NCT01347866|365092453|FG009|Overall Study|Lost to Follow-up|0|||
105845857|NCT01347866|365092454|FG010|Overall Study|Lost to Follow-up|0|||
105845858|NCT01347866|365092455|FG011|Overall Study|Lost to Follow-up|0|||
105845859|NCT01347866|365092456|FG012|Overall Study|Lost to Follow-up|0|||
105845860|NCT01347866|365092457|FG013|Overall Study|Lost to Follow-up|0|||
105845861|NCT01347866|365092458|FG014|Overall Study|Lost to Follow-up|0|||
105845862|NCT01347866|365092459|FG015|Overall Study|Lost to Follow-up|0|||
105845863|NCT01347866|365092460|FG016|Overall Study|Lost to Follow-up|0|||
105845864|NCT01347866|365092444|FG000|Overall Study|Other|3|||
105845865|NCT01347866|365092445|FG001|Overall Study|Other|1|||
105845866|NCT01347866|365092446|FG002|Overall Study|Other|1|||
105845867|NCT01347866|365092447|FG003|Overall Study|Other|4|||
105845868|NCT01347866|365092448|FG004|Overall Study|Other|5|||
105845869|NCT01347866|365092449|FG005|Overall Study|Other|0|||
105845870|NCT01347866|365092450|FG006|Overall Study|Other|5|||
105845871|NCT01347866|365092451|FG007|Overall Study|Other|3|||
105845872|NCT01347866|365092452|FG008|Overall Study|Other|22|||
105845873|NCT01347866|365092453|FG009|Overall Study|Other|5|||
105845874|NCT01347866|365092454|FG010|Overall Study|Other|0|||
105845875|NCT01347866|365092455|FG011|Overall Study|Other|3|||
105845876|NCT01347866|365092456|FG012|Overall Study|Other|4|||
105845877|NCT01347866|365092457|FG013|Overall Study|Other|4|||
105845878|NCT01347866|365092458|FG014|Overall Study|Other|2|||
105845879|NCT01347866|365092459|FG015|Overall Study|Other|3|||
105845880|NCT01347866|365092460|FG016|Overall Study|Other|0|||
105845881|NCT01347866|365092444|FG000|Overall Study|Subject refused further follow-up|2|||
105845882|NCT01347866|365092445|FG001|Overall Study|Subject refused further follow-up|0|||
105845883|NCT01347866|365092446|FG002|Overall Study|Subject refused further follow-up|0|||
105845884|NCT01347866|365092447|FG003|Overall Study|Subject refused further follow-up|2|||
105845885|NCT01347866|365092448|FG004|Overall Study|Subject refused further follow-up|0|||
105845886|NCT01347866|365092449|FG005|Overall Study|Subject refused further follow-up|1|||
105845887|NCT01347866|365092450|FG006|Overall Study|Subject refused further follow-up|0|||
105845888|NCT01347866|365092451|FG007|Overall Study|Subject refused further follow-up|0|||
105845889|NCT01347866|365092452|FG008|Overall Study|Subject refused further follow-up|4|||
105845890|NCT01347866|365092453|FG009|Overall Study|Subject refused further follow-up|1|||
105845891|NCT01347866|365092454|FG010|Overall Study|Subject refused further follow-up|0|||
105845892|NCT01347866|365092455|FG011|Overall Study|Subject refused further follow-up|0|||
105845893|NCT01347866|365092456|FG012|Overall Study|Subject refused further follow-up|1|||
105845894|NCT01347866|365092457|FG013|Overall Study|Subject refused further follow-up|3|||
105845895|NCT01347866|365092458|FG014|Overall Study|Subject refused further follow-up|1|||
105845896|NCT01347866|365092459|FG015|Overall Study|Subject refused further follow-up|0|||
105845897|NCT01347866|365092460|FG016|Overall Study|Subject refused further follow-up|2|||
105845898|NCT00307931|365092462|FG000|Overall Study|Adverse Event|1|||
105845899|NCT00430950|365092463|FG000|Overall Study|Adverse Event|7|||
105845900|NCT00430950|365092464|FG001|Overall Study|Adverse Event|6|||
105845901|NCT00430950|365092463|FG000|Overall Study|Withdrawal by Subject|1|||
105845902|NCT00430950|365092464|FG001|Overall Study|Withdrawal by Subject|0|||
105845903|NCT00430950|365092463|FG000|Overall Study|concomitant medication,etc.|5|||
105845904|NCT00430950|365092464|FG001|Overall Study|concomitant medication,etc.|7|||
105845905|NCT02080832|365092471|FG000|Overall Study|Excluded from analysis by MRI|9|||
105845906|NCT02080832|365092472|FG001|Overall Study|Excluded from analysis by MRI|10|||
105845907|NCT02080832|365092473|FG002|Overall Study|Excluded from analysis by MRI|14|||
105845908|NCT02080832|365092471|FG000|Overall Study|Lost to Follow-up|0|||
105845909|NCT02080832|365092472|FG001|Overall Study|Lost to Follow-up|2|||
105845910|NCT02080832|365092473|FG002|Overall Study|Lost to Follow-up|2|||
105845911|NCT01560507|365092474|FG000|Overall Study|Lost to Follow-up|3|||
105845912|NCT01560507|365092475|FG001|Overall Study|Lost to Follow-up|1|||
105845913|NCT01560507|365092476|FG002|Overall Study|Lost to Follow-up|2|||
105845914|NCT01560507|365092474|FG000|Overall Study|Withdrawal by Subject|1|||
105845915|NCT01560507|365092475|FG001|Overall Study|Withdrawal by Subject|1|||
105845916|NCT01560507|365092476|FG002|Overall Study|Withdrawal by Subject|0|||
105845917|NCT01277718|365092482|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
105845918|NCT01277718|365092483|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
105845919|NCT01277718|365092482|FG000|Period 2 - Second Intervention|Physician Decision|0|||
105845920|NCT01277718|365092483|FG001|Period 2 - Second Intervention|Physician Decision|2|||
105845921|NCT01524913|365092484|FG000|Overall Study|Lost to Follow-up|4|||
105845922|NCT01524913|365092485|FG001|Overall Study|Lost to Follow-up|0|||
105845923|NCT01524913|365092486|FG002|Overall Study|Lost to Follow-up|0|||
105845924|NCT00702208|365092487|FG000|Overall Study|Lost to Follow-up|28|||
105845925|NCT00702208|365092487|FG000|Overall Study|Did not self-lavage|1|||
105845926|NCT00702208|365092487|FG000|Overall Study|Unsatisfactory colposcopy|2|||
105845927|NCT03097588|365092488|FG000|Overall Study|Adverse Event|1|||
105845928|NCT02025751|365092489|FG000|Overall Study|Lost to Follow-up|1|||
105845929|NCT02025751|365092490|FG001|Overall Study|Lost to Follow-up|0|||
105845930|NCT02025751|365092489|FG000|Overall Study|Adverse Event|0|||
105845931|NCT02025751|365092490|FG001|Overall Study|Adverse Event|1|||
105845932|NCT02025751|365092489|FG000|Overall Study|Physician Decision|0|||
105845933|NCT02025751|365092490|FG001|Overall Study|Physician Decision|1|||
105845934|NCT02025751|365092489|FG000|Overall Study|Withdrawal by Subject|0|||
105845935|NCT02025751|365092490|FG001|Overall Study|Withdrawal by Subject|1|||
105845936|NCT02687360|365092491|FG000|Overall Study|Withdrawal by Subject|3|||
105845937|NCT02687360|365092492|FG001|Overall Study|Withdrawal by Subject|0|||
105845938|NCT02989168|365092493|FG000|Overall Study|Withdrawal by Subject|2|||
105845939|NCT02989168|365092494|FG001|Overall Study|Withdrawal by Subject|0|||
105845940|NCT02989168|365092493|FG000|Overall Study|Physician Decision|0|||
105845941|NCT02989168|365092494|FG001|Overall Study|Physician Decision|1|||
105845942|NCT02989168|365092493|FG000|Overall Study|Adverse Event|1|||
105845943|NCT02989168|365092494|FG001|Overall Study|Adverse Event|2|||
105845944|NCT02989168|365092493|FG000|Overall Study|Sponsor stopped study.|1|||
105845945|NCT02989168|365092494|FG001|Overall Study|Sponsor stopped study.|0|||
105845946|NCT01030341|365094184|FG000|Overall Study|Withdrawal by Subject|1|||
105845947|NCT01030341|365094184|FG000|Overall Study|Lost to Follow-up|2|||
105845948|NCT00821873|365094185|FG000|Overall Study|Lost to Follow-up|4|||
105845949|NCT02177136|365094191|FG000|DB Phase|Withdrawal by Subject|2|||
105845950|NCT02177136|365094192|FG001|DB Phase|Withdrawal by Subject|0|||
105845951|NCT02177136|365094193|FG002|DB Phase|Withdrawal by Subject|0|||
105845952|NCT02177136|365094194|FG003|DB Phase|Withdrawal by Subject|0|||
105845953|NCT02177136|365094191|FG000|DB Phase|Discontinued Due to Pruritus|1|||
105845954|NCT02177136|365094192|FG001|DB Phase|Discontinued Due to Pruritus|3|||
105845955|NCT02177136|365094193|FG002|DB Phase|Discontinued Due to Pruritus|0|||
105845956|NCT02177136|365094194|FG003|DB Phase|Discontinued Due to Pruritus|0|||
105845957|NCT02177136|365094191|FG000|DB Phase|Adverse Event|3|||
105845958|NCT02177136|365094192|FG001|DB Phase|Adverse Event|2|||
105845959|NCT02177136|365094193|FG002|DB Phase|Adverse Event|3|||
105845960|NCT02177136|365094194|FG003|DB Phase|Adverse Event|0|||
105845961|NCT02177136|365094191|FG000|DB Phase|Protocol Violation|0|||
105845962|NCT02177136|365094192|FG001|DB Phase|Protocol Violation|0|||
105845963|NCT02177136|365094193|FG002|DB Phase|Protocol Violation|1|||
105845964|NCT02177136|365094194|FG003|DB Phase|Protocol Violation|0|||
105845965|NCT02177136|365094191|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
105845966|NCT02177136|365094192|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
105845967|NCT02177136|365094193|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
105845968|NCT02177136|365094194|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
105845969|NCT02177136|365094191|FG000|LTSE Phase|Withdrawal by Subject|0|||
105845970|NCT02177136|365094192|FG001|LTSE Phase|Withdrawal by Subject|0|||
105845971|NCT02177136|365094193|FG002|LTSE Phase|Withdrawal by Subject|0|||
105845972|NCT02177136|365094194|FG003|LTSE Phase|Withdrawal by Subject|6|||
105845973|NCT02177136|365094191|FG000|LTSE Phase|Adverse Event|0|||
105845974|NCT02177136|365094192|FG001|LTSE Phase|Adverse Event|0|||
105845975|NCT02177136|365094193|FG002|LTSE Phase|Adverse Event|0|||
105845976|NCT02177136|365094194|FG003|LTSE Phase|Adverse Event|10|||
105845977|NCT02177136|365094191|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
105845978|NCT02177136|365094192|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
105845979|NCT02177136|365094193|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
105845980|NCT02177136|365094194|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
105845981|NCT02177136|365094191|FG000|LTSE Phase|Physician Decision|0|||
105845982|NCT02177136|365094192|FG001|LTSE Phase|Physician Decision|0|||
105845983|NCT02177136|365094193|FG002|LTSE Phase|Physician Decision|0|||
105845984|NCT02177136|365094194|FG003|LTSE Phase|Physician Decision|2|||
105845985|NCT02177136|365094191|FG000|LTSE Phase|Lost to Follow-up|0|||
105845986|NCT02177136|365094192|FG001|LTSE Phase|Lost to Follow-up|0|||
105845987|NCT02177136|365094193|FG002|LTSE Phase|Lost to Follow-up|0|||
105845988|NCT02177136|365094194|FG003|LTSE Phase|Lost to Follow-up|1|||
105845989|NCT02177136|365094191|FG000|LTSE Phase|Participant Moved|0|||
105845990|NCT02177136|365094192|FG001|LTSE Phase|Participant Moved|0|||
105845991|NCT02177136|365094193|FG002|LTSE Phase|Participant Moved|0|||
105845992|NCT02177136|365094194|FG003|LTSE Phase|Participant Moved|1|||
105845993|NCT00793780|365094195|FG000|Overall Study|Withdrawal by Subject|2|||
105845994|NCT00793780|365094196|FG001|Overall Study|Withdrawal by Subject|1|||
105845995|NCT01220297|365094197|FG000|Overall Study|Death|2|||
105845996|NCT01220297|365094197|FG000|Overall Study|Lost to Follow-up|1|||
105845997|NCT01287039|365094204|FG000|Overall Study|Noncompliance with study procedures|0|||
105845998|NCT01287039|365094205|FG001|Overall Study|Noncompliance with study procedures|1|||
105845999|NCT01287039|365094204|FG000|Overall Study|Change of location/residence|0|||
105846000|NCT01287039|365094205|FG001|Overall Study|Change of location/residence|3|||
105846001|NCT01287039|365094204|FG000|Overall Study|Elective surgery|0|||
105846002|NCT01287039|365094205|FG001|Overall Study|Elective surgery|1|||
105846003|NCT01287039|365094204|FG000|Overall Study|Protocol Violation|2|||
105846004|NCT01287039|365094205|FG001|Overall Study|Protocol Violation|3|||
105846005|NCT01287039|365094204|FG000|Overall Study|Excluded medication taken|1|||
105846006|NCT01287039|365094205|FG001|Overall Study|Excluded medication taken|0|||
105846007|NCT01287039|365094204|FG000|Overall Study|Noncompliance with study medication|0|||
105846008|NCT01287039|365094205|FG001|Overall Study|Noncompliance with study medication|1|||
105846009|NCT01287039|365094204|FG000|Overall Study|Problem with travel|0|||
105846010|NCT01287039|365094205|FG001|Overall Study|Problem with travel|1|||
105846011|NCT01287039|365094204|FG000|Overall Study|Death|1|||
105846012|NCT01287039|365094205|FG001|Overall Study|Death|0|||
105846013|NCT01287039|365094204|FG000|Overall Study|Change of residence|1|||
105846014|NCT01287039|365094205|FG001|Overall Study|Change of residence|0|||
105846015|NCT01287039|365094204|FG000|Overall Study|Adverse Event|7|||
105846016|NCT01287039|365094205|FG001|Overall Study|Adverse Event|4|||
105846017|NCT01287039|365094204|FG000|Overall Study|Withdrawal by Subject|14|||
105846018|NCT01287039|365094205|FG001|Overall Study|Withdrawal by Subject|11|||
105846019|NCT01287039|365094204|FG000|Overall Study|Lost to Follow-up|3|||
105846020|NCT01287039|365094205|FG001|Overall Study|Lost to Follow-up|2|||
105846021|NCT01570283|365094208|FG000|Cohort 1: Dose Level 1|Death|0|||
105846022|NCT01570283|365094209|FG001|Cohort 1: Dose Level 1|Death|1|||
105846023|NCT01570283|365094210|FG002|Cohort 1: Dose Level 1|Death|0|||
105846024|NCT01570283|365094211|FG003|Cohort 1: Dose Level 1|Death|0|||
105846025|NCT01570283|365094212|FG004|Cohort 1: Dose Level 1|Death|0|||
105846026|NCT01570283|365094213|FG005|Cohort 1: Dose Level 1|Death|0|||
105846027|NCT01570283|365094208|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846028|NCT01570283|365094209|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
105846029|NCT01570283|365094210|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846030|NCT01570283|365094211|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846031|NCT01570283|365094212|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846032|NCT01570283|365094213|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
105846033|NCT01570283|365094208|FG000|Cohort 2: Dose Level 2|Death|0|||
105846034|NCT01570283|365094209|FG001|Cohort 2: Dose Level 2|Death|0|||
105846035|NCT01570283|365094210|FG002|Cohort 2: Dose Level 2|Death|1|||
105846036|NCT01570283|365094211|FG003|Cohort 2: Dose Level 2|Death|0|||
105846037|NCT01570283|365094212|FG004|Cohort 2: Dose Level 2|Death|0|||
105846038|NCT01570283|365094213|FG005|Cohort 2: Dose Level 2|Death|0|||
105846039|NCT01570283|365094208|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846040|NCT01570283|365094209|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846041|NCT01570283|365094210|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846042|NCT01570283|365094211|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
105846043|NCT01570283|365094212|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846044|NCT01570283|365094213|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
105846045|NCT01570283|365094208|FG000|Cohort 3: Dose Level 3|Death|0|||
105846046|NCT01570283|365094209|FG001|Cohort 3: Dose Level 3|Death|0|||
105846047|NCT01570283|365094210|FG002|Cohort 3: Dose Level 3|Death|0|||
105846048|NCT01570283|365094211|FG003|Cohort 3: Dose Level 3|Death|0|||
105846049|NCT01570283|365094212|FG004|Cohort 3: Dose Level 3|Death|0|||
105846050|NCT01570283|365094213|FG005|Cohort 3: Dose Level 3|Death|1|||
105846051|NCT01570283|365094208|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846052|NCT01570283|365094209|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846053|NCT01570283|365094210|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846054|NCT01570283|365094211|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846055|NCT01570283|365094212|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
105846056|NCT01570283|365094213|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
105846057|NCT00841906|365094216|FG000|Overall Study|Withdrawal by Subject|2|||
105846058|NCT00841906|365094217|FG001|Overall Study|Withdrawal by Subject|0|||
105846059|NCT02072148|365094218|FG000|Overall Study|withdrew prior to surgery|23|||
105846060|NCT02072148|365094219|FG001|Overall Study|withdrew prior to surgery|0|||
105846061|NCT02072148|365094220|FG002|Overall Study|withdrew prior to surgery|0|||
105846062|NCT02072148|365094218|FG000|Overall Study|Death|0|||
105846063|NCT02072148|365094219|FG001|Overall Study|Death|0|||
105846064|NCT02072148|365094220|FG002|Overall Study|Death|1|||
105846065|NCT02072148|365094218|FG000|Overall Study|Withdrawal by Subject|0|||
105846066|NCT02072148|365094219|FG001|Overall Study|Withdrawal by Subject|13|||
105846067|NCT02072148|365094220|FG002|Overall Study|Withdrawal by Subject|12|||
105846068|NCT02017860|365094226|FG000|Overall Study|Adverse Event|1|||
105846069|NCT02017860|365094226|FG000|Overall Study|Withdrawal by Subject|1|||
105846070|NCT00857792|365094227|FG000|Overall Study|inadequate image quality for analysis|12|||
105846071|NCT01797835|365094231|FG000|Overall Study|Lost to Follow-up|31|||
105846072|NCT01797835|365094232|FG001|Overall Study|Lost to Follow-up|27|||
105846073|NCT02528123|365094236|FG000|Overall Study|Lost to Follow-up|1|||
105846074|NCT01195103|365094237|FG000|Overall Study|Withdrawal by Subject|1|||
105846075|NCT01195103|365094238|FG001|Overall Study|Withdrawal by Subject|0|||
105846076|NCT01195103|365094239|FG002|Overall Study|Withdrawal by Subject|0|||
105846077|NCT04421586|365094249|FG000|Overall Study|Death|0|||
105846078|NCT04421586|365094250|FG001|Overall Study|Death|1|||
105846079|NCT04421586|365094249|FG000|Overall Study|Lost to Follow-up|2|||
105846080|NCT04421586|365094250|FG001|Overall Study|Lost to Follow-up|2|||
105846081|NCT04421586|365094249|FG000|Overall Study|Withdrawn by PI|1|||
105846082|NCT04421586|365094250|FG001|Overall Study|Withdrawn by PI|0|||
105846083|NCT04421586|365094249|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
105846084|NCT04421586|365094250|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
105846085|NCT04920916|365094251|FG000|Phase IIa 60 Day Study|Death|2|||
105846086|NCT04920916|365094252|FG001|Phase IIa 60 Day Study|Death|5|||
105846087|NCT04920916|365094251|FG000|1 Year Follow up (Phone Call)|Death|1|||
105846088|NCT04920916|365094252|FG001|1 Year Follow up (Phone Call)|Death|3|||
105846089|NCT04920916|365094251|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
105846090|NCT04920916|365094252|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
105846091|NCT00973765|365094253|FG000|Overall Study|Lost to Follow-up|8|||
105846092|NCT00973765|365094254|FG001|Overall Study|Lost to Follow-up|14|||
105846093|NCT04505293|365094262|FG000|Overall Study|Lost to Follow-up|2|||
105846094|NCT04505293|365094262|FG000|Overall Study|Withdrawal by Subject|6|||
105846095|NCT04505293|365094262|FG000|Overall Study|CT scan unreadable|277|||
105846096|NCT00506129|365094263|FG000|Overall Study|Disease Progression/Relapse|15|||
105846097|NCT00506129|365094263|FG000|Overall Study|Death|7|||
105846098|NCT01642914|365094264|FG000|Overall Study|Adverse Event|11|||
105846099|NCT01642914|365094265|FG001|Overall Study|Adverse Event|7|||
105846100|NCT01642914|365094266|FG002|Overall Study|Adverse Event|15|||
105846101|NCT01642914|365094264|FG000|Overall Study|Lack of Efficacy|9|||
105846102|NCT01642914|365094265|FG001|Overall Study|Lack of Efficacy|4|||
106149719|NCT01388361|366209221|FG001|Overall Study|Protocol Violation|0|||
106149720|NCT01388361|366209222|FG002|Overall Study|Protocol Violation|2|||
106149721|NCT01388361|366209220|FG000|Overall Study|Withdrawal criteria|12|||
105846103|NCT01642914|365094266|FG002|Overall Study|Lack of Efficacy|2|||
105846104|NCT01642914|365094264|FG000|Overall Study|Protocol Violation|15|||
105846105|NCT01642914|365094265|FG001|Overall Study|Protocol Violation|13|||
105846106|NCT01642914|365094266|FG002|Overall Study|Protocol Violation|6|||
105846107|NCT01642914|365094264|FG000|Overall Study|Withdrawal by Subject|5|||
105846108|NCT01642914|365094265|FG001|Overall Study|Withdrawal by Subject|5|||
105846109|NCT01642914|365094266|FG002|Overall Study|Withdrawal by Subject|10|||
105846110|NCT01642914|365094264|FG000|Overall Study|Lost to Follow-up|5|||
105846111|NCT01642914|365094265|FG001|Overall Study|Lost to Follow-up|3|||
105846112|NCT01642914|365094266|FG002|Overall Study|Lost to Follow-up|7|||
105846113|NCT01642914|365094264|FG000|Overall Study|Other Reason|1|||
105846114|NCT01642914|365094265|FG001|Overall Study|Other Reason|0|||
105846115|NCT01642914|365094266|FG002|Overall Study|Other Reason|0|||
105846116|NCT04319159|365094268|FG000|Overall Study|Screening failure|13|||
105846117|NCT04319159|365094268|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
105846118|NCT04319159|365094268|FG000|Overall Study|Withdrawal by Subject|1|||
105846119|NCT02429934|365094273|FG000|Overall Study|Withdrawal by Subject|0|||
105846120|NCT02429934|365094274|FG001|Overall Study|Withdrawal by Subject|2|||
105846121|NCT02429934|365094273|FG000|Overall Study|Adverse Event|2|||
105846122|NCT02429934|365094274|FG001|Overall Study|Adverse Event|0|||
105846123|NCT02429934|365094273|FG000|Overall Study|Lost to Follow-up|1|||
105846124|NCT02429934|365094274|FG001|Overall Study|Lost to Follow-up|1|||
105846125|NCT02429934|365094273|FG000|Overall Study|Physician Decision|1|||
105846126|NCT02429934|365094274|FG001|Overall Study|Physician Decision|0|||
105846127|NCT00869024|365094275|FG000|Overall Study|Death|2|||
105846128|NCT00869024|365094276|FG001|Overall Study|Death|3|||
105846129|NCT00869024|365094275|FG000|Overall Study|Lost to Follow-up|0|||
105846130|NCT00869024|365094276|FG001|Overall Study|Lost to Follow-up|1|||
105846131|NCT00869024|365094275|FG000|Overall Study|Protocol Violation|0|||
105846132|NCT00869024|365094276|FG001|Overall Study|Protocol Violation|1|||
106149722|NCT01388361|366209221|FG001|Overall Study|Withdrawal criteria|7|||
106149723|NCT01388361|366209222|FG002|Overall Study|Withdrawal criteria|10|||
106149724|NCT01388361|366209220|FG000|Overall Study|Unclassified|0|||
106149725|NCT01388361|366209221|FG001|Overall Study|Unclassified|0|||
106149726|NCT01388361|366209222|FG002|Overall Study|Unclassified|1|||
105846133|NCT00293202|365094277|FG000|Overall Study|Withdrawal by Subject|1|||
105846134|NCT00293202|365094278|FG001|Overall Study|Withdrawal by Subject|2|||
105846135|NCT00293202|365094277|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
105846136|NCT00293202|365094278|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
105846137|NCT00293202|365094277|FG000|Overall Study|on-hold due to fistula maturation time|1|||
105846138|NCT00293202|365094278|FG001|Overall Study|on-hold due to fistula maturation time|0|||
105846139|NCT00560937|365094281|FG000|Overall Study|Withdrawal by Subject|0|||
105846140|NCT00560937|365094282|FG001|Overall Study|Withdrawal by Subject|1|||
105846141|NCT00560937|365094281|FG000|Overall Study|Physician Decision|1|||
105846142|NCT00560937|365094282|FG001|Overall Study|Physician Decision|1|||
105846143|NCT01138111|365094285|FG000|Overall Study|Withdrawal by Subject|5|||
105846144|NCT01138111|365094285|FG000|Overall Study|Adverse Event|1|||
105971692|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
105971693|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
105971694|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
105971695|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
105971696|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
105971697|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
105971698|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
105971699|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
105971700|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
105971701|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
105971702|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
105971703|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
105971704|NCT00433160|365556853|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
105846145|NCT01138111|365094285|FG000|Overall Study|Death|1|||
105846146|NCT01138111|365094285|FG000|Overall Study|Lost to Follow-up|2|||
105846147|NCT02377063|365094288|FG000|Overall Study|Non-compliance|5|||
105846148|NCT03456960|365094291|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105846149|NCT03456960|365094292|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105846150|NCT03456960|365094293|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
105846151|NCT03456960|365094294|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
105846152|NCT03456960|365094295|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105846153|NCT03456960|365094296|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
105846154|NCT03456960|365094291|FG000|Period 2 (1 Day)|Adverse Event|1|||
105846155|NCT03456960|365094292|FG001|Period 2 (1 Day)|Adverse Event|0|||
105846156|NCT03456960|365094293|FG002|Period 2 (1 Day)|Adverse Event|0|||
105846157|NCT03456960|365094294|FG003|Period 2 (1 Day)|Adverse Event|1|||
105846158|NCT03456960|365094295|FG004|Period 2 (1 Day)|Adverse Event|0|||
105846159|NCT03456960|365094296|FG005|Period 2 (1 Day)|Adverse Event|0|||
105846160|NCT03828448|365094297|FG000|Overall Study|Sponsor's Discretion|34|||
105846161|NCT02037165|365094300|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
105846162|NCT02037165|365094301|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
105846163|NCT02037165|365094302|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
105846164|NCT02037165|365094303|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
105846165|NCT02037165|365094304|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
105846166|NCT02939014|365094305|FG000|Overall Study|Lost to Follow-up|1|||
105846167|NCT02939014|365094306|FG001|Overall Study|Lost to Follow-up|0|||
105846168|NCT02939014|365094305|FG000|Overall Study|Death|4|||
105846169|NCT02939014|365094306|FG001|Overall Study|Death|3|||
105846170|NCT00456495|365094307|FG000|Overall Study|Physician Decision|2|||
105846171|NCT02192164|365094308|FG000|Overall Study|Other|8|||
105846172|NCT02192164|365094308|FG000|Overall Study|Withdrawal by Subject|1|||
105846173|NCT02192164|365094308|FG000|Overall Study|Physician Decision|4|||
105846174|NCT02192164|365094308|FG000|Overall Study|Did not meet the exclusion criteria|1|||
105846175|NCT01300923|365094309|FG000|Overall Study|Physician Decision|0|||
105846176|NCT01300923|365094310|FG001|Overall Study|Physician Decision|2|||
105846177|NCT01568866|365094311|FG000|Overall Study|Disease Progression|208|||
105846178|NCT01568866|365094312|FG001|Overall Study|Disease Progression|183|||
105846179|NCT01568866|365094311|FG000|Overall Study|Adverse Event|94|||
105846180|NCT01568866|365094312|FG001|Overall Study|Adverse Event|96|||
105846181|NCT01568866|365094311|FG000|Overall Study|Patient Request|55|||
105846182|NCT01568866|365094312|FG001|Overall Study|Patient Request|71|||
105846183|NCT01568866|365094311|FG000|Overall Study|Physician Decision|40|||
105846184|NCT01568866|365094312|FG001|Overall Study|Physician Decision|32|||
105846185|NCT01568866|365094311|FG000|Overall Study|Withdrawal by Subject|19|||
105846186|NCT01568866|365094312|FG001|Overall Study|Withdrawal by Subject|11|||
105846187|NCT01568866|365094311|FG000|Overall Study|Death|10|||
105846188|NCT01568866|365094312|FG001|Overall Study|Death|18|||
105846189|NCT01568866|365094311|FG000|Overall Study|Protocol Non-compliance|2|||
105846190|NCT01568866|365094312|FG001|Overall Study|Protocol Non-compliance|4|||
105846191|NCT01568866|365094311|FG000|Overall Study|Lost to Follow-up|1|||
105846192|NCT01568866|365094312|FG001|Overall Study|Lost to Follow-up|0|||
105846193|NCT01568866|365094311|FG000|Overall Study|Randomized but Not Dosed|9|||
106024782|NCT00653939|365756637|FG000|Overall Study|Other|2|||
105846194|NCT01568866|365094312|FG001|Overall Study|Randomized but Not Dosed|1|||
105846195|NCT03864042|365094313|FG000|DDI Phase|Adverse Event|2|||
105846196|NCT03864042|365094314|FG001|DDI Phase|Adverse Event|0|||
105846197|NCT03864042|365094315|FG002|DDI Phase|Adverse Event|0|||
106024783|NCT00653939|365756638|FG001|Overall Study|Other|6|||
106149727|NCT03750968|366209223|FG000|Overall Study|Adverse Event|2|||
105846198|NCT03864042|365094313|FG000|DDI Phase|Physician Decision|1|||
105846199|NCT03864042|365094314|FG001|DDI Phase|Physician Decision|0|||
105846200|NCT03864042|365094315|FG002|DDI Phase|Physician Decision|0|||
105846201|NCT03864042|365094313|FG000|DDI Phase|Progressive Disease|1|||
105846202|NCT03864042|365094314|FG001|DDI Phase|Progressive Disease|0|||
105846203|NCT03864042|365094315|FG002|DDI Phase|Progressive Disease|0|||
105846204|NCT03864042|365094313|FG000|Post-DDI Phase|Adverse Event|5|||
105846205|NCT03864042|365094314|FG001|Post-DDI Phase|Adverse Event|3|||
105846206|NCT03864042|365094315|FG002|Post-DDI Phase|Adverse Event|2|||
105846207|NCT03864042|365094313|FG000|Post-DDI Phase|Progressive Disease|11|||
105846208|NCT03864042|365094314|FG001|Post-DDI Phase|Progressive Disease|6|||
105846209|NCT03864042|365094315|FG002|Post-DDI Phase|Progressive Disease|13|||
105846210|NCT03864042|365094313|FG000|Post-DDI Phase|Discretion of investigator|1|||
105846211|NCT03864042|365094314|FG001|Post-DDI Phase|Discretion of investigator|1|||
105846212|NCT03864042|365094315|FG002|Post-DDI Phase|Discretion of investigator|0|||
105846213|NCT03864042|365094313|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
105846214|NCT03864042|365094314|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
105846215|NCT03864042|365094315|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
105846216|NCT03864042|365094313|FG000|Post-DDI Phase|Withdrawal of consent|1|||
105846217|NCT03864042|365094314|FG001|Post-DDI Phase|Withdrawal of consent|2|||
105846218|NCT03864042|365094315|FG002|Post-DDI Phase|Withdrawal of consent|0|||
105846219|NCT01244061|365094316|FG000|Overall Study|Death|1|||
105846220|NCT01244061|365094317|FG001|Overall Study|Death|0|||
105846221|NCT01244061|365094316|FG000|Overall Study|Did not meet entrance criteria|1|||
105846222|NCT01244061|365094317|FG001|Overall Study|Did not meet entrance criteria|0|||
105846223|NCT01244061|365094316|FG000|Overall Study|Lack of Efficacy|1|||
105846224|NCT01244061|365094317|FG001|Overall Study|Lack of Efficacy|3|||
105846225|NCT01244061|365094316|FG000|Overall Study|Lost to Follow-up|34|||
105846226|NCT01244061|365094317|FG001|Overall Study|Lost to Follow-up|30|||
105846227|NCT01244061|365094316|FG000|Overall Study|Withdrawal by Subject|29|||
105846228|NCT01244061|365094317|FG001|Overall Study|Withdrawal by Subject|46|||
105846229|NCT01244061|365094316|FG000|Overall Study|Other|8|||
105846230|NCT01244061|365094317|FG001|Overall Study|Other|19|||
105846231|NCT01244061|365094316|FG000|Overall Study|Protocol Violation|1|||
105846232|NCT01244061|365094317|FG001|Overall Study|Protocol Violation|1|||
105846233|NCT01244061|365094316|FG000|Overall Study|Adverse Event|5|||
105846234|NCT01244061|365094317|FG001|Overall Study|Adverse Event|2|||
105846235|NCT01244061|365094316|FG000|Overall Study|Randomized but not treated|2|||
105846236|NCT01244061|365094317|FG001|Overall Study|Randomized but not treated|2|||
105846237|NCT02450526|365094320|FG000|DB Period (Cycle 1)|Adverse Event|0|||
105846238|NCT02450526|365094321|FG001|DB Period (Cycle 1)|Adverse Event|0|||
105846239|NCT02450526|365094322|FG002|DB Period (Cycle 1)|Adverse Event|2|||
105846240|NCT02450526|365094323|FG003|DB Period (Cycle 1)|Adverse Event|0|||
105846241|NCT02450526|365094324|FG004|DB Period (Cycle 1)|Adverse Event|0|||
105846242|NCT02450526|365094320|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
105846243|NCT02450526|365094321|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
105846244|NCT02450526|365094322|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
105846245|NCT02450526|365094323|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
105846246|NCT02450526|365094324|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
105846247|NCT02450526|365094320|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
105846248|NCT02450526|365094321|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
105846249|NCT02450526|365094322|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
105846250|NCT02450526|365094323|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
105846251|NCT02450526|365094324|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
105846252|NCT02450526|365094320|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
105846253|NCT02450526|365094321|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
105846254|NCT02450526|365094322|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
105846255|NCT02450526|365094323|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
105846256|NCT02450526|365094324|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
105846257|NCT02450526|365094320|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
105846258|NCT02450526|365094321|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
105846259|NCT02450526|365094322|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
105846260|NCT02450526|365094323|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
105846261|NCT02450526|365094324|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
105846262|NCT02450526|365094320|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
105846263|NCT02450526|365094321|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
105846264|NCT02450526|365094322|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
105846265|NCT02450526|365094323|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
105846266|NCT02450526|365094324|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
105846267|NCT02450526|365094320|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
106149728|NCT03750968|366209224|FG001|Overall Study|Adverse Event|0|||
106149729|NCT03750968|366209223|FG000|Overall Study|Lost to Follow-up|1|||
106149730|NCT03750968|366209224|FG001|Overall Study|Lost to Follow-up|3|||
106149731|NCT03432858|366209233|FG000|Overall Study|Protocol Violation|2|||
106149732|NCT03432858|366209234|FG001|Overall Study|Protocol Violation|1|||
106149733|NCT03432858|366209235|FG002|Overall Study|Protocol Violation|9|||
105846268|NCT02450526|365094321|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
105846269|NCT02450526|365094322|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
105846270|NCT02450526|365094323|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
105846271|NCT02450526|365094324|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
106149734|NCT03432858|366209233|FG000|Overall Study|Withdrawal by Subject|0|||
106149735|NCT03432858|366209234|FG001|Overall Study|Withdrawal by Subject|1|||
106149736|NCT03432858|366209235|FG002|Overall Study|Withdrawal by Subject|1|||
105846272|NCT02450526|365094320|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
105846273|NCT02450526|365094321|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
105846274|NCT02450526|365094322|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
105846275|NCT02450526|365094323|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
105846276|NCT02450526|365094324|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
105846277|NCT00321737|365094327|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
105846278|NCT00321737|365094328|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
105846279|NCT00321737|365094329|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
105846280|NCT00321737|365094327|FG000|Overall Study|Adverse Event|11|||
105846281|NCT00321737|365094328|FG001|Overall Study|Adverse Event|3|||
105846282|NCT00321737|365094329|FG002|Overall Study|Adverse Event|6|||
105846283|NCT00321737|365094327|FG000|Overall Study|Lost to Follow-up|5|||
105846284|NCT00321737|365094328|FG001|Overall Study|Lost to Follow-up|5|||
105846285|NCT00321737|365094329|FG002|Overall Study|Lost to Follow-up|6|||
105846286|NCT00321737|365094327|FG000|Overall Study|Withdrawal by Subject|19|||
105846287|NCT00321737|365094328|FG001|Overall Study|Withdrawal by Subject|12|||
105846288|NCT00321737|365094329|FG002|Overall Study|Withdrawal by Subject|17|||
105846289|NCT00321737|365094327|FG000|Overall Study|Protocol Violation|0|||
105846290|NCT00321737|365094328|FG001|Overall Study|Protocol Violation|0|||
105846291|NCT00321737|365094329|FG002|Overall Study|Protocol Violation|1|||
105846292|NCT00321737|365094327|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
105846293|NCT00321737|365094328|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
105846294|NCT00321737|365094329|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
105846295|NCT00321737|365094327|FG000|Overall Study|Possible Barrett's Esophagus|2|||
105846296|NCT00321737|365094328|FG001|Overall Study|Possible Barrett's Esophagus|1|||
105846297|NCT00321737|365094329|FG002|Overall Study|Possible Barrett's Esophagus|1|||
105846298|NCT00321737|365094327|FG000|Overall Study|Therapeutic Failure|6|||
105846299|NCT00321737|365094328|FG001|Overall Study|Therapeutic Failure|0|||
105846300|NCT00321737|365094329|FG002|Overall Study|Therapeutic Failure|2|||
105846301|NCT00321737|365094327|FG000|Overall Study|Pregnancy|0|||
105846302|NCT00321737|365094328|FG001|Overall Study|Pregnancy|2|||
105846303|NCT00321737|365094329|FG002|Overall Study|Pregnancy|0|||
105846304|NCT00321737|365094327|FG000|Overall Study|Noncompliance|2|||
105846305|NCT00321737|365094328|FG001|Overall Study|Noncompliance|0|||
105846306|NCT00321737|365094329|FG002|Overall Study|Noncompliance|0|||
105846307|NCT00321737|365094327|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
105846308|NCT00321737|365094328|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
105846309|NCT00321737|365094329|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
105846310|NCT01079832|365094330|FG000|Overall Study|Withdrawal by Subject|1|||
105846311|NCT01232491|365094331|FG000|Overall Study|Adverse Event|13|||
105846312|NCT01232491|365094332|FG001|Overall Study|Adverse Event|8|||
105846313|NCT01232491|365094331|FG000|Overall Study|Lack of Efficacy|1|||
105846314|NCT01232491|365094332|FG001|Overall Study|Lack of Efficacy|5|||
105846315|NCT01232491|365094331|FG000|Overall Study|Protocol Violation|13|||
105846316|NCT01232491|365094332|FG001|Overall Study|Protocol Violation|11|||
105846317|NCT01232491|365094331|FG000|Overall Study|Withdrawal Criteria|12|||
105846318|NCT01232491|365094332|FG001|Overall Study|Withdrawal Criteria|21|||
105846319|NCT01232491|365094331|FG000|Overall Study|Other|21|||
105846320|NCT01232491|365094332|FG001|Overall Study|Other|18|||
105846321|NCT04969861|365094333|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
105846322|NCT04969861|365094334|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
105846323|NCT02932228|365094339|FG000|Overall Study|Death|8|||
105846324|NCT02932228|365094340|FG001|Overall Study|Death|23|||
105846325|NCT02932228|365094339|FG000|Overall Study|not eligible upon chart review|2|||
105846326|NCT02932228|365094340|FG001|Overall Study|not eligible upon chart review|5|||
105846327|NCT04223778|365094341|FG000|Overall Study|Ongoing|322|||
105846328|NCT04223778|365094342|FG001|Overall Study|Ongoing|326|||
106024784|NCT02032238|365756639|FG000|Overall Study|Lost to Follow-up|2|||
106024785|NCT02032238|365756640|FG001|Overall Study|Lost to Follow-up|0|||
105846329|NCT04223778|365094341|FG000|Overall Study|Death|0|||
105846330|NCT04223778|365094342|FG001|Overall Study|Death|1|||
105846331|NCT04223778|365094341|FG000|Overall Study|Lost to Follow-up|1|||
105846332|NCT04223778|365094342|FG001|Overall Study|Lost to Follow-up|5|||
105846333|NCT04223778|365094341|FG000|Overall Study|Physician Decision|3|||
105846334|NCT04223778|365094342|FG001|Overall Study|Physician Decision|1|||
105846335|NCT04223778|365094341|FG000|Overall Study|Withdrawal by Subject|10|||
105846336|NCT04223778|365094342|FG001|Overall Study|Withdrawal by Subject|1|||
105846337|NCT04223778|365094341|FG000|Overall Study|Lack of Efficacy|0|||
105846338|NCT04223778|365094342|FG001|Overall Study|Lack of Efficacy|2|||
105846339|NCT04905290|365096034|FG000|Overall Study|Adverse Event|4|||
105846340|NCT04905290|365096034|FG000|Overall Study|Death|2|||
105846341|NCT04905290|365096034|FG000|Overall Study|Withdrawal by Subject|4|||
105846342|NCT04905290|365096034|FG000|Overall Study|Physician Decision|2|||
105846343|NCT04905290|365096034|FG000|Overall Study|Lost to Follow-up|2|||
105846344|NCT04905290|365096034|FG000|Overall Study|Screen Failure|2|||
105846345|NCT04905290|365096034|FG000|Overall Study|Unsuccessful Procedure|2|||
105846346|NCT00003138|365096035|FG000|Step 1|Reasons off treatment not documented|60|||
105846347|NCT00003138|365096036|FG001|Step 1|Reasons off treatment not documented|57|||
105846348|NCT00003138|365096035|FG000|Step 1|Never started treatment|1|||
105846349|NCT00003138|365096036|FG001|Step 1|Never started treatment|0|||
105846350|NCT00003138|365096035|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
105846351|NCT00003138|365096036|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
105846352|NCT00003138|365096035|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
105846353|NCT00003138|365096036|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
105846354|NCT00003138|365096035|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
105846355|NCT00003138|365096036|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
105846356|NCT00003138|365096035|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
105846357|NCT00003138|365096036|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
105846358|NCT04319718|365096037|FG000|Overall Study|Adverse Event|0|||
105971705|NCT00433160|365556854|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
105971706|NCT00433160|365556853|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
105971707|NCT00433160|365556854|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
105971708|NCT00433160|365556853|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
105971709|NCT00433160|365556854|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
105971710|NCT00433160|365556853|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
105971711|NCT00433160|365556854|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
105971712|NCT00433160|365556853|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
105971713|NCT00433160|365556854|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
105971714|NCT00433160|365556853|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
105971715|NCT00433160|365556854|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
105971716|NCT00433160|365556853|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
105971717|NCT00433160|365556854|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
105971718|NCT00433160|365556853|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
105971719|NCT00433160|365556854|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
105971720|NCT00570037|365556855|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
105971721|NCT00570037|365556856|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
105971722|NCT01571284|365556857|FG000|Overall Study|Participant's decision|84|||
105971723|NCT01571284|365556857|FG000|Overall Study|Lost to Follow-up|3|||
105971724|NCT01571284|365556857|FG000|Overall Study|Enrolled but not treated|2|||
105971725|NCT01571284|365556857|FG000|Overall Study|Other than specified above|80|||
105971726|NCT00075725|365556858|FG000|Overall Study|Adverse Event|6|||
105971727|NCT00075725|365556859|FG001|Overall Study|Adverse Event|6|||
105971728|NCT00075725|365556860|FG002|Overall Study|Adverse Event|20|||
105971729|NCT00075725|365556861|FG003|Overall Study|Adverse Event|8|||
105971730|NCT00075725|365556862|FG004|Overall Study|Adverse Event|4|||
105971731|NCT00075725|365556863|FG005|Overall Study|Adverse Event|38|||
105971732|NCT00075725|365556864|FG006|Overall Study|Adverse Event|3|||
105971733|NCT00075725|365556865|FG007|Overall Study|Adverse Event|51|||
105971734|NCT00075725|365556866|FG008|Overall Study|Adverse Event|15|||
105971735|NCT00075725|365556867|FG009|Overall Study|Adverse Event|4|||
105971736|NCT00075725|365556868|FG010|Overall Study|Adverse Event|2|||
105971737|NCT00075725|365556869|FG011|Overall Study|Adverse Event|2|||
105971738|NCT00075725|365556858|FG000|Overall Study|Death|3|||
105971739|NCT00075725|365556859|FG001|Overall Study|Death|5|||
105971740|NCT00075725|365556860|FG002|Overall Study|Death|10|||
105971741|NCT00075725|365556861|FG003|Overall Study|Death|2|||
105971742|NCT00075725|365556862|FG004|Overall Study|Death|3|||
105971743|NCT00075725|365556863|FG005|Overall Study|Death|25|||
105971744|NCT00075725|365556864|FG006|Overall Study|Death|4|||
105971745|NCT00075725|365556865|FG007|Overall Study|Death|22|||
105971746|NCT00075725|365556866|FG008|Overall Study|Death|14|||
105971747|NCT00075725|365556867|FG009|Overall Study|Death|4|||
105971748|NCT00075725|365556868|FG010|Overall Study|Death|3|||
105971749|NCT00075725|365556869|FG011|Overall Study|Death|0|||
105971750|NCT00075725|365556858|FG000|Overall Study|Lost to Follow-up|1|||
105971751|NCT00075725|365556859|FG001|Overall Study|Lost to Follow-up|1|||
105971752|NCT00075725|365556860|FG002|Overall Study|Lost to Follow-up|4|||
105971753|NCT00075725|365556861|FG003|Overall Study|Lost to Follow-up|1|||
105846359|NCT04319718|365096038|FG001|Overall Study|Adverse Event|2|||
105971754|NCT00075725|365556862|FG004|Overall Study|Lost to Follow-up|0|||
105971755|NCT00075725|365556863|FG005|Overall Study|Lost to Follow-up|13|||
105971756|NCT00075725|365556864|FG006|Overall Study|Lost to Follow-up|2|||
105971757|NCT00075725|365556865|FG007|Overall Study|Lost to Follow-up|4|||
105971758|NCT00075725|365556866|FG008|Overall Study|Lost to Follow-up|1|||
105971759|NCT00075725|365556867|FG009|Overall Study|Lost to Follow-up|0|||
105846360|NCT04319718|365096037|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
105846361|NCT04319718|365096038|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
105846362|NCT03340064|365096039|FG000|First Period|Adverse Event, non-fatal|2|||
105846363|NCT03340064|365096040|FG001|First Period|Adverse Event, non-fatal|0|||
105846364|NCT03340064|365096039|FG000|First Period|Lack of Efficacy|3|||
105846365|NCT03340064|365096040|FG001|First Period|Lack of Efficacy|0|||
105846366|NCT03340064|365096039|FG000|Second Period|Adverse Event, non-fatal|1|||
105846367|NCT03340064|365096040|FG001|Second Period|Adverse Event, non-fatal|1|||
105846368|NCT03340064|365096039|FG000|Second Period|Lack of Efficacy|11|||
105846369|NCT03340064|365096040|FG001|Second Period|Lack of Efficacy|0|||
105846370|NCT03340064|365096039|FG000|Second Period|Physician Decision|3|||
105846371|NCT03340064|365096040|FG001|Second Period|Physician Decision|0|||
105846372|NCT03340064|365096039|FG000|Second Period|Withdrawal by Subject|2|||
105846373|NCT03340064|365096040|FG001|Second Period|Withdrawal by Subject|1|||
105846374|NCT03340064|365096039|FG000|Second Period|Approved Drug Available For Indication|1|||
105846375|NCT03340064|365096040|FG001|Second Period|Approved Drug Available For Indication|0|||
105846376|NCT03340064|365096039|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
105846377|NCT03340064|365096040|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
105846378|NCT01045421|365096041|FG000|Phase 1|Progressive Disease|0|||
105846379|NCT01045421|365096042|FG001|Phase 1|Progressive Disease|0|||
105846380|NCT01045421|365096043|FG002|Phase 1|Progressive Disease|0|||
105846381|NCT01045421|365096044|FG003|Phase 1|Progressive Disease|0|||
105846382|NCT01045421|365096045|FG004|Phase 1|Progressive Disease|1|||
105846383|NCT01045421|365096046|FG005|Phase 1|Progressive Disease|0|||
105846384|NCT01045421|365096047|FG006|Phase 1|Progressive Disease|0|||
105846385|NCT01045421|365096048|FG007|Phase 1|Progressive Disease|0|||
105846386|NCT01045421|365096049|FG008|Phase 1|Progressive Disease|0|||
105846387|NCT01045421|365096050|FG009|Phase 1|Progressive Disease|0|||
105846388|NCT01045421|365096051|FG010|Phase 1|Progressive Disease|0|||
105846389|NCT01045421|365096041|FG000|Phase 1|Withdrawal by Subject|0|||
105846390|NCT01045421|365096042|FG001|Phase 1|Withdrawal by Subject|0|||
105846391|NCT01045421|365096043|FG002|Phase 1|Withdrawal by Subject|0|||
105846392|NCT01045421|365096044|FG003|Phase 1|Withdrawal by Subject|1|||
105846393|NCT01045421|365096045|FG004|Phase 1|Withdrawal by Subject|0|||
105846394|NCT01045421|365096046|FG005|Phase 1|Withdrawal by Subject|0|||
105846395|NCT01045421|365096047|FG006|Phase 1|Withdrawal by Subject|0|||
105846396|NCT01045421|365096048|FG007|Phase 1|Withdrawal by Subject|0|||
105846397|NCT01045421|365096049|FG008|Phase 1|Withdrawal by Subject|0|||
105846398|NCT01045421|365096050|FG009|Phase 1|Withdrawal by Subject|0|||
105846399|NCT01045421|365096051|FG010|Phase 1|Withdrawal by Subject|0|||
105846400|NCT01045421|365096041|FG000|Phase 2|Progressive Disease|0|||
105846401|NCT01045421|365096042|FG001|Phase 2|Progressive Disease|0|||
105846402|NCT01045421|365096043|FG002|Phase 2|Progressive Disease|0|||
105846403|NCT01045421|365096044|FG003|Phase 2|Progressive Disease|0|||
105846404|NCT01045421|365096045|FG004|Phase 2|Progressive Disease|0|||
105846405|NCT01045421|365096046|FG005|Phase 2|Progressive Disease|0|||
105846406|NCT01045421|365096047|FG006|Phase 2|Progressive Disease|0|||
105846407|NCT01045421|365096048|FG007|Phase 2|Progressive Disease|1|||
105846408|NCT01045421|365096049|FG008|Phase 2|Progressive Disease|1|||
105846409|NCT01045421|365096050|FG009|Phase 2|Progressive Disease|1|||
105846410|NCT01045421|365096051|FG010|Phase 2|Progressive Disease|1|||
105846411|NCT01045421|365096041|FG000|Phase 2|Death|0|||
105846412|NCT01045421|365096042|FG001|Phase 2|Death|0|||
105846413|NCT01045421|365096043|FG002|Phase 2|Death|0|||
105846414|NCT01045421|365096044|FG003|Phase 2|Death|0|||
105846415|NCT01045421|365096045|FG004|Phase 2|Death|0|||
105846416|NCT01045421|365096046|FG005|Phase 2|Death|0|||
105846417|NCT01045421|365096047|FG006|Phase 2|Death|0|||
105846418|NCT01045421|365096048|FG007|Phase 2|Death|1|||
105846419|NCT01045421|365096049|FG008|Phase 2|Death|1|||
105846420|NCT01045421|365096050|FG009|Phase 2|Death|2|||
105846421|NCT01045421|365096051|FG010|Phase 2|Death|0|||
105846422|NCT01045421|365096041|FG000|Phase 2|Other|0|||
105846423|NCT01045421|365096042|FG001|Phase 2|Other|0|||
105846424|NCT01045421|365096043|FG002|Phase 2|Other|0|||
105846425|NCT01045421|365096044|FG003|Phase 2|Other|0|||
105971760|NCT00075725|365556868|FG010|Overall Study|Lost to Follow-up|0|||
105971761|NCT00075725|365556869|FG011|Overall Study|Lost to Follow-up|0|||
105846426|NCT01045421|365096045|FG004|Phase 2|Other|0|||
105971762|NCT00075725|365556858|FG000|Overall Study|Physician Decision|2|||
105971763|NCT00075725|365556859|FG001|Overall Study|Physician Decision|6|||
105971764|NCT00075725|365556860|FG002|Overall Study|Physician Decision|5|||
105846427|NCT01045421|365096046|FG005|Phase 2|Other|0|||
105846428|NCT01045421|365096047|FG006|Phase 2|Other|0|||
105846429|NCT01045421|365096048|FG007|Phase 2|Other|3|||
105846430|NCT01045421|365096049|FG008|Phase 2|Other|0|||
105846431|NCT01045421|365096050|FG009|Phase 2|Other|0|||
105846432|NCT01045421|365096051|FG010|Phase 2|Other|1|||
105846433|NCT02091141|365096059|FG000|Overall Study|Death|280|||
105846434|NCT02091141|365096060|FG001|Overall Study|Death|118|||
105846435|NCT02091141|365096061|FG002|Overall Study|Death|46|||
105846436|NCT02091141|365096062|FG003|Overall Study|Death|13|||
105971765|NCT00075725|365556861|FG003|Overall Study|Physician Decision|8|||
105971766|NCT00075725|365556862|FG004|Overall Study|Physician Decision|4|||
105971767|NCT00075725|365556863|FG005|Overall Study|Physician Decision|19|||
105971768|NCT00075725|365556864|FG006|Overall Study|Physician Decision|3|||
105971769|NCT00075725|365556865|FG007|Overall Study|Physician Decision|17|||
105971770|NCT00075725|365556866|FG008|Overall Study|Physician Decision|5|||
105971771|NCT00075725|365556867|FG009|Overall Study|Physician Decision|0|||
105971772|NCT00075725|365556868|FG010|Overall Study|Physician Decision|1|||
105971773|NCT00075725|365556869|FG011|Overall Study|Physician Decision|0|||
105971774|NCT00075725|365556858|FG000|Overall Study|Pregnancy|0|||
105971775|NCT00075725|365556859|FG001|Overall Study|Pregnancy|0|||
105971776|NCT00075725|365556860|FG002|Overall Study|Pregnancy|0|||
105971777|NCT00075725|365556861|FG003|Overall Study|Pregnancy|0|||
105971778|NCT00075725|365556862|FG004|Overall Study|Pregnancy|0|||
105971779|NCT00075725|365556863|FG005|Overall Study|Pregnancy|1|||
105971780|NCT00075725|365556864|FG006|Overall Study|Pregnancy|0|||
105971781|NCT00075725|365556865|FG007|Overall Study|Pregnancy|1|||
105971782|NCT00075725|365556866|FG008|Overall Study|Pregnancy|0|||
105971783|NCT00075725|365556867|FG009|Overall Study|Pregnancy|0|||
105971784|NCT00075725|365556868|FG010|Overall Study|Pregnancy|0|||
105971785|NCT00075725|365556869|FG011|Overall Study|Pregnancy|0|||
105971786|NCT00075725|365556858|FG000|Overall Study|Protocol Violation|1|||
105971787|NCT00075725|365556859|FG001|Overall Study|Protocol Violation|1|||
105971788|NCT00075725|365556860|FG002|Overall Study|Protocol Violation|0|||
105971789|NCT00075725|365556861|FG003|Overall Study|Protocol Violation|3|||
105971790|NCT00075725|365556862|FG004|Overall Study|Protocol Violation|3|||
105971791|NCT00075725|365556863|FG005|Overall Study|Protocol Violation|2|||
105971792|NCT00075725|365556864|FG006|Overall Study|Protocol Violation|1|||
105971793|NCT00075725|365556865|FG007|Overall Study|Protocol Violation|2|||
105971794|NCT00075725|365556866|FG008|Overall Study|Protocol Violation|3|||
105971795|NCT00075725|365556867|FG009|Overall Study|Protocol Violation|0|||
105971796|NCT00075725|365556868|FG010|Overall Study|Protocol Violation|0|||
105971797|NCT00075725|365556869|FG011|Overall Study|Protocol Violation|1|||
105971798|NCT00075725|365556858|FG000|Overall Study|Withdrawal by Subject|12|||
105971799|NCT00075725|365556859|FG001|Overall Study|Withdrawal by Subject|3|||
105971800|NCT00075725|365556860|FG002|Overall Study|Withdrawal by Subject|6|||
105971801|NCT00075725|365556861|FG003|Overall Study|Withdrawal by Subject|10|||
105971802|NCT00075725|365556862|FG004|Overall Study|Withdrawal by Subject|6|||
105971803|NCT00075725|365556863|FG005|Overall Study|Withdrawal by Subject|27|||
105971804|NCT00075725|365556864|FG006|Overall Study|Withdrawal by Subject|7|||
105971805|NCT00075725|365556865|FG007|Overall Study|Withdrawal by Subject|31|||
105971806|NCT00075725|365556866|FG008|Overall Study|Withdrawal by Subject|10|||
105971807|NCT00075725|365556867|FG009|Overall Study|Withdrawal by Subject|2|||
105971808|NCT00075725|365556868|FG010|Overall Study|Withdrawal by Subject|0|||
105971809|NCT00075725|365556869|FG011|Overall Study|Withdrawal by Subject|0|||
105971810|NCT00075725|365556858|FG000|Overall Study|Disease Progression, all other reasons|17|||
105971811|NCT00075725|365556859|FG001|Overall Study|Disease Progression, all other reasons|5|||
105971812|NCT00075725|365556860|FG002|Overall Study|Disease Progression, all other reasons|33|||
105971813|NCT00075725|365556861|FG003|Overall Study|Disease Progression, all other reasons|6|||
105971814|NCT00075725|365556862|FG004|Overall Study|Disease Progression, all other reasons|21|||
105971815|NCT00075725|365556863|FG005|Overall Study|Disease Progression, all other reasons|59|||
105971816|NCT00075725|365556864|FG006|Overall Study|Disease Progression, all other reasons|20|||
105971817|NCT00075725|365556865|FG007|Overall Study|Disease Progression, all other reasons|46|||
105971818|NCT00075725|365556866|FG008|Overall Study|Disease Progression, all other reasons|21|||
105971819|NCT00075725|365556867|FG009|Overall Study|Disease Progression, all other reasons|4|||
105971820|NCT00075725|365556868|FG010|Overall Study|Disease Progression, all other reasons|0|||
105971821|NCT00075725|365556869|FG011|Overall Study|Disease Progression, all other reasons|5|||
105971822|NCT00075725|365556858|FG000|Overall Study|Patient off treatment|0|||
105971823|NCT00075725|365556859|FG001|Overall Study|Patient off treatment|0|||
105971824|NCT00075725|365556860|FG002|Overall Study|Patient off treatment|1|||
105971825|NCT00075725|365556861|FG003|Overall Study|Patient off treatment|2|||
105971826|NCT00075725|365556862|FG004|Overall Study|Patient off treatment|1|||
105846437|NCT02091141|365096063|FG004|Overall Study|Death|31|||
105971827|NCT00075725|365556863|FG005|Overall Study|Patient off treatment|0|||
105971828|NCT00075725|365556864|FG006|Overall Study|Patient off treatment|0|||
105971829|NCT00075725|365556865|FG007|Overall Study|Patient off treatment|2|||
105971830|NCT00075725|365556866|FG008|Overall Study|Patient off treatment|1|||
105971831|NCT00075725|365556867|FG009|Overall Study|Patient off treatment|0|||
105971832|NCT00075725|365556868|FG010|Overall Study|Patient off treatment|0|||
105971833|NCT00075725|365556869|FG011|Overall Study|Patient off treatment|0|||
105971834|NCT00075725|365556858|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
105971835|NCT00075725|365556859|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
105971836|NCT00075725|365556860|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
105971837|NCT00075725|365556861|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
105846438|NCT02091141|365096064|FG005|Overall Study|Death|16|||
105971838|NCT00075725|365556862|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
105971839|NCT00075725|365556863|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
106149737|NCT03432858|366209233|FG000|Overall Study|Procedure canceled/rescheduled|0|||
106149738|NCT03432858|366209234|FG001|Overall Study|Procedure canceled/rescheduled|9|||
106149739|NCT03432858|366209235|FG002|Overall Study|Procedure canceled/rescheduled|6|||
106149740|NCT03432858|366209233|FG000|Overall Study|Required postop mobilization with splinting|0|||
106149741|NCT03432858|366209234|FG001|Overall Study|Required postop mobilization with splinting|0|||
106149742|NCT03432858|366209235|FG002|Overall Study|Required postop mobilization with splinting|1|||
105846439|NCT02091141|365096065|FG006|Overall Study|Death|12|||
105846440|NCT02091141|365096059|FG000|Overall Study|Withdrawal by Subject|21|||
105846441|NCT02091141|365096060|FG001|Overall Study|Withdrawal by Subject|13|||
105846442|NCT02091141|365096061|FG002|Overall Study|Withdrawal by Subject|3|||
105846443|NCT02091141|365096062|FG003|Overall Study|Withdrawal by Subject|2|||
105846444|NCT02091141|365096063|FG004|Overall Study|Withdrawal by Subject|2|||
105846445|NCT02091141|365096064|FG005|Overall Study|Withdrawal by Subject|3|||
105846446|NCT02091141|365096065|FG006|Overall Study|Withdrawal by Subject|0|||
105846447|NCT02091141|365096059|FG000|Overall Study|Lost to Follow-up|21|||
105846448|NCT02091141|365096060|FG001|Overall Study|Lost to Follow-up|5|||
105846449|NCT02091141|365096061|FG002|Overall Study|Lost to Follow-up|1|||
105846450|NCT02091141|365096062|FG003|Overall Study|Lost to Follow-up|0|||
105846451|NCT02091141|365096063|FG004|Overall Study|Lost to Follow-up|1|||
105846452|NCT02091141|365096064|FG005|Overall Study|Lost to Follow-up|2|||
105846453|NCT02091141|365096065|FG006|Overall Study|Lost to Follow-up|0|||
105846454|NCT02091141|365096059|FG000|Overall Study|Reason Not Specified|6|||
105846455|NCT02091141|365096060|FG001|Overall Study|Reason Not Specified|5|||
105846456|NCT02091141|365096061|FG002|Overall Study|Reason Not Specified|2|||
105846457|NCT02091141|365096062|FG003|Overall Study|Reason Not Specified|0|||
105846458|NCT02091141|365096063|FG004|Overall Study|Reason Not Specified|0|||
105846459|NCT02091141|365096064|FG005|Overall Study|Reason Not Specified|0|||
105846460|NCT02091141|365096065|FG006|Overall Study|Reason Not Specified|1|||
105846461|NCT02091141|365096059|FG000|Overall Study|Study Ended by Sponsor|1|||
105846462|NCT02091141|365096060|FG001|Overall Study|Study Ended by Sponsor|9|||
105846463|NCT02091141|365096061|FG002|Overall Study|Study Ended by Sponsor|0|||
105846464|NCT02091141|365096062|FG003|Overall Study|Study Ended by Sponsor|0|||
105846465|NCT02091141|365096063|FG004|Overall Study|Study Ended by Sponsor|0|||
105846466|NCT02091141|365096064|FG005|Overall Study|Study Ended by Sponsor|0|||
105846467|NCT02091141|365096065|FG006|Overall Study|Study Ended by Sponsor|0|||
105846468|NCT02091141|365096059|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846469|NCT02091141|365096060|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
105846470|NCT02091141|365096061|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846471|NCT02091141|365096062|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846472|NCT02091141|365096063|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846473|NCT02091141|365096064|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846474|NCT02091141|365096065|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
105846475|NCT04556552|365096068|FG000|Overall Study|Lost to Follow-up|1|||
105846476|NCT04556552|365096069|FG001|Overall Study|Lost to Follow-up|0|||
105846477|NCT04556552|365096068|FG000|Overall Study|Claustrophobia|0|||
105846478|NCT04556552|365096069|FG001|Overall Study|Claustrophobia|1|||
105846479|NCT04556552|365096068|FG000|Overall Study|Inability to continue|0|||
105846480|NCT04556552|365096069|FG001|Overall Study|Inability to continue|1|||
105846481|NCT03439852|365096070|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
105846482|NCT03439852|365096071|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
105846483|NCT03439852|365096070|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
105846484|NCT03439852|365096071|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
105846485|NCT03439852|365096070|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
105846486|NCT03439852|365096071|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
105846487|NCT01553279|365096072|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
105846488|NCT01553279|365096073|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
105846489|NCT01553279|365096072|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
105846490|NCT01553279|365096073|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
105846491|NCT01553279|365096072|FG000|Interim Period|Withdrawal by Subject|2|||
105846492|NCT01553279|365096073|FG001|Interim Period|Withdrawal by Subject|2|||
105846493|NCT01553279|365096072|FG000|Interim Period|Lost to Follow-up|1|||
105846494|NCT01553279|365096073|FG001|Interim Period|Lost to Follow-up|0|||
106149743|NCT02539225|366209236|FG000|Part A|Adverse Event|13|||
106149744|NCT02539225|366209237|FG001|Part A|Adverse Event|4|||
106149745|NCT02539225|366209236|FG000|Part A|Withdrawal by Subject|2|||
105846495|NCT01553279|365096072|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
105846496|NCT01553279|365096073|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
105846497|NCT01553279|365096072|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
105846498|NCT01553279|365096073|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
106024786|NCT00612105|365756641|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
106149746|NCT02539225|366209237|FG001|Part A|Withdrawal by Subject|4|||
106149747|NCT02539225|366209236|FG000|Part A|Physician Decision|4|||
105846499|NCT01215513|365096074|FG000|Overall Study|Not completed CS42|9|||
105846500|NCT01215513|365096074|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
105846501|NCT01215513|365096074|FG000|Overall Study|Adverse event (CS42A)|2|||
105846502|NCT01215513|365096074|FG000|Overall Study|Physician decision (CS42A)|6|||
105846503|NCT01215513|365096074|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
105846504|NCT01215513|365096074|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
105846505|NCT00605865|365096075|FG000|Overall Study|Protocol Violation|115|||
105846506|NCT03955471|365096076|FG000|Overall Study|Death|22|||
105846507|NCT03955471|365096076|FG000|Overall Study|Lost to Follow-up|1|||
105846508|NCT03955471|365096076|FG000|Overall Study|Withdrawal by Subject|6|||
105846509|NCT03955471|365096076|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
105846510|NCT01884311|365096079|FG000|Overall Study|Withdrawal by Subject|3|||
105846511|NCT01884311|365096079|FG000|Overall Study|withdrew consent due to AEs|1|||
105846512|NCT01884311|365096079|FG000|Overall Study|Precautionary measure|1|||
105846513|NCT02858492|365096085|FG000|Overall Study|Withdrawal by Subject|0|||
105846514|NCT02858492|365096086|FG001|Overall Study|Withdrawal by Subject|1|||
105846515|NCT02858492|365096087|FG002|Overall Study|Withdrawal by Subject|0|||
105846516|NCT02858492|365096088|FG003|Overall Study|Withdrawal by Subject|1|||
105846517|NCT02858492|365096085|FG000|Overall Study|Adverse Event|0|||
105846518|NCT02858492|365096086|FG001|Overall Study|Adverse Event|0|||
105846519|NCT02858492|365096087|FG002|Overall Study|Adverse Event|0|||
105846520|NCT02858492|365096088|FG003|Overall Study|Adverse Event|3|||
105846521|NCT02858492|365096085|FG000|Overall Study|Lack of Efficacy|0|||
105846522|NCT02858492|365096086|FG001|Overall Study|Lack of Efficacy|0|||
105846523|NCT02858492|365096087|FG002|Overall Study|Lack of Efficacy|0|||
105846524|NCT02858492|365096088|FG003|Overall Study|Lack of Efficacy|1|||
105846525|NCT02858492|365096085|FG000|Overall Study|Protocol defined stopping criteria|0|||
105846526|NCT02858492|365096086|FG001|Overall Study|Protocol defined stopping criteria|0|||
105846527|NCT02858492|365096087|FG002|Overall Study|Protocol defined stopping criteria|0|||
105846528|NCT02858492|365096088|FG003|Overall Study|Protocol defined stopping criteria|1|||
105846529|NCT02963441|365096092|FG000|Overall Study|Protocol violation or withdrawn|8|||
105846530|NCT02963441|365096092|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
105846531|NCT02963441|365096092|FG000|Overall Study|IDx-DR insufficient quality|33|||
105846532|NCT02011113|365096093|FG000|Overall Study|Adverse Event|4|||
105846533|NCT02011113|365096093|FG000|Overall Study|Disease Progression (DP)|16|||
105846534|NCT02011113|365096093|FG000|Overall Study|Death|1|||
105846535|NCT02011113|365096093|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
105846536|NCT02011113|365096093|FG000|Overall Study|Investigator's judgement- DP|3|||
105846537|NCT02011113|365096093|FG000|Overall Study|Study terminated by sponsor|11|||
105846538|NCT00616941|365096094|FG000|Overall Study|Progressive Disease|1|||
105846539|NCT00616941|365096095|FG001|Overall Study|Progressive Disease|2|||
105846540|NCT00616941|365096096|FG002|Overall Study|Progressive Disease|1|||
105971840|NCT00075725|365556864|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
105971841|NCT00075725|365556865|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
105971842|NCT00075725|365556866|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
105971843|NCT00075725|365556867|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
106149748|NCT02539225|366209237|FG001|Part A|Physician Decision|7|||
106149749|NCT02539225|366209236|FG000|Part A|Did Not Receive study Drug|1|||
106149750|NCT02539225|366209237|FG001|Part A|Did Not Receive study Drug|1|||
106149751|NCT02539225|366209236|FG000|Pre Treatment for Part B|Progressive disease|1|||
106149752|NCT02539225|366209237|FG001|Pre Treatment for Part B|Progressive disease|1|||
106149753|NCT02539225|366209236|FG000|Pre Treatment for Part B|Adverse Event|1|||
106149754|NCT02539225|366209237|FG001|Pre Treatment for Part B|Adverse Event|1|||
106149755|NCT02539225|366209236|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
106149756|NCT02539225|366209237|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
106149757|NCT02539225|366209236|FG000|Pre Treatment for Part B|Physician Decision|2|||
106149758|NCT02539225|366209237|FG001|Pre Treatment for Part B|Physician Decision|0|||
106149759|NCT02539225|366209236|FG000|Part B|Adverse Event|4|||
106149760|NCT02539225|366209237|FG001|Part B|Adverse Event|4|||
106149761|NCT02539225|366209236|FG000|Part B|Withdrawal by Subject|0|||
106149762|NCT02539225|366209237|FG001|Part B|Withdrawal by Subject|3|||
106149763|NCT02539225|366209236|FG000|Part B|Physician Decision|0|||
106149764|NCT02539225|366209237|FG001|Part B|Physician Decision|9|||
106149765|NCT01044303|366209238|FG000|Overall Study|Lost to Follow-up|2|||
106149766|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
106149767|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
106149768|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
105846541|NCT00616941|365096094|FG000|Overall Study|Adverse Event|0|||
105846542|NCT00616941|365096095|FG001|Overall Study|Adverse Event|1|||
105846543|NCT00616941|365096096|FG002|Overall Study|Adverse Event|1|||
105846544|NCT00616941|365096094|FG000|Overall Study|Subject Non-compliance|0|||
105846545|NCT00616941|365096095|FG001|Overall Study|Subject Non-compliance|0|||
105846546|NCT00616941|365096096|FG002|Overall Study|Subject Non-compliance|1|||
105846547|NCT00616941|365096094|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
105846548|NCT00616941|365096095|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
105846549|NCT00616941|365096096|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
105846550|NCT00616941|365096094|FG000|Overall Study|Vaccination Suspended|0|||
105846551|NCT00616941|365096095|FG001|Overall Study|Vaccination Suspended|0|||
105846552|NCT00616941|365096096|FG002|Overall Study|Vaccination Suspended|3|||
105846553|NCT02372071|365096097|FG000|Overall Study|Protocol Violation|18|||
105846554|NCT04492020|365096098|FG000|Overall Study|Adverse Event|1|||
105846555|NCT04492020|365096099|FG001|Overall Study|Adverse Event|3|||
105971844|NCT00075725|365556868|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
105971845|NCT00075725|365556869|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
105971846|NCT00075725|365556858|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
105971847|NCT00075725|365556859|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
105971848|NCT00075725|365556860|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
105971849|NCT00075725|365556861|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
105971850|NCT00075725|365556862|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
105971851|NCT00075725|365556863|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
105971852|NCT00075725|365556864|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
105846556|NCT04492020|365096098|FG000|Overall Study|Withdrawal by Subject|4|||
105846557|NCT04492020|365096099|FG001|Overall Study|Withdrawal by Subject|3|||
105846558|NCT04492020|365096098|FG000|Overall Study|Lost to Follow-up|4|||
105846559|NCT04492020|365096099|FG001|Overall Study|Lost to Follow-up|3|||
105846560|NCT04492020|365096098|FG000|Overall Study|Protocol Violation|5|||
105846561|NCT04492020|365096099|FG001|Overall Study|Protocol Violation|2|||
105846562|NCT04492020|365096098|FG000|Overall Study|Lack of Qualifying Event|25|||
105846563|NCT04492020|365096099|FG001|Overall Study|Lack of Qualifying Event|27|||
105846564|NCT04492020|365096098|FG000|Overall Study|Non-compliance with Study Drug|2|||
105846565|NCT04492020|365096099|FG001|Overall Study|Non-compliance with Study Drug|1|||
105846566|NCT02575911|365096103|FG000|Overall Study|Lost to Follow-up|1|||
105846567|NCT02408068|365096104|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846568|NCT02408068|365096105|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846569|NCT02408068|365096106|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
105846570|NCT02408068|365096107|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846571|NCT02408068|365096108|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846572|NCT02408068|365096109|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
105846573|NCT00629265|365096110|FG000|Overall Study|Lost to Follow-up|4|||
105846574|NCT00629265|365096111|FG001|Overall Study|Lost to Follow-up|5|||
105846575|NCT00629265|365096110|FG000|Overall Study|Withdrawal by Subject|11|||
105846576|NCT00629265|365096111|FG001|Overall Study|Withdrawal by Subject|8|||
105846577|NCT00629265|365096110|FG000|Overall Study|Death|1|||
105846578|NCT00629265|365096111|FG001|Overall Study|Death|0|||
105846579|NCT00629265|365096110|FG000|Overall Study|Adverse Event|2|||
105846580|NCT00629265|365096111|FG001|Overall Study|Adverse Event|0|||
105846581|NCT00629265|365096110|FG000|Overall Study|HNC Recurrence|4|||
105846582|NCT00629265|365096111|FG001|Overall Study|HNC Recurrence|0|||
105846583|NCT00629265|365096110|FG000|Overall Study|Other CA Requiring Treatment|1|||
105846584|NCT00629265|365096111|FG001|Overall Study|Other CA Requiring Treatment|3|||
105846585|NCT00629265|365096110|FG000|Overall Study|Needed Esophageal Dilation|4|||
105846586|NCT00629265|365096111|FG001|Overall Study|Needed Esophageal Dilation|1|||
105846587|NCT00629265|365096110|FG000|Overall Study|Unrelated Medical Complications|3|||
105846588|NCT00629265|365096111|FG001|Overall Study|Unrelated Medical Complications|1|||
105846589|NCT00629265|365096110|FG000|Overall Study|Unknown Reason|2|||
105846590|NCT00629265|365096111|FG001|Overall Study|Unknown Reason|2|||
105846591|NCT02566993|365096112|FG000|Overall Study|Randomized but not treated|5|||
105846592|NCT02566993|365096113|FG001|Overall Study|Randomized but not treated|16|||
105846593|NCT02566993|365096112|FG000|Overall Study|Progressive disease|213|||
105846594|NCT02566993|365096113|FG001|Overall Study|Progressive disease|152|||
105846595|NCT02566993|365096112|FG000|Overall Study|Withdrawal by Subject|12|||
105846596|NCT02566993|365096113|FG001|Overall Study|Withdrawal by Subject|28|||
105846597|NCT02566993|365096112|FG000|Overall Study|Death|17|||
105846598|NCT02566993|365096113|FG001|Overall Study|Death|23|||
105846599|NCT02566993|365096112|FG000|Overall Study|Physician Decision|10|||
105846600|NCT02566993|365096113|FG001|Overall Study|Physician Decision|17|||
105846601|NCT02566993|365096112|FG000|Overall Study|Study drug-related adverse event|20|||
105846602|NCT02566993|365096113|FG001|Overall Study|Study drug-related adverse event|41|||
105846603|NCT02566993|365096112|FG000|Overall Study|Non study drug-related adverse event|9|||
105971853|NCT00075725|365556865|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
106149769|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
106149770|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
105846604|NCT02566993|365096113|FG001|Overall Study|Non study drug-related adverse event|9|||
105846605|NCT02566993|365096112|FG000|Overall Study|Symptomatic deterioration|9|||
105846606|NCT02566993|365096113|FG001|Overall Study|Symptomatic deterioration|16|||
105971854|NCT00075725|365556866|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
105971855|NCT00075725|365556867|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
105971856|NCT00075725|365556868|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
105846607|NCT02566993|365096112|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
105846608|NCT02566993|365096113|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
105846609|NCT02566993|365096112|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
105846610|NCT02566993|365096113|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
105846611|NCT02566993|365096112|FG000|Overall Study|Screening failure|2|||
105846612|NCT02566993|365096113|FG001|Overall Study|Screening failure|0|||
105846613|NCT02566993|365096112|FG000|Overall Study|Lost to Follow-up|0|||
105846614|NCT02566993|365096113|FG001|Overall Study|Lost to Follow-up|1|||
105846615|NCT02566993|365096112|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
105846616|NCT02566993|365096113|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
105846617|NCT03835325|365096122|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
105846618|NCT03835325|365096122|FG000|Overall Study|Selection failure|1|||
105846619|NCT00857259|365096123|FG000|Overall Study|Protocol Violation|1|||
105846620|NCT00857259|365096124|FG001|Overall Study|Protocol Violation|0|||
105846621|NCT00857259|365096125|FG002|Overall Study|Protocol Violation|1|||
105846622|NCT02701413|365096126|FG000|Overall Study|Withdrawal by Subject|7|||
105846623|NCT02701413|365096127|FG001|Overall Study|Withdrawal by Subject|11|||
105846624|NCT02138136|365096131|FG000|Overall Study|Protocol Violation|4|||
105846625|NCT02138136|365096131|FG000|Overall Study|Physician Decision|7|||
105846626|NCT02138136|365096131|FG000|Overall Study|Lack of Efficacy|35|||
105846627|NCT02138136|365096131|FG000|Overall Study|Pregnancy|2|||
105846628|NCT02138136|365096131|FG000|Overall Study|Adverse Event|18|||
105846629|NCT02138136|365096131|FG000|Overall Study|Withdrawal by Subject|36|||
105846630|NCT02138136|365096131|FG000|Overall Study|Lost to Follow-up|32|||
105846631|NCT02138136|365096131|FG000|Overall Study|Withdrawn by Sponsor|5|||
105846632|NCT01616953|365096132|FG000|Overall Study|Lost to Follow-up|1|||
105846633|NCT01616953|365096133|FG001|Overall Study|Lost to Follow-up|0|||
105846634|NCT01616953|365096132|FG000|Overall Study|lack of bone and soft tissue|1|||
105846635|NCT01616953|365096133|FG001|Overall Study|lack of bone and soft tissue|0|||
105846636|NCT01621191|365096134|FG000|Overall Study|Adverse Event|9|||
105846637|NCT01621191|365096134|FG000|Overall Study|Withdrawal by Subject|8|||
105846638|NCT01621191|365096134|FG000|Overall Study|Lack of Efficacy|6|||
105846639|NCT01621191|365096134|FG000|Overall Study|Lost to Follow-up|1|||
105846640|NCT01621191|365096134|FG000|Overall Study|Site Removed From Study|1|||
105846641|NCT00706381|365096135|FG000|Overall Study|Lost to Follow-up|0|||
105846642|NCT00706381|365096136|FG001|Overall Study|Lost to Follow-up|1|||
105846643|NCT00706381|365096137|FG002|Overall Study|Lost to Follow-up|1|||
105846644|NCT00706381|365096138|FG003|Overall Study|Lost to Follow-up|0|||
105846645|NCT00038649|365096141|FG000|Overall Study|Adverse Event|9|||
105846646|NCT00597116|365096142|FG000|Overall Study|Adverse Event|2|||
105846647|NCT00597116|365096143|FG001|Overall Study|Adverse Event|1|||
105846648|NCT00597116|365096142|FG000|Overall Study|Withdrawal by Subject|0|||
105846649|NCT00597116|365096143|FG001|Overall Study|Withdrawal by Subject|2|||
105846650|NCT00597116|365096142|FG000|Overall Study|Physician Decision|0|||
105846651|NCT00597116|365096143|FG001|Overall Study|Physician Decision|1|||
105846652|NCT00597116|365096142|FG000|Overall Study|Death|0|||
105846653|NCT00597116|365096143|FG001|Overall Study|Death|1|||
105846654|NCT00597116|365096142|FG000|Overall Study|Lost to Follow-up|1|||
105846655|NCT00597116|365096143|FG001|Overall Study|Lost to Follow-up|0|||
105846656|NCT00597116|365096142|FG000|Overall Study|Progressive disease|11|||
105846657|NCT00597116|365096143|FG001|Overall Study|Progressive disease|6|||
105846658|NCT01355159|365096146|FG000|Overall Study|Withdrew consent|39|||
105846659|NCT01355159|365096147|FG001|Overall Study|Withdrew consent|47|||
105846660|NCT01355159|365096146|FG000|Overall Study|No primary outcome data|17|||
105846661|NCT01355159|365096147|FG001|Overall Study|No primary outcome data|11|||
105846662|NCT01355159|365096146|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
105846663|NCT01355159|365096147|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
105846664|NCT01355159|365096146|FG000|Overall Study|Early intrauterine fetal death|6|||
105846665|NCT01355159|365096147|FG001|Overall Study|Early intrauterine fetal death|6|||
105846666|NCT01338987|365096154|FG000|Overall Study|enrolled on new protocol|0|||
105846667|NCT01338987|365096155|FG001|Overall Study|enrolled on new protocol|0|||
105846668|NCT01338987|365096156|FG002|Overall Study|enrolled on new protocol|1|||
105846669|NCT01338987|365096157|FG003|Overall Study|enrolled on new protocol|0|||
105846670|NCT01338987|365096158|FG004|Overall Study|enrolled on new protocol|0|||
105846671|NCT01338987|365096154|FG000|Overall Study|Disease progression on study|2|||
106149771|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
106149772|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
106149773|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
105846672|NCT01338987|365096155|FG001|Overall Study|Disease progression on study|1|||
105846673|NCT01338987|365096156|FG002|Overall Study|Disease progression on study|1|||
105846674|NCT01338987|365096157|FG003|Overall Study|Disease progression on study|0|||
105846675|NCT01338987|365096158|FG004|Overall Study|Disease progression on study|0|||
105846676|NCT01640873|365096159|FG000|Overall Study|Protocol Violation|2|||
105846677|NCT01640873|365096160|FG001|Overall Study|Protocol Violation|1|||
105987459|NCT02814175|365614462|FG002|Part 1|Lost to Follow-up|0|||
105846678|NCT03832738|365096161|FG000|Overall Study|Withdrawal by Subject|6|||
105846679|NCT03832738|365096162|FG001|Overall Study|Withdrawal by Subject|7|||
105846680|NCT03832738|365096163|FG002|Overall Study|Withdrawal by Subject|16|||
105846681|NCT03832738|365096161|FG000|Overall Study|Physician Decision|0|||
105846682|NCT03832738|365096162|FG001|Overall Study|Physician Decision|1|||
105846683|NCT03832738|365096163|FG002|Overall Study|Physician Decision|2|||
105846684|NCT03832738|365096161|FG000|Overall Study|Adverse Event|2|||
105846685|NCT03832738|365096162|FG001|Overall Study|Adverse Event|3|||
105846686|NCT03832738|365096163|FG002|Overall Study|Adverse Event|1|||
105846687|NCT03832738|365096161|FG000|Overall Study|Pregnancy|0|||
105846688|NCT03832738|365096162|FG001|Overall Study|Pregnancy|1|||
105846689|NCT03832738|365096163|FG002|Overall Study|Pregnancy|0|||
105846690|NCT00770692|365096165|FG000|Overall Study|Withdrawal by Subject|7|||
105846691|NCT00770692|365096166|FG001|Overall Study|Withdrawal by Subject|9|||
106149774|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
106149775|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
106149776|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
106149777|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
105846692|NCT00770692|365096167|FG002|Overall Study|Withdrawal by Subject|9|||
105846693|NCT00770692|365096168|FG003|Overall Study|Withdrawal by Subject|6|||
105846694|NCT00770692|365096165|FG000|Overall Study|Adverse Event|3|||
105846695|NCT00770692|365096166|FG001|Overall Study|Adverse Event|0|||
105846696|NCT00770692|365096167|FG002|Overall Study|Adverse Event|4|||
105846697|NCT00770692|365096168|FG003|Overall Study|Adverse Event|4|||
105846698|NCT00770692|365096165|FG000|Overall Study|Investigator judgment|2|||
106149778|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
106149779|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
106149780|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
106149781|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
106149782|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
106149783|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
106149784|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
106149785|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
106149786|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
106149787|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
106149788|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
106149789|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
106149790|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
106149791|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
106149792|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
106149793|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
106149794|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
106149795|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
106149796|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
106149797|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
106149798|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
106149799|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
106149800|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
106149801|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
106149802|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
106149803|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
106149804|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
106149805|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
106149806|NCT02409667|366209245|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
106149807|NCT02409667|366209246|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
106149808|NCT02409667|366209247|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
106149809|NCT02409667|366209248|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
106149810|NCT02409667|366209249|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
106149811|NCT02409667|366209245|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
106149812|NCT02409667|366209246|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
106149813|NCT02409667|366209247|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
106149814|NCT02409667|366209248|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
106149815|NCT02409667|366209249|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
105846699|NCT00770692|365096166|FG001|Overall Study|Investigator judgment|0|||
105846700|NCT00770692|365096167|FG002|Overall Study|Investigator judgment|1|||
105971857|NCT00075725|365556869|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
105971858|NCT00075725|365556858|FG000|Overall Study|Pt non compliant with therapy|2|||
105971859|NCT00075725|365556859|FG001|Overall Study|Pt non compliant with therapy|1|||
105846701|NCT00770692|365096168|FG003|Overall Study|Investigator judgment|1|||
106149816|NCT02409667|366209245|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
106149817|NCT02409667|366209246|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
106149818|NCT02409667|366209247|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
106149819|NCT02409667|366209248|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
106149820|NCT02409667|366209249|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
105846702|NCT02562482|365096169|FG000|Overall Study|Enrolled, but did not receive product|4|||
105846703|NCT02562482|365096170|FG001|Overall Study|Enrolled, but did not receive product|0|||
105846704|NCT02562482|365096169|FG000|Overall Study|Lost to Follow-up|9|||
105846705|NCT02562482|365096170|FG001|Overall Study|Lost to Follow-up|6|||
105846706|NCT02562482|365096169|FG000|Overall Study|Moved from area|2|||
105846707|NCT02562482|365096170|FG001|Overall Study|Moved from area|3|||
105846708|NCT02562482|365096169|FG000|Overall Study|Withdrawal by Subject|5|||
105846709|NCT02562482|365096170|FG001|Overall Study|Withdrawal by Subject|3|||
105846710|NCT02562482|365096169|FG000|Overall Study|Physician Decision|1|||
105846711|NCT02562482|365096170|FG001|Overall Study|Physician Decision|3|||
105846712|NCT02562482|365096169|FG000|Overall Study|Illness/Injury unrelated to product|0|||
105846713|NCT02562482|365096170|FG001|Overall Study|Illness/Injury unrelated to product|1|||
105846714|NCT01230892|365096171|FG000|Overall Study|Withdrawal by Subject|1|||
105846715|NCT01230892|365096172|FG001|Overall Study|Withdrawal by Subject|1|||
105846716|NCT01230892|365096171|FG000|Overall Study|Lost to Follow-up|2|||
105846717|NCT01230892|365096172|FG001|Overall Study|Lost to Follow-up|0|||
105846718|NCT02357342|365096177|FG000|First 6 Months|Death|2|||
105846719|NCT02357342|365096178|FG001|First 6 Months|Death|0|||
105846720|NCT01189500|365096179|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
105846721|NCT01189500|365096179|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
105846722|NCT01000493|365096180|FG000|Overall Study|Adverse Event|3|||
105846723|NCT01000493|365096181|FG001|Overall Study|Adverse Event|6|||
105846724|NCT01000493|365096180|FG000|Overall Study|Lack of Efficacy|1|||
105846725|NCT01000493|365096181|FG001|Overall Study|Lack of Efficacy|1|||
105846726|NCT01000493|365096180|FG000|Overall Study|Protocol Violation|1|||
105846727|NCT01000493|365096181|FG001|Overall Study|Protocol Violation|8|||
105846728|NCT01000493|365096180|FG000|Overall Study|Study closed/terminated|25|||
105846729|NCT01000493|365096181|FG001|Overall Study|Study closed/terminated|23|||
105846730|NCT01000493|365096180|FG000|Overall Study|Lost to Follow-up|5|||
105846731|NCT01000493|365096181|FG001|Overall Study|Lost to Follow-up|9|||
105846732|NCT01000493|365096180|FG000|Overall Study|Physician Decision|1|||
105846733|NCT01000493|365096181|FG001|Overall Study|Physician Decision|1|||
105846734|NCT01000493|365096180|FG000|Overall Study|Withdrawal by Subject|3|||
105846735|NCT01000493|365096181|FG001|Overall Study|Withdrawal by Subject|7|||
105846736|NCT04932941|365096182|FG000|Overall Study|Lost to Follow-up|3|||
105846737|NCT04932941|365096183|FG001|Overall Study|Lost to Follow-up|1|||
105846738|NCT04932941|365096182|FG000|Overall Study|Withdrawal by Subject|7|||
105846739|NCT04932941|365096183|FG001|Overall Study|Withdrawal by Subject|4|||
105846740|NCT04932941|365096182|FG000|Overall Study|Other|4|||
105846741|NCT04932941|365096183|FG001|Overall Study|Other|2|||
105846742|NCT02333487|365096184|FG000|Overall Study|Adverse Event|0|||
105846743|NCT02333487|365096185|FG001|Overall Study|Adverse Event|2|||
105846744|NCT02333487|365096186|FG002|Overall Study|Adverse Event|0|||
105846745|NCT03510182|365096187|FG000|Overall Study|Withdrawal by Subject|2|||
105846746|NCT01558297|365096189|FG000|Overall Study|Withdrawal by Subject|2|||
105846747|NCT01558297|365096190|FG001|Overall Study|Withdrawal by Subject|2|||
105846748|NCT01558297|365096191|FG002|Overall Study|Withdrawal by Subject|1|||
105846749|NCT00375492|365096192|FG000|Overall Study|Adverse Event|4|||
105846750|NCT00375492|365096193|FG001|Overall Study|Adverse Event|5|||
105846751|NCT00375492|365096192|FG000|Overall Study|Entry Criteria Not Met|0|||
105846752|NCT00375492|365096193|FG001|Overall Study|Entry Criteria Not Met|1|||
105846753|NCT00375492|365096192|FG000|Overall Study|Loss of Glucose Control|0|||
106149821|NCT02409667|366209245|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
106149822|NCT02409667|366209246|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
106149823|NCT02409667|366209247|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
106149824|NCT02409667|366209248|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
105846754|NCT00375492|365096193|FG001|Overall Study|Loss of Glucose Control|1|||
105846755|NCT00375492|365096192|FG000|Overall Study|Lost to Follow-up|10|||
105846756|NCT00375492|365096193|FG001|Overall Study|Lost to Follow-up|5|||
105846757|NCT00375492|365096192|FG000|Overall Study|Physician Decision|0|||
105846758|NCT00375492|365096193|FG001|Overall Study|Physician Decision|4|||
106149825|NCT02409667|366209249|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
106149826|NCT02409667|366209245|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
105846759|NCT00375492|365096192|FG000|Overall Study|Protocol Violation|6|||
105846760|NCT00375492|365096193|FG001|Overall Study|Protocol Violation|3|||
105846761|NCT00375492|365096192|FG000|Overall Study|Sponsor Decision|0|||
105846762|NCT00375492|365096193|FG001|Overall Study|Sponsor Decision|1|||
105846763|NCT00375492|365096192|FG000|Overall Study|Withdrawal by Subject|6|||
105846764|NCT00375492|365096193|FG001|Overall Study|Withdrawal by Subject|6|||
105846765|NCT01032018|365097641|FG000|Overall Study|Lost to Follow-up|6|||
105846766|NCT01032018|365097642|FG001|Overall Study|Lost to Follow-up|5|||
105846767|NCT01032018|365097641|FG000|Overall Study|Death|0|||
105846768|NCT01032018|365097642|FG001|Overall Study|Death|1|||
105846769|NCT03247517|365097647|FG000|Overall Study|Adverse Event|0|||
105846770|NCT03247517|365097648|FG001|Overall Study|Adverse Event|4|||
105846771|NCT03247517|365097649|FG002|Overall Study|Adverse Event|2|||
105846772|NCT03247517|365097647|FG000|Overall Study|Lost to Follow-up|2|||
105846773|NCT03247517|365097648|FG001|Overall Study|Lost to Follow-up|6|||
105846774|NCT03247517|365097649|FG002|Overall Study|Lost to Follow-up|4|||
105846775|NCT03247517|365097647|FG000|Overall Study|Consent withdrawn by caregiver|1|||
105846776|NCT03247517|365097648|FG001|Overall Study|Consent withdrawn by caregiver|4|||
105846777|NCT03247517|365097649|FG002|Overall Study|Consent withdrawn by caregiver|7|||
105846778|NCT03247517|365097647|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
105846779|NCT03247517|365097648|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
105846780|NCT03247517|365097649|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
105846781|NCT03247517|365097647|FG000|Overall Study|Protocol Violation|0|||
105846782|NCT03247517|365097648|FG001|Overall Study|Protocol Violation|2|||
105846783|NCT03247517|365097649|FG002|Overall Study|Protocol Violation|0|||
105846784|NCT03247517|365097647|FG000|Overall Study|Multiple reasons|3|||
105846785|NCT03247517|365097648|FG001|Overall Study|Multiple reasons|1|||
105846786|NCT03247517|365097649|FG002|Overall Study|Multiple reasons|0|||
105846787|NCT00619112|365097650|FG000|Overall Study|Adverse Event|1|||
105846788|NCT00619112|365097651|FG001|Overall Study|Adverse Event|2|||
105846789|NCT05855616|365097654|FG000|Overall Study|Lost to Follow-up|1|||
105846790|NCT05855616|365097655|FG001|Overall Study|Lost to Follow-up|2|||
105846791|NCT04032158|365097656|FG000|Overall Study|Study Termination|2|||
105846792|NCT04032158|365097657|FG001|Overall Study|Study Termination|1|||
105846793|NCT00059787|365097658|FG000|Overall Study|Adverse Event|13|||
105846794|NCT00059787|365097658|FG000|Overall Study|disease progression|2|||
105846795|NCT00059787|365097658|FG000|Overall Study|ineligible|1|||
105846796|NCT00059787|365097658|FG000|Overall Study|Other|4|||
105846797|NCT00652028|365097659|FG000|Overall Study|Adverse Event|1|||
105846798|NCT00652028|365097660|FG001|Overall Study|Adverse Event|0|||
105846799|NCT00652028|365097661|FG002|Overall Study|Adverse Event|0|||
105846800|NCT00652028|365097662|FG003|Overall Study|Adverse Event|0|||
105846801|NCT00652028|365097659|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
105846802|NCT00652028|365097660|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
105846803|NCT00652028|365097661|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
105846804|NCT00652028|365097662|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
105846805|NCT00652028|365097659|FG000|Overall Study|Physician Decision|0|||
105846806|NCT00652028|365097660|FG001|Overall Study|Physician Decision|0|||
105846807|NCT00652028|365097661|FG002|Overall Study|Physician Decision|1|||
105846808|NCT00652028|365097662|FG003|Overall Study|Physician Decision|0|||
105846809|NCT02072824|365097663|FG000|Overall Study|Insufficient clinical response|1|||
105846810|NCT02072824|365097664|FG001|Overall Study|Insufficient clinical response|0|||
105846811|NCT02072824|365097665|FG002|Overall Study|Insufficient clinical response|1|||
105846812|NCT02072824|365097663|FG000|Overall Study|No longer willing to participate|1|||
105846813|NCT02072824|365097664|FG001|Overall Study|No longer willing to participate|0|||
105846814|NCT02072824|365097665|FG002|Overall Study|No longer willing to participate|1|||
105846815|NCT02072824|365097663|FG000|Overall Study|Medication error|0|||
105846816|NCT02072824|365097664|FG001|Overall Study|Medication error|1|||
105846817|NCT02072824|365097665|FG002|Overall Study|Medication error|0|||
105846818|NCT02072824|365097663|FG000|Overall Study|Adverse Event|0|||
105846819|NCT02072824|365097664|FG001|Overall Study|Adverse Event|0|||
105846820|NCT02072824|365097665|FG002|Overall Study|Adverse Event|1|||
105846821|NCT00430495|365097666|FG000|Overall Study|Adverse Event|2|||
105846822|NCT00430495|365097667|FG001|Overall Study|Adverse Event|3|||
105846823|NCT00430495|365097668|FG002|Overall Study|Adverse Event|2|||
105846824|NCT00430495|365097669|FG003|Overall Study|Adverse Event|0|||
105846825|NCT00430495|365097666|FG000|Overall Study|Death|0|||
105846826|NCT00430495|365097667|FG001|Overall Study|Death|0|||
105846827|NCT00430495|365097668|FG002|Overall Study|Death|1|||
105846828|NCT00430495|365097669|FG003|Overall Study|Death|0|||
105846829|NCT00430495|365097666|FG000|Overall Study|Lost to Follow-up|0|||
105846830|NCT00430495|365097667|FG001|Overall Study|Lost to Follow-up|1|||
105846831|NCT00430495|365097668|FG002|Overall Study|Lost to Follow-up|4|||
105846832|NCT00430495|365097669|FG003|Overall Study|Lost to Follow-up|0|||
105846833|NCT00430495|365097666|FG000|Overall Study|Protocol Violation|1|||
105846834|NCT00430495|365097667|FG001|Overall Study|Protocol Violation|0|||
105846835|NCT00430495|365097668|FG002|Overall Study|Protocol Violation|1|||
105846836|NCT00430495|365097669|FG003|Overall Study|Protocol Violation|0|||
105846837|NCT00430495|365097666|FG000|Overall Study|Disease Progression|1|||
105846838|NCT00430495|365097667|FG001|Overall Study|Disease Progression|1|||
105846839|NCT00430495|365097668|FG002|Overall Study|Disease Progression|0|||
105846840|NCT00430495|365097669|FG003|Overall Study|Disease Progression|0|||
105846841|NCT00430495|365097666|FG000|Overall Study|Other|8|||
105846842|NCT00430495|365097667|FG001|Overall Study|Other|2|||
105846843|NCT00430495|365097668|FG002|Overall Study|Other|5|||
105846844|NCT00430495|365097669|FG003|Overall Study|Other|4|||
105846845|NCT00430495|365097666|FG000|Overall Study|Randomized but not Treated|2|||
105846846|NCT00430495|365097667|FG001|Overall Study|Randomized but not Treated|0|||
105846847|NCT00430495|365097668|FG002|Overall Study|Randomized but not Treated|0|||
105846848|NCT00430495|365097669|FG003|Overall Study|Randomized but not Treated|0|||
105846849|NCT00912093|365097670|FG000|The Controlled Phase|Death|0|||
105846850|NCT00912093|365097671|FG001|The Controlled Phase|Death|1|||
105846851|NCT00912093|365097672|FG002|The Controlled Phase|Death|0|||
105846852|NCT00912093|365097673|FG003|The Controlled Phase|Death|0|||
105846853|NCT00912093|365097674|FG004|The Controlled Phase|Death|0|||
105846854|NCT00912093|365097670|FG000|The Controlled Phase|Medical Condition|0|||
105846855|NCT00912093|365097671|FG001|The Controlled Phase|Medical Condition|1|||
105846856|NCT00912093|365097672|FG002|The Controlled Phase|Medical Condition|0|||
105846857|NCT00912093|365097673|FG003|The Controlled Phase|Medical Condition|0|||
105846858|NCT00912093|365097674|FG004|The Controlled Phase|Medical Condition|0|||
105846859|NCT00912093|365097670|FG000|The Controlled Phase|Lost to Follow-up|0|||
105846860|NCT00912093|365097671|FG001|The Controlled Phase|Lost to Follow-up|0|||
105846861|NCT00912093|365097672|FG002|The Controlled Phase|Lost to Follow-up|0|||
105846862|NCT00912093|365097673|FG003|The Controlled Phase|Lost to Follow-up|0|||
105846863|NCT00912093|365097674|FG004|The Controlled Phase|Lost to Follow-up|1|||
105846864|NCT01196078|365097675|FG000|Overall Study|Withdrawal by Subject|3|||
105846865|NCT01196078|365097676|FG001|Overall Study|Withdrawal by Subject|5|||
105846866|NCT01196078|365097675|FG000|Overall Study|Adverse Event|4|||
105846867|NCT01196078|365097676|FG001|Overall Study|Adverse Event|4|||
105846868|NCT01196078|365097675|FG000|Overall Study|Protocol Violation|2|||
105846869|NCT01196078|365097676|FG001|Overall Study|Protocol Violation|1|||
105846870|NCT01196078|365097675|FG000|Overall Study|Lack of Efficacy|17|||
105846871|NCT01196078|365097676|FG001|Overall Study|Lack of Efficacy|23|||
105846872|NCT01196078|365097675|FG000|Overall Study|Lost to Follow-up|1|||
105846873|NCT01196078|365097676|FG001|Overall Study|Lost to Follow-up|0|||
105846874|NCT01196078|365097675|FG000|Overall Study|Death|6|||
105846875|NCT01196078|365097676|FG001|Overall Study|Death|4|||
105846876|NCT04132336|365097678|FG000|Overall Study|Investigator Decision|0|||
105846877|NCT04132336|365097679|FG001|Overall Study|Investigator Decision|1|||
105846878|NCT04132336|365097680|FG002|Overall Study|Investigator Decision|0|||
105846879|NCT04132336|365097681|FG003|Overall Study|Investigator Decision|0|||
105846880|NCT04132336|365097682|FG004|Overall Study|Investigator Decision|0|||
105846881|NCT04132336|365097683|FG005|Overall Study|Investigator Decision|0|||
105846882|NCT04132336|365097684|FG006|Overall Study|Investigator Decision|0|||
105846883|NCT02384941|365097691|FG000|Overall Study|Adverse Event|11|||
105846884|NCT02384941|365097692|FG001|Overall Study|Adverse Event|13|||
105846885|NCT02384941|365097693|FG002|Overall Study|Adverse Event|17|||
105846886|NCT02384941|365097691|FG000|Overall Study|Lost to Follow-up|3|||
105846887|NCT02384941|365097692|FG001|Overall Study|Lost to Follow-up|2|||
105846888|NCT02384941|365097693|FG002|Overall Study|Lost to Follow-up|1|||
105846889|NCT02384941|365097691|FG000|Overall Study|Non-Compliance With Study Drug|2|||
105846890|NCT02384941|365097692|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105846891|NCT02384941|365097693|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105846892|NCT02384941|365097691|FG000|Overall Study|Physician Decision|1|||
105846893|NCT02384941|365097692|FG001|Overall Study|Physician Decision|1|||
105846894|NCT02384941|365097693|FG002|Overall Study|Physician Decision|0|||
105846895|NCT02384941|365097691|FG000|Overall Study|Protocol Violation|3|||
105846896|NCT02384941|365097692|FG001|Overall Study|Protocol Violation|0|||
105846897|NCT02384941|365097693|FG002|Overall Study|Protocol Violation|0|||
105846898|NCT02384941|365097691|FG000|Overall Study|Withdrawal by Subject|26|||
105846899|NCT02384941|365097692|FG001|Overall Study|Withdrawal by Subject|19|||
105846900|NCT02384941|365097693|FG002|Overall Study|Withdrawal by Subject|20|||
106149827|NCT02409667|366209246|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
106149828|NCT02409667|366209247|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
106149829|NCT02409667|366209248|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
106149830|NCT02409667|366209249|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
106149831|NCT02409667|366209245|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
105846901|NCT02384941|365097691|FG000|Overall Study|Pregnancy|0|||
105846902|NCT02384941|365097692|FG001|Overall Study|Pregnancy|0|||
105846903|NCT02384941|365097693|FG002|Overall Study|Pregnancy|1|||
105846904|NCT02384941|365097691|FG000|Overall Study|Other than specified above|4|||
105846905|NCT02384941|365097692|FG001|Overall Study|Other than specified above|0|||
105846906|NCT02384941|365097693|FG002|Overall Study|Other than specified above|1|||
105846907|NCT01892657|365097694|FG000|Overall Study|Withdrawal by Subject|6|||
105846908|NCT01892657|365097694|FG000|Overall Study|Protocol Violation|12|||
105846909|NCT00076804|365097697|FG000|Overall Study|Death|9|||
105846910|NCT00076804|365097698|FG001|Overall Study|Death|20|||
105846911|NCT00076804|365097697|FG000|Overall Study|Lost to Follow-up|9|||
105846912|NCT00076804|365097698|FG001|Overall Study|Lost to Follow-up|9|||
105846913|NCT00076804|365097697|FG000|Overall Study|Withdrawal by Subject|10|||
105846914|NCT00076804|365097698|FG001|Overall Study|Withdrawal by Subject|8|||
105846915|NCT00076804|365097697|FG000|Overall Study|Early study Closure|32|||
105846916|NCT00076804|365097698|FG001|Overall Study|Early study Closure|32|||
105846917|NCT01400919|365097699|FG000|Overall Study|Withdrawal by Subject|4|||
105846918|NCT01400919|365097699|FG000|Overall Study|Lost to Follow-up|2|||
105846919|NCT01400919|365097699|FG000|Overall Study|Missed visit|2|||
105846920|NCT01846273|365097714|FG000|Overall Study|Adverse Event|9|||
105846921|NCT01846273|365097715|FG001|Overall Study|Adverse Event|7|||
105846922|NCT01846273|365097716|FG002|Overall Study|Adverse Event|0|||
105846923|NCT01846273|365097714|FG000|Overall Study|Subject withdrew consent|5|||
105846924|NCT01846273|365097715|FG001|Overall Study|Subject withdrew consent|8|||
105846925|NCT01846273|365097716|FG002|Overall Study|Subject withdrew consent|0|||
105846926|NCT01846273|365097714|FG000|Overall Study|Lost to Follow-up|2|||
105846927|NCT01846273|365097715|FG001|Overall Study|Lost to Follow-up|1|||
105846928|NCT01846273|365097716|FG002|Overall Study|Lost to Follow-up|0|||
105846929|NCT01846273|365097714|FG000|Overall Study|Administrative problems|1|||
105846930|NCT01846273|365097715|FG001|Overall Study|Administrative problems|0|||
105846931|NCT01846273|365097716|FG002|Overall Study|Administrative problems|0|||
105846932|NCT01846273|365097714|FG000|Overall Study|Death|2|||
105846933|NCT01846273|365097715|FG001|Overall Study|Death|1|||
105846934|NCT01846273|365097716|FG002|Overall Study|Death|0|||
105846935|NCT01846273|365097714|FG000|Overall Study|Disease Progression|0|||
105846936|NCT01846273|365097715|FG001|Overall Study|Disease Progression|4|||
105846937|NCT01846273|365097716|FG002|Overall Study|Disease Progression|0|||
105846938|NCT01846273|365097714|FG000|Overall Study|Protocol Deviation|2|||
105846939|NCT01846273|365097715|FG001|Overall Study|Protocol Deviation|3|||
105846940|NCT01846273|365097716|FG002|Overall Study|Protocol Deviation|0|||
105846941|NCT01846273|365097714|FG000|Overall Study|Physician Decision|1|||
105846942|NCT01846273|365097715|FG001|Overall Study|Physician Decision|2|||
105846943|NCT01846273|365097716|FG002|Overall Study|Physician Decision|0|||
105846944|NCT00891839|365097717|FG000|Overall Study|Adverse Event|2|||
105846945|NCT00891839|365097717|FG000|Overall Study|Withdrawal by Subject|2|||
105846946|NCT00891839|365097717|FG000|Overall Study|Disease progression|3|||
105846947|NCT00750308|365097718|FG000|First Treatment|Adverse Event|0|||
105846948|NCT00750308|365097719|FG001|First Treatment|Adverse Event|1|||
105846949|NCT00750308|365097720|FG002|First Treatment|Adverse Event|0|||
105846950|NCT00750308|365097721|FG003|First Treatment|Adverse Event|0|||
105846951|NCT00750308|365097722|FG004|First Treatment|Adverse Event|0|||
105846952|NCT00750308|365097723|FG005|First Treatment|Adverse Event|0|||
105846953|NCT00750308|365097724|FG006|First Treatment|Adverse Event|0|||
105846954|NCT00750308|365097725|FG007|First Treatment|Adverse Event|0|||
105846955|NCT00750308|365097726|FG008|First Treatment|Adverse Event|0|||
105846956|NCT00750308|365097727|FG009|First Treatment|Adverse Event|0|||
105846957|NCT00750308|365097728|FG010|First Treatment|Adverse Event|1|||
105846958|NCT00750308|365097729|FG011|First Treatment|Adverse Event|1|||
105846959|NCT00750308|365097718|FG000|First Treatment|Withdrawal by Subject|0|||
105846960|NCT00750308|365097719|FG001|First Treatment|Withdrawal by Subject|0|||
105846961|NCT00750308|365097720|FG002|First Treatment|Withdrawal by Subject|0|||
105846962|NCT00750308|365097721|FG003|First Treatment|Withdrawal by Subject|1|||
105846963|NCT00750308|365097722|FG004|First Treatment|Withdrawal by Subject|0|||
105846964|NCT00750308|365097723|FG005|First Treatment|Withdrawal by Subject|0|||
105846965|NCT00750308|365097724|FG006|First Treatment|Withdrawal by Subject|0|||
105846966|NCT00750308|365097725|FG007|First Treatment|Withdrawal by Subject|1|||
105846967|NCT00750308|365097726|FG008|First Treatment|Withdrawal by Subject|0|||
105846968|NCT00750308|365097727|FG009|First Treatment|Withdrawal by Subject|0|||
105846969|NCT00750308|365097728|FG010|First Treatment|Withdrawal by Subject|0|||
105846970|NCT00750308|365097729|FG011|First Treatment|Withdrawal by Subject|0|||
105846971|NCT00750308|365097718|FG000|Second Treatment|Adverse Event|0|||
105846972|NCT00750308|365097719|FG001|Second Treatment|Adverse Event|0|||
105846973|NCT00750308|365097720|FG002|Second Treatment|Adverse Event|0|||
105846974|NCT00750308|365097721|FG003|Second Treatment|Adverse Event|0|||
105846975|NCT00750308|365097722|FG004|Second Treatment|Adverse Event|0|||
105846976|NCT00750308|365097723|FG005|Second Treatment|Adverse Event|1|||
105846977|NCT00750308|365097724|FG006|Second Treatment|Adverse Event|0|||
105846978|NCT00750308|365097725|FG007|Second Treatment|Adverse Event|0|||
105846979|NCT00750308|365097726|FG008|Second Treatment|Adverse Event|1|||
106024787|NCT00612105|365756642|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
105846980|NCT00750308|365097727|FG009|Second Treatment|Adverse Event|0|||
105846981|NCT00750308|365097728|FG010|Second Treatment|Adverse Event|0|||
105846982|NCT00750308|365097729|FG011|Second Treatment|Adverse Event|0|||
105846983|NCT00750308|365097718|FG000|Second Treatment|Withdrawal by Subject|0|||
105846984|NCT00750308|365097719|FG001|Second Treatment|Withdrawal by Subject|0|||
105846985|NCT00750308|365097720|FG002|Second Treatment|Withdrawal by Subject|0|||
105846986|NCT00750308|365097721|FG003|Second Treatment|Withdrawal by Subject|0|||
105846987|NCT00750308|365097722|FG004|Second Treatment|Withdrawal by Subject|1|||
105846988|NCT00750308|365097723|FG005|Second Treatment|Withdrawal by Subject|0|||
105846989|NCT00750308|365097724|FG006|Second Treatment|Withdrawal by Subject|0|||
105846990|NCT00750308|365097725|FG007|Second Treatment|Withdrawal by Subject|0|||
105846991|NCT00750308|365097726|FG008|Second Treatment|Withdrawal by Subject|0|||
105846992|NCT00750308|365097727|FG009|Second Treatment|Withdrawal by Subject|0|||
105846993|NCT00750308|365097728|FG010|Second Treatment|Withdrawal by Subject|0|||
105846994|NCT00750308|365097729|FG011|Second Treatment|Withdrawal by Subject|0|||
105846995|NCT00750308|365097718|FG000|Third Treatment|Withdrawal by Subject|0|||
105971860|NCT00075725|365556860|FG002|Overall Study|Pt non compliant with therapy|1|||
105971861|NCT00075725|365556861|FG003|Overall Study|Pt non compliant with therapy|0|||
105971862|NCT00075725|365556862|FG004|Overall Study|Pt non compliant with therapy|2|||
105971863|NCT00075725|365556863|FG005|Overall Study|Pt non compliant with therapy|14|||
105971864|NCT00075725|365556864|FG006|Overall Study|Pt non compliant with therapy|2|||
105971865|NCT00075725|365556865|FG007|Overall Study|Pt non compliant with therapy|5|||
105971866|NCT00075725|365556866|FG008|Overall Study|Pt non compliant with therapy|3|||
105971867|NCT00075725|365556867|FG009|Overall Study|Pt non compliant with therapy|0|||
105971868|NCT00075725|365556868|FG010|Overall Study|Pt non compliant with therapy|0|||
105971869|NCT00075725|365556869|FG011|Overall Study|Pt non compliant with therapy|0|||
105971870|NCT00075725|365556858|FG000|Overall Study|Pt age out of range for treatment|0|||
105971871|NCT00075725|365556859|FG001|Overall Study|Pt age out of range for treatment|1|||
105971872|NCT00075725|365556860|FG002|Overall Study|Pt age out of range for treatment|0|||
105846996|NCT00750308|365097719|FG001|Third Treatment|Withdrawal by Subject|1|||
105846997|NCT00750308|365097720|FG002|Third Treatment|Withdrawal by Subject|0|||
105846998|NCT00750308|365097721|FG003|Third Treatment|Withdrawal by Subject|0|||
105846999|NCT00750308|365097722|FG004|Third Treatment|Withdrawal by Subject|0|||
105847000|NCT00750308|365097723|FG005|Third Treatment|Withdrawal by Subject|0|||
105847001|NCT00750308|365097724|FG006|Third Treatment|Withdrawal by Subject|0|||
105847002|NCT00750308|365097725|FG007|Third Treatment|Withdrawal by Subject|0|||
105847003|NCT00750308|365097726|FG008|Third Treatment|Withdrawal by Subject|0|||
105847004|NCT00750308|365097727|FG009|Third Treatment|Withdrawal by Subject|0|||
105847005|NCT00750308|365097728|FG010|Third Treatment|Withdrawal by Subject|0|||
105847006|NCT00750308|365097729|FG011|Third Treatment|Withdrawal by Subject|0|||
105847007|NCT01698775|365097732|FG000|Phase A|Adverse Event|2|||
105847008|NCT01698775|365097733|FG001|Phase A|Adverse Event|1|||
105847009|NCT01698775|365097732|FG000|Phase A|Death|1|||
105847010|NCT01698775|365097733|FG001|Phase A|Death|1|||
105847011|NCT01698775|365097732|FG000|Phase A|Lack of Efficacy|1|||
105847012|NCT01698775|365097733|FG001|Phase A|Lack of Efficacy|0|||
105847013|NCT01698775|365097732|FG000|Phase A|Lost to Follow-up|1|||
105847014|NCT01698775|365097733|FG001|Phase A|Lost to Follow-up|2|||
105847015|NCT01698775|365097732|FG000|Phase A|Protocol Violation|1|||
105847016|NCT01698775|365097733|FG001|Phase A|Protocol Violation|0|||
105847017|NCT01698775|365097732|FG000|Phase A|Withdrawal by Subject|3|||
105847018|NCT01698775|365097733|FG001|Phase A|Withdrawal by Subject|4|||
105847019|NCT01698775|365097732|FG000|Phase A|Kidney [transplant]|0|||
105847020|NCT01698775|365097733|FG001|Phase A|Kidney [transplant]|1|||
105847021|NCT01698775|365097732|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
105847022|NCT01698775|365097733|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
105847023|NCT01698775|365097732|FG000|Phase B|Adverse Event|6|||
105847024|NCT01698775|365097733|FG001|Phase B|Adverse Event|3|||
105847025|NCT01698775|365097732|FG000|Phase B|Death|0|||
105847026|NCT01698775|365097733|FG001|Phase B|Death|1|||
105847027|NCT01698775|365097732|FG000|Phase B|Lack of Efficacy|0|||
105847028|NCT01698775|365097733|FG001|Phase B|Lack of Efficacy|1|||
105847029|NCT01698775|365097732|FG000|Phase B|Lost to Follow-up|0|||
105847030|NCT01698775|365097733|FG001|Phase B|Lost to Follow-up|1|||
105847031|NCT01698775|365097732|FG000|Phase B|Physician Decision|1|||
105847032|NCT01698775|365097733|FG001|Phase B|Physician Decision|1|||
105847033|NCT01698775|365097732|FG000|Phase B|Protocol Violation|1|||
105847034|NCT01698775|365097733|FG001|Phase B|Protocol Violation|1|||
105847035|NCT01698775|365097732|FG000|Phase B|Withdrawal by Subject|6|||
105847036|NCT01698775|365097733|FG001|Phase B|Withdrawal by Subject|2|||
105847037|NCT00359788|365097734|FG000|Overall Study|Adverse Event|11|||
105847038|NCT00359788|365097735|FG001|Overall Study|Adverse Event|10|||
105847039|NCT00359788|365097734|FG000|Overall Study|Lack of Efficacy|1|||
105847040|NCT00359788|365097735|FG001|Overall Study|Lack of Efficacy|2|||
105847041|NCT00359788|365097734|FG000|Overall Study|Lost to Follow-up|3|||
105847042|NCT00359788|365097735|FG001|Overall Study|Lost to Follow-up|2|||
105847043|NCT00359788|365097734|FG000|Overall Study|Withdrawal by Subject|4|||
105847044|NCT00359788|365097735|FG001|Overall Study|Withdrawal by Subject|1|||
105847045|NCT00359788|365097734|FG000|Overall Study|Protocol Violation|4|||
105847046|NCT00359788|365097735|FG001|Overall Study|Protocol Violation|2|||
105847047|NCT00673933|365097738|FG000|Overall Study|Withdrawal by Subject|2|||
105847048|NCT00673933|365097738|FG000|Overall Study|Lost to Follow-up|1|||
105847049|NCT05069155|365097739|FG000|Overall Study|Withdrawal by Subject|1|||
105971873|NCT00075725|365556861|FG003|Overall Study|Pt age out of range for treatment|0|||
105971874|NCT00075725|365556862|FG004|Overall Study|Pt age out of range for treatment|0|||
105971875|NCT00075725|365556863|FG005|Overall Study|Pt age out of range for treatment|1|||
105971876|NCT00075725|365556864|FG006|Overall Study|Pt age out of range for treatment|0|||
105847050|NCT05069155|365097740|FG001|Overall Study|Withdrawal by Subject|3|||
105847051|NCT05816200|365097741|FG000|Overall Study|Lost to Follow-up|2|||
105847052|NCT05816200|365097742|FG001|Overall Study|Lost to Follow-up|1|||
105847053|NCT00712985|365097750|FG000|Overall Study|1 withdrew prior to start of drug|1|||
105847054|NCT00712985|365097750|FG000|Overall Study|1 patient moved out of state|1|||
105847055|NCT00712985|365097750|FG000|Overall Study|Lack of Efficacy|3|||
105847056|NCT03407430|365097753|FG000|Washout|Protocol Violation|1|||
105847057|NCT03407430|365097754|FG001|Washout|Protocol Violation|0|||
105847058|NCT01481324|365097755|FG000|Overall Study|Missing Data|0|||
105847059|NCT01481324|365097756|FG001|Overall Study|Missing Data|2|||
105847060|NCT01481324|365097757|FG002|Overall Study|Missing Data|2|||
105847061|NCT01172821|365097758|FG000|Overall Study|Adverse Event|5|||
105847062|NCT01172821|365097759|FG001|Overall Study|Adverse Event|2|||
105847063|NCT01172821|365097760|FG002|Overall Study|Adverse Event|2|||
105847064|NCT01172821|365097761|FG003|Overall Study|Adverse Event|7|||
105847065|NCT01172821|365097758|FG000|Overall Study|Protocol Violation|0|||
105847066|NCT01172821|365097759|FG001|Overall Study|Protocol Violation|2|||
105847067|NCT01172821|365097760|FG002|Overall Study|Protocol Violation|1|||
105847068|NCT01172821|365097761|FG003|Overall Study|Protocol Violation|2|||
105847069|NCT01172821|365097758|FG000|Overall Study|Lost to Follow-up|4|||
105847070|NCT01172821|365097759|FG001|Overall Study|Lost to Follow-up|1|||
105847071|NCT01172821|365097760|FG002|Overall Study|Lost to Follow-up|2|||
105847072|NCT01172821|365097761|FG003|Overall Study|Lost to Follow-up|2|||
105847073|NCT01172821|365097758|FG000|Overall Study|Withdrawal by Subject|2|||
105847074|NCT01172821|365097759|FG001|Overall Study|Withdrawal by Subject|3|||
105847075|NCT01172821|365097760|FG002|Overall Study|Withdrawal by Subject|3|||
105847076|NCT01172821|365097761|FG003|Overall Study|Withdrawal by Subject|3|||
105847077|NCT01172821|365097758|FG000|Overall Study|Other|3|||
105847078|NCT01172821|365097759|FG001|Overall Study|Other|4|||
105847079|NCT01172821|365097760|FG002|Overall Study|Other|5|||
105847080|NCT01172821|365097761|FG003|Overall Study|Other|3|||
105847081|NCT00123955|365097762|FG000|Overall Study|Adverse Event|1|||
105847082|NCT00123955|365097763|FG001|Overall Study|Adverse Event|0|||
105847083|NCT00123955|365097762|FG000|Overall Study|Withdrawal by Subject|4|||
105847084|NCT00123955|365097763|FG001|Overall Study|Withdrawal by Subject|3|||
105847085|NCT00123955|365097762|FG000|Overall Study|Death|0|||
105847086|NCT00123955|365097763|FG001|Overall Study|Death|1|||
105847087|NCT03334721|365097764|FG000|Overall Study|Withdrawal by Subject|1|||
105847088|NCT03334721|365097765|FG001|Overall Study|Withdrawal by Subject|0|||
105847089|NCT03334721|365097764|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
105847090|NCT03334721|365097765|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
105847091|NCT01769339|365097767|FG000|Overall Study|Lost to Follow-up|42|||
105847092|NCT01769339|365097767|FG000|Overall Study|Adverse Event|1|||
105847093|NCT01195272|365097768|FG000|Overall Study|Adverse Event|1|||
105847094|NCT01195272|365097768|FG000|Overall Study|Lack of Efficacy|3|||
105847095|NCT03907462|365097772|FG000|Overall Study|Physician Decision|1|||
105847096|NCT03907462|365097773|FG001|Overall Study|Physician Decision|3|||
105847097|NCT03907462|365097774|FG002|Overall Study|Physician Decision|1|||
105847098|NCT03907462|365097772|FG000|Overall Study|Withdrawal by Subject|6|||
105847099|NCT03907462|365097773|FG001|Overall Study|Withdrawal by Subject|3|||
105847100|NCT03907462|365097774|FG002|Overall Study|Withdrawal by Subject|3|||
105847101|NCT03907462|365097772|FG000|Overall Study|Pregnancy|4|||
105847102|NCT03907462|365097773|FG001|Overall Study|Pregnancy|2|||
105847103|NCT03907462|365097774|FG002|Overall Study|Pregnancy|6|||
105847104|NCT03907462|365097772|FG000|Overall Study|Lost to Follow-up|16|||
105847105|NCT03907462|365097773|FG001|Overall Study|Lost to Follow-up|18|||
105847106|NCT03907462|365097774|FG002|Overall Study|Lost to Follow-up|22|||
105847107|NCT00290251|365097775|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847108|NCT00290251|365097776|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847109|NCT00290251|365097777|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847110|NCT00290251|365097778|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847111|NCT00290251|365097779|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
105847112|NCT00290251|365097780|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
105847113|NCT00290251|365097775|FG000|Treatment 1 (Months 2-4)|headache|0|||
105847114|NCT00290251|365097776|FG001|Treatment 1 (Months 2-4)|headache|0|||
105971877|NCT00075725|365556865|FG007|Overall Study|Pt age out of range for treatment|1|||
106149832|NCT02409667|366209246|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
106149833|NCT02409667|366209247|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
105847115|NCT00290251|365097777|FG002|Treatment 1 (Months 2-4)|headache|0|||
105847116|NCT00290251|365097778|FG003|Treatment 1 (Months 2-4)|headache|0|||
105847117|NCT00290251|365097779|FG004|Treatment 1 (Months 2-4)|headache|1|||
105847118|NCT00290251|365097780|FG005|Treatment 1 (Months 2-4)|headache|0|||
105847119|NCT00290251|365097775|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847120|NCT00290251|365097776|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847121|NCT00290251|365097777|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847122|NCT00290251|365097778|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
105847123|NCT00290251|365097779|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847124|NCT00290251|365097780|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
105847125|NCT02221037|365098941|FG000|Overall Study|Physician Decision|0|||
105847126|NCT02221037|365098942|FG001|Overall Study|Physician Decision|0|||
105847127|NCT02221037|365098943|FG002|Overall Study|Physician Decision|1|||
105847128|NCT02221037|365098944|FG003|Overall Study|Physician Decision|0|||
105847129|NCT01996332|365098952|FG000|Overall Study|Adverse Event|117|||
105847130|NCT01996332|365098952|FG000|Overall Study|Lack of Efficacy|1245|||
105847131|NCT01996332|365098952|FG000|Overall Study|Death|264|||
105847132|NCT01996332|365098952|FG000|Overall Study|Protocol Violation|9|||
105847133|NCT01996332|365098952|FG000|Overall Study|Withdrawal by Subject|71|||
105847134|NCT01996332|365098952|FG000|Overall Study|Other|20|||
105847135|NCT01996332|365098952|FG000|Overall Study|Clinical Deterioration|28|||
105847136|NCT01996332|365098952|FG000|Overall Study|Physician Decision|17|||
105847137|NCT01996332|365098952|FG000|Overall Study|Lost to Follow-up|34|||
105847138|NCT02113189|365098953|FG000|Overall Study|Lost to follow up|2|||
105847139|NCT02113189|365098954|FG001|Overall Study|Lost to follow up|1|||
105847140|NCT02113189|365098955|FG002|Overall Study|Lost to follow up|3|||
105847141|NCT00292188|365098956|FG000|Single-Blind|Adverse Event|14|||
105847142|NCT00292188|365098957|FG001|Single-Blind|Adverse Event|0|||
105847143|NCT00292188|365098958|FG002|Single-Blind|Adverse Event|0|||
105847144|NCT00292188|365098956|FG000|Single-Blind|Lack of Efficacy|2|||
105847145|NCT00292188|365098957|FG001|Single-Blind|Lack of Efficacy|0|||
105847146|NCT00292188|365098958|FG002|Single-Blind|Lack of Efficacy|0|||
105847147|NCT00292188|365098956|FG000|Single-Blind|Laboratory Abnormality|5|||
105847148|NCT00292188|365098957|FG001|Single-Blind|Laboratory Abnormality|0|||
105847149|NCT00292188|365098958|FG002|Single-Blind|Laboratory Abnormality|0|||
105847150|NCT00292188|365098956|FG000|Single-Blind|Lost to Follow-up|3|||
105847151|NCT00292188|365098957|FG001|Single-Blind|Lost to Follow-up|0|||
105847152|NCT00292188|365098958|FG002|Single-Blind|Lost to Follow-up|0|||
106149834|NCT02409667|366209248|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
106149835|NCT02409667|366209249|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
106149836|NCT02409667|366209245|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
106149837|NCT02409667|366209246|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
106149838|NCT02409667|366209247|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
106149839|NCT02409667|366209248|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
106149840|NCT02409667|366209249|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
106149841|NCT02409667|366209245|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
105847153|NCT00292188|365098956|FG000|Single-Blind|Other|77|||
105847154|NCT00292188|365098957|FG001|Single-Blind|Other|0|||
105847155|NCT00292188|365098958|FG002|Single-Blind|Other|0|||
105847156|NCT00292188|365098956|FG000|Single-Blind|Withdrawal by Subject|12|||
105847157|NCT00292188|365098957|FG001|Single-Blind|Withdrawal by Subject|0|||
105847158|NCT00292188|365098958|FG002|Single-Blind|Withdrawal by Subject|0|||
105847159|NCT00292188|365098956|FG000|Single-Blind|Did not receive treatment|1|||
105847160|NCT00292188|365098957|FG001|Single-Blind|Did not receive treatment|0|||
105847161|NCT00292188|365098958|FG002|Single-Blind|Did not receive treatment|0|||
105847162|NCT00292188|365098956|FG000|Double-Blind|Adverse Event|0|||
105847163|NCT00292188|365098957|FG001|Double-Blind|Adverse Event|25|||
105847164|NCT00292188|365098958|FG002|Double-Blind|Adverse Event|9|||
105847165|NCT00292188|365098956|FG000|Double-Blind|Lack of Efficacy|0|||
105847166|NCT00292188|365098957|FG001|Double-Blind|Lack of Efficacy|2|||
105847167|NCT00292188|365098958|FG002|Double-Blind|Lack of Efficacy|12|||
105847168|NCT00292188|365098956|FG000|Double-Blind|Lost to Follow-up|0|||
105847169|NCT00292188|365098957|FG001|Double-Blind|Lost to Follow-up|1|||
105847170|NCT00292188|365098958|FG002|Double-Blind|Lost to Follow-up|0|||
105847171|NCT00292188|365098956|FG000|Double-Blind|Other|0|||
105847172|NCT00292188|365098957|FG001|Double-Blind|Other|3|||
105847173|NCT00292188|365098958|FG002|Double-Blind|Other|4|||
105847174|NCT00292188|365098956|FG000|Double-Blind|Withdrawal by Subject|0|||
105847175|NCT00292188|365098957|FG001|Double-Blind|Withdrawal by Subject|0|||
105847176|NCT00292188|365098958|FG002|Double-Blind|Withdrawal by Subject|3|||
105847177|NCT00292188|365098956|FG000|Double-Blind|Laboratory Abnormality|0|||
105847178|NCT00292188|365098957|FG001|Double-Blind|Laboratory Abnormality|0|||
105847179|NCT00292188|365098958|FG002|Double-Blind|Laboratory Abnormality|1|||
105847180|NCT03084367|365098959|FG000|Overall Study|Lost to Follow-up|32|||
105847181|NCT03084367|365098959|FG000|Overall Study|Withdrawal by Subject|4|||
105847182|NCT03084367|365098959|FG000|Overall Study|Other|1|||
105847183|NCT00931268|365098962|FG000|Overall Study|Lost to Follow-up|6|||
105847184|NCT02667288|365098963|FG000|Overall Study|Protocol Violation|5|||
105847185|NCT02667288|365098963|FG000|Overall Study|Lost to Follow-up|3|||
105847186|NCT02667288|365098963|FG000|Overall Study|Withdrawal by Subject|5|||
105971878|NCT00075725|365556866|FG008|Overall Study|Pt age out of range for treatment|0|||
105987460|NCT02814175|365614463|FG003|Part 1|Lost to Follow-up|0|||
106149842|NCT02409667|366209246|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
106149843|NCT02409667|366209247|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
105847187|NCT02145026|365098964|FG000|Overall Study|Adverse Event|2|||
105847188|NCT02145026|365098964|FG000|Overall Study|Death|4|||
105847189|NCT02145026|365098964|FG000|Overall Study|Withdrawal by Subject|2|||
105847190|NCT02145026|365098964|FG000|Overall Study|Physician Decision|4|||
105847191|NCT00127036|365098965|FG000|Overall Study|Insufficient Data for Analysis|6|||
105847192|NCT00127036|365098966|FG001|Overall Study|Insufficient Data for Analysis|11|||
105847193|NCT00127036|365098965|FG000|Overall Study|Screen Failure|2|||
105847194|NCT00127036|365098966|FG001|Overall Study|Screen Failure|0|||
105847195|NCT03656874|365098969|FG000|Overall Study|Lost to Follow-up|3|||
105847196|NCT03656874|365098970|FG001|Overall Study|Lost to Follow-up|17|||
105847197|NCT00584844|365098971|FG000|Overall Study|Withdrawal by Subject|59|||
105847198|NCT00584844|365098971|FG000|Overall Study|Screen Failure|20|||
105847199|NCT03001219|365098973|FG000|Proof of Concept|Study Termination by Sponsor|0|||
105847200|NCT03001219|365098974|FG001|Proof of Concept|Study Termination by Sponsor|1|||
105847201|NCT03001219|365098973|FG000|Proof of Concept|Withdrawal by Subject|0|||
105847202|NCT03001219|365098974|FG001|Proof of Concept|Withdrawal by Subject|4|||
105847203|NCT03001219|365098973|FG000|Proof of Concept|Protocol Deviation|0|||
105847204|NCT03001219|365098974|FG001|Proof of Concept|Protocol Deviation|1|||
105847205|NCT03001219|365098973|FG000|Proof of Concept|Adverse Event|1|||
105847206|NCT03001219|365098974|FG001|Proof of Concept|Adverse Event|1|||
105847207|NCT03001219|365098973|FG000|Proof of Concept|Physician Decision|1|||
105847208|NCT03001219|365098974|FG001|Proof of Concept|Physician Decision|0|||
105847209|NCT03001219|365098973|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
105847210|NCT03001219|365098974|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
105847211|NCT03001219|365098973|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
105847212|NCT03001219|365098974|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
105847213|NCT03001219|365098973|FG000|Extension Period Analysis|Physician Decision|0|||
105847214|NCT03001219|365098974|FG001|Extension Period Analysis|Physician Decision|1|||
105847215|NCT03001219|365098973|FG000|Extension Period Analysis|Adverse Event|1|||
105847216|NCT03001219|365098974|FG001|Extension Period Analysis|Adverse Event|1|||
105847217|NCT03001219|365098973|FG000|Extension Period Analysis|Protocol Deviation|0|||
105847218|NCT03001219|365098974|FG001|Extension Period Analysis|Protocol Deviation|1|||
105847219|NCT03001219|365098973|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
105847220|NCT03001219|365098974|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
105847221|NCT02034058|365098977|FG000|Overall Study|Death|3|||
105847222|NCT03254602|365098978|FG000|Overall Study|Lost to Follow-up|4|||
105847223|NCT00468728|365098981|FG000|Treatment|criteria for mITT population|4|||
105847224|NCT00468728|365098982|FG001|Treatment|criteria for mITT population|11|||
105847225|NCT00468728|365098981|FG000|Follow-up|mITT failure|34|||
105847226|NCT00468728|365098982|FG001|Follow-up|mITT failure|31|||
105847227|NCT02963311|365098983|FG000|Overall Study|Withdrawal by Subject|1|||
105847228|NCT02963311|365098983|FG000|Overall Study|Screen Failure|4|||
105847229|NCT05065983|365098984|FG000|Overall Study|Lost to Follow-up|2|||
105847230|NCT01765582|365098985|FG000|Overall Study|Other|3|||
105847231|NCT01765582|365098986|FG001|Overall Study|Other|6|||
105847232|NCT01765582|365098987|FG002|Overall Study|Other|9|||
105847233|NCT01765582|365098985|FG000|Overall Study|Lost to Follow-up|2|||
105847234|NCT01765582|365098986|FG001|Overall Study|Lost to Follow-up|2|||
105847235|NCT01765582|365098987|FG002|Overall Study|Lost to Follow-up|1|||
105847236|NCT01765582|365098985|FG000|Overall Study|Death|31|||
105847237|NCT01765582|365098986|FG001|Overall Study|Death|36|||
105847238|NCT01765582|365098987|FG002|Overall Study|Death|33|||
105847239|NCT01765582|365098985|FG000|Overall Study|Sponsor Decision|46|||
105847240|NCT01765582|365098986|FG001|Overall Study|Sponsor Decision|42|||
105847241|NCT01765582|365098987|FG002|Overall Study|Sponsor Decision|42|||
105847242|NCT01765582|365098985|FG000|Overall Study|Withdrawal of Consent|11|||
105847243|NCT01765582|365098986|FG001|Overall Study|Withdrawal of Consent|6|||
105847244|NCT01765582|365098987|FG002|Overall Study|Withdrawal of Consent|10|||
105847245|NCT01691820|365098988|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
105847246|NCT01691820|365098989|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
105847247|NCT01691820|365098988|FG000|Overall Study|Migrated/moved from study area|7|||
105847248|NCT01691820|365098989|FG001|Overall Study|Migrated/moved from study area|4|||
105847249|NCT01691820|365098988|FG000|Overall Study|Lost to Follow-up|6|||
105847250|NCT01691820|365098989|FG001|Overall Study|Lost to Follow-up|17|||
105847251|NCT01691820|365098988|FG000|Overall Study|Other (unspecified)|4|||
105847252|NCT01691820|365098989|FG001|Overall Study|Other (unspecified)|1|||
105847253|NCT00714493|365099004|FG000|Overall Study|Adverse Event|11|||
105847254|NCT00714493|365099004|FG000|Overall Study|Death|3|||
105847255|NCT00714493|365099004|FG000|Overall Study|Lack of Efficacy|10|||
105847256|NCT00714493|365099004|FG000|Overall Study|Lost to Follow-up|3|||
105847257|NCT00714493|365099004|FG000|Overall Study|Protocol Violation|12|||
105847258|NCT00714493|365099004|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
105847259|NCT00714493|365099004|FG000|Overall Study|OTHER|2|||
105847260|NCT01968694|365099005|FG000|Washout (1 Month)|Lost to Follow-up|0|||
105847261|NCT01968694|365099006|FG001|Washout (1 Month)|Lost to Follow-up|1|||
105847262|NCT00354341|365099009|FG000|Overall Study|Adverse Event|1|||
105847263|NCT00354341|365099010|FG001|Overall Study|Adverse Event|0|||
105847264|NCT00354341|365099009|FG000|Overall Study|Death|0|||
105847265|NCT00354341|365099010|FG001|Overall Study|Death|2|||
105847266|NCT00354341|365099009|FG000|Overall Study|Refused treatment|1|||
105847267|NCT00354341|365099010|FG001|Overall Study|Refused treatment|2|||
105847268|NCT00354341|365099009|FG000|Overall Study|Failure to return|0|||
105847269|NCT00354341|365099010|FG001|Overall Study|Failure to return|1|||
105847270|NCT00354341|365099009|FG000|Overall Study|Other|1|||
105847271|NCT00354341|365099010|FG001|Overall Study|Other|2|||
105847272|NCT02836496|365099011|FG000|Overall Study|Adverse Event|2|||
105847273|NCT02836496|365099012|FG001|Overall Study|Adverse Event|1|||
105847274|NCT02836496|365099011|FG000|Overall Study|Withdrawal by Subject|0|||
105847275|NCT02836496|365099012|FG001|Overall Study|Withdrawal by Subject|1|||
105847276|NCT04295135|365099013|FG000|Overall Study|Withdrawal by Subject|2|||
105847277|NCT04295135|365099014|FG001|Overall Study|Withdrawal by Subject|1|||
105847278|NCT04295135|365099013|FG000|Overall Study|Subject left organization|8|||
105847279|NCT04295135|365099014|FG001|Overall Study|Subject left organization|4|||
105847280|NCT00251719|365099015|FG000|Overall Study|Adverse Event|14|||
105847281|NCT00251719|365099016|FG001|Overall Study|Adverse Event|8|||
105847282|NCT00251719|365099017|FG002|Overall Study|Adverse Event|7|||
105847283|NCT00251719|365099015|FG000|Overall Study|Protocol Violation|1|||
105847284|NCT00251719|365099016|FG001|Overall Study|Protocol Violation|1|||
105847285|NCT00251719|365099017|FG002|Overall Study|Protocol Violation|1|||
105847286|NCT00251719|365099015|FG000|Overall Study|Lost to Follow-up|5|||
105847287|NCT00251719|365099016|FG001|Overall Study|Lost to Follow-up|11|||
105847288|NCT00251719|365099017|FG002|Overall Study|Lost to Follow-up|8|||
105847289|NCT00251719|365099015|FG000|Overall Study|Withdrawal by Subject|14|||
105847290|NCT00251719|365099016|FG001|Overall Study|Withdrawal by Subject|12|||
105847291|NCT00251719|365099017|FG002|Overall Study|Withdrawal by Subject|11|||
105847292|NCT00251719|365099015|FG000|Overall Study|Lack of Efficacy|2|||
105847293|NCT00251719|365099016|FG001|Overall Study|Lack of Efficacy|1|||
105847294|NCT00251719|365099017|FG002|Overall Study|Lack of Efficacy|0|||
105847295|NCT00251719|365099015|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
105847296|NCT00251719|365099016|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
105847297|NCT00251719|365099017|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
105847298|NCT00251719|365099015|FG000|Overall Study|Investigator decision|1|||
105847299|NCT00251719|365099016|FG001|Overall Study|Investigator decision|1|||
105847300|NCT00251719|365099017|FG002|Overall Study|Investigator decision|0|||
105847301|NCT00251719|365099015|FG000|Overall Study|Noncompliance|2|||
105847302|NCT00251719|365099016|FG001|Overall Study|Noncompliance|3|||
105847303|NCT00251719|365099017|FG002|Overall Study|Noncompliance|1|||
105847304|NCT00251719|365099015|FG000|Overall Study|Barrett's esophagus|2|||
105847305|NCT00251719|365099016|FG001|Overall Study|Barrett's esophagus|2|||
105847306|NCT00251719|365099017|FG002|Overall Study|Barrett's esophagus|0|||
105847307|NCT01732874|365099021|FG000|Overall Study|Withdrawal by Subject|5|||
105847308|NCT01732874|365099022|FG001|Overall Study|Withdrawal by Subject|1|||
105847309|NCT01732874|365099021|FG000|Overall Study|Death of Infant|3|||
105847310|NCT01732874|365099022|FG001|Overall Study|Death of Infant|2|||
105847311|NCT02923674|365099023|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
105847312|NCT02923674|365099024|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
105847313|NCT02923674|365099025|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
105847314|NCT02923674|365099023|FG000|Overall Study|Lost to Follow-up|7|||
105847315|NCT02923674|365099024|FG001|Overall Study|Lost to Follow-up|12|||
105847316|NCT02923674|365099025|FG002|Overall Study|Lost to Follow-up|7|||
105847317|NCT02923674|365099023|FG000|Overall Study|Problem with intervention|2|||
105847318|NCT02923674|365099024|FG001|Overall Study|Problem with intervention|2|||
105847319|NCT02923674|365099025|FG002|Overall Study|Problem with intervention|1|||
105847320|NCT02923674|365099023|FG000|Overall Study|Adverse Event|3|||
105847321|NCT02923674|365099024|FG001|Overall Study|Adverse Event|1|||
105847322|NCT02923674|365099025|FG002|Overall Study|Adverse Event|1|||
105847323|NCT02923674|365099023|FG000|Overall Study|Withdrawal by Subject|2|||
105847324|NCT02923674|365099024|FG001|Overall Study|Withdrawal by Subject|2|||
105847325|NCT02923674|365099025|FG002|Overall Study|Withdrawal by Subject|2|||
105847326|NCT03709823|365099028|FG000|Overall Study|Adverse Event|0|||
105847327|NCT03709823|365099029|FG001|Overall Study|Adverse Event|0|||
105847328|NCT03709823|365099030|FG002|Overall Study|Adverse Event|1|||
105847329|NCT03709823|365099031|FG003|Overall Study|Adverse Event|0|||
105847330|NCT03709823|365099032|FG004|Overall Study|Adverse Event|0|||
105847331|NCT03709823|365099033|FG005|Overall Study|Adverse Event|0|||
105847332|NCT03709823|365099028|FG000|Overall Study|Lost to Follow-up|2|||
105847333|NCT03709823|365099029|FG001|Overall Study|Lost to Follow-up|2|||
105847334|NCT03709823|365099030|FG002|Overall Study|Lost to Follow-up|2|||
105847335|NCT03709823|365099031|FG003|Overall Study|Lost to Follow-up|1|||
105847336|NCT03709823|365099032|FG004|Overall Study|Lost to Follow-up|1|||
105847337|NCT03709823|365099033|FG005|Overall Study|Lost to Follow-up|0|||
105847338|NCT03709823|365099028|FG000|Overall Study|Withdrawal by Subject|1|||
105847339|NCT03709823|365099029|FG001|Overall Study|Withdrawal by Subject|3|||
105847340|NCT03709823|365099030|FG002|Overall Study|Withdrawal by Subject|0|||
105847341|NCT03709823|365099031|FG003|Overall Study|Withdrawal by Subject|0|||
105847342|NCT03709823|365099032|FG004|Overall Study|Withdrawal by Subject|0|||
105847343|NCT03709823|365099033|FG005|Overall Study|Withdrawal by Subject|0|||
105847344|NCT03709823|365099028|FG000|Overall Study|Other, Not Specified|0|||
105847345|NCT03709823|365099029|FG001|Overall Study|Other, Not Specified|0|||
105847346|NCT03709823|365099030|FG002|Overall Study|Other, Not Specified|0|||
105847347|NCT03709823|365099031|FG003|Overall Study|Other, Not Specified|1|||
105847348|NCT03709823|365099032|FG004|Overall Study|Other, Not Specified|0|||
105847349|NCT03709823|365099033|FG005|Overall Study|Other, Not Specified|0|||
105847350|NCT01055132|365099036|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
105847351|NCT01055132|365099037|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
105847352|NCT01055132|365099036|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
105847353|NCT01055132|365099037|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
105847354|NCT00557076|365099040|FG000|Overall Study|Unblinding|0|||
105847355|NCT00557076|365099041|FG001|Overall Study|Unblinding|1|||
105847356|NCT00846521|365099043|FG000|Overall Study|Withdrawal by Subject|5|||
105847357|NCT00846521|365099043|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
105847358|NCT00846521|365099043|FG000|Overall Study|Protocol Violation|1|||
105847359|NCT01246011|365099045|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
105847360|NCT01246011|365099046|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
105847361|NCT01246011|365099047|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
105847362|NCT01246011|365099045|FG000|Overall Study|Withdrawal by Subject|0|||
105847363|NCT01246011|365099046|FG001|Overall Study|Withdrawal by Subject|0|||
105847364|NCT01246011|365099047|FG002|Overall Study|Withdrawal by Subject|1|||
105847365|NCT03914950|365099052|FG000|Overall Study|Physician Decision|54|||
105847366|NCT01593696|365099053|FG000|Dose Escalation|Progressive Disease|2|||
105847367|NCT01593696|365099054|FG001|Dose Escalation|Progressive Disease|0|||
105847368|NCT01593696|365099055|FG002|Dose Escalation|Progressive Disease|0|||
105847369|NCT01593696|365099056|FG003|Dose Escalation|Progressive Disease|0|||
105847370|NCT01593696|365099053|FG000|Dose Expansion|Fungal infection|0|||
105847371|NCT01593696|365099054|FG001|Dose Expansion|Fungal infection|0|||
105847372|NCT01593696|365099055|FG002|Dose Expansion|Fungal infection|1|||
105847373|NCT01593696|365099056|FG003|Dose Expansion|Fungal infection|0|||
105847374|NCT01249365|365099066|FG000|Overall Study|Lost to Follow-up|1|||
105847375|NCT03484117|365099070|FG000|Overall Study|Lost to Follow-up|1|||
105847376|NCT03484117|365099071|FG001|Overall Study|Lost to Follow-up|3|||
105847377|NCT03484117|365099070|FG000|Overall Study|Declined participation in exit assess|1|||
105847378|NCT03484117|365099071|FG001|Overall Study|Declined participation in exit assess|1|||
105847379|NCT02712333|365099072|FG000|First Period|Withdrawal by Subject|3|||
105847380|NCT02712333|365099073|FG001|First Period|Withdrawal by Subject|2|||
105847381|NCT03052959|365099074|FG000|Overall Study|Lost to Follow-up|4|||
105847382|NCT03052959|365099075|FG001|Overall Study|Lost to Follow-up|5|||
105847383|NCT04465630|365099076|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
105847384|NCT04465630|365099076|FG000|Overall Study|Screen failure|8|||
105847385|NCT04465630|365099076|FG000|Overall Study|Baseline failure|16|||
105847386|NCT01782482|365099080|FG000|Overall Study|Adverse Event|2|||
105847387|NCT01782482|365099081|FG001|Overall Study|Adverse Event|1|||
105847388|NCT01782482|365099080|FG000|Overall Study|Lost to Follow-up|2|||
105847389|NCT01782482|365099081|FG001|Overall Study|Lost to Follow-up|3|||
105847390|NCT01782482|365099080|FG000|Overall Study|Physician Decision|1|||
105847391|NCT01782482|365099081|FG001|Overall Study|Physician Decision|0|||
105847392|NCT01782482|365099080|FG000|Overall Study|Protocol Violation|1|||
105847393|NCT01782482|365099081|FG001|Overall Study|Protocol Violation|0|||
105847394|NCT01782482|365099080|FG000|Overall Study|Withdrawal by Subject|2|||
105847395|NCT01782482|365099081|FG001|Overall Study|Withdrawal by Subject|3|||
105847396|NCT01782482|365099080|FG000|Overall Study|Randomized in Error|2|||
105847397|NCT01782482|365099081|FG001|Overall Study|Randomized in Error|2|||
105847398|NCT01782482|365099080|FG000|Overall Study|Habitually wearing toric lens OS|0|||
105847399|NCT01782482|365099081|FG001|Overall Study|Habitually wearing toric lens OS|1|||
105847400|NCT01673698|365099083|FG000|Overall Study|Lost to Follow-up|51|||
105847401|NCT01673698|365099084|FG001|Overall Study|Lost to Follow-up|13|||
105847402|NCT01288053|365101021|FG000|Overall Study|Death|1|||
105847403|NCT03188666|365101022|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
105847404|NCT03188666|365101023|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
105847405|NCT03188666|365101024|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
105847406|NCT03188666|365101025|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
106149844|NCT02409667|366209248|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
106149845|NCT02409667|366209249|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
106149846|NCT02318134|366209250|FG000|Overall Study|Withdrawal by Subject|2|||
106149847|NCT02318134|366209251|FG001|Overall Study|Withdrawal by Subject|1|||
106149848|NCT02556138|366209252|FG000|Overall Study|Withdrawal by Subject|1|||
106149849|NCT01255670|366209253|FG000|Overall Study|Adverse Event|10|||
106149850|NCT01255670|366209254|FG001|Overall Study|Adverse Event|10|||
105847407|NCT03188666|365101022|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
105847408|NCT03188666|365101023|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
105847409|NCT03188666|365101024|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
105847410|NCT03188666|365101025|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
105847411|NCT03188666|365101022|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
105847412|NCT03188666|365101023|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
105847413|NCT03188666|365101024|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
105847414|NCT03188666|365101025|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
105847415|NCT03188666|365101022|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
105847416|NCT03188666|365101023|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
105847417|NCT03188666|365101024|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
105847418|NCT03188666|365101025|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
105847419|NCT02068092|365101026|FG000|Overall Study|Physician Decision|2|||
105847420|NCT02068092|365101026|FG000|Overall Study|Adverse Event|2|||
105847421|NCT02068092|365101026|FG000|Overall Study|Lost to Follow-up|4|||
105847422|NCT02068092|365101026|FG000|Overall Study|Withdrawal by Subject|2|||
105847423|NCT04551911|365101027|FG000|Overall Study|Lost to Follow-up|2|||
105847424|NCT04551911|365101028|FG001|Overall Study|Lost to Follow-up|1|||
105847425|NCT04551911|365101027|FG000|Overall Study|Withdrawal by Subject|10|||
105847426|NCT04551911|365101028|FG001|Overall Study|Withdrawal by Subject|10|||
105847427|NCT04551911|365101027|FG000|Overall Study|Did not receive the study drug|3|||
105847428|NCT04551911|365101028|FG001|Overall Study|Did not receive the study drug|4|||
105847429|NCT02307266|365101029|FG000|Overall Study|Adverse Event|3|||
105847430|NCT02307266|365101030|FG001|Overall Study|Adverse Event|1|||
105847431|NCT02307266|365101031|FG002|Overall Study|Adverse Event|5|||
105847432|NCT02307266|365101029|FG000|Overall Study|Withdrawal by Subject|2|||
105847433|NCT02307266|365101030|FG001|Overall Study|Withdrawal by Subject|0|||
105847434|NCT02307266|365101031|FG002|Overall Study|Withdrawal by Subject|1|||
105847435|NCT02307266|365101029|FG000|Overall Study|Lost to Follow-up|3|||
105847436|NCT02307266|365101030|FG001|Overall Study|Lost to Follow-up|0|||
105847437|NCT02307266|365101031|FG002|Overall Study|Lost to Follow-up|0|||
105847438|NCT00062010|365101032|FG000|Overall Study|Ineligible|3|||
105847439|NCT00858143|365101034|FG000|Overall Study|Adverse Event|16|||
105847440|NCT00858143|365101034|FG000|Overall Study|Lack of Efficacy|4|||
105847441|NCT00858143|365101034|FG000|Overall Study|Death|7|||
105847442|NCT00858143|365101034|FG000|Overall Study|Other|23|||
105847443|NCT01995266|365101040|FG000|Overall Study|Death|1|||
105847444|NCT01995266|365101040|FG000|Overall Study|Lack of Efficacy|6|||
105847445|NCT01995266|365101040|FG000|Overall Study|Adverse Event|2|||
105847446|NCT00852969|365101043|FG000|Overall Study|Adverse Event|0|||
105847447|NCT00852969|365101044|FG001|Overall Study|Adverse Event|1|||
105847448|NCT00852969|365101043|FG000|Overall Study|Lost to Follow-up|0|||
105847449|NCT00852969|365101044|FG001|Overall Study|Lost to Follow-up|1|||
105847450|NCT03853148|365101045|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
105847451|NCT03853148|365101046|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
105847452|NCT03853148|365101047|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
105847453|NCT03853148|365101048|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
105847454|NCT00658658|365101052|FG000|Overall Study|Withdrawal by Subject|0|||
105847455|NCT00658658|365101053|FG001|Overall Study|Withdrawal by Subject|1|||
105847456|NCT00658658|365101054|FG002|Overall Study|Withdrawal by Subject|0|||
105847457|NCT00658658|365101055|FG003|Overall Study|Withdrawal by Subject|0|||
105847458|NCT00658658|365101056|FG004|Overall Study|Withdrawal by Subject|0|||
105847459|NCT00658658|365101052|FG000|Overall Study|Death|4|||
105847460|NCT00658658|365101053|FG001|Overall Study|Death|0|||
105847461|NCT00658658|365101054|FG002|Overall Study|Death|0|||
105847462|NCT00658658|365101055|FG003|Overall Study|Death|1|||
105847463|NCT00658658|365101056|FG004|Overall Study|Death|1|||
105847464|NCT00658658|365101052|FG000|Overall Study|Disease Progression|0|||
105847465|NCT00658658|365101053|FG001|Overall Study|Disease Progression|1|||
105847466|NCT00658658|365101054|FG002|Overall Study|Disease Progression|0|||
105847467|NCT00658658|365101055|FG003|Overall Study|Disease Progression|1|||
105847468|NCT00658658|365101056|FG004|Overall Study|Disease Progression|3|||
105847469|NCT00658658|365101052|FG000|Overall Study|Protocol-specified Criteria|1|||
105847470|NCT00658658|365101053|FG001|Overall Study|Protocol-specified Criteria|0|||
105847471|NCT00658658|365101054|FG002|Overall Study|Protocol-specified Criteria|0|||
105847472|NCT00658658|365101055|FG003|Overall Study|Protocol-specified Criteria|0|||
105847473|NCT00658658|365101056|FG004|Overall Study|Protocol-specified Criteria|0|||
105847474|NCT00658658|365101052|FG000|Overall Study|Other|0|||
105847475|NCT00658658|365101053|FG001|Overall Study|Other|0|||
105847476|NCT00658658|365101054|FG002|Overall Study|Other|0|||
105847477|NCT00658658|365101055|FG003|Overall Study|Other|0|||
105847478|NCT00658658|365101056|FG004|Overall Study|Other|1|||
105847479|NCT00678041|365101057|FG000|Overall Study|Physician Decision|5|||
105847480|NCT00678041|365101058|FG001|Overall Study|Physician Decision|5|||
105847481|NCT01732484|365101061|FG000|Overall Study|Death|7|||
105847482|NCT01732484|365101061|FG000|Overall Study|Lost to Follow-up|14|||
105847483|NCT01732484|365101061|FG000|Overall Study|chronical illness|5|||
105847484|NCT02005887|365101062|FG000|Overall Study|Protocol Violation|0|||
105847485|NCT02005887|365101063|FG001|Overall Study|Protocol Violation|2|||
105847486|NCT01550744|365101064|FG000|Open-Label|Lost to Follow-up|7|||
105847487|NCT01550744|365101065|FG001|Open-Label|Lost to Follow-up|0|||
105847488|NCT01550744|365101066|FG002|Open-Label|Lost to Follow-up|0|||
105847489|NCT01550744|365101064|FG000|Open-Label|Withdrawal by Subject|13|||
105847490|NCT01550744|365101065|FG001|Open-Label|Withdrawal by Subject|0|||
105847491|NCT01550744|365101066|FG002|Open-Label|Withdrawal by Subject|0|||
105847492|NCT01550744|365101064|FG000|Open-Label|Adverse Event|11|||
105847493|NCT01550744|365101065|FG001|Open-Label|Adverse Event|0|||
105847494|NCT01550744|365101066|FG002|Open-Label|Adverse Event|0|||
105847495|NCT01550744|365101064|FG000|Open-Label|Lack of Efficacy|4|||
105847496|NCT01550744|365101065|FG001|Open-Label|Lack of Efficacy|0|||
105847497|NCT01550744|365101066|FG002|Open-Label|Lack of Efficacy|0|||
105847498|NCT01550744|365101064|FG000|Open-Label|Protocol Violation|4|||
105847499|NCT01550744|365101065|FG001|Open-Label|Protocol Violation|0|||
105847500|NCT01550744|365101066|FG002|Open-Label|Protocol Violation|0|||
105847501|NCT01550744|365101064|FG000|Open-Label|Not all 3 study drug injections received|2|||
105847502|NCT01550744|365101065|FG001|Open-Label|Not all 3 study drug injections received|0|||
105847503|NCT01550744|365101066|FG002|Open-Label|Not all 3 study drug injections received|0|||
105847504|NCT01550744|365101064|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
105847505|NCT01550744|365101065|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
105847506|NCT01550744|365101066|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
105847507|NCT01550744|365101064|FG000|Open-Label|Other|1|||
105847508|NCT01550744|365101065|FG001|Open-Label|Other|0|||
105847509|NCT01550744|365101066|FG002|Open-Label|Other|0|||
105847510|NCT01550744|365101064|FG000|Double-Blind|Lost to Follow-up|0|||
105847511|NCT01550744|365101065|FG001|Double-Blind|Lost to Follow-up|6|||
105847512|NCT01550744|365101066|FG002|Double-Blind|Lost to Follow-up|12|||
105847513|NCT01550744|365101064|FG000|Double-Blind|Withdrawal by Subject|0|||
105847514|NCT01550744|365101065|FG001|Double-Blind|Withdrawal by Subject|2|||
105847515|NCT01550744|365101066|FG002|Double-Blind|Withdrawal by Subject|15|||
105847516|NCT01550744|365101064|FG000|Double-Blind|Adverse Event|0|||
105847517|NCT01550744|365101065|FG001|Double-Blind|Adverse Event|4|||
105847518|NCT01550744|365101066|FG002|Double-Blind|Adverse Event|15|||
105847519|NCT01550744|365101064|FG000|Double-Blind|Death|0|||
105847520|NCT01550744|365101065|FG001|Double-Blind|Death|1|||
105847521|NCT01550744|365101066|FG002|Double-Blind|Death|0|||
105847522|NCT01550744|365101064|FG000|Double-Blind|Lack of Efficacy|0|||
105847523|NCT01550744|365101065|FG001|Double-Blind|Lack of Efficacy|2|||
105847524|NCT01550744|365101066|FG002|Double-Blind|Lack of Efficacy|8|||
105847525|NCT01550744|365101064|FG000|Double-Blind|Protocol Violation|0|||
105847526|NCT01550744|365101065|FG001|Double-Blind|Protocol Violation|0|||
105847527|NCT01550744|365101066|FG002|Double-Blind|Protocol Violation|4|||
105847528|NCT01550744|365101064|FG000|Double-Blind|Pregnancy|0|||
105847529|NCT01550744|365101065|FG001|Double-Blind|Pregnancy|0|||
105847530|NCT01550744|365101066|FG002|Double-Blind|Pregnancy|3|||
105847531|NCT01550744|365101064|FG000|Double-Blind|Other|0|||
105847532|NCT01550744|365101065|FG001|Double-Blind|Other|2|||
105847533|NCT01550744|365101066|FG002|Double-Blind|Other|10|||
105847534|NCT01359644|365101069|FG000|Treatment Period|Lack of Efficacy|0|||
105847535|NCT01359644|365101070|FG001|Treatment Period|Lack of Efficacy|1|||
105847536|NCT01359644|365101071|FG002|Treatment Period|Lack of Efficacy|0|||
105847537|NCT01359644|365101072|FG003|Treatment Period|Lack of Efficacy|0|||
105847538|NCT01359644|365101073|FG004|Treatment Period|Lack of Efficacy|0|||
105847539|NCT01359644|365101074|FG005|Treatment Period|Lack of Efficacy|0|||
105847540|NCT01359644|365101075|FG006|Treatment Period|Lack of Efficacy|0|||
105847541|NCT01359644|365101076|FG007|Treatment Period|Lack of Efficacy|0|||
105847542|NCT01359644|365101077|FG008|Treatment Period|Lack of Efficacy|0|||
105847543|NCT01359644|365101078|FG009|Treatment Period|Lack of Efficacy|0|||
105847544|NCT01359644|365101069|FG000|Treatment Period|Adverse Event|0|||
105847545|NCT01359644|365101070|FG001|Treatment Period|Adverse Event|0|||
105847546|NCT01359644|365101071|FG002|Treatment Period|Adverse Event|1|||
105847547|NCT01359644|365101072|FG003|Treatment Period|Adverse Event|0|||
105847548|NCT01359644|365101073|FG004|Treatment Period|Adverse Event|0|||
105847549|NCT01359644|365101074|FG005|Treatment Period|Adverse Event|1|||
105847550|NCT01359644|365101075|FG006|Treatment Period|Adverse Event|0|||
105847551|NCT01359644|365101076|FG007|Treatment Period|Adverse Event|0|||
105847552|NCT01359644|365101077|FG008|Treatment Period|Adverse Event|0|||
105847553|NCT01359644|365101078|FG009|Treatment Period|Adverse Event|0|||
105847554|NCT01359644|365101069|FG000|Treatment Period|Lost to Follow-up|0|||
105847555|NCT01359644|365101070|FG001|Treatment Period|Lost to Follow-up|0|||
105847556|NCT01359644|365101071|FG002|Treatment Period|Lost to Follow-up|0|||
105847557|NCT01359644|365101072|FG003|Treatment Period|Lost to Follow-up|0|||
105847558|NCT01359644|365101073|FG004|Treatment Period|Lost to Follow-up|0|||
105847559|NCT01359644|365101074|FG005|Treatment Period|Lost to Follow-up|1|||
105847560|NCT01359644|365101075|FG006|Treatment Period|Lost to Follow-up|0|||
105847561|NCT01359644|365101076|FG007|Treatment Period|Lost to Follow-up|0|||
105847562|NCT01359644|365101077|FG008|Treatment Period|Lost to Follow-up|0|||
105847563|NCT01359644|365101078|FG009|Treatment Period|Lost to Follow-up|0|||
105847564|NCT01359644|365101069|FG000|Follow-up Period|Withdrawal by Subject|0|||
105847565|NCT01359644|365101070|FG001|Follow-up Period|Withdrawal by Subject|0|||
105847566|NCT01359644|365101071|FG002|Follow-up Period|Withdrawal by Subject|0|||
105847567|NCT01359644|365101072|FG003|Follow-up Period|Withdrawal by Subject|0|||
105847568|NCT01359644|365101073|FG004|Follow-up Period|Withdrawal by Subject|0|||
105847569|NCT01359644|365101074|FG005|Follow-up Period|Withdrawal by Subject|1|||
105847570|NCT01359644|365101075|FG006|Follow-up Period|Withdrawal by Subject|0|||
105847571|NCT01359644|365101076|FG007|Follow-up Period|Withdrawal by Subject|0|||
105847572|NCT01359644|365101077|FG008|Follow-up Period|Withdrawal by Subject|0|||
105847573|NCT01359644|365101078|FG009|Follow-up Period|Withdrawal by Subject|0|||
105847574|NCT01359644|365101069|FG000|Follow-up Period|Lost to Follow-up|0|||
105847575|NCT01359644|365101070|FG001|Follow-up Period|Lost to Follow-up|0|||
105971879|NCT00075725|365556867|FG009|Overall Study|Pt age out of range for treatment|0|||
105971880|NCT00075725|365556868|FG010|Overall Study|Pt age out of range for treatment|0|||
105971881|NCT00075725|365556869|FG011|Overall Study|Pt age out of range for treatment|0|||
105971882|NCT00075725|365556858|FG000|Overall Study|Insurance issues|0|||
105971883|NCT00075725|365556859|FG001|Overall Study|Insurance issues|1|||
105971884|NCT00075725|365556860|FG002|Overall Study|Insurance issues|0|||
105971885|NCT00075725|365556861|FG003|Overall Study|Insurance issues|1|||
105971886|NCT00075725|365556862|FG004|Overall Study|Insurance issues|1|||
105971887|NCT00075725|365556863|FG005|Overall Study|Insurance issues|1|||
105971888|NCT00075725|365556864|FG006|Overall Study|Insurance issues|0|||
105971889|NCT00075725|365556865|FG007|Overall Study|Insurance issues|1|||
105971890|NCT00075725|365556866|FG008|Overall Study|Insurance issues|0|||
105971891|NCT00075725|365556867|FG009|Overall Study|Insurance issues|0|||
105971892|NCT00075725|365556868|FG010|Overall Study|Insurance issues|0|||
105971893|NCT00075725|365556869|FG011|Overall Study|Insurance issues|0|||
105971894|NCT00075725|365556858|FG000|Overall Study|MRD positive after extended ind|0|||
105971895|NCT00075725|365556859|FG001|Overall Study|MRD positive after extended ind|1|||
105971896|NCT00075725|365556860|FG002|Overall Study|MRD positive after extended ind|1|||
105971897|NCT00075725|365556861|FG003|Overall Study|MRD positive after extended ind|0|||
105847576|NCT01359644|365101071|FG002|Follow-up Period|Lost to Follow-up|0|||
105847577|NCT01359644|365101072|FG003|Follow-up Period|Lost to Follow-up|0|||
105847578|NCT01359644|365101073|FG004|Follow-up Period|Lost to Follow-up|0|||
105847579|NCT01359644|365101074|FG005|Follow-up Period|Lost to Follow-up|0|||
105847580|NCT01359644|365101075|FG006|Follow-up Period|Lost to Follow-up|1|||
105847581|NCT01359644|365101076|FG007|Follow-up Period|Lost to Follow-up|2|||
105847582|NCT01359644|365101077|FG008|Follow-up Period|Lost to Follow-up|0|||
105847583|NCT01359644|365101078|FG009|Follow-up Period|Lost to Follow-up|0|||
105847584|NCT02685202|365101079|FG000|Overall Study|Lost to Follow-up|9|||
105847585|NCT00160641|365101083|FG000|Overall Study|Adverse Event|102|||
105847586|NCT00160641|365101083|FG000|Overall Study|Withdrawal by Subject|87|||
105847587|NCT00160641|365101083|FG000|Overall Study|Lost to Follow-up|8|||
105847588|NCT00160641|365101083|FG000|Overall Study|Lack of Efficacy|12|||
105847589|NCT00160641|365101083|FG000|Overall Study|Protocol Violation|3|||
105847590|NCT00160641|365101083|FG000|Overall Study|Other|9|||
105847591|NCT00669071|365101086|FG000|Overall Study|Lost to Follow-up|3|||
105847592|NCT00669071|365101086|FG000|Overall Study|Final visit 40 days out of window|1|||
105847593|NCT00995085|365101087|FG000|Overall Study|Withdrawal by Subject|5|||
105847594|NCT00985712|365101088|FG000|Overall Study|Adverse Event|0|||
105847595|NCT00985712|365101089|FG001|Overall Study|Adverse Event|1|||
105847596|NCT00985712|365101088|FG000|Overall Study|Lost to Follow-up|2|||
105847597|NCT00985712|365101089|FG001|Overall Study|Lost to Follow-up|2|||
105847598|NCT00985712|365101088|FG000|Overall Study|Protocol Violation|0|||
105971898|NCT00075725|365556862|FG004|Overall Study|MRD positive after extended ind|1|||
105971899|NCT00075725|365556863|FG005|Overall Study|MRD positive after extended ind|2|||
105971900|NCT00075725|365556864|FG006|Overall Study|MRD positive after extended ind|0|||
105971901|NCT00075725|365556865|FG007|Overall Study|MRD positive after extended ind|1|||
105971902|NCT00075725|365556866|FG008|Overall Study|MRD positive after extended ind|0|||
105847599|NCT00985712|365101089|FG001|Overall Study|Protocol Violation|1|||
105847600|NCT00985712|365101088|FG000|Overall Study|Withdrawal by Subject|4|||
105847601|NCT00985712|365101089|FG001|Overall Study|Withdrawal by Subject|1|||
105847602|NCT00985712|365101088|FG000|Overall Study|Sponsor decision|0|||
105847603|NCT00985712|365101089|FG001|Overall Study|Sponsor decision|2|||
105847604|NCT01194973|365101090|FG000|Screening Period|Screen Failure|3|||
105971903|NCT00075725|365556867|FG009|Overall Study|MRD positive after extended ind|0|||
105847605|NCT01194973|365101090|FG000|26 Week Treatment Period|Adverse Event|1|||
105847606|NCT01194973|365101090|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
105847607|NCT01194973|365101090|FG000|26 Week Treatment Period|Pregnancy|1|||
105847608|NCT01157897|365101091|FG000|Overall Study|Lost to Follow-up|2|||
105847609|NCT01157897|365101092|FG001|Overall Study|Lost to Follow-up|0|||
105847610|NCT01157897|365101093|FG002|Overall Study|Lost to Follow-up|0|||
105847611|NCT01157897|365101094|FG003|Overall Study|Lost to Follow-up|1|||
105847612|NCT01157897|365101091|FG000|Overall Study|Relocated|0|||
105847613|NCT01157897|365101092|FG001|Overall Study|Relocated|2|||
105847614|NCT01157897|365101093|FG002|Overall Study|Relocated|0|||
105847615|NCT01157897|365101094|FG003|Overall Study|Relocated|0|||
105971904|NCT00075725|365556868|FG010|Overall Study|MRD positive after extended ind|0|||
105971905|NCT00075725|365556869|FG011|Overall Study|MRD positive after extended ind|0|||
105971906|NCT00075725|365556858|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
105971907|NCT00075725|365556859|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
105987461|NCT02814175|365614464|FG004|Part 1|Lost to Follow-up|0|||
105847616|NCT03096847|365101095|FG000|Overall Study|Other|2|||
105847617|NCT03096847|365101096|FG001|Overall Study|Other|1|||
105847618|NCT03096847|365101097|FG002|Overall Study|Other|2|||
105847619|NCT03096847|365101095|FG000|Overall Study|Lost to Follow-up|1|||
105847620|NCT03096847|365101096|FG001|Overall Study|Lost to Follow-up|0|||
105847621|NCT03096847|365101097|FG002|Overall Study|Lost to Follow-up|1|||
105847622|NCT03096847|365101095|FG000|Overall Study|Death|6|||
105847623|NCT03096847|365101096|FG001|Overall Study|Death|0|||
105847624|NCT03096847|365101097|FG002|Overall Study|Death|2|||
105847625|NCT03096847|365101095|FG000|Overall Study|Protocol Violation|3|||
105847626|NCT03096847|365101096|FG001|Overall Study|Protocol Violation|0|||
105847627|NCT03096847|365101097|FG002|Overall Study|Protocol Violation|6|||
105847628|NCT03096847|365101095|FG000|Overall Study|Physician Decision|12|||
105847629|NCT03096847|365101096|FG001|Overall Study|Physician Decision|2|||
105847630|NCT03096847|365101097|FG002|Overall Study|Physician Decision|8|||
105847631|NCT03096847|365101095|FG000|Overall Study|Withdrawal by Subject|24|||
105847632|NCT03096847|365101096|FG001|Overall Study|Withdrawal by Subject|1|||
105847633|NCT03096847|365101097|FG002|Overall Study|Withdrawal by Subject|12|||
105847634|NCT03096847|365101095|FG000|Overall Study|Adverse Event|72|||
105847635|NCT03096847|365101096|FG001|Overall Study|Adverse Event|6|||
105847636|NCT03096847|365101097|FG002|Overall Study|Adverse Event|28|||
105847637|NCT03096847|365101095|FG000|Overall Study|Progressive disease|97|||
105847638|NCT03096847|365101096|FG001|Overall Study|Progressive disease|10|||
105847639|NCT03096847|365101097|FG002|Overall Study|Progressive disease|78|||
105847640|NCT03096847|365101095|FG000|Overall Study|Non-compliance with study medication|1|||
105847641|NCT03096847|365101096|FG001|Overall Study|Non-compliance with study medication|0|||
105847642|NCT03096847|365101097|FG002|Overall Study|Non-compliance with study medication|0|||
105847643|NCT03096847|365101095|FG000|Overall Study|New therapy for study indication|1|||
105847644|NCT03096847|365101096|FG001|Overall Study|New therapy for study indication|0|||
105847645|NCT03096847|365101097|FG002|Overall Study|New therapy for study indication|1|||
105847646|NCT00757848|365101098|FG000|Overall Study|Voluntary discontinuation|1|||
105847647|NCT00757848|365101099|FG001|Overall Study|Voluntary discontinuation|0|||
105847648|NCT00757848|365101098|FG000|Overall Study|Adverse Event|1|||
105847649|NCT00757848|365101099|FG001|Overall Study|Adverse Event|2|||
105847650|NCT00757848|365101098|FG000|Overall Study|Incorrect enrolment|1|||
105847651|NCT00757848|365101099|FG001|Overall Study|Incorrect enrolment|0|||
105847652|NCT00359632|365101100|FG000|Overall Study|Death|2|||
105847653|NCT00359632|365101101|FG001|Overall Study|Death|0|||
105847654|NCT00359632|365101100|FG000|Overall Study|Adverse Event|1|||
105847655|NCT00359632|365101101|FG001|Overall Study|Adverse Event|0|||
105847656|NCT00359632|365101100|FG000|Overall Study|Non-compliance with visit schedule|1|||
105847657|NCT00359632|365101101|FG001|Overall Study|Non-compliance with visit schedule|0|||
105847658|NCT01321008|365101102|FG000|Overall Study|Early Study Termination|1|||
105847659|NCT02749292|365101105|FG000|Overall Study|Physician Decision|1|||
105847660|NCT02749292|365101106|FG001|Overall Study|Physician Decision|0|||
105847661|NCT02749292|365101105|FG000|Overall Study|Withdrawal by Subject|5|||
105847662|NCT02749292|365101106|FG001|Overall Study|Withdrawal by Subject|7|||
105847663|NCT02749292|365101105|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
105847664|NCT02749292|365101106|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
105847665|NCT02749292|365101105|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
105847666|NCT02749292|365101106|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
105847667|NCT02749292|365101105|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
105847668|NCT02749292|365101106|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
105847669|NCT02749292|365101105|FG000|Overall Study|Adverse Event|4|||
105847670|NCT02749292|365101106|FG001|Overall Study|Adverse Event|1|||
105847671|NCT02749292|365101105|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
105847672|NCT02749292|365101106|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
105847673|NCT02749292|365101105|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
106149851|NCT01255670|366209253|FG000|Overall Study|Lost to Follow-up|16|||
106149852|NCT01255670|366209254|FG001|Overall Study|Lost to Follow-up|10|||
106149853|NCT01037985|366209255|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
105847674|NCT02749292|365101106|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
105847675|NCT02749292|365101105|FG000|Overall Study|Requiring glucocorticoids|0|||
105847676|NCT02749292|365101106|FG001|Overall Study|Requiring glucocorticoids|3|||
105847677|NCT02749292|365101105|FG000|Overall Study|Cancer|1|||
105847678|NCT02749292|365101106|FG001|Overall Study|Cancer|0|||
105847679|NCT00251641|365101107|FG000|Overall Study|Adverse Event|80|||
105847680|NCT00251641|365101108|FG001|Overall Study|Adverse Event|8|||
105847681|NCT00251641|365101107|FG000|Overall Study|Lack of Efficacy|2|||
105847682|NCT00251641|365101108|FG001|Overall Study|Lack of Efficacy|1|||
105847683|NCT00251641|365101107|FG000|Overall Study|Progression of Disease|0|||
105847684|NCT00251641|365101108|FG001|Overall Study|Progression of Disease|2|||
105847685|NCT00251641|365101107|FG000|Overall Study|Lost to Follow-up|3|||
105847686|NCT00251641|365101108|FG001|Overall Study|Lost to Follow-up|3|||
105847687|NCT00251641|365101107|FG000|Overall Study|Withdrawal by Subject|6|||
105847688|NCT00251641|365101108|FG001|Overall Study|Withdrawal by Subject|8|||
105847689|NCT00251641|365101107|FG000|Overall Study|Protocol Violation|10|||
105847690|NCT00251641|365101108|FG001|Overall Study|Protocol Violation|2|||
105847691|NCT00251641|365101107|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
105971908|NCT00075725|365556860|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
106149854|NCT01037985|366209256|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
106149855|NCT01037985|366209255|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
106149856|NCT01037985|366209256|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
105847692|NCT00251641|365101108|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
105847693|NCT00251641|365101107|FG000|Overall Study|Switched Treatment|9|||
105847694|NCT00251641|365101108|FG001|Overall Study|Switched Treatment|63|||
105847695|NCT00679913|365101109|FG000|Overall Study|Protocol Violation|18|||
105847696|NCT00679913|365101110|FG001|Overall Study|Protocol Violation|13|||
105847697|NCT00062751|365101111|FG000|Overall Study|Disease progression|24|||
105847698|NCT00062751|365101112|FG001|Overall Study|Disease progression|17|||
105847699|NCT00062751|365101113|FG002|Overall Study|Disease progression|24|||
105847700|NCT00062751|365101114|FG003|Overall Study|Disease progression|2|||
105847701|NCT00062751|365101115|FG004|Overall Study|Disease progression|2|||
105847702|NCT00062751|365101111|FG000|Overall Study|Adverse Event|4|||
105847703|NCT00062751|365101112|FG001|Overall Study|Adverse Event|7|||
105847704|NCT00062751|365101113|FG002|Overall Study|Adverse Event|2|||
105847705|NCT00062751|365101114|FG003|Overall Study|Adverse Event|2|||
105847706|NCT00062751|365101115|FG004|Overall Study|Adverse Event|2|||
105847707|NCT00062751|365101111|FG000|Overall Study|Other|2|||
105847708|NCT00062751|365101112|FG001|Overall Study|Other|3|||
105847709|NCT00062751|365101113|FG002|Overall Study|Other|1|||
105847710|NCT00062751|365101114|FG003|Overall Study|Other|0|||
105847711|NCT00062751|365101115|FG004|Overall Study|Other|1|||
105847712|NCT00062751|365101111|FG000|Overall Study|Withdrawal by Subject|1|||
105847713|NCT00062751|365101112|FG001|Overall Study|Withdrawal by Subject|2|||
105847714|NCT00062751|365101113|FG002|Overall Study|Withdrawal by Subject|2|||
105847715|NCT00062751|365101114|FG003|Overall Study|Withdrawal by Subject|1|||
105847716|NCT00062751|365101115|FG004|Overall Study|Withdrawal by Subject|0|||
105847717|NCT00062751|365101111|FG000|Overall Study|Symptomatic deterioration|1|||
105847718|NCT00062751|365101112|FG001|Overall Study|Symptomatic deterioration|1|||
105847719|NCT00062751|365101113|FG002|Overall Study|Symptomatic deterioration|0|||
105847720|NCT00062751|365101114|FG003|Overall Study|Symptomatic deterioration|0|||
105847721|NCT00062751|365101115|FG004|Overall Study|Symptomatic deterioration|1|||
105847722|NCT00062751|365101111|FG000|Overall Study|Death|1|||
105847723|NCT00062751|365101112|FG001|Overall Study|Death|0|||
105847724|NCT00062751|365101113|FG002|Overall Study|Death|1|||
105847725|NCT00062751|365101114|FG003|Overall Study|Death|0|||
105847726|NCT00062751|365101115|FG004|Overall Study|Death|0|||
105847727|NCT01674647|365101116|FG000|Treatment Period|Death|4|||
105847728|NCT01674647|365101117|FG001|Treatment Period|Death|1|||
105847729|NCT01674647|365101116|FG000|Treatment Period|Efficacy outcome reached|0|||
105847730|NCT01674647|365101117|FG001|Treatment Period|Efficacy outcome reached|1|||
105847731|NCT01674647|365101116|FG000|Treatment Period|Physician Decision|3|||
105847732|NCT01674647|365101117|FG001|Treatment Period|Physician Decision|1|||
105847733|NCT01674647|365101116|FG000|Treatment Period|Adverse Event|60|||
105847734|NCT01674647|365101117|FG001|Treatment Period|Adverse Event|22|||
105847735|NCT01674647|365101116|FG000|Treatment Period|Non-compliance with study drug|3|||
105847736|NCT01674647|365101117|FG001|Treatment Period|Non-compliance with study drug|0|||
105847737|NCT01674647|365101116|FG000|Treatment Period|Lost to Follow-up|1|||
105847738|NCT01674647|365101117|FG001|Treatment Period|Lost to Follow-up|1|||
105847739|NCT01674647|365101116|FG000|Treatment Period|Withdrawal by Subject|19|||
105847740|NCT01674647|365101117|FG001|Treatment Period|Withdrawal by Subject|16|||
105847741|NCT01674647|365101116|FG000|Treatment Period|Switching to other therapy|5|||
105847742|NCT01674647|365101117|FG001|Treatment Period|Switching to other therapy|2|||
105847743|NCT01674647|365101116|FG000|Treatment Period|Logistical difficulties|5|||
105847744|NCT01674647|365101117|FG001|Treatment Period|Logistical difficulties|8|||
105847745|NCT01674647|365101116|FG000|Treatment Period|Treatment failure|0|||
105847746|NCT01674647|365101117|FG001|Treatment Period|Treatment failure|14|||
105847747|NCT01674647|365101116|FG000|Treatment Period|Protocol Violation|56|||
105847748|NCT01674647|365101117|FG001|Treatment Period|Protocol Violation|36|||
105847749|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Death|3|||
105847750|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Death|2|||
105847751|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
105847752|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
105847753|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
105847754|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
105847755|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
105847756|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
105847757|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
105847758|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
105847759|NCT01674647|365101116|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
105847760|NCT01674647|365101117|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
105847761|NCT00741936|365101124|FG000|Overall Study|Lost to Follow-up|1|||
105847762|NCT00741936|365101125|FG001|Overall Study|Lost to Follow-up|1|||
105847763|NCT00741936|365101124|FG000|Overall Study|Adverse Event|3|||
105847764|NCT00741936|365101125|FG001|Overall Study|Adverse Event|4|||
105847765|NCT00741936|365101124|FG000|Overall Study|Pregnancy|0|||
105847766|NCT00741936|365101125|FG001|Overall Study|Pregnancy|1|||
105847767|NCT00741936|365101124|FG000|Overall Study|Protocol Violation|2|||
105847768|NCT00741936|365101125|FG001|Overall Study|Protocol Violation|0|||
105847769|NCT00741936|365101124|FG000|Overall Study|Lack of Efficacy|0|||
105847770|NCT00741936|365101125|FG001|Overall Study|Lack of Efficacy|2|||
105847771|NCT00741936|365101124|FG000|Overall Study|Low compliance|3|||
105847772|NCT00741936|365101125|FG001|Overall Study|Low compliance|0|||
105847773|NCT01408628|365101126|FG000|Consented|Withdrawal by Subject|12|||
105847774|NCT01408628|365101126|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
105847775|NCT01408628|365101126|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
105847776|NCT01408628|365101126|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
105847777|NCT01144364|365101127|FG000|Induction Phase|Disease progression|14|||
105847778|NCT01144364|365101128|FG001|Induction Phase|Disease progression|0|||
105847779|NCT01144364|365101129|FG002|Induction Phase|Disease progression|0|||
105847780|NCT01144364|365101127|FG000|Induction Phase|Adverse Event|9|||
105847781|NCT01144364|365101128|FG001|Induction Phase|Adverse Event|0|||
105847782|NCT01144364|365101129|FG002|Induction Phase|Adverse Event|0|||
105847783|NCT01144364|365101127|FG000|Induction Phase|Death|1|||
105847784|NCT01144364|365101128|FG001|Induction Phase|Death|0|||
105847785|NCT01144364|365101129|FG002|Induction Phase|Death|0|||
105847786|NCT01144364|365101127|FG000|Induction Phase|Withdrawal by Subject|1|||
105971909|NCT00075725|365556861|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
105971910|NCT00075725|365556862|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
105971911|NCT00075725|365556863|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
105971912|NCT00075725|365556864|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
105971913|NCT00075725|365556865|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
105971914|NCT00075725|365556866|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
105847787|NCT01144364|365101128|FG001|Induction Phase|Withdrawal by Subject|0|||
105847788|NCT01144364|365101129|FG002|Induction Phase|Withdrawal by Subject|0|||
105847789|NCT01144364|365101127|FG000|Induction Phase|Lost to Follow-up|2|||
105847790|NCT01144364|365101128|FG001|Induction Phase|Lost to Follow-up|0|||
105971915|NCT00075725|365556867|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
105971916|NCT00075725|365556868|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
105971917|NCT00075725|365556869|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
105971918|NCT00075725|365556858|FG000|Overall Study|Inevaluable|1|||
105971919|NCT00075725|365556859|FG001|Overall Study|Inevaluable|1|||
105971920|NCT00075725|365556860|FG002|Overall Study|Inevaluable|4|||
105971921|NCT00075725|365556861|FG003|Overall Study|Inevaluable|2|||
105971922|NCT00075725|365556862|FG004|Overall Study|Inevaluable|2|||
105971923|NCT00075725|365556863|FG005|Overall Study|Inevaluable|9|||
105971924|NCT00075725|365556864|FG006|Overall Study|Inevaluable|1|||
105971925|NCT00075725|365556865|FG007|Overall Study|Inevaluable|11|||
105847791|NCT01144364|365101129|FG002|Induction Phase|Lost to Follow-up|0|||
105847792|NCT01144364|365101127|FG000|Induction Phase|Physician Decision|1|||
105847793|NCT01144364|365101128|FG001|Induction Phase|Physician Decision|0|||
105847794|NCT01144364|365101129|FG002|Induction Phase|Physician Decision|0|||
105847795|NCT01144364|365101127|FG000|Induction Phase|Stable disease|2|||
105847796|NCT01144364|365101128|FG001|Induction Phase|Stable disease|0|||
105847797|NCT01144364|365101129|FG002|Induction Phase|Stable disease|0|||
105847798|NCT01144364|365101127|FG000|Induction Phase|Secondary neoplasia|1|||
105847799|NCT01144364|365101128|FG001|Induction Phase|Secondary neoplasia|0|||
105847800|NCT01144364|365101129|FG002|Induction Phase|Secondary neoplasia|0|||
105847801|NCT01144364|365101127|FG000|Induction Phase|Protocol Violation|1|||
105847802|NCT01144364|365101128|FG001|Induction Phase|Protocol Violation|0|||
105847803|NCT01144364|365101129|FG002|Induction Phase|Protocol Violation|0|||
105847804|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
105847805|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
105847806|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
105847807|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
105847808|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
105847809|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
105847810|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Death|0|||
105847811|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Death|2|||
105847812|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Death|0|||
105847813|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
105847814|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
105847815|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
105847816|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
105971926|NCT00075725|365556866|FG008|Overall Study|Inevaluable|2|||
105971927|NCT00075725|365556867|FG009|Overall Study|Inevaluable|0|||
105971928|NCT00075725|365556868|FG010|Overall Study|Inevaluable|1|||
105971929|NCT00075725|365556869|FG011|Overall Study|Inevaluable|0|||
105971930|NCT00075725|365556858|FG000|Overall Study|Other|4|||
105971931|NCT00075725|365556859|FG001|Overall Study|Other|2|||
105847817|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
105847818|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
105847819|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
105847820|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
105847821|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
105847822|NCT01144364|365101127|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
105847823|NCT01144364|365101128|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
105847824|NCT01144364|365101129|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
105847825|NCT00653991|365101130|FG000|3 Month Follow-up|Participant would not respond|150|||
105847826|NCT00653991|365101131|FG001|3 Month Follow-up|Participant would not respond|157|||
105847827|NCT00653991|365101130|FG000|6 Month Follow-up|Participant would not respond|133|||
105847828|NCT00653991|365101131|FG001|6 Month Follow-up|Participant would not respond|141|||
105847829|NCT02707861|365101132|FG000|Overall Study|Went onto commercial drug|30|||
105847830|NCT02707861|365101133|FG001|Overall Study|Went onto commercial drug|23|||
105847831|NCT02707861|365101132|FG000|Overall Study|Adverse Event|2|||
105847832|NCT02707861|365101133|FG001|Overall Study|Adverse Event|3|||
105847833|NCT02707861|365101132|FG000|Overall Study|Death|5|||
105847834|NCT02707861|365101133|FG001|Overall Study|Death|2|||
105847835|NCT02707861|365101132|FG000|Overall Study|Lack of Efficacy|0|||
105847836|NCT02707861|365101133|FG001|Overall Study|Lack of Efficacy|2|||
105847837|NCT02707861|365101132|FG000|Overall Study|Physician Decision|1|||
105847838|NCT02707861|365101133|FG001|Overall Study|Physician Decision|4|||
105847839|NCT02707861|365101132|FG000|Overall Study|Withdrawal by Subject|2|||
105847840|NCT02707861|365101133|FG001|Overall Study|Withdrawal by Subject|1|||
105847841|NCT02707861|365101132|FG000|Overall Study|Lost to Follow-up|1|||
105847842|NCT02707861|365101133|FG001|Overall Study|Lost to Follow-up|3|||
105847843|NCT01346774|365101134|FG000|Overall Study|Did not take a single dose|6|||
105847844|NCT01346774|365101135|FG001|Overall Study|Did not take a single dose|4|||
105847845|NCT01346774|365101134|FG000|Overall Study|Lost to Follow-up|3|||
105847846|NCT01346774|365101135|FG001|Overall Study|Lost to Follow-up|4|||
105847847|NCT01346774|365101134|FG000|Overall Study|Withdrawal by Subject|1|||
105847848|NCT01346774|365101135|FG001|Overall Study|Withdrawal by Subject|4|||
105847849|NCT01346774|365101134|FG000|Overall Study|Protocol Violation|2|||
105847850|NCT01346774|365101135|FG001|Overall Study|Protocol Violation|3|||
105847851|NCT01346774|365101134|FG000|Overall Study|Adverse Event|1|||
105847852|NCT01346774|365101135|FG001|Overall Study|Adverse Event|2|||
105847853|NCT01929031|365101136|FG000|Overall Study|Adverse Event|3|||
105847854|NCT01929031|365101137|FG001|Overall Study|Adverse Event|1|||
105847855|NCT01929031|365101138|FG002|Overall Study|Adverse Event|1|||
105847856|NCT01929031|365101139|FG003|Overall Study|Adverse Event|0|||
105847857|NCT01929031|365101140|FG004|Overall Study|Adverse Event|0|||
105847858|NCT01929031|365101141|FG005|Overall Study|Adverse Event|0|||
105847859|NCT01929031|365101136|FG000|Overall Study|Protocol Violation|1|||
105847860|NCT01929031|365101137|FG001|Overall Study|Protocol Violation|0|||
105847861|NCT01929031|365101138|FG002|Overall Study|Protocol Violation|0|||
105847862|NCT01929031|365101139|FG003|Overall Study|Protocol Violation|0|||
105847863|NCT01929031|365101140|FG004|Overall Study|Protocol Violation|0|||
105847864|NCT01929031|365101141|FG005|Overall Study|Protocol Violation|1|||
105847865|NCT01929031|365101136|FG000|Overall Study|Reason other than specified above|0|||
105847866|NCT01929031|365101137|FG001|Overall Study|Reason other than specified above|1|||
105847867|NCT01929031|365101138|FG002|Overall Study|Reason other than specified above|0|||
105847868|NCT01929031|365101139|FG003|Overall Study|Reason other than specified above|0|||
105847869|NCT01929031|365101140|FG004|Overall Study|Reason other than specified above|1|||
105847870|NCT01929031|365101141|FG005|Overall Study|Reason other than specified above|0|||
105847871|NCT01366443|365101144|FG000|Overall Study|Lost to Follow-up|2|||
105847872|NCT01366443|365101144|FG000|Overall Study|Under 18 yo|1|||
105847873|NCT00369382|365101145|FG000|Overall Study|Death|0|||
105847874|NCT00369382|365101146|FG001|Overall Study|Death|2|||
105847875|NCT00369382|365101145|FG000|Overall Study|Physician Decision|2|||
105847876|NCT00369382|365101146|FG001|Overall Study|Physician Decision|1|||
105847877|NCT00369382|365101145|FG000|Overall Study|Withdrawal by Subject|5|||
105847878|NCT00369382|365101146|FG001|Overall Study|Withdrawal by Subject|0|||
105847879|NCT00369382|365101145|FG000|Overall Study|Randomized, not treated|2|||
105847880|NCT00369382|365101146|FG001|Overall Study|Randomized, not treated|0|||
105847881|NCT00369382|365101145|FG000|Overall Study|Other|1|||
105847882|NCT00369382|365101146|FG001|Overall Study|Other|0|||
105847883|NCT02394730|365101147|FG000|Overall Study|Lost to Follow-up|1|||
105847884|NCT02394730|365101148|FG001|Overall Study|Lost to Follow-up|0|||
105847885|NCT02394730|365101147|FG000|Overall Study|Withdrawal by Subject|0|||
105847886|NCT02394730|365101148|FG001|Overall Study|Withdrawal by Subject|1|||
105847887|NCT03487848|365101149|FG000|Overall Study|Lost to Follow-up|1|||
105847888|NCT00502801|365101150|FG000|Treatment Period|Withdrawal by Subject|3|||
105847889|NCT00502801|365101150|FG000|Treatment Period|Adverse Event|7|||
105847890|NCT00502801|365101150|FG000|Treatment Period|Death|14|||
105847891|NCT00502801|365101150|FG000|Treatment Period|OTHER|30|||
105847892|NCT00502801|365101150|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
105847893|NCT00502801|365101150|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
105847894|NCT00502801|365101150|FG000|End of Therapy to Test of Cure|Death|3|||
105847895|NCT00502801|365101150|FG000|End of Therapy to Test of Cure|OTHER|2|||
105847896|NCT00731549|365101151|FG000|Overall Study|Lost to Follow-up|19|||
105847897|NCT00731549|365101151|FG000|Overall Study|Met withdrawal criteria|24|||
105847898|NCT00731549|365101151|FG000|Overall Study|Physician Decision|16|||
105847899|NCT00731549|365101151|FG000|Overall Study|Withdrawal by Subject|89|||
105847900|NCT00731549|365101151|FG000|Overall Study|Protocol deviation|1|||
105847901|NCT00731549|365101151|FG000|Overall Study|Adverse Event|31|||
105847902|NCT00731549|365101151|FG000|Overall Study|Lack of efficacy with AE|37|||
105847903|NCT00731549|365101151|FG000|Overall Study|Lack of efficacy without AE|6|||
105847904|NCT00507546|365101153|FG000|Overall Study|Withdrawal by Subject|1|||
105847905|NCT00507546|365101154|FG001|Overall Study|Withdrawal by Subject|0|||
105847906|NCT00507546|365101153|FG000|Overall Study|Protocol Violation|1|||
105847907|NCT00507546|365101154|FG001|Overall Study|Protocol Violation|0|||
105847908|NCT00507546|365101153|FG000|Overall Study|Physician Decision|0|||
105847909|NCT00507546|365101154|FG001|Overall Study|Physician Decision|1|||
105847910|NCT02384850|365101155|FG000|Overall Study|Withdrawal by Subject|2|||
105847911|NCT02384850|365101156|FG001|Overall Study|Withdrawal by Subject|2|||
105847912|NCT01299805|365101165|FG000|Overall Study|Adverse Event|2|||
105847913|NCT01299805|365101166|FG001|Overall Study|Adverse Event|0|||
105847914|NCT01970865|365101167|FG000|Overall Study|Death|3|||
105847915|NCT01970865|365101168|FG001|Overall Study|Death|2|||
105847916|NCT01970865|365101169|FG002|Overall Study|Death|3|||
105847917|NCT01970865|365101170|FG003|Overall Study|Death|6|||
105847918|NCT01970865|365101171|FG004|Overall Study|Death|9|||
105847919|NCT01970865|365101172|FG005|Overall Study|Death|3|||
105847920|NCT01970865|365101173|FG006|Overall Study|Death|2|||
105847921|NCT01970865|365101174|FG007|Overall Study|Death|3|||
105847922|NCT01970865|365101175|FG008|Overall Study|Death|2|||
105847923|NCT01970865|365101176|FG009|Overall Study|Death|2|||
105847924|NCT01970865|365101177|FG010|Overall Study|Death|8|||
105847925|NCT01970865|365101178|FG011|Overall Study|Death|13|||
105847926|NCT01970865|365101179|FG012|Overall Study|Death|25|||
105847927|NCT01970865|365101180|FG013|Overall Study|Death|46|||
105847928|NCT01970865|365101181|FG014|Overall Study|Death|37|||
105847929|NCT01970865|365101182|FG015|Overall Study|Death|22|||
105847930|NCT01970865|365101183|FG016|Overall Study|Death|1|||
105847931|NCT01970865|365101184|FG017|Overall Study|Death|17|||
105847932|NCT01970865|365101167|FG000|Overall Study|Lost to Follow-up|0|||
105847933|NCT01970865|365101168|FG001|Overall Study|Lost to Follow-up|0|||
105847934|NCT01970865|365101169|FG002|Overall Study|Lost to Follow-up|0|||
105847935|NCT01970865|365101170|FG003|Overall Study|Lost to Follow-up|1|||
105847936|NCT01970865|365101171|FG004|Overall Study|Lost to Follow-up|1|||
105847937|NCT01970865|365101172|FG005|Overall Study|Lost to Follow-up|0|||
105847938|NCT01970865|365101173|FG006|Overall Study|Lost to Follow-up|0|||
105847939|NCT01970865|365101174|FG007|Overall Study|Lost to Follow-up|0|||
105847940|NCT01970865|365101175|FG008|Overall Study|Lost to Follow-up|0|||
105847941|NCT01970865|365101176|FG009|Overall Study|Lost to Follow-up|0|||
105847942|NCT01970865|365101177|FG010|Overall Study|Lost to Follow-up|1|||
105847943|NCT01970865|365101178|FG011|Overall Study|Lost to Follow-up|0|||
105847944|NCT01970865|365101179|FG012|Overall Study|Lost to Follow-up|2|||
105847945|NCT01970865|365101180|FG013|Overall Study|Lost to Follow-up|0|||
105847946|NCT01970865|365101181|FG014|Overall Study|Lost to Follow-up|1|||
105847947|NCT01970865|365101182|FG015|Overall Study|Lost to Follow-up|4|||
105847948|NCT01970865|365101183|FG016|Overall Study|Lost to Follow-up|0|||
105847949|NCT01970865|365101184|FG017|Overall Study|Lost to Follow-up|1|||
105847950|NCT01970865|365101167|FG000|Overall Study|Other|0|||
105847951|NCT01970865|365101168|FG001|Overall Study|Other|1|||
105847952|NCT01970865|365101169|FG002|Overall Study|Other|0|||
105847953|NCT01970865|365101170|FG003|Overall Study|Other|1|||
105847954|NCT01970865|365101171|FG004|Overall Study|Other|1|||
105847955|NCT01970865|365101172|FG005|Overall Study|Other|0|||
105847956|NCT01970865|365101173|FG006|Overall Study|Other|1|||
105847957|NCT01970865|365101174|FG007|Overall Study|Other|0|||
105847958|NCT01970865|365101175|FG008|Overall Study|Other|0|||
105847959|NCT01970865|365101176|FG009|Overall Study|Other|0|||
105847960|NCT01970865|365101177|FG010|Overall Study|Other|2|||
105847961|NCT01970865|365101178|FG011|Overall Study|Other|3|||
105847962|NCT01970865|365101179|FG012|Overall Study|Other|8|||
105847963|NCT01970865|365101180|FG013|Overall Study|Other|3|||
105847964|NCT01970865|365101181|FG014|Overall Study|Other|2|||
105847965|NCT01970865|365101182|FG015|Overall Study|Other|3|||
106149857|NCT01037985|366209255|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
105847966|NCT01970865|365101183|FG016|Overall Study|Other|0|||
105847967|NCT01970865|365101184|FG017|Overall Study|Other|2|||
105847968|NCT01970865|365101167|FG000|Overall Study|Participant refused further follow-up|0|||
106149858|NCT01037985|366209256|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
106149859|NCT01037985|366209255|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
105847969|NCT01970865|365101168|FG001|Overall Study|Participant refused further follow-up|0|||
105847970|NCT01970865|365101169|FG002|Overall Study|Participant refused further follow-up|0|||
105847971|NCT01970865|365101170|FG003|Overall Study|Participant refused further follow-up|2|||
105847972|NCT01970865|365101171|FG004|Overall Study|Participant refused further follow-up|3|||
105847973|NCT01970865|365101172|FG005|Overall Study|Participant refused further follow-up|0|||
105847974|NCT01970865|365101173|FG006|Overall Study|Participant refused further follow-up|0|||
105847975|NCT01970865|365101174|FG007|Overall Study|Participant refused further follow-up|0|||
105847976|NCT01970865|365101175|FG008|Overall Study|Participant refused further follow-up|0|||
105847977|NCT01970865|365101176|FG009|Overall Study|Participant refused further follow-up|0|||
105847978|NCT01970865|365101177|FG010|Overall Study|Participant refused further follow-up|1|||
105847979|NCT01970865|365101178|FG011|Overall Study|Participant refused further follow-up|4|||
105847980|NCT01970865|365101179|FG012|Overall Study|Participant refused further follow-up|7|||
105847981|NCT01970865|365101180|FG013|Overall Study|Participant refused further follow-up|8|||
105847982|NCT01970865|365101181|FG014|Overall Study|Participant refused further follow-up|3|||
105847983|NCT01970865|365101182|FG015|Overall Study|Participant refused further follow-up|11|||
105847984|NCT01970865|365101183|FG016|Overall Study|Participant refused further follow-up|0|||
105847985|NCT01970865|365101184|FG017|Overall Study|Participant refused further follow-up|6|||
105847986|NCT04062448|365103020|FG000|Overall Study|Lost to Follow-up|1|||
106149860|NCT01037985|366209256|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
105847987|NCT04062448|365103020|FG000|Overall Study|Withdrawal by Subject|2|||
105847988|NCT00759902|365103023|FG000|Overall Study|Adverse Event|0|||
105847989|NCT00759902|365103024|FG001|Overall Study|Adverse Event|1|||
105847990|NCT02128217|365103027|FG000|Overall Study|Lost to Follow-up|0|||
105847991|NCT02128217|365103028|FG001|Overall Study|Lost to Follow-up|1|||
105847992|NCT00541970|365103029|FG000|Month 7|Protocol Violation|9|||
105847993|NCT00541970|365103030|FG001|Month 7|Protocol Violation|13|||
105847994|NCT00541970|365103031|FG002|Month 7|Protocol Violation|11|||
105847995|NCT00541970|365103032|FG003|Month 7|Protocol Violation|5|||
105847996|NCT00541970|365103029|FG000|Month 12|Adverse Event|0|||
105847997|NCT00541970|365103030|FG001|Month 12|Adverse Event|1|||
105847998|NCT00541970|365103031|FG002|Month 12|Adverse Event|1|||
105847999|NCT00541970|365103032|FG003|Month 12|Adverse Event|1|||
105848000|NCT00541970|365103029|FG000|Month 12|Protocol Violation|12|||
105848001|NCT00541970|365103030|FG001|Month 12|Protocol Violation|21|||
105848002|NCT00541970|365103031|FG002|Month 12|Protocol Violation|20|||
105848003|NCT00541970|365103032|FG003|Month 12|Protocol Violation|15|||
105848004|NCT00541970|365103029|FG000|Month 18|Adverse Event|0|||
105848005|NCT00541970|365103030|FG001|Month 18|Adverse Event|1|||
105848006|NCT00541970|365103031|FG002|Month 18|Adverse Event|1|||
105848007|NCT00541970|365103032|FG003|Month 18|Adverse Event|1|||
105848008|NCT00541970|365103029|FG000|Month 18|Protocol Violation|14|||
105848009|NCT00541970|365103030|FG001|Month 18|Protocol Violation|23|||
105848010|NCT00541970|365103031|FG002|Month 18|Protocol Violation|24|||
105848011|NCT00541970|365103032|FG003|Month 18|Protocol Violation|16|||
105848012|NCT00541970|365103029|FG000|Month 24|Adverse Event|0|||
105848013|NCT00541970|365103030|FG001|Month 24|Adverse Event|1|||
105848014|NCT00541970|365103031|FG002|Month 24|Adverse Event|1|||
105848015|NCT00541970|365103032|FG003|Month 24|Adverse Event|1|||
105848016|NCT00541970|365103029|FG000|Month 24|Protocol Violation|29|||
105848017|NCT00541970|365103030|FG001|Month 24|Protocol Violation|31|||
105848018|NCT00541970|365103031|FG002|Month 24|Protocol Violation|31|||
105848019|NCT00541970|365103032|FG003|Month 24|Protocol Violation|21|||
105848020|NCT00541970|365103029|FG000|Month 36|Protocol Violation|61|||
105848021|NCT00541970|365103030|FG001|Month 36|Protocol Violation|66|||
105848022|NCT00541970|365103031|FG002|Month 36|Protocol Violation|66|||
105848023|NCT00541970|365103032|FG003|Month 36|Protocol Violation|60|||
105848024|NCT00541970|365103029|FG000|Month 48|Withdrawal by Subject|2|||
105848025|NCT00541970|365103030|FG001|Month 48|Withdrawal by Subject|4|||
105848026|NCT00541970|365103031|FG002|Month 48|Withdrawal by Subject|4|||
105848027|NCT00541970|365103032|FG003|Month 48|Withdrawal by Subject|2|||
105848028|NCT00541970|365103029|FG000|Month 48|Other|3|||
105848029|NCT00541970|365103030|FG001|Month 48|Other|1|||
105848030|NCT00541970|365103031|FG002|Month 48|Other|1|||
105848031|NCT00541970|365103032|FG003|Month 48|Other|0|||
105848032|NCT00541970|365103029|FG000|Month 48|Lost to Follow-up|66|||
105848033|NCT00541970|365103030|FG001|Month 48|Lost to Follow-up|68|||
105848034|NCT00541970|365103031|FG002|Month 48|Lost to Follow-up|68|||
105848035|NCT00541970|365103032|FG003|Month 48|Lost to Follow-up|73|||
105848036|NCT00541970|365103029|FG000|Month 60|Protocol Violation|78|||
105848037|NCT00541970|365103030|FG001|Month 60|Protocol Violation|77|||
106024788|NCT00612105|365756641|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
106149861|NCT04019444|366209257|FG000|Overall Study|Withdrawal by Subject|0|||
105848038|NCT00541970|365103031|FG002|Month 60|Protocol Violation|82|||
105848039|NCT00541970|365103032|FG003|Month 60|Protocol Violation|72|||
105848040|NCT02856880|365103033|FG000|Overall Study|Withdrawal of consent|1|||
105848041|NCT01183221|365103034|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
105848042|NCT01183221|365103035|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
105848043|NCT03596151|365103036|FG000|Overall Study|Withdrawal by Subject|1|||
105848044|NCT03310411|365103037|FG000|Period 1|Adverse Event|0|||
106149862|NCT04019444|366209258|FG001|Overall Study|Withdrawal by Subject|1|||
105848045|NCT03310411|365103038|FG001|Period 1|Adverse Event|0|||
105848046|NCT03310411|365103039|FG002|Period 1|Adverse Event|0|||
105848047|NCT03310411|365103040|FG003|Period 1|Adverse Event|1|||
105848048|NCT03623386|365103044|FG000|Overall Study|Protocol Violation|3|||
105848049|NCT03623386|365103045|FG001|Overall Study|Protocol Violation|2|||
105848050|NCT03623386|365103046|FG002|Overall Study|Protocol Violation|0|||
105848051|NCT03623386|365103044|FG000|Overall Study|Physician Decision|1|||
105848052|NCT03623386|365103045|FG001|Overall Study|Physician Decision|1|||
106149863|NCT04019444|366209259|FG002|Overall Study|Withdrawal by Subject|0|||
106149864|NCT04019444|366209260|FG003|Overall Study|Withdrawal by Subject|1|||
106149865|NCT04019444|366209257|FG000|Overall Study|Solicited Event|0|||
106149866|NCT04019444|366209258|FG001|Overall Study|Solicited Event|0|||
106149867|NCT04019444|366209259|FG002|Overall Study|Solicited Event|2|||
106149868|NCT04019444|366209260|FG003|Overall Study|Solicited Event|0|||
106149869|NCT01609218|366209261|FG000|Period 1|Adverse Event|3|||
106149870|NCT01609218|366209262|FG001|Period 1|Adverse Event|5|||
106149871|NCT01609218|366209261|FG000|Period 1|Sponsor Decision|0|||
106149872|NCT01609218|366209262|FG001|Period 1|Sponsor Decision|1|||
106149873|NCT01609218|366209261|FG000|Period 2|Adverse Event|1|||
106149874|NCT01609218|366209262|FG001|Period 2|Adverse Event|0|||
106149875|NCT01303445|366209265|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
106149876|NCT01303445|366209266|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
106149877|NCT01303445|366209265|FG000|Second Intervention (7 Days)|Adverse Event|0|||
106149878|NCT01303445|366209266|FG001|Second Intervention (7 Days)|Adverse Event|2|||
106149879|NCT01303445|366209265|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
106149880|NCT01303445|366209266|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
105848053|NCT03623386|365103046|FG002|Overall Study|Physician Decision|0|||
105848054|NCT03623386|365103044|FG000|Overall Study|Lost to Follow-up|0|||
105848055|NCT03623386|365103045|FG001|Overall Study|Lost to Follow-up|2|||
105848056|NCT03623386|365103046|FG002|Overall Study|Lost to Follow-up|0|||
105848057|NCT03623386|365103044|FG000|Overall Study|COVID-19|0|||
105848058|NCT03623386|365103045|FG001|Overall Study|COVID-19|1|||
105848059|NCT03623386|365103046|FG002|Overall Study|COVID-19|0|||
105848060|NCT00729248|365103047|FG000|Overall Study|Physician Decision|2|||
105848061|NCT03222583|365103048|FG000|Overall Study|Withdrawal by Subject|3|||
105848062|NCT03222583|365103049|FG001|Overall Study|Withdrawal by Subject|3|||
105848063|NCT03222583|365103048|FG000|Overall Study|Lost to Follow-up|1|||
105848064|NCT03222583|365103049|FG001|Overall Study|Lost to Follow-up|0|||
105848065|NCT03222583|365103048|FG000|Overall Study|Other|1|||
105848066|NCT03222583|365103049|FG001|Overall Study|Other|3|||
105848067|NCT04280705|365103050|FG000|Overall Study|Enrolled but not treated|4|||
105848068|NCT04280705|365103051|FG001|Overall Study|Enrolled but not treated|10|||
105848069|NCT04280705|365103050|FG000|Overall Study|Physician Decision|1|||
105848070|NCT04280705|365103051|FG001|Overall Study|Physician Decision|0|||
105848071|NCT04280705|365103050|FG000|Overall Study|Withdrawal by Subject|7|||
105848072|NCT04280705|365103051|FG001|Overall Study|Withdrawal by Subject|9|||
105848073|NCT04280705|365103050|FG000|Overall Study|Adverse Event|0|||
105848074|NCT04280705|365103051|FG001|Overall Study|Adverse Event|4|||
105848075|NCT04280705|365103050|FG000|Overall Study|Transferred to another hospital|1|||
105848076|NCT04280705|365103051|FG001|Overall Study|Transferred to another hospital|1|||
105848077|NCT03573505|365103052|FG000|Overall Study|Adverse Event|1|||
105848078|NCT03573505|365103053|FG001|Overall Study|Adverse Event|1|||
105848079|NCT03573505|365103052|FG000|Overall Study|Consent withdrawn|0|||
105848080|NCT03573505|365103053|FG001|Overall Study|Consent withdrawn|1|||
105848081|NCT03573505|365103052|FG000|Overall Study|Disease progression|0|||
105848082|NCT03573505|365103053|FG001|Overall Study|Disease progression|1|||
105848083|NCT03573505|365103052|FG000|Overall Study|Site Terminated by Sponsor|1|||
105848084|NCT03573505|365103053|FG001|Overall Study|Site Terminated by Sponsor|1|||
105848085|NCT03573505|365103052|FG000|Overall Study|Study terminated by sponsor|50|||
105848086|NCT03573505|365103053|FG001|Overall Study|Study terminated by sponsor|45|||
105848087|NCT03573505|365103052|FG000|Overall Study|Reason not specified|0|||
105848088|NCT03573505|365103053|FG001|Overall Study|Reason not specified|1|||
105848089|NCT03573505|365103052|FG000|Overall Study|Death|0|||
105848090|NCT03573505|365103053|FG001|Overall Study|Death|4|||
105848091|NCT04271735|365103054|FG000|Overall Study|Physician Decision|2|||
105848092|NCT04271735|365103055|FG001|Overall Study|Physician Decision|0|||
105848093|NCT00515541|365103056|FG000|Overall Study|Physician Decision|0|||
105848094|NCT00515541|365103057|FG001|Overall Study|Physician Decision|2|||
105848095|NCT00515541|365103058|FG002|Overall Study|Physician Decision|0|||
105848096|NCT00515541|365103059|FG003|Overall Study|Physician Decision|1|||
105848097|NCT00515541|365103056|FG000|Overall Study|No show for appointments|0|||
106149881|NCT01303445|366209265|FG000|Washout (14 Days)|Protocol Violation|1|||
106149882|NCT01303445|366209266|FG001|Washout (14 Days)|Protocol Violation|0|||
106149883|NCT01303445|366209265|FG000|Washout (14 Days)|Lost to Follow-up|0|||
106149884|NCT01303445|366209266|FG001|Washout (14 Days)|Lost to Follow-up|2|||
106149885|NCT01303445|366209265|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
106149886|NCT01303445|366209266|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
106149887|NCT01303445|366209265|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
106149888|NCT01303445|366209266|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
106149889|NCT03759379|366210386|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
106149890|NCT03759379|366210387|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
106149891|NCT03759379|366210386|FG000|Treatment Period|Death|2|||
105848098|NCT00515541|365103057|FG001|Overall Study|No show for appointments|1|||
105848099|NCT00515541|365103058|FG002|Overall Study|No show for appointments|0|||
105848100|NCT00515541|365103059|FG003|Overall Study|No show for appointments|2|||
106149892|NCT03759379|366210387|FG001|Treatment Period|Death|3|||
106149893|NCT03759379|366210386|FG000|Treatment Period|Lost to Follow-up|1|||
106149894|NCT03759379|366210387|FG001|Treatment Period|Lost to Follow-up|0|||
106149895|NCT03759379|366210386|FG000|Treatment Period|Physician Decision|0|||
106149896|NCT03759379|366210387|FG001|Treatment Period|Physician Decision|1|||
106149897|NCT03122886|366210388|FG000|Overall Study|Withdrawal by Subject|1|||
106149898|NCT03122886|366210389|FG001|Overall Study|Withdrawal by Subject|2|||
106149899|NCT05985044|366210392|FG000|Overall Study|Death|6|||
106149900|NCT05985044|366210392|FG000|Overall Study|Lost to Follow-up|4|||
106149901|NCT05985044|366210392|FG000|Overall Study|Incapacitation|3|||
106149902|NCT05985044|366210392|FG000|Overall Study|Withdrawal by Subject|2|||
106149903|NCT02279095|366210395|FG000|Overall Study|Non-Compliance|1|||
106149904|NCT02279095|366210395|FG000|Overall Study|Withdrawal by Subject|8|||
106149905|NCT02279095|366210395|FG000|Overall Study|Adverse Event|2|||
106149906|NCT02279095|366210395|FG000|Overall Study|Other|7|||
106149907|NCT02279095|366210395|FG000|Overall Study|Lost to Follow-up|1|||
106149908|NCT03073941|366210396|FG000|Overall Study|Received non-study device intraoperatively|0|||
106149909|NCT03073941|366210397|FG001|Overall Study|Received non-study device intraoperatively|2|||
106149910|NCT03073941|366210396|FG000|Overall Study|Death|1|||
106149911|NCT03073941|366210397|FG001|Overall Study|Death|0|||
106149912|NCT03073941|366210396|FG000|Overall Study|Withdrawal by Subject|1|||
105848101|NCT00515541|365103056|FG000|Overall Study|Withdrawal by Subject|0|||
105848102|NCT00515541|365103057|FG001|Overall Study|Withdrawal by Subject|2|||
105848103|NCT00515541|365103058|FG002|Overall Study|Withdrawal by Subject|0|||
105848104|NCT00515541|365103059|FG003|Overall Study|Withdrawal by Subject|2|||
105848105|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Adverse Event|9|||
105848106|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Adverse Event|4|||
105848107|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Adverse Event|5|||
105848108|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Adverse Event|9|||
105848109|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Adverse Event|8|||
105848110|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Adverse Event|0|||
105848111|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Adverse Event|0|||
105848112|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
105848113|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
105848114|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
105848115|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
105848116|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
105848117|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
105848118|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
105848119|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Death|1|||
105848120|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Death|1|||
105848121|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Death|1|||
105848122|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Death|1|||
105848123|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Death|0|||
105848124|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Death|0|||
105848125|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Death|0|||
105848126|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
105848127|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
105848128|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
105848129|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
105848130|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
105848131|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
105848132|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
105848133|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848134|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848135|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
105848136|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848137|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848138|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848139|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
105848140|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
105848141|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
105848142|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
105848143|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
105848144|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
105848145|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
105848146|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
106149913|NCT03073941|366210397|FG001|Overall Study|Withdrawal by Subject|3|||
106149914|NCT03073941|366210396|FG000|Overall Study|Lost to Follow-up|5|||
106149915|NCT03073941|366210397|FG001|Overall Study|Lost to Follow-up|4|||
106149916|NCT03073941|366210396|FG000|Overall Study|Adverse Event|4|||
106149917|NCT03073941|366210397|FG001|Overall Study|Adverse Event|2|||
106149918|NCT03073941|366210396|FG000|Overall Study|Met an exclusion criterion|0|||
106149919|NCT03073941|366210397|FG001|Overall Study|Met an exclusion criterion|1|||
106149920|NCT02763319|366210399|FG000|Overall Study|Adverse Event|12|||
105971932|NCT00075725|365556860|FG002|Overall Study|Other|1|||
105971933|NCT00075725|365556861|FG003|Overall Study|Other|1|||
105971934|NCT00075725|365556862|FG004|Overall Study|Other|1|||
105971935|NCT00075725|365556863|FG005|Overall Study|Other|4|||
105971936|NCT00075725|365556864|FG006|Overall Study|Other|2|||
105971937|NCT00075725|365556865|FG007|Overall Study|Other|9|||
105971938|NCT00075725|365556866|FG008|Overall Study|Other|2|||
105971939|NCT00075725|365556867|FG009|Overall Study|Other|1|||
105971940|NCT00075725|365556868|FG010|Overall Study|Other|0|||
105971941|NCT00075725|365556869|FG011|Overall Study|Other|3|||
105971942|NCT00075725|365556858|FG000|Overall Study|Pt trying to find a BM donor|0|||
105971943|NCT00075725|365556859|FG001|Overall Study|Pt trying to find a BM donor|1|||
105971944|NCT00075725|365556860|FG002|Overall Study|Pt trying to find a BM donor|0|||
105971945|NCT00075725|365556861|FG003|Overall Study|Pt trying to find a BM donor|0|||
105971946|NCT00075725|365556862|FG004|Overall Study|Pt trying to find a BM donor|0|||
105971947|NCT00075725|365556863|FG005|Overall Study|Pt trying to find a BM donor|0|||
105971948|NCT00075725|365556864|FG006|Overall Study|Pt trying to find a BM donor|0|||
105971949|NCT00075725|365556865|FG007|Overall Study|Pt trying to find a BM donor|0|||
105971950|NCT00075725|365556866|FG008|Overall Study|Pt trying to find a BM donor|0|||
105971951|NCT00075725|365556867|FG009|Overall Study|Pt trying to find a BM donor|0|||
105971952|NCT00075725|365556868|FG010|Overall Study|Pt trying to find a BM donor|0|||
105971953|NCT00075725|365556869|FG011|Overall Study|Pt trying to find a BM donor|0|||
105971954|NCT00075725|365556858|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
105971955|NCT00075725|365556859|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
105971956|NCT00075725|365556860|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
105971957|NCT00075725|365556861|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
105971958|NCT00075725|365556862|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
105971959|NCT00075725|365556863|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
105971960|NCT00075725|365556864|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
105971961|NCT00075725|365556865|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
105971962|NCT00075725|365556866|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
105971963|NCT00075725|365556867|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
105971964|NCT00075725|365556868|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
105971965|NCT00075725|365556869|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
105971966|NCT00075725|365556858|FG000|Overall Study|Unsuccessful institutional transfer|0|||
105971967|NCT00075725|365556859|FG001|Overall Study|Unsuccessful institutional transfer|0|||
105971968|NCT00075725|365556860|FG002|Overall Study|Unsuccessful institutional transfer|2|||
105971969|NCT00075725|365556861|FG003|Overall Study|Unsuccessful institutional transfer|0|||
105971970|NCT00075725|365556862|FG004|Overall Study|Unsuccessful institutional transfer|0|||
105971971|NCT00075725|365556863|FG005|Overall Study|Unsuccessful institutional transfer|0|||
105971972|NCT00075725|365556864|FG006|Overall Study|Unsuccessful institutional transfer|0|||
105971973|NCT00075725|365556865|FG007|Overall Study|Unsuccessful institutional transfer|0|||
105971974|NCT00075725|365556866|FG008|Overall Study|Unsuccessful institutional transfer|0|||
105971975|NCT00075725|365556867|FG009|Overall Study|Unsuccessful institutional transfer|1|||
105971976|NCT00075725|365556868|FG010|Overall Study|Unsuccessful institutional transfer|0|||
106149921|NCT02763319|366210400|FG001|Overall Study|Adverse Event|3|||
105848147|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Other|2|||
105848148|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Other|9|||
105848149|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Other|9|||
105848150|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Other|3|||
105848151|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Other|2|||
105848152|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Other|0|||
105848153|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Other|0|||
105848154|NCT00361335|365103060|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
105848155|NCT00361335|365103061|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
105848156|NCT00361335|365103062|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
105848157|NCT00361335|365103063|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
105848158|NCT00361335|365103064|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
105848159|NCT00361335|365103065|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
105848160|NCT00361335|365103066|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
105848161|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
105848162|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
105848163|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
105971977|NCT00075725|365556869|FG011|Overall Study|Unsuccessful institutional transfer|0|||
105971978|NCT00075725|365556858|FG000|Overall Study|specimen(s) not submitted|0|||
105971979|NCT00075725|365556859|FG001|Overall Study|specimen(s) not submitted|0|||
105971980|NCT00075725|365556860|FG002|Overall Study|specimen(s) not submitted|2|||
105971981|NCT00075725|365556861|FG003|Overall Study|specimen(s) not submitted|0|||
105971982|NCT00075725|365556862|FG004|Overall Study|specimen(s) not submitted|0|||
105971983|NCT00075725|365556863|FG005|Overall Study|specimen(s) not submitted|0|||
105971984|NCT00075725|365556864|FG006|Overall Study|specimen(s) not submitted|0|||
105971985|NCT00075725|365556865|FG007|Overall Study|specimen(s) not submitted|0|||
105848164|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
106149922|NCT02763319|366210399|FG000|Overall Study|Death|123|||
106149923|NCT02763319|366210400|FG001|Overall Study|Death|123|||
106149924|NCT02763319|366210399|FG000|Overall Study|Lost to Follow-up|6|||
106149925|NCT02763319|366210400|FG001|Overall Study|Lost to Follow-up|7|||
106149926|NCT02763319|366210399|FG000|Overall Study|Noncompliance with Study Drug|2|||
106149927|NCT02763319|366210400|FG001|Overall Study|Noncompliance with Study Drug|0|||
106149928|NCT02763319|366210399|FG000|Overall Study|"Captured as Other in Database"|29|||
106149929|NCT02763319|366210400|FG001|Overall Study|"Captured as Other in Database"|34|||
106149930|NCT02763319|366210399|FG000|Overall Study|Physician Decision|1|||
106149931|NCT02763319|366210400|FG001|Overall Study|Physician Decision|7|||
106149932|NCT02763319|366210399|FG000|Overall Study|Progressive Disease|24|||
106149933|NCT02763319|366210400|FG001|Overall Study|Progressive Disease|27|||
106149934|NCT02763319|366210399|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
106149935|NCT02763319|366210400|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
106149936|NCT02763319|366210399|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
106149937|NCT02763319|366210400|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
106149938|NCT02763319|366210399|FG000|Overall Study|Withdrawal by Subject|26|||
106149939|NCT02763319|366210400|FG001|Overall Study|Withdrawal by Subject|25|||
105848165|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
105848166|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
105848167|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
105848168|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
105848169|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
105848170|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
105848171|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
105848172|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
105848173|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
105848174|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
105848175|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Death|0|||
105848176|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Death|0|||
105848177|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Death|0|||
105848178|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Death|0|||
105848179|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Death|0|||
105848180|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Death|0|||
105848181|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Death|1|||
105848182|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
105848183|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
105848184|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
105848185|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
105848186|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
105848187|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
105848188|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
105848189|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Other|1|||
105848190|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Other|0|||
105848191|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Other|0|||
105848192|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Other|1|||
105848193|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Other|0|||
105848194|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Other|1|||
105848195|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Other|2|||
105848196|NCT00361335|365103060|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848197|NCT00361335|365103061|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848198|NCT00361335|365103062|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
105848199|NCT00361335|365103063|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848200|NCT00361335|365103064|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848201|NCT00361335|365103065|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
105848202|NCT00361335|365103066|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
105848203|NCT01959035|365103067|FG000|Overall Study|Adverse Event|5|||
105848204|NCT01959035|365103067|FG000|Overall Study|Withdrawal by Subject|4|||
105848205|NCT01959035|365103067|FG000|Overall Study|Lost to Follow-up|1|||
105848206|NCT01959035|365103067|FG000|Overall Study|Other (no primary reason given)|1|||
106149940|NCT04153565|366210401|FG000|Overall Study|Death|13|||
105848207|NCT00450619|365103068|FG000|Overall Study|refused treatment after randomization|2|||
105848208|NCT00450619|365103069|FG001|Overall Study|refused treatment after randomization|0|||
105848209|NCT00450619|365103068|FG000|Overall Study|did not progress; refused further trmt|1|||
105848210|NCT00450619|365103069|FG001|Overall Study|did not progress; refused further trmt|1|||
105848211|NCT00450619|365103068|FG000|Overall Study|Adverse Event|1|||
106149941|NCT04903288|366210404|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
105848212|NCT00450619|365103069|FG001|Overall Study|Adverse Event|0|||
106149942|NCT04903288|366210404|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
105848213|NCT00986180|365103070|FG000|Overall Study|Adverse Event|21|||
106149943|NCT04903288|366210404|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
106149944|NCT04903288|366210404|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
105848214|NCT00986180|365103071|FG001|Overall Study|Adverse Event|23|||
105848215|NCT00986180|365103070|FG000|Overall Study|Lack of Efficacy|4|||
105848216|NCT00986180|365103071|FG001|Overall Study|Lack of Efficacy|3|||
105848217|NCT00986180|365103070|FG000|Overall Study|Lost to Follow-up|5|||
105848218|NCT00986180|365103071|FG001|Overall Study|Lost to Follow-up|7|||
105848219|NCT00986180|365103070|FG000|Overall Study|Physician Decision|1|||
105848220|NCT00986180|365103071|FG001|Overall Study|Physician Decision|3|||
105848221|NCT00986180|365103070|FG000|Overall Study|Protocol Violation|2|||
105848222|NCT00986180|365103071|FG001|Overall Study|Protocol Violation|0|||
105848223|NCT00986180|365103070|FG000|Overall Study|Withdrawal by Subject|1|||
105848224|NCT00986180|365103071|FG001|Overall Study|Withdrawal by Subject|9|||
105848225|NCT00986180|365103070|FG000|Overall Study|Miscellanies|10|||
105848226|NCT00986180|365103071|FG001|Overall Study|Miscellanies|11|||
105848227|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
105848228|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
105848229|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
105848230|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
105848231|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
105848232|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
105848233|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
105848234|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
105848235|NCT03822832|365103079|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
105848236|NCT03822832|365103080|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
105848237|NCT03822832|365103079|FG000|Re-allocation|Not re-allocated to open label period|2|||
105848238|NCT03822832|365103080|FG001|Re-allocation|Not re-allocated to open label period|6|||
105848239|NCT03822832|365103079|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
105848240|NCT03822832|365103080|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
105848241|NCT03822832|365103079|FG000|Period 2 - Open Label Period|Adverse Event|0|||
105848242|NCT03822832|365103080|FG001|Period 2 - Open Label Period|Adverse Event|3|||
105848243|NCT03347422|365103081|FG000|Part A (26 Weeks)|Adverse Event|3|||
105848244|NCT03347422|365103082|FG001|Part A (26 Weeks)|Adverse Event|0|||
105848245|NCT03347422|365103081|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
105848246|NCT03347422|365103082|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
105848247|NCT03347422|365103081|FG000|Part B (149 Weeks)|Adverse Event|0|||
105848248|NCT03347422|365103082|FG001|Part B (149 Weeks)|Adverse Event|1|||
105848249|NCT03347422|365103081|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
105848250|NCT03347422|365103082|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
105848251|NCT03347422|365103081|FG000|Part B (149 Weeks)|Other|1|||
105848252|NCT03347422|365103082|FG001|Part B (149 Weeks)|Other|0|||
105848253|NCT02792959|365103087|FG000|Overall Study|Protocol Violation|1|||
105848254|NCT04594707|365103088|FG000|Overall Study|Adverse Event|0|||
106149945|NCT01939899|366210405|FG000|Lead-in Dose Finding Phase|Death|0|||
106149946|NCT01939899|366210406|FG001|Lead-in Dose Finding Phase|Death|3|||
106149947|NCT01939899|366210407|FG002|Lead-in Dose Finding Phase|Death|1|||
106149948|NCT01939899|366210408|FG003|Lead-in Dose Finding Phase|Death|0|||
106149949|NCT01939899|366210409|FG004|Lead-in Dose Finding Phase|Death|0|||
106149950|NCT01939899|366210405|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
106149951|NCT01939899|366210406|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
106149952|NCT01939899|366210407|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
106149953|NCT01939899|366210408|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
106149954|NCT01939899|366210409|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
106149955|NCT01939899|366210405|FG000|Lead-in Dose Finding Phase|Other|0|||
106149956|NCT01939899|366210406|FG001|Lead-in Dose Finding Phase|Other|0|||
106149957|NCT01939899|366210407|FG002|Lead-in Dose Finding Phase|Other|1|||
106149958|NCT01939899|366210408|FG003|Lead-in Dose Finding Phase|Other|0|||
106149959|NCT01939899|366210409|FG004|Lead-in Dose Finding Phase|Other|0|||
106149960|NCT01939899|366210405|FG000|Phase 2|Withdrawal by Subject|0|||
106149961|NCT01939899|366210406|FG001|Phase 2|Withdrawal by Subject|0|||
106149962|NCT01939899|366210407|FG002|Phase 2|Withdrawal by Subject|0|||
106149963|NCT01939899|366210408|FG003|Phase 2|Withdrawal by Subject|2|||
106149964|NCT01939899|366210409|FG004|Phase 2|Withdrawal by Subject|0|||
106149965|NCT01939899|366210405|FG000|Phase 2|Disease Progression|0|||
106149966|NCT01939899|366210406|FG001|Phase 2|Disease Progression|0|||
106149967|NCT01939899|366210407|FG002|Phase 2|Disease Progression|0|||
106149968|NCT01939899|366210408|FG003|Phase 2|Disease Progression|9|||
106149969|NCT01939899|366210409|FG004|Phase 2|Disease Progression|1|||
106149970|NCT00585052|366210410|FG000|Overall Study|Withdrawal by Subject|1|||
105848255|NCT04594707|365103089|FG001|Overall Study|Adverse Event|0|||
105848256|NCT04594707|365103090|FG002|Overall Study|Adverse Event|1|||
105971986|NCT00075725|365556866|FG008|Overall Study|specimen(s) not submitted|0|||
106149971|NCT05119855|366210411|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
106149972|NCT05119855|366210412|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
106149973|NCT05119855|366210411|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
106149974|NCT05119855|366210412|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
106149975|NCT05119855|366210411|FG000|Overall Study|Lost to Follow-up|6|||
106149976|NCT05119855|366210412|FG001|Overall Study|Lost to Follow-up|8|||
106149977|NCT02675244|366210414|FG000|Overall Study|Death|9|||
106149978|NCT02675244|366210415|FG001|Overall Study|Death|6|||
106149979|NCT02675244|366210414|FG000|Overall Study|Withdrawal by Subject|3|||
105848257|NCT04594707|365103088|FG000|Overall Study|Death|0|||
105848258|NCT04594707|365103089|FG001|Overall Study|Death|2|||
105848259|NCT04594707|365103090|FG002|Overall Study|Death|2|||
105848260|NCT04594707|365103088|FG000|Overall Study|Lung Transplant|0|||
105848261|NCT04594707|365103089|FG001|Overall Study|Lung Transplant|0|||
105848262|NCT04594707|365103090|FG002|Overall Study|Lung Transplant|1|||
105848263|NCT04594707|365103088|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
105848264|NCT04594707|365103089|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
105848265|NCT04594707|365103090|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
105848266|NCT04594707|365103088|FG000|Overall Study|Study Terminated By Sponsor|19|||
105848267|NCT04594707|365103089|FG001|Overall Study|Study Terminated By Sponsor|47|||
105848268|NCT04594707|365103090|FG002|Overall Study|Study Terminated By Sponsor|41|||
105848269|NCT04594707|365103088|FG000|Overall Study|Withdrawal by Subject|1|||
105848270|NCT04594707|365103089|FG001|Overall Study|Withdrawal by Subject|0|||
105848271|NCT04594707|365103090|FG002|Overall Study|Withdrawal by Subject|2|||
105848272|NCT04392583|365103091|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
105848273|NCT02303041|365103092|FG000|Overall Study|Adverse Event|1|||
105848274|NCT02303041|365103093|FG001|Overall Study|Adverse Event|2|||
105848275|NCT04168190|365103094|FG000|Overall Study|Lost to Follow-up|0|||
105848276|NCT04168190|365103095|FG001|Overall Study|Lost to Follow-up|1|||
105848277|NCT04168190|365103096|FG002|Overall Study|Lost to Follow-up|0|||
105848278|NCT04168190|365103097|FG003|Overall Study|Lost to Follow-up|7|||
105848279|NCT04168190|365103098|FG004|Overall Study|Lost to Follow-up|5|||
105848280|NCT04168190|365103094|FG000|Overall Study|Withdrawal by Subject|1|||
105848281|NCT04168190|365103095|FG001|Overall Study|Withdrawal by Subject|0|||
105848282|NCT04168190|365103096|FG002|Overall Study|Withdrawal by Subject|0|||
105848283|NCT04168190|365103097|FG003|Overall Study|Withdrawal by Subject|2|||
105848284|NCT04168190|365103098|FG004|Overall Study|Withdrawal by Subject|4|||
105848285|NCT04168190|365103094|FG000|Overall Study|Death|0|||
105848286|NCT04168190|365103095|FG001|Overall Study|Death|0|||
105848287|NCT04168190|365103096|FG002|Overall Study|Death|0|||
105848288|NCT04168190|365103097|FG003|Overall Study|Death|1|||
105848289|NCT04168190|365103098|FG004|Overall Study|Death|0|||
105848290|NCT01169532|365103099|FG000|Overall Study|Withdrawal by Subject|1|||
105848291|NCT02032706|365103102|FG000|Overall Study|Did not qualify|5|||
105848292|NCT02032706|365103102|FG000|Overall Study|Protocol Violation|1|||
105848293|NCT01156142|365103103|FG000|Overall Study|Withdrawal by Subject|8|||
105848294|NCT01156142|365103104|FG001|Overall Study|Withdrawal by Subject|6|||
105848295|NCT01156142|365103103|FG000|Overall Study|Ineligible|0|||
105848296|NCT01156142|365103104|FG001|Overall Study|Ineligible|1|||
105848297|NCT02731326|365103109|FG000|Overall Study|Withdrawal by Subject|4|||
105848298|NCT02731326|365103110|FG001|Overall Study|Withdrawal by Subject|1|||
105848299|NCT02731326|365103109|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
105848300|NCT02731326|365103110|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
105848301|NCT02731326|365103109|FG000|Overall Study|Discharged without AliveCor|10|||
105848302|NCT02731326|365103110|FG001|Overall Study|Discharged without AliveCor|0|||
105848303|NCT02731326|365103109|FG000|Overall Study|Duplicate Participant|1|||
105848304|NCT02731326|365103110|FG001|Overall Study|Duplicate Participant|1|||
105848305|NCT04620135|365103112|FG000|Study Completion|Adverse Event|2|||
105848306|NCT04620135|365103113|FG001|Study Completion|Adverse Event|3|||
105848307|NCT04620135|365103112|FG000|Study Completion|Withdrawal by Subject|2|||
105848308|NCT04620135|365103113|FG001|Study Completion|Withdrawal by Subject|0|||
105848309|NCT03979820|365103115|FG000|Overall Study|Protocol Violation|1|||
105848310|NCT03979820|365103116|FG001|Overall Study|Protocol Violation|0|||
105848311|NCT03979820|365103117|FG002|Overall Study|Protocol Violation|0|||
106149980|NCT02675244|366210415|FG001|Overall Study|Withdrawal by Subject|6|||
105848312|NCT03979820|365103118|FG003|Overall Study|Protocol Violation|0|||
105848313|NCT03979820|365103115|FG000|Overall Study|Withdrawal by Subject|0|||
105848314|NCT03979820|365103116|FG001|Overall Study|Withdrawal by Subject|0|||
105848315|NCT03979820|365103117|FG002|Overall Study|Withdrawal by Subject|1|||
105848316|NCT03979820|365103118|FG003|Overall Study|Withdrawal by Subject|0|||
105848317|NCT03979820|365103115|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
105848318|NCT03979820|365103116|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
106149981|NCT02675244|366210414|FG000|Overall Study|Lost to Follow-up|1|||
105848319|NCT03979820|365103117|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
105848320|NCT03979820|365103118|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
105848321|NCT02143583|365103127|FG000|Overall Study|Withdrawal by Subject|1|||
106149982|NCT02675244|366210415|FG001|Overall Study|Lost to Follow-up|1|||
106149983|NCT02675244|366210414|FG000|Overall Study|Ongoing at 2 Years|190|||
106149984|NCT02675244|366210415|FG001|Overall Study|Ongoing at 2 Years|185|||
106024789|NCT00612105|365756642|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
106024790|NCT00612105|365756641|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
106024791|NCT00612105|365756642|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
106024792|NCT00612105|365756641|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
106024793|NCT00612105|365756642|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
106024794|NCT00612105|365756641|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
106024795|NCT00612105|365756642|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
106024796|NCT00612105|365756641|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
106024797|NCT00612105|365756642|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
106024798|NCT00612105|365756641|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
106024799|NCT00612105|365756642|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
106024800|NCT00612105|365756641|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
106024801|NCT00612105|365756642|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
106024802|NCT00612105|365756641|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
106024803|NCT00612105|365756642|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
106024804|NCT00612105|365756641|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
106024805|NCT00612105|365756642|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
106024806|NCT00612105|365756641|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
106024807|NCT00612105|365756642|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
106024808|NCT00612105|365756641|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
106024809|NCT00612105|365756642|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
105848322|NCT02143583|365103128|FG001|Overall Study|Withdrawal by Subject|0|||
105848323|NCT02143583|365103129|FG002|Overall Study|Withdrawal by Subject|1|||
105848324|NCT02143583|365103127|FG000|Overall Study|husband illness|0|||
105848325|NCT02143583|365103128|FG001|Overall Study|husband illness|0|||
105848326|NCT02143583|365103129|FG002|Overall Study|husband illness|1|||
105848327|NCT01940497|365103130|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
105848328|NCT01940497|365103131|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
105848329|NCT01940497|365103130|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
105848330|NCT01940497|365103131|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
105848331|NCT01940497|365103130|FG000|Overall Study|Violation of Entry Criteria|1|||
105848332|NCT01940497|365103131|FG001|Overall Study|Violation of Entry Criteria|1|||
105848333|NCT01940497|365103130|FG000|Overall Study|Refused Treatment|1|||
105848334|NCT01940497|365103131|FG001|Overall Study|Refused Treatment|3|||
105848335|NCT01940497|365103130|FG000|Overall Study|Withdrew Consent|6|||
105848336|NCT01940497|365103131|FG001|Overall Study|Withdrew Consent|2|||
105848337|NCT01940497|365103130|FG000|Overall Study|Administrative/Other|1|||
105848338|NCT01940497|365103131|FG001|Overall Study|Administrative/Other|1|||
105848339|NCT01641133|365103132|FG000|Overall Study|Protocol Violation|0|||
105848340|NCT01641133|365103133|FG001|Overall Study|Protocol Violation|1|||
105848341|NCT01641133|365103134|FG002|Overall Study|Protocol Violation|1|||
105848342|NCT01641133|365103132|FG000|Overall Study|Migrated/moved from study area|5|||
105848343|NCT01641133|365103133|FG001|Overall Study|Migrated/moved from study area|3|||
105848344|NCT01641133|365103134|FG002|Overall Study|Migrated/moved from study area|1|||
105848345|NCT01641133|365103132|FG000|Overall Study|Adverse Event|0|||
105848346|NCT01641133|365103133|FG001|Overall Study|Adverse Event|0|||
105848347|NCT01641133|365103134|FG002|Overall Study|Adverse Event|1|||
106024810|NCT02929407|365756646|FG000|Overall Study|Adverse Event|1|||
105848348|NCT01641133|365103132|FG000|Overall Study|Withdrawal by Subject|5|||
105848349|NCT01641133|365103133|FG001|Overall Study|Withdrawal by Subject|3|||
105848350|NCT01641133|365103134|FG002|Overall Study|Withdrawal by Subject|3|||
105848351|NCT01641133|365103132|FG000|Overall Study|Lost to Follow-up|0|||
105848352|NCT01641133|365103133|FG001|Overall Study|Lost to Follow-up|2|||
105848353|NCT01641133|365103134|FG002|Overall Study|Lost to Follow-up|2|||
105848354|NCT03123861|365103135|FG000|Overall Study|Protocol Violation|1|||
105848355|NCT03123861|365103136|FG001|Overall Study|Protocol Violation|1|||
105848356|NCT03123861|365103135|FG000|Overall Study|Withdrawal by Subject|2|||
105848357|NCT03123861|365103136|FG001|Overall Study|Withdrawal by Subject|2|||
105848358|NCT00513682|365103137|FG000|Washout Phase|Adverse Event|2|||
105848359|NCT02206620|365103138|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105848360|NCT02206620|365103139|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105848361|NCT02206620|365103138|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
105848362|NCT02206620|365103139|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
105848363|NCT04156620|365103140|FG000|Overall Study|Adverse event - TP 1|5|||
105848364|NCT04156620|365103141|FG001|Overall Study|Adverse event - TP 1|2|||
105848365|NCT04156620|365103140|FG000|Overall Study|Lost to follow-up TP 1|1|||
105848366|NCT04156620|365103141|FG001|Overall Study|Lost to follow-up TP 1|1|||
105848367|NCT04156620|365103140|FG000|Overall Study|Progressive disease - TP 1|0|||
105971987|NCT00075725|365556867|FG009|Overall Study|specimen(s) not submitted|0|||
105971988|NCT00075725|365556868|FG010|Overall Study|specimen(s) not submitted|0|||
105971989|NCT00075725|365556869|FG011|Overall Study|specimen(s) not submitted|0|||
105971990|NCT00075725|365556858|FG000|Overall Study|Pt went to transplant|0|||
105971991|NCT00075725|365556859|FG001|Overall Study|Pt went to transplant|0|||
105971992|NCT00075725|365556860|FG002|Overall Study|Pt went to transplant|0|||
105971993|NCT00075725|365556861|FG003|Overall Study|Pt went to transplant|1|||
105971994|NCT00075725|365556862|FG004|Overall Study|Pt went to transplant|0|||
105971995|NCT00075725|365556863|FG005|Overall Study|Pt went to transplant|1|||
105971996|NCT00075725|365556864|FG006|Overall Study|Pt went to transplant|0|||
105971997|NCT00075725|365556865|FG007|Overall Study|Pt went to transplant|0|||
105971998|NCT00075725|365556866|FG008|Overall Study|Pt went to transplant|0|||
105971999|NCT00075725|365556867|FG009|Overall Study|Pt went to transplant|0|||
105972000|NCT00075725|365556868|FG010|Overall Study|Pt went to transplant|0|||
105972001|NCT00075725|365556869|FG011|Overall Study|Pt went to transplant|0|||
105972002|NCT00075725|365556858|FG000|Overall Study|Pt received additional steroids|0|||
105972003|NCT00075725|365556859|FG001|Overall Study|Pt received additional steroids|0|||
105972004|NCT00075725|365556860|FG002|Overall Study|Pt received additional steroids|0|||
105972005|NCT00075725|365556861|FG003|Overall Study|Pt received additional steroids|1|||
105972006|NCT00075725|365556862|FG004|Overall Study|Pt received additional steroids|0|||
105972007|NCT00075725|365556863|FG005|Overall Study|Pt received additional steroids|0|||
105972008|NCT00075725|365556864|FG006|Overall Study|Pt received additional steroids|0|||
105972009|NCT00075725|365556865|FG007|Overall Study|Pt received additional steroids|0|||
105972010|NCT00075725|365556866|FG008|Overall Study|Pt received additional steroids|0|||
105972011|NCT00075725|365556867|FG009|Overall Study|Pt received additional steroids|0|||
105972012|NCT00075725|365556868|FG010|Overall Study|Pt received additional steroids|0|||
105972013|NCT00075725|365556869|FG011|Overall Study|Pt received additional steroids|0|||
105972014|NCT00075725|365556858|FG000|Overall Study|Pt relocated|0|||
105972015|NCT00075725|365556859|FG001|Overall Study|Pt relocated|0|||
105972016|NCT00075725|365556860|FG002|Overall Study|Pt relocated|0|||
105972017|NCT00075725|365556861|FG003|Overall Study|Pt relocated|2|||
105972018|NCT00075725|365556862|FG004|Overall Study|Pt relocated|0|||
105972019|NCT00075725|365556863|FG005|Overall Study|Pt relocated|1|||
105972020|NCT00075725|365556864|FG006|Overall Study|Pt relocated|1|||
105972021|NCT00075725|365556865|FG007|Overall Study|Pt relocated|2|||
105972022|NCT00075725|365556866|FG008|Overall Study|Pt relocated|1|||
105972023|NCT00075725|365556867|FG009|Overall Study|Pt relocated|0|||
105972024|NCT00075725|365556868|FG010|Overall Study|Pt relocated|0|||
105972025|NCT00075725|365556869|FG011|Overall Study|Pt relocated|0|||
105972026|NCT00075725|365556858|FG000|Overall Study|Institution Terminated|0|||
105972027|NCT00075725|365556859|FG001|Overall Study|Institution Terminated|0|||
105972028|NCT00075725|365556860|FG002|Overall Study|Institution Terminated|0|||
105972029|NCT00075725|365556861|FG003|Overall Study|Institution Terminated|0|||
105972030|NCT00075725|365556862|FG004|Overall Study|Institution Terminated|1|||
105972031|NCT00075725|365556863|FG005|Overall Study|Institution Terminated|0|||
105972032|NCT00075725|365556864|FG006|Overall Study|Institution Terminated|0|||
105972033|NCT00075725|365556865|FG007|Overall Study|Institution Terminated|3|||
105972034|NCT00075725|365556866|FG008|Overall Study|Institution Terminated|0|||
105972035|NCT00075725|365556867|FG009|Overall Study|Institution Terminated|0|||
105972036|NCT00075725|365556868|FG010|Overall Study|Institution Terminated|0|||
105972037|NCT00075725|365556869|FG011|Overall Study|Institution Terminated|0|||
105972038|NCT00075725|365556858|FG000|Overall Study|Study Closure|1|||
105972039|NCT00075725|365556859|FG001|Overall Study|Study Closure|0|||
105972040|NCT00075725|365556860|FG002|Overall Study|Study Closure|0|||
105972041|NCT00075725|365556861|FG003|Overall Study|Study Closure|0|||
105972042|NCT00075725|365556862|FG004|Overall Study|Study Closure|1|||
105972043|NCT00075725|365556863|FG005|Overall Study|Study Closure|3|||
105972044|NCT00075725|365556864|FG006|Overall Study|Study Closure|0|||
105972045|NCT00075725|365556865|FG007|Overall Study|Study Closure|1|||
105972046|NCT00075725|365556866|FG008|Overall Study|Study Closure|0|||
105972047|NCT00075725|365556867|FG009|Overall Study|Study Closure|0|||
106024811|NCT00743106|365756648|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
106024812|NCT00743106|365756649|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
106024813|NCT01761240|365756656|FG000|Overall Study|Progressive disease:radiology assessment|3|||
105972048|NCT00075725|365556868|FG010|Overall Study|Study Closure|0|||
105972049|NCT00075725|365556869|FG011|Overall Study|Study Closure|0|||
105972050|NCT00075725|365556858|FG000|Overall Study|Other complications|0|||
105972051|NCT00075725|365556859|FG001|Overall Study|Other complications|0|||
105972052|NCT00075725|365556860|FG002|Overall Study|Other complications|0|||
106024814|NCT01761240|365756657|FG001|Overall Study|Progressive disease:radiology assessment|3|||
106149985|NCT05489484|366210416|FG000|Overall Study|withdrawn|1|||
106149986|NCT02462759|366210419|FG000|Part 1: Double Blind|Death|1|||
105972053|NCT00075725|365556861|FG003|Overall Study|Other complications|0|||
105972054|NCT00075725|365556862|FG004|Overall Study|Other complications|0|||
105972055|NCT00075725|365556863|FG005|Overall Study|Other complications|1|||
105972056|NCT00075725|365556864|FG006|Overall Study|Other complications|0|||
105848368|NCT04156620|365103141|FG001|Overall Study|Progressive disease - TP 1|1|||
105848369|NCT04156620|365103140|FG000|Overall Study|Subject decision - TP 1|3|||
105848370|NCT04156620|365103141|FG001|Overall Study|Subject decision - TP 1|5|||
105848371|NCT04156620|365103140|FG000|Overall Study|Adverse event - TP 2|5|||
105848372|NCT04156620|365103141|FG001|Overall Study|Adverse event - TP 2|6|||
105848373|NCT04156620|365103140|FG000|Overall Study|Death - TP 2|1|||
105848374|NCT04156620|365103141|FG001|Overall Study|Death - TP 2|0|||
105848375|NCT04156620|365103140|FG000|Overall Study|Lost to follow-up - TP 2|5|||
105848376|NCT04156620|365103141|FG001|Overall Study|Lost to follow-up - TP 2|2|||
105848377|NCT04156620|365103140|FG000|Overall Study|Physician decision - TP 2|4|||
105848378|NCT04156620|365103141|FG001|Overall Study|Physician decision - TP 2|2|||
105848379|NCT04156620|365103140|FG000|Overall Study|Pregnancy - TP 2|1|||
105848380|NCT04156620|365103141|FG001|Overall Study|Pregnancy - TP 2|1|||
105848381|NCT04156620|365103140|FG000|Overall Study|Subject decision - TP 2|11|||
105848382|NCT04156620|365103141|FG001|Overall Study|Subject decision - TP 2|9|||
105848383|NCT04156620|365103140|FG000|Overall Study|New therapy for study indication - TP 2|1|||
105848384|NCT04156620|365103141|FG001|Overall Study|New therapy for study indication - TP 2|0|||
105848385|NCT03212521|365103142|FG000|Overall Study|Adverse Event|1|||
105848386|NCT03212521|365103142|FG000|Overall Study|Lost to Follow-up|4|||
105848387|NCT03212521|365103142|FG000|Overall Study|Withdrawal by Subject|1|||
105848388|NCT03212521|365103142|FG000|Overall Study|Other|1|||
105848389|NCT01121666|365103145|FG000|Overall Study|Protocol Violation|29|||
105848390|NCT01121666|365103146|FG001|Overall Study|Protocol Violation|10|||
105848391|NCT00609466|365103147|FG000|Overall Study|Withdrawal by Subject|0|||
105848392|NCT00609466|365103148|FG001|Overall Study|Withdrawal by Subject|1|||
105848393|NCT00609466|365103149|FG002|Overall Study|Withdrawal by Subject|1|||
105848394|NCT00609466|365103147|FG000|Overall Study|Adverse Event|2|||
105848395|NCT00609466|365103148|FG001|Overall Study|Adverse Event|3|||
105848396|NCT00609466|365103149|FG002|Overall Study|Adverse Event|1|||
105848397|NCT00609466|365103147|FG000|Overall Study|Lack of Efficacy|0|||
105848398|NCT00609466|365103148|FG001|Overall Study|Lack of Efficacy|2|||
105848399|NCT00609466|365103149|FG002|Overall Study|Lack of Efficacy|2|||
105848400|NCT03512262|365103152|FG000|Overall Study|Adverse Event|8|||
105848401|NCT03512262|365103153|FG001|Overall Study|Adverse Event|3|||
105848402|NCT03512262|365103152|FG000|Overall Study|Death (non-treatment emergent)|1|||
105848403|NCT03512262|365103153|FG001|Overall Study|Death (non-treatment emergent)|0|||
105848404|NCT03512262|365103152|FG000|Overall Study|Withdrawal by Subject|17|||
105848405|NCT03512262|365103153|FG001|Overall Study|Withdrawal by Subject|9|||
105848406|NCT03512262|365103152|FG000|Overall Study|Lost to Follow-up|7|||
105848407|NCT03512262|365103153|FG001|Overall Study|Lost to Follow-up|1|||
105848408|NCT03512262|365103152|FG000|Overall Study|Other than Specified|2|||
105848409|NCT03512262|365103153|FG001|Overall Study|Other than Specified|2|||
105848410|NCT02013375|365103157|FG000|Overall Study|Did not engraft|1|||
105848411|NCT02013375|365103157|FG000|Overall Study|Did not engraft|1|||
105848412|NCT02674061|365103160|FG000|Overall Study|Death|229|||
105848413|NCT02674061|365103161|FG001|Overall Study|Death|77|||
105848414|NCT02674061|365103160|FG000|Overall Study|Lost to Follow-up|3|||
105848415|NCT02674061|365103161|FG001|Overall Study|Lost to Follow-up|3|||
105848416|NCT02674061|365103160|FG000|Overall Study|Withdrawal by Subject|9|||
105848417|NCT02674061|365103161|FG001|Overall Study|Withdrawal by Subject|1|||
105848418|NCT02674061|365103160|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
105848419|NCT02674061|365103161|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
105848420|NCT01602965|365103162|FG000|Overall Study|Lost to Follow-up|4|||
105848421|NCT01602965|365103163|FG001|Overall Study|Lost to Follow-up|2|||
105848422|NCT00477295|365103164|FG000|Overall Study|Adverse Event|31|||
105848423|NCT00477295|365103165|FG001|Overall Study|Adverse Event|35|||
105848424|NCT00477295|365103164|FG000|Overall Study|Withdrawal by Subject|35|||
105848425|NCT00477295|365103165|FG001|Overall Study|Withdrawal by Subject|24|||
105848426|NCT00477295|365103164|FG000|Overall Study|Lack of Efficacy|23|||
105848427|NCT00477295|365103165|FG001|Overall Study|Lack of Efficacy|23|||
105848428|NCT00477295|365103164|FG000|Overall Study|Protocol Violation|3|||
105848429|NCT00477295|365103165|FG001|Overall Study|Protocol Violation|8|||
105848430|NCT00477295|365103164|FG000|Overall Study|Physician Decision|4|||
105972057|NCT00075725|365556865|FG007|Overall Study|Other complications|0|||
105972058|NCT00075725|365556866|FG008|Overall Study|Other complications|0|||
105972059|NCT00075725|365556867|FG009|Overall Study|Other complications|0|||
105972060|NCT00075725|365556868|FG010|Overall Study|Other complications|0|||
105972061|NCT00075725|365556869|FG011|Overall Study|Other complications|0|||
105848431|NCT00477295|365103165|FG001|Overall Study|Physician Decision|5|||
105848432|NCT00477295|365103164|FG000|Overall Study|Lost to Follow-up|21|||
105848433|NCT00477295|365103165|FG001|Overall Study|Lost to Follow-up|11|||
105848434|NCT00477295|365103164|FG000|Overall Study|Other|4|||
105848435|NCT00477295|365103165|FG001|Overall Study|Other|3|||
105848436|NCT03870477|365103166|FG000|Overall Study|Early Study Termination|1|||
105848437|NCT02283294|365103167|FG000|Overall Study|Lost to Follow-up|1|||
105848438|NCT02283294|365103168|FG001|Overall Study|Lost to Follow-up|1|||
105848439|NCT02283294|365103167|FG000|Overall Study|Withdrawal by Subject|1|||
105848440|NCT02283294|365103168|FG001|Overall Study|Withdrawal by Subject|6|||
106149987|NCT02462759|366210420|FG001|Part 1: Double Blind|Death|0|||
106149988|NCT02462759|366210421|FG002|Part 1: Double Blind|Death|0|||
106149989|NCT04328727|366210427|FG000|Overall Study|Guardian Decision|1|||
106149990|NCT04328727|366210427|FG000|Overall Study|Participant decision|4|||
106149991|NCT04328727|366210427|FG000|Overall Study|Death|3|||
106149992|NCT04629950|366210428|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
106149993|NCT04629950|366210429|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
106149994|NCT04629950|366210430|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
106149995|NCT04629950|366210431|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
106149996|NCT04629950|366210428|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
106149997|NCT04629950|366210429|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
105848441|NCT02283294|365103167|FG000|Overall Study|Protocol Violation|1|||
105848442|NCT02283294|365103168|FG001|Overall Study|Protocol Violation|0|||
105848443|NCT02283294|365103167|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
105848444|NCT02283294|365103168|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
105848445|NCT00594646|365103169|FG000|Overall Study|Withdrawal by Subject|1|||
105848446|NCT00594646|365103169|FG000|Overall Study|Lost to Follow-up|15|||
105848447|NCT04268316|365104994|FG000|Overall Study|Withdrawal by Subject|2|||
105848448|NCT04268316|365104995|FG001|Overall Study|Withdrawal by Subject|1|||
105848449|NCT04268316|365104996|FG002|Overall Study|Withdrawal by Subject|0|||
105848450|NCT02040779|365104998|FG000|Overall Study|Adverse Event|1|||
105848451|NCT02040779|365104999|FG001|Overall Study|Adverse Event|0|||
105848452|NCT02040779|365105000|FG002|Overall Study|Adverse Event|0|||
105848453|NCT02040779|365104998|FG000|Overall Study|Withdrawal by Subject|4|||
105848454|NCT02040779|365104999|FG001|Overall Study|Withdrawal by Subject|1|||
105848455|NCT02040779|365105000|FG002|Overall Study|Withdrawal by Subject|3|||
105848456|NCT02040779|365104998|FG000|Overall Study|Non-compliance|0|||
105848457|NCT02040779|365104999|FG001|Overall Study|Non-compliance|1|||
105848458|NCT02040779|365105000|FG002|Overall Study|Non-compliance|0|||
105848459|NCT02040779|365104998|FG000|Overall Study|Protocol Violation|2|||
105848460|NCT02040779|365104999|FG001|Overall Study|Protocol Violation|1|||
105848461|NCT02040779|365105000|FG002|Overall Study|Protocol Violation|0|||
105848462|NCT02040779|365104998|FG000|Overall Study|Lost to Follow-up|1|||
105848463|NCT02040779|365104999|FG001|Overall Study|Lost to Follow-up|2|||
105848464|NCT02040779|365105000|FG002|Overall Study|Lost to Follow-up|1|||
105848465|NCT02040779|365104998|FG000|Overall Study|Lack of Efficacy|4|||
105848466|NCT02040779|365104999|FG001|Overall Study|Lack of Efficacy|2|||
105848467|NCT02040779|365105000|FG002|Overall Study|Lack of Efficacy|0|||
105848468|NCT03265288|365105001|FG000|Overall Study|Adverse Event|0|||
105848469|NCT03265288|365105002|FG001|Overall Study|Adverse Event|1|||
105848470|NCT03265288|365105001|FG000|Overall Study|Withdrawal by Subject|13|||
105848471|NCT03265288|365105002|FG001|Overall Study|Withdrawal by Subject|5|||
105848472|NCT03265288|365105001|FG000|Overall Study|Drug Withdrawn|3|||
105848473|NCT03265288|365105002|FG001|Overall Study|Drug Withdrawn|3|||
105848474|NCT03265288|365105001|FG000|Overall Study|Any Other Reason|7|||
105848475|NCT03265288|365105002|FG001|Overall Study|Any Other Reason|3|||
105848476|NCT02588950|365105011|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
105848477|NCT02588950|365105012|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
105848478|NCT02588950|365105013|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
105848479|NCT02588950|365105014|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
105848480|NCT02588950|365105011|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
105848481|NCT02588950|365105012|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
105848482|NCT02588950|365105013|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
105848483|NCT02588950|365105014|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
105848484|NCT00866658|365105015|FG000|Overall Study|Adverse Event|5|||
105848485|NCT00866658|365105016|FG001|Overall Study|Adverse Event|14|||
105848486|NCT00866658|365105015|FG000|Overall Study|Lack of Efficacy|2|||
105848487|NCT00866658|365105016|FG001|Overall Study|Lack of Efficacy|1|||
105848488|NCT00866658|365105015|FG000|Overall Study|Withdrawal by Subject|1|||
105848489|NCT00866658|365105016|FG001|Overall Study|Withdrawal by Subject|0|||
105848490|NCT00866658|365105015|FG000|Overall Study|Protocol Violation|1|||
105848491|NCT00866658|365105016|FG001|Overall Study|Protocol Violation|1|||
105848492|NCT00866658|365105015|FG000|Overall Study|Familial and Personal Reasons|4|||
105848493|NCT00866658|365105016|FG001|Overall Study|Familial and Personal Reasons|5|||
105848494|NCT03188718|365105020|FG000|Overall Study|Participant noncompliance|4|||
105848495|NCT03188718|365105020|FG000|Overall Study|Withdrawal by Subject|1|||
105848496|NCT03188718|365105020|FG000|Overall Study|Device failure|3|||
105848497|NCT04322149|365105024|FG000|Overall Study|Adverse Event|1|||
105848498|NCT04322149|365105025|FG001|Overall Study|Adverse Event|1|||
106149998|NCT04629950|366210430|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
106149999|NCT04629950|366210431|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
105848499|NCT04322149|365105026|FG002|Overall Study|Adverse Event|0|||
105848500|NCT04322149|365105027|FG003|Overall Study|Adverse Event|0|||
106150000|NCT04629950|366210428|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
106150001|NCT04629950|366210429|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
105972062|NCT00075725|365556858|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
105972063|NCT00075725|365556859|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
105848501|NCT04322149|365105024|FG000|Overall Study|Withdrawal by Subject|0|||
105848502|NCT04322149|365105025|FG001|Overall Study|Withdrawal by Subject|0|||
105848503|NCT04322149|365105026|FG002|Overall Study|Withdrawal by Subject|0|||
105848504|NCT04322149|365105027|FG003|Overall Study|Withdrawal by Subject|2|||
105848505|NCT04322149|365105024|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
105848506|NCT04322149|365105025|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
105848507|NCT04322149|365105026|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
105848508|NCT04322149|365105027|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
105848509|NCT02238626|365105034|FG000|Overall Study|Adverse Event|3|||
105848510|NCT02238626|365105035|FG001|Overall Study|Adverse Event|5|||
105972064|NCT00075725|365556860|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
105972065|NCT00075725|365556861|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
105972066|NCT00075725|365556862|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
105972067|NCT00075725|365556863|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
105972068|NCT00075725|365556864|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
105972069|NCT00075725|365556865|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
105972070|NCT00075725|365556866|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
105972071|NCT00075725|365556867|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
105972072|NCT00075725|365556868|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
105972073|NCT00075725|365556869|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
105972074|NCT00075725|365556858|FG000|Overall Study|Pt incarcerated|0|||
105972075|NCT00075725|365556859|FG001|Overall Study|Pt incarcerated|0|||
105972076|NCT00075725|365556860|FG002|Overall Study|Pt incarcerated|0|||
105972077|NCT00075725|365556861|FG003|Overall Study|Pt incarcerated|0|||
105972078|NCT00075725|365556862|FG004|Overall Study|Pt incarcerated|0|||
105972079|NCT00075725|365556863|FG005|Overall Study|Pt incarcerated|0|||
105972080|NCT00075725|365556864|FG006|Overall Study|Pt incarcerated|0|||
105972081|NCT00075725|365556865|FG007|Overall Study|Pt incarcerated|1|||
105972082|NCT00075725|365556866|FG008|Overall Study|Pt incarcerated|0|||
105972083|NCT00075725|365556867|FG009|Overall Study|Pt incarcerated|0|||
105972084|NCT00075725|365556868|FG010|Overall Study|Pt incarcerated|0|||
105972085|NCT00075725|365556869|FG011|Overall Study|Pt incarcerated|0|||
105972086|NCT03372460|365556870|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
105972087|NCT03372460|365556871|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
105972088|NCT02499900|365556872|FG000|Core Study Period|Other|1|||
106024815|NCT01761240|365756658|FG002|Overall Study|Progressive disease:radiology assessment|0|||
106024816|NCT01761240|365756659|FG003|Overall Study|Progressive disease:radiology assessment|0|||
106024817|NCT01761240|365756660|FG004|Overall Study|Progressive disease:radiology assessment|0|||
106024818|NCT01761240|365756656|FG000|Overall Study|Progressive disease:clinical assessment|0|||
106024819|NCT01761240|365756657|FG001|Overall Study|Progressive disease:clinical assessment|0|||
106024820|NCT01761240|365756658|FG002|Overall Study|Progressive disease:clinical assessment|3|||
106024821|NCT01761240|365756659|FG003|Overall Study|Progressive disease:clinical assessment|1|||
106024822|NCT01761240|365756660|FG004|Overall Study|Progressive disease:clinical assessment|0|||
106024823|NCT01761240|365756656|FG000|Overall Study|Withdrawal by Subject|0|||
106024824|NCT01761240|365756657|FG001|Overall Study|Withdrawal by Subject|0|||
106024825|NCT01761240|365756658|FG002|Overall Study|Withdrawal by Subject|0|||
106024826|NCT01761240|365756659|FG003|Overall Study|Withdrawal by Subject|3|||
106024827|NCT01761240|365756660|FG004|Overall Study|Withdrawal by Subject|1|||
106024828|NCT01761240|365756656|FG000|Overall Study|Adverse Event|0|||
106024829|NCT01761240|365756657|FG001|Overall Study|Adverse Event|0|||
106024830|NCT01761240|365756658|FG002|Overall Study|Adverse Event|0|||
106024831|NCT01761240|365756659|FG003|Overall Study|Adverse Event|1|||
106024832|NCT01761240|365756660|FG004|Overall Study|Adverse Event|6|||
106024833|NCT01761240|365756656|FG000|Overall Study|Death|0|||
106024834|NCT01761240|365756657|FG001|Overall Study|Death|1|||
106024835|NCT01761240|365756658|FG002|Overall Study|Death|1|||
106024836|NCT01761240|365756659|FG003|Overall Study|Death|2|||
106150002|NCT04629950|366210430|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
106150003|NCT04629950|366210431|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
105972089|NCT02499900|365556873|FG001|Core Study Period|Other|4|||
105972090|NCT02499900|365556872|FG000|Core Study Period|Lost to Follow-up|1|||
105972091|NCT02499900|365556873|FG001|Core Study Period|Lost to Follow-up|2|||
105972092|NCT02499900|365556872|FG000|Core Study Period|Per sponsor request|0|||
105972093|NCT02499900|365556873|FG001|Core Study Period|Per sponsor request|1|||
105972094|NCT02499900|365556872|FG000|Core Study Period|Pregnancy|1|||
106024837|NCT01761240|365756660|FG004|Overall Study|Death|1|||
106024838|NCT01761240|365756656|FG000|Overall Study|Non-compliance|0|||
106024839|NCT01761240|365756657|FG001|Overall Study|Non-compliance|0|||
106024840|NCT01761240|365756658|FG002|Overall Study|Non-compliance|1|||
105848511|NCT02238626|365105036|FG002|Overall Study|Adverse Event|0|||
105848512|NCT02238626|365105037|FG003|Overall Study|Adverse Event|3|||
105848513|NCT02238626|365105034|FG000|Overall Study|Lost to Follow-up|2|||
105848514|NCT02238626|365105035|FG001|Overall Study|Lost to Follow-up|4|||
105848515|NCT02238626|365105036|FG002|Overall Study|Lost to Follow-up|2|||
105848516|NCT02238626|365105037|FG003|Overall Study|Lost to Follow-up|2|||
105848517|NCT02238626|365105034|FG000|Overall Study|Withdrawal by Subject|0|||
105848518|NCT02238626|365105035|FG001|Overall Study|Withdrawal by Subject|3|||
105848519|NCT02238626|365105036|FG002|Overall Study|Withdrawal by Subject|0|||
105848520|NCT02238626|365105037|FG003|Overall Study|Withdrawal by Subject|1|||
105848521|NCT02238626|365105034|FG000|Overall Study|Death|0|||
105848522|NCT02238626|365105035|FG001|Overall Study|Death|0|||
105848523|NCT02238626|365105036|FG002|Overall Study|Death|1|||
105848524|NCT02238626|365105037|FG003|Overall Study|Death|1|||
105848525|NCT02238626|365105034|FG000|Overall Study|Other|0|||
105848526|NCT02238626|365105035|FG001|Overall Study|Other|2|||
105848527|NCT02238626|365105036|FG002|Overall Study|Other|0|||
105848528|NCT02238626|365105037|FG003|Overall Study|Other|0|||
105848529|NCT00270257|365105038|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
105848530|NCT00270257|365105039|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
105848531|NCT01403064|365105042|FG000|Overall Study|Death|0|||
105848532|NCT01403064|365105043|FG001|Overall Study|Death|0|||
105848533|NCT01403064|365105044|FG002|Overall Study|Death|1|||
105848534|NCT01403064|365105045|FG003|Overall Study|Death|1|||
105848535|NCT01403064|365105042|FG000|Overall Study|Withdrawal by Subject|0|||
105848536|NCT01403064|365105043|FG001|Overall Study|Withdrawal by Subject|0|||
105848537|NCT01403064|365105044|FG002|Overall Study|Withdrawal by Subject|1|||
105848538|NCT01403064|365105045|FG003|Overall Study|Withdrawal by Subject|1|||
105848539|NCT01403064|365105042|FG000|Overall Study|Other|1|||
105848540|NCT01403064|365105043|FG001|Overall Study|Other|0|||
105848541|NCT01403064|365105044|FG002|Overall Study|Other|2|||
105848542|NCT01403064|365105045|FG003|Overall Study|Other|1|||
105848543|NCT00307034|365105046|FG000|Overall Study|Adverse Event|1|||
105848544|NCT00307034|365105047|FG001|Overall Study|Adverse Event|2|||
105848545|NCT00307034|365105046|FG000|Overall Study|Withdrawal by Subject|1|||
105848546|NCT00307034|365105047|FG001|Overall Study|Withdrawal by Subject|2|||
105848547|NCT00307034|365105046|FG000|Overall Study|Lost to Follow-up|0|||
105848548|NCT00307034|365105047|FG001|Overall Study|Lost to Follow-up|3|||
105848549|NCT04688931|365105053|FG000|Overall Study|Adverse Event|4|||
105848550|NCT04688931|365105054|FG001|Overall Study|Adverse Event|1|||
105848551|NCT04688931|365105053|FG000|Overall Study|Withdrawal by Subject|5|||
105848552|NCT04688931|365105054|FG001|Overall Study|Withdrawal by Subject|16|||
105848553|NCT04688931|365105053|FG000|Overall Study|Physician Decision|3|||
105848554|NCT04688931|365105054|FG001|Overall Study|Physician Decision|5|||
105848555|NCT04688931|365105053|FG000|Overall Study|Noncompliance|0|||
105848556|NCT04688931|365105054|FG001|Overall Study|Noncompliance|1|||
105848557|NCT04688931|365105053|FG000|Overall Study|Lost to Follow-up|1|||
105848558|NCT04688931|365105054|FG001|Overall Study|Lost to Follow-up|3|||
105848559|NCT04688931|365105053|FG000|Overall Study|Randomization Error|3|||
105848560|NCT04688931|365105054|FG001|Overall Study|Randomization Error|0|||
105848561|NCT04688931|365105053|FG000|Overall Study|Not Eligible|1|||
105848562|NCT04688931|365105054|FG001|Overall Study|Not Eligible|3|||
105848563|NCT04688931|365105053|FG000|Overall Study|Disease Progression|0|||
105848564|NCT04688931|365105054|FG001|Overall Study|Disease Progression|2|||
105848565|NCT04688931|365105053|FG000|Overall Study|Sponsor Requirement|1|||
105848566|NCT04688931|365105054|FG001|Overall Study|Sponsor Requirement|1|||
105848567|NCT04688931|365105053|FG000|Overall Study|Other Reason|1|||
105848568|NCT04688931|365105054|FG001|Overall Study|Other Reason|2|||
105848569|NCT02669940|365105055|FG000|Overall Study|Failure to return|0|||
105848570|NCT02669940|365105056|FG001|Overall Study|Failure to return|3|||
105848571|NCT02669940|365105055|FG000|Overall Study|Insufficient follow-up data|1|||
105848572|NCT02669940|365105056|FG001|Overall Study|Insufficient follow-up data|0|||
105848573|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
105848574|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
105848575|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
105848576|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
105848577|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
105848578|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
105848579|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
105972095|NCT02499900|365556873|FG001|Core Study Period|Pregnancy|0|||
105972096|NCT02499900|365556872|FG000|Core Study Period|Protocol Violation|3|||
105972097|NCT02499900|365556873|FG001|Core Study Period|Protocol Violation|0|||
105972098|NCT02499900|365556872|FG000|Core Study Period|Withdrawal by Subject|11|||
105972099|NCT02499900|365556873|FG001|Core Study Period|Withdrawal by Subject|10|||
105972100|NCT02499900|365556872|FG000|Core Study Period|Adverse Event|18|||
105972101|NCT02499900|365556873|FG001|Core Study Period|Adverse Event|14|||
105972102|NCT02499900|365556872|FG000|Core Study Period|Death|0|||
105972103|NCT02499900|365556873|FG001|Core Study Period|Death|1|||
105972104|NCT02499900|365556872|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
105972105|NCT02499900|365556873|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
105972106|NCT02499900|365556872|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
105972107|NCT02499900|365556873|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
105972108|NCT02499900|365556872|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
105972109|NCT02499900|365556873|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
105972110|NCT02499900|365556872|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
105972111|NCT02499900|365556873|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
105972112|NCT02499900|365556872|FG000|Extension Study Period|Adverse Event|2|||
105972113|NCT02499900|365556873|FG001|Extension Study Period|Adverse Event|4|||
105972114|NCT02499900|365556872|FG000|Extension Study Period|Withdrawal by Subject|5|||
105972115|NCT02499900|365556873|FG001|Extension Study Period|Withdrawal by Subject|2|||
105972116|NCT02499900|365556872|FG000|Extension Study Period|Physician Decision|2|||
105972117|NCT02499900|365556873|FG001|Extension Study Period|Physician Decision|5|||
105972118|NCT02499900|365556872|FG000|Extension Study Period|Pregnancy|1|||
105848580|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
105848581|NCT00974974|365105057|FG000|IR CD-LD Dose Adjustment|Various|0|||
105848582|NCT00974974|365105058|FG001|IR CD-LD Dose Adjustment|Various|9|||
105848583|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Adverse Event|23|||
105848584|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Adverse Event|0|||
105848585|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Death|2|||
105848586|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Death|0|||
105848587|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
105848588|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
105848589|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
105848590|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
105848591|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Various|3|||
105848592|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Various|0|||
105848593|NCT00974974|365105057|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
105848594|NCT00974974|365105058|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
105848595|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
105848596|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
105848597|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
105848598|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
105848599|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
105848600|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
105848601|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
105848602|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
105848603|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
105848604|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
105848605|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
105848606|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
105848607|NCT00974974|365105057|FG000|Maintenance - Double Blind Treatment|Various|4|||
105848608|NCT00974974|365105058|FG001|Maintenance - Double Blind Treatment|Various|0|||
105848609|NCT00667810|365105059|FG000|Overall Study|Adverse Event|13|||
105848610|NCT00667810|365105060|FG001|Overall Study|Adverse Event|14|||
105848611|NCT00667810|365105061|FG002|Overall Study|Adverse Event|19|||
105848612|NCT00667810|365105062|FG003|Overall Study|Adverse Event|1|||
105848613|NCT00667810|365105059|FG000|Overall Study|Death|1|||
105848614|NCT00667810|365105060|FG001|Overall Study|Death|1|||
105848615|NCT00667810|365105061|FG002|Overall Study|Death|3|||
105848616|NCT00667810|365105062|FG003|Overall Study|Death|0|||
105848617|NCT00667810|365105059|FG000|Overall Study|Lack of Efficacy|1|||
105848618|NCT00667810|365105060|FG001|Overall Study|Lack of Efficacy|0|||
105848619|NCT00667810|365105061|FG002|Overall Study|Lack of Efficacy|2|||
105848620|NCT00667810|365105062|FG003|Overall Study|Lack of Efficacy|0|||
105848621|NCT00667810|365105059|FG000|Overall Study|Lost to Follow-up|1|||
105848622|NCT00667810|365105060|FG001|Overall Study|Lost to Follow-up|4|||
105848623|NCT00667810|365105061|FG002|Overall Study|Lost to Follow-up|2|||
105972119|NCT02499900|365556873|FG001|Extension Study Period|Pregnancy|2|||
105972120|NCT02499900|365556872|FG000|Extension Study Period|Lost to Follow-up|2|||
105972121|NCT02499900|365556873|FG001|Extension Study Period|Lost to Follow-up|5|||
105972122|NCT02499900|365556872|FG000|Extension Study Period|Other|0|||
105972123|NCT02499900|365556873|FG001|Extension Study Period|Other|2|||
105972124|NCT04065074|365556876|FG000|Overall Study|Adverse Event|1|||
105972125|NCT04065074|365556876|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
106150004|NCT04629950|366210428|FG000|Extension Study|Withdrawal by Subject|0|||
106150005|NCT04629950|366210429|FG001|Extension Study|Withdrawal by Subject|0|||
106150006|NCT04629950|366210430|FG002|Extension Study|Withdrawal by Subject|1|||
106150007|NCT04629950|366210431|FG003|Extension Study|Withdrawal by Subject|0|||
105848624|NCT00667810|365105062|FG003|Overall Study|Lost to Follow-up|0|||
105848625|NCT00667810|365105059|FG000|Overall Study|Physician Decision|1|||
105848626|NCT00667810|365105060|FG001|Overall Study|Physician Decision|1|||
105848627|NCT00667810|365105061|FG002|Overall Study|Physician Decision|2|||
105848628|NCT00667810|365105062|FG003|Overall Study|Physician Decision|0|||
105848629|NCT00667810|365105059|FG000|Overall Study|Protocol Violation|0|||
105848630|NCT00667810|365105060|FG001|Overall Study|Protocol Violation|2|||
105848631|NCT00667810|365105061|FG002|Overall Study|Protocol Violation|0|||
105848632|NCT00667810|365105062|FG003|Overall Study|Protocol Violation|0|||
105848633|NCT00667810|365105059|FG000|Overall Study|Withdrawal by Subject|14|||
105848634|NCT00667810|365105060|FG001|Overall Study|Withdrawal by Subject|20|||
105848635|NCT00667810|365105061|FG002|Overall Study|Withdrawal by Subject|29|||
105848636|NCT00667810|365105062|FG003|Overall Study|Withdrawal by Subject|1|||
105848637|NCT00667810|365105059|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
105848638|NCT00667810|365105060|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
105848639|NCT00667810|365105061|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
105848640|NCT00667810|365105062|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
105848641|NCT00667810|365105059|FG000|Overall Study|Failed to Return|0|||
105848642|NCT00667810|365105060|FG001|Overall Study|Failed to Return|0|||
105848643|NCT00667810|365105061|FG002|Overall Study|Failed to Return|2|||
105848644|NCT00667810|365105062|FG003|Overall Study|Failed to Return|0|||
105848645|NCT00667810|365105059|FG000|Overall Study|Loss of Caregiver|0|||
105972126|NCT03222973|365556879|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
105972127|NCT03222973|365556880|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
105972128|NCT03222973|365556881|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
105972129|NCT03222973|365556882|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
105972130|NCT03222973|365556879|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
105972131|NCT03222973|365556880|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
105972132|NCT03222973|365556881|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
105848646|NCT00667810|365105060|FG001|Overall Study|Loss of Caregiver|1|||
105972133|NCT03222973|365556882|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
105972134|NCT03222973|365556879|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
105972135|NCT03222973|365556880|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
105972136|NCT03222973|365556881|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
105972137|NCT03222973|365556882|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
105972138|NCT03222973|365556879|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
105972139|NCT03222973|365556880|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
105972140|NCT03222973|365556881|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
105972141|NCT03222973|365556882|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
105972142|NCT03222973|365556879|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
105972143|NCT03222973|365556880|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
105972144|NCT03222973|365556881|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
105972145|NCT03222973|365556882|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
105972146|NCT03222973|365556879|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
105972147|NCT03222973|365556880|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
105972148|NCT03222973|365556881|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
105972149|NCT03222973|365556882|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
105972150|NCT03222973|365556879|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
106024841|NCT01761240|365756659|FG003|Overall Study|Non-compliance|0|||
106024842|NCT01761240|365756660|FG004|Overall Study|Non-compliance|0|||
106024843|NCT00246740|365756661|FG000|Initial Enrollment|Death|1|||
106024844|NCT00246740|365756662|FG001|Initial Enrollment|Death|0|||
106024845|NCT00246740|365756661|FG000|Initial Enrollment|Additional surgery scheduled|0|||
106024846|NCT00246740|365756662|FG001|Initial Enrollment|Additional surgery scheduled|2|||
106024847|NCT00246740|365756661|FG000|Initial Enrollment|Surgery schedule change|4|||
106024848|NCT00246740|365756662|FG001|Initial Enrollment|Surgery schedule change|4|||
106024849|NCT00246740|365756661|FG000|Initial Enrollment|Other|1|||
106024850|NCT00246740|365756662|FG001|Initial Enrollment|Other|2|||
106024851|NCT00934440|365756663|FG000|Overall Study|Lost to Follow-up|1|||
106024852|NCT03158285|365756666|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
106024853|NCT03158285|365756667|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
106024854|NCT03158285|365756668|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
106024855|NCT03158285|365756666|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
106024856|NCT03158285|365756667|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
106024857|NCT03158285|365756668|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
106024858|NCT03158285|365756666|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
106024859|NCT03158285|365756667|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
106024860|NCT03158285|365756668|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
106024861|NCT03158285|365756666|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
105848647|NCT00667810|365105061|FG002|Overall Study|Loss of Caregiver|3|||
105848648|NCT00667810|365105062|FG003|Overall Study|Loss of Caregiver|0|||
105848649|NCT00667810|365105059|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
105848650|NCT00667810|365105060|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
105972151|NCT03222973|365556880|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
105972152|NCT03222973|365556881|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
106024862|NCT03158285|365756667|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
106024863|NCT03158285|365756668|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
105972153|NCT03222973|365556882|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
105972154|NCT03222973|365556879|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
105972155|NCT03222973|365556880|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
105972156|NCT03222973|365556881|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
105972157|NCT03222973|365556882|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
105972158|NCT03222973|365556879|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
105972159|NCT03222973|365556880|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
105972160|NCT03222973|365556881|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
105972161|NCT03222973|365556882|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
105972162|NCT03222973|365556879|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
105972163|NCT03222973|365556880|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
105972164|NCT03222973|365556881|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
105972165|NCT03222973|365556882|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
105972166|NCT03222973|365556879|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
105972167|NCT03222973|365556880|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
105972168|NCT03222973|365556881|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
105972169|NCT03222973|365556882|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
105972170|NCT03222973|365556879|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
105972171|NCT03222973|365556880|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
105972172|NCT03222973|365556881|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
105972173|NCT03222973|365556882|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
105972174|NCT02825420|365556883|FG000|Overall Study|Death|30|||
105972175|NCT02825420|365556884|FG001|Overall Study|Death|12|||
105972176|NCT02825420|365556883|FG000|Overall Study|Progressive disease|6|||
105972177|NCT02825420|365556884|FG001|Overall Study|Progressive disease|1|||
105972178|NCT02825420|365556883|FG000|Overall Study|Lost to Follow-up|2|||
105972179|NCT02825420|365556884|FG001|Overall Study|Lost to Follow-up|2|||
105972180|NCT02825420|365556883|FG000|Overall Study|Withdrawal by Subject|1|||
105972181|NCT02825420|365556884|FG001|Overall Study|Withdrawal by Subject|1|||
105972182|NCT02825420|365556883|FG000|Overall Study|Protocol amendment not signed|1|||
105972183|NCT02825420|365556884|FG001|Overall Study|Protocol amendment not signed|1|||
105972184|NCT02825420|365556883|FG000|Overall Study|Physician Decision|1|||
105972185|NCT02825420|365556884|FG001|Overall Study|Physician Decision|0|||
105972186|NCT02825420|365556883|FG000|Overall Study|Did not receive PLD|2|||
105972187|NCT02825420|365556884|FG001|Overall Study|Did not receive PLD|0|||
105972188|NCT02080481|365556885|FG000|Overall Study|Never received a block.|1|||
105972189|NCT02080481|365556886|FG001|Overall Study|Never received a block.|0|||
105972190|NCT04027049|365556887|FG000|Overall Study|Withdrawn by family|1|||
105972191|NCT04027049|365556888|FG001|Overall Study|Withdrawn by family|0|||
105972192|NCT04027049|365556887|FG000|Overall Study|Participant safety|1|||
105972193|NCT04027049|365556888|FG001|Overall Study|Participant safety|0|||
105972194|NCT02439450|365556889|FG000|Overall Study|Adverse Event|4|||
105972195|NCT02439450|365556890|FG001|Overall Study|Adverse Event|1|||
105972196|NCT02439450|365556891|FG002|Overall Study|Adverse Event|0|||
105972197|NCT02439450|365556892|FG003|Overall Study|Adverse Event|0|||
105972198|NCT02439450|365556889|FG000|Overall Study|Withdrawal by Subject|1|||
105972199|NCT02439450|365556890|FG001|Overall Study|Withdrawal by Subject|2|||
105972200|NCT02439450|365556891|FG002|Overall Study|Withdrawal by Subject|0|||
105972201|NCT02439450|365556892|FG003|Overall Study|Withdrawal by Subject|0|||
105972202|NCT02439450|365556889|FG000|Overall Study|Death|3|||
105972203|NCT02439450|365556890|FG001|Overall Study|Death|0|||
105972204|NCT02439450|365556891|FG002|Overall Study|Death|0|||
105972205|NCT02439450|365556892|FG003|Overall Study|Death|1|||
105972206|NCT02439450|365556889|FG000|Overall Study|Progressive Disease|18|||
106024864|NCT03158285|365756666|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
106024865|NCT03158285|365756667|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
106024866|NCT03158285|365756668|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
106024867|NCT03158285|365756666|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
106024868|NCT03158285|365756667|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
106024869|NCT03158285|365756668|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
106024870|NCT03158285|365756666|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
106024871|NCT03158285|365756667|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
106024872|NCT03158285|365756668|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
106150008|NCT04629950|366210428|FG000|Extension Study|Adverse Event|0|||
106150009|NCT04629950|366210429|FG001|Extension Study|Adverse Event|0|||
105972207|NCT02439450|365556890|FG001|Overall Study|Progressive Disease|41|||
105972208|NCT02439450|365556891|FG002|Overall Study|Progressive Disease|2|||
105972209|NCT02439450|365556892|FG003|Overall Study|Progressive Disease|3|||
105972210|NCT02323204|365556894|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
106150010|NCT04629950|366210430|FG002|Extension Study|Adverse Event|0|||
106150011|NCT04629950|366210431|FG003|Extension Study|Adverse Event|1|||
105972211|NCT02323204|365556895|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
105972212|NCT02323204|365556896|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
105972213|NCT02323204|365556897|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
106150012|NCT02088853|366210432|FG000|Overall Study|Pregnancy|1|||
105972214|NCT02323204|365556894|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
105972215|NCT02323204|365556895|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
105972216|NCT02323204|365556896|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
105972217|NCT02323204|365556897|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
106024873|NCT03158285|365756666|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
106024874|NCT03158285|365756667|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
106024875|NCT03158285|365756668|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
106024876|NCT03158285|365756666|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
106024877|NCT03158285|365756667|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
106024878|NCT03158285|365756668|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
106024879|NCT03158285|365756666|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
106024880|NCT03158285|365756667|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
106024881|NCT03158285|365756668|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
106024882|NCT03158285|365756666|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
106024883|NCT03158285|365756667|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
106024884|NCT03158285|365756668|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
106024885|NCT03158285|365756666|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
106024886|NCT03158285|365756667|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
106024887|NCT03158285|365756668|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
105972218|NCT02323204|365556894|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
105972219|NCT02323204|365556895|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
105972220|NCT02323204|365556896|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
105972221|NCT02323204|365556897|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
105972222|NCT02323204|365556894|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
105972223|NCT02323204|365556895|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
106024888|NCT03158285|365756666|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
106150013|NCT02088853|366210433|FG001|Overall Study|Pregnancy|0|||
106150014|NCT04583423|366210435|FG000|Overall Study|Lost to Follow-up|0|||
106150015|NCT04583423|366210436|FG001|Overall Study|Lost to Follow-up|1|||
106150016|NCT04583423|366210437|FG002|Overall Study|Lost to Follow-up|0|||
106150017|NCT04583423|366210438|FG003|Overall Study|Lost to Follow-up|2|||
106150018|NCT04583423|366210435|FG000|Overall Study|Study Terminated by Sponsor|32|||
106150019|NCT04583423|366210436|FG001|Overall Study|Study Terminated by Sponsor|35|||
106150020|NCT04583423|366210437|FG002|Overall Study|Study Terminated by Sponsor|36|||
106150021|NCT04583423|366210438|FG003|Overall Study|Study Terminated by Sponsor|33|||
106150022|NCT04583423|366210435|FG000|Overall Study|Withdrawal by Subject|3|||
106150023|NCT04583423|366210436|FG001|Overall Study|Withdrawal by Subject|1|||
106150024|NCT04583423|366210437|FG002|Overall Study|Withdrawal by Subject|2|||
106150025|NCT04583423|366210438|FG003|Overall Study|Withdrawal by Subject|1|||
106150026|NCT04704284|366210439|FG000|Overall Study|Withdrawal by Subject|1|||
106150027|NCT01017146|366210445|FG000|Overall Study|Adverse Event|11|||
106150028|NCT01017146|366210446|FG001|Overall Study|Adverse Event|1|||
106150029|NCT01017146|366210445|FG000|Overall Study|Lost to Follow-up|14|||
106150030|NCT01017146|366210446|FG001|Overall Study|Lost to Follow-up|14|||
106150031|NCT01017146|366210445|FG000|Overall Study|Noncompliance with Study Product|1|||
106150032|NCT01017146|366210446|FG001|Overall Study|Noncompliance with Study Product|1|||
106150033|NCT01017146|366210445|FG000|Overall Study|Withdrawal by Subject|32|||
106150034|NCT01017146|366210446|FG001|Overall Study|Withdrawal by Subject|16|||
106150035|NCT01017146|366210445|FG000|Overall Study|Relocation|0|||
106150036|NCT01017146|366210446|FG001|Overall Study|Relocation|4|||
106150037|NCT01017146|366210445|FG000|Overall Study|Pregnancy|2|||
106150038|NCT01017146|366210446|FG001|Overall Study|Pregnancy|1|||
106150039|NCT01017146|366210445|FG000|Overall Study|Protocol Violation|2|||
106150040|NCT01017146|366210446|FG001|Overall Study|Protocol Violation|0|||
106150041|NCT01017146|366210445|FG000|Overall Study|Took Excluded Medication|2|||
106150042|NCT01017146|366210446|FG001|Overall Study|Took Excluded Medication|0|||
106150043|NCT01017146|366210445|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
106150044|NCT01017146|366210446|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
106150045|NCT01017146|366210445|FG000|Overall Study|Change in Work Situation|1|||
106150046|NCT01017146|366210446|FG001|Overall Study|Change in Work Situation|0|||
106150047|NCT01747486|366210447|FG000|Stage 1|Physician Decision|3|||
106150048|NCT01747486|366210448|FG001|Stage 1|Physician Decision|0|||
106150049|NCT01747486|366210447|FG000|Stage 1|Withdrawal by Subject|4|||
106150050|NCT01747486|366210448|FG001|Stage 1|Withdrawal by Subject|3|||
106150051|NCT01747486|366210447|FG000|Stage 1|Disease progression|4|||
106150052|NCT01747486|366210448|FG001|Stage 1|Disease progression|9|||
106150053|NCT01747486|366210447|FG000|Stage 1|Death|1|||
106024889|NCT03158285|365756667|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
106150054|NCT01747486|366210448|FG001|Stage 1|Death|1|||
106150055|NCT01747486|366210447|FG000|Stage 2|Physician Decision|2|||
106150056|NCT01747486|366210448|FG001|Stage 2|Physician Decision|0|||
106150057|NCT01747486|366210447|FG000|Stage 2|Withdrawal by Subject|1|||
106150058|NCT01747486|366210448|FG001|Stage 2|Withdrawal by Subject|0|||
106150059|NCT01747486|366210447|FG000|Stage 2|New Cancer Therapy|3|||
105972224|NCT02323204|365556896|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
105972225|NCT02323204|365556897|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
105972226|NCT02323204|365556894|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
105972227|NCT02323204|365556895|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
105972228|NCT02323204|365556896|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
105972229|NCT02323204|365556897|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
105972230|NCT02323204|365556894|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
105972231|NCT02323204|365556895|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
105972232|NCT02323204|365556896|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
105972233|NCT02323204|365556897|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
105972234|NCT02323204|365556894|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
105972235|NCT02323204|365556895|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
105972236|NCT02323204|365556896|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
105972237|NCT02323204|365556897|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
105972238|NCT02323204|365556894|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
105972239|NCT02323204|365556895|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
105972240|NCT02323204|365556896|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
105972241|NCT02323204|365556897|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
105972242|NCT02323204|365556894|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
105972243|NCT02323204|365556895|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
105972244|NCT02323204|365556896|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
105972245|NCT02323204|365556897|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
105972246|NCT03576755|365556903|FG000|Overall Study|Withdrawal by Subject|1|||
105972247|NCT03576755|365556904|FG001|Overall Study|Withdrawal by Subject|0|||
105972248|NCT03576755|365556905|FG002|Overall Study|Withdrawal by Subject|0|||
105972249|NCT03576755|365556906|FG003|Overall Study|Withdrawal by Subject|0|||
105972250|NCT03444766|365556907|FG000|Overall Study|Other Reasons|2|||
105972251|NCT03444766|365556907|FG000|Overall Study|Participant Withdrew Consent|5|||
105972252|NCT03444766|365556907|FG000|Overall Study|Lost to Follow-up|2|||
105972253|NCT03444766|365556907|FG000|Overall Study|Death|2|||
105972254|NCT03444766|365556907|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
105972255|NCT03444766|365556907|FG000|Overall Study|Disease Progression|49|||
105972256|NCT02788201|365556908|FG000|Overall Study|Death|1|||
105972257|NCT02788201|365556909|FG001|Overall Study|Death|1|||
105972258|NCT02788201|365556910|FG002|Overall Study|Death|1|||
105972259|NCT02788201|365556911|FG003|Overall Study|Death|1|||
105972260|NCT02788201|365556912|FG004|Overall Study|Death|0|||
105972261|NCT02788201|365556913|FG005|Overall Study|Death|1|||
105972262|NCT02788201|365556908|FG000|Overall Study|Ineligible|0|||
105972263|NCT02788201|365556909|FG001|Overall Study|Ineligible|0|||
105972264|NCT02788201|365556910|FG002|Overall Study|Ineligible|0|||
105972265|NCT02788201|365556911|FG003|Overall Study|Ineligible|0|||
105972266|NCT02788201|365556912|FG004|Overall Study|Ineligible|0|||
105972267|NCT02788201|365556913|FG005|Overall Study|Ineligible|1|||
105972268|NCT02788201|365556908|FG000|Overall Study|Withdrawal by Subject|0|||
105972269|NCT02788201|365556909|FG001|Overall Study|Withdrawal by Subject|0|||
105972270|NCT02788201|365556910|FG002|Overall Study|Withdrawal by Subject|0|||
105972271|NCT02788201|365556911|FG003|Overall Study|Withdrawal by Subject|0|||
105972272|NCT02788201|365556912|FG004|Overall Study|Withdrawal by Subject|0|||
105972273|NCT02788201|365556913|FG005|Overall Study|Withdrawal by Subject|1|||
105972274|NCT01852825|365556914|FG000|Overall Study|Withdrawal by Subject|2|||
105972275|NCT01852825|365556915|FG001|Overall Study|Withdrawal by Subject|0|||
105972276|NCT01852825|365556916|FG002|Overall Study|Withdrawal by Subject|0|||
105972277|NCT01081301|365556920|FG000|Overall Study|Bereaved|3|||
105848651|NCT00667810|365105061|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
105848652|NCT00667810|365105062|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
105848653|NCT00667810|365105059|FG000|Overall Study|Other|6|||
105848654|NCT00667810|365105060|FG001|Overall Study|Other|6|||
105848655|NCT00667810|365105061|FG002|Overall Study|Other|5|||
105848656|NCT00667810|365105062|FG003|Overall Study|Other|0|||
105848657|NCT02227147|365105063|FG000|Controlled Treatment Period|Adverse Event|4|||
105848658|NCT02227147|365105064|FG001|Controlled Treatment Period|Adverse Event|3|||
105848659|NCT02227147|365105063|FG000|Controlled Treatment Period|Other|2|||
105848660|NCT02227147|365105064|FG001|Controlled Treatment Period|Other|0|||
105848661|NCT02227147|365105063|FG000|Follow-up Period|Other|3|||
105848662|NCT02227147|365105064|FG001|Follow-up Period|Other|5|||
105848663|NCT00158600|365105066|FG000|Overall Study|unable to commit time to study|0|||
105848664|NCT00158600|365105067|FG001|Overall Study|unable to commit time to study|1|||
105848665|NCT00158600|365105066|FG000|Overall Study|Adverse Event|2|||
105848666|NCT00158600|365105067|FG001|Overall Study|Adverse Event|1|||
105848667|NCT00158600|365105066|FG000|Overall Study|Death|1|||
105848668|NCT00158600|365105067|FG001|Overall Study|Death|0|||
105972278|NCT01081301|365556920|FG000|Overall Study|Too busy|5|||
105848669|NCT00158600|365105066|FG000|Overall Study|Withdrawal by Subject|2|||
105848670|NCT00158600|365105067|FG001|Overall Study|Withdrawal by Subject|2|||
105848671|NCT00910091|365105068|FG000|Pre-assignment|Withdrawal by Subject|0|||
105848672|NCT00910091|365105069|FG001|Pre-assignment|Withdrawal by Subject|2|||
105848673|NCT00910091|365105068|FG000|Treatment and Survival|Withdrawal by Subject|3|||
105848674|NCT00910091|365105069|FG001|Treatment and Survival|Withdrawal by Subject|4|||
105848675|NCT00910091|365105068|FG000|Treatment and Survival|Adverse Event|1|||
105848676|NCT00910091|365105069|FG001|Treatment and Survival|Adverse Event|0|||
105848677|NCT02618408|365105070|FG000|Overall Study|Withdrawal by Subject|1|||
105848678|NCT02618408|365105071|FG001|Overall Study|Withdrawal by Subject|0|||
105972279|NCT01081301|365556920|FG000|Overall Study|Patient too ill|2|||
105972280|NCT01081301|365556920|FG000|Overall Study|Lost to Follow-up|4|||
105972281|NCT02446418|365556921|FG000|Overall Study|Adverse Event|4|||
105972282|NCT02446418|365556922|FG001|Overall Study|Adverse Event|8|||
105972283|NCT02446418|365556921|FG000|Overall Study|Physician Decision|5|||
105972284|NCT02446418|365556922|FG001|Overall Study|Physician Decision|1|||
105972285|NCT02446418|365556921|FG000|Overall Study|Withdrawal by Subject|3|||
105972286|NCT02446418|365556922|FG001|Overall Study|Withdrawal by Subject|3|||
105972287|NCT02446418|365556921|FG000|Overall Study|Lost to Follow-up|2|||
105972288|NCT02446418|365556922|FG001|Overall Study|Lost to Follow-up|2|||
105972289|NCT02446418|365556921|FG000|Overall Study|Protocol Violation|1|||
105972290|NCT02446418|365556922|FG001|Overall Study|Protocol Violation|2|||
105972291|NCT02446418|365556921|FG000|Overall Study|Lack of Efficacy|2|||
105972292|NCT02446418|365556922|FG001|Overall Study|Lack of Efficacy|0|||
105972293|NCT02446418|365556921|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
105972294|NCT02446418|365556922|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
105972295|NCT01440517|365559144|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
105972296|NCT00642174|365559152|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
105972297|NCT00642174|365559153|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
105972298|NCT00896363|365559154|FG000|Overall Study|Adverse Event|3|||
105972299|NCT00896363|365559155|FG001|Overall Study|Adverse Event|4|||
105972300|NCT00896363|365559156|FG002|Overall Study|Adverse Event|2|||
105972301|NCT00896363|365559154|FG000|Overall Study|Lack of Efficacy|0|||
105972302|NCT00896363|365559155|FG001|Overall Study|Lack of Efficacy|2|||
105972303|NCT00896363|365559156|FG002|Overall Study|Lack of Efficacy|1|||
105972304|NCT00896363|365559154|FG000|Overall Study|Withdrawal by Subject|3|||
105972305|NCT00896363|365559155|FG001|Overall Study|Withdrawal by Subject|5|||
105972306|NCT00896363|365559156|FG002|Overall Study|Withdrawal by Subject|5|||
105972307|NCT00416715|365559157|FG000|Overall Study|Not evaluable for joint aches|7|||
105972308|NCT00416715|365559157|FG000|Overall Study|Vitamin D levels not evaluable|8|||
105972309|NCT03505788|365559158|FG000|Overall Study|Lost to Follow-up|2|||
105972310|NCT03505788|365559159|FG001|Overall Study|Lost to Follow-up|1|||
105972311|NCT03505788|365559158|FG000|Overall Study|Withdrawal by Subject|1|||
105972312|NCT03505788|365559159|FG001|Overall Study|Withdrawal by Subject|3|||
106024890|NCT03158285|365756668|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
106024891|NCT03158285|365756666|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
105848679|NCT02618408|365105072|FG002|Overall Study|Withdrawal by Subject|4|||
105848680|NCT02618408|365105070|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
105848681|NCT02618408|365105071|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
105848682|NCT02618408|365105072|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
105972313|NCT03505788|365559158|FG000|Overall Study|Physician Decision|0|||
105972314|NCT03505788|365559159|FG001|Overall Study|Physician Decision|1|||
106024892|NCT03158285|365756667|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
106024893|NCT03158285|365756668|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
106024894|NCT03158285|365756666|FG000|Active Treatment Period: Week 52-100|Death|1|||
106024895|NCT03158285|365756667|FG001|Active Treatment Period: Week 52-100|Death|0|||
106024896|NCT03158285|365756668|FG002|Active Treatment Period: Week 52-100|Death|0|||
106024897|NCT03158285|365756666|FG000|Active Treatment Period: Week 52-100|Other|4|||
106024898|NCT03158285|365756667|FG001|Active Treatment Period: Week 52-100|Other|1|||
106024899|NCT03158285|365756668|FG002|Active Treatment Period: Week 52-100|Other|0|||
106024900|NCT00870584|365756672|FG000|Overall Study|Adverse Event|3|||
106024901|NCT00870584|365756673|FG001|Overall Study|Adverse Event|3|||
106024902|NCT00870584|365756672|FG000|Overall Study|Withdrawal by Subject|6|||
106024903|NCT00870584|365756673|FG001|Overall Study|Withdrawal by Subject|7|||
106150060|NCT01747486|366210448|FG001|Stage 2|New Cancer Therapy|0|||
105972315|NCT00496197|365559163|FG000|Overall Study|Discontinued study due to death|43|||
105972316|NCT00496197|365559163|FG000|Overall Study|Adverse Event|13|||
105972317|NCT00496197|365559163|FG000|Overall Study|Does not meet entrance criteria|5|||
105972318|NCT00496197|365559163|FG000|Overall Study|Insufficient clinical response|3|||
105972319|NCT00496197|365559163|FG000|Overall Study|Insufficient bacteriological response|10|||
105848683|NCT02618408|365105070|FG000|Overall Study|Lost to Follow-up|4|||
105972320|NCT00496197|365559163|FG000|Overall Study|Lost to Follow-up|11|||
105972321|NCT00496197|365559163|FG000|Overall Study|Withdrawal by Subject|11|||
106024904|NCT00870584|365756672|FG000|Overall Study|Lost to Follow-up|5|||
106024905|NCT00870584|365756673|FG001|Overall Study|Lost to Follow-up|1|||
105972322|NCT00496197|365559163|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
105972323|NCT00496197|365559163|FG000|Overall Study|Other|14|||
105972324|NCT00496197|365559163|FG000|Overall Study|Protocol Violation|8|||
105972325|NCT00320255|365559166|FG000|Overall Study|Lack of Efficacy|1|||
105972326|NCT00320255|365559167|FG001|Overall Study|Lack of Efficacy|0|||
105972327|NCT00320255|365559168|FG002|Overall Study|Lack of Efficacy|0|||
105972328|NCT00320255|365559169|FG003|Overall Study|Lack of Efficacy|0|||
105972329|NCT00320255|365559170|FG004|Overall Study|Lack of Efficacy|0|||
105972330|NCT00320255|365559171|FG005|Overall Study|Lack of Efficacy|0|||
105972331|NCT00320255|365559166|FG000|Overall Study|Adverse Event|5|||
105972332|NCT00320255|365559167|FG001|Overall Study|Adverse Event|2|||
105972333|NCT00320255|365559168|FG002|Overall Study|Adverse Event|3|||
105972334|NCT00320255|365559169|FG003|Overall Study|Adverse Event|2|||
105972335|NCT00320255|365559170|FG004|Overall Study|Adverse Event|0|||
106024906|NCT00870584|365756672|FG000|Overall Study|Protocol Deviation|2|||
106024907|NCT00870584|365756673|FG001|Overall Study|Protocol Deviation|2|||
106024908|NCT01601652|365756680|FG000|Overall Study|Death|1|||
106024909|NCT01395524|365758440|FG000|Overall Study|Non-compliance with study schedule|1|||
106024910|NCT01395524|365758441|FG001|Overall Study|Non-compliance with study schedule|0|||
106024911|NCT01395524|365758442|FG002|Overall Study|Non-compliance with study schedule|1|||
106024912|NCT01395524|365758440|FG000|Overall Study|Lost to Follow-up|3|||
106024913|NCT01395524|365758441|FG001|Overall Study|Lost to Follow-up|1|||
106024914|NCT01395524|365758442|FG002|Overall Study|Lost to Follow-up|1|||
106024915|NCT01395524|365758440|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
106024916|NCT01395524|365758441|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
106024917|NCT01395524|365758442|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
106024918|NCT01395524|365758440|FG000|Overall Study|Severe noncompliance with protocol|1|||
106024919|NCT01395524|365758441|FG001|Overall Study|Severe noncompliance with protocol|0|||
106024920|NCT01395524|365758442|FG002|Overall Study|Severe noncompliance with protocol|0|||
106024921|NCT01395524|365758440|FG000|Overall Study|Adverse Event|4|||
106024922|NCT01395524|365758441|FG001|Overall Study|Adverse Event|4|||
106024923|NCT01395524|365758442|FG002|Overall Study|Adverse Event|3|||
106024924|NCT01395524|365758440|FG000|Overall Study|Death|1|||
106024925|NCT01395524|365758441|FG001|Overall Study|Death|0|||
106024926|NCT01395524|365758442|FG002|Overall Study|Death|0|||
106024927|NCT01395524|365758440|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
106024928|NCT01395524|365758441|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
106024929|NCT01395524|365758442|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
106024930|NCT01395524|365758440|FG000|Overall Study|Withdrawal by Subject|4|||
106024931|NCT01395524|365758441|FG001|Overall Study|Withdrawal by Subject|8|||
106024932|NCT01395524|365758442|FG002|Overall Study|Withdrawal by Subject|8|||
106024933|NCT01395524|365758440|FG000|Overall Study|Did not receive treatment|1|||
106024934|NCT01395524|365758441|FG001|Overall Study|Did not receive treatment|1|||
106024935|NCT01395524|365758442|FG002|Overall Study|Did not receive treatment|3|||
106024936|NCT01395524|365758440|FG000|Overall Study|Subject had spinal surgery|0|||
106024937|NCT01395524|365758441|FG001|Overall Study|Subject had spinal surgery|0|||
106024938|NCT01395524|365758442|FG002|Overall Study|Subject had spinal surgery|1|||
106024939|NCT01124864|365758443|FG000|Overall Study|Follow up phase competed as per protocol|18|||
106024940|NCT01124864|365758444|FG001|Overall Study|Follow up phase competed as per protocol|22|||
106024941|NCT01124864|365758445|FG002|Overall Study|Follow up phase competed as per protocol|24|||
106024942|NCT01124864|365758446|FG003|Overall Study|Follow up phase competed as per protocol|18|||
106024943|NCT01124864|365758447|FG004|Overall Study|Follow up phase competed as per protocol|26|||
106024944|NCT01124864|365758448|FG005|Overall Study|Follow up phase competed as per protocol|2|||
105972336|NCT00320255|365559171|FG005|Overall Study|Adverse Event|0|||
105972337|NCT00320255|365559166|FG000|Overall Study|Withdrawal by Subject|1|||
105972338|NCT00320255|365559167|FG001|Overall Study|Withdrawal by Subject|2|||
105972339|NCT00320255|365559168|FG002|Overall Study|Withdrawal by Subject|2|||
105972340|NCT00320255|365559169|FG003|Overall Study|Withdrawal by Subject|4|||
106024945|NCT01124864|365758443|FG000|Overall Study|Death|6|||
106024946|NCT01124864|365758444|FG001|Overall Study|Death|9|||
106024947|NCT01124864|365758445|FG002|Overall Study|Death|6|||
106024948|NCT01124864|365758446|FG003|Overall Study|Death|2|||
106150061|NCT01747486|366210447|FG000|Stage 2|Disease Progression|3|||
106150062|NCT01747486|366210448|FG001|Stage 2|Disease Progression|0|||
106150063|NCT02372253|366210452|FG000|Overall Study|Non Compliance|2|||
106150064|NCT02372253|366210453|FG001|Overall Study|Non Compliance|0|||
106150065|NCT03201562|366210454|FG000|Overall Study|Physician Decision|0|||
106150066|NCT03201562|366210455|FG001|Overall Study|Physician Decision|0|||
106150067|NCT03201562|366210456|FG002|Overall Study|Physician Decision|1|||
106150068|NCT03201562|366210454|FG000|Overall Study|Adverse Event|0|||
106150069|NCT03201562|366210455|FG001|Overall Study|Adverse Event|0|||
106150070|NCT03201562|366210456|FG002|Overall Study|Adverse Event|1|||
106150071|NCT03201562|366210454|FG000|Overall Study|Lost to Follow-up|0|||
106150072|NCT03201562|366210455|FG001|Overall Study|Lost to Follow-up|1|||
105972341|NCT00320255|365559170|FG004|Overall Study|Withdrawal by Subject|0|||
105972342|NCT00320255|365559171|FG005|Overall Study|Withdrawal by Subject|0|||
105972343|NCT00320255|365559166|FG000|Overall Study|Poor compliance/noncompliance|1|||
105972344|NCT00320255|365559167|FG001|Overall Study|Poor compliance/noncompliance|1|||
105972345|NCT00320255|365559168|FG002|Overall Study|Poor compliance/noncompliance|0|||
105972346|NCT00320255|365559169|FG003|Overall Study|Poor compliance/noncompliance|1|||
105972347|NCT00320255|365559170|FG004|Overall Study|Poor compliance/noncompliance|0|||
105972348|NCT00320255|365559171|FG005|Overall Study|Poor compliance/noncompliance|0|||
105972349|NCT00320255|365559166|FG000|Overall Study|No longer meets study criteria|0|||
105972350|NCT00320255|365559167|FG001|Overall Study|No longer meets study criteria|0|||
105972351|NCT00320255|365559168|FG002|Overall Study|No longer meets study criteria|0|||
105972352|NCT00320255|365559169|FG003|Overall Study|No longer meets study criteria|1|||
105972353|NCT00320255|365559170|FG004|Overall Study|No longer meets study criteria|0|||
105972354|NCT00320255|365559171|FG005|Overall Study|No longer meets study criteria|0|||
105972355|NCT00320255|365559166|FG000|Overall Study|Other|3|||
105972356|NCT00320255|365559167|FG001|Overall Study|Other|2|||
105972357|NCT00320255|365559168|FG002|Overall Study|Other|1|||
105972358|NCT00320255|365559169|FG003|Overall Study|Other|0|||
105972359|NCT00320255|365559170|FG004|Overall Study|Other|0|||
105972360|NCT00320255|365559171|FG005|Overall Study|Other|0|||
105972361|NCT04195438|365559177|FG000|Overall Study|Withdrawal by Subject|1|||
105972362|NCT01774097|365559178|FG000|Overall Study|Withdrawal by Subject|1|||
105972363|NCT01774097|365559179|FG001|Overall Study|Withdrawal by Subject|1|||
105972364|NCT01774097|365559178|FG000|Overall Study|Adverse Event|1|||
105972365|NCT01774097|365559179|FG001|Overall Study|Adverse Event|1|||
105972366|NCT00613925|365559180|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
105972367|NCT00613925|365559181|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
105972368|NCT00543296|365559182|FG000|Overall Study|Physician Decision|7|||
105972369|NCT00934947|365559187|FG000|Overall Study|Adverse Event|0|||
105972370|NCT00934947|365559188|FG001|Overall Study|Adverse Event|2|||
105972371|NCT03447314|365559194|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
105972372|NCT03447314|365559195|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
105972373|NCT03447314|365559196|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
105972374|NCT03447314|365559197|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
105972375|NCT03447314|365559198|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
105972376|NCT03447314|365559199|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
105972377|NCT03447314|365559200|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
105972378|NCT03447314|365559201|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972379|NCT03447314|365559202|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972380|NCT03447314|365559203|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972381|NCT03447314|365559204|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
105972382|NCT03447314|365559205|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
105972383|NCT03447314|365559206|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972384|NCT03447314|365559207|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972385|NCT03447314|365559208|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972386|NCT03447314|365559209|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972387|NCT03447314|365559210|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972388|NCT03447314|365559211|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
105972389|NCT03447314|365559194|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
105972390|NCT03447314|365559195|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972391|NCT03447314|365559196|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
105972392|NCT03447314|365559197|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972393|NCT03447314|365559198|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972394|NCT03447314|365559199|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
105972395|NCT03447314|365559200|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
105972396|NCT03447314|365559201|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972397|NCT03447314|365559202|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972398|NCT03447314|365559203|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972399|NCT03447314|365559204|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972400|NCT03447314|365559205|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972401|NCT03447314|365559206|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972402|NCT03447314|365559207|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972403|NCT03447314|365559208|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972404|NCT03447314|365559209|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
106024949|NCT01124864|365758447|FG004|Overall Study|Death|1|||
105972405|NCT03447314|365559210|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105848684|NCT02618408|365105071|FG001|Overall Study|Lost to Follow-up|2|||
105972406|NCT03447314|365559211|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
105972407|NCT03447314|365559194|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972408|NCT03447314|365559195|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972409|NCT03447314|365559196|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
105972410|NCT03447314|365559197|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972411|NCT03447314|365559198|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972412|NCT03447314|365559199|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972413|NCT03447314|365559200|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972414|NCT03447314|365559201|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972415|NCT03447314|365559202|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972416|NCT03447314|365559203|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972417|NCT03447314|365559204|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972418|NCT03447314|365559205|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972419|NCT03447314|365559206|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972420|NCT03447314|365559207|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972421|NCT03447314|365559208|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972422|NCT03447314|365559209|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972423|NCT03447314|365559210|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972424|NCT03447314|365559211|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
105972425|NCT03447314|365559194|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972426|NCT03447314|365559195|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972427|NCT03447314|365559196|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
105972428|NCT03447314|365559197|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972429|NCT03447314|365559198|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972430|NCT03447314|365559199|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972431|NCT03447314|365559200|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972432|NCT03447314|365559201|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972433|NCT03447314|365559202|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972434|NCT03447314|365559203|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972435|NCT03447314|365559204|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972436|NCT03447314|365559205|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972437|NCT03447314|365559206|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972438|NCT03447314|365559207|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972439|NCT03447314|365559208|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972440|NCT03447314|365559209|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972441|NCT03447314|365559210|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972442|NCT03447314|365559211|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
105972443|NCT03447314|365559194|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972444|NCT03447314|365559195|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972445|NCT03447314|365559196|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972446|NCT03447314|365559197|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972447|NCT03447314|365559198|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972448|NCT03447314|365559199|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972449|NCT03447314|365559200|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972450|NCT03447314|365559201|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972451|NCT03447314|365559202|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972452|NCT03447314|365559203|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972453|NCT03447314|365559204|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
105972454|NCT03447314|365559205|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972455|NCT03447314|365559206|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972456|NCT03447314|365559207|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
106024950|NCT01124864|365758448|FG005|Overall Study|Death|0|||
106024951|NCT01124864|365758443|FG000|Overall Study|Withdrawal by Subject|2|||
106024952|NCT01124864|365758444|FG001|Overall Study|Withdrawal by Subject|3|||
106024953|NCT01124864|365758445|FG002|Overall Study|Withdrawal by Subject|4|||
106024954|NCT01124864|365758446|FG003|Overall Study|Withdrawal by Subject|0|||
106024955|NCT01124864|365758447|FG004|Overall Study|Withdrawal by Subject|2|||
105848685|NCT02618408|365105072|FG002|Overall Study|Lost to Follow-up|6|||
105848686|NCT02618408|365105070|FG000|Overall Study|Adverse Event|4|||
105848687|NCT02618408|365105071|FG001|Overall Study|Adverse Event|0|||
105848688|NCT02618408|365105072|FG002|Overall Study|Adverse Event|10|||
105848689|NCT02618408|365105070|FG000|Overall Study|Physician Decision|1|||
105848690|NCT02618408|365105071|FG001|Overall Study|Physician Decision|1|||
105848691|NCT02618408|365105072|FG002|Overall Study|Physician Decision|2|||
105848692|NCT02618408|365105070|FG000|Overall Study|Protocol Violation|1|||
105848693|NCT02618408|365105071|FG001|Overall Study|Protocol Violation|1|||
105848694|NCT02618408|365105072|FG002|Overall Study|Protocol Violation|2|||
105848695|NCT02618408|365105070|FG000|Overall Study|Other, Multiple Categories|0|||
105848696|NCT02618408|365105071|FG001|Overall Study|Other, Multiple Categories|0|||
105848697|NCT02618408|365105072|FG002|Overall Study|Other, Multiple Categories|4|||
105848698|NCT01175811|365105075|FG000|Overall Study|Adverse Event|1|||
105848699|NCT01175811|365105076|FG001|Overall Study|Adverse Event|1|||
105848700|NCT01175811|365105075|FG000|Overall Study|Entry criteria not met|3|||
105848701|NCT01175811|365105076|FG001|Overall Study|Entry criteria not met|1|||
105848702|NCT01175811|365105075|FG000|Overall Study|Lack of Efficacy|1|||
105848703|NCT01175811|365105076|FG001|Overall Study|Lack of Efficacy|0|||
105848704|NCT01175811|365105075|FG000|Overall Study|Lost to Follow-up|3|||
105848705|NCT01175811|365105076|FG001|Overall Study|Lost to Follow-up|2|||
105848706|NCT01175811|365105075|FG000|Overall Study|Physician Decision|1|||
105848707|NCT01175811|365105076|FG001|Overall Study|Physician Decision|1|||
105848708|NCT01175811|365105075|FG000|Overall Study|Protocol Violation|1|||
105848709|NCT01175811|365105076|FG001|Overall Study|Protocol Violation|2|||
105848710|NCT01175811|365105075|FG000|Overall Study|Withdrawal by Subject|6|||
105848711|NCT01175811|365105076|FG001|Overall Study|Withdrawal by Subject|7|||
105848712|NCT01297465|365105077|FG000|Overall Study|Lack of Ovarian Response|1|||
105848713|NCT01297465|365105078|FG001|Overall Study|Lack of Ovarian Response|1|||
105848714|NCT01297465|365105077|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
105848715|NCT01297465|365105078|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
105848716|NCT01297465|365105077|FG000|Overall Study|No Oocytes Retrieved|1|||
105848717|NCT01297465|365105078|FG001|Overall Study|No Oocytes Retrieved|1|||
105848718|NCT01297465|365105077|FG000|Overall Study|Poor oocyte quality|0|||
105848719|NCT01297465|365105078|FG001|Overall Study|Poor oocyte quality|1|||
105848720|NCT01297465|365105077|FG000|Overall Study|No Fertilization|6|||
105848721|NCT01297465|365105078|FG001|Overall Study|No Fertilization|4|||
105848722|NCT01297465|365105077|FG000|Overall Study|All Embryos Discarded|0|||
105848723|NCT01297465|365105078|FG001|Overall Study|All Embryos Discarded|1|||
105848724|NCT01297465|365105077|FG000|Overall Study|Intention to Freeze all Embryos|0|||
105848725|NCT01297465|365105078|FG001|Overall Study|Intention to Freeze all Embryos|1|||
105848726|NCT03321630|365105079|FG000|Overall Study|Adverse Event|1|||
105848727|NCT03321630|365105079|FG000|Overall Study|Investigator Discretion|2|||
105848728|NCT03321630|365105079|FG000|Overall Study|Withdrawal by Subject|1|||
105848729|NCT00950963|365105080|FG000|Overall Study|Lost to Follow-up|29|||
105848730|NCT00950963|365105081|FG001|Overall Study|Lost to Follow-up|24|||
105848731|NCT01070771|365105082|FG000|Overall Study|Adverse Event|2|||
105848732|NCT01070771|365105082|FG000|Overall Study|Protocol Violation|1|||
105848733|NCT00302081|365105086|FG000|Overall Study|Adverse Event|6|||
105848734|NCT00302081|365105087|FG001|Overall Study|Adverse Event|5|||
105848735|NCT00302081|365105088|FG002|Overall Study|Adverse Event|4|||
105848736|NCT00302081|365105086|FG000|Overall Study|Lost to Follow-up|21|||
105848737|NCT00302081|365105087|FG001|Overall Study|Lost to Follow-up|18|||
105848738|NCT00302081|365105088|FG002|Overall Study|Lost to Follow-up|28|||
105848739|NCT00302081|365105086|FG000|Overall Study|Withdrawal by Subject|8|||
105848740|NCT00302081|365105087|FG001|Overall Study|Withdrawal by Subject|12|||
105848741|NCT00302081|365105088|FG002|Overall Study|Withdrawal by Subject|8|||
105848742|NCT00302081|365105086|FG000|Overall Study|Protocol Violation|5|||
105848743|NCT00302081|365105087|FG001|Overall Study|Protocol Violation|1|||
105848744|NCT00302081|365105088|FG002|Overall Study|Protocol Violation|2|||
105848745|NCT00302081|365105086|FG000|Overall Study|Lack of Efficacy|1|||
105848746|NCT00302081|365105087|FG001|Overall Study|Lack of Efficacy|0|||
105848747|NCT00302081|365105088|FG002|Overall Study|Lack of Efficacy|5|||
105848748|NCT00302081|365105086|FG000|Overall Study|Death|2|||
105848749|NCT00302081|365105087|FG001|Overall Study|Death|1|||
105848750|NCT00302081|365105088|FG002|Overall Study|Death|0|||
105848751|NCT00302081|365105086|FG000|Overall Study|Other|13|||
105848752|NCT00302081|365105087|FG001|Overall Study|Other|6|||
105848753|NCT00302081|365105088|FG002|Overall Study|Other|5|||
105848754|NCT01394952|365105089|FG000|Overall Study|Lost to Follow-up|0|||
105848755|NCT01394952|365105090|FG001|Overall Study|Lost to Follow-up|5|||
105848756|NCT01394952|365105089|FG000|Overall Study|Withdrawal by Subject|10|||
105848757|NCT01394952|365105090|FG001|Overall Study|Withdrawal by Subject|5|||
105848758|NCT01394952|365105089|FG000|Overall Study|Physician Decision|2|||
105848759|NCT01394952|365105090|FG001|Overall Study|Physician Decision|0|||
105848760|NCT01394952|365105089|FG000|Overall Study|Sponsor Decision|5|||
105848761|NCT01394952|365105090|FG001|Overall Study|Sponsor Decision|7|||
106024956|NCT01124864|365758448|FG005|Overall Study|Withdrawal by Subject|1|||
106024957|NCT01124864|365758443|FG000|Overall Study|Lost to Follow-up|1|||
106024958|NCT01124864|365758444|FG001|Overall Study|Lost to Follow-up|1|||
106024959|NCT01124864|365758445|FG002|Overall Study|Lost to Follow-up|0|||
106024960|NCT01124864|365758446|FG003|Overall Study|Lost to Follow-up|1|||
106024961|NCT01124864|365758447|FG004|Overall Study|Lost to Follow-up|0|||
106024962|NCT01124864|365758448|FG005|Overall Study|Lost to Follow-up|0|||
106024963|NCT01124864|365758443|FG000|Overall Study|Protocol Violation|1|||
106024964|NCT01124864|365758444|FG001|Overall Study|Protocol Violation|0|||
106024965|NCT01124864|365758445|FG002|Overall Study|Protocol Violation|0|||
106024966|NCT01124864|365758446|FG003|Overall Study|Protocol Violation|0|||
106024967|NCT01124864|365758447|FG004|Overall Study|Protocol Violation|1|||
106024968|NCT01124864|365758448|FG005|Overall Study|Protocol Violation|0|||
106024969|NCT02551991|365758451|FG000|Overall Study|Death|5|||
106024970|NCT02551991|365758452|FG001|Overall Study|Death|7|||
106024971|NCT02551991|365758453|FG002|Overall Study|Death|8|||
106024972|NCT02551991|365758454|FG003|Overall Study|Death|7|||
106024973|NCT02551991|365758455|FG004|Overall Study|Death|17|||
106024974|NCT02551991|365758451|FG000|Overall Study|Withdrawal by Subject|1|||
106024975|NCT02551991|365758452|FG001|Overall Study|Withdrawal by Subject|0|||
106024976|NCT02551991|365758453|FG002|Overall Study|Withdrawal by Subject|0|||
106024977|NCT02551991|365758454|FG003|Overall Study|Withdrawal by Subject|0|||
106024978|NCT02551991|365758455|FG004|Overall Study|Withdrawal by Subject|2|||
106024979|NCT02551991|365758451|FG000|Overall Study|Lost to Follow-up|0|||
106024980|NCT02551991|365758452|FG001|Overall Study|Lost to Follow-up|0|||
106024981|NCT02551991|365758453|FG002|Overall Study|Lost to Follow-up|1|||
106024982|NCT02551991|365758454|FG003|Overall Study|Lost to Follow-up|0|||
106024983|NCT02551991|365758455|FG004|Overall Study|Lost to Follow-up|0|||
106024984|NCT02551991|365758451|FG000|Overall Study|Sponsor Decision|1|||
106024985|NCT02551991|365758452|FG001|Overall Study|Sponsor Decision|0|||
106024986|NCT02551991|365758453|FG002|Overall Study|Sponsor Decision|1|||
106024987|NCT02551991|365758454|FG003|Overall Study|Sponsor Decision|0|||
106024988|NCT02551991|365758455|FG004|Overall Study|Sponsor Decision|5|||
106024989|NCT02551991|365758451|FG000|Overall Study|Other|0|||
106024990|NCT02551991|365758452|FG001|Overall Study|Other|0|||
106024991|NCT02551991|365758453|FG002|Overall Study|Other|0|||
106024992|NCT02551991|365758454|FG003|Overall Study|Other|0|||
106024993|NCT02551991|365758455|FG004|Overall Study|Other|1|||
106024994|NCT00265148|365758456|FG000|Overall Study|Adverse Event|2|||
106024995|NCT00265148|365758457|FG001|Overall Study|Adverse Event|2|||
106024996|NCT00265148|365758456|FG000|Overall Study|Lack of Efficacy|0|||
106024997|NCT00265148|365758457|FG001|Overall Study|Lack of Efficacy|2|||
106024998|NCT00265148|365758456|FG000|Overall Study|Protocol Violation|3|||
106024999|NCT00265148|365758457|FG001|Overall Study|Protocol Violation|2|||
106025000|NCT00265148|365758456|FG000|Overall Study|Lost to Follow-up|0|||
106025001|NCT00265148|365758457|FG001|Overall Study|Lost to Follow-up|1|||
106025002|NCT00265148|365758456|FG000|Overall Study|Withdrawal by Subject|2|||
106025003|NCT00265148|365758457|FG001|Overall Study|Withdrawal by Subject|1|||
106025004|NCT00265148|365758456|FG000|Overall Study|Physician Decision|1|||
106025005|NCT00265148|365758457|FG001|Overall Study|Physician Decision|0|||
106025006|NCT00265148|365758456|FG000|Overall Study|Increasing frailty|0|||
106025007|NCT00265148|365758457|FG001|Overall Study|Increasing frailty|1|||
106025008|NCT00265148|365758456|FG000|Overall Study|Subject chose to change of the dose|1|||
106025009|NCT00265148|365758457|FG001|Overall Study|Subject chose to change of the dose|0|||
106025010|NCT01311024|365758458|FG000|Overall Study|Protocol Violation|35|||
106025011|NCT01311024|365758459|FG001|Overall Study|Protocol Violation|22|||
106025012|NCT00591318|365758466|FG000|Overall Study|Lack of Efficacy|2|||
106025013|NCT00591318|365758467|FG001|Overall Study|Lack of Efficacy|0|||
106025014|NCT00591318|365758466|FG000|Overall Study|Adverse Event|2|||
106025015|NCT00591318|365758467|FG001|Overall Study|Adverse Event|0|||
106025016|NCT04074161|365758468|FG000|Overall Study|Withdrawal by Subject|2|||
106025017|NCT04074161|365758469|FG001|Overall Study|Withdrawal by Subject|4|||
106025018|NCT04074161|365758470|FG002|Overall Study|Withdrawal by Subject|1|||
106025019|NCT04074161|365758468|FG000|Overall Study|Lost to Follow-up|4|||
105848762|NCT03276221|365105093|FG000|Overall Study|Lost to Follow-up|6|||
106025020|NCT04074161|365758469|FG001|Overall Study|Lost to Follow-up|5|||
106025021|NCT04074161|365758470|FG002|Overall Study|Lost to Follow-up|3|||
106025022|NCT03595228|365758473|FG000|Overall Study|Death|2|||
106025023|NCT03595228|365758473|FG000|Overall Study|Lack of Efficacy|13|||
106025024|NCT03595228|365758473|FG000|Overall Study|Withdrawal by Subject|3|||
106025025|NCT03595228|365758473|FG000|Overall Study|Withdrawal by Sponsor|1|||
106025026|NCT00200356|365758474|FG000|Overall Study|Lack of Efficacy|3|||
106025027|NCT00200356|365758475|FG001|Overall Study|Lack of Efficacy|3|||
106025028|NCT00200356|365758474|FG000|Overall Study|Protocol Violation|4|||
106025029|NCT00200356|365758475|FG001|Overall Study|Protocol Violation|4|||
106025030|NCT00200356|365758474|FG000|Overall Study|Nontreatment|1|||
106025031|NCT00200356|365758475|FG001|Overall Study|Nontreatment|0|||
106025032|NCT02059291|365758482|FG000|Epoch 2|Lack of Efficacy|0|||
106025033|NCT02059291|365758483|FG001|Epoch 2|Lack of Efficacy|0|||
106025034|NCT02059291|365758484|FG002|Epoch 2|Lack of Efficacy|0|||
106025035|NCT02059291|365758485|FG003|Epoch 2|Lack of Efficacy|1|||
105972457|NCT03447314|365559208|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972458|NCT03447314|365559209|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972459|NCT03447314|365559210|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972460|NCT03447314|365559211|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
105972461|NCT03447314|365559194|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972462|NCT03447314|365559195|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972463|NCT03447314|365559196|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972464|NCT03447314|365559197|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
105972465|NCT03447314|365559198|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972466|NCT03447314|365559199|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
105972467|NCT03447314|365559200|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972468|NCT03447314|365559201|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972469|NCT03447314|365559202|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972470|NCT03447314|365559203|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972471|NCT03447314|365559204|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972472|NCT03447314|365559205|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972473|NCT03447314|365559206|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972474|NCT03447314|365559207|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972475|NCT03447314|365559208|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972476|NCT03447314|365559209|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972477|NCT03447314|365559210|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972478|NCT03447314|365559211|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
105972479|NCT01920568|365559212|FG000|Overall Study|Adverse Event|27|||
105972480|NCT01920568|365559213|FG001|Overall Study|Adverse Event|8|||
105972481|NCT01920568|365559212|FG000|Overall Study|Protocol Violation|5|||
105972482|NCT01920568|365559213|FG001|Overall Study|Protocol Violation|3|||
105972483|NCT01920568|365559212|FG000|Overall Study|Lost to Follow-up|2|||
105972484|NCT01920568|365559213|FG001|Overall Study|Lost to Follow-up|2|||
105972485|NCT01920568|365559212|FG000|Overall Study|Physician Decision|13|||
106025036|NCT02059291|365758486|FG004|Epoch 2|Lack of Efficacy|0|||
106025037|NCT02059291|365758487|FG005|Epoch 2|Lack of Efficacy|1|||
106025038|NCT02059291|365758488|FG006|Epoch 2|Lack of Efficacy|0|||
106025039|NCT02059291|365758489|FG007|Epoch 2|Lack of Efficacy|0|||
106025040|NCT02059291|365758490|FG008|Epoch 2|Lack of Efficacy|0|||
106025041|NCT02059291|365758491|FG009|Epoch 2|Lack of Efficacy|0|||
106025042|NCT02059291|365758492|FG010|Epoch 2|Lack of Efficacy|0|||
106025043|NCT02059291|365758493|FG011|Epoch 2|Lack of Efficacy|0|||
106025044|NCT02059291|365758494|FG012|Epoch 2|Lack of Efficacy|0|||
106025045|NCT02059291|365758495|FG013|Epoch 2|Lack of Efficacy|0|||
106025046|NCT02059291|365758496|FG014|Epoch 2|Lack of Efficacy|0|||
106025047|NCT02059291|365758497|FG015|Epoch 2|Lack of Efficacy|0|||
106025048|NCT02059291|365758498|FG016|Epoch 2|Lack of Efficacy|0|||
106025049|NCT02059291|365758499|FG017|Epoch 2|Lack of Efficacy|0|||
106025050|NCT02059291|365758500|FG018|Epoch 2|Lack of Efficacy|0|||
106025051|NCT02059291|365758501|FG019|Epoch 2|Lack of Efficacy|0|||
106025052|NCT02059291|365758502|FG020|Epoch 2|Lack of Efficacy|0|||
106025053|NCT02059291|365758503|FG021|Epoch 2|Lack of Efficacy|0|||
106025054|NCT02059291|365758504|FG022|Epoch 2|Lack of Efficacy|0|||
106025055|NCT02059291|365758505|FG023|Epoch 2|Lack of Efficacy|0|||
106025056|NCT02059291|365758506|FG024|Epoch 2|Lack of Efficacy|0|||
106025057|NCT02059291|365758482|FG000|Epoch 2|Adverse Event|0|||
106025058|NCT02059291|365758483|FG001|Epoch 2|Adverse Event|0|||
106025059|NCT02059291|365758484|FG002|Epoch 2|Adverse Event|1|||
105972486|NCT01920568|365559213|FG001|Overall Study|Physician Decision|4|||
106025060|NCT02059291|365758485|FG003|Epoch 2|Adverse Event|1|||
106025061|NCT02059291|365758486|FG004|Epoch 2|Adverse Event|0|||
106025062|NCT02059291|365758487|FG005|Epoch 2|Adverse Event|0|||
106025063|NCT02059291|365758488|FG006|Epoch 2|Adverse Event|0|||
106025064|NCT02059291|365758489|FG007|Epoch 2|Adverse Event|1|||
106025065|NCT02059291|365758490|FG008|Epoch 2|Adverse Event|1|||
106025066|NCT02059291|365758491|FG009|Epoch 2|Adverse Event|0|||
106025067|NCT02059291|365758492|FG010|Epoch 2|Adverse Event|0|||
106025068|NCT02059291|365758493|FG011|Epoch 2|Adverse Event|0|||
106025069|NCT02059291|365758494|FG012|Epoch 2|Adverse Event|0|||
106025070|NCT02059291|365758495|FG013|Epoch 2|Adverse Event|0|||
106025071|NCT02059291|365758496|FG014|Epoch 2|Adverse Event|0|||
106025072|NCT02059291|365758497|FG015|Epoch 2|Adverse Event|0|||
106025073|NCT02059291|365758498|FG016|Epoch 2|Adverse Event|0|||
106025074|NCT02059291|365758499|FG017|Epoch 2|Adverse Event|0|||
105972487|NCT01920568|365559212|FG000|Overall Study|Withdrawal by Subject|79|||
105972488|NCT01920568|365559213|FG001|Overall Study|Withdrawal by Subject|55|||
105972489|NCT01920568|365559212|FG000|Overall Study|Death due to disease progression|25|||
105972490|NCT01920568|365559213|FG001|Overall Study|Death due to disease progression|12|||
105972491|NCT01818258|365559215|FG000|Overall Study|Death|3|||
105972492|NCT01818258|365559216|FG001|Overall Study|Death|0|||
105972493|NCT01818258|365559215|FG000|Overall Study|Withdrawal by Subject|0|||
105972494|NCT01818258|365559216|FG001|Overall Study|Withdrawal by Subject|1|||
105972495|NCT01818258|365559215|FG000|Overall Study|Lost to Follow-up|0|||
105972496|NCT01818258|365559216|FG001|Overall Study|Lost to Follow-up|1|||
105972497|NCT01818258|365559215|FG000|Overall Study|Unable to Travel to Clinic|0|||
105972498|NCT01818258|365559216|FG001|Overall Study|Unable to Travel to Clinic|1|||
105972499|NCT02891681|365559218|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
105972500|NCT02891681|365559219|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
105972501|NCT02891681|365559220|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
105972502|NCT02891681|365559218|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
105972503|NCT02891681|365559219|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
105972504|NCT02891681|365559220|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
105972505|NCT02891681|365559218|FG000|Overall Study|Taken off study after first imaging appointment|1|||
105972506|NCT02891681|365559219|FG001|Overall Study|Taken off study after first imaging appointment|0|||
105972507|NCT02891681|365559220|FG002|Overall Study|Taken off study after first imaging appointment|0|||
105972508|NCT01342965|365559222|FG000|Overall Study|Death|58|||
105972509|NCT01342965|365559223|FG001|Overall Study|Death|57|||
105972510|NCT01342965|365559222|FG000|Overall Study|Lost to Follow-up|5|||
105972511|NCT01342965|365559223|FG001|Overall Study|Lost to Follow-up|3|||
105972512|NCT01342965|365559222|FG000|Overall Study|Other Reasons- Unspecified|44|||
105972513|NCT01342965|365559223|FG001|Overall Study|Other Reasons- Unspecified|38|||
105972514|NCT01342965|365559222|FG000|Overall Study|Withdrawal by Subject|2|||
105972515|NCT01342965|365559223|FG001|Overall Study|Withdrawal by Subject|9|||
105972516|NCT01327053|365559239|FG000|Overall Study|Adverse Event|23|||
105972517|NCT01327053|365559240|FG001|Overall Study|Adverse Event|57|||
105972518|NCT01327053|365559239|FG000|Overall Study|Patient/guardian decision|11|||
105972519|NCT01327053|365559240|FG001|Overall Study|Patient/guardian decision|35|||
105972520|NCT01327053|365559239|FG000|Overall Study|Physician Decision|10|||
105972521|NCT01327053|365559240|FG001|Overall Study|Physician Decision|14|||
105972522|NCT01327053|365559239|FG000|Overall Study|Death|1|||
105972523|NCT01327053|365559240|FG001|Overall Study|Death|5|||
105972524|NCT01327053|365559239|FG000|Overall Study|Lost to Follow-up|2|||
105972525|NCT01327053|365559240|FG001|Overall Study|Lost to Follow-up|4|||
105972526|NCT01327053|365559239|FG000|Overall Study|Non-compliance with study treatment|0|||
105972527|NCT01327053|365559240|FG001|Overall Study|Non-compliance with study treatment|5|||
105972528|NCT01327053|365559239|FG000|Overall Study|Study terminated by Sponsor|1|||
105972529|NCT01327053|365559240|FG001|Overall Study|Study terminated by Sponsor|3|||
105972530|NCT01327053|365559239|FG000|Overall Study|Progressive disease|31|||
105972531|NCT01327053|365559240|FG001|Overall Study|Progressive disease|26|||
105972532|NCT01327053|365559239|FG000|Overall Study|Protocol Violation|0|||
105972533|NCT01327053|365559240|FG001|Overall Study|Protocol Violation|1|||
105972534|NCT01327053|365559239|FG000|Overall Study|Untreated|0|||
105972535|NCT01327053|365559240|FG001|Overall Study|Untreated|1|||
105972536|NCT02233738|365559241|FG000|Overall Study|Lost to Follow-up|5|||
105972537|NCT02233738|365559242|FG001|Overall Study|Lost to Follow-up|12|||
105972538|NCT02233738|365559241|FG000|Overall Study|Death|0|||
105972539|NCT02233738|365559242|FG001|Overall Study|Death|1|||
105972540|NCT02233738|365559241|FG000|Overall Study|Withdrawal by Subject|0|||
105972541|NCT02233738|365559242|FG001|Overall Study|Withdrawal by Subject|1|||
105972542|NCT02233738|365559241|FG000|Overall Study|Did not return after Baseline|3|||
105972543|NCT02233738|365559242|FG001|Overall Study|Did not return after Baseline|2|||
105972544|NCT00096174|365559243|FG000|Overall Study|Lack of Efficacy|9|||
105972545|NCT00096174|365559243|FG000|Overall Study|Adverse Event|15|||
106025075|NCT02059291|365758500|FG018|Epoch 2|Adverse Event|0|||
106025076|NCT02059291|365758501|FG019|Epoch 2|Adverse Event|0|||
106025077|NCT02059291|365758502|FG020|Epoch 2|Adverse Event|0|||
106025078|NCT02059291|365758503|FG021|Epoch 2|Adverse Event|0|||
105972546|NCT00096174|365559243|FG000|Overall Study|Death|6|||
105972547|NCT00096174|365559243|FG000|Overall Study|Withdrawal by Subject|15|||
106025079|NCT02059291|365758504|FG022|Epoch 2|Adverse Event|0|||
105972548|NCT00096174|365559243|FG000|Overall Study|Not started protocol therapy|3|||
105972549|NCT00096174|365559243|FG000|Overall Study|Ineligible|6|||
105972550|NCT00096174|365559243|FG000|Overall Study|other reason|8|||
105972551|NCT04706273|365559244|FG000|Overall Study|Withdrawal by Subject|27|||
105972552|NCT04706273|365559244|FG000|Overall Study|Physician Decision|1|||
106025080|NCT02059291|365758505|FG023|Epoch 2|Adverse Event|0|||
105972553|NCT04706273|365559244|FG000|Overall Study|Lost to Follow-up|42|||
105972554|NCT04706273|365559244|FG000|Overall Study|Death|85|||
105972555|NCT04706273|365559244|FG000|Overall Study|Amputation that removes study device|2|||
106025081|NCT02059291|365758506|FG024|Epoch 2|Adverse Event|0|||
106025082|NCT02059291|365758482|FG000|Epoch 2|Withdrawal by Subject|0|||
106150073|NCT03201562|366210456|FG002|Overall Study|Lost to Follow-up|2|||
106150074|NCT00065260|366210457|FG000|Overall Study|Death|0|||
106150075|NCT00065260|366210458|FG001|Overall Study|Death|1|||
106150076|NCT00001277|366210459|FG000|Overall Study|Adverse Event|0|||
106150077|NCT00001277|366210460|FG001|Overall Study|Adverse Event|0|||
106150078|NCT00001277|366210461|FG002|Overall Study|Adverse Event|1|||
106150079|NCT00001277|366210459|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
106150080|NCT00001277|366210460|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
106150081|NCT00001277|366210461|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
106150082|NCT01109524|366210465|FG000|Overall Study|Disease Progression|29|||
106150083|NCT01109524|366210465|FG000|Overall Study|Study Drug toxicity|6|||
106150084|NCT01109524|366210465|FG000|Overall Study|Adverse Event|4|||
106150085|NCT01109524|366210465|FG000|Overall Study|Withdrawal by Subject|2|||
106150086|NCT01109524|366210465|FG000|Overall Study|Maximum clinical benefit|3|||
106150087|NCT01109524|366210465|FG000|Overall Study|Death|2|||
106150088|NCT01109524|366210465|FG000|Overall Study|No longer meets criteria|2|||
106150089|NCT01109524|366210465|FG000|Overall Study|Participant requested to end treatment|4|||
106150090|NCT01109524|366210465|FG000|Overall Study|Other|5|||
106150091|NCT02269475|366210468|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
106150092|NCT02269475|366210469|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
106150093|NCT02269475|366210468|FG000|Overall Study|Withdrawal by Subject|0|||
106150094|NCT02269475|366210469|FG001|Overall Study|Withdrawal by Subject|1|||
106150095|NCT02730871|366210470|FG000|Overall Study|Adverse Event|6|||
106150096|NCT02730871|366210471|FG001|Overall Study|Adverse Event|0|||
106150097|NCT03664960|366210472|FG000|Overall Study|Adverse Event|0|||
106150098|NCT03664960|366210473|FG001|Overall Study|Adverse Event|3|||
106150099|NCT03664960|366210472|FG000|Overall Study|Lost to Follow-up|3|||
106150100|NCT03664960|366210473|FG001|Overall Study|Lost to Follow-up|2|||
106150101|NCT03664960|366210472|FG000|Overall Study|Physician Decision|1|||
106150102|NCT03664960|366210473|FG001|Overall Study|Physician Decision|0|||
106150103|NCT03664960|366210472|FG000|Overall Study|Withdrawal by Subject|3|||
106150104|NCT03664960|366210473|FG001|Overall Study|Withdrawal by Subject|14|||
106150105|NCT03664960|366210472|FG000|Overall Study|Sponsor Decision|1|||
106150106|NCT03664960|366210473|FG001|Overall Study|Sponsor Decision|1|||
106150107|NCT03664960|366210472|FG000|Overall Study|Other|1|||
106150108|NCT03664960|366210473|FG001|Overall Study|Other|2|||
106150109|NCT00823472|366210474|FG000|Overall Study|Physician Decision|24|||
106150110|NCT00823472|366210475|FG001|Overall Study|Physician Decision|28|||
106150111|NCT04992390|366210479|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
106150112|NCT04992390|366210480|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
106150113|NCT04992390|366210481|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
106150114|NCT04992390|366210479|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
106150115|NCT04992390|366210480|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
106150116|NCT04992390|366210481|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
106150117|NCT04992390|366210479|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
106150118|NCT04992390|366210480|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
105972556|NCT04706273|365559244|FG000|Overall Study|Surgical bypass|3|||
105972557|NCT04706273|365559244|FG000|Overall Study|Changing hospital|23|||
105972558|NCT04706273|365559244|FG000|Overall Study|Unable to attend hospital|2|||
105972559|NCT03549871|365559245|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
105972560|NCT03549871|365559246|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
105972561|NCT03549871|365559245|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
105972562|NCT03549871|365559246|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
105972563|NCT03549871|365559245|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
105972564|NCT03549871|365559246|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
105972565|NCT03549871|365559245|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
105972566|NCT03549871|365559246|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
105972567|NCT03549871|365559245|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
105972568|NCT03549871|365559246|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
105972569|NCT03549871|365559245|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
106150119|NCT04992390|366210481|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
106150120|NCT04992390|366210479|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
106150121|NCT04992390|366210480|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
106150122|NCT04992390|366210481|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
106150123|NCT04992390|366210479|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
105972570|NCT03549871|365559246|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
106150124|NCT04992390|366210480|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
106150125|NCT04992390|366210481|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
106150126|NCT04992390|366210479|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
106150127|NCT04992390|366210480|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
106150128|NCT04992390|366210481|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
105848763|NCT03276221|365105094|FG001|Overall Study|Lost to Follow-up|2|||
105848764|NCT03276221|365105095|FG002|Overall Study|Lost to Follow-up|0|||
105848765|NCT03276221|365105093|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
105848766|NCT03276221|365105094|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
105848767|NCT03276221|365105095|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
105848768|NCT04700280|365105099|FG000|Overall Study|Adverse Event|4|||
105972571|NCT03549871|365559245|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
105972572|NCT03549871|365559246|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
105972573|NCT03549871|365559245|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
105972574|NCT03549871|365559246|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
105972575|NCT03549871|365559245|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
105972576|NCT03549871|365559246|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
105972577|NCT03549871|365559245|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
105972578|NCT03549871|365559246|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
105972579|NCT03549871|365559245|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
105972580|NCT03549871|365559246|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
105972581|NCT01133626|365559248|FG000|Overall Study|Adverse Event|0|||
105972582|NCT01133626|365559249|FG001|Overall Study|Adverse Event|1|||
105972583|NCT01133626|365559250|FG002|Overall Study|Adverse Event|0|||
105972584|NCT01133626|365559248|FG000|Overall Study|Withdrawal by Subject|1|||
105972585|NCT01133626|365559249|FG001|Overall Study|Withdrawal by Subject|2|||
105972586|NCT01133626|365559250|FG002|Overall Study|Withdrawal by Subject|2|||
105972587|NCT01133626|365559248|FG000|Overall Study|Other|0|||
105972588|NCT01133626|365559249|FG001|Overall Study|Other|2|||
105972589|NCT01133626|365559250|FG002|Overall Study|Other|0|||
105972590|NCT00759356|365559251|FG000|Overall Study|Adverse Event|0|||
105972591|NCT00759356|365559252|FG001|Overall Study|Adverse Event|1|||
105972592|NCT00759356|365559251|FG000|Overall Study|Withdrawal by Subject|0|||
105972593|NCT00759356|365559252|FG001|Overall Study|Withdrawal by Subject|2|||
105972594|NCT00759356|365559251|FG000|Overall Study|Subject was unable to return|1|||
105972595|NCT00759356|365559252|FG001|Overall Study|Subject was unable to return|0|||
105972596|NCT03199053|365559253|FG000|ST Period|Withdrawal by Subject|2|||
105848769|NCT04700280|365105100|FG001|Overall Study|Adverse Event|0|||
105848770|NCT04700280|365105099|FG000|Overall Study|Lack of Efficacy|1|||
105972597|NCT03199053|365559254|FG001|ST Period|Withdrawal by Subject|4|||
105972598|NCT03199053|365559255|FG002|ST Period|Withdrawal by Subject|6|||
105972599|NCT03199053|365559253|FG000|ST Period|Withdrawal by parent/guardian|1|||
105972600|NCT03199053|365559254|FG001|ST Period|Withdrawal by parent/guardian|1|||
105972601|NCT03199053|365559255|FG002|ST Period|Withdrawal by parent/guardian|1|||
105972602|NCT03199053|365559253|FG000|ST Period|Lost to Follow-up|2|||
105972603|NCT03199053|365559254|FG001|ST Period|Lost to Follow-up|0|||
105972604|NCT03199053|365559255|FG002|ST Period|Lost to Follow-up|1|||
105972605|NCT03199053|365559253|FG000|LT Period|Withdrawal by Subject|1|||
105972606|NCT03199053|365559254|FG001|LT Period|Withdrawal by Subject|3|||
105972607|NCT03199053|365559255|FG002|LT Period|Withdrawal by Subject|3|||
105972608|NCT03199053|365559253|FG000|LT Period|Withdrawal by parent/guardian|0|||
105972609|NCT03199053|365559254|FG001|LT Period|Withdrawal by parent/guardian|0|||
105972610|NCT03199053|365559255|FG002|LT Period|Withdrawal by parent/guardian|1|||
105972611|NCT03199053|365559253|FG000|LT Period|Lost to Follow-up|0|||
105972612|NCT03199053|365559254|FG001|LT Period|Lost to Follow-up|1|||
105972613|NCT03199053|365559255|FG002|LT Period|Lost to Follow-up|1|||
105972614|NCT03199053|365559253|FG000|LT Period|Miscellaneous|0|||
105972615|NCT03199053|365559254|FG001|LT Period|Miscellaneous|0|||
105972616|NCT03199053|365559255|FG002|LT Period|Miscellaneous|2|||
105972617|NCT03199053|365559253|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
105972618|NCT03199053|365559254|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
105972619|NCT03199053|365559255|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
105972620|NCT03199053|365559253|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
105972621|NCT03199053|365559254|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
105848771|NCT04700280|365105100|FG001|Overall Study|Lack of Efficacy|0|||
105848772|NCT04700280|365105099|FG000|Overall Study|Study terminated by sponsor|5|||
105972622|NCT03199053|365559255|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
105972623|NCT03199053|365559253|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
105972624|NCT03199053|365559254|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
105972625|NCT03199053|365559255|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
105972626|NCT03199053|365559253|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
105972627|NCT03199053|365559254|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
105972628|NCT03199053|365559255|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
105972629|NCT03298984|365559258|FG000|Overall Study|Physician Decision|1|||
105972630|NCT03298984|365559259|FG001|Overall Study|Physician Decision|0|||
105848773|NCT04700280|365105100|FG001|Overall Study|Study terminated by sponsor|3|||
105848774|NCT04700280|365105099|FG000|Overall Study|Other than specified|1|||
105848775|NCT04700280|365105100|FG001|Overall Study|Other than specified|0|||
105972631|NCT03298984|365559260|FG002|Overall Study|Physician Decision|0|||
105972632|NCT03298984|365559261|FG003|Overall Study|Physician Decision|6|||
105972633|NCT03298984|365559258|FG000|Overall Study|Lack of Efficacy|0|||
105972634|NCT03298984|365559259|FG001|Overall Study|Lack of Efficacy|1|||
105972635|NCT03298984|365559260|FG002|Overall Study|Lack of Efficacy|1|||
105972636|NCT03298984|365559261|FG003|Overall Study|Lack of Efficacy|4|||
105972637|NCT03298984|365559258|FG000|Overall Study|Relapsed disease (following remission)|0|||
105972638|NCT03298984|365559259|FG001|Overall Study|Relapsed disease (following remission)|0|||
105972639|NCT03298984|365559260|FG002|Overall Study|Relapsed disease (following remission)|1|||
105972640|NCT03298984|365559261|FG003|Overall Study|Relapsed disease (following remission)|1|||
105972641|NCT03298984|365559258|FG000|Overall Study|Adverse Event|0|||
105972642|NCT03298984|365559259|FG001|Overall Study|Adverse Event|0|||
105972643|NCT03298984|365559260|FG002|Overall Study|Adverse Event|0|||
106025083|NCT02059291|365758483|FG001|Epoch 2|Withdrawal by Subject|1|||
106025084|NCT02059291|365758484|FG002|Epoch 2|Withdrawal by Subject|0|||
106025085|NCT02059291|365758485|FG003|Epoch 2|Withdrawal by Subject|0|||
106025086|NCT02059291|365758486|FG004|Epoch 2|Withdrawal by Subject|0|||
106025087|NCT02059291|365758487|FG005|Epoch 2|Withdrawal by Subject|1|||
106025088|NCT02059291|365758488|FG006|Epoch 2|Withdrawal by Subject|0|||
106025089|NCT02059291|365758489|FG007|Epoch 2|Withdrawal by Subject|0|||
106025090|NCT02059291|365758490|FG008|Epoch 2|Withdrawal by Subject|1|||
106025091|NCT02059291|365758491|FG009|Epoch 2|Withdrawal by Subject|0|||
106025092|NCT02059291|365758492|FG010|Epoch 2|Withdrawal by Subject|0|||
106025093|NCT02059291|365758493|FG011|Epoch 2|Withdrawal by Subject|0|||
106025094|NCT02059291|365758494|FG012|Epoch 2|Withdrawal by Subject|0|||
106025095|NCT02059291|365758495|FG013|Epoch 2|Withdrawal by Subject|0|||
106025096|NCT02059291|365758496|FG014|Epoch 2|Withdrawal by Subject|0|||
106025097|NCT02059291|365758497|FG015|Epoch 2|Withdrawal by Subject|0|||
106025098|NCT02059291|365758498|FG016|Epoch 2|Withdrawal by Subject|0|||
106025099|NCT02059291|365758499|FG017|Epoch 2|Withdrawal by Subject|0|||
106025100|NCT02059291|365758500|FG018|Epoch 2|Withdrawal by Subject|0|||
106025101|NCT02059291|365758501|FG019|Epoch 2|Withdrawal by Subject|0|||
106025102|NCT02059291|365758502|FG020|Epoch 2|Withdrawal by Subject|0|||
106025103|NCT02059291|365758503|FG021|Epoch 2|Withdrawal by Subject|0|||
106025104|NCT02059291|365758504|FG022|Epoch 2|Withdrawal by Subject|0|||
106025105|NCT02059291|365758505|FG023|Epoch 2|Withdrawal by Subject|0|||
106025106|NCT02059291|365758506|FG024|Epoch 2|Withdrawal by Subject|0|||
106025107|NCT02059291|365758482|FG000|Epoch 3|Physician Decision|0|||
106025108|NCT02059291|365758483|FG001|Epoch 3|Physician Decision|0|||
106025109|NCT02059291|365758484|FG002|Epoch 3|Physician Decision|0|||
106025110|NCT02059291|365758485|FG003|Epoch 3|Physician Decision|0|||
106025111|NCT02059291|365758486|FG004|Epoch 3|Physician Decision|0|||
106025112|NCT02059291|365758487|FG005|Epoch 3|Physician Decision|0|||
106025113|NCT02059291|365758488|FG006|Epoch 3|Physician Decision|0|||
106025114|NCT02059291|365758489|FG007|Epoch 3|Physician Decision|0|||
106025115|NCT02059291|365758490|FG008|Epoch 3|Physician Decision|0|||
106025116|NCT02059291|365758491|FG009|Epoch 3|Physician Decision|0|||
106025117|NCT02059291|365758492|FG010|Epoch 3|Physician Decision|0|||
106025118|NCT02059291|365758493|FG011|Epoch 3|Physician Decision|0|||
106025119|NCT02059291|365758494|FG012|Epoch 3|Physician Decision|0|||
106025120|NCT02059291|365758495|FG013|Epoch 3|Physician Decision|1|||
106025121|NCT02059291|365758496|FG014|Epoch 3|Physician Decision|0|||
106025122|NCT02059291|365758497|FG015|Epoch 3|Physician Decision|1|||
106025123|NCT02059291|365758498|FG016|Epoch 3|Physician Decision|0|||
106025124|NCT02059291|365758499|FG017|Epoch 3|Physician Decision|0|||
106025125|NCT02059291|365758500|FG018|Epoch 3|Physician Decision|0|||
106025126|NCT02059291|365758501|FG019|Epoch 3|Physician Decision|0|||
106025127|NCT02059291|365758502|FG020|Epoch 3|Physician Decision|0|||
105972644|NCT03298984|365559261|FG003|Overall Study|Adverse Event|1|||
105972645|NCT03298984|365559258|FG000|Overall Study|Death|0|||
105972646|NCT03298984|365559259|FG001|Overall Study|Death|0|||
105972647|NCT03298984|365559260|FG002|Overall Study|Death|0|||
106025128|NCT02059291|365758503|FG021|Epoch 3|Physician Decision|0|||
106025129|NCT02059291|365758504|FG022|Epoch 3|Physician Decision|0|||
106025130|NCT02059291|365758505|FG023|Epoch 3|Physician Decision|0|||
106025131|NCT02059291|365758506|FG024|Epoch 3|Physician Decision|0|||
106025132|NCT02059291|365758482|FG000|Epoch 3|Adverse Event|0|||
106025133|NCT02059291|365758483|FG001|Epoch 3|Adverse Event|0|||
106025134|NCT02059291|365758484|FG002|Epoch 3|Adverse Event|0|||
106025135|NCT02059291|365758485|FG003|Epoch 3|Adverse Event|0|||
106025136|NCT02059291|365758486|FG004|Epoch 3|Adverse Event|0|||
106025137|NCT02059291|365758487|FG005|Epoch 3|Adverse Event|0|||
106025138|NCT02059291|365758488|FG006|Epoch 3|Adverse Event|0|||
106025139|NCT02059291|365758489|FG007|Epoch 3|Adverse Event|0|||
106025140|NCT02059291|365758490|FG008|Epoch 3|Adverse Event|0|||
105972648|NCT03298984|365559261|FG003|Overall Study|Death|2|||
105972649|NCT03298984|365559258|FG000|Overall Study|Insurance Company Decision|0|||
106025141|NCT02059291|365758491|FG009|Epoch 3|Adverse Event|0|||
106025142|NCT02059291|365758492|FG010|Epoch 3|Adverse Event|0|||
106025143|NCT02059291|365758493|FG011|Epoch 3|Adverse Event|0|||
106025144|NCT02059291|365758494|FG012|Epoch 3|Adverse Event|0|||
106025145|NCT02059291|365758495|FG013|Epoch 3|Adverse Event|0|||
105848776|NCT00876018|365105101|FG000|Overall Study|Lost to Follow-up|0|||
105848777|NCT00876018|365105102|FG001|Overall Study|Lost to Follow-up|1|||
105848778|NCT00876018|365105103|FG002|Overall Study|Lost to Follow-up|1|||
105848779|NCT00876018|365105101|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
105848780|NCT00876018|365105102|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
105848781|NCT00876018|365105103|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
105848782|NCT02615171|365105104|FG000|Overall Study|Lost to Follow-up|2|||
105848783|NCT02615171|365105105|FG001|Overall Study|Lost to Follow-up|1|||
105848784|NCT00725621|365105115|FG000|Overall Study|Adverse Event|25|||
105848785|NCT00725621|365105115|FG000|Overall Study|Lack of Efficacy|46|||
105848786|NCT00725621|365105115|FG000|Overall Study|Withdrawal by Subject|57|||
105848787|NCT00725621|365105115|FG000|Overall Study|Physician Decision|19|||
105848788|NCT00725621|365105115|FG000|Overall Study|Lost to Follow-up|52|||
105848789|NCT00725621|365105115|FG000|Overall Study|Non-compliance|8|||
105848790|NCT00725621|365105115|FG000|Overall Study|Continued treatment by other physician|6|||
105848791|NCT00725621|365105115|FG000|Overall Study|Switched to other study|1|||
105848792|NCT00725621|365105115|FG000|Overall Study|Switched to other drug|1|||
105848793|NCT00725621|365105115|FG000|Overall Study|Prepared for elective surgery|1|||
105848794|NCT00725621|365105115|FG000|Overall Study|Reason not specified|55|||
105848795|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
105848796|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
105848797|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
105848798|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
105848799|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
105848800|NCT01490866|365105119|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
105848801|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
105848802|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
105848803|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
105848804|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
105848805|NCT01490866|365105119|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
105848806|NCT03923530|365105120|FG000|Overall Study|Withdrawal by Subject|1|||
105848807|NCT03923530|365105120|FG000|Overall Study|screen failure|3|||
105848808|NCT00407758|365105121|FG000|Overall Study|ineligible -improper prior treatment|1|||
105848809|NCT01181271|365105122|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
105848810|NCT01181271|365105122|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
105848811|NCT01181271|365105122|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
105848812|NCT01181271|365105122|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
105848813|NCT01941940|365105125|FG000|Overall Study|Adverse Event|11|||
105848814|NCT01941940|365105125|FG000|Overall Study|Lost to Follow-up|2|||
105848815|NCT01941940|365105125|FG000|Overall Study|Physician Decision|2|||
105848816|NCT01941940|365105125|FG000|Overall Study|Withdrawal by Subject|15|||
105848817|NCT01941940|365105125|FG000|Overall Study|Death|1|||
105848818|NCT01941940|365105125|FG000|Overall Study|Other|1|||
105848819|NCT01941940|365105125|FG000|Overall Study|Other|1|||
105848820|NCT01301508|365105126|FG000|Overall Study|Withdrawal by Subject|1|||
105848821|NCT01301508|365105127|FG001|Overall Study|Withdrawal by Subject|2|||
105848822|NCT01301508|365105126|FG000|Overall Study|Lost to Follow-up|0|||
105848823|NCT01301508|365105127|FG001|Overall Study|Lost to Follow-up|1|||
105848824|NCT00851643|365105128|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
105848825|NCT00851643|365105129|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848826|NCT00851643|365105130|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848827|NCT00851643|365105131|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848828|NCT00851643|365105132|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848829|NCT00851643|365105133|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
105848830|NCT00851643|365105128|FG000|Base Study (Up to 12 Months)|Other|0|||
105848831|NCT00851643|365105129|FG001|Base Study (Up to 12 Months)|Other|0|||
106025146|NCT02059291|365758496|FG014|Epoch 3|Adverse Event|0|||
106025147|NCT02059291|365758497|FG015|Epoch 3|Adverse Event|1|||
106025148|NCT02059291|365758498|FG016|Epoch 3|Adverse Event|0|||
106025149|NCT02059291|365758499|FG017|Epoch 3|Adverse Event|0|||
106025150|NCT02059291|365758500|FG018|Epoch 3|Adverse Event|0|||
106025151|NCT02059291|365758501|FG019|Epoch 3|Adverse Event|0|||
106025152|NCT02059291|365758502|FG020|Epoch 3|Adverse Event|0|||
106025153|NCT02059291|365758503|FG021|Epoch 3|Adverse Event|0|||
106025154|NCT02059291|365758504|FG022|Epoch 3|Adverse Event|0|||
106025155|NCT02059291|365758505|FG023|Epoch 3|Adverse Event|0|||
105848832|NCT00851643|365105130|FG002|Base Study (Up to 12 Months)|Other|0|||
105848833|NCT00851643|365105131|FG003|Base Study (Up to 12 Months)|Other|0|||
106025156|NCT02059291|365758506|FG024|Epoch 3|Adverse Event|0|||
105848834|NCT00851643|365105132|FG004|Base Study (Up to 12 Months)|Other|0|||
105848835|NCT00851643|365105133|FG005|Base Study (Up to 12 Months)|Other|1|||
105848836|NCT00851643|365105128|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
105848837|NCT00851643|365105129|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
106025157|NCT02059291|365758482|FG000|Epoch 3|Lack of Efficacy|0|||
106025158|NCT02059291|365758483|FG001|Epoch 3|Lack of Efficacy|0|||
105972650|NCT03298984|365559259|FG001|Overall Study|Insurance Company Decision|0|||
105972651|NCT03298984|365559260|FG002|Overall Study|Insurance Company Decision|0|||
105972652|NCT03298984|365559261|FG003|Overall Study|Insurance Company Decision|1|||
105972653|NCT02403635|365559262|FG000|Overall Study|Not eligible|9|||
105972654|NCT00235391|365559264|FG000|Overall Study|Adverse Event|4|||
105972655|NCT00235391|365559265|FG001|Overall Study|Adverse Event|5|||
105972656|NCT00235391|365559266|FG002|Overall Study|Adverse Event|10|||
105972657|NCT00235391|365559267|FG003|Overall Study|Adverse Event|72|||
105972658|NCT00235391|365559268|FG004|Overall Study|Adverse Event|5|||
105972659|NCT00235391|365559269|FG005|Overall Study|Adverse Event|2|||
105972660|NCT00235391|365559264|FG000|Overall Study|Abnormal laboratory value(s)|3|||
105972661|NCT00235391|365559265|FG001|Overall Study|Abnormal laboratory value(s)|5|||
105972662|NCT00235391|365559266|FG002|Overall Study|Abnormal laboratory value(s)|4|||
105972663|NCT00235391|365559267|FG003|Overall Study|Abnormal laboratory value(s)|27|||
105972664|NCT00235391|365559268|FG004|Overall Study|Abnormal laboratory value(s)|1|||
105972665|NCT00235391|365559269|FG005|Overall Study|Abnormal laboratory value(s)|2|||
105972666|NCT00235391|365559264|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105972667|NCT00235391|365559265|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105972668|NCT00235391|365559266|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105972669|NCT00235391|365559267|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
105972670|NCT00235391|365559268|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
105972671|NCT00235391|365559269|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
105972672|NCT00235391|365559264|FG000|Overall Study|Condition no longer requires treatment|3|||
105972673|NCT00235391|365559265|FG001|Overall Study|Condition no longer requires treatment|0|||
105972674|NCT00235391|365559266|FG002|Overall Study|Condition no longer requires treatment|0|||
105972675|NCT00235391|365559267|FG003|Overall Study|Condition no longer requires treatment|11|||
105972676|NCT00235391|365559268|FG004|Overall Study|Condition no longer requires treatment|1|||
105972677|NCT00235391|365559269|FG005|Overall Study|Condition no longer requires treatment|0|||
105972678|NCT00235391|365559264|FG000|Overall Study|Protocol deviation|0|||
105972679|NCT00235391|365559265|FG001|Overall Study|Protocol deviation|0|||
105972680|NCT00235391|365559266|FG002|Overall Study|Protocol deviation|1|||
105972681|NCT00235391|365559267|FG003|Overall Study|Protocol deviation|11|||
105972682|NCT00235391|365559268|FG004|Overall Study|Protocol deviation|0|||
105972683|NCT00235391|365559269|FG005|Overall Study|Protocol deviation|0|||
105972684|NCT00235391|365559264|FG000|Overall Study|Withdrawal by Subject|2|||
105972685|NCT00235391|365559265|FG001|Overall Study|Withdrawal by Subject|3|||
105972686|NCT00235391|365559266|FG002|Overall Study|Withdrawal by Subject|3|||
105972687|NCT00235391|365559267|FG003|Overall Study|Withdrawal by Subject|61|||
105972688|NCT00235391|365559268|FG004|Overall Study|Withdrawal by Subject|5|||
105972689|NCT00235391|365559269|FG005|Overall Study|Withdrawal by Subject|0|||
105972690|NCT00235391|365559264|FG000|Overall Study|Lost to Follow-up|0|||
105972691|NCT00235391|365559265|FG001|Overall Study|Lost to Follow-up|3|||
105972692|NCT00235391|365559266|FG002|Overall Study|Lost to Follow-up|3|||
105972693|NCT00235391|365559267|FG003|Overall Study|Lost to Follow-up|16|||
105972694|NCT00235391|365559268|FG004|Overall Study|Lost to Follow-up|0|||
105972695|NCT00235391|365559269|FG005|Overall Study|Lost to Follow-up|0|||
105972696|NCT00235391|365559264|FG000|Overall Study|Administrative problems|0|||
105972697|NCT00235391|365559265|FG001|Overall Study|Administrative problems|0|||
105972698|NCT00235391|365559266|FG002|Overall Study|Administrative problems|0|||
105972699|NCT00235391|365559267|FG003|Overall Study|Administrative problems|1|||
105972700|NCT00235391|365559268|FG004|Overall Study|Administrative problems|0|||
105972701|NCT00235391|365559269|FG005|Overall Study|Administrative problems|0|||
105972702|NCT00235391|365559264|FG000|Overall Study|Death|0|||
105972703|NCT00235391|365559265|FG001|Overall Study|Death|0|||
105972704|NCT00235391|365559266|FG002|Overall Study|Death|1|||
105972705|NCT00235391|365559267|FG003|Overall Study|Death|4|||
105972706|NCT00235391|365559268|FG004|Overall Study|Death|0|||
106025159|NCT02059291|365758484|FG002|Epoch 3|Lack of Efficacy|0|||
106025160|NCT02059291|365758485|FG003|Epoch 3|Lack of Efficacy|0|||
106025161|NCT02059291|365758486|FG004|Epoch 3|Lack of Efficacy|0|||
106025162|NCT02059291|365758487|FG005|Epoch 3|Lack of Efficacy|0|||
106025163|NCT02059291|365758488|FG006|Epoch 3|Lack of Efficacy|0|||
105972707|NCT00235391|365559269|FG005|Overall Study|Death|0|||
105972708|NCT01095653|365559272|FG000|Overall Study|Lack of Efficacy|3|||
105972709|NCT01095653|365559273|FG001|Overall Study|Lack of Efficacy|0|||
105972710|NCT01095653|365559274|FG002|Overall Study|Lack of Efficacy|0|||
106025164|NCT02059291|365758489|FG007|Epoch 3|Lack of Efficacy|0|||
106025165|NCT02059291|365758490|FG008|Epoch 3|Lack of Efficacy|0|||
106025166|NCT02059291|365758491|FG009|Epoch 3|Lack of Efficacy|0|||
105972711|NCT01095653|365559272|FG000|Overall Study|Adverse Event|1|||
105972712|NCT01095653|365559273|FG001|Overall Study|Adverse Event|4|||
105972713|NCT01095653|365559274|FG002|Overall Study|Adverse Event|4|||
105972714|NCT01095653|365559272|FG000|Overall Study|Lost to Follow-up|1|||
105972715|NCT01095653|365559273|FG001|Overall Study|Lost to Follow-up|0|||
105972716|NCT01095653|365559274|FG002|Overall Study|Lost to Follow-up|4|||
105972717|NCT01095653|365559272|FG000|Overall Study|Withdrawal by Subject|4|||
105972718|NCT01095653|365559273|FG001|Overall Study|Withdrawal by Subject|5|||
106025167|NCT02059291|365758492|FG010|Epoch 3|Lack of Efficacy|0|||
105848838|NCT00851643|365105130|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
105848839|NCT00851643|365105131|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
105848840|NCT00851643|365105132|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
105848841|NCT00851643|365105133|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
105848842|NCT00851643|365105128|FG000|Extension Study (Up to 36 Months)|Moved|0|||
105848843|NCT00851643|365105129|FG001|Extension Study (Up to 36 Months)|Moved|2|||
105848844|NCT00851643|365105130|FG002|Extension Study (Up to 36 Months)|Moved|1|||
105848845|NCT00851643|365105131|FG003|Extension Study (Up to 36 Months)|Moved|1|||
105848846|NCT00851643|365105132|FG004|Extension Study (Up to 36 Months)|Moved|0|||
105848847|NCT00851643|365105133|FG005|Extension Study (Up to 36 Months)|Moved|1|||
105848848|NCT00444457|365105134|FG000|Infant Series|Other|0|||
105848849|NCT00444457|365105135|FG001|Infant Series|Other|1|||
105848850|NCT00444457|365105136|FG002|Infant Series|Other|0|||
105848851|NCT00444457|365105137|FG003|Infant Series|Other|0|||
105848852|NCT00444457|365105134|FG000|Infant Series|Parent or legal guardian request|18|||
105848853|NCT00444457|365105135|FG001|Infant Series|Parent or legal guardian request|29|||
105848854|NCT00444457|365105136|FG002|Infant Series|Parent or legal guardian request|34|||
105848855|NCT00444457|365105137|FG003|Infant Series|Parent or legal guardian request|14|||
105848856|NCT00444457|365105134|FG000|Infant Series|Lost to Follow-up|10|||
105848857|NCT00444457|365105135|FG001|Infant Series|Lost to Follow-up|11|||
105848858|NCT00444457|365105136|FG002|Infant Series|Lost to Follow-up|7|||
105848859|NCT00444457|365105137|FG003|Infant Series|Lost to Follow-up|6|||
105848860|NCT00444457|365105134|FG000|Infant Series|Protocol Violation|16|||
105848861|NCT00444457|365105135|FG001|Infant Series|Protocol Violation|8|||
105848862|NCT00444457|365105136|FG002|Infant Series|Protocol Violation|6|||
105848863|NCT00444457|365105137|FG003|Infant Series|Protocol Violation|3|||
105848864|NCT00444457|365105134|FG000|Infant Series|Failed to return|5|||
105848865|NCT00444457|365105135|FG001|Infant Series|Failed to return|4|||
105848866|NCT00444457|365105136|FG002|Infant Series|Failed to return|4|||
105848867|NCT00444457|365105137|FG003|Infant Series|Failed to return|2|||
105848868|NCT00444457|365105134|FG000|Infant Series|Investigator request|4|||
105848869|NCT00444457|365105135|FG001|Infant Series|Investigator request|3|||
105848870|NCT00444457|365105136|FG002|Infant Series|Investigator request|3|||
105848871|NCT00444457|365105137|FG003|Infant Series|Investigator request|2|||
105848872|NCT00444457|365105134|FG000|Infant Series|Other|0|||
105848873|NCT00444457|365105135|FG001|Infant Series|Other|2|||
105848874|NCT00444457|365105136|FG002|Infant Series|Other|4|||
105848875|NCT00444457|365105137|FG003|Infant Series|Other|0|||
105848876|NCT00444457|365105134|FG000|Infant Series|Adverse Event|1|||
105848877|NCT00444457|365105135|FG001|Infant Series|Adverse Event|2|||
105848878|NCT00444457|365105136|FG002|Infant Series|Adverse Event|2|||
105848879|NCT00444457|365105137|FG003|Infant Series|Adverse Event|0|||
105848880|NCT00444457|365105134|FG000|Infant Series|Death|0|||
105848881|NCT00444457|365105135|FG001|Infant Series|Death|1|||
105848882|NCT00444457|365105136|FG002|Infant Series|Death|1|||
105848883|NCT00444457|365105137|FG003|Infant Series|Death|1|||
105848884|NCT00444457|365105134|FG000|After Infant Series|Other|0|||
105848885|NCT00444457|365105135|FG001|After Infant Series|Other|1|||
105848886|NCT00444457|365105136|FG002|After Infant Series|Other|1|||
105848887|NCT00444457|365105137|FG003|After Infant Series|Other|1|||
105848888|NCT00444457|365105134|FG000|After Infant Series|Parent or legal guardian request|4|||
105848889|NCT00444457|365105135|FG001|After Infant Series|Parent or legal guardian request|11|||
105848890|NCT00444457|365105136|FG002|After Infant Series|Parent or legal guardian request|6|||
105848891|NCT00444457|365105137|FG003|After Infant Series|Parent or legal guardian request|3|||
105848892|NCT00444457|365105134|FG000|After Infant Series|Failed to return|7|||
105848893|NCT00444457|365105135|FG001|After Infant Series|Failed to return|6|||
105848894|NCT00444457|365105136|FG002|After Infant Series|Failed to return|5|||
105848895|NCT00444457|365105137|FG003|After Infant Series|Failed to return|1|||
105848896|NCT00444457|365105134|FG000|After Infant Series|Lost to Follow-up|5|||
105848897|NCT00444457|365105135|FG001|After Infant Series|Lost to Follow-up|5|||
105848898|NCT00444457|365105136|FG002|After Infant Series|Lost to Follow-up|5|||
105848899|NCT00444457|365105137|FG003|After Infant Series|Lost to Follow-up|2|||
105848900|NCT00444457|365105134|FG000|After Infant Series|Protocol Violation|2|||
105848901|NCT00444457|365105135|FG001|After Infant Series|Protocol Violation|4|||
105848902|NCT00444457|365105136|FG002|After Infant Series|Protocol Violation|2|||
105848903|NCT00444457|365105137|FG003|After Infant Series|Protocol Violation|2|||
105848904|NCT00444457|365105134|FG000|After Infant Series|Adverse Event|2|||
105848905|NCT00444457|365105135|FG001|After Infant Series|Adverse Event|2|||
105848906|NCT00444457|365105136|FG002|After Infant Series|Adverse Event|0|||
105848907|NCT00444457|365105137|FG003|After Infant Series|Adverse Event|0|||
105848908|NCT00444457|365105134|FG000|After Infant Series|Investigator request|0|||
105848909|NCT00444457|365105135|FG001|After Infant Series|Investigator request|0|||
105848910|NCT00444457|365105136|FG002|After Infant Series|Investigator request|0|||
105848911|NCT00444457|365105137|FG003|After Infant Series|Investigator request|1|||
105848912|NCT00444457|365105134|FG000|After Infant Series|Other|0|||
105848913|NCT00444457|365105135|FG001|After Infant Series|Other|1|||
105848914|NCT00444457|365105136|FG002|After Infant Series|Other|0|||
105848915|NCT00444457|365105137|FG003|After Infant Series|Other|0|||
105848916|NCT00444457|365105134|FG000|Toddler Dose|Lost to Follow-up|4|||
105848917|NCT00444457|365105135|FG001|Toddler Dose|Lost to Follow-up|1|||
106025168|NCT02059291|365758493|FG011|Epoch 3|Lack of Efficacy|0|||
106150129|NCT04992390|366210479|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
106150130|NCT04992390|366210480|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
106150131|NCT04992390|366210481|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
106150132|NCT04992390|366210479|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
106150133|NCT04992390|366210480|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
106150134|NCT04992390|366210481|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
106150135|NCT04992390|366210479|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
106150136|NCT04992390|366210480|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
106150137|NCT04992390|366210481|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
106150138|NCT04992390|366210479|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
106150139|NCT04992390|366210480|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
106150140|NCT04992390|366210481|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
106150141|NCT04992390|366210479|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
106150142|NCT04992390|366210480|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
106150143|NCT04992390|366210481|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
106150144|NCT04992390|366210479|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
106150145|NCT04992390|366210480|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
106150146|NCT04992390|366210481|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
106150147|NCT04992390|366210479|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
106150148|NCT04992390|366210480|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
106150149|NCT04992390|366210481|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
106150150|NCT04992390|366210479|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
106150151|NCT04992390|366210480|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
106150152|NCT04992390|366210481|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
106150153|NCT04992390|366210479|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
106150154|NCT04992390|366210480|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
106150155|NCT04992390|366210481|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
106150156|NCT04992390|366210479|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
106150157|NCT04992390|366210480|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
106150158|NCT04992390|366210481|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
106025169|NCT02059291|365758494|FG012|Epoch 3|Lack of Efficacy|0|||
106025170|NCT02059291|365758495|FG013|Epoch 3|Lack of Efficacy|0|||
106025171|NCT02059291|365758496|FG014|Epoch 3|Lack of Efficacy|0|||
106025172|NCT02059291|365758497|FG015|Epoch 3|Lack of Efficacy|3|||
106025173|NCT02059291|365758498|FG016|Epoch 3|Lack of Efficacy|0|||
106025174|NCT02059291|365758499|FG017|Epoch 3|Lack of Efficacy|0|||
106025175|NCT02059291|365758500|FG018|Epoch 3|Lack of Efficacy|0|||
106025176|NCT02059291|365758501|FG019|Epoch 3|Lack of Efficacy|0|||
106025177|NCT02059291|365758502|FG020|Epoch 3|Lack of Efficacy|0|||
106025178|NCT02059291|365758503|FG021|Epoch 3|Lack of Efficacy|0|||
106025179|NCT02059291|365758504|FG022|Epoch 3|Lack of Efficacy|0|||
106025180|NCT02059291|365758505|FG023|Epoch 3|Lack of Efficacy|0|||
106025181|NCT02059291|365758506|FG024|Epoch 3|Lack of Efficacy|0|||
106025182|NCT02059291|365758482|FG000|Epoch 3|Withdrawal by Subject|0|||
106025183|NCT02059291|365758483|FG001|Epoch 3|Withdrawal by Subject|0|||
106025184|NCT02059291|365758484|FG002|Epoch 3|Withdrawal by Subject|0|||
106025185|NCT02059291|365758485|FG003|Epoch 3|Withdrawal by Subject|0|||
106025186|NCT02059291|365758486|FG004|Epoch 3|Withdrawal by Subject|0|||
106025187|NCT02059291|365758487|FG005|Epoch 3|Withdrawal by Subject|0|||
106025188|NCT02059291|365758488|FG006|Epoch 3|Withdrawal by Subject|0|||
106025189|NCT02059291|365758489|FG007|Epoch 3|Withdrawal by Subject|0|||
106025190|NCT02059291|365758490|FG008|Epoch 3|Withdrawal by Subject|0|||
106025191|NCT02059291|365758491|FG009|Epoch 3|Withdrawal by Subject|0|||
106025192|NCT02059291|365758492|FG010|Epoch 3|Withdrawal by Subject|0|||
106025193|NCT02059291|365758493|FG011|Epoch 3|Withdrawal by Subject|0|||
106025194|NCT02059291|365758494|FG012|Epoch 3|Withdrawal by Subject|0|||
106025195|NCT02059291|365758495|FG013|Epoch 3|Withdrawal by Subject|0|||
106025196|NCT02059291|365758496|FG014|Epoch 3|Withdrawal by Subject|0|||
106025197|NCT02059291|365758497|FG015|Epoch 3|Withdrawal by Subject|1|||
106025198|NCT02059291|365758498|FG016|Epoch 3|Withdrawal by Subject|0|||
106150159|NCT01207492|366210483|FG000|Overall Study|Still on study|1|||
106150160|NCT01207492|366210483|FG000|Overall Study|Withdrawal by Subject|9|||
106025199|NCT02059291|365758499|FG017|Epoch 3|Withdrawal by Subject|0|||
106025200|NCT02059291|365758500|FG018|Epoch 3|Withdrawal by Subject|0|||
106025201|NCT02059291|365758501|FG019|Epoch 3|Withdrawal by Subject|0|||
106025202|NCT02059291|365758502|FG020|Epoch 3|Withdrawal by Subject|0|||
106025203|NCT02059291|365758503|FG021|Epoch 3|Withdrawal by Subject|0|||
106025204|NCT02059291|365758504|FG022|Epoch 3|Withdrawal by Subject|0|||
106025205|NCT02059291|365758505|FG023|Epoch 3|Withdrawal by Subject|0|||
105848918|NCT00444457|365105136|FG002|Toddler Dose|Lost to Follow-up|1|||
105848919|NCT00444457|365105137|FG003|Toddler Dose|Lost to Follow-up|3|||
105848920|NCT00444457|365105134|FG000|Toddler Dose|Failed to return|2|||
105848921|NCT00444457|365105135|FG001|Toddler Dose|Failed to return|2|||
105848922|NCT00444457|365105136|FG002|Toddler Dose|Failed to return|1|||
105848923|NCT00444457|365105137|FG003|Toddler Dose|Failed to return|3|||
105848924|NCT00444457|365105134|FG000|Toddler Dose|Parent or legal guardian request|0|||
105848925|NCT00444457|365105135|FG001|Toddler Dose|Parent or legal guardian request|3|||
105848926|NCT00444457|365105136|FG002|Toddler Dose|Parent or legal guardian request|2|||
105848927|NCT00444457|365105137|FG003|Toddler Dose|Parent or legal guardian request|1|||
105848928|NCT00444457|365105134|FG000|Toddler Dose|Protocol Violation|1|||
105848929|NCT00444457|365105135|FG001|Toddler Dose|Protocol Violation|0|||
105848930|NCT00444457|365105136|FG002|Toddler Dose|Protocol Violation|0|||
105848931|NCT00444457|365105137|FG003|Toddler Dose|Protocol Violation|1|||
105848932|NCT00448136|365105140|FG000|Overall Study|Death|3|||
105848933|NCT00448136|365105141|FG001|Overall Study|Death|8|||
105848934|NCT00448136|365105140|FG000|Overall Study|Investigator's decision (progression)|1|||
105848935|NCT00448136|365105141|FG001|Overall Study|Investigator's decision (progression)|0|||
105848936|NCT03176459|365105142|FG000|Overall Study|Lost to Follow-up|5|||
105848937|NCT03176459|365105143|FG001|Overall Study|Lost to Follow-up|7|||
105848938|NCT03071094|365105144|FG000|Overall Study|Death|1|||
105848939|NCT03071094|365105145|FG001|Overall Study|Death|1|||
105848940|NCT03071094|365105144|FG000|Overall Study|Adverse Event|1|||
105848941|NCT03071094|365105145|FG001|Overall Study|Adverse Event|0|||
105848942|NCT03753763|365105147|FG000|Overall Study|Adverse Event|2|||
105848943|NCT03753763|365105148|FG001|Overall Study|Adverse Event|0|||
105848944|NCT03753763|365105147|FG000|Overall Study|Withdrawal by Subject|3|||
105848945|NCT03753763|365105148|FG001|Overall Study|Withdrawal by Subject|1|||
105848946|NCT03753763|365105147|FG000|Overall Study|clinical deterioration|1|||
105848947|NCT03753763|365105148|FG001|Overall Study|clinical deterioration|0|||
105848948|NCT00389831|365105149|FG000|Overall Study|Lack of Efficacy|0|||
105848949|NCT00389831|365105150|FG001|Overall Study|Lack of Efficacy|2|||
105848950|NCT00389831|365105149|FG000|Overall Study|Did not receive treatment.|0|||
105848951|NCT00389831|365105150|FG001|Overall Study|Did not receive treatment.|2|||
105848952|NCT00389831|365105149|FG000|Overall Study|Other reasons|0|||
105848953|NCT00389831|365105150|FG001|Overall Study|Other reasons|2|||
105848954|NCT00389831|365105149|FG000|Overall Study|Lost to Follow-up|0|||
105848955|NCT00389831|365105150|FG001|Overall Study|Lost to Follow-up|1|||
105848956|NCT03433755|365105151|FG000|Overall Study|Lost to Follow-up|1|||
105848957|NCT03433755|365105152|FG001|Overall Study|Lost to Follow-up|0|||
105848958|NCT03433755|365105153|FG002|Overall Study|Lost to Follow-up|0|||
105972719|NCT01095653|365559274|FG002|Overall Study|Withdrawal by Subject|3|||
105972720|NCT01095653|365559272|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
105972721|NCT01095653|365559273|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
105972722|NCT01095653|365559274|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
105972723|NCT01166373|365559275|FG000|Overall Study|Lost to Follow-up|3|||
105972724|NCT01166373|365559276|FG001|Overall Study|Lost to Follow-up|2|||
105972725|NCT01166373|365559277|FG002|Overall Study|Lost to Follow-up|2|||
105972726|NCT01166373|365559278|FG003|Overall Study|Lost to Follow-up|2|||
105972727|NCT01166373|365559275|FG000|Overall Study|Withdrawal by Subject|1|||
105972728|NCT01166373|365559276|FG001|Overall Study|Withdrawal by Subject|2|||
105972729|NCT01166373|365559277|FG002|Overall Study|Withdrawal by Subject|2|||
105972730|NCT01166373|365559278|FG003|Overall Study|Withdrawal by Subject|3|||
105972731|NCT01166373|365559275|FG000|Overall Study|Physician Decision|1|||
105972732|NCT01166373|365559276|FG001|Overall Study|Physician Decision|0|||
105972733|NCT01166373|365559277|FG002|Overall Study|Physician Decision|0|||
105972734|NCT01166373|365559278|FG003|Overall Study|Physician Decision|0|||
105972735|NCT02752958|365559279|FG000|Overall Study|Adverse Event|3|||
105972736|NCT02752958|365559279|FG000|Overall Study|Lost to Follow-up|1|||
105972737|NCT02752958|365559279|FG000|Overall Study|Protocol Violation|1|||
105972738|NCT02752958|365559279|FG000|Overall Study|Withdrawal by Subject|2|||
105972739|NCT02752958|365559279|FG000|Overall Study|Other (Reason not specified)|2|||
105972740|NCT03746600|365559280|FG000|Overall Study|Withdrawal by Subject|3|||
105848959|NCT03433755|365105154|FG003|Overall Study|Lost to Follow-up|0|||
105848960|NCT03433755|365105151|FG000|Overall Study|Decision by Sponsor|1|||
105848961|NCT03433755|365105152|FG001|Overall Study|Decision by Sponsor|0|||
105848962|NCT03433755|365105153|FG002|Overall Study|Decision by Sponsor|0|||
105848963|NCT03433755|365105154|FG003|Overall Study|Decision by Sponsor|0|||
105848964|NCT04732221|365107563|FG000|Base Period|Death|2|||
105848965|NCT04732221|365107564|FG001|Base Period|Death|0|||
105848966|NCT04732221|365107565|FG002|Base Period|Death|0|||
105848967|NCT04732221|365107566|FG003|Base Period|Death|0|||
105972741|NCT03746600|365559281|FG001|Overall Study|Withdrawal by Subject|3|||
105972742|NCT03746600|365559280|FG000|Overall Study|dismissed from study|1|||
105972743|NCT03746600|365559281|FG001|Overall Study|dismissed from study|0|||
105972744|NCT03746600|365559280|FG000|Overall Study|Lost to Follow-up|1|||
105972745|NCT03746600|365559281|FG001|Overall Study|Lost to Follow-up|0|||
105972746|NCT00977938|365559282|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
105987462|NCT02814175|365614465|FG005|Part 1|Lost to Follow-up|0|||
105848968|NCT04732221|365107567|FG004|Base Period|Death|0|||
105848969|NCT04732221|365107568|FG005|Base Period|Death|0|||
105848970|NCT04732221|365107569|FG006|Base Period|Death|0|||
105848971|NCT04732221|365107563|FG000|Base Period|Withdrawal by Subject|0|||
105848972|NCT04732221|365107564|FG001|Base Period|Withdrawal by Subject|1|||
105848973|NCT04732221|365107565|FG002|Base Period|Withdrawal by Subject|1|||
105848974|NCT04732221|365107566|FG003|Base Period|Withdrawal by Subject|0|||
105848975|NCT04732221|365107567|FG004|Base Period|Withdrawal by Subject|0|||
105848976|NCT04732221|365107568|FG005|Base Period|Withdrawal by Subject|0|||
105848977|NCT04732221|365107569|FG006|Base Period|Withdrawal by Subject|0|||
105848978|NCT04732221|365107563|FG000|Extension Period|Adverse Event|0|||
105848979|NCT04732221|365107564|FG001|Extension Period|Adverse Event|0|||
105848980|NCT04732221|365107565|FG002|Extension Period|Adverse Event|0|||
105848981|NCT04732221|365107566|FG003|Extension Period|Adverse Event|0|||
105848982|NCT04732221|365107567|FG004|Extension Period|Adverse Event|0|||
105972747|NCT00977938|365559283|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
105972748|NCT00977938|365559284|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
105972749|NCT00977938|365559285|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
105972750|NCT00977938|365559282|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
105972751|NCT00977938|365559283|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
105972752|NCT00977938|365559284|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
105972753|NCT00977938|365559285|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
105972754|NCT00977938|365559282|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
105972755|NCT00977938|365559283|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
105972756|NCT00977938|365559284|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
105972757|NCT00977938|365559285|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
105972758|NCT00977938|365559282|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
105972759|NCT00977938|365559283|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
105972760|NCT00977938|365559284|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
105972761|NCT00977938|365559285|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
105972762|NCT00977938|365559282|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
105972763|NCT00977938|365559283|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
105972764|NCT00977938|365559284|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
105972765|NCT00977938|365559285|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
105972766|NCT00977938|365559282|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
105972767|NCT00977938|365559283|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
105972768|NCT00977938|365559284|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
105972769|NCT00977938|365559285|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
105972770|NCT02374814|365559296|FG000|Overall Study|Lost to Follow-up|1|||
105972771|NCT02374814|365559297|FG001|Overall Study|Lost to Follow-up|1|||
105972772|NCT02374814|365559298|FG002|Overall Study|Lost to Follow-up|0|||
105972773|NCT02374814|365559299|FG003|Overall Study|Lost to Follow-up|1|||
105972774|NCT02374814|365559300|FG004|Overall Study|Lost to Follow-up|0|||
105972775|NCT02374814|365559301|FG005|Overall Study|Lost to Follow-up|0|||
105972776|NCT02374814|365559296|FG000|Overall Study|Withdrawal by Subject|0|||
105972777|NCT02374814|365559297|FG001|Overall Study|Withdrawal by Subject|0|||
105972778|NCT02374814|365559298|FG002|Overall Study|Withdrawal by Subject|1|||
105972779|NCT02374814|365559299|FG003|Overall Study|Withdrawal by Subject|1|||
105972780|NCT02374814|365559300|FG004|Overall Study|Withdrawal by Subject|0|||
105972781|NCT02374814|365559301|FG005|Overall Study|Withdrawal by Subject|0|||
105972782|NCT00884039|365559302|FG000|Overall Study|Withdrawal by Subject|0|||
105972783|NCT00884039|365559303|FG001|Overall Study|Withdrawal by Subject|1|||
105972784|NCT00884039|365559302|FG000|Overall Study|Lack of Efficacy|2|||
105972785|NCT00884039|365559303|FG001|Overall Study|Lack of Efficacy|0|||
105972786|NCT02182440|365559304|FG000|Overall Study|Adverse Event|0|||
105972787|NCT02182440|365559305|FG001|Overall Study|Adverse Event|1|||
105972788|NCT02182440|365559306|FG002|Overall Study|Adverse Event|0|||
105972789|NCT02182440|365559307|FG003|Overall Study|Adverse Event|0|||
105972790|NCT02182440|365559304|FG000|Overall Study|Death|31|||
105972791|NCT02182440|365559305|FG001|Overall Study|Death|8|||
105972792|NCT02182440|365559306|FG002|Overall Study|Death|5|||
105972793|NCT02182440|365559307|FG003|Overall Study|Death|16|||
105972794|NCT02182440|365559304|FG000|Overall Study|Protocol Violation|0|||
105972795|NCT02182440|365559305|FG001|Overall Study|Protocol Violation|1|||
105972796|NCT02182440|365559306|FG002|Overall Study|Protocol Violation|0|||
105972797|NCT02182440|365559307|FG003|Overall Study|Protocol Violation|0|||
106025206|NCT02059291|365758506|FG024|Epoch 3|Withdrawal by Subject|0|||
106025207|NCT02059291|365758482|FG000|Epoch 4|Adverse Event|0|||
105848983|NCT04732221|365107568|FG005|Extension Period|Adverse Event|1|||
105848984|NCT04732221|365107569|FG006|Extension Period|Adverse Event|0|||
105848985|NCT04732221|365107563|FG000|Extension Period|Death|0|||
105848986|NCT04732221|365107564|FG001|Extension Period|Death|0|||
105972798|NCT02182440|365559304|FG000|Overall Study|Physician Decision|1|||
105972799|NCT02182440|365559305|FG001|Overall Study|Physician Decision|0|||
105972800|NCT02182440|365559306|FG002|Overall Study|Physician Decision|0|||
105972801|NCT02182440|365559307|FG003|Overall Study|Physician Decision|0|||
105848987|NCT04732221|365107565|FG002|Extension Period|Death|0|||
105848988|NCT04732221|365107566|FG003|Extension Period|Death|0|||
105848989|NCT04732221|365107567|FG004|Extension Period|Death|1|||
105848990|NCT04732221|365107568|FG005|Extension Period|Death|0|||
105848991|NCT04732221|365107569|FG006|Extension Period|Death|2|||
105848992|NCT04732221|365107563|FG000|Extension Period|Pregnancy|0|||
105848993|NCT04732221|365107564|FG001|Extension Period|Pregnancy|0|||
105848994|NCT04732221|365107565|FG002|Extension Period|Pregnancy|0|||
105848995|NCT04732221|365107566|FG003|Extension Period|Pregnancy|0|||
105848996|NCT04732221|365107567|FG004|Extension Period|Pregnancy|1|||
105848997|NCT04732221|365107568|FG005|Extension Period|Pregnancy|0|||
105848998|NCT04732221|365107569|FG006|Extension Period|Pregnancy|0|||
105848999|NCT04732221|365107563|FG000|Extension Period|Sponsors Decision|0|||
105849000|NCT04732221|365107564|FG001|Extension Period|Sponsors Decision|0|||
105849001|NCT04732221|365107565|FG002|Extension Period|Sponsors Decision|0|||
105849002|NCT04732221|365107566|FG003|Extension Period|Sponsors Decision|0|||
105849003|NCT04732221|365107567|FG004|Extension Period|Sponsors Decision|41|||
105849004|NCT04732221|365107568|FG005|Extension Period|Sponsors Decision|40|||
105849005|NCT04732221|365107569|FG006|Extension Period|Sponsors Decision|40|||
105849006|NCT04732221|365107563|FG000|Extension Period|Withdrawal by Subject|0|||
105849007|NCT04732221|365107564|FG001|Extension Period|Withdrawal by Subject|0|||
105849008|NCT04732221|365107565|FG002|Extension Period|Withdrawal by Subject|0|||
105972802|NCT02182440|365559304|FG000|Overall Study|Withdrawal by Subject|1|||
105972803|NCT02182440|365559305|FG001|Overall Study|Withdrawal by Subject|1|||
105972804|NCT02182440|365559306|FG002|Overall Study|Withdrawal by Subject|3|||
105972805|NCT02182440|365559307|FG003|Overall Study|Withdrawal by Subject|4|||
105972806|NCT02182440|365559304|FG000|Overall Study|different, e.g adm other hospital|12|||
105972807|NCT02182440|365559305|FG001|Overall Study|different, e.g adm other hospital|3|||
105972808|NCT02182440|365559306|FG002|Overall Study|different, e.g adm other hospital|3|||
105972809|NCT02182440|365559307|FG003|Overall Study|different, e.g adm other hospital|10|||
105972810|NCT00624819|365559308|FG000|Follow-up Period: Year 4|Parents decision|0|||
105972811|NCT00624819|365559309|FG001|Follow-up Period: Year 4|Parents decision|0|||
105972812|NCT00624819|365559310|FG002|Follow-up Period: Year 4|Parents decision|1|||
105972813|NCT00624819|365559311|FG003|Follow-up Period: Year 4|Parents decision|0|||
105972814|NCT00624819|365559308|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
105972815|NCT00624819|365559309|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
105972816|NCT00624819|365559310|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
105972817|NCT00624819|365559311|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
105972818|NCT05599451|365561585|FG000|Overall Study|Not randomized|11|||
105972819|NCT05599451|365561586|FG001|Overall Study|Not randomized|0|||
105972820|NCT05599451|365561587|FG002|Overall Study|Not randomized|0|||
105972821|NCT05599451|365561588|FG003|Overall Study|Not randomized|0|||
105972822|NCT05599451|365561589|FG004|Overall Study|Not randomized|0|||
105972823|NCT05599451|365561585|FG000|Overall Study|Physician Decision|0|||
105972824|NCT05599451|365561586|FG001|Overall Study|Physician Decision|0|||
105972825|NCT05599451|365561587|FG002|Overall Study|Physician Decision|0|||
105972826|NCT05599451|365561588|FG003|Overall Study|Physician Decision|1|||
105972827|NCT05599451|365561589|FG004|Overall Study|Physician Decision|0|||
105972828|NCT02723006|365561590|FG000|Overall Study|Withdrawal by Subject|0|||
105972829|NCT02723006|365561591|FG001|Overall Study|Withdrawal by Subject|1|||
105972830|NCT02723006|365561592|FG002|Overall Study|Withdrawal by Subject|1|||
105972831|NCT02723006|365561590|FG000|Overall Study|Study Terminated by Sponsor|1|||
105972832|NCT02723006|365561591|FG001|Overall Study|Study Terminated by Sponsor|6|||
105972833|NCT02723006|365561592|FG002|Overall Study|Study Terminated by Sponsor|6|||
105972834|NCT01514240|365561593|FG000|Overall Study|Adverse Event|4|||
105972835|NCT01514240|365561594|FG001|Overall Study|Adverse Event|4|||
105972836|NCT01514240|365561593|FG000|Overall Study|Subject Decision|2|||
105972837|NCT01514240|365561594|FG001|Overall Study|Subject Decision|7|||
105972838|NCT00303446|365561595|FG000|Overall Study|Withdrawal by Subject|2|||
105972839|NCT00303446|365561596|FG001|Overall Study|Withdrawal by Subject|2|||
105972840|NCT00303446|365561595|FG000|Overall Study|Death|0|||
105972841|NCT00303446|365561596|FG001|Overall Study|Death|1|||
105972842|NCT00303446|365561595|FG000|Overall Study|Physician Decision|0|||
105972843|NCT00303446|365561596|FG001|Overall Study|Physician Decision|1|||
105972844|NCT04258995|365561597|FG000|Overall Study|Lost to Follow-up|1|||
105972845|NCT04258995|365561598|FG001|Overall Study|Lost to Follow-up|1|||
105972846|NCT00549900|365561599|FG000|Overall Study|Adverse Event|1|||
105972847|NCT00711113|365561604|FG000|Overall Study|Lost to Follow-up|9|||
105849009|NCT04732221|365107566|FG003|Extension Period|Withdrawal by Subject|0|||
105972848|NCT00711113|365561604|FG000|Overall Study|Implant lost|2|||
105972849|NCT03356977|365561605|FG000|Overall Study|Lost to Follow-up|3|||
105849010|NCT04732221|365107567|FG004|Extension Period|Withdrawal by Subject|1|||
105849011|NCT04732221|365107568|FG005|Extension Period|Withdrawal by Subject|5|||
105849012|NCT04732221|365107569|FG006|Extension Period|Withdrawal by Subject|2|||
105972850|NCT03356977|365561605|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105972851|NCT05438602|365561606|FG000|Treatment (15 Days)|Adverse Event|2|||
105972852|NCT05438602|365561607|FG001|Treatment (15 Days)|Adverse Event|1|||
105972853|NCT05438602|365561608|FG002|Treatment (15 Days)|Adverse Event|3|||
106025208|NCT02059291|365758483|FG001|Epoch 4|Adverse Event|0|||
106025209|NCT02059291|365758484|FG002|Epoch 4|Adverse Event|0|||
106025210|NCT02059291|365758485|FG003|Epoch 4|Adverse Event|0|||
106025211|NCT02059291|365758486|FG004|Epoch 4|Adverse Event|0|||
106025212|NCT02059291|365758487|FG005|Epoch 4|Adverse Event|0|||
106025213|NCT02059291|365758488|FG006|Epoch 4|Adverse Event|0|||
106025214|NCT02059291|365758489|FG007|Epoch 4|Adverse Event|0|||
105849013|NCT00144781|365107570|FG000|Overall Study|Adverse Event|0|||
105849014|NCT00144781|365107571|FG001|Overall Study|Adverse Event|1|||
105849015|NCT00144781|365107572|FG002|Overall Study|Adverse Event|0|||
106025215|NCT02059291|365758490|FG008|Epoch 4|Adverse Event|0|||
105849016|NCT00144781|365107573|FG003|Overall Study|Adverse Event|0|||
105849017|NCT00144781|365107570|FG000|Overall Study|Non-compliant|0|||
105849018|NCT00144781|365107571|FG001|Overall Study|Non-compliant|1|||
105849019|NCT00144781|365107572|FG002|Overall Study|Non-compliant|0|||
105849020|NCT00144781|365107573|FG003|Overall Study|Non-compliant|0|||
105849021|NCT00321828|365107575|FG000|Overall Study|Ineligible|3|||
105849022|NCT00321828|365107575|FG000|Overall Study|No follow up data|1|||
105849023|NCT00112866|365107578|FG000|Overall Study|Protocol Violation|1|||
105849024|NCT00112866|365107579|FG001|Overall Study|Protocol Violation|0|||
105849025|NCT00112866|365107578|FG000|Overall Study|did not start treatment post-op|1|||
105849026|NCT00112866|365107579|FG001|Overall Study|did not start treatment post-op|2|||
105849027|NCT02944383|365107580|FG000|Overall Study|Lost to Follow-up|0|||
105849028|NCT02944383|365107581|FG001|Overall Study|Lost to Follow-up|0|||
105849029|NCT02944383|365107582|FG002|Overall Study|Lost to Follow-up|1|||
105849030|NCT02944383|365107580|FG000|Overall Study|Withdrawal by Subject|1|||
105849031|NCT02944383|365107581|FG001|Overall Study|Withdrawal by Subject|0|||
105849032|NCT02944383|365107582|FG002|Overall Study|Withdrawal by Subject|0|||
105849033|NCT02444793|365107585|FG000|Overall Study|Lost to Follow-up|2|||
105849034|NCT02444793|365107586|FG001|Overall Study|Lost to Follow-up|2|||
105849035|NCT02444793|365107587|FG002|Overall Study|Lost to Follow-up|0|||
105849036|NCT02444793|365107588|FG003|Overall Study|Lost to Follow-up|0|||
105849037|NCT02444793|365107585|FG000|Overall Study|Death|0|||
105849038|NCT02444793|365107586|FG001|Overall Study|Death|3|||
105849039|NCT02444793|365107587|FG002|Overall Study|Death|0|||
105849040|NCT02444793|365107588|FG003|Overall Study|Death|0|||
105849041|NCT02444793|365107585|FG000|Overall Study|Other|0|||
105849042|NCT02444793|365107586|FG001|Overall Study|Other|0|||
105849043|NCT02444793|365107587|FG002|Overall Study|Other|2|||
105849044|NCT02444793|365107588|FG003|Overall Study|Other|0|||
105849045|NCT02444793|365107585|FG000|Overall Study|Objective progression or relapse|9|||
105849046|NCT02444793|365107586|FG001|Overall Study|Objective progression or relapse|1|||
105849047|NCT02444793|365107587|FG002|Overall Study|Objective progression or relapse|2|||
105849048|NCT02444793|365107588|FG003|Overall Study|Objective progression or relapse|3|||
105849049|NCT02504671|365107592|FG000|Overall Study|Withdrawal by Subject|1|||
105849050|NCT02504671|365107593|FG001|Overall Study|Withdrawal by Subject|5|||
105849051|NCT02504671|365107594|FG002|Overall Study|Withdrawal by Subject|4|||
105849052|NCT02504671|365107595|FG003|Overall Study|Withdrawal by Subject|4|||
105849053|NCT02504671|365107596|FG004|Overall Study|Withdrawal by Subject|5|||
105849054|NCT02504671|365107597|FG005|Overall Study|Withdrawal by Subject|3|||
105849055|NCT02504671|365107592|FG000|Overall Study|Lack of Efficacy|1|||
105849056|NCT02504671|365107593|FG001|Overall Study|Lack of Efficacy|3|||
106025216|NCT02059291|365758491|FG009|Epoch 4|Adverse Event|0|||
106025217|NCT02059291|365758492|FG010|Epoch 4|Adverse Event|0|||
105849057|NCT02504671|365107594|FG002|Overall Study|Lack of Efficacy|1|||
105849058|NCT02504671|365107595|FG003|Overall Study|Lack of Efficacy|0|||
105849059|NCT02504671|365107596|FG004|Overall Study|Lack of Efficacy|4|||
105849060|NCT02504671|365107597|FG005|Overall Study|Lack of Efficacy|4|||
105849061|NCT02504671|365107592|FG000|Overall Study|Adverse Event|1|||
105849062|NCT02504671|365107593|FG001|Overall Study|Adverse Event|1|||
105849063|NCT02504671|365107594|FG002|Overall Study|Adverse Event|0|||
105849064|NCT02504671|365107595|FG003|Overall Study|Adverse Event|1|||
105849065|NCT02504671|365107596|FG004|Overall Study|Adverse Event|0|||
105849066|NCT02504671|365107597|FG005|Overall Study|Adverse Event|2|||
105849067|NCT02504671|365107592|FG000|Overall Study|Protocol Violation|2|||
106150161|NCT01207492|366210483|FG000|Overall Study|Physician Decision|1|||
105849068|NCT02504671|365107593|FG001|Overall Study|Protocol Violation|1|||
106025218|NCT02059291|365758493|FG011|Epoch 4|Adverse Event|0|||
105849069|NCT02504671|365107594|FG002|Overall Study|Protocol Violation|0|||
105849070|NCT02504671|365107595|FG003|Overall Study|Protocol Violation|0|||
105849071|NCT02504671|365107596|FG004|Overall Study|Protocol Violation|0|||
105849072|NCT02504671|365107597|FG005|Overall Study|Protocol Violation|1|||
105849073|NCT02504671|365107592|FG000|Overall Study|Lost to Follow-up|0|||
105849074|NCT02504671|365107593|FG001|Overall Study|Lost to Follow-up|0|||
105849075|NCT02504671|365107594|FG002|Overall Study|Lost to Follow-up|2|||
105849076|NCT02504671|365107595|FG003|Overall Study|Lost to Follow-up|0|||
106025219|NCT02059291|365758494|FG012|Epoch 4|Adverse Event|0|||
105849077|NCT02504671|365107596|FG004|Overall Study|Lost to Follow-up|0|||
105849078|NCT02504671|365107597|FG005|Overall Study|Lost to Follow-up|1|||
106025220|NCT02059291|365758495|FG013|Epoch 4|Adverse Event|0|||
106025221|NCT02059291|365758496|FG014|Epoch 4|Adverse Event|0|||
105849079|NCT02504671|365107592|FG000|Overall Study|Protocol defined stopping criteria|7|||
105849080|NCT02504671|365107593|FG001|Overall Study|Protocol defined stopping criteria|4|||
105849081|NCT02504671|365107594|FG002|Overall Study|Protocol defined stopping criteria|3|||
105849082|NCT02504671|365107595|FG003|Overall Study|Protocol defined stopping criteria|5|||
105849083|NCT02504671|365107596|FG004|Overall Study|Protocol defined stopping criteria|3|||
105849084|NCT02504671|365107597|FG005|Overall Study|Protocol defined stopping criteria|3|||
105849085|NCT00210249|365107598|FG000|Overall Study|Lost to Follow-up|5|||
105849086|NCT00210249|365107598|FG000|Overall Study|Protocol Violation|11|||
105849087|NCT02518919|365107601|FG000|Overall Study|Protocol Violation|1|||
105849088|NCT02518919|365107602|FG001|Overall Study|Protocol Violation|1|||
105849089|NCT02518919|365107603|FG002|Overall Study|Protocol Violation|2|||
105849090|NCT00599521|365107604|FG000|Overall Study|Lack of Efficacy|4|||
105849091|NCT00599521|365107605|FG001|Overall Study|Lack of Efficacy|8|||
105849092|NCT00599521|365107604|FG000|Overall Study|Adverse Event|4|||
105849093|NCT00599521|365107605|FG001|Overall Study|Adverse Event|1|||
105849094|NCT00599521|365107604|FG000|Overall Study|Withdrawal by Subject|28|||
105849095|NCT00599521|365107605|FG001|Overall Study|Withdrawal by Subject|34|||
105849096|NCT00599521|365107604|FG000|Overall Study|Protocol Violation|1|||
105849097|NCT00599521|365107605|FG001|Overall Study|Protocol Violation|1|||
105849098|NCT00599521|365107604|FG000|Overall Study|Lost to Follow-up|23|||
105849099|NCT00599521|365107605|FG001|Overall Study|Lost to Follow-up|23|||
105849100|NCT00599521|365107604|FG000|Overall Study|Pregnancy|0|||
105849101|NCT00599521|365107605|FG001|Overall Study|Pregnancy|2|||
105849102|NCT04498403|365107606|FG000|Overall Study|Adverse Event|1|||
105849103|NCT04498403|365107607|FG001|Overall Study|Adverse Event|0|||
105849104|NCT04498403|365107606|FG000|Overall Study|Study Terminated By Sponsor|29|||
105849105|NCT04498403|365107607|FG001|Overall Study|Study Terminated By Sponsor|10|||
105849106|NCT02132637|365107608|FG000|Study Period 1|Withdrawal by Subject|0|||
105849107|NCT02132637|365107609|FG001|Study Period 1|Withdrawal by Subject|4|||
105849108|NCT02132637|365107608|FG000|Study Period 1|Physician Decision|1|||
105849109|NCT02132637|365107609|FG001|Study Period 1|Physician Decision|0|||
105849110|NCT02132637|365107608|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
105849111|NCT02132637|365107609|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
105849112|NCT02132637|365107608|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
105849113|NCT02132637|365107609|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
105849114|NCT00922272|365107610|FG000|Open-label Phase|Adverse Event|5|||
105849115|NCT00922272|365107611|FG001|Open-label Phase|Adverse Event|0|||
105849116|NCT00922272|365107610|FG000|Open-label Phase|Protocol Violation|1|||
105849117|NCT00922272|365107611|FG001|Open-label Phase|Protocol Violation|0|||
105849118|NCT00922272|365107610|FG000|Open-label Phase|Withdrawal by Subject|11|||
105849119|NCT00922272|365107611|FG001|Open-label Phase|Withdrawal by Subject|0|||
105849120|NCT00922272|365107610|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
105849121|NCT00922272|365107611|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
105849122|NCT00922272|365107610|FG000|Open-label Phase|Withdrawal criteria met|5|||
105849123|NCT00922272|365107611|FG001|Open-label Phase|Withdrawal criteria met|0|||
105849124|NCT00922272|365107610|FG000|Double-blind Phase|Adverse Event|1|||
105849125|NCT00922272|365107611|FG001|Double-blind Phase|Adverse Event|1|||
105849126|NCT00922272|365107610|FG000|Double-blind Phase|Withdrawal by Subject|1|||
105849127|NCT00922272|365107611|FG001|Double-blind Phase|Withdrawal by Subject|1|||
105849128|NCT00922272|365107610|FG000|Double-blind Phase|Lost to Follow-up|2|||
105849129|NCT00922272|365107611|FG001|Double-blind Phase|Lost to Follow-up|1|||
105849130|NCT00922272|365107610|FG000|Double-blind Phase|Withdrawal criteria met|1|||
105849131|NCT00922272|365107611|FG001|Double-blind Phase|Withdrawal criteria met|1|||
105849132|NCT00922272|365107610|FG000|Double-blind Phase|Noncompliance|1|||
105849133|NCT00922272|365107611|FG001|Double-blind Phase|Noncompliance|1|||
105849134|NCT00922272|365107610|FG000|Double-blind Phase|Positive urine drug screen|1|||
105849135|NCT00922272|365107611|FG001|Double-blind Phase|Positive urine drug screen|1|||
105849136|NCT00609518|365107612|FG000|Overall Study|Death from Study Disease|32|||
105849137|NCT00609518|365107613|FG001|Overall Study|Death from Study Disease|32|||
105849138|NCT00609518|365107612|FG000|Overall Study|Withdrawal by Subject|5|||
105849139|NCT00609518|365107613|FG001|Overall Study|Withdrawal by Subject|3|||
105849140|NCT00609518|365107612|FG000|Overall Study|Lost to Follow-up|3|||
105849141|NCT00609518|365107613|FG001|Overall Study|Lost to Follow-up|0|||
105849142|NCT00609518|365107612|FG000|Overall Study|Physician Decision|1|||
106025222|NCT02059291|365758497|FG015|Epoch 4|Adverse Event|0|||
105849143|NCT00609518|365107613|FG001|Overall Study|Physician Decision|3|||
105849144|NCT00609518|365107612|FG000|Overall Study|Death from Adverse Event|2|||
105849145|NCT00609518|365107613|FG001|Overall Study|Death from Adverse Event|2|||
105849146|NCT00824616|365107614|FG000|Overall Study|Adverse Event|2|||
105849147|NCT00824616|365107615|FG001|Overall Study|Adverse Event|1|||
105849148|NCT00824616|365107614|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
105849149|NCT00824616|365107615|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
105849150|NCT00824616|365107614|FG000|Overall Study|Hyperglycemia|1|||
105849151|NCT00824616|365107615|FG001|Overall Study|Hyperglycemia|1|||
105849152|NCT00824616|365107614|FG000|Overall Study|Lack of Efficacy|2|||
105849153|NCT00824616|365107615|FG001|Overall Study|Lack of Efficacy|1|||
105849154|NCT00824616|365107614|FG000|Overall Study|Lost to Follow-up|0|||
105972854|NCT05438602|365561606|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
105972855|NCT05438602|365561607|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
105972856|NCT05438602|365561608|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
105972857|NCT05438602|365561606|FG000|Treatment (15 Days)|Other|0|||
105972858|NCT05438602|365561607|FG001|Treatment (15 Days)|Other|0|||
105972859|NCT05438602|365561608|FG002|Treatment (15 Days)|Other|1|||
105972860|NCT05438602|365561606|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
105972861|NCT05438602|365561607|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
105972862|NCT05438602|365561608|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
105972863|NCT05438602|365561606|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
105972864|NCT05438602|365561607|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
105972865|NCT05438602|365561608|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
105972866|NCT05438602|365561606|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
105972867|NCT05438602|365561607|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
105972868|NCT05438602|365561608|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
105972869|NCT05438602|365561606|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
105972870|NCT05438602|365561607|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
105972871|NCT05438602|365561608|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
105972872|NCT05438602|365561606|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
105972873|NCT05438602|365561607|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
105972874|NCT05438602|365561608|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
105972875|NCT05438602|365561606|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
105972876|NCT05438602|365561607|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
105972877|NCT05438602|365561608|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
105972878|NCT05438602|365561606|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
105972879|NCT05438602|365561607|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
105972880|NCT05438602|365561608|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
105972881|NCT00798317|365561610|FG000|Overall Study|Physician Decision|0|||
105972882|NCT00798317|365561611|FG001|Overall Study|Physician Decision|1|||
105972883|NCT00798317|365561610|FG000|Overall Study|Withdrawal by Subject|5|||
105972884|NCT00798317|365561611|FG001|Overall Study|Withdrawal by Subject|4|||
105972885|NCT00798317|365561610|FG000|Overall Study|Lost to Follow-up|2|||
105972886|NCT00798317|365561611|FG001|Overall Study|Lost to Follow-up|2|||
105972887|NCT00798317|365561610|FG000|Overall Study|Adverse Event|2|||
105972888|NCT00798317|365561611|FG001|Overall Study|Adverse Event|0|||
105972889|NCT00798317|365561610|FG000|Overall Study|Death|1|||
105972890|NCT00798317|365561611|FG001|Overall Study|Death|0|||
105972891|NCT00378599|365561615|FG000|Overall Study|Adverse Event|38|||
105972892|NCT00378599|365561615|FG000|Overall Study|Protocol Violation|2|||
105972893|NCT00378599|365561615|FG000|Overall Study|Treatment failure|7|||
105972894|NCT00378599|365561615|FG000|Overall Study|Withdrawal by Subject|5|||
105972895|NCT03812185|365561619|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
105972896|NCT02576535|365561629|FG000|Overall Study|Withdrawal by Subject|2|||
105972897|NCT01529515|365561632|FG000|TRANSITION PHASE|Adverse Event|16|||
105972898|NCT01529515|365561633|FG001|TRANSITION PHASE|Adverse Event|0|||
105972899|NCT01529515|365561634|FG002|TRANSITION PHASE|Adverse Event|0|||
105972900|NCT01529515|365561635|FG003|TRANSITION PHASE|Adverse Event|0|||
105972901|NCT01529515|365561632|FG000|TRANSITION PHASE|Death|1|||
105972902|NCT01529515|365561633|FG001|TRANSITION PHASE|Death|0|||
105972903|NCT01529515|365561634|FG002|TRANSITION PHASE|Death|0|||
105972904|NCT01529515|365561635|FG003|TRANSITION PHASE|Death|0|||
105972905|NCT01529515|365561632|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
105972906|NCT01529515|365561633|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
105972907|NCT01529515|365561634|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
105972908|NCT01529515|365561635|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
105972909|NCT01529515|365561632|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
105972910|NCT01529515|365561633|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
105972911|NCT01529515|365561634|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
105972912|NCT01529515|365561635|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
105972913|NCT01529515|365561632|FG000|TRANSITION PHASE|Protocol Violation|4|||
105972914|NCT01529515|365561633|FG001|TRANSITION PHASE|Protocol Violation|0|||
105972915|NCT01529515|365561634|FG002|TRANSITION PHASE|Protocol Violation|0|||
105972916|NCT01529515|365561635|FG003|TRANSITION PHASE|Protocol Violation|0|||
105972917|NCT01529515|365561632|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
105972918|NCT01529515|365561633|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
105972919|NCT01529515|365561634|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
105972920|NCT01529515|365561635|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
105972921|NCT01529515|365561632|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
105972922|NCT01529515|365561633|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
105972923|NCT01529515|365561634|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
105972924|NCT01529515|365561635|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
105972925|NCT01529515|365561632|FG000|TRANSITION PHASE|Other|9|||
105972926|NCT01529515|365561633|FG001|TRANSITION PHASE|Other|0|||
105972927|NCT01529515|365561634|FG002|TRANSITION PHASE|Other|0|||
105972928|NCT01529515|365561635|FG003|TRANSITION PHASE|Other|0|||
105972929|NCT01529515|365561632|FG000|MAINTENANCE PHASE|Adverse Event|0|||
106025223|NCT02059291|365758498|FG016|Epoch 4|Adverse Event|1|||
106025224|NCT02059291|365758499|FG017|Epoch 4|Adverse Event|0|||
106025225|NCT02059291|365758500|FG018|Epoch 4|Adverse Event|0|||
106025226|NCT02059291|365758501|FG019|Epoch 4|Adverse Event|0|||
106025227|NCT02059291|365758502|FG020|Epoch 4|Adverse Event|0|||
106025228|NCT02059291|365758503|FG021|Epoch 4|Adverse Event|0|||
106025229|NCT02059291|365758504|FG022|Epoch 4|Adverse Event|1|||
106025230|NCT02059291|365758505|FG023|Epoch 4|Adverse Event|0|||
106025231|NCT02059291|365758506|FG024|Epoch 4|Adverse Event|0|||
106025232|NCT02059291|365758482|FG000|Epoch 4|Pregnancy|0|||
106025233|NCT02059291|365758483|FG001|Epoch 4|Pregnancy|0|||
106025234|NCT02059291|365758484|FG002|Epoch 4|Pregnancy|0|||
106025235|NCT02059291|365758485|FG003|Epoch 4|Pregnancy|0|||
106025236|NCT02059291|365758486|FG004|Epoch 4|Pregnancy|0|||
106025237|NCT02059291|365758487|FG005|Epoch 4|Pregnancy|0|||
105849155|NCT00824616|365107615|FG001|Overall Study|Lost to Follow-up|1|||
105849156|NCT00824616|365107614|FG000|Overall Study|Withdrawal by Subject|1|||
105849157|NCT00824616|365107615|FG001|Overall Study|Withdrawal by Subject|1|||
105849158|NCT01700049|365107616|FG000|Overall Study|Withdrawal by Subject|1|||
105849159|NCT03827564|365107619|FG000|Overall Study|Discontinued due to Study Termination|1|||
105849160|NCT03827564|365107620|FG001|Overall Study|Discontinued due to Study Termination|0|||
105849161|NCT04397445|365107621|FG000|Overall Study|Withdrawal by Subject|1|||
105849162|NCT04397445|365107622|FG001|Overall Study|Withdrawal by Subject|0|||
105849163|NCT04397445|365107623|FG002|Overall Study|Withdrawal by Subject|0|||
105849164|NCT04397445|365107624|FG003|Overall Study|Withdrawal by Subject|0|||
105849165|NCT02622113|365107625|FG000|Overall Study|Adverse Event|4|||
105849166|NCT02622113|365107626|FG001|Overall Study|Adverse Event|4|||
105849167|NCT02622113|365107625|FG000|Overall Study|Physician Decision|0|||
105849168|NCT02622113|365107626|FG001|Overall Study|Physician Decision|1|||
105849169|NCT02622113|365107625|FG000|Overall Study|Withdrawal by Subject|0|||
105849170|NCT02622113|365107626|FG001|Overall Study|Withdrawal by Subject|2|||
105849171|NCT02622113|365107625|FG000|Overall Study|Stopping Criteria|1|||
105849172|NCT02622113|365107626|FG001|Overall Study|Stopping Criteria|3|||
105849173|NCT04112173|365107634|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
105849174|NCT01561430|365107635|FG000|Overall Study|Adverse Event|0|||
105849175|NCT01561430|365107636|FG001|Overall Study|Adverse Event|0|||
105849176|NCT01561430|365107637|FG002|Overall Study|Adverse Event|3|||
105849177|NCT01561430|365107638|FG003|Overall Study|Adverse Event|1|||
105849178|NCT01561430|365107635|FG000|Overall Study|Withdrawal by Subject|0|||
105849179|NCT01561430|365107636|FG001|Overall Study|Withdrawal by Subject|0|||
105849180|NCT01561430|365107637|FG002|Overall Study|Withdrawal by Subject|1|||
105849181|NCT01561430|365107638|FG003|Overall Study|Withdrawal by Subject|0|||
105849182|NCT01561430|365107635|FG000|Overall Study|Physician Decision|0|||
105849183|NCT01561430|365107636|FG001|Overall Study|Physician Decision|1|||
105849184|NCT01561430|365107637|FG002|Overall Study|Physician Decision|0|||
105849185|NCT01561430|365107638|FG003|Overall Study|Physician Decision|0|||
105849186|NCT01561430|365107635|FG000|Overall Study|Sponsor Decision|1|||
105849187|NCT01561430|365107636|FG001|Overall Study|Sponsor Decision|14|||
105849188|NCT01561430|365107637|FG002|Overall Study|Sponsor Decision|13|||
105849189|NCT01561430|365107638|FG003|Overall Study|Sponsor Decision|12|||
105849190|NCT02038907|365107639|FG000|Overall Study|Protocol Violation|0|||
105849191|NCT02038907|365107640|FG001|Overall Study|Protocol Violation|0|||
105849192|NCT02038907|365107641|FG002|Overall Study|Protocol Violation|0|||
105849193|NCT02038907|365107642|FG003|Overall Study|Protocol Violation|0|||
105849194|NCT02038907|365107643|FG004|Overall Study|Protocol Violation|0|||
105849195|NCT02038907|365107644|FG005|Overall Study|Protocol Violation|0|||
105849196|NCT02038907|365107645|FG006|Overall Study|Protocol Violation|0|||
105849197|NCT02038907|365107646|FG007|Overall Study|Protocol Violation|0|||
105849198|NCT02038907|365107647|FG008|Overall Study|Protocol Violation|0|||
105849199|NCT02038907|365107648|FG009|Overall Study|Protocol Violation|0|||
105849200|NCT02038907|365107649|FG010|Overall Study|Protocol Violation|1|||
105849201|NCT02038907|365107650|FG011|Overall Study|Protocol Violation|0|||
105849202|NCT02038907|365107651|FG012|Overall Study|Protocol Violation|0|||
105849203|NCT02038907|365107652|FG013|Overall Study|Protocol Violation|0|||
105849204|NCT02038907|365107639|FG000|Overall Study|Withdrawal by Subject|0|||
105849205|NCT02038907|365107640|FG001|Overall Study|Withdrawal by Subject|0|||
105849206|NCT02038907|365107641|FG002|Overall Study|Withdrawal by Subject|0|||
105849207|NCT02038907|365107642|FG003|Overall Study|Withdrawal by Subject|0|||
105849208|NCT02038907|365107643|FG004|Overall Study|Withdrawal by Subject|0|||
105849209|NCT02038907|365107644|FG005|Overall Study|Withdrawal by Subject|0|||
105849210|NCT02038907|365107645|FG006|Overall Study|Withdrawal by Subject|0|||
105849211|NCT02038907|365107646|FG007|Overall Study|Withdrawal by Subject|0|||
105849212|NCT02038907|365107647|FG008|Overall Study|Withdrawal by Subject|0|||
106025238|NCT02059291|365758488|FG006|Epoch 4|Pregnancy|0|||
105849213|NCT02038907|365107648|FG009|Overall Study|Withdrawal by Subject|0|||
105849214|NCT02038907|365107649|FG010|Overall Study|Withdrawal by Subject|1|||
105849215|NCT02038907|365107650|FG011|Overall Study|Withdrawal by Subject|0|||
106025239|NCT02059291|365758489|FG007|Epoch 4|Pregnancy|0|||
106025240|NCT02059291|365758490|FG008|Epoch 4|Pregnancy|0|||
106025241|NCT02059291|365758491|FG009|Epoch 4|Pregnancy|0|||
106025242|NCT02059291|365758492|FG010|Epoch 4|Pregnancy|0|||
106025243|NCT02059291|365758493|FG011|Epoch 4|Pregnancy|0|||
106025244|NCT02059291|365758494|FG012|Epoch 4|Pregnancy|0|||
106025245|NCT02059291|365758495|FG013|Epoch 4|Pregnancy|0|||
106025246|NCT02059291|365758496|FG014|Epoch 4|Pregnancy|0|||
106025247|NCT02059291|365758497|FG015|Epoch 4|Pregnancy|0|||
106025248|NCT02059291|365758498|FG016|Epoch 4|Pregnancy|1|||
106025249|NCT02059291|365758499|FG017|Epoch 4|Pregnancy|0|||
106025250|NCT02059291|365758500|FG018|Epoch 4|Pregnancy|0|||
106025251|NCT02059291|365758501|FG019|Epoch 4|Pregnancy|0|||
106025252|NCT02059291|365758502|FG020|Epoch 4|Pregnancy|0|||
106025253|NCT02059291|365758503|FG021|Epoch 4|Pregnancy|0|||
106025254|NCT02059291|365758504|FG022|Epoch 4|Pregnancy|0|||
106025255|NCT02059291|365758505|FG023|Epoch 4|Pregnancy|0|||
106025256|NCT02059291|365758506|FG024|Epoch 4|Pregnancy|0|||
106025257|NCT02059291|365758482|FG000|Epoch 4|Withdrawal by Subject|0|||
106025258|NCT02059291|365758483|FG001|Epoch 4|Withdrawal by Subject|0|||
106025259|NCT02059291|365758484|FG002|Epoch 4|Withdrawal by Subject|0|||
106025260|NCT02059291|365758485|FG003|Epoch 4|Withdrawal by Subject|0|||
106025261|NCT02059291|365758486|FG004|Epoch 4|Withdrawal by Subject|0|||
106025262|NCT02059291|365758487|FG005|Epoch 4|Withdrawal by Subject|0|||
106025263|NCT02059291|365758488|FG006|Epoch 4|Withdrawal by Subject|0|||
106025264|NCT02059291|365758489|FG007|Epoch 4|Withdrawal by Subject|0|||
105972930|NCT01529515|365561633|FG001|MAINTENANCE PHASE|Adverse Event|10|||
105972931|NCT01529515|365561634|FG002|MAINTENANCE PHASE|Adverse Event|0|||
105972932|NCT01529515|365561635|FG003|MAINTENANCE PHASE|Adverse Event|0|||
105972933|NCT01529515|365561632|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
105972934|NCT01529515|365561633|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
105972935|NCT01529515|365561634|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
105972936|NCT01529515|365561635|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
105972937|NCT01529515|365561632|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
105972938|NCT01529515|365561633|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
105972939|NCT01529515|365561634|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
105972940|NCT01529515|365561635|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
105972941|NCT01529515|365561632|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
105972942|NCT01529515|365561633|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
105972943|NCT01529515|365561634|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
105972944|NCT01529515|365561635|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
105972945|NCT01529515|365561632|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
105972946|NCT01529515|365561633|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
105972947|NCT01529515|365561634|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
105972948|NCT01529515|365561635|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
105972949|NCT01529515|365561632|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
105972950|NCT01529515|365561633|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
105972951|NCT01529515|365561634|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
105972952|NCT01529515|365561635|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
105972953|NCT01529515|365561632|FG000|MAINTENANCE PHASE|Other|0|||
105972954|NCT01529515|365561633|FG001|MAINTENANCE PHASE|Other|10|||
105972955|NCT01529515|365561634|FG002|MAINTENANCE PHASE|Other|0|||
105972956|NCT01529515|365561635|FG003|MAINTENANCE PHASE|Other|0|||
105972957|NCT01529515|365561632|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
105972958|NCT01529515|365561633|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
105972959|NCT01529515|365561634|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
106025265|NCT02059291|365758490|FG008|Epoch 4|Withdrawal by Subject|0|||
106025266|NCT02059291|365758491|FG009|Epoch 4|Withdrawal by Subject|0|||
106025267|NCT02059291|365758492|FG010|Epoch 4|Withdrawal by Subject|0|||
106025268|NCT02059291|365758493|FG011|Epoch 4|Withdrawal by Subject|0|||
106025269|NCT02059291|365758494|FG012|Epoch 4|Withdrawal by Subject|0|||
105972960|NCT01529515|365561635|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
105972961|NCT01529515|365561632|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
105972962|NCT01529515|365561633|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
105972963|NCT01529515|365561634|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
105972964|NCT01529515|365561635|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
105972965|NCT01529515|365561632|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
105972966|NCT01529515|365561633|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
105972967|NCT01529515|365561634|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
105972968|NCT01529515|365561635|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
105972969|NCT01529515|365561632|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
105972970|NCT01529515|365561633|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
105972971|NCT01529515|365561634|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
106025270|NCT02059291|365758495|FG013|Epoch 4|Withdrawal by Subject|0|||
106025271|NCT02059291|365758496|FG014|Epoch 4|Withdrawal by Subject|0|||
105972972|NCT01529515|365561635|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
105972973|NCT01529515|365561632|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
105972974|NCT01529515|365561633|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
106025272|NCT02059291|365758497|FG015|Epoch 4|Withdrawal by Subject|0|||
106025273|NCT02059291|365758498|FG016|Epoch 4|Withdrawal by Subject|0|||
105972975|NCT01529515|365561634|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
105972976|NCT01529515|365561635|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
106025274|NCT02059291|365758499|FG017|Epoch 4|Withdrawal by Subject|0|||
106025275|NCT02059291|365758500|FG018|Epoch 4|Withdrawal by Subject|0|||
106025276|NCT02059291|365758501|FG019|Epoch 4|Withdrawal by Subject|0|||
106025277|NCT02059291|365758502|FG020|Epoch 4|Withdrawal by Subject|1|||
106025278|NCT02059291|365758503|FG021|Epoch 4|Withdrawal by Subject|0|||
106025279|NCT02059291|365758504|FG022|Epoch 4|Withdrawal by Subject|0|||
106025280|NCT02059291|365758505|FG023|Epoch 4|Withdrawal by Subject|0|||
106025281|NCT02059291|365758506|FG024|Epoch 4|Withdrawal by Subject|0|||
106025282|NCT02059291|365758482|FG000|Epoch 4|Lack of Efficacy|0|||
106025283|NCT02059291|365758483|FG001|Epoch 4|Lack of Efficacy|0|||
106025284|NCT02059291|365758484|FG002|Epoch 4|Lack of Efficacy|0|||
106025285|NCT02059291|365758485|FG003|Epoch 4|Lack of Efficacy|0|||
106025286|NCT02059291|365758486|FG004|Epoch 4|Lack of Efficacy|0|||
106025287|NCT02059291|365758487|FG005|Epoch 4|Lack of Efficacy|0|||
106025288|NCT02059291|365758488|FG006|Epoch 4|Lack of Efficacy|0|||
106025289|NCT02059291|365758489|FG007|Epoch 4|Lack of Efficacy|0|||
106025290|NCT02059291|365758490|FG008|Epoch 4|Lack of Efficacy|0|||
106025291|NCT02059291|365758491|FG009|Epoch 4|Lack of Efficacy|0|||
106025292|NCT02059291|365758492|FG010|Epoch 4|Lack of Efficacy|0|||
106025293|NCT02059291|365758493|FG011|Epoch 4|Lack of Efficacy|0|||
106025294|NCT02059291|365758494|FG012|Epoch 4|Lack of Efficacy|0|||
106025295|NCT02059291|365758495|FG013|Epoch 4|Lack of Efficacy|0|||
106025296|NCT02059291|365758496|FG014|Epoch 4|Lack of Efficacy|0|||
106025297|NCT02059291|365758497|FG015|Epoch 4|Lack of Efficacy|0|||
106025298|NCT02059291|365758498|FG016|Epoch 4|Lack of Efficacy|0|||
106025299|NCT02059291|365758499|FG017|Epoch 4|Lack of Efficacy|0|||
106025300|NCT02059291|365758500|FG018|Epoch 4|Lack of Efficacy|0|||
106025301|NCT02059291|365758501|FG019|Epoch 4|Lack of Efficacy|0|||
106025302|NCT02059291|365758502|FG020|Epoch 4|Lack of Efficacy|0|||
106025303|NCT02059291|365758503|FG021|Epoch 4|Lack of Efficacy|0|||
106025304|NCT02059291|365758504|FG022|Epoch 4|Lack of Efficacy|0|||
106025305|NCT02059291|365758505|FG023|Epoch 4|Lack of Efficacy|1|||
106025306|NCT02059291|365758506|FG024|Epoch 4|Lack of Efficacy|0|||
106025307|NCT03531632|365758507|FG000|Overall Study|Adverse Event|0|||
106025308|NCT03531632|365758508|FG001|Overall Study|Adverse Event|0|||
106025309|NCT03531632|365758509|FG002|Overall Study|Adverse Event|1|||
106025310|NCT03531632|365758507|FG000|Overall Study|Death|4|||
106025311|NCT03531632|365758508|FG001|Overall Study|Death|0|||
106025312|NCT03531632|365758509|FG002|Overall Study|Death|14|||
106025313|NCT03531632|365758507|FG000|Overall Study|Study Terminated|1|||
106025314|NCT03531632|365758508|FG001|Overall Study|Study Terminated|3|||
106025315|NCT03531632|365758509|FG002|Overall Study|Study Terminated|11|||
106025316|NCT03241368|365758510|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
105849216|NCT02038907|365107651|FG012|Overall Study|Withdrawal by Subject|0|||
105849217|NCT02038907|365107652|FG013|Overall Study|Withdrawal by Subject|0|||
105849218|NCT00688376|365107653|FG000|Double-Blind Phase|Adverse Event|4|||
105849219|NCT00688376|365107654|FG001|Double-Blind Phase|Adverse Event|4|||
105849220|NCT00688376|365107653|FG000|Double-Blind Phase|Protocol Violation|1|||
105849221|NCT00688376|365107654|FG001|Double-Blind Phase|Protocol Violation|2|||
105849222|NCT00688376|365107653|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
105849223|NCT00688376|365107654|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
105849224|NCT00688376|365107653|FG000|Double-Blind Phase|Not treated|0|||
105849225|NCT00688376|365107654|FG001|Double-Blind Phase|Not treated|1|||
105849226|NCT00688376|365107653|FG000|Blinded Extension Phase|Adverse Event|3|||
105849227|NCT00688376|365107654|FG001|Blinded Extension Phase|Adverse Event|4|||
105849228|NCT00688376|365107653|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
105849229|NCT00688376|365107654|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
105849230|NCT00688376|365107653|FG000|Blinded Extension Phase|Physician Decision|1|||
105849231|NCT00688376|365107654|FG001|Blinded Extension Phase|Physician Decision|0|||
105849232|NCT00688376|365107653|FG000|Blinded Extension Phase|Other|1|||
105849233|NCT00688376|365107654|FG001|Blinded Extension Phase|Other|0|||
105849234|NCT03579966|365107658|FG000|Overall Study|Adverse Event|6|||
105849235|NCT03579966|365107658|FG000|Overall Study|Lost to Follow-up|4|||
105849236|NCT03579966|365107658|FG000|Overall Study|Physician Decision|10|||
105849237|NCT03579966|365107658|FG000|Overall Study|Pregnancy|1|||
105849238|NCT03579966|365107658|FG000|Overall Study|Withdrawal by Subject|16|||
105849239|NCT03579966|365107658|FG000|Overall Study|Study terminated by Sponsor|22|||
106025317|NCT03241368|365758510|FG000|Overall Study|Lost to Follow-up|1|||
105849240|NCT03579966|365107658|FG000|Overall Study|Protocol Violation|1|||
105849241|NCT00003875|365107659|FG000|Overall Study|Screen Failed|1|||
105849242|NCT00969540|365107660|FG000|Overall Study|Lost to Follow-up|1|||
105849243|NCT00969540|365107661|FG001|Overall Study|Lost to Follow-up|1|||
105849244|NCT01646138|365107662|FG000|Overall Study|Lost to Follow-up|0|||
106025318|NCT03241368|365758510|FG000|Overall Study|Physician Decision|6|||
106025319|NCT03241368|365758510|FG000|Overall Study|Withdrawal by Subject|6|||
106025320|NCT03241368|365758510|FG000|Overall Study|Protocol Violation|1|||
106025321|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
106025322|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
106025323|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Adverse Event|7|||
106025324|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Adverse Event|6|||
106025325|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
106025326|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
105972977|NCT01529515|365561632|FG000|DOUBLE BLIND PHASE|Other|0|||
105972978|NCT01529515|365561633|FG001|DOUBLE BLIND PHASE|Other|0|||
105972979|NCT01529515|365561634|FG002|DOUBLE BLIND PHASE|Other|9|||
105972980|NCT01529515|365561635|FG003|DOUBLE BLIND PHASE|Other|2|||
105972981|NCT03334851|365561637|FG000|Overall Study|Other|0|||
105972982|NCT03334851|365561638|FG001|Overall Study|Other|0|||
105972983|NCT03334851|365561639|FG002|Overall Study|Other|0|||
105972984|NCT03334851|365561640|FG003|Overall Study|Other|0|||
105972985|NCT03334851|365561641|FG004|Overall Study|Other|0|||
105972986|NCT03334851|365561642|FG005|Overall Study|Other|0|||
105972987|NCT03334851|365561643|FG006|Overall Study|Other|0|||
105972988|NCT03334851|365561644|FG007|Overall Study|Other|1|||
105972989|NCT03334851|365561645|FG008|Overall Study|Other|0|||
105972990|NCT03334851|365561646|FG009|Overall Study|Other|0|||
105972991|NCT03334851|365561647|FG010|Overall Study|Other|0|||
105972992|NCT03334851|365561648|FG011|Overall Study|Other|0|||
105972993|NCT03334851|365561649|FG012|Overall Study|Other|0|||
105972994|NCT03334851|365561637|FG000|Overall Study|Adverse Event|0|||
105972995|NCT03334851|365561638|FG001|Overall Study|Adverse Event|0|||
105972996|NCT03334851|365561639|FG002|Overall Study|Adverse Event|0|||
105972997|NCT03334851|365561640|FG003|Overall Study|Adverse Event|0|||
105972998|NCT03334851|365561641|FG004|Overall Study|Adverse Event|0|||
105972999|NCT03334851|365561642|FG005|Overall Study|Adverse Event|0|||
105973000|NCT03334851|365561643|FG006|Overall Study|Adverse Event|0|||
105973001|NCT03334851|365561644|FG007|Overall Study|Adverse Event|1|||
105973002|NCT03334851|365561645|FG008|Overall Study|Adverse Event|0|||
105973003|NCT03334851|365561646|FG009|Overall Study|Adverse Event|0|||
105973004|NCT03334851|365561647|FG010|Overall Study|Adverse Event|0|||
105973005|NCT03334851|365561648|FG011|Overall Study|Adverse Event|0|||
105973006|NCT03334851|365561649|FG012|Overall Study|Adverse Event|0|||
105973007|NCT03334851|365561637|FG000|Overall Study|Withdrawal by Subject|0|||
105973008|NCT03334851|365561638|FG001|Overall Study|Withdrawal by Subject|0|||
105973009|NCT03334851|365561639|FG002|Overall Study|Withdrawal by Subject|0|||
105973010|NCT03334851|365561640|FG003|Overall Study|Withdrawal by Subject|0|||
105973011|NCT03334851|365561641|FG004|Overall Study|Withdrawal by Subject|0|||
105973012|NCT03334851|365561642|FG005|Overall Study|Withdrawal by Subject|0|||
105973013|NCT03334851|365561643|FG006|Overall Study|Withdrawal by Subject|0|||
105973014|NCT03334851|365561644|FG007|Overall Study|Withdrawal by Subject|0|||
105973015|NCT03334851|365561645|FG008|Overall Study|Withdrawal by Subject|0|||
105973016|NCT03334851|365561646|FG009|Overall Study|Withdrawal by Subject|0|||
105973017|NCT03334851|365561647|FG010|Overall Study|Withdrawal by Subject|1|||
105973018|NCT03334851|365561648|FG011|Overall Study|Withdrawal by Subject|0|||
105973019|NCT03334851|365561649|FG012|Overall Study|Withdrawal by Subject|1|||
105973020|NCT03334851|365561637|FG000|Overall Study|Lost to Follow-up|0|||
105973021|NCT03334851|365561638|FG001|Overall Study|Lost to Follow-up|0|||
105973022|NCT03334851|365561639|FG002|Overall Study|Lost to Follow-up|0|||
105973023|NCT03334851|365561640|FG003|Overall Study|Lost to Follow-up|0|||
105973024|NCT03334851|365561641|FG004|Overall Study|Lost to Follow-up|0|||
105973025|NCT03334851|365561642|FG005|Overall Study|Lost to Follow-up|0|||
105973026|NCT03334851|365561643|FG006|Overall Study|Lost to Follow-up|0|||
106025327|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Physician Decision|4|||
106025328|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Physician Decision|4|||
106025329|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
106025330|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
106025331|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
105973027|NCT03334851|365561644|FG007|Overall Study|Lost to Follow-up|0|||
105973028|NCT03334851|365561645|FG008|Overall Study|Lost to Follow-up|0|||
105973029|NCT03334851|365561646|FG009|Overall Study|Lost to Follow-up|0|||
105973030|NCT03334851|365561647|FG010|Overall Study|Lost to Follow-up|2|||
105973031|NCT03334851|365561648|FG011|Overall Study|Lost to Follow-up|1|||
105973032|NCT03334851|365561649|FG012|Overall Study|Lost to Follow-up|0|||
105973033|NCT02534935|365561650|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
105973034|NCT02534935|365561651|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
105973035|NCT02534935|365561652|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
105973036|NCT02534935|365561650|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
105973037|NCT02534935|365561651|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
105973038|NCT02534935|365561652|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
105973039|NCT02534935|365561650|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
105973040|NCT02534935|365561651|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
105973041|NCT02534935|365561652|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
105973042|NCT02534935|365561650|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
105973043|NCT02534935|365561651|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
105973044|NCT02534935|365561652|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
105973045|NCT02534935|365561650|FG000|Stage 1: 24 Months|Adverse Event|0|||
105973046|NCT02534935|365561651|FG001|Stage 1: 24 Months|Adverse Event|2|||
105973047|NCT02534935|365561652|FG002|Stage 1: 24 Months|Adverse Event|0|||
105973048|NCT02534935|365561650|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
105973049|NCT02534935|365561651|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
106025332|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
106025333|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
106025334|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
105849245|NCT01646138|365107663|FG001|Overall Study|Lost to Follow-up|0|||
105849246|NCT01646138|365107664|FG002|Overall Study|Lost to Follow-up|0|||
105849247|NCT01646138|365107665|FG003|Overall Study|Lost to Follow-up|0|||
105849248|NCT01646138|365107666|FG004|Overall Study|Lost to Follow-up|2|||
105849249|NCT03551496|365107667|FG000|Overall Study|Death|11|||
105849250|NCT03551496|365107668|FG001|Overall Study|Death|7|||
105849251|NCT03551496|365107667|FG000|Overall Study|Withdrawal by Subject|4|||
105849252|NCT03551496|365107668|FG001|Overall Study|Withdrawal by Subject|3|||
105849253|NCT03551496|365107667|FG000|Overall Study|Other Reasons|1|||
105849254|NCT03551496|365107668|FG001|Overall Study|Other Reasons|0|||
105849255|NCT01780987|365107669|FG000|Overall Study|Adverse Event|0|||
105849256|NCT01780987|365107670|FG001|Overall Study|Adverse Event|4|||
105849257|NCT01780987|365107669|FG000|Overall Study|Withdrawal by Subject|2|||
105849258|NCT01780987|365107670|FG001|Overall Study|Withdrawal by Subject|0|||
105849259|NCT01780987|365107669|FG000|Overall Study|Request of Changing Hospital|0|||
105849260|NCT01780987|365107670|FG001|Overall Study|Request of Changing Hospital|1|||
105849261|NCT01780987|365107669|FG000|Overall Study|Changing Residence|1|||
105849262|NCT01780987|365107670|FG001|Overall Study|Changing Residence|0|||
105849263|NCT01780987|365107669|FG000|Overall Study|Not Receiving any Study Medication|0|||
105849264|NCT01780987|365107670|FG001|Overall Study|Not Receiving any Study Medication|1|||
105849265|NCT03560986|365107671|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
105849266|NCT03560986|365107672|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
105849267|NCT03560986|365107671|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
105849268|NCT03560986|365107672|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
105849269|NCT03560986|365107671|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
105849270|NCT03560986|365107672|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
105849271|NCT03560986|365107671|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
105849272|NCT03560986|365107672|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
105849273|NCT03560986|365107671|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
105849274|NCT03560986|365107672|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
105849275|NCT03560986|365107671|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
105849276|NCT03560986|365107672|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
105849277|NCT03560986|365107671|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
105849278|NCT03560986|365107672|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
105849279|NCT01971970|365107673|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
105849280|NCT01971970|365107674|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
105849281|NCT01971970|365107673|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
105849282|NCT01971970|365107674|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
105849283|NCT01971970|365107673|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
105849284|NCT01971970|365107674|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
105849285|NCT01971970|365107673|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
105849286|NCT01971970|365107674|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
105849287|NCT01971970|365107673|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
105849288|NCT01971970|365107674|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
105849289|NCT01971970|365107673|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
105849290|NCT01971970|365107674|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
105849291|NCT01971970|365107673|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
105849292|NCT01971970|365107674|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
105849293|NCT00848107|365107675|FG000|Overall Study|Lost to Follow-up|2|||
105849294|NCT00848107|365107675|FG000|Overall Study|Withdrawal by Subject|8|||
105849295|NCT00848107|365107675|FG000|Overall Study|Adverse Event|9|||
105849296|NCT00848107|365107675|FG000|Overall Study|Death|1|||
105849297|NCT00848107|365107675|FG000|Overall Study|Pregnancy|1|||
105849298|NCT00893737|365107676|FG000|Overall Study|Adverse Event|4|||
105849299|NCT00893737|365107676|FG000|Overall Study|Withdrawal by Subject|2|||
105849300|NCT00893737|365107676|FG000|Overall Study|Lost to Follow-up|6|||
105849301|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
105849302|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
106025335|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Non-compliance|1|||
105869195|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
106025336|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Non-compliance|0|||
106025337|NCT00470834|365758511|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
106025338|NCT00470834|365758512|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
106025339|NCT00470834|365758511|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
106150162|NCT01207492|366210483|FG000|Overall Study|Progressive disease|3|||
106150163|NCT01207492|366210483|FG000|Overall Study|Toxicity|1|||
106150164|NCT02807779|366210484|FG000|Overall Study|Lost to Follow-up|1|||
106150165|NCT02807779|366210485|FG001|Overall Study|Lost to Follow-up|0|||
106150166|NCT02807779|366210486|FG002|Overall Study|Lost to Follow-up|0|||
106025340|NCT00470834|365758512|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
106025341|NCT00470834|365758511|FG000|Extension Period (24 Months)|Adverse Event|3|||
106025342|NCT00470834|365758512|FG001|Extension Period (24 Months)|Adverse Event|4|||
106025343|NCT00470834|365758511|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
106025344|NCT00470834|365758512|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
106025345|NCT00470834|365758511|FG000|Extension Period (24 Months)|Physician Decision|4|||
106025346|NCT00470834|365758512|FG001|Extension Period (24 Months)|Physician Decision|3|||
106025347|NCT00470834|365758511|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
106025348|NCT00470834|365758512|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
106025349|NCT00470834|365758511|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
106025350|NCT00470834|365758512|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
106025351|NCT00470834|365758511|FG000|Extension Period (24 Months)|Non-compliance|0|||
106025352|NCT00470834|365758512|FG001|Extension Period (24 Months)|Non-compliance|1|||
106025353|NCT00470834|365758511|FG000|Extension Period (24 Months)|Disease Progression|0|||
106025354|NCT00470834|365758512|FG001|Extension Period (24 Months)|Disease Progression|1|||
106025355|NCT06351371|365758515|FG000|Overall Study|Mutation Status Not Confirmed|9|||
106025356|NCT06351371|365758515|FG000|Overall Study|Ineligible|1|||
106025357|NCT06351371|365758515|FG000|Overall Study|Adverse Event|4|||
106025358|NCT06351371|365758515|FG000|Overall Study|Death|1|||
106025359|NCT06351371|365758515|FG000|Overall Study|Disease progression|14|||
106025360|NCT06351371|365758515|FG000|Overall Study|Withdrawal by Subject|3|||
106025361|NCT06351371|365758515|FG000|Overall Study|Physician Decision|3|||
106025362|NCT00787267|365758516|FG000|Overall Study|Screen failure/Ineligible|10|||
106025363|NCT00787267|365758516|FG000|Overall Study|No Reason Provided|1|||
106025364|NCT00787267|365758516|FG000|Overall Study|Withdrawal by Subject|1|||
106025365|NCT01788215|365758518|FG000|Overall Study|Withdrawal by Subject|0|||
106025366|NCT01788215|365758519|FG001|Overall Study|Withdrawal by Subject|1|||
106025367|NCT01788215|365758518|FG000|Overall Study|Lost to Follow-up|2|||
106025368|NCT01788215|365758519|FG001|Overall Study|Lost to Follow-up|0|||
106025369|NCT03116152|365758520|FG000|Overall Study|Disease Progression|49|||
106025370|NCT03116152|365758521|FG001|Overall Study|Disease Progression|47|||
106025371|NCT03116152|365758520|FG000|Overall Study|Death|5|||
106025372|NCT03116152|365758521|FG001|Overall Study|Death|2|||
106025373|NCT03116152|365758520|FG000|Overall Study|Adverse Event|21|||
106025374|NCT03116152|365758521|FG001|Overall Study|Adverse Event|7|||
106025375|NCT03116152|365758520|FG000|Overall Study|Protocol Violation|2|||
106025376|NCT03116152|365758521|FG001|Overall Study|Protocol Violation|2|||
106025377|NCT03116152|365758520|FG000|Overall Study|Withdrawal by Subject|0|||
106025378|NCT03116152|365758521|FG001|Overall Study|Withdrawal by Subject|1|||
106025379|NCT03116152|365758520|FG000|Overall Study|Physician Decision|3|||
106025380|NCT03116152|365758521|FG001|Overall Study|Physician Decision|2|||
106025381|NCT03116152|365758520|FG000|Overall Study|other|11|||
106025382|NCT03116152|365758521|FG001|Overall Study|other|34|||
106025383|NCT01950013|365758522|FG000|Overall Study|Withdrawal by Subject|0|||
106025384|NCT01950013|365758523|FG001|Overall Study|Withdrawal by Subject|2|||
106025385|NCT01950013|365758524|FG002|Overall Study|Withdrawal by Subject|0|||
106025386|NCT00275340|365758525|FG000|Overall Study|Lost to Follow-up|2|||
106025387|NCT00275340|365758526|FG001|Overall Study|Lost to Follow-up|4|||
106025388|NCT02379637|365758530|FG000|Overall Study|Protocol Violation|0|||
106025389|NCT02379637|365758531|FG001|Overall Study|Protocol Violation|1|||
106025390|NCT02379637|365758530|FG000|Overall Study|Adverse Event|1|||
106025391|NCT02379637|365758531|FG001|Overall Study|Adverse Event|0|||
106025392|NCT02379637|365758530|FG000|Overall Study|Withdrawal by Subject|1|||
106025393|NCT02379637|365758531|FG001|Overall Study|Withdrawal by Subject|0|||
106025394|NCT02365480|365758532|FG000|Overall Study|Withdrawal by Subject|2|||
106025395|NCT02365480|365758533|FG001|Overall Study|Withdrawal by Subject|0|||
106150167|NCT02807779|366210484|FG000|Overall Study|Physician Decision|2|||
106150168|NCT02807779|366210485|FG001|Overall Study|Physician Decision|0|||
106150169|NCT02807779|366210486|FG002|Overall Study|Physician Decision|1|||
106150170|NCT02807779|366210484|FG000|Overall Study|Death|1|||
106150171|NCT02807779|366210485|FG001|Overall Study|Death|1|||
106150172|NCT02807779|366210486|FG002|Overall Study|Death|0|||
106025396|NCT03091348|365758534|FG000|Overall Study|Lost to Follow-up|2|||
106025397|NCT03091348|365758535|FG001|Overall Study|Lost to Follow-up|1|||
106025398|NCT02791763|365758536|FG000|Overall Study|Protocol Violation|0|||
106025399|NCT02791763|365758537|FG001|Overall Study|Protocol Violation|0|||
106025400|NCT02791763|365758538|FG002|Overall Study|Protocol Violation|1|||
106025401|NCT02791763|365758536|FG000|Overall Study|Withdrawal by Subject|5|||
106025402|NCT02791763|365758537|FG001|Overall Study|Withdrawal by Subject|1|||
106025403|NCT02791763|365758538|FG002|Overall Study|Withdrawal by Subject|0|||
106025404|NCT02791763|365758536|FG000|Overall Study|Physician Decision|0|||
106150173|NCT03312907|366211472|FG000|Overall Study|Adverse Event|1|||
106150174|NCT03312907|366211473|FG001|Overall Study|Adverse Event|6|||
106150175|NCT03312907|366211474|FG002|Overall Study|Adverse Event|1|||
105973050|NCT02534935|365561652|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
105973051|NCT02534935|365561650|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
105973052|NCT02534935|365561651|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
105973053|NCT02534935|365561652|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
105973054|NCT01069861|365561653|FG000|Overall Study|Death|1|||
105973055|NCT01069861|365561653|FG000|Overall Study|Adverse Event|1|||
105973056|NCT01069861|365561653|FG000|Overall Study|Did not meet entrance criteria|1|||
105973057|NCT03555981|365561654|FG000|Overall Study|Lost to Follow-up|0|||
105973058|NCT03555981|365561655|FG001|Overall Study|Lost to Follow-up|2|||
105973059|NCT03272828|365561656|FG000|Overall Study|Lost to Follow-up|7|||
105973060|NCT03272828|365561657|FG001|Overall Study|Lost to Follow-up|7|||
105973061|NCT03272828|365561656|FG000|Overall Study|Withdrawal by Subject|2|||
105973062|NCT03272828|365561657|FG001|Overall Study|Withdrawal by Subject|0|||
105973063|NCT03272828|365561656|FG000|Overall Study|Deceased|1|||
105973064|NCT03272828|365561657|FG001|Overall Study|Deceased|1|||
105973065|NCT03272828|365561656|FG000|Overall Study|Failed implant|1|||
105973066|NCT03272828|365561657|FG001|Overall Study|Failed implant|2|||
105973067|NCT04600076|365561660|FG000|Overall Study|Lost to Follow-up|3|||
105973068|NCT00252694|365561661|FG000|Overall Study|Withdrawal by Subject|83|||
105973069|NCT00252694|365561662|FG001|Overall Study|Withdrawal by Subject|91|||
105973070|NCT00252694|365561661|FG000|Overall Study|Death|36|||
105973071|NCT00252694|365561662|FG001|Overall Study|Death|34|||
105973072|NCT00252694|365561661|FG000|Overall Study|Mostly Lost to Follow Up|8|||
105973073|NCT00252694|365561662|FG001|Overall Study|Mostly Lost to Follow Up|13|||
105973074|NCT00252694|365561661|FG000|Overall Study|Patient Moving|17|||
105973075|NCT00252694|365561662|FG001|Overall Study|Patient Moving|16|||
105973076|NCT00683917|365561665|FG000|Overall Study|Study prematurely terminated|10|||
105973077|NCT03640052|365561678|FG000|Overall Study|Lost to Follow-up|0|||
105973078|NCT03640052|365561679|FG001|Overall Study|Lost to Follow-up|1|||
105973079|NCT03640052|365561680|FG002|Overall Study|Lost to Follow-up|0|||
105973080|NCT03640052|365561681|FG003|Overall Study|Lost to Follow-up|0|||
105973081|NCT03640052|365561682|FG004|Overall Study|Lost to Follow-up|0|||
105973082|NCT04422561|365561683|FG000|Overall Study|Lost to Follow-up|25|||
105973083|NCT04422561|365561684|FG001|Overall Study|Lost to Follow-up|11|||
105973084|NCT01666119|365561685|FG000|Overall Study|Adverse Event|6|||
105973085|NCT01666119|365561685|FG000|Overall Study|Withdrawal by Subject|16|||
105973086|NCT01666119|365561685|FG000|Overall Study|Lost to Follow-up|7|||
105973087|NCT01666119|365561685|FG000|Overall Study|non compliance with study medication, pa|18|||
105973088|NCT01666119|365561685|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
105973089|NCT00937404|365561686|FG000|Overall Study|Protocol Violation|1|||
105973090|NCT00937404|365561686|FG000|Overall Study|Withdrawal by Subject|1|||
105973091|NCT00230282|365561690|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
105973092|NCT00230282|365561690|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
105973093|NCT00230282|365561690|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
105973094|NCT00230282|365561690|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
105973095|NCT01323270|365561698|FG000|Overall Study|Withdrawal by Subject|19|||
105973096|NCT01323270|365561699|FG001|Overall Study|Withdrawal by Subject|10|||
105973097|NCT01323270|365561698|FG000|Overall Study|Protocol Violation|9|||
105973098|NCT01323270|365561699|FG001|Overall Study|Protocol Violation|7|||
105973099|NCT01323270|365561698|FG000|Overall Study|Lost to Follow-up|4|||
105973100|NCT01323270|365561699|FG001|Overall Study|Lost to Follow-up|6|||
105973101|NCT01323270|365561698|FG000|Overall Study|Adverse Event|8|||
105973102|NCT01323270|365561699|FG001|Overall Study|Adverse Event|0|||
105973103|NCT01323270|365561698|FG000|Overall Study|Other|0|||
105973104|NCT01323270|365561699|FG001|Overall Study|Other|3|||
105973105|NCT01323270|365561698|FG000|Overall Study|Physician Decision|0|||
105973106|NCT01323270|365561699|FG001|Overall Study|Physician Decision|2|||
105973107|NCT01323270|365561698|FG000|Overall Study|Not eligible|1|||
105973108|NCT01323270|365561699|FG001|Overall Study|Not eligible|1|||
105973109|NCT01323270|365561698|FG000|Overall Study|Death|1|||
105973110|NCT01323270|365561699|FG001|Overall Study|Death|0|||
105973111|NCT01323270|365561698|FG000|Overall Study|Randomized, but not vaccinated|1|||
105973112|NCT01323270|365561699|FG001|Overall Study|Randomized, but not vaccinated|0|||
105973113|NCT03349645|365561701|FG000|Overall Study|Sponsor Terminated Study|75|||
105973114|NCT03349645|365561701|FG000|Overall Study|Withdrawal by Subject|4|||
105973115|NCT03349645|365561701|FG000|Overall Study|Protocol Violation|1|||
105973116|NCT03349645|365561701|FG000|Overall Study|Other|2|||
105973117|NCT02229214|365561711|FG000|Overall Study|Adverse Event|2|||
105973118|NCT02229214|365561712|FG001|Overall Study|Adverse Event|0|||
106025405|NCT02791763|365758537|FG001|Overall Study|Physician Decision|1|||
105973119|NCT02229214|365561711|FG000|Overall Study|Withdrawal by Subject|4|||
105973120|NCT02229214|365561712|FG001|Overall Study|Withdrawal by Subject|0|||
105973121|NCT01133405|365561721|FG000|Period 1|Withdrawal by Subject|0|||
105973122|NCT01133405|365561722|FG001|Period 1|Withdrawal by Subject|1|||
105973123|NCT01133405|365561723|FG002|Period 1|Withdrawal by Subject|0|||
105973124|NCT01133405|365561724|FG003|Period 1|Withdrawal by Subject|1|||
105973125|NCT01133405|365561725|FG004|Period 1|Withdrawal by Subject|0|||
105973126|NCT01133405|365561726|FG005|Period 1|Withdrawal by Subject|1|||
105973127|NCT01133405|365561727|FG006|Period 1|Withdrawal by Subject|0|||
105973128|NCT01133405|365561728|FG007|Period 1|Withdrawal by Subject|0|||
105973129|NCT01133405|365561729|FG008|Period 1|Withdrawal by Subject|0|||
105973130|NCT01133405|365561730|FG009|Period 1|Withdrawal by Subject|0|||
105973131|NCT01133405|365561721|FG000|Period 1|Physician Decision|0|||
105973132|NCT01133405|365561722|FG001|Period 1|Physician Decision|0|||
105973133|NCT01133405|365561723|FG002|Period 1|Physician Decision|0|||
105973134|NCT01133405|365561724|FG003|Period 1|Physician Decision|1|||
105973135|NCT01133405|365561725|FG004|Period 1|Physician Decision|0|||
105973136|NCT01133405|365561726|FG005|Period 1|Physician Decision|0|||
105973137|NCT01133405|365561727|FG006|Period 1|Physician Decision|0|||
105973138|NCT01133405|365561728|FG007|Period 1|Physician Decision|0|||
105973139|NCT01133405|365561729|FG008|Period 1|Physician Decision|0|||
105973140|NCT01133405|365561730|FG009|Period 1|Physician Decision|0|||
105973141|NCT01133405|365561721|FG000|Period 1|Discontinued after randomization|1|||
105973142|NCT01133405|365561722|FG001|Period 1|Discontinued after randomization|0|||
105973143|NCT01133405|365561723|FG002|Period 1|Discontinued after randomization|0|||
105973144|NCT01133405|365561724|FG003|Period 1|Discontinued after randomization|0|||
105973145|NCT01133405|365561725|FG004|Period 1|Discontinued after randomization|0|||
105973146|NCT01133405|365561726|FG005|Period 1|Discontinued after randomization|0|||
105973147|NCT01133405|365561727|FG006|Period 1|Discontinued after randomization|1|||
105973148|NCT01133405|365561728|FG007|Period 1|Discontinued after randomization|0|||
105973149|NCT01133405|365561729|FG008|Period 1|Discontinued after randomization|0|||
105973150|NCT01133405|365561730|FG009|Period 1|Discontinued after randomization|0|||
105973151|NCT01133405|365561721|FG000|Period 1|Received drug only in period 2|0|||
105973152|NCT01133405|365561722|FG001|Period 1|Received drug only in period 2|1|||
105973153|NCT01133405|365561723|FG002|Period 1|Received drug only in period 2|0|||
105973154|NCT01133405|365561724|FG003|Period 1|Received drug only in period 2|2|||
105973155|NCT01133405|365561725|FG004|Period 1|Received drug only in period 2|0|||
105973156|NCT01133405|365561726|FG005|Period 1|Received drug only in period 2|1|||
105973157|NCT01133405|365561727|FG006|Period 1|Received drug only in period 2|0|||
105973158|NCT01133405|365561728|FG007|Period 1|Received drug only in period 2|0|||
105973159|NCT01133405|365561729|FG008|Period 1|Received drug only in period 2|0|||
105973160|NCT01133405|365561730|FG009|Period 1|Received drug only in period 2|0|||
105973161|NCT01133405|365561721|FG000|Period 1|Received drug only in period 3|0|||
105973162|NCT01133405|365561722|FG001|Period 1|Received drug only in period 3|1|||
105973163|NCT01133405|365561723|FG002|Period 1|Received drug only in period 3|1|||
105973164|NCT01133405|365561724|FG003|Period 1|Received drug only in period 3|0|||
105973165|NCT01133405|365561725|FG004|Period 1|Received drug only in period 3|0|||
105973166|NCT01133405|365561726|FG005|Period 1|Received drug only in period 3|0|||
105973167|NCT01133405|365561727|FG006|Period 1|Received drug only in period 3|0|||
105973168|NCT01133405|365561728|FG007|Period 1|Received drug only in period 3|0|||
105973169|NCT01133405|365561729|FG008|Period 1|Received drug only in period 3|0|||
105973170|NCT01133405|365561730|FG009|Period 1|Received drug only in period 3|0|||
105973171|NCT01133405|365561721|FG000|Period 2|Adverse Event|0|||
105973172|NCT01133405|365561722|FG001|Period 2|Adverse Event|0|||
105973173|NCT01133405|365561723|FG002|Period 2|Adverse Event|1|||
105973174|NCT01133405|365561724|FG003|Period 2|Adverse Event|0|||
105973175|NCT01133405|365561725|FG004|Period 2|Adverse Event|0|||
105973176|NCT01133405|365561726|FG005|Period 2|Adverse Event|0|||
105973177|NCT01133405|365561727|FG006|Period 2|Adverse Event|0|||
105973178|NCT01133405|365561728|FG007|Period 2|Adverse Event|0|||
105973179|NCT01133405|365561729|FG008|Period 2|Adverse Event|0|||
105973180|NCT01133405|365561730|FG009|Period 2|Adverse Event|0|||
105973181|NCT01133405|365561721|FG000|Period 2|Withdrawal by Subject|0|||
105973182|NCT01133405|365561722|FG001|Period 2|Withdrawal by Subject|0|||
105973183|NCT01133405|365561723|FG002|Period 2|Withdrawal by Subject|0|||
105973184|NCT01133405|365561724|FG003|Period 2|Withdrawal by Subject|1|||
105973185|NCT01133405|365561725|FG004|Period 2|Withdrawal by Subject|0|||
105973186|NCT01133405|365561726|FG005|Period 2|Withdrawal by Subject|1|||
105973187|NCT01133405|365561727|FG006|Period 2|Withdrawal by Subject|0|||
105973188|NCT01133405|365561728|FG007|Period 2|Withdrawal by Subject|0|||
105973189|NCT01133405|365561729|FG008|Period 2|Withdrawal by Subject|0|||
105973190|NCT01133405|365561730|FG009|Period 2|Withdrawal by Subject|0|||
105973191|NCT01133405|365561721|FG000|Period 2|Entry Criteria Not Met|0|||
105973192|NCT01133405|365561722|FG001|Period 2|Entry Criteria Not Met|1|||
105973193|NCT01133405|365561723|FG002|Period 2|Entry Criteria Not Met|0|||
105973194|NCT01133405|365561724|FG003|Period 2|Entry Criteria Not Met|0|||
105973195|NCT01133405|365561725|FG004|Period 2|Entry Criteria Not Met|0|||
105973196|NCT01133405|365561726|FG005|Period 2|Entry Criteria Not Met|0|||
105973197|NCT01133405|365561727|FG006|Period 2|Entry Criteria Not Met|0|||
105973198|NCT01133405|365561728|FG007|Period 2|Entry Criteria Not Met|0|||
105973199|NCT01133405|365561729|FG008|Period 2|Entry Criteria Not Met|0|||
105973200|NCT01133405|365561730|FG009|Period 2|Entry Criteria Not Met|0|||
105973201|NCT01133405|365561721|FG000|Period 2|Physician Decision|0|||
105973202|NCT01133405|365561722|FG001|Period 2|Physician Decision|0|||
105973203|NCT01133405|365561723|FG002|Period 2|Physician Decision|0|||
105973204|NCT01133405|365561724|FG003|Period 2|Physician Decision|0|||
105973205|NCT01133405|365561725|FG004|Period 2|Physician Decision|0|||
106025406|NCT02791763|365758538|FG002|Overall Study|Physician Decision|0|||
106025407|NCT02791763|365758536|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
106025408|NCT02791763|365758537|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
106025409|NCT02791763|365758538|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
106025410|NCT02791763|365758536|FG000|Overall Study|Cancer event|1|||
106025411|NCT02791763|365758537|FG001|Overall Study|Cancer event|3|||
106025412|NCT02791763|365758538|FG002|Overall Study|Cancer event|0|||
106025413|NCT02791763|365758536|FG000|Overall Study|Participant had renal transplant|3|||
106025414|NCT02791763|365758537|FG001|Overall Study|Participant had renal transplant|0|||
106025415|NCT02791763|365758538|FG002|Overall Study|Participant had renal transplant|0|||
106025416|NCT02791763|365758536|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
106025417|NCT02791763|365758537|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
106025418|NCT02791763|365758538|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
106025419|NCT02791763|365758536|FG000|Overall Study|Adverse Event|12|||
106025420|NCT02791763|365758537|FG001|Overall Study|Adverse Event|13|||
106025421|NCT02791763|365758538|FG002|Overall Study|Adverse Event|7|||
106025422|NCT03179605|365758539|FG000|Overall Study|Withdrawal by Subject|1|||
106025423|NCT00146848|365758544|FG000|Pre-randomization|Death|19|||
106025424|NCT00146848|365758545|FG001|Pre-randomization|Death|0|||
106025425|NCT00146848|365758546|FG002|Pre-randomization|Death|0|||
106025426|NCT00146848|365758544|FG000|Pre-randomization|Lost to Follow-up|70|||
106025427|NCT00146848|365758545|FG001|Pre-randomization|Lost to Follow-up|0|||
106025428|NCT00146848|365758546|FG002|Pre-randomization|Lost to Follow-up|0|||
106025429|NCT00146848|365758544|FG000|Pre-randomization|Physician Decision|8|||
106025430|NCT00146848|365758545|FG001|Pre-randomization|Physician Decision|0|||
106025431|NCT00146848|365758546|FG002|Pre-randomization|Physician Decision|0|||
106025432|NCT00146848|365758544|FG000|Pre-randomization|Protocol Violation|172|||
106025433|NCT00146848|365758545|FG001|Pre-randomization|Protocol Violation|0|||
106025434|NCT00146848|365758546|FG002|Pre-randomization|Protocol Violation|0|||
106025435|NCT00146848|365758544|FG000|Pre-randomization|Withdrawal by Subject|40|||
106025436|NCT00146848|365758545|FG001|Pre-randomization|Withdrawal by Subject|0|||
106025437|NCT00146848|365758546|FG002|Pre-randomization|Withdrawal by Subject|0|||
106025438|NCT00146848|365758544|FG000|Post-randomization|Lost to Follow-up|12|||
106025439|NCT00146848|365758545|FG001|Post-randomization|Lost to Follow-up|15|||
106025440|NCT00146848|365758546|FG002|Post-randomization|Lost to Follow-up|12|||
106025441|NCT00146848|365758544|FG000|Post-randomization|Withdrawn|26|||
106025442|NCT00146848|365758545|FG001|Post-randomization|Withdrawn|32|||
106025443|NCT00146848|365758546|FG002|Post-randomization|Withdrawn|27|||
106025444|NCT02636361|365758547|FG000|Period 4|Physician Decision|0|||
106025445|NCT02636361|365758548|FG001|Period 4|Physician Decision|0|||
106025446|NCT02636361|365758549|FG002|Period 4|Physician Decision|0|||
106025447|NCT02636361|365758550|FG003|Period 4|Physician Decision|1|||
106025448|NCT02636361|365758551|FG004|Period 4|Physician Decision|0|||
106025449|NCT00119678|365758552|FG000|Double-blind Treatment Period|Death|1|||
106025450|NCT00119678|365758553|FG001|Double-blind Treatment Period|Death|0|||
106025451|NCT00119678|365758552|FG000|Double-blind Treatment Period|Adverse Event|7|||
105849303|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
105849304|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
105849305|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
105849306|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
105849307|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
105849308|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
105849309|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
105849310|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
105849311|NCT04771403|365107680|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
105849312|NCT04771403|365107681|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
105849313|NCT04771403|365107680|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
105849314|NCT04771403|365107681|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
105849315|NCT04771403|365107680|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
106025452|NCT00119678|365758553|FG001|Double-blind Treatment Period|Adverse Event|1|||
106025453|NCT00119678|365758552|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
106025454|NCT00119678|365758553|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
106025455|NCT00119678|365758552|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
106025456|NCT00119678|365758553|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
106025457|NCT00119678|365758552|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
106025458|NCT00119678|365758553|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
105849316|NCT04771403|365107681|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
105849317|NCT01568320|365107686|FG000|Overall Study|Death|20|||
105849318|NCT01568320|365107686|FG000|Overall Study|Lost to Follow-up|9|||
105849319|NCT01568320|365107686|FG000|Overall Study|Withdrawal by Subject|10|||
105849320|NCT01568320|365107686|FG000|Overall Study|Conversion to open repair|1|||
105849321|NCT01568320|365107686|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
105849322|NCT01660334|365107687|FG000|Overall Study|Lost to Follow-up|1|||
105849323|NCT00311311|365107689|FG000|Overall Study|Adverse Event|3|||
105849324|NCT00311311|365107690|FG001|Overall Study|Adverse Event|2|||
105849325|NCT00311311|365107689|FG000|Overall Study|Withdrawal by Subject|1|||
105849326|NCT00311311|365107690|FG001|Overall Study|Withdrawal by Subject|1|||
105849327|NCT00311311|365107689|FG000|Overall Study|Noncompliance|0|||
105849328|NCT00311311|365107690|FG001|Overall Study|Noncompliance|1|||
105849329|NCT00311311|365107689|FG000|Overall Study|Study Termination by Sponsor|3|||
105849330|NCT00311311|365107690|FG001|Overall Study|Study Termination by Sponsor|4|||
105849331|NCT00311311|365107689|FG000|Overall Study|Death|1|||
105849332|NCT00311311|365107690|FG001|Overall Study|Death|0|||
105849333|NCT00311311|365107689|FG000|Overall Study|Lack of ancillary assistance|0|||
105849334|NCT00311311|365107690|FG001|Overall Study|Lack of ancillary assistance|1|||
105849335|NCT00816361|365107691|FG000|Overall Study|Withdrawal by Subject|0|||
105849336|NCT00816361|365107692|FG001|Overall Study|Withdrawal by Subject|0|||
105849337|NCT00816361|365107693|FG002|Overall Study|Withdrawal by Subject|0|||
105849338|NCT00816361|365107694|FG003|Overall Study|Withdrawal by Subject|0|||
105849339|NCT00816361|365107695|FG004|Overall Study|Withdrawal by Subject|1|||
105849340|NCT00816361|365107696|FG005|Overall Study|Withdrawal by Subject|2|||
105849341|NCT00816361|365107697|FG006|Overall Study|Withdrawal by Subject|0|||
105849342|NCT00816361|365107698|FG007|Overall Study|Withdrawal by Subject|2|||
105849343|NCT00816361|365107699|FG008|Overall Study|Withdrawal by Subject|1|||
105849344|NCT00816361|365107691|FG000|Overall Study|Death|4|||
105849345|NCT00816361|365107692|FG001|Overall Study|Death|3|||
105849346|NCT00816361|365107693|FG002|Overall Study|Death|3|||
105849347|NCT00816361|365107694|FG003|Overall Study|Death|3|||
105849348|NCT00816361|365107695|FG004|Overall Study|Death|1|||
105849349|NCT00816361|365107696|FG005|Overall Study|Death|1|||
105849350|NCT00816361|365107697|FG006|Overall Study|Death|3|||
105849351|NCT00816361|365107698|FG007|Overall Study|Death|7|||
105849352|NCT00816361|365107699|FG008|Overall Study|Death|8|||
105849353|NCT00816361|365107691|FG000|Overall Study|Other|0|||
105849354|NCT00816361|365107692|FG001|Overall Study|Other|0|||
105849355|NCT00816361|365107693|FG002|Overall Study|Other|0|||
105849356|NCT00816361|365107694|FG003|Overall Study|Other|0|||
105849357|NCT00816361|365107695|FG004|Overall Study|Other|0|||
105849358|NCT00816361|365107696|FG005|Overall Study|Other|0|||
105849359|NCT00816361|365107697|FG006|Overall Study|Other|0|||
105849360|NCT00816361|365107698|FG007|Overall Study|Other|0|||
105849361|NCT00816361|365107699|FG008|Overall Study|Other|1|||
105849362|NCT00546572|365107700|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
105849363|NCT00546572|365107701|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
105849364|NCT00546572|365107700|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
105849365|NCT00546572|365107701|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
105849366|NCT00546572|365107700|FG000|Vax 1 / Year 0|Protocol Violation|3|||
105849367|NCT00546572|365107701|FG001|Vax 1 / Year 0|Protocol Violation|4|||
105849368|NCT00546572|365107700|FG000|Vax 1 / Year 0|Death|2|||
105849369|NCT00546572|365107701|FG001|Vax 1 / Year 0|Death|2|||
105849370|NCT00546572|365107700|FG000|Vax 1 / Year 0|Adverse Event|0|||
105849371|NCT00546572|365107701|FG001|Vax 1 / Year 0|Adverse Event|1|||
105849372|NCT00546572|365107700|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
105973206|NCT01133405|365561726|FG005|Period 2|Physician Decision|1|||
105973207|NCT01133405|365561727|FG006|Period 2|Physician Decision|0|||
105973208|NCT01133405|365561728|FG007|Period 2|Physician Decision|0|||
105973209|NCT01133405|365561729|FG008|Period 2|Physician Decision|0|||
105973210|NCT01133405|365561730|FG009|Period 2|Physician Decision|0|||
105973211|NCT01238835|365561737|FG000|Overall Study|Death|124|||
105973212|NCT01238835|365561737|FG000|Overall Study|Withdrawal by Subject|9|||
105849373|NCT00546572|365107701|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
105973213|NCT01238835|365561737|FG000|Overall Study|Lost to Follow-up|1|||
105973214|NCT01238835|365561737|FG000|Overall Study|Site early discontinuation|2|||
105973215|NCT00871117|365561739|FG000|Overall Study|Lost to Follow-up|5|||
105973216|NCT00871117|365561740|FG001|Overall Study|Lost to Follow-up|6|||
105849374|NCT00546572|365107700|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
105849375|NCT00546572|365107701|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
105849376|NCT00546572|365107700|FG000|Vax 2 / Year 1|Other|1|||
105849377|NCT00546572|365107701|FG001|Vax 2 / Year 1|Other|1|||
105849378|NCT00546572|365107700|FG000|Vax 2 / Year 1|Adverse Event|1|||
105849379|NCT00546572|365107701|FG001|Vax 2 / Year 1|Adverse Event|0|||
105849380|NCT00546572|365107700|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
105849381|NCT00546572|365107701|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
105973217|NCT00871117|365561739|FG000|Overall Study|Other|0|||
105973218|NCT00871117|365561740|FG001|Overall Study|Other|4|||
105973219|NCT03385265|365561742|FG000|Overall Study|Withdrawal by Subject|5|||
105973220|NCT03385265|365561743|FG001|Overall Study|Withdrawal by Subject|2|||
105973221|NCT03385265|365561744|FG002|Overall Study|Withdrawal by Subject|5|||
105973222|NCT03385265|365561745|FG003|Overall Study|Withdrawal by Subject|2|||
105973223|NCT01218100|365561746|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
105973224|NCT01218100|365561747|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
105973225|NCT01218100|365561748|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
105973226|NCT01218100|365561749|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
105973227|NCT01218100|365561746|FG000|Overall Study|Adverse Event|4|||
105973228|NCT01218100|365561747|FG001|Overall Study|Adverse Event|6|||
105973229|NCT01218100|365561748|FG002|Overall Study|Adverse Event|6|||
105973230|NCT01218100|365561749|FG003|Overall Study|Adverse Event|7|||
105973231|NCT01218100|365561746|FG000|Overall Study|Lack of Efficacy|9|||
105973232|NCT01218100|365561747|FG001|Overall Study|Lack of Efficacy|6|||
106025459|NCT00119678|365758552|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
106025460|NCT00119678|365758553|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
106025461|NCT00119678|365758552|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
106025462|NCT00119678|365758553|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
106025463|NCT00119678|365758552|FG000|Double-blind Treatment Period|Pregnancy|0|||
106025464|NCT00119678|365758553|FG001|Double-blind Treatment Period|Pregnancy|2|||
106025465|NCT00119678|365758552|FG000|Double-blind Treatment Period|Not treated|1|||
106025466|NCT00119678|365758553|FG001|Double-blind Treatment Period|Not treated|2|||
106025467|NCT00119678|365758552|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
106025468|NCT00119678|365758553|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
106025469|NCT00119678|365758552|FG000|Open-label Treatment Period|Death|1|||
106025470|NCT00119678|365758553|FG001|Open-label Treatment Period|Death|0|||
106025471|NCT00119678|365758552|FG000|Open-label Treatment Period|Adverse Event|3|||
106025472|NCT00119678|365758553|FG001|Open-label Treatment Period|Adverse Event|0|||
106025473|NCT00119678|365758552|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
106025474|NCT00119678|365758553|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
106025475|NCT00119678|365758552|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
106025476|NCT00119678|365758553|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
106025477|NCT00119678|365758552|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
106025478|NCT00119678|365758553|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
106025479|NCT00119678|365758552|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
106025480|NCT00119678|365758553|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
106025481|NCT00119678|365758552|FG000|Open-label Treatment Period|Pregnancy|1|||
106025482|NCT00119678|365758553|FG001|Open-label Treatment Period|Pregnancy|0|||
106025483|NCT00119678|365758552|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
106025484|NCT00119678|365758553|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
106025485|NCT00539188|365758559|FG000|Overall Study|Withdrawal by Subject|1|||
106025486|NCT00539188|365758560|FG001|Overall Study|Withdrawal by Subject|0|||
106025487|NCT00539188|365758559|FG000|Overall Study|Lost to Follow-up|2|||
106025488|NCT00539188|365758560|FG001|Overall Study|Lost to Follow-up|1|||
106025489|NCT04784442|365758563|FG000|Overall Study|Adverse Event|1|||
106025490|NCT04784442|365758564|FG001|Overall Study|Adverse Event|0|||
106025491|NCT04784442|365758565|FG002|Overall Study|Adverse Event|2|||
106025492|NCT04784442|365758566|FG003|Overall Study|Adverse Event|1|||
106025493|NCT04784442|365758563|FG000|Overall Study|Protocol Violation|1|||
105973233|NCT01218100|365561748|FG002|Overall Study|Lack of Efficacy|5|||
105973234|NCT01218100|365561749|FG003|Overall Study|Lack of Efficacy|12|||
106025494|NCT04784442|365758564|FG001|Overall Study|Protocol Violation|0|||
106025495|NCT04784442|365758565|FG002|Overall Study|Protocol Violation|0|||
106025496|NCT04784442|365758566|FG003|Overall Study|Protocol Violation|0|||
106025497|NCT04784442|365758563|FG000|Overall Study|Non-compliance with study drug|1|||
106025498|NCT04784442|365758564|FG001|Overall Study|Non-compliance with study drug|0|||
106025499|NCT04784442|365758565|FG002|Overall Study|Non-compliance with study drug|0|||
106025500|NCT04784442|365758566|FG003|Overall Study|Non-compliance with study drug|0|||
106025501|NCT00509145|365758567|FG000|Overall Study|Death|0|||
105849382|NCT01335997|365107702|FG000|Period I and II|Adverse Event|63|||
105849383|NCT01335997|365107703|FG001|Period I and II|Adverse Event|43|||
105973235|NCT01218100|365561746|FG000|Overall Study|Protocol Violation|0|||
105973236|NCT01218100|365561747|FG001|Overall Study|Protocol Violation|0|||
105973237|NCT01218100|365561748|FG002|Overall Study|Protocol Violation|1|||
105973238|NCT01218100|365561749|FG003|Overall Study|Protocol Violation|1|||
105973239|NCT01218100|365561746|FG000|Overall Study|Withdrawal by Subject|5|||
105973240|NCT01218100|365561747|FG001|Overall Study|Withdrawal by Subject|2|||
106025502|NCT00509145|365758568|FG001|Overall Study|Death|2|||
106025503|NCT00509145|365758567|FG000|Overall Study|Adverse Event|42|||
106025504|NCT00509145|365758568|FG001|Overall Study|Adverse Event|28|||
106025505|NCT00509145|365758567|FG000|Overall Study|Withdrawal by Subject|32|||
105973241|NCT01218100|365561748|FG002|Overall Study|Withdrawal by Subject|6|||
105973242|NCT01218100|365561749|FG003|Overall Study|Withdrawal by Subject|7|||
106025506|NCT00509145|365758568|FG001|Overall Study|Withdrawal by Subject|38|||
106025507|NCT00509145|365758567|FG000|Overall Study|Physician Decision|11|||
106025508|NCT00509145|365758568|FG001|Overall Study|Physician Decision|14|||
106025509|NCT00509145|365758567|FG000|Overall Study|Protocol Violation|1|||
106025510|NCT00509145|365758568|FG001|Overall Study|Protocol Violation|6|||
106025511|NCT00509145|365758567|FG000|Overall Study|Pregnancy|3|||
106025512|NCT00509145|365758568|FG001|Overall Study|Pregnancy|8|||
106025513|NCT00509145|365758567|FG000|Overall Study|Lost to Follow-up|6|||
106025514|NCT00509145|365758568|FG001|Overall Study|Lost to Follow-up|5|||
106025515|NCT00509145|365758567|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
106025516|NCT00509145|365758568|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
106025517|NCT00509145|365758567|FG000|Overall Study|Other|6|||
106025518|NCT00509145|365758568|FG001|Overall Study|Other|6|||
106025519|NCT02969655|365758569|FG000|Overall Study|Withdrawal by Subject|3|||
106025520|NCT02969655|365758570|FG001|Overall Study|Withdrawal by Subject|2|||
106025521|NCT02969655|365758569|FG000|Overall Study|Physician Decision|4|||
106025522|NCT02969655|365758570|FG001|Overall Study|Physician Decision|3|||
106025523|NCT02969655|365758569|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
106025524|NCT02969655|365758570|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
106025525|NCT02969655|365758569|FG000|Overall Study|Adverse Event|10|||
106025526|NCT02969655|365758570|FG001|Overall Study|Adverse Event|8|||
106025527|NCT01014910|365758571|FG000|Overall Study|Withdrawal by Subject|0|||
106025528|NCT01014910|365758572|FG001|Overall Study|Withdrawal by Subject|2|||
106025529|NCT02445794|365758573|FG000|Overall Study|Adverse Event|0|||
106025530|NCT02445794|365758574|FG001|Overall Study|Adverse Event|0|||
106025531|NCT02445794|365758575|FG002|Overall Study|Adverse Event|2|||
106025532|NCT02445794|365758576|FG003|Overall Study|Adverse Event|0|||
106025533|NCT03753789|365758577|FG000|Overall Study|Withdrawal by Subject|2|||
106025534|NCT01136785|365758582|FG000|Overall Study|Protocol Violation|2|||
106025535|NCT01136785|365758583|FG001|Overall Study|Protocol Violation|1|||
106025536|NCT01590758|365758587|FG000|Overall Study|Withdrawal by Subject|0|||
106025537|NCT01590758|365758588|FG001|Overall Study|Withdrawal by Subject|3|||
105849384|NCT01335997|365107702|FG000|Period I and II|Noncompliance with Study Drug|1|||
105849385|NCT01335997|365107703|FG001|Period I and II|Noncompliance with Study Drug|1|||
105849386|NCT01335997|365107702|FG000|Period I and II|Lost to Follow-up|3|||
105849387|NCT01335997|365107703|FG001|Period I and II|Lost to Follow-up|5|||
105849388|NCT01335997|365107702|FG000|Period I and II|Withdrawal by Subject|9|||
105849389|NCT01335997|365107703|FG001|Period I and II|Withdrawal by Subject|4|||
105849390|NCT01335997|365107702|FG000|Period I and II|Study Terminated by Sponsor|406|||
105849391|NCT01335997|365107703|FG001|Period I and II|Study Terminated by Sponsor|415|||
105849392|NCT01335997|365107702|FG000|Period I and II|Protocol Violation|9|||
105973243|NCT01218100|365561746|FG000|Overall Study|Lost to Follow-up|3|||
105973244|NCT01218100|365561747|FG001|Overall Study|Lost to Follow-up|8|||
105973245|NCT01218100|365561748|FG002|Overall Study|Lost to Follow-up|2|||
105973246|NCT01218100|365561749|FG003|Overall Study|Lost to Follow-up|1|||
105973247|NCT01218100|365561746|FG000|Overall Study|Other Reason|2|||
105973248|NCT01218100|365561747|FG001|Overall Study|Other Reason|2|||
105973249|NCT01218100|365561748|FG002|Overall Study|Other Reason|6|||
105973250|NCT01218100|365561749|FG003|Overall Study|Other Reason|4|||
105973251|NCT01118520|365561750|FG000|Overall Study|AAA repair|9|||
105973252|NCT01118520|365561751|FG001|Overall Study|AAA repair|7|||
105973253|NCT01118520|365561752|FG002|Overall Study|AAA repair|9|||
105973254|NCT01118520|365561750|FG000|Overall Study|Adverse Event|3|||
105973255|NCT01118520|365561751|FG001|Overall Study|Adverse Event|3|||
105973256|NCT01118520|365561752|FG002|Overall Study|Adverse Event|3|||
105973257|NCT01118520|365561750|FG000|Overall Study|Withdrawal by Subject|8|||
105973258|NCT01118520|365561751|FG001|Overall Study|Withdrawal by Subject|13|||
105973259|NCT01118520|365561752|FG002|Overall Study|Withdrawal by Subject|8|||
105973260|NCT00413920|365561773|FG000|Overall Study|Adverse Event|9|||
105973261|NCT00413920|365561774|FG001|Overall Study|Adverse Event|11|||
105973262|NCT00413920|365561773|FG000|Overall Study|Lack of Efficacy|11|||
105973263|NCT00413920|365561774|FG001|Overall Study|Lack of Efficacy|9|||
105973264|NCT00413920|365561773|FG000|Overall Study|Death|3|||
105973265|NCT00413920|365561774|FG001|Overall Study|Death|5|||
105973266|NCT00413920|365561773|FG000|Overall Study|Graft Loss|5|||
105973267|NCT00413920|365561774|FG001|Overall Study|Graft Loss|3|||
105973268|NCT02434354|365561775|FG000|Overall Study|screen fail|3|||
105973269|NCT03730961|365561776|FG000|Overall Study|Adverse Event|0|||
105973270|NCT03730961|365561777|FG001|Overall Study|Adverse Event|1|||
105973271|NCT03762616|365561781|FG000|Overall Study|Protocol Violation|2|||
105973272|NCT04465877|365561784|FG000|Overall Study|Noncompliant with study requirements|0|||
105973273|NCT04465877|365561785|FG001|Overall Study|Noncompliant with study requirements|0|||
106025538|NCT01590758|365758587|FG000|Overall Study|Physician Decision|1|||
106025539|NCT01590758|365758588|FG001|Overall Study|Physician Decision|2|||
106025540|NCT01590758|365758587|FG000|Overall Study|Lost to Follow-up|4|||
106025541|NCT01590758|365758588|FG001|Overall Study|Lost to Follow-up|2|||
106025542|NCT02560025|365758589|FG000|Overall Study|Ineligible after consent/ registration|3|||
106025543|NCT00402740|365758591|FG000|Overall Study|Withdrawal by Subject|18|||
106025544|NCT00402740|365758591|FG000|Overall Study|Death|50|||
105973274|NCT04465877|365561786|FG002|Overall Study|Noncompliant with study requirements|1|||
105973275|NCT04465877|365561787|FG003|Overall Study|Noncompliant with study requirements|0|||
105973276|NCT03831880|365561788|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
105973277|NCT03831880|365561789|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
105973278|NCT03831880|365561788|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
105973279|NCT03831880|365561789|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
105973280|NCT02649855|365561794|FG000|Overall Study|Refused further treatment|2|||
105973281|NCT02649855|365561795|FG001|Overall Study|Refused further treatment|1|||
105973282|NCT02649855|365561796|FG002|Overall Study|Refused further treatment|1|||
105973283|NCT02649855|365561794|FG000|Overall Study|Withdrew consent|0|||
105973284|NCT02649855|365561795|FG001|Overall Study|Withdrew consent|1|||
105973285|NCT02649855|365561796|FG002|Overall Study|Withdrew consent|0|||
105973286|NCT02649855|365561794|FG000|Overall Study|Switched to alternative treatment|0|||
105973287|NCT02649855|365561795|FG001|Overall Study|Switched to alternative treatment|1|||
105973288|NCT02649855|365561796|FG002|Overall Study|Switched to alternative treatment|1|||
105973289|NCT02649855|365561794|FG000|Overall Study|Principal investigator discretion|0|||
105973290|NCT02649855|365561795|FG001|Overall Study|Principal investigator discretion|1|||
105973291|NCT02649855|365561796|FG002|Overall Study|Principal investigator discretion|1|||
105973292|NCT02649855|365561794|FG000|Overall Study|No treatment, per protocol|1|||
105973293|NCT02649855|365561795|FG001|Overall Study|No treatment, per protocol|0|||
105973294|NCT02649855|365561796|FG002|Overall Study|No treatment, per protocol|0|||
105973295|NCT02649855|365561794|FG000|Overall Study|Initiate new treatment|1|||
105973296|NCT02649855|365561795|FG001|Overall Study|Initiate new treatment|0|||
105973297|NCT02649855|365561796|FG002|Overall Study|Initiate new treatment|0|||
105973298|NCT02818036|365561797|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
105973299|NCT02818036|365561798|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
105973300|NCT02818036|365561797|FG000|Overall Study|Withdrawal by Subject|1|||
105973301|NCT02818036|365561798|FG001|Overall Study|Withdrawal by Subject|0|||
105973302|NCT01038713|365561799|FG000|Overall Study|Patient to hospice|1|||
105973303|NCT01038713|365561800|FG001|Overall Study|Patient to hospice|1|||
105973304|NCT01038713|365561801|FG002|Overall Study|Patient to hospice|1|||
105973305|NCT01038713|365561799|FG000|Overall Study|Lost to Follow-up|3|||
105973306|NCT01038713|365561800|FG001|Overall Study|Lost to Follow-up|0|||
105973307|NCT01038713|365561801|FG002|Overall Study|Lost to Follow-up|0|||
105973308|NCT01038713|365561799|FG000|Overall Study|Neuroendocrine Tumor|0|||
105973309|NCT01038713|365561800|FG001|Overall Study|Neuroendocrine Tumor|1|||
105973310|NCT01038713|365561801|FG002|Overall Study|Neuroendocrine Tumor|0|||
105973311|NCT01038713|365561799|FG000|Overall Study|died from PEP|0|||
105973312|NCT01038713|365561800|FG001|Overall Study|died from PEP|1|||
105973313|NCT01038713|365561801|FG002|Overall Study|died from PEP|0|||
105973314|NCT01038713|365561799|FG000|Overall Study|Autoimmune Pancreatitis|1|||
105973315|NCT01038713|365561800|FG001|Overall Study|Autoimmune Pancreatitis|0|||
105973316|NCT01038713|365561801|FG002|Overall Study|Autoimmune Pancreatitis|0|||
105973317|NCT01154283|365561802|FG000|0-6 Weeks|Withdrawal by Subject|7|||
105973318|NCT01154283|365561803|FG001|0-6 Weeks|Withdrawal by Subject|2|||
105973319|NCT01154283|365561802|FG000|0-6 Weeks|Death|0|||
105973320|NCT01154283|365561803|FG001|0-6 Weeks|Death|1|||
105973321|NCT01154283|365561802|FG000|7-12 Weeks|Death|1|||
105973322|NCT01154283|365561803|FG001|7-12 Weeks|Death|0|||
105973323|NCT01154283|365561802|FG000|7-12 Weeks|Withdrawal by Subject|0|||
105973324|NCT01154283|365561803|FG001|7-12 Weeks|Withdrawal by Subject|1|||
105973325|NCT01527383|365561804|FG000|Overall Study|Adverse Event|5|||
105973326|NCT01527383|365561805|FG001|Overall Study|Adverse Event|0|||
105973327|NCT01527383|365561804|FG000|Overall Study|Lost to Follow-up|3|||
105973328|NCT01527383|365561805|FG001|Overall Study|Lost to Follow-up|0|||
105973329|NCT01527383|365561804|FG000|Overall Study|Physician Decision|2|||
105973330|NCT01527383|365561805|FG001|Overall Study|Physician Decision|0|||
105973331|NCT01527383|365561804|FG000|Overall Study|Pregnancy|1|||
105973332|NCT01527383|365561805|FG001|Overall Study|Pregnancy|0|||
105973333|NCT01527383|365561804|FG000|Overall Study|Protocol Violation|1|||
105973334|NCT01527383|365561805|FG001|Overall Study|Protocol Violation|0|||
105973335|NCT01527383|365561804|FG000|Overall Study|Screen failure|1|||
105973336|NCT01527383|365561805|FG001|Overall Study|Screen failure|0|||
105973337|NCT01527383|365561804|FG000|Overall Study|Participant moved|0|||
105973338|NCT01527383|365561805|FG001|Overall Study|Participant moved|1|||
105973339|NCT01527383|365561804|FG000|Overall Study|Withdrawal by Subject|2|||
105973340|NCT01527383|365561805|FG001|Overall Study|Withdrawal by Subject|3|||
105973341|NCT00642369|365564003|FG000|Overall Study|Adverse Event|2|||
105973342|NCT00642369|365564004|FG001|Overall Study|Adverse Event|3|||
105973343|NCT00642369|365564003|FG000|Overall Study|Withdrawal by Subject|1|||
105973344|NCT00642369|365564004|FG001|Overall Study|Withdrawal by Subject|0|||
105973345|NCT00642369|365564003|FG000|Overall Study|misdiagnosis|0|||
105973346|NCT00642369|365564004|FG001|Overall Study|misdiagnosis|1|||
105973347|NCT00642369|365564003|FG000|Overall Study|Lack of Efficacy|2|||
105973348|NCT00642369|365564004|FG001|Overall Study|Lack of Efficacy|2|||
105973349|NCT00996281|365564006|FG000|Overall Study|Adverse Event|75|||
105973350|NCT00996281|365564007|FG001|Overall Study|Adverse Event|37|||
105973351|NCT00996281|365564006|FG000|Overall Study|Major Protocol Deviation|6|||
106025545|NCT00402740|365758591|FG000|Overall Study|Lost to Follow-up|6|||
106025546|NCT00402740|365758591|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
106025547|NCT00402740|365758591|FG000|Overall Study|Subject disposition unknown.|1|||
105849393|NCT01335997|365107703|FG001|Period I and II|Protocol Violation|10|||
105849394|NCT01335997|365107702|FG000|Period I and II|Physician Decision|2|||
105849395|NCT01335997|365107703|FG001|Period I and II|Physician Decision|1|||
105849396|NCT01335997|365107702|FG000|Period III|Adverse Event|0|||
105849397|NCT01335997|365107703|FG001|Period III|Adverse Event|2|||
105849398|NCT01335997|365107702|FG000|Period III|Study Terminated by Sponsor|77|||
105849399|NCT01335997|365107703|FG001|Period III|Study Terminated by Sponsor|76|||
105849400|NCT01335997|365107702|FG000|Period III|Protocol Violation|0|||
105849401|NCT01335997|365107703|FG001|Period III|Protocol Violation|1|||
105849402|NCT01335997|365107702|FG000|Period III|Lost to Follow-up|1|||
105849403|NCT01335997|365107703|FG001|Period III|Lost to Follow-up|0|||
105849404|NCT00988065|365107705|FG000|Overall Study|Adverse Event|4|||
105849405|NCT00988065|365107706|FG001|Overall Study|Adverse Event|10|||
105849406|NCT00988065|365107707|FG002|Overall Study|Adverse Event|2|||
105849407|NCT00988065|365107705|FG000|Overall Study|Lost to Follow-up|1|||
105849408|NCT00988065|365107706|FG001|Overall Study|Lost to Follow-up|2|||
105849409|NCT00988065|365107707|FG002|Overall Study|Lost to Follow-up|2|||
105849410|NCT00988065|365107705|FG000|Overall Study|Subject withdrew consent|3|||
105849411|NCT00988065|365107706|FG001|Overall Study|Subject withdrew consent|5|||
105849412|NCT00988065|365107707|FG002|Overall Study|Subject withdrew consent|2|||
105849413|NCT00988065|365107705|FG000|Overall Study|Noncompliance with protocol|5|||
105849414|NCT00988065|365107706|FG001|Overall Study|Noncompliance with protocol|6|||
105849415|NCT00988065|365107707|FG002|Overall Study|Noncompliance with protocol|9|||
105849416|NCT01229735|365107708|FG000|Overall Study|Lack of Efficacy|8|||
105849417|NCT01229735|365107709|FG001|Overall Study|Lack of Efficacy|8|||
105849418|NCT01229735|365107708|FG000|Overall Study|Protocol Violation|13|||
105849419|NCT01229735|365107709|FG001|Overall Study|Protocol Violation|8|||
105849420|NCT01229735|365107708|FG000|Overall Study|Lost to Follow-up|0|||
105849421|NCT01229735|365107709|FG001|Overall Study|Lost to Follow-up|2|||
105849422|NCT01229735|365107708|FG000|Overall Study|Withdrawal by Subject|18|||
105849423|NCT01229735|365107709|FG001|Overall Study|Withdrawal by Subject|17|||
105849424|NCT01229735|365107708|FG000|Overall Study|Other Reason|13|||
105849425|NCT01229735|365107709|FG001|Overall Study|Other Reason|10|||
105849426|NCT01229735|365107708|FG000|Overall Study|SAE, non-fatal|0|||
105849427|NCT01229735|365107709|FG001|Overall Study|SAE, non-fatal|4|||
105849428|NCT01229735|365107708|FG000|Overall Study|AE, non-serious non-fatal|13|||
105849429|NCT01229735|365107709|FG001|Overall Study|AE, non-serious non-fatal|17|||
105849430|NCT01229735|365107708|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
105849431|NCT01229735|365107709|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
105849432|NCT02130882|365107710|FG000|Overall Study|Withdrawal by Subject|0|||
105849433|NCT02130882|365107711|FG001|Overall Study|Withdrawal by Subject|1|||
105849434|NCT03734666|365107721|FG000|Overall Study|Other|7|||
105849435|NCT03734666|365107722|FG001|Overall Study|Other|4|||
105849436|NCT03734666|365107721|FG000|Overall Study|Lost to Follow-up|12|||
105849437|NCT03734666|365107722|FG001|Overall Study|Lost to Follow-up|12|||
105849438|NCT00975286|365107726|FG000|Overall Study|Adverse Event|9|||
105849439|NCT00975286|365107727|FG001|Overall Study|Adverse Event|19|||
105849440|NCT00975286|365107726|FG000|Overall Study|Protocol Violation|1|||
105849441|NCT00975286|365107727|FG001|Overall Study|Protocol Violation|2|||
105849442|NCT00975286|365107726|FG000|Overall Study|Withdrawal by Subject|0|||
105849443|NCT00975286|365107727|FG001|Overall Study|Withdrawal by Subject|2|||
105849444|NCT00975286|365107726|FG000|Overall Study|Familial and Personal Reasons|2|||
105849445|NCT00975286|365107727|FG001|Overall Study|Familial and Personal Reasons|2|||
105849446|NCT00975286|365107726|FG000|Overall Study|Poor Compliance to Protocol|0|||
106025548|NCT01028300|365758592|FG000|Overall Study|Study Terminated|4|||
106025549|NCT02703337|365758595|FG000|Period One (Part A)|Withdrawal by Subject|0|||
106025550|NCT02703337|365758596|FG001|Period One (Part A)|Withdrawal by Subject|0|||
106025551|NCT02703337|365758597|FG002|Period One (Part A)|Withdrawal by Subject|0|||
106025552|NCT02703337|365758598|FG003|Period One (Part A)|Withdrawal by Subject|0|||
106025553|NCT02703337|365758599|FG004|Period One (Part A)|Withdrawal by Subject|1|||
106025554|NCT02703337|365758600|FG005|Period One (Part A)|Withdrawal by Subject|0|||
106025555|NCT02703337|365758601|FG006|Period One (Part A)|Withdrawal by Subject|0|||
105849447|NCT00975286|365107727|FG001|Overall Study|Poor Compliance to Protocol|2|||
105849448|NCT00975286|365107726|FG000|Overall Study|Sponsor Decision|0|||
105849449|NCT00975286|365107727|FG001|Overall Study|Sponsor Decision|2|||
105849450|NCT02980874|365107731|FG000|Overall Study|Adverse Event|2|||
105849451|NCT02980874|365107732|FG001|Overall Study|Adverse Event|7|||
105849452|NCT02980874|365107731|FG000|Overall Study|Withdrawal by Subject|7|||
105849453|NCT02980874|365107732|FG001|Overall Study|Withdrawal by Subject|2|||
105849454|NCT02980874|365107731|FG000|Overall Study|Lost to Follow-up|5|||
105849455|NCT02980874|365107732|FG001|Overall Study|Lost to Follow-up|5|||
106025556|NCT02703337|365758602|FG007|Period One (Part A)|Withdrawal by Subject|0|||
106025557|NCT01214395|365758608|FG000|Overall Study|All patients had infection|5|||
106025558|NCT02034409|365758609|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
105973352|NCT00996281|365564007|FG001|Overall Study|Major Protocol Deviation|7|||
105973353|NCT00996281|365564006|FG000|Overall Study|Lost to Follow-up|14|||
105973354|NCT00996281|365564007|FG001|Overall Study|Lost to Follow-up|16|||
105973355|NCT00996281|365564006|FG000|Overall Study|Withdrawal by Subject|31|||
105973356|NCT00996281|365564007|FG001|Overall Study|Withdrawal by Subject|20|||
105973357|NCT00996281|365564006|FG000|Overall Study|Lack of Efficacy|0|||
105973358|NCT00996281|365564007|FG001|Overall Study|Lack of Efficacy|2|||
105973359|NCT00996281|365564006|FG000|Overall Study|Other|5|||
105973360|NCT00996281|365564007|FG001|Overall Study|Other|7|||
105973361|NCT03383783|365564008|FG000|Overall Study|Withdrawal by Subject|2|||
105973362|NCT00794365|365564009|FG000|Overall Study|Lost to Follow-up|38|||
105973363|NCT00794365|365564009|FG000|Overall Study|Other|17|||
105973364|NCT00794365|365564009|FG000|Overall Study|Poor Compliance|11|||
105973365|NCT00794365|365564009|FG000|Overall Study|Adverse Event|10|||
105973366|NCT00794365|365564009|FG000|Overall Study|Lack of Efficacy|3|||
105973367|NCT00856206|365564010|FG000|Overall Study|Protocol Violation|6|||
105973368|NCT00856206|365564011|FG001|Overall Study|Protocol Violation|18|||
105973369|NCT00856206|365564010|FG000|Overall Study|Adverse Event|10|||
105973370|NCT00856206|365564011|FG001|Overall Study|Adverse Event|46|||
105973371|NCT00856206|365564010|FG000|Overall Study|Lack of Efficacy|1|||
105973372|NCT00856206|365564011|FG001|Overall Study|Lack of Efficacy|2|||
105973373|NCT00856206|365564010|FG000|Overall Study|Withdrawal by Subject|15|||
105973374|NCT00856206|365564011|FG001|Overall Study|Withdrawal by Subject|36|||
105973375|NCT00856206|365564010|FG000|Overall Study|Lost to Follow-up|13|||
105973376|NCT00856206|365564011|FG001|Overall Study|Lost to Follow-up|39|||
105973377|NCT00856206|365564010|FG000|Overall Study|Death|2|||
105973378|NCT00856206|365564011|FG001|Overall Study|Death|2|||
105973379|NCT00856206|365564010|FG000|Overall Study|Decision by the Sponsor|4|||
105973380|NCT00856206|365564011|FG001|Overall Study|Decision by the Sponsor|8|||
105973381|NCT00856206|365564010|FG000|Overall Study|Other than specified above|3|||
105973382|NCT00856206|365564011|FG001|Overall Study|Other than specified above|10|||
105973383|NCT01170598|365564015|FG000|Overall Study|Withdrawal by Subject|1|||
105973384|NCT01170598|365564015|FG000|Overall Study|Death|3|||
105973385|NCT01170598|365564015|FG000|Overall Study|Lost to Follow-up|1|||
105973386|NCT01170598|365564015|FG000|Overall Study|Refused|1|||
105973387|NCT02119156|365564016|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
105973388|NCT02119156|365564017|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
105973389|NCT02119156|365564018|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
105973390|NCT02119156|365564016|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
105973391|NCT02119156|365564017|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
105973392|NCT02119156|365564018|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
105973393|NCT02119156|365564016|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
105973394|NCT02119156|365564017|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
105973395|NCT02119156|365564018|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
105973396|NCT02119156|365564016|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
105973397|NCT02119156|365564017|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
105973398|NCT02119156|365564018|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
105973399|NCT02119156|365564016|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
105973400|NCT02119156|365564017|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
105973401|NCT02119156|365564018|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
105973402|NCT02780856|365564021|FG000|Overall Study|Lost to Follow-up|1|||
105973403|NCT03500172|365564024|FG000|Period 1: Baseline Randomization|Death|0|||
105973404|NCT03500172|365564025|FG001|Period 1: Baseline Randomization|Death|0|||
105973405|NCT03500172|365564026|FG002|Period 1: Baseline Randomization|Death|0|||
105849456|NCT02980874|365107731|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
105849457|NCT02980874|365107732|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
105849458|NCT02980874|365107731|FG000|Overall Study|Unknown study completion status|1|||
105849459|NCT02980874|365107732|FG001|Overall Study|Unknown study completion status|0|||
105849460|NCT03295318|365109523|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
105849461|NCT03295318|365109524|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
105849462|NCT03295318|365109525|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
105973406|NCT03500172|365564027|FG003|Period 1: Baseline Randomization|Death|0|||
105973407|NCT03500172|365564028|FG004|Period 1: Baseline Randomization|Death|0|||
105973408|NCT03500172|365564029|FG005|Period 1: Baseline Randomization|Death|0|||
105973409|NCT03500172|365564030|FG006|Period 1: Baseline Randomization|Death|0|||
105973410|NCT03500172|365564031|FG007|Period 1: Baseline Randomization|Death|0|||
105973411|NCT03500172|365564032|FG008|Period 1: Baseline Randomization|Death|0|||
105973412|NCT03500172|365564033|FG009|Period 1: Baseline Randomization|Death|2|||
105973413|NCT03500172|365564034|FG010|Period 1: Baseline Randomization|Death|0|||
105973414|NCT03500172|365564024|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
105849463|NCT03295318|365109523|FG000|Overall Study|Death|1|||
105849464|NCT03295318|365109524|FG001|Overall Study|Death|1|||
105849465|NCT03295318|365109525|FG002|Overall Study|Death|1|||
105849466|NCT03295318|365109523|FG000|Overall Study|Protocol Violation|4|||
105849467|NCT03295318|365109524|FG001|Overall Study|Protocol Violation|3|||
105849468|NCT03295318|365109525|FG002|Overall Study|Protocol Violation|3|||
105849469|NCT03295318|365109523|FG000|Overall Study|Withdrawal by Subject|0|||
105849470|NCT03295318|365109524|FG001|Overall Study|Withdrawal by Subject|0|||
105849471|NCT03295318|365109525|FG002|Overall Study|Withdrawal by Subject|1|||
105849472|NCT03295318|365109523|FG000|Overall Study|Subject discontinued due to travel|0|||
105849473|NCT03295318|365109524|FG001|Overall Study|Subject discontinued due to travel|1|||
105849474|NCT03295318|365109525|FG002|Overall Study|Subject discontinued due to travel|0|||
105849475|NCT04908683|365109526|FG000|Overall Study|Failure to meet continuation criteria|34|||
105849476|NCT04908683|365109527|FG001|Overall Study|Failure to meet continuation criteria|22|||
105849477|NCT04908683|365109526|FG000|Overall Study|Initiated prohibited medication|3|||
105849478|NCT04908683|365109527|FG001|Overall Study|Initiated prohibited medication|0|||
105849479|NCT04908683|365109526|FG000|Overall Study|Randomized by mistake|1|||
105973415|NCT03500172|365564025|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
105973416|NCT03500172|365564026|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
105973417|NCT03500172|365564027|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
105973418|NCT03500172|365564028|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
105973419|NCT03500172|365564029|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
105973420|NCT03500172|365564030|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
105973421|NCT03500172|365564031|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
105973422|NCT03500172|365564032|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
105973423|NCT03500172|365564033|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
105973424|NCT03500172|365564034|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
105973425|NCT03500172|365564024|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
105973426|NCT03500172|365564025|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
105973427|NCT03500172|365564026|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
105973428|NCT03500172|365564027|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
105973429|NCT03500172|365564028|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
105973430|NCT03500172|365564029|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
105973431|NCT03500172|365564030|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
105973432|NCT03500172|365564031|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
105973433|NCT03500172|365564032|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
105973434|NCT03500172|365564033|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
105973435|NCT03500172|365564034|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
105973436|NCT03500172|365564024|FG000|Period 2: Re-Randomization|Death|0|||
105973437|NCT03500172|365564025|FG001|Period 2: Re-Randomization|Death|0|||
105973438|NCT03500172|365564026|FG002|Period 2: Re-Randomization|Death|0|||
105973439|NCT03500172|365564027|FG003|Period 2: Re-Randomization|Death|4|||
105973440|NCT03500172|365564028|FG004|Period 2: Re-Randomization|Death|2|||
105973441|NCT03500172|365564029|FG005|Period 2: Re-Randomization|Death|0|||
105973442|NCT03500172|365564030|FG006|Period 2: Re-Randomization|Death|5|||
105973443|NCT03500172|365564031|FG007|Period 2: Re-Randomization|Death|2|||
105973444|NCT03500172|365564032|FG008|Period 2: Re-Randomization|Death|0|||
105973445|NCT03500172|365564033|FG009|Period 2: Re-Randomization|Death|0|||
105973446|NCT03500172|365564034|FG010|Period 2: Re-Randomization|Death|0|||
105973447|NCT02536300|365564038|FG000|Overall Study|Investigator's Discretion|17|||
105973448|NCT02536300|365564039|FG001|Overall Study|Investigator's Discretion|11|||
105973449|NCT02536300|365564040|FG002|Overall Study|Investigator's Discretion|2|||
105973450|NCT02536300|365564038|FG000|Overall Study|Progressive Disease|11|||
105973451|NCT02536300|365564039|FG001|Overall Study|Progressive Disease|7|||
105973452|NCT02536300|365564040|FG002|Overall Study|Progressive Disease|6|||
105973453|NCT02536300|365564038|FG000|Overall Study|Study Terminated by Sponsor|6|||
105973454|NCT02536300|365564039|FG001|Overall Study|Study Terminated by Sponsor|4|||
105973455|NCT02536300|365564040|FG002|Overall Study|Study Terminated by Sponsor|7|||
105973456|NCT02536300|365564038|FG000|Overall Study|Death|7|||
105973457|NCT02536300|365564039|FG001|Overall Study|Death|0|||
105973458|NCT02536300|365564040|FG002|Overall Study|Death|5|||
105973459|NCT02536300|365564038|FG000|Overall Study|Withdrew Consent|4|||
106025559|NCT02034409|365758610|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
105849480|NCT04908683|365109527|FG001|Overall Study|Randomized by mistake|0|||
105849481|NCT04908683|365109526|FG000|Overall Study|Lost to Follow-up|679|||
105849482|NCT04908683|365109527|FG001|Overall Study|Lost to Follow-up|341|||
105849483|NCT04908683|365109526|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
105849484|NCT04908683|365109527|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
105849485|NCT04908683|365109526|FG000|Overall Study|Physician Decision|44|||
105849486|NCT04908683|365109527|FG001|Overall Study|Physician Decision|35|||
105849487|NCT04908683|365109526|FG000|Overall Study|Technical problems|12|||
105849488|NCT04908683|365109527|FG001|Overall Study|Technical problems|9|||
105849489|NCT04908683|365109526|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
105973460|NCT02536300|365564039|FG001|Overall Study|Withdrew Consent|2|||
105849490|NCT04908683|365109527|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
105849491|NCT04908683|365109526|FG000|Overall Study|Protocol Violation|2|||
105849492|NCT04908683|365109527|FG001|Overall Study|Protocol Violation|0|||
105849493|NCT04908683|365109526|FG000|Overall Study|Withdrawal by Subject|1188|||
105849494|NCT04908683|365109527|FG001|Overall Study|Withdrawal by Subject|570|||
105849495|NCT04908683|365109526|FG000|Overall Study|Site Closure by Sponsor|6|||
105849496|NCT04908683|365109527|FG001|Overall Study|Site Closure by Sponsor|3|||
105849497|NCT04908683|365109526|FG000|Overall Study|Adverse Event|21|||
105849498|NCT04908683|365109527|FG001|Overall Study|Adverse Event|11|||
105849499|NCT04908683|365109526|FG000|Overall Study|Death|101|||
105849500|NCT04908683|365109527|FG001|Overall Study|Death|61|||
105849501|NCT04908683|365109526|FG000|Overall Study|Sponsor's decision|14398|||
105849502|NCT04908683|365109527|FG001|Overall Study|Sponsor's decision|7205|||
105849503|NCT04908683|365109526|FG000|Overall Study|Other|92|||
105849504|NCT04908683|365109527|FG001|Overall Study|Other|50|||
105849505|NCT04908683|365109526|FG000|Overall Study|Randomized not vaccinated|108|||
105849506|NCT04908683|365109527|FG001|Overall Study|Randomized not vaccinated|52|||
105849507|NCT03047473|365109529|FG000|Overall Study|Lost to Follow-up|2|||
105849508|NCT06204887|365109530|FG000|Overall Study|Lost to Follow-up|3|||
105849509|NCT06204887|365109531|FG001|Overall Study|Lost to Follow-up|4|||
105849510|NCT06204887|365109532|FG002|Overall Study|Lost to Follow-up|1|||
105849511|NCT06204887|365109533|FG003|Overall Study|Lost to Follow-up|6|||
105849512|NCT02195479|365109534|FG000|Overall Study|Lost to Follow-up|3|||
105849513|NCT02195479|365109535|FG001|Overall Study|Lost to Follow-up|0|||
105849514|NCT02195479|365109534|FG000|Overall Study|Death|48|||
105849515|NCT02195479|365109535|FG001|Overall Study|Death|45|||
105849516|NCT02195479|365109534|FG000|Overall Study|Physician Decision|1|||
105849517|NCT02195479|365109535|FG001|Overall Study|Physician Decision|0|||
105849518|NCT02195479|365109534|FG000|Overall Study|Withdrawal by Subject|11|||
105849519|NCT02195479|365109535|FG001|Overall Study|Withdrawal by Subject|6|||
105849520|NCT02195479|365109534|FG000|Overall Study|Other|2|||
105849521|NCT02195479|365109535|FG001|Overall Study|Other|2|||
105849522|NCT02195479|365109534|FG000|Overall Study|Ongoing|291|||
105849523|NCT02195479|365109535|FG001|Overall Study|Ongoing|297|||
105849524|NCT03107026|365109538|FG000|Overall Study|Adverse Event|2|||
105849525|NCT03107026|365109539|FG001|Overall Study|Adverse Event|14|||
105849526|NCT03107026|365109540|FG002|Overall Study|Adverse Event|23|||
105849527|NCT03107026|365109538|FG000|Overall Study|Lost to Follow-up|12|||
105849528|NCT03107026|365109539|FG001|Overall Study|Lost to Follow-up|12|||
105849529|NCT03107026|365109540|FG002|Overall Study|Lost to Follow-up|13|||
105849530|NCT03107026|365109538|FG000|Overall Study|Protocol Violation|1|||
105849531|NCT03107026|365109539|FG001|Overall Study|Protocol Violation|2|||
105849532|NCT03107026|365109540|FG002|Overall Study|Protocol Violation|0|||
105849533|NCT03107026|365109538|FG000|Overall Study|Pregnancy|1|||
105849534|NCT03107026|365109539|FG001|Overall Study|Pregnancy|0|||
105849535|NCT03107026|365109540|FG002|Overall Study|Pregnancy|0|||
105849536|NCT03107026|365109538|FG000|Overall Study|Withdrawal by Subject|13|||
105849537|NCT03107026|365109539|FG001|Overall Study|Withdrawal by Subject|5|||
105849538|NCT03107026|365109540|FG002|Overall Study|Withdrawal by Subject|17|||
105849539|NCT03107026|365109538|FG000|Overall Study|non compliance with study visits|1|||
105849540|NCT03107026|365109539|FG001|Overall Study|non compliance with study visits|2|||
105849541|NCT03107026|365109540|FG002|Overall Study|non compliance with study visits|0|||
105849542|NCT03107026|365109538|FG000|Overall Study|non-compliance with study drug|2|||
105849543|NCT03107026|365109539|FG001|Overall Study|non-compliance with study drug|2|||
105849544|NCT03107026|365109540|FG002|Overall Study|non-compliance with study drug|3|||
105849545|NCT03107026|365109538|FG000|Overall Study|Physician Decision|0|||
105849546|NCT03107026|365109539|FG001|Overall Study|Physician Decision|1|||
105849547|NCT03107026|365109540|FG002|Overall Study|Physician Decision|0|||
105849548|NCT00573157|365109541|FG000|Overall Study|Adverse Event|3|||
105849549|NCT00573157|365109542|FG001|Overall Study|Adverse Event|1|||
105849550|NCT00573157|365109541|FG000|Overall Study|Other|1|||
105849551|NCT00573157|365109542|FG001|Overall Study|Other|1|||
105849552|NCT02358343|365109549|FG000|Screening Intervention|Death|0|||
105849553|NCT02358343|365109550|FG001|Screening Intervention|Death|2|||
106025560|NCT02034409|365758609|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
106025561|NCT02034409|365758610|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
105849554|NCT02358343|365109551|FG002|Screening Intervention|Death|0|||
105849555|NCT02358343|365109552|FG003|Screening Intervention|Death|0|||
105849556|NCT02358343|365109553|FG004|Screening Intervention|Death|0|||
105849557|NCT02358343|365109549|FG000|Screening Intervention|Withdrawal by Subject|1|||
105849558|NCT02358343|365109550|FG001|Screening Intervention|Withdrawal by Subject|0|||
105849559|NCT02358343|365109551|FG002|Screening Intervention|Withdrawal by Subject|0|||
105849560|NCT02358343|365109552|FG003|Screening Intervention|Withdrawal by Subject|0|||
105849561|NCT02358343|365109553|FG004|Screening Intervention|Withdrawal by Subject|0|||
105849562|NCT02358343|365109549|FG000|Screening Intervention|Determined Ineligible|5|||
105849563|NCT02358343|365109550|FG001|Screening Intervention|Determined Ineligible|6|||
105849564|NCT02358343|365109551|FG002|Screening Intervention|Determined Ineligible|0|||
105849565|NCT02358343|365109552|FG003|Screening Intervention|Determined Ineligible|0|||
105973461|NCT02536300|365564040|FG002|Overall Study|Withdrew Consent|0|||
105973462|NCT02536300|365564038|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
105973463|NCT02536300|365564039|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
105973464|NCT02536300|365564040|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
105973465|NCT02536300|365564038|FG000|Overall Study|Enrolled but Never Treated|0|||
105973466|NCT02536300|365564039|FG001|Overall Study|Enrolled but Never Treated|0|||
105973467|NCT02536300|365564040|FG002|Overall Study|Enrolled but Never Treated|1|||
105973468|NCT02536300|365564038|FG000|Overall Study|Non-compliance With Study Drug|1|||
106025562|NCT02034409|365758609|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
106025563|NCT02034409|365758610|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
106025564|NCT02034409|365758609|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
106025565|NCT02034409|365758610|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
106025566|NCT02034409|365758609|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
106025567|NCT02034409|365758610|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
106025568|NCT02034409|365758609|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
106025569|NCT02034409|365758610|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
106025570|NCT00946153|365758611|FG000|Phase 2|Adverse Event|0|||
106025571|NCT00946153|365758612|FG001|Phase 2|Adverse Event|0|||
106025572|NCT00946153|365758613|FG002|Phase 2|Adverse Event|0|||
106025573|NCT00946153|365758614|FG003|Phase 2|Adverse Event|0|||
106025574|NCT00946153|365758615|FG004|Phase 2|Adverse Event|6|||
106025575|NCT00946153|365758611|FG000|Phase 2|Need more reduction of dose|0|||
106025576|NCT00946153|365758612|FG001|Phase 2|Need more reduction of dose|0|||
106025577|NCT00946153|365758613|FG002|Phase 2|Need more reduction of dose|0|||
106025578|NCT00946153|365758614|FG003|Phase 2|Need more reduction of dose|0|||
106025579|NCT00946153|365758615|FG004|Phase 2|Need more reduction of dose|2|||
106025580|NCT00946153|365758611|FG000|Phase 2|Physician Decision|0|||
106025581|NCT00946153|365758612|FG001|Phase 2|Physician Decision|0|||
106025582|NCT00946153|365758613|FG002|Phase 2|Physician Decision|0|||
106025583|NCT00946153|365758614|FG003|Phase 2|Physician Decision|0|||
106025584|NCT00946153|365758615|FG004|Phase 2|Physician Decision|1|||
106025585|NCT00946153|365758611|FG000|Phase 2|14 days washout for recovery due to AE|0|||
106025586|NCT00946153|365758612|FG001|Phase 2|14 days washout for recovery due to AE|0|||
106025587|NCT00946153|365758613|FG002|Phase 2|14 days washout for recovery due to AE|0|||
106025588|NCT00946153|365758614|FG003|Phase 2|14 days washout for recovery due to AE|0|||
106025589|NCT00946153|365758615|FG004|Phase 2|14 days washout for recovery due to AE|4|||
106025590|NCT01030666|365758616|FG000|Overall Study|Lost to Follow-up|3|||
106025591|NCT01030666|365758617|FG001|Overall Study|Lost to Follow-up|2|||
106025592|NCT00934843|365758618|FG000|Overall Study|Protocol Violation|0|||
106025593|NCT00934843|365758619|FG001|Overall Study|Protocol Violation|1|||
106025594|NCT03698591|365758622|FG000|Overall Study|Withdrawal by Subject|2|||
106025595|NCT03698591|365758623|FG001|Overall Study|Withdrawal by Subject|2|||
106025596|NCT03698591|365758622|FG000|Overall Study|Failed drug screen|1|||
106025597|NCT03698591|365758623|FG001|Overall Study|Failed drug screen|1|||
106025598|NCT03698591|365758622|FG000|Overall Study|Failed health screen|0|||
106025599|NCT03698591|365758623|FG001|Overall Study|Failed health screen|1|||
106025600|NCT03698591|365758622|FG000|Overall Study|Ineligible for financial compensation|1|||
106025601|NCT03698591|365758623|FG001|Overall Study|Ineligible for financial compensation|0|||
106025602|NCT03698591|365758622|FG000|Overall Study|Equipment Error|1|||
106025603|NCT03698591|365758623|FG001|Overall Study|Equipment Error|0|||
106025604|NCT03698591|365758622|FG000|Overall Study|Could not establish TMS dosage|0|||
106025605|NCT03698591|365758623|FG001|Overall Study|Could not establish TMS dosage|1|||
106025606|NCT01011309|365758625|FG000|Overall Study|Adverse Event|2|||
106025607|NCT01011309|365758626|FG001|Overall Study|Adverse Event|1|||
106025608|NCT01011309|365758627|FG002|Overall Study|Adverse Event|2|||
106025609|NCT01011309|365758625|FG000|Overall Study|Lack of Efficacy|0|||
106025610|NCT01011309|365758626|FG001|Overall Study|Lack of Efficacy|1|||
106025611|NCT01011309|365758627|FG002|Overall Study|Lack of Efficacy|0|||
106025612|NCT01011309|365758625|FG000|Overall Study|Protocol Violation|0|||
106025613|NCT01011309|365758626|FG001|Overall Study|Protocol Violation|1|||
106025614|NCT01011309|365758627|FG002|Overall Study|Protocol Violation|3|||
106025615|NCT01338298|365758640|FG000|Overall Study|Withdrawal by Subject|1|||
106025616|NCT01338298|365758641|FG001|Overall Study|Withdrawal by Subject|1|||
106025617|NCT01338298|365758640|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
106025618|NCT01338298|365758641|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
106025619|NCT01338298|365758640|FG000|Overall Study|Administrative error|0|||
106025620|NCT01338298|365758641|FG001|Overall Study|Administrative error|1|||
106025621|NCT01338298|365758640|FG000|Overall Study|Positive symptom worsening|1|||
106025622|NCT01338298|365758641|FG001|Overall Study|Positive symptom worsening|0|||
106025623|NCT01338298|365758640|FG000|Overall Study|Depressive symptoms and nausea|1|||
105973469|NCT02536300|365564039|FG001|Overall Study|Non-compliance With Study Drug|0|||
106025624|NCT01338298|365758641|FG001|Overall Study|Depressive symptoms and nausea|0|||
105973470|NCT02536300|365564040|FG002|Overall Study|Non-compliance With Study Drug|0|||
106025625|NCT01338298|365758640|FG000|Overall Study|Non-adherence|1|||
105849566|NCT02358343|365109553|FG004|Screening Intervention|Determined Ineligible|0|||
105849567|NCT02358343|365109549|FG000|Comparative Efficacy Trial / Observation|Death|0|||
105849568|NCT02358343|365109550|FG001|Comparative Efficacy Trial / Observation|Death|0|||
105849569|NCT02358343|365109551|FG002|Comparative Efficacy Trial / Observation|Death|2|||
105849570|NCT02358343|365109552|FG003|Comparative Efficacy Trial / Observation|Death|0|||
106025626|NCT01338298|365758641|FG001|Overall Study|Non-adherence|0|||
106025627|NCT00557856|365758645|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
106025628|NCT00557856|365758646|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
106025629|NCT00557856|365758647|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
106025630|NCT00557856|365758648|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
106025631|NCT00557856|365758649|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
106025632|NCT00557856|365758650|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
106025633|NCT00557856|365758651|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
106025634|NCT00557856|365758652|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
106025635|NCT00557856|365758653|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
106025636|NCT00557856|365758645|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
106025637|NCT00557856|365758646|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
106025638|NCT00557856|365758647|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
106025639|NCT00557856|365758648|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
106025640|NCT00557856|365758649|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
106025641|NCT00557856|365758650|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
106025642|NCT00557856|365758651|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
106025643|NCT00557856|365758652|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
106025644|NCT00557856|365758653|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
106025645|NCT00557856|365758645|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
106025646|NCT00557856|365758646|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
106025647|NCT00557856|365758647|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
106025648|NCT00557856|365758648|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
106025649|NCT00557856|365758649|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
106025650|NCT00557856|365758650|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
106025651|NCT00557856|365758651|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
106025652|NCT00557856|365758652|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
106025653|NCT00557856|365758653|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
106025654|NCT00557856|365758645|FG000|Part 1: Dose Escalation Phase|Other|0|||
106025655|NCT00557856|365758646|FG001|Part 1: Dose Escalation Phase|Other|0|||
106025656|NCT00557856|365758647|FG002|Part 1: Dose Escalation Phase|Other|1|||
106025657|NCT00557856|365758648|FG003|Part 1: Dose Escalation Phase|Other|1|||
106025658|NCT00557856|365758649|FG004|Part 1: Dose Escalation Phase|Other|0|||
106025659|NCT00557856|365758650|FG005|Part 1: Dose Escalation Phase|Other|0|||
106025660|NCT00557856|365758651|FG006|Part 1: Dose Escalation Phase|Other|0|||
106025661|NCT00557856|365758652|FG007|Part 1: Dose Escalation Phase|Other|1|||
106025662|NCT00557856|365758653|FG008|Part 1: Dose Escalation Phase|Other|0|||
106025663|NCT00557856|365758645|FG000|Part 1: Dose Escalation Phase|Death|0|||
106025664|NCT00557856|365758646|FG001|Part 1: Dose Escalation Phase|Death|0|||
106025665|NCT00557856|365758647|FG002|Part 1: Dose Escalation Phase|Death|0|||
106025666|NCT00557856|365758648|FG003|Part 1: Dose Escalation Phase|Death|0|||
106025667|NCT00557856|365758649|FG004|Part 1: Dose Escalation Phase|Death|0|||
106025668|NCT00557856|365758650|FG005|Part 1: Dose Escalation Phase|Death|1|||
106025669|NCT00557856|365758651|FG006|Part 1: Dose Escalation Phase|Death|0|||
106025670|NCT00557856|365758652|FG007|Part 1: Dose Escalation Phase|Death|0|||
106025671|NCT00557856|365758653|FG008|Part 1: Dose Escalation Phase|Death|0|||
106025672|NCT00557856|365758645|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
106025673|NCT00557856|365758646|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
106025674|NCT00557856|365758647|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
106025675|NCT00557856|365758648|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
106025676|NCT00557856|365758649|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
106025677|NCT00557856|365758650|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
106025678|NCT00557856|365758651|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
106025679|NCT00557856|365758652|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
106025680|NCT00557856|365758653|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
106025681|NCT00557856|365758645|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
106150176|NCT03312907|366211472|FG000|Overall Study|Protocol Violation|2|||
106150177|NCT03312907|366211473|FG001|Overall Study|Protocol Violation|3|||
106150178|NCT03312907|366211474|FG002|Overall Study|Protocol Violation|4|||
106150179|NCT03312907|366211472|FG000|Overall Study|Lost to Follow-up|2|||
106150180|NCT03312907|366211473|FG001|Overall Study|Lost to Follow-up|3|||
106150181|NCT03312907|366211474|FG002|Overall Study|Lost to Follow-up|2|||
106150182|NCT03312907|366211472|FG000|Overall Study|Physician Decision|3|||
106150183|NCT03312907|366211473|FG001|Overall Study|Physician Decision|4|||
105973471|NCT02536300|365564038|FG000|Overall Study|Protocol Violation|0|||
105973472|NCT02536300|365564039|FG001|Overall Study|Protocol Violation|1|||
105973473|NCT02536300|365564040|FG002|Overall Study|Protocol Violation|0|||
105973474|NCT00585221|365564046|FG000|Overall Study|Protocol Violation|8|||
105973475|NCT00969761|365564047|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
105973476|NCT00969761|365564048|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105973477|NCT00969761|365564049|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105973478|NCT00969761|365564050|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
105973479|NCT00969761|365564051|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105973480|NCT00969761|365564052|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105973481|NCT00969761|365564053|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105973482|NCT00969761|365564054|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105973483|NCT00969761|365564055|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
105973484|NCT00969761|365564056|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
105973485|NCT00969761|365564057|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105973486|NCT00969761|365564058|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
105973487|NCT00969761|365564047|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973488|NCT00969761|365564048|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973489|NCT00969761|365564049|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
105973490|NCT00969761|365564050|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973491|NCT00969761|365564051|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973492|NCT00969761|365564052|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973493|NCT00969761|365564053|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973494|NCT00969761|365564054|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973495|NCT00969761|365564055|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973496|NCT00969761|365564056|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973497|NCT00969761|365564057|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973498|NCT00969761|365564058|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
105973499|NCT00969761|365564047|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973500|NCT00969761|365564048|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973501|NCT00969761|365564049|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
105973502|NCT00969761|365564050|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973503|NCT00969761|365564051|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973504|NCT00969761|365564052|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973505|NCT00969761|365564053|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973506|NCT00969761|365564054|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973507|NCT00969761|365564055|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973508|NCT00969761|365564056|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973509|NCT00969761|365564057|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973510|NCT00969761|365564058|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
105973511|NCT00969761|365564047|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973512|NCT00969761|365564048|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973513|NCT00969761|365564049|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973514|NCT00969761|365564050|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
106025682|NCT00557856|365758646|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
106025683|NCT00557856|365758647|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
106025684|NCT00557856|365758648|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
106025685|NCT00557856|365758649|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
106025686|NCT00557856|365758650|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
106025687|NCT00557856|365758651|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
106025688|NCT00557856|365758652|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
106025689|NCT00557856|365758653|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
106025690|NCT00557856|365758645|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
106025691|NCT00557856|365758646|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
106025692|NCT00557856|365758647|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
106025693|NCT00557856|365758648|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
106025694|NCT00557856|365758649|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
106025695|NCT00557856|365758650|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
106025696|NCT00557856|365758651|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
105973515|NCT00969761|365564051|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973516|NCT00969761|365564052|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973517|NCT00969761|365564053|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973518|NCT00969761|365564054|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973519|NCT00969761|365564055|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
105973520|NCT00969761|365564056|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973521|NCT00969761|365564057|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973522|NCT00969761|365564058|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
105973523|NCT00969761|365564047|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
105973524|NCT00969761|365564048|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105973525|NCT00969761|365564049|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
105973526|NCT00969761|365564050|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105973527|NCT00969761|365564051|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
105973528|NCT00969761|365564052|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105973529|NCT00969761|365564053|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105973530|NCT00969761|365564054|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
105973531|NCT00969761|365564055|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
105973532|NCT00969761|365564056|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
105973533|NCT00969761|365564057|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105973534|NCT00969761|365564058|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
105973535|NCT00969761|365564047|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105973536|NCT00969761|365564048|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105973537|NCT00969761|365564049|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105973538|NCT00969761|365564050|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
105973539|NCT00969761|365564051|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
105973540|NCT00969761|365564052|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105973541|NCT00969761|365564053|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
106025697|NCT00557856|365758652|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
106025698|NCT00557856|365758653|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
106025699|NCT00557856|365758645|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
106025700|NCT00557856|365758646|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
106025701|NCT00557856|365758647|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
106025702|NCT00557856|365758648|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
106025703|NCT00557856|365758649|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
106025704|NCT00557856|365758650|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
106025705|NCT00557856|365758651|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
106025706|NCT00557856|365758652|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
106025707|NCT00557856|365758653|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
106025708|NCT00557856|365758645|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
106025709|NCT00557856|365758646|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
106025710|NCT00557856|365758647|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
106025711|NCT00557856|365758648|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
106025712|NCT00557856|365758649|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
106025713|NCT00557856|365758650|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
106025714|NCT00557856|365758651|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
106025715|NCT00557856|365758652|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
106025716|NCT00557856|365758653|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
106025717|NCT00557856|365758645|FG000|Part 2: Exploratory Phase|Other|0|||
106025718|NCT00557856|365758646|FG001|Part 2: Exploratory Phase|Other|0|||
106025719|NCT00557856|365758647|FG002|Part 2: Exploratory Phase|Other|0|||
106025720|NCT00557856|365758648|FG003|Part 2: Exploratory Phase|Other|0|||
106025721|NCT00557856|365758649|FG004|Part 2: Exploratory Phase|Other|0|||
106025722|NCT00557856|365758650|FG005|Part 2: Exploratory Phase|Other|0|||
106025723|NCT00557856|365758651|FG006|Part 2: Exploratory Phase|Other|0|||
106025724|NCT00557856|365758652|FG007|Part 2: Exploratory Phase|Other|0|||
106025725|NCT00557856|365758653|FG008|Part 2: Exploratory Phase|Other|1|||
106025726|NCT00557856|365758645|FG000|Part 2: Exploratory Phase|Death|0|||
106025727|NCT00557856|365758646|FG001|Part 2: Exploratory Phase|Death|0|||
106025728|NCT00557856|365758647|FG002|Part 2: Exploratory Phase|Death|0|||
106025729|NCT00557856|365758648|FG003|Part 2: Exploratory Phase|Death|0|||
106025730|NCT00557856|365758649|FG004|Part 2: Exploratory Phase|Death|0|||
106025731|NCT00557856|365758650|FG005|Part 2: Exploratory Phase|Death|0|||
106025732|NCT00557856|365758651|FG006|Part 2: Exploratory Phase|Death|0|||
106025733|NCT00557856|365758652|FG007|Part 2: Exploratory Phase|Death|0|||
106025734|NCT00557856|365758653|FG008|Part 2: Exploratory Phase|Death|2|||
106025735|NCT00557856|365758645|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
106025736|NCT00557856|365758646|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
105973542|NCT00969761|365564054|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105973543|NCT00969761|365564055|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
106025737|NCT00557856|365758647|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
106025738|NCT00557856|365758648|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
106025739|NCT00557856|365758649|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
105849571|NCT02358343|365109553|FG004|Comparative Efficacy Trial / Observation|Death|0|||
105849572|NCT02358343|365109549|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
105849573|NCT02358343|365109550|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
105849574|NCT02358343|365109551|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
105849575|NCT02358343|365109552|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
105849576|NCT02358343|365109553|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
105849577|NCT02358343|365109549|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
105849578|NCT02358343|365109550|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
105849579|NCT02358343|365109551|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
105849580|NCT02358343|365109552|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
105849581|NCT02358343|365109553|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
105849582|NCT00090610|365109556|FG000|Overall Study|Withdrawal by Subject|1|||
105849583|NCT00090610|365109557|FG001|Overall Study|Withdrawal by Subject|1|||
105849584|NCT00807248|365109558|FG000|Overall Study|Adverse Event|1|||
105849585|NCT00807248|365109559|FG001|Overall Study|Adverse Event|2|||
105973544|NCT00969761|365564056|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
106150184|NCT03312907|366211474|FG002|Overall Study|Physician Decision|2|||
106150185|NCT03312907|366211472|FG000|Overall Study|Withdrawal by Subject|9|||
106150186|NCT03312907|366211473|FG001|Overall Study|Withdrawal by Subject|14|||
106150187|NCT03312907|366211474|FG002|Overall Study|Withdrawal by Subject|10|||
106150188|NCT03725722|366211475|FG000|Overall Study|Lack of Efficacy|2|||
106150189|NCT03725722|366211476|FG001|Overall Study|Lack of Efficacy|1|||
106150190|NCT03725722|366211477|FG002|Overall Study|Lack of Efficacy|2|||
106150191|NCT03725722|366211478|FG003|Overall Study|Lack of Efficacy|0|||
106150192|NCT03725722|366211479|FG004|Overall Study|Lack of Efficacy|2|||
106150193|NCT03725722|366211475|FG000|Overall Study|Adverse Event|2|||
106150194|NCT03725722|366211476|FG001|Overall Study|Adverse Event|2|||
106150195|NCT03725722|366211477|FG002|Overall Study|Adverse Event|1|||
106150196|NCT03725722|366211478|FG003|Overall Study|Adverse Event|0|||
106150197|NCT03725722|366211479|FG004|Overall Study|Adverse Event|6|||
106150198|NCT03725722|366211475|FG000|Overall Study|Withdrawal by Subject|4|||
106150199|NCT03725722|366211476|FG001|Overall Study|Withdrawal by Subject|1|||
106150200|NCT03725722|366211477|FG002|Overall Study|Withdrawal by Subject|0|||
106150201|NCT03725722|366211478|FG003|Overall Study|Withdrawal by Subject|4|||
106150202|NCT03725722|366211479|FG004|Overall Study|Withdrawal by Subject|4|||
106150203|NCT03725722|366211475|FG000|Overall Study|Lost to Follow-up|3|||
106150204|NCT03725722|366211476|FG001|Overall Study|Lost to Follow-up|1|||
106150205|NCT03725722|366211477|FG002|Overall Study|Lost to Follow-up|2|||
106150206|NCT03725722|366211478|FG003|Overall Study|Lost to Follow-up|2|||
106150207|NCT03725722|366211479|FG004|Overall Study|Lost to Follow-up|1|||
106150208|NCT03725722|366211475|FG000|Overall Study|Personal reasons|0|||
106150209|NCT03725722|366211476|FG001|Overall Study|Personal reasons|0|||
106150210|NCT03725722|366211477|FG002|Overall Study|Personal reasons|1|||
106150211|NCT03725722|366211478|FG003|Overall Study|Personal reasons|0|||
106150212|NCT03725722|366211479|FG004|Overall Study|Personal reasons|1|||
106150213|NCT03725722|366211475|FG000|Overall Study|COVID-19 situation|0|||
105849586|NCT00807248|365109560|FG002|Overall Study|Adverse Event|2|||
105849587|NCT00807248|365109561|FG003|Overall Study|Adverse Event|6|||
105849588|NCT00807248|365109558|FG000|Overall Study|Lack of Efficacy|14|||
105849589|NCT00807248|365109559|FG001|Overall Study|Lack of Efficacy|4|||
105849590|NCT00807248|365109560|FG002|Overall Study|Lack of Efficacy|8|||
105849591|NCT00807248|365109561|FG003|Overall Study|Lack of Efficacy|3|||
105849592|NCT00807248|365109558|FG000|Overall Study|Protocol Violation|0|||
105849593|NCT00807248|365109559|FG001|Overall Study|Protocol Violation|1|||
105849594|NCT00807248|365109560|FG002|Overall Study|Protocol Violation|1|||
105849595|NCT00807248|365109561|FG003|Overall Study|Protocol Violation|0|||
105849596|NCT00807248|365109558|FG000|Overall Study|Withdrawal of Consent|5|||
105849597|NCT00807248|365109559|FG001|Overall Study|Withdrawal of Consent|5|||
105849598|NCT00807248|365109560|FG002|Overall Study|Withdrawal of Consent|5|||
105849599|NCT00807248|365109561|FG003|Overall Study|Withdrawal of Consent|5|||
105849600|NCT00807248|365109558|FG000|Overall Study|Lost to Follow-up|1|||
105849601|NCT00807248|365109559|FG001|Overall Study|Lost to Follow-up|0|||
105849602|NCT00807248|365109560|FG002|Overall Study|Lost to Follow-up|0|||
105849603|NCT00807248|365109561|FG003|Overall Study|Lost to Follow-up|0|||
105849604|NCT00807248|365109558|FG000|Overall Study|Other Reason|0|||
105849605|NCT00807248|365109559|FG001|Overall Study|Other Reason|0|||
105849606|NCT00807248|365109560|FG002|Overall Study|Other Reason|2|||
105849607|NCT00807248|365109561|FG003|Overall Study|Other Reason|0|||
105849608|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Death|89|||
105849609|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Death|193|||
105849610|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Death|198|||
105849611|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
105973545|NCT00969761|365564057|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
106150214|NCT03725722|366211476|FG001|Overall Study|COVID-19 situation|1|||
106150215|NCT03725722|366211477|FG002|Overall Study|COVID-19 situation|0|||
106025740|NCT00557856|365758650|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
106025741|NCT00557856|365758651|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
106025742|NCT00557856|365758652|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
106025743|NCT00557856|365758653|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
106025744|NCT00881868|365758654|FG000|Overall Study|Adverse Event|0|||
106025745|NCT00881868|365758655|FG001|Overall Study|Adverse Event|1|||
106025746|NCT00881868|365758654|FG000|Overall Study|Lost to Follow-up|2|||
106025747|NCT00881868|365758655|FG001|Overall Study|Lost to Follow-up|1|||
106025748|NCT00881868|365758654|FG000|Overall Study|Physician Decision|4|||
106025749|NCT00881868|365758655|FG001|Overall Study|Physician Decision|0|||
106025750|NCT00881868|365758654|FG000|Overall Study|Protocol Violation|2|||
106025751|NCT00881868|365758655|FG001|Overall Study|Protocol Violation|0|||
106025752|NCT01217307|365759965|FG000|Overall Study|Withdrawal by Subject|0|||
106025753|NCT01217307|365759966|FG001|Overall Study|Withdrawal by Subject|1|||
106025754|NCT01657461|365759967|FG000|Overall Study|Death|9|||
106025755|NCT01657461|365759968|FG001|Overall Study|Death|12|||
106025756|NCT01657461|365759967|FG000|Overall Study|Lost to Follow-up|0|||
106025757|NCT01657461|365759968|FG001|Overall Study|Lost to Follow-up|3|||
106025758|NCT01657461|365759967|FG000|Overall Study|Physician Decision|0|||
106025759|NCT01657461|365759968|FG001|Overall Study|Physician Decision|2|||
106025760|NCT01657461|365759967|FG000|Overall Study|Withdrawal by Subject|1|||
106025761|NCT01657461|365759968|FG001|Overall Study|Withdrawal by Subject|3|||
106025762|NCT01868542|365759969|FG000|Overall Study|Protocol Violation|0|||
106025763|NCT01868542|365759970|FG001|Overall Study|Protocol Violation|1|||
106025764|NCT01868542|365759969|FG000|Overall Study|Unclassified|0|||
106025765|NCT01868542|365759970|FG001|Overall Study|Unclassified|1|||
106025766|NCT02156271|365759976|FG000|Overall Study|Physician Decision|4|||
106025767|NCT02156271|365759977|FG001|Overall Study|Physician Decision|3|||
106025768|NCT01221285|365759980|FG000|Overall Study|Withdrawal by Subject|1|||
106025769|NCT02123251|365759981|FG000|Overall Study|Death|1|||
106025770|NCT02123251|365759982|FG001|Overall Study|Death|1|||
106025771|NCT02123251|365759981|FG000|Overall Study|Withdrawal by Subject|0|||
106025772|NCT02123251|365759982|FG001|Overall Study|Withdrawal by Subject|3|||
106025773|NCT02123251|365759981|FG000|Overall Study|Lost Medicaid eligibility|29|||
106025774|NCT02123251|365759982|FG001|Overall Study|Lost Medicaid eligibility|22|||
106025775|NCT02123251|365759981|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
106025776|NCT02123251|365759982|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
106025777|NCT00409331|365759986|FG000|Overall Study|Physician Decision|1|||
106025778|NCT04657666|365759989|FG000|Period 1|Withdrawal of participant consent|2|||
106025779|NCT04657666|365759990|FG001|Period 1|Withdrawal of participant consent|1|||
106025780|NCT04657666|365759989|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
106025781|NCT04657666|365759990|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
106025782|NCT04657666|365759989|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
106025783|NCT04657666|365759990|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
106025784|NCT04657666|365759989|FG000|Period 2|Other|2|||
106025785|NCT04657666|365759990|FG001|Period 2|Other|0|||
106025786|NCT04657666|365759989|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
106025787|NCT04657666|365759990|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
106025788|NCT03319745|365759991|FG000|Overall Study|Death|1|||
106025789|NCT03319745|365759991|FG000|Overall Study|Toxicity Precluding Surgery|1|||
106025790|NCT01120782|365759992|FG000|Overall Study|Test article shipping error|11|||
106025791|NCT03255629|365759993|FG000|Overall Study|Adverse Event|1|||
106025792|NCT03255629|365759994|FG001|Overall Study|Adverse Event|0|||
106025793|NCT03255629|365759993|FG000|Overall Study|did not experience hypoglycemia|2|||
106025794|NCT03255629|365759994|FG001|Overall Study|did not experience hypoglycemia|1|||
106025795|NCT02082340|365759995|FG000|Overall Study|Lost to Follow-up|1|||
106025796|NCT02082340|365759996|FG001|Overall Study|Lost to Follow-up|1|||
106025797|NCT01625260|365759997|FG000|Overall Study|Adverse Event|3|||
106025798|NCT01625260|365759998|FG001|Overall Study|Adverse Event|0|||
106025799|NCT01625260|365759997|FG000|Overall Study|Study Terminated by Investigator|2|||
106025800|NCT01625260|365759998|FG001|Overall Study|Study Terminated by Investigator|0|||
106025801|NCT01625260|365759997|FG000|Overall Study|Disease Progression|2|||
106025802|NCT01625260|365759998|FG001|Overall Study|Disease Progression|0|||
106025803|NCT01625260|365759997|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
106025804|NCT01625260|365759998|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
106025805|NCT00635219|365759999|FG000|Overall Study|Adverse Event|12|||
106025806|NCT00635219|365760000|FG001|Overall Study|Adverse Event|10|||
106025807|NCT00635219|365760001|FG002|Overall Study|Adverse Event|18|||
106025808|NCT00635219|365760002|FG003|Overall Study|Adverse Event|15|||
106025809|NCT00635219|365760003|FG004|Overall Study|Adverse Event|19|||
106025810|NCT00635219|365759999|FG000|Overall Study|Lack of Efficacy|5|||
106025811|NCT00635219|365760000|FG001|Overall Study|Lack of Efficacy|6|||
106150216|NCT03725722|366211478|FG003|Overall Study|COVID-19 situation|0|||
106025812|NCT00635219|365760001|FG002|Overall Study|Lack of Efficacy|3|||
106025813|NCT00635219|365760002|FG003|Overall Study|Lack of Efficacy|4|||
106025814|NCT00635219|365760003|FG004|Overall Study|Lack of Efficacy|6|||
106150217|NCT03725722|366211479|FG004|Overall Study|COVID-19 situation|0|||
106150218|NCT03189524|366211480|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
106150219|NCT03189524|366211481|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
106150220|NCT03189524|366211482|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
106150221|NCT03189524|366211480|FG000|Overall Study|Death|2|||
106150222|NCT03189524|366211481|FG001|Overall Study|Death|2|||
106150223|NCT03189524|366211482|FG002|Overall Study|Death|1|||
106150224|NCT03189524|366211480|FG000|Overall Study|Lost to Follow-up|1|||
106150225|NCT03189524|366211481|FG001|Overall Study|Lost to Follow-up|0|||
106150226|NCT03189524|366211482|FG002|Overall Study|Lost to Follow-up|8|||
106150227|NCT03189524|366211480|FG000|Overall Study|Withdrawal by Subject|1|||
106150228|NCT03189524|366211481|FG001|Overall Study|Withdrawal by Subject|1|||
106150229|NCT03189524|366211482|FG002|Overall Study|Withdrawal by Subject|3|||
106150230|NCT03189524|366211480|FG000|Overall Study|Progressive Disease|0|||
106150231|NCT03189524|366211481|FG001|Overall Study|Progressive Disease|2|||
106150232|NCT03189524|366211482|FG002|Overall Study|Progressive Disease|0|||
106150233|NCT01780298|366211483|FG000|Overall Study|Physician Decision|1|||
106150234|NCT01780298|366211484|FG001|Overall Study|Physician Decision|5|||
106150235|NCT01780298|366211485|FG002|Overall Study|Physician Decision|1|||
106150236|NCT01780298|366211486|FG003|Overall Study|Physician Decision|1|||
106150237|NCT01780298|366211483|FG000|Overall Study|Subject not matched|1|||
106150238|NCT01780298|366211484|FG001|Overall Study|Subject not matched|0|||
106150239|NCT01780298|366211485|FG002|Overall Study|Subject not matched|1|||
106150240|NCT01780298|366211486|FG003|Overall Study|Subject not matched|0|||
106150241|NCT01780298|366211483|FG000|Overall Study|Adverse Event|0|||
106150242|NCT01780298|366211484|FG001|Overall Study|Adverse Event|0|||
106150243|NCT01780298|366211485|FG002|Overall Study|Adverse Event|2|||
106150244|NCT01780298|366211486|FG003|Overall Study|Adverse Event|0|||
106150245|NCT01843374|366211487|FG000|Overall Study|Death|155|||
106150246|NCT01843374|366211488|FG001|Overall Study|Death|313|||
106150247|NCT01843374|366211487|FG000|Overall Study|Withdrawal by Subject|14|||
106150248|NCT01843374|366211488|FG001|Overall Study|Withdrawal by Subject|20|||
106150249|NCT01843374|366211487|FG000|Overall Study|Withdrawing due to Other reason|20|||
106150250|NCT01843374|366211488|FG001|Overall Study|Withdrawing due to Other reason|46|||
106150251|NCT03613740|366211491|FG000|Overall Study|Lost to Follow-up|1|||
106150252|NCT03613740|366211492|FG001|Overall Study|Lost to Follow-up|1|||
105849612|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
105849613|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
105849614|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
105849615|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
105973546|NCT00969761|365564058|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
105973547|NCT00772369|365564061|FG000|Overall Study|Did not return record release form|1|||
105973548|NCT00554619|365564062|FG000|Overall Study|Adverse Event|1|||
105973549|NCT00554619|365564062|FG000|Overall Study|Physician Decision|1|||
105973550|NCT00554619|365564062|FG000|Overall Study|Liver Function Test Abnormality|1|||
105973551|NCT00907803|365564066|FG000|Overall Study|Withdrawal of consent - long commute|1|||
105973552|NCT00907803|365564067|FG001|Overall Study|Withdrawal of consent - long commute|0|||
105973553|NCT00907803|365564068|FG002|Overall Study|Withdrawal of consent - long commute|0|||
105973554|NCT00907803|365564066|FG000|Overall Study|Adverse Event|2|||
105973555|NCT00907803|365564067|FG001|Overall Study|Adverse Event|0|||
105973556|NCT00907803|365564068|FG002|Overall Study|Adverse Event|0|||
105973557|NCT00907803|365564066|FG000|Overall Study|Withdrawal by Subject|0|||
105973558|NCT00907803|365564067|FG001|Overall Study|Withdrawal by Subject|1|||
105973559|NCT00907803|365564068|FG002|Overall Study|Withdrawal by Subject|0|||
105973560|NCT00907803|365564066|FG000|Overall Study|Lost to Follow-up|0|||
105973561|NCT00907803|365564067|FG001|Overall Study|Lost to Follow-up|1|||
105973562|NCT00907803|365564068|FG002|Overall Study|Lost to Follow-up|0|||
105973563|NCT00907803|365564066|FG000|Overall Study|Protocol Violation|0|||
106150253|NCT04279574|366211493|FG000|Overall Study|Death|1|||
106150254|NCT04279574|366211494|FG001|Overall Study|Death|0|||
105849616|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
105849617|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
105849618|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
106150255|NCT04279574|366211493|FG000|Overall Study|lost restoration, tooth fracture|1|||
106150256|NCT04279574|366211494|FG001|Overall Study|lost restoration, tooth fracture|0|||
106150257|NCT04279574|366211493|FG000|Overall Study|Lost to Follow-up|0|||
106150258|NCT04279574|366211494|FG001|Overall Study|Lost to Follow-up|1|||
106150259|NCT01693120|366211496|FG000|Enrollment|Lost to Follow-up|1|||
106150260|NCT01693120|366211496|FG000|Enrollment|Withdrawal by Subject|10|||
105973564|NCT00907803|365564067|FG001|Overall Study|Protocol Violation|1|||
105973565|NCT00907803|365564068|FG002|Overall Study|Protocol Violation|0|||
105973566|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Death|1|||
105973567|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Death|1|||
105973568|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Death|0|||
105973569|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Death|0|||
105849619|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
105849620|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
105849621|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
105849622|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
105849623|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
105849624|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
105849625|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
105849626|NCT02031458|365109562|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
105849627|NCT02031458|365109563|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
105849628|NCT02031458|365109564|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
105849629|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Death|36|||
105849630|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Death|87|||
105849631|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Death|100|||
105849632|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
105849633|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
105849634|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
105849635|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Physician Decision|0|||
105849636|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Physician Decision|1|||
105849637|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Physician Decision|0|||
105849638|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
105849639|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
105849640|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
105849641|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
105849642|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
105849643|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
105849644|NCT02031458|365109562|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
105849645|NCT02031458|365109563|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
105849646|NCT02031458|365109564|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
105849647|NCT02031458|365109562|FG000|Baseline to May 8, 2015|On Treatment|43|||
105849648|NCT02031458|365109563|FG001|Baseline to May 8, 2015|On Treatment|81|||
105849649|NCT02031458|365109564|FG002|Baseline to May 8, 2015|On Treatment|73|||
105849650|NCT02031458|365109562|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
105849651|NCT02031458|365109563|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
105849652|NCT02031458|365109564|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
105849653|NCT01167257|365109565|FG000|Overall Study|Lost to Follow-up|2|||
105849654|NCT01167257|365109566|FG001|Overall Study|Lost to Follow-up|2|||
105849655|NCT01167257|365109565|FG000|Overall Study|Withdrew consent|1|||
105849656|NCT01167257|365109566|FG001|Overall Study|Withdrew consent|1|||
105849657|NCT04305587|365109567|FG000|Overall Study|Withdrawal by Subject|0|||
105849658|NCT04305587|365109568|FG001|Overall Study|Withdrawal by Subject|0|||
105849659|NCT04305587|365109569|FG002|Overall Study|Withdrawal by Subject|0|||
105849660|NCT04305587|365109570|FG003|Overall Study|Withdrawal by Subject|1|||
105849661|NCT04305587|365109571|FG004|Overall Study|Withdrawal by Subject|0|||
105849662|NCT04305587|365109572|FG005|Overall Study|Withdrawal by Subject|0|||
105849663|NCT04305587|365109573|FG006|Overall Study|Withdrawal by Subject|0|||
105849664|NCT04305587|365109574|FG007|Overall Study|Withdrawal by Subject|0|||
105849665|NCT04305587|365109575|FG008|Overall Study|Withdrawal by Subject|0|||
105849666|NCT01687478|365109576|FG000|Overall Study|Adverse Event|3|||
105849667|NCT01687478|365109577|FG001|Overall Study|Adverse Event|10|||
105849668|NCT01687478|365109576|FG000|Overall Study|Lost to Follow-up|1|||
105849669|NCT01687478|365109577|FG001|Overall Study|Lost to Follow-up|3|||
105849670|NCT01687478|365109576|FG000|Overall Study|Protocol Violation|0|||
105849671|NCT01687478|365109577|FG001|Overall Study|Protocol Violation|2|||
105849672|NCT01687478|365109576|FG000|Overall Study|Withdrawal by Subject|21|||
105849673|NCT01687478|365109577|FG001|Overall Study|Withdrawal by Subject|19|||
105849674|NCT01687478|365109576|FG000|Overall Study|Physician Decision|1|||
105849675|NCT01687478|365109577|FG001|Overall Study|Physician Decision|3|||
105849676|NCT01687478|365109576|FG000|Overall Study|Entry Criteria Not Met|6|||
105849677|NCT01687478|365109577|FG001|Overall Study|Entry Criteria Not Met|2|||
105849678|NCT02049450|365109578|FG000|Overall Study|Adverse Event|2|||
105849679|NCT02049450|365109578|FG000|Overall Study|Withdrawal by Subject|1|||
105849680|NCT02049450|365109578|FG000|Overall Study|Patients/guardian decision|1|||
105849681|NCT00577395|365109579|FG000|Overall Study|Study was terminated early by Sponsor|7|||
105973570|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Death|1|||
105973571|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Death|0|||
105973572|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Death|0|||
105973573|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Death|0|||
105973574|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Death|0|||
105973575|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Death|0|||
105973576|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
105973577|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
105973578|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
105849682|NCT00577395|365109580|FG001|Overall Study|Study was terminated early by Sponsor|6|||
106150261|NCT01693120|366211496|FG000|Enrollment|Protocol Violation|46|||
106025815|NCT00635219|365759999|FG000|Overall Study|Non-compliance With Study Product|0|||
106025816|NCT00635219|365760000|FG001|Overall Study|Non-compliance With Study Product|0|||
106025817|NCT00635219|365760001|FG002|Overall Study|Non-compliance With Study Product|0|||
106025818|NCT00635219|365760002|FG003|Overall Study|Non-compliance With Study Product|2|||
106025819|NCT00635219|365760003|FG004|Overall Study|Non-compliance With Study Product|1|||
106025820|NCT00635219|365759999|FG000|Overall Study|Protocol Violation|0|||
106025821|NCT00635219|365760000|FG001|Overall Study|Protocol Violation|2|||
106025822|NCT00635219|365760001|FG002|Overall Study|Protocol Violation|3|||
106025823|NCT00635219|365760002|FG003|Overall Study|Protocol Violation|2|||
106025824|NCT00635219|365760003|FG004|Overall Study|Protocol Violation|4|||
106025825|NCT00635219|365759999|FG000|Overall Study|Withdrawal of Consent|8|||
106025826|NCT00635219|365760000|FG001|Overall Study|Withdrawal of Consent|6|||
106025827|NCT00635219|365760001|FG002|Overall Study|Withdrawal of Consent|8|||
106025828|NCT00635219|365760002|FG003|Overall Study|Withdrawal of Consent|11|||
106025829|NCT00635219|365760003|FG004|Overall Study|Withdrawal of Consent|8|||
106025830|NCT00635219|365759999|FG000|Overall Study|Lost to Follow-up|0|||
106025831|NCT00635219|365760000|FG001|Overall Study|Lost to Follow-up|0|||
106025832|NCT00635219|365760001|FG002|Overall Study|Lost to Follow-up|2|||
106025833|NCT00635219|365760002|FG003|Overall Study|Lost to Follow-up|0|||
106025834|NCT00635219|365760003|FG004|Overall Study|Lost to Follow-up|3|||
106025835|NCT00635219|365759999|FG000|Overall Study|Administrative or Other Reasons|0|||
106025836|NCT00635219|365760000|FG001|Overall Study|Administrative or Other Reasons|1|||
106025837|NCT00635219|365760001|FG002|Overall Study|Administrative or Other Reasons|1|||
106025838|NCT00635219|365760002|FG003|Overall Study|Administrative or Other Reasons|0|||
105849683|NCT01206101|365109585|FG000|Overall Study|Adverse Event|1|||
105849684|NCT01206101|365109586|FG001|Overall Study|Adverse Event|0|||
105849685|NCT01206101|365109585|FG000|Overall Study|Physician Decision|0|||
105849686|NCT01206101|365109586|FG001|Overall Study|Physician Decision|1|||
105849687|NCT01206101|365109585|FG000|Overall Study|Unclassified|1|||
105849688|NCT01206101|365109586|FG001|Overall Study|Unclassified|0|||
105849689|NCT01248013|365109589|FG000|Overall Study|Withdrawal by Subject|14|||
105849690|NCT01859130|365109590|FG000|Overall Study|Death|4|||
105849691|NCT01859130|365109590|FG000|Overall Study|Lost to Follow-up|16|||
105849692|NCT01859130|365109590|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
105849693|NCT01859130|365109590|FG000|Overall Study|Physician Decision|6|||
105849694|NCT01859130|365109590|FG000|Overall Study|Withdrawal by Subject|17|||
105849695|NCT01859130|365109590|FG000|Overall Study|Adverse Event|11|||
105849696|NCT04711902|365109592|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849697|NCT04711902|365109593|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849698|NCT04711902|365109594|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
105849699|NCT04711902|365109595|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849700|NCT04711902|365109596|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849701|NCT04711902|365109597|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
105849702|NCT00368979|365109598|FG000|Overall Study|Adverse Event|9|||
105849703|NCT00368979|365109599|FG001|Overall Study|Adverse Event|16|||
105849704|NCT00368979|365109598|FG000|Overall Study|Lack of Efficacy|5|||
105849705|NCT00368979|365109599|FG001|Overall Study|Lack of Efficacy|3|||
105849706|NCT00368979|365109598|FG000|Overall Study|Other|3|||
105849707|NCT00368979|365109599|FG001|Overall Study|Other|1|||
105849708|NCT00368979|365109598|FG000|Overall Study|Lost to Follow-up|1|||
105849709|NCT00368979|365109599|FG001|Overall Study|Lost to Follow-up|0|||
105849710|NCT00368979|365109598|FG000|Overall Study|Protocol Violation|2|||
105849711|NCT00368979|365109599|FG001|Overall Study|Protocol Violation|1|||
105849712|NCT00368979|365109598|FG000|Overall Study|Withdrawal by Subject|5|||
105849713|NCT00368979|365109599|FG001|Overall Study|Withdrawal by Subject|9|||
105849714|NCT01462318|365109603|FG000|Main Study / TP-DI Study|Other|2|||
105849715|NCT01462318|365109604|FG001|Main Study / TP-DI Study|Other|0|||
105849716|NCT01462318|365109605|FG002|Main Study / TP-DI Study|Other|0|||
105849717|NCT01462318|365109603|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
105849718|NCT01462318|365109604|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
105849719|NCT01462318|365109605|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
105849720|NCT01462318|365109603|FG000|Main Study / TP-DI Study|Adverse Event|4|||
105849721|NCT01462318|365109604|FG001|Main Study / TP-DI Study|Adverse Event|0|||
106025839|NCT00635219|365760003|FG004|Overall Study|Administrative or Other Reasons|1|||
106150262|NCT01693120|366211496|FG000|Enrollment|Physician Decision|3|||
105849722|NCT01462318|365109605|FG002|Main Study / TP-DI Study|Adverse Event|0|||
105849723|NCT01462318|365109603|FG000|Extension Phase|Lost to Follow-up|0|||
106025840|NCT02238080|365760006|FG000|Overall Study|Death|13|||
106025841|NCT02238080|365760006|FG000|Overall Study|Treatment interrupted|6|||
106025842|NCT02238080|365760006|FG000|Overall Study|Withdrawal by Subject|2|||
105849724|NCT01462318|365109604|FG001|Extension Phase|Lost to Follow-up|0|||
105849725|NCT01462318|365109605|FG002|Extension Phase|Lost to Follow-up|1|||
105849726|NCT01462318|365109603|FG000|Extension Phase|Other|0|||
106025843|NCT02238080|365760006|FG000|Overall Study|Other|4|||
106025844|NCT01598129|365760007|FG000|Overall Study|Disease progression|6|||
106025845|NCT01598129|365760007|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
106150263|NCT01693120|366211496|FG000|Enrollment|Adverse Event|1|||
105973579|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
105973580|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
105973581|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
105973582|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
105973583|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
105973584|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
105973585|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
105973586|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973587|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973588|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973589|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973590|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
105973591|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973592|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973593|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973594|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973595|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
105973596|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
105973597|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973598|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973599|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973600|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973601|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973602|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973603|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973604|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973605|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
105973606|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
105973607|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105973608|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105973609|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
105973610|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
105973611|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105973612|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105973613|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105973614|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105973615|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
105973616|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
105973617|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
106025846|NCT01598129|365760007|FG000|Overall Study|Withdrawal by Subject|1|||
106025847|NCT02123472|365760008|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
106025848|NCT02123472|365760009|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
106025849|NCT02433080|365760011|FG000|Overall Study|Lost to Follow-up|1|||
106025850|NCT02433080|365760012|FG001|Overall Study|Lost to Follow-up|2|||
106025851|NCT02433080|365760011|FG000|Overall Study|Withdrawal by Subject|0|||
106025852|NCT02433080|365760012|FG001|Overall Study|Withdrawal by Subject|2|||
106025853|NCT01363349|365760017|FG000|Overall Study|Adverse Event|6|||
106025854|NCT01363349|365760018|FG001|Overall Study|Adverse Event|7|||
106025855|NCT01363349|365760017|FG000|Overall Study|Lack of Efficacy|3|||
106025856|NCT01363349|365760018|FG001|Overall Study|Lack of Efficacy|10|||
106025857|NCT01363349|365760017|FG000|Overall Study|Non compliance/Protocol deviations|2|||
106025858|NCT01363349|365760018|FG001|Overall Study|Non compliance/Protocol deviations|2|||
106025859|NCT01363349|365760017|FG000|Overall Study|Withdrawal by Subject|14|||
106025860|NCT01363349|365760018|FG001|Overall Study|Withdrawal by Subject|6|||
106025861|NCT01363349|365760017|FG000|Overall Study|Lost to Follow-up|5|||
106025862|NCT01363349|365760018|FG001|Overall Study|Lost to Follow-up|6|||
106025863|NCT01363349|365760017|FG000|Overall Study|Not reported|36|||
106025864|NCT01363349|365760018|FG001|Overall Study|Not reported|37|||
106025865|NCT01363349|365760017|FG000|Overall Study|missing|1|||
106025866|NCT01363349|365760018|FG001|Overall Study|missing|2|||
106025867|NCT01989208|365760026|FG000|200 mg (7 Days)|Protocol Violation|0|||
105973618|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105973619|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
105973620|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105973621|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105973622|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105973623|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105973624|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
106025868|NCT01989208|365760027|FG001|200 mg (7 Days)|Protocol Violation|1|||
106025869|NCT00080899|365760028|FG000|Overall Study|Adverse Event|1|||
106150264|NCT01693120|366211496|FG000|Enrollment|Study closed|8|||
106150265|NCT01693120|366211496|FG000|Enrollment|Other|1|||
106025870|NCT02640508|365760030|FG000|Overall Study|Death|19|||
106150266|NCT01693120|366211496|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
105849727|NCT01462318|365109604|FG001|Extension Phase|Other|0|||
105849728|NCT01462318|365109605|FG002|Extension Phase|Other|1|||
105849729|NCT01462318|365109603|FG000|Extension Phase|Disease Progression|0|||
105849730|NCT01462318|365109604|FG001|Extension Phase|Disease Progression|0|||
105849731|NCT01462318|365109605|FG002|Extension Phase|Disease Progression|1|||
105849732|NCT01462318|365109603|FG000|Extension Phase|Withdrawal by Subject|0|||
105849733|NCT01462318|365109604|FG001|Extension Phase|Withdrawal by Subject|0|||
105849734|NCT01462318|365109605|FG002|Extension Phase|Withdrawal by Subject|15|||
105849735|NCT01462318|365109603|FG000|Extension Phase|Investigator Decision|0|||
105849736|NCT01462318|365109604|FG001|Extension Phase|Investigator Decision|0|||
105849737|NCT01462318|365109605|FG002|Extension Phase|Investigator Decision|5|||
105849738|NCT01462318|365109603|FG000|Extension Phase|Adverse Event|0|||
105849739|NCT01462318|365109604|FG001|Extension Phase|Adverse Event|0|||
105849740|NCT01462318|365109605|FG002|Extension Phase|Adverse Event|22|||
105849741|NCT00891371|365109606|FG000|Pre-assignment|Inclusion/exclusion|5|||
105849742|NCT00891371|365109606|FG000|Pre-assignment|Consent withdrawal|1|||
105849743|NCT00891371|365109606|FG000|Treatment|Lack of Efficacy|5|||
105849744|NCT00891371|365109606|FG000|Treatment|Adverse Event|2|||
105849745|NCT00891371|365109606|FG000|Treatment|Death|1|||
105849746|NCT00891371|365109606|FG000|Treatment|Lost to Follow-up|1|||
105849747|NCT02771795|365109611|FG000|Overall Study|Withdrawal by Subject|47|||
105849748|NCT02771795|365109612|FG001|Overall Study|Withdrawal by Subject|37|||
105849749|NCT02771795|365109611|FG000|Overall Study|Termination by premature discontinuation of study|168|||
105849750|NCT02771795|365109612|FG001|Overall Study|Termination by premature discontinuation of study|185|||
105849751|NCT04442490|365109615|FG000|Overall Study|Withdrawal by Subject|18|||
105849752|NCT04442490|365109616|FG001|Overall Study|Withdrawal by Subject|10|||
105849753|NCT04442490|365109615|FG000|Overall Study|Lost to Follow-up|7|||
105849754|NCT04442490|365109616|FG001|Overall Study|Lost to Follow-up|7|||
105849755|NCT04442490|365109615|FG000|Overall Study|Adverse Event|2|||
105849756|NCT04442490|365109616|FG001|Overall Study|Adverse Event|6|||
105849757|NCT04442490|365109615|FG000|Overall Study|Noncompliance|3|||
105849758|NCT04442490|365109616|FG001|Overall Study|Noncompliance|1|||
105849759|NCT04442490|365109615|FG000|Overall Study|Physician Decision|2|||
105849760|NCT04442490|365109616|FG001|Overall Study|Physician Decision|1|||
105849761|NCT04442490|365109615|FG000|Overall Study|Reason not Specified|2|||
105849762|NCT04442490|365109616|FG001|Overall Study|Reason not Specified|1|||
105849763|NCT04442490|365109615|FG000|Overall Study|Randomized but not Treated|3|||
105849764|NCT04442490|365109616|FG001|Overall Study|Randomized but not Treated|3|||
105849765|NCT01449279|365109617|FG000|Overall Study|Lack of Efficacy|5|||
105849766|NCT01449279|365109617|FG000|Overall Study|Toxicity|2|||
105849767|NCT01345175|365109618|FG000|Overall Study|Physician Decision|0|||
105849768|NCT01345175|365109619|FG001|Overall Study|Physician Decision|1|||
105849769|NCT01345175|365109618|FG000|Overall Study|Withdrawal by Subject|1|||
105849770|NCT01345175|365109619|FG001|Overall Study|Withdrawal by Subject|1|||
105849771|NCT01345175|365109618|FG000|Overall Study|Failed to complete BFI|3|||
105849772|NCT01345175|365109619|FG001|Overall Study|Failed to complete BFI|2|||
105849773|NCT01345175|365109618|FG000|Overall Study|Stopped taking medication|2|||
105849774|NCT01345175|365109619|FG001|Overall Study|Stopped taking medication|2|||
105849775|NCT00505375|365109620|FG000|Overall Study|Death|1|||
105849776|NCT00505375|365109621|FG001|Overall Study|Death|0|||
105849777|NCT00505375|365109620|FG000|Overall Study|Withdrawal by Subject|2|||
105849778|NCT00505375|365109621|FG001|Overall Study|Withdrawal by Subject|2|||
105849779|NCT00505375|365109620|FG000|Overall Study|Lost to Follow-up|0|||
105849780|NCT00505375|365109621|FG001|Overall Study|Lost to Follow-up|2|||
105849781|NCT00505375|365109620|FG000|Overall Study|Pregnancy|1|||
105849782|NCT00505375|365109621|FG001|Overall Study|Pregnancy|0|||
105849783|NCT00505375|365109620|FG000|Overall Study|Travel issues|0|||
105849784|NCT00505375|365109621|FG001|Overall Study|Travel issues|1|||
105849785|NCT02906930|365109625|FG000|Overall Study|Withdrawal by Subject|0|||
105849786|NCT02906930|365109626|FG001|Overall Study|Withdrawal by Subject|5|||
105849787|NCT02906930|365109627|FG002|Overall Study|Withdrawal by Subject|5|||
105849788|NCT02906930|365109628|FG003|Overall Study|Withdrawal by Subject|4|||
105849789|NCT02906930|365109625|FG000|Overall Study|Lost to Follow-up|5|||
105849790|NCT02906930|365109626|FG001|Overall Study|Lost to Follow-up|7|||
105849791|NCT02906930|365109627|FG002|Overall Study|Lost to Follow-up|5|||
105849792|NCT02906930|365109628|FG003|Overall Study|Lost to Follow-up|2|||
105849793|NCT02906930|365109625|FG000|Overall Study|Death|0|||
105849794|NCT02906930|365109626|FG001|Overall Study|Death|0|||
105849795|NCT02906930|365109627|FG002|Overall Study|Death|1|||
105849796|NCT02906930|365109628|FG003|Overall Study|Death|0|||
105849797|NCT02906930|365109625|FG000|Overall Study|Other|1|||
105849798|NCT02906930|365109626|FG001|Overall Study|Other|2|||
105849799|NCT02906930|365109627|FG002|Overall Study|Other|1|||
105849800|NCT02906930|365109628|FG003|Overall Study|Other|2|||
105849801|NCT02570113|365109629|FG000|Overall Study|Withdrawal by Subject|3|||
105849802|NCT02746471|365109630|FG000|Overall Study|Death|43|||
105849803|NCT02746471|365109630|FG000|Overall Study|Exited before 36 months|1119|||
105849804|NCT00987389|365109642|FG000|Overall Study|Ineligible|0|||
105973625|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
105973626|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
105973627|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
105973628|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
105973629|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
105973630|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
105973631|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105973632|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105973633|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105973634|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105973635|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
105973636|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
105973637|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
105973638|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
105973639|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973640|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
105973641|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973642|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973643|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973644|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973645|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973646|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
105973647|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105973648|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105973649|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
105973650|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
105973651|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105973652|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105973653|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105973654|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105973655|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
105973656|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105973657|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105973658|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973659|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105973660|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105973661|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973662|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973663|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973664|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973665|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973666|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973667|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973668|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
105973669|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973670|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
105973671|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973672|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973673|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973674|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973675|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973676|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
105973677|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
105973678|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
105973679|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
105973680|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
105973681|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105973682|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105973683|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105973684|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105973685|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
105973686|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973687|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973688|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973689|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
105973690|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
105973691|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973692|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973693|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973694|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973695|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973696|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105973697|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973698|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105973699|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105973700|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105973701|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973702|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973703|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973704|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973705|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973706|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
105973707|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973708|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973709|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973710|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
105973711|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973712|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973713|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973714|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973715|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
105973716|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973717|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973718|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973719|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973720|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
105973721|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973722|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973723|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105987463|NCT02814175|365614460|FG000|Part 1|Lack of Efficacy|1|||
106150267|NCT01693120|366211496|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
106150268|NCT01693120|366211496|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
106150269|NCT01693120|366211496|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
106150270|NCT01693120|366211496|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
106150271|NCT03936660|366211497|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
106150272|NCT03936660|366211498|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
106150273|NCT00093015|366211503|FG000|Overall Study|Withdrawal by Subject|194|||
105973724|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973725|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973726|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105973727|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
105973728|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105973729|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105973730|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
105973731|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105973732|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105973733|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105973734|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105973735|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
105973736|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
105973737|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105973738|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105973739|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105973740|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
105973741|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105973742|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105973743|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105973744|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105973745|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
105973746|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
105973747|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105973748|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
105973749|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105973750|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
105973751|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105973752|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105973753|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105973754|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105973755|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
105973756|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Other|5|||
105973757|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Other|1|||
105973758|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Other|0|||
105973759|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Other|3|||
105973760|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Other|0|||
105973761|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Other|0|||
105973762|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Other|0|||
105973763|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Other|0|||
105973764|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Other|0|||
105973765|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Other|0|||
105973766|NCT03352557|365564069|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973767|NCT03352557|365564070|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973768|NCT03352557|365564071|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973769|NCT03352557|365564072|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973770|NCT03352557|365564073|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
105973771|NCT03352557|365564074|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973772|NCT03352557|365564075|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973773|NCT03352557|365564076|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973774|NCT03352557|365564077|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973775|NCT03352557|365564078|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
105973776|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Death|0|||
105973777|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Death|0|||
105973778|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Death|0|||
105973779|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Death|0|||
105973780|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Death|0|||
105973781|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Death|1|||
105973782|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Death|0|||
105973783|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Death|1|||
105973784|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Death|1|||
105973785|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Death|1|||
105973786|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973787|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973788|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973789|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973790|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973791|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
106150274|NCT00093015|366211504|FG001|Overall Study|Withdrawal by Subject|171|||
106150275|NCT00093015|366211503|FG000|Overall Study|Lost to Follow-up|96|||
106150276|NCT00093015|366211504|FG001|Overall Study|Lost to Follow-up|108|||
105973792|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973793|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973794|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973795|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
105973796|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973797|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973798|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973799|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973800|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973801|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973802|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973803|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973804|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
105973805|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
105973806|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105973807|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105973808|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105973809|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105973810|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
105973811|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
105973812|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
105973813|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
105973814|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
105973815|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
105973816|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973817|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973818|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973819|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973820|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973821|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
105973822|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
105973823|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
105973824|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
105973825|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
105973826|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973827|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973828|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973829|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973830|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973831|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105973832|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973833|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105973834|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
105973835|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
105973836|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105973837|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105973838|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105973839|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105973840|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105973841|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
105973842|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
105973843|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
105973844|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
105973845|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
105973846|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
106025871|NCT02640508|365760030|FG000|Overall Study|Withdrawal by Subject|8|||
106025872|NCT02640508|365760030|FG000|Overall Study|Physician Decision|1|||
106025873|NCT02640508|365760030|FG000|Overall Study|Lost to Follow-up|1|||
105973847|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973848|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973849|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973850|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973851|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973852|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973853|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
105973854|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
105973855|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
105973856|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973857|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973858|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973859|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973860|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105987464|NCT02814175|365614461|FG001|Part 1|Lack of Efficacy|2|||
105987465|NCT02814175|365614462|FG002|Part 1|Lack of Efficacy|0|||
105987466|NCT02814175|365614463|FG003|Part 1|Lack of Efficacy|0|||
105987467|NCT02814175|365614464|FG004|Part 1|Lack of Efficacy|0|||
106150277|NCT00093015|366211503|FG000|Overall Study|Death|375|||
106150278|NCT00093015|366211504|FG001|Overall Study|Death|385|||
106150279|NCT00522951|366211507|FG000|Period 1|body motion|0|||
106150280|NCT00522951|366211508|FG001|Period 1|body motion|1|||
106150281|NCT00522951|366211507|FG000|Washout Period|Adverse Event|0|||
106150282|NCT00522951|366211508|FG001|Washout Period|Adverse Event|1|||
106150283|NCT00522951|366211507|FG000|Washout Period|Death|0|||
106150284|NCT00522951|366211508|FG001|Washout Period|Death|1|||
106150285|NCT00522951|366211507|FG000|Period 2|Withdrawal by Subject|1|||
106150286|NCT00522951|366211508|FG001|Period 2|Withdrawal by Subject|0|||
106150287|NCT00522951|366211507|FG000|Period 2|residual contrast medium|1|||
106150288|NCT00522951|366211508|FG001|Period 2|residual contrast medium|1|||
106150289|NCT03930420|366211509|FG000|Overall Study|Withdrawal by Subject|7|||
106150290|NCT03930420|366211510|FG001|Overall Study|Withdrawal by Subject|9|||
106150291|NCT04556981|366211511|FG000|Overall Study|Death|0|||
106150292|NCT04556981|366211512|FG001|Overall Study|Death|1|||
106150293|NCT04556981|366211511|FG000|Overall Study|Lost to Follow-up|2|||
106150294|NCT04556981|366211512|FG001|Overall Study|Lost to Follow-up|11|||
106150295|NCT04556981|366211511|FG000|Overall Study|Moved from the study area|1|||
106150296|NCT04556981|366211512|FG001|Overall Study|Moved from the study area|4|||
106150297|NCT04556981|366211511|FG000|Overall Study|Withdrawal by Subject|2|||
106150298|NCT04556981|366211512|FG001|Overall Study|Withdrawal by Subject|2|||
106150299|NCT04556981|366211511|FG000|Overall Study|Other|2|||
106150300|NCT04556981|366211512|FG001|Overall Study|Other|1|||
106150301|NCT00580866|366211513|FG000|Overall Study|Lost to Follow-up|2|||
106150302|NCT00580866|366211514|FG001|Overall Study|Lost to Follow-up|2|||
105987468|NCT02814175|365614465|FG005|Part 1|Lack of Efficacy|0|||
105987469|NCT02814175|365614460|FG000|Part 2|Adverse Event|0|||
105987470|NCT02814175|365614461|FG001|Part 2|Adverse Event|0|||
105987471|NCT02814175|365614462|FG002|Part 2|Adverse Event|0|||
105987472|NCT02814175|365614463|FG003|Part 2|Adverse Event|1|||
105987473|NCT02814175|365614464|FG004|Part 2|Adverse Event|1|||
105987474|NCT02814175|365614465|FG005|Part 2|Adverse Event|2|||
105987475|NCT02814175|365614460|FG000|Part 2|Withdrawal Consent|0|||
105987476|NCT02814175|365614461|FG001|Part 2|Withdrawal Consent|0|||
105987477|NCT02814175|365614462|FG002|Part 2|Withdrawal Consent|0|||
105987478|NCT02814175|365614463|FG003|Part 2|Withdrawal Consent|2|||
105987479|NCT02814175|365614464|FG004|Part 2|Withdrawal Consent|1|||
105987480|NCT02814175|365614465|FG005|Part 2|Withdrawal Consent|1|||
105987481|NCT02814175|365614460|FG000|Part 2|Lost to Follow-up|0|||
105987482|NCT02814175|365614461|FG001|Part 2|Lost to Follow-up|0|||
105987483|NCT02814175|365614462|FG002|Part 2|Lost to Follow-up|0|||
105987484|NCT02814175|365614463|FG003|Part 2|Lost to Follow-up|1|||
105987485|NCT02814175|365614464|FG004|Part 2|Lost to Follow-up|0|||
105987486|NCT02814175|365614465|FG005|Part 2|Lost to Follow-up|0|||
105987487|NCT02814175|365614460|FG000|Part 2|Lack of Efficacy|0|||
105987488|NCT02814175|365614461|FG001|Part 2|Lack of Efficacy|0|||
105987489|NCT02814175|365614462|FG002|Part 2|Lack of Efficacy|0|||
105987490|NCT02814175|365614463|FG003|Part 2|Lack of Efficacy|0|||
105987491|NCT02814175|365614464|FG004|Part 2|Lack of Efficacy|0|||
105987492|NCT02814175|365614465|FG005|Part 2|Lack of Efficacy|3|||
105987493|NCT01450098|365614466|FG000|Period 3|Protocol Violation|0|||
105987494|NCT01450098|365614467|FG001|Period 3|Protocol Violation|1|||
105987495|NCT01450098|365614466|FG000|Period 3|Withdrawal by Subject|0|||
105987496|NCT01450098|365614467|FG001|Period 3|Withdrawal by Subject|2|||
105987497|NCT01363661|365614475|FG000|Overall Study|Adverse Event|9|||
105987498|NCT01363661|365614476|FG001|Overall Study|Adverse Event|2|||
106025874|NCT04343235|365760031|FG000|Overall Study|Lost to Follow-up|3|||
106025875|NCT04343235|365760032|FG001|Overall Study|Lost to Follow-up|2|||
106025876|NCT01763996|365760033|FG000|Treatment Period 2|Adverse Event|0|||
106025877|NCT01763996|365760034|FG001|Treatment Period 2|Adverse Event|1|||
106025878|NCT00865280|365760035|FG000|Overall Study|Withdrawal by Subject|4|||
106025879|NCT00865280|365760036|FG001|Overall Study|Withdrawal by Subject|1|||
106025880|NCT00865280|365760035|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
106025881|NCT00865280|365760036|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
106025882|NCT00865280|365760035|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
106025883|NCT00865280|365760036|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
106025884|NCT00865280|365760035|FG000|Overall Study|Exclusion Condition|1|||
106025885|NCT00865280|365760036|FG001|Overall Study|Exclusion Condition|0|||
106025886|NCT00865280|365760035|FG000|Overall Study|Adverse Event|0|||
106025887|NCT00865280|365760036|FG001|Overall Study|Adverse Event|1|||
106025888|NCT01616693|365760037|FG000|Evaluated for Safety|Physician Decision|1|||
106025889|NCT01616693|365760038|FG001|Evaluated for Safety|Physician Decision|0|||
106025890|NCT01616693|365760039|FG002|Evaluated for Safety|Physician Decision|1|||
106025891|NCT01616693|365760040|FG003|Evaluated for Safety|Physician Decision|0|||
106025892|NCT01616693|365760037|FG000|Received Both Vaccines|Adverse Event|2|||
106025893|NCT01616693|365760038|FG001|Received Both Vaccines|Adverse Event|0|||
106025894|NCT01616693|365760039|FG002|Received Both Vaccines|Adverse Event|0|||
106025895|NCT01616693|365760040|FG003|Received Both Vaccines|Adverse Event|0|||
106025896|NCT01616693|365760037|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
106025897|NCT01616693|365760038|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
106025898|NCT01616693|365760039|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
106025899|NCT01616693|365760040|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
106025900|NCT01616693|365760037|FG000|Received Both Vaccines|Lost to Follow-up|4|||
106025901|NCT01616693|365760038|FG001|Received Both Vaccines|Lost to Follow-up|3|||
106025902|NCT01616693|365760039|FG002|Received Both Vaccines|Lost to Follow-up|4|||
106025903|NCT01616693|365760040|FG003|Received Both Vaccines|Lost to Follow-up|4|||
106025904|NCT01616693|365760037|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
106025905|NCT01616693|365760038|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
106025906|NCT01616693|365760039|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
106025907|NCT01616693|365760040|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
106025908|NCT04556383|365760041|FG000|PCP|Lack of Efficacy|28|||
106025909|NCT04556383|365760042|FG001|PCP|Lack of Efficacy|23|||
106025910|NCT04556383|365760043|FG002|PCP|Lack of Efficacy|23|||
106025911|NCT04556383|365760044|FG003|PCP|Lack of Efficacy|0|||
106025912|NCT04556383|365760041|FG000|PCP|Study terminated by sponsor|15|||
106025913|NCT04556383|365760042|FG001|PCP|Study terminated by sponsor|13|||
106025914|NCT04556383|365760043|FG002|PCP|Study terminated by sponsor|16|||
106025915|NCT04556383|365760044|FG003|PCP|Study terminated by sponsor|0|||
106025916|NCT04556383|365760041|FG000|PCP|Withdrawal by Subject|8|||
106025917|NCT04556383|365760042|FG001|PCP|Withdrawal by Subject|6|||
106025918|NCT04556383|365760043|FG002|PCP|Withdrawal by Subject|6|||
106025919|NCT04556383|365760044|FG003|PCP|Withdrawal by Subject|0|||
106025920|NCT04556383|365760041|FG000|PCP|Adverse Event|1|||
106025921|NCT04556383|365760042|FG001|PCP|Adverse Event|7|||
106025922|NCT04556383|365760043|FG002|PCP|Adverse Event|7|||
106025923|NCT04556383|365760044|FG003|PCP|Adverse Event|0|||
106025924|NCT04556383|365760041|FG000|PCP|Other, Not Specified|1|||
106025925|NCT04556383|365760042|FG001|PCP|Other, Not Specified|2|||
106025926|NCT04556383|365760043|FG002|PCP|Other, Not Specified|1|||
106025927|NCT04556383|365760044|FG003|PCP|Other, Not Specified|0|||
106025928|NCT04556383|365760041|FG000|PCP|Protocol Violation|1|||
106025929|NCT04556383|365760042|FG001|PCP|Protocol Violation|0|||
106025930|NCT04556383|365760043|FG002|PCP|Protocol Violation|1|||
106025931|NCT04556383|365760044|FG003|PCP|Protocol Violation|0|||
106025932|NCT04556383|365760041|FG000|PCP|Lost to Follow-up|1|||
106025933|NCT04556383|365760042|FG001|PCP|Lost to Follow-up|0|||
106025934|NCT04556383|365760043|FG002|PCP|Lost to Follow-up|0|||
106025935|NCT04556383|365760044|FG003|PCP|Lost to Follow-up|0|||
106025936|NCT04556383|365760041|FG000|PCP|Physician Decision|0|||
106025937|NCT04556383|365760042|FG001|PCP|Physician Decision|1|||
106025938|NCT04556383|365760043|FG002|PCP|Physician Decision|0|||
106025939|NCT04556383|365760044|FG003|PCP|Physician Decision|0|||
106025940|NCT04556383|365760041|FG000|PCP|Site terminated by sponsor|0|||
106025941|NCT04556383|365760042|FG001|PCP|Site terminated by sponsor|1|||
106025942|NCT04556383|365760043|FG002|PCP|Site terminated by sponsor|0|||
106025943|NCT04556383|365760044|FG003|PCP|Site terminated by sponsor|0|||
106025944|NCT04556383|365760041|FG000|OLE|Study terminated by sponsor|0|||
106025945|NCT04556383|365760042|FG001|OLE|Study terminated by sponsor|0|||
106025946|NCT04556383|365760043|FG002|OLE|Study terminated by sponsor|0|||
106025947|NCT04556383|365760044|FG003|OLE|Study terminated by sponsor|68|||
106025948|NCT04556383|365760041|FG000|OLE|Withdrawal by Subject|0|||
106025949|NCT04556383|365760042|FG001|OLE|Withdrawal by Subject|0|||
106025950|NCT04556383|365760043|FG002|OLE|Withdrawal by Subject|0|||
106025951|NCT04556383|365760044|FG003|OLE|Withdrawal by Subject|10|||
106025952|NCT04556383|365760041|FG000|OLE|Lack of Efficacy|0|||
106025953|NCT04556383|365760042|FG001|OLE|Lack of Efficacy|0|||
106025954|NCT04556383|365760043|FG002|OLE|Lack of Efficacy|0|||
106025955|NCT04556383|365760044|FG003|OLE|Lack of Efficacy|7|||
106025956|NCT04556383|365760041|FG000|OLE|Adverse Event|0|||
106025957|NCT04556383|365760042|FG001|OLE|Adverse Event|0|||
106025958|NCT04556383|365760043|FG002|OLE|Adverse Event|0|||
106025959|NCT04556383|365760044|FG003|OLE|Adverse Event|2|||
106025960|NCT04556383|365760041|FG000|OLE|Other, Not Specified|0|||
106025961|NCT04556383|365760042|FG001|OLE|Other, Not Specified|0|||
106025962|NCT04556383|365760043|FG002|OLE|Other, Not Specified|0|||
106025963|NCT04556383|365760044|FG003|OLE|Other, Not Specified|2|||
106025964|NCT04556383|365760041|FG000|OLE|Death|0|||
106025965|NCT04556383|365760042|FG001|OLE|Death|0|||
106025966|NCT04556383|365760043|FG002|OLE|Death|0|||
106025967|NCT04556383|365760044|FG003|OLE|Death|1|||
106025968|NCT04556383|365760041|FG000|OLE|Lost to Follow-up|0|||
106025969|NCT04556383|365760042|FG001|OLE|Lost to Follow-up|0|||
106025970|NCT04556383|365760043|FG002|OLE|Lost to Follow-up|0|||
106025971|NCT04556383|365760044|FG003|OLE|Lost to Follow-up|1|||
106025972|NCT01510769|365760045|FG000|Overall Study|Adverse Event|7|||
106025973|NCT01510769|365760046|FG001|Overall Study|Adverse Event|6|||
106025974|NCT01510769|365760047|FG002|Overall Study|Adverse Event|4|||
106025975|NCT01510769|365760045|FG000|Overall Study|Gout Flare|0|||
106025976|NCT01510769|365760046|FG001|Overall Study|Gout Flare|3|||
106025977|NCT01510769|365760047|FG002|Overall Study|Gout Flare|1|||
106025978|NCT01510769|365760045|FG000|Overall Study|Protocol Violation|11|||
106025979|NCT01510769|365760046|FG001|Overall Study|Protocol Violation|10|||
106025980|NCT01510769|365760047|FG002|Overall Study|Protocol Violation|9|||
106025981|NCT01510769|365760045|FG000|Overall Study|Lost to Follow-up|5|||
106025982|NCT01510769|365760046|FG001|Overall Study|Lost to Follow-up|1|||
106025983|NCT01510769|365760047|FG002|Overall Study|Lost to Follow-up|5|||
106025984|NCT01510769|365760045|FG000|Overall Study|Withdrawal by Subject|3|||
106025985|NCT01510769|365760046|FG001|Overall Study|Withdrawal by Subject|4|||
106025986|NCT01510769|365760047|FG002|Overall Study|Withdrawal by Subject|3|||
106025987|NCT01510769|365760045|FG000|Overall Study|Death|1|||
106025988|NCT01510769|365760046|FG001|Overall Study|Death|1|||
106025989|NCT01510769|365760047|FG002|Overall Study|Death|0|||
106025990|NCT00929643|365760048|FG000|Overall Study|Protocol Violation|2|||
106025991|NCT02874144|365760049|FG000|Overall Study|Lost to Follow-up|3|||
106025992|NCT02874144|365760050|FG001|Overall Study|Lost to Follow-up|5|||
106025993|NCT00486811|365760052|FG000|Overall Study|Adverse Event|28|||
106025994|NCT00486811|365760053|FG001|Overall Study|Adverse Event|60|||
106025995|NCT00486811|365760054|FG002|Overall Study|Adverse Event|135|||
106150303|NCT02677896|366211515|FG000|Double Blind Period (up to 35 Months)|Death|117|||
106150304|NCT02677896|366211516|FG001|Double Blind Period (up to 35 Months)|Death|197|||
106150305|NCT02677896|366211515|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
106150306|NCT02677896|366211516|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
106150307|NCT02677896|366211515|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
106150308|NCT02677896|366211516|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
105849805|NCT00987389|365109643|FG001|Overall Study|Ineligible|3|||
105849806|NCT00987389|365109644|FG002|Overall Study|Ineligible|0|||
105849807|NCT00987389|365109645|FG003|Overall Study|Ineligible|0|||
105849808|NCT00987389|365109642|FG000|Overall Study|Lost to Follow-up|4|||
105849809|NCT00987389|365109643|FG001|Overall Study|Lost to Follow-up|1|||
105849810|NCT00987389|365109644|FG002|Overall Study|Lost to Follow-up|3|||
105849811|NCT00987389|365109645|FG003|Overall Study|Lost to Follow-up|1|||
105849812|NCT00987389|365109642|FG000|Overall Study|Withdrawal by Subject|4|||
105849813|NCT00987389|365109643|FG001|Overall Study|Withdrawal by Subject|3|||
105849814|NCT00987389|365109644|FG002|Overall Study|Withdrawal by Subject|2|||
105849815|NCT00987389|365109645|FG003|Overall Study|Withdrawal by Subject|1|||
106025996|NCT00486811|365760052|FG000|Overall Study|Lack of Efficacy|34|||
106150309|NCT02677896|366211515|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
105849816|NCT00987389|365109642|FG000|Overall Study|Withdrawn from Treatment|0|||
106025997|NCT00486811|365760053|FG001|Overall Study|Lack of Efficacy|14|||
106025998|NCT00486811|365760054|FG002|Overall Study|Lack of Efficacy|7|||
106150310|NCT02677896|366211516|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
106150311|NCT02677896|366211515|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
106150312|NCT02677896|366211516|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
105849817|NCT00987389|365109643|FG001|Overall Study|Withdrawn from Treatment|1|||
105849818|NCT00987389|365109644|FG002|Overall Study|Withdrawn from Treatment|0|||
106025999|NCT00486811|365760052|FG000|Overall Study|Lost to Follow-up|4|||
106026000|NCT00486811|365760053|FG001|Overall Study|Lost to Follow-up|6|||
106026001|NCT00486811|365760054|FG002|Overall Study|Lost to Follow-up|4|||
106026002|NCT00486811|365760052|FG000|Overall Study|Withdrawal by Subject|33|||
106026003|NCT00486811|365760053|FG001|Overall Study|Withdrawal by Subject|44|||
106026004|NCT00486811|365760054|FG002|Overall Study|Withdrawal by Subject|58|||
106026005|NCT00486811|365760052|FG000|Overall Study|Study drug non-compliant|5|||
106026006|NCT00486811|365760053|FG001|Overall Study|Study drug non-compliant|6|||
106026007|NCT00486811|365760054|FG002|Overall Study|Study drug non-compliant|3|||
106026008|NCT00486811|365760052|FG000|Overall Study|All other|18|||
106026009|NCT00486811|365760053|FG001|Overall Study|All other|11|||
106026010|NCT00486811|365760054|FG002|Overall Study|All other|7|||
106026011|NCT02756806|365760055|FG000|Overall Study|Study terminated early|5|||
106026012|NCT02717832|365760057|FG000|Overall Study|Inability to place IV|3|||
106026013|NCT01711216|365760058|FG000|Overall Study|Adverse Event|4|||
106026014|NCT01711216|365760058|FG000|Overall Study|Pregnancy|56|||
106026015|NCT01711216|365760058|FG000|Overall Study|Withdrawal by Subject|6|||
106026016|NCT01711216|365760058|FG000|Overall Study|Lost to Follow-up|46|||
106026017|NCT01711216|365760058|FG000|Overall Study|variety of other minor reasons|83|||
106026018|NCT01711216|365760058|FG000|Overall Study|no reason specified|22|||
106026019|NCT02259088|365760059|FG000|Overall Study|Adverse Event|6|||
106026020|NCT02259088|365760060|FG001|Overall Study|Adverse Event|4|||
106026021|NCT02259088|365760059|FG000|Overall Study|Lost to Follow-up|2|||
106026022|NCT02259088|365760060|FG001|Overall Study|Lost to Follow-up|0|||
106026023|NCT02259088|365760059|FG000|Overall Study|Death|2|||
106026024|NCT02259088|365760060|FG001|Overall Study|Death|0|||
106026025|NCT02259088|365760059|FG000|Overall Study|Physician Decision|5|||
106026026|NCT02259088|365760060|FG001|Overall Study|Physician Decision|2|||
106026027|NCT02259088|365760059|FG000|Overall Study|Protocol deviation|5|||
106026028|NCT02259088|365760060|FG001|Overall Study|Protocol deviation|0|||
106026029|NCT02259088|365760059|FG000|Overall Study|Subject/guardian decision|8|||
106026030|NCT02259088|365760060|FG001|Overall Study|Subject/guardian decision|8|||
106026031|NCT01033448|365760063|FG000|Overall Study|Withdrawal by Subject|4|||
106026032|NCT01033448|365760063|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
106026033|NCT01033448|365760063|FG000|Overall Study|Lost to Follow-up|3|||
106026034|NCT01033448|365760063|FG000|Overall Study|Withdrew due to other reasons|3|||
106026035|NCT01033448|365760063|FG000|Overall Study|Unknown disposition|1|||
106026036|NCT03060551|365760064|FG000|Overall Study|Withdrawal by Subject|1|||
106026037|NCT03060551|365760064|FG000|Overall Study|Adverse Event|1|||
106026038|NCT01642615|365760065|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
106026039|NCT01642615|365760066|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
106026040|NCT01642615|365760067|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
106026041|NCT01642615|365760065|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
106026042|NCT01642615|365760066|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
106026043|NCT01642615|365760067|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
106026044|NCT01642615|365760065|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
106026045|NCT01642615|365760066|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
106026046|NCT01642615|365760067|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
106026047|NCT01642615|365760065|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
106026048|NCT01642615|365760066|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
106026049|NCT01642615|365760067|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
106026050|NCT01642615|365760065|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
106026051|NCT01642615|365760066|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
106026052|NCT01642615|365760067|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
106026053|NCT01642615|365760065|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
106026054|NCT01642615|365760066|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
106026055|NCT01642615|365760067|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
106026056|NCT01642615|365760065|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
106026057|NCT01642615|365760066|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
106026058|NCT01642615|365760067|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
106026059|NCT01642615|365760065|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
106026060|NCT01642615|365760066|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
106150313|NCT02677896|366211515|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
106150314|NCT02677896|366211516|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
106026061|NCT01642615|365760067|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
106026062|NCT01642615|365760065|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
106026063|NCT01642615|365760066|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
106026064|NCT01642615|365760067|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
106026065|NCT00439738|365760070|FG000|Overall Study|Withdrawal by Subject|16|||
106026066|NCT00439738|365760071|FG001|Overall Study|Withdrawal by Subject|13|||
106026067|NCT00439738|365760070|FG000|Overall Study|Adverse Event|6|||
106026068|NCT00439738|365760071|FG001|Overall Study|Adverse Event|4|||
106026069|NCT00439738|365760070|FG000|Overall Study|Lost to Follow-up|5|||
106026070|NCT00439738|365760071|FG001|Overall Study|Lost to Follow-up|6|||
106026071|NCT00439738|365760070|FG000|Overall Study|Protocol Violation|6|||
106026072|NCT00439738|365760071|FG001|Overall Study|Protocol Violation|3|||
106026073|NCT00439738|365760070|FG000|Overall Study|Lack of Efficacy|2|||
106026074|NCT00439738|365760071|FG001|Overall Study|Lack of Efficacy|2|||
106026075|NCT00439738|365760070|FG000|Overall Study|Abnormal Lab Values|1|||
106026076|NCT00439738|365760071|FG001|Overall Study|Abnormal Lab Values|0|||
106026077|NCT03976648|365760074|FG000|Overall Study|Adverse Event|0|||
106026078|NCT03976648|365760075|FG001|Overall Study|Adverse Event|2|||
106026079|NCT03976648|365760074|FG000|Overall Study|Study terminated by sponsor|21|||
106026080|NCT03976648|365760075|FG001|Overall Study|Study terminated by sponsor|8|||
106026081|NCT03645434|365760078|FG000|Period 1|Adverse Event|0|||
105849819|NCT00987389|365109645|FG003|Overall Study|Withdrawn from Treatment|0|||
105849820|NCT00987389|365109642|FG000|Overall Study|Multiple different reasons|1|||
105849821|NCT00987389|365109643|FG001|Overall Study|Multiple different reasons|0|||
105849822|NCT00987389|365109644|FG002|Overall Study|Multiple different reasons|3|||
105849823|NCT00987389|365109645|FG003|Overall Study|Multiple different reasons|1|||
105849824|NCT00655876|365109646|FG000|Overall Study|Protocol Violation|9|||
105849825|NCT00655876|365109647|FG001|Overall Study|Protocol Violation|7|||
105849826|NCT02500641|365109648|FG000|Overall Study|Adverse Event|0|||
105849827|NCT02500641|365109649|FG001|Overall Study|Adverse Event|2|||
105849828|NCT02500641|365109648|FG000|Overall Study|Withdrawal by Subject|4|||
105849829|NCT02500641|365109649|FG001|Overall Study|Withdrawal by Subject|5|||
105849830|NCT02500641|365109648|FG000|Overall Study|Unable to follow study procedures|3|||
105849831|NCT02500641|365109649|FG001|Overall Study|Unable to follow study procedures|2|||
105849832|NCT02500641|365109648|FG000|Overall Study|Protocol Violation|1|||
105849833|NCT02500641|365109649|FG001|Overall Study|Protocol Violation|2|||
105849834|NCT02500641|365109648|FG000|Overall Study|Lost to Follow-up|1|||
105849835|NCT02500641|365109649|FG001|Overall Study|Lost to Follow-up|0|||
105849836|NCT02500641|365109648|FG000|Overall Study|Sponsor decision|1|||
105849837|NCT02500641|365109649|FG001|Overall Study|Sponsor decision|0|||
105849838|NCT02500641|365109648|FG000|Overall Study|Non compliance to study drug|0|||
105849839|NCT02500641|365109649|FG001|Overall Study|Non compliance to study drug|1|||
105973861|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973862|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973863|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
105973864|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973865|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
105973866|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973867|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973868|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973869|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973870|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973871|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973872|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973873|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
105973874|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973875|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
105973876|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973877|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973878|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973879|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973880|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973881|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973882|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973883|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
105973884|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
105973885|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
105973886|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105973887|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105973888|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105973889|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105973890|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105973891|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
105973892|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105973893|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105973894|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
105973895|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
105973896|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
106150315|NCT02677896|366211515|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
105849840|NCT04355663|365109650|FG000|Overall Study|Physician Decision|2|||
105849841|NCT04355663|365109651|FG001|Overall Study|Physician Decision|7|||
105849842|NCT04355663|365109652|FG002|Overall Study|Physician Decision|0|||
105849843|NCT04355663|365109650|FG000|Overall Study|Adverse Event|0|||
105973897|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105973898|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105973899|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105973900|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105973901|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105973902|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105973903|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105973904|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
105973905|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
105973906|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105973907|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105973908|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105973909|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105973910|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105973911|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105973912|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105973913|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
105973914|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
105973915|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
105973916|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105973917|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105973918|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105973919|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105973920|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
106026082|NCT03645434|365760079|FG001|Period 1|Adverse Event|0|||
106026083|NCT03645434|365760080|FG002|Period 1|Adverse Event|0|||
106026084|NCT03645434|365760081|FG003|Period 1|Adverse Event|1|||
106026085|NCT03645434|365760082|FG004|Period 1|Adverse Event|0|||
106026086|NCT03645434|365760083|FG005|Period 1|Adverse Event|0|||
106026087|NCT03645434|365760078|FG000|Period 1|COPD exacerbation|0|||
106026088|NCT03645434|365760079|FG001|Period 1|COPD exacerbation|0|||
106026089|NCT03645434|365760080|FG002|Period 1|COPD exacerbation|0|||
106026090|NCT03645434|365760081|FG003|Period 1|COPD exacerbation|0|||
106026091|NCT03645434|365760082|FG004|Period 1|COPD exacerbation|1|||
106026092|NCT03645434|365760083|FG005|Period 1|COPD exacerbation|0|||
106026093|NCT01379508|365760084|FG000|Treatment to Week 104|Adverse Event|2|||
106026094|NCT01379508|365760085|FG001|Treatment to Week 104|Adverse Event|0|||
106026095|NCT01379508|365760086|FG002|Treatment to Week 104|Adverse Event|5|||
106026096|NCT01379508|365760087|FG003|Treatment to Week 104|Adverse Event|0|||
106026097|NCT01379508|365760084|FG000|Treatment to Week 104|Abnormal lab value|1|||
106026098|NCT01379508|365760085|FG001|Treatment to Week 104|Abnormal lab value|0|||
106026099|NCT01379508|365760086|FG002|Treatment to Week 104|Abnormal lab value|0|||
106026100|NCT01379508|365760087|FG003|Treatment to Week 104|Abnormal lab value|0|||
106026101|NCT01379508|365760084|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
106026102|NCT01379508|365760085|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
106026103|NCT01379508|365760086|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
106026104|NCT01379508|365760087|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
106026105|NCT01379508|365760084|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
106026106|NCT01379508|365760085|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
106026107|NCT01379508|365760086|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
106026108|NCT01379508|365760087|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
106026109|NCT01379508|365760084|FG000|Treatment to Week 104|Lost to Follow-up|5|||
106026110|NCT01379508|365760085|FG001|Treatment to Week 104|Lost to Follow-up|0|||
106026111|NCT01379508|365760086|FG002|Treatment to Week 104|Lost to Follow-up|3|||
106026112|NCT01379508|365760087|FG003|Treatment to Week 104|Lost to Follow-up|0|||
106026113|NCT01379508|365760084|FG000|Treatment to Week 104|Administrative problems|3|||
106026114|NCT01379508|365760085|FG001|Treatment to Week 104|Administrative problems|1|||
106026115|NCT01379508|365760086|FG002|Treatment to Week 104|Administrative problems|0|||
106026116|NCT01379508|365760087|FG003|Treatment to Week 104|Administrative problems|0|||
106026117|NCT01379508|365760084|FG000|Treatment to Week 104|Protocol Violation|1|||
106026118|NCT01379508|365760085|FG001|Treatment to Week 104|Protocol Violation|1|||
105973921|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105973922|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105973923|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
106026119|NCT01379508|365760086|FG002|Treatment to Week 104|Protocol Violation|1|||
106026120|NCT01379508|365760087|FG003|Treatment to Week 104|Protocol Violation|0|||
106026121|NCT01379508|365760084|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
106026122|NCT01379508|365760085|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
106026123|NCT01379508|365760086|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
106026124|NCT01379508|365760087|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
106026125|NCT01379508|365760084|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
105973924|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
105973925|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
105973926|NCT03352557|365564069|FG000|LTE Period: Week 80 to Week 173|Other|0|||
105973927|NCT03352557|365564070|FG001|LTE Period: Week 80 to Week 173|Other|0|||
105973928|NCT03352557|365564071|FG002|LTE Period: Week 80 to Week 173|Other|0|||
105973929|NCT03352557|365564072|FG003|LTE Period: Week 80 to Week 173|Other|0|||
105973930|NCT03352557|365564073|FG004|LTE Period: Week 80 to Week 173|Other|0|||
105973931|NCT03352557|365564074|FG005|LTE Period: Week 80 to Week 173|Other|0|||
105973932|NCT03352557|365564075|FG006|LTE Period: Week 80 to Week 173|Other|0|||
105973933|NCT03352557|365564076|FG007|LTE Period: Week 80 to Week 173|Other|1|||
105973934|NCT03352557|365564077|FG008|LTE Period: Week 80 to Week 173|Other|0|||
105973935|NCT03352557|365564078|FG009|LTE Period: Week 80 to Week 173|Other|0|||
105973936|NCT03958656|365564085|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
105973937|NCT03958656|365564086|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
105973938|NCT03958656|365564087|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
105973939|NCT03958656|365564088|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
105973940|NCT03958656|365564085|FG000|Overall Study|No longer meets eligibility criteria|0|||
105973941|NCT03958656|365564086|FG001|Overall Study|No longer meets eligibility criteria|0|||
105973942|NCT03958656|365564087|FG002|Overall Study|No longer meets eligibility criteria|1|||
105973943|NCT03958656|365564088|FG003|Overall Study|No longer meets eligibility criteria|0|||
105973944|NCT03958656|365564085|FG000|Overall Study|Started anti-cancer treatment|0|||
105973945|NCT03958656|365564086|FG001|Overall Study|Started anti-cancer treatment|0|||
105973946|NCT03958656|365564087|FG002|Overall Study|Started anti-cancer treatment|1|||
106026126|NCT01379508|365760085|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
106026127|NCT01379508|365760086|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
106026128|NCT01379508|365760087|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
106026129|NCT01379508|365760084|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
106026130|NCT01379508|365760085|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
106026131|NCT01379508|365760086|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
106026132|NCT01379508|365760087|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
106026133|NCT01379508|365760084|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
106026134|NCT01379508|365760085|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
106026135|NCT01379508|365760086|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
106026136|NCT01379508|365760087|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
106026137|NCT01182844|365760088|FG000|Overall Study|Withdrawal by Subject|0|||
106026138|NCT01182844|365760089|FG001|Overall Study|Withdrawal by Subject|2|||
106026139|NCT01451437|365760090|FG000|Overall Study|Adverse Event|0|||
106026140|NCT01451437|365760091|FG001|Overall Study|Adverse Event|0|||
106026141|NCT01451437|365760092|FG002|Overall Study|Adverse Event|0|||
106026142|NCT01451437|365760093|FG003|Overall Study|Adverse Event|0|||
106026143|NCT01451437|365760094|FG004|Overall Study|Adverse Event|0|||
106026144|NCT01451437|365760095|FG005|Overall Study|Adverse Event|1|||
106026145|NCT01451437|365760096|FG006|Overall Study|Adverse Event|1|||
106026146|NCT01451437|365760097|FG007|Overall Study|Adverse Event|2|||
106026147|NCT01451437|365760098|FG008|Overall Study|Adverse Event|1|||
106026148|NCT01451437|365760090|FG000|Overall Study|Physician Decision|1|||
106026149|NCT01451437|365760091|FG001|Overall Study|Physician Decision|1|||
106026150|NCT01451437|365760092|FG002|Overall Study|Physician Decision|2|||
106026151|NCT01451437|365760093|FG003|Overall Study|Physician Decision|0|||
106026152|NCT01451437|365760094|FG004|Overall Study|Physician Decision|0|||
106026153|NCT01451437|365760095|FG005|Overall Study|Physician Decision|0|||
106026154|NCT01451437|365760096|FG006|Overall Study|Physician Decision|0|||
106026155|NCT01451437|365760097|FG007|Overall Study|Physician Decision|0|||
106026156|NCT01451437|365760098|FG008|Overall Study|Physician Decision|0|||
106026157|NCT01451437|365760090|FG000|Overall Study|Disease Progression|0|||
106026158|NCT01451437|365760091|FG001|Overall Study|Disease Progression|0|||
106026159|NCT01451437|365760092|FG002|Overall Study|Disease Progression|1|||
106026160|NCT01451437|365760093|FG003|Overall Study|Disease Progression|1|||
105973947|NCT03958656|365564088|FG003|Overall Study|Started anti-cancer treatment|0|||
105973948|NCT04346108|365564089|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
106026161|NCT01451437|365760094|FG004|Overall Study|Disease Progression|3|||
106026162|NCT01451437|365760095|FG005|Overall Study|Disease Progression|2|||
106026163|NCT01451437|365760096|FG006|Overall Study|Disease Progression|3|||
106026164|NCT01451437|365760097|FG007|Overall Study|Disease Progression|1|||
106026165|NCT01451437|365760098|FG008|Overall Study|Disease Progression|3|||
106026166|NCT01451437|365760090|FG000|Overall Study|Protocol Violation|0|||
106026167|NCT01451437|365760091|FG001|Overall Study|Protocol Violation|0|||
106026168|NCT01451437|365760092|FG002|Overall Study|Protocol Violation|0|||
106026169|NCT01451437|365760093|FG003|Overall Study|Protocol Violation|0|||
105849844|NCT04355663|365109651|FG001|Overall Study|Adverse Event|0|||
106026170|NCT01451437|365760094|FG004|Overall Study|Protocol Violation|0|||
106026171|NCT01451437|365760095|FG005|Overall Study|Protocol Violation|0|||
106026172|NCT01451437|365760096|FG006|Overall Study|Protocol Violation|1|||
106026173|NCT01451437|365760097|FG007|Overall Study|Protocol Violation|0|||
105973949|NCT04346108|365564090|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
105973950|NCT04346108|365564091|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
105973951|NCT04346108|365564089|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
105973952|NCT04346108|365564090|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
105973953|NCT04346108|365564091|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
105973954|NCT03158012|365564092|FG000|Overall Study|Withdrawal by Subject|0|||
105973955|NCT03158012|365564093|FG001|Overall Study|Withdrawal by Subject|1|||
105973956|NCT01598753|365564094|FG000|Overall Study|Adverse Event|1|||
105973957|NCT01598753|365564095|FG001|Overall Study|Adverse Event|9|||
105849845|NCT04355663|365109652|FG002|Overall Study|Adverse Event|1|||
105849846|NCT04355663|365109650|FG000|Overall Study|Withdrawal by Subject|0|||
105849847|NCT04355663|365109651|FG001|Overall Study|Withdrawal by Subject|8|||
105849848|NCT04355663|365109652|FG002|Overall Study|Withdrawal by Subject|3|||
105849849|NCT00536263|365109653|FG000|Overall Study|Adverse Event|5|||
105973958|NCT01598753|365564096|FG002|Overall Study|Adverse Event|1|||
105973959|NCT01598753|365564097|FG003|Overall Study|Adverse Event|7|||
105973960|NCT01598753|365564094|FG000|Overall Study|Lost to Follow-up|4|||
105973961|NCT01598753|365564095|FG001|Overall Study|Lost to Follow-up|3|||
105973962|NCT01598753|365564096|FG002|Overall Study|Lost to Follow-up|7|||
105973963|NCT01598753|365564097|FG003|Overall Study|Lost to Follow-up|5|||
105973964|NCT01598753|365564094|FG000|Overall Study|Physician Decision|0|||
105973965|NCT01598753|365564095|FG001|Overall Study|Physician Decision|1|||
105973966|NCT01598753|365564096|FG002|Overall Study|Physician Decision|0|||
105973967|NCT01598753|365564097|FG003|Overall Study|Physician Decision|2|||
105973968|NCT01598753|365564094|FG000|Overall Study|Withdrawal by Subject|7|||
105973969|NCT01598753|365564095|FG001|Overall Study|Withdrawal by Subject|2|||
105973970|NCT01598753|365564096|FG002|Overall Study|Withdrawal by Subject|0|||
105973971|NCT01598753|365564097|FG003|Overall Study|Withdrawal by Subject|1|||
105973972|NCT04508751|365564100|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
105973973|NCT04508751|365564101|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
105973974|NCT04508751|365564102|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
105973975|NCT01414205|365564103|FG000|Overall Study|Death|5|||
105973976|NCT01414205|365564104|FG001|Overall Study|Death|1|||
105973977|NCT01414205|365564103|FG000|Overall Study|Lost to Follow-up|1|||
105973978|NCT01414205|365564104|FG001|Overall Study|Lost to Follow-up|4|||
105973979|NCT01414205|365564103|FG000|Overall Study|Physician Decision|0|||
105973980|NCT01414205|365564104|FG001|Overall Study|Physician Decision|1|||
105973981|NCT01414205|365564103|FG000|Overall Study|Randomized but not Treated|1|||
105973982|NCT01414205|365564104|FG001|Overall Study|Randomized but not Treated|1|||
106026174|NCT01451437|365760098|FG008|Overall Study|Protocol Violation|0|||
106026175|NCT01451437|365760090|FG000|Overall Study|Withdrawal by Subject|0|||
106026176|NCT01451437|365760091|FG001|Overall Study|Withdrawal by Subject|0|||
106026177|NCT01451437|365760092|FG002|Overall Study|Withdrawal by Subject|0|||
106026178|NCT01451437|365760093|FG003|Overall Study|Withdrawal by Subject|0|||
106026179|NCT01451437|365760094|FG004|Overall Study|Withdrawal by Subject|1|||
106026180|NCT01451437|365760095|FG005|Overall Study|Withdrawal by Subject|0|||
106026181|NCT01451437|365760096|FG006|Overall Study|Withdrawal by Subject|1|||
106026182|NCT01451437|365760097|FG007|Overall Study|Withdrawal by Subject|0|||
106026183|NCT01451437|365760098|FG008|Overall Study|Withdrawal by Subject|0|||
106026184|NCT01256294|365762350|FG000|Overall Study|Adverse Event|1|||
106026185|NCT01256294|365762351|FG001|Overall Study|Adverse Event|0|||
106026186|NCT01256294|365762350|FG000|Overall Study|Withdrawal by Subject|1|||
106026187|NCT01256294|365762351|FG001|Overall Study|Withdrawal by Subject|1|||
106026188|NCT01256294|365762350|FG000|Overall Study|Protocol deviation|2|||
106026189|NCT01256294|365762351|FG001|Overall Study|Protocol deviation|1|||
106026190|NCT04681352|365762352|FG000|Overall Study|Lost to Follow-up|2|||
106026191|NCT04681352|365762352|FG000|Overall Study|Withdrawal by Subject|22|||
106026192|NCT01282463|365762353|FG000|Overall Study|Lost to Follow-up|1|||
106026193|NCT01282463|365762354|FG001|Overall Study|Lost to Follow-up|0|||
106026194|NCT01282463|365762355|FG002|Overall Study|Lost to Follow-up|0|||
106026195|NCT01282463|365762353|FG000|Overall Study|Withdrawal by Subject|6|||
106026196|NCT01282463|365762354|FG001|Overall Study|Withdrawal by Subject|2|||
106026197|NCT01282463|365762355|FG002|Overall Study|Withdrawal by Subject|3|||
106026198|NCT01282463|365762353|FG000|Overall Study|"Never Treated Death"|0|||
105973983|NCT00171925|365564108|FG000|Overall Study|Adverse Event|10|||
105973984|NCT00171925|365564109|FG001|Overall Study|Adverse Event|6|||
106026199|NCT01282463|365762354|FG001|Overall Study|"Never Treated Death"|1|||
106026200|NCT01282463|365762355|FG002|Overall Study|"Never Treated Death"|0|||
106026201|NCT01282463|365762353|FG000|Overall Study|"Never Treated PD"|0|||
106026202|NCT01282463|365762354|FG001|Overall Study|"Never Treated PD"|1|||
106026203|NCT01282463|365762355|FG002|Overall Study|"Never Treated PD"|0|||
106026204|NCT01282463|365762353|FG000|Overall Study|Protocol Violation|0|||
106026205|NCT01282463|365762354|FG001|Overall Study|Protocol Violation|0|||
106026206|NCT01282463|365762355|FG002|Overall Study|Protocol Violation|1|||
105849850|NCT00536263|365109654|FG001|Overall Study|Adverse Event|5|||
105973985|NCT00171925|365564108|FG000|Overall Study|Protocol Violation|1|||
106026207|NCT01282463|365762353|FG000|Overall Study|Physician Decision|1|||
105973986|NCT00171925|365564109|FG001|Overall Study|Protocol Violation|1|||
105973987|NCT00171925|365564108|FG000|Overall Study|Withdrawal by Subject|6|||
105973988|NCT00171925|365564109|FG001|Overall Study|Withdrawal by Subject|9|||
105973989|NCT00171925|365564108|FG000|Overall Study|Lost to Follow-up|2|||
105973990|NCT00171925|365564109|FG001|Overall Study|Lost to Follow-up|2|||
105973991|NCT00171925|365564108|FG000|Overall Study|Administrative problems|10|||
105973992|NCT00171925|365564109|FG001|Overall Study|Administrative problems|11|||
105973993|NCT00171925|365564108|FG000|Overall Study|Death|1|||
105973994|NCT00171925|365564109|FG001|Overall Study|Death|2|||
105973995|NCT02692040|365564110|FG000|Overall Study|Protocol Violation|0|||
105973996|NCT02692040|365564111|FG001|Overall Study|Protocol Violation|0|||
105973997|NCT02692040|365564112|FG002|Overall Study|Protocol Violation|0|||
105973998|NCT02692040|365564113|FG003|Overall Study|Protocol Violation|0|||
105973999|NCT02692040|365564114|FG004|Overall Study|Protocol Violation|0|||
105974000|NCT02692040|365564115|FG005|Overall Study|Protocol Violation|0|||
105974001|NCT02692040|365564116|FG006|Overall Study|Protocol Violation|0|||
105974002|NCT02692040|365564117|FG007|Overall Study|Protocol Violation|0|||
105974003|NCT02692040|365564118|FG008|Overall Study|Protocol Violation|0|||
105974004|NCT02692040|365564119|FG009|Overall Study|Protocol Violation|0|||
105974005|NCT02692040|365564120|FG010|Overall Study|Protocol Violation|0|||
105974006|NCT02692040|365564121|FG011|Overall Study|Protocol Violation|0|||
106026208|NCT01282463|365762354|FG001|Overall Study|Physician Decision|0|||
106026209|NCT01282463|365762355|FG002|Overall Study|Physician Decision|0|||
106026210|NCT01239992|365762356|FG000|Overall Study|Withdrawal by Subject|2|||
106026211|NCT02894502|365762365|FG000|Baseline|Withdrawal by Subject|24|||
106026212|NCT02894502|365762366|FG001|Baseline|Withdrawal by Subject|31|||
106026213|NCT02894502|365762367|FG002|Baseline|Withdrawal by Subject|36|||
106026214|NCT02894502|365762365|FG000|Baseline|Death|3|||
106026215|NCT02894502|365762366|FG001|Baseline|Death|1|||
106026216|NCT02894502|365762367|FG002|Baseline|Death|9|||
106026217|NCT02894502|365762365|FG000|First Follow up|Withdrawal by Subject|32|||
106026218|NCT02894502|365762366|FG001|First Follow up|Withdrawal by Subject|29|||
106026219|NCT02894502|365762367|FG002|First Follow up|Withdrawal by Subject|37|||
106026220|NCT02894502|365762365|FG000|First Follow up|Death|2|||
106026221|NCT02894502|365762366|FG001|First Follow up|Death|2|||
106026222|NCT02894502|365762367|FG002|First Follow up|Death|3|||
106026223|NCT02894502|365762365|FG000|Second Follow up|Withdrawal by Subject|13|||
106026224|NCT02894502|365762366|FG001|Second Follow up|Withdrawal by Subject|15|||
106026225|NCT02894502|365762367|FG002|Second Follow up|Withdrawal by Subject|13|||
106026226|NCT02894502|365762365|FG000|Second Follow up|Death|2|||
106026227|NCT02894502|365762366|FG001|Second Follow up|Death|3|||
106026228|NCT02894502|365762367|FG002|Second Follow up|Death|1|||
106026229|NCT02894502|365762365|FG000|Third Follow up|Withdrawal by Subject|5|||
106026230|NCT02894502|365762366|FG001|Third Follow up|Withdrawal by Subject|6|||
106026231|NCT02894502|365762367|FG002|Third Follow up|Withdrawal by Subject|3|||
106026232|NCT02894502|365762365|FG000|Third Follow up|Death|1|||
106026233|NCT02894502|365762366|FG001|Third Follow up|Death|1|||
106026234|NCT02894502|365762367|FG002|Third Follow up|Death|0|||
106026235|NCT00966875|365762370|FG000|Part A|Adverse Event|2|||
106026236|NCT00966875|365762371|FG001|Part A|Adverse Event|1|||
106026237|NCT00966875|365762372|FG002|Part A|Adverse Event|0|||
106026238|NCT00966875|365762373|FG003|Part A|Adverse Event|1|||
105849851|NCT00536263|365109655|FG002|Overall Study|Adverse Event|7|||
105849852|NCT00536263|365109653|FG000|Overall Study|Lost to Follow-up|3|||
105849853|NCT00536263|365109654|FG001|Overall Study|Lost to Follow-up|4|||
105849854|NCT00536263|365109655|FG002|Overall Study|Lost to Follow-up|4|||
105849855|NCT00536263|365109653|FG000|Overall Study|Subject withdrew - not treatment related|2|||
105849856|NCT00536263|365109654|FG001|Overall Study|Subject withdrew - not treatment related|0|||
105849857|NCT00536263|365109655|FG002|Overall Study|Subject withdrew - not treatment related|5|||
105849858|NCT00536263|365109653|FG000|Overall Study|Subject withdrew - treatment related|0|||
105974007|NCT02692040|365564122|FG012|Overall Study|Protocol Violation|1|||
105974008|NCT02692040|365564123|FG013|Overall Study|Protocol Violation|0|||
105974009|NCT02692040|365564124|FG014|Overall Study|Protocol Violation|0|||
105974010|NCT02692040|365564125|FG015|Overall Study|Protocol Violation|0|||
105974011|NCT02692040|365564126|FG016|Overall Study|Protocol Violation|0|||
106026239|NCT00966875|365762374|FG004|Part A|Adverse Event|0|||
106026240|NCT00966875|365762375|FG005|Part A|Adverse Event|1|||
106026241|NCT00966875|365762376|FG006|Part A|Adverse Event|0|||
106026242|NCT00966875|365762377|FG007|Part A|Adverse Event|3|||
106026243|NCT00966875|365762378|FG008|Part A|Adverse Event|3|||
106026244|NCT00966875|365762370|FG000|Part A|Entry Criteria|0|||
106026245|NCT00966875|365762371|FG001|Part A|Entry Criteria|0|||
106026246|NCT00966875|365762372|FG002|Part A|Entry Criteria|0|||
106150316|NCT02677896|366211516|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
105849859|NCT00536263|365109654|FG001|Overall Study|Subject withdrew - treatment related|3|||
105849860|NCT00536263|365109655|FG002|Overall Study|Subject withdrew - treatment related|2|||
105974012|NCT02692040|365564110|FG000|Overall Study|Adverse Event|0|||
105974013|NCT02692040|365564111|FG001|Overall Study|Adverse Event|0|||
106026247|NCT00966875|365762373|FG003|Part A|Entry Criteria|0|||
106026248|NCT00966875|365762374|FG004|Part A|Entry Criteria|0|||
106026249|NCT00966875|365762375|FG005|Part A|Entry Criteria|2|||
105974014|NCT02692040|365564112|FG002|Overall Study|Adverse Event|0|||
105974015|NCT02692040|365564113|FG003|Overall Study|Adverse Event|0|||
105974016|NCT02692040|365564114|FG004|Overall Study|Adverse Event|0|||
105974017|NCT02692040|365564115|FG005|Overall Study|Adverse Event|0|||
105974018|NCT02692040|365564116|FG006|Overall Study|Adverse Event|0|||
105974019|NCT02692040|365564117|FG007|Overall Study|Adverse Event|0|||
105974020|NCT02692040|365564118|FG008|Overall Study|Adverse Event|0|||
105974021|NCT02692040|365564119|FG009|Overall Study|Adverse Event|0|||
105974022|NCT02692040|365564120|FG010|Overall Study|Adverse Event|0|||
105974023|NCT02692040|365564121|FG011|Overall Study|Adverse Event|0|||
105974024|NCT02692040|365564122|FG012|Overall Study|Adverse Event|0|||
105974025|NCT02692040|365564123|FG013|Overall Study|Adverse Event|3|||
105974026|NCT02692040|365564124|FG014|Overall Study|Adverse Event|1|||
105974027|NCT02692040|365564125|FG015|Overall Study|Adverse Event|1|||
105974028|NCT02692040|365564126|FG016|Overall Study|Adverse Event|0|||
105974029|NCT02590562|365564129|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
105974030|NCT01457950|365564130|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
105974031|NCT01457950|365564131|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
105974032|NCT01457950|365564132|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
105974033|NCT01457950|365564133|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
105974034|NCT01457950|365564130|FG000|Double-Blind Phase|Protocol Violation|2|||
105974035|NCT01457950|365564131|FG001|Double-Blind Phase|Protocol Violation|1|||
105974036|NCT01457950|365564132|FG002|Double-Blind Phase|Protocol Violation|0|||
105974037|NCT01457950|365564133|FG003|Double-Blind Phase|Protocol Violation|0|||
105974038|NCT01457950|365564130|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
105974039|NCT01457950|365564131|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
105974040|NCT01457950|365564132|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105974041|NCT01457950|365564133|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105974042|NCT01457950|365564130|FG000|Open-Label Phase|Adverse Event|0|||
105974043|NCT01457950|365564131|FG001|Open-Label Phase|Adverse Event|0|||
105974044|NCT01457950|365564132|FG002|Open-Label Phase|Adverse Event|0|||
105974045|NCT01457950|365564133|FG003|Open-Label Phase|Adverse Event|1|||
105974046|NCT01457950|365564130|FG000|Open-Label Phase|Protocol Violation|0|||
105974047|NCT01457950|365564131|FG001|Open-Label Phase|Protocol Violation|0|||
105974048|NCT01457950|365564132|FG002|Open-Label Phase|Protocol Violation|0|||
105974049|NCT01457950|365564133|FG003|Open-Label Phase|Protocol Violation|1|||
105974050|NCT01457950|365564130|FG000|Open-Label Phase|Withdrawal by Subject|0|||
105974051|NCT01457950|365564131|FG001|Open-Label Phase|Withdrawal by Subject|0|||
105974052|NCT01457950|365564132|FG002|Open-Label Phase|Withdrawal by Subject|2|||
105974053|NCT01457950|365564133|FG003|Open-Label Phase|Withdrawal by Subject|0|||
105974054|NCT00072293|365564140|FG000|Overall Study|Lost to Follow-up|1|||
105974055|NCT00072293|365564141|FG001|Overall Study|Lost to Follow-up|1|||
105974056|NCT00072293|365564140|FG000|Overall Study|Withdrawal by Subject|0|||
105974057|NCT00072293|365564141|FG001|Overall Study|Withdrawal by Subject|1|||
105974058|NCT02680574|365564142|FG000|Overall Study|Death|137|||
105974059|NCT02680574|365564143|FG001|Overall Study|Death|137|||
105974060|NCT02680574|365564142|FG000|Overall Study|Withdrawal by Subject|17|||
105974061|NCT02680574|365564143|FG001|Overall Study|Withdrawal by Subject|9|||
105974062|NCT02680574|365564142|FG000|Overall Study|Lost to Follow-up|4|||
105974063|NCT02680574|365564143|FG001|Overall Study|Lost to Follow-up|6|||
105974064|NCT01166958|365564144|FG000|Overall Study|Withdrawal by Subject|1|||
105974065|NCT01166958|365564145|FG001|Overall Study|Withdrawal by Subject|0|||
105974066|NCT04209114|365564146|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
105974067|NCT04209114|365564147|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
105974068|NCT04209114|365564148|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
105974069|NCT04209114|365564146|FG000|Pre-Treatment Phase|Other reasons|0|||
105974070|NCT04209114|365564147|FG001|Pre-Treatment Phase|Other reasons|0|||
105974071|NCT04209114|365564148|FG002|Pre-Treatment Phase|Other reasons|1|||
105974072|NCT04209114|365564146|FG000|Pre-Treatment Phase|Death|0|||
105974073|NCT04209114|365564147|FG001|Pre-Treatment Phase|Death|0|||
105974074|NCT04209114|365564148|FG002|Pre-Treatment Phase|Death|1|||
105974075|NCT04209114|365564146|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
106026250|NCT00966875|365762376|FG006|Part A|Entry Criteria|0|||
106026251|NCT00966875|365762377|FG007|Part A|Entry Criteria|0|||
105974076|NCT04209114|365564147|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
105974077|NCT04209114|365564148|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
106026252|NCT00966875|365762378|FG008|Part A|Entry Criteria|0|||
105974078|NCT04209114|365564146|FG000|Treatment Phase|Other reasons|5|||
105849861|NCT00536263|365109653|FG000|Overall Study|Noncompliance with protocol|0|||
105974079|NCT04209114|365564147|FG001|Treatment Phase|Other reasons|3|||
106026253|NCT00966875|365762370|FG000|Part A|Lack of Efficacy|0|||
106026254|NCT00966875|365762371|FG001|Part A|Lack of Efficacy|1|||
105849862|NCT00536263|365109654|FG001|Overall Study|Noncompliance with protocol|0|||
105974080|NCT04209114|365564148|FG002|Treatment Phase|Other reasons|0|||
105974081|NCT04209114|365564146|FG000|Treatment Phase|Lost to Follow-up|1|||
105974082|NCT04209114|365564147|FG001|Treatment Phase|Lost to Follow-up|0|||
105974083|NCT04209114|365564148|FG002|Treatment Phase|Lost to Follow-up|0|||
105974084|NCT04209114|365564146|FG000|Treatment Phase|Participant withdrew consent|1|||
105849863|NCT00536263|365109655|FG002|Overall Study|Noncompliance with protocol|1|||
105849864|NCT00536263|365109653|FG000|Overall Study|Did not meet protocol eligibility|1|||
105849865|NCT00536263|365109654|FG001|Overall Study|Did not meet protocol eligibility|2|||
105849866|NCT00536263|365109655|FG002|Overall Study|Did not meet protocol eligibility|2|||
105849867|NCT00826449|365109658|FG000|Overall Study|Disease Progression|4|||
105849868|NCT00826449|365109658|FG000|Overall Study|Withdrawal by Subject|1|||
105849869|NCT02994940|365109659|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
105849870|NCT02994940|365109660|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
105849871|NCT02994940|365109659|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
105849872|NCT02994940|365109660|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
105849873|NCT02994940|365109659|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
105849874|NCT02994940|365109660|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
105849875|NCT02196701|365109666|FG000|Overall Study|Adverse Event|1|||
105849876|NCT02196701|365109666|FG000|Overall Study|Lost to Follow-up|1|||
105849877|NCT02196701|365109666|FG000|Overall Study|Non-adherence to Protocol|1|||
105849878|NCT02317614|365109670|FG000|Overall Study|Lost to Follow-up|1|||
105849879|NCT02317614|365109671|FG001|Overall Study|Lost to Follow-up|1|||
105849880|NCT02317614|365109670|FG000|Overall Study|Withdrawal by Subject|1|||
105849881|NCT02317614|365109671|FG001|Overall Study|Withdrawal by Subject|0|||
105849882|NCT02317614|365109670|FG000|Overall Study|Death|1|||
105849883|NCT02317614|365109671|FG001|Overall Study|Death|1|||
105849884|NCT03285308|365109674|FG000|Overall Study|Adverse Event|3|||
105849885|NCT03285308|365109675|FG001|Overall Study|Adverse Event|7|||
105849886|NCT03285308|365109674|FG000|Overall Study|Withdrawal by Subject|8|||
105849887|NCT03285308|365109675|FG001|Overall Study|Withdrawal by Subject|9|||
105849888|NCT03285308|365109674|FG000|Overall Study|Lost to Follow-up|3|||
105849889|NCT03285308|365109675|FG001|Overall Study|Lost to Follow-up|1|||
105974085|NCT04209114|365564147|FG001|Treatment Phase|Participant withdrew consent|0|||
105974086|NCT04209114|365564148|FG002|Treatment Phase|Participant withdrew consent|0|||
105974087|NCT04209114|365564146|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
105974088|NCT04209114|365564147|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
105974089|NCT04209114|365564148|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
105974090|NCT04209114|365564146|FG000|Treatment Phase|Death|4|||
105974091|NCT04209114|365564147|FG001|Treatment Phase|Death|1|||
105974092|NCT04209114|365564148|FG002|Treatment Phase|Death|0|||
105974093|NCT04209114|365564146|FG000|Treatment Phase|Study drug toxicity|4|||
105974094|NCT04209114|365564147|FG001|Treatment Phase|Study drug toxicity|6|||
105974095|NCT04209114|365564148|FG002|Treatment Phase|Study drug toxicity|0|||
105974096|NCT04209114|365564146|FG000|Treatment Phase|Disease progression|6|||
105974097|NCT04209114|365564147|FG001|Treatment Phase|Disease progression|9|||
105974098|NCT04209114|365564148|FG002|Treatment Phase|Disease progression|0|||
105974099|NCT00681564|365564151|FG000|Overall Study|Lost to Follow-up|6|||
105974100|NCT00681564|365564152|FG001|Overall Study|Lost to Follow-up|6|||
105974101|NCT00681564|365564151|FG000|Overall Study|Withdrawal by Subject|0|||
105974102|NCT00681564|365564152|FG001|Overall Study|Withdrawal by Subject|1|||
105974103|NCT00681564|365564151|FG000|Overall Study|Death|0|||
105974104|NCT00681564|365564152|FG001|Overall Study|Death|1|||
105974105|NCT02826421|365564153|FG000|Overall Study|Adverse Event|1|||
105974106|NCT02826421|365564154|FG001|Overall Study|Adverse Event|0|||
105974107|NCT02826421|365564155|FG002|Overall Study|Adverse Event|0|||
105974108|NCT02826421|365564156|FG003|Overall Study|Adverse Event|1|||
105974109|NCT02826421|365564153|FG000|Overall Study|Withdrawal by Subject|1|||
105974110|NCT02826421|365564154|FG001|Overall Study|Withdrawal by Subject|3|||
105974111|NCT02826421|365564155|FG002|Overall Study|Withdrawal by Subject|1|||
105974112|NCT02826421|365564156|FG003|Overall Study|Withdrawal by Subject|1|||
105974113|NCT02826421|365564153|FG000|Overall Study|Reason not given|1|||
105974114|NCT02826421|365564154|FG001|Overall Study|Reason not given|0|||
105974115|NCT02826421|365564155|FG002|Overall Study|Reason not given|1|||
105974116|NCT02826421|365564156|FG003|Overall Study|Reason not given|0|||
105974117|NCT02141490|365564157|FG000|Overall Study|Screening failures|4|||
105974118|NCT02141490|365564158|FG001|Overall Study|Screening failures|0|||
105974119|NCT02141490|365564159|FG002|Overall Study|Screening failures|0|||
105974120|NCT01253265|365564162|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
105974121|NCT01253265|365564163|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
105974122|NCT01253265|365564164|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
105974123|NCT01253265|365564165|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
105974124|NCT01253265|365564166|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
105974125|NCT01253265|365564162|FG000|Overall Study|Withdrawal by Subject|0|||
105849890|NCT03285308|365109674|FG000|Overall Study|Protocol Deviation|6|||
105849891|NCT03285308|365109675|FG001|Overall Study|Protocol Deviation|5|||
105849892|NCT03285308|365109674|FG000|Overall Study|Reason not Specified|0|||
105974126|NCT01253265|365564163|FG001|Overall Study|Withdrawal by Subject|0|||
105974127|NCT01253265|365564164|FG002|Overall Study|Withdrawal by Subject|0|||
105974128|NCT01253265|365564165|FG003|Overall Study|Withdrawal by Subject|0|||
105849893|NCT03285308|365109675|FG001|Overall Study|Reason not Specified|1|||
105849894|NCT02787408|365109676|FG000|Overall Study|Death|16|||
105849895|NCT02787408|365109676|FG000|Overall Study|Withdrawal by Subject|1|||
105849896|NCT02787408|365109676|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
105849897|NCT00424775|365109681|FG000|Overall Study|Adverse Event|2|||
105849898|NCT00424775|365109682|FG001|Overall Study|Adverse Event|0|||
105849899|NCT00424775|365109681|FG000|Overall Study|Lack of Efficacy|1|||
105849900|NCT00424775|365109682|FG001|Overall Study|Lack of Efficacy|0|||
105849901|NCT00911807|365109684|FG000|Overall Study|Adverse Event|2|||
105849902|NCT00911807|365109685|FG001|Overall Study|Adverse Event|1|||
105849903|NCT00911807|365109686|FG002|Overall Study|Adverse Event|5|||
105849904|NCT00911807|365109684|FG000|Overall Study|Death|0|||
105849905|NCT00911807|365109685|FG001|Overall Study|Death|0|||
105849906|NCT00911807|365109686|FG002|Overall Study|Death|1|||
105849907|NCT00911807|365109684|FG000|Overall Study|Protocol Violation|6|||
105849908|NCT00911807|365109685|FG001|Overall Study|Protocol Violation|4|||
105849909|NCT00911807|365109686|FG002|Overall Study|Protocol Violation|9|||
105849910|NCT00911807|365109684|FG000|Overall Study|Withdrawal by Subject|8|||
106026255|NCT00966875|365762372|FG002|Part A|Lack of Efficacy|0|||
106026256|NCT00966875|365762373|FG003|Part A|Lack of Efficacy|0|||
106026257|NCT00966875|365762374|FG004|Part A|Lack of Efficacy|0|||
106026258|NCT00966875|365762375|FG005|Part A|Lack of Efficacy|0|||
106026259|NCT00966875|365762376|FG006|Part A|Lack of Efficacy|4|||
106026260|NCT00966875|365762377|FG007|Part A|Lack of Efficacy|0|||
106026261|NCT00966875|365762378|FG008|Part A|Lack of Efficacy|0|||
106026262|NCT00966875|365762370|FG000|Part A|Lost to Follow-up|2|||
106026263|NCT00966875|365762371|FG001|Part A|Lost to Follow-up|0|||
106026264|NCT00966875|365762372|FG002|Part A|Lost to Follow-up|0|||
106026265|NCT00966875|365762373|FG003|Part A|Lost to Follow-up|0|||
106026266|NCT00966875|365762374|FG004|Part A|Lost to Follow-up|0|||
106026267|NCT00966875|365762375|FG005|Part A|Lost to Follow-up|1|||
106026268|NCT00966875|365762376|FG006|Part A|Lost to Follow-up|0|||
106026269|NCT00966875|365762377|FG007|Part A|Lost to Follow-up|0|||
106026270|NCT00966875|365762378|FG008|Part A|Lost to Follow-up|0|||
106026271|NCT00966875|365762370|FG000|Part A|Parent/Caregiver Decision|0|||
106026272|NCT00966875|365762371|FG001|Part A|Parent/Caregiver Decision|0|||
106026273|NCT00966875|365762372|FG002|Part A|Parent/Caregiver Decision|0|||
106026274|NCT00966875|365762373|FG003|Part A|Parent/Caregiver Decision|1|||
106026275|NCT00966875|365762374|FG004|Part A|Parent/Caregiver Decision|0|||
106026276|NCT00966875|365762375|FG005|Part A|Parent/Caregiver Decision|0|||
106026277|NCT00966875|365762376|FG006|Part A|Parent/Caregiver Decision|0|||
106026278|NCT00966875|365762377|FG007|Part A|Parent/Caregiver Decision|0|||
106026279|NCT00966875|365762378|FG008|Part A|Parent/Caregiver Decision|0|||
106026280|NCT00966875|365762370|FG000|Part A|Physician Decision|0|||
106026281|NCT00966875|365762371|FG001|Part A|Physician Decision|0|||
106026282|NCT00966875|365762372|FG002|Part A|Physician Decision|0|||
106026283|NCT00966875|365762373|FG003|Part A|Physician Decision|0|||
106026284|NCT00966875|365762374|FG004|Part A|Physician Decision|1|||
106026285|NCT00966875|365762375|FG005|Part A|Physician Decision|0|||
106026286|NCT00966875|365762376|FG006|Part A|Physician Decision|1|||
106026287|NCT00966875|365762377|FG007|Part A|Physician Decision|0|||
106026288|NCT00966875|365762378|FG008|Part A|Physician Decision|2|||
106026289|NCT00966875|365762370|FG000|Part A|Sponsor Decision|0|||
106026290|NCT00966875|365762371|FG001|Part A|Sponsor Decision|0|||
106026291|NCT00966875|365762372|FG002|Part A|Sponsor Decision|1|||
106026292|NCT00966875|365762373|FG003|Part A|Sponsor Decision|0|||
106026293|NCT00966875|365762374|FG004|Part A|Sponsor Decision|1|||
106026294|NCT00966875|365762375|FG005|Part A|Sponsor Decision|0|||
106026295|NCT00966875|365762376|FG006|Part A|Sponsor Decision|0|||
106026296|NCT00966875|365762377|FG007|Part A|Sponsor Decision|2|||
106026297|NCT00966875|365762378|FG008|Part A|Sponsor Decision|1|||
106026298|NCT00966875|365762370|FG000|Part A|Withdrawal by Subject|2|||
106026299|NCT00966875|365762371|FG001|Part A|Withdrawal by Subject|2|||
106026300|NCT00966875|365762372|FG002|Part A|Withdrawal by Subject|1|||
106026301|NCT00966875|365762373|FG003|Part A|Withdrawal by Subject|1|||
106026302|NCT00966875|365762374|FG004|Part A|Withdrawal by Subject|3|||
106026303|NCT00966875|365762375|FG005|Part A|Withdrawal by Subject|0|||
106026304|NCT00966875|365762376|FG006|Part A|Withdrawal by Subject|5|||
106026305|NCT00966875|365762377|FG007|Part A|Withdrawal by Subject|1|||
106026306|NCT00966875|365762378|FG008|Part A|Withdrawal by Subject|1|||
105849911|NCT00911807|365109685|FG001|Overall Study|Withdrawal by Subject|10|||
106026307|NCT00966875|365762370|FG000|Part A|Protocol Violation|0|||
106026308|NCT00966875|365762371|FG001|Part A|Protocol Violation|0|||
106026309|NCT00966875|365762372|FG002|Part A|Protocol Violation|0|||
105849912|NCT00911807|365109686|FG002|Overall Study|Withdrawal by Subject|7|||
105849913|NCT00911807|365109684|FG000|Overall Study|Organizational reasons|1|||
105849914|NCT00911807|365109685|FG001|Overall Study|Organizational reasons|3|||
106026310|NCT00966875|365762373|FG003|Part A|Protocol Violation|0|||
106026311|NCT00966875|365762374|FG004|Part A|Protocol Violation|0|||
106026312|NCT00966875|365762375|FG005|Part A|Protocol Violation|0|||
106026313|NCT00966875|365762376|FG006|Part A|Protocol Violation|2|||
106026314|NCT00966875|365762377|FG007|Part A|Protocol Violation|1|||
106026315|NCT00966875|365762378|FG008|Part A|Protocol Violation|1|||
106026316|NCT00966875|365762370|FG000|Part B|Adverse Event|0|||
105974129|NCT01253265|365564166|FG004|Overall Study|Withdrawal by Subject|1|||
105974130|NCT00711802|365564170|FG000|Overall Study|Not treated (no further detail)|2|||
105974131|NCT00711802|365564171|FG001|Overall Study|Not treated (no further detail)|1|||
105974132|NCT00711802|365564172|FG002|Overall Study|Not treated (no further detail)|2|||
105974133|NCT00711802|365564173|FG003|Overall Study|Not treated (no further detail)|0|||
105974134|NCT00711802|365564174|FG004|Overall Study|Not treated (no further detail)|2|||
105974135|NCT00711802|365564175|FG005|Overall Study|Not treated (no further detail)|0|||
105974136|NCT00711802|365564176|FG006|Overall Study|Not treated (no further detail)|0|||
105974137|NCT00711802|365564177|FG007|Overall Study|Not treated (no further detail)|0|||
105974138|NCT00711802|365564170|FG000|Overall Study|Adverse Event|0|||
105974139|NCT00711802|365564171|FG001|Overall Study|Adverse Event|0|||
105974140|NCT00711802|365564172|FG002|Overall Study|Adverse Event|0|||
105974141|NCT00711802|365564173|FG003|Overall Study|Adverse Event|0|||
105974142|NCT00711802|365564174|FG004|Overall Study|Adverse Event|1|||
105974143|NCT00711802|365564175|FG005|Overall Study|Adverse Event|1|||
105974144|NCT00711802|365564176|FG006|Overall Study|Adverse Event|0|||
105974145|NCT00711802|365564177|FG007|Overall Study|Adverse Event|0|||
105974146|NCT00711802|365564170|FG000|Overall Study|Microbiological failure|0|||
105974147|NCT00711802|365564171|FG001|Overall Study|Microbiological failure|1|||
105974148|NCT00711802|365564172|FG002|Overall Study|Microbiological failure|0|||
105974149|NCT00711802|365564173|FG003|Overall Study|Microbiological failure|0|||
105974150|NCT00711802|365564174|FG004|Overall Study|Microbiological failure|0|||
105974151|NCT00711802|365564175|FG005|Overall Study|Microbiological failure|1|||
105974152|NCT00711802|365564176|FG006|Overall Study|Microbiological failure|0|||
105974153|NCT00711802|365564177|FG007|Overall Study|Microbiological failure|0|||
105974154|NCT00711802|365564170|FG000|Overall Study|Protocol Violation|0|||
105974155|NCT00711802|365564171|FG001|Overall Study|Protocol Violation|0|||
105974156|NCT00711802|365564172|FG002|Overall Study|Protocol Violation|0|||
105974157|NCT00711802|365564173|FG003|Overall Study|Protocol Violation|1|||
105974158|NCT00711802|365564174|FG004|Overall Study|Protocol Violation|0|||
105974159|NCT00711802|365564175|FG005|Overall Study|Protocol Violation|0|||
105974160|NCT00711802|365564176|FG006|Overall Study|Protocol Violation|0|||
105974161|NCT00711802|365564177|FG007|Overall Study|Protocol Violation|0|||
105974162|NCT00711802|365564170|FG000|Overall Study|Physician Decision|0|||
105974163|NCT00711802|365564171|FG001|Overall Study|Physician Decision|2|||
105974164|NCT00711802|365564172|FG002|Overall Study|Physician Decision|0|||
105974165|NCT00711802|365564173|FG003|Overall Study|Physician Decision|0|||
105974166|NCT00711802|365564174|FG004|Overall Study|Physician Decision|0|||
105974167|NCT00711802|365564175|FG005|Overall Study|Physician Decision|0|||
105974168|NCT00711802|365564176|FG006|Overall Study|Physician Decision|0|||
105974169|NCT00711802|365564177|FG007|Overall Study|Physician Decision|0|||
105974170|NCT00711802|365564170|FG000|Overall Study|Withdrawal by Subject|0|||
105974171|NCT00711802|365564171|FG001|Overall Study|Withdrawal by Subject|1|||
105974172|NCT00711802|365564172|FG002|Overall Study|Withdrawal by Subject|0|||
105974173|NCT00711802|365564173|FG003|Overall Study|Withdrawal by Subject|1|||
105974174|NCT00711802|365564174|FG004|Overall Study|Withdrawal by Subject|0|||
105974175|NCT00711802|365564175|FG005|Overall Study|Withdrawal by Subject|0|||
105974176|NCT00711802|365564176|FG006|Overall Study|Withdrawal by Subject|0|||
105974177|NCT00711802|365564177|FG007|Overall Study|Withdrawal by Subject|0|||
105974178|NCT00711802|365564170|FG000|Overall Study|Lost to Follow-up|0|||
105974179|NCT00711802|365564171|FG001|Overall Study|Lost to Follow-up|0|||
105974180|NCT00711802|365564172|FG002|Overall Study|Lost to Follow-up|3|||
106026317|NCT00966875|365762371|FG001|Part B|Adverse Event|1|||
106026318|NCT00966875|365762372|FG002|Part B|Adverse Event|1|||
106026319|NCT00966875|365762373|FG003|Part B|Adverse Event|0|||
106026320|NCT00966875|365762374|FG004|Part B|Adverse Event|1|||
106026321|NCT00966875|365762375|FG005|Part B|Adverse Event|0|||
106026322|NCT00966875|365762376|FG006|Part B|Adverse Event|5|||
106026323|NCT00966875|365762377|FG007|Part B|Adverse Event|2|||
106026324|NCT00966875|365762378|FG008|Part B|Adverse Event|2|||
106026325|NCT00966875|365762370|FG000|Part B|Death|0|||
106026326|NCT00966875|365762371|FG001|Part B|Death|0|||
105974181|NCT00711802|365564173|FG003|Overall Study|Lost to Follow-up|1|||
105974182|NCT00711802|365564174|FG004|Overall Study|Lost to Follow-up|10|||
105974183|NCT00711802|365564175|FG005|Overall Study|Lost to Follow-up|6|||
106026327|NCT00966875|365762372|FG002|Part B|Death|1|||
105974184|NCT00711802|365564176|FG006|Overall Study|Lost to Follow-up|4|||
105974185|NCT00711802|365564177|FG007|Overall Study|Lost to Follow-up|2|||
105974186|NCT00711802|365564170|FG000|Overall Study|Reason not reported|0|||
105974187|NCT00711802|365564171|FG001|Overall Study|Reason not reported|1|||
105974188|NCT00711802|365564172|FG002|Overall Study|Reason not reported|1|||
105974189|NCT00711802|365564173|FG003|Overall Study|Reason not reported|0|||
105974190|NCT00711802|365564174|FG004|Overall Study|Reason not reported|1|||
106026328|NCT00966875|365762373|FG003|Part B|Death|0|||
105974191|NCT00711802|365564175|FG005|Overall Study|Reason not reported|0|||
105974192|NCT00711802|365564176|FG006|Overall Study|Reason not reported|1|||
106026329|NCT00966875|365762374|FG004|Part B|Death|0|||
106026330|NCT00966875|365762375|FG005|Part B|Death|0|||
106026331|NCT00966875|365762376|FG006|Part B|Death|0|||
106026332|NCT00966875|365762377|FG007|Part B|Death|1|||
106026333|NCT00966875|365762378|FG008|Part B|Death|0|||
106026334|NCT00966875|365762370|FG000|Part B|Lack of Efficacy|2|||
106026335|NCT00966875|365762371|FG001|Part B|Lack of Efficacy|1|||
106026336|NCT00966875|365762372|FG002|Part B|Lack of Efficacy|1|||
106026337|NCT00966875|365762373|FG003|Part B|Lack of Efficacy|1|||
106026338|NCT00966875|365762374|FG004|Part B|Lack of Efficacy|2|||
106026339|NCT00966875|365762375|FG005|Part B|Lack of Efficacy|3|||
106026340|NCT00966875|365762376|FG006|Part B|Lack of Efficacy|12|||
106026341|NCT00966875|365762377|FG007|Part B|Lack of Efficacy|9|||
106026342|NCT00966875|365762378|FG008|Part B|Lack of Efficacy|6|||
105849915|NCT00911807|365109686|FG002|Overall Study|Organizational reasons|1|||
105849916|NCT02435836|365109688|FG000|Overall Study|Lost to Follow-up|21|||
105849917|NCT02435836|365109688|FG000|Overall Study|Lack of Efficacy|1|||
105849918|NCT02435836|365109688|FG000|Overall Study|Withdrawal by Subject|236|||
105849919|NCT02435836|365109688|FG000|Overall Study|Insufficient Clinical Response|26|||
105849920|NCT02435836|365109688|FG000|Overall Study|Adverse Event|44|||
105849921|NCT02435836|365109688|FG000|Overall Study|Sponsor discontinued trial|167|||
105849922|NCT02435836|365109688|FG000|Overall Study|Noncompliance|27|||
105849923|NCT02435836|365109688|FG000|Overall Study|Protocol Violation|6|||
105849924|NCT02435836|365109688|FG000|Overall Study|Met Withdrawal Criteria|7|||
105849925|NCT02435836|365109688|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
105849926|NCT00809159|365109689|FG000|Part 1|Adverse Event|1|||
105849927|NCT00809159|365109690|FG001|Part 1|Adverse Event|1|||
105849928|NCT00809159|365109691|FG002|Part 1|Adverse Event|0|||
105849929|NCT00809159|365109692|FG003|Part 1|Adverse Event|0|||
105849930|NCT00809159|365109693|FG004|Part 1|Adverse Event|0|||
105849931|NCT00809159|365109694|FG005|Part 1|Adverse Event|0|||
105849932|NCT00809159|365109689|FG000|Part 1|Lost to Follow-up|1|||
105849933|NCT00809159|365109690|FG001|Part 1|Lost to Follow-up|0|||
105849934|NCT00809159|365109691|FG002|Part 1|Lost to Follow-up|0|||
105849935|NCT00809159|365109692|FG003|Part 1|Lost to Follow-up|0|||
105849936|NCT00809159|365109693|FG004|Part 1|Lost to Follow-up|0|||
105849937|NCT00809159|365109694|FG005|Part 1|Lost to Follow-up|0|||
105849938|NCT00809159|365109689|FG000|Part 1|Withdrawal by Subject|3|||
105849939|NCT00809159|365109690|FG001|Part 1|Withdrawal by Subject|1|||
105849940|NCT00809159|365109691|FG002|Part 1|Withdrawal by Subject|0|||
105849941|NCT00809159|365109692|FG003|Part 1|Withdrawal by Subject|0|||
105849942|NCT00809159|365109693|FG004|Part 1|Withdrawal by Subject|0|||
105849943|NCT00809159|365109694|FG005|Part 1|Withdrawal by Subject|0|||
105849944|NCT00809159|365109689|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
105849945|NCT00809159|365109690|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
105849946|NCT00809159|365109691|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
105849947|NCT00809159|365109692|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
105849948|NCT00809159|365109693|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
105849949|NCT00809159|365109694|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
105849950|NCT00809159|365109689|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
105849951|NCT00809159|365109690|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
105849952|NCT00809159|365109691|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
105849953|NCT00809159|365109692|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
105849954|NCT00809159|365109693|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
105849955|NCT00809159|365109694|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
105849956|NCT00809159|365109689|FG000|Part 1 and 2|Administrative problems|0|||
105849957|NCT00809159|365109690|FG001|Part 1 and 2|Administrative problems|0|||
105849958|NCT00809159|365109691|FG002|Part 1 and 2|Administrative problems|0|||
105849959|NCT00809159|365109692|FG003|Part 1 and 2|Administrative problems|1|||
105849960|NCT00809159|365109693|FG004|Part 1 and 2|Administrative problems|0|||
105849961|NCT00809159|365109694|FG005|Part 1 and 2|Administrative problems|0|||
105849962|NCT00809159|365109689|FG000|Part 1 and 2|Adverse Event|0|||
105849963|NCT00809159|365109690|FG001|Part 1 and 2|Adverse Event|0|||
105849964|NCT00809159|365109691|FG002|Part 1 and 2|Adverse Event|1|||
105849965|NCT00809159|365109692|FG003|Part 1 and 2|Adverse Event|0|||
105849966|NCT00809159|365109693|FG004|Part 1 and 2|Adverse Event|1|||
105849967|NCT00809159|365109694|FG005|Part 1 and 2|Adverse Event|1|||
105849968|NCT00809159|365109689|FG000|Part 1 and 2|Lost to Follow-up|0|||
105849969|NCT00809159|365109690|FG001|Part 1 and 2|Lost to Follow-up|0|||
105849970|NCT00809159|365109691|FG002|Part 1 and 2|Lost to Follow-up|1|||
105849971|NCT00809159|365109692|FG003|Part 1 and 2|Lost to Follow-up|1|||
105849972|NCT00809159|365109693|FG004|Part 1 and 2|Lost to Follow-up|0|||
105849973|NCT00809159|365109694|FG005|Part 1 and 2|Lost to Follow-up|0|||
105849974|NCT00809159|365109689|FG000|Part 1 and 2|Withdrawal by Subject|0|||
105849975|NCT00809159|365109690|FG001|Part 1 and 2|Withdrawal by Subject|0|||
105849976|NCT00809159|365109691|FG002|Part 1 and 2|Withdrawal by Subject|4|||
106026343|NCT00966875|365762370|FG000|Part B|Lost to Follow-up|0|||
106026344|NCT00966875|365762371|FG001|Part B|Lost to Follow-up|0|||
106026345|NCT00966875|365762372|FG002|Part B|Lost to Follow-up|0|||
106026346|NCT00966875|365762373|FG003|Part B|Lost to Follow-up|1|||
105849977|NCT00809159|365109692|FG003|Part 1 and 2|Withdrawal by Subject|0|||
105849978|NCT00809159|365109693|FG004|Part 1 and 2|Withdrawal by Subject|0|||
105849979|NCT00809159|365109694|FG005|Part 1 and 2|Withdrawal by Subject|1|||
105849980|NCT03201211|365109698|FG000|Overall Study|Adverse Event|1|||
105849981|NCT03201211|365109699|FG001|Overall Study|Adverse Event|0|||
105974193|NCT00711802|365564177|FG007|Overall Study|Reason not reported|0|||
105974194|NCT02436408|365564179|FG000|Overall Study|Death|1|||
105974195|NCT01300819|365564180|FG000|Overall Study|Adverse Event|9|||
105974196|NCT01300819|365564181|FG001|Overall Study|Adverse Event|27|||
105974197|NCT01300819|365564180|FG000|Overall Study|Lack of Efficacy|2|||
105974198|NCT01300819|365564181|FG001|Overall Study|Lack of Efficacy|1|||
105974199|NCT01300819|365564180|FG000|Overall Study|Withdrawal by Subject|10|||
105974200|NCT01300819|365564181|FG001|Overall Study|Withdrawal by Subject|12|||
105974201|NCT01300819|365564180|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
105974202|NCT01300819|365564181|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
105974203|NCT01300819|365564180|FG000|Overall Study|Refusal to down titrate study drug|0|||
105974204|NCT01300819|365564181|FG001|Overall Study|Refusal to down titrate study drug|1|||
105974205|NCT01300819|365564180|FG000|Overall Study|Administrative reason|0|||
105974206|NCT01300819|365564181|FG001|Overall Study|Administrative reason|1|||
105974207|NCT01300819|365564180|FG000|Overall Study|Safety follow up not done by mistake|0|||
105974208|NCT01300819|365564181|FG001|Overall Study|Safety follow up not done by mistake|1|||
105974209|NCT01300819|365564180|FG000|Overall Study|Follow up call was not done|1|||
105974210|NCT01300819|365564181|FG001|Overall Study|Follow up call was not done|0|||
105974211|NCT00042432|365564187|FG000|Overall Study|Adverse Event|4|||
105974212|NCT00042432|365564188|FG001|Overall Study|Adverse Event|1|||
105974213|NCT00042432|365564187|FG000|Overall Study|Withdrawal by Subject|1|||
105974214|NCT00042432|365564188|FG001|Overall Study|Withdrawal by Subject|3|||
105974215|NCT00042432|365564187|FG000|Overall Study|Death|0|||
105974216|NCT00042432|365564188|FG001|Overall Study|Death|2|||
105974217|NCT00042432|365564187|FG000|Overall Study|Ineligibility determined|1|||
105974218|NCT00042432|365564188|FG001|Overall Study|Ineligibility determined|0|||
105974219|NCT00042432|365564187|FG000|Overall Study|Initiation of maintenance dialysis|1|||
105974220|NCT00042432|365564188|FG001|Overall Study|Initiation of maintenance dialysis|1|||
105974221|NCT00042432|365564187|FG000|Overall Study|Other|2|||
106026347|NCT00966875|365762374|FG004|Part B|Lost to Follow-up|0|||
106026348|NCT00966875|365762375|FG005|Part B|Lost to Follow-up|0|||
106026349|NCT00966875|365762376|FG006|Part B|Lost to Follow-up|0|||
106026350|NCT00966875|365762377|FG007|Part B|Lost to Follow-up|0|||
106026351|NCT00966875|365762378|FG008|Part B|Lost to Follow-up|1|||
106026352|NCT00966875|365762370|FG000|Part B|Physician Decision|0|||
106026353|NCT00966875|365762371|FG001|Part B|Physician Decision|0|||
106026354|NCT00966875|365762372|FG002|Part B|Physician Decision|1|||
106026355|NCT00966875|365762373|FG003|Part B|Physician Decision|0|||
106026356|NCT00966875|365762374|FG004|Part B|Physician Decision|2|||
106026357|NCT00966875|365762375|FG005|Part B|Physician Decision|1|||
106026358|NCT00966875|365762376|FG006|Part B|Physician Decision|0|||
106026359|NCT00966875|365762377|FG007|Part B|Physician Decision|0|||
106026360|NCT00966875|365762378|FG008|Part B|Physician Decision|2|||
106026361|NCT00966875|365762370|FG000|Part B|Sponsor Decision|1|||
106026362|NCT00966875|365762371|FG001|Part B|Sponsor Decision|0|||
106026363|NCT00966875|365762372|FG002|Part B|Sponsor Decision|0|||
106026364|NCT00966875|365762373|FG003|Part B|Sponsor Decision|0|||
106026365|NCT00966875|365762374|FG004|Part B|Sponsor Decision|0|||
106026366|NCT00966875|365762375|FG005|Part B|Sponsor Decision|1|||
106026367|NCT00966875|365762376|FG006|Part B|Sponsor Decision|0|||
106026368|NCT00966875|365762377|FG007|Part B|Sponsor Decision|2|||
106026369|NCT00966875|365762378|FG008|Part B|Sponsor Decision|1|||
106026370|NCT00966875|365762370|FG000|Part B|Withdrawal by Subject|2|||
106026371|NCT00966875|365762371|FG001|Part B|Withdrawal by Subject|1|||
106026372|NCT00966875|365762372|FG002|Part B|Withdrawal by Subject|2|||
106026373|NCT00966875|365762373|FG003|Part B|Withdrawal by Subject|1|||
106026374|NCT00966875|365762374|FG004|Part B|Withdrawal by Subject|2|||
106026375|NCT00966875|365762375|FG005|Part B|Withdrawal by Subject|1|||
106026376|NCT00966875|365762376|FG006|Part B|Withdrawal by Subject|4|||
106026377|NCT00966875|365762377|FG007|Part B|Withdrawal by Subject|5|||
106026378|NCT00966875|365762378|FG008|Part B|Withdrawal by Subject|5|||
106026379|NCT00966875|365762370|FG000|Part B|Entry Criteria|0|||
106026380|NCT00966875|365762371|FG001|Part B|Entry Criteria|0|||
106026381|NCT00966875|365762372|FG002|Part B|Entry Criteria|0|||
106026382|NCT00966875|365762373|FG003|Part B|Entry Criteria|0|||
106026383|NCT00966875|365762374|FG004|Part B|Entry Criteria|0|||
106026384|NCT00966875|365762375|FG005|Part B|Entry Criteria|0|||
106026385|NCT00966875|365762376|FG006|Part B|Entry Criteria|1|||
106026386|NCT00966875|365762377|FG007|Part B|Entry Criteria|0|||
106026387|NCT00966875|365762378|FG008|Part B|Entry Criteria|1|||
106026388|NCT01206322|365762379|FG000|Overall Study|Adverse Event|0|||
106026389|NCT01206322|365762380|FG001|Overall Study|Adverse Event|0|||
106026390|NCT01206322|365762381|FG002|Overall Study|Adverse Event|0|||
106026391|NCT01206322|365762382|FG003|Overall Study|Adverse Event|1|||
106026392|NCT01425463|365762388|FG000|Overall Study|Adverse Event|5|||
106026393|NCT01425463|365762389|FG001|Overall Study|Adverse Event|7|||
106026394|NCT01425463|365762388|FG000|Overall Study|Lack of Efficacy|1|||
106026395|NCT01425463|365762389|FG001|Overall Study|Lack of Efficacy|1|||
105974222|NCT00042432|365564188|FG001|Overall Study|Other|0|||
105974223|NCT01287221|365564192|FG000|Overall Study|Lack of Perceived Benefit|1|||
106026396|NCT01425463|365762388|FG000|Overall Study|Protocol Violation|2|||
106026397|NCT01425463|365762389|FG001|Overall Study|Protocol Violation|2|||
106150317|NCT02677896|366211515|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
106150318|NCT02677896|366211516|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
106150319|NCT02677896|366211515|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
106150320|NCT02677896|366211516|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
106150321|NCT02677896|366211515|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
106150322|NCT02677896|366211516|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
106150323|NCT02677896|366211515|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
106150324|NCT02677896|366211516|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
106150325|NCT02677896|366211515|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
106150326|NCT02677896|366211516|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
106150327|NCT02677896|366211515|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
106150328|NCT02677896|366211516|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
106150329|NCT02677896|366211515|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
106150330|NCT02677896|366211516|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
106150331|NCT02321514|366211517|FG000|Overall Study|Death|15|||
106150332|NCT02321514|366211517|FG000|Overall Study|Missed Visit|7|||
105974224|NCT01287221|365564193|FG001|Overall Study|Lack of Perceived Benefit|1|||
105974225|NCT01287221|365564192|FG000|Overall Study|Adverse Event|3|||
105974226|NCT01287221|365564193|FG001|Overall Study|Adverse Event|3|||
105974227|NCT01287221|365564192|FG000|Overall Study|Withdrawal by Subject|0|||
105974228|NCT01287221|365564193|FG001|Overall Study|Withdrawal by Subject|1|||
105974229|NCT01444027|365564194|FG000|Overall Study|Withdrawal by Subject|4|||
105974230|NCT01444027|365564195|FG001|Overall Study|Withdrawal by Subject|10|||
105974231|NCT01444027|365564196|FG002|Overall Study|Withdrawal by Subject|24|||
105974232|NCT01444027|365564194|FG000|Overall Study|Lost to Follow-up|26|||
105974233|NCT01444027|365564195|FG001|Overall Study|Lost to Follow-up|20|||
105974234|NCT01444027|365564196|FG002|Overall Study|Lost to Follow-up|14|||
105974235|NCT02966795|365564198|FG000|Overall Study|Patient Left the Country|0|||
105974236|NCT02966795|365564199|FG001|Overall Study|Patient Left the Country|1|||
105974237|NCT00432744|365564200|FG000|Months 0-6|Withdrawal by Subject|4|||
105974238|NCT00432744|365564201|FG001|Months 0-6|Withdrawal by Subject|4|||
105974239|NCT00432744|365564200|FG000|Months 0-6|Too disabled to score|1|||
105974240|NCT00432744|365564201|FG001|Months 0-6|Too disabled to score|0|||
105974241|NCT00432744|365564200|FG000|Months 7 - 12|Withdrawal by Subject|1|||
105974242|NCT00432744|365564201|FG001|Months 7 - 12|Withdrawal by Subject|0|||
105974243|NCT00432744|365564200|FG000|Months 7 - 12|Too disabled to score|0|||
105974244|NCT00432744|365564201|FG001|Months 7 - 12|Too disabled to score|1|||
105974245|NCT01416441|365564202|FG000|Overall Study|Lost to Follow-up|5|||
105974246|NCT01416441|365564202|FG000|Overall Study|Adverse Event|6|||
105974247|NCT01416441|365564202|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
106150333|NCT02321514|366211517|FG000|Overall Study|Study Exit|3|||
106150334|NCT00976937|366211520|FG000|Overall Study|Adverse Event|4|||
106150335|NCT00976937|366211521|FG001|Overall Study|Adverse Event|5|||
106150336|NCT00976937|366211520|FG000|Overall Study|Lost to Follow-up|2|||
105974248|NCT01416441|365564202|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
105974249|NCT01416441|365564202|FG000|Overall Study|Investigator Withdrew Subject|2|||
105974250|NCT01416441|365564202|FG000|Overall Study|Subject Withdrew Consent|12|||
105974251|NCT01416441|365564202|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
105974252|NCT01319721|365564213|FG000|Overall Study|Lost to Follow-up|1|||
105974253|NCT01319721|365564214|FG001|Overall Study|Lost to Follow-up|6|||
105974254|NCT01360398|365564215|FG000|Overall Study|Withdrawal by Subject|14|||
105974255|NCT01360398|365564215|FG000|Overall Study|Other|7|||
105974256|NCT01360398|365564215|FG000|Overall Study|Migrated/moved from study area|1|||
105974257|NCT00737711|365564216|FG000|Overall Study|Adverse Event|2|||
105974258|NCT00737711|365564216|FG000|Overall Study|Death|8|||
105974259|NCT00737711|365564216|FG000|Overall Study|Failure to return|4|||
105974260|NCT00737711|365564216|FG000|Overall Study|Protocol Violation|1|||
105974261|NCT00737711|365564216|FG000|Overall Study|Withdrawal by Subject|5|||
105974262|NCT00737711|365564216|FG000|Overall Study|Blood transfusion|6|||
105974263|NCT00737711|365564216|FG000|Overall Study|Other|5|||
105974264|NCT01263015|365566145|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
105974265|NCT01263015|365566146|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
105974266|NCT01263015|365566145|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
105974267|NCT01263015|365566146|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
105974268|NCT01263015|365566145|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
105974269|NCT01263015|365566146|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
106150337|NCT00976937|366211521|FG001|Overall Study|Lost to Follow-up|1|||
106150338|NCT00976937|366211520|FG000|Overall Study|Withdrawal by Subject|5|||
106150339|NCT00976937|366211521|FG001|Overall Study|Withdrawal by Subject|3|||
105974270|NCT01263015|365566145|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
105974271|NCT01263015|365566146|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
105974272|NCT01263015|365566145|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
106026398|NCT01425463|365762388|FG000|Overall Study|Lost to Follow-up|5|||
106150340|NCT00976937|366211520|FG000|Overall Study|Poor compliance to protocol|3|||
106150341|NCT00976937|366211521|FG001|Overall Study|Poor compliance to protocol|0|||
106150342|NCT00976937|366211520|FG000|Overall Study|Personal and Familial Reason|2|||
106150343|NCT00976937|366211521|FG001|Overall Study|Personal and Familial Reason|2|||
105974273|NCT01263015|365566146|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
105974274|NCT01263015|365566145|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
105974275|NCT01263015|365566146|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
105974276|NCT01263015|365566145|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
106150344|NCT04484935|366211524|FG000|Overall Study|Other|0|||
106150345|NCT04484935|366211525|FG001|Overall Study|Other|1|||
106150346|NCT04484935|366211524|FG000|Overall Study|Withdrawal by parent/guardian|0|||
106150347|NCT04484935|366211525|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106150348|NCT04484935|366211524|FG000|Overall Study|Lost to Follow-up|1|||
106150349|NCT04484935|366211525|FG001|Overall Study|Lost to Follow-up|0|||
106150350|NCT04484935|366211524|FG000|Overall Study|Death|2|||
106150351|NCT04484935|366211525|FG001|Overall Study|Death|1|||
106150352|NCT02178098|366211526|FG000|Overall Study|Withdrawal by Subject|0|||
106150353|NCT02178098|366211527|FG001|Overall Study|Withdrawal by Subject|6|||
106150354|NCT02178098|366211526|FG000|Overall Study|Adverse Event|1|||
106150355|NCT02178098|366211527|FG001|Overall Study|Adverse Event|2|||
106150356|NCT02178098|366211526|FG000|Overall Study|Protocol Violation|1|||
106150357|NCT02178098|366211527|FG001|Overall Study|Protocol Violation|1|||
106150358|NCT02178098|366211526|FG000|Overall Study|Lost to Follow-up|0|||
106150359|NCT02178098|366211527|FG001|Overall Study|Lost to Follow-up|1|||
106150360|NCT02178098|366211526|FG000|Overall Study|Sponsor Request|1|||
106150361|NCT02178098|366211527|FG001|Overall Study|Sponsor Request|0|||
105974277|NCT01263015|365566146|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
105849982|NCT03201211|365109700|FG002|Overall Study|Adverse Event|0|||
105849983|NCT03201211|365109698|FG000|Overall Study|Protocol Violation|1|||
105849984|NCT03201211|365109699|FG001|Overall Study|Protocol Violation|0|||
105849985|NCT03201211|365109700|FG002|Overall Study|Protocol Violation|0|||
105974278|NCT01263015|365566145|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
105974279|NCT01263015|365566146|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
105974280|NCT01263015|365566145|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
105974281|NCT01263015|365566146|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
105974282|NCT01263015|365566145|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
105974283|NCT01263015|365566146|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
105974284|NCT01263015|365566145|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
105974285|NCT01263015|365566146|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
105974286|NCT01263015|365566145|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
105849986|NCT03201211|365109698|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105849987|NCT03201211|365109699|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
105849988|NCT03201211|365109700|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
105849989|NCT03201211|365109698|FG000|Overall Study|OTHER unknown reasons|0|||
105849990|NCT03201211|365109699|FG001|Overall Study|OTHER unknown reasons|1|||
105974287|NCT01263015|365566146|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
105974288|NCT01460719|365566149|FG000|Overall Study|Adverse Event|1|||
105974289|NCT01460719|365566149|FG000|Overall Study|Withdrawal by Subject|1|||
105974290|NCT04035564|365566150|FG000|Overall Study|Protocol Violation|1|||
105974291|NCT04035564|365566151|FG001|Overall Study|Protocol Violation|2|||
105974292|NCT04035564|365566150|FG000|Overall Study|No laboratory available|2|||
105974293|NCT04035564|365566151|FG001|Overall Study|No laboratory available|2|||
105974294|NCT04035564|365566150|FG000|Overall Study|Guardian declined consent|1|||
105974295|NCT04035564|365566151|FG001|Overall Study|Guardian declined consent|2|||
105974296|NCT02838901|365566152|FG000|Overall Study|Withdrawal by Subject|1|||
105974297|NCT02838901|365566153|FG001|Overall Study|Withdrawal by Subject|1|||
105974298|NCT02838901|365566152|FG000|Overall Study|Lost to Follow-up|1|||
105974299|NCT02838901|365566153|FG001|Overall Study|Lost to Follow-up|1|||
105974300|NCT00149994|365566154|FG000|Overall Study|Administrative problems:|1|||
105974301|NCT00149994|365566155|FG001|Overall Study|Administrative problems:|0|||
105974302|NCT00149994|365566154|FG000|Overall Study|Protocol Violation|0|||
105974303|NCT00149994|365566155|FG001|Overall Study|Protocol Violation|1|||
105974304|NCT03405935|365566157|FG000|Overall Study|Adverse Event|3|||
105974305|NCT03405935|365566157|FG000|Overall Study|Death|2|||
105974306|NCT03405935|365566157|FG000|Overall Study|Withdrawal by Subject|1|||
105974307|NCT03405935|365566157|FG000|Overall Study|Lost to Follow-up|2|||
105974308|NCT04979897|365566158|FG000|Overall Study|Death|1|||
105974309|NCT04979897|365566159|FG001|Overall Study|Death|8|||
105974310|NCT04979897|365566158|FG000|Overall Study|Lost to Follow-up|111|||
105974311|NCT04979897|365566159|FG001|Overall Study|Lost to Follow-up|56|||
105974312|NCT04979897|365566158|FG000|Overall Study|Withdrawal by Subject|7|||
105974313|NCT04979897|365566159|FG001|Overall Study|Withdrawal by Subject|2|||
105974314|NCT01224821|365566160|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
106150362|NCT02178098|366211526|FG000|Overall Study|Other|2|||
105849991|NCT03201211|365109700|FG002|Overall Study|OTHER unknown reasons|0|||
105974315|NCT01224821|365566160|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
105974316|NCT01224821|365566160|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
105974317|NCT01224821|365566160|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
105974318|NCT01224821|365566160|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
105974319|NCT01224821|365566160|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
105974320|NCT01224821|365566160|FG000|Long-Term Follow-Up|Death|2|||
105974321|NCT01224821|365566160|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
105974322|NCT03538444|365566161|FG000|Overall Study|opioid withdrawal|1|||
105974323|NCT03538444|365566162|FG001|Overall Study|opioid withdrawal|0|||
105974324|NCT00350623|365566165|FG000|Overall Study|Lost to Follow-up|8|||
105974325|NCT00350623|365566166|FG001|Overall Study|Lost to Follow-up|3|||
105974326|NCT00350623|365566167|FG002|Overall Study|Lost to Follow-up|4|||
105974327|NCT00350623|365566165|FG000|Overall Study|Withdrawal by Subject|0|||
105974328|NCT00350623|365566166|FG001|Overall Study|Withdrawal by Subject|1|||
105974329|NCT00350623|365566167|FG002|Overall Study|Withdrawal by Subject|1|||
105974330|NCT00350623|365566165|FG000|Overall Study|patient traveling outside the country|0|||
105974331|NCT00350623|365566166|FG001|Overall Study|patient traveling outside the country|0|||
105974332|NCT00350623|365566167|FG002|Overall Study|patient traveling outside the country|1|||
105974333|NCT02685748|365566168|FG000|Overall Study|Withdrawal by Subject|3|||
105974334|NCT02685748|365566169|FG001|Overall Study|Withdrawal by Subject|2|||
105974335|NCT04126564|365566170|FG000|Overall Study|Withdrawal by Subject|0|||
105974336|NCT04126564|365566171|FG001|Overall Study|Withdrawal by Subject|2|||
105974337|NCT04126564|365566170|FG000|Overall Study|Lost to Follow-up|0|||
105974338|NCT04126564|365566171|FG001|Overall Study|Lost to Follow-up|1|||
105974339|NCT02435680|365566173|FG000|Overall Study|Physician Decision|3|||
105974340|NCT02435680|365566174|FG001|Overall Study|Physician Decision|0|||
105974341|NCT02435680|365566175|FG002|Overall Study|Physician Decision|0|||
105974342|NCT02435680|365566173|FG000|Overall Study|subject / guardian decision|0|||
105974343|NCT02435680|365566174|FG001|Overall Study|subject / guardian decision|3|||
105974344|NCT02435680|365566175|FG002|Overall Study|subject / guardian decision|2|||
105974345|NCT02435680|365566173|FG000|Overall Study|Adverse Event|8|||
105974346|NCT02435680|365566174|FG001|Overall Study|Adverse Event|3|||
105974347|NCT02435680|365566175|FG002|Overall Study|Adverse Event|2|||
105974348|NCT02435680|365566173|FG000|Overall Study|progressive disease|10|||
105974349|NCT02435680|365566174|FG001|Overall Study|progressive disease|7|||
105974350|NCT02435680|365566175|FG002|Overall Study|progressive disease|11|||
105974351|NCT02435680|365566173|FG000|Overall Study|not treated|0|||
105974352|NCT02435680|365566174|FG001|Overall Study|not treated|0|||
105974353|NCT02435680|365566175|FG002|Overall Study|not treated|1|||
105974354|NCT03028480|365566176|FG000|Overall Study|No revisit after the first prescription date|2|||
105974355|NCT03028480|365566176|FG000|Overall Study|Did not use the drug|1|||
105974356|NCT03028480|365566176|FG000|Overall Study|Violation of the enrollment deadline|10|||
105974357|NCT03028480|365566176|FG000|Overall Study|Case report forms were not collected|21|||
105974358|NCT02509052|365566177|FG000|Overall Study|Non compliance|0|||
105974359|NCT02509052|365566178|FG001|Overall Study|Non compliance|0|||
105974360|NCT02509052|365566179|FG002|Overall Study|Non compliance|1|||
105974361|NCT02585830|365566180|FG000|Overall Study|Withdrawal by Subject|3|||
105974362|NCT01904149|365566181|FG000|Overall Study|Adverse Event|3|||
105974363|NCT01904149|365566182|FG001|Overall Study|Adverse Event|4|||
105974364|NCT01904149|365566183|FG002|Overall Study|Adverse Event|0|||
105974365|NCT01904149|365566184|FG003|Overall Study|Adverse Event|1|||
105974366|NCT01904149|365566185|FG004|Overall Study|Adverse Event|1|||
105974367|NCT01904149|365566186|FG005|Overall Study|Adverse Event|2|||
105974368|NCT01904149|365566181|FG000|Overall Study|Lack of Efficacy|0|||
105974369|NCT01904149|365566182|FG001|Overall Study|Lack of Efficacy|3|||
105974370|NCT01904149|365566183|FG002|Overall Study|Lack of Efficacy|1|||
105974371|NCT01904149|365566184|FG003|Overall Study|Lack of Efficacy|3|||
105974372|NCT01904149|365566185|FG004|Overall Study|Lack of Efficacy|3|||
105974373|NCT01904149|365566186|FG005|Overall Study|Lack of Efficacy|1|||
105974374|NCT01904149|365566181|FG000|Overall Study|Withdrawal by Subject|1|||
105974375|NCT01904149|365566182|FG001|Overall Study|Withdrawal by Subject|3|||
105974376|NCT01904149|365566183|FG002|Overall Study|Withdrawal by Subject|1|||
105974377|NCT01904149|365566184|FG003|Overall Study|Withdrawal by Subject|0|||
105974378|NCT01904149|365566185|FG004|Overall Study|Withdrawal by Subject|1|||
105974379|NCT01904149|365566186|FG005|Overall Study|Withdrawal by Subject|0|||
105974380|NCT01904149|365566181|FG000|Overall Study|Protocol Violation|0|||
105974381|NCT01904149|365566182|FG001|Overall Study|Protocol Violation|1|||
105974382|NCT01904149|365566183|FG002|Overall Study|Protocol Violation|0|||
105974383|NCT01904149|365566184|FG003|Overall Study|Protocol Violation|0|||
105974384|NCT01904149|365566185|FG004|Overall Study|Protocol Violation|0|||
105974385|NCT01904149|365566186|FG005|Overall Study|Protocol Violation|0|||
105974386|NCT01904149|365566181|FG000|Overall Study|non compliance with study drug|1|||
105974387|NCT01904149|365566182|FG001|Overall Study|non compliance with study drug|0|||
105974388|NCT01904149|365566183|FG002|Overall Study|non compliance with study drug|0|||
105974389|NCT01904149|365566184|FG003|Overall Study|non compliance with study drug|0|||
105974390|NCT01904149|365566185|FG004|Overall Study|non compliance with study drug|0|||
105974391|NCT01904149|365566186|FG005|Overall Study|non compliance with study drug|0|||
105974392|NCT00068250|365566187|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
105974393|NCT00068250|365566188|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
105974394|NCT00068250|365566189|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
105974395|NCT00068250|365566190|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
105974396|NCT02098369|365566192|FG000|Overall Study|Withdrawal by Subject|1|||
105974397|NCT02098369|365566193|FG001|Overall Study|Withdrawal by Subject|5|||
105974398|NCT02098369|365566194|FG002|Overall Study|Withdrawal by Subject|0|||
105974399|NCT02098369|365566192|FG000|Overall Study|Lost to Follow-up|5|||
105974400|NCT02098369|365566193|FG001|Overall Study|Lost to Follow-up|1|||
105974401|NCT02098369|365566194|FG002|Overall Study|Lost to Follow-up|3|||
105974402|NCT02098369|365566192|FG000|Overall Study|Death|1|||
105974403|NCT02098369|365566193|FG001|Overall Study|Death|1|||
105974404|NCT02098369|365566194|FG002|Overall Study|Death|1|||
105974405|NCT02098369|365566192|FG000|Overall Study|Other|0|||
105974406|NCT02098369|365566193|FG001|Overall Study|Other|2|||
105974407|NCT02098369|365566194|FG002|Overall Study|Other|1|||
105974408|NCT03362931|365566195|FG000|Overall Study|Adverse Event|1|||
105974409|NCT03362931|365566195|FG000|Overall Study|Death|2|||
105974410|NCT02927925|365566207|FG000|Overall Study|Death|16|||
105974411|NCT02927925|365566207|FG000|Overall Study|Physician Decision|1|||
105974412|NCT02927925|365566207|FG000|Overall Study|Withdrawal by Subject|11|||
105974413|NCT02927925|365566207|FG000|Overall Study|Other|3|||
105974414|NCT02927925|365566207|FG000|Overall Study|Disease progression at clinical cutoff|1|||
105974415|NCT01080768|365566208|FG000|Overall Study|Protocol Deviation|2|||
105974416|NCT01080768|365566209|FG001|Overall Study|Protocol Deviation|1|||
105974417|NCT00246025|365566214|FG000|Overall Study|Adverse Event|7|||
105974418|NCT00246025|365566215|FG001|Overall Study|Adverse Event|9|||
105974419|NCT00246025|365566216|FG002|Overall Study|Adverse Event|9|||
105974420|NCT00246025|365566217|FG003|Overall Study|Adverse Event|10|||
105974421|NCT00246025|365566214|FG000|Overall Study|Withdrawal by Subject|3|||
105974422|NCT00246025|365566215|FG001|Overall Study|Withdrawal by Subject|0|||
105974423|NCT00246025|365566216|FG002|Overall Study|Withdrawal by Subject|1|||
105974424|NCT00246025|365566217|FG003|Overall Study|Withdrawal by Subject|2|||
105974425|NCT00246025|365566214|FG000|Overall Study|unsuitable medical history was found|0|||
105974426|NCT00246025|365566215|FG001|Overall Study|unsuitable medical history was found|0|||
105974427|NCT00246025|365566216|FG002|Overall Study|unsuitable medical history was found|0|||
105974428|NCT00246025|365566217|FG003|Overall Study|unsuitable medical history was found|1|||
105974429|NCT01643850|365566218|FG000|Overall Study|Withdrawal by Subject|0|||
105974430|NCT01643850|365566219|FG001|Overall Study|Withdrawal by Subject|0|||
105974431|NCT01643850|365566220|FG002|Overall Study|Withdrawal by Subject|0|||
105974432|NCT01643850|365566221|FG003|Overall Study|Withdrawal by Subject|0|||
105974433|NCT01643850|365566222|FG004|Overall Study|Withdrawal by Subject|1|||
105974434|NCT01643850|365566223|FG005|Overall Study|Withdrawal by Subject|0|||
105974435|NCT01643850|365566224|FG006|Overall Study|Withdrawal by Subject|0|||
105974436|NCT01643850|365566225|FG007|Overall Study|Withdrawal by Subject|0|||
105974437|NCT01643850|365566226|FG008|Overall Study|Withdrawal by Subject|0|||
105974438|NCT01643850|365566218|FG000|Overall Study|Lost to Follow-up|0|||
105974439|NCT01643850|365566219|FG001|Overall Study|Lost to Follow-up|0|||
105974440|NCT01643850|365566220|FG002|Overall Study|Lost to Follow-up|0|||
105974441|NCT01643850|365566221|FG003|Overall Study|Lost to Follow-up|0|||
105974442|NCT01643850|365566222|FG004|Overall Study|Lost to Follow-up|0|||
105974443|NCT01643850|365566223|FG005|Overall Study|Lost to Follow-up|0|||
105974444|NCT01643850|365566224|FG006|Overall Study|Lost to Follow-up|1|||
105974445|NCT01643850|365566225|FG007|Overall Study|Lost to Follow-up|0|||
105974446|NCT01643850|365566226|FG008|Overall Study|Lost to Follow-up|1|||
105974447|NCT01643850|365566218|FG000|Overall Study|Adverse Event|0|||
105974448|NCT01643850|365566219|FG001|Overall Study|Adverse Event|0|||
105974449|NCT01643850|365566220|FG002|Overall Study|Adverse Event|0|||
105974450|NCT01643850|365566221|FG003|Overall Study|Adverse Event|0|||
105974451|NCT01643850|365566222|FG004|Overall Study|Adverse Event|1|||
105974452|NCT01643850|365566223|FG005|Overall Study|Adverse Event|0|||
105974453|NCT01643850|365566224|FG006|Overall Study|Adverse Event|0|||
105974454|NCT01643850|365566225|FG007|Overall Study|Adverse Event|0|||
105974455|NCT01643850|365566226|FG008|Overall Study|Adverse Event|0|||
105974456|NCT01643850|365566218|FG000|Overall Study|Administrative Problems|0|||
105974457|NCT01643850|365566219|FG001|Overall Study|Administrative Problems|0|||
105974458|NCT01643850|365566220|FG002|Overall Study|Administrative Problems|1|||
105974459|NCT01643850|365566221|FG003|Overall Study|Administrative Problems|0|||
105974460|NCT01643850|365566222|FG004|Overall Study|Administrative Problems|1|||
105974461|NCT01643850|365566223|FG005|Overall Study|Administrative Problems|0|||
105974462|NCT01643850|365566224|FG006|Overall Study|Administrative Problems|0|||
105974463|NCT01643850|365566225|FG007|Overall Study|Administrative Problems|0|||
105974464|NCT01643850|365566226|FG008|Overall Study|Administrative Problems|0|||
105974465|NCT00931723|365566227|FG000|Overall Study|Withdrawal by Subject|11|||
105974466|NCT00931723|365566228|FG001|Overall Study|Withdrawal by Subject|13|||
105974467|NCT00931723|365566227|FG000|Overall Study|Adverse Event|6|||
105974468|NCT00931723|365566228|FG001|Overall Study|Adverse Event|13|||
106026399|NCT01425463|365762389|FG001|Overall Study|Lost to Follow-up|2|||
106026400|NCT01425463|365762388|FG000|Overall Study|Withdrawal by Subject|7|||
106026401|NCT01425463|365762389|FG001|Overall Study|Withdrawal by Subject|5|||
106026402|NCT01425463|365762388|FG000|Overall Study|Unknown Reason|4|||
106026403|NCT01425463|365762389|FG001|Overall Study|Unknown Reason|7|||
106026404|NCT00668733|365762390|FG000|Overall Study|Lost to Follow-up|2|||
106026405|NCT00668733|365762391|FG001|Overall Study|Lost to Follow-up|3|||
106026406|NCT00668733|365762390|FG000|Overall Study|Withdrawal by Subject|0|||
106026407|NCT00668733|365762391|FG001|Overall Study|Withdrawal by Subject|4|||
105974469|NCT00931723|365566227|FG000|Overall Study|Lithium found in blood|0|||
105974470|NCT00931723|365566228|FG001|Overall Study|Lithium found in blood|1|||
105974471|NCT00931723|365566227|FG000|Overall Study|Condition under investigation worsened|1|||
105974472|NCT00931723|365566228|FG001|Overall Study|Condition under investigation worsened|2|||
105974473|NCT00931723|365566227|FG000|Overall Study|Lost to Follow-up|1|||
105974474|NCT00931723|365566228|FG001|Overall Study|Lost to Follow-up|2|||
105974475|NCT00931723|365566227|FG000|Overall Study|Study-specific discontinuation criteria|1|||
105974476|NCT00931723|365566228|FG001|Overall Study|Study-specific discontinuation criteria|1|||
105974477|NCT00931723|365566227|FG000|Overall Study|Severe non-compliance to protocol|2|||
105974478|NCT00931723|365566228|FG001|Overall Study|Severe non-compliance to protocol|0|||
105974479|NCT00931723|365566227|FG000|Overall Study|Safety reasons|0|||
105974480|NCT00931723|365566228|FG001|Overall Study|Safety reasons|1|||
105974481|NCT00931723|365566227|FG000|Overall Study|Took prohibited concomitant medication|0|||
105974482|NCT00931723|365566228|FG001|Overall Study|Took prohibited concomitant medication|1|||
105974483|NCT00931723|365566227|FG000|Overall Study|Lack or insufficient theraputic response|2|||
105974484|NCT00931723|365566228|FG001|Overall Study|Lack or insufficient theraputic response|5|||
105974485|NCT00931723|365566227|FG000|Overall Study|Sponsor decision|1|||
105974486|NCT00931723|365566228|FG001|Overall Study|Sponsor decision|0|||
105974487|NCT00931723|365566227|FG000|Overall Study|Late hospital discharge|1|||
105974488|NCT00931723|365566228|FG001|Overall Study|Late hospital discharge|0|||
105974489|NCT03054350|365566229|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
105849992|NCT02478320|365109701|FG000|Overall Study|Adverse Event|2|||
105849993|NCT02478320|365109702|FG001|Overall Study|Adverse Event|0|||
105849994|NCT02478320|365109701|FG000|Overall Study|Death|1|||
105849995|NCT02478320|365109702|FG001|Overall Study|Death|0|||
105849996|NCT02478320|365109701|FG000|Overall Study|Lack of Efficacy|4|||
105849997|NCT02478320|365109702|FG001|Overall Study|Lack of Efficacy|0|||
105849998|NCT02478320|365109701|FG000|Overall Study|Withdrawal by Subject|2|||
105849999|NCT02478320|365109702|FG001|Overall Study|Withdrawal by Subject|0|||
105850000|NCT02478320|365109701|FG000|Overall Study|Screen Failure|3|||
105850001|NCT02478320|365109702|FG001|Overall Study|Screen Failure|0|||
105850002|NCT02041091|365109703|FG000|Treatment|Adverse Event|3|||
105850003|NCT02041091|365109704|FG001|Treatment|Adverse Event|3|||
105850004|NCT02041091|365109703|FG000|Treatment|Withdrawal by Subject|2|||
105850005|NCT02041091|365109704|FG001|Treatment|Withdrawal by Subject|4|||
105850006|NCT02041091|365109703|FG000|Treatment|Physician Decision|1|||
105850007|NCT02041091|365109704|FG001|Treatment|Physician Decision|0|||
105850008|NCT02041091|365109703|FG000|Treatment|Sponsor Decision|15|||
105850009|NCT02041091|365109704|FG001|Treatment|Sponsor Decision|16|||
105850010|NCT02041091|365109703|FG000|Treatment|Lost to Follow-up|1|||
105850011|NCT02041091|365109704|FG001|Treatment|Lost to Follow-up|0|||
105850012|NCT02041091|365109703|FG000|Optional Safety Extension Period|Adverse Event|4|||
105850013|NCT02041091|365109704|FG001|Optional Safety Extension Period|Adverse Event|2|||
105850014|NCT02041091|365109703|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
105850015|NCT02041091|365109704|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
105850016|NCT02041091|365109703|FG000|Optional Safety Extension Period|Protocol Violation|2|||
105850017|NCT02041091|365109704|FG001|Optional Safety Extension Period|Protocol Violation|0|||
105850018|NCT02041091|365109703|FG000|Optional Safety Extension Period|Physician Decision|2|||
105850019|NCT02041091|365109704|FG001|Optional Safety Extension Period|Physician Decision|1|||
105850020|NCT02041091|365109703|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
105850021|NCT02041091|365109704|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
105850022|NCT02041091|365109703|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
105850023|NCT02041091|365109704|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
105850024|NCT00922987|365109705|FG000|Overall Study|Insufficient clinical response|1|||
105850025|NCT00922987|365109705|FG000|Overall Study|Protocol Violation|2|||
105850026|NCT00922987|365109705|FG000|Overall Study|Adverse Event|1|||
106026408|NCT02386189|365762394|FG000|Overall Study|Lost to Follow-up|2|||
106026409|NCT02386189|365762395|FG001|Overall Study|Lost to Follow-up|3|||
106026410|NCT02386189|365762394|FG000|Overall Study|Withdrawal by Subject|1|||
106026411|NCT02386189|365762395|FG001|Overall Study|Withdrawal by Subject|0|||
105974490|NCT03054350|365566230|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
105850027|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
105850028|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
106026412|NCT02386189|365762394|FG000|Overall Study|Death|1|||
106026413|NCT02386189|365762395|FG001|Overall Study|Death|0|||
105850029|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850030|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850031|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850032|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850033|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850034|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850035|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850036|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850037|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850038|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850039|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850040|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
105850041|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
105850042|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
105850043|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850044|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850045|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850046|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850047|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850048|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850049|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850050|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850051|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850052|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850053|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850054|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
105850055|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
105850056|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
105850057|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850058|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850059|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850060|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850061|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850062|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850063|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850064|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850065|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850066|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850067|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850068|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
105850069|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
105850070|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
105850071|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850072|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850073|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850074|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850075|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850076|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850077|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850078|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850079|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850080|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850081|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850082|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
105850083|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
105850084|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
105850085|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850086|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850087|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850088|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850089|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850090|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850091|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850092|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850093|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105850094|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105974491|NCT03054350|365566231|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
105974492|NCT03054350|365566232|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
105974493|NCT03054350|365566233|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
105974494|NCT03054350|365566234|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
105974495|NCT03054350|365566229|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105974496|NCT03054350|365566230|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105850095|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105974497|NCT03054350|365566231|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
105974498|NCT03054350|365566232|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
106150363|NCT02178098|366211527|FG001|Overall Study|Other|2|||
106150364|NCT00031694|366211528|FG000|Overall Study|Adverse Event|12|||
105974499|NCT03054350|365566233|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105974500|NCT03054350|365566234|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
105974501|NCT03054350|365566229|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
105974502|NCT03054350|365566230|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
105974503|NCT03054350|365566231|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
105974504|NCT03054350|365566232|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
105974505|NCT03054350|365566233|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
105974506|NCT03054350|365566234|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
105974507|NCT03054350|365566229|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105974508|NCT03054350|365566230|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105974509|NCT03054350|365566231|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
105974510|NCT03054350|365566232|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105974511|NCT03054350|365566233|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105974512|NCT03054350|365566234|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
105974513|NCT01774253|365566241|FG000|Overall Study|Lack of Efficacy|4|||
105974514|NCT01774253|365566241|FG000|Overall Study|Physician Decision|2|||
106150365|NCT00031694|366211528|FG000|Overall Study|Death|2|||
106150366|NCT00031694|366211528|FG000|Overall Study|Withdrawal by Subject|5|||
106150367|NCT04428112|366211536|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
106150368|NCT04428112|366211537|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
106150369|NCT04428112|366211536|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
106150370|NCT04428112|366211537|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
106150371|NCT04428112|366211536|FG000|Overall Study|Withdrawal by Subject|9|||
106150372|NCT04428112|366211537|FG001|Overall Study|Withdrawal by Subject|4|||
106150373|NCT04428112|366211536|FG000|Overall Study|Lost to Follow-up|27|||
106150374|NCT04428112|366211537|FG001|Overall Study|Lost to Follow-up|7|||
106150375|NCT03690206|366211539|FG000|Overall Study|Withdrawal by Subject|2|||
106150376|NCT03690206|366211540|FG001|Overall Study|Withdrawal by Subject|0|||
106150377|NCT03690206|366211541|FG002|Overall Study|Withdrawal by Subject|0|||
106150378|NCT03690206|366211539|FG000|Overall Study|ICF withdrawal|2|||
106150379|NCT03690206|366211540|FG001|Overall Study|ICF withdrawal|0|||
106150380|NCT03690206|366211541|FG002|Overall Study|ICF withdrawal|0|||
106150381|NCT04402294|366211542|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
106150382|NCT04402294|366211543|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
106150383|NCT04402294|366211542|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
106150384|NCT04402294|366211543|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
106150385|NCT04139668|366212522|FG000|Overall Study|Withdrawal by Subject|1|||
106150386|NCT05656911|366212525|FG000|Treatment Phase|Physician Decision|2|||
106150387|NCT05656911|366212526|FG001|Treatment Phase|Physician Decision|0|||
106150388|NCT05656911|366212525|FG000|Treatment Phase|Lack of Efficacy|6|||
106150389|NCT05656911|366212526|FG001|Treatment Phase|Lack of Efficacy|3|||
106150390|NCT05656911|366212525|FG000|Treatment Phase|Subject Decision|4|||
106150391|NCT05656911|366212526|FG001|Treatment Phase|Subject Decision|2|||
106150392|NCT05656911|366212525|FG000|Treatment Phase|Other Reasons|1|||
106150393|NCT05656911|366212526|FG001|Treatment Phase|Other Reasons|0|||
105850096|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
105974515|NCT01774253|365566241|FG000|Overall Study|Withdrawal by Subject|2|||
106150394|NCT05656911|366212525|FG000|Treatment Phase|Adverse Event|3|||
105974516|NCT01774253|365566241|FG000|Overall Study|Death|1|||
105974517|NCT02240368|365566242|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
105974518|NCT02240368|365566243|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
105974519|NCT02240368|365566244|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
105974520|NCT02240368|365566242|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
105974521|NCT02240368|365566243|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
106150395|NCT05656911|366212526|FG001|Treatment Phase|Adverse Event|1|||
106150396|NCT05656911|366212525|FG000|Follow-up Phase|Subject Decision|0|||
105850097|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
105974522|NCT02240368|365566244|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
105974523|NCT03510468|365566245|FG000|Overall Study|Lost to Follow-up|1|||
105850098|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
105850099|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850100|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850101|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850102|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850103|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850104|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850105|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850106|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850107|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850108|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850109|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850110|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
105850111|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
105850112|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
105850113|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850114|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850115|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850116|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105974524|NCT03510468|365566245|FG000|Overall Study|Adverse Event|5|||
105974525|NCT03510468|365566245|FG000|Overall Study|Physician Decision|1|||
105974526|NCT03510468|365566245|FG000|Overall Study|non-compliant with treatment|2|||
105974527|NCT03510468|365566245|FG000|Overall Study|Missed visit|1|||
105974528|NCT04612842|365566246|FG000|Overall Study|Lost to Follow-up|20|||
105974529|NCT04612842|365566247|FG001|Overall Study|Lost to Follow-up|11|||
105974530|NCT04612842|365566246|FG000|Overall Study|Withdrawal by Subject|26|||
105974531|NCT04612842|365566247|FG001|Overall Study|Withdrawal by Subject|15|||
105974532|NCT04612842|365566246|FG000|Overall Study|Death|2|||
105974533|NCT04612842|365566247|FG001|Overall Study|Death|2|||
105974534|NCT05426031|365566248|FG000|Overall Study|Circulatory Arrest|3|||
105974535|NCT05426031|365566249|FG001|Overall Study|Circulatory Arrest|2|||
105974536|NCT02419131|365566250|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
105974537|NCT02419131|365566251|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
105974538|NCT02419131|365566252|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
105974539|NCT02419131|365566250|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
105974540|NCT02419131|365566251|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
105974541|NCT02419131|365566252|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
105974542|NCT04677660|365566253|FG000|Overall Study|Lost to Follow-up|0|||
105974543|NCT04677660|365566254|FG001|Overall Study|Lost to Follow-up|2|||
105974544|NCT04677660|365566253|FG000|Overall Study|Withdrawal by Subject|0|||
105974545|NCT04677660|365566254|FG001|Overall Study|Withdrawal by Subject|1|||
105974546|NCT04677660|365566253|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
105974547|NCT04677660|365566254|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
105974548|NCT03242772|365566255|FG000|Overall Study|Lost to Follow-up|2|||
105974549|NCT03242772|365566256|FG001|Overall Study|Lost to Follow-up|0|||
105974550|NCT03242772|365566255|FG000|Overall Study|Physician Decision|0|||
105974551|NCT03242772|365566256|FG001|Overall Study|Physician Decision|1|||
105974552|NCT03242772|365566255|FG000|Overall Study|Withdrawal by Subject|1|||
105974553|NCT03242772|365566256|FG001|Overall Study|Withdrawal by Subject|0|||
105974554|NCT03060512|365566257|FG000|Overall Study|Adverse Event|4|||
105974555|NCT03060512|365566258|FG001|Overall Study|Adverse Event|6|||
105974556|NCT03060512|365566257|FG000|Overall Study|Lost to Follow-up|1|||
105974557|NCT03060512|365566258|FG001|Overall Study|Lost to Follow-up|1|||
105974558|NCT03060512|365566257|FG000|Overall Study|Withdrawal by Subject|1|||
105974559|NCT03060512|365566258|FG001|Overall Study|Withdrawal by Subject|0|||
105974560|NCT03060512|365566257|FG000|Overall Study|Non-compliance with study medication|1|||
105974561|NCT03060512|365566258|FG001|Overall Study|Non-compliance with study medication|2|||
105974562|NCT00089986|365566259|FG000|Overall Study|Adverse Event|6|||
105974563|NCT00089986|365566260|FG001|Overall Study|Adverse Event|9|||
105974564|NCT00089986|365566261|FG002|Overall Study|Adverse Event|6|||
105850117|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850118|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105974565|NCT00089986|365566259|FG000|Overall Study|Lost to Follow-up|3|||
105974566|NCT00089986|365566260|FG001|Overall Study|Lost to Follow-up|1|||
105974567|NCT00089986|365566261|FG002|Overall Study|Lost to Follow-up|1|||
105974568|NCT00089986|365566259|FG000|Overall Study|Protocol Violation|0|||
105974569|NCT00089986|365566260|FG001|Overall Study|Protocol Violation|1|||
105974570|NCT00089986|365566261|FG002|Overall Study|Protocol Violation|0|||
105974571|NCT00089986|365566259|FG000|Overall Study|Patient transferred to another hospital|2|||
105974572|NCT00089986|365566260|FG001|Overall Study|Patient transferred to another hospital|1|||
105974573|NCT00089986|365566261|FG002|Overall Study|Patient transferred to another hospital|0|||
105974574|NCT00089986|365566259|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
105974575|NCT00089986|365566260|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
105974576|NCT00089986|365566261|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
105974577|NCT00089986|365566259|FG000|Overall Study|Hemohlobin stopping rule|0|||
105974578|NCT00089986|365566260|FG001|Overall Study|Hemohlobin stopping rule|1|||
105974579|NCT00089986|365566261|FG002|Overall Study|Hemohlobin stopping rule|0|||
105974580|NCT00089986|365566259|FG000|Overall Study|Investigator decision to withdrew|0|||
105974581|NCT00089986|365566260|FG001|Overall Study|Investigator decision to withdrew|1|||
105974582|NCT00089986|365566261|FG002|Overall Study|Investigator decision to withdrew|0|||
105974583|NCT00089986|365566259|FG000|Overall Study|Enrollment in another study|0|||
105974584|NCT00089986|365566260|FG001|Overall Study|Enrollment in another study|1|||
105974585|NCT00089986|365566261|FG002|Overall Study|Enrollment in another study|0|||
105974586|NCT00089986|365566259|FG000|Overall Study|Family decision|0|||
105974587|NCT00089986|365566260|FG001|Overall Study|Family decision|1|||
105974588|NCT00089986|365566261|FG002|Overall Study|Family decision|0|||
105974589|NCT00089986|365566259|FG000|Overall Study|Do not resuscitate (DNR)|0|||
105974590|NCT00089986|365566260|FG001|Overall Study|Do not resuscitate (DNR)|0|||
105974591|NCT00089986|365566261|FG002|Overall Study|Do not resuscitate (DNR)|1|||
105974592|NCT00089986|365566259|FG000|Overall Study|Withdrawal by Subject|3|||
105974593|NCT00089986|365566260|FG001|Overall Study|Withdrawal by Subject|6|||
105974594|NCT00089986|365566261|FG002|Overall Study|Withdrawal by Subject|2|||
105974595|NCT00241631|365566269|FG000|Run in (2 Weeks)|Physician Decision|3|||
105974596|NCT00241631|365566270|FG001|Run in (2 Weeks)|Physician Decision|3|||
105974597|NCT00241631|365566269|FG000|Phase 1 (4 Weeks)|sore throat|1|||
105974598|NCT00241631|365566270|FG001|Phase 1 (4 Weeks)|sore throat|0|||
105974599|NCT00241631|365566269|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
105974600|NCT00241631|365566270|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
105974601|NCT00241631|365566269|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
105974602|NCT00241631|365566270|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
105974603|NCT00241631|365566269|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
106026414|NCT00945906|365762401|FG000|Overall Study|Withdrawal by Subject|1|||
106026415|NCT00945906|365762401|FG000|Overall Study|Did not want to return for last visit|2|||
106026416|NCT00945906|365762401|FG000|Overall Study|Unable to return for last visit|2|||
106026417|NCT00945906|365762401|FG000|Overall Study|Moved to another country|2|||
106026418|NCT03700684|365762402|FG000|Overall Study|COVID-19|0|||
106026419|NCT03700684|365762403|FG001|Overall Study|COVID-19|0|||
106026420|NCT03700684|365762404|FG002|Overall Study|COVID-19|2|||
106026421|NCT03206788|365762407|FG000|Overall Study|Withdrawal by Subject|0|||
106026422|NCT03206788|365762408|FG001|Overall Study|Withdrawal by Subject|1|||
106026423|NCT03206788|365762407|FG000|Overall Study|Adverse Event|0|||
106026424|NCT03206788|365762408|FG001|Overall Study|Adverse Event|1|||
106026425|NCT03206788|365762407|FG000|Overall Study|Physician Decision|0|||
106026426|NCT03206788|365762408|FG001|Overall Study|Physician Decision|1|||
106026427|NCT00361634|365762409|FG000|Overall Study|Lost to Follow-up|1|||
106026428|NCT00361634|365762409|FG000|Overall Study|Withdrawal by Subject|1|||
106026429|NCT00388583|365762414|FG000|Overall Study|Protocol Violation|1|||
106026430|NCT00388583|365762415|FG001|Overall Study|Protocol Violation|0|||
106026431|NCT00388583|365762414|FG000|Overall Study|Withdrawal by Subject|3|||
106026432|NCT00388583|365762415|FG001|Overall Study|Withdrawal by Subject|3|||
106026433|NCT00388583|365762414|FG000|Overall Study|Serious Adverse Event|2|||
106026434|NCT00388583|365762415|FG001|Overall Study|Serious Adverse Event|0|||
106026435|NCT00388583|365762414|FG000|Overall Study|Did not receive vaccine|0|||
106026436|NCT00388583|365762415|FG001|Overall Study|Did not receive vaccine|1|||
106026437|NCT02366091|365762416|FG000|Overall Study|Withdrawal by Subject|3|||
106026438|NCT02366091|365762417|FG001|Overall Study|Withdrawal by Subject|7|||
106026439|NCT02366091|365762418|FG002|Overall Study|Withdrawal by Subject|3|||
106026440|NCT02366091|365762419|FG003|Overall Study|Withdrawal by Subject|1|||
106026441|NCT00759564|365762421|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
106026442|NCT00759564|365762422|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
106026443|NCT00759564|365762423|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
106026444|NCT00759564|365762424|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
106026445|NCT00759564|365762425|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
106026446|NCT00357760|365762430|FG000|Overall Study|Disease progression|44|||
105974604|NCT00241631|365566270|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
105974605|NCT02437305|365566271|FG000|Overall Study|Lost to Follow-up|18|||
105974606|NCT02437305|365566272|FG001|Overall Study|Lost to Follow-up|12|||
105974607|NCT01071200|365566275|FG000|Overall Study|Lack of ovarian response|1|||
105974608|NCT01071200|365566276|FG001|Overall Study|Lack of ovarian response|1|||
105974609|NCT01071200|365566275|FG000|Overall Study|No fertilization|4|||
106026447|NCT00357760|365762431|FG001|Overall Study|Disease progression|17|||
106026448|NCT00357760|365762430|FG000|Overall Study|Adverse Event|10|||
106026449|NCT00357760|365762431|FG001|Overall Study|Adverse Event|7|||
106026450|NCT00357760|365762430|FG000|Overall Study|Death|0|||
106026451|NCT00357760|365762431|FG001|Overall Study|Death|3|||
105974610|NCT01071200|365566276|FG001|Overall Study|No fertilization|0|||
105974611|NCT01071200|365566275|FG000|Overall Study|No oocytes retrieved|1|||
105974612|NCT01071200|365566276|FG001|Overall Study|No oocytes retrieved|1|||
105974613|NCT01071200|365566275|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
105974614|NCT01071200|365566276|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
105974615|NCT01071200|365566275|FG000|Overall Study|No viable embryos|0|||
105974616|NCT01071200|365566276|FG001|Overall Study|No viable embryos|1|||
105974617|NCT01338610|365566277|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
105974618|NCT01338610|365566278|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
105974619|NCT01338610|365566279|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
105974620|NCT01338610|365566277|FG000|Overall Study|Protocol Violation|1|||
105974621|NCT01338610|365566278|FG001|Overall Study|Protocol Violation|0|||
105974622|NCT01338610|365566279|FG002|Overall Study|Protocol Violation|1|||
105974623|NCT01338610|365566277|FG000|Overall Study|Adverse Event|3|||
105974624|NCT01338610|365566278|FG001|Overall Study|Adverse Event|0|||
105974625|NCT01338610|365566279|FG002|Overall Study|Adverse Event|0|||
105974626|NCT02046226|365566280|FG000|Overall Study|Lost to Follow-up|7|||
105974627|NCT00853125|365566281|FG000|Overall Study|Study participant's donor was CMV +|1|||
105974628|NCT03023826|365566287|FG000|Period 1|Withdrawal by Subject|0|||
105974629|NCT03023826|365566288|FG001|Period 1|Withdrawal by Subject|0|||
105974630|NCT03023826|365566289|FG002|Period 1|Withdrawal by Subject|0|||
105974631|NCT03023826|365566290|FG003|Period 1|Withdrawal by Subject|0|||
105974632|NCT03023826|365566291|FG004|Period 1|Withdrawal by Subject|1|||
105974633|NCT03023826|365566292|FG005|Period 1|Withdrawal by Subject|0|||
105974634|NCT02498067|365566293|FG000|Overall Study|Lost to Follow-up|22|||
105974635|NCT02498067|365566293|FG000|Overall Study|Did not meet inclusion criteria|11|||
105974636|NCT02460783|365566296|FG000|Overall Study|Withdrawal by Subject|1|||
105974637|NCT02460783|365566297|FG001|Overall Study|Withdrawal by Subject|3|||
105974638|NCT02460783|365566296|FG000|Overall Study|Lost to Follow-up|1|||
105974639|NCT02460783|365566297|FG001|Overall Study|Lost to Follow-up|1|||
105974640|NCT01646645|365566298|FG000|Overall Study|No Treated|1|||
105974641|NCT01646645|365566298|FG000|Overall Study|Inevaluable Donor|29|||
105974642|NCT03754582|365566299|FG000|Treatment Phase|Adverse Event|0|||
105974643|NCT03754582|365566300|FG001|Treatment Phase|Adverse Event|1|||
105974644|NCT03754582|365566301|FG002|Treatment Phase|Adverse Event|0|||
105974645|NCT03754582|365566299|FG000|Follow-up Phase|Other|0|||
105974646|NCT03754582|365566300|FG001|Follow-up Phase|Other|0|||
105974647|NCT03754582|365566301|FG002|Follow-up Phase|Other|1|||
105974648|NCT02847858|365566304|FG000|Overall Study|Lost to Follow-up|401|||
105974649|NCT02847858|365566305|FG001|Overall Study|Lost to Follow-up|269|||
105974650|NCT02594098|365566306|FG000|Overall Study|Lack of Efficacy|17|||
105974651|NCT02594098|365566307|FG001|Overall Study|Lack of Efficacy|6|||
105974652|NCT02594098|365566306|FG000|Overall Study|Withdrawal by Subject|1|||
105974653|NCT02594098|365566307|FG001|Overall Study|Withdrawal by Subject|3|||
105974654|NCT02594098|365566306|FG000|Overall Study|Terminated participation|6|||
105974655|NCT02594098|365566307|FG001|Overall Study|Terminated participation|2|||
105974656|NCT02594098|365566306|FG000|Overall Study|Seek alternative treatment|2|||
105974657|NCT02594098|365566307|FG001|Overall Study|Seek alternative treatment|1|||
105974658|NCT02594098|365566306|FG000|Overall Study|Other|0|||
105974659|NCT02594098|365566307|FG001|Overall Study|Other|1|||
105974660|NCT02210221|365566308|FG000|Overall Study|Lack of Efficacy|7|||
105974661|NCT02210221|365566308|FG000|Overall Study|Withdrawal by Subject|43|||
105974662|NCT00033540|365566315|FG000|Overall Study|Adverse Event|14|||
105974663|NCT00033540|365566315|FG000|Overall Study|Death|1|||
105974664|NCT00033540|365566315|FG000|Overall Study|Progression|26|||
105974665|NCT00033540|365566315|FG000|Overall Study|Withdrawal by Subject|6|||
105974666|NCT00033540|365566315|FG000|Overall Study|Other|5|||
105974667|NCT00033540|365566315|FG000|Overall Study|Ineligible|3|||
105974668|NCT00033540|365566315|FG000|Overall Study|Never received treatment|2|||
105974669|NCT00405964|365566316|FG000|Overall Study|Treatment Failure|17|||
105974670|NCT00405964|365566317|FG001|Overall Study|Treatment Failure|45|||
105974671|NCT00405964|365566316|FG000|Overall Study|Adverse Event|7|||
105974672|NCT00405964|365566317|FG001|Overall Study|Adverse Event|16|||
105974673|NCT00405964|365566316|FG000|Overall Study|Lost to Follow-up|5|||
105974674|NCT00405964|365566317|FG001|Overall Study|Lost to Follow-up|5|||
105974675|NCT00405964|365566316|FG000|Overall Study|Withdrawal by Subject|19|||
105974676|NCT00405964|365566317|FG001|Overall Study|Withdrawal by Subject|23|||
105974677|NCT00405964|365566316|FG000|Overall Study|Protocol Violation|11|||
105974678|NCT00405964|365566317|FG001|Overall Study|Protocol Violation|6|||
105974679|NCT00066469|365566320|FG000|Overall Study|Death|3|||
105974680|NCT00066469|365566320|FG000|Overall Study|Lack of Efficacy|9|||
105974681|NCT00066469|365566320|FG000|Overall Study|Lost to Follow-up|1|||
105974682|NCT00066469|365566320|FG000|Overall Study|Physician Decision|1|||
105974683|NCT00066469|365566320|FG000|Overall Study|Withdrawal by Subject|1|||
105974684|NCT00066469|365566320|FG000|Overall Study|ineligible|1|||
105974685|NCT00840060|365567756|FG000|Overall Study|Withdrawal by Subject|1|||
105974686|NCT00840060|365567757|FG001|Overall Study|Withdrawal by Subject|0|||
105974687|NCT00840060|365567756|FG000|Overall Study|Change in emotional/behavioral status|0|||
105974688|NCT00840060|365567757|FG001|Overall Study|Change in emotional/behavioral status|1|||
105974689|NCT03187834|365567759|FG000|Overall Study|Lost to Follow-up|0|||
105974690|NCT03187834|365567760|FG001|Overall Study|Lost to Follow-up|1|||
105974691|NCT03187834|365567761|FG002|Overall Study|Lost to Follow-up|2|||
105974692|NCT03187834|365567762|FG003|Overall Study|Lost to Follow-up|2|||
105974693|NCT03187834|365567759|FG000|Overall Study|Had invalid anthropometric measurements|5|||
105974694|NCT03187834|365567760|FG001|Overall Study|Had invalid anthropometric measurements|3|||
105974695|NCT03187834|365567761|FG002|Overall Study|Had invalid anthropometric measurements|4|||
105974696|NCT03187834|365567762|FG003|Overall Study|Had invalid anthropometric measurements|2|||
105974697|NCT00076336|365567769|FG000|Overall Study|Death|13|||
105974698|NCT00076336|365567770|FG001|Overall Study|Death|17|||
105974699|NCT00076336|365567769|FG000|Overall Study|Adverse Event|4|||
105974700|NCT00076336|365567770|FG001|Overall Study|Adverse Event|4|||
105974701|NCT00076336|365567769|FG000|Overall Study|Lost to Follow-up|4|||
105974702|NCT00076336|365567770|FG001|Overall Study|Lost to Follow-up|4|||
105974703|NCT00076336|365567769|FG000|Overall Study|Non-Compliance|2|||
105974704|NCT00076336|365567770|FG001|Overall Study|Non-Compliance|0|||
105974705|NCT00076336|365567769|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
105974706|NCT00076336|365567770|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
105974707|NCT00076336|365567769|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
105974708|NCT00076336|365567770|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
105974709|NCT00076336|365567769|FG000|Overall Study|Liver Transplantation|3|||
105974710|NCT00076336|365567770|FG001|Overall Study|Liver Transplantation|3|||
105974711|NCT00076336|365567769|FG000|Overall Study|Virologic Breakthrough|14|||
105974712|NCT00076336|365567770|FG001|Overall Study|Virologic Breakthrough|16|||
105974713|NCT00076336|365567769|FG000|Overall Study|Treatment failure|4|||
105974714|NCT00076336|365567770|FG001|Overall Study|Treatment failure|5|||
105974715|NCT01007123|365567771|FG000|Overall Study|Adverse Event|3|||
105850119|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850120|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850121|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850122|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850123|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850124|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
105850125|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
105850126|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
105850127|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850128|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850129|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850130|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850131|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850132|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850133|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850134|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850135|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850136|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850137|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850138|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
105850139|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
105850140|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
105850141|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850142|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850143|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850144|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850145|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850146|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850147|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850148|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850149|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850150|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850151|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105974716|NCT01007123|365567772|FG001|Overall Study|Adverse Event|4|||
105974717|NCT01007123|365567773|FG002|Overall Study|Adverse Event|7|||
105974718|NCT01007123|365567774|FG003|Overall Study|Adverse Event|1|||
105974719|NCT01007123|365567771|FG000|Overall Study|Lack of Efficacy|1|||
105974720|NCT01007123|365567772|FG001|Overall Study|Lack of Efficacy|0|||
105974721|NCT01007123|365567773|FG002|Overall Study|Lack of Efficacy|1|||
105974722|NCT01007123|365567774|FG003|Overall Study|Lack of Efficacy|4|||
105974723|NCT01007123|365567771|FG000|Overall Study|Protocol Violation|1|||
105974724|NCT01007123|365567772|FG001|Overall Study|Protocol Violation|1|||
105850152|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
105850153|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
105974725|NCT01007123|365567773|FG002|Overall Study|Protocol Violation|2|||
105974726|NCT01007123|365567774|FG003|Overall Study|Protocol Violation|1|||
105974727|NCT01007123|365567771|FG000|Overall Study|Withdrawal by Subject|1|||
105974728|NCT01007123|365567772|FG001|Overall Study|Withdrawal by Subject|0|||
105974729|NCT01007123|365567773|FG002|Overall Study|Withdrawal by Subject|1|||
105974730|NCT01007123|365567774|FG003|Overall Study|Withdrawal by Subject|0|||
105974731|NCT01007123|365567771|FG000|Overall Study|Lost to Follow-up|0|||
105974732|NCT01007123|365567772|FG001|Overall Study|Lost to Follow-up|1|||
105974733|NCT01007123|365567773|FG002|Overall Study|Lost to Follow-up|0|||
105974734|NCT01007123|365567774|FG003|Overall Study|Lost to Follow-up|0|||
105974735|NCT00524589|365567775|FG000|Overall Study|Withdrawal by Subject|2|||
105974736|NCT00524589|365567775|FG000|Overall Study|Disease Progression|16|||
105974737|NCT01344538|365567776|FG000|Overall Study|Adverse Event|1|||
105974738|NCT01344538|365567777|FG001|Overall Study|Adverse Event|1|||
105974739|NCT01344538|365567776|FG000|Overall Study|Lost to Follow-up|1|||
105974740|NCT01344538|365567777|FG001|Overall Study|Lost to Follow-up|0|||
105974741|NCT01655381|365567778|FG000|Overall Study|Investigator Decision|1|||
105974742|NCT01655381|365567778|FG000|Overall Study|Moved to Another City|1|||
105974743|NCT01655381|365567778|FG000|Overall Study|Insufficient Treatment Response|1|||
105974744|NCT00445848|365567781|FG000|Overall Study|Adverse Event|14|||
105974745|NCT00445848|365567781|FG000|Overall Study|Withdrawal by Subject|4|||
105974746|NCT00445848|365567781|FG000|Overall Study|Progression|62|||
105974747|NCT00445848|365567781|FG000|Overall Study|Other-Not protocol specified|5|||
105974748|NCT01994863|365567782|FG000|Period 1|Adverse Event|4|||
105974749|NCT01994863|365567783|FG001|Period 1|Adverse Event|0|||
105974750|NCT01994863|365567782|FG000|Period 1|Withdrawal by Subject|1|||
105974751|NCT01994863|365567783|FG001|Period 1|Withdrawal by Subject|0|||
105974752|NCT01994863|365567782|FG000|Period 1|Trial stopped by sponsor|1|||
105974753|NCT01994863|365567783|FG001|Period 1|Trial stopped by sponsor|3|||
105974754|NCT01994863|365567782|FG000|Period 1|Lack of Efficacy|1|||
105974755|NCT01994863|365567783|FG001|Period 1|Lack of Efficacy|0|||
105974756|NCT01994863|365567782|FG000|Period 2|Adverse Event|0|||
105974757|NCT01994863|365567783|FG001|Period 2|Adverse Event|1|||
105974758|NCT01994863|365567782|FG000|Period 2|Lack of Efficacy|0|||
105974759|NCT01994863|365567783|FG001|Period 2|Lack of Efficacy|2|||
105974760|NCT01994863|365567782|FG000|Period 2|Withdrawal by Subject|1|||
105974761|NCT01994863|365567783|FG001|Period 2|Withdrawal by Subject|1|||
105974762|NCT03946124|365567784|FG000|Overall Study|Withdrawal by Subject|19|||
105974763|NCT01062841|365567785|FG000|Overall Study|Indwelling Device Removed|41|||
105974764|NCT01062841|365567786|FG001|Overall Study|Indwelling Device Removed|48|||
105974765|NCT01062841|365567785|FG000|Overall Study|Death|3|||
105974766|NCT01062841|365567786|FG001|Overall Study|Death|5|||
105974767|NCT01062841|365567785|FG000|Overall Study|Withdrawal by Subject|2|||
105974768|NCT01062841|365567786|FG001|Overall Study|Withdrawal by Subject|0|||
105974769|NCT01062841|365567785|FG000|Overall Study|Withdrawal by Study|3|||
105974770|NCT01062841|365567786|FG001|Overall Study|Withdrawal by Study|0|||
105974771|NCT01767493|365567787|FG000|Overall Study|screen failures|3|||
105974772|NCT02836873|365567790|FG000|Overall Study|Protocol Violation|0|||
105974773|NCT02836873|365567791|FG001|Overall Study|Protocol Violation|1|||
105974774|NCT02836873|365567790|FG000|Overall Study|Adverse Event|1|||
106026452|NCT00357760|365762430|FG000|Overall Study|Alternative therapy|1|||
106026453|NCT00357760|365762431|FG001|Overall Study|Alternative therapy|0|||
106026454|NCT00357760|365762430|FG000|Overall Study|Withdrawal by Subject|0|||
106026455|NCT00357760|365762431|FG001|Overall Study|Withdrawal by Subject|2|||
106026456|NCT00357760|365762430|FG000|Overall Study|Never started treatment|2|||
106026457|NCT00357760|365762431|FG001|Overall Study|Never started treatment|1|||
106026458|NCT00357760|365762430|FG000|Overall Study|Ineligible|0|||
106026459|NCT00357760|365762431|FG001|Overall Study|Ineligible|2|||
106026460|NCT00357760|365762430|FG000|Overall Study|Physician Decision|2|||
106026461|NCT00357760|365762431|FG001|Overall Study|Physician Decision|1|||
106026462|NCT00357760|365762430|FG000|Overall Study|Protocol Violation|0|||
106026463|NCT00357760|365762431|FG001|Overall Study|Protocol Violation|1|||
106026464|NCT00357760|365762430|FG000|Overall Study|To receive hospice care|0|||
106026465|NCT00357760|365762431|FG001|Overall Study|To receive hospice care|1|||
105974775|NCT02836873|365567791|FG001|Overall Study|Adverse Event|4|||
105974776|NCT02836873|365567790|FG000|Overall Study|Withdrawal by Subject|2|||
105974777|NCT02836873|365567791|FG001|Overall Study|Withdrawal by Subject|2|||
105974778|NCT02836873|365567790|FG000|Overall Study|Lost to Follow-up|1|||
105974779|NCT02836873|365567791|FG001|Overall Study|Lost to Follow-up|3|||
105974780|NCT02836873|365567790|FG000|Overall Study|Physician Decision|0|||
105974781|NCT02836873|365567791|FG001|Overall Study|Physician Decision|1|||
105974782|NCT02836873|365567790|FG000|Overall Study|Other|1|||
105974783|NCT02836873|365567791|FG001|Overall Study|Other|0|||
105974784|NCT02914548|365567794|FG000|Overall Study|Adverse Event|15|||
105974785|NCT02914548|365567795|FG001|Overall Study|Adverse Event|7|||
106026466|NCT02353143|365762432|FG000|Overall Study|Withdrawal by Subject|1|||
106026467|NCT02353143|365762433|FG001|Overall Study|Withdrawal by Subject|0|||
106026468|NCT02353143|365762434|FG002|Overall Study|Withdrawal by Subject|0|||
105974786|NCT02914548|365567796|FG002|Overall Study|Adverse Event|15|||
105974787|NCT02914548|365567794|FG000|Overall Study|Physician Decision|2|||
105974788|NCT02914548|365567795|FG001|Overall Study|Physician Decision|2|||
105974789|NCT02914548|365567796|FG002|Overall Study|Physician Decision|0|||
105974790|NCT02914548|365567794|FG000|Overall Study|Protocol Violation|1|||
105974791|NCT02914548|365567795|FG001|Overall Study|Protocol Violation|0|||
105974792|NCT02914548|365567796|FG002|Overall Study|Protocol Violation|0|||
105974793|NCT02914548|365567794|FG000|Overall Study|Withdrawal by Subject|3|||
105974794|NCT02914548|365567795|FG001|Overall Study|Withdrawal by Subject|4|||
105974795|NCT02914548|365567796|FG002|Overall Study|Withdrawal by Subject|4|||
105974796|NCT02914548|365567794|FG000|Overall Study|>40% of body surface area|0|||
105974797|NCT02914548|365567795|FG001|Overall Study|>40% of body surface area|1|||
105974798|NCT02914548|365567796|FG002|Overall Study|>40% of body surface area|1|||
105974799|NCT02142283|365567797|FG000|Overall Study|Death|20|||
105974800|NCT02142283|365567798|FG001|Overall Study|Death|18|||
105974801|NCT02142283|365567797|FG000|Overall Study|Withdrawal by Subject|1|||
105974802|NCT02142283|365567798|FG001|Overall Study|Withdrawal by Subject|3|||
105974803|NCT00747344|365567799|FG000|Controlled Period|Adverse Event|3|||
105974804|NCT00747344|365567800|FG001|Controlled Period|Adverse Event|0|||
105974805|NCT00747344|365567801|FG002|Controlled Period|Adverse Event|0|||
105974806|NCT00747344|365567802|FG003|Controlled Period|Adverse Event|0|||
105974807|NCT00747344|365567799|FG000|Controlled Period|Lack of Efficacy|2|||
105974808|NCT00747344|365567800|FG001|Controlled Period|Lack of Efficacy|1|||
105974809|NCT00747344|365567801|FG002|Controlled Period|Lack of Efficacy|0|||
105974810|NCT00747344|365567802|FG003|Controlled Period|Lack of Efficacy|0|||
105974811|NCT00747344|365567799|FG000|Controlled Period|Other|0|||
105974812|NCT00747344|365567800|FG001|Controlled Period|Other|3|||
105974813|NCT00747344|365567801|FG002|Controlled Period|Other|0|||
105974814|NCT00747344|365567802|FG003|Controlled Period|Other|0|||
105974815|NCT00747344|365567799|FG000|After Controlled Period|Adverse Event|0|||
105974816|NCT00747344|365567800|FG001|After Controlled Period|Adverse Event|0|||
105974817|NCT00747344|365567801|FG002|After Controlled Period|Adverse Event|0|||
105974818|NCT00747344|365567802|FG003|After Controlled Period|Adverse Event|1|||
105974819|NCT00765882|365567803|FG000|Overall Study|Adverse Event|10|||
105974820|NCT00765882|365567804|FG001|Overall Study|Adverse Event|21|||
105974821|NCT00765882|365567805|FG002|Overall Study|Adverse Event|20|||
105974822|NCT00765882|365567803|FG000|Overall Study|Lack of Efficacy|4|||
105974823|NCT00765882|365567804|FG001|Overall Study|Lack of Efficacy|0|||
105974824|NCT00765882|365567805|FG002|Overall Study|Lack of Efficacy|1|||
105974825|NCT00765882|365567803|FG000|Overall Study|Protocol Violation|4|||
105974826|NCT00765882|365567804|FG001|Overall Study|Protocol Violation|3|||
105974827|NCT00765882|365567805|FG002|Overall Study|Protocol Violation|1|||
105974828|NCT00765882|365567803|FG000|Overall Study|Withdrawal by Subject|2|||
105974829|NCT00765882|365567804|FG001|Overall Study|Withdrawal by Subject|6|||
105974830|NCT00765882|365567805|FG002|Overall Study|Withdrawal by Subject|6|||
105974831|NCT00765882|365567803|FG000|Overall Study|Lost to Follow-up|1|||
105974832|NCT00765882|365567804|FG001|Overall Study|Lost to Follow-up|9|||
105974833|NCT00765882|365567805|FG002|Overall Study|Lost to Follow-up|6|||
105974834|NCT00765882|365567803|FG000|Overall Study|Other Reason|3|||
105974835|NCT00765882|365567804|FG001|Overall Study|Other Reason|1|||
105974836|NCT00765882|365567805|FG002|Overall Study|Other Reason|2|||
105974837|NCT01605227|365567809|FG000|Overall Study|Did not receive study treatment|2|||
105974838|NCT01605227|365567810|FG001|Overall Study|Did not receive study treatment|3|||
105974839|NCT01605227|365567809|FG000|Overall Study|Adverse Event|228|||
105974840|NCT01605227|365567810|FG001|Overall Study|Adverse Event|42|||
105974841|NCT01605227|365567809|FG000|Overall Study|Progressive Disease|132|||
105974842|NCT01605227|365567810|FG001|Overall Study|Progressive Disease|128|||
105974843|NCT01605227|365567809|FG000|Overall Study|Clinical Deterioration|227|||
105974844|NCT01605227|365567810|FG001|Overall Study|Clinical Deterioration|133|||
105974845|NCT01605227|365567809|FG000|Overall Study|Lost to Follow-up|1|||
105974846|NCT01605227|365567810|FG001|Overall Study|Lost to Follow-up|0|||
105974847|NCT01605227|365567809|FG000|Overall Study|Protocol Violation|1|||
105974848|NCT01605227|365567810|FG001|Overall Study|Protocol Violation|0|||
105974849|NCT01605227|365567809|FG000|Overall Study|Physician Decision|9|||
105974850|NCT01605227|365567810|FG001|Overall Study|Physician Decision|7|||
105974851|NCT01605227|365567809|FG000|Overall Study|Withdrawal by Subject|18|||
106150397|NCT05656911|366212526|FG001|Follow-up Phase|Subject Decision|1|||
105974852|NCT01605227|365567810|FG001|Overall Study|Withdrawal by Subject|14|||
105974853|NCT01605227|365567809|FG000|Overall Study|Sponsor Decision|2|||
105974854|NCT01605227|365567810|FG001|Overall Study|Sponsor Decision|0|||
105974855|NCT01605227|365567809|FG000|Overall Study|Started New Therapy|1|||
105974856|NCT01605227|365567810|FG001|Overall Study|Started New Therapy|0|||
105974857|NCT01605227|365567809|FG000|Overall Study|Subject Decision|0|||
105974858|NCT01605227|365567810|FG001|Overall Study|Subject Decision|1|||
105974859|NCT01605227|365567809|FG000|Overall Study|Dose Held >6 weeks|0|||
105974860|NCT01605227|365567810|FG001|Overall Study|Dose Held >6 weeks|1|||
105974861|NCT02961790|365567816|FG000|Overall Study|Canceled|4|||
105974862|NCT02961790|365567817|FG001|Overall Study|Canceled|5|||
105974863|NCT02961790|365567818|FG002|Overall Study|Canceled|1|||
105974864|NCT02961790|365567819|FG003|Overall Study|Canceled|4|||
105974865|NCT02961790|365567816|FG000|Overall Study|without baseline data|4|||
105974866|NCT02961790|365567817|FG001|Overall Study|without baseline data|0|||
105974867|NCT02961790|365567818|FG002|Overall Study|without baseline data|1|||
105974868|NCT02961790|365567819|FG003|Overall Study|without baseline data|0|||
105974869|NCT02961790|365567816|FG000|Overall Study|without post baseline data|7|||
105974870|NCT02961790|365567817|FG001|Overall Study|without post baseline data|6|||
105974871|NCT02961790|365567818|FG002|Overall Study|without post baseline data|4|||
105974872|NCT02961790|365567819|FG003|Overall Study|without post baseline data|1|||
105974873|NCT01009346|365567824|FG000|Overall Study|Adverse Event|4|||
105974874|NCT03366103|365567825|FG000|Overall Study|Disease Progression|3|||
105974875|NCT03366103|365567826|FG001|Overall Study|Disease Progression|1|||
105974876|NCT03366103|365567827|FG002|Overall Study|Disease Progression|0|||
105974877|NCT03366103|365567825|FG000|Overall Study|Adverse Event|0|||
105974878|NCT03366103|365567826|FG001|Overall Study|Adverse Event|1|||
105974879|NCT03366103|365567827|FG002|Overall Study|Adverse Event|0|||
105974880|NCT01036529|365567828|FG000|Overall Study|Adverse Event|0|||
105974881|NCT01036529|365567829|FG001|Overall Study|Adverse Event|1|||
105974882|NCT01036529|365567828|FG000|Overall Study|Lost to Follow-up|0|||
105974883|NCT01036529|365567829|FG001|Overall Study|Lost to Follow-up|1|||
105974884|NCT01036529|365567828|FG000|Overall Study|Physician Decision|1|||
105974885|NCT01036529|365567829|FG001|Overall Study|Physician Decision|0|||
105974886|NCT01036529|365567828|FG000|Overall Study|Withdrawal by Subject|1|||
105974887|NCT01036529|365567829|FG001|Overall Study|Withdrawal by Subject|1|||
105974888|NCT01036529|365567828|FG000|Overall Study|Sponsor study termination|11|||
105974889|NCT01036529|365567829|FG001|Overall Study|Sponsor study termination|12|||
105974890|NCT00541099|365567830|FG000|Overall Study|Ineligible|3|||
105974891|NCT03271047|365567832|FG000|Phase 1b: Dose Finding Period|Death|8|||
105974892|NCT03271047|365567833|FG001|Phase 1b: Dose Finding Period|Death|8|||
105974893|NCT03271047|365567834|FG002|Phase 1b: Dose Finding Period|Death|0|||
105974894|NCT03271047|365567835|FG003|Phase 1b: Dose Finding Period|Death|0|||
105974895|NCT03271047|365567832|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
105974896|NCT03271047|365567833|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
105974897|NCT03271047|365567834|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
105974898|NCT03271047|365567835|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
105974899|NCT03271047|365567832|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
105974900|NCT03271047|365567833|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
105974901|NCT03271047|365567834|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
105974902|NCT03271047|365567835|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
105974903|NCT03271047|365567832|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
105974904|NCT03271047|365567833|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
105974905|NCT03271047|365567834|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
105974906|NCT03271047|365567835|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
105974907|NCT03271047|365567832|FG000|Randomized Phase 2 Period|Other|0|||
105974908|NCT03271047|365567833|FG001|Randomized Phase 2 Period|Other|0|||
105974909|NCT03271047|365567834|FG002|Randomized Phase 2 Period|Other|0|||
105974910|NCT03271047|365567835|FG003|Randomized Phase 2 Period|Other|1|||
105974911|NCT03271047|365567832|FG000|Randomized Phase 2 Period|Death|0|||
105974912|NCT03271047|365567833|FG001|Randomized Phase 2 Period|Death|0|||
105974913|NCT03271047|365567834|FG002|Randomized Phase 2 Period|Death|20|||
105974914|NCT03271047|365567835|FG003|Randomized Phase 2 Period|Death|21|||
105974915|NCT03271047|365567832|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
105974916|NCT03271047|365567833|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
105974917|NCT03271047|365567834|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
105974918|NCT03271047|365567835|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
105974919|NCT03271047|365567832|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
105974920|NCT03271047|365567833|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
105974921|NCT03271047|365567834|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
105974922|NCT03271047|365567835|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
105974923|NCT03271047|365567832|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
105974924|NCT03271047|365567833|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
105974925|NCT03271047|365567834|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
105974926|NCT03271047|365567835|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
105974927|NCT00882908|365567837|FG000|Overall Study|Adverse Event|0|||
105974928|NCT00882908|365567838|FG001|Overall Study|Adverse Event|0|||
105974929|NCT00882908|365567839|FG002|Overall Study|Adverse Event|1|||
105974930|NCT00882908|365567840|FG003|Overall Study|Adverse Event|0|||
105974931|NCT00882908|365567841|FG004|Overall Study|Adverse Event|1|||
105974932|NCT00882908|365567837|FG000|Overall Study|Lost to Follow-up|3|||
105974933|NCT00882908|365567838|FG001|Overall Study|Lost to Follow-up|5|||
105974934|NCT00882908|365567839|FG002|Overall Study|Lost to Follow-up|3|||
105974935|NCT00882908|365567840|FG003|Overall Study|Lost to Follow-up|1|||
105974936|NCT00882908|365567841|FG004|Overall Study|Lost to Follow-up|2|||
105974937|NCT00882908|365567837|FG000|Overall Study|Protocol Violation|0|||
105974938|NCT00882908|365567838|FG001|Overall Study|Protocol Violation|1|||
105974939|NCT00882908|365567839|FG002|Overall Study|Protocol Violation|0|||
105974940|NCT00882908|365567840|FG003|Overall Study|Protocol Violation|0|||
105974941|NCT00882908|365567841|FG004|Overall Study|Protocol Violation|0|||
105974942|NCT00882908|365567837|FG000|Overall Study|Withdrawal by Subject|0|||
105974943|NCT00882908|365567838|FG001|Overall Study|Withdrawal by Subject|0|||
105974944|NCT00882908|365567839|FG002|Overall Study|Withdrawal by Subject|3|||
105974945|NCT00882908|365567840|FG003|Overall Study|Withdrawal by Subject|5|||
105974946|NCT00882908|365567841|FG004|Overall Study|Withdrawal by Subject|2|||
105974947|NCT00882908|365567837|FG000|Overall Study|Subject reached a virologic endpoint|0|||
105974948|NCT00882908|365567838|FG001|Overall Study|Subject reached a virologic endpoint|0|||
105974949|NCT00882908|365567839|FG002|Overall Study|Subject reached a virologic endpoint|0|||
105974950|NCT00882908|365567840|FG003|Overall Study|Subject reached a virologic endpoint|0|||
105974951|NCT00882908|365567841|FG004|Overall Study|Subject reached a virologic endpoint|1|||
105974952|NCT00882908|365567837|FG000|Overall Study|Study terminated in error|0|||
105974953|NCT00882908|365567838|FG001|Overall Study|Study terminated in error|0|||
105974954|NCT00882908|365567839|FG002|Overall Study|Study terminated in error|0|||
105974955|NCT00882908|365567840|FG003|Overall Study|Study terminated in error|1|||
105974956|NCT00882908|365567841|FG004|Overall Study|Study terminated in error|0|||
105974957|NCT02981407|365567845|FG000|Overall Study|Withdrawal by Subject|2|||
105974958|NCT02981407|365567846|FG001|Overall Study|Withdrawal by Subject|0|||
105974959|NCT02305849|365567847|FG000|Overall Study|Adverse Event|10|||
105974960|NCT02305849|365567848|FG001|Overall Study|Adverse Event|12|||
105974961|NCT02305849|365567849|FG002|Overall Study|Adverse Event|7|||
105974962|NCT02305849|365567850|FG003|Overall Study|Adverse Event|3|||
105974963|NCT02305849|365567847|FG000|Overall Study|Lack of Efficacy|10|||
105974964|NCT02305849|365567848|FG001|Overall Study|Lack of Efficacy|6|||
105974965|NCT02305849|365567849|FG002|Overall Study|Lack of Efficacy|3|||
105974966|NCT02305849|365567850|FG003|Overall Study|Lack of Efficacy|9|||
105974967|NCT02305849|365567847|FG000|Overall Study|Withdrawal by Subject|2|||
105974968|NCT02305849|365567848|FG001|Overall Study|Withdrawal by Subject|2|||
105974969|NCT02305849|365567849|FG002|Overall Study|Withdrawal by Subject|1|||
105974970|NCT02305849|365567850|FG003|Overall Study|Withdrawal by Subject|4|||
105974971|NCT02305849|365567847|FG000|Overall Study|Lost to Follow-up|0|||
105974972|NCT02305849|365567848|FG001|Overall Study|Lost to Follow-up|2|||
105974973|NCT02305849|365567849|FG002|Overall Study|Lost to Follow-up|0|||
105974974|NCT02305849|365567850|FG003|Overall Study|Lost to Follow-up|0|||
105974975|NCT02305849|365567847|FG000|Overall Study|Protocol Violation|3|||
105974976|NCT02305849|365567848|FG001|Overall Study|Protocol Violation|2|||
105974977|NCT02305849|365567849|FG002|Overall Study|Protocol Violation|1|||
105974978|NCT02305849|365567850|FG003|Overall Study|Protocol Violation|1|||
105974979|NCT02305849|365567847|FG000|Overall Study|Lab data met discontinuation criteria|0|||
105974980|NCT02305849|365567848|FG001|Overall Study|Lab data met discontinuation criteria|1|||
105974981|NCT02305849|365567849|FG002|Overall Study|Lab data met discontinuation criteria|2|||
105974982|NCT02305849|365567850|FG003|Overall Study|Lab data met discontinuation criteria|1|||
105974983|NCT02305849|365567847|FG000|Overall Study|Miscellaneous|1|||
105974984|NCT02305849|365567848|FG001|Overall Study|Miscellaneous|2|||
105974985|NCT02305849|365567849|FG002|Overall Study|Miscellaneous|4|||
105974986|NCT02305849|365567850|FG003|Overall Study|Miscellaneous|1|||
105974987|NCT02305849|365567847|FG000|Overall Study|Not fulfill eligibility criteria|1|||
105974988|NCT02305849|365567848|FG001|Overall Study|Not fulfill eligibility criteria|1|||
105974989|NCT02305849|365567849|FG002|Overall Study|Not fulfill eligibility criteria|0|||
105974990|NCT02305849|365567850|FG003|Overall Study|Not fulfill eligibility criteria|0|||
105974991|NCT00355342|365567851|FG000|Overall Study|Adverse Event|13|||
105974992|NCT00355342|365567852|FG001|Overall Study|Adverse Event|15|||
105974993|NCT00355342|365567851|FG000|Overall Study|Lost to Follow-up|4|||
105974994|NCT00355342|365567852|FG001|Overall Study|Lost to Follow-up|2|||
105974995|NCT00355342|365567851|FG000|Overall Study|Withdrawal by Subject|14|||
105974996|NCT00355342|365567852|FG001|Overall Study|Withdrawal by Subject|11|||
105974997|NCT00355342|365567851|FG000|Overall Study|Sponsor terminated study|2|||
105974998|NCT00355342|365567852|FG001|Overall Study|Sponsor terminated study|2|||
105974999|NCT00355342|365567851|FG000|Overall Study|Overcompliant-PI discretion|1|||
105975000|NCT00355342|365567852|FG001|Overall Study|Overcompliant-PI discretion|0|||
105975001|NCT00355342|365567851|FG000|Overall Study|Use of prohibited medication|1|||
105975002|NCT00355342|365567852|FG001|Overall Study|Use of prohibited medication|0|||
105975003|NCT00355342|365567851|FG000|Overall Study|COPD exacerbation|1|||
105975004|NCT00355342|365567852|FG001|Overall Study|COPD exacerbation|1|||
105975005|NCT00355342|365567851|FG000|Overall Study|Dispensed wrong study drug kit|1|||
105975006|NCT00355342|365567852|FG001|Overall Study|Dispensed wrong study drug kit|0|||
105975007|NCT00355342|365567851|FG000|Overall Study|Non-compliance with Dexa scans|1|||
105975008|NCT00355342|365567852|FG001|Overall Study|Non-compliance with Dexa scans|0|||
105975009|NCT00355342|365567851|FG000|Overall Study|Withdrawal by participant and physician|1|||
105975010|NCT00355342|365567852|FG001|Overall Study|Withdrawal by participant and physician|0|||
105975011|NCT00355342|365567851|FG000|Overall Study|Participant relocated|0|||
105975012|NCT00355342|365567852|FG001|Overall Study|Participant relocated|1|||
105975013|NCT00355342|365567851|FG000|Overall Study|Participant discontinued study drug|0|||
105975014|NCT00355342|365567852|FG001|Overall Study|Participant discontinued study drug|1|||
105975015|NCT00355342|365567851|FG000|Overall Study|Study management|0|||
105975016|NCT00355342|365567852|FG001|Overall Study|Study management|1|||
105975017|NCT00355342|365567851|FG000|Overall Study|Protocol Violation|0|||
105975018|NCT00355342|365567852|FG001|Overall Study|Protocol Violation|1|||
105975019|NCT00355342|365567851|FG000|Overall Study|Use of protocol excluded medication|0|||
105975020|NCT00355342|365567852|FG001|Overall Study|Use of protocol excluded medication|1|||
105975021|NCT00495521|365567853|FG000|Overall Study|Physician Decision|0|||
105975022|NCT00495521|365567854|FG001|Overall Study|Physician Decision|1|||
105975023|NCT03777917|365567855|FG000|Overall Study|Withdrawal by Subject|1|||
105975024|NCT03777917|365567856|FG001|Overall Study|Withdrawal by Subject|0|||
105975025|NCT03777917|365567855|FG000|Overall Study|Physician Decision|1|||
105975026|NCT03777917|365567856|FG001|Overall Study|Physician Decision|0|||
105975027|NCT03777917|365567855|FG000|Overall Study|Lost to Follow-up|6|||
106026469|NCT02353143|365762435|FG003|Overall Study|Withdrawal by Subject|0|||
106026470|NCT02353143|365762436|FG004|Overall Study|Withdrawal by Subject|1|||
106026471|NCT02353143|365762437|FG005|Overall Study|Withdrawal by Subject|0|||
106026472|NCT02353143|365762438|FG006|Overall Study|Withdrawal by Subject|0|||
106026473|NCT02353143|365762439|FG007|Overall Study|Withdrawal by Subject|1|||
106026474|NCT02353143|365762440|FG008|Overall Study|Withdrawal by Subject|1|||
106026475|NCT02353143|365762432|FG000|Overall Study|Lack of Efficacy|2|||
106026476|NCT02353143|365762433|FG001|Overall Study|Lack of Efficacy|1|||
106026477|NCT02353143|365762434|FG002|Overall Study|Lack of Efficacy|2|||
106026478|NCT02353143|365762435|FG003|Overall Study|Lack of Efficacy|4|||
106026479|NCT02353143|365762436|FG004|Overall Study|Lack of Efficacy|13|||
106026480|NCT02353143|365762437|FG005|Overall Study|Lack of Efficacy|2|||
106026481|NCT02353143|365762438|FG006|Overall Study|Lack of Efficacy|2|||
106026482|NCT02353143|365762439|FG007|Overall Study|Lack of Efficacy|2|||
106026483|NCT02353143|365762440|FG008|Overall Study|Lack of Efficacy|1|||
106026484|NCT02353143|365762432|FG000|Overall Study|reason not specified|1|||
106026485|NCT02353143|365762433|FG001|Overall Study|reason not specified|2|||
106026486|NCT02353143|365762434|FG002|Overall Study|reason not specified|0|||
106026487|NCT02353143|365762435|FG003|Overall Study|reason not specified|0|||
106026488|NCT02353143|365762436|FG004|Overall Study|reason not specified|6|||
106026489|NCT02353143|365762437|FG005|Overall Study|reason not specified|1|||
106026490|NCT02353143|365762438|FG006|Overall Study|reason not specified|0|||
106026491|NCT02353143|365762439|FG007|Overall Study|reason not specified|3|||
106026492|NCT02353143|365762440|FG008|Overall Study|reason not specified|1|||
106026493|NCT02353143|365762432|FG000|Overall Study|Physician Decision|0|||
106026494|NCT02353143|365762433|FG001|Overall Study|Physician Decision|4|||
106026495|NCT02353143|365762434|FG002|Overall Study|Physician Decision|2|||
106026496|NCT02353143|365762435|FG003|Overall Study|Physician Decision|3|||
106026497|NCT02353143|365762436|FG004|Overall Study|Physician Decision|4|||
106026498|NCT02353143|365762437|FG005|Overall Study|Physician Decision|0|||
106026499|NCT02353143|365762438|FG006|Overall Study|Physician Decision|1|||
106026500|NCT02353143|365762439|FG007|Overall Study|Physician Decision|2|||
106026501|NCT02353143|365762440|FG008|Overall Study|Physician Decision|0|||
106026502|NCT02353143|365762432|FG000|Overall Study|Adverse Event|0|||
106026503|NCT02353143|365762433|FG001|Overall Study|Adverse Event|0|||
106026504|NCT02353143|365762434|FG002|Overall Study|Adverse Event|1|||
106026505|NCT02353143|365762435|FG003|Overall Study|Adverse Event|0|||
106026506|NCT02353143|365762436|FG004|Overall Study|Adverse Event|1|||
106026507|NCT02353143|365762437|FG005|Overall Study|Adverse Event|1|||
106026508|NCT02353143|365762438|FG006|Overall Study|Adverse Event|0|||
106026509|NCT02353143|365762439|FG007|Overall Study|Adverse Event|0|||
106026510|NCT02353143|365762440|FG008|Overall Study|Adverse Event|0|||
106026511|NCT02353143|365762432|FG000|Overall Study|patient receiving other treatment for AML|0|||
106026512|NCT02353143|365762433|FG001|Overall Study|patient receiving other treatment for AML|0|||
106026513|NCT02353143|365762434|FG002|Overall Study|patient receiving other treatment for AML|1|||
106026514|NCT02353143|365762435|FG003|Overall Study|patient receiving other treatment for AML|0|||
106026515|NCT02353143|365762436|FG004|Overall Study|patient receiving other treatment for AML|0|||
106026516|NCT02353143|365762437|FG005|Overall Study|patient receiving other treatment for AML|0|||
105975028|NCT03777917|365567856|FG001|Overall Study|Lost to Follow-up|2|||
105975029|NCT03777917|365567855|FG000|Overall Study|Other|1|||
105975030|NCT03777917|365567856|FG001|Overall Study|Other|0|||
105975031|NCT01853072|365567857|FG000|Overall Study|Adverse event prior to treatment|0|||
105975032|NCT01853072|365567858|FG001|Overall Study|Adverse event prior to treatment|1|||
106026517|NCT02353143|365762438|FG006|Overall Study|patient receiving other treatment for AML|0|||
106026518|NCT02353143|365762439|FG007|Overall Study|patient receiving other treatment for AML|0|||
106026519|NCT02353143|365762440|FG008|Overall Study|patient receiving other treatment for AML|0|||
106026520|NCT02353143|365762432|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
106026521|NCT02353143|365762433|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
106026522|NCT02353143|365762434|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
106026523|NCT02353143|365762435|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
106026524|NCT02353143|365762436|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
106026525|NCT02353143|365762437|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
106026526|NCT02353143|365762438|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
105975033|NCT01853072|365567857|FG000|Overall Study|Adverse Event|0|||
105850154|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
105850155|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850156|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850157|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850158|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850159|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850160|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850161|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850162|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850163|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850164|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850165|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850166|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
105850167|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
105850168|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
105850169|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850170|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850171|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850172|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850173|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850174|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850175|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850176|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850177|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850178|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850179|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105850180|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
105975034|NCT01853072|365567858|FG001|Overall Study|Adverse Event|3|||
105975035|NCT01853072|365567857|FG000|Overall Study|Death|1|||
105975036|NCT01853072|365567858|FG001|Overall Study|Death|4|||
105975037|NCT01853072|365567857|FG000|Overall Study|Lost to Follow-up|0|||
105975038|NCT01853072|365567858|FG001|Overall Study|Lost to Follow-up|3|||
105975039|NCT01853072|365567857|FG000|Overall Study|Non-compliance with study drug|0|||
105975040|NCT01853072|365567858|FG001|Overall Study|Non-compliance with study drug|1|||
105975041|NCT01853072|365567857|FG000|Overall Study|Physician Decision|1|||
105975042|NCT01853072|365567858|FG001|Overall Study|Physician Decision|1|||
105975043|NCT01853072|365567857|FG000|Overall Study|Withdrawal by Subject|1|||
105975044|NCT01853072|365567858|FG001|Overall Study|Withdrawal by Subject|2|||
105975045|NCT01853072|365567857|FG000|Overall Study|Reason not specified|9|||
105975046|NCT01853072|365567858|FG001|Overall Study|Reason not specified|6|||
105975047|NCT02653495|365567865|FG000|Overall Study|Lost to Follow-up|2|||
105975048|NCT02653495|365567866|FG001|Overall Study|Lost to Follow-up|0|||
105975049|NCT02653495|365567865|FG000|Overall Study|Screening Failure|10|||
105975050|NCT02653495|365567866|FG001|Overall Study|Screening Failure|0|||
105975051|NCT00787930|365567875|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
105975052|NCT04096820|365567881|FG000|Overall Study|Did not return for intervention|2|||
105975053|NCT04096820|365567881|FG000|Overall Study|Death|1|||
105975054|NCT03158272|365567882|FG000|Overall Study|Disease progression|3|||
105975055|NCT03158272|365567883|FG001|Overall Study|Disease progression|3|||
105975056|NCT03158272|365567884|FG002|Overall Study|Disease progression|4|||
105975057|NCT03158272|365567885|FG003|Overall Study|Disease progression|6|||
105975058|NCT03158272|365567882|FG000|Overall Study|Death|0|||
105975059|NCT03158272|365567883|FG001|Overall Study|Death|0|||
105975060|NCT03158272|365567884|FG002|Overall Study|Death|1|||
105975061|NCT03158272|365567885|FG003|Overall Study|Death|0|||
105975062|NCT03158272|365567882|FG000|Overall Study|Other reasons|0|||
105975063|NCT03158272|365567883|FG001|Overall Study|Other reasons|0|||
105975064|NCT03158272|365567884|FG002|Overall Study|Other reasons|1|||
105975065|NCT03158272|365567885|FG003|Overall Study|Other reasons|0|||
105975066|NCT03158272|365567882|FG000|Overall Study|Adverse event unrelated to the drug|0|||
105975067|NCT03158272|365567883|FG001|Overall Study|Adverse event unrelated to the drug|1|||
105975068|NCT03158272|365567884|FG002|Overall Study|Adverse event unrelated to the drug|0|||
105975069|NCT03158272|365567885|FG003|Overall Study|Adverse event unrelated to the drug|0|||
105975070|NCT01048866|365567886|FG000|Overall Study|Adverse Event|1|||
105975071|NCT01048866|365567887|FG001|Overall Study|Adverse Event|0|||
105975072|NCT01048866|365567886|FG000|Overall Study|Protocol Violation|1|||
105975073|NCT01048866|365567887|FG001|Overall Study|Protocol Violation|0|||
105975074|NCT01048866|365567886|FG000|Overall Study|Physician Decision|1|||
105975075|NCT01048866|365567887|FG001|Overall Study|Physician Decision|0|||
105975076|NCT01048866|365567886|FG000|Overall Study|Withdrawal by Subject|0|||
105975077|NCT01048866|365567887|FG001|Overall Study|Withdrawal by Subject|2|||
105975078|NCT01048866|365567886|FG000|Overall Study|Lost to Follow-up|0|||
105975079|NCT01048866|365567887|FG001|Overall Study|Lost to Follow-up|2|||
105975080|NCT01048866|365567886|FG000|Overall Study|Other|1|||
105975081|NCT01048866|365567887|FG001|Overall Study|Other|1|||
105975082|NCT04068519|365567890|FG000|Dose Verification|Death|15|||
105975083|NCT04068519|365567890|FG000|Dose Verification|Withdrawal by Subject|1|||
105975084|NCT04068519|365567890|FG000|Pharmacokinetic Sub-study|Death|35|||
105975085|NCT04068519|365567890|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
105975086|NCT04068519|365567890|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
105975087|NCT04068519|365567890|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
105975088|NCT04068519|365567890|FG000|Indication Expansion|Death|152|||
105975089|NCT04068519|365567890|FG000|Indication Expansion|Withdrawal by Subject|10|||
105975090|NCT04068519|365567890|FG000|Indication Expansion|Lost to Follow-up|7|||
105975091|NCT00509093|365569793|FG000|Overall Study|Adverse Event|10|||
105975092|NCT00509093|365569793|FG000|Overall Study|Disease Progression|9|||
105975093|NCT00509093|365569793|FG000|Overall Study|Transformed into MDS|1|||
105975094|NCT00509093|365569793|FG000|Overall Study|Withdrawal by Subject|3|||
105975095|NCT00509093|365569793|FG000|Overall Study|Physician Decision|1|||
105975096|NCT01777542|365569796|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
105975097|NCT01777542|365569797|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
105975098|NCT00953524|365569798|FG000|Overall Study|Adverse Event|2|||
105975099|NCT00953524|365569799|FG001|Overall Study|Adverse Event|0|||
105975100|NCT00953524|365569800|FG002|Overall Study|Adverse Event|1|||
105975101|NCT00953524|365569801|FG003|Overall Study|Adverse Event|2|||
105975102|NCT00953524|365569798|FG000|Overall Study|Protocol Violation|18|||
105975103|NCT00953524|365569799|FG001|Overall Study|Protocol Violation|10|||
105975104|NCT00953524|365569800|FG002|Overall Study|Protocol Violation|11|||
105975105|NCT00953524|365569801|FG003|Overall Study|Protocol Violation|6|||
105975106|NCT00953524|365569798|FG000|Overall Study|Lost to Follow-up|0|||
105975107|NCT00953524|365569799|FG001|Overall Study|Lost to Follow-up|1|||
105975108|NCT00953524|365569800|FG002|Overall Study|Lost to Follow-up|1|||
106150398|NCT05656911|366212525|FG000|Follow-up Phase|Missing|1|||
106150399|NCT05656911|366212526|FG001|Follow-up Phase|Missing|0|||
106150400|NCT04755660|366212529|FG000|Overall Study|Lost to Follow-up|1|||
106150401|NCT04755660|366212530|FG001|Overall Study|Lost to Follow-up|1|||
106150402|NCT04755660|366212531|FG002|Overall Study|Lost to Follow-up|0|||
106150403|NCT04755660|366212529|FG000|Overall Study|Withdrawal by Subject|0|||
106150404|NCT04755660|366212530|FG001|Overall Study|Withdrawal by Subject|1|||
106150405|NCT04755660|366212531|FG002|Overall Study|Withdrawal by Subject|1|||
106150406|NCT04755660|366212529|FG000|Overall Study|Physician Decision|0|||
106150407|NCT04755660|366212530|FG001|Overall Study|Physician Decision|0|||
106150408|NCT04755660|366212531|FG002|Overall Study|Physician Decision|1|||
106150409|NCT02566902|366212539|FG000|Overall Study|Protocol Violation|2|||
106150410|NCT02566902|366212540|FG001|Overall Study|Protocol Violation|1|||
106150411|NCT01471691|366212541|FG000|Overall Study|Lack of Efficacy|0|||
106150412|NCT01471691|366212542|FG001|Overall Study|Lack of Efficacy|1|||
106150413|NCT02461628|366212546|FG000|Overall Study|Refused to complete survey|4|||
106150414|NCT02461628|366212547|FG001|Overall Study|Refused to complete survey|7|||
106150415|NCT01610297|366212548|FG000|Overall Study|Lost to Follow-up|1|||
106150416|NCT02121002|366212549|FG000|Overall Study|Physician Decision|2|||
106150417|NCT02121002|366212550|FG001|Overall Study|Physician Decision|0|||
105850181|NCT03982199|365112496|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
106150418|NCT02121002|366212551|FG002|Overall Study|Physician Decision|0|||
105850182|NCT03982199|365112497|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
105850183|NCT03982199|365112498|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850184|NCT03982199|365112499|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850185|NCT03982199|365112500|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850186|NCT03982199|365112501|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850187|NCT03982199|365112502|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105975109|NCT00953524|365569801|FG003|Overall Study|Lost to Follow-up|0|||
105975110|NCT00953524|365569798|FG000|Overall Study|Withdrawal by Subject|2|||
105975111|NCT00953524|365569799|FG001|Overall Study|Withdrawal by Subject|4|||
105975112|NCT00953524|365569800|FG002|Overall Study|Withdrawal by Subject|1|||
105975113|NCT00953524|365569801|FG003|Overall Study|Withdrawal by Subject|0|||
106150419|NCT02121002|366212549|FG000|Overall Study|Withdrawal by Subject|3|||
106150420|NCT02121002|366212550|FG001|Overall Study|Withdrawal by Subject|1|||
106150421|NCT02121002|366212551|FG002|Overall Study|Withdrawal by Subject|4|||
106150422|NCT02121002|366212549|FG000|Overall Study|Protocol Violation|1|||
106150423|NCT02121002|366212550|FG001|Overall Study|Protocol Violation|2|||
106150424|NCT02121002|366212551|FG002|Overall Study|Protocol Violation|4|||
106150425|NCT02121002|366212549|FG000|Overall Study|Concomitant therapy|0|||
106150426|NCT02121002|366212550|FG001|Overall Study|Concomitant therapy|1|||
106150427|NCT02121002|366212551|FG002|Overall Study|Concomitant therapy|1|||
105975114|NCT00869050|365569808|FG000|Overall Study|Screen Failure|3|||
105975115|NCT03784846|365569812|FG000|Pre-COVID Study|Lost to Follow-up|3|||
106150428|NCT02121002|366212549|FG000|Overall Study|Others|1|||
106150429|NCT02121002|366212550|FG001|Overall Study|Others|0|||
106150430|NCT02121002|366212551|FG002|Overall Study|Others|1|||
106150431|NCT03076515|366212554|FG000|Overall Study|DMC decision based on interim analysis|25|||
106150432|NCT03076515|366212555|FG001|Overall Study|DMC decision based on interim analysis|29|||
106150433|NCT03655262|366212556|FG000|Overall Study|Withdrawal by Subject|0|||
106150434|NCT03655262|366212557|FG001|Overall Study|Withdrawal by Subject|0|||
106150435|NCT03655262|366212558|FG002|Overall Study|Withdrawal by Subject|1|||
106150436|NCT01989455|366212559|FG000|Overall Study|Adverse Event|0|||
106150437|NCT01989455|366212560|FG001|Overall Study|Adverse Event|1|||
106150438|NCT01989455|366212561|FG002|Overall Study|Adverse Event|0|||
106150439|NCT01989455|366212562|FG003|Overall Study|Adverse Event|0|||
106150440|NCT01989455|366212563|FG004|Overall Study|Adverse Event|0|||
106150441|NCT01989455|366212559|FG000|Overall Study|Withdrawal by Subject|0|||
106150442|NCT01989455|366212560|FG001|Overall Study|Withdrawal by Subject|1|||
106150443|NCT01989455|366212561|FG002|Overall Study|Withdrawal by Subject|0|||
106150444|NCT01989455|366212562|FG003|Overall Study|Withdrawal by Subject|0|||
106150445|NCT01989455|366212563|FG004|Overall Study|Withdrawal by Subject|0|||
106150446|NCT01989455|366212559|FG000|Overall Study|Technical problems with infusion|0|||
106026527|NCT02353143|365762439|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
106026528|NCT02353143|365762440|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
106026529|NCT03672097|365762442|FG000|Period 1|Withdrawal by Subject|2|||
106026530|NCT03672097|365762442|FG000|Period 1|Adverse Event|1|||
106026531|NCT03672097|365762442|FG000|Period 1|Did not receive treatment|1|||
106026532|NCT03672097|365762442|FG000|Period 2|Withdrawal by Subject|3|||
106026533|NCT03672097|365762442|FG000|Period 2|Other|1|||
106150447|NCT01989455|366212560|FG001|Overall Study|Technical problems with infusion|0|||
106150448|NCT01989455|366212561|FG002|Overall Study|Technical problems with infusion|1|||
106150449|NCT01989455|366212562|FG003|Overall Study|Technical problems with infusion|0|||
106150450|NCT01989455|366212563|FG004|Overall Study|Technical problems with infusion|1|||
106150451|NCT04452318|366212564|FG000|Overall Study|Physician Decision|1|||
106150452|NCT04452318|366212565|FG001|Overall Study|Physician Decision|2|||
106150453|NCT04452318|366212566|FG002|Overall Study|Physician Decision|0|||
106150454|NCT04452318|366212567|FG003|Overall Study|Physician Decision|2|||
106150455|NCT04452318|366212568|FG004|Overall Study|Physician Decision|0|||
106150456|NCT04452318|366212569|FG005|Overall Study|Physician Decision|2|||
106150457|NCT04452318|366212570|FG006|Overall Study|Physician Decision|5|||
106026534|NCT01290796|365762443|FG000|Overall Study|Lost to Follow-up|21|||
106026535|NCT01290796|365762443|FG000|Overall Study|Withdrawal by Subject|4|||
106026536|NCT01290796|365762443|FG000|Overall Study|Physician Decision|2|||
106026537|NCT01290796|365762443|FG000|Overall Study|Secondary Surgical Intervention|2|||
106026538|NCT01290796|365762443|FG000|Overall Study|Withdrawal by Sponsor|1|||
106026539|NCT02709538|365762445|FG000|Overall Study|Adverse Event|13|||
106150458|NCT04452318|366212564|FG000|Overall Study|Death|2|||
106150459|NCT04452318|366212565|FG001|Overall Study|Death|3|||
106150460|NCT04452318|366212566|FG002|Overall Study|Death|0|||
106150461|NCT04452318|366212567|FG003|Overall Study|Death|0|||
106150462|NCT04452318|366212568|FG004|Overall Study|Death|0|||
106150463|NCT04452318|366212569|FG005|Overall Study|Death|0|||
106150464|NCT04452318|366212570|FG006|Overall Study|Death|0|||
106150465|NCT04452318|366212564|FG000|Overall Study|Lost to Follow-up|38|||
106150466|NCT04452318|366212565|FG001|Overall Study|Lost to Follow-up|28|||
106150467|NCT04452318|366212566|FG002|Overall Study|Lost to Follow-up|0|||
106026540|NCT02709538|365762446|FG001|Overall Study|Adverse Event|2|||
106026541|NCT02709538|365762447|FG002|Overall Study|Adverse Event|3|||
106026542|NCT02709538|365762445|FG000|Overall Study|Lack of Efficacy|1|||
106026543|NCT02709538|365762446|FG001|Overall Study|Lack of Efficacy|0|||
106150468|NCT04452318|366212567|FG003|Overall Study|Lost to Follow-up|3|||
106150469|NCT04452318|366212568|FG004|Overall Study|Lost to Follow-up|3|||
106150470|NCT04452318|366212569|FG005|Overall Study|Lost to Follow-up|2|||
106150471|NCT04452318|366212570|FG006|Overall Study|Lost to Follow-up|1|||
106150472|NCT04452318|366212564|FG000|Overall Study|Withdrawal by Subject|46|||
106150473|NCT04452318|366212565|FG001|Overall Study|Withdrawal by Subject|40|||
106150474|NCT04452318|366212566|FG002|Overall Study|Withdrawal by Subject|0|||
106150475|NCT04452318|366212567|FG003|Overall Study|Withdrawal by Subject|18|||
106150476|NCT04452318|366212568|FG004|Overall Study|Withdrawal by Subject|6|||
106150477|NCT04452318|366212569|FG005|Overall Study|Withdrawal by Subject|8|||
106150478|NCT04452318|366212570|FG006|Overall Study|Withdrawal by Subject|6|||
106150479|NCT05052996|366212573|FG000|Overall Study|Still on study|0|||
106150480|NCT05052996|366212574|FG001|Overall Study|Still on study|0|||
106150481|NCT05052996|366212575|FG002|Overall Study|Still on study|47|||
106150482|NCT05052996|366212576|FG003|Overall Study|Still on study|44|||
106150483|NCT05052996|366212573|FG000|Overall Study|Cohort terminated by sponsor|21|||
106150484|NCT05052996|366212574|FG001|Overall Study|Cohort terminated by sponsor|12|||
106150485|NCT05052996|366212575|FG002|Overall Study|Cohort terminated by sponsor|0|||
106150486|NCT05052996|366212576|FG003|Overall Study|Cohort terminated by sponsor|0|||
106150487|NCT05052996|366212573|FG000|Overall Study|Withdrew consent|1|||
106150488|NCT05052996|366212574|FG001|Overall Study|Withdrew consent|0|||
106026544|NCT02709538|365762447|FG002|Overall Study|Lack of Efficacy|0|||
106150489|NCT05052996|366212575|FG002|Overall Study|Withdrew consent|1|||
106150490|NCT05052996|366212576|FG003|Overall Study|Withdrew consent|2|||
106150491|NCT05052996|366212573|FG000|Overall Study|Lost to Follow-up|1|||
106150492|NCT05052996|366212574|FG001|Overall Study|Lost to Follow-up|0|||
106150493|NCT05052996|366212575|FG002|Overall Study|Lost to Follow-up|0|||
106150494|NCT05052996|366212576|FG003|Overall Study|Lost to Follow-up|2|||
106150495|NCT05052996|366212573|FG000|Overall Study|Adverse Event|0|||
106150496|NCT05052996|366212574|FG001|Overall Study|Adverse Event|0|||
106150497|NCT05052996|366212575|FG002|Overall Study|Adverse Event|2|||
105975116|NCT03784846|365569813|FG001|Pre-COVID Study|Lost to Follow-up|3|||
105975117|NCT03784846|365569814|FG002|Pre-COVID Study|Lost to Follow-up|2|||
105975118|NCT03784846|365569812|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
105975119|NCT03784846|365569813|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
105975120|NCT03784846|365569814|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
105975121|NCT03784846|365569812|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
105975122|NCT03784846|365569813|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
105975123|NCT03784846|365569814|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
105975124|NCT03784846|365569812|FG000|Post-COVID Study|Lost to Follow-up|3|||
105975125|NCT03784846|365569813|FG001|Post-COVID Study|Lost to Follow-up|5|||
105975126|NCT03784846|365569814|FG002|Post-COVID Study|Lost to Follow-up|1|||
105975127|NCT03784846|365569812|FG000|Post-COVID Study|Withdrawal by Subject|1|||
105975128|NCT03784846|365569813|FG001|Post-COVID Study|Withdrawal by Subject|2|||
105975129|NCT03784846|365569814|FG002|Post-COVID Study|Withdrawal by Subject|0|||
105975130|NCT02334683|365569816|FG000|First 12 Week Period|Lost to Follow-up|1|||
105975131|NCT02334683|365569817|FG001|First 12 Week Period|Lost to Follow-up|0|||
105975132|NCT02334683|365569816|FG000|Second 12 Week Period|Adverse Event|0|||
105975133|NCT02334683|365569817|FG001|Second 12 Week Period|Adverse Event|1|||
105975134|NCT00916058|365569818|FG000|Phase 1|Screen Failure|0|||
105975135|NCT00916058|365569819|FG001|Phase 1|Screen Failure|0|||
105975136|NCT00916058|365569820|FG002|Phase 1|Screen Failure|0|||
105975137|NCT00916058|365569821|FG003|Phase 1|Screen Failure|0|||
105975138|NCT00916058|365569822|FG004|Phase 1|Screen Failure|0|||
105975139|NCT00916058|365569823|FG005|Phase 1|Screen Failure|1|||
105975140|NCT00916058|365569824|FG006|Phase 1|Screen Failure|0|||
105975141|NCT00916058|365569818|FG000|Phase 2|Screen Failure|0|||
105975142|NCT00916058|365569819|FG001|Phase 2|Screen Failure|0|||
105975143|NCT00916058|365569820|FG002|Phase 2|Screen Failure|0|||
105975144|NCT00916058|365569821|FG003|Phase 2|Screen Failure|0|||
105975145|NCT00916058|365569822|FG004|Phase 2|Screen Failure|0|||
105975146|NCT00916058|365569823|FG005|Phase 2|Screen Failure|0|||
105975147|NCT00916058|365569824|FG006|Phase 2|Screen Failure|3|||
105975148|NCT01089023|365569826|FG000|Overall Study|Lost to Follow-up|3|||
105975149|NCT01089023|365569826|FG000|Overall Study|Adverse Event|1|||
105975150|NCT01089023|365569826|FG000|Overall Study|Withdrawal by Subject|1|||
105975151|NCT01089023|365569826|FG000|Overall Study|Protocol Violation|1|||
105975152|NCT01089023|365569826|FG000|Overall Study|Lack of Efficacy|1|||
105975153|NCT01865812|365569833|FG000|Primary Treatment Phase|Adverse Event|2|||
105975154|NCT01865812|365569834|FG001|Primary Treatment Phase|Adverse Event|0|||
105975155|NCT01865812|365569833|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
105975156|NCT01865812|365569834|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
105975157|NCT01865812|365569833|FG000|Long-term Safety Extension Phase|Pruritus|0|||
105975158|NCT01865812|365569834|FG001|Long-term Safety Extension Phase|Pruritus|3|||
105975159|NCT01865812|365569833|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
105975160|NCT01865812|365569834|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
105975161|NCT01865812|365569833|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
105975162|NCT01865812|365569834|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
105975163|NCT03421743|365569837|FG000|Overall Study|Lack of Efficacy|1|||
105975164|NCT03421743|365569838|FG001|Overall Study|Lack of Efficacy|0|||
105975165|NCT03421743|365569837|FG000|Overall Study|Adverse Event|2|||
105975166|NCT03421743|365569838|FG001|Overall Study|Adverse Event|1|||
105975167|NCT03421743|365569837|FG000|Overall Study|Withdrawal by Subject|0|||
106150498|NCT05052996|366212576|FG003|Overall Study|Adverse Event|0|||
106150499|NCT05052996|366212573|FG000|Overall Study|Randomized but never treated|0|||
106150500|NCT05052996|366212574|FG001|Overall Study|Randomized but never treated|0|||
106150501|NCT05052996|366212575|FG002|Overall Study|Randomized but never treated|1|||
106150502|NCT05052996|366212576|FG003|Overall Study|Randomized but never treated|1|||
105975168|NCT03421743|365569838|FG001|Overall Study|Withdrawal by Subject|1|||
105975169|NCT00435162|365569839|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
105975170|NCT00435162|365569840|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
105975171|NCT00435162|365569841|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
105975172|NCT00435162|365569842|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
105975173|NCT00435162|365569843|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
105975174|NCT00435162|365569844|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
106150503|NCT05052996|366212573|FG000|Overall Study|Protocol Violation|1|||
105975175|NCT01765426|365569845|FG000|Overall Study|Lost to Follow-up|0|||
105975176|NCT01765426|365569846|FG001|Overall Study|Lost to Follow-up|1|||
106150504|NCT05052996|366212574|FG001|Overall Study|Protocol Violation|0|||
105975177|NCT01765426|365569847|FG002|Overall Study|Lost to Follow-up|0|||
105975178|NCT01765426|365569848|FG003|Overall Study|Lost to Follow-up|0|||
105975179|NCT01819129|365569849|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
105975180|NCT01819129|365569850|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
105975181|NCT01819129|365569849|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
105975182|NCT01819129|365569850|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
105975183|NCT01819129|365569849|FG000|Overall Study|Other, Subject moved out of the country|0|||
105975184|NCT01819129|365569850|FG001|Overall Study|Other, Subject moved out of the country|1|||
105975185|NCT01819129|365569849|FG000|Overall Study|Withdrawal by Subject|15|||
105975186|NCT01819129|365569850|FG001|Overall Study|Withdrawal by Subject|15|||
105975187|NCT01819129|365569849|FG000|Overall Study|Lost to Follow-up|5|||
105975188|NCT01819129|365569850|FG001|Overall Study|Lost to Follow-up|2|||
105975189|NCT01819129|365569849|FG000|Overall Study|Lack of Efficacy|0|||
105975190|NCT01819129|365569850|FG001|Overall Study|Lack of Efficacy|1|||
105975191|NCT01819129|365569849|FG000|Overall Study|Adverse Event|1|||
106026545|NCT02709538|365762445|FG000|Overall Study|Lost to Follow-up|24|||
106026546|NCT02709538|365762446|FG001|Overall Study|Lost to Follow-up|8|||
106026547|NCT02709538|365762447|FG002|Overall Study|Lost to Follow-up|4|||
106026548|NCT02709538|365762445|FG000|Overall Study|Physician Decision|1|||
106026549|NCT02709538|365762446|FG001|Overall Study|Physician Decision|0|||
106026550|NCT02709538|365762447|FG002|Overall Study|Physician Decision|0|||
106026551|NCT02709538|365762445|FG000|Overall Study|Withdrawal by Subject|40|||
106026552|NCT02709538|365762446|FG001|Overall Study|Withdrawal by Subject|7|||
106026553|NCT02709538|365762447|FG002|Overall Study|Withdrawal by Subject|4|||
106026554|NCT02709538|365762445|FG000|Overall Study|Non-compliance with study procedures|5|||
106026555|NCT02709538|365762446|FG001|Overall Study|Non-compliance with study procedures|0|||
106026556|NCT02709538|365762447|FG002|Overall Study|Non-compliance with study procedures|0|||
106026557|NCT02709538|365762445|FG000|Overall Study|Non-compliance with study drug|2|||
106026558|NCT02709538|365762446|FG001|Overall Study|Non-compliance with study drug|0|||
106026559|NCT02709538|365762447|FG002|Overall Study|Non-compliance with study drug|0|||
106026560|NCT02709538|365762445|FG000|Overall Study|Protocol deviation|10|||
106026561|NCT02709538|365762446|FG001|Overall Study|Protocol deviation|4|||
106026562|NCT02709538|365762447|FG002|Overall Study|Protocol deviation|4|||
106026563|NCT02709538|365762445|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
106026564|NCT02709538|365762446|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
106026565|NCT02709538|365762447|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
106026566|NCT02709538|365762445|FG000|Overall Study|Other|16|||
106026567|NCT02709538|365762446|FG001|Overall Study|Other|7|||
106026568|NCT02709538|365762447|FG002|Overall Study|Other|5|||
106026569|NCT00835211|365762448|FG000|First Intervention|Withdrawal by Subject|0|||
106026570|NCT00835211|365762449|FG001|First Intervention|Withdrawal by Subject|1|||
106026571|NCT00835211|365762448|FG000|Washout: 7 Days|Adverse Event|2|||
106026572|NCT00835211|365762449|FG001|Washout: 7 Days|Adverse Event|1|||
106026573|NCT00835211|365762448|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
106026574|NCT00835211|365762449|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
106026575|NCT02343549|365762450|FG000|Overall Study|Death|11|||
106026576|NCT02343549|365762450|FG000|Overall Study|Withdrawal by Subject|2|||
106026577|NCT03087617|365762451|FG000|Overall Study|Lost to Follow-up|32|||
106026578|NCT03087617|365762452|FG001|Overall Study|Lost to Follow-up|30|||
106026579|NCT03087617|365762453|FG002|Overall Study|Lost to Follow-up|30|||
106026580|NCT03087617|365762454|FG003|Overall Study|Lost to Follow-up|39|||
106026581|NCT02160041|365762455|FG000|Overall Study|Adverse Event|11|||
106026582|NCT02160041|365762455|FG000|Overall Study|Death|2|||
106026583|NCT02160041|365762455|FG000|Overall Study|disease progression|57|||
106026584|NCT02160041|365762455|FG000|Overall Study|Protocol Violation|1|||
106026585|NCT02160041|365762455|FG000|Overall Study|non-compliance with study|1|||
106026586|NCT02160041|365762455|FG000|Overall Study|Physician Decision|3|||
106026587|NCT02160041|365762455|FG000|Overall Study|Withdrawal by Subject|8|||
106026588|NCT02160041|365762455|FG000|Overall Study|study terminated by by sponsor|1|||
106026589|NCT01090323|365762456|FG000|Overall Study|Adverse Event|12|||
106026590|NCT01090323|365762457|FG001|Overall Study|Adverse Event|2|||
105975192|NCT01819129|365569850|FG001|Overall Study|Adverse Event|4|||
106026591|NCT01090323|365762456|FG000|Overall Study|Abnormal Lab Values|3|||
106026592|NCT01090323|365762457|FG001|Overall Study|Abnormal Lab Values|1|||
106026593|NCT01090323|365762456|FG000|Overall Study|Abnormal Test Procedure Results|2|||
106026594|NCT01090323|365762457|FG001|Overall Study|Abnormal Test Procedure Results|0|||
106026595|NCT01090323|365762456|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
106026596|NCT01090323|365762457|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
106026597|NCT01090323|365762456|FG000|Overall Study|Condition no longer requires drug|5|||
105975193|NCT01819129|365569849|FG000|Overall Study|Death|1|||
105975194|NCT01819129|365569850|FG001|Overall Study|Death|1|||
105850188|NCT03982199|365112503|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105975195|NCT01819129|365569849|FG000|Overall Study|Withdrawal Criteria|20|||
105975196|NCT01819129|365569850|FG001|Overall Study|Withdrawal Criteria|15|||
106026598|NCT01090323|365762457|FG001|Overall Study|Condition no longer requires drug|4|||
106026599|NCT01090323|365762456|FG000|Overall Study|Protocol Violation|2|||
105975197|NCT02230683|365569857|FG000|Overall Study|Adverse Event|1|||
105975198|NCT02231762|365569861|FG000|Combination Phase|Adverse Event|10|||
105975199|NCT02231762|365569862|FG001|Combination Phase|Adverse Event|0|||
105975200|NCT02231762|365569863|FG002|Combination Phase|Adverse Event|0|||
105975201|NCT02231762|365569864|FG003|Combination Phase|Adverse Event|0|||
105975202|NCT02231762|365569861|FG000|Combination Phase|Withdrawal by Subject|2|||
105975203|NCT02231762|365569862|FG001|Combination Phase|Withdrawal by Subject|0|||
105975204|NCT02231762|365569863|FG002|Combination Phase|Withdrawal by Subject|0|||
105975205|NCT02231762|365569864|FG003|Combination Phase|Withdrawal by Subject|0|||
105975206|NCT02231762|365569861|FG000|Combination Phase|Disease Progression|6|||
105975207|NCT02231762|365569862|FG001|Combination Phase|Disease Progression|0|||
105975208|NCT02231762|365569863|FG002|Combination Phase|Disease Progression|0|||
105975209|NCT02231762|365569864|FG003|Combination Phase|Disease Progression|0|||
105975210|NCT02231762|365569861|FG000|Combination Phase|Did not meet inclusion criteria|1|||
105975211|NCT02231762|365569862|FG001|Combination Phase|Did not meet inclusion criteria|0|||
105975212|NCT02231762|365569863|FG002|Combination Phase|Did not meet inclusion criteria|0|||
105975213|NCT02231762|365569864|FG003|Combination Phase|Did not meet inclusion criteria|0|||
105975214|NCT02231762|365569861|FG000|Combination Phase|Protocol Violation|1|||
105975215|NCT02231762|365569862|FG001|Combination Phase|Protocol Violation|0|||
105975216|NCT02231762|365569863|FG002|Combination Phase|Protocol Violation|0|||
105975217|NCT02231762|365569864|FG003|Combination Phase|Protocol Violation|0|||
105975218|NCT02231762|365569861|FG000|Maintenance Phase|Disease progression|0|||
105975219|NCT02231762|365569862|FG001|Maintenance Phase|Disease progression|3|||
105975220|NCT02231762|365569863|FG002|Maintenance Phase|Disease progression|4|||
105975221|NCT02231762|365569864|FG003|Maintenance Phase|Disease progression|3|||
105975222|NCT02231762|365569861|FG000|Maintenance Phase|Adverse Event|0|||
105975223|NCT02231762|365569862|FG001|Maintenance Phase|Adverse Event|0|||
105975224|NCT02231762|365569863|FG002|Maintenance Phase|Adverse Event|1|||
105975225|NCT02231762|365569864|FG003|Maintenance Phase|Adverse Event|2|||
105975226|NCT02310230|365569865|FG000|Overall Study|Physician Decision|1|||
105975227|NCT02310230|365569866|FG001|Overall Study|Physician Decision|3|||
105975228|NCT02310230|365569865|FG000|Overall Study|monitor baseline taken after induction|2|||
105975229|NCT02310230|365569866|FG001|Overall Study|monitor baseline taken after induction|7|||
105975230|NCT02310230|365569865|FG000|Overall Study|Poor signal quality|5|||
105975231|NCT02310230|365569866|FG001|Overall Study|Poor signal quality|8|||
105975232|NCT02310230|365569865|FG000|Overall Study|Case cancelled|1|||
105975233|NCT02310230|365569866|FG001|Overall Study|Case cancelled|0|||
105975234|NCT01697462|365569867|FG000|Overall Study|Disease Progression|1|||
105975235|NCT01697462|365569867|FG000|Overall Study|Adverse Event|6|||
105975236|NCT01697462|365569867|FG000|Overall Study|Lost to Follow-up|21|||
105975237|NCT01697462|365569867|FG000|Overall Study|Withdrawal by Subject|12|||
105975238|NCT01697462|365569867|FG000|Overall Study|Investigator Decision|21|||
105975239|NCT01697462|365569867|FG000|Overall Study|Death|1|||
105975240|NCT01697462|365569867|FG000|Overall Study|Other|10|||
105975241|NCT01697462|365569867|FG000|Overall Study|Missing|5|||
105975242|NCT01371643|365569872|FG000|Overall Study|Withdrawal by Subject|3|||
105975243|NCT01371643|365569873|FG001|Overall Study|Withdrawal by Subject|0|||
105975244|NCT00168103|365569874|FG000|Overall Study|Withdrawal by Subject|1|||
105975245|NCT00168103|365569875|FG001|Overall Study|Withdrawal by Subject|2|||
105975246|NCT00168103|365569876|FG002|Overall Study|Withdrawal by Subject|1|||
105975247|NCT00168103|365569877|FG003|Overall Study|Withdrawal by Subject|0|||
105975248|NCT00168103|365569874|FG000|Overall Study|Lost to Follow-up|1|||
105975249|NCT00168103|365569875|FG001|Overall Study|Lost to Follow-up|3|||
105975250|NCT00168103|365569876|FG002|Overall Study|Lost to Follow-up|0|||
105975251|NCT00168103|365569877|FG003|Overall Study|Lost to Follow-up|0|||
105975252|NCT03249935|365569878|FG000|Overall Study|Discharged from facility early|36|||
105975253|NCT03249935|365569878|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
105975254|NCT03249935|365569878|FG000|Overall Study|Protocol Violation|5|||
105975255|NCT00989235|365569879|FG000|Overall Study|Death|0|||
105975256|NCT00989235|365569880|FG001|Overall Study|Death|1|||
105975257|NCT00989235|365569879|FG000|Overall Study|Adverse Event|0|||
105975258|NCT00989235|365569880|FG001|Overall Study|Adverse Event|1|||
105975259|NCT00989235|365569879|FG000|Overall Study|Lack of Efficacy|1|||
105975260|NCT00989235|365569880|FG001|Overall Study|Lack of Efficacy|0|||
105975261|NCT00989235|365569879|FG000|Overall Study|Withdrawal of Consent|1|||
105975262|NCT00989235|365569880|FG001|Overall Study|Withdrawal of Consent|1|||
105975263|NCT00989235|365569879|FG000|Overall Study|Desire to Become Pregnant|1|||
105975264|NCT00989235|365569880|FG001|Overall Study|Desire to Become Pregnant|0|||
105975265|NCT00989235|365569879|FG000|Overall Study|Randomized by Mistake|0|||
105975266|NCT00989235|365569880|FG001|Overall Study|Randomized by Mistake|2|||
105975267|NCT00989235|365569879|FG000|Overall Study|Lost to Follow-up|0|||
105975268|NCT00989235|365569880|FG001|Overall Study|Lost to Follow-up|1|||
105975269|NCT03593681|365569881|FG000|Overall Study|Inadequate sample collected|12|||
105975270|NCT03593681|365569881|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
105975271|NCT03593681|365569881|FG000|Overall Study|Protocol Violation|3|||
105975272|NCT03593681|365569881|FG000|Overall Study|Withdrawal by Subject|3|||
105975273|NCT03593681|365569881|FG000|Overall Study|Procedure not attempted|3|||
106026600|NCT01090323|365762457|FG001|Overall Study|Protocol Violation|1|||
106026601|NCT01090323|365762456|FG000|Overall Study|Withdrew consent|33|||
106026602|NCT01090323|365762457|FG001|Overall Study|Withdrew consent|11|||
106026603|NCT01090323|365762456|FG000|Overall Study|Lost to Follow-up|11|||
106026604|NCT01090323|365762457|FG001|Overall Study|Lost to Follow-up|6|||
106026605|NCT01090323|365762456|FG000|Overall Study|Administrative problems|6|||
106026606|NCT01090323|365762457|FG001|Overall Study|Administrative problems|4|||
106026607|NCT01090323|365762456|FG000|Overall Study|Death|1|||
106026608|NCT01090323|365762457|FG001|Overall Study|Death|2|||
106026609|NCT01090323|365762456|FG000|Overall Study|Stopped end of core|7|||
106026610|NCT01090323|365762457|FG001|Overall Study|Stopped end of core|0|||
106026611|NCT01090323|365762456|FG000|Overall Study|Stopped end of extension 1#|3|||
106026612|NCT01090323|365762457|FG001|Overall Study|Stopped end of extension 1#|1|||
106026613|NCT01864005|365762458|FG000|Overall Study|Protocol Violation|0|||
106026614|NCT01864005|365762459|FG001|Overall Study|Protocol Violation|1|||
106026615|NCT01864005|365762458|FG000|Overall Study|Withdrawal by Subject|0|||
106026616|NCT01864005|365762459|FG001|Overall Study|Withdrawal by Subject|1|||
106026617|NCT01864005|365762458|FG000|Overall Study|Incorrect enrolment|1|||
106026618|NCT01864005|365762459|FG001|Overall Study|Incorrect enrolment|0|||
106026619|NCT01864005|365762458|FG000|Overall Study|Disease need|1|||
106026620|NCT01864005|365762459|FG001|Overall Study|Disease need|1|||
106026621|NCT01864005|365762458|FG000|Overall Study|Need GP IIb/IIIa|1|||
106026622|NCT01864005|365762459|FG001|Overall Study|Need GP IIb/IIIa|3|||
106026623|NCT00763698|365762460|FG000|Overall Study|Unsuccessful Implant|5|||
106026624|NCT00763698|365762460|FG000|Overall Study|Death|4|||
106026625|NCT00763698|365762460|FG000|Overall Study|Withdrawal by Subject|1|||
106026626|NCT00006409|365762461|FG000|Baseline|Protocol Violation|48|||
106026627|NCT00006409|365762462|FG001|Baseline|Protocol Violation|70|||
106026628|NCT00006409|365762463|FG002|Baseline|Protocol Violation|0|||
106026629|NCT00006409|365762464|FG003|Baseline|Protocol Violation|0|||
106026630|NCT00006409|365762465|FG004|Baseline|Protocol Violation|0|||
106026631|NCT00006409|365762466|FG005|Baseline|Protocol Violation|0|||
106026632|NCT00006409|365762461|FG000|Post-2 Year Intervention|Protocol Violation|0|||
106026633|NCT00006409|365762462|FG001|Post-2 Year Intervention|Protocol Violation|0|||
106026634|NCT00006409|365762463|FG002|Post-2 Year Intervention|Protocol Violation|251|||
106026635|NCT00006409|365762464|FG003|Post-2 Year Intervention|Protocol Violation|168|||
106026636|NCT00006409|365762465|FG004|Post-2 Year Intervention|Protocol Violation|0|||
106026637|NCT00006409|365762466|FG005|Post-2 Year Intervention|Protocol Violation|0|||
106026638|NCT00006409|365762461|FG000|Post-3 Year Intervention|Protocol Violation|0|||
106026639|NCT00006409|365762462|FG001|Post-3 Year Intervention|Protocol Violation|0|||
106026640|NCT00006409|365762463|FG002|Post-3 Year Intervention|Protocol Violation|0|||
106026641|NCT00006409|365762464|FG003|Post-3 Year Intervention|Protocol Violation|0|||
106026642|NCT00006409|365762465|FG004|Post-3 Year Intervention|Protocol Violation|62|||
106026643|NCT00006409|365762466|FG005|Post-3 Year Intervention|Protocol Violation|62|||
106026644|NCT02743611|365762467|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
106026645|NCT02743611|365762468|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
106150505|NCT05052996|366212575|FG002|Overall Study|Protocol Violation|0|||
106150506|NCT05052996|366212576|FG003|Overall Study|Protocol Violation|0|||
106150507|NCT03951805|366212577|FG000|Overall Study|Adverse Event|1|||
106150508|NCT03951805|366212578|FG001|Overall Study|Adverse Event|0|||
106150509|NCT03951805|366212579|FG002|Overall Study|Adverse Event|0|||
106150510|NCT03951805|366212580|FG003|Overall Study|Adverse Event|0|||
106150511|NCT02568683|366212582|FG000|Overall Study|Death|0|||
106150512|NCT02568683|366212583|FG001|Overall Study|Death|2|||
106150513|NCT02568683|366212582|FG000|Overall Study|Withdrew Consent|1|||
106150514|NCT02568683|366212583|FG001|Overall Study|Withdrew Consent|0|||
106150515|NCT02568683|366212582|FG000|Overall Study|Study Terminated By Sponsor|5|||
106150516|NCT02568683|366212583|FG001|Overall Study|Study Terminated By Sponsor|2|||
106150517|NCT00901901|366212584|FG000|Treatment Period|Adverse Event|120|||
106150518|NCT00901901|366212585|FG001|Treatment Period|Adverse Event|128|||
106150519|NCT00901901|366212584|FG000|Treatment Period|Withdrawal by Subject|26|||
106150520|NCT00901901|366212585|FG001|Treatment Period|Withdrawal by Subject|24|||
106150521|NCT00901901|366212584|FG000|Treatment Period|Physician Decision|2|||
106150522|NCT00901901|366212585|FG001|Treatment Period|Physician Decision|2|||
106150523|NCT00901901|366212584|FG000|Treatment Period|Lost to Follow-up|3|||
106150524|NCT00901901|366212585|FG001|Treatment Period|Lost to Follow-up|5|||
106150525|NCT00901901|366212584|FG000|Treatment Period|Noncompliance with study medication|4|||
106150526|NCT00901901|366212585|FG001|Treatment Period|Noncompliance with study medication|1|||
106150527|NCT00901901|366212584|FG000|Treatment Period|Missing|1|||
106150528|NCT00901901|366212585|FG001|Treatment Period|Missing|0|||
106150529|NCT00901901|366212584|FG000|Treatment Period|Never treated|0|||
106150530|NCT00901901|366212585|FG001|Treatment Period|Never treated|3|||
106150531|NCT00901901|366212584|FG000|Treatment Period|Protocol driven decision point|0|||
106150532|NCT00901901|366212585|FG001|Treatment Period|Protocol driven decision point|2|||
106150533|NCT00901901|366212584|FG000|Treatment Period|Study terminated by sponsor|2|||
106150534|NCT00901901|366212585|FG001|Treatment Period|Study terminated by sponsor|0|||
106150535|NCT00901901|366212584|FG000|Treatment Period|Protocol Violation|5|||
106150536|NCT00901901|366212585|FG001|Treatment Period|Protocol Violation|9|||
106150537|NCT00901901|366212584|FG000|Treatment Period|Switch to commercial drug|1|||
106150538|NCT00901901|366212585|FG001|Treatment Period|Switch to commercial drug|1|||
106026646|NCT02743611|365762469|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
106026647|NCT02743611|365762470|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
106026648|NCT02410343|365762476|FG000|Core Period (24 Weeks)|Adverse Event|1|||
106026649|NCT02410343|365762477|FG001|Core Period (24 Weeks)|Adverse Event|0|||
106026650|NCT02410343|365762476|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
106026651|NCT02410343|365762477|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
106026652|NCT02410343|365762476|FG000|Extension Period (12 Months)|Adverse Event|1|||
106026653|NCT02410343|365762477|FG001|Extension Period (12 Months)|Adverse Event|0|||
106026654|NCT02410343|365762476|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
106026655|NCT02410343|365762477|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
106026656|NCT00228553|365762480|FG000|Overall Study|Adverse Event|112|||
106026657|NCT00228553|365762480|FG000|Overall Study|Lack of Efficacy|34|||
106026658|NCT00228553|365762480|FG000|Overall Study|Lost to Follow-up|67|||
106026659|NCT00228553|365762480|FG000|Overall Study|Physician Decision|48|||
106026660|NCT00228553|365762480|FG000|Overall Study|Protocol Violation|6|||
106026661|NCT00228553|365762480|FG000|Overall Study|Withdrawal by Subject|115|||
106026662|NCT00228553|365762480|FG000|Overall Study|Pregnancy|2|||
106026663|NCT00228553|365762480|FG000|Overall Study|Miscellaneous|46|||
106026664|NCT00271505|365762482|FG000|Overall Study|Screen Failure|3|||
106026665|NCT00271505|365762482|FG000|Overall Study|Adverse Event|1|||
106026666|NCT00271505|365762482|FG000|Overall Study|Death|1|||
106026667|NCT03704636|365762485|FG000|Overall Study|Inadequate Venous Flow|3|||
106026668|NCT02720042|365762486|FG000|Overall Study|Death|3|||
106026669|NCT02720042|365762486|FG000|Overall Study|Lost to Follow-up|4|||
106026670|NCT02720042|365762486|FG000|Overall Study|Withdrawal by Subject|1|||
106026671|NCT02720042|365762486|FG000|Overall Study|Physician Decision|3|||
106026672|NCT02720042|365762486|FG000|Overall Study|Phasix Mesh explanted|1|||
106026673|NCT02720042|365762486|FG000|Overall Study|unable due to non-study-related illness|3|||
106026674|NCT02674204|365762490|FG000|Overall Study|Adverse Event|1|||
106026675|NCT02674204|365762491|FG001|Overall Study|Adverse Event|0|||
106026676|NCT02466659|365762494|FG000|Overall Study|Lost to Follow-up|5|||
106026677|NCT02466659|365762495|FG001|Overall Study|Lost to Follow-up|2|||
106026678|NCT04345367|365762496|FG000|Overall Study|Other|3|||
106026679|NCT04345367|365762497|FG001|Overall Study|Other|4|||
106026680|NCT04345367|365762496|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
106026681|NCT04345367|365762497|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
106026682|NCT04345367|365762496|FG000|Overall Study|Withdrawal by Subject|11|||
106026683|NCT04345367|365762497|FG001|Overall Study|Withdrawal by Subject|11|||
106026684|NCT04345367|365762496|FG000|Overall Study|Protocol Violation|4|||
106026685|NCT04345367|365762497|FG001|Overall Study|Protocol Violation|3|||
106026686|NCT04345367|365762496|FG000|Overall Study|Lost to Follow-up|2|||
106026687|NCT04345367|365762497|FG001|Overall Study|Lost to Follow-up|4|||
106026688|NCT04345367|365762496|FG000|Overall Study|Lack of Efficacy|2|||
106026689|NCT04345367|365762497|FG001|Overall Study|Lack of Efficacy|0|||
106026690|NCT04345367|365762496|FG000|Overall Study|Death|2|||
106026691|NCT04345367|365762497|FG001|Overall Study|Death|0|||
106026692|NCT04345367|365762496|FG000|Overall Study|Adverse Event|10|||
106026693|NCT04345367|365762497|FG001|Overall Study|Adverse Event|9|||
106026694|NCT01578850|365762498|FG000|Period 1|Insufficient Clinical Response|1|||
106026695|NCT01578850|365762499|FG001|Period 1|Insufficient Clinical Response|0|||
106026696|NCT01578850|365762500|FG002|Period 1|Insufficient Clinical Response|0|||
106026697|NCT01578850|365762498|FG000|Period 1|Adverse Event|11|||
106026698|NCT01578850|365762499|FG001|Period 1|Adverse Event|0|||
106026699|NCT01578850|365762500|FG002|Period 1|Adverse Event|0|||
106026700|NCT01578850|365762498|FG000|Period 1|Death|1|||
106026701|NCT01578850|365762499|FG001|Period 1|Death|0|||
106150539|NCT00901901|366212584|FG000|Treatment Period|Transfer to treatment continuation study|5|||
106150540|NCT00901901|366212585|FG001|Treatment Period|Transfer to treatment continuation study|2|||
106150541|NCT00901901|366212584|FG000|Follow-up Period|Death|181|||
106026702|NCT01578850|365762500|FG002|Period 1|Death|0|||
106026703|NCT01578850|365762498|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
106026704|NCT01578850|365762499|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
106026705|NCT01578850|365762500|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
106026706|NCT01578850|365762498|FG000|Period 1|Withdrawal by Subject|9|||
106026707|NCT01578850|365762499|FG001|Period 1|Withdrawal by Subject|0|||
106026708|NCT01578850|365762500|FG002|Period 1|Withdrawal by Subject|0|||
106026709|NCT01578850|365762498|FG000|Period 1|Study Terminated by Sponsor|3|||
106026710|NCT01578850|365762499|FG001|Period 1|Study Terminated by Sponsor|0|||
106026711|NCT01578850|365762500|FG002|Period 1|Study Terminated by Sponsor|0|||
106026712|NCT01578850|365762498|FG000|Period 2|Insufficient Clinical Response|0|||
106026713|NCT01578850|365762499|FG001|Period 2|Insufficient Clinical Response|1|||
106026714|NCT01578850|365762500|FG002|Period 2|Insufficient Clinical Response|0|||
106026715|NCT01578850|365762498|FG000|Period 2|Adverse Event|0|||
106026716|NCT01578850|365762499|FG001|Period 2|Adverse Event|3|||
105975274|NCT03593681|365569881|FG000|Overall Study|Adverse Event|2|||
105975275|NCT03593681|365569881|FG000|Overall Study|Physician Decision|1|||
105975276|NCT02214225|365569882|FG000|Overall Study|Lost to Follow-up|46|||
105975277|NCT02214225|365569883|FG001|Overall Study|Lost to Follow-up|18|||
105975278|NCT02214225|365569884|FG002|Overall Study|Lost to Follow-up|18|||
105975279|NCT02214225|365569882|FG000|Overall Study|Withdrawal by Subject|2|||
105975280|NCT02214225|365569883|FG001|Overall Study|Withdrawal by Subject|0|||
105975281|NCT02214225|365569884|FG002|Overall Study|Withdrawal by Subject|2|||
105975282|NCT02214225|365569882|FG000|Overall Study|Death|5|||
105975283|NCT02214225|365569883|FG001|Overall Study|Death|0|||
105975284|NCT02214225|365569884|FG002|Overall Study|Death|1|||
105975285|NCT02214225|365569882|FG000|Overall Study|randomized in error, not vaccinated|2|||
105975286|NCT02214225|365569883|FG001|Overall Study|randomized in error, not vaccinated|1|||
105975287|NCT02214225|365569884|FG002|Overall Study|randomized in error, not vaccinated|1|||
105975288|NCT00717522|365569885|FG000|Overall Study|Disease Progression|5|||
105975289|NCT00717522|365569885|FG000|Overall Study|Adverse Event|1|||
105975290|NCT00717522|365569885|FG000|Overall Study|Death|1|||
105975291|NCT04662073|365569892|FG000|Overall Study|Withdrawal by Subject|1|||
105975292|NCT04662073|365569893|FG001|Overall Study|Withdrawal by Subject|0|||
105975293|NCT02370641|365569896|FG000|Overall Study|dropped study|4|||
105975294|NCT02370641|365569897|FG001|Overall Study|dropped study|2|||
105975295|NCT02699450|365569902|FG000|Overall Study|Death|2|||
105975296|NCT02699450|365569903|FG001|Overall Study|Death|1|||
105975297|NCT02699450|365569904|FG002|Overall Study|Death|2|||
105975298|NCT02699450|365569902|FG000|Overall Study|Met Criteria for Study Exit|0|||
105975299|NCT02699450|365569903|FG001|Overall Study|Met Criteria for Study Exit|0|||
105975300|NCT02699450|365569904|FG002|Overall Study|Met Criteria for Study Exit|1|||
105975301|NCT02699450|365569902|FG000|Overall Study|Protocol Violation|4|||
105975302|NCT02699450|365569903|FG001|Overall Study|Protocol Violation|3|||
105975303|NCT02699450|365569904|FG002|Overall Study|Protocol Violation|5|||
105975304|NCT02699450|365569902|FG000|Overall Study|Lost to Follow-up|3|||
105975305|NCT02699450|365569903|FG001|Overall Study|Lost to Follow-up|0|||
105975306|NCT02699450|365569904|FG002|Overall Study|Lost to Follow-up|5|||
105975307|NCT02699450|365569902|FG000|Overall Study|Physician Decision|2|||
105975308|NCT02699450|365569903|FG001|Overall Study|Physician Decision|0|||
105975309|NCT02699450|365569904|FG002|Overall Study|Physician Decision|0|||
105975310|NCT02699450|365569902|FG000|Overall Study|Withdrawal by Subject|3|||
105975311|NCT02699450|365569903|FG001|Overall Study|Withdrawal by Subject|1|||
105975312|NCT02699450|365569904|FG002|Overall Study|Withdrawal by Subject|2|||
105975313|NCT02699450|365569902|FG000|Overall Study|Adverse Event|1|||
105975314|NCT02699450|365569903|FG001|Overall Study|Adverse Event|0|||
105975315|NCT02699450|365569904|FG002|Overall Study|Adverse Event|0|||
105975316|NCT02410824|365569905|FG000|First Intervention (One Week)|Headache|0|||
105975317|NCT02410824|365569906|FG001|First Intervention (One Week)|Headache|1|||
105975318|NCT02782325|365569907|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
105975319|NCT02782325|365569908|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
105975320|NCT02782325|365569909|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
105975321|NCT02782325|365569907|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
105975322|NCT02782325|365569908|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
105975323|NCT02782325|365569909|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
105975324|NCT01816906|365569910|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
105975325|NCT01816906|365569911|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
105975326|NCT01816906|365569910|FG000|Six Months|Lost to Follow-up|14|||
105975327|NCT01816906|365569911|FG001|Six Months|Lost to Follow-up|16|||
105975328|NCT01816906|365569910|FG000|12 Months|Adverse Event|2|||
105975329|NCT01816906|365569911|FG001|12 Months|Adverse Event|2|||
105975330|NCT01816906|365569910|FG000|12 Months|Death|0|||
105975331|NCT01816906|365569911|FG001|12 Months|Death|2|||
105975332|NCT01816906|365569910|FG000|12 Months|Lost to Follow-up|2|||
105975333|NCT01816906|365569911|FG001|12 Months|Lost to Follow-up|1|||
105975334|NCT00746733|365569912|FG000|Second Intervention|Adverse Event|1|||
105975335|NCT00746733|365569913|FG001|Second Intervention|Adverse Event|0|||
105975336|NCT00746733|365569912|FG000|Third Intervention|Withdrawal by Subject|1|||
105975337|NCT00746733|365569913|FG001|Third Intervention|Withdrawal by Subject|1|||
105975338|NCT00787137|365569918|FG000|Overall Study|Study Termination|0|||
105975339|NCT00787137|365569919|FG001|Overall Study|Study Termination|0|||
105975340|NCT00787137|365569920|FG002|Overall Study|Study Termination|1|||
105975341|NCT02395055|365569925|FG000|Overall Study|Withdrawal by Subject|7|||
105975342|NCT02395055|365569926|FG001|Overall Study|Withdrawal by Subject|3|||
105975343|NCT01628367|365569927|FG000|Overall Study|Adverse Event|1|||
105975344|NCT01628367|365569928|FG001|Overall Study|Adverse Event|0|||
105975345|NCT02513823|365569931|FG000|Overall Study|Lost to Follow-up|4|||
105975346|NCT02513823|365569931|FG000|Overall Study|Physician Decision|1|||
106026717|NCT01578850|365762500|FG002|Period 2|Adverse Event|6|||
105975347|NCT00740714|365569932|FG000|Overall Study|Withdrawal by Subject|17|||
105975348|NCT00740714|365569933|FG001|Overall Study|Withdrawal by Subject|19|||
105975349|NCT00740714|365569934|FG002|Overall Study|Withdrawal by Subject|29|||
105975350|NCT02743780|365569935|FG000|Part 3 (7 Days)|Adverse Event|0|||
105850189|NCT03982199|365112504|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850190|NCT03982199|365112505|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850191|NCT03982199|365112506|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850192|NCT03982199|365112507|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850193|NCT03982199|365112508|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850194|NCT03982199|365112509|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
105850195|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850196|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850197|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850198|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
105850199|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850200|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
106026718|NCT01578850|365762498|FG000|Period 2|Lost to Follow-up|0|||
106026719|NCT01578850|365762499|FG001|Period 2|Lost to Follow-up|1|||
106026720|NCT01578850|365762500|FG002|Period 2|Lost to Follow-up|2|||
106026721|NCT01578850|365762498|FG000|Period 2|Withdrawal by Subject|0|||
106026722|NCT01578850|365762499|FG001|Period 2|Withdrawal by Subject|2|||
106026723|NCT01578850|365762500|FG002|Period 2|Withdrawal by Subject|2|||
106026724|NCT01578850|365762498|FG000|Period 2|Study Terminated by Sponsor|0|||
106026725|NCT01578850|365762499|FG001|Period 2|Study Terminated by Sponsor|5|||
106026726|NCT01578850|365762500|FG002|Period 2|Study Terminated by Sponsor|4|||
106026727|NCT01578850|365762498|FG000|Period 2|Unspecified Reasons|0|||
106026728|NCT01578850|365762499|FG001|Period 2|Unspecified Reasons|1|||
106026729|NCT01578850|365762500|FG002|Period 2|Unspecified Reasons|0|||
106026730|NCT00744042|365762501|FG000|Overall Study|Withdrawal by Subject|1|||
106026731|NCT00978757|365762507|FG000|Overall Study|Physician Decision|1|||
106026732|NCT00978757|365762508|FG001|Overall Study|Physician Decision|3|||
106026733|NCT00781885|365762509|FG000|Overall Study|Physician Decision|1|||
106026734|NCT01755026|365762510|FG000|Overall Study|Adverse Event|1|||
106026735|NCT01755026|365762511|FG001|Overall Study|Adverse Event|0|||
106026736|NCT01755026|365762510|FG000|Overall Study|Withdrawal by Subject|1|||
106026737|NCT01755026|365762511|FG001|Overall Study|Withdrawal by Subject|1|||
106026738|NCT01185353|365762517|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
106026739|NCT01185353|365762518|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
106026740|NCT01185353|365762519|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
106026741|NCT01185353|365762520|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
106026742|NCT01185353|365762521|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
106026743|NCT01185353|365762522|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
106026744|NCT01185353|365762523|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
106026745|NCT01185353|365762524|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
106026746|NCT01185353|365762525|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
106026747|NCT01185353|365762526|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
106026748|NCT01185353|365762517|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026749|NCT01185353|365762518|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026750|NCT01185353|365762519|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026751|NCT01185353|365762520|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026752|NCT01185353|365762521|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
106026753|NCT01185353|365762522|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026754|NCT01185353|365762523|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026755|NCT01185353|365762524|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026756|NCT01185353|365762525|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026757|NCT01185353|365762526|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
106026758|NCT01185353|365762517|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
106026759|NCT01185353|365762518|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
106026760|NCT01185353|365762519|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
106026761|NCT01185353|365762520|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
105850201|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
106026762|NCT01185353|365762521|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
106026763|NCT01185353|365762522|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
106026764|NCT01185353|365762523|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
106026765|NCT01185353|365762524|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
106026766|NCT01185353|365762525|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
106026767|NCT01185353|365762526|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
106026768|NCT01185353|365762517|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
106150542|NCT00901901|366212585|FG001|Follow-up Period|Death|208|||
106150543|NCT00901901|366212584|FG000|Follow-up Period|Protocol driven decision point|47|||
106150544|NCT00901901|366212585|FG001|Follow-up Period|Protocol driven decision point|36|||
106150545|NCT00901901|366212584|FG000|Follow-up Period|Withdrawal by Subject|6|||
106150546|NCT00901901|366212585|FG001|Follow-up Period|Withdrawal by Subject|9|||
106150547|NCT00901901|366212584|FG000|Follow-up Period|Lost to Follow-up|12|||
106150548|NCT00901901|366212585|FG001|Follow-up Period|Lost to Follow-up|8|||
106150549|NCT00901901|366212584|FG000|Follow-up Period|Missing|94|||
106150550|NCT00901901|366212585|FG001|Follow-up Period|Missing|80|||
106150551|NCT00087139|366212586|FG000|Overall Study|Adverse Event|18|||
105975351|NCT02743780|365569936|FG001|Part 3 (7 Days)|Adverse Event|0|||
105975352|NCT02743780|365569937|FG002|Part 3 (7 Days)|Adverse Event|1|||
105975353|NCT02743780|365569938|FG003|Part 3 (7 Days)|Adverse Event|0|||
105975354|NCT02743780|365569939|FG004|Part 3 (7 Days)|Adverse Event|0|||
105975355|NCT00394901|365569940|FG000|Baseline Phase|Protocol Violation|0|||
105975356|NCT00394901|365569941|FG001|Baseline Phase|Protocol Violation|0|||
105975357|NCT00394901|365569942|FG002|Baseline Phase|Protocol Violation|1|||
105975358|NCT00394901|365569943|FG003|Baseline Phase|Protocol Violation|0|||
105975359|NCT00394901|365569940|FG000|Double-blind Phase|Adverse Event|5|||
105975360|NCT00394901|365569941|FG001|Double-blind Phase|Adverse Event|7|||
105975361|NCT00394901|365569942|FG002|Double-blind Phase|Adverse Event|16|||
105975362|NCT00394901|365569943|FG003|Double-blind Phase|Adverse Event|20|||
105975363|NCT00394901|365569940|FG000|Double-blind Phase|Lack of Efficacy|6|||
105975364|NCT00394901|365569941|FG001|Double-blind Phase|Lack of Efficacy|4|||
105975365|NCT00394901|365569942|FG002|Double-blind Phase|Lack of Efficacy|1|||
105975366|NCT00394901|365569943|FG003|Double-blind Phase|Lack of Efficacy|3|||
105975367|NCT00394901|365569940|FG000|Double-blind Phase|Withdrawal by Subject|2|||
105975368|NCT00394901|365569941|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105975369|NCT00394901|365569942|FG002|Double-blind Phase|Withdrawal by Subject|0|||
105975370|NCT00394901|365569943|FG003|Double-blind Phase|Withdrawal by Subject|0|||
105975371|NCT00394901|365569940|FG000|Double-blind Phase|Lost to Follow-up|0|||
105975372|NCT00394901|365569941|FG001|Double-blind Phase|Lost to Follow-up|0|||
105975373|NCT00394901|365569942|FG002|Double-blind Phase|Lost to Follow-up|0|||
105975374|NCT00394901|365569943|FG003|Double-blind Phase|Lost to Follow-up|1|||
105975375|NCT00394901|365569940|FG000|Double-blind Phase|Protocol Violation|0|||
105975376|NCT00394901|365569941|FG001|Double-blind Phase|Protocol Violation|0|||
105975377|NCT00394901|365569942|FG002|Double-blind Phase|Protocol Violation|0|||
105975378|NCT00394901|365569943|FG003|Double-blind Phase|Protocol Violation|1|||
105975379|NCT00394901|365569940|FG000|Double-blind Phase|Death|1|||
105975380|NCT00394901|365569941|FG001|Double-blind Phase|Death|0|||
105975381|NCT00394901|365569942|FG002|Double-blind Phase|Death|0|||
105975382|NCT00394901|365569943|FG003|Double-blind Phase|Death|0|||
105975383|NCT00394901|365569940|FG000|Double-blind Phase|Subject's Personal Reason|1|||
105975384|NCT00394901|365569941|FG001|Double-blind Phase|Subject's Personal Reason|0|||
105975385|NCT00394901|365569942|FG002|Double-blind Phase|Subject's Personal Reason|0|||
105975386|NCT00394901|365569943|FG003|Double-blind Phase|Subject's Personal Reason|1|||
105975387|NCT00394901|365569940|FG000|Double-blind Phase|Lack of Compliance|0|||
105975388|NCT00394901|365569941|FG001|Double-blind Phase|Lack of Compliance|3|||
105975389|NCT00394901|365569942|FG002|Double-blind Phase|Lack of Compliance|0|||
105975390|NCT00394901|365569943|FG003|Double-blind Phase|Lack of Compliance|0|||
105975391|NCT00394901|365569940|FG000|Double-blind Phase|Entry into another study was found|0|||
105975392|NCT00394901|365569941|FG001|Double-blind Phase|Entry into another study was found|0|||
105975393|NCT00394901|365569942|FG002|Double-blind Phase|Entry into another study was found|1|||
105975394|NCT00394901|365569943|FG003|Double-blind Phase|Entry into another study was found|0|||
105975395|NCT00394901|365569940|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
105975396|NCT00394901|365569941|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
105975397|NCT00394901|365569942|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
105975398|NCT00394901|365569943|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
105975399|NCT01460407|365569947|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
105975400|NCT01460407|365569948|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
105975401|NCT01140568|365569949|FG000|Overall Study|disease progression|31|||
105975402|NCT01140568|365569949|FG000|Overall Study|Withdrawal by Subject|1|||
105975403|NCT01140568|365569949|FG000|Overall Study|Screen Fail|4|||
105975404|NCT01510145|365569951|FG000|Overall Study|Adverse Event|6|||
105975405|NCT01510145|365569951|FG000|Overall Study|Lost to Follow-up|5|||
105975406|NCT01510145|365569951|FG000|Overall Study|Withdrawal by Subject|6|||
105975407|NCT01510145|365569951|FG000|Overall Study|Relative reported subject withdrew|1|||
105975408|NCT02279719|365569953|FG000|Overall Study|Patients randomized but never treated|0|||
105975409|NCT02279719|365569954|FG001|Overall Study|Patients randomized but never treated|0|||
105975410|NCT02279719|365569955|FG002|Overall Study|Patients randomized but never treated|0|||
105975411|NCT02279719|365569956|FG003|Overall Study|Patients randomized but never treated|0|||
106150552|NCT00087139|366212587|FG001|Overall Study|Adverse Event|17|||
105975412|NCT02279719|365569957|FG004|Overall Study|Patients randomized but never treated|3|||
105975413|NCT02279719|365569958|FG005|Overall Study|Patients randomized but never treated|0|||
106150553|NCT00087139|366212588|FG002|Overall Study|Adverse Event|13|||
105850202|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850203|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850204|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850205|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850206|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850207|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850208|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
105850209|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850210|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850211|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
106150554|NCT00087139|366212586|FG000|Overall Study|Death|2|||
105850212|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850213|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850214|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850215|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850216|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850217|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850218|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850219|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850220|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850221|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850222|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
105850223|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850224|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850225|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
105850226|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850227|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850228|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850229|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850230|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850231|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850232|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850233|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850234|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850235|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850236|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
105850237|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850238|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850239|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
105850240|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
105850241|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850242|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850243|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850244|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850245|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850246|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850247|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850248|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850249|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850250|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
105850251|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850252|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850253|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850254|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
105850255|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850256|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850257|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850258|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850259|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850260|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
106150555|NCT00087139|366212587|FG001|Overall Study|Death|1|||
106150556|NCT00087139|366212588|FG002|Overall Study|Death|0|||
106150557|NCT00087139|366212586|FG000|Overall Study|Withdrawal by Subject|3|||
106150558|NCT00087139|366212587|FG001|Overall Study|Withdrawal by Subject|2|||
106150559|NCT00087139|366212588|FG002|Overall Study|Withdrawal by Subject|2|||
106150560|NCT00087139|366212586|FG000|Overall Study|Physician Decision|1|||
106150561|NCT00087139|366212587|FG001|Overall Study|Physician Decision|1|||
106150562|NCT00087139|366212588|FG002|Overall Study|Physician Decision|1|||
106150563|NCT00087139|366212586|FG000|Overall Study|Disease progression|9|||
106150564|NCT00087139|366212587|FG001|Overall Study|Disease progression|19|||
106150565|NCT00087139|366212588|FG002|Overall Study|Disease progression|12|||
106150566|NCT00087139|366212586|FG000|Overall Study|Ineligible|4|||
106150567|NCT00087139|366212587|FG001|Overall Study|Ineligible|7|||
106150568|NCT00087139|366212588|FG002|Overall Study|Ineligible|4|||
106150569|NCT00087139|366212586|FG000|Overall Study|Symptomatic deterioration|1|||
106150570|NCT00087139|366212587|FG001|Overall Study|Symptomatic deterioration|1|||
106150571|NCT00087139|366212588|FG002|Overall Study|Symptomatic deterioration|3|||
106150572|NCT00087139|366212586|FG000|Overall Study|Use of coumadin|1|||
106150573|NCT00087139|366212587|FG001|Overall Study|Use of coumadin|0|||
106150574|NCT00087139|366212588|FG002|Overall Study|Use of coumadin|0|||
106150575|NCT00087139|366212586|FG000|Overall Study|Response achieved|0|||
106150576|NCT00087139|366212587|FG001|Overall Study|Response achieved|1|||
106150577|NCT00087139|366212588|FG002|Overall Study|Response achieved|0|||
106150578|NCT00087139|366212586|FG000|Overall Study|Extradural disease|0|||
106150579|NCT00087139|366212587|FG001|Overall Study|Extradural disease|0|||
106150580|NCT00087139|366212588|FG002|Overall Study|Extradural disease|1|||
106150581|NCT00976495|366212589|FG000|Overall Study|Withdrawal by Subject|0|||
106150582|NCT00976495|366212590|FG001|Overall Study|Withdrawal by Subject|1|||
106150583|NCT00976495|366212591|FG002|Overall Study|Withdrawal by Subject|0|||
106150584|NCT02272816|366212592|FG000|Overall Study|Adverse Event|1|||
106150585|NCT05171777|366212593|FG000|Treatment Crossover Period|Adverse Event|9|||
105850261|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850262|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850263|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850264|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
105850265|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850266|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850267|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
105850268|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
105850269|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850270|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850271|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850272|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850273|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850274|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850275|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850276|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850277|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850278|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
105850279|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850280|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850281|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850282|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850283|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850284|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850285|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850286|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850287|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
105850288|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850289|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850290|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850291|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850292|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
105850293|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850294|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850295|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
106150586|NCT05171777|366212594|FG001|Treatment Crossover Period|Adverse Event|6|||
106150587|NCT05171777|366212595|FG002|Treatment Crossover Period|Adverse Event|0|||
106150588|NCT05171777|366212596|FG003|Treatment Crossover Period|Adverse Event|0|||
105850296|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850297|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
106150589|NCT05171777|366212593|FG000|Treatment Crossover Period|Death|5|||
106150590|NCT05171777|366212594|FG001|Treatment Crossover Period|Death|5|||
106150591|NCT05171777|366212595|FG002|Treatment Crossover Period|Death|0|||
106150592|NCT05171777|366212596|FG003|Treatment Crossover Period|Death|0|||
106150593|NCT05171777|366212593|FG000|Treatment Crossover Period|Disease Relapse|0|||
106026769|NCT01185353|365762518|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
106026770|NCT01185353|365762519|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
106026771|NCT01185353|365762520|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
106026772|NCT01185353|365762521|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
106026773|NCT01185353|365762522|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
106026774|NCT01185353|365762523|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
106026775|NCT01185353|365762524|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
106026776|NCT01185353|365762525|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
106026777|NCT01185353|365762526|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
106026778|NCT01185353|365762517|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026779|NCT01185353|365762518|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026780|NCT01185353|365762519|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026781|NCT01185353|365762520|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026782|NCT01185353|365762521|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
106026783|NCT01185353|365762522|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026784|NCT01185353|365762523|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026785|NCT01185353|365762524|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026786|NCT01185353|365762525|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026787|NCT01185353|365762526|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
106026788|NCT01185353|365762517|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
106026789|NCT01185353|365762518|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
106026790|NCT01185353|365762519|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
106026791|NCT01185353|365762520|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
106026792|NCT01185353|365762521|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
106026793|NCT01185353|365762522|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
106026794|NCT01185353|365762523|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
106026795|NCT01185353|365762524|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
106026796|NCT01185353|365762525|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
106026797|NCT01185353|365762526|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
106026798|NCT01185353|365762517|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
106026799|NCT01185353|365762518|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
106026800|NCT01185353|365762519|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
106026801|NCT01185353|365762520|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
106026802|NCT01185353|365762521|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
106026803|NCT01185353|365762522|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
106026804|NCT01185353|365762523|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
106026805|NCT01185353|365762524|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
106026806|NCT01185353|365762525|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
106026807|NCT01185353|365762526|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
106026808|NCT01185353|365762517|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
106026809|NCT01185353|365762518|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
106026810|NCT01185353|365762519|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
106026811|NCT01185353|365762520|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
106026812|NCT01185353|365762521|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
106026813|NCT01185353|365762522|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
106026814|NCT01185353|365762523|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
106026815|NCT01185353|365762524|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
106026816|NCT01185353|365762525|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
106026817|NCT01185353|365762526|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
106026818|NCT01185353|365762517|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
106026819|NCT01185353|365762518|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
106026820|NCT01185353|365762519|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
106026821|NCT01185353|365762520|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
106026822|NCT01185353|365762521|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
106026823|NCT01185353|365762522|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
106026824|NCT01185353|365762523|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
106026825|NCT01185353|365762524|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
106026826|NCT01185353|365762525|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
106026827|NCT01185353|365762526|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
106026828|NCT01185353|365762517|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
106026829|NCT01185353|365762518|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
106026830|NCT01185353|365762519|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
106026831|NCT01185353|365762520|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
106026832|NCT01185353|365762521|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
106026833|NCT01185353|365762522|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
106026834|NCT01185353|365762523|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
106026835|NCT01185353|365762524|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
106026836|NCT01185353|365762525|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
106026837|NCT01185353|365762526|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
105975414|NCT02279719|365569959|FG006|Overall Study|Patients randomized but never treated|3|||
105975415|NCT00546260|365569960|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
105975416|NCT00546260|365569961|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
105975417|NCT02725593|365569962|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
105975418|NCT02725593|365569963|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
105975419|NCT02725593|365569962|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
105975420|NCT02725593|365569963|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
105975421|NCT02725593|365569962|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
105975422|NCT02725593|365569963|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
105975423|NCT02725593|365569962|FG000|Long Term Extension|Withdrawal by Subject|1|||
105975424|NCT02725593|365569963|FG001|Long Term Extension|Withdrawal by Subject|3|||
105975425|NCT04030247|365572098|FG000|Overall Study|Withdrawal by Subject|4|||
105975426|NCT04030247|365572098|FG000|Overall Study|Lost to Follow-up|13|||
105975427|NCT03220581|365572104|FG000|Overall Study|Withdrawal by Subject|0|||
105975428|NCT03220581|365572105|FG001|Overall Study|Withdrawal by Subject|1|||
105975429|NCT03220581|365572104|FG000|Overall Study|Lost to Follow-up|3|||
105975430|NCT03220581|365572105|FG001|Overall Study|Lost to Follow-up|6|||
105975431|NCT01185964|365572106|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
105975432|NCT01185964|365572107|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
105975433|NCT01185964|365572108|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
105975434|NCT01185964|365572109|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
105975435|NCT01185964|365572106|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
105975436|NCT01185964|365572107|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
105975437|NCT01185964|365572108|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
105975438|NCT01185964|365572109|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
105975439|NCT01185964|365572106|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
105975440|NCT01185964|365572107|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
105975441|NCT01185964|365572108|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
105975442|NCT01185964|365572109|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
105975443|NCT01185964|365572106|FG000|Phase 1b and Phase 2|Adverse Event|1|||
105975444|NCT01185964|365572107|FG001|Phase 1b and Phase 2|Adverse Event|0|||
105975445|NCT01185964|365572108|FG002|Phase 1b and Phase 2|Adverse Event|2|||
105975446|NCT01185964|365572109|FG003|Phase 1b and Phase 2|Adverse Event|0|||
105975447|NCT01185964|365572106|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
105975448|NCT01185964|365572107|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
105975449|NCT01185964|365572108|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
105975450|NCT01185964|365572109|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
105975451|NCT01185964|365572106|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
105975452|NCT01185964|365572107|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
105975453|NCT01185964|365572108|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
105975454|NCT01185964|365572109|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
105975455|NCT01185964|365572106|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
105975456|NCT01185964|365572107|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
105975457|NCT01185964|365572108|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
105975458|NCT01185964|365572109|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
105975459|NCT01185964|365572106|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
105975460|NCT01185964|365572107|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
105975461|NCT01185964|365572108|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
105975462|NCT01185964|365572109|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
105975463|NCT01920893|365572110|FG000|Overall Study|Adverse Event|5|||
105975464|NCT01920893|365572111|FG001|Overall Study|Adverse Event|2|||
105975465|NCT01920893|365572110|FG000|Overall Study|Lack of Efficacy|2|||
105975466|NCT01920893|365572111|FG001|Overall Study|Lack of Efficacy|0|||
105975467|NCT03440918|365572123|FG000|Overall Study|Protocol Violation|0|||
105975468|NCT03440918|365572124|FG001|Overall Study|Protocol Violation|16|||
105975469|NCT04962230|365572125|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
106026838|NCT01185353|365762517|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
106026839|NCT01185353|365762518|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
106026840|NCT01185353|365762519|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
106026841|NCT01185353|365762520|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
106026842|NCT01185353|365762521|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
106026843|NCT01185353|365762522|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
106026844|NCT01185353|365762523|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
105975470|NCT04962230|365572125|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
105975471|NCT01396265|365572126|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
105975472|NCT02118597|365572127|FG000|Overall Study|Sponsor terminated the study|14|||
105975473|NCT02118597|365572127|FG000|Overall Study|Serious Adverse Event|1|||
106026845|NCT01185353|365762524|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
106026846|NCT01185353|365762525|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
105975474|NCT02118597|365572127|FG000|Overall Study|Investigator's decision|1|||
105975475|NCT02275117|365572131|FG000|Overall Study|Adverse Event|0|||
105975476|NCT02275117|365572132|FG001|Overall Study|Adverse Event|0|||
105975477|NCT02275117|365572133|FG002|Overall Study|Adverse Event|0|||
105975478|NCT02275117|365572134|FG003|Overall Study|Adverse Event|0|||
105975479|NCT02275117|365572135|FG004|Overall Study|Adverse Event|1|||
105975480|NCT02275117|365572131|FG000|Overall Study|Lack of Efficacy|6|||
105975481|NCT02275117|365572132|FG001|Overall Study|Lack of Efficacy|7|||
105975482|NCT02275117|365572133|FG002|Overall Study|Lack of Efficacy|5|||
105975483|NCT02275117|365572134|FG003|Overall Study|Lack of Efficacy|2|||
105975484|NCT02275117|365572135|FG004|Overall Study|Lack of Efficacy|10|||
105975485|NCT02275117|365572131|FG000|Overall Study|Lost to Follow-up|11|||
105975486|NCT02275117|365572132|FG001|Overall Study|Lost to Follow-up|16|||
105975487|NCT02275117|365572133|FG002|Overall Study|Lost to Follow-up|15|||
105975488|NCT02275117|365572134|FG003|Overall Study|Lost to Follow-up|16|||
105975489|NCT02275117|365572135|FG004|Overall Study|Lost to Follow-up|8|||
105975490|NCT02275117|365572131|FG000|Overall Study|Physician Decision|0|||
105975491|NCT02275117|365572132|FG001|Overall Study|Physician Decision|1|||
106026847|NCT01185353|365762526|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
106026848|NCT01185353|365762517|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
106026849|NCT01185353|365762518|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
106026850|NCT01185353|365762519|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
106026851|NCT01185353|365762520|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
106026852|NCT01185353|365762521|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
106026853|NCT01185353|365762522|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
106026854|NCT01185353|365762523|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
106026855|NCT01185353|365762524|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
106026856|NCT01185353|365762525|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
106026857|NCT01185353|365762526|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
106026858|NCT01185353|365762517|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
106026859|NCT01185353|365762518|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
106026860|NCT01185353|365762519|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
106026861|NCT01185353|365762520|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
106026862|NCT01185353|365762521|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
106026863|NCT01185353|365762522|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
106026864|NCT01185353|365762523|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
106026865|NCT01185353|365762524|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
106026866|NCT01185353|365762525|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
106026867|NCT01185353|365762526|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
106026868|NCT01185353|365762517|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
106026869|NCT01185353|365762518|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
106026870|NCT01185353|365762519|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
106026871|NCT01185353|365762520|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
106026872|NCT01185353|365762521|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
106026873|NCT01185353|365762522|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
106026874|NCT01185353|365762523|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
106026875|NCT01185353|365762524|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
106026876|NCT01185353|365762525|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
106026877|NCT01185353|365762526|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
106026878|NCT01185353|365762517|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106026879|NCT01185353|365762518|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106026880|NCT01185353|365762519|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106026881|NCT01185353|365762520|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106026882|NCT01185353|365762521|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106026883|NCT01185353|365762522|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106026884|NCT01185353|365762523|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106026885|NCT01185353|365762524|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106026886|NCT01185353|365762525|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
106026887|NCT01185353|365762526|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
106150594|NCT05171777|366212594|FG001|Treatment Crossover Period|Disease Relapse|1|||
106150595|NCT05171777|366212595|FG002|Treatment Crossover Period|Disease Relapse|0|||
105975492|NCT02275117|365572133|FG002|Overall Study|Physician Decision|1|||
105975493|NCT02275117|365572134|FG003|Overall Study|Physician Decision|0|||
106026888|NCT01185353|365762517|FG000|Part C (Weeks 24 Through 76)|Death|0|||
106026889|NCT01185353|365762518|FG001|Part C (Weeks 24 Through 76)|Death|0|||
106026890|NCT01185353|365762519|FG002|Part C (Weeks 24 Through 76)|Death|0|||
106026891|NCT01185353|365762520|FG003|Part C (Weeks 24 Through 76)|Death|0|||
106026892|NCT01185353|365762521|FG004|Part C (Weeks 24 Through 76)|Death|0|||
106026893|NCT01185353|365762522|FG005|Part C (Weeks 24 Through 76)|Death|0|||
105975494|NCT02275117|365572135|FG004|Overall Study|Physician Decision|1|||
105975495|NCT02275117|365572131|FG000|Overall Study|Protocol Violation|1|||
105975496|NCT02275117|365572132|FG001|Overall Study|Protocol Violation|0|||
105975497|NCT02275117|365572133|FG002|Overall Study|Protocol Violation|1|||
105850298|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850299|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850300|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850301|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
105850302|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850303|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850304|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850305|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850306|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
105850307|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850308|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850309|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850310|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850311|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850312|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850313|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850314|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850315|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
105850316|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850317|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850318|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105975498|NCT02275117|365572134|FG003|Overall Study|Protocol Violation|1|||
105975499|NCT02275117|365572135|FG004|Overall Study|Protocol Violation|0|||
105975500|NCT02275117|365572131|FG000|Overall Study|Withdrawal by Subject|6|||
105975501|NCT02275117|365572132|FG001|Overall Study|Withdrawal by Subject|4|||
105975502|NCT02275117|365572133|FG002|Overall Study|Withdrawal by Subject|7|||
105975503|NCT02275117|365572134|FG003|Overall Study|Withdrawal by Subject|3|||
105975504|NCT02275117|365572135|FG004|Overall Study|Withdrawal by Subject|3|||
105975505|NCT02275117|365572131|FG000|Overall Study|Terminated by Sponsor|4|||
105975506|NCT02275117|365572132|FG001|Overall Study|Terminated by Sponsor|4|||
105975507|NCT02275117|365572133|FG002|Overall Study|Terminated by Sponsor|4|||
105975508|NCT02275117|365572134|FG003|Overall Study|Terminated by Sponsor|6|||
105975509|NCT02275117|365572135|FG004|Overall Study|Terminated by Sponsor|4|||
105975510|NCT02275117|365572131|FG000|Overall Study|Worsening of Study Indication|0|||
105975511|NCT02275117|365572132|FG001|Overall Study|Worsening of Study Indication|1|||
105975512|NCT02275117|365572133|FG002|Overall Study|Worsening of Study Indication|2|||
105975513|NCT02275117|365572134|FG003|Overall Study|Worsening of Study Indication|0|||
105975514|NCT02275117|365572135|FG004|Overall Study|Worsening of Study Indication|0|||
105975515|NCT02275117|365572131|FG000|Overall Study|Study Burden|5|||
105975516|NCT02275117|365572132|FG001|Overall Study|Study Burden|4|||
105975517|NCT02275117|365572133|FG002|Overall Study|Study Burden|7|||
105975518|NCT02275117|365572134|FG003|Overall Study|Study Burden|5|||
105975519|NCT02275117|365572135|FG004|Overall Study|Study Burden|7|||
105975520|NCT02275117|365572131|FG000|Overall Study|Other|1|||
105975521|NCT02275117|365572132|FG001|Overall Study|Other|0|||
105975522|NCT02275117|365572133|FG002|Overall Study|Other|0|||
105975523|NCT02275117|365572134|FG003|Overall Study|Other|0|||
105975524|NCT02275117|365572135|FG004|Overall Study|Other|2|||
105975525|NCT02014480|365572138|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105975526|NCT02014480|365572139|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105975527|NCT02014480|365572140|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
105975528|NCT02014480|365572141|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105975529|NCT02014480|365572142|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105975530|NCT02014480|365572143|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
105975531|NCT02014480|365572138|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105975532|NCT02014480|365572139|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105975533|NCT02014480|365572140|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105975534|NCT02014480|365572141|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
105975535|NCT02014480|365572142|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
105975536|NCT02014480|365572143|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
105975537|NCT02014480|365572138|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105975538|NCT02014480|365572139|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105975539|NCT02014480|365572140|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
105975540|NCT02014480|365572141|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105975541|NCT02014480|365572142|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105975542|NCT02014480|365572143|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
105975543|NCT02014480|365572138|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105975544|NCT02014480|365572139|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105975545|NCT02014480|365572140|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
105975546|NCT02014480|365572141|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
105975547|NCT02014480|365572142|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105975548|NCT02014480|365572143|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
105975549|NCT02014480|365572138|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105975550|NCT02014480|365572139|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
105975551|NCT02014480|365572140|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105975552|NCT02014480|365572141|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105975553|NCT02014480|365572142|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105975554|NCT02014480|365572143|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
105975555|NCT02014480|365572138|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
105975556|NCT02014480|365572139|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
105975557|NCT02014480|365572140|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
105975558|NCT02014480|365572141|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
106026894|NCT01185353|365762523|FG006|Part C (Weeks 24 Through 76)|Death|0|||
106026895|NCT01185353|365762524|FG007|Part C (Weeks 24 Through 76)|Death|0|||
106026896|NCT01185353|365762525|FG008|Part C (Weeks 24 Through 76)|Death|0|||
106026897|NCT01185353|365762526|FG009|Part C (Weeks 24 Through 76)|Death|1|||
106026898|NCT01185353|365762517|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
106026899|NCT01185353|365762518|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
106026900|NCT01185353|365762519|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
106026901|NCT01185353|365762520|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
106026902|NCT01185353|365762521|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
106026903|NCT01185353|365762522|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
106026904|NCT01185353|365762523|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
105850319|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850320|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
105850321|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850322|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850323|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
106026905|NCT01185353|365762524|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
106026906|NCT01185353|365762525|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
106026907|NCT01185353|365762526|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
105850324|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
106026908|NCT01185353|365762517|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105850325|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850326|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850327|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850328|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850329|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
105850330|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850331|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850332|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850333|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850334|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
105850335|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850336|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850337|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850338|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850339|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850340|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850341|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850342|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850343|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
105975559|NCT02014480|365572142|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
106026909|NCT01185353|365762518|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
106026910|NCT01185353|365762519|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
106026911|NCT01185353|365762520|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
106026912|NCT01185353|365762521|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
106026913|NCT01185353|365762522|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
106026914|NCT01185353|365762523|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
106026915|NCT01185353|365762524|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
105850344|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105975560|NCT02014480|365572143|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
106026916|NCT01185353|365762525|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
106026917|NCT01185353|365762526|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
106026918|NCT01185353|365762517|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
106026919|NCT01185353|365762518|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
105850345|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850346|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850347|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850348|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
105850349|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850350|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850351|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850352|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850353|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850354|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
105850355|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
106026920|NCT01185353|365762519|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
106026921|NCT01185353|365762520|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
106026922|NCT01185353|365762521|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
106026923|NCT01185353|365762522|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
106026924|NCT01185353|365762523|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
106026925|NCT01185353|365762524|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
106026926|NCT01185353|365762525|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
106026927|NCT01185353|365762526|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
106026928|NCT01185353|365762517|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
106026929|NCT01185353|365762518|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
106026930|NCT01185353|365762519|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
106026931|NCT01185353|365762520|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
106026932|NCT01185353|365762521|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
106026933|NCT01185353|365762522|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
106026934|NCT01185353|365762523|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
106026935|NCT01185353|365762524|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
106026936|NCT01185353|365762525|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
106026937|NCT01185353|365762526|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
106026938|NCT01185353|365762517|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
106026939|NCT01185353|365762518|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
106026940|NCT01185353|365762519|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
106026941|NCT01185353|365762520|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
106026942|NCT01185353|365762521|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
106026943|NCT01185353|365762522|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
106026944|NCT01185353|365762523|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
106026945|NCT01185353|365762524|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
106026946|NCT01185353|365762525|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
106026947|NCT01185353|365762526|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
106026948|NCT01185353|365762517|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
106026949|NCT01185353|365762518|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
106026950|NCT01185353|365762519|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
106026951|NCT01185353|365762520|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
106026952|NCT01185353|365762521|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
106026953|NCT01185353|365762522|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
106026954|NCT01185353|365762523|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
106026955|NCT01185353|365762524|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
106026956|NCT01185353|365762525|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
106026957|NCT01185353|365762526|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
106026958|NCT01144299|365762529|FG000|Overall Study|Lost to Follow-up|1|||
106026959|NCT01144299|365762530|FG001|Overall Study|Lost to Follow-up|0|||
106026960|NCT01144299|365762529|FG000|Overall Study|Withdrawal by Subject|1|||
106026961|NCT01144299|365762530|FG001|Overall Study|Withdrawal by Subject|0|||
106026962|NCT01699867|365762533|FG000|Overall Study|Screening Failure|3|||
106026963|NCT01375075|365762534|FG000|Overall Study|Adverse Event|0|||
106026964|NCT01375075|365762535|FG001|Overall Study|Adverse Event|0|||
106026965|NCT01375075|365762536|FG002|Overall Study|Adverse Event|3|||
106026966|NCT01375075|365762537|FG003|Overall Study|Adverse Event|1|||
106026967|NCT01375075|365762538|FG004|Overall Study|Adverse Event|0|||
106026968|NCT01375075|365762539|FG005|Overall Study|Adverse Event|1|||
106026969|NCT01375075|365762534|FG000|Overall Study|Entry Criterion Not Met|1|||
106026970|NCT01375075|365762535|FG001|Overall Study|Entry Criterion Not Met|0|||
106026971|NCT01375075|365762536|FG002|Overall Study|Entry Criterion Not Met|0|||
106026972|NCT01375075|365762537|FG003|Overall Study|Entry Criterion Not Met|0|||
106026973|NCT01375075|365762538|FG004|Overall Study|Entry Criterion Not Met|0|||
106026974|NCT01375075|365762539|FG005|Overall Study|Entry Criterion Not Met|1|||
106026975|NCT01375075|365762534|FG000|Overall Study|Withdrawal by Subject|0|||
106026976|NCT01375075|365762535|FG001|Overall Study|Withdrawal by Subject|1|||
106026977|NCT01375075|365762536|FG002|Overall Study|Withdrawal by Subject|0|||
106150596|NCT05171777|366212596|FG003|Treatment Crossover Period|Disease Relapse|0|||
106150597|NCT05171777|366212593|FG000|Treatment Crossover Period|Reason not Specified|2|||
106150598|NCT05171777|366212594|FG001|Treatment Crossover Period|Reason not Specified|1|||
106150599|NCT05171777|366212595|FG002|Treatment Crossover Period|Reason not Specified|0|||
105975561|NCT02014480|365572138|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105975562|NCT02014480|365572139|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105975563|NCT02014480|365572140|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105975564|NCT02014480|365572141|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105975565|NCT02014480|365572142|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
105975566|NCT02014480|365572143|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
105975567|NCT02763254|365572146|FG000|Overall Study|Adverse Event|1|||
105975568|NCT01149486|365572147|FG000|First Intervention|Adverse Event|0|||
105975569|NCT01149486|365572148|FG001|First Intervention|Adverse Event|1|||
105975570|NCT01669421|365572149|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
105975571|NCT01669421|365572149|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
105975572|NCT01286987|365572150|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
105975573|NCT01286987|365572151|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
105975574|NCT01286987|365572152|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
105975575|NCT01286987|365572153|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
105975576|NCT01286987|365572154|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
105975577|NCT01286987|365572155|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
105975578|NCT01286987|365572156|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
105975579|NCT01286987|365572157|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
105975580|NCT01286987|365572158|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
105975581|NCT01286987|365572159|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
105975582|NCT01286987|365572160|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
105975583|NCT01286987|365572161|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
105975584|NCT01286987|365572162|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
105975585|NCT01286987|365572163|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
105975586|NCT01286987|365572164|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
106150600|NCT05171777|366212596|FG003|Treatment Crossover Period|Reason not Specified|0|||
106150601|NCT05171777|366212593|FG000|Treatment Crossover Period|Physician Decision|0|||
106150602|NCT05171777|366212594|FG001|Treatment Crossover Period|Physician Decision|1|||
106150603|NCT05171777|366212595|FG002|Treatment Crossover Period|Physician Decision|0|||
106150604|NCT05171777|366212596|FG003|Treatment Crossover Period|Physician Decision|0|||
106150605|NCT05171777|366212593|FG000|Treatment Crossover Period|Progressive Disease|13|||
106150606|NCT05171777|366212594|FG001|Treatment Crossover Period|Progressive Disease|9|||
106150607|NCT05171777|366212595|FG002|Treatment Crossover Period|Progressive Disease|0|||
106150608|NCT05171777|366212596|FG003|Treatment Crossover Period|Progressive Disease|0|||
106150609|NCT05171777|366212593|FG000|Treatment Crossover Period|Protocol Violation|0|||
106150610|NCT05171777|366212594|FG001|Treatment Crossover Period|Protocol Violation|2|||
106150611|NCT05171777|366212595|FG002|Treatment Crossover Period|Protocol Violation|0|||
106150612|NCT05171777|366212596|FG003|Treatment Crossover Period|Protocol Violation|0|||
106150613|NCT05171777|366212593|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
106150614|NCT05171777|366212594|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
106150615|NCT05171777|366212595|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
106150616|NCT05171777|366212596|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
106150617|NCT05171777|366212593|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
106150618|NCT05171777|366212594|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
106150619|NCT05171777|366212595|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
106150620|NCT05171777|366212596|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
106150621|NCT05171777|366212593|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
106150622|NCT05171777|366212594|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
106150623|NCT05171777|366212595|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
106150624|NCT05171777|366212596|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
106150625|NCT05171777|366212593|FG000|Treatment Continuation Period|Death|0|||
106150626|NCT05171777|366212594|FG001|Treatment Continuation Period|Death|0|||
106150627|NCT05171777|366212595|FG002|Treatment Continuation Period|Death|1|||
106150628|NCT05171777|366212596|FG003|Treatment Continuation Period|Death|6|||
106150629|NCT05171777|366212593|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
106150630|NCT05171777|366212594|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
106150631|NCT05171777|366212595|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
106150632|NCT05171777|366212596|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
106150633|NCT01083316|366212597|FG000|Overall Study|Adverse Event|2|||
106150634|NCT01083316|366212597|FG000|Overall Study|Withdrawal by Subject|1|||
106150635|NCT04766034|366212607|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
106150636|NCT04766034|366212608|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
106150637|NCT04766034|366212609|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
106150638|NCT04766034|366212610|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
106150639|NCT04766034|366212611|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
106150640|NCT04766034|366212607|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
105850356|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
105850357|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
105850358|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850359|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850360|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850361|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850362|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
105850363|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850364|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850365|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850366|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850367|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850368|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850369|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850370|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850371|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
105850372|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850373|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850374|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850375|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850376|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
105850377|NCT03982199|365112496|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850378|NCT03982199|365112497|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850379|NCT03982199|365112498|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850380|NCT03982199|365112499|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850381|NCT03982199|365112500|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850382|NCT03982199|365112501|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
105850383|NCT03982199|365112502|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850384|NCT03982199|365112503|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
105850385|NCT03982199|365112504|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
105850386|NCT03982199|365112505|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850387|NCT03982199|365112506|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850388|NCT03982199|365112507|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850389|NCT03982199|365112508|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850390|NCT03982199|365112509|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
105850391|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850392|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850393|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850394|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850395|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850396|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850397|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850398|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850399|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
105850400|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
105850401|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
105850402|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
105850403|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
105850404|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
105850405|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850406|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850407|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850408|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850409|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
106150641|NCT04766034|366212608|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
106150642|NCT04766034|366212609|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
106150643|NCT04766034|366212610|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
106026978|NCT01375075|365762537|FG003|Overall Study|Withdrawal by Subject|0|||
106026979|NCT01375075|365762538|FG004|Overall Study|Withdrawal by Subject|0|||
106026980|NCT01375075|365762539|FG005|Overall Study|Withdrawal by Subject|1|||
106026981|NCT00831493|365762543|FG000|Overall Study|Intractable nausea and vomiting|1|||
106026982|NCT00243841|365762546|FG000|Overall Study|Physician Decision|0|||
106026983|NCT00243841|365762547|FG001|Overall Study|Physician Decision|0|||
106026984|NCT00243841|365762548|FG002|Overall Study|Physician Decision|1|||
106026985|NCT00243841|365762549|FG003|Overall Study|Physician Decision|0|||
106026986|NCT00243841|365762550|FG004|Overall Study|Physician Decision|0|||
106026987|NCT00243841|365762551|FG005|Overall Study|Physician Decision|2|||
106026988|NCT03255083|365762552|FG000|Overall Study|Clinical progression|1|||
106026989|NCT03255083|365762553|FG001|Overall Study|Clinical progression|0|||
106026990|NCT03255083|365762554|FG002|Overall Study|Clinical progression|0|||
106026991|NCT03255083|365762555|FG003|Overall Study|Clinical progression|0|||
106026992|NCT03255083|365762552|FG000|Overall Study|Adverse Event|0|||
106026993|NCT03255083|365762553|FG001|Overall Study|Adverse Event|1|||
106026994|NCT03255083|365762554|FG002|Overall Study|Adverse Event|0|||
106026995|NCT03255083|365762555|FG003|Overall Study|Adverse Event|0|||
106026996|NCT03255083|365762552|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
106026997|NCT03255083|365762553|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
106026998|NCT03255083|365762554|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
106026999|NCT03255083|365762555|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
106027000|NCT03255083|365762552|FG000|Overall Study|Withdrawal by Subject|1|||
106027001|NCT03255083|365762553|FG001|Overall Study|Withdrawal by Subject|1|||
106027002|NCT03255083|365762554|FG002|Overall Study|Withdrawal by Subject|1|||
106027003|NCT03255083|365762555|FG003|Overall Study|Withdrawal by Subject|0|||
106027004|NCT02537015|365762556|FG000|Overall Study|Adverse Event|3|||
106027005|NCT02537015|365762556|FG000|Overall Study|Withdrawal by Subject|2|||
106027006|NCT02537015|365762556|FG000|Overall Study|Other Miscellaneous Reasons|1|||
106027007|NCT01808092|365762557|FG000|Overall Study|Death|39|||
106027008|NCT01808092|365762558|FG001|Overall Study|Death|29|||
106027009|NCT01808092|365762557|FG000|Overall Study|Lost to Follow-up|3|||
106027010|NCT01808092|365762558|FG001|Overall Study|Lost to Follow-up|7|||
106027011|NCT01808092|365762557|FG000|Overall Study|Withdrawal by Subject|9|||
106027012|NCT01808092|365762558|FG001|Overall Study|Withdrawal by Subject|4|||
106027013|NCT01808092|365762557|FG000|Overall Study|Other Eligibility criteria|3|||
106027014|NCT01808092|365762558|FG001|Overall Study|Other Eligibility criteria|5|||
106027015|NCT01031836|365764576|FG000|Stage I|Adverse Event|1|||
106027016|NCT01031836|365764577|FG001|Stage I|Adverse Event|1|||
106027017|NCT01031836|365764578|FG002|Stage I|Adverse Event|0|||
106027018|NCT01031836|365764579|FG003|Stage I|Adverse Event|0|||
106027019|NCT01031836|365764580|FG004|Stage I|Adverse Event|0|||
106027020|NCT01031836|365764581|FG005|Stage I|Adverse Event|0|||
106027021|NCT01031836|365764576|FG000|Stage I|Other|0|||
106027022|NCT01031836|365764577|FG001|Stage I|Other|1|||
106027023|NCT01031836|365764578|FG002|Stage I|Other|0|||
106027024|NCT01031836|365764579|FG003|Stage I|Other|0|||
106027025|NCT01031836|365764580|FG004|Stage I|Other|0|||
106027026|NCT01031836|365764581|FG005|Stage I|Other|1|||
106027027|NCT01031836|365764576|FG000|Stage II|Adverse Event|0|||
106027028|NCT01031836|365764577|FG001|Stage II|Adverse Event|0|||
106027029|NCT01031836|365764578|FG002|Stage II|Adverse Event|2|||
106027030|NCT01031836|365764579|FG003|Stage II|Adverse Event|2|||
106027031|NCT01031836|365764580|FG004|Stage II|Adverse Event|1|||
106027032|NCT01031836|365764581|FG005|Stage II|Adverse Event|1|||
106027033|NCT01031836|365764576|FG000|Stage II|Other|2|||
106027034|NCT01031836|365764577|FG001|Stage II|Other|0|||
106027035|NCT01031836|365764578|FG002|Stage II|Other|0|||
106027036|NCT01031836|365764579|FG003|Stage II|Other|1|||
106027037|NCT01031836|365764580|FG004|Stage II|Other|1|||
106027038|NCT01031836|365764581|FG005|Stage II|Other|0|||
106027039|NCT01330017|365764585|FG000|Overall Study|Adverse Event|0|||
106027040|NCT01330017|365764586|FG001|Overall Study|Adverse Event|1|||
106027041|NCT01330017|365764587|FG002|Overall Study|Adverse Event|1|||
106027042|NCT01330017|365764588|FG003|Overall Study|Adverse Event|4|||
106027043|NCT01330017|365764589|FG004|Overall Study|Adverse Event|0|||
106027044|NCT01330017|365764585|FG000|Overall Study|Withdrawal by Subject|0|||
106027045|NCT01330017|365764586|FG001|Overall Study|Withdrawal by Subject|0|||
106027046|NCT01330017|365764587|FG002|Overall Study|Withdrawal by Subject|1|||
106027047|NCT01330017|365764588|FG003|Overall Study|Withdrawal by Subject|0|||
106027048|NCT01330017|365764589|FG004|Overall Study|Withdrawal by Subject|1|||
106027049|NCT01330017|365764585|FG000|Overall Study|Lost to Follow-up|0|||
106027050|NCT01330017|365764586|FG001|Overall Study|Lost to Follow-up|0|||
106027051|NCT01330017|365764587|FG002|Overall Study|Lost to Follow-up|1|||
106027052|NCT01330017|365764588|FG003|Overall Study|Lost to Follow-up|0|||
106027053|NCT01330017|365764589|FG004|Overall Study|Lost to Follow-up|0|||
106027054|NCT01330017|365764585|FG000|Overall Study|Protocol Violation|0|||
106027055|NCT01330017|365764586|FG001|Overall Study|Protocol Violation|0|||
106027056|NCT01330017|365764587|FG002|Overall Study|Protocol Violation|0|||
106027057|NCT01330017|365764588|FG003|Overall Study|Protocol Violation|1|||
106027058|NCT01330017|365764589|FG004|Overall Study|Protocol Violation|0|||
106027059|NCT01330017|365764585|FG000|Overall Study|Unknown Reason|5|||
106027060|NCT01330017|365764586|FG001|Overall Study|Unknown Reason|3|||
106027061|NCT01330017|365764587|FG002|Overall Study|Unknown Reason|5|||
106027062|NCT01330017|365764588|FG003|Overall Study|Unknown Reason|7|||
106027063|NCT01330017|365764589|FG004|Overall Study|Unknown Reason|2|||
106027064|NCT01888432|365764590|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
106027065|NCT01888432|365764591|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
105850410|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
106027066|NCT01888432|365764590|FG000|12-month Analysis (FAS)|Physician Decision|1|||
106027067|NCT01888432|365764591|FG001|12-month Analysis (FAS)|Physician Decision|1|||
106027068|NCT01888432|365764590|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
106027069|NCT01888432|365764591|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
106027070|NCT01888432|365764590|FG000|12-month Analysis (FAS)|Death|4|||
106027071|NCT01888432|365764591|FG001|12-month Analysis (FAS)|Death|3|||
106027072|NCT01888432|365764590|FG000|24-month Analysis (FAS)|Graft loss|0|||
106027073|NCT01888432|365764591|FG001|24-month Analysis (FAS)|Graft loss|1|||
106027074|NCT01888432|365764590|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
106027075|NCT01888432|365764591|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
106027076|NCT01888432|365764590|FG000|24-month Analysis (FAS)|Physician Decision|2|||
106027077|NCT01888432|365764591|FG001|24-month Analysis (FAS)|Physician Decision|4|||
106027078|NCT01888432|365764590|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
106027079|NCT01888432|365764591|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
106027080|NCT01888432|365764590|FG000|24-month Analysis (FAS)|Death|8|||
106027081|NCT01888432|365764591|FG001|24-month Analysis (FAS)|Death|4|||
106027082|NCT01888432|365764590|FG000|36-month Analysis (Extension)|Death|1|||
106027083|NCT01888432|365764591|FG001|36-month Analysis (Extension)|Death|0|||
106027084|NCT00130247|365764594|FG000|Overall Study|Pregnancy|1|||
106027085|NCT00130247|365764595|FG001|Overall Study|Pregnancy|0|||
106027086|NCT00130247|365764594|FG000|Overall Study|Post-randomization exclusion|1|||
106027087|NCT00130247|365764595|FG001|Overall Study|Post-randomization exclusion|2|||
106027088|NCT00130247|365764594|FG000|Overall Study|Not compliant with DOT|0|||
106027089|NCT00130247|365764595|FG001|Overall Study|Not compliant with DOT|2|||
106150644|NCT04766034|366212611|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
106150645|NCT04766034|366212607|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
106150646|NCT04766034|366212608|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
106150647|NCT04766034|366212609|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
106150648|NCT04766034|366212610|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
106150649|NCT04766034|366212611|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
106150650|NCT04766034|366212607|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
106150651|NCT04766034|366212608|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
106150652|NCT04766034|366212609|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
106150653|NCT04766034|366212610|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
106150654|NCT04766034|366212611|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
106150655|NCT05028582|366212617|FG000|Overall Study|Lost to Follow-up|11|||
106150656|NCT05028582|366212618|FG001|Overall Study|Lost to Follow-up|9|||
105850411|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
106150657|NCT05028582|366212617|FG000|Overall Study|Withdrawal by Subject|9|||
105850412|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850413|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850414|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
105850415|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850416|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850417|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850418|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
105850419|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850420|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850421|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
106150658|NCT05028582|366212618|FG001|Overall Study|Withdrawal by Subject|10|||
106150659|NCT05028582|366212617|FG000|Overall Study|Adverse Event|5|||
106150660|NCT05028582|366212618|FG001|Overall Study|Adverse Event|2|||
106150661|NCT05028582|366212617|FG000|Overall Study|Miscellaneous|3|||
106027090|NCT01696929|365764596|FG000|Overall Study|Physician Decision|1|||
106027091|NCT02522624|365764597|FG000|Overall Study|Technical failure|1|||
106027092|NCT02522624|365764598|FG001|Overall Study|Technical failure|0|||
106027093|NCT03254108|365764599|FG000|Overall Study|Adverse Event|0|||
106027094|NCT03254108|365764600|FG001|Overall Study|Adverse Event|2|||
106027095|NCT03254108|365764601|FG002|Overall Study|Adverse Event|0|||
106150662|NCT05028582|366212618|FG001|Overall Study|Miscellaneous|2|||
106150663|NCT05028582|366212617|FG000|Overall Study|Lack of Efficacy|3|||
106150664|NCT05028582|366212618|FG001|Overall Study|Lack of Efficacy|1|||
106150665|NCT05028582|366212617|FG000|Overall Study|Physician Decision|0|||
106150666|NCT05028582|366212618|FG001|Overall Study|Physician Decision|1|||
106150667|NCT04939246|366212619|FG000|After Treatment|Death|4|||
106150668|NCT04939246|366212619|FG000|After Treatment|Lost to Follow-up|1|||
105975587|NCT01286987|365572150|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
105975588|NCT01286987|365572151|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
105975589|NCT01286987|365572152|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
105975590|NCT01286987|365572153|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
106150669|NCT04939246|366212619|FG000|After Treatment|Discharged to hospice|2|||
105975591|NCT01286987|365572154|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
105975592|NCT01286987|365572155|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
105975593|NCT01286987|365572156|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
105975594|NCT01286987|365572157|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
105975595|NCT01286987|365572158|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
105975596|NCT01286987|365572159|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
105975597|NCT01286987|365572160|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
105975598|NCT01286987|365572161|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
105975599|NCT01286987|365572162|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
105975600|NCT01286987|365572163|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
105975601|NCT01286987|365572164|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
105975602|NCT01286987|365572150|FG000|Part 1: Dose Escalation|Physician Decision|0|||
105975603|NCT01286987|365572151|FG001|Part 1: Dose Escalation|Physician Decision|0|||
105975604|NCT01286987|365572152|FG002|Part 1: Dose Escalation|Physician Decision|0|||
105975605|NCT01286987|365572153|FG003|Part 1: Dose Escalation|Physician Decision|0|||
105975606|NCT01286987|365572154|FG004|Part 1: Dose Escalation|Physician Decision|1|||
105975607|NCT01286987|365572155|FG005|Part 1: Dose Escalation|Physician Decision|0|||
105975608|NCT01286987|365572156|FG006|Part 1: Dose Escalation|Physician Decision|0|||
105975609|NCT01286987|365572157|FG007|Part 1: Dose Escalation|Physician Decision|0|||
105975610|NCT01286987|365572158|FG008|Part 1: Dose Escalation|Physician Decision|0|||
105975611|NCT01286987|365572159|FG009|Part 1: Dose Escalation|Physician Decision|0|||
105975612|NCT01286987|365572160|FG010|Part 1: Dose Escalation|Physician Decision|0|||
105975613|NCT01286987|365572161|FG011|Part 1: Dose Escalation|Physician Decision|0|||
105975614|NCT01286987|365572162|FG012|Part 1: Dose Escalation|Physician Decision|0|||
105975615|NCT01286987|365572163|FG013|Part 1: Dose Escalation|Physician Decision|0|||
105975616|NCT01286987|365572164|FG014|Part 1: Dose Escalation|Physician Decision|0|||
105975617|NCT01286987|365572150|FG000|Part 2: Dose Expansion|Death|0|||
105975618|NCT01286987|365572151|FG001|Part 2: Dose Expansion|Death|0|||
105975619|NCT01286987|365572152|FG002|Part 2: Dose Expansion|Death|0|||
105975620|NCT01286987|365572153|FG003|Part 2: Dose Expansion|Death|0|||
105975621|NCT01286987|365572154|FG004|Part 2: Dose Expansion|Death|0|||
105975622|NCT01286987|365572155|FG005|Part 2: Dose Expansion|Death|0|||
105975623|NCT01286987|365572156|FG006|Part 2: Dose Expansion|Death|0|||
105975624|NCT01286987|365572157|FG007|Part 2: Dose Expansion|Death|0|||
105975625|NCT01286987|365572158|FG008|Part 2: Dose Expansion|Death|0|||
105975626|NCT01286987|365572159|FG009|Part 2: Dose Expansion|Death|0|||
105975627|NCT01286987|365572160|FG010|Part 2: Dose Expansion|Death|0|||
105975628|NCT01286987|365572161|FG011|Part 2: Dose Expansion|Death|0|||
105975629|NCT01286987|365572162|FG012|Part 2: Dose Expansion|Death|1|||
105975630|NCT01286987|365572163|FG013|Part 2: Dose Expansion|Death|1|||
105975631|NCT01286987|365572164|FG014|Part 2: Dose Expansion|Death|0|||
105975632|NCT01286987|365572150|FG000|Part 2: Dose Expansion|Physician Decision|0|||
105975633|NCT01286987|365572151|FG001|Part 2: Dose Expansion|Physician Decision|0|||
105975634|NCT01286987|365572152|FG002|Part 2: Dose Expansion|Physician Decision|0|||
105975635|NCT01286987|365572153|FG003|Part 2: Dose Expansion|Physician Decision|0|||
105975636|NCT01286987|365572154|FG004|Part 2: Dose Expansion|Physician Decision|0|||
105975637|NCT01286987|365572155|FG005|Part 2: Dose Expansion|Physician Decision|0|||
105975638|NCT01286987|365572156|FG006|Part 2: Dose Expansion|Physician Decision|0|||
105975639|NCT01286987|365572157|FG007|Part 2: Dose Expansion|Physician Decision|0|||
105975640|NCT01286987|365572158|FG008|Part 2: Dose Expansion|Physician Decision|0|||
105975641|NCT01286987|365572159|FG009|Part 2: Dose Expansion|Physician Decision|0|||
106150670|NCT04994509|366212620|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
106150671|NCT04994509|366212621|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
105975642|NCT01286987|365572160|FG010|Part 2: Dose Expansion|Physician Decision|1|||
105975643|NCT01286987|365572161|FG011|Part 2: Dose Expansion|Physician Decision|1|||
105975644|NCT01286987|365572162|FG012|Part 2: Dose Expansion|Physician Decision|0|||
105975645|NCT01286987|365572163|FG013|Part 2: Dose Expansion|Physician Decision|1|||
105975646|NCT01286987|365572164|FG014|Part 2: Dose Expansion|Physician Decision|0|||
105975647|NCT01286987|365572150|FG000|Part 2: Dose Expansion|Other|0|||
105975648|NCT01286987|365572151|FG001|Part 2: Dose Expansion|Other|0|||
105975649|NCT01286987|365572152|FG002|Part 2: Dose Expansion|Other|0|||
105975650|NCT01286987|365572153|FG003|Part 2: Dose Expansion|Other|0|||
105975651|NCT01286987|365572154|FG004|Part 2: Dose Expansion|Other|0|||
105975652|NCT01286987|365572155|FG005|Part 2: Dose Expansion|Other|0|||
105975653|NCT01286987|365572156|FG006|Part 2: Dose Expansion|Other|0|||
105975654|NCT01286987|365572157|FG007|Part 2: Dose Expansion|Other|0|||
105975655|NCT01286987|365572158|FG008|Part 2: Dose Expansion|Other|0|||
105975656|NCT01286987|365572159|FG009|Part 2: Dose Expansion|Other|0|||
105975657|NCT01286987|365572160|FG010|Part 2: Dose Expansion|Other|0|||
105975658|NCT01286987|365572161|FG011|Part 2: Dose Expansion|Other|0|||
105975659|NCT01286987|365572162|FG012|Part 2: Dose Expansion|Other|0|||
105975660|NCT01286987|365572163|FG013|Part 2: Dose Expansion|Other|1|||
105975661|NCT01286987|365572164|FG014|Part 2: Dose Expansion|Other|0|||
105975662|NCT01286987|365572150|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
105975663|NCT01286987|365572151|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
105975664|NCT01286987|365572152|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
105975665|NCT01286987|365572153|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
105975666|NCT01286987|365572154|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
105975667|NCT01286987|365572155|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
105975668|NCT01286987|365572156|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
105975669|NCT01286987|365572157|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
105975670|NCT01286987|365572158|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
105975671|NCT01286987|365572159|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
105975672|NCT01286987|365572160|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
105975673|NCT01286987|365572161|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
105975674|NCT01286987|365572162|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
105975675|NCT01286987|365572163|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
105975676|NCT01286987|365572164|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
105975677|NCT01286987|365572150|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
105975678|NCT01286987|365572151|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
105975679|NCT01286987|365572152|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
105975680|NCT01286987|365572153|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
105975681|NCT01286987|365572154|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
105975682|NCT01286987|365572155|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
105975683|NCT01286987|365572156|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
105975684|NCT01286987|365572157|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
105975685|NCT01286987|365572158|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
105975686|NCT01286987|365572159|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
105975687|NCT01286987|365572160|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
105975688|NCT01286987|365572161|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
105975689|NCT01286987|365572162|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
105975690|NCT01286987|365572163|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
105975691|NCT01286987|365572164|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
105975692|NCT01286987|365572150|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975693|NCT01286987|365572151|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975694|NCT01286987|365572152|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975695|NCT01286987|365572153|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975696|NCT01286987|365572154|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975697|NCT01286987|365572155|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975698|NCT01286987|365572156|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975699|NCT01286987|365572157|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975700|NCT01286987|365572158|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975701|NCT01286987|365572159|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975702|NCT01286987|365572160|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
105975703|NCT01286987|365572161|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975704|NCT01286987|365572162|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975705|NCT01286987|365572163|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975706|NCT01286987|365572164|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
105975707|NCT01135914|365572165|FG000|Overall Study|Withdrawal by Subject|1|||
105975708|NCT01135914|365572166|FG001|Overall Study|Withdrawal by Subject|3|||
105975709|NCT01135914|365572167|FG002|Overall Study|Withdrawal by Subject|6|||
105975710|NCT01135914|365572165|FG000|Overall Study|Lost to Follow-up|1|||
105975711|NCT01135914|365572166|FG001|Overall Study|Lost to Follow-up|0|||
105975712|NCT01135914|365572167|FG002|Overall Study|Lost to Follow-up|1|||
105975713|NCT01135914|365572165|FG000|Overall Study|Protocol Violation|0|||
105975714|NCT01135914|365572166|FG001|Overall Study|Protocol Violation|0|||
105975715|NCT01135914|365572167|FG002|Overall Study|Protocol Violation|3|||
105975716|NCT01135914|365572165|FG000|Overall Study|Lack of Efficacy|2|||
105975717|NCT01135914|365572166|FG001|Overall Study|Lack of Efficacy|1|||
105975718|NCT01135914|365572167|FG002|Overall Study|Lack of Efficacy|10|||
105975719|NCT01135914|365572165|FG000|Overall Study|Adverse Event|0|||
105975720|NCT01135914|365572166|FG001|Overall Study|Adverse Event|1|||
105975721|NCT01135914|365572167|FG002|Overall Study|Adverse Event|2|||
105975722|NCT02078102|365572170|FG000|Overall Study|Adverse Event|1|||
105975723|NCT02078102|365572171|FG001|Overall Study|Adverse Event|0|||
105975724|NCT02078102|365572170|FG000|Overall Study|Withdrawal by Subject|1|||
105975725|NCT02078102|365572171|FG001|Overall Study|Withdrawal by Subject|0|||
105975726|NCT02078102|365572170|FG000|Overall Study|Physician Decision|0|||
105975727|NCT02078102|365572171|FG001|Overall Study|Physician Decision|1|||
105975728|NCT02185014|365572172|FG000|Overall Study|Adverse Event|18|||
105975729|NCT02185014|365572172|FG000|Overall Study|Withdrew Consent|8|||
105975730|NCT02185014|365572172|FG000|Overall Study|Lost to Follow-up|4|||
105975731|NCT02185014|365572172|FG000|Overall Study|Lack of Efficacy|14|||
105975732|NCT02185014|365572172|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
105975733|NCT02185014|365572172|FG000|Overall Study|Subject Noncompliance|1|||
105975734|NCT02185014|365572172|FG000|Overall Study|Other|4|||
105975735|NCT03093974|365572173|FG000|Overall Study|Withdrawal by Subject|32|||
105975736|NCT03093974|365572174|FG001|Overall Study|Withdrawal by Subject|27|||
105975737|NCT03093974|365572173|FG000|Overall Study|Adverse Event|17|||
105975738|NCT03093974|365572174|FG001|Overall Study|Adverse Event|24|||
105975739|NCT03093974|365572173|FG000|Overall Study|Death|0|||
105975740|NCT03093974|365572174|FG001|Overall Study|Death|1|||
105975741|NCT03093974|365572173|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105975742|NCT03093974|365572174|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105975743|NCT03093974|365572173|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
105975744|NCT03093974|365572174|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
105975745|NCT03093974|365572173|FG000|Overall Study|Lost to Follow-up|0|||
105975746|NCT03093974|365572174|FG001|Overall Study|Lost to Follow-up|1|||
105975747|NCT03093974|365572173|FG000|Overall Study|Other|1|||
105975748|NCT03093974|365572174|FG001|Overall Study|Other|2|||
105975749|NCT01479595|365572176|FG000|Overall Study|Protocol deviation|0|||
105975750|NCT01479595|365572177|FG001|Overall Study|Protocol deviation|1|||
105975751|NCT01479595|365572176|FG000|Overall Study|Adverse Event|2|||
105975752|NCT01479595|365572177|FG001|Overall Study|Adverse Event|1|||
105975753|NCT02255565|365572178|FG000|Overall Study|Withdrawal by Subject|0|||
105975754|NCT02255565|365572179|FG001|Overall Study|Withdrawal by Subject|1|||
105975755|NCT02255565|365572180|FG002|Overall Study|Withdrawal by Subject|0|||
105975756|NCT00810901|365572181|FG000|Overall Study|Lost to Follow-up|88|||
105975757|NCT00810901|365572182|FG001|Overall Study|Lost to Follow-up|58|||
105975758|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
105975759|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
105975760|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
105975761|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
105975762|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
105975763|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
105975764|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
105975765|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
105975766|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
105975767|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
105975768|NCT03906656|365572183|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
105975769|NCT03906656|365572184|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
105975770|NCT03906656|365572183|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
105975771|NCT03906656|365572184|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
105975772|NCT03906656|365572183|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
105975773|NCT03906656|365572184|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
105975774|NCT03906656|365572183|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
105975775|NCT03906656|365572184|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
105975776|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
105975777|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
105975778|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
105975779|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
105975780|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
105975781|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
105975782|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
105975783|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
106027096|NCT03254108|365764602|FG003|Overall Study|Adverse Event|1|||
105975784|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
105975785|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
105975786|NCT03906656|365572183|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
105975787|NCT03906656|365572184|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
105975788|NCT03906656|365572183|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
105975789|NCT03906656|365572184|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
105975790|NCT03906656|365572183|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
105975791|NCT03906656|365572184|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
106027097|NCT03254108|365764603|FG004|Overall Study|Adverse Event|1|||
105850422|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850423|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850424|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850425|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850426|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850427|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850428|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850429|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850430|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850431|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
105850432|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
105850433|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850434|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850435|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850436|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850437|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105975792|NCT03906656|365572183|FG000|Home Use 2 (3 Months)|Death|2|||
105850438|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850439|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105975793|NCT03906656|365572184|FG001|Home Use 2 (3 Months)|Death|0|||
105975794|NCT03906656|365572183|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
105975795|NCT03906656|365572184|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
105975796|NCT03906656|365572183|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
105975797|NCT03906656|365572184|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
105975798|NCT02120365|365572191|FG000|Overall Study|Withdrawal by Subject|0|||
105975799|NCT02120365|365572192|FG001|Overall Study|Withdrawal by Subject|0|||
105975800|NCT02120365|365572193|FG002|Overall Study|Withdrawal by Subject|2|||
105975801|NCT02120365|365572194|FG003|Overall Study|Withdrawal by Subject|4|||
105975802|NCT02120365|365572195|FG004|Overall Study|Withdrawal by Subject|0|||
105975803|NCT02120365|365572196|FG005|Overall Study|Withdrawal by Subject|2|||
105975804|NCT00581828|365572198|FG000|Overall Study|Protocol Violation|1|||
105975805|NCT01129882|365572199|FG000|Overall Study|Adverse Event|39|||
105975806|NCT01129882|365572199|FG000|Overall Study|Death|6|||
105975807|NCT01129882|365572199|FG000|Overall Study|Lack of Efficacy|5|||
105975808|NCT01129882|365572199|FG000|Overall Study|Lost to Follow-up|13|||
105975809|NCT01129882|365572199|FG000|Overall Study|Physician Decision|27|||
105975810|NCT01129882|365572199|FG000|Overall Study|Protocol Deviation|3|||
105975811|NCT01129882|365572199|FG000|Overall Study|Withdrawal Criteria Met|19|||
105975812|NCT01129882|365572199|FG000|Overall Study|Trial Termination by Sponsor|6|||
105975813|NCT01129882|365572199|FG000|Overall Study|Withdrawal by Subject|160|||
105975814|NCT00392808|365572202|FG000|Overall Study|Lost to Follow-up|3|||
105975815|NCT00392808|365572203|FG001|Overall Study|Lost to Follow-up|2|||
105975816|NCT00392808|365572204|FG002|Overall Study|Lost to Follow-up|1|||
105975817|NCT00392808|365572205|FG003|Overall Study|Lost to Follow-up|2|||
105975818|NCT00392808|365572202|FG000|Overall Study|Unable to withdraw blood|3|||
105975819|NCT00392808|365572203|FG001|Overall Study|Unable to withdraw blood|1|||
105975820|NCT00392808|365572204|FG002|Overall Study|Unable to withdraw blood|1|||
105975821|NCT00392808|365572205|FG003|Overall Study|Unable to withdraw blood|2|||
105975822|NCT00320372|365572208|FG000|Overall Study|Physician Decision|4|||
105975823|NCT00320372|365572209|FG001|Overall Study|Physician Decision|7|||
105975824|NCT00320372|365572208|FG000|Overall Study|Death|7|||
105975825|NCT00320372|365572209|FG001|Overall Study|Death|8|||
105975826|NCT00320372|365572208|FG000|Overall Study|Withdrawal by Subject|55|||
105975827|NCT00320372|365572209|FG001|Overall Study|Withdrawal by Subject|37|||
105975828|NCT00320372|365572208|FG000|Overall Study|Non-Compliance|40|||
105975829|NCT00320372|365572209|FG001|Overall Study|Non-Compliance|39|||
105975830|NCT00320372|365572208|FG000|Overall Study|Did not Meet (I/E)|3|||
105975831|NCT00320372|365572209|FG001|Overall Study|Did not Meet (I/E)|1|||
105850440|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850441|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105975832|NCT00320372|365572208|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
105975833|NCT00320372|365572209|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
105975834|NCT00930969|365572211|FG000|Overall Study|Death|5|||
105975835|NCT00930969|365572211|FG000|Overall Study|Lost to Follow-up|1|||
105975836|NCT00930969|365572211|FG000|Overall Study|Physician Decision|13|||
105975837|NCT00930969|365572211|FG000|Overall Study|Withdrawal by Subject|19|||
105975838|NCT00657150|365572212|FG000|Overall Study|Adverse Event|19|||
105975839|NCT00657150|365572213|FG001|Overall Study|Adverse Event|10|||
105850442|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105975840|NCT00657150|365572212|FG000|Overall Study|Non-compliant with protocol|5|||
105975841|NCT00657150|365572213|FG001|Overall Study|Non-compliant with protocol|9|||
105975842|NCT00657150|365572212|FG000|Overall Study|Lost to Follow-up|2|||
105975843|NCT00657150|365572213|FG001|Overall Study|Lost to Follow-up|0|||
105975844|NCT00657150|365572212|FG000|Overall Study|Withdrawal by Subject|51|||
105850443|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
105850444|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
105850445|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
105850446|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
105850447|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850448|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850449|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850450|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850451|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850452|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850453|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850454|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850455|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850456|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850457|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850458|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850459|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
105850460|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
105850461|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850462|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850463|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850464|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850465|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850466|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850467|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850468|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850469|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850470|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850471|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850472|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
105850473|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
105850474|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
105850475|NCT03982199|365112496|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850476|NCT03982199|365112497|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850477|NCT03982199|365112498|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850478|NCT03982199|365112499|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850479|NCT03982199|365112500|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850480|NCT03982199|365112501|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850481|NCT03982199|365112502|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850482|NCT03982199|365112503|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850483|NCT03982199|365112504|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850484|NCT03982199|365112505|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850485|NCT03982199|365112506|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850486|NCT03982199|365112507|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850487|NCT03982199|365112508|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
105850488|NCT03982199|365112509|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
105850489|NCT03696953|365112510|FG000|Overall Study|Withdrawal by Subject|6|||
105850490|NCT03696953|365112511|FG001|Overall Study|Withdrawal by Subject|1|||
105850491|NCT03696953|365112510|FG000|Overall Study|missed GBS swabs|2|||
105850492|NCT03696953|365112511|FG001|Overall Study|missed GBS swabs|2|||
105850493|NCT03696953|365112510|FG000|Overall Study|lost study bottle containing capsules|2|||
105850494|NCT03696953|365112511|FG001|Overall Study|lost study bottle containing capsules|0|||
105850495|NCT03696953|365112510|FG000|Overall Study|Premature birth|1|||
105975845|NCT00657150|365572213|FG001|Overall Study|Withdrawal by Subject|36|||
105975846|NCT00657150|365572212|FG000|Overall Study|Other|38|||
105975847|NCT00657150|365572213|FG001|Overall Study|Other|38|||
105975848|NCT00657150|365572212|FG000|Treatment|Adverse Event|60|||
105975849|NCT00657150|365572213|FG001|Treatment|Adverse Event|53|||
105975850|NCT00657150|365572212|FG000|Treatment|Non-compliant with protocol|10|||
105975851|NCT00657150|365572213|FG001|Treatment|Non-compliant with protocol|9|||
105975852|NCT00657150|365572212|FG000|Treatment|Lost to Follow-up|1|||
105975853|NCT00657150|365572213|FG001|Treatment|Lost to Follow-up|0|||
105975854|NCT00657150|365572212|FG000|Treatment|Withdrawal by Subject|23|||
105975855|NCT00657150|365572213|FG001|Treatment|Withdrawal by Subject|20|||
105975856|NCT00657150|365572212|FG000|Treatment|Other|13|||
105975857|NCT00657150|365572213|FG001|Treatment|Other|15|||
105975858|NCT00993499|365572217|FG000|Run-in Period (8 Days)|Adverse Event|0|||
105975859|NCT00993499|365572218|FG001|Run-in Period (8 Days)|Adverse Event|1|||
105975860|NCT00993499|365572219|FG002|Run-in Period (8 Days)|Adverse Event|0|||
105975861|NCT00993499|365572220|FG003|Run-in Period (8 Days)|Adverse Event|0|||
105975862|NCT00993499|365572221|FG004|Run-in Period (8 Days)|Adverse Event|0|||
105975863|NCT00993499|365572222|FG005|Run-in Period (8 Days)|Adverse Event|0|||
105975864|NCT00993499|365572217|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
105975865|NCT00993499|365572218|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105975866|NCT00993499|365572219|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105975867|NCT00993499|365572220|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105975868|NCT00993499|365572221|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105975869|NCT00993499|365572222|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
105975870|NCT00993499|365572217|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
105975871|NCT00993499|365572218|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
105975872|NCT00993499|365572219|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
105975873|NCT00993499|365572220|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
105975874|NCT00993499|365572221|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
105975875|NCT00993499|365572222|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
105975876|NCT00993499|365572217|FG000|Run-in Period (8 Days)|Progressive disease|0|||
105975877|NCT00993499|365572218|FG001|Run-in Period (8 Days)|Progressive disease|1|||
105975878|NCT00993499|365572219|FG002|Run-in Period (8 Days)|Progressive disease|1|||
105975879|NCT00993499|365572220|FG003|Run-in Period (8 Days)|Progressive disease|0|||
105975880|NCT00993499|365572221|FG004|Run-in Period (8 Days)|Progressive disease|0|||
105975881|NCT00993499|365572222|FG005|Run-in Period (8 Days)|Progressive disease|0|||
105975882|NCT00993499|365572217|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
105975883|NCT00993499|365572218|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
105975884|NCT00993499|365572219|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
105975885|NCT00993499|365572220|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
105975886|NCT00993499|365572221|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
105975887|NCT00993499|365572222|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
105975888|NCT00993499|365572217|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
105975889|NCT00993499|365572218|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
105975890|NCT00993499|365572219|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
105975891|NCT00993499|365572220|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
105975892|NCT00993499|365572221|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
105975893|NCT00993499|365572222|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
105975894|NCT00993499|365572217|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
105975895|NCT00993499|365572218|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
105975896|NCT00993499|365572219|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
105975897|NCT00993499|365572220|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
105975898|NCT00993499|365572221|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
105975899|NCT00993499|365572222|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
105975900|NCT00993499|365572217|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105975901|NCT00993499|365572218|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105975902|NCT00993499|365572219|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
105975903|NCT00993499|365572220|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105975904|NCT00993499|365572221|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105975905|NCT00993499|365572222|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
105975906|NCT00993499|365572217|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105975907|NCT00993499|365572218|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
105975908|NCT00993499|365572219|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105975909|NCT00993499|365572220|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105975910|NCT00993499|365572221|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105975911|NCT00993499|365572222|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
105975912|NCT00993499|365572217|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
105975913|NCT00993499|365572218|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
105975914|NCT00993499|365572219|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
105975915|NCT00993499|365572220|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
105975916|NCT00993499|365572221|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
105975917|NCT00993499|365572222|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
105975918|NCT00993499|365572217|FG000|Discontinued After Starting Course 3|DLT|1|||
105975919|NCT00993499|365572218|FG001|Discontinued After Starting Course 3|DLT|0|||
105975920|NCT00993499|365572219|FG002|Discontinued After Starting Course 3|DLT|2|||
105975921|NCT00993499|365572220|FG003|Discontinued After Starting Course 3|DLT|1|||
105975922|NCT00993499|365572221|FG004|Discontinued After Starting Course 3|DLT|0|||
105975923|NCT00993499|365572222|FG005|Discontinued After Starting Course 3|DLT|0|||
105975924|NCT00993499|365572217|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
105975925|NCT00993499|365572218|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
105975926|NCT00993499|365572219|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
105975927|NCT00993499|365572220|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
105975928|NCT00993499|365572221|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
105975929|NCT00993499|365572222|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
105975930|NCT01420627|365572229|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
105975931|NCT02759315|365572230|FG000|Overall Study|Adverse Event|0|||
105975932|NCT02759315|365572231|FG001|Overall Study|Adverse Event|0|||
105975933|NCT02759315|365572232|FG002|Overall Study|Adverse Event|0|||
105975934|NCT02759315|365572233|FG003|Overall Study|Adverse Event|1|||
105975935|NCT02759315|365572234|FG004|Overall Study|Adverse Event|0|||
105975936|NCT02759315|365572230|FG000|Overall Study|Death|0|||
105975937|NCT02759315|365572231|FG001|Overall Study|Death|0|||
105975938|NCT02759315|365572232|FG002|Overall Study|Death|1|||
105975939|NCT02759315|365572233|FG003|Overall Study|Death|0|||
105975940|NCT02759315|365572234|FG004|Overall Study|Death|0|||
105975941|NCT02759315|365572230|FG000|Overall Study|Lost to Follow-up|2|||
105975942|NCT02759315|365572231|FG001|Overall Study|Lost to Follow-up|0|||
105975943|NCT02759315|365572232|FG002|Overall Study|Lost to Follow-up|4|||
105975944|NCT02759315|365572233|FG003|Overall Study|Lost to Follow-up|0|||
105975945|NCT02759315|365572234|FG004|Overall Study|Lost to Follow-up|0|||
105975946|NCT02759315|365572230|FG000|Overall Study|Protocol Violation|0|||
105975947|NCT02759315|365572231|FG001|Overall Study|Protocol Violation|1|||
105975948|NCT02759315|365572232|FG002|Overall Study|Protocol Violation|0|||
106027098|NCT03254108|365764599|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
105975949|NCT02759315|365572233|FG003|Overall Study|Protocol Violation|0|||
105975950|NCT02759315|365572234|FG004|Overall Study|Protocol Violation|0|||
105975951|NCT02759315|365572230|FG000|Overall Study|Study terminated prior to completion|2|||
105975952|NCT02759315|365572231|FG001|Overall Study|Study terminated prior to completion|0|||
105975953|NCT02759315|365572232|FG002|Overall Study|Study terminated prior to completion|5|||
105975954|NCT02759315|365572233|FG003|Overall Study|Study terminated prior to completion|0|||
105975955|NCT02759315|365572234|FG004|Overall Study|Study terminated prior to completion|1|||
105975956|NCT00461305|365572237|FG000|Treatment|Adverse Event|26|||
105975957|NCT00461305|365572238|FG001|Treatment|Adverse Event|3|||
105975958|NCT00461305|365572237|FG000|Treatment|Lost to Follow-up|4|||
105975959|NCT00461305|365572238|FG001|Treatment|Lost to Follow-up|2|||
105975960|NCT00461305|365572237|FG000|Treatment|Protocol Violation|13|||
105975961|NCT00461305|365572238|FG001|Treatment|Protocol Violation|2|||
105975962|NCT00461305|365572237|FG000|Treatment|Withdrawal by Subject|48|||
105975963|NCT00461305|365572238|FG001|Treatment|Withdrawal by Subject|2|||
105975964|NCT00461305|365572237|FG000|Treatment|Never dispensed|5|||
105975965|NCT00461305|365572238|FG001|Treatment|Never dispensed|0|||
105975966|NCT00461305|365572237|FG000|Treatment|Study drug not taken|1|||
105975967|NCT00461305|365572238|FG001|Treatment|Study drug not taken|0|||
105975968|NCT00461305|365572237|FG000|Treatment|Partially missing diary|2|||
105975969|NCT00461305|365572238|FG001|Treatment|Partially missing diary|0|||
105975970|NCT00461305|365572237|FG000|Treatment|Other (missing drug etc)|2|||
105975971|NCT00461305|365572238|FG001|Treatment|Other (missing drug etc)|0|||
106027099|NCT03254108|365764600|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
106027100|NCT03254108|365764601|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
106027101|NCT03254108|365764602|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
106027102|NCT03254108|365764603|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
106027103|NCT01325337|365764604|FG000|Overall Study|Adverse Event|0|||
106027104|NCT01325337|365764605|FG001|Overall Study|Adverse Event|2|||
106027105|NCT01325337|365764606|FG002|Overall Study|Adverse Event|2|||
106027106|NCT01325337|365764607|FG003|Overall Study|Adverse Event|1|||
106027107|NCT01325337|365764608|FG004|Overall Study|Adverse Event|2|||
106027108|NCT01325337|365764604|FG000|Overall Study|Lost to Follow-up|2|||
106027109|NCT01325337|365764605|FG001|Overall Study|Lost to Follow-up|2|||
106027110|NCT01325337|365764606|FG002|Overall Study|Lost to Follow-up|2|||
106027111|NCT01325337|365764607|FG003|Overall Study|Lost to Follow-up|1|||
106027112|NCT01325337|365764608|FG004|Overall Study|Lost to Follow-up|2|||
106027113|NCT01325337|365764604|FG000|Overall Study|Personal Reasons|2|||
106150672|NCT04994509|366212622|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
105975972|NCT00461305|365572237|FG000|Continued Treatment|Adverse Event|26|||
105975973|NCT00461305|365572238|FG001|Continued Treatment|Adverse Event|0|||
105975974|NCT00461305|365572237|FG000|Continued Treatment|Lost to Follow-up|4|||
105975975|NCT00461305|365572238|FG001|Continued Treatment|Lost to Follow-up|0|||
105975976|NCT00461305|365572237|FG000|Continued Treatment|Protocol Violation|13|||
105975977|NCT00461305|365572238|FG001|Continued Treatment|Protocol Violation|0|||
105975978|NCT00461305|365572237|FG000|Continued Treatment|Withdrawal by Subject|48|||
105975979|NCT00461305|365572238|FG001|Continued Treatment|Withdrawal by Subject|0|||
105975980|NCT00461305|365572237|FG000|Continued Treatment|Partially missing diary|2|||
105975981|NCT00461305|365572238|FG001|Continued Treatment|Partially missing diary|0|||
105975982|NCT00461305|365572237|FG000|Continued Treatment|Other (missing drug etc)|2|||
105975983|NCT00461305|365572238|FG001|Continued Treatment|Other (missing drug etc)|0|||
105975984|NCT03464422|365572240|FG000|Overall Study|Lost to Follow-up|2|||
105975985|NCT03464422|365572240|FG000|Overall Study|Withdrawal by Subject|2|||
105975986|NCT03353922|365572243|FG000|Overall Study|Withdrawal by Subject|1|||
105975987|NCT03353922|365572244|FG001|Overall Study|Withdrawal by Subject|0|||
105975988|NCT03353922|365572245|FG002|Overall Study|Withdrawal by Subject|1|||
105975989|NCT03353922|365572246|FG003|Overall Study|Withdrawal by Subject|1|||
105975990|NCT03353922|365572247|FG004|Overall Study|Withdrawal by Subject|0|||
105975991|NCT03353922|365572248|FG005|Overall Study|Withdrawal by Subject|0|||
105975992|NCT03353922|365572243|FG000|Overall Study|Adverse Event|0|||
105975993|NCT03353922|365572244|FG001|Overall Study|Adverse Event|1|||
105975994|NCT03353922|365572245|FG002|Overall Study|Adverse Event|0|||
105975995|NCT03353922|365572246|FG003|Overall Study|Adverse Event|0|||
105975996|NCT03353922|365572247|FG004|Overall Study|Adverse Event|0|||
105975997|NCT03353922|365572248|FG005|Overall Study|Adverse Event|0|||
105975998|NCT03688555|365572249|FG000|Treatment Period|Adverse Event|0|||
105975999|NCT03688555|365572250|FG001|Treatment Period|Adverse Event|0|||
105976000|NCT03688555|365572251|FG002|Treatment Period|Adverse Event|1|||
105976001|NCT01896271|365572252|FG000|Overall Study|Physician Decision|10|||
105976002|NCT01294462|365572253|FG000|Overall Study|Lost to Follow-up|1|||
105976003|NCT01294462|365572254|FG001|Overall Study|Lost to Follow-up|0|||
105976004|NCT01294462|365572253|FG000|Overall Study|Withdrawal by Subject|65|||
105976005|NCT01294462|365572254|FG001|Overall Study|Withdrawal by Subject|63|||
105976006|NCT05028517|365572255|FG000|Overall Study|Lost to Follow-up|13|||
105976007|NCT05028517|365572256|FG001|Overall Study|Lost to Follow-up|20|||
105976008|NCT05028517|365572257|FG002|Overall Study|Lost to Follow-up|12|||
105976009|NCT05028517|365572255|FG000|Overall Study|Withdrawal by Subject|0|||
105976010|NCT05028517|365572256|FG001|Overall Study|Withdrawal by Subject|0|||
105976011|NCT05028517|365572257|FG002|Overall Study|Withdrawal by Subject|1|||
105976012|NCT02256267|365572258|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
105976013|NCT02256267|365572258|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
105976014|NCT04342689|365572259|FG000|Overall Study|Withdrawal by Subject|32|||
105976015|NCT04342689|365572260|FG001|Overall Study|Withdrawal by Subject|33|||
105976016|NCT04342689|365572259|FG000|Overall Study|Lost to Follow-up|10|||
105976017|NCT04342689|365572260|FG001|Overall Study|Lost to Follow-up|12|||
105976018|NCT01352741|365572269|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
105976019|NCT01352741|365572270|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
105976020|NCT01352741|365572269|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
105976021|NCT01352741|365572270|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
105976022|NCT01352741|365572269|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
105976023|NCT01352741|365572270|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
105976024|NCT01352741|365572269|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
105976025|NCT01352741|365572270|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
105976026|NCT01352741|365572269|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
105976027|NCT01352741|365572270|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
105976028|NCT01352741|365572269|FG000|Open-label Tapentadol Titration Period|Other|4|||
105976029|NCT01352741|365572270|FG001|Open-label Tapentadol Titration Period|Other|0|||
105976030|NCT01352741|365572269|FG000|Double-blind Comparative Period|Protocol Violation|2|||
105976031|NCT01352741|365572270|FG001|Double-blind Comparative Period|Protocol Violation|0|||
105976032|NCT01352741|365572269|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
105976033|NCT01352741|365572270|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
105976034|NCT01352741|365572269|FG000|Double-blind Comparative Period|Adverse Event|16|||
105976035|NCT01352741|365572270|FG001|Double-blind Comparative Period|Adverse Event|17|||
105976036|NCT01352741|365572269|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
105976037|NCT01352741|365572270|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
105976038|NCT01352741|365572269|FG000|Double-blind Comparative Period|Death|0|||
105976039|NCT01352741|365572270|FG001|Double-blind Comparative Period|Death|1|||
105976040|NCT01352741|365572269|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
105976041|NCT01352741|365572270|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
105976042|NCT01352741|365572269|FG000|Double-blind Comparative Period|Other|1|||
105976043|NCT01352741|365572270|FG001|Double-blind Comparative Period|Other|2|||
105976044|NCT01352741|365572269|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
105976045|NCT01352741|365572270|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
105976046|NCT01352741|365572269|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
105976047|NCT01352741|365572270|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
105976048|NCT01352741|365572269|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
105976049|NCT01352741|365572270|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
105976050|NCT01352741|365572269|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
105976051|NCT01352741|365572270|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
106027114|NCT01325337|365764605|FG001|Overall Study|Personal Reasons|5|||
106027115|NCT01325337|365764606|FG002|Overall Study|Personal Reasons|4|||
105976052|NCT04070326|365572271|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
105976053|NCT04070326|365572272|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
105976054|NCT01367704|365572276|FG000|Overall Study|Lost to Follow-up|47|||
105976055|NCT01367704|365572277|FG001|Overall Study|Lost to Follow-up|161|||
105976056|NCT00526110|365572278|FG000|Overall Study|Adverse Event|2|||
105976057|NCT00526110|365572279|FG001|Overall Study|Adverse Event|9|||
105976058|NCT00526110|365572278|FG000|Overall Study|Disease Progression|0|||
105976059|NCT00526110|365572279|FG001|Overall Study|Disease Progression|19|||
105976060|NCT00526110|365572278|FG000|Overall Study|Maximal Response|0|||
105976061|NCT00526110|365572279|FG001|Overall Study|Maximal Response|6|||
105976062|NCT00526110|365572278|FG000|Overall Study|Withdrawal by Subject|0|||
105976063|NCT00526110|365572279|FG001|Overall Study|Withdrawal by Subject|2|||
105976064|NCT00526110|365572278|FG000|Overall Study|Poor Tolerance|0|||
105976065|NCT00526110|365572279|FG001|Overall Study|Poor Tolerance|5|||
105976066|NCT01886690|365572280|FG000|Overall Study|Protocol Violation|0|||
105976067|NCT01886690|365572281|FG001|Overall Study|Protocol Violation|1|||
106027116|NCT01325337|365764607|FG003|Overall Study|Personal Reasons|8|||
106027117|NCT01325337|365764608|FG004|Overall Study|Personal Reasons|3|||
106027118|NCT01325337|365764604|FG000|Overall Study|Withdrawal by Subject|1|||
106027119|NCT01325337|365764605|FG001|Overall Study|Withdrawal by Subject|0|||
106027120|NCT01325337|365764606|FG002|Overall Study|Withdrawal by Subject|1|||
106027121|NCT01325337|365764607|FG003|Overall Study|Withdrawal by Subject|0|||
106027122|NCT01325337|365764608|FG004|Overall Study|Withdrawal by Subject|1|||
106027123|NCT01106092|365764609|FG000|Overall Study|Withdrawal by Subject|0|||
106027124|NCT01106092|365764610|FG001|Overall Study|Withdrawal by Subject|0|||
106027125|NCT01106092|365764611|FG002|Overall Study|Withdrawal by Subject|0|||
106027126|NCT01106092|365764612|FG003|Overall Study|Withdrawal by Subject|1|||
106027127|NCT00220779|365764623|FG000|Overall Study|Adverse Event|1|||
106027128|NCT00220779|365764624|FG001|Overall Study|Adverse Event|0|||
106027129|NCT00220779|365764625|FG002|Overall Study|Adverse Event|0|||
106027130|NCT00220779|365764623|FG000|Overall Study|Withdrawal by Subject|1|||
106027131|NCT00220779|365764624|FG001|Overall Study|Withdrawal by Subject|4|||
106027132|NCT00220779|365764625|FG002|Overall Study|Withdrawal by Subject|1|||
106027133|NCT00220779|365764623|FG000|Overall Study|Non-compliance|1|||
106027134|NCT00220779|365764624|FG001|Overall Study|Non-compliance|0|||
106027135|NCT00220779|365764625|FG002|Overall Study|Non-compliance|0|||
106027136|NCT00220779|365764623|FG000|Overall Study|Too time consuming|1|||
106027137|NCT00220779|365764624|FG001|Overall Study|Too time consuming|0|||
106027138|NCT00220779|365764625|FG002|Overall Study|Too time consuming|0|||
106027139|NCT00220779|365764623|FG000|Overall Study|Pregnancy|0|||
106027140|NCT00220779|365764624|FG001|Overall Study|Pregnancy|0|||
106027141|NCT00220779|365764625|FG002|Overall Study|Pregnancy|2|||
106027142|NCT00220779|365764623|FG000|Overall Study|Lack of Efficacy|3|||
106027143|NCT00220779|365764624|FG001|Overall Study|Lack of Efficacy|0|||
106027144|NCT00220779|365764625|FG002|Overall Study|Lack of Efficacy|1|||
106027145|NCT03390101|365764626|FG000|Weeks 0-12|Withdrawal by Subject|0|||
106027146|NCT03390101|365764627|FG001|Weeks 0-12|Withdrawal by Subject|1|||
106027147|NCT03390101|365764628|FG002|Weeks 0-12|Withdrawal by Subject|1|||
106027148|NCT03390101|365764626|FG000|Weeks 0-12|Lost to Follow-up|0|||
106027149|NCT03390101|365764627|FG001|Weeks 0-12|Lost to Follow-up|1|||
106027150|NCT03390101|365764628|FG002|Weeks 0-12|Lost to Follow-up|0|||
106027151|NCT03390101|365764626|FG000|Weeks 12-54|Withdrawal by Subject|0|||
106027152|NCT03390101|365764627|FG001|Weeks 12-54|Withdrawal by Subject|3|||
106027153|NCT03390101|365764628|FG002|Weeks 12-54|Withdrawal by Subject|1|||
106027154|NCT03390101|365764626|FG000|Weeks 12-54|Pregnancy|1|||
106027155|NCT03390101|365764627|FG001|Weeks 12-54|Pregnancy|0|||
106027156|NCT03390101|365764628|FG002|Weeks 12-54|Pregnancy|0|||
106027157|NCT03390101|365764626|FG000|Weeks 12-54|Adverse Event|2|||
106027158|NCT03390101|365764627|FG001|Weeks 12-54|Adverse Event|1|||
106027159|NCT03390101|365764628|FG002|Weeks 12-54|Adverse Event|1|||
105976068|NCT01886690|365572280|FG000|Overall Study|Personal Reasons|0|||
105976069|NCT01886690|365572281|FG001|Overall Study|Personal Reasons|1|||
105976070|NCT01400243|365572282|FG000|Overall Study|Protocol Violation|8|||
106027160|NCT01511055|365764629|FG000|Overall Study|Withdrawal by Subject|6|||
106027161|NCT04590248|365764631|FG000|Overall Study|Lost to Follow-up|1|||
106027162|NCT04590248|365764631|FG000|Overall Study|Withdrawal by Subject|16|||
106027163|NCT04590248|365764631|FG000|Overall Study|Other|2|||
105976071|NCT01400243|365572283|FG001|Overall Study|Protocol Violation|11|||
105976072|NCT03618628|365572284|FG000|Overall Study|Death|1|||
106027164|NCT02052414|365764634|FG000|Overall Study|Adverse Event|12|||
106027165|NCT02052414|365764634|FG000|Overall Study|Lack of Efficacy|2|||
106027166|NCT02052414|365764634|FG000|Overall Study|Withdrawal by Subject|3|||
106027167|NCT02151773|365764637|FG000|Overall Study|Protocol Deviation|64|||
106027168|NCT00395343|365764638|FG000|Overall Study|Adverse Event|13|||
106027169|NCT00395343|365764639|FG001|Overall Study|Adverse Event|5|||
106027170|NCT00395343|365764638|FG000|Overall Study|Lack of Efficacy|0|||
106027171|NCT00395343|365764639|FG001|Overall Study|Lack of Efficacy|1|||
106027172|NCT00395343|365764638|FG000|Overall Study|Lost to Follow-up|4|||
106027173|NCT00395343|365764639|FG001|Overall Study|Lost to Follow-up|4|||
106027174|NCT00395343|365764638|FG000|Overall Study|Physician Decision|2|||
106027175|NCT00395343|365764639|FG001|Overall Study|Physician Decision|4|||
106027176|NCT00395343|365764638|FG000|Overall Study|Protocol Violation|6|||
106027177|NCT00395343|365764639|FG001|Overall Study|Protocol Violation|8|||
106027178|NCT00395343|365764638|FG000|Overall Study|Withdrawal by Subject|11|||
106027179|NCT00395343|365764639|FG001|Overall Study|Withdrawal by Subject|12|||
106027180|NCT00395343|365764638|FG000|Overall Study|Other|5|||
106027181|NCT00395343|365764639|FG001|Overall Study|Other|2|||
106027182|NCT01463007|365764644|FG000|Overall Study|Physician Decision|1|||
106027183|NCT00615901|365764646|FG000|Overall Study|Withdrawal by Subject|2|||
106027184|NCT00615901|365764646|FG000|Overall Study|Adverse Event|7|||
106027185|NCT01250496|365764647|FG000|Overall Study|Study terminated|124|||
106027186|NCT01250496|365764648|FG001|Overall Study|Study terminated|124|||
106027187|NCT01589653|365764649|FG000|Overall Study|Protocol Violation|3|||
106027188|NCT01589653|365764650|FG001|Overall Study|Protocol Violation|1|||
106027189|NCT01589653|365764649|FG000|Overall Study|Withdrawal criteria|4|||
106027190|NCT01589653|365764650|FG001|Overall Study|Withdrawal criteria|7|||
106027191|NCT01589653|365764649|FG000|Overall Study|Unclassified|0|||
106027192|NCT01589653|365764650|FG001|Overall Study|Unclassified|3|||
106027193|NCT01317550|365764652|FG000|Overall Study|Withdrawal by Subject|1|||
106027194|NCT01317550|365764653|FG001|Overall Study|Withdrawal by Subject|0|||
106027195|NCT01317550|365764654|FG002|Overall Study|Withdrawal by Subject|0|||
106027196|NCT01317550|365764655|FG003|Overall Study|Withdrawal by Subject|0|||
106027197|NCT01317550|365764652|FG000|Overall Study|Lack of compliance study med|1|||
106027198|NCT01317550|365764653|FG001|Overall Study|Lack of compliance study med|0|||
106027199|NCT01317550|365764654|FG002|Overall Study|Lack of compliance study med|0|||
106027200|NCT01317550|365764655|FG003|Overall Study|Lack of compliance study med|0|||
106027201|NCT00910624|365764656|FG000|Treatment Phase|Adverse Event|2|||
106027202|NCT00910624|365764657|FG001|Treatment Phase|Adverse Event|6|||
106027203|NCT00910624|365764658|FG002|Treatment Phase|Adverse Event|6|||
106027204|NCT00910624|365764659|FG003|Treatment Phase|Adverse Event|0|||
106027205|NCT00910624|365764656|FG000|Treatment Phase|Treatment Failure|23|||
106027206|NCT00910624|365764657|FG001|Treatment Phase|Treatment Failure|10|||
106027207|NCT00910624|365764658|FG002|Treatment Phase|Treatment Failure|0|||
106027208|NCT00910624|365764659|FG003|Treatment Phase|Treatment Failure|0|||
106027209|NCT00910624|365764656|FG000|Treatment Phase|Lost to Follow-up|0|||
106027210|NCT00910624|365764657|FG001|Treatment Phase|Lost to Follow-up|0|||
106027211|NCT00910624|365764658|FG002|Treatment Phase|Lost to Follow-up|1|||
106027212|NCT00910624|365764659|FG003|Treatment Phase|Lost to Follow-up|0|||
106027213|NCT00910624|365764656|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
106027214|NCT00910624|365764657|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
106027215|NCT00910624|365764658|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
106027216|NCT00910624|365764659|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
106027217|NCT00910624|365764656|FG000|Treatment Phase|Withdrawal by Subject|2|||
106027218|NCT00910624|365764657|FG001|Treatment Phase|Withdrawal by Subject|1|||
106027219|NCT00910624|365764658|FG002|Treatment Phase|Withdrawal by Subject|0|||
106027220|NCT00910624|365764659|FG003|Treatment Phase|Withdrawal by Subject|0|||
106027221|NCT00910624|365764656|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
106027222|NCT00910624|365764657|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
106027223|NCT00910624|365764658|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
106027224|NCT00910624|365764659|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
106027225|NCT00910624|365764656|FG000|Follow-Up Phase|Adverse Event|0|||
106027226|NCT00910624|365764657|FG001|Follow-Up Phase|Adverse Event|0|||
106027227|NCT00910624|365764658|FG002|Follow-Up Phase|Adverse Event|1|||
106027228|NCT00910624|365764659|FG003|Follow-Up Phase|Adverse Event|0|||
106027229|NCT00910624|365764656|FG000|Follow-Up Phase|Lost to Follow-up|3|||
106027230|NCT00910624|365764657|FG001|Follow-Up Phase|Lost to Follow-up|1|||
106027231|NCT00910624|365764658|FG002|Follow-Up Phase|Lost to Follow-up|2|||
106027232|NCT00910624|365764659|FG003|Follow-Up Phase|Lost to Follow-up|0|||
106027233|NCT00910624|365764656|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
106027234|NCT00910624|365764657|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
106027235|NCT00910624|365764658|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
106027236|NCT00910624|365764659|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
106027237|NCT00910624|365764656|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
106027238|NCT00910624|365764657|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
106027239|NCT00910624|365764658|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
106027240|NCT00910624|365764659|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
106027241|NCT00910624|365764656|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
106027242|NCT00910624|365764657|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
106027243|NCT00910624|365764658|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
106027244|NCT00910624|365764659|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
106027245|NCT00910624|365764656|FG000|Follow-Up Phase|Administrative|0|||
106027246|NCT00910624|365764657|FG001|Follow-Up Phase|Administrative|1|||
105850496|NCT03696953|365112511|FG001|Overall Study|Premature birth|4|||
106027247|NCT00910624|365764658|FG002|Follow-Up Phase|Administrative|1|||
106027248|NCT00910624|365764659|FG003|Follow-Up Phase|Administrative|0|||
105850497|NCT03696953|365112510|FG000|Overall Study|Gestational hypertension|1|||
105976073|NCT03618628|365572284|FG000|Overall Study|Lost to Follow-up|1|||
105976074|NCT00953680|365572285|FG000|Period 1|Withdrawal by Subject|0|||
105976075|NCT00953680|365572286|FG001|Period 1|Withdrawal by Subject|1|||
105976076|NCT02193087|365572287|FG000|Overall Study|Adverse Event|2|||
105976077|NCT02193087|365572288|FG001|Overall Study|Adverse Event|0|||
105976078|NCT02193087|365572289|FG002|Overall Study|Adverse Event|0|||
105976079|NCT02193087|365572290|FG003|Overall Study|Adverse Event|11|||
105976080|NCT02193087|365572287|FG000|Overall Study|Lost to Follow-up|14|||
105976081|NCT02193087|365572288|FG001|Overall Study|Lost to Follow-up|6|||
105976082|NCT02193087|365572289|FG002|Overall Study|Lost to Follow-up|4|||
105976083|NCT02193087|365572290|FG003|Overall Study|Lost to Follow-up|37|||
105976084|NCT02193087|365572287|FG000|Overall Study|Protocol Violation|2|||
105976085|NCT02193087|365572288|FG001|Overall Study|Protocol Violation|0|||
105976086|NCT02193087|365572289|FG002|Overall Study|Protocol Violation|1|||
105976087|NCT02193087|365572290|FG003|Overall Study|Protocol Violation|2|||
105976088|NCT02193087|365572287|FG000|Overall Study|Withdrawal by Subject|10|||
105976089|NCT02193087|365572288|FG001|Overall Study|Withdrawal by Subject|3|||
105976090|NCT02193087|365572289|FG002|Overall Study|Withdrawal by Subject|1|||
105976091|NCT02193087|365572290|FG003|Overall Study|Withdrawal by Subject|19|||
105976092|NCT02193087|365572287|FG000|Overall Study|Other Reason Not Specified|7|||
105976093|NCT02193087|365572288|FG001|Overall Study|Other Reason Not Specified|2|||
105976094|NCT02193087|365572289|FG002|Overall Study|Other Reason Not Specified|1|||
105976095|NCT02193087|365572290|FG003|Overall Study|Other Reason Not Specified|9|||
105850498|NCT03696953|365112511|FG001|Overall Study|Gestational hypertension|1|||
105850499|NCT03696953|365112510|FG000|Overall Study|Gestational diabetes|2|||
105850500|NCT03696953|365112511|FG001|Overall Study|Gestational diabetes|1|||
105850501|NCT03696953|365112510|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
105850502|NCT03696953|365112511|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
105850503|NCT03696953|365112510|FG000|Overall Study|Changed prenatal provider|1|||
105850504|NCT03696953|365112511|FG001|Overall Study|Changed prenatal provider|1|||
105850505|NCT05104476|365112512|FG000|Overall Study|Randomized But Not Treated|1|||
105850506|NCT05104476|365112513|FG001|Overall Study|Randomized But Not Treated|2|||
105850507|NCT05104476|365112512|FG000|Overall Study|Adverse Event|2|||
105850508|NCT05104476|365112513|FG001|Overall Study|Adverse Event|2|||
105850509|NCT05104476|365112512|FG000|Overall Study|Withdrawal by Subject|3|||
105850510|NCT05104476|365112513|FG001|Overall Study|Withdrawal by Subject|3|||
105850511|NCT05104476|365112512|FG000|Overall Study|Other Than Specified|0|||
105850512|NCT05104476|365112513|FG001|Overall Study|Other Than Specified|3|||
105850513|NCT02564211|365112514|FG000|Overall Study|Adverse Event|4|||
105976096|NCT02193087|365572287|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
105976097|NCT02193087|365572288|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
105976098|NCT02193087|365572289|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
105976099|NCT02193087|365572290|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
105976100|NCT01741532|365572292|FG000|Overall Study|Adverse Event|4|||
105976101|NCT01741532|365572293|FG001|Overall Study|Adverse Event|0|||
106027249|NCT00859638|365764663|FG000|Overall Study|Lost to Follow-up|6|||
106027250|NCT00859638|365764664|FG001|Overall Study|Lost to Follow-up|1|||
106027251|NCT00859638|365764663|FG000|Overall Study|Withdrawal by Subject|3|||
106027252|NCT00859638|365764664|FG001|Overall Study|Withdrawal by Subject|2|||
106027253|NCT00859638|365764663|FG000|Overall Study|Ill health|1|||
106027254|NCT00859638|365764664|FG001|Overall Study|Ill health|1|||
106027255|NCT00412373|365764665|FG000|Overall Study|Adverse Event|8|||
106027256|NCT00412373|365764666|FG001|Overall Study|Adverse Event|13|||
106027257|NCT00412373|365764665|FG000|Overall Study|Lack of Efficacy|16|||
106027258|NCT00412373|365764666|FG001|Overall Study|Lack of Efficacy|22|||
106027259|NCT00412373|365764665|FG000|Overall Study|Lost to Follow-up|7|||
106027260|NCT00412373|365764666|FG001|Overall Study|Lost to Follow-up|13|||
106027261|NCT00412373|365764665|FG000|Overall Study|Withdrawal by Subject|8|||
106027262|NCT00412373|365764666|FG001|Overall Study|Withdrawal by Subject|27|||
106027263|NCT00412373|365764665|FG000|Overall Study|Other|2|||
106027264|NCT00412373|365764666|FG001|Overall Study|Other|2|||
106027265|NCT02969408|365764668|FG000|Overall Study|Adverse Event|2|||
106027266|NCT02969408|365764668|FG000|Overall Study|Withdrawal by Subject|8|||
106027267|NCT02969408|365764668|FG000|Overall Study|Lost to Follow-up|4|||
106027268|NCT02969408|365764668|FG000|Overall Study|Protocol Violation|1|||
106027269|NCT02969408|365764668|FG000|Overall Study|Other than specified|1|||
106027270|NCT01104376|365764669|FG000|Overall Study|Withdrawal by Subject|15|||
106027271|NCT01104376|365764669|FG000|Overall Study|Consented but excluded after labs|13|||
106027272|NCT00797966|365764670|FG000|Phase A|Lost to Follow-up|0|||
106027273|NCT00797966|365764671|FG001|Phase A|Lost to Follow-up|0|||
106027274|NCT00797966|365764672|FG002|Phase A|Lost to Follow-up|0|||
106027275|NCT00797966|365764673|FG003|Phase A|Lost to Follow-up|0|||
106027276|NCT00797966|365764674|FG004|Phase A|Lost to Follow-up|33|||
106027277|NCT00797966|365764675|FG005|Phase A|Lost to Follow-up|0|||
106027278|NCT00797966|365764670|FG000|Phase A|Adverse Event|0|||
105976102|NCT01741532|365572292|FG000|Overall Study|Withdrawal by Subject|1|||
105976103|NCT01741532|365572293|FG001|Overall Study|Withdrawal by Subject|1|||
106027279|NCT00797966|365764671|FG001|Phase A|Adverse Event|0|||
105850514|NCT00622466|365112515|FG000|Overall Study|Death|1|||
105850515|NCT00622466|365112515|FG000|Overall Study|Adverse Event|1|||
105850516|NCT00622466|365112515|FG000|Overall Study|Withdrawal by Subject|2|||
105850517|NCT01908816|365112518|FG000|Overall Study|Subject's no longer requires study drug|0|||
105850518|NCT01908816|365112519|FG001|Overall Study|Subject's no longer requires study drug|0|||
105850519|NCT01908816|365112520|FG002|Overall Study|Subject's no longer requires study drug|0|||
105850520|NCT01908816|365112521|FG003|Overall Study|Subject's no longer requires study drug|1|||
105850521|NCT01908816|365112518|FG000|Overall Study|Protocol deviation|1|||
105850522|NCT01908816|365112519|FG001|Overall Study|Protocol deviation|2|||
105850523|NCT01908816|365112520|FG002|Overall Study|Protocol deviation|1|||
105850524|NCT01908816|365112521|FG003|Overall Study|Protocol deviation|1|||
105850525|NCT01908816|365112518|FG000|Overall Study|Withdrawal by Subject|0|||
105850526|NCT01908816|365112519|FG001|Overall Study|Withdrawal by Subject|4|||
105850527|NCT01908816|365112520|FG002|Overall Study|Withdrawal by Subject|2|||
105850528|NCT01908816|365112521|FG003|Overall Study|Withdrawal by Subject|2|||
105850529|NCT01908816|365112518|FG000|Overall Study|Lost to Follow-up|3|||
105850530|NCT01908816|365112519|FG001|Overall Study|Lost to Follow-up|5|||
105850531|NCT01908816|365112520|FG002|Overall Study|Lost to Follow-up|4|||
105850532|NCT01908816|365112521|FG003|Overall Study|Lost to Follow-up|2|||
105850533|NCT01908816|365112518|FG000|Overall Study|Death|1|||
105850534|NCT01908816|365112519|FG001|Overall Study|Death|0|||
105850535|NCT01908816|365112520|FG002|Overall Study|Death|7|||
105976104|NCT01741532|365572292|FG000|Overall Study|Protocol Violation|0|||
105976105|NCT01741532|365572293|FG001|Overall Study|Protocol Violation|1|||
105976106|NCT01741532|365572292|FG000|Overall Study|Worsening of the disease|3|||
105976107|NCT01741532|365572293|FG001|Overall Study|Worsening of the disease|1|||
105976108|NCT01741532|365572292|FG000|Overall Study|Sponsor decision|1|||
105976109|NCT01741532|365572293|FG001|Overall Study|Sponsor decision|0|||
105976110|NCT01741532|365572292|FG000|Overall Study|Medical event|1|||
105976111|NCT01741532|365572293|FG001|Overall Study|Medical event|0|||
105976112|NCT00475865|365572294|FG000|Overall Study|Adverse Event|0|||
105976113|NCT00475865|365572295|FG001|Overall Study|Adverse Event|3|||
105976114|NCT00475865|365572296|FG002|Overall Study|Adverse Event|4|||
105976115|NCT00475865|365572294|FG000|Overall Study|Lack of Efficacy|1|||
105976116|NCT00475865|365572295|FG001|Overall Study|Lack of Efficacy|0|||
105976117|NCT00475865|365572296|FG002|Overall Study|Lack of Efficacy|0|||
105976118|NCT00475865|365572294|FG000|Overall Study|Progressive disease|0|||
105976119|NCT00475865|365572295|FG001|Overall Study|Progressive disease|1|||
105976120|NCT00475865|365572296|FG002|Overall Study|Progressive disease|2|||
105976121|NCT00475865|365572294|FG000|Overall Study|Participant did not wish to continue|1|||
105976122|NCT00475865|365572295|FG001|Overall Study|Participant did not wish to continue|0|||
105976123|NCT00475865|365572296|FG002|Overall Study|Participant did not wish to continue|0|||
105976124|NCT00475865|365572294|FG000|Overall Study|Other than above|0|||
105976125|NCT00475865|365572295|FG001|Overall Study|Other than above|1|||
105976126|NCT00475865|365572296|FG002|Overall Study|Other than above|0|||
105976127|NCT02741570|365572299|FG000|Pre-Treatment Period|Other reasons|0|||
105976128|NCT02741570|365572300|FG001|Pre-Treatment Period|Other reasons|3|||
105976129|NCT02741570|365572299|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
105976130|NCT02741570|365572300|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
105976131|NCT02741570|365572299|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
105976132|NCT02741570|365572300|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
105976133|NCT02741570|365572299|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
105976134|NCT02741570|365572300|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
105976135|NCT02741570|365572299|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
105976136|NCT02741570|365572300|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
105976137|NCT02741570|365572299|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
105976138|NCT02741570|365572300|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
105976139|NCT02741570|365572299|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
105976140|NCT02741570|365572300|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
105976141|NCT02741570|365572299|FG000|Pre-Treatment Period|Death|0|||
105976142|NCT02741570|365572300|FG001|Pre-Treatment Period|Death|1|||
105976143|NCT02741570|365572299|FG000|Pre-Treatment Period|Disease progression|0|||
105976144|NCT02741570|365572300|FG001|Pre-Treatment Period|Disease progression|1|||
105976145|NCT02741570|365572299|FG000|Treatment Period|Other reasons|47|||
105976146|NCT02741570|365572300|FG001|Treatment Period|Other reasons|12|||
105976147|NCT02741570|365572299|FG000|Treatment Period|Poor/non-compliance|0|||
105850536|NCT01908816|365112521|FG003|Overall Study|Death|1|||
105976148|NCT02741570|365572300|FG001|Treatment Period|Poor/non-compliance|2|||
105976149|NCT02741570|365572299|FG000|Treatment Period|Maximum clinical benefit|4|||
105976150|NCT02741570|365572300|FG001|Treatment Period|Maximum clinical benefit|6|||
105976151|NCT02741570|365572299|FG000|Treatment Period|Lost to Follow-up|1|||
105976152|NCT02741570|365572300|FG001|Treatment Period|Lost to Follow-up|3|||
105976153|NCT02741570|365572299|FG000|Treatment Period|Participant withdrew consent|9|||
105976154|NCT02741570|365572300|FG001|Treatment Period|Participant withdrew consent|13|||
106150673|NCT04994509|366212620|FG000|Overall Study|Withdrew Consent|73|||
106150674|NCT04994509|366212621|FG001|Overall Study|Withdrew Consent|72|||
106150675|NCT04994509|366212622|FG002|Overall Study|Withdrew Consent|46|||
106150676|NCT04994509|366212620|FG000|Overall Study|Lost to Follow-up|39|||
106150677|NCT04994509|366212621|FG001|Overall Study|Lost to Follow-up|36|||
106150678|NCT04994509|366212622|FG002|Overall Study|Lost to Follow-up|26|||
106150679|NCT04994509|366212620|FG000|Overall Study|HIV-1 Infection|4|||
106150680|NCT04994509|366212621|FG001|Overall Study|HIV-1 Infection|20|||
106150681|NCT04994509|366212622|FG002|Overall Study|HIV-1 Infection|12|||
106150682|NCT04994509|366212620|FG000|Overall Study|Investigator's Discretion|9|||
105976155|NCT02741570|365572299|FG000|Treatment Period|Participant request to discontinue treatment|8|||
106150683|NCT04994509|366212621|FG001|Overall Study|Investigator's Discretion|8|||
106150684|NCT04994509|366212622|FG002|Overall Study|Investigator's Discretion|11|||
106150685|NCT04994509|366212620|FG000|Overall Study|Randomized but Never Treated|10|||
106150686|NCT04994509|366212621|FG001|Overall Study|Randomized but Never Treated|10|||
106150687|NCT04994509|366212622|FG002|Overall Study|Randomized but Never Treated|3|||
106150688|NCT04994509|366212620|FG000|Overall Study|Pregnancy|5|||
106150689|NCT04994509|366212621|FG001|Overall Study|Pregnancy|5|||
106150690|NCT04994509|366212622|FG002|Overall Study|Pregnancy|0|||
106150691|NCT04994509|366212620|FG000|Overall Study|Death|0|||
106150692|NCT04994509|366212621|FG001|Overall Study|Death|5|||
106150693|NCT04994509|366212622|FG002|Overall Study|Death|0|||
106150694|NCT04994509|366212620|FG000|Overall Study|Adverse Event|2|||
106150695|NCT04994509|366212621|FG001|Overall Study|Adverse Event|1|||
106150696|NCT04994509|366212622|FG002|Overall Study|Adverse Event|0|||
106150697|NCT04994509|366212620|FG000|Overall Study|Non-compliance With Study Drug|1|||
106150698|NCT04994509|366212621|FG001|Overall Study|Non-compliance With Study Drug|1|||
106150699|NCT04994509|366212622|FG002|Overall Study|Non-compliance With Study Drug|1|||
106150700|NCT04994509|366212620|FG000|Overall Study|Withdrew Assent|3|||
106150701|NCT04994509|366212621|FG001|Overall Study|Withdrew Assent|0|||
106150702|NCT04994509|366212622|FG002|Overall Study|Withdrew Assent|0|||
106150703|NCT04994509|366212620|FG000|Overall Study|Protocol Violation|1|||
106150704|NCT04994509|366212621|FG001|Overall Study|Protocol Violation|0|||
106150705|NCT04994509|366212622|FG002|Overall Study|Protocol Violation|0|||
106150706|NCT01959698|366212623|FG000|Overall Study|Adverse Event|0|||
106150707|NCT01959698|366212624|FG001|Overall Study|Adverse Event|0|||
106150708|NCT01959698|366212625|FG002|Overall Study|Adverse Event|0|||
106150709|NCT01959698|366212626|FG003|Overall Study|Adverse Event|0|||
106150710|NCT01959698|366212627|FG004|Overall Study|Adverse Event|0|||
106150711|NCT01959698|366212628|FG005|Overall Study|Adverse Event|0|||
106150712|NCT01959698|366212629|FG006|Overall Study|Adverse Event|1|||
106150713|NCT01959698|366212623|FG000|Overall Study|Physician Decision|1|||
106150714|NCT01959698|366212624|FG001|Overall Study|Physician Decision|0|||
106150715|NCT01959698|366212625|FG002|Overall Study|Physician Decision|1|||
106150716|NCT01959698|366212626|FG003|Overall Study|Physician Decision|2|||
106150717|NCT01959698|366212627|FG004|Overall Study|Physician Decision|0|||
106150718|NCT01959698|366212628|FG005|Overall Study|Physician Decision|3|||
106150719|NCT01959698|366212629|FG006|Overall Study|Physician Decision|3|||
106150720|NCT01853748|366215022|FG000|Allocation|Withdrawal by Subject|1|||
106150721|NCT01853748|366215023|FG001|Allocation|Withdrawal by Subject|13|||
106150722|NCT01853748|366215022|FG000|Allocation|not sufficient to receive intervention|0|||
106150723|NCT01853748|366215023|FG001|Allocation|not sufficient to receive intervention|1|||
106150724|NCT01853748|366215022|FG000|Follow-Up|Withdrawal by Subject|7|||
106150725|NCT01853748|366215023|FG001|Follow-Up|Withdrawal by Subject|6|||
106150726|NCT01853748|366215022|FG000|Follow-Up|Adverse Event|67|||
106150727|NCT01853748|366215023|FG001|Follow-Up|Adverse Event|7|||
106150728|NCT01853748|366215022|FG000|Follow-Up|not available for data collection|16|||
106150729|NCT01853748|366215023|FG001|Follow-Up|not available for data collection|4|||
106150730|NCT03960463|366215025|FG000|Overall Study|Withdrawal by Subject|2|||
106150731|NCT03960463|366215026|FG001|Overall Study|Withdrawal by Subject|0|||
106150732|NCT05194917|366215027|FG000|Overall Study|Lost to Follow-up|7|||
106150733|NCT05194917|366215028|FG001|Overall Study|Lost to Follow-up|5|||
106150734|NCT05194917|366215029|FG002|Overall Study|Lost to Follow-up|6|||
106150735|NCT05194917|366215030|FG003|Overall Study|Lost to Follow-up|5|||
106150736|NCT04922021|366215031|FG000|Overall Study|Withdrawal by Subject|4|||
106150737|NCT04922021|366215032|FG001|Overall Study|Withdrawal by Subject|10|||
106150738|NCT04922021|366215031|FG000|Overall Study|Adverse Event|2|||
105976156|NCT02741570|365572300|FG001|Treatment Period|Participant request to discontinue treatment|23|||
105976157|NCT02741570|365572299|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
105976158|NCT02741570|365572300|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
106150739|NCT04922021|366215032|FG001|Overall Study|Adverse Event|2|||
106150740|NCT04922021|366215031|FG000|Overall Study|Lack of Efficacy|0|||
106150741|NCT04922021|366215032|FG001|Overall Study|Lack of Efficacy|1|||
106150742|NCT04922021|366215031|FG000|Overall Study|Multiple reasons|1|||
106150743|NCT04922021|366215032|FG001|Overall Study|Multiple reasons|0|||
106150744|NCT05644444|366215037|FG000|Tolerance Phase|Adverse Event|0|||
106150745|NCT05644444|366215038|FG001|Tolerance Phase|Adverse Event|2|||
106150746|NCT05644444|366215037|FG000|Treatment Phase|Adverse Event|0|||
106150747|NCT05644444|366215038|FG001|Treatment Phase|Adverse Event|2|||
105976159|NCT02741570|365572299|FG000|Treatment Period|Death|9|||
105976160|NCT02741570|365572300|FG001|Treatment Period|Death|7|||
105976161|NCT02741570|365572299|FG000|Treatment Period|Study drug toxicity|55|||
105976162|NCT02741570|365572300|FG001|Treatment Period|Study drug toxicity|47|||
105976163|NCT02741570|365572299|FG000|Treatment Period|Disease progression|294|||
105976164|NCT02741570|365572300|FG001|Treatment Period|Disease progression|301|||
105976165|NCT02741570|365572299|FG000|Treatment Period|Administrative reason by sponsor|0|||
105976166|NCT02741570|365572300|FG001|Treatment Period|Administrative reason by sponsor|1|||
105976167|NCT01453946|365572301|FG000|Overall Study|Did not receive drug for the taper phase|1|||
105976168|NCT01453946|365572301|FG000|Overall Study|Protocol Violation|2|||
105976169|NCT01453946|365572301|FG000|Overall Study|Lack of Efficacy|3|||
105976170|NCT01453946|365572301|FG000|Overall Study|Adverse Event|3|||
105976171|NCT00846040|365572302|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
105976172|NCT00846040|365572303|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
105976173|NCT00846040|365572304|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
105976174|NCT00846040|365572302|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
105976175|NCT00846040|365572303|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
105976176|NCT00846040|365572304|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
105976177|NCT02279498|365572307|FG000|Overall Study|Adverse Event|3|||
105976178|NCT02279498|365572308|FG001|Overall Study|Adverse Event|0|||
105976179|NCT02279498|365572307|FG000|Overall Study|Lack of Efficacy|4|||
105976180|NCT02279498|365572308|FG001|Overall Study|Lack of Efficacy|0|||
105976181|NCT02279498|365572307|FG000|Overall Study|Lost to Follow-up|0|||
105976182|NCT02279498|365572308|FG001|Overall Study|Lost to Follow-up|1|||
105976183|NCT02279498|365572307|FG000|Overall Study|Withdrawal by Subject|9|||
105976184|NCT02279498|365572308|FG001|Overall Study|Withdrawal by Subject|2|||
105976185|NCT02279498|365572307|FG000|Overall Study|Undefined|2|||
105976186|NCT02279498|365572308|FG001|Overall Study|Undefined|1|||
105976187|NCT01146652|365573689|FG000|Overall Study|Adverse Event|506|||
105976188|NCT01146652|365573690|FG001|Overall Study|Adverse Event|15|||
105976189|NCT01146652|365573689|FG000|Overall Study|Lack of Efficacy|91|||
105976190|NCT01146652|365573690|FG001|Overall Study|Lack of Efficacy|7|||
105976191|NCT01146652|365573689|FG000|Overall Study|Poor compliance to protocol|38|||
105976192|NCT01146652|365573690|FG001|Overall Study|Poor compliance to protocol|1|||
105976193|NCT01146652|365573689|FG000|Overall Study|Other unspecified reasons|314|||
105976194|NCT01146652|365573690|FG001|Overall Study|Other unspecified reasons|22|||
105976195|NCT01146652|365573689|FG000|Overall Study|Enrolled but not treated|2|||
105976196|NCT01146652|365573690|FG001|Overall Study|Enrolled but not treated|0|||
105976197|NCT00919867|365573691|FG000|First Intervention|Withdrawal by Subject|0|||
105976198|NCT00919867|365573692|FG001|First Intervention|Withdrawal by Subject|0|||
105976199|NCT00919867|365573693|FG002|First Intervention|Withdrawal by Subject|1|||
105976200|NCT00919867|365573694|FG003|First Intervention|Withdrawal by Subject|0|||
105976201|NCT00919867|365573695|FG004|First Intervention|Withdrawal by Subject|0|||
105976202|NCT00919867|365573696|FG005|First Intervention|Withdrawal by Subject|0|||
105976203|NCT00919867|365573691|FG000|First Intervention|Physician Decision|0|||
105976204|NCT00919867|365573692|FG001|First Intervention|Physician Decision|0|||
105976205|NCT00919867|365573693|FG002|First Intervention|Physician Decision|0|||
105976206|NCT00919867|365573694|FG003|First Intervention|Physician Decision|0|||
105976207|NCT00919867|365573695|FG004|First Intervention|Physician Decision|0|||
105976208|NCT00919867|365573696|FG005|First Intervention|Physician Decision|1|||
105976209|NCT03294135|365573697|FG000|Overall Study|Serious Adverse Event|1|||
105976210|NCT03294135|365573698|FG001|Overall Study|Serious Adverse Event|0|||
105976211|NCT03294135|365573699|FG002|Overall Study|Serious Adverse Event|0|||
105976212|NCT03294135|365573697|FG000|Overall Study|Lost to Follow-up|1|||
105976213|NCT03294135|365573698|FG001|Overall Study|Lost to Follow-up|0|||
105976214|NCT03294135|365573699|FG002|Overall Study|Lost to Follow-up|1|||
105976215|NCT03294135|365573697|FG000|Overall Study|Withdrawal by Subject|0|||
105976216|NCT03294135|365573698|FG001|Overall Study|Withdrawal by Subject|0|||
105976217|NCT03294135|365573699|FG002|Overall Study|Withdrawal by Subject|1|||
105976218|NCT03294135|365573697|FG000|Overall Study|Other|2|||
105976219|NCT03294135|365573698|FG001|Overall Study|Other|0|||
105976220|NCT03294135|365573699|FG002|Overall Study|Other|0|||
105976221|NCT01510184|365573700|FG000|Overall Study|Sponsor discretion|28|||
105976222|NCT01510184|365573701|FG001|Overall Study|Sponsor discretion|28|||
106027280|NCT00797966|365764672|FG002|Phase A|Adverse Event|0|||
105976223|NCT01510184|365573700|FG000|Overall Study|Death|1|||
106027281|NCT00797966|365764673|FG003|Phase A|Adverse Event|0|||
105976224|NCT01510184|365573701|FG001|Overall Study|Death|2|||
105976225|NCT01510184|365573700|FG000|Overall Study|Withdrawal by Subject|1|||
105976226|NCT01510184|365573701|FG001|Overall Study|Withdrawal by Subject|4|||
105976227|NCT01510184|365573700|FG000|Overall Study|Other|0|||
105976228|NCT01510184|365573701|FG001|Overall Study|Other|1|||
105976229|NCT00054691|365573702|FG000|Overall Study|Unmeasurable Disease|2|||
105976230|NCT00054691|365573702|FG000|Overall Study|Noncompliant|1|||
105976231|NCT00694096|365573709|FG000|Overall Study|Withdrawal by Subject|5|||
105976232|NCT00260065|365573713|FG000|Overall Study|Progressive Disease|22|||
105976233|NCT00260065|365573713|FG000|Overall Study|Adverse Event|17|||
105976234|NCT00260065|365573713|FG000|Overall Study|Death|13|||
105976235|NCT00260065|365573713|FG000|Overall Study|Withdrawal by Subject|13|||
105976236|NCT00260065|365573713|FG000|Overall Study|Physician Decision|19|||
105976237|NCT00260065|365573713|FG000|Overall Study|Not otherwise specified|8|||
105976238|NCT00260065|365573713|FG000|Overall Study|Medication Noncompliance|1|||
105976239|NCT01390779|365573714|FG000|Overall Study|Physician Decision|1|||
105976240|NCT03351114|365573715|FG000|Overall Study|Withdrawal by Subject|1|||
105976241|NCT01665430|365573716|FG000|Overall Study|Adverse Event|1|||
105976242|NCT01665430|365573716|FG000|Overall Study|Withdrawal by Subject|6|||
105976243|NCT01665430|365573716|FG000|Overall Study|Other Unspecified|2|||
105976244|NCT03987932|365573725|FG000|Overall Study|Lost to Follow-up|2|||
105850537|NCT01908816|365112518|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
105850538|NCT01908816|365112519|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
105850539|NCT01908816|365112520|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
105850540|NCT01908816|365112521|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
105850541|NCT01908816|365112518|FG000|Overall Study|Early termination|87|||
105850542|NCT01908816|365112519|FG001|Overall Study|Early termination|60|||
105850543|NCT01908816|365112520|FG002|Overall Study|Early termination|43|||
105850544|NCT01908816|365112521|FG003|Overall Study|Early termination|28|||
105850545|NCT01155024|365112526|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
105850546|NCT01155024|365112527|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
105976245|NCT03987932|365573726|FG001|Overall Study|Lost to Follow-up|1|||
105976246|NCT03987932|365573727|FG002|Overall Study|Lost to Follow-up|1|||
105976247|NCT03987932|365573725|FG000|Overall Study|Non-study related elective surgery|0|||
105976248|NCT03987932|365573726|FG001|Overall Study|Non-study related elective surgery|0|||
105976249|NCT03987932|365573727|FG002|Overall Study|Non-study related elective surgery|1|||
105976250|NCT01799239|365573731|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
105976251|NCT01799239|365573732|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
105976252|NCT01799239|365573731|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
105976253|NCT01799239|365573732|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
105976254|NCT01799239|365573731|FG000|Period 1 (7 Days)|Protocol Violation|0|||
105976255|NCT01799239|365573732|FG001|Period 1 (7 Days)|Protocol Violation|1|||
105976256|NCT01799239|365573731|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
105850547|NCT01155024|365112526|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
105850548|NCT01155024|365112527|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
105850549|NCT01155024|365112526|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
105850550|NCT01155024|365112527|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
105850551|NCT01936623|365112530|FG000|Overall Study|Lost to Follow-up|0|||
105850552|NCT01936623|365112531|FG001|Overall Study|Lost to Follow-up|5|||
105976257|NCT01799239|365573732|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
105976258|NCT01799239|365573731|FG000|Period 2 (7 Days)|Protocol Violation|1|||
105976259|NCT01799239|365573732|FG001|Period 2 (7 Days)|Protocol Violation|0|||
105976260|NCT01561755|365573737|FG000|Overall Study|Lost to Follow-up|0|||
105976261|NCT01561755|365573738|FG001|Overall Study|Lost to Follow-up|1|||
105976262|NCT03630302|365573739|FG000|Surgery|hardware issue prevented LFP recordings|1|||
105976263|NCT03630302|365573739|FG000|3 Month Visit|Adverse Event|2|||
105976264|NCT03630302|365573739|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
105976265|NCT02813668|365573743|FG000|Overall Study|Death|4|||
105976266|NCT02813668|365573743|FG000|Overall Study|Lost to Follow-up|509|||
105976267|NCT02813668|365573743|FG000|Overall Study|Withdrawal by Subject|148|||
105976268|NCT02813668|365573743|FG000|Overall Study|No longer at worksite|85|||
105976269|NCT02813668|365573743|FG000|Overall Study|Medical reasons not related to the study|4|||
105976270|NCT00598078|365573750|FG000|Period 2 (Day 2)|Adverse Event|1|||
105976271|NCT00598078|365573751|FG001|Period 2 (Day 2)|Adverse Event|0|||
105976272|NCT01866423|365573755|FG000|Overall Study|Lack of Efficacy|3|||
105976273|NCT01866423|365573755|FG000|Overall Study|Sponsor Decision|1|||
105976274|NCT01813721|365573756|FG000|Overall Study|Ineligibility determined|63|||
105976275|NCT01813721|365573756|FG000|Overall Study|Withdrawal by Subject|1|||
105976276|NCT01996592|365573757|FG000|Overall Study|no response to text/no diary entry|32|||
105976277|NCT01996592|365573757|FG000|Overall Study|change in surgical date|4|||
105976278|NCT01996592|365573757|FG000|Overall Study|Withdrawal by Subject|5|||
105976279|NCT01996592|365573757|FG000|Overall Study|change in mode of delivery|4|||
105976280|NCT02387164|365573758|FG000|Overall Study|Lost to Follow-up|2|||
105976281|NCT02387164|365573759|FG001|Overall Study|Lost to Follow-up|0|||
105976282|NCT02387164|365573758|FG000|Overall Study|Diagnosed|1|||
105850553|NCT03201250|365112532|FG000|Overall Study|screen failures|3|||
105976283|NCT02387164|365573759|FG001|Overall Study|Diagnosed|2|||
105976284|NCT02133664|365573764|FG000|Overall Study|Lost to Follow-up|2|||
105976285|NCT02133664|365573765|FG001|Overall Study|Lost to Follow-up|1|||
105976286|NCT02133664|365573764|FG000|Overall Study|Adverse Event|3|||
106027282|NCT00797966|365764674|FG004|Phase A|Adverse Event|46|||
105976287|NCT02133664|365573765|FG001|Overall Study|Adverse Event|6|||
105976288|NCT00343915|365573766|FG000|Primary Study|Withdrawal by Subject|1|||
105976289|NCT00343915|365573767|FG001|Primary Study|Withdrawal by Subject|0|||
105976290|NCT00343915|365573766|FG000|Primary Study|Lost to Follow-up|2|||
105976291|NCT00343915|365573767|FG001|Primary Study|Lost to Follow-up|3|||
106150748|NCT02576509|366215042|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
105850554|NCT03201250|365112533|FG001|Overall Study|screen failures|0|||
105850555|NCT03201250|365112534|FG002|Overall Study|screen failures|0|||
105850556|NCT01383135|365112535|FG000|Overall Study|Not Scanned / Imaged|1|||
105850557|NCT01383135|365112536|FG001|Overall Study|Not Scanned / Imaged|0|||
105850558|NCT01383135|365112537|FG002|Overall Study|Not Scanned / Imaged|1|||
105850559|NCT01383135|365112538|FG003|Overall Study|Not Scanned / Imaged|0|||
105850560|NCT03167723|365112539|FG000|Overall Study|Protocol Violation|4|||
105850561|NCT03167723|365112540|FG001|Overall Study|Protocol Violation|6|||
105850562|NCT01340768|365112543|FG000|Overall Study|Lost to Follow-up|10|||
105850563|NCT01340768|365112544|FG001|Overall Study|Lost to Follow-up|4|||
105850564|NCT01340768|365112543|FG000|Overall Study|Withdrawal by Subject|5|||
105850565|NCT01340768|365112544|FG001|Overall Study|Withdrawal by Subject|1|||
105850566|NCT01340768|365112543|FG000|Overall Study|Other|2|||
105850567|NCT01340768|365112544|FG001|Overall Study|Other|0|||
105850568|NCT00415194|365112547|FG000|Overall Study|Adverse Event|37|||
105850569|NCT00415194|365112548|FG001|Overall Study|Adverse Event|32|||
105850570|NCT00415194|365112547|FG000|Overall Study|Entry Criteria Not Met|4|||
105850571|NCT00415194|365112548|FG001|Overall Study|Entry Criteria Not Met|8|||
105850572|NCT00415194|365112547|FG000|Overall Study|Lost to Follow-up|1|||
105850573|NCT00415194|365112548|FG001|Overall Study|Lost to Follow-up|0|||
105850574|NCT00415194|365112547|FG000|Overall Study|Physician Decision|10|||
105850575|NCT00415194|365112548|FG001|Overall Study|Physician Decision|16|||
105850576|NCT00415194|365112547|FG000|Overall Study|Progressive Disease|180|||
105850577|NCT00415194|365112548|FG001|Overall Study|Progressive Disease|217|||
105850578|NCT00415194|365112547|FG000|Overall Study|Protocol Violation|4|||
105850579|NCT00415194|365112548|FG001|Overall Study|Protocol Violation|2|||
105850580|NCT00415194|365112547|FG000|Overall Study|Withdrawal by Subject|28|||
105850581|NCT00415194|365112548|FG001|Overall Study|Withdrawal by Subject|21|||
105850582|NCT00415194|365112547|FG000|Overall Study|Death Due to Study Disease|26|||
105850583|NCT00415194|365112548|FG001|Overall Study|Death Due to Study Disease|29|||
105850584|NCT00415194|365112547|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
105850585|NCT00415194|365112548|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
105850586|NCT00415194|365112547|FG000|Overall Study|Death Due to Procedural Related AE|0|||
105850587|NCT00415194|365112548|FG001|Overall Study|Death Due to Procedural Related AE|1|||
105850588|NCT00415194|365112547|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
105850589|NCT00415194|365112548|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
105850590|NCT00369655|365112549|FG000|Overall Study|Refusal of further treatment|2|||
105850591|NCT01683838|365112550|FG000|Overall Study|Adverse Event|12|||
105850592|NCT01683838|365112551|FG001|Overall Study|Adverse Event|2|||
105850593|NCT01683838|365112550|FG000|Overall Study|Protocol Violation|3|||
105850594|NCT01683838|365112551|FG001|Overall Study|Protocol Violation|1|||
105850595|NCT01683838|365112550|FG000|Overall Study|Withdrawal by Subject|6|||
105850596|NCT01683838|365112551|FG001|Overall Study|Withdrawal by Subject|5|||
105850597|NCT01683838|365112550|FG000|Overall Study|Lost to Follow-up|1|||
105850598|NCT01683838|365112551|FG001|Overall Study|Lost to Follow-up|1|||
105850599|NCT01683838|365112550|FG000|Overall Study|Other|4|||
105850600|NCT01683838|365112551|FG001|Overall Study|Other|3|||
105850601|NCT04049617|365112552|FG000|Overall Study|Adverse Event|0|||
105850602|NCT04049617|365112553|FG001|Overall Study|Adverse Event|0|||
105850603|NCT04049617|365112554|FG002|Overall Study|Adverse Event|0|||
105850604|NCT04049617|365112555|FG003|Overall Study|Adverse Event|1|||
105850605|NCT04049617|365112556|FG004|Overall Study|Adverse Event|0|||
105850606|NCT04049617|365112557|FG005|Overall Study|Adverse Event|0|||
105850607|NCT04049617|365112552|FG000|Overall Study|Death|0|||
105850608|NCT04049617|365112553|FG001|Overall Study|Death|0|||
105850609|NCT04049617|365112554|FG002|Overall Study|Death|0|||
105850610|NCT04049617|365112555|FG003|Overall Study|Death|0|||
105850611|NCT04049617|365112556|FG004|Overall Study|Death|0|||
105850612|NCT04049617|365112557|FG005|Overall Study|Death|1|||
105850613|NCT04049617|365112552|FG000|Overall Study|Lost to Follow-up|0|||
105850614|NCT04049617|365112553|FG001|Overall Study|Lost to Follow-up|0|||
105850615|NCT04049617|365112554|FG002|Overall Study|Lost to Follow-up|0|||
106150749|NCT02576509|366215043|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
105850616|NCT04049617|365112555|FG003|Overall Study|Lost to Follow-up|1|||
105850617|NCT04049617|365112556|FG004|Overall Study|Lost to Follow-up|0|||
105850618|NCT04049617|365112557|FG005|Overall Study|Lost to Follow-up|0|||
105850619|NCT04049617|365112552|FG000|Overall Study|Withdrew consent|0|||
105850620|NCT04049617|365112553|FG001|Overall Study|Withdrew consent|0|||
105850621|NCT04049617|365112554|FG002|Overall Study|Withdrew consent|1|||
105850622|NCT04049617|365112555|FG003|Overall Study|Withdrew consent|0|||
106027283|NCT00797966|365764675|FG005|Phase A|Adverse Event|0|||
105850623|NCT04049617|365112556|FG004|Overall Study|Withdrew consent|0|||
105850624|NCT04049617|365112557|FG005|Overall Study|Withdrew consent|0|||
105850625|NCT01524679|365112558|FG000|Overall Study|Lost to Follow-up|1|||
106027284|NCT00797966|365764670|FG000|Phase A|Met withdrawal criteria|0|||
106027285|NCT00797966|365764671|FG001|Phase A|Met withdrawal criteria|0|||
105850626|NCT01524679|365112559|FG001|Overall Study|Lost to Follow-up|4|||
105850627|NCT01524679|365112558|FG000|Overall Study|Withdrawal by Subject|4|||
105850628|NCT01524679|365112559|FG001|Overall Study|Withdrawal by Subject|4|||
105850629|NCT01524679|365112558|FG000|Overall Study|Adverse Event|9|||
105850630|NCT01524679|365112559|FG001|Overall Study|Adverse Event|0|||
105850631|NCT01524679|365112558|FG000|Overall Study|Protocol Violation|1|||
105850632|NCT01524679|365112559|FG001|Overall Study|Protocol Violation|0|||
105850633|NCT01524679|365112558|FG000|Overall Study|Lack of Efficacy|2|||
105850634|NCT01524679|365112559|FG001|Overall Study|Lack of Efficacy|0|||
105850635|NCT01524679|365112558|FG000|Overall Study|e.g.wish for children, relocation|6|||
105850636|NCT01524679|365112559|FG001|Overall Study|e.g.wish for children, relocation|1|||
105850637|NCT01154816|365112560|FG000|Overall Study|Withdrawal by Subject|1|||
105850638|NCT01154816|365112561|FG001|Overall Study|Withdrawal by Subject|0|||
105850639|NCT01154816|365112562|FG002|Overall Study|Withdrawal by Subject|0|||
105850640|NCT01154816|365112563|FG003|Overall Study|Withdrawal by Subject|1|||
105850641|NCT01154816|365112564|FG004|Overall Study|Withdrawal by Subject|0|||
105850642|NCT01154816|365112565|FG005|Overall Study|Withdrawal by Subject|0|||
105850643|NCT01154816|365112566|FG006|Overall Study|Withdrawal by Subject|0|||
105850644|NCT01154816|365112567|FG007|Overall Study|Withdrawal by Subject|0|||
105850645|NCT01154816|365112568|FG008|Overall Study|Withdrawal by Subject|1|||
105850646|NCT01154816|365112569|FG009|Overall Study|Withdrawal by Subject|3|||
105850647|NCT01154816|365112570|FG010|Overall Study|Withdrawal by Subject|0|||
105850648|NCT01154816|365112571|FG011|Overall Study|Withdrawal by Subject|0|||
105850649|NCT01154816|365112560|FG000|Overall Study|Progressive Disease|13|||
105850650|NCT01154816|365112561|FG001|Overall Study|Progressive Disease|8|||
105850651|NCT01154816|365112562|FG002|Overall Study|Progressive Disease|9|||
105850652|NCT01154816|365112563|FG003|Overall Study|Progressive Disease|9|||
105850653|NCT01154816|365112564|FG004|Overall Study|Progressive Disease|8|||
105850654|NCT01154816|365112565|FG005|Overall Study|Progressive Disease|8|||
105850655|NCT01154816|365112566|FG006|Overall Study|Progressive Disease|5|||
105850656|NCT01154816|365112567|FG007|Overall Study|Progressive Disease|6|||
106027286|NCT00797966|365764672|FG002|Phase A|Met withdrawal criteria|0|||
106027287|NCT00797966|365764673|FG003|Phase A|Met withdrawal criteria|0|||
106027288|NCT00797966|365764674|FG004|Phase A|Met withdrawal criteria|4|||
106027289|NCT00797966|365764675|FG005|Phase A|Met withdrawal criteria|0|||
106027290|NCT00797966|365764670|FG000|Phase A|Physician Decision|0|||
106027291|NCT00797966|365764671|FG001|Phase A|Physician Decision|0|||
106027292|NCT00797966|365764672|FG002|Phase A|Physician Decision|0|||
106027293|NCT00797966|365764673|FG003|Phase A|Physician Decision|0|||
106027294|NCT00797966|365764674|FG004|Phase A|Physician Decision|13|||
106027295|NCT00797966|365764675|FG005|Phase A|Physician Decision|0|||
106027296|NCT00797966|365764670|FG000|Phase A|Withdrawal by Subject|0|||
106027297|NCT00797966|365764671|FG001|Phase A|Withdrawal by Subject|0|||
106027298|NCT00797966|365764672|FG002|Phase A|Withdrawal by Subject|0|||
106027299|NCT00797966|365764673|FG003|Phase A|Withdrawal by Subject|0|||
106027300|NCT00797966|365764674|FG004|Phase A|Withdrawal by Subject|33|||
106027301|NCT00797966|365764675|FG005|Phase A|Withdrawal by Subject|0|||
106027302|NCT00797966|365764670|FG000|Phase A|Protocol deviation|0|||
106027303|NCT00797966|365764671|FG001|Phase A|Protocol deviation|0|||
106027304|NCT00797966|365764672|FG002|Phase A|Protocol deviation|0|||
106027305|NCT00797966|365764673|FG003|Phase A|Protocol deviation|0|||
106027306|NCT00797966|365764674|FG004|Phase A|Protocol deviation|56|||
106027307|NCT00797966|365764675|FG005|Phase A|Protocol deviation|0|||
106027308|NCT00797966|365764670|FG000|Phase B|Lost to Follow-up|0|||
106027309|NCT00797966|365764671|FG001|Phase B|Lost to Follow-up|1|||
106027310|NCT00797966|365764672|FG002|Phase B|Lost to Follow-up|3|||
106027311|NCT00797966|365764673|FG003|Phase B|Lost to Follow-up|0|||
106027312|NCT00797966|365764674|FG004|Phase B|Lost to Follow-up|0|||
106027313|NCT00797966|365764675|FG005|Phase B|Lost to Follow-up|0|||
106027314|NCT00797966|365764670|FG000|Phase B|Adverse Event|2|||
106027315|NCT00797966|365764671|FG001|Phase B|Adverse Event|1|||
106027316|NCT00797966|365764672|FG002|Phase B|Adverse Event|3|||
106027317|NCT00797966|365764673|FG003|Phase B|Adverse Event|1|||
106027318|NCT00797966|365764674|FG004|Phase B|Adverse Event|0|||
106027319|NCT00797966|365764675|FG005|Phase B|Adverse Event|0|||
105850657|NCT01154816|365112568|FG008|Overall Study|Progressive Disease|8|||
105850658|NCT01154816|365112569|FG009|Overall Study|Progressive Disease|6|||
106027320|NCT00797966|365764670|FG000|Phase B|Met Withdrawal Criteria|3|||
106027321|NCT00797966|365764671|FG001|Phase B|Met Withdrawal Criteria|3|||
106027322|NCT00797966|365764672|FG002|Phase B|Met Withdrawal Criteria|6|||
105850659|NCT01154816|365112570|FG010|Overall Study|Progressive Disease|10|||
105850660|NCT01154816|365112571|FG011|Overall Study|Progressive Disease|3|||
106027323|NCT00797966|365764673|FG003|Phase B|Met Withdrawal Criteria|1|||
106027324|NCT00797966|365764674|FG004|Phase B|Met Withdrawal Criteria|0|||
106027325|NCT00797966|365764675|FG005|Phase B|Met Withdrawal Criteria|0|||
106027326|NCT00797966|365764670|FG000|Phase B|Physician Decision|1|||
105850661|NCT01154816|365112560|FG000|Overall Study|Physician Decision|1|||
105850662|NCT01154816|365112561|FG001|Overall Study|Physician Decision|0|||
106027327|NCT00797966|365764671|FG001|Phase B|Physician Decision|0|||
106027328|NCT00797966|365764672|FG002|Phase B|Physician Decision|3|||
106027329|NCT00797966|365764673|FG003|Phase B|Physician Decision|1|||
106027330|NCT00797966|365764674|FG004|Phase B|Physician Decision|0|||
106027331|NCT00797966|365764675|FG005|Phase B|Physician Decision|0|||
105976292|NCT00343915|365573766|FG000|Primary Study|Other|1|||
105976293|NCT00343915|365573767|FG001|Primary Study|Other|0|||
105976294|NCT01344629|365573770|FG000|Crossover Period 2|Withdrawal by Subject|0|||
105976295|NCT01344629|365573771|FG001|Crossover Period 2|Withdrawal by Subject|1|||
105976296|NCT02370095|365573772|FG000|Overall Study|Withdrawal by Subject|0|||
105976297|NCT02370095|365573773|FG001|Overall Study|Withdrawal by Subject|1|||
105976298|NCT01133275|365573774|FG000|Overall Study|Withdrawal by Subject|1|||
105976299|NCT01133275|365573774|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
105976300|NCT00700102|365573775|FG000|Overall Study|Died|394|||
105976301|NCT00700102|365573776|FG001|Overall Study|Died|385|||
105976302|NCT00700102|365573775|FG000|Overall Study|Lost to Follow-up|8|||
105976303|NCT00700102|365573776|FG001|Overall Study|Lost to Follow-up|10|||
105976304|NCT01667562|365573781|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
105976305|NCT01667562|365573782|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
105976306|NCT01667562|365573781|FG000|Erlotinib Phase|Lost to Follow-up|0|||
106027332|NCT00797966|365764670|FG000|Phase B|Withdrawal by Subject|1|||
106027333|NCT00797966|365764671|FG001|Phase B|Withdrawal by Subject|4|||
106027334|NCT00797966|365764672|FG002|Phase B|Withdrawal by Subject|3|||
106027335|NCT00797966|365764673|FG003|Phase B|Withdrawal by Subject|3|||
106027336|NCT00797966|365764674|FG004|Phase B|Withdrawal by Subject|0|||
106027337|NCT00797966|365764675|FG005|Phase B|Withdrawal by Subject|0|||
106027338|NCT00797966|365764670|FG000|Phase B|Protocol Deviation|4|||
106027339|NCT00797966|365764671|FG001|Phase B|Protocol Deviation|8|||
106027340|NCT00797966|365764672|FG002|Phase B|Protocol Deviation|2|||
106027341|NCT00797966|365764673|FG003|Phase B|Protocol Deviation|6|||
106027342|NCT00797966|365764674|FG004|Phase B|Protocol Deviation|0|||
106027343|NCT00797966|365764675|FG005|Phase B|Protocol Deviation|0|||
106027344|NCT00797966|365764670|FG000|Phase B|Lack of Efficacy|0|||
106027345|NCT00797966|365764671|FG001|Phase B|Lack of Efficacy|1|||
106027346|NCT00797966|365764672|FG002|Phase B|Lack of Efficacy|1|||
106027347|NCT00797966|365764673|FG003|Phase B|Lack of Efficacy|4|||
106027348|NCT00797966|365764674|FG004|Phase B|Lack of Efficacy|0|||
106027349|NCT00797966|365764675|FG005|Phase B|Lack of Efficacy|0|||
106027350|NCT00797966|365764670|FG000|Phase A+|Lost to Follow-up|0|||
106027351|NCT00797966|365764671|FG001|Phase A+|Lost to Follow-up|0|||
106027352|NCT00797966|365764672|FG002|Phase A+|Lost to Follow-up|0|||
106027353|NCT00797966|365764673|FG003|Phase A+|Lost to Follow-up|0|||
106027354|NCT00797966|365764674|FG004|Phase A+|Lost to Follow-up|0|||
106027355|NCT00797966|365764675|FG005|Phase A+|Lost to Follow-up|9|||
106027356|NCT00797966|365764670|FG000|Phase A+|Met withdrawal criteria|0|||
106027357|NCT00797966|365764671|FG001|Phase A+|Met withdrawal criteria|0|||
106027358|NCT00797966|365764672|FG002|Phase A+|Met withdrawal criteria|0|||
106027359|NCT00797966|365764673|FG003|Phase A+|Met withdrawal criteria|0|||
106027360|NCT00797966|365764674|FG004|Phase A+|Met withdrawal criteria|0|||
106027361|NCT00797966|365764675|FG005|Phase A+|Met withdrawal criteria|5|||
106027362|NCT00797966|365764670|FG000|Phase A+|Withdrawal by Subject|0|||
106027363|NCT00797966|365764671|FG001|Phase A+|Withdrawal by Subject|0|||
106027364|NCT00797966|365764672|FG002|Phase A+|Withdrawal by Subject|0|||
106027365|NCT00797966|365764673|FG003|Phase A+|Withdrawal by Subject|0|||
106027366|NCT00797966|365764674|FG004|Phase A+|Withdrawal by Subject|0|||
106027367|NCT00797966|365764675|FG005|Phase A+|Withdrawal by Subject|6|||
106027368|NCT00797966|365764670|FG000|Phase A+|Adverse Event|0|||
106027369|NCT00797966|365764671|FG001|Phase A+|Adverse Event|0|||
106027370|NCT00797966|365764672|FG002|Phase A+|Adverse Event|0|||
106027371|NCT00797966|365764673|FG003|Phase A+|Adverse Event|0|||
106150750|NCT02576509|366215042|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
105976307|NCT01667562|365573782|FG001|Erlotinib Phase|Lost to Follow-up|1|||
105976308|NCT01667562|365573781|FG000|Erlotinib Phase|Adverse Event|0|||
105976309|NCT01667562|365573782|FG001|Erlotinib Phase|Adverse Event|1|||
106027372|NCT00797966|365764674|FG004|Phase A+|Adverse Event|0|||
106027373|NCT00797966|365764675|FG005|Phase A+|Adverse Event|4|||
106027374|NCT00797966|365764670|FG000|Phase A+|Protocol deviation|0|||
106027375|NCT00797966|365764671|FG001|Phase A+|Protocol deviation|0|||
106027376|NCT00797966|365764672|FG002|Phase A+|Protocol deviation|0|||
106027377|NCT00797966|365764673|FG003|Phase A+|Protocol deviation|0|||
106027378|NCT00797966|365764674|FG004|Phase A+|Protocol deviation|0|||
106027379|NCT00797966|365764675|FG005|Phase A+|Protocol deviation|4|||
106027380|NCT00640224|365764676|FG000|Overall Study|Lost to Follow-up|5|||
105976310|NCT01667562|365573781|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
106027381|NCT00640224|365764677|FG001|Overall Study|Lost to Follow-up|2|||
106027382|NCT00640224|365764678|FG002|Overall Study|Lost to Follow-up|0|||
106027383|NCT00640224|365764679|FG003|Overall Study|Lost to Follow-up|0|||
106027384|NCT00640224|365764676|FG000|Overall Study|Withdrawal by Subject|1|||
105976311|NCT01667562|365573782|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
105976312|NCT01028716|365573783|FG000|Overall Study|Physician Decision|1|||
106027385|NCT00640224|365764677|FG001|Overall Study|Withdrawal by Subject|0|||
106027386|NCT00640224|365764678|FG002|Overall Study|Withdrawal by Subject|0|||
106027387|NCT00640224|365764679|FG003|Overall Study|Withdrawal by Subject|0|||
106027388|NCT00640224|365764676|FG000|Overall Study|Headaches|0|||
106027389|NCT00640224|365764677|FG001|Overall Study|Headaches|1|||
106027390|NCT00640224|365764678|FG002|Overall Study|Headaches|0|||
106150751|NCT02576509|366215043|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
106150752|NCT02576509|366215042|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
106150753|NCT02576509|366215043|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
106150754|NCT02576509|366215042|FG000|Treatment Period|Disease progression|263|||
106150755|NCT02576509|366215043|FG001|Treatment Period|Disease progression|244|||
106150756|NCT02576509|366215042|FG000|Treatment Period|Study drug toxicity|37|||
106150757|NCT02576509|366215043|FG001|Treatment Period|Study drug toxicity|41|||
106150758|NCT02576509|366215042|FG000|Treatment Period|Death|1|||
106150759|NCT02576509|366215043|FG001|Treatment Period|Death|1|||
106150760|NCT02576509|366215042|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
106150761|NCT02576509|366215043|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
105850663|NCT01154816|365112562|FG002|Overall Study|Physician Decision|1|||
105850664|NCT01154816|365112563|FG003|Overall Study|Physician Decision|0|||
105850665|NCT01154816|365112564|FG004|Overall Study|Physician Decision|2|||
105850666|NCT01154816|365112565|FG005|Overall Study|Physician Decision|0|||
105850667|NCT01154816|365112566|FG006|Overall Study|Physician Decision|0|||
105850668|NCT01154816|365112567|FG007|Overall Study|Physician Decision|0|||
105850669|NCT01154816|365112568|FG008|Overall Study|Physician Decision|0|||
105850670|NCT01154816|365112569|FG009|Overall Study|Physician Decision|1|||
105850671|NCT01154816|365112570|FG010|Overall Study|Physician Decision|1|||
105850672|NCT01154816|365112571|FG011|Overall Study|Physician Decision|1|||
105850673|NCT01154816|365112560|FG000|Overall Study|Adverse Event|5|||
105850674|NCT01154816|365112561|FG001|Overall Study|Adverse Event|2|||
105850675|NCT01154816|365112562|FG002|Overall Study|Adverse Event|0|||
105850676|NCT01154816|365112563|FG003|Overall Study|Adverse Event|0|||
106027391|NCT00640224|365764679|FG003|Overall Study|Headaches|0|||
106027392|NCT02937584|365764685|FG000|Period 1|Adverse Event|1|||
106027393|NCT02937584|365764686|FG001|Period 1|Adverse Event|2|||
106027394|NCT02937584|365764685|FG000|Washout|Adverse Event|0|||
106027395|NCT02937584|365764686|FG001|Washout|Adverse Event|1|||
106027396|NCT01883453|365764687|FG000|Overall Study|No episode of common cold|25|||
105850677|NCT01154816|365112564|FG004|Overall Study|Adverse Event|0|||
105850678|NCT01154816|365112565|FG005|Overall Study|Adverse Event|0|||
105850679|NCT01154816|365112566|FG006|Overall Study|Adverse Event|1|||
105850680|NCT01154816|365112567|FG007|Overall Study|Adverse Event|1|||
105850681|NCT01154816|365112568|FG008|Overall Study|Adverse Event|0|||
105850682|NCT01154816|365112569|FG009|Overall Study|Adverse Event|0|||
105850683|NCT01154816|365112570|FG010|Overall Study|Adverse Event|0|||
105850684|NCT01154816|365112571|FG011|Overall Study|Adverse Event|0|||
105850685|NCT00801099|365112572|FG000|Overall Study|Lost to Follow-up|101|||
105850686|NCT02534844|365112573|FG000|Part B|Withdrawal by Subject|0|||
105850687|NCT02534844|365112574|FG001|Part B|Withdrawal by Subject|0|||
105850688|NCT02534844|365112575|FG002|Part B|Withdrawal by Subject|0|||
105850689|NCT02534844|365112576|FG003|Part B|Withdrawal by Subject|0|||
105850690|NCT02534844|365112577|FG004|Part B|Withdrawal by Subject|2|||
105850691|NCT02534844|365112578|FG005|Part B|Withdrawal by Subject|1|||
105850692|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
106027397|NCT01883453|365764688|FG001|Overall Study|No episode of common cold|23|||
106027398|NCT01024309|365764689|FG000|Overall Study|Physician Decision|4|||
106027399|NCT01024309|365764690|FG001|Overall Study|Physician Decision|0|||
106027400|NCT01024309|365764689|FG000|Overall Study|Withdrawal by Subject|4|||
106027401|NCT01024309|365764690|FG001|Overall Study|Withdrawal by Subject|4|||
106027402|NCT02745145|365764691|FG000|Overall Study|Adverse Event|1|||
106027403|NCT02745145|365764692|FG001|Overall Study|Adverse Event|0|||
106027404|NCT02745145|365764693|FG002|Overall Study|Adverse Event|0|||
106027405|NCT02745145|365764691|FG000|Overall Study|Death|0|||
106027406|NCT02745145|365764692|FG001|Overall Study|Death|1|||
106027407|NCT02745145|365764693|FG002|Overall Study|Death|0|||
106027408|NCT02745145|365764691|FG000|Overall Study|Progressive disease|0|||
106027409|NCT02745145|365764692|FG001|Overall Study|Progressive disease|0|||
106027410|NCT02745145|365764693|FG002|Overall Study|Progressive disease|1|||
106027411|NCT02745145|365764691|FG000|Overall Study|Withdrew consent|1|||
106027412|NCT02745145|365764692|FG001|Overall Study|Withdrew consent|1|||
106027413|NCT02745145|365764693|FG002|Overall Study|Withdrew consent|1|||
106027414|NCT02745145|365764691|FG000|Overall Study|Study Termination|8|||
106027415|NCT02745145|365764692|FG001|Overall Study|Study Termination|3|||
106027416|NCT02745145|365764693|FG002|Overall Study|Study Termination|7|||
106027417|NCT02238067|365764694|FG000|Overall Study|Not completed survey at Month 6|45|||
106027418|NCT01853839|365764696|FG000|Overall Study|Violated inclusion criteria|2|||
106027419|NCT01853839|365764696|FG000|Overall Study|Not meet ITT population definition|58|||
105850693|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
105850694|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850695|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850696|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
106027420|NCT01853839|365764696|FG000|Overall Study|End of treatment visit too early|33|||
106027421|NCT01853839|365764696|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
106027422|NCT00280748|365764699|FG000|Overall Study|Decline in performance|3|||
106150762|NCT02576509|366215042|FG000|Treatment Period|Participant request to stop treatment|8|||
105976313|NCT05590000|365573784|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
105976314|NCT00536874|365573785|FG000|Overall Study|Adverse Event|1|||
105976315|NCT00536874|365573785|FG000|Overall Study|Death|2|||
105976316|NCT00536874|365573785|FG000|Overall Study|Withdrawal by Subject|1|||
106150763|NCT02576509|366215043|FG001|Treatment Period|Participant request to stop treatment|18|||
106150764|NCT02576509|366215042|FG000|Treatment Period|Participant withdrew consent|3|||
105976317|NCT00434759|365573787|FG000|Overall Study|Lack of Efficacy|5|||
105976318|NCT00434759|365573788|FG001|Overall Study|Lack of Efficacy|4|||
105976319|NCT00434759|365573787|FG000|Overall Study|Withdrawal by Subject|17|||
105976320|NCT00434759|365573788|FG001|Overall Study|Withdrawal by Subject|1|||
105976321|NCT00434759|365573787|FG000|Overall Study|family affairs|2|||
105976322|NCT00434759|365573788|FG001|Overall Study|family affairs|0|||
105976323|NCT00624780|365573800|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
105976324|NCT00624780|365573801|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
105976325|NCT00624780|365573802|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
105976326|NCT00624780|365573803|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
105976327|NCT00624780|365573804|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
105976328|NCT00624780|365573805|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
105976329|NCT00624780|365573800|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
105976330|NCT00624780|365573801|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
105976331|NCT00624780|365573802|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
105976332|NCT00624780|365573803|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
105976333|NCT00624780|365573804|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
105976334|NCT00624780|365573805|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
105976335|NCT00624780|365573800|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
105976336|NCT00624780|365573801|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
105976337|NCT00624780|365573802|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
105976338|NCT00624780|365573803|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
105976339|NCT00624780|365573804|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
105976340|NCT00624780|365573805|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
105976341|NCT00624780|365573800|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
105976342|NCT00624780|365573801|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
105976343|NCT00624780|365573802|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
105976344|NCT00624780|365573803|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
105976345|NCT00624780|365573804|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
105976346|NCT00624780|365573805|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
105976347|NCT00624780|365573800|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
105976348|NCT00624780|365573801|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
105976349|NCT00624780|365573802|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
105976350|NCT00624780|365573803|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
105976351|NCT00624780|365573804|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
105976352|NCT00624780|365573805|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
105976353|NCT00624780|365573800|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
105976354|NCT00624780|365573801|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
105976355|NCT00624780|365573802|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
105976356|NCT00624780|365573803|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
105976357|NCT00624780|365573804|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
105976358|NCT00624780|365573805|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
105976359|NCT00624780|365573800|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
105976360|NCT00624780|365573801|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
105976361|NCT00624780|365573802|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
105976362|NCT00624780|365573803|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
105976363|NCT00624780|365573804|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
105976364|NCT00624780|365573805|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
105976365|NCT00624780|365573800|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
105976366|NCT00624780|365573801|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
105976367|NCT00624780|365573802|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
105976368|NCT00624780|365573803|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
105976369|NCT00624780|365573804|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
105976370|NCT00624780|365573805|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
105976371|NCT00624780|365573800|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
105976372|NCT00624780|365573801|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
105976373|NCT00624780|365573802|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
106150765|NCT02576509|366215043|FG001|Treatment Period|Participant withdrew consent|7|||
106150766|NCT02576509|366215042|FG000|Treatment Period|Lost to Follow-up|0|||
105976374|NCT00624780|365573803|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
106150767|NCT02576509|366215043|FG001|Treatment Period|Lost to Follow-up|1|||
106150768|NCT02576509|366215042|FG000|Treatment Period|Maximum clinical benefit|1|||
105976375|NCT00624780|365573804|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
105976376|NCT00624780|365573805|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
105976377|NCT00624780|365573800|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
105976378|NCT00624780|365573801|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
105976379|NCT00624780|365573802|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
105976380|NCT00624780|365573803|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
105976381|NCT00624780|365573804|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
105976382|NCT00624780|365573805|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
105976383|NCT00624780|365573800|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
105976384|NCT00624780|365573801|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
105976385|NCT00624780|365573802|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
105976386|NCT00624780|365573803|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
105976387|NCT00624780|365573804|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
105976388|NCT00624780|365573805|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
105976389|NCT00624780|365573800|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
105976390|NCT00624780|365573801|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105976391|NCT00624780|365573802|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105976392|NCT00624780|365573803|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105976393|NCT00624780|365573804|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105976394|NCT00624780|365573805|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
105976395|NCT00624780|365573800|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105976396|NCT00624780|365573801|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105976397|NCT00624780|365573802|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
105976398|NCT00624780|365573803|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105976399|NCT00624780|365573804|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105976400|NCT00624780|365573805|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
105976401|NCT00624780|365573800|FG000|Follow-up (Week 26)|Death|0|||
105976402|NCT00624780|365573801|FG001|Follow-up (Week 26)|Death|0|||
105976403|NCT00624780|365573802|FG002|Follow-up (Week 26)|Death|1|||
105976404|NCT00624780|365573803|FG003|Follow-up (Week 26)|Death|0|||
105976405|NCT00624780|365573804|FG004|Follow-up (Week 26)|Death|0|||
105976406|NCT00624780|365573805|FG005|Follow-up (Week 26)|Death|0|||
105976407|NCT00624780|365573800|FG000|Follow-up (Week 26)|Adverse Event|0|||
105976408|NCT00624780|365573801|FG001|Follow-up (Week 26)|Adverse Event|0|||
105976409|NCT00624780|365573802|FG002|Follow-up (Week 26)|Adverse Event|0|||
105976410|NCT00624780|365573803|FG003|Follow-up (Week 26)|Adverse Event|0|||
105976411|NCT00624780|365573804|FG004|Follow-up (Week 26)|Adverse Event|1|||
105976412|NCT00624780|365573805|FG005|Follow-up (Week 26)|Adverse Event|0|||
105976413|NCT00624780|365573800|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
105976414|NCT00624780|365573801|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
105976415|NCT00624780|365573802|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
105976416|NCT00624780|365573803|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
105976417|NCT00624780|365573804|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
105976418|NCT00624780|365573805|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
105976419|NCT00624780|365573800|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
105976420|NCT00624780|365573801|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
105976421|NCT00624780|365573802|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
105976422|NCT00624780|365573803|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
105976423|NCT00624780|365573804|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
105976424|NCT00624780|365573805|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
105976425|NCT00624780|365573800|FG000|Follow-up (Week 26)|Other|1|||
105976426|NCT00624780|365573801|FG001|Follow-up (Week 26)|Other|1|||
105976427|NCT00624780|365573802|FG002|Follow-up (Week 26)|Other|0|||
105976428|NCT00624780|365573803|FG003|Follow-up (Week 26)|Other|0|||
105976429|NCT00624780|365573804|FG004|Follow-up (Week 26)|Other|0|||
105976430|NCT00624780|365573805|FG005|Follow-up (Week 26)|Other|0|||
105976431|NCT01515475|365573806|FG000|Overall Study|Lost to Follow-up|20|||
105976432|NCT01515475|365573807|FG001|Overall Study|Lost to Follow-up|15|||
105976433|NCT01515475|365573808|FG002|Overall Study|Lost to Follow-up|12|||
105976434|NCT01515475|365573809|FG003|Overall Study|Lost to Follow-up|12|||
105976435|NCT01100567|365573819|FG000|Overall Study|Withdrawal by Subject|5|||
105976436|NCT01100567|365573820|FG001|Overall Study|Withdrawal by Subject|8|||
105976437|NCT01100567|365573819|FG000|Overall Study|Early Hospital Discharge|6|||
105976438|NCT01100567|365573820|FG001|Overall Study|Early Hospital Discharge|4|||
105976439|NCT01100567|365573819|FG000|Overall Study|Lost to Follow-up|1|||
105976440|NCT01100567|365573820|FG001|Overall Study|Lost to Follow-up|2|||
105976441|NCT01100567|365573819|FG000|Overall Study|Physician Decision|0|||
105976442|NCT01100567|365573820|FG001|Overall Study|Physician Decision|1|||
105976443|NCT01100567|365573819|FG000|Overall Study|Deemed ineligible after consent|0|||
105976444|NCT01100567|365573820|FG001|Overall Study|Deemed ineligible after consent|1|||
105976445|NCT01498185|365573822|FG000|Overall Study|Adverse Event|0|||
105976446|NCT01498185|365573823|FG001|Overall Study|Adverse Event|0|||
105976447|NCT01498185|365573824|FG002|Overall Study|Adverse Event|0|||
105976448|NCT01498185|365573825|FG003|Overall Study|Adverse Event|1|||
105976449|NCT01498185|365573826|FG004|Overall Study|Adverse Event|0|||
105976450|NCT01498185|365573822|FG000|Overall Study|Withdrawal by Subject|1|||
105976451|NCT01498185|365573823|FG001|Overall Study|Withdrawal by Subject|1|||
105976452|NCT01498185|365573824|FG002|Overall Study|Withdrawal by Subject|0|||
105976453|NCT01498185|365573825|FG003|Overall Study|Withdrawal by Subject|2|||
105976454|NCT01498185|365573826|FG004|Overall Study|Withdrawal by Subject|1|||
105976455|NCT01498185|365573822|FG000|Overall Study|No longer met criteria, etc|0|||
105976456|NCT01498185|365573823|FG001|Overall Study|No longer met criteria, etc|0|||
105976457|NCT01498185|365573824|FG002|Overall Study|No longer met criteria, etc|0|||
105976458|NCT01498185|365573825|FG003|Overall Study|No longer met criteria, etc|0|||
105976459|NCT01498185|365573826|FG004|Overall Study|No longer met criteria, etc|2|||
105976460|NCT00946322|365573827|FG000|Pre-treatment|participant failure to follow up|1|||
105976461|NCT00946322|365573827|FG000|Post-treatment|participant failure to follow up|2|||
105976462|NCT02153346|365573828|FG000|Overall Study|Lost to Follow-up|11|||
105976463|NCT00758589|365575424|FG000|Overall Study|Adverse Event|3|||
105976464|NCT00758589|365575425|FG001|Overall Study|Adverse Event|2|||
105976465|NCT00758589|365575426|FG002|Overall Study|Adverse Event|5|||
105976466|NCT00758589|365575427|FG003|Overall Study|Adverse Event|4|||
105976467|NCT00758589|365575424|FG000|Overall Study|Withdrawal by Subject|0|||
105976468|NCT00758589|365575425|FG001|Overall Study|Withdrawal by Subject|1|||
105976469|NCT00758589|365575426|FG002|Overall Study|Withdrawal by Subject|1|||
105976470|NCT00758589|365575427|FG003|Overall Study|Withdrawal by Subject|1|||
105976471|NCT00758589|365575424|FG000|Overall Study|Palm stopped to work|0|||
105976472|NCT00758589|365575425|FG001|Overall Study|Palm stopped to work|0|||
105976473|NCT00758589|365575426|FG002|Overall Study|Palm stopped to work|0|||
105976474|NCT00758589|365575427|FG003|Overall Study|Palm stopped to work|1|||
105976475|NCT01350115|365575429|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
105976476|NCT01350115|365575430|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
105976477|NCT01350115|365575429|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
105976478|NCT01350115|365575430|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
105976479|NCT01350115|365575429|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
105976480|NCT01350115|365575430|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
105976481|NCT01103063|365575431|FG000|Overall Study|Adverse Event|3|||
105976482|NCT01103063|365575432|FG001|Overall Study|Adverse Event|1|||
105976483|NCT01103063|365575431|FG000|Overall Study|Lost to Follow-up|68|||
105976484|NCT01103063|365575432|FG001|Overall Study|Lost to Follow-up|51|||
105976485|NCT01103063|365575431|FG000|Overall Study|Withdrawal by Subject|60|||
105976486|NCT01103063|365575432|FG001|Overall Study|Withdrawal by Subject|15|||
105976487|NCT01103063|365575431|FG000|Overall Study|Other|16|||
105976488|NCT01103063|365575432|FG001|Overall Study|Other|11|||
105976489|NCT01103063|365575431|FG000|Overall Study|Protocol Violation|1|||
105976490|NCT01103063|365575432|FG001|Overall Study|Protocol Violation|0|||
105976491|NCT01103063|365575431|FG000|Overall Study|Study terminated by Sponsor|326|||
105976492|NCT01103063|365575432|FG001|Overall Study|Study terminated by Sponsor|342|||
105976493|NCT01103063|365575431|FG000|Overall Study|Death|3|||
105976494|NCT01103063|365575432|FG001|Overall Study|Death|1|||
105976495|NCT05320393|365575433|FG000|Overall Study|Withdrawal by Subject|1|||
105976496|NCT05320393|365575434|FG001|Overall Study|Withdrawal by Subject|0|||
105976497|NCT05320393|365575435|FG002|Overall Study|Withdrawal by Subject|2|||
105976498|NCT05320393|365575433|FG000|Overall Study|Lost to Follow-up|1|||
105976499|NCT05320393|365575434|FG001|Overall Study|Lost to Follow-up|2|||
105976500|NCT05320393|365575435|FG002|Overall Study|Lost to Follow-up|1|||
105976501|NCT05320393|365575433|FG000|Overall Study|Moved; too much driving|0|||
105976502|NCT05320393|365575434|FG001|Overall Study|Moved; too much driving|0|||
105976503|NCT05320393|365575435|FG002|Overall Study|Moved; too much driving|2|||
105976504|NCT05320393|365575433|FG000|Overall Study|Did not receive treatment|0|||
105976505|NCT05320393|365575434|FG001|Overall Study|Did not receive treatment|0|||
105976506|NCT05320393|365575435|FG002|Overall Study|Did not receive treatment|1|||
105976507|NCT01187446|365575436|FG000|Overall Study|Patient started non-protocol therapy|0|||
105976508|NCT01187446|365575437|FG001|Overall Study|Patient started non-protocol therapy|1|||
106027423|NCT00280748|365764699|FG000|Overall Study|Extra-cranial disease progression|1|||
106027424|NCT00946985|365764700|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
106027425|NCT00946985|365764700|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
106027426|NCT00946985|365764700|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
106027427|NCT00946985|365764700|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
105976509|NCT00623545|365575438|FG000|Overall Study|Adverse Event|6|||
105976510|NCT00623545|365575438|FG000|Overall Study|Withdrawal by Subject|4|||
105976511|NCT01974752|365575440|FG000|Overall Study|Death|33|||
105976512|NCT01974752|365575441|FG001|Overall Study|Death|11|||
105976513|NCT01974752|365575440|FG000|Overall Study|Lost to Follow-up|2|||
105976514|NCT01974752|365575441|FG001|Overall Study|Lost to Follow-up|0|||
105976515|NCT01974752|365575440|FG000|Overall Study|Withdrawal by Subject|2|||
105976516|NCT01974752|365575441|FG001|Overall Study|Withdrawal by Subject|3|||
105976517|NCT01974752|365575440|FG000|Overall Study|Other Eligibility Criteria|0|||
106027428|NCT00946985|365764700|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
105976518|NCT01974752|365575441|FG001|Overall Study|Other Eligibility Criteria|1|||
105976519|NCT00330928|365575444|FG000|Overall Study|Lost to Follow-up|6|||
106150769|NCT02576509|366215043|FG001|Treatment Period|Maximum clinical benefit|0|||
106150770|NCT02576509|366215042|FG000|Treatment Period|Poor/non-compliance|1|||
106150771|NCT02576509|366215043|FG001|Treatment Period|Poor/non-compliance|1|||
106150772|NCT02576509|366215042|FG000|Treatment Period|Participant no longer meets criteria|1|||
106150773|NCT02576509|366215043|FG001|Treatment Period|Participant no longer meets criteria|0|||
106150774|NCT02576509|366215042|FG000|Treatment Period|Other reason|12|||
106150775|NCT02576509|366215043|FG001|Treatment Period|Other reason|8|||
106150776|NCT02576509|366215042|FG000|Treatment Period|NOT REPORTED|1|||
105976520|NCT00330928|365575444|FG000|Overall Study|Physician Decision|9|||
105976521|NCT00330928|365575444|FG000|Overall Study|Death|1|||
105976522|NCT00330928|365575444|FG000|Overall Study|IVUS could not be performed.|1|||
105976523|NCT03541187|365575449|FG000|Overall Study|Lost to Follow-up|2|||
105976524|NCT03541187|365575450|FG001|Overall Study|Lost to Follow-up|6|||
105976525|NCT03541187|365575449|FG000|Overall Study|Pregnancy|0|||
105976526|NCT03541187|365575450|FG001|Overall Study|Pregnancy|1|||
105976527|NCT03541187|365575449|FG000|Overall Study|Withdrawal by Subject|6|||
105976528|NCT03541187|365575450|FG001|Overall Study|Withdrawal by Subject|2|||
105976529|NCT03541187|365575449|FG000|Overall Study|Moved out of town|1|||
105976530|NCT03541187|365575450|FG001|Overall Study|Moved out of town|0|||
105976531|NCT03541187|365575449|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
105976532|NCT03541187|365575450|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
105976533|NCT03541187|365575449|FG000|Overall Study|Did not meet randomization criteria|1|||
105976534|NCT03541187|365575450|FG001|Overall Study|Did not meet randomization criteria|1|||
105976535|NCT03541187|365575449|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
105976536|NCT03541187|365575450|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
105976537|NCT03541187|365575449|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
105976538|NCT03541187|365575450|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
105976539|NCT01369680|365575451|FG000|Overall Study|Lost to Follow-up|0|||
105976540|NCT01369680|365575452|FG001|Overall Study|Lost to Follow-up|0|||
105976541|NCT01369680|365575453|FG002|Overall Study|Lost to Follow-up|1|||
105976542|NCT01369680|365575454|FG003|Overall Study|Lost to Follow-up|2|||
105976543|NCT02088073|365575456|FG000|Acute Phase|Withdrawal by Subject|5|||
105976544|NCT02088073|365575457|FG001|Acute Phase|Withdrawal by Subject|0|||
105976545|NCT02088073|365575458|FG002|Acute Phase|Withdrawal by Subject|0|||
105976546|NCT02088073|365575459|FG003|Acute Phase|Withdrawal by Subject|0|||
105976547|NCT02088073|365575460|FG004|Acute Phase|Withdrawal by Subject|0|||
105976548|NCT02088073|365575456|FG000|Acute Phase|Hyperkalemia|2|||
105976549|NCT02088073|365575457|FG001|Acute Phase|Hyperkalemia|0|||
105976550|NCT02088073|365575458|FG002|Acute Phase|Hyperkalemia|0|||
105976551|NCT02088073|365575459|FG003|Acute Phase|Hyperkalemia|0|||
105976552|NCT02088073|365575460|FG004|Acute Phase|Hyperkalemia|0|||
105976553|NCT02088073|365575456|FG000|Maintanance Phase|Withdrawal by Subject|0|||
105976554|NCT02088073|365575457|FG001|Maintanance Phase|Withdrawal by Subject|2|||
106150777|NCT02576509|366215043|FG001|Treatment Period|NOT REPORTED|0|||
106150778|NCT02576509|366215042|FG000|Treatment Period|Administrative reason by sponsor|0|||
106150779|NCT02576509|366215043|FG001|Treatment Period|Administrative reason by sponsor|1|||
106150780|NCT01259401|366215050|FG000|4-month Follow-up|Death|0|||
106150781|NCT01259401|366215051|FG001|4-month Follow-up|Death|1|||
105850697|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
105850698|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
105976555|NCT02088073|365575458|FG002|Maintanance Phase|Withdrawal by Subject|0|||
105976556|NCT02088073|365575459|FG003|Maintanance Phase|Withdrawal by Subject|0|||
105850699|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850700|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850701|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850702|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850703|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850704|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850705|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105976557|NCT02088073|365575460|FG004|Maintanance Phase|Withdrawal by Subject|0|||
105976558|NCT02088073|365575456|FG000|Maintanance Phase|Adverse Event|0|||
105976559|NCT02088073|365575457|FG001|Maintanance Phase|Adverse Event|0|||
105976560|NCT02088073|365575458|FG002|Maintanance Phase|Adverse Event|3|||
105976561|NCT02088073|365575459|FG003|Maintanance Phase|Adverse Event|0|||
106150782|NCT01259401|366215050|FG000|4-month Follow-up|Lost to Follow-up|0|||
105976562|NCT02088073|365575460|FG004|Maintanance Phase|Adverse Event|1|||
105976563|NCT02088073|365575456|FG000|Maintanance Phase|Physician Decision|0|||
105976564|NCT02088073|365575457|FG001|Maintanance Phase|Physician Decision|0|||
105976565|NCT02088073|365575458|FG002|Maintanance Phase|Physician Decision|0|||
105976566|NCT02088073|365575459|FG003|Maintanance Phase|Physician Decision|0|||
105976567|NCT02088073|365575460|FG004|Maintanance Phase|Physician Decision|1|||
105976568|NCT02088073|365575456|FG000|Maintanance Phase|Sponsor's decision|0|||
106150783|NCT01259401|366215051|FG001|4-month Follow-up|Lost to Follow-up|1|||
105850706|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850707|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850708|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850709|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850710|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850711|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850712|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850713|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850714|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850715|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850716|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
105850717|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850718|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
105850719|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850720|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850721|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850722|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850723|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850724|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850725|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850726|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850727|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850728|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850729|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850730|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850731|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850732|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850733|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850734|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850735|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850736|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850737|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850738|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850739|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
106150784|NCT02652260|366215052|FG000|Base Study|Pregnancy|0|||
106150785|NCT02652260|366215053|FG001|Base Study|Pregnancy|1|||
106150786|NCT02652260|366215052|FG000|Base Study|Withdrawal by Subject|0|||
106150787|NCT02652260|366215053|FG001|Base Study|Withdrawal by Subject|1|||
106150788|NCT02652260|366215052|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
106150789|NCT02652260|366215053|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
106150790|NCT02652260|366215052|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
106150791|NCT02652260|366215053|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
106150792|NCT02652260|366215052|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
106150793|NCT02652260|366215053|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
106150794|NCT02652260|366215052|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
106150795|NCT02652260|366215053|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
106150796|NCT02652260|366215052|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
106150797|NCT02652260|366215053|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
106150798|NCT02652260|366215052|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
106150799|NCT02652260|366215053|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
106150800|NCT02652260|366215052|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
106150801|NCT02652260|366215053|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
106150802|NCT02652260|366215052|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
106150803|NCT02652260|366215053|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
106150804|NCT02652260|366215052|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
106150805|NCT02652260|366215053|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
106150806|NCT02652260|366215052|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
106150807|NCT02652260|366215053|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
106150808|NCT02652260|366215052|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
106150809|NCT02652260|366215053|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
106150810|NCT02652260|366215052|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
106150811|NCT02652260|366215053|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
106150812|NCT02723955|366215054|FG000|Escalation Phase|Death|1|||
106150813|NCT02723955|366215055|FG001|Escalation Phase|Death|1|||
106150814|NCT02723955|366215056|FG002|Escalation Phase|Death|2|||
106150815|NCT02723955|366215057|FG003|Escalation Phase|Death|7|||
106150816|NCT02723955|366215058|FG004|Escalation Phase|Death|18|||
106150817|NCT02723955|366215059|FG005|Escalation Phase|Death|17|||
105976569|NCT02088073|365575457|FG001|Maintanance Phase|Sponsor's decision|2|||
105976570|NCT02088073|365575458|FG002|Maintanance Phase|Sponsor's decision|0|||
105976571|NCT02088073|365575459|FG003|Maintanance Phase|Sponsor's decision|2|||
105976572|NCT02088073|365575460|FG004|Maintanance Phase|Sponsor's decision|1|||
105976573|NCT02088073|365575456|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
105976574|NCT02088073|365575457|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
105976575|NCT02088073|365575458|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
105976576|NCT02088073|365575459|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
105976577|NCT02088073|365575460|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
106027429|NCT00946985|365764700|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
106027430|NCT00946985|365764700|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
106027431|NCT00946985|365764700|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
106027432|NCT00946985|365764700|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
106027433|NCT00171834|365764701|FG000|Overall Study|Adverse Event|2|||
106150818|NCT02723955|366215060|FG006|Escalation Phase|Death|11|||
106150819|NCT02723955|366215061|FG007|Escalation Phase|Death|21|||
106150820|NCT02723955|366215062|FG008|Escalation Phase|Death|3|||
106150821|NCT02723955|366215063|FG009|Escalation Phase|Death|0|||
106150822|NCT02723955|366215064|FG010|Escalation Phase|Death|0|||
106150823|NCT02723955|366215065|FG011|Escalation Phase|Death|0|||
106150824|NCT02723955|366215066|FG012|Escalation Phase|Death|2|||
106150825|NCT02723955|366215067|FG013|Escalation Phase|Death|4|||
106150826|NCT02723955|366215068|FG014|Escalation Phase|Death|5|||
106150827|NCT02723955|366215069|FG015|Escalation Phase|Death|6|||
106150828|NCT02723955|366215070|FG016|Escalation Phase|Death|6|||
106150829|NCT02723955|366215071|FG017|Escalation Phase|Death|7|||
106150830|NCT02723955|366215072|FG018|Escalation Phase|Death|1|||
106150831|NCT02723955|366215073|FG019|Escalation Phase|Death|3|||
106150832|NCT02723955|366215074|FG020|Escalation Phase|Death|13|||
106027434|NCT00171834|365764702|FG001|Overall Study|Adverse Event|1|||
106027435|NCT00171834|365764703|FG002|Overall Study|Adverse Event|3|||
106027436|NCT00171834|365764704|FG003|Overall Study|Adverse Event|2|||
106027437|NCT00171834|365764705|FG004|Overall Study|Adverse Event|2|||
106027438|NCT00171834|365764706|FG005|Overall Study|Adverse Event|15|||
106027439|NCT00171834|365764707|FG006|Overall Study|Adverse Event|1|||
106027440|NCT00171834|365764701|FG000|Overall Study|Withdrawal by Subject|0|||
106027441|NCT00171834|365764702|FG001|Overall Study|Withdrawal by Subject|2|||
106027442|NCT00171834|365764703|FG002|Overall Study|Withdrawal by Subject|0|||
106027443|NCT00171834|365764704|FG003|Overall Study|Withdrawal by Subject|1|||
106027444|NCT00171834|365764705|FG004|Overall Study|Withdrawal by Subject|1|||
106027445|NCT00171834|365764706|FG005|Overall Study|Withdrawal by Subject|1|||
106027446|NCT00171834|365764707|FG006|Overall Study|Withdrawal by Subject|0|||
106027447|NCT00171834|365764701|FG000|Overall Study|Death from study indication|0|||
106027448|NCT00171834|365764702|FG001|Overall Study|Death from study indication|1|||
106027449|NCT00171834|365764703|FG002|Overall Study|Death from study indication|0|||
106027450|NCT00171834|365764704|FG003|Overall Study|Death from study indication|0|||
106027451|NCT00171834|365764705|FG004|Overall Study|Death from study indication|1|||
106027452|NCT00171834|365764706|FG005|Overall Study|Death from study indication|0|||
106027453|NCT00171834|365764707|FG006|Overall Study|Death from study indication|0|||
106027454|NCT00171834|365764701|FG000|Overall Study|Disease Progression|4|||
106027455|NCT00171834|365764702|FG001|Overall Study|Disease Progression|8|||
106027456|NCT00171834|365764703|FG002|Overall Study|Disease Progression|8|||
106150833|NCT02723955|366215075|FG021|Escalation Phase|Death|3|||
105976578|NCT02088073|365575456|FG000|Maintanance Phase|Miscellaneous|0|||
105976579|NCT02088073|365575457|FG001|Maintanance Phase|Miscellaneous|2|||
105976580|NCT02088073|365575458|FG002|Maintanance Phase|Miscellaneous|1|||
105976581|NCT02088073|365575459|FG003|Maintanance Phase|Miscellaneous|2|||
105976582|NCT02088073|365575460|FG004|Maintanance Phase|Miscellaneous|1|||
106027457|NCT00171834|365764704|FG003|Overall Study|Disease Progression|9|||
106027458|NCT00171834|365764705|FG004|Overall Study|Disease Progression|2|||
106027459|NCT00171834|365764706|FG005|Overall Study|Disease Progression|18|||
106027460|NCT00171834|365764707|FG006|Overall Study|Disease Progression|3|||
106027461|NCT00171834|365764701|FG000|Overall Study|Treatment Duration Completed|0|||
106027462|NCT00171834|365764702|FG001|Overall Study|Treatment Duration Completed|0|||
106027463|NCT00171834|365764703|FG002|Overall Study|Treatment Duration Completed|1|||
106027464|NCT00171834|365764704|FG003|Overall Study|Treatment Duration Completed|0|||
106027465|NCT00171834|365764705|FG004|Overall Study|Treatment Duration Completed|2|||
106027466|NCT00171834|365764706|FG005|Overall Study|Treatment Duration Completed|1|||
106027467|NCT00171834|365764707|FG006|Overall Study|Treatment Duration Completed|0|||
106027468|NCT01516034|365764708|FG000|Overall Study|Physician Decision|1|||
106150834|NCT02723955|366215076|FG022|Escalation Phase|Death|2|||
106150835|NCT02723955|366215077|FG023|Escalation Phase|Death|4|||
106150836|NCT02723955|366215078|FG024|Escalation Phase|Death|31|||
106150837|NCT02723955|366215079|FG025|Escalation Phase|Death|7|||
106150838|NCT02723955|366215080|FG026|Escalation Phase|Death|13|||
106150839|NCT02723955|366215081|FG027|Escalation Phase|Death|0|||
106150840|NCT02723955|366215082|FG028|Escalation Phase|Death|1|||
105976583|NCT02088073|365575456|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
106150841|NCT02723955|366215083|FG029|Escalation Phase|Death|0|||
106150842|NCT02723955|366215084|FG030|Escalation Phase|Death|0|||
106150843|NCT02723955|366215085|FG031|Escalation Phase|Death|0|||
106150844|NCT02723955|366215086|FG032|Escalation Phase|Death|0|||
105850740|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850741|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
105850742|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
105850743|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
105850744|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
105850745|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
105850746|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
105850747|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
106150845|NCT02723955|366215087|FG033|Escalation Phase|Death|0|||
106150846|NCT02723955|366215088|FG034|Escalation Phase|Death|0|||
106150847|NCT02723955|366215089|FG035|Escalation Phase|Death|0|||
106150848|NCT02723955|366215090|FG036|Escalation Phase|Death|0|||
106150849|NCT02723955|366215091|FG037|Escalation Phase|Death|0|||
106150850|NCT02723955|366215092|FG038|Escalation Phase|Death|0|||
106150851|NCT02723955|366215093|FG039|Escalation Phase|Death|0|||
106150852|NCT02723955|366215094|FG040|Escalation Phase|Death|0|||
106150853|NCT02723955|366215095|FG041|Escalation Phase|Death|0|||
106150854|NCT02723955|366215096|FG042|Escalation Phase|Death|0|||
106150855|NCT02723955|366215054|FG000|Escalation Phase|Lost to Follow-up|0|||
105850748|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
105850749|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
105850750|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
105850751|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
105850752|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
105850753|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
105850754|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
105850755|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
105850756|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
105850757|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
105850758|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
105850759|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
105850760|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
105850761|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
105850762|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
106150856|NCT02723955|366215055|FG001|Escalation Phase|Lost to Follow-up|0|||
106150857|NCT02723955|366215056|FG002|Escalation Phase|Lost to Follow-up|0|||
105850763|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
106027469|NCT01516034|365764708|FG000|Overall Study|Lack of Efficacy|7|||
106150858|NCT02723955|366215057|FG003|Escalation Phase|Lost to Follow-up|0|||
106150859|NCT02723955|366215058|FG004|Escalation Phase|Lost to Follow-up|0|||
106027470|NCT02929498|365764709|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
106027471|NCT02929498|365764710|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
106027472|NCT02929498|365764711|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
106027473|NCT02929498|365764709|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
106027474|NCT02929498|365764710|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
106027475|NCT02929498|365764711|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
106027476|NCT02744040|365764714|FG000|Overall Study|Withdrawal by Subject|3|||
106027477|NCT02744040|365764715|FG001|Overall Study|Withdrawal by Subject|2|||
106027478|NCT02744040|365764716|FG002|Overall Study|Withdrawal by Subject|2|||
106027479|NCT02744040|365764714|FG000|Overall Study|Physician Decision|0|||
106027480|NCT02744040|365764715|FG001|Overall Study|Physician Decision|8|||
106027481|NCT02744040|365764716|FG002|Overall Study|Physician Decision|13|||
106027482|NCT02744040|365764714|FG000|Overall Study|Lost to Follow-up|3|||
106027483|NCT02744040|365764715|FG001|Overall Study|Lost to Follow-up|1|||
106027484|NCT02744040|365764716|FG002|Overall Study|Lost to Follow-up|7|||
106027485|NCT01008423|365764717|FG000|Overall Study|Adverse Event|13|||
106027486|NCT01008423|365764718|FG001|Overall Study|Adverse Event|6|||
106027487|NCT01008423|365764717|FG000|Overall Study|Withdrawal by Subject|4|||
106027488|NCT01008423|365764718|FG001|Overall Study|Withdrawal by Subject|7|||
106027489|NCT01008423|365764717|FG000|Overall Study|Lost to Follow-up|0|||
106027490|NCT01008423|365764718|FG001|Overall Study|Lost to Follow-up|2|||
106027491|NCT01008423|365764717|FG000|Overall Study|Low Cortisol|0|||
106027492|NCT01008423|365764718|FG001|Overall Study|Low Cortisol|1|||
106027493|NCT01008423|365764717|FG000|Overall Study|Lack of Efficacy|0|||
106027494|NCT01008423|365764718|FG001|Overall Study|Lack of Efficacy|5|||
106027495|NCT01008423|365764717|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
106027496|NCT01008423|365764718|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
106027497|NCT01008423|365764717|FG000|Overall Study|Personal Conflict|1|||
106027498|NCT01008423|365764718|FG001|Overall Study|Personal Conflict|0|||
106027499|NCT01008423|365764717|FG000|Overall Study|Other|0|||
106027500|NCT01008423|365764718|FG001|Overall Study|Other|1|||
106027501|NCT03288142|365764723|FG000|Overall Study|Lost to Follow-up|22|||
106027502|NCT03288142|365764724|FG001|Overall Study|Lost to Follow-up|15|||
106027503|NCT01700387|365764725|FG000|Overall Study|Withdrawal by Subject|1|||
106027504|NCT01700387|365764726|FG001|Overall Study|Withdrawal by Subject|2|||
105850764|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
105850765|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
105850766|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
105850767|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
105850768|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850769|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850770|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850771|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850772|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850773|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850774|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850775|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850776|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850777|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850778|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850779|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850780|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850781|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850782|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850783|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850784|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850785|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850786|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850787|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850788|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850789|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850790|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850791|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
105850792|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850793|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850794|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850795|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
106027505|NCT01700387|365764725|FG000|Overall Study|Adverse Event|1|||
106027506|NCT01700387|365764726|FG001|Overall Study|Adverse Event|1|||
106027507|NCT01700387|365764725|FG000|Overall Study|Lost to Follow-up|2|||
106027508|NCT01700387|365764726|FG001|Overall Study|Lost to Follow-up|1|||
105976584|NCT02088073|365575457|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
105976585|NCT02088073|365575458|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
105976586|NCT02088073|365575459|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
105976587|NCT02088073|365575460|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
105976588|NCT02088073|365575456|FG000|Maintanance Phase|Subject compliance|0|||
105976589|NCT02088073|365575457|FG001|Maintanance Phase|Subject compliance|1|||
105976590|NCT02088073|365575458|FG002|Maintanance Phase|Subject compliance|0|||
105976591|NCT02088073|365575459|FG003|Maintanance Phase|Subject compliance|0|||
105976592|NCT02088073|365575460|FG004|Maintanance Phase|Subject compliance|0|||
105976593|NCT02785458|365575461|FG000|1 Month|Withdrawal by Subject|2|||
105976594|NCT02785458|365575462|FG001|1 Month|Withdrawal by Subject|1|||
105976595|NCT02785458|365575461|FG000|1 Month|Lost to Follow-up|38|||
105976596|NCT02785458|365575462|FG001|1 Month|Lost to Follow-up|31|||
105976597|NCT02785458|365575461|FG000|1 Month|Deemed Ineligible|1|||
105976598|NCT02785458|365575462|FG001|1 Month|Deemed Ineligible|0|||
105976599|NCT02785458|365575461|FG000|1 Month|Completed Evaluation by Baseline|42|||
105976600|NCT02785458|365575462|FG001|1 Month|Completed Evaluation by Baseline|39|||
105976601|NCT02785458|365575461|FG000|1 Month|Partial Interview|0|||
105976602|NCT02785458|365575462|FG001|1 Month|Partial Interview|4|||
105976603|NCT02785458|365575461|FG000|3 Months|Withdrawal by Subject|3|||
105976604|NCT02785458|365575462|FG001|3 Months|Withdrawal by Subject|1|||
105976605|NCT02785458|365575461|FG000|3 Months|Lost to Follow-up|25|||
105976606|NCT02785458|365575462|FG001|3 Months|Lost to Follow-up|21|||
105976607|NCT02785458|365575461|FG000|3 Months|Completed Evaluation at 1 Month|100|||
105976608|NCT02785458|365575462|FG001|3 Months|Completed Evaluation at 1 Month|89|||
105976609|NCT02046174|365575463|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
105976610|NCT02046174|365575464|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
105976611|NCT02525939|365575467|FG000|Overall Study|Lost to Follow-up|27|||
105976612|NCT02525939|365575468|FG001|Overall Study|Lost to Follow-up|24|||
105976613|NCT02525939|365575467|FG000|Overall Study|Physician Decision|0|||
105976614|NCT02525939|365575468|FG001|Overall Study|Physician Decision|1|||
105976615|NCT02525939|365575467|FG000|Overall Study|Withdrawal by Subject|24|||
105976616|NCT02525939|365575468|FG001|Overall Study|Withdrawal by Subject|39|||
105976617|NCT02525939|365575467|FG000|Overall Study|Death|180|||
105976618|NCT02525939|365575468|FG001|Overall Study|Death|179|||
105976619|NCT02130986|365575472|FG000|Overall Study|Withdrawal by Subject|4|||
105976620|NCT02130986|365575473|FG001|Overall Study|Withdrawal by Subject|4|||
105976621|NCT02130986|365575472|FG000|Overall Study|Lost to Follow-up|151|||
105976622|NCT02130986|365575473|FG001|Overall Study|Lost to Follow-up|160|||
105976623|NCT00762996|365575474|FG000|Period One|Protocol Violation|0|||
105976624|NCT00762996|365575475|FG001|Period One|Protocol Violation|0|||
105976625|NCT00762996|365575476|FG002|Period One|Protocol Violation|1|||
105976626|NCT00762996|365575477|FG003|Period One|Protocol Violation|0|||
105976627|NCT00762996|365575474|FG000|Period One|ineligible|0|||
105976628|NCT00762996|365575475|FG001|Period One|ineligible|0|||
105976629|NCT00762996|365575476|FG002|Period One|ineligible|1|||
105976630|NCT00762996|365575477|FG003|Period One|ineligible|1|||
105976631|NCT00762996|365575474|FG000|Period One|Adverse Event|0|||
105976632|NCT00762996|365575475|FG001|Period One|Adverse Event|0|||
105976633|NCT00762996|365575476|FG002|Period One|Adverse Event|1|||
105976634|NCT00762996|365575477|FG003|Period One|Adverse Event|0|||
105976635|NCT00762996|365575474|FG000|Period One|Withdrawal by Subject|0|||
105976636|NCT00762996|365575475|FG001|Period One|Withdrawal by Subject|0|||
105976637|NCT00762996|365575476|FG002|Period One|Withdrawal by Subject|1|||
105976638|NCT00762996|365575477|FG003|Period One|Withdrawal by Subject|0|||
105976639|NCT04063787|365575479|FG000|Overall Study|Inadequate Doppler data|4|||
105976640|NCT04063787|365575479|FG000|Overall Study|Lost to Follow-up|2|||
105976641|NCT04063787|365575479|FG000|Overall Study|Death|3|||
105976642|NCT01174004|365575480|FG000|Overall Study|Adverse Event|2|||
105976643|NCT01174004|365575481|FG001|Overall Study|Adverse Event|10|||
105976644|NCT01174004|365575480|FG000|Overall Study|Withdrawal by Subject|2|||
105976645|NCT01174004|365575481|FG001|Overall Study|Withdrawal by Subject|3|||
105976646|NCT01174004|365575480|FG000|Overall Study|At Discretion of Sponsor|2|||
105976647|NCT01174004|365575481|FG001|Overall Study|At Discretion of Sponsor|2|||
105976648|NCT01174004|365575480|FG000|Overall Study|Protocol Violation|0|||
105976649|NCT01174004|365575481|FG001|Overall Study|Protocol Violation|1|||
105976650|NCT01174004|365575480|FG000|Overall Study|Physician Decision|1|||
106027509|NCT03041129|365764729|FG000|Overall Study|Withdrawal by Subject|2|||
106027510|NCT03041129|365764730|FG001|Overall Study|Withdrawal by Subject|0|||
105976651|NCT01174004|365575481|FG001|Overall Study|Physician Decision|0|||
105976652|NCT00086502|365575487|FG000|Overall Study|Adverse Event|11|||
105976653|NCT00086502|365575488|FG001|Overall Study|Adverse Event|2|||
105976654|NCT00086502|365575487|FG000|Overall Study|Lack of Efficacy|0|||
105976655|NCT00086502|365575488|FG001|Overall Study|Lack of Efficacy|2|||
105976656|NCT00086502|365575487|FG000|Overall Study|Lost to Follow-up|3|||
105976657|NCT00086502|365575488|FG001|Overall Study|Lost to Follow-up|1|||
105976658|NCT00086502|365575487|FG000|Overall Study|Physician Decision|1|||
105976659|NCT00086502|365575488|FG001|Overall Study|Physician Decision|1|||
105976660|NCT00086502|365575487|FG000|Overall Study|Pregnancy|0|||
105976661|NCT00086502|365575488|FG001|Overall Study|Pregnancy|1|||
105976662|NCT00086502|365575487|FG000|Overall Study|Protocol Violation|3|||
105976663|NCT00086502|365575488|FG001|Overall Study|Protocol Violation|3|||
105976664|NCT00086502|365575487|FG000|Overall Study|Withdrawal by Subject|5|||
105976665|NCT00086502|365575488|FG001|Overall Study|Withdrawal by Subject|6|||
105976666|NCT00086502|365575487|FG000|Overall Study|Patient Moved|1|||
105976667|NCT00086502|365575488|FG001|Overall Study|Patient Moved|1|||
105976668|NCT00086502|365575487|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
105976669|NCT00086502|365575488|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
106027511|NCT03041129|365764731|FG002|Overall Study|Withdrawal by Subject|0|||
106027512|NCT03041129|365764732|FG003|Overall Study|Withdrawal by Subject|0|||
106027513|NCT00960570|365764735|FG000|21 Day Washout Period|Adverse Event|1|||
106027514|NCT00960570|365764735|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
106027515|NCT00960570|365764735|FG000|1 Day Period Between Dosing|Adverse Event|2|||
106027516|NCT00960570|365764735|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
106027517|NCT04473235|365767387|FG000|Overall Study|Lost to Follow-up|6|||
106027518|NCT04473235|365767388|FG001|Overall Study|Lost to Follow-up|5|||
106027519|NCT04473235|365767387|FG000|Overall Study|Declined continuation|2|||
106027520|NCT04473235|365767388|FG001|Overall Study|Declined continuation|0|||
106027521|NCT04473235|365767387|FG000|Overall Study|Physician Decision|1|||
106027522|NCT04473235|365767388|FG001|Overall Study|Physician Decision|1|||
106027523|NCT04473235|365767387|FG000|Overall Study|Protocol Violation|10|||
106027524|NCT04473235|365767388|FG001|Overall Study|Protocol Violation|6|||
106027525|NCT01754402|365767389|FG000|Overall Study|Death|0|||
106027526|NCT01754402|365767390|FG001|Overall Study|Death|0|||
106027527|NCT01754402|365767391|FG002|Overall Study|Death|1|||
105850796|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850797|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
105850798|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
105850799|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850800|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850801|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
105850802|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850803|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850804|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850805|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850806|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850807|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850808|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850809|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850810|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850811|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850812|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850813|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850814|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850815|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850816|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
105850817|NCT02393248|365112579|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850818|NCT02393248|365112580|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850819|NCT02393248|365112581|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850820|NCT02393248|365112582|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850821|NCT02393248|365112583|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850822|NCT02393248|365112584|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850823|NCT02393248|365112585|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
105850824|NCT02393248|365112586|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850825|NCT02393248|365112587|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850826|NCT02393248|365112588|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850827|NCT02393248|365112589|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105976670|NCT00086502|365575487|FG000|Overall Study|Patient Accidentally Unblinded|1|||
105976671|NCT00086502|365575488|FG001|Overall Study|Patient Accidentally Unblinded|0|||
105976672|NCT03412604|365575489|FG000|Overall Study|Withdrawal by Subject|1|||
105976673|NCT05545644|365575490|FG000|Overall Study|Lost to Follow-up|4|||
106027528|NCT01754402|365767389|FG000|Overall Study|Adverse Event|2|||
106027529|NCT01754402|365767390|FG001|Overall Study|Adverse Event|2|||
106027530|NCT01754402|365767391|FG002|Overall Study|Adverse Event|1|||
106027531|NCT01754402|365767389|FG000|Overall Study|Withdrawal by Subject|0|||
106027532|NCT01754402|365767390|FG001|Overall Study|Withdrawal by Subject|0|||
106027533|NCT01754402|365767391|FG002|Overall Study|Withdrawal by Subject|1|||
106027534|NCT01754402|365767389|FG000|Overall Study|Lack of Efficacy|0|||
105976674|NCT05545644|365575491|FG001|Overall Study|Lost to Follow-up|3|||
105976675|NCT00610441|365575492|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
105976676|NCT00610441|365575493|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
105976677|NCT00610441|365575494|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
105976678|NCT00610441|365575495|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
105976679|NCT00610441|365575492|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
105976680|NCT00610441|365575493|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
105976681|NCT00610441|365575494|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
105976682|NCT00610441|365575495|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
105976683|NCT00610441|365575492|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
105976684|NCT00610441|365575493|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
105976685|NCT00610441|365575494|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
105976686|NCT00610441|365575495|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
105976687|NCT00610441|365575492|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
105976688|NCT00610441|365575493|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
105976689|NCT00610441|365575494|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
105976690|NCT00610441|365575495|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
105976691|NCT00610441|365575492|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
105976692|NCT00610441|365575493|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
105976693|NCT00610441|365575494|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
105976694|NCT00610441|365575495|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
105976695|NCT00610441|365575492|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
105976696|NCT00610441|365575493|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
105976697|NCT00610441|365575494|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
105976698|NCT00610441|365575495|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
105976699|NCT00610441|365575492|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
105976700|NCT00610441|365575493|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
105976701|NCT00610441|365575494|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
105976702|NCT00610441|365575495|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
105976703|NCT00610441|365575492|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
105976704|NCT00610441|365575493|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
105976705|NCT00610441|365575494|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
105976706|NCT00610441|365575495|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
105976707|NCT00610441|365575492|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
105976708|NCT00610441|365575493|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
105976709|NCT00610441|365575494|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
105976710|NCT00610441|365575495|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
105976711|NCT01945775|365575496|FG000|Overall Study|Death|214|||
105976712|NCT01945775|365575497|FG001|Overall Study|Death|98|||
105976713|NCT01945775|365575496|FG000|Overall Study|Lost to Follow-up|12|||
105976714|NCT01945775|365575497|FG001|Overall Study|Lost to Follow-up|7|||
105976715|NCT01945775|365575496|FG000|Overall Study|Withdrawal by Subject|11|||
105976716|NCT01945775|365575497|FG001|Overall Study|Withdrawal by Subject|21|||
105976717|NCT01945775|365575496|FG000|Overall Study|Other|50|||
105976718|NCT01945775|365575497|FG001|Overall Study|Other|18|||
105976719|NCT02876328|365575498|FG000|Overall Study|Death|2|||
105976720|NCT02876328|365575499|FG001|Overall Study|Death|1|||
105976721|NCT02876328|365575500|FG002|Overall Study|Death|3|||
105976722|NCT02876328|365575501|FG003|Overall Study|Death|0|||
105976723|NCT02876328|365575502|FG004|Overall Study|Death|0|||
105976724|NCT02876328|365575503|FG005|Overall Study|Death|0|||
105976725|NCT02876328|365575504|FG006|Overall Study|Death|1|||
105976726|NCT02876328|365575505|FG007|Overall Study|Death|3|||
105976727|NCT02876328|365575506|FG008|Overall Study|Death|0|||
105976728|NCT02876328|365575507|FG009|Overall Study|Death|1|||
105976729|NCT02876328|365575508|FG010|Overall Study|Death|1|||
105976730|NCT02876328|365575509|FG011|Overall Study|Death|0|||
105976731|NCT02876328|365575510|FG012|Overall Study|Death|0|||
105976732|NCT02876328|365575511|FG013|Overall Study|Death|0|||
105976733|NCT02876328|365575512|FG014|Overall Study|Death|0|||
105976734|NCT02876328|365575513|FG015|Overall Study|Death|0|||
105976735|NCT02876328|365575514|FG016|Overall Study|Death|1|||
105976736|NCT02876328|365575515|FG017|Overall Study|Death|1|||
105976737|NCT02876328|365575516|FG018|Overall Study|Death|0|||
105976738|NCT02876328|365575517|FG019|Overall Study|Death|0|||
105976739|NCT02876328|365575518|FG020|Overall Study|Death|0|||
105976740|NCT02876328|365575519|FG021|Overall Study|Death|1|||
105976741|NCT02876328|365575520|FG022|Overall Study|Death|0|||
105976742|NCT02876328|365575521|FG023|Overall Study|Death|0|||
105976743|NCT02876328|365575498|FG000|Overall Study|Withdrawal by Subject|0|||
105976744|NCT02876328|365575499|FG001|Overall Study|Withdrawal by Subject|2|||
106027535|NCT01754402|365767390|FG001|Overall Study|Lack of Efficacy|0|||
105976745|NCT02876328|365575500|FG002|Overall Study|Withdrawal by Subject|3|||
105976746|NCT02876328|365575501|FG003|Overall Study|Withdrawal by Subject|3|||
105976747|NCT02876328|365575502|FG004|Overall Study|Withdrawal by Subject|0|||
105976748|NCT02876328|365575503|FG005|Overall Study|Withdrawal by Subject|1|||
105976749|NCT02876328|365575504|FG006|Overall Study|Withdrawal by Subject|0|||
106027536|NCT01754402|365767391|FG002|Overall Study|Lack of Efficacy|1|||
106027537|NCT00109590|365767392|FG000|Overall Study|Lost to Follow-up|1|||
106027538|NCT00109590|365767393|FG001|Overall Study|Lost to Follow-up|0|||
106027539|NCT00109590|365767394|FG002|Overall Study|Lost to Follow-up|1|||
106027540|NCT00109590|365767392|FG000|Overall Study|Never Started Treatment|1|||
106027541|NCT00109590|365767393|FG001|Overall Study|Never Started Treatment|2|||
106027542|NCT00109590|365767394|FG002|Overall Study|Never Started Treatment|3|||
106027543|NCT00490529|365767395|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
106027544|NCT00490529|365767395|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
106027545|NCT00490529|365767395|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
106027546|NCT00490529|365767395|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
106027547|NCT00490529|365767395|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
106027548|NCT00490529|365767395|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
106027549|NCT02617485|365767396|FG000|Treatment and Observation Period|Adverse Event|9|||
106027550|NCT02617485|365767397|FG001|Treatment and Observation Period|Adverse Event|1|||
106027551|NCT02617485|365767396|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
106027552|NCT02617485|365767397|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
106027553|NCT02617485|365767396|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
106027554|NCT02617485|365767397|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
106027555|NCT02617485|365767396|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
106027556|NCT02617485|365767397|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
106027557|NCT02617485|365767396|FG000|Treatment and Observation Period|Physician Decision|0|||
106027558|NCT02617485|365767397|FG001|Treatment and Observation Period|Physician Decision|1|||
106027559|NCT02617485|365767396|FG000|Follow-up Period|Adverse Event|1|||
106027560|NCT02617485|365767397|FG001|Follow-up Period|Adverse Event|0|||
106027561|NCT02617485|365767396|FG000|Follow-up Period|Withdrawal by Subject|1|||
106027562|NCT02617485|365767397|FG001|Follow-up Period|Withdrawal by Subject|0|||
106027563|NCT02617485|365767396|FG000|Follow-up Period|Disease progression|2|||
106027564|NCT02617485|365767397|FG001|Follow-up Period|Disease progression|1|||
106027565|NCT02617485|365767396|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
106027566|NCT02617485|365767397|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
106027567|NCT02617485|365767396|FG000|Follow-up Period|Patient needed radiotherapy|9|||
106027568|NCT02617485|365767397|FG001|Follow-up Period|Patient needed radiotherapy|5|||
106027569|NCT02617485|365767396|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
106027570|NCT02617485|365767397|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
106027571|NCT00791076|365767398|FG000|Overall Study|Study was terminated,PI left institution|8|||
106027572|NCT00281658|365767399|FG000|Randomized Phase|Adverse Event|0|||
106027573|NCT00281658|365767400|FG001|Randomized Phase|Adverse Event|2|||
106027574|NCT00281658|365767401|FG002|Randomized Phase|Adverse Event|0|||
106027575|NCT00281658|365767402|FG003|Randomized Phase|Adverse Event|0|||
106027576|NCT00281658|365767399|FG000|Randomized Phase|Lost to Follow-up|34|||
106027577|NCT00281658|365767400|FG001|Randomized Phase|Lost to Follow-up|27|||
106027578|NCT00281658|365767401|FG002|Randomized Phase|Lost to Follow-up|0|||
106027579|NCT00281658|365767402|FG003|Randomized Phase|Lost to Follow-up|0|||
106027580|NCT00281658|365767399|FG000|Randomized Phase|Withdrawal by Subject|8|||
106027581|NCT00281658|365767400|FG001|Randomized Phase|Withdrawal by Subject|7|||
106027582|NCT00281658|365767401|FG002|Randomized Phase|Withdrawal by Subject|0|||
106027583|NCT00281658|365767402|FG003|Randomized Phase|Withdrawal by Subject|0|||
106027584|NCT00281658|365767399|FG000|Randomized Phase|Study closed/terminated|1|||
106027585|NCT00281658|365767400|FG001|Randomized Phase|Study closed/terminated|1|||
106027586|NCT00281658|365767401|FG002|Randomized Phase|Study closed/terminated|0|||
106027587|NCT00281658|365767402|FG003|Randomized Phase|Study closed/terminated|0|||
105850828|NCT02393248|365112590|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850829|NCT02393248|365112591|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850830|NCT02393248|365112592|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850831|NCT02393248|365112593|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850832|NCT02393248|365112594|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850833|NCT02393248|365112595|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850834|NCT02393248|365112596|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850835|NCT02393248|365112597|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850836|NCT02393248|365112598|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
106027588|NCT00281658|365767399|FG000|Randomized Phase|Disease progression|36|||
106027589|NCT00281658|365767400|FG001|Randomized Phase|Disease progression|27|||
106027590|NCT00281658|365767401|FG002|Randomized Phase|Disease progression|0|||
106027591|NCT00281658|365767402|FG003|Randomized Phase|Disease progression|0|||
106027592|NCT00281658|365767399|FG000|Randomized Phase|Physician Decision|1|||
106027593|NCT00281658|365767400|FG001|Randomized Phase|Physician Decision|1|||
106027594|NCT00281658|365767401|FG002|Randomized Phase|Physician Decision|0|||
105850837|NCT02393248|365112599|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850838|NCT02393248|365112600|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850839|NCT02393248|365112601|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850840|NCT02393248|365112602|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850841|NCT02393248|365112603|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
105850842|NCT02393248|365112579|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850843|NCT02393248|365112580|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850844|NCT02393248|365112581|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850845|NCT02393248|365112582|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850846|NCT02393248|365112583|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850847|NCT02393248|365112584|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850848|NCT02393248|365112585|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850849|NCT02393248|365112586|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850850|NCT02393248|365112587|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850851|NCT02393248|365112588|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850852|NCT02393248|365112589|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850853|NCT02393248|365112590|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
105850854|NCT02393248|365112591|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
105850855|NCT02393248|365112592|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
105850856|NCT02393248|365112593|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
105850857|NCT02393248|365112594|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850858|NCT02393248|365112595|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850859|NCT02393248|365112596|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850860|NCT02393248|365112597|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850861|NCT02393248|365112598|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850862|NCT02393248|365112599|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850863|NCT02393248|365112600|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850864|NCT02393248|365112601|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850865|NCT02393248|365112602|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850866|NCT02393248|365112603|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
105850867|NCT02393248|365112579|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850868|NCT02393248|365112580|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850869|NCT02393248|365112581|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850870|NCT02393248|365112582|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850871|NCT02393248|365112583|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850872|NCT02393248|365112584|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850873|NCT02393248|365112585|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850874|NCT02393248|365112586|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850875|NCT02393248|365112587|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850876|NCT02393248|365112588|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850877|NCT02393248|365112589|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
105850878|NCT02393248|365112590|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
105850879|NCT02393248|365112591|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105976750|NCT02876328|365575505|FG007|Overall Study|Withdrawal by Subject|1|||
105976751|NCT02876328|365575506|FG008|Overall Study|Withdrawal by Subject|1|||
105976752|NCT02876328|365575507|FG009|Overall Study|Withdrawal by Subject|2|||
105976753|NCT02876328|365575508|FG010|Overall Study|Withdrawal by Subject|0|||
105976754|NCT02876328|365575509|FG011|Overall Study|Withdrawal by Subject|0|||
105976755|NCT02876328|365575510|FG012|Overall Study|Withdrawal by Subject|0|||
105976756|NCT02876328|365575511|FG013|Overall Study|Withdrawal by Subject|0|||
105976757|NCT02876328|365575512|FG014|Overall Study|Withdrawal by Subject|0|||
105976758|NCT02876328|365575513|FG015|Overall Study|Withdrawal by Subject|0|||
105976759|NCT02876328|365575514|FG016|Overall Study|Withdrawal by Subject|1|||
105976760|NCT02876328|365575515|FG017|Overall Study|Withdrawal by Subject|3|||
105976761|NCT02876328|365575516|FG018|Overall Study|Withdrawal by Subject|0|||
105976762|NCT02876328|365575517|FG019|Overall Study|Withdrawal by Subject|0|||
105976763|NCT02876328|365575518|FG020|Overall Study|Withdrawal by Subject|1|||
105976764|NCT02876328|365575519|FG021|Overall Study|Withdrawal by Subject|0|||
105976765|NCT02876328|365575520|FG022|Overall Study|Withdrawal by Subject|0|||
105976766|NCT02876328|365575521|FG023|Overall Study|Withdrawal by Subject|0|||
105976767|NCT02876328|365575498|FG000|Overall Study|Missed 12 Month Visit|15|||
105976768|NCT02876328|365575499|FG001|Overall Study|Missed 12 Month Visit|10|||
105976769|NCT02876328|365575500|FG002|Overall Study|Missed 12 Month Visit|11|||
105976770|NCT02876328|365575501|FG003|Overall Study|Missed 12 Month Visit|6|||
105976771|NCT02876328|365575502|FG004|Overall Study|Missed 12 Month Visit|10|||
105976772|NCT02876328|365575503|FG005|Overall Study|Missed 12 Month Visit|14|||
105976773|NCT02876328|365575504|FG006|Overall Study|Missed 12 Month Visit|3|||
105976774|NCT02876328|365575505|FG007|Overall Study|Missed 12 Month Visit|8|||
105976775|NCT02876328|365575506|FG008|Overall Study|Missed 12 Month Visit|9|||
105976776|NCT02876328|365575507|FG009|Overall Study|Missed 12 Month Visit|5|||
105976777|NCT02876328|365575508|FG010|Overall Study|Missed 12 Month Visit|4|||
105976778|NCT02876328|365575509|FG011|Overall Study|Missed 12 Month Visit|1|||
105976779|NCT02876328|365575510|FG012|Overall Study|Missed 12 Month Visit|5|||
105976780|NCT02876328|365575511|FG013|Overall Study|Missed 12 Month Visit|4|||
105976781|NCT02876328|365575512|FG014|Overall Study|Missed 12 Month Visit|4|||
105976782|NCT02876328|365575513|FG015|Overall Study|Missed 12 Month Visit|4|||
105976783|NCT02876328|365575514|FG016|Overall Study|Missed 12 Month Visit|3|||
105976784|NCT02876328|365575515|FG017|Overall Study|Missed 12 Month Visit|6|||
105976785|NCT02876328|365575516|FG018|Overall Study|Missed 12 Month Visit|2|||
105976786|NCT02876328|365575517|FG019|Overall Study|Missed 12 Month Visit|2|||
105976787|NCT02876328|365575518|FG020|Overall Study|Missed 12 Month Visit|11|||
105976788|NCT02876328|365575519|FG021|Overall Study|Missed 12 Month Visit|7|||
105976789|NCT02876328|365575520|FG022|Overall Study|Missed 12 Month Visit|1|||
105976790|NCT02876328|365575521|FG023|Overall Study|Missed 12 Month Visit|0|||
105976791|NCT02761694|365575524|FG000|Overall Study|Lack of Efficacy|0|||
105976792|NCT02761694|365575525|FG001|Overall Study|Lack of Efficacy|0|||
105976793|NCT02761694|365575526|FG002|Overall Study|Lack of Efficacy|0|||
105976794|NCT02761694|365575527|FG003|Overall Study|Lack of Efficacy|0|||
105976795|NCT02761694|365575528|FG004|Overall Study|Lack of Efficacy|0|||
105976796|NCT02761694|365575529|FG005|Overall Study|Lack of Efficacy|0|||
105976797|NCT02761694|365575530|FG006|Overall Study|Lack of Efficacy|6|||
105976798|NCT02761694|365575531|FG007|Overall Study|Lack of Efficacy|0|||
105976799|NCT02761694|365575532|FG008|Overall Study|Lack of Efficacy|0|||
105976800|NCT02761694|365575533|FG009|Overall Study|Lack of Efficacy|1|||
105976801|NCT02761694|365575534|FG010|Overall Study|Lack of Efficacy|1|||
105976802|NCT02761694|365575535|FG011|Overall Study|Lack of Efficacy|4|||
105976803|NCT02761694|365575524|FG000|Overall Study|Death|0|||
105976804|NCT02761694|365575525|FG001|Overall Study|Death|0|||
105976805|NCT02761694|365575526|FG002|Overall Study|Death|0|||
105976806|NCT02761694|365575527|FG003|Overall Study|Death|0|||
105976807|NCT02761694|365575528|FG004|Overall Study|Death|0|||
105976808|NCT02761694|365575529|FG005|Overall Study|Death|0|||
105976809|NCT02761694|365575530|FG006|Overall Study|Death|2|||
105976810|NCT02761694|365575531|FG007|Overall Study|Death|0|||
105976811|NCT02761694|365575532|FG008|Overall Study|Death|2|||
105976812|NCT02761694|365575533|FG009|Overall Study|Death|2|||
105976813|NCT02761694|365575534|FG010|Overall Study|Death|1|||
105976814|NCT02761694|365575535|FG011|Overall Study|Death|0|||
105976815|NCT02761694|365575524|FG000|Overall Study|Physician Decision|0|||
105976816|NCT02761694|365575525|FG001|Overall Study|Physician Decision|0|||
105976817|NCT02761694|365575526|FG002|Overall Study|Physician Decision|0|||
105976818|NCT02761694|365575527|FG003|Overall Study|Physician Decision|0|||
105976819|NCT02761694|365575528|FG004|Overall Study|Physician Decision|0|||
105976820|NCT02761694|365575529|FG005|Overall Study|Physician Decision|0|||
105976821|NCT02761694|365575530|FG006|Overall Study|Physician Decision|1|||
105976822|NCT02761694|365575531|FG007|Overall Study|Physician Decision|0|||
105976823|NCT02761694|365575532|FG008|Overall Study|Physician Decision|0|||
105976824|NCT02761694|365575533|FG009|Overall Study|Physician Decision|0|||
105976825|NCT02761694|365575534|FG010|Overall Study|Physician Decision|0|||
105976826|NCT02761694|365575535|FG011|Overall Study|Physician Decision|0|||
105976827|NCT02761694|365575524|FG000|Overall Study|Withdrawal by Subject|0|||
105976828|NCT02761694|365575525|FG001|Overall Study|Withdrawal by Subject|0|||
105976829|NCT02761694|365575526|FG002|Overall Study|Withdrawal by Subject|0|||
105976830|NCT02761694|365575527|FG003|Overall Study|Withdrawal by Subject|1|||
105976831|NCT02761694|365575528|FG004|Overall Study|Withdrawal by Subject|0|||
105976832|NCT02761694|365575529|FG005|Overall Study|Withdrawal by Subject|0|||
105976833|NCT02761694|365575530|FG006|Overall Study|Withdrawal by Subject|4|||
105976834|NCT02761694|365575531|FG007|Overall Study|Withdrawal by Subject|0|||
105976835|NCT02761694|365575532|FG008|Overall Study|Withdrawal by Subject|2|||
105976836|NCT02761694|365575533|FG009|Overall Study|Withdrawal by Subject|1|||
105976837|NCT02761694|365575534|FG010|Overall Study|Withdrawal by Subject|0|||
105976838|NCT02761694|365575535|FG011|Overall Study|Withdrawal by Subject|0|||
106027595|NCT00281658|365767402|FG003|Randomized Phase|Physician Decision|0|||
105976839|NCT02761694|365575524|FG000|Overall Study|Lost to Follow-up|0|||
105976840|NCT02761694|365575525|FG001|Overall Study|Lost to Follow-up|0|||
105976841|NCT02761694|365575526|FG002|Overall Study|Lost to Follow-up|0|||
105976842|NCT02761694|365575527|FG003|Overall Study|Lost to Follow-up|0|||
105976843|NCT02761694|365575528|FG004|Overall Study|Lost to Follow-up|0|||
105976844|NCT02761694|365575529|FG005|Overall Study|Lost to Follow-up|0|||
105976845|NCT02761694|365575530|FG006|Overall Study|Lost to Follow-up|1|||
105976846|NCT02761694|365575531|FG007|Overall Study|Lost to Follow-up|0|||
105976847|NCT02761694|365575532|FG008|Overall Study|Lost to Follow-up|0|||
105976848|NCT02761694|365575533|FG009|Overall Study|Lost to Follow-up|0|||
105976849|NCT02761694|365575534|FG010|Overall Study|Lost to Follow-up|0|||
105976850|NCT02761694|365575535|FG011|Overall Study|Lost to Follow-up|1|||
105976851|NCT02761694|365575524|FG000|Overall Study|Adverse Event|0|||
105976852|NCT02761694|365575525|FG001|Overall Study|Adverse Event|0|||
105850880|NCT02393248|365112592|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850881|NCT02393248|365112593|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850882|NCT02393248|365112594|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850883|NCT02393248|365112595|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850884|NCT02393248|365112596|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850885|NCT02393248|365112597|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850886|NCT02393248|365112598|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850887|NCT02393248|365112599|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850888|NCT02393248|365112600|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850889|NCT02393248|365112601|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850890|NCT02393248|365112602|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850891|NCT02393248|365112603|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
105850892|NCT02393248|365112579|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
105850893|NCT02393248|365112580|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
105850894|NCT02393248|365112581|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
105850895|NCT02393248|365112582|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
105850896|NCT02393248|365112583|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
105850897|NCT02393248|365112584|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
105850898|NCT02393248|365112585|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
105850899|NCT02393248|365112586|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
105850900|NCT02393248|365112587|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
105850901|NCT02393248|365112588|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
105850902|NCT02393248|365112589|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
105850903|NCT02393248|365112590|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
105850904|NCT02393248|365112591|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
105850905|NCT02393248|365112592|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
105850906|NCT02393248|365112593|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
105850907|NCT02393248|365112594|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
105850908|NCT02393248|365112595|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
105850909|NCT02393248|365112596|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
105850910|NCT02393248|365112597|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
105850911|NCT02393248|365112598|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
105850912|NCT02393248|365112599|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
105850913|NCT02393248|365112600|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
105850914|NCT02393248|365112601|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
105850915|NCT02393248|365112602|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
105850916|NCT02393248|365112603|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
105850917|NCT02393248|365112579|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850918|NCT02393248|365112580|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850919|NCT02393248|365112581|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850920|NCT02393248|365112582|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850921|NCT02393248|365112583|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850922|NCT02393248|365112584|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850923|NCT02393248|365112585|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
106150860|NCT02723955|366215059|FG005|Escalation Phase|Lost to Follow-up|2|||
106150861|NCT02723955|366215060|FG006|Escalation Phase|Lost to Follow-up|1|||
106150862|NCT02723955|366215061|FG007|Escalation Phase|Lost to Follow-up|1|||
106150863|NCT02723955|366215062|FG008|Escalation Phase|Lost to Follow-up|1|||
106150864|NCT02723955|366215063|FG009|Escalation Phase|Lost to Follow-up|0|||
106150865|NCT02723955|366215064|FG010|Escalation Phase|Lost to Follow-up|0|||
105850924|NCT02393248|365112586|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850925|NCT02393248|365112587|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850926|NCT02393248|365112588|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850927|NCT02393248|365112589|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105976853|NCT02761694|365575526|FG002|Overall Study|Adverse Event|0|||
105976854|NCT02761694|365575527|FG003|Overall Study|Adverse Event|0|||
105976855|NCT02761694|365575528|FG004|Overall Study|Adverse Event|0|||
105976856|NCT02761694|365575529|FG005|Overall Study|Adverse Event|0|||
105976857|NCT02761694|365575530|FG006|Overall Study|Adverse Event|1|||
105976858|NCT02761694|365575531|FG007|Overall Study|Adverse Event|0|||
105976859|NCT02761694|365575532|FG008|Overall Study|Adverse Event|1|||
105976860|NCT02761694|365575533|FG009|Overall Study|Adverse Event|0|||
105976861|NCT02761694|365575534|FG010|Overall Study|Adverse Event|0|||
106150866|NCT02723955|366215065|FG011|Escalation Phase|Lost to Follow-up|0|||
106150867|NCT02723955|366215066|FG012|Escalation Phase|Lost to Follow-up|1|||
105850928|NCT02393248|365112590|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
105850929|NCT02393248|365112591|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850930|NCT02393248|365112592|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
105976862|NCT02761694|365575535|FG011|Overall Study|Adverse Event|1|||
105976863|NCT02761694|365575524|FG000|Overall Study|Other|4|||
105976864|NCT02761694|365575525|FG001|Overall Study|Other|4|||
105976865|NCT02761694|365575526|FG002|Overall Study|Other|1|||
105976866|NCT02761694|365575527|FG003|Overall Study|Other|2|||
105976867|NCT02761694|365575528|FG004|Overall Study|Other|3|||
105976868|NCT02761694|365575529|FG005|Overall Study|Other|3|||
105976869|NCT02761694|365575530|FG006|Overall Study|Other|18|||
105976870|NCT02761694|365575531|FG007|Overall Study|Other|8|||
105976871|NCT02761694|365575532|FG008|Overall Study|Other|0|||
105976872|NCT02761694|365575533|FG009|Overall Study|Other|1|||
105976873|NCT02761694|365575534|FG010|Overall Study|Other|1|||
105976874|NCT02761694|365575535|FG011|Overall Study|Other|0|||
105976875|NCT00886119|365575536|FG000|Period 1|Did not meet inclusion criteria|1|||
105976876|NCT00886119|365575537|FG001|Period 1|Did not meet inclusion criteria|0|||
105976877|NCT03002623|365575538|FG000|Overall Study|Lost to Follow-up|1|||
105976878|NCT03002623|365575539|FG001|Overall Study|Lost to Follow-up|0|||
105976879|NCT03002623|365575538|FG000|Overall Study|Physician Decision|1|||
105976880|NCT03002623|365575539|FG001|Overall Study|Physician Decision|1|||
105976881|NCT00844805|365575541|FG000|Treatment Phase|Adverse Event|5|||
105976882|NCT00844805|365575542|FG001|Treatment Phase|Adverse Event|1|||
105976883|NCT00844805|365575543|FG002|Treatment Phase|Adverse Event|0|||
105976884|NCT00844805|365575544|FG003|Treatment Phase|Adverse Event|0|||
105976885|NCT00844805|365575541|FG000|Treatment Phase|Withdrawal by Subject|3|||
105976886|NCT00844805|365575542|FG001|Treatment Phase|Withdrawal by Subject|4|||
105976887|NCT00844805|365575543|FG002|Treatment Phase|Withdrawal by Subject|0|||
105976888|NCT00844805|365575544|FG003|Treatment Phase|Withdrawal by Subject|0|||
105976889|NCT00844805|365575541|FG000|Treatment Phase|Noncompliance With Protocol|1|||
105976890|NCT00844805|365575542|FG001|Treatment Phase|Noncompliance With Protocol|0|||
105976891|NCT00844805|365575543|FG002|Treatment Phase|Noncompliance With Protocol|0|||
105976892|NCT00844805|365575544|FG003|Treatment Phase|Noncompliance With Protocol|0|||
105976893|NCT00844805|365575541|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
105976894|NCT00844805|365575542|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
105976895|NCT00844805|365575543|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
105976896|NCT00844805|365575544|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
105976897|NCT00844805|365575541|FG000|Follow-Up Phase|Adverse Event|0|||
105976898|NCT00844805|365575542|FG001|Follow-Up Phase|Adverse Event|0|||
105976899|NCT00844805|365575543|FG002|Follow-Up Phase|Adverse Event|1|||
105976900|NCT00844805|365575544|FG003|Follow-Up Phase|Adverse Event|0|||
105976901|NCT00844805|365575541|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
105976902|NCT00844805|365575542|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
105976903|NCT00844805|365575543|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
105976904|NCT00844805|365575544|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
105976905|NCT00844805|365575541|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
105976906|NCT00844805|365575542|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
105976907|NCT00844805|365575543|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
105976908|NCT00844805|365575544|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
105976909|NCT00844805|365575541|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
105976910|NCT00844805|365575542|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
105976911|NCT00844805|365575543|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
105976912|NCT00844805|365575544|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
105976913|NCT00844805|365575541|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
105976914|NCT00844805|365575542|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
105976915|NCT00844805|365575543|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
105976916|NCT00844805|365575544|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
105976917|NCT00857948|365575552|FG000|Overall Study|Withdrawal by Subject|2|||
105976918|NCT00857948|365575553|FG001|Overall Study|Withdrawal by Subject|0|||
105976919|NCT00857948|365575554|FG002|Overall Study|Withdrawal by Subject|0|||
105976920|NCT00857948|365575555|FG003|Overall Study|Withdrawal by Subject|0|||
105976921|NCT00857948|365575552|FG000|Overall Study|Protocol Violation|1|||
106027596|NCT00281658|365767399|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
106027597|NCT00281658|365767400|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
106027598|NCT00281658|365767401|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
106027599|NCT00281658|365767402|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
105976922|NCT00857948|365575553|FG001|Overall Study|Protocol Violation|0|||
105976923|NCT00857948|365575554|FG002|Overall Study|Protocol Violation|1|||
105976924|NCT00857948|365575555|FG003|Overall Study|Protocol Violation|0|||
105976925|NCT00493636|365575556|FG000|Overall Study|Withdrawal by Subject|1|||
105976926|NCT00493636|365575557|FG001|Overall Study|Withdrawal by Subject|0|||
105976927|NCT00493636|365575556|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
105976928|NCT00493636|365575557|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
105976929|NCT00493636|365575556|FG000|Overall Study|Mis-randomization|1|||
105976930|NCT00493636|365575557|FG001|Overall Study|Mis-randomization|1|||
105976931|NCT01873729|365575558|FG000|Overall Study|Withdrawal by Subject|1|||
105976932|NCT02463032|365575559|FG000|Overall Study|Lack of Efficacy|61|||
105976933|NCT02463032|365575560|FG001|Overall Study|Lack of Efficacy|50|||
105976934|NCT02463032|365575559|FG000|Overall Study|Death|8|||
105976935|NCT02463032|365575560|FG001|Overall Study|Death|8|||
105976936|NCT02463032|365575559|FG000|Overall Study|Adverse Event|2|||
105976937|NCT02463032|365575560|FG001|Overall Study|Adverse Event|6|||
105976938|NCT01066780|365575561|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
105976939|NCT01066780|365575562|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
105976940|NCT00613080|365575563|FG000|Overall Study|Ineligible / no protocol treatment|11|||
105976941|NCT03757130|365575564|FG000|Overall Study|Lost to Follow-up|0|||
105976942|NCT03757130|365575565|FG001|Overall Study|Lost to Follow-up|0|||
105976943|NCT03757130|365575566|FG002|Overall Study|Lost to Follow-up|0|||
105976944|NCT03757130|365575567|FG003|Overall Study|Lost to Follow-up|1|||
105976945|NCT03757130|365575568|FG004|Overall Study|Lost to Follow-up|0|||
105976946|NCT03757130|365575569|FG005|Overall Study|Lost to Follow-up|0|||
105976947|NCT03757130|365575570|FG006|Overall Study|Lost to Follow-up|0|||
105976948|NCT03757130|365575571|FG007|Overall Study|Lost to Follow-up|1|||
105976949|NCT03757130|365575564|FG000|Overall Study|Withdrawal by Subject|0|||
105976950|NCT03757130|365575565|FG001|Overall Study|Withdrawal by Subject|0|||
105976951|NCT03757130|365575566|FG002|Overall Study|Withdrawal by Subject|0|||
105976952|NCT03757130|365575567|FG003|Overall Study|Withdrawal by Subject|0|||
105976953|NCT03757130|365575568|FG004|Overall Study|Withdrawal by Subject|0|||
105976954|NCT03757130|365575569|FG005|Overall Study|Withdrawal by Subject|0|||
105976955|NCT03757130|365575570|FG006|Overall Study|Withdrawal by Subject|1|||
105976956|NCT03757130|365575571|FG007|Overall Study|Withdrawal by Subject|0|||
105976957|NCT02360293|365575572|FG000|Overall Study|Lost to Follow-up|73|||
105976958|NCT02360293|365575573|FG001|Overall Study|Lost to Follow-up|95|||
105976959|NCT02360293|365575572|FG000|Overall Study|Withdrawal by Subject|2|||
105976960|NCT02360293|365575573|FG001|Overall Study|Withdrawal by Subject|1|||
105976961|NCT02360293|365575572|FG000|Overall Study|Excluded|1|||
105976962|NCT02360293|365575573|FG001|Overall Study|Excluded|0|||
105976963|NCT02726880|365575575|FG000|Overall Study|Withdrawal by Subject|2|||
105976964|NCT02726880|365575576|FG001|Overall Study|Withdrawal by Subject|0|||
105976965|NCT02726880|365575575|FG000|Overall Study|Lost to Follow-up|1|||
105976966|NCT02726880|365575576|FG001|Overall Study|Lost to Follow-up|3|||
105976967|NCT04316741|365575577|FG000|Baseline Enrollment|Lost to Follow-up|1|||
105976968|NCT04316741|365575578|FG001|Baseline Enrollment|Lost to Follow-up|1|||
105976969|NCT04316741|365575577|FG000|Immediate Post-Test|Lost to Follow-up|5|||
105976970|NCT04316741|365575578|FG001|Immediate Post-Test|Lost to Follow-up|1|||
105976971|NCT04316741|365575577|FG000|1-month Post-test|Lost to Follow-up|7|||
105976972|NCT04316741|365575578|FG001|1-month Post-test|Lost to Follow-up|2|||
105976973|NCT04316741|365575577|FG000|3-month Follow-up|Lost to Follow-up|10|||
105976974|NCT04316741|365575578|FG001|3-month Follow-up|Lost to Follow-up|2|||
105976975|NCT02312219|365575579|FG000|Overall Study|Withdrawal by Subject|1|||
105976976|NCT02312219|365575580|FG001|Overall Study|Withdrawal by Subject|2|||
105976977|NCT02312219|365575579|FG000|Overall Study|could not schedule imaging in time|0|||
105976978|NCT02312219|365575580|FG001|Overall Study|could not schedule imaging in time|2|||
105976979|NCT02312219|365575579|FG000|Overall Study|Other|0|||
105976980|NCT02312219|365575580|FG001|Overall Study|Other|1|||
105976981|NCT02312219|365575579|FG000|Overall Study|Not randomized. Ineligible|0|||
105976982|NCT02312219|365575580|FG001|Overall Study|Not randomized. Ineligible|1|||
105976983|NCT01269385|365575581|FG000|Overall Study|Adverse Event|1|||
105976984|NCT01269385|365575582|FG001|Overall Study|Adverse Event|1|||
105850931|NCT02393248|365112593|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850932|NCT02393248|365112594|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850933|NCT02393248|365112595|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850934|NCT02393248|365112596|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850935|NCT02393248|365112597|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850936|NCT02393248|365112598|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850937|NCT02393248|365112599|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850938|NCT02393248|365112600|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850939|NCT02393248|365112601|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850940|NCT02393248|365112602|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850941|NCT02393248|365112603|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
105850942|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850943|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850944|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850945|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105976985|NCT01269385|365575583|FG002|Overall Study|Adverse Event|0|||
105976986|NCT01269385|365575584|FG003|Overall Study|Adverse Event|0|||
105976987|NCT04941807|365575586|FG000|Overall Study|Lost to Follow-up|1|||
105976988|NCT04941807|365575587|FG001|Overall Study|Lost to Follow-up|1|||
105976989|NCT03553498|365575588|FG000|Overall Study|Missing primary outcome|1|||
105976990|NCT03553498|365575589|FG001|Overall Study|Missing primary outcome|2|||
105976991|NCT02278614|365575596|FG000|Overall Study|Withdrawal by Subject|3|||
105976992|NCT02278614|365575597|FG001|Overall Study|Withdrawal by Subject|5|||
105976993|NCT02278614|365575596|FG000|Overall Study|Adverse Event|1|||
105976994|NCT02278614|365575597|FG001|Overall Study|Adverse Event|0|||
105976995|NCT02278614|365575596|FG000|Overall Study|left eye was not eligible|1|||
105976996|NCT02278614|365575597|FG001|Overall Study|left eye was not eligible|0|||
105976997|NCT03697993|365575598|FG000|Overall Study|Became Ineligible after Enrollment|1|||
105976998|NCT03697993|365575599|FG001|Overall Study|Became Ineligible after Enrollment|3|||
105976999|NCT03697993|365575598|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
105977000|NCT03697993|365575599|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
105977001|NCT03697993|365575598|FG000|Overall Study|Lost to Follow-up|3|||
105977002|NCT03697993|365575599|FG001|Overall Study|Lost to Follow-up|0|||
105977003|NCT03697993|365575598|FG000|Overall Study|Physician Decision|4|||
105977004|NCT03697993|365575599|FG001|Overall Study|Physician Decision|0|||
105977005|NCT03697993|365575598|FG000|Overall Study|Initial Urine Culture Negative|0|||
105977006|NCT03697993|365575599|FG001|Overall Study|Initial Urine Culture Negative|1|||
105977007|NCT03759041|365575600|FG000|Overall Study|Withdrawal by Subject|4|||
105977008|NCT03759041|365575601|FG001|Overall Study|Withdrawal by Subject|10|||
105977009|NCT03759041|365575602|FG002|Overall Study|Withdrawal by Subject|10|||
105977010|NCT03759041|365575600|FG000|Overall Study|Adverse Event|1|||
105977011|NCT03759041|365575601|FG001|Overall Study|Adverse Event|3|||
105977012|NCT03759041|365575602|FG002|Overall Study|Adverse Event|4|||
105977013|NCT03759041|365575600|FG000|Overall Study|Lack of Efficacy|0|||
105977014|NCT03759041|365575601|FG001|Overall Study|Lack of Efficacy|0|||
105977015|NCT03759041|365575602|FG002|Overall Study|Lack of Efficacy|1|||
105977016|NCT03759041|365575600|FG000|Overall Study|Study Terminated by Sponsor|15|||
105977017|NCT03759041|365575601|FG001|Overall Study|Study Terminated by Sponsor|16|||
105977018|NCT03759041|365575602|FG002|Overall Study|Study Terminated by Sponsor|10|||
105977019|NCT03759041|365575600|FG000|Overall Study|Other reason for discontinuation|0|||
105977020|NCT03759041|365575601|FG001|Overall Study|Other reason for discontinuation|2|||
105977021|NCT03759041|365575602|FG002|Overall Study|Other reason for discontinuation|1|||
105977022|NCT03759041|365575600|FG000|Overall Study|Lost to Follow-up|7|||
105977023|NCT03759041|365575601|FG001|Overall Study|Lost to Follow-up|2|||
105977024|NCT03759041|365575602|FG002|Overall Study|Lost to Follow-up|2|||
105977025|NCT03759041|365575600|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
105977026|NCT03759041|365575601|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
105977027|NCT03759041|365575602|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
105977028|NCT04384107|365575603|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
105977029|NCT04384107|365575604|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
105977030|NCT04384107|365575603|FG000|Overall Study|Lost to Follow-up|1|||
105977031|NCT04384107|365575604|FG001|Overall Study|Lost to Follow-up|0|||
105977032|NCT02698371|365575607|FG000|All Participants Flow|Lost to Follow-up|3|||
105977033|NCT02698371|365575607|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
105977034|NCT02698371|365575607|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
105977035|NCT02698371|365575607|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
105977036|NCT02698371|365575607|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
105977037|NCT02698371|365575607|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
105977038|NCT02698371|365575607|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
105977039|NCT03582813|365575608|FG000|Overall Study|Lost to Follow-up|18|||
105977040|NCT03582813|365575609|FG001|Overall Study|Lost to Follow-up|21|||
105977041|NCT03582813|365575608|FG000|Overall Study|Withdrawal by Subject|1|||
105977042|NCT03582813|365575609|FG001|Overall Study|Withdrawal by Subject|0|||
105977043|NCT01591863|365575610|FG000|Overall Study|Adverse Event|3|||
105977044|NCT01591863|365575610|FG000|Overall Study|Withdrawal by Subject|1|||
105977045|NCT01591863|365575610|FG000|Overall Study|recurrence|9|||
105977046|NCT01591863|365575610|FG000|Overall Study|Lack of Efficacy|1|||
105977047|NCT00969436|365575612|FG000|Overall Study|Protocol Violation|1|||
105977048|NCT00969436|365575613|FG001|Overall Study|Protocol Violation|3|||
105977049|NCT00969436|365575614|FG002|Overall Study|Protocol Violation|0|||
105977050|NCT00969436|365575612|FG000|Overall Study|Migrated/moved from study area|12|||
105977051|NCT00969436|365575613|FG001|Overall Study|Migrated/moved from study area|10|||
105977052|NCT00969436|365575614|FG002|Overall Study|Migrated/moved from study area|2|||
105977053|NCT00969436|365575612|FG000|Overall Study|Father - serious health problem|0|||
105977054|NCT00969436|365575613|FG001|Overall Study|Father - serious health problem|0|||
105977055|NCT00969436|365575614|FG002|Overall Study|Father - serious health problem|1|||
105977056|NCT00969436|365575612|FG000|Overall Study|Parents personal problem|0|||
105977057|NCT00969436|365575613|FG001|Overall Study|Parents personal problem|0|||
105977058|NCT00969436|365575614|FG002|Overall Study|Parents personal problem|1|||
105977059|NCT00969436|365575612|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
106027600|NCT00281658|365767399|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
106027601|NCT00281658|365767400|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
106027602|NCT00281658|365767401|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
105977060|NCT00969436|365575613|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
105977061|NCT00969436|365575614|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
105977062|NCT00969436|365575612|FG000|Overall Study|Withdrawal by Subject|3|||
105977063|NCT00969436|365575613|FG001|Overall Study|Withdrawal by Subject|0|||
105977064|NCT00969436|365575614|FG002|Overall Study|Withdrawal by Subject|2|||
105977065|NCT00969436|365575612|FG000|Overall Study|Lost to Follow-up|8|||
105977066|NCT00969436|365575613|FG001|Overall Study|Lost to Follow-up|8|||
105977067|NCT00969436|365575614|FG002|Overall Study|Lost to Follow-up|5|||
105977068|NCT02366767|365575615|FG000|Overall Study|left for home after 1 day at camp|1|||
105977069|NCT02366767|365575616|FG001|Overall Study|left for home after 1 day at camp|0|||
105977070|NCT02242981|365575617|FG000|Overall Study|Withdrawal by Subject|1|||
105977071|NCT00459537|365575623|FG000|Overall Study|Adverse Event|1|||
105977072|NCT00459537|365575624|FG001|Overall Study|Adverse Event|6|||
105977073|NCT00459537|365575623|FG000|Overall Study|Lack of Efficacy|10|||
105977074|NCT00459537|365575624|FG001|Overall Study|Lack of Efficacy|11|||
105977075|NCT00459537|365575623|FG000|Overall Study|Withdrawal by Subject|20|||
105977076|NCT00459537|365575624|FG001|Overall Study|Withdrawal by Subject|26|||
105977077|NCT00459537|365575623|FG000|Overall Study|Lost to Follow-up|27|||
105977078|NCT00459537|365575624|FG001|Overall Study|Lost to Follow-up|30|||
105977079|NCT00459537|365575623|FG000|Overall Study|Administrative problems|3|||
105977080|NCT00459537|365575624|FG001|Overall Study|Administrative problems|0|||
105977081|NCT00459537|365575623|FG000|Overall Study|Protocol Violation|4|||
105977082|NCT00459537|365575624|FG001|Overall Study|Protocol Violation|3|||
105977083|NCT00459537|365575623|FG000|Overall Study|Missing|1|||
105977084|NCT00459537|365575624|FG001|Overall Study|Missing|0|||
105977085|NCT03159104|365575625|FG000|Overall Study|Violation of inclusion criteria|1|||
105977086|NCT03159104|365575626|FG001|Overall Study|Violation of inclusion criteria|2|||
105977087|NCT00456599|365575627|FG000|Overall Study|Non-compliance|1|||
105977088|NCT00456599|365575627|FG000|Overall Study|Withdrawal by Subject|2|||
105977089|NCT01999218|365575630|FG000|Overall Study|Hyperglycemia|18|||
105977090|NCT01999218|365575631|FG001|Overall Study|Hyperglycemia|17|||
105977091|NCT01999218|365575632|FG002|Overall Study|Hyperglycemia|17|||
106027603|NCT00281658|365767402|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
106027604|NCT00281658|365767399|FG000|Randomized Phase|Treatment ongoing|1|||
106027605|NCT00281658|365767400|FG001|Randomized Phase|Treatment ongoing|0|||
106027606|NCT00281658|365767401|FG002|Randomized Phase|Treatment ongoing|0|||
106027607|NCT00281658|365767402|FG003|Randomized Phase|Treatment ongoing|0|||
106027608|NCT00281658|365767399|FG000|Open Label Phase|Adverse Event|0|||
106027609|NCT00281658|365767400|FG001|Open Label Phase|Adverse Event|0|||
106027610|NCT00281658|365767401|FG002|Open Label Phase|Adverse Event|1|||
106027611|NCT00281658|365767402|FG003|Open Label Phase|Adverse Event|0|||
106027612|NCT00281658|365767399|FG000|Open Label Phase|Lost to Follow-up|0|||
106027613|NCT00281658|365767400|FG001|Open Label Phase|Lost to Follow-up|0|||
106027614|NCT00281658|365767401|FG002|Open Label Phase|Lost to Follow-up|16|||
106027615|NCT00281658|365767402|FG003|Open Label Phase|Lost to Follow-up|2|||
105850946|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850947|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
106027616|NCT00281658|365767399|FG000|Open Label Phase|Withdrawal by Subject|0|||
106027617|NCT00281658|365767400|FG001|Open Label Phase|Withdrawal by Subject|0|||
106027618|NCT00281658|365767401|FG002|Open Label Phase|Withdrawal by Subject|3|||
106027619|NCT00281658|365767402|FG003|Open Label Phase|Withdrawal by Subject|2|||
106027620|NCT00281658|365767399|FG000|Open Label Phase|Disease progression|0|||
106027621|NCT00281658|365767400|FG001|Open Label Phase|Disease progression|0|||
106027622|NCT00281658|365767401|FG002|Open Label Phase|Disease progression|18|||
106027623|NCT00281658|365767402|FG003|Open Label Phase|Disease progression|0|||
106027624|NCT00281658|365767399|FG000|Open Label Phase|Physician Decision|0|||
106027625|NCT00281658|365767400|FG001|Open Label Phase|Physician Decision|0|||
106150868|NCT02723955|366215067|FG013|Escalation Phase|Lost to Follow-up|0|||
105977092|NCT01999218|365575630|FG000|Overall Study|Lack of Efficacy|1|||
105977093|NCT01999218|365575631|FG001|Overall Study|Lack of Efficacy|0|||
105977094|NCT01999218|365575632|FG002|Overall Study|Lack of Efficacy|1|||
105977095|NCT01999218|365575630|FG000|Overall Study|Lost to Follow-up|22|||
105977096|NCT01999218|365575631|FG001|Overall Study|Lost to Follow-up|17|||
105977097|NCT01999218|365575632|FG002|Overall Study|Lost to Follow-up|18|||
105977098|NCT01999218|365575630|FG000|Overall Study|Non-Compliance With Study Drug|6|||
105977099|NCT01999218|365575631|FG001|Overall Study|Non-Compliance With Study Drug|4|||
105977100|NCT01999218|365575632|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105977101|NCT01999218|365575630|FG000|Overall Study|Physician Decision|1|||
106027626|NCT00281658|365767401|FG002|Open Label Phase|Physician Decision|1|||
106027627|NCT00281658|365767402|FG003|Open Label Phase|Physician Decision|0|||
106027628|NCT00281658|365767399|FG000|Open Label Phase|Relocation of patient|0|||
106027629|NCT00281658|365767400|FG001|Open Label Phase|Relocation of patient|0|||
106027630|NCT00281658|365767401|FG002|Open Label Phase|Relocation of patient|1|||
106027631|NCT00281658|365767402|FG003|Open Label Phase|Relocation of patient|0|||
106027632|NCT00281658|365767399|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
106027633|NCT00281658|365767400|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
105850948|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850949|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
106027634|NCT00281658|365767401|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
106150869|NCT02723955|366215068|FG014|Escalation Phase|Lost to Follow-up|0|||
105977102|NCT01999218|365575631|FG001|Overall Study|Physician Decision|4|||
105977103|NCT01999218|365575632|FG002|Overall Study|Physician Decision|6|||
106027635|NCT00281658|365767402|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
106027636|NCT00507728|365767403|FG000|Randomization to Month 3|Lost to Follow-up|15|||
106027637|NCT00507728|365767404|FG001|Randomization to Month 3|Lost to Follow-up|14|||
106027638|NCT00507728|365767405|FG002|Randomization to Month 3|Lost to Follow-up|20|||
106027639|NCT00507728|365767403|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
106027640|NCT00507728|365767404|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
106027641|NCT00507728|365767405|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
106027642|NCT00813943|365767408|FG000|Overall Study|Ongoing at cut-off date|5|||
106027643|NCT00813943|365767409|FG001|Overall Study|Ongoing at cut-off date|5|||
106027644|NCT00813943|365767410|FG002|Overall Study|Ongoing at cut-off date|3|||
106027645|NCT01343693|365767411|FG000|Overall Study|Lost to Follow-up|9|||
106027646|NCT02704143|365767412|FG000|Overall Study|disease progression|10|||
106027647|NCT01235598|365767413|FG000|Overall Study|Adverse Event|0|||
106027648|NCT01235598|365767414|FG001|Overall Study|Adverse Event|3|||
106027649|NCT01235598|365767413|FG000|Overall Study|Lack of Efficacy|0|||
106027650|NCT01235598|365767414|FG001|Overall Study|Lack of Efficacy|1|||
106027651|NCT01235598|365767413|FG000|Overall Study|Withdrawal by Subject|1|||
106027652|NCT01235598|365767414|FG001|Overall Study|Withdrawal by Subject|0|||
106027653|NCT03680742|365767415|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
106027654|NCT04605991|365767419|FG000|Overall Study|Adverse Event|5|||
106027655|NCT04605991|365767419|FG000|Overall Study|Lack of Efficacy|1|||
106027656|NCT04605991|365767419|FG000|Overall Study|Lost to Follow-up|8|||
106027657|NCT04605991|365767419|FG000|Overall Study|Physician Decision|4|||
106027658|NCT04605991|365767419|FG000|Overall Study|Withdrawal by Subject|14|||
106027659|NCT04605991|365767419|FG000|Overall Study|Non-compliance with study|1|||
106027660|NCT01410357|365767420|FG000|Overall Study|Death|2|||
106027661|NCT01410357|365767421|FG001|Overall Study|Death|1|||
106027662|NCT01410357|365767420|FG000|Overall Study|Withdrawal by Subject|1|||
106027663|NCT01410357|365767421|FG001|Overall Study|Withdrawal by Subject|2|||
106027664|NCT01410357|365767420|FG000|Overall Study|Lost to Follow-up|23|||
106027665|NCT01410357|365767421|FG001|Overall Study|Lost to Follow-up|21|||
106027666|NCT01523275|365767422|FG000|Overall Study|Lost to Follow-up|1|||
106027667|NCT01523275|365767423|FG001|Overall Study|Lost to Follow-up|2|||
106027668|NCT01523275|365767422|FG000|Overall Study|Withdrawal by Subject|1|||
106027669|NCT01523275|365767423|FG001|Overall Study|Withdrawal by Subject|0|||
106027670|NCT03263702|365767424|FG000|Overall Study|Lost to Follow-up|2|||
106027671|NCT03263702|365767425|FG001|Overall Study|Lost to Follow-up|2|||
106027672|NCT03263702|365767424|FG000|Overall Study|Withdrawal by Subject|1|||
106027673|NCT03263702|365767425|FG001|Overall Study|Withdrawal by Subject|2|||
106027674|NCT03598114|365767426|FG000|Overall Study|Staff turnover/left the program|3|||
106027675|NCT03598114|365767427|FG001|Overall Study|Staff turnover/left the program|39|||
106027676|NCT02527200|365767428|FG000|Overall Study|Withdrawal by Subject|3|||
106027677|NCT02527200|365767429|FG001|Overall Study|Withdrawal by Subject|2|||
106027678|NCT02527200|365767430|FG002|Overall Study|Withdrawal by Subject|1|||
106027679|NCT02527200|365767431|FG003|Overall Study|Withdrawal by Subject|0|||
105850950|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850951|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850952|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850953|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850954|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850955|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105977104|NCT01999218|365575630|FG000|Overall Study|Protocol Violation|4|||
105977105|NCT01999218|365575631|FG001|Overall Study|Protocol Violation|5|||
105977106|NCT01999218|365575632|FG002|Overall Study|Protocol Violation|4|||
105977107|NCT01999218|365575630|FG000|Overall Study|Screen failure|0|||
105977108|NCT01999218|365575631|FG001|Overall Study|Screen failure|1|||
105977109|NCT01999218|365575632|FG002|Overall Study|Screen failure|0|||
105977110|NCT01999218|365575630|FG000|Overall Study|Study Terminated By Sponsor|7|||
105977111|NCT01999218|365575631|FG001|Overall Study|Study Terminated By Sponsor|5|||
105977112|NCT01999218|365575632|FG002|Overall Study|Study Terminated By Sponsor|12|||
105977113|NCT01999218|365575630|FG000|Overall Study|Participant moves|2|||
105977114|NCT01999218|365575631|FG001|Overall Study|Participant moves|5|||
105977115|NCT01999218|365575632|FG002|Overall Study|Participant moves|3|||
105977116|NCT01999218|365575630|FG000|Overall Study|Withdrawal by Subject|28|||
105977117|NCT01999218|365575631|FG001|Overall Study|Withdrawal by Subject|29|||
105977118|NCT01999218|365575632|FG002|Overall Study|Withdrawal by Subject|34|||
105977119|NCT01999218|365575630|FG000|Overall Study|Creatinine/eGFR|0|||
105977120|NCT01999218|365575631|FG001|Overall Study|Creatinine/eGFR|0|||
105977121|NCT01999218|365575632|FG002|Overall Study|Creatinine/eGFR|1|||
105977122|NCT01999218|365575630|FG000|Overall Study|Death|7|||
105977123|NCT01999218|365575631|FG001|Overall Study|Death|1|||
105977124|NCT01999218|365575632|FG002|Overall Study|Death|2|||
105977125|NCT01999218|365575630|FG000|Overall Study|Excluded Medication|1|||
105977126|NCT01999218|365575631|FG001|Overall Study|Excluded Medication|1|||
105977127|NCT01999218|365575632|FG002|Overall Study|Excluded Medication|2|||
105977128|NCT01999218|365575630|FG000|Overall Study|Adverse Event|9|||
105977129|NCT01999218|365575631|FG001|Overall Study|Adverse Event|7|||
106150870|NCT02723955|366215069|FG015|Escalation Phase|Lost to Follow-up|0|||
106150871|NCT02723955|366215070|FG016|Escalation Phase|Lost to Follow-up|1|||
106150872|NCT02723955|366215071|FG017|Escalation Phase|Lost to Follow-up|2|||
106150873|NCT02723955|366215072|FG018|Escalation Phase|Lost to Follow-up|0|||
106150874|NCT02723955|366215073|FG019|Escalation Phase|Lost to Follow-up|1|||
106150875|NCT02723955|366215074|FG020|Escalation Phase|Lost to Follow-up|2|||
106150876|NCT02723955|366215075|FG021|Escalation Phase|Lost to Follow-up|1|||
106150877|NCT02723955|366215076|FG022|Escalation Phase|Lost to Follow-up|0|||
106150878|NCT02723955|366215077|FG023|Escalation Phase|Lost to Follow-up|0|||
106150879|NCT02723955|366215078|FG024|Escalation Phase|Lost to Follow-up|1|||
106150880|NCT02723955|366215079|FG025|Escalation Phase|Lost to Follow-up|1|||
106150881|NCT02723955|366215080|FG026|Escalation Phase|Lost to Follow-up|3|||
106150882|NCT02723955|366215081|FG027|Escalation Phase|Lost to Follow-up|0|||
106150883|NCT02723955|366215082|FG028|Escalation Phase|Lost to Follow-up|1|||
106150884|NCT02723955|366215083|FG029|Escalation Phase|Lost to Follow-up|0|||
106150885|NCT02723955|366215084|FG030|Escalation Phase|Lost to Follow-up|0|||
105850956|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105977130|NCT01999218|365575632|FG002|Overall Study|Adverse Event|7|||
105977131|NCT01999218|365575630|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
105977132|NCT01999218|365575631|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
105977133|NCT01999218|365575632|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
105977134|NCT03959982|365577257|FG000|Overall Study|Withdrawal by Subject|1|||
105977135|NCT03959982|365577258|FG001|Overall Study|Withdrawal by Subject|0|||
105977136|NCT03959982|365577257|FG000|Overall Study|Physician Decision|2|||
105977137|NCT03959982|365577258|FG001|Overall Study|Physician Decision|0|||
105977138|NCT03959982|365577257|FG000|Overall Study|Lost to Follow-up|1|||
105977139|NCT03959982|365577258|FG001|Overall Study|Lost to Follow-up|0|||
105977140|NCT01176565|365577277|FG000|Overall Study|Lost to Follow-up|12|||
105977141|NCT01176565|365577278|FG001|Overall Study|Lost to Follow-up|16|||
105977142|NCT01176565|365577277|FG000|Overall Study|Withdrawal by Subject|7|||
105977143|NCT01176565|365577278|FG001|Overall Study|Withdrawal by Subject|1|||
105977144|NCT01176565|365577277|FG000|Overall Study|Not Analyzed (any other reason)|1|||
105977145|NCT01176565|365577278|FG001|Overall Study|Not Analyzed (any other reason)|2|||
105977146|NCT01703117|365577283|FG000|Overall Study|Adverse Event|4|||
105977147|NCT01703117|365577284|FG001|Overall Study|Adverse Event|3|||
105977148|NCT01703117|365577283|FG000|Overall Study|Withdrawal by Subject|0|||
105977149|NCT01703117|365577284|FG001|Overall Study|Withdrawal by Subject|1|||
105977150|NCT01340937|365577285|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
105850957|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850958|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105977151|NCT01340937|365577286|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
105977152|NCT01340937|365577287|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
105977153|NCT01340937|365577288|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
105977154|NCT01340937|365577285|FG000|Period 1: Infant Series|Adverse Event|0|||
105977155|NCT01340937|365577286|FG001|Period 1: Infant Series|Adverse Event|1|||
105977156|NCT01340937|365577287|FG002|Period 1: Infant Series|Adverse Event|4|||
105977157|NCT01340937|365577288|FG003|Period 1: Infant Series|Adverse Event|0|||
105977158|NCT01340937|365577285|FG000|Period 1: Infant Series|Death|2|||
105977159|NCT01340937|365577286|FG001|Period 1: Infant Series|Death|0|||
105977160|NCT01340937|365577287|FG002|Period 1: Infant Series|Death|2|||
105850959|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105977161|NCT01340937|365577288|FG003|Period 1: Infant Series|Death|0|||
105977162|NCT01340937|365577285|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
105977163|NCT01340937|365577286|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
105977164|NCT01340937|365577287|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
105977165|NCT01340937|365577288|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
105977166|NCT01340937|365577285|FG000|Period 1: Infant Series|Physician Decision|2|||
105977167|NCT01340937|365577286|FG001|Period 1: Infant Series|Physician Decision|3|||
105977168|NCT01340937|365577287|FG002|Period 1: Infant Series|Physician Decision|1|||
105977169|NCT01340937|365577288|FG003|Period 1: Infant Series|Physician Decision|0|||
105977170|NCT01340937|365577285|FG000|Period 1: Infant Series|Protocol Violation|1|||
105977171|NCT01340937|365577286|FG001|Period 1: Infant Series|Protocol Violation|4|||
105977172|NCT01340937|365577287|FG002|Period 1: Infant Series|Protocol Violation|4|||
105977173|NCT01340937|365577288|FG003|Period 1: Infant Series|Protocol Violation|3|||
105977174|NCT01340937|365577285|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
105977175|NCT01340937|365577286|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
105977176|NCT01340937|365577287|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
105977177|NCT01340937|365577288|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
105977178|NCT01340937|365577285|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
105977179|NCT01340937|365577286|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
105977180|NCT01340937|365577287|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
105977181|NCT01340937|365577288|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
105977182|NCT01340937|365577285|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
105977183|NCT01340937|365577286|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
105977184|NCT01340937|365577287|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
105977185|NCT01340937|365577288|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
105977186|NCT01340937|365577285|FG000|Period 2: Interim Period|Adverse Event|1|||
105977187|NCT01340937|365577286|FG001|Period 2: Interim Period|Adverse Event|0|||
105977188|NCT01340937|365577287|FG002|Period 2: Interim Period|Adverse Event|1|||
105977189|NCT01340937|365577288|FG003|Period 2: Interim Period|Adverse Event|0|||
105977190|NCT01340937|365577285|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
106027680|NCT02527200|365767428|FG000|Overall Study|Unclassified|0|||
106027681|NCT02527200|365767429|FG001|Overall Study|Unclassified|1|||
106027682|NCT02527200|365767430|FG002|Overall Study|Unclassified|0|||
106027683|NCT02527200|365767431|FG003|Overall Study|Unclassified|0|||
106027684|NCT02527200|365767428|FG000|Overall Study|Lost to Follow-up|0|||
106027685|NCT02527200|365767429|FG001|Overall Study|Lost to Follow-up|0|||
106027686|NCT02527200|365767430|FG002|Overall Study|Lost to Follow-up|1|||
106027687|NCT02527200|365767431|FG003|Overall Study|Lost to Follow-up|0|||
106027688|NCT00874939|365767433|FG000|Overall Study|Study terminated|4|||
106027689|NCT02870933|365767434|FG000|Overall Study|Death|2|||
106027690|NCT02870933|365767435|FG001|Overall Study|Death|1|||
106027691|NCT02870933|365767434|FG000|Overall Study|Withdrawal by Subject|0|||
106027692|NCT02870933|365767435|FG001|Overall Study|Withdrawal by Subject|1|||
106027693|NCT00689117|365767436|FG000|Overall Study|Adverse Event|6|||
106027694|NCT00689117|365767437|FG001|Overall Study|Adverse Event|0|||
106027695|NCT00689117|365767438|FG002|Overall Study|Adverse Event|5|||
106027696|NCT00689117|365767439|FG003|Overall Study|Adverse Event|0|||
105850960|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
105850961|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850962|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
105850963|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
105850964|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850965|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
105850966|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
105850967|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Death|0|||
105850968|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Death|0|||
105850969|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Death|0|||
105850970|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Death|0|||
105850971|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Death|0|||
105850972|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Death|0|||
105850973|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Death|0|||
105850974|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Death|0|||
105850975|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Death|0|||
105850976|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Death|0|||
105850977|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Death|0|||
105850978|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Death|0|||
105850979|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Death|0|||
105850980|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Death|0|||
105850981|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Death|0|||
105850982|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Death|1|||
105850983|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Death|7|||
105850984|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Death|5|||
105850985|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Death|5|||
105850986|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Death|3|||
105850987|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Death|7|||
105850988|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Death|5|||
105850989|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Death|6|||
105850990|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Death|3|||
105850991|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Death|0|||
106027697|NCT00689117|365767436|FG000|Overall Study|Lost to Follow-up|26|||
106027698|NCT00689117|365767437|FG001|Overall Study|Lost to Follow-up|19|||
106027699|NCT00689117|365767438|FG002|Overall Study|Lost to Follow-up|17|||
106027700|NCT00689117|365767439|FG003|Overall Study|Lost to Follow-up|11|||
106027701|NCT00689117|365767436|FG000|Overall Study|Lack of Efficacy|1|||
106027702|NCT00689117|365767437|FG001|Overall Study|Lack of Efficacy|2|||
106027703|NCT00689117|365767438|FG002|Overall Study|Lack of Efficacy|2|||
106027704|NCT00689117|365767439|FG003|Overall Study|Lack of Efficacy|2|||
106027705|NCT00689117|365767436|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
106027706|NCT00689117|365767437|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
106027707|NCT00689117|365767438|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
106027708|NCT00689117|365767439|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
106027709|NCT00689117|365767436|FG000|Overall Study|Withdrawal by Subject|19|||
106027710|NCT00689117|365767437|FG001|Overall Study|Withdrawal by Subject|18|||
105850992|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
106027711|NCT00689117|365767438|FG002|Overall Study|Withdrawal by Subject|26|||
105850993|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850994|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850995|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105977191|NCT01340937|365577286|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
105977192|NCT01340937|365577287|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
105977193|NCT01340937|365577288|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
105977194|NCT01340937|365577285|FG000|Period 2: Interim Period|Physician Decision|0|||
105977195|NCT01340937|365577286|FG001|Period 2: Interim Period|Physician Decision|1|||
105977196|NCT01340937|365577287|FG002|Period 2: Interim Period|Physician Decision|1|||
105977197|NCT01340937|365577288|FG003|Period 2: Interim Period|Physician Decision|0|||
105977198|NCT01340937|365577285|FG000|Period 2: Interim Period|Protocol Violation|5|||
105977199|NCT01340937|365577286|FG001|Period 2: Interim Period|Protocol Violation|3|||
105977200|NCT01340937|365577287|FG002|Period 2: Interim Period|Protocol Violation|6|||
105977201|NCT01340937|365577288|FG003|Period 2: Interim Period|Protocol Violation|3|||
105977202|NCT01340937|365577285|FG000|Period 2: Interim Period|Technical problems|4|||
105977203|NCT01340937|365577286|FG001|Period 2: Interim Period|Technical problems|4|||
105977204|NCT01340937|365577287|FG002|Period 2: Interim Period|Technical problems|6|||
106027712|NCT00689117|365767439|FG003|Overall Study|Withdrawal by Subject|13|||
106027713|NCT00689117|365767436|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
106027714|NCT00689117|365767437|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
106027715|NCT00689117|365767438|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
106027716|NCT00689117|365767439|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
106027717|NCT00689117|365767436|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
106027718|NCT00689117|365767437|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
106027719|NCT00689117|365767438|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
106027720|NCT00689117|365767439|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
106027721|NCT00689117|365767436|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
106027722|NCT00689117|365767437|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
106027723|NCT00689117|365767438|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
106027724|NCT00689117|365767439|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
106027725|NCT00689117|365767436|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
106027726|NCT00689117|365767437|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
106027727|NCT00689117|365767438|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
106027728|NCT00689117|365767439|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
106027729|NCT00689117|365767436|FG000|Overall Study|Use of Prohibitive Medication|2|||
106027730|NCT00689117|365767437|FG001|Overall Study|Use of Prohibitive Medication|1|||
106027731|NCT00689117|365767438|FG002|Overall Study|Use of Prohibitive Medication|3|||
106027732|NCT00689117|365767439|FG003|Overall Study|Use of Prohibitive Medication|0|||
106027733|NCT00689117|365767436|FG000|Overall Study|Pregnancy|0|||
106027734|NCT00689117|365767437|FG001|Overall Study|Pregnancy|2|||
106027735|NCT00689117|365767438|FG002|Overall Study|Pregnancy|0|||
106027736|NCT00689117|365767439|FG003|Overall Study|Pregnancy|2|||
106027737|NCT00689117|365767436|FG000|Overall Study|Incarceration|2|||
106027738|NCT00689117|365767437|FG001|Overall Study|Incarceration|0|||
106027739|NCT00689117|365767438|FG002|Overall Study|Incarceration|0|||
106027740|NCT00689117|365767439|FG003|Overall Study|Incarceration|0|||
106027741|NCT00689117|365767436|FG000|Overall Study|Fear of Birth Defects|0|||
106027742|NCT00689117|365767437|FG001|Overall Study|Fear of Birth Defects|0|||
106027743|NCT00689117|365767438|FG002|Overall Study|Fear of Birth Defects|1|||
106027744|NCT00689117|365767439|FG003|Overall Study|Fear of Birth Defects|0|||
106027745|NCT00689117|365767436|FG000|Overall Study|Transportation|1|||
106027746|NCT00689117|365767437|FG001|Overall Study|Transportation|0|||
106027747|NCT00689117|365767438|FG002|Overall Study|Transportation|0|||
106027748|NCT00689117|365767439|FG003|Overall Study|Transportation|0|||
106027749|NCT00689117|365767436|FG000|Overall Study|Patient Withdrew from Study|0|||
106027750|NCT00689117|365767437|FG001|Overall Study|Patient Withdrew from Study|0|||
106027751|NCT00689117|365767438|FG002|Overall Study|Patient Withdrew from Study|0|||
106027752|NCT00689117|365767439|FG003|Overall Study|Patient Withdrew from Study|1|||
106027753|NCT00689117|365767436|FG000|Overall Study|Personal Reason|0|||
106027754|NCT00689117|365767437|FG001|Overall Study|Personal Reason|1|||
106027755|NCT00689117|365767438|FG002|Overall Study|Personal Reason|0|||
106027756|NCT00689117|365767439|FG003|Overall Study|Personal Reason|0|||
106027757|NCT00689117|365767436|FG000|Overall Study|Dispensing Error|0|||
105977205|NCT01340937|365577288|FG003|Period 2: Interim Period|Technical problems|3|||
106027758|NCT00689117|365767437|FG001|Overall Study|Dispensing Error|1|||
105977206|NCT01340937|365577285|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
106027759|NCT00689117|365767438|FG002|Overall Study|Dispensing Error|0|||
106027760|NCT00689117|365767439|FG003|Overall Study|Dispensing Error|0|||
106027761|NCT01332799|365767445|FG000|Overall Study|Insufficient funding|10|||
106027762|NCT01332799|365767446|FG001|Overall Study|Insufficient funding|10|||
106027763|NCT00294762|365767456|FG000|Overall Study|Did not receive study treatment|3|||
106027764|NCT00294762|365767457|FG001|Overall Study|Did not receive study treatment|3|||
105977207|NCT01340937|365577286|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
105977208|NCT01340937|365577287|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
105977209|NCT01340937|365577288|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
105977210|NCT01340937|365577285|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
105977211|NCT01340937|365577286|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
105977212|NCT01340937|365577287|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
105977213|NCT01340937|365577288|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
105977214|NCT01340937|365577285|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
105977215|NCT01340937|365577286|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
105977216|NCT01340937|365577287|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
105977217|NCT01340937|365577288|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
105977218|NCT01340937|365577285|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
105977219|NCT01340937|365577286|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
105977220|NCT01340937|365577287|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
105977221|NCT01340937|365577288|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
105977222|NCT04599166|365577292|FG000|Overall Study|Technological failure connecting to study app|80|||
105977223|NCT02317809|365577293|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
105977224|NCT02317809|365577294|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
105977225|NCT02317809|365577293|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
105977226|NCT02317809|365577294|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
105977227|NCT01030874|365577297|FG000|Overall Study|Withdrawal by Subject|1|||
105977228|NCT01030874|365577298|FG001|Overall Study|Withdrawal by Subject|0|||
105977229|NCT01030874|365577297|FG000|Overall Study|Discharged in first 2 weeks|17|||
105977230|NCT01030874|365577298|FG001|Overall Study|Discharged in first 2 weeks|16|||
105977231|NCT03106415|365577299|FG000|Phase 1|Withdrawal by Subject|1|||
105977232|NCT03106415|365577300|FG001|Phase 1|Withdrawal by Subject|0|||
105977233|NCT03106415|365577301|FG002|Phase 1|Withdrawal by Subject|0|||
105977234|NCT03106415|365577299|FG000|Phase 1|Adverse Event|1|||
105977235|NCT03106415|365577300|FG001|Phase 1|Adverse Event|1|||
105977236|NCT03106415|365577301|FG002|Phase 1|Adverse Event|0|||
105977237|NCT03106415|365577299|FG000|Phase 1|Protocol Violation|0|||
105977238|NCT03106415|365577300|FG001|Phase 1|Protocol Violation|1|||
105977239|NCT03106415|365577301|FG002|Phase 1|Protocol Violation|0|||
105977240|NCT01998893|365577305|FG000|Overall Study|Adverse Event|2|||
105977241|NCT01998893|365577305|FG000|Overall Study|Death|1|||
105977242|NCT01998893|365577305|FG000|Overall Study|Lost to Follow-up|8|||
105977243|NCT01998893|365577305|FG000|Overall Study|Physician Decision|2|||
105977244|NCT01998893|365577305|FG000|Overall Study|Protocol Violation|2|||
105977245|NCT01998893|365577305|FG000|Overall Study|Withdrawal by Subject|1|||
105977246|NCT01998893|365577305|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
105977247|NCT03276052|365577306|FG000|Overall Study|Withdrawal by Subject|5|||
105977248|NCT03276052|365577306|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
105977249|NCT01145053|365577307|FG000|Overall Study|Adverse Event|22|||
105977250|NCT01145053|365577307|FG000|Overall Study|Lost to Follow-up|28|||
106150886|NCT02723955|366215085|FG031|Escalation Phase|Lost to Follow-up|0|||
106150887|NCT02723955|366215086|FG032|Escalation Phase|Lost to Follow-up|0|||
106150888|NCT02723955|366215087|FG033|Escalation Phase|Lost to Follow-up|0|||
106150889|NCT02723955|366215088|FG034|Escalation Phase|Lost to Follow-up|0|||
106150890|NCT02723955|366215089|FG035|Escalation Phase|Lost to Follow-up|0|||
106150891|NCT02723955|366215090|FG036|Escalation Phase|Lost to Follow-up|0|||
106150892|NCT02723955|366215091|FG037|Escalation Phase|Lost to Follow-up|0|||
106150893|NCT02723955|366215092|FG038|Escalation Phase|Lost to Follow-up|0|||
106150894|NCT02723955|366215093|FG039|Escalation Phase|Lost to Follow-up|0|||
106150895|NCT02723955|366215094|FG040|Escalation Phase|Lost to Follow-up|0|||
106150896|NCT02723955|366215095|FG041|Escalation Phase|Lost to Follow-up|0|||
106150897|NCT02723955|366215096|FG042|Escalation Phase|Lost to Follow-up|0|||
106150898|NCT02723955|366215054|FG000|Escalation Phase|Physician Decision|0|||
106150899|NCT02723955|366215055|FG001|Escalation Phase|Physician Decision|0|||
105977251|NCT01145053|365577307|FG000|Overall Study|Withdrawal by Subject|25|||
105977252|NCT01145053|365577307|FG000|Overall Study|Other|18|||
105977253|NCT00867087|365577308|FG000|Overall Study|Other|1|||
105977254|NCT00867087|365577308|FG000|Overall Study|Withdrawal by Subject|4|||
105977255|NCT00867087|365577308|FG000|Overall Study|Death|37|||
105977256|NCT00293709|365577309|FG000|Overall Study|Other|47|||
105977257|NCT01804582|365577310|FG000|Overall Study|Lost to Follow-up|47|||
105977258|NCT01804582|365577311|FG001|Overall Study|Lost to Follow-up|56|||
106150900|NCT02723955|366215056|FG002|Escalation Phase|Physician Decision|0|||
106150901|NCT02723955|366215057|FG003|Escalation Phase|Physician Decision|0|||
106150902|NCT02723955|366215058|FG004|Escalation Phase|Physician Decision|0|||
105977259|NCT01804582|365577310|FG000|Overall Study|Physician Decision|2|||
105977260|NCT01804582|365577311|FG001|Overall Study|Physician Decision|0|||
105977261|NCT03883113|365577312|FG000|Overall Study|Physician Decision|4|||
105977262|NCT03883113|365577313|FG001|Overall Study|Physician Decision|2|||
105977263|NCT03883113|365577312|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
105850996|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850997|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850998|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105850999|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851000|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851001|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851002|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851003|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851004|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851005|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851006|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851007|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851008|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851009|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851010|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851011|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
105851012|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851013|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851014|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851015|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
105851016|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
105851017|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Disease Progression|0|||
105851018|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Disease Progression|0|||
105851019|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Disease Progression|0|||
105851020|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Disease Progression|0|||
105851021|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Disease Progression|0|||
105851022|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Disease Progression|0|||
105851023|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Disease Progression|0|||
105851024|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Disease Progression|0|||
105851025|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Disease Progression|0|||
105851026|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Disease Progression|0|||
105851027|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Disease Progression|0|||
105851028|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Disease Progression|0|||
105851029|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Disease Progression|0|||
105851030|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Disease Progression|0|||
105851031|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Disease Progression|0|||
105851032|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Disease Progression|0|||
105851033|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Disease Progression|0|||
105851034|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Disease Progression|0|||
105851035|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Disease Progression|0|||
105851036|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Disease Progression|0|||
105851037|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Disease Progression|2|||
105977264|NCT03883113|365577313|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
105977265|NCT03883113|365577312|FG000|Overall Study|Pregnancy|1|||
105977266|NCT03883113|365577313|FG001|Overall Study|Pregnancy|0|||
105977267|NCT03883113|365577312|FG000|Overall Study|Adverse Event|0|||
105977268|NCT03883113|365577313|FG001|Overall Study|Adverse Event|1|||
105977269|NCT03883113|365577312|FG000|Overall Study|Withdrawal by Subject|1|||
105977270|NCT03883113|365577313|FG001|Overall Study|Withdrawal by Subject|2|||
105977271|NCT03883113|365577312|FG000|Overall Study|Lost to Follow-up|1|||
105977272|NCT03883113|365577313|FG001|Overall Study|Lost to Follow-up|0|||
105977273|NCT00900146|365577318|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
105977274|NCT00900146|365577319|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
105977275|NCT00900146|365577320|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
105977276|NCT00900146|365577321|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
105977277|NCT00900146|365577322|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
105977278|NCT00900146|365577318|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
105977279|NCT00900146|365577319|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
105977280|NCT00900146|365577320|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
105977281|NCT00900146|365577321|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
105977282|NCT00900146|365577322|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
105977283|NCT00900146|365577318|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
105977284|NCT00900146|365577319|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
105977285|NCT00900146|365577320|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
105977286|NCT00900146|365577321|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
105851038|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Disease Progression|1|||
105977287|NCT00900146|365577322|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
105851039|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Disease Progression|0|||
105851040|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Disease Progression|0|||
105851041|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Disease Progression|0|||
105851042|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851043|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851044|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851045|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851046|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851047|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851048|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851049|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851050|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851051|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851052|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851053|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851054|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
105977288|NCT00900146|365577318|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
105977289|NCT00900146|365577319|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
105977290|NCT00900146|365577320|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
105977291|NCT00900146|365577321|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
105977292|NCT00900146|365577322|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
105977293|NCT00900146|365577318|FG000|Intermediate: Period III|Lost to Follow-up|2|||
105977294|NCT00900146|365577319|FG001|Intermediate: Period III|Lost to Follow-up|0|||
105977295|NCT00900146|365577320|FG002|Intermediate: Period III|Lost to Follow-up|0|||
105977296|NCT00900146|365577321|FG003|Intermediate: Period III|Lost to Follow-up|0|||
105977297|NCT00900146|365577322|FG004|Intermediate: Period III|Lost to Follow-up|1|||
105977298|NCT00900146|365577318|FG000|Intermediate: Period III|Administrative problems|85|||
105977299|NCT00900146|365577319|FG001|Intermediate: Period III|Administrative problems|92|||
105977300|NCT00900146|365577320|FG002|Intermediate: Period III|Administrative problems|84|||
105977301|NCT00900146|365577321|FG003|Intermediate: Period III|Administrative problems|90|||
105977302|NCT00900146|365577322|FG004|Intermediate: Period III|Administrative problems|163|||
105977303|NCT01143896|365577323|FG000|Overall Study|Did not complete Baseline Interview|5|||
105977304|NCT01143896|365577324|FG001|Overall Study|Did not complete Baseline Interview|4|||
105977305|NCT01143896|365577323|FG000|Overall Study|Lost to Follow-up|18|||
105977306|NCT01143896|365577324|FG001|Overall Study|Lost to Follow-up|13|||
105977307|NCT01143896|365577323|FG000|Overall Study|Withdrawal by Subject|13|||
105977308|NCT01143896|365577324|FG001|Overall Study|Withdrawal by Subject|5|||
105977309|NCT01143896|365577323|FG000|Overall Study|Death|6|||
105977310|NCT01143896|365577324|FG001|Overall Study|Death|3|||
105977311|NCT01304329|365577325|FG000|Third Intervention (3 Days)|Adverse Event|0|||
105977312|NCT01304329|365577326|FG001|Third Intervention (3 Days)|Adverse Event|1|||
105977313|NCT01304329|365577327|FG002|Third Intervention (3 Days)|Adverse Event|0|||
105977314|NCT01304329|365577328|FG003|Third Intervention (3 Days)|Adverse Event|0|||
105977315|NCT01304329|365577329|FG004|Third Intervention (3 Days)|Adverse Event|0|||
105977316|NCT01304329|365577330|FG005|Third Intervention (3 Days)|Adverse Event|0|||
105977317|NCT01995552|365577333|FG000|Overall Study|Protocol Violation|1|||
105977318|NCT01995552|365577333|FG000|Overall Study|Lack of Efficacy|15|||
105977319|NCT01995552|365577333|FG000|Overall Study|Death|1|||
105977320|NCT02068118|365577334|FG000|18-month Comparative Study Period|Death|90|||
105977321|NCT02068118|365577335|FG001|18-month Comparative Study Period|Death|97|||
105977322|NCT02068118|365577334|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
105977323|NCT02068118|365577335|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
105977324|NCT02068118|365577334|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
105977325|NCT02068118|365577335|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
105977326|NCT02068118|365577334|FG000|18-month Comparative Study Period|Heart transplant|9|||
105977327|NCT02068118|365577335|FG001|18-month Comparative Study Period|Heart transplant|15|||
105977328|NCT02068118|365577334|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
105977329|NCT02068118|365577335|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
105977330|NCT02068118|365577334|FG000|18-month Comparative Study Period|Hemiplegia|0|||
105977331|NCT02068118|365577335|FG001|18-month Comparative Study Period|Hemiplegia|1|||
105977332|NCT02068118|365577334|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
105851055|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851056|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851057|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851058|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
105977333|NCT02068118|365577335|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
105977334|NCT02068118|365577334|FG000|18-month Comparative Study Period|Move|0|||
105977335|NCT02068118|365577335|FG001|18-month Comparative Study Period|Move|1|||
105977336|NCT02068118|365577334|FG000|18-month Comparative Study Period|Hearing loss|0|||
105977337|NCT02068118|365577335|FG001|18-month Comparative Study Period|Hearing loss|1|||
105977338|NCT02068118|365577334|FG000|Extension Period|Death|0|||
105977339|NCT02068118|365577335|FG001|Extension Period|Death|2|||
105977340|NCT02068118|365577334|FG000|Extension Period|Withdrawal by Subject|1|||
105977341|NCT02068118|365577335|FG001|Extension Period|Withdrawal by Subject|0|||
105977342|NCT02068118|365577334|FG000|Extension Period|Heart transplant|1|||
105977343|NCT02068118|365577335|FG001|Extension Period|Heart transplant|0|||
105977344|NCT02068118|365577334|FG000|Extension Period|Wrong device use|0|||
105977345|NCT02068118|365577335|FG001|Extension Period|Wrong device use|1|||
105977346|NCT03515941|365577336|FG000|Overall Study|Adverse Event|1|||
105977347|NCT03515941|365577337|FG001|Overall Study|Adverse Event|0|||
105977348|NCT00334282|365577338|FG000|Overall Study|Lost to Follow-up|11|||
105977349|NCT00334282|365577339|FG001|Overall Study|Lost to Follow-up|5|||
105977350|NCT00334282|365577338|FG000|Overall Study|Withdrawal by Subject|17|||
105977351|NCT00334282|365577339|FG001|Overall Study|Withdrawal by Subject|3|||
105977352|NCT00334282|365577338|FG000|Overall Study|Death|194|||
105977353|NCT00334282|365577339|FG001|Overall Study|Death|100|||
105977354|NCT00468845|365577340|FG000|Overall Study|Adverse Event|9|||
105977355|NCT00468845|365577341|FG001|Overall Study|Adverse Event|14|||
105977356|NCT00468845|365577342|FG002|Overall Study|Adverse Event|11|||
105977357|NCT00468845|365577340|FG000|Overall Study|Lost to Follow-up|2|||
105977358|NCT00468845|365577341|FG001|Overall Study|Lost to Follow-up|1|||
105977359|NCT00468845|365577342|FG002|Overall Study|Lost to Follow-up|2|||
105977360|NCT00468845|365577340|FG000|Overall Study|Other|4|||
105977361|NCT00468845|365577341|FG001|Overall Study|Other|9|||
105977362|NCT00468845|365577342|FG002|Overall Study|Other|5|||
105977363|NCT00468845|365577340|FG000|Overall Study|No longer willing to participate|5|||
105977364|NCT00468845|365577341|FG001|Overall Study|No longer willing to participate|6|||
105977365|NCT00468845|365577342|FG002|Overall Study|No longer willing to participate|10|||
105977366|NCT00468845|365577340|FG000|Overall Study|Randomized, not treated|1|||
105977367|NCT00468845|365577341|FG001|Overall Study|Randomized, not treated|4|||
105977368|NCT00468845|365577342|FG002|Overall Study|Randomized, not treated|2|||
105977369|NCT00283868|365577343|FG000|Overall Study|Lost to Follow-up|7|||
105977370|NCT00283868|365577344|FG001|Overall Study|Lost to Follow-up|8|||
105977371|NCT01406015|365577345|FG000|Overall Study|Withdrawal by Subject|3|||
105977372|NCT01406015|365577346|FG001|Overall Study|Withdrawal by Subject|3|||
105977373|NCT02075632|365577352|FG000|Overall Study|Adverse Event|1|||
105977374|NCT02075632|365577353|FG001|Overall Study|Adverse Event|1|||
105977375|NCT02075632|365577352|FG000|Overall Study|Lost to Follow-up|0|||
105977376|NCT02075632|365577353|FG001|Overall Study|Lost to Follow-up|3|||
105977377|NCT02075632|365577352|FG000|Overall Study|Withdrawal by Subject|0|||
105977378|NCT02075632|365577353|FG001|Overall Study|Withdrawal by Subject|1|||
105977379|NCT00645528|365577357|FG000|Overall Study|Did not show up for Visit 2|7|||
105977380|NCT01011933|365577359|FG000|Overall Study|Wrong cell type|1|||
105977381|NCT01011933|365577359|FG000|Overall Study|Improper pre-protocol Rx|1|||
105977382|NCT01011933|365577359|FG000|Overall Study|Inadequate pathology|1|||
105977383|NCT01011933|365577359|FG000|Overall Study|Never treated|1|||
106027765|NCT00505076|365767459|FG000|Overall Study|Adverse Event|1|||
106027766|NCT00505076|365767460|FG001|Overall Study|Adverse Event|0|||
106027767|NCT00505076|365767461|FG002|Overall Study|Adverse Event|1|||
106027768|NCT00505076|365767459|FG000|Overall Study|Protocol Violation|2|||
106027769|NCT00505076|365767460|FG001|Overall Study|Protocol Violation|1|||
106027770|NCT00505076|365767461|FG002|Overall Study|Protocol Violation|2|||
106027771|NCT00505076|365767459|FG000|Overall Study|Withdrawal by Subject|0|||
106027772|NCT00505076|365767460|FG001|Overall Study|Withdrawal by Subject|1|||
106027773|NCT00505076|365767461|FG002|Overall Study|Withdrawal by Subject|2|||
106027774|NCT04093024|365767462|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
106027775|NCT04093024|365767463|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
106027776|NCT04093024|365767462|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
106027777|NCT04093024|365767463|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
106027778|NCT04093024|365767462|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
106027779|NCT04093024|365767463|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
106027780|NCT04093024|365767462|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
106027781|NCT04093024|365767463|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
105977384|NCT01439074|365577364|FG000|Overall Study|Lost to Follow-up|3|||
105977385|NCT01439074|365577365|FG001|Overall Study|Lost to Follow-up|4|||
105977386|NCT01439074|365577364|FG000|Overall Study|Subject shedding|1|||
105977387|NCT01439074|365577365|FG001|Overall Study|Subject shedding|0|||
105977388|NCT01439074|365577364|FG000|Overall Study|Withdrawal by Subject|1|||
105977389|NCT01439074|365577365|FG001|Overall Study|Withdrawal by Subject|5|||
105977390|NCT01439074|365577364|FG000|Overall Study|Other|4|||
105977391|NCT01439074|365577365|FG001|Overall Study|Other|4|||
105977392|NCT02226549|365577366|FG000|Overall Study|Randomized but Never Treated|1|||
105977393|NCT02226549|365577367|FG001|Overall Study|Randomized but Never Treated|0|||
105977394|NCT02226549|365577366|FG000|Overall Study|Lost to Follow-up|0|||
105977395|NCT02226549|365577367|FG001|Overall Study|Lost to Follow-up|1|||
105977396|NCT00612508|365577368|FG000|Overall Study|Withdrawal by Subject|3|||
105977397|NCT00612508|365577369|FG001|Overall Study|Withdrawal by Subject|4|||
106150903|NCT02723955|366215059|FG005|Escalation Phase|Physician Decision|2|||
106150904|NCT02723955|366215060|FG006|Escalation Phase|Physician Decision|0|||
106150905|NCT02723955|366215061|FG007|Escalation Phase|Physician Decision|0|||
106150906|NCT02723955|366215062|FG008|Escalation Phase|Physician Decision|0|||
106150907|NCT02723955|366215063|FG009|Escalation Phase|Physician Decision|0|||
106150908|NCT02723955|366215064|FG010|Escalation Phase|Physician Decision|0|||
106150909|NCT02723955|366215065|FG011|Escalation Phase|Physician Decision|0|||
106150910|NCT02723955|366215066|FG012|Escalation Phase|Physician Decision|0|||
106150911|NCT02723955|366215067|FG013|Escalation Phase|Physician Decision|0|||
106150912|NCT02723955|366215068|FG014|Escalation Phase|Physician Decision|0|||
106150913|NCT02723955|366215069|FG015|Escalation Phase|Physician Decision|0|||
106150914|NCT02723955|366215070|FG016|Escalation Phase|Physician Decision|0|||
106150915|NCT02723955|366215071|FG017|Escalation Phase|Physician Decision|0|||
106150916|NCT02723955|366215072|FG018|Escalation Phase|Physician Decision|0|||
106150917|NCT02723955|366215073|FG019|Escalation Phase|Physician Decision|0|||
106150918|NCT02723955|366215074|FG020|Escalation Phase|Physician Decision|0|||
106150919|NCT02723955|366215075|FG021|Escalation Phase|Physician Decision|0|||
106150920|NCT02723955|366215076|FG022|Escalation Phase|Physician Decision|0|||
106150921|NCT02723955|366215077|FG023|Escalation Phase|Physician Decision|0|||
106150922|NCT02723955|366215078|FG024|Escalation Phase|Physician Decision|0|||
106150923|NCT02723955|366215079|FG025|Escalation Phase|Physician Decision|0|||
106150924|NCT02723955|366215080|FG026|Escalation Phase|Physician Decision|2|||
106150925|NCT02723955|366215081|FG027|Escalation Phase|Physician Decision|0|||
106150926|NCT02723955|366215082|FG028|Escalation Phase|Physician Decision|0|||
106150927|NCT02723955|366215083|FG029|Escalation Phase|Physician Decision|0|||
106150928|NCT02723955|366215084|FG030|Escalation Phase|Physician Decision|0|||
106150929|NCT02723955|366215085|FG031|Escalation Phase|Physician Decision|0|||
106150930|NCT02723955|366215086|FG032|Escalation Phase|Physician Decision|0|||
106150931|NCT02723955|366215087|FG033|Escalation Phase|Physician Decision|0|||
106150932|NCT02723955|366215088|FG034|Escalation Phase|Physician Decision|0|||
106150933|NCT02723955|366215089|FG035|Escalation Phase|Physician Decision|0|||
106150934|NCT02723955|366215090|FG036|Escalation Phase|Physician Decision|0|||
106150935|NCT02723955|366215091|FG037|Escalation Phase|Physician Decision|0|||
106150936|NCT02723955|366215092|FG038|Escalation Phase|Physician Decision|0|||
106150937|NCT02723955|366215093|FG039|Escalation Phase|Physician Decision|0|||
106150938|NCT02723955|366215094|FG040|Escalation Phase|Physician Decision|0|||
106150939|NCT02723955|366215095|FG041|Escalation Phase|Physician Decision|0|||
106150940|NCT02723955|366215096|FG042|Escalation Phase|Physician Decision|0|||
106150941|NCT02723955|366215054|FG000|Escalation Phase|Withdrawal by Subject|0|||
106150942|NCT02723955|366215055|FG001|Escalation Phase|Withdrawal by Subject|0|||
106150943|NCT02723955|366215056|FG002|Escalation Phase|Withdrawal by Subject|0|||
106150944|NCT02723955|366215057|FG003|Escalation Phase|Withdrawal by Subject|0|||
106150945|NCT02723955|366215058|FG004|Escalation Phase|Withdrawal by Subject|1|||
106150946|NCT02723955|366215059|FG005|Escalation Phase|Withdrawal by Subject|1|||
106150947|NCT02723955|366215060|FG006|Escalation Phase|Withdrawal by Subject|1|||
106150948|NCT02723955|366215061|FG007|Escalation Phase|Withdrawal by Subject|1|||
106150949|NCT02723955|366215062|FG008|Escalation Phase|Withdrawal by Subject|0|||
106150950|NCT02723955|366215063|FG009|Escalation Phase|Withdrawal by Subject|0|||
106150951|NCT02723955|366215064|FG010|Escalation Phase|Withdrawal by Subject|0|||
106150952|NCT02723955|366215065|FG011|Escalation Phase|Withdrawal by Subject|0|||
105851059|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851060|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851061|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851062|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
105851063|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
105851064|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851065|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851066|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
105851067|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851068|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851069|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851070|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851071|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851072|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851073|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851074|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851075|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851076|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
106150953|NCT02723955|366215066|FG012|Escalation Phase|Withdrawal by Subject|1|||
106150954|NCT02723955|366215067|FG013|Escalation Phase|Withdrawal by Subject|0|||
106150955|NCT02723955|366215068|FG014|Escalation Phase|Withdrawal by Subject|0|||
106150956|NCT02723955|366215069|FG015|Escalation Phase|Withdrawal by Subject|0|||
106150957|NCT02723955|366215070|FG016|Escalation Phase|Withdrawal by Subject|1|||
106150958|NCT02723955|366215071|FG017|Escalation Phase|Withdrawal by Subject|0|||
106150959|NCT02723955|366215072|FG018|Escalation Phase|Withdrawal by Subject|0|||
106150960|NCT02723955|366215073|FG019|Escalation Phase|Withdrawal by Subject|0|||
106150961|NCT02723955|366215074|FG020|Escalation Phase|Withdrawal by Subject|0|||
106150962|NCT02723955|366215075|FG021|Escalation Phase|Withdrawal by Subject|0|||
106150963|NCT02723955|366215076|FG022|Escalation Phase|Withdrawal by Subject|0|||
106150964|NCT02723955|366215077|FG023|Escalation Phase|Withdrawal by Subject|2|||
106150965|NCT02723955|366215078|FG024|Escalation Phase|Withdrawal by Subject|0|||
106150966|NCT02723955|366215079|FG025|Escalation Phase|Withdrawal by Subject|1|||
106150967|NCT02723955|366215080|FG026|Escalation Phase|Withdrawal by Subject|0|||
106150968|NCT02723955|366215081|FG027|Escalation Phase|Withdrawal by Subject|0|||
106150969|NCT02723955|366215082|FG028|Escalation Phase|Withdrawal by Subject|1|||
106150970|NCT02723955|366215083|FG029|Escalation Phase|Withdrawal by Subject|0|||
106150971|NCT02723955|366215084|FG030|Escalation Phase|Withdrawal by Subject|0|||
106150972|NCT02723955|366215085|FG031|Escalation Phase|Withdrawal by Subject|0|||
106150973|NCT02723955|366215086|FG032|Escalation Phase|Withdrawal by Subject|0|||
106150974|NCT02723955|366215087|FG033|Escalation Phase|Withdrawal by Subject|0|||
106150975|NCT02723955|366215088|FG034|Escalation Phase|Withdrawal by Subject|0|||
106150976|NCT02723955|366215089|FG035|Escalation Phase|Withdrawal by Subject|0|||
106150977|NCT02723955|366215090|FG036|Escalation Phase|Withdrawal by Subject|0|||
106150978|NCT02723955|366215091|FG037|Escalation Phase|Withdrawal by Subject|0|||
106150979|NCT02723955|366215092|FG038|Escalation Phase|Withdrawal by Subject|0|||
106150980|NCT02723955|366215093|FG039|Escalation Phase|Withdrawal by Subject|0|||
106150981|NCT02723955|366215094|FG040|Escalation Phase|Withdrawal by Subject|0|||
106150982|NCT02723955|366215095|FG041|Escalation Phase|Withdrawal by Subject|0|||
106150983|NCT02723955|366215096|FG042|Escalation Phase|Withdrawal by Subject|0|||
106150984|NCT02723955|366215054|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150985|NCT02723955|366215055|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150986|NCT02723955|366215056|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105851077|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851078|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851079|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851080|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851081|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851082|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851083|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851084|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851085|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851086|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851087|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
105851088|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851089|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851090|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851091|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
105851092|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Adverse Event|0|||
105851093|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Adverse Event|0|||
105851094|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Adverse Event|0|||
105851095|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Adverse Event|0|||
105851096|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Adverse Event|0|||
105851097|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Adverse Event|0|||
105851098|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Adverse Event|0|||
105851099|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Adverse Event|0|||
105851100|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Adverse Event|0|||
105851101|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Adverse Event|0|||
105851102|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Adverse Event|0|||
106150987|NCT02723955|366215057|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150988|NCT02723955|366215058|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
106150989|NCT02723955|366215059|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
106150990|NCT02723955|366215060|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
106150991|NCT02723955|366215061|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
105851103|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Adverse Event|0|||
105851104|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Adverse Event|0|||
105851105|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Adverse Event|0|||
105851106|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Adverse Event|0|||
105851107|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Adverse Event|0|||
105851108|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Adverse Event|0|||
105851109|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Adverse Event|0|||
105851110|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Adverse Event|0|||
105851111|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Adverse Event|0|||
105851112|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Adverse Event|0|||
105851113|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Adverse Event|0|||
105851114|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Adverse Event|0|||
105851115|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Adverse Event|1|||
105851116|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Adverse Event|0|||
105851117|NCT02393248|365112579|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851118|NCT02393248|365112580|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851119|NCT02393248|365112581|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851120|NCT02393248|365112582|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851121|NCT02393248|365112583|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851122|NCT02393248|365112584|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851123|NCT02393248|365112585|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851124|NCT02393248|365112586|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851125|NCT02393248|365112587|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851126|NCT02393248|365112588|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851127|NCT02393248|365112589|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851128|NCT02393248|365112590|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851129|NCT02393248|365112591|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851130|NCT02393248|365112592|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851131|NCT02393248|365112593|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851132|NCT02393248|365112594|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851133|NCT02393248|365112595|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851134|NCT02393248|365112596|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851135|NCT02393248|365112597|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851136|NCT02393248|365112598|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105977398|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
105977399|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
105977400|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
105977401|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
105977402|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
105977403|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
105977404|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
105977405|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
105977406|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
105977407|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
105977408|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
105977409|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
105977410|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
105977411|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
105977412|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
105977413|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
105977414|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
105977415|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
105977416|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
105977417|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
105977418|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
105977419|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
105977420|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
105977421|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
105977422|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
105977423|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
105977424|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
105977425|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
106027782|NCT03642132|365767464|FG000|Chemotherapy Period|Adverse Event|1|||
105977426|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
105977427|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
105977428|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
105977429|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
105977430|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
105977431|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
106150992|NCT02723955|366215062|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
106150993|NCT02723955|366215063|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150994|NCT02723955|366215064|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150995|NCT02723955|366215065|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150996|NCT02723955|366215066|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150997|NCT02723955|366215067|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150998|NCT02723955|366215068|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106150999|NCT02723955|366215069|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151000|NCT02723955|366215070|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151001|NCT02723955|366215071|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151002|NCT02723955|366215072|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151003|NCT02723955|366215073|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105977432|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
105977433|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
105977434|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
105977435|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
105977436|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
105977437|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
105977438|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
105977439|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
105977440|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
105977441|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
105977442|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
105977443|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
105977444|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
105977445|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
105977446|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
105977447|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
105977448|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
105977449|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
105977450|NCT02008357|365577370|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
105977451|NCT02008357|365577371|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
105977452|NCT02008357|365577370|FG000|Open-label Extension Period|Adverse Event|8|||
105977453|NCT02008357|365577371|FG001|Open-label Extension Period|Adverse Event|7|||
105977454|NCT02008357|365577370|FG000|Open-label Extension Period|Death|7|||
105977455|NCT02008357|365577371|FG001|Open-label Extension Period|Death|4|||
105977456|NCT02008357|365577370|FG000|Open-label Extension Period|Lack of Efficacy|9|||
105977457|NCT02008357|365577371|FG001|Open-label Extension Period|Lack of Efficacy|5|||
105977458|NCT02008357|365577370|FG000|Open-label Extension Period|Lost to Follow-up|2|||
105977459|NCT02008357|365577371|FG001|Open-label Extension Period|Lost to Follow-up|2|||
105977460|NCT02008357|365577370|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
105977461|NCT02008357|365577371|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
105977462|NCT02008357|365577370|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
105977463|NCT02008357|365577371|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
105977464|NCT02008357|365577370|FG000|Open-label Extension Period|Safety Risk|2|||
105977465|NCT02008357|365577371|FG001|Open-label Extension Period|Safety Risk|1|||
105977466|NCT02008357|365577370|FG000|Open-label Extension Period|Non-Compliance|0|||
105977467|NCT02008357|365577371|FG001|Open-label Extension Period|Non-Compliance|1|||
105977468|NCT02008357|365577370|FG000|Open-label Extension Period|Investigator Recommendation|0|||
105977469|NCT02008357|365577371|FG001|Open-label Extension Period|Investigator Recommendation|1|||
105977470|NCT02008357|365577370|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
105977471|NCT02008357|365577371|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
105977472|NCT02008357|365577370|FG000|Open-label Extension Period|Coordinating Center Request|2|||
105977473|NCT02008357|365577371|FG001|Open-label Extension Period|Coordinating Center Request|4|||
105977474|NCT02008357|365577370|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
105977475|NCT02008357|365577371|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
105977476|NCT02008357|365577370|FG000|Open-label Extension Period|Study Ended|20|||
105977477|NCT02008357|365577371|FG001|Open-label Extension Period|Study Ended|25|||
105977478|NCT02008357|365577370|FG000|Open-label Extension Period|Personal Reasons|0|||
105977479|NCT02008357|365577371|FG001|Open-label Extension Period|Personal Reasons|1|||
105977480|NCT02008357|365577370|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
105977481|NCT02008357|365577371|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
105977482|NCT02008357|365577370|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
105977483|NCT02008357|365577371|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
105977484|NCT02008357|365577370|FG000|Open-label Extension Period|Other|2|||
105977485|NCT02008357|365577371|FG001|Open-label Extension Period|Other|0|||
105977486|NCT00787202|365577372|FG000|Overall Study|Adverse Event|3|||
105977487|NCT00787202|365577373|FG001|Overall Study|Adverse Event|2|||
105977488|NCT00787202|365577374|FG002|Overall Study|Adverse Event|0|||
105977489|NCT00787202|365577375|FG003|Overall Study|Adverse Event|0|||
105977490|NCT00787202|365577376|FG004|Overall Study|Adverse Event|2|||
105977491|NCT00787202|365577372|FG000|Overall Study|Lack of Efficacy|5|||
105977492|NCT00787202|365577373|FG001|Overall Study|Lack of Efficacy|6|||
105977493|NCT00787202|365577374|FG002|Overall Study|Lack of Efficacy|5|||
105977494|NCT00787202|365577375|FG003|Overall Study|Lack of Efficacy|2|||
105977495|NCT00787202|365577376|FG004|Overall Study|Lack of Efficacy|1|||
105977496|NCT00787202|365577372|FG000|Overall Study|Lost to Follow-up|1|||
105977497|NCT00787202|365577373|FG001|Overall Study|Lost to Follow-up|0|||
105977498|NCT00787202|365577374|FG002|Overall Study|Lost to Follow-up|0|||
105977499|NCT00787202|365577375|FG003|Overall Study|Lost to Follow-up|0|||
105977500|NCT00787202|365577376|FG004|Overall Study|Lost to Follow-up|0|||
105977501|NCT00787202|365577372|FG000|Overall Study|Withdrawal by Subject|2|||
105977502|NCT00787202|365577373|FG001|Overall Study|Withdrawal by Subject|2|||
105977503|NCT00787202|365577374|FG002|Overall Study|Withdrawal by Subject|2|||
105977504|NCT00787202|365577375|FG003|Overall Study|Withdrawal by Subject|0|||
105977505|NCT00787202|365577376|FG004|Overall Study|Withdrawal by Subject|0|||
105851137|NCT02393248|365112599|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851138|NCT02393248|365112600|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851139|NCT02393248|365112601|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851140|NCT02393248|365112602|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
105851141|NCT02393248|365112603|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
105851142|NCT04765384|365112604|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
105851143|NCT04765384|365112605|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
105851144|NCT04765384|365112606|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
105851145|NCT04765384|365112607|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
105851146|NCT04765384|365112608|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
105851147|NCT04765384|365112609|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
105851148|NCT04765384|365112604|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
105851149|NCT04765384|365112605|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
105851150|NCT04765384|365112606|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
105977506|NCT00787202|365577372|FG000|Overall Study|Protocol Violation|2|||
106027783|NCT03642132|365767465|FG001|Chemotherapy Period|Adverse Event|1|||
105851151|NCT04765384|365112607|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
105977507|NCT00787202|365577373|FG001|Overall Study|Protocol Violation|1|||
105977508|NCT00787202|365577374|FG002|Overall Study|Protocol Violation|0|||
105977509|NCT00787202|365577375|FG003|Overall Study|Protocol Violation|0|||
105977510|NCT00787202|365577376|FG004|Overall Study|Protocol Violation|1|||
105977511|NCT00787202|365577372|FG000|Overall Study|Randomized, not treated|1|||
105977512|NCT00787202|365577373|FG001|Overall Study|Randomized, not treated|0|||
105977513|NCT00787202|365577374|FG002|Overall Study|Randomized, not treated|0|||
105977514|NCT00787202|365577375|FG003|Overall Study|Randomized, not treated|0|||
106027784|NCT03642132|365767466|FG002|Chemotherapy Period|Adverse Event|0|||
105851152|NCT04765384|365112608|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
105977515|NCT00787202|365577376|FG004|Overall Study|Randomized, not treated|0|||
105851153|NCT04765384|365112609|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
105851154|NCT04765384|365112604|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851155|NCT04765384|365112605|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851156|NCT04765384|365112606|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851157|NCT04765384|365112607|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851158|NCT04765384|365112608|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
105851159|NCT04765384|365112609|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
105851160|NCT04765384|365112604|FG000|Post-natal: Neonates and Infants|Death|0|||
105851161|NCT04765384|365112605|FG001|Post-natal: Neonates and Infants|Death|0|||
105851162|NCT04765384|365112606|FG002|Post-natal: Neonates and Infants|Death|0|||
105851163|NCT04765384|365112607|FG003|Post-natal: Neonates and Infants|Death|1|||
105851164|NCT04765384|365112608|FG004|Post-natal: Neonates and Infants|Death|0|||
105851165|NCT04765384|365112609|FG005|Post-natal: Neonates and Infants|Death|0|||
105851166|NCT04765384|365112604|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851167|NCT04765384|365112605|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851168|NCT04765384|365112606|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851169|NCT04765384|365112607|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851170|NCT04765384|365112608|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
105851171|NCT04765384|365112609|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
105851172|NCT02335983|365112610|FG000|Overall Study|Sponsor Decision|0|||
105851173|NCT02335983|365112611|FG001|Overall Study|Sponsor Decision|0|||
105851174|NCT02335983|365112612|FG002|Overall Study|Sponsor Decision|1|||
105851175|NCT02335983|365112613|FG003|Overall Study|Sponsor Decision|1|||
105851176|NCT02335983|365112614|FG004|Overall Study|Sponsor Decision|0|||
105977516|NCT00966719|365577377|FG000|Overall Study|Lost to Follow-up|6|||
105977517|NCT00966719|365577378|FG001|Overall Study|Lost to Follow-up|11|||
105851177|NCT02335983|365112615|FG005|Overall Study|Sponsor Decision|1|||
105851178|NCT02335983|365112610|FG000|Overall Study|Withdrawal by Subject|3|||
105851179|NCT02335983|365112611|FG001|Overall Study|Withdrawal by Subject|2|||
105851180|NCT02335983|365112612|FG002|Overall Study|Withdrawal by Subject|2|||
105851181|NCT02335983|365112613|FG003|Overall Study|Withdrawal by Subject|1|||
105851182|NCT02335983|365112614|FG004|Overall Study|Withdrawal by Subject|3|||
105851183|NCT02335983|365112615|FG005|Overall Study|Withdrawal by Subject|9|||
105851184|NCT02335983|365112610|FG000|Overall Study|Death|0|||
105851185|NCT02335983|365112611|FG001|Overall Study|Death|0|||
105851186|NCT02335983|365112612|FG002|Overall Study|Death|2|||
105851187|NCT02335983|365112613|FG003|Overall Study|Death|0|||
105851188|NCT02335983|365112614|FG004|Overall Study|Death|0|||
105851189|NCT02335983|365112615|FG005|Overall Study|Death|0|||
105851190|NCT02335983|365112610|FG000|Overall Study|Lost to Follow-up|0|||
105851191|NCT02335983|365112611|FG001|Overall Study|Lost to Follow-up|0|||
105851192|NCT02335983|365112612|FG002|Overall Study|Lost to Follow-up|0|||
105851193|NCT02335983|365112613|FG003|Overall Study|Lost to Follow-up|0|||
105851194|NCT02335983|365112614|FG004|Overall Study|Lost to Follow-up|0|||
105977518|NCT00160199|365577379|FG000|Overall Study|Adverse Event|5|||
105977519|NCT00160199|365577380|FG001|Overall Study|Adverse Event|14|||
105977520|NCT00160199|365577379|FG000|Overall Study|Lack of Efficacy|0|||
105977521|NCT00160199|365577380|FG001|Overall Study|Lack of Efficacy|1|||
105977522|NCT00160199|365577379|FG000|Overall Study|Lost to Follow-up|7|||
105977523|NCT00160199|365577380|FG001|Overall Study|Lost to Follow-up|7|||
105977524|NCT00160199|365577379|FG000|Overall Study|Withdrawal by Subject|4|||
105977525|NCT00160199|365577380|FG001|Overall Study|Withdrawal by Subject|6|||
105977526|NCT00160199|365577379|FG000|Overall Study|Administrative|0|||
105977527|NCT00160199|365577380|FG001|Overall Study|Administrative|1|||
105977528|NCT00160199|365577379|FG000|Overall Study|Protocol Violation|8|||
105977529|NCT00160199|365577380|FG001|Overall Study|Protocol Violation|8|||
105977530|NCT02635347|365577383|FG000|Overall Study|Failed screening|20|||
105977531|NCT02635347|365577384|FG001|Overall Study|Failed screening|7|||
105977532|NCT03352453|365577385|FG000|Overall Study|Miscellaneous Reasons|1|||
105977533|NCT03352453|365577386|FG001|Overall Study|Miscellaneous Reasons|2|||
105977534|NCT03352453|365577385|FG000|Overall Study|Lack of Efficacy|1|||
105977535|NCT03352453|365577386|FG001|Overall Study|Lack of Efficacy|0|||
105977536|NCT03352453|365577385|FG000|Overall Study|Withdrawal by Subject|8|||
105977537|NCT03352453|365577386|FG001|Overall Study|Withdrawal by Subject|14|||
105977538|NCT03352453|365577385|FG000|Overall Study|Study Terminated by Sponsor|2|||
105977539|NCT03352453|365577386|FG001|Overall Study|Study Terminated by Sponsor|1|||
105977540|NCT03352453|365577385|FG000|Overall Study|Protocol Deviation|1|||
105977541|NCT03352453|365577386|FG001|Overall Study|Protocol Deviation|0|||
105977542|NCT03352453|365577385|FG000|Overall Study|Lost to Follow-up|7|||
105977543|NCT03352453|365577386|FG001|Overall Study|Lost to Follow-up|6|||
105977544|NCT03352453|365577385|FG000|Overall Study|Adverse Event|2|||
105977545|NCT03352453|365577386|FG001|Overall Study|Adverse Event|9|||
105977546|NCT03089944|365577387|FG000|Overall Study|Lost to Follow-up|8|||
105977547|NCT03089944|365577387|FG000|Overall Study|Withdrew Consent|2|||
105977548|NCT03089944|365577387|FG000|Overall Study|Adverse Event|1|||
105977549|NCT03089944|365577387|FG000|Overall Study|Other|1|||
105977550|NCT00831701|365577399|FG000|Overall Study|Withdrawal by Subject|2|||
105977551|NCT00831701|365577400|FG001|Overall Study|Withdrawal by Subject|0|||
105977552|NCT00831701|365577399|FG000|Overall Study|Stone expulsion before first medication|2|||
105977553|NCT00831701|365577400|FG001|Overall Study|Stone expulsion before first medication|2|||
105977554|NCT00831701|365577399|FG000|Overall Study|Lost to Follow-up|1|||
105977555|NCT00831701|365577400|FG001|Overall Study|Lost to Follow-up|3|||
105977556|NCT02739321|365577407|FG000|Overall Study|Lack of Efficacy|1|||
105977557|NCT02739321|365577408|FG001|Overall Study|Lack of Efficacy|1|||
105977558|NCT02739321|365577407|FG000|Overall Study|Lost to Follow-up|1|||
105977559|NCT02739321|365577408|FG001|Overall Study|Lost to Follow-up|1|||
105977560|NCT02739321|365577407|FG000|Overall Study|Withdrawal by Subject|1|||
105977561|NCT02739321|365577408|FG001|Overall Study|Withdrawal by Subject|2|||
105977562|NCT02558400|365577409|FG000|Overall Study|Adverse Event|47|||
105977563|NCT02558400|365577410|FG001|Overall Study|Adverse Event|53|||
105977564|NCT02558400|365577411|FG002|Overall Study|Adverse Event|4|||
105977565|NCT02558400|365577409|FG000|Overall Study|Withdrawal by Subject|13|||
105977566|NCT02558400|365577410|FG001|Overall Study|Withdrawal by Subject|9|||
105977567|NCT02558400|365577411|FG002|Overall Study|Withdrawal by Subject|8|||
105977568|NCT02558400|365577409|FG000|Overall Study|Non-Compliant|0|||
105977569|NCT02558400|365577410|FG001|Overall Study|Non-Compliant|1|||
105977570|NCT02558400|365577411|FG002|Overall Study|Non-Compliant|3|||
105977571|NCT02558400|365577409|FG000|Overall Study|Lost to Follow-up|5|||
105977572|NCT02558400|365577410|FG001|Overall Study|Lost to Follow-up|5|||
105977573|NCT02558400|365577411|FG002|Overall Study|Lost to Follow-up|4|||
105977574|NCT02558400|365577409|FG000|Overall Study|Lack of Efficacy|0|||
105977575|NCT02558400|365577410|FG001|Overall Study|Lack of Efficacy|13|||
105977576|NCT02558400|365577411|FG002|Overall Study|Lack of Efficacy|1|||
105977577|NCT02558400|365577409|FG000|Overall Study|Disallowed Concurrent Medication|6|||
105977578|NCT02558400|365577410|FG001|Overall Study|Disallowed Concurrent Medication|7|||
105977579|NCT02558400|365577411|FG002|Overall Study|Disallowed Concurrent Medication|5|||
105977580|NCT02558400|365577409|FG000|Overall Study|Physician Decision|2|||
105977581|NCT02558400|365577410|FG001|Overall Study|Physician Decision|2|||
105977582|NCT02558400|365577411|FG002|Overall Study|Physician Decision|0|||
105977583|NCT02558400|365577409|FG000|Overall Study|Protocol Violation|6|||
105977584|NCT02558400|365577410|FG001|Overall Study|Protocol Violation|3|||
105977585|NCT02558400|365577411|FG002|Overall Study|Protocol Violation|8|||
105977586|NCT02558400|365577409|FG000|Overall Study|Death|0|||
105977587|NCT02558400|365577410|FG001|Overall Study|Death|1|||
105977588|NCT02558400|365577411|FG002|Overall Study|Death|0|||
105977589|NCT02558400|365577409|FG000|Overall Study|Ineligible for the study|0|||
105977590|NCT02558400|365577410|FG001|Overall Study|Ineligible for the study|2|||
105977591|NCT02558400|365577411|FG002|Overall Study|Ineligible for the study|0|||
105977592|NCT00387647|365578978|FG000|Overall Study|Death|18|||
105977593|NCT03966885|365578979|FG000|Overall Study|Death|1|||
105977594|NCT03966885|365578980|FG001|Overall Study|Death|0|||
105977595|NCT03966885|365578979|FG000|Overall Study|Lost to Follow-up|1|||
105977596|NCT03966885|365578980|FG001|Overall Study|Lost to Follow-up|2|||
105977597|NCT03966885|365578979|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
105977598|NCT03966885|365578980|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
105977599|NCT03966885|365578979|FG000|Overall Study|Moved from study area.|0|||
105977600|NCT03966885|365578980|FG001|Overall Study|Moved from study area.|2|||
105977601|NCT02032407|365578981|FG000|Overall Study|Lost to Follow-up|2|||
105977602|NCT02032407|365578981|FG000|Overall Study|Pregnancy|1|||
105977603|NCT02032407|365578981|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105977604|NCT02191605|365578982|FG000|Overall Study|Lost to Follow-up|9|||
105977605|NCT02191605|365578983|FG001|Overall Study|Lost to Follow-up|4|||
105977606|NCT02191605|365578984|FG002|Overall Study|Lost to Follow-up|7|||
105977607|NCT02191605|365578985|FG003|Overall Study|Lost to Follow-up|3|||
105977608|NCT02191605|365578986|FG004|Overall Study|Lost to Follow-up|4|||
105977609|NCT01309269|365578987|FG000|Overall Study|Adverse Event|56|||
106027785|NCT03642132|365767464|FG000|Chemotherapy Period|Physician's decision|4|||
106027786|NCT03642132|365767465|FG001|Chemotherapy Period|Physician's decision|1|||
106027787|NCT03642132|365767466|FG002|Chemotherapy Period|Physician's decision|0|||
105977610|NCT01309269|365578987|FG000|Overall Study|Withdrawal by Subject|25|||
105977611|NCT01309269|365578987|FG000|Overall Study|Lack of Acceptance|15|||
105977612|NCT01309269|365578987|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
106027788|NCT03642132|365767464|FG000|Chemotherapy Period|Progressive disease|0|||
105977613|NCT01309269|365578987|FG000|Overall Study|Kidney Transplant|25|||
105977614|NCT01309269|365578987|FG000|Overall Study|Administrative Problems|141|||
105977615|NCT01309269|365578987|FG000|Overall Study|Other|256|||
105977616|NCT01309269|365578987|FG000|Overall Study|Other|1|||
105977617|NCT01309269|365578987|FG000|Overall Study|Study Completion Data Not Recorded|95|||
105977618|NCT01309269|365578987|FG000|Overall Study|Enrolled but not Treated|107|||
105977619|NCT03131596|365579005|FG000|Overall Study|Protocol Violation|3|||
105977620|NCT03131596|365579006|FG001|Overall Study|Protocol Violation|3|||
105977621|NCT03131596|365579005|FG000|Overall Study|Lost to Follow-up|3|||
105977622|NCT03131596|365579006|FG001|Overall Study|Lost to Follow-up|0|||
105977623|NCT00734071|365579007|FG000|Overall Study|Adverse Event|4|||
105977624|NCT00734071|365579008|FG001|Overall Study|Adverse Event|3|||
105851195|NCT02335983|365112615|FG005|Overall Study|Lost to Follow-up|1|||
106027789|NCT03642132|365767465|FG001|Chemotherapy Period|Progressive disease|0|||
106027790|NCT03642132|365767466|FG002|Chemotherapy Period|Progressive disease|1|||
106027791|NCT03642132|365767464|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
106027792|NCT03642132|365767465|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
106027793|NCT03642132|365767466|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
106027794|NCT03642132|365767464|FG000|Chemotherapy Period|Other|1|||
105851196|NCT02335983|365112610|FG000|Overall Study|Protocol Specified Criteria|5|||
105851197|NCT02335983|365112611|FG001|Overall Study|Protocol Specified Criteria|7|||
105851198|NCT02335983|365112612|FG002|Overall Study|Protocol Specified Criteria|27|||
105851199|NCT02335983|365112613|FG003|Overall Study|Protocol Specified Criteria|7|||
105851200|NCT02335983|365112614|FG004|Overall Study|Protocol Specified Criteria|5|||
105851201|NCT02335983|365112615|FG005|Overall Study|Protocol Specified Criteria|21|||
105851202|NCT01831765|365112616|FG000|Overall Study|Lack of Efficacy|1|||
105851203|NCT01831765|365112617|FG001|Overall Study|Lack of Efficacy|0|||
105851204|NCT01831765|365112618|FG002|Overall Study|Lack of Efficacy|0|||
105851205|NCT01831765|365112616|FG000|Overall Study|Other, sponsor withdrew subject|0|||
105851206|NCT01831765|365112617|FG001|Overall Study|Other, sponsor withdrew subject|1|||
105851207|NCT01831765|365112618|FG002|Overall Study|Other, sponsor withdrew subject|0|||
105851208|NCT01831765|365112616|FG000|Overall Study|Pregnancy|1|||
105851209|NCT01831765|365112617|FG001|Overall Study|Pregnancy|1|||
105851210|NCT01831765|365112618|FG002|Overall Study|Pregnancy|2|||
105851211|NCT01831765|365112616|FG000|Overall Study|Death|0|||
105851212|NCT01831765|365112617|FG001|Overall Study|Death|1|||
105851213|NCT01831765|365112618|FG002|Overall Study|Death|1|||
105851214|NCT01831765|365112616|FG000|Overall Study|Other, site closed|1|||
105851215|NCT01831765|365112617|FG001|Overall Study|Other, site closed|1|||
105851216|NCT01831765|365112618|FG002|Overall Study|Other, site closed|0|||
105851217|NCT01831765|365112616|FG000|Overall Study|Adverse Event|5|||
105851218|NCT01831765|365112617|FG001|Overall Study|Adverse Event|3|||
105851219|NCT01831765|365112618|FG002|Overall Study|Adverse Event|3|||
105851220|NCT01831765|365112616|FG000|Overall Study|Withdrawal by Subject|22|||
105851221|NCT01831765|365112617|FG001|Overall Study|Withdrawal by Subject|7|||
106027795|NCT03642132|365767465|FG001|Chemotherapy Period|Other|0|||
106027796|NCT03642132|365767466|FG002|Chemotherapy Period|Other|2|||
106027797|NCT03642132|365767464|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
106027798|NCT03642132|365767465|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
106027799|NCT03642132|365767466|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
106027800|NCT03642132|365767464|FG000|Maintenance Period|Adverse Event|1|||
106027801|NCT03642132|365767465|FG001|Maintenance Period|Adverse Event|2|||
106027802|NCT03642132|365767466|FG002|Maintenance Period|Adverse Event|0|||
106027803|NCT03642132|365767464|FG000|Maintenance Period|Non-compliance with study drug|0|||
106027804|NCT03642132|365767465|FG001|Maintenance Period|Non-compliance with study drug|0|||
106027805|NCT03642132|365767466|FG002|Maintenance Period|Non-compliance with study drug|1|||
106027806|NCT03642132|365767464|FG000|Maintenance Period|Physician's decision|2|||
106027807|NCT03642132|365767465|FG001|Maintenance Period|Physician's decision|2|||
106027808|NCT03642132|365767466|FG002|Maintenance Period|Physician's decision|2|||
106027809|NCT03642132|365767464|FG000|Maintenance Period|Progressive disease|9|||
106027810|NCT03642132|365767465|FG001|Maintenance Period|Progressive disease|3|||
106027811|NCT03642132|365767466|FG002|Maintenance Period|Progressive disease|6|||
106027812|NCT03642132|365767464|FG000|Maintenance Period|Other|0|||
106027813|NCT03642132|365767465|FG001|Maintenance Period|Other|0|||
106027814|NCT03642132|365767466|FG002|Maintenance Period|Other|3|||
106027815|NCT03642132|365767464|FG000|Maintenance Period|Withdrawal by Subject|1|||
106027816|NCT03642132|365767465|FG001|Maintenance Period|Withdrawal by Subject|1|||
106027817|NCT03642132|365767466|FG002|Maintenance Period|Withdrawal by Subject|2|||
106027818|NCT03642132|365767464|FG000|Follow-up Period|Other|0|||
106027819|NCT03642132|365767465|FG001|Follow-up Period|Other|0|||
106027820|NCT03642132|365767466|FG002|Follow-up Period|Other|1|||
106027821|NCT03642132|365767464|FG000|Follow-up Period|Withdrawal by Subject|1|||
106027822|NCT03642132|365767465|FG001|Follow-up Period|Withdrawal by Subject|2|||
106027823|NCT03642132|365767466|FG002|Follow-up Period|Withdrawal by Subject|0|||
106027824|NCT03642132|365767464|FG000|Follow-up Period|Study terminated by sponsor|1|||
106027825|NCT03642132|365767465|FG001|Follow-up Period|Study terminated by sponsor|0|||
105851222|NCT01831765|365112618|FG002|Overall Study|Withdrawal by Subject|17|||
105851223|NCT01831765|365112616|FG000|Overall Study|Withdrawal criteria|12|||
105851224|NCT01831765|365112617|FG001|Overall Study|Withdrawal criteria|10|||
105851225|NCT01831765|365112618|FG002|Overall Study|Withdrawal criteria|16|||
105851226|NCT01831765|365112616|FG000|Overall Study|Lost to Follow-up|2|||
105851227|NCT01831765|365112617|FG001|Overall Study|Lost to Follow-up|3|||
105851228|NCT01831765|365112618|FG002|Overall Study|Lost to Follow-up|3|||
106027826|NCT03642132|365767466|FG002|Follow-up Period|Study terminated by sponsor|1|||
106027827|NCT03642132|365767464|FG000|Follow-up Period|Lack of Efficacy|1|||
106027828|NCT03642132|365767465|FG001|Follow-up Period|Lack of Efficacy|0|||
106027829|NCT03642132|365767466|FG002|Follow-up Period|Lack of Efficacy|0|||
106027830|NCT03642132|365767464|FG000|Follow-up Period|Death|1|||
106027831|NCT03642132|365767465|FG001|Follow-up Period|Death|0|||
106027832|NCT03642132|365767466|FG002|Follow-up Period|Death|2|||
106027833|NCT03642132|365767464|FG000|Follow-up Period|Adverse Event|1|||
105977625|NCT00734071|365579007|FG000|Overall Study|Lack of Efficacy|3|||
105977626|NCT00734071|365579008|FG001|Overall Study|Lack of Efficacy|1|||
105977627|NCT00734071|365579007|FG000|Overall Study|Noncompliance|2|||
105977628|NCT00734071|365579008|FG001|Overall Study|Noncompliance|2|||
105977629|NCT00734071|365579007|FG000|Overall Study|Protocol Deviations|3|||
105977630|NCT00734071|365579008|FG001|Overall Study|Protocol Deviations|4|||
105977631|NCT00734071|365579007|FG000|Overall Study|Voluntary Withdrawal|9|||
105977632|NCT00734071|365579008|FG001|Overall Study|Voluntary Withdrawal|7|||
105977633|NCT00734071|365579007|FG000|Overall Study|Lost to Follow-up|16|||
105977634|NCT00734071|365579008|FG001|Overall Study|Lost to Follow-up|8|||
105977635|NCT00734071|365579007|FG000|Overall Study|Other|1|||
105977636|NCT00734071|365579008|FG001|Overall Study|Other|2|||
105977637|NCT04177355|365579010|FG000|Overall Study|Lost to Follow-up|0|||
105977638|NCT04177355|365579011|FG001|Overall Study|Lost to Follow-up|2|||
105977639|NCT04177355|365579012|FG002|Overall Study|Lost to Follow-up|0|||
105977640|NCT04177355|365579013|FG003|Overall Study|Lost to Follow-up|1|||
105977641|NCT04177355|365579014|FG004|Overall Study|Lost to Follow-up|2|||
105977642|NCT04177355|365579015|FG005|Overall Study|Lost to Follow-up|0|||
105977643|NCT04177355|365579016|FG006|Overall Study|Lost to Follow-up|1|||
105977644|NCT04177355|365579017|FG007|Overall Study|Lost to Follow-up|0|||
105977645|NCT04177355|365579018|FG008|Overall Study|Lost to Follow-up|0|||
105977646|NCT04177355|365579019|FG009|Overall Study|Lost to Follow-up|0|||
106027834|NCT03642132|365767465|FG001|Follow-up Period|Adverse Event|0|||
106027835|NCT03642132|365767466|FG002|Follow-up Period|Adverse Event|0|||
106027836|NCT00647270|365767473|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
106027837|NCT00647270|365767474|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
106027838|NCT00647270|365767475|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
106027839|NCT00647270|365767473|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
106027840|NCT00647270|365767474|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
106027841|NCT00647270|365767475|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
106027842|NCT00647270|365767473|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
105851229|NCT00507130|365112619|FG000|Overall Study|Lost to Follow-up|0|||
105851230|NCT00507130|365112620|FG001|Overall Study|Lost to Follow-up|0|||
105851231|NCT00507130|365112621|FG002|Overall Study|Lost to Follow-up|1|||
105851232|NCT00507130|365112622|FG003|Overall Study|Lost to Follow-up|1|||
105851233|NCT00507130|365112619|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
105851234|NCT00507130|365112620|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
105851235|NCT00507130|365112621|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
105851236|NCT00507130|365112622|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
105851237|NCT00080938|365112627|FG000|Overall Study|Adverse Event|3|||
105851238|NCT00080938|365112627|FG000|Overall Study|Withdrawal by Subject|6|||
105851239|NCT00080938|365112627|FG000|Overall Study|Death|2|||
105851240|NCT00080938|365112627|FG000|Overall Study|Lack of Efficacy|7|||
105851241|NCT00080938|365112627|FG000|Overall Study|other disease|1|||
105851242|NCT00080938|365112627|FG000|Overall Study|Not started protocol therapy|1|||
105851243|NCT00080938|365112627|FG000|Overall Study|Ineligible|4|||
105851244|NCT00706511|365112630|FG000|Overall Study|Withdrawal by Subject|1|||
105851245|NCT00706511|365112631|FG001|Overall Study|Withdrawal by Subject|0|||
105851246|NCT00706511|365112632|FG002|Overall Study|Withdrawal by Subject|0|||
105851247|NCT00706511|365112633|FG003|Overall Study|Withdrawal by Subject|0|||
105851248|NCT02605993|365112634|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
105851249|NCT02605993|365112635|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
105851250|NCT02605993|365112636|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
105851251|NCT02605993|365112637|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
105851252|NCT01868893|365112639|FG000|Overall Study|Adverse Event|2|||
105851253|NCT01868893|365112639|FG000|Overall Study|Commercial availability of study drug|17|||
105851254|NCT01868893|365112639|FG000|Overall Study|Neutropenia|1|||
105851255|NCT03127644|365112649|FG000|Overall Study|Study-specific withdrawal criteria|0|||
105851256|NCT03127644|365112650|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105851257|NCT03127644|365112651|FG002|Overall Study|Study-specific withdrawal criteria|2|||
105851258|NCT00928707|365112652|FG000|Overall Study|Protocol Violation|1|||
105851259|NCT00928707|365112653|FG001|Overall Study|Protocol Violation|0|||
105851260|NCT02140411|365112654|FG000|Overall Study|Adverse Event|1|||
105851261|NCT03981419|365112655|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
105977647|NCT04177355|365579020|FG010|Overall Study|Lost to Follow-up|0|||
105977648|NCT04177355|365579010|FG000|Overall Study|Withdrawal by Subject|0|||
106027843|NCT00647270|365767474|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
105851262|NCT03981419|365112656|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
105977649|NCT04177355|365579011|FG001|Overall Study|Withdrawal by Subject|0|||
105977650|NCT04177355|365579012|FG002|Overall Study|Withdrawal by Subject|0|||
105977651|NCT04177355|365579013|FG003|Overall Study|Withdrawal by Subject|1|||
105977652|NCT04177355|365579014|FG004|Overall Study|Withdrawal by Subject|1|||
105977653|NCT04177355|365579015|FG005|Overall Study|Withdrawal by Subject|0|||
105977654|NCT04177355|365579016|FG006|Overall Study|Withdrawal by Subject|0|||
105977655|NCT04177355|365579017|FG007|Overall Study|Withdrawal by Subject|0|||
105977656|NCT04177355|365579018|FG008|Overall Study|Withdrawal by Subject|1|||
105977657|NCT04177355|365579019|FG009|Overall Study|Withdrawal by Subject|0|||
105977658|NCT04177355|365579020|FG010|Overall Study|Withdrawal by Subject|0|||
105977659|NCT00541346|365579021|FG000|Follow-up|Adverse Event|1|||
105977660|NCT04411420|365579023|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
105977661|NCT04411420|365579024|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
105977662|NCT04411420|365579023|FG000|Survey Subset|Lost to Follow-up|134|||
105977663|NCT04411420|365579024|FG001|Survey Subset|Lost to Follow-up|120|||
105977664|NCT00240110|365579027|FG000|Overall Study|Lost to Follow-up|6|||
105977665|NCT00240110|365579028|FG001|Overall Study|Lost to Follow-up|7|||
105977666|NCT03899064|365579029|FG000|Overall Study|Lost to Follow-up|1|||
105977667|NCT03899064|365579029|FG000|Overall Study|Protocol Violation|2|||
105977668|NCT03899064|365579029|FG000|Overall Study|Withdrawal by Subject|2|||
105977669|NCT03899064|365579029|FG000|Overall Study|Other|2|||
105977670|NCT00583791|365579030|FG000|Overall Study|Other|67|||
105977671|NCT00583791|365579030|FG000|Overall Study|Death|6|||
105977672|NCT03559699|365579033|FG000|Overall Study|Withdrawal by Subject|6|||
105977673|NCT03559699|365579033|FG000|Overall Study|Lost to Follow-up|1|||
105977674|NCT02080260|365579042|FG000|Overall Study|Death|18|||
105977675|NCT02080260|365579042|FG000|Overall Study|Withdrawal by Subject|1|||
105977676|NCT02654236|365579045|FG000|Overall Study|Withdrawal by Subject|0|||
105977677|NCT02654236|365579046|FG001|Overall Study|Withdrawal by Subject|0|||
105977678|NCT02654236|365579047|FG002|Overall Study|Withdrawal by Subject|2|||
105977679|NCT01930890|365579048|FG000|Overall Study|Study Termination|14|||
105977680|NCT01930890|365579049|FG001|Overall Study|Study Termination|28|||
105977681|NCT01930890|365579050|FG002|Overall Study|Study Termination|13|||
105977682|NCT01930890|365579051|FG003|Overall Study|Study Termination|25|||
105977683|NCT01930890|365579048|FG000|Overall Study|Death|0|||
105977684|NCT01930890|365579049|FG001|Overall Study|Death|0|||
105977685|NCT01930890|365579050|FG002|Overall Study|Death|0|||
105977686|NCT01930890|365579051|FG003|Overall Study|Death|1|||
105977687|NCT01930890|365579048|FG000|Overall Study|Investigator Decision|0|||
105977688|NCT01930890|365579049|FG001|Overall Study|Investigator Decision|1|||
105977689|NCT01930890|365579050|FG002|Overall Study|Investigator Decision|0|||
105977690|NCT01930890|365579051|FG003|Overall Study|Investigator Decision|0|||
106027844|NCT00647270|365767475|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
105977691|NCT01930890|365579048|FG000|Overall Study|Consent Withdrawn|0|||
105977692|NCT01930890|365579049|FG001|Overall Study|Consent Withdrawn|3|||
105977693|NCT01930890|365579050|FG002|Overall Study|Consent Withdrawn|0|||
105977694|NCT01930890|365579051|FG003|Overall Study|Consent Withdrawn|1|||
105977695|NCT01930890|365579048|FG000|Overall Study|Adverse Event|0|||
105977696|NCT01930890|365579049|FG001|Overall Study|Adverse Event|1|||
105977697|NCT01930890|365579050|FG002|Overall Study|Adverse Event|0|||
105977698|NCT01930890|365579051|FG003|Overall Study|Adverse Event|0|||
105977699|NCT02091284|365579052|FG000|Overall Study|Withdrawal by Subject|2|||
105977700|NCT02091284|365579053|FG001|Overall Study|Withdrawal by Subject|1|||
105977701|NCT02091284|365579052|FG000|Overall Study|unreliable data|1|||
105977702|NCT02091284|365579053|FG001|Overall Study|unreliable data|0|||
105977703|NCT01278407|365579054|FG000|Confirmatory Phase|Adverse Event|5|||
105977704|NCT01278407|365579055|FG001|Confirmatory Phase|Adverse Event|10|||
105977705|NCT01278407|365579056|FG002|Confirmatory Phase|Adverse Event|1|||
105977706|NCT01278407|365579057|FG003|Confirmatory Phase|Adverse Event|0|||
106027845|NCT00647270|365767473|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
106027846|NCT00647270|365767474|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
106027847|NCT00647270|365767475|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
106027848|NCT00647270|365767473|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
106027849|NCT00647270|365767474|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
105977707|NCT01278407|365579058|FG004|Confirmatory Phase|Adverse Event|0|||
105977708|NCT01278407|365579054|FG000|Confirmatory Phase|Participant's Choice|3|||
105977709|NCT01278407|365579055|FG001|Confirmatory Phase|Participant's Choice|5|||
105977710|NCT01278407|365579056|FG002|Confirmatory Phase|Participant's Choice|3|||
105977711|NCT01278407|365579057|FG003|Confirmatory Phase|Participant's Choice|0|||
105977712|NCT01278407|365579058|FG004|Confirmatory Phase|Participant's Choice|0|||
105977713|NCT01278407|365579054|FG000|Confirmatory Phase|Other|1|||
105977714|NCT01278407|365579055|FG001|Confirmatory Phase|Other|1|||
105977715|NCT01278407|365579056|FG002|Confirmatory Phase|Other|2|||
105977716|NCT01278407|365579057|FG003|Confirmatory Phase|Other|0|||
105977717|NCT01278407|365579058|FG004|Confirmatory Phase|Other|0|||
105977718|NCT01278407|365579054|FG000|Extension Phase|Adverse Event|0|||
105977719|NCT01278407|365579055|FG001|Extension Phase|Adverse Event|0|||
105977720|NCT01278407|365579056|FG002|Extension Phase|Adverse Event|0|||
105977721|NCT01278407|365579057|FG003|Extension Phase|Adverse Event|7|||
105977722|NCT01278407|365579058|FG004|Extension Phase|Adverse Event|16|||
105977723|NCT01278407|365579054|FG000|Extension Phase|Participant's Choice|0|||
105977724|NCT01278407|365579055|FG001|Extension Phase|Participant's Choice|0|||
105977725|NCT01278407|365579056|FG002|Extension Phase|Participant's Choice|0|||
105977726|NCT01278407|365579057|FG003|Extension Phase|Participant's Choice|4|||
105977727|NCT01278407|365579058|FG004|Extension Phase|Participant's Choice|11|||
105977728|NCT01278407|365579054|FG000|Extension Phase|Other|0|||
105977729|NCT01278407|365579055|FG001|Extension Phase|Other|0|||
105977730|NCT01278407|365579056|FG002|Extension Phase|Other|0|||
105977731|NCT01278407|365579057|FG003|Extension Phase|Other|1|||
105977732|NCT01278407|365579058|FG004|Extension Phase|Other|3|||
105977733|NCT04431713|365579062|FG000|Overall Study|Withdrawal by Subject|2|||
105977734|NCT04431713|365579063|FG001|Overall Study|Withdrawal by Subject|0|||
105977735|NCT04431713|365579062|FG000|Overall Study|Death|2|||
105977736|NCT04431713|365579063|FG001|Overall Study|Death|2|||
105977737|NCT01156389|365579065|FG000|Overall Study|Elevated liver enzymes|4|||
105977738|NCT01156389|365579066|FG001|Overall Study|Elevated liver enzymes|0|||
105977739|NCT01156389|365579065|FG000|Overall Study|Vomiting|0|||
105977740|NCT01156389|365579066|FG001|Overall Study|Vomiting|1|||
105977741|NCT02469415|365579067|FG000|Overall Study|Withdrawal by Subject|1|||
105977742|NCT02469415|365579067|FG000|Overall Study|Investigational agent placed on hold|2|||
105977743|NCT03761394|365579068|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
105977744|NCT03761394|365579069|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
105977745|NCT03761394|365579070|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
105977746|NCT03761394|365579071|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
105977747|NCT03761394|365579068|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
105977748|NCT03761394|365579069|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
105977749|NCT03761394|365579070|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
105977750|NCT03761394|365579071|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
105977751|NCT03761394|365579068|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
105977752|NCT03761394|365579069|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
105977753|NCT03761394|365579070|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
105977754|NCT03761394|365579071|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
105977755|NCT03761394|365579068|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
105977756|NCT03761394|365579069|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
105977757|NCT03761394|365579070|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
105977758|NCT03761394|365579071|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
105977759|NCT01891344|365579072|FG000|Overall Study|Ongoing|6|||
105977760|NCT01891344|365579073|FG001|Overall Study|Ongoing|2|||
105977761|NCT01891344|365579074|FG002|Overall Study|Ongoing|0|||
106027850|NCT00647270|365767475|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
106027851|NCT00647270|365767473|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
106027852|NCT00647270|365767474|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
106027853|NCT00647270|365767475|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
105851263|NCT02272634|365112663|FG000|Overall Study|Adverse Event|1|||
105851264|NCT02272634|365112664|FG001|Overall Study|Adverse Event|0|||
105851265|NCT02272634|365112665|FG002|Overall Study|Adverse Event|0|||
105851266|NCT02272634|365112663|FG000|Overall Study|Protocol Violation|0|||
105851267|NCT02272634|365112664|FG001|Overall Study|Protocol Violation|0|||
105851268|NCT02272634|365112665|FG002|Overall Study|Protocol Violation|1|||
105851269|NCT02272634|365112663|FG000|Overall Study|Withdrawal by Subject|0|||
105851270|NCT02272634|365112664|FG001|Overall Study|Withdrawal by Subject|1|||
105851271|NCT02272634|365112665|FG002|Overall Study|Withdrawal by Subject|0|||
105851272|NCT01437943|365112667|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
105851273|NCT01437943|365112668|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
105851274|NCT01437943|365112667|FG000|Overall Study|Subject expressed pregnancy plans|1|||
105851275|NCT01437943|365112668|FG001|Overall Study|Subject expressed pregnancy plans|0|||
105851276|NCT01437943|365112667|FG000|Overall Study|Adverse Event|2|||
105851277|NCT01437943|365112668|FG001|Overall Study|Adverse Event|0|||
105851278|NCT05788289|365112669|FG000|Overall Study|Death|3|||
105851279|NCT00762437|365112670|FG000|Overall Study|Lost to Follow-up|7|||
105851280|NCT00762437|365112670|FG000|Overall Study|Missed final study visit|11|||
105851281|NCT00762437|365112670|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
105851282|NCT01986010|365112676|FG000|Overall Study|Adverse Event|0|||
105851283|NCT01986010|365112677|FG001|Overall Study|Adverse Event|1|||
105851284|NCT01986010|365112678|FG002|Overall Study|Adverse Event|0|||
105851285|NCT01986010|365112679|FG003|Overall Study|Adverse Event|0|||
105851286|NCT01986010|365112680|FG004|Overall Study|Adverse Event|0|||
105851287|NCT01986010|365112681|FG005|Overall Study|Adverse Event|0|||
105851288|NCT01986010|365112682|FG006|Overall Study|Adverse Event|0|||
105977762|NCT01891344|365579075|FG003|Overall Study|Ongoing|1|||
105851289|NCT01986010|365112683|FG007|Overall Study|Adverse Event|0|||
105851290|NCT01986010|365112684|FG008|Overall Study|Adverse Event|0|||
105851291|NCT01986010|365112685|FG009|Overall Study|Adverse Event|0|||
105851292|NCT01986010|365112686|FG010|Overall Study|Adverse Event|0|||
105851293|NCT01986010|365112687|FG011|Overall Study|Adverse Event|0|||
105851294|NCT01986010|365112688|FG012|Overall Study|Adverse Event|0|||
105851295|NCT01986010|365112689|FG013|Overall Study|Adverse Event|0|||
105977763|NCT01891344|365579076|FG004|Overall Study|Ongoing|4|||
105977764|NCT01891344|365579077|FG005|Overall Study|Ongoing|1|||
105977765|NCT01891344|365579078|FG006|Overall Study|Ongoing|0|||
105977766|NCT01891344|365579079|FG007|Overall Study|Ongoing|0|||
105977767|NCT00159913|365579081|FG000|Overall Study|Adverse Event|1|||
105977768|NCT00159913|365579082|FG001|Overall Study|Adverse Event|0|||
105977769|NCT00159913|365579083|FG002|Overall Study|Adverse Event|1|||
105977770|NCT00159913|365579084|FG003|Overall Study|Adverse Event|0|||
105977771|NCT00159913|365579081|FG000|Overall Study|Withdrawal by Subject|0|||
105977772|NCT00159913|365579082|FG001|Overall Study|Withdrawal by Subject|0|||
105977773|NCT00159913|365579083|FG002|Overall Study|Withdrawal by Subject|0|||
105977774|NCT00159913|365579084|FG003|Overall Study|Withdrawal by Subject|1|||
105977775|NCT00159913|365579081|FG000|Overall Study|Lost to Follow-up|0|||
105977776|NCT00159913|365579082|FG001|Overall Study|Lost to Follow-up|0|||
105977777|NCT00159913|365579083|FG002|Overall Study|Lost to Follow-up|0|||
105977778|NCT00159913|365579084|FG003|Overall Study|Lost to Follow-up|1|||
105977779|NCT00159913|365579081|FG000|Overall Study|Protocol Violation|1|||
105977780|NCT00159913|365579082|FG001|Overall Study|Protocol Violation|0|||
105977781|NCT00159913|365579083|FG002|Overall Study|Protocol Violation|1|||
105977782|NCT00159913|365579084|FG003|Overall Study|Protocol Violation|0|||
105977783|NCT01874275|365579085|FG000|Overall Study|Lost to Follow-up|1|||
105977784|NCT01874275|365579086|FG001|Overall Study|Lost to Follow-up|0|||
105977785|NCT00545532|365579087|FG000|Overall Study|Withdrawal by Subject|1|||
105977786|NCT00545532|365579088|FG001|Overall Study|Withdrawal by Subject|3|||
105977787|NCT00545532|365579087|FG000|Overall Study|Lost to Follow-up|5|||
105977788|NCT00545532|365579088|FG001|Overall Study|Lost to Follow-up|6|||
105977789|NCT00545532|365579087|FG000|Overall Study|Death|0|||
105977790|NCT00545532|365579088|FG001|Overall Study|Death|1|||
105977791|NCT01719003|365579089|FG000|Overall Study|Non compliant with protocol|1|||
105977792|NCT01719003|365579090|FG001|Overall Study|Non compliant with protocol|1|||
105977793|NCT01719003|365579091|FG002|Overall Study|Non compliant with protocol|0|||
105977794|NCT01719003|365579092|FG003|Overall Study|Non compliant with protocol|1|||
105977795|NCT01719003|365579093|FG004|Overall Study|Non compliant with protocol|2|||
105977796|NCT01719003|365579094|FG005|Overall Study|Non compliant with protocol|1|||
105977797|NCT01719003|365579095|FG006|Overall Study|Non compliant with protocol|2|||
105977798|NCT01719003|365579096|FG007|Overall Study|Non compliant with protocol|3|||
105977799|NCT01719003|365579097|FG008|Overall Study|Non compliant with protocol|0|||
105977800|NCT01719003|365579089|FG000|Overall Study|Adverse Event|6|||
105977801|NCT01719003|365579090|FG001|Overall Study|Adverse Event|5|||
105977802|NCT01719003|365579091|FG002|Overall Study|Adverse Event|4|||
105977803|NCT01719003|365579092|FG003|Overall Study|Adverse Event|3|||
106151004|NCT02723955|366215074|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151005|NCT02723955|366215075|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105977804|NCT01719003|365579093|FG004|Overall Study|Adverse Event|4|||
105977805|NCT01719003|365579094|FG005|Overall Study|Adverse Event|3|||
105977806|NCT01719003|365579095|FG006|Overall Study|Adverse Event|6|||
105977807|NCT01719003|365579096|FG007|Overall Study|Adverse Event|5|||
105977808|NCT01719003|365579097|FG008|Overall Study|Adverse Event|0|||
105977809|NCT01719003|365579089|FG000|Overall Study|Lost to Follow-up|0|||
105977810|NCT01719003|365579090|FG001|Overall Study|Lost to Follow-up|6|||
105977811|NCT01719003|365579091|FG002|Overall Study|Lost to Follow-up|7|||
105977812|NCT01719003|365579092|FG003|Overall Study|Lost to Follow-up|2|||
105977813|NCT01719003|365579093|FG004|Overall Study|Lost to Follow-up|3|||
105977814|NCT01719003|365579094|FG005|Overall Study|Lost to Follow-up|4|||
105977815|NCT01719003|365579095|FG006|Overall Study|Lost to Follow-up|3|||
105977816|NCT01719003|365579096|FG007|Overall Study|Lost to Follow-up|2|||
105977817|NCT01719003|365579097|FG008|Overall Study|Lost to Follow-up|2|||
105977818|NCT01719003|365579089|FG000|Overall Study|Refusal to continue, not due to AE|2|||
105977819|NCT01719003|365579090|FG001|Overall Study|Refusal to continue, not due to AE|5|||
105977820|NCT01719003|365579091|FG002|Overall Study|Refusal to continue, not due to AE|4|||
105977821|NCT01719003|365579092|FG003|Overall Study|Refusal to continue, not due to AE|4|||
105977822|NCT01719003|365579093|FG004|Overall Study|Refusal to continue, not due to AE|4|||
105977823|NCT01719003|365579094|FG005|Overall Study|Refusal to continue, not due to AE|3|||
105977824|NCT01719003|365579095|FG006|Overall Study|Refusal to continue, not due to AE|8|||
105977825|NCT01719003|365579096|FG007|Overall Study|Refusal to continue, not due to AE|7|||
105977826|NCT01719003|365579097|FG008|Overall Study|Refusal to continue, not due to AE|1|||
105977827|NCT01719003|365579089|FG000|Overall Study|Reason other than those specified|0|||
105977828|NCT01719003|365579090|FG001|Overall Study|Reason other than those specified|0|||
105977829|NCT01719003|365579091|FG002|Overall Study|Reason other than those specified|2|||
105977830|NCT01719003|365579092|FG003|Overall Study|Reason other than those specified|3|||
105977831|NCT01719003|365579093|FG004|Overall Study|Reason other than those specified|4|||
105977832|NCT01719003|365579094|FG005|Overall Study|Reason other than those specified|1|||
106151006|NCT02723955|366215076|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105977833|NCT01719003|365579095|FG006|Overall Study|Reason other than those specified|0|||
105977834|NCT01719003|365579096|FG007|Overall Study|Reason other than those specified|3|||
105977835|NCT01719003|365579097|FG008|Overall Study|Reason other than those specified|1|||
105851296|NCT01986010|365112690|FG014|Overall Study|Adverse Event|0|||
105851297|NCT01986010|365112691|FG015|Overall Study|Adverse Event|1|||
105851298|NCT01986010|365112692|FG016|Overall Study|Adverse Event|0|||
105851299|NCT01986010|365112676|FG000|Overall Study|Lost to Follow-up|2|||
105851300|NCT01986010|365112677|FG001|Overall Study|Lost to Follow-up|1|||
105851301|NCT01986010|365112678|FG002|Overall Study|Lost to Follow-up|2|||
105851302|NCT01986010|365112679|FG003|Overall Study|Lost to Follow-up|2|||
105851303|NCT01986010|365112680|FG004|Overall Study|Lost to Follow-up|2|||
105851304|NCT01986010|365112681|FG005|Overall Study|Lost to Follow-up|2|||
105851305|NCT01986010|365112682|FG006|Overall Study|Lost to Follow-up|0|||
105851306|NCT01986010|365112683|FG007|Overall Study|Lost to Follow-up|0|||
105851307|NCT01986010|365112684|FG008|Overall Study|Lost to Follow-up|4|||
105851308|NCT01986010|365112685|FG009|Overall Study|Lost to Follow-up|2|||
105851309|NCT01986010|365112686|FG010|Overall Study|Lost to Follow-up|0|||
105851310|NCT01986010|365112687|FG011|Overall Study|Lost to Follow-up|1|||
105851311|NCT01986010|365112688|FG012|Overall Study|Lost to Follow-up|1|||
105977836|NCT01719003|365579089|FG000|Overall Study|Lack of Efficacy|0|||
106027854|NCT00647270|365767473|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
106027855|NCT00647270|365767474|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
106027856|NCT00647270|365767475|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
106027857|NCT03337490|365767476|FG000|Overall Study|Withdrawal by Subject|1|||
106027858|NCT03337490|365767477|FG001|Overall Study|Withdrawal by Subject|0|||
106027859|NCT03337490|365767478|FG002|Overall Study|Withdrawal by Subject|0|||
105851312|NCT01986010|365112689|FG013|Overall Study|Lost to Follow-up|1|||
105851313|NCT01986010|365112690|FG014|Overall Study|Lost to Follow-up|2|||
105851314|NCT01986010|365112691|FG015|Overall Study|Lost to Follow-up|0|||
105977837|NCT01719003|365579090|FG001|Overall Study|Lack of Efficacy|0|||
105977838|NCT01719003|365579091|FG002|Overall Study|Lack of Efficacy|0|||
105977839|NCT01719003|365579092|FG003|Overall Study|Lack of Efficacy|0|||
105977840|NCT01719003|365579093|FG004|Overall Study|Lack of Efficacy|0|||
105977841|NCT01719003|365579094|FG005|Overall Study|Lack of Efficacy|0|||
105977842|NCT01719003|365579095|FG006|Overall Study|Lack of Efficacy|1|||
105977843|NCT01719003|365579096|FG007|Overall Study|Lack of Efficacy|0|||
105977844|NCT01719003|365579097|FG008|Overall Study|Lack of Efficacy|0|||
105977845|NCT00689793|365579098|FG000|Overall Study|Lost to Follow-up|4|||
105977846|NCT00689793|365579099|FG001|Overall Study|Lost to Follow-up|5|||
105977847|NCT01299571|365579100|FG000|Overall Study|Protocol Violation|107|||
105977848|NCT04375397|365579101|FG000|Overall Study|Death|1|||
105977849|NCT04375397|365579102|FG001|Overall Study|Death|1|||
105977850|NCT04375397|365579101|FG000|Overall Study|Withdrew consent|2|||
105977851|NCT04375397|365579102|FG001|Overall Study|Withdrew consent|0|||
105977852|NCT04375397|365579101|FG000|Overall Study|Lost to Follow-up|6|||
105977853|NCT04375397|365579102|FG001|Overall Study|Lost to Follow-up|4|||
105977854|NCT04375397|365579101|FG000|Overall Study|Other, not specified|0|||
105977855|NCT04375397|365579102|FG001|Overall Study|Other, not specified|1|||
105977856|NCT00849875|365579103|FG000|Overall Study|Death|28|||
105977857|NCT00849875|365579103|FG000|Overall Study|Ongoing (unknown completion status)|11|||
105977858|NCT00849875|365579103|FG000|Overall Study|Others|6|||
105977859|NCT00849875|365579103|FG000|Overall Study|Lost to Follow-up|2|||
105977860|NCT00259298|365579105|FG000|Overall Study|Withdrawal by Subject|1|||
105977861|NCT00259298|365579105|FG000|Overall Study|Physician Decision|2|||
105977862|NCT01969500|365579106|FG000|Overall Study|Death|0|||
105977863|NCT01969500|365579107|FG001|Overall Study|Death|1|||
105977864|NCT01969500|365579106|FG000|Overall Study|extended hospitalization|1|||
105977865|NCT01969500|365579107|FG001|Overall Study|extended hospitalization|1|||
105977866|NCT02639338|365579108|FG000|Overall Study|Lost to Follow-up|2|||
105977867|NCT02639338|365579109|FG001|Overall Study|Lost to Follow-up|2|||
105977868|NCT02639338|365579108|FG000|Overall Study|Withdrew Consent|1|||
105977869|NCT02639338|365579109|FG001|Overall Study|Withdrew Consent|2|||
105977870|NCT02639338|365579108|FG000|Overall Study|Death|1|||
105977871|NCT02639338|365579109|FG001|Overall Study|Death|0|||
105977872|NCT02639338|365579108|FG000|Overall Study|Randomized but Not Treated|0|||
105977873|NCT02639338|365579109|FG001|Overall Study|Randomized but Not Treated|1|||
105977874|NCT01710527|365579114|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
105977875|NCT01710527|365579115|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
105977876|NCT01827332|365579118|FG000|Overall Study|Lost to Follow-up|2|||
105977877|NCT01827332|365579119|FG001|Overall Study|Lost to Follow-up|1|||
105851315|NCT01986010|365112692|FG016|Overall Study|Lost to Follow-up|0|||
105851316|NCT01986010|365112676|FG000|Overall Study|Physician Decision|0|||
105977878|NCT01241760|365579124|FG000|Overall Study|Adverse Event|1|||
105977879|NCT01241760|365579125|FG001|Overall Study|Adverse Event|0|||
105977880|NCT01241760|365579124|FG000|Overall Study|Lost to Follow-up|18|||
105977881|NCT01241760|365579125|FG001|Overall Study|Lost to Follow-up|22|||
105977882|NCT01241760|365579124|FG000|Overall Study|Withdrawal by Subject|13|||
105977883|NCT01241760|365579125|FG001|Overall Study|Withdrawal by Subject|13|||
105977884|NCT01241760|365579124|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
105977885|NCT01241760|365579125|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
105977886|NCT01241760|365579124|FG000|Overall Study|Other|1|||
105977887|NCT01241760|365579125|FG001|Overall Study|Other|1|||
105977888|NCT01688921|365579126|FG000|Overall Study|Lost to Follow-up|7|||
105977889|NCT01688921|365579127|FG001|Overall Study|Lost to Follow-up|13|||
105977890|NCT01688921|365579126|FG000|Overall Study|Physician Decision|6|||
105977891|NCT01688921|365579127|FG001|Overall Study|Physician Decision|1|||
105977892|NCT01688921|365579126|FG000|Overall Study|Protocol Violation|0|||
105977893|NCT01688921|365579127|FG001|Overall Study|Protocol Violation|1|||
105977894|NCT01688921|365579126|FG000|Overall Study|informed consent|3|||
105977895|NCT01688921|365579127|FG001|Overall Study|informed consent|0|||
105977896|NCT02358044|365579129|FG000|Overall Study|Adverse Event|0|||
105977897|NCT02358044|365579130|FG001|Overall Study|Adverse Event|1|||
105977898|NCT02358044|365579129|FG000|Overall Study|Lost to Follow-up|2|||
105977899|NCT02358044|365579130|FG001|Overall Study|Lost to Follow-up|1|||
105977900|NCT02358044|365579129|FG000|Overall Study|Physician Decision|0|||
105977901|NCT02358044|365579130|FG001|Overall Study|Physician Decision|1|||
105977902|NCT02358044|365579129|FG000|Overall Study|Withdrawal by Subject|0|||
105977903|NCT02358044|365579130|FG001|Overall Study|Withdrawal by Subject|4|||
105977904|NCT01636713|365579131|FG000|Overall Study|Adverse Event|16|||
105977905|NCT01636713|365579132|FG001|Overall Study|Adverse Event|16|||
105977906|NCT01636713|365579133|FG002|Overall Study|Adverse Event|7|||
105977907|NCT01636713|365579131|FG000|Overall Study|Lack of Efficacy|6|||
105977908|NCT01636713|365579132|FG001|Overall Study|Lack of Efficacy|6|||
105977909|NCT01636713|365579133|FG002|Overall Study|Lack of Efficacy|2|||
105977910|NCT01636713|365579131|FG000|Overall Study|Protocol Violation|3|||
105977911|NCT01636713|365579132|FG001|Overall Study|Protocol Violation|0|||
105977912|NCT01636713|365579133|FG002|Overall Study|Protocol Violation|1|||
105977913|NCT01636713|365579131|FG000|Overall Study|Lost to Follow-up|0|||
105977914|NCT01636713|365579132|FG001|Overall Study|Lost to Follow-up|0|||
105977915|NCT01636713|365579133|FG002|Overall Study|Lost to Follow-up|1|||
105977916|NCT01636713|365579131|FG000|Overall Study|Withdrawal by Subject|5|||
105977917|NCT01636713|365579132|FG001|Overall Study|Withdrawal by Subject|4|||
105977918|NCT01636713|365579133|FG002|Overall Study|Withdrawal by Subject|8|||
105977919|NCT01636713|365579131|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
105977920|NCT01636713|365579132|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
105977921|NCT01636713|365579133|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
105977922|NCT03689244|365579134|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
105977923|NCT03689244|365579135|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
105977924|NCT03689244|365579136|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
105977925|NCT03689244|365579137|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
105977926|NCT03689244|365579134|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
105977927|NCT03689244|365579135|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
105977928|NCT03689244|365579136|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
105977929|NCT03689244|365579137|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
105977930|NCT03689244|365579134|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
105977931|NCT03689244|365579135|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
105977932|NCT03689244|365579136|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
105977933|NCT03689244|365579137|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
105977934|NCT03689244|365579134|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
105977935|NCT03689244|365579135|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
105977936|NCT03689244|365579136|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
105977937|NCT03689244|365579137|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
105977938|NCT03689244|365579134|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
105977939|NCT03689244|365579135|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
105977940|NCT03689244|365579136|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
105977941|NCT03689244|365579137|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
105977942|NCT03689244|365579134|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
105977943|NCT03689244|365579135|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
105977944|NCT03689244|365579136|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
105977945|NCT03689244|365579137|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
106027860|NCT03337490|365767476|FG000|Overall Study|Lack of Efficacy|10|||
106027861|NCT03337490|365767477|FG001|Overall Study|Lack of Efficacy|12|||
106027862|NCT03337490|365767478|FG002|Overall Study|Lack of Efficacy|35|||
106027863|NCT03337490|365767476|FG000|Overall Study|Physician Decision|0|||
106027864|NCT03337490|365767477|FG001|Overall Study|Physician Decision|1|||
106027865|NCT03337490|365767478|FG002|Overall Study|Physician Decision|0|||
106027866|NCT03337490|365767476|FG000|Overall Study|Lost to Follow-up|0|||
105977946|NCT03689244|365579134|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
105977947|NCT03689244|365579135|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
105977948|NCT03689244|365579136|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
106027867|NCT03337490|365767477|FG001|Overall Study|Lost to Follow-up|1|||
106027868|NCT03337490|365767478|FG002|Overall Study|Lost to Follow-up|0|||
106027869|NCT04493892|365767479|FG000|Overall Study|Withdrawal by Subject|15|||
106027870|NCT01541397|365767482|FG000|Overall Study|Study ended prior to data collection|4|||
106027871|NCT01541397|365767483|FG001|Overall Study|Study ended prior to data collection|2|||
106027872|NCT02267317|365767484|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
106027873|NCT02267317|365767485|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
106027874|NCT02267317|365767486|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
106027875|NCT02267317|365767487|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
106027876|NCT02267317|365767488|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
106027877|NCT02267317|365767489|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
106027878|NCT02267317|365767484|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
106027879|NCT02267317|365767485|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
106027880|NCT02267317|365767486|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
106027881|NCT02267317|365767487|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
106027882|NCT02267317|365767488|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
106027883|NCT02267317|365767489|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
106027884|NCT01128621|365767490|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
106027885|NCT01128621|365767491|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
106027886|NCT00233454|365767497|FG000|Overall Study|Death|6|||
106027887|NCT04224688|365767498|FG000|Overall Study|Withdrawal by Subject|1|||
106027888|NCT04224688|365767499|FG001|Overall Study|Withdrawal by Subject|3|||
106027889|NCT04224688|365767498|FG000|Overall Study|Lack of Efficacy|1|||
106027890|NCT04224688|365767499|FG001|Overall Study|Lack of Efficacy|1|||
106027891|NCT04224688|365767498|FG000|Overall Study|Adverse event, not fatal|0|||
106027892|NCT04224688|365767499|FG001|Overall Study|Adverse event, not fatal|2|||
106027893|NCT04224688|365767498|FG000|Overall Study|COVID-19|0|||
106027894|NCT04224688|365767499|FG001|Overall Study|COVID-19|1|||
106027895|NCT01689532|365767505|FG000|Overall Study|Adverse Event|9|||
106027896|NCT01689532|365767506|FG001|Overall Study|Adverse Event|5|||
106027897|NCT01689532|365767505|FG000|Overall Study|Lack of Efficacy|2|||
106027898|NCT01689532|365767506|FG001|Overall Study|Lack of Efficacy|2|||
106027899|NCT01689532|365767505|FG000|Overall Study|Withdrawal by Subject|1|||
106027900|NCT01689532|365767506|FG001|Overall Study|Withdrawal by Subject|2|||
106027901|NCT01689532|365767505|FG000|Overall Study|Physician Decision|2|||
106027902|NCT01689532|365767506|FG001|Overall Study|Physician Decision|0|||
106027903|NCT00796445|365767507|FG000|Overall Study|Protocol Violation|5|||
106027904|NCT00796445|365767508|FG001|Overall Study|Protocol Violation|3|||
106027905|NCT00796445|365767507|FG000|Overall Study|Adverse event, serious fatal|10|||
106027906|NCT00796445|365767508|FG001|Overall Study|Adverse event, serious fatal|5|||
105851317|NCT01986010|365112677|FG001|Overall Study|Physician Decision|0|||
105851318|NCT01986010|365112678|FG002|Overall Study|Physician Decision|0|||
105851319|NCT01986010|365112679|FG003|Overall Study|Physician Decision|0|||
105851320|NCT01986010|365112680|FG004|Overall Study|Physician Decision|0|||
105851321|NCT01986010|365112681|FG005|Overall Study|Physician Decision|0|||
105851322|NCT01986010|365112682|FG006|Overall Study|Physician Decision|0|||
105851323|NCT01986010|365112683|FG007|Overall Study|Physician Decision|0|||
105851324|NCT01986010|365112684|FG008|Overall Study|Physician Decision|0|||
105851325|NCT01986010|365112685|FG009|Overall Study|Physician Decision|0|||
105851326|NCT01986010|365112686|FG010|Overall Study|Physician Decision|0|||
105851327|NCT01986010|365112687|FG011|Overall Study|Physician Decision|0|||
105851328|NCT01986010|365112688|FG012|Overall Study|Physician Decision|0|||
105851329|NCT01986010|365112689|FG013|Overall Study|Physician Decision|0|||
105851330|NCT01986010|365112690|FG014|Overall Study|Physician Decision|1|||
105851331|NCT01986010|365112691|FG015|Overall Study|Physician Decision|0|||
105851332|NCT01986010|365112692|FG016|Overall Study|Physician Decision|0|||
105851333|NCT01986010|365112676|FG000|Overall Study|Withdrawal by Subject|2|||
105851334|NCT01986010|365112677|FG001|Overall Study|Withdrawal by Subject|2|||
105851335|NCT01986010|365112678|FG002|Overall Study|Withdrawal by Subject|3|||
105851336|NCT01986010|365112679|FG003|Overall Study|Withdrawal by Subject|0|||
105851337|NCT01986010|365112680|FG004|Overall Study|Withdrawal by Subject|2|||
105851338|NCT01986010|365112681|FG005|Overall Study|Withdrawal by Subject|4|||
105851339|NCT01986010|365112682|FG006|Overall Study|Withdrawal by Subject|0|||
105851340|NCT01986010|365112683|FG007|Overall Study|Withdrawal by Subject|0|||
105851341|NCT01986010|365112684|FG008|Overall Study|Withdrawal by Subject|0|||
105851342|NCT01986010|365112685|FG009|Overall Study|Withdrawal by Subject|0|||
105851343|NCT01986010|365112686|FG010|Overall Study|Withdrawal by Subject|0|||
105851344|NCT01986010|365112687|FG011|Overall Study|Withdrawal by Subject|2|||
105851345|NCT01986010|365112688|FG012|Overall Study|Withdrawal by Subject|0|||
105851346|NCT01986010|365112689|FG013|Overall Study|Withdrawal by Subject|1|||
105851347|NCT01986010|365112690|FG014|Overall Study|Withdrawal by Subject|2|||
105851348|NCT01986010|365112691|FG015|Overall Study|Withdrawal by Subject|0|||
105851349|NCT01986010|365112692|FG016|Overall Study|Withdrawal by Subject|0|||
105851350|NCT01986010|365112676|FG000|Overall Study|Status Not Recorded|2|||
105851351|NCT01986010|365112677|FG001|Overall Study|Status Not Recorded|4|||
105851352|NCT01986010|365112678|FG002|Overall Study|Status Not Recorded|2|||
105851353|NCT01986010|365112679|FG003|Overall Study|Status Not Recorded|0|||
105851354|NCT01986010|365112680|FG004|Overall Study|Status Not Recorded|1|||
105851355|NCT01986010|365112681|FG005|Overall Study|Status Not Recorded|2|||
105851356|NCT01986010|365112682|FG006|Overall Study|Status Not Recorded|0|||
105851357|NCT01986010|365112683|FG007|Overall Study|Status Not Recorded|0|||
105851358|NCT01986010|365112684|FG008|Overall Study|Status Not Recorded|2|||
105851359|NCT01986010|365112685|FG009|Overall Study|Status Not Recorded|1|||
105977949|NCT03689244|365579137|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
105977950|NCT03689244|365579134|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
105977951|NCT03689244|365579135|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
105977952|NCT03689244|365579136|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
105977953|NCT03689244|365579137|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
105977954|NCT01822535|365579138|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
105977955|NCT01822535|365579139|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
105977956|NCT01822535|365579138|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
105977957|NCT01822535|365579139|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
105977958|NCT01822535|365579138|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
105977959|NCT01822535|365579139|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
105977960|NCT01739803|365579140|FG000|Overall Study|Lost to Follow-up|9|||
105977961|NCT01739803|365579141|FG001|Overall Study|Lost to Follow-up|6|||
105977962|NCT01522404|365579146|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
105977963|NCT01522404|365579147|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
105977964|NCT01522404|365579146|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
105977965|NCT01522404|365579147|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
105977966|NCT01522404|365579146|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
105977967|NCT01522404|365579147|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
105977968|NCT03734029|365579148|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
105977969|NCT03734029|365579149|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
105977970|NCT03734029|365579148|FG000|Overall Study|Adverse Event|60|||
105977971|NCT03734029|365579149|FG001|Overall Study|Adverse Event|14|||
105977972|NCT03734029|365579148|FG000|Overall Study|Withdrawal by Subject|12|||
105977973|NCT03734029|365579149|FG001|Overall Study|Withdrawal by Subject|11|||
105977974|NCT03734029|365579148|FG000|Overall Study|Clinical progression by investigator|10|||
105977975|NCT03734029|365579149|FG001|Overall Study|Clinical progression by investigator|8|||
105977976|NCT03734029|365579148|FG000|Overall Study|Death|5|||
105977977|NCT03734029|365579149|FG001|Overall Study|Death|2|||
105977978|NCT03734029|365579148|FG000|Overall Study|Physician Decision|4|||
105977979|NCT03734029|365579149|FG001|Overall Study|Physician Decision|3|||
105977980|NCT03734029|365579148|FG000|Overall Study|Other|2|||
105977981|NCT03734029|365579149|FG001|Overall Study|Other|0|||
105977982|NCT03734029|365579148|FG000|Overall Study|Lost to Follow-up|0|||
105977983|NCT03734029|365579149|FG001|Overall Study|Lost to Follow-up|1|||
105977984|NCT03734029|365579148|FG000|Overall Study|Randomized, but not treated|2|||
105977985|NCT03734029|365579149|FG001|Overall Study|Randomized, but not treated|12|||
105977986|NCT02525094|365579150|FG000|Overall Study|Lost to Follow-up|2|||
105977987|NCT02525094|365579151|FG001|Overall Study|Lost to Follow-up|1|||
105977988|NCT02525094|365579150|FG000|Overall Study|Withdrawal by Subject|5|||
105977989|NCT02525094|365579151|FG001|Overall Study|Withdrawal by Subject|6|||
105977990|NCT02525094|365579150|FG000|Overall Study|Not Treated|1|||
105977991|NCT02525094|365579151|FG001|Overall Study|Not Treated|1|||
105977992|NCT03081858|365581197|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
105977993|NCT03081858|365581198|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
105977994|NCT03081858|365581199|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
105977995|NCT03081858|365581200|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
105977996|NCT00664326|365581205|FG000|Overall Study|Adverse Event|14|||
105977997|NCT00664326|365581205|FG000|Overall Study|Noncompliance with study medication|3|||
105977998|NCT00664326|365581205|FG000|Overall Study|Withdrawal by Subject|1|||
105977999|NCT00664326|365581205|FG000|Overall Study|Physician Decision|1|||
105978000|NCT00664326|365581205|FG000|Overall Study|Other Reasons|3|||
105978001|NCT00664326|365581205|FG000|Overall Study|Death|2|||
105978002|NCT00664326|365581205|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
105978003|NCT00262847|365581206|FG000|Overall Study|Disease Progression|309|||
105978004|NCT00262847|365581207|FG001|Overall Study|Disease Progression|274|||
105978005|NCT00262847|365581208|FG002|Overall Study|Disease Progression|195|||
105978006|NCT00262847|365581206|FG000|Overall Study|Patient Refusal|41|||
105978007|NCT00262847|365581207|FG001|Overall Study|Patient Refusal|52|||
105851360|NCT01986010|365112686|FG010|Overall Study|Status Not Recorded|7|||
105851361|NCT01986010|365112687|FG011|Overall Study|Status Not Recorded|7|||
105978008|NCT00262847|365581208|FG002|Overall Study|Patient Refusal|47|||
105978009|NCT00262847|365581206|FG000|Overall Study|Adverse Event|74|||
105978010|NCT00262847|365581207|FG001|Overall Study|Adverse Event|88|||
105978011|NCT00262847|365581208|FG002|Overall Study|Adverse Event|108|||
105978012|NCT00262847|365581206|FG000|Overall Study|Death|8|||
105978013|NCT00262847|365581207|FG001|Overall Study|Death|8|||
105978014|NCT00262847|365581208|FG002|Overall Study|Death|11|||
105978015|NCT00262847|365581206|FG000|Overall Study|Concomitant disease|3|||
105978016|NCT00262847|365581207|FG001|Overall Study|Concomitant disease|2|||
105978017|NCT00262847|365581208|FG002|Overall Study|Concomitant disease|4|||
105978018|NCT00262847|365581206|FG000|Overall Study|Other Reasons|79|||
105978019|NCT00262847|365581207|FG001|Overall Study|Other Reasons|88|||
105978020|NCT00262847|365581208|FG002|Overall Study|Other Reasons|27|||
105978021|NCT00262847|365581206|FG000|Overall Study|Did not receive study treatment|4|||
105978022|NCT00262847|365581207|FG001|Overall Study|Did not receive study treatment|1|||
105978023|NCT00262847|365581208|FG002|Overall Study|Did not receive study treatment|4|||
105978024|NCT05079477|365581209|FG000|Overall Study|Lost to Follow-up|2|||
105978025|NCT05079477|365581210|FG001|Overall Study|Lost to Follow-up|0|||
105978026|NCT05079477|365581209|FG000|Overall Study|Withdrawal by Subject|1|||
105978027|NCT05079477|365581210|FG001|Overall Study|Withdrawal by Subject|0|||
105978028|NCT05079477|365581209|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
105978029|NCT05079477|365581210|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
105978030|NCT05079477|365581209|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
105978031|NCT05079477|365581210|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
105978032|NCT05013424|365581213|FG000|Overall Study|Lost to Follow-up|1|||
105978033|NCT05013424|365581214|FG001|Overall Study|Lost to Follow-up|1|||
105978034|NCT05013424|365581215|FG002|Overall Study|Lost to Follow-up|1|||
105978035|NCT05013424|365581213|FG000|Overall Study|Withdrawal by Subject|0|||
105978036|NCT05013424|365581214|FG001|Overall Study|Withdrawal by Subject|1|||
105978037|NCT05013424|365581215|FG002|Overall Study|Withdrawal by Subject|0|||
105978038|NCT03654885|365581216|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
105978039|NCT03654885|365581217|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
105978040|NCT03654885|365581216|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
105978041|NCT03654885|365581217|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
105978042|NCT03654885|365581216|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
105978043|NCT03654885|365581217|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
105978044|NCT03654885|365581216|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
105978045|NCT03654885|365581217|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
105978046|NCT03654885|365581216|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
105978047|NCT03654885|365581217|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
105978048|NCT03654885|365581216|FG000|Overall Study|Adverse Event in Study Eye|3|||
105978049|NCT03654885|365581217|FG001|Overall Study|Adverse Event in Study Eye|0|||
105978050|NCT03654885|365581216|FG000|Overall Study|Consent Withdrawn|1|||
105978051|NCT03654885|365581217|FG001|Overall Study|Consent Withdrawn|0|||
105978052|NCT03654885|365581216|FG000|Overall Study|Death|3|||
105978053|NCT03654885|365581217|FG001|Overall Study|Death|1|||
105978054|NCT03654885|365581216|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
105978055|NCT03654885|365581217|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
105978056|NCT03654885|365581216|FG000|Overall Study|Lost to Follow-up|3|||
105978057|NCT03654885|365581217|FG001|Overall Study|Lost to Follow-up|3|||
105978058|NCT05275582|365581218|FG000|Overall Study|Lost to Follow-up|1|||
105978059|NCT05275582|365581219|FG001|Overall Study|Lost to Follow-up|0|||
105978060|NCT05275582|365581218|FG000|Overall Study|Withdrawal by Subject|0|||
105978061|NCT05275582|365581219|FG001|Overall Study|Withdrawal by Subject|2|||
105978062|NCT05275582|365581218|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
105978063|NCT05275582|365581219|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
105978064|NCT05275582|365581218|FG000|Overall Study|Death|1|||
105978065|NCT05275582|365581219|FG001|Overall Study|Death|0|||
105978066|NCT05275582|365581218|FG000|Overall Study|Protocol Violation|1|||
105978067|NCT05275582|365581219|FG001|Overall Study|Protocol Violation|0|||
105978068|NCT04732949|365581220|FG000|Overall Study|Withdrawal by Subject|23|||
105978069|NCT04732949|365581221|FG001|Overall Study|Withdrawal by Subject|27|||
105978070|NCT04732949|365581220|FG000|Overall Study|Protocol Violation|0|||
105978071|NCT04732949|365581221|FG001|Overall Study|Protocol Violation|1|||
105978072|NCT04732949|365581220|FG000|Overall Study|Non-compliance|0|||
105978073|NCT04732949|365581221|FG001|Overall Study|Non-compliance|2|||
106027907|NCT00796445|365767507|FG000|Overall Study|Adverse event, non-fatal|4|||
106027908|NCT00796445|365767508|FG001|Overall Study|Adverse event, non-fatal|0|||
105978074|NCT04732949|365581220|FG000|Overall Study|Physician Decision|2|||
106027909|NCT00796445|365767507|FG000|Overall Study|Disease progression/recurrence|537|||
105978075|NCT04732949|365581221|FG001|Overall Study|Physician Decision|1|||
105978076|NCT04732949|365581220|FG000|Overall Study|Serious adverse event (Fatal)|16|||
105978077|NCT04732949|365581221|FG001|Overall Study|Serious adverse event (Fatal)|18|||
105978078|NCT04732949|365581220|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
105978079|NCT04732949|365581221|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
105978080|NCT04732949|365581220|FG000|Overall Study|Non-serious adverse event|1|||
105978081|NCT04732949|365581221|FG001|Overall Study|Non-serious adverse event|3|||
105978082|NCT04732949|365581220|FG000|Overall Study|Lost to Follow-up|26|||
105978083|NCT04732949|365581221|FG001|Overall Study|Lost to Follow-up|27|||
105978084|NCT04732949|365581220|FG000|Overall Study|Other|6|||
105978085|NCT04732949|365581221|FG001|Overall Study|Other|3|||
105978086|NCT03627065|365581224|FG000|Overall Study|Study Terminated by sponsor|1|||
105978087|NCT03627065|365581224|FG000|Overall Study|Withdrawal by Subject|2|||
105978088|NCT04524455|365581226|FG000|Overall Study|Death|3|||
105978089|NCT04524455|365581227|FG001|Overall Study|Death|3|||
105978090|NCT04524455|365581226|FG000|Overall Study|Decision by Sponsor|0|||
105978091|NCT04524455|365581227|FG001|Overall Study|Decision by Sponsor|2|||
105978092|NCT04524455|365581226|FG000|Overall Study|Withdrawal of Consent From Study|1|||
105978093|NCT04524455|365581227|FG001|Overall Study|Withdrawal of Consent From Study|0|||
105978094|NCT04524455|365581226|FG000|Overall Study|Lost to Follow-up|0|||
105978095|NCT04524455|365581227|FG001|Overall Study|Lost to Follow-up|1|||
105978096|NCT00289198|365581230|FG000|Overall Study|Adverse Event|0|||
105978097|NCT00289198|365581231|FG001|Overall Study|Adverse Event|2|||
105978098|NCT00289198|365581230|FG000|Overall Study|Protocol Violation|2|||
105978099|NCT00289198|365581231|FG001|Overall Study|Protocol Violation|1|||
105978100|NCT00289198|365581230|FG000|Overall Study|Withdrawal by Subject|4|||
105978101|NCT00289198|365581231|FG001|Overall Study|Withdrawal by Subject|1|||
105978102|NCT00289198|365581230|FG000|Overall Study|Lack of Efficacy|2|||
105978103|NCT00289198|365581231|FG001|Overall Study|Lack of Efficacy|0|||
105978104|NCT00289198|365581230|FG000|Overall Study|Other: Low compliance|0|||
105978105|NCT00289198|365581231|FG001|Overall Study|Other: Low compliance|1|||
105978106|NCT00289198|365581230|FG000|Overall Study|Other: Physician's decision|0|||
105978107|NCT00289198|365581231|FG001|Overall Study|Other: Physician's decision|1|||
105978108|NCT00289198|365581230|FG000|Overall Study|Other: Unable to attend on schedule|2|||
105978109|NCT00289198|365581231|FG001|Overall Study|Other: Unable to attend on schedule|1|||
105978110|NCT00289198|365581230|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
105978111|NCT00289198|365581231|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
105978112|NCT00289198|365581230|FG000|Overall Study|Other: Impossible to come on visit|0|||
105978113|NCT00289198|365581231|FG001|Overall Study|Other: Impossible to come on visit|1|||
105978114|NCT02804750|365581238|FG000|Period 1|Adverse Event|0|||
105978115|NCT02804750|365581239|FG001|Period 1|Adverse Event|2|||
105978116|NCT02804750|365581238|FG000|Period 1|Withdrawal by Subject|0|||
105978117|NCT02804750|365581239|FG001|Period 1|Withdrawal by Subject|1|||
105978118|NCT02804750|365581238|FG000|Period 2|Adverse Event|1|||
105978119|NCT02804750|365581239|FG001|Period 2|Adverse Event|0|||
105978120|NCT02804750|365581238|FG000|Period 3|Adverse Event|0|||
105978121|NCT02804750|365581239|FG001|Period 3|Adverse Event|2|||
105978122|NCT02804750|365581238|FG000|Period 4|Adverse Event|0|||
105978123|NCT02804750|365581239|FG001|Period 4|Adverse Event|5|||
105978124|NCT03602885|365581240|FG000|Overall Study|Lost to Follow-up|3|||
105978125|NCT03602885|365581241|FG001|Overall Study|Lost to Follow-up|0|||
105978126|NCT02559414|365581244|FG000|Overall Study|Lost to Follow-up|0|||
105978127|NCT02559414|365581245|FG001|Overall Study|Lost to Follow-up|1|||
105978128|NCT02559414|365581246|FG002|Overall Study|Lost to Follow-up|0|||
105978129|NCT02559414|365581244|FG000|Overall Study|Withdrawal by Subject|1|||
105978130|NCT02559414|365581245|FG001|Overall Study|Withdrawal by Subject|0|||
105978131|NCT02559414|365581246|FG002|Overall Study|Withdrawal by Subject|1|||
105978132|NCT02559414|365581244|FG000|Overall Study|Other|0|||
105978133|NCT02559414|365581245|FG001|Overall Study|Other|1|||
105978134|NCT02559414|365581246|FG002|Overall Study|Other|1|||
105978135|NCT03369431|365581247|FG000|Overall Study|Lost to Follow-up|1|||
105978136|NCT03369431|365581248|FG001|Overall Study|Lost to Follow-up|3|||
105978137|NCT03369431|365581247|FG000|Overall Study|Withdrawal by Subject|2|||
105978138|NCT03369431|365581248|FG001|Overall Study|Withdrawal by Subject|3|||
105978139|NCT03369431|365581247|FG000|Overall Study|Protocol Violation|1|||
105978140|NCT03369431|365581248|FG001|Overall Study|Protocol Violation|1|||
105978141|NCT05323656|365581257|FG000|Overall Study|Still On-Treatment|6|||
105978142|NCT05323656|365581258|FG001|Overall Study|Still On-Treatment|6|||
105978143|NCT05323656|365581257|FG000|Overall Study|Progressive Disease|15|||
105978144|NCT05323656|365581258|FG001|Overall Study|Progressive Disease|14|||
105978145|NCT05323656|365581257|FG000|Overall Study|Adverse Event|2|||
105978146|NCT05323656|365581258|FG001|Overall Study|Adverse Event|3|||
105978147|NCT05323656|365581257|FG000|Overall Study|Death|1|||
105978148|NCT05323656|365581258|FG001|Overall Study|Death|2|||
105978149|NCT05323656|365581257|FG000|Overall Study|Withdrawal by Subject|1|||
105978150|NCT05323656|365581258|FG001|Overall Study|Withdrawal by Subject|0|||
105978151|NCT05323656|365581257|FG000|Overall Study|Clinical disease progression|0|||
105978152|NCT05323656|365581258|FG001|Overall Study|Clinical disease progression|1|||
105978153|NCT05323656|365581257|FG000|Overall Study|Patient and Investigator decision|1|||
106151007|NCT02723955|366215077|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151008|NCT02723955|366215078|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151009|NCT02723955|366215079|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
105851362|NCT01986010|365112688|FG012|Overall Study|Status Not Recorded|9|||
105978154|NCT05323656|365581258|FG001|Overall Study|Patient and Investigator decision|0|||
105978155|NCT05323656|365581257|FG000|Overall Study|Physician Decision|0|||
105978156|NCT05323656|365581258|FG001|Overall Study|Physician Decision|1|||
105978157|NCT00098722|365581263|FG000|Double Blind Phase|Adverse Event|7|||
105978158|NCT00098722|365581264|FG001|Double Blind Phase|Adverse Event|7|||
105978159|NCT00098722|365581265|FG002|Double Blind Phase|Adverse Event|3|||
105978160|NCT00098722|365581266|FG003|Double Blind Phase|Adverse Event|0|||
105978161|NCT00098722|365581267|FG004|Double Blind Phase|Adverse Event|0|||
105978162|NCT00098722|365581268|FG005|Double Blind Phase|Adverse Event|0|||
105978163|NCT00098722|365581269|FG006|Double Blind Phase|Adverse Event|0|||
105978164|NCT00098722|365581263|FG000|Double Blind Phase|Death|2|||
105978165|NCT00098722|365581264|FG001|Double Blind Phase|Death|5|||
105978166|NCT00098722|365581265|FG002|Double Blind Phase|Death|0|||
105978167|NCT00098722|365581266|FG003|Double Blind Phase|Death|0|||
105978168|NCT00098722|365581267|FG004|Double Blind Phase|Death|0|||
105978169|NCT00098722|365581268|FG005|Double Blind Phase|Death|0|||
105978170|NCT00098722|365581269|FG006|Double Blind Phase|Death|0|||
105978171|NCT00098722|365581263|FG000|Double Blind Phase|Lack of Efficacy|21|||
105978172|NCT00098722|365581264|FG001|Double Blind Phase|Lack of Efficacy|23|||
105978173|NCT00098722|365581265|FG002|Double Blind Phase|Lack of Efficacy|15|||
105978174|NCT00098722|365581266|FG003|Double Blind Phase|Lack of Efficacy|0|||
105978175|NCT00098722|365581267|FG004|Double Blind Phase|Lack of Efficacy|0|||
105978176|NCT00098722|365581268|FG005|Double Blind Phase|Lack of Efficacy|0|||
105978177|NCT00098722|365581269|FG006|Double Blind Phase|Lack of Efficacy|0|||
105978178|NCT00098722|365581263|FG000|Double Blind Phase|Participant defaulted|16|||
105978179|NCT00098722|365581264|FG001|Double Blind Phase|Participant defaulted|11|||
105978180|NCT00098722|365581265|FG002|Double Blind Phase|Participant defaulted|9|||
105978181|NCT00098722|365581266|FG003|Double Blind Phase|Participant defaulted|0|||
105978182|NCT00098722|365581267|FG004|Double Blind Phase|Participant defaulted|0|||
105978183|NCT00098722|365581268|FG005|Double Blind Phase|Participant defaulted|0|||
105978184|NCT00098722|365581269|FG006|Double Blind Phase|Participant defaulted|0|||
105978185|NCT00098722|365581263|FG000|Double Blind Phase|Pregnancy|1|||
105978186|NCT00098722|365581264|FG001|Double Blind Phase|Pregnancy|0|||
105978187|NCT00098722|365581265|FG002|Double Blind Phase|Pregnancy|0|||
105978188|NCT00098722|365581266|FG003|Double Blind Phase|Pregnancy|0|||
105978189|NCT00098722|365581267|FG004|Double Blind Phase|Pregnancy|0|||
105978190|NCT00098722|365581268|FG005|Double Blind Phase|Pregnancy|0|||
105978191|NCT00098722|365581269|FG006|Double Blind Phase|Pregnancy|0|||
105978192|NCT00098722|365581263|FG000|Double Blind Phase|Randomized, not treated|4|||
105978193|NCT00098722|365581264|FG001|Double Blind Phase|Randomized, not treated|3|||
105978194|NCT00098722|365581265|FG002|Double Blind Phase|Randomized, not treated|3|||
105978195|NCT00098722|365581266|FG003|Double Blind Phase|Randomized, not treated|0|||
105978196|NCT00098722|365581267|FG004|Double Blind Phase|Randomized, not treated|0|||
105978197|NCT00098722|365581268|FG005|Double Blind Phase|Randomized, not treated|0|||
105978198|NCT00098722|365581269|FG006|Double Blind Phase|Randomized, not treated|0|||
105978199|NCT00098722|365581263|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
105978200|NCT00098722|365581264|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
105978201|NCT00098722|365581265|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
105978202|NCT00098722|365581266|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
105978203|NCT00098722|365581267|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
105978204|NCT00098722|365581268|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
105978205|NCT00098722|365581269|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
105978206|NCT00098722|365581263|FG000|Double Blind Phase|Other|7|||
105978207|NCT00098722|365581264|FG001|Double Blind Phase|Other|8|||
105978208|NCT00098722|365581265|FG002|Double Blind Phase|Other|7|||
105978209|NCT00098722|365581266|FG003|Double Blind Phase|Other|0|||
105978210|NCT00098722|365581267|FG004|Double Blind Phase|Other|0|||
105978211|NCT00098722|365581268|FG005|Double Blind Phase|Other|0|||
105978212|NCT00098722|365581269|FG006|Double Blind Phase|Other|0|||
105978213|NCT00098722|365581263|FG000|Open Label Phase|Adverse Event|0|||
105978214|NCT00098722|365581264|FG001|Open Label Phase|Adverse Event|0|||
105978215|NCT00098722|365581265|FG002|Open Label Phase|Adverse Event|0|||
105978216|NCT00098722|365581266|FG003|Open Label Phase|Adverse Event|5|||
105978217|NCT00098722|365581267|FG004|Open Label Phase|Adverse Event|0|||
105978218|NCT00098722|365581268|FG005|Open Label Phase|Adverse Event|0|||
105978219|NCT00098722|365581269|FG006|Open Label Phase|Adverse Event|0|||
105978220|NCT00098722|365581263|FG000|Open Label Phase|Death|0|||
105978221|NCT00098722|365581264|FG001|Open Label Phase|Death|0|||
105978222|NCT00098722|365581265|FG002|Open Label Phase|Death|0|||
105978223|NCT00098722|365581266|FG003|Open Label Phase|Death|2|||
105978224|NCT00098722|365581267|FG004|Open Label Phase|Death|0|||
105978225|NCT00098722|365581268|FG005|Open Label Phase|Death|0|||
105978226|NCT00098722|365581269|FG006|Open Label Phase|Death|0|||
105978227|NCT00098722|365581263|FG000|Open Label Phase|Lack of Efficacy|0|||
105978228|NCT00098722|365581264|FG001|Open Label Phase|Lack of Efficacy|0|||
105978229|NCT00098722|365581265|FG002|Open Label Phase|Lack of Efficacy|0|||
105978230|NCT00098722|365581266|FG003|Open Label Phase|Lack of Efficacy|8|||
105978231|NCT00098722|365581267|FG004|Open Label Phase|Lack of Efficacy|0|||
105978232|NCT00098722|365581268|FG005|Open Label Phase|Lack of Efficacy|0|||
105978233|NCT00098722|365581269|FG006|Open Label Phase|Lack of Efficacy|0|||
105978234|NCT00098722|365581263|FG000|Open Label Phase|Pregnancy|0|||
105978235|NCT00098722|365581264|FG001|Open Label Phase|Pregnancy|0|||
105978236|NCT00098722|365581265|FG002|Open Label Phase|Pregnancy|0|||
105978237|NCT00098722|365581266|FG003|Open Label Phase|Pregnancy|1|||
105978238|NCT00098722|365581267|FG004|Open Label Phase|Pregnancy|0|||
105978239|NCT00098722|365581268|FG005|Open Label Phase|Pregnancy|0|||
105978240|NCT00098722|365581269|FG006|Open Label Phase|Pregnancy|0|||
105978241|NCT00098722|365581263|FG000|Open Label Phase|Participant defaulted|0|||
105978242|NCT00098722|365581264|FG001|Open Label Phase|Participant defaulted|0|||
105978243|NCT00098722|365581265|FG002|Open Label Phase|Participant defaulted|0|||
105978244|NCT00098722|365581266|FG003|Open Label Phase|Participant defaulted|18|||
105978245|NCT00098722|365581267|FG004|Open Label Phase|Participant defaulted|0|||
105978246|NCT00098722|365581268|FG005|Open Label Phase|Participant defaulted|0|||
105978247|NCT00098722|365581269|FG006|Open Label Phase|Participant defaulted|0|||
105978248|NCT00098722|365581263|FG000|Open Label Phase|Ongoing at cut-off date|0|||
105978249|NCT00098722|365581264|FG001|Open Label Phase|Ongoing at cut-off date|0|||
105978250|NCT00098722|365581265|FG002|Open Label Phase|Ongoing at cut-off date|0|||
105978251|NCT00098722|365581266|FG003|Open Label Phase|Ongoing at cut-off date|220|||
105978252|NCT00098722|365581267|FG004|Open Label Phase|Ongoing at cut-off date|50|||
105978253|NCT00098722|365581268|FG005|Open Label Phase|Ongoing at cut-off date|0|||
105978254|NCT00098722|365581269|FG006|Open Label Phase|Ongoing at cut-off date|0|||
105978255|NCT00098722|365581263|FG000|Open Label Phase|Other|0|||
105978256|NCT00098722|365581264|FG001|Open Label Phase|Other|0|||
105978257|NCT00098722|365581265|FG002|Open Label Phase|Other|0|||
105978258|NCT00098722|365581266|FG003|Open Label Phase|Other|18|||
105978259|NCT00098722|365581267|FG004|Open Label Phase|Other|0|||
105978260|NCT00098722|365581268|FG005|Open Label Phase|Other|0|||
105978261|NCT00098722|365581269|FG006|Open Label Phase|Other|0|||
105978262|NCT00098722|365581263|FG000|Observation Phase|Death|0|||
105978263|NCT00098722|365581264|FG001|Observation Phase|Death|0|||
105978264|NCT00098722|365581265|FG002|Observation Phase|Death|0|||
105978265|NCT00098722|365581266|FG003|Observation Phase|Death|0|||
105978266|NCT00098722|365581267|FG004|Observation Phase|Death|0|||
105978267|NCT00098722|365581268|FG005|Observation Phase|Death|5|||
105978268|NCT00098722|365581269|FG006|Observation Phase|Death|3|||
105978269|NCT00098722|365581263|FG000|Observation Phase|Lack of Efficacy|0|||
105978270|NCT00098722|365581264|FG001|Observation Phase|Lack of Efficacy|0|||
105978271|NCT00098722|365581265|FG002|Observation Phase|Lack of Efficacy|0|||
105978272|NCT00098722|365581266|FG003|Observation Phase|Lack of Efficacy|0|||
105978273|NCT00098722|365581267|FG004|Observation Phase|Lack of Efficacy|0|||
105978274|NCT00098722|365581268|FG005|Observation Phase|Lack of Efficacy|2|||
105978275|NCT00098722|365581269|FG006|Observation Phase|Lack of Efficacy|0|||
105978276|NCT00098722|365581263|FG000|Observation Phase|Participant defaulted|0|||
105978277|NCT00098722|365581264|FG001|Observation Phase|Participant defaulted|0|||
105978278|NCT00098722|365581265|FG002|Observation Phase|Participant defaulted|0|||
105978279|NCT00098722|365581266|FG003|Observation Phase|Participant defaulted|0|||
105978280|NCT00098722|365581267|FG004|Observation Phase|Participant defaulted|0|||
105978281|NCT00098722|365581268|FG005|Observation Phase|Participant defaulted|17|||
105978282|NCT00098722|365581269|FG006|Observation Phase|Participant defaulted|4|||
105978283|NCT00098722|365581263|FG000|Observation Phase|Other|0|||
105978284|NCT00098722|365581264|FG001|Observation Phase|Other|0|||
106027910|NCT00796445|365767508|FG001|Overall Study|Disease progression/recurrence|268|||
106027911|NCT00796445|365767507|FG000|Overall Study|Other|10|||
105978285|NCT00098722|365581265|FG002|Observation Phase|Other|0|||
105978286|NCT00098722|365581266|FG003|Observation Phase|Other|0|||
105978287|NCT00098722|365581267|FG004|Observation Phase|Other|0|||
105978288|NCT00098722|365581268|FG005|Observation Phase|Other|21|||
105978289|NCT00098722|365581269|FG006|Observation Phase|Other|10|||
105978290|NCT02285114|365581270|FG000|Main Phase|Investigator's Discretion|0|||
105978291|NCT02285114|365581271|FG001|Main Phase|Investigator's Discretion|2|||
105978292|NCT02285114|365581272|FG002|Main Phase|Investigator's Discretion|0|||
105978293|NCT02285114|365581273|FG003|Main Phase|Investigator's Discretion|0|||
105978294|NCT02285114|365581274|FG004|Main Phase|Investigator's Discretion|0|||
105978295|NCT02285114|365581275|FG005|Main Phase|Investigator's Discretion|0|||
105978296|NCT02285114|365581270|FG000|Main Phase|Enrolled but Never Treated|1|||
105978297|NCT02285114|365581271|FG001|Main Phase|Enrolled but Never Treated|0|||
106027912|NCT00796445|365767508|FG001|Overall Study|Other|7|||
105978298|NCT02285114|365581272|FG002|Main Phase|Enrolled but Never Treated|0|||
105978299|NCT02285114|365581273|FG003|Main Phase|Enrolled but Never Treated|0|||
105978300|NCT02285114|365581274|FG004|Main Phase|Enrolled but Never Treated|0|||
105978301|NCT02285114|365581275|FG005|Main Phase|Enrolled but Never Treated|0|||
105978302|NCT02285114|365581270|FG000|Main Phase|Withdrew Consent|0|||
105978303|NCT02285114|365581271|FG001|Main Phase|Withdrew Consent|0|||
106027913|NCT00796445|365767507|FG000|Overall Study|Withdrawal by Subject|18|||
105978304|NCT02285114|365581272|FG002|Main Phase|Withdrew Consent|1|||
105978305|NCT02285114|365581273|FG003|Main Phase|Withdrew Consent|0|||
105978306|NCT02285114|365581274|FG004|Main Phase|Withdrew Consent|0|||
105978307|NCT02285114|365581275|FG005|Main Phase|Withdrew Consent|0|||
105978308|NCT02285114|365581270|FG000|Extension Phase|Investigator's Discretion|0|||
105978309|NCT02285114|365581271|FG001|Extension Phase|Investigator's Discretion|0|||
105978310|NCT02285114|365581272|FG002|Extension Phase|Investigator's Discretion|0|||
105978311|NCT02285114|365581273|FG003|Extension Phase|Investigator's Discretion|14|||
105978312|NCT02285114|365581274|FG004|Extension Phase|Investigator's Discretion|1|||
105978313|NCT02285114|365581275|FG005|Extension Phase|Investigator's Discretion|0|||
105978314|NCT02285114|365581270|FG000|Extension Phase|Lost to Follow-up|0|||
105978315|NCT02285114|365581271|FG001|Extension Phase|Lost to Follow-up|0|||
105978316|NCT02285114|365581272|FG002|Extension Phase|Lost to Follow-up|0|||
105978317|NCT02285114|365581273|FG003|Extension Phase|Lost to Follow-up|1|||
105978318|NCT02285114|365581274|FG004|Extension Phase|Lost to Follow-up|1|||
105978319|NCT02285114|365581275|FG005|Extension Phase|Lost to Follow-up|0|||
105978320|NCT02285114|365581270|FG000|Extension Phase|Non-compliance with Study Drug|0|||
105978321|NCT02285114|365581271|FG001|Extension Phase|Non-compliance with Study Drug|0|||
105978322|NCT02285114|365581272|FG002|Extension Phase|Non-compliance with Study Drug|0|||
106027914|NCT00796445|365767508|FG001|Overall Study|Withdrawal by Subject|9|||
106027915|NCT00796445|365767507|FG000|Overall Study|Invalid Informed Consent Form|1|||
106027916|NCT00796445|365767508|FG001|Overall Study|Invalid Informed Consent Form|0|||
106027917|NCT02208063|365767509|FG000|Overall Study|Death|3|||
106027918|NCT02208063|365767510|FG001|Overall Study|Death|5|||
106027919|NCT02208063|365767509|FG000|Overall Study|Not Specified in report|3|||
106027920|NCT02208063|365767510|FG001|Overall Study|Not Specified in report|4|||
106027921|NCT02208063|365767509|FG000|Overall Study|Withdrawal by Subject|5|||
106027922|NCT02208063|365767510|FG001|Overall Study|Withdrawal by Subject|2|||
106027923|NCT02208063|365767509|FG000|Overall Study|Lost to Follow-up|1|||
106027924|NCT02208063|365767510|FG001|Overall Study|Lost to Follow-up|0|||
106027925|NCT03180619|365767514|FG000|Overall Study|Withdrew Consent|5|||
106027926|NCT03180619|365767515|FG001|Overall Study|Withdrew Consent|0|||
106027927|NCT03180619|365767516|FG002|Overall Study|Withdrew Consent|2|||
106027928|NCT03180619|365767514|FG000|Overall Study|Death|2|||
106027929|NCT03180619|365767515|FG001|Overall Study|Death|1|||
106027930|NCT03180619|365767516|FG002|Overall Study|Death|2|||
106027931|NCT03180619|365767514|FG000|Overall Study|Adverse Event|2|||
106027932|NCT03180619|365767515|FG001|Overall Study|Adverse Event|0|||
106027933|NCT03180619|365767516|FG002|Overall Study|Adverse Event|1|||
106027934|NCT03180619|365767514|FG000|Overall Study|Investigator's discretion|2|||
106027935|NCT03180619|365767515|FG001|Overall Study|Investigator's discretion|0|||
106027936|NCT03180619|365767516|FG002|Overall Study|Investigator's discretion|1|||
106027937|NCT01433289|365767517|FG000|Overall Study|Pregnancy|0|||
106027938|NCT01433289|365767518|FG001|Overall Study|Pregnancy|1|||
106027939|NCT01433289|365767519|FG002|Overall Study|Pregnancy|0|||
106027940|NCT01433289|365767520|FG003|Overall Study|Pregnancy|0|||
106027941|NCT04620798|365767523|FG000|Overall Study|Lost to Follow-up|126|||
106027942|NCT04620798|365767524|FG001|Overall Study|Lost to Follow-up|138|||
106027943|NCT00862641|365767529|FG000|Overall Study|Randomized, but drug not received|1|||
106027944|NCT00862641|365767530|FG001|Overall Study|Randomized, but drug not received|4|||
106027945|NCT00862641|365767531|FG002|Overall Study|Randomized, but drug not received|1|||
106027946|NCT00862641|365767532|FG003|Overall Study|Randomized, but drug not received|4|||
106027947|NCT01105767|365767534|FG000|Overall Study|Lost to Follow-up|1160|||
106027948|NCT01105767|365767535|FG001|Overall Study|Lost to Follow-up|1614|||
106027949|NCT01105767|365767536|FG002|Overall Study|Lost to Follow-up|1184|||
106027950|NCT00475982|365767537|FG000|Overall Study|surgery rescheduled|7|||
106027951|NCT00475982|365767538|FG001|Overall Study|surgery rescheduled|3|||
106027952|NCT00796523|365767540|FG000|Overall Study|Lost to Follow-up|9|||
106027953|NCT00796523|365767541|FG001|Overall Study|Lost to Follow-up|7|||
106027954|NCT04525885|365767542|FG000|Overall Study|Screen Failure|1|||
106027955|NCT04525885|365767543|FG001|Overall Study|Screen Failure|0|||
106027956|NCT04525885|365767544|FG002|Overall Study|Screen Failure|0|||
106027957|NCT04525885|365767542|FG000|Overall Study|Withdrawal by Subject|14|||
106027958|NCT04525885|365767543|FG001|Overall Study|Withdrawal by Subject|6|||
106027959|NCT04525885|365767544|FG002|Overall Study|Withdrawal by Subject|20|||
106027960|NCT04525885|365767542|FG000|Overall Study|Physician Decision|1|||
105978323|NCT02285114|365581273|FG003|Extension Phase|Non-compliance with Study Drug|2|||
105978324|NCT02285114|365581274|FG004|Extension Phase|Non-compliance with Study Drug|0|||
105978325|NCT02285114|365581275|FG005|Extension Phase|Non-compliance with Study Drug|0|||
105978326|NCT02285114|365581270|FG000|Extension Phase|Pregnancy|0|||
105978327|NCT02285114|365581271|FG001|Extension Phase|Pregnancy|0|||
106027961|NCT04525885|365767543|FG001|Overall Study|Physician Decision|0|||
106027962|NCT04525885|365767544|FG002|Overall Study|Physician Decision|1|||
106027963|NCT00096356|365767547|FG000|Overall Study|Adverse Event|11|||
106027964|NCT00096356|365767548|FG001|Overall Study|Adverse Event|9|||
106027965|NCT00096356|365767547|FG000|Overall Study|Physician Decision|5|||
106027966|NCT00096356|365767548|FG001|Overall Study|Physician Decision|3|||
106027967|NCT00096356|365767547|FG000|Overall Study|Withdrawal by Subject|17|||
106027968|NCT00096356|365767548|FG001|Overall Study|Withdrawal by Subject|23|||
105978328|NCT02285114|365581272|FG002|Extension Phase|Pregnancy|0|||
105978329|NCT02285114|365581273|FG003|Extension Phase|Pregnancy|1|||
105978330|NCT02285114|365581274|FG004|Extension Phase|Pregnancy|0|||
105978331|NCT02285114|365581275|FG005|Extension Phase|Pregnancy|0|||
105978332|NCT02781792|365581286|FG000|Overall Study|Adverse Event|1|||
105978333|NCT02781792|365581287|FG001|Overall Study|Adverse Event|2|||
105978334|NCT02781792|365581286|FG000|Overall Study|Withdrawal by Subject|3|||
105978335|NCT02781792|365581287|FG001|Overall Study|Withdrawal by Subject|1|||
105978336|NCT02781792|365581286|FG000|Overall Study|Lack of Efficacy|1|||
105978337|NCT02781792|365581287|FG001|Overall Study|Lack of Efficacy|1|||
105978338|NCT02781792|365581286|FG000|Overall Study|Hospice|0|||
105978339|NCT02781792|365581287|FG001|Overall Study|Hospice|1|||
105978340|NCT02838420|365581288|FG000|Overall Study|Ongoing in Study|113|||
105978341|NCT02838420|365581289|FG001|Overall Study|Ongoing in Study|45|||
105978342|NCT02838420|365581288|FG000|Overall Study|Lost to Follow-up|1|||
105978343|NCT02838420|365581289|FG001|Overall Study|Lost to Follow-up|0|||
105978344|NCT02838420|365581288|FG000|Overall Study|Withdrawal by Subject|3|||
105978345|NCT02838420|365581289|FG001|Overall Study|Withdrawal by Subject|4|||
105978346|NCT02838420|365581288|FG000|Overall Study|Death|8|||
105851363|NCT01986010|365112689|FG013|Overall Study|Status Not Recorded|9|||
105851364|NCT01986010|365112690|FG014|Overall Study|Status Not Recorded|5|||
105851365|NCT01986010|365112691|FG015|Overall Study|Status Not Recorded|10|||
106027969|NCT00096356|365767547|FG000|Overall Study|Lack of Efficacy|1|||
106027970|NCT00096356|365767548|FG001|Overall Study|Lack of Efficacy|0|||
106027971|NCT00096356|365767547|FG000|Overall Study|multiple reasons|10|||
106027972|NCT00096356|365767548|FG001|Overall Study|multiple reasons|18|||
106027973|NCT01576159|365767554|FG000|Overall Study|Withdrawal by Subject|0|||
106027974|NCT01576159|365767555|FG001|Overall Study|Withdrawal by Subject|1|||
106027975|NCT01576159|365767556|FG002|Overall Study|Withdrawal by Subject|0|||
106027976|NCT01576159|365767557|FG003|Overall Study|Withdrawal by Subject|0|||
106027977|NCT01576159|365767554|FG000|Overall Study|Physician Decision|0|||
106027978|NCT01576159|365767555|FG001|Overall Study|Physician Decision|0|||
105978347|NCT02838420|365581289|FG001|Overall Study|Death|13|||
105978348|NCT00046930|365581290|FG000|Overall Study|Ineligible|12|||
105978349|NCT00046930|365581291|FG001|Overall Study|Ineligible|4|||
105978350|NCT00440310|365581292|FG000|Overall Study|Lost to Follow-up|4|||
105978351|NCT00440310|365581293|FG001|Overall Study|Lost to Follow-up|5|||
105978352|NCT00440310|365581292|FG000|Overall Study|Protocol Violation|0|||
105978353|NCT00440310|365581293|FG001|Overall Study|Protocol Violation|1|||
105978354|NCT00440310|365581292|FG000|Overall Study|Withdrawal by Subject|15|||
105978355|NCT00440310|365581293|FG001|Overall Study|Withdrawal by Subject|14|||
105978356|NCT00440310|365581292|FG000|Overall Study|No Reply at EOS|7|||
105978357|NCT00440310|365581293|FG001|Overall Study|No Reply at EOS|7|||
105978358|NCT00440310|365581292|FG000|Overall Study|Other|1|||
105978359|NCT00440310|365581293|FG001|Overall Study|Other|0|||
105978360|NCT00440310|365581292|FG000|Overall Study|Status Unknown|1|||
105978361|NCT00440310|365581293|FG001|Overall Study|Status Unknown|3|||
105978362|NCT03554772|365581297|FG000|Overall Study|Lost to Follow-up|0|||
105978363|NCT03554772|365581298|FG001|Overall Study|Lost to Follow-up|0|||
105978364|NCT03554772|365581299|FG002|Overall Study|Lost to Follow-up|0|||
105978365|NCT03554772|365581300|FG003|Overall Study|Lost to Follow-up|2|||
105978366|NCT05136898|365581301|FG000|Overall Study|Adverse Event|2|||
105978367|NCT00520013|365581302|FG000|Overall Study|Withdrawal by Subject|0|||
105978368|NCT00520013|365581303|FG001|Overall Study|Withdrawal by Subject|0|||
105978369|NCT00520013|365581304|FG002|Overall Study|Withdrawal by Subject|1|||
105978370|NCT00520013|365581302|FG000|Overall Study|Adverse Event|2|||
105978371|NCT00520013|365581303|FG001|Overall Study|Adverse Event|10|||
105978372|NCT00520013|365581304|FG002|Overall Study|Adverse Event|7|||
105978373|NCT00520013|365581302|FG000|Overall Study|Progressive Disease|7|||
105978374|NCT00520013|365581303|FG001|Overall Study|Progressive Disease|3|||
105978375|NCT00520013|365581304|FG002|Overall Study|Progressive Disease|0|||
105978376|NCT00520013|365581302|FG000|Overall Study|Clinical Progression|3|||
105978377|NCT00520013|365581303|FG001|Overall Study|Clinical Progression|1|||
105978378|NCT00520013|365581304|FG002|Overall Study|Clinical Progression|0|||
105978379|NCT00520013|365581302|FG000|Overall Study|Death|0|||
105978380|NCT00520013|365581303|FG001|Overall Study|Death|1|||
105978381|NCT00520013|365581304|FG002|Overall Study|Death|0|||
105978382|NCT00520013|365581302|FG000|Overall Study|Physician Decision|0|||
105978383|NCT00520013|365581303|FG001|Overall Study|Physician Decision|0|||
105978384|NCT00520013|365581304|FG002|Overall Study|Physician Decision|3|||
105978385|NCT02969590|365581305|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
105978386|NCT02969590|365581306|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
105978387|NCT02969590|365581307|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
105978388|NCT00186537|365581308|FG000|Overall Study|Withdrawal by Subject|4|||
105978389|NCT00186537|365581309|FG001|Overall Study|Withdrawal by Subject|0|||
105978390|NCT00186537|365581310|FG002|Overall Study|Withdrawal by Subject|3|||
105978391|NCT00186537|365581308|FG000|Overall Study|ALT > 1.5 x ULN|3|||
105978392|NCT00186537|365581309|FG001|Overall Study|ALT > 1.5 x ULN|0|||
105978393|NCT00186537|365581310|FG002|Overall Study|ALT > 1.5 x ULN|0|||
106027979|NCT01576159|365767556|FG002|Overall Study|Physician Decision|1|||
105978394|NCT03684304|365581311|FG000|Overall Study|Lost to Follow-up|19|||
105978395|NCT03684304|365581312|FG001|Overall Study|Lost to Follow-up|17|||
105978396|NCT00824005|365581313|FG000|Overall Study|Death|0|||
105978397|NCT00824005|365581314|FG001|Overall Study|Death|1|||
105978398|NCT00824005|365581313|FG000|Overall Study|Lost to Follow-up|0|||
105978399|NCT00824005|365581314|FG001|Overall Study|Lost to Follow-up|1|||
105978400|NCT00431951|365581315|FG000|Overall Study|Inability to follow study procedures|1|||
105978401|NCT00431951|365581316|FG001|Overall Study|Inability to follow study procedures|0|||
105978402|NCT00431951|365581317|FG002|Overall Study|Inability to follow study procedures|1|||
105978403|NCT00431951|365581318|FG003|Overall Study|Inability to follow study procedures|2|||
105978404|NCT00431951|365581315|FG000|Overall Study|Lost to Follow-up|0|||
105978405|NCT00431951|365581316|FG001|Overall Study|Lost to Follow-up|1|||
105978406|NCT00431951|365581317|FG002|Overall Study|Lost to Follow-up|0|||
105978407|NCT00431951|365581318|FG003|Overall Study|Lost to Follow-up|0|||
105978408|NCT00431951|365581315|FG000|Overall Study|Withdrawal by Subject|0|||
105978409|NCT00431951|365581316|FG001|Overall Study|Withdrawal by Subject|1|||
105978410|NCT00431951|365581317|FG002|Overall Study|Withdrawal by Subject|0|||
105978411|NCT00431951|365581318|FG003|Overall Study|Withdrawal by Subject|0|||
105978412|NCT00431951|365581315|FG000|Overall Study|Adverse Event|0|||
105978413|NCT00431951|365581316|FG001|Overall Study|Adverse Event|0|||
105978414|NCT00431951|365581317|FG002|Overall Study|Adverse Event|1|||
105978415|NCT00431951|365581318|FG003|Overall Study|Adverse Event|0|||
105978416|NCT01143051|365581320|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
105978417|NCT01143051|365581321|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
105978418|NCT01143051|365581322|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
105978419|NCT01143051|365581323|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
105978420|NCT01143051|365581324|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
105978421|NCT01143051|365581325|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
105978422|NCT01143051|365581320|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
105978423|NCT01143051|365581321|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
105978424|NCT01143051|365581322|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
105978425|NCT01143051|365581323|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
105978426|NCT01143051|365581324|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
105978427|NCT01143051|365581325|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
105978428|NCT03458702|365581326|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
105978429|NCT03458702|365581327|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
105978430|NCT03458702|365581326|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
105978431|NCT03458702|365581327|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
105978432|NCT01484834|365581328|FG000|Overall Study|Lost to Follow-up|5|||
105978433|NCT01484834|365581329|FG001|Overall Study|Lost to Follow-up|8|||
105978434|NCT01484834|365581330|FG002|Overall Study|Lost to Follow-up|1|||
105978435|NCT01484834|365581331|FG003|Overall Study|Lost to Follow-up|4|||
105978436|NCT03532932|365581332|FG000|Overall Study|Protocol Deviation|33|||
105978437|NCT03532932|365581333|FG001|Overall Study|Protocol Deviation|31|||
105978438|NCT03532932|365581332|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
105978439|NCT03532932|365581333|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
105978440|NCT03532932|365581332|FG000|Overall Study|Withdrawal by Subject|2|||
105978441|NCT03532932|365581333|FG001|Overall Study|Withdrawal by Subject|0|||
105978442|NCT03532932|365581332|FG000|Overall Study|Lost to Follow-up|15|||
105978443|NCT03532932|365581333|FG001|Overall Study|Lost to Follow-up|9|||
105978444|NCT03532932|365581332|FG000|Overall Study|Adverse Event|4|||
105978445|NCT03532932|365581333|FG001|Overall Study|Adverse Event|3|||
105978446|NCT03532932|365581332|FG000|Overall Study|Death|0|||
105978447|NCT03532932|365581333|FG001|Overall Study|Death|2|||
105978448|NCT03532932|365581332|FG000|Overall Study|Other|11|||
105978449|NCT03532932|365581333|FG001|Overall Study|Other|16|||
105978450|NCT00096018|365581336|FG000|Overall Study|Became Ineligible (not treated)|0|||
105978451|NCT00096018|365581337|FG001|Overall Study|Became Ineligible (not treated)|3|||
105978452|NCT00096018|365581336|FG000|Overall Study|Miscellaneous (not treated)|0|||
105978453|NCT00096018|365581337|FG001|Overall Study|Miscellaneous (not treated)|2|||
105978454|NCT00096018|365581336|FG000|Overall Study|Adverse Event|0|||
105978455|NCT00096018|365581337|FG001|Overall Study|Adverse Event|5|||
105978456|NCT00096018|365581336|FG000|Overall Study|Death|0|||
105978457|NCT00096018|365581337|FG001|Overall Study|Death|1|||
105978458|NCT00096018|365581336|FG000|Overall Study|Withdrawal by Subject|0|||
105978459|NCT00096018|365581337|FG001|Overall Study|Withdrawal by Subject|2|||
105978460|NCT00096018|365581336|FG000|Overall Study|Miscellaneous|2|||
105978461|NCT00096018|365581337|FG001|Overall Study|Miscellaneous|1|||
105978462|NCT01100528|365581341|FG000|Overall Study|Death|1|||
105978463|NCT01100528|365581341|FG000|Overall Study|Withdrawal by Subject|2|||
105978464|NCT03968159|365581342|FG000|Overall Study|Adverse Event|4|||
105978465|NCT03968159|365581343|FG001|Overall Study|Adverse Event|4|||
105978466|NCT03968159|365581342|FG000|Overall Study|Lost to Follow-up|1|||
105978467|NCT03968159|365581343|FG001|Overall Study|Lost to Follow-up|1|||
106027980|NCT01576159|365767557|FG003|Overall Study|Physician Decision|0|||
106027981|NCT01576159|365767554|FG000|Overall Study|Lost to Follow-up|0|||
105978468|NCT03968159|365581342|FG000|Overall Study|Use of prohibited medication|0|||
105978469|NCT03968159|365581343|FG001|Overall Study|Use of prohibited medication|1|||
105978470|NCT03968159|365581342|FG000|Overall Study|Protocol Violation|2|||
105978471|NCT03968159|365581343|FG001|Overall Study|Protocol Violation|2|||
105978472|NCT03968159|365581342|FG000|Overall Study|Withdrawal by Subject|4|||
105978473|NCT03968159|365581343|FG001|Overall Study|Withdrawal by Subject|6|||
105978474|NCT03968159|365581342|FG000|Overall Study|Lack of Efficacy|0|||
105978475|NCT03968159|365581343|FG001|Overall Study|Lack of Efficacy|1|||
105978476|NCT03968159|365581342|FG000|Overall Study|Not further specified|2|||
105978477|NCT03968159|365581343|FG001|Overall Study|Not further specified|0|||
105978478|NCT01635764|365581344|FG000|Overall Study|Adverse Event|46|||
105978479|NCT01635764|365581344|FG000|Overall Study|Lack of Efficacy|76|||
105978480|NCT01635764|365581344|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
105978481|NCT01635764|365581344|FG000|Overall Study|Protocol Deviation|1|||
105978482|NCT01635764|365581344|FG000|Overall Study|Withdrew Consent|67|||
105978483|NCT01635764|365581344|FG000|Overall Study|Lost to Follow-up|53|||
105978484|NCT01635764|365581344|FG000|Overall Study|Other|28|||
105978485|NCT00933244|365581345|FG000|Overall Study|Withdrawal by Subject|5|||
105978486|NCT00933244|365581346|FG001|Overall Study|Withdrawal by Subject|1|||
105978487|NCT00933244|365581347|FG002|Overall Study|Withdrawal by Subject|3|||
105978488|NCT02689076|365581348|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
105978489|NCT02689076|365581349|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
105978490|NCT02689076|365581350|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
105978491|NCT02689076|365581348|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
105978492|NCT02689076|365581349|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
105978493|NCT02689076|365581350|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
105978494|NCT02689076|365581348|FG000|Overall Study|Did not have an HIE match|2|||
105978495|NCT02689076|365581349|FG001|Overall Study|Did not have an HIE match|0|||
105978496|NCT02689076|365581350|FG002|Overall Study|Did not have an HIE match|0|||
105978497|NCT02689076|365581348|FG000|Overall Study|Death during non-VA encounter|2|||
105978498|NCT02689076|365581349|FG001|Overall Study|Death during non-VA encounter|5|||
105978499|NCT02689076|365581350|FG002|Overall Study|Death during non-VA encounter|0|||
105978500|NCT02689076|365581348|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
105978501|NCT02689076|365581349|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
105978502|NCT02689076|365581350|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
106027982|NCT01576159|365767555|FG001|Overall Study|Lost to Follow-up|0|||
106027983|NCT01576159|365767556|FG002|Overall Study|Lost to Follow-up|0|||
106027984|NCT01576159|365767557|FG003|Overall Study|Lost to Follow-up|1|||
106027985|NCT01576159|365767554|FG000|Overall Study|Protocol Violation|1|||
105978503|NCT02689076|365581348|FG000|Overall Study|Participant no longer active in VA system|1|||
105978504|NCT02689076|365581349|FG001|Overall Study|Participant no longer active in VA system|0|||
105978505|NCT02689076|365581350|FG002|Overall Study|Participant no longer active in VA system|0|||
105978506|NCT02689076|365581348|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
105978507|NCT02689076|365581349|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
105978508|NCT02689076|365581350|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
105978509|NCT02956850|365581351|FG000|Overall Study|Withdrawal by Subject|0|||
105978510|NCT02956850|365581352|FG001|Overall Study|Withdrawal by Subject|0|||
105978511|NCT02956850|365581353|FG002|Overall Study|Withdrawal by Subject|0|||
105978512|NCT02956850|365581354|FG003|Overall Study|Withdrawal by Subject|0|||
105978513|NCT02956850|365581355|FG004|Overall Study|Withdrawal by Subject|0|||
105978514|NCT02956850|365581356|FG005|Overall Study|Withdrawal by Subject|0|||
105978515|NCT02956850|365581357|FG006|Overall Study|Withdrawal by Subject|0|||
105978516|NCT02956850|365581358|FG007|Overall Study|Withdrawal by Subject|0|||
105978517|NCT02956850|365581359|FG008|Overall Study|Withdrawal by Subject|0|||
105978518|NCT02956850|365581360|FG009|Overall Study|Withdrawal by Subject|0|||
105978519|NCT02956850|365581361|FG010|Overall Study|Withdrawal by Subject|0|||
105978520|NCT02956850|365581362|FG011|Overall Study|Withdrawal by Subject|0|||
105978521|NCT02956850|365581363|FG012|Overall Study|Withdrawal by Subject|0|||
105978522|NCT02956850|365581364|FG013|Overall Study|Withdrawal by Subject|0|||
105978523|NCT02956850|365581365|FG014|Overall Study|Withdrawal by Subject|0|||
105978524|NCT02956850|365581366|FG015|Overall Study|Withdrawal by Subject|0|||
105978525|NCT02956850|365581367|FG016|Overall Study|Withdrawal by Subject|0|||
105978526|NCT02956850|365581368|FG017|Overall Study|Withdrawal by Subject|1|||
105978527|NCT00391391|365581369|FG000|Overall Study|Adverse Event|0|||
105978528|NCT00391391|365581370|FG001|Overall Study|Adverse Event|0|||
105978529|NCT00391391|365581371|FG002|Overall Study|Adverse Event|0|||
105978530|NCT00391391|365581372|FG003|Overall Study|Adverse Event|1|||
105978531|NCT00391391|365581369|FG000|Overall Study|Lost to Follow-up|1|||
106027986|NCT01576159|365767555|FG001|Overall Study|Protocol Violation|0|||
106027987|NCT01576159|365767556|FG002|Overall Study|Protocol Violation|0|||
105851366|NCT01986010|365112692|FG016|Overall Study|Status Not Recorded|4|||
105851367|NCT04740814|365112695|FG000|Overall Study|Adverse Event|3|||
105851368|NCT04740814|365112695|FG000|Overall Study|Protocol Violation|2|||
105851369|NCT04740814|365112695|FG000|Overall Study|Lost to Follow-up|2|||
105851370|NCT04740814|365112695|FG000|Overall Study|Withdrawal by Subject|3|||
105851371|NCT02440568|365112698|FG000|Overall Study|Death|1|||
105851372|NCT02440568|365112699|FG001|Overall Study|Death|3|||
105851373|NCT02440568|365112700|FG002|Overall Study|Death|4|||
105851374|NCT02440568|365112701|FG003|Overall Study|Death|2|||
105851375|NCT02440568|365112698|FG000|Overall Study|Lack of Efficacy|2|||
105851376|NCT02440568|365112699|FG001|Overall Study|Lack of Efficacy|0|||
105851377|NCT02440568|365112700|FG002|Overall Study|Lack of Efficacy|1|||
105851378|NCT02440568|365112701|FG003|Overall Study|Lack of Efficacy|0|||
105851379|NCT02440568|365112698|FG000|Overall Study|Lost to Follow-up|1|||
105851380|NCT02440568|365112699|FG001|Overall Study|Lost to Follow-up|0|||
105851381|NCT02440568|365112700|FG002|Overall Study|Lost to Follow-up|0|||
105851382|NCT02440568|365112701|FG003|Overall Study|Lost to Follow-up|0|||
105851383|NCT03233230|365112704|FG000|Overall Study|Adverse Event|6|||
105851384|NCT03233230|365112705|FG001|Overall Study|Adverse Event|3|||
105851385|NCT03233230|365112706|FG002|Overall Study|Adverse Event|6|||
105851386|NCT03233230|365112707|FG003|Overall Study|Adverse Event|3|||
105851387|NCT03233230|365112704|FG000|Overall Study|Protocol Violation|1|||
105851388|NCT03233230|365112705|FG001|Overall Study|Protocol Violation|2|||
105851389|NCT03233230|365112706|FG002|Overall Study|Protocol Violation|1|||
105851390|NCT03233230|365112707|FG003|Overall Study|Protocol Violation|1|||
105851391|NCT03233230|365112704|FG000|Overall Study|Lack of Efficacy|1|||
105851392|NCT03233230|365112705|FG001|Overall Study|Lack of Efficacy|0|||
105851393|NCT03233230|365112706|FG002|Overall Study|Lack of Efficacy|0|||
105851394|NCT03233230|365112707|FG003|Overall Study|Lack of Efficacy|0|||
105851395|NCT03233230|365112704|FG000|Overall Study|Other|5|||
105851396|NCT03233230|365112705|FG001|Overall Study|Other|5|||
105851397|NCT03233230|365112706|FG002|Overall Study|Other|5|||
105851398|NCT03233230|365112707|FG003|Overall Study|Other|3|||
105851399|NCT03233230|365112704|FG000|Overall Study|Withdrawal by Subject|2|||
105851400|NCT03233230|365112705|FG001|Overall Study|Withdrawal by Subject|2|||
105851401|NCT03233230|365112706|FG002|Overall Study|Withdrawal by Subject|0|||
105851402|NCT03233230|365112707|FG003|Overall Study|Withdrawal by Subject|1|||
105851403|NCT03233230|365112704|FG000|Overall Study|Lost to Follow-up|0|||
105851404|NCT03233230|365112705|FG001|Overall Study|Lost to Follow-up|3|||
105851405|NCT03233230|365112706|FG002|Overall Study|Lost to Follow-up|0|||
105851406|NCT03233230|365112707|FG003|Overall Study|Lost to Follow-up|0|||
105851407|NCT02331368|365112708|FG000|Overall Study|Withdrawal by Subject|3|||
105851408|NCT04126213|365112716|FG000|Overall Study|Lost to Follow-up|9|||
105851409|NCT04126213|365112717|FG001|Overall Study|Lost to Follow-up|1|||
105851410|NCT04126213|365112718|FG002|Overall Study|Lost to Follow-up|5|||
105851411|NCT04126213|365112719|FG003|Overall Study|Lost to Follow-up|10|||
105851412|NCT04126213|365112720|FG004|Overall Study|Lost to Follow-up|4|||
105851413|NCT04126213|365112721|FG005|Overall Study|Lost to Follow-up|7|||
105851414|NCT04126213|365112716|FG000|Overall Study|Withdrawal by Subject|3|||
105851415|NCT04126213|365112717|FG001|Overall Study|Withdrawal by Subject|2|||
105851416|NCT04126213|365112718|FG002|Overall Study|Withdrawal by Subject|1|||
105851417|NCT04126213|365112719|FG003|Overall Study|Withdrawal by Subject|1|||
105851418|NCT04126213|365112720|FG004|Overall Study|Withdrawal by Subject|1|||
105851419|NCT04126213|365112721|FG005|Overall Study|Withdrawal by Subject|1|||
105851420|NCT04126213|365112716|FG000|Overall Study|Other|0|||
105851421|NCT04126213|365112717|FG001|Overall Study|Other|0|||
105851422|NCT04126213|365112718|FG002|Overall Study|Other|2|||
105851423|NCT04126213|365112719|FG003|Overall Study|Other|2|||
105851424|NCT04126213|365112720|FG004|Overall Study|Other|0|||
105851425|NCT04126213|365112721|FG005|Overall Study|Other|1|||
105851426|NCT04126213|365112716|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105851427|NCT04126213|365112717|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105851428|NCT04126213|365112718|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105851429|NCT04126213|365112719|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105851430|NCT04126213|365112720|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
105851431|NCT04126213|365112721|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105851432|NCT02853370|365112724|FG000|Overall Study|Physician Decision|1|||
105851433|NCT02853370|365112724|FG000|Overall Study|Lack of Efficacy|2|||
105851434|NCT02853370|365112724|FG000|Overall Study|Death|1|||
105851435|NCT02853370|365112724|FG000|Overall Study|Adverse Event|4|||
105851436|NCT02853370|365112724|FG000|Overall Study|Withdrawal by Subject|3|||
105851437|NCT02302859|365112725|FG000|Overall Study|Lost Phone|1|||
105851438|NCT02302859|365112726|FG001|Overall Study|Lost Phone|1|||
105851439|NCT02302859|365112725|FG000|Overall Study|Withdrawal by Subject|0|||
105851440|NCT02302859|365112726|FG001|Overall Study|Withdrawal by Subject|1|||
105851441|NCT02912650|365112727|FG000|Overall Study|Withdrawal by Subject|1|||
105851442|NCT02912650|365112728|FG001|Overall Study|Withdrawal by Subject|0|||
105851443|NCT02912650|365112729|FG002|Overall Study|Withdrawal by Subject|1|||
105851444|NCT02912650|365112730|FG003|Overall Study|Withdrawal by Subject|5|||
105978532|NCT00391391|365581370|FG001|Overall Study|Lost to Follow-up|3|||
105978533|NCT00391391|365581371|FG002|Overall Study|Lost to Follow-up|7|||
105978534|NCT00391391|365581372|FG003|Overall Study|Lost to Follow-up|4|||
105978535|NCT00391391|365581369|FG000|Overall Study|Protocol Violation|2|||
105978536|NCT00391391|365581370|FG001|Overall Study|Protocol Violation|3|||
105978537|NCT00391391|365581371|FG002|Overall Study|Protocol Violation|6|||
105978538|NCT00391391|365581372|FG003|Overall Study|Protocol Violation|7|||
105978539|NCT00391391|365581369|FG000|Overall Study|Withdrawal by Subject|6|||
105978540|NCT00391391|365581370|FG001|Overall Study|Withdrawal by Subject|4|||
105978541|NCT00391391|365581371|FG002|Overall Study|Withdrawal by Subject|10|||
105978542|NCT00391391|365581372|FG003|Overall Study|Withdrawal by Subject|7|||
105978543|NCT02084238|365581373|FG000|Overall Study|Lost to Follow-up|2|||
105978544|NCT00693472|365581374|FG000|Part 1|Adverse Event|1|||
105978545|NCT00693472|365581375|FG001|Part 1|Adverse Event|1|||
105978546|NCT00693472|365581376|FG002|Part 1|Adverse Event|0|||
105978547|NCT00693472|365581377|FG003|Part 1|Adverse Event|0|||
105978548|NCT00693472|365581374|FG000|Part 1|Lost to Follow-up|0|||
105978549|NCT00693472|365581375|FG001|Part 1|Lost to Follow-up|1|||
105978550|NCT00693472|365581376|FG002|Part 1|Lost to Follow-up|0|||
105978551|NCT00693472|365581377|FG003|Part 1|Lost to Follow-up|0|||
105978552|NCT00693472|365581374|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
105978553|NCT00693472|365581375|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
105978554|NCT00693472|365581376|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
105978555|NCT00693472|365581377|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
105978556|NCT00693472|365581374|FG000|Part 2|Adverse Event|0|||
105978557|NCT00693472|365581375|FG001|Part 2|Adverse Event|0|||
105978558|NCT00693472|365581376|FG002|Part 2|Adverse Event|1|||
105978559|NCT00693472|365581377|FG003|Part 2|Adverse Event|0|||
105978560|NCT00693472|365581374|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
105978561|NCT00693472|365581375|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
105978562|NCT00693472|365581376|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
105978563|NCT00693472|365581377|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
105978564|NCT00353873|365581378|FG000|Overall Study|Protocol Violation|1|||
105978565|NCT00353873|365581379|FG001|Overall Study|Protocol Violation|2|||
105978566|NCT00353873|365581378|FG000|Overall Study|Exacerbation|1|||
105978567|NCT00353873|365581379|FG001|Overall Study|Exacerbation|0|||
105978568|NCT00353873|365581378|FG000|Overall Study|Adverse Event|1|||
105978569|NCT00353873|365581379|FG001|Overall Study|Adverse Event|0|||
105978570|NCT00353873|365581378|FG000|Overall Study|Physician Decision|2|||
105978571|NCT00353873|365581379|FG001|Overall Study|Physician Decision|0|||
105978572|NCT00353873|365581378|FG000|Overall Study|Withdrawal by Subject|1|||
105978573|NCT00353873|365581379|FG001|Overall Study|Withdrawal by Subject|1|||
105978574|NCT00837876|365581381|FG000|Overall Study|Death|2|||
105978575|NCT00837876|365581381|FG000|Overall Study|Adverse Event|7|||
105978576|NCT00837876|365581381|FG000|Overall Study|Physician Decision|1|||
105978577|NCT00837876|365581381|FG000|Overall Study|Withdrawal by Subject|3|||
105978578|NCT00837876|365581381|FG000|Overall Study|disease progression|24|||
105978579|NCT00453973|365581383|FG000|Overall Study|Adverse Event|4|||
105978580|NCT00453973|365581384|FG001|Overall Study|Adverse Event|9|||
105978581|NCT00453973|365581383|FG000|Overall Study|Withdrawal by Subject|7|||
105978582|NCT00453973|365581384|FG001|Overall Study|Withdrawal by Subject|6|||
105978583|NCT00453973|365581383|FG000|Overall Study|PI Decision|0|||
105978584|NCT00453973|365581384|FG001|Overall Study|PI Decision|2|||
105978585|NCT00453973|365581383|FG000|Overall Study|Relocation|1|||
105978586|NCT00453973|365581384|FG001|Overall Study|Relocation|0|||
105978587|NCT00453973|365581383|FG000|Overall Study|Renal transplant|1|||
105978588|NCT00453973|365581384|FG001|Overall Study|Renal transplant|1|||
105978589|NCT00453973|365581383|FG000|Overall Study|Site closed by sponsor|3|||
105978590|NCT00453973|365581384|FG001|Overall Study|Site closed by sponsor|0|||
105978591|NCT00453973|365581383|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
105978592|NCT00453973|365581384|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
105978593|NCT00276094|365581385|FG000|Overall Study|Adverse Event|15|||
105978594|NCT00276094|365581386|FG001|Overall Study|Adverse Event|13|||
105978595|NCT00276094|365581387|FG002|Overall Study|Adverse Event|11|||
105978596|NCT00276094|365581385|FG000|Overall Study|Withdrawal by Subject|14|||
105978597|NCT00276094|365581386|FG001|Overall Study|Withdrawal by Subject|14|||
105978598|NCT00276094|365581387|FG002|Overall Study|Withdrawal by Subject|12|||
105978599|NCT00276094|365581385|FG000|Overall Study|Protocol Violation|16|||
105978600|NCT00276094|365581386|FG001|Overall Study|Protocol Violation|7|||
105978601|NCT00276094|365581387|FG002|Overall Study|Protocol Violation|10|||
105978602|NCT00276094|365581385|FG000|Overall Study|Lost to Follow-up|8|||
105978603|NCT00276094|365581386|FG001|Overall Study|Lost to Follow-up|6|||
105978604|NCT00276094|365581387|FG002|Overall Study|Lost to Follow-up|4|||
105978605|NCT00276094|365581385|FG000|Overall Study|Other-Subject moved out of country|1|||
105978606|NCT00276094|365581386|FG001|Overall Study|Other-Subject moved out of country|0|||
105978607|NCT00276094|365581387|FG002|Overall Study|Other-Subject moved out of country|0|||
105978608|NCT00276094|365581385|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
105978609|NCT00276094|365581386|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
105978610|NCT00276094|365581387|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
105978611|NCT00276094|365581385|FG000|Overall Study|Other-Lack of efficacy|1|||
105978612|NCT00276094|365581386|FG001|Overall Study|Other-Lack of efficacy|0|||
105978613|NCT00276094|365581387|FG002|Overall Study|Other-Lack of efficacy|0|||
105978614|NCT00276094|365581385|FG000|Overall Study|Other-Refused follow-up visit|1|||
105978615|NCT00276094|365581386|FG001|Overall Study|Other-Refused follow-up visit|0|||
105978616|NCT00276094|365581387|FG002|Overall Study|Other-Refused follow-up visit|0|||
105978617|NCT00276094|365581385|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
105978618|NCT00276094|365581386|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
105978619|NCT00276094|365581387|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
105978620|NCT00276094|365581385|FG000|Overall Study|Other-Relocation|0|||
105978621|NCT00276094|365581386|FG001|Overall Study|Other-Relocation|1|||
105978622|NCT00276094|365581387|FG002|Overall Study|Other-Relocation|0|||
105978623|NCT00276094|365581385|FG000|Overall Study|Other-Study medication lost|0|||
105978624|NCT00276094|365581386|FG001|Overall Study|Other-Study medication lost|0|||
105978625|NCT00276094|365581387|FG002|Overall Study|Other-Study medication lost|1|||
105978626|NCT00530920|365581390|FG000|Overall Study|Randomized but not treated|0|||
105978627|NCT00530920|365581391|FG001|Overall Study|Randomized but not treated|2|||
105978628|NCT00530920|365581392|FG002|Overall Study|Randomized but not treated|0|||
105978629|NCT00530920|365581390|FG000|Overall Study|Adverse Event|0|||
105978630|NCT00530920|365581391|FG001|Overall Study|Adverse Event|0|||
105978631|NCT00530920|365581392|FG002|Overall Study|Adverse Event|3|||
105978632|NCT00530920|365581390|FG000|Overall Study|Withdrawal by Subject|0|||
105978633|NCT00530920|365581391|FG001|Overall Study|Withdrawal by Subject|0|||
105978634|NCT00530920|365581392|FG002|Overall Study|Withdrawal by Subject|1|||
105978635|NCT00685373|365581393|FG000|Overall Study|Adverse Event|3|||
105978636|NCT00685373|365581393|FG000|Overall Study|Withdrawal by Subject|5|||
105978637|NCT00685373|365581393|FG000|Overall Study|Lack of Efficacy|3|||
105978638|NCT00685373|365581393|FG000|Overall Study|Condition no longer requires study drug|1|||
105978639|NCT00685373|365581393|FG000|Overall Study|Lost to Follow-up|2|||
105978640|NCT00685373|365581393|FG000|Overall Study|Protocol Violation|1|||
105978641|NCT03461406|365581394|FG000|Overall Study|Death|1|||
105978642|NCT03461406|365581395|FG001|Overall Study|Death|2|||
105978643|NCT03461406|365581394|FG000|Overall Study|Consent Withdrawn by Participant|0|||
105978644|NCT03461406|365581395|FG001|Overall Study|Consent Withdrawn by Participant|1|||
105978645|NCT03461406|365581394|FG000|Overall Study|Screen Failure|3|||
105978646|NCT03461406|365581395|FG001|Overall Study|Screen Failure|1|||
105978647|NCT03461406|365581394|FG000|Overall Study|Reason not Specified|1|||
106027988|NCT01576159|365767557|FG003|Overall Study|Protocol Violation|0|||
106027989|NCT01457352|365767560|FG000|Period 1|Adverse Event|2|||
106027990|NCT01457352|365767561|FG001|Period 1|Adverse Event|0|||
106027991|NCT01457352|365767560|FG000|Period 1|Withdrawal by Subject|2|||
106027992|NCT01457352|365767561|FG001|Period 1|Withdrawal by Subject|0|||
106027993|NCT01457352|365767560|FG000|Period 1|Physician Decision|2|||
106027994|NCT01457352|365767561|FG001|Period 1|Physician Decision|0|||
106027995|NCT01457352|365767560|FG000|Period 1|MS related disease progression|1|||
106027996|NCT01457352|365767561|FG001|Period 1|MS related disease progression|0|||
106027997|NCT01457352|365767560|FG000|Period 1|Withdrawn|1|||
106027998|NCT01457352|365767561|FG001|Period 1|Withdrawn|0|||
106027999|NCT01457352|365767560|FG000|Period 1|withdrew per sponsor|1|||
106028000|NCT01457352|365767561|FG001|Period 1|withdrew per sponsor|0|||
106028001|NCT01457352|365767560|FG000|Period 1|Protocol Violation|4|||
106028002|NCT01457352|365767561|FG001|Period 1|Protocol Violation|0|||
106028003|NCT01457352|365767560|FG000|Period 1|Did not meet eligibility criteria|3|||
106028004|NCT01457352|365767561|FG001|Period 1|Did not meet eligibility criteria|0|||
106028005|NCT01457352|365767560|FG000|Period 2|Withdrawal by Subject|23|||
106028006|NCT01457352|365767561|FG001|Period 2|Withdrawal by Subject|0|||
106028007|NCT01457352|365767560|FG000|Period 2|Adverse Event|22|||
106028008|NCT01457352|365767561|FG001|Period 2|Adverse Event|0|||
105978648|NCT03461406|365581395|FG001|Overall Study|Reason not Specified|3|||
105978649|NCT03461406|365581394|FG000|Overall Study|Lost to Follow-up|3|||
105978650|NCT03461406|365581395|FG001|Overall Study|Lost to Follow-up|0|||
105978651|NCT00151372|365582835|FG000|Overall Study|Death|12|||
105978652|NCT00151372|365582836|FG001|Overall Study|Death|11|||
105978653|NCT00151372|365582835|FG000|Overall Study|Lost to Follow-up|5|||
105978654|NCT00151372|365582836|FG001|Overall Study|Lost to Follow-up|5|||
106028009|NCT01457352|365767560|FG000|Period 2|no analysis|10|||
106028010|NCT01457352|365767561|FG001|Period 2|no analysis|0|||
106028011|NCT01457352|365767560|FG000|Period 2|Lack of Efficacy|8|||
106028012|NCT01457352|365767561|FG001|Period 2|Lack of Efficacy|0|||
106028013|NCT01457352|365767560|FG000|Period 2|Protocol Violation|4|||
105978655|NCT00151372|365582835|FG000|Overall Study|Too sick medically to continue|5|||
105978656|NCT00151372|365582836|FG001|Overall Study|Too sick medically to continue|6|||
105978657|NCT00151372|365582835|FG000|Overall Study|Withdrawal by Subject|7|||
105978658|NCT00151372|365582836|FG001|Overall Study|Withdrawal by Subject|7|||
105978659|NCT03320330|365582837|FG000|Overall Study|Lack of Efficacy|5|||
105978660|NCT03320330|365582838|FG001|Overall Study|Lack of Efficacy|5|||
106028014|NCT01457352|365767561|FG001|Period 2|Protocol Violation|0|||
106028015|NCT01457352|365767560|FG000|Period 2|Sponsor's withdrawal|7|||
105978661|NCT03320330|365582839|FG002|Overall Study|Lack of Efficacy|14|||
105978662|NCT03320330|365582837|FG000|Overall Study|Physician Decision|1|||
105978663|NCT03320330|365582838|FG001|Overall Study|Physician Decision|0|||
105978664|NCT03320330|365582839|FG002|Overall Study|Physician Decision|0|||
105978665|NCT03204890|365582841|FG000|Overall Study|Withdrawal by Subject|1|||
105978666|NCT03710876|365582842|FG000|Overall Study|Death|0|||
105978667|NCT03710876|365582843|FG001|Overall Study|Death|2|||
105978668|NCT03710876|365582842|FG000|Overall Study|Withdrawal by Subject|0|||
105978669|NCT03710876|365582843|FG001|Overall Study|Withdrawal by Subject|2|||
105978670|NCT03747120|365582846|FG000|Overall Study|treatment related toxicity|3|||
105978671|NCT03747120|365582847|FG001|Overall Study|treatment related toxicity|0|||
105978672|NCT03747120|365582848|FG002|Overall Study|treatment related toxicity|0|||
105978673|NCT03747120|365582846|FG000|Overall Study|Withdrawal by Subject|0|||
105978674|NCT03747120|365582847|FG001|Overall Study|Withdrawal by Subject|1|||
105978675|NCT03747120|365582848|FG002|Overall Study|Withdrawal by Subject|2|||
105978676|NCT01596335|365582849|FG000|Overall Study|exacerbation of primary disease|5|||
105978677|NCT01596335|365582850|FG001|Overall Study|exacerbation of primary disease|9|||
105978678|NCT01688739|365582851|FG000|Overall Study|Administrative Decision|1|||
105978679|NCT01688739|365582852|FG001|Overall Study|Administrative Decision|0|||
105978680|NCT01688739|365582853|FG002|Overall Study|Administrative Decision|0|||
105978681|NCT01688739|365582854|FG003|Overall Study|Administrative Decision|0|||
105978682|NCT01688739|365582855|FG004|Overall Study|Administrative Decision|0|||
105978683|NCT01688739|365582856|FG005|Overall Study|Administrative Decision|0|||
105978684|NCT01688739|365582857|FG006|Overall Study|Administrative Decision|0|||
105978685|NCT01688739|365582858|FG007|Overall Study|Administrative Decision|0|||
105978686|NCT01688739|365582859|FG008|Overall Study|Administrative Decision|0|||
105978687|NCT01688739|365582860|FG009|Overall Study|Administrative Decision|0|||
105978688|NCT00996801|365582861|FG000|Overall Study|Adverse Event|6|||
105978689|NCT00996801|365582862|FG001|Overall Study|Adverse Event|4|||
105978690|NCT00996801|365582863|FG002|Overall Study|Adverse Event|12|||
105978691|NCT00996801|365582864|FG003|Overall Study|Adverse Event|17|||
105978692|NCT00996801|365582865|FG004|Overall Study|Adverse Event|31|||
105978693|NCT00996801|365582866|FG005|Overall Study|Adverse Event|3|||
105978694|NCT00996801|365582861|FG000|Overall Study|Lack of Efficacy|3|||
105978695|NCT00996801|365582862|FG001|Overall Study|Lack of Efficacy|0|||
105978696|NCT00996801|365582863|FG002|Overall Study|Lack of Efficacy|1|||
105978697|NCT00996801|365582864|FG003|Overall Study|Lack of Efficacy|3|||
105978698|NCT00996801|365582865|FG004|Overall Study|Lack of Efficacy|0|||
105978699|NCT00996801|365582866|FG005|Overall Study|Lack of Efficacy|1|||
105978700|NCT00996801|365582861|FG000|Overall Study|Lost to Follow-up|0|||
105978701|NCT00996801|365582862|FG001|Overall Study|Lost to Follow-up|0|||
105978702|NCT00996801|365582863|FG002|Overall Study|Lost to Follow-up|0|||
105978703|NCT00996801|365582864|FG003|Overall Study|Lost to Follow-up|3|||
105978704|NCT00996801|365582865|FG004|Overall Study|Lost to Follow-up|3|||
105978705|NCT00996801|365582866|FG005|Overall Study|Lost to Follow-up|2|||
105978706|NCT00996801|365582861|FG000|Overall Study|Physician Decision|0|||
105978707|NCT00996801|365582862|FG001|Overall Study|Physician Decision|0|||
105978708|NCT00996801|365582863|FG002|Overall Study|Physician Decision|0|||
105978709|NCT00996801|365582864|FG003|Overall Study|Physician Decision|1|||
105978710|NCT00996801|365582865|FG004|Overall Study|Physician Decision|0|||
105978711|NCT00996801|365582866|FG005|Overall Study|Physician Decision|0|||
105978712|NCT00996801|365582861|FG000|Overall Study|Progressive Disease|0|||
105978713|NCT00996801|365582862|FG001|Overall Study|Progressive Disease|1|||
105978714|NCT00996801|365582863|FG002|Overall Study|Progressive Disease|0|||
105978715|NCT00996801|365582864|FG003|Overall Study|Progressive Disease|0|||
105978716|NCT00996801|365582865|FG004|Overall Study|Progressive Disease|0|||
105978717|NCT00996801|365582866|FG005|Overall Study|Progressive Disease|0|||
105978718|NCT00996801|365582861|FG000|Overall Study|Protocol Violation|3|||
105978719|NCT00996801|365582862|FG001|Overall Study|Protocol Violation|4|||
105978720|NCT00996801|365582863|FG002|Overall Study|Protocol Violation|1|||
105978721|NCT00996801|365582864|FG003|Overall Study|Protocol Violation|2|||
105978722|NCT00996801|365582865|FG004|Overall Study|Protocol Violation|3|||
105978723|NCT00996801|365582866|FG005|Overall Study|Protocol Violation|4|||
105978724|NCT00996801|365582861|FG000|Overall Study|Study Terminated by Sponsor|0|||
105978725|NCT00996801|365582862|FG001|Overall Study|Study Terminated by Sponsor|1|||
105978726|NCT00996801|365582863|FG002|Overall Study|Study Terminated by Sponsor|0|||
105978727|NCT00996801|365582864|FG003|Overall Study|Study Terminated by Sponsor|0|||
105978728|NCT00996801|365582865|FG004|Overall Study|Study Terminated by Sponsor|46|||
105978729|NCT00996801|365582866|FG005|Overall Study|Study Terminated by Sponsor|0|||
105978730|NCT00996801|365582861|FG000|Overall Study|Withdrawal by Subject|8|||
105978731|NCT00996801|365582862|FG001|Overall Study|Withdrawal by Subject|6|||
105978732|NCT00996801|365582863|FG002|Overall Study|Withdrawal by Subject|9|||
105978733|NCT00996801|365582864|FG003|Overall Study|Withdrawal by Subject|5|||
105978734|NCT00996801|365582865|FG004|Overall Study|Withdrawal by Subject|5|||
105978735|NCT00996801|365582866|FG005|Overall Study|Withdrawal by Subject|9|||
105978736|NCT01062061|365582867|FG000|Overall Study|Enrolled more than once|2|||
105978737|NCT01062061|365582867|FG000|Overall Study|Investigated before study start|13|||
105978738|NCT01062061|365582867|FG000|Overall Study|Outside chief indications|10|||
105978739|NCT01062061|365582867|FG000|Overall Study|Failed to meet inclusion criteria|2|||
105978740|NCT04191499|365582868|FG000|Overall Study|Adverse Event|1|||
105978741|NCT04191499|365582869|FG001|Overall Study|Adverse Event|0|||
105978742|NCT04191499|365582868|FG000|Overall Study|Death|42|||
105978743|NCT04191499|365582869|FG001|Overall Study|Death|55|||
105978744|NCT04191499|365582868|FG000|Overall Study|Lost to Follow-up|4|||
105978745|NCT04191499|365582869|FG001|Overall Study|Lost to Follow-up|1|||
105978746|NCT04191499|365582868|FG000|Overall Study|Physician Decision|1|||
105978747|NCT04191499|365582869|FG001|Overall Study|Physician Decision|0|||
105978748|NCT04191499|365582868|FG000|Overall Study|Progressive Disease|1|||
105978749|NCT04191499|365582869|FG001|Overall Study|Progressive Disease|0|||
105978750|NCT04191499|365582868|FG000|Overall Study|Symptomatic Deterioration|1|||
105978751|NCT04191499|365582869|FG001|Overall Study|Symptomatic Deterioration|0|||
105978752|NCT04191499|365582868|FG000|Overall Study|Withdrawal by Subject|7|||
105978753|NCT04191499|365582869|FG001|Overall Study|Withdrawal by Subject|11|||
105978754|NCT04191499|365582868|FG000|Overall Study|Ongoing in the study|104|||
105978755|NCT04191499|365582869|FG001|Overall Study|Ongoing in the study|97|||
105978756|NCT04912895|365582878|FG000|Overall Study|Unable to provide specimen|2|||
105978757|NCT04912895|365582879|FG001|Overall Study|Unable to provide specimen|0|||
105978758|NCT04912895|365582880|FG002|Overall Study|Unable to provide specimen|0|||
105978759|NCT04639219|365582881|FG000|Overall Study|Withdrawal by Subject|8|||
105978760|NCT04639219|365582881|FG000|Overall Study|Lost to Follow-up|6|||
105978761|NCT04639219|365582881|FG000|Overall Study|Death|55|||
105978762|NCT00931801|365582883|FG000|Overall Study|Adverse Event|0|||
105978763|NCT00931801|365582884|FG001|Overall Study|Adverse Event|0|||
105978764|NCT00931801|365582885|FG002|Overall Study|Adverse Event|1|||
105978765|NCT00931801|365582883|FG000|Overall Study|Lost to Follow-up|0|||
105978766|NCT00931801|365582884|FG001|Overall Study|Lost to Follow-up|1|||
105978767|NCT00931801|365582885|FG002|Overall Study|Lost to Follow-up|0|||
105978768|NCT00931801|365582883|FG000|Overall Study|Withdrawal by Subject|1|||
105978769|NCT00931801|365582884|FG001|Overall Study|Withdrawal by Subject|0|||
105978770|NCT00931801|365582885|FG002|Overall Study|Withdrawal by Subject|0|||
105978771|NCT00931801|365582883|FG000|Overall Study|Confirmed Virologic Failure|0|||
105978772|NCT00931801|365582884|FG001|Overall Study|Confirmed Virologic Failure|0|||
105978773|NCT00931801|365582885|FG002|Overall Study|Confirmed Virologic Failure|3|||
105978774|NCT03283150|365582887|FG000|Overall Study|Withdrawal by Subject|6|||
105978775|NCT03283150|365582888|FG001|Overall Study|Withdrawal by Subject|0|||
105978776|NCT03283150|365582889|FG002|Overall Study|Withdrawal by Subject|0|||
105978777|NCT05291936|365582890|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
105978778|NCT05291936|365582891|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
105978779|NCT05291936|365582890|FG000|Period 1|Withdrew Consent during study|1|||
105978780|NCT05291936|365582891|FG001|Period 1|Withdrew Consent during study|0|||
105978781|NCT05291936|365582890|FG000|Period 2|Adverse Event|0|||
105978782|NCT05291936|365582891|FG001|Period 2|Adverse Event|1|||
105978783|NCT05291936|365582890|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
105978784|NCT05291936|365582891|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
105978785|NCT01318070|365582895|FG000|Overall Study|Adverse Event|1|||
105978786|NCT01318070|365582896|FG001|Overall Study|Adverse Event|1|||
105978787|NCT01318070|365582897|FG002|Overall Study|Adverse Event|5|||
105978788|NCT01318070|365582895|FG000|Overall Study|Withdrawal by Subject|0|||
105978789|NCT01318070|365582896|FG001|Overall Study|Withdrawal by Subject|1|||
105978790|NCT01318070|365582897|FG002|Overall Study|Withdrawal by Subject|1|||
105978791|NCT01318070|365582895|FG000|Overall Study|Lack of Efficacy|0|||
105978792|NCT01318070|365582896|FG001|Overall Study|Lack of Efficacy|0|||
105978793|NCT01318070|365582897|FG002|Overall Study|Lack of Efficacy|1|||
105978794|NCT01318070|365582895|FG000|Overall Study|Principal Investigator Discretion|1|||
105978795|NCT01318070|365582896|FG001|Overall Study|Principal Investigator Discretion|0|||
105978796|NCT01318070|365582897|FG002|Overall Study|Principal Investigator Discretion|0|||
105978797|NCT01920152|365582898|FG000|Overall Study|Withdrawal by Subject|1|||
105978798|NCT01920152|365582899|FG001|Overall Study|Withdrawal by Subject|2|||
105978799|NCT01167907|365582900|FG000|Overall Study|Protocol Violation|1|||
105978800|NCT01167907|365582901|FG001|Overall Study|Protocol Violation|0|||
105978801|NCT01167907|365582900|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
105978802|NCT01167907|365582901|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
105978803|NCT00525824|365582912|FG000|Overall Study|Adverse Event|7|||
105978804|NCT00525824|365582913|FG001|Overall Study|Adverse Event|11|||
105978805|NCT00525824|365582914|FG002|Overall Study|Adverse Event|6|||
105978806|NCT00525824|365582915|FG003|Overall Study|Adverse Event|7|||
105978807|NCT00525824|365582912|FG000|Overall Study|Withdrawal by Subject|5|||
105978808|NCT00525824|365582913|FG001|Overall Study|Withdrawal by Subject|9|||
105978809|NCT00525824|365582914|FG002|Overall Study|Withdrawal by Subject|3|||
105978810|NCT00525824|365582915|FG003|Overall Study|Withdrawal by Subject|4|||
105978811|NCT00525824|365582912|FG000|Overall Study|Lost to Follow-up|4|||
105978812|NCT00525824|365582913|FG001|Overall Study|Lost to Follow-up|2|||
105978813|NCT00525824|365582914|FG002|Overall Study|Lost to Follow-up|4|||
105978814|NCT00525824|365582915|FG003|Overall Study|Lost to Follow-up|0|||
105978815|NCT00525824|365582912|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
105978816|NCT00525824|365582913|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
105978817|NCT00525824|365582914|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
105978818|NCT00525824|365582915|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
105978819|NCT00525824|365582912|FG000|Overall Study|Severe non-compliance|0|||
105978820|NCT00525824|365582913|FG001|Overall Study|Severe non-compliance|1|||
105978821|NCT00525824|365582914|FG002|Overall Study|Severe non-compliance|1|||
105978822|NCT00525824|365582915|FG003|Overall Study|Severe non-compliance|1|||
105978823|NCT00525824|365582912|FG000|Overall Study|Safety reasons|1|||
105978824|NCT00525824|365582913|FG001|Overall Study|Safety reasons|0|||
105978825|NCT00525824|365582914|FG002|Overall Study|Safety reasons|1|||
105978826|NCT00525824|365582915|FG003|Overall Study|Safety reasons|0|||
105978827|NCT00525824|365582912|FG000|Overall Study|Other|1|||
105978828|NCT00525824|365582913|FG001|Overall Study|Other|3|||
105851445|NCT02912650|365112727|FG000|Overall Study|Adverse Event|0|||
105851446|NCT02912650|365112728|FG001|Overall Study|Adverse Event|0|||
105851447|NCT02912650|365112729|FG002|Overall Study|Adverse Event|1|||
105851448|NCT02912650|365112730|FG003|Overall Study|Adverse Event|0|||
105851449|NCT01791153|365112731|FG000|Part 1: Blinded Period|Adverse Event|7|||
105851450|NCT01791153|365112732|FG001|Part 1: Blinded Period|Adverse Event|3|||
105851451|NCT01791153|365112733|FG002|Part 1: Blinded Period|Adverse Event|2|||
105851452|NCT01791153|365112734|FG003|Part 1: Blinded Period|Adverse Event|0|||
105851453|NCT01791153|365112735|FG004|Part 1: Blinded Period|Adverse Event|0|||
105851454|NCT01791153|365112736|FG005|Part 1: Blinded Period|Adverse Event|0|||
105851455|NCT01791153|365112737|FG006|Part 1: Blinded Period|Adverse Event|0|||
105851456|NCT01791153|365112738|FG007|Part 1: Blinded Period|Adverse Event|0|||
105851457|NCT01791153|365112731|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
105851458|NCT01791153|365112732|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
105851459|NCT01791153|365112733|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
105851460|NCT01791153|365112734|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
105851461|NCT01791153|365112735|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
105851462|NCT01791153|365112736|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
105851463|NCT01791153|365112737|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
105851464|NCT01791153|365112738|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
105851465|NCT01791153|365112731|FG000|Part 1: Blinded Period|Non-Compliance|1|||
105851466|NCT01791153|365112732|FG001|Part 1: Blinded Period|Non-Compliance|0|||
105851467|NCT01791153|365112733|FG002|Part 1: Blinded Period|Non-Compliance|0|||
105851468|NCT01791153|365112734|FG003|Part 1: Blinded Period|Non-Compliance|0|||
105851469|NCT01791153|365112735|FG004|Part 1: Blinded Period|Non-Compliance|0|||
105851470|NCT01791153|365112736|FG005|Part 1: Blinded Period|Non-Compliance|0|||
105851471|NCT01791153|365112737|FG006|Part 1: Blinded Period|Non-Compliance|0|||
105851472|NCT01791153|365112738|FG007|Part 1: Blinded Period|Non-Compliance|0|||
105851473|NCT01791153|365112731|FG000|Part 1: Blinded Period|Physician Decision|0|||
105851474|NCT01791153|365112732|FG001|Part 1: Blinded Period|Physician Decision|0|||
105851475|NCT01791153|365112733|FG002|Part 1: Blinded Period|Physician Decision|0|||
105851476|NCT01791153|365112734|FG003|Part 1: Blinded Period|Physician Decision|1|||
105851477|NCT01791153|365112735|FG004|Part 1: Blinded Period|Physician Decision|0|||
105851478|NCT01791153|365112736|FG005|Part 1: Blinded Period|Physician Decision|0|||
105851479|NCT01791153|365112737|FG006|Part 1: Blinded Period|Physician Decision|0|||
105978829|NCT00525824|365582914|FG002|Overall Study|Other|3|||
106028016|NCT01457352|365767561|FG001|Period 2|Sponsor's withdrawal|0|||
105978830|NCT00525824|365582915|FG003|Overall Study|Other|1|||
105978831|NCT01839656|365582952|FG000|Overall Study|Withdrawal by Subject|1|||
105978832|NCT01839656|365582953|FG001|Overall Study|Withdrawal by Subject|1|||
105978833|NCT01839656|365582952|FG000|Overall Study|Adverse event, serious fatal|1|||
105978834|NCT01839656|365582953|FG001|Overall Study|Adverse event, serious fatal|4|||
105978835|NCT01839656|365582952|FG000|Overall Study|Early study closure|0|||
105978836|NCT01839656|365582953|FG001|Overall Study|Early study closure|11|||
105978837|NCT01839656|365582952|FG000|Overall Study|Adverse Event|1|||
105978838|NCT01839656|365582953|FG001|Overall Study|Adverse Event|0|||
105978839|NCT02621073|365582963|FG000|Overall Study|Lost to Follow-up|0|||
105978840|NCT02621073|365582964|FG001|Overall Study|Lost to Follow-up|1|||
105978841|NCT02621073|365582963|FG000|Overall Study|Physician Decision|3|||
105978842|NCT02621073|365582964|FG001|Overall Study|Physician Decision|2|||
105978843|NCT02383433|365582967|FG000|Overall Study|Disease progression|2|||
105978844|NCT02535416|365582968|FG000|Overall Study|Family bereavement overseas|1|||
105978845|NCT02535416|365582969|FG001|Overall Study|Family bereavement overseas|0|||
105978846|NCT02535416|365582970|FG002|Overall Study|Family bereavement overseas|0|||
105978847|NCT02535416|365582971|FG003|Overall Study|Family bereavement overseas|0|||
105978848|NCT02535416|365582972|FG004|Overall Study|Family bereavement overseas|0|||
105978849|NCT02535416|365582973|FG005|Overall Study|Family bereavement overseas|0|||
105978850|NCT02535416|365582974|FG006|Overall Study|Family bereavement overseas|0|||
105978851|NCT02535416|365582975|FG007|Overall Study|Family bereavement overseas|0|||
105978852|NCT02535416|365582976|FG008|Overall Study|Family bereavement overseas|0|||
105978853|NCT02920957|365582977|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
105978854|NCT02920957|365582978|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
105978855|NCT02920957|365582977|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
105978856|NCT02920957|365582978|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
105978857|NCT02920957|365582977|FG000|First Intervention : 1 Month|Adverse Event|1|||
105978858|NCT02920957|365582978|FG001|First Intervention : 1 Month|Adverse Event|0|||
105978859|NCT02920957|365582977|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
105978860|NCT02920957|365582978|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
105978861|NCT02210091|365582984|FG000|Overall Study|Physician Decision|0|||
105978862|NCT02210091|365582985|FG001|Overall Study|Physician Decision|1|||
105978863|NCT02210091|365582984|FG000|Overall Study|Withdrawal by Sponsor|0|||
105851480|NCT01791153|365112738|FG007|Part 1: Blinded Period|Physician Decision|0|||
105851481|NCT01791153|365112731|FG000|Part 1: Blinded Period|Protocol Violation|0|||
105851482|NCT01791153|365112732|FG001|Part 1: Blinded Period|Protocol Violation|0|||
105851483|NCT01791153|365112733|FG002|Part 1: Blinded Period|Protocol Violation|0|||
105851484|NCT01791153|365112734|FG003|Part 1: Blinded Period|Protocol Violation|1|||
105851485|NCT01791153|365112735|FG004|Part 1: Blinded Period|Protocol Violation|0|||
105851486|NCT01791153|365112736|FG005|Part 1: Blinded Period|Protocol Violation|0|||
105851487|NCT01791153|365112737|FG006|Part 1: Blinded Period|Protocol Violation|0|||
105978864|NCT02210091|365582985|FG001|Overall Study|Withdrawal by Sponsor|1|||
105978865|NCT00897390|365582986|FG000|Overall Study|Adverse Event|2|||
105978866|NCT00897390|365582986|FG000|Overall Study|No Longer Met Study Criteria|1|||
105978867|NCT00897390|365582986|FG000|Overall Study|Personal Reasons|1|||
105978868|NCT00897390|365582986|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
105978869|NCT01831817|365582987|FG000|Overall Study|Lost to Follow-up|1|||
105978870|NCT01831817|365582988|FG001|Overall Study|Lost to Follow-up|0|||
105978871|NCT01831817|365582989|FG002|Overall Study|Lost to Follow-up|0|||
105978872|NCT01831817|365582990|FG003|Overall Study|Lost to Follow-up|0|||
105978873|NCT01831817|365582987|FG000|Overall Study|Withdrawl of Consent|3|||
105978874|NCT01831817|365582988|FG001|Overall Study|Withdrawl of Consent|0|||
105978875|NCT01831817|365582989|FG002|Overall Study|Withdrawl of Consent|0|||
105978876|NCT01831817|365582990|FG003|Overall Study|Withdrawl of Consent|0|||
105978877|NCT03647267|365584393|FG000|Overall Study|Lost to Follow-up|1|||
105978878|NCT03647267|365584394|FG001|Overall Study|Lost to Follow-up|0|||
105978879|NCT05565937|365584395|FG000|Overall Study|Adverse Event|0|||
105978880|NCT05565937|365584396|FG001|Overall Study|Adverse Event|1|||
105978881|NCT05565937|365584395|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
105978882|NCT05565937|365584396|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
105978883|NCT05565937|365584395|FG000|Overall Study|Lost to Follow-up|2|||
105978884|NCT05565937|365584396|FG001|Overall Study|Lost to Follow-up|0|||
105978885|NCT05565937|365584395|FG000|Overall Study|Pregnancy|0|||
105851488|NCT01791153|365112738|FG007|Part 1: Blinded Period|Protocol Violation|0|||
105978886|NCT05565937|365584396|FG001|Overall Study|Pregnancy|2|||
105978887|NCT05565937|365584395|FG000|Overall Study|Anisometropia|0|||
105978888|NCT05565937|365584396|FG001|Overall Study|Anisometropia|1|||
105978889|NCT01022424|365584397|FG000|Overall Study|Adverse Event|1|||
105978890|NCT01022424|365584397|FG000|Overall Study|Physician Decision|1|||
105978891|NCT01022424|365584397|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
105978892|NCT03323736|365584401|FG000|Overall Study|Screen Failure|14|||
105978893|NCT03323736|365584402|FG001|Overall Study|Screen Failure|9|||
105978894|NCT03323736|365584403|FG002|Overall Study|Screen Failure|1|||
105978895|NCT03323736|365584401|FG000|Overall Study|Withdrawal Before Treatment|3|||
105978896|NCT03323736|365584402|FG001|Overall Study|Withdrawal Before Treatment|1|||
105978897|NCT03323736|365584403|FG002|Overall Study|Withdrawal Before Treatment|1|||
105978898|NCT03323736|365584401|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
105978899|NCT03323736|365584402|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
105978900|NCT03323736|365584403|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
105978901|NCT00031460|365584404|FG000|Overall Study|Lost to Follow-up|0|||
105978902|NCT00031460|365584405|FG001|Overall Study|Lost to Follow-up|1|||
105978903|NCT00031460|365584404|FG000|Overall Study|Withdrawal by Subject|1|||
105978904|NCT00031460|365584405|FG001|Overall Study|Withdrawal by Subject|1|||
105978905|NCT00031460|365584404|FG000|Overall Study|Non-Compliant|1|||
105978906|NCT00031460|365584405|FG001|Overall Study|Non-Compliant|1|||
105978907|NCT00031460|365584404|FG000|Overall Study|Death|0|||
105978908|NCT00031460|365584405|FG001|Overall Study|Death|1|||
105978909|NCT00031460|365584404|FG000|Overall Study|Reactivation of Disease|5|||
105978910|NCT00031460|365584405|FG001|Overall Study|Reactivation of Disease|9|||
105978911|NCT00031460|365584404|FG000|Overall Study|Disruption of blinded drug supply|2|||
105978912|NCT00031460|365584405|FG001|Overall Study|Disruption of blinded drug supply|0|||
105978913|NCT00031460|365584404|FG000|Overall Study|Confirmed unevaluable|0|||
105978914|NCT00031460|365584405|FG001|Overall Study|Confirmed unevaluable|1|||
105978915|NCT02210832|365584406|FG000|Overall Study|Pregnancy termination .|3|||
105978916|NCT02210832|365584407|FG001|Overall Study|Pregnancy termination .|4|||
105978917|NCT02210832|365584408|FG002|Overall Study|Pregnancy termination .|1|||
105978918|NCT02210832|365584406|FG000|Overall Study|Lost to Follow-up|26|||
105978919|NCT02210832|365584407|FG001|Overall Study|Lost to Follow-up|32|||
105978920|NCT02210832|365584408|FG002|Overall Study|Lost to Follow-up|17|||
105978921|NCT00799591|365584409|FG000|Overall Study|De-escalation of doses|20|||
105978922|NCT00799591|365584409|FG000|Overall Study|Death|14|||
105978923|NCT00799591|365584409|FG000|Overall Study|Technical failure|12|||
105978924|NCT00799591|365584409|FG000|Overall Study|Resistant germ|11|||
105978925|NCT00799591|365584409|FG000|Overall Study|New infection|4|||
105978926|NCT00799591|365584409|FG000|Overall Study|Resistance germ and technical failure|2|||
105978927|NCT00799591|365584409|FG000|Overall Study|Persistance of fever undetermined origin|1|||
105978928|NCT00799591|365584409|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
105978929|NCT00799591|365584409|FG000|Overall Study|Infectious origin not probable|1|||
105978930|NCT02266875|365584413|FG000|Overall Study|Withdrawal by Subject|9|||
105978931|NCT02266875|365584414|FG001|Overall Study|Withdrawal by Subject|0|||
105978932|NCT02266875|365584413|FG000|Overall Study|Lost to Follow-up|2|||
105978933|NCT02266875|365584414|FG001|Overall Study|Lost to Follow-up|0|||
105978934|NCT02258529|365584415|FG000|Overall Study|Study Terminated by Sponsor|9|||
105978935|NCT02258529|365584415|FG000|Overall Study|Adverse Event|1|||
105978936|NCT00875056|365584416|FG000|Overall Study|Adverse Event|6|||
105978937|NCT00875056|365584417|FG001|Overall Study|Adverse Event|1|||
105978938|NCT00875056|365584418|FG002|Overall Study|Adverse Event|2|||
105978939|NCT00875056|365584416|FG000|Overall Study|Progressive Disease|14|||
105978940|NCT00875056|365584417|FG001|Overall Study|Progressive Disease|8|||
105978941|NCT00875056|365584418|FG002|Overall Study|Progressive Disease|3|||
105978942|NCT00875056|365584416|FG000|Overall Study|Withdrawal by Subject|3|||
105978943|NCT00875056|365584417|FG001|Overall Study|Withdrawal by Subject|0|||
105978944|NCT00875056|365584418|FG002|Overall Study|Withdrawal by Subject|1|||
105978945|NCT00870194|365584425|FG000|Overall Study|Adverse Event|10|||
105978946|NCT00870194|365584426|FG001|Overall Study|Adverse Event|5|||
105978947|NCT00870194|365584425|FG000|Overall Study|Lack of Efficacy|0|||
105978948|NCT00870194|365584426|FG001|Overall Study|Lack of Efficacy|1|||
105978949|NCT00870194|365584425|FG000|Overall Study|Lost to Follow-up|2|||
105978950|NCT00870194|365584426|FG001|Overall Study|Lost to Follow-up|0|||
105978951|NCT00870194|365584425|FG000|Overall Study|Physician Decision|3|||
105978952|NCT00870194|365584426|FG001|Overall Study|Physician Decision|1|||
105978953|NCT00870194|365584425|FG000|Overall Study|Protocol Violation|3|||
105978954|NCT00870194|365584426|FG001|Overall Study|Protocol Violation|3|||
105978955|NCT00870194|365584425|FG000|Overall Study|Entry Criteria Not Met|1|||
105978956|NCT00870194|365584426|FG001|Overall Study|Entry Criteria Not Met|2|||
105978957|NCT00870194|365584425|FG000|Overall Study|Subject Decision|7|||
105978958|NCT00870194|365584426|FG001|Overall Study|Subject Decision|2|||
105978959|NCT02717130|365584427|FG000|Overall Study|Withdrawal by Subject|1|||
105978960|NCT02717130|365584427|FG000|Overall Study|Adverse Event|1|||
105978961|NCT02717130|365584427|FG000|Overall Study|Physician Decision|1|||
105978962|NCT02717130|365584427|FG000|Overall Study|Study Closure|4|||
105978963|NCT00554099|365584428|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
105978964|NCT00554099|365584429|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
105978965|NCT00554099|365584430|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
105978966|NCT00554099|365584428|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
105978967|NCT00554099|365584429|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
105978968|NCT00554099|365584430|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
105978969|NCT00554099|365584428|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
105978970|NCT00554099|365584429|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
105978971|NCT00554099|365584430|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
105978972|NCT00554099|365584428|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
105978973|NCT00554099|365584429|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
105978974|NCT00554099|365584430|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
105978975|NCT00554099|365584428|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
105978976|NCT00554099|365584429|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
105978977|NCT00554099|365584430|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
105978978|NCT00554099|365584428|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
105978979|NCT00554099|365584429|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
105978980|NCT00554099|365584430|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
105978981|NCT00554099|365584428|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
105978982|NCT00554099|365584429|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
105978983|NCT00554099|365584430|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
105978984|NCT00554099|365584428|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
105978985|NCT00554099|365584429|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
105978986|NCT00554099|365584430|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
105978987|NCT00554099|365584428|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
105978988|NCT00554099|365584429|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
105978989|NCT00554099|365584430|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
105978990|NCT01754194|365584431|FG000|Overall Study|Lost to Follow-up|39|||
105978991|NCT01754194|365584432|FG001|Overall Study|Lost to Follow-up|14|||
105978992|NCT01754194|365584431|FG000|Overall Study|Withdrawal by Subject|4|||
105978993|NCT01754194|365584432|FG001|Overall Study|Withdrawal by Subject|5|||
105978994|NCT01754194|365584431|FG000|Overall Study|Other|9|||
105978995|NCT01754194|365584432|FG001|Overall Study|Other|8|||
105978996|NCT00907296|365584433|FG000|Overall Study|Ineligibility Determined|1|||
105978997|NCT00907296|365584434|FG001|Overall Study|Ineligibility Determined|0|||
105978998|NCT00907296|365584435|FG002|Overall Study|Ineligibility Determined|0|||
105978999|NCT00907296|365584436|FG003|Overall Study|Ineligibility Determined|1|||
105979000|NCT00907296|365584437|FG004|Overall Study|Ineligibility Determined|0|||
105979001|NCT00907296|365584438|FG005|Overall Study|Ineligibility Determined|0|||
105979002|NCT00907296|365584439|FG006|Overall Study|Ineligibility Determined|0|||
105979003|NCT00907296|365584440|FG007|Overall Study|Ineligibility Determined|1|||
105979004|NCT00907296|365584441|FG008|Overall Study|Ineligibility Determined|0|||
105979005|NCT00907296|365584442|FG009|Overall Study|Ineligibility Determined|0|||
105979006|NCT00907296|365584433|FG000|Overall Study|Protocol Deviation|0|||
105979007|NCT00907296|365584434|FG001|Overall Study|Protocol Deviation|1|||
105979008|NCT00907296|365584435|FG002|Overall Study|Protocol Deviation|0|||
105979009|NCT00907296|365584436|FG003|Overall Study|Protocol Deviation|0|||
105979010|NCT00907296|365584437|FG004|Overall Study|Protocol Deviation|0|||
105979011|NCT00907296|365584438|FG005|Overall Study|Protocol Deviation|0|||
105979012|NCT00907296|365584439|FG006|Overall Study|Protocol Deviation|0|||
105979013|NCT00907296|365584440|FG007|Overall Study|Protocol Deviation|0|||
105979014|NCT00907296|365584441|FG008|Overall Study|Protocol Deviation|0|||
105979015|NCT00907296|365584442|FG009|Overall Study|Protocol Deviation|0|||
105979016|NCT00907296|365584433|FG000|Overall Study|Noncompliance|1|||
105979017|NCT00907296|365584434|FG001|Overall Study|Noncompliance|1|||
105979018|NCT00907296|365584435|FG002|Overall Study|Noncompliance|1|||
105979019|NCT00907296|365584436|FG003|Overall Study|Noncompliance|0|||
105979020|NCT00907296|365584437|FG004|Overall Study|Noncompliance|0|||
105979021|NCT00907296|365584438|FG005|Overall Study|Noncompliance|1|||
105979022|NCT00907296|365584439|FG006|Overall Study|Noncompliance|0|||
105979023|NCT00907296|365584440|FG007|Overall Study|Noncompliance|2|||
106028017|NCT01457352|365767560|FG000|Period 2|Lost to Follow-up|1|||
106028018|NCT01457352|365767561|FG001|Period 2|Lost to Follow-up|0|||
106028019|NCT01457352|365767560|FG000|Period 2|dose change|1|||
106028020|NCT01457352|365767561|FG001|Period 2|dose change|0|||
106028021|NCT01457352|365767560|FG000|Period 2|Physician Decision|1|||
105979024|NCT00907296|365584441|FG008|Overall Study|Noncompliance|0|||
105979025|NCT00907296|365584442|FG009|Overall Study|Noncompliance|0|||
105979026|NCT00907296|365584433|FG000|Overall Study|Adverse Event|2|||
106028022|NCT01457352|365767561|FG001|Period 2|Physician Decision|0|||
105979027|NCT00907296|365584434|FG001|Overall Study|Adverse Event|0|||
105979028|NCT00907296|365584435|FG002|Overall Study|Adverse Event|0|||
105979029|NCT00907296|365584436|FG003|Overall Study|Adverse Event|0|||
105979030|NCT00907296|365584437|FG004|Overall Study|Adverse Event|0|||
105979031|NCT00907296|365584438|FG005|Overall Study|Adverse Event|0|||
105979032|NCT00907296|365584439|FG006|Overall Study|Adverse Event|1|||
105979033|NCT00907296|365584440|FG007|Overall Study|Adverse Event|0|||
105979034|NCT00907296|365584441|FG008|Overall Study|Adverse Event|0|||
105979035|NCT00907296|365584442|FG009|Overall Study|Adverse Event|1|||
105979036|NCT00907296|365584433|FG000|Overall Study|Withdrawal by Subject|7|||
105979037|NCT00907296|365584434|FG001|Overall Study|Withdrawal by Subject|2|||
105979038|NCT00907296|365584435|FG002|Overall Study|Withdrawal by Subject|1|||
105979039|NCT00907296|365584436|FG003|Overall Study|Withdrawal by Subject|1|||
105979040|NCT00907296|365584437|FG004|Overall Study|Withdrawal by Subject|1|||
105979041|NCT00907296|365584438|FG005|Overall Study|Withdrawal by Subject|5|||
105979042|NCT00907296|365584439|FG006|Overall Study|Withdrawal by Subject|3|||
105979043|NCT00907296|365584440|FG007|Overall Study|Withdrawal by Subject|2|||
105979044|NCT00907296|365584441|FG008|Overall Study|Withdrawal by Subject|4|||
105979045|NCT00907296|365584442|FG009|Overall Study|Withdrawal by Subject|2|||
105979046|NCT00907296|365584433|FG000|Overall Study|Lost to Follow-up|9|||
105979047|NCT00907296|365584434|FG001|Overall Study|Lost to Follow-up|1|||
105979048|NCT00907296|365584435|FG002|Overall Study|Lost to Follow-up|0|||
105979049|NCT00907296|365584436|FG003|Overall Study|Lost to Follow-up|2|||
105979050|NCT00907296|365584437|FG004|Overall Study|Lost to Follow-up|0|||
105979051|NCT00907296|365584438|FG005|Overall Study|Lost to Follow-up|3|||
105979052|NCT00907296|365584439|FG006|Overall Study|Lost to Follow-up|2|||
105979053|NCT00907296|365584440|FG007|Overall Study|Lost to Follow-up|2|||
105979054|NCT00907296|365584441|FG008|Overall Study|Lost to Follow-up|0|||
105979055|NCT00907296|365584442|FG009|Overall Study|Lost to Follow-up|4|||
105979056|NCT00707746|365584445|FG000|Treatment Period|Adverse Event|2|||
105979057|NCT00707746|365584446|FG001|Treatment Period|Adverse Event|4|||
105979058|NCT00707746|365584445|FG000|Treatment Period|Ineligibility|0|||
105979059|NCT00707746|365584446|FG001|Treatment Period|Ineligibility|1|||
105979060|NCT02322190|365584447|FG000|Overall Study|Death on study|1|||
105979061|NCT02322190|365584448|FG001|Overall Study|Death on study|0|||
105979062|NCT01685983|365584453|FG000|Overall Study|Adverse Event|7|||
105979063|NCT01685983|365584453|FG000|Overall Study|Death|1|||
105979064|NCT01685983|365584453|FG000|Overall Study|Withdrawal by Subject|19|||
105979065|NCT01685983|365584453|FG000|Overall Study|Protocol Violation|2|||
105979066|NCT01685983|365584453|FG000|Overall Study|Physician Decision|13|||
105979067|NCT01685983|365584453|FG000|Overall Study|Other|7|||
105979068|NCT01685983|365584453|FG000|Overall Study|Progressive Disease|32|||
105979069|NCT01685983|365584453|FG000|Overall Study|Noncompliance with Study Drug|1|||
105979070|NCT01443130|365584455|FG000|Overall Study|Lost to Follow-up|44|||
105979071|NCT01443130|365584456|FG001|Overall Study|Lost to Follow-up|42|||
105979072|NCT01443130|365584457|FG002|Overall Study|Lost to Follow-up|50|||
105979073|NCT01443130|365584458|FG003|Overall Study|Lost to Follow-up|23|||
105979074|NCT01443130|365584459|FG004|Overall Study|Lost to Follow-up|25|||
105979075|NCT01443130|365584460|FG005|Overall Study|Lost to Follow-up|21|||
105979076|NCT01443130|365584455|FG000|Overall Study|Death|0|||
105979077|NCT01443130|365584456|FG001|Overall Study|Death|1|||
105979078|NCT01443130|365584457|FG002|Overall Study|Death|0|||
105979079|NCT01443130|365584458|FG003|Overall Study|Death|7|||
105979080|NCT01443130|365584459|FG004|Overall Study|Death|10|||
105979081|NCT01443130|365584460|FG005|Overall Study|Death|8|||
105979082|NCT01443130|365584455|FG000|Overall Study|Adverse Event|2|||
105979083|NCT01443130|365584456|FG001|Overall Study|Adverse Event|1|||
105979084|NCT01443130|365584457|FG002|Overall Study|Adverse Event|1|||
105979085|NCT01443130|365584458|FG003|Overall Study|Adverse Event|0|||
105979086|NCT01443130|365584459|FG004|Overall Study|Adverse Event|0|||
105979087|NCT01443130|365584460|FG005|Overall Study|Adverse Event|0|||
105979088|NCT01443130|365584455|FG000|Overall Study|Protocol Violation|2|||
105979089|NCT01443130|365584456|FG001|Overall Study|Protocol Violation|1|||
106028023|NCT01457352|365767560|FG000|Period 2|Did not meet eligibility criteria|3|||
106028024|NCT01457352|365767561|FG001|Period 2|Did not meet eligibility criteria|0|||
106028025|NCT01457352|365767560|FG000|Period 3|Adverse Event|1|||
106028026|NCT01457352|365767561|FG001|Period 3|Adverse Event|1|||
106028027|NCT01457352|365767560|FG000|Period 3|Withdrawal by Subject|0|||
106028028|NCT01457352|365767561|FG001|Period 3|Withdrawal by Subject|2|||
106028029|NCT01457352|365767560|FG000|Period 3|incorrect treatment|0|||
106028030|NCT01457352|365767561|FG001|Period 3|incorrect treatment|1|||
106028031|NCT01457352|365767560|FG000|Period 3|Sponsor's withdrawal|0|||
106028032|NCT01457352|365767561|FG001|Period 3|Sponsor's withdrawal|1|||
106028033|NCT03254459|365769100|FG000|Overall Study|Adverse Event|7|||
105979090|NCT01443130|365584457|FG002|Overall Study|Protocol Violation|3|||
105979091|NCT01443130|365584458|FG003|Overall Study|Protocol Violation|2|||
106028034|NCT03254459|365769101|FG001|Overall Study|Adverse Event|20|||
106028035|NCT03254459|365769100|FG000|Overall Study|Withdrawal by Subject Consent|3|||
105979092|NCT01443130|365584459|FG004|Overall Study|Protocol Violation|2|||
105979093|NCT01443130|365584460|FG005|Overall Study|Protocol Violation|3|||
105979094|NCT01443130|365584455|FG000|Overall Study|Withdrawal by Subject|15|||
105979095|NCT01443130|365584456|FG001|Overall Study|Withdrawal by Subject|14|||
105979096|NCT01443130|365584457|FG002|Overall Study|Withdrawal by Subject|12|||
105979097|NCT01443130|365584458|FG003|Overall Study|Withdrawal by Subject|7|||
105979098|NCT01443130|365584459|FG004|Overall Study|Withdrawal by Subject|7|||
105979099|NCT01443130|365584460|FG005|Overall Study|Withdrawal by Subject|2|||
105979100|NCT01443130|365584455|FG000|Overall Study|Death of Subject's Infant|5|||
105851489|NCT01791153|365112731|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
105851490|NCT01791153|365112732|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
105851491|NCT01791153|365112733|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
105851492|NCT01791153|365112734|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
105851493|NCT01791153|365112735|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
105851494|NCT01791153|365112736|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
105851495|NCT01791153|365112737|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
105851496|NCT01791153|365112738|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
105851497|NCT01791153|365112731|FG000|Part 2: Open-label Period|Adverse Event|0|||
105851498|NCT01791153|365112732|FG001|Part 2: Open-label Period|Adverse Event|0|||
105851499|NCT01791153|365112733|FG002|Part 2: Open-label Period|Adverse Event|0|||
105851500|NCT01791153|365112734|FG003|Part 2: Open-label Period|Adverse Event|0|||
105851501|NCT01791153|365112735|FG004|Part 2: Open-label Period|Adverse Event|0|||
105851502|NCT01791153|365112736|FG005|Part 2: Open-label Period|Adverse Event|1|||
105851503|NCT01791153|365112737|FG006|Part 2: Open-label Period|Adverse Event|1|||
105851504|NCT01791153|365112738|FG007|Part 2: Open-label Period|Adverse Event|2|||
105851505|NCT01791153|365112731|FG000|Part 2: Open-label Period|Death|0|||
105851506|NCT01791153|365112732|FG001|Part 2: Open-label Period|Death|0|||
105851507|NCT01791153|365112733|FG002|Part 2: Open-label Period|Death|0|||
105851508|NCT01791153|365112734|FG003|Part 2: Open-label Period|Death|0|||
105851509|NCT01791153|365112735|FG004|Part 2: Open-label Period|Death|0|||
105851510|NCT01791153|365112736|FG005|Part 2: Open-label Period|Death|1|||
105851511|NCT01791153|365112737|FG006|Part 2: Open-label Period|Death|1|||
105979101|NCT01443130|365584456|FG001|Overall Study|Death of Subject's Infant|10|||
105979102|NCT01443130|365584457|FG002|Overall Study|Death of Subject's Infant|11|||
105979103|NCT01443130|365584458|FG003|Overall Study|Death of Subject's Infant|0|||
105979104|NCT01443130|365584459|FG004|Overall Study|Death of Subject's Infant|0|||
105979105|NCT01443130|365584460|FG005|Overall Study|Death of Subject's Infant|0|||
105979106|NCT02642965|365584462|FG000|Overall Study|Lack of Efficacy|4|||
105979107|NCT02642965|365584462|FG000|Overall Study|Physician Decision|9|||
105979108|NCT03077698|365584463|FG000|Progestin Monotherapy|Stable Disease|8|||
105979109|NCT03077698|365584464|FG001|Progestin Monotherapy|Stable Disease|0|||
105979110|NCT03077698|365584463|FG000|Progestin Monotherapy|Adverse Event|1|||
105979111|NCT03077698|365584464|FG001|Progestin Monotherapy|Adverse Event|0|||
105979112|NCT03077698|365584463|FG000|Progestin Monotherapy|Death|1|||
105979113|NCT03077698|365584464|FG001|Progestin Monotherapy|Death|0|||
105979114|NCT03077698|365584463|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
105979115|NCT03077698|365584464|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
105979116|NCT03077698|365584463|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
105979117|NCT03077698|365584464|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
105979118|NCT03077698|365584463|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
105979119|NCT03077698|365584464|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
105979120|NCT03077698|365584463|FG000|Safety Follow Up|Withdrawal by Subject|2|||
105979121|NCT03077698|365584464|FG001|Safety Follow Up|Withdrawal by Subject|1|||
105979122|NCT03077698|365584463|FG000|Safety Follow Up|Transfer of care to hospice|1|||
105979123|NCT03077698|365584464|FG001|Safety Follow Up|Transfer of care to hospice|0|||
105979124|NCT04135859|365584466|FG000|Overall Study|Withdrawal by Subject|1|||
105979125|NCT04135859|365584467|FG001|Overall Study|Withdrawal by Subject|0|||
105979126|NCT04135859|365584466|FG000|Overall Study|Withdrawal due to screening failure|1|||
105979127|NCT04135859|365584467|FG001|Overall Study|Withdrawal due to screening failure|2|||
105979128|NCT04135859|365584466|FG000|Overall Study|Did not complete stress test|3|||
105979129|NCT04135859|365584467|FG001|Overall Study|Did not complete stress test|3|||
105979130|NCT04135859|365584466|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
105979131|NCT04135859|365584467|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
105979132|NCT00815191|365584468|FG000|Overall Study|Protocol Violation|1|||
105979133|NCT00815191|365584469|FG001|Overall Study|Protocol Violation|1|||
105979134|NCT00973102|365584472|FG000|Overall Study|Protocol Violation|1|||
105979135|NCT00973102|365584473|FG001|Overall Study|Protocol Violation|0|||
105979136|NCT00973102|365584472|FG000|Overall Study|Prisoner|0|||
105979137|NCT00973102|365584473|FG001|Overall Study|Prisoner|1|||
105979138|NCT02012686|365584476|FG000|Overall Study|muscle contraction|0|||
105979139|NCT02012686|365584477|FG001|Overall Study|muscle contraction|1|||
105979140|NCT02012686|365584476|FG000|Overall Study|electrocardiography monitoring noise|0|||
105979141|NCT02012686|365584477|FG001|Overall Study|electrocardiography monitoring noise|1|||
105979142|NCT01442064|365584478|FG000|Overall Study|Adverse Event|2|||
105979143|NCT01442064|365584479|FG001|Overall Study|Adverse Event|2|||
105979144|NCT01442064|365584480|FG002|Overall Study|Adverse Event|2|||
106028036|NCT03254459|365769101|FG001|Overall Study|Withdrawal by Subject Consent|1|||
106028037|NCT03254459|365769100|FG000|Overall Study|Lost to Follow-up|0|||
106028038|NCT03254459|365769101|FG001|Overall Study|Lost to Follow-up|1|||
105979145|NCT01442064|365584481|FG003|Overall Study|Adverse Event|1|||
105979146|NCT01442064|365584482|FG004|Overall Study|Adverse Event|2|||
105979147|NCT01442064|365584483|FG005|Overall Study|Adverse Event|0|||
105979148|NCT01442064|365584478|FG000|Overall Study|Death|0|||
105979149|NCT01442064|365584479|FG001|Overall Study|Death|1|||
105979150|NCT01442064|365584480|FG002|Overall Study|Death|3|||
105979151|NCT01442064|365584481|FG003|Overall Study|Death|3|||
105979152|NCT01442064|365584482|FG004|Overall Study|Death|1|||
105979153|NCT01442064|365584483|FG005|Overall Study|Death|3|||
105979154|NCT01442064|365584478|FG000|Overall Study|Lost to Follow-up|5|||
105979155|NCT01442064|365584479|FG001|Overall Study|Lost to Follow-up|5|||
105979156|NCT01442064|365584480|FG002|Overall Study|Lost to Follow-up|1|||
105979157|NCT01442064|365584481|FG003|Overall Study|Lost to Follow-up|1|||
105979158|NCT01442064|365584482|FG004|Overall Study|Lost to Follow-up|3|||
105979159|NCT01442064|365584483|FG005|Overall Study|Lost to Follow-up|3|||
105979160|NCT01442064|365584478|FG000|Overall Study|Physician Decision|1|||
105979161|NCT01442064|365584479|FG001|Overall Study|Physician Decision|1|||
105979162|NCT01442064|365584480|FG002|Overall Study|Physician Decision|2|||
105979163|NCT01442064|365584481|FG003|Overall Study|Physician Decision|3|||
105979164|NCT01442064|365584482|FG004|Overall Study|Physician Decision|3|||
105979165|NCT01442064|365584483|FG005|Overall Study|Physician Decision|1|||
105979166|NCT01442064|365584478|FG000|Overall Study|Withdrawal by Subject|6|||
105979167|NCT01442064|365584479|FG001|Overall Study|Withdrawal by Subject|3|||
105979168|NCT01442064|365584480|FG002|Overall Study|Withdrawal by Subject|2|||
105979169|NCT01442064|365584481|FG003|Overall Study|Withdrawal by Subject|2|||
105979170|NCT01442064|365584482|FG004|Overall Study|Withdrawal by Subject|2|||
105979171|NCT01442064|365584483|FG005|Overall Study|Withdrawal by Subject|1|||
105979172|NCT01442064|365584478|FG000|Overall Study|Sponsor decision|82|||
105979173|NCT01442064|365584479|FG001|Overall Study|Sponsor decision|88|||
105979174|NCT01442064|365584480|FG002|Overall Study|Sponsor decision|92|||
105979175|NCT01442064|365584481|FG003|Overall Study|Sponsor decision|88|||
105979176|NCT01442064|365584482|FG004|Overall Study|Sponsor decision|95|||
105979177|NCT01442064|365584483|FG005|Overall Study|Sponsor decision|87|||
105979178|NCT01442064|365584478|FG000|Overall Study|Subject non-compliance|0|||
105979179|NCT01442064|365584479|FG001|Overall Study|Subject non-compliance|0|||
105979180|NCT01442064|365584480|FG002|Overall Study|Subject non-compliance|0|||
105979181|NCT01442064|365584481|FG003|Overall Study|Subject non-compliance|0|||
105979182|NCT01442064|365584482|FG004|Overall Study|Subject non-compliance|0|||
105979183|NCT01442064|365584483|FG005|Overall Study|Subject non-compliance|2|||
105979184|NCT01442064|365584478|FG000|Overall Study|Condition mandated other intervention|1|||
105979185|NCT01442064|365584479|FG001|Overall Study|Condition mandated other intervention|1|||
105851512|NCT01791153|365112738|FG007|Part 2: Open-label Period|Death|1|||
105851513|NCT01791153|365112731|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
105851514|NCT01791153|365112732|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
105851515|NCT01791153|365112733|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
105851516|NCT01791153|365112734|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
105851517|NCT01791153|365112735|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
105851518|NCT01791153|365112736|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
105851519|NCT01791153|365112737|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
105851520|NCT01791153|365112738|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
105851521|NCT01791153|365112731|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
105851522|NCT01791153|365112732|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
105851523|NCT01791153|365112733|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
105851524|NCT01791153|365112734|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
105851525|NCT01791153|365112735|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
105851526|NCT01791153|365112736|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
105851527|NCT01791153|365112737|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
105851528|NCT01791153|365112738|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
105851529|NCT01791153|365112731|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
105851530|NCT01791153|365112732|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
105851531|NCT01791153|365112733|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
105851532|NCT01791153|365112734|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
105979186|NCT01442064|365584480|FG002|Overall Study|Condition mandated other intervention|2|||
105851533|NCT01791153|365112735|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
105851534|NCT01791153|365112736|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
105979187|NCT01442064|365584481|FG003|Overall Study|Condition mandated other intervention|0|||
105979188|NCT01442064|365584482|FG004|Overall Study|Condition mandated other intervention|0|||
105979189|NCT01442064|365584483|FG005|Overall Study|Condition mandated other intervention|2|||
105979190|NCT03099148|365584484|FG000|Wash-out|scheduling conflict|0|||
105979191|NCT03099148|365584485|FG001|Wash-out|scheduling conflict|1|||
105979192|NCT03099148|365584486|FG002|Wash-out|scheduling conflict|0|||
105979193|NCT03099148|365584487|FG003|Wash-out|scheduling conflict|0|||
105979194|NCT03099148|365584484|FG000|Wash-out|Adverse Event|0|||
105979195|NCT03099148|365584485|FG001|Wash-out|Adverse Event|1|||
105979196|NCT03099148|365584486|FG002|Wash-out|Adverse Event|0|||
105979197|NCT03099148|365584487|FG003|Wash-out|Adverse Event|0|||
105979198|NCT01703065|365584488|FG000|Overall Study|Lack of Efficacy|1|||
105979199|NCT01703065|365584489|FG001|Overall Study|Lack of Efficacy|0|||
105979200|NCT03242018|365584490|FG000|Overall Study|Adverse Event|7|||
105979201|NCT03242018|365584491|FG001|Overall Study|Adverse Event|7|||
105979202|NCT03242018|365584492|FG002|Overall Study|Adverse Event|6|||
105979203|NCT03242018|365584490|FG000|Overall Study|Lost to Follow-up|2|||
105979204|NCT03242018|365584491|FG001|Overall Study|Lost to Follow-up|2|||
105979205|NCT03242018|365584492|FG002|Overall Study|Lost to Follow-up|2|||
105979206|NCT03242018|365584490|FG000|Overall Study|At the Participant's Own Request|5|||
105979207|NCT03242018|365584491|FG001|Overall Study|At the Participant's Own Request|1|||
105979208|NCT03242018|365584492|FG002|Overall Study|At the Participant's Own Request|4|||
105979209|NCT03242018|365584490|FG000|Overall Study|Reason Not Specified|3|||
105979210|NCT03242018|365584491|FG001|Overall Study|Reason Not Specified|4|||
105979211|NCT03242018|365584492|FG002|Overall Study|Reason Not Specified|1|||
105979212|NCT03242018|365584490|FG000|Overall Study|Study Terminated by Sponsor|1|||
105979213|NCT03242018|365584491|FG001|Overall Study|Study Terminated by Sponsor|0|||
105979214|NCT03242018|365584492|FG002|Overall Study|Study Terminated by Sponsor|1|||
105979215|NCT02365285|365584493|FG000|Overall Study|Physician Decision|0|||
105979216|NCT02365285|365584494|FG001|Overall Study|Physician Decision|1|||
105979217|NCT02365285|365584495|FG002|Overall Study|Physician Decision|1|||
105979218|NCT02365285|365584496|FG003|Overall Study|Physician Decision|0|||
105979219|NCT02365285|365584493|FG000|Overall Study|Adverse Event|0|||
105979220|NCT02365285|365584494|FG001|Overall Study|Adverse Event|0|||
105979221|NCT02365285|365584495|FG002|Overall Study|Adverse Event|0|||
105979222|NCT02365285|365584496|FG003|Overall Study|Adverse Event|2|||
105979223|NCT00490022|365584497|FG000|Overall Study|Adverse Event|0|||
105979224|NCT00490022|365584498|FG001|Overall Study|Adverse Event|2|||
105979225|NCT00490022|365584497|FG000|Overall Study|Withdrawal by Subject|1|||
105979226|NCT00490022|365584498|FG001|Overall Study|Withdrawal by Subject|0|||
105979227|NCT00490022|365584497|FG000|Overall Study|Subject failed to disclose concommitant|0|||
105979228|NCT00490022|365584498|FG001|Overall Study|Subject failed to disclose concommitant|1|||
105979229|NCT02124772|365584499|FG000|Overall Study|Lack of Efficacy|2|||
105979230|NCT02124772|365584500|FG001|Overall Study|Lack of Efficacy|0|||
105979231|NCT02124772|365584501|FG002|Overall Study|Lack of Efficacy|0|||
105979232|NCT02124772|365584502|FG003|Overall Study|Lack of Efficacy|1|||
105979233|NCT02124772|365584503|FG004|Overall Study|Lack of Efficacy|2|||
105979234|NCT02124772|365584504|FG005|Overall Study|Lack of Efficacy|3|||
105979235|NCT02124772|365584505|FG006|Overall Study|Lack of Efficacy|0|||
105979236|NCT02124772|365584506|FG007|Overall Study|Lack of Efficacy|2|||
105979237|NCT02124772|365584507|FG008|Overall Study|Lack of Efficacy|0|||
105979238|NCT02124772|365584508|FG009|Overall Study|Lack of Efficacy|1|||
105979239|NCT02124772|365584509|FG010|Overall Study|Lack of Efficacy|0|||
105979240|NCT02124772|365584510|FG011|Overall Study|Lack of Efficacy|0|||
105979241|NCT02124772|365584511|FG012|Overall Study|Lack of Efficacy|1|||
105979242|NCT02124772|365584499|FG000|Overall Study|Adverse Event|1|||
105979243|NCT02124772|365584500|FG001|Overall Study|Adverse Event|4|||
105979244|NCT02124772|365584501|FG002|Overall Study|Adverse Event|1|||
105979245|NCT02124772|365584502|FG003|Overall Study|Adverse Event|5|||
105979246|NCT02124772|365584503|FG004|Overall Study|Adverse Event|2|||
105979247|NCT02124772|365584504|FG005|Overall Study|Adverse Event|1|||
105979248|NCT02124772|365584505|FG006|Overall Study|Adverse Event|1|||
105979249|NCT02124772|365584506|FG007|Overall Study|Adverse Event|5|||
105979250|NCT02124772|365584507|FG008|Overall Study|Adverse Event|0|||
105979251|NCT02124772|365584508|FG009|Overall Study|Adverse Event|3|||
106028039|NCT03254459|365769100|FG000|Overall Study|Miscellaneous|0|||
106028040|NCT03254459|365769101|FG001|Overall Study|Miscellaneous|1|||
106028041|NCT00727441|365769104|FG000|Overall Study|Disease Progression|11|||
106028042|NCT00727441|365769105|FG001|Overall Study|Disease Progression|14|||
106028043|NCT00727441|365769106|FG002|Overall Study|Disease Progression|17|||
106028044|NCT00727441|365769104|FG000|Overall Study|Eligibility|7|||
106028045|NCT00727441|365769105|FG001|Overall Study|Eligibility|5|||
106028046|NCT00727441|365769106|FG002|Overall Study|Eligibility|7|||
106028047|NCT00727441|365769104|FG000|Overall Study|Death|0|||
106028048|NCT00727441|365769105|FG001|Overall Study|Death|1|||
105979252|NCT02124772|365584509|FG010|Overall Study|Adverse Event|1|||
105979253|NCT02124772|365584510|FG011|Overall Study|Adverse Event|3|||
105979254|NCT02124772|365584511|FG012|Overall Study|Adverse Event|1|||
105979255|NCT02124772|365584499|FG000|Overall Study|Withdrawal consent|0|||
105979256|NCT02124772|365584500|FG001|Overall Study|Withdrawal consent|1|||
105979257|NCT02124772|365584501|FG002|Overall Study|Withdrawal consent|1|||
105979258|NCT02124772|365584502|FG003|Overall Study|Withdrawal consent|1|||
105979259|NCT02124772|365584503|FG004|Overall Study|Withdrawal consent|0|||
105979260|NCT02124772|365584504|FG005|Overall Study|Withdrawal consent|1|||
105979261|NCT02124772|365584505|FG006|Overall Study|Withdrawal consent|1|||
105979262|NCT02124772|365584506|FG007|Overall Study|Withdrawal consent|0|||
105979263|NCT02124772|365584507|FG008|Overall Study|Withdrawal consent|0|||
105979264|NCT02124772|365584508|FG009|Overall Study|Withdrawal consent|1|||
105979265|NCT02124772|365584509|FG010|Overall Study|Withdrawal consent|0|||
105979266|NCT02124772|365584510|FG011|Overall Study|Withdrawal consent|1|||
106028049|NCT00727441|365769106|FG002|Overall Study|Death|1|||
105979267|NCT02124772|365584511|FG012|Overall Study|Withdrawal consent|0|||
105979268|NCT02124772|365584499|FG000|Overall Study|Investigator discretion|0|||
105979269|NCT02124772|365584500|FG001|Overall Study|Investigator discretion|2|||
106151010|NCT02723955|366215080|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151011|NCT02723955|366215081|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151012|NCT02723955|366215082|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151013|NCT02723955|366215083|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151014|NCT02723955|366215084|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151015|NCT02723955|366215085|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151016|NCT02723955|366215086|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151017|NCT02723955|366215087|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151018|NCT02723955|366215088|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151019|NCT02723955|366215089|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151020|NCT02723955|366215090|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151021|NCT02723955|366215091|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151022|NCT02723955|366215092|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151023|NCT02723955|366215093|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151024|NCT02723955|366215094|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151025|NCT02723955|366215095|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151026|NCT02723955|366215096|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
106151027|NCT02723955|366215054|FG000|Escalation Phase|Site Closed|0|||
106151028|NCT02723955|366215055|FG001|Escalation Phase|Site Closed|0|||
106151029|NCT02723955|366215056|FG002|Escalation Phase|Site Closed|0|||
106151030|NCT02723955|366215057|FG003|Escalation Phase|Site Closed|0|||
106151031|NCT02723955|366215058|FG004|Escalation Phase|Site Closed|0|||
106151032|NCT02723955|366215059|FG005|Escalation Phase|Site Closed|0|||
106151033|NCT02723955|366215060|FG006|Escalation Phase|Site Closed|0|||
106151034|NCT02723955|366215061|FG007|Escalation Phase|Site Closed|0|||
106151035|NCT02723955|366215062|FG008|Escalation Phase|Site Closed|0|||
106151036|NCT02723955|366215063|FG009|Escalation Phase|Site Closed|0|||
106151037|NCT02723955|366215064|FG010|Escalation Phase|Site Closed|0|||
106151038|NCT02723955|366215065|FG011|Escalation Phase|Site Closed|0|||
106151039|NCT02723955|366215066|FG012|Escalation Phase|Site Closed|0|||
106151040|NCT02723955|366215067|FG013|Escalation Phase|Site Closed|0|||
106151041|NCT02723955|366215068|FG014|Escalation Phase|Site Closed|0|||
105979270|NCT02124772|365584501|FG002|Overall Study|Investigator discretion|2|||
105979271|NCT02124772|365584502|FG003|Overall Study|Investigator discretion|1|||
105979272|NCT02124772|365584503|FG004|Overall Study|Investigator discretion|1|||
105979273|NCT02124772|365584504|FG005|Overall Study|Investigator discretion|0|||
105979274|NCT02124772|365584505|FG006|Overall Study|Investigator discretion|1|||
105979275|NCT02124772|365584506|FG007|Overall Study|Investigator discretion|0|||
105979276|NCT02124772|365584507|FG008|Overall Study|Investigator discretion|0|||
105979277|NCT02124772|365584508|FG009|Overall Study|Investigator discretion|1|||
105979278|NCT02124772|365584509|FG010|Overall Study|Investigator discretion|0|||
105979279|NCT02124772|365584510|FG011|Overall Study|Investigator discretion|1|||
105979280|NCT02124772|365584511|FG012|Overall Study|Investigator discretion|0|||
105979281|NCT02124772|365584499|FG000|Overall Study|Progressive disease|0|||
105979282|NCT02124772|365584500|FG001|Overall Study|Progressive disease|0|||
105979283|NCT02124772|365584501|FG002|Overall Study|Progressive disease|0|||
105979284|NCT02124772|365584502|FG003|Overall Study|Progressive disease|0|||
105979285|NCT02124772|365584503|FG004|Overall Study|Progressive disease|0|||
105979286|NCT02124772|365584504|FG005|Overall Study|Progressive disease|0|||
106028050|NCT00727441|365769104|FG000|Overall Study|Physician Decision|0|||
106028051|NCT00727441|365769105|FG001|Overall Study|Physician Decision|1|||
106028052|NCT00727441|365769106|FG002|Overall Study|Physician Decision|0|||
106028053|NCT00727441|365769104|FG000|Overall Study|Withdrawal by Subject|0|||
106028054|NCT00727441|365769105|FG001|Overall Study|Withdrawal by Subject|1|||
106028055|NCT00727441|365769106|FG002|Overall Study|Withdrawal by Subject|0|||
106028056|NCT00745849|365769107|FG000|First Intervention|Withdrawal by Subject|0|||
106028057|NCT00745849|365769108|FG001|First Intervention|Withdrawal by Subject|1|||
106028058|NCT00745849|365769107|FG000|First Intervention|Lost to Follow-up|1|||
106028059|NCT00745849|365769108|FG001|First Intervention|Lost to Follow-up|1|||
106028060|NCT00745849|365769107|FG000|Second Intervention|Lost to Follow-up|2|||
105979287|NCT02124772|365584505|FG006|Overall Study|Progressive disease|1|||
105979288|NCT02124772|365584506|FG007|Overall Study|Progressive disease|1|||
105979289|NCT02124772|365584507|FG008|Overall Study|Progressive disease|0|||
105979290|NCT02124772|365584508|FG009|Overall Study|Progressive disease|0|||
105979291|NCT02124772|365584509|FG010|Overall Study|Progressive disease|0|||
105979292|NCT02124772|365584510|FG011|Overall Study|Progressive disease|0|||
106028061|NCT00745849|365769108|FG001|Second Intervention|Lost to Follow-up|1|||
105979293|NCT02124772|365584511|FG012|Overall Study|Progressive disease|0|||
105979294|NCT02124772|365584499|FG000|Overall Study|Other|0|||
105979295|NCT02124772|365584500|FG001|Overall Study|Other|7|||
105979296|NCT02124772|365584501|FG002|Overall Study|Other|2|||
105979297|NCT02124772|365584502|FG003|Overall Study|Other|5|||
105979298|NCT02124772|365584503|FG004|Overall Study|Other|4|||
105979299|NCT02124772|365584504|FG005|Overall Study|Other|3|||
105979300|NCT02124772|365584505|FG006|Overall Study|Other|4|||
105979301|NCT02124772|365584506|FG007|Overall Study|Other|1|||
105979302|NCT02124772|365584507|FG008|Overall Study|Other|1|||
105979303|NCT02124772|365584508|FG009|Overall Study|Other|1|||
105979304|NCT02124772|365584509|FG010|Overall Study|Other|1|||
105979305|NCT02124772|365584510|FG011|Overall Study|Other|1|||
105979306|NCT02124772|365584511|FG012|Overall Study|Other|0|||
105979307|NCT01617447|365584512|FG000|Overall Study|Adverse Event|0|||
105979308|NCT01617447|365584513|FG001|Overall Study|Adverse Event|1|||
105979309|NCT01617447|365584512|FG000|Overall Study|Physician Decision|0|||
105979310|NCT01617447|365584513|FG001|Overall Study|Physician Decision|2|||
105979311|NCT02713529|365584514|FG000|Overall Study|Withdrawal by Subject|3|||
105979312|NCT02713529|365584515|FG001|Overall Study|Withdrawal by Subject|1|||
105979313|NCT02713529|365584516|FG002|Overall Study|Withdrawal by Subject|4|||
105979314|NCT02713529|365584517|FG003|Overall Study|Withdrawal by Subject|2|||
105979315|NCT02713529|365584518|FG004|Overall Study|Withdrawal by Subject|0|||
105979316|NCT02713529|365584519|FG005|Overall Study|Withdrawal by Subject|1|||
105979317|NCT02713529|365584520|FG006|Overall Study|Withdrawal by Subject|1|||
105979318|NCT02713529|365584514|FG000|Overall Study|Lost to Follow-up|1|||
105979319|NCT02713529|365584515|FG001|Overall Study|Lost to Follow-up|0|||
105979320|NCT02713529|365584516|FG002|Overall Study|Lost to Follow-up|1|||
105979321|NCT02713529|365584517|FG003|Overall Study|Lost to Follow-up|0|||
105979322|NCT02713529|365584518|FG004|Overall Study|Lost to Follow-up|0|||
105979323|NCT02713529|365584519|FG005|Overall Study|Lost to Follow-up|0|||
105979324|NCT02713529|365584520|FG006|Overall Study|Lost to Follow-up|0|||
105979325|NCT02713529|365584514|FG000|Overall Study|Death|3|||
105979326|NCT02713529|365584515|FG001|Overall Study|Death|3|||
105979327|NCT02713529|365584516|FG002|Overall Study|Death|26|||
105979328|NCT02713529|365584517|FG003|Overall Study|Death|27|||
105979329|NCT02713529|365584518|FG004|Overall Study|Death|3|||
105979330|NCT02713529|365584519|FG005|Overall Study|Death|13|||
105979331|NCT02713529|365584520|FG006|Overall Study|Death|3|||
105979332|NCT02576860|365584521|FG000|Overall Study|Adverse Event|6|||
105979333|NCT02576860|365584522|FG001|Overall Study|Adverse Event|6|||
105979334|NCT02576860|365584521|FG000|Overall Study|Lost to Follow-up|5|||
105979335|NCT02576860|365584522|FG001|Overall Study|Lost to Follow-up|7|||
105979336|NCT02576860|365584521|FG000|Overall Study|Physician Decision|0|||
105979337|NCT02576860|365584522|FG001|Overall Study|Physician Decision|1|||
105979338|NCT02576860|365584521|FG000|Overall Study|Protocol Violation|0|||
105979339|NCT02576860|365584522|FG001|Overall Study|Protocol Violation|2|||
105979340|NCT02576860|365584521|FG000|Overall Study|Withdrawal by Subject|13|||
105979341|NCT02576860|365584522|FG001|Overall Study|Withdrawal by Subject|8|||
105979342|NCT02576860|365584521|FG000|Overall Study|Disallowed medication|1|||
105979343|NCT02576860|365584522|FG001|Overall Study|Disallowed medication|0|||
105979344|NCT02827500|365584523|FG000|Overall Study|Death|7|||
105979345|NCT02827500|365584524|FG001|Overall Study|Death|3|||
105979346|NCT02827500|365584523|FG000|Overall Study|Lost to Follow-up|1|||
105979347|NCT02827500|365584524|FG001|Overall Study|Lost to Follow-up|1|||
105979348|NCT02827500|365584523|FG000|Overall Study|Withdrawal by Subject|3|||
105979349|NCT02827500|365584524|FG001|Overall Study|Withdrawal by Subject|1|||
105979350|NCT02827500|365584523|FG000|Overall Study|Missing primary endpoint data|3|||
105979351|NCT02827500|365584524|FG001|Overall Study|Missing primary endpoint data|1|||
105979352|NCT02827500|365584523|FG000|Overall Study|Other|5|||
105979353|NCT02827500|365584524|FG001|Overall Study|Other|1|||
106028062|NCT02600871|365769109|FG000|Overall Study|Lost to Follow-up|13|||
106028063|NCT02600871|365769110|FG001|Overall Study|Lost to Follow-up|10|||
106028064|NCT00617669|365769111|FG000|Overall Study|Withdrawal by Subject|71|||
105979354|NCT00514020|365584525|FG000|Overall Study|Adverse Event|6|||
106028065|NCT00617669|365769112|FG001|Overall Study|Withdrawal by Subject|77|||
105979355|NCT00514020|365584525|FG000|Overall Study|Withdrawal by Subject|3|||
105979356|NCT00514020|365584525|FG000|Overall Study|Physician Decision|1|||
105979357|NCT00514020|365584525|FG000|Overall Study|disease progression|9|||
105979358|NCT00514020|365584525|FG000|Overall Study|other complicating disease|2|||
105979359|NCT00514020|365584525|FG000|Overall Study|patient went to radiation treatment|1|||
105979360|NCT00514020|365584525|FG000|Overall Study|"patients moved to the no tx group"|6|||
105979361|NCT03780959|365584529|FG000|Part 1|Adverse Event|1|||
105979362|NCT03780959|365584530|FG001|Part 1|Adverse Event|0|||
105979363|NCT03780959|365584531|FG002|Part 1|Adverse Event|0|||
105979364|NCT03780959|365584529|FG000|Part 1|Withdrawal by Subject|1|||
105979365|NCT03780959|365584530|FG001|Part 1|Withdrawal by Subject|0|||
105979366|NCT03780959|365584531|FG002|Part 1|Withdrawal by Subject|0|||
105979367|NCT03780959|365584529|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
105979368|NCT03780959|365584530|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
106028066|NCT00617669|365769111|FG000|Overall Study|Lost to Follow-up|3|||
106028067|NCT00617669|365769112|FG001|Overall Study|Lost to Follow-up|2|||
106028068|NCT00617669|365769111|FG000|Overall Study|Adverse Event|87|||
106028069|NCT00617669|365769112|FG001|Overall Study|Adverse Event|76|||
106028070|NCT00617669|365769111|FG000|Overall Study|Protocol Violation|2|||
106028071|NCT00617669|365769112|FG001|Overall Study|Protocol Violation|3|||
106028072|NCT00617669|365769111|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
106028073|NCT00617669|365769112|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
106028074|NCT00617669|365769111|FG000|Overall Study|Patients randomized but not treated|2|||
106028075|NCT00617669|365769112|FG001|Overall Study|Patients randomized but not treated|3|||
106028076|NCT03328182|365769113|FG000|Overall Study|Withdrawal by Subject|1|||
106028077|NCT03328182|365769113|FG000|Overall Study|Protocol Violation|2|||
106028078|NCT03328182|365769113|FG000|Overall Study|No Product Evaluated|1|||
106028079|NCT01964755|365769114|FG000|Overall Study|Death|2|||
106028080|NCT01012219|365769115|FG000|Period 1|Withdrawal by Subject|1|||
106028081|NCT01012219|365769115|FG000|Period 2|Withdrawal by Subject|1|||
106028082|NCT00003590|365769118|FG000|Overall Study|Ineligible Patient|1|||
106028083|NCT00003590|365769118|FG000|Overall Study|Adverse Event|7|||
106028084|NCT00003590|365769118|FG000|Overall Study|Withdrawal by Subject|1|||
106028085|NCT00003590|365769118|FG000|Overall Study|Lack of Efficacy|11|||
106028086|NCT00003590|365769118|FG000|Overall Study|Death|1|||
106028087|NCT00003590|365769118|FG000|Overall Study|Physician Decision|1|||
106028088|NCT01909791|365769122|FG000|Overall Study|Death|9|||
106028089|NCT01909791|365769123|FG001|Overall Study|Death|8|||
106028090|NCT01909791|365769124|FG002|Overall Study|Death|4|||
106028091|NCT01909791|365769122|FG000|Overall Study|Withdrawal by Subject|5|||
106028092|NCT01909791|365769123|FG001|Overall Study|Withdrawal by Subject|9|||
106028093|NCT01909791|365769124|FG002|Overall Study|Withdrawal by Subject|13|||
106028094|NCT01909791|365769122|FG000|Overall Study|Lost to Follow-up|5|||
106028095|NCT01909791|365769123|FG001|Overall Study|Lost to Follow-up|11|||
106028096|NCT01909791|365769124|FG002|Overall Study|Lost to Follow-up|10|||
106028097|NCT01909791|365769122|FG000|Overall Study|Missed Visit|2|||
106028098|NCT01909791|365769123|FG001|Overall Study|Missed Visit|0|||
106028099|NCT01909791|365769124|FG002|Overall Study|Missed Visit|1|||
106028100|NCT01236547|365769126|FG000|Overall Study|Protocol Violation|0|||
106028101|NCT01236547|365769127|FG001|Overall Study|Protocol Violation|1|||
106028102|NCT01236547|365769128|FG002|Overall Study|Protocol Violation|1|||
106028103|NCT01236547|365769129|FG003|Overall Study|Protocol Violation|6|||
106028104|NCT01236547|365769130|FG004|Overall Study|Protocol Violation|12|||
106028105|NCT01022398|365769135|FG000|Overall Study|Study terminated|2|||
106028106|NCT01022398|365769136|FG001|Overall Study|Study terminated|2|||
106028107|NCT00870103|365769137|FG000|Overall Study|Physician Decision|2|||
106028108|NCT00870103|365769137|FG000|Overall Study|Lost to Follow-up|2|||
106028109|NCT03179202|365769138|FG000|Overall Study|Screen Failure|67|||
106028110|NCT03179202|365769138|FG000|Overall Study|Subject Lost to Follow Up|12|||
106028111|NCT03179202|365769138|FG000|Overall Study|Withdrawal by Subject|7|||
106028112|NCT03179202|365769138|FG000|Overall Study|Adverse Event|3|||
106028113|NCT03179202|365769138|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
106028114|NCT03179202|365769138|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
106028115|NCT03595618|365769142|FG000|Overall Study|Adverse Event|16|||
106028116|NCT03595618|365769143|FG001|Overall Study|Adverse Event|17|||
106028117|NCT03595618|365769144|FG002|Overall Study|Adverse Event|20|||
106028118|NCT03595618|365769145|FG003|Overall Study|Adverse Event|8|||
106028119|NCT03595618|365769142|FG000|Overall Study|Withdrawal by Subject|12|||
106028120|NCT03595618|365769143|FG001|Overall Study|Withdrawal by Subject|14|||
106028121|NCT03595618|365769144|FG002|Overall Study|Withdrawal by Subject|14|||
106028122|NCT03595618|365769145|FG003|Overall Study|Withdrawal by Subject|10|||
106028123|NCT03595618|365769142|FG000|Overall Study|Lost to Follow-up|6|||
106028124|NCT03595618|365769143|FG001|Overall Study|Lost to Follow-up|4|||
106028125|NCT03595618|365769144|FG002|Overall Study|Lost to Follow-up|5|||
106028126|NCT03595618|365769145|FG003|Overall Study|Lost to Follow-up|6|||
106028127|NCT03595618|365769142|FG000|Overall Study|Protocol Violation|2|||
106028128|NCT03595618|365769143|FG001|Overall Study|Protocol Violation|0|||
106028129|NCT03595618|365769144|FG002|Overall Study|Protocol Violation|6|||
106028130|NCT03595618|365769145|FG003|Overall Study|Protocol Violation|2|||
106028131|NCT03595618|365769142|FG000|Overall Study|Physician Decision|0|||
106028132|NCT03595618|365769143|FG001|Overall Study|Physician Decision|0|||
106028133|NCT03595618|365769144|FG002|Overall Study|Physician Decision|1|||
106028134|NCT03595618|365769145|FG003|Overall Study|Physician Decision|2|||
106028135|NCT03595618|365769142|FG000|Overall Study|Miscellaneous|7|||
106028136|NCT03595618|365769143|FG001|Overall Study|Miscellaneous|5|||
106028137|NCT03595618|365769144|FG002|Overall Study|Miscellaneous|10|||
106028138|NCT03595618|365769145|FG003|Overall Study|Miscellaneous|6|||
106028139|NCT01782469|365769149|FG000|Overall Study|Lost to Follow-up|1|||
106028140|NCT02184572|365769154|FG000|Overall Study|Lost to Follow-up|29|||
106028141|NCT02184572|365769155|FG001|Overall Study|Lost to Follow-up|21|||
106028142|NCT02184572|365769154|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
106028143|NCT02184572|365769155|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
106028144|NCT02184572|365769154|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
105979369|NCT03780959|365584531|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
105979370|NCT03780959|365584529|FG000|Part 1|Response Status|2|||
105979371|NCT03780959|365584530|FG001|Part 1|Response Status|0|||
105979372|NCT03780959|365584531|FG002|Part 1|Response Status|0|||
105979373|NCT03780959|365584529|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
105979374|NCT03780959|365584530|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
105979375|NCT03780959|365584531|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
105979376|NCT03780959|365584529|FG000|Part 2|Response Status|0|||
105979377|NCT03780959|365584530|FG001|Part 2|Response Status|18|||
105979378|NCT03780959|365584531|FG002|Part 2|Response Status|6|||
105979379|NCT02308488|365584534|FG000|Overall Study|Withdrawal by Subject|2|||
105979380|NCT01541917|365584535|FG000|Overall Study|Lost to Follow-up|2|||
105979381|NCT01541917|365584536|FG001|Overall Study|Lost to Follow-up|2|||
106151042|NCT02723955|366215069|FG015|Escalation Phase|Site Closed|1|||
106151043|NCT02723955|366215070|FG016|Escalation Phase|Site Closed|0|||
106151044|NCT02723955|366215071|FG017|Escalation Phase|Site Closed|2|||
106151045|NCT02723955|366215072|FG018|Escalation Phase|Site Closed|0|||
106151046|NCT02723955|366215073|FG019|Escalation Phase|Site Closed|0|||
106151047|NCT02723955|366215074|FG020|Escalation Phase|Site Closed|1|||
106151048|NCT02723955|366215075|FG021|Escalation Phase|Site Closed|0|||
106151049|NCT02723955|366215076|FG022|Escalation Phase|Site Closed|0|||
106151050|NCT02723955|366215077|FG023|Escalation Phase|Site Closed|0|||
106151051|NCT02723955|366215078|FG024|Escalation Phase|Site Closed|3|||
106151052|NCT02723955|366215079|FG025|Escalation Phase|Site Closed|1|||
106151053|NCT02723955|366215080|FG026|Escalation Phase|Site Closed|3|||
106151054|NCT02723955|366215081|FG027|Escalation Phase|Site Closed|1|||
106151055|NCT02723955|366215082|FG028|Escalation Phase|Site Closed|1|||
106151056|NCT02723955|366215083|FG029|Escalation Phase|Site Closed|0|||
106151057|NCT02723955|366215084|FG030|Escalation Phase|Site Closed|0|||
106151058|NCT02723955|366215085|FG031|Escalation Phase|Site Closed|0|||
106151059|NCT02723955|366215086|FG032|Escalation Phase|Site Closed|0|||
106151060|NCT02723955|366215087|FG033|Escalation Phase|Site Closed|0|||
106151061|NCT02723955|366215088|FG034|Escalation Phase|Site Closed|0|||
106151062|NCT02723955|366215089|FG035|Escalation Phase|Site Closed|0|||
106151063|NCT02723955|366215090|FG036|Escalation Phase|Site Closed|0|||
106151064|NCT02723955|366215091|FG037|Escalation Phase|Site Closed|0|||
106151065|NCT02723955|366215092|FG038|Escalation Phase|Site Closed|0|||
106151066|NCT02723955|366215093|FG039|Escalation Phase|Site Closed|0|||
106151067|NCT02723955|366215094|FG040|Escalation Phase|Site Closed|0|||
106151068|NCT02723955|366215095|FG041|Escalation Phase|Site Closed|0|||
106151069|NCT02723955|366215096|FG042|Escalation Phase|Site Closed|0|||
106151070|NCT02723955|366215054|FG000|Expansion Phase|Death|0|||
106151071|NCT02723955|366215055|FG001|Expansion Phase|Death|0|||
106151072|NCT02723955|366215056|FG002|Expansion Phase|Death|0|||
106151073|NCT02723955|366215057|FG003|Expansion Phase|Death|0|||
106151074|NCT02723955|366215058|FG004|Expansion Phase|Death|0|||
106151075|NCT02723955|366215059|FG005|Expansion Phase|Death|0|||
106151076|NCT02723955|366215060|FG006|Expansion Phase|Death|0|||
106151077|NCT02723955|366215061|FG007|Expansion Phase|Death|0|||
106151078|NCT02723955|366215062|FG008|Expansion Phase|Death|0|||
106151079|NCT02723955|366215063|FG009|Expansion Phase|Death|25|||
105979382|NCT01541917|365584535|FG000|Overall Study|Withdrawal by Subject|13|||
105979383|NCT01541917|365584536|FG001|Overall Study|Withdrawal by Subject|7|||
105979384|NCT01565564|365584542|FG000|Overall Study|Lost to Follow-up|5|||
105979385|NCT01565564|365584543|FG001|Overall Study|Lost to Follow-up|1|||
105979386|NCT00276614|365584548|FG000|Overall Study|Progression of disease under study|3|||
105979387|NCT00203021|365586260|FG000|Overall Study|Death|4|||
105979388|NCT00203021|365586261|FG001|Overall Study|Death|1|||
105979389|NCT00203021|365586260|FG000|Overall Study|Adverse Event|10|||
105979390|NCT00203021|365586261|FG001|Overall Study|Adverse Event|5|||
105979391|NCT00203021|365586260|FG000|Overall Study|Withdrawal by Subject|45|||
105979392|NCT00203021|365586261|FG001|Overall Study|Withdrawal by Subject|48|||
106028145|NCT02184572|365769155|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
106151080|NCT02723955|366215064|FG010|Expansion Phase|Death|69|||
106151081|NCT02723955|366215065|FG011|Expansion Phase|Death|48|||
106151082|NCT02723955|366215066|FG012|Expansion Phase|Death|0|||
106151083|NCT02723955|366215067|FG013|Expansion Phase|Death|0|||
106151084|NCT02723955|366215068|FG014|Expansion Phase|Death|0|||
106028146|NCT02184572|365769154|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
106151085|NCT02723955|366215069|FG015|Expansion Phase|Death|0|||
106151086|NCT02723955|366215070|FG016|Expansion Phase|Death|0|||
106151087|NCT02723955|366215071|FG017|Expansion Phase|Death|0|||
106151088|NCT02723955|366215072|FG018|Expansion Phase|Death|0|||
105979393|NCT00203021|365586260|FG000|Overall Study|Lost to Follow-up|9|||
105979394|NCT00203021|365586261|FG001|Overall Study|Lost to Follow-up|7|||
105979395|NCT00203021|365586260|FG000|Overall Study|Other than specified|11|||
105979396|NCT00203021|365586261|FG001|Overall Study|Other than specified|16|||
105979397|NCT00471887|365586264|FG000|Overall Study|Adverse Event|9|||
106151089|NCT02723955|366215073|FG019|Expansion Phase|Death|0|||
106151090|NCT02723955|366215074|FG020|Expansion Phase|Death|0|||
106151091|NCT02723955|366215075|FG021|Expansion Phase|Death|0|||
106151092|NCT02723955|366215076|FG022|Expansion Phase|Death|0|||
105979398|NCT05160766|365586267|FG000|Overall Study|Adverse Event|0|||
105979399|NCT05160766|365586268|FG001|Overall Study|Adverse Event|1|||
105979400|NCT05160766|365586269|FG002|Overall Study|Adverse Event|0|||
105979401|NCT05160766|365586270|FG003|Overall Study|Adverse Event|0|||
105979402|NCT05160766|365586267|FG000|Overall Study|COVID-19 infection|0|||
105979403|NCT05160766|365586268|FG001|Overall Study|COVID-19 infection|1|||
105979404|NCT05160766|365586269|FG002|Overall Study|COVID-19 infection|0|||
105979405|NCT05160766|365586270|FG003|Overall Study|COVID-19 infection|0|||
106028147|NCT02184572|365769155|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
106028148|NCT02184572|365769154|FG000|Overall Study|Traveling Outside The Country|1|||
106028149|NCT02184572|365769155|FG001|Overall Study|Traveling Outside The Country|0|||
106028150|NCT02184572|365769154|FG000|Overall Study|Withdrawal by Subject|14|||
106028151|NCT02184572|365769155|FG001|Overall Study|Withdrawal by Subject|9|||
106028152|NCT00638183|365769159|FG000|Overall Study|Adverse Event|23|||
106028153|NCT00638183|365769159|FG000|Overall Study|Lack of Efficacy|14|||
106028154|NCT00638183|365769159|FG000|Overall Study|Physician Decision|9|||
106028155|NCT00638183|365769159|FG000|Overall Study|Lost to Follow-up|46|||
106028156|NCT00638183|365769159|FG000|Overall Study|Other reason not defined above|27|||
106028157|NCT02350764|365769160|FG000|Overall Study|Adverse Event|4|||
106028158|NCT02350764|365769160|FG000|Overall Study|Death|3|||
106028159|NCT02350764|365769160|FG000|Overall Study|Physician Decision|2|||
106028160|NCT02350764|365769160|FG000|Overall Study|Withdrawal by Subject|2|||
106028161|NCT02395172|365769163|FG000|Overall Study|Participants randomized but not treated|3|||
106028162|NCT02395172|365769164|FG001|Overall Study|Participants randomized but not treated|31|||
106028163|NCT00717236|365769165|FG000|Double-Blind Period|Adverse Event|33|||
106028164|NCT00717236|365769166|FG001|Double-Blind Period|Adverse Event|6|||
106028165|NCT00717236|365769165|FG000|Double-Blind Period|Lack of Efficacy|6|||
106028166|NCT00717236|365769166|FG001|Double-Blind Period|Lack of Efficacy|6|||
106028167|NCT00717236|365769165|FG000|Double-Blind Period|Lost to Follow-up|3|||
106028168|NCT00717236|365769166|FG001|Double-Blind Period|Lost to Follow-up|5|||
106028169|NCT00717236|365769165|FG000|Double-Blind Period|Withdrawal by Subject|10|||
106028170|NCT00717236|365769166|FG001|Double-Blind Period|Withdrawal by Subject|2|||
106028171|NCT00717236|365769165|FG000|Double-Blind Period|Loss of efficacy|3|||
106028172|NCT00717236|365769166|FG001|Double-Blind Period|Loss of efficacy|0|||
106028173|NCT00717236|365769165|FG000|Double-Blind Period|Other: Death|1|||
106028174|NCT00717236|365769166|FG001|Double-Blind Period|Other: Death|0|||
106028175|NCT00717236|365769165|FG000|Double-Blind Period|Other: Pregnancy|1|||
106028176|NCT00717236|365769166|FG001|Double-Blind Period|Other: Pregnancy|0|||
106028177|NCT00717236|365769165|FG000|Double-Blind Period|Other: Protocol Violation|2|||
106028178|NCT00717236|365769166|FG001|Double-Blind Period|Other: Protocol Violation|0|||
106028179|NCT00717236|365769165|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
106028180|NCT00717236|365769166|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
106028181|NCT00717236|365769165|FG000|Double-Blind Period|Other: Site withdrew|2|||
106028182|NCT00717236|365769166|FG001|Double-Blind Period|Other: Site withdrew|0|||
106028183|NCT00717236|365769165|FG000|Double-Blind Period|Other: Screening failure|1|||
106028184|NCT00717236|365769166|FG001|Double-Blind Period|Other: Screening failure|0|||
106028185|NCT00717236|365769165|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
106028186|NCT00717236|365769166|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
106028187|NCT00717236|365769165|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
106028188|NCT00717236|365769166|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
106028189|NCT00717236|365769165|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
106028190|NCT00717236|365769166|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
106028191|NCT00717236|365769165|FG000|Double-Blind Period|Other: History of cancer|1|||
106028192|NCT00717236|365769166|FG001|Double-Blind Period|Other: History of cancer|0|||
106028193|NCT00717236|365769165|FG000|Double-Blind Period|Other: Sponsor request|1|||
106028194|NCT00717236|365769166|FG001|Double-Blind Period|Other: Sponsor request|0|||
106028195|NCT00717236|365769165|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
106028196|NCT00717236|365769166|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
106028197|NCT00717236|365769165|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
106028198|NCT00717236|365769166|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
106028199|NCT00717236|365769165|FG000|Double-Blind Period|Other: Subject moved|1|||
106028200|NCT00717236|365769166|FG001|Double-Blind Period|Other: Subject moved|1|||
106028201|NCT00717236|365769165|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
106028202|NCT00717236|365769166|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
106028203|NCT00717236|365769165|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
106028204|NCT00717236|365769166|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
106028205|NCT00717236|365769165|FG000|Double-Blind Period|Other: Transportation problems|0|||
106028206|NCT00717236|365769166|FG001|Double-Blind Period|Other: Transportation problems|1|||
106028207|NCT00717236|365769165|FG000|Double-Blind Period|Other: Investigator Decision|0|||
106028208|NCT00717236|365769166|FG001|Double-Blind Period|Other: Investigator Decision|1|||
106151093|NCT02723955|366215077|FG023|Expansion Phase|Death|0|||
105979406|NCT05160766|365586267|FG000|Overall Study|travel time|1|||
105979407|NCT05160766|365586268|FG001|Overall Study|travel time|0|||
105979408|NCT05160766|365586269|FG002|Overall Study|travel time|0|||
105979409|NCT05160766|365586270|FG003|Overall Study|travel time|1|||
105979410|NCT05160766|365586267|FG000|Overall Study|Withdrawal by Subject|3|||
105979411|NCT05160766|365586268|FG001|Overall Study|Withdrawal by Subject|5|||
105979412|NCT05160766|365586269|FG002|Overall Study|Withdrawal by Subject|4|||
105979413|NCT05160766|365586270|FG003|Overall Study|Withdrawal by Subject|2|||
105979414|NCT05160766|365586267|FG000|Overall Study|Death|0|||
105979415|NCT05160766|365586268|FG001|Overall Study|Death|0|||
105979416|NCT05160766|365586269|FG002|Overall Study|Death|2|||
105979417|NCT05160766|365586270|FG003|Overall Study|Death|5|||
106028209|NCT00717236|365769165|FG000|Open-Label Period|Adverse Event|29|||
106028210|NCT00717236|365769166|FG001|Open-Label Period|Adverse Event|4|||
106028211|NCT00717236|365769165|FG000|Open-Label Period|Lack of Efficacy|30|||
106028212|NCT00717236|365769166|FG001|Open-Label Period|Lack of Efficacy|8|||
106028213|NCT00717236|365769165|FG000|Open-Label Period|Lost to Follow-up|28|||
106028214|NCT00717236|365769166|FG001|Open-Label Period|Lost to Follow-up|4|||
106028215|NCT00717236|365769165|FG000|Open-Label Period|Withdrawal by Subject|20|||
106028216|NCT00717236|365769166|FG001|Open-Label Period|Withdrawal by Subject|2|||
106028217|NCT00717236|365769165|FG000|Open-Label Period|Loss of Efficacy|6|||
106028218|NCT00717236|365769166|FG001|Open-Label Period|Loss of Efficacy|1|||
106028219|NCT00717236|365769165|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
106028220|NCT00717236|365769166|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
106028221|NCT00717236|365769165|FG000|Open-Label Period|Other: Lack of Compliance|1|||
106028222|NCT00717236|365769166|FG001|Open-Label Period|Other: Lack of Compliance|1|||
106028223|NCT00717236|365769165|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
106028224|NCT00717236|365769166|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
106028225|NCT00717236|365769165|FG000|Open-Label Period|Other: Moved|1|||
106028226|NCT00717236|365769166|FG001|Open-Label Period|Other: Moved|0|||
106028227|NCT00717236|365769165|FG000|Open-Label Period|Other: Investigator Decision|1|||
106028228|NCT00717236|365769166|FG001|Open-Label Period|Other: Investigator Decision|0|||
106028229|NCT00717236|365769165|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
106028230|NCT00717236|365769166|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
106028231|NCT00717236|365769165|FG000|Open-Label Period|Other: Sponsor Request|3|||
106028232|NCT00717236|365769166|FG001|Open-Label Period|Other: Sponsor Request|0|||
106028233|NCT00717236|365769165|FG000|Open-Label Period|Other: Cataract Surgery|1|||
106028234|NCT00717236|365769166|FG001|Open-Label Period|Other: Cataract Surgery|0|||
106028235|NCT00717236|365769165|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
106028236|NCT00717236|365769166|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
106028237|NCT00717236|365769165|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
106028238|NCT00717236|365769166|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
106028239|NCT00717236|365769165|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
106028240|NCT00717236|365769166|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
106028241|NCT00783198|365769173|FG000|Overall Study|Adverse Event|15|||
106028242|NCT00783198|365769174|FG001|Overall Study|Adverse Event|19|||
106028243|NCT00783198|365769175|FG002|Overall Study|Adverse Event|3|||
106028244|NCT00783198|365769173|FG000|Overall Study|Lost to Follow-up|11|||
106028245|NCT00783198|365769174|FG001|Overall Study|Lost to Follow-up|1|||
106028246|NCT00783198|365769175|FG002|Overall Study|Lost to Follow-up|7|||
106028247|NCT00783198|365769173|FG000|Overall Study|Withdrawal by Subject|22|||
106028248|NCT00783198|365769174|FG001|Overall Study|Withdrawal by Subject|14|||
106028249|NCT00783198|365769175|FG002|Overall Study|Withdrawal by Subject|20|||
106028250|NCT00783198|365769173|FG000|Overall Study|Noncompliance with protocol|7|||
106028251|NCT00783198|365769174|FG001|Overall Study|Noncompliance with protocol|7|||
106028252|NCT00783198|365769175|FG002|Overall Study|Noncompliance with protocol|10|||
106028253|NCT00783198|365769173|FG000|Overall Study|Did not meet protocol eligibility|0|||
106028254|NCT00783198|365769174|FG001|Overall Study|Did not meet protocol eligibility|1|||
106028255|NCT00783198|365769175|FG002|Overall Study|Did not meet protocol eligibility|0|||
106028256|NCT00783198|365769173|FG000|Overall Study|Administrative|2|||
106028257|NCT00783198|365769174|FG001|Overall Study|Administrative|1|||
106028258|NCT00783198|365769175|FG002|Overall Study|Administrative|2|||
106028259|NCT01765218|365769176|FG000|Overall Study|Protocol Violation|1|||
106028260|NCT01765218|365769177|FG001|Overall Study|Protocol Violation|2|||
106028261|NCT00852371|365769180|FG000|Overall Study|Lost to Follow-up|2|||
106028262|NCT00852371|365769181|FG001|Overall Study|Lost to Follow-up|3|||
106028263|NCT00852371|365769182|FG002|Overall Study|Lost to Follow-up|4|||
106028264|NCT00852371|365769183|FG003|Overall Study|Lost to Follow-up|2|||
106028265|NCT02576145|365769187|FG000|Overall Study|Adverse Event|1|||
105979418|NCT05160766|365586267|FG000|Overall Study|Lost to Follow-up|0|||
105979419|NCT05160766|365586268|FG001|Overall Study|Lost to Follow-up|0|||
105979420|NCT05160766|365586269|FG002|Overall Study|Lost to Follow-up|1|||
106028266|NCT02576145|365769188|FG001|Overall Study|Adverse Event|0|||
106028267|NCT02576145|365769187|FG000|Overall Study|Withdrawal by Subject|1|||
106028268|NCT02576145|365769188|FG001|Overall Study|Withdrawal by Subject|0|||
106028269|NCT02576145|365769187|FG000|Overall Study|Acute rejection|1|||
106028270|NCT02576145|365769188|FG001|Overall Study|Acute rejection|0|||
106028271|NCT02576145|365769187|FG000|Overall Study|Tetanus Titers Decreased|0|||
105979421|NCT05160766|365586270|FG003|Overall Study|Lost to Follow-up|2|||
105979422|NCT05160766|365586267|FG000|Overall Study|No show|0|||
105979423|NCT05160766|365586268|FG001|Overall Study|No show|0|||
105979424|NCT05160766|365586269|FG002|Overall Study|No show|1|||
105979425|NCT05160766|365586270|FG003|Overall Study|No show|1|||
105979426|NCT05160766|365586267|FG000|Overall Study|Physician Decision|0|||
106028272|NCT02576145|365769188|FG001|Overall Study|Tetanus Titers Decreased|1|||
106028273|NCT02660138|365769189|FG000|Overall Study|Adverse Event|0|||
106028274|NCT02660138|365769190|FG001|Overall Study|Adverse Event|3|||
106028275|NCT02660138|365769191|FG002|Overall Study|Adverse Event|2|||
106028276|NCT02660138|365769189|FG000|Overall Study|Lack of Efficacy|1|||
106028277|NCT02660138|365769190|FG001|Overall Study|Lack of Efficacy|2|||
106028278|NCT02660138|365769191|FG002|Overall Study|Lack of Efficacy|1|||
106028279|NCT02660138|365769189|FG000|Overall Study|Withdrawal by Subject|7|||
106028280|NCT02660138|365769190|FG001|Overall Study|Withdrawal by Subject|6|||
106028281|NCT02660138|365769191|FG002|Overall Study|Withdrawal by Subject|6|||
106028282|NCT02660138|365769189|FG000|Overall Study|Lost to Follow-up|4|||
106028283|NCT02660138|365769190|FG001|Overall Study|Lost to Follow-up|4|||
106028284|NCT02660138|365769191|FG002|Overall Study|Lost to Follow-up|1|||
106028285|NCT02660138|365769189|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
106028286|NCT02660138|365769190|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
106028287|NCT02660138|365769191|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
106028288|NCT02660138|365769189|FG000|Overall Study|Other|1|||
106028289|NCT02660138|365769190|FG001|Overall Study|Other|1|||
106028290|NCT02660138|365769191|FG002|Overall Study|Other|0|||
106028291|NCT02660138|365769189|FG000|Overall Study|Not treated|0|||
106028292|NCT02660138|365769190|FG001|Overall Study|Not treated|1|||
106028293|NCT02660138|365769191|FG002|Overall Study|Not treated|0|||
106028294|NCT02270944|365769193|FG000|Overall Study|Lost to Follow-up|9|||
106028295|NCT02270944|365769194|FG001|Overall Study|Lost to Follow-up|4|||
106028296|NCT02270944|365769193|FG000|Overall Study|Withdrawal by Subject|2|||
106028297|NCT02270944|365769194|FG001|Overall Study|Withdrawal by Subject|1|||
106028298|NCT01978938|365769195|FG000|Overall Study|Lost to Follow-up|12|||
106028299|NCT01978938|365769196|FG001|Overall Study|Lost to Follow-up|6|||
106028300|NCT01978938|365769195|FG000|Overall Study|Withdrawal by Subject|8|||
106028301|NCT01978938|365769196|FG001|Overall Study|Withdrawal by Subject|4|||
106028302|NCT01978938|365769195|FG000|Overall Study|Adverse Event, non-fatal|2|||
106028303|NCT01978938|365769196|FG001|Overall Study|Adverse Event, non-fatal|1|||
106028304|NCT01978938|365769195|FG000|Overall Study|Participant noncompliance|1|||
106028305|NCT01978938|365769196|FG001|Overall Study|Participant noncompliance|1|||
106028306|NCT01978938|365769195|FG000|Overall Study|Did not meet inclusion criteria|0|||
106028307|NCT01978938|365769196|FG001|Overall Study|Did not meet inclusion criteria|1|||
106028308|NCT01978938|365769195|FG000|Overall Study|Previously scheduled procedure|0|||
106028309|NCT01978938|365769196|FG001|Overall Study|Previously scheduled procedure|1|||
106028310|NCT00095147|365769197|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
106028311|NCT00095147|365769198|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
106028312|NCT00095147|365769199|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
106028313|NCT00095147|365769200|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
106028314|NCT00095147|365769201|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
106028315|NCT00095147|365769197|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
106151094|NCT02723955|366215078|FG024|Expansion Phase|Death|0|||
106151095|NCT02723955|366215079|FG025|Expansion Phase|Death|0|||
106151096|NCT02723955|366215080|FG026|Expansion Phase|Death|0|||
106151097|NCT02723955|366215081|FG027|Expansion Phase|Death|0|||
105979427|NCT05160766|365586268|FG001|Overall Study|Physician Decision|0|||
105979428|NCT05160766|365586269|FG002|Overall Study|Physician Decision|0|||
105979429|NCT05160766|365586270|FG003|Overall Study|Physician Decision|1|||
105979430|NCT05160766|365586267|FG000|Overall Study|Protocol Violation|0|||
105979431|NCT05160766|365586268|FG001|Overall Study|Protocol Violation|0|||
105979432|NCT05160766|365586269|FG002|Overall Study|Protocol Violation|1|||
105979433|NCT05160766|365586270|FG003|Overall Study|Protocol Violation|0|||
105979434|NCT01266317|365586274|FG000|Overall Study|Withdrawal by Subject|2|||
105979435|NCT02753127|365586275|FG000|Overall Study|Lost to Follow-up|13|||
105979436|NCT02753127|365586276|FG001|Overall Study|Lost to Follow-up|11|||
106028316|NCT00095147|365769198|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
106028317|NCT00095147|365769199|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
106151098|NCT02723955|366215082|FG028|Expansion Phase|Death|0|||
106028318|NCT00095147|365769200|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
106151099|NCT02723955|366215083|FG029|Expansion Phase|Death|12|||
106028319|NCT00095147|365769201|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
106028320|NCT00095147|365769197|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
106151100|NCT02723955|366215084|FG030|Expansion Phase|Death|202|||
105979437|NCT02753127|365586275|FG000|Overall Study|Withdrawal by Subject|37|||
105979438|NCT02753127|365586276|FG001|Overall Study|Withdrawal by Subject|47|||
105979439|NCT02753127|365586275|FG000|Overall Study|Other|3|||
106028321|NCT00095147|365769198|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
106028322|NCT00095147|365769199|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
106151101|NCT02723955|366215085|FG031|Expansion Phase|Death|31|||
105979440|NCT02753127|365586276|FG001|Overall Study|Other|8|||
105979441|NCT02753127|365586275|FG000|Overall Study|Hospice|0|||
105979442|NCT02753127|365586276|FG001|Overall Study|Hospice|2|||
105979443|NCT02351349|365586279|FG000|Overall Study|Withdrawal by Subject|2|||
105979444|NCT02351349|365586280|FG001|Overall Study|Withdrawal by Subject|3|||
105979445|NCT06048367|365586281|FG000|Overall Study|Withdrawal by Subject|0|||
105979446|NCT06048367|365586282|FG001|Overall Study|Withdrawal by Subject|1|||
105979447|NCT06048367|365586283|FG002|Overall Study|Withdrawal by Subject|0|||
105979448|NCT06048367|365586284|FG003|Overall Study|Withdrawal by Subject|0|||
105979449|NCT06048367|365586285|FG004|Overall Study|Withdrawal by Subject|0|||
105979450|NCT06048367|365586281|FG000|Overall Study|Withdrawal by Subject|0|||
106028323|NCT00095147|365769200|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
106028324|NCT00095147|365769201|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
106028325|NCT00095147|365769197|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
105979451|NCT06048367|365586282|FG001|Overall Study|Withdrawal by Subject|0|||
105979452|NCT06048367|365586283|FG002|Overall Study|Withdrawal by Subject|1|||
105979453|NCT06048367|365586284|FG003|Overall Study|Withdrawal by Subject|0|||
105979454|NCT06048367|365586285|FG004|Overall Study|Withdrawal by Subject|0|||
105979455|NCT06048367|365586281|FG000|Overall Study|Withdrawal by Subject|0|||
105979456|NCT06048367|365586282|FG001|Overall Study|Withdrawal by Subject|0|||
105979457|NCT06048367|365586283|FG002|Overall Study|Withdrawal by Subject|0|||
105979458|NCT06048367|365586284|FG003|Overall Study|Withdrawal by Subject|1|||
105979459|NCT06048367|365586285|FG004|Overall Study|Withdrawal by Subject|0|||
105979460|NCT06048367|365586281|FG000|Overall Study|Withdrawal by Subject|0|||
105979461|NCT06048367|365586282|FG001|Overall Study|Withdrawal by Subject|0|||
105979462|NCT06048367|365586283|FG002|Overall Study|Withdrawal by Subject|0|||
105979463|NCT06048367|365586284|FG003|Overall Study|Withdrawal by Subject|1|||
105979464|NCT06048367|365586285|FG004|Overall Study|Withdrawal by Subject|0|||
105979465|NCT02936284|365586286|FG000|Overall Study|Withdrawal by Subject|3|||
105979466|NCT02936284|365586287|FG001|Overall Study|Withdrawal by Subject|1|||
105979467|NCT02936284|365586286|FG000|Overall Study|Lost to Follow-up|7|||
105979468|NCT02936284|365586287|FG001|Overall Study|Lost to Follow-up|8|||
105979469|NCT03681678|365586288|FG000|Overall Study|Lost to Follow-up|20|||
105979470|NCT04284813|365586289|FG000|Overall Study|Withdrawal by Subject|1|||
105979471|NCT02677844|365586290|FG000|Period 3|Withdrawal by Subject|0|||
105979472|NCT02677844|365586291|FG001|Period 3|Withdrawal by Subject|0|||
105979473|NCT02677844|365586292|FG002|Period 3|Withdrawal by Subject|0|||
105979474|NCT02677844|365586293|FG003|Period 3|Withdrawal by Subject|1|||
105979475|NCT02677844|365586294|FG004|Period 3|Withdrawal by Subject|0|||
105979476|NCT02677844|365586295|FG005|Period 3|Withdrawal by Subject|0|||
105979477|NCT02677844|365586296|FG006|Period 3|Withdrawal by Subject|0|||
105979478|NCT04094584|365586299|FG000|Overall Study|No interest in study|88|||
105979479|NCT04094584|365586299|FG000|Overall Study|Unwilling to undergo screening tests|36|||
105979480|NCT04094584|365586299|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
105979481|NCT04094584|365586299|FG000|Overall Study|Opioid use|7|||
105979482|NCT04094584|365586299|FG000|Overall Study|Need for major surgery in study period|4|||
105979483|NCT04094584|365586299|FG000|Overall Study|eligible but declined enrollment|4|||
105979484|NCT04094584|365586299|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
105979485|NCT04094584|365586299|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
105979486|NCT04094584|365586299|FG000|Overall Study|Lost to Follow-up|3|||
105979487|NCT04094584|365586299|FG000|Overall Study|Withdrawal by Subject|2|||
105979488|NCT00106691|365586300|FG000|Overall Study|Adverse Event|60|||
105979489|NCT00106691|365586301|FG001|Overall Study|Adverse Event|64|||
105979490|NCT00106691|365586300|FG000|Overall Study|Lost to Follow-up|23|||
105979491|NCT00106691|365586301|FG001|Overall Study|Lost to Follow-up|18|||
105979492|NCT00106691|365586300|FG000|Overall Study|Physician Decision|18|||
105979493|NCT00106691|365586301|FG001|Overall Study|Physician Decision|21|||
105979494|NCT00106691|365586300|FG000|Overall Study|Protocol Violation|13|||
106028326|NCT00095147|365769198|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
106028327|NCT00095147|365769199|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
106028328|NCT00095147|365769200|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
105979495|NCT00106691|365586301|FG001|Overall Study|Protocol Violation|18|||
105979496|NCT00106691|365586300|FG000|Overall Study|Withdrawal by Subject|75|||
106028329|NCT00095147|365769201|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
105979497|NCT00106691|365586301|FG001|Overall Study|Withdrawal by Subject|70|||
105979498|NCT00106691|365586300|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
105979499|NCT00106691|365586301|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
105979500|NCT00106691|365586300|FG000|Overall Study|QTc>480|3|||
105979501|NCT00106691|365586301|FG001|Overall Study|QTc>480|1|||
105979502|NCT00106691|365586300|FG000|Overall Study|mililtary deployment|2|||
105979503|NCT00106691|365586301|FG001|Overall Study|mililtary deployment|0|||
105979504|NCT00106691|365586300|FG000|Overall Study|Study Site Closing/PI Moved|1|||
105979505|NCT00106691|365586301|FG001|Overall Study|Study Site Closing/PI Moved|2|||
105979506|NCT00106691|365586300|FG000|Overall Study|Cardiologist recommendation|1|||
105979507|NCT00106691|365586301|FG001|Overall Study|Cardiologist recommendation|0|||
105979508|NCT00106691|365586300|FG000|Overall Study|Pt. moved to another state|1|||
105979509|NCT00106691|365586301|FG001|Overall Study|Pt. moved to another state|0|||
105979510|NCT00106691|365586300|FG000|Overall Study|Taking exclusionary avodart|1|||
105979511|NCT00106691|365586301|FG001|Overall Study|Taking exclusionary avodart|0|||
105979512|NCT00106691|365586300|FG000|Overall Study|Not able to discontinue plavix|0|||
105979513|NCT00106691|365586301|FG001|Overall Study|Not able to discontinue plavix|1|||
105979514|NCT00791557|365586302|FG000|Overall Study|Adverse Event|1|||
105979515|NCT04957758|365586303|FG000|Overall Study|Adverse Event|1|||
105979516|NCT04957758|365586304|FG001|Overall Study|Adverse Event|0|||
105979517|NCT04957758|365586303|FG000|Overall Study|Lost to Follow-up|0|||
105979518|NCT04957758|365586304|FG001|Overall Study|Lost to Follow-up|2|||
105979519|NCT04957758|365586303|FG000|Overall Study|Withdrawal by Subject|4|||
105979520|NCT04957758|365586304|FG001|Overall Study|Withdrawal by Subject|2|||
105979521|NCT04957758|365586303|FG000|Overall Study|Protocol Violation|0|||
105979522|NCT04957758|365586304|FG001|Overall Study|Protocol Violation|1|||
106028330|NCT00095147|365769197|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
106028331|NCT00095147|365769198|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
106028332|NCT00095147|365769199|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
106028333|NCT00095147|365769200|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
106028334|NCT00095147|365769201|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
106028335|NCT00095147|365769197|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
106028336|NCT00095147|365769198|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
106028337|NCT00095147|365769199|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
106028338|NCT00095147|365769200|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
106028339|NCT00095147|365769201|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
106028340|NCT00095147|365769197|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
106028341|NCT00095147|365769198|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
106028342|NCT00095147|365769199|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
106028343|NCT00095147|365769200|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
106028344|NCT00095147|365769201|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
106028345|NCT00095147|365769197|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
106028346|NCT00095147|365769198|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
106028347|NCT00095147|365769199|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
106028348|NCT00095147|365769200|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
106028349|NCT00095147|365769201|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
106028350|NCT00095147|365769197|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
106028351|NCT00095147|365769198|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
106028352|NCT00095147|365769199|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
106028353|NCT00095147|365769200|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
106028354|NCT00095147|365769201|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
106028355|NCT00095147|365769197|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
106028356|NCT00095147|365769198|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
106028357|NCT00095147|365769199|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
106028358|NCT00095147|365769200|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
106028359|NCT00095147|365769201|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
106028360|NCT00095147|365769197|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
106028361|NCT00095147|365769198|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
106028362|NCT00095147|365769199|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
106028363|NCT00095147|365769200|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
106028364|NCT00095147|365769201|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
106028365|NCT00095147|365769197|FG000|Long-term Extension Period|Death|0|||
106028366|NCT00095147|365769198|FG001|Long-term Extension Period|Death|0|||
106028367|NCT00095147|365769199|FG002|Long-term Extension Period|Death|0|||
106028368|NCT00095147|365769200|FG003|Long-term Extension Period|Death|0|||
106028369|NCT00095147|365769201|FG004|Long-term Extension Period|Death|3|||
106028370|NCT00095147|365769197|FG000|Long-term Extension Period|Adverse Event|0|||
106028371|NCT00095147|365769198|FG001|Long-term Extension Period|Adverse Event|0|||
106028372|NCT00095147|365769199|FG002|Long-term Extension Period|Adverse Event|0|||
106028373|NCT00095147|365769200|FG003|Long-term Extension Period|Adverse Event|0|||
106028374|NCT00095147|365769201|FG004|Long-term Extension Period|Adverse Event|11|||
106028375|NCT00095147|365769197|FG000|Long-term Extension Period|Lack of Efficacy|0|||
106028376|NCT00095147|365769198|FG001|Long-term Extension Period|Lack of Efficacy|0|||
106028377|NCT00095147|365769199|FG002|Long-term Extension Period|Lack of Efficacy|0|||
105851535|NCT01791153|365112737|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
105979523|NCT03344640|365586305|FG000|Overall Study|Adverse Event|1|||
105979524|NCT03344640|365586306|FG001|Overall Study|Adverse Event|0|||
105979525|NCT03344640|365586305|FG000|Overall Study|Physician Decision|1|||
105979526|NCT03344640|365586306|FG001|Overall Study|Physician Decision|1|||
105979527|NCT03344640|365586305|FG000|Overall Study|Withdrawal by Subject|1|||
105979528|NCT03344640|365586306|FG001|Overall Study|Withdrawal by Subject|2|||
105979529|NCT03344640|365586305|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
105979530|NCT03344640|365586306|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
105979531|NCT02573246|365586307|FG000|Overall Study|Lost to Follow-up|2|||
105979532|NCT02573246|365586308|FG001|Overall Study|Lost to Follow-up|0|||
105979533|NCT02573246|365586309|FG002|Overall Study|Lost to Follow-up|0|||
105979534|NCT02573246|365586310|FG003|Overall Study|Lost to Follow-up|0|||
105979535|NCT02573246|365586311|FG004|Overall Study|Lost to Follow-up|1|||
105979536|NCT02573246|365586307|FG000|Overall Study|Withdrawal by Subject|0|||
105979537|NCT02573246|365586308|FG001|Overall Study|Withdrawal by Subject|0|||
105979538|NCT02573246|365586309|FG002|Overall Study|Withdrawal by Subject|0|||
105979539|NCT02573246|365586310|FG003|Overall Study|Withdrawal by Subject|0|||
105979540|NCT02573246|365586311|FG004|Overall Study|Withdrawal by Subject|1|||
105979541|NCT02573246|365586307|FG000|Overall Study|Physician Decision|1|||
105979542|NCT02573246|365586308|FG001|Overall Study|Physician Decision|1|||
105979543|NCT02573246|365586309|FG002|Overall Study|Physician Decision|3|||
105979544|NCT02573246|365586310|FG003|Overall Study|Physician Decision|2|||
106028378|NCT00095147|365769200|FG003|Long-term Extension Period|Lack of Efficacy|0|||
106028379|NCT00095147|365769201|FG004|Long-term Extension Period|Lack of Efficacy|9|||
106028380|NCT00095147|365769197|FG000|Long-term Extension Period|Lost to Follow-up|0|||
106028381|NCT00095147|365769198|FG001|Long-term Extension Period|Lost to Follow-up|0|||
106028382|NCT00095147|365769199|FG002|Long-term Extension Period|Lost to Follow-up|0|||
106028383|NCT00095147|365769200|FG003|Long-term Extension Period|Lost to Follow-up|0|||
106028384|NCT00095147|365769201|FG004|Long-term Extension Period|Lost to Follow-up|6|||
106028385|NCT00095147|365769197|FG000|Long-term Extension Period|Withdrawal of consent|0|||
106028386|NCT00095147|365769198|FG001|Long-term Extension Period|Withdrawal of consent|0|||
106028387|NCT00095147|365769199|FG002|Long-term Extension Period|Withdrawal of consent|0|||
106028388|NCT00095147|365769200|FG003|Long-term Extension Period|Withdrawal of consent|0|||
106028389|NCT00095147|365769201|FG004|Long-term Extension Period|Withdrawal of consent|12|||
106028390|NCT00095147|365769197|FG000|Long-term Extension Period|Pregnancy|0|||
106028391|NCT00095147|365769198|FG001|Long-term Extension Period|Pregnancy|0|||
106028392|NCT00095147|365769199|FG002|Long-term Extension Period|Pregnancy|0|||
106028393|NCT00095147|365769200|FG003|Long-term Extension Period|Pregnancy|0|||
106028394|NCT00095147|365769201|FG004|Long-term Extension Period|Pregnancy|1|||
106028395|NCT00095147|365769197|FG000|Long-term Extension Period|No longer meets study criteria|0|||
106028396|NCT00095147|365769198|FG001|Long-term Extension Period|No longer meets study criteria|0|||
106028397|NCT00095147|365769199|FG002|Long-term Extension Period|No longer meets study criteria|0|||
106028398|NCT00095147|365769200|FG003|Long-term Extension Period|No longer meets study criteria|0|||
106028399|NCT00095147|365769201|FG004|Long-term Extension Period|No longer meets study criteria|1|||
106028400|NCT00095147|365769197|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
106028401|NCT00095147|365769198|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
106028402|NCT00095147|365769199|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
106028403|NCT00095147|365769200|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
106028404|NCT00095147|365769201|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
106028405|NCT00095147|365769197|FG000|Long-term Extension Period|Leaving country|0|||
106028406|NCT00095147|365769198|FG001|Long-term Extension Period|Leaving country|0|||
106028407|NCT00095147|365769199|FG002|Long-term Extension Period|Leaving country|0|||
106028408|NCT00095147|365769200|FG003|Long-term Extension Period|Leaving country|0|||
106028409|NCT00095147|365769201|FG004|Long-term Extension Period|Leaving country|1|||
106028410|NCT04268823|365769202|FG000|Overall Study|Adverse Event|1|||
106028411|NCT04268823|365769203|FG001|Overall Study|Adverse Event|0|||
106028412|NCT04268823|365769202|FG000|Overall Study|Participant Decision|1|||
106028413|NCT04268823|365769203|FG001|Overall Study|Participant Decision|0|||
106028414|NCT00952380|365769204|FG000|Overall Study|Other|0|||
106028415|NCT00952380|365769205|FG001|Overall Study|Other|0|||
106028416|NCT00952380|365769206|FG002|Overall Study|Other|0|||
106028417|NCT00952380|365769207|FG003|Overall Study|Other|0|||
106028418|NCT00952380|365769208|FG004|Overall Study|Other|1|||
106151102|NCT02723955|366215086|FG032|Expansion Phase|Death|17|||
106151103|NCT02723955|366215087|FG033|Expansion Phase|Death|2|||
105979545|NCT02573246|365586311|FG004|Overall Study|Physician Decision|2|||
105979546|NCT01902888|365586312|FG000|Overall Study|Study Terminated|3|||
105979547|NCT00316888|365586316|FG000|Overall Study|Adverse Event|4|||
105979548|NCT00316888|365586317|FG001|Overall Study|Adverse Event|5|||
105979549|NCT00316888|365586316|FG000|Overall Study|Withdrawal by Subject|2|||
105979550|NCT00316888|365586317|FG001|Overall Study|Withdrawal by Subject|2|||
105979551|NCT00316888|365586316|FG000|Overall Study|Not start protocol therapy|0|||
105979552|NCT00316888|365586317|FG001|Overall Study|Not start protocol therapy|1|||
105979553|NCT03149003|365586318|FG000|Overall Study|Randomized but not treated|0|||
105979554|NCT03149003|365586319|FG001|Overall Study|Randomized but not treated|1|||
106028419|NCT00952380|365769204|FG000|Overall Study|Withdrawal by Subject|0|||
106028420|NCT00952380|365769205|FG001|Overall Study|Withdrawal by Subject|0|||
106028421|NCT00952380|365769206|FG002|Overall Study|Withdrawal by Subject|1|||
106028422|NCT00952380|365769207|FG003|Overall Study|Withdrawal by Subject|0|||
106028423|NCT00952380|365769208|FG004|Overall Study|Withdrawal by Subject|2|||
106028424|NCT00952380|365769204|FG000|Overall Study|Adverse Event|0|||
106028425|NCT00952380|365769205|FG001|Overall Study|Adverse Event|1|||
106028426|NCT00952380|365769206|FG002|Overall Study|Adverse Event|0|||
106028427|NCT00952380|365769207|FG003|Overall Study|Adverse Event|0|||
106028428|NCT00952380|365769208|FG004|Overall Study|Adverse Event|3|||
106028429|NCT00952380|365769204|FG000|Overall Study|Physician Decision|0|||
106028430|NCT00952380|365769205|FG001|Overall Study|Physician Decision|0|||
106028431|NCT00952380|365769206|FG002|Overall Study|Physician Decision|1|||
106028432|NCT00952380|365769207|FG003|Overall Study|Physician Decision|2|||
106028433|NCT00952380|365769208|FG004|Overall Study|Physician Decision|0|||
106028434|NCT00952380|365769204|FG000|Overall Study|Non-compliant to protocol|0|||
106028435|NCT00952380|365769205|FG001|Overall Study|Non-compliant to protocol|0|||
106028436|NCT00952380|365769206|FG002|Overall Study|Non-compliant to protocol|0|||
106028437|NCT00952380|365769207|FG003|Overall Study|Non-compliant to protocol|1|||
106028438|NCT00952380|365769208|FG004|Overall Study|Non-compliant to protocol|0|||
106028439|NCT00160667|365769209|FG000|Overall Study|Adverse Event|3|||
106028440|NCT00160667|365769210|FG001|Overall Study|Adverse Event|1|||
106028441|NCT00160667|365769211|FG002|Overall Study|Adverse Event|4|||
106028442|NCT00160667|365769209|FG000|Overall Study|Withdrawal by Subject|2|||
106028443|NCT00160667|365769210|FG001|Overall Study|Withdrawal by Subject|0|||
106028444|NCT00160667|365769211|FG002|Overall Study|Withdrawal by Subject|1|||
106028445|NCT00160667|365769209|FG000|Overall Study|Lack of Efficacy|0|||
106028446|NCT00160667|365769210|FG001|Overall Study|Lack of Efficacy|1|||
106028447|NCT00160667|365769211|FG002|Overall Study|Lack of Efficacy|0|||
106028448|NCT00160667|365769209|FG000|Overall Study|Protocol Violation|0|||
106028449|NCT00160667|365769210|FG001|Overall Study|Protocol Violation|1|||
106028450|NCT00160667|365769211|FG002|Overall Study|Protocol Violation|0|||
106028451|NCT00160667|365769209|FG000|Overall Study|Patient decision|0|||
106028452|NCT00160667|365769210|FG001|Overall Study|Patient decision|0|||
106028453|NCT00160667|365769211|FG002|Overall Study|Patient decision|1|||
106028454|NCT02342418|365769214|FG000|Overall Study|Adverse Event|0|||
106028455|NCT02342418|365769215|FG001|Overall Study|Adverse Event|1|||
106028456|NCT04255394|365769216|FG000|Overall Study|Death|35|||
106028457|NCT04255394|365769217|FG001|Overall Study|Death|25|||
106028458|NCT04255394|365769216|FG000|Overall Study|Device removed|2|||
106028459|NCT04255394|365769217|FG001|Overall Study|Device removed|10|||
106028460|NCT04255394|365769216|FG000|Overall Study|Withdrawal by Subject|9|||
106028461|NCT04255394|365769217|FG001|Overall Study|Withdrawal by Subject|8|||
106028462|NCT04255394|365769216|FG000|Overall Study|Screen Failure/Not treated|12|||
106028463|NCT04255394|365769217|FG001|Overall Study|Screen Failure/Not treated|8|||
106028464|NCT04255394|365769216|FG000|Overall Study|Lost to Follow-up|123|||
106028465|NCT04255394|365769217|FG001|Overall Study|Lost to Follow-up|265|||
106028466|NCT04255394|365769216|FG000|Overall Study|Adverse Event|1|||
106028467|NCT04255394|365769217|FG001|Overall Study|Adverse Event|3|||
106028468|NCT01870076|365769228|FG000|Overall Study|Withdrawal by Subject|1|||
106028469|NCT01870076|365769229|FG001|Overall Study|Withdrawal by Subject|0|||
106028470|NCT01870076|365769230|FG002|Overall Study|Withdrawal by Subject|1|||
106028471|NCT01870076|365769231|FG003|Overall Study|Withdrawal by Subject|0|||
106028472|NCT00363545|365769233|FG000|Overall Study|Serious Adverse Event|0|||
106028473|NCT00363545|365769234|FG001|Overall Study|Serious Adverse Event|1|||
106028474|NCT00363545|365769233|FG000|Overall Study|Withdrawal by Subject|12|||
106028475|NCT00363545|365769234|FG001|Overall Study|Withdrawal by Subject|15|||
106028476|NCT00363545|365769233|FG000|Overall Study|Migrated/moved from study area|3|||
106028477|NCT00363545|365769234|FG001|Overall Study|Migrated/moved from study area|6|||
105851536|NCT01791153|365112738|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
105851537|NCT01791153|365112731|FG000|Part 2: Open-label Period|Physician Decision|0|||
105851538|NCT01791153|365112732|FG001|Part 2: Open-label Period|Physician Decision|0|||
105851539|NCT01791153|365112733|FG002|Part 2: Open-label Period|Physician Decision|0|||
105851540|NCT01791153|365112734|FG003|Part 2: Open-label Period|Physician Decision|0|||
105851541|NCT01791153|365112735|FG004|Part 2: Open-label Period|Physician Decision|1|||
105851542|NCT01791153|365112736|FG005|Part 2: Open-label Period|Physician Decision|1|||
105851543|NCT01791153|365112737|FG006|Part 2: Open-label Period|Physician Decision|0|||
105851544|NCT01791153|365112738|FG007|Part 2: Open-label Period|Physician Decision|0|||
105851545|NCT04135196|365112741|FG000|Overall Study|Lost to Follow-up|8|||
106028478|NCT00363545|365769233|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
105851546|NCT04135196|365112742|FG001|Overall Study|Lost to Follow-up|7|||
106028479|NCT00363545|365769234|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
106028480|NCT00363545|365769233|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
106028481|NCT00363545|365769234|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
106028482|NCT00363545|365769233|FG000|Overall Study|Others|1|||
106151104|NCT02723955|366215088|FG034|Expansion Phase|Death|3|||
106151105|NCT02723955|366215089|FG035|Expansion Phase|Death|3|||
105851547|NCT04135196|365112743|FG002|Overall Study|Lost to Follow-up|8|||
106028483|NCT00363545|365769234|FG001|Overall Study|Others|0|||
106028484|NCT00336856|365770731|FG000|Overall Study|Withdrawal by Subject|3|||
106028485|NCT00336856|365770731|FG000|Overall Study|Found ineligible at time of analysis|1|||
105979555|NCT03149003|365586320|FG002|Overall Study|Randomized but not treated|18|||
105979556|NCT02758301|365586322|FG000|Overall Study|Death|12|||
105979557|NCT02758301|365586323|FG001|Overall Study|Death|0|||
105979558|NCT02758301|365586322|FG000|Overall Study|Physician Decision|10|||
105979559|NCT02758301|365586323|FG001|Overall Study|Physician Decision|1|||
105979560|NCT02758301|365586322|FG000|Overall Study|Withdrawal by Subject|5|||
105979561|NCT02758301|365586323|FG001|Overall Study|Withdrawal by Subject|6|||
105979562|NCT02758301|365586322|FG000|Overall Study|Lost to Follow-up|7|||
105979563|NCT02758301|365586323|FG001|Overall Study|Lost to Follow-up|0|||
105979564|NCT02758301|365586322|FG000|Overall Study|Protocol Violation|0|||
105979565|NCT02758301|365586323|FG001|Overall Study|Protocol Violation|1|||
105979566|NCT05239221|365586324|FG000|Overall Study|Adverse Event|0|||
105979567|NCT05239221|365586325|FG001|Overall Study|Adverse Event|0|||
105979568|NCT05239221|365586326|FG002|Overall Study|Adverse Event|0|||
105979569|NCT05239221|365586327|FG003|Overall Study|Adverse Event|0|||
105979570|NCT05239221|365586328|FG004|Overall Study|Adverse Event|0|||
105979571|NCT05239221|365586329|FG005|Overall Study|Adverse Event|0|||
105979572|NCT05239221|365586330|FG006|Overall Study|Adverse Event|1|||
105979573|NCT05239221|365586331|FG007|Overall Study|Adverse Event|0|||
105979574|NCT05239221|365586332|FG008|Overall Study|Adverse Event|0|||
105979575|NCT05239221|365586333|FG009|Overall Study|Adverse Event|0|||
105979576|NCT05239221|365586334|FG010|Overall Study|Adverse Event|1|||
105979577|NCT05239221|365586335|FG011|Overall Study|Adverse Event|1|||
105979578|NCT05239221|365586336|FG012|Overall Study|Adverse Event|0|||
105979579|NCT05239221|365586337|FG013|Overall Study|Adverse Event|0|||
105979580|NCT05239221|365586338|FG014|Overall Study|Adverse Event|0|||
105979581|NCT05239221|365586339|FG015|Overall Study|Adverse Event|0|||
105979582|NCT05239221|365586324|FG000|Overall Study|Withdrawal by Subject|0|||
105979583|NCT05239221|365586325|FG001|Overall Study|Withdrawal by Subject|0|||
105979584|NCT05239221|365586326|FG002|Overall Study|Withdrawal by Subject|0|||
105979585|NCT05239221|365586327|FG003|Overall Study|Withdrawal by Subject|0|||
105979586|NCT05239221|365586328|FG004|Overall Study|Withdrawal by Subject|0|||
105979587|NCT05239221|365586329|FG005|Overall Study|Withdrawal by Subject|0|||
105979588|NCT05239221|365586330|FG006|Overall Study|Withdrawal by Subject|0|||
105979589|NCT05239221|365586331|FG007|Overall Study|Withdrawal by Subject|0|||
105979590|NCT05239221|365586332|FG008|Overall Study|Withdrawal by Subject|0|||
105979591|NCT05239221|365586333|FG009|Overall Study|Withdrawal by Subject|0|||
105979592|NCT05239221|365586334|FG010|Overall Study|Withdrawal by Subject|1|||
105979593|NCT05239221|365586335|FG011|Overall Study|Withdrawal by Subject|0|||
105979594|NCT05239221|365586336|FG012|Overall Study|Withdrawal by Subject|0|||
105979595|NCT05239221|365586337|FG013|Overall Study|Withdrawal by Subject|0|||
105979596|NCT05239221|365586338|FG014|Overall Study|Withdrawal by Subject|0|||
105979597|NCT05239221|365586339|FG015|Overall Study|Withdrawal by Subject|1|||
105979598|NCT00652899|365586340|FG000|Overall Study|Death|1|||
106028486|NCT03320824|365770732|FG000|Overall Study|Withdrawal by Subject|8|||
106028487|NCT03320824|365770733|FG001|Overall Study|Withdrawal by Subject|1|||
106028488|NCT03320824|365770732|FG000|Overall Study|Lost to Follow-up|10|||
106028489|NCT03320824|365770733|FG001|Overall Study|Lost to Follow-up|1|||
105979599|NCT00652899|365586340|FG000|Overall Study|Treating physician decision|1|||
105979600|NCT02900170|365586344|FG000|Overall Study|Lost to Follow-up|8|||
105979601|NCT01814670|365586345|FG000|Overall Study|Protocol Violation|12|||
105979602|NCT00780273|365586346|FG000|Overall Study|Death|1|||
105979603|NCT00780273|365586346|FG000|Overall Study|Lost to Follow-up|1|||
105979604|NCT03332160|365586347|FG000|Overall Study|Withdrawal by Subject|1|||
105979605|NCT03332160|365586348|FG001|Overall Study|Withdrawal by Subject|1|||
105979606|NCT03332160|365586347|FG000|Overall Study|Adverse Event|0|||
105979607|NCT03332160|365586348|FG001|Overall Study|Adverse Event|1|||
106028490|NCT03320824|365770732|FG000|Overall Study|moved out of state|0|||
105979608|NCT03332160|365586347|FG000|Overall Study|Developed Exclusion Criteria|0|||
105979609|NCT03332160|365586348|FG001|Overall Study|Developed Exclusion Criteria|1|||
105979610|NCT03332160|365586347|FG000|Overall Study|Non-adherence to treatment|0|||
105979611|NCT03332160|365586348|FG001|Overall Study|Non-adherence to treatment|2|||
106028491|NCT03320824|365770733|FG001|Overall Study|moved out of state|1|||
105979612|NCT01378429|365586350|FG000|Overall Study|Noncompliance with study drug|1|||
105979613|NCT01378429|365586351|FG001|Overall Study|Noncompliance with study drug|0|||
105979614|NCT02241187|365586354|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
105979615|NCT02356887|365586355|FG000|Overall Study|poor compliance|2|||
105979616|NCT01490294|365586356|FG000|Overall Study|Prematurely discontinuation|4|||
105979617|NCT01490294|365586357|FG001|Overall Study|Prematurely discontinuation|0|||
105979618|NCT01490294|365586358|FG002|Overall Study|Prematurely discontinuation|1|||
105979619|NCT01490294|365586359|FG003|Overall Study|Prematurely discontinuation|1|||
105979620|NCT01490294|365586356|FG000|Overall Study|Adverse Event|1|||
105979621|NCT01490294|365586357|FG001|Overall Study|Adverse Event|0|||
105979622|NCT01490294|365586358|FG002|Overall Study|Adverse Event|0|||
105979623|NCT01490294|365586359|FG003|Overall Study|Adverse Event|0|||
105979624|NCT00199888|365586362|FG000|Overall Study|Lost to Follow-up|1|||
105979625|NCT05219669|365586365|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
105979626|NCT05219669|365586366|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
105979627|NCT05219669|365586367|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
105979628|NCT05219669|365586368|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
105979629|NCT05219669|365586369|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
105979630|NCT05219669|365586370|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
105979631|NCT02544373|365586373|FG000|Overall Study|Lost to Follow-up|5|||
105979632|NCT02544373|365586374|FG001|Overall Study|Lost to Follow-up|3|||
105979633|NCT02544373|365586373|FG000|Overall Study|Withdrawal by Subject|8|||
105979634|NCT02544373|365586374|FG001|Overall Study|Withdrawal by Subject|2|||
105979635|NCT02404649|365586375|FG000|Overall Study|Adverse Event|1|||
106028492|NCT03320824|365770732|FG000|Overall Study|could not complete final visit|0|||
106028493|NCT03320824|365770733|FG001|Overall Study|could not complete final visit|1|||
106028494|NCT00955305|365770734|FG000|Overall Study|Disease progression|39|||
106028495|NCT00955305|365770735|FG001|Overall Study|Disease progression|41|||
106028496|NCT00955305|365770734|FG000|Overall Study|Adverse Event|22|||
106028497|NCT00955305|365770735|FG001|Overall Study|Adverse Event|22|||
106028498|NCT00955305|365770734|FG000|Overall Study|Death|2|||
106028499|NCT00955305|365770735|FG001|Overall Study|Death|1|||
106028500|NCT00955305|365770734|FG000|Overall Study|Withdrawal by Subject|5|||
106028501|NCT00955305|365770735|FG001|Overall Study|Withdrawal by Subject|4|||
106028502|NCT00955305|365770734|FG000|Overall Study|Alternative therapy|4|||
106028503|NCT00955305|365770735|FG001|Overall Study|Alternative therapy|0|||
106028504|NCT00955305|365770734|FG000|Overall Study|Other complicating disease|2|||
106028505|NCT00955305|365770735|FG001|Overall Study|Other complicating disease|4|||
106028506|NCT00955305|365770734|FG000|Overall Study|Physician Decision|1|||
106028507|NCT00955305|365770735|FG001|Overall Study|Physician Decision|0|||
106028508|NCT00955305|365770734|FG000|Overall Study|Continued presence of residual disease|0|||
106028509|NCT00955305|365770735|FG001|Overall Study|Continued presence of residual disease|1|||
106028510|NCT00955305|365770734|FG000|Overall Study|Functional decline|2|||
106028511|NCT00955305|365770735|FG001|Overall Study|Functional decline|0|||
106028512|NCT00955305|365770734|FG000|Overall Study|Maximum response achieved|0|||
106028513|NCT00955305|365770735|FG001|Overall Study|Maximum response achieved|1|||
106028514|NCT00955305|365770734|FG000|Overall Study|Lost to Follow-up|0|||
106028515|NCT00955305|365770735|FG001|Overall Study|Lost to Follow-up|1|||
106028516|NCT00955305|365770734|FG000|Overall Study|No off-treatment reason submitted|1|||
106028517|NCT00955305|365770735|FG001|Overall Study|No off-treatment reason submitted|0|||
106028518|NCT00955305|365770734|FG000|Overall Study|Never started protocol treatment|5|||
106028519|NCT00955305|365770735|FG001|Overall Study|Never started protocol treatment|5|||
106028520|NCT00955305|365770734|FG000|Overall Study|Ineligible|5|||
106028521|NCT00955305|365770735|FG001|Overall Study|Ineligible|7|||
106028522|NCT03472547|365770736|FG000|Overall Study|Withdrawal by Subject|30|||
106028523|NCT00369629|365770741|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
106028524|NCT00369629|365770742|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
106028525|NCT00369629|365770743|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
106028526|NCT00369629|365770744|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
106028527|NCT00369629|365770741|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
106028528|NCT00369629|365770742|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
106028529|NCT00369629|365770743|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
106028530|NCT00369629|365770744|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
106028531|NCT00369629|365770741|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
106028532|NCT00369629|365770742|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
105979636|NCT02404649|365586376|FG001|Overall Study|Adverse Event|2|||
105979637|NCT02299076|365586380|FG000|Overall Study|Fraudulent Entries|20|||
105979638|NCT02299076|365586381|FG001|Overall Study|Fraudulent Entries|14|||
105979639|NCT00330668|365586382|FG000|BID Dosing Period|Adverse Event|1|||
105979640|NCT00330668|365586382|FG000|BID Dosing Period|Lost to Follow-up|7|||
105979641|NCT00330668|365586382|FG000|BID Dosing Period|Non-Compliance|5|||
105979642|NCT00330668|365586382|FG000|BID Dosing Period|Withdrawal by Subject|19|||
105979643|NCT00330668|365586382|FG000|BID Dosing Period|Sponsor's decision|1|||
105979644|NCT00330668|365586382|FG000|BID Dosing Period|Other|3|||
105979645|NCT00330668|365586382|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
105979646|NCT00330668|365586382|FG000|QD Dosing Period|Other|1|||
105979647|NCT00330668|365586382|FG000|QD Dosing Period|Withdrawal by Subject|1|||
105979648|NCT00330668|365586382|FG000|QD Dosing Period|Lost to Follow-up|2|||
105979649|NCT01595581|365586385|FG000|Overall Study|Withdrawal by Subject|1|||
105979650|NCT01595581|365586386|FG001|Overall Study|Withdrawal by Subject|0|||
105979651|NCT03474081|365586392|FG000|Overall Study|Adverse Event|6|||
105979652|NCT03474081|365586393|FG001|Overall Study|Adverse Event|3|||
105979653|NCT03474081|365586392|FG000|Overall Study|Lost to Follow-up|2|||
105979654|NCT03474081|365586393|FG001|Overall Study|Lost to Follow-up|1|||
105979655|NCT03474081|365586392|FG000|Overall Study|Physician Decision|3|||
105979656|NCT03474081|365586393|FG001|Overall Study|Physician Decision|2|||
105979657|NCT03474081|365586392|FG000|Overall Study|Withdrawal by Subject|5|||
105979658|NCT03474081|365586393|FG001|Overall Study|Withdrawal by Subject|7|||
105979659|NCT03474081|365586392|FG000|Overall Study|Investigator site closed|1|||
105979660|NCT03474081|365586393|FG001|Overall Study|Investigator site closed|0|||
105979661|NCT02198235|365586396|FG000|Overall Study|Lost to Follow-up|3|||
105979662|NCT02198235|365586397|FG001|Overall Study|Lost to Follow-up|2|||
105979663|NCT02198235|365586398|FG002|Overall Study|Lost to Follow-up|2|||
105979664|NCT00447122|365586402|FG000|Overall Study|worsening medical condition -came off|0|||
105979665|NCT00447122|365586403|FG001|Overall Study|worsening medical condition -came off|1|||
105979666|NCT00447122|365586404|FG002|Overall Study|worsening medical condition -came off|0|||
105979667|NCT00447122|365586405|FG003|Overall Study|worsening medical condition -came off|0|||
105979668|NCT02440789|365586406|FG000|Overall Study|Withdrawal by Subject|3|||
105979669|NCT02440789|365586406|FG000|Overall Study|Not willing to adhere to reqs|1|||
105979670|NCT04573881|365586407|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
105979671|NCT02564978|365586412|FG000|Overall Study|Adverse Event|8|||
105979672|NCT02564978|365586412|FG000|Overall Study|Death|1|||
105979673|NCT02564978|365586412|FG000|Overall Study|Lost to Follow-up|1|||
105979674|NCT02564978|365586412|FG000|Overall Study|Withdrawal by Subject|15|||
105979675|NCT02564978|365586412|FG000|Overall Study|Early Study Closure|2|||
105979676|NCT02564978|365586412|FG000|Overall Study|Other Reason|5|||
105979677|NCT03684694|365586413|FG000|Phase 1|Withdrawal by Subject|1|||
105979678|NCT03684694|365586414|FG001|Phase 1|Withdrawal by Subject|0|||
105979679|NCT03684694|365586415|FG002|Phase 1|Withdrawal by Subject|0|||
105979680|NCT03684694|365586416|FG003|Phase 1|Withdrawal by Subject|0|||
105979681|NCT03684694|365586417|FG004|Phase 1|Withdrawal by Subject|0|||
105979682|NCT03684694|365586418|FG005|Phase 1|Withdrawal by Subject|0|||
105979683|NCT03684694|365586413|FG000|Phase 1|Investigator/Sponsor Decision|12|||
105979684|NCT03684694|365586414|FG001|Phase 1|Investigator/Sponsor Decision|2|||
105979685|NCT03684694|365586415|FG002|Phase 1|Investigator/Sponsor Decision|1|||
105979686|NCT03684694|365586416|FG003|Phase 1|Investigator/Sponsor Decision|0|||
105979687|NCT03684694|365586417|FG004|Phase 1|Investigator/Sponsor Decision|0|||
105979688|NCT03684694|365586418|FG005|Phase 1|Investigator/Sponsor Decision|0|||
105979689|NCT03684694|365586413|FG000|Phase 1|Death|24|||
105979690|NCT03684694|365586414|FG001|Phase 1|Death|0|||
105979691|NCT03684694|365586415|FG002|Phase 1|Death|3|||
105979692|NCT03684694|365586416|FG003|Phase 1|Death|0|||
105979693|NCT03684694|365586417|FG004|Phase 1|Death|0|||
105979694|NCT03684694|365586418|FG005|Phase 1|Death|0|||
105979695|NCT03684694|365586413|FG000|Phase 1|Lost to Follow-up|0|||
105979696|NCT03684694|365586414|FG001|Phase 1|Lost to Follow-up|0|||
105979697|NCT03684694|365586415|FG002|Phase 1|Lost to Follow-up|1|||
105979698|NCT03684694|365586416|FG003|Phase 1|Lost to Follow-up|0|||
106028533|NCT00369629|365770743|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
106151106|NCT02723955|366215090|FG036|Expansion Phase|Death|1|||
106151107|NCT02723955|366215091|FG037|Expansion Phase|Death|0|||
105979699|NCT03684694|365586417|FG004|Phase 1|Lost to Follow-up|0|||
105979700|NCT03684694|365586418|FG005|Phase 1|Lost to Follow-up|0|||
105979701|NCT03684694|365586413|FG000|Phase 1|Miscellaneous|0|||
105979702|NCT03684694|365586414|FG001|Phase 1|Miscellaneous|1|||
105979703|NCT03684694|365586415|FG002|Phase 1|Miscellaneous|0|||
105979704|NCT03684694|365586416|FG003|Phase 1|Miscellaneous|0|||
105979705|NCT03684694|365586417|FG004|Phase 1|Miscellaneous|0|||
105979706|NCT03684694|365586418|FG005|Phase 1|Miscellaneous|0|||
105979707|NCT03684694|365586413|FG000|Phase 2|Withdrawal by Subject|0|||
105979708|NCT03684694|365586414|FG001|Phase 2|Withdrawal by Subject|0|||
105979709|NCT03684694|365586415|FG002|Phase 2|Withdrawal by Subject|0|||
105979710|NCT03684694|365586416|FG003|Phase 2|Withdrawal by Subject|0|||
105979711|NCT03684694|365586417|FG004|Phase 2|Withdrawal by Subject|0|||
105979712|NCT03684694|365586418|FG005|Phase 2|Withdrawal by Subject|1|||
105979713|NCT03684694|365586413|FG000|Phase 2|Investigator/Sponsor Decision|0|||
105979714|NCT03684694|365586414|FG001|Phase 2|Investigator/Sponsor Decision|0|||
105979715|NCT03684694|365586415|FG002|Phase 2|Investigator/Sponsor Decision|0|||
105979716|NCT03684694|365586416|FG003|Phase 2|Investigator/Sponsor Decision|17|||
105979717|NCT03684694|365586417|FG004|Phase 2|Investigator/Sponsor Decision|16|||
105979718|NCT03684694|365586418|FG005|Phase 2|Investigator/Sponsor Decision|6|||
105979719|NCT03684694|365586413|FG000|Phase 2|Death|0|||
105979720|NCT03684694|365586414|FG001|Phase 2|Death|0|||
105979721|NCT03684694|365586415|FG002|Phase 2|Death|0|||
105979722|NCT03684694|365586416|FG003|Phase 2|Death|28|||
105979723|NCT03684694|365586417|FG004|Phase 2|Death|14|||
105979724|NCT03684694|365586418|FG005|Phase 2|Death|3|||
105979725|NCT03684694|365586413|FG000|Phase 2|Lost to Follow-up|0|||
105979726|NCT03684694|365586414|FG001|Phase 2|Lost to Follow-up|0|||
105979727|NCT03684694|365586415|FG002|Phase 2|Lost to Follow-up|0|||
105979728|NCT03684694|365586416|FG003|Phase 2|Lost to Follow-up|1|||
105979729|NCT03684694|365586417|FG004|Phase 2|Lost to Follow-up|0|||
105979730|NCT03684694|365586418|FG005|Phase 2|Lost to Follow-up|0|||
105979731|NCT03684694|365586413|FG000|Phase 2|Miscellaneous|0|||
105979732|NCT03684694|365586414|FG001|Phase 2|Miscellaneous|0|||
105979733|NCT03684694|365586415|FG002|Phase 2|Miscellaneous|0|||
105979734|NCT03684694|365586416|FG003|Phase 2|Miscellaneous|3|||
105979735|NCT03684694|365586417|FG004|Phase 2|Miscellaneous|0|||
105979736|NCT03684694|365586418|FG005|Phase 2|Miscellaneous|0|||
105979737|NCT03172130|365587486|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
105979738|NCT03172130|365587487|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
105979739|NCT01825941|365587488|FG000|Overall Study|Lost to Follow-up|4|||
105979740|NCT01825941|365587489|FG001|Overall Study|Lost to Follow-up|1|||
105979741|NCT05065190|365587490|FG000|Overall Study|Other than listed|2|||
105979742|NCT05065190|365587491|FG001|Overall Study|Other than listed|12|||
105979743|NCT05065190|365587490|FG000|Overall Study|Lack of Efficacy|4|||
105979744|NCT05065190|365587491|FG001|Overall Study|Lack of Efficacy|0|||
105979745|NCT05065190|365587490|FG000|Overall Study|Adverse Event|1|||
105979746|NCT05065190|365587491|FG001|Overall Study|Adverse Event|10|||
105979747|NCT01806064|365587496|FG000|Overall Study|Randomized Not Enrolled|0|||
105979748|NCT01806064|365587497|FG001|Overall Study|Randomized Not Enrolled|0|||
105979749|NCT01806064|365587498|FG002|Overall Study|Randomized Not Enrolled|0|||
105979750|NCT01806064|365587499|FG003|Overall Study|Randomized Not Enrolled|1|||
105979751|NCT01806064|365587500|FG004|Overall Study|Randomized Not Enrolled|2|||
105979752|NCT00004445|365587503|FG000|Overall Study|Physician Decision|2|||
105979753|NCT00004445|365587503|FG000|Overall Study|Withdrawal by Subject|1|||
105979754|NCT03826342|365587504|FG000|Overall Study|Withdrawal by Subject|8|||
105979755|NCT03826342|365587505|FG001|Overall Study|Withdrawal by Subject|1|||
105979756|NCT03826342|365587504|FG000|Overall Study|Lost to Follow-up|7|||
105979757|NCT03826342|365587505|FG001|Overall Study|Lost to Follow-up|7|||
105979758|NCT03826342|365587504|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
105979759|NCT03826342|365587505|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
105979760|NCT00940485|365587511|FG000|Overall Study|HBeAb positive at Baseline|3|||
105979761|NCT00940485|365587512|FG001|Overall Study|HBeAb positive at Baseline|2|||
105979762|NCT00940485|365587511|FG000|Overall Study|Lost to Follow-up|2|||
105979763|NCT00940485|365587512|FG001|Overall Study|Lost to Follow-up|3|||
105979764|NCT00940485|365587511|FG000|Overall Study|Adverse Event|8|||
105979765|NCT00940485|365587512|FG001|Overall Study|Adverse Event|0|||
105979766|NCT00940485|365587511|FG000|Overall Study|Withdrawal by Subject|1|||
105979767|NCT00940485|365587512|FG001|Overall Study|Withdrawal by Subject|1|||
105979768|NCT00940485|365587511|FG000|Overall Study|Others|1|||
105979769|NCT00940485|365587512|FG001|Overall Study|Others|1|||
105979770|NCT04271475|365587515|FG000|DB Period: Day 1 up to EODBT|Death|1|||
105979771|NCT04271475|365587516|FG001|DB Period: Day 1 up to EODBT|Death|0|||
105979772|NCT04271475|365587517|FG002|DB Period: Day 1 up to EODBT|Death|0|||
105979773|NCT04271475|365587518|FG003|DB Period: Day 1 up to EODBT|Death|0|||
105979774|NCT04271475|365587515|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
105979775|NCT04271475|365587516|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
105979776|NCT04271475|365587517|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
105979777|NCT04271475|365587518|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
105979778|NCT04271475|365587515|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
105979779|NCT04271475|365587516|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
105979780|NCT04271475|365587517|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
105979781|NCT04271475|365587518|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
105979782|NCT04271475|365587515|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
106028534|NCT00369629|365770744|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
106028535|NCT00369629|365770741|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
105979783|NCT04271475|365587516|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
105979784|NCT04271475|365587517|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
105979785|NCT04271475|365587518|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
105979786|NCT04271475|365587515|FG000|DB Period: Day 1 up to EODBT|Other|8|||
105979787|NCT04271475|365587516|FG001|DB Period: Day 1 up to EODBT|Other|5|||
105979788|NCT04271475|365587517|FG002|DB Period: Day 1 up to EODBT|Other|0|||
105979789|NCT04271475|365587518|FG003|DB Period: Day 1 up to EODBT|Other|0|||
105979790|NCT04271475|365587515|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
105979791|NCT04271475|365587516|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
105979792|NCT04271475|365587517|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
105979793|NCT04271475|365587518|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
105979794|NCT04271475|365587515|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
105979795|NCT04271475|365587516|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
105979796|NCT04271475|365587517|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
105979797|NCT04271475|365587518|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
105979798|NCT06250738|365587519|FG000|Overall Study|Lost to Follow-up|1|||
105979799|NCT01610596|365587525|FG000|Overall Study|Lost to Follow-up|0|||
105979800|NCT01610596|365587526|FG001|Overall Study|Lost to Follow-up|1|||
105979801|NCT02046070|365587527|FG000|Overall Study|Progressive Disease|18|||
105979802|NCT02046070|365587528|FG001|Overall Study|Progressive Disease|11|||
105979803|NCT02046070|365587529|FG002|Overall Study|Progressive Disease|40|||
105979804|NCT02046070|365587527|FG000|Overall Study|Adverse Event|8|||
105979805|NCT02046070|365587528|FG001|Overall Study|Adverse Event|10|||
105979806|NCT02046070|365587529|FG002|Overall Study|Adverse Event|17|||
105979807|NCT02046070|365587527|FG000|Overall Study|Withdrawal by Subject|1|||
105979808|NCT02046070|365587528|FG001|Overall Study|Withdrawal by Subject|2|||
105979809|NCT02046070|365587529|FG002|Overall Study|Withdrawal by Subject|6|||
105979810|NCT02046070|365587527|FG000|Overall Study|Study Terminated by Sponsor|1|||
105979811|NCT02046070|365587528|FG001|Overall Study|Study Terminated by Sponsor|1|||
105979812|NCT02046070|365587529|FG002|Overall Study|Study Terminated by Sponsor|1|||
105979813|NCT02046070|365587527|FG000|Overall Study|Reason not Specified|4|||
105979814|NCT02046070|365587528|FG001|Overall Study|Reason not Specified|4|||
105979815|NCT02046070|365587529|FG002|Overall Study|Reason not Specified|6|||
106151108|NCT02723955|366215092|FG038|Expansion Phase|Death|0|||
105979816|NCT01519674|365587530|FG000|Overall Study|Adverse Event|3|||
106151109|NCT02723955|366215093|FG039|Expansion Phase|Death|0|||
106151110|NCT02723955|366215094|FG040|Expansion Phase|Death|0|||
106151111|NCT02723955|366215095|FG041|Expansion Phase|Death|0|||
106151112|NCT02723955|366215096|FG042|Expansion Phase|Death|0|||
106151113|NCT02723955|366215054|FG000|Expansion Phase|Lost to Follow-up|0|||
106151114|NCT02723955|366215055|FG001|Expansion Phase|Lost to Follow-up|0|||
106151115|NCT02723955|366215056|FG002|Expansion Phase|Lost to Follow-up|0|||
106151116|NCT02723955|366215057|FG003|Expansion Phase|Lost to Follow-up|0|||
106151117|NCT02723955|366215058|FG004|Expansion Phase|Lost to Follow-up|0|||
106151118|NCT02723955|366215059|FG005|Expansion Phase|Lost to Follow-up|0|||
106151119|NCT02723955|366215060|FG006|Expansion Phase|Lost to Follow-up|0|||
106151120|NCT02723955|366215061|FG007|Expansion Phase|Lost to Follow-up|0|||
106151121|NCT02723955|366215062|FG008|Expansion Phase|Lost to Follow-up|0|||
105979817|NCT01519674|365587531|FG001|Overall Study|Adverse Event|3|||
105979818|NCT01519674|365587532|FG002|Overall Study|Adverse Event|0|||
105979819|NCT01519674|365587530|FG000|Overall Study|Lack of Efficacy|1|||
106151122|NCT02723955|366215063|FG009|Expansion Phase|Lost to Follow-up|0|||
106151123|NCT02723955|366215064|FG010|Expansion Phase|Lost to Follow-up|4|||
106151124|NCT02723955|366215065|FG011|Expansion Phase|Lost to Follow-up|1|||
105851548|NCT04135196|365112744|FG003|Overall Study|Lost to Follow-up|9|||
105979820|NCT01519674|365587531|FG001|Overall Study|Lack of Efficacy|1|||
105979821|NCT01519674|365587532|FG002|Overall Study|Lack of Efficacy|1|||
105979822|NCT01519674|365587530|FG000|Overall Study|Protocol Violation|0|||
105979823|NCT01519674|365587531|FG001|Overall Study|Protocol Violation|3|||
105979824|NCT01519674|365587532|FG002|Overall Study|Protocol Violation|1|||
105979825|NCT01519674|365587530|FG000|Overall Study|Withdrawal Criteria|7|||
105979826|NCT01519674|365587531|FG001|Overall Study|Withdrawal Criteria|2|||
105979827|NCT01519674|365587532|FG002|Overall Study|Withdrawal Criteria|7|||
105979828|NCT01519674|365587530|FG000|Overall Study|Unsclassified|10|||
105979829|NCT01519674|365587531|FG001|Overall Study|Unsclassified|4|||
105979830|NCT01519674|365587532|FG002|Overall Study|Unsclassified|3|||
105979831|NCT05288166|365587535|FG000|Overall Study|Adverse Event|1|||
105979832|NCT05288166|365587536|FG001|Overall Study|Adverse Event|0|||
105979833|NCT05288166|365587535|FG000|Overall Study|Lost to Follow-up|2|||
105979834|NCT05288166|365587536|FG001|Overall Study|Lost to Follow-up|0|||
105979835|NCT05288166|365587535|FG000|Overall Study|Physician Decision|0|||
105979836|NCT05288166|365587536|FG001|Overall Study|Physician Decision|2|||
105979837|NCT05288166|365587535|FG000|Overall Study|Screen Failure|1|||
105979838|NCT05288166|365587536|FG001|Overall Study|Screen Failure|1|||
105979839|NCT05288166|365587535|FG000|Overall Study|Withdrawal by Subject|4|||
105979840|NCT05288166|365587536|FG001|Overall Study|Withdrawal by Subject|2|||
105979841|NCT05288166|365587535|FG000|Overall Study|On Study Treatment|408|||
105979842|NCT05288166|365587536|FG001|Overall Study|On Study Treatment|418|||
106151125|NCT02723955|366215066|FG012|Expansion Phase|Lost to Follow-up|0|||
105979843|NCT01565941|365587537|FG000|Overall Study|Withdrawn by parent/guardian|3|||
105979844|NCT01565941|365587538|FG001|Overall Study|Withdrawn by parent/guardian|2|||
105979845|NCT01565941|365587537|FG000|Overall Study|Randomized; did not receive intevention|8|||
105979846|NCT01565941|365587538|FG001|Overall Study|Randomized; did not receive intevention|2|||
105979847|NCT04047420|365587539|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
105979848|NCT04047420|365587539|FG000|Washout Period|Refused Participation|2|||
105979849|NCT01439126|365587543|FG000|Overall Study|Adverse Event|2|||
105979850|NCT01439126|365587544|FG001|Overall Study|Adverse Event|0|||
106151126|NCT02723955|366215067|FG013|Expansion Phase|Lost to Follow-up|0|||
105979851|NCT01439126|365587543|FG000|Overall Study|Withdrawal by Subject|5|||
105979852|NCT01439126|365587544|FG001|Overall Study|Withdrawal by Subject|21|||
105979853|NCT01439126|365587543|FG000|Overall Study|Protocol Violation|6|||
105979854|NCT01439126|365587544|FG001|Overall Study|Protocol Violation|4|||
105979855|NCT01439126|365587543|FG000|Overall Study|Lost to Follow-up|6|||
105979856|NCT01439126|365587544|FG001|Overall Study|Lost to Follow-up|3|||
105979857|NCT01439126|365587543|FG000|Overall Study|Other-Use of prohibited treatment|0|||
105979858|NCT01439126|365587544|FG001|Overall Study|Other-Use of prohibited treatment|2|||
106028536|NCT00369629|365770742|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
106028537|NCT00369629|365770743|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
106028538|NCT00369629|365770744|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
106028539|NCT00369629|365770741|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
106028540|NCT00369629|365770742|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
106028541|NCT00369629|365770743|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
106028542|NCT00369629|365770744|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
106028543|NCT00369629|365770741|FG000|Completed 4 More Cycles|Progressive disease|2|||
106028544|NCT00369629|365770742|FG001|Completed 4 More Cycles|Progressive disease|1|||
106028545|NCT00369629|365770743|FG002|Completed 4 More Cycles|Progressive disease|2|||
106028546|NCT00369629|365770744|FG003|Completed 4 More Cycles|Progressive disease|0|||
106028547|NCT00369629|365770741|FG000|Follow up for 1 Year|Death|2|||
106028548|NCT00369629|365770742|FG001|Follow up for 1 Year|Death|1|||
106028549|NCT00369629|365770743|FG002|Follow up for 1 Year|Death|1|||
106028550|NCT00369629|365770744|FG003|Follow up for 1 Year|Death|0|||
106028551|NCT00369629|365770741|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
106028552|NCT00369629|365770742|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
106028553|NCT00369629|365770743|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
106028554|NCT00369629|365770744|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
106028555|NCT00369629|365770741|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
106028556|NCT00369629|365770742|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
106028557|NCT00369629|365770743|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
106028558|NCT00369629|365770744|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
106028559|NCT01129583|365770745|FG000|Overall Study|Death|1|||
106028560|NCT01129583|365770746|FG001|Overall Study|Death|0|||
106028561|NCT01129583|365770745|FG000|Overall Study|Lost to Follow-up|1|||
106028562|NCT01129583|365770746|FG001|Overall Study|Lost to Follow-up|1|||
106028563|NCT01129583|365770745|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
106028564|NCT01129583|365770746|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
106028565|NCT01904773|365770750|FG000|Screen|Screen failure|3|||
106028566|NCT01904773|365770751|FG001|Screen|Screen failure|0|||
106028567|NCT01904773|365770752|FG002|Screen|Screen failure|0|||
106028568|NCT01904773|365770753|FG003|Screen|Screen failure|0|||
106028569|NCT01904773|365770754|FG004|Screen|Screen failure|0|||
106028570|NCT01904773|365770755|FG005|Screen|Screen failure|0|||
106028571|NCT01904773|365770756|FG006|Screen|Screen failure|0|||
106028572|NCT01904773|365770757|FG007|Screen|Screen failure|0|||
106028573|NCT01904773|365770758|FG008|Screen|Screen failure|0|||
106028574|NCT01904773|365770750|FG000|Screen|Withdrawal by Subject|1|||
106028575|NCT01904773|365770751|FG001|Screen|Withdrawal by Subject|0|||
106028576|NCT01904773|365770752|FG002|Screen|Withdrawal by Subject|0|||
106028577|NCT01904773|365770753|FG003|Screen|Withdrawal by Subject|0|||
106028578|NCT01904773|365770754|FG004|Screen|Withdrawal by Subject|0|||
106028579|NCT01904773|365770755|FG005|Screen|Withdrawal by Subject|0|||
106028580|NCT01904773|365770756|FG006|Screen|Withdrawal by Subject|0|||
106028581|NCT01904773|365770757|FG007|Screen|Withdrawal by Subject|0|||
106028582|NCT01904773|365770758|FG008|Screen|Withdrawal by Subject|0|||
106028583|NCT01904773|365770750|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
106028584|NCT01904773|365770751|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
106028585|NCT01904773|365770752|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
106028586|NCT01904773|365770753|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
106028587|NCT01904773|365770754|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
106028588|NCT01904773|365770755|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
106028589|NCT01904773|365770756|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
106028590|NCT01904773|365770757|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
106151127|NCT02723955|366215068|FG014|Expansion Phase|Lost to Follow-up|0|||
106151128|NCT02723955|366215069|FG015|Expansion Phase|Lost to Follow-up|0|||
106151129|NCT02723955|366215070|FG016|Expansion Phase|Lost to Follow-up|0|||
106151130|NCT02723955|366215071|FG017|Expansion Phase|Lost to Follow-up|0|||
106151131|NCT02723955|366215072|FG018|Expansion Phase|Lost to Follow-up|0|||
106151132|NCT02723955|366215073|FG019|Expansion Phase|Lost to Follow-up|0|||
105979859|NCT01439126|365587543|FG000|Overall Study|Other-Miscellaneous|12|||
106028591|NCT01904773|365770758|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
106028592|NCT01904773|365770750|FG000|First Intervention|Adverse Event|0|||
106028593|NCT01904773|365770751|FG001|First Intervention|Adverse Event|0|||
106028594|NCT01904773|365770752|FG002|First Intervention|Adverse Event|0|||
106151133|NCT02723955|366215074|FG020|Expansion Phase|Lost to Follow-up|0|||
105979860|NCT01439126|365587544|FG001|Overall Study|Other-Miscellaneous|12|||
105979861|NCT03262116|365587546|FG000|Overall Study|Physician Decision|0|||
105979862|NCT03262116|365587547|FG001|Overall Study|Physician Decision|2|||
105979863|NCT03262116|365587548|FG002|Overall Study|Physician Decision|1|||
105979864|NCT03262116|365587549|FG003|Overall Study|Physician Decision|1|||
105979865|NCT03262116|365587550|FG004|Overall Study|Physician Decision|1|||
105979866|NCT03262116|365587551|FG005|Overall Study|Physician Decision|2|||
105979867|NCT02608450|365587552|FG000|Overall Study|Lost to Follow-up|39|||
105979868|NCT02608450|365587553|FG001|Overall Study|Lost to Follow-up|32|||
105979869|NCT02608450|365587552|FG000|Overall Study|Withdrawal by Subject|21|||
105979870|NCT02608450|365587553|FG001|Overall Study|Withdrawal by Subject|15|||
105979871|NCT02608450|365587552|FG000|Overall Study|Adverse Event|3|||
105979872|NCT02608450|365587553|FG001|Overall Study|Adverse Event|6|||
105979873|NCT02608450|365587552|FG000|Overall Study|Withdrawal by parent|2|||
105979874|NCT02608450|365587553|FG001|Overall Study|Withdrawal by parent|3|||
105979875|NCT02608450|365587552|FG000|Overall Study|Lack of Efficacy|0|||
105979876|NCT02608450|365587553|FG001|Overall Study|Lack of Efficacy|3|||
105979877|NCT02608450|365587552|FG000|Overall Study|Noncompliance with study drug|0|||
105979878|NCT02608450|365587553|FG001|Overall Study|Noncompliance with study drug|2|||
105979879|NCT02608450|365587552|FG000|Overall Study|Physician Decision|0|||
105979880|NCT02608450|365587553|FG001|Overall Study|Physician Decision|1|||
105979881|NCT02608450|365587552|FG000|Overall Study|Pregnancy|0|||
105979882|NCT02608450|365587553|FG001|Overall Study|Pregnancy|1|||
105979883|NCT02608450|365587552|FG000|Overall Study|Progressive disease|1|||
105979884|NCT02608450|365587553|FG001|Overall Study|Progressive disease|0|||
105979885|NCT02608450|365587552|FG000|Overall Study|Multiple reasons|0|||
105979886|NCT02608450|365587553|FG001|Overall Study|Multiple reasons|2|||
105979887|NCT00477269|365587557|FG000|Core Study|Adverse Event|6|||
105979888|NCT00477269|365587558|FG001|Core Study|Adverse Event|4|||
105979889|NCT00477269|365587559|FG002|Core Study|Adverse Event|0|||
105979890|NCT00477269|365587557|FG000|Core Study|Death|3|||
105979891|NCT00477269|365587558|FG001|Core Study|Death|3|||
105979892|NCT00477269|365587559|FG002|Core Study|Death|0|||
105979893|NCT00477269|365587557|FG000|Core Study|Withdrawn Consent|0|||
105979894|NCT00477269|365587558|FG001|Core Study|Withdrawn Consent|1|||
105979895|NCT00477269|365587559|FG002|Core Study|Withdrawn Consent|0|||
105979896|NCT00477269|365587557|FG000|Open Label Extension|Adverse Event|0|||
105979897|NCT00477269|365587558|FG001|Open Label Extension|Adverse Event|0|||
105979898|NCT00477269|365587559|FG002|Open Label Extension|Adverse Event|4|||
105979899|NCT00477269|365587557|FG000|Open Label Extension|Abnormal laboratory values|0|||
105979900|NCT00477269|365587558|FG001|Open Label Extension|Abnormal laboratory values|0|||
105979901|NCT00477269|365587559|FG002|Open Label Extension|Abnormal laboratory values|1|||
105979902|NCT00477269|365587557|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
105979903|NCT00477269|365587558|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
105979904|NCT00477269|365587559|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
105979905|NCT00477269|365587557|FG000|Open Label Extension|Adminiatrative problems|0|||
105979906|NCT00477269|365587558|FG001|Open Label Extension|Adminiatrative problems|0|||
105979907|NCT00477269|365587559|FG002|Open Label Extension|Adminiatrative problems|2|||
105979908|NCT00477269|365587557|FG000|Open Label Extension|Death|0|||
105979909|NCT00477269|365587558|FG001|Open Label Extension|Death|0|||
105979910|NCT00477269|365587559|FG002|Open Label Extension|Death|4|||
105979911|NCT03263780|365587560|FG000|Overall Study|Withdrawal by Subject|3|||
105979912|NCT03263780|365587560|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
105979913|NCT02449018|365587563|FG000|Overall Study|Abnormal laboratory value|0|||
105979914|NCT02449018|365587564|FG001|Overall Study|Abnormal laboratory value|1|||
105979915|NCT02449018|365587563|FG000|Overall Study|Administrative problems|1|||
105979916|NCT02449018|365587564|FG001|Overall Study|Administrative problems|0|||
105979917|NCT02449018|365587563|FG000|Overall Study|Adverse Event|5|||
105979918|NCT02449018|365587564|FG001|Overall Study|Adverse Event|1|||
105979919|NCT02449018|365587563|FG000|Overall Study|Protocol deviation|4|||
105979920|NCT02449018|365587564|FG001|Overall Study|Protocol deviation|0|||
105979921|NCT02449018|365587563|FG000|Overall Study|Patient decision|2|||
105979922|NCT02449018|365587564|FG001|Overall Study|Patient decision|0|||
105979923|NCT00094107|365587565|FG000|Overall Study|Lack of Efficacy|23|||
105979924|NCT00094107|365587565|FG000|Overall Study|Death|5|||
106151134|NCT02723955|366215075|FG021|Expansion Phase|Lost to Follow-up|0|||
105979925|NCT00094107|365587565|FG000|Overall Study|Adverse Event|3|||
105979926|NCT00094107|365587565|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
105979927|NCT03426631|365587567|FG000|Overall Study|Lost to Follow-up|0|||
105979928|NCT03426631|365587568|FG001|Overall Study|Lost to Follow-up|1|||
105979929|NCT03831945|365587569|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
106151135|NCT02723955|366215076|FG022|Expansion Phase|Lost to Follow-up|0|||
105979930|NCT03831945|365587570|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
105979931|NCT03831945|365587569|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
105979932|NCT03831945|365587570|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
105979933|NCT03831945|365587569|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
106028595|NCT01904773|365770753|FG003|First Intervention|Adverse Event|0|||
106028596|NCT01904773|365770754|FG004|First Intervention|Adverse Event|0|||
106028597|NCT01904773|365770755|FG005|First Intervention|Adverse Event|0|||
106028598|NCT01904773|365770756|FG006|First Intervention|Adverse Event|1|||
106028599|NCT01904773|365770757|FG007|First Intervention|Adverse Event|0|||
106028600|NCT01904773|365770758|FG008|First Intervention|Adverse Event|0|||
106028601|NCT01904773|365770750|FG000|Placebo Washout First Intervention|Condition worsened|0|||
106028602|NCT01904773|365770751|FG001|Placebo Washout First Intervention|Condition worsened|1|||
106028603|NCT01904773|365770752|FG002|Placebo Washout First Intervention|Condition worsened|0|||
106028604|NCT01904773|365770753|FG003|Placebo Washout First Intervention|Condition worsened|0|||
106028605|NCT01904773|365770754|FG004|Placebo Washout First Intervention|Condition worsened|0|||
106028606|NCT01904773|365770755|FG005|Placebo Washout First Intervention|Condition worsened|0|||
106028607|NCT01904773|365770756|FG006|Placebo Washout First Intervention|Condition worsened|0|||
106028608|NCT01904773|365770757|FG007|Placebo Washout First Intervention|Condition worsened|0|||
106028609|NCT01904773|365770758|FG008|Placebo Washout First Intervention|Condition worsened|0|||
106028610|NCT01904773|365770750|FG000|Fifth Intervention|Adverse Event|0|||
106028611|NCT01904773|365770751|FG001|Fifth Intervention|Adverse Event|0|||
106028612|NCT01904773|365770752|FG002|Fifth Intervention|Adverse Event|0|||
106028613|NCT01904773|365770753|FG003|Fifth Intervention|Adverse Event|0|||
106028614|NCT01904773|365770754|FG004|Fifth Intervention|Adverse Event|0|||
106028615|NCT01904773|365770755|FG005|Fifth Intervention|Adverse Event|0|||
106028616|NCT01904773|365770756|FG006|Fifth Intervention|Adverse Event|0|||
106028617|NCT01904773|365770757|FG007|Fifth Intervention|Adverse Event|1|||
106028618|NCT01904773|365770758|FG008|Fifth Intervention|Adverse Event|0|||
106028619|NCT01904773|365770750|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
106028620|NCT01904773|365770751|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
106028621|NCT01904773|365770752|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
106028622|NCT01904773|365770753|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
106028623|NCT01904773|365770754|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
106028624|NCT01904773|365770755|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
106028625|NCT01904773|365770756|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
106028626|NCT01904773|365770757|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
106028627|NCT01904773|365770758|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
106028628|NCT02168387|365770775|FG000|Overall Study|Planned exubation|6|||
106028629|NCT02168387|365770776|FG001|Overall Study|Planned exubation|3|||
106028630|NCT02168387|365770775|FG000|Overall Study|Death|1|||
106028631|NCT02168387|365770776|FG001|Overall Study|Death|0|||
106028632|NCT01659554|365770777|FG000|Overall Study|Study Termination|4|||
106028633|NCT03467152|365770780|FG000|Overall Study|Adverse Event|4|||
106028634|NCT03467152|365770781|FG001|Overall Study|Adverse Event|5|||
106028635|NCT03467152|365770782|FG002|Overall Study|Adverse Event|0|||
106028636|NCT03467152|365770780|FG000|Overall Study|Subject Choice|1|||
106028637|NCT03467152|365770781|FG001|Overall Study|Subject Choice|3|||
106028638|NCT03467152|365770782|FG002|Overall Study|Subject Choice|0|||
106028639|NCT03467152|365770780|FG000|Overall Study|Lost to Follow-up|1|||
106028640|NCT03467152|365770781|FG001|Overall Study|Lost to Follow-up|0|||
106028641|NCT03467152|365770782|FG002|Overall Study|Lost to Follow-up|0|||
106028642|NCT03467152|365770780|FG000|Overall Study|Withdrawal by Subject|4|||
106028643|NCT03467152|365770781|FG001|Overall Study|Withdrawal by Subject|2|||
106028644|NCT03467152|365770782|FG002|Overall Study|Withdrawal by Subject|0|||
106028645|NCT03467152|365770780|FG000|Overall Study|Others|3|||
106028646|NCT03467152|365770781|FG001|Overall Study|Others|0|||
106028647|NCT03467152|365770782|FG002|Overall Study|Others|0|||
106028648|NCT03467152|365770780|FG000|Overall Study|Not treated|3|||
106028649|NCT03467152|365770781|FG001|Overall Study|Not treated|1|||
106028650|NCT03467152|365770782|FG002|Overall Study|Not treated|6|||
106028651|NCT04250077|365770783|FG000|Overall Study|Withdrawal by Subject|0|||
106028652|NCT04250077|365770784|FG001|Overall Study|Withdrawal by Subject|1|||
106151136|NCT02723955|366215077|FG023|Expansion Phase|Lost to Follow-up|0|||
106151137|NCT02723955|366215078|FG024|Expansion Phase|Lost to Follow-up|0|||
106151138|NCT02723955|366215079|FG025|Expansion Phase|Lost to Follow-up|0|||
106151139|NCT02723955|366215080|FG026|Expansion Phase|Lost to Follow-up|0|||
105851549|NCT04135196|365112745|FG004|Overall Study|Lost to Follow-up|1|||
106028653|NCT04250077|365770785|FG002|Overall Study|Withdrawal by Subject|0|||
106028654|NCT04250077|365770783|FG000|Overall Study|Lost to Follow-up|2|||
106028655|NCT04250077|365770784|FG001|Overall Study|Lost to Follow-up|3|||
106028656|NCT04250077|365770785|FG002|Overall Study|Lost to Follow-up|0|||
106028657|NCT01444092|365770786|FG000|Overall Study|Adverse Event|8|||
106028658|NCT01444092|365770786|FG000|Overall Study|Protocol Violation|1|||
106028659|NCT01444092|365770786|FG000|Overall Study|Withdrawal by Subject|1|||
106028660|NCT01444092|365770786|FG000|Overall Study|Other Eligibility criteria|7|||
106028661|NCT03560518|365770797|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
106028662|NCT03560518|365770798|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
106151140|NCT02723955|366215081|FG027|Expansion Phase|Lost to Follow-up|0|||
106151141|NCT02723955|366215082|FG028|Expansion Phase|Lost to Follow-up|0|||
106028663|NCT03560518|365770799|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
106028664|NCT03560518|365770797|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
106028665|NCT03560518|365770798|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
106028666|NCT03560518|365770799|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
106028667|NCT03560518|365770797|FG000|Double Blind Treatment Period|Protocol Violation|1|||
106028668|NCT03560518|365770798|FG001|Double Blind Treatment Period|Protocol Violation|2|||
106028669|NCT03560518|365770799|FG002|Double Blind Treatment Period|Protocol Violation|0|||
106028670|NCT03560518|365770797|FG000|Double Blind Treatment Period|Pregnancy|0|||
106028671|NCT03560518|365770798|FG001|Double Blind Treatment Period|Pregnancy|2|||
106028672|NCT03560518|365770799|FG002|Double Blind Treatment Period|Pregnancy|0|||
106028673|NCT03560518|365770797|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
106028674|NCT03560518|365770798|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
106028675|NCT03560518|365770799|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
106028676|NCT03560518|365770797|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
106028677|NCT03560518|365770798|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
106028678|NCT03560518|365770799|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
106028679|NCT03560518|365770797|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
106028680|NCT03560518|365770798|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
106028681|NCT03560518|365770799|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
106028682|NCT03560518|365770797|FG000|Double Blind Treatment Period|Adverse Event|0|||
106028683|NCT03560518|365770798|FG001|Double Blind Treatment Period|Adverse Event|3|||
106028684|NCT03560518|365770799|FG002|Double Blind Treatment Period|Adverse Event|1|||
106028685|NCT00913458|365770800|FG000|Phase 1|Non-Responder|54|||
106028686|NCT00913458|365770801|FG001|Phase 1|Non-Responder|0|||
106028687|NCT00913458|365770802|FG002|Phase 1|Non-Responder|0|||
106028688|NCT00913458|365770803|FG003|Phase 1|Non-Responder|0|||
106028689|NCT00913458|365770804|FG004|Phase 1|Non-Responder|0|||
106028690|NCT00913458|365770805|FG005|Phase 1|Non-Responder|0|||
106028691|NCT00913458|365770806|FG006|Phase 1|Non-Responder|0|||
106028692|NCT00913458|365770800|FG000|Phase 1|Subject Request|17|||
106028693|NCT00913458|365770801|FG001|Phase 1|Subject Request|0|||
106028694|NCT00913458|365770802|FG002|Phase 1|Subject Request|0|||
106028695|NCT00913458|365770803|FG003|Phase 1|Subject Request|0|||
106028696|NCT00913458|365770804|FG004|Phase 1|Subject Request|0|||
106028697|NCT00913458|365770805|FG005|Phase 1|Subject Request|0|||
106028698|NCT00913458|365770806|FG006|Phase 1|Subject Request|0|||
106028699|NCT00913458|365770800|FG000|Phase 1|Adverse Event|20|||
106028700|NCT00913458|365770801|FG001|Phase 1|Adverse Event|0|||
106028701|NCT00913458|365770802|FG002|Phase 1|Adverse Event|0|||
106028702|NCT00913458|365770803|FG003|Phase 1|Adverse Event|0|||
106028703|NCT00913458|365770804|FG004|Phase 1|Adverse Event|0|||
106028704|NCT00913458|365770805|FG005|Phase 1|Adverse Event|0|||
106028705|NCT00913458|365770806|FG006|Phase 1|Adverse Event|0|||
106028706|NCT00913458|365770800|FG000|Phase 1|Lost to Follow-up|2|||
106028707|NCT00913458|365770801|FG001|Phase 1|Lost to Follow-up|0|||
106028708|NCT00913458|365770802|FG002|Phase 1|Lost to Follow-up|0|||
106028709|NCT00913458|365770803|FG003|Phase 1|Lost to Follow-up|0|||
106028710|NCT00913458|365770804|FG004|Phase 1|Lost to Follow-up|0|||
106028711|NCT00913458|365770805|FG005|Phase 1|Lost to Follow-up|0|||
106028712|NCT00913458|365770806|FG006|Phase 1|Lost to Follow-up|0|||
106028713|NCT00913458|365770800|FG000|Phase 1|Protocol Violation|10|||
106028714|NCT00913458|365770801|FG001|Phase 1|Protocol Violation|0|||
106028715|NCT00913458|365770802|FG002|Phase 1|Protocol Violation|0|||
106028716|NCT00913458|365770803|FG003|Phase 1|Protocol Violation|0|||
106028717|NCT00913458|365770804|FG004|Phase 1|Protocol Violation|0|||
106028718|NCT00913458|365770805|FG005|Phase 1|Protocol Violation|0|||
106028719|NCT00913458|365770806|FG006|Phase 1|Protocol Violation|0|||
106028720|NCT00913458|365770800|FG000|Phase 1|Sponsor|2|||
106028721|NCT00913458|365770801|FG001|Phase 1|Sponsor|0|||
106028722|NCT00913458|365770802|FG002|Phase 1|Sponsor|0|||
106028723|NCT00913458|365770803|FG003|Phase 1|Sponsor|0|||
106028724|NCT00913458|365770804|FG004|Phase 1|Sponsor|0|||
106028725|NCT00913458|365770805|FG005|Phase 1|Sponsor|0|||
106028726|NCT00913458|365770806|FG006|Phase 1|Sponsor|0|||
106028727|NCT00913458|365770800|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
106028728|NCT00913458|365770801|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
106028729|NCT00913458|365770802|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
106028730|NCT00913458|365770803|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
106028731|NCT00913458|365770804|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
106028732|NCT00913458|365770805|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
106028733|NCT00913458|365770806|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
106028734|NCT00913458|365770800|FG000|Phase 2|Non-Responder|0|||
106028735|NCT00913458|365770801|FG001|Phase 2|Non-Responder|5|||
106028736|NCT00913458|365770802|FG002|Phase 2|Non-Responder|7|||
106028737|NCT00913458|365770803|FG003|Phase 2|Non-Responder|12|||
106028738|NCT00913458|365770804|FG004|Phase 2|Non-Responder|0|||
106028739|NCT00913458|365770805|FG005|Phase 2|Non-Responder|0|||
106028740|NCT00913458|365770806|FG006|Phase 2|Non-Responder|0|||
106028741|NCT00913458|365770800|FG000|Phase 2|Subject Request|0|||
106028742|NCT00913458|365770801|FG001|Phase 2|Subject Request|0|||
105851550|NCT04135196|365112741|FG000|Overall Study|Pregnancy|0|||
105851551|NCT04135196|365112742|FG001|Overall Study|Pregnancy|0|||
105851552|NCT04135196|365112743|FG002|Overall Study|Pregnancy|1|||
105851553|NCT04135196|365112744|FG003|Overall Study|Pregnancy|0|||
105979934|NCT03831945|365587570|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
105979935|NCT00806442|365587571|FG000|Overall Study|Lost to Follow-up|3|||
105979936|NCT00806442|365587572|FG001|Overall Study|Lost to Follow-up|2|||
105979937|NCT00806442|365587571|FG000|Overall Study|Withdrawal by Subject|1|||
105979938|NCT00806442|365587572|FG001|Overall Study|Withdrawal by Subject|5|||
105979939|NCT00654004|365587576|FG000|Overall Study|Lost to Follow-up|1|||
105979940|NCT00654004|365587577|FG001|Overall Study|Lost to Follow-up|0|||
105979941|NCT01264770|365587578|FG000|Overall Study|Not reported|0|||
105979942|NCT01264770|365587579|FG001|Overall Study|Not reported|0|||
105979943|NCT01264770|365587580|FG002|Overall Study|Not reported|1|||
105979944|NCT01264770|365587581|FG003|Overall Study|Not reported|0|||
105979945|NCT01264770|365587582|FG004|Overall Study|Not reported|0|||
105979946|NCT01264770|365587583|FG005|Overall Study|Not reported|0|||
105979947|NCT01264770|365587578|FG000|Overall Study|e.g., change in circumstances|8|||
105979948|NCT01264770|365587579|FG001|Overall Study|e.g., change in circumstances|3|||
105979949|NCT01264770|365587580|FG002|Overall Study|e.g., change in circumstances|3|||
105979950|NCT01264770|365587581|FG003|Overall Study|e.g., change in circumstances|3|||
105979951|NCT01264770|365587582|FG004|Overall Study|e.g., change in circumstances|4|||
105979952|NCT01264770|365587583|FG005|Overall Study|e.g., change in circumstances|4|||
105979953|NCT01264770|365587578|FG000|Overall Study|Severe non-compliance to protocol|0|||
105979954|NCT01264770|365587579|FG001|Overall Study|Severe non-compliance to protocol|0|||
105979955|NCT01264770|365587580|FG002|Overall Study|Severe non-compliance to protocol|1|||
106028743|NCT00913458|365770802|FG002|Phase 2|Subject Request|1|||
106028744|NCT00913458|365770803|FG003|Phase 2|Subject Request|2|||
106028745|NCT00913458|365770804|FG004|Phase 2|Subject Request|0|||
106028746|NCT00913458|365770805|FG005|Phase 2|Subject Request|0|||
106028747|NCT00913458|365770806|FG006|Phase 2|Subject Request|0|||
106028748|NCT00913458|365770800|FG000|Phase 2|Adverse Event|0|||
106028749|NCT00913458|365770801|FG001|Phase 2|Adverse Event|3|||
106028750|NCT00913458|365770802|FG002|Phase 2|Adverse Event|0|||
106028751|NCT00913458|365770803|FG003|Phase 2|Adverse Event|1|||
106028752|NCT00913458|365770804|FG004|Phase 2|Adverse Event|0|||
106028753|NCT00913458|365770805|FG005|Phase 2|Adverse Event|0|||
106028754|NCT00913458|365770806|FG006|Phase 2|Adverse Event|0|||
106028755|NCT00913458|365770800|FG000|Phase 2|Lost to Follow-up|0|||
106028756|NCT00913458|365770801|FG001|Phase 2|Lost to Follow-up|0|||
106028757|NCT00913458|365770802|FG002|Phase 2|Lost to Follow-up|0|||
106028758|NCT00913458|365770803|FG003|Phase 2|Lost to Follow-up|1|||
106028759|NCT00913458|365770804|FG004|Phase 2|Lost to Follow-up|0|||
106028760|NCT00913458|365770805|FG005|Phase 2|Lost to Follow-up|0|||
106028761|NCT00913458|365770806|FG006|Phase 2|Lost to Follow-up|0|||
106028762|NCT00913458|365770800|FG000|Phase 2|Protocol Violation|0|||
106028763|NCT00913458|365770801|FG001|Phase 2|Protocol Violation|2|||
106028764|NCT00913458|365770802|FG002|Phase 2|Protocol Violation|0|||
106028765|NCT00913458|365770803|FG003|Phase 2|Protocol Violation|0|||
106028766|NCT00913458|365770804|FG004|Phase 2|Protocol Violation|0|||
106028767|NCT00913458|365770805|FG005|Phase 2|Protocol Violation|0|||
106028768|NCT00913458|365770806|FG006|Phase 2|Protocol Violation|0|||
106028769|NCT00913458|365770800|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
106028770|NCT00913458|365770801|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
106028771|NCT00913458|365770802|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
106028772|NCT00913458|365770803|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
106028773|NCT00913458|365770804|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
106028774|NCT00913458|365770805|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
106028775|NCT00913458|365770806|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
106028776|NCT00913458|365770800|FG000|Phase 3|Adverse Event|0|||
106028777|NCT00913458|365770801|FG001|Phase 3|Adverse Event|0|||
106028778|NCT00913458|365770802|FG002|Phase 3|Adverse Event|0|||
106028779|NCT00913458|365770803|FG003|Phase 3|Adverse Event|0|||
106028780|NCT00913458|365770804|FG004|Phase 3|Adverse Event|5|||
106028781|NCT00913458|365770805|FG005|Phase 3|Adverse Event|4|||
106028782|NCT00913458|365770806|FG006|Phase 3|Adverse Event|1|||
106028783|NCT00913458|365770800|FG000|Phase 3|Lost to Follow-up|0|||
106028784|NCT00913458|365770801|FG001|Phase 3|Lost to Follow-up|0|||
106028785|NCT00913458|365770802|FG002|Phase 3|Lost to Follow-up|0|||
106028786|NCT00913458|365770803|FG003|Phase 3|Lost to Follow-up|0|||
106028787|NCT00913458|365770804|FG004|Phase 3|Lost to Follow-up|2|||
106028788|NCT00913458|365770805|FG005|Phase 3|Lost to Follow-up|0|||
106151142|NCT02723955|366215083|FG029|Expansion Phase|Lost to Follow-up|1|||
105979956|NCT01264770|365587581|FG003|Overall Study|Severe non-compliance to protocol|1|||
105979957|NCT01264770|365587582|FG004|Overall Study|Severe non-compliance to protocol|0|||
105979958|NCT01264770|365587583|FG005|Overall Study|Severe non-compliance to protocol|0|||
106028789|NCT00913458|365770806|FG006|Phase 3|Lost to Follow-up|0|||
106028790|NCT00913458|365770800|FG000|Phase 3|Non-Responder|0|||
106028791|NCT00913458|365770801|FG001|Phase 3|Non-Responder|0|||
106028792|NCT00913458|365770802|FG002|Phase 3|Non-Responder|0|||
105851554|NCT04135196|365112745|FG004|Overall Study|Pregnancy|0|||
105851555|NCT04135196|365112741|FG000|Overall Study|Withdrawal by Subject|0|||
105851556|NCT04135196|365112742|FG001|Overall Study|Withdrawal by Subject|0|||
105851557|NCT04135196|365112743|FG002|Overall Study|Withdrawal by Subject|0|||
105851558|NCT04135196|365112744|FG003|Overall Study|Withdrawal by Subject|0|||
105851559|NCT04135196|365112745|FG004|Overall Study|Withdrawal by Subject|1|||
105851560|NCT00073021|365112746|FG000|Overall Study|Protocol Violation|2|||
106028793|NCT00913458|365770803|FG003|Phase 3|Non-Responder|0|||
106028794|NCT00913458|365770804|FG004|Phase 3|Non-Responder|0|||
106028795|NCT00913458|365770805|FG005|Phase 3|Non-Responder|1|||
106028796|NCT00913458|365770806|FG006|Phase 3|Non-Responder|3|||
106028797|NCT00913458|365770800|FG000|Phase 3|Withdrawal by Subject|0|||
106028798|NCT00913458|365770801|FG001|Phase 3|Withdrawal by Subject|0|||
106028799|NCT00913458|365770802|FG002|Phase 3|Withdrawal by Subject|0|||
106028800|NCT00913458|365770803|FG003|Phase 3|Withdrawal by Subject|0|||
106028801|NCT00913458|365770804|FG004|Phase 3|Withdrawal by Subject|1|||
106028802|NCT00913458|365770805|FG005|Phase 3|Withdrawal by Subject|2|||
106028803|NCT00913458|365770806|FG006|Phase 3|Withdrawal by Subject|0|||
106028804|NCT00913458|365770800|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
106028805|NCT00913458|365770801|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
106028806|NCT00913458|365770802|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
106028807|NCT00913458|365770803|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
106028808|NCT00913458|365770804|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
106028809|NCT00913458|365770805|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
106028810|NCT00913458|365770806|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
106028811|NCT01155011|365770807|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
106028812|NCT01155011|365770808|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
106028813|NCT01155011|365770807|FG000|Baseline to 6 Months|investigator decision, moved|4|||
106028814|NCT01155011|365770808|FG001|Baseline to 6 Months|investigator decision, moved|5|||
106028815|NCT01155011|365770807|FG000|Baseline to 6 Months|Death|0|||
106028816|NCT01155011|365770808|FG001|Baseline to 6 Months|Death|1|||
106028817|NCT01155011|365770807|FG000|6 to 12 Months|Withdrawal by Subject|8|||
106028818|NCT01155011|365770808|FG001|6 to 12 Months|Withdrawal by Subject|5|||
106028819|NCT01155011|365770807|FG000|6 to 12 Months|Death|1|||
106028820|NCT01155011|365770808|FG001|6 to 12 Months|Death|5|||
106028821|NCT00869778|365770815|FG000|Overall Study|Adverse Event|2|||
106028822|NCT00869778|365770816|FG001|Overall Study|Adverse Event|0|||
106028823|NCT00869778|365770817|FG002|Overall Study|Adverse Event|0|||
106028824|NCT00869778|365770815|FG000|Overall Study|Withdrawal by Subject|3|||
106028825|NCT00869778|365770816|FG001|Overall Study|Withdrawal by Subject|4|||
106028826|NCT00869778|365770817|FG002|Overall Study|Withdrawal by Subject|5|||
106028827|NCT00869778|365770815|FG000|Overall Study|Pregnancy|1|||
106028828|NCT00869778|365770816|FG001|Overall Study|Pregnancy|0|||
106028829|NCT00869778|365770817|FG002|Overall Study|Pregnancy|0|||
106028830|NCT00869778|365770815|FG000|Overall Study|Protocol Violation|5|||
106028831|NCT00869778|365770816|FG001|Overall Study|Protocol Violation|3|||
106028832|NCT00869778|365770817|FG002|Overall Study|Protocol Violation|5|||
106028833|NCT00869778|365770815|FG000|Overall Study|Unblinding|1|||
106028834|NCT00869778|365770816|FG001|Overall Study|Unblinding|0|||
106028835|NCT00869778|365770817|FG002|Overall Study|Unblinding|0|||
106028836|NCT01403948|365770818|FG000|Overall Study|Progressive disease|0|||
106028837|NCT01403948|365770819|FG001|Overall Study|Progressive disease|2|||
106028838|NCT01403948|365770820|FG002|Overall Study|Progressive disease|2|||
106028839|NCT01403948|365770821|FG003|Overall Study|Progressive disease|4|||
105851561|NCT00073021|365112747|FG001|Overall Study|Protocol Violation|1|||
106028840|NCT01403948|365770822|FG004|Overall Study|Progressive disease|2|||
106028841|NCT01403948|365770823|FG005|Overall Study|Progressive disease|6|||
106028842|NCT01403948|365770824|FG006|Overall Study|Progressive disease|2|||
106028843|NCT01403948|365770825|FG007|Overall Study|Progressive disease|4|||
106028844|NCT01403948|365770826|FG008|Overall Study|Progressive disease|5|||
106028845|NCT01403948|365770827|FG009|Overall Study|Progressive disease|5|||
106028846|NCT01403948|365770818|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
106028847|NCT01403948|365770819|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
106028848|NCT01403948|365770820|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
106028849|NCT01403948|365770821|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
106028850|NCT01403948|365770822|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
106028851|NCT01403948|365770823|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
106028852|NCT01403948|365770824|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
106028853|NCT01403948|365770825|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
106151143|NCT02723955|366215084|FG030|Expansion Phase|Lost to Follow-up|19|||
106151144|NCT02723955|366215085|FG031|Expansion Phase|Lost to Follow-up|2|||
106151145|NCT02723955|366215086|FG032|Expansion Phase|Lost to Follow-up|1|||
105851562|NCT00073021|365112746|FG000|Overall Study|Adverse Event|4|||
106028854|NCT01403948|365770826|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
106028855|NCT01403948|365770827|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
106028856|NCT01403948|365770818|FG000|Overall Study|Lost to Follow-up|0|||
106151146|NCT02723955|366215087|FG033|Expansion Phase|Lost to Follow-up|0|||
106028857|NCT01403948|365770819|FG001|Overall Study|Lost to Follow-up|0|||
106028858|NCT01403948|365770820|FG002|Overall Study|Lost to Follow-up|0|||
106028859|NCT01403948|365770821|FG003|Overall Study|Lost to Follow-up|0|||
106028860|NCT01403948|365770822|FG004|Overall Study|Lost to Follow-up|0|||
106028861|NCT01403948|365770823|FG005|Overall Study|Lost to Follow-up|0|||
106028862|NCT01403948|365770824|FG006|Overall Study|Lost to Follow-up|0|||
106028863|NCT01403948|365770825|FG007|Overall Study|Lost to Follow-up|0|||
106028864|NCT01403948|365770826|FG008|Overall Study|Lost to Follow-up|0|||
106028865|NCT01403948|365770827|FG009|Overall Study|Lost to Follow-up|1|||
106028866|NCT01403948|365770818|FG000|Overall Study|Refused cont. medication|0|||
106028867|NCT01403948|365770819|FG001|Overall Study|Refused cont. medication|0|||
106028868|NCT01403948|365770820|FG002|Overall Study|Refused cont. medication|0|||
106028869|NCT01403948|365770821|FG003|Overall Study|Refused cont. medication|0|||
106028870|NCT01403948|365770822|FG004|Overall Study|Refused cont. medication|1|||
106028871|NCT01403948|365770823|FG005|Overall Study|Refused cont. medication|0|||
106028872|NCT01403948|365770824|FG006|Overall Study|Refused cont. medication|0|||
106028873|NCT01403948|365770825|FG007|Overall Study|Refused cont. medication|0|||
106028874|NCT01403948|365770826|FG008|Overall Study|Refused cont. medication|0|||
106028875|NCT01403948|365770827|FG009|Overall Study|Refused cont. medication|1|||
106028876|NCT01403948|365770818|FG000|Overall Study|other than above|1|||
106028877|NCT01403948|365770819|FG001|Overall Study|other than above|2|||
106028878|NCT01403948|365770820|FG002|Overall Study|other than above|1|||
106028879|NCT01403948|365770821|FG003|Overall Study|other than above|0|||
106028880|NCT01403948|365770822|FG004|Overall Study|other than above|1|||
106028881|NCT01403948|365770823|FG005|Overall Study|other than above|1|||
106028882|NCT01403948|365770824|FG006|Overall Study|other than above|2|||
106028883|NCT01403948|365770825|FG007|Overall Study|other than above|0|||
106028884|NCT01403948|365770826|FG008|Overall Study|other than above|0|||
106028885|NCT01403948|365770827|FG009|Overall Study|other than above|0|||
106028886|NCT03726996|365770828|FG000|Overall Study|Parent's decision|2|||
106028887|NCT03726996|365770828|FG000|Overall Study|Study early termination|2|||
106028888|NCT00600119|365770829|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
106028889|NCT00600119|365770830|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
106028890|NCT00600119|365770831|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
106028891|NCT00600119|365770832|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
106028892|NCT00600119|365770833|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
106028893|NCT00600119|365770834|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
106028894|NCT00600119|365770829|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
106028895|NCT00600119|365770830|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
106028896|NCT00600119|365770831|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
106028897|NCT00600119|365770832|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
106028898|NCT00600119|365770833|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
106028899|NCT00600119|365770834|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
106028900|NCT00600119|365770829|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
106028901|NCT00600119|365770830|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
106028902|NCT00600119|365770831|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
106028903|NCT00600119|365770832|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
106028904|NCT00600119|365770833|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
106028905|NCT00600119|365770834|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
106028906|NCT00600119|365770829|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
106028907|NCT00600119|365770830|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
106028908|NCT00600119|365770831|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
106028909|NCT00600119|365770832|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
106028910|NCT00600119|365770833|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
106028911|NCT00600119|365770834|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
106151147|NCT02723955|366215088|FG034|Expansion Phase|Lost to Follow-up|0|||
106151148|NCT02723955|366215089|FG035|Expansion Phase|Lost to Follow-up|0|||
106151149|NCT02723955|366215090|FG036|Expansion Phase|Lost to Follow-up|0|||
106028912|NCT00600119|365770829|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
106028913|NCT00600119|365770830|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
106028914|NCT00600119|365770831|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
106028915|NCT00600119|365770832|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
106028916|NCT00600119|365770833|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
106028917|NCT00600119|365770834|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
106028918|NCT00600119|365770829|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
106028919|NCT00600119|365770830|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
106028920|NCT00600119|365770831|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
106028921|NCT00600119|365770832|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
106028922|NCT00600119|365770833|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
106028923|NCT00600119|365770834|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
106151150|NCT02723955|366215091|FG037|Expansion Phase|Lost to Follow-up|0|||
105979959|NCT01264770|365587578|FG000|Overall Study|Lack of therapeutic response|1|||
105979960|NCT01264770|365587579|FG001|Overall Study|Lack of therapeutic response|0|||
105979961|NCT01264770|365587580|FG002|Overall Study|Lack of therapeutic response|2|||
105979962|NCT01264770|365587581|FG003|Overall Study|Lack of therapeutic response|1|||
105979963|NCT01264770|365587582|FG004|Overall Study|Lack of therapeutic response|1|||
105979964|NCT01264770|365587583|FG005|Overall Study|Lack of therapeutic response|0|||
105979965|NCT01264770|365587578|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
105979966|NCT01264770|365587579|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
105979967|NCT01264770|365587580|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
105979968|NCT01264770|365587581|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
105979969|NCT01264770|365587582|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
105979970|NCT01264770|365587583|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
105979971|NCT01264770|365587578|FG000|Overall Study|Lost to Follow-up|0|||
105979972|NCT01264770|365587579|FG001|Overall Study|Lost to Follow-up|0|||
105979973|NCT01264770|365587580|FG002|Overall Study|Lost to Follow-up|1|||
105979974|NCT01264770|365587581|FG003|Overall Study|Lost to Follow-up|1|||
105979975|NCT01264770|365587582|FG004|Overall Study|Lost to Follow-up|0|||
105979976|NCT01264770|365587583|FG005|Overall Study|Lost to Follow-up|0|||
105979977|NCT01264770|365587578|FG000|Overall Study|Adverse Event|7|||
105979978|NCT01264770|365587579|FG001|Overall Study|Adverse Event|7|||
105979979|NCT01264770|365587580|FG002|Overall Study|Adverse Event|8|||
105979980|NCT01264770|365587581|FG003|Overall Study|Adverse Event|0|||
105979981|NCT01264770|365587582|FG004|Overall Study|Adverse Event|2|||
105979982|NCT01264770|365587583|FG005|Overall Study|Adverse Event|1|||
105979983|NCT00351273|365587588|FG000|Overall Study|Lost to Follow-up|1|||
105979984|NCT00351273|365587589|FG001|Overall Study|Lost to Follow-up|2|||
105979985|NCT00351273|365587590|FG002|Overall Study|Lost to Follow-up|5|||
105979986|NCT01977690|365587593|FG000|Overall Study|Withdrawal by Subject|0|||
105979987|NCT01977690|365587594|FG001|Overall Study|Withdrawal by Subject|4|||
105979988|NCT00952614|365587595|FG000|Overall Study|Death|3|||
105979989|NCT00952614|365587595|FG000|Overall Study|Lost to Follow-up|3|||
105979990|NCT00952614|365587595|FG000|Overall Study|other reason|1|||
105979991|NCT02644356|365587596|FG000|Overall Study|Withdrawal by Subject|2|||
105979992|NCT04023682|365587597|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
105979993|NCT01711866|365587599|FG000|Overall Study|Noncompliant|3|||
105979994|NCT01711866|365587599|FG000|Overall Study|Withdrawal by Subject|3|||
105979995|NCT01711866|365587599|FG000|Overall Study|Adverse Event|2|||
105979996|NCT02290938|365587600|FG000|Overall Study|Lost to Follow-up|14|||
105979997|NCT02290938|365587601|FG001|Overall Study|Lost to Follow-up|43|||
105979998|NCT04938037|365589130|FG000|Overall Study|Lost to Follow-up|4|||
105979999|NCT04938037|365589131|FG001|Overall Study|Lost to Follow-up|3|||
105980000|NCT02797184|365589133|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
105980001|NCT02797184|365589134|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
105980002|NCT04692077|365589135|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
105980003|NCT05149313|365589136|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
105980004|NCT05149313|365589137|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
105980005|NCT05149313|365589138|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
105980006|NCT05149313|365589139|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
105980007|NCT05149313|365589136|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
105980008|NCT05149313|365589137|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
105980009|NCT05149313|365589138|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
105980010|NCT05149313|365589139|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
105980011|NCT05149313|365589136|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
105980012|NCT05149313|365589137|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
105980013|NCT05149313|365589138|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
105980014|NCT05149313|365589139|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
105980015|NCT05149313|365589136|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
105980016|NCT05149313|365589137|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
105980017|NCT05149313|365589138|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
105980018|NCT05149313|365589139|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
105980019|NCT05149313|365589136|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
105980020|NCT05149313|365589137|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
105980021|NCT05149313|365589138|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
105980022|NCT05149313|365589139|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
106151151|NCT02723955|366215092|FG038|Expansion Phase|Lost to Follow-up|0|||
106151152|NCT02723955|366215093|FG039|Expansion Phase|Lost to Follow-up|0|||
105980023|NCT05149313|365589136|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
105980024|NCT05149313|365589137|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
105980025|NCT05149313|365589138|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
106151153|NCT02723955|366215094|FG040|Expansion Phase|Lost to Follow-up|0|||
106151154|NCT02723955|366215095|FG041|Expansion Phase|Lost to Follow-up|0|||
106151155|NCT02723955|366215096|FG042|Expansion Phase|Lost to Follow-up|0|||
106151156|NCT02723955|366215054|FG000|Expansion Phase|Physician Decision|0|||
106151157|NCT02723955|366215055|FG001|Expansion Phase|Physician Decision|0|||
106151158|NCT02723955|366215056|FG002|Expansion Phase|Physician Decision|0|||
106151159|NCT02723955|366215057|FG003|Expansion Phase|Physician Decision|0|||
106151160|NCT02723955|366215058|FG004|Expansion Phase|Physician Decision|0|||
106151161|NCT02723955|366215059|FG005|Expansion Phase|Physician Decision|0|||
106151162|NCT02723955|366215060|FG006|Expansion Phase|Physician Decision|0|||
106151163|NCT02723955|366215061|FG007|Expansion Phase|Physician Decision|0|||
106151164|NCT02723955|366215062|FG008|Expansion Phase|Physician Decision|0|||
106151165|NCT02723955|366215063|FG009|Expansion Phase|Physician Decision|0|||
106151166|NCT02723955|366215064|FG010|Expansion Phase|Physician Decision|0|||
106151167|NCT02723955|366215065|FG011|Expansion Phase|Physician Decision|0|||
106151168|NCT02723955|366215066|FG012|Expansion Phase|Physician Decision|0|||
106151169|NCT02723955|366215067|FG013|Expansion Phase|Physician Decision|0|||
106151170|NCT02723955|366215068|FG014|Expansion Phase|Physician Decision|0|||
106151171|NCT02723955|366215069|FG015|Expansion Phase|Physician Decision|0|||
106151172|NCT02723955|366215070|FG016|Expansion Phase|Physician Decision|0|||
106151173|NCT02723955|366215071|FG017|Expansion Phase|Physician Decision|0|||
106151174|NCT02723955|366215072|FG018|Expansion Phase|Physician Decision|0|||
106151175|NCT02723955|366215073|FG019|Expansion Phase|Physician Decision|0|||
106151176|NCT02723955|366215074|FG020|Expansion Phase|Physician Decision|0|||
106151177|NCT02723955|366215075|FG021|Expansion Phase|Physician Decision|0|||
106151178|NCT02723955|366215076|FG022|Expansion Phase|Physician Decision|0|||
106151179|NCT02723955|366215077|FG023|Expansion Phase|Physician Decision|0|||
106151180|NCT02723955|366215078|FG024|Expansion Phase|Physician Decision|0|||
106151181|NCT02723955|366215079|FG025|Expansion Phase|Physician Decision|0|||
106151182|NCT02723955|366215080|FG026|Expansion Phase|Physician Decision|0|||
106151183|NCT02723955|366215081|FG027|Expansion Phase|Physician Decision|0|||
106151184|NCT02723955|366215082|FG028|Expansion Phase|Physician Decision|0|||
106151185|NCT02723955|366215083|FG029|Expansion Phase|Physician Decision|0|||
106151186|NCT02723955|366215084|FG030|Expansion Phase|Physician Decision|1|||
106151187|NCT02723955|366215085|FG031|Expansion Phase|Physician Decision|1|||
106151188|NCT02723955|366215086|FG032|Expansion Phase|Physician Decision|0|||
106151189|NCT02723955|366215087|FG033|Expansion Phase|Physician Decision|0|||
106151190|NCT02723955|366215088|FG034|Expansion Phase|Physician Decision|0|||
106151191|NCT02723955|366215089|FG035|Expansion Phase|Physician Decision|0|||
106151192|NCT02723955|366215090|FG036|Expansion Phase|Physician Decision|0|||
106151193|NCT02723955|366215091|FG037|Expansion Phase|Physician Decision|0|||
106151194|NCT02723955|366215092|FG038|Expansion Phase|Physician Decision|0|||
106151195|NCT02723955|366215093|FG039|Expansion Phase|Physician Decision|0|||
106151196|NCT02723955|366215094|FG040|Expansion Phase|Physician Decision|0|||
106151197|NCT02723955|366215095|FG041|Expansion Phase|Physician Decision|0|||
106151198|NCT02723955|366215096|FG042|Expansion Phase|Physician Decision|0|||
106151199|NCT02723955|366215054|FG000|Expansion Phase|Withdrawal by Subject|0|||
106151200|NCT02723955|366215055|FG001|Expansion Phase|Withdrawal by Subject|0|||
106151201|NCT02723955|366215056|FG002|Expansion Phase|Withdrawal by Subject|0|||
106151202|NCT02723955|366215057|FG003|Expansion Phase|Withdrawal by Subject|0|||
106151203|NCT02723955|366215058|FG004|Expansion Phase|Withdrawal by Subject|0|||
106151204|NCT02723955|366215059|FG005|Expansion Phase|Withdrawal by Subject|0|||
106151205|NCT02723955|366215060|FG006|Expansion Phase|Withdrawal by Subject|0|||
106151206|NCT02723955|366215061|FG007|Expansion Phase|Withdrawal by Subject|0|||
106151207|NCT02723955|366215062|FG008|Expansion Phase|Withdrawal by Subject|0|||
106151208|NCT02723955|366215063|FG009|Expansion Phase|Withdrawal by Subject|2|||
105851563|NCT00073021|365112747|FG001|Overall Study|Adverse Event|4|||
106151209|NCT02723955|366215064|FG010|Expansion Phase|Withdrawal by Subject|1|||
106151210|NCT02723955|366215065|FG011|Expansion Phase|Withdrawal by Subject|0|||
106151211|NCT02723955|366215066|FG012|Expansion Phase|Withdrawal by Subject|0|||
106151212|NCT02723955|366215067|FG013|Expansion Phase|Withdrawal by Subject|0|||
106151213|NCT02723955|366215068|FG014|Expansion Phase|Withdrawal by Subject|0|||
106151214|NCT02723955|366215069|FG015|Expansion Phase|Withdrawal by Subject|0|||
106151215|NCT02723955|366215070|FG016|Expansion Phase|Withdrawal by Subject|0|||
106151216|NCT02723955|366215071|FG017|Expansion Phase|Withdrawal by Subject|0|||
105851564|NCT00073021|365112746|FG000|Overall Study|Withdrawal by Subject|6|||
105851565|NCT00073021|365112747|FG001|Overall Study|Withdrawal by Subject|5|||
106151217|NCT02723955|366215072|FG018|Expansion Phase|Withdrawal by Subject|0|||
106151218|NCT02723955|366215073|FG019|Expansion Phase|Withdrawal by Subject|0|||
106151219|NCT02723955|366215074|FG020|Expansion Phase|Withdrawal by Subject|0|||
106151220|NCT02723955|366215075|FG021|Expansion Phase|Withdrawal by Subject|0|||
105980026|NCT05149313|365589139|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
105980027|NCT05149313|365589136|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
105980028|NCT05149313|365589137|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
105980029|NCT05149313|365589138|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
105980030|NCT05149313|365589139|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
105980031|NCT05149313|365589136|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105980032|NCT05149313|365589137|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
105980033|NCT05149313|365589138|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
105980034|NCT05149313|365589139|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
105980035|NCT05149313|365589136|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
105980036|NCT05149313|365589137|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
105980037|NCT05149313|365589138|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
105980038|NCT05149313|365589139|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
105980039|NCT05149313|365589136|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105980040|NCT05149313|365589137|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105980041|NCT05149313|365589138|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
105980042|NCT05149313|365589139|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
105980043|NCT05149313|365589136|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
105980044|NCT05149313|365589137|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
105980045|NCT05149313|365589138|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
105980046|NCT05149313|365589139|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
105980047|NCT03199391|365589140|FG000|Overall Study|Death|1|||
105980048|NCT03199391|365589140|FG000|Overall Study|Lost to Follow-up|3|||
105980049|NCT03199391|365589140|FG000|Overall Study|Adverse Event|2|||
105980050|NCT03199391|365589140|FG000|Overall Study|Withdrawal by Subject|10|||
105980051|NCT00490776|365589141|FG000|Overall Study|Withdrawal by Subject|1|||
105980052|NCT00490776|365589141|FG000|Overall Study|Administrative Problems|1|||
105980053|NCT00490776|365589141|FG000|Overall Study|Death|1|||
105980054|NCT00490776|365589141|FG000|Overall Study|New Cancer Therapy|1|||
105980055|NCT00490776|365589141|FG000|Overall Study|Disease Progression|5|||
105980056|NCT04736628|365589144|FG000|Overall Study|Not treated|0|||
105980057|NCT04736628|365589145|FG001|Overall Study|Not treated|0|||
105980058|NCT04736628|365589146|FG002|Overall Study|Not treated|0|||
105980059|NCT04736628|365589147|FG003|Overall Study|Not treated|2|||
105980060|NCT04736628|365589144|FG000|Overall Study|Other reason than listed|1|||
105980061|NCT04736628|365589145|FG001|Overall Study|Other reason than listed|2|||
105980062|NCT04736628|365589146|FG002|Overall Study|Other reason than listed|2|||
105980063|NCT04736628|365589147|FG003|Overall Study|Other reason than listed|3|||
105980064|NCT04736628|365589144|FG000|Overall Study|Protocol deviation|0|||
105980065|NCT04736628|365589145|FG001|Overall Study|Protocol deviation|0|||
105980066|NCT04736628|365589146|FG002|Overall Study|Protocol deviation|0|||
105980067|NCT04736628|365589147|FG003|Overall Study|Protocol deviation|1|||
105980068|NCT04736628|365589144|FG000|Overall Study|Burden of study procedures|1|||
105980069|NCT04736628|365589145|FG001|Overall Study|Burden of study procedures|0|||
105980070|NCT04736628|365589146|FG002|Overall Study|Burden of study procedures|0|||
105980071|NCT04736628|365589147|FG003|Overall Study|Burden of study procedures|1|||
105980072|NCT04736628|365589144|FG000|Overall Study|Change of residence|0|||
105980073|NCT04736628|365589145|FG001|Overall Study|Change of residence|1|||
105980074|NCT04736628|365589146|FG002|Overall Study|Change of residence|0|||
105980075|NCT04736628|365589147|FG003|Overall Study|Change of residence|0|||
105980076|NCT04736628|365589144|FG000|Overall Study|Perceived lack of efficacy|1|||
105980077|NCT04736628|365589145|FG001|Overall Study|Perceived lack of efficacy|0|||
105980078|NCT04736628|365589146|FG002|Overall Study|Perceived lack of efficacy|0|||
105980079|NCT04736628|365589147|FG003|Overall Study|Perceived lack of efficacy|1|||
105980080|NCT04736628|365589144|FG000|Overall Study|Adverse Event|3|||
105980081|NCT04736628|365589145|FG001|Overall Study|Adverse Event|2|||
105980082|NCT04736628|365589146|FG002|Overall Study|Adverse Event|4|||
105980083|NCT04736628|365589147|FG003|Overall Study|Adverse Event|3|||
105980084|NCT03007745|365589152|FG000|Overall Study|Sleep test negative for OSA|53|||
105980085|NCT03007745|365589153|FG001|Overall Study|Sleep test negative for OSA|49|||
105980086|NCT03007745|365589152|FG000|Overall Study|Physician Decision|6|||
105980087|NCT03007745|365589153|FG001|Overall Study|Physician Decision|9|||
105980088|NCT03007745|365589152|FG000|Overall Study|Withdrawal by Subject|38|||
105980089|NCT03007745|365589153|FG001|Overall Study|Withdrawal by Subject|16|||
105980090|NCT03007745|365589152|FG000|Overall Study|Lost to Follow-up|19|||
105980091|NCT03007745|365589153|FG001|Overall Study|Lost to Follow-up|25|||
105980092|NCT03007745|365589152|FG000|Overall Study|Unable to login to website|17|||
105980093|NCT03007745|365589153|FG001|Overall Study|Unable to login to website|4|||
105980094|NCT03921554|365589156|FG000|Overall Study|Adverse Event|2|||
105980095|NCT03921554|365589156|FG000|Overall Study|Withdrawal by Subject|1|||
105980096|NCT03921554|365589156|FG000|Overall Study|Death|3|||
105980097|NCT01300351|365589163|FG000|Overall Study|Did not receive treatment|2|||
105980098|NCT01300351|365589164|FG001|Overall Study|Did not receive treatment|0|||
105980099|NCT01300351|365589163|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
105980100|NCT01300351|365589164|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
105980101|NCT01300351|365589163|FG000|Overall Study|Lost to Follow-up|0|||
105980102|NCT01300351|365589164|FG001|Overall Study|Lost to Follow-up|1|||
105980103|NCT01300351|365589163|FG000|Overall Study|Adverse Event|0|||
105980104|NCT01300351|365589164|FG001|Overall Study|Adverse Event|4|||
105980105|NCT01300351|365589163|FG000|Overall Study|Withdrawal by Subject|7|||
105980106|NCT01300351|365589164|FG001|Overall Study|Withdrawal by Subject|10|||
105980107|NCT00864851|365589172|FG000|Overall Study|Withdrawal by Subject|0|||
105980108|NCT00864851|365589173|FG001|Overall Study|Withdrawal by Subject|1|||
105980109|NCT00864851|365589174|FG002|Overall Study|Withdrawal by Subject|0|||
105980110|NCT00864851|365589172|FG000|Overall Study|Physician Decision|1|||
105980111|NCT00864851|365589173|FG001|Overall Study|Physician Decision|0|||
105980112|NCT00864851|365589174|FG002|Overall Study|Physician Decision|0|||
105980113|NCT00864851|365589172|FG000|Overall Study|Death|1|||
105980114|NCT00864851|365589173|FG001|Overall Study|Death|0|||
105980115|NCT00864851|365589174|FG002|Overall Study|Death|0|||
105980116|NCT00864851|365589172|FG000|Overall Study|Patient uncooperative|1|||
105980117|NCT00864851|365589173|FG001|Overall Study|Patient uncooperative|0|||
105980118|NCT00864851|365589174|FG002|Overall Study|Patient uncooperative|0|||
105980119|NCT00413010|365589175|FG000|Overall Study|Adverse Event|8|||
105980120|NCT00413010|365589176|FG001|Overall Study|Adverse Event|4|||
105980121|NCT00413010|365589175|FG000|Overall Study|Laboratory abnormality|0|||
105980122|NCT00413010|365589176|FG001|Overall Study|Laboratory abnormality|2|||
105980123|NCT00413010|365589175|FG000|Overall Study|Lack of Efficacy|0|||
105980124|NCT00413010|365589176|FG001|Overall Study|Lack of Efficacy|3|||
105980125|NCT00413010|365589175|FG000|Overall Study|Lost to Follow-up|3|||
105980126|NCT00413010|365589176|FG001|Overall Study|Lost to Follow-up|0|||
105980127|NCT00413010|365589175|FG000|Overall Study|Withdrawal by Subject|7|||
105980128|NCT00413010|365589176|FG001|Overall Study|Withdrawal by Subject|2|||
105980129|NCT00413010|365589175|FG000|Overall Study|Due to termination of the study|54|||
105980130|NCT00413010|365589176|FG001|Overall Study|Due to termination of the study|52|||
105980131|NCT00708734|365589179|FG000|Overall Study|scheduling conflict|2|||
105980132|NCT00708734|365589179|FG000|Overall Study|moved|1|||
105980133|NCT00708734|365589179|FG000|Overall Study|leg injury|1|||
105980134|NCT00708734|365589179|FG000|Overall Study|knee replacement|1|||
105980135|NCT00708734|365589179|FG000|Overall Study|vertigo|1|||
105980136|NCT00708734|365589179|FG000|Overall Study|leg fracture|1|||
105980137|NCT01533922|365589180|FG000|Overall Study|Adverse Event|5|||
105980138|NCT01533922|365589181|FG001|Overall Study|Adverse Event|8|||
105980139|NCT01533922|365589182|FG002|Overall Study|Adverse Event|6|||
105980140|NCT01533922|365589183|FG003|Overall Study|Adverse Event|3|||
105980141|NCT01533922|365589184|FG004|Overall Study|Adverse Event|4|||
105980142|NCT01533922|365589180|FG000|Overall Study|Lack of Efficacy|0|||
105980143|NCT01533922|365589181|FG001|Overall Study|Lack of Efficacy|0|||
105980144|NCT01533922|365589182|FG002|Overall Study|Lack of Efficacy|1|||
105980145|NCT01533922|365589183|FG003|Overall Study|Lack of Efficacy|0|||
105980146|NCT01533922|365589184|FG004|Overall Study|Lack of Efficacy|0|||
105980147|NCT01533922|365589180|FG000|Overall Study|Protocol Violation|0|||
105980148|NCT01533922|365589181|FG001|Overall Study|Protocol Violation|3|||
105980149|NCT01533922|365589182|FG002|Overall Study|Protocol Violation|0|||
105980150|NCT01533922|365589183|FG003|Overall Study|Protocol Violation|0|||
105980151|NCT01533922|365589184|FG004|Overall Study|Protocol Violation|1|||
105980152|NCT01533922|365589180|FG000|Overall Study|Withdrawal by Subject|3|||
105980153|NCT01533922|365589181|FG001|Overall Study|Withdrawal by Subject|1|||
105980154|NCT01533922|365589182|FG002|Overall Study|Withdrawal by Subject|2|||
105980155|NCT01533922|365589183|FG003|Overall Study|Withdrawal by Subject|2|||
105980156|NCT01533922|365589184|FG004|Overall Study|Withdrawal by Subject|1|||
105980157|NCT01533922|365589180|FG000|Overall Study|Other reason not defined above|2|||
106028924|NCT00600119|365770829|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
106028925|NCT00600119|365770830|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
106028926|NCT00600119|365770831|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
106028927|NCT00600119|365770832|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
106028928|NCT00600119|365770833|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
106028929|NCT00600119|365770834|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
105980158|NCT01533922|365589181|FG001|Overall Study|Other reason not defined above|0|||
105980159|NCT01533922|365589182|FG002|Overall Study|Other reason not defined above|1|||
105980160|NCT01533922|365589183|FG003|Overall Study|Other reason not defined above|0|||
105980161|NCT01533922|365589184|FG004|Overall Study|Other reason not defined above|0|||
105980162|NCT03242252|365589187|FG000|Overall Study|At the Participant's own Request|18|||
105980163|NCT03242252|365589188|FG001|Overall Study|At the Participant's own Request|10|||
105980164|NCT03242252|365589189|FG002|Overall Study|At the Participant's own Request|15|||
105980165|NCT03242252|365589187|FG000|Overall Study|Adverse Event|8|||
105980166|NCT03242252|365589188|FG001|Overall Study|Adverse Event|6|||
105980167|NCT03242252|365589189|FG002|Overall Study|Adverse Event|9|||
105980168|NCT03242252|365589187|FG000|Overall Study|Poor Compliance to Protocol|0|||
105980169|NCT03242252|365589188|FG001|Overall Study|Poor Compliance to Protocol|2|||
105980170|NCT03242252|365589189|FG002|Overall Study|Poor Compliance to Protocol|3|||
105980171|NCT03242252|365589187|FG000|Overall Study|Study Terminated by Sponsor|1|||
105980172|NCT03242252|365589188|FG001|Overall Study|Study Terminated by Sponsor|0|||
105980173|NCT03242252|365589189|FG002|Overall Study|Study Terminated by Sponsor|0|||
105980174|NCT03242252|365589187|FG000|Overall Study|Reason not Specified|4|||
105980175|NCT03242252|365589188|FG001|Overall Study|Reason not Specified|4|||
105980176|NCT03242252|365589189|FG002|Overall Study|Reason not Specified|1|||
105980177|NCT03242252|365589187|FG000|Overall Study|Lost to Follow-up|5|||
105980178|NCT03242252|365589188|FG001|Overall Study|Lost to Follow-up|1|||
105980179|NCT03242252|365589189|FG002|Overall Study|Lost to Follow-up|4|||
105980180|NCT01659255|365589192|FG000|Overall Study|Adverse Event|0|||
105980181|NCT01659255|365589193|FG001|Overall Study|Adverse Event|0|||
105980182|NCT01659255|365589194|FG002|Overall Study|Adverse Event|0|||
105980183|NCT01659255|365589195|FG003|Overall Study|Adverse Event|0|||
105980184|NCT01659255|365589196|FG004|Overall Study|Adverse Event|0|||
105980185|NCT01659255|365589197|FG005|Overall Study|Adverse Event|1|||
105980186|NCT01659255|365589198|FG006|Overall Study|Adverse Event|1|||
105980187|NCT01659255|365589199|FG007|Overall Study|Adverse Event|0|||
105980188|NCT01659255|365589200|FG008|Overall Study|Adverse Event|0|||
105980189|NCT01659255|365589201|FG009|Overall Study|Adverse Event|1|||
105980190|NCT01659255|365589202|FG010|Overall Study|Adverse Event|0|||
105980191|NCT01659255|365589203|FG011|Overall Study|Adverse Event|1|||
105980192|NCT01659255|365589204|FG012|Overall Study|Adverse Event|0|||
105980193|NCT01659255|365589205|FG013|Overall Study|Adverse Event|2|||
105980194|NCT01659255|365589206|FG014|Overall Study|Adverse Event|0|||
105980195|NCT01659255|365589207|FG015|Overall Study|Adverse Event|1|||
105980196|NCT01659255|365589208|FG016|Overall Study|Adverse Event|0|||
105980197|NCT01659255|365589192|FG000|Overall Study|Death|0|||
105980198|NCT01659255|365589193|FG001|Overall Study|Death|1|||
105980199|NCT01659255|365589194|FG002|Overall Study|Death|0|||
105980200|NCT01659255|365589195|FG003|Overall Study|Death|0|||
105980201|NCT01659255|365589196|FG004|Overall Study|Death|0|||
105980202|NCT01659255|365589197|FG005|Overall Study|Death|0|||
105980203|NCT01659255|365589198|FG006|Overall Study|Death|0|||
105980204|NCT01659255|365589199|FG007|Overall Study|Death|1|||
105980205|NCT01659255|365589200|FG008|Overall Study|Death|1|||
105980206|NCT01659255|365589201|FG009|Overall Study|Death|0|||
105980207|NCT01659255|365589202|FG010|Overall Study|Death|0|||
105980208|NCT01659255|365589203|FG011|Overall Study|Death|0|||
105980209|NCT01659255|365589204|FG012|Overall Study|Death|1|||
105980210|NCT01659255|365589205|FG013|Overall Study|Death|1|||
105980211|NCT01659255|365589206|FG014|Overall Study|Death|2|||
105980212|NCT01659255|365589207|FG015|Overall Study|Death|1|||
105980213|NCT01659255|365589208|FG016|Overall Study|Death|0|||
105980214|NCT01659255|365589192|FG000|Overall Study|Progressive Disease|2|||
105980215|NCT01659255|365589193|FG001|Overall Study|Progressive Disease|0|||
105980216|NCT01659255|365589194|FG002|Overall Study|Progressive Disease|0|||
105980217|NCT01659255|365589195|FG003|Overall Study|Progressive Disease|0|||
105980218|NCT01659255|365589196|FG004|Overall Study|Progressive Disease|0|||
105980219|NCT01659255|365589197|FG005|Overall Study|Progressive Disease|0|||
105980220|NCT01659255|365589198|FG006|Overall Study|Progressive Disease|0|||
105980221|NCT01659255|365589199|FG007|Overall Study|Progressive Disease|1|||
105980222|NCT01659255|365589200|FG008|Overall Study|Progressive Disease|0|||
105980223|NCT01659255|365589201|FG009|Overall Study|Progressive Disease|2|||
105980224|NCT01659255|365589202|FG010|Overall Study|Progressive Disease|2|||
105980225|NCT01659255|365589203|FG011|Overall Study|Progressive Disease|3|||
105980226|NCT01659255|365589204|FG012|Overall Study|Progressive Disease|5|||
105980227|NCT01659255|365589205|FG013|Overall Study|Progressive Disease|13|||
105980228|NCT01659255|365589206|FG014|Overall Study|Progressive Disease|6|||
105980229|NCT01659255|365589207|FG015|Overall Study|Progressive Disease|2|||
105980230|NCT01659255|365589208|FG016|Overall Study|Progressive Disease|3|||
105980231|NCT01659255|365589192|FG000|Overall Study|Withdrew Consent|0|||
105980232|NCT01659255|365589193|FG001|Overall Study|Withdrew Consent|0|||
105980233|NCT01659255|365589194|FG002|Overall Study|Withdrew Consent|0|||
105980234|NCT01659255|365589195|FG003|Overall Study|Withdrew Consent|0|||
105980235|NCT01659255|365589196|FG004|Overall Study|Withdrew Consent|0|||
105980236|NCT01659255|365589197|FG005|Overall Study|Withdrew Consent|0|||
105980237|NCT01659255|365589198|FG006|Overall Study|Withdrew Consent|0|||
105980238|NCT01659255|365589199|FG007|Overall Study|Withdrew Consent|0|||
105980239|NCT01659255|365589200|FG008|Overall Study|Withdrew Consent|0|||
105980240|NCT01659255|365589201|FG009|Overall Study|Withdrew Consent|0|||
105980241|NCT01659255|365589202|FG010|Overall Study|Withdrew Consent|1|||
105980242|NCT01659255|365589203|FG011|Overall Study|Withdrew Consent|0|||
105980243|NCT01659255|365589204|FG012|Overall Study|Withdrew Consent|0|||
105980244|NCT01659255|365589205|FG013|Overall Study|Withdrew Consent|1|||
105980245|NCT01659255|365589206|FG014|Overall Study|Withdrew Consent|0|||
105980246|NCT01659255|365589207|FG015|Overall Study|Withdrew Consent|0|||
105980247|NCT01659255|365589208|FG016|Overall Study|Withdrew Consent|0|||
105980248|NCT01659255|365589192|FG000|Overall Study|Investigator Decision|0|||
105980249|NCT01659255|365589193|FG001|Overall Study|Investigator Decision|0|||
105980250|NCT01659255|365589194|FG002|Overall Study|Investigator Decision|0|||
105980251|NCT01659255|365589195|FG003|Overall Study|Investigator Decision|0|||
105980252|NCT01659255|365589196|FG004|Overall Study|Investigator Decision|0|||
106151221|NCT02723955|366215076|FG022|Expansion Phase|Withdrawal by Subject|0|||
106151222|NCT02723955|366215077|FG023|Expansion Phase|Withdrawal by Subject|0|||
106151223|NCT02723955|366215078|FG024|Expansion Phase|Withdrawal by Subject|0|||
106151224|NCT02723955|366215079|FG025|Expansion Phase|Withdrawal by Subject|0|||
106151225|NCT02723955|366215080|FG026|Expansion Phase|Withdrawal by Subject|0|||
106151226|NCT02723955|366215081|FG027|Expansion Phase|Withdrawal by Subject|0|||
105980253|NCT01659255|365589197|FG005|Overall Study|Investigator Decision|0|||
105980254|NCT01659255|365589198|FG006|Overall Study|Investigator Decision|0|||
105980255|NCT01659255|365589199|FG007|Overall Study|Investigator Decision|0|||
105980256|NCT01659255|365589200|FG008|Overall Study|Investigator Decision|0|||
105980257|NCT01659255|365589201|FG009|Overall Study|Investigator Decision|0|||
105980258|NCT01659255|365589202|FG010|Overall Study|Investigator Decision|0|||
105980259|NCT01659255|365589203|FG011|Overall Study|Investigator Decision|0|||
105980260|NCT01659255|365589204|FG012|Overall Study|Investigator Decision|1|||
105980261|NCT01659255|365589205|FG013|Overall Study|Investigator Decision|1|||
105980262|NCT01659255|365589206|FG014|Overall Study|Investigator Decision|0|||
105980263|NCT01659255|365589207|FG015|Overall Study|Investigator Decision|0|||
105980264|NCT01659255|365589208|FG016|Overall Study|Investigator Decision|0|||
105980265|NCT01659255|365589192|FG000|Overall Study|Sponsor's Decision|0|||
105980266|NCT01659255|365589193|FG001|Overall Study|Sponsor's Decision|0|||
105980267|NCT01659255|365589194|FG002|Overall Study|Sponsor's Decision|0|||
105980268|NCT01659255|365589195|FG003|Overall Study|Sponsor's Decision|0|||
105980269|NCT01659255|365589196|FG004|Overall Study|Sponsor's Decision|0|||
105980270|NCT01659255|365589197|FG005|Overall Study|Sponsor's Decision|0|||
105980271|NCT01659255|365589198|FG006|Overall Study|Sponsor's Decision|1|||
105980272|NCT01659255|365589199|FG007|Overall Study|Sponsor's Decision|0|||
105980273|NCT01659255|365589200|FG008|Overall Study|Sponsor's Decision|0|||
105980274|NCT01659255|365589201|FG009|Overall Study|Sponsor's Decision|0|||
105980275|NCT01659255|365589202|FG010|Overall Study|Sponsor's Decision|0|||
105980276|NCT01659255|365589203|FG011|Overall Study|Sponsor's Decision|0|||
105980277|NCT01659255|365589204|FG012|Overall Study|Sponsor's Decision|0|||
105980278|NCT01659255|365589205|FG013|Overall Study|Sponsor's Decision|0|||
105980279|NCT01659255|365589206|FG014|Overall Study|Sponsor's Decision|0|||
105980280|NCT01659255|365589207|FG015|Overall Study|Sponsor's Decision|0|||
105980281|NCT01659255|365589208|FG016|Overall Study|Sponsor's Decision|0|||
105980282|NCT01659255|365589192|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980283|NCT01659255|365589193|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980284|NCT01659255|365589194|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980285|NCT01659255|365589195|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980286|NCT01659255|365589196|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980287|NCT01659255|365589197|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980288|NCT01659255|365589198|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980289|NCT01659255|365589199|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980290|NCT01659255|365589200|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980291|NCT01659255|365589201|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980292|NCT01659255|365589202|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980293|NCT01659255|365589203|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980294|NCT01659255|365589204|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980295|NCT01659255|365589205|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980296|NCT01659255|365589206|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980297|NCT01659255|365589207|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
105980298|NCT01659255|365589208|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
105980299|NCT01659255|365589192|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
105980300|NCT01659255|365589193|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
105980301|NCT01659255|365589194|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
105980302|NCT01659255|365589195|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
105980303|NCT01659255|365589196|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
105980304|NCT01659255|365589197|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
105980305|NCT01659255|365589198|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
105980306|NCT01659255|365589199|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
105980307|NCT01659255|365589200|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
105980308|NCT01659255|365589201|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
105980309|NCT01659255|365589202|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
105980310|NCT01659255|365589203|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
105980311|NCT01659255|365589204|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
105980312|NCT01659255|365589205|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
105980313|NCT01659255|365589206|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
105980314|NCT01659255|365589207|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
105980315|NCT01659255|365589208|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
106151227|NCT02723955|366215082|FG028|Expansion Phase|Withdrawal by Subject|0|||
106028930|NCT00600119|365770829|FG000|Double-blind Treatment Period|Other|0|||
106028931|NCT00600119|365770830|FG001|Double-blind Treatment Period|Other|0|||
106028932|NCT00600119|365770831|FG002|Double-blind Treatment Period|Other|0|||
106028933|NCT00600119|365770832|FG003|Double-blind Treatment Period|Other|0|||
106028934|NCT00600119|365770833|FG004|Double-blind Treatment Period|Other|2|||
106028935|NCT00600119|365770834|FG005|Double-blind Treatment Period|Other|1|||
106028936|NCT00600119|365770829|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
106028937|NCT00600119|365770830|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
106028938|NCT00600119|365770831|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
105980316|NCT01842581|365589209|FG000|Overall Study|Adverse Event|6|||
105980317|NCT01842581|365589210|FG001|Overall Study|Adverse Event|4|||
105980318|NCT01842581|365589209|FG000|Overall Study|HE breakthrough|26|||
105980319|NCT01842581|365589210|FG001|Overall Study|HE breakthrough|13|||
105980320|NCT01842581|365589209|FG000|Overall Study|Liver transplant|2|||
105980321|NCT01842581|365589210|FG001|Overall Study|Liver transplant|0|||
105980322|NCT01842581|365589209|FG000|Overall Study|Lost to Follow-up|2|||
105980323|NCT01842581|365589210|FG001|Overall Study|Lost to Follow-up|5|||
105980324|NCT01842581|365589209|FG000|Overall Study|Withdrawal by Subject|5|||
105980325|NCT01842581|365589210|FG001|Overall Study|Withdrawal by Subject|7|||
105980326|NCT01842581|365589209|FG000|Overall Study|Other than specified|3|||
105980327|NCT01842581|365589210|FG001|Overall Study|Other than specified|1|||
105980328|NCT05432167|365589211|FG000|Overall Study|Adverse Event|0|||
105980329|NCT05432167|365589212|FG001|Overall Study|Adverse Event|2|||
105980330|NCT05432167|365589213|FG002|Overall Study|Adverse Event|1|||
105980331|NCT05432167|365589211|FG000|Overall Study|Lost to Follow-up|3|||
105980332|NCT05432167|365589212|FG001|Overall Study|Lost to Follow-up|3|||
105980333|NCT05432167|365589213|FG002|Overall Study|Lost to Follow-up|2|||
105980334|NCT05432167|365589211|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
105980335|NCT05432167|365589212|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
105980336|NCT05432167|365589213|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
105980337|NCT05432167|365589211|FG000|Overall Study|Physician Decision|1|||
105980338|NCT05432167|365589212|FG001|Overall Study|Physician Decision|0|||
105980339|NCT05432167|365589213|FG002|Overall Study|Physician Decision|0|||
105980340|NCT05432167|365589211|FG000|Overall Study|Withdrawal by Subject|7|||
105980341|NCT05432167|365589212|FG001|Overall Study|Withdrawal by Subject|4|||
105980342|NCT05432167|365589213|FG002|Overall Study|Withdrawal by Subject|11|||
105980343|NCT05432167|365589211|FG000|Overall Study|Other|0|||
105980344|NCT05432167|365589212|FG001|Overall Study|Other|0|||
105980345|NCT05432167|365589213|FG002|Overall Study|Other|1|||
105980346|NCT01287195|365589214|FG000|Overall Study|Withdrawal by Subject|2|||
105980347|NCT01267175|365589215|FG000|Overall Study|Withdrawal by Subject|1|||
105980348|NCT01267175|365589215|FG000|Overall Study|Lost to Follow-up|1|||
105980349|NCT00357656|365589217|FG000|Overall Study|Other, No surgery performed|0|||
105980350|NCT00357656|365589218|FG001|Overall Study|Other, No surgery performed|3|||
105980351|NCT01219933|365589219|FG000|Overall Study|Adverse Event|8|||
105980352|NCT01219933|365589219|FG000|Overall Study|No LDA reached|5|||
105980353|NCT01219933|365589219|FG000|Overall Study|No LDA maintained|7|||
105980354|NCT01219933|365589219|FG000|Overall Study|Lost to Follow-up|3|||
105980355|NCT01219933|365589219|FG000|Overall Study|GC free|1|||
105980356|NCT01219933|365589219|FG000|Overall Study|Withdrawal by Subject|5|||
105980357|NCT01219933|365589219|FG000|Overall Study|Protocol Violation|8|||
105980358|NCT01219933|365589219|FG000|Overall Study|Lack of Efficacy|1|||
105980359|NCT01177969|365589220|FG000|Overall Study|Protocol Violation|2|||
105980360|NCT01177969|365589221|FG001|Overall Study|Protocol Violation|1|||
105980361|NCT01177969|365589220|FG000|Overall Study|Withdrawal by Subject|1|||
105980362|NCT01177969|365589221|FG001|Overall Study|Withdrawal by Subject|2|||
105980363|NCT02855944|365589222|FG000|Period 1: Treatment|Ongoing|14|||
105980364|NCT02855944|365589223|FG001|Period 1: Treatment|Ongoing|0|||
105980365|NCT02855944|365589222|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
105980366|NCT02855944|365589223|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
105980367|NCT02855944|365589222|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
105980368|NCT02855944|365589223|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
105980369|NCT01283542|365589224|FG000|Main Phase|Acute or progressive vision loss|1|||
105980370|NCT01283542|365589224|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
105980371|NCT01283542|365589224|FG000|Main Phase|abnormal laboratory values|5|||
105980372|NCT01283542|365589224|FG000|Extension Phase|Physician Decision|1|||
105980373|NCT01283542|365589224|FG000|Extension Phase|Adverse Event|1|||
105980374|NCT01283542|365589224|FG000|Extension Phase|Administrative problems|1|||
105980375|NCT02636946|365589225|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
105980376|NCT02636946|365589226|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
105980377|NCT02636946|365589225|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
105980378|NCT02636946|365589226|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
105980379|NCT02636946|365589225|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
105980380|NCT02636946|365589226|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
105980381|NCT02636946|365589225|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
105980382|NCT02636946|365589226|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
105980383|NCT02636946|365589225|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
106028939|NCT00600119|365770832|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
106028940|NCT00600119|365770833|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
106028941|NCT00600119|365770834|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
106028942|NCT00600119|365770829|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
106028943|NCT00600119|365770830|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
106028944|NCT00600119|365770831|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
106028945|NCT00600119|365770832|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
106028946|NCT00600119|365770833|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
106028947|NCT00600119|365770834|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
106028948|NCT00600119|365770829|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
106028949|NCT00600119|365770830|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
106028950|NCT00600119|365770831|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
106028951|NCT00600119|365770832|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
106028952|NCT00600119|365770833|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
106028953|NCT00600119|365770834|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
106028954|NCT00600119|365770829|FG000|Double-blind Treatment Period|Physician Decision|2|||
106028955|NCT00600119|365770830|FG001|Double-blind Treatment Period|Physician Decision|0|||
106028956|NCT00600119|365770831|FG002|Double-blind Treatment Period|Physician Decision|0|||
105980384|NCT02636946|365589226|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
105980385|NCT02636946|365589225|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
105980386|NCT02636946|365589226|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
105980387|NCT05059977|365589227|FG000|Overall Study|Withdrawal by Subject|0|||
105980388|NCT05059977|365589228|FG001|Overall Study|Withdrawal by Subject|0|||
105980389|NCT05059977|365589229|FG002|Overall Study|Withdrawal by Subject|1|||
105980390|NCT00121641|365589230|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
105980391|NCT00121641|365589231|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
105980392|NCT00121641|365589232|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
105980393|NCT00121641|365589233|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
105980394|NCT00121641|365589234|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
105980395|NCT00121641|365589230|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
105980396|NCT00121641|365589231|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
105980397|NCT00121641|365589232|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
105980398|NCT00121641|365589233|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
105980399|NCT00121641|365589234|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
105980400|NCT00121641|365589230|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
105980401|NCT00121641|365589231|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
105980402|NCT00121641|365589232|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
105980403|NCT00121641|365589233|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
105980404|NCT00121641|365589234|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
105980405|NCT00121641|365589230|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
105980406|NCT00121641|365589231|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
105980407|NCT00121641|365589232|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
105980408|NCT00121641|365589233|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
105980409|NCT00121641|365589234|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
105980410|NCT00121641|365589230|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
105980411|NCT00121641|365589231|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
105980412|NCT00121641|365589232|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
105980413|NCT00121641|365589233|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
105980414|NCT00121641|365589234|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
105980415|NCT00121641|365589230|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
105980416|NCT00121641|365589231|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
105980417|NCT00121641|365589232|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
105980418|NCT00121641|365589233|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
106028957|NCT00600119|365770832|FG003|Double-blind Treatment Period|Physician Decision|0|||
106028958|NCT00600119|365770833|FG004|Double-blind Treatment Period|Physician Decision|0|||
106028959|NCT00600119|365770834|FG005|Double-blind Treatment Period|Physician Decision|0|||
106151228|NCT02723955|366215083|FG029|Expansion Phase|Withdrawal by Subject|0|||
106151229|NCT02723955|366215084|FG030|Expansion Phase|Withdrawal by Subject|8|||
106151230|NCT02723955|366215085|FG031|Expansion Phase|Withdrawal by Subject|4|||
106151231|NCT02723955|366215086|FG032|Expansion Phase|Withdrawal by Subject|0|||
106151232|NCT02723955|366215087|FG033|Expansion Phase|Withdrawal by Subject|0|||
106151233|NCT02723955|366215088|FG034|Expansion Phase|Withdrawal by Subject|0|||
106151234|NCT02723955|366215089|FG035|Expansion Phase|Withdrawal by Subject|1|||
106151235|NCT02723955|366215090|FG036|Expansion Phase|Withdrawal by Subject|0|||
106151236|NCT02723955|366215091|FG037|Expansion Phase|Withdrawal by Subject|0|||
106151237|NCT02723955|366215092|FG038|Expansion Phase|Withdrawal by Subject|0|||
106151238|NCT02723955|366215093|FG039|Expansion Phase|Withdrawal by Subject|0|||
105851566|NCT00073021|365112746|FG000|Overall Study|Physician Decision|3|||
105851567|NCT00073021|365112747|FG001|Overall Study|Physician Decision|1|||
105851568|NCT00073021|365112746|FG000|Overall Study|Lack of Efficacy|11|||
105851569|NCT00073021|365112747|FG001|Overall Study|Lack of Efficacy|5|||
105851570|NCT01753336|365112748|FG000|Overall Study|Patient decision|12|||
105851571|NCT01753336|365112748|FG000|Overall Study|Lost to Follow-up|3|||
105980419|NCT00121641|365589234|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
105980420|NCT00121641|365589230|FG000|24-week Short-term Treatment Period|Other Reason|1|||
105980421|NCT00121641|365589231|FG001|24-week Short-term Treatment Period|Other Reason|0|||
105980422|NCT00121641|365589232|FG002|24-week Short-term Treatment Period|Other Reason|0|||
105980423|NCT00121641|365589233|FG003|24-week Short-term Treatment Period|Other Reason|0|||
105980424|NCT00121641|365589234|FG004|24-week Short-term Treatment Period|Other Reason|0|||
105980425|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
105980426|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
105980427|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
105980428|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
105980429|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
105980430|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
105980431|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
105980432|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
105980433|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
105980434|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
105980435|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
105980436|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
106151239|NCT02723955|366215094|FG040|Expansion Phase|Withdrawal by Subject|0|||
106151240|NCT02723955|366215095|FG041|Expansion Phase|Withdrawal by Subject|0|||
106151241|NCT02723955|366215096|FG042|Expansion Phase|Withdrawal by Subject|0|||
106151242|NCT02723955|366215054|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105980437|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
105980438|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
105980439|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
105980440|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
105980441|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
105980442|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
105851572|NCT01753336|365112748|FG000|Overall Study|Physician Decision|2|||
105851573|NCT01753336|365112748|FG000|Overall Study|Sponsor's decision|2|||
105851574|NCT01753336|365112748|FG000|Overall Study|Withdrawal by Subject|1|||
105851575|NCT00914459|365112749|FG000|Overall Study|Protocol Violation|0|||
105851576|NCT00914459|365112750|FG001|Overall Study|Protocol Violation|1|||
105851577|NCT00914459|365112749|FG000|Overall Study|Parent/Legal guardian request|1|||
105851578|NCT00914459|365112750|FG001|Overall Study|Parent/Legal guardian request|0|||
105851579|NCT01661179|365112753|FG000|Overall Study|Death|1|||
105851580|NCT01661179|365112753|FG000|Overall Study|Withdrawal by Subject|1|||
105851581|NCT01661179|365112753|FG000|Overall Study|Other Eligibility criteria|4|||
105851582|NCT01083810|365112754|FG000|Overall Study|Lost to Follow-up|23|||
105851583|NCT01083810|365112755|FG001|Overall Study|Lost to Follow-up|11|||
105980443|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
105980444|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
105980445|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
105980446|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
105980447|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
105980448|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
105851584|NCT01083810|365112756|FG002|Overall Study|Lost to Follow-up|4|||
105851585|NCT01083810|365112754|FG000|Overall Study|Adverse Event|15|||
105851586|NCT01083810|365112755|FG001|Overall Study|Adverse Event|11|||
106028960|NCT00600119|365770829|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
106028961|NCT00600119|365770830|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
106028962|NCT00600119|365770831|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
106028963|NCT00600119|365770832|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
106028964|NCT00600119|365770833|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
106028965|NCT00600119|365770834|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
106028966|NCT00600119|365770829|FG000|Double-blind Treatment Period|Adverse Event|1|||
106028967|NCT00600119|365770830|FG001|Double-blind Treatment Period|Adverse Event|1|||
106028968|NCT00600119|365770831|FG002|Double-blind Treatment Period|Adverse Event|0|||
106028969|NCT00600119|365770832|FG003|Double-blind Treatment Period|Adverse Event|1|||
106028970|NCT00600119|365770833|FG004|Double-blind Treatment Period|Adverse Event|2|||
106028971|NCT00600119|365770834|FG005|Double-blind Treatment Period|Adverse Event|10|||
106028972|NCT00600119|365770829|FG000|Follow-up Period|Adverse Event|0|||
106028973|NCT00600119|365770830|FG001|Follow-up Period|Adverse Event|0|||
106028974|NCT00600119|365770831|FG002|Follow-up Period|Adverse Event|0|||
106028975|NCT00600119|365770832|FG003|Follow-up Period|Adverse Event|0|||
106028976|NCT00600119|365770833|FG004|Follow-up Period|Adverse Event|0|||
106028977|NCT00600119|365770834|FG005|Follow-up Period|Adverse Event|1|||
106028978|NCT00600119|365770829|FG000|Follow-up Period|Other|1|||
106028979|NCT00600119|365770830|FG001|Follow-up Period|Other|0|||
105851587|NCT01083810|365112756|FG002|Overall Study|Adverse Event|4|||
106028980|NCT00600119|365770831|FG002|Follow-up Period|Other|0|||
106028981|NCT00600119|365770832|FG003|Follow-up Period|Other|0|||
106028982|NCT00600119|365770833|FG004|Follow-up Period|Other|0|||
106028983|NCT00600119|365770834|FG005|Follow-up Period|Other|0|||
106028984|NCT00729469|365770839|FG000|Overall Study|Adverse Event|14|||
106028985|NCT00729469|365770840|FG001|Overall Study|Adverse Event|25|||
106028986|NCT00729469|365770839|FG000|Overall Study|Lost to Follow-up|9|||
106028987|NCT00729469|365770840|FG001|Overall Study|Lost to Follow-up|9|||
106151243|NCT02723955|366215055|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151244|NCT02723955|366215056|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151245|NCT02723955|366215057|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151246|NCT02723955|366215058|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151247|NCT02723955|366215059|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151248|NCT02723955|366215060|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151249|NCT02723955|366215061|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151250|NCT02723955|366215062|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151251|NCT02723955|366215063|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
106151252|NCT02723955|366215064|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
106151253|NCT02723955|366215065|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
106151254|NCT02723955|366215066|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151255|NCT02723955|366215067|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151256|NCT02723955|366215068|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151257|NCT02723955|366215069|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151258|NCT02723955|366215070|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151259|NCT02723955|366215071|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151260|NCT02723955|366215072|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151261|NCT02723955|366215073|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151262|NCT02723955|366215074|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151263|NCT02723955|366215075|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151264|NCT02723955|366215076|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151265|NCT02723955|366215077|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151266|NCT02723955|366215078|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151267|NCT02723955|366215079|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151268|NCT02723955|366215080|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151269|NCT02723955|366215081|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151270|NCT02723955|366215082|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151271|NCT02723955|366215083|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151272|NCT02723955|366215084|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
106151273|NCT02723955|366215085|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151274|NCT02723955|366215086|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105980449|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
105980450|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
105980451|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
105980452|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
105980453|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
105980454|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
105980455|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
105980456|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
105980457|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
105980458|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
105980459|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
105980460|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
105980461|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
105980462|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
105980463|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
105980464|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
105980465|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Death|0|||
105980466|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Death|0|||
105980467|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Death|0|||
105980468|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Death|1|||
105980469|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Death|0|||
105980470|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Missing|0|||
105980471|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Missing|0|||
105980472|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Missing|1|||
105980473|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Missing|0|||
105980474|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Missing|0|||
105980475|NCT00121641|365589230|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
105980476|NCT00121641|365589231|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
105980477|NCT00121641|365589232|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
105980478|NCT00121641|365589233|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
105980479|NCT00121641|365589234|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
105980480|NCT03691779|365589242|FG000|Part B (24 Weeks)|Adverse Event|0|||
105980481|NCT03691779|365589243|FG001|Part B (24 Weeks)|Adverse Event|1|||
105980482|NCT03691779|365589242|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
105980483|NCT03691779|365589243|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
105980484|NCT00267150|365589246|FG000|Overall Study|Adverse Event|1|||
105980485|NCT01561963|365589247|FG000|Overall Study|Adverse Event|1|||
105980486|NCT01459913|365589248|FG000|Overall Study|Adverse Event|0|||
105980487|NCT01459913|365589249|FG001|Overall Study|Adverse Event|0|||
105980488|NCT01459913|365589250|FG002|Overall Study|Adverse Event|0|||
105980489|NCT01459913|365589251|FG003|Overall Study|Adverse Event|3|||
105980490|NCT01459913|365589248|FG000|Overall Study|Withdrawal by Subject|4|||
105980491|NCT01459913|365589249|FG001|Overall Study|Withdrawal by Subject|0|||
105980492|NCT01459913|365589250|FG002|Overall Study|Withdrawal by Subject|0|||
105980493|NCT01459913|365589251|FG003|Overall Study|Withdrawal by Subject|5|||
105980494|NCT01459913|365589248|FG000|Overall Study|Lost to Follow-up|7|||
105980495|NCT01459913|365589249|FG001|Overall Study|Lost to Follow-up|4|||
105980496|NCT01459913|365589250|FG002|Overall Study|Lost to Follow-up|1|||
105980497|NCT01459913|365589251|FG003|Overall Study|Lost to Follow-up|8|||
105980498|NCT01459913|365589248|FG000|Overall Study|Death|0|||
105980499|NCT01459913|365589249|FG001|Overall Study|Death|0|||
105980500|NCT01459913|365589250|FG002|Overall Study|Death|0|||
105980501|NCT01459913|365589251|FG003|Overall Study|Death|1|||
105980502|NCT01459913|365589248|FG000|Overall Study|Non- Compliance|0|||
105980503|NCT01459913|365589249|FG001|Overall Study|Non- Compliance|0|||
105980504|NCT01459913|365589250|FG002|Overall Study|Non- Compliance|0|||
105980505|NCT01459913|365589251|FG003|Overall Study|Non- Compliance|3|||
105980506|NCT01459913|365589248|FG000|Overall Study|Physician Decision|0|||
105980507|NCT01459913|365589249|FG001|Overall Study|Physician Decision|1|||
105980508|NCT01459913|365589250|FG002|Overall Study|Physician Decision|0|||
105980509|NCT01459913|365589251|FG003|Overall Study|Physician Decision|0|||
105980510|NCT01459913|365589248|FG000|Overall Study|Study Terminated by Sponsor|30|||
105980511|NCT01459913|365589249|FG001|Overall Study|Study Terminated by Sponsor|15|||
105980512|NCT01459913|365589250|FG002|Overall Study|Study Terminated by Sponsor|9|||
105980513|NCT01459913|365589251|FG003|Overall Study|Study Terminated by Sponsor|11|||
105980514|NCT01459913|365589248|FG000|Overall Study|Other|0|||
105980515|NCT01459913|365589249|FG001|Overall Study|Other|0|||
105980516|NCT01459913|365589250|FG002|Overall Study|Other|3|||
106151275|NCT02723955|366215087|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105980517|NCT01459913|365589251|FG003|Overall Study|Other|1|||
105980518|NCT01459913|365589248|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
105980519|NCT01459913|365589249|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
105980520|NCT01459913|365589250|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
105980521|NCT01459913|365589251|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
105980522|NCT01064687|365589254|FG000|Overall Study|Adverse Event|9|||
105980523|NCT01064687|365589255|FG001|Overall Study|Adverse Event|4|||
105980524|NCT01064687|365589256|FG002|Overall Study|Adverse Event|10|||
105980525|NCT01064687|365589257|FG003|Overall Study|Adverse Event|3|||
105980526|NCT01064687|365589254|FG000|Overall Study|Death|1|||
105980527|NCT01064687|365589255|FG001|Overall Study|Death|1|||
105980528|NCT01064687|365589256|FG002|Overall Study|Death|0|||
105980529|NCT01064687|365589257|FG003|Overall Study|Death|0|||
105980530|NCT01064687|365589254|FG000|Overall Study|Entry Criteria Not Met|3|||
105980531|NCT01064687|365589255|FG001|Overall Study|Entry Criteria Not Met|0|||
105980532|NCT01064687|365589256|FG002|Overall Study|Entry Criteria Not Met|0|||
105980533|NCT01064687|365589257|FG003|Overall Study|Entry Criteria Not Met|0|||
105980534|NCT01064687|365589254|FG000|Overall Study|Lack of Efficacy|1|||
105980535|NCT01064687|365589255|FG001|Overall Study|Lack of Efficacy|0|||
105980536|NCT01064687|365589256|FG002|Overall Study|Lack of Efficacy|2|||
105980537|NCT01064687|365589257|FG003|Overall Study|Lack of Efficacy|3|||
105980538|NCT01064687|365589254|FG000|Overall Study|Lost to Follow-up|7|||
105980539|NCT01064687|365589255|FG001|Overall Study|Lost to Follow-up|10|||
105980540|NCT01064687|365589256|FG002|Overall Study|Lost to Follow-up|13|||
105980541|NCT01064687|365589257|FG003|Overall Study|Lost to Follow-up|5|||
105980542|NCT01064687|365589254|FG000|Overall Study|Physician Decision|2|||
105980543|NCT01064687|365589255|FG001|Overall Study|Physician Decision|2|||
105980544|NCT01064687|365589256|FG002|Overall Study|Physician Decision|0|||
105980545|NCT01064687|365589257|FG003|Overall Study|Physician Decision|0|||
105980546|NCT01064687|365589254|FG000|Overall Study|Protocol Violation|1|||
105980547|NCT01064687|365589255|FG001|Overall Study|Protocol Violation|1|||
105980548|NCT01064687|365589256|FG002|Overall Study|Protocol Violation|0|||
105980549|NCT01064687|365589257|FG003|Overall Study|Protocol Violation|1|||
105980550|NCT01064687|365589254|FG000|Overall Study|Sponsor Decision|0|||
105980551|NCT01064687|365589255|FG001|Overall Study|Sponsor Decision|0|||
105980552|NCT01064687|365589256|FG002|Overall Study|Sponsor Decision|3|||
105980553|NCT01064687|365589257|FG003|Overall Study|Sponsor Decision|0|||
105980554|NCT01064687|365589254|FG000|Overall Study|Withdrawal by Subject|9|||
105980555|NCT01064687|365589255|FG001|Overall Study|Withdrawal by Subject|7|||
105980556|NCT01064687|365589256|FG002|Overall Study|Withdrawal by Subject|12|||
105980557|NCT01064687|365589257|FG003|Overall Study|Withdrawal by Subject|5|||
105980558|NCT01064687|365589254|FG000|Overall Study|Treatment Noncompliance|1|||
105980559|NCT01064687|365589255|FG001|Overall Study|Treatment Noncompliance|1|||
105980560|NCT01064687|365589256|FG002|Overall Study|Treatment Noncompliance|1|||
105980561|NCT01064687|365589257|FG003|Overall Study|Treatment Noncompliance|0|||
105980562|NCT00958217|365589260|FG000|Overall Study|Death|2|||
105980563|NCT00958217|365589261|FG001|Overall Study|Death|1|||
105980564|NCT00958217|365589260|FG000|Overall Study|Withdrawal by Subject|4|||
105980565|NCT00958217|365589261|FG001|Overall Study|Withdrawal by Subject|3|||
105980566|NCT00958217|365589260|FG000|Overall Study|Lost to Follow-up|17|||
105980567|NCT00958217|365589261|FG001|Overall Study|Lost to Follow-up|19|||
105980568|NCT00958217|365589260|FG000|Overall Study|Moved out of area|1|||
105980569|NCT00958217|365589261|FG001|Overall Study|Moved out of area|1|||
105980570|NCT00958217|365589260|FG000|Overall Study|Inpatient hospitalization|0|||
105980571|NCT00958217|365589261|FG001|Overall Study|Inpatient hospitalization|1|||
105980572|NCT01075984|365589264|FG000|Treatment Phase|Adverse Event|0|||
105980573|NCT01075984|365589265|FG001|Treatment Phase|Adverse Event|1|||
105980574|NCT01075984|365589266|FG002|Treatment Phase|Adverse Event|3|||
105980575|NCT01075984|365589267|FG003|Treatment Phase|Adverse Event|7|||
106028988|NCT00729469|365770839|FG000|Overall Study|Protocol Violation|2|||
106028989|NCT00729469|365770840|FG001|Overall Study|Protocol Violation|1|||
105980576|NCT01075984|365589268|FG004|Treatment Phase|Adverse Event|35|||
105980577|NCT01075984|365589264|FG000|Treatment Phase|Protocol Violation|0|||
105980578|NCT01075984|365589265|FG001|Treatment Phase|Protocol Violation|0|||
105980579|NCT01075984|365589266|FG002|Treatment Phase|Protocol Violation|1|||
105980580|NCT01075984|365589267|FG003|Treatment Phase|Protocol Violation|0|||
105980581|NCT01075984|365589268|FG004|Treatment Phase|Protocol Violation|3|||
105980582|NCT01075984|365589264|FG000|Treatment Phase|Withdrawal by Subject|0|||
105980583|NCT01075984|365589265|FG001|Treatment Phase|Withdrawal by Subject|0|||
105980584|NCT01075984|365589266|FG002|Treatment Phase|Withdrawal by Subject|2|||
105980585|NCT01075984|365589267|FG003|Treatment Phase|Withdrawal by Subject|0|||
105980586|NCT01075984|365589268|FG004|Treatment Phase|Withdrawal by Subject|15|||
105980587|NCT01075984|365589264|FG000|Treatment Phase|Treatment Failure|0|||
105980588|NCT01075984|365589265|FG001|Treatment Phase|Treatment Failure|0|||
105980589|NCT01075984|365589266|FG002|Treatment Phase|Treatment Failure|1|||
105980590|NCT01075984|365589267|FG003|Treatment Phase|Treatment Failure|0|||
105980591|NCT01075984|365589268|FG004|Treatment Phase|Treatment Failure|5|||
105980592|NCT01075984|365589264|FG000|Treatment Phase|Progression of disease|0|||
105980593|NCT01075984|365589265|FG001|Treatment Phase|Progression of disease|0|||
105980594|NCT01075984|365589266|FG002|Treatment Phase|Progression of disease|0|||
106028990|NCT00729469|365770839|FG000|Overall Study|Withdrawal by Subject|19|||
106028991|NCT00729469|365770840|FG001|Overall Study|Withdrawal by Subject|8|||
106028992|NCT00729469|365770839|FG000|Overall Study|Other-Not mentioned|9|||
106028993|NCT00729469|365770840|FG001|Overall Study|Other-Not mentioned|4|||
106028994|NCT01566214|365770841|FG000|Overall Study|Lost to Follow-up|3|||
106028995|NCT01566214|365770842|FG001|Overall Study|Lost to Follow-up|0|||
106028996|NCT00561977|365770843|FG000|Overall Study|Withdrawal by Subject|0|||
106028997|NCT00561977|365770844|FG001|Overall Study|Withdrawal by Subject|2|||
106028998|NCT00561977|365770845|FG002|Overall Study|Withdrawal by Subject|1|||
106028999|NCT00561977|365770843|FG000|Overall Study|Pregnancy|0|||
106029000|NCT00561977|365770844|FG001|Overall Study|Pregnancy|1|||
106029001|NCT00561977|365770845|FG002|Overall Study|Pregnancy|1|||
106029002|NCT00393510|365770846|FG000|Overall Study|Physician Decision|3|||
106029003|NCT00393510|365770847|FG001|Overall Study|Physician Decision|9|||
106029004|NCT02112045|365770852|FG000|Overall Study|Withdrawal by Subject|1|||
106029005|NCT02112045|365770853|FG001|Overall Study|Withdrawal by Subject|0|||
106029006|NCT01960907|365770854|FG000|Overall Study|Death|4|||
105851588|NCT01083810|365112754|FG000|Overall Study|Withdrawal by Subject|7|||
105851589|NCT01083810|365112755|FG001|Overall Study|Withdrawal by Subject|2|||
105851590|NCT01083810|365112756|FG002|Overall Study|Withdrawal by Subject|4|||
105851591|NCT01083810|365112754|FG000|Overall Study|Reason not reported|6|||
105851592|NCT01083810|365112755|FG001|Overall Study|Reason not reported|1|||
105851593|NCT01083810|365112756|FG002|Overall Study|Reason not reported|1|||
105851594|NCT01083810|365112754|FG000|Overall Study|Non-compliance|4|||
105851595|NCT01083810|365112755|FG001|Overall Study|Non-compliance|7|||
105851596|NCT01083810|365112756|FG002|Overall Study|Non-compliance|2|||
105851597|NCT01083810|365112754|FG000|Overall Study|Simplification|4|||
105851598|NCT01083810|365112755|FG001|Overall Study|Simplification|1|||
106029007|NCT01960907|365770855|FG001|Overall Study|Death|3|||
106029008|NCT01960907|365770854|FG000|Overall Study|Withdrawal by Subject|32|||
106029009|NCT01960907|365770855|FG001|Overall Study|Withdrawal by Subject|42|||
106029010|NCT00065429|365770856|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
105851599|NCT01083810|365112756|FG002|Overall Study|Simplification|0|||
105851600|NCT01083810|365112754|FG000|Overall Study|Death|2|||
105851601|NCT01083810|365112755|FG001|Overall Study|Death|2|||
105851602|NCT01083810|365112756|FG002|Overall Study|Death|3|||
105851603|NCT01083810|365112754|FG000|Overall Study|Co-morbidities|1|||
105851604|NCT01083810|365112755|FG001|Overall Study|Co-morbidities|0|||
105851605|NCT01083810|365112756|FG002|Overall Study|Co-morbidities|0|||
105851606|NCT01083810|365112754|FG000|Overall Study|Participation in study|1|||
105851607|NCT01083810|365112755|FG001|Overall Study|Participation in study|0|||
105851608|NCT01083810|365112756|FG002|Overall Study|Participation in study|0|||
105851609|NCT01083810|365112754|FG000|Overall Study|Therapy break|1|||
105851610|NCT01083810|365112755|FG001|Overall Study|Therapy break|2|||
105851611|NCT01083810|365112756|FG002|Overall Study|Therapy break|2|||
105851612|NCT01083810|365112754|FG000|Overall Study|Virologic failure|1|||
105851613|NCT01083810|365112755|FG001|Overall Study|Virologic failure|8|||
105851614|NCT01083810|365112756|FG002|Overall Study|Virologic failure|0|||
105851615|NCT01855074|365112758|FG000|Overall Study|Adverse Event|1|||
105851616|NCT01855074|365112758|FG000|Overall Study|Lost to Follow-up|4|||
105851617|NCT01855074|365112758|FG000|Overall Study|Withdrawal by Subject|8|||
105851618|NCT01855074|365112758|FG000|Overall Study|Started but not treated|1|||
105851619|NCT03118570|365112759|FG000|Overall Study|Adverse Event|2|||
105851620|NCT03118570|365112760|FG001|Overall Study|Adverse Event|0|||
105851621|NCT03118570|365112761|FG002|Overall Study|Adverse Event|0|||
105851622|NCT03118570|365112762|FG003|Overall Study|Adverse Event|0|||
105851623|NCT03118570|365112763|FG004|Overall Study|Adverse Event|3|||
105851624|NCT03118570|365112759|FG000|Overall Study|Withdrawal by Subject|0|||
105851625|NCT03118570|365112760|FG001|Overall Study|Withdrawal by Subject|1|||
105851626|NCT03118570|365112761|FG002|Overall Study|Withdrawal by Subject|4|||
105851627|NCT03118570|365112762|FG003|Overall Study|Withdrawal by Subject|0|||
105851628|NCT03118570|365112763|FG004|Overall Study|Withdrawal by Subject|1|||
105851629|NCT03118570|365112759|FG000|Overall Study|Lost to Follow-up|2|||
105851630|NCT03118570|365112760|FG001|Overall Study|Lost to Follow-up|3|||
105851631|NCT03118570|365112761|FG002|Overall Study|Lost to Follow-up|1|||
105851632|NCT03118570|365112762|FG003|Overall Study|Lost to Follow-up|0|||
105851633|NCT03118570|365112763|FG004|Overall Study|Lost to Follow-up|1|||
105851634|NCT03118570|365112759|FG000|Overall Study|Other, Not Specified|1|||
105851635|NCT03118570|365112760|FG001|Overall Study|Other, Not Specified|3|||
105851636|NCT03118570|365112761|FG002|Overall Study|Other, Not Specified|0|||
105851637|NCT03118570|365112762|FG003|Overall Study|Other, Not Specified|0|||
105851638|NCT03118570|365112763|FG004|Overall Study|Other, Not Specified|0|||
105851639|NCT02304458|365112766|FG000|Overall Study|Adverse Event|0|||
105851640|NCT02304458|365112767|FG001|Overall Study|Adverse Event|0|||
105851641|NCT02304458|365112768|FG002|Overall Study|Adverse Event|7|||
105851642|NCT02304458|365112769|FG003|Overall Study|Adverse Event|0|||
105851643|NCT02304458|365112770|FG004|Overall Study|Adverse Event|0|||
105851644|NCT02304458|365112771|FG005|Overall Study|Adverse Event|0|||
105851645|NCT02304458|365112772|FG006|Overall Study|Adverse Event|3|||
105851646|NCT02304458|365112773|FG007|Overall Study|Adverse Event|4|||
105851647|NCT02304458|365112766|FG000|Overall Study|Death|0|||
105851648|NCT02304458|365112767|FG001|Overall Study|Death|0|||
105851649|NCT02304458|365112768|FG002|Overall Study|Death|2|||
105851650|NCT02304458|365112769|FG003|Overall Study|Death|0|||
105851651|NCT02304458|365112770|FG004|Overall Study|Death|0|||
105851652|NCT02304458|365112771|FG005|Overall Study|Death|0|||
105851653|NCT02304458|365112772|FG006|Overall Study|Death|1|||
105851654|NCT02304458|365112773|FG007|Overall Study|Death|0|||
105980595|NCT01075984|365589267|FG003|Treatment Phase|Progression of disease|0|||
105980596|NCT01075984|365589268|FG004|Treatment Phase|Progression of disease|2|||
105980597|NCT01075984|365589264|FG000|Follow-up Phase|Protocol Violation|0|||
105980598|NCT01075984|365589265|FG001|Follow-up Phase|Protocol Violation|0|||
105980599|NCT01075984|365589266|FG002|Follow-up Phase|Protocol Violation|1|||
105980600|NCT01075984|365589267|FG003|Follow-up Phase|Protocol Violation|0|||
105980601|NCT01075984|365589268|FG004|Follow-up Phase|Protocol Violation|3|||
105980602|NCT01075984|365589264|FG000|Follow-up Phase|Adverse Event|0|||
105980603|NCT01075984|365589265|FG001|Follow-up Phase|Adverse Event|0|||
105980604|NCT01075984|365589266|FG002|Follow-up Phase|Adverse Event|0|||
105851655|NCT02304458|365112766|FG000|Overall Study|Lack of Efficacy|4|||
105980605|NCT01075984|365589267|FG003|Follow-up Phase|Adverse Event|2|||
105980606|NCT01075984|365589268|FG004|Follow-up Phase|Adverse Event|27|||
106029011|NCT00065429|365770857|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
105851656|NCT02304458|365112767|FG001|Overall Study|Lack of Efficacy|6|||
105851657|NCT02304458|365112768|FG002|Overall Study|Lack of Efficacy|38|||
105851658|NCT02304458|365112769|FG003|Overall Study|Lack of Efficacy|5|||
105851659|NCT02304458|365112770|FG004|Overall Study|Lack of Efficacy|6|||
105851660|NCT02304458|365112771|FG005|Overall Study|Lack of Efficacy|6|||
105851661|NCT02304458|365112772|FG006|Overall Study|Lack of Efficacy|21|||
105851662|NCT02304458|365112773|FG007|Overall Study|Lack of Efficacy|4|||
105851663|NCT02304458|365112766|FG000|Overall Study|Physician Decision|2|||
105851664|NCT02304458|365112767|FG001|Overall Study|Physician Decision|0|||
105980607|NCT01075984|365589264|FG000|Follow-up Phase|Administrative|0|||
105980608|NCT01075984|365589265|FG001|Follow-up Phase|Administrative|0|||
105980609|NCT01075984|365589266|FG002|Follow-up Phase|Administrative|0|||
105980610|NCT01075984|365589267|FG003|Follow-up Phase|Administrative|0|||
105980611|NCT01075984|365589268|FG004|Follow-up Phase|Administrative|1|||
105980612|NCT01075984|365589264|FG000|Follow-up Phase|Withdrawal by Subject|0|||
105980613|NCT01075984|365589265|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105980614|NCT01075984|365589266|FG002|Follow-up Phase|Withdrawal by Subject|0|||
105980615|NCT01075984|365589267|FG003|Follow-up Phase|Withdrawal by Subject|0|||
105980616|NCT01075984|365589268|FG004|Follow-up Phase|Withdrawal by Subject|10|||
105980617|NCT01075984|365589264|FG000|Follow-up Phase|Progression of disease|0|||
105980618|NCT01075984|365589265|FG001|Follow-up Phase|Progression of disease|0|||
105980619|NCT01075984|365589266|FG002|Follow-up Phase|Progression of disease|0|||
105980620|NCT01075984|365589267|FG003|Follow-up Phase|Progression of disease|0|||
105980621|NCT01075984|365589268|FG004|Follow-up Phase|Progression of disease|2|||
105980622|NCT01075984|365589264|FG000|Follow-up Phase|Treatment failure|0|||
105980623|NCT01075984|365589265|FG001|Follow-up Phase|Treatment failure|0|||
105980624|NCT01075984|365589266|FG002|Follow-up Phase|Treatment failure|0|||
105980625|NCT01075984|365589267|FG003|Follow-up Phase|Treatment failure|0|||
105980626|NCT01075984|365589268|FG004|Follow-up Phase|Treatment failure|4|||
105980627|NCT02540291|365589277|FG000|Overall Study|Death|7|||
105980628|NCT02540291|365589278|FG001|Overall Study|Death|7|||
105980629|NCT02540291|365589279|FG002|Overall Study|Death|5|||
105980630|NCT02540291|365589280|FG003|Overall Study|Death|7|||
106029012|NCT00065429|365770858|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
106029013|NCT00065429|365770859|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
106029014|NCT00065429|365770860|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
106029015|NCT00065429|365770861|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
106029016|NCT00065429|365770862|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
106029017|NCT00065429|365770856|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
106029018|NCT00065429|365770857|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
106029019|NCT00065429|365770858|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
106029020|NCT00065429|365770859|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
106029021|NCT00065429|365770860|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
106029022|NCT00065429|365770861|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
106029023|NCT00065429|365770862|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
106029024|NCT00065429|365770856|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
106029025|NCT00065429|365770857|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
106029026|NCT00065429|365770858|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
106029027|NCT00065429|365770859|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
106029028|NCT00065429|365770860|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
106029029|NCT00065429|365770861|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
106029030|NCT00065429|365770862|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
106029031|NCT00065429|365770856|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
106029032|NCT00065429|365770857|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
106029033|NCT00065429|365770858|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
106029034|NCT00065429|365770859|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
106029035|NCT00065429|365770860|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
106029036|NCT00065429|365770861|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
106029037|NCT00065429|365770862|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
106029038|NCT00065429|365770856|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
106029039|NCT00065429|365770857|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
106029040|NCT00065429|365770858|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
106029041|NCT00065429|365770859|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
106029042|NCT00065429|365770860|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
106029043|NCT00065429|365770861|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
106029044|NCT00065429|365770862|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
106029045|NCT00065429|365770856|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
106029046|NCT00065429|365770857|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
106029047|NCT00065429|365770858|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
106029048|NCT00065429|365770859|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
106029049|NCT00065429|365770860|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
106029050|NCT00065429|365770861|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
106029051|NCT00065429|365770862|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
106029052|NCT00065429|365770856|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
106151276|NCT02723955|366215088|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151277|NCT02723955|366215089|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
105980631|NCT02540291|365589277|FG000|Overall Study|Lost to Follow-up|0|||
105980632|NCT02540291|365589278|FG001|Overall Study|Lost to Follow-up|0|||
105980633|NCT02540291|365589279|FG002|Overall Study|Lost to Follow-up|1|||
105980634|NCT02540291|365589280|FG003|Overall Study|Lost to Follow-up|0|||
106029053|NCT00065429|365770857|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
106029054|NCT00065429|365770858|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
106151278|NCT02723955|366215090|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151279|NCT02723955|366215091|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151280|NCT02723955|366215092|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151281|NCT02723955|366215093|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151282|NCT02723955|366215094|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151283|NCT02723955|366215095|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151284|NCT02723955|366215096|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
106151285|NCT02723955|366215054|FG000|Expansion Phase|Site Closed|0|||
106151286|NCT02723955|366215055|FG001|Expansion Phase|Site Closed|0|||
106151287|NCT02723955|366215056|FG002|Expansion Phase|Site Closed|0|||
106151288|NCT02723955|366215057|FG003|Expansion Phase|Site Closed|0|||
106151289|NCT02723955|366215058|FG004|Expansion Phase|Site Closed|0|||
106151290|NCT02723955|366215059|FG005|Expansion Phase|Site Closed|0|||
105851665|NCT02304458|365112768|FG002|Overall Study|Physician Decision|16|||
105851666|NCT02304458|365112769|FG003|Overall Study|Physician Decision|1|||
105851667|NCT02304458|365112770|FG004|Overall Study|Physician Decision|0|||
105980635|NCT02540291|365589277|FG000|Overall Study|Withdrawal Of Consent|0|||
106029055|NCT00065429|365770859|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
106029056|NCT00065429|365770860|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
106029057|NCT00065429|365770861|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
106029058|NCT00065429|365770862|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
106029059|NCT03554486|365770866|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
106029060|NCT03554486|365770867|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
106029061|NCT03554486|365770868|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
106029062|NCT03554486|365770866|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
106029063|NCT03554486|365770867|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
106029064|NCT03554486|365770868|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
106029065|NCT03554486|365770866|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
106029066|NCT03554486|365770867|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
106029067|NCT03554486|365770868|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
106029068|NCT00441116|365770874|FG000|Overall Study|Adverse Event|1|||
106029069|NCT00441116|365770875|FG001|Overall Study|Adverse Event|1|||
106029070|NCT00441116|365770874|FG000|Overall Study|Withdrawal by Subject|1|||
106029071|NCT00441116|365770875|FG001|Overall Study|Withdrawal by Subject|0|||
106029072|NCT00441116|365770874|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
106029073|NCT00441116|365770875|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
106029074|NCT02925338|365770876|FG000|Overall Study|Death|0|||
106029075|NCT02925338|365770877|FG001|Overall Study|Death|2|||
106029076|NCT02925338|365770878|FG002|Overall Study|Death|1|||
106029077|NCT02925338|365770879|FG003|Overall Study|Death|0|||
106029078|NCT02925338|365770880|FG004|Overall Study|Death|0|||
106029079|NCT02925338|365770876|FG000|Overall Study|Lost to Follow-up|30|||
106029080|NCT02925338|365770877|FG001|Overall Study|Lost to Follow-up|10|||
106029081|NCT02925338|365770878|FG002|Overall Study|Lost to Follow-up|1|||
106029082|NCT02925338|365770879|FG003|Overall Study|Lost to Follow-up|16|||
106029083|NCT02925338|365770880|FG004|Overall Study|Lost to Follow-up|3|||
105980636|NCT02540291|365589278|FG001|Overall Study|Withdrawal Of Consent|1|||
105980637|NCT02540291|365589279|FG002|Overall Study|Withdrawal Of Consent|0|||
105980638|NCT02540291|365589280|FG003|Overall Study|Withdrawal Of Consent|0|||
105980639|NCT02540291|365589277|FG000|Overall Study|Study Terminated By Sponsor|1|||
105980640|NCT02540291|365589278|FG001|Overall Study|Study Terminated By Sponsor|0|||
105980641|NCT02540291|365589279|FG002|Overall Study|Study Terminated By Sponsor|0|||
105980642|NCT02540291|365589280|FG003|Overall Study|Study Terminated By Sponsor|0|||
105980643|NCT02540291|365589277|FG000|Overall Study|Other|0|||
105980644|NCT02540291|365589278|FG001|Overall Study|Other|0|||
105980645|NCT02540291|365589279|FG002|Overall Study|Other|1|||
105980646|NCT02540291|365589280|FG003|Overall Study|Other|0|||
105980647|NCT01282294|365590518|FG000|Overall Study|Lost to Follow-up|14|||
105980648|NCT01282294|365590518|FG000|Overall Study|Screening failure|1|||
105980649|NCT01282294|365590518|FG000|Overall Study|Adverse Event|1|||
105980650|NCT01282294|365590518|FG000|Overall Study|Patient non-compliance|2|||
105980651|NCT01282294|365590518|FG000|Overall Study|Physician Decision|1|||
105980652|NCT01549873|365590519|FG000|Overall Study|Physician Decision|0|||
105980653|NCT01549873|365590520|FG001|Overall Study|Physician Decision|1|||
105980654|NCT03769311|365590521|FG000|Overall Study|Withdrawal by Subject|1|||
105980655|NCT04435600|365590522|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105980656|NCT04435600|365590523|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
106029084|NCT02925338|365770876|FG000|Overall Study|Withdrawal by Subject|3|||
106029085|NCT02925338|365770877|FG001|Overall Study|Withdrawal by Subject|0|||
106029086|NCT02925338|365770878|FG002|Overall Study|Withdrawal by Subject|3|||
106151291|NCT02723955|366215060|FG006|Expansion Phase|Site Closed|0|||
106151292|NCT02723955|366215061|FG007|Expansion Phase|Site Closed|0|||
106151293|NCT02723955|366215062|FG008|Expansion Phase|Site Closed|0|||
105851668|NCT02304458|365112771|FG005|Overall Study|Physician Decision|0|||
105851669|NCT02304458|365112772|FG006|Overall Study|Physician Decision|3|||
105851670|NCT02304458|365112773|FG007|Overall Study|Physician Decision|0|||
105851671|NCT02304458|365112766|FG000|Overall Study|Protocol Violation|0|||
105851672|NCT02304458|365112767|FG001|Overall Study|Protocol Violation|0|||
105851673|NCT02304458|365112768|FG002|Overall Study|Protocol Violation|1|||
105851674|NCT02304458|365112769|FG003|Overall Study|Protocol Violation|0|||
105851675|NCT02304458|365112770|FG004|Overall Study|Protocol Violation|0|||
105851676|NCT02304458|365112771|FG005|Overall Study|Protocol Violation|0|||
105851677|NCT02304458|365112772|FG006|Overall Study|Protocol Violation|0|||
105851678|NCT02304458|365112773|FG007|Overall Study|Protocol Violation|0|||
105851679|NCT02304458|365112766|FG000|Overall Study|Withdrawal by Subject|1|||
105851680|NCT02304458|365112767|FG001|Overall Study|Withdrawal by Subject|0|||
105851681|NCT02304458|365112768|FG002|Overall Study|Withdrawal by Subject|7|||
105851682|NCT02304458|365112769|FG003|Overall Study|Withdrawal by Subject|0|||
105851683|NCT02304458|365112770|FG004|Overall Study|Withdrawal by Subject|0|||
105851684|NCT02304458|365112771|FG005|Overall Study|Withdrawal by Subject|0|||
105851685|NCT02304458|365112772|FG006|Overall Study|Withdrawal by Subject|1|||
105851686|NCT02304458|365112773|FG007|Overall Study|Withdrawal by Subject|0|||
105851687|NCT01214915|365112778|FG000|Overall Study|Adverse Event|8|||
105851688|NCT01214915|365112778|FG000|Overall Study|Lack of Efficacy|3|||
105851689|NCT04024462|365115907|FG000|Overall Study|Withdrawal by Subject|6|||
105851690|NCT04024462|365115908|FG001|Overall Study|Withdrawal by Subject|7|||
105851691|NCT04024462|365115907|FG000|Overall Study|Progressive Disease|0|||
105851692|NCT04024462|365115908|FG001|Overall Study|Progressive Disease|1|||
105851693|NCT04024462|365115907|FG000|Overall Study|Adverse Event|0|||
105851694|NCT04024462|365115908|FG001|Overall Study|Adverse Event|1|||
105851695|NCT04024462|365115907|FG000|Overall Study|Death|0|||
105851696|NCT04024462|365115908|FG001|Overall Study|Death|1|||
105851697|NCT04024462|365115907|FG000|Overall Study|Lost to Follow-up|1|||
105851698|NCT04024462|365115908|FG001|Overall Study|Lost to Follow-up|0|||
105851699|NCT04024462|365115907|FG000|Overall Study|Ongoing in the Study|94|||
105851700|NCT04024462|365115908|FG001|Overall Study|Ongoing in the Study|89|||
105851701|NCT05101486|365115909|FG000|Overall Study|Death|1|||
105851702|NCT05101486|365115910|FG001|Overall Study|Death|0|||
105851703|NCT05101486|365115911|FG002|Overall Study|Death|1|||
105851704|NCT05101486|365115909|FG000|Overall Study|Lost to Follow-up|12|||
105851705|NCT05101486|365115910|FG001|Overall Study|Lost to Follow-up|8|||
105851706|NCT05101486|365115911|FG002|Overall Study|Lost to Follow-up|17|||
105851707|NCT05101486|365115909|FG000|Overall Study|Physician Decision|1|||
105851708|NCT05101486|365115910|FG001|Overall Study|Physician Decision|0|||
105851709|NCT05101486|365115911|FG002|Overall Study|Physician Decision|0|||
105851710|NCT05101486|365115909|FG000|Overall Study|Protocol Violation|0|||
105851711|NCT05101486|365115910|FG001|Overall Study|Protocol Violation|0|||
105851712|NCT05101486|365115911|FG002|Overall Study|Protocol Violation|1|||
105851713|NCT05101486|365115909|FG000|Overall Study|Withdrawal by Subject|5|||
105851714|NCT05101486|365115910|FG001|Overall Study|Withdrawal by Subject|2|||
105851715|NCT05101486|365115911|FG002|Overall Study|Withdrawal by Subject|4|||
105851716|NCT05101486|365115909|FG000|Overall Study|Randomized but not vaccinated|1|||
105851717|NCT05101486|365115910|FG001|Overall Study|Randomized but not vaccinated|1|||
105851718|NCT05101486|365115911|FG002|Overall Study|Randomized but not vaccinated|1|||
105851719|NCT03747601|365115912|FG000|Overall Study|COVID halt to visits|4|||
105851720|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
105851721|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
105851722|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
105851723|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
105851724|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
105851725|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
105851726|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
105980657|NCT04435600|365590524|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
105851727|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
105851728|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
105851729|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
105851730|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
105851731|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
105851732|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
105851733|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
105851734|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
105851735|NCT02788045|365115913|FG000|Main Study (Up to Week 72)|Other|3|||
105851736|NCT02788045|365115914|FG001|Main Study (Up to Week 72)|Other|0|||
105851737|NCT02788045|365115915|FG002|Main Study (Up to Week 72)|Other|0|||
105851738|NCT02788045|365115913|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
105851739|NCT02788045|365115914|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
105851740|NCT02788045|365115915|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
105851741|NCT02788045|365115913|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
105851742|NCT02788045|365115914|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
105980658|NCT04435600|365590525|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105980659|NCT04435600|365590526|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105980660|NCT04435600|365590527|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105980661|NCT04435600|365590528|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105980662|NCT04435600|365590529|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105980663|NCT04435600|365590530|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105980664|NCT04435600|365590531|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
105980665|NCT04435600|365590522|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980666|NCT04435600|365590523|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980667|NCT04435600|365590524|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980668|NCT04435600|365590525|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980669|NCT04435600|365590526|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980670|NCT04435600|365590527|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980671|NCT04435600|365590528|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980672|NCT04435600|365590529|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980673|NCT04435600|365590530|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
105980674|NCT04435600|365590531|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
105980675|NCT04435600|365590522|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980676|NCT04435600|365590523|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980677|NCT04435600|365590524|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980678|NCT04435600|365590525|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980679|NCT04435600|365590526|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980680|NCT04435600|365590527|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980681|NCT04435600|365590528|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980682|NCT04435600|365590529|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980683|NCT04435600|365590530|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
105980684|NCT04435600|365590531|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
105980685|NCT04435600|365590522|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980686|NCT04435600|365590523|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980687|NCT04435600|365590524|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980688|NCT04435600|365590525|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980689|NCT04435600|365590526|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980690|NCT04435600|365590527|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980691|NCT04435600|365590528|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980692|NCT04435600|365590529|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980693|NCT04435600|365590530|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
105980694|NCT04435600|365590531|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
105980695|NCT01657760|365590545|FG000|Overall Study|Withdrawal by Subject|0|||
105980696|NCT01657760|365590546|FG001|Overall Study|Withdrawal by Subject|0|||
105980697|NCT01657760|365590547|FG002|Overall Study|Withdrawal by Subject|0|||
105980698|NCT01657760|365590548|FG003|Overall Study|Withdrawal by Subject|1|||
105980699|NCT01657760|365590545|FG000|Overall Study|Physician Decision|1|||
105980700|NCT01657760|365590546|FG001|Overall Study|Physician Decision|1|||
105980701|NCT01657760|365590547|FG002|Overall Study|Physician Decision|1|||
105980702|NCT01657760|365590548|FG003|Overall Study|Physician Decision|2|||
105980703|NCT01113580|365590549|FG000|Overall Study|Protocol Violation|1|||
105980704|NCT01113580|365590550|FG001|Overall Study|Protocol Violation|0|||
105980705|NCT01068249|365590558|FG000|Overall Study|Death|1|||
105980706|NCT01068249|365590558|FG000|Overall Study|Withdrawal by Subject|3|||
105980707|NCT04619004|365590559|FG000|Overall Study|Death|114|||
105980708|NCT04619004|365590560|FG001|Overall Study|Death|28|||
105980709|NCT04619004|365590559|FG000|Overall Study|Lost to Follow-up|1|||
105980710|NCT04619004|365590560|FG001|Overall Study|Lost to Follow-up|1|||
105980711|NCT04619004|365590559|FG000|Overall Study|Withdrawal by Subject|24|||
105980712|NCT04619004|365590560|FG001|Overall Study|Withdrawal by Subject|7|||
105980713|NCT04619004|365590559|FG000|Overall Study|Other - Not specified|0|||
105980714|NCT04619004|365590560|FG001|Overall Study|Other - Not specified|1|||
105980715|NCT05601102|365590562|FG000|Overall Study|Death|1|||
105980716|NCT05601102|365590563|FG001|Overall Study|Death|2|||
105980717|NCT05601102|365590562|FG000|Overall Study|Withdrawal by Subject|1|||
105980718|NCT05601102|365590563|FG001|Overall Study|Withdrawal by Subject|1|||
105980719|NCT05601102|365590562|FG000|Overall Study|Lost to Follow-up|0|||
105980720|NCT05601102|365590563|FG001|Overall Study|Lost to Follow-up|2|||
105980721|NCT01114360|365590564|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
105980722|NCT01114360|365590565|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
105980723|NCT05824936|365590568|FG000|Overall Study|Lost to Follow-up|1|||
105980724|NCT00673881|365590569|FG000|Overall Study|Withdrawal by Subject|1|||
105980725|NCT00895661|365590572|FG000|Overall Study|Death|1|||
105980726|NCT00895661|365590572|FG000|Overall Study|reason unknown|2|||
105980727|NCT02006069|365590575|FG000|Overall Study|MPP other programming|239|||
105980728|NCT02006069|365590576|FG001|Overall Study|MPP other programming|0|||
105980729|NCT02006069|365590575|FG000|Overall Study|RV only pacing|0|||
105980730|NCT02006069|365590576|FG001|Overall Study|RV only pacing|3|||
105980731|NCT00286221|365590577|FG000|Overall Study|Protocol Violation|2|||
105980732|NCT00286221|365590578|FG001|Overall Study|Protocol Violation|1|||
105980733|NCT00286221|365590579|FG002|Overall Study|Protocol Violation|6|||
105980734|NCT00286221|365590580|FG003|Overall Study|Protocol Violation|4|||
105980735|NCT00286221|365590577|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
105980736|NCT00286221|365590578|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
105980737|NCT00286221|365590579|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
105980738|NCT00286221|365590580|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
105980739|NCT00286221|365590577|FG000|Overall Study|Inability to trigger PCA|2|||
105980740|NCT00286221|365590578|FG001|Overall Study|Inability to trigger PCA|0|||
105980741|NCT00286221|365590579|FG002|Overall Study|Inability to trigger PCA|0|||
105980742|NCT00286221|365590580|FG003|Overall Study|Inability to trigger PCA|0|||
105980743|NCT00286221|365590577|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
105980744|NCT00286221|365590578|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
105980745|NCT00286221|365590579|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
105980746|NCT00286221|365590580|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
105980747|NCT01554514|365590581|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
105980748|NCT01554514|365590581|FG000|Overall Study|Physician Decision|1|||
105980749|NCT02553538|365590582|FG000|Overall Study|Could Not Reach by Telephone|133|||
105980750|NCT02553538|365590583|FG001|Overall Study|Could Not Reach by Telephone|0|||
105980751|NCT02553538|365590582|FG000|Overall Study|Died or Left Network|54|||
105980752|NCT02553538|365590583|FG001|Overall Study|Died or Left Network|56|||
105980753|NCT02276547|365590584|FG000|Overall Study|Death|2|||
105980754|NCT02276547|365590584|FG000|Overall Study|Explant|2|||
105980755|NCT02066129|365590587|FG000|Overall Study|Lost to Follow-up|13|||
105980756|NCT02066129|365590588|FG001|Overall Study|Lost to Follow-up|12|||
105980757|NCT02066129|365590587|FG000|Overall Study|Withdrawal by Subject|7|||
105980758|NCT02066129|365590588|FG001|Overall Study|Withdrawal by Subject|10|||
105980759|NCT02066129|365590587|FG000|Overall Study|Lack of Efficacy|8|||
105980760|NCT02066129|365590588|FG001|Overall Study|Lack of Efficacy|10|||
105980761|NCT02066129|365590587|FG000|Overall Study|Physician Decision|1|||
105980762|NCT02066129|365590588|FG001|Overall Study|Physician Decision|1|||
105980763|NCT02616393|365590592|FG000|Overall Study|Death|5|||
105980764|NCT02616393|365590593|FG001|Overall Study|Death|12|||
105980765|NCT02616393|365590594|FG002|Overall Study|Death|1|||
105980766|NCT02616393|365590592|FG000|Overall Study|Termination by Sponsor|4|||
105980767|NCT02616393|365590593|FG001|Overall Study|Termination by Sponsor|5|||
105980768|NCT02616393|365590594|FG002|Overall Study|Termination by Sponsor|2|||
105980769|NCT02616393|365590592|FG000|Overall Study|Other|3|||
105980770|NCT02616393|365590593|FG001|Overall Study|Other|0|||
105980771|NCT02616393|365590594|FG002|Overall Study|Other|0|||
105980772|NCT02616393|365590592|FG000|Overall Study|Withdrawal by Subject|1|||
105980773|NCT02616393|365590593|FG001|Overall Study|Withdrawal by Subject|1|||
105980774|NCT02616393|365590594|FG002|Overall Study|Withdrawal by Subject|0|||
105980775|NCT02616393|365590592|FG000|Overall Study|Lost to Follow-up|0|||
105980776|NCT02616393|365590593|FG001|Overall Study|Lost to Follow-up|2|||
105980777|NCT02616393|365590594|FG002|Overall Study|Lost to Follow-up|0|||
105980778|NCT02712424|365590595|FG000|Overall Study|Lost to Follow-up|34|||
105980779|NCT02712424|365590596|FG001|Overall Study|Lost to Follow-up|32|||
105980780|NCT00657371|365590597|FG000|Overall Study|Poor bowel preparation|15|||
105980781|NCT00657371|365590597|FG000|Overall Study|Unable to intubate the cecum|5|||
105980782|NCT00657371|365590597|FG000|Overall Study|Protocol Violation|2|||
105980783|NCT00657371|365590597|FG000|Overall Study|Device- related reasons|13|||
105980784|NCT00657371|365590597|FG000|Overall Study|Pre-existing medical condition|4|||
105980785|NCT01141478|365590598|FG000|Overall Study|Withdrawal by Subject|1|||
105980786|NCT01141478|365590599|FG001|Overall Study|Withdrawal by Subject|1|||
106029087|NCT02925338|365770879|FG003|Overall Study|Withdrawal by Subject|2|||
106029088|NCT02925338|365770880|FG004|Overall Study|Withdrawal by Subject|2|||
106029089|NCT02925338|365770876|FG000|Overall Study|Missing|38|||
106029090|NCT02925338|365770877|FG001|Overall Study|Missing|27|||
105980787|NCT00551291|365590600|FG000|Overall Study|Physician Decision|1|||
105980788|NCT01600053|365590601|FG000|Overall Study|Adverse Event|2|||
105980789|NCT01600053|365590601|FG000|Overall Study|trial will not meet the interim endpoint|9|||
105980790|NCT03230292|365590602|FG000|Overall Study|Adverse Event|1|||
105980791|NCT03230292|365590602|FG000|Overall Study|Protocol Violation|1|||
105980792|NCT03230292|365590602|FG000|Overall Study|Lost to Follow-up|1|||
105980793|NCT03230292|365590602|FG000|Overall Study|Withdrawal by Subject|3|||
105980794|NCT00661388|365590604|FG000|Overall Study|Adverse Event|14|||
105980795|NCT00661388|365590604|FG000|Overall Study|Protocol Violation|7|||
106029091|NCT02925338|365770878|FG002|Overall Study|Missing|0|||
105980796|NCT00661388|365590604|FG000|Overall Study|Renal transplantation|1|||
105980797|NCT00661388|365590604|FG000|Overall Study|Dialysis initiation|1|||
105980798|NCT00661388|365590604|FG000|Overall Study|Administrative reasons|1|||
105980799|NCT02914561|365590605|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
105980800|NCT02914561|365590606|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
106029092|NCT02925338|365770879|FG003|Overall Study|Missing|3|||
106029093|NCT02925338|365770880|FG004|Overall Study|Missing|2|||
106029094|NCT02925338|365770876|FG000|Overall Study|Participant's Decision|11|||
106029095|NCT02925338|365770877|FG001|Overall Study|Participant's Decision|7|||
106029096|NCT02925338|365770878|FG002|Overall Study|Participant's Decision|3|||
106029097|NCT02925338|365770879|FG003|Overall Study|Participant's Decision|8|||
106029098|NCT02925338|365770880|FG004|Overall Study|Participant's Decision|1|||
106029099|NCT02925338|365770876|FG000|Overall Study|Treatment Discontinuation|144|||
106029100|NCT02925338|365770877|FG001|Overall Study|Treatment Discontinuation|65|||
106029101|NCT02925338|365770878|FG002|Overall Study|Treatment Discontinuation|56|||
106029102|NCT02925338|365770879|FG003|Overall Study|Treatment Discontinuation|131|||
106029103|NCT02925338|365770880|FG004|Overall Study|Treatment Discontinuation|22|||
106029104|NCT01306929|365770881|FG000|Overall Study|Withdrawal by Subject|23|||
106029105|NCT01306929|365770881|FG000|Overall Study|Adverse Event|21|||
106029106|NCT01306929|365770881|FG000|Overall Study|Physician Decision|13|||
105851743|NCT02788045|365115915|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
105851744|NCT02788045|365115913|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
105851745|NCT02788045|365115914|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
105851746|NCT02788045|365115915|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
105851747|NCT03303625|365115916|FG000|Overall Study|Withdrawal by Subject|2|||
105851748|NCT03303625|365115917|FG001|Overall Study|Withdrawal by Subject|0|||
105851749|NCT03303625|365115918|FG002|Overall Study|Withdrawal by Subject|0|||
105851750|NCT03303625|365115919|FG003|Overall Study|Withdrawal by Subject|0|||
105851751|NCT03502707|365115920|FG000|Overall Study|Adverse Event|0|||
105851752|NCT03502707|365115921|FG001|Overall Study|Adverse Event|0|||
105851753|NCT03502707|365115922|FG002|Overall Study|Adverse Event|0|||
105851754|NCT03502707|365115923|FG003|Overall Study|Adverse Event|0|||
105851755|NCT03502707|365115924|FG004|Overall Study|Adverse Event|0|||
105851756|NCT03502707|365115925|FG005|Overall Study|Adverse Event|0|||
105851757|NCT03502707|365115926|FG006|Overall Study|Adverse Event|0|||
105851758|NCT03502707|365115927|FG007|Overall Study|Adverse Event|0|||
105851759|NCT03502707|365115928|FG008|Overall Study|Adverse Event|0|||
105851760|NCT03502707|365115929|FG009|Overall Study|Adverse Event|0|||
105851761|NCT03502707|365115930|FG010|Overall Study|Adverse Event|0|||
105851762|NCT03502707|365115931|FG011|Overall Study|Adverse Event|0|||
105851763|NCT03502707|365115932|FG012|Overall Study|Adverse Event|0|||
105851764|NCT03502707|365115933|FG013|Overall Study|Adverse Event|0|||
105851765|NCT03502707|365115934|FG014|Overall Study|Adverse Event|0|||
105851766|NCT03502707|365115935|FG015|Overall Study|Adverse Event|1|||
105851767|NCT03502707|365115936|FG016|Overall Study|Adverse Event|5|||
105851768|NCT03502707|365115937|FG017|Overall Study|Adverse Event|0|||
105851769|NCT03502707|365115920|FG000|Overall Study|Death|0|||
105851770|NCT03502707|365115921|FG001|Overall Study|Death|0|||
105851771|NCT03502707|365115922|FG002|Overall Study|Death|0|||
105851772|NCT03502707|365115923|FG003|Overall Study|Death|1|||
105851773|NCT03502707|365115924|FG004|Overall Study|Death|0|||
105851774|NCT03502707|365115925|FG005|Overall Study|Death|0|||
105851775|NCT03502707|365115926|FG006|Overall Study|Death|0|||
105851776|NCT03502707|365115927|FG007|Overall Study|Death|0|||
105851777|NCT03502707|365115928|FG008|Overall Study|Death|1|||
105851778|NCT03502707|365115929|FG009|Overall Study|Death|1|||
105851779|NCT03502707|365115930|FG010|Overall Study|Death|0|||
105851780|NCT03502707|365115931|FG011|Overall Study|Death|0|||
105851781|NCT03502707|365115932|FG012|Overall Study|Death|1|||
105851782|NCT03502707|365115933|FG013|Overall Study|Death|0|||
105851783|NCT03502707|365115934|FG014|Overall Study|Death|0|||
105851784|NCT03502707|365115935|FG015|Overall Study|Death|1|||
105851785|NCT03502707|365115936|FG016|Overall Study|Death|0|||
105851786|NCT03502707|365115937|FG017|Overall Study|Death|0|||
105851787|NCT03502707|365115920|FG000|Overall Study|Lost to Follow-up|0|||
105851788|NCT03502707|365115921|FG001|Overall Study|Lost to Follow-up|0|||
105851789|NCT03502707|365115922|FG002|Overall Study|Lost to Follow-up|0|||
105851790|NCT03502707|365115923|FG003|Overall Study|Lost to Follow-up|0|||
105851791|NCT03502707|365115924|FG004|Overall Study|Lost to Follow-up|0|||
105851792|NCT03502707|365115925|FG005|Overall Study|Lost to Follow-up|0|||
105851793|NCT03502707|365115926|FG006|Overall Study|Lost to Follow-up|0|||
105851794|NCT03502707|365115927|FG007|Overall Study|Lost to Follow-up|5|||
105851795|NCT03502707|365115928|FG008|Overall Study|Lost to Follow-up|0|||
105851796|NCT03502707|365115929|FG009|Overall Study|Lost to Follow-up|2|||
105851797|NCT03502707|365115930|FG010|Overall Study|Lost to Follow-up|1|||
106029107|NCT01306929|365770881|FG000|Overall Study|Death|8|||
106029108|NCT01306929|365770881|FG000|Overall Study|Withdrawal by parent/guardian|5|||
105851798|NCT03502707|365115931|FG011|Overall Study|Lost to Follow-up|2|||
105851799|NCT03502707|365115932|FG012|Overall Study|Lost to Follow-up|1|||
105851800|NCT03502707|365115933|FG013|Overall Study|Lost to Follow-up|1|||
105851801|NCT03502707|365115934|FG014|Overall Study|Lost to Follow-up|0|||
105851802|NCT03502707|365115935|FG015|Overall Study|Lost to Follow-up|4|||
105851803|NCT03502707|365115936|FG016|Overall Study|Lost to Follow-up|9|||
106029109|NCT01306929|365770881|FG000|Overall Study|Protocol Violation|3|||
105851804|NCT03502707|365115937|FG017|Overall Study|Lost to Follow-up|2|||
105851805|NCT03502707|365115920|FG000|Overall Study|Physician Decision|0|||
106151294|NCT02723955|366215063|FG009|Expansion Phase|Site Closed|1|||
105980801|NCT02914561|365590607|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
105980802|NCT02914561|365590608|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
105980803|NCT02914561|365590609|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
105980804|NCT02914561|365590610|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
105980805|NCT02914561|365590611|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105980806|NCT02914561|365590612|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105980807|NCT02914561|365590613|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105980808|NCT02914561|365590614|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105980809|NCT02914561|365590615|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
105980810|NCT02914561|365590605|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
105980811|NCT02914561|365590606|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
105980812|NCT02914561|365590607|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
105980813|NCT02914561|365590608|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105980814|NCT02914561|365590609|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
105980815|NCT02914561|365590610|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
105980816|NCT02914561|365590611|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105980817|NCT02914561|365590612|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105980818|NCT02914561|365590613|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105980819|NCT02914561|365590614|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105980820|NCT02914561|365590615|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
105980821|NCT02914561|365590605|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105980822|NCT02914561|365590606|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
105980823|NCT02914561|365590607|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
105980824|NCT02914561|365590608|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
105980825|NCT02914561|365590609|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
105980826|NCT02914561|365590610|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
105980827|NCT02914561|365590611|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105980828|NCT02914561|365590612|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105980829|NCT02914561|365590613|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105980830|NCT02914561|365590614|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105980831|NCT02914561|365590615|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
105980832|NCT02914561|365590605|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
105980833|NCT02914561|365590606|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
105980834|NCT02914561|365590607|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
105980835|NCT02914561|365590608|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105980836|NCT02914561|365590609|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
105980837|NCT02914561|365590610|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
105980838|NCT02914561|365590611|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105980839|NCT02914561|365590612|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105980840|NCT02914561|365590613|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105980841|NCT02914561|365590614|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105980842|NCT02914561|365590615|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
105980843|NCT02914561|365590605|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105980844|NCT02914561|365590606|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105980845|NCT02914561|365590607|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
105980846|NCT02914561|365590608|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105980847|NCT02914561|365590609|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105980848|NCT02914561|365590610|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
105980849|NCT02914561|365590611|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105980850|NCT02914561|365590612|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105980851|NCT02914561|365590613|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105980852|NCT02914561|365590614|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105851806|NCT03502707|365115921|FG001|Overall Study|Physician Decision|0|||
105851807|NCT03502707|365115922|FG002|Overall Study|Physician Decision|0|||
105980853|NCT02914561|365590615|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
105980854|NCT02914561|365590605|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
105980855|NCT02914561|365590606|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105980856|NCT02914561|365590607|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105980857|NCT02914561|365590608|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105980858|NCT02914561|365590609|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105980859|NCT02914561|365590610|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105980860|NCT02914561|365590611|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105980861|NCT02914561|365590612|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105851808|NCT03502707|365115923|FG003|Overall Study|Physician Decision|0|||
105980862|NCT02914561|365590613|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105980863|NCT02914561|365590614|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105980864|NCT02914561|365590615|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
105851809|NCT03502707|365115924|FG004|Overall Study|Physician Decision|0|||
105851810|NCT03502707|365115925|FG005|Overall Study|Physician Decision|0|||
105851811|NCT03502707|365115926|FG006|Overall Study|Physician Decision|0|||
105851812|NCT03502707|365115927|FG007|Overall Study|Physician Decision|0|||
105851813|NCT03502707|365115928|FG008|Overall Study|Physician Decision|2|||
105851814|NCT03502707|365115929|FG009|Overall Study|Physician Decision|1|||
105851815|NCT03502707|365115930|FG010|Overall Study|Physician Decision|0|||
105851816|NCT03502707|365115931|FG011|Overall Study|Physician Decision|0|||
105851817|NCT03502707|365115932|FG012|Overall Study|Physician Decision|0|||
105851818|NCT03502707|365115933|FG013|Overall Study|Physician Decision|0|||
105851819|NCT03502707|365115934|FG014|Overall Study|Physician Decision|1|||
105851820|NCT03502707|365115935|FG015|Overall Study|Physician Decision|3|||
105851821|NCT03502707|365115936|FG016|Overall Study|Physician Decision|0|||
105851822|NCT03502707|365115937|FG017|Overall Study|Physician Decision|0|||
105851823|NCT03502707|365115920|FG000|Overall Study|Protocol Violation|0|||
105851824|NCT03502707|365115921|FG001|Overall Study|Protocol Violation|0|||
105851825|NCT03502707|365115922|FG002|Overall Study|Protocol Violation|0|||
105851826|NCT03502707|365115923|FG003|Overall Study|Protocol Violation|0|||
105851827|NCT03502707|365115924|FG004|Overall Study|Protocol Violation|0|||
105851828|NCT03502707|365115925|FG005|Overall Study|Protocol Violation|0|||
105851829|NCT03502707|365115926|FG006|Overall Study|Protocol Violation|0|||
105851830|NCT03502707|365115927|FG007|Overall Study|Protocol Violation|0|||
105851831|NCT03502707|365115928|FG008|Overall Study|Protocol Violation|0|||
105851832|NCT03502707|365115929|FG009|Overall Study|Protocol Violation|0|||
105851833|NCT03502707|365115930|FG010|Overall Study|Protocol Violation|0|||
105851834|NCT03502707|365115931|FG011|Overall Study|Protocol Violation|0|||
105851835|NCT03502707|365115932|FG012|Overall Study|Protocol Violation|0|||
105851836|NCT03502707|365115933|FG013|Overall Study|Protocol Violation|0|||
105851837|NCT03502707|365115934|FG014|Overall Study|Protocol Violation|0|||
105851838|NCT03502707|365115935|FG015|Overall Study|Protocol Violation|1|||
105851839|NCT03502707|365115936|FG016|Overall Study|Protocol Violation|0|||
105851840|NCT03502707|365115937|FG017|Overall Study|Protocol Violation|0|||
105851841|NCT03502707|365115920|FG000|Overall Study|Withdrawal by Subject|1|||
105851842|NCT03502707|365115921|FG001|Overall Study|Withdrawal by Subject|1|||
105851843|NCT03502707|365115922|FG002|Overall Study|Withdrawal by Subject|0|||
105851844|NCT03502707|365115923|FG003|Overall Study|Withdrawal by Subject|0|||
105851845|NCT03502707|365115924|FG004|Overall Study|Withdrawal by Subject|0|||
105851846|NCT03502707|365115925|FG005|Overall Study|Withdrawal by Subject|2|||
105851847|NCT03502707|365115926|FG006|Overall Study|Withdrawal by Subject|0|||
105851848|NCT03502707|365115927|FG007|Overall Study|Withdrawal by Subject|3|||
105851849|NCT03502707|365115928|FG008|Overall Study|Withdrawal by Subject|1|||
105851850|NCT03502707|365115929|FG009|Overall Study|Withdrawal by Subject|2|||
105851851|NCT03502707|365115930|FG010|Overall Study|Withdrawal by Subject|12|||
105851852|NCT03502707|365115931|FG011|Overall Study|Withdrawal by Subject|23|||
105851853|NCT03502707|365115932|FG012|Overall Study|Withdrawal by Subject|5|||
105851854|NCT03502707|365115933|FG013|Overall Study|Withdrawal by Subject|3|||
105851855|NCT03502707|365115934|FG014|Overall Study|Withdrawal by Subject|3|||
105851856|NCT03502707|365115935|FG015|Overall Study|Withdrawal by Subject|43|||
105851857|NCT03502707|365115936|FG016|Overall Study|Withdrawal by Subject|44|||
105851858|NCT03502707|365115937|FG017|Overall Study|Withdrawal by Subject|18|||
105851859|NCT03502707|365115920|FG000|Overall Study|Sponsor's Decision|1|||
105851860|NCT03502707|365115921|FG001|Overall Study|Sponsor's Decision|0|||
105851861|NCT03502707|365115922|FG002|Overall Study|Sponsor's Decision|0|||
105851862|NCT03502707|365115923|FG003|Overall Study|Sponsor's Decision|0|||
105851863|NCT03502707|365115924|FG004|Overall Study|Sponsor's Decision|0|||
105851864|NCT03502707|365115925|FG005|Overall Study|Sponsor's Decision|0|||
105980865|NCT02914561|365590605|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980866|NCT02914561|365590606|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980867|NCT02914561|365590607|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
105980868|NCT02914561|365590608|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980869|NCT02914561|365590609|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980870|NCT02914561|365590610|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980871|NCT02914561|365590611|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980872|NCT02914561|365590612|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
106029110|NCT01306929|365770881|FG000|Overall Study|Non-compliance with study drug|2|||
106029111|NCT01306929|365770881|FG000|Overall Study|Lost to Follow-up|2|||
106029112|NCT01306929|365770881|FG000|Overall Study|Various|17|||
106029113|NCT02282293|365770882|FG000|Overall Study|Lost to Follow-up|2|||
106029114|NCT02282293|365770883|FG001|Overall Study|Lost to Follow-up|2|||
106029115|NCT02282293|365770882|FG000|Overall Study|Unable to comply with study procedures|1|||
106029116|NCT02282293|365770883|FG001|Overall Study|Unable to comply with study procedures|0|||
106029117|NCT02282293|365770882|FG000|Overall Study|Moved out of study area|0|||
106151295|NCT02723955|366215064|FG010|Expansion Phase|Site Closed|2|||
105851865|NCT03502707|365115926|FG006|Overall Study|Sponsor's Decision|0|||
105851866|NCT03502707|365115927|FG007|Overall Study|Sponsor's Decision|0|||
105851867|NCT03502707|365115928|FG008|Overall Study|Sponsor's Decision|0|||
105851868|NCT03502707|365115929|FG009|Overall Study|Sponsor's Decision|1|||
105980873|NCT02914561|365590613|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980874|NCT02914561|365590614|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980875|NCT02914561|365590615|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
105980876|NCT02914561|365590605|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
105980877|NCT02914561|365590606|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105980878|NCT02914561|365590607|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
105980879|NCT02914561|365590608|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
105980880|NCT02914561|365590609|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
105980881|NCT02914561|365590610|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
105980882|NCT02914561|365590611|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105980883|NCT02914561|365590612|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105980884|NCT02914561|365590613|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105980885|NCT02914561|365590614|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105980886|NCT02914561|365590615|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
105980887|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105980888|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105980889|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105980890|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105980891|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105980892|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
105980893|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
105980894|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
105980895|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
105980896|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
105980897|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
105980898|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105980899|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105980900|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105980901|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105980902|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105980903|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
105980904|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
105980905|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
105980906|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
105980907|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
105980908|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
105980909|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105980910|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105980911|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105980912|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105980913|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105980914|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
105980915|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
105980916|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
105980917|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
105980918|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
105980919|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
105980920|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105980921|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105980922|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105980923|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105980924|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105980925|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105980926|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
105980927|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105980928|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
105980929|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
105980930|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
105980931|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105980932|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105980933|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105980934|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105980935|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
106029118|NCT02282293|365770883|FG001|Overall Study|Moved out of study area|1|||
105851869|NCT03502707|365115930|FG010|Overall Study|Sponsor's Decision|0|||
105851870|NCT03502707|365115931|FG011|Overall Study|Sponsor's Decision|0|||
105851871|NCT03502707|365115932|FG012|Overall Study|Sponsor's Decision|0|||
105851872|NCT03502707|365115933|FG013|Overall Study|Sponsor's Decision|0|||
105851873|NCT03502707|365115934|FG014|Overall Study|Sponsor's Decision|0|||
105851874|NCT03502707|365115935|FG015|Overall Study|Sponsor's Decision|2|||
105851875|NCT03502707|365115936|FG016|Overall Study|Sponsor's Decision|1|||
105851876|NCT03502707|365115937|FG017|Overall Study|Sponsor's Decision|0|||
105851877|NCT03502707|365115920|FG000|Overall Study|Initiated Prohibited Medication|0|||
105851878|NCT03502707|365115921|FG001|Overall Study|Initiated Prohibited Medication|0|||
105851879|NCT03502707|365115922|FG002|Overall Study|Initiated Prohibited Medication|0|||
105851880|NCT03502707|365115923|FG003|Overall Study|Initiated Prohibited Medication|0|||
105851881|NCT03502707|365115924|FG004|Overall Study|Initiated Prohibited Medication|0|||
105851882|NCT03502707|365115925|FG005|Overall Study|Initiated Prohibited Medication|0|||
105851883|NCT03502707|365115926|FG006|Overall Study|Initiated Prohibited Medication|0|||
105851884|NCT03502707|365115927|FG007|Overall Study|Initiated Prohibited Medication|0|||
105851885|NCT03502707|365115928|FG008|Overall Study|Initiated Prohibited Medication|0|||
105851886|NCT03502707|365115929|FG009|Overall Study|Initiated Prohibited Medication|0|||
105851887|NCT03502707|365115930|FG010|Overall Study|Initiated Prohibited Medication|0|||
105851888|NCT03502707|365115931|FG011|Overall Study|Initiated Prohibited Medication|0|||
105851889|NCT03502707|365115932|FG012|Overall Study|Initiated Prohibited Medication|0|||
105851890|NCT03502707|365115933|FG013|Overall Study|Initiated Prohibited Medication|0|||
105851891|NCT03502707|365115934|FG014|Overall Study|Initiated Prohibited Medication|0|||
105851892|NCT03502707|365115935|FG015|Overall Study|Initiated Prohibited Medication|0|||
105851893|NCT03502707|365115936|FG016|Overall Study|Initiated Prohibited Medication|1|||
105851894|NCT03502707|365115937|FG017|Overall Study|Initiated Prohibited Medication|0|||
105851895|NCT03502707|365115920|FG000|Overall Study|Other|0|||
105851896|NCT03502707|365115921|FG001|Overall Study|Other|0|||
105851897|NCT03502707|365115922|FG002|Overall Study|Other|0|||
105851898|NCT03502707|365115923|FG003|Overall Study|Other|0|||
105851899|NCT03502707|365115924|FG004|Overall Study|Other|0|||
105851900|NCT03502707|365115925|FG005|Overall Study|Other|0|||
105851901|NCT03502707|365115926|FG006|Overall Study|Other|0|||
105851902|NCT03502707|365115927|FG007|Overall Study|Other|0|||
105851903|NCT03502707|365115928|FG008|Overall Study|Other|1|||
105851904|NCT03502707|365115929|FG009|Overall Study|Other|1|||
105851905|NCT03502707|365115930|FG010|Overall Study|Other|2|||
105851906|NCT03502707|365115931|FG011|Overall Study|Other|0|||
105851907|NCT03502707|365115932|FG012|Overall Study|Other|0|||
105851908|NCT03502707|365115933|FG013|Overall Study|Other|0|||
105851909|NCT03502707|365115934|FG014|Overall Study|Other|0|||
105851910|NCT03502707|365115935|FG015|Overall Study|Other|4|||
105851911|NCT03502707|365115936|FG016|Overall Study|Other|1|||
105851912|NCT03502707|365115937|FG017|Overall Study|Other|0|||
105851913|NCT03502707|365115920|FG000|Overall Study|Randomized but not vaccinated|0|||
105851914|NCT03502707|365115921|FG001|Overall Study|Randomized but not vaccinated|0|||
105851915|NCT03502707|365115922|FG002|Overall Study|Randomized but not vaccinated|0|||
105851916|NCT03502707|365115923|FG003|Overall Study|Randomized but not vaccinated|0|||
105851917|NCT03502707|365115924|FG004|Overall Study|Randomized but not vaccinated|0|||
105851918|NCT03502707|365115925|FG005|Overall Study|Randomized but not vaccinated|0|||
105851919|NCT03502707|365115926|FG006|Overall Study|Randomized but not vaccinated|0|||
105851920|NCT03502707|365115927|FG007|Overall Study|Randomized but not vaccinated|0|||
105851921|NCT03502707|365115928|FG008|Overall Study|Randomized but not vaccinated|0|||
105851922|NCT03502707|365115929|FG009|Overall Study|Randomized but not vaccinated|0|||
105851923|NCT03502707|365115930|FG010|Overall Study|Randomized but not vaccinated|0|||
105851924|NCT03502707|365115931|FG011|Overall Study|Randomized but not vaccinated|1|||
105851925|NCT03502707|365115932|FG012|Overall Study|Randomized but not vaccinated|0|||
105851926|NCT03502707|365115933|FG013|Overall Study|Randomized but not vaccinated|0|||
105851927|NCT03502707|365115934|FG014|Overall Study|Randomized but not vaccinated|0|||
105851928|NCT03502707|365115935|FG015|Overall Study|Randomized but not vaccinated|0|||
105851929|NCT03502707|365115936|FG016|Overall Study|Randomized but not vaccinated|0|||
105851930|NCT03502707|365115937|FG017|Overall Study|Randomized but not vaccinated|1|||
105851931|NCT02511106|365115938|FG000|Overall Study|Lost to Follow-up|6|||
105851932|NCT02511106|365115939|FG001|Overall Study|Lost to Follow-up|4|||
105851933|NCT02511106|365115938|FG000|Overall Study|Withdrawal by Subject|24|||
105851934|NCT02511106|365115939|FG001|Overall Study|Withdrawal by Subject|21|||
105851935|NCT02511106|365115938|FG000|Overall Study|Death|42|||
105851936|NCT02511106|365115939|FG001|Overall Study|Death|82|||
105851937|NCT02511106|365115938|FG000|Overall Study|Ongoing study at data cut-off|3|||
105851938|NCT02511106|365115939|FG001|Overall Study|Ongoing study at data cut-off|2|||
105851939|NCT02511106|365115938|FG000|Overall Study|Without specified reason|3|||
105851940|NCT02511106|365115939|FG001|Overall Study|Without specified reason|0|||
105851941|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
105851942|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
105851943|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
105851944|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
105980936|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105980937|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
105980938|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
105980939|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
105980940|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
105980941|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
105980942|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980943|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980944|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980945|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980946|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980947|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980948|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
105980949|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980950|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
105980951|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980952|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
105980953|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980954|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980955|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980956|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980957|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980958|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980959|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980960|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980961|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
105980962|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980963|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
105980964|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980965|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980966|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980967|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980968|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980969|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980970|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
105980971|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980972|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980973|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980974|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
105980975|NCT02914561|365590605|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105980976|NCT02914561|365590606|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105980977|NCT02914561|365590607|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105980978|NCT02914561|365590608|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105980979|NCT02914561|365590609|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105980980|NCT02914561|365590610|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105980981|NCT02914561|365590611|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105980982|NCT02914561|365590612|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
105980983|NCT02914561|365590613|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
105980984|NCT02914561|365590614|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
105851945|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
105851946|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
105851947|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
105851948|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
105851949|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
105851950|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
105851951|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
105851952|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
105851953|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
105851954|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
105851955|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
105851956|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
106029119|NCT03011892|365770884|FG000|Double Blind (DB) Period|Adverse Event|0|||
106029120|NCT03011892|365770885|FG001|Double Blind (DB) Period|Adverse Event|1|||
106029121|NCT03011892|365770886|FG002|Double Blind (DB) Period|Adverse Event|1|||
106029122|NCT03011892|365770887|FG003|Double Blind (DB) Period|Adverse Event|0|||
105980985|NCT02914561|365590615|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
105980986|NCT03869333|365590618|FG000|Overall Study|Lost to Follow-up|1|||
105980987|NCT03869333|365590619|FG001|Overall Study|Lost to Follow-up|0|||
105980988|NCT03869333|365590620|FG002|Overall Study|Lost to Follow-up|0|||
105980989|NCT03869333|365590621|FG003|Overall Study|Lost to Follow-up|0|||
105980990|NCT03869333|365590618|FG000|Overall Study|Pregnancy|1|||
105980991|NCT03869333|365590619|FG001|Overall Study|Pregnancy|0|||
105980992|NCT03869333|365590620|FG002|Overall Study|Pregnancy|0|||
105980993|NCT03869333|365590621|FG003|Overall Study|Pregnancy|0|||
105980994|NCT03869333|365590618|FG000|Overall Study|Physician Decision|0|||
105980995|NCT03869333|365590619|FG001|Overall Study|Physician Decision|1|||
105980996|NCT03869333|365590620|FG002|Overall Study|Physician Decision|0|||
105980997|NCT03869333|365590621|FG003|Overall Study|Physician Decision|0|||
105980998|NCT02598128|365590622|FG000|Period A: Days -7 to -1|Adverse Event|1|||
105980999|NCT02598128|365590623|FG001|Period A: Days -7 to -1|Adverse Event|0|||
105981000|NCT02598128|365590624|FG002|Period A: Days -7 to -1|Adverse Event|0|||
105981001|NCT02598128|365590625|FG003|Period A: Days -7 to -1|Adverse Event|0|||
105981002|NCT03134183|365590627|FG000|Overall Study|Withdrawal by Subject|1|||
105981003|NCT03134183|365590628|FG001|Overall Study|Withdrawal by Subject|1|||
105981004|NCT01183468|365590629|FG000|Overall Study|Lost to Follow-up|2|||
105981005|NCT01183468|365590630|FG001|Overall Study|Lost to Follow-up|1|||
105981006|NCT01183468|365590631|FG002|Overall Study|Lost to Follow-up|0|||
105981007|NCT01183468|365590632|FG003|Overall Study|Lost to Follow-up|0|||
105981008|NCT01183468|365590629|FG000|Overall Study|Physician Decision|1|||
105981009|NCT01183468|365590630|FG001|Overall Study|Physician Decision|0|||
105981010|NCT01183468|365590631|FG002|Overall Study|Physician Decision|0|||
105981011|NCT01183468|365590632|FG003|Overall Study|Physician Decision|0|||
105981012|NCT01183468|365590629|FG000|Overall Study|Withdrawal by Subject|0|||
105981013|NCT01183468|365590630|FG001|Overall Study|Withdrawal by Subject|1|||
105981014|NCT01183468|365590631|FG002|Overall Study|Withdrawal by Subject|0|||
105981015|NCT01183468|365590632|FG003|Overall Study|Withdrawal by Subject|0|||
105981016|NCT04208087|365590633|FG000|Overall Study|Adverse Event|1|||
105981017|NCT04208087|365590634|FG001|Overall Study|Adverse Event|0|||
105981018|NCT04208087|365590635|FG002|Overall Study|Adverse Event|0|||
105981019|NCT04208087|365590636|FG003|Overall Study|Adverse Event|0|||
105981020|NCT04208087|365590637|FG004|Overall Study|Adverse Event|0|||
105981021|NCT04208087|365590633|FG000|Overall Study|Withdrawal by Subject|0|||
105981022|NCT04208087|365590634|FG001|Overall Study|Withdrawal by Subject|0|||
105981023|NCT04208087|365590635|FG002|Overall Study|Withdrawal by Subject|1|||
105981024|NCT04208087|365590636|FG003|Overall Study|Withdrawal by Subject|0|||
105981025|NCT04208087|365590637|FG004|Overall Study|Withdrawal by Subject|0|||
105981026|NCT04208087|365590633|FG000|Overall Study|Other|0|||
105981027|NCT04208087|365590634|FG001|Overall Study|Other|0|||
105981028|NCT04208087|365590635|FG002|Overall Study|Other|0|||
105981029|NCT04208087|365590636|FG003|Overall Study|Other|0|||
105981030|NCT04208087|365590637|FG004|Overall Study|Other|1|||
105981031|NCT01198509|365590638|FG000|Overall Study|Withdrawal by Subject|1|||
105981032|NCT01198509|365590639|FG001|Overall Study|Withdrawal by Subject|0|||
105981033|NCT01198509|365590640|FG002|Overall Study|Withdrawal by Subject|0|||
106029123|NCT03011892|365770888|FG004|Double Blind (DB) Period|Adverse Event|0|||
106029124|NCT03011892|365770889|FG005|Double Blind (DB) Period|Adverse Event|0|||
106029125|NCT03011892|365770890|FG006|Double Blind (DB) Period|Adverse Event|0|||
106029126|NCT03011892|365770891|FG007|Double Blind (DB) Period|Adverse Event|0|||
106029127|NCT03011892|365770892|FG008|Double Blind (DB) Period|Adverse Event|0|||
106029128|NCT03011892|365770893|FG009|Double Blind (DB) Period|Adverse Event|0|||
106029129|NCT03011892|365770894|FG010|Double Blind (DB) Period|Adverse Event|0|||
106029130|NCT03011892|365770895|FG011|Double Blind (DB) Period|Adverse Event|0|||
106029131|NCT03011892|365770884|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
106029132|NCT03011892|365770885|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
106029133|NCT03011892|365770886|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
106029134|NCT03011892|365770887|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
106029135|NCT03011892|365770888|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
105981034|NCT01198509|365590641|FG003|Overall Study|Withdrawal by Subject|0|||
105981035|NCT01198509|365590642|FG004|Overall Study|Withdrawal by Subject|0|||
105981036|NCT01198509|365590643|FG005|Overall Study|Withdrawal by Subject|0|||
105981037|NCT01291277|365590645|FG000|Overall Study|Death|2|||
105981038|NCT01291277|365590646|FG001|Overall Study|Death|2|||
105981039|NCT01291277|365590645|FG000|Overall Study|Lost to Follow-up|3|||
105981040|NCT01291277|365590646|FG001|Overall Study|Lost to Follow-up|1|||
105981041|NCT01345682|365590647|FG000|Overall Study|Progressive disease per RECIST|226|||
105981042|NCT01345682|365590648|FG001|Overall Study|Progressive disease per RECIST|93|||
105981043|NCT01345682|365590647|FG000|Overall Study|Worsening of underlying cancer disease|23|||
105981044|NCT01345682|365590648|FG001|Overall Study|Worsening of underlying cancer disease|12|||
105981045|NCT01345682|365590647|FG000|Overall Study|Adverse Event|51|||
105981046|NCT01345682|365590648|FG001|Overall Study|Adverse Event|41|||
105981047|NCT01345682|365590647|FG000|Overall Study|Non-compliance with protocol|0|||
105981048|NCT01345682|365590648|FG001|Overall Study|Non-compliance with protocol|1|||
106029136|NCT03011892|365770889|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
105851957|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
105851958|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
105851959|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
105851960|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
105851961|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
105851962|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
105851963|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
105851964|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
105851965|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
105851966|NCT02935686|365115940|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
105851967|NCT02935686|365115941|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
105851968|NCT02935686|365115942|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
105851969|NCT02935686|365115943|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
105851970|NCT02935686|365115944|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
105851971|NCT02935686|365115940|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
105851972|NCT02935686|365115941|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
105851973|NCT02935686|365115942|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
105851974|NCT02935686|365115943|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
105851975|NCT02935686|365115944|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
105851976|NCT02935686|365115940|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
105851977|NCT02935686|365115941|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
105851978|NCT02935686|365115942|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
105851979|NCT02935686|365115943|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
105851980|NCT02935686|365115944|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
105851981|NCT02935686|365115940|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
105851982|NCT02935686|365115941|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
105851983|NCT02935686|365115942|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
105851984|NCT02935686|365115943|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
105851985|NCT02935686|365115944|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
105851986|NCT02935686|365115940|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
105851987|NCT02935686|365115941|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
105851988|NCT02935686|365115942|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
105851989|NCT02935686|365115943|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
105851990|NCT02935686|365115944|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
105851991|NCT02935686|365115940|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
105851992|NCT02935686|365115941|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
105851993|NCT02935686|365115942|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
105851994|NCT02935686|365115943|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
105851995|NCT02935686|365115944|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
105851996|NCT05071313|365115945|FG000|Overall Study|Lost to Follow-up|17|||
105851997|NCT05071313|365115946|FG001|Overall Study|Lost to Follow-up|10|||
105851998|NCT05071313|365115945|FG000|Overall Study|Physician Decision|1|||
105851999|NCT05071313|365115946|FG001|Overall Study|Physician Decision|6|||
105852000|NCT05071313|365115945|FG000|Overall Study|Death|1|||
105852001|NCT05071313|365115946|FG001|Overall Study|Death|0|||
105852002|NCT05071313|365115945|FG000|Overall Study|Withdrawal by Subject|10|||
105852003|NCT05071313|365115946|FG001|Overall Study|Withdrawal by Subject|15|||
105852004|NCT05071313|365115945|FG000|Overall Study|Other|1|||
105852005|NCT05071313|365115946|FG001|Overall Study|Other|0|||
105852006|NCT05071313|365115945|FG000|Overall Study|Randomized but not vaccinated|4|||
105852007|NCT05071313|365115946|FG001|Overall Study|Randomized but not vaccinated|2|||
105852008|NCT01951885|365115948|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
105852009|NCT01951885|365115949|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
105852010|NCT01951885|365115948|FG000|Overall Study|Adverse Event|1|||
105852011|NCT01951885|365115949|FG001|Overall Study|Adverse Event|0|||
105852012|NCT01951885|365115948|FG000|Overall Study|Withdrawal by Subject|0|||
105852013|NCT01951885|365115949|FG001|Overall Study|Withdrawal by Subject|1|||
105852014|NCT01951885|365115948|FG000|Overall Study|ineligible due to a change in donor|0|||
105981049|NCT01345682|365590647|FG000|Overall Study|Lost to Follow-up|0|||
105981050|NCT01345682|365590648|FG001|Overall Study|Lost to Follow-up|1|||
105852015|NCT01951885|365115949|FG001|Overall Study|ineligible due to a change in donor|1|||
105852016|NCT01951885|365115948|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
105852017|NCT01951885|365115949|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
105981051|NCT01345682|365590647|FG000|Overall Study|Refused to continue trial medication|16|||
105852018|NCT01293539|365115950|FG000|Overall Study|Physician Decision|1|||
105852019|NCT01367665|365115951|FG000|Overall Study|Death|102|||
105852020|NCT01367665|365115952|FG001|Overall Study|Death|19|||
105852021|NCT01367665|365115951|FG000|Overall Study|Lost to Follow-up|222|||
105852022|NCT01367665|365115952|FG001|Overall Study|Lost to Follow-up|22|||
105852023|NCT01367665|365115951|FG000|Overall Study|Not Done|118|||
105852024|NCT01367665|365115952|FG001|Overall Study|Not Done|14|||
106029137|NCT03011892|365770890|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
105852025|NCT02752906|365115953|FG000|Overall Study|Protocol Violation|2|||
105852026|NCT02752906|365115954|FG001|Overall Study|Protocol Violation|1|||
105852027|NCT02752906|365115953|FG000|Overall Study|Withdrawal by Subject|2|||
105852028|NCT02752906|365115954|FG001|Overall Study|Withdrawal by Subject|2|||
105852029|NCT02752906|365115953|FG000|Overall Study|Lost to Follow-up|3|||
105852030|NCT02752906|365115954|FG001|Overall Study|Lost to Follow-up|2|||
105852031|NCT02492880|365115955|FG000|Overall Study|Lost to Follow-up|1|||
105852032|NCT02492880|365115955|FG000|Overall Study|Protocol Violation|1|||
105852033|NCT04462471|365115956|FG000|Overall Study|Adverse Event|0|||
105852034|NCT04462471|365115957|FG001|Overall Study|Adverse Event|1|||
105852035|NCT04462471|365115958|FG002|Overall Study|Adverse Event|0|||
105852036|NCT04462471|365115959|FG003|Overall Study|Adverse Event|0|||
105852037|NCT04462471|365115956|FG000|Overall Study|Disease progression|1|||
105852038|NCT04462471|365115957|FG001|Overall Study|Disease progression|0|||
105852039|NCT04462471|365115958|FG002|Overall Study|Disease progression|0|||
105852040|NCT04462471|365115959|FG003|Overall Study|Disease progression|0|||
105852041|NCT01200992|365115960|FG000|Overall Study|Study terminated early|35|||
105852042|NCT01200992|365115961|FG001|Overall Study|Study terminated early|41|||
105852043|NCT01200992|365115960|FG000|Overall Study|Randomized but not treated|2|||
105852044|NCT01200992|365115961|FG001|Overall Study|Randomized but not treated|0|||
105852045|NCT00554190|365115962|FG000|Overall Study|Termination forms not completed|10|||
105852046|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
105852047|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
105852048|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
105852049|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
105852050|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
105852051|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
105852052|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
105852053|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
105852054|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
105852055|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
105852056|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
105852057|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
105852058|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
105852059|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
105852060|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
105852061|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
105852062|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
105852063|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
105852064|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
105852065|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
105852066|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
105852067|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
105852068|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
105852069|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
105852070|NCT03514641|365115964|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
105852071|NCT03514641|365115965|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
105852072|NCT03514641|365115966|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
105852073|NCT03514641|365115967|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
105852074|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
105852075|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
105852076|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
105852077|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
105852078|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
105852079|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
106029138|NCT03011892|365770891|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
106029139|NCT03011892|365770892|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
106029140|NCT03011892|365770893|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
106029141|NCT03011892|365770894|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
105852080|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
105852081|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
105852082|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
105852083|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
105852084|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
105852085|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
105852086|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
105852087|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
105852088|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
105852089|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
105852090|NCT03514641|365115964|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
106151296|NCT02723955|366215065|FG011|Expansion Phase|Site Closed|6|||
105852091|NCT03514641|365115965|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
105852092|NCT03514641|365115966|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
105852093|NCT03514641|365115967|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
105852094|NCT00114166|365115977|FG000|Overall Study|Wrong primary|0|||
105852095|NCT00114166|365115978|FG001|Overall Study|Wrong primary|1|||
105852096|NCT02397408|365115979|FG000|Overall Study|Physician Decision|4|||
105852097|NCT02397408|365115979|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
105852098|NCT03397771|365115982|FG000|Overall Study|2 erroneously randomized, never treated|3|||
105852099|NCT03397771|365115983|FG001|Overall Study|2 erroneously randomized, never treated|1|||
105852100|NCT03397771|365115982|FG000|Overall Study|Withdrawal by Subject|1|||
105852101|NCT03397771|365115983|FG001|Overall Study|Withdrawal by Subject|3|||
105852102|NCT03397771|365115982|FG000|Overall Study|Protocol Violation|2|||
105852103|NCT03397771|365115983|FG001|Overall Study|Protocol Violation|2|||
105852104|NCT03397771|365115982|FG000|Overall Study|Adverse Event|2|||
105852105|NCT03397771|365115983|FG001|Overall Study|Adverse Event|1|||
105852106|NCT04078126|365115987|FG000|Washout|Study put on hold due to COVID-19|0|||
105852107|NCT04078126|365115988|FG001|Washout|Study put on hold due to COVID-19|2|||
105852108|NCT04078126|365115987|FG000|Period 2|Study put on hold due to COVID-19|1|||
105852109|NCT04078126|365115988|FG001|Period 2|Study put on hold due to COVID-19|1|||
105852110|NCT00140426|365115989|FG000|Overall Study|Withdrawal by Subject|0|||
105852111|NCT00140426|365115990|FG001|Overall Study|Withdrawal by Subject|3|||
105852112|NCT02669758|365115991|FG000|Overall Study|Withdrawal by Subject|43|||
105852113|NCT02669758|365115991|FG000|Overall Study|Lost to Follow-up|19|||
105852114|NCT02669758|365115991|FG000|Overall Study|Adverse Event|16|||
105852115|NCT02669758|365115991|FG000|Overall Study|Non-Compliance with Study Drug|8|||
105852116|NCT02669758|365115991|FG000|Overall Study|Lack of Efficacy|5|||
105852117|NCT02669758|365115991|FG000|Overall Study|Pregnancy|1|||
105852118|NCT02669758|365115991|FG000|Overall Study|Study noncompliance|1|||
105852119|NCT02669758|365115991|FG000|Overall Study|Protocol Violation|1|||
105852120|NCT02149108|365115992|FG000|Overall Study|Not treated|1|||
105852121|NCT02149108|365115993|FG001|Overall Study|Not treated|2|||
105852122|NCT02149108|365115992|FG000|Overall Study|Progressive Disease (PD)|324|||
105852123|NCT02149108|365115993|FG001|Overall Study|Progressive Disease (PD)|318|||
105852124|NCT02149108|365115992|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
105852125|NCT02149108|365115993|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
105852126|NCT02149108|365115992|FG000|Overall Study|Other Adverse Event (AE)|8|||
105852127|NCT02149108|365115993|FG001|Overall Study|Other Adverse Event (AE)|18|||
105852128|NCT02149108|365115992|FG000|Overall Study|Other not defined above|0|||
105852129|NCT02149108|365115993|FG001|Overall Study|Other not defined above|2|||
105852130|NCT02149108|365115992|FG000|Overall Study|Refusal to continue trial medication|15|||
105852131|NCT02149108|365115993|FG001|Overall Study|Refusal to continue trial medication|11|||
105852132|NCT02149108|365115992|FG000|Overall Study|Lost to Follow-up|1|||
105852133|NCT02149108|365115993|FG001|Overall Study|Lost to Follow-up|0|||
105852134|NCT00806286|365115994|FG000|Overall Study|Adverse Event|5|||
105852135|NCT00806286|365115995|FG001|Overall Study|Adverse Event|2|||
105852136|NCT00806286|365115996|FG002|Overall Study|Adverse Event|0|||
105852137|NCT00806286|365115994|FG000|Overall Study|Disease progression|31|||
105852138|NCT00806286|365115995|FG001|Overall Study|Disease progression|38|||
105852139|NCT00806286|365115996|FG002|Overall Study|Disease progression|1|||
105852140|NCT00806286|365115994|FG000|Overall Study|Death|1|||
105852141|NCT00806286|365115995|FG001|Overall Study|Death|6|||
105852142|NCT00806286|365115996|FG002|Overall Study|Death|0|||
105852143|NCT00806286|365115994|FG000|Overall Study|Lost to Follow-up|0|||
105852144|NCT00806286|365115995|FG001|Overall Study|Lost to Follow-up|1|||
105852145|NCT00806286|365115996|FG002|Overall Study|Lost to Follow-up|0|||
105852146|NCT00806286|365115994|FG000|Overall Study|Withdrawal by Subject|8|||
105852147|NCT00806286|365115995|FG001|Overall Study|Withdrawal by Subject|3|||
105852148|NCT00806286|365115996|FG002|Overall Study|Withdrawal by Subject|1|||
105852149|NCT00806286|365115994|FG000|Overall Study|Physician Decision|2|||
105852150|NCT00806286|365115995|FG001|Overall Study|Physician Decision|2|||
105852151|NCT00806286|365115996|FG002|Overall Study|Physician Decision|0|||
106029142|NCT03011892|365770895|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
106029143|NCT03011892|365770884|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
105852152|NCT00806286|365115994|FG000|Overall Study|Due to a variety of reasons|7|||
105852153|NCT00806286|365115995|FG001|Overall Study|Due to a variety of reasons|2|||
105852154|NCT00806286|365115996|FG002|Overall Study|Due to a variety of reasons|1|||
105852155|NCT02455050|365115997|FG000|Treatment Period 1|Lost to Follow-up|1|||
106029144|NCT03011892|365770885|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
105852156|NCT02455050|365115998|FG001|Treatment Period 1|Lost to Follow-up|1|||
105852157|NCT02455050|365115999|FG002|Treatment Period 1|Lost to Follow-up|1|||
105852158|NCT02455050|365116000|FG003|Treatment Period 1|Lost to Follow-up|2|||
105852159|NCT02455050|365115997|FG000|Treatment Period 2|Lost to Follow-up|1|||
105852160|NCT02455050|365115998|FG001|Treatment Period 2|Lost to Follow-up|0|||
105852161|NCT02455050|365115999|FG002|Treatment Period 2|Lost to Follow-up|2|||
105852162|NCT02455050|365116000|FG003|Treatment Period 2|Lost to Follow-up|1|||
105852163|NCT03402750|365116001|FG000|Overall Study|Lost to Follow-up|2|||
105981052|NCT01345682|365590648|FG001|Overall Study|Refused to continue trial medication|9|||
105981053|NCT01345682|365590647|FG000|Overall Study|Not treated|2|||
105981054|NCT01345682|365590648|FG001|Overall Study|Not treated|1|||
105981055|NCT01345682|365590647|FG000|Overall Study|Reason other than those specified above|4|||
105981056|NCT01345682|365590648|FG001|Overall Study|Reason other than those specified above|3|||
105981057|NCT01638559|365590652|FG000|Overall Study|Lost to Follow-up|1|||
105981058|NCT01638559|365590652|FG000|Overall Study|Withdrawal by Subject|1|||
105981059|NCT01638559|365590652|FG000|Overall Study|Subject declined to travel for biopsy|1|||
105981060|NCT00279812|365590667|FG000|Overall Study|Protocol Violation|1|||
105981061|NCT00279812|365590668|FG001|Overall Study|Protocol Violation|1|||
105981062|NCT00279812|365590669|FG002|Overall Study|Protocol Violation|0|||
105981063|NCT00279812|365590670|FG003|Overall Study|Protocol Violation|0|||
105981064|NCT00279812|365590671|FG004|Overall Study|Protocol Violation|1|||
105981065|NCT00279812|365590672|FG005|Overall Study|Protocol Violation|0|||
105981066|NCT00279812|365590667|FG000|Overall Study|Withdrawal by Subject|0|||
105981067|NCT00279812|365590668|FG001|Overall Study|Withdrawal by Subject|4|||
105981068|NCT00279812|365590669|FG002|Overall Study|Withdrawal by Subject|2|||
105981069|NCT00279812|365590670|FG003|Overall Study|Withdrawal by Subject|0|||
105981070|NCT00279812|365590671|FG004|Overall Study|Withdrawal by Subject|0|||
105981071|NCT00279812|365590672|FG005|Overall Study|Withdrawal by Subject|0|||
105981072|NCT00279812|365590667|FG000|Overall Study|Adverse Event|0|||
105981073|NCT00279812|365590668|FG001|Overall Study|Adverse Event|1|||
105981074|NCT00279812|365590669|FG002|Overall Study|Adverse Event|1|||
105981075|NCT00279812|365590670|FG003|Overall Study|Adverse Event|0|||
105981076|NCT00279812|365590671|FG004|Overall Study|Adverse Event|2|||
105981077|NCT00279812|365590672|FG005|Overall Study|Adverse Event|1|||
105981078|NCT04046250|365590673|FG000|Overall Study|Death|0|||
105981079|NCT04046250|365590674|FG001|Overall Study|Death|1|||
105981080|NCT04046250|365590673|FG000|Overall Study|Withdrawal by Subject|3|||
105981081|NCT04046250|365590674|FG001|Overall Study|Withdrawal by Subject|3|||
105981082|NCT01174173|365590675|FG000|Overall Study|drug-drug interaction|1|||
105981083|NCT02212678|365592248|FG000|Overall Study|Adverse Event|1|||
105981084|NCT01818284|365592249|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
105981085|NCT01818284|365592250|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
105981086|NCT01818284|365592249|FG000|Overall Study|Death|0|||
105981087|NCT01818284|365592250|FG001|Overall Study|Death|2|||
105981088|NCT04030962|365592251|FG000|Stage 2|Adverse Event|0|||
105981089|NCT04030962|365592252|FG001|Stage 2|Adverse Event|0|||
105981090|NCT04030962|365592253|FG002|Stage 2|Adverse Event|0|||
105981091|NCT04030962|365592254|FG003|Stage 2|Adverse Event|0|||
105981092|NCT04030962|365592255|FG004|Stage 2|Adverse Event|0|||
105981093|NCT04030962|365592256|FG005|Stage 2|Adverse Event|0|||
105981094|NCT04030962|365592257|FG006|Stage 2|Adverse Event|0|||
105981095|NCT04030962|365592258|FG007|Stage 2|Adverse Event|0|||
105981096|NCT04030962|365592259|FG008|Stage 2|Adverse Event|1|||
105981097|NCT04030962|365592260|FG009|Stage 2|Adverse Event|0|||
105981098|NCT04030962|365592261|FG010|Stage 2|Adverse Event|1|||
105981099|NCT04030962|365592262|FG011|Stage 2|Adverse Event|1|||
105981100|NCT04030962|365592263|FG012|Stage 2|Adverse Event|1|||
105981101|NCT04030962|365592251|FG000|Stage 2|Withdrawal by Subject|0|||
105981102|NCT04030962|365592252|FG001|Stage 2|Withdrawal by Subject|0|||
105852164|NCT03402750|365116002|FG001|Overall Study|Lost to Follow-up|1|||
105852165|NCT02628743|365116004|FG000|Overall Study|Other|3|||
105852166|NCT02628743|365116004|FG000|Overall Study|Withdrawal by Subject|50|||
105852167|NCT02628743|365116004|FG000|Overall Study|Study Terminated by Sponsor|76|||
105852168|NCT02628743|365116004|FG000|Overall Study|Physician Decision|2|||
105852169|NCT02981303|365116005|FG000|Overall Study|Progressive Disease|17|||
105852170|NCT02981303|365116006|FG001|Overall Study|Progressive Disease|37|||
105852171|NCT02981303|365116005|FG000|Overall Study|Adverse Event|1|||
105852172|NCT02981303|365116006|FG001|Overall Study|Adverse Event|4|||
105852173|NCT02981303|365116005|FG000|Overall Study|Withdrawal by Subject|0|||
105981103|NCT04030962|365592253|FG002|Stage 2|Withdrawal by Subject|0|||
105981104|NCT04030962|365592254|FG003|Stage 2|Withdrawal by Subject|0|||
105981105|NCT04030962|365592255|FG004|Stage 2|Withdrawal by Subject|0|||
105981106|NCT04030962|365592256|FG005|Stage 2|Withdrawal by Subject|0|||
106029145|NCT03011892|365770886|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
105981107|NCT04030962|365592257|FG006|Stage 2|Withdrawal by Subject|0|||
106029146|NCT03011892|365770887|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
106029147|NCT03011892|365770888|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
105981108|NCT04030962|365592258|FG007|Stage 2|Withdrawal by Subject|0|||
105981109|NCT04030962|365592259|FG008|Stage 2|Withdrawal by Subject|1|||
106029148|NCT03011892|365770889|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
105852174|NCT02981303|365116006|FG001|Overall Study|Withdrawal by Subject|1|||
105981110|NCT04030962|365592260|FG009|Stage 2|Withdrawal by Subject|0|||
105852175|NCT02325518|365116007|FG000|Overall Study|Adverse Event|4|||
105981111|NCT04030962|365592261|FG010|Stage 2|Withdrawal by Subject|0|||
105981112|NCT04030962|365592262|FG011|Stage 2|Withdrawal by Subject|2|||
105981113|NCT04030962|365592263|FG012|Stage 2|Withdrawal by Subject|1|||
105981114|NCT04030962|365592251|FG000|Stage 2|Lost to Follow-up|0|||
105981115|NCT04030962|365592252|FG001|Stage 2|Lost to Follow-up|0|||
105981116|NCT04030962|365592253|FG002|Stage 2|Lost to Follow-up|0|||
105981117|NCT04030962|365592254|FG003|Stage 2|Lost to Follow-up|0|||
105981118|NCT04030962|365592255|FG004|Stage 2|Lost to Follow-up|0|||
105981119|NCT04030962|365592256|FG005|Stage 2|Lost to Follow-up|0|||
105981120|NCT04030962|365592257|FG006|Stage 2|Lost to Follow-up|0|||
105981121|NCT04030962|365592258|FG007|Stage 2|Lost to Follow-up|0|||
105981122|NCT04030962|365592259|FG008|Stage 2|Lost to Follow-up|1|||
105981123|NCT04030962|365592260|FG009|Stage 2|Lost to Follow-up|0|||
105981124|NCT04030962|365592261|FG010|Stage 2|Lost to Follow-up|0|||
105981125|NCT04030962|365592262|FG011|Stage 2|Lost to Follow-up|0|||
105981126|NCT04030962|365592263|FG012|Stage 2|Lost to Follow-up|0|||
105981127|NCT04030962|365592251|FG000|Stage 2|Technical Problems|0|||
105981128|NCT04030962|365592252|FG001|Stage 2|Technical Problems|0|||
105981129|NCT04030962|365592253|FG002|Stage 2|Technical Problems|0|||
105981130|NCT04030962|365592254|FG003|Stage 2|Technical Problems|0|||
105981131|NCT04030962|365592255|FG004|Stage 2|Technical Problems|0|||
105981132|NCT04030962|365592256|FG005|Stage 2|Technical Problems|0|||
105981133|NCT04030962|365592257|FG006|Stage 2|Technical Problems|0|||
105981134|NCT04030962|365592258|FG007|Stage 2|Technical Problems|0|||
105981135|NCT04030962|365592259|FG008|Stage 2|Technical Problems|0|||
105981136|NCT04030962|365592260|FG009|Stage 2|Technical Problems|0|||
105981137|NCT04030962|365592261|FG010|Stage 2|Technical Problems|0|||
105981138|NCT04030962|365592262|FG011|Stage 2|Technical Problems|1|||
105981139|NCT04030962|365592263|FG012|Stage 2|Technical Problems|0|||
105981140|NCT01646203|365592264|FG000|Overall Study|Adverse Event|2|||
105981141|NCT01646203|365592265|FG001|Overall Study|Adverse Event|0|||
105981142|NCT01646203|365592266|FG002|Overall Study|Adverse Event|1|||
105981143|NCT01646203|365592264|FG000|Overall Study|Withdrawal by Subject|0|||
105981144|NCT01646203|365592265|FG001|Overall Study|Withdrawal by Subject|1|||
105981145|NCT01646203|365592266|FG002|Overall Study|Withdrawal by Subject|0|||
105981146|NCT01646203|365592264|FG000|Overall Study|Physician's Decision|0|||
105981147|NCT01646203|365592265|FG001|Overall Study|Physician's Decision|1|||
105981148|NCT01646203|365592266|FG002|Overall Study|Physician's Decision|0|||
105981149|NCT00385723|365592267|FG000|Overall Study|Lost to Follow-up|1|||
105981150|NCT00385723|365592268|FG001|Overall Study|Lost to Follow-up|1|||
105981151|NCT00385723|365592269|FG002|Overall Study|Lost to Follow-up|0|||
105981152|NCT00385723|365592267|FG000|Overall Study|Withdrawal by Subject|1|||
105981153|NCT00385723|365592268|FG001|Overall Study|Withdrawal by Subject|0|||
105981154|NCT00385723|365592269|FG002|Overall Study|Withdrawal by Subject|2|||
105981155|NCT03455829|365592270|FG000|Overall Study|Death|2|||
105981156|NCT03455829|365592271|FG001|Overall Study|Death|3|||
105981157|NCT03455829|365592272|FG002|Overall Study|Death|2|||
105981158|NCT03455829|365592273|FG003|Overall Study|Death|4|||
105981159|NCT03455829|365592274|FG004|Overall Study|Death|2|||
105981160|NCT03455829|365592270|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
106029149|NCT03011892|365770890|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
106029150|NCT03011892|365770891|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
106029151|NCT03011892|365770892|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
106029152|NCT03011892|365770893|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
106029153|NCT03011892|365770894|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
106029154|NCT03011892|365770895|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
106029155|NCT03011892|365770884|FG000|Double Blind (DB) Period|Other|1|||
106029156|NCT03011892|365770885|FG001|Double Blind (DB) Period|Other|1|||
106029157|NCT03011892|365770886|FG002|Double Blind (DB) Period|Other|1|||
106029158|NCT03011892|365770887|FG003|Double Blind (DB) Period|Other|0|||
106029159|NCT03011892|365770888|FG004|Double Blind (DB) Period|Other|1|||
106029160|NCT03011892|365770889|FG005|Double Blind (DB) Period|Other|0|||
106029161|NCT03011892|365770890|FG006|Double Blind (DB) Period|Other|0|||
105981161|NCT03455829|365592271|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
105981162|NCT03455829|365592272|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
105981163|NCT03455829|365592273|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
105981164|NCT03455829|365592274|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
105981165|NCT03455829|365592270|FG000|Overall Study|Disease progression|0|||
106029162|NCT03011892|365770891|FG007|Double Blind (DB) Period|Other|0|||
106029163|NCT03011892|365770892|FG008|Double Blind (DB) Period|Other|0|||
106029164|NCT03011892|365770893|FG009|Double Blind (DB) Period|Other|0|||
106029165|NCT03011892|365770894|FG010|Double Blind (DB) Period|Other|0|||
106029166|NCT03011892|365770895|FG011|Double Blind (DB) Period|Other|0|||
106029167|NCT03011892|365770884|FG000|Double Blind (DB) Period|Physician Decision|1|||
105981166|NCT03455829|365592271|FG001|Overall Study|Disease progression|0|||
105981167|NCT03455829|365592272|FG002|Overall Study|Disease progression|0|||
105981168|NCT03455829|365592273|FG003|Overall Study|Disease progression|1|||
105981169|NCT03455829|365592274|FG004|Overall Study|Disease progression|1|||
105981170|NCT03689712|365592275|FG000|Overall Study|Adverse Event|1|||
105981171|NCT03689712|365592276|FG001|Overall Study|Adverse Event|0|||
105981172|NCT03689712|365592275|FG000|Overall Study|Death|20|||
105981173|NCT03689712|365592276|FG001|Overall Study|Death|10|||
105981174|NCT03689712|365592275|FG000|Overall Study|Lost to Follow-up|6|||
105852176|NCT02325518|365116008|FG001|Overall Study|Adverse Event|1|||
105852177|NCT02325518|365116007|FG000|Overall Study|Physician Decision|0|||
105852178|NCT02325518|365116008|FG001|Overall Study|Physician Decision|1|||
105852179|NCT02325518|365116007|FG000|Overall Study|Withdrawal by Subject|0|||
105852180|NCT02325518|365116008|FG001|Overall Study|Withdrawal by Subject|1|||
105852181|NCT04715932|365116009|FG000|Overall Study|Lost to Follow-up|1|||
105852182|NCT04715932|365116010|FG001|Overall Study|Lost to Follow-up|0|||
105852183|NCT02740699|365116023|FG000|Overall Study|Lost to Follow-up|5|||
105852184|NCT02740699|365116023|FG000|Overall Study|Withdrawal by Subject|14|||
105852185|NCT02740699|365116023|FG000|Overall Study|Physician Decision|5|||
105852186|NCT03393806|365116024|FG000|Overall Study|Physician Decision|1|||
105852187|NCT03393806|365116025|FG001|Overall Study|Physician Decision|0|||
105852188|NCT00886288|365116026|FG000|Overall Study|no respect of the 12 weeks period|657|||
105852189|NCT00886288|365116027|FG001|Overall Study|no respect of the 12 weeks period|227|||
105852190|NCT00886288|365116026|FG000|Overall Study|Lost to Follow-up|86|||
105852191|NCT00886288|365116027|FG001|Overall Study|Lost to Follow-up|0|||
105852192|NCT01259115|365116028|FG000|Period 1|Adverse Event|1|||
105852193|NCT01259115|365116029|FG001|Period 1|Adverse Event|0|||
105852194|NCT01259115|365116028|FG000|Period 1|Protocol Violation|2|||
105852195|NCT01259115|365116029|FG001|Period 1|Protocol Violation|0|||
105852196|NCT01259115|365116028|FG000|Period 1|Lost to Follow-up|0|||
105852197|NCT01259115|365116029|FG001|Period 1|Lost to Follow-up|1|||
105852198|NCT01259115|365116028|FG000|Period 2|Adverse Event|1|||
105852199|NCT01259115|365116029|FG001|Period 2|Adverse Event|0|||
105852200|NCT01675661|365116030|FG000|Overall Study|Lost to Follow-up|22|||
105852201|NCT01675661|365116031|FG001|Overall Study|Lost to Follow-up|23|||
105852202|NCT01675661|365116030|FG000|Overall Study|Practical problems|9|||
105852203|NCT01675661|365116031|FG001|Overall Study|Practical problems|5|||
105852204|NCT01675661|365116030|FG000|Overall Study|Moved away|5|||
105852205|NCT01675661|365116031|FG001|Overall Study|Moved away|6|||
105852206|NCT01675661|365116030|FG000|Overall Study|Withdrawal by Subject|3|||
105852207|NCT01675661|365116031|FG001|Overall Study|Withdrawal by Subject|7|||
105852208|NCT01675661|365116030|FG000|Overall Study|Physician Decision|0|||
105852209|NCT01675661|365116031|FG001|Overall Study|Physician Decision|2|||
105852210|NCT01675661|365116030|FG000|Overall Study|Death|0|||
105852211|NCT01675661|365116031|FG001|Overall Study|Death|1|||
105852212|NCT01675661|365116030|FG000|Overall Study|Other reason|1|||
105852213|NCT01675661|365116031|FG001|Overall Study|Other reason|2|||
105852214|NCT00326963|365116032|FG000|Overall Study|Adverse Event|2|||
105852215|NCT00326963|365116032|FG000|Overall Study|Injection site reaction|1|||
105852216|NCT00326963|365116032|FG000|Overall Study|Death|1|||
105852217|NCT00326963|365116032|FG000|Overall Study|Failure to return|10|||
105852218|NCT00326963|365116032|FG000|Overall Study|Withdrawal by Subject|10|||
105852219|NCT00326963|365116032|FG000|Overall Study|Refused treatment / did not cooperate|5|||
105852220|NCT00326963|365116032|FG000|Overall Study|Violation of selection criteria at entry|2|||
105852221|NCT00326963|365116032|FG000|Overall Study|Other protocol violation|1|||
105852222|NCT00326963|365116032|FG000|Overall Study|Administrative / other|1|||
105852223|NCT00859586|365116033|FG000|Overall Study|Donors|4|||
105852224|NCT01783548|365116035|FG000|Overall Study|Adverse Event|8|||
105852225|NCT01783548|365116036|FG001|Overall Study|Adverse Event|4|||
105852226|NCT01783548|365116035|FG000|Overall Study|Withdrawal by Subject|11|||
105852227|NCT01783548|365116036|FG001|Overall Study|Withdrawal by Subject|8|||
105852228|NCT01783548|365116035|FG000|Overall Study|Non-compliance|4|||
105852229|NCT01783548|365116036|FG001|Overall Study|Non-compliance|0|||
105852230|NCT01783548|365116035|FG000|Overall Study|Protocol Violation|2|||
105852231|NCT01783548|365116036|FG001|Overall Study|Protocol Violation|2|||
105852232|NCT01783548|365116035|FG000|Overall Study|Lost to Follow-up|8|||
105852233|NCT01783548|365116036|FG001|Overall Study|Lost to Follow-up|3|||
105852234|NCT01783548|365116035|FG000|Overall Study|Lack of Efficacy|1|||
105852235|NCT01783548|365116036|FG001|Overall Study|Lack of Efficacy|1|||
106029168|NCT03011892|365770885|FG001|Double Blind (DB) Period|Physician Decision|0|||
105852236|NCT02992418|365116037|FG000|Overall Study|Withdrawal by Subject|11|||
105852237|NCT02992418|365116038|FG001|Overall Study|Withdrawal by Subject|12|||
106029169|NCT03011892|365770886|FG002|Double Blind (DB) Period|Physician Decision|1|||
106029170|NCT03011892|365770887|FG003|Double Blind (DB) Period|Physician Decision|0|||
106029171|NCT03011892|365770888|FG004|Double Blind (DB) Period|Physician Decision|0|||
105852238|NCT02992418|365116037|FG000|Overall Study|Non-compliance with the protocol|308|||
105852239|NCT02992418|365116038|FG001|Overall Study|Non-compliance with the protocol|308|||
105852240|NCT02992418|365116037|FG000|Overall Study|Lost to Follow-up|27|||
105852241|NCT02992418|365116038|FG001|Overall Study|Lost to Follow-up|22|||
105852242|NCT03246126|365116043|FG000|Overall Study|Withdrawal by Subject|0|||
105852243|NCT03246126|365116044|FG001|Overall Study|Withdrawal by Subject|1|||
105852244|NCT01460901|365116050|FG000|Overall Study|Withdrawal by Subject|2|||
105852245|NCT01006135|365116053|FG000|Overall Study|Adverse Event|22|||
105852246|NCT01006135|365116053|FG000|Overall Study|Protocol Violation|14|||
105852247|NCT01006135|365116053|FG000|Overall Study|Lost to Follow-up|32|||
105852248|NCT01006135|365116053|FG000|Overall Study|Other|72|||
105852249|NCT02387983|365116063|FG000|Overall Study|Adverse Event|4|||
105852250|NCT02387983|365116063|FG000|Overall Study|Protocol Violation|1|||
105981175|NCT03689712|365592276|FG001|Overall Study|Lost to Follow-up|6|||
105981176|NCT03689712|365592275|FG000|Overall Study|Other|1|||
105981177|NCT03689712|365592276|FG001|Overall Study|Other|0|||
105981178|NCT03689712|365592275|FG000|Overall Study|Patient Non-Compliance|0|||
105981179|NCT03689712|365592276|FG001|Overall Study|Patient Non-Compliance|1|||
105981180|NCT03689712|365592275|FG000|Overall Study|Withdrawal by Subject|20|||
105981181|NCT03689712|365592276|FG001|Overall Study|Withdrawal by Subject|4|||
105981182|NCT03689712|365592275|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
105981183|NCT03689712|365592276|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
105981184|NCT03689712|365592275|FG000|Overall Study|Randomized but not Treated|13|||
105981185|NCT03689712|365592276|FG001|Overall Study|Randomized but not Treated|7|||
105981186|NCT03689712|365592275|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
105981187|NCT03689712|365592276|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
105981188|NCT02634606|365592278|FG000|Overall Study|unable to obtain the drug at start|13|||
105981189|NCT02989805|365592285|FG000|Overall Study|invalid consent|6|||
105981190|NCT02989805|365592286|FG001|Overall Study|invalid consent|4|||
105981191|NCT02211313|365592287|FG000|Overall Study|Treatment Failure|5|||
105981192|NCT02211313|365592288|FG001|Overall Study|Treatment Failure|2|||
105981193|NCT02211313|365592287|FG000|Overall Study|No Follow up Questionnaires|1|||
105981194|NCT02211313|365592288|FG001|Overall Study|No Follow up Questionnaires|1|||
105981195|NCT02648217|365592293|FG000|Overall Study|Adverse Event|0|||
105981196|NCT02648217|365592294|FG001|Overall Study|Adverse Event|1|||
105981197|NCT02648217|365592293|FG000|Overall Study|Lost to Follow-up|1|||
105981198|NCT02648217|365592294|FG001|Overall Study|Lost to Follow-up|1|||
105981199|NCT02648217|365592293|FG000|Overall Study|Withdrawal by Subject|4|||
105981200|NCT02648217|365592294|FG001|Overall Study|Withdrawal by Subject|3|||
105981201|NCT02648217|365592293|FG000|Overall Study|Unclassified|5|||
105981202|NCT02648217|365592294|FG001|Overall Study|Unclassified|0|||
105981203|NCT02690649|365592295|FG000|Overall Study|Withdrawal by Subject|1|||
105981204|NCT02690649|365592296|FG001|Overall Study|Withdrawal by Subject|1|||
105981205|NCT02690649|365592295|FG000|Overall Study|Protocol Violation|0|||
105981206|NCT02690649|365592296|FG001|Overall Study|Protocol Violation|3|||
105981207|NCT00549770|365592297|FG000|Overall Study|Protocol deviation|1|||
105981208|NCT00549770|365592298|FG001|Overall Study|Protocol deviation|1|||
105981209|NCT00549770|365592299|FG002|Overall Study|Protocol deviation|1|||
105981210|NCT00549770|365592300|FG003|Overall Study|Protocol deviation|2|||
105981211|NCT00549770|365592301|FG004|Overall Study|Protocol deviation|2|||
105981212|NCT00549770|365592302|FG005|Overall Study|Protocol deviation|2|||
105981213|NCT00549770|365592303|FG006|Overall Study|Protocol deviation|1|||
105981214|NCT00549770|365592304|FG007|Overall Study|Protocol deviation|2|||
105981215|NCT00549770|365592297|FG000|Overall Study|Administrative problems|0|||
105981216|NCT00549770|365592298|FG001|Overall Study|Administrative problems|1|||
105981217|NCT00549770|365592299|FG002|Overall Study|Administrative problems|0|||
105981218|NCT00549770|365592300|FG003|Overall Study|Administrative problems|0|||
105981219|NCT00549770|365592301|FG004|Overall Study|Administrative problems|0|||
105981220|NCT00549770|365592302|FG005|Overall Study|Administrative problems|0|||
105981221|NCT00549770|365592303|FG006|Overall Study|Administrative problems|0|||
105981222|NCT00549770|365592304|FG007|Overall Study|Administrative problems|1|||
105981223|NCT00549770|365592297|FG000|Overall Study|Lost to Follow-up|0|||
105981224|NCT00549770|365592298|FG001|Overall Study|Lost to Follow-up|0|||
105981225|NCT00549770|365592299|FG002|Overall Study|Lost to Follow-up|2|||
105981226|NCT00549770|365592300|FG003|Overall Study|Lost to Follow-up|2|||
105981227|NCT00549770|365592301|FG004|Overall Study|Lost to Follow-up|3|||
105981228|NCT00549770|365592302|FG005|Overall Study|Lost to Follow-up|2|||
105981229|NCT00549770|365592303|FG006|Overall Study|Lost to Follow-up|0|||
105981230|NCT00549770|365592304|FG007|Overall Study|Lost to Follow-up|0|||
105981231|NCT00549770|365592297|FG000|Overall Study|Withdrawal by Subject|4|||
105981232|NCT00549770|365592298|FG001|Overall Study|Withdrawal by Subject|6|||
105981233|NCT00549770|365592299|FG002|Overall Study|Withdrawal by Subject|4|||
105981234|NCT00549770|365592300|FG003|Overall Study|Withdrawal by Subject|5|||
105981235|NCT00549770|365592301|FG004|Overall Study|Withdrawal by Subject|6|||
105981236|NCT00549770|365592302|FG005|Overall Study|Withdrawal by Subject|6|||
105981237|NCT00549770|365592303|FG006|Overall Study|Withdrawal by Subject|4|||
105981238|NCT00549770|365592304|FG007|Overall Study|Withdrawal by Subject|9|||
105981239|NCT00549770|365592297|FG000|Overall Study|Lack of Efficacy|1|||
105981240|NCT00549770|365592298|FG001|Overall Study|Lack of Efficacy|0|||
105981241|NCT00549770|365592299|FG002|Overall Study|Lack of Efficacy|2|||
105981242|NCT00549770|365592300|FG003|Overall Study|Lack of Efficacy|3|||
105981243|NCT00549770|365592301|FG004|Overall Study|Lack of Efficacy|5|||
105981244|NCT00549770|365592302|FG005|Overall Study|Lack of Efficacy|1|||
105981245|NCT00549770|365592303|FG006|Overall Study|Lack of Efficacy|3|||
105981246|NCT00549770|365592304|FG007|Overall Study|Lack of Efficacy|8|||
105981247|NCT00549770|365592297|FG000|Overall Study|Abnormal test procedure results|0|||
105981248|NCT00549770|365592298|FG001|Overall Study|Abnormal test procedure results|0|||
105981249|NCT00549770|365592299|FG002|Overall Study|Abnormal test procedure results|0|||
105981250|NCT00549770|365592300|FG003|Overall Study|Abnormal test procedure results|2|||
105981251|NCT00549770|365592301|FG004|Overall Study|Abnormal test procedure results|0|||
105852251|NCT02387983|365116063|FG000|Overall Study|Withdrawal by Subject|2|||
105852252|NCT00423319|365116066|FG000|Overall Study|Death|2|||
105852253|NCT00423319|365116067|FG001|Overall Study|Death|0|||
105852254|NCT00423319|365116066|FG000|Overall Study|Adverse Event|93|||
105852255|NCT00423319|365116067|FG001|Overall Study|Adverse Event|112|||
105852256|NCT00423319|365116066|FG000|Overall Study|Withdrawal by Subject|86|||
105852257|NCT00423319|365116067|FG001|Overall Study|Withdrawal by Subject|99|||
105852258|NCT00423319|365116066|FG000|Overall Study|Lost to Follow-up|4|||
105852259|NCT00423319|365116067|FG001|Overall Study|Lost to Follow-up|3|||
105852260|NCT00423319|365116066|FG000|Overall Study|Poor compliance or noncompliance|1|||
105852261|NCT00423319|365116067|FG001|Overall Study|Poor compliance or noncompliance|1|||
105852262|NCT00423319|365116066|FG000|Overall Study|No longer meets study criteria|15|||
105852263|NCT00423319|365116067|FG001|Overall Study|No longer meets study criteria|15|||
105852264|NCT00423319|365116066|FG000|Overall Study|Other|23|||
105852265|NCT00423319|365116067|FG001|Overall Study|Other|22|||
105852266|NCT01763684|365116068|FG000|Overall Study|Study terminated early due to low enrollment|126|||
105852267|NCT01763684|365116069|FG001|Overall Study|Study terminated early due to low enrollment|127|||
105852268|NCT01763684|365116068|FG000|Overall Study|Study surgery not performed|7|||
105852269|NCT01763684|365116069|FG001|Overall Study|Study surgery not performed|6|||
105852270|NCT02283983|365116070|FG000|Overall Study|Inclusion criteria not met|0|||
105852271|NCT02283983|365116071|FG001|Overall Study|Inclusion criteria not met|1|||
105852272|NCT02283983|365116070|FG000|Overall Study|Withdrawal by Subject|4|||
105852273|NCT02283983|365116071|FG001|Overall Study|Withdrawal by Subject|2|||
105852274|NCT02283983|365116070|FG000|Overall Study|Protocol Violation|0|||
105852275|NCT02283983|365116071|FG001|Overall Study|Protocol Violation|4|||
105852276|NCT02283983|365116070|FG000|Overall Study|Physician Decision|2|||
105852277|NCT02283983|365116071|FG001|Overall Study|Physician Decision|4|||
105852278|NCT02283983|365116070|FG000|Overall Study|Death|1|||
105852279|NCT02283983|365116071|FG001|Overall Study|Death|0|||
105852280|NCT02283983|365116070|FG000|Overall Study|Adverse Event|1|||
105852281|NCT02283983|365116071|FG001|Overall Study|Adverse Event|0|||
105852282|NCT02283983|365116070|FG000|Overall Study|Lost to Follow-up|9|||
105852283|NCT02283983|365116071|FG001|Overall Study|Lost to Follow-up|8|||
105852284|NCT02283983|365116070|FG000|Overall Study|Relapse|1|||
105852285|NCT02283983|365116071|FG001|Overall Study|Relapse|0|||
105852286|NCT01898650|365116074|FG000|Overall Study|the subject would not lie still for imaging|1|||
105852287|NCT01822275|365116075|FG000|Overall Study|Withdrawal by Subject|3|||
105852288|NCT01822275|365116075|FG000|Overall Study|Adverse Event|3|||
105852289|NCT01822275|365116075|FG000|Overall Study|Progression|14|||
105852290|NCT01822275|365116075|FG000|Overall Study|Physician Decision|2|||
105852291|NCT03970837|365116076|FG000|Overall Study|Adverse Event|23|||
105852292|NCT03970837|365116077|FG001|Overall Study|Adverse Event|20|||
105852293|NCT03970837|365116078|FG002|Overall Study|Adverse Event|16|||
105852294|NCT03970837|365116079|FG003|Overall Study|Adverse Event|6|||
105852295|NCT03970837|365116080|FG004|Overall Study|Adverse Event|4|||
105852296|NCT03970837|365116081|FG005|Overall Study|Adverse Event|5|||
105852297|NCT03970837|365116082|FG006|Overall Study|Adverse Event|1|||
105852298|NCT03970837|365116083|FG007|Overall Study|Adverse Event|5|||
105852299|NCT03970837|365116084|FG008|Overall Study|Adverse Event|0|||
105852300|NCT03970837|365116085|FG009|Overall Study|Adverse Event|0|||
105852301|NCT03970837|365116086|FG010|Overall Study|Adverse Event|1|||
105852302|NCT03970837|365116087|FG011|Overall Study|Adverse Event|1|||
105981252|NCT00549770|365592302|FG005|Overall Study|Abnormal test procedure results|1|||
105981253|NCT00549770|365592303|FG006|Overall Study|Abnormal test procedure results|1|||
105981254|NCT00549770|365592304|FG007|Overall Study|Abnormal test procedure results|1|||
105981255|NCT00549770|365592297|FG000|Overall Study|Abnormal laboratory values|0|||
105981256|NCT00549770|365592298|FG001|Overall Study|Abnormal laboratory values|0|||
105981257|NCT00549770|365592299|FG002|Overall Study|Abnormal laboratory values|0|||
105981258|NCT00549770|365592300|FG003|Overall Study|Abnormal laboratory values|0|||
105981259|NCT00549770|365592301|FG004|Overall Study|Abnormal laboratory values|0|||
105981260|NCT00549770|365592302|FG005|Overall Study|Abnormal laboratory values|1|||
105981261|NCT00549770|365592303|FG006|Overall Study|Abnormal laboratory values|0|||
105981262|NCT00549770|365592304|FG007|Overall Study|Abnormal laboratory values|0|||
105981263|NCT00549770|365592297|FG000|Overall Study|Adverse Event|1|||
105981264|NCT00549770|365592298|FG001|Overall Study|Adverse Event|3|||
105852303|NCT03970837|365116076|FG000|Overall Study|Lack of Efficacy|14|||
105852304|NCT03970837|365116077|FG001|Overall Study|Lack of Efficacy|12|||
105852305|NCT03970837|365116078|FG002|Overall Study|Lack of Efficacy|1|||
105852306|NCT03970837|365116079|FG003|Overall Study|Lack of Efficacy|2|||
105852307|NCT03970837|365116080|FG004|Overall Study|Lack of Efficacy|3|||
105852308|NCT03970837|365116081|FG005|Overall Study|Lack of Efficacy|4|||
105852309|NCT03970837|365116082|FG006|Overall Study|Lack of Efficacy|6|||
105852310|NCT03970837|365116083|FG007|Overall Study|Lack of Efficacy|1|||
105852311|NCT03970837|365116084|FG008|Overall Study|Lack of Efficacy|1|||
105852312|NCT03970837|365116085|FG009|Overall Study|Lack of Efficacy|0|||
105852313|NCT03970837|365116086|FG010|Overall Study|Lack of Efficacy|0|||
105852314|NCT03970837|365116087|FG011|Overall Study|Lack of Efficacy|0|||
105981265|NCT00549770|365592299|FG002|Overall Study|Adverse Event|1|||
105981266|NCT00549770|365592300|FG003|Overall Study|Adverse Event|2|||
105981267|NCT00549770|365592301|FG004|Overall Study|Adverse Event|1|||
105981268|NCT00549770|365592302|FG005|Overall Study|Adverse Event|0|||
105981269|NCT00549770|365592303|FG006|Overall Study|Adverse Event|5|||
105981270|NCT00549770|365592304|FG007|Overall Study|Adverse Event|4|||
105981271|NCT02392403|365592305|FG000|Overall Study|Adverse Event|1|||
105981272|NCT02392403|365592305|FG000|Overall Study|Death|1|||
105981273|NCT02392403|365592305|FG000|Overall Study|Withdrawal by Subject|1|||
105981274|NCT02335424|365592309|FG000|Overall Study|Withdrawal by Subject|19|||
105981275|NCT02335424|365592309|FG000|Overall Study|Adverse Event|25|||
105981276|NCT02335424|365592309|FG000|Overall Study|Death|273|||
105981277|NCT02335424|365592309|FG000|Overall Study|Lost to Follow-up|3|||
105981278|NCT02335424|365592309|FG000|Overall Study|Physician Decision|13|||
105981279|NCT02335424|365592309|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
105981280|NCT02335424|365592309|FG000|Overall Study|Protocol Violation|1|||
105981281|NCT02335424|365592309|FG000|Overall Study|Screen failure|1|||
105981282|NCT02776033|365592310|FG000|Overall Study|Withdrawal by Subject|0|||
105981283|NCT02776033|365592311|FG001|Overall Study|Withdrawal by Subject|0|||
105981284|NCT02776033|365592312|FG002|Overall Study|Withdrawal by Subject|2|||
105981285|NCT02776033|365592310|FG000|Overall Study|Physician Decision|2|||
105981286|NCT02776033|365592311|FG001|Overall Study|Physician Decision|0|||
105981287|NCT02776033|365592312|FG002|Overall Study|Physician Decision|0|||
105981288|NCT02776033|365592310|FG000|Overall Study|Lost to Follow-up|1|||
105981289|NCT02776033|365592311|FG001|Overall Study|Lost to Follow-up|0|||
105981290|NCT02776033|365592312|FG002|Overall Study|Lost to Follow-up|0|||
105981291|NCT02776033|365592310|FG000|Overall Study|Adverse Event|1|||
105981292|NCT02776033|365592311|FG001|Overall Study|Adverse Event|2|||
105981293|NCT02776033|365592312|FG002|Overall Study|Adverse Event|0|||
105981294|NCT00548717|365592313|FG000|Overall Study|Death|5|||
105981295|NCT00548717|365592314|FG001|Overall Study|Death|2|||
105981296|NCT00548717|365592313|FG000|Overall Study|Relapse|3|||
105981297|NCT00548717|365592314|FG001|Overall Study|Relapse|0|||
105981298|NCT00548717|365592313|FG000|Overall Study|Alternative treatment for GVHD|1|||
105981299|NCT00548717|365592314|FG001|Overall Study|Alternative treatment for GVHD|0|||
105981300|NCT00582738|365592321|FG000|Overall Study|Administrative Problems|7|||
105981301|NCT00582738|365592322|FG001|Overall Study|Administrative Problems|8|||
105981302|NCT00582738|365592321|FG000|Overall Study|Adverse Event|0|||
105981303|NCT00582738|365592322|FG001|Overall Study|Adverse Event|5|||
105981304|NCT00582738|365592321|FG000|Overall Study|Graft Lost|0|||
105981305|NCT00582738|365592322|FG001|Overall Study|Graft Lost|1|||
105981306|NCT00582738|365592321|FG000|Overall Study|Other|1|||
105981307|NCT00582738|365592322|FG001|Overall Study|Other|0|||
105981308|NCT00582738|365592321|FG000|Overall Study|Protocol Violation|1|||
105981309|NCT00582738|365592322|FG001|Overall Study|Protocol Violation|1|||
105981310|NCT00582738|365592321|FG000|Overall Study|Withdrawal by Subject|0|||
105981311|NCT00582738|365592322|FG001|Overall Study|Withdrawal by Subject|3|||
105981312|NCT00847015|365592324|FG000|Overall Study|Withdrawal by Subject|1|||
105981313|NCT00847015|365592324|FG000|Overall Study|declined any surgery|1|||
105981314|NCT00847015|365592324|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
105981315|NCT01943552|365592325|FG000|Overall Study|Adverse Event|3|||
105981316|NCT01943552|365592326|FG001|Overall Study|Adverse Event|2|||
105981317|NCT01943552|365592325|FG000|Overall Study|Withdrawal by Subject|6|||
105981318|NCT01943552|365592326|FG001|Overall Study|Withdrawal by Subject|6|||
105981319|NCT01943552|365592325|FG000|Overall Study|Other Reasons|16|||
105981320|NCT01943552|365592326|FG001|Overall Study|Other Reasons|17|||
105981321|NCT02715726|365592327|FG000|Overall Study|Adverse Event|2|||
105981322|NCT02715726|365592328|FG001|Overall Study|Adverse Event|6|||
105981323|NCT02715726|365592327|FG000|Overall Study|Protocol Violation|1|||
105981324|NCT02715726|365592328|FG001|Overall Study|Protocol Violation|0|||
105981325|NCT02715726|365592327|FG000|Overall Study|Death|2|||
105981326|NCT02715726|365592328|FG001|Overall Study|Death|1|||
105981327|NCT02715726|365592327|FG000|Overall Study|Participant moved|1|||
105981328|NCT02715726|365592328|FG001|Overall Study|Participant moved|3|||
105981329|NCT02715726|365592327|FG000|Overall Study|Other than specified above|11|||
105981330|NCT02715726|365592328|FG001|Overall Study|Other than specified above|15|||
105981331|NCT02715726|365592327|FG000|Overall Study|Randomized but not treated|1|||
105981332|NCT02715726|365592328|FG001|Overall Study|Randomized but not treated|2|||
105981333|NCT02445573|365592329|FG000|Overall Study|Withdrawal by Subject|1|||
105981334|NCT02445573|365592330|FG001|Overall Study|Withdrawal by Subject|1|||
105981335|NCT02445573|365592329|FG000|Overall Study|Lost to Follow-up|0|||
105981336|NCT02445573|365592330|FG001|Overall Study|Lost to Follow-up|1|||
105981337|NCT00635089|365592335|FG000|Overall Study|Adverse Event|7|||
105981338|NCT00635089|365592335|FG000|Overall Study|Lack of Efficacy|28|||
105981339|NCT00635089|365592335|FG000|Overall Study|Protocol Deviation|4|||
105981340|NCT00635089|365592335|FG000|Overall Study|Lost to Follow-up|8|||
105981341|NCT00635089|365592335|FG000|Overall Study|Other|31|||
105981342|NCT00869401|365592340|FG000|Overall Study|Withdrawal by Subject|0|||
105981343|NCT00869401|365592341|FG001|Overall Study|Withdrawal by Subject|0|||
105981344|NCT00869401|365592342|FG002|Overall Study|Withdrawal by Subject|0|||
105852315|NCT03970837|365116076|FG000|Overall Study|Lost to Follow-up|6|||
105852316|NCT03970837|365116077|FG001|Overall Study|Lost to Follow-up|5|||
105852317|NCT03970837|365116078|FG002|Overall Study|Lost to Follow-up|5|||
105852318|NCT03970837|365116079|FG003|Overall Study|Lost to Follow-up|1|||
105852319|NCT03970837|365116080|FG004|Overall Study|Lost to Follow-up|0|||
105852320|NCT03970837|365116081|FG005|Overall Study|Lost to Follow-up|2|||
105852321|NCT03970837|365116082|FG006|Overall Study|Lost to Follow-up|0|||
105852322|NCT03970837|365116083|FG007|Overall Study|Lost to Follow-up|0|||
105852323|NCT03970837|365116084|FG008|Overall Study|Lost to Follow-up|0|||
105852324|NCT03970837|365116085|FG009|Overall Study|Lost to Follow-up|0|||
105852325|NCT03970837|365116086|FG010|Overall Study|Lost to Follow-up|0|||
105852326|NCT03970837|365116087|FG011|Overall Study|Lost to Follow-up|0|||
105852327|NCT03970837|365116076|FG000|Overall Study|Protocol Violation|1|||
105981345|NCT00869401|365592343|FG003|Overall Study|Withdrawal by Subject|5|||
105981346|NCT00869401|365592344|FG004|Overall Study|Withdrawal by Subject|3|||
105981347|NCT01147900|365592345|FG000|At Year 10|Lost to Follow-up|0|||
105981348|NCT01147900|365592346|FG001|At Year 10|Lost to Follow-up|1|||
105852328|NCT03970837|365116077|FG001|Overall Study|Protocol Violation|0|||
105852329|NCT03970837|365116078|FG002|Overall Study|Protocol Violation|0|||
105852330|NCT03970837|365116079|FG003|Overall Study|Protocol Violation|0|||
105852331|NCT03970837|365116080|FG004|Overall Study|Protocol Violation|0|||
105852332|NCT03970837|365116081|FG005|Overall Study|Protocol Violation|0|||
105852333|NCT03970837|365116082|FG006|Overall Study|Protocol Violation|0|||
105852334|NCT03970837|365116083|FG007|Overall Study|Protocol Violation|0|||
105852335|NCT03970837|365116084|FG008|Overall Study|Protocol Violation|0|||
105852336|NCT03970837|365116085|FG009|Overall Study|Protocol Violation|0|||
105852337|NCT03970837|365116086|FG010|Overall Study|Protocol Violation|0|||
105852338|NCT03970837|365116087|FG011|Overall Study|Protocol Violation|0|||
105852339|NCT03970837|365116076|FG000|Overall Study|Physician Decision|5|||
105852340|NCT03970837|365116077|FG001|Overall Study|Physician Decision|8|||
105852341|NCT03970837|365116078|FG002|Overall Study|Physician Decision|4|||
105852342|NCT03970837|365116079|FG003|Overall Study|Physician Decision|1|||
105852343|NCT03970837|365116080|FG004|Overall Study|Physician Decision|5|||
105852344|NCT03970837|365116081|FG005|Overall Study|Physician Decision|2|||
105852345|NCT03970837|365116082|FG006|Overall Study|Physician Decision|4|||
105852346|NCT03970837|365116083|FG007|Overall Study|Physician Decision|5|||
105852347|NCT03970837|365116084|FG008|Overall Study|Physician Decision|0|||
105852348|NCT03970837|365116085|FG009|Overall Study|Physician Decision|1|||
105852349|NCT03970837|365116086|FG010|Overall Study|Physician Decision|0|||
105852350|NCT03970837|365116087|FG011|Overall Study|Physician Decision|0|||
105852351|NCT03970837|365116076|FG000|Overall Study|Withdrawal by Subject|32|||
105852352|NCT03970837|365116077|FG001|Overall Study|Withdrawal by Subject|35|||
105852353|NCT03970837|365116078|FG002|Overall Study|Withdrawal by Subject|12|||
105852354|NCT03970837|365116079|FG003|Overall Study|Withdrawal by Subject|8|||
105852355|NCT03970837|365116080|FG004|Overall Study|Withdrawal by Subject|6|||
105852356|NCT03970837|365116081|FG005|Overall Study|Withdrawal by Subject|8|||
105852357|NCT03970837|365116082|FG006|Overall Study|Withdrawal by Subject|2|||
105852358|NCT03970837|365116083|FG007|Overall Study|Withdrawal by Subject|3|||
105852359|NCT03970837|365116084|FG008|Overall Study|Withdrawal by Subject|0|||
105852360|NCT03970837|365116085|FG009|Overall Study|Withdrawal by Subject|0|||
105852361|NCT03970837|365116086|FG010|Overall Study|Withdrawal by Subject|0|||
105852362|NCT03970837|365116087|FG011|Overall Study|Withdrawal by Subject|1|||
105852363|NCT03970837|365116076|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
105852364|NCT03970837|365116077|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
105852365|NCT03970837|365116078|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
105852366|NCT03970837|365116079|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105852367|NCT03970837|365116080|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
105852368|NCT03970837|365116081|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105852369|NCT03970837|365116082|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105852370|NCT03970837|365116083|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105852371|NCT03970837|365116084|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
105852372|NCT03970837|365116085|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105852373|NCT03970837|365116086|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105981349|NCT01147900|365592347|FG002|At Year 10|Lost to Follow-up|0|||
105981350|NCT00576472|365592348|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981351|NCT00576472|365592349|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981352|NCT00576472|365592350|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981353|NCT00576472|365592351|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
105981354|NCT00576472|365592352|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981355|NCT00576472|365592353|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981356|NCT00576472|365592354|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981357|NCT00576472|365592355|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981358|NCT00576472|365592356|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981359|NCT00576472|365592357|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981360|NCT00576472|365592358|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981361|NCT00576472|365592359|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981362|NCT00576472|365592360|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981363|NCT00576472|365592361|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981364|NCT00576472|365592362|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
105981365|NCT00576472|365592348|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
105981366|NCT00576472|365592349|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
105981367|NCT00576472|365592350|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
105981368|NCT00576472|365592351|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
105981369|NCT00576472|365592352|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
105981370|NCT00576472|365592353|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
105981371|NCT00576472|365592354|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
105981372|NCT00576472|365592355|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
105981373|NCT00576472|365592356|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
105981374|NCT00576472|365592357|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
105981375|NCT00576472|365592358|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
105981376|NCT00576472|365592359|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
105981377|NCT00576472|365592360|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
105981378|NCT00576472|365592361|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
105981379|NCT00576472|365592362|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
105981380|NCT00576472|365592348|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981381|NCT00576472|365592349|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981382|NCT00576472|365592350|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981383|NCT00576472|365592351|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
105981384|NCT00576472|365592352|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981385|NCT00576472|365592353|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981386|NCT00576472|365592354|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981387|NCT00576472|365592355|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981388|NCT00576472|365592356|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981389|NCT00576472|365592357|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981390|NCT00576472|365592358|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981391|NCT00576472|365592359|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981392|NCT00576472|365592360|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981393|NCT00576472|365592361|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981394|NCT00576472|365592362|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
105981395|NCT00576472|365592348|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
105981396|NCT00576472|365592349|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
105981397|NCT00576472|365592350|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
105981398|NCT00576472|365592351|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
105981399|NCT00576472|365592352|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
105981400|NCT00576472|365592353|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
105981401|NCT00576472|365592354|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
105981402|NCT00576472|365592355|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
105981403|NCT00576472|365592356|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
105981404|NCT00576472|365592357|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
105981405|NCT00576472|365592358|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
105981406|NCT00576472|365592359|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
105981407|NCT00576472|365592360|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
105981408|NCT00576472|365592361|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
105981409|NCT00576472|365592362|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
105981410|NCT00576472|365592348|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981411|NCT00576472|365592349|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981412|NCT00576472|365592350|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981413|NCT00576472|365592351|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
105981414|NCT00576472|365592352|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981415|NCT00576472|365592353|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981416|NCT00576472|365592354|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981417|NCT00576472|365592355|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981418|NCT00576472|365592356|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981419|NCT00576472|365592357|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981420|NCT00576472|365592358|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981421|NCT00576472|365592359|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981422|NCT00576472|365592360|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981423|NCT00576472|365592361|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981424|NCT00576472|365592362|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
105981425|NCT00576472|365592348|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981426|NCT00576472|365592349|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981427|NCT00576472|365592350|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981428|NCT00576472|365592351|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981429|NCT00576472|365592352|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981430|NCT00576472|365592353|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981431|NCT00576472|365592354|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
106029172|NCT03011892|365770889|FG005|Double Blind (DB) Period|Physician Decision|0|||
106029173|NCT03011892|365770890|FG006|Double Blind (DB) Period|Physician Decision|0|||
106029174|NCT03011892|365770891|FG007|Double Blind (DB) Period|Physician Decision|0|||
106029175|NCT03011892|365770892|FG008|Double Blind (DB) Period|Physician Decision|0|||
106029176|NCT03011892|365770893|FG009|Double Blind (DB) Period|Physician Decision|0|||
106029177|NCT03011892|365770894|FG010|Double Blind (DB) Period|Physician Decision|0|||
106029178|NCT03011892|365770895|FG011|Double Blind (DB) Period|Physician Decision|0|||
106029179|NCT03011892|365770884|FG000|Double Blind (DB) Period|Pregnancy|0|||
106029180|NCT03011892|365770885|FG001|Double Blind (DB) Period|Pregnancy|0|||
106029181|NCT03011892|365770886|FG002|Double Blind (DB) Period|Pregnancy|0|||
106029182|NCT03011892|365770887|FG003|Double Blind (DB) Period|Pregnancy|0|||
106029183|NCT03011892|365770888|FG004|Double Blind (DB) Period|Pregnancy|1|||
106029184|NCT03011892|365770889|FG005|Double Blind (DB) Period|Pregnancy|0|||
106029185|NCT03011892|365770890|FG006|Double Blind (DB) Period|Pregnancy|0|||
106029186|NCT03011892|365770891|FG007|Double Blind (DB) Period|Pregnancy|0|||
106029187|NCT03011892|365770892|FG008|Double Blind (DB) Period|Pregnancy|0|||
106029188|NCT03011892|365770893|FG009|Double Blind (DB) Period|Pregnancy|0|||
106029189|NCT03011892|365770894|FG010|Double Blind (DB) Period|Pregnancy|0|||
106029190|NCT03011892|365770895|FG011|Double Blind (DB) Period|Pregnancy|0|||
106029191|NCT03011892|365770884|FG000|Double Blind (DB) Period|Protocol Violation|1|||
106029192|NCT03011892|365770885|FG001|Double Blind (DB) Period|Protocol Violation|0|||
106029193|NCT03011892|365770886|FG002|Double Blind (DB) Period|Protocol Violation|0|||
106029194|NCT03011892|365770887|FG003|Double Blind (DB) Period|Protocol Violation|0|||
106029195|NCT03011892|365770888|FG004|Double Blind (DB) Period|Protocol Violation|0|||
106029196|NCT03011892|365770889|FG005|Double Blind (DB) Period|Protocol Violation|0|||
106029197|NCT03011892|365770890|FG006|Double Blind (DB) Period|Protocol Violation|0|||
106029198|NCT03011892|365770891|FG007|Double Blind (DB) Period|Protocol Violation|0|||
106029199|NCT03011892|365770892|FG008|Double Blind (DB) Period|Protocol Violation|0|||
106029200|NCT03011892|365770893|FG009|Double Blind (DB) Period|Protocol Violation|0|||
106029201|NCT03011892|365770894|FG010|Double Blind (DB) Period|Protocol Violation|0|||
106029202|NCT03011892|365770895|FG011|Double Blind (DB) Period|Protocol Violation|0|||
106029203|NCT03011892|365770884|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
106029204|NCT03011892|365770885|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
106029205|NCT03011892|365770886|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
106029206|NCT03011892|365770887|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
106029207|NCT03011892|365770888|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
106029208|NCT03011892|365770889|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
106029209|NCT03011892|365770890|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
105981432|NCT00576472|365592355|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
105852374|NCT03970837|365116087|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
105852375|NCT03970837|365116076|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852376|NCT03970837|365116077|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852377|NCT03970837|365116078|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852378|NCT03970837|365116079|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852379|NCT03970837|365116080|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852380|NCT03970837|365116081|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105852381|NCT03970837|365116082|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
105852382|NCT03970837|365116083|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
105852383|NCT03970837|365116084|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
105852384|NCT03970837|365116085|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
105852385|NCT03970837|365116086|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
105852386|NCT03970837|365116087|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
105852387|NCT05327816|365117986|FG000|Overall Study|Lost to Follow-up|1|||
105852388|NCT05327816|365117987|FG001|Overall Study|Lost to Follow-up|0|||
105981433|NCT00576472|365592356|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981434|NCT00576472|365592357|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981435|NCT00576472|365592358|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981436|NCT00576472|365592359|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981437|NCT00576472|365592360|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981438|NCT00576472|365592361|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981439|NCT00576472|365592362|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
105981440|NCT00576472|365592348|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
105981441|NCT00576472|365592349|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
105981442|NCT00576472|365592350|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
105981443|NCT00576472|365592351|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
106029210|NCT03011892|365770891|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
106029211|NCT03011892|365770892|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
105852389|NCT05327816|365117988|FG002|Overall Study|Lost to Follow-up|0|||
105852390|NCT05327816|365117989|FG003|Overall Study|Lost to Follow-up|0|||
105852391|NCT05327816|365117990|FG004|Overall Study|Lost to Follow-up|0|||
105852392|NCT05327816|365117991|FG005|Overall Study|Lost to Follow-up|0|||
105981444|NCT00576472|365592352|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
105852393|NCT05327816|365117992|FG006|Overall Study|Lost to Follow-up|0|||
105852394|NCT05327816|365117993|FG007|Overall Study|Lost to Follow-up|0|||
105852395|NCT05327816|365117994|FG008|Overall Study|Lost to Follow-up|0|||
105852396|NCT05327816|365117995|FG009|Overall Study|Lost to Follow-up|1|||
105852397|NCT05327816|365117996|FG010|Overall Study|Lost to Follow-up|0|||
105852398|NCT05327816|365117986|FG000|Overall Study|Withdrawal by Subject|0|||
105852399|NCT05327816|365117987|FG001|Overall Study|Withdrawal by Subject|0|||
105852400|NCT05327816|365117988|FG002|Overall Study|Withdrawal by Subject|0|||
105852401|NCT05327816|365117989|FG003|Overall Study|Withdrawal by Subject|0|||
105852402|NCT05327816|365117990|FG004|Overall Study|Withdrawal by Subject|1|||
105852403|NCT05327816|365117991|FG005|Overall Study|Withdrawal by Subject|1|||
105852404|NCT05327816|365117992|FG006|Overall Study|Withdrawal by Subject|0|||
105852405|NCT05327816|365117993|FG007|Overall Study|Withdrawal by Subject|0|||
105852406|NCT05327816|365117994|FG008|Overall Study|Withdrawal by Subject|0|||
105852407|NCT05327816|365117995|FG009|Overall Study|Withdrawal by Subject|0|||
105852408|NCT05327816|365117996|FG010|Overall Study|Withdrawal by Subject|0|||
105852409|NCT05327816|365117986|FG000|Overall Study|Study Terminated by Sponsor|11|||
105852410|NCT05327816|365117987|FG001|Overall Study|Study Terminated by Sponsor|12|||
105852411|NCT05327816|365117988|FG002|Overall Study|Study Terminated by Sponsor|12|||
105852412|NCT05327816|365117989|FG003|Overall Study|Study Terminated by Sponsor|12|||
105852413|NCT05327816|365117990|FG004|Overall Study|Study Terminated by Sponsor|11|||
105852414|NCT05327816|365117991|FG005|Overall Study|Study Terminated by Sponsor|11|||
105852415|NCT05327816|365117992|FG006|Overall Study|Study Terminated by Sponsor|11|||
105852416|NCT05327816|365117993|FG007|Overall Study|Study Terminated by Sponsor|11|||
105852417|NCT05327816|365117994|FG008|Overall Study|Study Terminated by Sponsor|11|||
105852418|NCT05327816|365117995|FG009|Overall Study|Study Terminated by Sponsor|11|||
105852419|NCT05327816|365117996|FG010|Overall Study|Study Terminated by Sponsor|12|||
105852420|NCT05327816|365117986|FG000|Overall Study|Randomized but not treated|0|||
105852421|NCT05327816|365117987|FG001|Overall Study|Randomized but not treated|0|||
105852422|NCT05327816|365117988|FG002|Overall Study|Randomized but not treated|0|||
105852423|NCT05327816|365117989|FG003|Overall Study|Randomized but not treated|0|||
105852424|NCT05327816|365117990|FG004|Overall Study|Randomized but not treated|0|||
105852425|NCT05327816|365117991|FG005|Overall Study|Randomized but not treated|0|||
105852426|NCT05327816|365117992|FG006|Overall Study|Randomized but not treated|1|||
105852427|NCT05327816|365117993|FG007|Overall Study|Randomized but not treated|1|||
105852428|NCT05327816|365117994|FG008|Overall Study|Randomized but not treated|1|||
105852429|NCT05327816|365117995|FG009|Overall Study|Randomized but not treated|0|||
105852430|NCT05327816|365117996|FG010|Overall Study|Randomized but not treated|0|||
105852431|NCT00792935|365117997|FG000|Overall Study|Adverse Event|2|||
105852432|NCT00792935|365117998|FG001|Overall Study|Adverse Event|1|||
105852433|NCT00792935|365117997|FG000|Overall Study|Lost to Follow-up|0|||
105852434|NCT00792935|365117998|FG001|Overall Study|Lost to Follow-up|1|||
105852435|NCT00792935|365117997|FG000|Overall Study|Protocol Violation|2|||
105852436|NCT00792935|365117998|FG001|Overall Study|Protocol Violation|0|||
105852437|NCT00792935|365117997|FG000|Overall Study|Withdrawal by Subject|0|||
105852438|NCT00792935|365117998|FG001|Overall Study|Withdrawal by Subject|1|||
105852439|NCT03665441|365117999|FG000|Overall Study|survival follow up ongoing|23|||
105852440|NCT03665441|365118000|FG001|Overall Study|survival follow up ongoing|0|||
105852441|NCT03665441|365117999|FG000|Overall Study|Patients ongoing on treatment|9|||
105852442|NCT03665441|365118000|FG001|Overall Study|Patients ongoing on treatment|6|||
105852443|NCT03665441|365117999|FG000|Overall Study|Randomized but not treated|7|||
105852444|NCT03665441|365118000|FG001|Overall Study|Randomized but not treated|11|||
105852445|NCT02213510|365118001|FG000|Overall Study|Death|0|||
105852446|NCT02213510|365118002|FG001|Overall Study|Death|1|||
105852447|NCT02213510|365118001|FG000|Overall Study|Lost to Follow-up|1|||
105852448|NCT02213510|365118002|FG001|Overall Study|Lost to Follow-up|0|||
105852449|NCT04325204|365118004|FG000|Overall Study|Death|0|||
105852450|NCT04325204|365118005|FG001|Overall Study|Death|1|||
105852451|NCT04325204|365118004|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
105852452|NCT04325204|365118005|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
105852453|NCT04325204|365118004|FG000|Overall Study|Lost to Follow-up|8|||
105852454|NCT04325204|365118005|FG001|Overall Study|Lost to Follow-up|8|||
105852455|NCT04325204|365118004|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
105852456|NCT04325204|365118005|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
105852457|NCT04234984|365118006|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
105852458|NCT04234984|365118006|FG000|Follow-up at the Second Time Point|Death|1|||
105852459|NCT04234984|365118006|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
105852460|NCT05183217|365118007|FG000|Overall Study|Withdrawal by Subject|1|||
105852461|NCT05183217|365118008|FG001|Overall Study|Withdrawal by Subject|1|||
105852462|NCT02524730|365118010|FG000|Overall Study|Lost to Follow-up|5|||
105852463|NCT02524730|365118010|FG000|Overall Study|Withdrawal by Subject|18|||
105852464|NCT02524730|365118010|FG000|Overall Study|Death|10|||
105852465|NCT02524730|365118010|FG000|Overall Study|Adverse Event|8|||
105852466|NCT02524730|365118010|FG000|Overall Study|Protocol Violation|1|||
105981445|NCT00576472|365592353|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
105981446|NCT00576472|365592354|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
105981447|NCT00576472|365592355|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
105852467|NCT02524730|365118010|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
105852468|NCT03783039|365118011|FG000|Overall Study|Death|2|||
105852469|NCT03783039|365118012|FG001|Overall Study|Death|1|||
105852470|NCT00977379|365118013|FG000|Overall Study|Withdrawal by Subject|1|||
105852471|NCT00977379|365118014|FG001|Overall Study|Withdrawal by Subject|1|||
105852472|NCT00977379|365118013|FG000|Overall Study|Death|7|||
105852473|NCT00977379|365118014|FG001|Overall Study|Death|9|||
105852474|NCT00977379|365118013|FG000|Overall Study|Premature Study Termination|4|||
105852475|NCT00977379|365118014|FG001|Overall Study|Premature Study Termination|0|||
105852476|NCT00977379|365118013|FG000|Overall Study|Participant Moving House|0|||
105852477|NCT00977379|365118014|FG001|Overall Study|Participant Moving House|1|||
105852478|NCT00977379|365118013|FG000|Overall Study|Randomization Error|0|||
105852479|NCT00977379|365118014|FG001|Overall Study|Randomization Error|1|||
105852480|NCT02603393|365118017|FG000|Overall Study|Patient/guardian decision|32|||
105852481|NCT02603393|365118018|FG001|Overall Study|Patient/guardian decision|18|||
105852482|NCT02603393|365118017|FG000|Overall Study|Adverse Event|17|||
105852483|NCT02603393|365118018|FG001|Overall Study|Adverse Event|15|||
105852484|NCT02603393|365118017|FG000|Overall Study|Technical problems|4|||
105852485|NCT02603393|365118018|FG001|Overall Study|Technical problems|7|||
105852486|NCT02603393|365118017|FG000|Overall Study|Lack of Efficacy|7|||
105852487|NCT02603393|365118018|FG001|Overall Study|Lack of Efficacy|2|||
105852488|NCT02603393|365118017|FG000|Overall Study|Death|3|||
105852489|NCT02603393|365118018|FG001|Overall Study|Death|4|||
105852490|NCT02603393|365118017|FG000|Overall Study|Physician Decision|3|||
105852491|NCT02603393|365118018|FG001|Overall Study|Physician Decision|3|||
105852492|NCT02603393|365118017|FG000|Overall Study|Protocol deviation|2|||
105852493|NCT02603393|365118018|FG001|Overall Study|Protocol deviation|3|||
105852494|NCT02603393|365118017|FG000|Overall Study|Lost to Follow-up|1|||
105852495|NCT02603393|365118018|FG001|Overall Study|Lost to Follow-up|2|||
105852496|NCT02603393|365118017|FG000|Overall Study|Non-compliance with study treatment|1|||
105852497|NCT02603393|365118018|FG001|Overall Study|Non-compliance with study treatment|0|||
105852498|NCT02603393|365118017|FG000|Overall Study|Sponsor decision|1|||
105852499|NCT02603393|365118018|FG001|Overall Study|Sponsor decision|0|||
105852500|NCT01359969|365118019|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
105852501|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
105852502|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
105852503|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
105852504|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
105852505|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
105852506|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
105852507|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
105852508|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
105852509|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
105852510|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
105852511|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
105852512|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
105852513|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
105852514|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
105852515|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
105852516|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
105852517|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
105852518|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
105852519|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
105852520|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
105852521|NCT00593736|365118022|FG000|Screening Period and Placebo Run-in|Various|0|||
105852522|NCT00593736|365118023|FG001|Screening Period and Placebo Run-in|Various|0|||
105852523|NCT00593736|365118024|FG002|Screening Period and Placebo Run-in|Various|0|||
105852524|NCT00593736|365118025|FG003|Screening Period and Placebo Run-in|Various|25|||
105852525|NCT00593736|365118022|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
105852526|NCT00593736|365118023|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
105852527|NCT00593736|365118024|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
105852528|NCT00593736|365118025|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
105852529|NCT00593736|365118022|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
105852530|NCT00593736|365118023|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
105852531|NCT00593736|365118024|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
105852532|NCT00593736|365118025|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
105852533|NCT00593736|365118022|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
105981448|NCT00576472|365592356|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
106151297|NCT02723955|366215066|FG012|Expansion Phase|Site Closed|0|||
105852534|NCT00593736|365118023|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
105852535|NCT00593736|365118024|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
105852536|NCT00593736|365118025|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
105852537|NCT00593736|365118022|FG000|Treatment Period and Placebo Run-out|Various|1|||
105852538|NCT00593736|365118023|FG001|Treatment Period and Placebo Run-out|Various|1|||
105852539|NCT00593736|365118024|FG002|Treatment Period and Placebo Run-out|Various|1|||
105852540|NCT00593736|365118025|FG003|Treatment Period and Placebo Run-out|Various|0|||
105852541|NCT01857271|365118026|FG000|Overall Study|Lost to Follow-up|1|||
105852542|NCT04645966|365118027|FG000|Vaccination Phase|Adverse Event|1|||
105852543|NCT04645966|365118028|FG001|Vaccination Phase|Adverse Event|0|||
105852544|NCT04645966|365118029|FG002|Vaccination Phase|Adverse Event|0|||
105852545|NCT04645966|365118030|FG003|Vaccination Phase|Adverse Event|0|||
105852546|NCT04645966|365118031|FG004|Vaccination Phase|Adverse Event|0|||
105981449|NCT00576472|365592357|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
105852547|NCT04645966|365118032|FG005|Vaccination Phase|Adverse Event|0|||
105852548|NCT04645966|365118033|FG006|Vaccination Phase|Adverse Event|1|||
105852549|NCT04645966|365118034|FG007|Vaccination Phase|Adverse Event|0|||
105852550|NCT04645966|365118035|FG008|Vaccination Phase|Adverse Event|0|||
105852551|NCT04645966|365118027|FG000|Vaccination Phase|Death|0|||
105852552|NCT04645966|365118028|FG001|Vaccination Phase|Death|0|||
105852553|NCT04645966|365118029|FG002|Vaccination Phase|Death|0|||
105852554|NCT04645966|365118030|FG003|Vaccination Phase|Death|0|||
105852555|NCT04645966|365118031|FG004|Vaccination Phase|Death|0|||
105852556|NCT04645966|365118032|FG005|Vaccination Phase|Death|1|||
105852557|NCT04645966|365118033|FG006|Vaccination Phase|Death|0|||
105852558|NCT04645966|365118034|FG007|Vaccination Phase|Death|0|||
105852559|NCT04645966|365118035|FG008|Vaccination Phase|Death|0|||
105852560|NCT04645966|365118027|FG000|Vaccination Phase|Protocol Violation|0|||
105852561|NCT04645966|365118028|FG001|Vaccination Phase|Protocol Violation|0|||
105852562|NCT04645966|365118029|FG002|Vaccination Phase|Protocol Violation|0|||
105852563|NCT04645966|365118030|FG003|Vaccination Phase|Protocol Violation|0|||
105852564|NCT04645966|365118031|FG004|Vaccination Phase|Protocol Violation|1|||
105852565|NCT04645966|365118032|FG005|Vaccination Phase|Protocol Violation|0|||
105852566|NCT04645966|365118033|FG006|Vaccination Phase|Protocol Violation|0|||
105852567|NCT04645966|365118034|FG007|Vaccination Phase|Protocol Violation|0|||
105852568|NCT04645966|365118035|FG008|Vaccination Phase|Protocol Violation|0|||
105852569|NCT04645966|365118027|FG000|Vaccination Phase|Study terminated by sponsor|0|||
105852570|NCT04645966|365118028|FG001|Vaccination Phase|Study terminated by sponsor|0|||
105852571|NCT04645966|365118029|FG002|Vaccination Phase|Study terminated by sponsor|14|||
105852572|NCT04645966|365118030|FG003|Vaccination Phase|Study terminated by sponsor|15|||
105852573|NCT04645966|365118031|FG004|Vaccination Phase|Study terminated by sponsor|47|||
105852574|NCT04645966|365118032|FG005|Vaccination Phase|Study terminated by sponsor|43|||
105852575|NCT04645966|365118033|FG006|Vaccination Phase|Study terminated by sponsor|29|||
105852576|NCT04645966|365118034|FG007|Vaccination Phase|Study terminated by sponsor|29|||
105852577|NCT04645966|365118035|FG008|Vaccination Phase|Study terminated by sponsor|12|||
105852578|NCT04645966|365118027|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
105852579|NCT04645966|365118028|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
105852580|NCT04645966|365118029|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
105852581|NCT04645966|365118030|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
105852582|NCT04645966|365118031|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
105852583|NCT04645966|365118032|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
105852584|NCT04645966|365118033|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
105852585|NCT04645966|365118034|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
105852586|NCT04645966|365118035|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
105852587|NCT04645966|365118027|FG000|Vaccination Phase|Other|0|||
105852588|NCT04645966|365118028|FG001|Vaccination Phase|Other|0|||
105852589|NCT04645966|365118029|FG002|Vaccination Phase|Other|0|||
105852590|NCT04645966|365118030|FG003|Vaccination Phase|Other|0|||
105852591|NCT04645966|365118031|FG004|Vaccination Phase|Other|0|||
105852592|NCT04645966|365118032|FG005|Vaccination Phase|Other|2|||
105852593|NCT04645966|365118033|FG006|Vaccination Phase|Other|0|||
105852594|NCT04645966|365118034|FG007|Vaccination Phase|Other|0|||
105852595|NCT04645966|365118035|FG008|Vaccination Phase|Other|0|||
105852596|NCT04645966|365118027|FG000|Vaccination Phase|Lost to Follow-up|0|||
105852597|NCT04645966|365118028|FG001|Vaccination Phase|Lost to Follow-up|0|||
105852598|NCT04645966|365118029|FG002|Vaccination Phase|Lost to Follow-up|0|||
105852599|NCT04645966|365118030|FG003|Vaccination Phase|Lost to Follow-up|0|||
105852600|NCT04645966|365118031|FG004|Vaccination Phase|Lost to Follow-up|0|||
105852601|NCT04645966|365118032|FG005|Vaccination Phase|Lost to Follow-up|0|||
105852602|NCT04645966|365118033|FG006|Vaccination Phase|Lost to Follow-up|0|||
105981450|NCT00576472|365592358|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
105981451|NCT00576472|365592359|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
105852603|NCT04645966|365118034|FG007|Vaccination Phase|Lost to Follow-up|1|||
105852604|NCT04645966|365118035|FG008|Vaccination Phase|Lost to Follow-up|0|||
105852605|NCT04645966|365118027|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
105981452|NCT00576472|365592360|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
106029212|NCT03011892|365770893|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
106029213|NCT03011892|365770894|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
106029214|NCT03011892|365770895|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
106029215|NCT03011892|365770884|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
106029216|NCT03011892|365770885|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
106029217|NCT03011892|365770886|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
106029218|NCT03011892|365770887|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
106029219|NCT03011892|365770888|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
106029220|NCT03011892|365770889|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
106029221|NCT03011892|365770890|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
106029222|NCT03011892|365770891|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
106029223|NCT03011892|365770892|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
106029224|NCT03011892|365770893|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
106029225|NCT03011892|365770894|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
106029226|NCT03011892|365770895|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
106029227|NCT03011892|365770884|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
106029228|NCT03011892|365770885|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
106029229|NCT03011892|365770886|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
106029230|NCT03011892|365770887|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
106029231|NCT03011892|365770888|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
106029232|NCT03011892|365770889|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
106029233|NCT03011892|365770890|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
106029234|NCT03011892|365770891|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
106029235|NCT03011892|365770892|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
106029236|NCT03011892|365770893|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
106029237|NCT03011892|365770894|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
106029238|NCT03011892|365770895|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
106029239|NCT03011892|365770884|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
106029240|NCT03011892|365770885|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
106029241|NCT03011892|365770886|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
106029242|NCT03011892|365770887|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
106029243|NCT03011892|365770888|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
106029244|NCT03011892|365770889|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
106029245|NCT03011892|365770890|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
106029246|NCT03011892|365770891|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
106029247|NCT03011892|365770892|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
106029248|NCT03011892|365770893|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
106029249|NCT03011892|365770894|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
106029250|NCT03011892|365770895|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
106029251|NCT03011892|365770884|FG000|Open Label (OL) Period|Reason not specified|0|||
106029252|NCT03011892|365770885|FG001|Open Label (OL) Period|Reason not specified|0|||
106029253|NCT03011892|365770886|FG002|Open Label (OL) Period|Reason not specified|0|||
106029254|NCT03011892|365770887|FG003|Open Label (OL) Period|Reason not specified|0|||
106029255|NCT03011892|365770888|FG004|Open Label (OL) Period|Reason not specified|0|||
106029256|NCT03011892|365770889|FG005|Open Label (OL) Period|Reason not specified|0|||
106029257|NCT03011892|365770890|FG006|Open Label (OL) Period|Reason not specified|0|||
106029258|NCT03011892|365770891|FG007|Open Label (OL) Period|Reason not specified|1|||
106029259|NCT03011892|365770892|FG008|Open Label (OL) Period|Reason not specified|0|||
106029260|NCT03011892|365770893|FG009|Open Label (OL) Period|Reason not specified|0|||
106029261|NCT03011892|365770894|FG010|Open Label (OL) Period|Reason not specified|0|||
106029262|NCT03011892|365770895|FG011|Open Label (OL) Period|Reason not specified|0|||
106029263|NCT00821509|365770896|FG000|Overall Study|Withdrawal by Subject|12|||
106029264|NCT00821509|365770897|FG001|Overall Study|Withdrawal by Subject|11|||
106029265|NCT00821509|365770898|FG002|Overall Study|Withdrawal by Subject|34|||
106029266|NCT04054947|365770899|FG000|Overall Study|Withdrawal by Subject|1|||
106029267|NCT04054947|365770900|FG001|Overall Study|Withdrawal by Subject|0|||
106029268|NCT04054947|365770899|FG000|Overall Study|Lost to Follow-up|2|||
106029269|NCT04054947|365770900|FG001|Overall Study|Lost to Follow-up|5|||
106029270|NCT04463069|365770901|FG000|Overall Study|Withdrawal by Subject|2|||
106029271|NCT04463069|365770902|FG001|Overall Study|Withdrawal by Subject|10|||
106029272|NCT04463069|365770901|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
106029273|NCT04463069|365770902|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
106029274|NCT01181986|365770903|FG000|Phase 1|Lost to Follow-up|0|||
106029275|NCT01181986|365770904|FG001|Phase 1|Lost to Follow-up|1|||
106029276|NCT01181986|365770905|FG002|Phase 1|Lost to Follow-up|1|||
106029277|NCT01181986|365770903|FG000|Phase 1|Adverse Event|0|||
106029278|NCT01181986|365770904|FG001|Phase 1|Adverse Event|0|||
106029279|NCT01181986|365770905|FG002|Phase 1|Adverse Event|1|||
106029280|NCT01181986|365770903|FG000|Phase 1|Protocol Violation|1|||
106029281|NCT01181986|365770904|FG001|Phase 1|Protocol Violation|0|||
106029282|NCT01181986|365770905|FG002|Phase 1|Protocol Violation|0|||
106029283|NCT01181986|365770903|FG000|Phase 2|Adverse Event|0|||
106151298|NCT02723955|366215067|FG013|Expansion Phase|Site Closed|0|||
106151299|NCT02723955|366215068|FG014|Expansion Phase|Site Closed|0|||
106151300|NCT02723955|366215069|FG015|Expansion Phase|Site Closed|0|||
106151301|NCT02723955|366215070|FG016|Expansion Phase|Site Closed|0|||
106151302|NCT02723955|366215071|FG017|Expansion Phase|Site Closed|0|||
106151303|NCT02723955|366215072|FG018|Expansion Phase|Site Closed|0|||
106151304|NCT02723955|366215073|FG019|Expansion Phase|Site Closed|0|||
106151305|NCT02723955|366215074|FG020|Expansion Phase|Site Closed|0|||
106151306|NCT02723955|366215075|FG021|Expansion Phase|Site Closed|0|||
106151307|NCT02723955|366215076|FG022|Expansion Phase|Site Closed|0|||
106151308|NCT02723955|366215077|FG023|Expansion Phase|Site Closed|0|||
106151309|NCT02723955|366215078|FG024|Expansion Phase|Site Closed|0|||
106151310|NCT02723955|366215079|FG025|Expansion Phase|Site Closed|0|||
106151311|NCT02723955|366215080|FG026|Expansion Phase|Site Closed|0|||
106151312|NCT02723955|366215081|FG027|Expansion Phase|Site Closed|0|||
106151313|NCT02723955|366215082|FG028|Expansion Phase|Site Closed|0|||
106151314|NCT02723955|366215083|FG029|Expansion Phase|Site Closed|0|||
106151315|NCT02723955|366215084|FG030|Expansion Phase|Site Closed|8|||
106151316|NCT02723955|366215085|FG031|Expansion Phase|Site Closed|4|||
106151317|NCT02723955|366215086|FG032|Expansion Phase|Site Closed|2|||
106151318|NCT02723955|366215087|FG033|Expansion Phase|Site Closed|2|||
106151319|NCT02723955|366215088|FG034|Expansion Phase|Site Closed|0|||
106151320|NCT02723955|366215089|FG035|Expansion Phase|Site Closed|0|||
106151321|NCT02723955|366215090|FG036|Expansion Phase|Site Closed|0|||
106151322|NCT02723955|366215091|FG037|Expansion Phase|Site Closed|0|||
106151323|NCT02723955|366215092|FG038|Expansion Phase|Site Closed|0|||
106151324|NCT02723955|366215093|FG039|Expansion Phase|Site Closed|0|||
106151325|NCT02723955|366215094|FG040|Expansion Phase|Site Closed|0|||
106151326|NCT02723955|366215095|FG041|Expansion Phase|Site Closed|0|||
106151327|NCT02723955|366215096|FG042|Expansion Phase|Site Closed|0|||
106151328|NCT02723955|366215054|FG000|Crossover/ Re-treatment Phase|Death|0|||
106151329|NCT02723955|366215055|FG001|Crossover/ Re-treatment Phase|Death|0|||
106151330|NCT02723955|366215056|FG002|Crossover/ Re-treatment Phase|Death|0|||
106151331|NCT02723955|366215057|FG003|Crossover/ Re-treatment Phase|Death|0|||
106151332|NCT02723955|366215058|FG004|Crossover/ Re-treatment Phase|Death|0|||
106151333|NCT02723955|366215059|FG005|Crossover/ Re-treatment Phase|Death|0|||
106151334|NCT02723955|366215060|FG006|Crossover/ Re-treatment Phase|Death|0|||
106151335|NCT02723955|366215061|FG007|Crossover/ Re-treatment Phase|Death|0|||
105852606|NCT04645966|365118028|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
105852607|NCT04645966|365118029|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
105852608|NCT04645966|365118030|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
105852609|NCT04645966|365118031|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
105852610|NCT04645966|365118032|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
105852611|NCT04645966|365118033|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
105981453|NCT00576472|365592361|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
106029284|NCT01181986|365770904|FG001|Phase 2|Adverse Event|3|||
106029285|NCT01181986|365770905|FG002|Phase 2|Adverse Event|0|||
106029286|NCT01181986|365770903|FG000|Phase 2|Medical condition|0|||
106029287|NCT01181986|365770904|FG001|Phase 2|Medical condition|1|||
106029288|NCT01181986|365770905|FG002|Phase 2|Medical condition|0|||
106029289|NCT01159431|365770906|FG000|Overall Study|Adverse Event|1|||
106029290|NCT01159431|365770907|FG001|Overall Study|Adverse Event|2|||
106029291|NCT01159431|365770906|FG000|Overall Study|non-compliance|1|||
106029292|NCT01159431|365770907|FG001|Overall Study|non-compliance|1|||
106029293|NCT01159431|365770906|FG000|Overall Study|Lack of Efficacy|0|||
106029294|NCT01159431|365770907|FG001|Overall Study|Lack of Efficacy|3|||
106029295|NCT01981551|365770913|FG000|Overall Study|Refused further treatment|8|||
106029296|NCT01981551|365770913|FG000|Overall Study|Adverse Event|1|||
105981454|NCT00576472|365592362|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
105981455|NCT00576472|365592348|FG000|MPH Cross Over Phase|Physician Decision|0|||
105981456|NCT00576472|365592349|FG001|MPH Cross Over Phase|Physician Decision|0|||
105981457|NCT00576472|365592350|FG002|MPH Cross Over Phase|Physician Decision|0|||
105981458|NCT00576472|365592351|FG003|MPH Cross Over Phase|Physician Decision|0|||
105981459|NCT00576472|365592352|FG004|MPH Cross Over Phase|Physician Decision|0|||
105981460|NCT00576472|365592353|FG005|MPH Cross Over Phase|Physician Decision|0|||
105981461|NCT00576472|365592354|FG006|MPH Cross Over Phase|Physician Decision|4|||
106151336|NCT02723955|366215062|FG008|Crossover/ Re-treatment Phase|Death|0|||
106151337|NCT02723955|366215063|FG009|Crossover/ Re-treatment Phase|Death|0|||
106151338|NCT02723955|366215064|FG010|Crossover/ Re-treatment Phase|Death|0|||
106151339|NCT02723955|366215065|FG011|Crossover/ Re-treatment Phase|Death|0|||
106151340|NCT02723955|366215066|FG012|Crossover/ Re-treatment Phase|Death|0|||
105981462|NCT00576472|365592355|FG007|MPH Cross Over Phase|Physician Decision|0|||
105981463|NCT00576472|365592356|FG008|MPH Cross Over Phase|Physician Decision|0|||
106029297|NCT00362180|365772573|FG000|Treated Period|Withdrawal by Subject|1|||
106029298|NCT00362180|365772574|FG001|Treated Period|Withdrawal by Subject|0|||
106151341|NCT02723955|366215067|FG013|Crossover/ Re-treatment Phase|Death|0|||
106029299|NCT00362180|365772575|FG002|Treated Period|Withdrawal by Subject|0|||
106029300|NCT00362180|365772576|FG003|Treated Period|Withdrawal by Subject|0|||
106029301|NCT00362180|365772577|FG004|Treated Period|Withdrawal by Subject|0|||
106029302|NCT00362180|365772578|FG005|Treated Period|Withdrawal by Subject|0|||
106029303|NCT00362180|365772579|FG006|Treated Period|Withdrawal by Subject|0|||
105852612|NCT04645966|365118034|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
105852613|NCT04645966|365118035|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
105852614|NCT04645966|365118027|FG000|Follow-up Phase|Lost to Follow-up|0|||
105852615|NCT04645966|365118028|FG001|Follow-up Phase|Lost to Follow-up|0|||
105852616|NCT04645966|365118029|FG002|Follow-up Phase|Lost to Follow-up|0|||
105852617|NCT04645966|365118030|FG003|Follow-up Phase|Lost to Follow-up|0|||
105852618|NCT04645966|365118031|FG004|Follow-up Phase|Lost to Follow-up|0|||
105852619|NCT04645966|365118032|FG005|Follow-up Phase|Lost to Follow-up|0|||
105852620|NCT04645966|365118033|FG006|Follow-up Phase|Lost to Follow-up|0|||
105852621|NCT04645966|365118034|FG007|Follow-up Phase|Lost to Follow-up|1|||
105852622|NCT04645966|365118035|FG008|Follow-up Phase|Lost to Follow-up|0|||
105852623|NCT03825341|365118036|FG000|Overall Study|Withdrawal by Subject|0|||
105852624|NCT03825341|365118037|FG001|Overall Study|Withdrawal by Subject|1|||
105852625|NCT01735955|365118038|FG000|Overall Study|Administrative problems|1|||
105852626|NCT01735955|365118038|FG000|Overall Study|Patient/guardian decision|1|||
105852627|NCT01735955|365118038|FG000|Overall Study|Patient withdrew consent|2|||
105852628|NCT01735955|365118038|FG000|Overall Study|Physician Decision|4|||
105852629|NCT01735955|365118038|FG000|Overall Study|Disease progression|24|||
105852630|NCT01735955|365118038|FG000|Overall Study|Adverse Event|5|||
105852631|NCT01330459|365118039|FG000|Overall Study|Physician Decision|0|||
105852632|NCT01330459|365118040|FG001|Overall Study|Physician Decision|2|||
105852633|NCT00895947|365118041|FG000|Overall Study|Adverse Event|3|||
105852634|NCT00895947|365118042|FG001|Overall Study|Adverse Event|4|||
105852635|NCT00895947|365118041|FG000|Overall Study|Lost to Follow-up|3|||
105852636|NCT00895947|365118042|FG001|Overall Study|Lost to Follow-up|4|||
105852637|NCT00895947|365118041|FG000|Overall Study|Protocol Violation|4|||
105852638|NCT00895947|365118042|FG001|Overall Study|Protocol Violation|2|||
105852639|NCT00895947|365118041|FG000|Overall Study|Withdrawal by Subject|2|||
105852640|NCT00895947|365118042|FG001|Overall Study|Withdrawal by Subject|0|||
105852641|NCT04562155|365118045|FG000|Overall Study|COVID-19 pandemic|0|||
105852642|NCT04562155|365118046|FG001|Overall Study|COVID-19 pandemic|0|||
105852643|NCT04562155|365118047|FG002|Overall Study|COVID-19 pandemic|0|||
105852644|NCT04562155|365118048|FG003|Overall Study|COVID-19 pandemic|1|||
105852645|NCT04562155|365118045|FG000|Overall Study|Adverse Event|7|||
105852646|NCT04562155|365118046|FG001|Overall Study|Adverse Event|3|||
105852647|NCT04562155|365118047|FG002|Overall Study|Adverse Event|8|||
105852648|NCT04562155|365118048|FG003|Overall Study|Adverse Event|1|||
105852649|NCT04562155|365118045|FG000|Overall Study|Withdrawal by Subject|3|||
105852650|NCT04562155|365118046|FG001|Overall Study|Withdrawal by Subject|6|||
105852651|NCT04562155|365118047|FG002|Overall Study|Withdrawal by Subject|3|||
105852652|NCT04562155|365118048|FG003|Overall Study|Withdrawal by Subject|3|||
105981464|NCT00576472|365592357|FG009|MPH Cross Over Phase|Physician Decision|0|||
105981465|NCT00576472|365592358|FG010|MPH Cross Over Phase|Physician Decision|0|||
105981466|NCT00576472|365592359|FG011|MPH Cross Over Phase|Physician Decision|0|||
105981467|NCT00576472|365592360|FG012|MPH Cross Over Phase|Physician Decision|0|||
105981468|NCT00576472|365592361|FG013|MPH Cross Over Phase|Physician Decision|0|||
105981469|NCT00576472|365592362|FG014|MPH Cross Over Phase|Physician Decision|0|||
105981470|NCT00576472|365592348|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981471|NCT00576472|365592349|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981472|NCT00576472|365592350|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981473|NCT00576472|365592351|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981474|NCT00576472|365592352|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981475|NCT00576472|365592353|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981476|NCT00576472|365592354|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981477|NCT00576472|365592355|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981478|NCT00576472|365592356|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
105981479|NCT00576472|365592357|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981480|NCT00576472|365592358|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
105981481|NCT00576472|365592359|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
105981482|NCT00576472|365592360|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981483|NCT00576472|365592361|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
105981484|NCT00576472|365592362|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
105852653|NCT04562155|365118045|FG000|Overall Study|Participant personal reason|1|||
105852654|NCT04562155|365118046|FG001|Overall Study|Participant personal reason|0|||
105852655|NCT04562155|365118047|FG002|Overall Study|Participant personal reason|2|||
105852656|NCT04562155|365118048|FG003|Overall Study|Participant personal reason|1|||
106029304|NCT00362180|365772580|FG007|Treated Period|Withdrawal by Subject|0|||
105981485|NCT00576472|365592348|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
106029305|NCT00362180|365772581|FG008|Treated Period|Withdrawal by Subject|0|||
105981486|NCT00576472|365592349|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981487|NCT00576472|365592350|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981488|NCT00576472|365592351|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981489|NCT00576472|365592352|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981490|NCT00576472|365592353|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981491|NCT00576472|365592354|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981492|NCT00576472|365592355|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981493|NCT00576472|365592356|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981494|NCT00576472|365592357|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981495|NCT00576472|365592358|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981496|NCT00576472|365592359|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981497|NCT00576472|365592360|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981498|NCT00576472|365592361|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
105981499|NCT00576472|365592362|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
105981500|NCT00576472|365592348|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
105981501|NCT00576472|365592349|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
105981502|NCT00576472|365592350|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
105981503|NCT00576472|365592351|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
105981504|NCT00576472|365592352|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
105981505|NCT00576472|365592353|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
105981506|NCT00576472|365592354|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
105981507|NCT00576472|365592355|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
105981508|NCT00576472|365592356|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
105981509|NCT00576472|365592357|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
105981510|NCT00576472|365592358|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
105981511|NCT00576472|365592359|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
105981512|NCT00576472|365592360|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
105981513|NCT00576472|365592361|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
105981514|NCT00576472|365592362|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
105981515|NCT00576472|365592348|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
105981516|NCT00576472|365592349|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
105981517|NCT00576472|365592350|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
105981518|NCT00576472|365592351|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
105981519|NCT00576472|365592352|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
105981520|NCT00576472|365592353|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
105981521|NCT00576472|365592354|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
105981522|NCT00576472|365592355|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
105981523|NCT00576472|365592356|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
105981524|NCT00576472|365592357|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
105981525|NCT00576472|365592358|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
105981526|NCT00576472|365592359|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
105981527|NCT00576472|365592360|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
105981528|NCT00576472|365592361|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
105981529|NCT00576472|365592362|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
105981530|NCT00576472|365592348|FG000|MPH Home Maintenance Phase|Side effects|0|||
105981531|NCT00576472|365592349|FG001|MPH Home Maintenance Phase|Side effects|0|||
105981532|NCT00576472|365592350|FG002|MPH Home Maintenance Phase|Side effects|0|||
105981533|NCT00576472|365592351|FG003|MPH Home Maintenance Phase|Side effects|0|||
105981534|NCT00576472|365592352|FG004|MPH Home Maintenance Phase|Side effects|0|||
105981535|NCT00576472|365592353|FG005|MPH Home Maintenance Phase|Side effects|0|||
105981536|NCT00576472|365592354|FG006|MPH Home Maintenance Phase|Side effects|0|||
105981537|NCT00576472|365592355|FG007|MPH Home Maintenance Phase|Side effects|0|||
105981538|NCT00576472|365592356|FG008|MPH Home Maintenance Phase|Side effects|0|||
105981539|NCT00576472|365592357|FG009|MPH Home Maintenance Phase|Side effects|0|||
105981540|NCT00576472|365592358|FG010|MPH Home Maintenance Phase|Side effects|0|||
105981541|NCT00576472|365592359|FG011|MPH Home Maintenance Phase|Side effects|0|||
105981542|NCT00576472|365592360|FG012|MPH Home Maintenance Phase|Side effects|0|||
105981543|NCT00576472|365592361|FG013|MPH Home Maintenance Phase|Side effects|0|||
105981544|NCT00576472|365592362|FG014|MPH Home Maintenance Phase|Side effects|8|||
105981545|NCT00576472|365592348|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981546|NCT00576472|365592349|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981547|NCT00576472|365592350|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981548|NCT00576472|365592351|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
106029306|NCT00362180|365772573|FG000|Treated Period|Adverse Event|0|||
106029307|NCT00362180|365772574|FG001|Treated Period|Adverse Event|0|||
105981549|NCT00576472|365592352|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
106029308|NCT00362180|365772575|FG002|Treated Period|Adverse Event|0|||
106029309|NCT00362180|365772576|FG003|Treated Period|Adverse Event|0|||
106029310|NCT00362180|365772577|FG004|Treated Period|Adverse Event|0|||
106029311|NCT00362180|365772578|FG005|Treated Period|Adverse Event|1|||
105981550|NCT00576472|365592353|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981551|NCT00576472|365592354|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981552|NCT00576472|365592355|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981553|NCT00576472|365592356|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981554|NCT00576472|365592357|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981555|NCT00576472|365592358|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981556|NCT00576472|365592359|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981557|NCT00576472|365592360|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981558|NCT00576472|365592361|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
105981559|NCT00576472|365592362|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
105981560|NCT00576472|365592348|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
105981561|NCT00576472|365592349|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
105981562|NCT00576472|365592350|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
105981563|NCT00576472|365592351|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
105981564|NCT00576472|365592352|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
105981565|NCT00576472|365592353|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
105981566|NCT00576472|365592354|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
105981567|NCT00576472|365592355|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
105981568|NCT00576472|365592356|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
105981569|NCT00576472|365592357|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
105981570|NCT00576472|365592358|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
105981571|NCT00576472|365592359|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
105981572|NCT00576472|365592360|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
105981573|NCT00576472|365592361|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
105981574|NCT00576472|365592362|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
105981575|NCT00576472|365592348|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981576|NCT00576472|365592349|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981577|NCT00576472|365592350|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981578|NCT00576472|365592351|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981579|NCT00576472|365592352|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981580|NCT00576472|365592353|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981581|NCT00576472|365592354|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981582|NCT00576472|365592355|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981583|NCT00576472|365592356|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981584|NCT00576472|365592357|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981585|NCT00576472|365592358|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981586|NCT00576472|365592359|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981587|NCT00576472|365592360|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981588|NCT00576472|365592361|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
105981589|NCT00576472|365592362|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
105981590|NCT03443427|365592364|FG000|Overall Study|Adverse Event|2|||
105981591|NCT03443427|365592365|FG001|Overall Study|Adverse Event|3|||
105981592|NCT03443427|365592364|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
105981593|NCT03443427|365592365|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
105981594|NCT03443427|365592364|FG000|Overall Study|Other|4|||
105981595|NCT03443427|365592365|FG001|Overall Study|Other|6|||
105981596|NCT02391961|365592368|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
105981597|NCT02391961|365592369|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
105981598|NCT02391961|365592368|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
105981599|NCT02391961|365592369|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
105981600|NCT02391961|365592368|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105981601|NCT02391961|365592369|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
105981602|NCT02723175|365592372|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
105981603|NCT02723175|365592373|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
105981604|NCT02723175|365592372|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
106029312|NCT00362180|365772579|FG006|Treated Period|Adverse Event|0|||
106029313|NCT00362180|365772580|FG007|Treated Period|Adverse Event|1|||
106029314|NCT00362180|365772581|FG008|Treated Period|Adverse Event|0|||
106029315|NCT02434471|365772582|FG000|Overall Study|Physician Decision|9|||
106029316|NCT00843778|365772583|FG000|Overall Study|Adverse Event|15|||
106029317|NCT00843778|365772583|FG000|Overall Study|Lack of Efficacy|14|||
106029318|NCT00843778|365772583|FG000|Overall Study|Loss of efficacy|2|||
106029319|NCT00843778|365772583|FG000|Overall Study|Withdrawal by Subject|4|||
106029320|NCT04839562|365772586|FG000|Overall Study|Withdrawal by Subject|0|||
106029321|NCT04839562|365772587|FG001|Overall Study|Withdrawal by Subject|1|||
106029322|NCT04839562|365772586|FG000|Overall Study|Physician Decision|0|||
106151342|NCT02723955|366215068|FG014|Crossover/ Re-treatment Phase|Death|0|||
106151343|NCT02723955|366215069|FG015|Crossover/ Re-treatment Phase|Death|0|||
105981605|NCT02723175|365592373|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
105981606|NCT03995355|365592374|FG000|Overall Study|Adverse Event|1|||
105981607|NCT03995355|365592375|FG001|Overall Study|Adverse Event|0|||
105981608|NCT03995355|365592374|FG000|Overall Study|Withdrawal by Subject|1|||
106029323|NCT04839562|365772587|FG001|Overall Study|Physician Decision|1|||
105981609|NCT03995355|365592375|FG001|Overall Study|Withdrawal by Subject|0|||
105981610|NCT03995355|365592374|FG000|Overall Study|Scheduling Issues|0|||
105981611|NCT03995355|365592375|FG001|Overall Study|Scheduling Issues|1|||
105981612|NCT01751776|365592386|FG000|Overall Study|Adverse Event|0|||
105981613|NCT01751776|365592387|FG001|Overall Study|Adverse Event|0|||
105981614|NCT01751776|365592388|FG002|Overall Study|Adverse Event|0|||
105981615|NCT01751776|365592389|FG003|Overall Study|Adverse Event|0|||
105981616|NCT01751776|365592390|FG004|Overall Study|Adverse Event|0|||
105981617|NCT01751776|365592391|FG005|Overall Study|Adverse Event|0|||
105981618|NCT01751776|365592392|FG006|Overall Study|Adverse Event|4|||
105981619|NCT01751776|365592393|FG007|Overall Study|Adverse Event|2|||
105981620|NCT01751776|365592386|FG000|Overall Study|Consent withdrawn|0|||
105981621|NCT01751776|365592387|FG001|Overall Study|Consent withdrawn|0|||
105981622|NCT01751776|365592388|FG002|Overall Study|Consent withdrawn|0|||
105981623|NCT01751776|365592389|FG003|Overall Study|Consent withdrawn|0|||
105981624|NCT01751776|365592390|FG004|Overall Study|Consent withdrawn|0|||
105981625|NCT01751776|365592391|FG005|Overall Study|Consent withdrawn|0|||
105981626|NCT01751776|365592392|FG006|Overall Study|Consent withdrawn|0|||
105981627|NCT01751776|365592393|FG007|Overall Study|Consent withdrawn|1|||
105981628|NCT01751776|365592386|FG000|Overall Study|Other reason not specified above|0|||
105981629|NCT01751776|365592387|FG001|Overall Study|Other reason not specified above|0|||
105981630|NCT01751776|365592388|FG002|Overall Study|Other reason not specified above|0|||
105981631|NCT01751776|365592389|FG003|Overall Study|Other reason not specified above|0|||
105981632|NCT01751776|365592390|FG004|Overall Study|Other reason not specified above|0|||
105981633|NCT01751776|365592391|FG005|Overall Study|Other reason not specified above|0|||
105981634|NCT01751776|365592392|FG006|Overall Study|Other reason not specified above|0|||
105981635|NCT01751776|365592393|FG007|Overall Study|Other reason not specified above|1|||
105981636|NCT00160654|365592394|FG000|Overall Study|Adverse Event|14|||
105981637|NCT00160654|365592394|FG000|Overall Study|Lack of Efficacy|4|||
105981638|NCT00160654|365592394|FG000|Overall Study|Lost to Follow-up|2|||
105981639|NCT00160654|365592394|FG000|Overall Study|Intake of expired drug|7|||
105981640|NCT00160654|365592394|FG000|Overall Study|Psychological trauma|1|||
105981641|NCT00160654|365592394|FG000|Overall Study|Sponsor decision|1|||
105981642|NCT00160654|365592394|FG000|Overall Study|Patient met exclusion criteria|1|||
105981643|NCT00160654|365592394|FG000|Overall Study|Patient decision|1|||
105981644|NCT00160654|365592394|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
105981645|NCT00160654|365592394|FG000|Overall Study|Met exclusion criteria|1|||
106151344|NCT02723955|366215070|FG016|Crossover/ Re-treatment Phase|Death|0|||
106151345|NCT02723955|366215071|FG017|Crossover/ Re-treatment Phase|Death|0|||
105981646|NCT00162266|365592395|FG000|Double-Blind Period|Adverse Event|5|||
105981647|NCT00162266|365592396|FG001|Double-Blind Period|Adverse Event|9|||
105981648|NCT00162266|365592397|FG002|Double-Blind Period|Adverse Event|11|||
105981649|NCT00162266|365592398|FG003|Double-Blind Period|Adverse Event|0|||
105981650|NCT00162266|365592395|FG000|Double-Blind Period|Death|0|||
105981651|NCT00162266|365592396|FG001|Double-Blind Period|Death|1|||
105981652|NCT00162266|365592397|FG002|Double-Blind Period|Death|0|||
105981653|NCT00162266|365592398|FG003|Double-Blind Period|Death|0|||
105981654|NCT00162266|365592395|FG000|Double-Blind Period|Lost to Follow-up|1|||
105981655|NCT00162266|365592396|FG001|Double-Blind Period|Lost to Follow-up|2|||
105981656|NCT00162266|365592397|FG002|Double-Blind Period|Lost to Follow-up|0|||
105981657|NCT00162266|365592398|FG003|Double-Blind Period|Lost to Follow-up|0|||
105981658|NCT00162266|365592395|FG000|Double-Blind Period|Other Reason|1|||
105981659|NCT00162266|365592396|FG001|Double-Blind Period|Other Reason|0|||
105981660|NCT00162266|365592397|FG002|Double-Blind Period|Other Reason|1|||
105981661|NCT00162266|365592398|FG003|Double-Blind Period|Other Reason|0|||
105981662|NCT00162266|365592395|FG000|Double-Blind Period|Lack of Efficacy|13|||
105981663|NCT00162266|365592396|FG001|Double-Blind Period|Lack of Efficacy|17|||
105981664|NCT00162266|365592397|FG002|Double-Blind Period|Lack of Efficacy|30|||
105981665|NCT00162266|365592398|FG003|Double-Blind Period|Lack of Efficacy|0|||
105981666|NCT00162266|365592395|FG000|Double-Blind Period|Withdrawal by Subject|5|||
105981667|NCT00162266|365592396|FG001|Double-Blind Period|Withdrawal by Subject|2|||
105981668|NCT00162266|365592397|FG002|Double-Blind Period|Withdrawal by Subject|6|||
105981669|NCT00162266|365592398|FG003|Double-Blind Period|Withdrawal by Subject|0|||
105981670|NCT00162266|365592395|FG000|Open-Label Period|Death|0|||
105981671|NCT00162266|365592396|FG001|Open-Label Period|Death|0|||
105981672|NCT00162266|365592397|FG002|Open-Label Period|Death|0|||
105981673|NCT00162266|365592398|FG003|Open-Label Period|Death|7|||
105981674|NCT00162266|365592395|FG000|Open-Label Period|Adverse Event|0|||
105981675|NCT00162266|365592396|FG001|Open-Label Period|Adverse Event|0|||
105981676|NCT00162266|365592397|FG002|Open-Label Period|Adverse Event|0|||
105981677|NCT00162266|365592398|FG003|Open-Label Period|Adverse Event|46|||
105981678|NCT00162266|365592395|FG000|Open-Label Period|Lack of Efficacy|0|||
105981679|NCT00162266|365592396|FG001|Open-Label Period|Lack of Efficacy|0|||
105981680|NCT00162266|365592397|FG002|Open-Label Period|Lack of Efficacy|0|||
106151346|NCT02723955|366215072|FG018|Crossover/ Re-treatment Phase|Death|0|||
105981681|NCT00162266|365592398|FG003|Open-Label Period|Lack of Efficacy|26|||
105981682|NCT00162266|365592395|FG000|Open-Label Period|Lost to Follow-up|0|||
105981683|NCT00162266|365592396|FG001|Open-Label Period|Lost to Follow-up|0|||
105852657|NCT05070546|365118049|FG000|Overall Study|Death|0|||
105852658|NCT05070546|365118050|FG001|Overall Study|Death|0|||
105852659|NCT05070546|365118051|FG002|Overall Study|Death|0|||
105852660|NCT05070546|365118052|FG003|Overall Study|Death|0|||
105852661|NCT05070546|365118053|FG004|Overall Study|Death|0|||
105852662|NCT05070546|365118054|FG005|Overall Study|Death|1|||
105852663|NCT05070546|365118049|FG000|Overall Study|Lost to Follow-up|8|||
105852664|NCT05070546|365118050|FG001|Overall Study|Lost to Follow-up|2|||
105852665|NCT05070546|365118051|FG002|Overall Study|Lost to Follow-up|7|||
105852666|NCT05070546|365118052|FG003|Overall Study|Lost to Follow-up|1|||
105852667|NCT05070546|365118053|FG004|Overall Study|Lost to Follow-up|2|||
105852668|NCT05070546|365118054|FG005|Overall Study|Lost to Follow-up|0|||
105852669|NCT05070546|365118049|FG000|Overall Study|Withdrawal by Subject|1|||
105852670|NCT05070546|365118050|FG001|Overall Study|Withdrawal by Subject|1|||
105852671|NCT05070546|365118051|FG002|Overall Study|Withdrawal by Subject|3|||
105852672|NCT05070546|365118052|FG003|Overall Study|Withdrawal by Subject|0|||
105852673|NCT05070546|365118053|FG004|Overall Study|Withdrawal by Subject|0|||
105852674|NCT05070546|365118054|FG005|Overall Study|Withdrawal by Subject|0|||
105852675|NCT05070546|365118049|FG000|Overall Study|Other|0|||
105852676|NCT05070546|365118050|FG001|Overall Study|Other|0|||
105852677|NCT05070546|365118051|FG002|Overall Study|Other|0|||
105852678|NCT05070546|365118052|FG003|Overall Study|Other|0|||
105852679|NCT05070546|365118053|FG004|Overall Study|Other|3|||
105852680|NCT05070546|365118054|FG005|Overall Study|Other|0|||
105852681|NCT05070546|365118049|FG000|Overall Study|Randomized but not vaccinated|1|||
105852682|NCT05070546|365118050|FG001|Overall Study|Randomized but not vaccinated|0|||
105852683|NCT05070546|365118051|FG002|Overall Study|Randomized but not vaccinated|1|||
105852684|NCT05070546|365118052|FG003|Overall Study|Randomized but not vaccinated|1|||
105852685|NCT05070546|365118053|FG004|Overall Study|Randomized but not vaccinated|3|||
105852686|NCT05070546|365118054|FG005|Overall Study|Randomized but not vaccinated|0|||
105852687|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
105852688|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
105852689|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852690|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852691|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
105852692|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852693|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852694|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852695|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
105852696|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852697|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
105852698|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852699|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852700|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852701|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852702|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852703|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852704|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
105852705|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852706|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
105852707|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852708|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
105852709|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852710|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852711|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852712|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852713|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852714|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105852715|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
105852716|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
106029324|NCT03338959|365772588|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
106029325|NCT03338959|365772588|FG000|Overall Study|Physician Decision|1|||
106029326|NCT02848729|365772589|FG000|Overall Study|Withdrawal by Subject|1|||
106029327|NCT02848729|365772590|FG001|Overall Study|Withdrawal by Subject|0|||
105852717|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
105852718|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
106029328|NCT02848729|365772589|FG000|Overall Study|Emesis|15|||
106029329|NCT02848729|365772590|FG001|Overall Study|Emesis|11|||
105852719|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105852720|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
106029330|NCT01604278|365772594|FG000|Overall Study|Lack of Efficacy|0|||
106029331|NCT01604278|365772595|FG001|Overall Study|Lack of Efficacy|1|||
106151347|NCT02723955|366215073|FG019|Crossover/ Re-treatment Phase|Death|0|||
106151348|NCT02723955|366215074|FG020|Crossover/ Re-treatment Phase|Death|0|||
106151349|NCT02723955|366215075|FG021|Crossover/ Re-treatment Phase|Death|0|||
106151350|NCT02723955|366215076|FG022|Crossover/ Re-treatment Phase|Death|0|||
106151351|NCT02723955|366215077|FG023|Crossover/ Re-treatment Phase|Death|0|||
106151352|NCT02723955|366215078|FG024|Crossover/ Re-treatment Phase|Death|0|||
106151353|NCT02723955|366215079|FG025|Crossover/ Re-treatment Phase|Death|0|||
106151354|NCT02723955|366215080|FG026|Crossover/ Re-treatment Phase|Death|0|||
106151355|NCT02723955|366215081|FG027|Crossover/ Re-treatment Phase|Death|0|||
106151356|NCT02723955|366215082|FG028|Crossover/ Re-treatment Phase|Death|0|||
106151357|NCT02723955|366215083|FG029|Crossover/ Re-treatment Phase|Death|0|||
106151358|NCT02723955|366215084|FG030|Crossover/ Re-treatment Phase|Death|0|||
106151359|NCT02723955|366215085|FG031|Crossover/ Re-treatment Phase|Death|0|||
106151360|NCT02723955|366215086|FG032|Crossover/ Re-treatment Phase|Death|0|||
106151361|NCT02723955|366215087|FG033|Crossover/ Re-treatment Phase|Death|0|||
106151362|NCT02723955|366215088|FG034|Crossover/ Re-treatment Phase|Death|0|||
106151363|NCT02723955|366215089|FG035|Crossover/ Re-treatment Phase|Death|0|||
106151364|NCT02723955|366215090|FG036|Crossover/ Re-treatment Phase|Death|0|||
106151365|NCT02723955|366215091|FG037|Crossover/ Re-treatment Phase|Death|1|||
106151366|NCT02723955|366215092|FG038|Crossover/ Re-treatment Phase|Death|14|||
106151367|NCT02723955|366215093|FG039|Crossover/ Re-treatment Phase|Death|32|||
106151368|NCT02723955|366215094|FG040|Crossover/ Re-treatment Phase|Death|2|||
106151369|NCT02723955|366215095|FG041|Crossover/ Re-treatment Phase|Death|1|||
106151370|NCT02723955|366215096|FG042|Crossover/ Re-treatment Phase|Death|0|||
106151371|NCT02723955|366215054|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151372|NCT02723955|366215055|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151373|NCT02723955|366215056|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151374|NCT02723955|366215057|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151375|NCT02723955|366215058|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151376|NCT02723955|366215059|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151377|NCT02723955|366215060|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151378|NCT02723955|366215061|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151379|NCT02723955|366215062|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151380|NCT02723955|366215063|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151381|NCT02723955|366215064|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151382|NCT02723955|366215065|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151383|NCT02723955|366215066|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151384|NCT02723955|366215067|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151385|NCT02723955|366215068|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151386|NCT02723955|366215069|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151387|NCT02723955|366215070|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151388|NCT02723955|366215071|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151389|NCT02723955|366215072|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151390|NCT02723955|366215073|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151391|NCT02723955|366215074|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151392|NCT02723955|366215075|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151393|NCT02723955|366215076|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151394|NCT02723955|366215077|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151395|NCT02723955|366215078|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151396|NCT02723955|366215079|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
105981684|NCT00162266|365592397|FG002|Open-Label Period|Lost to Follow-up|0|||
105981685|NCT00162266|365592398|FG003|Open-Label Period|Lost to Follow-up|3|||
105981686|NCT00162266|365592395|FG000|Open-Label Period|Withdrawal by Subject|0|||
105981687|NCT00162266|365592396|FG001|Open-Label Period|Withdrawal by Subject|0|||
105981688|NCT00162266|365592397|FG002|Open-Label Period|Withdrawal by Subject|0|||
105981689|NCT00162266|365592398|FG003|Open-Label Period|Withdrawal by Subject|31|||
105981690|NCT00162266|365592395|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
105981691|NCT00162266|365592396|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
105981692|NCT00162266|365592397|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
105981693|NCT00162266|365592398|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
105981694|NCT00162266|365592395|FG000|Open-Label Period|Other Reasons|0|||
105981695|NCT00162266|365592396|FG001|Open-Label Period|Other Reasons|0|||
105981696|NCT00162266|365592397|FG002|Open-Label Period|Other Reasons|0|||
105852721|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105981697|NCT00162266|365592398|FG003|Open-Label Period|Other Reasons|15|||
105981698|NCT04232215|365592399|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
105981699|NCT04232215|365592400|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
105981700|NCT04268745|365592401|FG000|Overall Study|Lost to Follow-up|2|||
105981701|NCT04268745|365592402|FG001|Overall Study|Lost to Follow-up|3|||
105981702|NCT04268745|365592401|FG000|Overall Study|Withdrawal by Subject|4|||
105981703|NCT04268745|365592402|FG001|Overall Study|Withdrawal by Subject|2|||
105981704|NCT04268745|365592401|FG000|Overall Study|Death in the family|1|||
105981705|NCT04268745|365592402|FG001|Overall Study|Death in the family|0|||
105852722|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
105852723|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
105852724|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
105852725|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
105852726|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852727|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
105852728|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852729|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852730|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852731|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852732|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852733|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
105852734|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852735|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852736|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852737|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852738|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852739|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852740|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
105852741|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852742|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852743|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852744|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
105852745|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852746|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852747|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852748|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852749|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852750|NCT03893565|365118055|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852751|NCT03893565|365118056|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
105852752|NCT03893565|365118057|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
105852753|NCT03893565|365118058|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
105852754|NCT03893565|365118059|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852755|NCT03893565|365118060|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852756|NCT03893565|365118061|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852757|NCT03893565|365118062|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852758|NCT03893565|365118063|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
105852759|NCT03893565|365118055|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
105852760|NCT03893565|365118056|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
105852761|NCT03893565|365118057|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
105852762|NCT03893565|365118058|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
105852763|NCT03893565|365118059|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
105852764|NCT03893565|365118060|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
105852765|NCT03893565|365118061|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
105852766|NCT03893565|365118062|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
105852767|NCT03893565|365118063|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
105852768|NCT03893565|365118055|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852769|NCT03893565|365118056|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852770|NCT03893565|365118057|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852771|NCT03893565|365118058|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852772|NCT03893565|365118059|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852773|NCT03893565|365118060|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852774|NCT03893565|365118061|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
105852775|NCT03893565|365118062|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852776|NCT03893565|365118063|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
105852777|NCT03893565|365118055|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852778|NCT03893565|365118056|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852779|NCT03893565|365118057|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852780|NCT03893565|365118058|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852781|NCT03893565|365118059|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852782|NCT03893565|365118060|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
105852783|NCT03893565|365118061|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
105852784|NCT03893565|365118062|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852785|NCT03893565|365118063|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
105852786|NCT03893565|365118055|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
105852787|NCT03893565|365118056|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
105852788|NCT03893565|365118057|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
105852789|NCT03893565|365118058|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
105852790|NCT03893565|365118059|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
105852791|NCT03893565|365118060|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
105852792|NCT03893565|365118061|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
105852793|NCT03893565|365118062|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
105852794|NCT03893565|365118063|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
105852795|NCT03893565|365118055|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852796|NCT03893565|365118056|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852797|NCT03893565|365118057|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852798|NCT03893565|365118058|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852799|NCT03893565|365118059|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852800|NCT03893565|365118060|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852801|NCT03893565|365118061|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852802|NCT03893565|365118062|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
105852803|NCT03893565|365118063|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
105852804|NCT03893565|365118055|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852805|NCT03893565|365118056|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852806|NCT03893565|365118057|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852807|NCT03893565|365118058|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852808|NCT03893565|365118059|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852809|NCT03893565|365118060|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852810|NCT03893565|365118061|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852811|NCT03893565|365118062|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
105852812|NCT03893565|365118063|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
105852813|NCT03893565|365118055|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852814|NCT03893565|365118056|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852815|NCT03893565|365118057|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852816|NCT03893565|365118058|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852817|NCT03893565|365118059|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852818|NCT03893565|365118060|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852819|NCT03893565|365118061|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852820|NCT03893565|365118062|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
105852821|NCT03893565|365118063|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
105852822|NCT03893565|365118055|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852823|NCT03893565|365118056|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852824|NCT03893565|365118057|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852825|NCT03893565|365118058|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852826|NCT03893565|365118059|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852827|NCT03893565|365118060|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852828|NCT03893565|365118061|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852829|NCT03893565|365118062|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
105852830|NCT03893565|365118063|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
105852831|NCT01715571|365118064|FG000|Overall Study|Lost to Follow-up|8|||
105852832|NCT04076059|365118065|FG000|Double Blind Phase|Progressive disease|22|||
105852833|NCT04076059|365118066|FG001|Double Blind Phase|Progressive disease|26|||
105852834|NCT04076059|365118067|FG002|Double Blind Phase|Progressive disease|0|||
105852835|NCT04076059|365118065|FG000|Double Blind Phase|Withdrawal by Subject|4|||
105852836|NCT04076059|365118066|FG001|Double Blind Phase|Withdrawal by Subject|11|||
105852837|NCT04076059|365118067|FG002|Double Blind Phase|Withdrawal by Subject|0|||
105852838|NCT04076059|365118065|FG000|Double Blind Phase|Death|1|||
105852839|NCT04076059|365118066|FG001|Double Blind Phase|Death|1|||
105852840|NCT04076059|365118067|FG002|Double Blind Phase|Death|0|||
105852841|NCT04076059|365118065|FG000|Double Blind Phase|Lost to Follow-up|1|||
105852842|NCT04076059|365118066|FG001|Double Blind Phase|Lost to Follow-up|0|||
105852843|NCT04076059|365118067|FG002|Double Blind Phase|Lost to Follow-up|0|||
105852844|NCT04076059|365118065|FG000|Double Blind Phase|Adverse Event|5|||
105852845|NCT04076059|365118066|FG001|Double Blind Phase|Adverse Event|1|||
105852846|NCT04076059|365118067|FG002|Double Blind Phase|Adverse Event|0|||
105852847|NCT04076059|365118065|FG000|Double Blind Phase|Ongoing Participants|82|||
105852848|NCT04076059|365118066|FG001|Double Blind Phase|Ongoing Participants|18|||
105852849|NCT04076059|365118067|FG002|Double Blind Phase|Ongoing Participants|0|||
105852850|NCT04076059|365118065|FG000|Double Blind Phase|Miscellaneous|3|||
105852851|NCT04076059|365118066|FG001|Double Blind Phase|Miscellaneous|1|||
105852852|NCT04076059|365118067|FG002|Double Blind Phase|Miscellaneous|0|||
105852853|NCT04076059|365118065|FG000|Double Blind Phase|Protocol Deviation|1|||
105852854|NCT04076059|365118066|FG001|Double Blind Phase|Protocol Deviation|1|||
105852855|NCT04076059|365118067|FG002|Double Blind Phase|Protocol Deviation|0|||
105852856|NCT04076059|365118065|FG000|Double Blind Phase|Did not take study drug|1|||
105852857|NCT04076059|365118066|FG001|Double Blind Phase|Did not take study drug|1|||
105852858|NCT04076059|365118067|FG002|Double Blind Phase|Did not take study drug|0|||
105852859|NCT04076059|365118065|FG000|Open Label Phase|Progressive disease|0|||
105852860|NCT04076059|365118066|FG001|Open Label Phase|Progressive disease|0|||
105981706|NCT00528996|365594217|FG000|Overall Study|Other reasons than listing|6|||
105981707|NCT00528996|365594218|FG001|Overall Study|Other reasons than listing|7|||
105981708|NCT00528996|365594219|FG002|Overall Study|Other reasons than listing|14|||
105981709|NCT00528996|365594220|FG003|Overall Study|Other reasons than listing|11|||
105981710|NCT00528996|365594221|FG004|Overall Study|Other reasons than listing|5|||
105981711|NCT00528996|365594217|FG000|Overall Study|Refused continue medication|16|||
105981712|NCT00528996|365594218|FG001|Overall Study|Refused continue medication|0|||
105981713|NCT00528996|365594219|FG002|Overall Study|Refused continue medication|3|||
105981714|NCT00528996|365594220|FG003|Overall Study|Refused continue medication|3|||
105981715|NCT00528996|365594221|FG004|Overall Study|Refused continue medication|6|||
105981716|NCT00528996|365594217|FG000|Overall Study|Lost to Follow-up|2|||
105981717|NCT00528996|365594218|FG001|Overall Study|Lost to Follow-up|0|||
105981718|NCT00528996|365594219|FG002|Overall Study|Lost to Follow-up|4|||
105981719|NCT00528996|365594220|FG003|Overall Study|Lost to Follow-up|1|||
105981720|NCT00528996|365594221|FG004|Overall Study|Lost to Follow-up|3|||
105852861|NCT04076059|365118067|FG002|Open Label Phase|Progressive disease|7|||
105852862|NCT04076059|365118065|FG000|Open Label Phase|Withdrawal by Subject|0|||
105852863|NCT04076059|365118066|FG001|Open Label Phase|Withdrawal by Subject|0|||
105852864|NCT04076059|365118067|FG002|Open Label Phase|Withdrawal by Subject|3|||
105852865|NCT04076059|365118065|FG000|Open Label Phase|Death|0|||
105852866|NCT04076059|365118066|FG001|Open Label Phase|Death|0|||
105852867|NCT04076059|365118067|FG002|Open Label Phase|Death|2|||
105852868|NCT04076059|365118065|FG000|Open Label Phase|Ongoing Participants|0|||
105852869|NCT04076059|365118066|FG001|Open Label Phase|Ongoing Participants|0|||
105852870|NCT04076059|365118067|FG002|Open Label Phase|Ongoing Participants|11|||
105852871|NCT06354998|365118068|FG000|Overall Study|Withdrawal by Subject|3|||
105852872|NCT06354998|365118069|FG001|Overall Study|Withdrawal by Subject|0|||
105852873|NCT03819049|365118070|FG000|Overall Study|Lost to Follow-up|1|||
105981721|NCT00528996|365594217|FG000|Overall Study|Protocol Violation|1|||
105981722|NCT00528996|365594218|FG001|Overall Study|Protocol Violation|2|||
105981723|NCT00528996|365594219|FG002|Overall Study|Protocol Violation|3|||
105981724|NCT00528996|365594220|FG003|Overall Study|Protocol Violation|3|||
105981725|NCT00528996|365594221|FG004|Overall Study|Protocol Violation|2|||
105981726|NCT00528996|365594217|FG000|Overall Study|Lack of Efficacy|7|||
105981727|NCT00528996|365594218|FG001|Overall Study|Lack of Efficacy|2|||
105981728|NCT00528996|365594219|FG002|Overall Study|Lack of Efficacy|1|||
105981729|NCT00528996|365594220|FG003|Overall Study|Lack of Efficacy|3|||
105981730|NCT00528996|365594221|FG004|Overall Study|Lack of Efficacy|3|||
105981731|NCT00528996|365594217|FG000|Overall Study|Adverse Event|32|||
105981732|NCT00528996|365594218|FG001|Overall Study|Adverse Event|13|||
105981733|NCT00528996|365594219|FG002|Overall Study|Adverse Event|18|||
105981734|NCT00528996|365594220|FG003|Overall Study|Adverse Event|29|||
105981735|NCT00528996|365594221|FG004|Overall Study|Adverse Event|18|||
105981736|NCT04544683|365594223|FG000|Overall Study|Lost to Follow-up|2|||
105981737|NCT04544683|365594223|FG000|Overall Study|Underwent cervical spine surgery|6|||
105981738|NCT01073930|365594224|FG000|Overall Study|Withdrawal by Subject|3|||
105981739|NCT01073930|365594225|FG001|Overall Study|Withdrawal by Subject|2|||
105981740|NCT01073930|365594224|FG000|Overall Study|Lost to Follow-up|0|||
105981741|NCT01073930|365594225|FG001|Overall Study|Lost to Follow-up|1|||
105852874|NCT03819049|365118071|FG001|Overall Study|Lost to Follow-up|2|||
105852875|NCT03819049|365118072|FG002|Overall Study|Lost to Follow-up|9|||
105852876|NCT03819049|365118073|FG003|Overall Study|Lost to Follow-up|0|||
105852877|NCT03819049|365118074|FG004|Overall Study|Lost to Follow-up|3|||
105981742|NCT01073930|365594224|FG000|Overall Study|Adverse Event|0|||
105981743|NCT01073930|365594225|FG001|Overall Study|Adverse Event|1|||
105981744|NCT01073930|365594224|FG000|Overall Study|Noncompliance with study drug|0|||
105852878|NCT03819049|365118075|FG005|Overall Study|Lost to Follow-up|1|||
105852879|NCT03819049|365118076|FG006|Overall Study|Lost to Follow-up|0|||
105981745|NCT01073930|365594225|FG001|Overall Study|Noncompliance with study drug|1|||
105981746|NCT01073930|365594224|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
105852880|NCT03819049|365118070|FG000|Overall Study|Withdrawal by Subject|0|||
105852881|NCT03819049|365118071|FG001|Overall Study|Withdrawal by Subject|0|||
105852882|NCT03819049|365118072|FG002|Overall Study|Withdrawal by Subject|18|||
105852883|NCT03819049|365118073|FG003|Overall Study|Withdrawal by Subject|0|||
105852884|NCT03819049|365118074|FG004|Overall Study|Withdrawal by Subject|10|||
105852885|NCT03819049|365118075|FG005|Overall Study|Withdrawal by Subject|9|||
105852886|NCT03819049|365118076|FG006|Overall Study|Withdrawal by Subject|1|||
105852887|NCT03819049|365118070|FG000|Overall Study|Ongoing|0|||
105852888|NCT03819049|365118071|FG001|Overall Study|Ongoing|0|||
105852889|NCT03819049|365118072|FG002|Overall Study|Ongoing|75|||
105852890|NCT03819049|365118073|FG003|Overall Study|Ongoing|0|||
105852891|NCT03819049|365118074|FG004|Overall Study|Ongoing|41|||
105852892|NCT03819049|365118075|FG005|Overall Study|Ongoing|0|||
105852893|NCT03819049|365118076|FG006|Overall Study|Ongoing|0|||
105852894|NCT03819049|365118070|FG000|Overall Study|Other|0|||
105852895|NCT03819049|365118071|FG001|Overall Study|Other|0|||
105852896|NCT03819049|365118072|FG002|Overall Study|Other|2|||
105852897|NCT03819049|365118073|FG003|Overall Study|Other|0|||
105852898|NCT03819049|365118074|FG004|Overall Study|Other|0|||
105852899|NCT03819049|365118075|FG005|Overall Study|Other|0|||
105852900|NCT03819049|365118076|FG006|Overall Study|Other|0|||
105852901|NCT03819049|365118070|FG000|Overall Study|Randomized but not vaccinated|0|||
105852902|NCT03819049|365118071|FG001|Overall Study|Randomized but not vaccinated|0|||
105852903|NCT03819049|365118072|FG002|Overall Study|Randomized but not vaccinated|0|||
105852904|NCT03819049|365118073|FG003|Overall Study|Randomized but not vaccinated|1|||
105852905|NCT03819049|365118074|FG004|Overall Study|Randomized but not vaccinated|0|||
105852906|NCT03819049|365118075|FG005|Overall Study|Randomized but not vaccinated|2|||
105852907|NCT03819049|365118076|FG006|Overall Study|Randomized but not vaccinated|1|||
105852908|NCT03819049|365118070|FG000|Overall Study|Physician Decision|0|||
105852909|NCT03819049|365118071|FG001|Overall Study|Physician Decision|0|||
105852910|NCT03819049|365118072|FG002|Overall Study|Physician Decision|0|||
105852911|NCT03819049|365118073|FG003|Overall Study|Physician Decision|0|||
105852912|NCT03819049|365118074|FG004|Overall Study|Physician Decision|0|||
105852913|NCT03819049|365118075|FG005|Overall Study|Physician Decision|0|||
105852914|NCT03819049|365118076|FG006|Overall Study|Physician Decision|1|||
105852915|NCT01103466|365118077|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
105852916|NCT01103466|365118078|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
105852917|NCT01103466|365118079|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
105852918|NCT01103466|365118077|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
105852919|NCT01103466|365118078|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
105852920|NCT01103466|365118079|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
105852921|NCT01103466|365118077|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
105852922|NCT01103466|365118078|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
105852923|NCT01103466|365118079|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
105852924|NCT01103466|365118077|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
105852925|NCT01103466|365118078|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
105852926|NCT01103466|365118079|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
105852927|NCT01103466|365118077|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
105852928|NCT01103466|365118078|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
105852929|NCT01103466|365118079|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
105852930|NCT01103466|365118077|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
105852931|NCT01103466|365118078|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
105852932|NCT01103466|365118079|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
105852933|NCT02987959|365118084|FG000|Overall Study|Grantor stopped supply of drugs|6|||
105852934|NCT00643565|365118086|FG000|Overall Study|Death|12|||
105852935|NCT00643565|365118087|FG001|Overall Study|Death|11|||
105852936|NCT00643565|365118086|FG000|Overall Study|Withdrawal by Subject|4|||
105852937|NCT00643565|365118087|FG001|Overall Study|Withdrawal by Subject|1|||
105852938|NCT00643565|365118086|FG000|Overall Study|Lost to Follow-up|0|||
105981747|NCT01073930|365594225|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
105981748|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
105852939|NCT00643565|365118087|FG001|Overall Study|Lost to Follow-up|6|||
105852940|NCT00643565|365118086|FG000|Overall Study|Other|7|||
105852941|NCT00643565|365118087|FG001|Overall Study|Other|8|||
105852942|NCT00643565|365118086|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
105852943|NCT00643565|365118087|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
105852944|NCT00643565|365118086|FG000|Overall Study|Recurrence of Disease|2|||
105981749|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
105981750|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
105981751|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
105981752|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
105981753|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
105981754|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
105981755|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
105852945|NCT00643565|365118087|FG001|Overall Study|Recurrence of Disease|1|||
105852946|NCT00643565|365118086|FG000|Overall Study|Progression of Disease|18|||
105852947|NCT00643565|365118087|FG001|Overall Study|Progression of Disease|14|||
106029332|NCT01604278|365772594|FG000|Overall Study|Lost to Follow-up|1|||
106029333|NCT01604278|365772595|FG001|Overall Study|Lost to Follow-up|0|||
106029334|NCT01604278|365772594|FG000|Overall Study|Administrative problems|2|||
105981756|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
105981757|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
105981758|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
105981759|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
105981760|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
105981761|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
105981762|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
105981763|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
105981764|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
105981765|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
105981766|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
105981767|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
105981768|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
105981769|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
105981770|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
105981771|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
105981772|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
105981773|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
105981774|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
105981775|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
105981776|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
105981777|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
105981778|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
105981779|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
105981780|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
105981781|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
105981782|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
105981783|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
105981784|NCT02198794|365594226|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
105981785|NCT02198794|365594227|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
105981786|NCT02198794|365594228|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
105981787|NCT02198794|365594229|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
105981788|NCT02198794|365594226|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
105981789|NCT02198794|365594227|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
105981790|NCT02198794|365594228|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
105981791|NCT02198794|365594229|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
105981792|NCT02198794|365594226|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
105981793|NCT02198794|365594227|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
105981794|NCT02198794|365594228|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
105981795|NCT02198794|365594229|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
105981796|NCT02198794|365594226|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
105981797|NCT02198794|365594227|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
105981798|NCT02198794|365594228|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
105981799|NCT02198794|365594229|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
105981800|NCT02198794|365594226|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
105981801|NCT02198794|365594227|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
105981802|NCT02198794|365594228|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
105981803|NCT02198794|365594229|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
105981804|NCT02198794|365594226|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
105981805|NCT02198794|365594227|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
105981806|NCT02198794|365594228|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
105981807|NCT02198794|365594229|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
105981808|NCT02408523|365594230|FG000|Overall Study|Adverse Event|4|||
105981809|NCT02408523|365594231|FG001|Overall Study|Adverse Event|10|||
105981810|NCT02408523|365594230|FG000|Overall Study|Lack of Efficacy|0|||
105981811|NCT02408523|365594231|FG001|Overall Study|Lack of Efficacy|1|||
105981812|NCT02408523|365594230|FG000|Overall Study|Protocol Violation|1|||
105981813|NCT02408523|365594231|FG001|Overall Study|Protocol Violation|2|||
105981814|NCT02408523|365594230|FG000|Overall Study|Lost to Follow-up|2|||
105981815|NCT02408523|365594231|FG001|Overall Study|Lost to Follow-up|3|||
105981816|NCT02408523|365594230|FG000|Overall Study|Withdrawal by Subject|3|||
105981817|NCT02408523|365594231|FG001|Overall Study|Withdrawal by Subject|1|||
105981818|NCT02408523|365594230|FG000|Overall Study|Sponsor request|1|||
105981819|NCT02408523|365594231|FG001|Overall Study|Sponsor request|0|||
105981820|NCT02408523|365594230|FG000|Overall Study|Did not satisfy extension conditions|0|||
105981821|NCT02408523|365594231|FG001|Overall Study|Did not satisfy extension conditions|1|||
105981822|NCT02943915|365594232|FG000|Overall Study|Withdrawal by Subject|2|||
105981823|NCT02943915|365594233|FG001|Overall Study|Withdrawal by Subject|1|||
105981824|NCT02943915|365594234|FG002|Overall Study|Withdrawal by Subject|0|||
105981825|NCT02943915|365594235|FG003|Overall Study|Withdrawal by Subject|0|||
105981826|NCT02943915|365594232|FG000|Overall Study|Lost to Follow-up|3|||
105981827|NCT02943915|365594233|FG001|Overall Study|Lost to Follow-up|1|||
105981828|NCT02943915|365594234|FG002|Overall Study|Lost to Follow-up|0|||
105981829|NCT02943915|365594235|FG003|Overall Study|Lost to Follow-up|0|||
106151397|NCT02723955|366215080|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151398|NCT02723955|366215081|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151399|NCT02723955|366215082|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151400|NCT02723955|366215083|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151401|NCT02723955|366215084|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151402|NCT02723955|366215085|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151403|NCT02723955|366215086|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151404|NCT02723955|366215087|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151405|NCT02723955|366215088|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151406|NCT02723955|366215089|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151407|NCT02723955|366215090|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151408|NCT02723955|366215091|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151409|NCT02723955|366215092|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151410|NCT02723955|366215093|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
106151411|NCT02723955|366215094|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151412|NCT02723955|366215095|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151413|NCT02723955|366215096|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
106151414|NCT02723955|366215054|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151415|NCT02723955|366215055|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151416|NCT02723955|366215056|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151417|NCT02723955|366215057|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151418|NCT02723955|366215058|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151419|NCT02723955|366215059|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151420|NCT02723955|366215060|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151421|NCT02723955|366215061|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151422|NCT02723955|366215062|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151423|NCT02723955|366215063|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151424|NCT02723955|366215064|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151425|NCT02723955|366215065|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151426|NCT02723955|366215066|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151427|NCT02723955|366215067|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151428|NCT02723955|366215068|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151429|NCT02723955|366215069|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151430|NCT02723955|366215070|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151431|NCT02723955|366215071|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151432|NCT02723955|366215072|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151433|NCT02723955|366215073|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
105852948|NCT00643565|365118086|FG000|Overall Study|Protocol Violation|3|||
105852949|NCT00643565|365118087|FG001|Overall Study|Protocol Violation|0|||
105852950|NCT00643565|365118086|FG000|Overall Study|Did Not Cooperate|0|||
105852951|NCT00643565|365118087|FG001|Overall Study|Did Not Cooperate|1|||
105852952|NCT00643565|365118086|FG000|Overall Study|Administrative|22|||
105852953|NCT00643565|365118087|FG001|Overall Study|Administrative|16|||
105852954|NCT00643565|365118086|FG000|Overall Study|Adverse Event|5|||
105852955|NCT00643565|365118087|FG001|Overall Study|Adverse Event|8|||
105852956|NCT00311402|365118089|FG000|Overall Study|Adverse Event|118|||
105852957|NCT00311402|365118090|FG001|Overall Study|Adverse Event|105|||
105852958|NCT00311402|365118089|FG000|Overall Study|Lost to Follow-up|0|||
105852959|NCT00311402|365118090|FG001|Overall Study|Lost to Follow-up|3|||
105852960|NCT00311402|365118089|FG000|Overall Study|Withdrawal by Subject|17|||
105852961|NCT00311402|365118090|FG001|Overall Study|Withdrawal by Subject|18|||
105852962|NCT00311402|365118089|FG000|Overall Study|Lack of Efficacy|58|||
105852963|NCT00311402|365118090|FG001|Overall Study|Lack of Efficacy|42|||
105852964|NCT00311402|365118089|FG000|Overall Study|Protocol Violation|7|||
105852965|NCT00311402|365118090|FG001|Overall Study|Protocol Violation|6|||
105852966|NCT00311402|365118089|FG000|Overall Study|IRB's rejection etc.|10|||
105852967|NCT00311402|365118090|FG001|Overall Study|IRB's rejection etc.|3|||
105852968|NCT03275064|365118095|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
105852969|NCT03275064|365118096|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
105852970|NCT03275064|365118097|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
105981830|NCT02943915|365594232|FG000|Overall Study|excluded|0|||
105981831|NCT02943915|365594233|FG001|Overall Study|excluded|1|||
106151434|NCT02723955|366215074|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151435|NCT02723955|366215075|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151436|NCT02723955|366215076|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
105852971|NCT03275064|365118098|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
105852972|NCT03275064|365118099|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
105852973|NCT03275064|365118095|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
105852974|NCT03275064|365118096|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
105852975|NCT03275064|365118097|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
105852976|NCT03275064|365118098|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
105852977|NCT03275064|365118099|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
105852978|NCT03275064|365118095|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
105852979|NCT03275064|365118096|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
105852980|NCT03275064|365118097|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
105852981|NCT03275064|365118098|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
105852982|NCT03275064|365118099|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
105852983|NCT03275064|365118095|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
105852984|NCT03275064|365118096|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
105852985|NCT03275064|365118097|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
105852986|NCT03275064|365118098|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
105852987|NCT03275064|365118099|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
105852988|NCT03275064|365118095|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
105852989|NCT03275064|365118096|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
105852990|NCT03275064|365118097|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
105852991|NCT03275064|365118098|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
105852992|NCT03275064|365118099|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
105852993|NCT04159935|365118100|FG000|Overall Study|Study terminated due to COVID-19|1|||
105852994|NCT04159935|365118101|FG001|Overall Study|Study terminated due to COVID-19|3|||
105852995|NCT02348723|365118102|FG000|Overall Study|No ablation|21|||
105852996|NCT02348723|365118103|FG001|Overall Study|No ablation|20|||
105852997|NCT02348723|365118102|FG000|Overall Study|Non-compliant with Protocol|1|||
105852998|NCT02348723|365118103|FG001|Overall Study|Non-compliant with Protocol|0|||
105852999|NCT02348723|365118102|FG000|Overall Study|Lost to Follow-up|1|||
105853000|NCT02348723|365118103|FG001|Overall Study|Lost to Follow-up|1|||
105853001|NCT02348723|365118102|FG000|Overall Study|Consent withdrawn|1|||
105853002|NCT02348723|365118103|FG001|Overall Study|Consent withdrawn|3|||
105853003|NCT02348723|365118102|FG000|Overall Study|Reason other than specified|1|||
105853004|NCT02348723|365118103|FG001|Overall Study|Reason other than specified|1|||
105853005|NCT02348723|365118102|FG000|Overall Study|Adverse Event|3|||
105853006|NCT02348723|365118103|FG001|Overall Study|Adverse Event|1|||
105853007|NCT00724048|365118104|FG000|Overall Study|Adverse Event|1|||
105853008|NCT00724048|365118105|FG001|Overall Study|Adverse Event|1|||
105853009|NCT00724048|365118106|FG002|Overall Study|Adverse Event|1|||
105853010|NCT00724048|365118107|FG003|Overall Study|Adverse Event|0|||
105853011|NCT00724048|365118104|FG000|Overall Study|Lost to Follow-up|0|||
105853012|NCT00724048|365118105|FG001|Overall Study|Lost to Follow-up|1|||
105853013|NCT00724048|365118106|FG002|Overall Study|Lost to Follow-up|0|||
105853014|NCT00724048|365118107|FG003|Overall Study|Lost to Follow-up|0|||
105853015|NCT00724048|365118104|FG000|Overall Study|Withdrawal by Subject|1|||
105853016|NCT00724048|365118105|FG001|Overall Study|Withdrawal by Subject|2|||
105853017|NCT00724048|365118106|FG002|Overall Study|Withdrawal by Subject|1|||
105853018|NCT00724048|365118107|FG003|Overall Study|Withdrawal by Subject|2|||
105853019|NCT00724048|365118104|FG000|Overall Study|Investigator decision|0|||
105853020|NCT00724048|365118105|FG001|Overall Study|Investigator decision|0|||
105853021|NCT00724048|365118106|FG002|Overall Study|Investigator decision|1|||
105853022|NCT00724048|365118107|FG003|Overall Study|Investigator decision|0|||
105853023|NCT00724048|365118104|FG000|Overall Study|Did not tolerate study drug|0|||
105853024|NCT00724048|365118105|FG001|Overall Study|Did not tolerate study drug|0|||
105853025|NCT00724048|365118106|FG002|Overall Study|Did not tolerate study drug|0|||
105853026|NCT00724048|365118107|FG003|Overall Study|Did not tolerate study drug|1|||
105853027|NCT00724048|365118104|FG000|Overall Study|Other than specified|1|||
105981832|NCT02943915|365594234|FG002|Overall Study|excluded|0|||
105981833|NCT02943915|365594235|FG003|Overall Study|excluded|0|||
105981834|NCT00701805|365594236|FG000|Overall Study|Withdrawal by Subject|3|||
105981835|NCT00701805|365594237|FG001|Overall Study|Withdrawal by Subject|1|||
105981836|NCT00701805|365594238|FG002|Overall Study|Withdrawal by Subject|4|||
105853028|NCT00724048|365118105|FG001|Overall Study|Other than specified|1|||
105853029|NCT00724048|365118106|FG002|Overall Study|Other than specified|0|||
105853030|NCT00724048|365118107|FG003|Overall Study|Other than specified|0|||
105853031|NCT00681590|365118108|FG000|Overall Study|Withdrawal by Subject|2|||
105853032|NCT00681590|365118109|FG001|Overall Study|Withdrawal by Subject|12|||
105981837|NCT00701805|365594239|FG003|Overall Study|Withdrawal by Subject|3|||
105981838|NCT00701805|365594236|FG000|Overall Study|Adverse Event|0|||
105981839|NCT00701805|365594237|FG001|Overall Study|Adverse Event|1|||
105853033|NCT02722148|365118122|FG000|Overall Study|Lost to Follow-up|2|||
105853034|NCT02722148|365118122|FG000|Overall Study|Non compliant with treatment regimen|3|||
105853035|NCT01946191|365118123|FG000|Allocation|Did not complete orientation|1|||
105853036|NCT01946191|365118124|FG001|Allocation|Did not complete orientation|1|||
105853037|NCT01946191|365118123|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
105853038|NCT01946191|365118124|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
105853039|NCT01946191|365118123|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
105853040|NCT01946191|365118124|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
105853041|NCT01946191|365118123|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
105853042|NCT01946191|365118124|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
105853043|NCT01629966|365118125|FG000|Overall Study|Pregnancy|0|||
105853044|NCT01629966|365118126|FG001|Overall Study|Pregnancy|1|||
105853045|NCT01629966|365118127|FG002|Overall Study|Pregnancy|0|||
105853046|NCT01629966|365118125|FG000|Overall Study|Lost to Follow-up|10|||
105853047|NCT01629966|365118126|FG001|Overall Study|Lost to Follow-up|13|||
105853048|NCT01629966|365118127|FG002|Overall Study|Lost to Follow-up|9|||
105853049|NCT01629966|365118125|FG000|Overall Study|Withdrawal by Subject|8|||
105853050|NCT01629966|365118126|FG001|Overall Study|Withdrawal by Subject|9|||
105853051|NCT01629966|365118127|FG002|Overall Study|Withdrawal by Subject|16|||
105853052|NCT01629966|365118125|FG000|Overall Study|Protocol Violation|7|||
105853053|NCT01629966|365118126|FG001|Overall Study|Protocol Violation|9|||
105853054|NCT01629966|365118127|FG002|Overall Study|Protocol Violation|7|||
106029335|NCT01604278|365772595|FG001|Overall Study|Administrative problems|1|||
106029336|NCT01604278|365772594|FG000|Overall Study|Withdrawal by Subject|3|||
106029337|NCT01604278|365772595|FG001|Overall Study|Withdrawal by Subject|3|||
106029338|NCT01604278|365772594|FG000|Overall Study|Adverse Event|3|||
106029339|NCT01604278|365772595|FG001|Overall Study|Adverse Event|5|||
106029340|NCT01604278|365772594|FG000|Overall Study|Protocol Deviation|5|||
106029341|NCT01604278|365772595|FG001|Overall Study|Protocol Deviation|3|||
106029342|NCT02184455|365772596|FG000|Overall Study|Lost to Follow-up|1|||
106029343|NCT00003472|365772597|FG000|Overall Study|Not evaluable|3|||
106029344|NCT01328366|365772600|FG000|Overall Study|Death|1|||
106029345|NCT01328366|365772600|FG000|Overall Study|Withdrawal by Subject|2|||
106029346|NCT01328366|365772600|FG000|Overall Study|Lost to Follow-up|7|||
106029347|NCT03565367|365772601|FG000|Overall Study|No scan due to technical issues|4|||
106029348|NCT03565367|365772602|FG001|Overall Study|No scan due to technical issues|0|||
106029349|NCT03005873|365772603|FG000|Overall Study|Prohibited medication use post radnomization|1|||
106029350|NCT03005873|365772604|FG001|Overall Study|Prohibited medication use post radnomization|1|||
106029351|NCT03005873|365772605|FG002|Overall Study|Prohibited medication use post radnomization|1|||
106029352|NCT03005873|365772603|FG000|Overall Study|Withdrew consent|0|||
106029353|NCT03005873|365772604|FG001|Overall Study|Withdrew consent|1|||
106029354|NCT03005873|365772605|FG002|Overall Study|Withdrew consent|2|||
106029355|NCT03005873|365772603|FG000|Overall Study|Lost to Follow-up|0|||
106029356|NCT03005873|365772604|FG001|Overall Study|Lost to Follow-up|1|||
106029357|NCT03005873|365772605|FG002|Overall Study|Lost to Follow-up|0|||
106029358|NCT03005873|365772603|FG000|Overall Study|Ineligible post randomization|0|||
106029359|NCT03005873|365772604|FG001|Overall Study|Ineligible post randomization|0|||
106029360|NCT03005873|365772605|FG002|Overall Study|Ineligible post randomization|1|||
106029361|NCT04585009|365772614|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
106029362|NCT04585009|365772615|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029363|NCT04585009|365772616|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029364|NCT04585009|365772617|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029365|NCT04585009|365772618|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029366|NCT04585009|365772619|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029367|NCT04585009|365772620|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029368|NCT04585009|365772621|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029369|NCT04585009|365772622|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029370|NCT04585009|365772623|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029371|NCT04585009|365772624|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029372|NCT04585009|365772625|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
106029373|NCT04585009|365772614|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
106029374|NCT04585009|365772615|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029375|NCT04585009|365772616|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029376|NCT04585009|365772617|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029377|NCT04585009|365772618|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029378|NCT04585009|365772619|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
105853055|NCT01629966|365118125|FG000|Overall Study|Lack of Efficacy|5|||
105853056|NCT01629966|365118126|FG001|Overall Study|Lack of Efficacy|2|||
105853057|NCT01629966|365118127|FG002|Overall Study|Lack of Efficacy|4|||
105853058|NCT01629966|365118125|FG000|Overall Study|Adverse Event|11|||
105853059|NCT01629966|365118126|FG001|Overall Study|Adverse Event|18|||
105853060|NCT01629966|365118127|FG002|Overall Study|Adverse Event|30|||
105853061|NCT01150890|365118128|FG000|Overall Study|Other|0|||
105853062|NCT01150890|365118129|FG001|Overall Study|Other|1|||
105853063|NCT01150890|365118130|FG002|Overall Study|Other|0|||
105853064|NCT01150890|365118131|FG003|Overall Study|Other|2|||
105853065|NCT01150890|365118128|FG000|Overall Study|Pregnancy|0|||
105853066|NCT01150890|365118129|FG001|Overall Study|Pregnancy|0|||
105853067|NCT01150890|365118130|FG002|Overall Study|Pregnancy|0|||
105853068|NCT01150890|365118131|FG003|Overall Study|Pregnancy|1|||
105853069|NCT01150890|365118128|FG000|Overall Study|Administrative Decision|4|||
105853070|NCT01150890|365118129|FG001|Overall Study|Administrative Decision|4|||
105853071|NCT01150890|365118130|FG002|Overall Study|Administrative Decision|5|||
105853072|NCT01150890|365118131|FG003|Overall Study|Administrative Decision|6|||
105853073|NCT01150890|365118128|FG000|Overall Study|Ineligibility determined|0|||
105853074|NCT01150890|365118129|FG001|Overall Study|Ineligibility determined|1|||
105853075|NCT01150890|365118130|FG002|Overall Study|Ineligibility determined|0|||
105853076|NCT01150890|365118131|FG003|Overall Study|Ineligibility determined|0|||
105853077|NCT01150890|365118128|FG000|Overall Study|Adverse Event|0|||
105853078|NCT01150890|365118129|FG001|Overall Study|Adverse Event|0|||
105853079|NCT01150890|365118130|FG002|Overall Study|Adverse Event|2|||
105853080|NCT01150890|365118131|FG003|Overall Study|Adverse Event|0|||
105853081|NCT01150890|365118128|FG000|Overall Study|Withdrawal by Subject|0|||
105853082|NCT01150890|365118129|FG001|Overall Study|Withdrawal by Subject|0|||
105853083|NCT01150890|365118130|FG002|Overall Study|Withdrawal by Subject|2|||
105853084|NCT01150890|365118131|FG003|Overall Study|Withdrawal by Subject|1|||
105853085|NCT01150890|365118128|FG000|Overall Study|Disease progression|0|||
105853086|NCT01150890|365118129|FG001|Overall Study|Disease progression|7|||
105853087|NCT01150890|365118130|FG002|Overall Study|Disease progression|3|||
105853088|NCT01150890|365118131|FG003|Overall Study|Disease progression|7|||
105853089|NCT04568031|365118134|FG000|Overall Study|Lost to Follow-up|1|||
105853090|NCT04568031|365118135|FG001|Overall Study|Lost to Follow-up|0|||
105853091|NCT04568031|365118136|FG002|Overall Study|Lost to Follow-up|0|||
105853092|NCT04568031|365118137|FG003|Overall Study|Lost to Follow-up|0|||
105853093|NCT04568031|365118134|FG000|Overall Study|Physician Decision|1|||
105853094|NCT04568031|365118135|FG001|Overall Study|Physician Decision|0|||
105853095|NCT04568031|365118136|FG002|Overall Study|Physician Decision|1|||
105853096|NCT04568031|365118137|FG003|Overall Study|Physician Decision|0|||
105853097|NCT04568031|365118134|FG000|Overall Study|Withdrawal by Subject|1|||
105853098|NCT04568031|365118135|FG001|Overall Study|Withdrawal by Subject|0|||
105981840|NCT00701805|365594238|FG002|Overall Study|Adverse Event|1|||
105981841|NCT00701805|365594239|FG003|Overall Study|Adverse Event|0|||
105981842|NCT00701805|365594236|FG000|Overall Study|Missed 7 consecutive doses|0|||
105981843|NCT00701805|365594237|FG001|Overall Study|Missed 7 consecutive doses|1|||
105981844|NCT00701805|365594238|FG002|Overall Study|Missed 7 consecutive doses|0|||
105981845|NCT00701805|365594239|FG003|Overall Study|Missed 7 consecutive doses|0|||
105981846|NCT00701805|365594236|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
105981847|NCT00701805|365594237|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
105981848|NCT00701805|365594238|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
105981849|NCT00701805|365594239|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
105981850|NCT00701805|365594236|FG000|Overall Study|Physician decision, change of therapy|0|||
106029379|NCT04585009|365772620|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029380|NCT04585009|365772621|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029381|NCT04585009|365772622|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029382|NCT04585009|365772623|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029383|NCT04585009|365772624|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029384|NCT04585009|365772625|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
106029385|NCT04585009|365772614|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029386|NCT04585009|365772615|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029387|NCT04585009|365772616|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029388|NCT04585009|365772617|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029389|NCT04585009|365772618|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029390|NCT04585009|365772619|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029391|NCT04585009|365772620|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105853099|NCT04568031|365118136|FG002|Overall Study|Withdrawal by Subject|4|||
105853100|NCT04568031|365118137|FG003|Overall Study|Withdrawal by Subject|1|||
105853101|NCT01425723|365118138|FG000|Overall Study|Lack of Efficacy|0|||
105853102|NCT01425723|365118139|FG001|Overall Study|Lack of Efficacy|1|||
105853103|NCT01425723|365118138|FG000|Overall Study|Withdrawal by Subject|1|||
105853104|NCT01425723|365118139|FG001|Overall Study|Withdrawal by Subject|4|||
105853105|NCT01425723|365118138|FG000|Overall Study|Lost to Follow-up|0|||
105853106|NCT01425723|365118139|FG001|Overall Study|Lost to Follow-up|3|||
105853107|NCT01425723|365118138|FG000|Overall Study|Physician Decision|2|||
105853108|NCT01425723|365118139|FG001|Overall Study|Physician Decision|0|||
105853109|NCT01425723|365118138|FG000|Overall Study|Other|1|||
105853110|NCT01425723|365118139|FG001|Overall Study|Other|10|||
105853111|NCT00186043|365118140|FG000|Overall Study|Lack of Efficacy|1|||
105853112|NCT00186043|365118141|FG001|Overall Study|Lack of Efficacy|3|||
105853113|NCT00186043|365118140|FG000|Overall Study|Lost to Follow-up|4|||
105853114|NCT00186043|365118141|FG001|Overall Study|Lost to Follow-up|6|||
105853115|NCT00186043|365118140|FG000|Overall Study|Withdrawal by Subject|1|||
105853116|NCT00186043|365118141|FG001|Overall Study|Withdrawal by Subject|0|||
105853117|NCT00186043|365118140|FG000|Overall Study|Adverse Event|7|||
105853118|NCT00186043|365118141|FG001|Overall Study|Adverse Event|3|||
105853119|NCT00186043|365118140|FG000|Overall Study|Protocol Violation|2|||
105853120|NCT00186043|365118141|FG001|Overall Study|Protocol Violation|1|||
105853121|NCT02312063|365118147|FG000|Overall Study|Withdrawal by Subject|0|||
105853122|NCT02312063|365118148|FG001|Overall Study|Withdrawal by Subject|1|||
105853123|NCT00228423|365118149|FG000|Overall Study|Adverse Event|2|||
105853124|NCT00228423|365118150|FG001|Overall Study|Adverse Event|5|||
105853125|NCT00228423|365118149|FG000|Overall Study|Withdrawal by Subject|7|||
105853126|NCT00228423|365118150|FG001|Overall Study|Withdrawal by Subject|3|||
105853127|NCT00228423|365118149|FG000|Overall Study|Protocol Violation|1|||
105853128|NCT00228423|365118150|FG001|Overall Study|Protocol Violation|3|||
105853129|NCT00228423|365118149|FG000|Overall Study|Physician Decision|0|||
105853130|NCT00228423|365118150|FG001|Overall Study|Physician Decision|1|||
105853131|NCT03258853|365118160|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
105853132|NCT03258853|365118161|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
105853133|NCT00620659|365118166|FG000|Treatment Period 1|Adverse Event|1|||
105853134|NCT00620659|365118167|FG001|Treatment Period 1|Adverse Event|0|||
105853135|NCT00620659|365118168|FG002|Treatment Period 1|Adverse Event|0|||
105853136|NCT00620659|365118169|FG003|Treatment Period 1|Adverse Event|3|||
105853137|NCT00620659|365118170|FG004|Treatment Period 1|Adverse Event|0|||
105853138|NCT00620659|365118171|FG005|Treatment Period 1|Adverse Event|0|||
105853139|NCT00620659|365118166|FG000|Treatment Period 1|Protocol Violation|1|||
105853140|NCT00620659|365118167|FG001|Treatment Period 1|Protocol Violation|0|||
105853141|NCT00620659|365118168|FG002|Treatment Period 1|Protocol Violation|0|||
105853142|NCT00620659|365118169|FG003|Treatment Period 1|Protocol Violation|0|||
105853143|NCT00620659|365118170|FG004|Treatment Period 1|Protocol Violation|0|||
105853144|NCT00620659|365118171|FG005|Treatment Period 1|Protocol Violation|0|||
105853145|NCT00620659|365118166|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105853146|NCT00620659|365118167|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105853147|NCT00620659|365118168|FG002|Treatment Period 1|Withdrawal by Subject|1|||
105853148|NCT00620659|365118169|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105853149|NCT00620659|365118170|FG004|Treatment Period 1|Withdrawal by Subject|1|||
105853150|NCT00620659|365118171|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105853151|NCT00620659|365118166|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853152|NCT00620659|365118167|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853153|NCT00620659|365118168|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853154|NCT00620659|365118169|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
105853155|NCT00620659|365118170|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853156|NCT00620659|365118171|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
105853157|NCT00620659|365118166|FG000|Treatment Period 2|Adverse Event|0|||
105853158|NCT00620659|365118167|FG001|Treatment Period 2|Adverse Event|3|||
105853159|NCT00620659|365118168|FG002|Treatment Period 2|Adverse Event|0|||
105853160|NCT00620659|365118169|FG003|Treatment Period 2|Adverse Event|0|||
105853161|NCT00620659|365118170|FG004|Treatment Period 2|Adverse Event|2|||
105853162|NCT00620659|365118171|FG005|Treatment Period 2|Adverse Event|0|||
105853163|NCT00620659|365118166|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105853164|NCT00620659|365118167|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105853165|NCT00620659|365118168|FG002|Treatment Period 2|Withdrawal by Subject|1|||
105853166|NCT00620659|365118169|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105853167|NCT00620659|365118170|FG004|Treatment Period 2|Withdrawal by Subject|3|||
106029392|NCT04585009|365772621|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
105853168|NCT00620659|365118171|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105853169|NCT00620659|365118166|FG000|Placebo Washout Period 2|Adverse Event|2|||
106029393|NCT04585009|365772622|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029394|NCT04585009|365772623|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
105853170|NCT00620659|365118167|FG001|Placebo Washout Period 2|Adverse Event|0|||
105853171|NCT00620659|365118168|FG002|Placebo Washout Period 2|Adverse Event|0|||
105853172|NCT00620659|365118169|FG003|Placebo Washout Period 2|Adverse Event|0|||
105853173|NCT00620659|365118170|FG004|Placebo Washout Period 2|Adverse Event|0|||
105853174|NCT00620659|365118171|FG005|Placebo Washout Period 2|Adverse Event|0|||
105853175|NCT00620659|365118166|FG000|Treatment Period 3|Adverse Event|0|||
105853176|NCT00620659|365118167|FG001|Treatment Period 3|Adverse Event|2|||
105853177|NCT00620659|365118168|FG002|Treatment Period 3|Adverse Event|0|||
105853178|NCT00620659|365118169|FG003|Treatment Period 3|Adverse Event|0|||
105853179|NCT00620659|365118170|FG004|Treatment Period 3|Adverse Event|0|||
105853180|NCT00620659|365118171|FG005|Treatment Period 3|Adverse Event|0|||
105853181|NCT00620659|365118166|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105853182|NCT00620659|365118167|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105853183|NCT00620659|365118168|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105853184|NCT00620659|365118169|FG003|Treatment Period 3|Withdrawal by Subject|1|||
105981851|NCT00701805|365594237|FG001|Overall Study|Physician decision, change of therapy|0|||
105981852|NCT00701805|365594238|FG002|Overall Study|Physician decision, change of therapy|0|||
105981853|NCT00701805|365594239|FG003|Overall Study|Physician decision, change of therapy|1|||
105981854|NCT00701805|365594236|FG000|Overall Study|Difficult to travel to dialysis site|0|||
105981855|NCT00701805|365594237|FG001|Overall Study|Difficult to travel to dialysis site|0|||
105981856|NCT00701805|365594238|FG002|Overall Study|Difficult to travel to dialysis site|1|||
105981857|NCT00701805|365594239|FG003|Overall Study|Difficult to travel to dialysis site|0|||
105981858|NCT00701805|365594236|FG000|Overall Study|Resumption criteria were not met|0|||
105981859|NCT00701805|365594237|FG001|Overall Study|Resumption criteria were not met|1|||
105981860|NCT00701805|365594238|FG002|Overall Study|Resumption criteria were not met|0|||
105981861|NCT00701805|365594239|FG003|Overall Study|Resumption criteria were not met|0|||
105981862|NCT02252965|365594243|FG000|Overall Study|Adverse Event|9|||
105981863|NCT02252965|365594244|FG001|Overall Study|Adverse Event|14|||
105981864|NCT02252965|365594243|FG000|Overall Study|Lost to Follow-up|16|||
105981865|NCT02252965|365594244|FG001|Overall Study|Lost to Follow-up|8|||
105981866|NCT02252965|365594243|FG000|Overall Study|Protocol Violation|4|||
105981867|NCT02252965|365594244|FG001|Overall Study|Protocol Violation|5|||
105981868|NCT02252965|365594243|FG000|Overall Study|Lack of Efficacy|0|||
105981869|NCT02252965|365594244|FG001|Overall Study|Lack of Efficacy|2|||
105981870|NCT02252965|365594243|FG000|Overall Study|Withdrawal by Subject|7|||
105981871|NCT02252965|365594244|FG001|Overall Study|Withdrawal by Subject|9|||
105981872|NCT02252965|365594243|FG000|Overall Study|Other|4|||
105981873|NCT02252965|365594244|FG001|Overall Study|Other|5|||
105981874|NCT02853435|365594245|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105981875|NCT02853435|365594246|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105981876|NCT02853435|365594247|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105981877|NCT02853435|365594248|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105981878|NCT02853435|365594249|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
105981879|NCT02853435|365594250|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
105981880|NCT04279613|365594258|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
105981881|NCT04279613|365594259|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
105981882|NCT04279613|365594260|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
105981883|NCT04279613|365594261|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
105981884|NCT04279613|365594262|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
105981885|NCT04279613|365594258|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
105981886|NCT04279613|365594259|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
105981887|NCT04279613|365594260|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
105981888|NCT04279613|365594261|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
105981889|NCT04279613|365594262|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
105981890|NCT04279613|365594258|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
105981891|NCT04279613|365594259|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
105981892|NCT04279613|365594260|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
105981893|NCT04279613|365594261|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
105981894|NCT04279613|365594262|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
105981895|NCT04279613|365594258|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
105981896|NCT04279613|365594259|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
105981897|NCT04279613|365594260|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
105981898|NCT04279613|365594261|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
105981899|NCT04279613|365594262|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
105981900|NCT04279613|365594258|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
105981901|NCT04279613|365594259|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
105981902|NCT04279613|365594260|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
105981903|NCT04279613|365594261|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
105981904|NCT04279613|365594262|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
105981905|NCT00527319|365594265|FG000|Overall Study|Withdrawal by Subject|5|||
105981906|NCT00527319|365594266|FG001|Overall Study|Withdrawal by Subject|0|||
105981907|NCT00527319|365594267|FG002|Overall Study|Withdrawal by Subject|1|||
105981908|NCT00527319|365594265|FG000|Overall Study|Lost to Follow-up|1|||
105981909|NCT00527319|365594266|FG001|Overall Study|Lost to Follow-up|0|||
105981910|NCT00527319|365594267|FG002|Overall Study|Lost to Follow-up|0|||
105981911|NCT00527319|365594265|FG000|Overall Study|Death|0|||
105981912|NCT00527319|365594266|FG001|Overall Study|Death|3|||
105981913|NCT00527319|365594267|FG002|Overall Study|Death|1|||
105981914|NCT00527319|365594265|FG000|Overall Study|Intercurrent Medical Illness|0|||
105981915|NCT00527319|365594266|FG001|Overall Study|Intercurrent Medical Illness|1|||
105981916|NCT00527319|365594267|FG002|Overall Study|Intercurrent Medical Illness|3|||
105981917|NCT00527319|365594265|FG000|Overall Study|Adverse Event|0|||
105981918|NCT00527319|365594266|FG001|Overall Study|Adverse Event|0|||
105981919|NCT00527319|365594267|FG002|Overall Study|Adverse Event|1|||
105981920|NCT02981524|365594274|FG000|Overall Study|Progressive Disease|14|||
105981921|NCT02981524|365594274|FG000|Overall Study|Death (unrelated)|1|||
105981922|NCT02981524|365594274|FG000|Overall Study|Treatment Related Toxicity|1|||
105981923|NCT02981524|365594274|FG000|Overall Study|Withdrawal by Subject|1|||
105853185|NCT00620659|365118170|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105853186|NCT00620659|365118171|FG005|Treatment Period 3|Withdrawal by Subject|0|||
105853187|NCT02352779|365118174|FG000|Overall Study|Personal Issues|1|||
105853188|NCT02352779|365118175|FG001|Overall Study|Personal Issues|1|||
105853189|NCT02352779|365118176|FG002|Overall Study|Personal Issues|0|||
105853190|NCT02352779|365118174|FG000|Overall Study|Too Many Forms|2|||
105853191|NCT02352779|365118175|FG001|Overall Study|Too Many Forms|0|||
105853192|NCT02352779|365118176|FG002|Overall Study|Too Many Forms|0|||
105853193|NCT02352779|365118174|FG000|Overall Study|Feeling Overwhelmed|1|||
105853194|NCT02352779|365118175|FG001|Overall Study|Feeling Overwhelmed|0|||
105853195|NCT02352779|365118176|FG002|Overall Study|Feeling Overwhelmed|0|||
105853196|NCT02352779|365118174|FG000|Overall Study|Disliked Intervention|1|||
105853197|NCT02352779|365118175|FG001|Overall Study|Disliked Intervention|0|||
105853198|NCT02352779|365118176|FG002|Overall Study|Disliked Intervention|0|||
105853199|NCT02352779|365118174|FG000|Overall Study|Changed Mind|1|||
105853200|NCT02352779|365118175|FG001|Overall Study|Changed Mind|0|||
105853201|NCT02352779|365118176|FG002|Overall Study|Changed Mind|0|||
105853202|NCT02352779|365118174|FG000|Overall Study|Study Related Symptoms|1|||
105853203|NCT02352779|365118175|FG001|Overall Study|Study Related Symptoms|0|||
105853204|NCT02352779|365118176|FG002|Overall Study|Study Related Symptoms|0|||
105853205|NCT02352779|365118174|FG000|Overall Study|Absence of Symptoms|1|||
105853206|NCT02352779|365118175|FG001|Overall Study|Absence of Symptoms|0|||
105853207|NCT02352779|365118176|FG002|Overall Study|Absence of Symptoms|0|||
105853208|NCT02352779|365118174|FG000|Overall Study|Other Medical Reason|0|||
105853209|NCT02352779|365118175|FG001|Overall Study|Other Medical Reason|0|||
105853210|NCT02352779|365118176|FG002|Overall Study|Other Medical Reason|1|||
105853211|NCT02352779|365118174|FG000|Overall Study|No Reason|0|||
105853212|NCT02352779|365118175|FG001|Overall Study|No Reason|0|||
105853213|NCT02352779|365118176|FG002|Overall Study|No Reason|1|||
105853214|NCT01104779|365118181|FG000|Overall Study|Protocol Violation|1|||
105853215|NCT01104779|365118182|FG001|Overall Study|Protocol Violation|2|||
105853216|NCT01104779|365118183|FG002|Overall Study|Protocol Violation|2|||
105853217|NCT01104779|365118181|FG000|Overall Study|Lack of Efficacy|26|||
105853218|NCT01104779|365118182|FG001|Overall Study|Lack of Efficacy|12|||
105853219|NCT01104779|365118183|FG002|Overall Study|Lack of Efficacy|13|||
105853220|NCT01104779|365118181|FG000|Overall Study|Adverse Event|13|||
105853221|NCT01104779|365118182|FG001|Overall Study|Adverse Event|14|||
105853222|NCT01104779|365118183|FG002|Overall Study|Adverse Event|13|||
105853223|NCT01104779|365118181|FG000|Overall Study|Did not meet inc/exc criteria|1|||
105853224|NCT01104779|365118182|FG001|Overall Study|Did not meet inc/exc criteria|1|||
105853225|NCT01104779|365118183|FG002|Overall Study|Did not meet inc/exc criteria|1|||
105853226|NCT01104779|365118181|FG000|Overall Study|Other reasons|0|||
105853227|NCT01104779|365118182|FG001|Overall Study|Other reasons|1|||
105853228|NCT01104779|365118183|FG002|Overall Study|Other reasons|0|||
105853229|NCT01104779|365118181|FG000|Overall Study|Lost to Follow-up|2|||
105853230|NCT01104779|365118182|FG001|Overall Study|Lost to Follow-up|0|||
105853231|NCT01104779|365118183|FG002|Overall Study|Lost to Follow-up|1|||
105853232|NCT01104779|365118181|FG000|Overall Study|Withdrawal by Subject|16|||
105853233|NCT01104779|365118182|FG001|Overall Study|Withdrawal by Subject|25|||
105853234|NCT01104779|365118183|FG002|Overall Study|Withdrawal by Subject|32|||
105853235|NCT02968849|365118184|FG000|Overall Study|Death|8|||
105853236|NCT02968849|365118185|FG001|Overall Study|Death|10|||
105853237|NCT02968849|365118184|FG000|Overall Study|Lost to Follow-up|31|||
105853238|NCT02968849|365118185|FG001|Overall Study|Lost to Follow-up|29|||
105853239|NCT02968849|365118184|FG000|Overall Study|Withdrawal by Subject|73|||
105853240|NCT02968849|365118185|FG001|Overall Study|Withdrawal by Subject|64|||
105853241|NCT02968849|365118184|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
105853242|NCT02968849|365118185|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
105853243|NCT02968849|365118184|FG000|Overall Study|Physician Decision|6|||
105853244|NCT02968849|365118185|FG001|Overall Study|Physician Decision|9|||
105853245|NCT02968849|365118184|FG000|Overall Study|Other|16|||
105853246|NCT02968849|365118185|FG001|Overall Study|Other|10|||
105853247|NCT02201290|365118186|FG000|Overall Study|Withdrawal by Subject|2|||
105853248|NCT02201290|365118186|FG000|Overall Study|Lack of Efficacy|2|||
105853249|NCT02201290|365118186|FG000|Overall Study|Adverse Event|1|||
105853250|NCT00871741|365118187|FG000|Overall Study|Premature study termination|9|||
105853251|NCT00871741|365118188|FG001|Overall Study|Premature study termination|7|||
105853252|NCT01565850|365118193|FG000|Overall Study|Adverse Event|0|||
105853253|NCT01565850|365118194|FG001|Overall Study|Adverse Event|1|||
105853254|NCT01565850|365118193|FG000|Overall Study|Lost to Follow-up|12|||
105853255|NCT01565850|365118194|FG001|Overall Study|Lost to Follow-up|4|||
105853256|NCT01565850|365118193|FG000|Overall Study|Investigator's Discretion|2|||
105853257|NCT01565850|365118194|FG001|Overall Study|Investigator's Discretion|1|||
105853258|NCT01565850|365118193|FG000|Overall Study|Participant noncompliance|2|||
105853259|NCT01565850|365118194|FG001|Overall Study|Participant noncompliance|0|||
105853260|NCT01565850|365118193|FG000|Overall Study|Withdrew Consent|4|||
105853261|NCT01565850|365118194|FG001|Overall Study|Withdrew Consent|2|||
105853262|NCT00704730|365118195|FG000|Overall Study|Adverse Event|35|||
105853263|NCT00704730|365118196|FG001|Overall Study|Adverse Event|9|||
106029395|NCT04585009|365772624|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029396|NCT04585009|365772625|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
106029397|NCT04585009|365772614|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029398|NCT04585009|365772615|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029399|NCT04585009|365772616|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029400|NCT04585009|365772617|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029401|NCT04585009|365772618|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
106029402|NCT04585009|365772619|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029403|NCT04585009|365772620|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029404|NCT04585009|365772621|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029405|NCT04585009|365772622|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029406|NCT04585009|365772623|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029407|NCT04585009|365772624|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029408|NCT04585009|365772625|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
106029409|NCT04585009|365772614|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029410|NCT04585009|365772615|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029411|NCT04585009|365772616|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029412|NCT04585009|365772617|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029413|NCT04585009|365772618|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029414|NCT04585009|365772619|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029415|NCT04585009|365772620|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029416|NCT04585009|365772621|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106151437|NCT02723955|366215077|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151438|NCT02723955|366215078|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151439|NCT02723955|366215079|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151440|NCT02723955|366215080|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
105981924|NCT00483041|365594276|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
105981925|NCT00483041|365594277|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
105981926|NCT00443781|365594278|FG000|Overall Study|Lost to Follow-up|10|||
105981927|NCT00443781|365594278|FG000|Overall Study|Physician Decision|2|||
105981928|NCT00443781|365594278|FG000|Overall Study|Protocol Violation|1|||
105981929|NCT00443781|365594278|FG000|Overall Study|Withdrawal by Subject|6|||
105981930|NCT00443781|365594278|FG000|Overall Study|Unable to comply with study follow up|2|||
105981931|NCT00443781|365594278|FG000|Overall Study|Investigator terminated participation|1|||
105981932|NCT00443781|365594278|FG000|Overall Study|Insurance not covered|2|||
105981933|NCT00443781|365594278|FG000|Overall Study|PD/FAD not done|1|||
105981934|NCT00430937|365594279|FG000|Overall Study|Adverse Event|3|||
105981935|NCT00430937|365594280|FG001|Overall Study|Adverse Event|8|||
105981936|NCT00430937|365594279|FG000|Overall Study|Death|0|||
105981937|NCT00430937|365594280|FG001|Overall Study|Death|1|||
105981938|NCT00430937|365594279|FG000|Overall Study|Lost to Follow-up|6|||
105981939|NCT00430937|365594280|FG001|Overall Study|Lost to Follow-up|6|||
105981940|NCT00430937|365594279|FG000|Overall Study|Withdrawal by Subject|5|||
105981941|NCT00430937|365594280|FG001|Overall Study|Withdrawal by Subject|2|||
105981942|NCT00430937|365594279|FG000|Overall Study|Protocol Violation|3|||
105981943|NCT00430937|365594280|FG001|Overall Study|Protocol Violation|2|||
105981944|NCT00430937|365594279|FG000|Overall Study|Lack of Efficacy|6|||
105981945|NCT00430937|365594280|FG001|Overall Study|Lack of Efficacy|5|||
105853264|NCT00704730|365118195|FG000|Overall Study|Death|11|||
105853265|NCT00704730|365118196|FG001|Overall Study|Death|5|||
105853266|NCT00704730|365118195|FG000|Overall Study|Physician Decision|2|||
105853267|NCT00704730|365118196|FG001|Overall Study|Physician Decision|0|||
105853268|NCT00704730|365118195|FG000|Overall Study|Did not receive drug|5|||
105853269|NCT00704730|365118196|FG001|Overall Study|Did not receive drug|2|||
105853270|NCT00704730|365118195|FG000|Overall Study|Disease progression per PI|58|||
105853271|NCT00704730|365118196|FG001|Overall Study|Disease progression per PI|67|||
105853272|NCT00704730|365118195|FG000|Overall Study|data unavailable|1|||
105853273|NCT00704730|365118196|FG001|Overall Study|data unavailable|0|||
105981946|NCT00430937|365594279|FG000|Overall Study|Inappropriate enrollment|2|||
105981947|NCT00430937|365594280|FG001|Overall Study|Inappropriate enrollment|1|||
105981948|NCT00430937|365594279|FG000|Overall Study|Administrative reasons|1|||
105853274|NCT00704730|365118195|FG000|Overall Study|Withdrawal by Subject|9|||
105853275|NCT00704730|365118196|FG001|Overall Study|Withdrawal by Subject|13|||
105853276|NCT02551666|365118197|FG000|Overall Study|Withdrawal by Subject|1|||
105853277|NCT02551666|365118198|FG001|Overall Study|Withdrawal by Subject|3|||
105981949|NCT00430937|365594280|FG001|Overall Study|Administrative reasons|0|||
105981950|NCT00430937|365594279|FG000|Overall Study|Protocol discontinuation criteria met|1|||
105981951|NCT00430937|365594280|FG001|Overall Study|Protocol discontinuation criteria met|2|||
105981952|NCT00430937|365594279|FG000|Overall Study|Unable to classify|0|||
105981953|NCT00430937|365594280|FG001|Overall Study|Unable to classify|1|||
105981954|NCT01116427|365594281|FG000|Core Phase|Adverse Event|0|||
105981955|NCT01116427|365594282|FG001|Core Phase|Adverse Event|1|||
105981956|NCT01116427|365594281|FG000|Core Phase|Lost to Follow-up|1|||
105981957|NCT01116427|365594282|FG001|Core Phase|Lost to Follow-up|0|||
105981958|NCT01116427|365594281|FG000|Core Phase|Withdrawal by Subject|3|||
105981959|NCT01116427|365594282|FG001|Core Phase|Withdrawal by Subject|0|||
105981960|NCT01116427|365594281|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
105981961|NCT01116427|365594282|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
105981962|NCT01116427|365594281|FG000|Extension Phase|Adverse Event|1|||
105981963|NCT01116427|365594282|FG001|Extension Phase|Adverse Event|1|||
105981964|NCT01116427|365594281|FG000|Extension Phase|Lost to Follow-up|2|||
105981965|NCT01116427|365594282|FG001|Extension Phase|Lost to Follow-up|0|||
105981966|NCT01116427|365594281|FG000|Extension Phase|Withdrawal by Subject|5|||
105981967|NCT01116427|365594282|FG001|Extension Phase|Withdrawal by Subject|1|||
105981968|NCT01116427|365594281|FG000|Extension Phase|Not using appropriate birth control|1|||
105981969|NCT01116427|365594282|FG001|Extension Phase|Not using appropriate birth control|0|||
105981970|NCT02771626|365594283|FG000|Overall Study|Adverse Event|1|||
105981971|NCT02771626|365594284|FG001|Overall Study|Adverse Event|5|||
105981972|NCT02771626|365594285|FG002|Overall Study|Adverse Event|3|||
105981973|NCT02771626|365594286|FG003|Overall Study|Adverse Event|0|||
105981974|NCT02771626|365594287|FG004|Overall Study|Adverse Event|1|||
105981975|NCT02771626|365594288|FG005|Overall Study|Adverse Event|1|||
105981976|NCT02771626|365594283|FG000|Overall Study|Radiologic Disease Progression|6|||
105981977|NCT02771626|365594284|FG001|Overall Study|Radiologic Disease Progression|13|||
105981978|NCT02771626|365594285|FG002|Overall Study|Radiologic Disease Progression|10|||
105981979|NCT02771626|365594286|FG003|Overall Study|Radiologic Disease Progression|7|||
106151441|NCT02723955|366215081|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151442|NCT02723955|366215082|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151443|NCT02723955|366215083|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151444|NCT02723955|366215084|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151445|NCT02723955|366215085|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151446|NCT02723955|366215086|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151447|NCT02723955|366215087|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151448|NCT02723955|366215088|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151449|NCT02723955|366215089|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151450|NCT02723955|366215090|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151451|NCT02723955|366215091|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151452|NCT02723955|366215092|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
106151453|NCT02723955|366215093|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
106151454|NCT02723955|366215094|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151455|NCT02723955|366215095|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
106151456|NCT02723955|366215096|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
106151457|NCT02723955|366215054|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
106151458|NCT02723955|366215055|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
106151459|NCT02723955|366215056|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
106151460|NCT02723955|366215057|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
106151461|NCT02723955|366215058|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
106151462|NCT02723955|366215059|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
106151463|NCT02723955|366215060|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
106151464|NCT02723955|366215061|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
106151465|NCT02723955|366215062|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
106151466|NCT02723955|366215063|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
106151467|NCT02723955|366215064|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
106151468|NCT02723955|366215065|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
105981980|NCT02771626|365594287|FG004|Overall Study|Radiologic Disease Progression|28|||
105981981|NCT02771626|365594288|FG005|Overall Study|Radiologic Disease Progression|15|||
105981982|NCT02771626|365594283|FG000|Overall Study|Symptomatic Deterioration|0|||
106151469|NCT02723955|366215066|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
106151470|NCT02723955|366215067|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
106151471|NCT02723955|366215068|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
106151472|NCT02723955|366215069|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
106029417|NCT04585009|365772622|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029418|NCT04585009|365772623|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
106029419|NCT04585009|365772624|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029420|NCT04585009|365772625|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
106029421|NCT04585009|365772614|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029422|NCT04585009|365772615|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029423|NCT04585009|365772616|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029424|NCT04585009|365772617|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029425|NCT04585009|365772618|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029426|NCT04585009|365772619|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029427|NCT04585009|365772620|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029428|NCT04585009|365772621|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029429|NCT04585009|365772622|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029430|NCT04585009|365772623|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029431|NCT04585009|365772624|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
106029432|NCT04585009|365772625|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
106029433|NCT00097981|365772626|FG000|Overall Study|Adverse Event|31|||
106029434|NCT00097981|365772627|FG001|Overall Study|Adverse Event|44|||
106029435|NCT00097981|365772626|FG000|Overall Study|Withdrawal by Subject|10|||
106029436|NCT00097981|365772627|FG001|Overall Study|Withdrawal by Subject|8|||
106029437|NCT00097981|365772626|FG000|Overall Study|Protocol Violation|1|||
106029438|NCT00097981|365772627|FG001|Overall Study|Protocol Violation|1|||
106029439|NCT00097981|365772626|FG000|Overall Study|Death|2|||
106029440|NCT00097981|365772627|FG001|Overall Study|Death|4|||
106029441|NCT00097981|365772626|FG000|Overall Study|Physician Decision|7|||
106029442|NCT00097981|365772627|FG001|Overall Study|Physician Decision|1|||
106029443|NCT00097981|365772626|FG000|Overall Study|Disease Progression|8|||
106029444|NCT00097981|365772627|FG001|Overall Study|Disease Progression|2|||
106029445|NCT00097981|365772626|FG000|Overall Study|Transplant planned|28|||
106029446|NCT00097981|365772627|FG001|Overall Study|Transplant planned|27|||
106029447|NCT00097981|365772626|FG000|Overall Study|Other|19|||
106029448|NCT00097981|365772627|FG001|Overall Study|Other|13|||
106029449|NCT04140227|365772628|FG000|Overall Study|Withdrawal by Subject|26|||
106029450|NCT04140227|365772628|FG000|Overall Study|Lost to Follow-up|8|||
106029451|NCT04140227|365772628|FG000|Overall Study|Adverse Event|8|||
106029452|NCT04140227|365772628|FG000|Overall Study|Death|1|||
106029453|NCT04140227|365772628|FG000|Overall Study|Other|3|||
106029454|NCT04140227|365772628|FG000|Overall Study|Protocol Violation|2|||
106029455|NCT01713933|365772629|FG000|Overall Study|Lost to Follow-up|2|||
106029456|NCT01713933|365772629|FG000|Overall Study|Withdrawal by Subject|3|||
106029457|NCT01713933|365772629|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
106029458|NCT00528970|365772630|FG000|Overall Study|Adverse Event|6|||
106029459|NCT00528970|365772631|FG001|Overall Study|Adverse Event|8|||
106029460|NCT00528970|365772632|FG002|Overall Study|Adverse Event|5|||
106029461|NCT00528970|365772630|FG000|Overall Study|Lost to Follow-up|0|||
106029462|NCT00528970|365772631|FG001|Overall Study|Lost to Follow-up|0|||
106029463|NCT00528970|365772632|FG002|Overall Study|Lost to Follow-up|1|||
106029464|NCT00528970|365772630|FG000|Overall Study|Other than specified|2|||
106029465|NCT00528970|365772631|FG001|Overall Study|Other than specified|3|||
106029466|NCT00528970|365772632|FG002|Overall Study|Other than specified|3|||
106029467|NCT00528970|365772630|FG000|Overall Study|Protocol Violation|2|||
106029468|NCT00528970|365772631|FG001|Overall Study|Protocol Violation|1|||
106029469|NCT00528970|365772632|FG002|Overall Study|Protocol Violation|4|||
106029470|NCT00528970|365772630|FG000|Overall Study|Lack of Efficacy|0|||
106029471|NCT00528970|365772631|FG001|Overall Study|Lack of Efficacy|0|||
106029472|NCT00528970|365772632|FG002|Overall Study|Lack of Efficacy|1|||
106029473|NCT00528970|365772630|FG000|Overall Study|Withdrawal by Subject|4|||
106029474|NCT00528970|365772631|FG001|Overall Study|Withdrawal by Subject|3|||
106029475|NCT00528970|365772632|FG002|Overall Study|Withdrawal by Subject|5|||
106029476|NCT00528970|365772630|FG000|Overall Study|Randomized but not treated|0|||
106029477|NCT00528970|365772631|FG001|Overall Study|Randomized but not treated|0|||
106029478|NCT00528970|365772632|FG002|Overall Study|Randomized but not treated|1|||
106029479|NCT00538785|365772633|FG000|Overall Study|Death|9|||
106029480|NCT00538785|365772634|FG001|Overall Study|Death|10|||
106029481|NCT00538785|365772633|FG000|Overall Study|Withdrawal of consent|9|||
106029482|NCT00538785|365772634|FG001|Overall Study|Withdrawal of consent|7|||
106029483|NCT00538785|365772633|FG000|Overall Study|Lost to Follow-up|1|||
106029484|NCT00538785|365772634|FG001|Overall Study|Lost to Follow-up|0|||
106029485|NCT01009840|365772635|FG000|Overall Study|Lost to Follow-up|1|||
106151473|NCT02723955|366215070|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
106151474|NCT02723955|366215071|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
106151475|NCT02723955|366215072|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
106151476|NCT02723955|366215073|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
106151477|NCT02723955|366215074|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
106151478|NCT02723955|366215075|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
106151479|NCT02723955|366215076|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
106151480|NCT02723955|366215077|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
106151481|NCT02723955|366215078|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
106029486|NCT01009840|365772635|FG000|Overall Study|Adverse Event|4|||
106029487|NCT01009840|365772635|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
106151482|NCT02723955|366215079|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
106029488|NCT01009840|365772635|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
106029489|NCT01009840|365772635|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
106029490|NCT04022733|365772636|FG000|Overall Study|conversion to open surgery|3|||
106029491|NCT04022733|365772637|FG001|Overall Study|conversion to open surgery|2|||
106029492|NCT04022733|365772636|FG000|Overall Study|bradycardia|0|||
106029493|NCT04022733|365772637|FG001|Overall Study|bradycardia|1|||
105981983|NCT02771626|365594284|FG001|Overall Study|Symptomatic Deterioration|4|||
105981984|NCT02771626|365594285|FG002|Overall Study|Symptomatic Deterioration|2|||
105981985|NCT02771626|365594286|FG003|Overall Study|Symptomatic Deterioration|0|||
105981986|NCT02771626|365594287|FG004|Overall Study|Symptomatic Deterioration|5|||
105981987|NCT02771626|365594288|FG005|Overall Study|Symptomatic Deterioration|2|||
105981988|NCT02771626|365594283|FG000|Overall Study|Participant Request|0|||
105981989|NCT02771626|365594284|FG001|Overall Study|Participant Request|1|||
105981990|NCT02771626|365594285|FG002|Overall Study|Participant Request|0|||
105981991|NCT02771626|365594286|FG003|Overall Study|Participant Request|2|||
105981992|NCT02771626|365594287|FG004|Overall Study|Participant Request|0|||
105981993|NCT02771626|365594288|FG005|Overall Study|Participant Request|1|||
105981994|NCT02771626|365594283|FG000|Overall Study|Investigator Decision|0|||
105981995|NCT02771626|365594284|FG001|Overall Study|Investigator Decision|1|||
105981996|NCT02771626|365594285|FG002|Overall Study|Investigator Decision|0|||
105981997|NCT02771626|365594286|FG003|Overall Study|Investigator Decision|0|||
105981998|NCT02771626|365594287|FG004|Overall Study|Investigator Decision|1|||
105981999|NCT02771626|365594288|FG005|Overall Study|Investigator Decision|0|||
105982000|NCT02771626|365594283|FG000|Overall Study|Study Termination by Sponsor|0|||
105982001|NCT02771626|365594284|FG001|Overall Study|Study Termination by Sponsor|2|||
105982002|NCT02771626|365594285|FG002|Overall Study|Study Termination by Sponsor|1|||
105982003|NCT02771626|365594286|FG003|Overall Study|Study Termination by Sponsor|0|||
105982004|NCT02771626|365594287|FG004|Overall Study|Study Termination by Sponsor|1|||
105982005|NCT02771626|365594288|FG005|Overall Study|Study Termination by Sponsor|0|||
105982006|NCT02771626|365594283|FG000|Overall Study|Informed Consent Withdrawn|0|||
105982007|NCT02771626|365594284|FG001|Overall Study|Informed Consent Withdrawn|0|||
105982008|NCT02771626|365594285|FG002|Overall Study|Informed Consent Withdrawn|1|||
105982009|NCT02771626|365594286|FG003|Overall Study|Informed Consent Withdrawn|0|||
105982010|NCT02771626|365594287|FG004|Overall Study|Informed Consent Withdrawn|1|||
105982011|NCT02771626|365594288|FG005|Overall Study|Informed Consent Withdrawn|1|||
105982012|NCT02771626|365594283|FG000|Overall Study|Other, Not Specified|1|||
105982013|NCT02771626|365594284|FG001|Overall Study|Other, Not Specified|0|||
105982014|NCT02771626|365594285|FG002|Overall Study|Other, Not Specified|0|||
105982015|NCT02771626|365594286|FG003|Overall Study|Other, Not Specified|0|||
105982016|NCT02771626|365594287|FG004|Overall Study|Other, Not Specified|0|||
105982017|NCT02771626|365594288|FG005|Overall Study|Other, Not Specified|1|||
105982018|NCT00364533|365594293|FG000|Overall Study|Adverse Event|8|||
105982019|NCT00364533|365594294|FG001|Overall Study|Adverse Event|7|||
105982020|NCT00364533|365594295|FG002|Overall Study|Adverse Event|15|||
105982021|NCT00364533|365594296|FG003|Overall Study|Adverse Event|5|||
105982022|NCT00364533|365594297|FG004|Overall Study|Adverse Event|2|||
105982023|NCT00364533|365594293|FG000|Overall Study|Withdrawal by Subject|4|||
105982024|NCT00364533|365594294|FG001|Overall Study|Withdrawal by Subject|8|||
105982025|NCT00364533|365594295|FG002|Overall Study|Withdrawal by Subject|6|||
105982026|NCT00364533|365594296|FG003|Overall Study|Withdrawal by Subject|6|||
105982027|NCT00364533|365594297|FG004|Overall Study|Withdrawal by Subject|6|||
105982028|NCT00364533|365594293|FG000|Overall Study|Lack of Efficacy|22|||
105982029|NCT00364533|365594294|FG001|Overall Study|Lack of Efficacy|22|||
105982030|NCT00364533|365594295|FG002|Overall Study|Lack of Efficacy|21|||
105982031|NCT00364533|365594296|FG003|Overall Study|Lack of Efficacy|17|||
105982032|NCT00364533|365594297|FG004|Overall Study|Lack of Efficacy|42|||
105982033|NCT00364533|365594293|FG000|Overall Study|Subject discharged from hospital|4|||
105982034|NCT00364533|365594294|FG001|Overall Study|Subject discharged from hospital|1|||
105982035|NCT00364533|365594295|FG002|Overall Study|Subject discharged from hospital|2|||
105982036|NCT00364533|365594296|FG003|Overall Study|Subject discharged from hospital|3|||
105982037|NCT00364533|365594297|FG004|Overall Study|Subject discharged from hospital|1|||
105982038|NCT00364533|365594293|FG000|Overall Study|Variations in drug compliance|2|||
105982039|NCT00364533|365594294|FG001|Overall Study|Variations in drug compliance|1|||
106029494|NCT03086967|365772638|FG000|Overall Study|Screen Failure|2|||
106029495|NCT03086967|365772639|FG001|Overall Study|Screen Failure|2|||
106029496|NCT02661178|365772642|FG000|Part 1|Protocol Violation|1|||
106029497|NCT02661178|365772643|FG001|Part 1|Protocol Violation|0|||
105982040|NCT00364533|365594295|FG002|Overall Study|Variations in drug compliance|1|||
105982041|NCT00364533|365594296|FG003|Overall Study|Variations in drug compliance|0|||
105982042|NCT00364533|365594297|FG004|Overall Study|Variations in drug compliance|0|||
105982043|NCT00364533|365594293|FG000|Overall Study|Non-compliance|1|||
106029498|NCT02661178|365772644|FG002|Part 1|Protocol Violation|0|||
106029499|NCT02661178|365772645|FG003|Part 1|Protocol Violation|0|||
105982044|NCT00364533|365594294|FG001|Overall Study|Non-compliance|0|||
105982045|NCT00364533|365594295|FG002|Overall Study|Non-compliance|0|||
105982046|NCT00364533|365594296|FG003|Overall Study|Non-compliance|0|||
105982047|NCT00364533|365594297|FG004|Overall Study|Non-compliance|0|||
105982048|NCT00364533|365594293|FG000|Overall Study|Protocol Violation|1|||
105982049|NCT00364533|365594294|FG001|Overall Study|Protocol Violation|1|||
105982050|NCT00364533|365594295|FG002|Overall Study|Protocol Violation|0|||
105982051|NCT00364533|365594296|FG003|Overall Study|Protocol Violation|0|||
105982052|NCT00364533|365594297|FG004|Overall Study|Protocol Violation|0|||
105982053|NCT03157583|365594298|FG000|Overall Study|Other (did not meet study criteria)|1|||
105982054|NCT01302054|365594301|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
105982055|NCT01302054|365594302|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
105982056|NCT01302054|365594303|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
105982057|NCT01302054|365594301|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
105982058|NCT01302054|365594302|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
105982059|NCT01302054|365594303|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
105982060|NCT01302054|365594301|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
105982061|NCT01302054|365594302|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
105982062|NCT01302054|365594303|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
105982063|NCT01302054|365594301|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
105982064|NCT01302054|365594302|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
105982065|NCT01302054|365594303|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
105982066|NCT01302054|365594301|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
106029500|NCT02661178|365772646|FG004|Part 1|Protocol Violation|0|||
106029501|NCT02661178|365772647|FG005|Part 1|Protocol Violation|0|||
106029502|NCT02661178|365772648|FG006|Part 1|Protocol Violation|0|||
106029503|NCT02661178|365772649|FG007|Part 1|Protocol Violation|0|||
106029504|NCT02661178|365772650|FG008|Part 1|Protocol Violation|0|||
106029505|NCT02661178|365772651|FG009|Part 1|Protocol Violation|0|||
106029506|NCT02661178|365772652|FG010|Part 1|Protocol Violation|0|||
106029507|NCT02661178|365772653|FG011|Part 1|Protocol Violation|0|||
106029508|NCT02661178|365772654|FG012|Part 1|Protocol Violation|0|||
106029509|NCT02661178|365772655|FG013|Part 1|Protocol Violation|0|||
106029510|NCT02661178|365772656|FG014|Part 1|Protocol Violation|0|||
106029511|NCT03859973|365772659|FG000|Overall Study|Other reason than listed|3|||
106029512|NCT03859973|365772660|FG001|Overall Study|Other reason than listed|2|||
106029513|NCT03859973|365772659|FG000|Overall Study|COVID-19 related, not due to AE|3|||
106029514|NCT03859973|365772660|FG001|Overall Study|COVID-19 related, not due to AE|4|||
106029515|NCT03859973|365772659|FG000|Overall Study|Withdrawal by Subject|8|||
106029516|NCT03859973|365772660|FG001|Overall Study|Withdrawal by Subject|9|||
106029517|NCT03859973|365772659|FG000|Overall Study|Lost to Follow-up|2|||
106029518|NCT03859973|365772660|FG001|Overall Study|Lost to Follow-up|3|||
106029519|NCT03859973|365772659|FG000|Overall Study|Protocol Violation|1|||
106029520|NCT03859973|365772660|FG001|Overall Study|Protocol Violation|3|||
106029521|NCT03859973|365772659|FG000|Overall Study|Adverse Event|3|||
106029522|NCT03859973|365772660|FG001|Overall Study|Adverse Event|5|||
106029523|NCT02855541|365772661|FG000|Overall Study|Change in health status|2|||
106029524|NCT02855541|365772661|FG000|Overall Study|Withdrawal by Subject|2|||
106029525|NCT00422513|365772662|FG000|Overall Study|Lack of Efficacy|4|||
106029526|NCT00422513|365772663|FG001|Overall Study|Lack of Efficacy|5|||
106029527|NCT00422513|365772662|FG000|Overall Study|Protocol Violation|23|||
106029528|NCT00422513|365772663|FG001|Overall Study|Protocol Violation|7|||
106029529|NCT00422513|365772662|FG000|Overall Study|Refused Treatment|4|||
106029530|NCT00422513|365772663|FG001|Overall Study|Refused Treatment|2|||
106029531|NCT00422513|365772662|FG000|Overall Study|Withdrawal by Subject|2|||
106029532|NCT00422513|365772663|FG001|Overall Study|Withdrawal by Subject|1|||
106029533|NCT00422513|365772662|FG000|Overall Study|early termination of the study|67|||
106029534|NCT00422513|365772663|FG001|Overall Study|early termination of the study|80|||
106029535|NCT00422513|365772662|FG000|Overall Study|Adverse Event|4|||
106029536|NCT00422513|365772663|FG001|Overall Study|Adverse Event|4|||
106029537|NCT00422513|365772662|FG000|Overall Study|Death|3|||
106029538|NCT00422513|365772663|FG001|Overall Study|Death|7|||
106029539|NCT03085914|365772664|FG000|Overall Study|Death|6|||
106029540|NCT03085914|365772665|FG001|Overall Study|Death|6|||
106029541|NCT03085914|365772666|FG002|Overall Study|Death|4|||
106029542|NCT03085914|365772667|FG003|Overall Study|Death|1|||
106029543|NCT03085914|365772668|FG004|Overall Study|Death|5|||
106029544|NCT03085914|365772669|FG005|Overall Study|Death|2|||
106029545|NCT03085914|365772670|FG006|Overall Study|Death|2|||
106029546|NCT03085914|365772664|FG000|Overall Study|Withdrawal by Subject|1|||
106029547|NCT03085914|365772665|FG001|Overall Study|Withdrawal by Subject|1|||
106029548|NCT03085914|365772666|FG002|Overall Study|Withdrawal by Subject|2|||
106029549|NCT03085914|365772667|FG003|Overall Study|Withdrawal by Subject|2|||
106029550|NCT03085914|365772668|FG004|Overall Study|Withdrawal by Subject|2|||
106029551|NCT03085914|365772669|FG005|Overall Study|Withdrawal by Subject|0|||
106029552|NCT03085914|365772670|FG006|Overall Study|Withdrawal by Subject|1|||
106029553|NCT03085914|365772664|FG000|Overall Study|Lost to Follow-up|0|||
106029554|NCT03085914|365772665|FG001|Overall Study|Lost to Follow-up|0|||
106029555|NCT03085914|365772666|FG002|Overall Study|Lost to Follow-up|1|||
106029556|NCT03085914|365772667|FG003|Overall Study|Lost to Follow-up|0|||
106029557|NCT03085914|365772668|FG004|Overall Study|Lost to Follow-up|0|||
106029558|NCT03085914|365772669|FG005|Overall Study|Lost to Follow-up|1|||
106029559|NCT03085914|365772670|FG006|Overall Study|Lost to Follow-up|1|||
106029560|NCT03085914|365772664|FG000|Overall Study|Reason was not specified,|2|||
106029561|NCT03085914|365772665|FG001|Overall Study|Reason was not specified,|2|||
106029562|NCT03085914|365772666|FG002|Overall Study|Reason was not specified,|2|||
106029563|NCT03085914|365772667|FG003|Overall Study|Reason was not specified,|3|||
106029564|NCT03085914|365772668|FG004|Overall Study|Reason was not specified,|3|||
106029565|NCT03085914|365772669|FG005|Overall Study|Reason was not specified,|3|||
106029566|NCT03085914|365772670|FG006|Overall Study|Reason was not specified,|6|||
106151483|NCT02723955|366215080|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
106151484|NCT02723955|366215081|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
106151485|NCT02723955|366215082|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
106029567|NCT03085914|365772664|FG000|Overall Study|Progressive Disease|0|||
106151486|NCT02723955|366215083|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
106151487|NCT02723955|366215084|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
106151488|NCT02723955|366215085|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
105982067|NCT01302054|365594302|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
105982068|NCT01302054|365594303|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
105982069|NCT01302054|365594301|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
105982070|NCT01302054|365594302|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
105982071|NCT01302054|365594303|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
105982072|NCT01302054|365594301|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
106029568|NCT03085914|365772665|FG001|Overall Study|Progressive Disease|0|||
106029569|NCT03085914|365772666|FG002|Overall Study|Progressive Disease|2|||
105982073|NCT01302054|365594302|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
105982074|NCT01302054|365594303|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
105982075|NCT01302054|365594301|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
106151489|NCT02723955|366215086|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
106151490|NCT02723955|366215087|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
105982076|NCT01302054|365594302|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
105982077|NCT01302054|365594303|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
105982078|NCT01302054|365594301|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
105982079|NCT01302054|365594302|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
105982080|NCT01302054|365594303|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
105982081|NCT01302054|365594301|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
105982082|NCT01302054|365594302|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
105982083|NCT01302054|365594303|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
105982084|NCT01302054|365594301|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105982085|NCT01302054|365594302|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
105982086|NCT01302054|365594303|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
105982087|NCT01302054|365594301|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
105982088|NCT01302054|365594302|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
105982089|NCT01302054|365594303|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
105982090|NCT01302054|365594301|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
105982091|NCT01302054|365594302|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
105982092|NCT01302054|365594303|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
105982093|NCT01302054|365594301|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
105982094|NCT01302054|365594302|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
105982095|NCT01302054|365594303|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
105982096|NCT01302054|365594301|FG000|Double-Blind Treatment Phase|Other|0|||
105982097|NCT01302054|365594302|FG001|Double-Blind Treatment Phase|Other|4|||
106151491|NCT02723955|366215088|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
106029570|NCT03085914|365772667|FG003|Overall Study|Progressive Disease|2|||
106029571|NCT03085914|365772668|FG004|Overall Study|Progressive Disease|1|||
106029572|NCT03085914|365772669|FG005|Overall Study|Progressive Disease|1|||
106151492|NCT02723955|366215089|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
106151493|NCT02723955|366215090|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
106151494|NCT02723955|366215091|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
106151495|NCT02723955|366215092|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
106151496|NCT02723955|366215093|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
106151497|NCT02723955|366215094|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
106151498|NCT02723955|366215095|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
106151499|NCT02723955|366215096|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
106151500|NCT04300647|366215097|FG000|Pre-Crossover|Death|19|||
106151501|NCT04300647|366215098|FG001|Pre-Crossover|Death|58|||
106151502|NCT04300647|366215099|FG002|Pre-Crossover|Death|0|||
106151503|NCT04300647|366215097|FG000|Pre-Crossover|Lost to Follow-up|0|||
106151504|NCT04300647|366215098|FG001|Pre-Crossover|Lost to Follow-up|3|||
106151505|NCT04300647|366215099|FG002|Pre-Crossover|Lost to Follow-up|0|||
106151506|NCT04300647|366215097|FG000|Pre-Crossover|Withdrawal by Subject|2|||
106151507|NCT04300647|366215098|FG001|Pre-Crossover|Withdrawal by Subject|4|||
106151508|NCT04300647|366215099|FG002|Pre-Crossover|Withdrawal by Subject|0|||
106151509|NCT04300647|366215097|FG000|Pre-Crossover|On-going in Study|24|||
106151510|NCT04300647|366215098|FG001|Pre-Crossover|On-going in Study|61|||
106151511|NCT04300647|366215099|FG002|Pre-Crossover|On-going in Study|0|||
106151512|NCT04300647|366215097|FG000|Post-Crossover|Death|0|||
106151513|NCT04300647|366215098|FG001|Post-Crossover|Death|0|||
106151514|NCT04300647|366215099|FG002|Post-Crossover|Death|3|||
106151515|NCT04300647|366215097|FG000|Post-Crossover|Lost to Follow-up|0|||
106151516|NCT04300647|366215098|FG001|Post-Crossover|Lost to Follow-up|0|||
106151517|NCT04300647|366215099|FG002|Post-Crossover|Lost to Follow-up|1|||
106151518|NCT04300647|366215097|FG000|Post-Crossover|Withdrawal by Subject|0|||
106151519|NCT04300647|366215098|FG001|Post-Crossover|Withdrawal by Subject|0|||
106151520|NCT04300647|366215099|FG002|Post-Crossover|Withdrawal by Subject|1|||
106151521|NCT04300647|366215097|FG000|Post-Crossover|On-going in Study|0|||
106151522|NCT04300647|366215098|FG001|Post-Crossover|On-going in Study|0|||
106151523|NCT04300647|366215099|FG002|Post-Crossover|On-going in Study|8|||
106151524|NCT04999085|366215100|FG000|Overall Study|Death|1|||
106151525|NCT02824029|366215101|FG000|Overall Study|Didn't receive treatment|2|||
106151526|NCT02824029|366215101|FG000|Overall Study|Patient decision to discontinue treatment|3|||
105982098|NCT01302054|365594303|FG002|Double-Blind Treatment Phase|Other|9|||
105982099|NCT02713867|365594304|FG000|Randomization|Other Reason|2|||
105982100|NCT02713867|365594305|FG001|Randomization|Other Reason|1|||
105982101|NCT02713867|365594304|FG000|Randomization|Participant Withdrew consent|0|||
105982102|NCT02713867|365594305|FG001|Randomization|Participant Withdrew consent|2|||
105982103|NCT02713867|365594304|FG000|Treatment Period|Other Reasons|22|||
105982104|NCT02713867|365594305|FG001|Treatment Period|Other Reasons|28|||
105982105|NCT02713867|365594304|FG000|Treatment Period|Administrative reason by sponsor|21|||
105982106|NCT02713867|365594305|FG001|Treatment Period|Administrative reason by sponsor|16|||
105982107|NCT02713867|365594304|FG000|Treatment Period|No longer meets study criteria|2|||
105982108|NCT02713867|365594305|FG001|Treatment Period|No longer meets study criteria|1|||
105982109|NCT02713867|365594304|FG000|Treatment Period|Poor/Non Compliance|1|||
105982110|NCT02713867|365594305|FG001|Treatment Period|Poor/Non Compliance|0|||
105982111|NCT02713867|365594304|FG000|Treatment Period|Maximum Clinical Benefit|5|||
105982112|NCT02713867|365594305|FG001|Treatment Period|Maximum Clinical Benefit|6|||
105982113|NCT02713867|365594304|FG000|Treatment Period|Withdrew consent|3|||
105982114|NCT02713867|365594305|FG001|Treatment Period|Withdrew consent|6|||
105982115|NCT02713867|365594304|FG000|Treatment Period|Requested to Discontinue|8|||
105982116|NCT02713867|365594305|FG001|Treatment Period|Requested to Discontinue|8|||
105982117|NCT02713867|365594304|FG000|Treatment Period|AE unrelated to Study Drug|11|||
105982118|NCT02713867|365594305|FG001|Treatment Period|AE unrelated to Study Drug|10|||
105982119|NCT02713867|365594304|FG000|Treatment Period|Death|7|||
105982120|NCT02713867|365594305|FG001|Treatment Period|Death|3|||
105982121|NCT02713867|365594304|FG000|Treatment Period|Study Drug Toxicity|16|||
105982122|NCT02713867|365594305|FG001|Treatment Period|Study Drug Toxicity|19|||
105982123|NCT02713867|365594304|FG000|Treatment Period|Disease Progression|82|||
105982124|NCT02713867|365594305|FG001|Treatment Period|Disease Progression|83|||
105982125|NCT00908037|365594313|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982126|NCT00908037|365594314|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982127|NCT00908037|365594315|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982128|NCT00908037|365594316|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982129|NCT00908037|365594317|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
105982130|NCT00908037|365594318|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982131|NCT00908037|365594319|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
106151527|NCT02824029|366215101|FG000|Overall Study|Non-compliant|5|||
106151528|NCT02824029|366215101|FG000|Overall Study|Progression of disease|15|||
106151529|NCT02824029|366215101|FG000|Overall Study|Inadequate response to therapy|2|||
106151530|NCT02824029|366215101|FG000|Overall Study|Possible progression per treating physician|1|||
106029573|NCT03085914|365772670|FG006|Overall Study|Progressive Disease|1|||
106029574|NCT03085914|365772664|FG000|Overall Study|Study Terminated by the Sponsor|0|||
106029575|NCT03085914|365772665|FG001|Overall Study|Study Terminated by the Sponsor|0|||
106029576|NCT03085914|365772666|FG002|Overall Study|Study Terminated by the Sponsor|0|||
106029577|NCT03085914|365772667|FG003|Overall Study|Study Terminated by the Sponsor|1|||
106029578|NCT03085914|365772668|FG004|Overall Study|Study Terminated by the Sponsor|2|||
106029579|NCT03085914|365772669|FG005|Overall Study|Study Terminated by the Sponsor|1|||
106029580|NCT03085914|365772670|FG006|Overall Study|Study Terminated by the Sponsor|0|||
106029581|NCT01478048|365772671|FG000|Overall Study|Disease Progression|52|||
106029582|NCT01478048|365772672|FG001|Overall Study|Disease Progression|35|||
106029583|NCT01478048|365772671|FG000|Overall Study|study drug toxicity|11|||
106029584|NCT01478048|365772672|FG001|Overall Study|study drug toxicity|14|||
106029585|NCT01478048|365772671|FG000|Overall Study|Adverse Event|2|||
106029586|NCT01478048|365772672|FG001|Overall Study|Adverse Event|11|||
106029587|NCT01478048|365772671|FG000|Overall Study|subject request to discontinue treatment|3|||
106029588|NCT01478048|365772672|FG001|Overall Study|subject request to discontinue treatment|5|||
106029589|NCT01478048|365772671|FG000|Overall Study|Withdrawal by Subject|2|||
106029590|NCT01478048|365772672|FG001|Overall Study|Withdrawal by Subject|5|||
106029591|NCT01478048|365772671|FG000|Overall Study|non-specified|6|||
106029592|NCT01478048|365772672|FG001|Overall Study|non-specified|4|||
106029593|NCT01478048|365772671|FG000|Overall Study|poor/non-compliance|0|||
106029594|NCT01478048|365772672|FG001|Overall Study|poor/non-compliance|1|||
106029595|NCT01478048|365772671|FG000|Overall Study|no longer meets study criteria|1|||
106029596|NCT01478048|365772672|FG001|Overall Study|no longer meets study criteria|0|||
106029597|NCT00833417|365772675|FG000|Overall Study|Adverse Event|5|||
106029598|NCT00833417|365772676|FG001|Overall Study|Adverse Event|16|||
106029599|NCT00833417|365772675|FG000|Overall Study|Death|1|||
106029600|NCT00833417|365772676|FG001|Overall Study|Death|3|||
106029601|NCT00833417|365772675|FG000|Overall Study|Lost to Follow-up|1|||
106029602|NCT00833417|365772676|FG001|Overall Study|Lost to Follow-up|2|||
106029603|NCT00833417|365772675|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
106029604|NCT00833417|365772676|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
106029605|NCT00833417|365772675|FG000|Overall Study|Patient Decision to Withdraw|4|||
106029606|NCT00833417|365772676|FG001|Overall Study|Patient Decision to Withdraw|23|||
106029607|NCT00833417|365772675|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
106029608|NCT00833417|365772676|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
106029609|NCT00833417|365772675|FG000|Overall Study|Disease Progression|18|||
106029610|NCT00833417|365772676|FG001|Overall Study|Disease Progression|17|||
106029611|NCT00833417|365772675|FG000|Overall Study|Reason Not Specified|0|||
106029612|NCT00833417|365772676|FG001|Overall Study|Reason Not Specified|1|||
106029613|NCT03032380|365772677|FG000|Overall Study|Adverse Event|0|||
106029614|NCT03032380|365772678|FG001|Overall Study|Adverse Event|1|||
106029615|NCT03032380|365772677|FG000|Overall Study|Lack of Efficacy|1|||
106029616|NCT03032380|365772678|FG001|Overall Study|Lack of Efficacy|0|||
106029617|NCT03032380|365772677|FG000|Overall Study|Withdrawal by Subject|2|||
106029618|NCT03032380|365772678|FG001|Overall Study|Withdrawal by Subject|3|||
106029619|NCT03032380|365772677|FG000|Overall Study|Recovery|0|||
106029620|NCT03032380|365772678|FG001|Overall Study|Recovery|1|||
106029621|NCT03032380|365772677|FG000|Overall Study|Death|39|||
106029622|NCT03032380|365772678|FG001|Overall Study|Death|34|||
106029623|NCT03032380|365772677|FG000|Overall Study|Other - Miscellaneous|0|||
106029624|NCT03032380|365772678|FG001|Overall Study|Other - Miscellaneous|1|||
106029625|NCT04644315|365772679|FG000|Overall Study|Subject withdrawal of consent|1|||
106029626|NCT05315908|365772680|FG000|Overall Study|Lost to Follow-up|4477|||
106029627|NCT05315908|365772681|FG001|Overall Study|Lost to Follow-up|4606|||
106029628|NCT01561898|365772682|FG000|Overall Study|Withdrawal by Subject|0|||
106029629|NCT01561898|365772683|FG001|Overall Study|Withdrawal by Subject|8|||
106029630|NCT01561898|365772684|FG002|Overall Study|Withdrawal by Subject|12|||
106029631|NCT01561898|365772685|FG003|Overall Study|Withdrawal by Subject|5|||
106029632|NCT01561898|365772682|FG000|Overall Study|Lack of Efficacy|0|||
106029633|NCT01561898|365772683|FG001|Overall Study|Lack of Efficacy|8|||
106029634|NCT01561898|365772684|FG002|Overall Study|Lack of Efficacy|10|||
106029635|NCT01561898|365772685|FG003|Overall Study|Lack of Efficacy|5|||
106029636|NCT01561898|365772682|FG000|Overall Study|Worsening of complications|0|||
106029637|NCT01561898|365772683|FG001|Overall Study|Worsening of complications|1|||
106029638|NCT01561898|365772684|FG002|Overall Study|Worsening of complications|0|||
106029639|NCT01561898|365772685|FG003|Overall Study|Worsening of complications|0|||
106029640|NCT01561898|365772682|FG000|Overall Study|Lost to Follow-up|0|||
106029641|NCT01561898|365772683|FG001|Overall Study|Lost to Follow-up|0|||
106029642|NCT01561898|365772684|FG002|Overall Study|Lost to Follow-up|1|||
106029643|NCT01561898|365772685|FG003|Overall Study|Lost to Follow-up|0|||
106029644|NCT01561898|365772682|FG000|Overall Study|Adverse Event|1|||
106029645|NCT01561898|365772683|FG001|Overall Study|Adverse Event|19|||
106029646|NCT01561898|365772684|FG002|Overall Study|Adverse Event|14|||
106029647|NCT01561898|365772685|FG003|Overall Study|Adverse Event|9|||
106029648|NCT01561898|365772682|FG000|Overall Study|Physician Decision|1|||
106029649|NCT01561898|365772683|FG001|Overall Study|Physician Decision|5|||
106029650|NCT01561898|365772684|FG002|Overall Study|Physician Decision|7|||
106029651|NCT01561898|365772685|FG003|Overall Study|Physician Decision|1|||
106029652|NCT01445548|365772686|FG000|Overall Study|Adverse Event|1|||
106029653|NCT01738646|365772687|FG000|Overall Study|Still Receiving Treatment|2|||
106029654|NCT03232333|365772688|FG000|Overall Study|Infection or Osteomyelitis|9|||
106151531|NCT02581215|366215104|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
106151532|NCT02581215|366215105|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
106151533|NCT02581215|366215104|FG000|Overall Study|Eligibility Criteria Not Met|0|||
106151534|NCT02581215|366215105|FG001|Overall Study|Eligibility Criteria Not Met|1|||
106151535|NCT00670046|366215113|FG000|Overall Study|Lost to Follow-up|1|||
106151536|NCT00670046|366215114|FG001|Overall Study|Lost to Follow-up|1|||
106151537|NCT00670046|366215113|FG000|Overall Study|Withdrawal by Subject|0|||
106151538|NCT00670046|366215114|FG001|Overall Study|Withdrawal by Subject|1|||
106151539|NCT02015520|366215115|FG000|Overall Study|Lack of Efficacy|1|||
106151540|NCT02015520|366215116|FG001|Overall Study|Lack of Efficacy|0|||
106151541|NCT02015520|366215117|FG002|Overall Study|Lack of Efficacy|3|||
106151542|NCT02015520|366215118|FG003|Overall Study|Lack of Efficacy|2|||
106151543|NCT02015520|366215115|FG000|Overall Study|Adverse Event|0|||
106151544|NCT02015520|366215116|FG001|Overall Study|Adverse Event|0|||
106151545|NCT02015520|366215117|FG002|Overall Study|Adverse Event|0|||
106151546|NCT02015520|366215118|FG003|Overall Study|Adverse Event|1|||
106151547|NCT02015520|366215115|FG000|Overall Study|Withdrawal by Subject|2|||
106151548|NCT02015520|366215116|FG001|Overall Study|Withdrawal by Subject|2|||
106151549|NCT02015520|366215117|FG002|Overall Study|Withdrawal by Subject|1|||
106151550|NCT02015520|366215118|FG003|Overall Study|Withdrawal by Subject|0|||
106151551|NCT02015520|366215115|FG000|Overall Study|Death|1|||
106151552|NCT02015520|366215116|FG001|Overall Study|Death|0|||
106151553|NCT02015520|366215117|FG002|Overall Study|Death|0|||
106151554|NCT02015520|366215118|FG003|Overall Study|Death|0|||
106151555|NCT02015520|366215115|FG000|Overall Study|Lost to Follow-up|0|||
106151556|NCT02015520|366215116|FG001|Overall Study|Lost to Follow-up|0|||
106151557|NCT02015520|366215117|FG002|Overall Study|Lost to Follow-up|1|||
106151558|NCT02015520|366215118|FG003|Overall Study|Lost to Follow-up|0|||
106151559|NCT02015520|366215115|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
106151560|NCT02015520|366215116|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
106151561|NCT02015520|366215117|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
106151562|NCT02015520|366215118|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
106151563|NCT02015520|366215115|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
106151564|NCT02015520|366215116|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
106151565|NCT02015520|366215117|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
106151566|NCT02015520|366215118|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
106151567|NCT04759833|366215119|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
106151568|NCT04759833|366215120|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
106151569|NCT04759833|366215121|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
106151570|NCT04759833|366215122|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
106029655|NCT03232333|365772688|FG000|Overall Study|Lost to Follow-up|4|||
106029656|NCT03232333|365772688|FG000|Overall Study|Withdrawal by Subject|2|||
106151571|NCT04759833|366215123|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
106151572|NCT04759833|366215119|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
106151573|NCT04759833|366215120|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
106151574|NCT04759833|366215121|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
106151575|NCT04759833|366215122|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
106151576|NCT04759833|366215123|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
106029657|NCT00422084|365772689|FG000|Overall Study|Adverse Event|21|||
106029658|NCT00422084|365772690|FG001|Overall Study|Adverse Event|7|||
106029659|NCT00422084|365772689|FG000|Overall Study|Withdrawal by Subject|12|||
106151577|NCT04759833|366215119|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
106151578|NCT04759833|366215120|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
106151579|NCT04759833|366215121|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
105982132|NCT00908037|365594320|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982133|NCT00908037|365594321|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
105982134|NCT00908037|365594322|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982135|NCT00908037|365594323|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982136|NCT00908037|365594324|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
105982137|NCT00908037|365594313|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982138|NCT00908037|365594314|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982139|NCT00908037|365594315|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982140|NCT00908037|365594316|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982141|NCT00908037|365594317|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
105982142|NCT00908037|365594318|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982143|NCT00908037|365594319|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982144|NCT00908037|365594320|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982145|NCT00908037|365594321|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
105982146|NCT00908037|365594322|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982147|NCT00908037|365594323|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982148|NCT00908037|365594324|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
105982149|NCT00908037|365594313|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982150|NCT00908037|365594314|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982151|NCT00908037|365594315|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982152|NCT00908037|365594316|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
105982153|NCT00908037|365594317|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982154|NCT00908037|365594318|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982155|NCT00908037|365594319|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
105982156|NCT00908037|365594320|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982157|NCT00908037|365594321|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982158|NCT00908037|365594322|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982159|NCT00908037|365594323|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982160|NCT00908037|365594324|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
105982161|NCT00908037|365594313|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982162|NCT00908037|365594314|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982163|NCT00908037|365594315|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982164|NCT00908037|365594316|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982165|NCT00908037|365594317|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982166|NCT00908037|365594318|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982167|NCT00908037|365594319|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982168|NCT00908037|365594320|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982169|NCT00908037|365594321|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982170|NCT00908037|365594322|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982171|NCT00908037|365594323|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
105982172|NCT00908037|365594324|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
105982173|NCT00908037|365594313|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982174|NCT00908037|365594314|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982175|NCT00908037|365594315|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982176|NCT00908037|365594316|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982177|NCT00908037|365594317|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982178|NCT00908037|365594318|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982179|NCT00908037|365594319|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982180|NCT00908037|365594320|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982181|NCT00908037|365594321|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
106029660|NCT00422084|365772690|FG001|Overall Study|Withdrawal by Subject|9|||
106029661|NCT00422084|365772689|FG000|Overall Study|Lost to Follow-up|14|||
106151580|NCT04759833|366215122|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
106151581|NCT04759833|366215123|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
106151582|NCT04759833|366215119|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
106151583|NCT04759833|366215120|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
106151584|NCT04759833|366215121|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
106151585|NCT04759833|366215122|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
106151586|NCT04759833|366215123|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
106151587|NCT04759833|366215119|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
106151588|NCT04759833|366215120|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
106151589|NCT04759833|366215121|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
106151590|NCT04759833|366215122|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
106151591|NCT04759833|366215123|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
106151592|NCT04759833|366215119|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
106151593|NCT04759833|366215120|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
106151594|NCT04759833|366215121|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
106151595|NCT04759833|366215122|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
106151596|NCT04759833|366215123|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
106151597|NCT04759833|366215119|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
106151598|NCT04759833|366215120|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
106151599|NCT04759833|366215121|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
106151600|NCT04759833|366215122|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
106151601|NCT04759833|366215123|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
106151602|NCT04759833|366215119|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
106151603|NCT04759833|366215120|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
106151604|NCT04759833|366215121|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
106151605|NCT04759833|366215122|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
106151606|NCT04759833|366215123|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
106151607|NCT04759833|366215119|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
106151608|NCT04759833|366215120|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
106151609|NCT04759833|366215121|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
106151610|NCT04759833|366215122|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
106151611|NCT04759833|366215123|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
106151612|NCT04759833|366215119|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
106151613|NCT04759833|366215120|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
106151614|NCT04759833|366215121|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
106151615|NCT04759833|366215122|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
106151616|NCT04759833|366215123|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
106151617|NCT04759833|366215119|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
106151618|NCT04759833|366215120|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
106151619|NCT04759833|366215121|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
106151620|NCT04759833|366215122|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
106151621|NCT04759833|366215123|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
106151622|NCT04759833|366215119|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
106151623|NCT04759833|366215120|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
106151624|NCT04759833|366215121|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
106151625|NCT04759833|366215122|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
106151626|NCT04759833|366215123|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
106151627|NCT04759833|366215119|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
106151628|NCT04759833|366215120|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
106151629|NCT04759833|366215121|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
106151630|NCT04759833|366215122|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
106151631|NCT04759833|366215123|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
106151632|NCT00111813|366215124|FG000|Overall Study|Adverse Event|1|||
106151633|NCT00111813|366215125|FG001|Overall Study|Adverse Event|2|||
106151634|NCT00111813|366215126|FG002|Overall Study|Adverse Event|4|||
106151635|NCT00111813|366215127|FG003|Overall Study|Adverse Event|2|||
106151636|NCT00111813|366215128|FG004|Overall Study|Adverse Event|2|||
106151637|NCT00111813|366215129|FG005|Overall Study|Adverse Event|2|||
106151638|NCT00111813|366215124|FG000|Overall Study|Progressive disease|2|||
106151639|NCT00111813|366215125|FG001|Overall Study|Progressive disease|1|||
106151640|NCT00111813|366215126|FG002|Overall Study|Progressive disease|5|||
106151641|NCT00111813|366215127|FG003|Overall Study|Progressive disease|3|||
106151642|NCT00111813|366215128|FG004|Overall Study|Progressive disease|4|||
106151643|NCT00111813|366215129|FG005|Overall Study|Progressive disease|3|||
106029662|NCT00422084|365772690|FG001|Overall Study|Lost to Follow-up|9|||
106151644|NCT00111813|366215124|FG000|Overall Study|Lack of Efficacy|0|||
106151645|NCT00111813|366215125|FG001|Overall Study|Lack of Efficacy|0|||
105982182|NCT00908037|365594322|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
105982183|NCT00908037|365594323|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
105982184|NCT00908037|365594324|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
105982185|NCT00908037|365594313|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982186|NCT00908037|365594314|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982187|NCT00908037|365594315|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982188|NCT00908037|365594316|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982189|NCT00908037|365594317|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982190|NCT00908037|365594318|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982191|NCT00908037|365594319|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982192|NCT00908037|365594320|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982193|NCT00908037|365594321|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982194|NCT00908037|365594322|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
105982195|NCT00908037|365594323|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982196|NCT00908037|365594324|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
105982197|NCT00908037|365594313|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982198|NCT00908037|365594314|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982199|NCT00908037|365594315|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982200|NCT00908037|365594316|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982201|NCT00908037|365594317|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982202|NCT00908037|365594318|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982203|NCT00908037|365594319|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982204|NCT00908037|365594320|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982205|NCT00908037|365594321|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982206|NCT00908037|365594322|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982207|NCT00908037|365594323|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
105982208|NCT00908037|365594324|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
105982209|NCT00908037|365594313|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
106029663|NCT00422084|365772689|FG000|Overall Study|Protocol Violation|4|||
106029664|NCT00422084|365772690|FG001|Overall Study|Protocol Violation|1|||
106029665|NCT00422084|365772689|FG000|Overall Study|Lack of Efficacy|40|||
106029666|NCT00422084|365772690|FG001|Overall Study|Lack of Efficacy|42|||
106029667|NCT00422084|365772689|FG000|Overall Study|P. vivax infection|3|||
106029668|NCT00422084|365772690|FG001|Overall Study|P. vivax infection|6|||
106029669|NCT00422084|365772689|FG000|Overall Study|Cyesis|1|||
106029670|NCT00422084|365772690|FG001|Overall Study|Cyesis|0|||
106029671|NCT00422084|365772689|FG000|Overall Study|Withdrawn from study accidentally|1|||
106029672|NCT00422084|365772690|FG001|Overall Study|Withdrawn from study accidentally|0|||
106029673|NCT00422084|365772689|FG000|Overall Study|Non-compliance|1|||
106029674|NCT00422084|365772690|FG001|Overall Study|Non-compliance|0|||
106029675|NCT00422084|365772689|FG000|Overall Study|Re-location|0|||
106029676|NCT00422084|365772690|FG001|Overall Study|Re-location|1|||
106029677|NCT00422084|365772689|FG000|Overall Study|Not defined|1|||
106029678|NCT00422084|365772690|FG001|Overall Study|Not defined|1|||
106029679|NCT00958438|365772691|FG000|Overall Study|Protocol Violation|3|||
106029680|NCT00958438|365772692|FG001|Overall Study|Protocol Violation|2|||
106029681|NCT00958438|365772693|FG002|Overall Study|Protocol Violation|2|||
106029682|NCT00958438|365772691|FG000|Overall Study|Withdrawal by Subject|4|||
106029683|NCT00958438|365772692|FG001|Overall Study|Withdrawal by Subject|2|||
106029684|NCT00958438|365772693|FG002|Overall Study|Withdrawal by Subject|1|||
106029685|NCT00958438|365772691|FG000|Overall Study|Adverse Event|0|||
106029686|NCT00958438|365772692|FG001|Overall Study|Adverse Event|3|||
106029687|NCT00958438|365772693|FG002|Overall Study|Adverse Event|0|||
106029688|NCT00958438|365772691|FG000|Overall Study|Physician Decision|1|||
106029689|NCT00958438|365772692|FG001|Overall Study|Physician Decision|0|||
106029690|NCT00958438|365772693|FG002|Overall Study|Physician Decision|1|||
106029691|NCT00958438|365772691|FG000|Overall Study|Other than specified above|2|||
106029692|NCT00958438|365772692|FG001|Overall Study|Other than specified above|3|||
106029693|NCT00958438|365772693|FG002|Overall Study|Other than specified above|2|||
106029694|NCT03996369|365772695|FG000|Overall Study|Protocol deviation|1|||
106029695|NCT03996369|365772696|FG001|Overall Study|Protocol deviation|1|||
106029696|NCT03996369|365772695|FG000|Overall Study|Physician Decision|4|||
106029697|NCT03996369|365772696|FG001|Overall Study|Physician Decision|2|||
106029698|NCT03996369|365772695|FG000|Overall Study|Participant decision|0|||
106029699|NCT03996369|365772696|FG001|Overall Study|Participant decision|1|||
106029700|NCT03996369|365772695|FG000|Overall Study|Lack of Efficacy|4|||
106029701|NCT03996369|365772696|FG001|Overall Study|Lack of Efficacy|0|||
106029702|NCT03996369|365772695|FG000|Overall Study|Adverse Event|9|||
106029703|NCT03996369|365772696|FG001|Overall Study|Adverse Event|0|||
106029704|NCT03996369|365772695|FG000|Overall Study|Withdrawal by Subject|6|||
106029705|NCT03996369|365772696|FG001|Overall Study|Withdrawal by Subject|8|||
106029706|NCT03996369|365772695|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
106029707|NCT03996369|365772696|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
106029708|NCT03996369|365772695|FG000|Overall Study|Lost to Follow-up|0|||
106029709|NCT03996369|365772696|FG001|Overall Study|Lost to Follow-up|1|||
106029710|NCT00653432|365772697|FG000|Overall Study|Adverse Event|4|||
106029711|NCT00653432|365772698|FG001|Overall Study|Adverse Event|1|||
106029712|NCT00653432|365772697|FG000|Overall Study|Withdrawal by Subject|4|||
106029713|NCT00653432|365772698|FG001|Overall Study|Withdrawal by Subject|5|||
106029714|NCT00653432|365772697|FG000|Overall Study|Lost to Follow-up|7|||
106029715|NCT00653432|365772698|FG001|Overall Study|Lost to Follow-up|6|||
106029716|NCT00653432|365772697|FG000|Overall Study|Use/Need of Con Therapy|2|||
106029717|NCT00653432|365772698|FG001|Overall Study|Use/Need of Con Therapy|1|||
106029718|NCT00653432|365772697|FG000|Overall Study|Other - Reason Not Provided|5|||
106029719|NCT00653432|365772698|FG001|Overall Study|Other - Reason Not Provided|3|||
106029720|NCT01133990|365772699|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
106029721|NCT01133990|365772700|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106029722|NCT01133990|365772701|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106029723|NCT01133990|365772702|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106029724|NCT01133990|365772703|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106029725|NCT01133990|365772704|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
106029726|NCT01133990|365772699|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
106029727|NCT01133990|365772700|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
106029728|NCT01133990|365772701|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
106029729|NCT01133990|365772702|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
106029730|NCT01133990|365772703|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
106029731|NCT01133990|365772704|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
106029732|NCT01133990|365772699|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
106029733|NCT01133990|365772700|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
106029734|NCT01133990|365772701|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
106151646|NCT00111813|366215126|FG002|Overall Study|Lack of Efficacy|0|||
106151647|NCT00111813|366215127|FG003|Overall Study|Lack of Efficacy|0|||
106151648|NCT00111813|366215128|FG004|Overall Study|Lack of Efficacy|0|||
106151649|NCT00111813|366215129|FG005|Overall Study|Lack of Efficacy|1|||
106151650|NCT00111813|366215124|FG000|Overall Study|Other|0|||
106151651|NCT00111813|366215125|FG001|Overall Study|Other|0|||
106151652|NCT00111813|366215126|FG002|Overall Study|Other|1|||
106151653|NCT00111813|366215127|FG003|Overall Study|Other|0|||
106151654|NCT00111813|366215128|FG004|Overall Study|Other|0|||
106151655|NCT00111813|366215129|FG005|Overall Study|Other|0|||
106151656|NCT00818246|366215130|FG000|Overall Study|Impossible to match pictures|5|||
106151657|NCT01007396|366215131|FG000|Overall Study|Lost to Follow-up|47|||
106151658|NCT02590432|366215132|FG000|Open-label Treatment Period|Adverse Event|97|||
106029735|NCT01133990|365772702|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
106029736|NCT01133990|365772703|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
106029737|NCT01133990|365772704|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
106029738|NCT01133990|365772699|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
106029739|NCT01133990|365772700|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
106029740|NCT01133990|365772701|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
106029741|NCT01133990|365772702|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
106029742|NCT01133990|365772703|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
106151659|NCT02590432|366215133|FG001|Open-label Treatment Period|Adverse Event|79|||
106151660|NCT02590432|366215134|FG002|Open-label Treatment Period|Adverse Event|0|||
106151661|NCT02590432|366215135|FG003|Open-label Treatment Period|Adverse Event|0|||
106029743|NCT01133990|365772704|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
106029744|NCT00567255|365772705|FG000|Overall Study|Adverse Event|241|||
106151662|NCT02590432|366215136|FG004|Open-label Treatment Period|Adverse Event|0|||
106151663|NCT02590432|366215137|FG005|Open-label Treatment Period|Adverse Event|0|||
106151664|NCT02590432|366215138|FG006|Open-label Treatment Period|Adverse Event|0|||
105982210|NCT00908037|365594314|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982211|NCT00908037|365594315|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982212|NCT00908037|365594316|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982213|NCT00908037|365594317|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982214|NCT00908037|365594318|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982215|NCT00908037|365594319|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982216|NCT00908037|365594320|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982217|NCT00908037|365594321|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982218|NCT00908037|365594322|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
105982219|NCT00908037|365594323|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982220|NCT00908037|365594324|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
105982221|NCT00908037|365594313|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982222|NCT00908037|365594314|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982223|NCT00908037|365594315|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982224|NCT00908037|365594316|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982225|NCT00908037|365594317|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982226|NCT00908037|365594318|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982227|NCT00908037|365594319|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982228|NCT00908037|365594320|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982229|NCT00908037|365594321|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982230|NCT00908037|365594322|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982231|NCT00908037|365594323|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
105982232|NCT00908037|365594324|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
105982233|NCT00975143|365594326|FG000|Overall Study|Adverse Event|19|||
106029745|NCT00567255|365772706|FG001|Overall Study|Adverse Event|68|||
105982234|NCT00975143|365594327|FG001|Overall Study|Adverse Event|15|||
105982235|NCT00975143|365594326|FG000|Overall Study|Withdrawal by Subject|15|||
106029746|NCT00567255|365772705|FG000|Overall Study|Lost to Follow-up|77|||
106029747|NCT00567255|365772706|FG001|Overall Study|Lost to Follow-up|48|||
106029748|NCT00567255|365772705|FG000|Overall Study|Withdrawal by Subject|75|||
106029749|NCT00567255|365772706|FG001|Overall Study|Withdrawal by Subject|56|||
106029750|NCT00567255|365772705|FG000|Overall Study|Lack of Efficacy|19|||
106029751|NCT00567255|365772706|FG001|Overall Study|Lack of Efficacy|33|||
106029752|NCT00567255|365772705|FG000|Overall Study|Protocol Violation|20|||
106029753|NCT00567255|365772706|FG001|Overall Study|Protocol Violation|8|||
106029754|NCT00567255|365772705|FG000|Overall Study|Pregnancy|6|||
106029755|NCT00567255|365772706|FG001|Overall Study|Pregnancy|0|||
106029756|NCT00567255|365772705|FG000|Overall Study|Drug noncompliance,moved,other|25|||
106029757|NCT00567255|365772706|FG001|Overall Study|Drug noncompliance,moved,other|15|||
106029758|NCT04136444|365772712|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
106029759|NCT04136444|365772713|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
106029760|NCT01565343|365772714|FG000|Overall Study|Administrative decision/technical issues|1|||
106029761|NCT01565343|365772715|FG001|Overall Study|Administrative decision/technical issues|0|||
106029762|NCT01565343|365772716|FG002|Overall Study|Administrative decision/technical issues|0|||
106029763|NCT01270802|365772717|FG000|Overall Study|Withdrawal by Subject|1|||
106029764|NCT01270802|365772718|FG001|Overall Study|Withdrawal by Subject|0|||
106029765|NCT01270802|365772717|FG000|Overall Study|Adverse Event|1|||
106029766|NCT01270802|365772718|FG001|Overall Study|Adverse Event|0|||
106029767|NCT01270802|365772717|FG000|Overall Study|Lost to Follow-up|0|||
106029768|NCT01270802|365772718|FG001|Overall Study|Lost to Follow-up|1|||
106029769|NCT03077087|365772719|FG000|Overall Study|Physician Decision|2|||
106029770|NCT01989468|365772720|FG000|Overall Study|Adverse Event|10|||
106029771|NCT01989468|365772721|FG001|Overall Study|Adverse Event|15|||
106029772|NCT01989468|365772722|FG002|Overall Study|Adverse Event|4|||
106029773|NCT01989468|365772723|FG003|Overall Study|Adverse Event|5|||
106029774|NCT01989468|365772724|FG004|Overall Study|Adverse Event|4|||
106029775|NCT01989468|365772720|FG000|Overall Study|Lack of Efficacy|11|||
106029776|NCT01989468|365772721|FG001|Overall Study|Lack of Efficacy|11|||
106029777|NCT01989468|365772722|FG002|Overall Study|Lack of Efficacy|7|||
106029778|NCT01989468|365772723|FG003|Overall Study|Lack of Efficacy|4|||
106029779|NCT01989468|365772724|FG004|Overall Study|Lack of Efficacy|2|||
106029780|NCT01989468|365772720|FG000|Overall Study|Lost to Follow-up|5|||
106029781|NCT01989468|365772721|FG001|Overall Study|Lost to Follow-up|2|||
106029782|NCT01989468|365772722|FG002|Overall Study|Lost to Follow-up|0|||
106029783|NCT01989468|365772723|FG003|Overall Study|Lost to Follow-up|1|||
106029784|NCT01989468|365772724|FG004|Overall Study|Lost to Follow-up|1|||
106029785|NCT01989468|365772720|FG000|Overall Study|Physician Decision|4|||
106029786|NCT01989468|365772721|FG001|Overall Study|Physician Decision|1|||
106029787|NCT01989468|365772722|FG002|Overall Study|Physician Decision|0|||
106029788|NCT01989468|365772723|FG003|Overall Study|Physician Decision|1|||
106029789|NCT01989468|365772724|FG004|Overall Study|Physician Decision|0|||
106029790|NCT01989468|365772720|FG000|Overall Study|Pregnancy|0|||
106029791|NCT01989468|365772721|FG001|Overall Study|Pregnancy|1|||
106029792|NCT01989468|365772722|FG002|Overall Study|Pregnancy|0|||
106029793|NCT01989468|365772723|FG003|Overall Study|Pregnancy|0|||
106029794|NCT01989468|365772724|FG004|Overall Study|Pregnancy|0|||
106029795|NCT01989468|365772720|FG000|Overall Study|Technical Problems|3|||
106029796|NCT01989468|365772721|FG001|Overall Study|Technical Problems|1|||
106029797|NCT01989468|365772722|FG002|Overall Study|Technical Problems|3|||
106029798|NCT01989468|365772723|FG003|Overall Study|Technical Problems|1|||
106029799|NCT01989468|365772724|FG004|Overall Study|Technical Problems|0|||
106029800|NCT01989468|365772720|FG000|Overall Study|Subject Guardian Decision|11|||
106029801|NCT01989468|365772721|FG001|Overall Study|Subject Guardian Decision|6|||
106029802|NCT01989468|365772722|FG002|Overall Study|Subject Guardian Decision|4|||
106029803|NCT01989468|365772723|FG003|Overall Study|Subject Guardian Decision|4|||
106029804|NCT01989468|365772724|FG004|Overall Study|Subject Guardian Decision|1|||
106029805|NCT01989468|365772720|FG000|Overall Study|Death|3|||
106029806|NCT01989468|365772721|FG001|Overall Study|Death|0|||
106029807|NCT01989468|365772722|FG002|Overall Study|Death|1|||
106029808|NCT01989468|365772723|FG003|Overall Study|Death|0|||
106029809|NCT01989468|365772724|FG004|Overall Study|Death|0|||
106029810|NCT01738477|365772728|FG000|Overall Study|Lost to Follow-up|1|||
106029811|NCT01738477|365772729|FG001|Overall Study|Lost to Follow-up|4|||
106029812|NCT00217464|365772730|FG000|Overall Study|Progression|15|||
106029813|NCT00217464|365772730|FG000|Overall Study|Other|2|||
106029814|NCT00311584|365772735|FG000|Overall Study|Death|1|||
106029815|NCT00311584|365772736|FG001|Overall Study|Death|0|||
106029816|NCT00311584|365772735|FG000|Overall Study|Lack of Efficacy|12|||
106029817|NCT00311584|365772736|FG001|Overall Study|Lack of Efficacy|15|||
106029818|NCT00311584|365772735|FG000|Overall Study|Physician Decision|4|||
106029819|NCT00311584|365772736|FG001|Overall Study|Physician Decision|5|||
106029820|NCT00311584|365772735|FG000|Overall Study|Withdrawal by Subject|1|||
106029821|NCT00311584|365772736|FG001|Overall Study|Withdrawal by Subject|1|||
106029822|NCT00311584|365772735|FG000|Overall Study|ineligible|2|||
106029823|NCT00311584|365772736|FG001|Overall Study|ineligible|2|||
106029824|NCT03073733|365772737|FG000|Overall Study|Lost to Follow-up|1|||
106029825|NCT03073733|365772738|FG001|Overall Study|Lost to Follow-up|0|||
106029826|NCT03073733|365772739|FG002|Overall Study|Lost to Follow-up|0|||
106029827|NCT03073733|365772737|FG000|Overall Study|Physician Decision|0|||
106029828|NCT03073733|365772738|FG001|Overall Study|Physician Decision|1|||
106029829|NCT03073733|365772739|FG002|Overall Study|Physician Decision|0|||
106029830|NCT03073733|365772737|FG000|Overall Study|Withdrawal by Subject|0|||
106029831|NCT03073733|365772738|FG001|Overall Study|Withdrawal by Subject|0|||
106029832|NCT03073733|365772739|FG002|Overall Study|Withdrawal by Subject|1|||
106029833|NCT03658876|365774530|FG000|Overall Study|Protocol Violation|3|||
106029834|NCT03658876|365774531|FG001|Overall Study|Protocol Violation|2|||
106029835|NCT03658876|365774530|FG000|Overall Study|Withdrawal by Subject|2|||
106029836|NCT03658876|365774531|FG001|Overall Study|Withdrawal by Subject|0|||
106029837|NCT03658876|365774530|FG000|Overall Study|Death|0|||
106029838|NCT03658876|365774531|FG001|Overall Study|Death|1|||
106029839|NCT03658876|365774530|FG000|Overall Study|Intercurrent illness|6|||
106029840|NCT03658876|365774531|FG001|Overall Study|Intercurrent illness|4|||
106029841|NCT03658876|365774530|FG000|Overall Study|Transplantation/other operation|1|||
106029842|NCT03658876|365774531|FG001|Overall Study|Transplantation/other operation|5|||
106029843|NCT03137069|365774532|FG000|Overall Study|Withdrawal by Subject|1|||
106029844|NCT03137069|365774533|FG001|Overall Study|Withdrawal by Subject|2|||
106029845|NCT03137069|365774534|FG002|Overall Study|Withdrawal by Subject|2|||
106029846|NCT03137069|365774535|FG003|Overall Study|Withdrawal by Subject|2|||
106029847|NCT03137069|365774536|FG004|Overall Study|Withdrawal by Subject|0|||
106029848|NCT03137069|365774537|FG005|Overall Study|Withdrawal by Subject|0|||
106029849|NCT03137069|365774532|FG000|Overall Study|Adverse Event|0|||
106029850|NCT03137069|365774533|FG001|Overall Study|Adverse Event|3|||
106029851|NCT03137069|365774534|FG002|Overall Study|Adverse Event|1|||
106029852|NCT03137069|365774535|FG003|Overall Study|Adverse Event|1|||
106029853|NCT03137069|365774536|FG004|Overall Study|Adverse Event|0|||
106029854|NCT03137069|365774537|FG005|Overall Study|Adverse Event|1|||
106029855|NCT03137069|365774532|FG000|Overall Study|Protocol Violation|0|||
106029856|NCT03137069|365774533|FG001|Overall Study|Protocol Violation|1|||
106029857|NCT03137069|365774534|FG002|Overall Study|Protocol Violation|0|||
106029858|NCT03137069|365774535|FG003|Overall Study|Protocol Violation|1|||
106029859|NCT03137069|365774536|FG004|Overall Study|Protocol Violation|1|||
106029860|NCT03137069|365774537|FG005|Overall Study|Protocol Violation|1|||
106029861|NCT03137069|365774532|FG000|Overall Study|Physician Decision|0|||
106029862|NCT03137069|365774533|FG001|Overall Study|Physician Decision|0|||
106029863|NCT03137069|365774534|FG002|Overall Study|Physician Decision|0|||
106029864|NCT03137069|365774535|FG003|Overall Study|Physician Decision|1|||
106029865|NCT03137069|365774536|FG004|Overall Study|Physician Decision|0|||
106029866|NCT03137069|365774537|FG005|Overall Study|Physician Decision|0|||
106029867|NCT03137069|365774532|FG000|Overall Study|Study Terminated by Sponsor|0|||
106029868|NCT03137069|365774533|FG001|Overall Study|Study Terminated by Sponsor|0|||
106029869|NCT03137069|365774534|FG002|Overall Study|Study Terminated by Sponsor|0|||
106029870|NCT03137069|365774535|FG003|Overall Study|Study Terminated by Sponsor|0|||
106029871|NCT03137069|365774536|FG004|Overall Study|Study Terminated by Sponsor|1|||
106029872|NCT03137069|365774537|FG005|Overall Study|Study Terminated by Sponsor|0|||
106029873|NCT03137069|365774532|FG000|Overall Study|Data Entry Error|0|||
106029874|NCT03137069|365774533|FG001|Overall Study|Data Entry Error|0|||
106029875|NCT03137069|365774534|FG002|Overall Study|Data Entry Error|0|||
106029876|NCT03137069|365774535|FG003|Overall Study|Data Entry Error|1|||
106029877|NCT03137069|365774536|FG004|Overall Study|Data Entry Error|0|||
106029878|NCT03137069|365774537|FG005|Overall Study|Data Entry Error|0|||
106029879|NCT01794338|365774539|FG000|Overall Study|Death|2|||
106029880|NCT01794338|365774540|FG001|Overall Study|Death|0|||
106029881|NCT01794338|365774539|FG000|Overall Study|Lost to Follow-up|6|||
106029882|NCT01794338|365774540|FG001|Overall Study|Lost to Follow-up|9|||
106029883|NCT02043899|365774541|FG000|Overall Study|Adverse Event|3|||
106029884|NCT02043899|365774541|FG000|Overall Study|Physician Decision|1|||
106029885|NCT02043899|365774541|FG000|Overall Study|Withdrawal by Subject|2|||
106029886|NCT02043899|365774541|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
106029887|NCT02043899|365774541|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
106029888|NCT02043899|365774541|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
106029889|NCT02043899|365774541|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
106029890|NCT02043899|365774541|FG000|Overall Study|Treatment delayed|1|||
106029891|NCT01954927|365774543|FG000|Overall Study|Withdrawal by Subject|3|||
106029892|NCT01954927|365774544|FG001|Overall Study|Withdrawal by Subject|1|||
106029893|NCT03387111|365774545|FG000|Overall Study|Progressive Disease|3|||
106029894|NCT03387111|365774545|FG000|Overall Study|Other|1|||
106029895|NCT01771809|365774549|FG000|Overall Study|Adverse Event|4|||
106029896|NCT01771809|365774550|FG001|Overall Study|Adverse Event|12|||
106029897|NCT01771809|365774549|FG000|Overall Study|Protocol Violation|0|||
106029898|NCT01771809|365774550|FG001|Overall Study|Protocol Violation|1|||
106029899|NCT01771809|365774549|FG000|Overall Study|Withdrawal by Subject|34|||
106029900|NCT01771809|365774550|FG001|Overall Study|Withdrawal by Subject|42|||
106029901|NCT01771809|365774549|FG000|Overall Study|Lost to Follow-up|1|||
106029902|NCT01771809|365774550|FG001|Overall Study|Lost to Follow-up|3|||
106029903|NCT01771809|365774549|FG000|Overall Study|Other (Insufficient clinical response)|22|||
106029904|NCT01771809|365774550|FG001|Overall Study|Other (Insufficient clinical response)|20|||
106029905|NCT01771809|365774549|FG000|Overall Study|Death|1|||
106029906|NCT01771809|365774550|FG001|Overall Study|Death|0|||
106029907|NCT01771809|365774549|FG000|Overall Study|Other (other)|9|||
106029908|NCT01771809|365774550|FG001|Overall Study|Other (other)|5|||
106029909|NCT03745820|365774558|FG000|Overall Study|Adverse Event|0|||
106029910|NCT03745820|365774559|FG001|Overall Study|Adverse Event|3|||
106029911|NCT03745820|365774560|FG002|Overall Study|Adverse Event|2|||
106029912|NCT03745820|365774558|FG000|Overall Study|Non-Compliance with Study Drug|4|||
106029913|NCT03745820|365774559|FG001|Overall Study|Non-Compliance with Study Drug|3|||
106029914|NCT03745820|365774560|FG002|Overall Study|Non-Compliance with Study Drug|0|||
106029915|NCT03745820|365774558|FG000|Overall Study|Withdrawal by Subject|4|||
106029916|NCT03745820|365774559|FG001|Overall Study|Withdrawal by Subject|4|||
106029917|NCT03745820|365774560|FG002|Overall Study|Withdrawal by Subject|4|||
106029918|NCT03745820|365774558|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
106029919|NCT03745820|365774559|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
106029920|NCT03745820|365774560|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
106029921|NCT03745820|365774558|FG000|Overall Study|Lost to Follow-up|2|||
106029922|NCT03745820|365774559|FG001|Overall Study|Lost to Follow-up|0|||
106029923|NCT03745820|365774560|FG002|Overall Study|Lost to Follow-up|3|||
106029924|NCT03745820|365774558|FG000|Overall Study|Reason not Specified|2|||
106029925|NCT03745820|365774559|FG001|Overall Study|Reason not Specified|4|||
106029926|NCT03745820|365774560|FG002|Overall Study|Reason not Specified|1|||
106029927|NCT02230527|365774564|FG000|Overall Study|Withdrawal by Subject|1|||
106029928|NCT02230527|365774565|FG001|Overall Study|Withdrawal by Subject|1|||
106029929|NCT02230527|365774564|FG000|Overall Study|Death|1|||
106029930|NCT02230527|365774565|FG001|Overall Study|Death|0|||
106029931|NCT02230527|365774564|FG000|Overall Study|Lost to Follow-up|2|||
106029932|NCT02230527|365774565|FG001|Overall Study|Lost to Follow-up|1|||
106029933|NCT02230527|365774564|FG000|Overall Study|Other|1|||
106029934|NCT02230527|365774565|FG001|Overall Study|Other|0|||
106029935|NCT04461600|365774567|FG000|Overall Study|Death|6|||
106029936|NCT04461600|365774568|FG001|Overall Study|Death|5|||
106029937|NCT04461600|365774567|FG000|Overall Study|Withdrawal by Subject|0|||
106029938|NCT04461600|365774568|FG001|Overall Study|Withdrawal by Subject|1|||
106029939|NCT01242813|365774569|FG000|Overall Study|Lost to Follow-up|2|||
106029940|NCT03135119|365774570|FG000|Overall Study|Lost to Follow-up|2|||
106029941|NCT03135119|365774571|FG001|Overall Study|Lost to Follow-up|0|||
106029942|NCT03135119|365774570|FG000|Overall Study|Physician Decision|1|||
106029943|NCT03135119|365774571|FG001|Overall Study|Physician Decision|1|||
106029944|NCT03135119|365774570|FG000|Overall Study|COVID-19 Shutdown|2|||
105982236|NCT00975143|365594327|FG001|Overall Study|Withdrawal by Subject|15|||
105982237|NCT00975143|365594326|FG000|Overall Study|Lost to Follow-up|20|||
105982238|NCT00975143|365594327|FG001|Overall Study|Lost to Follow-up|16|||
105982239|NCT00975143|365594326|FG000|Overall Study|Non-compliance|5|||
105982240|NCT00975143|365594327|FG001|Overall Study|Non-compliance|8|||
105982241|NCT00975143|365594326|FG000|Overall Study|Physician Decision|1|||
105982242|NCT00975143|365594327|FG001|Overall Study|Physician Decision|2|||
105982243|NCT00975143|365594326|FG000|Overall Study|Details not available|10|||
105982244|NCT00975143|365594327|FG001|Overall Study|Details not available|4|||
105982245|NCT01375608|365594330|FG000|Overall Study|Withdrawal by Subject|2|||
105982246|NCT01792518|365594335|FG000|Overall Study|Adverse Event|3|||
105982247|NCT01792518|365594336|FG001|Overall Study|Adverse Event|4|||
105982248|NCT01792518|365594335|FG000|Overall Study|Protocol Violation|0|||
105982249|NCT01792518|365594336|FG001|Overall Study|Protocol Violation|1|||
105982250|NCT01792518|365594335|FG000|Overall Study|Lost to Follow-up|3|||
105982251|NCT01792518|365594336|FG001|Overall Study|Lost to Follow-up|1|||
105982252|NCT01792518|365594335|FG000|Overall Study|Withdrawal by Subject|2|||
105982253|NCT01792518|365594336|FG001|Overall Study|Withdrawal by Subject|0|||
105982254|NCT01792518|365594335|FG000|Overall Study|Other Reason|0|||
105982255|NCT01792518|365594336|FG001|Overall Study|Other Reason|1|||
105982256|NCT00491608|365594339|FG000|Overall Study|Death|2|||
105982257|NCT00491608|365594339|FG000|Overall Study|Withdrawal by Subject|1|||
105982258|NCT00257660|365594340|FG000|Overall Study|Lack of Efficacy|5|||
105982259|NCT00257660|365594341|FG001|Overall Study|Lack of Efficacy|23|||
105982260|NCT00257660|365594340|FG000|Overall Study|Withdrawal by Subject|2|||
105982261|NCT00257660|365594341|FG001|Overall Study|Withdrawal by Subject|0|||
105982262|NCT00257660|365594340|FG000|Overall Study|Lost to Follow-up|1|||
105982263|NCT00257660|365594341|FG001|Overall Study|Lost to Follow-up|0|||
105982264|NCT00257660|365594340|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
105982265|NCT00257660|365594341|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
105982266|NCT00257660|365594340|FG000|Overall Study|No longer wanted to do blood draws|1|||
105982267|NCT00257660|365594341|FG001|Overall Study|No longer wanted to do blood draws|0|||
105982268|NCT04109976|365594342|FG000|Overall Study|Withdrawal by Subject|1|||
105982269|NCT04109976|365594343|FG001|Overall Study|Withdrawal by Subject|0|||
105982270|NCT00249613|365594346|FG000|12 Month Follow-up|Death|1|||
105982271|NCT00249613|365594347|FG001|12 Month Follow-up|Death|1|||
105982272|NCT00249613|365594346|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
105982273|NCT00249613|365594347|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
105982274|NCT00249613|365594346|FG000|12 Month Follow-up|Lost to Follow-up|10|||
105982275|NCT00249613|365594347|FG001|12 Month Follow-up|Lost to Follow-up|8|||
105982276|NCT00552760|365594348|FG000|Overall Study|Adverse Event|3|||
105982277|NCT00552760|365594349|FG001|Overall Study|Adverse Event|5|||
105982278|NCT00552760|365594348|FG000|Overall Study|Relapsed- Depressed Event|10|||
105982279|NCT00552760|365594349|FG001|Overall Study|Relapsed- Depressed Event|16|||
105982280|NCT00552760|365594348|FG000|Overall Study|Relapse- Manic Event|3|||
105982281|NCT00552760|365594349|FG001|Overall Study|Relapse- Manic Event|3|||
105982282|NCT00552760|365594348|FG000|Overall Study|Relapsed- Mixed Event|3|||
105982283|NCT00552760|365594349|FG001|Overall Study|Relapsed- Mixed Event|5|||
105982284|NCT00552760|365594348|FG000|Overall Study|Protocol Violation|0|||
105982285|NCT00552760|365594349|FG001|Overall Study|Protocol Violation|1|||
105982286|NCT00552760|365594348|FG000|Overall Study|Lost to Follow-up|1|||
105982287|NCT00552760|365594349|FG001|Overall Study|Lost to Follow-up|1|||
105982288|NCT00552760|365594348|FG000|Overall Study|Non-compliance|1|||
105982289|NCT00552760|365594349|FG001|Overall Study|Non-compliance|1|||
105982290|NCT00552760|365594348|FG000|Overall Study|Medical Condition|1|||
105982291|NCT00552760|365594349|FG001|Overall Study|Medical Condition|1|||
105982292|NCT00552760|365594348|FG000|Overall Study|Withdrawal by Subject|3|||
105982293|NCT00552760|365594349|FG001|Overall Study|Withdrawal by Subject|0|||
105982294|NCT00552760|365594348|FG000|Overall Study|Medication Change|1|||
105982295|NCT00552760|365594349|FG001|Overall Study|Medication Change|0|||
105982296|NCT00521222|365594350|FG000|Overall Study|Lost to Follow-up|0|||
105982297|NCT00521222|365594351|FG001|Overall Study|Lost to Follow-up|0|||
105982298|NCT00521222|365594352|FG002|Overall Study|Lost to Follow-up|1|||
105982299|NCT00521222|365594353|FG003|Overall Study|Lost to Follow-up|1|||
105982300|NCT00521222|365594350|FG000|Overall Study|Withdrawal by Subject|0|||
105982301|NCT00521222|365594351|FG001|Overall Study|Withdrawal by Subject|0|||
105982302|NCT00521222|365594352|FG002|Overall Study|Withdrawal by Subject|2|||
105982303|NCT00521222|365594353|FG003|Overall Study|Withdrawal by Subject|0|||
105982304|NCT00521222|365594350|FG000|Overall Study|Physician Decision|0|||
105982305|NCT00521222|365594351|FG001|Overall Study|Physician Decision|1|||
105982306|NCT00521222|365594352|FG002|Overall Study|Physician Decision|0|||
105982307|NCT00521222|365594353|FG003|Overall Study|Physician Decision|1|||
105982308|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
105982309|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
105982310|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
105982311|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
105982312|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
105982313|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
105982314|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
105982315|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
105982316|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
105982317|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
105982318|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
105982319|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
105982320|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
105982321|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
105982322|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
105982323|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
105982324|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
105982325|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
105982326|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
105982327|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
105982328|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
106029945|NCT03135119|365774571|FG001|Overall Study|COVID-19 Shutdown|2|||
105982329|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
105982330|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
105982331|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
105982332|NCT01672866|365594356|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
105982333|NCT01672866|365594357|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
105982334|NCT01672866|365594358|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
105982335|NCT01672866|365594356|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
105982336|NCT01672866|365594357|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
105982337|NCT01672866|365594358|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
105982338|NCT01672866|365594356|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
105982339|NCT01672866|365594357|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
105982340|NCT01672866|365594358|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
105982341|NCT01672866|365594356|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
105982342|NCT01672866|365594357|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
105982343|NCT01672866|365594358|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
105982344|NCT01672866|365594356|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
105982345|NCT01672866|365594357|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
105982346|NCT01672866|365594358|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
105982347|NCT00619489|365594361|FG000|Overall Study|Adverse Event|0|||
105982348|NCT00619489|365594362|FG001|Overall Study|Adverse Event|7|||
105982349|NCT00619489|365594361|FG000|Overall Study|Withdrawal by Subject|1|||
105982350|NCT00619489|365594362|FG001|Overall Study|Withdrawal by Subject|1|||
105982351|NCT00619489|365594361|FG000|Overall Study|Lack of Efficacy|0|||
105982352|NCT00619489|365594362|FG001|Overall Study|Lack of Efficacy|11|||
105982353|NCT00619489|365594361|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
105982354|NCT00619489|365594362|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
105982355|NCT05098509|365594367|FG000|Overall Study|Withdrawal by Subject|0|||
105982356|NCT05098509|365594368|FG001|Overall Study|Withdrawal by Subject|0|||
105982357|NCT05098509|365594369|FG002|Overall Study|Withdrawal by Subject|1|||
105982358|NCT05098509|365594370|FG003|Overall Study|Withdrawal by Subject|0|||
105982359|NCT05098509|365594367|FG000|Overall Study|Early study termination|1|||
105982360|NCT05098509|365594368|FG001|Overall Study|Early study termination|1|||
105982361|NCT05098509|365594369|FG002|Overall Study|Early study termination|1|||
105982362|NCT05098509|365594370|FG003|Overall Study|Early study termination|0|||
105982363|NCT04033068|365594371|FG000|Overall Study|Withdrawal by Subject|0|||
105982364|NCT04033068|365594372|FG001|Overall Study|Withdrawal by Subject|0|||
105982365|NCT04033068|365594373|FG002|Overall Study|Withdrawal by Subject|1|||
105982366|NCT04033068|365594374|FG003|Overall Study|Withdrawal by Subject|0|||
105982367|NCT04033068|365594371|FG000|Overall Study|Lost to Follow-up|0|||
105982368|NCT04033068|365594372|FG001|Overall Study|Lost to Follow-up|1|||
105982369|NCT04033068|365594373|FG002|Overall Study|Lost to Follow-up|0|||
105982370|NCT04033068|365594374|FG003|Overall Study|Lost to Follow-up|0|||
105982371|NCT04033068|365594371|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
105982372|NCT04033068|365594372|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
105982373|NCT04033068|365594373|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
105982374|NCT04033068|365594374|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
105982375|NCT01105377|365594375|FG000|Overall Study|Withdrawal by Subject|0|||
105982376|NCT01105377|365594376|FG001|Overall Study|Withdrawal by Subject|1|||
106029946|NCT01369329|365774575|FG000|Overall Study|Withdrawal by Subject|8|||
106029947|NCT01369329|365774576|FG001|Overall Study|Withdrawal by Subject|6|||
105982377|NCT03281304|365594377|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
105982378|NCT03281304|365594378|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
105982379|NCT03281304|365594377|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
105982380|NCT03281304|365594378|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
106029948|NCT01369329|365774577|FG002|Overall Study|Withdrawal by Subject|10|||
105982381|NCT03281304|365594377|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
105982382|NCT03281304|365594378|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
105982383|NCT03281304|365594377|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
105982384|NCT03281304|365594378|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
105982385|NCT03281304|365594377|FG000|Treatment Phase (up to 42 Months)|Death|0|||
105982386|NCT03281304|365594378|FG001|Treatment Phase (up to 42 Months)|Death|1|||
105982387|NCT03281304|365594377|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
105982388|NCT03281304|365594378|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
105982389|NCT03281304|365594377|FG000|Treatment Phase (up to 42 Months)|Other|0|||
105982390|NCT03281304|365594378|FG001|Treatment Phase (up to 42 Months)|Other|2|||
105982391|NCT03281304|365594377|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
105982392|NCT03281304|365594378|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
105982393|NCT02831933|365596214|FG000|Overall Study|Physician Decision|11|||
105982394|NCT00837759|365596215|FG000|Overall Study|Protocol Violation|3|||
105982395|NCT00837759|365596215|FG000|Overall Study|Lost to Follow-up|1|||
105982396|NCT01276223|365596216|FG000|Overall Study|Adverse Event|7|||
105982397|NCT01276223|365596217|FG001|Overall Study|Adverse Event|4|||
105982398|NCT01276223|365596218|FG002|Overall Study|Adverse Event|1|||
105982399|NCT01276223|365596216|FG000|Overall Study|Lost to Follow-up|0|||
105982400|NCT01276223|365596217|FG001|Overall Study|Lost to Follow-up|0|||
105982401|NCT01276223|365596218|FG002|Overall Study|Lost to Follow-up|1|||
105982402|NCT01276223|365596216|FG000|Overall Study|Other|0|||
105982403|NCT01276223|365596217|FG001|Overall Study|Other|0|||
105982404|NCT01276223|365596218|FG002|Overall Study|Other|1|||
105982405|NCT01276223|365596216|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
105982406|NCT01276223|365596217|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
105982407|NCT01276223|365596218|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
105982408|NCT01276223|365596216|FG000|Overall Study|Protocol Violation|1|||
105982409|NCT01276223|365596217|FG001|Overall Study|Protocol Violation|0|||
105982410|NCT01276223|365596218|FG002|Overall Study|Protocol Violation|0|||
106029949|NCT01369329|365774575|FG000|Overall Study|Lost to Follow-up|2|||
106029950|NCT01369329|365774576|FG001|Overall Study|Lost to Follow-up|2|||
106029951|NCT01369329|365774577|FG002|Overall Study|Lost to Follow-up|2|||
106029952|NCT01369329|365774575|FG000|Overall Study|Other|2|||
106029953|NCT01369329|365774576|FG001|Overall Study|Other|3|||
106029954|NCT01369329|365774577|FG002|Overall Study|Other|2|||
106029955|NCT01252667|365774578|FG000|Overall Study|Transplant aborted post-conditioning|0|||
106029956|NCT01252667|365774579|FG001|Overall Study|Transplant aborted post-conditioning|0|||
106029957|NCT01252667|365774580|FG002|Overall Study|Transplant aborted post-conditioning|0|||
106029958|NCT01252667|365774581|FG003|Overall Study|Transplant aborted post-conditioning|0|||
106029959|NCT01252667|365774582|FG004|Overall Study|Transplant aborted post-conditioning|0|||
106029960|NCT01252667|365774583|FG005|Overall Study|Transplant aborted post-conditioning|1|||
106029961|NCT03330002|365774584|FG000|Overall Study|Lost to Follow-up|15|||
106029962|NCT03330002|365774584|FG000|Overall Study|Death|7|||
106029963|NCT01836276|365774585|FG000|Overall Study|Lost to Follow-up|28|||
106029964|NCT01836276|365774586|FG001|Overall Study|Lost to Follow-up|51|||
106029965|NCT00331552|365774589|FG000|Period 3: Phase II|Neurological Symptoms|1|||
106029966|NCT00331552|365774590|FG001|Period 3: Phase II|Neurological Symptoms|0|||
106029967|NCT00331552|365774589|FG000|Period 3: Phase II|Severe Nausea|1|||
106029968|NCT00331552|365774590|FG001|Period 3: Phase II|Severe Nausea|0|||
106029969|NCT00704522|365774591|FG000|Overall Study|Lack of Efficacy|65|||
106029970|NCT00704522|365774592|FG001|Overall Study|Lack of Efficacy|17|||
106029971|NCT00704522|365774591|FG000|Overall Study|Failure to appear again at hospital|56|||
106029972|NCT00704522|365774592|FG001|Overall Study|Failure to appear again at hospital|10|||
106029973|NCT00704522|365774591|FG000|Overall Study|Withdrawal by Subject|17|||
106029974|NCT00704522|365774592|FG001|Overall Study|Withdrawal by Subject|8|||
106029975|NCT00704522|365774591|FG000|Overall Study|Adverse Event|9|||
106029976|NCT00704522|365774592|FG001|Overall Study|Adverse Event|1|||
106029977|NCT00704522|365774591|FG000|Overall Study|Undefined causes|9|||
106029978|NCT00704522|365774592|FG001|Overall Study|Undefined causes|7|||
105982411|NCT00802893|365596221|FG000|Overall Study|study terminated|3|||
105982412|NCT02868229|365596222|FG000|Overall Study|Adverse Event|1|||
105982413|NCT02868229|365596223|FG001|Overall Study|Adverse Event|0|||
106029979|NCT00704522|365774591|FG000|Overall Study|No information on therapy end|27|||
105982414|NCT02868229|365596224|FG002|Overall Study|Adverse Event|0|||
105982415|NCT02868229|365596225|FG003|Overall Study|Adverse Event|1|||
105982416|NCT02868229|365596222|FG000|Overall Study|Death|0|||
105982417|NCT02868229|365596223|FG001|Overall Study|Death|0|||
105982418|NCT02868229|365596224|FG002|Overall Study|Death|1|||
105982419|NCT02868229|365596225|FG003|Overall Study|Death|1|||
106029980|NCT00704522|365774592|FG001|Overall Study|No information on therapy end|2|||
106029981|NCT00329849|365774597|FG000|Overall Study|Withdrawal by Subject|6|||
106029982|NCT00329849|365774598|FG001|Overall Study|Withdrawal by Subject|4|||
106029983|NCT02984943|365774601|FG000|Overall Study|Withdrawal by Subject|3|||
106029984|NCT02984943|365774601|FG000|Overall Study|Physician Decision|1|||
106029985|NCT05277337|365774602|FG000|Overall Study|Lost to Follow-up|2|||
106029986|NCT05277337|365774603|FG001|Overall Study|Lost to Follow-up|0|||
105982420|NCT02868229|365596222|FG000|Overall Study|Missed dose|0|||
105982421|NCT02868229|365596223|FG001|Overall Study|Missed dose|0|||
105982422|NCT02868229|365596224|FG002|Overall Study|Missed dose|0|||
105982423|NCT02868229|365596225|FG003|Overall Study|Missed dose|3|||
105982424|NCT00680368|365596228|FG000|Overall Study|not supervised, not eligible|15|||
105982425|NCT01146288|365596229|FG000|First Intervention(1 Day)|Adverse Event|0|||
105982426|NCT01146288|365596230|FG001|First Intervention(1 Day)|Adverse Event|1|||
105982427|NCT03316950|365596232|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
105982428|NCT03316950|365596233|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
105982429|NCT03316950|365596234|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
105982430|NCT03316950|365596235|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
105982431|NCT03316950|365596232|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
105982432|NCT03316950|365596233|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
105982433|NCT03316950|365596234|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
105982434|NCT03316950|365596235|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
105982435|NCT03316950|365596232|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
105982436|NCT03316950|365596233|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
105982437|NCT03316950|365596234|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
105982438|NCT03316950|365596235|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
105982439|NCT01639755|365596238|FG000|Overall Study|Study Ongoing|15|||
105982440|NCT01639755|365596238|FG000|Overall Study|Patient had device explantation|4|||
105982441|NCT03629912|365596242|FG000|Overall Study|Lost to Follow-up|19|||
105982442|NCT03629912|365596243|FG001|Overall Study|Lost to Follow-up|7|||
105982443|NCT03629912|365596244|FG002|Overall Study|Lost to Follow-up|5|||
105982444|NCT03629912|365596245|FG003|Overall Study|Lost to Follow-up|1|||
105982445|NCT03629912|365596242|FG000|Overall Study|Withdrawal by Subject|6|||
105982446|NCT03629912|365596243|FG001|Overall Study|Withdrawal by Subject|0|||
105982447|NCT03629912|365596244|FG002|Overall Study|Withdrawal by Subject|1|||
105982448|NCT03629912|365596245|FG003|Overall Study|Withdrawal by Subject|2|||
105982449|NCT03629912|365596242|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
105982450|NCT03629912|365596243|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
105982451|NCT03629912|365596244|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
105982452|NCT03629912|365596245|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
105982453|NCT03629912|365596242|FG000|Overall Study|Death|1|||
105982454|NCT03629912|365596243|FG001|Overall Study|Death|0|||
105982455|NCT03629912|365596244|FG002|Overall Study|Death|0|||
105982456|NCT03629912|365596245|FG003|Overall Study|Death|0|||
105982457|NCT00687609|365596246|FG000|Overall Study|Physician Decision|1|||
105982458|NCT00687609|365596246|FG000|Overall Study|Withdrawal by Subject|2|||
105982459|NCT01475162|365596247|FG000|Overall Study|Physician Decision|1|||
105982460|NCT01475162|365596247|FG000|Overall Study|Death|10|||
105982461|NCT01475162|365596247|FG000|Overall Study|Study closed for safety|3|||
105982462|NCT00903331|365596248|FG000|Overall Study|Death|4|||
105982463|NCT00903331|365596249|FG001|Overall Study|Death|8|||
105982464|NCT00903331|365596248|FG000|Overall Study|Withdrawal of consent|1|||
105982465|NCT00903331|365596249|FG001|Overall Study|Withdrawal of consent|8|||
105982466|NCT00903331|365596248|FG000|Overall Study|Lung transplant|0|||
105982467|NCT00903331|365596249|FG001|Overall Study|Lung transplant|2|||
105982468|NCT00025155|365596252|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
105982469|NCT00025155|365596252|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
105982470|NCT00413374|365596253|FG000|Overall Study|Ineligible due to screening criteria.|3|||
105982471|NCT00413374|365596254|FG001|Overall Study|Ineligible due to screening criteria.|0|||
105982472|NCT00413374|365596253|FG000|Overall Study|Adverse Event|1|||
105982473|NCT00413374|365596254|FG001|Overall Study|Adverse Event|0|||
105982474|NCT00413374|365596253|FG000|Overall Study|Lost to Follow-up|1|||
105982475|NCT00413374|365596254|FG001|Overall Study|Lost to Follow-up|0|||
105982476|NCT00413374|365596253|FG000|Overall Study|Surgery|1|||
105982477|NCT00413374|365596254|FG001|Overall Study|Surgery|0|||
105982478|NCT01571453|365596256|FG000|Overall Study|Adverse Event|14|||
105982479|NCT01571453|365596257|FG001|Overall Study|Adverse Event|32|||
105982480|NCT01571453|365596256|FG000|Overall Study|Lack of Efficacy|8|||
105982481|NCT01571453|365596257|FG001|Overall Study|Lack of Efficacy|3|||
105982482|NCT01571453|365596256|FG000|Overall Study|Non-compliance|2|||
105982483|NCT01571453|365596257|FG001|Overall Study|Non-compliance|4|||
105982484|NCT01571453|365596256|FG000|Overall Study|Protocol Violation|1|||
105982485|NCT01571453|365596257|FG001|Overall Study|Protocol Violation|5|||
105982486|NCT01571453|365596256|FG000|Overall Study|Withdrawal of consent|5|||
105982487|NCT01571453|365596257|FG001|Overall Study|Withdrawal of consent|13|||
105982488|NCT01571453|365596256|FG000|Overall Study|Lost to Follow-up|4|||
105982489|NCT01571453|365596257|FG001|Overall Study|Lost to Follow-up|2|||
105982490|NCT01571453|365596256|FG000|Overall Study|Administrative or other reason(s)|4|||
105982491|NCT01571453|365596257|FG001|Overall Study|Administrative or other reason(s)|3|||
105982492|NCT00710385|365596262|FG000|Overall Study|Did not qualify|1|||
105982493|NCT00710385|365596262|FG000|Overall Study|Withdrawal by Subject|1|||
105982494|NCT00710385|365596262|FG000|Overall Study|Undisclosed back pain|1|||
105982495|NCT00710385|365596262|FG000|Overall Study|Physician Decision|1|||
105982496|NCT00710385|365596262|FG000|Overall Study|Undisclosed excessive methadone use|1|||
105982497|NCT04598269|365596265|FG000|Overall Study|Adverse Event|0|||
105982498|NCT04598269|365596266|FG001|Overall Study|Adverse Event|3|||
105982499|NCT04598269|365596265|FG000|Overall Study|Withdrawal by Subject|1|||
105982500|NCT04598269|365596266|FG001|Overall Study|Withdrawal by Subject|4|||
105982501|NCT04598269|365596265|FG000|Overall Study|Lost to Follow-up|1|||
105982502|NCT04598269|365596266|FG001|Overall Study|Lost to Follow-up|0|||
105982503|NCT04598269|365596265|FG000|Overall Study|Not Treated|2|||
105982504|NCT04598269|365596266|FG001|Overall Study|Not Treated|0|||
105982505|NCT00424190|365596267|FG000|Overall Study|Withdrew consent|3|||
105982506|NCT00424190|365596268|FG001|Overall Study|Withdrew consent|4|||
105982507|NCT00424190|365596267|FG000|Overall Study|Death|3|||
105982508|NCT00424190|365596268|FG001|Overall Study|Death|0|||
105982509|NCT00424190|365596267|FG000|Overall Study|Noncompliance|1|||
105982510|NCT00424190|365596268|FG001|Overall Study|Noncompliance|2|||
105982511|NCT00424190|365596267|FG000|Overall Study|Request of sponsor or investigator|0|||
105982512|NCT00424190|365596268|FG001|Overall Study|Request of sponsor or investigator|2|||
105982513|NCT00424190|365596267|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
105982514|NCT00424190|365596268|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
105982515|NCT00424190|365596267|FG000|Overall Study|Other|15|||
105982516|NCT00424190|365596268|FG001|Overall Study|Other|21|||
105982517|NCT02966015|365596270|FG000|Inclusion Visit|did not answer questionnaire|8|||
105982518|NCT02966015|365596271|FG001|Inclusion Visit|did not answer questionnaire|3|||
105982519|NCT03040986|365596276|FG000|Overall Study|Hospice|1|||
105982520|NCT03040986|365596277|FG001|Overall Study|Hospice|0|||
105982521|NCT03040986|365596276|FG000|Overall Study|Adverse Event|2|||
105982522|NCT03040986|365596277|FG001|Overall Study|Adverse Event|1|||
105982523|NCT03040986|365596276|FG000|Overall Study|Disease progression on study|3|||
105982524|NCT03040986|365596277|FG001|Overall Study|Disease progression on study|1|||
105982525|NCT00845065|365596279|FG000|Overall Study|Adverse Event|3|||
105982526|NCT00845065|365596280|FG001|Overall Study|Adverse Event|23|||
105982527|NCT00845065|365596279|FG000|Overall Study|Lack of Efficacy|43|||
105982528|NCT00845065|365596280|FG001|Overall Study|Lack of Efficacy|21|||
105982529|NCT00845065|365596279|FG000|Overall Study|Non-Medical Reasons|1|||
105982530|NCT00845065|365596280|FG001|Overall Study|Non-Medical Reasons|11|||
105982531|NCT00499746|365596284|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
105982532|NCT00499746|365596284|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
105982533|NCT00499746|365596284|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
105982534|NCT00499746|365596284|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
105982535|NCT02228096|365596285|FG000|Overall Study|Study terminated by Sponsor|24|||
105982536|NCT02228096|365596285|FG000|Overall Study|Lack of Efficacy|18|||
105982537|NCT02228096|365596285|FG000|Overall Study|Death|12|||
105982538|NCT02228096|365596285|FG000|Overall Study|Physician Decision|3|||
105982539|NCT02228096|365596285|FG000|Overall Study|Subject/guardian decision|2|||
105982540|NCT02228096|365596285|FG000|Overall Study|New therapy for study indication|1|||
105982541|NCT02228096|365596285|FG000|Overall Study|Enrolled, not infused|11|||
105982542|NCT01969721|365596287|FG000|Overall Study|Adverse Event|3|||
105982543|NCT01969721|365596288|FG001|Overall Study|Adverse Event|8|||
105982544|NCT01969721|365596289|FG002|Overall Study|Adverse Event|3|||
105982545|NCT01969721|365596290|FG003|Overall Study|Adverse Event|2|||
105982546|NCT01969721|365596287|FG000|Overall Study|Lack of Efficacy|0|||
105982547|NCT01969721|365596288|FG001|Overall Study|Lack of Efficacy|0|||
105982548|NCT01969721|365596289|FG002|Overall Study|Lack of Efficacy|1|||
105982549|NCT01969721|365596290|FG003|Overall Study|Lack of Efficacy|0|||
105982550|NCT01969721|365596287|FG000|Overall Study|Non compliant with protocol|1|||
105982551|NCT01969721|365596288|FG001|Overall Study|Non compliant with protocol|1|||
105982552|NCT01969721|365596289|FG002|Overall Study|Non compliant with protocol|0|||
105982553|NCT01969721|365596290|FG003|Overall Study|Non compliant with protocol|2|||
105982554|NCT01969721|365596287|FG000|Overall Study|Other not defined above|0|||
105982555|NCT01969721|365596288|FG001|Overall Study|Other not defined above|2|||
105982556|NCT01969721|365596289|FG002|Overall Study|Other not defined above|0|||
106029987|NCT05277337|365774602|FG000|Overall Study|Withdrawal by Subject|1|||
106029988|NCT05277337|365774603|FG001|Overall Study|Withdrawal by Subject|0|||
106029989|NCT04905498|365774609|FG000|Overall Study|Lost to Follow-up|0|||
106029990|NCT04905498|365774610|FG001|Overall Study|Lost to Follow-up|2|||
106029991|NCT04905498|365774609|FG000|Overall Study|COVID lockdown|1|||
106029992|NCT04905498|365774610|FG001|Overall Study|COVID lockdown|0|||
106029993|NCT02946931|365774611|FG000|Overall Study|Did not require collection of CRFs|588|||
106029994|NCT02946931|365774611|FG000|Overall Study|Other than listed|37|||
106029995|NCT02946931|365774611|FG000|Overall Study|Discharge from hospital|118|||
106029996|NCT02946931|365774611|FG000|Overall Study|Adverse Event|81|||
106029997|NCT02946931|365774611|FG000|Overall Study|CRFs not valid|1|||
106029998|NCT02946931|365774611|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
106029999|NCT03339297|365774612|FG000|Overall Study|Relapse of Hematologic Disease|1|||
106030000|NCT03339297|365774613|FG001|Overall Study|Relapse of Hematologic Disease|0|||
106030001|NCT03339297|365774612|FG000|Overall Study|Death|10|||
106030002|NCT03339297|365774613|FG001|Overall Study|Death|7|||
106030003|NCT03339297|365774612|FG000|Overall Study|Hepatic Candidosis|1|||
106030004|NCT03339297|365774613|FG001|Overall Study|Hepatic Candidosis|0|||
106030005|NCT03339297|365774612|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
106030006|NCT03339297|365774613|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
106030007|NCT03339297|365774612|FG000|Overall Study|Consent Withdrawn by Participant|3|||
106030008|NCT03339297|365774613|FG001|Overall Study|Consent Withdrawn by Participant|3|||
106030009|NCT03339297|365774612|FG000|Overall Study|Disease Relapse|2|||
106030010|NCT03339297|365774613|FG001|Overall Study|Disease Relapse|0|||
106030011|NCT03339297|365774612|FG000|Overall Study|Physician Decision|1|||
106030012|NCT03339297|365774613|FG001|Overall Study|Physician Decision|1|||
106030013|NCT03339297|365774612|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
106030014|NCT03339297|365774613|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
106030015|NCT03339297|365774612|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
106030016|NCT03339297|365774613|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
106030017|NCT03339297|365774612|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
106030018|NCT03339297|365774613|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
106030019|NCT03339297|365774612|FG000|Overall Study|Adverse Event, Non-fatal|1|||
106030020|NCT03339297|365774613|FG001|Overall Study|Adverse Event, Non-fatal|0|||
106030021|NCT03339297|365774612|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
106030022|NCT03339297|365774613|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
106030023|NCT03339297|365774612|FG000|Overall Study|Patient Was Not Eligible|1|||
106030024|NCT03339297|365774613|FG001|Overall Study|Patient Was Not Eligible|0|||
106030025|NCT05498701|365774614|FG000|Period 3|Adverse Event|1|||
106030026|NCT05498701|365774615|FG001|Period 3|Adverse Event|0|||
106030027|NCT01328444|365774616|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
106030028|NCT01328444|365774617|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
106030029|NCT01328444|365774618|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
106030030|NCT01328444|365774619|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
106030031|NCT01328444|365774620|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
105982557|NCT01969721|365596290|FG003|Overall Study|Other not defined above|0|||
105982558|NCT01969721|365596287|FG000|Overall Study|Discontinued during washout periods.|0|||
105982559|NCT01969721|365596288|FG001|Overall Study|Discontinued during washout periods.|1|||
105982560|NCT01969721|365596289|FG002|Overall Study|Discontinued during washout periods.|1|||
105982561|NCT01969721|365596290|FG003|Overall Study|Discontinued during washout periods.|2|||
105982562|NCT00495755|365596291|FG000|Overall Study|Adverse Event|3|||
105982563|NCT01012323|365596292|FG000|Overall Study|Investigator Judgment|1|||
106030032|NCT01328444|365774621|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
106030033|NCT01328444|365774616|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
106030034|NCT01328444|365774617|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
106030035|NCT01328444|365774618|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
106030036|NCT01328444|365774619|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
106030037|NCT01328444|365774620|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
106030038|NCT01328444|365774621|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
106030039|NCT01328444|365774616|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
106030040|NCT01328444|365774617|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
106030041|NCT01328444|365774618|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
106030042|NCT01328444|365774619|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
106030043|NCT01328444|365774620|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
106030044|NCT01328444|365774621|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
105982564|NCT02117349|365596293|FG000|Overall Study|Withdrawal by Subject|1|||
105982565|NCT02117349|365596294|FG001|Overall Study|Withdrawal by Subject|0|||
106030045|NCT01328444|365774616|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
106030046|NCT01328444|365774617|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
106030047|NCT01328444|365774618|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
106030048|NCT01328444|365774619|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
106030049|NCT01328444|365774620|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
106030050|NCT01328444|365774621|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
106030051|NCT01328444|365774616|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
106030052|NCT01328444|365774617|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106030053|NCT01328444|365774618|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106030054|NCT01328444|365774619|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
106030055|NCT01328444|365774620|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
106030056|NCT01328444|365774621|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
106030057|NCT01328444|365774616|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
106030058|NCT01328444|365774617|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
106030059|NCT01328444|365774618|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
106030060|NCT01328444|365774619|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
106030061|NCT01328444|365774620|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
106030062|NCT01328444|365774621|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
106030063|NCT01328444|365774616|FG000|Washout Period (14 Days)|Adverse Event|1|||
106030064|NCT01328444|365774617|FG001|Washout Period (14 Days)|Adverse Event|1|||
105982566|NCT02117349|365596293|FG000|Overall Study|Lost to Follow-up|1|||
105982567|NCT02117349|365596294|FG001|Overall Study|Lost to Follow-up|1|||
105982568|NCT02117349|365596293|FG000|Overall Study|Death|1|||
105982569|NCT02117349|365596294|FG001|Overall Study|Death|0|||
105982570|NCT02273960|365596295|FG000|Short Term Period|Lost to Follow-up|1|||
105982571|NCT02273960|365596296|FG001|Short Term Period|Lost to Follow-up|0|||
106030065|NCT01328444|365774618|FG002|Washout Period (14 Days)|Adverse Event|0|||
106030066|NCT01328444|365774619|FG003|Washout Period (14 Days)|Adverse Event|1|||
106030067|NCT01328444|365774620|FG004|Washout Period (14 Days)|Adverse Event|1|||
106030068|NCT01328444|365774621|FG005|Washout Period (14 Days)|Adverse Event|2|||
106030069|NCT01328444|365774616|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
106030070|NCT01328444|365774617|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
106030071|NCT01328444|365774618|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
106030072|NCT01328444|365774619|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
106030073|NCT01328444|365774620|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
106030074|NCT01328444|365774621|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
105982572|NCT02273960|365596297|FG002|Short Term Period|Lost to Follow-up|0|||
105982573|NCT02273960|365596298|FG003|Short Term Period|Lost to Follow-up|0|||
105982574|NCT02273960|365596295|FG000|Short Term Period|Lack of Efficacy|0|||
105982575|NCT02273960|365596296|FG001|Short Term Period|Lack of Efficacy|0|||
105982576|NCT02273960|365596297|FG002|Short Term Period|Lack of Efficacy|0|||
105982577|NCT02273960|365596298|FG003|Short Term Period|Lack of Efficacy|1|||
105982578|NCT02273960|365596295|FG000|Short Term Period|ST complete, not entering LTE|4|||
105982579|NCT02273960|365596296|FG001|Short Term Period|ST complete, not entering LTE|6|||
105982580|NCT02273960|365596297|FG002|Short Term Period|ST complete, not entering LTE|4|||
105982581|NCT02273960|365596298|FG003|Short Term Period|ST complete, not entering LTE|5|||
105982582|NCT02273960|365596295|FG000|Long Term Extension|Death|0|||
106030075|NCT01328444|365774616|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
106030076|NCT01328444|365774617|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
106030077|NCT01328444|365774618|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
106030078|NCT01328444|365774619|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
106030079|NCT01328444|365774620|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
106030080|NCT01328444|365774621|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
106030081|NCT01328444|365774616|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
105982583|NCT02273960|365596296|FG001|Long Term Extension|Death|0|||
105982584|NCT02273960|365596297|FG002|Long Term Extension|Death|0|||
105982585|NCT02273960|365596298|FG003|Long Term Extension|Death|1|||
105982586|NCT01440881|365596301|FG000|Overall Study|Death|0|||
105982587|NCT01440881|365596302|FG001|Overall Study|Death|1|||
106030082|NCT01328444|365774617|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
106030083|NCT01328444|365774618|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
106030084|NCT01328444|365774619|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
106030085|NCT01328444|365774620|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
106030086|NCT01328444|365774621|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
106030087|NCT01328444|365774616|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
106030088|NCT01328444|365774617|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
106030089|NCT01328444|365774618|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
105982588|NCT02265796|365596303|FG000|Overall Study|Death|1|||
105982589|NCT02265796|365596304|FG001|Overall Study|Death|0|||
105982590|NCT02265796|365596303|FG000|Overall Study|started on excluded medication|1|||
105982591|NCT02265796|365596304|FG001|Overall Study|started on excluded medication|0|||
105982592|NCT02265796|365596303|FG000|Overall Study|Withdrawal by Subject|1|||
106030090|NCT01328444|365774619|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
106030091|NCT01328444|365774620|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
106030092|NCT01328444|365774621|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
106030093|NCT01328444|365774616|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
106030094|NCT01328444|365774617|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
106030095|NCT01328444|365774618|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
106030096|NCT01328444|365774619|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
105982593|NCT02265796|365596304|FG001|Overall Study|Withdrawal by Subject|1|||
105982594|NCT02477553|365596305|FG000|Overall Study|Screening up-to-date|12|||
105982595|NCT02477553|365596306|FG001|Overall Study|Screening up-to-date|13|||
105982596|NCT02477553|365596305|FG000|Overall Study|No MD visit|1|||
105982597|NCT02477553|365596306|FG001|Overall Study|No MD visit|1|||
105982598|NCT02477553|365596305|FG000|Overall Study|Workup consistent w/CRC|1|||
105982599|NCT02477553|365596306|FG001|Overall Study|Workup consistent w/CRC|1|||
105982600|NCT02477553|365596305|FG000|Overall Study|Technical issues with intervention|2|||
105982601|NCT02477553|365596306|FG001|Overall Study|Technical issues with intervention|0|||
105982602|NCT02477553|365596305|FG000|Overall Study|Elevated risk for CRC|2|||
105982603|NCT02477553|365596306|FG001|Overall Study|Elevated risk for CRC|2|||
105982604|NCT02477553|365596305|FG000|Overall Study|MD advised against screening|1|||
105982605|NCT02477553|365596306|FG001|Overall Study|MD advised against screening|3|||
105982606|NCT02477553|365596305|FG000|Overall Study|patient deceased|1|||
105982607|NCT02477553|365596306|FG001|Overall Study|patient deceased|0|||
105982608|NCT02745535|365596309|FG000|Overall Study|Death|1|||
105982609|NCT02745535|365596309|FG000|Overall Study|Adverse Event|3|||
105982610|NCT02745535|365596309|FG000|Overall Study|Lost to Follow-up|2|||
105982611|NCT01789606|365596310|FG000|Overall Study|Participant not Purchased the Product|0|||
105982612|NCT01789606|365596311|FG001|Overall Study|Participant not Purchased the Product|20|||
105982613|NCT01789606|365596310|FG000|Overall Study|Withdrawal by Subject|0|||
105982614|NCT01789606|365596311|FG001|Overall Study|Withdrawal by Subject|1|||
105982615|NCT01789606|365596310|FG000|Overall Study|Ineligible|6|||
105982616|NCT01789606|365596311|FG001|Overall Study|Ineligible|2|||
106030097|NCT01328444|365774620|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
106030098|NCT01328444|365774621|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
106030099|NCT01328444|365774616|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
106030100|NCT01328444|365774617|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
106030101|NCT01328444|365774618|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
106030102|NCT01328444|365774619|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
106030103|NCT01328444|365774620|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
105982617|NCT01789606|365596310|FG000|Overall Study|Administrative Reasons|17|||
105982618|NCT01789606|365596311|FG001|Overall Study|Administrative Reasons|6|||
105982619|NCT01789606|365596310|FG000|Overall Study|No Study Medication Taken|0|||
106030104|NCT01328444|365774621|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
106030105|NCT01328444|365774616|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
106030106|NCT01328444|365774617|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
106030107|NCT01328444|365774618|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
106030108|NCT01328444|365774619|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
106030109|NCT01328444|365774620|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
106030110|NCT01328444|365774621|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
106030111|NCT01328444|365774616|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
106030112|NCT01328444|365774617|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
106030113|NCT01328444|365774618|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
106030114|NCT01328444|365774619|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
106030115|NCT01328444|365774620|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
106030116|NCT01328444|365774621|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
105982620|NCT01789606|365596311|FG001|Overall Study|No Study Medication Taken|1|||
105982621|NCT01789606|365596310|FG000|Overall Study|Protocol Violation|0|||
105982622|NCT01789606|365596311|FG001|Overall Study|Protocol Violation|55|||
106030117|NCT02486627|365774627|FG000|Overall Study|Death|1|||
106030118|NCT02486627|365774628|FG001|Overall Study|Death|0|||
105982623|NCT01789606|365596310|FG000|Overall Study|Adverse Event|0|||
105982624|NCT01789606|365596311|FG001|Overall Study|Adverse Event|3|||
105982625|NCT01789606|365596310|FG000|Overall Study|Lost to Follow-up|0|||
105982626|NCT01789606|365596311|FG001|Overall Study|Lost to Follow-up|14|||
105982627|NCT01789606|365596310|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
105982628|NCT01789606|365596311|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
105982629|NCT00849108|365596315|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
105982630|NCT00849108|365596316|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
105982631|NCT00849108|365596315|FG000|Cohort 2 Efficacy|Adverse Event|0|||
105982632|NCT00849108|365596316|FG001|Cohort 2 Efficacy|Adverse Event|1|||
105982633|NCT00849108|365596315|FG000|Cohort 2 Efficacy|Other|0|||
105982634|NCT00849108|365596316|FG001|Cohort 2 Efficacy|Other|9|||
105982635|NCT02925728|365596317|FG000|Overall Study|Death|3|||
105982636|NCT02925728|365596318|FG001|Overall Study|Death|5|||
105982637|NCT02925728|365596317|FG000|Overall Study|Physician Decision|1|||
105982638|NCT02925728|365596318|FG001|Overall Study|Physician Decision|0|||
105982639|NCT02925728|365596317|FG000|Overall Study|Withdrawal by Subject|1|||
105982640|NCT02925728|365596318|FG001|Overall Study|Withdrawal by Subject|0|||
105982641|NCT02963701|365596319|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
105982642|NCT02963701|365596320|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
105982643|NCT03480009|365596323|FG000|Overall Study|Lost to Follow-up|4|||
105982644|NCT03480009|365596324|FG001|Overall Study|Lost to Follow-up|5|||
105982645|NCT03480009|365596325|FG002|Overall Study|Lost to Follow-up|4|||
105982646|NCT03480009|365596326|FG003|Overall Study|Lost to Follow-up|0|||
105982647|NCT00637572|365596327|FG000|Overall Study|Adverse Event|1|||
105982648|NCT00637572|365596328|FG001|Overall Study|Adverse Event|2|||
106030119|NCT02486627|365774627|FG000|Overall Study|Other Unspecified|0|||
106030120|NCT02486627|365774628|FG001|Overall Study|Other Unspecified|2|||
106030121|NCT02486627|365774627|FG000|Overall Study|Consent Withdrawn by Participant|4|||
106030122|NCT02486627|365774628|FG001|Overall Study|Consent Withdrawn by Participant|3|||
106030123|NCT02486627|365774627|FG000|Overall Study|Significant Participant Noncompliance|1|||
106030124|NCT02486627|365774628|FG001|Overall Study|Significant Participant Noncompliance|1|||
106030125|NCT02486627|365774627|FG000|Overall Study|Lost to Follow-up|1|||
106030126|NCT02486627|365774628|FG001|Overall Study|Lost to Follow-up|3|||
106030127|NCT01509053|365774629|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
106030128|NCT01509053|365774629|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
106030129|NCT01509053|365774629|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
106030130|NCT01509053|365774629|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
106030131|NCT01509053|365774629|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
106030132|NCT01509053|365774629|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
106030133|NCT01915303|365774633|FG000|Core Phase|Adverse Event|7|||
106030134|NCT01915303|365774633|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
106030135|NCT01915303|365774633|FG000|Core Phase|Death|2|||
106030136|NCT01915303|365774633|FG000|Core Phase|Protocol Violation|2|||
106030137|NCT01915303|365774633|FG000|Core Phase|Abnormal lab value|1|||
106030138|NCT01915303|365774633|FG000|Core Phase|Withdrawal by Subject|1|||
106030139|NCT01915303|365774633|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
106030140|NCT01915303|365774633|FG000|Extension Phase|Withdrawal by Subject|4|||
106030141|NCT01915303|365774633|FG000|Extension Phase|Adverse Event|3|||
106030142|NCT01915303|365774633|FG000|Extension Phase|Death|1|||
106030143|NCT01915303|365774633|FG000|Extension Phase|Protocol Violation|1|||
106030144|NCT02509117|365774634|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
106030145|NCT02509117|365774635|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
106030146|NCT02509117|365774636|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
106030147|NCT02509117|365774637|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
106030148|NCT02509117|365774638|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
106030149|NCT02509117|365774639|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
106030150|NCT02509117|365774640|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
106030151|NCT02509117|365774641|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
106030152|NCT02509117|365774642|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
105982649|NCT00637572|365596327|FG000|Overall Study|Death|0|||
105982650|NCT00637572|365596328|FG001|Overall Study|Death|1|||
105982651|NCT00637572|365596327|FG000|Overall Study|Lost to Follow-up|0|||
105982652|NCT00637572|365596328|FG001|Overall Study|Lost to Follow-up|1|||
105982653|NCT00637572|365596327|FG000|Overall Study|Physician Decision|1|||
105982654|NCT00637572|365596328|FG001|Overall Study|Physician Decision|1|||
105982655|NCT00637572|365596327|FG000|Overall Study|Withdrawal by Subject|0|||
106030153|NCT02509117|365774643|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
106030154|NCT02509117|365774634|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
106030155|NCT02509117|365774635|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
106030156|NCT02509117|365774636|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
106030157|NCT02509117|365774637|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
106030158|NCT02509117|365774638|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
106030159|NCT02509117|365774639|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
106030160|NCT02509117|365774640|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
106030161|NCT02509117|365774641|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
106030162|NCT02509117|365774642|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
105982656|NCT00637572|365596328|FG001|Overall Study|Withdrawal by Subject|2|||
105982657|NCT00637572|365596327|FG000|Overall Study|Illicit Drug Use|1|||
105982658|NCT00637572|365596328|FG001|Overall Study|Illicit Drug Use|0|||
105982659|NCT00896649|365596329|FG000|Overall Study|Physician Decision|1|||
105982660|NCT00896649|365596329|FG000|Overall Study|Pregnancy|1|||
105982661|NCT00896649|365596329|FG000|Overall Study|missing documentation|1|||
105982662|NCT00896649|365596329|FG000|Overall Study|technical difficulties|2|||
105982663|NCT01563172|365596330|FG000|Overall Study|Adverse Event|5|||
105982664|NCT01563172|365596330|FG000|Overall Study|Lost to Follow-up|2|||
105982665|NCT01563172|365596330|FG000|Overall Study|Other (Protocol deviation)|5|||
105982666|NCT01563172|365596330|FG000|Overall Study|Other (Not specified)|1|||
105982667|NCT03652675|365596331|FG000|Overall Study|Lost to Follow-up|4|||
105982668|NCT03652675|365596332|FG001|Overall Study|Lost to Follow-up|4|||
105982669|NCT03834220|365596344|FG000|Overall Study|Adverse Event|1|||
105982670|NCT03834220|365596345|FG001|Overall Study|Adverse Event|0|||
105982671|NCT03834220|365596346|FG002|Overall Study|Adverse Event|0|||
105982672|NCT03834220|365596344|FG000|Overall Study|Death|8|||
105982673|NCT03834220|365596345|FG001|Overall Study|Death|1|||
105982674|NCT03834220|365596346|FG002|Overall Study|Death|17|||
105982675|NCT03834220|365596344|FG000|Overall Study|Reason not Specified|9|||
105982676|NCT03834220|365596345|FG001|Overall Study|Reason not Specified|0|||
106030163|NCT02509117|365774643|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
106030164|NCT02509117|365774634|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
105982677|NCT03834220|365596346|FG002|Overall Study|Reason not Specified|6|||
105982678|NCT03834220|365596344|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
105982679|NCT03834220|365596345|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
105982680|NCT03834220|365596346|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
105982681|NCT03834220|365596344|FG000|Overall Study|Withdrawal of Consent|2|||
105982682|NCT03834220|365596345|FG001|Overall Study|Withdrawal of Consent|2|||
105982683|NCT03834220|365596346|FG002|Overall Study|Withdrawal of Consent|2|||
105982684|NCT01161537|365598230|FG000|Part B|Withdrawal by Subject|2|||
105982685|NCT01629953|365598237|FG000|Overall Study|Death|3|||
105982686|NCT01629953|365598238|FG001|Overall Study|Death|1|||
105982687|NCT01629953|365598237|FG000|Overall Study|Lost to Follow-up|10|||
105982688|NCT01629953|365598238|FG001|Overall Study|Lost to Follow-up|14|||
105982689|NCT00720343|365598241|FG000|Overall Study|Lost to Follow-up|1|||
105982690|NCT00720343|365598242|FG001|Overall Study|Lost to Follow-up|0|||
105982691|NCT00720343|365598241|FG000|Overall Study|Protocol Violation|0|||
105982692|NCT00720343|365598242|FG001|Overall Study|Protocol Violation|2|||
105982693|NCT02008773|365598243|FG000|Overall Study|Adverse Event|3|||
105982694|NCT02008773|365598244|FG001|Overall Study|Adverse Event|3|||
105982695|NCT02008773|365598245|FG002|Overall Study|Adverse Event|1|||
105982696|NCT02008773|365598246|FG003|Overall Study|Adverse Event|2|||
105982697|NCT02008773|365598243|FG000|Overall Study|Medication Non-compliance|2|||
105982698|NCT02008773|365598244|FG001|Overall Study|Medication Non-compliance|1|||
105982699|NCT02008773|365598245|FG002|Overall Study|Medication Non-compliance|3|||
105982700|NCT02008773|365598246|FG003|Overall Study|Medication Non-compliance|2|||
105982701|NCT02008773|365598243|FG000|Overall Study|Withdrawal by Subject|8|||
105982702|NCT02008773|365598244|FG001|Overall Study|Withdrawal by Subject|4|||
105982703|NCT02008773|365598245|FG002|Overall Study|Withdrawal by Subject|7|||
105982704|NCT02008773|365598246|FG003|Overall Study|Withdrawal by Subject|6|||
105982705|NCT02008773|365598243|FG000|Overall Study|Lost to Follow-up|0|||
105982706|NCT02008773|365598244|FG001|Overall Study|Lost to Follow-up|1|||
105982707|NCT02008773|365598245|FG002|Overall Study|Lost to Follow-up|3|||
105982708|NCT02008773|365598246|FG003|Overall Study|Lost to Follow-up|2|||
105982709|NCT00707954|365598247|FG000|Overall Study|Physician Decision|0|||
105982710|NCT00707954|365598248|FG001|Overall Study|Physician Decision|0|||
105982711|NCT00707954|365598249|FG002|Overall Study|Physician Decision|0|||
105982712|NCT00707954|365598250|FG003|Overall Study|Physician Decision|0|||
105982713|NCT00707954|365598251|FG004|Overall Study|Physician Decision|1|||
105982714|NCT00306527|365598252|FG000|Overall Study|Lost to Follow-up|3|||
105982715|NCT00306527|365598253|FG001|Overall Study|Lost to Follow-up|4|||
105982716|NCT00306527|365598254|FG002|Overall Study|Lost to Follow-up|3|||
105982717|NCT00306527|365598255|FG003|Overall Study|Lost to Follow-up|0|||
105982718|NCT00306527|365598252|FG000|Overall Study|Withdrawal by Subject|2|||
105982719|NCT00306527|365598253|FG001|Overall Study|Withdrawal by Subject|3|||
105982720|NCT00306527|365598254|FG002|Overall Study|Withdrawal by Subject|0|||
105982721|NCT00306527|365598255|FG003|Overall Study|Withdrawal by Subject|3|||
105982722|NCT00306527|365598252|FG000|Overall Study|Adverse Event|0|||
105982723|NCT00306527|365598253|FG001|Overall Study|Adverse Event|0|||
105982724|NCT00306527|365598254|FG002|Overall Study|Adverse Event|1|||
105982725|NCT00306527|365598255|FG003|Overall Study|Adverse Event|1|||
105982726|NCT00306527|365598252|FG000|Overall Study|Death|1|||
105982727|NCT00306527|365598253|FG001|Overall Study|Death|0|||
105982728|NCT00306527|365598254|FG002|Overall Study|Death|1|||
105982729|NCT00306527|365598255|FG003|Overall Study|Death|2|||
105982730|NCT01918332|365598256|FG000|Overall Study|Adverse Event|0|||
105982731|NCT01918332|365598257|FG001|Overall Study|Adverse Event|0|||
105982732|NCT01918332|365598258|FG002|Overall Study|Adverse Event|0|||
105982733|NCT01918332|365598259|FG003|Overall Study|Adverse Event|1|||
105982734|NCT01918332|365598256|FG000|Overall Study|Withdrawal by Subject|2|||
105982735|NCT01918332|365598257|FG001|Overall Study|Withdrawal by Subject|3|||
105982736|NCT01918332|365598258|FG002|Overall Study|Withdrawal by Subject|2|||
105982737|NCT01918332|365598259|FG003|Overall Study|Withdrawal by Subject|3|||
105982738|NCT01918332|365598256|FG000|Overall Study|Protocol Violation|6|||
105982739|NCT01918332|365598257|FG001|Overall Study|Protocol Violation|2|||
105982740|NCT01918332|365598258|FG002|Overall Study|Protocol Violation|6|||
105982741|NCT01918332|365598259|FG003|Overall Study|Protocol Violation|3|||
105982742|NCT01918332|365598256|FG000|Overall Study|lipid result by central lab did not meet|0|||
105982743|NCT01918332|365598257|FG001|Overall Study|lipid result by central lab did not meet|0|||
105982744|NCT01918332|365598258|FG002|Overall Study|lipid result by central lab did not meet|1|||
105982745|NCT01918332|365598259|FG003|Overall Study|lipid result by central lab did not meet|0|||
105982746|NCT02905006|365598260|FG000|Overall Study|Adverse Event|1|||
105982747|NCT02905006|365598261|FG001|Overall Study|Adverse Event|1|||
105982748|NCT02905006|365598262|FG002|Overall Study|Adverse Event|1|||
105982749|NCT02905006|365598263|FG003|Overall Study|Adverse Event|1|||
105982750|NCT02905006|365598264|FG004|Overall Study|Adverse Event|0|||
105982751|NCT02905006|365598265|FG005|Overall Study|Adverse Event|1|||
105982752|NCT02905006|365598260|FG000|Overall Study|Lack of Efficacy|1|||
105982753|NCT02905006|365598261|FG001|Overall Study|Lack of Efficacy|0|||
105982754|NCT02905006|365598262|FG002|Overall Study|Lack of Efficacy|0|||
105982755|NCT02905006|365598263|FG003|Overall Study|Lack of Efficacy|0|||
105982756|NCT02905006|365598264|FG004|Overall Study|Lack of Efficacy|0|||
105982757|NCT02905006|365598265|FG005|Overall Study|Lack of Efficacy|0|||
105982758|NCT02905006|365598260|FG000|Overall Study|Protocol Violation|2|||
105982759|NCT02905006|365598261|FG001|Overall Study|Protocol Violation|0|||
105982760|NCT02905006|365598262|FG002|Overall Study|Protocol Violation|0|||
105982761|NCT02905006|365598263|FG003|Overall Study|Protocol Violation|0|||
105982762|NCT02905006|365598264|FG004|Overall Study|Protocol Violation|0|||
105982763|NCT02905006|365598265|FG005|Overall Study|Protocol Violation|0|||
105982764|NCT02905006|365598260|FG000|Overall Study|Lost to Follow-up|0|||
105982765|NCT02905006|365598261|FG001|Overall Study|Lost to Follow-up|0|||
105982766|NCT02905006|365598262|FG002|Overall Study|Lost to Follow-up|0|||
105982767|NCT02905006|365598263|FG003|Overall Study|Lost to Follow-up|1|||
105982768|NCT02905006|365598264|FG004|Overall Study|Lost to Follow-up|1|||
105982769|NCT02905006|365598265|FG005|Overall Study|Lost to Follow-up|0|||
105982770|NCT02905006|365598260|FG000|Overall Study|Withdrawal by Subject|0|||
105982771|NCT02905006|365598261|FG001|Overall Study|Withdrawal by Subject|0|||
105982772|NCT02905006|365598262|FG002|Overall Study|Withdrawal by Subject|1|||
105982773|NCT02905006|365598263|FG003|Overall Study|Withdrawal by Subject|1|||
105982774|NCT02905006|365598264|FG004|Overall Study|Withdrawal by Subject|0|||
105982775|NCT02905006|365598265|FG005|Overall Study|Withdrawal by Subject|1|||
105982776|NCT02905006|365598260|FG000|Overall Study|Screening exclusion criteria met|1|||
105982777|NCT02905006|365598261|FG001|Overall Study|Screening exclusion criteria met|0|||
105982778|NCT02905006|365598262|FG002|Overall Study|Screening exclusion criteria met|0|||
105982779|NCT02905006|365598263|FG003|Overall Study|Screening exclusion criteria met|0|||
105982780|NCT02905006|365598264|FG004|Overall Study|Screening exclusion criteria met|0|||
105982781|NCT02905006|365598265|FG005|Overall Study|Screening exclusion criteria met|0|||
105982782|NCT02905006|365598260|FG000|Overall Study|Lab withdrawal criterion met|0|||
105982783|NCT02905006|365598261|FG001|Overall Study|Lab withdrawal criterion met|1|||
105982784|NCT02905006|365598262|FG002|Overall Study|Lab withdrawal criterion met|2|||
105982785|NCT02905006|365598263|FG003|Overall Study|Lab withdrawal criterion met|2|||
105982786|NCT02905006|365598264|FG004|Overall Study|Lab withdrawal criterion met|2|||
105982787|NCT02905006|365598265|FG005|Overall Study|Lab withdrawal criterion met|1|||
105982788|NCT02905006|365598260|FG000|Overall Study|Positive for Tuberculosis|0|||
105982789|NCT02905006|365598261|FG001|Overall Study|Positive for Tuberculosis|1|||
106030165|NCT02509117|365774635|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
106030166|NCT02509117|365774636|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
106030167|NCT02509117|365774637|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
106030168|NCT02509117|365774638|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
106030169|NCT02509117|365774639|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
106030170|NCT02509117|365774640|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
106030171|NCT02509117|365774641|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
106030172|NCT02509117|365774642|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
106030173|NCT02509117|365774643|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
106030174|NCT00832624|365774644|FG000|Overall Study|Study Terminated|10|||
106030175|NCT00636363|365774647|FG000|Overall Study|Conjunctivitis|0|||
106030176|NCT00636363|365774648|FG001|Overall Study|Conjunctivitis|0|||
105982790|NCT02905006|365598262|FG002|Overall Study|Positive for Tuberculosis|0|||
105982791|NCT02905006|365598263|FG003|Overall Study|Positive for Tuberculosis|0|||
105982792|NCT02905006|365598264|FG004|Overall Study|Positive for Tuberculosis|0|||
105982793|NCT02905006|365598265|FG005|Overall Study|Positive for Tuberculosis|0|||
105982794|NCT02905006|365598260|FG000|Overall Study|Subject positive for Hep B|0|||
105982795|NCT02905006|365598261|FG001|Overall Study|Subject positive for Hep B|0|||
105982796|NCT02905006|365598262|FG002|Overall Study|Subject positive for Hep B|1|||
105982797|NCT02905006|365598263|FG003|Overall Study|Subject positive for Hep B|0|||
105982798|NCT02905006|365598264|FG004|Overall Study|Subject positive for Hep B|0|||
105982799|NCT02905006|365598265|FG005|Overall Study|Subject positive for Hep B|0|||
105982800|NCT02905006|365598260|FG000|Overall Study|Patient moved abroad|0|||
105982801|NCT02905006|365598261|FG001|Overall Study|Patient moved abroad|0|||
105982802|NCT02905006|365598262|FG002|Overall Study|Patient moved abroad|0|||
105982803|NCT02905006|365598263|FG003|Overall Study|Patient moved abroad|1|||
105982804|NCT02905006|365598264|FG004|Overall Study|Patient moved abroad|0|||
105982805|NCT02905006|365598265|FG005|Overall Study|Patient moved abroad|0|||
105982806|NCT02905006|365598260|FG000|Overall Study|Patient randomized by mistake|0|||
105982807|NCT02905006|365598261|FG001|Overall Study|Patient randomized by mistake|0|||
105982808|NCT02905006|365598262|FG002|Overall Study|Patient randomized by mistake|0|||
105982809|NCT02905006|365598263|FG003|Overall Study|Patient randomized by mistake|0|||
105982810|NCT02905006|365598264|FG004|Overall Study|Patient randomized by mistake|0|||
105982811|NCT02905006|365598265|FG005|Overall Study|Patient randomized by mistake|1|||
105982812|NCT01939366|365598266|FG000|Overall Study|Adverse Event|8|||
105982813|NCT01939366|365598267|FG001|Overall Study|Adverse Event|17|||
105982814|NCT01939366|365598268|FG002|Overall Study|Adverse Event|30|||
105982815|NCT01939366|365598269|FG003|Overall Study|Adverse Event|8|||
105982816|NCT01939366|365598270|FG004|Overall Study|Adverse Event|5|||
105982817|NCT01939366|365598266|FG000|Overall Study|Lack of Efficacy|2|||
105982818|NCT01939366|365598267|FG001|Overall Study|Lack of Efficacy|1|||
105982819|NCT01939366|365598268|FG002|Overall Study|Lack of Efficacy|1|||
105982820|NCT01939366|365598269|FG003|Overall Study|Lack of Efficacy|1|||
105982821|NCT01939366|365598270|FG004|Overall Study|Lack of Efficacy|3|||
105982822|NCT01939366|365598266|FG000|Overall Study|Lost to Follow-up|1|||
105982823|NCT01939366|365598267|FG001|Overall Study|Lost to Follow-up|1|||
105982824|NCT01939366|365598268|FG002|Overall Study|Lost to Follow-up|0|||
105982825|NCT01939366|365598269|FG003|Overall Study|Lost to Follow-up|0|||
105982826|NCT01939366|365598270|FG004|Overall Study|Lost to Follow-up|0|||
105982827|NCT01939366|365598266|FG000|Overall Study|Withdrawal by Subject|1|||
105982828|NCT01939366|365598267|FG001|Overall Study|Withdrawal by Subject|0|||
105982829|NCT01939366|365598268|FG002|Overall Study|Withdrawal by Subject|2|||
105982830|NCT01939366|365598269|FG003|Overall Study|Withdrawal by Subject|2|||
105982831|NCT01939366|365598270|FG004|Overall Study|Withdrawal by Subject|3|||
105982832|NCT01939366|365598266|FG000|Overall Study|Inclusion criteria not met|0|||
105982833|NCT01939366|365598267|FG001|Overall Study|Inclusion criteria not met|1|||
105982834|NCT01939366|365598268|FG002|Overall Study|Inclusion criteria not met|1|||
105982835|NCT01939366|365598269|FG003|Overall Study|Inclusion criteria not met|0|||
105982836|NCT01939366|365598270|FG004|Overall Study|Inclusion criteria not met|1|||
105982837|NCT01939366|365598266|FG000|Overall Study|Other|0|||
105982838|NCT01939366|365598267|FG001|Overall Study|Other|0|||
105982839|NCT01939366|365598268|FG002|Overall Study|Other|2|||
106030177|NCT00636363|365774649|FG002|Overall Study|Conjunctivitis|1|||
105982840|NCT01939366|365598269|FG003|Overall Study|Other|2|||
105982841|NCT01939366|365598270|FG004|Overall Study|Other|1|||
105982842|NCT01939366|365598266|FG000|Overall Study|Protocol Violation|0|||
105982843|NCT01939366|365598267|FG001|Overall Study|Protocol Violation|0|||
105982844|NCT01939366|365598268|FG002|Overall Study|Protocol Violation|0|||
105982845|NCT01939366|365598269|FG003|Overall Study|Protocol Violation|1|||
105982846|NCT01939366|365598270|FG004|Overall Study|Protocol Violation|0|||
105982847|NCT01939366|365598266|FG000|Overall Study|Sponsor decision|0|||
105982848|NCT01939366|365598267|FG001|Overall Study|Sponsor decision|0|||
105982849|NCT01939366|365598268|FG002|Overall Study|Sponsor decision|0|||
105982850|NCT01939366|365598269|FG003|Overall Study|Sponsor decision|0|||
105982851|NCT01939366|365598270|FG004|Overall Study|Sponsor decision|2|||
105982852|NCT01939366|365598266|FG000|Overall Study|GCP non-compliance at site|2|||
105982853|NCT01939366|365598267|FG001|Overall Study|GCP non-compliance at site|3|||
105982854|NCT01939366|365598268|FG002|Overall Study|GCP non-compliance at site|2|||
106030178|NCT00636363|365774647|FG000|Overall Study|Adverse Event|0|||
105982855|NCT01939366|365598269|FG003|Overall Study|GCP non-compliance at site|3|||
105982856|NCT01939366|365598270|FG004|Overall Study|GCP non-compliance at site|3|||
106030179|NCT00636363|365774648|FG001|Overall Study|Adverse Event|0|||
105982857|NCT02429791|365598274|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
105982858|NCT02429791|365598275|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
105982859|NCT02429791|365598274|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
105982860|NCT02429791|365598275|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
105982861|NCT02429791|365598274|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
105982862|NCT02429791|365598275|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
106030180|NCT00636363|365774649|FG002|Overall Study|Adverse Event|1|||
106030181|NCT00636363|365774647|FG000|Overall Study|Positive slit lamp finding|0|||
106030182|NCT00636363|365774648|FG001|Overall Study|Positive slit lamp finding|2|||
106030183|NCT00636363|365774649|FG002|Overall Study|Positive slit lamp finding|1|||
106030184|NCT00636363|365774647|FG000|Overall Study|Study related symptoms/complaints|8|||
106030185|NCT00636363|365774648|FG001|Overall Study|Study related symptoms/complaints|7|||
106030186|NCT00636363|365774649|FG002|Overall Study|Study related symptoms/complaints|4|||
106030187|NCT00636363|365774647|FG000|Overall Study|Met ineligibility criteria|0|||
106030188|NCT00636363|365774648|FG001|Overall Study|Met ineligibility criteria|0|||
106030189|NCT00636363|365774649|FG002|Overall Study|Met ineligibility criteria|3|||
106030190|NCT00636363|365774647|FG000|Overall Study|Missed > 1 visit|0|||
106030191|NCT00636363|365774648|FG001|Overall Study|Missed > 1 visit|1|||
106030192|NCT00636363|365774649|FG002|Overall Study|Missed > 1 visit|3|||
106030193|NCT00636363|365774647|FG000|Overall Study|Lack of motivation|1|||
106030194|NCT00636363|365774648|FG001|Overall Study|Lack of motivation|0|||
106030195|NCT00636363|365774649|FG002|Overall Study|Lack of motivation|1|||
106030196|NCT00636363|365774647|FG000|Overall Study|Protocol Violation|0|||
106030197|NCT00636363|365774648|FG001|Overall Study|Protocol Violation|3|||
105982863|NCT02429791|365598274|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
105982864|NCT02429791|365598275|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
105982865|NCT02429791|365598274|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
105982866|NCT02429791|365598275|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
105982867|NCT02429791|365598274|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
105982868|NCT02429791|365598275|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
105982869|NCT02429791|365598274|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
105982870|NCT02429791|365598275|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
105982871|NCT02429791|365598274|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
105982872|NCT02429791|365598275|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
105982873|NCT02429791|365598274|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
105982874|NCT02429791|365598275|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
105982875|NCT02429791|365598274|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
105982876|NCT02429791|365598275|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
105982877|NCT02429791|365598274|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
105982878|NCT02429791|365598275|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
105982879|NCT02429791|365598274|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
105982880|NCT02429791|365598275|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
105982881|NCT02429791|365598274|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
105982882|NCT02429791|365598275|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
105982883|NCT02429791|365598274|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
106030198|NCT00636363|365774649|FG002|Overall Study|Protocol Violation|0|||
106030199|NCT00636363|365774647|FG000|Overall Study|Lost to Follow-up|3|||
106030200|NCT00636363|365774648|FG001|Overall Study|Lost to Follow-up|4|||
105982884|NCT02429791|365598275|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
105982885|NCT02429791|365598274|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
105982886|NCT02429791|365598275|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
105982887|NCT02429791|365598274|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
105982888|NCT02429791|365598275|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
105982889|NCT02429791|365598274|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
105982890|NCT02429791|365598275|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
105982891|NCT02429791|365598274|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
105982892|NCT02429791|365598275|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
105982893|NCT00881504|365598276|FG000|Overall Study|Withdrawal by Subject|1|||
105982894|NCT00007020|365598277|FG000|Overall Study|Death|16|||
105982895|NCT00007020|365598277|FG000|Overall Study|Lost to Follow-up|13|||
105982896|NCT00007020|365598277|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
105982897|NCT00007020|365598277|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
105982898|NCT00007020|365598277|FG000|Overall Study|Pt cared for by outside physician|4|||
105982899|NCT00007020|365598277|FG000|Overall Study|No evidence of treatment|6|||
105982900|NCT02017522|365598278|FG000|Overall Study|Withdrawal by Subject|1|||
105982901|NCT01571232|365598279|FG000|Overall Study|Lost to Follow-up|0|||
105982902|NCT01571232|365598280|FG001|Overall Study|Lost to Follow-up|1|||
105982903|NCT01571232|365598279|FG000|Overall Study|Withdrawal by Subject|1|||
105982904|NCT01571232|365598280|FG001|Overall Study|Withdrawal by Subject|0|||
105982905|NCT01751139|365598281|FG000|Overall Study|Other|135|||
105982906|NCT01751139|365598281|FG000|Overall Study|Sponsor study termination|1609|||
105982907|NCT01751139|365598281|FG000|Overall Study|Lost to Follow-up|240|||
105982908|NCT01751139|365598281|FG000|Overall Study|Withdrawal by Subject|251|||
105982909|NCT01751139|365598281|FG000|Overall Study|Adverse Event|1|||
105982910|NCT01751139|365598281|FG000|Overall Study|Death|31|||
105982911|NCT01867086|365598283|FG000|Overall Study|Disease Progression|1|||
105982912|NCT02337634|365598284|FG000|Overall Study|Protocol Violation|3|||
105982913|NCT02337634|365598285|FG001|Overall Study|Protocol Violation|1|||
105982914|NCT02337634|365598284|FG000|Overall Study|Lost to Follow-up|1|||
105982915|NCT02337634|365598285|FG001|Overall Study|Lost to Follow-up|0|||
105982916|NCT01424566|365598286|FG000|Single-blind Treatment|Adverse Event|71|||
105982917|NCT01424566|365598287|FG001|Single-blind Treatment|Adverse Event|0|||
105982918|NCT01424566|365598288|FG002|Single-blind Treatment|Adverse Event|0|||
105982919|NCT01424566|365598286|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
105982920|NCT01424566|365598287|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
105982921|NCT01424566|365598288|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
105982922|NCT01424566|365598286|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
105982923|NCT01424566|365598287|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
105982924|NCT01424566|365598288|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
105982925|NCT01424566|365598286|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
105982926|NCT01424566|365598287|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
105982927|NCT01424566|365598288|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
105982928|NCT01424566|365598286|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
105982929|NCT01424566|365598287|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
105982930|NCT01424566|365598288|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
105982931|NCT01424566|365598286|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
105982932|NCT01424566|365598287|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
105982933|NCT01424566|365598288|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
105982934|NCT01424566|365598286|FG000|Double-blind Treatment|Adverse Event|0|||
105982935|NCT01424566|365598287|FG001|Double-blind Treatment|Adverse Event|21|||
105982936|NCT01424566|365598288|FG002|Double-blind Treatment|Adverse Event|13|||
105982937|NCT01424566|365598286|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
105982938|NCT01424566|365598287|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
105982939|NCT01424566|365598288|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
105982940|NCT01424566|365598286|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
105982941|NCT01424566|365598287|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
105982942|NCT01424566|365598288|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
105982943|NCT01424566|365598286|FG000|Double-blind Treatment|Lack of Efficacy|0|||
105982944|NCT01424566|365598287|FG001|Double-blind Treatment|Lack of Efficacy|1|||
105982945|NCT01424566|365598288|FG002|Double-blind Treatment|Lack of Efficacy|1|||
105982946|NCT03344172|365598291|FG000|Overall Study|Received <1 dose of treatment|1|||
105982947|NCT03344172|365598292|FG001|Overall Study|Received <1 dose of treatment|0|||
105982948|NCT04676867|365598293|FG000|Overall Study|Screen failure|0|||
105982949|NCT04676867|365598294|FG001|Overall Study|Screen failure|0|||
105982950|NCT04676867|365598295|FG002|Overall Study|Screen failure|6|||
105982951|NCT04676867|365598296|FG003|Overall Study|Screen failure|2|||
105982952|NCT04676867|365598293|FG000|Overall Study|Death|0|||
105982953|NCT04676867|365598294|FG001|Overall Study|Death|0|||
105982954|NCT04676867|365598295|FG002|Overall Study|Death|1|||
105982955|NCT04676867|365598296|FG003|Overall Study|Death|0|||
105982956|NCT04676867|365598293|FG000|Overall Study|Withdrawal by Subject|2|||
105982957|NCT04676867|365598294|FG001|Overall Study|Withdrawal by Subject|2|||
105982958|NCT04676867|365598295|FG002|Overall Study|Withdrawal by Subject|4|||
105982959|NCT04676867|365598296|FG003|Overall Study|Withdrawal by Subject|4|||
105982960|NCT04676867|365598293|FG000|Overall Study|Lost to Follow-up|1|||
105982961|NCT04676867|365598294|FG001|Overall Study|Lost to Follow-up|0|||
105982962|NCT04676867|365598295|FG002|Overall Study|Lost to Follow-up|0|||
105982963|NCT04676867|365598296|FG003|Overall Study|Lost to Follow-up|0|||
105982964|NCT03779503|365598297|FG000|First Intervention|Adverse Event|0|||
105982965|NCT03779503|365598298|FG001|First Intervention|Adverse Event|1|||
105982966|NCT03779503|365598297|FG000|First Intervention|Withdrawal by Subject|1|||
105982967|NCT03779503|365598298|FG001|First Intervention|Withdrawal by Subject|0|||
105982968|NCT02066415|365598299|FG000|Overall Study|Decision by Sponsor|5|||
105982969|NCT02066415|365598300|FG001|Overall Study|Decision by Sponsor|4|||
105982970|NCT02066415|365598301|FG002|Overall Study|Decision by Sponsor|2|||
105982971|NCT02066415|365598299|FG000|Overall Study|Withdrawal by Subject|9|||
105982972|NCT02066415|365598300|FG001|Overall Study|Withdrawal by Subject|1|||
105982973|NCT02066415|365598301|FG002|Overall Study|Withdrawal by Subject|4|||
105982974|NCT02066415|365598299|FG000|Overall Study|Lost to Follow-up|7|||
105982975|NCT02066415|365598300|FG001|Overall Study|Lost to Follow-up|2|||
105982976|NCT02066415|365598301|FG002|Overall Study|Lost to Follow-up|2|||
105982977|NCT02809053|365598302|FG000|Overall Study|Death|0|||
105982978|NCT02809053|365598303|FG001|Overall Study|Death|1|||
105982979|NCT02809053|365598302|FG000|Overall Study|Lost to Follow-up|3|||
105982980|NCT02809053|365598303|FG001|Overall Study|Lost to Follow-up|1|||
105982981|NCT02809053|365598302|FG000|Overall Study|Withdrawal by Subject|2|||
105982982|NCT02809053|365598303|FG001|Overall Study|Withdrawal by Subject|3|||
105982983|NCT02809053|365598302|FG000|Overall Study|Disease Progression|2|||
105982984|NCT02809053|365598303|FG001|Overall Study|Disease Progression|1|||
105982985|NCT00117793|365598307|FG000|Overall Study|Withdrawal by Subject|12|||
105982986|NCT01732913|365598312|FG000|Overall Study|Study Terminated by Sponsor|105|||
105982987|NCT01732913|365598313|FG001|Overall Study|Study Terminated by Sponsor|55|||
105982988|NCT01732913|365598312|FG000|Overall Study|Withdrawal by Subject|27|||
105982989|NCT01732913|365598313|FG001|Overall Study|Withdrawal by Subject|4|||
105982990|NCT01732913|365598312|FG000|Overall Study|Physician Decision|14|||
105982991|NCT01732913|365598313|FG001|Overall Study|Physician Decision|7|||
105982992|NCT01732913|365598312|FG000|Overall Study|Other|7|||
105982993|NCT01732913|365598313|FG001|Overall Study|Other|1|||
105982994|NCT01732913|365598312|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
105982995|NCT01732913|365598313|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
105982996|NCT01504204|365598316|FG000|Overall Study|Lost to Follow-up|1|||
105982997|NCT01504204|365598317|FG001|Overall Study|Lost to Follow-up|1|||
105982998|NCT01818492|365598318|FG000|Overall Study|Adverse Event|2|||
105982999|NCT01818492|365598318|FG000|Overall Study|Death|3|||
105983000|NCT01818492|365598318|FG000|Overall Study|Withdrawal by Subject|1|||
105983001|NCT01818492|365598318|FG000|Overall Study|Additional therapy when not allowed PP|4|||
105983002|NCT02428413|365598320|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
105983003|NCT02428413|365598321|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
105983004|NCT02428413|365598320|FG000|Overall Study|Protocol Violation|1|||
105983005|NCT02428413|365598321|FG001|Overall Study|Protocol Violation|2|||
105983006|NCT02428413|365598320|FG000|Overall Study|Case Cancelled|2|||
105983007|NCT02428413|365598321|FG001|Overall Study|Case Cancelled|0|||
105983008|NCT02428413|365598320|FG000|Overall Study|Missed Cases|1|||
105983009|NCT02428413|365598321|FG001|Overall Study|Missed Cases|2|||
105983010|NCT02428413|365598320|FG000|Overall Study|Nurse Refusal|1|||
105983011|NCT02428413|365598321|FG001|Overall Study|Nurse Refusal|0|||
105983012|NCT02049138|365598322|FG000|Overall Study|Adverse Event|46|||
105983013|NCT02049138|365598323|FG001|Overall Study|Adverse Event|25|||
105983014|NCT02049138|365598324|FG002|Overall Study|Adverse Event|1|||
105983015|NCT02049138|365598322|FG000|Overall Study|Withdrawal by Subject|57|||
105983016|NCT02049138|365598323|FG001|Overall Study|Withdrawal by Subject|21|||
105983017|NCT02049138|365598324|FG002|Overall Study|Withdrawal by Subject|5|||
105983018|NCT02049138|365598322|FG000|Overall Study|Lost to Follow-up|18|||
105983019|NCT02049138|365598323|FG001|Overall Study|Lost to Follow-up|5|||
105983020|NCT02049138|365598324|FG002|Overall Study|Lost to Follow-up|1|||
105983021|NCT02049138|365598322|FG000|Overall Study|Lack of Efficacy|10|||
105983022|NCT02049138|365598323|FG001|Overall Study|Lack of Efficacy|26|||
105983023|NCT02049138|365598324|FG002|Overall Study|Lack of Efficacy|1|||
105983024|NCT02049138|365598322|FG000|Overall Study|Non-Compliance|15|||
105983025|NCT02049138|365598323|FG001|Overall Study|Non-Compliance|6|||
105983026|NCT02049138|365598324|FG002|Overall Study|Non-Compliance|0|||
105983027|NCT02049138|365598322|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
105983028|NCT02049138|365598323|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
105983029|NCT02049138|365598324|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
105983030|NCT02049138|365598322|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
105983031|NCT02049138|365598323|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105983032|NCT02049138|365598324|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
105983033|NCT02049138|365598322|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
105983034|NCT02049138|365598323|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
105983035|NCT02049138|365598324|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
105983036|NCT02049138|365598322|FG000|Overall Study|Other|15|||
105983037|NCT02049138|365598323|FG001|Overall Study|Other|13|||
105983038|NCT02049138|365598324|FG002|Overall Study|Other|0|||
105983039|NCT02049138|365598322|FG000|Overall Study|Missing|0|||
105983040|NCT02049138|365598323|FG001|Overall Study|Missing|1|||
105983041|NCT02049138|365598324|FG002|Overall Study|Missing|0|||
105983042|NCT02925741|365598325|FG000|Overall Study|Withdrawal by Subject|11|||
105983043|NCT02925741|365598326|FG001|Overall Study|Withdrawal by Subject|0|||
105983044|NCT05086510|365598327|FG000|Overall Study|Lost to Follow-up|0|||
105983045|NCT05086510|365598328|FG001|Overall Study|Lost to Follow-up|2|||
105983046|NCT05086510|365598327|FG000|Overall Study|Death|0|||
105983047|NCT05086510|365598328|FG001|Overall Study|Death|2|||
105983048|NCT02613169|365598330|FG000|Overall Study|Withdrawal by Subject|4|||
105983049|NCT02613169|365598331|FG001|Overall Study|Withdrawal by Subject|1|||
105983050|NCT02613169|365598330|FG000|Overall Study|Lost to Follow-up|0|||
105983051|NCT02613169|365598331|FG001|Overall Study|Lost to Follow-up|5|||
105983052|NCT02613169|365598330|FG000|Overall Study|HIV|0|||
105983053|NCT02613169|365598331|FG001|Overall Study|HIV|2|||
105983054|NCT02613169|365598330|FG000|Overall Study|No TB infection endpoint|14|||
105983055|NCT02613169|365598331|FG001|Overall Study|No TB infection endpoint|9|||
105983056|NCT04891107|365598332|FG000|Overall Study|Physician Decision|1|||
105983057|NCT04891107|365598332|FG000|Overall Study|Withdrawal by Subject|1|||
105983058|NCT04891107|365598332|FG000|Overall Study|Screen failure after consent|1|||
105983059|NCT02453555|365598333|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
105983060|NCT02453555|365598334|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
105983061|NCT02453555|365598335|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
105983062|NCT02453555|365598336|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
105983063|NCT02453555|365598337|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
105983064|NCT02453555|365598338|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
105983065|NCT02453555|365598333|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
105983066|NCT02453555|365598334|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105983067|NCT02453555|365598335|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105983068|NCT02453555|365598336|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105983069|NCT02453555|365598337|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105983070|NCT02453555|365598338|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
105983071|NCT02453555|365598333|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
105983072|NCT02453555|365598334|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
105983073|NCT02453555|365598335|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105983074|NCT02453555|365598336|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105983075|NCT02453555|365598337|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105983076|NCT02453555|365598338|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
105983077|NCT02453555|365598333|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
105983078|NCT02453555|365598334|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
105983079|NCT02453555|365598335|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
105983080|NCT02453555|365598336|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
105983081|NCT02453555|365598337|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
105983082|NCT02453555|365598338|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
105983083|NCT02453555|365598333|FG000|Extension Period|Adverse Event|0|||
105983084|NCT02453555|365598334|FG001|Extension Period|Adverse Event|0|||
105983085|NCT02453555|365598335|FG002|Extension Period|Adverse Event|1|||
105983086|NCT02453555|365598336|FG003|Extension Period|Adverse Event|2|||
105983087|NCT02453555|365598337|FG004|Extension Period|Adverse Event|1|||
105983088|NCT02453555|365598338|FG005|Extension Period|Adverse Event|1|||
105983089|NCT02453555|365598333|FG000|Extension Period|Protocol Violation|0|||
105983090|NCT02453555|365598334|FG001|Extension Period|Protocol Violation|0|||
105983091|NCT02453555|365598335|FG002|Extension Period|Protocol Violation|1|||
105983092|NCT02453555|365598336|FG003|Extension Period|Protocol Violation|0|||
105983093|NCT02453555|365598337|FG004|Extension Period|Protocol Violation|0|||
105983094|NCT02453555|365598338|FG005|Extension Period|Protocol Violation|0|||
105983095|NCT02453555|365598333|FG000|Extension Period|Withdrawal by Subject|0|||
105983096|NCT02453555|365598334|FG001|Extension Period|Withdrawal by Subject|0|||
105983097|NCT02453555|365598335|FG002|Extension Period|Withdrawal by Subject|1|||
105983098|NCT02453555|365598336|FG003|Extension Period|Withdrawal by Subject|0|||
105983099|NCT02453555|365598337|FG004|Extension Period|Withdrawal by Subject|0|||
105983100|NCT02453555|365598338|FG005|Extension Period|Withdrawal by Subject|0|||
105983101|NCT00444067|365598339|FG000|Overall Study|Lost to Follow-up|0|||
105983102|NCT00444067|365598340|FG001|Overall Study|Lost to Follow-up|1|||
105983103|NCT02528357|365598341|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983104|NCT02528357|365598342|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
105983105|NCT02528357|365598343|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983106|NCT02528357|365598344|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983107|NCT02528357|365598345|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983108|NCT02528357|365598346|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983109|NCT02528357|365598347|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983110|NCT02528357|365598348|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983111|NCT02528357|365598349|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983112|NCT02528357|365598350|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983113|NCT02528357|365598351|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983114|NCT02528357|365598352|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983115|NCT02528357|365598353|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983116|NCT02528357|365598354|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983117|NCT02528357|365598355|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983118|NCT02528357|365598356|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983119|NCT02528357|365598357|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983120|NCT02528357|365598358|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983121|NCT02528357|365598359|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
105983122|NCT02528357|365598341|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983123|NCT02528357|365598342|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983124|NCT02528357|365598343|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983125|NCT02528357|365598344|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
105983126|NCT02528357|365598345|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983127|NCT02528357|365598346|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
105983128|NCT02528357|365598347|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983129|NCT02528357|365598348|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
105983130|NCT02528357|365598349|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983131|NCT02528357|365598350|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983132|NCT02528357|365598351|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983133|NCT02528357|365598352|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983134|NCT02528357|365598353|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983135|NCT02528357|365598354|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983136|NCT02528357|365598355|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983137|NCT02528357|365598356|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983138|NCT02528357|365598357|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983139|NCT02528357|365598358|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983140|NCT02528357|365598359|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
105983141|NCT02528357|365598341|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983142|NCT02528357|365598342|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983143|NCT02528357|365598343|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
105983144|NCT02528357|365598344|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983145|NCT02528357|365598345|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
105983146|NCT02528357|365598346|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983147|NCT02528357|365598347|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
105983148|NCT02528357|365598348|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
105983149|NCT02528357|365598349|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983150|NCT02528357|365598350|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
106030201|NCT00636363|365774649|FG002|Overall Study|Lost to Follow-up|2|||
105983151|NCT02528357|365598351|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983152|NCT02528357|365598352|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983153|NCT02528357|365598353|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983154|NCT02528357|365598354|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983155|NCT02528357|365598355|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983156|NCT02528357|365598356|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983157|NCT02528357|365598357|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983158|NCT02528357|365598358|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983159|NCT02528357|365598359|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
105983160|NCT02528357|365598341|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983161|NCT02528357|365598342|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983162|NCT02528357|365598343|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983163|NCT02528357|365598344|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983164|NCT02528357|365598345|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105983165|NCT02528357|365598346|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983166|NCT02528357|365598347|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983167|NCT02528357|365598348|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105987499|NCT01363661|365614475|FG000|Overall Study|Withdrawal by Subject|1|||
105987500|NCT01363661|365614476|FG001|Overall Study|Withdrawal by Subject|1|||
105987501|NCT01363661|365614475|FG000|Overall Study|Protocol Violation|1|||
105987502|NCT01363661|365614476|FG001|Overall Study|Protocol Violation|0|||
105987503|NCT01363661|365614475|FG000|Overall Study|Lost to Follow-up|3|||
105987504|NCT01363661|365614476|FG001|Overall Study|Lost to Follow-up|1|||
105987505|NCT03775512|365614477|FG000|Overall Study|Death|1|||
105987506|NCT03775512|365614478|FG001|Overall Study|Death|1|||
105987507|NCT03775512|365614477|FG000|Overall Study|Withdrawal by Subject|7|||
105987508|NCT03775512|365614478|FG001|Overall Study|Withdrawal by Subject|4|||
105987509|NCT03775512|365614477|FG000|Overall Study|Lost to Follow-up|5|||
105987510|NCT03775512|365614478|FG001|Overall Study|Lost to Follow-up|5|||
105987511|NCT03775512|365614477|FG000|Overall Study|Excluded before Catheter insertion|14|||
105987512|NCT03775512|365614478|FG001|Overall Study|Excluded before Catheter insertion|5|||
105987513|NCT03775512|365614477|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
105987514|NCT03775512|365614478|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
105987515|NCT03775512|365614477|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
105987516|NCT03775512|365614478|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
105987517|NCT01378325|365614484|FG000|Overall Study|Protocol Violation|0|||
105987518|NCT01378325|365614485|FG001|Overall Study|Protocol Violation|1|||
105987519|NCT03464019|365614486|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
105987520|NCT03464019|365614487|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
105987521|NCT03464019|365614488|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
105987522|NCT03464019|365614486|FG000|NODE-301 Part 1|Ablation|0|||
105987523|NCT03464019|365614487|FG001|NODE-301 Part 1|Ablation|0|||
105987524|NCT03464019|365614488|FG002|NODE-301 Part 1|Ablation|16|||
105987525|NCT03464019|365614486|FG000|NODE-301 Part 1|Test Dose Failure|0|||
105987526|NCT03464019|365614487|FG001|NODE-301 Part 1|Test Dose Failure|0|||
105987527|NCT03464019|365614488|FG002|NODE-301 Part 1|Test Dose Failure|8|||
105987528|NCT03464019|365614486|FG000|NODE-301 Part 1|Adverse Event|0|||
105987529|NCT03464019|365614487|FG001|NODE-301 Part 1|Adverse Event|0|||
105987530|NCT03464019|365614488|FG002|NODE-301 Part 1|Adverse Event|5|||
105987531|NCT03464019|365614486|FG000|NODE-301 Part 1|Physician Decision|0|||
105987532|NCT03464019|365614487|FG001|NODE-301 Part 1|Physician Decision|0|||
105987533|NCT03464019|365614488|FG002|NODE-301 Part 1|Physician Decision|4|||
105987534|NCT03464019|365614486|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
105987535|NCT03464019|365614487|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
105987536|NCT03464019|365614488|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
105987537|NCT03464019|365614486|FG000|NODE-301 Part 1|Protocol Violation|0|||
105987538|NCT03464019|365614487|FG001|NODE-301 Part 1|Protocol Violation|0|||
105987539|NCT03464019|365614488|FG002|NODE-301 Part 1|Protocol Violation|2|||
105987540|NCT03464019|365614486|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
105987541|NCT03464019|365614487|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
105987542|NCT03464019|365614488|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
105987543|NCT03464019|365614486|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
105987544|NCT03464019|365614487|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
105987545|NCT03464019|365614488|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
105987546|NCT03464019|365614486|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
105983168|NCT02528357|365598349|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983169|NCT02528357|365598350|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983170|NCT02528357|365598351|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983171|NCT02528357|365598352|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983172|NCT02528357|365598353|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983173|NCT02528357|365598354|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983174|NCT02528357|365598355|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983175|NCT02528357|365598356|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983176|NCT02528357|365598357|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983177|NCT02528357|365598358|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983178|NCT02528357|365598359|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983179|NCT02528357|365598341|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983180|NCT02528357|365598342|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983181|NCT02528357|365598343|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983182|NCT02528357|365598344|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983183|NCT02528357|365598345|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983184|NCT02528357|365598346|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983185|NCT02528357|365598347|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983186|NCT02528357|365598348|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983187|NCT02528357|365598349|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983188|NCT02528357|365598350|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983189|NCT02528357|365598351|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983190|NCT02528357|365598352|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983191|NCT02528357|365598353|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983192|NCT02528357|365598354|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
105983193|NCT02528357|365598355|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
105983194|NCT02528357|365598356|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983195|NCT02528357|365598357|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983196|NCT02528357|365598358|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983197|NCT02528357|365598359|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
105983198|NCT02528357|365598341|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983199|NCT02528357|365598342|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
106030202|NCT00636363|365774647|FG000|Overall Study|Withdrawal by Subject|1|||
105983200|NCT02528357|365598343|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
106030203|NCT00636363|365774648|FG001|Overall Study|Withdrawal by Subject|3|||
106030204|NCT00636363|365774649|FG002|Overall Study|Withdrawal by Subject|2|||
106030205|NCT00796991|365774656|FG000|Overall Study|Adverse Event|0|||
106030206|NCT00796991|365774657|FG001|Overall Study|Adverse Event|0|||
106030207|NCT00796991|365774658|FG002|Overall Study|Adverse Event|1|||
106030208|NCT00796991|365774656|FG000|Overall Study|Death|2|||
106030209|NCT00796991|365774657|FG001|Overall Study|Death|0|||
106030210|NCT00796991|365774658|FG002|Overall Study|Death|0|||
106030211|NCT00796991|365774656|FG000|Overall Study|Disease Progression|10|||
106030212|NCT00796991|365774657|FG001|Overall Study|Disease Progression|9|||
106030213|NCT00796991|365774658|FG002|Overall Study|Disease Progression|7|||
106030214|NCT00796991|365774656|FG000|Overall Study|Study Drug Toxicity|3|||
106030215|NCT00796991|365774657|FG001|Overall Study|Study Drug Toxicity|3|||
106030216|NCT00796991|365774658|FG002|Overall Study|Study Drug Toxicity|5|||
106030217|NCT00796991|365774656|FG000|Overall Study|Withdrawal by Subject|0|||
106030218|NCT00796991|365774657|FG001|Overall Study|Withdrawal by Subject|0|||
106030219|NCT00796991|365774658|FG002|Overall Study|Withdrawal by Subject|1|||
106030220|NCT00029146|365774660|FG000|Overall Study|Lost to Follow-up|2|||
106030221|NCT00029146|365774661|FG001|Overall Study|Lost to Follow-up|1|||
106030222|NCT01546623|365774662|FG000|Overall Study|Adverse Event|2|||
106030223|NCT01546623|365774663|FG001|Overall Study|Adverse Event|3|||
106030224|NCT01546623|365774662|FG000|Overall Study|Major Protocol Deviation|1|||
106030225|NCT01546623|365774663|FG001|Overall Study|Major Protocol Deviation|1|||
106030226|NCT01546623|365774662|FG000|Overall Study|High Prostate specific antigen|2|||
106030227|NCT01546623|365774663|FG001|Overall Study|High Prostate specific antigen|1|||
106030228|NCT01546623|365774662|FG000|Overall Study|Did Not Receive Study Drug|1|||
106030229|NCT01546623|365774663|FG001|Overall Study|Did Not Receive Study Drug|1|||
106030230|NCT03567343|365774665|FG000|Overall Study|Lost to Follow-up|2|||
106030231|NCT03567343|365774666|FG001|Overall Study|Lost to Follow-up|1|||
106030232|NCT03567343|365774665|FG000|Overall Study|No longer eligible|2|||
106030233|NCT03567343|365774666|FG001|Overall Study|No longer eligible|1|||
106030234|NCT03567343|365774665|FG000|Overall Study|Adverse Event|1|||
106030235|NCT03567343|365774666|FG001|Overall Study|Adverse Event|0|||
106030236|NCT03567343|365774665|FG000|Overall Study|Protocol Violation|1|||
106030237|NCT03567343|365774666|FG001|Overall Study|Protocol Violation|1|||
106030238|NCT03148691|365774667|FG000|Overall Study|Protocol Violation|1|||
106030239|NCT03148691|365774668|FG001|Overall Study|Protocol Violation|2|||
106030240|NCT03148691|365774669|FG002|Overall Study|Protocol Violation|7|||
106030241|NCT03148691|365774667|FG000|Overall Study|Lost to Follow-up|0|||
106030242|NCT03148691|365774668|FG001|Overall Study|Lost to Follow-up|0|||
106030243|NCT03148691|365774669|FG002|Overall Study|Lost to Follow-up|1|||
106030244|NCT03148691|365774667|FG000|Overall Study|Other|1|||
106030245|NCT03148691|365774668|FG001|Overall Study|Other|0|||
106030246|NCT03148691|365774669|FG002|Overall Study|Other|0|||
105983201|NCT02528357|365598344|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983202|NCT02528357|365598345|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983203|NCT02528357|365598346|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983204|NCT02528357|365598347|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983205|NCT02528357|365598348|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983206|NCT02528357|365598349|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983207|NCT02528357|365598350|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983208|NCT02528357|365598351|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983209|NCT02528357|365598352|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983210|NCT02528357|365598353|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983211|NCT02528357|365598354|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
105983212|NCT02528357|365598355|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983213|NCT02528357|365598356|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983214|NCT02528357|365598357|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983215|NCT02528357|365598358|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983216|NCT02528357|365598359|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
105983217|NCT02528357|365598341|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983218|NCT02528357|365598342|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
106030247|NCT03148691|365774667|FG000|Overall Study|Withdrawal by Subject|1|||
106030248|NCT03148691|365774668|FG001|Overall Study|Withdrawal by Subject|0|||
106030249|NCT03148691|365774669|FG002|Overall Study|Withdrawal by Subject|0|||
106030250|NCT00834080|365774670|FG000|Overall Study|Adverse Event|7|||
106030251|NCT00834080|365774670|FG000|Overall Study|Lost to Follow-up|7|||
106030252|NCT00834080|365774670|FG000|Overall Study|Withdrawal by Subject|5|||
106030253|NCT00834080|365774670|FG000|Overall Study|Other - Pregnancy|1|||
106030254|NCT00834080|365774670|FG000|Overall Study|Other - False positive tests of the UDS|1|||
106030255|NCT00834080|365774670|FG000|Overall Study|Physician Decision|1|||
106030256|NCT00834080|365774670|FG000|Overall Study|Subject Relocated|1|||
106030257|NCT00321646|365774671|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
106030258|NCT00321646|365774671|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
106030259|NCT00321646|365774671|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
106030260|NCT00392379|365774672|FG000|Overall Study|Withdrawal by Subject|17|||
106030261|NCT00392379|365774673|FG001|Overall Study|Withdrawal by Subject|28|||
106030262|NCT00392379|365774672|FG000|Overall Study|Lost to Follow-up|4|||
106030263|NCT00392379|365774673|FG001|Overall Study|Lost to Follow-up|9|||
106030264|NCT00392379|365774672|FG000|Overall Study|Adverse Event|1|||
106030265|NCT00392379|365774673|FG001|Overall Study|Adverse Event|1|||
106030266|NCT02365233|365774678|FG000|Overall Study|IRB withheld the data|1|||
106030267|NCT02365233|365774679|FG001|Overall Study|IRB withheld the data|2|||
106030268|NCT02365233|365774680|FG002|Overall Study|IRB withheld the data|2|||
106030269|NCT04604132|365774681|FG000|Overall Study|Adverse Event|2|||
106030270|NCT04604132|365774682|FG001|Overall Study|Adverse Event|0|||
106030271|NCT04604132|365774683|FG002|Overall Study|Adverse Event|0|||
106030272|NCT04604132|365774684|FG003|Overall Study|Adverse Event|1|||
105983219|NCT02528357|365598343|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983220|NCT02528357|365598344|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983221|NCT02528357|365598345|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983222|NCT02528357|365598346|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983223|NCT02528357|365598347|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983224|NCT02528357|365598348|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983225|NCT02528357|365598349|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983226|NCT02528357|365598350|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983227|NCT02528357|365598351|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
105983228|NCT02528357|365598352|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983229|NCT02528357|365598353|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
105983230|NCT02528357|365598354|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
105983231|NCT02528357|365598355|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
105983232|NCT02528357|365598356|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983233|NCT02528357|365598357|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983234|NCT02528357|365598358|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983235|NCT02528357|365598359|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
105983236|NCT02528357|365598341|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983237|NCT02528357|365598342|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983238|NCT02528357|365598343|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983239|NCT02528357|365598344|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983240|NCT02528357|365598345|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983241|NCT02528357|365598346|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983242|NCT02528357|365598347|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983243|NCT02528357|365598348|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983244|NCT02528357|365598349|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105983245|NCT02528357|365598350|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105983246|NCT02528357|365598351|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983247|NCT02528357|365598352|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
105983248|NCT02528357|365598353|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
105983249|NCT02528357|365598354|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105983250|NCT02528357|365598355|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105983251|NCT02528357|365598356|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983252|NCT02528357|365598357|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983253|NCT02528357|365598358|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983254|NCT02528357|365598359|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983255|NCT02528357|365598341|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983256|NCT02528357|365598342|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983257|NCT02528357|365598343|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983258|NCT02528357|365598344|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983259|NCT02528357|365598345|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983260|NCT02528357|365598346|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
106030273|NCT04604132|365774685|FG004|Overall Study|Adverse Event|2|||
106030274|NCT04604132|365774681|FG000|Overall Study|Study terminated by sponsor|0|||
106030275|NCT04604132|365774682|FG001|Overall Study|Study terminated by sponsor|0|||
105983261|NCT02528357|365598347|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983262|NCT02528357|365598348|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983263|NCT02528357|365598349|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983264|NCT02528357|365598350|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983265|NCT02528357|365598351|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983266|NCT02528357|365598352|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983267|NCT02528357|365598353|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983268|NCT02528357|365598354|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983269|NCT02528357|365598355|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983270|NCT02528357|365598356|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983271|NCT02528357|365598357|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
105983272|NCT02528357|365598358|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983273|NCT02528357|365598359|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
105983274|NCT02528357|365598341|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983275|NCT02528357|365598342|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983276|NCT02528357|365598343|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983277|NCT02528357|365598344|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983278|NCT02528357|365598345|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983279|NCT02528357|365598346|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983280|NCT02528357|365598347|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983281|NCT02528357|365598348|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983282|NCT02528357|365598349|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983283|NCT02528357|365598350|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983284|NCT02528357|365598351|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983285|NCT02528357|365598352|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983286|NCT02528357|365598353|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983287|NCT02528357|365598354|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983288|NCT02528357|365598355|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983289|NCT02528357|365598356|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
105983290|NCT02528357|365598357|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
105983291|NCT02528357|365598358|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
105983292|NCT02528357|365598359|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
105983293|NCT00558272|365598363|FG000|Overall Study|Adverse Event|10|||
105983294|NCT00558272|365598364|FG001|Overall Study|Adverse Event|0|||
105983295|NCT00558272|365598363|FG000|Overall Study|Death|1|||
105983296|NCT00558272|365598364|FG001|Overall Study|Death|0|||
105983297|NCT00558272|365598363|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
105983298|NCT00558272|365598364|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
105983299|NCT00558272|365598363|FG000|Overall Study|AZ study team decision|0|||
105983300|NCT00558272|365598364|FG001|Overall Study|AZ study team decision|1|||
105983301|NCT00558272|365598363|FG000|Overall Study|Incorrectly enrolled|1|||
105983302|NCT00558272|365598364|FG001|Overall Study|Incorrectly enrolled|0|||
105983303|NCT00558272|365598363|FG000|Overall Study|Withdrawal by Subject|0|||
105983304|NCT00558272|365598364|FG001|Overall Study|Withdrawal by Subject|1|||
105983305|NCT02986854|365598365|FG000|Overall Study|Withdrawal by Subject|0|||
105983306|NCT02986854|365598366|FG001|Overall Study|Withdrawal by Subject|1|||
105983307|NCT02986854|365598367|FG002|Overall Study|Withdrawal by Subject|1|||
105983308|NCT02986854|365598365|FG000|Overall Study|Lost to Follow-up|3|||
105983309|NCT02986854|365598366|FG001|Overall Study|Lost to Follow-up|11|||
105983310|NCT02986854|365598367|FG002|Overall Study|Lost to Follow-up|2|||
105983311|NCT00324233|365598370|FG000|First Period|unable to insert catheter|1|||
105983312|NCT00324233|365598371|FG001|First Period|unable to insert catheter|0|||
105983313|NCT00324233|365598370|FG000|Second Period|unable to insert catheter|1|||
105983314|NCT00324233|365598371|FG001|Second Period|unable to insert catheter|1|||
105983315|NCT00324233|365598370|FG000|Second Period|Protocol Violation|4|||
105983316|NCT00324233|365598371|FG001|Second Period|Protocol Violation|6|||
105983317|NCT00483002|365598372|FG000|Overall Study|Adverse Event|68|||
105983318|NCT00483002|365598372|FG000|Overall Study|Lack of Efficacy|555|||
105983319|NCT00483002|365598372|FG000|Overall Study|Lost to Follow-up|962|||
105983320|NCT00483002|365598372|FG000|Overall Study|Other|2|||
105983321|NCT00483002|365598372|FG000|Overall Study|Other|967|||
105983322|NCT00086411|365598373|FG000|Overall Study|Lost to Follow-up|11|||
105983323|NCT00086411|365598374|FG001|Overall Study|Lost to Follow-up|11|||
105983324|NCT00086411|365598375|FG002|Overall Study|Lost to Follow-up|13|||
105983325|NCT00086411|365598376|FG003|Overall Study|Lost to Follow-up|12|||
105983326|NCT03442296|365598377|FG000|3 Month Follow-up|Death|3|||
105983327|NCT03442296|365598378|FG001|3 Month Follow-up|Death|1|||
105983328|NCT03442296|365598377|FG000|3 Month Follow-up|Lost to Follow-up|1|||
105983329|NCT03442296|365598378|FG001|3 Month Follow-up|Lost to Follow-up|1|||
105983330|NCT03442296|365598377|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
105983331|NCT03442296|365598378|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
105983332|NCT03442296|365598377|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
105983333|NCT03442296|365598378|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
105983334|NCT03442296|365598377|FG000|12 Month Follow-up|Incomplete measurement|1|||
105983335|NCT03442296|365598378|FG001|12 Month Follow-up|Incomplete measurement|1|||
105983336|NCT01624090|365598379|FG000|Overall Study|DLT, taken off therapy|0|||
105983337|NCT01624090|365598380|FG001|Overall Study|DLT, taken off therapy|1|||
105983338|NCT01624090|365598381|FG002|Overall Study|DLT, taken off therapy|0|||
105983339|NCT01624090|365598382|FG003|Overall Study|DLT, taken off therapy|0|||
105983340|NCT01624090|365598379|FG000|Overall Study|Withdrew prior to treatment|0|||
105983341|NCT01624090|365598380|FG001|Overall Study|Withdrew prior to treatment|1|||
105983342|NCT01624090|365598381|FG002|Overall Study|Withdrew prior to treatment|0|||
105983343|NCT01624090|365598382|FG003|Overall Study|Withdrew prior to treatment|0|||
105983344|NCT01624090|365598379|FG000|Overall Study|Died on study|0|||
105983345|NCT01624090|365598380|FG001|Overall Study|Died on study|0|||
105983346|NCT01624090|365598381|FG002|Overall Study|Died on study|2|||
105983347|NCT01624090|365598382|FG003|Overall Study|Died on study|0|||
105983348|NCT01624090|365598379|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
105983349|NCT01624090|365598380|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
105983350|NCT01624090|365598381|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
105983351|NCT01624090|365598382|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
105983352|NCT01624090|365598379|FG000|Overall Study|Dose escalated|0|||
105983353|NCT01624090|365598380|FG001|Overall Study|Dose escalated|0|||
105983354|NCT01624090|365598381|FG002|Overall Study|Dose escalated|3|||
105983355|NCT01624090|365598382|FG003|Overall Study|Dose escalated|0|||
105983356|NCT00772109|365598383|FG000|Overall Study|Serious adverse event|1|||
105983357|NCT00772109|365598384|FG001|Overall Study|Serious adverse event|0|||
105983358|NCT00772109|365598385|FG002|Overall Study|Serious adverse event|1|||
105983359|NCT00772109|365598386|FG003|Overall Study|Serious adverse event|0|||
105983360|NCT00772109|365598383|FG000|Overall Study|Protocol Violation|5|||
105983361|NCT00772109|365598384|FG001|Overall Study|Protocol Violation|8|||
105983362|NCT00772109|365598385|FG002|Overall Study|Protocol Violation|7|||
105983363|NCT00772109|365598386|FG003|Overall Study|Protocol Violation|6|||
105983364|NCT00772109|365598383|FG000|Overall Study|Lost to Follow-up|7|||
105983365|NCT00772109|365598384|FG001|Overall Study|Lost to Follow-up|3|||
105983366|NCT00772109|365598385|FG002|Overall Study|Lost to Follow-up|5|||
105983367|NCT00772109|365598386|FG003|Overall Study|Lost to Follow-up|9|||
105983368|NCT00772109|365598383|FG000|Overall Study|Withdrawal by Subject|8|||
105983369|NCT00772109|365598384|FG001|Overall Study|Withdrawal by Subject|8|||
105983370|NCT00772109|365598385|FG002|Overall Study|Withdrawal by Subject|6|||
105983371|NCT00772109|365598386|FG003|Overall Study|Withdrawal by Subject|16|||
105983372|NCT00752726|365598387|FG000|Overall Study|Lost to Follow-up|2|||
105983373|NCT00752726|365598388|FG001|Overall Study|Lost to Follow-up|1|||
105983374|NCT00752726|365598387|FG000|Overall Study|Adverse Event|3|||
105983375|NCT00752726|365598388|FG001|Overall Study|Adverse Event|0|||
105983376|NCT00752726|365598387|FG000|Overall Study|Withdrawal by Subject|5|||
105983377|NCT00752726|365598388|FG001|Overall Study|Withdrawal by Subject|10|||
105983378|NCT00752726|365598387|FG000|Overall Study|Other Reason|1|||
105983379|NCT00752726|365598388|FG001|Overall Study|Other Reason|2|||
105983380|NCT00626405|365598392|FG000|Overall Study|Deemed Ineligible|1|||
105983381|NCT00626405|365598393|FG001|Overall Study|Deemed Ineligible|0|||
105983382|NCT00626405|365598392|FG000|Overall Study|Withdrawal by Subject|0|||
105983383|NCT00626405|365598393|FG001|Overall Study|Withdrawal by Subject|1|||
105983384|NCT01264419|365598394|FG000|Overall Study|Lost to Follow-up|3|||
105983385|NCT01266590|365600467|FG000|Overall Study|Adverse Event|3|||
105983386|NCT01266590|365600467|FG000|Overall Study|Lost to Follow-up|1|||
105983387|NCT01266590|365600467|FG000|Overall Study|Withdrawal by Subject|1|||
105983388|NCT01266590|365600467|FG000|Overall Study|Physician Decision|1|||
105983389|NCT06359080|365600468|FG000|Overall Study|Withdrawal by Subject|3|||
105983390|NCT01306656|365600469|FG000|Overall Study|Lost to Follow-up|1|||
105983391|NCT01306656|365600470|FG001|Overall Study|Lost to Follow-up|0|||
105983392|NCT01286077|365600471|FG000|Overall Study|Adverse Event|2|||
105983393|NCT01286077|365600472|FG001|Overall Study|Adverse Event|0|||
105983394|NCT01286077|365600471|FG000|Overall Study|Death|1|||
105983395|NCT01286077|365600472|FG001|Overall Study|Death|0|||
105983396|NCT01286077|365600471|FG000|Overall Study|Protocol Violation|1|||
105983397|NCT01286077|365600472|FG001|Overall Study|Protocol Violation|1|||
105983398|NCT01286077|365600471|FG000|Overall Study|Withdrawal by Subject|0|||
105983399|NCT01286077|365600472|FG001|Overall Study|Withdrawal by Subject|2|||
105983400|NCT01286077|365600471|FG000|Overall Study|Intercurrent illness|1|||
105983401|NCT01286077|365600472|FG001|Overall Study|Intercurrent illness|0|||
105983402|NCT01286077|365600471|FG000|Overall Study|Non-compliance|1|||
105983403|NCT01286077|365600472|FG001|Overall Study|Non-compliance|0|||
105983404|NCT01286077|365600471|FG000|Overall Study|The subject starts with alternative MMY|0|||
105983405|NCT01286077|365600472|FG001|Overall Study|The subject starts with alternative MMY|3|||
105983406|NCT01286077|365600471|FG000|Overall Study|Patient's decision to stop treatment|3|||
105983407|NCT01286077|365600472|FG001|Overall Study|Patient's decision to stop treatment|0|||
105983408|NCT01286077|365600471|FG000|Overall Study|Progression of disease|0|||
105983409|NCT01286077|365600472|FG001|Overall Study|Progression of disease|1|||
105983410|NCT01286077|365600471|FG000|Overall Study|refill medication not received in time|1|||
105983411|NCT01286077|365600472|FG001|Overall Study|refill medication not received in time|0|||
105983412|NCT01272869|365600473|FG000|Period 2 (14 Days)|Adverse Event|1|||
105983413|NCT01272869|365600474|FG001|Period 2 (14 Days)|Adverse Event|0|||
105983414|NCT00771615|365600475|FG000|Overall Study|Withdrawal by Subject|0|||
105983415|NCT00771615|365600476|FG001|Overall Study|Withdrawal by Subject|1|||
105983416|NCT00771615|365600477|FG002|Overall Study|Withdrawal by Subject|0|||
105983417|NCT00771615|365600478|FG003|Overall Study|Withdrawal by Subject|0|||
105983418|NCT00771615|365600479|FG004|Overall Study|Withdrawal by Subject|0|||
105983419|NCT00771615|365600480|FG005|Overall Study|Withdrawal by Subject|0|||
105983420|NCT00771615|365600481|FG006|Overall Study|Withdrawal by Subject|0|||
105983421|NCT00771615|365600482|FG007|Overall Study|Withdrawal by Subject|1|||
105983422|NCT00771615|365600483|FG008|Overall Study|Withdrawal by Subject|0|||
105983423|NCT00771615|365600475|FG000|Overall Study|Lost to Follow-up|1|||
105983424|NCT00771615|365600476|FG001|Overall Study|Lost to Follow-up|1|||
105983425|NCT00771615|365600477|FG002|Overall Study|Lost to Follow-up|1|||
105983426|NCT00771615|365600478|FG003|Overall Study|Lost to Follow-up|1|||
105983427|NCT00771615|365600479|FG004|Overall Study|Lost to Follow-up|0|||
105983428|NCT00771615|365600480|FG005|Overall Study|Lost to Follow-up|1|||
105983429|NCT00771615|365600481|FG006|Overall Study|Lost to Follow-up|1|||
105983430|NCT00771615|365600482|FG007|Overall Study|Lost to Follow-up|0|||
105983431|NCT00771615|365600483|FG008|Overall Study|Lost to Follow-up|0|||
105983432|NCT02455076|365600484|FG000|Inpatient|Withdrawal by Subject|1|||
105983433|NCT02455076|365600485|FG001|Inpatient|Withdrawal by Subject|0|||
105983434|NCT02455076|365600486|FG002|Inpatient|Withdrawal by Subject|0|||
105983435|NCT02455076|365600487|FG003|Inpatient|Withdrawal by Subject|0|||
105983436|NCT02455076|365600488|FG004|Inpatient|Withdrawal by Subject|0|||
105983437|NCT02455076|365600484|FG000|Inpatient|Discharged <24 h after admission|0|||
105983438|NCT02455076|365600485|FG001|Inpatient|Discharged <24 h after admission|1|||
105983439|NCT02455076|365600486|FG002|Inpatient|Discharged <24 h after admission|0|||
105983440|NCT02455076|365600487|FG003|Inpatient|Discharged <24 h after admission|0|||
105983441|NCT02455076|365600488|FG004|Inpatient|Discharged <24 h after admission|0|||
105983442|NCT02455076|365600484|FG000|Inpatient|Adverse Event|3|||
105983443|NCT02455076|365600485|FG001|Inpatient|Adverse Event|0|||
105983444|NCT02455076|365600486|FG002|Inpatient|Adverse Event|0|||
105983445|NCT02455076|365600487|FG003|Inpatient|Adverse Event|0|||
105983446|NCT02455076|365600488|FG004|Inpatient|Adverse Event|0|||
105983447|NCT02455076|365600484|FG000|Outpatient|Adverse Event|0|||
105983448|NCT02455076|365600485|FG001|Outpatient|Adverse Event|0|||
105983449|NCT02455076|365600486|FG002|Outpatient|Adverse Event|0|||
105983450|NCT02455076|365600487|FG003|Outpatient|Adverse Event|5|||
105983451|NCT02455076|365600488|FG004|Outpatient|Adverse Event|0|||
105983452|NCT02455076|365600484|FG000|Outpatient|Lost to Follow-up|0|||
105983453|NCT02455076|365600485|FG001|Outpatient|Lost to Follow-up|0|||
105983454|NCT02455076|365600486|FG002|Outpatient|Lost to Follow-up|0|||
105983455|NCT02455076|365600487|FG003|Outpatient|Lost to Follow-up|1|||
105983456|NCT02455076|365600488|FG004|Outpatient|Lost to Follow-up|12|||
105983457|NCT00859937|365600489|FG000|Overall Study|Protocol Violation|1|||
105983458|NCT00859937|365600490|FG001|Overall Study|Protocol Violation|0|||
105983459|NCT00151476|365600491|FG000|FAP Identified Subjects|Protocol Violation|0|||
105983460|NCT00151476|365600492|FG001|FAP Identified Subjects|Protocol Violation|1|||
105983461|NCT00151476|365600491|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
105983462|NCT00151476|365600492|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
105983463|NCT00151476|365600491|FG000|FAP Analyzed Subjects|Other study participation|0|||
105983464|NCT00151476|365600492|FG001|FAP Analyzed Subjects|Other study participation|1|||
105983465|NCT03446456|365600493|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
105983466|NCT03446456|365600494|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
105983467|NCT03446456|365600493|FG000|Overall Study|Lost to Follow-up|1|||
105983468|NCT03446456|365600494|FG001|Overall Study|Lost to Follow-up|3|||
105983469|NCT03446456|365600493|FG000|Overall Study|Participant failed the toxicology test|1|||
105983470|NCT03446456|365600494|FG001|Overall Study|Participant failed the toxicology test|0|||
105983471|NCT03446456|365600493|FG000|Overall Study|Break down of the experimental equipment|1|||
105983472|NCT03446456|365600494|FG001|Overall Study|Break down of the experimental equipment|0|||
105983473|NCT02478164|365600495|FG000|Overall Study|Lack of Efficacy|13|||
105983474|NCT02478164|365600495|FG000|Overall Study|Adverse Event|1|||
105983475|NCT02478164|365600495|FG000|Overall Study|Withdrawal by Subject|1|||
105983476|NCT02704689|365600500|FG000|Overall Study|Physician Decision|1|||
105983477|NCT02704689|365600500|FG000|Overall Study|Study device not implanted|2|||
105983478|NCT02428205|365600501|FG000|Overall Study|Lack of Efficacy|1|||
105983479|NCT02428205|365600502|FG001|Overall Study|Lack of Efficacy|0|||
105983480|NCT02428205|365600501|FG000|Overall Study|Lost to Follow-up|1|||
105983481|NCT02428205|365600502|FG001|Overall Study|Lost to Follow-up|1|||
105983482|NCT02428205|365600501|FG000|Overall Study|Worse behavior|0|||
105983483|NCT02428205|365600502|FG001|Overall Study|Worse behavior|1|||
105983484|NCT03194438|365600503|FG000|Overall Study|Withdrawal by Subject|2|||
105983485|NCT03266172|365600508|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
105983486|NCT03266172|365600509|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
105983487|NCT03266172|365600510|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
105983488|NCT03266172|365600508|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
105983489|NCT03266172|365600509|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
105983490|NCT03266172|365600510|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
105983491|NCT03266172|365600508|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
105983492|NCT03266172|365600509|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
105983493|NCT03266172|365600510|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
105983494|NCT03266172|365600508|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
105983495|NCT03266172|365600509|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
105983496|NCT03266172|365600510|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
105983497|NCT03266172|365600508|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
105983498|NCT03266172|365600509|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
105983499|NCT03266172|365600510|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
105983500|NCT03266172|365600508|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
105983501|NCT03266172|365600509|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
105983502|NCT03266172|365600510|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
105983503|NCT03743064|365600513|FG000|Overall Study|Adverse Event|7|||
105983504|NCT03743064|365600514|FG001|Overall Study|Adverse Event|9|||
105983505|NCT03743064|365600513|FG000|Overall Study|Death|25|||
105983506|NCT03743064|365600514|FG001|Overall Study|Death|28|||
105983507|NCT03743064|365600513|FG000|Overall Study|Lost to Follow-up|3|||
105983508|NCT03743064|365600514|FG001|Overall Study|Lost to Follow-up|6|||
105983509|NCT03743064|365600513|FG000|Overall Study|Withdrawal by Subject|28|||
105983510|NCT03743064|365600514|FG001|Overall Study|Withdrawal by Subject|25|||
105983511|NCT03743064|365600513|FG000|Overall Study|Physician Decision|2|||
105983512|NCT03743064|365600514|FG001|Overall Study|Physician Decision|4|||
105983513|NCT03743064|365600513|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
105983514|NCT03743064|365600514|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
105983515|NCT02294734|365600515|FG000|Overall Study|Adverse Event|5|||
105983516|NCT02294734|365600516|FG001|Overall Study|Adverse Event|5|||
105983517|NCT02294734|365600515|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
105983518|NCT02294734|365600516|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
105983519|NCT02294734|365600515|FG000|Overall Study|Lost to Follow-up|2|||
105983520|NCT02294734|365600516|FG001|Overall Study|Lost to Follow-up|0|||
105983521|NCT02294734|365600515|FG000|Overall Study|Physician Decision|2|||
105983522|NCT02294734|365600516|FG001|Overall Study|Physician Decision|1|||
105983523|NCT02294734|365600515|FG000|Overall Study|Withdrawal by Subject|4|||
105983524|NCT02294734|365600516|FG001|Overall Study|Withdrawal by Subject|2|||
105983525|NCT03006887|365600518|FG000|Overall Study|Adverse Event|1|||
105983526|NCT03836677|365600519|FG000|Period 1|Adverse Event|0|||
105983527|NCT03836677|365600520|FG001|Period 1|Adverse Event|1|||
105983528|NCT03836677|365600519|FG000|Period 2|Severe non-compliance to protocol|1|||
105983529|NCT03836677|365600520|FG001|Period 2|Severe non-compliance to protocol|0|||
105983530|NCT02096263|365600521|FG000|Overall Study|Adverse Event|1|||
105983531|NCT02096263|365600522|FG001|Overall Study|Adverse Event|0|||
105983532|NCT02096263|365600523|FG002|Overall Study|Adverse Event|1|||
105983533|NCT02096263|365600521|FG000|Overall Study|Lost to Follow-up|14|||
105983534|NCT02096263|365600522|FG001|Overall Study|Lost to Follow-up|18|||
105983535|NCT02096263|365600523|FG002|Overall Study|Lost to Follow-up|15|||
105983536|NCT02096263|365600521|FG000|Overall Study|Other|7|||
105983537|NCT02096263|365600522|FG001|Overall Study|Other|9|||
105983538|NCT02096263|365600523|FG002|Overall Study|Other|6|||
105983539|NCT02096263|365600521|FG000|Overall Study|Sponsor study termination|0|||
105983540|NCT02096263|365600522|FG001|Overall Study|Sponsor study termination|0|||
105983541|NCT02096263|365600523|FG002|Overall Study|Sponsor study termination|1|||
105983542|NCT02096263|365600521|FG000|Overall Study|Protocol Violation|7|||
105983543|NCT02096263|365600522|FG001|Overall Study|Protocol Violation|2|||
105983544|NCT02096263|365600523|FG002|Overall Study|Protocol Violation|8|||
105983545|NCT02096263|365600521|FG000|Overall Study|Withdrawal by Subject|5|||
105983546|NCT02096263|365600522|FG001|Overall Study|Withdrawal by Subject|7|||
105983547|NCT02096263|365600523|FG002|Overall Study|Withdrawal by Subject|8|||
105983548|NCT02976103|365600524|FG000|Overall Study|Withdrawal by Subject|1|||
105983549|NCT02976103|365600525|FG001|Overall Study|Withdrawal by Subject|0|||
105983550|NCT02976103|365600524|FG000|Overall Study|Lost to Follow-up|12|||
105983551|NCT02976103|365600525|FG001|Overall Study|Lost to Follow-up|8|||
105983552|NCT01985360|365600526|FG000|Overall Study|Withdrawal by Subject|4|||
106030276|NCT04604132|365774683|FG002|Overall Study|Study terminated by sponsor|0|||
106030277|NCT04604132|365774684|FG003|Overall Study|Study terminated by sponsor|0|||
106030278|NCT04604132|365774685|FG004|Overall Study|Study terminated by sponsor|1|||
106030279|NCT04604132|365774681|FG000|Overall Study|Progressive disease: Clinical progression|0|||
106030280|NCT04604132|365774682|FG001|Overall Study|Progressive disease: Clinical progression|0|||
105983553|NCT01985360|365600527|FG001|Overall Study|Withdrawal by Subject|0|||
105983554|NCT01985360|365600526|FG000|Overall Study|Lost to Follow-up|5|||
105983555|NCT01985360|365600527|FG001|Overall Study|Lost to Follow-up|3|||
105983556|NCT01300455|365600528|FG000|Washout|Withdrawal by Subject|1|||
106030281|NCT04604132|365774683|FG002|Overall Study|Progressive disease: Clinical progression|1|||
106030282|NCT04604132|365774684|FG003|Overall Study|Progressive disease: Clinical progression|0|||
106030283|NCT04604132|365774685|FG004|Overall Study|Progressive disease: Clinical progression|0|||
105983557|NCT01300455|365600529|FG001|Washout|Withdrawal by Subject|0|||
105983558|NCT01455220|365600530|FG000|Overall Study|screen fail|30|||
105983559|NCT02438813|365600533|FG000|Overall Study|Patient Decision|59|||
105983560|NCT02438813|365600533|FG000|Overall Study|Patient Lost to Follow-Up|137|||
106030284|NCT04604132|365774681|FG000|Overall Study|Progressive disease: Radiological progression|8|||
105983561|NCT02438813|365600533|FG000|Overall Study|Study Ended by Sponsor|80|||
105983562|NCT02438813|365600533|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
105983563|NCT04881747|365600534|FG000|Period 2 Washout|Adverse Event|1|||
105983564|NCT04881747|365600535|FG001|Period 2 Washout|Adverse Event|0|||
105983565|NCT04881747|365600536|FG002|Period 2 Washout|Adverse Event|0|||
105983566|NCT04881747|365600537|FG003|Period 2 Washout|Adverse Event|0|||
105983567|NCT04881747|365600538|FG004|Period 2 Washout|Adverse Event|1|||
106030285|NCT04604132|365774682|FG001|Overall Study|Progressive disease: Radiological progression|7|||
106030286|NCT04604132|365774683|FG002|Overall Study|Progressive disease: Radiological progression|10|||
106030287|NCT04604132|365774684|FG003|Overall Study|Progressive disease: Radiological progression|4|||
106030288|NCT04604132|365774685|FG004|Overall Study|Progressive disease: Radiological progression|3|||
106030289|NCT04604132|365774681|FG000|Overall Study|Death|3|||
106030290|NCT04604132|365774682|FG001|Overall Study|Death|1|||
106030291|NCT04604132|365774683|FG002|Overall Study|Death|2|||
106030292|NCT04604132|365774684|FG003|Overall Study|Death|1|||
106030293|NCT04604132|365774685|FG004|Overall Study|Death|0|||
106030294|NCT00995566|365774686|FG000|Overall Study|Adverse Event|2|||
106030295|NCT00995566|365774686|FG000|Overall Study|Early study termination|52|||
106030296|NCT00510653|365774687|FG000|Overall Study|Withdrawal by Subject|8|||
106030297|NCT00510653|365774687|FG000|Overall Study|Monetary|3|||
106030298|NCT01924429|365774689|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
106030299|NCT01924429|365774690|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
105983568|NCT04881747|365600539|FG005|Period 2 Washout|Adverse Event|0|||
105983569|NCT04881747|365600534|FG000|Period 2 Washout|Withdrawal by Subject|1|||
105983570|NCT04881747|365600535|FG001|Period 2 Washout|Withdrawal by Subject|0|||
105983571|NCT04881747|365600536|FG002|Period 2 Washout|Withdrawal by Subject|0|||
105983572|NCT04881747|365600537|FG003|Period 2 Washout|Withdrawal by Subject|1|||
105983573|NCT04881747|365600538|FG004|Period 2 Washout|Withdrawal by Subject|0|||
106030300|NCT00384111|365774691|FG000|Overall Study|Disease Progression|3|||
106030301|NCT00384111|365774691|FG000|Overall Study|Adverse Event|1|||
106030302|NCT00384111|365774691|FG000|Overall Study|Investigator Decision|3|||
106030303|NCT00384111|365774691|FG000|Overall Study|Study Terminated by the Sponsor|19|||
106030304|NCT00545129|365774694|FG000|Overall Study|Lack of Efficacy|2|||
106030305|NCT00545129|365774695|FG001|Overall Study|Lack of Efficacy|5|||
106030306|NCT00545129|365774694|FG000|Overall Study|Death|2|||
106030307|NCT00545129|365774695|FG001|Overall Study|Death|1|||
106030308|NCT00545129|365774694|FG000|Overall Study|Adverse Event|1|||
106030309|NCT00545129|365774695|FG001|Overall Study|Adverse Event|1|||
106030310|NCT00545129|365774694|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
106030311|NCT00545129|365774695|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
106030312|NCT00545129|365774694|FG000|Overall Study|Other|3|||
106030313|NCT00545129|365774695|FG001|Overall Study|Other|3|||
106030314|NCT03678870|365774696|FG000|Overall Study|prescribed non- protocol medications|10|||
106030315|NCT03678870|365774697|FG001|Overall Study|prescribed non- protocol medications|6|||
106030316|NCT03678870|365774696|FG000|Overall Study|Lost to Follow-up|3|||
106030317|NCT03678870|365774697|FG001|Overall Study|Lost to Follow-up|2|||
106030318|NCT03720652|365774698|FG000|Overall Study|Withdrawal by Subject|2|||
105983574|NCT04881747|365600539|FG005|Period 2 Washout|Withdrawal by Subject|0|||
105983575|NCT01270256|365600540|FG000|Overall Study|Withdrawal by Subject|1|||
105983576|NCT01270256|365600541|FG001|Overall Study|Withdrawal by Subject|0|||
105983577|NCT00454649|365600545|FG000|Overall Study|Lack of Efficacy|2|||
106030319|NCT03720652|365774699|FG001|Overall Study|Withdrawal by Subject|7|||
106030320|NCT03720652|365774698|FG000|Overall Study|Lost to Follow-up|0|||
106030321|NCT03720652|365774699|FG001|Overall Study|Lost to Follow-up|4|||
106030322|NCT01454778|365774701|FG000|Overall Study|Lost to Follow-up|2|||
106030323|NCT01454778|365774701|FG000|Overall Study|Death|1|||
106030324|NCT00835731|365774702|FG000|Overall Study|Withdrawal by Subject|1|||
106030325|NCT00835731|365774703|FG001|Overall Study|Withdrawal by Subject|0|||
106030326|NCT00835731|365774702|FG000|Overall Study|Physician Decision|1|||
106030327|NCT00835731|365774703|FG001|Overall Study|Physician Decision|1|||
105983578|NCT00454649|365600546|FG001|Overall Study|Lack of Efficacy|2|||
106030328|NCT00348881|365774704|FG000|Overall Study|Lost to Follow-up|12|||
106030329|NCT00348881|365774705|FG001|Overall Study|Lost to Follow-up|6|||
106030330|NCT00348881|365774704|FG000|Overall Study|Withdrawal by Subject|3|||
105983579|NCT00454649|365600547|FG002|Overall Study|Lack of Efficacy|10|||
105983580|NCT00454649|365600548|FG003|Overall Study|Lack of Efficacy|3|||
105983581|NCT00454649|365600549|FG004|Overall Study|Lack of Efficacy|0|||
106030331|NCT00348881|365774705|FG001|Overall Study|Withdrawal by Subject|4|||
106030332|NCT00348881|365774704|FG000|Overall Study|Adverse Event|2|||
106030333|NCT00348881|365774705|FG001|Overall Study|Adverse Event|0|||
106030334|NCT00348881|365774704|FG000|Overall Study|Serious Adverse Event|0|||
105983582|NCT00454649|365600550|FG005|Overall Study|Lack of Efficacy|4|||
105983583|NCT00454649|365600551|FG006|Overall Study|Lack of Efficacy|5|||
105983584|NCT00454649|365600552|FG007|Overall Study|Lack of Efficacy|13|||
105983585|NCT00454649|365600553|FG008|Overall Study|Lack of Efficacy|10|||
105983586|NCT00454649|365600554|FG009|Overall Study|Lack of Efficacy|2|||
105983587|NCT00454649|365600545|FG000|Overall Study|Adverse Event|0|||
105983588|NCT00454649|365600546|FG001|Overall Study|Adverse Event|1|||
105983589|NCT00454649|365600547|FG002|Overall Study|Adverse Event|3|||
105983590|NCT00454649|365600548|FG003|Overall Study|Adverse Event|0|||
105983591|NCT00454649|365600549|FG004|Overall Study|Adverse Event|1|||
105983592|NCT00454649|365600550|FG005|Overall Study|Adverse Event|2|||
105983593|NCT00454649|365600551|FG006|Overall Study|Adverse Event|3|||
105983594|NCT00454649|365600552|FG007|Overall Study|Adverse Event|4|||
105983595|NCT00454649|365600553|FG008|Overall Study|Adverse Event|6|||
105983596|NCT00454649|365600554|FG009|Overall Study|Adverse Event|2|||
105983597|NCT00454649|365600545|FG000|Overall Study|Lost to Follow-up|0|||
105983598|NCT00454649|365600546|FG001|Overall Study|Lost to Follow-up|0|||
105983599|NCT00454649|365600547|FG002|Overall Study|Lost to Follow-up|1|||
105983600|NCT00454649|365600548|FG003|Overall Study|Lost to Follow-up|0|||
105983601|NCT00454649|365600549|FG004|Overall Study|Lost to Follow-up|0|||
105983602|NCT00454649|365600550|FG005|Overall Study|Lost to Follow-up|0|||
105983603|NCT00454649|365600551|FG006|Overall Study|Lost to Follow-up|1|||
105983604|NCT00454649|365600552|FG007|Overall Study|Lost to Follow-up|0|||
105983605|NCT00454649|365600553|FG008|Overall Study|Lost to Follow-up|0|||
105983606|NCT00454649|365600554|FG009|Overall Study|Lost to Follow-up|0|||
105983607|NCT00454649|365600545|FG000|Overall Study|Other|1|||
105983608|NCT00454649|365600546|FG001|Overall Study|Other|1|||
105983609|NCT00454649|365600547|FG002|Overall Study|Other|5|||
105983610|NCT00454649|365600548|FG003|Overall Study|Other|3|||
105983611|NCT00454649|365600549|FG004|Overall Study|Other|0|||
105983612|NCT00454649|365600550|FG005|Overall Study|Other|0|||
105983613|NCT00454649|365600551|FG006|Overall Study|Other|0|||
105983614|NCT00454649|365600552|FG007|Overall Study|Other|0|||
105983615|NCT00454649|365600553|FG008|Overall Study|Other|3|||
105983616|NCT00454649|365600554|FG009|Overall Study|Other|1|||
105983617|NCT00454649|365600545|FG000|Overall Study|Withdrawal by Subject|0|||
105983618|NCT00454649|365600546|FG001|Overall Study|Withdrawal by Subject|0|||
105983619|NCT00454649|365600547|FG002|Overall Study|Withdrawal by Subject|0|||
105983620|NCT00454649|365600548|FG003|Overall Study|Withdrawal by Subject|0|||
105983621|NCT00454649|365600549|FG004|Overall Study|Withdrawal by Subject|0|||
105983622|NCT00454649|365600550|FG005|Overall Study|Withdrawal by Subject|1|||
105983623|NCT00454649|365600551|FG006|Overall Study|Withdrawal by Subject|0|||
105983624|NCT00454649|365600552|FG007|Overall Study|Withdrawal by Subject|2|||
105983625|NCT00454649|365600553|FG008|Overall Study|Withdrawal by Subject|1|||
105983626|NCT00454649|365600554|FG009|Overall Study|Withdrawal by Subject|0|||
105983627|NCT00377364|365600555|FG000|Overall Study|Lost to Follow-up|1|||
105983628|NCT00377364|365600556|FG001|Overall Study|Lost to Follow-up|0|||
105983629|NCT00377364|365600555|FG000|Overall Study|Withdrawal by Subject|1|||
105983630|NCT00377364|365600556|FG001|Overall Study|Withdrawal by Subject|0|||
105983631|NCT02014584|365600559|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105983632|NCT02014584|365600560|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
105983633|NCT02014584|365600561|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105983634|NCT02014584|365600562|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105983635|NCT02014584|365600563|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105983636|NCT02014584|365600564|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
105983637|NCT02014584|365600559|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
105983638|NCT02014584|365600560|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
105983639|NCT02014584|365600561|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105983640|NCT02014584|365600562|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105983641|NCT02014584|365600563|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105983642|NCT02014584|365600564|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
105983643|NCT02014584|365600559|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105983644|NCT02014584|365600560|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105983645|NCT02014584|365600561|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
105983646|NCT02014584|365600562|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105983647|NCT02014584|365600563|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105983648|NCT02014584|365600564|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
105983649|NCT02014584|365600559|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
105983650|NCT02014584|365600560|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
105983651|NCT02014584|365600561|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
105983652|NCT02014584|365600562|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
105983653|NCT02014584|365600563|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
105983654|NCT02014584|365600564|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
105983655|NCT02014584|365600559|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105983656|NCT02014584|365600560|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105983657|NCT02014584|365600561|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105983658|NCT02014584|365600562|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105983659|NCT02014584|365600563|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
105983660|NCT02014584|365600564|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
105983661|NCT01704456|365600568|FG000|Overall Study|Lost to Follow-up|8|||
105983662|NCT01704456|365600569|FG001|Overall Study|Lost to Follow-up|14|||
105983663|NCT03596450|365600570|FG000|Overall Study|Death|9|||
105983664|NCT03596450|365600571|FG001|Overall Study|Death|9|||
105983665|NCT03596450|365600570|FG000|Overall Study|Protocol Violation|18|||
105983666|NCT03596450|365600571|FG001|Overall Study|Protocol Violation|26|||
105983667|NCT03596450|365600570|FG000|Overall Study|Lost to Follow-up|50|||
105983668|NCT03596450|365600571|FG001|Overall Study|Lost to Follow-up|56|||
105983669|NCT03596450|365600570|FG000|Overall Study|Adverse Event|14|||
105983670|NCT03596450|365600571|FG001|Overall Study|Adverse Event|7|||
105983671|NCT03596450|365600570|FG000|Overall Study|Withdrawal by Subject|38|||
105983672|NCT03596450|365600571|FG001|Overall Study|Withdrawal by Subject|36|||
105983673|NCT03596450|365600570|FG000|Overall Study|Accidentally Randomized|2|||
105983674|NCT03596450|365600571|FG001|Overall Study|Accidentally Randomized|0|||
105983675|NCT03596450|365600570|FG000|Overall Study|Other reasons|48|||
105983676|NCT03596450|365600571|FG001|Overall Study|Other reasons|53|||
105983677|NCT03596450|365600570|FG000|Overall Study|Pregnancy|2|||
105983678|NCT03596450|365600571|FG001|Overall Study|Pregnancy|0|||
105983679|NCT01403116|365600572|FG000|Overall Study|Adverse Event|7|||
105983680|NCT01403116|365600573|FG001|Overall Study|Adverse Event|4|||
105983681|NCT01403116|365600572|FG000|Overall Study|Lost to Follow-up|7|||
105983682|NCT01403116|365600573|FG001|Overall Study|Lost to Follow-up|5|||
105983683|NCT01403116|365600572|FG000|Overall Study|Withdrawal by Subject|12|||
105983684|NCT01403116|365600573|FG001|Overall Study|Withdrawal by Subject|15|||
105983685|NCT01403116|365600572|FG000|Overall Study|Non-compliance of study drug|3|||
105983686|NCT01403116|365600573|FG001|Overall Study|Non-compliance of study drug|0|||
105983687|NCT01403116|365600572|FG000|Overall Study|Protocol Violation|0|||
105983688|NCT01403116|365600573|FG001|Overall Study|Protocol Violation|1|||
105983689|NCT01403116|365600572|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
105983690|NCT01403116|365600573|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
105983691|NCT01403116|365600572|FG000|Overall Study|Hct >54%|2|||
105983692|NCT01403116|365600573|FG001|Overall Study|Hct >54%|0|||
105983693|NCT01403116|365600572|FG000|Overall Study|unable to keep appointments|0|||
105983694|NCT01403116|365600573|FG001|Overall Study|unable to keep appointments|2|||
105983695|NCT00042666|365600574|FG000|Overall Study|Adverse Event|2|||
105983696|NCT00042666|365600574|FG000|Overall Study|Death|4|||
105983697|NCT00042666|365600574|FG000|Overall Study|Protocol Violation|1|||
105983698|NCT00042666|365600574|FG000|Overall Study|Participant/Physician Perception|1|||
105983699|NCT00042666|365600574|FG000|Overall Study|Progressive Disease|41|||
105983700|NCT00042666|365600574|FG000|Overall Study|Other|1|||
105983701|NCT00042666|365600574|FG000|Overall Study|Other|4|||
105983702|NCT02039856|365600575|FG000|Overall Study|Death|5|||
105983703|NCT02039856|365600576|FG001|Overall Study|Death|3|||
106030335|NCT00348881|365774705|FG001|Overall Study|Serious Adverse Event|2|||
106030336|NCT00534599|365774706|FG000|Overall Study|Adverse Event|25|||
106030337|NCT00534599|365774707|FG001|Overall Study|Adverse Event|4|||
106030338|NCT00534599|365774706|FG000|Overall Study|Incorrect enrollment|2|||
106030339|NCT00534599|365774707|FG001|Overall Study|Incorrect enrollment|1|||
106030340|NCT00534599|365774706|FG000|Overall Study|Mis-randomization|2|||
106030341|NCT00534599|365774707|FG001|Overall Study|Mis-randomization|2|||
106030342|NCT00534599|365774706|FG000|Overall Study|Developed study-specific d/c criteria|5|||
106030343|NCT00534599|365774707|FG001|Overall Study|Developed study-specific d/c criteria|0|||
106030344|NCT00534599|365774706|FG000|Overall Study|Lack of Efficacy|0|||
106030345|NCT00534599|365774707|FG001|Overall Study|Lack of Efficacy|1|||
106030346|NCT00534599|365774706|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
106030347|NCT00534599|365774707|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
106030348|NCT00534599|365774706|FG000|Overall Study|Protocol Violation|1|||
105983704|NCT02039856|365600575|FG000|Overall Study|Partial survey completion|61|||
105983705|NCT02039856|365600576|FG001|Overall Study|Partial survey completion|26|||
105983706|NCT02039856|365600575|FG000|Overall Study|Lost to Follow-up|388|||
105983707|NCT02039856|365600576|FG001|Overall Study|Lost to Follow-up|206|||
105983708|NCT02039856|365600575|FG000|Overall Study|Withdrawal by Subject|1573|||
105983709|NCT02039856|365600576|FG001|Overall Study|Withdrawal by Subject|618|||
105983710|NCT02999633|365600577|FG000|Overall Study|Adverse Event|2|||
105983711|NCT02999633|365600577|FG000|Overall Study|Progressive disease|12|||
105983712|NCT03238924|365600579|FG000|Overall Study|Withdrawal by Subject|2|||
105983713|NCT03238924|365600580|FG001|Overall Study|Withdrawal by Subject|2|||
105983714|NCT02516228|365600581|FG000|Overall Study|Lost to Follow-up|1|||
105983715|NCT02516228|365600581|FG000|Overall Study|Withdrawal by Subject|1|||
105983716|NCT02516228|365600581|FG000|Overall Study|Physician Decision|1|||
105983717|NCT03908970|365600585|FG000|Overall Study|Adverse Event|7|||
105983718|NCT03908970|365600586|FG001|Overall Study|Adverse Event|21|||
105983719|NCT03908970|365600585|FG000|Overall Study|Physician Decision|1|||
105983720|NCT03908970|365600586|FG001|Overall Study|Physician Decision|4|||
106030349|NCT00534599|365774707|FG001|Overall Study|Protocol Violation|3|||
106030350|NCT00534599|365774706|FG000|Overall Study|Lost to Follow-up|11|||
106030351|NCT00534599|365774707|FG001|Overall Study|Lost to Follow-up|14|||
106030352|NCT00534599|365774706|FG000|Overall Study|Withdrawal by Subject|4|||
106030353|NCT00534599|365774707|FG001|Overall Study|Withdrawal by Subject|6|||
106030354|NCT00534599|365774706|FG000|Overall Study|Other|7|||
106030355|NCT00534599|365774707|FG001|Overall Study|Other|0|||
106030356|NCT00535288|365776819|FG000|Overall Study|Adverse Event|20|||
106030357|NCT00535288|365776820|FG001|Overall Study|Adverse Event|19|||
106030358|NCT00535288|365776821|FG002|Overall Study|Adverse Event|25|||
105983721|NCT03908970|365600585|FG000|Overall Study|Withdrawal by Subject|9|||
105983722|NCT03908970|365600586|FG001|Overall Study|Withdrawal by Subject|22|||
105983723|NCT01983774|365600587|FG000|Overall Study|Lung Transplant|0|||
105983724|NCT01983774|365600588|FG001|Overall Study|Lung Transplant|1|||
106030359|NCT00535288|365776822|FG003|Overall Study|Adverse Event|20|||
106030360|NCT00535288|365776823|FG004|Overall Study|Adverse Event|30|||
105983725|NCT01983774|365600587|FG000|Overall Study|Lost to Follow-up|1|||
105983726|NCT01983774|365600588|FG001|Overall Study|Lost to Follow-up|0|||
105983727|NCT01274429|365600589|FG000|Overall Study|Study closed do to lack of funding|5|||
105983728|NCT01879072|365600591|FG000|Overall Study|Withdrawal by Subject|121|||
105983729|NCT01879072|365600591|FG000|Overall Study|Not Transplanted|30|||
105983730|NCT05327361|365600592|FG000|Overall Study|Lost to Follow-up|4|||
105983731|NCT01439373|365600598|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
105983732|NCT01439373|365600599|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
105983733|NCT01439373|365600598|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
105983734|NCT01439373|365600599|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
105983735|NCT04576897|365600604|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
105983736|NCT02593318|365600605|FG000|Overall Study|Withdrawal by Subject|1|||
105983737|NCT02593318|365600606|FG001|Overall Study|Withdrawal by Subject|1|||
105983738|NCT00527332|365600612|FG000|Overall Study|Protocol Violation|4|||
105983739|NCT00527332|365600613|FG001|Overall Study|Protocol Violation|8|||
105983740|NCT00527332|365600612|FG000|Overall Study|Withdrew consent|5|||
105983741|NCT00527332|365600613|FG001|Overall Study|Withdrew consent|1|||
105983742|NCT02666105|365600614|FG000|Overall Study|Death|1|||
105983743|NCT01078168|365600615|FG000|Overall Study|Physician Decision|0|||
105983744|NCT01078168|365600616|FG001|Overall Study|Physician Decision|1|||
105983745|NCT02503501|365602252|FG000|Overall Study|Physician Decision|1|||
105983746|NCT02503501|365602253|FG001|Overall Study|Physician Decision|0|||
105983747|NCT02503501|365602252|FG000|Overall Study|Protocol Violation|0|||
105983748|NCT02503501|365602253|FG001|Overall Study|Protocol Violation|1|||
105983749|NCT02503501|365602252|FG000|Overall Study|Withdrawal by Subject|0|||
105983750|NCT02503501|365602253|FG001|Overall Study|Withdrawal by Subject|2|||
105983751|NCT01740401|365602254|FG000|Overall Study|Progression of disease|6|||
105983752|NCT01740401|365602254|FG000|Overall Study|Adverse Event|2|||
105983753|NCT01740401|365602254|FG000|Overall Study|Did not reach primary endpoint|2|||
105983754|NCT02806960|365602255|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
105983755|NCT02806960|365602256|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
105983756|NCT02806960|365602257|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
106030361|NCT00535288|365776819|FG000|Overall Study|Lost to Follow-up|0|||
106030362|NCT00535288|365776820|FG001|Overall Study|Lost to Follow-up|3|||
106030363|NCT00535288|365776821|FG002|Overall Study|Lost to Follow-up|0|||
106030364|NCT00535288|365776822|FG003|Overall Study|Lost to Follow-up|0|||
106030365|NCT00535288|365776823|FG004|Overall Study|Lost to Follow-up|0|||
106030366|NCT00535288|365776819|FG000|Overall Study|Lack of Efficacy|26|||
105983757|NCT02806960|365602258|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
105983758|NCT02315560|365602259|FG000|Overall Study|noncompliance by subjects|3|||
105983759|NCT03667690|365602260|FG000|Overall Study|Adverse Event|0|||
105983760|NCT03667690|365602261|FG001|Overall Study|Adverse Event|3|||
105983761|NCT03667690|365602260|FG000|Overall Study|Death|22|||
105983762|NCT03667690|365602261|FG001|Overall Study|Death|21|||
106030367|NCT00535288|365776820|FG001|Overall Study|Lack of Efficacy|3|||
106030368|NCT00535288|365776821|FG002|Overall Study|Lack of Efficacy|4|||
106030369|NCT00535288|365776822|FG003|Overall Study|Lack of Efficacy|4|||
106030370|NCT00535288|365776823|FG004|Overall Study|Lack of Efficacy|7|||
106030371|NCT00535288|365776819|FG000|Overall Study|Unwilling to cooperate|6|||
106030372|NCT00535288|365776820|FG001|Overall Study|Unwilling to cooperate|6|||
106030373|NCT00535288|365776821|FG002|Overall Study|Unwilling to cooperate|3|||
106030374|NCT00535288|365776822|FG003|Overall Study|Unwilling to cooperate|3|||
106030375|NCT00535288|365776823|FG004|Overall Study|Unwilling to cooperate|4|||
106030376|NCT00535288|365776819|FG000|Overall Study|Other|2|||
106030377|NCT00535288|365776820|FG001|Overall Study|Other|1|||
105983763|NCT03667690|365602260|FG000|Overall Study|Lost to Follow-up|4|||
105983764|NCT03667690|365602261|FG001|Overall Study|Lost to Follow-up|5|||
105983765|NCT03667690|365602260|FG000|Overall Study|Withdrawal by Subject|7|||
105983766|NCT03667690|365602261|FG001|Overall Study|Withdrawal by Subject|8|||
105983767|NCT03667690|365602260|FG000|Overall Study|Subject could not return for additional investigational product|1|||
105983768|NCT03667690|365602261|FG001|Overall Study|Subject could not return for additional investigational product|0|||
105983769|NCT03667690|365602260|FG000|Overall Study|Subject discharged to hospice care|2|||
105983770|NCT03667690|365602261|FG001|Overall Study|Subject discharged to hospice care|0|||
105983771|NCT03667690|365602260|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
105983772|NCT03667690|365602261|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
105983773|NCT03667690|365602260|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
105983774|NCT03667690|365602261|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
105983775|NCT03667690|365602260|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
105983776|NCT03667690|365602261|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
105983777|NCT03667690|365602260|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
105983778|NCT03667690|365602261|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
105983779|NCT03667690|365602260|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
105983780|NCT03667690|365602261|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
105983781|NCT01209078|365602263|FG000|Overall Study|Adverse Event|5|||
105983782|NCT01209078|365602264|FG001|Overall Study|Adverse Event|0|||
105983783|NCT01209078|365602263|FG000|Overall Study|Lost to Follow-up|4|||
105983784|NCT01209078|365602264|FG001|Overall Study|Lost to Follow-up|0|||
105983785|NCT01209078|365602263|FG000|Overall Study|Physician Decision|5|||
105983786|NCT01209078|365602264|FG001|Overall Study|Physician Decision|2|||
105983787|NCT01209078|365602263|FG000|Overall Study|Withdrawal by Subject|2|||
105983788|NCT01209078|365602264|FG001|Overall Study|Withdrawal by Subject|1|||
105983789|NCT02100969|365602265|FG000|Overall Study|Did not pass screening phase|1|||
105983790|NCT00924508|365602266|FG000|Overall Study|Withdrawal by Subject|3|||
105983791|NCT02081599|365602267|FG000|Period 1：Double-blind Period|Adverse Event|3|||
105983792|NCT02081599|365602268|FG001|Period 1：Double-blind Period|Adverse Event|0|||
105983793|NCT02081599|365602267|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
105983794|NCT02081599|365602268|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
105983795|NCT02081599|365602267|FG000|Period 1：Double-blind Period|Physician Decision|1|||
105983796|NCT02081599|365602268|FG001|Period 1：Double-blind Period|Physician Decision|0|||
105983797|NCT02081599|365602267|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
105983798|NCT02081599|365602268|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
105983799|NCT02081599|365602267|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
105983800|NCT02081599|365602268|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
105983801|NCT02081599|365602267|FG000|Period 1：Double-blind Period|stopping criteria|1|||
105983802|NCT02081599|365602268|FG001|Period 1：Double-blind Period|stopping criteria|0|||
105983803|NCT02081599|365602267|FG000|Period 2：Open-label Period|Adverse Event|1|||
105983804|NCT02081599|365602268|FG001|Period 2：Open-label Period|Adverse Event|0|||
105983805|NCT02081599|365602267|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
105983806|NCT02081599|365602268|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
105983807|NCT02081599|365602267|FG000|Period 2：Open-label Period|Physician Decision|1|||
105983808|NCT02081599|365602268|FG001|Period 2：Open-label Period|Physician Decision|0|||
105983809|NCT02081599|365602267|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
105983810|NCT02081599|365602268|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
105983811|NCT01912339|365602269|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
105983812|NCT01912339|365602270|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
105983813|NCT01912339|365602271|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
105983814|NCT01912339|365602269|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
105983815|NCT01912339|365602270|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
105983816|NCT01912339|365602271|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
105983817|NCT01912339|365602269|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
105983818|NCT01912339|365602270|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
105983819|NCT01912339|365602271|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
105983820|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
105983821|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
105983822|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
105983823|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
105983824|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
105983825|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
105983826|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
105983827|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
105983828|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
105983829|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
105983830|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
105983831|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
105983832|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
105983833|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
105983834|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
105983835|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
105983836|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
105983837|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
105983838|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
105983839|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
105983840|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
105983841|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
105983842|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
105983843|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
105983844|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
105983845|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
105983846|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
105983847|NCT01912339|365602269|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
105983848|NCT01912339|365602270|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
105983849|NCT01912339|365602271|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
105983850|NCT03459365|365602274|FG000|Overall Study|Withdrawal by Subject|6|||
105983851|NCT03459365|365602274|FG000|Overall Study|Protocol Violation|8|||
105983852|NCT01543776|365602275|FG000|Overall Study|Withdrawal by Subject|2|||
105983853|NCT01543776|365602276|FG001|Overall Study|Withdrawal by Subject|2|||
105983854|NCT00528801|365602279|FG000|Overall Study|Withdrawal by Subject|1|||
105983855|NCT00528801|365602280|FG001|Overall Study|Withdrawal by Subject|1|||
105983856|NCT00528801|365602279|FG000|Overall Study|Protocol Violation|11|||
105983857|NCT00528801|365602280|FG001|Overall Study|Protocol Violation|5|||
105983858|NCT00528801|365602279|FG000|Overall Study|Lost to Follow-up|15|||
105983859|NCT00528801|365602280|FG001|Overall Study|Lost to Follow-up|4|||
105983860|NCT00528801|365602279|FG000|Overall Study|Administrative Reasons|0|||
106030378|NCT00535288|365776821|FG002|Overall Study|Other|1|||
106030379|NCT00535288|365776822|FG003|Overall Study|Other|2|||
106030380|NCT00535288|365776823|FG004|Overall Study|Other|1|||
105983861|NCT00528801|365602280|FG001|Overall Study|Administrative Reasons|1|||
105983862|NCT03626545|365602282|FG000|Overall Study|Progressive disease|3|||
106030381|NCT00830869|365776826|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
106030382|NCT00830869|365776827|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
106030383|NCT00830869|365776828|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
106030384|NCT00830869|365776829|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
106030385|NCT00830869|365776830|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
106030386|NCT00830869|365776831|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
106030387|NCT00830869|365776832|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
106030388|NCT00830869|365776833|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
106030389|NCT00830869|365776834|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
106030390|NCT00830869|365776835|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
106030391|NCT00830869|365776836|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
106030392|NCT00830869|365776837|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
106030393|NCT00830869|365776826|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
106030394|NCT00830869|365776827|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
106030395|NCT00830869|365776828|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
106030396|NCT00830869|365776829|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
106030397|NCT00830869|365776830|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
106030398|NCT00830869|365776831|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
106030399|NCT00830869|365776832|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
106030400|NCT00830869|365776833|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
106030401|NCT00830869|365776834|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
106030402|NCT00830869|365776835|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
106030403|NCT00830869|365776836|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
106030404|NCT00830869|365776837|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
106030405|NCT00830869|365776826|FG000|Period 1: Part 1|Adverse Event|0|||
106030406|NCT00830869|365776827|FG001|Period 1: Part 1|Adverse Event|0|||
106030407|NCT00830869|365776828|FG002|Period 1: Part 1|Adverse Event|0|||
106030408|NCT00830869|365776829|FG003|Period 1: Part 1|Adverse Event|0|||
106030409|NCT00830869|365776830|FG004|Period 1: Part 1|Adverse Event|0|||
106030410|NCT00830869|365776831|FG005|Period 1: Part 1|Adverse Event|1|||
106030411|NCT00830869|365776832|FG006|Period 1: Part 1|Adverse Event|1|||
106030412|NCT00830869|365776833|FG007|Period 1: Part 1|Adverse Event|0|||
106030413|NCT00830869|365776834|FG008|Period 1: Part 1|Adverse Event|0|||
106030414|NCT00830869|365776835|FG009|Period 1: Part 1|Adverse Event|0|||
106030415|NCT00830869|365776836|FG010|Period 1: Part 1|Adverse Event|0|||
106030416|NCT00830869|365776837|FG011|Period 1: Part 1|Adverse Event|0|||
106030417|NCT00830869|365776826|FG000|Period 1: Part 1|Progressive disease|1|||
106030418|NCT00830869|365776827|FG001|Period 1: Part 1|Progressive disease|0|||
106030419|NCT00830869|365776828|FG002|Period 1: Part 1|Progressive disease|1|||
105983863|NCT03626545|365602283|FG001|Overall Study|Progressive disease|82|||
105983864|NCT03626545|365602284|FG002|Overall Study|Progressive disease|85|||
105983865|NCT03626545|365602282|FG000|Overall Study|Adverse Event|3|||
105983866|NCT03626545|365602283|FG001|Overall Study|Adverse Event|13|||
105983867|NCT03626545|365602284|FG002|Overall Study|Adverse Event|10|||
105983868|NCT03626545|365602282|FG000|Overall Study|Physician Decision|1|||
105983869|NCT03626545|365602283|FG001|Overall Study|Physician Decision|18|||
105983870|NCT03626545|365602284|FG002|Overall Study|Physician Decision|14|||
105983871|NCT03626545|365602282|FG000|Overall Study|Subject Decision|0|||
105983872|NCT03626545|365602283|FG001|Overall Study|Subject Decision|5|||
105983873|NCT03626545|365602284|FG002|Overall Study|Subject Decision|5|||
105983874|NCT03626545|365602282|FG000|Overall Study|Death|1|||
105983875|NCT03626545|365602283|FG001|Overall Study|Death|1|||
105983876|NCT03626545|365602284|FG002|Overall Study|Death|1|||
105983877|NCT03626545|365602282|FG000|Overall Study|Protocol Deviation|0|||
105983878|NCT03626545|365602283|FG001|Overall Study|Protocol Deviation|1|||
105983879|NCT03626545|365602284|FG002|Overall Study|Protocol Deviation|1|||
105983880|NCT03626545|365602282|FG000|Overall Study|Guardian Decision|0|||
105983881|NCT03626545|365602283|FG001|Overall Study|Guardian Decision|0|||
105983882|NCT03626545|365602284|FG002|Overall Study|Guardian Decision|1|||
105983883|NCT00679172|365602287|FG000|Overall Study|Non-compliance|1|||
105983884|NCT00679172|365602288|FG001|Overall Study|Non-compliance|1|||
106030420|NCT00830869|365776829|FG003|Period 1: Part 1|Progressive disease|6|||
106030421|NCT00830869|365776830|FG004|Period 1: Part 1|Progressive disease|4|||
106030422|NCT00830869|365776831|FG005|Period 1: Part 1|Progressive disease|4|||
106030423|NCT00830869|365776832|FG006|Period 1: Part 1|Progressive disease|1|||
106030424|NCT00830869|365776833|FG007|Period 1: Part 1|Progressive disease|0|||
106030425|NCT00830869|365776834|FG008|Period 1: Part 1|Progressive disease|0|||
106030426|NCT00830869|365776835|FG009|Period 1: Part 1|Progressive disease|0|||
106030427|NCT00830869|365776836|FG010|Period 1: Part 1|Progressive disease|0|||
106030428|NCT00830869|365776837|FG011|Period 1: Part 1|Progressive disease|0|||
106030429|NCT00830869|365776826|FG000|Period 2: Part 2|Protocol Violation|0|||
106030430|NCT00830869|365776827|FG001|Period 2: Part 2|Protocol Violation|0|||
106030431|NCT00830869|365776828|FG002|Period 2: Part 2|Protocol Violation|0|||
106030432|NCT00830869|365776829|FG003|Period 2: Part 2|Protocol Violation|0|||
106030433|NCT00830869|365776830|FG004|Period 2: Part 2|Protocol Violation|0|||
106030434|NCT00830869|365776831|FG005|Period 2: Part 2|Protocol Violation|0|||
106030435|NCT00830869|365776832|FG006|Period 2: Part 2|Protocol Violation|0|||
106030436|NCT00830869|365776833|FG007|Period 2: Part 2|Protocol Violation|1|||
106030437|NCT00830869|365776834|FG008|Period 2: Part 2|Protocol Violation|0|||
106030438|NCT00830869|365776835|FG009|Period 2: Part 2|Protocol Violation|1|||
106030439|NCT00830869|365776836|FG010|Period 2: Part 2|Protocol Violation|0|||
106030440|NCT00830869|365776837|FG011|Period 2: Part 2|Protocol Violation|0|||
106030441|NCT00830869|365776826|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
106030442|NCT00830869|365776827|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
106030443|NCT00830869|365776828|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
106030444|NCT00830869|365776829|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
106030445|NCT00830869|365776830|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
106030446|NCT00830869|365776831|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
106030447|NCT00830869|365776832|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
106030448|NCT00830869|365776833|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
106030449|NCT00830869|365776834|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
106030450|NCT00830869|365776835|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
106030451|NCT00830869|365776836|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
106030452|NCT00830869|365776837|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
106030453|NCT00830869|365776826|FG000|Period 2: Part 2|Adverse Event|0|||
106030454|NCT00830869|365776827|FG001|Period 2: Part 2|Adverse Event|0|||
105983885|NCT00679172|365602289|FG002|Overall Study|Non-compliance|0|||
105983886|NCT00679172|365602290|FG003|Overall Study|Non-compliance|1|||
105983887|NCT00679172|365602291|FG004|Overall Study|Non-compliance|0|||
105983888|NCT00679172|365602287|FG000|Overall Study|Other not specified|0|||
105983889|NCT00679172|365602288|FG001|Overall Study|Other not specified|0|||
106030455|NCT00830869|365776828|FG002|Period 2: Part 2|Adverse Event|0|||
106030456|NCT00830869|365776829|FG003|Period 2: Part 2|Adverse Event|0|||
106030457|NCT00830869|365776830|FG004|Period 2: Part 2|Adverse Event|0|||
106030458|NCT00830869|365776831|FG005|Period 2: Part 2|Adverse Event|0|||
106030459|NCT00830869|365776832|FG006|Period 2: Part 2|Adverse Event|0|||
106030460|NCT00830869|365776833|FG007|Period 2: Part 2|Adverse Event|4|||
105983890|NCT00679172|365602289|FG002|Overall Study|Other not specified|1|||
105983891|NCT00679172|365602290|FG003|Overall Study|Other not specified|0|||
105983892|NCT00679172|365602291|FG004|Overall Study|Other not specified|0|||
105983893|NCT02271945|365602293|FG000|Overall Study|Death|3|||
106030461|NCT00830869|365776834|FG008|Period 2: Part 2|Adverse Event|3|||
106030462|NCT00830869|365776835|FG009|Period 2: Part 2|Adverse Event|2|||
106030463|NCT00830869|365776836|FG010|Period 2: Part 2|Adverse Event|2|||
106030464|NCT00830869|365776837|FG011|Period 2: Part 2|Adverse Event|0|||
106030465|NCT00830869|365776826|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
105983894|NCT02271945|365602294|FG001|Overall Study|Death|3|||
105983895|NCT02271945|365602293|FG000|Overall Study|Withdrawal by Subject|1|||
105983896|NCT02271945|365602294|FG001|Overall Study|Withdrawal by Subject|1|||
105983897|NCT02271945|365602293|FG000|Overall Study|Other|1|||
105983898|NCT02271945|365602294|FG001|Overall Study|Other|1|||
105983899|NCT00308074|365602295|FG000|Overall Study|Withdrawal by Subject|1|||
105983900|NCT03002311|365602296|FG000|Overall Study|Lost to Follow-up|13|||
105983901|NCT03002311|365602297|FG001|Overall Study|Lost to Follow-up|26|||
105983902|NCT03002311|365602296|FG000|Overall Study|Referral provider called to schedule app|3|||
105983903|NCT03002311|365602297|FG001|Overall Study|Referral provider called to schedule app|3|||
105983904|NCT03002311|365602296|FG000|Overall Study|Physician Decision|3|||
105983905|NCT03002311|365602297|FG001|Overall Study|Physician Decision|1|||
105983906|NCT03908476|365602298|FG000|Overall Study|Death|3|||
105983907|NCT03908476|365602299|FG001|Overall Study|Death|0|||
105983908|NCT03908476|365602298|FG000|Overall Study|Lost to Follow-up|3|||
105983909|NCT03908476|365602299|FG001|Overall Study|Lost to Follow-up|1|||
105983910|NCT03908476|365602298|FG000|Overall Study|Withdrawal by Subject|7|||
105983911|NCT03908476|365602299|FG001|Overall Study|Withdrawal by Subject|1|||
105983912|NCT03908476|365602298|FG000|Overall Study|Physician Decision|2|||
105983913|NCT03908476|365602299|FG001|Overall Study|Physician Decision|0|||
105983914|NCT03908476|365602298|FG000|Overall Study|System Explanted and not Replaced|4|||
105983915|NCT03908476|365602299|FG001|Overall Study|System Explanted and not Replaced|0|||
105983916|NCT03908476|365602298|FG000|Overall Study|Intrathecal Pump|1|||
105983917|NCT03908476|365602299|FG001|Overall Study|Intrathecal Pump|0|||
105983918|NCT03908476|365602298|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
105983919|NCT03908476|365602299|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
105983920|NCT01110382|365602301|FG000|Overall Study|Withdrawal by Subject|0|||
105983921|NCT01110382|365602302|FG001|Overall Study|Withdrawal by Subject|1|||
105983922|NCT01110382|365602301|FG000|Overall Study|Protocol Violation|0|||
105983923|NCT01110382|365602302|FG001|Overall Study|Protocol Violation|1|||
105983924|NCT00300365|365602306|FG000|Overall Study|Lost to Follow-up|1|||
105983925|NCT00300365|365602307|FG001|Overall Study|Lost to Follow-up|0|||
105983926|NCT00300365|365602306|FG000|Overall Study|Physician Decision|2|||
105983927|NCT00300365|365602307|FG001|Overall Study|Physician Decision|0|||
105983928|NCT00300365|365602306|FG000|Overall Study|Withdrawal by Subject|1|||
105983929|NCT00300365|365602307|FG001|Overall Study|Withdrawal by Subject|0|||
105983930|NCT00300365|365602306|FG000|Overall Study|Adverse Event|0|||
105983931|NCT00300365|365602307|FG001|Overall Study|Adverse Event|2|||
105983932|NCT01079936|365602308|FG000|Phase I: MTD|First Remission Status|2|||
105983933|NCT01079936|365602309|FG001|Phase I: MTD|First Remission Status|0|||
105983934|NCT01079936|365602310|FG002|Phase I: MTD|First Remission Status|0|||
106030466|NCT00830869|365776827|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
106030467|NCT00830869|365776828|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
106030468|NCT00830869|365776829|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
106030469|NCT00830869|365776830|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
106030470|NCT00830869|365776831|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
106030471|NCT00830869|365776832|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
106030472|NCT00830869|365776833|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
106030473|NCT00830869|365776834|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
106030474|NCT00830869|365776835|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
106030475|NCT00830869|365776836|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
106030476|NCT00830869|365776837|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
105983935|NCT01079936|365602311|FG003|Phase I: MTD|First Remission Status|0|||
105983936|NCT01079936|365602312|FG004|Phase I: MTD|First Remission Status|0|||
105983937|NCT01079936|365602308|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
106030477|NCT00830869|365776826|FG000|Period 2: Part 2|Progressive disease|0|||
106030478|NCT00830869|365776827|FG001|Period 2: Part 2|Progressive disease|0|||
105983938|NCT01079936|365602309|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
105983939|NCT01079936|365602310|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
105983940|NCT01079936|365602311|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
105983941|NCT01079936|365602312|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
105983942|NCT01079936|365602308|FG000|Phase II|Adverse Event|0|||
105983943|NCT01079936|365602309|FG001|Phase II|Adverse Event|0|||
105983944|NCT01079936|365602310|FG002|Phase II|Adverse Event|1|||
105983945|NCT01079936|365602311|FG003|Phase II|Adverse Event|0|||
105983946|NCT01079936|365602312|FG004|Phase II|Adverse Event|0|||
105983947|NCT01079936|365602308|FG000|Phase II|Insurance Issue|0|||
105983948|NCT01079936|365602309|FG001|Phase II|Insurance Issue|0|||
106030479|NCT00830869|365776828|FG002|Period 2: Part 2|Progressive disease|0|||
106030480|NCT00830869|365776829|FG003|Period 2: Part 2|Progressive disease|0|||
106030481|NCT00830869|365776830|FG004|Period 2: Part 2|Progressive disease|0|||
106030482|NCT00830869|365776831|FG005|Period 2: Part 2|Progressive disease|0|||
106030483|NCT00830869|365776832|FG006|Period 2: Part 2|Progressive disease|0|||
106030484|NCT00830869|365776833|FG007|Period 2: Part 2|Progressive disease|14|||
106030485|NCT00830869|365776834|FG008|Period 2: Part 2|Progressive disease|11|||
106030486|NCT00830869|365776835|FG009|Period 2: Part 2|Progressive disease|12|||
106030487|NCT00830869|365776836|FG010|Period 2: Part 2|Progressive disease|8|||
106030488|NCT00830869|365776837|FG011|Period 2: Part 2|Progressive disease|15|||
106030489|NCT00830869|365776826|FG000|Period 2: Part 2|Other|0|||
106030490|NCT00830869|365776827|FG001|Period 2: Part 2|Other|0|||
106030491|NCT00830869|365776828|FG002|Period 2: Part 2|Other|0|||
106030492|NCT00830869|365776829|FG003|Period 2: Part 2|Other|0|||
106030493|NCT00830869|365776830|FG004|Period 2: Part 2|Other|0|||
106030494|NCT00830869|365776831|FG005|Period 2: Part 2|Other|0|||
106030495|NCT00830869|365776832|FG006|Period 2: Part 2|Other|0|||
106030496|NCT00830869|365776833|FG007|Period 2: Part 2|Other|0|||
106030497|NCT00830869|365776834|FG008|Period 2: Part 2|Other|0|||
106030498|NCT00830869|365776835|FG009|Period 2: Part 2|Other|1|||
106030499|NCT00830869|365776836|FG010|Period 2: Part 2|Other|0|||
106030500|NCT00830869|365776837|FG011|Period 2: Part 2|Other|0|||
106030501|NCT00877773|365776838|FG000|Overall Study|Disease Progression|44|||
105983949|NCT01079936|365602310|FG002|Phase II|Insurance Issue|0|||
105983950|NCT01079936|365602311|FG003|Phase II|Insurance Issue|0|||
105983951|NCT01079936|365602312|FG004|Phase II|Insurance Issue|1|||
105983952|NCT01422824|365602313|FG000|Overall Study|Case record form not evaluated|1|||
105983953|NCT01422824|365602313|FG000|Overall Study|Lost to Follow-up|37|||
105983954|NCT02421601|365602316|FG000|Overall Study|Adverse Event|4|||
105983955|NCT02421601|365602316|FG000|Overall Study|Lack of Efficacy|5|||
105983956|NCT02421601|365602316|FG000|Overall Study|Physician Decision|1|||
105983957|NCT02421601|365602316|FG000|Overall Study|Withdrawal by Subject|31|||
105983958|NCT02421601|365602316|FG000|Overall Study|Others|41|||
105983959|NCT01581619|365602317|FG000|Overall Study|Withdrawal by Subject|1|||
105983960|NCT01581619|365602317|FG000|Overall Study|Lost to Follow-up|1|||
105983961|NCT00290498|365602320|FG000|Overall Study|Death|2|||
105983962|NCT00290498|365602321|FG001|Overall Study|Death|0|||
105983963|NCT00290498|365602320|FG000|Overall Study|Physician Decision|1|||
105983964|NCT00290498|365602321|FG001|Overall Study|Physician Decision|0|||
105983965|NCT00290498|365602320|FG000|Overall Study|Withdrawal by Subject|1|||
106030502|NCT02446171|365776845|FG000|Overall Study|Withdrawal by Subject|0|||
106030503|NCT02446171|365776846|FG001|Overall Study|Withdrawal by Subject|0|||
106030504|NCT02446171|365776847|FG002|Overall Study|Withdrawal by Subject|2|||
106030505|NCT02446171|365776848|FG003|Overall Study|Withdrawal by Subject|0|||
106030506|NCT01347580|365776851|FG000|Overall Study|Withdrawal by Subject|13|||
105983966|NCT00290498|365602321|FG001|Overall Study|Withdrawal by Subject|0|||
105983967|NCT00290498|365602320|FG000|Overall Study|Ineligible|3|||
105983968|NCT00290498|365602321|FG001|Overall Study|Ineligible|0|||
105983969|NCT00290498|365602320|FG000|Overall Study|Non-Compliance|1|||
106030507|NCT01347580|365776852|FG001|Overall Study|Withdrawal by Subject|23|||
106030508|NCT01347580|365776851|FG000|Overall Study|Death|30|||
106030509|NCT01347580|365776852|FG001|Overall Study|Death|19|||
106030510|NCT01347580|365776851|FG000|Overall Study|Protocol Violation|10|||
106030511|NCT01347580|365776852|FG001|Overall Study|Protocol Violation|7|||
106030512|NCT01347580|365776851|FG000|Overall Study|Lost to Follow-up|3|||
106030513|NCT01347580|365776852|FG001|Overall Study|Lost to Follow-up|1|||
105983970|NCT00290498|365602321|FG001|Overall Study|Non-Compliance|0|||
105983971|NCT02250664|365602324|FG000|Overall Study|Lost to Follow-up|18|||
106030514|NCT01347580|365776851|FG000|Overall Study|Had other reason|9|||
106030515|NCT01347580|365776852|FG001|Overall Study|Had other reason|6|||
106030516|NCT00883688|365776853|FG000|Overall Study|Ineligible|2|||
106030517|NCT01122264|365776854|FG000|Overall Study|Adverse Event|6|||
106030518|NCT01122264|365776855|FG001|Overall Study|Adverse Event|5|||
105983972|NCT02250664|365602325|FG001|Overall Study|Lost to Follow-up|28|||
105983973|NCT02250664|365602326|FG002|Overall Study|Lost to Follow-up|33|||
105983974|NCT02250664|365602324|FG000|Overall Study|Personal Reasons|7|||
105983975|NCT02250664|365602325|FG001|Overall Study|Personal Reasons|8|||
105983976|NCT02250664|365602326|FG002|Overall Study|Personal Reasons|14|||
105983977|NCT02250664|365602324|FG000|Overall Study|Adverse Event|6|||
105983978|NCT02250664|365602325|FG001|Overall Study|Adverse Event|3|||
106030519|NCT01122264|365776856|FG002|Overall Study|Adverse Event|7|||
106030520|NCT01122264|365776854|FG000|Overall Study|Death|1|||
106030521|NCT01122264|365776855|FG001|Overall Study|Death|0|||
106030522|NCT01122264|365776856|FG002|Overall Study|Death|0|||
105983979|NCT02250664|365602326|FG002|Overall Study|Adverse Event|8|||
105983980|NCT02250664|365602324|FG000|Overall Study|Incarcerated|2|||
105983981|NCT02250664|365602325|FG001|Overall Study|Incarcerated|1|||
105983982|NCT02250664|365602326|FG002|Overall Study|Incarcerated|2|||
105983983|NCT02250664|365602324|FG000|Overall Study|Withdrawal by Subject|0|||
105983984|NCT02250664|365602325|FG001|Overall Study|Withdrawal by Subject|1|||
105983985|NCT02250664|365602326|FG002|Overall Study|Withdrawal by Subject|2|||
105983986|NCT02250664|365602324|FG000|Overall Study|Death|0|||
105983987|NCT02250664|365602325|FG001|Overall Study|Death|1|||
105983988|NCT02250664|365602326|FG002|Overall Study|Death|1|||
105983989|NCT02250664|365602324|FG000|Overall Study|Physician Decision|1|||
105983990|NCT02250664|365602325|FG001|Overall Study|Physician Decision|3|||
105983991|NCT02250664|365602326|FG002|Overall Study|Physician Decision|1|||
105983992|NCT02250664|365602324|FG000|Overall Study|Protocol Violation|1|||
105983993|NCT02250664|365602325|FG001|Overall Study|Protocol Violation|0|||
105983994|NCT02250664|365602326|FG002|Overall Study|Protocol Violation|1|||
105983995|NCT02250664|365602324|FG000|Overall Study|Reason unknown|1|||
105983996|NCT02250664|365602325|FG001|Overall Study|Reason unknown|0|||
105983997|NCT02250664|365602326|FG002|Overall Study|Reason unknown|0|||
105983998|NCT03847909|365602327|FG000|Overall Study|Withdrawal by Subject|1|||
105983999|NCT03847909|365602328|FG001|Overall Study|Withdrawal by Subject|1|||
105984000|NCT01716104|365602330|FG000|Overall Study|Do not meet inclusion criteria|6|||
105984001|NCT01716104|365602331|FG001|Overall Study|Do not meet inclusion criteria|7|||
105984002|NCT02565810|365602332|FG000|Overall Study|Withdrawal by Subject|1|||
105984003|NCT04268173|365602333|FG000|Overall Study|Lost to Follow-up|75|||
105984004|NCT04268173|365602334|FG001|Overall Study|Lost to Follow-up|108|||
105984005|NCT00581360|365602337|FG000|Overall Study|Withdrawal by Subject|1|||
105984006|NCT04405245|365602338|FG000|Overall Study|Adverse Event|0|||
105984007|NCT04405245|365602339|FG001|Overall Study|Adverse Event|1|||
105984008|NCT04405245|365602340|FG002|Overall Study|Adverse Event|0|||
105984009|NCT00545103|365602341|FG000|Overall Study|Lack of Efficacy|48|||
105984010|NCT00545103|365602342|FG001|Overall Study|Lack of Efficacy|45|||
105984011|NCT00545103|365602343|FG002|Overall Study|Lack of Efficacy|31|||
105984012|NCT00545103|365602344|FG003|Overall Study|Lack of Efficacy|27|||
105984013|NCT00545103|365602341|FG000|Overall Study|Withdrawal by Subject|6|||
105984014|NCT00545103|365602342|FG001|Overall Study|Withdrawal by Subject|10|||
105984015|NCT00545103|365602343|FG002|Overall Study|Withdrawal by Subject|18|||
105984016|NCT00545103|365602344|FG003|Overall Study|Withdrawal by Subject|22|||
105984017|NCT00545103|365602341|FG000|Overall Study|Adverse Event|11|||
105984018|NCT00545103|365602342|FG001|Overall Study|Adverse Event|12|||
105984019|NCT00545103|365602343|FG002|Overall Study|Adverse Event|17|||
105984020|NCT00545103|365602344|FG003|Overall Study|Adverse Event|10|||
105984021|NCT00545103|365602341|FG000|Overall Study|Lost to Follow-up|4|||
105984022|NCT00545103|365602342|FG001|Overall Study|Lost to Follow-up|6|||
105984023|NCT00545103|365602343|FG002|Overall Study|Lost to Follow-up|3|||
105984024|NCT00545103|365602344|FG003|Overall Study|Lost to Follow-up|4|||
105984025|NCT00545103|365602341|FG000|Overall Study|Protocol Violation|1|||
105984026|NCT00545103|365602342|FG001|Overall Study|Protocol Violation|2|||
105984027|NCT00545103|365602343|FG002|Overall Study|Protocol Violation|3|||
105984028|NCT00545103|365602344|FG003|Overall Study|Protocol Violation|0|||
105984029|NCT00545103|365602341|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
105984030|NCT00545103|365602342|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
105984031|NCT00545103|365602343|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
105984032|NCT00545103|365602344|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
105984033|NCT00545103|365602341|FG000|Overall Study|Difficult to open package|0|||
105984034|NCT00545103|365602342|FG001|Overall Study|Difficult to open package|0|||
105984035|NCT00545103|365602343|FG002|Overall Study|Difficult to open package|0|||
105984036|NCT00545103|365602344|FG003|Overall Study|Difficult to open package|1|||
105984037|NCT00545103|365602341|FG000|Overall Study|Investigational product not taken|1|||
105984038|NCT00545103|365602342|FG001|Overall Study|Investigational product not taken|0|||
105984039|NCT00545103|365602343|FG002|Overall Study|Investigational product not taken|0|||
105984040|NCT00545103|365602344|FG003|Overall Study|Investigational product not taken|1|||
105984041|NCT00545103|365602341|FG000|Overall Study|Wish to start a family|0|||
105984042|NCT00545103|365602342|FG001|Overall Study|Wish to start a family|0|||
105984043|NCT00545103|365602343|FG002|Overall Study|Wish to start a family|0|||
105984044|NCT00545103|365602344|FG003|Overall Study|Wish to start a family|1|||
105984045|NCT00545103|365602341|FG000|Overall Study|Diverticulitis crisis|0|||
105984046|NCT00545103|365602342|FG001|Overall Study|Diverticulitis crisis|0|||
105984047|NCT00545103|365602343|FG002|Overall Study|Diverticulitis crisis|0|||
105984048|NCT00545103|365602344|FG003|Overall Study|Diverticulitis crisis|1|||
105984049|NCT00545103|365602341|FG000|Overall Study|Personal reasons|1|||
105984050|NCT00545103|365602342|FG001|Overall Study|Personal reasons|0|||
105984051|NCT00545103|365602343|FG002|Overall Study|Personal reasons|0|||
105984052|NCT00545103|365602344|FG003|Overall Study|Personal reasons|0|||
105984053|NCT00545103|365602341|FG000|Overall Study|Subject's decision|1|||
105984054|NCT00545103|365602342|FG001|Overall Study|Subject's decision|0|||
105984055|NCT00545103|365602343|FG002|Overall Study|Subject's decision|0|||
105984056|NCT00545103|365602344|FG003|Overall Study|Subject's decision|0|||
105984057|NCT00545103|365602341|FG000|Overall Study|Noncompliance|0|||
105984058|NCT00545103|365602342|FG001|Overall Study|Noncompliance|1|||
105984059|NCT00545103|365602343|FG002|Overall Study|Noncompliance|0|||
105984060|NCT00545103|365602344|FG003|Overall Study|Noncompliance|0|||
105984061|NCT00545103|365602341|FG000|Overall Study|Investigator decision|0|||
105984062|NCT00545103|365602342|FG001|Overall Study|Investigator decision|0|||
105984063|NCT00545103|365602343|FG002|Overall Study|Investigator decision|1|||
105984064|NCT00545103|365602344|FG003|Overall Study|Investigator decision|0|||
105984065|NCT00545103|365602341|FG000|Overall Study|Subject moved|0|||
105984066|NCT00545103|365602342|FG001|Overall Study|Subject moved|1|||
105984067|NCT00545103|365602343|FG002|Overall Study|Subject moved|0|||
105984068|NCT00545103|365602344|FG003|Overall Study|Subject moved|0|||
105984069|NCT00545103|365602341|FG000|Overall Study|Use of prohibited medication|0|||
105984070|NCT00545103|365602342|FG001|Overall Study|Use of prohibited medication|0|||
105984071|NCT00545103|365602343|FG002|Overall Study|Use of prohibited medication|1|||
105984072|NCT00545103|365602344|FG003|Overall Study|Use of prohibited medication|0|||
105984073|NCT00545103|365602341|FG000|Overall Study|Does not want to take study drug anymore|1|||
105984074|NCT00545103|365602342|FG001|Overall Study|Does not want to take study drug anymore|0|||
105984075|NCT00545103|365602343|FG002|Overall Study|Does not want to take study drug anymore|1|||
105984076|NCT00545103|365602344|FG003|Overall Study|Does not want to take study drug anymore|0|||
105984077|NCT00545103|365602341|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
105984078|NCT00545103|365602342|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
105984079|NCT00545103|365602343|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
105984080|NCT00545103|365602344|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
105984081|NCT00545103|365602341|FG000|Overall Study|Death|0|||
105984082|NCT00545103|365602342|FG001|Overall Study|Death|1|||
105984083|NCT00545103|365602343|FG002|Overall Study|Death|0|||
105984084|NCT00545103|365602344|FG003|Overall Study|Death|0|||
105984085|NCT01953913|365602345|FG000|Overall Study|Disease Progression|349|||
105984086|NCT01953913|365602345|FG000|Overall Study|Worsening of underlying cancer|22|||
105984087|NCT01953913|365602345|FG000|Overall Study|Adverse Event|20|||
105984088|NCT01953913|365602345|FG000|Overall Study|Protocol Violation|6|||
105984089|NCT01953913|365602345|FG000|Overall Study|Lost to Follow-up|4|||
105984090|NCT01953913|365602345|FG000|Overall Study|Withdrawal by Subject|32|||
105984091|NCT01953913|365602345|FG000|Overall Study|Other than listed|108|||
105984092|NCT01953913|365602345|FG000|Overall Study|Not Treated|1|||
105984093|NCT05026853|365602346|FG000|Overall Study|Cancelled appointment|1|||
105984094|NCT05026853|365602347|FG001|Overall Study|Cancelled appointment|0|||
105984095|NCT05026853|365602346|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
105984096|NCT05026853|365602347|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
105984097|NCT05026853|365602346|FG000|Overall Study|Did not complete 12-week survey|16|||
105984098|NCT05026853|365602347|FG001|Overall Study|Did not complete 12-week survey|16|||
105984099|NCT01353911|365602348|FG000|Overall Study|Lost to Follow-up|2|||
105984100|NCT01353911|365602349|FG001|Overall Study|Lost to Follow-up|6|||
105984101|NCT01353911|365602350|FG002|Overall Study|Lost to Follow-up|4|||
105984102|NCT01353911|365602351|FG003|Overall Study|Lost to Follow-up|0|||
105984103|NCT01353911|365602352|FG004|Overall Study|Lost to Follow-up|4|||
105984104|NCT01353911|365602353|FG005|Overall Study|Lost to Follow-up|4|||
105984105|NCT01353911|365602354|FG006|Overall Study|Lost to Follow-up|3|||
105984106|NCT01353911|365602355|FG007|Overall Study|Lost to Follow-up|6|||
105984107|NCT01353911|365602348|FG000|Overall Study|Withdrawal by Subject|2|||
105984108|NCT01353911|365602349|FG001|Overall Study|Withdrawal by Subject|3|||
105984109|NCT01353911|365602350|FG002|Overall Study|Withdrawal by Subject|4|||
105984110|NCT01353911|365602351|FG003|Overall Study|Withdrawal by Subject|2|||
105984111|NCT01353911|365602352|FG004|Overall Study|Withdrawal by Subject|2|||
105984112|NCT01353911|365602353|FG005|Overall Study|Withdrawal by Subject|3|||
105984113|NCT01353911|365602354|FG006|Overall Study|Withdrawal by Subject|3|||
105984114|NCT01353911|365602355|FG007|Overall Study|Withdrawal by Subject|9|||
105984115|NCT01353911|365602348|FG000|Overall Study|Status Not Recorded|4|||
105984116|NCT01353911|365602349|FG001|Overall Study|Status Not Recorded|0|||
105984117|NCT01353911|365602350|FG002|Overall Study|Status Not Recorded|1|||
105984118|NCT01353911|365602351|FG003|Overall Study|Status Not Recorded|0|||
105984119|NCT01353911|365602352|FG004|Overall Study|Status Not Recorded|0|||
105984120|NCT01353911|365602353|FG005|Overall Study|Status Not Recorded|0|||
105984121|NCT01353911|365602354|FG006|Overall Study|Status Not Recorded|0|||
105984122|NCT01353911|365602355|FG007|Overall Study|Status Not Recorded|0|||
105984123|NCT03233438|365602356|FG000|Overall Study|Lost to Follow-up|4|||
105984124|NCT03233438|365602357|FG001|Overall Study|Lost to Follow-up|9|||
105984125|NCT03233438|365602356|FG000|Overall Study|Withdrawal by Subject|2|||
105984126|NCT03233438|365602357|FG001|Overall Study|Withdrawal by Subject|1|||
105984127|NCT03233438|365602356|FG000|Overall Study|No recording of dalbavancin|0|||
105984128|NCT03233438|365602357|FG001|Overall Study|No recording of dalbavancin|1|||
105984129|NCT03429543|365602358|FG000|Overall Study|Adverse Event|1|||
105984130|NCT03429543|365602359|FG001|Overall Study|Adverse Event|1|||
105984131|NCT03429543|365602360|FG002|Overall Study|Adverse Event|0|||
105984132|NCT03429543|365602361|FG003|Overall Study|Adverse Event|0|||
105984133|NCT03429543|365602362|FG004|Overall Study|Adverse Event|0|||
105984134|NCT03429543|365602363|FG005|Overall Study|Adverse Event|2|||
105984135|NCT03429543|365602364|FG006|Overall Study|Adverse Event|0|||
105984136|NCT03429543|365602358|FG000|Overall Study|Lost to Follow-up|1|||
105984137|NCT03429543|365602359|FG001|Overall Study|Lost to Follow-up|0|||
105984138|NCT03429543|365602360|FG002|Overall Study|Lost to Follow-up|0|||
105984139|NCT03429543|365602361|FG003|Overall Study|Lost to Follow-up|0|||
105984140|NCT03429543|365602362|FG004|Overall Study|Lost to Follow-up|1|||
105984141|NCT03429543|365602363|FG005|Overall Study|Lost to Follow-up|0|||
105984142|NCT03429543|365602364|FG006|Overall Study|Lost to Follow-up|0|||
105984143|NCT03429543|365602358|FG000|Overall Study|Withdrawal by Subject|5|||
105984144|NCT03429543|365602359|FG001|Overall Study|Withdrawal by Subject|0|||
105984145|NCT03429543|365602360|FG002|Overall Study|Withdrawal by Subject|1|||
105984146|NCT03429543|365602361|FG003|Overall Study|Withdrawal by Subject|2|||
105984147|NCT03429543|365602362|FG004|Overall Study|Withdrawal by Subject|6|||
105984148|NCT03429543|365602363|FG005|Overall Study|Withdrawal by Subject|3|||
105984149|NCT03429543|365602364|FG006|Overall Study|Withdrawal by Subject|1|||
105984150|NCT03429543|365602358|FG000|Overall Study|Other reason than listed|0|||
105984151|NCT03429543|365602359|FG001|Overall Study|Other reason than listed|1|||
105984152|NCT03429543|365602360|FG002|Overall Study|Other reason than listed|0|||
105984153|NCT03429543|365602361|FG003|Overall Study|Other reason than listed|0|||
105984154|NCT03429543|365602362|FG004|Overall Study|Other reason than listed|4|||
105984155|NCT03429543|365602363|FG005|Overall Study|Other reason than listed|4|||
105984156|NCT03429543|365602364|FG006|Overall Study|Other reason than listed|0|||
105984157|NCT03429543|365602358|FG000|Overall Study|Not treated|0|||
105984158|NCT03429543|365602359|FG001|Overall Study|Not treated|0|||
105984159|NCT03429543|365602360|FG002|Overall Study|Not treated|0|||
105984160|NCT03429543|365602361|FG003|Overall Study|Not treated|0|||
105984161|NCT03429543|365602362|FG004|Overall Study|Not treated|1|||
105984162|NCT03429543|365602363|FG005|Overall Study|Not treated|0|||
105984163|NCT03429543|365602364|FG006|Overall Study|Not treated|0|||
105984164|NCT00082381|365602365|FG000|Overall Study|Adverse Event|27|||
105984165|NCT00082381|365602366|FG001|Overall Study|Adverse Event|2|||
105984166|NCT00082381|365602365|FG000|Overall Study|Lost to Follow-up|5|||
105984167|NCT00082381|365602366|FG001|Overall Study|Lost to Follow-up|7|||
105984168|NCT00082381|365602365|FG000|Overall Study|Patient Decision|8|||
105984169|NCT00082381|365602366|FG001|Overall Study|Patient Decision|4|||
105984170|NCT00082381|365602365|FG000|Overall Study|Physician Decision|1|||
105984171|NCT00082381|365602366|FG001|Overall Study|Physician Decision|2|||
105984172|NCT00082381|365602365|FG000|Overall Study|Protocol Violation|10|||
105984173|NCT00082381|365602366|FG001|Overall Study|Protocol Violation|11|||
105984174|NCT00082381|365602365|FG000|Overall Study|Loss of Glucose Control|4|||
105984175|NCT00082381|365602366|FG001|Overall Study|Loss of Glucose Control|0|||
105984176|NCT03022981|365602367|FG000|Overall Study|Adverse Event|0|||
105984177|NCT03022981|365602368|FG001|Overall Study|Adverse Event|1|||
105984178|NCT03022981|365602369|FG002|Overall Study|Adverse Event|0|||
105984179|NCT03022981|365602367|FG000|Overall Study|Investigator's Discretion|0|||
105984180|NCT03022981|365602368|FG001|Overall Study|Investigator's Discretion|1|||
105984181|NCT03022981|365602369|FG002|Overall Study|Investigator's Discretion|2|||
105984182|NCT03022981|365602367|FG000|Overall Study|Lost to Follow-up|6|||
105984183|NCT03022981|365602368|FG001|Overall Study|Lost to Follow-up|2|||
105984184|NCT03022981|365602369|FG002|Overall Study|Lost to Follow-up|1|||
105984185|NCT03022981|365602367|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105984186|NCT03022981|365602368|FG001|Overall Study|Non-Compliance With Study Drug|0|||
105984187|NCT03022981|365602369|FG002|Overall Study|Non-Compliance With Study Drug|2|||
105984188|NCT03022981|365602367|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
105984189|NCT03022981|365602368|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
105984190|NCT03022981|365602369|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
105984191|NCT03688100|365602372|FG000|Overall Study|Lost to Follow-up|21|||
105984192|NCT03688100|365602373|FG001|Overall Study|Lost to Follow-up|15|||
105984193|NCT03688100|365602374|FG002|Overall Study|Lost to Follow-up|15|||
105984194|NCT03688100|365602375|FG003|Overall Study|Lost to Follow-up|18|||
105984195|NCT03688100|365602372|FG000|Overall Study|Withdrawal by Subject|19|||
105984196|NCT03688100|365602373|FG001|Overall Study|Withdrawal by Subject|16|||
105984197|NCT03688100|365602374|FG002|Overall Study|Withdrawal by Subject|0|||
105984198|NCT03688100|365602375|FG003|Overall Study|Withdrawal by Subject|0|||
105984199|NCT03688100|365602372|FG000|Overall Study|Death|36|||
105984200|NCT03688100|365602373|FG001|Overall Study|Death|27|||
105984201|NCT03688100|365602374|FG002|Overall Study|Death|0|||
105984202|NCT03688100|365602375|FG003|Overall Study|Death|0|||
105984203|NCT00924404|365602378|FG000|Overall Study|Lost to Follow-up|6|||
105984204|NCT00924404|365602379|FG001|Overall Study|Lost to Follow-up|4|||
105984205|NCT00295932|365602380|FG000|Overall Study|Not Treated|0|||
105984206|NCT00295932|365602381|FG001|Overall Study|Not Treated|0|||
105984207|NCT00295932|365602382|FG002|Overall Study|Not Treated|0|||
105984208|NCT00295932|365602383|FG003|Overall Study|Not Treated|0|||
105984209|NCT00295932|365602384|FG004|Overall Study|Not Treated|0|||
105984210|NCT00295932|365602385|FG005|Overall Study|Not Treated|0|||
105984211|NCT00295932|365602386|FG006|Overall Study|Not Treated|0|||
105984212|NCT00295932|365602387|FG007|Overall Study|Not Treated|0|||
105984213|NCT00295932|365602388|FG008|Overall Study|Not Treated|0|||
105984214|NCT00295932|365602389|FG009|Overall Study|Not Treated|0|||
105984215|NCT00295932|365602390|FG010|Overall Study|Not Treated|1|||
105984216|NCT00587847|365602391|FG000|Overall Study|Lack of Efficacy|5|||
105984217|NCT00587847|365602391|FG000|Overall Study|Adverse Event|2|||
105984218|NCT00343382|365602392|FG000|Overall Study|Adverse Event|2|||
105984219|NCT00343382|365602393|FG001|Overall Study|Adverse Event|10|||
105984220|NCT00343382|365602394|FG002|Overall Study|Adverse Event|7|||
105984221|NCT00343382|365602392|FG000|Overall Study|Withdrawal by Subject|1|||
105984222|NCT00343382|365602393|FG001|Overall Study|Withdrawal by Subject|2|||
105984223|NCT00343382|365602394|FG002|Overall Study|Withdrawal by Subject|6|||
105984224|NCT00343382|365602392|FG000|Overall Study|Other Reason Not Specified|1|||
105984225|NCT00343382|365602393|FG001|Overall Study|Other Reason Not Specified|2|||
105984226|NCT00343382|365602394|FG002|Overall Study|Other Reason Not Specified|4|||
105984227|NCT04032080|365602395|FG000|Overall Study|Death|6|||
105984228|NCT00884832|365602396|FG000|Overall Study|Withdrawal by Subject|0|||
105984229|NCT00884832|365602397|FG001|Overall Study|Withdrawal by Subject|1|||
105984230|NCT03322423|365602398|FG000|Period 1|Subject no longer eligible|0|||
105984231|NCT03322423|365602399|FG001|Period 1|Subject no longer eligible|1|||
105984232|NCT03322423|365602398|FG000|Period 1|Withdrawal by Subject|0|||
105984233|NCT03322423|365602399|FG001|Period 1|Withdrawal by Subject|1|||
105984234|NCT03322423|365602398|FG000|Period 1|Incorrect Lens Dispensed|1|||
105984235|NCT03322423|365602399|FG001|Period 1|Incorrect Lens Dispensed|0|||
105984236|NCT03322423|365602398|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
105984237|NCT03322423|365602399|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
105984238|NCT03322423|365602398|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
105984239|NCT03322423|365602399|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
105984240|NCT03322423|365602398|FG000|Period 2|Protocol Violation|1|||
105984241|NCT03322423|365602399|FG001|Period 2|Protocol Violation|0|||
105984242|NCT03322423|365602398|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
105984243|NCT03322423|365602399|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
105984244|NCT02337725|365602400|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
105984245|NCT02337725|365602401|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
105984246|NCT02337725|365602400|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
105984247|NCT02337725|365602401|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
105984248|NCT02337725|365602400|FG000|Overall Study|Major Protocol Deviation|0|||
105984249|NCT02337725|365602401|FG001|Overall Study|Major Protocol Deviation|1|||
105984250|NCT02337725|365602400|FG000|Overall Study|Voluntary Withdrawal|14|||
105984251|NCT02337725|365602401|FG001|Overall Study|Voluntary Withdrawal|3|||
105984252|NCT02337725|365602400|FG000|Overall Study|Lack of Efficacy|4|||
105984253|NCT02337725|365602401|FG001|Overall Study|Lack of Efficacy|0|||
105984254|NCT00500760|365602403|FG000|Overall Study|Death|32|||
105984255|NCT00500760|365602404|FG001|Overall Study|Death|15|||
105984256|NCT00500760|365602403|FG000|Overall Study|Withdrawal by Subject|5|||
105984257|NCT00500760|365602404|FG001|Overall Study|Withdrawal by Subject|7|||
105984258|NCT00500760|365602403|FG000|Overall Study|Administrative decision|2|||
105984259|NCT00500760|365602404|FG001|Overall Study|Administrative decision|0|||
105984260|NCT00500760|365602403|FG000|Overall Study|Lost to Follow-up|3|||
105984261|NCT00500760|365602404|FG001|Overall Study|Lost to Follow-up|0|||
105984262|NCT00500760|365602403|FG000|Overall Study|Other|1|||
105984263|NCT00500760|365602404|FG001|Overall Study|Other|2|||
105984264|NCT00079677|365602405|FG000|Overall Study|Adverse Event|5|||
105984265|NCT00079677|365602406|FG001|Overall Study|Adverse Event|6|||
105984266|NCT00079677|365602405|FG000|Overall Study|Lack of Efficacy|1|||
105984267|NCT00079677|365602406|FG001|Overall Study|Lack of Efficacy|0|||
105984268|NCT00079677|365602405|FG000|Overall Study|Lost to Follow-up|2|||
105984269|NCT00079677|365602406|FG001|Overall Study|Lost to Follow-up|2|||
105984270|NCT00079677|365602405|FG000|Overall Study|Physician Decision|3|||
105984271|NCT00079677|365602406|FG001|Overall Study|Physician Decision|0|||
105984272|NCT00079677|365602405|FG000|Overall Study|Protocol Violation|2|||
105984273|NCT00079677|365602406|FG001|Overall Study|Protocol Violation|3|||
105984274|NCT00079677|365602405|FG000|Overall Study|Withdrawal by Subject|5|||
105984275|NCT00079677|365602406|FG001|Overall Study|Withdrawal by Subject|3|||
105984276|NCT00079677|365602405|FG000|Overall Study|Miscellaneous|2|||
105984277|NCT00079677|365602406|FG001|Overall Study|Miscellaneous|0|||
105984278|NCT02177838|365602410|FG000|Overall Study|Withdrawal by Subject|1|||
105984279|NCT02177838|365602410|FG000|Overall Study|Physician Decision|1|||
105984280|NCT02177838|365602410|FG000|Overall Study|Death|1|||
105984281|NCT02879578|365602411|FG000|Overall Study|Adverse Event|1|||
105984282|NCT02879578|365602412|FG001|Overall Study|Adverse Event|2|||
105984283|NCT02879578|365602413|FG002|Overall Study|Adverse Event|14|||
105984284|NCT02879578|365602411|FG000|Overall Study|Protocol Violation|0|||
105984285|NCT02879578|365602412|FG001|Overall Study|Protocol Violation|1|||
105984286|NCT02879578|365602413|FG002|Overall Study|Protocol Violation|1|||
105984287|NCT02879578|365602411|FG000|Overall Study|Withdrawal by Subject|8|||
105984288|NCT02879578|365602412|FG001|Overall Study|Withdrawal by Subject|6|||
105984289|NCT02879578|365602413|FG002|Overall Study|Withdrawal by Subject|9|||
105984290|NCT02879578|365602411|FG000|Overall Study|Lost to Follow-up|1|||
105984291|NCT02879578|365602412|FG001|Overall Study|Lost to Follow-up|0|||
105984292|NCT02879578|365602413|FG002|Overall Study|Lost to Follow-up|4|||
105984293|NCT02879578|365602411|FG000|Overall Study|Physician Decision|0|||
105984294|NCT02879578|365602412|FG001|Overall Study|Physician Decision|0|||
105984295|NCT02879578|365602413|FG002|Overall Study|Physician Decision|4|||
105984296|NCT04566692|365602415|FG000|Overall Study|Adverse Event|2|||
105984297|NCT04566692|365602416|FG001|Overall Study|Adverse Event|0|||
105984298|NCT04566692|365602415|FG000|Overall Study|Withdrawal by Subject|1|||
105984299|NCT04566692|365602416|FG001|Overall Study|Withdrawal by Subject|1|||
105984300|NCT03203291|365602419|FG000|Overall Study|Withdrawal by Subject|1|||
105984301|NCT02540265|365602422|FG000|Overall Study|Lost to Follow-up|0|||
105984302|NCT02540265|365602423|FG001|Overall Study|Lost to Follow-up|0|||
105984303|NCT02540265|365602424|FG002|Overall Study|Lost to Follow-up|1|||
105984304|NCT04349033|365602425|FG000|Overall Study|Lost to Follow-up|3|||
105984305|NCT04349033|365602426|FG001|Overall Study|Lost to Follow-up|1|||
105984306|NCT04349033|365602427|FG002|Overall Study|Lost to Follow-up|1|||
105984307|NCT01972789|365602428|FG000|Overall Study|Adverse Event|11|||
105984308|NCT01972789|365602429|FG001|Overall Study|Adverse Event|4|||
105984309|NCT01972789|365602428|FG000|Overall Study|Subject withdrew consent|14|||
105984310|NCT01972789|365602429|FG001|Overall Study|Subject withdrew consent|12|||
105984311|NCT01972789|365602428|FG000|Overall Study|Lost to Follow-up|4|||
105984312|NCT01972789|365602429|FG001|Overall Study|Lost to Follow-up|7|||
105984313|NCT01972789|365602428|FG000|Overall Study|Death|7|||
105984314|NCT01972789|365602429|FG001|Overall Study|Death|5|||
105984315|NCT01972789|365602428|FG000|Overall Study|Protocol deviation|1|||
105984316|NCT01972789|365602429|FG001|Overall Study|Protocol deviation|0|||
105984317|NCT01972789|365602428|FG000|Overall Study|Physician Decision|3|||
105984318|NCT01972789|365602429|FG001|Overall Study|Physician Decision|2|||
105984319|NCT02720692|365604030|FG000|Overall Study|Withdrawal by Subject|3|||
105984320|NCT02720692|365604031|FG001|Overall Study|Withdrawal by Subject|0|||
105984321|NCT02720692|365604030|FG000|Overall Study|Physician Decision|1|||
105984322|NCT02720692|365604031|FG001|Overall Study|Physician Decision|0|||
106030523|NCT01122264|365776854|FG000|Overall Study|Lost to Follow-up|5|||
106030524|NCT01122264|365776855|FG001|Overall Study|Lost to Follow-up|9|||
106030525|NCT01122264|365776856|FG002|Overall Study|Lost to Follow-up|13|||
106030526|NCT01122264|365776854|FG000|Overall Study|Entry Criteria Not Met|1|||
106030527|NCT01122264|365776855|FG001|Overall Study|Entry Criteria Not Met|0|||
106030528|NCT01122264|365776856|FG002|Overall Study|Entry Criteria Not Met|0|||
106030529|NCT01122264|365776854|FG000|Overall Study|Protocol Violation|7|||
106030530|NCT01122264|365776855|FG001|Overall Study|Protocol Violation|7|||
106030531|NCT01122264|365776856|FG002|Overall Study|Protocol Violation|9|||
106030532|NCT01122264|365776854|FG000|Overall Study|Withdrawal by Subject|6|||
106030533|NCT01122264|365776855|FG001|Overall Study|Withdrawal by Subject|6|||
106030534|NCT01122264|365776856|FG002|Overall Study|Withdrawal by Subject|16|||
106030535|NCT01122264|365776854|FG000|Overall Study|Physician Decision|3|||
106030536|NCT01122264|365776855|FG001|Overall Study|Physician Decision|1|||
106030537|NCT01122264|365776856|FG002|Overall Study|Physician Decision|1|||
106030538|NCT01122264|365776854|FG000|Overall Study|Lack of Efficacy|3|||
106030539|NCT01122264|365776855|FG001|Overall Study|Lack of Efficacy|1|||
106030540|NCT01122264|365776856|FG002|Overall Study|Lack of Efficacy|1|||
106030541|NCT01002820|365776867|FG000|Overall Study|Adverse Event|1|||
106030542|NCT01002820|365776867|FG000|Overall Study|Withdrawal by Subject|2|||
106030543|NCT01002820|365776867|FG000|Overall Study|Lack of Efficacy|1|||
105984323|NCT02720692|365604030|FG000|Overall Study|Lost to Follow-up|8|||
105984324|NCT02720692|365604031|FG001|Overall Study|Lost to Follow-up|3|||
105984325|NCT02720692|365604030|FG000|Overall Study|Subject unable to return for visit|1|||
105984326|NCT02720692|365604031|FG001|Overall Study|Subject unable to return for visit|0|||
105984327|NCT05011513|365604034|FG000|Overall Study|Death|0|||
105984328|NCT05011513|365604035|FG001|Overall Study|Death|1|||
105984329|NCT05011513|365604034|FG000|Overall Study|Lost to Follow-up|4|||
105984330|NCT05011513|365604035|FG001|Overall Study|Lost to Follow-up|0|||
105984331|NCT05011513|365604034|FG000|Overall Study|Withdrawal by Subject|18|||
105984332|NCT05011513|365604035|FG001|Overall Study|Withdrawal by Subject|17|||
105984333|NCT05011513|365604034|FG000|Overall Study|Other|4|||
105984334|NCT05011513|365604035|FG001|Overall Study|Other|2|||
105984335|NCT03878758|365604036|FG000|Overall Study|Withdrawal by Subject|1|||
105984336|NCT03878758|365604036|FG000|Overall Study|Protocol defined|2|||
105984337|NCT03878758|365604036|FG000|Overall Study|Improper consent documentation|1|||
105984338|NCT04599465|365604037|FG000|Overall Study|Physician Decision|1|||
105984339|NCT04599465|365604037|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
105984340|NCT00358436|365604038|FG000|Overall Study|Adverse Event|29|||
105984341|NCT00358436|365604039|FG001|Overall Study|Adverse Event|13|||
105984342|NCT00358436|365604038|FG000|Overall Study|Lack of Efficacy|34|||
105984343|NCT00358436|365604039|FG001|Overall Study|Lack of Efficacy|36|||
105984344|NCT00358436|365604038|FG000|Overall Study|Lost to Follow-up|11|||
105984345|NCT00358436|365604039|FG001|Overall Study|Lost to Follow-up|6|||
105984346|NCT00358436|365604038|FG000|Overall Study|Protocol Violation|8|||
105984347|NCT00358436|365604039|FG001|Overall Study|Protocol Violation|3|||
105984348|NCT00358436|365604038|FG000|Overall Study|Withdrawal by Subject|40|||
105984349|NCT00358436|365604039|FG001|Overall Study|Withdrawal by Subject|17|||
105984350|NCT00358436|365604038|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
105984351|NCT00358436|365604039|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
105984352|NCT00358436|365604038|FG000|Overall Study|COPD exacerbation|22|||
105984353|NCT00358436|365604039|FG001|Overall Study|COPD exacerbation|10|||
105984354|NCT00358436|365604038|FG000|Overall Study|Other|6|||
105984355|NCT00358436|365604039|FG001|Overall Study|Other|1|||
105984356|NCT01041287|365604042|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
105984357|NCT01041287|365604043|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
105984358|NCT01041287|365604042|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
105984359|NCT01041287|365604043|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
105984360|NCT04327024|365604044|FG000|Overall Study|Death|1|||
105984361|NCT04327024|365604045|FG001|Overall Study|Death|2|||
105984362|NCT04327024|365604046|FG002|Overall Study|Death|1|||
105984363|NCT04327024|365604044|FG000|Overall Study|Non-compliance with study drug|0|||
105984364|NCT04327024|365604045|FG001|Overall Study|Non-compliance with study drug|1|||
105984365|NCT04327024|365604046|FG002|Overall Study|Non-compliance with study drug|0|||
105984366|NCT04327024|365604044|FG000|Overall Study|Withdrawal by Subject|1|||
105984367|NCT04327024|365604045|FG001|Overall Study|Withdrawal by Subject|1|||
105984368|NCT04327024|365604046|FG002|Overall Study|Withdrawal by Subject|2|||
105984369|NCT01597635|365604048|FG000|Part A|Adverse Event|3|||
105984370|NCT01597635|365604049|FG001|Part A|Adverse Event|0|||
105984371|NCT01597635|365604050|FG002|Part A|Adverse Event|0|||
105984372|NCT01597635|365604048|FG000|Part B|Adverse Event|0|||
105984373|NCT01597635|365604049|FG001|Part B|Adverse Event|0|||
105984374|NCT01597635|365604050|FG002|Part B|Adverse Event|1|||
105984375|NCT01597635|365604048|FG000|Part B|Protocol Violation|0|||
105984376|NCT01597635|365604049|FG001|Part B|Protocol Violation|1|||
105984377|NCT01597635|365604050|FG002|Part B|Protocol Violation|0|||
105984378|NCT01597635|365604048|FG000|Part B|Protocol-defined stopping criteria|0|||
105984379|NCT01597635|365604049|FG001|Part B|Protocol-defined stopping criteria|4|||
106030544|NCT01673347|365776869|FG000|Overall Study|failure of allograft|7|||
106030545|NCT01430754|365776870|FG000|Run-In Phase|Circadian Period Ineligible|24|||
106030546|NCT01430754|365776871|FG001|Run-In Phase|Circadian Period Ineligible|0|||
106030547|NCT01430754|365776870|FG000|Run-In Phase|Protocol Violation|6|||
106030548|NCT01430754|365776871|FG001|Run-In Phase|Protocol Violation|0|||
105984380|NCT01597635|365604050|FG002|Part B|Protocol-defined stopping criteria|3|||
105984381|NCT01597635|365604048|FG000|Part B|Withdrawal by Subject|0|||
105984382|NCT01597635|365604049|FG001|Part B|Withdrawal by Subject|1|||
106030549|NCT01430754|365776870|FG000|Run-In Phase|Adverse Event|2|||
106030550|NCT01430754|365776871|FG001|Run-In Phase|Adverse Event|0|||
106030551|NCT01430754|365776870|FG000|Run-In Phase|Other|2|||
105984383|NCT01597635|365604050|FG002|Part B|Withdrawal by Subject|0|||
105984384|NCT02593825|365604051|FG000|Intervention|Lost to Follow-up|10|||
105984385|NCT02593825|365604052|FG001|Intervention|Lost to Follow-up|12|||
105984386|NCT01206582|365604053|FG000|Overall Study|Withdrew prior to study|1|||
105984387|NCT01206582|365604054|FG001|Overall Study|Withdrew prior to study|0|||
105984388|NCT01206582|365604053|FG000|Overall Study|Discontinued intervention before week 8|1|||
105984389|NCT01206582|365604054|FG001|Overall Study|Discontinued intervention before week 8|2|||
106030552|NCT01430754|365776871|FG001|Run-In Phase|Other|0|||
106030553|NCT01430754|365776870|FG000|Run-In Phase|Withdrawal by Subject|2|||
106030554|NCT01430754|365776871|FG001|Run-In Phase|Withdrawal by Subject|0|||
106030555|NCT01430754|365776870|FG000|Run-In Phase|Lost to Follow-up|1|||
106030556|NCT01430754|365776871|FG001|Run-In Phase|Lost to Follow-up|0|||
106030557|NCT00895011|365776872|FG000|Overall Study|Withdrawal by Subject|14|||
106030558|NCT00895011|365776873|FG001|Overall Study|Withdrawal by Subject|7|||
106030559|NCT00895011|365776874|FG002|Overall Study|Withdrawal by Subject|2|||
105984390|NCT01971008|365604055|FG000|Overall Study|Protocol Violation|2|||
105984391|NCT01971008|365604056|FG001|Overall Study|Protocol Violation|1|||
105984392|NCT04395690|365604063|FG000|Overall Study|Lost to Follow-up|1|||
105984393|NCT04395690|365604064|FG001|Overall Study|Lost to Follow-up|1|||
105984394|NCT00434642|365604065|FG000|Blinded Treatment Phase|Adverse Event|12|||
105984395|NCT00434642|365604066|FG001|Blinded Treatment Phase|Adverse Event|58|||
105984396|NCT00434642|365604065|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
105984397|NCT00434642|365604066|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
105984398|NCT00434642|365604065|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
105984399|NCT00434642|365604066|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
105984400|NCT00434642|365604065|FG000|Blinded Treatment Phase|Physician Decision|19|||
105984401|NCT00434642|365604066|FG001|Blinded Treatment Phase|Physician Decision|27|||
105984402|NCT00434642|365604065|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
105984403|NCT00434642|365604066|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
106030560|NCT00895011|365776872|FG000|Overall Study|Lost to Follow-up|5|||
105984404|NCT00434642|365604065|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
105984405|NCT00434642|365604066|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
105984406|NCT00434642|365604065|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
105984407|NCT00434642|365604066|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
106030561|NCT00895011|365776873|FG001|Overall Study|Lost to Follow-up|4|||
106030562|NCT00895011|365776874|FG002|Overall Study|Lost to Follow-up|1|||
106030563|NCT00895011|365776872|FG000|Overall Study|Protocol Violation|3|||
106030564|NCT00895011|365776873|FG001|Overall Study|Protocol Violation|1|||
106030565|NCT00895011|365776874|FG002|Overall Study|Protocol Violation|3|||
106030566|NCT00895011|365776872|FG000|Overall Study|Adverse Event|1|||
106030567|NCT00895011|365776873|FG001|Overall Study|Adverse Event|2|||
106030568|NCT00895011|365776874|FG002|Overall Study|Adverse Event|2|||
106030569|NCT00895011|365776872|FG000|Overall Study|schedule conflict|1|||
106030570|NCT00895011|365776873|FG001|Overall Study|schedule conflict|0|||
106030571|NCT00895011|365776874|FG002|Overall Study|schedule conflict|0|||
106030572|NCT02500056|365776879|FG000|Overall Study|Lost to Follow-up|3|||
106030573|NCT02500056|365776880|FG001|Overall Study|Lost to Follow-up|7|||
106030574|NCT02500056|365776879|FG000|Overall Study|Recurrence|1|||
106030575|NCT02500056|365776880|FG001|Overall Study|Recurrence|0|||
106030576|NCT02500056|365776879|FG000|Overall Study|Death|3|||
106030577|NCT02500056|365776880|FG001|Overall Study|Death|1|||
106030578|NCT00864916|365776881|FG000|Overall Study|Lost to Follow-up|4|||
106030579|NCT00864916|365776882|FG001|Overall Study|Lost to Follow-up|4|||
106030580|NCT00864916|365776881|FG000|Overall Study|Protocol Violation|1|||
106030581|NCT00864916|365776882|FG001|Overall Study|Protocol Violation|0|||
106030582|NCT00864916|365776881|FG000|Overall Study|Withdrawal by Subject|1|||
106030583|NCT00864916|365776882|FG001|Overall Study|Withdrawal by Subject|0|||
106030584|NCT00329901|365776883|FG000|Overall Study|Withdrawal by Subject|4|||
106030585|NCT00329901|365776884|FG001|Overall Study|Withdrawal by Subject|3|||
106030586|NCT00329901|365776885|FG002|Overall Study|Withdrawal by Subject|2|||
106030587|NCT00329901|365776883|FG000|Overall Study|Lost to Follow-up|2|||
106030588|NCT00329901|365776884|FG001|Overall Study|Lost to Follow-up|0|||
106030589|NCT00329901|365776885|FG002|Overall Study|Lost to Follow-up|1|||
105984408|NCT00434642|365604065|FG000|Open-label Treatment Phase|Adverse Event|0|||
105984409|NCT00434642|365604066|FG001|Open-label Treatment Phase|Adverse Event|5|||
105984410|NCT00434642|365604065|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
105984411|NCT00434642|365604066|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
105984412|NCT03149029|365604067|FG000|Overall Study|Adverse Event|2|||
105984413|NCT03149029|365604068|FG001|Overall Study|Adverse Event|0|||
106030590|NCT00329901|365776883|FG000|Overall Study|Protocol Violation|1|||
106030591|NCT00329901|365776884|FG001|Overall Study|Protocol Violation|0|||
106030592|NCT00329901|365776885|FG002|Overall Study|Protocol Violation|1|||
106030593|NCT00329901|365776883|FG000|Overall Study|Unable to classify|2|||
106030594|NCT00329901|365776884|FG001|Overall Study|Unable to classify|2|||
106030595|NCT00329901|365776885|FG002|Overall Study|Unable to classify|0|||
106030596|NCT01105065|365776886|FG000|Overall Study|Adverse Event|5|||
106030597|NCT01105065|365776886|FG000|Overall Study|Technical Problems|1|||
106030598|NCT03774823|365776887|FG000|Overall Study|Withdrawal by Subject|1|||
106030599|NCT03774823|365776888|FG001|Overall Study|Withdrawal by Subject|1|||
106030600|NCT01253811|365776889|FG000|Overall Study|Withdrawal criteria|1|||
106030601|NCT02788279|365776890|FG000|Overall Study|Death|62|||
106030602|NCT02788279|365776891|FG001|Overall Study|Death|136|||
106030603|NCT02788279|365776892|FG002|Overall Study|Death|72|||
106030604|NCT02788279|365776890|FG000|Overall Study|Withdrawal by Subject|10|||
105984414|NCT02516592|365604069|FG000|Overall Study|Patient withdrew consent|5|||
105984415|NCT02516592|365604070|FG001|Overall Study|Patient withdrew consent|2|||
105984416|NCT02516592|365604069|FG000|Overall Study|Protocol deviation|4|||
105984417|NCT02516592|365604070|FG001|Overall Study|Protocol deviation|4|||
105984418|NCT02516592|365604069|FG000|Overall Study|Lost to Follow-up|2|||
105984419|NCT02516592|365604070|FG001|Overall Study|Lost to Follow-up|3|||
105984420|NCT02516592|365604069|FG000|Overall Study|Patient/guardian decision|2|||
105984421|NCT02516592|365604070|FG001|Overall Study|Patient/guardian decision|1|||
106030605|NCT02788279|365776891|FG001|Overall Study|Withdrawal by Subject|15|||
106030606|NCT02788279|365776892|FG002|Overall Study|Withdrawal by Subject|5|||
106030607|NCT02788279|365776890|FG000|Overall Study|Lost to Follow-up|0|||
106030608|NCT02788279|365776891|FG001|Overall Study|Lost to Follow-up|3|||
106030609|NCT02788279|365776892|FG002|Overall Study|Lost to Follow-up|2|||
106030610|NCT02788279|365776890|FG000|Overall Study|Sponsor decision|18|||
106030611|NCT02788279|365776891|FG001|Overall Study|Sponsor decision|29|||
106030612|NCT02788279|365776892|FG002|Overall Study|Sponsor decision|11|||
106030613|NCT00322621|365776896|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
106030614|NCT00322621|365776897|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
106030615|NCT00322621|365776898|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
106030616|NCT00322621|365776896|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
106030617|NCT00322621|365776897|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
106030618|NCT00322621|365776898|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
106030619|NCT00322621|365776896|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
106030620|NCT00322621|365776897|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
106030621|NCT00322621|365776898|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
106030622|NCT00322621|365776896|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
106030623|NCT00322621|365776897|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
106030624|NCT00322621|365776898|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
106030625|NCT00322621|365776896|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
106030626|NCT00322621|365776897|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
106030627|NCT00322621|365776898|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
106030628|NCT00322621|365776896|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
106030629|NCT00322621|365776897|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
106030630|NCT00322621|365776898|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
106030631|NCT00322621|365776896|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
106030632|NCT00322621|365776897|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
106030633|NCT00322621|365776898|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
106030634|NCT00322621|365776896|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
106030635|NCT00322621|365776897|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
106030636|NCT00322621|365776898|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
106030637|NCT00322621|365776896|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
106030638|NCT00322621|365776897|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
106030639|NCT00322621|365776898|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
106030640|NCT00322621|365776896|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
106030641|NCT00322621|365776897|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
106030642|NCT00322621|365776898|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
106030643|NCT00322621|365776896|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
106030644|NCT00322621|365776897|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
106030645|NCT00322621|365776898|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
106030646|NCT01743001|365776899|FG000|Overall Study|Physician Decision|1|||
106030647|NCT01743001|365776900|FG001|Overall Study|Physician Decision|0|||
106030648|NCT01743001|365776899|FG000|Overall Study|Pregnancy|1|||
106030649|NCT01743001|365776900|FG001|Overall Study|Pregnancy|0|||
106030650|NCT01743001|365776899|FG000|Overall Study|Death|1|||
106030651|NCT01743001|365776900|FG001|Overall Study|Death|0|||
106030652|NCT02047318|365776901|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
106030653|NCT02047318|365776901|FG000|Core Study Period|Adverse Event|1|||
106030654|NCT02047318|365776901|FG000|Core Study Period|Withdrawal by caregiver|3|||
106030655|NCT02047318|365776901|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
106030656|NCT01038869|365776904|FG000|Overall Study|Withdrawal by Subject|1|||
106030657|NCT01038869|365776904|FG000|Overall Study|Lost to Follow-up|6|||
106030658|NCT00711516|365776905|FG000|Overall Study|Adverse Event|1|||
106030659|NCT00711516|365776906|FG001|Overall Study|Adverse Event|1|||
106030660|NCT00711516|365776905|FG000|Overall Study|Withdrawal by Subject|0|||
106030661|NCT00711516|365776906|FG001|Overall Study|Withdrawal by Subject|1|||
106030662|NCT00711516|365776905|FG000|Overall Study|Protocol Violation|0|||
106030663|NCT00711516|365776906|FG001|Overall Study|Protocol Violation|1|||
105984422|NCT02516592|365604069|FG000|Overall Study|Adverse Event|1|||
106030664|NCT00466687|365776908|FG000|Overall Study|Adverse Event|1|||
105984423|NCT02516592|365604070|FG001|Overall Study|Adverse Event|2|||
105984424|NCT02516592|365604069|FG000|Overall Study|Abnormal test procedure result|1|||
105984425|NCT02516592|365604070|FG001|Overall Study|Abnormal test procedure result|0|||
106030665|NCT00466687|365776908|FG000|Overall Study|Other complicating illness|3|||
106030666|NCT00466687|365776908|FG000|Overall Study|Withdrawal by Subject|1|||
106030667|NCT00466687|365776908|FG000|Overall Study|Disease progression|29|||
106030668|NCT04740905|365776909|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
106030669|NCT04740905|365776910|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
106030670|NCT04740905|365776909|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
106030671|NCT04740905|365776910|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
106030672|NCT04740905|365776909|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
105984426|NCT02516592|365604069|FG000|Overall Study|Death|1|||
105984427|NCT02516592|365604070|FG001|Overall Study|Death|1|||
105984428|NCT02708485|365604071|FG000|Overall Study|Withdrawal by Subject|3|||
105984429|NCT02708485|365604072|FG001|Overall Study|Withdrawal by Subject|2|||
105984430|NCT00454584|365604075|FG000|Controlled Period|Adverse Event|5|||
105984431|NCT00454584|365604076|FG001|Controlled Period|Adverse Event|2|||
105984432|NCT00454584|365604077|FG002|Controlled Period|Adverse Event|1|||
105984433|NCT00454584|365604078|FG003|Controlled Period|Adverse Event|0|||
105984434|NCT00454584|365604079|FG004|Controlled Period|Adverse Event|0|||
105984435|NCT00454584|365604080|FG005|Controlled Period|Adverse Event|0|||
105984436|NCT00454584|365604075|FG000|Controlled Period|Lost to Follow-up|1|||
105984437|NCT00454584|365604076|FG001|Controlled Period|Lost to Follow-up|2|||
105984438|NCT00454584|365604077|FG002|Controlled Period|Lost to Follow-up|2|||
106030673|NCT04740905|365776910|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
106030674|NCT04740905|365776909|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
105984439|NCT00454584|365604078|FG003|Controlled Period|Lost to Follow-up|0|||
105984440|NCT00454584|365604079|FG004|Controlled Period|Lost to Follow-up|0|||
105984441|NCT00454584|365604080|FG005|Controlled Period|Lost to Follow-up|0|||
105984442|NCT00454584|365604075|FG000|Controlled Period|Other|5|||
105984443|NCT00454584|365604076|FG001|Controlled Period|Other|4|||
105984444|NCT00454584|365604077|FG002|Controlled Period|Other|2|||
105984445|NCT00454584|365604078|FG003|Controlled Period|Other|0|||
105984446|NCT00454584|365604079|FG004|Controlled Period|Other|0|||
105984447|NCT00454584|365604080|FG005|Controlled Period|Other|0|||
106030675|NCT04740905|365776910|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
106030676|NCT04740905|365776909|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
106030677|NCT04740905|365776910|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
106030678|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
106030679|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
106030680|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
106030681|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
106030682|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
106030683|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
106030684|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
106030685|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
106030686|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
106030687|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
106030688|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
106030689|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
106030690|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
106030691|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
106030692|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
106030693|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
106030694|NCT04740905|365776909|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
106030695|NCT04740905|365776910|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
106030696|NCT00770146|365776917|FG000|Treatment Period|Withdrawal by Subject|6|||
106030697|NCT00770146|365776918|FG001|Treatment Period|Withdrawal by Subject|13|||
106030698|NCT00770146|365776917|FG000|Treatment Period|Adverse Event|2|||
106030699|NCT00770146|365776918|FG001|Treatment Period|Adverse Event|26|||
106030700|NCT00770146|365776917|FG000|Treatment Period|Other|1|||
106030701|NCT00770146|365776918|FG001|Treatment Period|Other|5|||
106030702|NCT00770146|365776917|FG000|Treatment Period|Protocol non-compliance|0|||
105984448|NCT00454584|365604075|FG000|After Controlled Period|Adverse Event|0|||
105984449|NCT00454584|365604076|FG001|After Controlled Period|Adverse Event|0|||
105984450|NCT00454584|365604077|FG002|After Controlled Period|Adverse Event|0|||
105984451|NCT00454584|365604078|FG003|After Controlled Period|Adverse Event|9|||
105984452|NCT00454584|365604079|FG004|After Controlled Period|Adverse Event|3|||
105984453|NCT00454584|365604080|FG005|After Controlled Period|Adverse Event|9|||
105984454|NCT00454584|365604075|FG000|After Controlled Period|Lack of Efficacy|0|||
105984455|NCT00454584|365604076|FG001|After Controlled Period|Lack of Efficacy|0|||
105984456|NCT00454584|365604077|FG002|After Controlled Period|Lack of Efficacy|0|||
105984457|NCT00454584|365604078|FG003|After Controlled Period|Lack of Efficacy|1|||
105984458|NCT00454584|365604079|FG004|After Controlled Period|Lack of Efficacy|0|||
105984459|NCT00454584|365604080|FG005|After Controlled Period|Lack of Efficacy|0|||
105984460|NCT00454584|365604075|FG000|After Controlled Period|Lost to Follow-up|0|||
105984461|NCT00454584|365604076|FG001|After Controlled Period|Lost to Follow-up|0|||
105984462|NCT00454584|365604077|FG002|After Controlled Period|Lost to Follow-up|0|||
105984463|NCT00454584|365604078|FG003|After Controlled Period|Lost to Follow-up|2|||
105984464|NCT00454584|365604079|FG004|After Controlled Period|Lost to Follow-up|4|||
105984465|NCT00454584|365604080|FG005|After Controlled Period|Lost to Follow-up|6|||
105984466|NCT00454584|365604075|FG000|After Controlled Period|Other|0|||
105984467|NCT00454584|365604076|FG001|After Controlled Period|Other|0|||
105984468|NCT00454584|365604077|FG002|After Controlled Period|Other|0|||
105984469|NCT00454584|365604078|FG003|After Controlled Period|Other|1|||
106030703|NCT00770146|365776918|FG001|Treatment Period|Protocol non-compliance|1|||
105984470|NCT00454584|365604079|FG004|After Controlled Period|Other|0|||
106030704|NCT00770146|365776917|FG000|Follow-up Period|Withdrawal by Subject|7|||
106030705|NCT00770146|365776918|FG001|Follow-up Period|Withdrawal by Subject|13|||
105984471|NCT00454584|365604080|FG005|After Controlled Period|Other|0|||
105984472|NCT00454584|365604075|FG000|After Controlled Period|Other|0|||
105984473|NCT00454584|365604076|FG001|After Controlled Period|Other|0|||
105984474|NCT00454584|365604077|FG002|After Controlled Period|Other|0|||
105984475|NCT00454584|365604078|FG003|After Controlled Period|Other|13|||
105984476|NCT00454584|365604079|FG004|After Controlled Period|Other|5|||
105984477|NCT00454584|365604080|FG005|After Controlled Period|Other|17|||
106030706|NCT00770146|365776917|FG000|Follow-up Period|Adverse Event|0|||
105984478|NCT01729208|365604081|FG000|Baseline|Physician Decision|5|||
105984479|NCT01729208|365604082|FG001|Baseline|Physician Decision|4|||
105984480|NCT01729208|365604081|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
105984481|NCT01729208|365604082|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
105984482|NCT01729208|365604081|FG000|12 Months Follow-up|Lost to Follow-up|3|||
105984483|NCT01729208|365604082|FG001|12 Months Follow-up|Lost to Follow-up|3|||
105984484|NCT01729208|365604081|FG000|24 Months Follow-up|Lost to Follow-up|3|||
105984485|NCT01729208|365604082|FG001|24 Months Follow-up|Lost to Follow-up|0|||
105984486|NCT01729208|365604081|FG000|36 Months Follow-up|Physician Decision|1|||
105984487|NCT01729208|365604082|FG001|36 Months Follow-up|Physician Decision|0|||
105984488|NCT01729208|365604081|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
105984489|NCT01729208|365604082|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
105984490|NCT03689855|365604092|FG000|Overall Study|Adverse Event|3|||
105984491|NCT03689855|365604092|FG000|Overall Study|Withdrawal by Subject|1|||
105984492|NCT00129961|365604099|FG000|Overall Study|Adverse Event|1|||
105984493|NCT00129961|365604100|FG001|Overall Study|Adverse Event|0|||
105984494|NCT00129961|365604099|FG000|Overall Study|Death|1|||
105984495|NCT00129961|365604100|FG001|Overall Study|Death|1|||
105984496|NCT00129961|365604099|FG000|Overall Study|Withdrawal by Sponsor|14|||
105984497|NCT00129961|365604100|FG001|Overall Study|Withdrawal by Sponsor|20|||
105984498|NCT00129961|365604099|FG000|Overall Study|Physician Decision|1|||
105984499|NCT00129961|365604100|FG001|Overall Study|Physician Decision|0|||
105984500|NCT00129961|365604099|FG000|Overall Study|Withdrawal by Subject|2|||
105984501|NCT00129961|365604100|FG001|Overall Study|Withdrawal by Subject|1|||
105984502|NCT00129961|365604099|FG000|Overall Study|Missing Record|0|||
105984503|NCT00129961|365604100|FG001|Overall Study|Missing Record|1|||
105984504|NCT01600092|365604101|FG000|Overall Study|Adverse Event|2|||
105984505|NCT01600092|365604102|FG001|Overall Study|Adverse Event|0|||
105984506|NCT01600092|365604101|FG000|Overall Study|Lost to Follow-up|4|||
105984507|NCT01600092|365604102|FG001|Overall Study|Lost to Follow-up|6|||
105984508|NCT01600092|365604101|FG000|Overall Study|Withdrawal by parent/guardian|8|||
105984509|NCT01600092|365604102|FG001|Overall Study|Withdrawal by parent/guardian|6|||
105984510|NCT01600092|365604101|FG000|Overall Study|Physician Decision|1|||
105984511|NCT01600092|365604102|FG001|Overall Study|Physician Decision|1|||
105984512|NCT01600092|365604101|FG000|Overall Study|Randomized but not vaccinated|3|||
105984513|NCT01600092|365604102|FG001|Overall Study|Randomized but not vaccinated|3|||
105984514|NCT01927055|365604107|FG000|Open-label|Adverse Event|6|||
106030707|NCT00770146|365776918|FG001|Follow-up Period|Adverse Event|2|||
106030708|NCT00770146|365776917|FG000|Follow-up Period|Other|4|||
106030709|NCT00770146|365776918|FG001|Follow-up Period|Other|5|||
106030710|NCT02158364|365776919|FG000|Overall Study|Case report forms uncollected|10|||
106030711|NCT02158364|365776919|FG000|Overall Study|Protocol Deviation|50|||
106030712|NCT02412488|365776920|FG000|Overall Study|Lost to Follow-up|10|||
106030713|NCT02412488|365776920|FG000|Overall Study|Withdrawal by Subject|5|||
106030714|NCT02412488|365776920|FG000|Overall Study|Physician Decision|1|||
106030715|NCT02412488|365776920|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
106030716|NCT02412488|365776920|FG000|Overall Study|Reveal LINQ explant|1|||
106030717|NCT01073462|365776921|FG000|Overall Study|Death|14|||
106030718|NCT01073462|365776921|FG000|Overall Study|Kidney transplant|10|||
106030719|NCT01073462|365776921|FG000|Overall Study|Low parathyroid hormone levels|8|||
106030720|NCT01073462|365776921|FG000|Overall Study|Serious adverse event|2|||
105984515|NCT01927055|365604108|FG001|Open-label|Adverse Event|0|||
105984516|NCT01927055|365604109|FG002|Open-label|Adverse Event|0|||
105984517|NCT01927055|365604107|FG000|Open-label|Withdrawal by Subject|1|||
105984518|NCT01927055|365604108|FG001|Open-label|Withdrawal by Subject|0|||
105984519|NCT01927055|365604109|FG002|Open-label|Withdrawal by Subject|0|||
105984520|NCT01927055|365604107|FG000|Open-label|Study Stopped|4|||
105984521|NCT01927055|365604108|FG001|Open-label|Study Stopped|0|||
105984522|NCT01927055|365604109|FG002|Open-label|Study Stopped|0|||
105984523|NCT01927055|365604107|FG000|Open-label|Supine Hypertension|4|||
105984524|NCT01927055|365604108|FG001|Open-label|Supine Hypertension|0|||
106030721|NCT01073462|365776921|FG000|Overall Study|Lost to Follow-up|7|||
105984525|NCT01927055|365604109|FG002|Open-label|Supine Hypertension|0|||
105984526|NCT01927055|365604107|FG000|Open-label|Difficulty attending study visits|1|||
105984527|NCT01927055|365604108|FG001|Open-label|Difficulty attending study visits|0|||
105984528|NCT01927055|365604109|FG002|Open-label|Difficulty attending study visits|0|||
106030722|NCT00548184|365776922|FG000|Overall Study|Adverse Event|3|||
106030723|NCT00548184|365776922|FG000|Overall Study|took other drug|1|||
105984529|NCT01927055|365604107|FG000|Double-Blind|Adverse Event|0|||
105984530|NCT01927055|365604108|FG001|Double-Blind|Adverse Event|1|||
105984531|NCT01927055|365604109|FG002|Double-Blind|Adverse Event|1|||
105984532|NCT01927055|365604107|FG000|Double-Blind|Protocol Violation|0|||
105984533|NCT01927055|365604108|FG001|Double-Blind|Protocol Violation|0|||
105984534|NCT01927055|365604109|FG002|Double-Blind|Protocol Violation|1|||
105984535|NCT01927055|365604107|FG000|Double-Blind|Withdrawal by Subject|0|||
105984536|NCT01927055|365604108|FG001|Double-Blind|Withdrawal by Subject|2|||
105984537|NCT01927055|365604109|FG002|Double-Blind|Withdrawal by Subject|3|||
105984538|NCT01927055|365604107|FG000|Double-Blind|Study Stopped|0|||
105984539|NCT01927055|365604108|FG001|Double-Blind|Study Stopped|7|||
105984540|NCT01927055|365604109|FG002|Double-Blind|Study Stopped|7|||
105984541|NCT01927055|365604107|FG000|Double-Blind|Supine Hypertension|0|||
105984542|NCT01927055|365604108|FG001|Double-Blind|Supine Hypertension|0|||
105984543|NCT01927055|365604109|FG002|Double-Blind|Supine Hypertension|1|||
105984544|NCT01927055|365604107|FG000|Double-Blind|Extended Vacation|0|||
105984545|NCT01927055|365604108|FG001|Double-Blind|Extended Vacation|1|||
105984546|NCT01927055|365604109|FG002|Double-Blind|Extended Vacation|0|||
105984547|NCT01389323|365604110|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
105984548|NCT01389323|365604110|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
105984549|NCT01389323|365604110|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
105984550|NCT01389323|365604110|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
105984551|NCT01389323|365604110|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
105984552|NCT01389323|365604110|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
105984553|NCT01389323|365604110|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
106030724|NCT00548184|365776922|FG000|Overall Study|Found Her2 negative|1|||
106030725|NCT00773838|365776926|FG000|Overall Study|Adverse Event|29|||
106030726|NCT00773838|365776926|FG000|Overall Study|Lost to Follow-up|1|||
106030727|NCT00773838|365776926|FG000|Overall Study|Physician Decision|8|||
106030728|NCT00773838|365776926|FG000|Overall Study|Progressive Disease|82|||
106030729|NCT00773838|365776926|FG000|Overall Study|Protocol Violation|2|||
106030730|NCT00773838|365776926|FG000|Overall Study|Withdrawal by Subject|21|||
106030731|NCT02694757|365776932|FG000|Overall Study|Lack of Efficacy|3|||
106030732|NCT02285062|365776933|FG000|Pre-Treatment Period|Protocol Violation|0|||
106030733|NCT02285062|365776934|FG001|Pre-Treatment Period|Protocol Violation|2|||
106030734|NCT02285062|365776933|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
106030735|NCT02285062|365776934|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
106030736|NCT00890045|365776946|FG000|Overall Study|Death|0|||
106030737|NCT00890045|365776947|FG001|Overall Study|Death|1|||
106030738|NCT00890045|365776946|FG000|Overall Study|Did not receive HeRO Graft|0|||
106030739|NCT00890045|365776947|FG001|Overall Study|Did not receive HeRO Graft|2|||
106030740|NCT00890045|365776946|FG000|Overall Study|Lost to Follow-up|5|||
106030741|NCT00890045|365776947|FG001|Overall Study|Lost to Follow-up|7|||
106030742|NCT00906971|365776950|FG000|Overall Study|Withdrawal by Subject|8|||
106030743|NCT00906971|365776951|FG001|Overall Study|Withdrawal by Subject|2|||
106030744|NCT00906971|365776950|FG000|Overall Study|Lost to Follow-up|0|||
106030745|NCT00906971|365776951|FG001|Overall Study|Lost to Follow-up|1|||
106030746|NCT03612856|365776952|FG000|Pre-dose Period|Physician Decision|0|||
106030747|NCT03612856|365776953|FG001|Pre-dose Period|Physician Decision|1|||
106030748|NCT03612856|365776954|FG002|Pre-dose Period|Physician Decision|1|||
106030749|NCT03612856|365776952|FG000|Pre-dose Period|Withdrawal by Subject|0|||
106030750|NCT03612856|365776953|FG001|Pre-dose Period|Withdrawal by Subject|1|||
106030751|NCT03612856|365776954|FG002|Pre-dose Period|Withdrawal by Subject|0|||
106030752|NCT00169442|365776955|FG000|Overall Study|Withdrawal by Subject|0|||
106030753|NCT00169442|365776956|FG001|Overall Study|Withdrawal by Subject|0|||
106030754|NCT00169442|365776957|FG002|Overall Study|Withdrawal by Subject|1|||
106030755|NCT00169442|365776958|FG003|Overall Study|Withdrawal by Subject|0|||
106030756|NCT00169442|365776959|FG004|Overall Study|Withdrawal by Subject|0|||
106030757|NCT00169442|365776960|FG005|Overall Study|Withdrawal by Subject|0|||
106030758|NCT00169442|365776955|FG000|Overall Study|Migrated/moved from study area|0|||
106030759|NCT00169442|365776956|FG001|Overall Study|Migrated/moved from study area|0|||
106030760|NCT00169442|365776957|FG002|Overall Study|Migrated/moved from study area|0|||
106030761|NCT00169442|365776958|FG003|Overall Study|Migrated/moved from study area|0|||
106030762|NCT00169442|365776959|FG004|Overall Study|Migrated/moved from study area|0|||
106030763|NCT00169442|365776960|FG005|Overall Study|Migrated/moved from study area|2|||
106030764|NCT00169442|365776955|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
106030765|NCT00169442|365776956|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
106030766|NCT00169442|365776957|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
106030767|NCT00169442|365776958|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
106030768|NCT00169442|365776959|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
106030769|NCT00169442|365776960|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
106030770|NCT00169442|365776955|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
106030771|NCT00169442|365776956|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
106030772|NCT00169442|365776957|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
106030773|NCT00169442|365776958|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
106030774|NCT00169442|365776959|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
106030775|NCT00169442|365776960|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
106030776|NCT01426789|365776961|FG000|Part 1|Protocol deviation|0|||
106030777|NCT01426789|365776962|FG001|Part 1|Protocol deviation|1|||
106030778|NCT01426789|365776963|FG002|Part 1|Protocol deviation|0|||
106030779|NCT01426789|365776964|FG003|Part 1|Protocol deviation|0|||
106030780|NCT01426789|365776965|FG004|Part 1|Protocol deviation|0|||
106030781|NCT01426789|365776966|FG005|Part 1|Protocol deviation|0|||
106030782|NCT01426789|365776961|FG000|Part 1|Lost to Follow-up|1|||
106030783|NCT01426789|365776962|FG001|Part 1|Lost to Follow-up|2|||
106030784|NCT01426789|365776963|FG002|Part 1|Lost to Follow-up|0|||
106030785|NCT01426789|365776964|FG003|Part 1|Lost to Follow-up|0|||
106030786|NCT01426789|365776965|FG004|Part 1|Lost to Follow-up|0|||
106030787|NCT01426789|365776966|FG005|Part 1|Lost to Follow-up|0|||
106030788|NCT01426789|365776961|FG000|Part 1|Lack of Efficacy|2|||
106030789|NCT01426789|365776962|FG001|Part 1|Lack of Efficacy|1|||
106030790|NCT01426789|365776963|FG002|Part 1|Lack of Efficacy|0|||
106030791|NCT01426789|365776964|FG003|Part 1|Lack of Efficacy|0|||
106030792|NCT01426789|365776965|FG004|Part 1|Lack of Efficacy|0|||
106030793|NCT01426789|365776966|FG005|Part 1|Lack of Efficacy|0|||
106030794|NCT01426789|365776961|FG000|Part 1|Adverse Event|3|||
106030795|NCT01426789|365776962|FG001|Part 1|Adverse Event|0|||
106030796|NCT01426789|365776963|FG002|Part 1|Adverse Event|0|||
106030797|NCT01426789|365776964|FG003|Part 1|Adverse Event|0|||
106030798|NCT01426789|365776965|FG004|Part 1|Adverse Event|0|||
106030799|NCT01426789|365776966|FG005|Part 1|Adverse Event|0|||
106030800|NCT01426789|365776961|FG000|Part 2|Protocol deviation|0|||
106030801|NCT01426789|365776962|FG001|Part 2|Protocol deviation|0|||
106030802|NCT01426789|365776963|FG002|Part 2|Protocol deviation|1|||
105984554|NCT01389323|365604110|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
105984555|NCT01389323|365604110|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
105984556|NCT01389323|365604110|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
105984557|NCT01389323|365604110|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
105984558|NCT03157037|365604118|FG000|Overall Study|Death|1|||
105984559|NCT02102399|365604119|FG000|Overall Study|Withdrawal by Subject|6|||
105984560|NCT02102399|365604120|FG001|Overall Study|Withdrawal by Subject|4|||
105984561|NCT03101085|365604121|FG000|Overall Study|Lost to Follow-up|0|||
105984562|NCT03101085|365604122|FG001|Overall Study|Lost to Follow-up|1|||
105984563|NCT00695864|365604128|FG000|Placebo|Withdrawal by Subject|1|||
105984564|NCT00695864|365604128|FG000|Placebo|Physician Decision|4|||
105984565|NCT00718770|365604129|FG000|Overall Study|Adverse Event|1|||
105984566|NCT00718770|365604129|FG000|Overall Study|Lack of Efficacy|1|||
105984567|NCT00718770|365604129|FG000|Overall Study|Lack of Efficacy|1|||
105984568|NCT00718770|365604129|FG000|Overall Study|Adverse Event|1|||
105984569|NCT00718770|365604129|FG000|Overall Study|Lack of Efficacy|1|||
105984570|NCT00718770|365604129|FG000|Overall Study|Adverse Event|1|||
105984571|NCT00718770|365604129|FG000|Overall Study|Lack of Efficacy|1|||
105984572|NCT00718770|365604129|FG000|Overall Study|Adverse Event|1|||
105984573|NCT00498355|365604130|FG000|Overall Study|Lost to Follow-up|1|||
105984574|NCT01895309|365604134|FG000|Overall Study|Adverse Event|13|||
105984575|NCT01895309|365604135|FG001|Overall Study|Adverse Event|17|||
105984576|NCT01895309|365604134|FG000|Overall Study|Protocol Violation|1|||
105984577|NCT01895309|365604135|FG001|Overall Study|Protocol Violation|0|||
105984578|NCT01895309|365604134|FG000|Overall Study|Lack of Efficacy|1|||
105984579|NCT01895309|365604135|FG001|Overall Study|Lack of Efficacy|3|||
105984580|NCT01895309|365604134|FG000|Overall Study|Lost to Follow-up|1|||
105984581|NCT01895309|365604135|FG001|Overall Study|Lost to Follow-up|3|||
105984582|NCT01895309|365604134|FG000|Overall Study|Physician Decision|15|||
105984583|NCT01895309|365604135|FG001|Overall Study|Physician Decision|10|||
105984584|NCT01895309|365604134|FG000|Overall Study|Withdrawal by Subject|9|||
105984585|NCT01895309|365604135|FG001|Overall Study|Withdrawal by Subject|18|||
105984586|NCT04496453|365604136|FG000|Overall Study|Lost to Follow-up|6|||
105984587|NCT01555125|365604137|FG000|Induction Period|Lost to Follow-up|0|||
105984588|NCT01555125|365604138|FG001|Induction Period|Lost to Follow-up|2|||
105984589|NCT01555125|365604139|FG002|Induction Period|Lost to Follow-up|0|||
105984590|NCT01555125|365604140|FG003|Induction Period|Lost to Follow-up|0|||
105984591|NCT01555125|365604141|FG004|Induction Period|Lost to Follow-up|0|||
105984592|NCT01555125|365604137|FG000|Induction Period|Adverse Event|0|||
105984593|NCT01555125|365604138|FG001|Induction Period|Adverse Event|1|||
106030803|NCT01426789|365776964|FG003|Part 2|Protocol deviation|0|||
106030804|NCT01426789|365776965|FG004|Part 2|Protocol deviation|0|||
106030805|NCT01426789|365776966|FG005|Part 2|Protocol deviation|0|||
106030806|NCT01426789|365776961|FG000|Part 2|Death|0|||
106030807|NCT01426789|365776962|FG001|Part 2|Death|0|||
106030808|NCT01426789|365776963|FG002|Part 2|Death|1|||
106030809|NCT01426789|365776964|FG003|Part 2|Death|0|||
106030810|NCT01426789|365776965|FG004|Part 2|Death|1|||
106030811|NCT01426789|365776966|FG005|Part 2|Death|0|||
106030812|NCT01426789|365776961|FG000|Part 2|Administrative problems|0|||
106030813|NCT01426789|365776962|FG001|Part 2|Administrative problems|0|||
106030814|NCT01426789|365776963|FG002|Part 2|Administrative problems|2|||
105984594|NCT01555125|365604139|FG002|Induction Period|Adverse Event|0|||
105984595|NCT01555125|365604140|FG003|Induction Period|Adverse Event|0|||
105984596|NCT01555125|365604141|FG004|Induction Period|Adverse Event|1|||
105984597|NCT01555125|365604137|FG000|Induction Period|Subject / guardian decision|0|||
105984598|NCT01555125|365604138|FG001|Induction Period|Subject / guardian decision|0|||
106030815|NCT01426789|365776964|FG003|Part 2|Administrative problems|0|||
106030816|NCT01426789|365776965|FG004|Part 2|Administrative problems|1|||
106030817|NCT01426789|365776966|FG005|Part 2|Administrative problems|0|||
106030818|NCT01426789|365776961|FG000|Part 2|Lost to Follow-up|0|||
106030819|NCT01426789|365776962|FG001|Part 2|Lost to Follow-up|0|||
106030820|NCT01426789|365776963|FG002|Part 2|Lost to Follow-up|4|||
106030821|NCT01426789|365776964|FG003|Part 2|Lost to Follow-up|0|||
106030822|NCT01426789|365776965|FG004|Part 2|Lost to Follow-up|1|||
106030823|NCT01426789|365776966|FG005|Part 2|Lost to Follow-up|0|||
106030824|NCT01426789|365776961|FG000|Part 2|Withdrawal by Subject|0|||
106030825|NCT01426789|365776962|FG001|Part 2|Withdrawal by Subject|0|||
106030826|NCT01426789|365776963|FG002|Part 2|Withdrawal by Subject|0|||
106030827|NCT01426789|365776964|FG003|Part 2|Withdrawal by Subject|1|||
106030828|NCT01426789|365776965|FG004|Part 2|Withdrawal by Subject|2|||
106030829|NCT01426789|365776966|FG005|Part 2|Withdrawal by Subject|0|||
106030830|NCT01426789|365776961|FG000|Part 2|Lack of Efficacy|0|||
106030831|NCT01426789|365776962|FG001|Part 2|Lack of Efficacy|0|||
106030832|NCT01426789|365776963|FG002|Part 2|Lack of Efficacy|5|||
106030833|NCT01426789|365776964|FG003|Part 2|Lack of Efficacy|0|||
106030834|NCT01426789|365776965|FG004|Part 2|Lack of Efficacy|2|||
106030835|NCT01426789|365776966|FG005|Part 2|Lack of Efficacy|0|||
106030836|NCT01426789|365776961|FG000|Part 2|Adverse Event|0|||
106030837|NCT01426789|365776962|FG001|Part 2|Adverse Event|0|||
105984599|NCT01555125|365604139|FG002|Induction Period|Subject / guardian decision|0|||
105984600|NCT01555125|365604140|FG003|Induction Period|Subject / guardian decision|0|||
105984601|NCT01555125|365604141|FG004|Induction Period|Subject / guardian decision|2|||
105984602|NCT01555125|365604137|FG000|Induction Period|Death|1|||
105984603|NCT01555125|365604138|FG001|Induction Period|Death|0|||
105984604|NCT01555125|365604139|FG002|Induction Period|Death|0|||
105984605|NCT01555125|365604140|FG003|Induction Period|Death|0|||
105984606|NCT01555125|365604141|FG004|Induction Period|Death|0|||
105984607|NCT01555125|365604137|FG000|Maintenance Period|Adverse Event|1|||
105984608|NCT01555125|365604138|FG001|Maintenance Period|Adverse Event|1|||
105984609|NCT01555125|365604139|FG002|Maintenance Period|Adverse Event|0|||
105984610|NCT01555125|365604140|FG003|Maintenance Period|Adverse Event|0|||
105984611|NCT01555125|365604141|FG004|Maintenance Period|Adverse Event|0|||
105984612|NCT01555125|365604137|FG000|Maintenance Period|Subject / guardian decision|1|||
105984613|NCT01555125|365604138|FG001|Maintenance Period|Subject / guardian decision|2|||
105984614|NCT01555125|365604139|FG002|Maintenance Period|Subject / guardian decision|0|||
105984615|NCT01555125|365604140|FG003|Maintenance Period|Subject / guardian decision|0|||
105984616|NCT01555125|365604141|FG004|Maintenance Period|Subject / guardian decision|0|||
105984617|NCT01555125|365604137|FG000|Maintenance Period|Lost to Follow-up|2|||
105984618|NCT01555125|365604138|FG001|Maintenance Period|Lost to Follow-up|0|||
105984619|NCT01555125|365604139|FG002|Maintenance Period|Lost to Follow-up|0|||
105984620|NCT01555125|365604140|FG003|Maintenance Period|Lost to Follow-up|1|||
105984621|NCT01555125|365604141|FG004|Maintenance Period|Lost to Follow-up|0|||
105984622|NCT01555125|365604137|FG000|Maintenance Period|Lack of Efficacy|6|||
105984623|NCT01555125|365604138|FG001|Maintenance Period|Lack of Efficacy|1|||
105984624|NCT01555125|365604139|FG002|Maintenance Period|Lack of Efficacy|3|||
105984625|NCT01555125|365604140|FG003|Maintenance Period|Lack of Efficacy|0|||
105984626|NCT01555125|365604141|FG004|Maintenance Period|Lack of Efficacy|0|||
105984627|NCT01555125|365604137|FG000|Maintenance Period|Physician Decision|0|||
105984628|NCT01555125|365604138|FG001|Maintenance Period|Physician Decision|0|||
105984629|NCT01555125|365604139|FG002|Maintenance Period|Physician Decision|1|||
105984630|NCT01555125|365604140|FG003|Maintenance Period|Physician Decision|0|||
105984631|NCT01555125|365604141|FG004|Maintenance Period|Physician Decision|0|||
105984632|NCT01555125|365604137|FG000|Maintenance Period|Death|0|||
105984633|NCT01555125|365604138|FG001|Maintenance Period|Death|0|||
105984634|NCT01555125|365604139|FG002|Maintenance Period|Death|0|||
105984635|NCT01555125|365604140|FG003|Maintenance Period|Death|1|||
105984636|NCT01555125|365604141|FG004|Maintenance Period|Death|0|||
105984637|NCT01555125|365604137|FG000|Extension|Adverse Event|1|||
105984638|NCT01555125|365604138|FG001|Extension|Adverse Event|2|||
105984639|NCT01555125|365604139|FG002|Extension|Adverse Event|1|||
105984640|NCT01555125|365604140|FG003|Extension|Adverse Event|1|||
105984641|NCT01555125|365604141|FG004|Extension|Adverse Event|0|||
105984642|NCT01555125|365604137|FG000|Extension|Protocol deviation|1|||
105984643|NCT01555125|365604138|FG001|Extension|Protocol deviation|0|||
105984644|NCT01555125|365604139|FG002|Extension|Protocol deviation|0|||
105984645|NCT01555125|365604140|FG003|Extension|Protocol deviation|0|||
105984646|NCT01555125|365604141|FG004|Extension|Protocol deviation|0|||
105984647|NCT01555125|365604137|FG000|Extension|Lack of Efficacy|7|||
105984648|NCT01555125|365604138|FG001|Extension|Lack of Efficacy|6|||
105984649|NCT01555125|365604139|FG002|Extension|Lack of Efficacy|3|||
105984650|NCT01555125|365604140|FG003|Extension|Lack of Efficacy|0|||
105984651|NCT01555125|365604141|FG004|Extension|Lack of Efficacy|0|||
105984652|NCT01555125|365604137|FG000|Extension|Lost to Follow-up|2|||
105984653|NCT01555125|365604138|FG001|Extension|Lost to Follow-up|1|||
105984654|NCT01555125|365604139|FG002|Extension|Lost to Follow-up|2|||
105984655|NCT01555125|365604140|FG003|Extension|Lost to Follow-up|0|||
105984656|NCT01555125|365604141|FG004|Extension|Lost to Follow-up|0|||
105984657|NCT01555125|365604137|FG000|Extension|Study terminated by sponsor|32|||
105984658|NCT01555125|365604138|FG001|Extension|Study terminated by sponsor|33|||
106030838|NCT01426789|365776963|FG002|Part 2|Adverse Event|2|||
106030839|NCT01426789|365776964|FG003|Part 2|Adverse Event|0|||
106030840|NCT01426789|365776965|FG004|Part 2|Adverse Event|1|||
106030841|NCT01426789|365776966|FG005|Part 2|Adverse Event|0|||
105984659|NCT01555125|365604139|FG002|Extension|Study terminated by sponsor|16|||
105984660|NCT01555125|365604140|FG003|Extension|Study terminated by sponsor|20|||
105984661|NCT01555125|365604141|FG004|Extension|Study terminated by sponsor|0|||
105984662|NCT01555125|365604137|FG000|Extension|Subject/guardian decision|1|||
105984663|NCT01555125|365604138|FG001|Extension|Subject/guardian decision|9|||
105984664|NCT01555125|365604139|FG002|Extension|Subject/guardian decision|1|||
105984665|NCT01555125|365604140|FG003|Extension|Subject/guardian decision|0|||
105984666|NCT01555125|365604141|FG004|Extension|Subject/guardian decision|0|||
105984667|NCT01555125|365604137|FG000|Extension|Technical Problems|1|||
105984668|NCT01555125|365604138|FG001|Extension|Technical Problems|0|||
105984669|NCT01555125|365604139|FG002|Extension|Technical Problems|0|||
105984670|NCT01555125|365604140|FG003|Extension|Technical Problems|1|||
105984671|NCT01555125|365604141|FG004|Extension|Technical Problems|0|||
105984672|NCT01555125|365604137|FG000|Follow-Up Period|Lost to Follow-up|1|||
105984673|NCT01555125|365604138|FG001|Follow-Up Period|Lost to Follow-up|0|||
105984674|NCT01555125|365604139|FG002|Follow-Up Period|Lost to Follow-up|0|||
105984675|NCT01555125|365604140|FG003|Follow-Up Period|Lost to Follow-up|0|||
105984676|NCT01555125|365604141|FG004|Follow-Up Period|Lost to Follow-up|0|||
105984677|NCT01555125|365604137|FG000|Follow-Up Period|Subject / guardian decision|3|||
105984678|NCT01555125|365604138|FG001|Follow-Up Period|Subject / guardian decision|1|||
105984679|NCT01555125|365604139|FG002|Follow-Up Period|Subject / guardian decision|1|||
105984680|NCT01555125|365604140|FG003|Follow-Up Period|Subject / guardian decision|1|||
105984681|NCT01555125|365604141|FG004|Follow-Up Period|Subject / guardian decision|0|||
105984682|NCT02651220|365604142|FG000|Overall Study|Adverse Event|1|||
105984683|NCT02651220|365604143|FG001|Overall Study|Adverse Event|5|||
105984684|NCT02651220|365604144|FG002|Overall Study|Adverse Event|1|||
106030842|NCT01227629|365776968|FG000|Overall Study|Adverse Event|2|||
106030843|NCT01227629|365776969|FG001|Overall Study|Adverse Event|2|||
106030844|NCT01227629|365776970|FG002|Overall Study|Adverse Event|1|||
106030845|NCT01227629|365776971|FG003|Overall Study|Adverse Event|6|||
106030846|NCT01227629|365776972|FG004|Overall Study|Adverse Event|1|||
106030847|NCT01227629|365776973|FG005|Overall Study|Adverse Event|1|||
105984685|NCT02651220|365604142|FG000|Overall Study|Lost to Follow-up|8|||
105984686|NCT02651220|365604143|FG001|Overall Study|Lost to Follow-up|14|||
105984687|NCT02651220|365604144|FG002|Overall Study|Lost to Follow-up|14|||
105984688|NCT02651220|365604142|FG000|Overall Study|Non-Compliance with Study Drug|4|||
105984689|NCT02651220|365604143|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105984690|NCT02651220|365604144|FG002|Overall Study|Non-Compliance with Study Drug|1|||
105984691|NCT02651220|365604142|FG000|Overall Study|Pregnancy|1|||
105984692|NCT02651220|365604143|FG001|Overall Study|Pregnancy|0|||
105984693|NCT02651220|365604144|FG002|Overall Study|Pregnancy|1|||
105984694|NCT02651220|365604142|FG000|Overall Study|Protocol Violation|0|||
105984695|NCT02651220|365604143|FG001|Overall Study|Protocol Violation|0|||
105984696|NCT02651220|365604144|FG002|Overall Study|Protocol Violation|1|||
105984697|NCT02651220|365604142|FG000|Overall Study|Withdrawal by Subject|5|||
105984698|NCT02651220|365604143|FG001|Overall Study|Withdrawal by Subject|6|||
105984699|NCT02651220|365604144|FG002|Overall Study|Withdrawal by Subject|8|||
105984700|NCT02651220|365604142|FG000|Overall Study|Miscellaneous|4|||
105984701|NCT02651220|365604143|FG001|Overall Study|Miscellaneous|1|||
105984702|NCT02651220|365604144|FG002|Overall Study|Miscellaneous|2|||
105984703|NCT02651220|365604142|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105984704|NCT02651220|365604143|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105984705|NCT02651220|365604144|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
105984706|NCT04058886|365604146|FG000|Overall Study|Withdrawal by Subject|4|||
105984707|NCT04058886|365604146|FG000|Overall Study|Inadequate deafness interpreter service|1|||
105984708|NCT01092663|365604157|FG000|Overall Study|Withdrawal by Subject|3|||
105984709|NCT01092663|365604158|FG001|Overall Study|Withdrawal by Subject|2|||
105984710|NCT01092663|365604157|FG000|Overall Study|Glucose >300mg/dL|1|||
105984711|NCT01092663|365604158|FG001|Overall Study|Glucose >300mg/dL|0|||
105984712|NCT01092663|365604157|FG000|Overall Study|High fasting triglyceride|2|||
105984713|NCT01092663|365604158|FG001|Overall Study|High fasting triglyceride|0|||
105984714|NCT01092663|365604157|FG000|Overall Study|Adverse Event|1|||
106030848|NCT01227629|365776974|FG006|Overall Study|Adverse Event|6|||
105984715|NCT01092663|365604158|FG001|Overall Study|Adverse Event|1|||
106030849|NCT01227629|365776975|FG007|Overall Study|Adverse Event|6|||
106030850|NCT01227629|365776976|FG008|Overall Study|Adverse Event|4|||
105984716|NCT01092663|365604157|FG000|Overall Study|Protocol Violation|0|||
105984717|NCT01092663|365604158|FG001|Overall Study|Protocol Violation|1|||
105984718|NCT02409342|365604159|FG000|Overall Study|Death|211|||
106030851|NCT01227629|365776977|FG009|Overall Study|Adverse Event|0|||
105984719|NCT02409342|365604160|FG001|Overall Study|Death|201|||
105984720|NCT02409342|365604159|FG000|Overall Study|Withdrawal by Subject|24|||
105984721|NCT02409342|365604160|FG001|Overall Study|Withdrawal by Subject|17|||
105984722|NCT02409342|365604159|FG000|Overall Study|Study Terminated By Sponsor|48|||
105984723|NCT02409342|365604160|FG001|Overall Study|Study Terminated By Sponsor|59|||
105984724|NCT02409342|365604159|FG000|Overall Study|Lost to Follow-up|3|||
105984725|NCT02409342|365604160|FG001|Overall Study|Lost to Follow-up|5|||
105984726|NCT02409342|365604159|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
105984727|NCT02409342|365604160|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
105984728|NCT02409342|365604159|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
105984729|NCT02409342|365604160|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
105984730|NCT02409342|365604159|FG000|Overall Study|Sponsor Decision|1|||
105984731|NCT02409342|365604160|FG001|Overall Study|Sponsor Decision|0|||
105984732|NCT00788710|365604161|FG000|Overall Study|Adverse Event|1|||
105984733|NCT00788710|365604162|FG001|Overall Study|Adverse Event|3|||
105984734|NCT00788710|365604163|FG002|Overall Study|Adverse Event|4|||
105984735|NCT00788710|365604161|FG000|Overall Study|Lack of Efficacy|0|||
105984736|NCT00788710|365604162|FG001|Overall Study|Lack of Efficacy|0|||
106030852|NCT01227629|365776968|FG000|Overall Study|Protocol Violation|0|||
105984737|NCT00788710|365604163|FG002|Overall Study|Lack of Efficacy|1|||
106030853|NCT01227629|365776969|FG001|Overall Study|Protocol Violation|0|||
105984738|NCT00788710|365604161|FG000|Overall Study|Lost to Follow-up|0|||
105984739|NCT00788710|365604162|FG001|Overall Study|Lost to Follow-up|1|||
105984740|NCT00788710|365604163|FG002|Overall Study|Lost to Follow-up|0|||
105984741|NCT00788710|365604161|FG000|Overall Study|Physician Decision|2|||
105984742|NCT00788710|365604162|FG001|Overall Study|Physician Decision|1|||
105984743|NCT00788710|365604163|FG002|Overall Study|Physician Decision|0|||
105984744|NCT00788710|365604161|FG000|Overall Study|Protocol Violation|0|||
105984745|NCT00788710|365604162|FG001|Overall Study|Protocol Violation|1|||
105984746|NCT00788710|365604163|FG002|Overall Study|Protocol Violation|1|||
105984747|NCT00788710|365604161|FG000|Overall Study|Withdrawal by Subject|2|||
105984748|NCT00788710|365604162|FG001|Overall Study|Withdrawal by Subject|2|||
105984749|NCT00788710|365604163|FG002|Overall Study|Withdrawal by Subject|0|||
105984750|NCT04407234|365604164|FG000|Overall Study|Adverse Event|3|||
105984751|NCT04407234|365604165|FG001|Overall Study|Adverse Event|3|||
105984752|NCT01183065|365604166|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
105984753|NCT01990859|365604175|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
105984754|NCT01990859|365604175|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
105984755|NCT02262754|365604177|FG000|Overall Study|Adverse Event|3|||
105984756|NCT02262754|365604178|FG001|Overall Study|Adverse Event|4|||
105984757|NCT02262754|365604179|FG002|Overall Study|Adverse Event|0|||
105984758|NCT02262754|365604177|FG000|Overall Study|Lack of Efficacy|2|||
105984759|NCT02262754|365604178|FG001|Overall Study|Lack of Efficacy|0|||
105984760|NCT02262754|365604179|FG002|Overall Study|Lack of Efficacy|1|||
105984761|NCT02262754|365604177|FG000|Overall Study|Lost to Follow-up|0|||
105984762|NCT02262754|365604178|FG001|Overall Study|Lost to Follow-up|0|||
105984763|NCT02262754|365604179|FG002|Overall Study|Lost to Follow-up|1|||
105984764|NCT02262754|365604177|FG000|Overall Study|No longer meets eligibility criteria|0|||
105984765|NCT02262754|365604178|FG001|Overall Study|No longer meets eligibility criteria|1|||
105984766|NCT02262754|365604179|FG002|Overall Study|No longer meets eligibility criteria|0|||
105984767|NCT02262754|365604177|FG000|Overall Study|Study terminated by sponsor|5|||
105984768|NCT02262754|365604178|FG001|Overall Study|Study terminated by sponsor|4|||
105984769|NCT02262754|365604179|FG002|Overall Study|Study terminated by sponsor|4|||
105984770|NCT02262754|365604177|FG000|Overall Study|Protocol Violation|1|||
105984771|NCT02262754|365604178|FG001|Overall Study|Protocol Violation|0|||
105984772|NCT02262754|365604179|FG002|Overall Study|Protocol Violation|0|||
105984773|NCT02262754|365604177|FG000|Overall Study|Withdrawal by Subject|1|||
105984774|NCT02262754|365604178|FG001|Overall Study|Withdrawal by Subject|0|||
105984775|NCT02262754|365604179|FG002|Overall Study|Withdrawal by Subject|1|||
105984776|NCT02262754|365604177|FG000|Overall Study|Other|4|||
105984777|NCT02262754|365604178|FG001|Overall Study|Other|0|||
105984778|NCT02262754|365604179|FG002|Overall Study|Other|2|||
105984779|NCT01673620|365605932|FG000|Overall Study|Adverse Event|1|||
105984780|NCT01673620|365605933|FG001|Overall Study|Adverse Event|0|||
105984781|NCT01192568|365605934|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
105984782|NCT01192568|365605935|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
105984783|NCT01192568|365605936|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
105984784|NCT01192568|365605937|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
105984785|NCT01192568|365605934|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
105984786|NCT01192568|365605935|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
105984787|NCT01192568|365605936|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
105984788|NCT01192568|365605937|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
105984789|NCT02522325|365605938|FG000|Overall Study|Adverse Event|0|||
105984790|NCT02522325|365605939|FG001|Overall Study|Adverse Event|1|||
105984791|NCT03416127|365605940|FG000|Overall Study|Withdrawal by Subject|0|||
105984792|NCT03416127|365605941|FG001|Overall Study|Withdrawal by Subject|1|||
105984793|NCT03416127|365605942|FG002|Overall Study|Withdrawal by Subject|1|||
105984794|NCT00344500|365605943|FG000|Overall Study|Adverse Event|6|||
105984795|NCT00344500|365605944|FG001|Overall Study|Adverse Event|2|||
105984796|NCT00344500|365605945|FG002|Overall Study|Adverse Event|0|||
105984797|NCT00344500|365605943|FG000|Overall Study|Lost to Follow-up|5|||
105984798|NCT00344500|365605944|FG001|Overall Study|Lost to Follow-up|13|||
105984799|NCT00344500|365605945|FG002|Overall Study|Lost to Follow-up|1|||
105984800|NCT00344500|365605943|FG000|Overall Study|Withdrawal by Subject|7|||
105984801|NCT00344500|365605944|FG001|Overall Study|Withdrawal by Subject|10|||
105984802|NCT00344500|365605945|FG002|Overall Study|Withdrawal by Subject|0|||
105984803|NCT00344500|365605943|FG000|Overall Study|Protocol Violation|4|||
105984804|NCT00344500|365605944|FG001|Overall Study|Protocol Violation|7|||
105984805|NCT00344500|365605945|FG002|Overall Study|Protocol Violation|1|||
105984806|NCT00344500|365605943|FG000|Overall Study|Not Noted|1|||
105984807|NCT00344500|365605944|FG001|Overall Study|Not Noted|3|||
105984808|NCT00344500|365605945|FG002|Overall Study|Not Noted|0|||
105984809|NCT00126776|365605946|FG000|Overall Study|follow up complete on all patients|0|||
105984810|NCT00126776|365605947|FG001|Overall Study|follow up complete on all patients|0|||
105984811|NCT00599755|365605948|FG000|Overall Study|Adverse Event|11|||
105984812|NCT00599755|365605948|FG000|Overall Study|Withdrawal by Subject|2|||
106030854|NCT01227629|365776970|FG002|Overall Study|Protocol Violation|0|||
106030855|NCT01227629|365776971|FG003|Overall Study|Protocol Violation|1|||
106030856|NCT01227629|365776972|FG004|Overall Study|Protocol Violation|0|||
106030857|NCT01227629|365776973|FG005|Overall Study|Protocol Violation|0|||
106030858|NCT01227629|365776974|FG006|Overall Study|Protocol Violation|0|||
106030859|NCT01227629|365776975|FG007|Overall Study|Protocol Violation|0|||
106030860|NCT01227629|365776976|FG008|Overall Study|Protocol Violation|0|||
106030861|NCT01227629|365776977|FG009|Overall Study|Protocol Violation|0|||
106030862|NCT01227629|365776968|FG000|Overall Study|Lost to Follow-up|0|||
106030863|NCT01227629|365776969|FG001|Overall Study|Lost to Follow-up|0|||
106030864|NCT01227629|365776970|FG002|Overall Study|Lost to Follow-up|0|||
106030865|NCT01227629|365776971|FG003|Overall Study|Lost to Follow-up|0|||
106030866|NCT01227629|365776972|FG004|Overall Study|Lost to Follow-up|1|||
106030867|NCT01227629|365776973|FG005|Overall Study|Lost to Follow-up|0|||
106030868|NCT01227629|365776974|FG006|Overall Study|Lost to Follow-up|0|||
106030869|NCT01227629|365776975|FG007|Overall Study|Lost to Follow-up|0|||
106030870|NCT01227629|365776976|FG008|Overall Study|Lost to Follow-up|0|||
106030871|NCT01227629|365776977|FG009|Overall Study|Lost to Follow-up|0|||
106030872|NCT01227629|365776968|FG000|Overall Study|Withdrawal by Subject|0|||
106030873|NCT01227629|365776969|FG001|Overall Study|Withdrawal by Subject|0|||
106030874|NCT01227629|365776970|FG002|Overall Study|Withdrawal by Subject|0|||
106030875|NCT01227629|365776971|FG003|Overall Study|Withdrawal by Subject|0|||
106030876|NCT01227629|365776972|FG004|Overall Study|Withdrawal by Subject|0|||
106030877|NCT01227629|365776973|FG005|Overall Study|Withdrawal by Subject|0|||
106030878|NCT01227629|365776974|FG006|Overall Study|Withdrawal by Subject|2|||
106030879|NCT01227629|365776975|FG007|Overall Study|Withdrawal by Subject|0|||
106030880|NCT01227629|365776976|FG008|Overall Study|Withdrawal by Subject|0|||
106030881|NCT01227629|365776977|FG009|Overall Study|Withdrawal by Subject|1|||
106030882|NCT01227629|365776968|FG000|Overall Study|Other|0|||
106030883|NCT01227629|365776969|FG001|Overall Study|Other|0|||
106030884|NCT01227629|365776970|FG002|Overall Study|Other|0|||
106030885|NCT01227629|365776971|FG003|Overall Study|Other|1|||
106030886|NCT01227629|365776972|FG004|Overall Study|Other|0|||
106030887|NCT01227629|365776973|FG005|Overall Study|Other|0|||
106030888|NCT01227629|365776974|FG006|Overall Study|Other|0|||
106030889|NCT01227629|365776975|FG007|Overall Study|Other|0|||
106030890|NCT01227629|365776976|FG008|Overall Study|Other|2|||
106030891|NCT01227629|365776977|FG009|Overall Study|Other|1|||
106030892|NCT01258998|365778528|FG000|Overall Study|Ineligible|1|||
106030893|NCT02276027|365778529|FG000|Overall Study|Death|1|||
106030894|NCT02276027|365778530|FG001|Overall Study|Death|0|||
106030895|NCT02276027|365778531|FG002|Overall Study|Death|0|||
106030896|NCT02276027|365778532|FG003|Overall Study|Death|2|||
106030897|NCT02276027|365778529|FG000|Overall Study|Physician Decision|0|||
106030898|NCT02276027|365778530|FG001|Overall Study|Physician Decision|0|||
106030899|NCT02276027|365778531|FG002|Overall Study|Physician Decision|0|||
106030900|NCT02276027|365778532|FG003|Overall Study|Physician Decision|1|||
106030901|NCT02276027|365778529|FG000|Overall Study|Progressive disease|1|||
106030902|NCT02276027|365778530|FG001|Overall Study|Progressive disease|13|||
106030903|NCT02276027|365778531|FG002|Overall Study|Progressive disease|12|||
106030904|NCT02276027|365778532|FG003|Overall Study|Progressive disease|14|||
106030905|NCT02276027|365778529|FG000|Overall Study|Subject/guardian decision|0|||
106030906|NCT02276027|365778530|FG001|Overall Study|Subject/guardian decision|1|||
106030907|NCT02276027|365778531|FG002|Overall Study|Subject/guardian decision|0|||
106030908|NCT02276027|365778532|FG003|Overall Study|Subject/guardian decision|3|||
106030909|NCT02276027|365778529|FG000|Overall Study|Adverse Event|0|||
106030910|NCT02276027|365778530|FG001|Overall Study|Adverse Event|2|||
106030911|NCT02276027|365778531|FG002|Overall Study|Adverse Event|8|||
106030912|NCT02276027|365778532|FG003|Overall Study|Adverse Event|2|||
106030913|NCT01343823|365778537|FG000|Overall Study|Study Terminated|1|||
106030914|NCT01343823|365778538|FG001|Overall Study|Study Terminated|0|||
106030915|NCT01343823|365778539|FG002|Overall Study|Study Terminated|0|||
106030916|NCT01343823|365778540|FG003|Overall Study|Study Terminated|1|||
106030917|NCT01343823|365778537|FG000|Overall Study|Withdrawal by Subject|1|||
106030918|NCT01343823|365778538|FG001|Overall Study|Withdrawal by Subject|0|||
106030919|NCT01343823|365778539|FG002|Overall Study|Withdrawal by Subject|0|||
106030920|NCT01343823|365778540|FG003|Overall Study|Withdrawal by Subject|0|||
106030921|NCT02577887|365778543|FG000|Overall Study|Death|93|||
106030922|NCT02577887|365778543|FG000|Overall Study|Protocol Violation|125|||
106030923|NCT02577887|365778543|FG000|Overall Study|Withdrawal by Subject|80|||
106030924|NCT01958489|365778544|FG000|Period 2|Adverse Event|0|||
106030925|NCT01958489|365778545|FG001|Period 2|Adverse Event|1|||
106030926|NCT00917644|365778546|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
106030927|NCT00917644|365778547|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
106030928|NCT00917644|365778546|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
106030929|NCT00917644|365778547|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
106030930|NCT00917644|365778546|FG000|Period 2: Second Intervention|family emergency|1|||
106030931|NCT00917644|365778547|FG001|Period 2: Second Intervention|family emergency|0|||
106030932|NCT02338232|365778548|FG000|Overall Study|Screen Failure|3|||
106030933|NCT02338232|365778548|FG000|Overall Study|Withdrawal by Subject|6|||
106030934|NCT02338232|365778548|FG000|Overall Study|Adverse Event|2|||
106030935|NCT00713310|365778549|FG000|Overall Study|Adverse Event|5|||
106030936|NCT00713310|365778550|FG001|Overall Study|Adverse Event|2|||
106030937|NCT00713310|365778549|FG000|Overall Study|Lack of Efficacy|0|||
106030938|NCT00713310|365778550|FG001|Overall Study|Lack of Efficacy|2|||
106030939|NCT00713310|365778549|FG000|Overall Study|Withdrawal by Subject|0|||
106030940|NCT00713310|365778550|FG001|Overall Study|Withdrawal by Subject|2|||
106030941|NCT01215916|365778551|FG000|Overall Study|Progressive Disease|0|||
106030942|NCT01215916|365778552|FG001|Overall Study|Progressive Disease|2|||
106030943|NCT01215916|365778553|FG002|Overall Study|Progressive Disease|1|||
106030944|NCT01215916|365778554|FG003|Overall Study|Progressive Disease|2|||
106030945|NCT01215916|365778555|FG004|Overall Study|Progressive Disease|5|||
106030946|NCT01215916|365778556|FG005|Overall Study|Progressive Disease|4|||
106030947|NCT01215916|365778557|FG006|Overall Study|Progressive Disease|5|||
106030948|NCT01215916|365778558|FG007|Overall Study|Progressive Disease|3|||
106030949|NCT01215916|365778559|FG008|Overall Study|Progressive Disease|1|||
106030950|NCT01215916|365778551|FG000|Overall Study|Adverse Event|1|||
106030951|NCT01215916|365778552|FG001|Overall Study|Adverse Event|1|||
106030952|NCT01215916|365778553|FG002|Overall Study|Adverse Event|0|||
106030953|NCT01215916|365778554|FG003|Overall Study|Adverse Event|1|||
106030954|NCT01215916|365778555|FG004|Overall Study|Adverse Event|0|||
106030955|NCT01215916|365778556|FG005|Overall Study|Adverse Event|0|||
106030956|NCT01215916|365778557|FG006|Overall Study|Adverse Event|3|||
106030957|NCT01215916|365778558|FG007|Overall Study|Adverse Event|0|||
106030958|NCT01215916|365778559|FG008|Overall Study|Adverse Event|0|||
106030959|NCT01215916|365778551|FG000|Overall Study|Withdrawal by Subject|0|||
106030960|NCT01215916|365778552|FG001|Overall Study|Withdrawal by Subject|1|||
106030961|NCT01215916|365778553|FG002|Overall Study|Withdrawal by Subject|1|||
106030962|NCT01215916|365778554|FG003|Overall Study|Withdrawal by Subject|2|||
106030963|NCT01215916|365778555|FG004|Overall Study|Withdrawal by Subject|0|||
106030964|NCT01215916|365778556|FG005|Overall Study|Withdrawal by Subject|0|||
106030965|NCT01215916|365778557|FG006|Overall Study|Withdrawal by Subject|1|||
106030966|NCT01215916|365778558|FG007|Overall Study|Withdrawal by Subject|0|||
106030967|NCT01215916|365778559|FG008|Overall Study|Withdrawal by Subject|0|||
106030968|NCT01215916|365778551|FG000|Overall Study|Death|0|||
106030969|NCT01215916|365778552|FG001|Overall Study|Death|1|||
106030970|NCT01215916|365778553|FG002|Overall Study|Death|0|||
106030971|NCT01215916|365778554|FG003|Overall Study|Death|0|||
106030972|NCT01215916|365778555|FG004|Overall Study|Death|1|||
106030973|NCT01215916|365778556|FG005|Overall Study|Death|0|||
106030974|NCT01215916|365778557|FG006|Overall Study|Death|0|||
106030975|NCT01215916|365778558|FG007|Overall Study|Death|0|||
106030976|NCT01215916|365778559|FG008|Overall Study|Death|1|||
106030977|NCT01215916|365778551|FG000|Overall Study|Physician Decision|0|||
106030978|NCT01215916|365778552|FG001|Overall Study|Physician Decision|0|||
106030979|NCT01215916|365778553|FG002|Overall Study|Physician Decision|1|||
106030980|NCT01215916|365778554|FG003|Overall Study|Physician Decision|1|||
106030981|NCT01215916|365778555|FG004|Overall Study|Physician Decision|0|||
106030982|NCT01215916|365778556|FG005|Overall Study|Physician Decision|0|||
106030983|NCT01215916|365778557|FG006|Overall Study|Physician Decision|0|||
106030984|NCT01215916|365778558|FG007|Overall Study|Physician Decision|0|||
106030985|NCT01215916|365778559|FG008|Overall Study|Physician Decision|0|||
106030986|NCT01087736|365778562|FG000|Overall Study|Lost to Follow-up|1|||
106030987|NCT01087736|365778563|FG001|Overall Study|Lost to Follow-up|0|||
106030988|NCT01087736|365778562|FG000|Overall Study|Death|0|||
106030989|NCT01087736|365778563|FG001|Overall Study|Death|1|||
106030990|NCT01087736|365778562|FG000|Overall Study|Withdrawal by Subject|0|||
106030991|NCT01087736|365778563|FG001|Overall Study|Withdrawal by Subject|1|||
106030992|NCT01101308|365778566|FG000|Period 1|Adverse Event|2|||
106030993|NCT01101308|365778567|FG001|Period 1|Adverse Event|1|||
106030994|NCT01101308|365778566|FG000|Period 1|Positive for cotinine|1|||
105984813|NCT00599755|365605948|FG000|Overall Study|Progression of Disease|3|||
105984814|NCT00599755|365605948|FG000|Overall Study|Other Reason|2|||
105984815|NCT00599755|365605948|FG000|Overall Study|No data available|1|||
105984816|NCT00417963|365605949|FG000|Overall Study|Lost to Follow-up|3|||
105984817|NCT00417963|365605949|FG000|Overall Study|Withdrawal by Subject|18|||
105984818|NCT00417963|365605949|FG000|Overall Study|Death|17|||
105984819|NCT00417963|365605949|FG000|Overall Study|Study device could not be deployed|3|||
105984820|NCT00477152|365605953|FG000|Overall Study|Parent withdrew consent|2|||
105984821|NCT00477152|365605953|FG000|Overall Study|Adverse Event|1|||
105984822|NCT01023672|365605954|FG000|Overall Study|Worsening disease|2|||
105984823|NCT01023672|365605954|FG000|Overall Study|Death|1|||
105984824|NCT00448747|365605956|FG000|Overall Study|collapsed veins|1|||
106030995|NCT01101308|365778567|FG001|Period 1|Positive for cotinine|0|||
106030996|NCT01579812|365778568|FG000|Overall Study|Ineligible after treatment start|40|||
106030997|NCT01579812|365778568|FG000|Overall Study|Patient choice|3|||
106030998|NCT01579812|365778568|FG000|Overall Study|Noncompliance|3|||
106030999|NCT01579812|365778568|FG000|Overall Study|Withdrawal by Subject|6|||
106031000|NCT02282345|365778569|FG000|Overall Study|Progression|0|||
106031001|NCT02282345|365778570|FG001|Overall Study|Progression|1|||
106031002|NCT01185301|365778571|FG000|Overall Study|Adverse Event|3|||
106031003|NCT01185301|365778572|FG001|Overall Study|Adverse Event|0|||
106031004|NCT01185301|365778573|FG002|Overall Study|Adverse Event|2|||
106031005|NCT01185301|365778574|FG003|Overall Study|Adverse Event|3|||
106031006|NCT01185301|365778571|FG000|Overall Study|Withdrawal by Subject|7|||
106031007|NCT01185301|365778572|FG001|Overall Study|Withdrawal by Subject|5|||
106031008|NCT01185301|365778573|FG002|Overall Study|Withdrawal by Subject|2|||
106031009|NCT01185301|365778574|FG003|Overall Study|Withdrawal by Subject|3|||
106031010|NCT01185301|365778571|FG000|Overall Study|Lost to Follow-up|2|||
106031011|NCT01185301|365778572|FG001|Overall Study|Lost to Follow-up|0|||
106031012|NCT01185301|365778573|FG002|Overall Study|Lost to Follow-up|0|||
105869196|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
105869197|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
105869198|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
105869199|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
105869200|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
106031013|NCT01185301|365778574|FG003|Overall Study|Lost to Follow-up|1|||
106031014|NCT01185301|365778571|FG000|Overall Study|Other Reason|3|||
106031015|NCT01185301|365778572|FG001|Overall Study|Other Reason|2|||
106031016|NCT01185301|365778573|FG002|Overall Study|Other Reason|2|||
106031017|NCT01185301|365778574|FG003|Overall Study|Other Reason|2|||
106031018|NCT02683746|365778576|FG000|Overall Study|Adverse Event|3|||
106031019|NCT02683746|365778577|FG001|Overall Study|Adverse Event|2|||
106031020|NCT02683746|365778576|FG000|Overall Study|Lost to Follow-up|5|||
106031021|NCT02683746|365778577|FG001|Overall Study|Lost to Follow-up|6|||
106031022|NCT02683746|365778576|FG000|Overall Study|Withdrawal by Subject|6|||
106031023|NCT02683746|365778577|FG001|Overall Study|Withdrawal by Subject|5|||
106031024|NCT02683746|365778576|FG000|Overall Study|Physician Decision|2|||
105869201|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
105869202|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
105869203|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
105869204|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
105869205|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
105869206|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
105869207|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
106031025|NCT02683746|365778577|FG001|Overall Study|Physician Decision|1|||
106031026|NCT04987944|365778582|FG000|Overall Study|Adverse Event|0|||
105856641|NCT03190330|365126779|FG000|Overall Study|Adverse Event|2|||
105856642|NCT03190330|365126779|FG000|Overall Study|Death|10|||
105856643|NCT03190330|365126779|FG000|Overall Study|Lost to Follow-up|1|||
105856644|NCT03190330|365126779|FG000|Overall Study|Withdrawal by Subject|6|||
105856645|NCT03190330|365126779|FG000|Overall Study|Progressive Disease|1|||
105856646|NCT05091307|365126788|FG000|Overall Study|Death|0|||
105856647|NCT05091307|365126789|FG001|Overall Study|Death|0|||
105856648|NCT05091307|365126790|FG002|Overall Study|Death|1|||
105856649|NCT05091307|365126791|FG003|Overall Study|Death|0|||
105856650|NCT05091307|365126788|FG000|Overall Study|Lost to Follow-up|33|||
105856651|NCT05091307|365126789|FG001|Overall Study|Lost to Follow-up|33|||
105856652|NCT05091307|365126790|FG002|Overall Study|Lost to Follow-up|2|||
105856653|NCT05091307|365126791|FG003|Overall Study|Lost to Follow-up|0|||
105856654|NCT05091307|365126788|FG000|Overall Study|Physician Decision|1|||
105856655|NCT05091307|365126789|FG001|Overall Study|Physician Decision|0|||
105856656|NCT05091307|365126790|FG002|Overall Study|Physician Decision|0|||
105856657|NCT05091307|365126791|FG003|Overall Study|Physician Decision|0|||
105856658|NCT05091307|365126788|FG000|Overall Study|Protocol Violation|1|||
105856659|NCT05091307|365126789|FG001|Overall Study|Protocol Violation|0|||
106031027|NCT04987944|365778583|FG001|Overall Study|Adverse Event|1|||
106031028|NCT04987944|365778582|FG000|Overall Study|Withdrawal by Subject|0|||
106031029|NCT04987944|365778583|FG001|Overall Study|Withdrawal by Subject|1|||
106031030|NCT03316911|365778587|FG000|Overall Study|Lost to Follow-up|33|||
106031031|NCT03316911|365778588|FG001|Overall Study|Lost to Follow-up|29|||
105856660|NCT05091307|365126790|FG002|Overall Study|Protocol Violation|0|||
105856661|NCT05091307|365126791|FG003|Overall Study|Protocol Violation|0|||
105856662|NCT05091307|365126788|FG000|Overall Study|Withdrawal by Subject|16|||
105856663|NCT05091307|365126789|FG001|Overall Study|Withdrawal by Subject|16|||
105856664|NCT05091307|365126790|FG002|Overall Study|Withdrawal by Subject|0|||
105856665|NCT05091307|365126791|FG003|Overall Study|Withdrawal by Subject|1|||
105856666|NCT05091307|365126788|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
105856667|NCT05091307|365126789|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
105856668|NCT05091307|365126790|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
105856669|NCT05091307|365126791|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
105856670|NCT05091307|365126788|FG000|Overall Study|Initiated Prohibited Medication|1|||
105856671|NCT05091307|365126789|FG001|Overall Study|Initiated Prohibited Medication|0|||
105856672|NCT05091307|365126790|FG002|Overall Study|Initiated Prohibited Medication|0|||
105856673|NCT05091307|365126791|FG003|Overall Study|Initiated Prohibited Medication|0|||
105856674|NCT05091307|365126788|FG000|Overall Study|Other|4|||
105856675|NCT05091307|365126789|FG001|Overall Study|Other|4|||
105856676|NCT05091307|365126790|FG002|Overall Study|Other|0|||
105856677|NCT05091307|365126791|FG003|Overall Study|Other|0|||
105856678|NCT05091307|365126788|FG000|Overall Study|Randomized but not vaccinated|0|||
105856679|NCT05091307|365126789|FG001|Overall Study|Randomized but not vaccinated|2|||
105856680|NCT05091307|365126790|FG002|Overall Study|Randomized but not vaccinated|0|||
105856681|NCT05091307|365126791|FG003|Overall Study|Randomized but not vaccinated|0|||
105856682|NCT04994483|365126792|FG000|Overall Study|Adverse Event|26|||
106031032|NCT02586506|365778595|FG000|Overall Study|Protocol Violation|6|||
106031033|NCT02586506|365778595|FG000|Overall Study|Lost to Follow-up|1|||
106031034|NCT02586506|365778595|FG000|Overall Study|Other Reason|2|||
106031035|NCT03051620|365778596|FG000|Overall Study|Lost to Follow-up|6|||
106031036|NCT03051620|365778596|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
106031037|NCT03499964|365778597|FG000|Overall Study|Lack of Efficacy|6|||
106031038|NCT03499964|365778598|FG001|Overall Study|Lack of Efficacy|26|||
106031039|NCT03499964|365778597|FG000|Overall Study|Adverse Event|1|||
106031040|NCT03499964|365778598|FG001|Overall Study|Adverse Event|0|||
106031041|NCT03499964|365778597|FG000|Overall Study|Death|1|||
106031042|NCT03499964|365778598|FG001|Overall Study|Death|0|||
106031043|NCT03499964|365778597|FG000|Overall Study|Withdrawal by Subject|2|||
106031044|NCT03499964|365778598|FG001|Overall Study|Withdrawal by Subject|1|||
106031045|NCT03499964|365778597|FG000|Overall Study|Lost to Follow-up|1|||
106031046|NCT03499964|365778598|FG001|Overall Study|Lost to Follow-up|0|||
106031047|NCT00313781|365778610|FG000|Before Crossover|Death|22|||
105856683|NCT04994483|365126793|FG001|Overall Study|Adverse Event|17|||
105856684|NCT04994483|365126792|FG000|Overall Study|Lost to Follow-up|6|||
105856685|NCT04994483|365126793|FG001|Overall Study|Lost to Follow-up|10|||
105856686|NCT04994483|365126792|FG000|Overall Study|Noncompliance with study drug|8|||
105856687|NCT04994483|365126793|FG001|Overall Study|Noncompliance with study drug|5|||
106031048|NCT00313781|365778611|FG001|Before Crossover|Death|8|||
106031049|NCT00313781|365778612|FG002|Before Crossover|Death|0|||
106031050|NCT00313781|365778610|FG000|Before Crossover|Lost to Follow-up|0|||
105856688|NCT04994483|365126792|FG000|Overall Study|Physician Decision|5|||
105856689|NCT04994483|365126793|FG001|Overall Study|Physician Decision|0|||
106031051|NCT00313781|365778611|FG001|Before Crossover|Lost to Follow-up|3|||
106031052|NCT00313781|365778612|FG002|Before Crossover|Lost to Follow-up|0|||
106031053|NCT00313781|365778610|FG000|Before Crossover|Withdrawal by Subject|3|||
105856690|NCT04994483|365126792|FG000|Overall Study|Withdrawal by Subject|41|||
105856691|NCT04994483|365126793|FG001|Overall Study|Withdrawal by Subject|38|||
106031054|NCT00313781|365778611|FG001|Before Crossover|Withdrawal by Subject|1|||
105856692|NCT04994483|365126792|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
105856693|NCT04994483|365126793|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
105856694|NCT04994483|365126792|FG000|Overall Study|Met stopping criteria|1|||
105856695|NCT04994483|365126793|FG001|Overall Study|Met stopping criteria|0|||
105856696|NCT04994483|365126792|FG000|Overall Study|Randomized in error, not treated|4|||
105856697|NCT04994483|365126793|FG001|Overall Study|Randomized in error, not treated|3|||
105856698|NCT04994483|365126792|FG000|Overall Study|Lack of a reliable study partner|0|||
105856699|NCT04994483|365126793|FG001|Overall Study|Lack of a reliable study partner|1|||
105856700|NCT04994483|365126792|FG000|Overall Study|Met MRI exclusion criteria|0|||
105856701|NCT04994483|365126793|FG001|Overall Study|Met MRI exclusion criteria|1|||
105856702|NCT03283319|365126794|FG000|Overall Study|Lost to Follow-up|5|||
105856703|NCT03283319|365126795|FG001|Overall Study|Lost to Follow-up|4|||
105856704|NCT03283319|365126796|FG002|Overall Study|Lost to Follow-up|5|||
105856705|NCT03283319|365126797|FG003|Overall Study|Lost to Follow-up|5|||
105856706|NCT03283319|365126798|FG004|Overall Study|Lost to Follow-up|4|||
105856707|NCT03283319|365126799|FG005|Overall Study|Lost to Follow-up|3|||
105856708|NCT03283319|365126794|FG000|Overall Study|Withdrawal by Subject|2|||
105856709|NCT03283319|365126795|FG001|Overall Study|Withdrawal by Subject|2|||
105856710|NCT03283319|365126796|FG002|Overall Study|Withdrawal by Subject|2|||
105856711|NCT03283319|365126797|FG003|Overall Study|Withdrawal by Subject|1|||
105856712|NCT03283319|365126798|FG004|Overall Study|Withdrawal by Subject|0|||
105856713|NCT03283319|365126799|FG005|Overall Study|Withdrawal by Subject|1|||
105856714|NCT03283319|365126794|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
105856715|NCT03283319|365126795|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
105856716|NCT03283319|365126796|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
105856717|NCT03283319|365126797|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
105856718|NCT03283319|365126798|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
105856719|NCT03283319|365126799|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
105856720|NCT03186781|365126800|FG000|Overall Study|Lost to Follow-up|0|||
105856721|NCT03186781|365126801|FG001|Overall Study|Lost to Follow-up|0|||
105856722|NCT03186781|365126802|FG002|Overall Study|Lost to Follow-up|1|||
105856723|NCT03186781|365126803|FG003|Overall Study|Lost to Follow-up|0|||
105856724|NCT03186781|365126804|FG004|Overall Study|Lost to Follow-up|1|||
105856725|NCT03186781|365126805|FG005|Overall Study|Lost to Follow-up|0|||
105856726|NCT03186781|365126800|FG000|Overall Study|Moved from Area|0|||
105856727|NCT03186781|365126801|FG001|Overall Study|Moved from Area|0|||
105856728|NCT03186781|365126802|FG002|Overall Study|Moved from Area|0|||
105856729|NCT03186781|365126803|FG003|Overall Study|Moved from Area|0|||
105856730|NCT03186781|365126804|FG004|Overall Study|Moved from Area|1|||
105856731|NCT03186781|365126805|FG005|Overall Study|Moved from Area|0|||
105856732|NCT03186781|365126800|FG000|Overall Study|Withdrawal by Subject|0|||
105856733|NCT03186781|365126801|FG001|Overall Study|Withdrawal by Subject|0|||
105856734|NCT03186781|365126802|FG002|Overall Study|Withdrawal by Subject|0|||
105856735|NCT03186781|365126803|FG003|Overall Study|Withdrawal by Subject|0|||
105856736|NCT03186781|365126804|FG004|Overall Study|Withdrawal by Subject|1|||
105856737|NCT03186781|365126805|FG005|Overall Study|Withdrawal by Subject|0|||
105856738|NCT04713553|365126809|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
105856739|NCT04713553|365126810|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
105856740|NCT04713553|365126811|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
105856741|NCT04713553|365126812|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
105856742|NCT04713553|365126813|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
105856743|NCT04713553|365126814|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
105856744|NCT04713553|365126815|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
105856745|NCT04713553|365126809|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105856746|NCT04713553|365126810|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105856747|NCT04713553|365126811|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105856748|NCT04713553|365126812|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
105856749|NCT04713553|365126813|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105856750|NCT04713553|365126814|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105856751|NCT04713553|365126815|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
105856752|NCT04713553|365126809|FG000|Primary Study (2 Months)|Other|1|||
105856753|NCT04713553|365126810|FG001|Primary Study (2 Months)|Other|2|||
105856754|NCT04713553|365126811|FG002|Primary Study (2 Months)|Other|0|||
105856755|NCT04713553|365126812|FG003|Primary Study (2 Months)|Other|0|||
105856756|NCT04713553|365126813|FG004|Primary Study (2 Months)|Other|1|||
105856757|NCT04713553|365126814|FG005|Primary Study (2 Months)|Other|0|||
105856758|NCT04713553|365126815|FG006|Primary Study (2 Months)|Other|0|||
105856759|NCT04713553|365126809|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
105856760|NCT04713553|365126810|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
105856761|NCT04713553|365126811|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
105856762|NCT04713553|365126812|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
105856763|NCT04713553|365126813|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
105856764|NCT04713553|365126814|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
105984825|NCT00448747|365605957|FG001|Overall Study|collapsed veins|0|||
105856765|NCT04713553|365126815|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
105856766|NCT04713553|365126809|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
105856767|NCT04713553|365126810|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
106031055|NCT00313781|365778612|FG002|Before Crossover|Withdrawal by Subject|0|||
106031056|NCT00313781|365778610|FG000|Before Crossover|Other|45|||
106031057|NCT00313781|365778611|FG001|Before Crossover|Other|30|||
105856768|NCT04713553|365126811|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
105856769|NCT04713553|365126812|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
105856770|NCT04713553|365126813|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
105856771|NCT04713553|365126814|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
105856772|NCT04713553|365126815|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
105856773|NCT00289536|365126817|FG000|Period 3|Lost to Follow-up|0|||
105856774|NCT00289536|365126818|FG001|Period 3|Lost to Follow-up|0|||
105856775|NCT00289536|365126819|FG002|Period 3|Lost to Follow-up|1|||
105856776|NCT00988442|365126823|FG000|Overall Study|Death|1|||
105856777|NCT00988442|365126824|FG001|Overall Study|Death|2|||
105856778|NCT00988442|365126823|FG000|Overall Study|Lost to Follow-up|0|||
105856779|NCT00988442|365126824|FG001|Overall Study|Lost to Follow-up|1|||
106031058|NCT00313781|365778612|FG002|Before Crossover|Other|0|||
106031059|NCT00313781|365778610|FG000|Before Crossover|Crossover|0|||
106031060|NCT00313781|365778611|FG001|Before Crossover|Crossover|37|||
106031061|NCT00313781|365778612|FG002|Before Crossover|Crossover|0|||
106031062|NCT00313781|365778610|FG000|Before Crossover|Randomized, not treated|5|||
106031063|NCT00313781|365778611|FG001|Before Crossover|Randomized, not treated|0|||
106031064|NCT00313781|365778612|FG002|Before Crossover|Randomized, not treated|0|||
106031065|NCT00313781|365778610|FG000|After Crossover|Death|0|||
106031066|NCT00313781|365778611|FG001|After Crossover|Death|0|||
106031067|NCT00313781|365778612|FG002|After Crossover|Death|6|||
106031068|NCT00313781|365778610|FG000|After Crossover|Withdrawal by Subject|0|||
106031069|NCT00313781|365778611|FG001|After Crossover|Withdrawal by Subject|0|||
106031070|NCT00313781|365778612|FG002|After Crossover|Withdrawal by Subject|3|||
106031071|NCT00313781|365778610|FG000|After Crossover|Other|0|||
106031072|NCT00313781|365778611|FG001|After Crossover|Other|0|||
106031073|NCT00313781|365778612|FG002|After Crossover|Other|18|||
106031074|NCT01903252|365778613|FG000|Double-Blind Induction|Adverse Event|20|||
106031075|NCT01903252|365778614|FG001|Double-Blind Induction|Adverse Event|18|||
106031076|NCT01903252|365778615|FG002|Double-Blind Induction|Adverse Event|0|||
106031077|NCT01903252|365778616|FG003|Double-Blind Induction|Adverse Event|0|||
106031078|NCT01903252|365778617|FG004|Double-Blind Induction|Adverse Event|0|||
106031079|NCT01903252|365778618|FG005|Double-Blind Induction|Adverse Event|0|||
106031080|NCT01903252|365778613|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
106031081|NCT01903252|365778614|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
106031082|NCT01903252|365778615|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
106031083|NCT01903252|365778616|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
106031084|NCT01903252|365778617|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
106031085|NCT01903252|365778618|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
106031086|NCT01903252|365778613|FG000|Double-Blind Induction|Physician Decision|2|||
106031087|NCT01903252|365778614|FG001|Double-Blind Induction|Physician Decision|3|||
106031088|NCT01903252|365778615|FG002|Double-Blind Induction|Physician Decision|0|||
106031089|NCT01903252|365778616|FG003|Double-Blind Induction|Physician Decision|0|||
106031090|NCT01903252|365778617|FG004|Double-Blind Induction|Physician Decision|0|||
106031091|NCT01903252|365778618|FG005|Double-Blind Induction|Physician Decision|0|||
106031092|NCT01903252|365778613|FG000|Double-Blind Induction|non-compliance,|7|||
106031093|NCT01903252|365778614|FG001|Double-Blind Induction|non-compliance,|7|||
106031094|NCT01903252|365778615|FG002|Double-Blind Induction|non-compliance,|0|||
106031095|NCT01903252|365778616|FG003|Double-Blind Induction|non-compliance,|0|||
106031096|NCT01903252|365778617|FG004|Double-Blind Induction|non-compliance,|0|||
106031097|NCT01903252|365778618|FG005|Double-Blind Induction|non-compliance,|0|||
106031098|NCT01903252|365778613|FG000|Extended Induction, Open-Label|Adverse Event|0|||
106031099|NCT01903252|365778614|FG001|Extended Induction, Open-Label|Adverse Event|0|||
106031100|NCT01903252|365778615|FG002|Extended Induction, Open-Label|Adverse Event|17|||
105856780|NCT00988442|365126823|FG000|Overall Study|Early Study Closure|29|||
105856781|NCT00988442|365126824|FG001|Overall Study|Early Study Closure|25|||
105856782|NCT04053465|365126829|FG000|Overall Study|Withdrawal by Subject|4|||
106031101|NCT01903252|365778616|FG003|Extended Induction, Open-Label|Adverse Event|0|||
105856783|NCT04053465|365126830|FG001|Overall Study|Withdrawal by Subject|4|||
105856784|NCT05297578|365126831|FG000|Overall Study|Lost to Follow-up|1|||
106031102|NCT01903252|365778617|FG004|Extended Induction, Open-Label|Adverse Event|0|||
106031103|NCT01903252|365778618|FG005|Extended Induction, Open-Label|Adverse Event|0|||
106031104|NCT01903252|365778613|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
106031105|NCT01903252|365778614|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
106031106|NCT01903252|365778615|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
106031107|NCT01903252|365778616|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
105856785|NCT05297578|365126832|FG001|Overall Study|Lost to Follow-up|1|||
106031108|NCT01903252|365778617|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
105856786|NCT05297578|365126833|FG002|Overall Study|Lost to Follow-up|2|||
105856787|NCT05297578|365126834|FG003|Overall Study|Lost to Follow-up|1|||
105856788|NCT05297578|365126831|FG000|Overall Study|Death|0|||
105856789|NCT05297578|365126832|FG001|Overall Study|Death|1|||
105856790|NCT05297578|365126833|FG002|Overall Study|Death|0|||
105856791|NCT05297578|365126834|FG003|Overall Study|Death|0|||
105856792|NCT05297578|365126831|FG000|Overall Study|Withdrawal by Subject|0|||
105856793|NCT05297578|365126832|FG001|Overall Study|Withdrawal by Subject|0|||
105856794|NCT05297578|365126833|FG002|Overall Study|Withdrawal by Subject|1|||
105856795|NCT05297578|365126834|FG003|Overall Study|Withdrawal by Subject|0|||
105856796|NCT01468818|365126839|FG000|Overall Study|Death during treatment|2|||
105856797|NCT01212588|365126840|FG000|Overall Study|Physician Decision|0|||
105856798|NCT01212588|365126841|FG001|Overall Study|Physician Decision|1|||
105856799|NCT01212588|365126840|FG000|Overall Study|Protocol Violation|1|||
105856800|NCT01212588|365126841|FG001|Overall Study|Protocol Violation|1|||
105856801|NCT02338193|365126842|FG000|Overall Study|Withdrawal by Subject|0|||
105856802|NCT02338193|365126843|FG001|Overall Study|Withdrawal by Subject|0|||
105856803|NCT02338193|365126844|FG002|Overall Study|Withdrawal by Subject|2|||
105856804|NCT02338193|365126842|FG000|Overall Study|Pregnancy|0|||
105856805|NCT02338193|365126843|FG001|Overall Study|Pregnancy|1|||
105856806|NCT02338193|365126844|FG002|Overall Study|Pregnancy|1|||
105856807|NCT02338193|365126842|FG000|Overall Study|Noncompliant with visits|2|||
105856808|NCT02338193|365126843|FG001|Overall Study|Noncompliant with visits|2|||
105856809|NCT02338193|365126844|FG002|Overall Study|Noncompliant with visits|7|||
105856810|NCT02338193|365126842|FG000|Overall Study|moved out of state|0|||
105856811|NCT02338193|365126843|FG001|Overall Study|moved out of state|1|||
105856812|NCT02338193|365126844|FG002|Overall Study|moved out of state|0|||
105856813|NCT02338193|365126842|FG000|Overall Study|intolerant of side effects|1|||
105856814|NCT02338193|365126843|FG001|Overall Study|intolerant of side effects|0|||
105856815|NCT02338193|365126844|FG002|Overall Study|intolerant of side effects|0|||
105856816|NCT00132028|365126845|FG000|Overall Study|Adverse Event|7|||
105856817|NCT00132028|365126845|FG000|Overall Study|Death|2|||
105856818|NCT00132028|365126845|FG000|Overall Study|Lack of Efficacy|11|||
105856819|NCT00132028|365126845|FG000|Overall Study|Withdrawal by Subject|2|||
105856820|NCT00132028|365126845|FG000|Overall Study|not eligible|2|||
105856821|NCT00132028|365126845|FG000|Overall Study|Physician Decision|3|||
105856822|NCT04228783|365126854|FG000|Overall Study|Adverse Event|1|||
105856823|NCT04228783|365126855|FG001|Overall Study|Adverse Event|0|||
105856824|NCT04228783|365126856|FG002|Overall Study|Adverse Event|2|||
105856825|NCT04228783|365126857|FG003|Overall Study|Adverse Event|0|||
105856826|NCT04228783|365126858|FG004|Overall Study|Adverse Event|0|||
105856827|NCT04228783|365126859|FG005|Overall Study|Adverse Event|1|||
105856828|NCT04228783|365126854|FG000|Overall Study|Death|0|||
105856829|NCT04228783|365126855|FG001|Overall Study|Death|0|||
105856830|NCT04228783|365126856|FG002|Overall Study|Death|0|||
105856831|NCT04228783|365126857|FG003|Overall Study|Death|0|||
105856832|NCT04228783|365126858|FG004|Overall Study|Death|1|||
105856833|NCT04228783|365126859|FG005|Overall Study|Death|0|||
105856834|NCT04228783|365126854|FG000|Overall Study|Lost to Follow-up|36|||
105856835|NCT04228783|365126855|FG001|Overall Study|Lost to Follow-up|36|||
105856836|NCT04228783|365126856|FG002|Overall Study|Lost to Follow-up|28|||
105856837|NCT04228783|365126857|FG003|Overall Study|Lost to Follow-up|6|||
105856838|NCT04228783|365126858|FG004|Overall Study|Lost to Follow-up|14|||
105856839|NCT04228783|365126859|FG005|Overall Study|Lost to Follow-up|3|||
105856840|NCT04228783|365126854|FG000|Overall Study|Physician Decision|1|||
105984826|NCT00387725|365605958|FG000|Overall Study|Adverse Event|0|||
105984827|NCT00387725|365605959|FG001|Overall Study|Adverse Event|0|||
105984828|NCT00387725|365605960|FG002|Overall Study|Adverse Event|0|||
105984829|NCT00387725|365605961|FG003|Overall Study|Adverse Event|1|||
105984830|NCT00387725|365605958|FG000|Overall Study|Protocol Violation|0|||
106031109|NCT01903252|365778618|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
105984831|NCT00387725|365605959|FG001|Overall Study|Protocol Violation|1|||
105984832|NCT00387725|365605960|FG002|Overall Study|Protocol Violation|0|||
105984833|NCT00387725|365605961|FG003|Overall Study|Protocol Violation|0|||
105984834|NCT00387725|365605958|FG000|Overall Study|Withdrawal by Subject|1|||
105984835|NCT00387725|365605959|FG001|Overall Study|Withdrawal by Subject|0|||
105984836|NCT00387725|365605960|FG002|Overall Study|Withdrawal by Subject|1|||
105984837|NCT00387725|365605961|FG003|Overall Study|Withdrawal by Subject|0|||
105984838|NCT00387725|365605958|FG000|Overall Study|Parent/legal guardian request|0|||
105984839|NCT00387725|365605959|FG001|Overall Study|Parent/legal guardian request|0|||
105984840|NCT00387725|365605960|FG002|Overall Study|Parent/legal guardian request|1|||
105984841|NCT00387725|365605961|FG003|Overall Study|Parent/legal guardian request|1|||
105984842|NCT00568126|365605962|FG000|Overall Study|Adverse Event|3|||
105984843|NCT00568126|365605963|FG001|Overall Study|Adverse Event|0|||
105984844|NCT00568126|365605962|FG000|Overall Study|Withdrawal by Subject|2|||
105984845|NCT00568126|365605963|FG001|Overall Study|Withdrawal by Subject|3|||
106031110|NCT01903252|365778613|FG000|Extended Induction, Open-Label|Physician Decision|0|||
106031111|NCT01903252|365778614|FG001|Extended Induction, Open-Label|Physician Decision|0|||
106031112|NCT01903252|365778615|FG002|Extended Induction, Open-Label|Physician Decision|1|||
106031113|NCT01903252|365778616|FG003|Extended Induction, Open-Label|Physician Decision|0|||
106031114|NCT01903252|365778617|FG004|Extended Induction, Open-Label|Physician Decision|0|||
106031115|NCT01903252|365778618|FG005|Extended Induction, Open-Label|Physician Decision|0|||
106031116|NCT01903252|365778613|FG000|Maintenance, Open-Label|Adverse Event|0|||
106031117|NCT01903252|365778614|FG001|Maintenance, Open-Label|Adverse Event|0|||
106031118|NCT01903252|365778615|FG002|Maintenance, Open-Label|Adverse Event|0|||
106031119|NCT01903252|365778616|FG003|Maintenance, Open-Label|Adverse Event|3|||
106031120|NCT01903252|365778617|FG004|Maintenance, Open-Label|Adverse Event|9|||
106031121|NCT01903252|365778618|FG005|Maintenance, Open-Label|Adverse Event|14|||
105984846|NCT00568126|365605962|FG000|Overall Study|Lost to Follow-up|4|||
105984847|NCT00568126|365605963|FG001|Overall Study|Lost to Follow-up|3|||
105856841|NCT04228783|365126855|FG001|Overall Study|Physician Decision|2|||
105856842|NCT04228783|365126856|FG002|Overall Study|Physician Decision|0|||
105856843|NCT04228783|365126857|FG003|Overall Study|Physician Decision|0|||
105856844|NCT04228783|365126858|FG004|Overall Study|Physician Decision|0|||
105856845|NCT04228783|365126859|FG005|Overall Study|Physician Decision|0|||
105856846|NCT04228783|365126854|FG000|Overall Study|Protocol Violation|0|||
105856847|NCT04228783|365126855|FG001|Overall Study|Protocol Violation|0|||
106031122|NCT01903252|365778613|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
106031123|NCT01903252|365778614|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
106031124|NCT01903252|365778615|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
106031125|NCT01903252|365778616|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
106031126|NCT01903252|365778617|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
106031127|NCT01903252|365778618|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
106031128|NCT01903252|365778613|FG000|Maintenance, Open-Label|Other|0|||
106031129|NCT01903252|365778614|FG001|Maintenance, Open-Label|Other|0|||
106031130|NCT01903252|365778615|FG002|Maintenance, Open-Label|Other|0|||
106031131|NCT01903252|365778616|FG003|Maintenance, Open-Label|Other|2|||
106031132|NCT01903252|365778617|FG004|Maintenance, Open-Label|Other|6|||
106031133|NCT01903252|365778618|FG005|Maintenance, Open-Label|Other|2|||
106031134|NCT01642732|365778621|FG000|Overall Study|Withdrawal by Subject|1|||
106031135|NCT02395302|365778626|FG000|Overall Study|Screen Failure|3|||
106031136|NCT02395302|365778626|FG000|Overall Study|Run In Failure|7|||
106031137|NCT02395302|365778626|FG000|Overall Study|Withdrawal by Subject|2|||
106031138|NCT02395302|365778626|FG000|Overall Study|Physician Decision|2|||
106031139|NCT01087788|365778627|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
106031140|NCT01087788|365778628|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
106031141|NCT01087788|365778629|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
106031142|NCT01087788|365778627|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
106031143|NCT01087788|365778628|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
106031144|NCT01087788|365778629|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
106031145|NCT01087788|365778627|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
106031146|NCT01087788|365778628|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
106031147|NCT01087788|365778629|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
106031148|NCT01087788|365778627|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
106031149|NCT01087788|365778628|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
105856848|NCT04228783|365126856|FG002|Overall Study|Protocol Violation|0|||
105856849|NCT04228783|365126857|FG003|Overall Study|Protocol Violation|1|||
105856850|NCT04228783|365126858|FG004|Overall Study|Protocol Violation|0|||
105984848|NCT00568126|365605962|FG000|Overall Study|Lack of Efficacy|0|||
105984849|NCT00568126|365605963|FG001|Overall Study|Lack of Efficacy|1|||
105984850|NCT00568126|365605962|FG000|Overall Study|Physician Decision|2|||
105984851|NCT00568126|365605963|FG001|Overall Study|Physician Decision|2|||
105984852|NCT01452919|365605967|FG000|Open-Label Treatment|Adverse Event|5|||
105984853|NCT01452919|365605968|FG001|Open-Label Treatment|Adverse Event|0|||
105984854|NCT01452919|365605969|FG002|Open-Label Treatment|Adverse Event|0|||
105984855|NCT01452919|365605967|FG000|Open-Label Treatment|Lost to Follow-up|4|||
105984856|NCT01452919|365605968|FG001|Open-Label Treatment|Lost to Follow-up|0|||
105984857|NCT01452919|365605969|FG002|Open-Label Treatment|Lost to Follow-up|0|||
105984858|NCT01452919|365605967|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
105984859|NCT01452919|365605968|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
105984860|NCT01452919|365605969|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
105984861|NCT01452919|365605967|FG000|Open-Label Treatment|Protocol Violation|4|||
105984862|NCT01452919|365605968|FG001|Open-Label Treatment|Protocol Violation|0|||
105984863|NCT01452919|365605969|FG002|Open-Label Treatment|Protocol Violation|0|||
105984864|NCT01452919|365605967|FG000|Open-Label Treatment|Sponsor Decision|1|||
105984865|NCT01452919|365605968|FG001|Open-Label Treatment|Sponsor Decision|0|||
105984866|NCT01452919|365605969|FG002|Open-Label Treatment|Sponsor Decision|0|||
105984867|NCT01452919|365605967|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
105984868|NCT01452919|365605968|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
105984869|NCT01452919|365605969|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
105984870|NCT01452919|365605967|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
105984871|NCT01452919|365605968|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
105856851|NCT04228783|365126859|FG005|Overall Study|Protocol Violation|0|||
105856852|NCT04228783|365126854|FG000|Overall Study|Withdrawal by Subject|6|||
105856853|NCT04228783|365126855|FG001|Overall Study|Withdrawal by Subject|10|||
105856854|NCT04228783|365126856|FG002|Overall Study|Withdrawal by Subject|19|||
105856855|NCT04228783|365126857|FG003|Overall Study|Withdrawal by Subject|1|||
105856856|NCT04228783|365126858|FG004|Overall Study|Withdrawal by Subject|2|||
105856857|NCT04228783|365126859|FG005|Overall Study|Withdrawal by Subject|0|||
105856858|NCT04228783|365126854|FG000|Overall Study|Other|4|||
105856859|NCT04228783|365126855|FG001|Overall Study|Other|3|||
105856860|NCT04228783|365126856|FG002|Overall Study|Other|2|||
105856861|NCT04228783|365126857|FG003|Overall Study|Other|1|||
105856862|NCT04228783|365126858|FG004|Overall Study|Other|0|||
105856863|NCT04228783|365126859|FG005|Overall Study|Other|0|||
105856864|NCT02266134|365126862|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
105856865|NCT02266134|365126863|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
105856866|NCT02266134|365126864|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
105856867|NCT02266134|365126865|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
105856868|NCT02266134|365126862|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
105856869|NCT02266134|365126863|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
105856870|NCT02266134|365126864|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
105856871|NCT02266134|365126865|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
105856872|NCT02266134|365126862|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
105856873|NCT02266134|365126863|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
105856874|NCT02266134|365126864|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
105856875|NCT02266134|365126865|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
106031150|NCT01087788|365778629|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
106031151|NCT01087788|365778627|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
106031152|NCT01087788|365778628|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
106031153|NCT01087788|365778629|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
106031154|NCT01087788|365778627|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
106031155|NCT01087788|365778628|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
106031156|NCT01087788|365778629|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
106031157|NCT01087788|365778627|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
106031158|NCT01087788|365778628|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
106031159|NCT01087788|365778629|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
106031160|NCT01087788|365778627|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
106031161|NCT01087788|365778628|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
106031162|NCT01087788|365778629|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
106031163|NCT01087788|365778627|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
106031164|NCT01087788|365778628|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
106031165|NCT01087788|365778629|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
106031166|NCT01087788|365778627|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
106031167|NCT01087788|365778628|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
106031168|NCT01087788|365778629|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
106031169|NCT01087788|365778627|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
106031170|NCT01087788|365778628|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
106031171|NCT01087788|365778629|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
106031172|NCT01087788|365778627|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
106031173|NCT01087788|365778628|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
106031174|NCT01087788|365778629|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
106031175|NCT01087788|365778627|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
106031176|NCT01087788|365778628|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
106031177|NCT01087788|365778629|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
106031178|NCT01087788|365778627|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
106031179|NCT01087788|365778628|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
106031180|NCT01087788|365778629|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
106031181|NCT01087788|365778627|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
106031182|NCT01087788|365778628|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
106031183|NCT01087788|365778629|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
106031184|NCT01087788|365778627|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
106031185|NCT01087788|365778628|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
106031186|NCT01087788|365778629|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
106031187|NCT01087788|365778627|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
106031188|NCT01087788|365778628|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
106031189|NCT01087788|365778629|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
106031190|NCT01087788|365778627|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
106031191|NCT01087788|365778628|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
106031192|NCT01087788|365778629|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
106031193|NCT01087788|365778627|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
106031194|NCT01087788|365778628|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
106031195|NCT01087788|365778629|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
106031196|NCT01087788|365778627|FG000|24-weeks Dose-blind Period|Patient moved|0|||
106031197|NCT01087788|365778628|FG001|24-weeks Dose-blind Period|Patient moved|0|||
106031198|NCT01087788|365778629|FG002|24-weeks Dose-blind Period|Patient moved|1|||
106031199|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
106031200|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
106031201|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
106031202|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
106031203|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
106031204|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
106031205|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
106031206|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
106031207|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
106031208|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
106031209|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
106031210|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
106031211|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
106031212|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
106031213|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
106031214|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
106031215|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
106031216|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
106031217|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
106031218|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
106031219|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
106031220|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
106031221|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
106031222|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
106031223|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
106031224|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
106031225|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
106031226|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
106031227|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
106031228|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
106031229|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
106031230|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
106031231|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
106031232|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
106031233|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
106031234|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
106031235|NCT01087788|365778627|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
106031236|NCT01087788|365778628|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
106031237|NCT01087788|365778629|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
106031238|NCT03400956|365778630|FG000|Treatment Period 1|Adverse Event|0|||
106031239|NCT03400956|365778631|FG001|Treatment Period 1|Adverse Event|1|||
106031240|NCT03400956|365778632|FG002|Treatment Period 1|Adverse Event|0|||
106031241|NCT03400956|365778630|FG000|Treatment Period 1|Lost to Follow-up|0|||
106031242|NCT03400956|365778631|FG001|Treatment Period 1|Lost to Follow-up|0|||
106031243|NCT03400956|365778632|FG002|Treatment Period 1|Lost to Follow-up|1|||
106031244|NCT03400956|365778630|FG000|Treatment Period 1|Protocol Violation|0|||
106031245|NCT03400956|365778631|FG001|Treatment Period 1|Protocol Violation|2|||
106031246|NCT03400956|365778632|FG002|Treatment Period 1|Protocol Violation|0|||
106031247|NCT03400956|365778630|FG000|Treatment Period 1|Study terminated by sponsor|3|||
106031248|NCT03400956|365778631|FG001|Treatment Period 1|Study terminated by sponsor|1|||
106031249|NCT03400956|365778632|FG002|Treatment Period 1|Study terminated by sponsor|1|||
106031250|NCT03400956|365778630|FG000|Treatment Period 1|Withdrawal by Subject|0|||
106031251|NCT03400956|365778631|FG001|Treatment Period 1|Withdrawal by Subject|2|||
106031252|NCT03400956|365778632|FG002|Treatment Period 1|Withdrawal by Subject|4|||
106031253|NCT03400956|365778630|FG000|Treatment Period 1|Other|1|||
106031254|NCT03400956|365778631|FG001|Treatment Period 1|Other|2|||
106031255|NCT03400956|365778632|FG002|Treatment Period 1|Other|3|||
106031256|NCT03400956|365778630|FG000|Post-treatment Period 1|Adverse Event|0|||
106031257|NCT03400956|365778631|FG001|Post-treatment Period 1|Adverse Event|0|||
106031258|NCT03400956|365778632|FG002|Post-treatment Period 1|Adverse Event|1|||
106031259|NCT03400956|365778630|FG000|Post-treatment Period 1|Physician Decision|2|||
106031260|NCT03400956|365778631|FG001|Post-treatment Period 1|Physician Decision|3|||
106031261|NCT03400956|365778632|FG002|Post-treatment Period 1|Physician Decision|0|||
106031262|NCT03400956|365778630|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
106031263|NCT03400956|365778631|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
106031264|NCT03400956|365778632|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
106031265|NCT03400956|365778630|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
106031266|NCT03400956|365778631|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
106031267|NCT03400956|365778632|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
106031268|NCT03400956|365778630|FG000|Post-treatment Period 1|Other|4|||
106031269|NCT03400956|365778631|FG001|Post-treatment Period 1|Other|3|||
106031270|NCT03400956|365778632|FG002|Post-treatment Period 1|Other|4|||
106031271|NCT03400956|365778630|FG000|Treatment Period 2|Adverse Event|2|||
106031272|NCT03400956|365778631|FG001|Treatment Period 2|Adverse Event|1|||
106031273|NCT03400956|365778632|FG002|Treatment Period 2|Adverse Event|1|||
106031274|NCT03400956|365778630|FG000|Treatment Period 2|Lost to Follow-up|1|||
106031275|NCT03400956|365778631|FG001|Treatment Period 2|Lost to Follow-up|1|||
106031276|NCT03400956|365778632|FG002|Treatment Period 2|Lost to Follow-up|0|||
106031277|NCT03400956|365778630|FG000|Treatment Period 2|Withdrawal by Subject|0|||
106031278|NCT03400956|365778631|FG001|Treatment Period 2|Withdrawal by Subject|0|||
106031279|NCT03400956|365778632|FG002|Treatment Period 2|Withdrawal by Subject|3|||
106031280|NCT03400956|365778630|FG000|Treatment Period 2|Other|1|||
106031281|NCT03400956|365778631|FG001|Treatment Period 2|Other|1|||
106031282|NCT03400956|365778632|FG002|Treatment Period 2|Other|0|||
106031283|NCT03400956|365778630|FG000|Follow-up Period|Withdrawal by Subject|0|||
106031284|NCT03400956|365778631|FG001|Follow-up Period|Withdrawal by Subject|0|||
106031285|NCT03400956|365778632|FG002|Follow-up Period|Withdrawal by Subject|1|||
106031286|NCT03400956|365778630|FG000|Follow-up Period|Other|0|||
106031287|NCT03400956|365778631|FG001|Follow-up Period|Other|0|||
106031288|NCT03400956|365778632|FG002|Follow-up Period|Other|1|||
106031289|NCT00534313|365778633|FG000|Short-term Period|Adverse Event|1|||
106031290|NCT00534313|365778634|FG001|Short-term Period|Adverse Event|2|||
106031291|NCT00534313|365778635|FG002|Short-term Period|Adverse Event|1|||
106031292|NCT00534313|365778636|FG003|Short-term Period|Adverse Event|3|||
106031293|NCT00534313|365778633|FG000|Short-term Period|Lack of Efficacy|3|||
106031294|NCT00534313|365778634|FG001|Short-term Period|Lack of Efficacy|4|||
106031295|NCT00534313|365778635|FG002|Short-term Period|Lack of Efficacy|0|||
106031296|NCT00534313|365778636|FG003|Short-term Period|Lack of Efficacy|3|||
106031297|NCT00534313|365778633|FG000|Short-term Period|Participant not meeting study criteria|0|||
106031298|NCT00534313|365778634|FG001|Short-term Period|Participant not meeting study criteria|0|||
106031299|NCT00534313|365778635|FG002|Short-term Period|Participant not meeting study criteria|0|||
106031300|NCT00534313|365778636|FG003|Short-term Period|Participant not meeting study criteria|1|||
106031301|NCT00534313|365778633|FG000|Short-term Period|Participant withdrew consent|2|||
106031302|NCT00534313|365778634|FG001|Short-term Period|Participant withdrew consent|0|||
106031303|NCT00534313|365778635|FG002|Short-term Period|Participant withdrew consent|0|||
106031304|NCT00534313|365778636|FG003|Short-term Period|Participant withdrew consent|2|||
106031305|NCT00534313|365778633|FG000|Short-term Period|Pregnancy|0|||
106031306|NCT00534313|365778634|FG001|Short-term Period|Pregnancy|0|||
106031307|NCT00534313|365778635|FG002|Short-term Period|Pregnancy|1|||
106031308|NCT00534313|365778636|FG003|Short-term Period|Pregnancy|0|||
106031309|NCT00534313|365778633|FG000|Long-term Period|Adverse Event|2|||
106031310|NCT00534313|365778634|FG001|Long-term Period|Adverse Event|1|||
106031311|NCT00534313|365778635|FG002|Long-term Period|Adverse Event|0|||
106031312|NCT00534313|365778636|FG003|Long-term Period|Adverse Event|1|||
106031313|NCT00534313|365778633|FG000|Long-term Period|Lack of Efficacy|14|||
106031314|NCT00534313|365778634|FG001|Long-term Period|Lack of Efficacy|10|||
106031315|NCT00534313|365778635|FG002|Long-term Period|Lack of Efficacy|14|||
106031316|NCT00534313|365778636|FG003|Long-term Period|Lack of Efficacy|12|||
106031317|NCT00534313|365778633|FG000|Long-term Period|Lost to Follow-up|1|||
106031318|NCT00534313|365778634|FG001|Long-term Period|Lost to Follow-up|2|||
106031319|NCT00534313|365778635|FG002|Long-term Period|Lost to Follow-up|0|||
106031320|NCT00534313|365778636|FG003|Long-term Period|Lost to Follow-up|0|||
106031321|NCT00534313|365778633|FG000|Long-term Period|Withdrawal by Subject|2|||
106031322|NCT00534313|365778634|FG001|Long-term Period|Withdrawal by Subject|2|||
106031323|NCT00534313|365778635|FG002|Long-term Period|Withdrawal by Subject|0|||
106031324|NCT00534313|365778636|FG003|Long-term Period|Withdrawal by Subject|0|||
106031325|NCT00534313|365778633|FG000|Long-term Period|No longer meets study criteria|0|||
106031326|NCT00534313|365778634|FG001|Long-term Period|No longer meets study criteria|1|||
106031327|NCT00534313|365778635|FG002|Long-term Period|No longer meets study criteria|0|||
106031328|NCT00534313|365778636|FG003|Long-term Period|No longer meets study criteria|0|||
106031329|NCT00534313|365778633|FG000|Long-term Period|Poor compliance/noncompliance|0|||
106031330|NCT00534313|365778634|FG001|Long-term Period|Poor compliance/noncompliance|1|||
106031331|NCT00534313|365778635|FG002|Long-term Period|Poor compliance/noncompliance|1|||
106031332|NCT00534313|365778636|FG003|Long-term Period|Poor compliance/noncompliance|0|||
106031333|NCT00534313|365778633|FG000|Long-term Period|Administrative reason by sponsor|17|||
106031334|NCT00534313|365778634|FG001|Long-term Period|Administrative reason by sponsor|15|||
106031335|NCT00534313|365778635|FG002|Long-term Period|Administrative reason by sponsor|26|||
106031336|NCT00534313|365778636|FG003|Long-term Period|Administrative reason by sponsor|18|||
106031337|NCT00534313|365778633|FG000|Long-term Period|Other|1|||
106031338|NCT00534313|365778634|FG001|Long-term Period|Other|2|||
106031339|NCT00534313|365778635|FG002|Long-term Period|Other|2|||
106031340|NCT00534313|365778636|FG003|Long-term Period|Other|2|||
106031341|NCT03007888|365778637|FG000|First Intervention (14 Days)|Adverse Event|1|||
106031342|NCT03007888|365778638|FG001|First Intervention (14 Days)|Adverse Event|0|||
106031343|NCT01806662|365778639|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
106031344|NCT01806662|365778640|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
106031345|NCT01806662|365778639|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
106031346|NCT01806662|365778640|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
106031347|NCT01806662|365778639|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
106031348|NCT01806662|365778640|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
105856876|NCT02266134|365126862|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
105856877|NCT02266134|365126863|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
106031349|NCT01806662|365778639|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
106031350|NCT01806662|365778640|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
106031351|NCT00043550|365778643|FG000|Overall Study|Withdrawal by Subject|22|||
106031352|NCT00043550|365778644|FG001|Overall Study|Withdrawal by Subject|12|||
106031353|NCT00043550|365778645|FG002|Overall Study|Withdrawal by Subject|20|||
106031354|NCT01917656|365778652|FG000|Overall Study|Adverse Event|11|||
106031355|NCT01917656|365778653|FG001|Overall Study|Adverse Event|0|||
106031356|NCT01917656|365778652|FG000|Overall Study|Withdrawal criteria|8|||
106031357|NCT01917656|365778653|FG001|Overall Study|Withdrawal criteria|14|||
106031358|NCT01917656|365778652|FG000|Overall Study|Unclassified|0|||
106031359|NCT01917656|365778653|FG001|Overall Study|Unclassified|3|||
106031360|NCT01917656|365778652|FG000|Overall Study|Withdrawal by Subject|4|||
106031361|NCT01917656|365778653|FG001|Overall Study|Withdrawal by Subject|3|||
106031362|NCT01917656|365778652|FG000|Overall Study|Lost to Follow-up|3|||
106031363|NCT01917656|365778653|FG001|Overall Study|Lost to Follow-up|4|||
106031364|NCT02081859|365778654|FG000|Overall Study|No fertilization|2|||
106031365|NCT02081859|365778655|FG001|Overall Study|No fertilization|2|||
106031366|NCT02081859|365778654|FG000|Overall Study|No sperm|1|||
106031367|NCT02081859|365778655|FG001|Overall Study|No sperm|0|||
106031368|NCT02081859|365778654|FG000|Overall Study|Unanticipated freeze all cycle|2|||
106031369|NCT02081859|365778655|FG001|Overall Study|Unanticipated freeze all cycle|6|||
106031370|NCT02081859|365778654|FG000|Overall Study|< 4 embryos|27|||
106031371|NCT02081859|365778655|FG001|Overall Study|< 4 embryos|23|||
106031372|NCT02081859|365778654|FG000|Overall Study|Other reasons|2|||
106031373|NCT02081859|365778655|FG001|Overall Study|Other reasons|0|||
106031374|NCT02015221|365778656|FG000|Overall Study|Withdrawal by Subject|8|||
106031375|NCT02015221|365778657|FG001|Overall Study|Withdrawal by Subject|6|||
106031376|NCT02015221|365778656|FG000|Overall Study|Lost to Follow-up|1|||
106031377|NCT02015221|365778657|FG001|Overall Study|Lost to Follow-up|0|||
106031378|NCT00492063|365778658|FG000|Overall Study|Death|0|||
106031379|NCT00492063|365778659|FG001|Overall Study|Death|0|||
106031380|NCT00492063|365778660|FG002|Overall Study|Death|1|||
106031381|NCT00492063|365778661|FG003|Overall Study|Death|2|||
106031382|NCT00492063|365778658|FG000|Overall Study|Withdrawal by Subject|4|||
106031383|NCT00492063|365778659|FG001|Overall Study|Withdrawal by Subject|3|||
106031384|NCT00492063|365778660|FG002|Overall Study|Withdrawal by Subject|5|||
106031385|NCT00492063|365778661|FG003|Overall Study|Withdrawal by Subject|4|||
106031386|NCT00492063|365778658|FG000|Overall Study|Lost to Follow-up|6|||
106031387|NCT00492063|365778659|FG001|Overall Study|Lost to Follow-up|11|||
106031388|NCT00492063|365778660|FG002|Overall Study|Lost to Follow-up|5|||
106031389|NCT00492063|365778661|FG003|Overall Study|Lost to Follow-up|3|||
106031390|NCT00492063|365778658|FG000|Overall Study|Protocol Violation|0|||
106031391|NCT00492063|365778659|FG001|Overall Study|Protocol Violation|0|||
106031392|NCT00492063|365778660|FG002|Overall Study|Protocol Violation|0|||
106031393|NCT00492063|365778661|FG003|Overall Study|Protocol Violation|1|||
106031394|NCT03709576|365778662|FG000|Overall Study|progression prior to enrollment|1|||
106031395|NCT03044574|365778665|FG000|Overall Study|Lost to Follow-up|37|||
106031396|NCT03044574|365778666|FG001|Overall Study|Lost to Follow-up|45|||
106031397|NCT01947855|365778669|FG000|Overall Study|Withdrawal by Subject|1|||
106031398|NCT01947855|365778670|FG001|Overall Study|Withdrawal by Subject|0|||
106031399|NCT01947855|365778671|FG002|Overall Study|Withdrawal by Subject|0|||
106031400|NCT00710762|365778672|FG000|Overall Study|Progressive disease|27|||
106031401|NCT00710762|365778673|FG001|Overall Study|Progressive disease|30|||
106031402|NCT00710762|365778672|FG000|Overall Study|Adverse Event other disease worsening|2|||
106031403|NCT00710762|365778673|FG001|Overall Study|Adverse Event other disease worsening|1|||
106031404|NCT00710762|365778672|FG000|Overall Study|Other Adverse Event|7|||
106031405|NCT00710762|365778673|FG001|Overall Study|Other Adverse Event|7|||
106031406|NCT00710762|365778672|FG000|Overall Study|Lost to Follow-up|1|||
106031407|NCT00710762|365778673|FG001|Overall Study|Lost to Follow-up|0|||
106031408|NCT00710762|365778672|FG000|Overall Study|Reason other than listed above|2|||
106031409|NCT00710762|365778673|FG001|Overall Study|Reason other than listed above|2|||
106031410|NCT00621621|365778677|FG000|Overall Study|Subjects were exited at EP study|30|||
106031411|NCT00621621|365778678|FG001|Overall Study|Subjects were exited at EP study|0|||
106031412|NCT00807573|365778681|FG000|Overall Study|Withdrawal by Subject|1|||
106031413|NCT00807573|365778681|FG000|Overall Study|Adverse Event|1|||
106031414|NCT01037088|365778684|FG000|Overall Study|Withdrawal by Subject|3|||
106031415|NCT02207946|365778685|FG000|Overall Study|Lost to Follow-up|1|||
106031416|NCT02207946|365778686|FG001|Overall Study|Lost to Follow-up|0|||
106031417|NCT02207946|365778685|FG000|Overall Study|Adverse Event|0|||
106031418|NCT02207946|365778686|FG001|Overall Study|Adverse Event|1|||
106031419|NCT02880956|365778691|FG000|Overall Study|Adverse Event|3|||
106031420|NCT02880956|365778692|FG001|Overall Study|Adverse Event|6|||
106031421|NCT02880956|365778693|FG002|Overall Study|Adverse Event|5|||
106031422|NCT02880956|365778694|FG003|Overall Study|Adverse Event|4|||
106031423|NCT02880956|365778691|FG000|Overall Study|Withdrawal by Subject|9|||
106031424|NCT02880956|365778692|FG001|Overall Study|Withdrawal by Subject|4|||
106031425|NCT02880956|365778693|FG002|Overall Study|Withdrawal by Subject|6|||
106031426|NCT02880956|365778694|FG003|Overall Study|Withdrawal by Subject|11|||
106031427|NCT02880956|365778691|FG000|Overall Study|Lost to Follow-up|0|||
106031428|NCT02880956|365778692|FG001|Overall Study|Lost to Follow-up|1|||
106031429|NCT02880956|365778693|FG002|Overall Study|Lost to Follow-up|0|||
106031430|NCT02880956|365778694|FG003|Overall Study|Lost to Follow-up|0|||
106031431|NCT02880956|365778691|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
106031432|NCT02880956|365778692|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
106031433|NCT02880956|365778693|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
106031434|NCT02880956|365778694|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
106031435|NCT02880956|365778691|FG000|Overall Study|Other, Not Specified|4|||
106031436|NCT02880956|365778692|FG001|Overall Study|Other, Not Specified|2|||
106031437|NCT02880956|365778693|FG002|Overall Study|Other, Not Specified|0|||
106031438|NCT02880956|365778694|FG003|Overall Study|Other, Not Specified|3|||
106031439|NCT04236141|365780173|FG000|Overall Study|Death|18|||
106031440|NCT04236141|365780174|FG001|Overall Study|Death|10|||
106031441|NCT04236141|365780173|FG000|Overall Study|Withdrawal by Participant|1|||
106031442|NCT04236141|365780174|FG001|Overall Study|Withdrawal by Participant|0|||
106031443|NCT04236141|365780173|FG000|Overall Study|Reason not Specified|1|||
106031444|NCT04236141|365780174|FG001|Overall Study|Reason not Specified|0|||
106031445|NCT04236141|365780173|FG000|Overall Study|Study terminated by Sponsor|8|||
106031446|NCT04236141|365780174|FG001|Overall Study|Study terminated by Sponsor|4|||
106031447|NCT01925131|365780179|FG000|Overall Study|Death|0|||
106031448|NCT01925131|365780180|FG001|Overall Study|Death|0|||
106031449|NCT01925131|365780181|FG002|Overall Study|Death|1|||
106031450|NCT01925131|365780182|FG003|Overall Study|Death|0|||
106031451|NCT01925131|365780183|FG004|Overall Study|Death|0|||
106031452|NCT01925131|365780184|FG005|Overall Study|Death|0|||
106031453|NCT01925131|365780179|FG000|Overall Study|Progression/Relapse|1|||
106031454|NCT01925131|365780180|FG001|Overall Study|Progression/Relapse|1|||
106031455|NCT01925131|365780181|FG002|Overall Study|Progression/Relapse|4|||
106031456|NCT01925131|365780182|FG003|Overall Study|Progression/Relapse|0|||
106031457|NCT01925131|365780183|FG004|Overall Study|Progression/Relapse|0|||
106031458|NCT01925131|365780184|FG005|Overall Study|Progression/Relapse|1|||
106031459|NCT01925131|365780179|FG000|Overall Study|Patient Refusal|1|||
106031460|NCT01925131|365780180|FG001|Overall Study|Patient Refusal|0|||
106031461|NCT01925131|365780181|FG002|Overall Study|Patient Refusal|0|||
106031462|NCT01925131|365780182|FG003|Overall Study|Patient Refusal|0|||
106031463|NCT01925131|365780183|FG004|Overall Study|Patient Refusal|0|||
106031464|NCT01925131|365780184|FG005|Overall Study|Patient Refusal|0|||
106031465|NCT01925131|365780179|FG000|Overall Study|Adverse Event|0|||
106031466|NCT01925131|365780180|FG001|Overall Study|Adverse Event|0|||
106031467|NCT01925131|365780181|FG002|Overall Study|Adverse Event|2|||
106031468|NCT01925131|365780182|FG003|Overall Study|Adverse Event|0|||
106031469|NCT01925131|365780183|FG004|Overall Study|Adverse Event|1|||
106031470|NCT01925131|365780184|FG005|Overall Study|Adverse Event|3|||
106031471|NCT01925131|365780179|FG000|Overall Study|Other - Not Protocol Specified|3|||
106031472|NCT01925131|365780180|FG001|Overall Study|Other - Not Protocol Specified|1|||
106031473|NCT01925131|365780181|FG002|Overall Study|Other - Not Protocol Specified|2|||
106031474|NCT01925131|365780182|FG003|Overall Study|Other - Not Protocol Specified|5|||
106031475|NCT01925131|365780183|FG004|Overall Study|Other - Not Protocol Specified|10|||
106031476|NCT01925131|365780184|FG005|Overall Study|Other - Not Protocol Specified|6|||
106031477|NCT01948193|365780186|FG000|Overall Study|Serious event|2|||
106031478|NCT01948193|365780186|FG000|Overall Study|Lost to Follow-up|7|||
106031479|NCT03860935|365780187|FG000|Overall Study|Withdrawal of Consent|15|||
106031480|NCT03860935|365780188|FG001|Overall Study|Withdrawal of Consent|6|||
106031481|NCT03860935|365780187|FG000|Overall Study|Death|75|||
106031482|NCT03860935|365780188|FG001|Overall Study|Death|51|||
105856878|NCT02266134|365126864|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
105856879|NCT02266134|365126865|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
105856880|NCT02266134|365126862|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
105856881|NCT02266134|365126863|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
106031483|NCT00775203|365780192|FG000|Overall Study|Adverse Event|25|||
106031484|NCT00775203|365780193|FG001|Overall Study|Adverse Event|6|||
106031485|NCT00775203|365780192|FG000|Overall Study|Lack of Efficacy|8|||
106031486|NCT00775203|365780193|FG001|Overall Study|Lack of Efficacy|9|||
105856882|NCT02266134|365126864|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
105856883|NCT02266134|365126865|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
106031487|NCT00775203|365780192|FG000|Overall Study|Withdrawal by Subject|11|||
106031488|NCT00775203|365780193|FG001|Overall Study|Withdrawal by Subject|9|||
106031489|NCT00775203|365780192|FG000|Overall Study|Lost to Follow-up|11|||
106031490|NCT00775203|365780193|FG001|Overall Study|Lost to Follow-up|15|||
106031491|NCT00775203|365780192|FG000|Overall Study|Administrative reason|2|||
106031492|NCT00775203|365780193|FG001|Overall Study|Administrative reason|0|||
106031493|NCT00775203|365780192|FG000|Overall Study|Noncompliance|4|||
106031494|NCT00775203|365780193|FG001|Overall Study|Noncompliance|2|||
105856884|NCT02266134|365126862|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
105856885|NCT02266134|365126863|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
105856886|NCT02266134|365126864|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
105856887|NCT02266134|365126865|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
105856888|NCT00742924|365126866|FG000|Overall Study|Adverse Event|0|||
105856889|NCT00742924|365126867|FG001|Overall Study|Adverse Event|0|||
105856890|NCT00742924|365126868|FG002|Overall Study|Adverse Event|1|||
105856891|NCT00742924|365126869|FG003|Overall Study|Adverse Event|1|||
105856892|NCT00742924|365126866|FG000|Overall Study|Lack of Efficacy|5|||
105856893|NCT00742924|365126867|FG001|Overall Study|Lack of Efficacy|1|||
105856894|NCT00742924|365126868|FG002|Overall Study|Lack of Efficacy|2|||
105856895|NCT00742924|365126869|FG003|Overall Study|Lack of Efficacy|4|||
105856896|NCT00742924|365126866|FG000|Overall Study|Physician Decision|0|||
105856897|NCT00742924|365126867|FG001|Overall Study|Physician Decision|0|||
105856898|NCT00742924|365126868|FG002|Overall Study|Physician Decision|0|||
105856899|NCT00742924|365126869|FG003|Overall Study|Physician Decision|1|||
105856900|NCT00742924|365126866|FG000|Overall Study|Withdrawal by Subject|0|||
105856901|NCT00742924|365126867|FG001|Overall Study|Withdrawal by Subject|1|||
105856902|NCT00742924|365126868|FG002|Overall Study|Withdrawal by Subject|1|||
105856903|NCT00742924|365126869|FG003|Overall Study|Withdrawal by Subject|0|||
105856904|NCT00660400|365126870|FG000|Overall Study|Lack of insurance approval|1|||
105856905|NCT00660400|365126870|FG000|Overall Study|Suboptimal organ function|1|||
105856906|NCT00660400|365126870|FG000|Overall Study|Intracranial hemorrhage|1|||
105856907|NCT00660400|365126870|FG000|Overall Study|Withdrawal by Subject|1|||
105856908|NCT04647721|365126871|FG000|Overall Study|Withdrawal by Subject|0|||
106031495|NCT00775203|365780192|FG000|Overall Study|Protocol Violation|0|||
106031496|NCT00775203|365780193|FG001|Overall Study|Protocol Violation|1|||
106031497|NCT00775203|365780192|FG000|Overall Study|Entered other study|1|||
106031498|NCT00775203|365780193|FG001|Overall Study|Entered other study|0|||
106031499|NCT00775203|365780192|FG000|Overall Study|Physician Decision|0|||
106031500|NCT00775203|365780193|FG001|Overall Study|Physician Decision|1|||
106031501|NCT00701662|365780194|FG000|Overall Study|Lack of Efficacy|1|||
106031502|NCT00635024|365780197|FG000|Overall Study|Adverse Event|1|||
106031503|NCT02279407|365780198|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
106031504|NCT02279407|365780199|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
106031505|NCT02279407|365780200|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
106031506|NCT02279407|365780201|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
106031507|NCT02279407|365780198|FG000|Overall Study|Withdrawal by Subject|1|||
106031508|NCT02279407|365780199|FG001|Overall Study|Withdrawal by Subject|0|||
106031509|NCT02279407|365780200|FG002|Overall Study|Withdrawal by Subject|1|||
106031510|NCT02279407|365780201|FG003|Overall Study|Withdrawal by Subject|1|||
106031511|NCT02279407|365780198|FG000|Overall Study|Adverse Event|1|||
106031512|NCT02279407|365780199|FG001|Overall Study|Adverse Event|1|||
106031513|NCT02279407|365780200|FG002|Overall Study|Adverse Event|2|||
106031514|NCT02279407|365780201|FG003|Overall Study|Adverse Event|0|||
106031515|NCT05028361|365780203|FG000|Overall Study|Withdrawal by Subject|1|||
106031516|NCT05028361|365780204|FG001|Overall Study|Withdrawal by Subject|0|||
106031517|NCT02122783|365780212|FG000|Overall Study|Adverse Event|0|||
106031518|NCT02122783|365780213|FG001|Overall Study|Adverse Event|1|||
106031519|NCT02239120|365780215|FG000|Overall Study|Death|56|||
106031520|NCT02239120|365780216|FG001|Overall Study|Death|58|||
106031521|NCT02239120|365780215|FG000|Overall Study|Lost to Follow-up|19|||
106031522|NCT02239120|365780216|FG001|Overall Study|Lost to Follow-up|14|||
106031523|NCT02213133|365780217|FG000|Overall Study|Participant discontinued study therapy|2|||
106031524|NCT02213133|365780218|FG001|Overall Study|Participant discontinued study therapy|0|||
106031525|NCT02213133|365780219|FG002|Overall Study|Participant discontinued study therapy|0|||
106031526|NCT02213133|365780217|FG000|Overall Study|Participant withdrew informed consent|2|||
106031527|NCT02213133|365780218|FG001|Overall Study|Participant withdrew informed consent|1|||
106031528|NCT02213133|365780219|FG002|Overall Study|Participant withdrew informed consent|2|||
106031529|NCT02213133|365780217|FG000|Overall Study|Disease progression|11|||
105856909|NCT04647721|365126872|FG001|Overall Study|Withdrawal by Subject|2|||
105856910|NCT04647721|365126871|FG000|Overall Study|Lost to Follow-up|2|||
105856911|NCT04647721|365126872|FG001|Overall Study|Lost to Follow-up|0|||
106031530|NCT02213133|365780218|FG001|Overall Study|Disease progression|2|||
106031531|NCT02213133|365780219|FG002|Overall Study|Disease progression|0|||
106031532|NCT02213133|365780217|FG000|Overall Study|Adverse Event (AE)|1|||
106031533|NCT02213133|365780218|FG001|Overall Study|Adverse Event (AE)|0|||
106031534|NCT02213133|365780219|FG002|Overall Study|Adverse Event (AE)|0|||
106031535|NCT02213133|365780217|FG000|Overall Study|Death|16|||
105856912|NCT03196635|365126875|FG000|Overall Study|Withdrawal by Subject|1|||
105856913|NCT01974440|365126879|FG000|Overall Study|Lost to Follow-up|7|||
105856914|NCT01974440|365126880|FG001|Overall Study|Lost to Follow-up|7|||
105856915|NCT01974440|365126879|FG000|Overall Study|Withdrawal by Subject|24|||
106031536|NCT02213133|365780218|FG001|Overall Study|Death|2|||
106031537|NCT02213133|365780219|FG002|Overall Study|Death|1|||
106031538|NCT02213133|365780217|FG000|Overall Study|Other|5|||
106031539|NCT02213133|365780218|FG001|Overall Study|Other|0|||
106031540|NCT02213133|365780219|FG002|Overall Study|Other|0|||
106031541|NCT01009281|365780232|FG000|Overall Study|Administrative problems|7|||
106031542|NCT01224782|365780233|FG000|Overall Study|Lost to Follow-up|177|||
106031543|NCT01224782|365780233|FG000|Overall Study|Withdrawal by Subject|16|||
106031544|NCT01224782|365780233|FG000|Overall Study|Death|14|||
106031545|NCT01224782|365780233|FG000|Overall Study|Improvement|13|||
106031546|NCT01224782|365780233|FG000|Overall Study|Adverse Event|12|||
106031547|NCT01224782|365780233|FG000|Overall Study|Adverse Reaction|11|||
106031548|NCT01224782|365780233|FG000|Overall Study|Noncompliance|10|||
106031549|NCT01224782|365780233|FG000|Overall Study|Other|4|||
106031550|NCT01224782|365780233|FG000|Overall Study|Start of Dialysis|3|||
106031551|NCT01224782|365780233|FG000|Overall Study|Change of Treatment|1|||
106031552|NCT01224782|365780233|FG000|Overall Study|Financial Reasons|1|||
106031553|NCT01224782|365780233|FG000|Overall Study|Deterioration|1|||
106031554|NCT01224782|365780233|FG000|Overall Study|Transplantation|1|||
106031555|NCT00977080|365780234|FG000|Overall Study|Adverse Event|2|||
106031556|NCT00977080|365780235|FG001|Overall Study|Adverse Event|7|||
106031557|NCT00977080|365780236|FG002|Overall Study|Adverse Event|7|||
106031558|NCT00977080|365780237|FG003|Overall Study|Adverse Event|7|||
106031559|NCT00977080|365780234|FG000|Overall Study|Withdrawal by Subject|1|||
105856916|NCT01974440|365126880|FG001|Overall Study|Withdrawal by Subject|20|||
105856917|NCT01974440|365126879|FG000|Overall Study|Sponsor decision|109|||
105856918|NCT01974440|365126880|FG001|Overall Study|Sponsor decision|110|||
105856919|NCT05084963|365126881|FG000|Overall Study|Withdrawal by Subject|0|||
105856920|NCT05084963|365126882|FG001|Overall Study|Withdrawal by Subject|0|||
105856921|NCT05084963|365126883|FG002|Overall Study|Withdrawal by Subject|1|||
106031560|NCT00977080|365780235|FG001|Overall Study|Withdrawal by Subject|5|||
106031561|NCT00977080|365780236|FG002|Overall Study|Withdrawal by Subject|1|||
105856922|NCT03569228|365126884|FG000|Overall Study|Withdrawal by PI|0|||
105856923|NCT03569228|365126885|FG001|Overall Study|Withdrawal by PI|0|||
105856924|NCT03569228|365126886|FG002|Overall Study|Withdrawal by PI|2|||
105856925|NCT03569228|365126887|FG003|Overall Study|Withdrawal by PI|2|||
105856926|NCT03569228|365126888|FG004|Overall Study|Withdrawal by PI|1|||
106031562|NCT00977080|365780237|FG003|Overall Study|Withdrawal by Subject|5|||
106031563|NCT00977080|365780234|FG000|Overall Study|Protocol Violation|7|||
106031564|NCT00977080|365780235|FG001|Overall Study|Protocol Violation|3|||
106031565|NCT00977080|365780236|FG002|Overall Study|Protocol Violation|4|||
106031566|NCT00977080|365780237|FG003|Overall Study|Protocol Violation|3|||
106031567|NCT00977080|365780234|FG000|Overall Study|Noncompliance|0|||
106031568|NCT00977080|365780235|FG001|Overall Study|Noncompliance|2|||
106031569|NCT00977080|365780236|FG002|Overall Study|Noncompliance|1|||
106031570|NCT00977080|365780237|FG003|Overall Study|Noncompliance|0|||
106031571|NCT00977080|365780234|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
106031572|NCT00977080|365780235|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
106031573|NCT00977080|365780236|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
106031574|NCT00977080|365780237|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
106031575|NCT00977080|365780234|FG000|Overall Study|Required kidney transplantation|1|||
106031576|NCT00977080|365780235|FG001|Overall Study|Required kidney transplantation|3|||
106031577|NCT00977080|365780236|FG002|Overall Study|Required kidney transplantation|3|||
106031578|NCT00977080|365780237|FG003|Overall Study|Required kidney transplantation|1|||
106031579|NCT00977080|365780234|FG000|Overall Study|Travel for family reasons|1|||
105856927|NCT03569228|365126889|FG005|Overall Study|Withdrawal by PI|0|||
105856928|NCT03569228|365126890|FG006|Overall Study|Withdrawal by PI|0|||
106031580|NCT00977080|365780235|FG001|Overall Study|Travel for family reasons|0|||
106031581|NCT00977080|365780236|FG002|Overall Study|Travel for family reasons|0|||
106031582|NCT00977080|365780237|FG003|Overall Study|Travel for family reasons|0|||
106031583|NCT00502203|365780239|FG000|Overall Study|Inevaluable|1|||
106031584|NCT00732940|365780242|FG000|Overall Study|Withdrawal by Subject|1|||
106031585|NCT00732940|365780243|FG001|Overall Study|Withdrawal by Subject|2|||
106031586|NCT00732940|365780242|FG000|Overall Study|Adverse Event|0|||
106031587|NCT00732940|365780243|FG001|Overall Study|Adverse Event|1|||
106031588|NCT00732940|365780242|FG000|Overall Study|Lost to Follow-up|1|||
106031589|NCT00732940|365780243|FG001|Overall Study|Lost to Follow-up|0|||
106031590|NCT02431260|365780244|FG000|Overall Study|Subject Decision|0|||
106031591|NCT02431260|365780245|FG001|Overall Study|Subject Decision|1|||
106031592|NCT02431260|365780246|FG002|Overall Study|Subject Decision|1|||
106031593|NCT02431260|365780247|FG003|Overall Study|Subject Decision|0|||
106031594|NCT02431260|365780248|FG004|Overall Study|Subject Decision|0|||
106031595|NCT02431260|365780249|FG005|Overall Study|Subject Decision|0|||
106031596|NCT02431260|365780250|FG006|Overall Study|Subject Decision|0|||
106031597|NCT02431260|365780251|FG007|Overall Study|Subject Decision|0|||
106031598|NCT02431260|365780252|FG008|Overall Study|Subject Decision|1|||
106031599|NCT02431260|365780253|FG009|Overall Study|Subject Decision|1|||
106031600|NCT02431260|365780254|FG010|Overall Study|Subject Decision|0|||
106031601|NCT02431260|365780255|FG011|Overall Study|Subject Decision|1|||
106031602|NCT02431260|365780256|FG012|Overall Study|Subject Decision|0|||
106031603|NCT02431260|365780257|FG013|Overall Study|Subject Decision|0|||
106031604|NCT02431260|365780244|FG000|Overall Study|Death|4|||
106031605|NCT02431260|365780245|FG001|Overall Study|Death|4|||
106031606|NCT02431260|365780246|FG002|Overall Study|Death|3|||
106031607|NCT02431260|365780247|FG003|Overall Study|Death|4|||
106031608|NCT02431260|365780248|FG004|Overall Study|Death|2|||
106031609|NCT02431260|365780249|FG005|Overall Study|Death|2|||
106031610|NCT02431260|365780250|FG006|Overall Study|Death|3|||
106031611|NCT02431260|365780251|FG007|Overall Study|Death|1|||
106031612|NCT02431260|365780252|FG008|Overall Study|Death|6|||
106031613|NCT02431260|365780253|FG009|Overall Study|Death|6|||
106031614|NCT02431260|365780254|FG010|Overall Study|Death|3|||
106031615|NCT02431260|365780255|FG011|Overall Study|Death|2|||
106031616|NCT02431260|365780256|FG012|Overall Study|Death|5|||
106031617|NCT02431260|365780257|FG013|Overall Study|Death|1|||
106031618|NCT02431260|365780244|FG000|Overall Study|Lost to Follow-up|0|||
106031619|NCT02431260|365780245|FG001|Overall Study|Lost to Follow-up|0|||
106031620|NCT02431260|365780246|FG002|Overall Study|Lost to Follow-up|0|||
106031621|NCT02431260|365780247|FG003|Overall Study|Lost to Follow-up|0|||
106031622|NCT02431260|365780248|FG004|Overall Study|Lost to Follow-up|0|||
106031623|NCT02431260|365780249|FG005|Overall Study|Lost to Follow-up|1|||
106031624|NCT02431260|365780250|FG006|Overall Study|Lost to Follow-up|0|||
106031625|NCT02431260|365780251|FG007|Overall Study|Lost to Follow-up|0|||
106031626|NCT02431260|365780252|FG008|Overall Study|Lost to Follow-up|0|||
106031627|NCT02431260|365780253|FG009|Overall Study|Lost to Follow-up|0|||
106031628|NCT02431260|365780254|FG010|Overall Study|Lost to Follow-up|0|||
106031629|NCT02431260|365780255|FG011|Overall Study|Lost to Follow-up|0|||
106031630|NCT02431260|365780256|FG012|Overall Study|Lost to Follow-up|0|||
106031631|NCT02431260|365780257|FG013|Overall Study|Lost to Follow-up|0|||
106031632|NCT02431260|365780244|FG000|Overall Study|Study Terminated by the Sponsor|0|||
106031633|NCT02431260|365780245|FG001|Overall Study|Study Terminated by the Sponsor|0|||
106031634|NCT02431260|365780246|FG002|Overall Study|Study Terminated by the Sponsor|2|||
105856929|NCT03569228|365126891|FG007|Overall Study|Withdrawal by PI|0|||
105856930|NCT03569228|365126892|FG008|Overall Study|Withdrawal by PI|0|||
106031635|NCT02431260|365780247|FG003|Overall Study|Study Terminated by the Sponsor|1|||
106031636|NCT02431260|365780248|FG004|Overall Study|Study Terminated by the Sponsor|1|||
106031637|NCT02431260|365780249|FG005|Overall Study|Study Terminated by the Sponsor|0|||
106031638|NCT02431260|365780250|FG006|Overall Study|Study Terminated by the Sponsor|1|||
106031639|NCT02431260|365780251|FG007|Overall Study|Study Terminated by the Sponsor|2|||
106031640|NCT02431260|365780252|FG008|Overall Study|Study Terminated by the Sponsor|1|||
106031641|NCT02431260|365780253|FG009|Overall Study|Study Terminated by the Sponsor|1|||
106031642|NCT02431260|365780254|FG010|Overall Study|Study Terminated by the Sponsor|1|||
106031643|NCT02431260|365780255|FG011|Overall Study|Study Terminated by the Sponsor|0|||
106031644|NCT02431260|365780256|FG012|Overall Study|Study Terminated by the Sponsor|4|||
106031645|NCT02431260|365780257|FG013|Overall Study|Study Terminated by the Sponsor|0|||
106031646|NCT02431260|365780244|FG000|Overall Study|Physician Decision|0|||
106031647|NCT02431260|365780245|FG001|Overall Study|Physician Decision|0|||
106031648|NCT02431260|365780246|FG002|Overall Study|Physician Decision|0|||
106031649|NCT02431260|365780247|FG003|Overall Study|Physician Decision|0|||
106031650|NCT02431260|365780248|FG004|Overall Study|Physician Decision|0|||
106031651|NCT02431260|365780249|FG005|Overall Study|Physician Decision|1|||
106031652|NCT02431260|365780250|FG006|Overall Study|Physician Decision|0|||
106031653|NCT02431260|365780251|FG007|Overall Study|Physician Decision|0|||
106031654|NCT02431260|365780252|FG008|Overall Study|Physician Decision|0|||
106031655|NCT02431260|365780253|FG009|Overall Study|Physician Decision|0|||
106031656|NCT02431260|365780254|FG010|Overall Study|Physician Decision|0|||
106031657|NCT02431260|365780255|FG011|Overall Study|Physician Decision|0|||
106031658|NCT02431260|365780256|FG012|Overall Study|Physician Decision|0|||
106031659|NCT02431260|365780257|FG013|Overall Study|Physician Decision|0|||
106031660|NCT02431260|365780244|FG000|Overall Study|Other Unspecified|0|||
106031661|NCT02431260|365780245|FG001|Overall Study|Other Unspecified|0|||
106031662|NCT02431260|365780246|FG002|Overall Study|Other Unspecified|0|||
106031663|NCT02431260|365780247|FG003|Overall Study|Other Unspecified|0|||
106031664|NCT02431260|365780248|FG004|Overall Study|Other Unspecified|0|||
106031665|NCT02431260|365780249|FG005|Overall Study|Other Unspecified|0|||
106031666|NCT02431260|365780250|FG006|Overall Study|Other Unspecified|0|||
106031667|NCT02431260|365780251|FG007|Overall Study|Other Unspecified|0|||
106031668|NCT02431260|365780252|FG008|Overall Study|Other Unspecified|0|||
106031669|NCT02431260|365780253|FG009|Overall Study|Other Unspecified|0|||
106031670|NCT02431260|365780254|FG010|Overall Study|Other Unspecified|0|||
106031671|NCT02431260|365780255|FG011|Overall Study|Other Unspecified|1|||
106031672|NCT02431260|365780256|FG012|Overall Study|Other Unspecified|1|||
106031673|NCT02431260|365780257|FG013|Overall Study|Other Unspecified|0|||
106031674|NCT00308581|365780259|FG000|Induction Phase|Adverse Event|0|||
106031675|NCT00308581|365780260|FG001|Induction Phase|Adverse Event|0|||
106031676|NCT00308581|365780261|FG002|Induction Phase|Adverse Event|37|||
106031677|NCT00308581|365780259|FG000|Induction Phase|Lack of Efficacy|0|||
106031678|NCT00308581|365780260|FG001|Induction Phase|Lack of Efficacy|0|||
106031679|NCT00308581|365780261|FG002|Induction Phase|Lack of Efficacy|121|||
106031680|NCT00308581|365780259|FG000|Induction Phase|Withdrawal by Subject|0|||
106031681|NCT00308581|365780260|FG001|Induction Phase|Withdrawal by Subject|0|||
106031682|NCT00308581|365780261|FG002|Induction Phase|Withdrawal by Subject|5|||
106031683|NCT00308581|365780259|FG000|Induction Phase|Unknown reason|0|||
106031684|NCT00308581|365780260|FG001|Induction Phase|Unknown reason|0|||
106031685|NCT00308581|365780261|FG002|Induction Phase|Unknown reason|3|||
106031686|NCT00308581|365780259|FG000|Randomized Maintenance Phase|Adverse Event|10|||
106031687|NCT00308581|365780260|FG001|Randomized Maintenance Phase|Adverse Event|17|||
106031688|NCT00308581|365780261|FG002|Randomized Maintenance Phase|Adverse Event|0|||
106031689|NCT00308581|365780259|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
106031690|NCT00308581|365780260|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
106031691|NCT00308581|365780261|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
106031692|NCT00308581|365780259|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
106031693|NCT00308581|365780260|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
106031694|NCT00308581|365780261|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
106031695|NCT00308581|365780259|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
106031696|NCT00308581|365780260|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
106031697|NCT00308581|365780261|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
106031698|NCT00308581|365780259|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
106031699|NCT00308581|365780260|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
106031700|NCT00308581|365780261|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
106031701|NCT00308581|365780259|FG000|Randomized Maintenance Phase|Unknown reason|3|||
106031702|NCT00308581|365780260|FG001|Randomized Maintenance Phase|Unknown reason|0|||
106031703|NCT00308581|365780261|FG002|Randomized Maintenance Phase|Unknown reason|0|||
106031704|NCT00899353|365780262|FG000|Overall Study|Adverse Event|2|||
106031705|NCT00899353|365780262|FG000|Overall Study|Lost to Follow-up|1|||
106031706|NCT00899353|365780262|FG000|Overall Study|Withdrawal by Subject|2|||
106031707|NCT00436501|365780268|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
106031708|NCT00436501|365780269|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
106031709|NCT00436501|365780268|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
106031710|NCT00436501|365780269|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
106031711|NCT00495040|365780271|FG000|Overall Study|Withdrawal by Subject|3|||
106031712|NCT01700439|365780272|FG000|Overall Study|Lost to Follow-up|47|||
106031713|NCT01700439|365780272|FG000|Overall Study|Withdrawal by Subject|183|||
106031714|NCT01700439|365780272|FG000|Overall Study|Death|186|||
106031715|NCT01892384|365780273|FG000|Overall Study|Withdrawal by Subject|1|||
106031716|NCT01892384|365780274|FG001|Overall Study|Withdrawal by Subject|1|||
106031717|NCT01892384|365780275|FG002|Overall Study|Withdrawal by Subject|0|||
106031718|NCT01892384|365780276|FG003|Overall Study|Withdrawal by Subject|0|||
106031719|NCT02518464|365780277|FG000|Overall Study|Adverse Event|2|||
106031720|NCT01829243|365780284|FG000|First Intervention|Screen Failure|4|||
106031721|NCT01829243|365780285|FG001|First Intervention|Screen Failure|2|||
106031722|NCT00608569|365780289|FG000|Overall Study|Death|4|||
106031723|NCT00608569|365780290|FG001|Overall Study|Death|3|||
106031724|NCT00608569|365780289|FG000|Overall Study|Lost to Follow-up|4|||
106031725|NCT00608569|365780290|FG001|Overall Study|Lost to Follow-up|5|||
106031726|NCT00608569|365780289|FG000|Overall Study|Withdrawal by Subject|1|||
106031727|NCT00608569|365780290|FG001|Overall Study|Withdrawal by Subject|0|||
106031728|NCT00608569|365780289|FG000|Overall Study|Adverse Event|1|||
106031729|NCT00608569|365780290|FG001|Overall Study|Adverse Event|0|||
106031730|NCT00608569|365780289|FG000|Overall Study|Unable to adhere with study requirements|0|||
106031731|NCT00608569|365780290|FG001|Overall Study|Unable to adhere with study requirements|1|||
105856931|NCT03569228|365126884|FG000|Overall Study|Lost to Follow-up|0|||
106031732|NCT02312687|365780304|FG000|Overall Study|Other, Not Specified|1|||
106031733|NCT01606878|365780306|FG000|Overall Study|Adverse Event|1|||
106031734|NCT01606878|365780307|FG001|Overall Study|Adverse Event|1|||
106031735|NCT01606878|365780308|FG002|Overall Study|Adverse Event|0|||
106031736|NCT01606878|365780309|FG003|Overall Study|Adverse Event|0|||
106031737|NCT01606878|365780310|FG004|Overall Study|Adverse Event|0|||
106031738|NCT01606878|365780311|FG005|Overall Study|Adverse Event|0|||
106031739|NCT01606878|365780312|FG006|Overall Study|Adverse Event|1|||
106031740|NCT01606878|365780313|FG007|Overall Study|Adverse Event|0|||
106031741|NCT01606878|365780314|FG008|Overall Study|Adverse Event|1|||
106031742|NCT01606878|365780315|FG009|Overall Study|Adverse Event|3|||
106031743|NCT01606878|365780316|FG010|Overall Study|Adverse Event|0|||
106031744|NCT01606878|365780306|FG000|Overall Study|Lack of Efficacy|1|||
106031745|NCT01606878|365780307|FG001|Overall Study|Lack of Efficacy|1|||
106031746|NCT01606878|365780308|FG002|Overall Study|Lack of Efficacy|1|||
106031747|NCT01606878|365780309|FG003|Overall Study|Lack of Efficacy|2|||
106031748|NCT01606878|365780310|FG004|Overall Study|Lack of Efficacy|1|||
106031749|NCT01606878|365780311|FG005|Overall Study|Lack of Efficacy|2|||
106031750|NCT01606878|365780312|FG006|Overall Study|Lack of Efficacy|1|||
106031751|NCT01606878|365780313|FG007|Overall Study|Lack of Efficacy|2|||
106031752|NCT01606878|365780314|FG008|Overall Study|Lack of Efficacy|2|||
106031753|NCT01606878|365780315|FG009|Overall Study|Lack of Efficacy|0|||
106031754|NCT01606878|365780316|FG010|Overall Study|Lack of Efficacy|1|||
106031755|NCT01606878|365780306|FG000|Overall Study|Physician Decision|1|||
106031756|NCT01606878|365780307|FG001|Overall Study|Physician Decision|0|||
106031757|NCT01606878|365780308|FG002|Overall Study|Physician Decision|2|||
106031758|NCT01606878|365780309|FG003|Overall Study|Physician Decision|1|||
106031759|NCT01606878|365780310|FG004|Overall Study|Physician Decision|1|||
106031760|NCT01606878|365780311|FG005|Overall Study|Physician Decision|1|||
106031761|NCT01606878|365780312|FG006|Overall Study|Physician Decision|2|||
106031762|NCT01606878|365780313|FG007|Overall Study|Physician Decision|0|||
106031763|NCT01606878|365780314|FG008|Overall Study|Physician Decision|1|||
106031764|NCT01606878|365780315|FG009|Overall Study|Physician Decision|0|||
106031765|NCT01606878|365780316|FG010|Overall Study|Physician Decision|0|||
106031766|NCT01606878|365780306|FG000|Overall Study|Withdrawal by Subject|3|||
106031767|NCT01606878|365780307|FG001|Overall Study|Withdrawal by Subject|2|||
106031768|NCT01606878|365780308|FG002|Overall Study|Withdrawal by Subject|2|||
106031769|NCT01606878|365780309|FG003|Overall Study|Withdrawal by Subject|0|||
106031770|NCT01606878|365780310|FG004|Overall Study|Withdrawal by Subject|1|||
106031771|NCT01606878|365780311|FG005|Overall Study|Withdrawal by Subject|1|||
106031772|NCT01606878|365780312|FG006|Overall Study|Withdrawal by Subject|2|||
106031773|NCT01606878|365780313|FG007|Overall Study|Withdrawal by Subject|1|||
106031774|NCT01606878|365780314|FG008|Overall Study|Withdrawal by Subject|2|||
106031775|NCT01606878|365780315|FG009|Overall Study|Withdrawal by Subject|0|||
106031776|NCT01606878|365780316|FG010|Overall Study|Withdrawal by Subject|2|||
106031777|NCT00278915|365780317|FG000|Overall Study|Disease progression|1|||
106031778|NCT03353740|365780318|FG000|Overall Study|Images for these participants not viable|52|||
106031779|NCT03473548|365780319|FG000|Overall Study|Did not attempt HST testing|3|||
106031780|NCT03473548|365780320|FG001|Overall Study|Did not attempt HST testing|0|||
106031781|NCT02545543|365780324|FG000|Overall Study|Lost to Follow-up|67|||
106031782|NCT02545543|365780325|FG001|Overall Study|Lost to Follow-up|25|||
106031783|NCT02545543|365780324|FG000|Overall Study|Physician Decision|3|||
106031784|NCT02545543|365780325|FG001|Overall Study|Physician Decision|0|||
106031785|NCT02545543|365780324|FG000|Overall Study|Withdrawal by Subject|9|||
106031786|NCT02545543|365780325|FG001|Overall Study|Withdrawal by Subject|8|||
106031787|NCT02545543|365780324|FG000|Overall Study|Noncomplaince|1|||
106031788|NCT02545543|365780325|FG001|Overall Study|Noncomplaince|0|||
106031789|NCT02545543|365780324|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
106031790|NCT02545543|365780325|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
106031791|NCT01155167|365780326|FG000|Overall Study|Insufficient ultrasound data|2|||
106031792|NCT01155167|365780327|FG001|Overall Study|Insufficient ultrasound data|0|||
106031793|NCT01155167|365780326|FG000|Overall Study|Access site changed to femoral artery|1|||
106031794|NCT01155167|365780327|FG001|Overall Study|Access site changed to femoral artery|0|||
106031795|NCT00167778|365780328|FG000|Overall Study|Withdrawal by Subject|1|||
106031796|NCT02654717|365780329|FG000|Overall Study|Adverse Event|2|||
106031797|NCT02654717|365780330|FG001|Overall Study|Adverse Event|2|||
106031798|NCT02654717|365780329|FG000|Overall Study|Protocol Violation|1|||
106031799|NCT02654717|365780330|FG001|Overall Study|Protocol Violation|2|||
106031800|NCT02654717|365780329|FG000|Overall Study|Withdrawal by Subject|0|||
106031801|NCT02654717|365780330|FG001|Overall Study|Withdrawal by Subject|1|||
106031802|NCT02654717|365780329|FG000|Overall Study|Non-permitted medication|3|||
106031803|NCT02654717|365780330|FG001|Overall Study|Non-permitted medication|0|||
106031804|NCT01395784|365780331|FG000|Overall Study|Lost to Follow-up|7|||
106031805|NCT01395784|365780331|FG000|Overall Study|Withdrawal by Subject|3|||
106031806|NCT01395784|365780331|FG000|Overall Study|Physician Decision|5|||
106031807|NCT02055365|365782120|FG000|Overall Study|Prematurely Withdrawn|1|||
106031808|NCT04966910|365782123|FG000|Baseline|Participant did not complete measure|0|||
106031809|NCT04966910|365782124|FG001|Baseline|Participant did not complete measure|0|||
106031810|NCT04966910|365782125|FG002|Baseline|Participant did not complete measure|1|||
106031811|NCT04966910|365782126|FG003|Baseline|Participant did not complete measure|0|||
106031812|NCT04966910|365782123|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
106031813|NCT04966910|365782124|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
106031814|NCT04966910|365782125|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
106031815|NCT04966910|365782126|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
106031816|NCT04966910|365782123|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
106031817|NCT04966910|365782124|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
106031818|NCT04966910|365782125|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
106031819|NCT04966910|365782126|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
106031820|NCT04966910|365782123|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
106031821|NCT04966910|365782124|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
106031822|NCT04966910|365782125|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
106031823|NCT04966910|365782126|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
106031824|NCT03811093|365782127|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
106031825|NCT03811093|365782128|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
106031826|NCT03811093|365782127|FG000|Overall Study|Unable to measure body fat percentage|2|||
106031827|NCT03811093|365782128|FG001|Overall Study|Unable to measure body fat percentage|0|||
106031828|NCT01350544|365782129|FG000|Overall Study|Administrative Withdrawal|0|||
106031829|NCT01350544|365782130|FG001|Overall Study|Administrative Withdrawal|1|||
106031830|NCT01350544|365782129|FG000|Overall Study|Death|1|||
106031831|NCT01350544|365782130|FG001|Overall Study|Death|2|||
106031832|NCT01350544|365782129|FG000|Overall Study|Moved out of LA County|2|||
106031833|NCT01350544|365782130|FG001|Overall Study|Moved out of LA County|2|||
106031834|NCT01350544|365782129|FG000|Overall Study|Medical Issues|1|||
106031835|NCT01350544|365782130|FG001|Overall Study|Medical Issues|1|||
106031836|NCT01350544|365782129|FG000|Overall Study|Withdrawal by Subject|0|||
106031837|NCT01350544|365782130|FG001|Overall Study|Withdrawal by Subject|1|||
106031838|NCT01350544|365782129|FG000|Overall Study|Incarceration|1|||
106031839|NCT01350544|365782130|FG001|Overall Study|Incarceration|0|||
106031840|NCT01350544|365782129|FG000|Overall Study|Lost to Follow-up|18|||
106031841|NCT01350544|365782130|FG001|Overall Study|Lost to Follow-up|15|||
106031842|NCT04456673|365782140|FG000|Overall Study|Adverse Event|7|||
106031843|NCT04456673|365782141|FG001|Overall Study|Adverse Event|14|||
106031844|NCT04456673|365782140|FG000|Overall Study|Poor compliance to protocol|1|||
106031845|NCT04456673|365782141|FG001|Overall Study|Poor compliance to protocol|0|||
106031846|NCT04456673|365782140|FG000|Overall Study|Withdrawal by Subject|31|||
106031847|NCT04456673|365782141|FG001|Overall Study|Withdrawal by Subject|23|||
106031848|NCT04456673|365782140|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
106031849|NCT04456673|365782141|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
106031850|NCT00779259|365782142|FG000|Quinine Alone|Adverse Event|2|||
106031851|NCT04575597|365782143|FG000|Overall Study|Death|0|||
106031852|NCT04575597|365782144|FG001|Overall Study|Death|0|||
106031853|NCT04575597|365782145|FG002|Overall Study|Death|0|||
106031854|NCT04575597|365782146|FG003|Overall Study|Death|1|||
106031855|NCT04575597|365782147|FG004|Overall Study|Death|3|||
106031856|NCT04575597|365782148|FG005|Overall Study|Death|14|||
106031857|NCT04575597|365782143|FG000|Overall Study|Lost to Follow-up|2|||
106031858|NCT04575597|365782144|FG001|Overall Study|Lost to Follow-up|1|||
106031859|NCT04575597|365782145|FG002|Overall Study|Lost to Follow-up|1|||
106031860|NCT04575597|365782146|FG003|Overall Study|Lost to Follow-up|2|||
106031861|NCT04575597|365782147|FG004|Overall Study|Lost to Follow-up|10|||
106031862|NCT04575597|365782148|FG005|Overall Study|Lost to Follow-up|8|||
106031863|NCT04575597|365782143|FG000|Overall Study|Withdrawal by Subject|2|||
106031864|NCT04575597|365782144|FG001|Overall Study|Withdrawal by Subject|2|||
106031865|NCT04575597|365782145|FG002|Overall Study|Withdrawal by Subject|4|||
106031866|NCT04575597|365782146|FG003|Overall Study|Withdrawal by Subject|2|||
106031867|NCT04575597|365782147|FG004|Overall Study|Withdrawal by Subject|25|||
106031868|NCT04575597|365782148|FG005|Overall Study|Withdrawal by Subject|28|||
106031869|NCT04575597|365782143|FG000|Overall Study|Not Recorded|0|||
106031870|NCT04575597|365782144|FG001|Overall Study|Not Recorded|0|||
106031871|NCT04575597|365782145|FG002|Overall Study|Not Recorded|0|||
106031872|NCT04575597|365782146|FG003|Overall Study|Not Recorded|0|||
106031873|NCT04575597|365782147|FG004|Overall Study|Not Recorded|0|||
106031874|NCT04575597|365782148|FG005|Overall Study|Not Recorded|2|||
106031875|NCT04575597|365782143|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106031876|NCT04575597|365782144|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106031877|NCT04575597|365782145|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106031878|NCT04575597|365782146|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106031879|NCT04575597|365782147|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
106031880|NCT04575597|365782148|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
106031881|NCT02095132|365782152|FG000|Overall Study|Adverse Event|0|||
106031882|NCT02095132|365782153|FG001|Overall Study|Adverse Event|0|||
106031883|NCT02095132|365782154|FG002|Overall Study|Adverse Event|0|||
106031884|NCT02095132|365782155|FG003|Overall Study|Adverse Event|0|||
106031885|NCT02095132|365782156|FG004|Overall Study|Adverse Event|1|||
106031886|NCT02095132|365782157|FG005|Overall Study|Adverse Event|0|||
106031887|NCT02095132|365782158|FG006|Overall Study|Adverse Event|1|||
106031888|NCT02095132|365782159|FG007|Overall Study|Adverse Event|0|||
106031889|NCT02095132|365782160|FG008|Overall Study|Adverse Event|0|||
106031890|NCT02095132|365782152|FG000|Overall Study|Death|0|||
106031891|NCT02095132|365782153|FG001|Overall Study|Death|0|||
106031892|NCT02095132|365782154|FG002|Overall Study|Death|0|||
106031893|NCT02095132|365782155|FG003|Overall Study|Death|0|||
106031894|NCT02095132|365782156|FG004|Overall Study|Death|0|||
106031895|NCT02095132|365782157|FG005|Overall Study|Death|0|||
106031896|NCT02095132|365782158|FG006|Overall Study|Death|1|||
106031897|NCT02095132|365782159|FG007|Overall Study|Death|0|||
106031898|NCT02095132|365782160|FG008|Overall Study|Death|0|||
106031899|NCT02095132|365782152|FG000|Overall Study|Lack of Efficacy|3|||
106031900|NCT02095132|365782153|FG001|Overall Study|Lack of Efficacy|5|||
106031901|NCT02095132|365782154|FG002|Overall Study|Lack of Efficacy|2|||
106031902|NCT02095132|365782155|FG003|Overall Study|Lack of Efficacy|8|||
106031903|NCT02095132|365782156|FG004|Overall Study|Lack of Efficacy|3|||
106031904|NCT02095132|365782157|FG005|Overall Study|Lack of Efficacy|6|||
106031905|NCT02095132|365782158|FG006|Overall Study|Lack of Efficacy|10|||
106031906|NCT02095132|365782159|FG007|Overall Study|Lack of Efficacy|9|||
106031907|NCT02095132|365782160|FG008|Overall Study|Lack of Efficacy|8|||
106031908|NCT02095132|365782152|FG000|Overall Study|Physician Decision|1|||
106031909|NCT02095132|365782153|FG001|Overall Study|Physician Decision|0|||
106031910|NCT02095132|365782154|FG002|Overall Study|Physician Decision|0|||
106031911|NCT02095132|365782155|FG003|Overall Study|Physician Decision|0|||
106031912|NCT02095132|365782156|FG004|Overall Study|Physician Decision|0|||
106031913|NCT02095132|365782157|FG005|Overall Study|Physician Decision|0|||
106031914|NCT02095132|365782158|FG006|Overall Study|Physician Decision|1|||
106031915|NCT02095132|365782159|FG007|Overall Study|Physician Decision|0|||
106031916|NCT02095132|365782160|FG008|Overall Study|Physician Decision|2|||
106031917|NCT02095132|365782152|FG000|Overall Study|Withdrawal by Subject|0|||
106031918|NCT02095132|365782153|FG001|Overall Study|Withdrawal by Subject|0|||
106031919|NCT02095132|365782154|FG002|Overall Study|Withdrawal by Subject|2|||
106031920|NCT02095132|365782155|FG003|Overall Study|Withdrawal by Subject|2|||
106031921|NCT02095132|365782156|FG004|Overall Study|Withdrawal by Subject|3|||
106031922|NCT02095132|365782157|FG005|Overall Study|Withdrawal by Subject|0|||
106031923|NCT02095132|365782158|FG006|Overall Study|Withdrawal by Subject|5|||
106031924|NCT02095132|365782159|FG007|Overall Study|Withdrawal by Subject|0|||
106031925|NCT02095132|365782160|FG008|Overall Study|Withdrawal by Subject|0|||
106031926|NCT02108262|365782163|FG000|Overall Study|Non-compliance|0|||
106031927|NCT02108262|365782164|FG001|Overall Study|Non-compliance|2|||
106031928|NCT02108262|365782165|FG002|Overall Study|Non-compliance|1|||
106031929|NCT02108262|365782166|FG003|Overall Study|Non-compliance|1|||
106031930|NCT02108262|365782163|FG000|Overall Study|Randomized by error/screen failure|0|||
106031931|NCT02108262|365782164|FG001|Overall Study|Randomized by error/screen failure|0|||
106031932|NCT02108262|365782165|FG002|Overall Study|Randomized by error/screen failure|1|||
106031933|NCT02108262|365782166|FG003|Overall Study|Randomized by error/screen failure|0|||
106031934|NCT02108262|365782163|FG000|Overall Study|Distance to center|0|||
106031935|NCT02108262|365782164|FG001|Overall Study|Distance to center|1|||
106031936|NCT02108262|365782165|FG002|Overall Study|Distance to center|1|||
106031937|NCT02108262|365782166|FG003|Overall Study|Distance to center|0|||
106031938|NCT02108262|365782163|FG000|Overall Study|Adverse Event|0|||
106031939|NCT02108262|365782164|FG001|Overall Study|Adverse Event|11|||
106031940|NCT02108262|365782165|FG002|Overall Study|Adverse Event|6|||
106031941|NCT02108262|365782166|FG003|Overall Study|Adverse Event|12|||
106031942|NCT02108262|365782163|FG000|Overall Study|Death|0|||
106031943|NCT02108262|365782164|FG001|Overall Study|Death|2|||
106031944|NCT02108262|365782165|FG002|Overall Study|Death|2|||
106031945|NCT02108262|365782166|FG003|Overall Study|Death|1|||
106031946|NCT02108262|365782163|FG000|Overall Study|Lost to Follow-up|0|||
106031947|NCT02108262|365782164|FG001|Overall Study|Lost to Follow-up|0|||
106031948|NCT02108262|365782165|FG002|Overall Study|Lost to Follow-up|1|||
106031949|NCT02108262|365782166|FG003|Overall Study|Lost to Follow-up|0|||
106031950|NCT02108262|365782163|FG000|Overall Study|Physician Decision|0|||
106031951|NCT02108262|365782164|FG001|Overall Study|Physician Decision|0|||
106031952|NCT02108262|365782165|FG002|Overall Study|Physician Decision|2|||
106031953|NCT02108262|365782166|FG003|Overall Study|Physician Decision|0|||
106031954|NCT02108262|365782163|FG000|Overall Study|Withdrawal by Subject|0|||
106031955|NCT02108262|365782164|FG001|Overall Study|Withdrawal by Subject|7|||
106031956|NCT02108262|365782165|FG002|Overall Study|Withdrawal by Subject|3|||
106031957|NCT02108262|365782166|FG003|Overall Study|Withdrawal by Subject|4|||
106031958|NCT02108262|365782163|FG000|Overall Study|Due to key hepatic values|0|||
106031959|NCT02108262|365782164|FG001|Overall Study|Due to key hepatic values|1|||
106031960|NCT02108262|365782165|FG002|Overall Study|Due to key hepatic values|0|||
106031961|NCT02108262|365782166|FG003|Overall Study|Due to key hepatic values|0|||
106031962|NCT02108262|365782163|FG000|Overall Study|Unable to contact patient|0|||
106031963|NCT02108262|365782164|FG001|Overall Study|Unable to contact patient|3|||
106031964|NCT02108262|365782165|FG002|Overall Study|Unable to contact patient|1|||
106031965|NCT02108262|365782166|FG003|Overall Study|Unable to contact patient|2|||
106031966|NCT02108262|365782163|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
106031967|NCT02108262|365782164|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
106031968|NCT02108262|365782165|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
106031969|NCT02108262|365782166|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
106031970|NCT02108262|365782163|FG000|Overall Study|Patient did not want another infusion|0|||
106031971|NCT02108262|365782164|FG001|Overall Study|Patient did not want another infusion|3|||
106031972|NCT02108262|365782165|FG002|Overall Study|Patient did not want another infusion|3|||
106031973|NCT02108262|365782166|FG003|Overall Study|Patient did not want another infusion|2|||
106031974|NCT02108262|365782163|FG000|Overall Study|Vacation|0|||
106031975|NCT02108262|365782164|FG001|Overall Study|Vacation|1|||
106031976|NCT02108262|365782165|FG002|Overall Study|Vacation|0|||
106031977|NCT02108262|365782166|FG003|Overall Study|Vacation|0|||
106031978|NCT02108262|365782163|FG000|Overall Study|Patient decision|0|||
106031979|NCT02108262|365782164|FG001|Overall Study|Patient decision|7|||
106031980|NCT02108262|365782165|FG002|Overall Study|Patient decision|9|||
105856932|NCT03569228|365126885|FG001|Overall Study|Lost to Follow-up|0|||
105856933|NCT03569228|365126886|FG002|Overall Study|Lost to Follow-up|0|||
105856934|NCT03569228|365126887|FG003|Overall Study|Lost to Follow-up|0|||
105856935|NCT03569228|365126888|FG004|Overall Study|Lost to Follow-up|0|||
106031981|NCT02108262|365782166|FG003|Overall Study|Patient decision|14|||
105856936|NCT03569228|365126889|FG005|Overall Study|Lost to Follow-up|0|||
105856937|NCT03569228|365126890|FG006|Overall Study|Lost to Follow-up|0|||
105856938|NCT03569228|365126891|FG007|Overall Study|Lost to Follow-up|0|||
106031982|NCT02108262|365782163|FG000|Overall Study|Missed IV due to pharmacy error|0|||
106031983|NCT02108262|365782164|FG001|Overall Study|Missed IV due to pharmacy error|0|||
106031984|NCT02108262|365782165|FG002|Overall Study|Missed IV due to pharmacy error|1|||
106031985|NCT02108262|365782166|FG003|Overall Study|Missed IV due to pharmacy error|0|||
106031986|NCT02536404|365782175|FG000|Overall Study|Adverse Event|5|||
106031987|NCT02536404|365782176|FG001|Overall Study|Adverse Event|0|||
106031988|NCT02536404|365782175|FG000|Overall Study|Withdrawal by Subject|4|||
106031989|NCT02536404|365782176|FG001|Overall Study|Withdrawal by Subject|1|||
106031990|NCT02536404|365782175|FG000|Overall Study|Physician Decision|10|||
106031991|NCT02536404|365782176|FG001|Overall Study|Physician Decision|0|||
106031992|NCT02536404|365782175|FG000|Overall Study|Sponsor decision|1|||
106031993|NCT02536404|365782176|FG001|Overall Study|Sponsor decision|0|||
106031994|NCT00816023|365782180|FG000|Overall Study|Lost to Follow-up|1|||
106031995|NCT00816023|365782181|FG001|Overall Study|Lost to Follow-up|1|||
106031996|NCT00816023|365782182|FG002|Overall Study|Lost to Follow-up|0|||
106031997|NCT00816023|365782183|FG003|Overall Study|Lost to Follow-up|0|||
106031998|NCT00816023|365782180|FG000|Overall Study|Withdrawal by Subject|1|||
106031999|NCT00816023|365782181|FG001|Overall Study|Withdrawal by Subject|0|||
106032000|NCT00816023|365782182|FG002|Overall Study|Withdrawal by Subject|0|||
106032001|NCT00816023|365782183|FG003|Overall Study|Withdrawal by Subject|0|||
106032002|NCT00816023|365782180|FG000|Overall Study|Physician Decision|0|||
106032003|NCT00816023|365782181|FG001|Overall Study|Physician Decision|0|||
106032004|NCT00816023|365782182|FG002|Overall Study|Physician Decision|1|||
106032005|NCT00816023|365782183|FG003|Overall Study|Physician Decision|0|||
106032006|NCT00816023|365782180|FG000|Overall Study|assessments complete prior to window|1|||
106032007|NCT00816023|365782181|FG001|Overall Study|assessments complete prior to window|1|||
106032008|NCT00816023|365782182|FG002|Overall Study|assessments complete prior to window|2|||
106032009|NCT00816023|365782183|FG003|Overall Study|assessments complete prior to window|1|||
106032010|NCT00816023|365782180|FG000|Overall Study|Randomized Not Treated|6|||
106032011|NCT00816023|365782181|FG001|Overall Study|Randomized Not Treated|4|||
106032012|NCT00816023|365782182|FG002|Overall Study|Randomized Not Treated|6|||
106032013|NCT00816023|365782183|FG003|Overall Study|Randomized Not Treated|11|||
106032014|NCT01525901|365782184|FG000|Period 2: 12 Weeks|Adverse Event|0|||
106032015|NCT01525901|365782185|FG001|Period 2: 12 Weeks|Adverse Event|1|||
106032016|NCT01525901|365782186|FG002|Period 2: 12 Weeks|Adverse Event|0|||
106032017|NCT01525901|365782187|FG003|Period 2: 12 Weeks|Adverse Event|0|||
106032018|NCT04449029|365782188|FG000|Overall Study|Adverse Event|0|||
106032019|NCT04449029|365782189|FG001|Overall Study|Adverse Event|1|||
106032020|NCT04449029|365782190|FG002|Overall Study|Adverse Event|1|||
106032021|NCT04449029|365782191|FG003|Overall Study|Adverse Event|0|||
105856939|NCT03569228|365126892|FG008|Overall Study|Lost to Follow-up|1|||
106032022|NCT04449029|365782192|FG004|Overall Study|Adverse Event|1|||
106032023|NCT04449029|365782193|FG005|Overall Study|Adverse Event|0|||
106032024|NCT04449029|365782194|FG006|Overall Study|Adverse Event|1|||
106032025|NCT04449029|365782195|FG007|Overall Study|Adverse Event|0|||
106032026|NCT04449029|365782188|FG000|Overall Study|Lost to Follow-up|0|||
106032027|NCT04449029|365782189|FG001|Overall Study|Lost to Follow-up|1|||
106032028|NCT04449029|365782190|FG002|Overall Study|Lost to Follow-up|0|||
106032029|NCT04449029|365782191|FG003|Overall Study|Lost to Follow-up|0|||
106032030|NCT04449029|365782192|FG004|Overall Study|Lost to Follow-up|0|||
106032031|NCT04449029|365782193|FG005|Overall Study|Lost to Follow-up|0|||
106032032|NCT04449029|365782194|FG006|Overall Study|Lost to Follow-up|0|||
106032033|NCT04449029|365782195|FG007|Overall Study|Lost to Follow-up|0|||
106032034|NCT04449029|365782188|FG000|Overall Study|Protocol Violation|0|||
106032035|NCT04449029|365782189|FG001|Overall Study|Protocol Violation|1|||
106032036|NCT04449029|365782190|FG002|Overall Study|Protocol Violation|0|||
106032037|NCT04449029|365782191|FG003|Overall Study|Protocol Violation|0|||
106032038|NCT04449029|365782192|FG004|Overall Study|Protocol Violation|0|||
106032039|NCT04449029|365782193|FG005|Overall Study|Protocol Violation|0|||
106032040|NCT04449029|365782194|FG006|Overall Study|Protocol Violation|0|||
106032041|NCT04449029|365782195|FG007|Overall Study|Protocol Violation|0|||
106032042|NCT04449029|365782188|FG000|Overall Study|Physician Decision|0|||
106032043|NCT04449029|365782189|FG001|Overall Study|Physician Decision|0|||
106032044|NCT04449029|365782190|FG002|Overall Study|Physician Decision|0|||
106032045|NCT04449029|365782191|FG003|Overall Study|Physician Decision|0|||
106032046|NCT04449029|365782192|FG004|Overall Study|Physician Decision|0|||
106032047|NCT04449029|365782193|FG005|Overall Study|Physician Decision|1|||
106032048|NCT04449029|365782194|FG006|Overall Study|Physician Decision|0|||
106032049|NCT04449029|365782195|FG007|Overall Study|Physician Decision|0|||
106032050|NCT04449029|365782188|FG000|Overall Study|Withdrawal by Subject|3|||
106032051|NCT04449029|365782189|FG001|Overall Study|Withdrawal by Subject|0|||
106032052|NCT04449029|365782190|FG002|Overall Study|Withdrawal by Subject|1|||
106032053|NCT04449029|365782191|FG003|Overall Study|Withdrawal by Subject|1|||
106032054|NCT04449029|365782192|FG004|Overall Study|Withdrawal by Subject|5|||
106032055|NCT04449029|365782193|FG005|Overall Study|Withdrawal by Subject|1|||
106032056|NCT04449029|365782194|FG006|Overall Study|Withdrawal by Subject|4|||
106032057|NCT04449029|365782195|FG007|Overall Study|Withdrawal by Subject|0|||
106032058|NCT01203852|365782202|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
106032059|NCT01203852|365782202|FG000|Washout 2 Weeks|Physician Decision|46|||
106032060|NCT01238588|365782207|FG000|Overall Study|Withdrawal by Subject|1|||
106032061|NCT01238588|365782207|FG000|Overall Study|Physician Decision|2|||
106032062|NCT01587898|365782211|FG000|Overall Study|Adverse Event|1|||
106032063|NCT01587898|365782212|FG001|Overall Study|Adverse Event|1|||
106032064|NCT01587898|365782213|FG002|Overall Study|Adverse Event|0|||
106032065|NCT01587898|365782214|FG003|Overall Study|Adverse Event|0|||
106032066|NCT01587898|365782211|FG000|Overall Study|Protocol Violation|0|||
106032067|NCT01587898|365782212|FG001|Overall Study|Protocol Violation|2|||
106032068|NCT01587898|365782213|FG002|Overall Study|Protocol Violation|1|||
106032069|NCT01587898|365782214|FG003|Overall Study|Protocol Violation|1|||
106032070|NCT01587898|365782211|FG000|Overall Study|Lost to Follow-up|0|||
106032071|NCT01587898|365782212|FG001|Overall Study|Lost to Follow-up|0|||
106032072|NCT01587898|365782213|FG002|Overall Study|Lost to Follow-up|0|||
106032073|NCT01587898|365782214|FG003|Overall Study|Lost to Follow-up|1|||
106032074|NCT01587898|365782211|FG000|Overall Study|Withdrawal by Subject|2|||
106032075|NCT01587898|365782212|FG001|Overall Study|Withdrawal by Subject|1|||
106032076|NCT01587898|365782213|FG002|Overall Study|Withdrawal by Subject|0|||
106032077|NCT01587898|365782214|FG003|Overall Study|Withdrawal by Subject|0|||
106032078|NCT01587898|365782211|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
106032079|NCT01587898|365782212|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
106032080|NCT01587898|365782213|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
106032081|NCT01587898|365782214|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
106032082|NCT01433250|365782217|FG000|Overall Study|Protocol Violation|0|||
106032083|NCT01433250|365782218|FG001|Overall Study|Protocol Violation|1|||
106032084|NCT01433250|365782217|FG000|Overall Study|Withdrawal by Subject|3|||
106032085|NCT01433250|365782218|FG001|Overall Study|Withdrawal by Subject|2|||
106032086|NCT01239732|365782225|FG000|Overall Study|Termination of study per protocol|667|||
106032087|NCT01239732|365782225|FG000|Overall Study|Death|226|||
106032088|NCT01239732|365782225|FG000|Overall Study|Withdrawal by Subject|87|||
106032089|NCT01239732|365782225|FG000|Overall Study|Adverse Event|6|||
106032090|NCT01239732|365782225|FG000|Overall Study|Protocol Violation|3|||
106032091|NCT01239732|365782225|FG000|Overall Study|Participant non compliance|5|||
106032092|NCT01239732|365782225|FG000|Overall Study|Study termination by sponsor|2|||
106032093|NCT01239732|365782225|FG000|Overall Study|Investigator's decision|4|||
106032094|NCT01239732|365782225|FG000|Overall Study|Treatment failure|2|||
106032095|NCT01239732|365782225|FG000|Overall Study|Other|19|||
106032096|NCT02730793|365782227|FG000|Overall Study|Physician Decision|0|||
106032097|NCT02730793|365782228|FG001|Overall Study|Physician Decision|1|||
106032098|NCT02730793|365782227|FG000|Overall Study|Withdrawal by Subject|0|||
106032099|NCT02730793|365782228|FG001|Overall Study|Withdrawal by Subject|1|||
106032100|NCT01284491|365782229|FG000|Overall Study|Study termination|13|||
106032101|NCT04658940|365782231|FG000|Overall Study|Withdrawal by Subject|1|||
106032102|NCT00483756|365782243|FG000|Overall Study|Death|2|||
106032103|NCT00483756|365782244|FG001|Overall Study|Death|0|||
106032104|NCT00483756|365782245|FG002|Overall Study|Death|1|||
106032105|NCT00483756|365782243|FG000|Overall Study|Adverse Event|19|||
106032106|NCT00483756|365782244|FG001|Overall Study|Adverse Event|38|||
106032107|NCT00483756|365782245|FG002|Overall Study|Adverse Event|40|||
106032108|NCT00483756|365782243|FG000|Overall Study|Lack of Efficacy|1|||
106032109|NCT00483756|365782244|FG001|Overall Study|Lack of Efficacy|0|||
106032110|NCT00483756|365782245|FG002|Overall Study|Lack of Efficacy|0|||
106032111|NCT00483756|365782243|FG000|Overall Study|Lost to Follow-up|3|||
106032112|NCT00483756|365782244|FG001|Overall Study|Lost to Follow-up|1|||
106032113|NCT00483756|365782245|FG002|Overall Study|Lost to Follow-up|0|||
106032114|NCT00483756|365782243|FG000|Overall Study|Withdrawal by Subject|5|||
106032115|NCT00483756|365782244|FG001|Overall Study|Withdrawal by Subject|3|||
106032116|NCT00483756|365782245|FG002|Overall Study|Withdrawal by Subject|4|||
106032117|NCT00483756|365782243|FG000|Overall Study|Other|2|||
106032118|NCT00483756|365782244|FG001|Overall Study|Other|4|||
106032119|NCT00483756|365782245|FG002|Overall Study|Other|3|||
106032120|NCT00483756|365782243|FG000|Overall Study|Randomized, Not Treated|1|||
106032121|NCT00483756|365782244|FG001|Overall Study|Randomized, Not Treated|4|||
106032122|NCT00483756|365782245|FG002|Overall Study|Randomized, Not Treated|4|||
106032123|NCT01120067|365782252|FG000|Overall Study|Lost to Follow-up|3|||
106032124|NCT01120067|365782253|FG001|Overall Study|Lost to Follow-up|1|||
106032125|NCT01120067|365782252|FG000|Overall Study|fail to engage >3 sessions|2|||
106032126|NCT01120067|365782253|FG001|Overall Study|fail to engage >3 sessions|0|||
106032127|NCT00053898|365782254|FG000|Overall Study|No follow-up data from any source|9|||
106032128|NCT00053898|365782255|FG001|Overall Study|No follow-up data from any source|12|||
106032129|NCT00053898|365782254|FG000|Overall Study|Follow-up from telephone contact only|5|||
106032130|NCT00053898|365782255|FG001|Overall Study|Follow-up from telephone contact only|1|||
106032131|NCT01894568|365782256|FG000|Overall Study|Adverse Event|2|||
106032132|NCT01894568|365782257|FG001|Overall Study|Adverse Event|3|||
106032133|NCT01894568|365782256|FG000|Overall Study|Protocol required discontinuation|2|||
106032134|NCT01894568|365782257|FG001|Overall Study|Protocol required discontinuation|1|||
106032135|NCT01894568|365782256|FG000|Overall Study|Withdrawal by Subject|5|||
106032136|NCT01894568|365782257|FG001|Overall Study|Withdrawal by Subject|5|||
106032137|NCT01894568|365782256|FG000|Overall Study|Physician Decision|1|||
106032138|NCT01894568|365782257|FG001|Overall Study|Physician Decision|0|||
106032139|NCT01894568|365782256|FG000|Overall Study|Lost to Follow-up|0|||
106032140|NCT01894568|365782257|FG001|Overall Study|Lost to Follow-up|1|||
106032141|NCT01089361|365782258|FG000|Overall Study|Death|1|||
106032142|NCT01089361|365782259|FG001|Overall Study|Death|0|||
106032143|NCT01551420|365782260|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
106032144|NCT01551420|365782261|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
106032145|NCT01551420|365782260|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
106032146|NCT01551420|365782261|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
106032147|NCT01551420|365782260|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
106032148|NCT01551420|365782261|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
106032149|NCT01551420|365782260|FG000|Screened for Part B Eligibility|Declined participation|8|||
106032150|NCT01551420|365782261|FG001|Screened for Part B Eligibility|Declined participation|1|||
106032151|NCT01551420|365782260|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
106032152|NCT01551420|365782261|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
106032153|NCT01551420|365782260|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
106032154|NCT01551420|365782261|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
106032155|NCT01551420|365782260|FG000|Home Use (Part B)|Withdrawal by staff|0|||
106032156|NCT01551420|365782261|FG001|Home Use (Part B)|Withdrawal by staff|1|||
106032157|NCT00686998|365782262|FG000|Overall Study|Adverse Event|3|||
106032158|NCT00686998|365782263|FG001|Overall Study|Adverse Event|2|||
106032159|NCT00686998|365782264|FG002|Overall Study|Adverse Event|1|||
106032160|NCT00686998|365782262|FG000|Overall Study|Withdrawal by Subject|2|||
106032161|NCT00686998|365782263|FG001|Overall Study|Withdrawal by Subject|1|||
106032162|NCT00686998|365782264|FG002|Overall Study|Withdrawal by Subject|2|||
106032163|NCT00686998|365782262|FG000|Overall Study|Lack of Efficacy|7|||
106032164|NCT00686998|365782263|FG001|Overall Study|Lack of Efficacy|5|||
106032165|NCT00686998|365782264|FG002|Overall Study|Lack of Efficacy|0|||
106032166|NCT00686998|365782262|FG000|Overall Study|Other|0|||
106032167|NCT00686998|365782263|FG001|Overall Study|Other|0|||
106032168|NCT00686998|365782264|FG002|Overall Study|Other|1|||
106032169|NCT00686998|365782262|FG000|Overall Study|Safety Reasons|1|||
106032170|NCT00686998|365782263|FG001|Overall Study|Safety Reasons|0|||
106032171|NCT00686998|365782264|FG002|Overall Study|Safety Reasons|0|||
106032172|NCT03865316|365783944|FG000|Overall Study|Procedure Cancelled|4|||
106032173|NCT03865316|365783944|FG000|Overall Study|Equipment failure|4|||
106032174|NCT00576420|365783946|FG000|Overall Study|Death|0|||
106032175|NCT00576420|365783947|FG001|Overall Study|Death|0|||
106032176|NCT00576420|365783948|FG002|Overall Study|Death|1|||
106032177|NCT02616146|365783949|FG000|Overall Study|Adverse Event|64|||
106032178|NCT02616146|365783950|FG001|Overall Study|Adverse Event|24|||
106032179|NCT02616146|365783949|FG000|Overall Study|Lost to Follow-up|23|||
106032180|NCT02616146|365783950|FG001|Overall Study|Lost to Follow-up|13|||
106032181|NCT02616146|365783949|FG000|Overall Study|Non-compliance with study protocol|2|||
106032182|NCT02616146|365783950|FG001|Overall Study|Non-compliance with study protocol|0|||
106032183|NCT02616146|365783949|FG000|Overall Study|Non-compliance with study drug|4|||
106032184|NCT02616146|365783950|FG001|Overall Study|Non-compliance with study drug|2|||
106032185|NCT02616146|365783949|FG000|Overall Study|Pregnancy|2|||
106032186|NCT02616146|365783950|FG001|Overall Study|Pregnancy|2|||
106032187|NCT02616146|365783949|FG000|Overall Study|Pregnancy wish|3|||
106032188|NCT02616146|365783950|FG001|Overall Study|Pregnancy wish|0|||
106032189|NCT02616146|365783949|FG000|Overall Study|Protocol Violation|6|||
106032190|NCT02616146|365783950|FG001|Overall Study|Protocol Violation|3|||
106032191|NCT02616146|365783949|FG000|Overall Study|Study terminated by sponsor|1372|||
106032192|NCT02616146|365783950|FG001|Overall Study|Study terminated by sponsor|432|||
106032193|NCT02616146|365783949|FG000|Overall Study|Participant moved|4|||
106032194|NCT02616146|365783950|FG001|Overall Study|Participant moved|3|||
106032195|NCT02616146|365783949|FG000|Overall Study|Withdrawal by Subject|30|||
106032196|NCT02616146|365783950|FG001|Overall Study|Withdrawal by Subject|24|||
106032197|NCT02616146|365783949|FG000|Overall Study|Physician Decision|2|||
106032198|NCT02616146|365783950|FG001|Overall Study|Physician Decision|1|||
106032199|NCT01221272|365783951|FG000|Period 1|Adverse Event|2|||
106032200|NCT01221272|365783952|FG001|Period 1|Adverse Event|0|||
106032201|NCT01221272|365783951|FG000|Period 1|Consent Withdrawal|0|||
106032202|NCT01221272|365783952|FG001|Period 1|Consent Withdrawal|1|||
106032203|NCT01221272|365783951|FG000|Period 1|Significant Dosing Noncompliance|0|||
106032204|NCT01221272|365783952|FG001|Period 1|Significant Dosing Noncompliance|1|||
106032205|NCT01221272|365783951|FG000|Period 2|Adverse Event|0|||
106032206|NCT01221272|365783952|FG001|Period 2|Adverse Event|2|||
106032207|NCT01143389|365783955|FG000|Overall Study|Lost to Follow-up|26|||
106032208|NCT01143389|365783956|FG001|Overall Study|Lost to Follow-up|25|||
106032209|NCT00002931|365783957|FG000|Overall Study|rapidly progressing disease during|2|||
106032210|NCT03224598|365783958|FG000|Overall Study|Lost to Follow-up|0|||
106032211|NCT03224598|365783959|FG001|Overall Study|Lost to Follow-up|2|||
106032212|NCT03224598|365783960|FG002|Overall Study|Lost to Follow-up|0|||
106032213|NCT03224598|365783958|FG000|Overall Study|Other|0|||
106032214|NCT03224598|365783959|FG001|Overall Study|Other|1|||
106032215|NCT03224598|365783960|FG002|Overall Study|Other|0|||
106032216|NCT00814333|365783962|FG000|Enrollment|Lost to Follow-up|1|||
106032217|NCT00814333|365783963|FG001|Enrollment|Lost to Follow-up|0|||
106032218|NCT02907892|365783968|FG000|Overall Study|Lost to Follow-up|27|||
106032219|NCT02907892|365783969|FG001|Overall Study|Lost to Follow-up|40|||
106032220|NCT01974765|365783970|FG000|Overall Study|Withdrawal by Subject|1|||
106032221|NCT01974765|365783970|FG000|Overall Study|Death|1|||
106032222|NCT01974765|365783970|FG000|Overall Study|Adverse Event|2|||
106032223|NCT02519855|365783975|FG000|Overall Study|Adverse Event|0|||
106032224|NCT02519855|365783976|FG001|Overall Study|Adverse Event|1|||
106032225|NCT02519855|365783975|FG000|Overall Study|Lost to Follow-up|3|||
106032226|NCT02519855|365783976|FG001|Overall Study|Lost to Follow-up|3|||
106032227|NCT03621475|365783977|FG000|Overall Study|No longer required restraints at initiation|0|||
106032228|NCT03621475|365783978|FG001|Overall Study|No longer required restraints at initiation|1|||
106032229|NCT00003830|365783992|FG000|Overall Study|No follow up data|3|||
106032230|NCT00003830|365783993|FG001|Overall Study|No follow up data|0|||
106032231|NCT00003830|365783992|FG000|Overall Study|Sentinel node positive patients|829|||
106032232|NCT00003830|365783993|FG001|Overall Study|Sentinel node positive patients|793|||
106032233|NCT01095094|365783997|FG000|Overall Study|Withdrawal by Subject|1|||
106032234|NCT01095094|365783997|FG000|Overall Study|Death|1|||
106032235|NCT01095094|365783997|FG000|Overall Study|Physician Decision|1|||
106032236|NCT05347147|365783998|FG000|Overall Study|Lost to Follow-up|0|||
106032237|NCT05347147|365783999|FG001|Overall Study|Lost to Follow-up|1|||
106032238|NCT05347147|365783998|FG000|Overall Study|Sponsor request|3|||
106032239|NCT05347147|365783999|FG001|Overall Study|Sponsor request|3|||
106032240|NCT05347147|365783998|FG000|Overall Study|Study termination|2|||
106032241|NCT05347147|365783999|FG001|Overall Study|Study termination|1|||
106032242|NCT03188042|365784000|FG000|Overall Study|Withdrawal by Subject|1|||
106032243|NCT03188042|365784001|FG001|Overall Study|Withdrawal by Subject|1|||
106032244|NCT00923364|365784007|FG000|Overall Study|Death|3|||
106032245|NCT00923364|365784008|FG001|Overall Study|Death|0|||
106032246|NCT00923364|365784007|FG000|Overall Study|Did not go to transplant|1|||
106032247|NCT00923364|365784008|FG001|Overall Study|Did not go to transplant|0|||
106032248|NCT01752036|365784009|FG000|Overall Study|Death|2|||
106032249|NCT01011478|365784010|FG000|Overall Study|No follow up data|12|||
106032250|NCT01011478|365784011|FG001|Overall Study|No follow up data|7|||
106032251|NCT02142387|365784013|FG000|Overall Study|<19 years old|49|||
106032252|NCT02142387|365784014|FG001|Overall Study|<19 years old|326|||
106032253|NCT02142387|365784013|FG000|Overall Study|non-cardiac etiology|504|||
106032254|NCT02142387|365784014|FG001|Overall Study|non-cardiac etiology|3431|||
106032255|NCT02142387|365784013|FG000|Overall Study|CPR not performed|74|||
106032256|NCT02142387|365784014|FG001|Overall Study|CPR not performed|473|||
106032257|NCT02142387|365784013|FG000|Overall Study|witnessed by paramedic|139|||
106032258|NCT02142387|365784014|FG001|Overall Study|witnessed by paramedic|917|||
106032259|NCT02142387|365784013|FG000|Overall Study|incomplete data|1|||
106032260|NCT02142387|365784014|FG001|Overall Study|incomplete data|9|||
106032261|NCT02142387|365784013|FG000|Overall Study|occurred not at home|298|||
106032262|NCT02142387|365784014|FG001|Overall Study|occurred not at home|2474|||
106032263|NCT03459690|365784018|FG000|Overall Study|Lost to Follow-up|0|||
106032264|NCT03459690|365784019|FG001|Overall Study|Lost to Follow-up|1|||
106032265|NCT03459690|365784018|FG000|Overall Study|Withdrawal by Subject|1|||
106032266|NCT03459690|365784019|FG001|Overall Study|Withdrawal by Subject|1|||
106032267|NCT02815280|365784020|FG000|Double-Blind Phase|Adverse Event|1|||
106032268|NCT02815280|365784021|FG001|Double-Blind Phase|Adverse Event|1|||
106032269|NCT02815280|365784020|FG000|Double-Blind Phase|Lost to Follow-up|10|||
106032270|NCT02815280|365784021|FG001|Double-Blind Phase|Lost to Follow-up|9|||
106032271|NCT02815280|365784020|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
106032272|NCT02815280|365784021|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
106032273|NCT02815280|365784020|FG000|Double-Blind Phase|Protocol Violation|2|||
106032274|NCT02815280|365784021|FG001|Double-Blind Phase|Protocol Violation|2|||
106032275|NCT02815280|365784020|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
106032276|NCT02815280|365784021|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
106032277|NCT02815280|365784020|FG000|Open-Label Phase|Adverse Event|2|||
106032278|NCT02815280|365784021|FG001|Open-Label Phase|Adverse Event|3|||
106032279|NCT02815280|365784020|FG000|Open-Label Phase|Lost to Follow-up|18|||
106032280|NCT02815280|365784021|FG001|Open-Label Phase|Lost to Follow-up|9|||
106032281|NCT02815280|365784020|FG000|Open-Label Phase|Withdrawal by Subject|33|||
106032282|NCT02815280|365784021|FG001|Open-Label Phase|Withdrawal by Subject|18|||
106032283|NCT02815280|365784020|FG000|Open-Label Phase|Protocol Violation|3|||
106032284|NCT02815280|365784021|FG001|Open-Label Phase|Protocol Violation|0|||
106032285|NCT02815280|365784020|FG000|Open-Label Phase|Administrative|26|||
106032286|NCT02815280|365784021|FG001|Open-Label Phase|Administrative|12|||
106032287|NCT02815280|365784020|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
106032288|NCT02815280|365784021|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
106032289|NCT01107379|365784024|FG000|Overall Study|Withdrawal by Subject|18|||
106032290|NCT01107379|365784024|FG000|Overall Study|Lost to Follow-up|3|||
106032291|NCT00924170|365784025|FG000|Overall Study|Refused further treatment|0|||
106032292|NCT00924170|365784026|FG001|Overall Study|Refused further treatment|1|||
106032293|NCT00924170|365784025|FG000|Overall Study|Physician Decision|0|||
106032294|NCT00924170|365784026|FG001|Overall Study|Physician Decision|1|||
106032295|NCT00924170|365784025|FG000|Overall Study|Progressive disease|3|||
106032296|NCT00924170|365784026|FG001|Overall Study|Progressive disease|6|||
106032297|NCT00924170|365784025|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
106032298|NCT00924170|365784026|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
106032299|NCT00924170|365784025|FG000|Overall Study|Death|1|||
106032300|NCT00924170|365784026|FG001|Overall Study|Death|0|||
106032301|NCT05027971|365784029|FG000|Overall Study|Physician Decision|7|||
105856940|NCT03569228|365126884|FG000|Overall Study|Screen Fail|2|||
105856941|NCT03569228|365126885|FG001|Overall Study|Screen Fail|2|||
105856942|NCT03569228|365126886|FG002|Overall Study|Screen Fail|1|||
105856943|NCT03569228|365126887|FG003|Overall Study|Screen Fail|1|||
105856944|NCT03569228|365126888|FG004|Overall Study|Screen Fail|1|||
105856945|NCT03569228|365126889|FG005|Overall Study|Screen Fail|3|||
105856946|NCT03569228|365126890|FG006|Overall Study|Screen Fail|1|||
105856947|NCT03569228|365126891|FG007|Overall Study|Screen Fail|5|||
105856948|NCT03569228|365126892|FG008|Overall Study|Screen Fail|2|||
105856949|NCT05442866|365126893|FG000|Overall Study|Death|1|||
105856950|NCT05442866|365126893|FG000|Overall Study|Lost to Follow-up|9|||
105856951|NCT05442866|365126893|FG000|Overall Study|Protocol Violation|1|||
105856952|NCT03384654|365126894|FG000|Overall Study|Withdrawal by Subject|0|||
105856953|NCT03384654|365126895|FG001|Overall Study|Withdrawal by Subject|0|||
105856954|NCT03384654|365126896|FG002|Overall Study|Withdrawal by Subject|1|||
105856955|NCT03384654|365126897|FG003|Overall Study|Withdrawal by Subject|0|||
105856956|NCT00085423|365126898|FG000|Overall Study|Withdrawal by Subject|1|||
105856957|NCT00085423|365126898|FG000|Overall Study|screen failure|1|||
105856958|NCT01341782|365126899|FG000|Overall Study|Adverse Event|1|||
105856959|NCT01341782|365126900|FG001|Overall Study|Adverse Event|1|||
105856960|NCT01341782|365126899|FG000|Overall Study|Withdrawal by Subject|6|||
105856961|NCT01341782|365126900|FG001|Overall Study|Withdrawal by Subject|5|||
105856962|NCT01341782|365126899|FG000|Overall Study|Missed 3 consecutive doses|0|||
105856963|NCT01341782|365126900|FG001|Overall Study|Missed 3 consecutive doses|4|||
105856964|NCT01341782|365126899|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
105856965|NCT01341782|365126900|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
105856966|NCT01341782|365126899|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
105856967|NCT01341782|365126900|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
105856968|NCT01341782|365126899|FG000|Overall Study|Other|5|||
105856969|NCT01341782|365126900|FG001|Overall Study|Other|0|||
105856970|NCT02036775|365126901|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105856971|NCT02036775|365126902|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105856972|NCT02036775|365126903|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105856973|NCT02036775|365126904|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105856974|NCT02036775|365126905|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
105856975|NCT02036775|365126906|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
105856976|NCT02365558|365126909|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
105856977|NCT02365558|365126910|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
105856978|NCT02365558|365126909|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
105856979|NCT02365558|365126910|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
105856980|NCT00855803|365126912|FG000|Overall Study|Death|2|||
105856981|NCT00855803|365126912|FG000|Overall Study|Lost to Follow-up|2|||
105856982|NCT00855803|365126912|FG000|Overall Study|Technical inability to undergo procedure|2|||
106032302|NCT05027971|365784030|FG001|Overall Study|Physician Decision|3|||
106032303|NCT05027971|365784029|FG000|Overall Study|Lost to Follow-up|1|||
105856983|NCT00855803|365126912|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
105856984|NCT00855803|365126912|FG000|Overall Study|Withdrawal by Subject|3|||
105856985|NCT00855803|365126912|FG000|Overall Study|Physician Decision|3|||
105856986|NCT02991430|365126913|FG000|Treatment Period 1|Adverse Event|1|||
105856987|NCT02991430|365126914|FG001|Treatment Period 1|Adverse Event|0|||
105856988|NCT02991430|365126915|FG002|Treatment Period 1|Adverse Event|2|||
105856989|NCT02991430|365126913|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105856990|NCT02991430|365126914|FG001|Treatment Period 1|Withdrawal by Subject|4|||
105856991|NCT02991430|365126915|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105856992|NCT02991430|365126913|FG000|Treatment Period 2|Study Termination|6|||
105856993|NCT02991430|365126914|FG001|Treatment Period 2|Study Termination|3|||
105856994|NCT02991430|365126915|FG002|Treatment Period 2|Study Termination|3|||
105856995|NCT02991430|365126913|FG000|Treatment Period 2|Lost to Follow-up|0|||
105856996|NCT02991430|365126914|FG001|Treatment Period 2|Lost to Follow-up|0|||
105856997|NCT02991430|365126915|FG002|Treatment Period 2|Lost to Follow-up|1|||
105856998|NCT02991430|365126913|FG000|Post-treatment Observation Period|Study Termination|3|||
105856999|NCT02991430|365126914|FG001|Post-treatment Observation Period|Study Termination|6|||
105857000|NCT02991430|365126915|FG002|Post-treatment Observation Period|Study Termination|5|||
105857001|NCT01672970|365126916|FG000|Overall Study|Lack of Efficacy|12|||
105857002|NCT01672970|365126916|FG000|Overall Study|Adverse Event|18|||
105857003|NCT01672970|365126916|FG000|Overall Study|Withdrawal by Subject|2|||
105857004|NCT01672970|365126916|FG000|Overall Study|Lost to Follow-up|5|||
105857005|NCT01672970|365126916|FG000|Overall Study|Other|9|||
105857006|NCT01672970|365126916|FG000|Overall Study|Enrolled but not treated|1|||
105857007|NCT03918109|365126917|FG000|Overall Study|Withdrawal by Subject|0|||
105857008|NCT03918109|365126918|FG001|Overall Study|Withdrawal by Subject|0|||
105857009|NCT03918109|365126919|FG002|Overall Study|Withdrawal by Subject|2|||
105857010|NCT03918109|365126920|FG003|Overall Study|Withdrawal by Subject|1|||
105857011|NCT03918109|365126917|FG000|Overall Study|Lost to Follow-up|0|||
105857012|NCT03918109|365126918|FG001|Overall Study|Lost to Follow-up|0|||
105857013|NCT03918109|365126919|FG002|Overall Study|Lost to Follow-up|0|||
105857014|NCT03918109|365126920|FG003|Overall Study|Lost to Follow-up|1|||
105857015|NCT03185013|365126923|FG000|Overall Study|Withdrawal by Subject|5|||
105857016|NCT03185013|365126924|FG001|Overall Study|Withdrawal by Subject|3|||
105857017|NCT03185013|365126923|FG000|Overall Study|Adverse Event|1|||
105857018|NCT03185013|365126924|FG001|Overall Study|Adverse Event|0|||
105857019|NCT03185013|365126923|FG000|Overall Study|Progressive Disease|1|||
105857020|NCT03185013|365126924|FG001|Overall Study|Progressive Disease|0|||
105857021|NCT03185013|365126923|FG000|Overall Study|Lost to Follow-up|8|||
105857022|NCT03185013|365126924|FG001|Overall Study|Lost to Follow-up|2|||
105857023|NCT03185013|365126923|FG000|Overall Study|Physician Decision|1|||
105857024|NCT03185013|365126924|FG001|Overall Study|Physician Decision|0|||
105857025|NCT03185013|365126923|FG000|Overall Study|Protocol Deviation|2|||
105857026|NCT03185013|365126924|FG001|Overall Study|Protocol Deviation|0|||
105857027|NCT03185013|365126923|FG000|Overall Study|Reason not Specified|3|||
105857028|NCT03185013|365126924|FG001|Overall Study|Reason not Specified|2|||
105857029|NCT03185013|365126923|FG000|Overall Study|Death|1|||
105857030|NCT03185013|365126924|FG001|Overall Study|Death|0|||
105857031|NCT04430855|365126927|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
105857032|NCT04430855|365126928|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
105857033|NCT04430855|365126927|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
105857034|NCT04430855|365126928|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
105857035|NCT04430855|365126927|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
105857036|NCT04430855|365126928|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
105857037|NCT04430855|365126927|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
105857038|NCT04430855|365126928|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
105857039|NCT04430855|365126927|FG000|Period 1 (Weeks 1-12)|Other|0|||
105857040|NCT04430855|365126928|FG001|Period 1 (Weeks 1-12)|Other|1|||
105857041|NCT04430855|365126927|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
105857042|NCT04430855|365126928|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
105857043|NCT04430855|365126927|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
105857044|NCT04430855|365126928|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
105857045|NCT04430855|365126927|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
105857046|NCT04430855|365126928|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
105857047|NCT03835221|365126929|FG000|Methafilcon A|Withdrawal by Subject|1|||
105857048|NCT04874636|365126930|FG000|Overall Study|Adverse Event|17|||
105857049|NCT04874636|365126931|FG001|Overall Study|Adverse Event|7|||
105857050|NCT04874636|365126930|FG000|Overall Study|Lost to Follow-up|1|||
105857051|NCT04874636|365126931|FG001|Overall Study|Lost to Follow-up|0|||
106032304|NCT05027971|365784030|FG001|Overall Study|Lost to Follow-up|1|||
106032305|NCT05027971|365784029|FG000|Overall Study|Withdrawal by Subject|0|||
106032306|NCT05027971|365784030|FG001|Overall Study|Withdrawal by Subject|2|||
106032307|NCT05027971|365784029|FG000|Overall Study|Non-study fiber used.|0|||
106032308|NCT05027971|365784030|FG001|Overall Study|Non-study fiber used.|1|||
106032309|NCT05027971|365784029|FG000|Overall Study|Protocol Violation|0|||
106032310|NCT05027971|365784030|FG001|Overall Study|Protocol Violation|2|||
106032311|NCT02025556|365784031|FG000|Overall Study|Adverse Event|0|||
106032312|NCT02025556|365784032|FG001|Overall Study|Adverse Event|4|||
106032313|NCT02025556|365784033|FG002|Overall Study|Adverse Event|2|||
106032314|NCT02025556|365784031|FG000|Overall Study|Lack of Efficacy|2|||
106032315|NCT02025556|365784032|FG001|Overall Study|Lack of Efficacy|1|||
106032316|NCT02025556|365784033|FG002|Overall Study|Lack of Efficacy|0|||
106032317|NCT02025556|365784031|FG000|Overall Study|Protocol Violation|2|||
106032318|NCT02025556|365784032|FG001|Overall Study|Protocol Violation|1|||
106032319|NCT02025556|365784033|FG002|Overall Study|Protocol Violation|0|||
106032320|NCT02025556|365784031|FG000|Overall Study|Withdrawal by Subject|0|||
106032321|NCT02025556|365784032|FG001|Overall Study|Withdrawal by Subject|3|||
106032322|NCT02025556|365784033|FG002|Overall Study|Withdrawal by Subject|6|||
106032323|NCT02025556|365784031|FG000|Overall Study|Lost to Follow-up|2|||
106032324|NCT02025556|365784032|FG001|Overall Study|Lost to Follow-up|4|||
106032325|NCT02025556|365784033|FG002|Overall Study|Lost to Follow-up|0|||
106032326|NCT02025556|365784031|FG000|Overall Study|Reason not reported|0|||
106032327|NCT02025556|365784032|FG001|Overall Study|Reason not reported|0|||
106032328|NCT02025556|365784033|FG002|Overall Study|Reason not reported|1|||
106032329|NCT05395091|365784034|FG000|Baseline to Month 12|Adverse Event|7|||
106032330|NCT05395091|365784035|FG001|Baseline to Month 12|Adverse Event|2|||
106032331|NCT05395091|365784036|FG002|Baseline to Month 12|Adverse Event|0|||
106032332|NCT05395091|365784034|FG000|Baseline to Month 12|Death|3|||
106032333|NCT05395091|365784035|FG001|Baseline to Month 12|Death|1|||
106032334|NCT05395091|365784036|FG002|Baseline to Month 12|Death|0|||
106032335|NCT05395091|365784034|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
106032336|NCT05395091|365784035|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
106032337|NCT05395091|365784036|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
106032338|NCT05395091|365784034|FG000|Baseline to Month 12|Protocol Violation|2|||
106032339|NCT05395091|365784035|FG001|Baseline to Month 12|Protocol Violation|3|||
106032340|NCT05395091|365784036|FG002|Baseline to Month 12|Protocol Violation|0|||
106032341|NCT05395091|365784034|FG000|Baseline to Month 12|Physician Decision|1|||
106032342|NCT05395091|365784035|FG001|Baseline to Month 12|Physician Decision|0|||
106032343|NCT05395091|365784036|FG002|Baseline to Month 12|Physician Decision|0|||
106032344|NCT05395091|365784034|FG000|Month 12 to Month 18|Death|1|||
106032345|NCT05395091|365784035|FG001|Month 12 to Month 18|Death|0|||
106032346|NCT05395091|365784036|FG002|Month 12 to Month 18|Death|0|||
106032347|NCT05395091|365784034|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
106032348|NCT05395091|365784035|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
106032349|NCT05395091|365784036|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
106032350|NCT05395091|365784034|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
106032351|NCT05395091|365784035|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
106032352|NCT05395091|365784036|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
106032353|NCT05395091|365784034|FG000|Month 12 to Month 18|Other reasons|0|||
106032354|NCT05395091|365784035|FG001|Month 12 to Month 18|Other reasons|0|||
106032355|NCT05395091|365784036|FG002|Month 12 to Month 18|Other reasons|1|||
105857052|NCT04874636|365126930|FG000|Overall Study|Non-Compliance with Study Drug|2|||
105857053|NCT04874636|365126931|FG001|Overall Study|Non-Compliance with Study Drug|0|||
105857054|NCT04874636|365126930|FG000|Overall Study|Physician Decision|1|||
105857055|NCT04874636|365126931|FG001|Overall Study|Physician Decision|0|||
105857056|NCT04874636|365126930|FG000|Overall Study|Withdrawal by Subject|6|||
105857057|NCT04874636|365126931|FG001|Overall Study|Withdrawal by Subject|5|||
105857058|NCT00446199|365126932|FG000|Overall Study|Adverse Event|7|||
105857059|NCT00446199|365126933|FG001|Overall Study|Adverse Event|4|||
105857060|NCT00446199|365126934|FG002|Overall Study|Adverse Event|6|||
105857061|NCT00446199|365126935|FG003|Overall Study|Adverse Event|4|||
106032356|NCT00899392|365784037|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
106032357|NCT00899392|365784038|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
106032358|NCT02437110|365784039|FG000|Screening|Lost to Follow-up|3|||
106032359|NCT02437110|365784039|FG000|Screening|Physician Decision|1|||
106032360|NCT02437110|365784039|FG000|ART|Adverse Event|3|||
106032361|NCT02437110|365784039|FG000|ART|Protocol Violation|3|||
106032362|NCT02437110|365784039|FG000|ART|Withdrawal by Subject|4|||
106032363|NCT02437110|365784039|FG000|ART|Lost to follow-up prior to start of intervention|1|||
106032364|NCT02437110|365784039|FG000|ART|Physician decision prior to start of intervention|2|||
106032365|NCT02437110|365784039|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
106032366|NCT02437110|365784039|FG000|Post-ART|Lost to Follow-up|3|||
106032367|NCT02437110|365784039|FG000|Post-ART|Protocol Violation|4|||
106032368|NCT02437110|365784039|FG000|Post-ART|Withdrawal by Subject|3|||
106032369|NCT01431638|365784043|FG000|Overall Study|Adverse Event|1|||
106032370|NCT01431638|365784044|FG001|Overall Study|Adverse Event|3|||
106032371|NCT01431638|365784045|FG002|Overall Study|Adverse Event|1|||
106032372|NCT01431638|365784043|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106032373|NCT01431638|365784044|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
106032374|NCT01431638|365784045|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
106032375|NCT01431638|365784043|FG000|Overall Study|Participants condition no longer requires study drug|0|||
106032376|NCT01431638|365784044|FG001|Overall Study|Participants condition no longer requires study drug|1|||
106032377|NCT01431638|365784045|FG002|Overall Study|Participants condition no longer requires study drug|0|||
106032378|NCT01431638|365784043|FG000|Overall Study|Participant withdrew consent|14|||
106032379|NCT01431638|365784044|FG001|Overall Study|Participant withdrew consent|5|||
106032380|NCT01431638|365784045|FG002|Overall Study|Participant withdrew consent|8|||
106032381|NCT01431638|365784043|FG000|Overall Study|Lost to Follow-up|7|||
106032382|NCT01431638|365784044|FG001|Overall Study|Lost to Follow-up|9|||
106032383|NCT01431638|365784045|FG002|Overall Study|Lost to Follow-up|7|||
106032384|NCT01431638|365784043|FG000|Overall Study|Administrative problems|1|||
106032385|NCT01431638|365784044|FG001|Overall Study|Administrative problems|4|||
106032386|NCT01431638|365784045|FG002|Overall Study|Administrative problems|6|||
106032387|NCT01431638|365784043|FG000|Overall Study|Death|1|||
106032388|NCT01431638|365784044|FG001|Overall Study|Death|0|||
106032389|NCT01431638|365784045|FG002|Overall Study|Death|0|||
106032390|NCT01431638|365784043|FG000|Overall Study|Protocol deviation|1|||
106032391|NCT01431638|365784044|FG001|Overall Study|Protocol deviation|1|||
106032392|NCT01431638|365784045|FG002|Overall Study|Protocol deviation|4|||
106032393|NCT01431638|365784043|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
106032394|NCT01431638|365784044|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
106032395|NCT01431638|365784045|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
106032396|NCT01261780|365784046|FG000|Overall Study|Withdrawal by Subject|1|||
106032397|NCT01261780|365784047|FG001|Overall Study|Withdrawal by Subject|0|||
106032398|NCT01261780|365784046|FG000|Overall Study|Event not related to subject|1|||
106032399|NCT01261780|365784047|FG001|Overall Study|Event not related to subject|2|||
106032400|NCT01227824|365784051|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
106032401|NCT01227824|365784052|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
106032402|NCT01227824|365784053|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
106032403|NCT01227824|365784051|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
106032404|NCT01227824|365784052|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
106032405|NCT01227824|365784053|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
106032406|NCT01227824|365784051|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
106032407|NCT01227824|365784052|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
106032408|NCT01227824|365784053|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
106032409|NCT01227824|365784051|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
106032410|NCT01227824|365784052|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
106032411|NCT01227824|365784053|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
106032412|NCT01227824|365784051|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
106032413|NCT01227824|365784052|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
106032414|NCT01227824|365784053|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
106032415|NCT01227824|365784051|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
106032416|NCT01227824|365784052|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
106032417|NCT01227824|365784053|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
106032418|NCT01227824|365784051|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
106032419|NCT01227824|365784052|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
106032420|NCT01227824|365784053|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
106032421|NCT01227824|365784051|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
106032422|NCT01227824|365784052|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
106032423|NCT01227824|365784053|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
106032424|NCT01227824|365784051|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
106032425|NCT01227824|365784052|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
106032426|NCT01227824|365784053|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
105857062|NCT00446199|365126932|FG000|Overall Study|Lost to Follow-up|4|||
105857063|NCT00446199|365126933|FG001|Overall Study|Lost to Follow-up|5|||
105857064|NCT00446199|365126934|FG002|Overall Study|Lost to Follow-up|2|||
105857065|NCT00446199|365126935|FG003|Overall Study|Lost to Follow-up|6|||
105857066|NCT00446199|365126932|FG000|Overall Study|Protocol Violation|1|||
105857067|NCT00446199|365126933|FG001|Overall Study|Protocol Violation|2|||
105857068|NCT00446199|365126934|FG002|Overall Study|Protocol Violation|1|||
105857069|NCT00446199|365126935|FG003|Overall Study|Protocol Violation|3|||
106032427|NCT01227824|365784051|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
106032428|NCT01227824|365784052|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
106032429|NCT01227824|365784053|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
106032430|NCT01227824|365784051|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
106032431|NCT01227824|365784052|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
106032432|NCT01227824|365784053|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
106032433|NCT01227824|365784051|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
106032434|NCT01227824|365784052|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
106032435|NCT01227824|365784053|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
106032436|NCT01227824|365784051|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
106032437|NCT01227824|365784052|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
106032438|NCT01227824|365784053|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
106032439|NCT01227824|365784051|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
106032440|NCT01227824|365784052|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
106032441|NCT01227824|365784053|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
106032442|NCT01227824|365784051|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
106032443|NCT01227824|365784052|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
106032444|NCT01227824|365784053|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
106032445|NCT03836001|365784054|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
106032446|NCT03836001|365784055|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
106032447|NCT03836001|365784056|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
106032448|NCT03836001|365784054|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
106032449|NCT03836001|365784055|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
106032450|NCT03836001|365784056|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
106032451|NCT03836001|365784054|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
106032452|NCT03836001|365784055|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
106032453|NCT03836001|365784056|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
106032454|NCT03836001|365784054|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
106032455|NCT03836001|365784055|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
106032456|NCT03836001|365784056|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
106032457|NCT01381562|365784057|FG000|Overall Study|Adverse Event|0|||
106032458|NCT01381562|365784058|FG001|Overall Study|Adverse Event|1|||
106032459|NCT01381562|365784059|FG002|Overall Study|Adverse Event|0|||
106032460|NCT02119676|365784073|FG000|Overall Study|Adverse Event|9|||
106032461|NCT02119676|365784074|FG001|Overall Study|Adverse Event|17|||
106032462|NCT02119676|365784075|FG002|Overall Study|Adverse Event|10|||
106032463|NCT02119676|365784076|FG003|Overall Study|Adverse Event|10|||
106032464|NCT02119676|365784073|FG000|Overall Study|Disease progression|53|||
106032465|NCT02119676|365784074|FG001|Overall Study|Disease progression|55|||
106032466|NCT02119676|365784075|FG002|Overall Study|Disease progression|68|||
106032467|NCT02119676|365784076|FG003|Overall Study|Disease progression|73|||
106032468|NCT02119676|365784073|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
106032469|NCT02119676|365784074|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
106032470|NCT02119676|365784075|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
106032471|NCT02119676|365784076|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
106032472|NCT02119676|365784073|FG000|Overall Study|Physician Decision|4|||
106032473|NCT02119676|365784074|FG001|Overall Study|Physician Decision|2|||
106032474|NCT02119676|365784075|FG002|Overall Study|Physician Decision|3|||
106032475|NCT02119676|365784076|FG003|Overall Study|Physician Decision|2|||
106032476|NCT02119676|365784073|FG000|Overall Study|Death|9|||
106032477|NCT02119676|365784074|FG001|Overall Study|Death|3|||
106032478|NCT02119676|365784075|FG002|Overall Study|Death|2|||
106032479|NCT02119676|365784076|FG003|Overall Study|Death|1|||
106032480|NCT02119676|365784073|FG000|Overall Study|Noncompliance|0|||
106032481|NCT02119676|365784074|FG001|Overall Study|Noncompliance|1|||
106032482|NCT02119676|365784075|FG002|Overall Study|Noncompliance|0|||
106032483|NCT02119676|365784076|FG003|Overall Study|Noncompliance|0|||
106032484|NCT02119676|365784073|FG000|Overall Study|Lost to Follow-up|0|||
106032485|NCT02119676|365784074|FG001|Overall Study|Lost to Follow-up|0|||
106032486|NCT02119676|365784075|FG002|Overall Study|Lost to Follow-up|1|||
106032487|NCT02119676|365784076|FG003|Overall Study|Lost to Follow-up|0|||
106032488|NCT02119676|365784073|FG000|Overall Study|Protocol deviation|0|||
106032489|NCT02119676|365784074|FG001|Overall Study|Protocol deviation|0|||
106032490|NCT02119676|365784075|FG002|Overall Study|Protocol deviation|1|||
106032491|NCT02119676|365784076|FG003|Overall Study|Protocol deviation|0|||
106032492|NCT02119676|365784073|FG000|Overall Study|Other, unspecified|2|||
106032493|NCT02119676|365784074|FG001|Overall Study|Other, unspecified|1|||
106032494|NCT02119676|365784075|FG002|Overall Study|Other, unspecified|3|||
106032495|NCT02119676|365784076|FG003|Overall Study|Other, unspecified|4|||
106032496|NCT02119676|365784073|FG000|Overall Study|Did not receive study med|2|||
106032497|NCT02119676|365784074|FG001|Overall Study|Did not receive study med|2|||
106032498|NCT02119676|365784075|FG002|Overall Study|Did not receive study med|4|||
106032499|NCT02119676|365784076|FG003|Overall Study|Did not receive study med|5|||
106032500|NCT01514370|365784078|FG000|Overall Study|Protocol Violation|2|||
106032501|NCT01514370|365784079|FG001|Overall Study|Protocol Violation|3|||
106032502|NCT01514370|365784078|FG000|Overall Study|Lost to Follow-up|0|||
106032503|NCT01514370|365784079|FG001|Overall Study|Lost to Follow-up|2|||
106032504|NCT01514370|365784078|FG000|Overall Study|Withdrawal by Subject|2|||
106032505|NCT01514370|365784079|FG001|Overall Study|Withdrawal by Subject|1|||
106032506|NCT01514370|365784078|FG000|Overall Study|Adverse Event|1|||
106032507|NCT01514370|365784079|FG001|Overall Study|Adverse Event|3|||
106032508|NCT01514370|365784078|FG000|Overall Study|Other|6|||
106032509|NCT01514370|365784079|FG001|Overall Study|Other|7|||
106032510|NCT02520089|365784080|FG000|Overall Study|Lost to Follow-up|3|||
106032511|NCT02520089|365784081|FG001|Overall Study|Lost to Follow-up|4|||
106032512|NCT02216812|365784084|FG000|Overall Study|Lost to Follow-up|10|||
106032513|NCT02216812|365784085|FG001|Overall Study|Lost to Follow-up|5|||
106032514|NCT00129311|365784087|FG000|Overall Study|Withdrawal by Subject|12|||
106032515|NCT00129311|365784088|FG001|Overall Study|Withdrawal by Subject|19|||
106032516|NCT02232880|365784089|FG000|Overall Study|study stopped prior to randomization|1|||
106032517|NCT02829944|365784094|FG000|Overall Study|Physician Decision|0|||
106032518|NCT02829944|365784095|FG001|Overall Study|Physician Decision|1|||
106032519|NCT02829944|365784094|FG000|Overall Study|Screen Failure|2|||
106032520|NCT02829944|365784095|FG001|Overall Study|Screen Failure|2|||
106032521|NCT02829944|365784094|FG000|Overall Study|Inadequate Neuraxial Block|1|||
106032522|NCT02829944|365784095|FG001|Overall Study|Inadequate Neuraxial Block|1|||
106032523|NCT02829944|365784094|FG000|Overall Study|Withdrawal by Subject|2|||
106032524|NCT02829944|365784095|FG001|Overall Study|Withdrawal by Subject|1|||
106032525|NCT02829944|365784094|FG000|Overall Study|Catheter Displacement|1|||
106032526|NCT02829944|365784095|FG001|Overall Study|Catheter Displacement|0|||
106032527|NCT02829944|365784094|FG000|Overall Study|Catheter broke|0|||
106032528|NCT02829944|365784095|FG001|Overall Study|Catheter broke|1|||
106032529|NCT02829944|365784094|FG000|Overall Study|Staff unavailable|0|||
106032530|NCT02829944|365784095|FG001|Overall Study|Staff unavailable|1|||
106032531|NCT00853970|365784097|FG000|Overall Study|Withdrawal by Subject|2|||
106032532|NCT00853970|365784098|FG001|Overall Study|Withdrawal by Subject|1|||
106032533|NCT00853970|365784097|FG000|Overall Study|Cancelled surgery|4|||
106032534|NCT00853970|365784098|FG001|Overall Study|Cancelled surgery|2|||
106032535|NCT04531462|365785892|FG000|Overall Study|Withdrawal by Subject|3|||
106032536|NCT04531462|365785893|FG001|Overall Study|Withdrawal by Subject|1|||
106032537|NCT04531462|365785892|FG000|Overall Study|Adverse Event|3|||
106032538|NCT04531462|365785893|FG001|Overall Study|Adverse Event|3|||
106032539|NCT02292784|365785896|FG000|Overall Study|Lost to Follow-up|1|||
106032540|NCT02292784|365785897|FG001|Overall Study|Lost to Follow-up|17|||
106032541|NCT02292784|365785898|FG002|Overall Study|Lost to Follow-up|18|||
106032542|NCT02292784|365785896|FG000|Overall Study|Withdrawal by Subject|0|||
106032543|NCT02292784|365785897|FG001|Overall Study|Withdrawal by Subject|3|||
106032544|NCT02292784|365785898|FG002|Overall Study|Withdrawal by Subject|3|||
106032545|NCT00348933|365785899|FG000|Overall Study|Withdrawal by Subject|10|||
106032546|NCT00348933|365785899|FG000|Overall Study|Lost to Follow-up|6|||
106032547|NCT00348933|365785899|FG000|Overall Study|Protocol Violation|2|||
106032548|NCT00348933|365785899|FG000|Overall Study|Adverse Event|7|||
106032549|NCT01264081|365785900|FG000|Participants Screened|Screening failures|30|||
106032550|NCT01264081|365785900|FG000|Started Treatment|Withdrawal by Subject|1|||
106032551|NCT01264081|365785900|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
106032552|NCT01489111|365785901|FG000|Overall Study|Withdrawal criterion|1|||
106032553|NCT02716896|365785902|FG000|Overall Study|Physician Decision|0|||
106032554|NCT02716896|365785903|FG001|Overall Study|Physician Decision|1|||
106032555|NCT02054481|365785905|FG000|Overall Study|Adverse Event|1|||
106032556|NCT02054481|365785906|FG001|Overall Study|Adverse Event|1|||
106032557|NCT02054481|365785907|FG002|Overall Study|Adverse Event|0|||
106032558|NCT02054481|365785908|FG003|Overall Study|Adverse Event|1|||
106032559|NCT02054481|365785905|FG000|Overall Study|Lost to Follow-up|1|||
106032560|NCT02054481|365785906|FG001|Overall Study|Lost to Follow-up|0|||
106032561|NCT02054481|365785907|FG002|Overall Study|Lost to Follow-up|0|||
106032562|NCT02054481|365785908|FG003|Overall Study|Lost to Follow-up|0|||
106032563|NCT02054481|365785905|FG000|Overall Study|Other reason|2|||
106032564|NCT02054481|365785906|FG001|Overall Study|Other reason|1|||
106032565|NCT02054481|365785907|FG002|Overall Study|Other reason|2|||
106032566|NCT02054481|365785908|FG003|Overall Study|Other reason|0|||
106032567|NCT02320903|365785909|FG000|Overall Study|Withdrawal by Subject|0|||
106032568|NCT02320903|365785910|FG001|Overall Study|Withdrawal by Subject|9|||
106032569|NCT02320903|365785911|FG002|Overall Study|Withdrawal by Subject|9|||
106032570|NCT02320903|365785909|FG000|Overall Study|Exited therapy; no longer eligible|8|||
106032571|NCT02320903|365785910|FG001|Overall Study|Exited therapy; no longer eligible|2|||
106032572|NCT02320903|365785911|FG002|Overall Study|Exited therapy; no longer eligible|2|||
106032573|NCT02320903|365785909|FG000|Overall Study|Lost to Follow-up|0|||
106032574|NCT02320903|365785910|FG001|Overall Study|Lost to Follow-up|5|||
106032575|NCT02320903|365785911|FG002|Overall Study|Lost to Follow-up|5|||
106032576|NCT00730028|365785913|FG000|Overall Study|Adverse Event|23|||
106032577|NCT00730028|365785914|FG001|Overall Study|Adverse Event|26|||
106032578|NCT00730028|365785915|FG002|Overall Study|Adverse Event|16|||
105857070|NCT00446199|365126932|FG000|Overall Study|Withdrawal by Subject|2|||
105857071|NCT00446199|365126933|FG001|Overall Study|Withdrawal by Subject|5|||
105857072|NCT00446199|365126934|FG002|Overall Study|Withdrawal by Subject|9|||
106032579|NCT00730028|365785916|FG003|Overall Study|Adverse Event|20|||
106032580|NCT00730028|365785917|FG004|Overall Study|Adverse Event|43|||
106032581|NCT00730028|365785913|FG000|Overall Study|Lost to Follow-up|13|||
106032582|NCT00730028|365785914|FG001|Overall Study|Lost to Follow-up|26|||
106032583|NCT00730028|365785915|FG002|Overall Study|Lost to Follow-up|22|||
106032584|NCT00730028|365785916|FG003|Overall Study|Lost to Follow-up|26|||
106032585|NCT00730028|365785917|FG004|Overall Study|Lost to Follow-up|25|||
106032586|NCT00730028|365785913|FG000|Overall Study|Protocol Violation|6|||
106032587|NCT00730028|365785914|FG001|Overall Study|Protocol Violation|1|||
106032588|NCT00730028|365785915|FG002|Overall Study|Protocol Violation|1|||
106032589|NCT00730028|365785916|FG003|Overall Study|Protocol Violation|2|||
106032590|NCT00730028|365785917|FG004|Overall Study|Protocol Violation|0|||
106032591|NCT00730028|365785913|FG000|Overall Study|Withdrawal by Subject|9|||
106032592|NCT00730028|365785914|FG001|Overall Study|Withdrawal by Subject|5|||
106032593|NCT00730028|365785915|FG002|Overall Study|Withdrawal by Subject|4|||
106032594|NCT00730028|365785916|FG003|Overall Study|Withdrawal by Subject|5|||
106032595|NCT00730028|365785917|FG004|Overall Study|Withdrawal by Subject|9|||
106032596|NCT00730028|365785913|FG000|Overall Study|Physician Decision|3|||
106032597|NCT00730028|365785914|FG001|Overall Study|Physician Decision|3|||
106032598|NCT00730028|365785915|FG002|Overall Study|Physician Decision|2|||
106032599|NCT00730028|365785916|FG003|Overall Study|Physician Decision|3|||
106032600|NCT00730028|365785917|FG004|Overall Study|Physician Decision|2|||
106032601|NCT00730028|365785913|FG000|Overall Study|Treatment Failure|5|||
106032602|NCT00730028|365785914|FG001|Overall Study|Treatment Failure|5|||
106032603|NCT00730028|365785915|FG002|Overall Study|Treatment Failure|0|||
106032604|NCT00730028|365785916|FG003|Overall Study|Treatment Failure|0|||
106032605|NCT00730028|365785917|FG004|Overall Study|Treatment Failure|1|||
106032606|NCT00730028|365785913|FG000|Overall Study|Randomization Error|1|||
106032607|NCT00730028|365785914|FG001|Overall Study|Randomization Error|0|||
106032608|NCT00730028|365785915|FG002|Overall Study|Randomization Error|0|||
106032609|NCT00730028|365785916|FG003|Overall Study|Randomization Error|0|||
106032610|NCT00730028|365785917|FG004|Overall Study|Randomization Error|2|||
106032611|NCT01931670|365785920|FG000|Treatment Period|Exclusionary Medication Received|1|||
106032612|NCT01931670|365785921|FG001|Treatment Period|Exclusionary Medication Received|1|||
106032613|NCT01931670|365785922|FG002|Treatment Period|Exclusionary Medication Received|1|||
106032614|NCT01931670|365785920|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
106032615|NCT01931670|365785921|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
106032616|NCT01931670|365785922|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
106032617|NCT01931670|365785920|FG000|Treatment Period|Subject Noncompliant|4|||
106032618|NCT01931670|365785921|FG001|Treatment Period|Subject Noncompliant|9|||
106032619|NCT01931670|365785922|FG002|Treatment Period|Subject Noncompliant|5|||
106032620|NCT01931670|365785920|FG000|Treatment Period|Adverse Event|19|||
106032621|NCT01931670|365785921|FG001|Treatment Period|Adverse Event|8|||
106032622|NCT01931670|365785922|FG002|Treatment Period|Adverse Event|21|||
106032623|NCT01931670|365785920|FG000|Treatment Period|Lack of Efficacy|11|||
106032624|NCT01931670|365785921|FG001|Treatment Period|Lack of Efficacy|2|||
106032625|NCT01931670|365785922|FG002|Treatment Period|Lack of Efficacy|2|||
106032626|NCT01931670|365785920|FG000|Treatment Period|Pregnancy|7|||
106032627|NCT01931670|365785921|FG001|Treatment Period|Pregnancy|2|||
106032628|NCT01931670|365785922|FG002|Treatment Period|Pregnancy|0|||
106032629|NCT01931670|365785920|FG000|Treatment Period|Other|8|||
106032630|NCT01931670|365785921|FG001|Treatment Period|Other|7|||
106032631|NCT01931670|365785922|FG002|Treatment Period|Other|2|||
106032632|NCT01931670|365785920|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
106032633|NCT01931670|365785921|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
106032634|NCT01931670|365785922|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
106032635|NCT01931670|365785920|FG000|Treatment Period|Lost to Follow-up|19|||
106032636|NCT01931670|365785921|FG001|Treatment Period|Lost to Follow-up|5|||
106032637|NCT01931670|365785922|FG002|Treatment Period|Lost to Follow-up|7|||
106032638|NCT01931670|365785920|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
106032639|NCT01931670|365785921|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
106032640|NCT01931670|365785922|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
106032641|NCT01931670|365785920|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
106032642|NCT01931670|365785921|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
106032643|NCT01931670|365785922|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
106032644|NCT01931670|365785920|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
106032645|NCT01931670|365785921|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
106032646|NCT01931670|365785922|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
106032647|NCT01931670|365785920|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
106032648|NCT01931670|365785921|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
106032649|NCT01931670|365785922|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
106097363|NCT03950739|366014391|FG000|Optional Extension Phase|Progressive Disease|5|||
106032650|NCT01931670|365785920|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
106032651|NCT01931670|365785921|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
106032652|NCT01931670|365785922|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
106032653|NCT01931670|365785920|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
106032654|NCT01931670|365785921|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
106032655|NCT01931670|365785922|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
106032656|NCT00976508|365785923|FG000|Overall Study|Death|7|||
106032657|NCT00976508|365785924|FG001|Overall Study|Death|1|||
106032658|NCT00976508|365785923|FG000|Overall Study|Lost to Follow-up|1|||
106032659|NCT00976508|365785924|FG001|Overall Study|Lost to Follow-up|0|||
106032660|NCT00976508|365785923|FG000|Overall Study|Withdrawal by Subject|1|||
106032661|NCT00976508|365785924|FG001|Overall Study|Withdrawal by Subject|0|||
106032662|NCT00976508|365785923|FG000|Overall Study|Disease Progression|4|||
106032663|NCT00976508|365785924|FG001|Overall Study|Disease Progression|4|||
106032664|NCT00976508|365785923|FG000|Overall Study|Subject Enrolled in Hospice|1|||
106032665|NCT00976508|365785924|FG001|Overall Study|Subject Enrolled in Hospice|0|||
106032666|NCT00976508|365785923|FG000|Overall Study|Terminated by the Sponsor|0|||
106032667|NCT00976508|365785924|FG001|Overall Study|Terminated by the Sponsor|1|||
106032668|NCT00095238|365785925|FG000|Overall Study|Lack of Efficacy|9|||
106032669|NCT00095238|365785926|FG001|Overall Study|Lack of Efficacy|9|||
106032670|NCT00095238|365785925|FG000|Overall Study|Adverse Event|331|||
106032671|NCT00095238|365785926|FG001|Overall Study|Adverse Event|287|||
106032672|NCT00095238|365785925|FG000|Overall Study|Subject Withdrew Consent|208|||
106032673|NCT00095238|365785926|FG001|Overall Study|Subject Withdrew Consent|223|||
106032674|NCT00095238|365785925|FG000|Overall Study|Death|154|||
106032675|NCT00095238|365785926|FG001|Overall Study|Death|170|||
106032676|NCT00095238|365785925|FG000|Overall Study|Lost to Follow-up|19|||
106032677|NCT00095238|365785926|FG001|Overall Study|Lost to Follow-up|24|||
106032678|NCT00095238|365785925|FG000|Overall Study|Noncompliance|44|||
106032679|NCT00095238|365785926|FG001|Overall Study|Noncompliance|45|||
106032680|NCT00095238|365785925|FG000|Overall Study|No longer met study criteria|4|||
106032681|NCT00095238|365785926|FG001|Overall Study|No longer met study criteria|5|||
106032682|NCT00095238|365785925|FG000|Overall Study|Study terminated by sponsor|0|||
106032683|NCT00095238|365785926|FG001|Overall Study|Study terminated by sponsor|1|||
106032684|NCT00095238|365785925|FG000|Overall Study|Missing|1|||
106032685|NCT00095238|365785926|FG001|Overall Study|Missing|0|||
106032686|NCT00095238|365785925|FG000|Overall Study|Other Reasons|87|||
106032687|NCT00095238|365785926|FG001|Overall Study|Other Reasons|88|||
106032688|NCT05338671|365785927|FG000|Overall Study|Lost to Follow-up|2|||
106032689|NCT05338671|365785928|FG001|Overall Study|Lost to Follow-up|2|||
106032690|NCT05338671|365785927|FG000|Overall Study|Root canal completed in a single visit|1|||
106032691|NCT05338671|365785928|FG001|Overall Study|Root canal completed in a single visit|0|||
106032692|NCT04391049|365785929|FG000|Overall Study|Protocol Violation|1|||
106032693|NCT00075270|365785930|FG000|Overall Study|Withdrawal by Subject|28|||
106032694|NCT00075270|365785931|FG001|Overall Study|Withdrawal by Subject|21|||
106032695|NCT00075270|365785930|FG000|Overall Study|Lost to Follow-up|25|||
106032696|NCT00075270|365785931|FG001|Overall Study|Lost to Follow-up|28|||
106032697|NCT00075270|365785930|FG000|Overall Study|Protocol Violation|0|||
106032698|NCT00075270|365785931|FG001|Overall Study|Protocol Violation|2|||
106032699|NCT00075270|365785930|FG000|Overall Study|Death|198|||
106032700|NCT00075270|365785931|FG001|Overall Study|Death|215|||
106032701|NCT00075270|365785930|FG000|Overall Study|Other/Unknown|9|||
106032702|NCT00075270|365785931|FG001|Overall Study|Other/Unknown|5|||
106032703|NCT00075270|365785930|FG000|Overall Study|Missing|26|||
106032704|NCT00075270|365785931|FG001|Overall Study|Missing|13|||
106032705|NCT03874429|365785932|FG000|Overall Study|Adverse Event|2|||
106032706|NCT03874429|365785933|FG001|Overall Study|Adverse Event|2|||
106032707|NCT03874429|365785932|FG000|Overall Study|Lack of Efficacy|0|||
106032708|NCT03874429|365785933|FG001|Overall Study|Lack of Efficacy|1|||
106032709|NCT03874429|365785932|FG000|Overall Study|Covid-19 pandemic|4|||
106032710|NCT03874429|365785933|FG001|Overall Study|Covid-19 pandemic|2|||
106032711|NCT02160002|365785934|FG000|Overall Study|Withdrawal by Subject|2|||
106032712|NCT02160002|365785935|FG001|Overall Study|Withdrawal by Subject|1|||
106032713|NCT00246571|365785936|FG000|Overall Study|Adverse Event|7|||
106032714|NCT00246571|365785937|FG001|Overall Study|Adverse Event|0|||
106032715|NCT00246571|365785936|FG000|Overall Study|Protocol Violation|0|||
106032716|NCT00246571|365785937|FG001|Overall Study|Protocol Violation|1|||
106032717|NCT00246571|365785936|FG000|Overall Study|Withdrawal by Subject|2|||
106032718|NCT00246571|365785937|FG001|Overall Study|Withdrawal by Subject|3|||
106032719|NCT00246571|365785936|FG000|Overall Study|Lack of Efficacy|84|||
106032720|NCT00246571|365785937|FG001|Overall Study|Lack of Efficacy|21|||
106032721|NCT00246571|365785936|FG000|Overall Study|Death|17|||
106032722|NCT00246571|365785937|FG001|Overall Study|Death|3|||
106032723|NCT00246571|365785936|FG000|Overall Study|Sponsor|0|||
106032724|NCT00246571|365785937|FG001|Overall Study|Sponsor|1|||
106032725|NCT00246571|365785936|FG000|Overall Study|Did not meet entrance criteria|2|||
106032726|NCT00246571|365785937|FG001|Overall Study|Did not meet entrance criteria|1|||
106032727|NCT00246571|365785936|FG000|Overall Study|Laboratory abnormalities|1|||
106032728|NCT00246571|365785937|FG001|Overall Study|Laboratory abnormalities|0|||
106032729|NCT00246571|365785936|FG000|Overall Study|Crossover participants|0|||
106032730|NCT00246571|365785937|FG001|Overall Study|Crossover participants|74|||
106032731|NCT04896229|365785938|FG000|Overall Study|Lost to Follow-up|113|||
106032732|NCT04896229|365785939|FG001|Overall Study|Lost to Follow-up|113|||
106032733|NCT01129024|365785943|FG000|Overall Study|Physician Decision|5|||
106032734|NCT01129024|365785943|FG000|Overall Study|Study Terminated by Sponsor|8|||
106032735|NCT01129024|365785943|FG000|Overall Study|Withdrawal by Subject|2|||
106032736|NCT01129024|365785943|FG000|Overall Study|Lack of Efficacy|3|||
106032737|NCT01129024|365785943|FG000|Overall Study|Needed a Platelet Transfusion|1|||
106032738|NCT00275821|365785945|FG000|Overall Study|Adverse Event|4|||
106032739|NCT00275821|365785946|FG001|Overall Study|Adverse Event|12|||
106032740|NCT00275821|365785947|FG002|Overall Study|Adverse Event|5|||
106032741|NCT00275821|365785945|FG000|Overall Study|Administrative problems|3|||
106032742|NCT00275821|365785946|FG001|Overall Study|Administrative problems|4|||
106032743|NCT00275821|365785947|FG002|Overall Study|Administrative problems|4|||
106032744|NCT00275821|365785945|FG000|Overall Study|Withdrawal by Subject|0|||
106032745|NCT00275821|365785946|FG001|Overall Study|Withdrawal by Subject|2|||
106032746|NCT00275821|365785947|FG002|Overall Study|Withdrawal by Subject|1|||
106032747|NCT00275821|365785945|FG000|Overall Study|Lost to Follow-up|0|||
106032748|NCT00275821|365785946|FG001|Overall Study|Lost to Follow-up|1|||
106032749|NCT00275821|365785947|FG002|Overall Study|Lost to Follow-up|1|||
106032750|NCT00275821|365785945|FG000|Overall Study|Death|0|||
106032751|NCT00275821|365785946|FG001|Overall Study|Death|2|||
106032752|NCT00275821|365785947|FG002|Overall Study|Death|1|||
106032753|NCT00275821|365785945|FG000|Overall Study|Lack of Efficacy|2|||
106032754|NCT00275821|365785946|FG001|Overall Study|Lack of Efficacy|1|||
106032755|NCT00275821|365785947|FG002|Overall Study|Lack of Efficacy|0|||
106032756|NCT00275821|365785945|FG000|Overall Study|Protocol Violation|5|||
106032757|NCT00275821|365785946|FG001|Overall Study|Protocol Violation|1|||
106032758|NCT00275821|365785947|FG002|Overall Study|Protocol Violation|0|||
106032759|NCT00992589|365785948|FG000|Open-Label Phase|Adverse Event|4|||
106032760|NCT00992589|365785949|FG001|Open-Label Phase|Adverse Event|0|||
106032761|NCT00992589|365785950|FG002|Open-Label Phase|Adverse Event|0|||
106032762|NCT00992589|365785951|FG003|Open-Label Phase|Adverse Event|0|||
106032763|NCT00992589|365785948|FG000|Open-Label Phase|Withdrawal by Subject|20|||
106032764|NCT00992589|365785949|FG001|Open-Label Phase|Withdrawal by Subject|0|||
106032765|NCT00992589|365785950|FG002|Open-Label Phase|Withdrawal by Subject|0|||
106032766|NCT00992589|365785951|FG003|Open-Label Phase|Withdrawal by Subject|0|||
106032767|NCT00992589|365785948|FG000|Open-Label Phase|Lost to Follow-up|1|||
106032768|NCT00992589|365785949|FG001|Open-Label Phase|Lost to Follow-up|0|||
106032769|NCT00992589|365785950|FG002|Open-Label Phase|Lost to Follow-up|0|||
106032770|NCT00992589|365785951|FG003|Open-Label Phase|Lost to Follow-up|0|||
106032771|NCT00992589|365785948|FG000|Open-Label Phase|Protocol Violation|3|||
106032772|NCT00992589|365785949|FG001|Open-Label Phase|Protocol Violation|0|||
106032773|NCT00992589|365785950|FG002|Open-Label Phase|Protocol Violation|0|||
106032774|NCT00992589|365785951|FG003|Open-Label Phase|Protocol Violation|0|||
106032775|NCT00992589|365785948|FG000|Open-Label Phase|Physician Decision|4|||
106032776|NCT00992589|365785949|FG001|Open-Label Phase|Physician Decision|0|||
106032777|NCT00992589|365785950|FG002|Open-Label Phase|Physician Decision|0|||
106032778|NCT00992589|365785951|FG003|Open-Label Phase|Physician Decision|0|||
106032779|NCT00992589|365785948|FG000|Open-Label Phase|Other|45|||
106032780|NCT00992589|365785949|FG001|Open-Label Phase|Other|0|||
106032781|NCT00992589|365785950|FG002|Open-Label Phase|Other|0|||
106032782|NCT00992589|365785951|FG003|Open-Label Phase|Other|0|||
106032783|NCT00992589|365785948|FG000|Double-Blind Phase|Adverse Event|0|||
106032784|NCT00992589|365785949|FG001|Double-Blind Phase|Adverse Event|6|||
106032785|NCT00992589|365785950|FG002|Double-Blind Phase|Adverse Event|2|||
106032786|NCT00992589|365785951|FG003|Double-Blind Phase|Adverse Event|3|||
106032787|NCT00992589|365785948|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
106032788|NCT00992589|365785949|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
106032789|NCT00992589|365785950|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
106032790|NCT00992589|365785951|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
106032791|NCT00992589|365785948|FG000|Double-Blind Phase|Lost to Follow-up|0|||
106032792|NCT00992589|365785949|FG001|Double-Blind Phase|Lost to Follow-up|0|||
106032793|NCT00992589|365785950|FG002|Double-Blind Phase|Lost to Follow-up|0|||
106032794|NCT00992589|365785951|FG003|Double-Blind Phase|Lost to Follow-up|2|||
106032795|NCT00992589|365785948|FG000|Double-Blind Phase|Other|0|||
106032796|NCT00992589|365785949|FG001|Double-Blind Phase|Other|1|||
106032797|NCT00992589|365785950|FG002|Double-Blind Phase|Other|6|||
106032798|NCT00992589|365785951|FG003|Double-Blind Phase|Other|3|||
106032799|NCT00045942|365785952|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
106032800|NCT00045942|365785953|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
106032801|NCT00045942|365785954|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
106032802|NCT00045942|365785955|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
106032803|NCT00045942|365785956|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
106032804|NCT00045942|365785957|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
106032805|NCT00045942|365785958|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
106032806|NCT00045942|365785959|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
106032807|NCT00045942|365785960|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
106032808|NCT00045942|365785952|FG000|PKC412A2104 (Core)|Adverse Event|5|||
106032809|NCT00045942|365785953|FG001|PKC412A2104 (Core)|Adverse Event|0|||
106032810|NCT00045942|365785954|FG002|PKC412A2104 (Core)|Adverse Event|0|||
106032811|NCT00045942|365785955|FG003|PKC412A2104 (Core)|Adverse Event|0|||
106032812|NCT00045942|365785956|FG004|PKC412A2104 (Core)|Adverse Event|0|||
106032813|NCT00045942|365785957|FG005|PKC412A2104 (Core)|Adverse Event|0|||
106032814|NCT00045942|365785958|FG006|PKC412A2104 (Core)|Adverse Event|0|||
106032815|NCT00045942|365785959|FG007|PKC412A2104 (Core)|Adverse Event|0|||
106032816|NCT00045942|365785960|FG008|PKC412A2104 (Core)|Adverse Event|0|||
106032817|NCT00045942|365785952|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
106032818|NCT00045942|365785953|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
106032819|NCT00045942|365785954|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
106032820|NCT00045942|365785955|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
106032821|NCT00045942|365785956|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
106032822|NCT00045942|365785957|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
106032823|NCT00045942|365785958|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
106032824|NCT00045942|365785959|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
106032825|NCT00045942|365785960|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
106032826|NCT00045942|365785952|FG000|PKC412A2104 (Core)|Death|1|||
106032827|NCT00045942|365785953|FG001|PKC412A2104 (Core)|Death|0|||
106032828|NCT00045942|365785954|FG002|PKC412A2104 (Core)|Death|0|||
106032829|NCT00045942|365785955|FG003|PKC412A2104 (Core)|Death|0|||
106032830|NCT00045942|365785956|FG004|PKC412A2104 (Core)|Death|0|||
106032831|NCT00045942|365785957|FG005|PKC412A2104 (Core)|Death|0|||
106032832|NCT00045942|365785958|FG006|PKC412A2104 (Core)|Death|0|||
106032833|NCT00045942|365785959|FG007|PKC412A2104 (Core)|Death|0|||
106032834|NCT00045942|365785960|FG008|PKC412A2104 (Core)|Death|0|||
106032835|NCT00045942|365785952|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
106032836|NCT00045942|365785953|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
106032837|NCT00045942|365785954|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
106032838|NCT00045942|365785955|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
106032839|NCT00045942|365785956|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
106032840|NCT00045942|365785957|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
106032841|NCT00045942|365785958|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
106032842|NCT00045942|365785959|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
106032843|NCT00045942|365785960|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
106032844|NCT00045942|365785952|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
106032845|NCT00045942|365785953|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
106032846|NCT00045942|365785954|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
106032847|NCT00045942|365785955|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
106032848|NCT00045942|365785956|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
106032849|NCT00045942|365785957|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
106032850|NCT00045942|365785958|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
106032851|NCT00045942|365785959|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
106032852|NCT00045942|365785960|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
106032853|NCT00045942|365785952|FG000|PKC412A2104E1|Lack of Efficacy|0|||
106032854|NCT00045942|365785953|FG001|PKC412A2104E1|Lack of Efficacy|11|||
106032855|NCT00045942|365785954|FG002|PKC412A2104E1|Lack of Efficacy|11|||
106032856|NCT00045942|365785955|FG003|PKC412A2104E1|Lack of Efficacy|23|||
106032857|NCT00045942|365785956|FG004|PKC412A2104E1|Lack of Efficacy|17|||
106032858|NCT00045942|365785957|FG005|PKC412A2104E1|Lack of Efficacy|0|||
106032859|NCT00045942|365785958|FG006|PKC412A2104E1|Lack of Efficacy|0|||
106032860|NCT00045942|365785959|FG007|PKC412A2104E1|Lack of Efficacy|0|||
106032861|NCT00045942|365785960|FG008|PKC412A2104E1|Lack of Efficacy|0|||
106032862|NCT00045942|365785952|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
106032863|NCT00045942|365785953|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
106032864|NCT00045942|365785954|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
106032865|NCT00045942|365785955|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
106032866|NCT00045942|365785956|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
106032867|NCT00045942|365785957|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
106032868|NCT00045942|365785958|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
106032869|NCT00045942|365785959|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
106032870|NCT00045942|365785960|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
106032871|NCT00045942|365785952|FG000|PKC412A2104E1|Adverse Event|0|||
106032872|NCT00045942|365785953|FG001|PKC412A2104E1|Adverse Event|1|||
106032873|NCT00045942|365785954|FG002|PKC412A2104E1|Adverse Event|1|||
106032874|NCT00045942|365785955|FG003|PKC412A2104E1|Adverse Event|3|||
106032875|NCT00045942|365785956|FG004|PKC412A2104E1|Adverse Event|6|||
106032876|NCT00045942|365785957|FG005|PKC412A2104E1|Adverse Event|0|||
106032877|NCT00045942|365785958|FG006|PKC412A2104E1|Adverse Event|0|||
106032878|NCT00045942|365785959|FG007|PKC412A2104E1|Adverse Event|0|||
106032879|NCT00045942|365785960|FG008|PKC412A2104E1|Adverse Event|0|||
106032880|NCT00045942|365785952|FG000|PKC412A2104E1|Death|0|||
106032881|NCT00045942|365785953|FG001|PKC412A2104E1|Death|4|||
106032882|NCT00045942|365785954|FG002|PKC412A2104E1|Death|1|||
106032883|NCT00045942|365785955|FG003|PKC412A2104E1|Death|1|||
106032884|NCT00045942|365785956|FG004|PKC412A2104E1|Death|1|||
106032885|NCT00045942|365785957|FG005|PKC412A2104E1|Death|0|||
106032886|NCT00045942|365785958|FG006|PKC412A2104E1|Death|0|||
106032887|NCT00045942|365785959|FG007|PKC412A2104E1|Death|0|||
106032888|NCT00045942|365785960|FG008|PKC412A2104E1|Death|0|||
106032889|NCT00045942|365785952|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
106032890|NCT00045942|365785953|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
106032891|NCT00045942|365785954|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
106032892|NCT00045942|365785955|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
106032893|NCT00045942|365785956|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
106032894|NCT00045942|365785957|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
106032895|NCT00045942|365785958|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
106032896|NCT00045942|365785959|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
106032897|NCT00045942|365785960|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
106032898|NCT00045942|365785952|FG000|PKC412A2104E2|Lost to Follow-up|0|||
106032899|NCT00045942|365785953|FG001|PKC412A2104E2|Lost to Follow-up|0|||
106032900|NCT00045942|365785954|FG002|PKC412A2104E2|Lost to Follow-up|0|||
106032901|NCT00045942|365785955|FG003|PKC412A2104E2|Lost to Follow-up|0|||
106032902|NCT00045942|365785956|FG004|PKC412A2104E2|Lost to Follow-up|0|||
106032903|NCT00045942|365785957|FG005|PKC412A2104E2|Lost to Follow-up|0|||
106032904|NCT00045942|365785958|FG006|PKC412A2104E2|Lost to Follow-up|0|||
106032905|NCT00045942|365785959|FG007|PKC412A2104E2|Lost to Follow-up|3|||
106032906|NCT00045942|365785960|FG008|PKC412A2104E2|Lost to Follow-up|0|||
106032907|NCT00045942|365785952|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
106032908|NCT00045942|365785953|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
106032909|NCT00045942|365785954|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
106032910|NCT00045942|365785955|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
106032911|NCT00045942|365785956|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
106032912|NCT00045942|365785957|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
106032913|NCT00045942|365785958|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
106032914|NCT00045942|365785959|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
106032915|NCT00045942|365785960|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
106032916|NCT00045942|365785952|FG000|PKC412A2104E2|Lack of Efficacy|0|||
106032917|NCT00045942|365785953|FG001|PKC412A2104E2|Lack of Efficacy|0|||
106032918|NCT00045942|365785954|FG002|PKC412A2104E2|Lack of Efficacy|0|||
106032919|NCT00045942|365785955|FG003|PKC412A2104E2|Lack of Efficacy|0|||
106032920|NCT00045942|365785956|FG004|PKC412A2104E2|Lack of Efficacy|0|||
106032921|NCT00045942|365785957|FG005|PKC412A2104E2|Lack of Efficacy|3|||
106032922|NCT00045942|365785958|FG006|PKC412A2104E2|Lack of Efficacy|2|||
106032923|NCT00045942|365785959|FG007|PKC412A2104E2|Lack of Efficacy|2|||
106032924|NCT00045942|365785960|FG008|PKC412A2104E2|Lack of Efficacy|6|||
106032925|NCT00045942|365785952|FG000|PKC412A2104E2|Adverse Event|0|||
106032926|NCT00045942|365785953|FG001|PKC412A2104E2|Adverse Event|0|||
106032927|NCT00045942|365785954|FG002|PKC412A2104E2|Adverse Event|0|||
106032928|NCT00045942|365785955|FG003|PKC412A2104E2|Adverse Event|0|||
106032929|NCT00045942|365785956|FG004|PKC412A2104E2|Adverse Event|0|||
106032930|NCT00045942|365785957|FG005|PKC412A2104E2|Adverse Event|4|||
106032931|NCT00045942|365785958|FG006|PKC412A2104E2|Adverse Event|3|||
106032932|NCT00045942|365785959|FG007|PKC412A2104E2|Adverse Event|1|||
106032933|NCT00045942|365785960|FG008|PKC412A2104E2|Adverse Event|0|||
106032934|NCT00045942|365785952|FG000|PKC412A2104E2|Death|0|||
106032935|NCT00045942|365785953|FG001|PKC412A2104E2|Death|0|||
106032936|NCT00045942|365785954|FG002|PKC412A2104E2|Death|0|||
106032937|NCT00045942|365785955|FG003|PKC412A2104E2|Death|0|||
106032938|NCT00045942|365785956|FG004|PKC412A2104E2|Death|0|||
106032939|NCT00045942|365785957|FG005|PKC412A2104E2|Death|1|||
106032940|NCT00045942|365785958|FG006|PKC412A2104E2|Death|2|||
106032941|NCT00045942|365785959|FG007|PKC412A2104E2|Death|0|||
106032942|NCT00045942|365785960|FG008|PKC412A2104E2|Death|0|||
106032943|NCT00686634|365785963|FG000|Overall Study|Protocol Violation|6|||
106032944|NCT00924781|365785969|FG000|Overall Study|Study terminated by sponsor|12|||
106032945|NCT00924781|365785970|FG001|Overall Study|Study terminated by sponsor|10|||
106032946|NCT02296138|365785971|FG000|Overall Study|Adverse Event|348|||
106032947|NCT02296138|365785972|FG001|Overall Study|Adverse Event|259|||
106032948|NCT02296138|365785971|FG000|Overall Study|Lack of Efficacy|59|||
106032949|NCT02296138|365785972|FG001|Overall Study|Lack of Efficacy|37|||
106032950|NCT02296138|365785971|FG000|Overall Study|Protocol Violation|35|||
106032951|NCT02296138|365785972|FG001|Overall Study|Protocol Violation|36|||
106032952|NCT02296138|365785971|FG000|Overall Study|Lost to Follow-up|9|||
106032953|NCT02296138|365785972|FG001|Overall Study|Lost to Follow-up|12|||
106032954|NCT02296138|365785971|FG000|Overall Study|Withdrawal by Subject|184|||
106032955|NCT02296138|365785972|FG001|Overall Study|Withdrawal by Subject|131|||
106032956|NCT02296138|365785971|FG000|Overall Study|Not Treated|1|||
106032957|NCT02296138|365785972|FG001|Overall Study|Not Treated|1|||
106032958|NCT02296138|365785971|FG000|Overall Study|Patients with data irregularities|10|||
106032959|NCT02296138|365785972|FG001|Overall Study|Patients with data irregularities|11|||
106032960|NCT02296138|365785971|FG000|Overall Study|Other than specified|15|||
106032961|NCT02296138|365785972|FG001|Overall Study|Other than specified|13|||
106032962|NCT01925989|365785975|FG000|Period 1|Sponsor Decision|1|||
106032963|NCT01925989|365785976|FG001|Period 1|Sponsor Decision|1|||
106032964|NCT01925989|365785977|FG002|Period 1|Sponsor Decision|0|||
106032965|NCT01925989|365785975|FG000|Period 1|Withdrawal by Subject|0|||
106032966|NCT01925989|365785976|FG001|Period 1|Withdrawal by Subject|1|||
106032967|NCT01925989|365785977|FG002|Period 1|Withdrawal by Subject|0|||
106032968|NCT01119937|365785978|FG000|Overall Study|Adverse Event|11|||
106032969|NCT01119937|365785979|FG001|Overall Study|Adverse Event|5|||
106032970|NCT01119937|365785978|FG000|Overall Study|Protocol deviation|3|||
106032971|NCT01119937|365785979|FG001|Overall Study|Protocol deviation|1|||
106032972|NCT01119937|365785978|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
106032973|NCT01119937|365785979|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
106032974|NCT01119937|365785978|FG000|Overall Study|Withdrawal by Subject|2|||
106032975|NCT01119937|365785979|FG001|Overall Study|Withdrawal by Subject|1|||
106032976|NCT00420641|365785980|FG000|Overall Study|Adverse Event|3|||
106032977|NCT00420641|365785981|FG001|Overall Study|Adverse Event|25|||
106032978|NCT00420641|365785982|FG002|Overall Study|Adverse Event|10|||
106032979|NCT00420641|365785980|FG000|Overall Study|Lost to Follow-up|2|||
106032980|NCT00420641|365785981|FG001|Overall Study|Lost to Follow-up|4|||
106032981|NCT00420641|365785982|FG002|Overall Study|Lost to Follow-up|2|||
106032982|NCT00420641|365785980|FG000|Overall Study|Protocol Violation|8|||
106032983|NCT00420641|365785981|FG001|Overall Study|Protocol Violation|8|||
106032984|NCT00420641|365785982|FG002|Overall Study|Protocol Violation|7|||
106032985|NCT00420641|365785980|FG000|Overall Study|Withdrawal by Subject|15|||
106032986|NCT00420641|365785981|FG001|Overall Study|Withdrawal by Subject|21|||
106032987|NCT00420641|365785982|FG002|Overall Study|Withdrawal by Subject|14|||
106032988|NCT00420641|365785980|FG000|Overall Study|Lack of Efficacy|6|||
106032989|NCT00420641|365785981|FG001|Overall Study|Lack of Efficacy|5|||
106032990|NCT00420641|365785982|FG002|Overall Study|Lack of Efficacy|4|||
106032991|NCT00420641|365785980|FG000|Overall Study|Non-compliance|7|||
106032992|NCT00420641|365785981|FG001|Overall Study|Non-compliance|5|||
106032993|NCT00420641|365785982|FG002|Overall Study|Non-compliance|4|||
106032994|NCT00420641|365785980|FG000|Overall Study|Other|4|||
106032995|NCT00420641|365785981|FG001|Overall Study|Other|4|||
106032996|NCT00420641|365785982|FG002|Overall Study|Other|3|||
106032997|NCT02514473|365785988|FG000|Overall Study|Adverse Event|0|||
106032998|NCT02514473|365785989|FG001|Overall Study|Adverse Event|2|||
106032999|NCT02514473|365785988|FG000|Overall Study|Withdrawal by Subject|2|||
106033000|NCT02514473|365785989|FG001|Overall Study|Withdrawal by Subject|1|||
106033001|NCT02514473|365785988|FG000|Overall Study|Lost to Follow-up|0|||
106033002|NCT02514473|365785989|FG001|Overall Study|Lost to Follow-up|1|||
106033003|NCT02514473|365785988|FG000|Overall Study|Other|1|||
106033004|NCT02514473|365785989|FG001|Overall Study|Other|1|||
106033005|NCT01944839|365785990|FG000|Overall Study|Physician Decision|2|||
106033006|NCT01944839|365785991|FG001|Overall Study|Physician Decision|2|||
106033007|NCT01944839|365785990|FG000|Overall Study|Protocol Violation|0|||
106033008|NCT01944839|365785991|FG001|Overall Study|Protocol Violation|1|||
106033009|NCT01944839|365785990|FG000|Overall Study|Adverse Event|10|||
106033010|NCT01944839|365785991|FG001|Overall Study|Adverse Event|5|||
106033011|NCT01944839|365785990|FG000|Overall Study|Withdrawal by Subject|9|||
106033012|NCT01944839|365785991|FG001|Overall Study|Withdrawal by Subject|17|||
106033013|NCT01944839|365785990|FG000|Overall Study|Lost to Follow-up|1|||
106033014|NCT01944839|365785991|FG001|Overall Study|Lost to Follow-up|0|||
106033015|NCT01944839|365785990|FG000|Overall Study|Subject non-compliance|0|||
106033016|NCT01944839|365785991|FG001|Overall Study|Subject non-compliance|3|||
106033017|NCT00548405|365785992|FG000|Overall Study|Adverse Event|6|||
106033018|NCT00548405|365785993|FG001|Overall Study|Adverse Event|2|||
106033019|NCT00548405|365785994|FG002|Overall Study|Adverse Event|0|||
106033020|NCT00548405|365785992|FG000|Overall Study|Lack of Efficacy|6|||
106033021|NCT00548405|365785993|FG001|Overall Study|Lack of Efficacy|0|||
106033022|NCT00548405|365785994|FG002|Overall Study|Lack of Efficacy|0|||
106033023|NCT00548405|365785992|FG000|Overall Study|Physician Decision|3|||
106033024|NCT00548405|365785993|FG001|Overall Study|Physician Decision|4|||
106033025|NCT00548405|365785994|FG002|Overall Study|Physician Decision|1|||
106033026|NCT00548405|365785992|FG000|Overall Study|Pregnancy|1|||
106033027|NCT00548405|365785993|FG001|Overall Study|Pregnancy|0|||
106033028|NCT00548405|365785994|FG002|Overall Study|Pregnancy|0|||
106033029|NCT00548405|365785992|FG000|Overall Study|Protocol Violation|1|||
106033030|NCT00548405|365785993|FG001|Overall Study|Protocol Violation|0|||
106033031|NCT00548405|365785994|FG002|Overall Study|Protocol Violation|0|||
106033032|NCT00548405|365785992|FG000|Overall Study|Withdrawal by Subject|36|||
106033033|NCT00548405|365785993|FG001|Overall Study|Withdrawal by Subject|12|||
106033034|NCT00548405|365785994|FG002|Overall Study|Withdrawal by Subject|5|||
106033035|NCT00548405|365785992|FG000|Overall Study|Lost to Follow-up|1|||
106033036|NCT00548405|365785993|FG001|Overall Study|Lost to Follow-up|1|||
106033037|NCT00548405|365785994|FG002|Overall Study|Lost to Follow-up|2|||
106033038|NCT00548405|365785992|FG000|Overall Study|Death|0|||
106033039|NCT00548405|365785993|FG001|Overall Study|Death|1|||
106033040|NCT00548405|365785994|FG002|Overall Study|Death|1|||
106033041|NCT00548405|365785992|FG000|Overall Study|Sponsor decision|1|||
106033042|NCT00548405|365785993|FG001|Overall Study|Sponsor decision|0|||
106033043|NCT00548405|365785994|FG002|Overall Study|Sponsor decision|0|||
106033044|NCT00548405|365785992|FG000|Overall Study|Randomized but not treated|1|||
106033045|NCT00548405|365785993|FG001|Overall Study|Randomized but not treated|0|||
106033046|NCT00548405|365785994|FG002|Overall Study|Randomized but not treated|0|||
106033047|NCT00402233|365785995|FG000|Overall Study|Adverse Event|1|||
106033048|NCT00402233|365785996|FG001|Overall Study|Adverse Event|7|||
106033049|NCT00402233|365785997|FG002|Overall Study|Adverse Event|9|||
106033050|NCT00402233|365785998|FG003|Overall Study|Adverse Event|9|||
106033051|NCT00402233|365785995|FG000|Overall Study|Protocol Violation|0|||
106033052|NCT00402233|365785996|FG001|Overall Study|Protocol Violation|1|||
106033053|NCT00402233|365785997|FG002|Overall Study|Protocol Violation|0|||
106033054|NCT00402233|365785998|FG003|Overall Study|Protocol Violation|0|||
106033055|NCT00402233|365785995|FG000|Overall Study|Withdrawal by Subject|2|||
106033056|NCT00402233|365785996|FG001|Overall Study|Withdrawal by Subject|1|||
106033057|NCT00402233|365785997|FG002|Overall Study|Withdrawal by Subject|2|||
106033058|NCT00402233|365785998|FG003|Overall Study|Withdrawal by Subject|2|||
106033059|NCT00402233|365785995|FG000|Overall Study|Worsening of disease under study|2|||
106033060|NCT00402233|365785996|FG001|Overall Study|Worsening of disease under study|0|||
106033061|NCT00402233|365785997|FG002|Overall Study|Worsening of disease under study|0|||
106033062|NCT00402233|365785998|FG003|Overall Study|Worsening of disease under study|0|||
106033063|NCT00402233|365785995|FG000|Overall Study|Worsening of other pre-existing disease|0|||
106033064|NCT00402233|365785996|FG001|Overall Study|Worsening of other pre-existing disease|1|||
106033065|NCT00402233|365785997|FG002|Overall Study|Worsening of other pre-existing disease|0|||
106033066|NCT00402233|365785998|FG003|Overall Study|Worsening of other pre-existing disease|0|||
106033067|NCT00927940|365786001|FG000|Overall Study|Death|1|||
106033068|NCT00827931|365786003|FG000|Overall Study|Death|3|||
106033069|NCT00827931|365786004|FG001|Overall Study|Death|5|||
106033070|NCT00827931|365786003|FG000|Overall Study|Adverse Event|1|||
106033071|NCT00827931|365786004|FG001|Overall Study|Adverse Event|0|||
106033072|NCT00827931|365786003|FG000|Overall Study|Lost to Follow-up|1|||
106033073|NCT00827931|365786004|FG001|Overall Study|Lost to Follow-up|0|||
106033074|NCT00827931|365786003|FG000|Overall Study|Withdrawal by Subject|0|||
106033075|NCT00827931|365786004|FG001|Overall Study|Withdrawal by Subject|1|||
106033076|NCT00827931|365786003|FG000|Overall Study|Other|1|||
106033077|NCT00827931|365786004|FG001|Overall Study|Other|0|||
106033078|NCT00266877|365786009|FG000|Overall Study|Death|1|||
106033079|NCT00266877|365786010|FG001|Overall Study|Death|1|||
106033080|NCT00266877|365786011|FG002|Overall Study|Death|1|||
106033081|NCT00266877|365786009|FG000|Overall Study|Adverse Event|6|||
106033082|NCT00266877|365786010|FG001|Overall Study|Adverse Event|4|||
106033083|NCT00266877|365786011|FG002|Overall Study|Adverse Event|1|||
106033084|NCT00266877|365786009|FG000|Overall Study|Physician Decision|2|||
106033085|NCT00266877|365786010|FG001|Overall Study|Physician Decision|1|||
106033086|NCT00266877|365786011|FG002|Overall Study|Physician Decision|1|||
106033087|NCT00266877|365786009|FG000|Overall Study|Withdrawal by Subject|3|||
106033088|NCT00266877|365786010|FG001|Overall Study|Withdrawal by Subject|1|||
106033089|NCT00266877|365786011|FG002|Overall Study|Withdrawal by Subject|1|||
106033090|NCT00266877|365786009|FG000|Overall Study|Disease Progression|72|||
106033091|NCT00266877|365786010|FG001|Overall Study|Disease Progression|37|||
106033092|NCT00266877|365786011|FG002|Overall Study|Disease Progression|23|||
106033093|NCT00266877|365786009|FG000|Overall Study|Symptomatic Deterioration|6|||
106033094|NCT00266877|365786010|FG001|Overall Study|Symptomatic Deterioration|3|||
106033095|NCT00266877|365786011|FG002|Overall Study|Symptomatic Deterioration|1|||
106033096|NCT00266877|365786009|FG000|Overall Study|Hospitalization|1|||
106033097|NCT00266877|365786010|FG001|Overall Study|Hospitalization|0|||
106033098|NCT00266877|365786011|FG002|Overall Study|Hospitalization|0|||
106033099|NCT00266877|365786009|FG000|Overall Study|Concomitant Radiotherapy|0|||
106033100|NCT00266877|365786010|FG001|Overall Study|Concomitant Radiotherapy|1|||
106033101|NCT00266877|365786011|FG002|Overall Study|Concomitant Radiotherapy|0|||
106033102|NCT01077375|365786015|FG000|Overall Study|Adverse Event|2|||
106033103|NCT01077375|365786016|FG001|Overall Study|Adverse Event|15|||
106033104|NCT01077375|365786015|FG000|Overall Study|Lack of Efficacy|6|||
106033105|NCT01077375|365786016|FG001|Overall Study|Lack of Efficacy|8|||
106033106|NCT01077375|365786015|FG000|Overall Study|Withdrawal by Subject|0|||
106033107|NCT01077375|365786016|FG001|Overall Study|Withdrawal by Subject|6|||
106033108|NCT01077375|365786015|FG000|Overall Study|Lost to Follow-up|2|||
106033109|NCT01077375|365786016|FG001|Overall Study|Lost to Follow-up|5|||
106033110|NCT01077375|365786015|FG000|Overall Study|Other Reason|0|||
106033111|NCT01077375|365786016|FG001|Overall Study|Other Reason|1|||
106033112|NCT00400153|365786019|FG000|Overall Study|AE due to study disease worsening|14|||
106033113|NCT00400153|365786020|FG001|Overall Study|AE due to study disease worsening|19|||
106033114|NCT00400153|365786021|FG002|Overall Study|AE due to study disease worsening|20|||
106033115|NCT00400153|365786019|FG000|Overall Study|AE due to other disease worsening|2|||
106033116|NCT00400153|365786020|FG001|Overall Study|AE due to other disease worsening|1|||
106033117|NCT00400153|365786021|FG002|Overall Study|AE due to other disease worsening|0|||
106033118|NCT00400153|365786019|FG000|Overall Study|AE due to other condition|3|||
106033119|NCT00400153|365786020|FG001|Overall Study|AE due to other condition|14|||
106033120|NCT00400153|365786021|FG002|Overall Study|AE due to other condition|15|||
106033121|NCT00400153|365786019|FG000|Overall Study|Protocol Violation|7|||
106033122|NCT00400153|365786020|FG001|Overall Study|Protocol Violation|4|||
106033123|NCT00400153|365786021|FG002|Overall Study|Protocol Violation|9|||
106033124|NCT00400153|365786019|FG000|Overall Study|Lost to Follow-up|2|||
106033125|NCT00400153|365786020|FG001|Overall Study|Lost to Follow-up|1|||
106033126|NCT00400153|365786021|FG002|Overall Study|Lost to Follow-up|4|||
106033127|NCT00400153|365786019|FG000|Overall Study|Withdrawal by Subject|12|||
106033128|NCT00400153|365786020|FG001|Overall Study|Withdrawal by Subject|11|||
106033129|NCT00400153|365786021|FG002|Overall Study|Withdrawal by Subject|10|||
106033130|NCT00400153|365786019|FG000|Overall Study|Other reasons - not mentioned above|8|||
106033131|NCT00400153|365786020|FG001|Overall Study|Other reasons - not mentioned above|5|||
106033132|NCT00400153|365786021|FG002|Overall Study|Other reasons - not mentioned above|3|||
106033133|NCT01150474|365786024|FG000|Overall Study|Withdrawal by Subject|5|||
106033134|NCT01150474|365786025|FG001|Overall Study|Withdrawal by Subject|2|||
106033135|NCT01150474|365786024|FG000|Overall Study|Cancer found|1|||
106033136|NCT01150474|365786025|FG001|Overall Study|Cancer found|0|||
106033137|NCT01150474|365786024|FG000|Overall Study|Multiple Studies|0|||
106033138|NCT01150474|365786025|FG001|Overall Study|Multiple Studies|1|||
106033139|NCT01150474|365786024|FG000|Overall Study|Rectotomy|1|||
106033140|NCT01150474|365786025|FG001|Overall Study|Rectotomy|0|||
106033141|NCT01150474|365786024|FG000|Overall Study|Drug did not arrive in time|1|||
106033142|NCT01150474|365786025|FG001|Overall Study|Drug did not arrive in time|0|||
106033143|NCT01150474|365786024|FG000|Overall Study|Drug not administered|1|||
106033144|NCT01150474|365786025|FG001|Overall Study|Drug not administered|0|||
106033145|NCT01150474|365786024|FG000|Overall Study|Surgery Changed|1|||
106033146|NCT01150474|365786025|FG001|Overall Study|Surgery Changed|0|||
106033147|NCT03104816|365786026|FG000|Overall Study|Lack of Efficacy|0|||
106033148|NCT03104816|365786027|FG001|Overall Study|Lack of Efficacy|2|||
106033149|NCT03104816|365786028|FG002|Overall Study|Lack of Efficacy|0|||
106033150|NCT03104816|365786026|FG000|Overall Study|Protocol Violation|2|||
106033151|NCT03104816|365786027|FG001|Overall Study|Protocol Violation|0|||
106033152|NCT03104816|365786028|FG002|Overall Study|Protocol Violation|2|||
106033153|NCT00811642|365786029|FG000|Overall Study|Adverse Event|3|||
106033154|NCT00811642|365786029|FG000|Overall Study|Protocol Violation|1|||
106033155|NCT00811642|365786029|FG000|Overall Study|Death|2|||
106033156|NCT00811642|365786029|FG000|Overall Study|Withdrawal by Subject|7|||
106033157|NCT00811642|365786029|FG000|Overall Study|Cumulative use of antifungal agent|2|||
106033158|NCT01006603|365786032|FG000|Overall Study|Withdrawal by Subject|17|||
106033159|NCT01006603|365786033|FG001|Overall Study|Withdrawal by Subject|19|||
106033160|NCT01006603|365786032|FG000|Overall Study|Lost to Follow-up|0|||
106033161|NCT01006603|365786033|FG001|Overall Study|Lost to Follow-up|1|||
106033162|NCT01006603|365786032|FG000|Overall Study|Safety reason|1|||
106033163|NCT01006603|365786033|FG001|Overall Study|Safety reason|1|||
106033164|NCT01006603|365786032|FG000|Overall Study|Protocol Violation|1|||
106033165|NCT01006603|365786033|FG001|Overall Study|Protocol Violation|3|||
106033166|NCT01006603|365786032|FG000|Overall Study|Incorrect enrolment|0|||
106033167|NCT01006603|365786033|FG001|Overall Study|Incorrect enrolment|2|||
106033168|NCT01006603|365786032|FG000|Overall Study|Adverse Event|15|||
106033169|NCT01006603|365786033|FG001|Overall Study|Adverse Event|7|||
106033170|NCT01006603|365786032|FG000|Overall Study|Death|1|||
106033171|NCT01006603|365786033|FG001|Overall Study|Death|1|||
106033172|NCT01006603|365786032|FG000|Overall Study|Study specific discontinuation criteria|33|||
106033173|NCT01006603|365786033|FG001|Overall Study|Study specific discontinuation criteria|34|||
106033174|NCT01006603|365786032|FG000|Overall Study|Other|3|||
106033175|NCT01006603|365786033|FG001|Overall Study|Other|7|||
106033176|NCT01340872|365787458|FG000|Double-blind Phase|Adverse Event|6|||
106033177|NCT01340872|365787459|FG001|Double-blind Phase|Adverse Event|4|||
106033178|NCT01340872|365787460|FG002|Double-blind Phase|Adverse Event|0|||
106033179|NCT01340872|365787461|FG003|Double-blind Phase|Adverse Event|0|||
106033180|NCT01340872|365787458|FG000|Double-blind Phase|Withdrawal by Subject|3|||
106033181|NCT01340872|365787459|FG001|Double-blind Phase|Withdrawal by Subject|5|||
106033182|NCT01340872|365787460|FG002|Double-blind Phase|Withdrawal by Subject|0|||
106033183|NCT01340872|365787461|FG003|Double-blind Phase|Withdrawal by Subject|0|||
106033184|NCT01340872|365787458|FG000|Double-blind Phase|Lost to Follow-up|0|||
106033185|NCT01340872|365787459|FG001|Double-blind Phase|Lost to Follow-up|1|||
106033186|NCT01340872|365787460|FG002|Double-blind Phase|Lost to Follow-up|0|||
106033187|NCT01340872|365787461|FG003|Double-blind Phase|Lost to Follow-up|0|||
106033188|NCT01340872|365787458|FG000|Double-blind Phase|Protocol Violation|0|||
106033189|NCT01340872|365787459|FG001|Double-blind Phase|Protocol Violation|1|||
106033190|NCT01340872|365787460|FG002|Double-blind Phase|Protocol Violation|0|||
106033191|NCT01340872|365787461|FG003|Double-blind Phase|Protocol Violation|0|||
106033192|NCT01340872|365787458|FG000|Open-label Phase|Physician Decision|0|||
106033193|NCT01340872|365787459|FG001|Open-label Phase|Physician Decision|0|||
106033194|NCT01340872|365787460|FG002|Open-label Phase|Physician Decision|2|||
106033195|NCT01340872|365787461|FG003|Open-label Phase|Physician Decision|1|||
106033196|NCT01340872|365787458|FG000|Open-label Phase|Pregnancy|0|||
106033197|NCT01340872|365787459|FG001|Open-label Phase|Pregnancy|0|||
106033198|NCT01340872|365787460|FG002|Open-label Phase|Pregnancy|1|||
106033199|NCT01340872|365787461|FG003|Open-label Phase|Pregnancy|0|||
106033200|NCT01340872|365787458|FG000|Open-label Phase|Adverse Event|0|||
106033201|NCT01340872|365787459|FG001|Open-label Phase|Adverse Event|0|||
106033202|NCT01340872|365787460|FG002|Open-label Phase|Adverse Event|8|||
106033203|NCT01340872|365787461|FG003|Open-label Phase|Adverse Event|4|||
106033204|NCT01340872|365787458|FG000|Open-label Phase|Withdrawal by Subject|0|||
106033205|NCT01340872|365787459|FG001|Open-label Phase|Withdrawal by Subject|0|||
106033206|NCT01340872|365787460|FG002|Open-label Phase|Withdrawal by Subject|1|||
106033207|NCT01340872|365787461|FG003|Open-label Phase|Withdrawal by Subject|6|||
106033208|NCT01340872|365787458|FG000|Open-label Phase|Worsening of IBD|0|||
106033209|NCT01340872|365787459|FG001|Open-label Phase|Worsening of IBD|0|||
106033210|NCT01340872|365787460|FG002|Open-label Phase|Worsening of IBD|1|||
106033211|NCT01340872|365787461|FG003|Open-label Phase|Worsening of IBD|0|||
106033212|NCT03039621|365787464|FG000|Overall Study|Violation of inclusion criteria|3|||
106033213|NCT03039621|365787465|FG001|Overall Study|Violation of inclusion criteria|2|||
106033214|NCT03039621|365787464|FG000|Overall Study|Non-compliance with protocol requirement|4|||
106033215|NCT03039621|365787465|FG001|Overall Study|Non-compliance with protocol requirement|5|||
106033216|NCT03039621|365787464|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
106033217|NCT03039621|365787465|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
106033218|NCT03039621|365787464|FG000|Overall Study|Violation of non-inclusion criteria|1|||
106033219|NCT03039621|365787465|FG001|Overall Study|Violation of non-inclusion criteria|2|||
106033220|NCT02656680|365787467|FG000|Overall Study|Lost to Follow-up|0|||
106033221|NCT02656680|365787468|FG001|Overall Study|Lost to Follow-up|1|||
106033222|NCT02656680|365787469|FG002|Overall Study|Lost to Follow-up|7|||
106033223|NCT00134784|365787470|FG000|Overall Study|Withdrawal by Subject|2|||
106033224|NCT00134784|365787471|FG001|Overall Study|Withdrawal by Subject|2|||
106033225|NCT00134784|365787472|FG002|Overall Study|Withdrawal by Subject|2|||
106033226|NCT00134784|365787473|FG003|Overall Study|Withdrawal by Subject|1|||
106033227|NCT01842633|365787476|FG000|Overall Study|Screen Failure|1|||
106033228|NCT01842633|365787477|FG001|Overall Study|Screen Failure|0|||
106033229|NCT01842633|365787478|FG002|Overall Study|Screen Failure|0|||
106033230|NCT01842633|365787476|FG000|Overall Study|Adverse Event|1|||
106033231|NCT01842633|365787477|FG001|Overall Study|Adverse Event|1|||
106033232|NCT01842633|365787478|FG002|Overall Study|Adverse Event|0|||
106033233|NCT01842633|365787476|FG000|Overall Study|Withdrawal by Subject|0|||
106033234|NCT01842633|365787477|FG001|Overall Study|Withdrawal by Subject|1|||
106033235|NCT01842633|365787478|FG002|Overall Study|Withdrawal by Subject|0|||
106033236|NCT01842633|365787476|FG000|Overall Study|Technical issues|1|||
106033237|NCT01842633|365787477|FG001|Overall Study|Technical issues|0|||
106033238|NCT01842633|365787478|FG002|Overall Study|Technical issues|0|||
106033239|NCT00464490|365787479|FG000|Overall Study|Physician Decision|11|||
106033240|NCT00464490|365787480|FG001|Overall Study|Physician Decision|11|||
106033241|NCT00603590|365787481|FG000|Overall Study|Did not attend study clinic|39|||
106033242|NCT00603590|365787482|FG001|Overall Study|Did not attend study clinic|30|||
106033243|NCT00603590|365787481|FG000|Overall Study|Refused blood test|5|||
106033244|NCT00603590|365787482|FG001|Overall Study|Refused blood test|1|||
106033245|NCT00603590|365787481|FG000|Overall Study|Patient discontinued study drug|22|||
106033246|NCT00603590|365787482|FG001|Overall Study|Patient discontinued study drug|15|||
106033247|NCT00603590|365787481|FG000|Overall Study|Adverse Event|2|||
106033248|NCT00603590|365787482|FG001|Overall Study|Adverse Event|0|||
106033249|NCT00603590|365787481|FG000|Overall Study|Lost to Follow-up|8|||
106033250|NCT00603590|365787482|FG001|Overall Study|Lost to Follow-up|4|||
106033251|NCT00603590|365787481|FG000|Overall Study|Cardiovascular event|0|||
106033252|NCT00603590|365787482|FG001|Overall Study|Cardiovascular event|1|||
106033253|NCT03699475|365787485|FG000|Overall Study|Death|1|||
106033254|NCT00137839|365787486|FG000|Overall Study|Adverse Event|7|||
106033255|NCT00137839|365787486|FG000|Overall Study|Physician Decision|7|||
106033256|NCT00137839|365787486|FG000|Overall Study|Death|8|||
106033257|NCT00137839|365787486|FG000|Overall Study|Disease Progression|60|||
106033258|NCT00137839|365787486|FG000|Overall Study|Not Start Treatment|1|||
106033259|NCT00137839|365787486|FG000|Overall Study|Prolonged Treatment Delay|1|||
106033260|NCT01099709|365787487|FG000|Period 1|Withdrawal by Subject|0|||
106033261|NCT01099709|365787488|FG001|Period 1|Withdrawal by Subject|1|||
106033262|NCT01099709|365787487|FG000|Period 1|Positive cotinine test|0|||
106033263|NCT01099709|365787488|FG001|Period 1|Positive cotinine test|1|||
106033264|NCT01099709|365787487|FG000|Period 1|Adverse Event|1|||
106033265|NCT01099709|365787488|FG001|Period 1|Adverse Event|0|||
106033266|NCT02882152|365787489|FG000|Overall Study|Lost to Follow-up|1|||
106033267|NCT02882152|365787490|FG001|Overall Study|Lost to Follow-up|0|||
106033268|NCT03739242|365787491|FG000|Overall Study|Withdrawal by Subject|1|||
106033269|NCT03739242|365787492|FG001|Overall Study|Withdrawal by Subject|1|||
106033270|NCT03739242|365787491|FG000|Overall Study|Protocol Violation|0|||
106033271|NCT03739242|365787492|FG001|Overall Study|Protocol Violation|1|||
106033272|NCT04352127|365787493|FG000|Overall Study|Unable to obtain readings|4|||
106033273|NCT04352127|365787494|FG001|Overall Study|Unable to obtain readings|1|||
106033274|NCT00997438|365787498|FG000|Overall Study|Blood draw difficulty|2|||
106033275|NCT00997438|365787499|FG001|Overall Study|Blood draw difficulty|0|||
106033276|NCT00997438|365787500|FG002|Overall Study|Blood draw difficulty|1|||
106033277|NCT00997438|365787498|FG000|Overall Study|Withdrawal by Subject|1|||
106033278|NCT00997438|365787499|FG001|Overall Study|Withdrawal by Subject|1|||
106033279|NCT00997438|365787500|FG002|Overall Study|Withdrawal by Subject|0|||
106033280|NCT00997438|365787498|FG000|Overall Study|Exclusion criteria at visit 1|2|||
106033281|NCT00997438|365787499|FG001|Overall Study|Exclusion criteria at visit 1|2|||
106033282|NCT00997438|365787500|FG002|Overall Study|Exclusion criteria at visit 1|3|||
106033283|NCT04393298|365787501|FG000|Overall Study|Adverse Event|0|||
106033284|NCT04393298|365787502|FG001|Overall Study|Adverse Event|0|||
106033285|NCT04393298|365787503|FG002|Overall Study|Adverse Event|0|||
106033286|NCT04393298|365787504|FG003|Overall Study|Adverse Event|0|||
106033287|NCT04393298|365787505|FG004|Overall Study|Adverse Event|1|||
106033288|NCT04393298|365787506|FG005|Overall Study|Adverse Event|0|||
106033289|NCT04393298|365787507|FG006|Overall Study|Adverse Event|0|||
106033290|NCT04393298|365787508|FG007|Overall Study|Adverse Event|0|||
106033291|NCT04393298|365787509|FG008|Overall Study|Adverse Event|2|||
106033292|NCT04393298|365787510|FG009|Overall Study|Adverse Event|0|||
106033293|NCT04393298|365787511|FG010|Overall Study|Adverse Event|0|||
106033294|NCT04393298|365787512|FG011|Overall Study|Adverse Event|0|||
106033295|NCT04393298|365787513|FG012|Overall Study|Adverse Event|1|||
106033296|NCT04393298|365787514|FG013|Overall Study|Adverse Event|1|||
106033297|NCT04393298|365787515|FG014|Overall Study|Adverse Event|0|||
106033298|NCT04393298|365787501|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033299|NCT04393298|365787502|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033300|NCT04393298|365787503|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
106033301|NCT04393298|365787504|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033302|NCT04393298|365787505|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033303|NCT04393298|365787506|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033304|NCT04393298|365787507|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033305|NCT04393298|365787508|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033306|NCT04393298|365787509|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033307|NCT04393298|365787510|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033308|NCT04393298|365787511|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033309|NCT04393298|365787512|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033310|NCT04393298|365787513|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033311|NCT04393298|365787514|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
106033312|NCT04393298|365787515|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
106033313|NCT04393298|365787501|FG000|Overall Study|Lack of Efficacy|0|||
106033314|NCT04393298|365787502|FG001|Overall Study|Lack of Efficacy|0|||
106033315|NCT04393298|365787503|FG002|Overall Study|Lack of Efficacy|0|||
106033316|NCT04393298|365787504|FG003|Overall Study|Lack of Efficacy|0|||
106033317|NCT04393298|365787505|FG004|Overall Study|Lack of Efficacy|0|||
106033318|NCT04393298|365787506|FG005|Overall Study|Lack of Efficacy|0|||
106033319|NCT04393298|365787507|FG006|Overall Study|Lack of Efficacy|0|||
106033320|NCT04393298|365787508|FG007|Overall Study|Lack of Efficacy|0|||
106033321|NCT04393298|365787509|FG008|Overall Study|Lack of Efficacy|0|||
106033322|NCT04393298|365787510|FG009|Overall Study|Lack of Efficacy|0|||
106033323|NCT04393298|365787511|FG010|Overall Study|Lack of Efficacy|0|||
106033324|NCT04393298|365787512|FG011|Overall Study|Lack of Efficacy|0|||
106033325|NCT04393298|365787513|FG012|Overall Study|Lack of Efficacy|0|||
106033326|NCT04393298|365787514|FG013|Overall Study|Lack of Efficacy|0|||
106033327|NCT04393298|365787515|FG014|Overall Study|Lack of Efficacy|1|||
106033328|NCT04393298|365787501|FG000|Overall Study|Progression|1|||
106033329|NCT04393298|365787502|FG001|Overall Study|Progression|0|||
106033330|NCT04393298|365787503|FG002|Overall Study|Progression|0|||
106033331|NCT04393298|365787504|FG003|Overall Study|Progression|0|||
106033332|NCT04393298|365787505|FG004|Overall Study|Progression|0|||
106033333|NCT04393298|365787506|FG005|Overall Study|Progression|0|||
106033334|NCT04393298|365787507|FG006|Overall Study|Progression|0|||
106033335|NCT04393298|365787508|FG007|Overall Study|Progression|0|||
106033336|NCT04393298|365787509|FG008|Overall Study|Progression|0|||
106033337|NCT04393298|365787510|FG009|Overall Study|Progression|0|||
106033338|NCT04393298|365787511|FG010|Overall Study|Progression|1|||
106033339|NCT04393298|365787512|FG011|Overall Study|Progression|1|||
106033340|NCT04393298|365787513|FG012|Overall Study|Progression|0|||
106033341|NCT04393298|365787514|FG013|Overall Study|Progression|0|||
106033342|NCT04393298|365787515|FG014|Overall Study|Progression|0|||
106033343|NCT04393298|365787501|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
106033344|NCT04393298|365787502|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033345|NCT04393298|365787503|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033346|NCT04393298|365787504|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033347|NCT04393298|365787505|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033348|NCT04393298|365787506|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033349|NCT04393298|365787507|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033350|NCT04393298|365787508|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033351|NCT04393298|365787509|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033352|NCT04393298|365787510|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033353|NCT04393298|365787511|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033354|NCT04393298|365787512|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033355|NCT04393298|365787513|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033356|NCT04393298|365787514|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033357|NCT04393298|365787515|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
106033358|NCT04393298|365787501|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033359|NCT04393298|365787502|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
106033360|NCT04393298|365787503|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033361|NCT04393298|365787504|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033362|NCT04393298|365787505|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033363|NCT04393298|365787506|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033364|NCT04393298|365787507|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033365|NCT04393298|365787508|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033366|NCT04393298|365787509|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033367|NCT04393298|365787510|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033368|NCT04393298|365787511|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033369|NCT04393298|365787512|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033370|NCT04393298|365787513|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033371|NCT04393298|365787514|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033372|NCT04393298|365787515|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
106033373|NCT04393298|365787501|FG000|Overall Study|Clinical Progression|0|||
106033374|NCT04393298|365787502|FG001|Overall Study|Clinical Progression|2|||
106033375|NCT04393298|365787503|FG002|Overall Study|Clinical Progression|0|||
106033376|NCT04393298|365787504|FG003|Overall Study|Clinical Progression|0|||
106033377|NCT04393298|365787505|FG004|Overall Study|Clinical Progression|0|||
106033378|NCT04393298|365787506|FG005|Overall Study|Clinical Progression|0|||
106033379|NCT04393298|365787507|FG006|Overall Study|Clinical Progression|0|||
106033380|NCT04393298|365787508|FG007|Overall Study|Clinical Progression|0|||
106033381|NCT04393298|365787509|FG008|Overall Study|Clinical Progression|0|||
106033382|NCT04393298|365787510|FG009|Overall Study|Clinical Progression|0|||
106033383|NCT04393298|365787511|FG010|Overall Study|Clinical Progression|0|||
106033384|NCT04393298|365787512|FG011|Overall Study|Clinical Progression|0|||
106033385|NCT04393298|365787513|FG012|Overall Study|Clinical Progression|0|||
106033386|NCT04393298|365787514|FG013|Overall Study|Clinical Progression|0|||
106033387|NCT04393298|365787515|FG014|Overall Study|Clinical Progression|0|||
106033388|NCT04393298|365787501|FG000|Overall Study|Disease Progression|0|||
106033389|NCT04393298|365787502|FG001|Overall Study|Disease Progression|1|||
106033390|NCT04393298|365787503|FG002|Overall Study|Disease Progression|0|||
106033391|NCT04393298|365787504|FG003|Overall Study|Disease Progression|0|||
106033392|NCT04393298|365787505|FG004|Overall Study|Disease Progression|0|||
106033393|NCT04393298|365787506|FG005|Overall Study|Disease Progression|3|||
106033394|NCT04393298|365787507|FG006|Overall Study|Disease Progression|2|||
106033395|NCT04393298|365787508|FG007|Overall Study|Disease Progression|1|||
106033396|NCT04393298|365787509|FG008|Overall Study|Disease Progression|2|||
106033397|NCT04393298|365787510|FG009|Overall Study|Disease Progression|1|||
106033398|NCT04393298|365787511|FG010|Overall Study|Disease Progression|0|||
106033399|NCT04393298|365787512|FG011|Overall Study|Disease Progression|3|||
106033400|NCT04393298|365787513|FG012|Overall Study|Disease Progression|0|||
106033401|NCT04393298|365787514|FG013|Overall Study|Disease Progression|0|||
106033402|NCT04393298|365787515|FG014|Overall Study|Disease Progression|1|||
106033403|NCT04393298|365787501|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033404|NCT04393298|365787502|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033405|NCT04393298|365787503|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
106033406|NCT04393298|365787504|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033407|NCT04393298|365787505|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033408|NCT04393298|365787506|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033409|NCT04393298|365787507|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033410|NCT04393298|365787508|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033411|NCT04393298|365787509|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033412|NCT04393298|365787510|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033413|NCT04393298|365787511|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033414|NCT04393298|365787512|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033415|NCT04393298|365787513|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033416|NCT04393298|365787514|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033417|NCT04393298|365787515|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
106033418|NCT04393298|365787501|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033419|NCT04393298|365787502|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033420|NCT04393298|365787503|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
106033421|NCT04393298|365787504|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033422|NCT04393298|365787505|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033423|NCT04393298|365787506|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033424|NCT04393298|365787507|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033425|NCT04393298|365787508|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033426|NCT04393298|365787509|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033427|NCT04393298|365787510|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033428|NCT04393298|365787511|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033429|NCT04393298|365787512|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033430|NCT04393298|365787513|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033431|NCT04393298|365787514|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033432|NCT04393298|365787515|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
106033433|NCT04393298|365787501|FG000|Overall Study|Progressive Disease (PD)|0|||
106033434|NCT04393298|365787502|FG001|Overall Study|Progressive Disease (PD)|0|||
106033435|NCT04393298|365787503|FG002|Overall Study|Progressive Disease (PD)|0|||
106033436|NCT04393298|365787504|FG003|Overall Study|Progressive Disease (PD)|3|||
106033437|NCT04393298|365787505|FG004|Overall Study|Progressive Disease (PD)|0|||
106033438|NCT04393298|365787506|FG005|Overall Study|Progressive Disease (PD)|0|||
106033439|NCT04393298|365787507|FG006|Overall Study|Progressive Disease (PD)|0|||
106033440|NCT04393298|365787508|FG007|Overall Study|Progressive Disease (PD)|0|||
106033441|NCT04393298|365787509|FG008|Overall Study|Progressive Disease (PD)|0|||
106033442|NCT04393298|365787510|FG009|Overall Study|Progressive Disease (PD)|0|||
106033443|NCT04393298|365787511|FG010|Overall Study|Progressive Disease (PD)|0|||
106033444|NCT04393298|365787512|FG011|Overall Study|Progressive Disease (PD)|0|||
106033445|NCT04393298|365787513|FG012|Overall Study|Progressive Disease (PD)|0|||
106033446|NCT04393298|365787514|FG013|Overall Study|Progressive Disease (PD)|0|||
106033447|NCT04393298|365787515|FG014|Overall Study|Progressive Disease (PD)|0|||
106033448|NCT04393298|365787501|FG000|Overall Study|Started a New Cancer Treatment|0|||
106033449|NCT04393298|365787502|FG001|Overall Study|Started a New Cancer Treatment|0|||
106033450|NCT04393298|365787503|FG002|Overall Study|Started a New Cancer Treatment|0|||
106033451|NCT04393298|365787504|FG003|Overall Study|Started a New Cancer Treatment|0|||
106033452|NCT04393298|365787505|FG004|Overall Study|Started a New Cancer Treatment|1|||
106033453|NCT04393298|365787506|FG005|Overall Study|Started a New Cancer Treatment|0|||
106033454|NCT04393298|365787507|FG006|Overall Study|Started a New Cancer Treatment|0|||
106033455|NCT04393298|365787508|FG007|Overall Study|Started a New Cancer Treatment|0|||
106033456|NCT04393298|365787509|FG008|Overall Study|Started a New Cancer Treatment|0|||
106033457|NCT04393298|365787510|FG009|Overall Study|Started a New Cancer Treatment|0|||
106033458|NCT04393298|365787511|FG010|Overall Study|Started a New Cancer Treatment|0|||
106033459|NCT04393298|365787512|FG011|Overall Study|Started a New Cancer Treatment|0|||
106033460|NCT04393298|365787513|FG012|Overall Study|Started a New Cancer Treatment|0|||
106033461|NCT04393298|365787514|FG013|Overall Study|Started a New Cancer Treatment|0|||
106033462|NCT04393298|365787515|FG014|Overall Study|Started a New Cancer Treatment|0|||
106033463|NCT04393298|365787501|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033464|NCT04393298|365787502|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033465|NCT04393298|365787503|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033466|NCT04393298|365787504|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033467|NCT04393298|365787505|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
106033468|NCT04393298|365787506|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033469|NCT04393298|365787507|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033470|NCT04393298|365787508|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033471|NCT04393298|365787509|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033472|NCT04393298|365787510|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033473|NCT04393298|365787511|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033474|NCT04393298|365787512|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033475|NCT04393298|365787513|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033476|NCT04393298|365787514|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033477|NCT04393298|365787515|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
106033478|NCT04393298|365787501|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033479|NCT04393298|365787502|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033480|NCT04393298|365787503|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033481|NCT04393298|365787504|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033482|NCT04393298|365787505|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033483|NCT04393298|365787506|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
106033484|NCT04393298|365787507|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033485|NCT04393298|365787508|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033486|NCT04393298|365787509|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033487|NCT04393298|365787510|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033488|NCT04393298|365787511|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033489|NCT04393298|365787512|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033490|NCT04393298|365787513|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033491|NCT04393298|365787514|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033492|NCT04393298|365787515|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
106033493|NCT04393298|365787501|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033494|NCT04393298|365787502|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033495|NCT04393298|365787503|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033496|NCT04393298|365787504|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033497|NCT04393298|365787505|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033498|NCT04393298|365787506|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
106033499|NCT04393298|365787507|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033500|NCT04393298|365787508|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033501|NCT04393298|365787509|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033502|NCT04393298|365787510|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033503|NCT04393298|365787511|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033504|NCT04393298|365787512|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033505|NCT04393298|365787513|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033506|NCT04393298|365787514|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
106033507|NCT04393298|365787515|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
106033508|NCT04393298|365787501|FG000|Overall Study|Death|0|||
106033509|NCT04393298|365787502|FG001|Overall Study|Death|0|||
106033510|NCT04393298|365787503|FG002|Overall Study|Death|0|||
106033511|NCT04393298|365787504|FG003|Overall Study|Death|0|||
106033512|NCT04393298|365787505|FG004|Overall Study|Death|0|||
106033513|NCT04393298|365787506|FG005|Overall Study|Death|1|||
106033514|NCT04393298|365787507|FG006|Overall Study|Death|1|||
106033515|NCT04393298|365787508|FG007|Overall Study|Death|0|||
106033516|NCT04393298|365787509|FG008|Overall Study|Death|1|||
106033517|NCT04393298|365787510|FG009|Overall Study|Death|1|||
106033518|NCT04393298|365787511|FG010|Overall Study|Death|0|||
106033519|NCT04393298|365787512|FG011|Overall Study|Death|1|||
106033520|NCT04393298|365787513|FG012|Overall Study|Death|1|||
106033521|NCT04393298|365787514|FG013|Overall Study|Death|0|||
106033522|NCT04393298|365787515|FG014|Overall Study|Death|1|||
106033523|NCT04393298|365787501|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033524|NCT04393298|365787502|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033525|NCT04393298|365787503|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033526|NCT04393298|365787504|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033527|NCT04393298|365787505|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033528|NCT04393298|365787506|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
106033529|NCT04393298|365787507|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033530|NCT04393298|365787508|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033531|NCT04393298|365787509|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033532|NCT04393298|365787510|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033533|NCT04393298|365787511|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033534|NCT04393298|365787512|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033535|NCT04393298|365787513|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033536|NCT04393298|365787514|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033537|NCT04393298|365787515|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
106033538|NCT04393298|365787501|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
106033539|NCT04393298|365787502|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
106033540|NCT04393298|365787503|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
106033541|NCT04393298|365787504|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
106033542|NCT04393298|365787505|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
106033543|NCT04393298|365787506|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
106033544|NCT04393298|365787507|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
106033545|NCT04393298|365787508|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
106033546|NCT04393298|365787509|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
106033547|NCT04393298|365787510|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
106033548|NCT04393298|365787511|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
106033549|NCT04393298|365787512|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
106033550|NCT04393298|365787513|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
106033551|NCT04393298|365787514|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
106033552|NCT04393298|365787515|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
106033553|NCT04393298|365787501|FG000|Overall Study|Patient Passed Away|0|||
106033554|NCT04393298|365787502|FG001|Overall Study|Patient Passed Away|0|||
106033555|NCT04393298|365787503|FG002|Overall Study|Patient Passed Away|0|||
106033556|NCT04393298|365787504|FG003|Overall Study|Patient Passed Away|0|||
106033557|NCT04393298|365787505|FG004|Overall Study|Patient Passed Away|0|||
106033558|NCT04393298|365787506|FG005|Overall Study|Patient Passed Away|0|||
106033559|NCT04393298|365787507|FG006|Overall Study|Patient Passed Away|0|||
106033560|NCT04393298|365787508|FG007|Overall Study|Patient Passed Away|1|||
106033561|NCT04393298|365787509|FG008|Overall Study|Patient Passed Away|0|||
106033562|NCT04393298|365787510|FG009|Overall Study|Patient Passed Away|0|||
106033563|NCT04393298|365787511|FG010|Overall Study|Patient Passed Away|0|||
106033564|NCT04393298|365787512|FG011|Overall Study|Patient Passed Away|0|||
106033565|NCT04393298|365787513|FG012|Overall Study|Patient Passed Away|0|||
106033566|NCT04393298|365787514|FG013|Overall Study|Patient Passed Away|0|||
106033567|NCT04393298|365787515|FG014|Overall Study|Patient Passed Away|0|||
106033568|NCT04393298|365787501|FG000|Overall Study|Patient Deceased|0|||
106033569|NCT04393298|365787502|FG001|Overall Study|Patient Deceased|0|||
106033570|NCT04393298|365787503|FG002|Overall Study|Patient Deceased|0|||
106033571|NCT04393298|365787504|FG003|Overall Study|Patient Deceased|0|||
106033572|NCT04393298|365787505|FG004|Overall Study|Patient Deceased|0|||
106033573|NCT04393298|365787506|FG005|Overall Study|Patient Deceased|0|||
106033574|NCT04393298|365787507|FG006|Overall Study|Patient Deceased|0|||
106033575|NCT04393298|365787508|FG007|Overall Study|Patient Deceased|1|||
106033576|NCT04393298|365787509|FG008|Overall Study|Patient Deceased|0|||
106033577|NCT04393298|365787510|FG009|Overall Study|Patient Deceased|0|||
106033578|NCT04393298|365787511|FG010|Overall Study|Patient Deceased|0|||
106033579|NCT04393298|365787512|FG011|Overall Study|Patient Deceased|0|||
106033580|NCT04393298|365787513|FG012|Overall Study|Patient Deceased|0|||
106033581|NCT04393298|365787514|FG013|Overall Study|Patient Deceased|0|||
106033582|NCT04393298|365787515|FG014|Overall Study|Patient Deceased|0|||
106033583|NCT04393298|365787501|FG000|Overall Study|Patient Discharged to Hospice|0|||
106033584|NCT04393298|365787502|FG001|Overall Study|Patient Discharged to Hospice|0|||
106033585|NCT04393298|365787503|FG002|Overall Study|Patient Discharged to Hospice|0|||
106033586|NCT04393298|365787504|FG003|Overall Study|Patient Discharged to Hospice|0|||
106033587|NCT04393298|365787505|FG004|Overall Study|Patient Discharged to Hospice|0|||
106033588|NCT04393298|365787506|FG005|Overall Study|Patient Discharged to Hospice|0|||
106033589|NCT04393298|365787507|FG006|Overall Study|Patient Discharged to Hospice|0|||
106033590|NCT04393298|365787508|FG007|Overall Study|Patient Discharged to Hospice|0|||
106033591|NCT04393298|365787509|FG008|Overall Study|Patient Discharged to Hospice|1|||
106033592|NCT04393298|365787510|FG009|Overall Study|Patient Discharged to Hospice|0|||
106033593|NCT04393298|365787511|FG010|Overall Study|Patient Discharged to Hospice|0|||
106033594|NCT04393298|365787512|FG011|Overall Study|Patient Discharged to Hospice|0|||
106033595|NCT04393298|365787513|FG012|Overall Study|Patient Discharged to Hospice|0|||
106033596|NCT04393298|365787514|FG013|Overall Study|Patient Discharged to Hospice|0|||
106033597|NCT04393298|365787515|FG014|Overall Study|Patient Discharged to Hospice|0|||
106033598|NCT04393298|365787501|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033599|NCT04393298|365787502|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033600|NCT04393298|365787503|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033601|NCT04393298|365787504|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033602|NCT04393298|365787505|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033603|NCT04393298|365787506|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033604|NCT04393298|365787507|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033605|NCT04393298|365787508|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033606|NCT04393298|365787509|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033607|NCT04393298|365787510|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
106033608|NCT04393298|365787511|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033609|NCT04393298|365787512|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033610|NCT04393298|365787513|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033611|NCT04393298|365787514|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033612|NCT04393298|365787515|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
106033613|NCT04393298|365787501|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
106033614|NCT04393298|365787502|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
106033615|NCT04393298|365787503|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
106033616|NCT04393298|365787504|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
106033617|NCT04393298|365787505|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
106033618|NCT04393298|365787506|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
106033619|NCT04393298|365787507|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
106033620|NCT04393298|365787508|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
106033621|NCT04393298|365787509|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
106033622|NCT04393298|365787510|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
106033623|NCT04393298|365787511|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
106033624|NCT04393298|365787512|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
106033625|NCT04393298|365787513|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
106033626|NCT04393298|365787514|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
106033627|NCT04393298|365787515|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
106033628|NCT03754972|365787518|FG000|Overall Study|Protocol Violation|25|||
106033629|NCT04418661|365787523|FG000|Overall Study|Adverse Event|0|||
106033630|NCT04418661|365787524|FG001|Overall Study|Adverse Event|1|||
106033631|NCT04418661|365787525|FG002|Overall Study|Adverse Event|5|||
106033632|NCT04418661|365787526|FG003|Overall Study|Adverse Event|3|||
106033633|NCT04418661|365787527|FG004|Overall Study|Adverse Event|0|||
106033634|NCT04418661|365787528|FG005|Overall Study|Adverse Event|2|||
106033635|NCT04418661|365787523|FG000|Overall Study|Progressive disease|4|||
106033636|NCT04418661|365787524|FG001|Overall Study|Progressive disease|11|||
106033637|NCT04418661|365787525|FG002|Overall Study|Progressive disease|6|||
106033638|NCT04418661|365787526|FG003|Overall Study|Progressive disease|11|||
106033639|NCT04418661|365787527|FG004|Overall Study|Progressive disease|1|||
106033640|NCT04418661|365787528|FG005|Overall Study|Progressive disease|12|||
106033641|NCT04418661|365787523|FG000|Overall Study|Withdrawal by Subject|0|||
106033642|NCT04418661|365787524|FG001|Overall Study|Withdrawal by Subject|1|||
106033643|NCT04418661|365787525|FG002|Overall Study|Withdrawal by Subject|0|||
106033644|NCT04418661|365787526|FG003|Overall Study|Withdrawal by Subject|1|||
106033645|NCT04418661|365787527|FG004|Overall Study|Withdrawal by Subject|0|||
106033646|NCT04418661|365787528|FG005|Overall Study|Withdrawal by Subject|0|||
106033647|NCT04418661|365787523|FG000|Overall Study|Other|0|||
106033648|NCT04418661|365787524|FG001|Overall Study|Other|0|||
106033649|NCT04418661|365787525|FG002|Overall Study|Other|1|||
106033650|NCT04418661|365787526|FG003|Overall Study|Other|3|||
106033651|NCT04418661|365787527|FG004|Overall Study|Other|0|||
106033652|NCT04418661|365787528|FG005|Overall Study|Other|1|||
106033653|NCT00934648|365787530|FG000|Overall Study|Failure to return|8|||
106033654|NCT00934648|365787530|FG000|Overall Study|Withdrawal by Subject|1|||
106033655|NCT01534182|365787538|FG000|Overall Study|Administrative problems|1|||
106033656|NCT01534182|365787539|FG001|Overall Study|Administrative problems|0|||
106033657|NCT01534182|365787538|FG000|Overall Study|Withdrawal by Subject|4|||
106033658|NCT01534182|365787539|FG001|Overall Study|Withdrawal by Subject|7|||
106033659|NCT01534182|365787538|FG000|Overall Study|Adverse Event|7|||
106033660|NCT01534182|365787539|FG001|Overall Study|Adverse Event|3|||
106033661|NCT00674154|365787540|FG000|Overall Study|Withdrawal by Subject|3|||
106033662|NCT00674154|365787541|FG001|Overall Study|Withdrawal by Subject|1|||
106033663|NCT00674154|365787540|FG000|Overall Study|Did not want parathyroidectomy|0|||
106033664|NCT00674154|365787541|FG001|Overall Study|Did not want parathyroidectomy|2|||
106033665|NCT03222492|365787542|FG000|Overall Study|Withdrawal by Subject|0|||
106033666|NCT03222492|365787543|FG001|Overall Study|Withdrawal by Subject|0|||
106033667|NCT03222492|365787544|FG002|Overall Study|Withdrawal by Subject|1|||
106033668|NCT03222492|365787545|FG003|Overall Study|Withdrawal by Subject|0|||
106033669|NCT03222492|365787542|FG000|Overall Study|COVID-19 related|0|||
106033670|NCT03222492|365787543|FG001|Overall Study|COVID-19 related|0|||
106033671|NCT03222492|365787544|FG002|Overall Study|COVID-19 related|1|||
106033672|NCT03222492|365787545|FG003|Overall Study|COVID-19 related|0|||
106033673|NCT00609362|365787549|FG000|Overall Study|Withdrawal by Subject|2|||
106033674|NCT00609362|365787550|FG001|Overall Study|Withdrawal by Subject|1|||
106033675|NCT00609362|365787549|FG000|Overall Study|Adverse Event|1|||
106033676|NCT00609362|365787550|FG001|Overall Study|Adverse Event|0|||
106033677|NCT04559529|365787551|FG000|First Intervention (1 Day)|Adverse Event|0|||
106033678|NCT04559529|365787552|FG001|First Intervention (1 Day)|Adverse Event|0|||
106033679|NCT04559529|365787553|FG002|First Intervention (1 Day)|Adverse Event|0|||
106033680|NCT04559529|365787554|FG003|First Intervention (1 Day)|Adverse Event|1|||
106033681|NCT04559529|365787551|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
106033682|NCT04559529|365787552|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
106033683|NCT04559529|365787553|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
106033684|NCT04559529|365787554|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
106033685|NCT04559529|365787551|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
106033686|NCT04559529|365787552|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
106033687|NCT04559529|365787553|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
106033688|NCT04559529|365787554|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
106033689|NCT05093790|365787555|FG000|Overall Study|Failure to meet continuation criteria|0|||
106033690|NCT05093790|365787556|FG001|Overall Study|Failure to meet continuation criteria|0|||
106033691|NCT05093790|365787557|FG002|Overall Study|Failure to meet continuation criteria|1|||
106033692|NCT05093790|365787558|FG003|Overall Study|Failure to meet continuation criteria|0|||
106033693|NCT05093790|365787555|FG000|Overall Study|Adverse Event|1|||
106033694|NCT05093790|365787556|FG001|Overall Study|Adverse Event|0|||
106033695|NCT05093790|365787557|FG002|Overall Study|Adverse Event|0|||
106033696|NCT05093790|365787558|FG003|Overall Study|Adverse Event|0|||
106033725|NCT00627445|365787564|FG000|Overall Study|Adverse Event|3|||
106033726|NCT00627445|365787565|FG001|Overall Study|Adverse Event|3|||
106033727|NCT00627445|365787564|FG000|Overall Study|Lack of Efficacy|0|||
106033728|NCT00627445|365787565|FG001|Overall Study|Lack of Efficacy|1|||
106033729|NCT00627445|365787564|FG000|Overall Study|Other|6|||
106033730|NCT00627445|365787565|FG001|Overall Study|Other|8|||
106033731|NCT04098224|365787566|FG000|Overall Study|Adverse Event|1|||
106033732|NCT04098224|365787567|FG001|Overall Study|Adverse Event|0|||
106033733|NCT04098224|365787566|FG000|Overall Study|Physician Decision|1|||
106033734|NCT04098224|365787567|FG001|Overall Study|Physician Decision|0|||
106033735|NCT04098224|365787566|FG000|Overall Study|Patient not required enteral feeding|1|||
106033736|NCT04098224|365787567|FG001|Overall Study|Patient not required enteral feeding|0|||
106033737|NCT04098224|365787566|FG000|Overall Study|Patient failure nasogastric tube|1|||
106033738|NCT04098224|365787567|FG001|Overall Study|Patient failure nasogastric tube|0|||
106033739|NCT04098224|365787566|FG000|Overall Study|Patient early extubation|1|||
106033740|NCT04098224|365787567|FG001|Overall Study|Patient early extubation|3|||
106033741|NCT00247611|365787569|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
106033742|NCT00247611|365787570|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
106033743|NCT00247611|365787569|FG000|Baselined|Completed baseline only|9|||
106033744|NCT00247611|365787570|FG001|Baselined|Completed baseline only|8|||
106033745|NCT02582684|365787572|FG000|Overall Study|Unable to contact subject/parent|4|||
106033746|NCT02582684|365787572|FG000|Overall Study|Subject not able to get to clinic|10|||
106033747|NCT02582684|365787572|FG000|Overall Study|Subject withdrew consent|1|||
106033748|NCT02582684|365787572|FG000|Overall Study|Found to be ineligible after enrollment|2|||
106033749|NCT00783302|365787573|FG000|Overall Study|Lost to Follow-up|17|||
106033750|NCT00783302|365787573|FG000|Overall Study|Technical Problems|11|||
106033751|NCT00783302|365787573|FG000|Overall Study|Protocol Violation|3|||
106033752|NCT00783302|365787573|FG000|Overall Study|Physician Decision|1|||
106033753|NCT00783302|365787573|FG000|Overall Study|Withdrawal by Subject|3|||
106033754|NCT00725842|365787576|FG000|Overall Study|Lost to Follow-up|19|||
106033755|NCT00725842|365787576|FG000|Overall Study|Death|1|||
106033756|NCT00725842|365787576|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
106033757|NCT00725842|365787576|FG000|Overall Study|Consent date prior to study start date|5|||
106033758|NCT00725842|365787576|FG000|Overall Study|Inclusion criterion not met|1|||
106033759|NCT00725842|365787576|FG000|Overall Study|No Visit 1 data|1|||
106033760|NCT03579602|365787577|FG000|Overall Study|Subject unable to receive study drug|0|||
106033761|NCT03579602|365787578|FG001|Overall Study|Subject unable to receive study drug|2|||
106033762|NCT03579602|365787577|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
106033763|NCT03579602|365787578|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
106033764|NCT02793622|365787579|FG000|Overall Study|Lost to Follow-up|31|||
106033765|NCT02793622|365787580|FG001|Overall Study|Lost to Follow-up|19|||
106033766|NCT02793622|365787579|FG000|Overall Study|Withdrawal by Subject|21|||
106033767|NCT02793622|365787580|FG001|Overall Study|Withdrawal by Subject|17|||
106033768|NCT02793622|365787579|FG000|Overall Study|Adverse Event|0|||
106033769|NCT02793622|365787580|FG001|Overall Study|Adverse Event|1|||
106033770|NCT02793622|365787579|FG000|Overall Study|Protocol Violation|1|||
106033771|NCT02793622|365787580|FG001|Overall Study|Protocol Violation|5|||
106033772|NCT01075191|365787581|FG000|Overall Study|Death|1|||
106033773|NCT01075191|365787581|FG000|Overall Study|Intensification|3|||
106033774|NCT01075191|365787581|FG000|Overall Study|Co-morbidities|1|||
106033775|NCT01075191|365787581|FG000|Overall Study|Adverse Event|4|||
106033776|NCT01075191|365787581|FG000|Overall Study|Noncompliance|3|||
106033777|NCT01075191|365787581|FG000|Overall Study|Therapy Break|3|||
106033778|NCT01075191|365787581|FG000|Overall Study|Patient's Wish|2|||
106033779|NCT01075191|365787581|FG000|Overall Study|Unknown Reasons|1|||
106033780|NCT00555425|365787582|FG000|Overall Study|Missed Medication > 1 wk|34|||
106033781|NCT00555425|365787583|FG001|Overall Study|Missed Medication > 1 wk|15|||
106033782|NCT00555425|365787582|FG000|Overall Study|Missed 3 physician management visits|1|||
106033783|NCT00555425|365787583|FG001|Overall Study|Missed 3 physician management visits|0|||
106033784|NCT00555425|365787582|FG000|Overall Study|Met criteria for protective transfer|16|||
106033785|NCT00555425|365787583|FG001|Overall Study|Met criteria for protective transfer|3|||
106033786|NCT00555425|365787582|FG000|Overall Study|Became pregnant and transferred care|0|||
106033787|NCT00555425|365787583|FG001|Overall Study|Became pregnant and transferred care|1|||
106033788|NCT00592774|365787584|FG000|Overall Study|Adverse Event|5|||
106033789|NCT00592774|365787585|FG001|Overall Study|Adverse Event|19|||
106033790|NCT00592774|365787586|FG002|Overall Study|Adverse Event|2|||
106033791|NCT00592774|365787587|FG003|Overall Study|Adverse Event|14|||
106033792|NCT00592774|365787588|FG004|Overall Study|Adverse Event|8|||
106033793|NCT00592774|365787584|FG000|Overall Study|Protocol Violation|0|||
106033794|NCT00592774|365787585|FG001|Overall Study|Protocol Violation|1|||
106033795|NCT00592774|365787586|FG002|Overall Study|Protocol Violation|0|||
106033796|NCT00592774|365787587|FG003|Overall Study|Protocol Violation|0|||
106033797|NCT00592774|365787588|FG004|Overall Study|Protocol Violation|1|||
106033798|NCT00592774|365787584|FG000|Overall Study|Withdrawal by Subject|3|||
106033799|NCT00592774|365787585|FG001|Overall Study|Withdrawal by Subject|7|||
106033800|NCT00592774|365787586|FG002|Overall Study|Withdrawal by Subject|0|||
106033801|NCT00592774|365787587|FG003|Overall Study|Withdrawal by Subject|0|||
106033802|NCT00592774|365787588|FG004|Overall Study|Withdrawal by Subject|0|||
106033803|NCT00592774|365787584|FG000|Overall Study|Lack of Efficacy|3|||
106033804|NCT00592774|365787585|FG001|Overall Study|Lack of Efficacy|3|||
105857073|NCT00446199|365126935|FG003|Overall Study|Withdrawal by Subject|10|||
105857074|NCT00446199|365126932|FG000|Overall Study|Site termination|2|||
105857075|NCT00446199|365126933|FG001|Overall Study|Site termination|0|||
105857076|NCT00446199|365126934|FG002|Overall Study|Site termination|0|||
105857077|NCT00446199|365126935|FG003|Overall Study|Site termination|1|||
105857078|NCT00446199|365126932|FG000|Overall Study|Randomization in Error|2|||
106033805|NCT00592774|365787586|FG002|Overall Study|Lack of Efficacy|0|||
106033806|NCT00592774|365787587|FG003|Overall Study|Lack of Efficacy|0|||
106033807|NCT00592774|365787588|FG004|Overall Study|Lack of Efficacy|2|||
105857079|NCT00446199|365126933|FG001|Overall Study|Randomization in Error|0|||
105857080|NCT00446199|365126934|FG002|Overall Study|Randomization in Error|1|||
105857081|NCT00446199|365126935|FG003|Overall Study|Randomization in Error|1|||
105857082|NCT00446199|365126932|FG000|Overall Study|Lack of Efficacy|1|||
106033808|NCT00592774|365787584|FG000|Overall Study|Physician Decision|0|||
105857083|NCT00446199|365126933|FG001|Overall Study|Lack of Efficacy|0|||
106033809|NCT00592774|365787585|FG001|Overall Study|Physician Decision|1|||
106033810|NCT00592774|365787586|FG002|Overall Study|Physician Decision|1|||
106033811|NCT00592774|365787587|FG003|Overall Study|Physician Decision|0|||
106033812|NCT00592774|365787588|FG004|Overall Study|Physician Decision|1|||
106033813|NCT00592774|365787584|FG000|Overall Study|Other|0|||
106033814|NCT00592774|365787585|FG001|Overall Study|Other|1|||
106033815|NCT00592774|365787586|FG002|Overall Study|Other|1|||
106033816|NCT00592774|365787587|FG003|Overall Study|Other|0|||
106033817|NCT00592774|365787588|FG004|Overall Study|Other|2|||
106033818|NCT02674854|365787589|FG000|Overall Study|Adverse Event|17|||
106033819|NCT02674854|365787590|FG001|Overall Study|Adverse Event|15|||
106033820|NCT02674854|365787591|FG002|Overall Study|Adverse Event|5|||
106033821|NCT02674854|365787589|FG000|Overall Study|Withdrawal by Subject|1|||
106033822|NCT02674854|365787590|FG001|Overall Study|Withdrawal by Subject|5|||
106033823|NCT02674854|365787591|FG002|Overall Study|Withdrawal by Subject|4|||
106033824|NCT02674854|365787589|FG000|Overall Study|No-compliant subject|1|||
106033825|NCT02674854|365787590|FG001|Overall Study|No-compliant subject|0|||
106033826|NCT02674854|365787591|FG002|Overall Study|No-compliant subject|1|||
106033827|NCT02674854|365787589|FG000|Overall Study|Lost to Follow-up|1|||
106033828|NCT02674854|365787590|FG001|Overall Study|Lost to Follow-up|0|||
106033829|NCT02674854|365787591|FG002|Overall Study|Lost to Follow-up|2|||
106033830|NCT02674854|365787589|FG000|Overall Study|Lack of Efficacy|0|||
106033831|NCT02674854|365787590|FG001|Overall Study|Lack of Efficacy|3|||
106033832|NCT02674854|365787591|FG002|Overall Study|Lack of Efficacy|0|||
106033833|NCT02674854|365787589|FG000|Overall Study|Disallowed Concurrent Medication|2|||
106033834|NCT02674854|365787590|FG001|Overall Study|Disallowed Concurrent Medication|2|||
106033835|NCT02674854|365787591|FG002|Overall Study|Disallowed Concurrent Medication|0|||
106033836|NCT02674854|365787589|FG000|Overall Study|Protocol Violation|1|||
106033837|NCT02674854|365787590|FG001|Overall Study|Protocol Violation|1|||
106033838|NCT02674854|365787591|FG002|Overall Study|Protocol Violation|2|||
106033839|NCT02674854|365787589|FG000|Overall Study|Death|0|||
106033840|NCT02674854|365787590|FG001|Overall Study|Death|1|||
105857084|NCT00446199|365126934|FG002|Overall Study|Lack of Efficacy|0|||
106033841|NCT02674854|365787591|FG002|Overall Study|Death|0|||
105857085|NCT00446199|365126935|FG003|Overall Study|Lack of Efficacy|1|||
105857086|NCT00446199|365126932|FG000|Overall Study|Non-compliant with study drug|1|||
105857087|NCT00446199|365126933|FG001|Overall Study|Non-compliant with study drug|0|||
105857088|NCT00446199|365126934|FG002|Overall Study|Non-compliant with study drug|5|||
105857089|NCT00446199|365126935|FG003|Overall Study|Non-compliant with study drug|0|||
105857090|NCT00446199|365126932|FG000|Overall Study|Non-compliant with visit schedule|1|||
106033842|NCT02674854|365787589|FG000|Overall Study|Subject missed V6.2|1|||
105857091|NCT00446199|365126933|FG001|Overall Study|Non-compliant with visit schedule|1|||
105857092|NCT00446199|365126934|FG002|Overall Study|Non-compliant with visit schedule|1|||
105857093|NCT00446199|365126935|FG003|Overall Study|Non-compliant with visit schedule|2|||
105857094|NCT00446199|365126932|FG000|Overall Study|Hormone fear|0|||
105857095|NCT00446199|365126933|FG001|Overall Study|Hormone fear|0|||
105857096|NCT00446199|365126934|FG002|Overall Study|Hormone fear|0|||
105857097|NCT00446199|365126935|FG003|Overall Study|Hormone fear|1|||
105857098|NCT00446199|365126932|FG000|Overall Study|Lost interest in study participation|0|||
105857099|NCT00446199|365126933|FG001|Overall Study|Lost interest in study participation|1|||
105857100|NCT00446199|365126934|FG002|Overall Study|Lost interest in study participation|0|||
105857101|NCT00446199|365126935|FG003|Overall Study|Lost interest in study participation|0|||
105857102|NCT00446199|365126932|FG000|Overall Study|In-/Exclusion criterion violated|2|||
105857103|NCT00446199|365126933|FG001|Overall Study|In-/Exclusion criterion violated|1|||
105857104|NCT00446199|365126934|FG002|Overall Study|In-/Exclusion criterion violated|2|||
106033843|NCT02674854|365787590|FG001|Overall Study|Subject missed V6.2|0|||
106033844|NCT02674854|365787591|FG002|Overall Study|Subject missed V6.2|0|||
106033845|NCT00913692|365787592|FG000|Screening (4 Months)|Physician Decision|3|||
106033846|NCT00913692|365787592|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
106033847|NCT00913692|365787592|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
106033848|NCT03985878|365787594|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
106033849|NCT03985878|365787594|FG000|Overall Study|Study Terminated by Sponsor|12|||
106033850|NCT03985878|365787594|FG000|Overall Study|Withdrawal by Subject|1|||
106033851|NCT01470989|365787597|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
106033852|NCT01470989|365787598|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
106033853|NCT01470989|365787597|FG000|Overall Study|Adverse Event|2|||
106033854|NCT01470989|365787598|FG001|Overall Study|Adverse Event|5|||
106033855|NCT01470989|365787597|FG000|Overall Study|Abnormal laboratory value|1|||
106033856|NCT01470989|365787598|FG001|Overall Study|Abnormal laboratory value|1|||
106033857|NCT01470989|365787597|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
106033858|NCT01470989|365787598|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
106033859|NCT01470989|365787597|FG000|Overall Study|Withdrawal by Subject|19|||
106033860|NCT01470989|365787598|FG001|Overall Study|Withdrawal by Subject|17|||
106033861|NCT01470989|365787597|FG000|Overall Study|Lost to Follow-up|18|||
106033862|NCT01470989|365787598|FG001|Overall Study|Lost to Follow-up|13|||
106033863|NCT01470989|365787597|FG000|Overall Study|Administrative problems|2|||
106033864|NCT01470989|365787598|FG001|Overall Study|Administrative problems|4|||
106033865|NCT01470989|365787597|FG000|Overall Study|Death|2|||
106033866|NCT01470989|365787598|FG001|Overall Study|Death|2|||
106033867|NCT01470989|365787597|FG000|Overall Study|Protocol deviation|1|||
106033868|NCT01470989|365787598|FG001|Overall Study|Protocol deviation|2|||
106033869|NCT00969280|365787599|FG000|Overall Study|Protocol Violation|2|||
106033870|NCT00969280|365787600|FG001|Overall Study|Protocol Violation|1|||
106033871|NCT00969280|365787599|FG000|Overall Study|Withdrawal by Subject|0|||
106033872|NCT00969280|365787600|FG001|Overall Study|Withdrawal by Subject|1|||
106033873|NCT00969280|365787599|FG000|Overall Study|infection of influenza A(H1N1)|0|||
106033874|NCT00969280|365787600|FG001|Overall Study|infection of influenza A(H1N1)|1|||
106033875|NCT02290431|365787601|FG000|Overall Study|Adverse Event|20|||
106033876|NCT02290431|365787601|FG000|Overall Study|Progressive disease|4|||
106033877|NCT02290431|365787601|FG000|Overall Study|Study terminated by Sponsor|1|||
106033878|NCT02290431|365787601|FG000|Overall Study|Physician Decision|2|||
106033879|NCT00282347|365787607|FG000|Treatment Period|Death|2|||
106033880|NCT00282347|365787608|FG001|Treatment Period|Death|0|||
106033881|NCT00282347|365787607|FG000|Treatment Period|Lost to Follow-up|2|||
106033882|NCT00282347|365787608|FG001|Treatment Period|Lost to Follow-up|5|||
106033883|NCT00282347|365787607|FG000|Treatment Period|Withdrawal by Subject|1|||
106033884|NCT00282347|365787608|FG001|Treatment Period|Withdrawal by Subject|3|||
106033885|NCT00282347|365787607|FG000|Treatment Period|Physician Decision|0|||
106033886|NCT00282347|365787608|FG001|Treatment Period|Physician Decision|1|||
106033887|NCT00282347|365787607|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
106033888|NCT00282347|365787608|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
106033889|NCT00282347|365787607|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
106033890|NCT00282347|365787608|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
106033891|NCT00282347|365787607|FG000|Safety Follow-up Period|Physician Decision|1|||
106033892|NCT00282347|365787608|FG001|Safety Follow-up Period|Physician Decision|1|||
106033893|NCT00282347|365787607|FG000|Safety Follow-up Period|Protocol Deviation|0|||
105857105|NCT00446199|365126935|FG003|Overall Study|In-/Exclusion criterion violated|1|||
105857106|NCT00446199|365126932|FG000|Overall Study|Move|0|||
105857107|NCT00446199|365126933|FG001|Overall Study|Move|1|||
106033894|NCT00282347|365787608|FG001|Safety Follow-up Period|Protocol Deviation|2|||
106033895|NCT00282347|365787607|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
106033896|NCT00282347|365787608|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
106033897|NCT00282347|365787607|FG000|B Cell Follow-up Period|Physician Decision|1|||
106033898|NCT00282347|365787608|FG001|B Cell Follow-up Period|Physician Decision|0|||
106033899|NCT00282347|365787607|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
106033900|NCT00282347|365787608|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
105857108|NCT00446199|365126934|FG002|Overall Study|Move|0|||
105857109|NCT00446199|365126935|FG003|Overall Study|Move|0|||
105857110|NCT04188301|365126942|FG000|Month 3|Lost to Follow-up|0|||
105857111|NCT04188301|365126943|FG001|Month 3|Lost to Follow-up|0|||
105857112|NCT04188301|365126944|FG002|Month 3|Lost to Follow-up|1|||
105857113|NCT04188301|365126942|FG000|Month 12|Lost to Follow-up|0|||
105857114|NCT04188301|365126943|FG001|Month 12|Lost to Follow-up|0|||
105857115|NCT04188301|365126944|FG002|Month 12|Lost to Follow-up|2|||
105857116|NCT04188301|365126942|FG000|Month 12|Death|1|||
105857117|NCT04188301|365126943|FG001|Month 12|Death|1|||
106033901|NCT00734747|365787612|FG000|SRS Procedure|No staples placed|3|||
106033902|NCT00734747|365787612|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
106033903|NCT03603509|365788816|FG000|Overall Study|Lost to Follow-up|3|||
106033904|NCT03603509|365788817|FG001|Overall Study|Lost to Follow-up|4|||
106033905|NCT01246466|365788820|FG000|Overall Study|Death|1|||
106033906|NCT01246466|365788820|FG000|Overall Study|Withdrawal by Subject|1|||
106033907|NCT01727700|365788823|FG000|Overall Study|Adverse Event|0|||
106033908|NCT01727700|365788824|FG001|Overall Study|Adverse Event|7|||
106033909|NCT01727700|365788825|FG002|Overall Study|Adverse Event|1|||
106033910|NCT01727700|365788823|FG000|Overall Study|Particpant withdrew consent|0|||
106033911|NCT01727700|365788824|FG001|Overall Study|Particpant withdrew consent|3|||
106033912|NCT01727700|365788825|FG002|Overall Study|Particpant withdrew consent|1|||
106033913|NCT01727700|365788823|FG000|Overall Study|Protocol Violation|2|||
106033914|NCT01727700|365788824|FG001|Overall Study|Protocol Violation|0|||
106033915|NCT01727700|365788825|FG002|Overall Study|Protocol Violation|0|||
106033916|NCT02616601|365788826|FG000|Overall Study|Withdrawal by Subject|4|||
106033917|NCT02616601|365788827|FG001|Overall Study|Withdrawal by Subject|4|||
106033918|NCT02616601|365788828|FG002|Overall Study|Withdrawal by Subject|3|||
106033919|NCT02616601|365788826|FG000|Overall Study|Adverse Event|2|||
106033920|NCT02616601|365788827|FG001|Overall Study|Adverse Event|0|||
106033921|NCT02616601|365788828|FG002|Overall Study|Adverse Event|2|||
106033922|NCT02616601|365788826|FG000|Overall Study|Death|1|||
106033923|NCT02616601|365788827|FG001|Overall Study|Death|0|||
106033924|NCT02616601|365788828|FG002|Overall Study|Death|0|||
106033925|NCT02616601|365788826|FG000|Overall Study|Lost to Follow-up|1|||
106033926|NCT02616601|365788827|FG001|Overall Study|Lost to Follow-up|0|||
106033927|NCT02616601|365788828|FG002|Overall Study|Lost to Follow-up|1|||
106033928|NCT02616601|365788826|FG000|Overall Study|Non-Compliance with Test Article|1|||
106033929|NCT02616601|365788827|FG001|Overall Study|Non-Compliance with Test Article|0|||
106033930|NCT02616601|365788828|FG002|Overall Study|Non-Compliance with Test Article|1|||
106033931|NCT01397825|365788838|FG000|Overall Study|Progressive Disease|10|||
106033932|NCT01397825|365788839|FG001|Overall Study|Progressive Disease|3|||
106033933|NCT01397825|365788840|FG002|Overall Study|Progressive Disease|11|||
106033934|NCT01397825|365788841|FG003|Overall Study|Progressive Disease|1|||
106033935|NCT01397825|365788842|FG004|Overall Study|Progressive Disease|0|||
106033936|NCT01397825|365788838|FG000|Overall Study|Symptomatic Deterioration|2|||
106033937|NCT01397825|365788839|FG001|Overall Study|Symptomatic Deterioration|0|||
106033938|NCT01397825|365788840|FG002|Overall Study|Symptomatic Deterioration|4|||
106033939|NCT01397825|365788841|FG003|Overall Study|Symptomatic Deterioration|0|||
106033940|NCT01397825|365788842|FG004|Overall Study|Symptomatic Deterioration|0|||
106033941|NCT01397825|365788838|FG000|Overall Study|Adverse Event|0|||
106033942|NCT01397825|365788839|FG001|Overall Study|Adverse Event|1|||
106033943|NCT01397825|365788840|FG002|Overall Study|Adverse Event|5|||
106033944|NCT01397825|365788841|FG003|Overall Study|Adverse Event|1|||
106033945|NCT01397825|365788842|FG004|Overall Study|Adverse Event|0|||
106033946|NCT01397825|365788838|FG000|Overall Study|Withdrawal by Subject|1|||
106033947|NCT01397825|365788839|FG001|Overall Study|Withdrawal by Subject|0|||
106033948|NCT01397825|365788840|FG002|Overall Study|Withdrawal by Subject|5|||
106033949|NCT01397825|365788841|FG003|Overall Study|Withdrawal by Subject|1|||
106033950|NCT01397825|365788842|FG004|Overall Study|Withdrawal by Subject|0|||
106033951|NCT04618770|365788843|FG000|Overall Study|Censored from Analysis|12|||
106033952|NCT04618770|365788843|FG000|Overall Study|Early Termination|25|||
106033953|NCT02311582|365788846|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
106033954|NCT02311582|365788847|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
106033955|NCT02311582|365788848|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
106033956|NCT02311582|365788849|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
106033957|NCT02311582|365788850|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
106033958|NCT04972630|365788851|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
106033959|NCT04972630|365788852|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
106033960|NCT04972630|365788853|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
106033961|NCT04656275|365788854|FG000|Overall Study|Study terminated by sponsor|2|||
106033962|NCT04656275|365788855|FG001|Overall Study|Study terminated by sponsor|4|||
106033963|NCT00159822|365788861|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
106033964|NCT00159822|365788861|FG000|Voriconazole Treatment Period|Adverse Event|9|||
106033965|NCT00159822|365788861|FG000|Voriconazole Treatment Period|Death|4|||
106033966|NCT00159822|365788861|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
106033967|NCT00159822|365788861|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
105857118|NCT04188301|365126944|FG002|Month 12|Death|0|||
106033968|NCT00159822|365788861|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
106033969|NCT00159822|365788861|FG000|Post-treatment Follow-up Period|Death|1|||
105857119|NCT04188301|365126942|FG000|Month 18|Lost to Follow-up|6|||
105857120|NCT04188301|365126943|FG001|Month 18|Lost to Follow-up|0|||
105857121|NCT04188301|365126944|FG002|Month 18|Lost to Follow-up|0|||
105857122|NCT04639713|365126945|FG000|Overall Study|Protocol Noncompliance|2|||
106033970|NCT00159822|365788861|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
106033971|NCT00159822|365788861|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
106033972|NCT01653132|365788865|FG000|First Intervention|Protocol Violation|1|||
106033973|NCT01653132|365788866|FG001|First Intervention|Protocol Violation|0|||
106033974|NCT03828370|365788867|FG000|3 Month Follow-up|Lost to Follow-up|4|||
106033975|NCT03828370|365788868|FG001|3 Month Follow-up|Lost to Follow-up|12|||
106033976|NCT03828370|365788867|FG000|9 Month Follow up|Lost to Follow-up|12|||
106033977|NCT03828370|365788868|FG001|9 Month Follow up|Lost to Follow-up|20|||
106033978|NCT01029405|365788869|FG000|Overall Study|Withdrawal by Subject|0|||
106033979|NCT01029405|365788870|FG001|Overall Study|Withdrawal by Subject|1|||
106033980|NCT01029405|365788871|FG002|Overall Study|Withdrawal by Subject|2|||
106033981|NCT01029405|365788872|FG003|Overall Study|Withdrawal by Subject|0|||
106033982|NCT01029405|365788869|FG000|Overall Study|Protocol Violation|0|||
106033983|NCT01029405|365788870|FG001|Overall Study|Protocol Violation|0|||
106033984|NCT01029405|365788871|FG002|Overall Study|Protocol Violation|0|||
106033985|NCT01029405|365788872|FG003|Overall Study|Protocol Violation|1|||
106033986|NCT01029405|365788869|FG000|Overall Study|Adverse Event|0|||
106033987|NCT01029405|365788870|FG001|Overall Study|Adverse Event|0|||
106033988|NCT01029405|365788871|FG002|Overall Study|Adverse Event|1|||
106033989|NCT01029405|365788872|FG003|Overall Study|Adverse Event|1|||
106033990|NCT01029405|365788869|FG000|Overall Study|Lost to Follow-up|2|||
106033991|NCT01029405|365788870|FG001|Overall Study|Lost to Follow-up|1|||
106033992|NCT01029405|365788871|FG002|Overall Study|Lost to Follow-up|1|||
106033993|NCT01029405|365788872|FG003|Overall Study|Lost to Follow-up|2|||
106033994|NCT01029405|365788869|FG000|Overall Study|Other|0|||
106033995|NCT01029405|365788870|FG001|Overall Study|Other|1|||
106033996|NCT01029405|365788871|FG002|Overall Study|Other|0|||
106033997|NCT01029405|365788872|FG003|Overall Study|Other|1|||
106033998|NCT00409175|365788873|FG000|Overall Study|Adverse Event|4|||
106033999|NCT00409175|365788874|FG001|Overall Study|Adverse Event|3|||
106034000|NCT00409175|365788873|FG000|Overall Study|Withdrawal by Subject|1|||
106034001|NCT00409175|365788874|FG001|Overall Study|Withdrawal by Subject|2|||
106034002|NCT00409175|365788873|FG000|Overall Study|Negative genotype|0|||
106034003|NCT00409175|365788874|FG001|Overall Study|Negative genotype|1|||
106034004|NCT00409175|365788873|FG000|Overall Study|Liver transplantation|13|||
106034005|NCT00409175|365788874|FG001|Overall Study|Liver transplantation|13|||
106034006|NCT01860846|365788877|FG000|Overall Study|Lost to Follow-up|33|||
106034007|NCT00868517|365788878|FG000|Overall Study|Withdrawal by Subject|3|||
106034008|NCT00868517|365788879|FG001|Overall Study|Withdrawal by Subject|3|||
106034009|NCT00868517|365788880|FG002|Overall Study|Withdrawal by Subject|2|||
106034010|NCT00868517|365788878|FG000|Overall Study|Protocol Violation|1|||
106034011|NCT00868517|365788879|FG001|Overall Study|Protocol Violation|1|||
106034012|NCT00868517|365788880|FG002|Overall Study|Protocol Violation|0|||
106034013|NCT00723203|365788881|FG000|Overall Study|Withdrawal by Subject|3|||
106034014|NCT03901456|365788887|FG000|Overall Study|Withdrawal by Subject|0|||
106034015|NCT03901456|365788888|FG001|Overall Study|Withdrawal by Subject|0|||
106034016|NCT03901456|365788889|FG002|Overall Study|Withdrawal by Subject|1|||
106034017|NCT03901456|365788887|FG000|Overall Study|Lost to Follow-up|0|||
106034018|NCT03901456|365788888|FG001|Overall Study|Lost to Follow-up|1|||
106034019|NCT03901456|365788889|FG002|Overall Study|Lost to Follow-up|0|||
106034020|NCT00768469|365788891|FG000|Overall Study|Adverse Event|0|||
106034021|NCT00768469|365788892|FG001|Overall Study|Adverse Event|2|||
106034022|NCT00768469|365788891|FG000|Overall Study|Disease Progression|3|||
106034023|NCT00768469|365788892|FG001|Overall Study|Disease Progression|4|||
106034024|NCT00768469|365788891|FG000|Overall Study|Withdrawal by Subject|0|||
106034025|NCT00768469|365788892|FG001|Overall Study|Withdrawal by Subject|1|||
106034026|NCT01878149|365788893|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
106034027|NCT01878149|365788894|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
106034028|NCT04672252|365788895|FG000|Overall Study|Protocol Violation|1|||
106034029|NCT04672252|365788896|FG001|Overall Study|Protocol Violation|0|||
106034030|NCT04391569|365788899|FG000|Overall Study|Death|15|||
106034031|NCT04391569|365788900|FG001|Overall Study|Death|10|||
106034032|NCT04391569|365788899|FG000|Overall Study|Withdrawal by Subject|1|||
106034033|NCT04391569|365788900|FG001|Overall Study|Withdrawal by Subject|0|||
106034034|NCT04391569|365788899|FG000|Overall Study|Lost to Follow-up|3|||
106034035|NCT04391569|365788900|FG001|Overall Study|Lost to Follow-up|2|||
106034036|NCT04391569|365788899|FG000|Overall Study|Lack of Efficacy|0|||
106034037|NCT04391569|365788900|FG001|Overall Study|Lack of Efficacy|1|||
106034038|NCT04391569|365788899|FG000|Overall Study|Participant discharged to hospice facility|0|||
106034039|NCT04391569|365788900|FG001|Overall Study|Participant discharged to hospice facility|1|||
106034040|NCT04391569|365788899|FG000|Overall Study|Participant family decision|1|||
106034041|NCT04391569|365788900|FG001|Overall Study|Participant family decision|0|||
106034042|NCT04391569|365788899|FG000|Overall Study|Participant discharged prematurely|1|||
106034043|NCT04391569|365788900|FG001|Overall Study|Participant discharged prematurely|0|||
106034044|NCT03025035|365788901|FG000|Overall Study|Death|2|||
106034045|NCT03025035|365788901|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
106034046|NCT02241889|365788902|FG000|Overall Study|device issues|0|||
106034047|NCT02241889|365788903|FG001|Overall Study|device issues|0|||
106034048|NCT02241889|365788904|FG002|Overall Study|device issues|1|||
106034049|NCT02241889|365788905|FG003|Overall Study|device issues|0|||
106034050|NCT02241889|365788906|FG004|Overall Study|device issues|0|||
106034051|NCT02241889|365788907|FG005|Overall Study|device issues|0|||
106034052|NCT02241889|365788902|FG000|Overall Study|Withdrawal by Subject|0|||
106034053|NCT02241889|365788903|FG001|Overall Study|Withdrawal by Subject|0|||
106034054|NCT02241889|365788904|FG002|Overall Study|Withdrawal by Subject|0|||
106034055|NCT02241889|365788905|FG003|Overall Study|Withdrawal by Subject|0|||
106034056|NCT02241889|365788906|FG004|Overall Study|Withdrawal by Subject|0|||
106034057|NCT02241889|365788907|FG005|Overall Study|Withdrawal by Subject|1|||
106034058|NCT00484185|365788908|FG000|Overall Study|Lost to Follow-up|44|||
106034059|NCT00484185|365788908|FG000|Overall Study|Other|20|||
106034060|NCT00484185|365788908|FG000|Overall Study|Randomized but not treated|5|||
106034061|NCT00484185|365788908|FG000|Overall Study|Death|2|||
106034062|NCT02650921|365788910|FG000|Overall Study|Withdrawal by Subject|4|||
106034063|NCT02650921|365788910|FG000|Overall Study|Lost to Follow-up|2|||
106034064|NCT02650921|365788910|FG000|Overall Study|Adverse Event|1|||
106034065|NCT02650921|365788910|FG000|Overall Study|Due to Medical Condition|1|||
106034066|NCT03562767|365788913|FG000|Overall Study|Physician Decision|2|||
106034067|NCT03562767|365788914|FG001|Overall Study|Physician Decision|0|||
106034068|NCT03562767|365788915|FG002|Overall Study|Physician Decision|0|||
106034069|NCT03562767|365788913|FG000|Overall Study|Logistic Reason|1|||
106034070|NCT03562767|365788914|FG001|Overall Study|Logistic Reason|3|||
106034071|NCT03562767|365788915|FG002|Overall Study|Logistic Reason|0|||
106034072|NCT02048241|365788918|FG000|Overall Study|Withdrawal by Subject|0|||
106034073|NCT02048241|365788919|FG001|Overall Study|Withdrawal by Subject|1|||
106034074|NCT01853618|365788922|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
106034075|NCT01853618|365788923|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
106034076|NCT01853618|365788924|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
106034077|NCT01853618|365788925|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
106034078|NCT01853618|365788926|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
106034079|NCT01853618|365788922|FG000|Overall Study|Progressive disease|1|||
106034080|NCT01853618|365788923|FG001|Overall Study|Progressive disease|1|||
106034081|NCT01853618|365788924|FG002|Overall Study|Progressive disease|1|||
106034082|NCT01853618|365788925|FG003|Overall Study|Progressive disease|1|||
106034083|NCT01853618|365788926|FG004|Overall Study|Progressive disease|2|||
106034084|NCT01853618|365788922|FG000|Overall Study|Physician Decision|0|||
106034085|NCT01853618|365788923|FG001|Overall Study|Physician Decision|1|||
106034086|NCT01853618|365788924|FG002|Overall Study|Physician Decision|1|||
106034087|NCT01853618|365788925|FG003|Overall Study|Physician Decision|0|||
106034088|NCT01853618|365788926|FG004|Overall Study|Physician Decision|0|||
106034089|NCT01853618|365788922|FG000|Overall Study|Refused further treatment|0|||
106034090|NCT01853618|365788923|FG001|Overall Study|Refused further treatment|0|||
106034091|NCT01853618|365788924|FG002|Overall Study|Refused further treatment|0|||
106034092|NCT01853618|365788925|FG003|Overall Study|Refused further treatment|0|||
106034093|NCT01853618|365788926|FG004|Overall Study|Refused further treatment|1|||
106034094|NCT01658813|365788927|FG000|Overall Study|Disease progression|3|||
106034095|NCT05615935|365788928|FG000|Overall Study|Lost to Follow-up|1|||
106034096|NCT05615935|365788929|FG001|Overall Study|Lost to Follow-up|1|||
106034097|NCT00938886|365788930|FG000|Overall Study|Death|0|||
106034098|NCT00938886|365788931|FG001|Overall Study|Death|1|||
106034099|NCT00938886|365788930|FG000|Overall Study|Withdrawal by Subject|4|||
106034100|NCT00938886|365788931|FG001|Overall Study|Withdrawal by Subject|7|||
106034101|NCT00938886|365788930|FG000|Overall Study|Lost to Follow-up|3|||
106034102|NCT00938886|365788931|FG001|Overall Study|Lost to Follow-up|2|||
106034103|NCT01585584|365788938|FG000|Overall Study|Lack of Efficacy|1|||
106034104|NCT01585584|365788938|FG000|Overall Study|Withdrawal by Subject|1|||
106034105|NCT01585584|365788938|FG000|Overall Study|Physician Decision|2|||
106034106|NCT00527488|365788939|FG000|Overall Study|Withdrawn prior to dosing|0|||
106034107|NCT00527488|365788940|FG001|Overall Study|Withdrawn prior to dosing|1|||
106034108|NCT00527488|365788941|FG002|Overall Study|Withdrawn prior to dosing|1|||
106034109|NCT00527488|365788942|FG003|Overall Study|Withdrawn prior to dosing|0|||
106034110|NCT00523367|365788947|FG000|Overall Study|19 screen failures|19|||
106034111|NCT00523367|365788947|FG000|Overall Study|4 Withdrawn by PI|4|||
106034112|NCT04480424|365788950|FG000|Overall Study|Withdrawal by Subject|0|||
105857123|NCT04639713|365126945|FG000|Overall Study|Withdrawal by Subject|1|||
106034113|NCT04480424|365788951|FG001|Overall Study|Withdrawal by Subject|2|||
106034114|NCT04480424|365788950|FG000|Overall Study|Lost to Follow-up|3|||
106034115|NCT04480424|365788951|FG001|Overall Study|Lost to Follow-up|3|||
106034116|NCT04480424|365788950|FG000|Overall Study|Death|14|||
106034117|NCT04480424|365788951|FG001|Overall Study|Death|16|||
106034118|NCT04480424|365788950|FG000|Overall Study|Reason not Specified|5|||
106034119|NCT04480424|365788951|FG001|Overall Study|Reason not Specified|5|||
106034120|NCT01163318|365788952|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
106034121|NCT01163318|365788952|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
106034122|NCT01163318|365788952|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
106034123|NCT01163318|365788952|FG000|Overall Study|Participants Without Case Report Form|7|||
106034124|NCT01163318|365788952|FG000|Overall Study|Multiple Reasons Per Participant|224|||
106034125|NCT00336583|365790168|FG000|Overall Study|Lost to Follow-up|1|||
106034126|NCT00336583|365790168|FG000|Overall Study|Death|1|||
106034127|NCT01527357|365790171|FG000|Overall Study|Death|8|||
106034128|NCT01527357|365790172|FG001|Overall Study|Death|2|||
106034129|NCT01527357|365790171|FG000|Overall Study|Lost to Follow-up|6|||
106034130|NCT01527357|365790172|FG001|Overall Study|Lost to Follow-up|4|||
106034131|NCT01527357|365790171|FG000|Overall Study|Withdrew Consent|1|||
106034132|NCT01527357|365790172|FG001|Overall Study|Withdrew Consent|1|||
106034133|NCT01527357|365790171|FG000|Overall Study|Non-compliance|0|||
106034134|NCT01527357|365790172|FG001|Overall Study|Non-compliance|1|||
106034135|NCT01527357|365790171|FG000|Overall Study|No Day 29 Visit|0|||
106034136|NCT01527357|365790172|FG001|Overall Study|No Day 29 Visit|1|||
106034137|NCT01527357|365790171|FG000|Overall Study|Did Not Receive Treatment|2|||
106034138|NCT01527357|365790172|FG001|Overall Study|Did Not Receive Treatment|0|||
106034139|NCT01142089|365790178|FG000|Overall Study|Physician Decision|1|||
106034140|NCT01142089|365790179|FG001|Overall Study|Physician Decision|0|||
106034141|NCT01142089|365790178|FG000|Overall Study|Withdrawal by Subject|1|||
106034142|NCT01142089|365790179|FG001|Overall Study|Withdrawal by Subject|2|||
106034143|NCT01142089|365790178|FG000|Overall Study|Use of prohibited medications|0|||
106034144|NCT01142089|365790179|FG001|Overall Study|Use of prohibited medications|1|||
106034145|NCT01142089|365790178|FG000|Overall Study|Noncompliance with study procedures|2|||
106034146|NCT01142089|365790179|FG001|Overall Study|Noncompliance with study procedures|1|||
106034147|NCT01142089|365790178|FG000|Overall Study|Patient required rescue medication|8|||
106034148|NCT01142089|365790179|FG001|Overall Study|Patient required rescue medication|17|||
106034149|NCT00910247|365790180|FG000|Overall Study|Adverse Event|15|||
106034150|NCT00910247|365790180|FG000|Overall Study|Death|2|||
106034151|NCT00910247|365790180|FG000|Overall Study|Lost to Follow-up|10|||
106034152|NCT00910247|365790180|FG000|Overall Study|Physician Decision|3|||
106034153|NCT00910247|365790180|FG000|Overall Study|Protocol Violation|10|||
106034154|NCT00910247|365790180|FG000|Overall Study|Withdrawal by Subject|25|||
106034155|NCT00910247|365790180|FG000|Overall Study|Not collected|4|||
106034156|NCT00504582|365790181|FG000|Overall Study|Lost to Follow-up|1|||
106034157|NCT00504582|365790182|FG001|Overall Study|Lost to Follow-up|0|||
106034158|NCT00504582|365790183|FG002|Overall Study|Lost to Follow-up|0|||
106034159|NCT01992159|365790186|FG000|Overall Study|Withdrawal by Subject|4|||
106034160|NCT01992159|365790187|FG001|Overall Study|Withdrawal by Subject|7|||
106034161|NCT01992159|365790188|FG002|Overall Study|Withdrawal by Subject|0|||
106034162|NCT01992159|365790189|FG003|Overall Study|Withdrawal by Subject|3|||
106034163|NCT01992159|365790186|FG000|Overall Study|Adverse Event|0|||
106034164|NCT01992159|365790187|FG001|Overall Study|Adverse Event|1|||
106034165|NCT01992159|365790188|FG002|Overall Study|Adverse Event|0|||
106034166|NCT01992159|365790189|FG003|Overall Study|Adverse Event|1|||
106034167|NCT01992159|365790186|FG000|Overall Study|Death|0|||
106034168|NCT01992159|365790187|FG001|Overall Study|Death|0|||
106034169|NCT01992159|365790188|FG002|Overall Study|Death|1|||
106034170|NCT01992159|365790189|FG003|Overall Study|Death|0|||
106034171|NCT01437995|365790190|FG000|Overall Study|Lost to Follow-up|11|||
106034172|NCT01437995|365790191|FG001|Overall Study|Lost to Follow-up|18|||
106034173|NCT01437995|365790192|FG002|Overall Study|Lost to Follow-up|20|||
106034174|NCT02038829|365790195|FG000|Washout Period 1|Death|0|||
106034175|NCT02038829|365790196|FG001|Washout Period 1|Death|0|||
106034176|NCT02038829|365790197|FG002|Washout Period 1|Death|0|||
106034177|NCT02038829|365790198|FG003|Washout Period 1|Death|0|||
106034178|NCT02038829|365790199|FG004|Washout Period 1|Death|1|||
106034179|NCT02038829|365790200|FG005|Washout Period 1|Death|0|||
106034180|NCT02038829|365790201|FG006|Washout Period 1|Death|0|||
106034181|NCT02038829|365790202|FG007|Washout Period 1|Death|0|||
106034182|NCT02038829|365790203|FG008|Washout Period 1|Death|0|||
106034183|NCT02038829|365790204|FG009|Washout Period 1|Death|0|||
106034184|NCT02038829|365790205|FG010|Washout Period 1|Death|0|||
106034185|NCT02038829|365790206|FG011|Washout Period 1|Death|0|||
106034186|NCT02038829|365790195|FG000|Treatment Period 2|Adverse Event|0|||
106034187|NCT02038829|365790196|FG001|Treatment Period 2|Adverse Event|0|||
106034188|NCT02038829|365790197|FG002|Treatment Period 2|Adverse Event|0|||
106034189|NCT02038829|365790198|FG003|Treatment Period 2|Adverse Event|0|||
106034190|NCT02038829|365790199|FG004|Treatment Period 2|Adverse Event|0|||
106034191|NCT02038829|365790200|FG005|Treatment Period 2|Adverse Event|0|||
106034192|NCT02038829|365790201|FG006|Treatment Period 2|Adverse Event|0|||
106034193|NCT02038829|365790202|FG007|Treatment Period 2|Adverse Event|0|||
106034194|NCT02038829|365790203|FG008|Treatment Period 2|Adverse Event|0|||
106034195|NCT02038829|365790204|FG009|Treatment Period 2|Adverse Event|0|||
106034196|NCT02038829|365790205|FG010|Treatment Period 2|Adverse Event|1|||
106034197|NCT02038829|365790206|FG011|Treatment Period 2|Adverse Event|0|||
106034198|NCT02038829|365790195|FG000|Treatment Period 2|Withdrawal by Subject|1|||
106034199|NCT02038829|365790196|FG001|Treatment Period 2|Withdrawal by Subject|0|||
106034200|NCT02038829|365790197|FG002|Treatment Period 2|Withdrawal by Subject|0|||
106034201|NCT02038829|365790198|FG003|Treatment Period 2|Withdrawal by Subject|0|||
106034202|NCT02038829|365790199|FG004|Treatment Period 2|Withdrawal by Subject|0|||
106034203|NCT02038829|365790200|FG005|Treatment Period 2|Withdrawal by Subject|0|||
106034204|NCT02038829|365790201|FG006|Treatment Period 2|Withdrawal by Subject|0|||
106034205|NCT02038829|365790202|FG007|Treatment Period 2|Withdrawal by Subject|0|||
106034206|NCT02038829|365790203|FG008|Treatment Period 2|Withdrawal by Subject|0|||
106034207|NCT02038829|365790204|FG009|Treatment Period 2|Withdrawal by Subject|0|||
106034208|NCT02038829|365790205|FG010|Treatment Period 2|Withdrawal by Subject|0|||
106034209|NCT02038829|365790206|FG011|Treatment Period 2|Withdrawal by Subject|0|||
106034210|NCT02038829|365790195|FG000|Washout Period 2|Adverse Event|0|||
106034211|NCT02038829|365790196|FG001|Washout Period 2|Adverse Event|0|||
106034212|NCT02038829|365790197|FG002|Washout Period 2|Adverse Event|0|||
106034213|NCT02038829|365790198|FG003|Washout Period 2|Adverse Event|0|||
106034214|NCT02038829|365790199|FG004|Washout Period 2|Adverse Event|0|||
106034215|NCT02038829|365790200|FG005|Washout Period 2|Adverse Event|0|||
106034216|NCT02038829|365790201|FG006|Washout Period 2|Adverse Event|0|||
106034217|NCT02038829|365790202|FG007|Washout Period 2|Adverse Event|0|||
106034218|NCT02038829|365790203|FG008|Washout Period 2|Adverse Event|1|||
106034219|NCT02038829|365790204|FG009|Washout Period 2|Adverse Event|0|||
106034220|NCT02038829|365790205|FG010|Washout Period 2|Adverse Event|0|||
106034221|NCT02038829|365790206|FG011|Washout Period 2|Adverse Event|0|||
106034222|NCT02038829|365790195|FG000|Washout Period 2|Withdrawal by Subject|0|||
106034223|NCT02038829|365790196|FG001|Washout Period 2|Withdrawal by Subject|0|||
106034224|NCT02038829|365790197|FG002|Washout Period 2|Withdrawal by Subject|0|||
106034225|NCT02038829|365790198|FG003|Washout Period 2|Withdrawal by Subject|0|||
106034226|NCT02038829|365790199|FG004|Washout Period 2|Withdrawal by Subject|0|||
106034227|NCT02038829|365790200|FG005|Washout Period 2|Withdrawal by Subject|1|||
106034228|NCT02038829|365790201|FG006|Washout Period 2|Withdrawal by Subject|0|||
106034229|NCT02038829|365790202|FG007|Washout Period 2|Withdrawal by Subject|0|||
106034230|NCT02038829|365790203|FG008|Washout Period 2|Withdrawal by Subject|0|||
106034231|NCT02038829|365790204|FG009|Washout Period 2|Withdrawal by Subject|0|||
106034232|NCT02038829|365790205|FG010|Washout Period 2|Withdrawal by Subject|0|||
106034233|NCT02038829|365790206|FG011|Washout Period 2|Withdrawal by Subject|0|||
106034234|NCT02038829|365790195|FG000|Treatment Period 4|Adverse Event|0|||
106034235|NCT02038829|365790196|FG001|Treatment Period 4|Adverse Event|1|||
106034236|NCT02038829|365790197|FG002|Treatment Period 4|Adverse Event|0|||
106034237|NCT02038829|365790198|FG003|Treatment Period 4|Adverse Event|0|||
106034238|NCT02038829|365790199|FG004|Treatment Period 4|Adverse Event|0|||
106034239|NCT02038829|365790200|FG005|Treatment Period 4|Adverse Event|0|||
106034240|NCT02038829|365790201|FG006|Treatment Period 4|Adverse Event|0|||
106034241|NCT02038829|365790202|FG007|Treatment Period 4|Adverse Event|0|||
106034242|NCT02038829|365790203|FG008|Treatment Period 4|Adverse Event|0|||
106034243|NCT02038829|365790204|FG009|Treatment Period 4|Adverse Event|0|||
106034244|NCT02038829|365790205|FG010|Treatment Period 4|Adverse Event|0|||
106034245|NCT02038829|365790206|FG011|Treatment Period 4|Adverse Event|0|||
106034246|NCT02038829|365790195|FG000|Washout Period 4|Adverse Event|0|||
106034247|NCT02038829|365790196|FG001|Washout Period 4|Adverse Event|0|||
106034248|NCT02038829|365790197|FG002|Washout Period 4|Adverse Event|0|||
106034249|NCT02038829|365790198|FG003|Washout Period 4|Adverse Event|0|||
106034250|NCT02038829|365790199|FG004|Washout Period 4|Adverse Event|0|||
106034251|NCT02038829|365790200|FG005|Washout Period 4|Adverse Event|0|||
106034252|NCT02038829|365790201|FG006|Washout Period 4|Adverse Event|1|||
106034253|NCT02038829|365790202|FG007|Washout Period 4|Adverse Event|0|||
106034254|NCT02038829|365790203|FG008|Washout Period 4|Adverse Event|0|||
106034255|NCT02038829|365790204|FG009|Washout Period 4|Adverse Event|0|||
106034256|NCT02038829|365790205|FG010|Washout Period 4|Adverse Event|0|||
106034257|NCT02038829|365790206|FG011|Washout Period 4|Adverse Event|0|||
106034258|NCT02038829|365790195|FG000|Treatment Period 6|Adverse Event|0|||
106034259|NCT02038829|365790196|FG001|Treatment Period 6|Adverse Event|0|||
105857124|NCT00390221|365126946|FG000|Overall Study|Lost to Follow-up|0|||
106034260|NCT02038829|365790197|FG002|Treatment Period 6|Adverse Event|1|||
106034261|NCT02038829|365790198|FG003|Treatment Period 6|Adverse Event|0|||
106034262|NCT02038829|365790199|FG004|Treatment Period 6|Adverse Event|0|||
106034263|NCT02038829|365790200|FG005|Treatment Period 6|Adverse Event|0|||
106034264|NCT02038829|365790201|FG006|Treatment Period 6|Adverse Event|0|||
106034265|NCT02038829|365790202|FG007|Treatment Period 6|Adverse Event|0|||
105857125|NCT00390221|365126947|FG001|Overall Study|Lost to Follow-up|3|||
106034266|NCT02038829|365790203|FG008|Treatment Period 6|Adverse Event|0|||
106034267|NCT02038829|365790204|FG009|Treatment Period 6|Adverse Event|0|||
106034268|NCT02038829|365790205|FG010|Treatment Period 6|Adverse Event|0|||
105857126|NCT00390221|365126948|FG002|Overall Study|Lost to Follow-up|0|||
105857127|NCT00390221|365126946|FG000|Overall Study|Adverse Event|1|||
105857128|NCT00390221|365126947|FG001|Overall Study|Adverse Event|4|||
105857129|NCT00390221|365126948|FG002|Overall Study|Adverse Event|3|||
105857130|NCT00390221|365126946|FG000|Overall Study|Investigator Decision|0|||
105857131|NCT00390221|365126947|FG001|Overall Study|Investigator Decision|0|||
105857132|NCT00390221|365126948|FG002|Overall Study|Investigator Decision|1|||
105857133|NCT00390221|365126946|FG000|Overall Study|Withdrawal by Subject|13|||
105857134|NCT00390221|365126947|FG001|Overall Study|Withdrawal by Subject|9|||
105857135|NCT00390221|365126948|FG002|Overall Study|Withdrawal by Subject|7|||
105857136|NCT00390221|365126946|FG000|Overall Study|Subject Non-compliance|1|||
105857137|NCT00390221|365126947|FG001|Overall Study|Subject Non-compliance|0|||
105857138|NCT00390221|365126948|FG002|Overall Study|Subject Non-compliance|2|||
105857139|NCT00390221|365126946|FG000|Overall Study|Other|3|||
105857140|NCT00390221|365126947|FG001|Overall Study|Other|4|||
105857141|NCT00390221|365126948|FG002|Overall Study|Other|2|||
105857142|NCT00857584|365126949|FG000|Overall Study|Lack of Efficacy|1|||
105857143|NCT00857584|365126950|FG001|Overall Study|Lack of Efficacy|2|||
106034269|NCT02038829|365790206|FG011|Treatment Period 6|Adverse Event|0|||
106034270|NCT00978432|365790207|FG000|Overall Study|Withdrawal by Subject|0|||
106034271|NCT00978432|365790208|FG001|Overall Study|Withdrawal by Subject|0|||
106034272|NCT00978432|365790209|FG002|Overall Study|Withdrawal by Subject|1|||
105857144|NCT00857584|365126949|FG000|Overall Study|Adverse Event|2|||
105857145|NCT00857584|365126950|FG001|Overall Study|Adverse Event|2|||
105857146|NCT00857584|365126949|FG000|Overall Study|Physician Decision|1|||
106034273|NCT00978432|365790207|FG000|Overall Study|Lack of Efficacy|1|||
106034274|NCT00978432|365790208|FG001|Overall Study|Lack of Efficacy|1|||
106034275|NCT00978432|365790209|FG002|Overall Study|Lack of Efficacy|3|||
106034276|NCT00978432|365790207|FG000|Overall Study|Adverse Event|2|||
106034277|NCT00978432|365790208|FG001|Overall Study|Adverse Event|0|||
106034278|NCT00978432|365790209|FG002|Overall Study|Adverse Event|1|||
106034279|NCT01895361|365790214|FG000|Overall Study|Adverse Event|1|||
106034280|NCT01895361|365790215|FG001|Overall Study|Adverse Event|1|||
106034281|NCT01895361|365790216|FG002|Overall Study|Adverse Event|3|||
106034282|NCT01895361|365790214|FG000|Overall Study|Death|2|||
106034283|NCT01895361|365790215|FG001|Overall Study|Death|1|||
106034284|NCT01895361|365790216|FG002|Overall Study|Death|2|||
106034285|NCT01895361|365790214|FG000|Overall Study|Lost to Follow-up|4|||
106034286|NCT01895361|365790215|FG001|Overall Study|Lost to Follow-up|4|||
106034287|NCT01895361|365790216|FG002|Overall Study|Lost to Follow-up|6|||
106034288|NCT01895361|365790214|FG000|Overall Study|Non-compliance with study|1|||
106034289|NCT01895361|365790215|FG001|Overall Study|Non-compliance with study|3|||
106034290|NCT01895361|365790216|FG002|Overall Study|Non-compliance with study|1|||
106034291|NCT01895361|365790214|FG000|Overall Study|Physician Decision|2|||
106034292|NCT01895361|365790215|FG001|Overall Study|Physician Decision|2|||
106034293|NCT01895361|365790216|FG002|Overall Study|Physician Decision|2|||
106034294|NCT01895361|365790214|FG000|Overall Study|Withdrawal by Subject|7|||
106034295|NCT01895361|365790215|FG001|Overall Study|Withdrawal by Subject|6|||
106034296|NCT01895361|365790216|FG002|Overall Study|Withdrawal by Subject|6|||
106034297|NCT01895361|365790214|FG000|Overall Study|Lack of Efficacy|0|||
106034298|NCT01895361|365790215|FG001|Overall Study|Lack of Efficacy|1|||
106034299|NCT01895361|365790216|FG002|Overall Study|Lack of Efficacy|0|||
106034300|NCT01895361|365790214|FG000|Overall Study|Reasons different from categories above|7|||
106034301|NCT01895361|365790215|FG001|Overall Study|Reasons different from categories above|3|||
106034302|NCT01895361|365790216|FG002|Overall Study|Reasons different from categories above|4|||
106034303|NCT01209832|365790220|FG000|Period 1|Sponsor Decision and was not dosed|1|||
106034304|NCT01209832|365790220|FG000|Period 2|Sponsor Decision|1|||
106034305|NCT01268579|365790221|FG000|Overall Study|Adverse Event|1|||
106034306|NCT01268579|365790221|FG000|Overall Study|Withdrawal by Subject|2|||
106034307|NCT00761150|365790222|FG000|Open-label Period|Adverse Event|36|||
106034308|NCT00761150|365790223|FG001|Open-label Period|Adverse Event|0|||
106034309|NCT00761150|365790224|FG002|Open-label Period|Adverse Event|0|||
106034310|NCT00761150|365790222|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
106034311|NCT00761150|365790223|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
106034312|NCT00761150|365790224|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
106034313|NCT00761150|365790222|FG000|Open-label Period|Lost to Follow-up|7|||
106034314|NCT00761150|365790223|FG001|Open-label Period|Lost to Follow-up|0|||
106034315|NCT00761150|365790224|FG002|Open-label Period|Lost to Follow-up|0|||
106034316|NCT00761150|365790222|FG000|Open-label Period|Lack of Efficacy|4|||
106034317|NCT00761150|365790223|FG001|Open-label Period|Lack of Efficacy|0|||
106034318|NCT00761150|365790224|FG002|Open-label Period|Lack of Efficacy|0|||
106034319|NCT00761150|365790222|FG000|Open-label Period|Withdrawal by Subject|5|||
106034320|NCT00761150|365790223|FG001|Open-label Period|Withdrawal by Subject|0|||
106034321|NCT00761150|365790224|FG002|Open-label Period|Withdrawal by Subject|0|||
106034322|NCT00761150|365790222|FG000|Open-label Period|Noncompliance|2|||
106034323|NCT00761150|365790223|FG001|Open-label Period|Noncompliance|0|||
106034324|NCT00761150|365790224|FG002|Open-label Period|Noncompliance|0|||
106034325|NCT00761150|365790222|FG000|Open-label Period|Other|5|||
106034326|NCT00761150|365790223|FG001|Open-label Period|Other|0|||
106034327|NCT00761150|365790224|FG002|Open-label Period|Other|0|||
106034328|NCT00761150|365790222|FG000|Double-blind Period|Lack of Efficacy|0|||
106034329|NCT00761150|365790223|FG001|Double-blind Period|Lack of Efficacy|2|||
106034330|NCT00761150|365790224|FG002|Double-blind Period|Lack of Efficacy|19|||
106034331|NCT00761150|365790222|FG000|Double-blind Period|Adverse Event|0|||
106034332|NCT00761150|365790223|FG001|Double-blind Period|Adverse Event|3|||
106034333|NCT00761150|365790224|FG002|Double-blind Period|Adverse Event|3|||
106034334|NCT00761150|365790222|FG000|Double-blind Period|Withdrawal by Subject|0|||
106034335|NCT00761150|365790223|FG001|Double-blind Period|Withdrawal by Subject|3|||
106034336|NCT00761150|365790224|FG002|Double-blind Period|Withdrawal by Subject|2|||
106034337|NCT00761150|365790222|FG000|Double-blind Period|Lost to Follow-up|0|||
106034338|NCT00761150|365790223|FG001|Double-blind Period|Lost to Follow-up|2|||
106034339|NCT00761150|365790224|FG002|Double-blind Period|Lost to Follow-up|1|||
106034340|NCT00761150|365790222|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
106034341|NCT00761150|365790223|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
106034342|NCT00761150|365790224|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
106034343|NCT00761150|365790222|FG000|Double-blind Period|Noncompliance|0|||
106034344|NCT00761150|365790223|FG001|Double-blind Period|Noncompliance|1|||
106034345|NCT00761150|365790224|FG002|Double-blind Period|Noncompliance|0|||
106034346|NCT00761150|365790222|FG000|Double-blind Period|Other|0|||
106034347|NCT00761150|365790223|FG001|Double-blind Period|Other|3|||
106034348|NCT00761150|365790224|FG002|Double-blind Period|Other|3|||
106034349|NCT03312751|365790225|FG000|Overall Study|Death|7|||
106034350|NCT03312751|365790226|FG001|Overall Study|Death|9|||
106034351|NCT03312751|365790225|FG000|Overall Study|Study discontinuation due to other reason|0|||
106034352|NCT03312751|365790226|FG001|Overall Study|Study discontinuation due to other reason|1|||
106034353|NCT02692651|365790227|FG000|Study Treatment|Death|7|||
106034354|NCT02692651|365790228|FG001|Study Treatment|Death|3|||
106034355|NCT02692651|365790227|FG000|Study Treatment|comfort care|1|||
106034356|NCT02692651|365790228|FG001|Study Treatment|comfort care|1|||
106034357|NCT02692651|365790227|FG000|Study Treatment|Protocol violation per treating team preference|8|||
106034358|NCT02692651|365790228|FG001|Study Treatment|Protocol violation per treating team preference|6|||
106034359|NCT02692651|365790227|FG000|Post Study Treatment Follow-up|Death|4|||
106034360|NCT02692651|365790228|FG001|Post Study Treatment Follow-up|Death|4|||
106034361|NCT03490981|365790229|FG000|Overall Study|Lost to Follow-up|1|||
106034362|NCT03490981|365790230|FG001|Overall Study|Lost to Follow-up|2|||
106034363|NCT00282464|365790237|FG000|Overall Study|Adverse Event|26|||
106034364|NCT00282464|365790238|FG001|Overall Study|Adverse Event|20|||
106034365|NCT00282464|365790237|FG000|Overall Study|Lack of Efficacy|8|||
106034366|NCT00282464|365790238|FG001|Overall Study|Lack of Efficacy|8|||
106034367|NCT00282464|365790237|FG000|Overall Study|Lost to Follow-up|10|||
106034368|NCT00282464|365790238|FG001|Overall Study|Lost to Follow-up|10|||
106034369|NCT00282464|365790237|FG000|Overall Study|Withdrawal by Subject|24|||
106034370|NCT00282464|365790238|FG001|Overall Study|Withdrawal by Subject|10|||
106034371|NCT00282464|365790237|FG000|Overall Study|laboratory abnormality|1|||
106034372|NCT00282464|365790238|FG001|Overall Study|laboratory abnormality|2|||
105857147|NCT00857584|365126950|FG001|Overall Study|Physician Decision|1|||
105857148|NCT00960115|365126953|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
105857149|NCT00960115|365126954|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
105857150|NCT01177059|365126960|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
105857151|NCT01177059|365126960|FG000|Overall Study|Withdrew consent|2|||
105857152|NCT01177059|365126960|FG000|Overall Study|Lost to Follow-up|18|||
105857153|NCT00006721|365129355|FG000|Overall Study|Adverse Event|0|||
105857154|NCT00006721|365129356|FG001|Overall Study|Adverse Event|4|||
105857155|NCT00006721|365129357|FG002|Overall Study|Adverse Event|4|||
105857156|NCT00006721|365129355|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
105857157|NCT00006721|365129356|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
105857158|NCT00006721|365129357|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
105857159|NCT00006721|365129355|FG000|Overall Study|Progression/Relapse|0|||
105857160|NCT00006721|365129356|FG001|Overall Study|Progression/Relapse|1|||
105857161|NCT00006721|365129357|FG002|Overall Study|Progression/Relapse|2|||
105857162|NCT00006721|365129355|FG000|Overall Study|Death|0|||
105857163|NCT00006721|365129356|FG001|Overall Study|Death|1|||
105857164|NCT00006721|365129357|FG002|Overall Study|Death|2|||
105857165|NCT00006721|365129355|FG000|Overall Study|Other - Not Protocol Specified|0|||
105857166|NCT00006721|365129356|FG001|Overall Study|Other - Not Protocol Specified|7|||
105857167|NCT00006721|365129357|FG002|Overall Study|Other - Not Protocol Specified|7|||
105857168|NCT00006721|365129355|FG000|Overall Study|Ineligible|2|||
105857169|NCT00006721|365129356|FG001|Overall Study|Ineligible|12|||
105857170|NCT00006721|365129357|FG002|Overall Study|Ineligible|10|||
105857171|NCT00006721|365129355|FG000|Overall Study|Eligible but no Treatment Received|1|||
105857172|NCT00006721|365129356|FG001|Overall Study|Eligible but no Treatment Received|0|||
105857173|NCT00006721|365129357|FG002|Overall Study|Eligible but no Treatment Received|0|||
105857174|NCT03845296|365129358|FG000|Overall Study|On Treatment|2|||
105857175|NCT03845296|365129359|FG001|Overall Study|On Treatment|1|||
105857176|NCT03845296|365129358|FG000|Overall Study|Adverse Event|4|||
105857177|NCT03845296|365129359|FG001|Overall Study|Adverse Event|11|||
105857178|NCT03845296|365129358|FG000|Overall Study|Refusal unrelated to adverse event|0|||
105857179|NCT03845296|365129359|FG001|Overall Study|Refusal unrelated to adverse event|1|||
105857180|NCT03845296|365129358|FG000|Overall Study|Progression/relapse|14|||
105857181|NCT03845296|365129359|FG001|Overall Study|Progression/relapse|18|||
105857182|NCT03845296|365129358|FG000|Overall Study|Death|4|||
105857183|NCT03845296|365129359|FG001|Overall Study|Death|0|||
105857184|NCT03845296|365129358|FG000|Overall Study|Other - not protocol specified|1|||
105857185|NCT03845296|365129359|FG001|Overall Study|Other - not protocol specified|3|||
105857186|NCT06077487|365129362|FG000|Overall Study|Withdrawal by Subject|0|||
105857187|NCT06077487|365129363|FG001|Overall Study|Withdrawal by Subject|1|||
105857188|NCT00721630|365129370|FG000|Overall Study|Participant found to be ineligible|1|||
105857189|NCT00191113|365129378|FG000|Core Study|Withdrawal by Subject|25|||
105857190|NCT00191113|365129379|FG001|Core Study|Withdrawal by Subject|9|||
105857191|NCT00191113|365129378|FG000|Core Study|Protocol Violation|6|||
105857192|NCT00191113|365129379|FG001|Core Study|Protocol Violation|2|||
105857193|NCT00191113|365129378|FG000|Core Study|Lost to Follow-up|3|||
105857194|NCT00191113|365129379|FG001|Core Study|Lost to Follow-up|0|||
106034373|NCT00282464|365790237|FG000|Overall Study|Protocol Violation|0|||
106034374|NCT00282464|365790238|FG001|Overall Study|Protocol Violation|7|||
106034375|NCT00282464|365790237|FG000|Overall Study|Patient moved|1|||
106034376|NCT00282464|365790238|FG001|Overall Study|Patient moved|0|||
106034377|NCT00282464|365790237|FG000|Overall Study|patient non-compliant|3|||
106034378|NCT00282464|365790238|FG001|Overall Study|patient non-compliant|0|||
106034379|NCT00282464|365790237|FG000|Overall Study|patient no show|0|||
106034380|NCT00282464|365790238|FG001|Overall Study|patient no show|1|||
106034381|NCT00282464|365790237|FG000|Overall Study|patient incarcerated|0|||
106034382|NCT00282464|365790238|FG001|Overall Study|patient incarcerated|1|||
106034383|NCT00282464|365790237|FG000|Overall Study|family crisis|0|||
106034384|NCT00282464|365790238|FG001|Overall Study|family crisis|1|||
106034385|NCT00282464|365790237|FG000|Overall Study|dispensed wrong kit|0|||
106034386|NCT00282464|365790238|FG001|Overall Study|dispensed wrong kit|1|||
106034387|NCT00282464|365790237|FG000|Overall Study|dropped due to missed visits|0|||
106034388|NCT00282464|365790238|FG001|Overall Study|dropped due to missed visits|1|||
106034389|NCT00475423|365790239|FG000|Overall Study|Protocol Violation|5|||
106034390|NCT00475423|365790239|FG000|Overall Study|Adverse Event|4|||
106034391|NCT00475423|365790239|FG000|Overall Study|Withdrawal by Subject|6|||
106034392|NCT00475423|365790239|FG000|Overall Study|Lack of Efficacy|8|||
106034393|NCT00475423|365790239|FG000|Overall Study|Death|1|||
106034394|NCT00475423|365790239|FG000|Overall Study|Reason not specified|1|||
106034395|NCT00475423|365790239|FG000|Overall Study|Lost to Follow-up|7|||
106034396|NCT01609478|365790240|FG000|Overall Study|Adverse Event|3|||
106034397|NCT01609478|365790241|FG001|Overall Study|Adverse Event|1|||
106034398|NCT01609478|365790242|FG002|Overall Study|Adverse Event|5|||
106034399|NCT01609478|365790240|FG000|Overall Study|Protocol Deviation|0|||
106034400|NCT01609478|365790241|FG001|Overall Study|Protocol Deviation|1|||
106034401|NCT01609478|365790242|FG002|Overall Study|Protocol Deviation|1|||
106034402|NCT01609478|365790240|FG000|Overall Study|Non-Compliance with study treatment|1|||
106034403|NCT01609478|365790241|FG001|Overall Study|Non-Compliance with study treatment|0|||
106034404|NCT01609478|365790242|FG002|Overall Study|Non-Compliance with study treatment|0|||
106034405|NCT01609478|365790240|FG000|Overall Study|Physician Decision|1|||
106034406|NCT01609478|365790241|FG001|Overall Study|Physician Decision|0|||
106034407|NCT01609478|365790242|FG002|Overall Study|Physician Decision|1|||
106034408|NCT01609478|365790240|FG000|Overall Study|Withdrawal by Subject|2|||
106034409|NCT01609478|365790241|FG001|Overall Study|Withdrawal by Subject|0|||
106034410|NCT01609478|365790242|FG002|Overall Study|Withdrawal by Subject|2|||
106034411|NCT01056380|365790244|FG000|Overall Study|Lost to Follow-up|2|||
106034412|NCT01056380|365790245|FG001|Overall Study|Lost to Follow-up|3|||
106034413|NCT01624870|365790246|FG000|Overall Study|Death|19|||
106034414|NCT01624870|365790246|FG000|Overall Study|Withdrawal by Subject|1|||
106034415|NCT01624870|365790246|FG000|Overall Study|CoreValve not implanted|6|||
106034416|NCT01624870|365790246|FG000|Overall Study|Lost to follow up|1|||
106034417|NCT02217527|365790249|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
106034418|NCT02217527|365790250|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
106034419|NCT02217527|365790249|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
106034420|NCT02217527|365790250|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
106034421|NCT01589770|365790256|FG000|Overall Study|EGFR <60ml/min|6|||
106034422|NCT01589770|365790257|FG001|Overall Study|EGFR <60ml/min|4|||
106034423|NCT01589770|365790256|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
106034424|NCT01589770|365790257|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
105857195|NCT00191113|365129378|FG000|Core Study|Adverse Event|0|||
105857196|NCT00191113|365129379|FG001|Core Study|Adverse Event|2|||
105857197|NCT00191113|365129378|FG000|Core Study|Lack of Efficacy|0|||
105857198|NCT00191113|365129379|FG001|Core Study|Lack of Efficacy|2|||
105857199|NCT00191113|365129378|FG000|Core Study|Death|1|||
105857200|NCT00191113|365129379|FG001|Core Study|Death|0|||
105857201|NCT04709835|365129383|FG000|Overall Study|Withdrawal by Subject|0|||
105857202|NCT04709835|365129384|FG001|Overall Study|Withdrawal by Subject|1|||
105857203|NCT04709835|365129385|FG002|Overall Study|Withdrawal by Subject|0|||
105857204|NCT03954834|365129386|FG000|Overall Study|Adverse Event|1|||
105857205|NCT03954834|365129387|FG001|Overall Study|Adverse Event|3|||
105857206|NCT03954834|365129388|FG002|Overall Study|Adverse Event|1|||
105857207|NCT03954834|365129389|FG003|Overall Study|Adverse Event|1|||
105857208|NCT03954834|365129386|FG000|Overall Study|Death|0|||
105857209|NCT03954834|365129387|FG001|Overall Study|Death|0|||
105857210|NCT03954834|365129388|FG002|Overall Study|Death|0|||
105857211|NCT03954834|365129389|FG003|Overall Study|Death|1|||
105857212|NCT03954834|365129386|FG000|Overall Study|Physician Decision|0|||
105857213|NCT03954834|365129387|FG001|Overall Study|Physician Decision|1|||
105857214|NCT03954834|365129388|FG002|Overall Study|Physician Decision|0|||
105857215|NCT03954834|365129389|FG003|Overall Study|Physician Decision|2|||
105857216|NCT03954834|365129386|FG000|Overall Study|Protocol Violation|1|||
105857217|NCT03954834|365129387|FG001|Overall Study|Protocol Violation|0|||
105857218|NCT03954834|365129388|FG002|Overall Study|Protocol Violation|0|||
105857219|NCT03954834|365129389|FG003|Overall Study|Protocol Violation|1|||
105857220|NCT03954834|365129386|FG000|Overall Study|Withdrawal by Subject|2|||
105857221|NCT03954834|365129387|FG001|Overall Study|Withdrawal by Subject|3|||
105857222|NCT03954834|365129388|FG002|Overall Study|Withdrawal by Subject|13|||
105857223|NCT03954834|365129389|FG003|Overall Study|Withdrawal by Subject|6|||
105857224|NCT03954834|365129386|FG000|Overall Study|Participant left the country|0|||
105857225|NCT03954834|365129387|FG001|Overall Study|Participant left the country|0|||
105857226|NCT03954834|365129388|FG002|Overall Study|Participant left the country|1|||
105857227|NCT03954834|365129389|FG003|Overall Study|Participant left the country|0|||
105857228|NCT03954834|365129386|FG000|Overall Study|Lost to Follow-up|3|||
105857229|NCT03954834|365129387|FG001|Overall Study|Lost to Follow-up|2|||
105857230|NCT03954834|365129388|FG002|Overall Study|Lost to Follow-up|3|||
105857231|NCT03954834|365129389|FG003|Overall Study|Lost to Follow-up|5|||
105857232|NCT00324649|365129395|FG000|Overall Study|Adverse Event|1|||
105857233|NCT00324649|365129396|FG001|Overall Study|Adverse Event|4|||
105857234|NCT00324649|365129395|FG000|Overall Study|Withdrawal by Subject|0|||
105857235|NCT00324649|365129396|FG001|Overall Study|Withdrawal by Subject|1|||
105857236|NCT00324649|365129395|FG000|Overall Study|Noncompliance|1|||
105857237|NCT00324649|365129396|FG001|Overall Study|Noncompliance|0|||
105857238|NCT00540293|365129397|FG000|Overall Study|Adverse event related to study drug|10|||
105857239|NCT00540293|365129397|FG000|Overall Study|Adverse event not related to study drug|7|||
106034425|NCT01715129|365790258|FG000|Overall Study|Adverse Event, fatal|1|||
106034426|NCT01715129|365790258|FG000|Overall Study|Lack of Efficacy|3|||
106034427|NCT01715129|365790258|FG000|Overall Study|Protocol Violation|1|||
106034428|NCT01715129|365790258|FG000|Overall Study|Consent Withdrawn|2|||
106034429|NCT01715129|365790258|FG000|Overall Study|Lost to Follow-up|1|||
106034430|NCT01715129|365790258|FG000|Overall Study|Other|1|||
106034431|NCT01423604|365790261|FG000|Safety Run-In|Adverse Event|3|||
106034432|NCT01423604|365790262|FG001|Safety Run-In|Adverse Event|0|||
106034433|NCT01423604|365790261|FG000|Safety Run-In|Death|1|||
106034434|NCT01423604|365790262|FG001|Safety Run-In|Death|0|||
106034435|NCT01423604|365790261|FG000|Safety Run-In|Physician Decision|1|||
106034436|NCT01423604|365790262|FG001|Safety Run-In|Physician Decision|0|||
106034437|NCT01423604|365790261|FG000|Safety Run-In|Disease progression|3|||
106034438|NCT01423604|365790262|FG001|Safety Run-In|Disease progression|0|||
106034439|NCT01423604|365790261|FG000|Safety Run-In|Patient decision|1|||
106034440|NCT01423604|365790262|FG001|Safety Run-In|Patient decision|0|||
106034441|NCT01423604|365790261|FG000|Randomized|Adverse Event|4|||
106034442|NCT01423604|365790262|FG001|Randomized|Adverse Event|10|||
106034443|NCT01423604|365790261|FG000|Randomized|Death|1|||
106034444|NCT01423604|365790262|FG001|Randomized|Death|0|||
106034445|NCT01423604|365790261|FG000|Randomized|Physician Decision|16|||
105857240|NCT00540293|365129397|FG000|Overall Study|Withdrawal by Subject|6|||
105857241|NCT00540293|365129397|FG000|Overall Study|Protocol violation, & subject schedule|12|||
106034446|NCT01423604|365790262|FG001|Randomized|Physician Decision|13|||
106034447|NCT01423604|365790261|FG000|Randomized|Other - unspecified|37|||
105857242|NCT01007942|365129400|FG000|Overall Study|Adverse Event|29|||
106034448|NCT01423604|365790262|FG001|Randomized|Other - unspecified|31|||
106034449|NCT01423604|365790261|FG000|Randomized|Patient decision|5|||
106034450|NCT01423604|365790262|FG001|Randomized|Patient decision|9|||
106034451|NCT04738318|365790265|FG000|Overall Study|Protocol Violation|1|||
106034452|NCT04738318|365790266|FG001|Overall Study|Protocol Violation|0|||
106034453|NCT04231981|365790267|FG000|Overall Study|Adverse Event|1|||
106034454|NCT04231981|365790267|FG000|Overall Study|Death|16|||
105857243|NCT01007942|365129401|FG001|Overall Study|Adverse Event|14|||
106034455|NCT04231981|365790267|FG000|Overall Study|Lost to Follow-up|1|||
106034456|NCT02581943|365790268|FG000|Overall Study|Death|5|||
106034457|NCT02581943|365790269|FG001|Overall Study|Death|2|||
106034458|NCT02581943|365790268|FG000|Overall Study|Disease Progression|12|||
105857244|NCT01007942|365129400|FG000|Overall Study|Abnormal test procedure|0|||
105857245|NCT01007942|365129401|FG001|Overall Study|Abnormal test procedure|1|||
105857246|NCT01007942|365129400|FG000|Overall Study|Disease progression|217|||
105857247|NCT01007942|365129401|FG001|Overall Study|Disease progression|242|||
105857248|NCT01007942|365129400|FG000|Overall Study|New cancer therapy|5|||
105857249|NCT01007942|365129401|FG001|Overall Study|New cancer therapy|1|||
105857250|NCT01007942|365129400|FG000|Overall Study|Protocol Violation|1|||
105857251|NCT01007942|365129401|FG001|Overall Study|Protocol Violation|1|||
105857252|NCT01007942|365129400|FG000|Overall Study|Withdrawal by Subject|19|||
105857253|NCT01007942|365129401|FG001|Overall Study|Withdrawal by Subject|14|||
105857254|NCT01007942|365129400|FG000|Overall Study|Lost to Follow-up|1|||
105857255|NCT01007942|365129401|FG001|Overall Study|Lost to Follow-up|0|||
105857256|NCT01007942|365129400|FG000|Overall Study|Administrative problems|2|||
105857257|NCT01007942|365129401|FG001|Overall Study|Administrative problems|0|||
105857258|NCT01007942|365129400|FG000|Overall Study|Death|3|||
105857259|NCT01007942|365129401|FG001|Overall Study|Death|2|||
105857260|NCT01007942|365129400|FG000|Overall Study|Patients untreated|4|||
105857261|NCT01007942|365129401|FG001|Overall Study|Patients untreated|3|||
105857262|NCT00325195|365129402|FG000|Randomized|Not dosed|5|||
105857263|NCT00325195|365129403|FG001|Randomized|Not dosed|5|||
105857264|NCT00325195|365129404|FG002|Randomized|Not dosed|3|||
105857265|NCT00325195|365129402|FG000|Received Intervention: ITT Population|Adverse Event|15|||
105857266|NCT00325195|365129403|FG001|Received Intervention: ITT Population|Adverse Event|17|||
105857267|NCT00325195|365129404|FG002|Received Intervention: ITT Population|Adverse Event|1|||
105857268|NCT00325195|365129402|FG000|Received Intervention: ITT Population|Death|3|||
105857269|NCT00325195|365129403|FG001|Received Intervention: ITT Population|Death|1|||
105857270|NCT00325195|365129404|FG002|Received Intervention: ITT Population|Death|0|||
105857271|NCT00325195|365129402|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
105857272|NCT00325195|365129403|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
105857273|NCT00325195|365129404|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
105857274|NCT00325195|365129402|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
105857275|NCT00325195|365129403|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
105857276|NCT00325195|365129404|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
105857277|NCT00325195|365129402|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
105857278|NCT00325195|365129403|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
105857279|NCT00325195|365129404|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
105857280|NCT04585789|365129405|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
105857281|NCT04585789|365129406|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
105857282|NCT04585789|365129407|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
105857283|NCT04585789|365129405|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
106034459|NCT02581943|365790269|FG001|Overall Study|Disease Progression|15|||
106034460|NCT02581943|365790268|FG000|Overall Study|Withdrawal by Subject|1|||
106034461|NCT02581943|365790269|FG001|Overall Study|Withdrawal by Subject|2|||
106034462|NCT02889562|365790270|FG000|Overall Study|Physician Decision|0|||
106034463|NCT02889562|365790271|FG001|Overall Study|Physician Decision|1|||
106034464|NCT02889562|365790270|FG000|Overall Study|Withdrawal by Subject|0|||
106034465|NCT02889562|365790271|FG001|Overall Study|Withdrawal by Subject|1|||
106034466|NCT00219544|365790272|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
106034467|NCT00219544|365790273|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
106034468|NCT00219544|365790272|FG000|Single Blind Treatment Period|Adverse Event|9|||
106034469|NCT00219544|365790273|FG001|Single Blind Treatment Period|Adverse Event|0|||
106034470|NCT00219544|365790272|FG000|Single Blind Treatment Period|Protocol Violation|4|||
106034471|NCT00219544|365790273|FG001|Single Blind Treatment Period|Protocol Violation|0|||
106034472|NCT00219544|365790272|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
106034473|NCT00219544|365790273|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
106034474|NCT00219544|365790272|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
106034475|NCT00219544|365790273|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
106034476|NCT00219544|365790272|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
106034477|NCT00219544|365790273|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
106034478|NCT00570232|365790274|FG000|Overall Study|Adverse Event|10|||
106034479|NCT00570232|365790274|FG000|Overall Study|discontinued due to medical condition|3|||
106034480|NCT00570232|365790274|FG000|Overall Study|discontinued due to recurrence|8|||
106034481|NCT00570232|365790274|FG000|Overall Study|discontinued due to noncompliance|2|||
106034482|NCT01007253|365790277|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
106034483|NCT01007253|365790278|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
106034484|NCT01007253|365790279|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
106034485|NCT01007253|365790280|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
106034486|NCT00814801|365790281|FG000|Overall Study|Adverse Event|15|||
106034487|NCT00814801|365790282|FG001|Overall Study|Adverse Event|16|||
106034488|NCT00814801|365790283|FG002|Overall Study|Adverse Event|19|||
106034489|NCT00814801|365790281|FG000|Overall Study|Withdrawal by Subject|9|||
106034490|NCT00814801|365790282|FG001|Overall Study|Withdrawal by Subject|11|||
106034491|NCT00814801|365790283|FG002|Overall Study|Withdrawal by Subject|14|||
106034492|NCT00814801|365790281|FG000|Overall Study|Inappropriate as a subject|1|||
106034493|NCT00814801|365790282|FG001|Overall Study|Inappropriate as a subject|1|||
106034494|NCT00814801|365790283|FG002|Overall Study|Inappropriate as a subject|1|||
106034495|NCT00814801|365790281|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
106034496|NCT00814801|365790282|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
106034497|NCT00814801|365790283|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
106034498|NCT00814801|365790281|FG000|Overall Study|Missing or change of caregiver|6|||
106034499|NCT00814801|365790282|FG001|Overall Study|Missing or change of caregiver|2|||
106034500|NCT00814801|365790283|FG002|Overall Study|Missing or change of caregiver|4|||
106034501|NCT00814801|365790281|FG000|Overall Study|Non-compliance|0|||
106034502|NCT00814801|365790282|FG001|Overall Study|Non-compliance|1|||
106034503|NCT00814801|365790283|FG002|Overall Study|Non-compliance|1|||
106034504|NCT00814801|365790281|FG000|Overall Study|Other|2|||
106034505|NCT00814801|365790282|FG001|Overall Study|Other|6|||
106034506|NCT00814801|365790283|FG002|Overall Study|Other|4|||
106034507|NCT00586664|365790284|FG000|Overall Study|Withdrawal by Subject|3|||
106034508|NCT00586664|365790285|FG001|Overall Study|Withdrawal by Subject|7|||
106034509|NCT00586664|365790286|FG002|Overall Study|Withdrawal by Subject|1|||
106034510|NCT00586664|365790284|FG000|Overall Study|Exclusion criteria met|2|||
106034511|NCT00586664|365790285|FG001|Overall Study|Exclusion criteria met|0|||
106034512|NCT00586664|365790286|FG002|Overall Study|Exclusion criteria met|0|||
106034513|NCT01077154|365790293|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
106034514|NCT01077154|365790294|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
106034515|NCT01077154|365790293|FG000|Overall Study|Withdrawal by Subject|369|||
106034516|NCT01077154|365790294|FG001|Overall Study|Withdrawal by Subject|385|||
106034517|NCT01077154|365790293|FG000|Overall Study|Death|215|||
106034518|NCT01077154|365790294|FG001|Overall Study|Death|214|||
106034519|NCT01077154|365790293|FG000|Overall Study|Lost to Follow-up|43|||
106034520|NCT01077154|365790294|FG001|Overall Study|Lost to Follow-up|35|||
106034521|NCT01077154|365790293|FG000|Overall Study|Noncompliance|22|||
106034522|NCT01077154|365790294|FG001|Overall Study|Noncompliance|20|||
106034523|NCT01077154|365790293|FG000|Overall Study|Disease Progression|18|||
106034524|NCT01077154|365790294|FG001|Overall Study|Disease Progression|20|||
106034525|NCT01077154|365790293|FG000|Overall Study|Ineligibility Determined|10|||
106034526|NCT01077154|365790294|FG001|Overall Study|Ineligibility Determined|14|||
106034527|NCT01077154|365790293|FG000|Overall Study|Other|14|||
106034528|NCT01077154|365790294|FG001|Overall Study|Other|11|||
106034529|NCT01077154|365790293|FG000|Overall Study|Adverse Event|9|||
106034530|NCT01077154|365790294|FG001|Overall Study|Adverse Event|9|||
106034531|NCT01077154|365790293|FG000|Overall Study|Administrative Decision|1|||
106034532|NCT01077154|365790294|FG001|Overall Study|Administrative Decision|6|||
106034533|NCT01077154|365790293|FG000|Overall Study|Protocol Deviation|1|||
106034534|NCT01077154|365790294|FG001|Overall Study|Protocol Deviation|0|||
106034535|NCT00604214|365790295|FG000|Baseline to Day 28|Death|223|||
106034536|NCT00604214|365790296|FG001|Baseline to Day 28|Death|202|||
106034537|NCT00604214|365790295|FG000|Baseline to Day 28|Lost to Follow-up|2|||
106034538|NCT00604214|365790296|FG001|Baseline to Day 28|Lost to Follow-up|4|||
106034539|NCT00604214|365790295|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
106034540|NCT00604214|365790296|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
106034541|NCT00604214|365790295|FG000|Day 29 to Day 90|Death|64|||
106034542|NCT00604214|365790296|FG001|Day 29 to Day 90|Death|67|||
106034543|NCT00604214|365790295|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
106034544|NCT00604214|365790296|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
106034545|NCT00604214|365790295|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
106034546|NCT00604214|365790296|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
106034547|NCT00604214|365790295|FG000|Day 91 to Day 180|Death|19|||
106034548|NCT00604214|365790296|FG001|Day 91 to Day 180|Death|23|||
106034549|NCT00604214|365790295|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
106034550|NCT00604214|365790296|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
106034551|NCT00604214|365790295|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
106034552|NCT00604214|365790296|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
106034553|NCT05985980|365790297|FG000|Overall Study|Withdrawal by Subject|1|||
106034554|NCT05985980|365790297|FG000|Overall Study|Withdrawal by Subject|1|||
106034555|NCT05985980|365790297|FG000|Overall Study|Withdrawal by Subject|1|||
106034556|NCT05985980|365790297|FG000|Overall Study|Withdrawal by Subject|1|||
106034557|NCT04030026|365790299|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
106034558|NCT04030026|365790300|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
106034559|NCT04030026|365790299|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
106034560|NCT04030026|365790300|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
106034561|NCT04030026|365790299|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
106034562|NCT04030026|365790300|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
106034563|NCT04030026|365790299|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
106034564|NCT04030026|365790300|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
105857284|NCT04585789|365129406|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
105857285|NCT04585789|365129407|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
105857286|NCT05083585|365129408|FG000|Overall Study|Death|1|||
105857287|NCT05083585|365129409|FG001|Overall Study|Death|1|||
105857288|NCT05083585|365129408|FG000|Overall Study|Lost to Follow-up|1|||
105857289|NCT05083585|365129409|FG001|Overall Study|Lost to Follow-up|1|||
105857290|NCT05083585|365129408|FG000|Overall Study|Withdrawal by Subject|2|||
105857291|NCT05083585|365129409|FG001|Overall Study|Withdrawal by Subject|0|||
105857292|NCT05083585|365129408|FG000|Overall Study|Randomized but not vaccinated|2|||
105857293|NCT05083585|365129409|FG001|Overall Study|Randomized but not vaccinated|0|||
105857294|NCT03929757|365129410|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
105857295|NCT03929757|365129411|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
105857296|NCT03929757|365129412|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
105857297|NCT03929757|365129410|FG000|Main Study: Up to Day 365|Other|1|||
105857298|NCT03929757|365129411|FG001|Main Study: Up to Day 365|Other|0|||
105857299|NCT03929757|365129412|FG002|Main Study: Up to Day 365|Other|0|||
105857300|NCT03929757|365129410|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
105857301|NCT03929757|365129411|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
105857302|NCT03929757|365129412|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
105857303|NCT03469336|365129416|FG000|Overall Study|Adverse Event|1|||
105857304|NCT02006693|365129418|FG000|Overall Study|No Reason Specified|6|||
105857305|NCT02006693|365129419|FG001|Overall Study|No Reason Specified|8|||
105857306|NCT02006693|365129418|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
105857307|NCT02006693|365129419|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
105857308|NCT02006693|365129418|FG000|Overall Study|XEN Implant Explantation|0|||
105857309|NCT02006693|365129419|FG001|Overall Study|XEN Implant Explantation|1|||
105857310|NCT02006693|365129418|FG000|Overall Study|Death|2|||
105857311|NCT02006693|365129419|FG001|Overall Study|Death|2|||
105857312|NCT02006693|365129418|FG000|Overall Study|Lost to Follow-up|4|||
105857313|NCT02006693|365129419|FG001|Overall Study|Lost to Follow-up|1|||
105857314|NCT02006693|365129418|FG000|Overall Study|Patient Decision|4|||
105857315|NCT02006693|365129419|FG001|Overall Study|Patient Decision|0|||
105857316|NCT04729309|365129420|FG000|Period 1|Subject unable to return for Period 2|3|||
105857317|NCT04729309|365129421|FG001|Period 1|Subject unable to return for Period 2|0|||
105857318|NCT04729309|365129420|FG000|Period 1|Lost to Follow-up|1|||
105857319|NCT04729309|365129421|FG001|Period 1|Lost to Follow-up|0|||
106034565|NCT04030026|365790299|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
106034566|NCT04030026|365790300|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
106034567|NCT04030026|365790299|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
106034568|NCT04030026|365790300|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
106034569|NCT04030026|365790299|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
106034570|NCT04030026|365790300|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
106034571|NCT00782795|365790301|FG000|Overall Study|Withdrawal by Subject|1|||
106034572|NCT00782795|365790302|FG001|Overall Study|Withdrawal by Subject|2|||
106034573|NCT04158648|365790306|FG000|Overall Study|Ongoing in the Study|69|||
106034574|NCT04158648|365790306|FG000|Overall Study|Withdrawal by Subject|4|||
106034575|NCT01757691|365791532|FG000|Overall Study|Administrative problems|2|||
106034576|NCT01757691|365791533|FG001|Overall Study|Administrative problems|0|||
106034577|NCT00773383|365791536|FG000|Overall Study|Adverse Event|4|||
106034578|NCT00773383|365791536|FG000|Overall Study|Death|1|||
106034579|NCT00773383|365791536|FG000|Overall Study|Progression of Disease|23|||
106034580|NCT00773383|365791536|FG000|Overall Study|Other|2|||
106034581|NCT00773383|365791536|FG000|Overall Study|No study dose received|1|||
106034582|NCT02919969|365791539|FG000|Overall Study|Lack of Efficacy|22|||
106034583|NCT02919969|365791539|FG000|Overall Study|Death|4|||
106034584|NCT02919969|365791539|FG000|Overall Study|Physician Decision|3|||
106034585|NCT02919969|365791539|FG000|Overall Study|Withdrawal by Subject|2|||
106034586|NCT00371761|365791541|FG000|Overall Study|Adverse Event|1|||
106034587|NCT00371761|365791542|FG001|Overall Study|Adverse Event|1|||
106034588|NCT00371761|365791541|FG000|Overall Study|Withdrawal by Subject|1|||
106034589|NCT00371761|365791542|FG001|Overall Study|Withdrawal by Subject|3|||
106034590|NCT00371761|365791541|FG000|Overall Study|Investigator Judgment|2|||
106034591|NCT00371761|365791542|FG001|Overall Study|Investigator Judgment|3|||
105857320|NCT01087489|365129422|FG000|Overall Study|enrolled in another VA study|0|||
105857321|NCT01087489|365129423|FG001|Overall Study|enrolled in another VA study|1|||
106034592|NCT00371761|365791541|FG000|Overall Study|Study termination|4|||
106034593|NCT00371761|365791542|FG001|Overall Study|Study termination|3|||
106034594|NCT03718299|365791544|FG000|Overall Study|Adverse Event|1|||
106034595|NCT03718299|365791544|FG000|Overall Study|Withdrawal by Subject|6|||
106034596|NCT03718299|365791544|FG000|Overall Study|Physician Decision|2|||
105857322|NCT01087489|365129422|FG000|Overall Study|Death|0|||
105857323|NCT01087489|365129423|FG001|Overall Study|Death|1|||
105857324|NCT01087489|365129422|FG000|Overall Study|unable to survey by telephone|0|||
106034597|NCT03718299|365791544|FG000|Overall Study|Lost to Follow-up|1|||
105857325|NCT01087489|365129423|FG001|Overall Study|unable to survey by telephone|1|||
105857326|NCT00117325|365129424|FG000|Overall Study|Adverse Event|3|||
105857327|NCT00117325|365129425|FG001|Overall Study|Adverse Event|3|||
105857328|NCT00117325|365129424|FG000|Overall Study|Lost to Follow-up|1|||
105857329|NCT00117325|365129425|FG001|Overall Study|Lost to Follow-up|1|||
105857330|NCT00117325|365129424|FG000|Overall Study|Protocol Violation|2|||
105857331|NCT00117325|365129425|FG001|Overall Study|Protocol Violation|3|||
105857332|NCT00117325|365129424|FG000|Overall Study|Withdrawal by Subject|3|||
105857333|NCT00117325|365129425|FG001|Overall Study|Withdrawal by Subject|2|||
105857334|NCT00117325|365129424|FG000|Overall Study|Lack of Efficacy|1|||
105857335|NCT00117325|365129425|FG001|Overall Study|Lack of Efficacy|0|||
105857336|NCT00117325|365129424|FG000|Overall Study|Use of prohibited medicine|1|||
105857337|NCT00117325|365129425|FG001|Overall Study|Use of prohibited medicine|2|||
105857338|NCT00117325|365129424|FG000|Overall Study|Early termination|1|||
105857339|NCT00117325|365129425|FG001|Overall Study|Early termination|1|||
105857340|NCT00117325|365129424|FG000|Overall Study|Admisnitrative|1|||
105857341|NCT00117325|365129425|FG001|Overall Study|Admisnitrative|0|||
105857342|NCT02885181|365129428|FG000|Overall Study|Investigator's Discretion|0|||
105857343|NCT02885181|365129429|FG001|Overall Study|Investigator's Discretion|1|||
105857344|NCT02885181|365129430|FG002|Overall Study|Investigator's Discretion|0|||
105857345|NCT02885181|365129431|FG003|Overall Study|Investigator's Discretion|1|||
105857346|NCT02885181|365129428|FG000|Overall Study|Adverse Event|0|||
105857347|NCT02885181|365129429|FG001|Overall Study|Adverse Event|0|||
105857348|NCT02885181|365129430|FG002|Overall Study|Adverse Event|0|||
105857349|NCT02885181|365129431|FG003|Overall Study|Adverse Event|1|||
105857350|NCT02885181|365129428|FG000|Overall Study|Withdrawal by Subject|0|||
105857351|NCT02885181|365129429|FG001|Overall Study|Withdrawal by Subject|0|||
105857352|NCT02885181|365129430|FG002|Overall Study|Withdrawal by Subject|0|||
105857353|NCT02885181|365129431|FG003|Overall Study|Withdrawal by Subject|1|||
105857354|NCT04091659|365129432|FG000|Overall Study|Protocol Violation|3|||
105857355|NCT04091659|365129433|FG001|Overall Study|Protocol Violation|0|||
105857356|NCT04091659|365129432|FG000|Overall Study|Lost to Follow-up|0|||
105857357|NCT04091659|365129433|FG001|Overall Study|Lost to Follow-up|1|||
105857358|NCT03327792|365129434|FG000|Overall Study|Adverse Event|4|||
105857359|NCT03327792|365129435|FG001|Overall Study|Adverse Event|0|||
105857360|NCT03327792|365129434|FG000|Overall Study|Family/Personal issues|3|||
105857361|NCT03327792|365129435|FG001|Overall Study|Family/Personal issues|2|||
105857362|NCT03327792|365129434|FG000|Overall Study|Lost to Follow-up|0|||
105857363|NCT03327792|365129435|FG001|Overall Study|Lost to Follow-up|1|||
105857364|NCT00626392|365129436|FG000|Run-in Period|Adverse Event|0|||
105857365|NCT00626392|365129437|FG001|Run-in Period|Adverse Event|0|||
105857366|NCT00626392|365129438|FG002|Run-in Period|Adverse Event|1|||
105857367|NCT00626392|365129439|FG003|Run-in Period|Adverse Event|0|||
105857368|NCT00626392|365129440|FG004|Run-in Period|Adverse Event|1|||
105857369|NCT00626392|365129441|FG005|Run-in Period|Adverse Event|0|||
105857370|NCT00626392|365129436|FG000|Run-in Period|Withdrawal by Subject|0|||
105857371|NCT00626392|365129437|FG001|Run-in Period|Withdrawal by Subject|1|||
105857372|NCT00626392|365129438|FG002|Run-in Period|Withdrawal by Subject|1|||
105857373|NCT00626392|365129439|FG003|Run-in Period|Withdrawal by Subject|1|||
105857374|NCT00626392|365129440|FG004|Run-in Period|Withdrawal by Subject|3|||
105857375|NCT00626392|365129441|FG005|Run-in Period|Withdrawal by Subject|1|||
105857376|NCT00626392|365129436|FG000|Run-in Period|Noncompliance|1|||
105857377|NCT00626392|365129437|FG001|Run-in Period|Noncompliance|0|||
105857378|NCT00626392|365129438|FG002|Run-in Period|Noncompliance|1|||
105857379|NCT00626392|365129439|FG003|Run-in Period|Noncompliance|0|||
105857380|NCT00626392|365129440|FG004|Run-in Period|Noncompliance|0|||
105857381|NCT00626392|365129441|FG005|Run-in Period|Noncompliance|0|||
105857382|NCT00626392|365129436|FG000|Coadministration Period|Adverse Event|3|||
105857383|NCT00626392|365129437|FG001|Coadministration Period|Adverse Event|1|||
105857384|NCT00626392|365129438|FG002|Coadministration Period|Adverse Event|7|||
105857385|NCT00626392|365129439|FG003|Coadministration Period|Adverse Event|4|||
105857386|NCT00626392|365129440|FG004|Coadministration Period|Adverse Event|3|||
106034598|NCT01362595|365791545|FG000|Overall Study|Screen failure|10|||
106034599|NCT01362595|365791545|FG000|Overall Study|Withdrawal by Subject|2|||
105857387|NCT00626392|365129441|FG005|Coadministration Period|Adverse Event|4|||
105857388|NCT00626392|365129436|FG000|Coadministration Period|Withdrawal by Subject|1|||
105857389|NCT00626392|365129437|FG001|Coadministration Period|Withdrawal by Subject|1|||
105857390|NCT00626392|365129438|FG002|Coadministration Period|Withdrawal by Subject|0|||
105857391|NCT00626392|365129439|FG003|Coadministration Period|Withdrawal by Subject|1|||
105857392|NCT00626392|365129440|FG004|Coadministration Period|Withdrawal by Subject|0|||
106034600|NCT00959374|365791546|FG000|Overall Study|Withdrawal by Subject|2|||
105857393|NCT00626392|365129441|FG005|Coadministration Period|Withdrawal by Subject|1|||
105857394|NCT00626392|365129436|FG000|Coadministration Period|Protocol Violation|0|||
105857395|NCT00626392|365129437|FG001|Coadministration Period|Protocol Violation|1|||
106034601|NCT00959374|365791546|FG000|Overall Study|Lost to Follow-up|14|||
106034602|NCT00959374|365791546|FG000|Overall Study|Death|1|||
106034603|NCT00959374|365791546|FG000|Overall Study|Protocol Violation|1|||
106034604|NCT00959374|365791546|FG000|Overall Study|Implant Removed/Not Replaced|4|||
106034605|NCT00959374|365791546|FG000|Overall Study|Physician Decision|1|||
106034606|NCT01475071|365791547|FG000|Overall Study|Physician Decision|1|||
106034607|NCT01475071|365791547|FG000|Overall Study|Withdrawal by Subject|6|||
106034608|NCT01475071|365791547|FG000|Overall Study|Lost to Follow-up|1|||
106034609|NCT00718081|365791548|FG000|Overall Study|Adverse Event|0|||
106034610|NCT00718081|365791549|FG001|Overall Study|Adverse Event|1|||
106034611|NCT00718081|365791550|FG002|Overall Study|Adverse Event|0|||
106034612|NCT00718081|365791548|FG000|Overall Study|Lack of Efficacy|7|||
106034613|NCT00718081|365791549|FG001|Overall Study|Lack of Efficacy|3|||
106034614|NCT00718081|365791550|FG002|Overall Study|Lack of Efficacy|21|||
106034615|NCT01205581|365791557|FG000|Overall Study|Withdrawal by Subject|1|||
106034616|NCT01205581|365791558|FG001|Overall Study|Withdrawal by Subject|0|||
106034617|NCT01205581|365791559|FG002|Overall Study|Withdrawal by Subject|0|||
106034618|NCT01205581|365791560|FG003|Overall Study|Withdrawal by Subject|0|||
106034619|NCT01205581|365791561|FG004|Overall Study|Withdrawal by Subject|0|||
106034620|NCT01205581|365791562|FG005|Overall Study|Withdrawal by Subject|0|||
106034621|NCT04535167|365791563|FG000|Treatment|Adverse Event|0|||
106034622|NCT04535167|365791564|FG001|Treatment|Adverse Event|0|||
106034623|NCT04535167|365791565|FG002|Treatment|Adverse Event|0|||
106034624|NCT04535167|365791566|FG003|Treatment|Adverse Event|0|||
106034625|NCT04535167|365791567|FG004|Treatment|Adverse Event|0|||
106034626|NCT04535167|365791568|FG005|Treatment|Adverse Event|0|||
106034627|NCT04535167|365791569|FG006|Treatment|Adverse Event|1|||
106034628|NCT04535167|365791563|FG000|Follow-Up|Death|0|||
106034629|NCT04535167|365791564|FG001|Follow-Up|Death|0|||
106034630|NCT04535167|365791565|FG002|Follow-Up|Death|0|||
106034631|NCT04535167|365791566|FG003|Follow-Up|Death|0|||
106034632|NCT04535167|365791567|FG004|Follow-Up|Death|0|||
106034633|NCT04535167|365791568|FG005|Follow-Up|Death|0|||
106034634|NCT04535167|365791569|FG006|Follow-Up|Death|1|||
106034635|NCT04535167|365791563|FG000|Follow-Up|Lost to Follow-up|0|||
106034636|NCT04535167|365791564|FG001|Follow-Up|Lost to Follow-up|0|||
106034637|NCT04535167|365791565|FG002|Follow-Up|Lost to Follow-up|0|||
106034638|NCT04535167|365791566|FG003|Follow-Up|Lost to Follow-up|1|||
106034639|NCT04535167|365791567|FG004|Follow-Up|Lost to Follow-up|0|||
106034640|NCT04535167|365791568|FG005|Follow-Up|Lost to Follow-up|0|||
106034641|NCT04535167|365791569|FG006|Follow-Up|Lost to Follow-up|0|||
106034642|NCT02579928|365791570|FG000|Overall Study|Withdrawal by Subject|1|||
106034643|NCT02579928|365791571|FG001|Overall Study|Withdrawal by Subject|0|||
106034644|NCT01993836|365791574|FG000|Overall Study|Surgery Cancelled|3|||
106034645|NCT01993836|365791575|FG001|Overall Study|Surgery Cancelled|0|||
106034646|NCT01993836|365791576|FG002|Overall Study|Surgery Cancelled|0|||
106034647|NCT01993836|365791574|FG000|Overall Study|Physician Decision|2|||
106034648|NCT01993836|365791575|FG001|Overall Study|Physician Decision|1|||
106034649|NCT01993836|365791576|FG002|Overall Study|Physician Decision|0|||
106034650|NCT01993836|365791574|FG000|Overall Study|Death|0|||
106034651|NCT01993836|365791575|FG001|Overall Study|Death|2|||
106034652|NCT01993836|365791576|FG002|Overall Study|Death|0|||
106034653|NCT01993836|365791574|FG000|Overall Study|Withdrawal by Subject|12|||
106034654|NCT01993836|365791575|FG001|Overall Study|Withdrawal by Subject|10|||
106034655|NCT01993836|365791576|FG002|Overall Study|Withdrawal by Subject|5|||
106034656|NCT02195687|365791577|FG000|Overall Study|Personal Reasons|1|||
106034657|NCT02195687|365791578|FG001|Overall Study|Personal Reasons|1|||
106034658|NCT02195687|365791577|FG000|Overall Study|Lost to Follow-up|4|||
106034659|NCT02195687|365791578|FG001|Overall Study|Lost to Follow-up|1|||
106034660|NCT02361580|365791579|FG000|Overall Study|Lost to Follow-up|6|||
106034661|NCT02361580|365791580|FG001|Overall Study|Lost to Follow-up|3|||
106034662|NCT04369924|365791583|FG000|Overall Study|Lost to Follow-up|302|||
106034663|NCT04369924|365791584|FG001|Overall Study|Lost to Follow-up|339|||
106034664|NCT03780400|365791585|FG000|Overall Study|Lost to Follow-up|5|||
106034665|NCT03780400|365791585|FG000|Overall Study|Withdrawal by Subject|2|||
106034666|NCT02480712|365791586|FG000|Overall Study|Enrolled but Never Treated|1|||
106034667|NCT02480712|365791586|FG000|Overall Study|Lost to Follow-up|5|||
106034668|NCT02480712|365791586|FG000|Overall Study|Withdrew Consent|3|||
106034669|NCT02480712|365791586|FG000|Overall Study|Death|1|||
106034670|NCT02480712|365791586|FG000|Overall Study|Lack of Efficacy|1|||
106034671|NCT01857310|365791587|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
106034672|NCT01857310|365791588|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
106034673|NCT02554279|365791589|FG000|Overall Study|Adverse Event|2|||
106034674|NCT02554279|365791590|FG001|Overall Study|Adverse Event|5|||
106034675|NCT02554279|365791589|FG000|Overall Study|Lost to Follow-up|3|||
106034676|NCT02554279|365791590|FG001|Overall Study|Lost to Follow-up|2|||
106034677|NCT02554279|365791589|FG000|Overall Study|Withdrawal by Subject|6|||
106034678|NCT02554279|365791590|FG001|Overall Study|Withdrawal by Subject|4|||
106034679|NCT02554279|365791589|FG000|Overall Study|Protocol Violation|2|||
106034680|NCT02554279|365791590|FG001|Overall Study|Protocol Violation|1|||
106034681|NCT02554279|365791589|FG000|Overall Study|Other reason|19|||
106034682|NCT02554279|365791590|FG001|Overall Study|Other reason|6|||
106034683|NCT00812487|365791591|FG000|Overall Study|Lost to Follow-up|2|||
106034684|NCT00812487|365791592|FG001|Overall Study|Lost to Follow-up|0|||
106034685|NCT00812487|365791591|FG000|Overall Study|Withdrawal by Subject|3|||
106034686|NCT00812487|365791592|FG001|Overall Study|Withdrawal by Subject|2|||
106034687|NCT00812487|365791591|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
106034688|NCT00812487|365791592|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
106034689|NCT00812487|365791591|FG000|Overall Study|Protocol Violation|0|||
106034690|NCT00812487|365791592|FG001|Overall Study|Protocol Violation|1|||
106034691|NCT02360605|365791593|FG000|Overall Study|Withdrawal by Subject|4|||
106034692|NCT02360605|365791594|FG001|Overall Study|Withdrawal by Subject|9|||
106034693|NCT02360605|365791593|FG000|Overall Study|Lost to Follow-up|7|||
106034694|NCT02360605|365791594|FG001|Overall Study|Lost to Follow-up|8|||
106034695|NCT02360605|365791593|FG000|Overall Study|Death|0|||
106034696|NCT02360605|365791594|FG001|Overall Study|Death|1|||
106034697|NCT05463198|365791595|FG000|Overall Study|Withdrawal by Subject|19|||
106034698|NCT05463198|365791595|FG000|Overall Study|Procedure Notes Missing|18|||
106034699|NCT00274924|365791598|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
106034700|NCT00274924|365791599|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
106034701|NCT00274924|365791600|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
106034702|NCT00274924|365791598|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
106034703|NCT00274924|365791599|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
106034704|NCT00274924|365791600|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
106034705|NCT00274924|365791598|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
106034706|NCT00274924|365791599|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
106034707|NCT00274924|365791600|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
106034708|NCT00274924|365791598|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
106034709|NCT00274924|365791599|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
106034710|NCT00274924|365791600|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
106034711|NCT00274924|365791598|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
106034712|NCT00274924|365791599|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
106034713|NCT00274924|365791600|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
106034714|NCT00274924|365791598|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
106034715|NCT00274924|365791599|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
106034716|NCT00274924|365791600|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
106034717|NCT00274924|365791598|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
106034718|NCT00274924|365791599|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
106034719|NCT00274924|365791600|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
106034720|NCT00274924|365791598|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
106034721|NCT00274924|365791599|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
106034722|NCT00274924|365791600|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
106034723|NCT00274924|365791598|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
106034724|NCT00274924|365791599|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
106034725|NCT00274924|365791600|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
106034726|NCT00274924|365791598|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
106034727|NCT00274924|365791599|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
106034728|NCT00274924|365791600|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
106034729|NCT00274924|365791598|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
106034730|NCT00274924|365791599|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
106034731|NCT00274924|365791600|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
106034732|NCT00274924|365791598|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
106034733|NCT00274924|365791599|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
106034734|NCT00274924|365791600|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
106034735|NCT00274924|365791598|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
106034736|NCT00274924|365791599|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
106034737|NCT00274924|365791600|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
106034738|NCT00740051|365791601|FG000|Overall Study|Lack of Efficacy|2|||
106034739|NCT00740051|365791602|FG001|Overall Study|Lack of Efficacy|5|||
106034740|NCT00740051|365791601|FG000|Overall Study|Adverse Event|1|||
106034741|NCT00740051|365791602|FG001|Overall Study|Adverse Event|4|||
106034742|NCT00740051|365791601|FG000|Overall Study|Protocol Violation|2|||
106034743|NCT00740051|365791602|FG001|Overall Study|Protocol Violation|6|||
106034744|NCT00740051|365791601|FG000|Overall Study|Lost to Follow-up|3|||
106034745|NCT00740051|365791602|FG001|Overall Study|Lost to Follow-up|8|||
106034746|NCT00740051|365791601|FG000|Overall Study|Withdrawal by Subject|6|||
106034747|NCT00740051|365791602|FG001|Overall Study|Withdrawal by Subject|8|||
106034748|NCT00740051|365791601|FG000|Overall Study|Other reason (not specified)|4|||
106034749|NCT00740051|365791602|FG001|Overall Study|Other reason (not specified)|1|||
106034750|NCT01903525|365791604|FG000|Overall Study|Lost to Follow-up|5|||
106034751|NCT01903525|365791605|FG001|Overall Study|Lost to Follow-up|9|||
106034752|NCT01903525|365791604|FG000|Overall Study|Adverse Event|0|||
106034753|NCT01903525|365791605|FG001|Overall Study|Adverse Event|1|||
106034754|NCT00991952|365791606|FG000|Overall Study|Adverse Event|0|||
106034755|NCT00991952|365791607|FG001|Overall Study|Adverse Event|1|||
106034756|NCT02093026|365791608|FG000|Overall Study|Adverse Event|26|||
106034757|NCT02093026|365791608|FG000|Overall Study|Death|10|||
106034758|NCT02093026|365791608|FG000|Overall Study|Other|157|||
106034759|NCT01673282|365791610|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
106034760|NCT01673282|365791611|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
106034761|NCT01673282|365791610|FG000|Overall Study|Lack of Efficacy|9|||
106034762|NCT01673282|365791611|FG001|Overall Study|Lack of Efficacy|2|||
106034763|NCT01673282|365791610|FG000|Overall Study|Lost to Follow-up|11|||
106034764|NCT01673282|365791611|FG001|Overall Study|Lost to Follow-up|10|||
106034765|NCT01673282|365791610|FG000|Overall Study|Withdrawal by Subject|3|||
106034766|NCT01673282|365791611|FG001|Overall Study|Withdrawal by Subject|3|||
106034767|NCT01673282|365791610|FG000|Overall Study|Other|1|||
106034768|NCT01673282|365791611|FG001|Overall Study|Other|6|||
106034769|NCT00582816|365791612|FG000|Overall Study|Engraftment Failure|3|||
106034770|NCT04381988|365791615|FG000|Overall Study|The study was terminated|4|||
106034771|NCT04381988|365791616|FG001|Overall Study|The study was terminated|0|||
106034772|NCT02106923|365791617|FG000|Overall Study|Protocol Violation|0|||
106034773|NCT02106923|365791618|FG001|Overall Study|Protocol Violation|0|||
106034774|NCT02106923|365791619|FG002|Overall Study|Protocol Violation|0|||
106034775|NCT02106923|365791620|FG003|Overall Study|Protocol Violation|0|||
106034776|NCT02106923|365791621|FG004|Overall Study|Protocol Violation|0|||
106034777|NCT02106923|365791622|FG005|Overall Study|Protocol Violation|1|||
106034778|NCT03485495|365791623|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
106034779|NCT03485495|365791624|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
106034780|NCT02915874|365791625|FG000|Overall Study|Lost to Follow-up|5|||
106034781|NCT02915874|365791626|FG001|Overall Study|Lost to Follow-up|4|||
106034782|NCT02915874|365791625|FG000|Overall Study|Withdrawal by Subject|1|||
106034783|NCT02915874|365791626|FG001|Overall Study|Withdrawal by Subject|1|||
106034784|NCT02915874|365791625|FG000|Overall Study|Started New Anxiety Medication|0|||
106034785|NCT02915874|365791626|FG001|Overall Study|Started New Anxiety Medication|1|||
106034786|NCT03915860|365791628|FG000|Overall Study|Adverse Event|3|||
106034787|NCT03915860|365791628|FG000|Overall Study|Withdrawal by Subject|6|||
106034788|NCT03915860|365791628|FG000|Overall Study|Lost to Follow-up|2|||
106034789|NCT03915860|365791628|FG000|Overall Study|Other than specified|3|||
106034790|NCT02195011|365791629|FG000|Overall Study|Adverse Event|4|||
106034791|NCT02195011|365791630|FG001|Overall Study|Adverse Event|0|||
106034792|NCT02195011|365791629|FG000|Overall Study|Progressive Disease|18|||
106034793|NCT02195011|365791630|FG001|Overall Study|Progressive Disease|1|||
106034794|NCT02195011|365791629|FG000|Overall Study|Withdrawal by Subject|3|||
106034795|NCT02195011|365791630|FG001|Overall Study|Withdrawal by Subject|0|||
106034796|NCT00424255|365791632|FG000|Overall Study|Death|115|||
106034797|NCT00424255|365791633|FG001|Overall Study|Death|111|||
106034798|NCT00424255|365791632|FG000|Overall Study|Lost to Follow-up|26|||
106034799|NCT00424255|365791633|FG001|Overall Study|Lost to Follow-up|20|||
106034800|NCT00424255|365791632|FG000|Overall Study|Protocol Violation|0|||
106034801|NCT00424255|365791633|FG001|Overall Study|Protocol Violation|1|||
106034802|NCT00424255|365791632|FG000|Overall Study|Withdrawal by Subject|34|||
106034803|NCT00424255|365791633|FG001|Overall Study|Withdrawal by Subject|38|||
106034804|NCT00424255|365791632|FG000|Overall Study|Physician Decision|3|||
106034805|NCT00424255|365791633|FG001|Overall Study|Physician Decision|7|||
106034806|NCT00424255|365791632|FG000|Overall Study|Cognitive Disturbance|1|||
106034807|NCT00424255|365791633|FG001|Overall Study|Cognitive Disturbance|0|||
106034808|NCT00424255|365791632|FG000|Overall Study|Non-compliance by Participants|1|||
106034809|NCT00424255|365791633|FG001|Overall Study|Non-compliance by Participants|0|||
106034810|NCT00424255|365791632|FG000|Overall Study|Fatigue|1|||
106034811|NCT00424255|365791633|FG001|Overall Study|Fatigue|0|||
106034812|NCT00424255|365791632|FG000|Overall Study|Disease Progression|0|||
106034813|NCT00424255|365791633|FG001|Overall Study|Disease Progression|2|||
106034814|NCT00424255|365791632|FG000|Overall Study|Sponsor Terminated Study|161|||
106034815|NCT00424255|365791633|FG001|Overall Study|Sponsor Terminated Study|167|||
106034816|NCT01226121|365791634|FG000|Overall Study|Lost to Follow-up|2|||
106034817|NCT01226121|365791635|FG001|Overall Study|Lost to Follow-up|0|||
106034818|NCT01226121|365791636|FG002|Overall Study|Lost to Follow-up|1|||
106034819|NCT04221230|365791639|FG000|Overall Study|Lost to Follow-up|12|||
106034820|NCT04221230|365791640|FG001|Overall Study|Lost to Follow-up|12|||
106034821|NCT04221230|365791639|FG000|Overall Study|Protocol Violation|2|||
106034822|NCT04221230|365791640|FG001|Overall Study|Protocol Violation|2|||
106034823|NCT04221230|365791639|FG000|Overall Study|Adverse Event|0|||
106034824|NCT04221230|365791640|FG001|Overall Study|Adverse Event|8|||
106034825|NCT04221230|365791639|FG000|Overall Study|Physician Decision|1|||
106034826|NCT04221230|365791640|FG001|Overall Study|Physician Decision|0|||
106034827|NCT04221230|365791639|FG000|Overall Study|Withdrawal by Subject|13|||
106034828|NCT04221230|365791640|FG001|Overall Study|Withdrawal by Subject|11|||
106034829|NCT04221230|365791639|FG000|Overall Study|Non-Compliance with Study Drug|1|||
106034830|NCT04221230|365791640|FG001|Overall Study|Non-Compliance with Study Drug|1|||
106034831|NCT04221230|365791639|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
106034832|NCT04221230|365791640|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
106034833|NCT04221230|365791639|FG000|Overall Study|Pregnancy|0|||
106034834|NCT04221230|365791640|FG001|Overall Study|Pregnancy|1|||
106034835|NCT04221230|365791639|FG000|Overall Study|Other|1|||
106034836|NCT04221230|365791640|FG001|Overall Study|Other|2|||
106034837|NCT03036800|365791647|FG000|Overall Study|Protocol Violation|1|||
106034838|NCT03036800|365791648|FG001|Overall Study|Protocol Violation|0|||
106034839|NCT03036800|365791647|FG000|Overall Study|Non-compliance|1|||
106034840|NCT03036800|365791648|FG001|Overall Study|Non-compliance|0|||
106034841|NCT03036800|365791647|FG000|Overall Study|Lost to Follow-up|1|||
106034842|NCT03036800|365791648|FG001|Overall Study|Lost to Follow-up|0|||
106034843|NCT03036800|365791647|FG000|Overall Study|Death|1|||
106034844|NCT03036800|365791648|FG001|Overall Study|Death|0|||
106034845|NCT03036800|365791647|FG000|Overall Study|Tolerance|5|||
106034846|NCT03036800|365791648|FG001|Overall Study|Tolerance|0|||
106034847|NCT03036800|365791647|FG000|Overall Study|Unknown/no reason given|50|||
106034848|NCT03036800|365791648|FG001|Overall Study|Unknown/no reason given|39|||
106034849|NCT00829933|365791649|FG000|Overall Study|Adverse Event|2|||
106034850|NCT00829933|365791650|FG001|Overall Study|Adverse Event|3|||
106034851|NCT00829933|365791651|FG002|Overall Study|Adverse Event|2|||
106034852|NCT00829933|365791652|FG003|Overall Study|Adverse Event|1|||
106034853|NCT00829933|365791649|FG000|Overall Study|Death|0|||
106034854|NCT00829933|365791650|FG001|Overall Study|Death|0|||
106034855|NCT00829933|365791651|FG002|Overall Study|Death|1|||
106034856|NCT00829933|365791652|FG003|Overall Study|Death|1|||
106034857|NCT00829933|365791649|FG000|Overall Study|Lack of Efficacy|0|||
106034858|NCT00829933|365791650|FG001|Overall Study|Lack of Efficacy|1|||
106034859|NCT00829933|365791651|FG002|Overall Study|Lack of Efficacy|0|||
106034860|NCT00829933|365791652|FG003|Overall Study|Lack of Efficacy|0|||
106034861|NCT00829933|365791649|FG000|Overall Study|Physician Decision|5|||
106034862|NCT00829933|365791650|FG001|Overall Study|Physician Decision|7|||
106034863|NCT00829933|365791651|FG002|Overall Study|Physician Decision|8|||
106034864|NCT00829933|365791652|FG003|Overall Study|Physician Decision|1|||
106034865|NCT00829933|365791649|FG000|Overall Study|Pregnancy|0|||
106034866|NCT00829933|365791650|FG001|Overall Study|Pregnancy|0|||
106034867|NCT00829933|365791651|FG002|Overall Study|Pregnancy|0|||
106034868|NCT00829933|365791652|FG003|Overall Study|Pregnancy|2|||
106034869|NCT00829933|365791649|FG000|Overall Study|Protocol Violation|2|||
106034870|NCT00829933|365791650|FG001|Overall Study|Protocol Violation|1|||
106034871|NCT00829933|365791651|FG002|Overall Study|Protocol Violation|0|||
106034872|NCT00829933|365791652|FG003|Overall Study|Protocol Violation|0|||
106034873|NCT00829933|365791649|FG000|Overall Study|withdrew before treatment started|5|||
106034874|NCT00829933|365791650|FG001|Overall Study|withdrew before treatment started|1|||
106034875|NCT00829933|365791651|FG002|Overall Study|withdrew before treatment started|2|||
106034876|NCT00829933|365791652|FG003|Overall Study|withdrew before treatment started|9|||
106034877|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
106034878|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
106034879|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
106034880|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
106034881|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
106034882|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
106034883|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
106034884|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
106034885|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
106034886|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
106034887|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
106034888|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
106034889|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
106034890|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
106034891|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
106034892|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
106034893|NCT00491556|365791657|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
106034894|NCT00491556|365791658|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
106034895|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
106034896|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
106034897|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
106034898|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
106034899|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
106034900|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
106034901|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
106034902|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
106034903|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
106034904|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
106034905|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
105857396|NCT00626392|365129438|FG002|Coadministration Period|Protocol Violation|0|||
105857397|NCT00626392|365129439|FG003|Coadministration Period|Protocol Violation|1|||
105857398|NCT00626392|365129440|FG004|Coadministration Period|Protocol Violation|1|||
105857399|NCT00626392|365129441|FG005|Coadministration Period|Protocol Violation|0|||
105857400|NCT00626392|365129436|FG000|Coadministration Period|Other|0|||
105857401|NCT00626392|365129437|FG001|Coadministration Period|Other|2|||
105857402|NCT00626392|365129438|FG002|Coadministration Period|Other|3|||
105857403|NCT00626392|365129439|FG003|Coadministration Period|Other|1|||
105857404|NCT00626392|365129440|FG004|Coadministration Period|Other|1|||
105857405|NCT00626392|365129441|FG005|Coadministration Period|Other|1|||
105857406|NCT00338455|365129442|FG000|Overall Study|Death|2|||
106034906|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
106034907|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
106034908|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
106034909|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
106034910|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
106034911|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
106034912|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
106034913|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
106034914|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
106034915|NCT00491556|365791657|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
106034916|NCT00491556|365791658|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
106034917|NCT02418156|365791659|FG000|Overall Study|Lost to Follow-up|12|||
106034918|NCT02418156|365791659|FG000|Overall Study|Death|2|||
106034919|NCT02418156|365791659|FG000|Overall Study|Physician Decision|1|||
106034920|NCT02418156|365791659|FG000|Overall Study|Withdrawal by Subject|1|||
106034921|NCT02418156|365791659|FG000|Overall Study|Subject refused to return|1|||
106034922|NCT00993044|365791660|FG000|Irinotecan 50 mg|Physician Decision|1|||
106034923|NCT00130442|365792832|FG000|Overall Study|Withdrawal by Subject|0|||
106034924|NCT00130442|365792833|FG001|Overall Study|Withdrawal by Subject|1|||
106034925|NCT00130442|365792832|FG000|Overall Study|did not meet criteria|1|||
106034926|NCT00130442|365792833|FG001|Overall Study|did not meet criteria|1|||
106034927|NCT01879579|365792835|FG000|Overall Study|Phone incompatible with texting platform|3|||
106034928|NCT01879579|365792836|FG001|Overall Study|Phone incompatible with texting platform|0|||
106034929|NCT01879579|365792835|FG000|Overall Study|Did not enroll in texting platform|1|||
106034930|NCT01879579|365792836|FG001|Overall Study|Did not enroll in texting platform|0|||
106034931|NCT01879579|365792835|FG000|Overall Study|Did not initiate insulin treatment|1|||
106034932|NCT01879579|365792836|FG001|Overall Study|Did not initiate insulin treatment|0|||
106034933|NCT01879579|365792835|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
106034934|NCT01879579|365792836|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
106034935|NCT01879579|365792835|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
106034936|NCT01879579|365792836|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
106034937|NCT02927067|365792837|FG000|Overall Study|Withdrawn Consent|20|||
106034938|NCT02927067|365792838|FG001|Overall Study|Withdrawn Consent|12|||
106034939|NCT02927067|365792837|FG000|Overall Study|Death|18|||
106034940|NCT02927067|365792838|FG001|Overall Study|Death|31|||
106034941|NCT02927067|365792837|FG000|Overall Study|Adverse Event|13|||
106034942|NCT02927067|365792838|FG001|Overall Study|Adverse Event|10|||
106034943|NCT02927067|365792837|FG000|Overall Study|Noncompliance|5|||
106034944|NCT02927067|365792838|FG001|Overall Study|Noncompliance|2|||
106034945|NCT02927067|365792837|FG000|Overall Study|Reason not Specified|4|||
106034946|NCT02927067|365792838|FG001|Overall Study|Reason not Specified|6|||
106034947|NCT02093351|365792842|FG000|Part A|Adverse Event|0|||
106034948|NCT02093351|365792843|FG001|Part A|Adverse Event|1|||
106034949|NCT02093351|365792844|FG002|Part A|Adverse Event|1|||
106034950|NCT02093351|365792845|FG003|Part A|Adverse Event|0|||
106034951|NCT02093351|365792842|FG000|Part A|Condition under investigation worsened|2|||
106034952|NCT02093351|365792843|FG001|Part A|Condition under investigation worsened|0|||
106034953|NCT02093351|365792844|FG002|Part A|Condition under investigation worsened|2|||
106034954|NCT02093351|365792845|FG003|Part A|Condition under investigation worsened|0|||
106034955|NCT02093351|365792842|FG000|Part A|Death|0|||
106034956|NCT02093351|365792843|FG001|Part A|Death|1|||
106034957|NCT02093351|365792844|FG002|Part A|Death|0|||
106034958|NCT02093351|365792845|FG003|Part A|Death|0|||
106034959|NCT02093351|365792842|FG000|Part B|Patient decision|0|||
106034960|NCT02093351|365792843|FG001|Part B|Patient decision|0|||
106034961|NCT02093351|365792844|FG002|Part B|Patient decision|0|||
106034962|NCT02093351|365792845|FG003|Part B|Patient decision|3|||
106034963|NCT02093351|365792842|FG000|Part B|Disease progression|0|||
106034964|NCT02093351|365792843|FG001|Part B|Disease progression|0|||
106034965|NCT02093351|365792844|FG002|Part B|Disease progression|0|||
106034966|NCT02093351|365792845|FG003|Part B|Disease progression|4|||
106034967|NCT02093351|365792842|FG000|Part B|Complete response|0|||
106034968|NCT02093351|365792843|FG001|Part B|Complete response|0|||
106034969|NCT02093351|365792844|FG002|Part B|Complete response|0|||
106034970|NCT02093351|365792845|FG003|Part B|Complete response|1|||
106034971|NCT02093351|365792842|FG000|Part B|Adverse event + disease progression|0|||
106034972|NCT02093351|365792843|FG001|Part B|Adverse event + disease progression|0|||
106034973|NCT02093351|365792844|FG002|Part B|Adverse event + disease progression|0|||
106034974|NCT02093351|365792845|FG003|Part B|Adverse event + disease progression|1|||
106034975|NCT02093351|365792842|FG000|Part B|Lack of therapeutic response|0|||
106034976|NCT02093351|365792843|FG001|Part B|Lack of therapeutic response|0|||
106034977|NCT02093351|365792844|FG002|Part B|Lack of therapeutic response|0|||
106034978|NCT02093351|365792845|FG003|Part B|Lack of therapeutic response|12|||
106034979|NCT02093351|365792842|FG000|Part B|Condition under investigation worsened|0|||
106034980|NCT02093351|365792843|FG001|Part B|Condition under investigation worsened|0|||
106034981|NCT02093351|365792844|FG002|Part B|Condition under investigation worsened|0|||
106034982|NCT02093351|365792845|FG003|Part B|Condition under investigation worsened|39|||
106034983|NCT02093351|365792842|FG000|Part B|Adverse Event|0|||
106034984|NCT02093351|365792843|FG001|Part B|Adverse Event|0|||
106034985|NCT02093351|365792844|FG002|Part B|Adverse Event|0|||
106034986|NCT02093351|365792845|FG003|Part B|Adverse Event|2|||
106034987|NCT02093351|365792842|FG000|Part B|Death|0|||
106034988|NCT02093351|365792843|FG001|Part B|Death|0|||
106034989|NCT02093351|365792844|FG002|Part B|Death|0|||
106034990|NCT02093351|365792845|FG003|Part B|Death|1|||
106034991|NCT00706849|365792853|FG000|Treatment Period|Adverse Event|0|||
106034992|NCT00706849|365792854|FG001|Treatment Period|Adverse Event|9|||
106034993|NCT00706849|365792853|FG000|Treatment Period|Other|0|||
106034994|NCT00706849|365792854|FG001|Treatment Period|Other|1|||
106034995|NCT00706849|365792853|FG000|Follow-up Period|Withdrawal by Subject|0|||
106034996|NCT00706849|365792854|FG001|Follow-up Period|Withdrawal by Subject|2|||
106034997|NCT00706849|365792853|FG000|Follow-up Period|Protocol non-compliance|0|||
106034998|NCT00706849|365792854|FG001|Follow-up Period|Protocol non-compliance|1|||
106034999|NCT01611454|365792855|FG000|Overall Study|Lack of Efficacy|18|||
106035000|NCT01611454|365792856|FG001|Overall Study|Lack of Efficacy|10|||
106035001|NCT00920907|365792857|FG000|Induction Period|Adverse Event|0|||
106035002|NCT00920907|365792858|FG001|Induction Period|Adverse Event|2|||
106035003|NCT00920907|365792857|FG000|Induction Period|Death|1|||
106035004|NCT00920907|365792858|FG001|Induction Period|Death|1|||
106035005|NCT00920907|365792857|FG000|Induction Period|Disease Progression|12|||
106035006|NCT00920907|365792858|FG001|Induction Period|Disease Progression|11|||
106035007|NCT00920907|365792857|FG000|Induction Period|Study Drug Toxicity|8|||
106035008|NCT00920907|365792858|FG001|Induction Period|Study Drug Toxicity|6|||
106035009|NCT00920907|365792857|FG000|Induction Period|No longer meets study criteria|0|||
106035010|NCT00920907|365792858|FG001|Induction Period|No longer meets study criteria|1|||
106035011|NCT00920907|365792857|FG000|Induction Period|Withdrawal by Subject|1|||
106035012|NCT00920907|365792858|FG001|Induction Period|Withdrawal by Subject|1|||
106035013|NCT00920907|365792857|FG000|Maintenance Period|Disease Progression|3|||
106035014|NCT00920907|365792858|FG001|Maintenance Period|Disease Progression|7|||
106035015|NCT00920907|365792857|FG000|Maintenance Period|Administrative (study closure)|7|||
106035016|NCT00920907|365792858|FG001|Maintenance Period|Administrative (study closure)|2|||
106035017|NCT00920907|365792857|FG000|Maintenance Period|Study Drug Toxicity|0|||
106035018|NCT00920907|365792858|FG001|Maintenance Period|Study Drug Toxicity|2|||
106035019|NCT00920907|365792857|FG000|Maintenance Period|Death|1|||
106035020|NCT00920907|365792858|FG001|Maintenance Period|Death|1|||
106035021|NCT00920907|365792857|FG000|Maintenance Period|Withdrawal by Subject|1|||
106035022|NCT00920907|365792858|FG001|Maintenance Period|Withdrawal by Subject|0|||
106035023|NCT00920907|365792857|FG000|Maintenance Period|Adverse Event|0|||
106035024|NCT00920907|365792858|FG001|Maintenance Period|Adverse Event|1|||
106035025|NCT01122394|365792859|FG000|Overall Study|Withdrawal by Subject|1|||
106035026|NCT01122394|365792860|FG001|Overall Study|Withdrawal by Subject|1|||
106035027|NCT01122394|365792859|FG000|Overall Study|Lost to Follow-up|2|||
106035028|NCT01122394|365792860|FG001|Overall Study|Lost to Follow-up|2|||
106035029|NCT01122394|365792859|FG000|Overall Study|Adverse Event|0|||
106035030|NCT01122394|365792860|FG001|Overall Study|Adverse Event|1|||
106035031|NCT00039871|365792861|FG000|Overall Study|Adverse Event|165|||
106035032|NCT00039871|365792861|FG000|Overall Study|Lost to Follow-up|18|||
106035033|NCT00039871|365792861|FG000|Overall Study|Protocol Violation|24|||
106035034|NCT00039871|365792861|FG000|Overall Study|Withdrawal by Subject|97|||
106035035|NCT00039871|365792861|FG000|Overall Study|Did not meet eligibility criteria|11|||
106035036|NCT00039871|365792861|FG000|Overall Study|Administrative|1|||
106035037|NCT00039871|365792861|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
106035038|NCT00039871|365792861|FG000|Overall Study|Never entered follow-up|7|||
106035039|NCT02186301|365792862|FG000|Overall Study|Progressive Disease|7|||
106035040|NCT02186301|365792863|FG001|Overall Study|Progressive Disease|22|||
106035041|NCT02186301|365792864|FG002|Overall Study|Progressive Disease|27|||
106035042|NCT02186301|365792862|FG000|Overall Study|Adverse Event|5|||
106035043|NCT02186301|365792863|FG001|Overall Study|Adverse Event|5|||
106035044|NCT02186301|365792864|FG002|Overall Study|Adverse Event|5|||
106035045|NCT02186301|365792862|FG000|Overall Study|Death|1|||
106035046|NCT02186301|365792863|FG001|Overall Study|Death|0|||
106035047|NCT02186301|365792864|FG002|Overall Study|Death|0|||
106035048|NCT02186301|365792862|FG000|Overall Study|Withdrawal by Subject|5|||
106035049|NCT02186301|365792863|FG001|Overall Study|Withdrawal by Subject|1|||
106035050|NCT02186301|365792864|FG002|Overall Study|Withdrawal by Subject|3|||
106035051|NCT02186301|365792862|FG000|Overall Study|Physician Decision|1|||
106035052|NCT02186301|365792863|FG001|Overall Study|Physician Decision|0|||
106035053|NCT02186301|365792864|FG002|Overall Study|Physician Decision|1|||
106035054|NCT02186301|365792862|FG000|Overall Study|Study Terminated by Sponsor|1|||
106035055|NCT02186301|365792863|FG001|Overall Study|Study Terminated by Sponsor|0|||
106035056|NCT02186301|365792864|FG002|Overall Study|Study Terminated by Sponsor|11|||
106035057|NCT02186301|365792862|FG000|Overall Study|Protocol Deviation|0|||
106035058|NCT02186301|365792863|FG001|Overall Study|Protocol Deviation|2|||
106035059|NCT02186301|365792864|FG002|Overall Study|Protocol Deviation|0|||
106035060|NCT02186301|365792862|FG000|Overall Study|Missing|0|||
106035061|NCT02186301|365792863|FG001|Overall Study|Missing|0|||
106035062|NCT02186301|365792864|FG002|Overall Study|Missing|2|||
106035063|NCT02186301|365792862|FG000|Overall Study|Other|0|||
106035064|NCT02186301|365792863|FG001|Overall Study|Other|0|||
106035065|NCT02186301|365792864|FG002|Overall Study|Other|1|||
106151665|NCT02590432|366215139|FG007|Open-label Treatment Period|Adverse Event|0|||
106035066|NCT03560739|365792865|FG000|Overall Study|Adverse Event|0|||
106035067|NCT03560739|365792866|FG001|Overall Study|Adverse Event|1|||
106151666|NCT02590432|366215140|FG008|Open-label Treatment Period|Adverse Event|0|||
106151667|NCT02590432|366215132|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
106151668|NCT02590432|366215133|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
106151669|NCT02590432|366215134|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
106151670|NCT02590432|366215135|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
106151671|NCT02590432|366215136|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
106151672|NCT02590432|366215137|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
106151673|NCT02590432|366215138|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
106151674|NCT02590432|366215139|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
106151675|NCT02590432|366215140|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
106151676|NCT02590432|366215132|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
106151677|NCT02590432|366215133|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
106151678|NCT02590432|366215134|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
106151679|NCT02590432|366215135|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
106151680|NCT02590432|366215136|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
106151681|NCT02590432|366215137|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
106151682|NCT02590432|366215138|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
106151683|NCT02590432|366215139|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
106151684|NCT02590432|366215140|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
106151685|NCT02590432|366215132|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
106151686|NCT02590432|366215133|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
106151687|NCT02590432|366215134|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
106151688|NCT02590432|366215135|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
106151689|NCT02590432|366215136|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
106151690|NCT02590432|366215137|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
106151691|NCT02590432|366215138|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
106151692|NCT02590432|366215139|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
106151693|NCT02590432|366215140|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
106151694|NCT02590432|366215132|FG000|Open-label Treatment Period|Protocol Violation|10|||
106151695|NCT02590432|366215133|FG001|Open-label Treatment Period|Protocol Violation|4|||
106151696|NCT02590432|366215134|FG002|Open-label Treatment Period|Protocol Violation|0|||
106151697|NCT02590432|366215135|FG003|Open-label Treatment Period|Protocol Violation|0|||
106151698|NCT02590432|366215136|FG004|Open-label Treatment Period|Protocol Violation|0|||
106151699|NCT02590432|366215137|FG005|Open-label Treatment Period|Protocol Violation|0|||
106151700|NCT02590432|366215138|FG006|Open-label Treatment Period|Protocol Violation|0|||
106151701|NCT02590432|366215139|FG007|Open-label Treatment Period|Protocol Violation|0|||
106151702|NCT02590432|366215140|FG008|Open-label Treatment Period|Protocol Violation|0|||
106151703|NCT02590432|366215132|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
106151704|NCT02590432|366215133|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
106151705|NCT02590432|366215134|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
106151706|NCT02590432|366215135|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
106151707|NCT02590432|366215136|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
106151708|NCT02590432|366215137|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
106151709|NCT02590432|366215138|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
106151710|NCT02590432|366215139|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
106151711|NCT02590432|366215140|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
106151712|NCT02590432|366215132|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
106151713|NCT02590432|366215133|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
106151714|NCT02590432|366215134|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
106151715|NCT02590432|366215135|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
106151716|NCT02590432|366215136|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
106151717|NCT02590432|366215137|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
106151718|NCT02590432|366215138|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
106151719|NCT02590432|366215139|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
106151720|NCT02590432|366215140|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
106035068|NCT03560739|365792867|FG002|Overall Study|Adverse Event|0|||
106035069|NCT03560739|365792868|FG003|Overall Study|Adverse Event|0|||
106035070|NCT03361176|365792869|FG000|Overall Study|Lost to Follow-up|1|||
106035071|NCT03361176|365792870|FG001|Overall Study|Lost to Follow-up|2|||
106035072|NCT03361176|365792869|FG000|Overall Study|Adverse Event|0|||
106035073|NCT03361176|365792870|FG001|Overall Study|Adverse Event|2|||
106035074|NCT03361176|365792869|FG000|Overall Study|Withdrawal by Subject|0|||
106035075|NCT03361176|365792870|FG001|Overall Study|Withdrawal by Subject|1|||
106035076|NCT02478398|365792871|FG000|Overall Study|Adverse Event|20|||
106035077|NCT02478398|365792872|FG001|Overall Study|Adverse Event|5|||
106035078|NCT02478398|365792871|FG000|Overall Study|Lost to Follow-up|5|||
106035079|NCT02478398|365792872|FG001|Overall Study|Lost to Follow-up|4|||
106035080|NCT02478398|365792871|FG000|Overall Study|Non-Compliance With Study Drug|5|||
106035081|NCT02478398|365792872|FG001|Overall Study|Non-Compliance With Study Drug|1|||
106035082|NCT02478398|365792871|FG000|Overall Study|Protocol Violation|3|||
106035083|NCT02478398|365792872|FG001|Overall Study|Protocol Violation|1|||
106035084|NCT02478398|365792871|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
106035085|NCT02478398|365792872|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
106035086|NCT02478398|365792871|FG000|Overall Study|Withdrawal By Participant|10|||
106035087|NCT02478398|365792872|FG001|Overall Study|Withdrawal By Participant|4|||
106035088|NCT04389970|365792874|FG000|Overall Study|Lost to Follow-up|1|||
106035089|NCT03123185|365792875|FG000|Overall Study|Withdrawal by Subject|0|||
106035090|NCT03123185|365792876|FG001|Overall Study|Withdrawal by Subject|0|||
106035091|NCT03123185|365792877|FG002|Overall Study|Withdrawal by Subject|0|||
106035092|NCT03123185|365792878|FG003|Overall Study|Withdrawal by Subject|0|||
106035093|NCT03123185|365792879|FG004|Overall Study|Withdrawal by Subject|0|||
106035094|NCT03123185|365792880|FG005|Overall Study|Withdrawal by Subject|0|||
106035095|NCT03123185|365792881|FG006|Overall Study|Withdrawal by Subject|0|||
106035096|NCT03123185|365792882|FG007|Overall Study|Withdrawal by Subject|0|||
106035097|NCT03123185|365792883|FG008|Overall Study|Withdrawal by Subject|0|||
106035098|NCT03123185|365792884|FG009|Overall Study|Withdrawal by Subject|0|||
106035099|NCT03123185|365792885|FG010|Overall Study|Withdrawal by Subject|0|||
106035100|NCT03123185|365792886|FG011|Overall Study|Withdrawal by Subject|0|||
106035101|NCT03123185|365792887|FG012|Overall Study|Withdrawal by Subject|1|||
106035102|NCT03123185|365792888|FG013|Overall Study|Withdrawal by Subject|0|||
106035103|NCT02469038|365792891|FG000|Overall Study|Physician Decision|4|||
106035104|NCT02469038|365792892|FG001|Overall Study|Physician Decision|5|||
106035105|NCT00636987|365792895|FG000|Overall Study|Death|44|||
106035106|NCT00636987|365792895|FG000|Overall Study|Explanted|13|||
106035107|NCT00636987|365792895|FG000|Overall Study|Lost to Follow-up|63|||
106035108|NCT00636987|365792895|FG000|Overall Study|5 year visit window not complete|69|||
106035109|NCT03468543|365792896|FG000|Overall Study|Protocol stopping rules met|3|||
106035110|NCT04179890|365792897|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
106035111|NCT04179890|365792898|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
106035112|NCT04179890|365792897|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
106035113|NCT04179890|365792898|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
106035114|NCT04179890|365792897|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
106035115|NCT04179890|365792898|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
106035116|NCT04179890|365792897|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
106035117|NCT04179890|365792898|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
106035118|NCT04179890|365792897|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
106035119|NCT04179890|365792898|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
106035120|NCT04179890|365792897|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
106035121|NCT04179890|365792898|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
106035122|NCT04179890|365792897|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
106035123|NCT04179890|365792898|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
106035124|NCT04179890|365792897|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
106035125|NCT04179890|365792898|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
106097364|NCT03950739|366014391|FG000|Optional Extension Phase|Adverse Event|7|||
106035126|NCT04179890|365792897|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
106035127|NCT04179890|365792898|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
106035128|NCT01653782|365792903|FG000|Overall Study|Withdrawal by Subject|9|||
106035129|NCT01653782|365792904|FG001|Overall Study|Withdrawal by Subject|15|||
106035130|NCT01653782|365792905|FG002|Overall Study|Withdrawal by Subject|4|||
106035131|NCT01653782|365792903|FG000|Overall Study|Lost to Follow-up|7|||
106035132|NCT01653782|365792904|FG001|Overall Study|Lost to Follow-up|3|||
106035133|NCT01653782|365792905|FG002|Overall Study|Lost to Follow-up|2|||
106035134|NCT02677324|365792910|FG000|Overall Study|Disease Progression|6|||
106035135|NCT02677324|365792910|FG000|Overall Study|Inability to Swallow pills|1|||
106035136|NCT02677324|365792910|FG000|Overall Study|Non-compliance|1|||
106035137|NCT02677324|365792910|FG000|Overall Study|Lack of Efficacy|1|||
106035138|NCT02677324|365792910|FG000|Overall Study|Medical insurance coverage|1|||
106035139|NCT02677324|365792910|FG000|Overall Study|Adverse Event|1|||
106035140|NCT02677324|365792910|FG000|Overall Study|IgM Myeloma diagnosis|1|||
106035141|NCT00662532|365792911|FG000|Overall Study|Adverse Event|0|||
106035142|NCT00662532|365792912|FG001|Overall Study|Adverse Event|1|||
106035143|NCT00662532|365792911|FG000|Overall Study|Lost to Follow-up|0|||
106035144|NCT00662532|365792912|FG001|Overall Study|Lost to Follow-up|1|||
106035145|NCT01850602|365792913|FG000|Overall Study|Adverse Event|7|||
106035146|NCT01850602|365792914|FG001|Overall Study|Adverse Event|10|||
106035147|NCT01850602|365792913|FG000|Overall Study|Physician Decision|2|||
106035148|NCT01850602|365792914|FG001|Overall Study|Physician Decision|1|||
106035149|NCT01850602|365792913|FG000|Overall Study|Withdrawal by Subject|2|||
106035150|NCT01850602|365792914|FG001|Overall Study|Withdrawal by Subject|4|||
106035151|NCT01850602|365792913|FG000|Overall Study|Decrease in serum calcium|2|||
106035152|NCT01850602|365792914|FG001|Overall Study|Decrease in serum calcium|3|||
106035153|NCT01850602|365792913|FG000|Overall Study|Increase in serum ferritin|1|||
106035154|NCT01850602|365792914|FG001|Overall Study|Increase in serum ferritin|0|||
106035155|NCT00761748|365792915|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
106035156|NCT00761748|365792916|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
106035157|NCT00761748|365792915|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
106035158|NCT00761748|365792916|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
106035159|NCT01155479|365792919|FG000|Part I|Adverse Event|13|||
106035160|NCT01155479|365792920|FG001|Part I|Adverse Event|8|||
106035161|NCT01155479|365792921|FG002|Part I|Adverse Event|18|||
106035162|NCT01155479|365792922|FG003|Part I|Adverse Event|7|||
106035163|NCT01155479|365792923|FG004|Part I|Adverse Event|6|||
106035164|NCT01155479|365792919|FG000|Part I|Administrative|2|||
106035165|NCT01155479|365792920|FG001|Part I|Administrative|2|||
106035166|NCT01155479|365792921|FG002|Part I|Administrative|2|||
106035167|NCT01155479|365792922|FG003|Part I|Administrative|0|||
106035168|NCT01155479|365792923|FG004|Part I|Administrative|0|||
106035169|NCT01155479|365792919|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
106035170|NCT01155479|365792920|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
106035171|NCT01155479|365792921|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
106035172|NCT01155479|365792922|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
106035173|NCT01155479|365792923|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
106035174|NCT01155479|365792919|FG000|Part I|Withdrawal by Subject|11|||
106035175|NCT01155479|365792920|FG001|Part I|Withdrawal by Subject|13|||
106035176|NCT01155479|365792921|FG002|Part I|Withdrawal by Subject|8|||
106035177|NCT01155479|365792922|FG003|Part I|Withdrawal by Subject|8|||
106035178|NCT01155479|365792923|FG004|Part I|Withdrawal by Subject|9|||
106035179|NCT01155479|365792919|FG000|Part I|Lost to Follow-up|0|||
106035180|NCT01155479|365792920|FG001|Part I|Lost to Follow-up|0|||
106035181|NCT01155479|365792921|FG002|Part I|Lost to Follow-up|1|||
106035182|NCT01155479|365792922|FG003|Part I|Lost to Follow-up|1|||
106035183|NCT01155479|365792923|FG004|Part I|Lost to Follow-up|0|||
106035184|NCT01155479|365792919|FG000|Part I|Treatment Failure|3|||
106035185|NCT01155479|365792920|FG001|Part I|Treatment Failure|0|||
106035186|NCT01155479|365792921|FG002|Part I|Treatment Failure|3|||
106035187|NCT01155479|365792922|FG003|Part I|Treatment Failure|1|||
106035188|NCT01155479|365792923|FG004|Part I|Treatment Failure|2|||
105857407|NCT00338455|365129443|FG001|Overall Study|Death|1|||
106035189|NCT01155479|365792919|FG000|Part I|Did Not Receive Treatment|4|||
106035190|NCT01155479|365792920|FG001|Part I|Did Not Receive Treatment|2|||
106035191|NCT01155479|365792921|FG002|Part I|Did Not Receive Treatment|2|||
106035192|NCT01155479|365792922|FG003|Part I|Did Not Receive Treatment|6|||
106035193|NCT01155479|365792923|FG004|Part I|Did Not Receive Treatment|1|||
106035194|NCT01155479|365792919|FG000|Part I|Non-Compliance with Protocol|2|||
106035195|NCT01155479|365792920|FG001|Part I|Non-Compliance with Protocol|1|||
106035196|NCT01155479|365792921|FG002|Part I|Non-Compliance with Protocol|3|||
106035197|NCT01155479|365792922|FG003|Part I|Non-Compliance with Protocol|3|||
106035198|NCT01155479|365792923|FG004|Part I|Non-Compliance with Protocol|2|||
106035199|NCT01155479|365792919|FG000|Part II|Adverse Event|7|||
106035200|NCT01155479|365792920|FG001|Part II|Adverse Event|6|||
106035201|NCT01155479|365792921|FG002|Part II|Adverse Event|8|||
106035202|NCT01155479|365792922|FG003|Part II|Adverse Event|3|||
106035203|NCT01155479|365792923|FG004|Part II|Adverse Event|4|||
106035204|NCT01155479|365792919|FG000|Part II|Administrative|43|||
106035205|NCT01155479|365792920|FG001|Part II|Administrative|49|||
106035206|NCT01155479|365792921|FG002|Part II|Administrative|36|||
105857408|NCT00338455|365129442|FG000|Overall Study|Physician Decision|1|||
105857409|NCT00338455|365129443|FG001|Overall Study|Physician Decision|0|||
105857410|NCT01475097|365129446|FG000|Overall Study|Protocol Violation|1|||
105857411|NCT01475097|365129447|FG001|Overall Study|Protocol Violation|1|||
105857412|NCT00528411|365129448|FG000|Overall Study|Adverse Event|4|||
105857413|NCT00528411|365129449|FG001|Overall Study|Adverse Event|0|||
105857414|NCT00528411|365129450|FG002|Overall Study|Adverse Event|1|||
105857415|NCT00528411|365129448|FG000|Overall Study|Incorrect Enrolment|1|||
105857416|NCT00528411|365129449|FG001|Overall Study|Incorrect Enrolment|1|||
105857417|NCT00528411|365129450|FG002|Overall Study|Incorrect Enrolment|0|||
105857418|NCT00528411|365129448|FG000|Overall Study|Severe non-compliance to protocol|0|||
105857419|NCT00528411|365129449|FG001|Overall Study|Severe non-compliance to protocol|1|||
105857420|NCT00528411|365129450|FG002|Overall Study|Severe non-compliance to protocol|0|||
106035207|NCT01155479|365792922|FG003|Part II|Administrative|38|||
106035208|NCT01155479|365792923|FG004|Part II|Administrative|46|||
106035209|NCT01155479|365792919|FG000|Part II|Withdrawal by Subject|8|||
106035210|NCT01155479|365792920|FG001|Part II|Withdrawal by Subject|4|||
105857421|NCT00528411|365129448|FG000|Overall Study|Prior commitment medication|0|||
105857422|NCT00528411|365129449|FG001|Overall Study|Prior commitment medication|1|||
105857423|NCT00528411|365129450|FG002|Overall Study|Prior commitment medication|0|||
105857424|NCT04524364|365129454|FG000|Overall Study|Physician Decision|3|||
105857425|NCT04524364|365129455|FG001|Overall Study|Physician Decision|6|||
105857426|NCT04524364|365129454|FG000|Overall Study|Adverse Event|0|||
105857427|NCT04524364|365129455|FG001|Overall Study|Adverse Event|1|||
105857428|NCT04524364|365129454|FG000|Overall Study|Investigational device deficiency|0|||
105857429|NCT04524364|365129455|FG001|Overall Study|Investigational device deficiency|1|||
105857430|NCT04524364|365129454|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
105857431|NCT04524364|365129455|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
106035211|NCT01155479|365792921|FG002|Part II|Withdrawal by Subject|12|||
106035212|NCT01155479|365792922|FG003|Part II|Withdrawal by Subject|7|||
106035213|NCT01155479|365792923|FG004|Part II|Withdrawal by Subject|3|||
106035214|NCT01155479|365792919|FG000|Part II|Lost to Follow-up|1|||
106035215|NCT01155479|365792920|FG001|Part II|Lost to Follow-up|0|||
106035216|NCT01155479|365792921|FG002|Part II|Lost to Follow-up|0|||
105857432|NCT04524364|365129454|FG000|Overall Study|Device unavailability|0|||
105857433|NCT04524364|365129455|FG001|Overall Study|Device unavailability|2|||
105857434|NCT04524364|365129454|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
105857435|NCT04524364|365129455|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
105857436|NCT04524364|365129454|FG000|Overall Study|Low International normalized ratio (INR)|1|||
105857437|NCT04524364|365129455|FG001|Overall Study|Low International normalized ratio (INR)|0|||
105857438|NCT00380744|365129456|FG000|Overall Study|Death|0|||
105857439|NCT00380744|365129457|FG001|Overall Study|Death|0|||
105857440|NCT00380744|365129458|FG002|Overall Study|Death|0|||
106035217|NCT01155479|365792922|FG003|Part II|Lost to Follow-up|0|||
106035218|NCT01155479|365792923|FG004|Part II|Lost to Follow-up|1|||
106035219|NCT01155479|365792919|FG000|Part II|Treatment Failure|0|||
106035220|NCT01155479|365792920|FG001|Part II|Treatment Failure|1|||
106035221|NCT01155479|365792921|FG002|Part II|Treatment Failure|2|||
106035222|NCT01155479|365792922|FG003|Part II|Treatment Failure|0|||
106035223|NCT01155479|365792923|FG004|Part II|Treatment Failure|1|||
106035224|NCT01155479|365792919|FG000|Part II|Non-Compliance with Protocol|0|||
106035225|NCT01155479|365792920|FG001|Part II|Non-Compliance with Protocol|1|||
106035226|NCT01155479|365792921|FG002|Part II|Non-Compliance with Protocol|0|||
106035227|NCT01155479|365792922|FG003|Part II|Non-Compliance with Protocol|2|||
106035228|NCT01155479|365792923|FG004|Part II|Non-Compliance with Protocol|0|||
106035229|NCT01117792|365792924|FG000|Overall Study|Death|1|||
106035230|NCT01117792|365792924|FG000|Overall Study|Adverse Event|3|||
106035231|NCT00046891|365792925|FG000|Overall Study|Cancels|5|||
106035232|NCT00046891|365792926|FG001|Overall Study|Cancels|9|||
106035233|NCT00046891|365792925|FG000|Overall Study|Ineligible|1|||
106035234|NCT00046891|365792926|FG001|Overall Study|Ineligible|1|||
106035235|NCT00046891|365792925|FG000|Overall Study|Withdrawal by Subject|18|||
106035236|NCT00046891|365792926|FG001|Overall Study|Withdrawal by Subject|15|||
106035237|NCT00046891|365792925|FG000|Overall Study|Adverse Event|5|||
106035238|NCT00046891|365792926|FG001|Overall Study|Adverse Event|5|||
106035239|NCT02009384|365792931|FG000|Overall Study|Death|2|||
106035240|NCT01146860|365792932|FG000|Overall Study|Withdrawal by Subject|0|||
106035241|NCT01146860|365792933|FG001|Overall Study|Withdrawal by Subject|1|||
106035242|NCT00393042|365792935|FG000|First Intervention|Withdrawal by Subject|1|||
106035243|NCT00393042|365792936|FG001|First Intervention|Withdrawal by Subject|2|||
106035244|NCT00393042|365792935|FG000|First Intervention|Lost to Follow-up|3|||
106035245|NCT00393042|365792936|FG001|First Intervention|Lost to Follow-up|3|||
106035246|NCT00393042|365792935|FG000|First Intervention|Protocol Violation|1|||
106035247|NCT00393042|365792936|FG001|First Intervention|Protocol Violation|0|||
106035248|NCT00393042|365792935|FG000|First Intervention|Adverse Event|0|||
106035249|NCT00393042|365792936|FG001|First Intervention|Adverse Event|1|||
106035250|NCT00393042|365792935|FG000|Second Intervetion|Adverse Event|0|||
106035251|NCT00393042|365792936|FG001|Second Intervetion|Adverse Event|3|||
106035252|NCT00393042|365792935|FG000|Second Intervetion|Withdrawal by Subject|0|||
106035253|NCT00393042|365792936|FG001|Second Intervetion|Withdrawal by Subject|2|||
106035254|NCT00393042|365792935|FG000|Second Intervetion|Lack of Efficacy|1|||
106035255|NCT00393042|365792936|FG001|Second Intervetion|Lack of Efficacy|0|||
106035256|NCT00393042|365792935|FG000|Second Intervetion|Lost to Follow-up|0|||
106035257|NCT00393042|365792936|FG001|Second Intervetion|Lost to Follow-up|2|||
106035258|NCT00393042|365792935|FG000|Second Intervetion|Protocol Violation|1|||
106035259|NCT00393042|365792936|FG001|Second Intervetion|Protocol Violation|1|||
106035260|NCT00266864|365792937|FG000|Overall Study|Lost to Follow-up|4|||
106035261|NCT00266864|365792938|FG001|Overall Study|Lost to Follow-up|1|||
106035262|NCT00266864|365792937|FG000|Overall Study|Withdrawal by Subject|1|||
106035263|NCT00266864|365792938|FG001|Overall Study|Withdrawal by Subject|1|||
106035264|NCT05772702|365792948|FG000|Overall Study|Adverse Event|1|||
106035265|NCT01909453|365792949|FG000|Overall Study|Ongoing|118|||
106035266|NCT01909453|365792950|FG001|Overall Study|Ongoing|103|||
106035267|NCT01909453|365792951|FG002|Overall Study|Ongoing|83|||
106035268|NCT01909453|365792952|FG003|Overall Study|Ongoing|164|||
106035269|NCT01909453|365792953|FG004|Overall Study|Ongoing|50|||
106035270|NCT01909453|365792949|FG000|Overall Study|Death|69|||
106035271|NCT01909453|365792950|FG001|Overall Study|Death|74|||
106035272|NCT01909453|365792951|FG002|Overall Study|Death|88|||
106035273|NCT01909453|365792952|FG003|Overall Study|Death|86|||
106035274|NCT01909453|365792953|FG004|Overall Study|Death|29|||
106035275|NCT01909453|365792949|FG000|Overall Study|Lost to Follow-up|3|||
106035276|NCT01909453|365792950|FG001|Overall Study|Lost to Follow-up|4|||
106035277|NCT01909453|365792951|FG002|Overall Study|Lost to Follow-up|4|||
106035278|NCT01909453|365792952|FG003|Overall Study|Lost to Follow-up|3|||
106035279|NCT01909453|365792953|FG004|Overall Study|Lost to Follow-up|3|||
106035280|NCT01909453|365792949|FG000|Overall Study|Withdrawal by Subject|2|||
106035281|NCT01909453|365792950|FG001|Overall Study|Withdrawal by Subject|13|||
106035282|NCT01909453|365792951|FG002|Overall Study|Withdrawal by Subject|16|||
106035283|NCT01909453|365792952|FG003|Overall Study|Withdrawal by Subject|5|||
106035284|NCT01909453|365792953|FG004|Overall Study|Withdrawal by Subject|4|||
106035285|NCT04224272|365792954|FG000|Part 1 - Dose Finding|Death|4|||
106035286|NCT04224272|365792954|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
105857441|NCT00380744|365129459|FG003|Overall Study|Death|0|||
105857442|NCT00380744|365129460|FG004|Overall Study|Death|0|||
105857443|NCT00380744|365129461|FG005|Overall Study|Death|0|||
106035287|NCT04224272|365792954|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
106035288|NCT04224272|365792954|FG000|Part 2 - Dose Expansion|Death|10|||
106035289|NCT04224272|365792954|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
105857444|NCT00380744|365129462|FG006|Overall Study|Death|1|||
105857445|NCT00380744|365129456|FG000|Overall Study|Withdrawal by Subject|1|||
105857446|NCT00380744|365129457|FG001|Overall Study|Withdrawal by Subject|0|||
105857447|NCT00380744|365129458|FG002|Overall Study|Withdrawal by Subject|0|||
105857448|NCT00380744|365129459|FG003|Overall Study|Withdrawal by Subject|0|||
105857449|NCT00380744|365129460|FG004|Overall Study|Withdrawal by Subject|0|||
105857450|NCT00380744|365129461|FG005|Overall Study|Withdrawal by Subject|0|||
105857451|NCT00380744|365129462|FG006|Overall Study|Withdrawal by Subject|0|||
106035290|NCT04085367|365794715|FG000|Overall Study|Adverse Event|1|||
106035291|NCT04085367|365794716|FG001|Overall Study|Adverse Event|1|||
106035292|NCT04085367|365794715|FG000|Overall Study|Withdrawal by Subject|13|||
106035293|NCT04085367|365794716|FG001|Overall Study|Withdrawal by Subject|4|||
106035294|NCT04085367|365794715|FG000|Overall Study|Lost to Follow-up|3|||
106035295|NCT04085367|365794716|FG001|Overall Study|Lost to Follow-up|1|||
106035296|NCT04085367|365794715|FG000|Overall Study|Other unspecified|2|||
106035297|NCT04085367|365794716|FG001|Overall Study|Other unspecified|1|||
106035298|NCT04085367|365794715|FG000|Overall Study|Status Unknown|1|||
106035299|NCT04085367|365794716|FG001|Overall Study|Status Unknown|1|||
106035300|NCT01547780|365794720|FG000|Baseline PET Scan|Physician Decision|1|||
106035301|NCT01547780|365794721|FG001|Baseline PET Scan|Physician Decision|0|||
106035302|NCT01547780|365794722|FG002|Baseline PET Scan|Physician Decision|1|||
106035303|NCT01547780|365794723|FG003|Baseline PET Scan|Physician Decision|0|||
106035304|NCT01547780|365794720|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
106035305|NCT01547780|365794721|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
106035306|NCT01547780|365794722|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
106035307|NCT01547780|365794723|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
106035308|NCT01288976|365794725|FG000|Overall Study|Withdrawal by Subject|58|||
106035309|NCT01288976|365794726|FG001|Overall Study|Withdrawal by Subject|12|||
106035310|NCT01288976|365794727|FG002|Overall Study|Withdrawal by Subject|9|||
106035311|NCT01288976|365794725|FG000|Overall Study|Death|98|||
106035312|NCT01288976|365794726|FG001|Overall Study|Death|6|||
106035313|NCT01288976|365794727|FG002|Overall Study|Death|4|||
106035314|NCT01288976|365794725|FG000|Overall Study|Data unavailable|22|||
106035315|NCT01288976|365794726|FG001|Overall Study|Data unavailable|9|||
106035316|NCT01288976|365794727|FG002|Overall Study|Data unavailable|7|||
106035317|NCT02446743|365794728|FG000|Overall Study|Withdrawal by Subject|1|||
106035318|NCT02446743|365794729|FG001|Overall Study|Withdrawal by Subject|1|||
106035319|NCT02446743|365794728|FG000|Overall Study|Lost to Follow-up|1|||
106035320|NCT02446743|365794729|FG001|Overall Study|Lost to Follow-up|0|||
106035321|NCT02446743|365794728|FG000|Overall Study|Adverse Event|1|||
106035322|NCT02446743|365794729|FG001|Overall Study|Adverse Event|1|||
106035323|NCT02446743|365794728|FG000|Overall Study|Other|2|||
106035324|NCT02446743|365794729|FG001|Overall Study|Other|3|||
106035325|NCT01736657|365794734|FG000|Overall Study|insufficient vascular access|1|||
106035326|NCT03023046|365794745|FG000|Overall Study|Withdrawal by Subject|1|||
106035327|NCT00470158|365794746|FG000|Overall Study|Death|0|||
106035328|NCT00470158|365794747|FG001|Overall Study|Death|0|||
106035329|NCT00470158|365794748|FG002|Overall Study|Death|0|||
106035330|NCT00470158|365794749|FG003|Overall Study|Death|0|||
106035331|NCT00470158|365794750|FG004|Overall Study|Death|2|||
106035332|NCT00470158|365794746|FG000|Overall Study|Lost to Follow-up|7|||
106035333|NCT00470158|365794747|FG001|Overall Study|Lost to Follow-up|8|||
106035334|NCT00470158|365794748|FG002|Overall Study|Lost to Follow-up|8|||
106035335|NCT00470158|365794749|FG003|Overall Study|Lost to Follow-up|5|||
106035336|NCT00470158|365794750|FG004|Overall Study|Lost to Follow-up|4|||
106035337|NCT00470158|365794746|FG000|Overall Study|Protocol Violation|1|||
106035338|NCT00470158|365794747|FG001|Overall Study|Protocol Violation|0|||
106035339|NCT00470158|365794748|FG002|Overall Study|Protocol Violation|0|||
106035340|NCT00470158|365794749|FG003|Overall Study|Protocol Violation|0|||
106035341|NCT00470158|365794750|FG004|Overall Study|Protocol Violation|0|||
106035342|NCT01236118|365794751|FG000|Overall Study|Adverse Event|2|||
106035343|NCT01236118|365794752|FG001|Overall Study|Adverse Event|0|||
106035344|NCT01236118|365794753|FG002|Overall Study|Adverse Event|2|||
106035345|NCT01236118|365794751|FG000|Overall Study|Physician Decision|0|||
106035346|NCT01236118|365794752|FG001|Overall Study|Physician Decision|1|||
106035347|NCT01236118|365794753|FG002|Overall Study|Physician Decision|0|||
106035348|NCT01236118|365794751|FG000|Overall Study|Withdrawal by Subject|0|||
106035349|NCT01236118|365794752|FG001|Overall Study|Withdrawal by Subject|0|||
106035350|NCT01236118|365794753|FG002|Overall Study|Withdrawal by Subject|1|||
106035351|NCT03505671|365794754|FG000|Overall Study|Withdrawal by Subject|2|||
106035352|NCT03505671|365794755|FG001|Overall Study|Withdrawal by Subject|1|||
106035353|NCT03505671|365794754|FG000|Overall Study|Lost to Follow-up|1|||
106035354|NCT03505671|365794755|FG001|Overall Study|Lost to Follow-up|0|||
106035355|NCT02742246|365794758|FG000|Overall Study|Never initiated treatment|5|||
106035356|NCT02742246|365794759|FG001|Overall Study|Never initiated treatment|3|||
106035357|NCT02742246|365794760|FG002|Overall Study|Never initiated treatment|1|||
106035358|NCT02742246|365794758|FG000|Overall Study|dropped out during treatment|7|||
106035359|NCT02742246|365794759|FG001|Overall Study|dropped out during treatment|13|||
106035360|NCT02742246|365794760|FG002|Overall Study|dropped out during treatment|10|||
106035361|NCT02742246|365794758|FG000|Overall Study|Death|1|||
106035362|NCT02742246|365794759|FG001|Overall Study|Death|0|||
106035363|NCT02742246|365794760|FG002|Overall Study|Death|0|||
106035364|NCT03422627|365794761|FG000|Overall Study|Protocol-specified Criteria|1|||
106035365|NCT03422627|365794762|FG001|Overall Study|Protocol-specified Criteria|1|||
106035366|NCT03422627|365794763|FG002|Overall Study|Protocol-specified Criteria|0|||
106035367|NCT03422627|365794764|FG003|Overall Study|Protocol-specified Criteria|0|||
106035368|NCT03422627|365794765|FG004|Overall Study|Protocol-specified Criteria|2|||
106035369|NCT03422627|365794761|FG000|Overall Study|Requirement for Alternative Therapy|1|||
106035370|NCT03422627|365794762|FG001|Overall Study|Requirement for Alternative Therapy|1|||
106035371|NCT03422627|365794763|FG002|Overall Study|Requirement for Alternative Therapy|2|||
106035372|NCT03422627|365794764|FG003|Overall Study|Requirement for Alternative Therapy|0|||
106035373|NCT03422627|365794765|FG004|Overall Study|Requirement for Alternative Therapy|0|||
106035374|NCT03422627|365794761|FG000|Overall Study|Disease Progression|1|||
106035375|NCT03422627|365794762|FG001|Overall Study|Disease Progression|0|||
106035376|NCT03422627|365794763|FG002|Overall Study|Disease Progression|1|||
106035377|NCT03422627|365794764|FG003|Overall Study|Disease Progression|2|||
106035378|NCT03422627|365794765|FG004|Overall Study|Disease Progression|0|||
106035379|NCT03422627|365794761|FG000|Overall Study|Adverse Event|2|||
106035380|NCT03422627|365794762|FG001|Overall Study|Adverse Event|1|||
106035381|NCT03422627|365794763|FG002|Overall Study|Adverse Event|0|||
106035382|NCT03422627|365794764|FG003|Overall Study|Adverse Event|0|||
106035383|NCT03422627|365794765|FG004|Overall Study|Adverse Event|2|||
106035384|NCT03422627|365794761|FG000|Overall Study|Ineligibility Determined|0|||
106035385|NCT03422627|365794762|FG001|Overall Study|Ineligibility Determined|1|||
106035386|NCT03422627|365794763|FG002|Overall Study|Ineligibility Determined|0|||
106035387|NCT03422627|365794764|FG003|Overall Study|Ineligibility Determined|0|||
106035388|NCT03422627|365794765|FG004|Overall Study|Ineligibility Determined|0|||
106035389|NCT03422627|365794761|FG000|Overall Study|Death|0|||
106035390|NCT03422627|365794762|FG001|Overall Study|Death|1|||
106035391|NCT03422627|365794763|FG002|Overall Study|Death|1|||
106035392|NCT03422627|365794764|FG003|Overall Study|Death|0|||
106035393|NCT03422627|365794765|FG004|Overall Study|Death|0|||
106035394|NCT03422627|365794761|FG000|Overall Study|Withdrawal by Subject|0|||
106035395|NCT03422627|365794762|FG001|Overall Study|Withdrawal by Subject|0|||
106035396|NCT03422627|365794763|FG002|Overall Study|Withdrawal by Subject|0|||
106035397|NCT03422627|365794764|FG003|Overall Study|Withdrawal by Subject|1|||
106035398|NCT03422627|365794765|FG004|Overall Study|Withdrawal by Subject|0|||
106035399|NCT03584373|365794768|FG000|Overall Study|Lost to Follow-up|7|||
106035400|NCT03584373|365794769|FG001|Overall Study|Lost to Follow-up|8|||
106035401|NCT01487577|365794770|FG000|Overall Study|Became ineligible after signing consent|1|||
106035402|NCT00708201|365794771|FG000|Overall Study|Adverse Event|4|||
106035403|NCT00708201|365794772|FG001|Overall Study|Adverse Event|4|||
106035404|NCT00708201|365794771|FG000|Overall Study|Withdrawal by Subject|1|||
106035405|NCT00708201|365794772|FG001|Overall Study|Withdrawal by Subject|1|||
106035406|NCT00708201|365794771|FG000|Overall Study|Lost to Follow-up|2|||
106035407|NCT00708201|365794772|FG001|Overall Study|Lost to Follow-up|0|||
106035408|NCT00708201|365794771|FG000|Overall Study|Protocol Violation|0|||
106035409|NCT00708201|365794772|FG001|Overall Study|Protocol Violation|1|||
106035410|NCT04761627|365794773|FG000|Run-in Period|Death|1|||
106035411|NCT04761627|365794774|FG001|Run-in Period|Death|0|||
106035412|NCT04761627|365794775|FG002|Run-in Period|Death|0|||
106035413|NCT04761627|365794773|FG000|Run-in Period|Required alternative therapy|2|||
106035414|NCT04761627|365794774|FG001|Run-in Period|Required alternative therapy|0|||
106035415|NCT04761627|365794775|FG002|Run-in Period|Required alternative therapy|0|||
106035416|NCT04761627|365794773|FG000|Run-in Period|Lost to Follow-up|2|||
106035417|NCT04761627|365794774|FG001|Run-in Period|Lost to Follow-up|0|||
106035418|NCT04761627|365794775|FG002|Run-in Period|Lost to Follow-up|0|||
106035419|NCT04761627|365794773|FG000|Run-in Period|Protocol Violation|3|||
106035420|NCT04761627|365794774|FG001|Run-in Period|Protocol Violation|0|||
106035421|NCT04761627|365794775|FG002|Run-in Period|Protocol Violation|0|||
106035422|NCT04761627|365794773|FG000|Run-in Period|Abnormal liver function|1|||
106035423|NCT04761627|365794774|FG001|Run-in Period|Abnormal liver function|0|||
106035424|NCT04761627|365794775|FG002|Run-in Period|Abnormal liver function|0|||
106035425|NCT04761627|365794773|FG000|Run-in Period|Adverse Event|6|||
106035426|NCT04761627|365794774|FG001|Run-in Period|Adverse Event|0|||
106035427|NCT04761627|365794775|FG002|Run-in Period|Adverse Event|0|||
106035428|NCT04761627|365794773|FG000|Run-in Period|Withdrawal by Subject|7|||
106035429|NCT04761627|365794774|FG001|Run-in Period|Withdrawal by Subject|0|||
106035430|NCT04761627|365794775|FG002|Run-in Period|Withdrawal by Subject|0|||
106035431|NCT04761627|365794773|FG000|Run-in Period|Did not meet PASI 50|15|||
106035432|NCT04761627|365794774|FG001|Run-in Period|Did not meet PASI 50|0|||
106035433|NCT04761627|365794775|FG002|Run-in Period|Did not meet PASI 50|0|||
106035434|NCT04761627|365794773|FG000|Run-in Period|Study site closure|2|||
106035435|NCT04761627|365794774|FG001|Run-in Period|Study site closure|0|||
106035436|NCT04761627|365794775|FG002|Run-in Period|Study site closure|0|||
106035437|NCT04761627|365794773|FG000|Run-in Period|Pregnancy|2|||
106035438|NCT04761627|365794774|FG001|Run-in Period|Pregnancy|0|||
106035439|NCT04761627|365794775|FG002|Run-in Period|Pregnancy|0|||
106035440|NCT04761627|365794773|FG000|Post-randomization Period|Military service|0|||
106035441|NCT04761627|365794774|FG001|Post-randomization Period|Military service|1|||
106035442|NCT04761627|365794775|FG002|Post-randomization Period|Military service|0|||
106035443|NCT04761627|365794773|FG000|Post-randomization Period|Adverse Event|0|||
106035444|NCT04761627|365794774|FG001|Post-randomization Period|Adverse Event|4|||
106035445|NCT04761627|365794775|FG002|Post-randomization Period|Adverse Event|2|||
106035446|NCT04761627|365794773|FG000|Post-randomization Period|Lost to Follow-up|0|||
106035447|NCT04761627|365794774|FG001|Post-randomization Period|Lost to Follow-up|6|||
106035448|NCT04761627|365794775|FG002|Post-randomization Period|Lost to Follow-up|6|||
106035449|NCT04761627|365794773|FG000|Post-randomization Period|Withdrawal by Subject|0|||
106035450|NCT04761627|365794774|FG001|Post-randomization Period|Withdrawal by Subject|7|||
106035451|NCT04761627|365794775|FG002|Post-randomization Period|Withdrawal by Subject|6|||
106035452|NCT04761627|365794773|FG000|Post-randomization Period|Pregnancy|0|||
106035453|NCT04761627|365794774|FG001|Post-randomization Period|Pregnancy|0|||
106035454|NCT04761627|365794775|FG002|Post-randomization Period|Pregnancy|1|||
106035455|NCT04761627|365794773|FG000|Post-randomization Period|Study site closure|0|||
106035456|NCT04761627|365794774|FG001|Post-randomization Period|Study site closure|0|||
106035457|NCT04761627|365794775|FG002|Post-randomization Period|Study site closure|1|||
106035458|NCT04761627|365794773|FG000|Post-randomization Period|Family planning|0|||
106035459|NCT04761627|365794774|FG001|Post-randomization Period|Family planning|1|||
106035460|NCT04761627|365794775|FG002|Post-randomization Period|Family planning|0|||
106035461|NCT01214174|365794776|FG000|Overall Study|Withdrawal by Subject|0|||
106035462|NCT01214174|365794777|FG001|Overall Study|Withdrawal by Subject|0|||
106035463|NCT01214174|365794778|FG002|Overall Study|Withdrawal by Subject|1|||
106035464|NCT01634178|365794779|FG000|Treatment Period 1|Adverse Event|0|||
106035465|NCT01634178|365794780|FG001|Treatment Period 1|Adverse Event|1|||
106035466|NCT01634178|365794779|FG000|Treatment Period 2|Adverse Event|1|||
106035467|NCT01634178|365794780|FG001|Treatment Period 2|Adverse Event|0|||
106035468|NCT01933789|365794781|FG000|Overall Study|Death|0|||
106035469|NCT01933789|365794782|FG001|Overall Study|Death|0|||
106035470|NCT01933789|365794783|FG002|Overall Study|Death|0|||
106035471|NCT01933789|365794784|FG003|Overall Study|Death|0|||
106035472|NCT01933789|365794785|FG004|Overall Study|Death|21|||
106035473|NCT01933789|365794786|FG005|Overall Study|Death|32|||
106035474|NCT01933789|365794787|FG006|Overall Study|Death|0|||
106035475|NCT01933789|365794788|FG007|Overall Study|Death|0|||
106035476|NCT01933789|365794789|FG008|Overall Study|Death|0|||
106035477|NCT01933789|365794781|FG000|Overall Study|Lost to Follow-up|0|||
106035478|NCT01933789|365794782|FG001|Overall Study|Lost to Follow-up|0|||
106035479|NCT01933789|365794783|FG002|Overall Study|Lost to Follow-up|0|||
106035480|NCT01933789|365794784|FG003|Overall Study|Lost to Follow-up|1|||
106035481|NCT01933789|365794785|FG004|Overall Study|Lost to Follow-up|8|||
106035482|NCT01933789|365794786|FG005|Overall Study|Lost to Follow-up|9|||
106035483|NCT01933789|365794787|FG006|Overall Study|Lost to Follow-up|1|||
106035484|NCT01933789|365794788|FG007|Overall Study|Lost to Follow-up|4|||
106035485|NCT01933789|365794789|FG008|Overall Study|Lost to Follow-up|0|||
106035486|NCT01933789|365794781|FG000|Overall Study|Withdrawal by Subject|2|||
106035487|NCT01933789|365794782|FG001|Overall Study|Withdrawal by Subject|1|||
106035488|NCT01933789|365794783|FG002|Overall Study|Withdrawal by Subject|0|||
106035489|NCT01933789|365794784|FG003|Overall Study|Withdrawal by Subject|0|||
106035490|NCT01933789|365794785|FG004|Overall Study|Withdrawal by Subject|17|||
106035491|NCT01933789|365794786|FG005|Overall Study|Withdrawal by Subject|16|||
106035492|NCT01933789|365794787|FG006|Overall Study|Withdrawal by Subject|1|||
106035493|NCT01933789|365794788|FG007|Overall Study|Withdrawal by Subject|4|||
106035494|NCT01933789|365794789|FG008|Overall Study|Withdrawal by Subject|0|||
106035495|NCT01933789|365794781|FG000|Overall Study|Became Ineligible|4|||
106035496|NCT01933789|365794782|FG001|Overall Study|Became Ineligible|0|||
105857452|NCT01441947|365129463|FG000|Overall Study|Withdrawal by Subject|3|||
106035497|NCT01933789|365794783|FG002|Overall Study|Became Ineligible|0|||
106035498|NCT01933789|365794784|FG003|Overall Study|Became Ineligible|0|||
105857453|NCT01441947|365129464|FG001|Overall Study|Withdrawal by Subject|0|||
106035499|NCT01933789|365794785|FG004|Overall Study|Became Ineligible|13|||
106035500|NCT01933789|365794786|FG005|Overall Study|Became Ineligible|10|||
106035501|NCT01933789|365794787|FG006|Overall Study|Became Ineligible|13|||
106035502|NCT01933789|365794788|FG007|Overall Study|Became Ineligible|6|||
106035503|NCT01933789|365794789|FG008|Overall Study|Became Ineligible|0|||
106035504|NCT05442775|365794792|FG000|Overall Study|Trial terminated|61|||
106035505|NCT05442775|365794792|FG000|Overall Study|Lack of Efficacy|4|||
106035506|NCT05442775|365794792|FG000|Overall Study|Withdrawal by Subject|4|||
106035507|NCT05442775|365794792|FG000|Overall Study|Death|1|||
106035508|NCT05442775|365794792|FG000|Overall Study|Participant removed at Sponsor request|1|||
106035509|NCT02497976|365794793|FG000|Overall Study|Withdrawal by Subject|2|||
106035510|NCT02497976|365794794|FG001|Overall Study|Withdrawal by Subject|0|||
106035511|NCT02497976|365794793|FG000|Overall Study|Moved out of area|0|||
106035512|NCT02497976|365794794|FG001|Overall Study|Moved out of area|1|||
106035513|NCT00584740|365794802|FG000|Overall Study|Adverse Event|1|||
106035514|NCT00584740|365794803|FG001|Overall Study|Adverse Event|1|||
106035515|NCT00584740|365794802|FG000|Overall Study|Lack of Efficacy|8|||
106035516|NCT00584740|365794803|FG001|Overall Study|Lack of Efficacy|2|||
106035517|NCT00584740|365794802|FG000|Overall Study|Withdrawal by Subject|3|||
106035518|NCT00584740|365794803|FG001|Overall Study|Withdrawal by Subject|2|||
106035519|NCT00584740|365794802|FG000|Overall Study|Lost to Follow-up|0|||
106035520|NCT00584740|365794803|FG001|Overall Study|Lost to Follow-up|1|||
106035521|NCT02483533|365794806|FG000|Overall Study|Lack of Efficacy|50|||
106035522|NCT02483533|365794807|FG001|Overall Study|Lack of Efficacy|50|||
106035523|NCT04966741|365794813|FG000|Overall Study|Lost to Follow-up|1|||
106035524|NCT04966741|365794814|FG001|Overall Study|Lost to Follow-up|0|||
106035525|NCT02953509|365794816|FG000|Overall Study|Death|1|||
106035526|NCT02953509|365794817|FG001|Overall Study|Death|3|||
106035527|NCT02953509|365794818|FG002|Overall Study|Death|3|||
106035528|NCT02953509|365794819|FG003|Overall Study|Death|4|||
106035529|NCT02953509|365794820|FG004|Overall Study|Death|12|||
106035530|NCT02953509|365794821|FG005|Overall Study|Death|3|||
106035531|NCT02953509|365794822|FG006|Overall Study|Death|25|||
106035532|NCT02953509|365794823|FG007|Overall Study|Death|10|||
106035533|NCT02953509|365794824|FG008|Overall Study|Death|21|||
106035534|NCT02953509|365794825|FG009|Overall Study|Death|20|||
106035535|NCT02953509|365794816|FG000|Overall Study|Reason Not Specified|0|||
106035536|NCT02953509|365794817|FG001|Overall Study|Reason Not Specified|2|||
106035537|NCT02953509|365794818|FG002|Overall Study|Reason Not Specified|8|||
106035538|NCT02953509|365794819|FG003|Overall Study|Reason Not Specified|2|||
106035539|NCT02953509|365794820|FG004|Overall Study|Reason Not Specified|11|||
106035540|NCT02953509|365794821|FG005|Overall Study|Reason Not Specified|4|||
106035541|NCT02953509|365794822|FG006|Overall Study|Reason Not Specified|12|||
106035542|NCT02953509|365794823|FG007|Overall Study|Reason Not Specified|2|||
106035543|NCT02953509|365794824|FG008|Overall Study|Reason Not Specified|7|||
106035544|NCT02953509|365794825|FG009|Overall Study|Reason Not Specified|2|||
106035545|NCT02953509|365794816|FG000|Overall Study|Consent Withdrawn|1|||
106035546|NCT02953509|365794817|FG001|Overall Study|Consent Withdrawn|1|||
106035547|NCT02953509|365794818|FG002|Overall Study|Consent Withdrawn|2|||
106035548|NCT02953509|365794819|FG003|Overall Study|Consent Withdrawn|1|||
106035549|NCT02953509|365794820|FG004|Overall Study|Consent Withdrawn|3|||
106035550|NCT02953509|365794821|FG005|Overall Study|Consent Withdrawn|0|||
106035551|NCT02953509|365794822|FG006|Overall Study|Consent Withdrawn|4|||
106035552|NCT02953509|365794823|FG007|Overall Study|Consent Withdrawn|1|||
106035553|NCT02953509|365794824|FG008|Overall Study|Consent Withdrawn|1|||
106035554|NCT02953509|365794825|FG009|Overall Study|Consent Withdrawn|4|||
106035555|NCT02953509|365794816|FG000|Overall Study|Lost to Follow-up|0|||
106035556|NCT02953509|365794817|FG001|Overall Study|Lost to Follow-up|0|||
106035557|NCT02953509|365794818|FG002|Overall Study|Lost to Follow-up|0|||
106035558|NCT02953509|365794819|FG003|Overall Study|Lost to Follow-up|0|||
106035559|NCT02953509|365794820|FG004|Overall Study|Lost to Follow-up|0|||
106035560|NCT02953509|365794821|FG005|Overall Study|Lost to Follow-up|0|||
106035561|NCT02953509|365794822|FG006|Overall Study|Lost to Follow-up|1|||
106035562|NCT02953509|365794823|FG007|Overall Study|Lost to Follow-up|1|||
106035563|NCT02953509|365794824|FG008|Overall Study|Lost to Follow-up|1|||
106035564|NCT02953509|365794825|FG009|Overall Study|Lost to Follow-up|1|||
106035565|NCT02953509|365794816|FG000|Overall Study|Study terminated by sponsor|1|||
106035566|NCT02953509|365794817|FG001|Overall Study|Study terminated by sponsor|0|||
106035567|NCT02953509|365794818|FG002|Overall Study|Study terminated by sponsor|0|||
106035568|NCT02953509|365794819|FG003|Overall Study|Study terminated by sponsor|0|||
106035569|NCT02953509|365794820|FG004|Overall Study|Study terminated by sponsor|0|||
106035570|NCT02953509|365794821|FG005|Overall Study|Study terminated by sponsor|0|||
106035571|NCT02953509|365794822|FG006|Overall Study|Study terminated by sponsor|1|||
106035572|NCT02953509|365794823|FG007|Overall Study|Study terminated by sponsor|0|||
106035573|NCT02953509|365794824|FG008|Overall Study|Study terminated by sponsor|1|||
106035574|NCT02953509|365794825|FG009|Overall Study|Study terminated by sponsor|1|||
106035575|NCT00509262|365794826|FG000|Overall Study|Adverse Event|16|||
106035576|NCT00509262|365794827|FG001|Overall Study|Adverse Event|18|||
106035577|NCT00509262|365794826|FG000|Overall Study|Other|2|||
106035578|NCT00509262|365794827|FG001|Overall Study|Other|2|||
106035579|NCT00509262|365794826|FG000|Overall Study|Lack of Efficacy|1|||
106035580|NCT00509262|365794827|FG001|Overall Study|Lack of Efficacy|0|||
106035581|NCT00509262|365794826|FG000|Overall Study|Lost to Follow-up|1|||
106035582|NCT00509262|365794827|FG001|Overall Study|Lost to Follow-up|6|||
106035583|NCT00509262|365794826|FG000|Overall Study|Physician Decision|1|||
106035584|NCT00509262|365794827|FG001|Overall Study|Physician Decision|3|||
106035585|NCT00509262|365794826|FG000|Overall Study|Protocol Violation|2|||
106035586|NCT00509262|365794827|FG001|Overall Study|Protocol Violation|2|||
106035587|NCT00509262|365794826|FG000|Overall Study|Withdrawal by Subject|24|||
106035588|NCT00509262|365794827|FG001|Overall Study|Withdrawal by Subject|11|||
106035589|NCT01101191|365794828|FG000|Period 1|Withdrawal by Subject|1|||
106035590|NCT01101191|365794829|FG001|Period 1|Withdrawal by Subject|0|||
106035591|NCT01101191|365794828|FG000|Period 1|Adverse Event|1|||
106035592|NCT01101191|365794829|FG001|Period 1|Adverse Event|2|||
106035593|NCT01092832|365794831|FG000|Overall Study|Other|1|||
106035594|NCT01092832|365794832|FG001|Overall Study|Other|0|||
106035595|NCT00718237|365794837|FG000|Overall Study|Adverse Event|1|||
106035596|NCT00718237|365794838|FG001|Overall Study|Adverse Event|3|||
106035597|NCT00718237|365794837|FG000|Overall Study|Lost to Follow-up|2|||
106035598|NCT00718237|365794838|FG001|Overall Study|Lost to Follow-up|2|||
106035599|NCT00718237|365794837|FG000|Overall Study|Physician Decision|1|||
106035600|NCT00718237|365794838|FG001|Overall Study|Physician Decision|0|||
106035601|NCT00718237|365794837|FG000|Overall Study|Withdrawal by Subject|9|||
106035602|NCT00718237|365794838|FG001|Overall Study|Withdrawal by Subject|10|||
106035603|NCT02068768|365794839|FG000|Overall Study|Lost to Follow-up|5|||
106035604|NCT02068768|365794839|FG000|Overall Study|Early Termination by Sponsor|2|||
106035605|NCT03761797|365794840|FG000|Overall Study|Changing hospital|11|||
106035606|NCT03761797|365794840|FG000|Overall Study|Improvement/remission|6|||
106035607|NCT03761797|365794840|FG000|Overall Study|Withdrawal by Subject|19|||
106035608|NCT03761797|365794840|FG000|Overall Study|Lost to Follow-up|33|||
106035609|NCT03761797|365794840|FG000|Overall Study|Adverse Event|37|||
106035610|NCT03761797|365794840|FG000|Overall Study|Case report form (CRF) not collected|5|||
106035611|NCT03761797|365794840|FG000|Overall Study|No patient visit after entry|13|||
106035612|NCT03761797|365794840|FG000|Overall Study|Switch to other diabetes medication|10|||
106035613|NCT03761797|365794840|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
106035614|NCT03761797|365794840|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
106035615|NCT03761797|365794840|FG000|Overall Study|Insufficient effectives|2|||
106035616|NCT03761797|365794840|FG000|Overall Study|Excessive alcohol intake|1|||
106035617|NCT03021564|365794843|FG000|Overall Study|Death|84|||
106035618|NCT03021564|365794844|FG001|Overall Study|Death|466|||
106035619|NCT03021564|365794843|FG000|Overall Study|Lost to Follow-up|0|||
106035620|NCT03021564|365794844|FG001|Overall Study|Lost to Follow-up|2|||
106035621|NCT02380690|365794845|FG000|Overall Study|Lost to Follow-up|14|||
106035622|NCT02380690|365794846|FG001|Overall Study|Lost to Follow-up|4|||
106035623|NCT02380690|365794845|FG000|Overall Study|Withdrawal by Subject|20|||
106035624|NCT02380690|365794846|FG001|Overall Study|Withdrawal by Subject|8|||
106035625|NCT01958827|365794847|FG000|Overall Study|Adverse Event|3|||
106035626|NCT01958827|365794847|FG000|Overall Study|Lack of Efficacy|6|||
106035627|NCT01958827|365794847|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
106035628|NCT03119701|365794848|FG000|6-day Dosing|Death|4|||
106035629|NCT03119701|365794849|FG001|6-day Dosing|Death|1|||
106035630|NCT03119701|365794848|FG000|6-day Dosing|Adverse Event|3|||
106035631|NCT03119701|365794849|FG001|6-day Dosing|Adverse Event|0|||
106035632|NCT03119701|365794848|FG000|6-day Dosing|Physician Decision|0|||
106035633|NCT03119701|365794849|FG001|6-day Dosing|Physician Decision|1|||
106035634|NCT03119701|365794848|FG000|6-day Dosing|Withdrawal by Subject|0|||
106035635|NCT03119701|365794849|FG001|6-day Dosing|Withdrawal by Subject|1|||
106035636|NCT03119701|365794848|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
106035637|NCT03119701|365794849|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
106035638|NCT00596362|365794850|FG000|Overall Study|Progressive Disease|1|||
106035639|NCT00817479|365794851|FG000|Overall Study|Physician Decision|1|||
106035640|NCT00817479|365794852|FG001|Overall Study|Physician Decision|1|||
106035641|NCT03640559|365794855|FG000|Overall Study|Physician Decision|1|||
106035642|NCT03640559|365794856|FG001|Overall Study|Physician Decision|1|||
106035643|NCT03640559|365794855|FG000|Overall Study|Withdrawal by Subject|1|||
106035644|NCT03640559|365794856|FG001|Overall Study|Withdrawal by Subject|0|||
106035645|NCT00356122|365794857|FG000|TREATMENT|Lack of Efficacy|26|||
106035646|NCT00356122|365794857|FG000|TREATMENT|Adverse Event|10|||
106035647|NCT00356122|365794857|FG000|TREATMENT|Subject's request|4|||
106035648|NCT00356122|365794857|FG000|TREATMENT|Other|4|||
106035649|NCT00356122|365794857|FG000|TREATMENT|Did not receive study medication|1|||
106035650|NCT00356122|365794857|FG000|FOLLOW-UP|Death|37|||
106035651|NCT00356122|365794857|FG000|FOLLOW-UP|Lost to Follow-up|2|||
106035652|NCT00356122|365794857|FG000|FOLLOW-UP|Other|2|||
106035653|NCT02361346|365794858|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
106035654|NCT02361346|365794859|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
106035655|NCT02361346|365794860|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
106035656|NCT02361346|365794861|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
106035657|NCT02361346|365794862|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
106035658|NCT02361346|365794863|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
106035659|NCT02361346|365794864|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
106035660|NCT02361346|365794865|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
106035661|NCT02361346|365794866|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
106035662|NCT02361346|365794858|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
106035663|NCT02361346|365794859|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
106035664|NCT02361346|365794860|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
106035665|NCT02361346|365794861|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
106035666|NCT02361346|365794862|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
106035667|NCT02361346|365794863|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
106035668|NCT02361346|365794864|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
106035669|NCT02361346|365794865|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
106035670|NCT02361346|365794866|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
106035671|NCT02361346|365794858|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
106035672|NCT02361346|365794859|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
106035673|NCT02361346|365794860|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
106035674|NCT02361346|365794861|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
106035675|NCT02361346|365794862|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
106035676|NCT02361346|365794863|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
106035677|NCT02361346|365794864|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
106035678|NCT02361346|365794865|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
106035679|NCT02361346|365794866|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
106035680|NCT02361346|365794858|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
106035681|NCT02361346|365794859|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
106035682|NCT02361346|365794860|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
106035683|NCT02361346|365794861|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
106035684|NCT02361346|365794862|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
106035685|NCT02361346|365794863|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
106035686|NCT02361346|365794864|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
106035687|NCT02361346|365794865|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
106035688|NCT02361346|365794866|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
106035689|NCT02361346|365794858|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
106035690|NCT02361346|365794859|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
106035691|NCT02361346|365794860|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
106035692|NCT02361346|365794861|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
106035693|NCT02361346|365794862|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
106035694|NCT02361346|365794863|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
106035695|NCT02361346|365794864|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
106035696|NCT02361346|365794865|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
106035697|NCT02361346|365794866|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
106035698|NCT02361346|365794858|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
106035699|NCT02361346|365794859|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
106035700|NCT02361346|365794860|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
106035701|NCT02361346|365794861|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
106035702|NCT02361346|365794862|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
106035703|NCT02361346|365794863|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
106035704|NCT02361346|365794864|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
106035705|NCT02361346|365794865|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
106035706|NCT02361346|365794866|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
106035707|NCT03670836|365794874|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
106035708|NCT03670836|365794875|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
106035709|NCT03670836|365794874|FG000|Per Protocol Population (PP)|Physician Decision|9|||
106035710|NCT03670836|365794875|FG001|Per Protocol Population (PP)|Physician Decision|10|||
106035711|NCT03670836|365794874|FG000|Per Protocol Population (PP)|Physician Decision|4|||
106035712|NCT03670836|365794875|FG001|Per Protocol Population (PP)|Physician Decision|6|||
106035713|NCT03670836|365794874|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
106035714|NCT03670836|365794875|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
106035715|NCT02278471|365796677|FG000|Overall Study|Lost to Follow-up|6|||
106035716|NCT02278471|365796678|FG001|Overall Study|Lost to Follow-up|15|||
106035717|NCT02278471|365796677|FG000|Overall Study|Death|2|||
106035718|NCT02278471|365796678|FG001|Overall Study|Death|2|||
106035719|NCT02278471|365796677|FG000|Overall Study|Withdrawal by Subject|0|||
106035720|NCT02278471|365796678|FG001|Overall Study|Withdrawal by Subject|3|||
106035721|NCT01741012|365796680|FG000|Overall Study|Lost to Follow-up|1|||
106035722|NCT01741012|365796680|FG000|Overall Study|Withdrawal by Subject|2|||
106035723|NCT00640835|365796681|FG000|Overall Study|Adverse Event|5|||
106035724|NCT00640835|365796682|FG001|Overall Study|Adverse Event|3|||
106035725|NCT00640835|365796681|FG000|Overall Study|Withdrawal by Subject|12|||
106035726|NCT00640835|365796682|FG001|Overall Study|Withdrawal by Subject|14|||
106035727|NCT00640835|365796681|FG000|Overall Study|Physician Decision|10|||
106035728|NCT00640835|365796682|FG001|Overall Study|Physician Decision|14|||
106035729|NCT00640835|365796681|FG000|Overall Study|Sponsor's Decision|11|||
106035730|NCT00640835|365796682|FG001|Overall Study|Sponsor's Decision|7|||
106035731|NCT00640835|365796681|FG000|Overall Study|Protocol Violation|2|||
106035732|NCT00640835|365796682|FG001|Overall Study|Protocol Violation|2|||
106035733|NCT00640835|365796681|FG000|Overall Study|Lost to Follow-up|17|||
106151721|NCT02590432|366215132|FG000|Double-blind Treatment Period|Adverse Event|0|||
106035734|NCT00640835|365796682|FG001|Overall Study|Lost to Follow-up|13|||
106035735|NCT00640835|365796681|FG000|Overall Study|Other Reason|19|||
106035736|NCT00640835|365796682|FG001|Overall Study|Other Reason|4|||
106035737|NCT01249118|365796683|FG000|First Washout Period|Physician Decision|0|||
106035738|NCT01249118|365796684|FG001|First Washout Period|Physician Decision|1|||
106035739|NCT01249118|365796685|FG002|First Washout Period|Physician Decision|0|||
106035740|NCT00737464|365796692|FG000|Overall Study|Adverse Event|1|||
106035741|NCT00737464|365796692|FG000|Overall Study|Death|6|||
106035742|NCT00737464|365796692|FG000|Overall Study|Other - Failure to Return|1|||
106035743|NCT00737464|365796692|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
106035744|NCT00737464|365796692|FG000|Overall Study|Other reasons|4|||
106035745|NCT00442468|365796694|FG000|Overall Study|Adverse Event|4|||
106035746|NCT00442468|365796694|FG000|Overall Study|Withdrawal by Subject|91|||
106035747|NCT00442468|365796694|FG000|Overall Study|Did not complete all study procedures|88|||
106035748|NCT00290407|365796697|FG000|Overall Study|Physician Decision|2|||
106035749|NCT01082640|365796711|FG000|Overall Study|Adverse Event|9|||
106035750|NCT01082640|365796712|FG001|Overall Study|Adverse Event|5|||
106035751|NCT01082640|365796713|FG002|Overall Study|Adverse Event|3|||
106035752|NCT01082640|365796711|FG000|Overall Study|Withdrawal by Subject|3|||
106035753|NCT01082640|365796712|FG001|Overall Study|Withdrawal by Subject|3|||
106035754|NCT01082640|365796713|FG002|Overall Study|Withdrawal by Subject|2|||
106035755|NCT01082640|365796711|FG000|Overall Study|Major protocol deviation|3|||
106035756|NCT01082640|365796712|FG001|Overall Study|Major protocol deviation|3|||
106035757|NCT01082640|365796713|FG002|Overall Study|Major protocol deviation|0|||
106035758|NCT01082640|365796711|FG000|Overall Study|Lost to Follow-up|0|||
106035759|NCT01082640|365796712|FG001|Overall Study|Lost to Follow-up|3|||
106035760|NCT01082640|365796713|FG002|Overall Study|Lost to Follow-up|0|||
106035761|NCT01082640|365796711|FG000|Overall Study|Other|2|||
106035762|NCT01082640|365796712|FG001|Overall Study|Other|1|||
106035763|NCT01082640|365796713|FG002|Overall Study|Other|3|||
106035764|NCT01721577|365796714|FG000|Overall Study|Lack of Efficacy|1|||
106035765|NCT01721577|365796715|FG001|Overall Study|Lack of Efficacy|0|||
106035766|NCT01721577|365796714|FG000|Overall Study|Death|1|||
106035767|NCT01721577|365796715|FG001|Overall Study|Death|0|||
106035768|NCT01721577|365796714|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
106035769|NCT01721577|365796715|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
106035770|NCT01721577|365796714|FG000|Overall Study|Adverse Event|0|||
106035771|NCT01721577|365796715|FG001|Overall Study|Adverse Event|2|||
106035772|NCT02496676|365796716|FG000|Phase 1 - Period 1|Adverse Event|0|||
106035773|NCT02496676|365796717|FG001|Phase 1 - Period 1|Adverse Event|1|||
106035774|NCT02496676|365796716|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
106035775|NCT02496676|365796717|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
106035776|NCT03823378|365796719|FG000|Overall Study|Adverse Event|2|||
106035777|NCT03823378|365796720|FG001|Overall Study|Adverse Event|2|||
106035778|NCT03823378|365796721|FG002|Overall Study|Adverse Event|0|||
106035779|NCT03823378|365796722|FG003|Overall Study|Adverse Event|0|||
106035780|NCT03823378|365796723|FG004|Overall Study|Adverse Event|0|||
106035781|NCT03823378|365796724|FG005|Overall Study|Adverse Event|0|||
106035782|NCT03823378|365796719|FG000|Overall Study|Lost to Follow-up|0|||
106035783|NCT03823378|365796720|FG001|Overall Study|Lost to Follow-up|1|||
106035784|NCT03823378|365796721|FG002|Overall Study|Lost to Follow-up|0|||
106035785|NCT03823378|365796722|FG003|Overall Study|Lost to Follow-up|0|||
106035786|NCT03823378|365796723|FG004|Overall Study|Lost to Follow-up|1|||
106035787|NCT03823378|365796724|FG005|Overall Study|Lost to Follow-up|0|||
106035788|NCT03823378|365796719|FG000|Overall Study|Withdrawal by Subject|0|||
106035789|NCT03823378|365796720|FG001|Overall Study|Withdrawal by Subject|1|||
106035790|NCT03823378|365796721|FG002|Overall Study|Withdrawal by Subject|4|||
106035791|NCT03823378|365796722|FG003|Overall Study|Withdrawal by Subject|2|||
106035792|NCT03823378|365796723|FG004|Overall Study|Withdrawal by Subject|0|||
106035793|NCT03823378|365796724|FG005|Overall Study|Withdrawal by Subject|1|||
106035794|NCT03823378|365796719|FG000|Overall Study|Other, not specified|19|||
106035795|NCT03823378|365796720|FG001|Overall Study|Other, not specified|12|||
106035796|NCT03823378|365796721|FG002|Overall Study|Other, not specified|6|||
106035797|NCT03823378|365796722|FG003|Overall Study|Other, not specified|8|||
106035798|NCT03823378|365796723|FG004|Overall Study|Other, not specified|17|||
106035799|NCT03823378|365796724|FG005|Overall Study|Other, not specified|7|||
106035800|NCT00058539|365796725|FG000|Overall Study|Disease progression|24|||
106035801|NCT00058539|365796725|FG000|Overall Study|Adverse Event|3|||
106035802|NCT00058539|365796725|FG000|Overall Study|Withdrawal by Subject|5|||
106035803|NCT00058539|365796725|FG000|Overall Study|Physician Decision|9|||
106035804|NCT00058539|365796725|FG000|Overall Study|Death|1|||
106035805|NCT01966432|365796728|FG000|Overall Study|Lost to Follow-up|3|||
106035806|NCT01966432|365796729|FG001|Overall Study|Lost to Follow-up|2|||
106035807|NCT01966432|365796730|FG002|Overall Study|Lost to Follow-up|5|||
106035808|NCT01966432|365796728|FG000|Overall Study|Withdrawal by Subject|1|||
106035809|NCT01966432|365796729|FG001|Overall Study|Withdrawal by Subject|3|||
106035810|NCT01966432|365796730|FG002|Overall Study|Withdrawal by Subject|0|||
106035811|NCT01966432|365796728|FG000|Overall Study|Subject Incarcerated|0|||
106035812|NCT01966432|365796729|FG001|Overall Study|Subject Incarcerated|0|||
106035813|NCT01966432|365796730|FG002|Overall Study|Subject Incarcerated|1|||
106035814|NCT01966432|365796728|FG000|Overall Study|SBIRT program ended|1|||
106035815|NCT01966432|365796729|FG001|Overall Study|SBIRT program ended|8|||
106035816|NCT01966432|365796730|FG002|Overall Study|SBIRT program ended|20|||
106035817|NCT01055496|365796731|FG000|Overall Study|Withdrawal by Subject|2|||
106035818|NCT01055496|365796732|FG001|Overall Study|Withdrawal by Subject|4|||
106035819|NCT01055496|365796731|FG000|Overall Study|Death|13|||
106035820|NCT01055496|365796732|FG001|Overall Study|Death|23|||
106035821|NCT01055496|365796731|FG000|Overall Study|Lost to Follow-up|0|||
106035822|NCT01055496|365796732|FG001|Overall Study|Lost to Follow-up|2|||
106035823|NCT01055496|365796731|FG000|Overall Study|Other - Unspecified|0|||
106035824|NCT01055496|365796732|FG001|Overall Study|Other - Unspecified|1|||
106035825|NCT00930982|365796734|FG000|Overall Study|Adverse Event|19|||
106035826|NCT00930982|365796735|FG001|Overall Study|Adverse Event|23|||
106035827|NCT00930982|365796734|FG000|Overall Study|Protocol Violation|1|||
106035828|NCT00930982|365796735|FG001|Overall Study|Protocol Violation|5|||
106035829|NCT00930982|365796734|FG000|Overall Study|Withdrawal by Subject|1|||
106035830|NCT00930982|365796735|FG001|Overall Study|Withdrawal by Subject|1|||
106035831|NCT02129777|365796742|FG000|Double-Blind Period|Adverse Event|0|||
106035832|NCT02129777|365796743|FG001|Double-Blind Period|Adverse Event|0|||
106035833|NCT02129777|365796744|FG002|Double-Blind Period|Adverse Event|0|||
106035834|NCT02129777|365796745|FG003|Double-Blind Period|Adverse Event|0|||
106035835|NCT02129777|365796746|FG004|Double-Blind Period|Adverse Event|1|||
106035836|NCT02129777|365796747|FG005|Double-Blind Period|Adverse Event|0|||
106035837|NCT02129777|365796748|FG006|Double-Blind Period|Adverse Event|0|||
106035838|NCT02129777|365796742|FG000|Double-Blind Period|Lost to Follow-up|1|||
106035839|NCT02129777|365796743|FG001|Double-Blind Period|Lost to Follow-up|1|||
106035840|NCT02129777|365796744|FG002|Double-Blind Period|Lost to Follow-up|1|||
106035841|NCT02129777|365796745|FG003|Double-Blind Period|Lost to Follow-up|2|||
106035842|NCT02129777|365796746|FG004|Double-Blind Period|Lost to Follow-up|0|||
106035843|NCT02129777|365796747|FG005|Double-Blind Period|Lost to Follow-up|0|||
106035844|NCT02129777|365796748|FG006|Double-Blind Period|Lost to Follow-up|0|||
106035845|NCT02129777|365796742|FG000|Double-Blind Period|Withdrawal by Subject|2|||
106035846|NCT02129777|365796743|FG001|Double-Blind Period|Withdrawal by Subject|4|||
106035847|NCT02129777|365796744|FG002|Double-Blind Period|Withdrawal by Subject|3|||
106035848|NCT02129777|365796745|FG003|Double-Blind Period|Withdrawal by Subject|2|||
106035849|NCT02129777|365796746|FG004|Double-Blind Period|Withdrawal by Subject|3|||
106035850|NCT02129777|365796747|FG005|Double-Blind Period|Withdrawal by Subject|0|||
106035851|NCT02129777|365796748|FG006|Double-Blind Period|Withdrawal by Subject|0|||
106035852|NCT02129777|365796742|FG000|Double-Blind Period|Pregnancy|0|||
106035853|NCT02129777|365796743|FG001|Double-Blind Period|Pregnancy|0|||
106035854|NCT02129777|365796744|FG002|Double-Blind Period|Pregnancy|0|||
106035855|NCT02129777|365796745|FG003|Double-Blind Period|Pregnancy|0|||
106035856|NCT02129777|365796746|FG004|Double-Blind Period|Pregnancy|1|||
106035857|NCT02129777|365796747|FG005|Double-Blind Period|Pregnancy|0|||
106035858|NCT02129777|365796748|FG006|Double-Blind Period|Pregnancy|0|||
106035859|NCT02129777|365796742|FG000|Double-Blind Period|Lack of Efficacy|3|||
106035860|NCT02129777|365796743|FG001|Double-Blind Period|Lack of Efficacy|1|||
106035861|NCT02129777|365796744|FG002|Double-Blind Period|Lack of Efficacy|0|||
106035862|NCT02129777|365796745|FG003|Double-Blind Period|Lack of Efficacy|3|||
106035863|NCT02129777|365796746|FG004|Double-Blind Period|Lack of Efficacy|2|||
106035864|NCT02129777|365796747|FG005|Double-Blind Period|Lack of Efficacy|0|||
106035865|NCT02129777|365796748|FG006|Double-Blind Period|Lack of Efficacy|0|||
106035866|NCT02129777|365796742|FG000|Double-Blind Period|Other|1|||
106035867|NCT02129777|365796743|FG001|Double-Blind Period|Other|2|||
106035868|NCT02129777|365796744|FG002|Double-Blind Period|Other|0|||
106035869|NCT02129777|365796745|FG003|Double-Blind Period|Other|0|||
106035870|NCT02129777|365796746|FG004|Double-Blind Period|Other|0|||
106035871|NCT02129777|365796747|FG005|Double-Blind Period|Other|0|||
106035872|NCT02129777|365796748|FG006|Double-Blind Period|Other|0|||
106035873|NCT02129777|365796742|FG000|Open-Label Period|Lack of Efficacy|0|||
106035874|NCT02129777|365796743|FG001|Open-Label Period|Lack of Efficacy|0|||
106035875|NCT02129777|365796744|FG002|Open-Label Period|Lack of Efficacy|0|||
106035876|NCT02129777|365796745|FG003|Open-Label Period|Lack of Efficacy|0|||
106035877|NCT02129777|365796746|FG004|Open-Label Period|Lack of Efficacy|0|||
106035878|NCT02129777|365796747|FG005|Open-Label Period|Lack of Efficacy|0|||
106035879|NCT02129777|365796748|FG006|Open-Label Period|Lack of Efficacy|5|||
106035880|NCT02129777|365796742|FG000|Open-Label Period|Lost to Follow-up|0|||
106035881|NCT02129777|365796743|FG001|Open-Label Period|Lost to Follow-up|0|||
106035882|NCT02129777|365796744|FG002|Open-Label Period|Lost to Follow-up|0|||
106035883|NCT02129777|365796745|FG003|Open-Label Period|Lost to Follow-up|0|||
106035884|NCT02129777|365796746|FG004|Open-Label Period|Lost to Follow-up|0|||
106035885|NCT02129777|365796747|FG005|Open-Label Period|Lost to Follow-up|1|||
106035886|NCT02129777|365796748|FG006|Open-Label Period|Lost to Follow-up|1|||
106035887|NCT02129777|365796742|FG000|Open-Label Period|Withdrawal by Subject|0|||
106035888|NCT02129777|365796743|FG001|Open-Label Period|Withdrawal by Subject|0|||
106035889|NCT02129777|365796744|FG002|Open-Label Period|Withdrawal by Subject|0|||
106035890|NCT02129777|365796745|FG003|Open-Label Period|Withdrawal by Subject|0|||
106035891|NCT02129777|365796746|FG004|Open-Label Period|Withdrawal by Subject|0|||
106035892|NCT02129777|365796747|FG005|Open-Label Period|Withdrawal by Subject|1|||
106035893|NCT02129777|365796748|FG006|Open-Label Period|Withdrawal by Subject|3|||
106035894|NCT02129777|365796742|FG000|Open-Label Period|Study Termination|0|||
106035895|NCT02129777|365796743|FG001|Open-Label Period|Study Termination|0|||
106035896|NCT02129777|365796744|FG002|Open-Label Period|Study Termination|0|||
106035897|NCT02129777|365796745|FG003|Open-Label Period|Study Termination|0|||
106035898|NCT02129777|365796746|FG004|Open-Label Period|Study Termination|0|||
106035899|NCT02129777|365796747|FG005|Open-Label Period|Study Termination|10|||
106035900|NCT02129777|365796748|FG006|Open-Label Period|Study Termination|39|||
106035901|NCT02376829|365796751|FG000|Overall Study|Withdrawal by Subject|27|||
106035902|NCT02376829|365796752|FG001|Overall Study|Withdrawal by Subject|44|||
106035903|NCT01439347|365796753|FG000|Overall Study|Death|10|||
106035904|NCT01439347|365796754|FG001|Overall Study|Death|9|||
106035905|NCT01439347|365796753|FG000|Overall Study|Withdrawal by Subject|0|||
106035906|NCT01439347|365796754|FG001|Overall Study|Withdrawal by Subject|1|||
106035907|NCT01439347|365796753|FG000|Overall Study|Physician Decision|1|||
106035908|NCT01439347|365796754|FG001|Overall Study|Physician Decision|0|||
106035909|NCT01439347|365796753|FG000|Overall Study|Sponsor Terminated Study|2|||
106035910|NCT01439347|365796754|FG001|Overall Study|Sponsor Terminated Study|3|||
106035911|NCT01582854|365796758|FG000|Overall Study|Death|8|||
106035912|NCT01582854|365796759|FG001|Overall Study|Death|5|||
106035913|NCT01582854|365796758|FG000|Overall Study|Adverse Event|2|||
106035914|NCT01582854|365796759|FG001|Overall Study|Adverse Event|3|||
106035915|NCT01582854|365796758|FG000|Overall Study|Withdrawal by Participant|8|||
106035916|NCT01582854|365796759|FG001|Overall Study|Withdrawal by Participant|11|||
106035917|NCT01582854|365796758|FG000|Overall Study|Lost to Follow-up|1|||
106035918|NCT01582854|365796759|FG001|Overall Study|Lost to Follow-up|2|||
106035919|NCT01582854|365796758|FG000|Overall Study|Physician Decision|0|||
106035920|NCT01582854|365796759|FG001|Overall Study|Physician Decision|1|||
106035921|NCT01582854|365796758|FG000|Overall Study|Recurrent Stroke|13|||
106035922|NCT01582854|365796759|FG001|Overall Study|Recurrent Stroke|8|||
106035923|NCT01582854|365796758|FG000|Overall Study|Disallowed Concomitant Medication|3|||
106035924|NCT01582854|365796759|FG001|Overall Study|Disallowed Concomitant Medication|2|||
106035925|NCT01582854|365796758|FG000|Overall Study|Carotid or Neurosurgery|0|||
106035926|NCT01582854|365796759|FG001|Overall Study|Carotid or Neurosurgery|1|||
106035927|NCT01582854|365796758|FG000|Overall Study|General Anaesthesia|0|||
106035928|NCT01582854|365796759|FG001|Overall Study|General Anaesthesia|1|||
106035929|NCT01582854|365796758|FG000|Overall Study|Other Miscellaneous Reason|1|||
106035930|NCT01582854|365796759|FG001|Overall Study|Other Miscellaneous Reason|0|||
106035931|NCT04068896|365796760|FG000|Overall Study|Adverse Event|2|||
106035932|NCT04068896|365796761|FG001|Overall Study|Adverse Event|0|||
106035933|NCT04068896|365796762|FG002|Overall Study|Adverse Event|1|||
106035934|NCT04068896|365796763|FG003|Overall Study|Adverse Event|0|||
106035935|NCT04068896|365796764|FG004|Overall Study|Adverse Event|0|||
106035936|NCT04068896|365796765|FG005|Overall Study|Adverse Event|0|||
106035937|NCT04068896|365796760|FG000|Overall Study|Death|3|||
106035938|NCT04068896|365796761|FG001|Overall Study|Death|1|||
106035939|NCT04068896|365796762|FG002|Overall Study|Death|3|||
106035940|NCT04068896|365796763|FG003|Overall Study|Death|19|||
106035941|NCT04068896|365796764|FG004|Overall Study|Death|17|||
106035942|NCT04068896|365796765|FG005|Overall Study|Death|0|||
106035943|NCT04068896|365796760|FG000|Overall Study|Physician Decision|0|||
106035944|NCT04068896|365796761|FG001|Overall Study|Physician Decision|0|||
106035945|NCT04068896|365796762|FG002|Overall Study|Physician Decision|0|||
106035946|NCT04068896|365796763|FG003|Overall Study|Physician Decision|1|||
106035947|NCT04068896|365796764|FG004|Overall Study|Physician Decision|0|||
106035948|NCT04068896|365796765|FG005|Overall Study|Physician Decision|0|||
106035949|NCT04068896|365796760|FG000|Overall Study|progressive disease|3|||
106035950|NCT04068896|365796761|FG001|Overall Study|progressive disease|5|||
106035951|NCT04068896|365796762|FG002|Overall Study|progressive disease|3|||
106035952|NCT04068896|365796763|FG003|Overall Study|progressive disease|2|||
106035953|NCT04068896|365796764|FG004|Overall Study|progressive disease|1|||
106035954|NCT04068896|365796765|FG005|Overall Study|progressive disease|2|||
106035955|NCT04068896|365796760|FG000|Overall Study|Study terminated by sponsor|0|||
106035956|NCT04068896|365796761|FG001|Overall Study|Study terminated by sponsor|0|||
106035957|NCT04068896|365796762|FG002|Overall Study|Study terminated by sponsor|1|||
106035958|NCT04068896|365796763|FG003|Overall Study|Study terminated by sponsor|2|||
106035959|NCT04068896|365796764|FG004|Overall Study|Study terminated by sponsor|1|||
106035960|NCT04068896|365796765|FG005|Overall Study|Study terminated by sponsor|4|||
106035961|NCT04068896|365796760|FG000|Overall Study|Protocol Violation|0|||
106035962|NCT04068896|365796761|FG001|Overall Study|Protocol Violation|0|||
106035963|NCT04068896|365796762|FG002|Overall Study|Protocol Violation|0|||
106035964|NCT04068896|365796763|FG003|Overall Study|Protocol Violation|1|||
106035965|NCT04068896|365796764|FG004|Overall Study|Protocol Violation|0|||
106035966|NCT04068896|365796765|FG005|Overall Study|Protocol Violation|0|||
106035967|NCT04068896|365796760|FG000|Overall Study|Withdrawal by Subject|0|||
106035968|NCT04068896|365796761|FG001|Overall Study|Withdrawal by Subject|3|||
106035969|NCT04068896|365796762|FG002|Overall Study|Withdrawal by Subject|0|||
106035970|NCT04068896|365796763|FG003|Overall Study|Withdrawal by Subject|2|||
106035971|NCT04068896|365796764|FG004|Overall Study|Withdrawal by Subject|1|||
106035972|NCT04068896|365796765|FG005|Overall Study|Withdrawal by Subject|0|||
105857454|NCT04480021|365129465|FG000|Overall Study|Lost to Follow-up|3|||
105857455|NCT04480021|365129466|FG001|Overall Study|Lost to Follow-up|4|||
105857456|NCT01584843|365129470|FG000|First Treatment Period|Adverse Event|0|||
105857457|NCT01584843|365129471|FG001|First Treatment Period|Adverse Event|0|||
105857458|NCT01584843|365129472|FG002|First Treatment Period|Adverse Event|1|||
105857459|NCT01584843|365129473|FG003|First Treatment Period|Adverse Event|0|||
105857460|NCT01584843|365129474|FG004|First Treatment Period|Adverse Event|0|||
105857461|NCT01584843|365129475|FG005|First Treatment Period|Adverse Event|0|||
105857462|NCT01584843|365129470|FG000|First Treatment Period|Protocol Violation|0|||
105857463|NCT01584843|365129471|FG001|First Treatment Period|Protocol Violation|0|||
106035973|NCT04068896|365796760|FG000|Overall Study|Symptomatic deterioration|2|||
106035974|NCT04068896|365796761|FG001|Overall Study|Symptomatic deterioration|0|||
106035975|NCT04068896|365796762|FG002|Overall Study|Symptomatic deterioration|0|||
106035976|NCT04068896|365796763|FG003|Overall Study|Symptomatic deterioration|0|||
106035977|NCT04068896|365796764|FG004|Overall Study|Symptomatic deterioration|0|||
106035978|NCT04068896|365796765|FG005|Overall Study|Symptomatic deterioration|0|||
106035979|NCT02522871|365796766|FG000|Overall Study|Protocol Violation|1|||
106035980|NCT02522871|365796767|FG001|Overall Study|Protocol Violation|4|||
106035981|NCT02522871|365796766|FG000|Overall Study|Treated without randomization|1|||
106035982|NCT02522871|365796767|FG001|Overall Study|Treated without randomization|0|||
106035983|NCT02522871|365796766|FG000|Overall Study|Death|9|||
106035984|NCT02522871|365796767|FG001|Overall Study|Death|9|||
106035985|NCT02522871|365796766|FG000|Overall Study|Died in operating room prior to transplant|0|||
106035986|NCT02522871|365796767|FG001|Overall Study|Died in operating room prior to transplant|1|||
106035987|NCT00722371|365796773|FG000|Overall Study|Adverse Event|6|||
106035988|NCT00722371|365796774|FG001|Overall Study|Adverse Event|13|||
106035989|NCT00722371|365796775|FG002|Overall Study|Adverse Event|9|||
106035990|NCT00722371|365796776|FG003|Overall Study|Adverse Event|10|||
106035991|NCT00722371|365796777|FG004|Overall Study|Adverse Event|6|||
106035992|NCT00722371|365796778|FG005|Overall Study|Adverse Event|8|||
106035993|NCT00722371|365796779|FG006|Overall Study|Adverse Event|4|||
106035994|NCT00722371|365796773|FG000|Overall Study|Contraindication|0|||
106035995|NCT00722371|365796774|FG001|Overall Study|Contraindication|0|||
106035996|NCT00722371|365796775|FG002|Overall Study|Contraindication|1|||
106035997|NCT00722371|365796776|FG003|Overall Study|Contraindication|0|||
106035998|NCT00722371|365796777|FG004|Overall Study|Contraindication|0|||
106035999|NCT00722371|365796778|FG005|Overall Study|Contraindication|0|||
106036000|NCT00722371|365796779|FG006|Overall Study|Contraindication|0|||
106036001|NCT00722371|365796773|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
106036002|NCT00722371|365796774|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
106036003|NCT00722371|365796775|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
106036004|NCT00722371|365796776|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
106036005|NCT00722371|365796777|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
106036006|NCT00722371|365796778|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
106036007|NCT00722371|365796779|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
106036008|NCT00722371|365796773|FG000|Overall Study|Excluded medication|0|||
106036009|NCT00722371|365796774|FG001|Overall Study|Excluded medication|1|||
106036010|NCT00722371|365796775|FG002|Overall Study|Excluded medication|1|||
106036011|NCT00722371|365796776|FG003|Overall Study|Excluded medication|0|||
106036012|NCT00722371|365796777|FG004|Overall Study|Excluded medication|0|||
106036013|NCT00722371|365796778|FG005|Overall Study|Excluded medication|0|||
106036014|NCT00722371|365796779|FG006|Overall Study|Excluded medication|1|||
106036015|NCT00722371|365796773|FG000|Overall Study|Hyperglycemia|2|||
106036016|NCT00722371|365796774|FG001|Overall Study|Hyperglycemia|6|||
106036017|NCT00722371|365796775|FG002|Overall Study|Hyperglycemia|4|||
106036018|NCT00722371|365796776|FG003|Overall Study|Hyperglycemia|2|||
106036019|NCT00722371|365796777|FG004|Overall Study|Hyperglycemia|5|||
106036020|NCT00722371|365796778|FG005|Overall Study|Hyperglycemia|1|||
106036021|NCT00722371|365796779|FG006|Overall Study|Hyperglycemia|1|||
106036022|NCT00722371|365796773|FG000|Overall Study|Hypoglycemia|1|||
106036023|NCT00722371|365796774|FG001|Overall Study|Hypoglycemia|0|||
106036024|NCT00722371|365796775|FG002|Overall Study|Hypoglycemia|0|||
106036025|NCT00722371|365796776|FG003|Overall Study|Hypoglycemia|0|||
106036026|NCT00722371|365796777|FG004|Overall Study|Hypoglycemia|0|||
106036027|NCT00722371|365796778|FG005|Overall Study|Hypoglycemia|0|||
106036028|NCT00722371|365796779|FG006|Overall Study|Hypoglycemia|0|||
106036029|NCT00722371|365796773|FG000|Overall Study|Lack of Efficacy|4|||
106036030|NCT00722371|365796774|FG001|Overall Study|Lack of Efficacy|6|||
106036031|NCT00722371|365796775|FG002|Overall Study|Lack of Efficacy|6|||
106036032|NCT00722371|365796776|FG003|Overall Study|Lack of Efficacy|6|||
106036033|NCT00722371|365796777|FG004|Overall Study|Lack of Efficacy|2|||
106036034|NCT00722371|365796778|FG005|Overall Study|Lack of Efficacy|3|||
106036035|NCT00722371|365796779|FG006|Overall Study|Lack of Efficacy|0|||
106036036|NCT00722371|365796773|FG000|Overall Study|Lost to Follow-up|11|||
106036037|NCT00722371|365796774|FG001|Overall Study|Lost to Follow-up|14|||
106036038|NCT00722371|365796775|FG002|Overall Study|Lost to Follow-up|21|||
106036039|NCT00722371|365796776|FG003|Overall Study|Lost to Follow-up|13|||
106036040|NCT00722371|365796777|FG004|Overall Study|Lost to Follow-up|8|||
106036041|NCT00722371|365796778|FG005|Overall Study|Lost to Follow-up|16|||
106036042|NCT00722371|365796779|FG006|Overall Study|Lost to Follow-up|13|||
106036043|NCT00722371|365796773|FG000|Overall Study|Physician Decision|5|||
106036044|NCT00722371|365796774|FG001|Overall Study|Physician Decision|2|||
106036045|NCT00722371|365796775|FG002|Overall Study|Physician Decision|2|||
106036046|NCT00722371|365796776|FG003|Overall Study|Physician Decision|5|||
106036047|NCT00722371|365796777|FG004|Overall Study|Physician Decision|2|||
106036048|NCT00722371|365796778|FG005|Overall Study|Physician Decision|3|||
106036049|NCT00722371|365796779|FG006|Overall Study|Physician Decision|4|||
106036050|NCT00722371|365796773|FG000|Overall Study|Pregnancy|1|||
106036051|NCT00722371|365796774|FG001|Overall Study|Pregnancy|1|||
106036052|NCT00722371|365796775|FG002|Overall Study|Pregnancy|0|||
106036053|NCT00722371|365796776|FG003|Overall Study|Pregnancy|0|||
106036054|NCT00722371|365796777|FG004|Overall Study|Pregnancy|0|||
106036055|NCT00722371|365796778|FG005|Overall Study|Pregnancy|1|||
106036056|NCT00722371|365796779|FG006|Overall Study|Pregnancy|0|||
106036057|NCT00722371|365796773|FG000|Overall Study|Protocol Violation|6|||
106036058|NCT00722371|365796774|FG001|Overall Study|Protocol Violation|1|||
106036059|NCT00722371|365796775|FG002|Overall Study|Protocol Violation|0|||
106036060|NCT00722371|365796776|FG003|Overall Study|Protocol Violation|1|||
106036061|NCT00722371|365796777|FG004|Overall Study|Protocol Violation|4|||
106036062|NCT00722371|365796778|FG005|Overall Study|Protocol Violation|2|||
106036063|NCT00722371|365796779|FG006|Overall Study|Protocol Violation|1|||
106036064|NCT00722371|365796773|FG000|Overall Study|Withdrawal by Subject|18|||
106036065|NCT00722371|365796774|FG001|Overall Study|Withdrawal by Subject|27|||
106036066|NCT00722371|365796775|FG002|Overall Study|Withdrawal by Subject|19|||
106036067|NCT00722371|365796776|FG003|Overall Study|Withdrawal by Subject|23|||
106036068|NCT00722371|365796777|FG004|Overall Study|Withdrawal by Subject|19|||
106036069|NCT00722371|365796778|FG005|Overall Study|Withdrawal by Subject|18|||
106036070|NCT00722371|365796779|FG006|Overall Study|Withdrawal by Subject|26|||
106036071|NCT00378079|365796780|FG000|Overall Study|Lost to Follow-up|6|||
106036072|NCT00378079|365796781|FG001|Overall Study|Lost to Follow-up|1|||
106036073|NCT00378079|365796782|FG002|Overall Study|Lost to Follow-up|0|||
106036074|NCT00745615|365796793|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
106036075|NCT00745615|365796794|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
106036076|NCT00745615|365796795|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
106036077|NCT00745615|365796796|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
106036078|NCT00745615|365796797|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
106036079|NCT00745615|365796798|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
106036080|NCT00745615|365796793|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
106036081|NCT00745615|365796794|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
106036082|NCT00745615|365796795|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
106036083|NCT00745615|365796796|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
106036084|NCT00745615|365796797|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
106036085|NCT00745615|365796798|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
106036086|NCT00745615|365796793|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
106036087|NCT00745615|365796794|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
106036088|NCT00745615|365796795|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
106036089|NCT00745615|365796796|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
106036090|NCT00745615|365796797|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
106036091|NCT00745615|365796798|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
106036092|NCT00745615|365796793|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
106036093|NCT00745615|365796794|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
106036094|NCT00745615|365796795|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
106036095|NCT00745615|365796796|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
106036096|NCT00745615|365796797|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
106036097|NCT00745615|365796798|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
106036098|NCT00745615|365796793|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
106036099|NCT00745615|365796794|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
106036100|NCT00745615|365796795|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
106036101|NCT00745615|365796796|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
106036102|NCT00745615|365796797|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
106036103|NCT00745615|365796798|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
106036104|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
106036105|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
106036106|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
106036107|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
106036108|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
106036109|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
106036110|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
106036111|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
106036112|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
106036113|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
106036114|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
106036115|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
106036116|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
106036117|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
106036118|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
106036119|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
106036120|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
106036121|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
106036122|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
106036123|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
106036124|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
106036125|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
106036126|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
106036127|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
106036128|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
106036129|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
106036130|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
106036131|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
106036132|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
106036133|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
106036134|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
106036135|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
106036136|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
106036137|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
106036138|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
106036139|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
106036140|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
106036141|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
106036142|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
106036143|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
106036144|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
106036145|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
106036146|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
106036147|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
106036148|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
106036149|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
106036150|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
106036151|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
106036152|NCT00745615|365796793|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
106036153|NCT00745615|365796794|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
106036154|NCT00745615|365796795|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
106036155|NCT00745615|365796796|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
106036156|NCT00745615|365796797|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
106036157|NCT00745615|365796798|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
106036158|NCT03224546|365796801|FG000|Overall Study|Lost to Follow-up|9|||
106036159|NCT03224546|365796802|FG001|Overall Study|Lost to Follow-up|8|||
106036160|NCT03224546|365796803|FG002|Overall Study|Lost to Follow-up|3|||
106036161|NCT03224546|365796801|FG000|Overall Study|Withdrawal by Subject|7|||
106036162|NCT03224546|365796802|FG001|Overall Study|Withdrawal by Subject|14|||
106036163|NCT03224546|365796803|FG002|Overall Study|Withdrawal by Subject|12|||
106036164|NCT01163032|365796807|FG000|Randomization Phase|Withdrawal by Subject|2|||
106036165|NCT01163032|365796808|FG001|Randomization Phase|Withdrawal by Subject|3|||
106036166|NCT01163032|365796809|FG002|Randomization Phase|Withdrawal by Subject|0|||
106036167|NCT01163032|365796807|FG000|Randomization Phase|Adverse Event|3|||
106036168|NCT01163032|365796808|FG001|Randomization Phase|Adverse Event|3|||
106036169|NCT01163032|365796809|FG002|Randomization Phase|Adverse Event|0|||
106036170|NCT01163032|365796807|FG000|Randomization Phase|Protocol Violation|0|||
106036171|NCT01163032|365796808|FG001|Randomization Phase|Protocol Violation|1|||
106036172|NCT01163032|365796809|FG002|Randomization Phase|Protocol Violation|0|||
106036173|NCT01163032|365796807|FG000|Randomization Phase|Various*|5|||
106036174|NCT01163032|365796808|FG001|Randomization Phase|Various*|4|||
106036175|NCT01163032|365796809|FG002|Randomization Phase|Various*|0|||
106036176|NCT01163032|365796807|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
106036177|NCT01163032|365796808|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
106036178|NCT01163032|365796809|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
106036179|NCT01163032|365796807|FG000|Open Label Extension Phase|Adverse Event|0|||
106036180|NCT01163032|365796808|FG001|Open Label Extension Phase|Adverse Event|0|||
106036181|NCT01163032|365796809|FG002|Open Label Extension Phase|Adverse Event|3|||
106036182|NCT01163032|365796807|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
106036183|NCT01163032|365796808|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
106036184|NCT01163032|365796809|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
106036185|NCT01163032|365796807|FG000|Open Label Extension Phase|Protocol Violation|0|||
106036186|NCT01163032|365796808|FG001|Open Label Extension Phase|Protocol Violation|0|||
106036187|NCT01163032|365796809|FG002|Open Label Extension Phase|Protocol Violation|1|||
106036188|NCT01163032|365796807|FG000|Open Label Extension Phase|Study Termination|0|||
106036189|NCT01163032|365796808|FG001|Open Label Extension Phase|Study Termination|0|||
106036190|NCT01163032|365796809|FG002|Open Label Extension Phase|Study Termination|7|||
106036191|NCT01163032|365796807|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
106036192|NCT01163032|365796808|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
106036193|NCT01163032|365796809|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
106036194|NCT02751931|365796812|FG000|Overall Study|Adverse Event|3|||
106036195|NCT02751931|365796813|FG001|Overall Study|Adverse Event|0|||
106036196|NCT02751931|365796812|FG000|Overall Study|Other: Miscelleneous|10|||
106036197|NCT02751931|365796813|FG001|Overall Study|Other: Miscelleneous|8|||
106036198|NCT05080660|365796814|FG000|Overall Study|Adverse Event|4|||
106036199|NCT05080660|365796815|FG001|Overall Study|Adverse Event|0|||
106036200|NCT05080660|365796814|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
106036201|NCT05080660|365796815|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
106036202|NCT05080660|365796814|FG000|Overall Study|Physician Decision|1|||
106036203|NCT05080660|365796815|FG001|Overall Study|Physician Decision|0|||
106036204|NCT05080660|365796814|FG000|Overall Study|Protocol Deviation|2|||
106036205|NCT05080660|365796815|FG001|Overall Study|Protocol Deviation|0|||
106036206|NCT05080660|365796814|FG000|Overall Study|Withdrawal by Subject|5|||
106036207|NCT05080660|365796815|FG001|Overall Study|Withdrawal by Subject|2|||
106036208|NCT00937391|365796816|FG000|Stage 2|Withdrawal by Subject|1|||
106036209|NCT01307020|365796817|FG000|Overall Study|Lost to Follow-up|0|||
106036210|NCT01307020|365796818|FG001|Overall Study|Lost to Follow-up|0|||
106036211|NCT01307020|365796819|FG002|Overall Study|Lost to Follow-up|1|||
106036212|NCT01307020|365796820|FG003|Overall Study|Lost to Follow-up|1|||
106036213|NCT01307020|365796821|FG004|Overall Study|Lost to Follow-up|0|||
106036214|NCT01307020|365796822|FG005|Overall Study|Lost to Follow-up|0|||
106036215|NCT01307020|365796823|FG006|Overall Study|Lost to Follow-up|1|||
106036216|NCT01307020|365796824|FG007|Overall Study|Lost to Follow-up|0|||
106036217|NCT01307020|365796825|FG008|Overall Study|Lost to Follow-up|0|||
106036218|NCT01307020|365796826|FG009|Overall Study|Lost to Follow-up|0|||
106036219|NCT01307020|365796817|FG000|Overall Study|Electronic data capture failure|0|||
106036220|NCT01307020|365796818|FG001|Overall Study|Electronic data capture failure|1|||
106036221|NCT01307020|365796819|FG002|Overall Study|Electronic data capture failure|0|||
106036222|NCT01307020|365796820|FG003|Overall Study|Electronic data capture failure|0|||
106036223|NCT01307020|365796821|FG004|Overall Study|Electronic data capture failure|0|||
106036224|NCT01307020|365796822|FG005|Overall Study|Electronic data capture failure|0|||
106036225|NCT01307020|365796823|FG006|Overall Study|Electronic data capture failure|0|||
106036226|NCT01307020|365796824|FG007|Overall Study|Electronic data capture failure|0|||
106036227|NCT01307020|365796825|FG008|Overall Study|Electronic data capture failure|0|||
106036228|NCT01307020|365796826|FG009|Overall Study|Electronic data capture failure|0|||
106036229|NCT00727532|365796827|FG000|Overall Study|Adverse Event|1|||
106036230|NCT00727532|365796827|FG000|Overall Study|Withdrawal by Subject|1|||
106036231|NCT01986933|365796828|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
106036232|NCT01986933|365796829|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
106036233|NCT01986933|365796830|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
106036234|NCT01986933|365796831|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
106036235|NCT01986933|365796832|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
106036236|NCT01986933|365796828|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
106036237|NCT01986933|365796829|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
106036238|NCT01986933|365796830|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
106036239|NCT01986933|365796831|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
106036240|NCT01986933|365796832|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
106036241|NCT01986933|365796828|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
106036242|NCT01986933|365796829|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
106036243|NCT01986933|365796830|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
106036244|NCT01986933|365796831|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
106036245|NCT01986933|365796832|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
106036246|NCT01986933|365796828|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
106036247|NCT01986933|365796829|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
106036248|NCT01986933|365796830|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
106036249|NCT01986933|365796831|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
106036250|NCT01986933|365796832|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
106036251|NCT01986933|365796828|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
106036252|NCT01986933|365796829|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
106036253|NCT01986933|365796830|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
106036254|NCT01986933|365796831|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
106036255|NCT01986933|365796832|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
106036256|NCT01986933|365796828|FG000|Active-to-active (Part B)|Adverse Event|0|||
106036257|NCT01986933|365796829|FG001|Active-to-active (Part B)|Adverse Event|2|||
106036258|NCT01986933|365796830|FG002|Active-to-active (Part B)|Adverse Event|0|||
106036259|NCT01986933|365796831|FG003|Active-to-active (Part B)|Adverse Event|1|||
106036260|NCT01986933|365796832|FG004|Active-to-active (Part B)|Adverse Event|3|||
106036261|NCT01986933|365796828|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
106036262|NCT01986933|365796829|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
106036263|NCT01986933|365796830|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
106036264|NCT01986933|365796831|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
106036265|NCT01986933|365796832|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
106036266|NCT01986933|365796828|FG000|Active-to-active (Part B)|Pregnancy|0|||
106036267|NCT01986933|365796829|FG001|Active-to-active (Part B)|Pregnancy|0|||
106036268|NCT01986933|365796830|FG002|Active-to-active (Part B)|Pregnancy|0|||
106036269|NCT01986933|365796831|FG003|Active-to-active (Part B)|Pregnancy|0|||
105857464|NCT01584843|365129472|FG002|First Treatment Period|Protocol Violation|0|||
105857465|NCT01584843|365129473|FG003|First Treatment Period|Protocol Violation|0|||
105857466|NCT01584843|365129474|FG004|First Treatment Period|Protocol Violation|0|||
105857467|NCT01584843|365129475|FG005|First Treatment Period|Protocol Violation|1|||
105857468|NCT01584843|365129470|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105857469|NCT01584843|365129471|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105857470|NCT01584843|365129472|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105857471|NCT01584843|365129473|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105857472|NCT01584843|365129474|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
105857473|NCT01584843|365129475|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
105857474|NCT01584843|365129470|FG000|Second Treatment Period|Withdrawal by Subject|0|||
105857475|NCT01584843|365129471|FG001|Second Treatment Period|Withdrawal by Subject|0|||
105857476|NCT01584843|365129472|FG002|Second Treatment Period|Withdrawal by Subject|0|||
105857477|NCT01584843|365129473|FG003|Second Treatment Period|Withdrawal by Subject|0|||
105857478|NCT01584843|365129474|FG004|Second Treatment Period|Withdrawal by Subject|0|||
105857479|NCT01584843|365129475|FG005|Second Treatment Period|Withdrawal by Subject|1|||
106036270|NCT01986933|365796832|FG004|Active-to-active (Part B)|Pregnancy|1|||
106036271|NCT01986933|365796828|FG000|Active-to-active (Part B)|Physician Decision|0|||
106036272|NCT01986933|365796829|FG001|Active-to-active (Part B)|Physician Decision|0|||
106036273|NCT01986933|365796830|FG002|Active-to-active (Part B)|Physician Decision|1|||
105857480|NCT02640053|365129482|FG000|Overall Study|Withdrawal by Subject|2|||
105857481|NCT02640053|365129483|FG001|Overall Study|Withdrawal by Subject|1|||
105857482|NCT02640053|365129482|FG000|Overall Study|Adverse Event|1|||
105857483|NCT02640053|365129483|FG001|Overall Study|Adverse Event|1|||
105857484|NCT02640053|365129482|FG000|Overall Study|Alternative Therapy|1|||
105857485|NCT02640053|365129483|FG001|Overall Study|Alternative Therapy|1|||
106036274|NCT01986933|365796831|FG003|Active-to-active (Part B)|Physician Decision|1|||
106036275|NCT01986933|365796832|FG004|Active-to-active (Part B)|Physician Decision|0|||
106036276|NCT01986933|365796828|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
106036277|NCT01986933|365796829|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
106036278|NCT01986933|365796830|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
106036279|NCT01986933|365796831|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
106036280|NCT01986933|365796832|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
106036281|NCT01986933|365796828|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
106036282|NCT01986933|365796829|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
106036283|NCT01986933|365796830|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
106036284|NCT01986933|365796831|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
106036285|NCT01986933|365796832|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
106036286|NCT01986933|365796828|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
106036287|NCT01986933|365796829|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
106036288|NCT01986933|365796830|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
106036289|NCT01986933|365796831|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
106036290|NCT01986933|365796832|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
106036291|NCT01986933|365796828|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
106036292|NCT01986933|365796829|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
106036293|NCT01986933|365796830|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
106036294|NCT01986933|365796831|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
106036295|NCT01986933|365796832|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
106036296|NCT01986933|365796828|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
106036297|NCT01986933|365796829|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
106036298|NCT01986933|365796830|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
106036299|NCT01986933|365796831|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
106036300|NCT01986933|365796832|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
106036301|NCT01986933|365796828|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
106036302|NCT01986933|365796829|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
106036303|NCT01986933|365796830|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
106036304|NCT01986933|365796831|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
106036305|NCT01986933|365796832|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
105857486|NCT02640053|365129482|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
105857487|NCT02640053|365129483|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
105857488|NCT03283761|365129484|FG000|Study Treatment|Patient Non-Compliance|1|||
105857489|NCT03283761|365129484|FG000|Study Treatment|Alternative Cancer Therapy|7|||
105857490|NCT03283761|365129484|FG000|Study Treatment|Disease progression|21|||
105857491|NCT03283761|365129484|FG000|Study Treatment|Adverse Event|3|||
105857492|NCT03283761|365129484|FG000|Study Treatment|Withdrawal by Subject|4|||
105857493|NCT03283761|365129484|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
105857494|NCT03283761|365129484|FG000|Study Treatment|Symptomatic Deterioration|1|||
105857495|NCT03283761|365129484|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
105857496|NCT03283761|365129484|FG000|Follow up|Lost to Follow-up|1|||
105857497|NCT03283761|365129484|FG000|Follow up|Symptomatic Deterioration|1|||
105857498|NCT03283761|365129484|FG000|Follow up|Death|29|||
105857499|NCT03283761|365129484|FG000|Follow up|study terminated|4|||
105857500|NCT03283761|365129484|FG000|Follow up|Primary Investigator Withdrawal|1|||
105857501|NCT03283761|365129484|FG000|Follow up|Switched to alternative therapy|1|||
105857502|NCT03283761|365129484|FG000|Follow up|Subject is now in Hospice|1|||
105857503|NCT00620555|365129487|FG000|Overall Study|Adverse Event|4|||
105857504|NCT00620555|365129487|FG000|Overall Study|Protocol Violation|2|||
105857505|NCT00620555|365129487|FG000|Overall Study|Lack of Efficacy|12|||
105857506|NCT00620555|365129487|FG000|Overall Study|Withdrawal by Subject|1|||
105857507|NCT00620555|365129487|FG000|Overall Study|Choice of other treatment|1|||
105857508|NCT00620555|365129487|FG000|Overall Study|Visit failure against planned|1|||
105857509|NCT02329847|365129488|FG000|Overall Study|Death|4|||
105857510|NCT02329847|365129489|FG001|Overall Study|Death|4|||
105857511|NCT02329847|365129490|FG002|Overall Study|Death|22|||
105857512|NCT02329847|365129491|FG003|Overall Study|Death|12|||
105857513|NCT02329847|365129492|FG004|Overall Study|Death|20|||
105857514|NCT02329847|365129493|FG005|Overall Study|Death|13|||
105857515|NCT02329847|365129488|FG000|Overall Study|Lost to Follow-up|0|||
105857516|NCT02329847|365129489|FG001|Overall Study|Lost to Follow-up|0|||
105857517|NCT02329847|365129490|FG002|Overall Study|Lost to Follow-up|2|||
105857518|NCT02329847|365129491|FG003|Overall Study|Lost to Follow-up|3|||
105857519|NCT02329847|365129492|FG004|Overall Study|Lost to Follow-up|0|||
105857520|NCT02329847|365129493|FG005|Overall Study|Lost to Follow-up|1|||
105857521|NCT02329847|365129488|FG000|Overall Study|Physician Decision|0|||
105857522|NCT02329847|365129489|FG001|Overall Study|Physician Decision|0|||
105857523|NCT02329847|365129490|FG002|Overall Study|Physician Decision|0|||
105857524|NCT02329847|365129491|FG003|Overall Study|Physician Decision|0|||
105857525|NCT02329847|365129492|FG004|Overall Study|Physician Decision|1|||
105857526|NCT02329847|365129493|FG005|Overall Study|Physician Decision|0|||
105857527|NCT02329847|365129488|FG000|Overall Study|Withdrawal by Subject|2|||
105857528|NCT02329847|365129489|FG001|Overall Study|Withdrawal by Subject|1|||
105857529|NCT02329847|365129490|FG002|Overall Study|Withdrawal by Subject|5|||
105857530|NCT02329847|365129491|FG003|Overall Study|Withdrawal by Subject|7|||
105857531|NCT02329847|365129492|FG004|Overall Study|Withdrawal by Subject|8|||
105857532|NCT02329847|365129493|FG005|Overall Study|Withdrawal by Subject|3|||
105857533|NCT02329847|365129488|FG000|Overall Study|Other|1|||
105857534|NCT02329847|365129489|FG001|Overall Study|Other|2|||
105857535|NCT02329847|365129490|FG002|Overall Study|Other|6|||
105857536|NCT02329847|365129491|FG003|Overall Study|Other|13|||
105857537|NCT02329847|365129492|FG004|Overall Study|Other|10|||
105857538|NCT02329847|365129493|FG005|Overall Study|Other|3|||
105857539|NCT03290079|365129494|FG000|Overall Study|Death|2|||
105857540|NCT01910389|365129497|FG000|Overall Study|Withdrawal by Subject|2|||
105857541|NCT01910389|365129498|FG001|Overall Study|Withdrawal by Subject|0|||
105857542|NCT01910389|365129497|FG000|Overall Study|Study Closed|13|||
105857543|NCT01910389|365129498|FG001|Overall Study|Study Closed|8|||
105857544|NCT04669691|365129502|FG000|Overall Study|Death|0|||
105857545|NCT04669691|365129503|FG001|Overall Study|Death|1|||
105857546|NCT04669691|365129504|FG002|Overall Study|Death|0|||
105857547|NCT04669691|365129505|FG003|Overall Study|Death|0|||
105857548|NCT04669691|365129506|FG004|Overall Study|Death|0|||
105857549|NCT04669691|365129507|FG005|Overall Study|Death|0|||
105857550|NCT03276780|365129509|FG000|Overall Study|Withdrawal by Subject|5|||
105857551|NCT03276780|365129510|FG001|Overall Study|Withdrawal by Subject|3|||
105857552|NCT03276780|365129509|FG000|Overall Study|Lost to Follow-up|3|||
105857553|NCT03276780|365129510|FG001|Overall Study|Lost to Follow-up|5|||
105857554|NCT03276780|365129509|FG000|Overall Study|Moved out of state|1|||
105857555|NCT03276780|365129510|FG001|Overall Study|Moved out of state|1|||
105857556|NCT03276780|365129509|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
105857557|NCT03276780|365129510|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
105857558|NCT03276780|365129509|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
105857559|NCT03276780|365129510|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
105857560|NCT00673387|365129511|FG000|Overall Study|Withdrawal by Subject|15|||
105857561|NCT00673387|365129512|FG001|Overall Study|Withdrawal by Subject|16|||
105857562|NCT00673387|365129513|FG002|Overall Study|Withdrawal by Subject|20|||
105857563|NCT00673387|365129514|FG003|Overall Study|Withdrawal by Subject|16|||
105857564|NCT00673387|365129515|FG004|Overall Study|Withdrawal by Subject|18|||
105857565|NCT00673387|365129516|FG005|Overall Study|Withdrawal by Subject|21|||
105857566|NCT00673387|365129517|FG006|Overall Study|Withdrawal by Subject|15|||
105857567|NCT00673387|365129518|FG007|Overall Study|Withdrawal by Subject|21|||
105857568|NCT00673387|365129511|FG000|Overall Study|Adverse Event|3|||
105857569|NCT00673387|365129512|FG001|Overall Study|Adverse Event|1|||
105857570|NCT00673387|365129513|FG002|Overall Study|Adverse Event|5|||
105857571|NCT00673387|365129514|FG003|Overall Study|Adverse Event|2|||
105857572|NCT00673387|365129515|FG004|Overall Study|Adverse Event|6|||
105857573|NCT00673387|365129516|FG005|Overall Study|Adverse Event|2|||
105857574|NCT00673387|365129517|FG006|Overall Study|Adverse Event|5|||
105857575|NCT00673387|365129518|FG007|Overall Study|Adverse Event|5|||
105857576|NCT00673387|365129511|FG000|Overall Study|Physician Decision|0|||
105857577|NCT00673387|365129512|FG001|Overall Study|Physician Decision|0|||
105857578|NCT00673387|365129513|FG002|Overall Study|Physician Decision|0|||
105857579|NCT00673387|365129514|FG003|Overall Study|Physician Decision|0|||
105857580|NCT00673387|365129515|FG004|Overall Study|Physician Decision|0|||
105857581|NCT00673387|365129516|FG005|Overall Study|Physician Decision|5|||
105857582|NCT00673387|365129517|FG006|Overall Study|Physician Decision|1|||
105857583|NCT00673387|365129518|FG007|Overall Study|Physician Decision|1|||
105857584|NCT00673387|365129511|FG000|Overall Study|Protocol Violation|3|||
105857585|NCT00673387|365129512|FG001|Overall Study|Protocol Violation|0|||
105857586|NCT00673387|365129513|FG002|Overall Study|Protocol Violation|1|||
105857587|NCT00673387|365129514|FG003|Overall Study|Protocol Violation|2|||
105857588|NCT00673387|365129515|FG004|Overall Study|Protocol Violation|0|||
105857589|NCT00673387|365129516|FG005|Overall Study|Protocol Violation|1|||
105857590|NCT00673387|365129517|FG006|Overall Study|Protocol Violation|1|||
105857591|NCT00673387|365129518|FG007|Overall Study|Protocol Violation|3|||
105857592|NCT00673387|365129511|FG000|Overall Study|Lost to Follow-up|8|||
106036306|NCT01986933|365796828|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
106036307|NCT01986933|365796829|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
106036308|NCT01986933|365796830|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
106036309|NCT01986933|365796831|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
106036310|NCT01986933|365796832|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
106036311|NCT01986933|365796828|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
106036312|NCT01986933|365796829|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
106036313|NCT01986933|365796830|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
106036314|NCT01986933|365796831|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
106036315|NCT01986933|365796832|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
106036316|NCT02125604|365796833|FG000|Overall Study|Other|4|||
106036317|NCT02125604|365796833|FG000|Overall Study|Investigator Decision|1|||
106036318|NCT02125604|365796833|FG000|Overall Study|Lost to Follow-up|2|||
106036319|NCT02125604|365796833|FG000|Overall Study|Consent Withdrawn|4|||
106036320|NCT02125604|365796833|FG000|Overall Study|Adverse Event|20|||
106036321|NCT03384693|365798209|FG000|Overall Study|Adverse Event|3|||
106036322|NCT03442764|365798210|FG000|Overall Study|Adverse Event|1|||
106036323|NCT03442764|365798211|FG001|Overall Study|Adverse Event|0|||
106036324|NCT03442764|365798212|FG002|Overall Study|Adverse Event|0|||
106036325|NCT03269552|365798213|FG000|Overall Study|Adverse Event|2|||
106036326|NCT02448680|365798214|FG000|Overall Study|Physician Decision|1|||
106036327|NCT02448680|365798215|FG001|Overall Study|Physician Decision|1|||
106036328|NCT02448680|365798214|FG000|Overall Study|Withdrawal by Subject|0|||
106036329|NCT02448680|365798215|FG001|Overall Study|Withdrawal by Subject|2|||
106036330|NCT00815516|365798216|FG000|Overall Study|Death|3|||
106036331|NCT00815516|365798217|FG001|Overall Study|Death|1|||
106036332|NCT00815516|365798216|FG000|Overall Study|Physician Decision|1|||
106036333|NCT00815516|365798217|FG001|Overall Study|Physician Decision|0|||
106036334|NCT03410823|365798230|FG000|Overall Study|Death|1|||
106036335|NCT03410823|365798230|FG000|Overall Study|Withdrawal by Subject|2|||
106036336|NCT03410823|365798230|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
106036337|NCT01142128|365798231|FG000|Overall Study|Physician Decision|1|||
105857593|NCT00673387|365129512|FG001|Overall Study|Lost to Follow-up|6|||
106036338|NCT01142128|365798231|FG000|Overall Study|Lost to Follow-up|1|||
106036339|NCT01142128|365798231|FG000|Overall Study|Withdrawal by Subject|2|||
106036340|NCT03355664|365798232|FG000|Overall Study|Adverse Event|1|||
106036341|NCT03355664|365798233|FG001|Overall Study|Adverse Event|2|||
106036342|NCT03355664|365798232|FG000|Overall Study|Lost to Follow-up|11|||
106036343|NCT03355664|365798233|FG001|Overall Study|Lost to Follow-up|7|||
106036344|NCT03355664|365798232|FG000|Overall Study|Protocol Violation|1|||
106036345|NCT03355664|365798233|FG001|Overall Study|Protocol Violation|2|||
106036346|NCT03355664|365798232|FG000|Overall Study|Withdrawal by Subject|2|||
106036347|NCT03355664|365798233|FG001|Overall Study|Withdrawal by Subject|1|||
106036348|NCT02821910|365798234|FG000|Overall Study|Withdrawal by Subject|0|||
106036349|NCT02821910|365798235|FG001|Overall Study|Withdrawal by Subject|0|||
106036350|NCT02821910|365798236|FG002|Overall Study|Withdrawal by Subject|1|||
106036351|NCT02821910|365798237|FG003|Overall Study|Withdrawal by Subject|0|||
106036352|NCT02821910|365798238|FG004|Overall Study|Withdrawal by Subject|0|||
106036353|NCT02821910|365798239|FG005|Overall Study|Withdrawal by Subject|1|||
106036354|NCT02821910|365798234|FG000|Overall Study|Other than specified|1|||
106036355|NCT02821910|365798235|FG001|Overall Study|Other than specified|0|||
106036356|NCT02821910|365798236|FG002|Overall Study|Other than specified|1|||
106036357|NCT02821910|365798237|FG003|Overall Study|Other than specified|0|||
106036358|NCT02821910|365798238|FG004|Overall Study|Other than specified|0|||
106036359|NCT02821910|365798239|FG005|Overall Study|Other than specified|0|||
106036360|NCT00470184|365798242|FG000|Overall Study|Not Treated(became ineligible)|4|||
106036361|NCT00470184|365798242|FG000|Overall Study|Not treated (other)|1|||
106036362|NCT00470184|365798242|FG000|Overall Study|disease Progression|4|||
106036363|NCT00470184|365798242|FG000|Overall Study|Adverse Event|3|||
106036364|NCT00470184|365798242|FG000|Overall Study|Withdrawal by Subject|4|||
106036365|NCT00470184|365798242|FG000|Overall Study|other|5|||
106036366|NCT00470184|365798242|FG000|Overall Study|recurrence|1|||
106036367|NCT04365257|365798245|FG000|Overall Study|Physician Decision|1|||
106036368|NCT04365257|365798246|FG001|Overall Study|Physician Decision|0|||
106036369|NCT04365257|365798245|FG000|Overall Study|Patient Noncompliance|1|||
106036370|NCT04365257|365798246|FG001|Overall Study|Patient Noncompliance|0|||
106036371|NCT04365257|365798245|FG000|Overall Study|Withdrawal by Subject|0|||
106036372|NCT04365257|365798246|FG001|Overall Study|Withdrawal by Subject|1|||
106036373|NCT03452527|365798247|FG000|Overall Study|Withdrawal by Subject|1|||
106036374|NCT03452527|365798248|FG001|Overall Study|Withdrawal by Subject|1|||
106036375|NCT03452527|365798247|FG000|Overall Study|Study Terminated|2|||
106036376|NCT03452527|365798248|FG001|Overall Study|Study Terminated|3|||
106036377|NCT01001299|365798249|FG000|Overall Study|Insufficient Therapeutic Response|20|||
106036378|NCT01001299|365798249|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
106036379|NCT01001299|365798249|FG000|Overall Study|Death|1|||
106036380|NCT01001299|365798249|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
106036381|NCT01001299|365798249|FG000|Overall Study|Withdrew Consent|1|||
106036382|NCT01323920|365798250|FG000|Overall Study|Death|5|||
106036383|NCT01323920|365798250|FG000|Overall Study|Withdrawal by Subject|1|||
106036384|NCT02117414|365798251|FG000|Overall Study|Death|5|||
106036385|NCT02117414|365798252|FG001|Overall Study|Death|2|||
106036386|NCT02117414|365798251|FG000|Overall Study|Withdrawal by Subject|10|||
106036387|NCT02117414|365798252|FG001|Overall Study|Withdrawal by Subject|4|||
106036388|NCT03101267|365798256|FG000|Primary Study Period|Withdrawal by Subject|1|||
105857594|NCT00673387|365129513|FG002|Overall Study|Lost to Follow-up|5|||
105857595|NCT00673387|365129514|FG003|Overall Study|Lost to Follow-up|6|||
105857596|NCT00673387|365129515|FG004|Overall Study|Lost to Follow-up|6|||
105857597|NCT00673387|365129516|FG005|Overall Study|Lost to Follow-up|5|||
105857598|NCT00673387|365129517|FG006|Overall Study|Lost to Follow-up|8|||
105857599|NCT00673387|365129518|FG007|Overall Study|Lost to Follow-up|5|||
105857600|NCT02533375|365129519|FG000|Overall Study|Lack of Efficacy|3|||
105857601|NCT02533375|365129519|FG000|Overall Study|Adverse Event|2|||
105857602|NCT02582866|365129523|FG000|Overall Study|Death|1|||
105857603|NCT02582866|365129523|FG000|Overall Study|Lack of Efficacy|2|||
105857604|NCT02582866|365129523|FG000|Overall Study|Lost to Follow-up|2|||
105857605|NCT02582866|365129523|FG000|Overall Study|Withdrawal by Subject|7|||
105857606|NCT02582866|365129523|FG000|Overall Study|Investigator decision|5|||
105857607|NCT02582866|365129523|FG000|Overall Study|Participant wants to get pregnant|1|||
105857608|NCT02582866|365129523|FG000|Overall Study|Pregnancy|2|||
105857609|NCT02582866|365129523|FG000|Overall Study|Sponsor decision|1|||
105857610|NCT02582866|365129523|FG000|Overall Study|Withdrawal due to personal reasons|1|||
105857611|NCT01709838|365129526|FG000|Overall Study|Withdrawal by Subject|21|||
105857612|NCT01709838|365129526|FG000|Overall Study|Lost to Follow-up|16|||
105857613|NCT01709838|365129526|FG000|Overall Study|Pregnancy|10|||
105857614|NCT01709838|365129526|FG000|Overall Study|Subject/guardian decision|8|||
105857615|NCT01709838|365129526|FG000|Overall Study|Adverse Event|4|||
105857616|NCT01709838|365129526|FG000|Overall Study|Physician Decision|4|||
105857617|NCT01709838|365129526|FG000|Overall Study|Death|3|||
105857618|NCT01709838|365129526|FG000|Overall Study|Protocol Violation|1|||
105857619|NCT03365011|365129527|FG000|Overall Study|Withdrawal by Subject|1|||
105857620|NCT03365011|365129528|FG001|Overall Study|Withdrawal by Subject|2|||
105857621|NCT01193127|365129529|FG000|Randomized|Surgery Cancelled|0|||
105857622|NCT01193127|365129530|FG001|Randomized|Surgery Cancelled|0|||
105857623|NCT01193127|365129531|FG002|Randomized|Surgery Cancelled|0|||
105857624|NCT01193127|365129532|FG003|Randomized|Surgery Cancelled|1|||
105857625|NCT01193127|365129529|FG000|Treated|Withdrawal by Subject|0|||
105857626|NCT01193127|365129530|FG001|Treated|Withdrawal by Subject|0|||
105857627|NCT01193127|365129531|FG002|Treated|Withdrawal by Subject|0|||
105857628|NCT01193127|365129532|FG003|Treated|Withdrawal by Subject|1|||
105857629|NCT04853992|365129533|FG000|Treatment Period A|Adverse Event|0|||
105857630|NCT04853992|365129534|FG001|Treatment Period A|Adverse Event|1|||
105857631|NCT04853992|365129533|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
105857632|NCT04853992|365129534|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
105857633|NCT03246646|365129535|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
105857634|NCT03246646|365129536|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
105857635|NCT03246646|365129535|FG000|Overall Study|Withdrawal by Subject|3|||
105857636|NCT03246646|365129536|FG001|Overall Study|Withdrawal by Subject|0|||
105857637|NCT03246646|365129535|FG000|Overall Study|Lost to Follow-up|7|||
105857638|NCT03246646|365129536|FG001|Overall Study|Lost to Follow-up|0|||
105857639|NCT03582826|365129537|FG000|Overall Study|Lost to Follow-up|39|||
105857640|NCT03582826|365129538|FG001|Overall Study|Lost to Follow-up|0|||
105857641|NCT03582826|365129537|FG000|Overall Study|Withdrawal by Subject|2|||
105857642|NCT03582826|365129538|FG001|Overall Study|Withdrawal by Subject|0|||
105857643|NCT00499174|365129539|FG000|Overall Study|Physician Decision|78|||
105857644|NCT00499174|365129540|FG001|Overall Study|Physician Decision|9|||
105857645|NCT00278889|365129543|FG000|Overall Study|Withdrawal by Subject|0|||
106036389|NCT03101267|365798257|FG001|Primary Study Period|Withdrawal by Subject|2|||
105857646|NCT00278889|365129544|FG001|Overall Study|Withdrawal by Subject|5|||
106036390|NCT03101267|365798258|FG002|Primary Study Period|Withdrawal by Subject|3|||
106036391|NCT03101267|365798256|FG000|Primary Study Period|Miscellaneous|2|||
105857647|NCT00278889|365129545|FG002|Overall Study|Withdrawal by Subject|3|||
105857648|NCT00278889|365129543|FG000|Overall Study|Lost to Follow-up|1|||
105857649|NCT00278889|365129544|FG001|Overall Study|Lost to Follow-up|1|||
105857650|NCT00278889|365129545|FG002|Overall Study|Lost to Follow-up|0|||
105857651|NCT00278889|365129543|FG000|Overall Study|Death|24|||
106036392|NCT03101267|365798257|FG001|Primary Study Period|Miscellaneous|0|||
106036393|NCT03101267|365798258|FG002|Primary Study Period|Miscellaneous|0|||
106036394|NCT00459056|365798259|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
105857652|NCT00278889|365129544|FG001|Overall Study|Death|21|||
105857653|NCT00278889|365129545|FG002|Overall Study|Death|17|||
105857654|NCT01372774|365129546|FG000|Overall Study|Withdrawal prior to treatment|4|||
105857655|NCT01372774|365129547|FG001|Overall Study|Withdrawal prior to treatment|5|||
105869208|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
105869209|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
105857656|NCT01496976|365131116|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
105857657|NCT03548064|365131117|FG000|Overall Study|Withdrawal by Subject|0|||
105857658|NCT03548064|365131118|FG001|Overall Study|Withdrawal by Subject|0|||
105857659|NCT03548064|365131119|FG002|Overall Study|Withdrawal by Subject|0|||
105857660|NCT03548064|365131120|FG003|Overall Study|Withdrawal by Subject|1|||
105857661|NCT03548064|365131121|FG004|Overall Study|Withdrawal by Subject|0|||
105857662|NCT03548064|365131122|FG005|Overall Study|Withdrawal by Subject|0|||
105857663|NCT03548064|365131123|FG006|Overall Study|Withdrawal by Subject|0|||
105857664|NCT03548064|365131124|FG007|Overall Study|Withdrawal by Subject|0|||
105857665|NCT03548064|365131117|FG000|Overall Study|Lost to Follow-up|0|||
105857666|NCT03548064|365131118|FG001|Overall Study|Lost to Follow-up|0|||
106036395|NCT00459056|365798260|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
106036396|NCT02283177|365798261|FG000|Overall Study|Withdrawal by Subject|1|||
105857667|NCT03548064|365131119|FG002|Overall Study|Lost to Follow-up|0|||
105857668|NCT03548064|365131120|FG003|Overall Study|Lost to Follow-up|0|||
105857669|NCT03548064|365131121|FG004|Overall Study|Lost to Follow-up|2|||
105857670|NCT03548064|365131122|FG005|Overall Study|Lost to Follow-up|0|||
105857671|NCT03548064|365131123|FG006|Overall Study|Lost to Follow-up|0|||
105857672|NCT03548064|365131124|FG007|Overall Study|Lost to Follow-up|0|||
105857673|NCT03548064|365131117|FG000|Overall Study|Covid-19 Pandemic|0|||
105857674|NCT03548064|365131118|FG001|Overall Study|Covid-19 Pandemic|0|||
105857675|NCT03548064|365131119|FG002|Overall Study|Covid-19 Pandemic|0|||
105857676|NCT03548064|365131120|FG003|Overall Study|Covid-19 Pandemic|0|||
105857677|NCT03548064|365131121|FG004|Overall Study|Covid-19 Pandemic|10|||
105857678|NCT03548064|365131122|FG005|Overall Study|Covid-19 Pandemic|3|||
105857679|NCT03548064|365131123|FG006|Overall Study|Covid-19 Pandemic|0|||
105857680|NCT03548064|365131124|FG007|Overall Study|Covid-19 Pandemic|0|||
105857681|NCT05011123|365131125|FG000|Overall Study|Withdrawal by Subject|4|||
105857682|NCT05011123|365131126|FG001|Overall Study|Withdrawal by Subject|2|||
105857683|NCT05011123|365131125|FG000|Overall Study|Lost to Follow-up|7|||
105857684|NCT05011123|365131126|FG001|Overall Study|Lost to Follow-up|6|||
105857685|NCT05011123|365131125|FG000|Overall Study|Ongoing at the time of DBL date|36|||
105857686|NCT05011123|365131126|FG001|Overall Study|Ongoing at the time of DBL date|10|||
105857687|NCT05011123|365131125|FG000|Overall Study|Randomized but did not receive vaccination|1|||
105857688|NCT05011123|365131126|FG001|Overall Study|Randomized but did not receive vaccination|0|||
105857689|NCT04941729|365131127|FG000|Overall Study|Death|0|||
105857690|NCT04941729|365131128|FG001|Overall Study|Death|1|||
105857691|NCT04941729|365131127|FG000|Overall Study|Study terminated by sponsor|11|||
105857692|NCT04941729|365131128|FG001|Overall Study|Study terminated by sponsor|10|||
105857693|NCT04221789|365131129|FG000|Overall Study|deviation from protoco|22|||
105857694|NCT04221789|365131130|FG001|Overall Study|deviation from protoco|8|||
105857695|NCT03611543|365131131|FG000|Overall Study|Withdrawal by Subject|4|||
105857696|NCT03611543|365131132|FG001|Overall Study|Withdrawal by Subject|4|||
105857697|NCT03611543|365131131|FG000|Overall Study|Physician Decision|1|||
105857698|NCT03611543|365131132|FG001|Overall Study|Physician Decision|1|||
105857699|NCT03611543|365131131|FG000|Overall Study|Protocol Violation|2|||
105857700|NCT03611543|365131132|FG001|Overall Study|Protocol Violation|2|||
105857701|NCT03611543|365131131|FG000|Overall Study|Device failure|2|||
106036397|NCT02283177|365798262|FG001|Overall Study|Withdrawal by Subject|1|||
106036398|NCT01185834|365798266|FG000|Overall Study|Lost to Follow-up|2|||
106036399|NCT01185834|365798266|FG000|Overall Study|Discomfort|4|||
106036400|NCT01185834|365798266|FG000|Overall Study|Biomicroscopy|4|||
106036401|NCT01185834|365798266|FG000|Overall Study|Time/Job Conflict|2|||
106036402|NCT01185834|365798266|FG000|Overall Study|Early exit - Site error|2|||
106036403|NCT02635646|365798267|FG000|Overall Study|Lost to Follow-up|24|||
106036404|NCT02635646|365798268|FG001|Overall Study|Lost to Follow-up|25|||
106036405|NCT02635646|365798267|FG000|Overall Study|Pregnancy|1|||
106036406|NCT02635646|365798268|FG001|Overall Study|Pregnancy|1|||
106036407|NCT01975831|365798277|FG000|Overall Study|Adverse Event|1|||
106036408|NCT01975831|365798278|FG001|Overall Study|Adverse Event|2|||
106036409|NCT01975831|365798279|FG002|Overall Study|Adverse Event|2|||
106036410|NCT01975831|365798280|FG003|Overall Study|Adverse Event|0|||
106036411|NCT01975831|365798281|FG004|Overall Study|Adverse Event|1|||
106036412|NCT01975831|365798282|FG005|Overall Study|Adverse Event|1|||
106036413|NCT01975831|365798283|FG006|Overall Study|Adverse Event|3|||
106036414|NCT01975831|365798284|FG007|Overall Study|Adverse Event|4|||
106036415|NCT01975831|365798285|FG008|Overall Study|Adverse Event|1|||
106036416|NCT01975831|365798277|FG000|Overall Study|Death|1|||
106036417|NCT01975831|365798278|FG001|Overall Study|Death|1|||
106036418|NCT01975831|365798279|FG002|Overall Study|Death|0|||
106036419|NCT01975831|365798280|FG003|Overall Study|Death|0|||
106036420|NCT01975831|365798281|FG004|Overall Study|Death|1|||
106036421|NCT01975831|365798282|FG005|Overall Study|Death|0|||
106036422|NCT01975831|365798283|FG006|Overall Study|Death|1|||
106036423|NCT01975831|365798284|FG007|Overall Study|Death|0|||
106036424|NCT01975831|365798285|FG008|Overall Study|Death|0|||
106036425|NCT01975831|365798277|FG000|Overall Study|Progressive Disease|1|||
106036426|NCT01975831|365798278|FG001|Overall Study|Progressive Disease|3|||
106036427|NCT01975831|365798279|FG002|Overall Study|Progressive Disease|2|||
106036428|NCT01975831|365798280|FG003|Overall Study|Progressive Disease|4|||
106036429|NCT01975831|365798281|FG004|Overall Study|Progressive Disease|13|||
106036430|NCT01975831|365798282|FG005|Overall Study|Progressive Disease|9|||
106036431|NCT01975831|365798283|FG006|Overall Study|Progressive Disease|10|||
106036432|NCT01975831|365798284|FG007|Overall Study|Progressive Disease|8|||
106036433|NCT01975831|365798285|FG008|Overall Study|Progressive Disease|10|||
106036434|NCT01975831|365798277|FG000|Overall Study|Withdrawal by Subject|0|||
106036435|NCT01975831|365798278|FG001|Overall Study|Withdrawal by Subject|3|||
106036436|NCT01975831|365798279|FG002|Overall Study|Withdrawal by Subject|0|||
106036437|NCT01975831|365798280|FG003|Overall Study|Withdrawal by Subject|0|||
106036438|NCT01975831|365798281|FG004|Overall Study|Withdrawal by Subject|3|||
106036439|NCT01975831|365798282|FG005|Overall Study|Withdrawal by Subject|1|||
106036440|NCT01975831|365798283|FG006|Overall Study|Withdrawal by Subject|1|||
106036441|NCT01975831|365798284|FG007|Overall Study|Withdrawal by Subject|0|||
106036442|NCT01975831|365798285|FG008|Overall Study|Withdrawal by Subject|0|||
106036443|NCT01975831|365798277|FG000|Overall Study|Physician Decision|0|||
106036444|NCT01975831|365798278|FG001|Overall Study|Physician Decision|0|||
106036445|NCT01975831|365798279|FG002|Overall Study|Physician Decision|0|||
106036446|NCT01975831|365798280|FG003|Overall Study|Physician Decision|0|||
106036447|NCT01975831|365798281|FG004|Overall Study|Physician Decision|0|||
106036448|NCT01975831|365798282|FG005|Overall Study|Physician Decision|1|||
106036449|NCT01975831|365798283|FG006|Overall Study|Physician Decision|0|||
106036450|NCT01975831|365798284|FG007|Overall Study|Physician Decision|1|||
106036451|NCT01975831|365798285|FG008|Overall Study|Physician Decision|0|||
106036452|NCT01975831|365798277|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
106036453|NCT01975831|365798278|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
106036454|NCT01975831|365798279|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
106036455|NCT01975831|365798280|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
106036456|NCT01975831|365798281|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
106036457|NCT01975831|365798282|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
106036458|NCT01975831|365798283|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
106036459|NCT01975831|365798284|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
106036460|NCT01975831|365798285|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
106036461|NCT01975831|365798277|FG000|Overall Study|Entered Hospice|0|||
106036462|NCT01975831|365798278|FG001|Overall Study|Entered Hospice|0|||
106036463|NCT01975831|365798279|FG002|Overall Study|Entered Hospice|0|||
106036464|NCT01975831|365798280|FG003|Overall Study|Entered Hospice|0|||
106036465|NCT01975831|365798281|FG004|Overall Study|Entered Hospice|0|||
106036466|NCT01975831|365798282|FG005|Overall Study|Entered Hospice|1|||
106036467|NCT01975831|365798283|FG006|Overall Study|Entered Hospice|0|||
106036468|NCT01975831|365798284|FG007|Overall Study|Entered Hospice|0|||
106036469|NCT01975831|365798285|FG008|Overall Study|Entered Hospice|0|||
106036470|NCT01975831|365798277|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
106036471|NCT01975831|365798278|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
106036472|NCT01975831|365798279|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
106036473|NCT01975831|365798280|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
106036474|NCT01975831|365798281|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
106036475|NCT01975831|365798282|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
106036476|NCT01975831|365798283|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
106036477|NCT01975831|365798284|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
106036478|NCT01975831|365798285|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
106036479|NCT02694718|365798290|FG000|Overall Study|Death|1|||
106036480|NCT02694718|365798290|FG000|Overall Study|Withdrawal by Subject|1|||
106036481|NCT02925793|365798291|FG000|Overall Study|Adverse Event|3|||
106036482|NCT02925793|365798292|FG001|Overall Study|Adverse Event|3|||
106036483|NCT02925793|365798293|FG002|Overall Study|Adverse Event|6|||
106036484|NCT02925793|365798291|FG000|Overall Study|Withdrawal by Subject|16|||
106036485|NCT02925793|365798292|FG001|Overall Study|Withdrawal by Subject|15|||
106036486|NCT02925793|365798293|FG002|Overall Study|Withdrawal by Subject|13|||
106036487|NCT02925793|365798291|FG000|Overall Study|Investigator Discretion|0|||
106036488|NCT02925793|365798292|FG001|Overall Study|Investigator Discretion|1|||
106036489|NCT02925793|365798293|FG002|Overall Study|Investigator Discretion|1|||
106036490|NCT02925793|365798291|FG000|Overall Study|Lost to Follow-up|2|||
106036491|NCT02925793|365798292|FG001|Overall Study|Lost to Follow-up|3|||
106036492|NCT02925793|365798293|FG002|Overall Study|Lost to Follow-up|1|||
106036493|NCT02925793|365798291|FG000|Overall Study|Lack of Efficacy|2|||
106036494|NCT02925793|365798292|FG001|Overall Study|Lack of Efficacy|6|||
106036495|NCT02925793|365798293|FG002|Overall Study|Lack of Efficacy|4|||
106036496|NCT02925793|365798291|FG000|Overall Study|Other:|2|||
106036497|NCT02925793|365798292|FG001|Overall Study|Other:|1|||
106036498|NCT02925793|365798293|FG002|Overall Study|Other:|3|||
106036499|NCT00879879|365798294|FG000|Overall Study|Death|1|||
106036500|NCT00879879|365798294|FG000|Overall Study|Withdrawal by Subject|1|||
106036501|NCT00879879|365798294|FG000|Overall Study|Physician Decision|1|||
106036502|NCT00645788|365798297|FG000|Overall Study|Did not receive study drug|1|||
106036503|NCT00645788|365798298|FG001|Overall Study|Did not receive study drug|1|||
106036504|NCT00645788|365798299|FG002|Overall Study|Did not receive study drug|0|||
106036505|NCT00645788|365798300|FG003|Overall Study|Did not receive study drug|0|||
106036506|NCT00645788|365798297|FG000|Overall Study|Adverse Event|4|||
106036507|NCT00645788|365798298|FG001|Overall Study|Adverse Event|9|||
106036508|NCT00645788|365798299|FG002|Overall Study|Adverse Event|5|||
105857702|NCT03611543|365131132|FG001|Overall Study|Device failure|2|||
105857703|NCT03611543|365131131|FG000|Overall Study|Missing information|5|||
105857704|NCT03611543|365131132|FG001|Overall Study|Missing information|5|||
105857705|NCT02081209|365131133|FG000|Overall Study|Withdrawal by Subject|1|||
105857742|NCT04654468|365131144|FG000|Overall Study|Death|1|||
105857743|NCT04654468|365131144|FG000|Overall Study|Ongoing in the Study|50|||
105857744|NCT03786718|365131149|FG000|Overall Study|Lost to Follow-up|3|||
105857745|NCT03786718|365131149|FG000|Overall Study|Withdrawal by Subject|1|||
105857746|NCT03786718|365131149|FG000|Overall Study|Did not use the intervention|2|||
105857747|NCT03786718|365131149|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
105857748|NCT04710979|365131150|FG000|Overall Study|Lost to Follow-up|2|||
105857749|NCT04710979|365131151|FG001|Overall Study|Lost to Follow-up|4|||
105857750|NCT04710979|365131150|FG000|Overall Study|Withdrawal by Subject|1|||
105857751|NCT04710979|365131151|FG001|Overall Study|Withdrawal by Subject|0|||
105857752|NCT04241315|365131162|FG000|Overall Study|Withdrawal by Subject|0|||
105857753|NCT04241315|365131163|FG001|Overall Study|Withdrawal by Subject|1|||
105857754|NCT00372411|365131164|FG000|Overall Study|Withdrawal by Subject|3|||
106036509|NCT00645788|365798300|FG003|Overall Study|Adverse Event|3|||
106036510|NCT00645788|365798297|FG000|Overall Study|Lost to Follow-up|1|||
106036511|NCT00645788|365798298|FG001|Overall Study|Lost to Follow-up|0|||
105857755|NCT00372411|365131165|FG001|Overall Study|Withdrawal by Subject|4|||
105857756|NCT00372411|365131166|FG002|Overall Study|Withdrawal by Subject|1|||
105857757|NCT00372411|365131164|FG000|Overall Study|Death|0|||
105857758|NCT00372411|365131165|FG001|Overall Study|Death|2|||
105857759|NCT00372411|365131166|FG002|Overall Study|Death|1|||
105857760|NCT00372411|365131164|FG000|Overall Study|Lost to Follow-up|1|||
105857761|NCT00372411|365131165|FG001|Overall Study|Lost to Follow-up|1|||
105857762|NCT00372411|365131166|FG002|Overall Study|Lost to Follow-up|1|||
105857763|NCT00372411|365131164|FG000|Overall Study|Adverse Event|1|||
105857764|NCT00372411|365131165|FG001|Overall Study|Adverse Event|1|||
105857765|NCT00372411|365131166|FG002|Overall Study|Adverse Event|0|||
105857766|NCT00699283|365131167|FG000|Overall Study|Lack of Efficacy|15|||
105857767|NCT00699283|365131168|FG001|Overall Study|Lack of Efficacy|5|||
105857768|NCT00699283|365131167|FG000|Overall Study|Lost to Follow-up|2|||
105857769|NCT00699283|365131168|FG001|Overall Study|Lost to Follow-up|0|||
106036512|NCT00645788|365798299|FG002|Overall Study|Lost to Follow-up|0|||
106036513|NCT00645788|365798300|FG003|Overall Study|Lost to Follow-up|0|||
106036514|NCT00645788|365798297|FG000|Overall Study|Protocol Violation|1|||
106036515|NCT00645788|365798298|FG001|Overall Study|Protocol Violation|0|||
106036516|NCT00645788|365798299|FG002|Overall Study|Protocol Violation|2|||
106036517|NCT00645788|365798300|FG003|Overall Study|Protocol Violation|0|||
106036518|NCT00645788|365798297|FG000|Overall Study|Withdrawal by Subject|0|||
106036519|NCT00645788|365798298|FG001|Overall Study|Withdrawal by Subject|1|||
106036520|NCT00645788|365798299|FG002|Overall Study|Withdrawal by Subject|0|||
106036521|NCT00645788|365798300|FG003|Overall Study|Withdrawal by Subject|2|||
106036522|NCT00645788|365798297|FG000|Overall Study|Pulmonary exacerbation|13|||
106036523|NCT00645788|365798298|FG001|Overall Study|Pulmonary exacerbation|16|||
106036524|NCT00645788|365798299|FG002|Overall Study|Pulmonary exacerbation|11|||
106036525|NCT00645788|365798300|FG003|Overall Study|Pulmonary exacerbation|9|||
106036526|NCT03149848|365798301|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
106036527|NCT03149848|365798301|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
106036528|NCT01390220|365798308|FG000|Test Dose Phase|Adverse Event|17|||
106036529|NCT01390220|365798309|FG001|Test Dose Phase|Adverse Event|0|||
106036530|NCT01390220|365798310|FG002|Test Dose Phase|Adverse Event|0|||
106036531|NCT01390220|365798308|FG000|Test Dose Phase|Withdrawal by Subject|8|||
106036532|NCT01390220|365798309|FG001|Test Dose Phase|Withdrawal by Subject|0|||
106036533|NCT01390220|365798310|FG002|Test Dose Phase|Withdrawal by Subject|0|||
106036534|NCT01390220|365798308|FG000|Test Dose Phase|Lost to Follow-up|2|||
106036535|NCT01390220|365798309|FG001|Test Dose Phase|Lost to Follow-up|0|||
106036536|NCT01390220|365798310|FG002|Test Dose Phase|Lost to Follow-up|0|||
106036537|NCT01390220|365798308|FG000|Test Dose Phase|Protocol Violation|8|||
106036538|NCT01390220|365798309|FG001|Test Dose Phase|Protocol Violation|0|||
106036539|NCT01390220|365798310|FG002|Test Dose Phase|Protocol Violation|0|||
106036540|NCT01390220|365798308|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
106036541|NCT01390220|365798309|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
106036542|NCT01390220|365798310|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
106036543|NCT01390220|365798308|FG000|Test Dose Phase|Study/Site closure|6|||
106036544|NCT01390220|365798309|FG001|Test Dose Phase|Study/Site closure|0|||
106036545|NCT01390220|365798310|FG002|Test Dose Phase|Study/Site closure|0|||
106036546|NCT01390220|365798308|FG000|Test Dose Phase|Caregiver no longer available|5|||
106036547|NCT01390220|365798309|FG001|Test Dose Phase|Caregiver no longer available|0|||
106036548|NCT01390220|365798310|FG002|Test Dose Phase|Caregiver no longer available|0|||
106036549|NCT01390220|365798308|FG000|Test Dose Phase|Noncompliance|2|||
106036550|NCT01390220|365798309|FG001|Test Dose Phase|Noncompliance|0|||
106036551|NCT01390220|365798310|FG002|Test Dose Phase|Noncompliance|0|||
106036552|NCT01390220|365798308|FG000|Test Dose Phase|Logistical|6|||
106036553|NCT01390220|365798309|FG001|Test Dose Phase|Logistical|0|||
106036554|NCT01390220|365798310|FG002|Test Dose Phase|Logistical|0|||
106036555|NCT01390220|365798308|FG000|Comparative Phase|Withdrawal by Subject|0|||
106036556|NCT01390220|365798309|FG001|Comparative Phase|Withdrawal by Subject|1|||
106036557|NCT01390220|365798310|FG002|Comparative Phase|Withdrawal by Subject|0|||
106036558|NCT02045303|365798311|FG000|Overall Study|Protocol Violation|2|||
106036559|NCT02045303|365798312|FG001|Overall Study|Protocol Violation|1|||
106036560|NCT02045303|365798313|FG002|Overall Study|Protocol Violation|0|||
106036561|NCT02045303|365798311|FG000|Overall Study|Withdrawal by Subject|0|||
106036562|NCT02045303|365798312|FG001|Overall Study|Withdrawal by Subject|2|||
106036563|NCT02045303|365798313|FG002|Overall Study|Withdrawal by Subject|0|||
106036564|NCT03533686|365798314|FG000|Overall Study|Withdrawal by Subject|1|||
106036565|NCT03533686|365798315|FG001|Overall Study|Withdrawal by Subject|0|||
106036566|NCT03533686|365798316|FG002|Overall Study|Withdrawal by Subject|0|||
106036567|NCT03533686|365798317|FG003|Overall Study|Withdrawal by Subject|3|||
106036568|NCT03533686|365798318|FG004|Overall Study|Withdrawal by Subject|5|||
106036569|NCT03533686|365798319|FG005|Overall Study|Withdrawal by Subject|1|||
106036570|NCT03533686|365798314|FG000|Overall Study|Lost to Follow-up|0|||
106036571|NCT03533686|365798315|FG001|Overall Study|Lost to Follow-up|1|||
106036572|NCT03533686|365798316|FG002|Overall Study|Lost to Follow-up|0|||
106036573|NCT03533686|365798317|FG003|Overall Study|Lost to Follow-up|0|||
106036574|NCT03533686|365798318|FG004|Overall Study|Lost to Follow-up|2|||
106036575|NCT03533686|365798319|FG005|Overall Study|Lost to Follow-up|0|||
106036576|NCT03533686|365798314|FG000|Overall Study|Screen Failure|0|||
106036577|NCT03533686|365798315|FG001|Overall Study|Screen Failure|0|||
106036578|NCT03533686|365798316|FG002|Overall Study|Screen Failure|0|||
106036579|NCT03533686|365798317|FG003|Overall Study|Screen Failure|2|||
106036580|NCT03533686|365798318|FG004|Overall Study|Screen Failure|0|||
106036581|NCT03533686|365798319|FG005|Overall Study|Screen Failure|0|||
106036582|NCT00327470|365798320|FG000|Overall Study|Randomized, but not treated|0|||
106036583|NCT00327470|365798321|FG001|Overall Study|Randomized, but not treated|2|||
106036584|NCT00327470|365798320|FG000|Overall Study|Adverse Event|9|||
106036585|NCT00327470|365798321|FG001|Overall Study|Adverse Event|14|||
106036586|NCT00327470|365798320|FG000|Overall Study|Lack of Efficacy|7|||
106036587|NCT00327470|365798321|FG001|Overall Study|Lack of Efficacy|19|||
106036588|NCT00327470|365798320|FG000|Overall Study|Other|5|||
106036589|NCT00327470|365798321|FG001|Overall Study|Other|9|||
106036590|NCT00327470|365798320|FG000|Overall Study|Lost to Follow-up|1|||
106036591|NCT00327470|365798321|FG001|Overall Study|Lost to Follow-up|3|||
106036592|NCT00327470|365798320|FG000|Overall Study|Withdrawal by Subject|6|||
106036593|NCT00327470|365798321|FG001|Overall Study|Withdrawal by Subject|12|||
106036594|NCT00327470|365798320|FG000|Overall Study|Death|1|||
106036595|NCT00327470|365798321|FG001|Overall Study|Death|4|||
106036596|NCT01076075|365798327|FG000|Overall Study|Adverse Event|3|||
106036597|NCT01076075|365798328|FG001|Overall Study|Adverse Event|9|||
106036598|NCT01076075|365798327|FG000|Overall Study|Lack of Efficacy|5|||
106036599|NCT01076075|365798328|FG001|Overall Study|Lack of Efficacy|4|||
106036600|NCT01076075|365798327|FG000|Overall Study|Lost to Follow-up|6|||
106036601|NCT01076075|365798328|FG001|Overall Study|Lost to Follow-up|5|||
106036602|NCT01076075|365798327|FG000|Overall Study|other|19|||
105857770|NCT00699283|365131167|FG000|Overall Study|Withdrawal by Subject|1|||
105857771|NCT00699283|365131168|FG001|Overall Study|Withdrawal by Subject|0|||
105857772|NCT00699283|365131167|FG000|Overall Study|Other Reason|5|||
105857773|NCT00699283|365131168|FG001|Overall Study|Other Reason|1|||
105857774|NCT00699283|365131167|FG000|Overall Study|SAE, non-fatal|1|||
105857775|NCT00699283|365131168|FG001|Overall Study|SAE, non-fatal|1|||
105857776|NCT00699283|365131167|FG000|Overall Study|AE, non-serious non-fatal|8|||
105857777|NCT00699283|365131168|FG001|Overall Study|AE, non-serious non-fatal|1|||
105857778|NCT00699283|365131167|FG000|Overall Study|AE of unknown type|1|||
105857779|NCT00699283|365131168|FG001|Overall Study|AE of unknown type|0|||
105857780|NCT00394524|365131169|FG000|Overall Study|Protocol Violation|2|||
105857781|NCT00394524|365131170|FG001|Overall Study|Protocol Violation|3|||
105857782|NCT00394524|365131169|FG000|Overall Study|Death|1|||
105857783|NCT00394524|365131170|FG001|Overall Study|Death|0|||
105857784|NCT00394524|365131169|FG000|Overall Study|Withdrawal by Subject|0|||
105857785|NCT00394524|365131170|FG001|Overall Study|Withdrawal by Subject|1|||
105857786|NCT01398514|365131175|FG000|Overall Study|Adverse Event|1|||
105857787|NCT01398514|365131176|FG001|Overall Study|Adverse Event|0|||
105857788|NCT01398514|365131175|FG000|Overall Study|Non-compliance with study procedures|2|||
105857789|NCT01398514|365131176|FG001|Overall Study|Non-compliance with study procedures|0|||
105857790|NCT01398514|365131175|FG000|Overall Study|Physiologic non-responsiveness|1|||
105857791|NCT01398514|365131176|FG001|Overall Study|Physiologic non-responsiveness|3|||
105857792|NCT01398514|365131175|FG000|Overall Study|Failure to show a conditioned response|4|||
105857793|NCT01398514|365131176|FG001|Overall Study|Failure to show a conditioned response|3|||
105857794|NCT01284361|365131177|FG000|Overall Study|Withdrawal by Subject|1|||
105857795|NCT01284361|365131177|FG000|Overall Study|Protocol Violation|5|||
105857796|NCT01284361|365131177|FG000|Overall Study|Adverse Event|1|||
105857797|NCT01284361|365131177|FG000|Overall Study|Lost to Follow-up|2|||
105857798|NCT04283500|365131183|FG000|Overall Study|Lost to Follow-up|8|||
105857799|NCT04283500|365131183|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
105857800|NCT01119508|365131188|FG000|Overall Study|Adverse Event|56|||
105857801|NCT01119508|365131188|FG000|Overall Study|Withdrawal by Subject|2|||
105857802|NCT01119508|365131188|FG000|Overall Study|Died before tumor response evaluation|1|||
105857803|NCT00265395|365131189|FG000|Overall Study|Adverse Event|3|||
105857804|NCT00265395|365131190|FG001|Overall Study|Adverse Event|6|||
105857805|NCT00265395|365131189|FG000|Overall Study|Lost to Follow-up|2|||
105857806|NCT00265395|365131190|FG001|Overall Study|Lost to Follow-up|1|||
105857807|NCT00265395|365131189|FG000|Overall Study|Withdrawal by Subject|1|||
105857808|NCT00265395|365131190|FG001|Overall Study|Withdrawal by Subject|6|||
105857809|NCT00265395|365131189|FG000|Overall Study|Protocol Violation|2|||
105857810|NCT00265395|365131190|FG001|Overall Study|Protocol Violation|2|||
105857811|NCT00265395|365131189|FG000|Overall Study|Lack of Efficacy|0|||
105857812|NCT00265395|365131190|FG001|Overall Study|Lack of Efficacy|1|||
105857813|NCT00265395|365131189|FG000|Overall Study|Administrative|0|||
105857814|NCT00265395|365131190|FG001|Overall Study|Administrative|1|||
105857815|NCT02315196|365131191|FG000|Overall Study|Withdrew consent|9|||
105857816|NCT03317834|365131192|FG000|Overall Study|Death|2|||
105857817|NCT03317834|365131192|FG000|Overall Study|Device Revision|5|||
105857818|NCT03317834|365131192|FG000|Overall Study|Withdrawal by Subject|13|||
105857819|NCT03317834|365131192|FG000|Overall Study|Lost to Follow-up|13|||
105857820|NCT01739348|365131193|FG000|Part I (Base Study)|Adverse Event|41|||
105857821|NCT01739348|365131194|FG001|Part I (Base Study)|Adverse Event|52|||
105857822|NCT01739348|365131195|FG002|Part I (Base Study)|Adverse Event|8|||
106036603|NCT01076075|365798328|FG001|Overall Study|other|9|||
106036604|NCT01076075|365798327|FG000|Overall Study|Protocol Violation|0|||
106036605|NCT01076075|365798328|FG001|Overall Study|Protocol Violation|1|||
106036606|NCT01076075|365798327|FG000|Overall Study|Withdrawal by Subject|8|||
106036607|NCT01076075|365798328|FG001|Overall Study|Withdrawal by Subject|19|||
106036608|NCT01017575|365798332|FG000|Overall Study|Lack of Efficacy|0|||
105857823|NCT01739348|365131196|FG003|Part I (Base Study)|Adverse Event|33|||
105857824|NCT01739348|365131193|FG000|Part I (Base Study)|Death|10|||
105857825|NCT01739348|365131194|FG001|Part I (Base Study)|Death|7|||
105857826|NCT01739348|365131195|FG002|Part I (Base Study)|Death|2|||
105857827|NCT01739348|365131196|FG003|Part I (Base Study)|Death|8|||
105857828|NCT01739348|365131193|FG000|Part I (Base Study)|Lack of Efficacy|3|||
105857829|NCT01739348|365131194|FG001|Part I (Base Study)|Lack of Efficacy|8|||
106036609|NCT01017575|365798333|FG001|Overall Study|Lack of Efficacy|1|||
105857830|NCT01739348|365131195|FG002|Part I (Base Study)|Lack of Efficacy|0|||
105857831|NCT01739348|365131196|FG003|Part I (Base Study)|Lack of Efficacy|7|||
105857832|NCT01739348|365131193|FG000|Part I (Base Study)|Lost to Follow-up|4|||
105857833|NCT01739348|365131194|FG001|Part I (Base Study)|Lost to Follow-up|2|||
105857834|NCT01739348|365131195|FG002|Part I (Base Study)|Lost to Follow-up|4|||
105857835|NCT01739348|365131196|FG003|Part I (Base Study)|Lost to Follow-up|4|||
105857836|NCT01739348|365131193|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
105857837|NCT01739348|365131194|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
105857838|NCT01739348|365131195|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
105857839|NCT01739348|365131196|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
105857840|NCT01739348|365131193|FG000|Part I (Base Study)|Physician Decision|10|||
105857841|NCT01739348|365131194|FG001|Part I (Base Study)|Physician Decision|7|||
105857842|NCT01739348|365131195|FG002|Part I (Base Study)|Physician Decision|1|||
105857843|NCT01739348|365131196|FG003|Part I (Base Study)|Physician Decision|4|||
105857844|NCT01739348|365131193|FG000|Part I (Base Study)|Protocol Violation|2|||
105857845|NCT01739348|365131194|FG001|Part I (Base Study)|Protocol Violation|0|||
105857846|NCT01739348|365131195|FG002|Part I (Base Study)|Protocol Violation|1|||
105857847|NCT01739348|365131196|FG003|Part I (Base Study)|Protocol Violation|2|||
105857848|NCT01739348|365131193|FG000|Part I (Base Study)|Screen Failure|2|||
105857849|NCT01739348|365131194|FG001|Part I (Base Study)|Screen Failure|0|||
105857850|NCT01739348|365131195|FG002|Part I (Base Study)|Screen Failure|0|||
105857851|NCT01739348|365131196|FG003|Part I (Base Study)|Screen Failure|0|||
105857852|NCT01739348|365131193|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
105857853|NCT01739348|365131194|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
105857854|NCT01739348|365131195|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
105857855|NCT01739348|365131196|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
105857856|NCT01739348|365131193|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
105857857|NCT01739348|365131194|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
105857858|NCT01739348|365131195|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
106036610|NCT01017575|365798334|FG002|Overall Study|Lack of Efficacy|0|||
106036611|NCT01017575|365798335|FG003|Overall Study|Lack of Efficacy|1|||
106036612|NCT01017575|365798336|FG004|Overall Study|Lack of Efficacy|1|||
106036613|NCT01017575|365798332|FG000|Overall Study|Adverse Event|0|||
106036614|NCT01017575|365798333|FG001|Overall Study|Adverse Event|1|||
106036615|NCT01017575|365798334|FG002|Overall Study|Adverse Event|0|||
106036616|NCT01017575|365798335|FG003|Overall Study|Adverse Event|0|||
106036617|NCT01017575|365798336|FG004|Overall Study|Adverse Event|2|||
106036618|NCT01017575|365798332|FG000|Overall Study|Withdrawal by Subject|1|||
106036619|NCT01017575|365798333|FG001|Overall Study|Withdrawal by Subject|0|||
106036620|NCT01017575|365798334|FG002|Overall Study|Withdrawal by Subject|0|||
106036621|NCT01017575|365798335|FG003|Overall Study|Withdrawal by Subject|0|||
106036622|NCT01017575|365798336|FG004|Overall Study|Withdrawal by Subject|0|||
106036623|NCT01445886|365798337|FG000|Overall Study|Lost to Follow-up|2|||
106036624|NCT01445886|365798337|FG000|Overall Study|Protocol Violation|3|||
106036625|NCT00995865|365798341|FG000|Overall Study|Protocol Violation|2|||
106036626|NCT00995865|365798342|FG001|Overall Study|Protocol Violation|0|||
106036627|NCT00995865|365798343|FG002|Overall Study|Protocol Violation|0|||
106036628|NCT00995865|365798341|FG000|Overall Study|Lost to Follow-up|0|||
106036629|NCT00995865|365798342|FG001|Overall Study|Lost to Follow-up|0|||
106036630|NCT00995865|365798343|FG002|Overall Study|Lost to Follow-up|1|||
106036631|NCT00144027|365798344|FG000|Overall Study|Lost to Follow-up|1|||
106036632|NCT00144027|365798345|FG001|Overall Study|Lost to Follow-up|3|||
106036633|NCT00144027|365798344|FG000|Overall Study|Withdrawal by Subject|2|||
106036634|NCT00144027|365798345|FG001|Overall Study|Withdrawal by Subject|2|||
106036635|NCT00144027|365798344|FG000|Overall Study|did not complete baseline assessment|0|||
106036636|NCT00144027|365798345|FG001|Overall Study|did not complete baseline assessment|6|||
106036637|NCT01074047|365798356|FG000|Treatment Phase|Adverse Event|89|||
106036638|NCT01074047|365798357|FG001|Treatment Phase|Adverse Event|66|||
106036639|NCT01074047|365798356|FG000|Treatment Phase|Disease Progression|16|||
106036640|NCT01074047|365798357|FG001|Treatment Phase|Disease Progression|21|||
106036641|NCT01074047|365798356|FG000|Treatment Phase|Withdrawal by Subject|27|||
106036642|NCT01074047|365798357|FG001|Treatment Phase|Withdrawal by Subject|48|||
106036643|NCT01074047|365798356|FG000|Treatment Phase|Death|53|||
106036644|NCT01074047|365798357|FG001|Treatment Phase|Death|58|||
106036645|NCT01074047|365798356|FG000|Treatment Phase|Lost to Follow-up|0|||
106036646|NCT01074047|365798357|FG001|Treatment Phase|Lost to Follow-up|1|||
106036647|NCT01074047|365798356|FG000|Treatment Phase|Protocol Violation|0|||
106036648|NCT01074047|365798357|FG001|Treatment Phase|Protocol Violation|1|||
106036649|NCT01074047|365798356|FG000|Treatment Phase|Miscellaneous|32|||
106036650|NCT01074047|365798357|FG001|Treatment Phase|Miscellaneous|39|||
106036651|NCT01074047|365798356|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
106036652|NCT01074047|365798357|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
106036653|NCT01074047|365798356|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
106036654|NCT01074047|365798357|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
105857859|NCT01739348|365131196|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
105857860|NCT01739348|365131193|FG000|Part I (Base Study)|Participant Moved|4|||
105857861|NCT01739348|365131194|FG001|Part I (Base Study)|Participant Moved|3|||
105857862|NCT01739348|365131195|FG002|Part I (Base Study)|Participant Moved|1|||
105857863|NCT01739348|365131196|FG003|Part I (Base Study)|Participant Moved|7|||
105857864|NCT01739348|365131193|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
105857865|NCT01739348|365131194|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
105857866|NCT01739348|365131195|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
105857867|NCT01739348|365131196|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
105857868|NCT01739348|365131193|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
105857869|NCT01739348|365131194|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
105857870|NCT01739348|365131195|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
105857871|NCT01739348|365131196|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
105857872|NCT01739348|365131193|FG000|Part II (Extension Study)|Adverse Event|10|||
105857873|NCT01739348|365131194|FG001|Part II (Extension Study)|Adverse Event|11|||
105857874|NCT01739348|365131195|FG002|Part II (Extension Study)|Adverse Event|7|||
105857875|NCT01739348|365131196|FG003|Part II (Extension Study)|Adverse Event|26|||
105857876|NCT01739348|365131193|FG000|Part II (Extension Study)|Death|3|||
105857877|NCT01739348|365131194|FG001|Part II (Extension Study)|Death|3|||
105857878|NCT01739348|365131195|FG002|Part II (Extension Study)|Death|2|||
105857879|NCT01739348|365131196|FG003|Part II (Extension Study)|Death|6|||
105857880|NCT01739348|365131193|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
105857881|NCT01739348|365131194|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
105857882|NCT01739348|365131195|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
105857883|NCT01739348|365131196|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
105857884|NCT01739348|365131193|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
105857885|NCT01739348|365131194|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
105857886|NCT01739348|365131195|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
105857887|NCT01739348|365131196|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
105857888|NCT01739348|365131193|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
105857889|NCT01739348|365131194|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
105857890|NCT01739348|365131195|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
105857891|NCT01739348|365131196|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
105857892|NCT01739348|365131193|FG000|Part II (Extension Study)|Physician Decision|7|||
105857893|NCT01739348|365131194|FG001|Part II (Extension Study)|Physician Decision|11|||
105857894|NCT01739348|365131195|FG002|Part II (Extension Study)|Physician Decision|6|||
105857895|NCT01739348|365131196|FG003|Part II (Extension Study)|Physician Decision|12|||
105857896|NCT01739348|365131193|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
105857897|NCT01739348|365131194|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
105857898|NCT01739348|365131195|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
105857899|NCT01739348|365131196|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
105857900|NCT01739348|365131193|FG000|Part II (Extension Study)|Participant Moved|3|||
105857901|NCT01739348|365131194|FG001|Part II (Extension Study)|Participant Moved|3|||
105857902|NCT01739348|365131195|FG002|Part II (Extension Study)|Participant Moved|0|||
105857903|NCT01739348|365131196|FG003|Part II (Extension Study)|Participant Moved|3|||
105857904|NCT01739348|365131193|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
105857905|NCT01739348|365131194|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
105857906|NCT01739348|365131195|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
105857907|NCT01739348|365131196|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
105857908|NCT01739348|365131193|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
105857909|NCT01739348|365131194|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
105857910|NCT01739348|365131195|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
105857911|NCT01739348|365131196|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
105857912|NCT01268501|365131197|FG000|Overall Study|Lost to Follow-up|1|||
105857913|NCT01268501|365131197|FG000|Overall Study|Withdrawal by Subject|3|||
105857914|NCT01268501|365131197|FG000|Overall Study|Unacceptable Subjective Vision|3|||
105857915|NCT01268501|365131197|FG000|Overall Study|Handling Difficulties|2|||
105857916|NCT01140503|365131198|FG000|Overall Study|Withdrawal by Subject|1|||
105857917|NCT04453202|365131199|FG000|Overall Study|Adverse Event|0|||
105857918|NCT04453202|365131200|FG001|Overall Study|Adverse Event|0|||
105857919|NCT04453202|365131201|FG002|Overall Study|Adverse Event|0|||
105857920|NCT04453202|365131202|FG003|Overall Study|Adverse Event|0|||
105857921|NCT04453202|365131203|FG004|Overall Study|Adverse Event|0|||
106036655|NCT01074047|365798356|FG000|Survival Follow-Up Phase|Death|116|||
106036656|NCT01074047|365798357|FG001|Survival Follow-Up Phase|Death|124|||
106036657|NCT01074047|365798356|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
106036658|NCT01074047|365798357|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
106036659|NCT01074047|365798356|FG000|Extension Phase|Physician Decision|1|||
106036660|NCT01074047|365798357|FG001|Extension Phase|Physician Decision|0|||
106036661|NCT01074047|365798356|FG000|Extension Phase|Adverse Event|5|||
106036662|NCT01074047|365798357|FG001|Extension Phase|Adverse Event|0|||
106036663|NCT01074047|365798356|FG000|Extension Phase|Disease Progression|9|||
106036664|NCT01074047|365798357|FG001|Extension Phase|Disease Progression|0|||
106036665|NCT01074047|365798356|FG000|Extension Phase|Withdrawal by Subject|2|||
106036666|NCT01074047|365798357|FG001|Extension Phase|Withdrawal by Subject|0|||
106036667|NCT01074047|365798356|FG000|Extension Phase|Death|5|||
106036668|NCT01074047|365798357|FG001|Extension Phase|Death|0|||
106036669|NCT04340063|365798358|FG000|Overall Study|Withdrawal by Subject|1|||
106036670|NCT04340063|365798359|FG001|Overall Study|Withdrawal by Subject|2|||
106036671|NCT04340063|365798358|FG000|Overall Study|Lost to Follow-up|3|||
106036672|NCT04340063|365798359|FG001|Overall Study|Lost to Follow-up|1|||
106036673|NCT04340063|365798358|FG000|Overall Study|Protocol Violation|0|||
106036674|NCT04340063|365798359|FG001|Overall Study|Protocol Violation|1|||
106036675|NCT01857583|365798362|FG000|Overall Study|Adverse Event|0|||
106036676|NCT01857583|365798363|FG001|Overall Study|Adverse Event|0|||
106036677|NCT01857583|365798364|FG002|Overall Study|Adverse Event|1|||
106036678|NCT01857583|365798365|FG003|Overall Study|Adverse Event|1|||
106036679|NCT01857583|365798362|FG000|Overall Study|Death|0|||
106036680|NCT01857583|365798363|FG001|Overall Study|Death|1|||
106036681|NCT01857583|365798364|FG002|Overall Study|Death|1|||
106036682|NCT01857583|365798365|FG003|Overall Study|Death|0|||
106036683|NCT01857583|365798362|FG000|Overall Study|Physician Decision|0|||
106036684|NCT01857583|365798363|FG001|Overall Study|Physician Decision|0|||
106036685|NCT01857583|365798364|FG002|Overall Study|Physician Decision|0|||
106036686|NCT01857583|365798365|FG003|Overall Study|Physician Decision|1|||
106036687|NCT01857583|365798362|FG000|Overall Study|Withdrawal by Subject|1|||
106036688|NCT01857583|365798363|FG001|Overall Study|Withdrawal by Subject|0|||
106036689|NCT01857583|365798364|FG002|Overall Study|Withdrawal by Subject|1|||
106036690|NCT01857583|365798365|FG003|Overall Study|Withdrawal by Subject|2|||
106036691|NCT02211638|365798366|FG000|Overall Study|Case Report Forms Uncollected|291|||
106036692|NCT02211638|365798366|FG000|Overall Study|Protocol Violation|692|||
106036693|NCT02782923|365798367|FG000|Overall Study|Lost to Follow-up|15|||
106036694|NCT03287635|365798369|FG000|Overall Study|Lost to Follow-up|5|||
106036695|NCT03287635|365798369|FG000|Overall Study|Withdrawal by Subject|1|||
106036696|NCT03287635|365798369|FG000|Overall Study|Physician Decision|1|||
106036697|NCT00323869|365798372|FG000|Overall Study|Death|1|||
106036698|NCT02233946|365800223|FG000|Baseline|Withdrawal by Subject|2|||
106036699|NCT02233946|365800224|FG001|Baseline|Withdrawal by Subject|0|||
106036700|NCT02233946|365800223|FG000|3-months Follow-up|Lost to Follow-up|53|||
106036701|NCT02233946|365800224|FG001|3-months Follow-up|Lost to Follow-up|29|||
106036702|NCT02233946|365800223|FG000|6-months Follow-up|Lost to Follow-up|21|||
106036703|NCT02233946|365800224|FG001|6-months Follow-up|Lost to Follow-up|2|||
106036704|NCT02233946|365800223|FG000|9-month Follow-up|Lost to Follow-up|20|||
106036705|NCT02233946|365800224|FG001|9-month Follow-up|Lost to Follow-up|11|||
106036706|NCT02233946|365800223|FG000|12-month Follow-up|Lost to Follow-up|28|||
106036707|NCT02233946|365800224|FG001|12-month Follow-up|Lost to Follow-up|11|||
106036708|NCT01314911|365800228|FG000|Overall Study|Lost to Follow-up|3|||
106036709|NCT01314911|365800229|FG001|Overall Study|Lost to Follow-up|2|||
106036710|NCT01314911|365800228|FG000|Overall Study|Withdrawal by Subject|1|||
106036711|NCT01314911|365800229|FG001|Overall Study|Withdrawal by Subject|3|||
106036712|NCT01314911|365800228|FG000|Overall Study|Received Non-randomized Study Drug|0|||
106036713|NCT01314911|365800229|FG001|Overall Study|Received Non-randomized Study Drug|1|||
106036714|NCT01314911|365800228|FG000|Overall Study|Never Started Treatment|1|||
106036715|NCT01314911|365800229|FG001|Overall Study|Never Started Treatment|0|||
106036716|NCT03387150|365800233|FG000|Overall Study|Withdrawal by Subject|3|||
106036717|NCT03387150|365800234|FG001|Overall Study|Withdrawal by Subject|0|||
106036718|NCT03387150|365800235|FG002|Overall Study|Withdrawal by Subject|3|||
106036719|NCT03387150|365800236|FG003|Overall Study|Withdrawal by Subject|4|||
106036720|NCT03387150|365800237|FG004|Overall Study|Withdrawal by Subject|1|||
106036721|NCT03387150|365800238|FG005|Overall Study|Withdrawal by Subject|2|||
106036722|NCT03387150|365800239|FG006|Overall Study|Withdrawal by Subject|0|||
106036723|NCT03387150|365800233|FG000|Overall Study|Lost to Follow-up|3|||
106036724|NCT03387150|365800234|FG001|Overall Study|Lost to Follow-up|2|||
106036725|NCT03387150|365800235|FG002|Overall Study|Lost to Follow-up|2|||
106036726|NCT03387150|365800236|FG003|Overall Study|Lost to Follow-up|3|||
106036727|NCT03387150|365800237|FG004|Overall Study|Lost to Follow-up|3|||
106036728|NCT03387150|365800238|FG005|Overall Study|Lost to Follow-up|3|||
106036729|NCT03387150|365800239|FG006|Overall Study|Lost to Follow-up|0|||
106036730|NCT03387150|365800233|FG000|Overall Study|Participant unable to adhere to visit|0|||
106036731|NCT03387150|365800234|FG001|Overall Study|Participant unable to adhere to visit|1|||
106036732|NCT03387150|365800235|FG002|Overall Study|Participant unable to adhere to visit|0|||
106036733|NCT03387150|365800236|FG003|Overall Study|Participant unable to adhere to visit|0|||
106036734|NCT03387150|365800237|FG004|Overall Study|Participant unable to adhere to visit|2|||
106036735|NCT03387150|365800238|FG005|Overall Study|Participant unable to adhere to visit|2|||
106036736|NCT03387150|365800239|FG006|Overall Study|Participant unable to adhere to visit|0|||
106036737|NCT00719264|365800240|FG000|Overall Study|Adverse Event|41|||
106036738|NCT00719264|365800241|FG001|Overall Study|Adverse Event|49|||
106036739|NCT00719264|365800240|FG000|Overall Study|Death|13|||
106036740|NCT00719264|365800241|FG001|Overall Study|Death|10|||
105857922|NCT04453202|365131204|FG005|Overall Study|Adverse Event|0|||
105857923|NCT04453202|365131205|FG006|Overall Study|Adverse Event|1|||
105857924|NCT04453202|365131206|FG007|Overall Study|Adverse Event|0|||
105857925|NCT04453202|365131207|FG008|Overall Study|Adverse Event|0|||
105857926|NCT04453202|365131208|FG009|Overall Study|Adverse Event|0|||
105857927|NCT04453202|365131209|FG010|Overall Study|Adverse Event|0|||
105857928|NCT04453202|365131199|FG000|Overall Study|Death|0|||
105857929|NCT04453202|365131200|FG001|Overall Study|Death|0|||
105857930|NCT04453202|365131201|FG002|Overall Study|Death|0|||
105857931|NCT04453202|365131202|FG003|Overall Study|Death|0|||
105857932|NCT04453202|365131203|FG004|Overall Study|Death|0|||
105857933|NCT04453202|365131204|FG005|Overall Study|Death|0|||
105857934|NCT04453202|365131205|FG006|Overall Study|Death|0|||
105857935|NCT04453202|365131206|FG007|Overall Study|Death|0|||
105857936|NCT04453202|365131207|FG008|Overall Study|Death|0|||
105857937|NCT04453202|365131208|FG009|Overall Study|Death|1|||
105857938|NCT04453202|365131209|FG010|Overall Study|Death|0|||
105857939|NCT04453202|365131199|FG000|Overall Study|Lost to Follow-up|0|||
105857940|NCT04453202|365131200|FG001|Overall Study|Lost to Follow-up|1|||
105857941|NCT04453202|365131201|FG002|Overall Study|Lost to Follow-up|0|||
105857942|NCT04453202|365131202|FG003|Overall Study|Lost to Follow-up|1|||
105857943|NCT04453202|365131203|FG004|Overall Study|Lost to Follow-up|0|||
105857944|NCT04453202|365131204|FG005|Overall Study|Lost to Follow-up|0|||
105857945|NCT04453202|365131205|FG006|Overall Study|Lost to Follow-up|0|||
105857946|NCT04453202|365131206|FG007|Overall Study|Lost to Follow-up|0|||
105857947|NCT04453202|365131207|FG008|Overall Study|Lost to Follow-up|0|||
105857948|NCT04453202|365131208|FG009|Overall Study|Lost to Follow-up|1|||
105857949|NCT04453202|365131209|FG010|Overall Study|Lost to Follow-up|1|||
105857950|NCT04453202|365131199|FG000|Overall Study|Withdrawal by Subject|1|||
105857951|NCT04453202|365131200|FG001|Overall Study|Withdrawal by Subject|2|||
105857952|NCT04453202|365131201|FG002|Overall Study|Withdrawal by Subject|1|||
105857953|NCT04453202|365131202|FG003|Overall Study|Withdrawal by Subject|2|||
105857954|NCT04453202|365131203|FG004|Overall Study|Withdrawal by Subject|1|||
105857955|NCT04453202|365131204|FG005|Overall Study|Withdrawal by Subject|1|||
105857956|NCT04453202|365131205|FG006|Overall Study|Withdrawal by Subject|0|||
105857957|NCT04453202|365131206|FG007|Overall Study|Withdrawal by Subject|0|||
105857958|NCT04453202|365131207|FG008|Overall Study|Withdrawal by Subject|0|||
105857959|NCT04453202|365131208|FG009|Overall Study|Withdrawal by Subject|1|||
105857960|NCT04453202|365131209|FG010|Overall Study|Withdrawal by Subject|0|||
105857961|NCT04453202|365131199|FG000|Overall Study|Adverse Event|0|||
105857962|NCT04453202|365131200|FG001|Overall Study|Adverse Event|0|||
105857963|NCT04453202|365131201|FG002|Overall Study|Adverse Event|0|||
105857964|NCT04453202|365131202|FG003|Overall Study|Adverse Event|0|||
105857965|NCT04453202|365131203|FG004|Overall Study|Adverse Event|0|||
105857966|NCT04453202|365131204|FG005|Overall Study|Adverse Event|1|||
105857967|NCT04453202|365131205|FG006|Overall Study|Adverse Event|0|||
105857968|NCT04453202|365131206|FG007|Overall Study|Adverse Event|0|||
105857969|NCT04453202|365131207|FG008|Overall Study|Adverse Event|0|||
105857970|NCT04453202|365131208|FG009|Overall Study|Adverse Event|0|||
105857971|NCT04453202|365131209|FG010|Overall Study|Adverse Event|0|||
105857972|NCT02288182|365131212|FG000|Overall Study|Adverse Event|0|||
105857973|NCT02288182|365131213|FG001|Overall Study|Adverse Event|1|||
105857974|NCT02288182|365131212|FG000|Overall Study|Lost to Follow-up|0|||
105857975|NCT02288182|365131213|FG001|Overall Study|Lost to Follow-up|1|||
105857976|NCT02823652|365131214|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
105857977|NCT02823652|365131215|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
105857978|NCT02823652|365131216|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
105857979|NCT02823652|365131214|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
105857980|NCT02823652|365131215|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
105857981|NCT02823652|365131216|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
105857982|NCT02823652|365131214|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
105857983|NCT02823652|365131215|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
105857984|NCT02823652|365131216|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
105857985|NCT02823652|365131214|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
105857986|NCT02823652|365131215|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
105857987|NCT02823652|365131216|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
105857988|NCT03567382|365131225|FG000|Overall Study|Lost to Follow-up|1|||
105857989|NCT03567382|365131226|FG001|Overall Study|Lost to Follow-up|21|||
105857990|NCT03567382|365131227|FG002|Overall Study|Lost to Follow-up|1|||
105857991|NCT03567382|365131228|FG003|Overall Study|Lost to Follow-up|21|||
105857992|NCT03567382|365131225|FG000|Overall Study|Withdrawal by Subject|2|||
105857993|NCT03567382|365131226|FG001|Overall Study|Withdrawal by Subject|14|||
105857994|NCT03567382|365131227|FG002|Overall Study|Withdrawal by Subject|1|||
105857995|NCT03567382|365131228|FG003|Overall Study|Withdrawal by Subject|12|||
105857996|NCT01197755|365131231|FG000|Overall Study|Adverse Event|8|||
105857997|NCT01197755|365131232|FG001|Overall Study|Adverse Event|10|||
105857998|NCT01197755|365131233|FG002|Overall Study|Adverse Event|10|||
105857999|NCT01197755|365131231|FG000|Overall Study|Study-specific discontinuation criteria|2|||
105858000|NCT01197755|365131232|FG001|Overall Study|Study-specific discontinuation criteria|1|||
105858001|NCT01197755|365131233|FG002|Overall Study|Study-specific discontinuation criteria|0|||
105858002|NCT01197755|365131231|FG000|Overall Study|Entered the long-term extension study|18|||
105858003|NCT01197755|365131232|FG001|Overall Study|Entered the long-term extension study|21|||
105858004|NCT01197755|365131233|FG002|Overall Study|Entered the long-term extension study|35|||
105858005|NCT01197755|365131231|FG000|Overall Study|Lack of therapeutic response|0|||
105858006|NCT01197755|365131232|FG001|Overall Study|Lack of therapeutic response|7|||
105858007|NCT01197755|365131233|FG002|Overall Study|Lack of therapeutic response|4|||
105858008|NCT01197755|365131231|FG000|Overall Study|Severe non-compliance to the protocol|2|||
105858009|NCT01197755|365131232|FG001|Overall Study|Severe non-compliance to the protocol|1|||
105858010|NCT01197755|365131233|FG002|Overall Study|Severe non-compliance to the protocol|2|||
105858011|NCT01197755|365131231|FG000|Overall Study|Withdrawal by Subject|1|||
105858012|NCT01197755|365131232|FG001|Overall Study|Withdrawal by Subject|0|||
105858013|NCT01197755|365131233|FG002|Overall Study|Withdrawal by Subject|0|||
105858014|NCT01197755|365131231|FG000|Overall Study|Lost to Follow-up|0|||
105858015|NCT01197755|365131232|FG001|Overall Study|Lost to Follow-up|0|||
105858016|NCT01197755|365131233|FG002|Overall Study|Lost to Follow-up|1|||
105858017|NCT01197755|365131231|FG000|Overall Study|eg, change in circumstances|7|||
105858018|NCT01197755|365131232|FG001|Overall Study|eg, change in circumstances|3|||
105858019|NCT01197755|365131233|FG002|Overall Study|eg, change in circumstances|2|||
105858020|NCT02056392|365131237|FG000|Overall Study|Lost to Follow-up|0|||
105858021|NCT02056392|365131238|FG001|Overall Study|Lost to Follow-up|1|||
105858022|NCT02056392|365131239|FG002|Overall Study|Lost to Follow-up|2|||
105858023|NCT02056392|365131240|FG003|Overall Study|Lost to Follow-up|0|||
105858024|NCT02056392|365131241|FG004|Overall Study|Lost to Follow-up|0|||
105858025|NCT02056392|365131242|FG005|Overall Study|Lost to Follow-up|0|||
105858026|NCT02056392|365131237|FG000|Overall Study|Protocol Violation|1|||
105858027|NCT02056392|365131238|FG001|Overall Study|Protocol Violation|0|||
105858028|NCT02056392|365131239|FG002|Overall Study|Protocol Violation|1|||
105858029|NCT02056392|365131240|FG003|Overall Study|Protocol Violation|0|||
105858030|NCT02056392|365131241|FG004|Overall Study|Protocol Violation|0|||
105858031|NCT02056392|365131242|FG005|Overall Study|Protocol Violation|0|||
105858032|NCT02056392|365131237|FG000|Overall Study|Withdrawal by Subject|1|||
105858033|NCT02056392|365131238|FG001|Overall Study|Withdrawal by Subject|0|||
105858034|NCT02056392|365131239|FG002|Overall Study|Withdrawal by Subject|0|||
105858035|NCT02056392|365131240|FG003|Overall Study|Withdrawal by Subject|0|||
105858036|NCT02056392|365131241|FG004|Overall Study|Withdrawal by Subject|1|||
105858037|NCT02056392|365131242|FG005|Overall Study|Withdrawal by Subject|0|||
105858038|NCT00761865|365131245|FG000|Overall Study|Lost to Follow-up|8|||
105858039|NCT00761865|365131246|FG001|Overall Study|Lost to Follow-up|7|||
105858040|NCT00574912|365131247|FG000|Overall Study|Could not place IV lines.|3|||
105858041|NCT00574912|365131247|FG000|Overall Study|scheduling conflicts|3|||
105858042|NCT00574912|365131247|FG000|Overall Study|Physician Decision|2|||
105858043|NCT00968799|365131255|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
105858044|NCT04730349|365131260|FG000|Overall Study|Participant withdrew consent|1|||
105858045|NCT04730349|365131261|FG001|Overall Study|Participant withdrew consent|0|||
105858046|NCT04730349|365131260|FG000|Overall Study|Disease progression|6|||
105858047|NCT04730349|365131261|FG001|Overall Study|Disease progression|4|||
105858048|NCT04730349|365131260|FG000|Overall Study|Study drug toxicity|0|||
105858049|NCT04730349|365131261|FG001|Overall Study|Study drug toxicity|1|||
105858050|NCT00638027|365131264|FG000|Overall Study|Adverse Event|0|||
105858051|NCT00638027|365131265|FG001|Overall Study|Adverse Event|2|||
105858052|NCT00371397|365131266|FG000|Session 1|Withdrawal by Subject|1|||
106036741|NCT00719264|365800240|FG000|Overall Study|Administrative Problems|6|||
106036742|NCT00719264|365800241|FG001|Overall Study|Administrative Problems|4|||
106036743|NCT00719264|365800240|FG000|Overall Study|Lost to Follow-up|1|||
106036744|NCT00719264|365800241|FG001|Overall Study|Lost to Follow-up|1|||
106036745|NCT00719264|365800240|FG000|Overall Study|Withdrawal by Subject|12|||
106036746|NCT00719264|365800241|FG001|Overall Study|Withdrawal by Subject|7|||
106036747|NCT00719264|365800240|FG000|Overall Study|Protocol Deviation|1|||
106036748|NCT00719264|365800241|FG001|Overall Study|Protocol Deviation|3|||
106036749|NCT00719264|365800240|FG000|Overall Study|New Cancer Therapy|4|||
105858053|NCT00371397|365131267|FG001|Session 1|Withdrawal by Subject|0|||
105858054|NCT00371397|365131268|FG002|Session 1|Withdrawal by Subject|0|||
106036750|NCT00719264|365800241|FG001|Overall Study|New Cancer Therapy|2|||
106036751|NCT00719264|365800240|FG000|Overall Study|Disease Progression|104|||
106036752|NCT00719264|365800241|FG001|Overall Study|Disease Progression|107|||
105858055|NCT00371397|365131269|FG003|Session 1|Withdrawal by Subject|0|||
105858056|NCT00371397|365131270|FG004|Session 1|Withdrawal by Subject|0|||
105858057|NCT00371397|365131271|FG005|Session 1|Withdrawal by Subject|0|||
105858058|NCT00371397|365131272|FG006|Session 1|Withdrawal by Subject|0|||
105858059|NCT00371397|365131273|FG007|Session 1|Withdrawal by Subject|1|||
105858060|NCT00371397|365131274|FG008|Session 1|Withdrawal by Subject|0|||
105858061|NCT00371397|365131275|FG009|Session 1|Withdrawal by Subject|0|||
105858062|NCT00371397|365131276|FG010|Session 1|Withdrawal by Subject|0|||
105858063|NCT00371397|365131277|FG011|Session 1|Withdrawal by Subject|0|||
106036753|NCT00814879|365800242|FG000|By Week 24|Cancer Diagnosis|1|||
106036754|NCT00814879|365800243|FG001|By Week 24|Cancer Diagnosis|0|||
106036755|NCT00814879|365800242|FG000|By Week 24|Incarceration|0|||
106036756|NCT00814879|365800243|FG001|By Week 24|Incarceration|1|||
106036757|NCT00814879|365800242|FG000|By Week 48|Lost to Follow-up|2|||
106036758|NCT00814879|365800243|FG001|By Week 48|Lost to Follow-up|2|||
106036759|NCT00814879|365800242|FG000|By Week 48|Death|0|||
106036760|NCT00814879|365800243|FG001|By Week 48|Death|1|||
106036761|NCT01461057|365800244|FG000|Overall Study|Death|10|||
106036762|NCT01461057|365800245|FG001|Overall Study|Death|9|||
106036763|NCT01461057|365800244|FG000|Overall Study|Withdrawal by Subject|2|||
106036764|NCT01461057|365800245|FG001|Overall Study|Withdrawal by Subject|3|||
106036765|NCT01461057|365800244|FG000|Overall Study|Physician Decision|0|||
106036766|NCT01461057|365800245|FG001|Overall Study|Physician Decision|2|||
106036767|NCT01461057|365800244|FG000|Overall Study|Adverse Event|0|||
106036768|NCT01461057|365800245|FG001|Overall Study|Adverse Event|1|||
106036769|NCT01461057|365800244|FG000|Overall Study|Progression of Disease|1|||
106036770|NCT01461057|365800245|FG001|Overall Study|Progression of Disease|0|||
106036771|NCT01461057|365800244|FG000|Overall Study|Study Terminated by Sponsor|2|||
106036772|NCT01461057|365800245|FG001|Overall Study|Study Terminated by Sponsor|0|||
106036773|NCT01275339|365800246|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
106036774|NCT01275339|365800247|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
106036775|NCT01275339|365800248|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
106036776|NCT01275339|365800249|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
106036777|NCT01275339|365800246|FG000|Overall Study|Withdrawal by Subject|0|||
106036778|NCT01275339|365800247|FG001|Overall Study|Withdrawal by Subject|0|||
106036779|NCT01275339|365800248|FG002|Overall Study|Withdrawal by Subject|1|||
106036780|NCT01275339|365800249|FG003|Overall Study|Withdrawal by Subject|0|||
106036781|NCT05523323|365800250|FG000|Overall Study|Death|26|||
106036782|NCT05523323|365800251|FG001|Overall Study|Death|21|||
106036783|NCT05523323|365800250|FG000|Overall Study|Ongoing participants|35|||
106036784|NCT05523323|365800251|FG001|Overall Study|Ongoing participants|30|||
106036785|NCT01606254|365800254|FG000|Overall Study|Withdrawal by Subject|1|||
106036786|NCT01606254|365800255|FG001|Overall Study|Withdrawal by Subject|3|||
106036787|NCT01606254|365800256|FG002|Overall Study|Withdrawal by Subject|0|||
106036788|NCT01606254|365800257|FG003|Overall Study|Withdrawal by Subject|2|||
106036789|NCT01606254|365800254|FG000|Overall Study|Adverse Event|1|||
106036790|NCT01606254|365800255|FG001|Overall Study|Adverse Event|1|||
106036791|NCT01606254|365800256|FG002|Overall Study|Adverse Event|0|||
106036792|NCT01606254|365800257|FG003|Overall Study|Adverse Event|1|||
106036793|NCT02011893|365800259|FG000|Enrollment to Randomization|Adverse Event|2|||
106036794|NCT02011893|365800260|FG001|Enrollment to Randomization|Adverse Event|0|||
106036795|NCT02011893|365800261|FG002|Enrollment to Randomization|Adverse Event|0|||
106036796|NCT02011893|365800259|FG000|Enrollment to Randomization|Physician Decision|10|||
106036797|NCT02011893|365800260|FG001|Enrollment to Randomization|Physician Decision|0|||
106036798|NCT02011893|365800261|FG002|Enrollment to Randomization|Physician Decision|0|||
106036799|NCT02011893|365800259|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
106036800|NCT02011893|365800260|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
106036801|NCT02011893|365800261|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
106036802|NCT02011893|365800259|FG000|Enrollment to Randomization|Screening Failure|29|||
106036803|NCT02011893|365800260|FG001|Enrollment to Randomization|Screening Failure|0|||
106036804|NCT02011893|365800261|FG002|Enrollment to Randomization|Screening Failure|0|||
106036805|NCT02011893|365800259|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
106036806|NCT02011893|365800260|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
106036807|NCT02011893|365800261|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
106036808|NCT02011893|365800259|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
106036809|NCT02011893|365800260|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
106036810|NCT02011893|365800261|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
106036811|NCT02011893|365800259|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
106036812|NCT02011893|365800260|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
106036813|NCT02011893|365800261|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
105858064|NCT03014180|365131278|FG000|Overall Study|Protocol Violation|2|||
105858065|NCT01284621|365131279|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105858066|NCT01284621|365131280|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
106036814|NCT02011893|365800259|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
106036815|NCT02011893|365800260|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
106036816|NCT02011893|365800261|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
106036817|NCT02011893|365800259|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
106036818|NCT02011893|365800260|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
106036819|NCT02011893|365800261|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
105858067|NCT01284621|365131281|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105858068|NCT01284621|365131282|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105858069|NCT01284621|365131283|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
106036820|NCT02131532|365800262|FG000|Overall Study|Withdrawal by Subject|1|||
106036821|NCT02131532|365800262|FG000|Overall Study|Physician Decision|1|||
106036822|NCT02131532|365800262|FG000|Overall Study|Other health conditions|2|||
106036823|NCT01466595|365800266|FG000|Overall Study|Withdrawal by Subject|0|||
106036824|NCT01466595|365800267|FG001|Overall Study|Withdrawal by Subject|1|||
106036825|NCT03418571|365800268|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
106036826|NCT03418571|365800269|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
106036827|NCT02964507|365800270|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
106036828|NCT02964507|365800271|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
106036829|NCT02964507|365800272|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
106036830|NCT02964507|365800273|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
106036831|NCT02964507|365800274|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
106036832|NCT02964507|365800275|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
106036833|NCT02964507|365800276|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
106036834|NCT02964507|365800277|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
106036835|NCT02964507|365800270|FG000|Overall Study|Study terminated by Sponsor|9|||
106036836|NCT02964507|365800271|FG001|Overall Study|Study terminated by Sponsor|1|||
106036837|NCT02964507|365800272|FG002|Overall Study|Study terminated by Sponsor|9|||
106036838|NCT02964507|365800273|FG003|Overall Study|Study terminated by Sponsor|3|||
106036839|NCT02964507|365800274|FG004|Overall Study|Study terminated by Sponsor|3|||
106036840|NCT02964507|365800275|FG005|Overall Study|Study terminated by Sponsor|2|||
106036841|NCT02964507|365800276|FG006|Overall Study|Study terminated by Sponsor|0|||
106036842|NCT02964507|365800277|FG007|Overall Study|Study terminated by Sponsor|0|||
106036843|NCT02964507|365800270|FG000|Overall Study|Other|3|||
106036844|NCT02964507|365800271|FG001|Overall Study|Other|0|||
106036845|NCT02964507|365800272|FG002|Overall Study|Other|0|||
106036846|NCT02964507|365800273|FG003|Overall Study|Other|0|||
106036847|NCT02964507|365800274|FG004|Overall Study|Other|1|||
106036848|NCT02964507|365800275|FG005|Overall Study|Other|0|||
106036849|NCT02964507|365800276|FG006|Overall Study|Other|0|||
106036850|NCT02964507|365800277|FG007|Overall Study|Other|0|||
105858070|NCT01284621|365131284|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
105858071|NCT02802631|365131287|FG000|Overall Study|Withdrawal by Subject|1|||
105858072|NCT02802631|365131288|FG001|Overall Study|Withdrawal by Subject|0|||
105858073|NCT02802631|365131289|FG002|Overall Study|Withdrawal by Subject|0|||
105858074|NCT02802631|365131290|FG003|Overall Study|Withdrawal by Subject|0|||
105858075|NCT02802631|365131291|FG004|Overall Study|Withdrawal by Subject|0|||
105858076|NCT02802631|365131292|FG005|Overall Study|Withdrawal by Subject|0|||
105858077|NCT02802631|365131293|FG006|Overall Study|Withdrawal by Subject|0|||
105858078|NCT02802631|365131294|FG007|Overall Study|Withdrawal by Subject|0|||
105858079|NCT02802631|365131287|FG000|Overall Study|Physician Decision|1|||
105858080|NCT02802631|365131288|FG001|Overall Study|Physician Decision|0|||
105858081|NCT02802631|365131289|FG002|Overall Study|Physician Decision|0|||
105858082|NCT02802631|365131290|FG003|Overall Study|Physician Decision|0|||
105858083|NCT02802631|365131291|FG004|Overall Study|Physician Decision|0|||
105858084|NCT02802631|365131292|FG005|Overall Study|Physician Decision|0|||
105858085|NCT02802631|365131293|FG006|Overall Study|Physician Decision|1|||
105858086|NCT02802631|365131294|FG007|Overall Study|Physician Decision|0|||
105858087|NCT02802631|365131287|FG000|Overall Study|Adverse Event|0|||
105858088|NCT02802631|365131288|FG001|Overall Study|Adverse Event|2|||
105858089|NCT02802631|365131289|FG002|Overall Study|Adverse Event|0|||
105858090|NCT02802631|365131290|FG003|Overall Study|Adverse Event|1|||
105858091|NCT02802631|365131291|FG004|Overall Study|Adverse Event|6|||
105858092|NCT02802631|365131292|FG005|Overall Study|Adverse Event|1|||
105858093|NCT02802631|365131293|FG006|Overall Study|Adverse Event|4|||
105858094|NCT02802631|365131294|FG007|Overall Study|Adverse Event|0|||
105858095|NCT02802631|365131287|FG000|Overall Study|Sponsor Decision|0|||
105858096|NCT02802631|365131288|FG001|Overall Study|Sponsor Decision|0|||
105858097|NCT02802631|365131289|FG002|Overall Study|Sponsor Decision|6|||
106036851|NCT02964507|365800270|FG000|Overall Study|Death|11|||
106036852|NCT02964507|365800271|FG001|Overall Study|Death|9|||
106036853|NCT02964507|365800272|FG002|Overall Study|Death|12|||
106036854|NCT02964507|365800273|FG003|Overall Study|Death|2|||
106036855|NCT02964507|365800274|FG004|Overall Study|Death|10|||
106036856|NCT02964507|365800275|FG005|Overall Study|Death|5|||
106036857|NCT02964507|365800276|FG006|Overall Study|Death|0|||
106036858|NCT02964507|365800277|FG007|Overall Study|Death|0|||
106036859|NCT02964507|365800270|FG000|Overall Study|Withdrawal by Subject|1|||
106036860|NCT02964507|365800271|FG001|Overall Study|Withdrawal by Subject|0|||
105858098|NCT02802631|365131290|FG003|Overall Study|Sponsor Decision|0|||
105858099|NCT02802631|365131291|FG004|Overall Study|Sponsor Decision|2|||
105858100|NCT02802631|365131292|FG005|Overall Study|Sponsor Decision|0|||
105858101|NCT02802631|365131293|FG006|Overall Study|Sponsor Decision|0|||
105858102|NCT02802631|365131294|FG007|Overall Study|Sponsor Decision|4|||
105858103|NCT02377427|365131295|FG000|Part A (Up to Week 20)|Physician Decision|1|||
105858104|NCT02377427|365131296|FG001|Part A (Up to Week 20)|Physician Decision|0|||
105858105|NCT02377427|365131297|FG002|Part A (Up to Week 20)|Physician Decision|0|||
106036861|NCT02964507|365800272|FG002|Overall Study|Withdrawal by Subject|1|||
106036862|NCT02964507|365800273|FG003|Overall Study|Withdrawal by Subject|1|||
106036863|NCT02964507|365800274|FG004|Overall Study|Withdrawal by Subject|0|||
106036864|NCT02964507|365800275|FG005|Overall Study|Withdrawal by Subject|1|||
106036865|NCT02964507|365800276|FG006|Overall Study|Withdrawal by Subject|0|||
106036866|NCT02964507|365800277|FG007|Overall Study|Withdrawal by Subject|0|||
106036867|NCT02964507|365800270|FG000|Overall Study|Physician Decision|2|||
106036868|NCT02964507|365800271|FG001|Overall Study|Physician Decision|0|||
106036869|NCT02964507|365800272|FG002|Overall Study|Physician Decision|3|||
106036870|NCT02964507|365800273|FG003|Overall Study|Physician Decision|0|||
106036871|NCT02964507|365800274|FG004|Overall Study|Physician Decision|1|||
106036872|NCT02964507|365800275|FG005|Overall Study|Physician Decision|0|||
106036873|NCT02964507|365800276|FG006|Overall Study|Physician Decision|0|||
106036874|NCT02964507|365800277|FG007|Overall Study|Physician Decision|0|||
106036875|NCT04341662|365800278|FG000|Overall Study|Did not have source-verified blood loss data|423|||
106036876|NCT04341662|365800279|FG001|Overall Study|Did not have source-verified blood loss data|514|||
106036877|NCT02398227|365800280|FG000|Overall Study|Lost to Follow-up|21|||
106036878|NCT02398227|365800281|FG001|Overall Study|Lost to Follow-up|12|||
106036879|NCT02398227|365800280|FG000|Overall Study|Withdrawal by Subject|5|||
106036880|NCT02398227|365800281|FG001|Overall Study|Withdrawal by Subject|6|||
106036881|NCT02398227|365800280|FG000|Overall Study|Removed from treatment and dropped out|1|||
106036882|NCT02398227|365800281|FG001|Overall Study|Removed from treatment and dropped out|0|||
106036883|NCT03189381|365800282|FG000|Overall Study|Death|1|||
106036884|NCT03189381|365800283|FG001|Overall Study|Death|0|||
106036885|NCT01401959|365800284|FG000|Enrolled|Withdrawal by Subject|1|||
106036886|NCT01401959|365800285|FG001|Enrolled|Withdrawal by Subject|0|||
106036887|NCT01401959|365800286|FG002|Enrolled|Withdrawal by Subject|0|||
106036888|NCT01401959|365800284|FG000|Treated|Disease Progression|2|||
106036889|NCT01401959|365800285|FG001|Treated|Disease Progression|2|||
106036890|NCT01401959|365800286|FG002|Treated|Disease Progression|1|||
106036891|NCT01401959|365800284|FG000|Treated|Adverse Event|4|||
106036892|NCT01401959|365800285|FG001|Treated|Adverse Event|3|||
106036893|NCT01401959|365800286|FG002|Treated|Adverse Event|2|||
106036894|NCT01401959|365800284|FG000|Treated|Withdrawal by Subject|1|||
106036895|NCT01401959|365800285|FG001|Treated|Withdrawal by Subject|2|||
106036896|NCT01401959|365800286|FG002|Treated|Withdrawal by Subject|2|||
106036897|NCT01401959|365800284|FG000|Treated|Protocol Violation|0|||
106036898|NCT01401959|365800285|FG001|Treated|Protocol Violation|1|||
106036899|NCT01401959|365800286|FG002|Treated|Protocol Violation|0|||
106036900|NCT00251004|365800287|FG000|Overall Study|Withdrawal by Subject|23|||
106036901|NCT00251004|365800288|FG001|Overall Study|Withdrawal by Subject|16|||
106036902|NCT00251004|365800289|FG002|Overall Study|Withdrawal by Subject|14|||
106036903|NCT00251004|365800287|FG000|Overall Study|Death|9|||
106036904|NCT00251004|365800288|FG001|Overall Study|Death|10|||
106036905|NCT00251004|365800289|FG002|Overall Study|Death|8|||
106036906|NCT00251004|365800287|FG000|Overall Study|Lost to Follow-up|1|||
106036907|NCT00251004|365800288|FG001|Overall Study|Lost to Follow-up|2|||
106036908|NCT00251004|365800289|FG002|Overall Study|Lost to Follow-up|1|||
106036909|NCT00251004|365800287|FG000|Overall Study|Graft Loss|12|||
106036910|NCT00251004|365800288|FG001|Overall Study|Graft Loss|13|||
106036911|NCT00251004|365800289|FG002|Overall Study|Graft Loss|8|||
106036912|NCT00887744|365800290|FG000|Overall Study|Adverse Event|3|||
106036913|NCT00887744|365800290|FG000|Overall Study|Death|1|||
106036914|NCT00887744|365800290|FG000|Overall Study|Lost to Follow-up|3|||
106036915|NCT00887744|365800290|FG000|Overall Study|Withdrawal by Subject|18|||
106036916|NCT00887744|365800290|FG000|Overall Study|Various reasons|9|||
106036917|NCT00450385|365800291|FG000|Overall Study|Death|3|||
106036918|NCT00450385|365800291|FG000|Overall Study|Protocol Violation|1|||
106036919|NCT00450385|365800291|FG000|Overall Study|Withdrawal by Subject|2|||
106036920|NCT00450385|365800291|FG000|Overall Study|Lack of Efficacy|2|||
106036921|NCT00450385|365800291|FG000|Overall Study|Adverse Event|1|||
106036922|NCT00450385|365800291|FG000|Overall Study|Physician Decision|1|||
106036923|NCT00450385|365800291|FG000|Overall Study|Other|3|||
106036924|NCT01244490|365800293|FG000|Overall Study|Lack of Efficacy|14|||
106036925|NCT01244490|365800294|FG001|Overall Study|Lack of Efficacy|5|||
106036926|NCT01244490|365800295|FG002|Overall Study|Lack of Efficacy|5|||
106036927|NCT01244490|365800293|FG000|Overall Study|Withdrawal by Subject|4|||
106036928|NCT01244490|365800294|FG001|Overall Study|Withdrawal by Subject|4|||
106036929|NCT01244490|365800295|FG002|Overall Study|Withdrawal by Subject|9|||
106036930|NCT01244490|365800293|FG000|Overall Study|Adverse Event|1|||
106036931|NCT01244490|365800294|FG001|Overall Study|Adverse Event|9|||
106036932|NCT01244490|365800295|FG002|Overall Study|Adverse Event|5|||
106036933|NCT01244490|365800293|FG000|Overall Study|Lost to Follow-up|0|||
106036934|NCT01244490|365800294|FG001|Overall Study|Lost to Follow-up|6|||
106036935|NCT01244490|365800295|FG002|Overall Study|Lost to Follow-up|3|||
106036936|NCT01244490|365800293|FG000|Overall Study|Other|0|||
106036937|NCT01244490|365800294|FG001|Overall Study|Other|0|||
106036938|NCT01244490|365800295|FG002|Overall Study|Other|1|||
106036939|NCT00245583|365800299|FG000|Overall Study|Lost to Follow-up|1|||
106036940|NCT00245583|365800300|FG001|Overall Study|Lost to Follow-up|5|||
106036941|NCT00245583|365800299|FG000|Overall Study|Adverse Event|2|||
105858106|NCT02377427|365131298|FG003|Part A (Up to Week 20)|Physician Decision|0|||
105858107|NCT02377427|365131299|FG004|Part A (Up to Week 20)|Physician Decision|0|||
105858108|NCT02377427|365131295|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
105858109|NCT02377427|365131296|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
105858110|NCT02377427|365131297|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
105858111|NCT02377427|365131298|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
105858112|NCT02377427|365131299|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
105858113|NCT02377427|365131295|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
105858114|NCT02377427|365131296|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
105858115|NCT02377427|365131297|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
105858116|NCT02377427|365131298|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
105858117|NCT02377427|365131299|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
105858118|NCT02377427|365131295|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
105858119|NCT02377427|365131296|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
105858120|NCT02377427|365131297|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
105858121|NCT02377427|365131298|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
105858122|NCT02377427|365131299|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
105858123|NCT02013674|365131300|FG000|Overall Study|Death|0|||
106036942|NCT00245583|365800300|FG001|Overall Study|Adverse Event|1|||
106036943|NCT00245583|365800299|FG000|Overall Study|Lack of Efficacy|1|||
106036944|NCT00245583|365800300|FG001|Overall Study|Lack of Efficacy|0|||
106036945|NCT00245583|365800299|FG000|Overall Study|Withdrawal by Subject|2|||
106036946|NCT00245583|365800300|FG001|Overall Study|Withdrawal by Subject|3|||
106036947|NCT00591578|365800302|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
106036948|NCT00591578|365800303|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
106036949|NCT00591578|365800304|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
106036950|NCT00591578|365800302|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
106036951|NCT00591578|365800303|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
106036952|NCT00591578|365800304|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
106036953|NCT00591578|365800302|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
106036954|NCT00591578|365800303|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
106036955|NCT00591578|365800304|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
106036956|NCT00591578|365800302|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
106036957|NCT00591578|365800303|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
106036958|NCT00591578|365800304|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
106036959|NCT00591578|365800302|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
106036960|NCT00591578|365800303|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
106036961|NCT00591578|365800304|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
106036962|NCT00591578|365800302|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
106036963|NCT00591578|365800303|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
106036964|NCT00591578|365800304|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
106036965|NCT00591578|365800302|FG000|Double-Blind Treatment Phase|Other|4|||
106036966|NCT00591578|365800303|FG001|Double-Blind Treatment Phase|Other|9|||
106036967|NCT00591578|365800304|FG002|Double-Blind Treatment Phase|Other|4|||
106036968|NCT00591578|365800302|FG000|Open-Label Extension Phase|Adverse Event|3|||
106036969|NCT00591578|365800303|FG001|Open-Label Extension Phase|Adverse Event|5|||
106036970|NCT00591578|365800304|FG002|Open-Label Extension Phase|Adverse Event|0|||
106036971|NCT00591578|365800302|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
106036972|NCT00591578|365800303|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
106036973|NCT00591578|365800304|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
106036974|NCT00591578|365800302|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
106036975|NCT00591578|365800303|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
106036976|NCT00591578|365800304|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
106036977|NCT00591578|365800302|FG000|Open-Label Extension Phase|Other|1|||
106036978|NCT00591578|365800303|FG001|Open-Label Extension Phase|Other|0|||
106036979|NCT00591578|365800304|FG002|Open-Label Extension Phase|Other|0|||
106036980|NCT03455764|365800305|FG000|Overall Study|Adverse Event|1|||
106036981|NCT03455764|365800306|FG001|Overall Study|Adverse Event|0|||
106036982|NCT03455764|365800307|FG002|Overall Study|Adverse Event|0|||
106036983|NCT03455764|365800308|FG003|Overall Study|Adverse Event|0|||
106036984|NCT03455764|365800309|FG004|Overall Study|Adverse Event|0|||
106036985|NCT03455764|365800305|FG000|Overall Study|Disease Progression|4|||
106036986|NCT03455764|365800306|FG001|Overall Study|Disease Progression|0|||
106036987|NCT03455764|365800307|FG002|Overall Study|Disease Progression|0|||
106036988|NCT03455764|365800308|FG003|Overall Study|Disease Progression|0|||
106036989|NCT03455764|365800309|FG004|Overall Study|Disease Progression|0|||
106036990|NCT03455764|365800305|FG000|Overall Study|On Treatment|1|||
106036991|NCT03455764|365800306|FG001|Overall Study|On Treatment|0|||
106036992|NCT03455764|365800307|FG002|Overall Study|On Treatment|0|||
106036993|NCT03455764|365800308|FG003|Overall Study|On Treatment|0|||
106036994|NCT03455764|365800309|FG004|Overall Study|On Treatment|0|||
106036995|NCT04706416|365800312|FG000|Overall Study|Lost to Follow-up|2|||
106036996|NCT04706416|365800313|FG001|Overall Study|Lost to Follow-up|0|||
106036997|NCT02021656|365800326|FG000|Overall Study|Adverse Event|1|||
105858124|NCT02013674|365131301|FG001|Overall Study|Death|1|||
105858125|NCT02013674|365131300|FG000|Overall Study|Lost to Follow-up|1|||
105858126|NCT02013674|365131301|FG001|Overall Study|Lost to Follow-up|0|||
105858127|NCT00416884|365131302|FG000|Overall Study|Study terminated due to low accrual|1|||
105858128|NCT00719849|365131303|FG000|Overall Study|Death|0|||
105858129|NCT00719849|365131304|FG001|Overall Study|Death|1|||
105858130|NCT02799095|365132737|FG000|Part A|Adverse Event|1|||
105858131|NCT02799095|365132738|FG001|Part A|Adverse Event|0|||
105858132|NCT02799095|365132739|FG002|Part A|Adverse Event|1|||
105858133|NCT02799095|365132740|FG003|Part A|Adverse Event|4|||
105858134|NCT02799095|365132741|FG004|Part A|Adverse Event|1|||
105858135|NCT02799095|365132742|FG005|Part A|Adverse Event|0|||
105858136|NCT02799095|365132743|FG006|Part A|Adverse Event|0|||
105858137|NCT02799095|365132744|FG007|Part A|Adverse Event|0|||
105858138|NCT02799095|365132745|FG008|Part A|Adverse Event|0|||
105858139|NCT02799095|365132746|FG009|Part A|Adverse Event|0|||
105858140|NCT02799095|365132747|FG010|Part A|Adverse Event|0|||
105858141|NCT02799095|365132748|FG011|Part A|Adverse Event|0|||
105858142|NCT02799095|365132749|FG012|Part A|Adverse Event|0|||
105858143|NCT02799095|365132750|FG013|Part A|Adverse Event|0|||
105858144|NCT02799095|365132751|FG014|Part A|Adverse Event|0|||
105858145|NCT02799095|365132752|FG015|Part A|Adverse Event|0|||
105858146|NCT02799095|365132753|FG016|Part A|Adverse Event|0|||
105858147|NCT02799095|365132737|FG000|Part A|Death|0|||
105858148|NCT02799095|365132738|FG001|Part A|Death|0|||
105858149|NCT02799095|365132739|FG002|Part A|Death|0|||
105858150|NCT02799095|365132740|FG003|Part A|Death|0|||
105858151|NCT02799095|365132741|FG004|Part A|Death|0|||
105858152|NCT02799095|365132742|FG005|Part A|Death|0|||
105858153|NCT02799095|365132743|FG006|Part A|Death|3|||
105858154|NCT02799095|365132744|FG007|Part A|Death|0|||
105858155|NCT02799095|365132745|FG008|Part A|Death|0|||
105858156|NCT02799095|365132746|FG009|Part A|Death|0|||
105858157|NCT02799095|365132747|FG010|Part A|Death|0|||
105858158|NCT02799095|365132748|FG011|Part A|Death|0|||
105858159|NCT02799095|365132749|FG012|Part A|Death|0|||
105858160|NCT02799095|365132750|FG013|Part A|Death|0|||
105858161|NCT02799095|365132751|FG014|Part A|Death|0|||
105858162|NCT02799095|365132752|FG015|Part A|Death|0|||
105858163|NCT02799095|365132753|FG016|Part A|Death|0|||
105858164|NCT02799095|365132737|FG000|Part A|Lost to Follow-up|0|||
105858165|NCT02799095|365132738|FG001|Part A|Lost to Follow-up|1|||
105858166|NCT02799095|365132739|FG002|Part A|Lost to Follow-up|0|||
105858167|NCT02799095|365132740|FG003|Part A|Lost to Follow-up|0|||
105858168|NCT02799095|365132741|FG004|Part A|Lost to Follow-up|0|||
105858169|NCT02799095|365132742|FG005|Part A|Lost to Follow-up|0|||
105858170|NCT02799095|365132743|FG006|Part A|Lost to Follow-up|1|||
105858171|NCT02799095|365132744|FG007|Part A|Lost to Follow-up|0|||
105858172|NCT02799095|365132745|FG008|Part A|Lost to Follow-up|0|||
105858173|NCT02799095|365132746|FG009|Part A|Lost to Follow-up|0|||
106036998|NCT02021656|365800326|FG000|Overall Study|Lack of Efficacy|2|||
106036999|NCT02021656|365800326|FG000|Overall Study|Lost to Follow-up|1|||
106037000|NCT02021656|365800326|FG000|Overall Study|Withdrew Consent|2|||
106037001|NCT03194490|365800329|FG000|Overall Study|Lost to Follow-up|1|||
106037002|NCT03194490|365800330|FG001|Overall Study|Lost to Follow-up|3|||
106037003|NCT03194490|365800329|FG000|Overall Study|participant developed specific neck pain|1|||
106037004|NCT03194490|365800330|FG001|Overall Study|participant developed specific neck pain|0|||
106037005|NCT03687970|365800331|FG000|Overall Study|visit scheduling conflicts|2|||
106037006|NCT03687970|365800332|FG001|Overall Study|visit scheduling conflicts|0|||
106037007|NCT02793128|365800346|FG000|Overall Study|Death|4|||
106037008|NCT02793128|365800346|FG000|Overall Study|Withdrawal by Subject|2|||
105858174|NCT02799095|365132747|FG010|Part A|Lost to Follow-up|0|||
105858175|NCT02799095|365132748|FG011|Part A|Lost to Follow-up|0|||
105858176|NCT02799095|365132749|FG012|Part A|Lost to Follow-up|0|||
105858177|NCT02799095|365132750|FG013|Part A|Lost to Follow-up|0|||
105858178|NCT02799095|365132751|FG014|Part A|Lost to Follow-up|0|||
105858179|NCT02799095|365132752|FG015|Part A|Lost to Follow-up|0|||
105858180|NCT02799095|365132753|FG016|Part A|Lost to Follow-up|0|||
105858181|NCT02799095|365132737|FG000|Part A|Progressive Disease|3|||
105858182|NCT02799095|365132738|FG001|Part A|Progressive Disease|3|||
105858183|NCT02799095|365132739|FG002|Part A|Progressive Disease|3|||
105858184|NCT02799095|365132740|FG003|Part A|Progressive Disease|2|||
105858185|NCT02799095|365132741|FG004|Part A|Progressive Disease|2|||
105858186|NCT02799095|365132742|FG005|Part A|Progressive Disease|0|||
105858187|NCT02799095|365132743|FG006|Part A|Progressive Disease|0|||
105858188|NCT02799095|365132744|FG007|Part A|Progressive Disease|0|||
105858189|NCT02799095|365132745|FG008|Part A|Progressive Disease|0|||
105858190|NCT02799095|365132746|FG009|Part A|Progressive Disease|0|||
105858191|NCT02799095|365132747|FG010|Part A|Progressive Disease|0|||
105858192|NCT02799095|365132748|FG011|Part A|Progressive Disease|0|||
105858193|NCT02799095|365132749|FG012|Part A|Progressive Disease|0|||
105858194|NCT02799095|365132750|FG013|Part A|Progressive Disease|0|||
105858195|NCT02799095|365132751|FG014|Part A|Progressive Disease|0|||
105858196|NCT02799095|365132752|FG015|Part A|Progressive Disease|0|||
105858197|NCT02799095|365132753|FG016|Part A|Progressive Disease|0|||
106037009|NCT02793128|365800346|FG000|Overall Study|Physician Decision|1|||
106037010|NCT02793128|365800346|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
106037011|NCT02793128|365800346|FG000|Overall Study|Patient elected nephroureterectomy|1|||
106037012|NCT01888003|365800350|FG000|Overall Study|Study Terminated|5|||
106037013|NCT01888003|365800351|FG001|Overall Study|Study Terminated|6|||
106037014|NCT01888003|365800352|FG002|Overall Study|Study Terminated|40|||
106037015|NCT02359851|365800353|FG000|Overall Study|Death|1|||
106037016|NCT02359851|365800353|FG000|Overall Study|Disease progression|1|||
106037017|NCT00055471|365800354|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
106037018|NCT00055471|365800355|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
106037019|NCT00055471|365800356|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
106037020|NCT00055471|365800354|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
106037021|NCT00055471|365800355|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
106037022|NCT00055471|365800356|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
106037023|NCT00055471|365800354|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
106037024|NCT00055471|365800355|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
106037025|NCT00055471|365800356|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
106037026|NCT01854944|365800357|FG000|Overall Study|Withdrawal by Subject|0|||
106037027|NCT01854944|365800358|FG001|Overall Study|Withdrawal by Subject|0|||
106037028|NCT01854944|365800359|FG002|Overall Study|Withdrawal by Subject|1|||
106037029|NCT02101112|365800360|FG000|Overall Study|Adverse Event|0|||
106037030|NCT02101112|365800361|FG001|Overall Study|Adverse Event|0|||
106037031|NCT02101112|365800362|FG002|Overall Study|Adverse Event|1|||
106037032|NCT02101112|365800363|FG003|Overall Study|Adverse Event|0|||
106037033|NCT02101112|365800364|FG004|Overall Study|Adverse Event|0|||
106037034|NCT02101112|365800365|FG005|Overall Study|Adverse Event|0|||
106037035|NCT02101112|365800360|FG000|Overall Study|Withdrawal by Subject|0|||
106037036|NCT02101112|365800361|FG001|Overall Study|Withdrawal by Subject|0|||
106037037|NCT02101112|365800362|FG002|Overall Study|Withdrawal by Subject|0|||
106037038|NCT02101112|365800363|FG003|Overall Study|Withdrawal by Subject|0|||
106037039|NCT02101112|365800364|FG004|Overall Study|Withdrawal by Subject|1|||
106037040|NCT02101112|365800365|FG005|Overall Study|Withdrawal by Subject|0|||
106037041|NCT00395538|365800368|FG000|Overall Study|Did not re-consent to revised protocol|1|||
106037042|NCT00395538|365800369|FG001|Overall Study|Did not re-consent to revised protocol|10|||
106037043|NCT00395538|365800370|FG002|Overall Study|Did not re-consent to revised protocol|0|||
106037044|NCT00395538|365800368|FG000|Overall Study|FDA partial hold on PTH|0|||
106037045|NCT00395538|365800369|FG001|Overall Study|FDA partial hold on PTH|0|||
106037046|NCT00395538|365800370|FG002|Overall Study|FDA partial hold on PTH|11|||
106037047|NCT00395538|365800368|FG000|Overall Study|Failed screening|0|||
106037048|NCT00395538|365800369|FG001|Overall Study|Failed screening|0|||
106037049|NCT00395538|365800370|FG002|Overall Study|Failed screening|4|||
106037050|NCT00395538|365800368|FG000|Overall Study|Switch to Natpara|0|||
106037051|NCT00395538|365800369|FG001|Overall Study|Switch to Natpara|0|||
106037052|NCT00395538|365800370|FG002|Overall Study|Switch to Natpara|3|||
106037053|NCT00395538|365800368|FG000|Overall Study|Adverse Event|1|||
106037054|NCT00395538|365800369|FG001|Overall Study|Adverse Event|0|||
106037055|NCT00395538|365800370|FG002|Overall Study|Adverse Event|2|||
106037056|NCT00395538|365800368|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
106037057|NCT00395538|365800369|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
106037058|NCT00395538|365800370|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
106037059|NCT00395538|365800368|FG000|Overall Study|Non-compliance with study protocol|0|||
106037060|NCT00395538|365800369|FG001|Overall Study|Non-compliance with study protocol|1|||
106037061|NCT00395538|365800370|FG002|Overall Study|Non-compliance with study protocol|0|||
106037062|NCT00395538|365800368|FG000|Overall Study|PTH resistance|0|||
106037063|NCT00395538|365800369|FG001|Overall Study|PTH resistance|0|||
106037064|NCT00395538|365800370|FG002|Overall Study|PTH resistance|1|||
106037065|NCT00395538|365800368|FG000|Overall Study|Pregnancy|1|||
106037066|NCT00395538|365800369|FG001|Overall Study|Pregnancy|0|||
106037067|NCT00395538|365800370|FG002|Overall Study|Pregnancy|0|||
106037068|NCT00395538|365800368|FG000|Overall Study|Partial recovery of parathyroid function|0|||
106037069|NCT00395538|365800369|FG001|Overall Study|Partial recovery of parathyroid function|0|||
106037070|NCT00395538|365800370|FG002|Overall Study|Partial recovery of parathyroid function|1|||
106037071|NCT00395538|365800368|FG000|Overall Study|Participant elected to discontinue|0|||
106037072|NCT00395538|365800369|FG001|Overall Study|Participant elected to discontinue|0|||
106037073|NCT00395538|365800370|FG002|Overall Study|Participant elected to discontinue|1|||
106037074|NCT01876810|365800373|FG000|Overall Study|Physician Decision|0|||
106037075|NCT01876810|365800374|FG001|Overall Study|Physician Decision|1|||
106037076|NCT04382755|365800377|FG000|Overall Study|Withdrawal by Subject|1|||
106037077|NCT04382755|365800378|FG001|Overall Study|Withdrawal by Subject|0|||
106037078|NCT04382755|365800377|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
106037079|NCT04382755|365800378|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
106037080|NCT04382755|365800377|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
106037081|NCT04382755|365800378|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
106037082|NCT00285207|365800380|FG000|Overall Study|Lost to Follow-up|3|||
106037083|NCT00285207|365800381|FG001|Overall Study|Lost to Follow-up|2|||
106037084|NCT00285207|365800380|FG000|Overall Study|Withdrawal by Subject|5|||
106037085|NCT00285207|365800381|FG001|Overall Study|Withdrawal by Subject|2|||
106037086|NCT00285207|365800380|FG000|Overall Study|Pregnancy|1|||
106037087|NCT00285207|365800381|FG001|Overall Study|Pregnancy|1|||
106037088|NCT00285207|365800380|FG000|Overall Study|non-compliance|0|||
106037089|NCT00285207|365800381|FG001|Overall Study|non-compliance|1|||
106037090|NCT04571515|365800382|FG000|Overall Study|Physician Decision|0|||
106037091|NCT04571515|365800383|FG001|Overall Study|Physician Decision|0|||
106037092|NCT04571515|365800384|FG002|Overall Study|Physician Decision|0|||
106037093|NCT04571515|365800385|FG003|Overall Study|Physician Decision|0|||
106037094|NCT04571515|365800386|FG004|Overall Study|Physician Decision|1|||
106037095|NCT04571515|365800382|FG000|Overall Study|Withdrawal by Subject|0|||
106037096|NCT04571515|365800383|FG001|Overall Study|Withdrawal by Subject|0|||
106037097|NCT04571515|365800384|FG002|Overall Study|Withdrawal by Subject|0|||
106037098|NCT04571515|365800385|FG003|Overall Study|Withdrawal by Subject|0|||
106037099|NCT04571515|365800386|FG004|Overall Study|Withdrawal by Subject|1|||
106037100|NCT04571515|365800382|FG000|Overall Study|insufficient pain|1|||
106037101|NCT04571515|365800383|FG001|Overall Study|insufficient pain|0|||
106037102|NCT04571515|365800384|FG002|Overall Study|insufficient pain|0|||
106037103|NCT04571515|365800385|FG003|Overall Study|insufficient pain|0|||
106037104|NCT04571515|365800386|FG004|Overall Study|insufficient pain|1|||
106037105|NCT04285580|365802047|FG000|Overall Study|Protocol Violation|0|||
106037106|NCT04285580|365802048|FG001|Overall Study|Protocol Violation|1|||
106037107|NCT03729362|365802049|FG000|Overall Study|Withdrawal by Subject|2|||
106037108|NCT03729362|365802050|FG001|Overall Study|Withdrawal by Subject|0|||
106037109|NCT03729362|365802049|FG000|Overall Study|Physician Decision|1|||
106037110|NCT03729362|365802050|FG001|Overall Study|Physician Decision|0|||
106037111|NCT03729362|365802049|FG000|Overall Study|COVID-19 Pandemic|1|||
106037112|NCT03729362|365802050|FG001|Overall Study|COVID-19 Pandemic|0|||
106037113|NCT03729362|365802049|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
106037114|NCT03729362|365802050|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
106037115|NCT03729362|365802049|FG000|Overall Study|Adverse Event|0|||
106037116|NCT03729362|365802050|FG001|Overall Study|Adverse Event|1|||
106037117|NCT03729362|365802049|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
106037118|NCT03729362|365802050|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
106037119|NCT04617795|365802051|FG000|Main Study|Lost to Follow-up|1|||
106037120|NCT04617795|365802052|FG001|Main Study|Lost to Follow-up|0|||
106037121|NCT02284178|365802055|FG000|Overall Study|Met exclusion criteria|49|||
106037122|NCT02284178|365802056|FG001|Overall Study|Met exclusion criteria|54|||
106037123|NCT00880685|365802059|FG000|Memantine 10mg|Lost to Follow-up|2|||
106037124|NCT00880685|365802059|FG000|Memantine 20mg|Withdrawal by Subject|1|||
106037125|NCT01083173|365802061|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
106037126|NCT01083173|365802062|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
106037127|NCT01083173|365802061|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
106037128|NCT01083173|365802062|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
106037129|NCT01083173|365802061|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
106037130|NCT01083173|365802062|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
106037131|NCT01083173|365802061|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
106037132|NCT01083173|365802062|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
106037133|NCT01083173|365802061|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
106037134|NCT01083173|365802062|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
106037135|NCT01083173|365802061|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
106037136|NCT01083173|365802062|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
106037137|NCT01083173|365802061|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
106037138|NCT01083173|365802062|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
106037139|NCT01083173|365802061|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
106037140|NCT01083173|365802062|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
106037141|NCT01083173|365802061|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
106037142|NCT01083173|365802062|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
106037143|NCT01083173|365802061|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
106037144|NCT01083173|365802062|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
106037145|NCT01083173|365802061|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
106037146|NCT01083173|365802062|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
106037147|NCT03981822|365802064|FG000|Overall Study|Lost to Follow-up|0|||
106037148|NCT03981822|365802065|FG001|Overall Study|Lost to Follow-up|1|||
106037149|NCT03981822|365802066|FG002|Overall Study|Lost to Follow-up|1|||
106037150|NCT03981822|365802067|FG003|Overall Study|Lost to Follow-up|0|||
105858198|NCT02799095|365132737|FG000|Part A|Clinical Progression|1|||
105858199|NCT02799095|365132738|FG001|Part A|Clinical Progression|0|||
105858200|NCT02799095|365132739|FG002|Part A|Clinical Progression|2|||
105858201|NCT02799095|365132740|FG003|Part A|Clinical Progression|1|||
105858202|NCT02799095|365132741|FG004|Part A|Clinical Progression|5|||
105858203|NCT02799095|365132742|FG005|Part A|Clinical Progression|0|||
105858204|NCT02799095|365132743|FG006|Part A|Clinical Progression|0|||
105858205|NCT02799095|365132744|FG007|Part A|Clinical Progression|0|||
105858206|NCT02799095|365132745|FG008|Part A|Clinical Progression|0|||
105858207|NCT02799095|365132746|FG009|Part A|Clinical Progression|0|||
105858208|NCT02799095|365132747|FG010|Part A|Clinical Progression|0|||
105858209|NCT02799095|365132748|FG011|Part A|Clinical Progression|0|||
105858210|NCT02799095|365132749|FG012|Part A|Clinical Progression|0|||
105858211|NCT02799095|365132750|FG013|Part A|Clinical Progression|0|||
105858212|NCT02799095|365132751|FG014|Part A|Clinical Progression|0|||
105858213|NCT02799095|365132752|FG015|Part A|Clinical Progression|0|||
105858214|NCT02799095|365132753|FG016|Part A|Clinical Progression|0|||
105858215|NCT02799095|365132737|FG000|Part A|Protocol Deviation|0|||
105858216|NCT02799095|365132738|FG001|Part A|Protocol Deviation|0|||
106037151|NCT03981822|365802068|FG004|Overall Study|Lost to Follow-up|6|||
105858217|NCT02799095|365132739|FG002|Part A|Protocol Deviation|1|||
105858218|NCT02799095|365132740|FG003|Part A|Protocol Deviation|0|||
105858219|NCT02799095|365132741|FG004|Part A|Protocol Deviation|0|||
105858220|NCT02799095|365132742|FG005|Part A|Protocol Deviation|0|||
105858221|NCT02799095|365132743|FG006|Part A|Protocol Deviation|0|||
105858222|NCT02799095|365132744|FG007|Part A|Protocol Deviation|0|||
105858223|NCT02799095|365132745|FG008|Part A|Protocol Deviation|0|||
105858224|NCT02799095|365132746|FG009|Part A|Protocol Deviation|0|||
105858225|NCT02799095|365132747|FG010|Part A|Protocol Deviation|0|||
105858226|NCT02799095|365132748|FG011|Part A|Protocol Deviation|0|||
105858227|NCT02799095|365132749|FG012|Part A|Protocol Deviation|0|||
105858228|NCT02799095|365132750|FG013|Part A|Protocol Deviation|0|||
105858229|NCT02799095|365132751|FG014|Part A|Protocol Deviation|0|||
105858230|NCT02799095|365132752|FG015|Part A|Protocol Deviation|0|||
105858231|NCT02799095|365132753|FG016|Part A|Protocol Deviation|0|||
106037152|NCT03981822|365802069|FG005|Overall Study|Lost to Follow-up|4|||
106037153|NCT03981822|365802070|FG006|Overall Study|Lost to Follow-up|4|||
106037154|NCT03981822|365802071|FG007|Overall Study|Lost to Follow-up|2|||
106037155|NCT03981822|365802064|FG000|Overall Study|Withdrawal by Subject|0|||
106037156|NCT03981822|365802065|FG001|Overall Study|Withdrawal by Subject|1|||
106037157|NCT03981822|365802066|FG002|Overall Study|Withdrawal by Subject|0|||
106037158|NCT03981822|365802067|FG003|Overall Study|Withdrawal by Subject|0|||
106037159|NCT03981822|365802068|FG004|Overall Study|Withdrawal by Subject|0|||
106037160|NCT03981822|365802069|FG005|Overall Study|Withdrawal by Subject|1|||
106037161|NCT03981822|365802070|FG006|Overall Study|Withdrawal by Subject|0|||
106037162|NCT03981822|365802071|FG007|Overall Study|Withdrawal by Subject|2|||
106037163|NCT03981822|365802064|FG000|Overall Study|COVID-19 Related|0|||
106037164|NCT03981822|365802065|FG001|Overall Study|COVID-19 Related|0|||
106037165|NCT03981822|365802066|FG002|Overall Study|COVID-19 Related|0|||
106037166|NCT03981822|365802067|FG003|Overall Study|COVID-19 Related|0|||
106037167|NCT03981822|365802068|FG004|Overall Study|COVID-19 Related|2|||
106037168|NCT03981822|365802069|FG005|Overall Study|COVID-19 Related|1|||
106037169|NCT03981822|365802070|FG006|Overall Study|COVID-19 Related|2|||
106037170|NCT03981822|365802071|FG007|Overall Study|COVID-19 Related|1|||
106037171|NCT02987660|365802072|FG000|Overall Study|Study terminated by sponsor|10|||
106037172|NCT02987660|365802073|FG001|Overall Study|Study terminated by sponsor|10|||
106037173|NCT04704154|365802074|FG000|Overall Study|Adverse Event|3|||
106037174|NCT04704154|365802075|FG001|Overall Study|Adverse Event|2|||
106037175|NCT04704154|365802076|FG002|Overall Study|Adverse Event|4|||
106037176|NCT04704154|365802077|FG003|Overall Study|Adverse Event|2|||
106037177|NCT04704154|365802078|FG004|Overall Study|Adverse Event|3|||
106037178|NCT04704154|365802079|FG005|Overall Study|Adverse Event|0|||
106037179|NCT04704154|365802074|FG000|Overall Study|Death|3|||
106037180|NCT04704154|365802075|FG001|Overall Study|Death|0|||
106037181|NCT04704154|365802076|FG002|Overall Study|Death|0|||
106037182|NCT04704154|365802077|FG003|Overall Study|Death|0|||
106037183|NCT04704154|365802078|FG004|Overall Study|Death|3|||
106037184|NCT04704154|365802079|FG005|Overall Study|Death|0|||
105858232|NCT02799095|365132737|FG000|Part A|Withdrawal by Subject|0|||
105858233|NCT02799095|365132738|FG001|Part A|Withdrawal by Subject|0|||
105858234|NCT02799095|365132739|FG002|Part A|Withdrawal by Subject|0|||
105858235|NCT02799095|365132740|FG003|Part A|Withdrawal by Subject|1|||
105858236|NCT02799095|365132741|FG004|Part A|Withdrawal by Subject|3|||
105858237|NCT02799095|365132742|FG005|Part A|Withdrawal by Subject|1|||
105858238|NCT02799095|365132743|FG006|Part A|Withdrawal by Subject|1|||
105858239|NCT02799095|365132744|FG007|Part A|Withdrawal by Subject|0|||
105858240|NCT02799095|365132745|FG008|Part A|Withdrawal by Subject|0|||
106037185|NCT04704154|365802074|FG000|Overall Study|Physician Decision|1|||
105858241|NCT02799095|365132746|FG009|Part A|Withdrawal by Subject|0|||
105858242|NCT02799095|365132747|FG010|Part A|Withdrawal by Subject|0|||
105858243|NCT02799095|365132748|FG011|Part A|Withdrawal by Subject|0|||
105858244|NCT02799095|365132749|FG012|Part A|Withdrawal by Subject|0|||
106037186|NCT04704154|365802075|FG001|Overall Study|Physician Decision|0|||
106037187|NCT04704154|365802076|FG002|Overall Study|Physician Decision|1|||
106037188|NCT04704154|365802077|FG003|Overall Study|Physician Decision|0|||
106037189|NCT04704154|365802078|FG004|Overall Study|Physician Decision|2|||
106037190|NCT04704154|365802079|FG005|Overall Study|Physician Decision|0|||
106037191|NCT04704154|365802074|FG000|Overall Study|Participant Decision|1|||
106037192|NCT04704154|365802075|FG001|Overall Study|Participant Decision|1|||
106037193|NCT04704154|365802076|FG002|Overall Study|Participant Decision|0|||
106037194|NCT04704154|365802077|FG003|Overall Study|Participant Decision|0|||
106037195|NCT04704154|365802078|FG004|Overall Study|Participant Decision|0|||
106037196|NCT04704154|365802079|FG005|Overall Study|Participant Decision|0|||
106037197|NCT04704154|365802074|FG000|Overall Study|Progressive Disease|19|||
106037198|NCT04704154|365802075|FG001|Overall Study|Progressive Disease|17|||
106037199|NCT04704154|365802076|FG002|Overall Study|Progressive Disease|20|||
106037200|NCT04704154|365802077|FG003|Overall Study|Progressive Disease|18|||
106037201|NCT04704154|365802078|FG004|Overall Study|Progressive Disease|36|||
106037202|NCT04704154|365802079|FG005|Overall Study|Progressive Disease|30|||
106037203|NCT04704154|365802074|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
106037204|NCT04704154|365802075|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
106037205|NCT04704154|365802076|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
106037206|NCT04704154|365802077|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
106037207|NCT04704154|365802078|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
106037208|NCT04704154|365802079|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
106037209|NCT04704154|365802074|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
106037210|NCT04704154|365802075|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
106037211|NCT04704154|365802076|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
106037212|NCT04704154|365802077|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
106037213|NCT04704154|365802078|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
106037214|NCT04704154|365802079|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
106037215|NCT04251156|365802080|FG000|Overall Study|Lost to Follow-up|1|||
106037216|NCT04251156|365802081|FG001|Overall Study|Lost to Follow-up|1|||
106037217|NCT04251156|365802080|FG000|Overall Study|Withdrawal by Subject|4|||
106037218|NCT04251156|365802081|FG001|Overall Study|Withdrawal by Subject|4|||
106037219|NCT03553836|365802082|FG000|Overall Study|Ongoing in Study|460|||
106037220|NCT03553836|365802083|FG001|Overall Study|Ongoing in Study|459|||
106037221|NCT03553836|365802082|FG000|Overall Study|Withdrawal by Subject|9|||
106037222|NCT03553836|365802083|FG001|Overall Study|Withdrawal by Subject|10|||
106037223|NCT03553836|365802082|FG000|Overall Study|Lost to Follow-up|1|||
106037224|NCT03553836|365802083|FG001|Overall Study|Lost to Follow-up|3|||
106037225|NCT03553836|365802082|FG000|Overall Study|Death|17|||
106037226|NCT03553836|365802083|FG001|Overall Study|Death|17|||
106037227|NCT04423939|365802084|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
106037228|NCT04423939|365802085|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
106037229|NCT04423939|365802084|FG000|Overall Study|Death|3|||
106037230|NCT04423939|365802085|FG001|Overall Study|Death|0|||
106037231|NCT04423939|365802084|FG000|Overall Study|Withdrawal by Subject|3|||
106037232|NCT04423939|365802085|FG001|Overall Study|Withdrawal by Subject|0|||
106037233|NCT04423939|365802084|FG000|Overall Study|Caregiver to patient who died|0|||
106037234|NCT04423939|365802085|FG001|Overall Study|Caregiver to patient who died|3|||
106037235|NCT04423939|365802084|FG000|Overall Study|Caregiver to patient who withdrew|0|||
106037236|NCT04423939|365802085|FG001|Overall Study|Caregiver to patient who withdrew|3|||
106037237|NCT01041495|365802086|FG000|Overall Study|Withdrawal by Subject|2|||
106037238|NCT01041495|365802087|FG001|Overall Study|Withdrawal by Subject|5|||
106037239|NCT01041495|365802086|FG000|Overall Study|Adverse Event|2|||
106037240|NCT01041495|365802087|FG001|Overall Study|Adverse Event|1|||
106037241|NCT01041495|365802086|FG000|Overall Study|Lost to Follow-up|0|||
106037242|NCT01041495|365802087|FG001|Overall Study|Lost to Follow-up|1|||
106037243|NCT01479985|365802090|FG000|Overall Study|Tablet malfunction, no data saved|1|||
106037244|NCT01479985|365802091|FG001|Overall Study|Tablet malfunction, no data saved|1|||
106037245|NCT01479985|365802090|FG000|Overall Study|No decisional conflict scale responses|0|||
106037246|NCT01479985|365802091|FG001|Overall Study|No decisional conflict scale responses|2|||
106037247|NCT01479985|365802090|FG000|Overall Study|No post-visit survey|5|||
106037248|NCT01479985|365802091|FG001|Overall Study|No post-visit survey|3|||
106037249|NCT00367770|365802094|FG000|Overall Study|Adverse Event|1|||
106037250|NCT00367770|365802094|FG000|Overall Study|Withdrawal by Subject|1|||
106037251|NCT00998764|365802095|FG000|Overall Study|Lack of Efficacy|3|||
106037252|NCT00998764|365802096|FG001|Overall Study|Lack of Efficacy|6|||
106037253|NCT00998764|365802095|FG000|Overall Study|Adverse Event|17|||
106037254|NCT00998764|365802096|FG001|Overall Study|Adverse Event|12|||
106037255|NCT00998764|365802095|FG000|Overall Study|Withdrawal by Subject|19|||
106037256|NCT00998764|365802096|FG001|Overall Study|Withdrawal by Subject|25|||
106037257|NCT00998764|365802095|FG000|Overall Study|Physician Decision|3|||
106037258|NCT00998764|365802096|FG001|Overall Study|Physician Decision|3|||
106037259|NCT00998764|365802095|FG000|Overall Study|Death|3|||
106037260|NCT00998764|365802096|FG001|Overall Study|Death|1|||
106037261|NCT00998764|365802095|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
106037262|NCT00998764|365802096|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
106037263|NCT00998764|365802095|FG000|Overall Study|Protocol Violation|0|||
106037264|NCT00998764|365802096|FG001|Overall Study|Protocol Violation|1|||
106037265|NCT00998764|365802095|FG000|Overall Study|Failed to Return|1|||
106037266|NCT00998764|365802096|FG001|Overall Study|Failed to Return|1|||
106037267|NCT00998764|365802095|FG000|Overall Study|Lost to Follow-up|1|||
106037268|NCT00998764|365802096|FG001|Overall Study|Lost to Follow-up|1|||
106037269|NCT00998764|365802095|FG000|Overall Study|Loss of Caregiver|0|||
106037270|NCT00998764|365802096|FG001|Overall Study|Loss of Caregiver|3|||
106037271|NCT00998764|365802095|FG000|Overall Study|Other|4|||
106037272|NCT00998764|365802096|FG001|Overall Study|Other|4|||
106037273|NCT00998764|365802095|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
106037274|NCT00998764|365802096|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
106037275|NCT03416374|365802099|FG000|Between Treatment Period I and II|Other|0|||
106037276|NCT03416374|365802100|FG001|Between Treatment Period I and II|Other|9|||
106037277|NCT03416374|365802099|FG000|Treatment Period II|Lack of Efficacy|3|||
106037278|NCT03416374|365802100|FG001|Treatment Period II|Lack of Efficacy|11|||
106037279|NCT03416374|365802099|FG000|Treatment Period II|Adverse Event|1|||
106037280|NCT03416374|365802100|FG001|Treatment Period II|Adverse Event|4|||
106037281|NCT03416374|365802099|FG000|Treatment Period II|Death|0|||
106037282|NCT03416374|365802100|FG001|Treatment Period II|Death|1|||
106037283|NCT03416374|365802099|FG000|Treatment Period II|Other|0|||
106037284|NCT03416374|365802100|FG001|Treatment Period II|Other|2|||
106037285|NCT04543409|365802101|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
106037286|NCT04543409|365802102|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
106037287|NCT04543409|365802101|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
106037288|NCT04543409|365802102|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
106037289|NCT04543409|365802101|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
106037290|NCT04543409|365802102|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
106037291|NCT04543409|365802101|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
106037292|NCT04543409|365802102|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
106037293|NCT04543409|365802101|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
106037294|NCT04543409|365802102|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
106037295|NCT04543409|365802101|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
106037296|NCT04543409|365802102|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
106037297|NCT04543409|365802101|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
106037298|NCT04543409|365802102|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
106037299|NCT04543409|365802101|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
106037300|NCT04543409|365802102|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
106037301|NCT04543409|365802101|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
106037302|NCT04543409|365802102|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
106037303|NCT04543409|365802101|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
106037304|NCT04543409|365802102|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
106037305|NCT04543409|365802101|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
106037306|NCT04543409|365802102|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
106037307|NCT03977454|365802103|FG000|Overall Study|immediate postoperative revision|2|||
106037308|NCT03977454|365802104|FG001|Overall Study|immediate postoperative revision|2|||
106037309|NCT01565499|365802112|FG000|Overall Study|Physician Decision|1|||
106037310|NCT01565499|365802112|FG000|Overall Study|Adverse Event|5|||
106037311|NCT01565499|365802112|FG000|Overall Study|Withdrawal by Subject|2|||
106037312|NCT00174291|365802117|FG000|Overall Study|Lost to Follow-up|1|||
106037313|NCT00174291|365802118|FG001|Overall Study|Lost to Follow-up|1|||
106037314|NCT00174291|365802117|FG000|Overall Study|Protocol Violation|0|||
106037315|NCT00174291|365802118|FG001|Overall Study|Protocol Violation|2|||
106037316|NCT00174291|365802117|FG000|Overall Study|Study terminated by sponsor|1|||
106037317|NCT00174291|365802118|FG001|Overall Study|Study terminated by sponsor|0|||
106037318|NCT00174291|365802117|FG000|Overall Study|Withdrawal by Subject|3|||
106037319|NCT00174291|365802118|FG001|Overall Study|Withdrawal by Subject|3|||
106037320|NCT01923168|365802121|FG000|Overall Study|Protocol Violation|1|||
106037321|NCT01923168|365802122|FG001|Overall Study|Protocol Violation|1|||
106037322|NCT01923168|365802123|FG002|Overall Study|Protocol Violation|0|||
106037323|NCT01923168|365802121|FG000|Overall Study|Subject/guardian decision|14|||
106037324|NCT01923168|365802122|FG001|Overall Study|Subject/guardian decision|14|||
106037325|NCT01923168|365802123|FG002|Overall Study|Subject/guardian decision|4|||
106037326|NCT01923168|365802121|FG000|Overall Study|Adverse Event|12|||
106037327|NCT01923168|365802122|FG001|Overall Study|Adverse Event|12|||
106037328|NCT01923168|365802123|FG002|Overall Study|Adverse Event|0|||
106037329|NCT01923168|365802121|FG000|Overall Study|Physician Decision|6|||
105858245|NCT02799095|365132750|FG013|Part A|Withdrawal by Subject|0|||
105858246|NCT02799095|365132751|FG014|Part A|Withdrawal by Subject|0|||
105858247|NCT02799095|365132752|FG015|Part A|Withdrawal by Subject|0|||
105858248|NCT02799095|365132753|FG016|Part A|Withdrawal by Subject|0|||
105858249|NCT02799095|365132737|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
105858250|NCT02799095|365132738|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
105858251|NCT02799095|365132739|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
106037330|NCT01923168|365802122|FG001|Overall Study|Physician Decision|9|||
106037331|NCT01923168|365802123|FG002|Overall Study|Physician Decision|5|||
106037332|NCT01923168|365802121|FG000|Overall Study|Progressive disease|4|||
106037333|NCT01923168|365802122|FG001|Overall Study|Progressive disease|3|||
105858252|NCT02799095|365132740|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
105858253|NCT02799095|365132741|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
105858254|NCT02799095|365132742|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
105858255|NCT02799095|365132743|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
105858256|NCT02799095|365132744|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
105858257|NCT02799095|365132745|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
105858258|NCT02799095|365132746|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
105858259|NCT02799095|365132747|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
105858260|NCT02799095|365132748|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
105858261|NCT02799095|365132749|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
105858262|NCT02799095|365132750|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
105858263|NCT02799095|365132751|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
105858264|NCT02799095|365132752|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
105858265|NCT02799095|365132753|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
105858266|NCT02799095|365132737|FG000|Part B|Death|0|||
105858267|NCT02799095|365132738|FG001|Part B|Death|0|||
105858268|NCT02799095|365132739|FG002|Part B|Death|0|||
105858269|NCT02799095|365132740|FG003|Part B|Death|0|||
105858270|NCT02799095|365132741|FG004|Part B|Death|0|||
105858271|NCT02799095|365132742|FG005|Part B|Death|0|||
105858272|NCT02799095|365132743|FG006|Part B|Death|0|||
105858273|NCT02799095|365132744|FG007|Part B|Death|7|||
105858274|NCT02799095|365132745|FG008|Part B|Death|7|||
105858275|NCT02799095|365132746|FG009|Part B|Death|0|||
105858276|NCT02799095|365132747|FG010|Part B|Death|0|||
105858277|NCT02799095|365132748|FG011|Part B|Death|0|||
105858278|NCT02799095|365132749|FG012|Part B|Death|0|||
105858279|NCT02799095|365132750|FG013|Part B|Death|0|||
105858280|NCT02799095|365132751|FG014|Part B|Death|0|||
105858281|NCT02799095|365132752|FG015|Part B|Death|0|||
105858282|NCT02799095|365132753|FG016|Part B|Death|0|||
105858283|NCT02799095|365132737|FG000|Part B|Progressive Disease|0|||
105858284|NCT02799095|365132738|FG001|Part B|Progressive Disease|0|||
105858285|NCT02799095|365132739|FG002|Part B|Progressive Disease|0|||
105858286|NCT02799095|365132740|FG003|Part B|Progressive Disease|0|||
105858287|NCT02799095|365132741|FG004|Part B|Progressive Disease|0|||
105858288|NCT02799095|365132742|FG005|Part B|Progressive Disease|0|||
105858289|NCT02799095|365132743|FG006|Part B|Progressive Disease|0|||
105858290|NCT02799095|365132744|FG007|Part B|Progressive Disease|1|||
105858291|NCT02799095|365132745|FG008|Part B|Progressive Disease|0|||
105858292|NCT02799095|365132746|FG009|Part B|Progressive Disease|0|||
105858293|NCT02799095|365132747|FG010|Part B|Progressive Disease|0|||
105858294|NCT02799095|365132748|FG011|Part B|Progressive Disease|0|||
105858295|NCT02799095|365132749|FG012|Part B|Progressive Disease|0|||
105858296|NCT02799095|365132750|FG013|Part B|Progressive Disease|0|||
105858297|NCT02799095|365132751|FG014|Part B|Progressive Disease|0|||
105858298|NCT02799095|365132752|FG015|Part B|Progressive Disease|0|||
105858299|NCT02799095|365132753|FG016|Part B|Progressive Disease|0|||
105858300|NCT02799095|365132737|FG000|Part B|Withdrawal by Subject|0|||
105858301|NCT02799095|365132738|FG001|Part B|Withdrawal by Subject|0|||
105858302|NCT02799095|365132739|FG002|Part B|Withdrawal by Subject|0|||
105858303|NCT02799095|365132740|FG003|Part B|Withdrawal by Subject|0|||
105858304|NCT02799095|365132741|FG004|Part B|Withdrawal by Subject|0|||
105858305|NCT02799095|365132742|FG005|Part B|Withdrawal by Subject|0|||
105858306|NCT02799095|365132743|FG006|Part B|Withdrawal by Subject|0|||
105858307|NCT02799095|365132744|FG007|Part B|Withdrawal by Subject|10|||
105858308|NCT02799095|365132745|FG008|Part B|Withdrawal by Subject|7|||
105858309|NCT02799095|365132746|FG009|Part B|Withdrawal by Subject|0|||
105858310|NCT02799095|365132747|FG010|Part B|Withdrawal by Subject|0|||
106037334|NCT01923168|365802123|FG002|Overall Study|Progressive disease|7|||
106037335|NCT01923168|365802121|FG000|Overall Study|Death|0|||
106037336|NCT01923168|365802122|FG001|Overall Study|Death|0|||
106037337|NCT01923168|365802123|FG002|Overall Study|Death|1|||
106037338|NCT03116347|365802124|FG000|Overall Study|Withdrawal by Subject|1|||
106037339|NCT03116347|365802125|FG001|Overall Study|Withdrawal by Subject|2|||
106037340|NCT01255787|365802126|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
106037341|NCT01255787|365802127|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
106037342|NCT01255787|365802128|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
106037343|NCT01255787|365802129|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
106037344|NCT01255787|365802126|FG000|Overall Study|Major Protocol Deviation|1|||
106037345|NCT01255787|365802127|FG001|Overall Study|Major Protocol Deviation|1|||
106037346|NCT01255787|365802128|FG002|Overall Study|Major Protocol Deviation|0|||
106037347|NCT01255787|365802129|FG003|Overall Study|Major Protocol Deviation|4|||
106037348|NCT01255787|365802126|FG000|Overall Study|Lost to Follow-up|1|||
106037349|NCT01255787|365802127|FG001|Overall Study|Lost to Follow-up|2|||
106037350|NCT01255787|365802128|FG002|Overall Study|Lost to Follow-up|4|||
106037351|NCT01255787|365802129|FG003|Overall Study|Lost to Follow-up|2|||
106037352|NCT01255787|365802126|FG000|Overall Study|Withdrawal of Consent|3|||
106037353|NCT01255787|365802127|FG001|Overall Study|Withdrawal of Consent|9|||
106037354|NCT01255787|365802128|FG002|Overall Study|Withdrawal of Consent|3|||
106037355|NCT01255787|365802129|FG003|Overall Study|Withdrawal of Consent|4|||
106037356|NCT01255787|365802126|FG000|Overall Study|Pregnancy|0|||
106037357|NCT01255787|365802127|FG001|Overall Study|Pregnancy|0|||
106037358|NCT01255787|365802128|FG002|Overall Study|Pregnancy|0|||
106037359|NCT01255787|365802129|FG003|Overall Study|Pregnancy|1|||
106037360|NCT01255787|365802126|FG000|Overall Study|Lack of Efficacy|2|||
106037361|NCT01255787|365802127|FG001|Overall Study|Lack of Efficacy|2|||
106037362|NCT01255787|365802128|FG002|Overall Study|Lack of Efficacy|2|||
106037363|NCT01255787|365802129|FG003|Overall Study|Lack of Efficacy|2|||
106037364|NCT01255787|365802126|FG000|Overall Study|Noncompliance with Study Drug|3|||
106037365|NCT01255787|365802127|FG001|Overall Study|Noncompliance with Study Drug|1|||
106037366|NCT01255787|365802128|FG002|Overall Study|Noncompliance with Study Drug|0|||
106037367|NCT01255787|365802129|FG003|Overall Study|Noncompliance with Study Drug|0|||
106037368|NCT00476047|365802130|FG000|Overall Study|Lost to Follow-up|1|||
106037369|NCT03170232|365802131|FG000|Overall Study|Adverse Event|0|||
106037370|NCT03170232|365802132|FG001|Overall Study|Adverse Event|1|||
106037371|NCT03170232|365802131|FG000|Overall Study|Protocol Violation|0|||
106037372|NCT03170232|365802132|FG001|Overall Study|Protocol Violation|1|||
106037373|NCT03170232|365802131|FG000|Overall Study|Lack of Efficacy|0|||
106037374|NCT03170232|365802132|FG001|Overall Study|Lack of Efficacy|1|||
106037375|NCT03170232|365802131|FG000|Overall Study|Study closed/terminated|26|||
106037376|NCT03170232|365802132|FG001|Overall Study|Study closed/terminated|23|||
106037377|NCT03170232|365802131|FG000|Overall Study|Lost to Follow-up|1|||
106037378|NCT03170232|365802132|FG001|Overall Study|Lost to Follow-up|0|||
106037379|NCT03170232|365802131|FG000|Overall Study|Withdrawal by Subject|0|||
106037380|NCT03170232|365802132|FG001|Overall Study|Withdrawal by Subject|1|||
106037381|NCT00586326|365802133|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
106037382|NCT00586326|365802133|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
105858311|NCT02799095|365132748|FG011|Part B|Withdrawal by Subject|0|||
105858312|NCT02799095|365132749|FG012|Part B|Withdrawal by Subject|0|||
105858313|NCT02799095|365132750|FG013|Part B|Withdrawal by Subject|0|||
105858314|NCT02799095|365132751|FG014|Part B|Withdrawal by Subject|0|||
105858315|NCT02799095|365132752|FG015|Part B|Withdrawal by Subject|0|||
105858316|NCT02799095|365132753|FG016|Part B|Withdrawal by Subject|0|||
105858317|NCT02799095|365132737|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
105858318|NCT02799095|365132738|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
105858319|NCT02799095|365132739|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
105858320|NCT02799095|365132740|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
105858321|NCT02799095|365132741|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
105858322|NCT02799095|365132742|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
105858323|NCT02799095|365132743|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
105858324|NCT02799095|365132744|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
105858325|NCT02799095|365132745|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
105858326|NCT02799095|365132746|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
105858327|NCT02799095|365132747|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
105858328|NCT02799095|365132748|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
105858329|NCT02799095|365132749|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
105858330|NCT02799095|365132750|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
106037383|NCT00586326|365802133|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
106037384|NCT00586326|365802133|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
106037385|NCT00586326|365802133|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
106037386|NCT00586326|365802133|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
105858331|NCT02799095|365132751|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
105858332|NCT02799095|365132752|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
105858333|NCT02799095|365132753|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
105858334|NCT02799095|365132737|FG000|Part C|Adverse Event|0|||
105858335|NCT02799095|365132738|FG001|Part C|Adverse Event|0|||
105858336|NCT02799095|365132739|FG002|Part C|Adverse Event|0|||
106037387|NCT00586326|365802133|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
106037388|NCT00586326|365802133|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
106037389|NCT00586326|365802133|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
106037390|NCT00586326|365802133|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
106037391|NCT00586326|365802133|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
106037392|NCT00586326|365802133|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
105858337|NCT02799095|365132740|FG003|Part C|Adverse Event|0|||
106037393|NCT00586326|365802133|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
106037394|NCT00586326|365802133|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
106037395|NCT00586326|365802133|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
106037396|NCT00586326|365802133|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
106037397|NCT00586326|365802133|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
106037398|NCT03882008|365802134|FG000|Overall Study|Withdrawal by Subject|1|||
106037399|NCT03882008|365802134|FG000|Overall Study|Lost to Follow-up|1|||
106037400|NCT05153473|365802135|FG000|Overall Study|Death|46|||
106037401|NCT05153473|365802135|FG000|Overall Study|Lost to Follow-up|3|||
106037402|NCT03519386|365802136|FG000|Overall Study|Withdrawal by Subject|4|||
106037403|NCT03519386|365802137|FG001|Overall Study|Withdrawal by Subject|1|||
106037404|NCT03519386|365802138|FG002|Overall Study|Withdrawal by Subject|2|||
106037405|NCT03519386|365802136|FG000|Overall Study|Physician Decision|1|||
106037406|NCT03519386|365802137|FG001|Overall Study|Physician Decision|1|||
106037407|NCT03519386|365802138|FG002|Overall Study|Physician Decision|1|||
106037408|NCT03519386|365802136|FG000|Overall Study|Lost to Follow-up|0|||
106037409|NCT03519386|365802137|FG001|Overall Study|Lost to Follow-up|1|||
106037410|NCT03519386|365802138|FG002|Overall Study|Lost to Follow-up|1|||
106037411|NCT03519386|365802136|FG000|Overall Study|Death|1|||
106037412|NCT03519386|365802137|FG001|Overall Study|Death|0|||
106037413|NCT03519386|365802138|FG002|Overall Study|Death|4|||
106037414|NCT03519386|365802136|FG000|Overall Study|Adverse Event|2|||
106037415|NCT03519386|365802137|FG001|Overall Study|Adverse Event|1|||
106037416|NCT03519386|365802138|FG002|Overall Study|Adverse Event|2|||
106037417|NCT03519386|365802136|FG000|Overall Study|Explanted|2|||
106037418|NCT03519386|365802137|FG001|Overall Study|Explanted|1|||
106037419|NCT03519386|365802138|FG002|Overall Study|Explanted|0|||
106037420|NCT03519386|365802136|FG000|Overall Study|Ongoing in study|190|||
106037421|NCT03519386|365802137|FG001|Overall Study|Ongoing in study|192|||
106037422|NCT03519386|365802138|FG002|Overall Study|Ongoing in study|183|||
106037423|NCT02632838|365802139|FG000|Overall Study|Withdrawal by Subject|3|||
106037424|NCT02632838|365802140|FG001|Overall Study|Withdrawal by Subject|0|||
106037425|NCT02632838|365802139|FG000|Overall Study|Lost to Follow-up|0|||
106037426|NCT02632838|365802140|FG001|Overall Study|Lost to Follow-up|2|||
106037427|NCT03324581|365802145|FG000|Overall Study|Adverse Event|18|||
106037428|NCT03324581|365802146|FG001|Overall Study|Adverse Event|11|||
106037429|NCT03324581|365802147|FG002|Overall Study|Adverse Event|7|||
106037430|NCT03324581|365802145|FG000|Overall Study|Lack of Efficacy|0|||
106037431|NCT03324581|365802146|FG001|Overall Study|Lack of Efficacy|1|||
106037432|NCT03324581|365802147|FG002|Overall Study|Lack of Efficacy|0|||
106037433|NCT03324581|365802145|FG000|Overall Study|Lost to Follow-up|5|||
106037434|NCT03324581|365802146|FG001|Overall Study|Lost to Follow-up|3|||
106037435|NCT03324581|365802147|FG002|Overall Study|Lost to Follow-up|6|||
106037436|NCT03324581|365802145|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
106037437|NCT03324581|365802146|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
106037438|NCT03324581|365802147|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
106037439|NCT03324581|365802145|FG000|Overall Study|Physician Decision|0|||
106037440|NCT03324581|365802146|FG001|Overall Study|Physician Decision|1|||
106037441|NCT03324581|365802147|FG002|Overall Study|Physician Decision|2|||
106037442|NCT03324581|365802145|FG000|Overall Study|Protocol Deviation|8|||
106037443|NCT03324581|365802146|FG001|Overall Study|Protocol Deviation|9|||
106037444|NCT03324581|365802147|FG002|Overall Study|Protocol Deviation|4|||
106037445|NCT03324581|365802145|FG000|Overall Study|Withdrawal by Subject|6|||
106037446|NCT03324581|365802146|FG001|Overall Study|Withdrawal by Subject|8|||
106037447|NCT03324581|365802147|FG002|Overall Study|Withdrawal by Subject|6|||
106037448|NCT03324581|365802145|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
106037449|NCT03324581|365802146|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
106037450|NCT03324581|365802147|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
106037451|NCT00821327|365802148|FG000|Overall Study|Adverse Event|13|||
106037452|NCT00821327|365802148|FG000|Overall Study|Patient Request|1|||
106037453|NCT00821327|365802148|FG000|Overall Study|Investigator Request|2|||
106037454|NCT00821327|365802148|FG000|Overall Study|Sponsor Request|1|||
106037455|NCT00821327|365802148|FG000|Overall Study|Disease Progression|13|||
106037456|NCT00821327|365802148|FG000|Overall Study|Other/Unknown|5|||
106037457|NCT03783702|365802149|FG000|Overall Study|Lost to Follow-up|6|||
106037458|NCT03783702|365802150|FG001|Overall Study|Lost to Follow-up|8|||
106037459|NCT03783702|365802149|FG000|Overall Study|Protocol Violation|1|||
106037460|NCT03783702|365802150|FG001|Overall Study|Protocol Violation|3|||
106037461|NCT02274038|365802151|FG000|Overall Study|Death|1|||
106037462|NCT02942576|365802153|FG000|Overall Study|Adverse Event|28|||
106037463|NCT02942576|365802154|FG001|Overall Study|Adverse Event|6|||
106037464|NCT02942576|365802153|FG000|Overall Study|Withdrawal by Subject|7|||
106037465|NCT02942576|365802154|FG001|Overall Study|Withdrawal by Subject|5|||
106037466|NCT02942576|365802153|FG000|Overall Study|Physician Decision|1|||
106037467|NCT02942576|365802154|FG001|Overall Study|Physician Decision|4|||
106037468|NCT02942576|365802153|FG000|Overall Study|Other|10|||
106037469|NCT02942576|365802154|FG001|Overall Study|Other|8|||
106037470|NCT04473482|365802155|FG000|Overall Study|Death|0|||
106037471|NCT04473482|365802156|FG001|Overall Study|Death|3|||
106037472|NCT04473482|365802155|FG000|Overall Study|Lost to Follow-up|9|||
106037473|NCT04473482|365802156|FG001|Overall Study|Lost to Follow-up|7|||
106037474|NCT04473482|365802155|FG000|Overall Study|Withdrawal by Subject|2|||
106037475|NCT04473482|365802156|FG001|Overall Study|Withdrawal by Subject|1|||
106037476|NCT00459979|365802159|FG000|Overall Study|Withdrawal by Subject|1|||
106037477|NCT00459979|365802159|FG000|Overall Study|Protocol Violation|1|||
106037478|NCT00999921|365802160|FG000|Overall Study|Lost to Follow-up|10|||
106037479|NCT00999921|365802161|FG001|Overall Study|Lost to Follow-up|19|||
106037480|NCT00772070|365802167|FG000|Overall Study|Lost to Follow-up|0|||
106037481|NCT00772070|365802168|FG001|Overall Study|Lost to Follow-up|8|||
106037482|NCT00772070|365802167|FG000|Overall Study|Withdrawal by Subject|0|||
106037483|NCT00772070|365802168|FG001|Overall Study|Withdrawal by Subject|2|||
106037484|NCT00772070|365802167|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
106037485|NCT00772070|365802168|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
106037486|NCT03500679|365802173|FG000|Overall Study|Lost to Follow-up|6|||
106037487|NCT03500679|365802174|FG001|Overall Study|Lost to Follow-up|3|||
106037488|NCT03500679|365802173|FG000|Overall Study|Withdrawal by Subject|3|||
106037489|NCT03500679|365802174|FG001|Overall Study|Withdrawal by Subject|0|||
106037490|NCT01962922|365802175|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
106037491|NCT01962922|365802176|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
106037492|NCT01962922|365802175|FG000|PK Portion Day 7|non-compliance|1|||
106037493|NCT01962922|365802176|FG001|PK Portion Day 7|non-compliance|0|||
106037494|NCT01962922|365802175|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
106037495|NCT01962922|365802176|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
106037496|NCT01962922|365802175|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
106037497|NCT01962922|365802176|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
106037498|NCT04271280|365802177|FG000|Overall Study|Lost to Follow-up|300|||
106037499|NCT04271280|365802177|FG000|Overall Study|Death|153|||
106037500|NCT04271280|365802177|FG000|Overall Study|Withdrawal of consent by patient|59|||
106037501|NCT04271280|365802177|FG000|Overall Study|Other|51|||
106037502|NCT04271280|365802177|FG000|Overall Study|No end of study information|42|||
106037503|NCT00744471|365802178|FG000|Overall Study|Randomized but not treated|1|||
106037504|NCT00744471|365802179|FG001|Overall Study|Randomized but not treated|1|||
106037505|NCT00744471|365802180|FG002|Overall Study|Randomized but not treated|4|||
106037506|NCT00744471|365802181|FG003|Overall Study|Randomized but not treated|0|||
106037507|NCT00744471|365802178|FG000|Overall Study|Death|0|||
106037508|NCT00744471|365802179|FG001|Overall Study|Death|0|||
106037509|NCT00744471|365802180|FG002|Overall Study|Death|0|||
106037510|NCT00744471|365802181|FG003|Overall Study|Death|1|||
106037511|NCT00744471|365802178|FG000|Overall Study|Adverse Event|6|||
106037512|NCT00744471|365802179|FG001|Overall Study|Adverse Event|7|||
106037513|NCT00744471|365802180|FG002|Overall Study|Adverse Event|5|||
106037514|NCT00744471|365802181|FG003|Overall Study|Adverse Event|9|||
106037515|NCT00744471|365802178|FG000|Overall Study|Withdrawal by Subject|9|||
106037516|NCT00744471|365802179|FG001|Overall Study|Withdrawal by Subject|9|||
106037517|NCT00744471|365802180|FG002|Overall Study|Withdrawal by Subject|15|||
106037518|NCT00744471|365802181|FG003|Overall Study|Withdrawal by Subject|12|||
106037519|NCT00744471|365802178|FG000|Overall Study|Protocol Violation|1|||
106037520|NCT00744471|365802179|FG001|Overall Study|Protocol Violation|4|||
106037521|NCT00744471|365802180|FG002|Overall Study|Protocol Violation|1|||
106037522|NCT00744471|365802181|FG003|Overall Study|Protocol Violation|2|||
106037523|NCT00744471|365802178|FG000|Overall Study|Entered extension study|41|||
106037524|NCT00744471|365802179|FG001|Overall Study|Entered extension study|84|||
106037525|NCT00744471|365802180|FG002|Overall Study|Entered extension study|100|||
106037526|NCT00744471|365802181|FG003|Overall Study|Entered extension study|91|||
106037527|NCT00744471|365802178|FG000|Overall Study|Other|2|||
106037528|NCT00744471|365802179|FG001|Overall Study|Other|3|||
106037529|NCT00744471|365802180|FG002|Overall Study|Other|6|||
106037530|NCT00744471|365802181|FG003|Overall Study|Other|2|||
106037531|NCT00744471|365802178|FG000|Overall Study|Lack of Efficacy|83|||
106037532|NCT00744471|365802179|FG001|Overall Study|Lack of Efficacy|37|||
106037533|NCT00744471|365802180|FG002|Overall Study|Lack of Efficacy|19|||
106037534|NCT00744471|365802181|FG003|Overall Study|Lack of Efficacy|31|||
106037535|NCT00744471|365802178|FG000|Overall Study|Lost to Follow-up|0|||
106037536|NCT00744471|365802179|FG001|Overall Study|Lost to Follow-up|0|||
106037537|NCT00744471|365802180|FG002|Overall Study|Lost to Follow-up|2|||
106037538|NCT00744471|365802181|FG003|Overall Study|Lost to Follow-up|0|||
106037539|NCT02730208|365802188|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
106037540|NCT02730208|365802189|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
106037541|NCT00510952|365802193|FG000|Overall Study|Adverse Event|1|||
106037542|NCT00510952|365802194|FG001|Overall Study|Adverse Event|0|||
106037543|NCT00510952|365802193|FG000|Overall Study|Entry Criteria Not Met|3|||
106037544|NCT00510952|365802194|FG001|Overall Study|Entry Criteria Not Met|1|||
106037545|NCT00510952|365802193|FG000|Overall Study|Lost to Follow-up|5|||
106037546|NCT00510952|365802194|FG001|Overall Study|Lost to Follow-up|3|||
106037547|NCT00510952|365802193|FG000|Overall Study|Physician Decision|1|||
106037548|NCT00510952|365802194|FG001|Overall Study|Physician Decision|1|||
106037549|NCT00510952|365802193|FG000|Overall Study|Protocol Violation|7|||
106037550|NCT00510952|365802194|FG001|Overall Study|Protocol Violation|4|||
106037551|NCT00510952|365802193|FG000|Overall Study|Sponsor Decision|1|||
106037552|NCT00510952|365802194|FG001|Overall Study|Sponsor Decision|0|||
106037553|NCT00510952|365802193|FG000|Overall Study|Withdrawal by Subject|6|||
106037554|NCT00510952|365802194|FG001|Overall Study|Withdrawal by Subject|7|||
106037555|NCT00510952|365802193|FG000|Overall Study|Did Not Receive Study Drug|2|||
106037556|NCT00510952|365802194|FG001|Overall Study|Did Not Receive Study Drug|0|||
106037557|NCT01931202|365802196|FG000|Overall Study|Withdrawal by Subject|0|||
106037558|NCT01931202|365802197|FG001|Overall Study|Withdrawal by Subject|0|||
106037559|NCT01931202|365802198|FG002|Overall Study|Withdrawal by Subject|2|||
106037560|NCT01931202|365802196|FG000|Overall Study|Lost to Follow-up|0|||
106037561|NCT01931202|365802197|FG001|Overall Study|Lost to Follow-up|5|||
106037562|NCT01931202|365802198|FG002|Overall Study|Lost to Follow-up|2|||
106037563|NCT00458536|365802199|FG000|Overall Study|Disease progression prior to treatment|7|||
106037564|NCT00458536|365802199|FG000|Overall Study|Unable to make vaccine|3|||
106037565|NCT00458536|365802199|FG000|Overall Study|No measurable disease after surgery|2|||
106037566|NCT00458536|365802199|FG000|Overall Study|Did not have renal cell carcinoma|2|||
106037567|NCT00458536|365802199|FG000|Overall Study|Patient did not have surgery|1|||
106037568|NCT00458536|365802199|FG000|Overall Study|Ineligible due to toxicity|1|||
106037569|NCT00458536|365802199|FG000|Overall Study|Withdrawal by Subject|1|||
106037570|NCT00458536|365802199|FG000|Overall Study|Progressive disease during treatment|2|||
106037571|NCT02003365|365803598|FG000|Overall Study|Lost to Follow-up|0|||
106037572|NCT02003365|365803599|FG001|Overall Study|Lost to Follow-up|0|||
106037573|NCT02003365|365803600|FG002|Overall Study|Lost to Follow-up|1|||
106037574|NCT00543855|365803607|FG000|Overall Study|Adverse Event|3|||
106037575|NCT00543855|365803608|FG001|Overall Study|Adverse Event|1|||
106037576|NCT00543855|365803609|FG002|Overall Study|Adverse Event|3|||
106037577|NCT00543855|365803610|FG003|Overall Study|Adverse Event|4|||
106037578|NCT00543855|365803607|FG000|Overall Study|Lost to Follow-up|0|||
106037579|NCT00543855|365803608|FG001|Overall Study|Lost to Follow-up|0|||
106037580|NCT00543855|365803609|FG002|Overall Study|Lost to Follow-up|1|||
106037581|NCT00543855|365803610|FG003|Overall Study|Lost to Follow-up|0|||
106037582|NCT00543855|365803607|FG000|Overall Study|Withdrawal by Subject|0|||
106037583|NCT00543855|365803608|FG001|Overall Study|Withdrawal by Subject|1|||
106037584|NCT00543855|365803609|FG002|Overall Study|Withdrawal by Subject|2|||
106037585|NCT00543855|365803610|FG003|Overall Study|Withdrawal by Subject|0|||
106037586|NCT00543855|365803607|FG000|Overall Study|Protocol Violation|1|||
106037587|NCT00543855|365803608|FG001|Overall Study|Protocol Violation|0|||
106037588|NCT00543855|365803609|FG002|Overall Study|Protocol Violation|0|||
106037589|NCT00543855|365803610|FG003|Overall Study|Protocol Violation|0|||
106037590|NCT00622739|365803611|FG000|Overall Study|Physician Decision|1|||
106037591|NCT00622739|365803612|FG001|Overall Study|Physician Decision|0|||
106037592|NCT00622739|365803611|FG000|Overall Study|Adverse Event|1|||
106037593|NCT00622739|365803612|FG001|Overall Study|Adverse Event|2|||
106037594|NCT00622739|365803611|FG000|Overall Study|Lack of Efficacy|0|||
106037595|NCT00622739|365803612|FG001|Overall Study|Lack of Efficacy|2|||
106037596|NCT00622739|365803611|FG000|Overall Study|Withdrawal by Subject|0|||
106037597|NCT00622739|365803612|FG001|Overall Study|Withdrawal by Subject|1|||
106037598|NCT00622739|365803611|FG000|Overall Study|Lost to Follow-up|0|||
106037599|NCT00622739|365803612|FG001|Overall Study|Lost to Follow-up|1|||
106037600|NCT00562627|365803613|FG000|Overall Study|Protocol Violation|1|||
106037601|NCT00562627|365803614|FG001|Overall Study|Protocol Violation|1|||
106037602|NCT00562627|365803615|FG002|Overall Study|Protocol Violation|1|||
106037603|NCT04099251|365803616|FG000|Pre-Treatment|Other reasons|1|||
106037604|NCT04099251|365803617|FG001|Pre-Treatment|Other reasons|0|||
106037605|NCT04099251|365803616|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
106037606|NCT04099251|365803617|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
106037607|NCT04099251|365803616|FG000|Blinded Treatment Phase|Other reasons|16|||
106037608|NCT04099251|365803617|FG001|Blinded Treatment Phase|Other reasons|7|||
106037609|NCT04099251|365803616|FG000|Blinded Treatment Phase|Disease recurrence|26|||
106037610|NCT04099251|365803617|FG001|Blinded Treatment Phase|Disease recurrence|41|||
106037611|NCT04099251|365803616|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
106037612|NCT04099251|365803617|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
106037613|NCT04099251|365803616|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
106037614|NCT04099251|365803617|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
106037615|NCT04099251|365803616|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
106037616|NCT04099251|365803617|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
106037617|NCT04099251|365803616|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
106037618|NCT04099251|365803617|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
106037619|NCT04099251|365803616|FG000|Blinded Treatment Phase|Death|6|||
106037620|NCT04099251|365803617|FG001|Blinded Treatment Phase|Death|2|||
106037621|NCT04099251|365803616|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
106037622|NCT04099251|365803617|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
106037623|NCT04099251|365803616|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
106037624|NCT04099251|365803617|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
106037625|NCT04099251|365803616|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
106037626|NCT04099251|365803617|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
106037627|NCT04099251|365803616|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
106037628|NCT04099251|365803617|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
106037629|NCT04099251|365803616|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
106037630|NCT04099251|365803617|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
106037631|NCT04099251|365803616|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
106037632|NCT04099251|365803617|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
106037633|NCT04099251|365803616|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
106037634|NCT04099251|365803617|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
106037635|NCT04099251|365803616|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
106037636|NCT04099251|365803617|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
106037637|NCT04099251|365803616|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
106037638|NCT04099251|365803617|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
106037639|NCT00597701|365803618|FG000|Overall Study|Withdrawal by Subject|5|||
106037640|NCT00597701|365803619|FG001|Overall Study|Withdrawal by Subject|5|||
106037641|NCT00597701|365803618|FG000|Overall Study|Death|0|||
106037642|NCT00597701|365803619|FG001|Overall Study|Death|1|||
106037643|NCT00597701|365803618|FG000|Overall Study|Physician Decision|2|||
106037644|NCT00597701|365803619|FG001|Overall Study|Physician Decision|0|||
106037645|NCT00597701|365803618|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
106037646|NCT00597701|365803619|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
106037647|NCT01107418|365803620|FG000|Overall Study|Disease Progression|45|||
106037648|NCT01107418|365803620|FG000|Overall Study|Adverse Event|3|||
106037649|NCT01107418|365803620|FG000|Overall Study|Withdrawal by Subject|1|||
106037650|NCT01107418|365803620|FG000|Overall Study|Study Closing|1|||
106037651|NCT01107418|365803620|FG000|Overall Study|Started Other Therapy|1|||
106037652|NCT01107418|365803620|FG000|Overall Study|Entered Extension Study|1|||
106037653|NCT00076024|365803621|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
106037654|NCT00076024|365803622|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
106037655|NCT00076024|365803623|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
106037656|NCT00076024|365803624|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
106037657|NCT00076024|365803621|FG000|Phase 1, Lead-in|Adverse Event|1|||
106037658|NCT00076024|365803622|FG001|Phase 1, Lead-in|Adverse Event|0|||
106037659|NCT00076024|365803623|FG002|Phase 1, Lead-in|Adverse Event|0|||
106037660|NCT00076024|365803624|FG003|Phase 1, Lead-in|Adverse Event|0|||
106037661|NCT00076024|365803621|FG000|Phase 1, Lead-in|Clinical progression|1|||
106037662|NCT00076024|365803622|FG001|Phase 1, Lead-in|Clinical progression|0|||
106037663|NCT00076024|365803623|FG002|Phase 1, Lead-in|Clinical progression|0|||
106037664|NCT00076024|365803624|FG003|Phase 1, Lead-in|Clinical progression|0|||
106037665|NCT00076024|365803621|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
106037666|NCT00076024|365803622|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
106037667|NCT00076024|365803623|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
106037668|NCT00076024|365803624|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
106037669|NCT00076024|365803621|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
106037670|NCT00076024|365803622|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
106037671|NCT00076024|365803623|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
106037672|NCT00076024|365803624|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
106037673|NCT00076024|365803621|FG000|Phase 2, Double-blind|Adverse Event|0|||
106037674|NCT00076024|365803622|FG001|Phase 2, Double-blind|Adverse Event|25|||
106037675|NCT00076024|365803623|FG002|Phase 2, Double-blind|Adverse Event|6|||
106037676|NCT00076024|365803624|FG003|Phase 2, Double-blind|Adverse Event|0|||
106037677|NCT00076024|365803621|FG000|Phase 2, Double-blind|Un-specified|0|||
106037678|NCT00076024|365803622|FG001|Phase 2, Double-blind|Un-specified|14|||
106037679|NCT00076024|365803623|FG002|Phase 2, Double-blind|Un-specified|6|||
106037680|NCT00076024|365803624|FG003|Phase 2, Double-blind|Un-specified|0|||
106037681|NCT00076024|365803621|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
106037682|NCT00076024|365803622|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
106037683|NCT00076024|365803623|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
106037684|NCT00076024|365803624|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
106037685|NCT00076024|365803621|FG000|Phase 2, Open-label|Adverse Event|0|||
106037686|NCT00076024|365803622|FG001|Phase 2, Open-label|Adverse Event|0|||
106037687|NCT00076024|365803623|FG002|Phase 2, Open-label|Adverse Event|0|||
106037688|NCT00076024|365803624|FG003|Phase 2, Open-label|Adverse Event|2|||
106037689|NCT00076024|365803621|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
105858338|NCT02799095|365132741|FG004|Part C|Adverse Event|0|||
105858339|NCT02799095|365132742|FG005|Part C|Adverse Event|0|||
106037690|NCT00076024|365803622|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
106037691|NCT00076024|365803623|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
106037692|NCT00076024|365803624|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
106037693|NCT00076024|365803621|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
106037694|NCT00076024|365803622|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
105858340|NCT02799095|365132743|FG006|Part C|Adverse Event|0|||
105858341|NCT02799095|365132744|FG007|Part C|Adverse Event|0|||
106037695|NCT00076024|365803623|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
106037696|NCT00076024|365803624|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
106037697|NCT00076024|365803621|FG000|Phase 2, Open-label|Other|0|||
106037698|NCT00076024|365803622|FG001|Phase 2, Open-label|Other|0|||
106037699|NCT00076024|365803623|FG002|Phase 2, Open-label|Other|0|||
106037700|NCT00076024|365803624|FG003|Phase 2, Open-label|Other|2|||
106037701|NCT01155219|365803628|FG000|Overall Study|Adverse Event|3|||
106037702|NCT01155219|365803629|FG001|Overall Study|Adverse Event|1|||
106037703|NCT01155219|365803628|FG000|Overall Study|non-medical reason|1|||
106037704|NCT01155219|365803629|FG001|Overall Study|non-medical reason|2|||
106037705|NCT03150485|365803630|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
106037706|NCT03150485|365803631|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
106037707|NCT03150485|365803632|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
106037708|NCT03150485|365803633|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
106037709|NCT03150485|365803634|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
106037710|NCT03150485|365803635|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
106037711|NCT03206073|365803637|FG000|Overall Study|Participant Noncompliance|0|||
106037712|NCT03206073|365803638|FG001|Overall Study|Participant Noncompliance|1|||
106037713|NCT03206073|365803639|FG002|Overall Study|Participant Noncompliance|0|||
106037714|NCT03206073|365803640|FG003|Overall Study|Participant Noncompliance|0|||
106037715|NCT03206073|365803637|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
106037716|NCT03206073|365803638|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
106037717|NCT03206073|365803639|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
106037718|NCT03206073|365803640|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
106037719|NCT03206073|365803637|FG000|Overall Study|Death|0|||
106037720|NCT03206073|365803638|FG001|Overall Study|Death|0|||
106037721|NCT03206073|365803639|FG002|Overall Study|Death|1|||
106037722|NCT03206073|365803640|FG003|Overall Study|Death|0|||
106037723|NCT03206073|365803637|FG000|Overall Study|Taken off active treatment|0|||
106037724|NCT03206073|365803638|FG001|Overall Study|Taken off active treatment|0|||
106037725|NCT03206073|365803639|FG002|Overall Study|Taken off active treatment|3|||
106037726|NCT03206073|365803640|FG003|Overall Study|Taken off active treatment|0|||
106037727|NCT01394718|365803642|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
106037728|NCT01394718|365803643|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
106037729|NCT04006119|365803644|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
106037730|NCT04006119|365803644|FG000|End of Treatment Veledimex|Adverse Event|2|||
106037731|NCT04006119|365803644|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
106037732|NCT04006119|365803644|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
106037733|NCT04006119|365803644|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
106037734|NCT04006119|365803644|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
106037735|NCT01711879|365803645|FG000|Overall Study|Death|1|||
106037736|NCT01711879|365803646|FG001|Overall Study|Death|0|||
106037737|NCT05128929|365803649|FG000|Overall Study|Adverse Event|0|||
106037738|NCT05128929|365803650|FG001|Overall Study|Adverse Event|1|||
106037739|NCT03220438|365803651|FG000|Overall Study|Lost to Follow-up|0|||
106037740|NCT03220438|365803652|FG001|Overall Study|Lost to Follow-up|0|||
106037741|NCT03220438|365803653|FG002|Overall Study|Lost to Follow-up|1|||
106037742|NCT03220438|365803654|FG003|Overall Study|Lost to Follow-up|0|||
106037743|NCT04062123|365803655|FG000|Overall Study|Withdrawal by Subject|0|||
106037744|NCT04062123|365803656|FG001|Overall Study|Withdrawal by Subject|1|||
106037745|NCT04062123|365803657|FG002|Overall Study|Withdrawal by Subject|0|||
106037746|NCT00417482|365803660|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
106037747|NCT00417482|365803661|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
106037748|NCT00417482|365803662|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
106037749|NCT00417482|365803660|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
106037750|NCT00417482|365803661|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
106037751|NCT00417482|365803662|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
106037752|NCT00417482|365803660|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
106037753|NCT00417482|365803661|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
106037754|NCT00417482|365803662|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
106037755|NCT00417482|365803660|FG000|Phase B 1st 16 Weeks|Death|1|||
106037756|NCT00417482|365803661|FG001|Phase B 1st 16 Weeks|Death|0|||
106037757|NCT00417482|365803662|FG002|Phase B 1st 16 Weeks|Death|0|||
106037758|NCT00417482|365803660|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
106037759|NCT00417482|365803661|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
106037760|NCT00417482|365803662|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
106037761|NCT00417482|365803660|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
106037762|NCT00417482|365803661|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
106037763|NCT00417482|365803662|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
106037764|NCT00417482|365803660|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
106037765|NCT00417482|365803661|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
106037766|NCT00417482|365803662|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
106037767|NCT00417482|365803660|FG000|Phase B 2nd 16 Weeks|Death|1|||
106037768|NCT00417482|365803661|FG001|Phase B 2nd 16 Weeks|Death|1|||
106037769|NCT00417482|365803662|FG002|Phase B 2nd 16 Weeks|Death|0|||
105858342|NCT02799095|365132745|FG008|Part C|Adverse Event|0|||
105858343|NCT02799095|365132746|FG009|Part C|Adverse Event|0|||
105858344|NCT02799095|365132747|FG010|Part C|Adverse Event|3|||
105858345|NCT02799095|365132748|FG011|Part C|Adverse Event|1|||
105858346|NCT02799095|365132749|FG012|Part C|Adverse Event|0|||
105858347|NCT02799095|365132750|FG013|Part C|Adverse Event|1|||
105858348|NCT02799095|365132751|FG014|Part C|Adverse Event|0|||
105858349|NCT02799095|365132752|FG015|Part C|Adverse Event|0|||
105858350|NCT02799095|365132753|FG016|Part C|Adverse Event|0|||
105858351|NCT02799095|365132737|FG000|Part C|Death|0|||
105858352|NCT02799095|365132738|FG001|Part C|Death|0|||
105858353|NCT02799095|365132739|FG002|Part C|Death|0|||
105858354|NCT02799095|365132740|FG003|Part C|Death|0|||
105858355|NCT02799095|365132741|FG004|Part C|Death|0|||
105858356|NCT02799095|365132742|FG005|Part C|Death|0|||
105858357|NCT02799095|365132743|FG006|Part C|Death|0|||
105858358|NCT02799095|365132744|FG007|Part C|Death|0|||
105858359|NCT02799095|365132745|FG008|Part C|Death|0|||
105858360|NCT02799095|365132746|FG009|Part C|Death|0|||
105858361|NCT02799095|365132747|FG010|Part C|Death|7|||
105858362|NCT02799095|365132748|FG011|Part C|Death|5|||
105858363|NCT02799095|365132749|FG012|Part C|Death|6|||
105858364|NCT02799095|365132750|FG013|Part C|Death|8|||
105858365|NCT02799095|365132751|FG014|Part C|Death|1|||
105858366|NCT02799095|365132752|FG015|Part C|Death|8|||
105858367|NCT02799095|365132753|FG016|Part C|Death|1|||
105858368|NCT02799095|365132737|FG000|Part C|Lost to Follow-up|0|||
105858369|NCT02799095|365132738|FG001|Part C|Lost to Follow-up|0|||
105858370|NCT02799095|365132739|FG002|Part C|Lost to Follow-up|0|||
105858371|NCT02799095|365132740|FG003|Part C|Lost to Follow-up|0|||
105858372|NCT02799095|365132741|FG004|Part C|Lost to Follow-up|0|||
105858373|NCT02799095|365132742|FG005|Part C|Lost to Follow-up|0|||
105858374|NCT02799095|365132743|FG006|Part C|Lost to Follow-up|0|||
105858375|NCT02799095|365132744|FG007|Part C|Lost to Follow-up|0|||
105858376|NCT02799095|365132745|FG008|Part C|Lost to Follow-up|0|||
105858377|NCT02799095|365132746|FG009|Part C|Lost to Follow-up|0|||
105858378|NCT02799095|365132747|FG010|Part C|Lost to Follow-up|1|||
105858379|NCT02799095|365132748|FG011|Part C|Lost to Follow-up|1|||
105858380|NCT02799095|365132749|FG012|Part C|Lost to Follow-up|1|||
105858381|NCT02799095|365132750|FG013|Part C|Lost to Follow-up|3|||
105858382|NCT02799095|365132751|FG014|Part C|Lost to Follow-up|0|||
105858383|NCT02799095|365132752|FG015|Part C|Lost to Follow-up|0|||
105858384|NCT02799095|365132753|FG016|Part C|Lost to Follow-up|0|||
105858385|NCT02799095|365132737|FG000|Part C|Progressive Disease|0|||
105858386|NCT02799095|365132738|FG001|Part C|Progressive Disease|0|||
105858387|NCT02799095|365132739|FG002|Part C|Progressive Disease|0|||
105858388|NCT02799095|365132740|FG003|Part C|Progressive Disease|0|||
105858389|NCT02799095|365132741|FG004|Part C|Progressive Disease|0|||
105858390|NCT02799095|365132742|FG005|Part C|Progressive Disease|0|||
105858391|NCT02799095|365132743|FG006|Part C|Progressive Disease|0|||
105858392|NCT02799095|365132744|FG007|Part C|Progressive Disease|0|||
105858393|NCT02799095|365132745|FG008|Part C|Progressive Disease|0|||
105858394|NCT02799095|365132746|FG009|Part C|Progressive Disease|2|||
105858395|NCT02799095|365132747|FG010|Part C|Progressive Disease|13|||
106037770|NCT00829283|365803663|FG000|Overall Study|Lost to Follow-up|7|||
106037771|NCT00829283|365803664|FG001|Overall Study|Lost to Follow-up|25|||
106037772|NCT00667446|365803665|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
106037773|NCT00667446|365803666|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
106037774|NCT00667446|365803665|FG000|Treatment Period (36 Months)|Other|2|||
106037775|NCT00667446|365803666|FG001|Treatment Period (36 Months)|Other|2|||
106037776|NCT00667446|365803665|FG000|Treatment Period (36 Months)|Personal reasons|2|||
106037777|NCT00667446|365803666|FG001|Treatment Period (36 Months)|Personal reasons|2|||
106037778|NCT00667446|365803665|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
106037779|NCT00667446|365803666|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
106037780|NCT00667446|365803665|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
106037781|NCT00667446|365803666|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
106037782|NCT00667446|365803665|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
106037783|NCT00667446|365803666|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
106037784|NCT00667446|365803665|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
106037785|NCT00667446|365803666|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
106037786|NCT00667446|365803665|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
106037787|NCT00667446|365803666|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
106037788|NCT00667446|365803665|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
106037789|NCT00667446|365803666|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
106037790|NCT00136604|365803667|FG000|Overall Study|Lost to Follow-up|1|||
106037791|NCT00136604|365803668|FG001|Overall Study|Lost to Follow-up|0|||
106037792|NCT00136604|365803669|FG002|Overall Study|Lost to Follow-up|0|||
106037793|NCT00136604|365803670|FG003|Overall Study|Lost to Follow-up|0|||
106037794|NCT00136604|365803671|FG004|Overall Study|Lost to Follow-up|1|||
106037795|NCT00136604|365803667|FG000|Overall Study|Migrated/moved from study area|0|||
106037796|NCT00136604|365803668|FG001|Overall Study|Migrated/moved from study area|1|||
106037797|NCT00136604|365803669|FG002|Overall Study|Migrated/moved from study area|0|||
106037798|NCT00136604|365803670|FG003|Overall Study|Migrated/moved from study area|0|||
106037799|NCT00136604|365803671|FG004|Overall Study|Migrated/moved from study area|0|||
106037800|NCT03945175|365803673|FG000|Overall Study|Did not meet inclusion criteria|31|||
106037801|NCT03945175|365803673|FG000|Overall Study|Withdrew consent|2|||
106037802|NCT03945175|365803673|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
106037803|NCT03945175|365803673|FG000|Overall Study|Early termination during Mydayis treatment|1|||
106037804|NCT00870233|365803677|FG000|Overall Study|Withdrawal by Subject|18|||
106037805|NCT00870233|365803677|FG000|Overall Study|Did not undergo laparotomy|3|||
106037806|NCT00870233|365803677|FG000|Overall Study|Incompatible internet browser|2|||
106037807|NCT00870233|365803677|FG000|Overall Study|Death|1|||
106037808|NCT01233687|365803679|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
106037809|NCT01233687|365803679|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
106037810|NCT01233687|365803679|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
106037811|NCT01858636|365803680|FG000|Overall Study|No Device Deployment Attempted|24|||
106037812|NCT01858636|365803680|FG000|Overall Study|Physician Decision|1|||
106037813|NCT01858636|365803680|FG000|Overall Study|Death|1|||
106037814|NCT01858636|365803680|FG000|Overall Study|Lost to Follow-up|1|||
106037815|NCT01858636|365803680|FG000|Overall Study|Withdrawal by Subject|1|||
106037816|NCT00006389|365803683|FG000|Overall Study|Adverse Event|1|||
106037817|NCT01227564|365803684|FG000|Overall Study|No Longer Willing to Participate|4|||
106037818|NCT01227564|365803685|FG001|Overall Study|No Longer Willing to Participate|2|||
106037819|NCT01227564|365803686|FG002|Overall Study|No Longer Willing to Participate|5|||
106037820|NCT01227564|365803684|FG000|Overall Study|Participant moved to another town|0|||
106037821|NCT01227564|365803685|FG001|Overall Study|Participant moved to another town|0|||
106037822|NCT01227564|365803686|FG002|Overall Study|Participant moved to another town|1|||
106037823|NCT00989573|365803698|FG000|Overall Study|Adverse Event|8|||
106037824|NCT00989573|365803699|FG001|Overall Study|Adverse Event|12|||
106037825|NCT00989573|365803700|FG002|Overall Study|Adverse Event|4|||
106037826|NCT00989573|365803698|FG000|Overall Study|Physician Decision|0|||
106037827|NCT00989573|365803699|FG001|Overall Study|Physician Decision|2|||
106037828|NCT00989573|365803700|FG002|Overall Study|Physician Decision|0|||
106037829|NCT00989573|365803698|FG000|Overall Study|Protocol Violation|1|||
106037830|NCT00989573|365803699|FG001|Overall Study|Protocol Violation|1|||
106037831|NCT00989573|365803700|FG002|Overall Study|Protocol Violation|1|||
106037832|NCT00989573|365803698|FG000|Overall Study|Withdrawal by Subject|4|||
106037833|NCT00989573|365803699|FG001|Overall Study|Withdrawal by Subject|7|||
105858396|NCT02799095|365132748|FG011|Part C|Progressive Disease|2|||
105858397|NCT02799095|365132749|FG012|Part C|Progressive Disease|0|||
106037834|NCT00989573|365803700|FG002|Overall Study|Withdrawal by Subject|3|||
106037835|NCT00194675|365803702|FG000|Overall Study|Lost to Follow-up|1|||
106037836|NCT00194675|365803703|FG001|Overall Study|Lost to Follow-up|1|||
106037837|NCT00194675|365803702|FG000|Overall Study|lack of interest|1|||
106037838|NCT00194675|365803703|FG001|Overall Study|lack of interest|1|||
106037839|NCT00194675|365803702|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
106037840|NCT00194675|365803703|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
106037841|NCT00194675|365803702|FG000|Overall Study|Protocol Violation|1|||
106037842|NCT00194675|365803703|FG001|Overall Study|Protocol Violation|0|||
106037843|NCT00194675|365803702|FG000|Overall Study|Death|1|||
106037844|NCT00194675|365803703|FG001|Overall Study|Death|0|||
106037845|NCT01476644|365803706|FG000|Overall Study|Death|5|||
106037846|NCT01476644|365803706|FG000|Overall Study|moved to another state|2|||
106037847|NCT01476644|365803706|FG000|Overall Study|Lost to Follow-up|19|||
106037848|NCT01476644|365803706|FG000|Overall Study|Withdrawal by Subject|13|||
106037849|NCT00976573|365803707|FG000|Overall Study|Ineligible|0|||
106037850|NCT00976573|365803708|FG001|Overall Study|Ineligible|1|||
106037851|NCT00976573|365803707|FG000|Overall Study|Cancel prior to receiving treatment|4|||
106037852|NCT00976573|365803708|FG001|Overall Study|Cancel prior to receiving treatment|2|||
106037853|NCT04597918|365803713|FG000|Overall Study|Withdrawal by Subject|6|||
106037854|NCT04597918|365803713|FG000|Overall Study|Lost to Follow-up|3|||
106037855|NCT04597918|365803713|FG000|Overall Study|Death|1|||
106037856|NCT01015131|365803715|FG000|Overall Study|Physician Decision|1|||
106037857|NCT01015131|365803715|FG000|Overall Study|Protocol Violation|1|||
106037858|NCT01015131|365803715|FG000|Overall Study|Withdrawal by Subject|2|||
106037859|NCT01015131|365803715|FG000|Overall Study|Other Protocol Specified Criteria|4|||
106037860|NCT02775903|365803720|FG000|Overall Study|Death|7|||
106037861|NCT02775903|365803721|FG001|Overall Study|Death|11|||
106037862|NCT02775903|365803722|FG002|Overall Study|Death|12|||
106037863|NCT02775903|365803723|FG003|Overall Study|Death|11|||
106037864|NCT02775903|365803720|FG000|Overall Study|Adverse Event|0|||
106037865|NCT02775903|365803721|FG001|Overall Study|Adverse Event|1|||
106037866|NCT02775903|365803722|FG002|Overall Study|Adverse Event|12|||
106037867|NCT02775903|365803723|FG003|Overall Study|Adverse Event|3|||
106037868|NCT02775903|365803720|FG000|Overall Study|Progressive disease|15|||
106037869|NCT02775903|365803721|FG001|Overall Study|Progressive disease|14|||
106037870|NCT02775903|365803722|FG002|Overall Study|Progressive disease|30|||
106037871|NCT02775903|365803723|FG003|Overall Study|Progressive disease|20|||
106037872|NCT02775903|365803720|FG000|Overall Study|Lack of Efficacy|2|||
106037873|NCT02775903|365803721|FG001|Overall Study|Lack of Efficacy|2|||
106037874|NCT02775903|365803722|FG002|Overall Study|Lack of Efficacy|2|||
106037875|NCT02775903|365803723|FG003|Overall Study|Lack of Efficacy|6|||
106037876|NCT02775903|365803720|FG000|Overall Study|Withdrawal by Subject|7|||
106037877|NCT02775903|365803721|FG001|Overall Study|Withdrawal by Subject|5|||
106037878|NCT02775903|365803722|FG002|Overall Study|Withdrawal by Subject|5|||
106037879|NCT02775903|365803723|FG003|Overall Study|Withdrawal by Subject|8|||
106037880|NCT02775903|365803720|FG000|Overall Study|Other reasons|7|||
106037881|NCT02775903|365803721|FG001|Overall Study|Other reasons|8|||
106037882|NCT02775903|365803722|FG002|Overall Study|Other reasons|2|||
106037883|NCT02775903|365803723|FG003|Overall Study|Other reasons|12|||
106037884|NCT04041700|365803724|FG000|Overall Study|Pregnancy|1|||
106037885|NCT04041700|365803724|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
106037886|NCT05140382|365803725|FG000|Overall Study|Death|3|||
106037887|NCT05140382|365803726|FG001|Overall Study|Death|0|||
106037888|NCT05140382|365803727|FG002|Overall Study|Death|0|||
106037889|NCT05140382|365803725|FG000|Overall Study|Investigator decision|1|||
106037890|NCT05140382|365803726|FG001|Overall Study|Investigator decision|0|||
106037891|NCT05140382|365803727|FG002|Overall Study|Investigator decision|0|||
106037892|NCT05140382|365803725|FG000|Overall Study|Other|4|||
106037893|NCT05140382|365803726|FG001|Overall Study|Other|0|||
106037894|NCT05140382|365803727|FG002|Overall Study|Other|1|||
106037895|NCT05140382|365803725|FG000|Overall Study|Progressive disease|20|||
106037896|NCT05140382|365803726|FG001|Overall Study|Progressive disease|1|||
106037897|NCT05140382|365803727|FG002|Overall Study|Progressive disease|12|||
106037898|NCT05140382|365803725|FG000|Overall Study|Subjective disease progression|2|||
106037899|NCT05140382|365803726|FG001|Overall Study|Subjective disease progression|1|||
106037900|NCT05140382|365803727|FG002|Overall Study|Subjective disease progression|0|||
106037901|NCT05140382|365803725|FG000|Overall Study|Unknown at data cut-off|0|||
106037902|NCT05140382|365803726|FG001|Overall Study|Unknown at data cut-off|0|||
106037903|NCT05140382|365803727|FG002|Overall Study|Unknown at data cut-off|1|||
106037904|NCT05140382|365803725|FG000|Overall Study|Withdrawal by Subject|1|||
106037905|NCT05140382|365803726|FG001|Overall Study|Withdrawal by Subject|0|||
106037906|NCT05140382|365803727|FG002|Overall Study|Withdrawal by Subject|4|||
106037907|NCT05140382|365803725|FG000|Overall Study|Withdrawal of consent|0|||
106037908|NCT05140382|365803726|FG001|Overall Study|Withdrawal of consent|0|||
106037909|NCT05140382|365803727|FG002|Overall Study|Withdrawal of consent|1|||
106037910|NCT00884377|365805295|FG000|Overall Study|Withdrawal by Subject|1|||
106037911|NCT00884377|365805296|FG001|Overall Study|Withdrawal by Subject|0|||
106037912|NCT00884377|365805295|FG000|Overall Study|Could not confirm diagnosis|1|||
106037913|NCT00884377|365805296|FG001|Overall Study|Could not confirm diagnosis|0|||
106037914|NCT00884377|365805295|FG000|Overall Study|Physician Decision|0|||
106037915|NCT00884377|365805296|FG001|Overall Study|Physician Decision|1|||
106037916|NCT01683019|365805297|FG000|Overall Study|Withdrawal by Subject|2|||
106037917|NCT01683019|365805298|FG001|Overall Study|Withdrawal by Subject|1|||
106037918|NCT01683019|365805299|FG002|Overall Study|Withdrawal by Subject|4|||
106037919|NCT04854642|365805300|FG000|Overall Study|Adverse Event|1|||
105858398|NCT02799095|365132750|FG013|Part C|Progressive Disease|1|||
105858399|NCT02799095|365132751|FG014|Part C|Progressive Disease|0|||
105858400|NCT02799095|365132752|FG015|Part C|Progressive Disease|0|||
105858401|NCT02799095|365132753|FG016|Part C|Progressive Disease|0|||
105858402|NCT02799095|365132737|FG000|Part C|Clinical Progression|0|||
105858403|NCT02799095|365132738|FG001|Part C|Clinical Progression|0|||
105858404|NCT02799095|365132739|FG002|Part C|Clinical Progression|0|||
105858405|NCT02799095|365132740|FG003|Part C|Clinical Progression|0|||
105858406|NCT02799095|365132741|FG004|Part C|Clinical Progression|0|||
105858407|NCT02799095|365132742|FG005|Part C|Clinical Progression|0|||
105858408|NCT02799095|365132743|FG006|Part C|Clinical Progression|0|||
105858409|NCT02799095|365132744|FG007|Part C|Clinical Progression|0|||
105858410|NCT02799095|365132745|FG008|Part C|Clinical Progression|0|||
105858411|NCT02799095|365132746|FG009|Part C|Clinical Progression|1|||
105858412|NCT02799095|365132747|FG010|Part C|Clinical Progression|3|||
105858413|NCT02799095|365132748|FG011|Part C|Clinical Progression|0|||
105858414|NCT02799095|365132749|FG012|Part C|Clinical Progression|0|||
105858415|NCT02799095|365132750|FG013|Part C|Clinical Progression|1|||
105858416|NCT02799095|365132751|FG014|Part C|Clinical Progression|0|||
105858417|NCT02799095|365132752|FG015|Part C|Clinical Progression|0|||
105858418|NCT02799095|365132753|FG016|Part C|Clinical Progression|0|||
105858419|NCT02799095|365132737|FG000|Part C|Withdrawal by Subject|0|||
105858420|NCT02799095|365132738|FG001|Part C|Withdrawal by Subject|0|||
105858421|NCT02799095|365132739|FG002|Part C|Withdrawal by Subject|0|||
105858422|NCT02799095|365132740|FG003|Part C|Withdrawal by Subject|0|||
105858423|NCT02799095|365132741|FG004|Part C|Withdrawal by Subject|0|||
105858424|NCT02799095|365132742|FG005|Part C|Withdrawal by Subject|0|||
105858425|NCT02799095|365132743|FG006|Part C|Withdrawal by Subject|0|||
105858426|NCT02799095|365132744|FG007|Part C|Withdrawal by Subject|0|||
105858427|NCT02799095|365132745|FG008|Part C|Withdrawal by Subject|0|||
105858428|NCT02799095|365132746|FG009|Part C|Withdrawal by Subject|0|||
105858429|NCT02799095|365132747|FG010|Part C|Withdrawal by Subject|13|||
105858430|NCT02799095|365132748|FG011|Part C|Withdrawal by Subject|15|||
105858431|NCT02799095|365132749|FG012|Part C|Withdrawal by Subject|13|||
105858432|NCT02799095|365132750|FG013|Part C|Withdrawal by Subject|21|||
105858433|NCT02799095|365132751|FG014|Part C|Withdrawal by Subject|0|||
105858434|NCT02799095|365132752|FG015|Part C|Withdrawal by Subject|12|||
105858435|NCT02799095|365132753|FG016|Part C|Withdrawal by Subject|1|||
105858436|NCT02799095|365132737|FG000|Part C|Physician Decision|0|||
105858437|NCT02799095|365132738|FG001|Part C|Physician Decision|0|||
105858438|NCT02799095|365132739|FG002|Part C|Physician Decision|0|||
105858439|NCT02799095|365132740|FG003|Part C|Physician Decision|0|||
105858440|NCT02799095|365132741|FG004|Part C|Physician Decision|0|||
105858441|NCT02799095|365132742|FG005|Part C|Physician Decision|0|||
105858442|NCT02799095|365132743|FG006|Part C|Physician Decision|0|||
105858443|NCT02799095|365132744|FG007|Part C|Physician Decision|0|||
105858444|NCT02799095|365132745|FG008|Part C|Physician Decision|0|||
105858445|NCT02799095|365132746|FG009|Part C|Physician Decision|0|||
105858446|NCT02799095|365132747|FG010|Part C|Physician Decision|1|||
105858447|NCT02799095|365132748|FG011|Part C|Physician Decision|0|||
105858448|NCT02799095|365132749|FG012|Part C|Physician Decision|0|||
105858449|NCT02799095|365132750|FG013|Part C|Physician Decision|0|||
105858450|NCT02799095|365132751|FG014|Part C|Physician Decision|0|||
105858451|NCT02799095|365132752|FG015|Part C|Physician Decision|0|||
105858452|NCT02799095|365132753|FG016|Part C|Physician Decision|0|||
105858453|NCT02799095|365132737|FG000|Part C|Other|0|||
105858454|NCT02799095|365132738|FG001|Part C|Other|0|||
105858455|NCT02799095|365132739|FG002|Part C|Other|0|||
105858456|NCT02799095|365132740|FG003|Part C|Other|0|||
105858457|NCT02799095|365132741|FG004|Part C|Other|0|||
105858458|NCT02799095|365132742|FG005|Part C|Other|0|||
105858459|NCT02799095|365132743|FG006|Part C|Other|0|||
105858460|NCT02799095|365132744|FG007|Part C|Other|0|||
105858461|NCT02799095|365132745|FG008|Part C|Other|0|||
105858462|NCT02799095|365132746|FG009|Part C|Other|0|||
105858463|NCT02799095|365132747|FG010|Part C|Other|0|||
105858464|NCT02799095|365132748|FG011|Part C|Other|2|||
105858465|NCT02799095|365132749|FG012|Part C|Other|2|||
105858466|NCT02799095|365132750|FG013|Part C|Other|0|||
105858467|NCT02799095|365132751|FG014|Part C|Other|0|||
105858468|NCT02799095|365132752|FG015|Part C|Other|0|||
105858469|NCT02799095|365132753|FG016|Part C|Other|0|||
105858470|NCT04347122|365132754|FG000|Overall Study|Physician Decision|0|||
105858471|NCT04347122|365132755|FG001|Overall Study|Physician Decision|3|||
105858472|NCT04347122|365132756|FG002|Overall Study|Physician Decision|3|||
105858473|NCT04347122|365132757|FG003|Overall Study|Physician Decision|6|||
105858474|NCT04663295|365132760|FG000|Run-in Period|Withdrawal by Subject|3|||
106037920|NCT04854642|365805301|FG001|Overall Study|Adverse Event|2|||
106037921|NCT04854642|365805300|FG000|Overall Study|Withdrawal by Subject|0|||
106037922|NCT04854642|365805301|FG001|Overall Study|Withdrawal by Subject|1|||
106037923|NCT02395016|365805302|FG000|Overall Study|Adverse Event|4|||
106037924|NCT02395016|365805303|FG001|Overall Study|Adverse Event|3|||
106037925|NCT02395016|365805302|FG000|Overall Study|Withdrawal by Subject|9|||
106037926|NCT02395016|365805303|FG001|Overall Study|Withdrawal by Subject|6|||
106037927|NCT02395016|365805302|FG000|Overall Study|Protocol Violation|2|||
105858475|NCT04663295|365132760|FG000|Overall Study Period|Pregnancy|1|||
105858476|NCT04663295|365132760|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
105858477|NCT02932306|365132766|FG000|Overall Study|Withdrawal by Subject|16|||
105858478|NCT02932306|365132767|FG001|Overall Study|Withdrawal by Subject|25|||
105858479|NCT02932306|365132766|FG000|Overall Study|Adverse Event|3|||
105858480|NCT02932306|365132767|FG001|Overall Study|Adverse Event|0|||
105858481|NCT02932306|365132766|FG000|Overall Study|Pregnancy|2|||
105858482|NCT02932306|365132767|FG001|Overall Study|Pregnancy|0|||
105858483|NCT02932306|365132766|FG000|Overall Study|Protocol Violation|1|||
105858484|NCT02932306|365132767|FG001|Overall Study|Protocol Violation|1|||
105858485|NCT02932306|365132766|FG000|Overall Study|Noncompliance with Study Drug|1|||
105858486|NCT02932306|365132767|FG001|Overall Study|Noncompliance with Study Drug|1|||
105858487|NCT02932306|365132766|FG000|Overall Study|Lost to Follow-up|36|||
105858488|NCT02932306|365132767|FG001|Overall Study|Lost to Follow-up|40|||
105858489|NCT02932306|365132766|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
105858490|NCT02932306|365132767|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
105858491|NCT02932306|365132766|FG000|Overall Study|Lack of Efficacy|0|||
105858492|NCT02932306|365132767|FG001|Overall Study|Lack of Efficacy|2|||
105858493|NCT02932306|365132766|FG000|Overall Study|Worsening condition|2|||
105858494|NCT02932306|365132767|FG001|Overall Study|Worsening condition|0|||
105858495|NCT02932306|365132766|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
105858496|NCT02932306|365132767|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
105858497|NCT02116608|365132769|FG000|Overall Study|Lost to Follow-up|0|||
105858498|NCT02116608|365132770|FG001|Overall Study|Lost to Follow-up|0|||
105858499|NCT02116608|365132771|FG002|Overall Study|Lost to Follow-up|1|||
105858500|NCT02116608|365132769|FG000|Overall Study|Physician Decision|0|||
105858501|NCT02116608|365132770|FG001|Overall Study|Physician Decision|1|||
105858502|NCT02116608|365132771|FG002|Overall Study|Physician Decision|0|||
105858503|NCT02116608|365132769|FG000|Overall Study|Death|0|||
105858504|NCT02116608|365132770|FG001|Overall Study|Death|1|||
105858505|NCT02116608|365132771|FG002|Overall Study|Death|0|||
105858506|NCT00552578|365132774|FG000|Overall Study|Lost to Follow-up|1|||
105858507|NCT00552578|365132775|FG001|Overall Study|Lost to Follow-up|1|||
105858508|NCT03400943|365132776|FG000|Treatment Period 1|Adverse Event|0|||
105858509|NCT03400943|365132777|FG001|Treatment Period 1|Adverse Event|0|||
105858510|NCT03400943|365132778|FG002|Treatment Period 1|Adverse Event|0|||
105858511|NCT03400943|365132779|FG003|Treatment Period 1|Adverse Event|1|||
105858512|NCT03400943|365132776|FG000|Treatment Period 1|Lost to Follow-up|1|||
105858513|NCT03400943|365132777|FG001|Treatment Period 1|Lost to Follow-up|0|||
105858514|NCT03400943|365132778|FG002|Treatment Period 1|Lost to Follow-up|0|||
105858515|NCT03400943|365132779|FG003|Treatment Period 1|Lost to Follow-up|0|||
105858516|NCT03400943|365132776|FG000|Treatment Period 1|Protocol Violation|0|||
105858517|NCT03400943|365132777|FG001|Treatment Period 1|Protocol Violation|1|||
105858518|NCT03400943|365132778|FG002|Treatment Period 1|Protocol Violation|1|||
105858519|NCT03400943|365132779|FG003|Treatment Period 1|Protocol Violation|0|||
105858520|NCT03400943|365132776|FG000|Treatment Period 1|Study terminated by sponsor|2|||
105858521|NCT03400943|365132777|FG001|Treatment Period 1|Study terminated by sponsor|0|||
105858522|NCT03400943|365132778|FG002|Treatment Period 1|Study terminated by sponsor|0|||
105858523|NCT03400943|365132779|FG003|Treatment Period 1|Study terminated by sponsor|1|||
105858524|NCT03400943|365132776|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105858525|NCT03400943|365132777|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105858526|NCT03400943|365132778|FG002|Treatment Period 1|Withdrawal by Subject|3|||
105858527|NCT03400943|365132779|FG003|Treatment Period 1|Withdrawal by Subject|1|||
105858528|NCT03400943|365132776|FG000|Treatment Period 1|Other|2|||
105858529|NCT03400943|365132777|FG001|Treatment Period 1|Other|1|||
105858530|NCT03400943|365132778|FG002|Treatment Period 1|Other|2|||
105858531|NCT03400943|365132779|FG003|Treatment Period 1|Other|2|||
105858532|NCT03400943|365132776|FG000|Post-treatment Period 1|Adverse Event|2|||
105858533|NCT03400943|365132777|FG001|Post-treatment Period 1|Adverse Event|0|||
105858534|NCT03400943|365132778|FG002|Post-treatment Period 1|Adverse Event|0|||
105858535|NCT03400943|365132779|FG003|Post-treatment Period 1|Adverse Event|0|||
105858536|NCT03400943|365132776|FG000|Post-treatment Period 1|Protocol Violation|1|||
105858537|NCT03400943|365132777|FG001|Post-treatment Period 1|Protocol Violation|0|||
105858538|NCT03400943|365132778|FG002|Post-treatment Period 1|Protocol Violation|0|||
105858539|NCT03400943|365132779|FG003|Post-treatment Period 1|Protocol Violation|0|||
105858540|NCT03400943|365132776|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
105858541|NCT03400943|365132777|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
106037928|NCT02395016|365805303|FG001|Overall Study|Protocol Violation|3|||
106037929|NCT01277042|365805304|FG000|Overall Study|Adverse Event|4|||
106037930|NCT01277042|365805305|FG001|Overall Study|Adverse Event|3|||
106037931|NCT01277042|365805304|FG000|Overall Study|Lost to Follow-up|2|||
106037932|NCT01277042|365805305|FG001|Overall Study|Lost to Follow-up|2|||
106037933|NCT01277042|365805304|FG000|Overall Study|Withdrawal by Subject|2|||
106037934|NCT01277042|365805305|FG001|Overall Study|Withdrawal by Subject|0|||
106037935|NCT00588952|365805306|FG000|Overall Study|Adverse Event|0|||
106037936|NCT00588952|365805307|FG001|Overall Study|Adverse Event|2|||
106037937|NCT00588952|365805306|FG000|Overall Study|Withdrawal by Subject|3|||
106037938|NCT00588952|365805307|FG001|Overall Study|Withdrawal by Subject|5|||
106037939|NCT03435640|365805308|FG000|Overall Study|Withdrawal by Subject|0|||
106037940|NCT03435640|365805309|FG001|Overall Study|Withdrawal by Subject|1|||
106037941|NCT03435640|365805310|FG002|Overall Study|Withdrawal by Subject|0|||
106037942|NCT03435640|365805311|FG003|Overall Study|Withdrawal by Subject|2|||
106037943|NCT03435640|365805312|FG004|Overall Study|Withdrawal by Subject|0|||
106037944|NCT03435640|365805313|FG005|Overall Study|Withdrawal by Subject|0|||
106037945|NCT03435640|365805314|FG006|Overall Study|Withdrawal by Subject|3|||
106037946|NCT03435640|365805315|FG007|Overall Study|Withdrawal by Subject|0|||
106037947|NCT03435640|365805316|FG008|Overall Study|Withdrawal by Subject|0|||
106037948|NCT03435640|365805317|FG009|Overall Study|Withdrawal by Subject|2|||
106037949|NCT03435640|365805318|FG010|Overall Study|Withdrawal by Subject|3|||
106037950|NCT03435640|365805308|FG000|Overall Study|Lost to Follow-up|0|||
106037951|NCT03435640|365805309|FG001|Overall Study|Lost to Follow-up|0|||
106037952|NCT03435640|365805310|FG002|Overall Study|Lost to Follow-up|1|||
106037953|NCT03435640|365805311|FG003|Overall Study|Lost to Follow-up|0|||
106037954|NCT03435640|365805312|FG004|Overall Study|Lost to Follow-up|0|||
106037955|NCT03435640|365805313|FG005|Overall Study|Lost to Follow-up|0|||
106037956|NCT03435640|365805314|FG006|Overall Study|Lost to Follow-up|0|||
106037957|NCT03435640|365805315|FG007|Overall Study|Lost to Follow-up|0|||
106037958|NCT03435640|365805316|FG008|Overall Study|Lost to Follow-up|0|||
105858542|NCT03400943|365132778|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
105858543|NCT03400943|365132779|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
105858544|NCT03400943|365132776|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
105858545|NCT03400943|365132777|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
105858546|NCT03400943|365132778|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
105858547|NCT03400943|365132779|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
105858548|NCT03400943|365132776|FG000|Post-treatment Period 1|Other|2|||
105858549|NCT03400943|365132777|FG001|Post-treatment Period 1|Other|0|||
105858550|NCT03400943|365132778|FG002|Post-treatment Period 1|Other|4|||
105858551|NCT03400943|365132779|FG003|Post-treatment Period 1|Other|5|||
105858552|NCT03400943|365132776|FG000|Treatment Period 2|Study terminated by sponsor|0|||
105858553|NCT03400943|365132777|FG001|Treatment Period 2|Study terminated by sponsor|1|||
105858554|NCT03400943|365132778|FG002|Treatment Period 2|Study terminated by sponsor|0|||
105858555|NCT03400943|365132779|FG003|Treatment Period 2|Study terminated by sponsor|0|||
105858556|NCT03400943|365132776|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105858557|NCT03400943|365132777|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105858558|NCT03400943|365132778|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105858559|NCT03400943|365132779|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105858560|NCT03400943|365132776|FG000|Treatment Period 2|Other|1|||
105858561|NCT03400943|365132777|FG001|Treatment Period 2|Other|6|||
105858562|NCT03400943|365132778|FG002|Treatment Period 2|Other|0|||
105858563|NCT03400943|365132779|FG003|Treatment Period 2|Other|0|||
105858564|NCT03400943|365132776|FG000|Follow-up Period|Withdrawal by Subject|1|||
105858565|NCT03400943|365132777|FG001|Follow-up Period|Withdrawal by Subject|0|||
105858566|NCT03400943|365132778|FG002|Follow-up Period|Withdrawal by Subject|0|||
105858567|NCT03400943|365132779|FG003|Follow-up Period|Withdrawal by Subject|0|||
105858568|NCT02563106|365132780|FG000|Overall Study|Withdrawal by Subject|7|||
105858569|NCT02563106|365132781|FG001|Overall Study|Withdrawal by Subject|8|||
105858570|NCT02563106|365132780|FG000|Overall Study|Adverse Event|17|||
105858571|NCT02563106|365132781|FG001|Overall Study|Adverse Event|15|||
105858572|NCT02563106|365132780|FG000|Overall Study|Protocol Violation|1|||
106037959|NCT03435640|365805317|FG009|Overall Study|Lost to Follow-up|0|||
106037960|NCT03435640|365805318|FG010|Overall Study|Lost to Follow-up|0|||
106037961|NCT03868124|365805321|FG000|Overall Study|Withdrawal by Subject|4|||
105858573|NCT02563106|365132781|FG001|Overall Study|Protocol Violation|0|||
105858574|NCT02563106|365132780|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
105858575|NCT02563106|365132781|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
105858576|NCT02563106|365132780|FG000|Overall Study|Lost to Follow-up|3|||
106037962|NCT03868124|365805322|FG001|Overall Study|Withdrawal by Subject|0|||
106037963|NCT03868124|365805323|FG002|Overall Study|Withdrawal by Subject|1|||
106037964|NCT03868124|365805321|FG000|Overall Study|Physician Decision|1|||
106037965|NCT03868124|365805322|FG001|Overall Study|Physician Decision|0|||
106037966|NCT03868124|365805323|FG002|Overall Study|Physician Decision|1|||
106037967|NCT03868124|365805321|FG000|Overall Study|Lost to Follow-up|1|||
106037968|NCT03868124|365805322|FG001|Overall Study|Lost to Follow-up|1|||
106037969|NCT03868124|365805323|FG002|Overall Study|Lost to Follow-up|2|||
105858577|NCT02563106|365132781|FG001|Overall Study|Lost to Follow-up|2|||
105858578|NCT02563106|365132780|FG000|Overall Study|Physician Decision|3|||
106037970|NCT03868124|365805321|FG000|Overall Study|Death|1|||
106037971|NCT03868124|365805322|FG001|Overall Study|Death|1|||
106037972|NCT03868124|365805323|FG002|Overall Study|Death|2|||
106037973|NCT03868124|365805321|FG000|Overall Study|Adverse Event|0|||
106037974|NCT03868124|365805322|FG001|Overall Study|Adverse Event|0|||
106037975|NCT03868124|365805323|FG002|Overall Study|Adverse Event|3|||
106037976|NCT03868124|365805321|FG000|Overall Study|Explanted|2|||
106037977|NCT03868124|365805322|FG001|Overall Study|Explanted|1|||
106037978|NCT03868124|365805323|FG002|Overall Study|Explanted|0|||
106037979|NCT03868124|365805321|FG000|Overall Study|Ongoing in study|176|||
106037980|NCT03868124|365805322|FG001|Overall Study|Ongoing in study|180|||
106037981|NCT03868124|365805323|FG002|Overall Study|Ongoing in study|183|||
106037982|NCT00397943|365805324|FG000|Overall Study|Unspecified reasons|12|||
106037983|NCT00397943|365805325|FG001|Overall Study|Unspecified reasons|9|||
106037984|NCT00397943|365805326|FG002|Overall Study|Unspecified reasons|0|||
106037985|NCT00397943|365805327|FG003|Overall Study|Unspecified reasons|0|||
106037986|NCT00397943|365805328|FG004|Overall Study|Unspecified reasons|0|||
106037987|NCT04626310|365805331|FG000|Overall Study|4-miss from treatment|6|||
106037988|NCT04626310|365805332|FG001|Overall Study|4-miss from treatment|5|||
106037989|NCT04626310|365805333|FG002|Overall Study|4-miss from treatment|5|||
106037990|NCT04626310|365805331|FG000|Overall Study|Withdrawal by Subject|1|||
106037991|NCT04626310|365805332|FG001|Overall Study|Withdrawal by Subject|0|||
106037992|NCT04626310|365805333|FG002|Overall Study|Withdrawal by Subject|3|||
106037993|NCT02604017|365805334|FG000|Overall Study|Withdrew Consent|0|||
106037994|NCT02604017|365805335|FG001|Overall Study|Withdrew Consent|2|||
106037995|NCT02604017|365805334|FG000|Overall Study|Lost to Follow-up|5|||
106037996|NCT02604017|365805335|FG001|Overall Study|Lost to Follow-up|6|||
106037997|NCT02604017|365805334|FG000|Overall Study|Other|1|||
106037998|NCT02604017|365805335|FG001|Overall Study|Other|0|||
106037999|NCT01751802|365805339|FG000|Overall Study|Adverse Event|4|||
106038000|NCT01751802|365805340|FG001|Overall Study|Adverse Event|2|||
106038001|NCT00589784|365805343|FG000|Overall Study|Withdrawal by Subject|0|||
106038002|NCT00589784|365805344|FG001|Overall Study|Withdrawal by Subject|6|||
106038003|NCT00589784|365805343|FG000|Overall Study|Patient inevaluable|1|||
106038004|NCT00589784|365805344|FG001|Overall Study|Patient inevaluable|0|||
106038005|NCT00589784|365805343|FG000|Overall Study|Adverse Event|0|||
106038006|NCT00589784|365805344|FG001|Overall Study|Adverse Event|4|||
106038007|NCT00521001|365805347|FG000|Overall Study|Ineligible|1|||
106038008|NCT05867342|365805349|FG000|Overall Study|Investigator Decision|3|||
106038009|NCT05867342|365805350|FG001|Overall Study|Investigator Decision|3|||
106038010|NCT00608543|365805351|FG000|Overall Study|Adverse Event|4|||
106038011|NCT01282203|365805356|FG000|Overall Study|Adverse Event|1|||
106038012|NCT03190369|365805360|FG000|Overall Study|Poor compliance to protocol|0|||
106038013|NCT03190369|365805361|FG001|Overall Study|Poor compliance to protocol|1|||
106038014|NCT03190369|365805360|FG000|Overall Study|Withdraw before treatment|1|||
106038015|NCT03190369|365805361|FG001|Overall Study|Withdraw before treatment|5|||
106038016|NCT03190369|365805360|FG000|Overall Study|Randomized but not treated|0|||
106038017|NCT03190369|365805361|FG001|Overall Study|Randomized but not treated|2|||
106038018|NCT04163718|365805362|FG000|Overall Study|Study terminated|12|||
106038019|NCT02963831|365805367|FG000|Overall Study|Progressive Disease|3|||
106038020|NCT02963831|365805368|FG001|Overall Study|Progressive Disease|3|||
106038021|NCT02963831|365805369|FG002|Overall Study|Progressive Disease|16|||
106038022|NCT02963831|365805370|FG003|Overall Study|Progressive Disease|27|||
106038023|NCT02963831|365805367|FG000|Overall Study|Withdrawal by Subject|1|||
106038024|NCT02963831|365805368|FG001|Overall Study|Withdrawal by Subject|0|||
106038025|NCT02963831|365805369|FG002|Overall Study|Withdrawal by Subject|2|||
106038026|NCT02963831|365805370|FG003|Overall Study|Withdrawal by Subject|4|||
106038027|NCT02963831|365805367|FG000|Overall Study|Adverse Event|0|||
106038028|NCT02963831|365805368|FG001|Overall Study|Adverse Event|1|||
106038029|NCT02963831|365805369|FG002|Overall Study|Adverse Event|1|||
106038030|NCT02963831|365805370|FG003|Overall Study|Adverse Event|2|||
106038031|NCT02963831|365805367|FG000|Overall Study|Death|0|||
106038032|NCT02963831|365805368|FG001|Overall Study|Death|0|||
106038033|NCT02963831|365805369|FG002|Overall Study|Death|0|||
106038034|NCT02963831|365805370|FG003|Overall Study|Death|2|||
106038035|NCT03463031|365805373|FG000|Overall Study|Withdrawal by Subject|4|||
106038036|NCT03463031|365805374|FG001|Overall Study|Withdrawal by Subject|2|||
106038037|NCT03463031|365805373|FG000|Overall Study|Investigator/Sponsor Decision|0|||
106038038|NCT03463031|365805374|FG001|Overall Study|Investigator/Sponsor Decision|1|||
106038039|NCT03463031|365805373|FG000|Overall Study|Lost to Follow-up|1|||
106038040|NCT03463031|365805374|FG001|Overall Study|Lost to Follow-up|1|||
106038041|NCT03463031|365805373|FG000|Overall Study|Adverse Event|4|||
106038042|NCT03463031|365805374|FG001|Overall Study|Adverse Event|1|||
106038043|NCT03463031|365805373|FG000|Overall Study|Use of prohibited medication by subject|1|||
106038044|NCT03463031|365805374|FG001|Overall Study|Use of prohibited medication by subject|0|||
106038045|NCT01289782|365805375|FG000|Overall Study|Lost to Follow-up|14|||
106038046|NCT01289782|365805376|FG001|Overall Study|Lost to Follow-up|7|||
106038047|NCT01289782|365805375|FG000|Overall Study|Protocol Violation|1|||
106038048|NCT01289782|365805376|FG001|Overall Study|Protocol Violation|1|||
106038049|NCT01289782|365805375|FG000|Overall Study|Withdrawal by Subject|8|||
106038050|NCT01289782|365805376|FG001|Overall Study|Withdrawal by Subject|2|||
105858579|NCT02563106|365132781|FG001|Overall Study|Physician Decision|1|||
105858580|NCT02563106|365132780|FG000|Overall Study|Other reason - not specified|2|||
105858581|NCT02563106|365132781|FG001|Overall Study|Other reason - not specified|1|||
105858582|NCT01059539|365132782|FG000|Overall Study|Adverse Event|66|||
105858583|NCT01059539|365132782|FG000|Overall Study|Insufficient Therapeutic Response|26|||
105858584|NCT01059539|365132782|FG000|Overall Study|Protocol Violation|55|||
105858585|NCT01059539|365132782|FG000|Overall Study|Withdrawal of Consent|80|||
105858586|NCT01059539|365132782|FG000|Overall Study|Lost to Follow-up|42|||
105858587|NCT01059539|365132782|FG000|Overall Study|Reason Not Specified|2|||
105858588|NCT00537303|365132783|FG000|Overall Study|Adverse Event|1|||
105858589|NCT00537303|365132784|FG001|Overall Study|Adverse Event|4|||
105858590|NCT00537303|365132783|FG000|Overall Study|Lack of Efficacy|6|||
105858591|NCT00537303|365132784|FG001|Overall Study|Lack of Efficacy|7|||
105858592|NCT00537303|365132783|FG000|Overall Study|Protocol Violation|8|||
105858593|NCT00537303|365132784|FG001|Overall Study|Protocol Violation|4|||
105858594|NCT00537303|365132783|FG000|Overall Study|Withdrawal criteria|3|||
105858595|NCT00537303|365132784|FG001|Overall Study|Withdrawal criteria|3|||
105858596|NCT00537303|365132783|FG000|Overall Study|Unclassified|8|||
105858597|NCT00537303|365132784|FG001|Overall Study|Unclassified|7|||
105858598|NCT02085135|365132785|FG000|Overall Study|Adverse Event|4|||
105858599|NCT02085135|365132786|FG001|Overall Study|Adverse Event|7|||
105858600|NCT02085135|365132785|FG000|Overall Study|Lost to Follow-up|2|||
105858601|NCT02085135|365132786|FG001|Overall Study|Lost to Follow-up|2|||
105858602|NCT02085135|365132785|FG000|Overall Study|Withdrawal by Subject|3|||
105858603|NCT02085135|365132786|FG001|Overall Study|Withdrawal by Subject|0|||
105858604|NCT02085135|365132785|FG000|Overall Study|Lack of Efficacy|2|||
105858605|NCT02085135|365132786|FG001|Overall Study|Lack of Efficacy|0|||
105858606|NCT03839823|365132787|FG000|Overall Study|Adverse Event|8|||
105858607|NCT03839823|365132788|FG001|Overall Study|Adverse Event|4|||
105858608|NCT03839823|365132787|FG000|Overall Study|Death|1|||
105858609|NCT03839823|365132788|FG001|Overall Study|Death|0|||
105858610|NCT03839823|365132787|FG000|Overall Study|Physician Decision|1|||
105858611|NCT03839823|365132788|FG001|Overall Study|Physician Decision|5|||
105858612|NCT03839823|365132787|FG000|Overall Study|Progressive Disease (PD)|65|||
105858613|NCT03839823|365132788|FG001|Overall Study|Progressive Disease (PD)|65|||
105858614|NCT03839823|365132787|FG000|Overall Study|Subject Decision|2|||
105858615|NCT03839823|365132788|FG001|Overall Study|Subject Decision|9|||
105858616|NCT03839823|365132787|FG000|Overall Study|Not Treated|0|||
105858617|NCT03839823|365132788|FG001|Overall Study|Not Treated|10|||
105858618|NCT01447420|365132794|FG000|Overall Study|Adverse Event|2|||
105858619|NCT01447420|365132795|FG001|Overall Study|Adverse Event|4|||
105858620|NCT01447420|365132796|FG002|Overall Study|Adverse Event|2|||
105858621|NCT01447420|365132794|FG000|Overall Study|Protocol Violation|3|||
105858622|NCT01447420|365132795|FG001|Overall Study|Protocol Violation|3|||
105858623|NCT01447420|365132796|FG002|Overall Study|Protocol Violation|0|||
105858624|NCT01447420|365132794|FG000|Overall Study|Withdrawal by Subject|4|||
105858625|NCT01447420|365132795|FG001|Overall Study|Withdrawal by Subject|1|||
105858626|NCT01447420|365132796|FG002|Overall Study|Withdrawal by Subject|0|||
105858627|NCT01447420|365132794|FG000|Overall Study|Lack of Efficacy|1|||
105858628|NCT01447420|365132795|FG001|Overall Study|Lack of Efficacy|19|||
105858629|NCT01447420|365132796|FG002|Overall Study|Lack of Efficacy|8|||
105858630|NCT01777620|365132797|FG000|Overall Study|Subject Withdrawal|1|||
105858631|NCT01777620|365132798|FG001|Overall Study|Subject Withdrawal|0|||
105858632|NCT04516759|365132808|FG000|Overall Study|Withdrawal by Subject|1|||
105858633|NCT04516759|365132809|FG001|Overall Study|Withdrawal by Subject|1|||
105858634|NCT04516759|365132808|FG000|Overall Study|Other|0|||
105858635|NCT04516759|365132809|FG001|Overall Study|Other|1|||
105858636|NCT00936897|365132812|FG000|Overall Study|Withdrawal by Subject|9|||
105858637|NCT00936897|365132813|FG001|Overall Study|Withdrawal by Subject|19|||
105858638|NCT00936897|365132812|FG000|Overall Study|Adverse Event|4|||
105858639|NCT00936897|365132813|FG001|Overall Study|Adverse Event|13|||
105858640|NCT00936897|365132812|FG000|Overall Study|Other|3|||
105858641|NCT00936897|365132813|FG001|Overall Study|Other|9|||
105858642|NCT00936897|365132812|FG000|Overall Study|Lost to Follow-up|1|||
105858643|NCT00936897|365132813|FG001|Overall Study|Lost to Follow-up|10|||
106038051|NCT01289782|365805375|FG000|Overall Study|Sponsor's Decision|1|||
106038052|NCT01289782|365805376|FG001|Overall Study|Sponsor's Decision|0|||
105858644|NCT00936897|365132812|FG000|Overall Study|Administrative Decision|1|||
105858645|NCT00936897|365132813|FG001|Overall Study|Administrative Decision|2|||
105858646|NCT00936897|365132812|FG000|Overall Study|Protocol Violation|1|||
106038053|NCT01289782|365805375|FG000|Overall Study|Reason not specified|1|||
106038054|NCT01289782|365805376|FG001|Overall Study|Reason not specified|2|||
105858647|NCT00936897|365132813|FG001|Overall Study|Protocol Violation|1|||
105858648|NCT00936897|365132812|FG000|Overall Study|Ineligibility Determined|0|||
105858649|NCT00936897|365132813|FG001|Overall Study|Ineligibility Determined|3|||
105858650|NCT00936897|365132812|FG000|Overall Study|Noncompliance|0|||
105858651|NCT00936897|365132813|FG001|Overall Study|Noncompliance|2|||
105858652|NCT00936897|365132812|FG000|Overall Study|Death|0|||
105858653|NCT00936897|365132813|FG001|Overall Study|Death|1|||
105858654|NCT01283035|365132815|FG000|Overall Study|Subject later found ineligible|1|||
105858655|NCT00867503|365132816|FG000|Overall Study|Withdrawal by Subject|1|||
105858656|NCT01442688|365132819|FG000|First Intervention|Withdrawal by Subject|1|||
105858657|NCT01442688|365132820|FG001|First Intervention|Withdrawal by Subject|0|||
105858658|NCT01442688|365132819|FG000|First Intervention|subject incarcerated|1|||
105858659|NCT01442688|365132820|FG001|First Intervention|subject incarcerated|0|||
105858660|NCT01442688|365132819|FG000|Second Intervention|Adverse Event|1|||
105858661|NCT01442688|365132820|FG001|Second Intervention|Adverse Event|0|||
105858662|NCT03257865|365132821|FG000|Overall Study|Adverse Event|4|||
105858663|NCT03257865|365132822|FG001|Overall Study|Adverse Event|8|||
105858664|NCT03257865|365132821|FG000|Overall Study|Lack of Efficacy|1|||
105858665|NCT03257865|365132822|FG001|Overall Study|Lack of Efficacy|2|||
105858666|NCT03257865|365132821|FG000|Overall Study|Non-compliance with Study Drug|0|||
105858667|NCT03257865|365132822|FG001|Overall Study|Non-compliance with Study Drug|2|||
105858668|NCT03257865|365132821|FG000|Overall Study|Withdrawal by Subject|23|||
105858669|NCT03257865|365132822|FG001|Overall Study|Withdrawal by Subject|17|||
105858670|NCT03257865|365132821|FG000|Overall Study|Physician Decision|3|||
105858671|NCT03257865|365132822|FG001|Overall Study|Physician Decision|1|||
105858672|NCT03257865|365132821|FG000|Overall Study|Other|0|||
105858673|NCT03257865|365132822|FG001|Overall Study|Other|1|||
105858674|NCT03257865|365132821|FG000|Overall Study|Lost to Follow-up|4|||
105858675|NCT03257865|365132822|FG001|Overall Study|Lost to Follow-up|4|||
105858676|NCT02677714|365132823|FG000|Overall Study|Withdrawal by Subject|2|||
105858677|NCT02677714|365132824|FG001|Overall Study|Withdrawal by Subject|0|||
105858678|NCT02643355|365132825|FG000|Overall Study|Withdrawal by Subject|1|||
105858679|NCT02643355|365132826|FG001|Overall Study|Withdrawal by Subject|3|||
105858680|NCT02643355|365132825|FG000|Overall Study|Protocol Violation|0|||
105858681|NCT02643355|365132826|FG001|Overall Study|Protocol Violation|2|||
105858682|NCT00191165|365132829|FG000|Overall Study|Adverse Event|2|||
105858683|NCT00191165|365132830|FG001|Overall Study|Adverse Event|0|||
105858684|NCT00191165|365132829|FG000|Overall Study|Protocol Violation|0|||
105858685|NCT00191165|365132830|FG001|Overall Study|Protocol Violation|1|||
105858686|NCT00191165|365132829|FG000|Overall Study|Participant Moved Away|0|||
105858687|NCT00191165|365132830|FG001|Overall Study|Participant Moved Away|1|||
105858688|NCT02865460|365132834|FG000|Overall Study|Adverse Event|1|||
105858689|NCT02865460|365132835|FG001|Overall Study|Adverse Event|0|||
105858690|NCT02865460|365132834|FG000|Overall Study|Withdrawal by Subject|1|||
105858691|NCT02865460|365132835|FG001|Overall Study|Withdrawal by Subject|1|||
105858692|NCT02865460|365132834|FG000|Overall Study|Lost to Follow-up|7|||
105858693|NCT02865460|365132835|FG001|Overall Study|Lost to Follow-up|4|||
105858694|NCT02865460|365132834|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
105858695|NCT02865460|365132835|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
105858696|NCT04546724|365132844|FG000|Overall Study|Withdrawal by Subject|145|||
105858697|NCT04546724|365132845|FG001|Overall Study|Withdrawal by Subject|41|||
105858698|NCT04546724|365132844|FG000|Overall Study|Adverse Event|1|||
105858699|NCT04546724|365132845|FG001|Overall Study|Adverse Event|1|||
105858700|NCT04546724|365132844|FG000|Overall Study|Lost to Follow-up|186|||
105858701|NCT04546724|365132845|FG001|Overall Study|Lost to Follow-up|63|||
105858702|NCT04546724|365132844|FG000|Overall Study|Physician Decision|8|||
105858703|NCT04546724|365132845|FG001|Overall Study|Physician Decision|2|||
105858704|NCT04546724|365132844|FG000|Overall Study|Death|2|||
105858705|NCT04546724|365132845|FG001|Overall Study|Death|1|||
105858706|NCT04546724|365132844|FG000|Overall Study|subject has been out of town|1|||
105858707|NCT04546724|365132845|FG001|Overall Study|subject has been out of town|0|||
105858708|NCT04546724|365132844|FG000|Overall Study|subject is incarcerated|2|||
105858709|NCT04546724|365132845|FG001|Overall Study|subject is incarcerated|0|||
105858710|NCT04546724|365132844|FG000|Overall Study|subject is relocating|12|||
105858711|NCT04546724|365132845|FG001|Overall Study|subject is relocating|4|||
105858712|NCT04546724|365132844|FG000|Overall Study|Subject in another study|1|||
105858713|NCT04546724|365132845|FG001|Overall Study|Subject in another study|1|||
105858714|NCT02238795|365132846|FG000|Overall Study|Patient without purpura fulminans|1|||
105858715|NCT00077857|365132847|FG000|Overall Study|Adverse Event|30|||
105858716|NCT00077857|365132848|FG001|Overall Study|Adverse Event|32|||
105858717|NCT00077857|365132847|FG000|Overall Study|Death|7|||
105858718|NCT00077857|365132848|FG001|Overall Study|Death|3|||
105858719|NCT00077857|365132847|FG000|Overall Study|Insufficient therapeutic response|112|||
105858720|NCT00077857|365132848|FG001|Overall Study|Insufficient therapeutic response|128|||
105858721|NCT00077857|365132847|FG000|Overall Study|Violation of selection criteria at entry|3|||
105858722|NCT00077857|365132848|FG001|Overall Study|Violation of selection criteria at entry|1|||
106038055|NCT01241240|365805377|FG000|Overall Study|Adverse Event|5|||
106038056|NCT01241240|365805378|FG001|Overall Study|Adverse Event|4|||
106038057|NCT01241240|365805377|FG000|Overall Study|Lost to Follow-up|2|||
106038058|NCT01241240|365805378|FG001|Overall Study|Lost to Follow-up|4|||
106038059|NCT01241240|365805377|FG000|Overall Study|Personal Reasons|1|||
105858723|NCT00077857|365132847|FG000|Overall Study|Other protocol violation|0|||
105858724|NCT00077857|365132848|FG001|Overall Study|Other protocol violation|1|||
105858725|NCT00077857|365132847|FG000|Overall Study|Refused treatment|29|||
105858726|NCT00077857|365132848|FG001|Overall Study|Refused treatment|21|||
105858727|NCT00077857|365132847|FG000|Overall Study|Failure to return|5|||
105858728|NCT00077857|365132848|FG001|Overall Study|Failure to return|5|||
105858729|NCT00077857|365132847|FG000|Overall Study|Other|15|||
105858730|NCT00077857|365132848|FG001|Overall Study|Other|13|||
105858731|NCT05119569|365132849|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
105858732|NCT05119569|365132850|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
105858733|NCT05119569|365132851|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
105858734|NCT05119569|365132852|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
105858735|NCT05119569|365132849|FG000|Double Blind Treatment Phase|Adverse Event|6|||
105858736|NCT05119569|365132850|FG001|Double Blind Treatment Phase|Adverse Event|0|||
105858737|NCT05119569|365132851|FG002|Double Blind Treatment Phase|Adverse Event|0|||
105858738|NCT05119569|365132852|FG003|Double Blind Treatment Phase|Adverse Event|0|||
105858739|NCT05119569|365132849|FG000|Open Label Extension Phase|Ongoing in the study|0|||
105858740|NCT05119569|365132850|FG001|Open Label Extension Phase|Ongoing in the study|0|||
105858741|NCT05119569|365132851|FG002|Open Label Extension Phase|Ongoing in the study|65|||
105858742|NCT05119569|365132852|FG003|Open Label Extension Phase|Ongoing in the study|34|||
105858743|NCT04874155|365132853|FG000|Overall Study|Lost to Follow-up|1|||
105858744|NCT04874155|365132854|FG001|Overall Study|Lost to Follow-up|1|||
105858745|NCT04874155|365132853|FG000|Overall Study|Withdrawal by Subject|2|||
105858746|NCT04874155|365132854|FG001|Overall Study|Withdrawal by Subject|2|||
105858747|NCT03477903|365132855|FG000|Overall Study|Study Terminated by Sponsor|1|||
105858748|NCT03201965|365132856|FG000|Overall Study|Death|5|||
105858749|NCT03201965|365132857|FG001|Overall Study|Death|27|||
105858750|NCT03201965|365132858|FG002|Overall Study|Death|27|||
105858751|NCT03201965|365132856|FG000|Overall Study|Lost to Follow-up|0|||
105858752|NCT03201965|365132857|FG001|Overall Study|Lost to Follow-up|1|||
105858753|NCT03201965|365132858|FG002|Overall Study|Lost to Follow-up|0|||
105858754|NCT03201965|365132856|FG000|Overall Study|Withdrawal by Subject|3|||
105858755|NCT03201965|365132857|FG001|Overall Study|Withdrawal by Subject|13|||
105858756|NCT03201965|365132858|FG002|Overall Study|Withdrawal by Subject|4|||
105858757|NCT03201965|365132856|FG000|Overall Study|Ongoing|20|||
105858758|NCT03201965|365132857|FG001|Overall Study|Ongoing|152|||
106038060|NCT01241240|365805378|FG001|Overall Study|Personal Reasons|1|||
106038061|NCT00450112|365805379|FG000|Overall Study|Other Treatment Required|5|||
105984872|NCT01452919|365605969|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
105984873|NCT01452919|365605967|FG000|Randomization Treatment|Adverse Event|0|||
105984874|NCT01452919|365605968|FG001|Randomization Treatment|Adverse Event|0|||
106038062|NCT00450112|365805380|FG001|Overall Study|Other Treatment Required|1|||
106038063|NCT00450112|365805379|FG000|Overall Study|Withdrawal by Subject|4|||
106038064|NCT00450112|365805380|FG001|Overall Study|Withdrawal by Subject|1|||
106038065|NCT00450112|365805379|FG000|Overall Study|Lost to Follow-up|2|||
106038066|NCT00450112|365805380|FG001|Overall Study|Lost to Follow-up|1|||
106038067|NCT00450112|365805379|FG000|Overall Study|Others|2|||
106038068|NCT00450112|365805380|FG001|Overall Study|Others|3|||
106038069|NCT00433654|365805381|FG000|Overall Study|Death|4|||
106038070|NCT00433654|365805382|FG001|Overall Study|Death|0|||
106038071|NCT00433654|365805381|FG000|Overall Study|Missed visit|6|||
106038072|NCT00433654|365805382|FG001|Overall Study|Missed visit|3|||
106038073|NCT00433654|365805381|FG000|Overall Study|Subject not yet due for visit|4|||
105858759|NCT03201965|365132858|FG002|Overall Study|Ongoing|164|||
105858760|NCT05293639|365132859|FG000|Overall Study|Withdrawal by Subject|1|||
105858761|NCT05293639|365132860|FG001|Overall Study|Withdrawal by Subject|1|||
105858762|NCT05293639|365132861|FG002|Overall Study|Withdrawal by Subject|2|||
105858763|NCT05293639|365132859|FG000|Overall Study|Death|0|||
105984875|NCT01452919|365605969|FG002|Randomization Treatment|Adverse Event|2|||
105984876|NCT01452919|365605967|FG000|Randomization Treatment|Sponsor Decision|0|||
105984877|NCT01452919|365605968|FG001|Randomization Treatment|Sponsor Decision|1|||
105984878|NCT01452919|365605969|FG002|Randomization Treatment|Sponsor Decision|0|||
105984879|NCT01452919|365605967|FG000|Randomization Treatment|Withdrawal by Subject|0|||
105984880|NCT01452919|365605968|FG001|Randomization Treatment|Withdrawal by Subject|1|||
105984881|NCT01452919|365605969|FG002|Randomization Treatment|Withdrawal by Subject|0|||
105984882|NCT01452919|365605967|FG000|Randomization Treatment|Subject is moving or has moved|0|||
105984883|NCT01452919|365605968|FG001|Randomization Treatment|Subject is moving or has moved|1|||
105984884|NCT01452919|365605969|FG002|Randomization Treatment|Subject is moving or has moved|0|||
105984885|NCT02678923|365605973|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
105984886|NCT02678923|365605974|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
105984887|NCT02678923|365605973|FG000|Overall Study|Withdrawal by Subject|3|||
105984888|NCT02678923|365605974|FG001|Overall Study|Withdrawal by Subject|2|||
105984889|NCT02678923|365605973|FG000|Overall Study|Lost to Follow-up|1|||
105984890|NCT02678923|365605974|FG001|Overall Study|Lost to Follow-up|0|||
105984891|NCT02678923|365605973|FG000|Overall Study|Did Not Return for Study Visits|1|||
106038074|NCT00433654|365805382|FG001|Overall Study|Subject not yet due for visit|0|||
106038075|NCT00433654|365805381|FG000|Overall Study|Withdrawal by Subject|1|||
106038076|NCT00433654|365805382|FG001|Overall Study|Withdrawal by Subject|2|||
106038077|NCT00542451|365805383|FG000|Overall Study|Adverse Event|31|||
106038078|NCT00542451|365805383|FG000|Overall Study|Withdrawal by Subject|30|||
106038079|NCT00542451|365805383|FG000|Overall Study|Physician Decision|4|||
106038080|NCT00542451|365805383|FG000|Overall Study|Recurrent disease|1|||
106038081|NCT00542451|365805383|FG000|Overall Study|unknown reason|1|||
106038082|NCT00542451|365805383|FG000|Overall Study|Death|2|||
106038083|NCT00542451|365805383|FG000|Overall Study|Lost to Follow-up|10|||
106038084|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
106038085|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
106038086|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
106038087|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
106038088|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
106038089|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
106038090|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
106038091|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
106038092|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
106038093|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
106038094|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
106038095|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
106038096|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
106038097|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
106038098|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
106038099|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
106038100|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Program Termination|3|||
106038101|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Program Termination|0|||
106038102|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Program Termination|1|||
106038103|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Program Termination|1|||
106038104|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
106038105|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
106038106|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
106038107|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
106038108|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
106038109|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
106038110|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
106038111|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
106038112|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
106038113|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
106038114|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
106038115|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
106038116|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
106038117|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
106038118|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
106038119|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
106038120|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
106038121|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
106038122|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
106038123|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
106038124|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
106038125|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
106038126|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
106038127|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
106038128|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
106038129|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
105858764|NCT05293639|365132860|FG001|Overall Study|Death|1|||
105858765|NCT05293639|365132861|FG002|Overall Study|Death|0|||
105858766|NCT05293639|365132859|FG000|Overall Study|Lost to Follow-up|0|||
105858767|NCT05293639|365132860|FG001|Overall Study|Lost to Follow-up|0|||
105858768|NCT05293639|365132861|FG002|Overall Study|Lost to Follow-up|5|||
105858769|NCT05293639|365132859|FG000|Overall Study|Other|0|||
105858770|NCT05293639|365132860|FG001|Overall Study|Other|0|||
105858771|NCT05293639|365132861|FG002|Overall Study|Other|1|||
105858772|NCT00827632|365132862|FG000|Overall Study|Lost to Follow-up|8|||
105858773|NCT00827632|365132863|FG001|Overall Study|Lost to Follow-up|12|||
105858774|NCT00827632|365132862|FG000|Overall Study|Early withdrawal|14|||
105858775|NCT00827632|365132863|FG001|Overall Study|Early withdrawal|11|||
105858776|NCT03456453|365132864|FG000|Overall Study|Withdrawal by Subject|2|||
105858777|NCT03456453|365132865|FG001|Overall Study|Withdrawal by Subject|0|||
105858778|NCT03456453|365132864|FG000|Overall Study|Not released to community|1|||
105858779|NCT03456453|365132865|FG001|Overall Study|Not released to community|5|||
105858780|NCT03456453|365132864|FG000|Overall Study|Lost to Follow-up|0|||
105858781|NCT03456453|365132865|FG001|Overall Study|Lost to Follow-up|2|||
106038130|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
106038131|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
106038132|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
106038133|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
106038134|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
106038135|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
106038136|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
106038137|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
106038138|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
106038139|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
106038140|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
106038141|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
106038142|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
106038143|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
106038144|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
106038145|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
106038146|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
106038147|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
106038148|NCT03739840|365805384|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
106038149|NCT03739840|365805385|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
106038150|NCT03739840|365805386|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
106038151|NCT03739840|365805387|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
106038152|NCT03739840|365805384|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
106038153|NCT03739840|365805385|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
106038154|NCT03739840|365805386|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
106038155|NCT03739840|365805387|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
106038156|NCT03739840|365805384|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
106038157|NCT03739840|365805385|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
106038158|NCT03739840|365805386|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
106038159|NCT03739840|365805387|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
106038160|NCT03739840|365805384|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
106038161|NCT03739840|365805385|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
106038162|NCT03739840|365805386|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
106038163|NCT03739840|365805387|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
106038164|NCT03739840|365805384|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
106038165|NCT03739840|365805385|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
106038166|NCT03739840|365805386|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
106038167|NCT03739840|365805387|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
106038168|NCT03739840|365805384|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
106038169|NCT03739840|365805385|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
106038170|NCT03739840|365805386|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
106038171|NCT03739840|365805387|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
105858782|NCT04762277|365132866|FG000|Overall Study|Withdrawal by Subject|0|||
105858783|NCT04762277|365132867|FG001|Overall Study|Withdrawal by Subject|2|||
105858784|NCT04762277|365132866|FG000|Overall Study|Protocol Violation|0|||
105858785|NCT04762277|365132867|FG001|Overall Study|Protocol Violation|1|||
105858786|NCT04762277|365132866|FG000|Overall Study|Adverse Event|1|||
105858787|NCT04762277|365132867|FG001|Overall Study|Adverse Event|0|||
105858788|NCT02828241|365132874|FG000|Overall Study|Adverse Event|7|||
105858789|NCT02828241|365132875|FG001|Overall Study|Adverse Event|2|||
105858790|NCT02828241|365132874|FG000|Overall Study|Protocol Violation|1|||
105858791|NCT02828241|365132875|FG001|Overall Study|Protocol Violation|0|||
105858792|NCT01458106|365132876|FG000|Overall Study|Withdrawal by Subject|2|||
105858793|NCT01458106|365132877|FG001|Overall Study|Withdrawal by Subject|0|||
105858794|NCT01458106|365132876|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
105858795|NCT01458106|365132877|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
105858796|NCT01458106|365132876|FG000|Overall Study|Withdrawn Per Protocol|0|||
105858797|NCT01458106|365132877|FG001|Overall Study|Withdrawn Per Protocol|1|||
105858798|NCT03047330|365134795|FG000|Sleep Block 1|Withdrawal by Subject|3|||
105858799|NCT03493386|365134801|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105858800|NCT03493386|365134802|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
105858801|NCT03493386|365134803|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105858802|NCT03493386|365134804|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105858803|NCT03262038|365134810|FG000|Overall Study|Withdrawal by Subject|0|||
105858804|NCT03262038|365134811|FG001|Overall Study|Withdrawal by Subject|1|||
106038172|NCT03739840|365805384|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
105858805|NCT01716715|365134813|FG000|Overall Study|Never Treated|2|||
105858806|NCT01716715|365134814|FG001|Overall Study|Never Treated|4|||
105858807|NCT01085734|365134815|FG000|Overall Study|Adverse Event|0|||
105858808|NCT01085734|365134816|FG001|Overall Study|Adverse Event|2|||
105858809|NCT01085734|365134815|FG000|Overall Study|Death|1|||
105858810|NCT01085734|365134816|FG001|Overall Study|Death|0|||
105858811|NCT01085734|365134815|FG000|Overall Study|Lost to Follow-up|0|||
105858812|NCT01085734|365134816|FG001|Overall Study|Lost to Follow-up|1|||
105858813|NCT01085734|365134815|FG000|Overall Study|Withdrawal by Subject|0|||
105858814|NCT01085734|365134816|FG001|Overall Study|Withdrawal by Subject|1|||
105858815|NCT03678285|365134817|FG000|Overall Study|Adverse Event|2|||
105858816|NCT03678285|365134817|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
105858817|NCT03678285|365134817|FG000|Overall Study|Dehydrated prior to start of workout|1|||
105858818|NCT00492024|365134823|FG000|Treatment|Adverse Event|3|||
105858819|NCT00492024|365134824|FG001|Treatment|Adverse Event|1|||
105858820|NCT00492024|365134823|FG000|Treatment|Lack of Efficacy|21|||
105858821|NCT00492024|365134824|FG001|Treatment|Lack of Efficacy|20|||
105858822|NCT00492024|365134823|FG000|Treatment|Lost to Follow-up|3|||
105858823|NCT00492024|365134824|FG001|Treatment|Lost to Follow-up|1|||
105858824|NCT00492024|365134823|FG000|Treatment|Withdrawal by Subject|2|||
105858825|NCT00492024|365134824|FG001|Treatment|Withdrawal by Subject|0|||
105858826|NCT00492024|365134823|FG000|Follow up|Lack of Efficacy|0|||
105858827|NCT00492024|365134824|FG001|Follow up|Lack of Efficacy|1|||
105858828|NCT00492024|365134823|FG000|Follow up|Lost to Follow-up|1|||
105858829|NCT00492024|365134824|FG001|Follow up|Lost to Follow-up|1|||
105858830|NCT03247816|365134827|FG000|Overall Study|Adverse Event|12|||
105858831|NCT03247816|365134827|FG000|Overall Study|Physician Decision|3|||
105858832|NCT03247816|365134827|FG000|Overall Study|Lack of Efficacy|1|||
105858833|NCT03247816|365134827|FG000|Overall Study|Lost to Follow-up|10|||
106038173|NCT03739840|365805385|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
106038174|NCT03739840|365805386|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
106038175|NCT03739840|365805387|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
106038176|NCT03739840|365805384|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
106038177|NCT03739840|365805385|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
106038178|NCT03739840|365805386|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
106038179|NCT03739840|365805387|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
106038180|NCT03739840|365805384|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
106038181|NCT03739840|365805385|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
106038182|NCT03739840|365805386|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
106038183|NCT03739840|365805387|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
106038184|NCT01058265|365805390|FG000|Overall Study|Lost to Follow-up|11|||
106038185|NCT01058265|365805391|FG001|Overall Study|Lost to Follow-up|12|||
106038186|NCT00750880|365805394|FG000|Overall Study|Adverse Event|76|||
106038187|NCT00750880|365805394|FG000|Overall Study|Death|4|||
106038188|NCT00750880|365805394|FG000|Overall Study|Lack of Efficacy|46|||
106038189|NCT00750880|365805394|FG000|Overall Study|Lost to Follow-up|10|||
106038190|NCT00750880|365805394|FG000|Overall Study|Protocol Violation|15|||
106038191|NCT00750880|365805394|FG000|Overall Study|Withdrawal by Subject|33|||
106038192|NCT00750880|365805394|FG000|Overall Study|Physician Decision|20|||
106038193|NCT00750880|365805394|FG000|Overall Study|Administrative|11|||
106038194|NCT00984568|365805395|FG000|Overall Study|Withdrawal by Subject|1|||
106038195|NCT00984568|365805396|FG001|Overall Study|Withdrawal by Subject|2|||
106038196|NCT00984568|365805395|FG000|Overall Study|Lack of Efficacy|2|||
106038197|NCT00984568|365805396|FG001|Overall Study|Lack of Efficacy|0|||
106038198|NCT00984568|365805395|FG000|Overall Study|Adverse Event|2|||
106038199|NCT00984568|365805396|FG001|Overall Study|Adverse Event|0|||
106038200|NCT00984568|365805395|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
106038201|NCT00984568|365805396|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
106038202|NCT00984568|365805395|FG000|Overall Study|Lost to Follow-up|0|||
106038203|NCT00984568|365805396|FG001|Overall Study|Lost to Follow-up|1|||
106038204|NCT00984568|365805395|FG000|Overall Study|Opportunistic Infection|1|||
106038205|NCT00984568|365805396|FG001|Overall Study|Opportunistic Infection|0|||
106038206|NCT00984568|365805395|FG000|Overall Study|Unknown Reason|1|||
106038207|NCT00984568|365805396|FG001|Overall Study|Unknown Reason|3|||
106038208|NCT01367119|365805397|FG000|Overall Study|Adverse Event|1|||
106038209|NCT01367119|365805398|FG001|Overall Study|Adverse Event|0|||
106038210|NCT01367119|365805397|FG000|Overall Study|Withdrawal by Subject|1|||
105858834|NCT03247816|365134827|FG000|Overall Study|Missing Feraccru stop date|3|||
105858835|NCT03464630|365134831|FG000|Overall Study|Lost to Follow-up|62|||
105858836|NCT03464630|365134832|FG001|Overall Study|Lost to Follow-up|52|||
105858837|NCT03464630|365134831|FG000|Overall Study|Withdrawal by Subject|16|||
105858838|NCT03464630|365134832|FG001|Overall Study|Withdrawal by Subject|10|||
105858839|NCT03464630|365134831|FG000|Overall Study|Passive Disengagement|8|||
106038211|NCT01367119|365805398|FG001|Overall Study|Withdrawal by Subject|1|||
106038212|NCT05342532|365805399|FG000|Overall Study|Adverse Event|5|||
106038213|NCT05342532|365805400|FG001|Overall Study|Adverse Event|20|||
105858840|NCT03464630|365134832|FG001|Overall Study|Passive Disengagement|4|||
105858841|NCT04480710|365134835|FG000|Overall Study|Adverse Event|0|||
105858842|NCT04480710|365134836|FG001|Overall Study|Adverse Event|2|||
105858843|NCT04480710|365134837|FG002|Overall Study|Adverse Event|0|||
105858844|NCT04480710|365134838|FG003|Overall Study|Adverse Event|0|||
105858845|NCT04480710|365134835|FG000|Overall Study|Withdrawal by Subject|0|||
105858846|NCT04480710|365134836|FG001|Overall Study|Withdrawal by Subject|1|||
105858847|NCT04480710|365134837|FG002|Overall Study|Withdrawal by Subject|0|||
105858848|NCT04480710|365134838|FG003|Overall Study|Withdrawal by Subject|0|||
105858849|NCT04480710|365134835|FG000|Overall Study|Physician Decision|0|||
105858850|NCT04480710|365134836|FG001|Overall Study|Physician Decision|0|||
105858851|NCT04480710|365134837|FG002|Overall Study|Physician Decision|1|||
105858852|NCT04480710|365134838|FG003|Overall Study|Physician Decision|0|||
105858853|NCT00468650|365134840|FG000|Overall Study|Lost to Follow-up|4|||
105858854|NCT00468650|365134840|FG000|Overall Study|Withdrawal by Subject|2|||
105858855|NCT00468650|365134840|FG000|Overall Study|Protocol Violation|1|||
105858856|NCT00678886|365134841|FG000|Overall Study|Withdrawal by Subject|0|||
105858857|NCT00678886|365134842|FG001|Overall Study|Withdrawal by Subject|0|||
105858858|NCT00678886|365134843|FG002|Overall Study|Withdrawal by Subject|4|||
105858859|NCT00678886|365134844|FG003|Overall Study|Withdrawal by Subject|6|||
105858860|NCT00678886|365134841|FG000|Overall Study|Physician Decision|0|||
105858861|NCT00678886|365134842|FG001|Overall Study|Physician Decision|0|||
106038214|NCT05342532|365805399|FG000|Overall Study|Lost to Follow-up|10|||
105858862|NCT00678886|365134843|FG002|Overall Study|Physician Decision|1|||
105858863|NCT00678886|365134844|FG003|Overall Study|Physician Decision|1|||
105858864|NCT00678886|365134841|FG000|Overall Study|Lost to Follow-up|0|||
105858865|NCT00678886|365134842|FG001|Overall Study|Lost to Follow-up|0|||
105858866|NCT00678886|365134843|FG002|Overall Study|Lost to Follow-up|3|||
105858867|NCT00678886|365134844|FG003|Overall Study|Lost to Follow-up|2|||
105858868|NCT00678886|365134841|FG000|Overall Study|Other|0|||
105858869|NCT00678886|365134842|FG001|Overall Study|Other|0|||
105858870|NCT00678886|365134843|FG002|Overall Study|Other|1|||
105858871|NCT00678886|365134844|FG003|Overall Study|Other|0|||
105858872|NCT00206323|365134845|FG000|Overall Study|Lack of Efficacy|4|||
105858873|NCT00206323|365134846|FG001|Overall Study|Lack of Efficacy|1|||
105858874|NCT00206323|365134845|FG000|Overall Study|Adverse Event|1|||
105858875|NCT00206323|365134846|FG001|Overall Study|Adverse Event|1|||
105858876|NCT00206323|365134845|FG000|Overall Study|Lost to Follow-up|1|||
105858877|NCT00206323|365134846|FG001|Overall Study|Lost to Follow-up|1|||
105858878|NCT00426361|365134849|FG000|Overall Study|Lost to Follow-up|3|||
105858879|NCT00426361|365134850|FG001|Overall Study|Lost to Follow-up|2|||
105858880|NCT00426361|365134851|FG002|Overall Study|Lost to Follow-up|5|||
105858881|NCT00426361|365134849|FG000|Overall Study|Withdrawal by Subject|1|||
105858882|NCT00426361|365134850|FG001|Overall Study|Withdrawal by Subject|3|||
106038215|NCT05342532|365805400|FG001|Overall Study|Lost to Follow-up|15|||
106038216|NCT03180684|365805401|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
106038217|NCT03180684|365805402|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
106038218|NCT03180684|365805401|FG000|Overall Study|Physician Decision|1|||
106038219|NCT03180684|365805402|FG001|Overall Study|Physician Decision|0|||
106038220|NCT03180684|365805401|FG000|Overall Study|Lost to Follow-up|1|||
106038221|NCT03180684|365805402|FG001|Overall Study|Lost to Follow-up|0|||
106038222|NCT03180684|365805401|FG000|Overall Study|Progressive Disease|1|||
106038223|NCT03180684|365805402|FG001|Overall Study|Progressive Disease|0|||
106038224|NCT02310321|365805403|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
106038225|NCT02310321|365805404|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
106038226|NCT02310321|365805405|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
106038227|NCT02310321|365805403|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
106038228|NCT02310321|365805404|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
106038229|NCT02310321|365805405|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
106038230|NCT02310321|365805403|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
106038231|NCT02310321|365805404|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
105858883|NCT00426361|365134851|FG002|Overall Study|Withdrawal by Subject|0|||
105858884|NCT02132754|365134852|FG000|Overall Study|Adverse Event|0|||
105858885|NCT02132754|365134853|FG001|Overall Study|Adverse Event|0|||
105858886|NCT02132754|365134854|FG002|Overall Study|Adverse Event|0|||
105858887|NCT02132754|365134855|FG003|Overall Study|Adverse Event|0|||
105858888|NCT02132754|365134856|FG004|Overall Study|Adverse Event|0|||
105858889|NCT02132754|365134857|FG005|Overall Study|Adverse Event|0|||
105858890|NCT02132754|365134858|FG006|Overall Study|Adverse Event|0|||
105858891|NCT02132754|365134859|FG007|Overall Study|Adverse Event|0|||
105858892|NCT02132754|365134860|FG008|Overall Study|Adverse Event|0|||
105858893|NCT02132754|365134861|FG009|Overall Study|Adverse Event|0|||
105858894|NCT02132754|365134862|FG010|Overall Study|Adverse Event|0|||
105858895|NCT02132754|365134863|FG011|Overall Study|Adverse Event|0|||
105858896|NCT02132754|365134864|FG012|Overall Study|Adverse Event|0|||
105858897|NCT02132754|365134865|FG013|Overall Study|Adverse Event|0|||
105858898|NCT02132754|365134866|FG014|Overall Study|Adverse Event|0|||
106038232|NCT02310321|365805405|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
106038233|NCT02310321|365805403|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
106038234|NCT02310321|365805404|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
106038235|NCT02310321|365805405|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
106038236|NCT02310321|365805403|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
106038237|NCT02310321|365805404|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
106038238|NCT02310321|365805405|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
105858899|NCT02132754|365134867|FG015|Overall Study|Adverse Event|0|||
105858900|NCT02132754|365134868|FG016|Overall Study|Adverse Event|0|||
105858901|NCT02132754|365134869|FG017|Overall Study|Adverse Event|1|||
105858902|NCT02132754|365134870|FG018|Overall Study|Adverse Event|0|||
105858903|NCT02132754|365134871|FG019|Overall Study|Adverse Event|0|||
105858904|NCT02132754|365134872|FG020|Overall Study|Adverse Event|0|||
105858905|NCT02132754|365134873|FG021|Overall Study|Adverse Event|0|||
105858906|NCT02132754|365134874|FG022|Overall Study|Adverse Event|0|||
105858907|NCT02132754|365134875|FG023|Overall Study|Adverse Event|0|||
105858908|NCT02132754|365134876|FG024|Overall Study|Adverse Event|0|||
105858909|NCT02132754|365134877|FG025|Overall Study|Adverse Event|1|||
105858910|NCT02132754|365134878|FG026|Overall Study|Adverse Event|1|||
105858911|NCT02132754|365134879|FG027|Overall Study|Adverse Event|0|||
105858912|NCT02132754|365134880|FG028|Overall Study|Adverse Event|0|||
105858913|NCT02132754|365134881|FG029|Overall Study|Adverse Event|0|||
105858914|NCT02132754|365134882|FG030|Overall Study|Adverse Event|1|||
105858915|NCT02132754|365134883|FG031|Overall Study|Adverse Event|0|||
105858916|NCT02132754|365134884|FG032|Overall Study|Adverse Event|1|||
105858917|NCT02132754|365134885|FG033|Overall Study|Adverse Event|1|||
105858918|NCT02132754|365134852|FG000|Overall Study|Clinical Progression|0|||
105858919|NCT02132754|365134853|FG001|Overall Study|Clinical Progression|0|||
105858920|NCT02132754|365134854|FG002|Overall Study|Clinical Progression|0|||
105858921|NCT02132754|365134855|FG003|Overall Study|Clinical Progression|0|||
105858922|NCT02132754|365134856|FG004|Overall Study|Clinical Progression|0|||
105858923|NCT02132754|365134857|FG005|Overall Study|Clinical Progression|0|||
105858924|NCT02132754|365134858|FG006|Overall Study|Clinical Progression|0|||
105858925|NCT02132754|365134859|FG007|Overall Study|Clinical Progression|0|||
105858926|NCT02132754|365134860|FG008|Overall Study|Clinical Progression|0|||
105858927|NCT02132754|365134861|FG009|Overall Study|Clinical Progression|1|||
105858928|NCT02132754|365134862|FG010|Overall Study|Clinical Progression|0|||
105858929|NCT02132754|365134863|FG011|Overall Study|Clinical Progression|0|||
105858930|NCT02132754|365134864|FG012|Overall Study|Clinical Progression|0|||
105858931|NCT02132754|365134865|FG013|Overall Study|Clinical Progression|0|||
105858932|NCT02132754|365134866|FG014|Overall Study|Clinical Progression|0|||
105858933|NCT02132754|365134867|FG015|Overall Study|Clinical Progression|0|||
105858934|NCT02132754|365134868|FG016|Overall Study|Clinical Progression|1|||
105858935|NCT02132754|365134869|FG017|Overall Study|Clinical Progression|1|||
105858936|NCT02132754|365134870|FG018|Overall Study|Clinical Progression|0|||
105858937|NCT02132754|365134871|FG019|Overall Study|Clinical Progression|1|||
106038239|NCT02310321|365805403|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
106038240|NCT02310321|365805404|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
106038241|NCT02310321|365805405|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
106038242|NCT02310321|365805403|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
106038243|NCT02310321|365805404|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
106038244|NCT02310321|365805405|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
106038245|NCT02310321|365805403|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
106038246|NCT02310321|365805404|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
106038247|NCT02310321|365805405|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
106038248|NCT02310321|365805403|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
106038249|NCT02310321|365805404|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
106038250|NCT02310321|365805405|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
106038251|NCT02310321|365805403|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
106038252|NCT02310321|365805404|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
106038253|NCT02310321|365805405|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
106038254|NCT02310321|365805403|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
106038255|NCT02310321|365805404|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
106038256|NCT02310321|365805405|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
106038257|NCT02310321|365805403|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
106038258|NCT02310321|365805404|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
106038259|NCT02310321|365805405|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
106038260|NCT02310321|365805403|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
106038261|NCT02310321|365805404|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
106038262|NCT02310321|365805405|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
106038263|NCT02310321|365805403|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
106038264|NCT02310321|365805404|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
106038265|NCT02310321|365805405|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
106038266|NCT02310321|365805403|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
106038267|NCT02310321|365805404|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
106038268|NCT02310321|365805405|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
105858938|NCT02132754|365134872|FG020|Overall Study|Clinical Progression|0|||
105858939|NCT02132754|365134873|FG021|Overall Study|Clinical Progression|0|||
105858940|NCT02132754|365134874|FG022|Overall Study|Clinical Progression|1|||
105858941|NCT02132754|365134875|FG023|Overall Study|Clinical Progression|0|||
105858942|NCT02132754|365134876|FG024|Overall Study|Clinical Progression|1|||
105858943|NCT02132754|365134877|FG025|Overall Study|Clinical Progression|1|||
105858944|NCT02132754|365134878|FG026|Overall Study|Clinical Progression|0|||
105858945|NCT02132754|365134879|FG027|Overall Study|Clinical Progression|1|||
105858946|NCT02132754|365134880|FG028|Overall Study|Clinical Progression|1|||
105858947|NCT02132754|365134881|FG029|Overall Study|Clinical Progression|0|||
105858948|NCT02132754|365134882|FG030|Overall Study|Clinical Progression|1|||
105858949|NCT02132754|365134883|FG031|Overall Study|Clinical Progression|0|||
105858950|NCT02132754|365134884|FG032|Overall Study|Clinical Progression|0|||
105858951|NCT02132754|365134885|FG033|Overall Study|Clinical Progression|2|||
105858952|NCT02132754|365134852|FG000|Overall Study|Death|0|||
105858953|NCT02132754|365134853|FG001|Overall Study|Death|0|||
105858954|NCT02132754|365134854|FG002|Overall Study|Death|0|||
105858955|NCT02132754|365134855|FG003|Overall Study|Death|0|||
105858956|NCT02132754|365134856|FG004|Overall Study|Death|0|||
105858957|NCT02132754|365134857|FG005|Overall Study|Death|0|||
105858958|NCT02132754|365134858|FG006|Overall Study|Death|0|||
105858959|NCT02132754|365134859|FG007|Overall Study|Death|0|||
105858960|NCT02132754|365134860|FG008|Overall Study|Death|0|||
105858961|NCT02132754|365134861|FG009|Overall Study|Death|0|||
105858962|NCT02132754|365134862|FG010|Overall Study|Death|0|||
105858963|NCT02132754|365134863|FG011|Overall Study|Death|0|||
105858964|NCT02132754|365134864|FG012|Overall Study|Death|0|||
105858965|NCT02132754|365134865|FG013|Overall Study|Death|0|||
105858966|NCT02132754|365134866|FG014|Overall Study|Death|0|||
105858967|NCT02132754|365134867|FG015|Overall Study|Death|1|||
105858968|NCT02132754|365134868|FG016|Overall Study|Death|0|||
105858969|NCT02132754|365134869|FG017|Overall Study|Death|0|||
105858970|NCT02132754|365134870|FG018|Overall Study|Death|0|||
105858971|NCT02132754|365134871|FG019|Overall Study|Death|1|||
105858972|NCT02132754|365134872|FG020|Overall Study|Death|0|||
105858973|NCT02132754|365134873|FG021|Overall Study|Death|1|||
106038269|NCT02310321|365805403|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
106038270|NCT02310321|365805404|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
106038271|NCT02310321|365805405|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
106038272|NCT02310321|365805403|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
106038273|NCT02310321|365805404|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
106038274|NCT02310321|365805405|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
106038275|NCT02310321|365805403|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
106038276|NCT02310321|365805404|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
106038277|NCT02310321|365805405|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
106038278|NCT02310321|365805403|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
106038279|NCT02310321|365805404|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
106038280|NCT02310321|365805405|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
106038281|NCT02310321|365805403|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
106038282|NCT02310321|365805404|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
106038283|NCT02310321|365805405|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
106038284|NCT02310321|365805403|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
106038285|NCT02310321|365805404|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
106038286|NCT02310321|365805405|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
106038287|NCT02310321|365805403|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
106038288|NCT02310321|365805404|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
106038289|NCT02310321|365805405|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
106038290|NCT00256282|365805407|FG000|Overall Study|Disease progression, relapse during acti|12|||
106038291|NCT00256282|365805407|FG000|Overall Study|Adverse Event|3|||
106038292|NCT00256282|365805407|FG000|Overall Study|Physician Decision|1|||
106038293|NCT02414139|365805408|FG000|Treatment Period|Adverse Event|11|||
106038294|NCT02414139|365805409|FG001|Treatment Period|Adverse Event|6|||
106038295|NCT02414139|365805410|FG002|Treatment Period|Adverse Event|8|||
106038296|NCT02414139|365805411|FG003|Treatment Period|Adverse Event|5|||
106038297|NCT02414139|365805412|FG004|Treatment Period|Adverse Event|14|||
106038298|NCT02414139|365805413|FG005|Treatment Period|Adverse Event|3|||
106038299|NCT02414139|365805414|FG006|Treatment Period|Adverse Event|6|||
106038300|NCT02414139|365805415|FG007|Treatment Period|Adverse Event|1|||
106038301|NCT02414139|365805416|FG008|Treatment Period|Adverse Event|6|||
106038302|NCT02414139|365805417|FG009|Treatment Period|Adverse Event|8|||
106038303|NCT02414139|365805408|FG000|Treatment Period|Death|0|||
106038304|NCT02414139|365805409|FG001|Treatment Period|Death|0|||
106038305|NCT02414139|365805410|FG002|Treatment Period|Death|1|||
106038306|NCT02414139|365805411|FG003|Treatment Period|Death|1|||
106038307|NCT02414139|365805412|FG004|Treatment Period|Death|0|||
106038308|NCT02414139|365805413|FG005|Treatment Period|Death|0|||
106038309|NCT02414139|365805414|FG006|Treatment Period|Death|0|||
106038310|NCT02414139|365805415|FG007|Treatment Period|Death|0|||
106038311|NCT02414139|365805416|FG008|Treatment Period|Death|0|||
106038312|NCT02414139|365805417|FG009|Treatment Period|Death|1|||
106038313|NCT02414139|365805408|FG000|Treatment Period|Physician Decision|5|||
106038314|NCT02414139|365805409|FG001|Treatment Period|Physician Decision|4|||
106038315|NCT02414139|365805410|FG002|Treatment Period|Physician Decision|6|||
106038316|NCT02414139|365805411|FG003|Treatment Period|Physician Decision|1|||
106038317|NCT02414139|365805412|FG004|Treatment Period|Physician Decision|4|||
106038318|NCT02414139|365805413|FG005|Treatment Period|Physician Decision|0|||
106038319|NCT02414139|365805414|FG006|Treatment Period|Physician Decision|2|||
106038320|NCT02414139|365805415|FG007|Treatment Period|Physician Decision|0|||
106038321|NCT02414139|365805416|FG008|Treatment Period|Physician Decision|1|||
106038322|NCT02414139|365805417|FG009|Treatment Period|Physician Decision|4|||
106038323|NCT02414139|365805408|FG000|Treatment Period|Progressive disease|48|||
106038324|NCT02414139|365805409|FG001|Treatment Period|Progressive disease|31|||
106038325|NCT02414139|365805410|FG002|Treatment Period|Progressive disease|37|||
106038326|NCT02414139|365805411|FG003|Treatment Period|Progressive disease|21|||
106038327|NCT02414139|365805412|FG004|Treatment Period|Progressive disease|43|||
106038328|NCT02414139|365805413|FG005|Treatment Period|Progressive disease|12|||
106038329|NCT02414139|365805414|FG006|Treatment Period|Progressive disease|16|||
106038330|NCT02414139|365805415|FG007|Treatment Period|Progressive disease|2|||
106038331|NCT02414139|365805416|FG008|Treatment Period|Progressive disease|20|||
106038332|NCT02414139|365805417|FG009|Treatment Period|Progressive disease|14|||
106038333|NCT02414139|365805408|FG000|Treatment Period|Protocol deviation|0|||
106038334|NCT02414139|365805409|FG001|Treatment Period|Protocol deviation|0|||
106038335|NCT02414139|365805410|FG002|Treatment Period|Protocol deviation|1|||
106038336|NCT02414139|365805411|FG003|Treatment Period|Protocol deviation|0|||
106038337|NCT02414139|365805412|FG004|Treatment Period|Protocol deviation|0|||
106038338|NCT02414139|365805413|FG005|Treatment Period|Protocol deviation|0|||
106038339|NCT02414139|365805414|FG006|Treatment Period|Protocol deviation|0|||
106038340|NCT02414139|365805415|FG007|Treatment Period|Protocol deviation|0|||
106038341|NCT02414139|365805416|FG008|Treatment Period|Protocol deviation|0|||
106038342|NCT02414139|365805417|FG009|Treatment Period|Protocol deviation|0|||
106038343|NCT02414139|365805408|FG000|Treatment Period|Subject/Guardian decision|5|||
106038344|NCT02414139|365805409|FG001|Treatment Period|Subject/Guardian decision|1|||
106038345|NCT02414139|365805410|FG002|Treatment Period|Subject/Guardian decision|1|||
106038346|NCT02414139|365805411|FG003|Treatment Period|Subject/Guardian decision|2|||
106038347|NCT02414139|365805412|FG004|Treatment Period|Subject/Guardian decision|5|||
106038348|NCT02414139|365805413|FG005|Treatment Period|Subject/Guardian decision|0|||
106038349|NCT02414139|365805414|FG006|Treatment Period|Subject/Guardian decision|2|||
106038350|NCT02414139|365805415|FG007|Treatment Period|Subject/Guardian decision|0|||
106038351|NCT02414139|365805416|FG008|Treatment Period|Subject/Guardian decision|1|||
106038352|NCT02414139|365805417|FG009|Treatment Period|Subject/Guardian decision|1|||
106038353|NCT02414139|365805408|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
106038354|NCT02414139|365805409|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
106038355|NCT02414139|365805410|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
106038356|NCT02414139|365805411|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
106038357|NCT02414139|365805412|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
106038358|NCT02414139|365805413|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
106038359|NCT02414139|365805414|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
106038360|NCT02414139|365805415|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
106038361|NCT02414139|365805416|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
106038362|NCT02414139|365805417|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
106038363|NCT02414139|365805408|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
106038364|NCT02414139|365805409|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
106038365|NCT02414139|365805410|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
106038366|NCT02414139|365805411|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
106038367|NCT02414139|365805412|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
106038368|NCT02414139|365805413|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
106038369|NCT02414139|365805414|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
106038370|NCT02414139|365805415|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
106038371|NCT02414139|365805416|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
106038372|NCT02414139|365805417|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
106038373|NCT02414139|365805408|FG000|Post-treatment Efficacy Follow-up|Death|0|||
106038374|NCT02414139|365805409|FG001|Post-treatment Efficacy Follow-up|Death|1|||
106038375|NCT02414139|365805410|FG002|Post-treatment Efficacy Follow-up|Death|0|||
105858974|NCT02132754|365134874|FG022|Overall Study|Death|0|||
105858975|NCT02132754|365134875|FG023|Overall Study|Death|0|||
105858976|NCT02132754|365134876|FG024|Overall Study|Death|0|||
105858977|NCT02132754|365134877|FG025|Overall Study|Death|0|||
105858978|NCT02132754|365134878|FG026|Overall Study|Death|1|||
105858979|NCT02132754|365134879|FG027|Overall Study|Death|0|||
105858980|NCT02132754|365134880|FG028|Overall Study|Death|0|||
105858981|NCT02132754|365134881|FG029|Overall Study|Death|0|||
105858982|NCT02132754|365134882|FG030|Overall Study|Death|0|||
105858983|NCT02132754|365134883|FG031|Overall Study|Death|0|||
105858984|NCT02132754|365134884|FG032|Overall Study|Death|0|||
105858985|NCT02132754|365134885|FG033|Overall Study|Death|2|||
105858986|NCT02132754|365134852|FG000|Overall Study|Excluded Medication|0|||
105858987|NCT02132754|365134853|FG001|Overall Study|Excluded Medication|0|||
105858988|NCT02132754|365134854|FG002|Overall Study|Excluded Medication|0|||
105858989|NCT02132754|365134855|FG003|Overall Study|Excluded Medication|0|||
105858990|NCT02132754|365134856|FG004|Overall Study|Excluded Medication|0|||
105858991|NCT02132754|365134857|FG005|Overall Study|Excluded Medication|0|||
105858992|NCT02132754|365134858|FG006|Overall Study|Excluded Medication|0|||
105858993|NCT02132754|365134859|FG007|Overall Study|Excluded Medication|0|||
105858994|NCT02132754|365134860|FG008|Overall Study|Excluded Medication|0|||
105858995|NCT02132754|365134861|FG009|Overall Study|Excluded Medication|0|||
105858996|NCT02132754|365134862|FG010|Overall Study|Excluded Medication|0|||
105858997|NCT02132754|365134863|FG011|Overall Study|Excluded Medication|0|||
105858998|NCT02132754|365134864|FG012|Overall Study|Excluded Medication|0|||
105858999|NCT02132754|365134865|FG013|Overall Study|Excluded Medication|0|||
105859000|NCT02132754|365134866|FG014|Overall Study|Excluded Medication|0|||
105859001|NCT02132754|365134867|FG015|Overall Study|Excluded Medication|0|||
105859002|NCT02132754|365134868|FG016|Overall Study|Excluded Medication|0|||
105859003|NCT02132754|365134869|FG017|Overall Study|Excluded Medication|0|||
105859004|NCT02132754|365134870|FG018|Overall Study|Excluded Medication|0|||
105859005|NCT02132754|365134871|FG019|Overall Study|Excluded Medication|0|||
105859006|NCT02132754|365134872|FG020|Overall Study|Excluded Medication|1|||
105859007|NCT02132754|365134873|FG021|Overall Study|Excluded Medication|0|||
105859008|NCT02132754|365134874|FG022|Overall Study|Excluded Medication|0|||
105859009|NCT02132754|365134875|FG023|Overall Study|Excluded Medication|0|||
105859010|NCT02132754|365134876|FG024|Overall Study|Excluded Medication|0|||
105859011|NCT02132754|365134877|FG025|Overall Study|Excluded Medication|0|||
105859012|NCT02132754|365134878|FG026|Overall Study|Excluded Medication|0|||
105859013|NCT02132754|365134879|FG027|Overall Study|Excluded Medication|0|||
105859014|NCT02132754|365134880|FG028|Overall Study|Excluded Medication|0|||
105859015|NCT02132754|365134881|FG029|Overall Study|Excluded Medication|0|||
105859016|NCT02132754|365134882|FG030|Overall Study|Excluded Medication|0|||
105859017|NCT02132754|365134883|FG031|Overall Study|Excluded Medication|0|||
105859018|NCT02132754|365134884|FG032|Overall Study|Excluded Medication|0|||
105859019|NCT02132754|365134885|FG033|Overall Study|Excluded Medication|1|||
105859020|NCT02132754|365134852|FG000|Overall Study|Physician Decision|0|||
105859021|NCT02132754|365134853|FG001|Overall Study|Physician Decision|0|||
105859022|NCT02132754|365134854|FG002|Overall Study|Physician Decision|0|||
106038376|NCT02414139|365805411|FG003|Post-treatment Efficacy Follow-up|Death|0|||
106038377|NCT02414139|365805412|FG004|Post-treatment Efficacy Follow-up|Death|1|||
106038378|NCT02414139|365805413|FG005|Post-treatment Efficacy Follow-up|Death|0|||
106038379|NCT02414139|365805414|FG006|Post-treatment Efficacy Follow-up|Death|0|||
106038380|NCT02414139|365805415|FG007|Post-treatment Efficacy Follow-up|Death|0|||
106038381|NCT02414139|365805416|FG008|Post-treatment Efficacy Follow-up|Death|0|||
106038382|NCT02414139|365805417|FG009|Post-treatment Efficacy Follow-up|Death|1|||
106038383|NCT02414139|365805408|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
106038384|NCT02414139|365805409|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
106038385|NCT02414139|365805410|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105859023|NCT02132754|365134855|FG003|Overall Study|Physician Decision|0|||
106038386|NCT02414139|365805411|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
106038387|NCT02414139|365805412|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
106038388|NCT02414139|365805413|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105859024|NCT02132754|365134856|FG004|Overall Study|Physician Decision|0|||
105859025|NCT02132754|365134857|FG005|Overall Study|Physician Decision|0|||
105859026|NCT02132754|365134858|FG006|Overall Study|Physician Decision|0|||
105859027|NCT02132754|365134859|FG007|Overall Study|Physician Decision|0|||
105859028|NCT02132754|365134860|FG008|Overall Study|Physician Decision|0|||
105859029|NCT02132754|365134861|FG009|Overall Study|Physician Decision|1|||
105859030|NCT02132754|365134862|FG010|Overall Study|Physician Decision|0|||
105859031|NCT02132754|365134863|FG011|Overall Study|Physician Decision|1|||
105859032|NCT02132754|365134864|FG012|Overall Study|Physician Decision|1|||
105859033|NCT02132754|365134865|FG013|Overall Study|Physician Decision|0|||
105859034|NCT02132754|365134866|FG014|Overall Study|Physician Decision|0|||
105859035|NCT02132754|365134867|FG015|Overall Study|Physician Decision|1|||
105859036|NCT02132754|365134868|FG016|Overall Study|Physician Decision|0|||
105859037|NCT02132754|365134869|FG017|Overall Study|Physician Decision|0|||
105859038|NCT02132754|365134870|FG018|Overall Study|Physician Decision|0|||
105859039|NCT02132754|365134871|FG019|Overall Study|Physician Decision|0|||
105859040|NCT02132754|365134872|FG020|Overall Study|Physician Decision|0|||
106038389|NCT02414139|365805414|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
106038390|NCT02414139|365805415|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
106038391|NCT02414139|365805416|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
106038392|NCT02414139|365805417|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
106038393|NCT02414139|365805408|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
106038394|NCT02414139|365805409|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
106038395|NCT02414139|365805410|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
106038396|NCT02414139|365805411|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
106038397|NCT02414139|365805412|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
106038398|NCT02414139|365805413|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
106038399|NCT02414139|365805414|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
106038400|NCT02414139|365805415|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
106038401|NCT02414139|365805416|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
106038402|NCT02414139|365805417|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
106038403|NCT02414139|365805408|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
106038404|NCT02414139|365805409|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
106038405|NCT02414139|365805410|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
106038406|NCT02414139|365805411|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
106038407|NCT02414139|365805412|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
106038408|NCT02414139|365805413|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
106038409|NCT02414139|365805414|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
106038410|NCT02414139|365805415|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
106038411|NCT02414139|365805416|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
106038412|NCT02414139|365805417|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
106038413|NCT02414139|365805408|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
106038414|NCT02414139|365805409|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
106038415|NCT02414139|365805410|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
106038416|NCT02414139|365805411|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
106038417|NCT02414139|365805412|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
106038418|NCT02414139|365805413|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
106038419|NCT02414139|365805414|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
106038420|NCT02414139|365805415|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
106038421|NCT02414139|365805416|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
106038422|NCT02414139|365805417|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
106038423|NCT02414139|365805408|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
106038424|NCT02414139|365805409|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
106038425|NCT02414139|365805410|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
106038426|NCT02414139|365805411|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
106038427|NCT02414139|365805412|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
106038428|NCT02414139|365805413|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
106038429|NCT02414139|365805414|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
106038430|NCT02414139|365805415|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
106038431|NCT02414139|365805416|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
106038432|NCT02414139|365805417|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
106038433|NCT01343901|365805418|FG000|Overall Study|Death|85|||
106038434|NCT01343901|365805418|FG000|Overall Study|Physician Decision|4|||
106038435|NCT01343901|365805418|FG000|Overall Study|Lost to Follow-up|12|||
106038436|NCT01343901|365805418|FG000|Overall Study|Management by another medical team|11|||
106038437|NCT01343901|365805418|FG000|Overall Study|Participant decision|1|||
106038438|NCT03631355|365805419|FG000|Overall Study|Lost to Follow-up|1|||
106038439|NCT03631355|365805420|FG001|Overall Study|Lost to Follow-up|2|||
106038440|NCT00938964|365805423|FG000|Overall Study|Death|3|||
106038441|NCT00938964|365805424|FG001|Overall Study|Death|3|||
106038442|NCT00938964|365805423|FG000|Overall Study|Lost to Follow-up|2|||
106038443|NCT00938964|365805424|FG001|Overall Study|Lost to Follow-up|3|||
106038444|NCT00938964|365805423|FG000|Overall Study|Withdrawal by Subject|22|||
106038445|NCT00938964|365805424|FG001|Overall Study|Withdrawal by Subject|18|||
106038446|NCT00938964|365805423|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
106038447|NCT00938964|365805424|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
106038448|NCT00321893|365805425|FG000|Overall Study|Non-Compliance/Refusal|16|||
106038449|NCT00321893|365805426|FG001|Overall Study|Non-Compliance/Refusal|10|||
106038450|NCT00321893|365805425|FG000|Overall Study|Lost to Follow-up|2|||
106038451|NCT00321893|365805426|FG001|Overall Study|Lost to Follow-up|1|||
106038452|NCT00321893|365805425|FG000|Overall Study|Adverse Event|6|||
106038453|NCT00321893|365805426|FG001|Overall Study|Adverse Event|3|||
106038454|NCT00769483|365805427|FG000|Overall Study|Withdrawal by Subject|0|||
106038455|NCT00769483|365805428|FG001|Overall Study|Withdrawal by Subject|1|||
106038456|NCT00769483|365805429|FG002|Overall Study|Withdrawal by Subject|0|||
106038457|NCT00769483|365805430|FG003|Overall Study|Withdrawal by Subject|0|||
106038458|NCT00769483|365805431|FG004|Overall Study|Withdrawal by Subject|1|||
106038459|NCT00769483|365805432|FG005|Overall Study|Withdrawal by Subject|0|||
106038460|NCT01306877|365805433|FG000|Overall Study|Lost to Follow-up|3|||
106038461|NCT01306877|365805434|FG001|Overall Study|Lost to Follow-up|3|||
106038462|NCT01306877|365805433|FG000|Overall Study|Physician Decision|0|||
106038463|NCT01306877|365805434|FG001|Overall Study|Physician Decision|1|||
106038464|NCT03523000|365805435|FG000|Overall Study|Withdrawal by Subject|3|||
106038465|NCT03523000|365805436|FG001|Overall Study|Withdrawal by Subject|0|||
106038466|NCT03523000|365805435|FG000|Overall Study|Unsuccessful trial|2|||
106038467|NCT03523000|365805436|FG001|Overall Study|Unsuccessful trial|0|||
106038468|NCT02862600|365805442|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
106038469|NCT02862600|365805442|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
106038470|NCT02862600|365805442|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
106038471|NCT02862600|365805442|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
106038472|NCT04650854|365805443|FG000|Overall Study|Adverse Event|1|||
106038473|NCT04650854|365805444|FG001|Overall Study|Adverse Event|12|||
106038474|NCT04650854|365805445|FG002|Overall Study|Adverse Event|14|||
106038475|NCT04650854|365805443|FG000|Overall Study|Lack of Efficacy|1|||
106038476|NCT04650854|365805444|FG001|Overall Study|Lack of Efficacy|3|||
106038477|NCT04650854|365805445|FG002|Overall Study|Lack of Efficacy|6|||
106038478|NCT04650854|365805443|FG000|Overall Study|Lost to Follow-up|1|||
106038479|NCT04650854|365805444|FG001|Overall Study|Lost to Follow-up|1|||
106038480|NCT04650854|365805445|FG002|Overall Study|Lost to Follow-up|0|||
106038481|NCT04650854|365805443|FG000|Overall Study|Withdrawal by Subject|2|||
106038482|NCT04650854|365805444|FG001|Overall Study|Withdrawal by Subject|17|||
106038483|NCT04650854|365805445|FG002|Overall Study|Withdrawal by Subject|9|||
106038484|NCT04650854|365805443|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
106038485|NCT04650854|365805444|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
106038486|NCT04650854|365805445|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
106038487|NCT04650854|365805443|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
106038488|NCT04650854|365805444|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
106038489|NCT04650854|365805445|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
106038490|NCT04650854|365805443|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
106038491|NCT04650854|365805444|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
106038492|NCT04650854|365805445|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
106038493|NCT04650854|365805443|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
106038494|NCT04650854|365805444|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
106038495|NCT04650854|365805445|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
106038496|NCT04650854|365805443|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
106038497|NCT04650854|365805444|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
106038498|NCT04650854|365805445|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
106038499|NCT04650854|365805443|FG000|Overall Study|Use of Rescue Medication|0|||
106038500|NCT04650854|365805444|FG001|Overall Study|Use of Rescue Medication|0|||
106038501|NCT04650854|365805445|FG002|Overall Study|Use of Rescue Medication|1|||
106038502|NCT04650854|365805443|FG000|Overall Study|Last Treatment Per Sponsor|0|||
106038503|NCT04650854|365805444|FG001|Overall Study|Last Treatment Per Sponsor|0|||
106038504|NCT04650854|365805445|FG002|Overall Study|Last Treatment Per Sponsor|2|||
106038505|NCT04650854|365805443|FG000|Overall Study|Rescue Medication|0|||
106038506|NCT04650854|365805444|FG001|Overall Study|Rescue Medication|0|||
106038507|NCT04650854|365805445|FG002|Overall Study|Rescue Medication|1|||
106038508|NCT04650854|365805443|FG000|Overall Study|Participant Want to Start a Family|0|||
105859041|NCT02132754|365134873|FG021|Overall Study|Physician Decision|0|||
105859042|NCT02132754|365134874|FG022|Overall Study|Physician Decision|0|||
105859043|NCT02132754|365134875|FG023|Overall Study|Physician Decision|0|||
105859044|NCT02132754|365134876|FG024|Overall Study|Physician Decision|1|||
105859045|NCT02132754|365134877|FG025|Overall Study|Physician Decision|0|||
105859046|NCT02132754|365134878|FG026|Overall Study|Physician Decision|0|||
105859047|NCT02132754|365134879|FG027|Overall Study|Physician Decision|0|||
105859048|NCT02132754|365134880|FG028|Overall Study|Physician Decision|0|||
105859049|NCT02132754|365134881|FG029|Overall Study|Physician Decision|0|||
105859050|NCT02132754|365134882|FG030|Overall Study|Physician Decision|0|||
105859051|NCT02132754|365134883|FG031|Overall Study|Physician Decision|1|||
106038509|NCT04650854|365805444|FG001|Overall Study|Participant Want to Start a Family|0|||
106038510|NCT04650854|365805445|FG002|Overall Study|Participant Want to Start a Family|1|||
106038511|NCT04650854|365805443|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
106038512|NCT04650854|365805444|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
106038513|NCT04650854|365805445|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
105859052|NCT02132754|365134884|FG032|Overall Study|Physician Decision|0|||
105859053|NCT02132754|365134885|FG033|Overall Study|Physician Decision|3|||
105859054|NCT02132754|365134852|FG000|Overall Study|Progressive Disease|1|||
105859055|NCT02132754|365134853|FG001|Overall Study|Progressive Disease|1|||
105859056|NCT02132754|365134854|FG002|Overall Study|Progressive Disease|1|||
106038514|NCT04650854|365805443|FG000|Overall Study|Participant Screened For MG0020|0|||
106038515|NCT04650854|365805444|FG001|Overall Study|Participant Screened For MG0020|2|||
106038516|NCT04650854|365805445|FG002|Overall Study|Participant Screened For MG0020|3|||
106038517|NCT04650854|365805443|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
106038518|NCT04650854|365805444|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
106038519|NCT04650854|365805445|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
106038520|NCT04650854|365805443|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
106038521|NCT04650854|365805444|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
106038522|NCT04650854|365805445|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
106038523|NCT04650854|365805443|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
106038524|NCT04650854|365805444|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
106038525|NCT04650854|365805445|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
106038526|NCT04650854|365805443|FG000|Overall Study|End Of Study|0|||
106038527|NCT04650854|365805444|FG001|Overall Study|End Of Study|2|||
106038528|NCT04650854|365805445|FG002|Overall Study|End Of Study|1|||
106038529|NCT04650854|365805443|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
106038530|NCT04650854|365805444|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
106038531|NCT04650854|365805445|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
106038532|NCT04650854|365805443|FG000|Overall Study|Participant Received Rescue Medication|0|||
106038533|NCT04650854|365805444|FG001|Overall Study|Participant Received Rescue Medication|1|||
106038534|NCT04650854|365805445|FG002|Overall Study|Participant Received Rescue Medication|0|||
106038535|NCT04650854|365805443|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
106038536|NCT04650854|365805444|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
106038537|NCT04650854|365805445|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
106038538|NCT04650854|365805443|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
106038539|NCT04650854|365805444|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
106038540|NCT04650854|365805445|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
106038541|NCT04650854|365805443|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
106038542|NCT04650854|365805444|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
106038543|NCT04650854|365805445|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
106038544|NCT04650854|365805443|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
106038545|NCT04650854|365805444|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
106038546|NCT04650854|365805445|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
106038547|NCT04650854|365805443|FG000|Overall Study|Enrollment Cup|0|||
106038548|NCT04650854|365805444|FG001|Overall Study|Enrollment Cup|0|||
106038549|NCT04650854|365805445|FG002|Overall Study|Enrollment Cup|1|||
106038550|NCT01574079|365805451|FG000|Overall Study|Physician Decision|0|||
106038551|NCT01574079|365805452|FG001|Overall Study|Physician Decision|2|||
106038552|NCT01574079|365805451|FG000|Overall Study|Lost to Follow-up|1|||
106038553|NCT01574079|365805452|FG001|Overall Study|Lost to Follow-up|0|||
106038554|NCT00625742|365807285|FG000|Overall Study|Disease Progression|2|||
106038555|NCT00625742|365807285|FG000|Overall Study|Withdrawal by Subject|1|||
106038556|NCT00625742|365807285|FG000|Overall Study|Adverse Event|4|||
106038557|NCT00625742|365807285|FG000|Overall Study|Lost to Follow-up|4|||
106038558|NCT00625742|365807285|FG000|Overall Study|Ineligible|1|||
106038559|NCT04050371|365807286|FG000|Overall Study|Withdrawal by Subject|1|||
106038560|NCT04050371|365807287|FG001|Overall Study|Withdrawal by Subject|0|||
106038561|NCT00301821|365807289|FG000|Overall Study|Ineligible|25|||
106038562|NCT00301821|365807289|FG000|Overall Study|Cancel|1|||
106038563|NCT00472459|365807292|FG000|Overall Study|Adverse Event|13|||
106038564|NCT00472459|365807293|FG001|Overall Study|Adverse Event|13|||
106038565|NCT00472459|365807292|FG000|Overall Study|Withdrawal by Subject|5|||
106038566|NCT00472459|365807293|FG001|Overall Study|Withdrawal by Subject|5|||
106038567|NCT00472459|365807292|FG000|Overall Study|Protocol Violation|3|||
106038568|NCT00472459|365807293|FG001|Overall Study|Protocol Violation|3|||
106038569|NCT00472459|365807292|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
106038570|NCT00472459|365807293|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
106038571|NCT00472459|365807292|FG000|Overall Study|Lost to Follow-up|1|||
106038572|NCT00472459|365807293|FG001|Overall Study|Lost to Follow-up|1|||
106038573|NCT04850313|365807294|FG000|Overall Study|Withdrawal by Subject|0|||
106038574|NCT04850313|365807295|FG001|Overall Study|Withdrawal by Subject|1|||
106038575|NCT04761822|365807296|FG000|Overall Study|Adverse Event|3|||
106038576|NCT04761822|365807297|FG001|Overall Study|Adverse Event|1|||
106038577|NCT04761822|365807298|FG002|Overall Study|Adverse Event|1|||
106038578|NCT04761822|365807299|FG003|Overall Study|Adverse Event|3|||
106038579|NCT04761822|365807296|FG000|Overall Study|Lost to Follow-up|1|||
106038580|NCT04761822|365807297|FG001|Overall Study|Lost to Follow-up|0|||
106038581|NCT04761822|365807298|FG002|Overall Study|Lost to Follow-up|2|||
106038582|NCT04761822|365807299|FG003|Overall Study|Lost to Follow-up|3|||
106038583|NCT04761822|365807296|FG000|Overall Study|Physician Decision|0|||
106038584|NCT04761822|365807297|FG001|Overall Study|Physician Decision|1|||
106038585|NCT04761822|365807298|FG002|Overall Study|Physician Decision|0|||
106038586|NCT04761822|365807299|FG003|Overall Study|Physician Decision|0|||
106038587|NCT04761822|365807296|FG000|Overall Study|Withdrawal by Subject|3|||
106038588|NCT04761822|365807297|FG001|Overall Study|Withdrawal by Subject|8|||
106038589|NCT04761822|365807298|FG002|Overall Study|Withdrawal by Subject|1|||
106038590|NCT04761822|365807299|FG003|Overall Study|Withdrawal by Subject|11|||
106038591|NCT04761822|365807296|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
106038592|NCT04761822|365807297|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
106038593|NCT04761822|365807298|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
106038594|NCT04761822|365807299|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
106038595|NCT04761822|365807296|FG000|Overall Study|Participant requested unblinding|0|||
106038596|NCT04761822|365807297|FG001|Overall Study|Participant requested unblinding|0|||
106038597|NCT04761822|365807298|FG002|Overall Study|Participant requested unblinding|0|||
106038598|NCT04761822|365807299|FG003|Overall Study|Participant requested unblinding|1|||
106038599|NCT03034200|365807301|FG000|Overall Study|Disease progression|8|||
106038600|NCT03034200|365807302|FG001|Overall Study|Disease progression|10|||
106038601|NCT03034200|365807303|FG002|Overall Study|Disease progression|4|||
106038602|NCT03034200|365807301|FG000|Overall Study|Physician Decision|2|||
106038603|NCT03034200|365807302|FG001|Overall Study|Physician Decision|0|||
106038604|NCT03034200|365807303|FG002|Overall Study|Physician Decision|3|||
106038605|NCT03034200|365807301|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
106038606|NCT03034200|365807302|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
106038607|NCT03034200|365807303|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
106038608|NCT03034200|365807301|FG000|Overall Study|Adjuvant Therapy|0|||
106038609|NCT03034200|365807302|FG001|Overall Study|Adjuvant Therapy|0|||
106038610|NCT03034200|365807303|FG002|Overall Study|Adjuvant Therapy|1|||
106038611|NCT01251146|365807308|FG000|Overall Study|Lost to Follow-up|3|||
106038612|NCT01251146|365807309|FG001|Overall Study|Lost to Follow-up|10|||
106038613|NCT03350984|365807310|FG000|Overall Study|Death|1|||
106038614|NCT03350984|365807311|FG001|Overall Study|Death|0|||
106038615|NCT03350984|365807310|FG000|Overall Study|Lost to Follow-up|5|||
106038616|NCT03350984|365807311|FG001|Overall Study|Lost to Follow-up|6|||
106038617|NCT03350984|365807310|FG000|Overall Study|Protocol Violation|1|||
106038618|NCT03350984|365807311|FG001|Overall Study|Protocol Violation|2|||
106038619|NCT03350984|365807310|FG000|Overall Study|Physician Decision|1|||
106038620|NCT03350984|365807311|FG001|Overall Study|Physician Decision|0|||
106038621|NCT00642473|365807312|FG000|Overall Study|Withdrawal by Subject|0|||
106038622|NCT00642473|365807313|FG001|Overall Study|Withdrawal by Subject|5|||
106038623|NCT00642473|365807312|FG000|Overall Study|Progression or death|2|||
106038624|NCT00642473|365807313|FG001|Overall Study|Progression or death|4|||
106038625|NCT00642473|365807312|FG000|Overall Study|Other|2|||
106038626|NCT00642473|365807313|FG001|Overall Study|Other|2|||
106038627|NCT01466179|365807317|FG000|Overall Study|Ongoing in core study|2|||
106038628|NCT01466179|365807317|FG000|Overall Study|Physician Decision|46|||
106038629|NCT01466179|365807317|FG000|Overall Study|Progressive disease|43|||
106038630|NCT01466179|365807317|FG000|Overall Study|Adverse Event|32|||
106038631|NCT01466179|365807317|FG000|Overall Study|Disease relapse|23|||
106038632|NCT01466179|365807317|FG000|Overall Study|Lack of Efficacy|14|||
106038633|NCT01466179|365807317|FG000|Overall Study|Death|7|||
106038634|NCT01466179|365807317|FG000|Overall Study|Withdrawal by Subject|7|||
106038635|NCT01466179|365807317|FG000|Overall Study|Protocol Violation|2|||
106038636|NCT01466179|365807317|FG000|Overall Study|Other|3|||
106038637|NCT03569293|365807320|FG000|Overall Study|Adverse Event|4|||
106038638|NCT03569293|365807321|FG001|Overall Study|Adverse Event|1|||
106038639|NCT03569293|365807322|FG002|Overall Study|Adverse Event|5|||
106038640|NCT03569293|365807323|FG003|Overall Study|Adverse Event|1|||
106038641|NCT03569293|365807324|FG004|Overall Study|Adverse Event|0|||
106038642|NCT03569293|365807325|FG005|Overall Study|Adverse Event|0|||
106038643|NCT03569293|365807320|FG000|Overall Study|Withdrawal by Subject|16|||
106038644|NCT03569293|365807321|FG001|Overall Study|Withdrawal by Subject|2|||
106038645|NCT03569293|365807322|FG002|Overall Study|Withdrawal by Subject|4|||
106038646|NCT03569293|365807323|FG003|Overall Study|Withdrawal by Subject|1|||
106038647|NCT03569293|365807324|FG004|Overall Study|Withdrawal by Subject|0|||
106038648|NCT03569293|365807325|FG005|Overall Study|Withdrawal by Subject|0|||
106038649|NCT03569293|365807320|FG000|Overall Study|Lost to Follow-up|1|||
106038650|NCT03569293|365807321|FG001|Overall Study|Lost to Follow-up|3|||
106038651|NCT03569293|365807322|FG002|Overall Study|Lost to Follow-up|1|||
106038652|NCT03569293|365807323|FG003|Overall Study|Lost to Follow-up|1|||
106038653|NCT03569293|365807324|FG004|Overall Study|Lost to Follow-up|0|||
106038654|NCT03569293|365807325|FG005|Overall Study|Lost to Follow-up|0|||
106038655|NCT03569293|365807320|FG000|Overall Study|Other|8|||
106038656|NCT03569293|365807321|FG001|Overall Study|Other|2|||
106038657|NCT03569293|365807322|FG002|Overall Study|Other|1|||
106038658|NCT03569293|365807323|FG003|Overall Study|Other|1|||
106038659|NCT03569293|365807324|FG004|Overall Study|Other|0|||
106038660|NCT03569293|365807325|FG005|Overall Study|Other|0|||
106038661|NCT03569293|365807320|FG000|Overall Study|Ongoing at Time of Analysis|8|||
106038662|NCT03569293|365807321|FG001|Overall Study|Ongoing at Time of Analysis|1|||
106038663|NCT03569293|365807322|FG002|Overall Study|Ongoing at Time of Analysis|3|||
106038664|NCT03569293|365807323|FG003|Overall Study|Ongoing at Time of Analysis|0|||
106038665|NCT03569293|365807324|FG004|Overall Study|Ongoing at Time of Analysis|0|||
106038666|NCT03569293|365807325|FG005|Overall Study|Ongoing at Time of Analysis|0|||
106038667|NCT06460493|365807329|FG000|Overall Study|Withdrawal by Subject|2|||
106038668|NCT03489551|365807332|FG000|Overall Study|Withdrawal by Subject|2|||
106038669|NCT00054717|365807335|FG000|Overall Study|Randomized but not treated|2|||
106038670|NCT00054717|365807336|FG001|Overall Study|Randomized but not treated|8|||
106038671|NCT00054717|365807335|FG000|Overall Study|Adverse Event|70|||
106038672|NCT00054717|365807336|FG001|Overall Study|Adverse Event|22|||
106038673|NCT00054717|365807335|FG000|Overall Study|Protocol Violation|18|||
106038674|NCT00054717|365807336|FG001|Overall Study|Protocol Violation|19|||
106038675|NCT00054717|365807335|FG000|Overall Study|Lost to Follow-up|23|||
106038676|NCT00054717|365807336|FG001|Overall Study|Lost to Follow-up|13|||
106038677|NCT00054717|365807335|FG000|Overall Study|Withdrawal by Subject|32|||
106038678|NCT00054717|365807336|FG001|Overall Study|Withdrawal by Subject|20|||
106038679|NCT00054717|365807335|FG000|Overall Study|Other reason not defined above|117|||
106038680|NCT00054717|365807336|FG001|Overall Study|Other reason not defined above|217|||
106038681|NCT03707184|365807337|FG000|Overall Study|Withdrawal by Subject|2|||
106038682|NCT02278341|365807338|FG000|Overall Study|Randomized but never received study drug|1|||
106038683|NCT02278341|365807339|FG001|Overall Study|Randomized but never received study drug|1|||
106038684|NCT02278341|365807338|FG000|Overall Study|Adverse Event|3|||
106038685|NCT02278341|365807339|FG001|Overall Study|Adverse Event|0|||
106038686|NCT02278341|365807338|FG000|Overall Study|Death|68|||
106038687|NCT02278341|365807339|FG001|Overall Study|Death|56|||
106038688|NCT02278341|365807338|FG000|Overall Study|Withdrawal by Subject|30|||
106038689|NCT02278341|365807339|FG001|Overall Study|Withdrawal by Subject|19|||
106038690|NCT02278341|365807338|FG000|Overall Study|Lost to Follow-up|0|||
106038691|NCT02278341|365807339|FG001|Overall Study|Lost to Follow-up|1|||
106038692|NCT02278341|365807338|FG000|Overall Study|Physician Decision|1|||
106038693|NCT02278341|365807339|FG001|Overall Study|Physician Decision|1|||
106038694|NCT02278341|365807338|FG000|Overall Study|Miscellaneous|15|||
106038695|NCT02278341|365807339|FG001|Overall Study|Miscellaneous|14|||
105859057|NCT02132754|365134855|FG003|Overall Study|Progressive Disease|1|||
105859058|NCT02132754|365134856|FG004|Overall Study|Progressive Disease|1|||
105859059|NCT02132754|365134857|FG005|Overall Study|Progressive Disease|1|||
105859060|NCT02132754|365134858|FG006|Overall Study|Progressive Disease|1|||
105859061|NCT02132754|365134859|FG007|Overall Study|Progressive Disease|1|||
105859062|NCT02132754|365134860|FG008|Overall Study|Progressive Disease|1|||
105859063|NCT02132754|365134861|FG009|Overall Study|Progressive Disease|3|||
105859064|NCT02132754|365134862|FG010|Overall Study|Progressive Disease|3|||
105859065|NCT02132754|365134863|FG011|Overall Study|Progressive Disease|2|||
105859066|NCT02132754|365134864|FG012|Overall Study|Progressive Disease|2|||
105859067|NCT02132754|365134865|FG013|Overall Study|Progressive Disease|3|||
105859068|NCT02132754|365134866|FG014|Overall Study|Progressive Disease|2|||
106038696|NCT00740246|365807340|FG000|Overall Study|Received Blood Transfusion|0|||
106038697|NCT00740246|365807341|FG001|Overall Study|Received Blood Transfusion|1|||
106038698|NCT00740246|365807340|FG000|Overall Study|Adverse Event|1|||
106038699|NCT00740246|365807341|FG001|Overall Study|Adverse Event|2|||
106038700|NCT00740246|365807340|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
106038701|NCT00740246|365807341|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
106038702|NCT00740246|365807340|FG000|Overall Study|Lost to Follow-up|2|||
106038703|NCT00740246|365807341|FG001|Overall Study|Lost to Follow-up|2|||
106038704|NCT00740246|365807340|FG000|Overall Study|Withdrawal by Subject|4|||
106038705|NCT00740246|365807341|FG001|Overall Study|Withdrawal by Subject|3|||
106038706|NCT00740246|365807340|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
106038707|NCT00740246|365807341|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
106038708|NCT00740246|365807340|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
106038709|NCT00740246|365807341|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
106038710|NCT00740246|365807340|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
106038711|NCT00740246|365807341|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
106038712|NCT00740246|365807340|FG000|Overall Study|Unable To Comply With Study Visits|2|||
105859069|NCT02132754|365134867|FG015|Overall Study|Progressive Disease|1|||
106038713|NCT00740246|365807341|FG001|Overall Study|Unable To Comply With Study Visits|0|||
106038714|NCT00740246|365807340|FG000|Overall Study|Unable to Access Vein|0|||
106038715|NCT00740246|365807341|FG001|Overall Study|Unable to Access Vein|2|||
106038716|NCT00740246|365807340|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
106038717|NCT00740246|365807341|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
106038718|NCT00206076|365807343|FG000|Overall Study|Physician Decision|2|||
106038719|NCT00206076|365807344|FG001|Overall Study|Physician Decision|0|||
106038720|NCT00206076|365807343|FG000|Overall Study|Withdrawal by Subject|1|||
106151722|NCT02590432|366215133|FG001|Double-blind Treatment Period|Adverse Event|0|||
106151723|NCT02590432|366215134|FG002|Double-blind Treatment Period|Adverse Event|14|||
105859070|NCT02132754|365134868|FG016|Overall Study|Progressive Disease|2|||
105859071|NCT02132754|365134869|FG017|Overall Study|Progressive Disease|1|||
105859072|NCT02132754|365134870|FG018|Overall Study|Progressive Disease|3|||
105859073|NCT02132754|365134871|FG019|Overall Study|Progressive Disease|1|||
106038721|NCT00206076|365807344|FG001|Overall Study|Withdrawal by Subject|1|||
106038722|NCT01151098|365807347|FG000|Overall Study|Adverse Event|82|||
106038723|NCT01151098|365807347|FG000|Overall Study|Lost to Follow-up|6|||
106038724|NCT01151098|365807347|FG000|Overall Study|Lack of Efficacy|15|||
106038725|NCT01151098|365807347|FG000|Overall Study|Protocol Violation|1|||
106038726|NCT01151098|365807347|FG000|Overall Study|Miscellaneous|13|||
106038727|NCT02788474|365807350|FG000|Double Blind Treatment Period|Not treated|1|||
106038728|NCT02788474|365807351|FG001|Double Blind Treatment Period|Not treated|0|||
106038729|NCT02788474|365807350|FG000|Double Blind Treatment Period|Patient's refusal|3|||
106038730|NCT02788474|365807351|FG001|Double Blind Treatment Period|Patient's refusal|0|||
106038731|NCT02788474|365807350|FG000|Double Blind Treatment Period|Adverse Event|6|||
106038732|NCT02788474|365807351|FG001|Double Blind Treatment Period|Adverse Event|4|||
106038733|NCT02788474|365807350|FG000|Open Label Treatment Period|Adverse Event|29|||
106038734|NCT02788474|365807351|FG001|Open Label Treatment Period|Adverse Event|9|||
106038735|NCT02788474|365807350|FG000|Open Label Treatment Period|Other than reason specified|1|||
106038736|NCT02788474|365807351|FG001|Open Label Treatment Period|Other than reason specified|0|||
106038737|NCT02788474|365807350|FG000|Open Label Treatment Period|Patient's refusal|1|||
106038738|NCT02788474|365807351|FG001|Open Label Treatment Period|Patient's refusal|3|||
106038739|NCT02788474|365807350|FG000|Open Label Treatment Period|Non-compliance|1|||
106038740|NCT02788474|365807351|FG001|Open Label Treatment Period|Non-compliance|0|||
106038741|NCT02962765|365807352|FG000|Overall Study|Protocol Violation|9|||
106038742|NCT02962765|365807352|FG000|Overall Study|Withdrawal by Subject|3|||
106038743|NCT02962765|365807352|FG000|Overall Study|Lost to Follow-up|1|||
106038744|NCT02962765|365807352|FG000|Overall Study|Death|1|||
106038745|NCT02962765|365807352|FG000|Overall Study|Limited access to study medication|3|||
106038746|NCT04505540|365807356|FG000|Baseline|Protocol Violation|10|||
106038747|NCT04505540|365807356|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
106038748|NCT04505540|365807356|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
106038749|NCT04505540|365807356|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
106038750|NCT04505540|365807356|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
106038751|NCT04505540|365807356|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
106038752|NCT04505540|365807356|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
106038753|NCT04505540|365807356|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
106038754|NCT04505540|365807356|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
106038755|NCT04505540|365807356|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
106038756|NCT04505540|365807356|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
106038757|NCT04505540|365807356|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
106038758|NCT04505540|365807356|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
106038759|NCT02057393|365807357|FG000|Overall Study|Withdrawal by Subject|1|||
106038760|NCT02057393|365807357|FG000|Overall Study|Patient did not meet criteria|1|||
106038761|NCT02652767|365807359|FG000|Overall Study|Death|2|||
106038762|NCT02652767|365807359|FG000|Overall Study|Lost to Follow-up|1|||
106038763|NCT02652767|365807359|FG000|Overall Study|Withdrawal by Subject|1|||
106038764|NCT01222403|365807360|FG000|Overall Study|Inappropriate enrollment|0|||
106038765|NCT01222403|365807361|FG001|Overall Study|Inappropriate enrollment|2|||
106038766|NCT01262352|365807362|FG000|Period 1|Illness after randomization|1|||
106038767|NCT01262352|365807363|FG001|Period 1|Illness after randomization|0|||
106038768|NCT01262352|365807362|FG000|Washout|Adverse Event|1|||
106038769|NCT01262352|365807363|FG001|Washout|Adverse Event|1|||
106038770|NCT01262352|365807362|FG000|Washout|Extended Washout|0|||
106038771|NCT01262352|365807363|FG001|Washout|Extended Washout|1|||
106038772|NCT00064298|365807364|FG000|Overall Study|Withdrawal by Subject|2|||
106038773|NCT00064298|365807365|FG001|Overall Study|Withdrawal by Subject|1|||
106038774|NCT00064298|365807364|FG000|Overall Study|Lost to Follow-up|2|||
106038775|NCT00064298|365807365|FG001|Overall Study|Lost to Follow-up|2|||
106038776|NCT00064298|365807364|FG000|Overall Study|Death|0|||
106038777|NCT00064298|365807365|FG001|Overall Study|Death|1|||
106038778|NCT00064298|365807364|FG000|Overall Study|Disease Progression|2|||
106038779|NCT00064298|365807365|FG001|Overall Study|Disease Progression|1|||
106038780|NCT03614975|365807366|FG000|Overall Study|Physician Decision|7|||
106038781|NCT03614975|365807367|FG001|Overall Study|Physician Decision|5|||
106038782|NCT03614975|365807366|FG000|Overall Study|Withdrawal by Subject|2|||
106038783|NCT03614975|365807367|FG001|Overall Study|Withdrawal by Subject|2|||
106038784|NCT03614975|365807366|FG000|Overall Study|Specimens not in lab batch shipment|1|||
106038785|NCT03614975|365807367|FG001|Overall Study|Specimens not in lab batch shipment|1|||
106038786|NCT01569464|365807368|FG000|Overall Study|Adverse Event|4|||
106038787|NCT01569464|365807369|FG001|Overall Study|Adverse Event|0|||
106038788|NCT01569464|365807368|FG000|Overall Study|Lack of Efficacy|1|||
106038789|NCT01569464|365807369|FG001|Overall Study|Lack of Efficacy|0|||
106038790|NCT01569464|365807368|FG000|Overall Study|Protocol Violation|1|||
106038791|NCT01569464|365807369|FG001|Overall Study|Protocol Violation|0|||
106038792|NCT01569464|365807368|FG000|Overall Study|Lost to Follow-up|2|||
106038793|NCT01569464|365807369|FG001|Overall Study|Lost to Follow-up|3|||
106038794|NCT01569464|365807368|FG000|Overall Study|Withdrawal by Subject|1|||
106038795|NCT01569464|365807369|FG001|Overall Study|Withdrawal by Subject|1|||
106038796|NCT01569464|365807368|FG000|Overall Study|Other|1|||
106038797|NCT01569464|365807369|FG001|Overall Study|Other|1|||
106038798|NCT03063203|365807370|FG000|Overall Study|Chose alternative therapy|3|||
106038799|NCT03063203|365807370|FG000|Overall Study|Death|2|||
106038800|NCT03063203|365807370|FG000|Overall Study|Disease progression|4|||
106038801|NCT03063203|365807370|FG000|Overall Study|Physician Decision|5|||
106038802|NCT02431247|365807373|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
106038803|NCT02431247|365807374|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
106038804|NCT02431247|365807375|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
106038805|NCT02431247|365807373|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
106038806|NCT02431247|365807374|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
106038807|NCT02431247|365807375|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
106038808|NCT02431247|365807373|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
106038809|NCT02431247|365807374|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
106038810|NCT02431247|365807375|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
106038811|NCT02431247|365807373|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
106038812|NCT02431247|365807374|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
106038813|NCT02431247|365807375|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
106038814|NCT02431247|365807373|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
106038815|NCT02431247|365807374|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
106038816|NCT02431247|365807375|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
106038817|NCT02431247|365807373|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
106038818|NCT02431247|365807374|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
106038819|NCT02431247|365807375|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
106038820|NCT02431247|365807373|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
106038821|NCT02431247|365807374|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
106038822|NCT02431247|365807375|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
106038823|NCT02431247|365807373|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
106038824|NCT02431247|365807374|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
106038825|NCT02431247|365807375|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
106038826|NCT02431247|365807373|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
106038827|NCT02431247|365807374|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
106038828|NCT02431247|365807375|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
106038829|NCT02431247|365807373|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
106038830|NCT02431247|365807374|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
106038831|NCT02431247|365807375|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
106038832|NCT02431247|365807373|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
106038833|NCT02431247|365807374|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
106038834|NCT02431247|365807375|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
106038835|NCT02431247|365807373|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
106038836|NCT02431247|365807374|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
106038837|NCT02431247|365807375|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
106038838|NCT02431247|365807373|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
106038839|NCT02431247|365807374|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
106038840|NCT02431247|365807375|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
106038841|NCT02431247|365807373|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
106038842|NCT02431247|365807374|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
106038843|NCT02431247|365807375|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
106038844|NCT02273739|365807376|FG000|Overall Study|Progression of Disease|3|||
106038845|NCT02273739|365807377|FG001|Overall Study|Progression of Disease|4|||
106038846|NCT02273739|365807378|FG002|Overall Study|Progression of Disease|5|||
106038847|NCT02273739|365807379|FG003|Overall Study|Progression of Disease|2|||
106038848|NCT02273739|365807376|FG000|Overall Study|Death|0|||
106038849|NCT02273739|365807377|FG001|Overall Study|Death|0|||
106038850|NCT02273739|365807378|FG002|Overall Study|Death|0|||
106038851|NCT02273739|365807379|FG003|Overall Study|Death|2|||
106038852|NCT02273739|365807376|FG000|Overall Study|Adverse Event|0|||
106038853|NCT02273739|365807377|FG001|Overall Study|Adverse Event|0|||
106038854|NCT02273739|365807378|FG002|Overall Study|Adverse Event|0|||
106038855|NCT02273739|365807379|FG003|Overall Study|Adverse Event|1|||
106038856|NCT02273739|365807376|FG000|Overall Study|Withdrawal by Subject|0|||
106038857|NCT02273739|365807377|FG001|Overall Study|Withdrawal by Subject|0|||
105859074|NCT02132754|365134872|FG020|Overall Study|Progressive Disease|1|||
105859075|NCT02132754|365134873|FG021|Overall Study|Progressive Disease|3|||
105859076|NCT02132754|365134874|FG022|Overall Study|Progressive Disease|2|||
105859077|NCT02132754|365134875|FG023|Overall Study|Progressive Disease|3|||
105859078|NCT02132754|365134876|FG024|Overall Study|Progressive Disease|0|||
105859079|NCT02132754|365134877|FG025|Overall Study|Progressive Disease|1|||
105859080|NCT02132754|365134878|FG026|Overall Study|Progressive Disease|2|||
105859081|NCT02132754|365134879|FG027|Overall Study|Progressive Disease|1|||
105859082|NCT02132754|365134880|FG028|Overall Study|Progressive Disease|2|||
106038858|NCT02273739|365807378|FG002|Overall Study|Withdrawal by Subject|2|||
106038859|NCT02273739|365807379|FG003|Overall Study|Withdrawal by Subject|1|||
106038860|NCT02273739|365807376|FG000|Overall Study|Physician Decision|0|||
106038861|NCT02273739|365807377|FG001|Overall Study|Physician Decision|0|||
106038862|NCT02273739|365807378|FG002|Overall Study|Physician Decision|0|||
106038863|NCT02273739|365807379|FG003|Overall Study|Physician Decision|1|||
106038864|NCT00322153|365807382|FG000|Overall Study|Adverse Event|21|||
106038865|NCT00322153|365807383|FG001|Overall Study|Adverse Event|34|||
106038866|NCT00322153|365807382|FG000|Overall Study|Protocol Violation|6|||
106038867|NCT00322153|365807383|FG001|Overall Study|Protocol Violation|14|||
106038868|NCT00322153|365807382|FG000|Overall Study|Withdrawal by Subject|18|||
106038869|NCT00322153|365807383|FG001|Overall Study|Withdrawal by Subject|10|||
106038870|NCT00322153|365807382|FG000|Overall Study|Lack of Efficacy|8|||
106038871|NCT00322153|365807383|FG001|Overall Study|Lack of Efficacy|3|||
106038872|NCT00322153|365807382|FG000|Overall Study|Lost to Follow-up|5|||
106038873|NCT00322153|365807383|FG001|Overall Study|Lost to Follow-up|4|||
106038874|NCT00322153|365807382|FG000|Overall Study|Withdrawn for other reasons|5|||
106038875|NCT00322153|365807383|FG001|Overall Study|Withdrawn for other reasons|4|||
106038876|NCT01309893|365807384|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
106038877|NCT01309893|365807385|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
106038878|NCT01309893|365807384|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
106038879|NCT01309893|365807385|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
106038880|NCT01562873|365807386|FG000|Overall Study|Disease Progression per RECIST|10|||
106038881|NCT01562873|365807387|FG001|Overall Study|Disease Progression per RECIST|0|||
106038882|NCT01562873|365807386|FG000|Overall Study|Adverse Event|1|||
106038883|NCT01562873|365807387|FG001|Overall Study|Adverse Event|0|||
106038884|NCT01562873|365807386|FG000|Overall Study|Clinical Disease Progression|9|||
106038885|NCT01562873|365807387|FG001|Overall Study|Clinical Disease Progression|0|||
106038886|NCT01562873|365807386|FG000|Overall Study|Clinical PD and adverse event|1|||
106038887|NCT01562873|365807387|FG001|Overall Study|Clinical PD and adverse event|0|||
106038888|NCT00873860|365807392|FG000|Overall Study|Lost to Follow-up|1|||
106038889|NCT00873860|365807393|FG001|Overall Study|Lost to Follow-up|0|||
106038890|NCT00873860|365807394|FG002|Overall Study|Lost to Follow-up|0|||
106038891|NCT00873860|365807395|FG003|Overall Study|Lost to Follow-up|1|||
106038892|NCT00873860|365807392|FG000|Overall Study|Withdrawal by Subject|1|||
106038893|NCT00873860|365807393|FG001|Overall Study|Withdrawal by Subject|0|||
106038894|NCT00873860|365807394|FG002|Overall Study|Withdrawal by Subject|2|||
106038895|NCT00873860|365807395|FG003|Overall Study|Withdrawal by Subject|0|||
106038896|NCT00873860|365807392|FG000|Overall Study|Death|1|||
106038897|NCT00873860|365807393|FG001|Overall Study|Death|0|||
106038898|NCT00873860|365807394|FG002|Overall Study|Death|0|||
106038899|NCT00873860|365807395|FG003|Overall Study|Death|0|||
106038900|NCT00873860|365807392|FG000|Overall Study|Other|1|||
106038901|NCT00873860|365807393|FG001|Overall Study|Other|0|||
106038902|NCT00873860|365807394|FG002|Overall Study|Other|1|||
106038903|NCT00873860|365807395|FG003|Overall Study|Other|0|||
106038904|NCT02764190|365807396|FG000|Overall Study|Lost to Follow-up|17|||
106038905|NCT02764190|365807397|FG001|Overall Study|Lost to Follow-up|13|||
106038906|NCT00089674|365807398|FG000|Overall Study|Physician Decision|4|||
106038907|NCT00089674|365807399|FG001|Overall Study|Physician Decision|2|||
106038908|NCT00089674|365807398|FG000|Overall Study|Adverse Event|23|||
106038909|NCT00089674|365807399|FG001|Overall Study|Adverse Event|29|||
106038910|NCT00089674|365807398|FG000|Overall Study|Withdrawal by Subject|143|||
106038911|NCT00089674|365807399|FG001|Overall Study|Withdrawal by Subject|127|||
106038912|NCT00089674|365807398|FG000|Overall Study|Death|43|||
106038913|NCT00089674|365807399|FG001|Overall Study|Death|43|||
106038914|NCT00089674|365807398|FG000|Overall Study|Disease progression|21|||
106038915|NCT00089674|365807399|FG001|Overall Study|Disease progression|23|||
106038916|NCT00089674|365807398|FG000|Overall Study|Ineligibility determined|8|||
106038917|NCT00089674|365807399|FG001|Overall Study|Ineligibility determined|10|||
106038918|NCT00089674|365807398|FG000|Overall Study|Lost to Follow-up|21|||
106038919|NCT00089674|365807399|FG001|Overall Study|Lost to Follow-up|17|||
106038920|NCT00089674|365807398|FG000|Overall Study|Noncompliance|7|||
106038921|NCT00089674|365807399|FG001|Overall Study|Noncompliance|3|||
106038922|NCT00089674|365807398|FG000|Overall Study|Other|5|||
106038923|NCT00089674|365807399|FG001|Overall Study|Other|9|||
106038924|NCT00089674|365807398|FG000|Overall Study|Requirement for alternative therapy|14|||
106038925|NCT00089674|365807399|FG001|Overall Study|Requirement for alternative therapy|4|||
106038926|NCT01484938|365807400|FG000|Overall Study|Adverse Event|2|||
106038927|NCT01484938|365807400|FG000|Overall Study|Lost to Follow-up|1|||
106038928|NCT01484938|365807400|FG000|Overall Study|Noncompliance|1|||
106038929|NCT02140775|365807402|FG000|Overall Study|Withdrawal by Subject|30|||
106038930|NCT02140775|365807403|FG001|Overall Study|Withdrawal by Subject|7|||
106038931|NCT01285960|365807412|FG000|Overall Study|Withdrawal by Subject|2|||
106038932|NCT01285960|365807412|FG000|Overall Study|Lost to Follow-up|2|||
106038933|NCT01285960|365807412|FG000|Overall Study|2 subjects received less 10 sonications|2|||
106038934|NCT00495131|365807415|FG000|Overall Study|Adverse Event|6|||
106038935|NCT00495131|365807416|FG001|Overall Study|Adverse Event|2|||
106038936|NCT00495131|365807415|FG000|Overall Study|Lack of Efficacy|0|||
106038937|NCT00495131|365807416|FG001|Overall Study|Lack of Efficacy|2|||
106038938|NCT00495131|365807415|FG000|Overall Study|Lost to Follow-up|0|||
106038939|NCT00495131|365807416|FG001|Overall Study|Lost to Follow-up|2|||
106038940|NCT00495131|365807415|FG000|Overall Study|Withdrawal by Subject|1|||
106038941|NCT00495131|365807416|FG001|Overall Study|Withdrawal by Subject|0|||
106038942|NCT02204007|365807417|FG000|Overall Study|Surgery Canceled|1|||
106038943|NCT02204007|365807418|FG001|Overall Study|Surgery Canceled|1|||
106038944|NCT03911843|365807424|FG000|Overall Study|Adverse Event|2|||
106038945|NCT03911843|365807425|FG001|Overall Study|Adverse Event|0|||
106038946|NCT03911843|365807424|FG000|Overall Study|Protocol Violation|2|||
106038947|NCT03911843|365807425|FG001|Overall Study|Protocol Violation|0|||
106038948|NCT03911843|365807424|FG000|Overall Study|Lost to Follow-up|0|||
106038949|NCT03911843|365807425|FG001|Overall Study|Lost to Follow-up|1|||
106038950|NCT00920829|365808810|FG000|Allocation|No post randomization data|3|||
106038951|NCT00920829|365808811|FG001|Allocation|No post randomization data|1|||
106038952|NCT00920829|365808812|FG002|Allocation|No post randomization data|0|||
105859083|NCT02132754|365134881|FG029|Overall Study|Progressive Disease|3|||
105859084|NCT02132754|365134882|FG030|Overall Study|Progressive Disease|1|||
105859085|NCT02132754|365134883|FG031|Overall Study|Progressive Disease|1|||
105859086|NCT02132754|365134884|FG032|Overall Study|Progressive Disease|3|||
105859087|NCT02132754|365134885|FG033|Overall Study|Progressive Disease|6|||
105859088|NCT02132754|365134852|FG000|Overall Study|Screen Failure|0|||
105859089|NCT02132754|365134853|FG001|Overall Study|Screen Failure|0|||
105859090|NCT02132754|365134854|FG002|Overall Study|Screen Failure|0|||
105859091|NCT02132754|365134855|FG003|Overall Study|Screen Failure|0|||
105859092|NCT02132754|365134856|FG004|Overall Study|Screen Failure|0|||
105859093|NCT02132754|365134857|FG005|Overall Study|Screen Failure|0|||
105859094|NCT02132754|365134858|FG006|Overall Study|Screen Failure|0|||
105859095|NCT02132754|365134859|FG007|Overall Study|Screen Failure|0|||
105859096|NCT02132754|365134860|FG008|Overall Study|Screen Failure|0|||
105859097|NCT02132754|365134861|FG009|Overall Study|Screen Failure|0|||
105859098|NCT02132754|365134862|FG010|Overall Study|Screen Failure|0|||
105859099|NCT02132754|365134863|FG011|Overall Study|Screen Failure|0|||
105859100|NCT02132754|365134864|FG012|Overall Study|Screen Failure|0|||
105859101|NCT02132754|365134865|FG013|Overall Study|Screen Failure|0|||
105859102|NCT02132754|365134866|FG014|Overall Study|Screen Failure|0|||
105859103|NCT02132754|365134867|FG015|Overall Study|Screen Failure|0|||
105859104|NCT02132754|365134868|FG016|Overall Study|Screen Failure|0|||
105859105|NCT02132754|365134869|FG017|Overall Study|Screen Failure|0|||
105859106|NCT02132754|365134870|FG018|Overall Study|Screen Failure|0|||
105859107|NCT02132754|365134871|FG019|Overall Study|Screen Failure|1|||
105859108|NCT02132754|365134872|FG020|Overall Study|Screen Failure|0|||
105859109|NCT02132754|365134873|FG021|Overall Study|Screen Failure|1|||
105859110|NCT02132754|365134874|FG022|Overall Study|Screen Failure|0|||
105859111|NCT02132754|365134875|FG023|Overall Study|Screen Failure|0|||
105859112|NCT02132754|365134876|FG024|Overall Study|Screen Failure|0|||
105859113|NCT02132754|365134877|FG025|Overall Study|Screen Failure|0|||
105859114|NCT02132754|365134878|FG026|Overall Study|Screen Failure|0|||
105859115|NCT02132754|365134879|FG027|Overall Study|Screen Failure|0|||
105859116|NCT02132754|365134880|FG028|Overall Study|Screen Failure|0|||
105859117|NCT02132754|365134881|FG029|Overall Study|Screen Failure|0|||
105859118|NCT02132754|365134882|FG030|Overall Study|Screen Failure|0|||
105859119|NCT02132754|365134883|FG031|Overall Study|Screen Failure|0|||
105859120|NCT02132754|365134884|FG032|Overall Study|Screen Failure|0|||
105859121|NCT02132754|365134885|FG033|Overall Study|Screen Failure|0|||
105859122|NCT02132754|365134852|FG000|Overall Study|Transferred to Extension Study|0|||
105859123|NCT02132754|365134853|FG001|Overall Study|Transferred to Extension Study|0|||
105859124|NCT02132754|365134854|FG002|Overall Study|Transferred to Extension Study|0|||
105859125|NCT02132754|365134855|FG003|Overall Study|Transferred to Extension Study|0|||
105859126|NCT02132754|365134856|FG004|Overall Study|Transferred to Extension Study|0|||
106038953|NCT00920829|365808813|FG003|Allocation|No post randomization data|2|||
106038954|NCT00920829|365808810|FG000|Available for Analysis|Withdrawal by Subject|6|||
106038955|NCT00920829|365808811|FG001|Available for Analysis|Withdrawal by Subject|6|||
106038956|NCT00920829|365808812|FG002|Available for Analysis|Withdrawal by Subject|6|||
106038957|NCT00920829|365808813|FG003|Available for Analysis|Withdrawal by Subject|10|||
106038958|NCT00920829|365808810|FG000|Available for Analysis|Required Medical Treatment|0|||
105859127|NCT02132754|365134857|FG005|Overall Study|Transferred to Extension Study|0|||
105859128|NCT02132754|365134858|FG006|Overall Study|Transferred to Extension Study|0|||
105859129|NCT02132754|365134859|FG007|Overall Study|Transferred to Extension Study|0|||
105859130|NCT02132754|365134860|FG008|Overall Study|Transferred to Extension Study|0|||
105859131|NCT02132754|365134861|FG009|Overall Study|Transferred to Extension Study|0|||
105859132|NCT02132754|365134862|FG010|Overall Study|Transferred to Extension Study|0|||
105859133|NCT02132754|365134863|FG011|Overall Study|Transferred to Extension Study|0|||
105859134|NCT02132754|365134864|FG012|Overall Study|Transferred to Extension Study|0|||
105859135|NCT02132754|365134865|FG013|Overall Study|Transferred to Extension Study|0|||
105859136|NCT02132754|365134866|FG014|Overall Study|Transferred to Extension Study|0|||
105859137|NCT02132754|365134867|FG015|Overall Study|Transferred to Extension Study|0|||
105859138|NCT02132754|365134868|FG016|Overall Study|Transferred to Extension Study|0|||
105859139|NCT02132754|365134869|FG017|Overall Study|Transferred to Extension Study|0|||
105859140|NCT02132754|365134870|FG018|Overall Study|Transferred to Extension Study|0|||
105859141|NCT02132754|365134871|FG019|Overall Study|Transferred to Extension Study|0|||
105859142|NCT02132754|365134872|FG020|Overall Study|Transferred to Extension Study|0|||
105859143|NCT02132754|365134873|FG021|Overall Study|Transferred to Extension Study|0|||
105859144|NCT02132754|365134874|FG022|Overall Study|Transferred to Extension Study|0|||
105859145|NCT02132754|365134875|FG023|Overall Study|Transferred to Extension Study|0|||
105859146|NCT02132754|365134876|FG024|Overall Study|Transferred to Extension Study|0|||
105859147|NCT02132754|365134877|FG025|Overall Study|Transferred to Extension Study|0|||
105859148|NCT02132754|365134878|FG026|Overall Study|Transferred to Extension Study|0|||
105859149|NCT02132754|365134879|FG027|Overall Study|Transferred to Extension Study|0|||
105859150|NCT02132754|365134880|FG028|Overall Study|Transferred to Extension Study|0|||
105859151|NCT02132754|365134881|FG029|Overall Study|Transferred to Extension Study|0|||
105859152|NCT02132754|365134882|FG030|Overall Study|Transferred to Extension Study|0|||
105859153|NCT02132754|365134883|FG031|Overall Study|Transferred to Extension Study|0|||
105859154|NCT02132754|365134884|FG032|Overall Study|Transferred to Extension Study|0|||
105859155|NCT02132754|365134885|FG033|Overall Study|Transferred to Extension Study|6|||
105859156|NCT02132754|365134852|FG000|Overall Study|Withdrawal by Subject|0|||
105859157|NCT02132754|365134853|FG001|Overall Study|Withdrawal by Subject|0|||
105859158|NCT02132754|365134854|FG002|Overall Study|Withdrawal by Subject|0|||
105859159|NCT02132754|365134855|FG003|Overall Study|Withdrawal by Subject|0|||
105859160|NCT02132754|365134856|FG004|Overall Study|Withdrawal by Subject|0|||
105859161|NCT02132754|365134857|FG005|Overall Study|Withdrawal by Subject|0|||
105859162|NCT02132754|365134858|FG006|Overall Study|Withdrawal by Subject|0|||
105859163|NCT02132754|365134859|FG007|Overall Study|Withdrawal by Subject|0|||
105859164|NCT02132754|365134860|FG008|Overall Study|Withdrawal by Subject|0|||
105859165|NCT02132754|365134861|FG009|Overall Study|Withdrawal by Subject|1|||
105859166|NCT02132754|365134862|FG010|Overall Study|Withdrawal by Subject|0|||
105859167|NCT02132754|365134863|FG011|Overall Study|Withdrawal by Subject|0|||
105859168|NCT02132754|365134864|FG012|Overall Study|Withdrawal by Subject|1|||
105859169|NCT02132754|365134865|FG013|Overall Study|Withdrawal by Subject|0|||
105859170|NCT02132754|365134866|FG014|Overall Study|Withdrawal by Subject|1|||
105859171|NCT02132754|365134867|FG015|Overall Study|Withdrawal by Subject|2|||
105859172|NCT02132754|365134868|FG016|Overall Study|Withdrawal by Subject|1|||
105859173|NCT02132754|365134869|FG017|Overall Study|Withdrawal by Subject|0|||
105859174|NCT02132754|365134870|FG018|Overall Study|Withdrawal by Subject|0|||
105859175|NCT02132754|365134871|FG019|Overall Study|Withdrawal by Subject|0|||
105859176|NCT02132754|365134872|FG020|Overall Study|Withdrawal by Subject|1|||
105859177|NCT02132754|365134873|FG021|Overall Study|Withdrawal by Subject|0|||
105859178|NCT02132754|365134874|FG022|Overall Study|Withdrawal by Subject|0|||
105859179|NCT02132754|365134875|FG023|Overall Study|Withdrawal by Subject|0|||
105859180|NCT02132754|365134876|FG024|Overall Study|Withdrawal by Subject|1|||
105859181|NCT02132754|365134877|FG025|Overall Study|Withdrawal by Subject|0|||
105859182|NCT02132754|365134878|FG026|Overall Study|Withdrawal by Subject|0|||
105859183|NCT02132754|365134879|FG027|Overall Study|Withdrawal by Subject|1|||
105859184|NCT02132754|365134880|FG028|Overall Study|Withdrawal by Subject|0|||
105859185|NCT02132754|365134881|FG029|Overall Study|Withdrawal by Subject|0|||
105859186|NCT02132754|365134882|FG030|Overall Study|Withdrawal by Subject|0|||
105859187|NCT02132754|365134883|FG031|Overall Study|Withdrawal by Subject|1|||
105859188|NCT02132754|365134884|FG032|Overall Study|Withdrawal by Subject|0|||
105859189|NCT02132754|365134885|FG033|Overall Study|Withdrawal by Subject|2|||
105859190|NCT03050060|365134889|FG000|Overall Study|Adverse Event|7|||
105859191|NCT03050060|365134889|FG000|Overall Study|Withdrawal by Subject|1|||
105859192|NCT03050060|365134889|FG000|Overall Study|Progression|7|||
105859193|NCT00510289|365134890|FG000|Overall Study|Withdrawal by Subject|7|||
105859194|NCT00510289|365134890|FG000|Overall Study|Refused bone marrow biopsy|2|||
105859195|NCT00510289|365134890|FG000|Overall Study|Lost to Follow-up|1|||
105859196|NCT00510289|365134890|FG000|Overall Study|Progressed prior to starting drug|2|||
106038959|NCT00920829|365808811|FG001|Available for Analysis|Required Medical Treatment|1|||
106038960|NCT00920829|365808812|FG002|Available for Analysis|Required Medical Treatment|2|||
106038961|NCT00920829|365808813|FG003|Available for Analysis|Required Medical Treatment|0|||
106038962|NCT00920829|365808810|FG000|Available for Analysis|Adverse Event|1|||
106038963|NCT00920829|365808811|FG001|Available for Analysis|Adverse Event|2|||
105859197|NCT00197496|365134892|FG000|Baseline to Discharge|not interested|1|||
105859198|NCT00197496|365134893|FG001|Baseline to Discharge|not interested|0|||
105859199|NCT00197496|365134892|FG000|Baseline to Discharge|MRSA|1|||
105859200|NCT00197496|365134893|FG001|Baseline to Discharge|MRSA|0|||
105859201|NCT00197496|365134892|FG000|Baseline to Discharge|Physician Decision|0|||
105859202|NCT00197496|365134893|FG001|Baseline to Discharge|Physician Decision|1|||
105859203|NCT00197496|365134892|FG000|Baseline to Discharge|Protocol Violation|0|||
105859204|NCT00197496|365134893|FG001|Baseline to Discharge|Protocol Violation|1|||
105859205|NCT00197496|365134892|FG000|Follow-up|Lost to Follow-up|2|||
106038964|NCT00920829|365808812|FG002|Available for Analysis|Adverse Event|1|||
106038965|NCT00920829|365808813|FG003|Available for Analysis|Adverse Event|0|||
106038966|NCT00920829|365808810|FG000|Available for Analysis|Death|1|||
106038967|NCT00920829|365808811|FG001|Available for Analysis|Death|0|||
106038968|NCT00920829|365808812|FG002|Available for Analysis|Death|0|||
105859206|NCT00197496|365134893|FG001|Follow-up|Lost to Follow-up|1|||
105859207|NCT01770392|365134894|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
105859208|NCT03401450|365134898|FG000|Overall Study|Lost to Follow-up|4|||
105859209|NCT03401450|365134899|FG001|Overall Study|Lost to Follow-up|6|||
105859210|NCT03401450|365134898|FG000|Overall Study|Anesthesia plan changed|2|||
105859211|NCT03401450|365134899|FG001|Overall Study|Anesthesia plan changed|2|||
105859212|NCT03401450|365134898|FG000|Overall Study|Did not complete medication diary|4|||
105859213|NCT03401450|365134899|FG001|Overall Study|Did not complete medication diary|2|||
105859214|NCT03401450|365134898|FG000|Overall Study|post surgery medication change|2|||
105859215|NCT03401450|365134899|FG001|Overall Study|post surgery medication change|1|||
105859216|NCT03401450|365134898|FG000|Overall Study|Cancelled surgery|0|||
105859217|NCT03401450|365134899|FG001|Overall Study|Cancelled surgery|2|||
105859218|NCT00861198|365134904|FG000|Overall Study|SpyGlass Failed|5|||
105859219|NCT02269163|365134908|FG000|Overall Study|Lost to Follow-up|1|||
105859220|NCT02269163|365134909|FG001|Overall Study|Lost to Follow-up|0|||
105859221|NCT02269163|365134908|FG000|Overall Study|Major protocol violation|0|||
105859222|NCT02269163|365134909|FG001|Overall Study|Major protocol violation|1|||
105859223|NCT02269163|365134908|FG000|Overall Study|Other|2|||
105859224|NCT02269163|365134909|FG001|Overall Study|Other|2|||
105859225|NCT02269163|365134908|FG000|Overall Study|Withdrawal by Subject|0|||
105859226|NCT02269163|365134909|FG001|Overall Study|Withdrawal by Subject|3|||
105859227|NCT02269163|365134908|FG000|Overall Study|Physician Decision|0|||
105859228|NCT02269163|365134909|FG001|Overall Study|Physician Decision|1|||
105859229|NCT00319982|365134910|FG000|Overall Study|Withdrawal by Subject|1|||
105859230|NCT00319982|365134911|FG001|Overall Study|Withdrawal by Subject|0|||
105859231|NCT00259272|365134912|FG000|Overall Study|Adverse Event|2|||
105859232|NCT00259272|365134913|FG001|Overall Study|Adverse Event|1|||
105859233|NCT00259272|365134914|FG002|Overall Study|Adverse Event|0|||
105859234|NCT00259272|365134915|FG003|Overall Study|Adverse Event|3|||
105859235|NCT00259272|365134912|FG000|Overall Study|Lack of Efficacy|5|||
105859236|NCT00259272|365134913|FG001|Overall Study|Lack of Efficacy|1|||
105859237|NCT00259272|365134914|FG002|Overall Study|Lack of Efficacy|2|||
105859238|NCT00259272|365134915|FG003|Overall Study|Lack of Efficacy|6|||
105859239|NCT00259272|365134912|FG000|Overall Study|Physician Decision|1|||
105859240|NCT00259272|365134913|FG001|Overall Study|Physician Decision|2|||
105859241|NCT00259272|365134914|FG002|Overall Study|Physician Decision|1|||
105859242|NCT00259272|365134915|FG003|Overall Study|Physician Decision|3|||
105859243|NCT00259272|365134912|FG000|Overall Study|Protocol Violation|2|||
105859244|NCT00259272|365134913|FG001|Overall Study|Protocol Violation|0|||
105859245|NCT00259272|365134914|FG002|Overall Study|Protocol Violation|0|||
105859246|NCT00259272|365134915|FG003|Overall Study|Protocol Violation|1|||
105859247|NCT00259272|365134912|FG000|Overall Study|Sponsor Decision|0|||
105859248|NCT00259272|365134913|FG001|Overall Study|Sponsor Decision|1|||
105859249|NCT00259272|365134914|FG002|Overall Study|Sponsor Decision|0|||
105859250|NCT00259272|365134915|FG003|Overall Study|Sponsor Decision|0|||
105859251|NCT00259272|365134912|FG000|Overall Study|Withdrawal by Subject|4|||
105859252|NCT00259272|365134913|FG001|Overall Study|Withdrawal by Subject|2|||
105859253|NCT00259272|365134914|FG002|Overall Study|Withdrawal by Subject|2|||
105859254|NCT00259272|365134915|FG003|Overall Study|Withdrawal by Subject|7|||
105859255|NCT00259272|365134912|FG000|Overall Study|Lost to Follow-up|1|||
105859256|NCT00259272|365134913|FG001|Overall Study|Lost to Follow-up|0|||
106038969|NCT00920829|365808813|FG003|Available for Analysis|Death|0|||
106038970|NCT00920829|365808810|FG000|Available for Analysis|Protocol Violation|0|||
106038971|NCT00920829|365808811|FG001|Available for Analysis|Protocol Violation|0|||
106038972|NCT00920829|365808812|FG002|Available for Analysis|Protocol Violation|1|||
106038973|NCT00920829|365808813|FG003|Available for Analysis|Protocol Violation|0|||
106038974|NCT00920829|365808810|FG000|Available for Analysis|Required more treatment|0|||
106038975|NCT00920829|365808811|FG001|Available for Analysis|Required more treatment|2|||
106038976|NCT00920829|365808812|FG002|Available for Analysis|Required more treatment|0|||
106038977|NCT00920829|365808813|FG003|Available for Analysis|Required more treatment|1|||
106038978|NCT04533880|365808814|FG000|Overall Study|Lost to Follow-up|0|||
106038979|NCT04533880|365808815|FG001|Overall Study|Lost to Follow-up|1|||
106038980|NCT04533880|365808816|FG002|Overall Study|Lost to Follow-up|1|||
106038981|NCT01483690|365808820|FG000|Overall Study|Adverse Event|1|||
105859257|NCT00259272|365134914|FG002|Overall Study|Lost to Follow-up|0|||
105859258|NCT00259272|365134915|FG003|Overall Study|Lost to Follow-up|1|||
105859259|NCT03480386|365134916|FG000|Overall Study|Did not complete measures at 3-months|17|||
105859260|NCT03480386|365134917|FG001|Overall Study|Did not complete measures at 3-months|14|||
105859261|NCT03480386|365134916|FG000|Overall Study|No baseline measures|11|||
105859262|NCT03480386|365134917|FG001|Overall Study|No baseline measures|14|||
105859263|NCT03480386|365134916|FG000|Overall Study|Death|0|||
105859264|NCT03480386|365134917|FG001|Overall Study|Death|5|||
106038982|NCT01483690|365808821|FG001|Overall Study|Adverse Event|2|||
106038983|NCT01483690|365808820|FG000|Overall Study|clinical deterioration|1|||
106038984|NCT01483690|365808821|FG001|Overall Study|clinical deterioration|0|||
106038985|NCT01483690|365808820|FG000|Overall Study|Physician Decision|0|||
106038986|NCT01483690|365808821|FG001|Overall Study|Physician Decision|2|||
106038987|NCT01483690|365808820|FG000|Overall Study|exclusionary procedure|0|||
106038988|NCT01483690|365808821|FG001|Overall Study|exclusionary procedure|1|||
106038989|NCT02239224|365808825|FG000|Overall Study|Administrative|0|||
106038990|NCT02239224|365808826|FG001|Overall Study|Administrative|0|||
106038991|NCT02239224|365808827|FG002|Overall Study|Administrative|3|||
106038992|NCT02239224|365808828|FG003|Overall Study|Administrative|1|||
106038993|NCT03183778|365808829|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
106038994|NCT00749580|365808830|FG000|Overall Study|Lost to Follow-up|4|||
106038995|NCT00749580|365808831|FG001|Overall Study|Lost to Follow-up|8|||
106038996|NCT00749580|365808830|FG000|Overall Study|Adverse Event|0|||
106038997|NCT00749580|365808831|FG001|Overall Study|Adverse Event|1|||
106038998|NCT02428608|365808835|FG000|Overall Study|Pregnancy|2|||
106038999|NCT02428608|365808835|FG000|Overall Study|Lost to Follow-up|37|||
106039000|NCT02428608|365808835|FG000|Overall Study|Withdrawal by Subject|2|||
106039001|NCT02428608|365808835|FG000|Overall Study|scheduling conflicts|15|||
106039002|NCT02428608|365808835|FG000|Overall Study|moved away|10|||
106039003|NCT02428608|365808835|FG000|Overall Study|Death|1|||
106039004|NCT02428608|365808835|FG000|Overall Study|various|16|||
106039005|NCT02806973|365808840|FG000|Period 1|Withdrawal by Subject|0|||
106039006|NCT02806973|365808841|FG001|Period 1|Withdrawal by Subject|2|||
106039007|NCT02806973|365808842|FG002|Period 1|Withdrawal by Subject|1|||
106039008|NCT02806973|365808843|FG003|Period 1|Withdrawal by Subject|1|||
106039009|NCT02806973|365808840|FG000|Period 1|Adverse Event|0|||
106039010|NCT02806973|365808841|FG001|Period 1|Adverse Event|0|||
106039011|NCT02806973|365808842|FG002|Period 1|Adverse Event|0|||
106039012|NCT02806973|365808843|FG003|Period 1|Adverse Event|1|||
106039013|NCT02806973|365808840|FG000|Period 3|Withdrawal by Subject|0|||
106039014|NCT02806973|365808841|FG001|Period 3|Withdrawal by Subject|0|||
106039015|NCT02806973|365808842|FG002|Period 3|Withdrawal by Subject|0|||
106039016|NCT02806973|365808843|FG003|Period 3|Withdrawal by Subject|3|||
106039017|NCT02806973|365808840|FG000|Period 3|Adverse Event|0|||
106039018|NCT02806973|365808841|FG001|Period 3|Adverse Event|0|||
106039019|NCT02806973|365808842|FG002|Period 3|Adverse Event|1|||
105859265|NCT03480386|365134916|FG000|Overall Study|Withdrawal by Subject|12|||
105859266|NCT03480386|365134917|FG001|Overall Study|Withdrawal by Subject|8|||
105859267|NCT03480386|365134916|FG000|Overall Study|Lost to Follow-up|2|||
105859268|NCT03480386|365134917|FG001|Overall Study|Lost to Follow-up|1|||
105859269|NCT03480386|365134916|FG000|Overall Study|Complicating disease|0|||
105859270|NCT03480386|365134917|FG001|Overall Study|Complicating disease|1|||
105859271|NCT03480386|365134916|FG000|Overall Study|Disease progression|3|||
105859272|NCT03480386|365134917|FG001|Overall Study|Disease progression|0|||
105859273|NCT03480386|365134916|FG000|Overall Study|Became ineligible|0|||
105859274|NCT03480386|365134917|FG001|Overall Study|Became ineligible|2|||
105859275|NCT01094886|365134918|FG000|Overall Study|Adverse Event|2|||
105859276|NCT01094886|365134918|FG000|Overall Study|Withdrawal by Subject|5|||
105859277|NCT03866902|365134920|FG000|Overall Study|Lost to Follow-up|98|||
105859278|NCT03866902|365134921|FG001|Overall Study|Lost to Follow-up|82|||
105859279|NCT03866902|365134920|FG000|Overall Study|Pregnancy|18|||
105859280|NCT03866902|365134921|FG001|Overall Study|Pregnancy|24|||
105859281|NCT02342639|365134923|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
105859282|NCT02342639|365134924|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
105859283|NCT02342639|365134923|FG000|Overall Study|Protocol Violation|0|||
105859284|NCT02342639|365134924|FG001|Overall Study|Protocol Violation|2|||
105859285|NCT03155945|365134925|FG000|Overall Study|Lost to Follow-up|0|||
105859286|NCT03155945|365134926|FG001|Overall Study|Lost to Follow-up|1|||
105859287|NCT03155945|365134925|FG000|Overall Study|Withdrawal by Subject|0|||
105859288|NCT03155945|365134926|FG001|Overall Study|Withdrawal by Subject|1|||
106039020|NCT02806973|365808843|FG003|Period 3|Adverse Event|0|||
106039021|NCT04209426|365808847|FG000|Overall Study|Lost to Follow-up|3|||
106039022|NCT04209426|365808848|FG001|Overall Study|Lost to Follow-up|2|||
106039023|NCT04902326|365808849|FG000|Overall Study|Withdrawal by Subject|1|||
106039024|NCT04902326|365808850|FG001|Overall Study|Withdrawal by Subject|3|||
106039025|NCT04902326|365808851|FG002|Overall Study|Withdrawal by Subject|0|||
106039026|NCT04902326|365808852|FG003|Overall Study|Withdrawal by Subject|1|||
106039027|NCT04902326|365808849|FG000|Overall Study|Lost to Follow-up|14|||
106039028|NCT04902326|365808850|FG001|Overall Study|Lost to Follow-up|14|||
106039029|NCT04902326|365808851|FG002|Overall Study|Lost to Follow-up|14|||
105859289|NCT03155945|365134925|FG000|Overall Study|Other Reason|0|||
105859290|NCT03155945|365134926|FG001|Overall Study|Other Reason|1|||
105859291|NCT03462459|365134933|FG000|Overall Study|Death|1|||
105859292|NCT03462459|365134934|FG001|Overall Study|Death|0|||
105859293|NCT03462459|365134933|FG000|Overall Study|Lack of Efficacy|2|||
105859294|NCT03462459|365134934|FG001|Overall Study|Lack of Efficacy|4|||
106039030|NCT04902326|365808852|FG003|Overall Study|Lost to Follow-up|6|||
106039031|NCT01117051|365808860|FG000|Overall Study|Withdrawal by Subject|5|||
106039032|NCT01117051|365808861|FG001|Overall Study|Withdrawal by Subject|3|||
105859295|NCT03462459|365134933|FG000|Overall Study|Lost to Follow-up|1|||
105859296|NCT03462459|365134934|FG001|Overall Study|Lost to Follow-up|3|||
105859297|NCT03462459|365134933|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
105859298|NCT03462459|365134934|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
105859299|NCT03462459|365134933|FG000|Overall Study|Withdrawal by Subject|3|||
105859300|NCT03462459|365134934|FG001|Overall Study|Withdrawal by Subject|2|||
105859301|NCT03462459|365134933|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
105859302|NCT03462459|365134934|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
105859303|NCT04042376|365134936|FG000|Overall Study|Withdrawal by Subject|1|||
105859304|NCT04042376|365134936|FG000|Overall Study|Death|3|||
105859305|NCT04191096|365134937|FG000|Overall Study|Death|102|||
105859306|NCT04191096|365134938|FG001|Overall Study|Death|89|||
105859307|NCT04191096|365134937|FG000|Overall Study|Lost to Follow-up|1|||
105859308|NCT04191096|365134938|FG001|Overall Study|Lost to Follow-up|1|||
105859309|NCT04191096|365134937|FG000|Overall Study|Withdrawal by Subject|5|||
105859310|NCT04191096|365134938|FG001|Overall Study|Withdrawal by Subject|5|||
105859311|NCT04191096|365134937|FG000|Overall Study|Participants Ongoing|518|||
105859312|NCT04191096|365134938|FG001|Overall Study|Participants Ongoing|530|||
105859313|NCT04051619|365134939|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
105859314|NCT04051619|365134940|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
105859315|NCT04051619|365134939|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
105859316|NCT04051619|365134940|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
105859317|NCT04395001|365136546|FG000|Overall Study|Lost to Follow-up|8|||
105859318|NCT04395001|365136547|FG001|Overall Study|Lost to Follow-up|9|||
105859319|NCT04395001|365136548|FG002|Overall Study|Lost to Follow-up|5|||
105859320|NCT04395001|365136546|FG000|Overall Study|Withdrawal by Subject|3|||
105859321|NCT04395001|365136547|FG001|Overall Study|Withdrawal by Subject|1|||
105859322|NCT04395001|365136548|FG002|Overall Study|Withdrawal by Subject|3|||
105859323|NCT04395001|365136546|FG000|Overall Study|missed appointment|7|||
105859324|NCT04395001|365136547|FG001|Overall Study|missed appointment|4|||
105859325|NCT04395001|365136548|FG002|Overall Study|missed appointment|1|||
105859326|NCT00633243|365136552|FG000|Overall Study|Withdrawal by Subject|0|||
105859327|NCT00633243|365136553|FG001|Overall Study|Withdrawal by Subject|1|||
105859328|NCT00633243|365136552|FG000|Overall Study|incarceration|0|||
105859329|NCT00633243|365136553|FG001|Overall Study|incarceration|2|||
105859330|NCT00633243|365136552|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
105859331|NCT00633243|365136553|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
105859332|NCT00633243|365136552|FG000|Overall Study|Not comfortable with self-injecting|0|||
105859333|NCT00633243|365136553|FG001|Overall Study|Not comfortable with self-injecting|1|||
105859334|NCT00633243|365136552|FG000|Overall Study|Mental Health--Depression|0|||
105859335|NCT00633243|365136553|FG001|Overall Study|Mental Health--Depression|1|||
105859336|NCT00633243|365136552|FG000|Overall Study|Couldn't tolerate side-effects|1|||
105859337|NCT00633243|365136553|FG001|Overall Study|Couldn't tolerate side-effects|1|||
105859338|NCT02022748|365136554|FG000|Overall Study|Adverse Event|1|||
105859339|NCT02022748|365136555|FG001|Overall Study|Adverse Event|1|||
105859340|NCT02022748|365136556|FG002|Overall Study|Adverse Event|0|||
105859341|NCT02022748|365136554|FG000|Overall Study|Withdrawal by Subject|0|||
105859342|NCT02022748|365136555|FG001|Overall Study|Withdrawal by Subject|1|||
105859343|NCT02022748|365136556|FG002|Overall Study|Withdrawal by Subject|0|||
105859344|NCT04240392|365136561|FG000|Overall Study|Withdrawal by Subject|13|||
105859345|NCT04240392|365136562|FG001|Overall Study|Withdrawal by Subject|4|||
105859346|NCT04240392|365136561|FG000|Overall Study|Lost to Follow-up|11|||
105859347|NCT04240392|365136562|FG001|Overall Study|Lost to Follow-up|12|||
105859348|NCT03589768|365136567|FG000|Overall Study|Death|1|||
105859349|NCT03589768|365136568|FG001|Overall Study|Death|0|||
105859350|NCT03589768|365136569|FG002|Overall Study|Death|8|||
105859351|NCT03589768|365136570|FG003|Overall Study|Death|3|||
105859352|NCT03589768|365136567|FG000|Overall Study|Withdrawal by Subject|2|||
105859353|NCT03589768|365136568|FG001|Overall Study|Withdrawal by Subject|0|||
105859354|NCT03589768|365136569|FG002|Overall Study|Withdrawal by Subject|0|||
105859355|NCT03589768|365136570|FG003|Overall Study|Withdrawal by Subject|0|||
105859356|NCT03589768|365136567|FG000|Overall Study|Protocol Violation|1|||
105859357|NCT03589768|365136568|FG001|Overall Study|Protocol Violation|0|||
105859358|NCT03589768|365136569|FG002|Overall Study|Protocol Violation|0|||
106039033|NCT01117051|365808860|FG000|Overall Study|Adverse Event|4|||
106039034|NCT01117051|365808861|FG001|Overall Study|Adverse Event|3|||
106039035|NCT01117051|365808860|FG000|Overall Study|Lost to Follow-up|0|||
105859359|NCT03589768|365136570|FG003|Overall Study|Protocol Violation|0|||
105859360|NCT01502410|365136571|FG000|Overall Study|Adverse Event|1|||
105859361|NCT01502410|365136572|FG001|Overall Study|Adverse Event|2|||
105859362|NCT01502410|365136573|FG002|Overall Study|Adverse Event|0|||
105859363|NCT01502410|365136574|FG003|Overall Study|Adverse Event|0|||
105859364|NCT01502410|365136571|FG000|Overall Study|Lack of Efficacy|7|||
105859365|NCT01502410|365136572|FG001|Overall Study|Lack of Efficacy|7|||
105859366|NCT01502410|365136573|FG002|Overall Study|Lack of Efficacy|0|||
105859367|NCT01502410|365136574|FG003|Overall Study|Lack of Efficacy|0|||
106039036|NCT01117051|365808861|FG001|Overall Study|Lost to Follow-up|1|||
106039037|NCT01117051|365808860|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
106039038|NCT01117051|365808861|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
106039039|NCT01117051|365808860|FG000|Overall Study|Sponsor's decision|3|||
106039040|NCT01117051|365808861|FG001|Overall Study|Sponsor's decision|1|||
106039041|NCT01117051|365808860|FG000|Overall Study|Surgical procedure|0|||
106039042|NCT01117051|365808861|FG001|Overall Study|Surgical procedure|1|||
106039043|NCT01117051|365808860|FG000|Overall Study|Randomized by mistake|0|||
106039044|NCT01117051|365808861|FG001|Overall Study|Randomized by mistake|1|||
106039045|NCT01117051|365808860|FG000|Overall Study|Convenience issue|1|||
106039046|NCT01117051|365808861|FG001|Overall Study|Convenience issue|0|||
106039047|NCT00427960|365808862|FG000|Overall Study|Adverse Event|2|||
106039048|NCT00427960|365808863|FG001|Overall Study|Adverse Event|0|||
106039049|NCT00427960|365808862|FG000|Overall Study|Withdrawal by Subject|0|||
106039050|NCT00427960|365808863|FG001|Overall Study|Withdrawal by Subject|3|||
106039051|NCT00427960|365808862|FG000|Overall Study|Other|0|||
106039052|NCT00427960|365808863|FG001|Overall Study|Other|1|||
106039053|NCT01052844|365808869|FG000|Overall Study|Adverse Event|0|||
106039054|NCT01052844|365808870|FG001|Overall Study|Adverse Event|1|||
106039055|NCT00518973|365808871|FG000|Overall Study|Withdrawal by Subject|3|||
106039056|NCT00518973|365808872|FG001|Overall Study|Withdrawal by Subject|2|||
106039057|NCT01264016|365808877|FG000|Overall Study|Withdrawal by Subject|1|||
106039058|NCT01264016|365808877|FG000|Overall Study|Felt faint at sight of blood|1|||
106039059|NCT06400979|365808878|FG000|Overall Study|Lost to Follow-up|29|||
106039060|NCT06400979|365808878|FG000|Overall Study|Withdrawal by Subject|1|||
106039061|NCT02675231|365808881|FG000|Overall Study|Withdrawal by Subject|2|||
106039062|NCT02675231|365808882|FG001|Overall Study|Withdrawal by Subject|4|||
106039063|NCT02675231|365808883|FG002|Overall Study|Withdrawal by Subject|2|||
106039064|NCT02675231|365808881|FG000|Overall Study|Lost to Follow-up|3|||
106039065|NCT02675231|365808882|FG001|Overall Study|Lost to Follow-up|4|||
106039066|NCT02675231|365808883|FG002|Overall Study|Lost to Follow-up|3|||
106039067|NCT01856023|365808889|FG000|Overall Study|Death|1|||
106039068|NCT01856023|365808890|FG001|Overall Study|Death|2|||
106039069|NCT01856023|365808889|FG000|Overall Study|Adverse Event|2|||
106039070|NCT01856023|365808890|FG001|Overall Study|Adverse Event|1|||
106039071|NCT01856023|365808889|FG000|Overall Study|Lack of Efficacy|5|||
106039072|NCT01856023|365808890|FG001|Overall Study|Lack of Efficacy|5|||
106039073|NCT01856023|365808889|FG000|Overall Study|non compliance, study closure|1|||
106039074|NCT01856023|365808890|FG001|Overall Study|non compliance, study closure|3|||
106039075|NCT01856023|365808889|FG000|Overall Study|Withdrawal by Subject|1|||
106039076|NCT01856023|365808890|FG001|Overall Study|Withdrawal by Subject|1|||
106039077|NCT03091777|365808891|FG000|Overall Study|Pregnancy|2|||
106039078|NCT03091777|365808892|FG001|Overall Study|Pregnancy|1|||
106039079|NCT03091777|365808893|FG002|Overall Study|Pregnancy|0|||
106039080|NCT03091777|365808891|FG000|Overall Study|Adverse Event|2|||
106039081|NCT03091777|365808892|FG001|Overall Study|Adverse Event|1|||
106039082|NCT03091777|365808893|FG002|Overall Study|Adverse Event|4|||
106039083|NCT03091777|365808891|FG000|Overall Study|Withdrawal by Subject|4|||
106039084|NCT03091777|365808892|FG001|Overall Study|Withdrawal by Subject|2|||
106039085|NCT03091777|365808893|FG002|Overall Study|Withdrawal by Subject|6|||
106039086|NCT03091777|365808891|FG000|Overall Study|Protocol Violation|2|||
106039087|NCT03091777|365808892|FG001|Overall Study|Protocol Violation|1|||
106039088|NCT03091777|365808893|FG002|Overall Study|Protocol Violation|1|||
106039089|NCT03091777|365808891|FG000|Overall Study|Lost to Follow-up|12|||
106039090|NCT03091777|365808892|FG001|Overall Study|Lost to Follow-up|14|||
106039091|NCT03091777|365808893|FG002|Overall Study|Lost to Follow-up|7|||
106039092|NCT03091777|365808891|FG000|Overall Study|Lack of Efficacy|0|||
106039093|NCT03091777|365808892|FG001|Overall Study|Lack of Efficacy|0|||
106039094|NCT03091777|365808893|FG002|Overall Study|Lack of Efficacy|5|||
106039095|NCT03091777|365808891|FG000|Overall Study|Noncompliance with study drug|2|||
106039096|NCT03091777|365808892|FG001|Overall Study|Noncompliance with study drug|3|||
106039097|NCT03091777|365808893|FG002|Overall Study|Noncompliance with study drug|1|||
106039098|NCT03091777|365808891|FG000|Overall Study|Physician Decision|1|||
106039099|NCT03091777|365808892|FG001|Overall Study|Physician Decision|0|||
106039100|NCT03091777|365808893|FG002|Overall Study|Physician Decision|1|||
106039101|NCT03091777|365808891|FG000|Overall Study|Abnormal Laboratory Value|7|||
106039102|NCT03091777|365808892|FG001|Overall Study|Abnormal Laboratory Value|11|||
106039103|NCT03091777|365808893|FG002|Overall Study|Abnormal Laboratory Value|12|||
106039104|NCT02536833|365808894|FG000|Overall Study|Discontinued Before Treatment|0|||
106039105|NCT02536833|365808895|FG001|Overall Study|Discontinued Before Treatment|0|||
106039106|NCT02536833|365808896|FG002|Overall Study|Discontinued Before Treatment|1|||
106039107|NCT02536833|365808897|FG003|Overall Study|Discontinued Before Treatment|2|||
106039108|NCT02536833|365808894|FG000|Overall Study|Adverse Event|1|||
106039109|NCT02536833|365808895|FG001|Overall Study|Adverse Event|3|||
106039110|NCT02536833|365808896|FG002|Overall Study|Adverse Event|4|||
106039111|NCT02536833|365808897|FG003|Overall Study|Adverse Event|1|||
106039112|NCT02536833|365808894|FG000|Overall Study|Lost to Follow-up|2|||
106039113|NCT02536833|365808895|FG001|Overall Study|Lost to Follow-up|1|||
106039114|NCT02536833|365808896|FG002|Overall Study|Lost to Follow-up|2|||
106039115|NCT02536833|365808897|FG003|Overall Study|Lost to Follow-up|2|||
106039116|NCT02536833|365808894|FG000|Overall Study|Physician Decision|0|||
106039117|NCT02536833|365808895|FG001|Overall Study|Physician Decision|0|||
106039118|NCT02536833|365808896|FG002|Overall Study|Physician Decision|0|||
106039119|NCT02536833|365808897|FG003|Overall Study|Physician Decision|1|||
106039120|NCT02536833|365808894|FG000|Overall Study|Site Terminated by Sponsor|2|||
106039121|NCT02536833|365808895|FG001|Overall Study|Site Terminated by Sponsor|2|||
106039122|NCT02536833|365808896|FG002|Overall Study|Site Terminated by Sponsor|2|||
106039123|NCT02536833|365808897|FG003|Overall Study|Site Terminated by Sponsor|2|||
106039124|NCT02536833|365808894|FG000|Overall Study|Subject Non-Compliance|0|||
106039125|NCT02536833|365808895|FG001|Overall Study|Subject Non-Compliance|1|||
106039126|NCT02536833|365808896|FG002|Overall Study|Subject Non-Compliance|1|||
106039127|NCT02536833|365808897|FG003|Overall Study|Subject Non-Compliance|0|||
106039128|NCT02536833|365808894|FG000|Overall Study|Withdrawal by Subject|4|||
106039129|NCT02536833|365808895|FG001|Overall Study|Withdrawal by Subject|3|||
106039130|NCT02536833|365808896|FG002|Overall Study|Withdrawal by Subject|5|||
106039131|NCT02536833|365808897|FG003|Overall Study|Withdrawal by Subject|11|||
106039132|NCT02220998|365808898|FG000|Overall Study|Randomized but Never Treated|1|||
106039133|NCT02220998|365808899|FG001|Overall Study|Randomized but Never Treated|2|||
106039134|NCT02220998|365808898|FG000|Overall Study|Death|2|||
106039135|NCT02220998|365808899|FG001|Overall Study|Death|0|||
106039136|NCT02220998|365808898|FG000|Overall Study|Lack of Efficacy|0|||
106039137|NCT02220998|365808899|FG001|Overall Study|Lack of Efficacy|5|||
106039138|NCT02220998|365808898|FG000|Overall Study|Lost to Follow-up|4|||
106039139|NCT02220998|365808899|FG001|Overall Study|Lost to Follow-up|4|||
106039140|NCT03309046|365808900|FG000|Overall Study|Withdrawal by Subject|4|||
106039141|NCT03309046|365808901|FG001|Overall Study|Withdrawal by Subject|17|||
106039142|NCT02314143|365808902|FG000|Overall Study|Adverse Event|0|||
106039143|NCT02314143|365808903|FG001|Overall Study|Adverse Event|6|||
106039144|NCT02314143|365808904|FG002|Overall Study|Adverse Event|4|||
106039145|NCT02314143|365808902|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
106039146|NCT02314143|365808903|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
106039147|NCT02314143|365808904|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
106039148|NCT02314143|365808902|FG000|Overall Study|Physician Decision|2|||
106039149|NCT02314143|365808903|FG001|Overall Study|Physician Decision|1|||
106039150|NCT02314143|365808904|FG002|Overall Study|Physician Decision|0|||
106039151|NCT02314143|365808902|FG000|Overall Study|Withdrawal by Subject|1|||
106039152|NCT02314143|365808903|FG001|Overall Study|Withdrawal by Subject|0|||
106039153|NCT02314143|365808904|FG002|Overall Study|Withdrawal by Subject|1|||
106039154|NCT03963401|365808905|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
106039155|NCT03963401|365808906|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
106039156|NCT03963401|365808907|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
106039157|NCT03963401|365808908|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
106039158|NCT03963401|365808909|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
106039159|NCT03963401|365808910|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
106039160|NCT03963401|365808905|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
106039161|NCT03963401|365808906|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
106039162|NCT03963401|365808907|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
106039163|NCT03963401|365808908|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
106039164|NCT03963401|365808909|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
106039165|NCT03963401|365808910|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
106039166|NCT03963401|365808905|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
106039167|NCT03963401|365808906|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
106039168|NCT03963401|365808907|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
106039169|NCT03963401|365808908|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
106039170|NCT03963401|365808909|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
106039171|NCT03963401|365808910|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
106039172|NCT03963401|365808905|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
106039173|NCT03963401|365808906|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
106039174|NCT03963401|365808907|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
106039175|NCT03963401|365808908|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
106039176|NCT03963401|365808909|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
106039177|NCT03963401|365808910|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
106039178|NCT03963401|365808905|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
106039179|NCT03963401|365808906|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
106039180|NCT03963401|365808907|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
106039181|NCT03963401|365808908|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
106039182|NCT03963401|365808909|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
106039183|NCT03963401|365808910|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
106039184|NCT03963401|365808905|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
106039185|NCT03963401|365808906|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
105859368|NCT01502410|365136571|FG000|Overall Study|Physician Decision|0|||
105859369|NCT01502410|365136572|FG001|Overall Study|Physician Decision|1|||
105859370|NCT01502410|365136573|FG002|Overall Study|Physician Decision|0|||
105859371|NCT01502410|365136574|FG003|Overall Study|Physician Decision|0|||
105859372|NCT01502410|365136571|FG000|Overall Study|Withdrawal by Subject|2|||
105859373|NCT01502410|365136572|FG001|Overall Study|Withdrawal by Subject|0|||
105859374|NCT01502410|365136573|FG002|Overall Study|Withdrawal by Subject|0|||
105859375|NCT01502410|365136574|FG003|Overall Study|Withdrawal by Subject|0|||
105859376|NCT02903030|365136575|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
105859377|NCT02903030|365136576|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
105859378|NCT03700385|365136582|FG000|Overall Study|Lost to Follow-up|1|||
105859379|NCT04590040|365136583|FG000|Treatment Period|Lost to Follow-up|2|||
105859380|NCT04590040|365136584|FG001|Treatment Period|Lost to Follow-up|5|||
105859381|NCT04590040|365136585|FG002|Treatment Period|Lost to Follow-up|0|||
105859382|NCT04590040|365136583|FG000|Treatment Period|Physician Decision|0|||
105859383|NCT04590040|365136584|FG001|Treatment Period|Physician Decision|0|||
105859384|NCT04590040|365136585|FG002|Treatment Period|Physician Decision|2|||
105859385|NCT00663026|365136592|FG000|Overall Study|Lost to Follow-up|1|||
105859386|NCT00663026|365136593|FG001|Overall Study|Lost to Follow-up|0|||
105859387|NCT00663026|365136594|FG002|Overall Study|Lost to Follow-up|0|||
105859388|NCT00663026|365136592|FG000|Overall Study|Other|1|||
105859389|NCT00663026|365136593|FG001|Overall Study|Other|2|||
105859390|NCT00663026|365136594|FG002|Overall Study|Other|0|||
105859391|NCT00663026|365136592|FG000|Overall Study|Adverse Event|0|||
105859392|NCT00663026|365136593|FG001|Overall Study|Adverse Event|2|||
105859393|NCT00663026|365136594|FG002|Overall Study|Adverse Event|3|||
105859394|NCT00663026|365136592|FG000|Overall Study|Caregiver Request|0|||
105859395|NCT00663026|365136593|FG001|Overall Study|Caregiver Request|2|||
105859396|NCT00663026|365136594|FG002|Overall Study|Caregiver Request|0|||
105859397|NCT00663026|365136592|FG000|Overall Study|Withdrawal by Subject|0|||
105859398|NCT00663026|365136593|FG001|Overall Study|Withdrawal by Subject|0|||
105859399|NCT00663026|365136594|FG002|Overall Study|Withdrawal by Subject|1|||
105859400|NCT01570686|365136595|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105859401|NCT01570686|365136596|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105859402|NCT01570686|365136595|FG000|Overall Study|Administrative problems|0|||
105859403|NCT01570686|365136596|FG001|Overall Study|Administrative problems|1|||
105859404|NCT01570686|365136595|FG000|Overall Study|Adverse Event|8|||
105859405|NCT01570686|365136596|FG001|Overall Study|Adverse Event|6|||
105859406|NCT01570686|365136595|FG000|Overall Study|Lost to Follow-up|4|||
105859407|NCT01570686|365136596|FG001|Overall Study|Lost to Follow-up|3|||
105859408|NCT01570686|365136595|FG000|Overall Study|Protocol Deviation|3|||
105859409|NCT01570686|365136596|FG001|Overall Study|Protocol Deviation|0|||
105859410|NCT01570686|365136595|FG000|Overall Study|Withdrawal by Subject|4|||
105859411|NCT01570686|365136596|FG001|Overall Study|Withdrawal by Subject|4|||
105859412|NCT01570686|365136595|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105859413|NCT01570686|365136596|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105859414|NCT04003896|365136597|FG000|Overall Study|Withdrawal by Subject|3|||
105859415|NCT04003896|365136597|FG000|Overall Study|Physician Decision|1|||
105859416|NCT03537599|365136601|FG000|Overall Study|Disease Progression|2|||
105859417|NCT03537599|365136602|FG001|Overall Study|Disease Progression|1|||
105859418|NCT03537599|365136601|FG000|Overall Study|Death|0|||
105859419|NCT03537599|365136602|FG001|Overall Study|Death|1|||
105859420|NCT00686075|365136607|FG000|Overall Study|Withdrawal by Subject|4|||
105859421|NCT00686075|365136608|FG001|Overall Study|Withdrawal by Subject|3|||
105859422|NCT00686075|365136609|FG002|Overall Study|Withdrawal by Subject|3|||
105859423|NCT00686075|365136610|FG003|Overall Study|Withdrawal by Subject|7|||
105859424|NCT00686075|365136611|FG004|Overall Study|Withdrawal by Subject|1|||
105859425|NCT00686075|365136612|FG005|Overall Study|Withdrawal by Subject|0|||
105859426|NCT00686075|365136613|FG006|Overall Study|Withdrawal by Subject|0|||
105859427|NCT00686075|365136614|FG007|Overall Study|Withdrawal by Subject|2|||
105859428|NCT00686075|365136615|FG008|Overall Study|Withdrawal by Subject|4|||
105859429|NCT00686075|365136616|FG009|Overall Study|Withdrawal by Subject|6|||
105859430|NCT00686075|365136607|FG000|Overall Study|Lost to Follow-up|3|||
105859431|NCT00686075|365136608|FG001|Overall Study|Lost to Follow-up|6|||
105859432|NCT00686075|365136609|FG002|Overall Study|Lost to Follow-up|3|||
105859433|NCT00686075|365136610|FG003|Overall Study|Lost to Follow-up|2|||
105859434|NCT00686075|365136611|FG004|Overall Study|Lost to Follow-up|3|||
105859435|NCT00686075|365136612|FG005|Overall Study|Lost to Follow-up|3|||
106039186|NCT03963401|365808907|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
106039187|NCT03963401|365808908|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
106039188|NCT03963401|365808909|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
105859436|NCT00686075|365136613|FG006|Overall Study|Lost to Follow-up|0|||
105859437|NCT00686075|365136614|FG007|Overall Study|Lost to Follow-up|0|||
105859438|NCT00686075|365136615|FG008|Overall Study|Lost to Follow-up|2|||
105859439|NCT00686075|365136616|FG009|Overall Study|Lost to Follow-up|3|||
105859440|NCT00686075|365136607|FG000|Overall Study|Other|1|||
105859441|NCT00686075|365136608|FG001|Overall Study|Other|1|||
105859442|NCT00686075|365136609|FG002|Overall Study|Other|0|||
105859443|NCT00686075|365136610|FG003|Overall Study|Other|0|||
105859444|NCT00686075|365136611|FG004|Overall Study|Other|0|||
105859445|NCT00686075|365136612|FG005|Overall Study|Other|0|||
105859446|NCT00686075|365136613|FG006|Overall Study|Other|0|||
105859447|NCT00686075|365136614|FG007|Overall Study|Other|0|||
105859448|NCT00686075|365136615|FG008|Overall Study|Other|0|||
105859449|NCT00686075|365136616|FG009|Overall Study|Other|1|||
105859450|NCT05776862|365136618|FG000|Overall Study|Adverse Event|0|||
105859451|NCT05776862|365136619|FG001|Overall Study|Adverse Event|1|||
105859452|NCT05776862|365136618|FG000|Overall Study|non-compliance|1|||
105859453|NCT05776862|365136619|FG001|Overall Study|non-compliance|0|||
105859454|NCT01682863|365136620|FG000|Overall Study|Subject/guardian decision|19|||
105859455|NCT01682863|365136621|FG001|Overall Study|Subject/guardian decision|12|||
105859456|NCT01682863|365136622|FG002|Overall Study|Subject/guardian decision|10|||
105859457|NCT01682863|365136620|FG000|Overall Study|Lost to Follow-up|5|||
105859458|NCT01682863|365136621|FG001|Overall Study|Lost to Follow-up|1|||
105859459|NCT01682863|365136622|FG002|Overall Study|Lost to Follow-up|6|||
105859460|NCT01682863|365136620|FG000|Overall Study|Death|1|||
105859461|NCT01682863|365136621|FG001|Overall Study|Death|3|||
105859462|NCT01682863|365136622|FG002|Overall Study|Death|4|||
105859463|NCT01682863|365136620|FG000|Overall Study|Protocol deviation|1|||
105859464|NCT01682863|365136621|FG001|Overall Study|Protocol deviation|0|||
105859465|NCT01682863|365136622|FG002|Overall Study|Protocol deviation|1|||
105859466|NCT01682863|365136620|FG000|Overall Study|Technical problems|1|||
105859467|NCT01682863|365136621|FG001|Overall Study|Technical problems|0|||
106039189|NCT03963401|365808910|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
106039190|NCT03963401|365808905|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
106039191|NCT03963401|365808906|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
106039192|NCT03963401|365808907|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
106039193|NCT03963401|365808908|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
106039194|NCT03963401|365808909|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
106039195|NCT03963401|365808910|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
106039196|NCT03963401|365808905|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
106039197|NCT03963401|365808906|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
106039198|NCT03963401|365808907|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
106039199|NCT03963401|365808908|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
106039200|NCT03963401|365808909|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
106039201|NCT03963401|365808910|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
106039202|NCT03963401|365808905|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
106039203|NCT03963401|365808906|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
106039204|NCT03963401|365808907|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
106039205|NCT03963401|365808908|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
106039206|NCT03963401|365808909|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
106039207|NCT03963401|365808910|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
106039208|NCT03963401|365808905|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
106039209|NCT03963401|365808906|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
106039210|NCT03963401|365808907|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
106039211|NCT03963401|365808908|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
106039212|NCT03963401|365808909|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
106039213|NCT03963401|365808910|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
106039214|NCT03963401|365808905|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
106039215|NCT03963401|365808906|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
106039216|NCT03963401|365808907|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
106039217|NCT03963401|365808908|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
106039218|NCT03963401|365808909|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
106039219|NCT03963401|365808910|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
106039220|NCT01172275|365808913|FG000|Overall Study|Lost to Follow-up|1|||
106039221|NCT01172275|365808914|FG001|Overall Study|Lost to Follow-up|0|||
106039222|NCT01172275|365808913|FG000|Overall Study|Protocol Violation|1|||
106039223|NCT01172275|365808914|FG001|Overall Study|Protocol Violation|0|||
106039224|NCT00095628|365808915|FG000|Overall Study|Disease progression prior to treatment|1|||
106039225|NCT01484054|365808921|FG000|Period 1|Withdrawal by Subject|0|||
106039226|NCT01484054|365808922|FG001|Period 1|Withdrawal by Subject|1|||
106039227|NCT01539317|365808923|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
106039228|NCT01539317|365808924|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
105859468|NCT01682863|365136622|FG002|Overall Study|Technical problems|0|||
105859469|NCT01682863|365136620|FG000|Overall Study|Adverse Event|0|||
105859470|NCT01682863|365136621|FG001|Overall Study|Adverse Event|1|||
105859471|NCT01682863|365136622|FG002|Overall Study|Adverse Event|2|||
105859472|NCT01682863|365136620|FG000|Overall Study|Physician Decision|0|||
105859473|NCT01682863|365136621|FG001|Overall Study|Physician Decision|0|||
105859474|NCT01682863|365136622|FG002|Overall Study|Physician Decision|1|||
105859475|NCT00918138|365136623|FG000|Overall Study|Subject withdrew consent|1|||
105859476|NCT00918138|365136624|FG001|Overall Study|Subject withdrew consent|1|||
105859477|NCT00918138|365136623|FG000|Overall Study|Death|1|||
105859478|NCT00918138|365136624|FG001|Overall Study|Death|0|||
105859479|NCT02448706|365136625|FG000|Overall Study|Withdrawal by Subject|4|||
105859480|NCT02448706|365136626|FG001|Overall Study|Withdrawal by Subject|3|||
105859481|NCT02448706|365136625|FG000|Overall Study|Protocol Violation|1|||
105859482|NCT02448706|365136626|FG001|Overall Study|Protocol Violation|1|||
105859483|NCT00699374|365136629|FG000|Overall Study|Death|93|||
105859484|NCT00699374|365136630|FG001|Overall Study|Death|83|||
105859485|NCT00699374|365136629|FG000|Overall Study|Adverse Event|70|||
105859486|NCT00699374|365136630|FG001|Overall Study|Adverse Event|67|||
105859487|NCT00699374|365136629|FG000|Overall Study|Global deterioration of health status|7|||
105859488|NCT00699374|365136630|FG001|Overall Study|Global deterioration of health status|8|||
106039229|NCT02117427|365808925|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
106039230|NCT02117427|365808926|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
106039231|NCT02117427|365808927|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
106039232|NCT02117427|365808925|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
106039233|NCT02117427|365808926|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
106039234|NCT02117427|365808927|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
106039235|NCT02117427|365808925|FG000|Overall Study|Physician Decision|0|||
106039236|NCT02117427|365808926|FG001|Overall Study|Physician Decision|2|||
106039237|NCT02117427|365808927|FG002|Overall Study|Physician Decision|0|||
106039238|NCT02117427|365808925|FG000|Overall Study|No longer meets inclusion criteria|0|||
106039239|NCT02117427|365808926|FG001|Overall Study|No longer meets inclusion criteria|1|||
106039240|NCT02117427|365808927|FG002|Overall Study|No longer meets inclusion criteria|0|||
106039241|NCT02117427|365808925|FG000|Overall Study|Death|0|||
106039242|NCT02117427|365808926|FG001|Overall Study|Death|1|||
106039243|NCT02117427|365808927|FG002|Overall Study|Death|0|||
106039244|NCT00364130|365808928|FG000|Intervention Period|Lost to Follow-up|4|||
106039245|NCT00364130|365808929|FG001|Intervention Period|Lost to Follow-up|3|||
106039246|NCT00364130|365808928|FG000|Intervention Period|Pregnancy|1|||
106039247|NCT00364130|365808929|FG001|Intervention Period|Pregnancy|0|||
106039248|NCT00364130|365808928|FG000|Intervention Period|Withdrawal by Subject|4|||
106039249|NCT00364130|365808929|FG001|Intervention Period|Withdrawal by Subject|5|||
106039250|NCT00364130|365808928|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
106039251|NCT00364130|365808929|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
106039252|NCT05281601|365808930|FG000|Overall Study|Physician Decision|2|||
106039253|NCT05281601|365808931|FG001|Overall Study|Physician Decision|0|||
106039254|NCT05281601|365808930|FG000|Overall Study|Lost to Follow-up|2|||
106039255|NCT05281601|365808931|FG001|Overall Study|Lost to Follow-up|0|||
106039256|NCT05281601|365808930|FG000|Overall Study|Death|1|||
106039257|NCT05281601|365808931|FG001|Overall Study|Death|0|||
106039258|NCT05281601|365808930|FG000|Overall Study|Withdrawal by parent/guardian|2|||
106039259|NCT05281601|365808931|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106039260|NCT01674634|365808933|FG000|Overall Study|Withdrawal by Subject|3|||
106039261|NCT01674634|365808933|FG000|Overall Study|Lost to Follow-up|3|||
106039262|NCT01505647|365808934|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
106039263|NCT01505647|365808935|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
106039264|NCT01505647|365808934|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
106039265|NCT01505647|365808935|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
106039266|NCT01505647|365808934|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
106039267|NCT01505647|365808935|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
106039268|NCT01505647|365808934|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
106039269|NCT01505647|365808935|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
106039270|NCT01505647|365808934|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
106039271|NCT01505647|365808935|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
106039272|NCT01907100|365808936|FG000|Overall Study|PD based on modified RECIST criteria|31|||
106039273|NCT01907100|365808937|FG001|Overall Study|PD based on modified RECIST criteria|32|||
106039274|NCT01907100|365808938|FG002|Overall Study|PD based on modified RECIST criteria|95|||
106039275|NCT01907100|365808939|FG003|Overall Study|PD based on modified RECIST criteria|92|||
106039276|NCT01907100|365808936|FG000|Overall Study|Withdrawal by Subject|2|||
106039277|NCT01907100|365808937|FG001|Overall Study|Withdrawal by Subject|5|||
105859489|NCT00699374|365136629|FG000|Overall Study|Lost to Follow-up|3|||
106039278|NCT01907100|365808938|FG002|Overall Study|Withdrawal by Subject|10|||
106039279|NCT01907100|365808939|FG003|Overall Study|Withdrawal by Subject|13|||
106039280|NCT01907100|365808936|FG000|Overall Study|Protocol Violation|0|||
106039281|NCT01907100|365808937|FG001|Overall Study|Protocol Violation|0|||
106039282|NCT01907100|365808938|FG002|Overall Study|Protocol Violation|1|||
106039283|NCT01907100|365808939|FG003|Overall Study|Protocol Violation|1|||
106039284|NCT01907100|365808936|FG000|Overall Study|Lost to Follow-up|0|||
105859490|NCT00699374|365136630|FG001|Overall Study|Lost to Follow-up|5|||
106039285|NCT01907100|365808937|FG001|Overall Study|Lost to Follow-up|0|||
105859491|NCT00699374|365136629|FG000|Overall Study|Withdrawal by Subject|34|||
105859492|NCT00699374|365136630|FG001|Overall Study|Withdrawal by Subject|44|||
105859493|NCT00699374|365136629|FG000|Overall Study|Objective progression or relapse|281|||
105859494|NCT00699374|365136630|FG001|Overall Study|Objective progression or relapse|277|||
105859495|NCT00699374|365136629|FG000|Overall Study|Other|18|||
105859496|NCT00699374|365136630|FG001|Overall Study|Other|15|||
105859497|NCT00699374|365136629|FG000|Overall Study|Protocol Violation|2|||
105859498|NCT00699374|365136630|FG001|Overall Study|Protocol Violation|6|||
105859499|NCT00699374|365136629|FG000|Overall Study|Study terminated by sponsor|13|||
105859500|NCT00699374|365136630|FG001|Overall Study|Study terminated by sponsor|28|||
105859501|NCT00699374|365136629|FG000|Overall Study|Randomized but not treated|4|||
105859502|NCT00699374|365136630|FG001|Overall Study|Randomized but not treated|2|||
105859503|NCT00699374|365136629|FG000|Overall Study|Died 28 days after last dose|5|||
105859504|NCT00699374|365136630|FG001|Overall Study|Died 28 days after last dose|9|||
105859505|NCT03972163|365136634|FG000|Overall Study|Death|0|||
105859506|NCT03972163|365136635|FG001|Overall Study|Death|1|||
105859507|NCT01199471|365136636|FG000|Overall Study|Protocol Violation|4|||
105859508|NCT01199471|365136636|FG000|Overall Study|Withdrawal by Subject|1|||
105859509|NCT01199471|365136636|FG000|Overall Study|Physician Decision|1|||
105859510|NCT01136967|365136640|FG000|Overall Study|Adverse Event|9|||
105859511|NCT01136967|365136641|FG001|Overall Study|Adverse Event|12|||
105859512|NCT01136967|365136640|FG000|Overall Study|Participant Choice|8|||
105859513|NCT01136967|365136641|FG001|Overall Study|Participant Choice|3|||
105859514|NCT01136967|365136640|FG000|Overall Study|Lost to Follow-up|0|||
105859515|NCT01136967|365136641|FG001|Overall Study|Lost to Follow-up|1|||
105859516|NCT01136967|365136640|FG000|Overall Study|Withdrawal by Subject|1|||
105859517|NCT01136967|365136641|FG001|Overall Study|Withdrawal by Subject|2|||
105859518|NCT01136967|365136640|FG000|Overall Study|Clinical Progression|3|||
105859519|NCT01136967|365136641|FG001|Overall Study|Clinical Progression|5|||
105859520|NCT01136967|365136640|FG000|Overall Study|Radiation|1|||
105859521|NCT01136967|365136641|FG001|Overall Study|Radiation|0|||
105859522|NCT01136967|365136640|FG000|Overall Study|Non-compliance|1|||
105859523|NCT01136967|365136641|FG001|Overall Study|Non-compliance|0|||
105859524|NCT01136967|365136640|FG000|Overall Study|Investigator's Choice|1|||
105859525|NCT01136967|365136641|FG001|Overall Study|Investigator's Choice|1|||
105859526|NCT01136967|365136640|FG000|Overall Study|Increase in Lesion Size|0|||
105859527|NCT01136967|365136641|FG001|Overall Study|Increase in Lesion Size|2|||
105859528|NCT01136967|365136640|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
105859529|NCT01136967|365136641|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
105859530|NCT03151811|365136644|FG000|Overall Study|Randomized But Not Treated|18|||
105859531|NCT03151811|365136645|FG001|Overall Study|Randomized But Not Treated|3|||
105859532|NCT03151811|365136644|FG000|Overall Study|Progressive Disease|130|||
105859533|NCT03151811|365136645|FG001|Overall Study|Progressive Disease|170|||
105859534|NCT03151811|365136644|FG000|Overall Study|Adverse Event|49|||
105859535|NCT03151811|365136645|FG001|Overall Study|Adverse Event|40|||
105859536|NCT03151811|365136644|FG000|Overall Study|Lack of Efficacy|6|||
105859537|NCT03151811|365136645|FG001|Overall Study|Lack of Efficacy|8|||
105859538|NCT03151811|365136644|FG000|Overall Study|Physician Decision|21|||
105859539|NCT03151811|365136645|FG001|Overall Study|Physician Decision|9|||
105859540|NCT03151811|365136644|FG000|Overall Study|Withdrawal by Subject|17|||
105859541|NCT03151811|365136645|FG001|Overall Study|Withdrawal by Subject|7|||
105859542|NCT03151811|365136644|FG000|Overall Study|Lost to Follow-up|0|||
105859543|NCT03151811|365136645|FG001|Overall Study|Lost to Follow-up|1|||
105859544|NCT03151811|365136644|FG000|Overall Study|Study Terminated by Sponsor|5|||
105859545|NCT03151811|365136645|FG001|Overall Study|Study Terminated by Sponsor|11|||
105859546|NCT01664130|365136648|FG000|Overall Study|competing secondary disease|2|||
105859547|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
105859548|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
105859549|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
105859550|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
105859551|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
105859552|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
105859553|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
105859554|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
105859555|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
106039286|NCT01907100|365808938|FG002|Overall Study|Lost to Follow-up|0|||
105859556|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
105859557|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Death|1|||
105859558|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Death|0|||
105859559|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Death|0|||
105859560|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Death|0|||
105859561|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Death|0|||
105859562|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
105859563|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
106039287|NCT01907100|365808939|FG003|Overall Study|Lost to Follow-up|1|||
106039288|NCT01907100|365808936|FG000|Overall Study|Not treated|2|||
106039289|NCT01907100|365808937|FG001|Overall Study|Not treated|0|||
106039290|NCT01907100|365808938|FG002|Overall Study|Not treated|1|||
106039291|NCT01907100|365808939|FG003|Overall Study|Not treated|2|||
106039292|NCT01907100|365808936|FG000|Overall Study|Other than reasons specified|1|||
106039293|NCT01907100|365808937|FG001|Overall Study|Other than reasons specified|0|||
106039294|NCT01907100|365808938|FG002|Overall Study|Other than reasons specified|10|||
106039295|NCT01907100|365808939|FG003|Overall Study|Other than reasons specified|6|||
106039296|NCT01907100|365808936|FG000|Overall Study|Adverse event (AE)|6|||
106039297|NCT01907100|365808937|FG001|Overall Study|Adverse event (AE)|3|||
106039298|NCT01907100|365808938|FG002|Overall Study|Adverse event (AE)|22|||
106039299|NCT01907100|365808939|FG003|Overall Study|Adverse event (AE)|23|||
106039300|NCT01907100|365808936|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
106039301|NCT01907100|365808937|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
106039302|NCT01907100|365808938|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
106039303|NCT01907100|365808939|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
106039304|NCT03112590|365808940|FG000|Overall Study|Adverse Event|0|||
106039305|NCT03112590|365808941|FG001|Overall Study|Adverse Event|1|||
106039306|NCT03112590|365808942|FG002|Overall Study|Adverse Event|0|||
106039307|NCT01758289|365808943|FG000|Overall Study|Premature Study Termination|44|||
106039308|NCT01758289|365808943|FG000|Overall Study|Adverse Event|9|||
106039309|NCT02059005|365808946|FG000|Overall Study|Death|1|||
105859564|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
105859565|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
105859566|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
105859567|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
105859568|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
105859569|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
105859570|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
105859571|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
105859572|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
105859573|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
105859574|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
105859575|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
105859576|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
105859577|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
105859578|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
105859579|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
105859580|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
105859581|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
105859582|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
105859583|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105859584|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105859585|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105859586|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
105859587|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Other|4|||
105859588|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Other|4|||
105859589|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Other|3|||
105859590|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Other|1|||
105859591|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Other|0|||
105859592|NCT01081834|365136653|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
105859593|NCT01081834|365136654|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
105859594|NCT01081834|365136655|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
105859595|NCT01081834|365136656|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
105859596|NCT01081834|365136657|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
105859597|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
105859598|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
106039310|NCT02059005|365808947|FG001|Overall Study|Death|3|||
106039311|NCT02059005|365808946|FG000|Overall Study|Lost to Follow-up|19|||
106039312|NCT02059005|365808947|FG001|Overall Study|Lost to Follow-up|19|||
106039313|NCT02059005|365808946|FG000|Overall Study|Incarceration|0|||
106039314|NCT02059005|365808947|FG001|Overall Study|Incarceration|1|||
106039315|NCT02059005|365808946|FG000|Overall Study|Inpatient|0|||
106039316|NCT02059005|365808947|FG001|Overall Study|Inpatient|1|||
106039317|NCT01436162|365808949|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
106039318|NCT01436162|365808950|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
106039319|NCT01436162|365808951|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
106039320|NCT01436162|365808949|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
106039321|NCT01436162|365808950|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
106039322|NCT01436162|365808951|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
105859599|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
105859600|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
105859601|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
105859602|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Death|1|||
105859603|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Death|0|||
105859604|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Death|0|||
105859605|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Death|0|||
105859606|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Death|0|||
105859607|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
105859608|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
105859609|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105859610|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105859611|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
105859612|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105859613|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
105859614|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105859615|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105859616|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
105859617|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
106039323|NCT01436162|365808949|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
105859618|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
105859619|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105859620|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105859621|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
105859622|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
106039324|NCT01436162|365808950|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
106039325|NCT01436162|365808951|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
106039326|NCT01436162|365808949|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
106039327|NCT01436162|365808950|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
106039328|NCT01436162|365808951|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
106039329|NCT01436162|365808949|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
106039330|NCT01436162|365808950|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105859623|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105859624|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
105859625|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105859626|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
105859627|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
105859628|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
105859629|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
105859630|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
105859631|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
105859632|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Other|4|||
105859633|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Other|5|||
105859634|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Other|4|||
105859635|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Other|0|||
105859636|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Other|0|||
105859637|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
105859638|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
105859639|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
105859640|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
105859641|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
105859642|NCT01081834|365136653|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105859643|NCT01081834|365136654|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
105859644|NCT01081834|365136655|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105859645|NCT01081834|365136656|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105859646|NCT01081834|365136657|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
105859647|NCT00554606|365136658|FG000|Overall Study|Adverse Event|3|||
105859648|NCT00554606|365136658|FG000|Overall Study|Abnormal laboratory values|1|||
106039331|NCT01436162|365808951|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
105859649|NCT00554606|365136658|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
105859650|NCT00554606|365136658|FG000|Overall Study|Subject withdrew consent|2|||
105859651|NCT00554606|365136658|FG000|Overall Study|Lost to Follow-up|2|||
106039332|NCT01436162|365808949|FG000|Single-blind Lead-in Phase|Other|107|||
106039333|NCT01436162|365808950|FG001|Single-blind Lead-in Phase|Other|0|||
106039334|NCT01436162|365808951|FG002|Single-blind Lead-in Phase|Other|0|||
105859652|NCT00554606|365136658|FG000|Overall Study|Administrative problems|60|||
105859653|NCT00554606|365136658|FG000|Overall Study|Death|1|||
105859654|NCT00554606|365136658|FG000|Overall Study|Protocol deviation|2|||
105859655|NCT00123474|365136659|FG000|Randomized to Treatment|Randomized, never treated|1|||
105859656|NCT00123474|365136660|FG001|Randomized to Treatment|Randomized, never treated|4|||
105859657|NCT00123474|365136661|FG002|Randomized to Treatment|Randomized, never treated|2|||
105859658|NCT00123474|365136662|FG003|Randomized to Treatment|Randomized, never treated|1|||
105859659|NCT00123474|365136659|FG000|As Treated at Study Closure|not reported when site closed|1|||
105859660|NCT00123474|365136660|FG001|As Treated at Study Closure|not reported when site closed|0|||
105859661|NCT00123474|365136661|FG002|As Treated at Study Closure|not reported when site closed|1|||
105859662|NCT00123474|365136662|FG003|As Treated at Study Closure|not reported when site closed|0|||
105859663|NCT00123474|365136659|FG000|As Treated at Study Closure|Adverse Event|10|||
105859664|NCT00123474|365136660|FG001|As Treated at Study Closure|Adverse Event|4|||
105859665|NCT00123474|365136661|FG002|As Treated at Study Closure|Adverse Event|10|||
105859666|NCT00123474|365136662|FG003|As Treated at Study Closure|Adverse Event|8|||
105859667|NCT00123474|365136659|FG000|As Treated at Study Closure|Disease Progression|35|||
105859668|NCT00123474|365136660|FG001|As Treated at Study Closure|Disease Progression|42|||
105859669|NCT00123474|365136661|FG002|As Treated at Study Closure|Disease Progression|29|||
105859670|NCT00123474|365136662|FG003|As Treated at Study Closure|Disease Progression|27|||
105859671|NCT00123474|365136659|FG000|As Treated at Study Closure|Investigator Request|12|||
105859672|NCT00123474|365136660|FG001|As Treated at Study Closure|Investigator Request|6|||
105859673|NCT00123474|365136661|FG002|As Treated at Study Closure|Investigator Request|7|||
105859674|NCT00123474|365136662|FG003|As Treated at Study Closure|Investigator Request|5|||
105859675|NCT00123474|365136659|FG000|As Treated at Study Closure|non-specified|54|||
105859676|NCT00123474|365136660|FG001|As Treated at Study Closure|non-specified|47|||
105859677|NCT00123474|365136661|FG002|As Treated at Study Closure|non-specified|57|||
105859678|NCT00123474|365136662|FG003|As Treated at Study Closure|non-specified|60|||
105859679|NCT00123474|365136659|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
105859680|NCT00123474|365136660|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
105859681|NCT00123474|365136661|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
105859682|NCT00123474|365136662|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
105859683|NCT00123474|365136659|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
106039335|NCT01436162|365808949|FG000|Randomized Phase|Adverse Event|1|||
106039336|NCT01436162|365808950|FG001|Randomized Phase|Adverse Event|5|||
106039337|NCT01436162|365808951|FG002|Randomized Phase|Adverse Event|6|||
106039338|NCT01436162|365808949|FG000|Randomized Phase|Protocol Violation|4|||
106039339|NCT01436162|365808950|FG001|Randomized Phase|Protocol Violation|4|||
106039340|NCT01436162|365808951|FG002|Randomized Phase|Protocol Violation|2|||
106039341|NCT01436162|365808949|FG000|Randomized Phase|Withdrawal by Subject|16|||
106039342|NCT01436162|365808950|FG001|Randomized Phase|Withdrawal by Subject|9|||
106039343|NCT01436162|365808951|FG002|Randomized Phase|Withdrawal by Subject|8|||
106039344|NCT01436162|365808949|FG000|Randomized Phase|Lost to Follow-up|17|||
106039345|NCT01436162|365808950|FG001|Randomized Phase|Lost to Follow-up|5|||
106039346|NCT01436162|365808951|FG002|Randomized Phase|Lost to Follow-up|4|||
106039347|NCT01436162|365808949|FG000|Randomized Phase|Lack of Efficacy|0|||
106039348|NCT01436162|365808950|FG001|Randomized Phase|Lack of Efficacy|1|||
106039349|NCT01436162|365808951|FG002|Randomized Phase|Lack of Efficacy|1|||
106039350|NCT01436162|365808949|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
106039351|NCT01436162|365808950|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
106039352|NCT01436162|365808951|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
106039353|NCT01436162|365808949|FG000|Randomized Phase|Other|2|||
106039354|NCT01436162|365808950|FG001|Randomized Phase|Other|5|||
105859684|NCT00123474|365136660|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
105859685|NCT00123474|365136661|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
105859686|NCT00123474|365136662|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
105859687|NCT01059344|365136663|FG000|Overall Study|Adverse Event|12|||
105859688|NCT01059344|365136664|FG001|Overall Study|Adverse Event|30|||
105859689|NCT01059344|365136663|FG000|Overall Study|Withdrawal by Subject|6|||
105859690|NCT01059344|365136664|FG001|Overall Study|Withdrawal by Subject|9|||
105859691|NCT01059344|365136663|FG000|Overall Study|Lost to Follow-up|1|||
105859692|NCT01059344|365136664|FG001|Overall Study|Lost to Follow-up|1|||
105859693|NCT01059344|365136663|FG000|Overall Study|Other|3|||
105859694|NCT01059344|365136664|FG001|Overall Study|Other|6|||
105859695|NCT00616629|365136665|FG000|Overall Study|Protocol Violation|1|||
105859696|NCT00616629|365136666|FG001|Overall Study|Protocol Violation|2|||
105859697|NCT00616629|365136667|FG002|Overall Study|Protocol Violation|1|||
105859698|NCT00616629|365136668|FG003|Overall Study|Protocol Violation|0|||
105859699|NCT00616629|365136669|FG004|Overall Study|Protocol Violation|0|||
105859700|NCT00616629|365136665|FG000|Overall Study|AV-block|1|||
105859701|NCT00616629|365136666|FG001|Overall Study|AV-block|0|||
106039355|NCT01436162|365808951|FG002|Randomized Phase|Other|4|||
106039356|NCT00760084|365808952|FG000|Overall Study|Physician Decision|5|||
106039357|NCT00760084|365808952|FG000|Overall Study|Withdrawal by Subject|2|||
106039358|NCT00760084|365808952|FG000|Overall Study|Progressive Disease|3|||
106039359|NCT02628769|365808953|FG000|First Intervention|Adverse Event|1|||
105859702|NCT00616629|365136667|FG002|Overall Study|AV-block|0|||
105859703|NCT00616629|365136668|FG003|Overall Study|AV-block|0|||
105859704|NCT00616629|365136669|FG004|Overall Study|AV-block|0|||
105859705|NCT01221363|365136671|FG000|Overall Study|Pregnancy|1|||
105859706|NCT01221363|365136672|FG001|Overall Study|Pregnancy|0|||
105859707|NCT01221363|365136671|FG000|Overall Study|Withdrawal by Subject|11|||
105859708|NCT01221363|365136672|FG001|Overall Study|Withdrawal by Subject|5|||
105859709|NCT04628793|365136673|FG000|Overall Study|Study terminated by sponsor|0|||
105859710|NCT04628793|365136674|FG001|Overall Study|Study terminated by sponsor|0|||
105859711|NCT04628793|365136675|FG002|Overall Study|Study terminated by sponsor|8|||
105859712|NCT04628793|365136673|FG000|Overall Study|Withdrawal by Subject|2|||
105859713|NCT04628793|365136674|FG001|Overall Study|Withdrawal by Subject|3|||
105859714|NCT04628793|365136675|FG002|Overall Study|Withdrawal by Subject|0|||
105859715|NCT04628793|365136673|FG000|Overall Study|Lost to Follow-up|0|||
105859716|NCT04628793|365136674|FG001|Overall Study|Lost to Follow-up|1|||
105859717|NCT04628793|365136675|FG002|Overall Study|Lost to Follow-up|0|||
105859718|NCT02278055|365136678|FG000|Overall Study|Adverse Event|1|||
105859719|NCT02278055|365136678|FG000|Overall Study|Lost to Follow-up|1|||
105859720|NCT02278055|365136678|FG000|Overall Study|Withdrawal by Subject|2|||
105859721|NCT02278055|365136678|FG000|Overall Study|Progressive Disease|4|||
105859722|NCT01934335|365136680|FG000|Overall Study|Withdrawal by Subject|1|||
105859723|NCT01934335|365136681|FG001|Overall Study|Withdrawal by Subject|1|||
105859724|NCT04040192|365136682|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
105859725|NCT04040192|365136683|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
105859726|NCT04040192|365136684|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
105859727|NCT04040192|365136682|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
105859728|NCT04040192|365136683|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
105859729|NCT04040192|365136684|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
105859730|NCT04040192|365136682|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
105859731|NCT04040192|365136683|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
105859732|NCT04040192|365136684|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
105859733|NCT04040192|365136682|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
105859734|NCT04040192|365136683|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
105859735|NCT04040192|365136684|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
105859736|NCT04040192|365136682|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
105859737|NCT04040192|365136683|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
105859738|NCT04040192|365136684|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
105859739|NCT04040192|365136682|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
105859740|NCT04040192|365136683|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
105859741|NCT04040192|365136684|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
105859742|NCT04040192|365136682|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
105859743|NCT04040192|365136683|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
105859744|NCT04040192|365136684|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
105859745|NCT04040192|365136682|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
105859746|NCT04040192|365136683|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
105859747|NCT04040192|365136684|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
105859748|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
105859749|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
105859750|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
105859751|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
105859752|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
105859753|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
105859754|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
105859755|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
105859756|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
105859757|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
105859758|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
105859759|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
105859760|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
105859761|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
105859762|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
105859763|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
105859764|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
105859765|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
105859766|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
105859767|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
105859768|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
106039360|NCT02628769|365808954|FG001|First Intervention|Adverse Event|0|||
106039361|NCT02628769|365808953|FG000|First Intervention|Withdrawal by Subject|0|||
106039362|NCT02628769|365808954|FG001|First Intervention|Withdrawal by Subject|1|||
106039363|NCT02628769|365808953|FG000|Second Intervention|Adverse Event|2|||
106039364|NCT02628769|365808954|FG001|Second Intervention|Adverse Event|0|||
106039365|NCT02628769|365808953|FG000|Second Intervention|Physician Decision|0|||
106039366|NCT02628769|365808954|FG001|Second Intervention|Physician Decision|1|||
106039367|NCT02452697|365808956|FG000|Overall Study|Physician Decision|4|||
106039368|NCT02452697|365808957|FG001|Overall Study|Physician Decision|4|||
106039369|NCT02452697|365808958|FG002|Overall Study|Physician Decision|3|||
106039370|NCT02452697|365808959|FG003|Overall Study|Physician Decision|2|||
106039371|NCT02452697|365808956|FG000|Overall Study|Withdrawal by Subject|1|||
106039372|NCT02452697|365808957|FG001|Overall Study|Withdrawal by Subject|0|||
106039373|NCT02452697|365808958|FG002|Overall Study|Withdrawal by Subject|0|||
106039374|NCT02452697|365808959|FG003|Overall Study|Withdrawal by Subject|0|||
106039375|NCT02452697|365808956|FG000|Overall Study|still in follow-up|2|||
105859769|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
106039376|NCT02452697|365808957|FG001|Overall Study|still in follow-up|2|||
106039377|NCT02452697|365808958|FG002|Overall Study|still in follow-up|1|||
106039378|NCT02452697|365808959|FG003|Overall Study|still in follow-up|3|||
106039379|NCT01709578|365810779|FG000|Overall Study|Rescued and entered in long term safety|63|||
106039380|NCT01709578|365810780|FG001|Overall Study|Rescued and entered in long term safety|25|||
106039381|NCT01709578|365810781|FG002|Overall Study|Rescued and entered in long term safety|26|||
106039382|NCT01709578|365810779|FG000|Overall Study|Adverse Event|9|||
106039383|NCT01709578|365810780|FG001|Overall Study|Adverse Event|18|||
105859770|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
105859771|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
105859772|NCT04040192|365136682|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
106039384|NCT01709578|365810781|FG002|Overall Study|Adverse Event|17|||
106039385|NCT01709578|365810779|FG000|Overall Study|Lack of Efficacy|5|||
106039386|NCT01709578|365810780|FG001|Overall Study|Lack of Efficacy|4|||
106039387|NCT01709578|365810781|FG002|Overall Study|Lack of Efficacy|2|||
106039388|NCT01709578|365810779|FG000|Overall Study|Poor compliance to protocol|1|||
106039389|NCT01709578|365810780|FG001|Overall Study|Poor compliance to protocol|2|||
106039390|NCT01709578|365810781|FG002|Overall Study|Poor compliance to protocol|1|||
106039391|NCT01709578|365810779|FG000|Overall Study|Other, not related to safety or efficacy|2|||
106039392|NCT01709578|365810780|FG001|Overall Study|Other, not related to safety or efficacy|7|||
106039393|NCT01709578|365810781|FG002|Overall Study|Other, not related to safety or efficacy|5|||
106039394|NCT04565236|365810784|FG000|Overall Study|Patient/Guardian Decision|0|||
106039395|NCT04565236|365810785|FG001|Overall Study|Patient/Guardian Decision|0|||
106039396|NCT04565236|365810786|FG002|Overall Study|Patient/Guardian Decision|1|||
106039397|NCT04565236|365810787|FG003|Overall Study|Patient/Guardian Decision|0|||
106039398|NCT00366340|365810788|FG000|Infant Series|Protocol Violation|3|||
106039399|NCT00366340|365810789|FG001|Infant Series|Protocol Violation|4|||
106039400|NCT00366340|365810788|FG000|Infant Series|Withdrawal by Subject|3|||
106039401|NCT00366340|365810789|FG001|Infant Series|Withdrawal by Subject|3|||
106039402|NCT00366340|365810788|FG000|Infant Series|Adverse Event|0|||
105859773|NCT04040192|365136683|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
105859774|NCT04040192|365136684|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
105859775|NCT03597529|365136685|FG000|Overall Study|Lost to Follow-up|10|||
105859776|NCT03597529|365136686|FG001|Overall Study|Lost to Follow-up|12|||
105859777|NCT03597529|365136685|FG000|Overall Study|Physician Decision|3|||
105859778|NCT03597529|365136686|FG001|Overall Study|Physician Decision|1|||
105859779|NCT03597529|365136685|FG000|Overall Study|Withdrawal by Subject|6|||
105859780|NCT03597529|365136686|FG001|Overall Study|Withdrawal by Subject|3|||
105859781|NCT03597529|365136685|FG000|Overall Study|Non-compliant with study activities|1|||
105859782|NCT03597529|365136686|FG001|Overall Study|Non-compliant with study activities|2|||
105859783|NCT04555720|365136689|FG000|Overall Study|Lost to Follow-up|2|||
105859784|NCT04555720|365136690|FG001|Overall Study|Lost to Follow-up|0|||
106039403|NCT00366340|365810789|FG001|Infant Series|Adverse Event|2|||
106039404|NCT00366340|365810788|FG000|Infant Series|Lost to Follow-up|1|||
106039405|NCT00366340|365810789|FG001|Infant Series|Lost to Follow-up|1|||
106039406|NCT00366340|365810788|FG000|Infant Series|Failure to return|1|||
106039407|NCT00366340|365810789|FG001|Infant Series|Failure to return|0|||
106039408|NCT00366340|365810788|FG000|After the Infant Series|Parent/legal guardian request|1|||
105859785|NCT04555720|365136691|FG002|Overall Study|Lost to Follow-up|0|||
105859786|NCT04555720|365136692|FG003|Overall Study|Lost to Follow-up|0|||
105859787|NCT04555720|365136689|FG000|Overall Study|Withdrawal by Subject|4|||
105859788|NCT04555720|365136690|FG001|Overall Study|Withdrawal by Subject|6|||
106039409|NCT00366340|365810789|FG001|After the Infant Series|Parent/legal guardian request|1|||
106039410|NCT00366340|365810788|FG000|After the Infant Series|Failed to return|0|||
106039411|NCT00366340|365810789|FG001|After the Infant Series|Failed to return|1|||
106039412|NCT00366340|365810788|FG000|After the Infant Series|Protocol Violation|2|||
106039413|NCT00366340|365810789|FG001|After the Infant Series|Protocol Violation|2|||
106039414|NCT00366340|365810788|FG000|After the Infant Series|Adverse Event|0|||
106039415|NCT00366340|365810789|FG001|After the Infant Series|Adverse Event|1|||
106039416|NCT00366340|365810788|FG000|After the Infant Series|Lost to Follow-up|0|||
105859789|NCT04555720|365136691|FG002|Overall Study|Withdrawal by Subject|0|||
105859790|NCT04555720|365136692|FG003|Overall Study|Withdrawal by Subject|0|||
105859791|NCT03395405|365138531|FG000|Overall Study|Death|0|||
105859792|NCT03395405|365138532|FG001|Overall Study|Death|2|||
105859793|NCT03395405|365138531|FG000|Overall Study|Lost to Follow-up|0|||
105859794|NCT03395405|365138532|FG001|Overall Study|Lost to Follow-up|1|||
105859795|NCT03395405|365138531|FG000|Overall Study|Protocol Violation|0|||
105859796|NCT03395405|365138532|FG001|Overall Study|Protocol Violation|1|||
105859797|NCT03395405|365138531|FG000|Overall Study|Withdrawal by Subject|3|||
105859798|NCT03395405|365138532|FG001|Overall Study|Withdrawal by Subject|1|||
105859799|NCT03395405|365138531|FG000|Overall Study|COVID-19 Pandemic|1|||
105859800|NCT03395405|365138532|FG001|Overall Study|COVID-19 Pandemic|0|||
105859801|NCT01523457|365138533|FG000|Overall Study|Withdrawal by Subject|7|||
105859802|NCT01523457|365138534|FG001|Overall Study|Withdrawal by Subject|2|||
105859803|NCT04345601|365138535|FG000|Overall Study|Death|0|||
105859804|NCT04345601|365138536|FG001|Overall Study|Death|3|||
105859805|NCT04345601|365138537|FG002|Overall Study|Death|2|||
105859806|NCT04345601|365138535|FG000|Overall Study|Lost to Follow-up|0|||
105859807|NCT04345601|365138536|FG001|Overall Study|Lost to Follow-up|0|||
105859808|NCT04345601|365138537|FG002|Overall Study|Lost to Follow-up|2|||
105859809|NCT03610516|365138538|FG000|Treatment Epoch|Adverse Event|3|||
105859810|NCT03610516|365138539|FG001|Treatment Epoch|Adverse Event|1|||
105859811|NCT03610516|365138538|FG000|Treatment Epoch|Death|1|||
105859812|NCT03610516|365138539|FG001|Treatment Epoch|Death|0|||
105859813|NCT03610516|365138538|FG000|Treatment Epoch|Lack of Efficacy|0|||
105859814|NCT03610516|365138539|FG001|Treatment Epoch|Lack of Efficacy|1|||
105859815|NCT03610516|365138538|FG000|Treatment Epoch|No longer requires treatment|1|||
105859816|NCT03610516|365138539|FG001|Treatment Epoch|No longer requires treatment|0|||
105859817|NCT03610516|365138538|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
105859818|NCT03610516|365138539|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
105859819|NCT03610516|365138538|FG000|Treatment Epoch|Physician Decision|8|||
105859820|NCT03610516|365138539|FG001|Treatment Epoch|Physician Decision|5|||
105859821|NCT03610516|365138538|FG000|Treatment Epoch|Protocol Deviation|1|||
105859822|NCT03610516|365138539|FG001|Treatment Epoch|Protocol Deviation|0|||
105859823|NCT03610516|365138538|FG000|Treatment Epoch|Withdrawal by Subject|3|||
105859824|NCT03610516|365138539|FG001|Treatment Epoch|Withdrawal by Subject|1|||
105859825|NCT03610516|365138538|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
105859826|NCT03610516|365138539|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
105859827|NCT03610516|365138538|FG000|Post-Treatment Follow-up|Death|1|||
105859828|NCT03610516|365138539|FG001|Post-Treatment Follow-up|Death|0|||
105859829|NCT01555671|365138542|FG000|Overall Study|Physician Decision|20|||
105859830|NCT01555671|365138543|FG001|Overall Study|Physician Decision|25|||
105859831|NCT00000378|365138550|FG000|Overall Study|Lack of Efficacy|16|||
105859832|NCT00000378|365138551|FG001|Overall Study|Lack of Efficacy|14|||
105859833|NCT00660907|365138552|FG000|Overall Study|Incorrect Enrollment|1|||
105859834|NCT00660907|365138553|FG001|Overall Study|Incorrect Enrollment|1|||
105859835|NCT00660907|365138552|FG000|Overall Study|Adverse Event|33|||
105859836|NCT00660907|365138553|FG001|Overall Study|Adverse Event|19|||
105859837|NCT00660907|365138552|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
105859838|NCT00660907|365138553|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
105859839|NCT00660907|365138552|FG000|Overall Study|Withdrawal by Subject|23|||
105859840|NCT00660907|365138553|FG001|Overall Study|Withdrawal by Subject|32|||
105859841|NCT00660907|365138552|FG000|Overall Study|Lost to Follow-up|3|||
105859842|NCT00660907|365138553|FG001|Overall Study|Lost to Follow-up|3|||
105859843|NCT00660907|365138552|FG000|Overall Study|Poor/Non-Compliance|5|||
105859844|NCT00660907|365138553|FG001|Overall Study|Poor/Non-Compliance|1|||
105859845|NCT00660907|365138552|FG000|Overall Study|Safety|1|||
105859846|NCT00660907|365138553|FG001|Overall Study|Safety|0|||
105859847|NCT00660907|365138552|FG000|Overall Study|Death|1|||
106039417|NCT00366340|365810789|FG001|After the Infant Series|Lost to Follow-up|1|||
106039418|NCT00366340|365810788|FG000|Toddler Dose|Failed to return|1|||
106039419|NCT00366340|365810789|FG001|Toddler Dose|Failed to return|0|||
106039420|NCT00366340|365810788|FG000|Toddler Dose|Parent/legal guardian request|0|||
105859848|NCT00660907|365138553|FG001|Overall Study|Death|3|||
106039421|NCT00366340|365810789|FG001|Toddler Dose|Parent/legal guardian request|1|||
105859849|NCT00660907|365138552|FG000|Overall Study|Various|11|||
105859850|NCT00660907|365138553|FG001|Overall Study|Various|8|||
105859851|NCT00631657|365138558|FG000|6-Month Treatment Period|Adverse Event|47|||
105859852|NCT00631657|365138559|FG001|6-Month Treatment Period|Adverse Event|0|||
105859853|NCT00631657|365138560|FG002|6-Month Treatment Period|Adverse Event|7|||
105859854|NCT00631657|365138558|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
105859855|NCT00631657|365138559|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
105859856|NCT00631657|365138560|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
105859857|NCT00631657|365138558|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
105859858|NCT00631657|365138559|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
106039422|NCT00423670|365810791|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
105859859|NCT00631657|365138560|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
105859860|NCT00631657|365138558|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
105859861|NCT00631657|365138559|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
105859862|NCT00631657|365138560|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
105859863|NCT00631657|365138558|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
105859864|NCT00631657|365138559|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
105859865|NCT00631657|365138560|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
105859866|NCT00631657|365138558|FG000|6-Month Treatment Period|Other|16|||
105859867|NCT00631657|365138559|FG001|6-Month Treatment Period|Other|0|||
105859868|NCT00631657|365138560|FG002|6-Month Treatment Period|Other|4|||
106039423|NCT00423670|365810792|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
106039424|NCT00423670|365810793|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
106039425|NCT00423670|365810794|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
106039426|NCT00423670|365810795|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
106039427|NCT00423670|365810796|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
106039428|NCT00423670|365810797|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
106039429|NCT00423670|365810798|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
106039430|NCT00423670|365810791|FG000|Treatment Period|Adverse Event|8|||
106039431|NCT00423670|365810792|FG001|Treatment Period|Adverse Event|12|||
106039432|NCT00423670|365810793|FG002|Treatment Period|Adverse Event|15|||
106039433|NCT00423670|365810794|FG003|Treatment Period|Adverse Event|20|||
106039434|NCT00423670|365810795|FG004|Treatment Period|Adverse Event|9|||
106039435|NCT00423670|365810796|FG005|Treatment Period|Adverse Event|4|||
106039436|NCT00423670|365810797|FG006|Treatment Period|Adverse Event|7|||
106039437|NCT00423670|365810798|FG007|Treatment Period|Adverse Event|2|||
106039438|NCT00423670|365810791|FG000|Treatment Period|Protocol-defined clinical event|0|||
106039439|NCT00423670|365810792|FG001|Treatment Period|Protocol-defined clinical event|7|||
106039440|NCT00423670|365810793|FG002|Treatment Period|Protocol-defined clinical event|4|||
106039441|NCT00423670|365810794|FG003|Treatment Period|Protocol-defined clinical event|12|||
106039442|NCT00423670|365810795|FG004|Treatment Period|Protocol-defined clinical event|5|||
106039443|NCT00423670|365810796|FG005|Treatment Period|Protocol-defined clinical event|4|||
106039444|NCT00423670|365810797|FG006|Treatment Period|Protocol-defined clinical event|16|||
106039445|NCT00423670|365810798|FG007|Treatment Period|Protocol-defined clinical event|15|||
106039446|NCT00423670|365810791|FG000|Treatment Period|Lost to Follow-up|2|||
106039447|NCT00423670|365810792|FG001|Treatment Period|Lost to Follow-up|1|||
106039448|NCT00423670|365810793|FG002|Treatment Period|Lost to Follow-up|3|||
106039449|NCT00423670|365810794|FG003|Treatment Period|Lost to Follow-up|1|||
106039450|NCT00423670|365810795|FG004|Treatment Period|Lost to Follow-up|6|||
106039451|NCT00423670|365810796|FG005|Treatment Period|Lost to Follow-up|0|||
106039452|NCT00423670|365810797|FG006|Treatment Period|Lost to Follow-up|3|||
106039453|NCT00423670|365810798|FG007|Treatment Period|Lost to Follow-up|1|||
106039454|NCT00423670|365810791|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
106039455|NCT00423670|365810792|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
106039456|NCT00423670|365810793|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
106039457|NCT00423670|365810794|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
106039458|NCT00423670|365810795|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
106039459|NCT00423670|365810796|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
106039460|NCT00423670|365810797|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
106039461|NCT00423670|365810798|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
106039462|NCT00423670|365810791|FG000|Treatment Period|Investigator decision|0|||
106039463|NCT00423670|365810792|FG001|Treatment Period|Investigator decision|0|||
106039464|NCT00423670|365810793|FG002|Treatment Period|Investigator decision|0|||
106039465|NCT00423670|365810794|FG003|Treatment Period|Investigator decision|0|||
106039466|NCT00423670|365810795|FG004|Treatment Period|Investigator decision|0|||
106039467|NCT00423670|365810796|FG005|Treatment Period|Investigator decision|0|||
106039468|NCT00423670|365810797|FG006|Treatment Period|Investigator decision|0|||
106039469|NCT00423670|365810798|FG007|Treatment Period|Investigator decision|1|||
106039470|NCT00423670|365810791|FG000|Treatment Period|Non-compliance with protocol|3|||
106039471|NCT00423670|365810792|FG001|Treatment Period|Non-compliance with protocol|1|||
106039472|NCT00423670|365810793|FG002|Treatment Period|Non-compliance with protocol|1|||
106039473|NCT00423670|365810794|FG003|Treatment Period|Non-compliance with protocol|3|||
106039474|NCT00423670|365810795|FG004|Treatment Period|Non-compliance with protocol|2|||
105859869|NCT00631657|365138558|FG000|6-Month Treatment Period|Not Treated|2|||
105859870|NCT00631657|365138559|FG001|6-Month Treatment Period|Not Treated|0|||
105859871|NCT00631657|365138560|FG002|6-Month Treatment Period|Not Treated|1|||
106039475|NCT00423670|365810796|FG005|Treatment Period|Non-compliance with protocol|0|||
106039476|NCT00423670|365810797|FG006|Treatment Period|Non-compliance with protocol|2|||
106039477|NCT00423670|365810798|FG007|Treatment Period|Non-compliance with protocol|2|||
106039478|NCT00423670|365810791|FG000|Follow-up Period|Lost to Follow-up|0|||
106039479|NCT00423670|365810792|FG001|Follow-up Period|Lost to Follow-up|12|||
106039480|NCT00423670|365810793|FG002|Follow-up Period|Lost to Follow-up|8|||
106039481|NCT00423670|365810794|FG003|Follow-up Period|Lost to Follow-up|3|||
105859872|NCT00631657|365138558|FG000|7-Day Discontinuation Period|Not Treated|1|||
105859873|NCT00631657|365138559|FG001|7-Day Discontinuation Period|Not Treated|1|||
105859874|NCT00631657|365138560|FG002|7-Day Discontinuation Period|Not Treated|1|||
105859875|NCT00631657|365138558|FG000|7-Day Discontinuation Period|Other|1|||
105859876|NCT00631657|365138559|FG001|7-Day Discontinuation Period|Other|0|||
105859877|NCT00631657|365138560|FG002|7-Day Discontinuation Period|Other|0|||
105859878|NCT02886624|365138564|FG000|12-week Post Treatment Follow-up|Death|1|||
105859879|NCT02886624|365138564|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
105859880|NCT00805675|365138571|FG000|Overall Study|Adverse Event|0|||
105859881|NCT00805675|365138572|FG001|Overall Study|Adverse Event|0|||
105859882|NCT00805675|365138573|FG002|Overall Study|Adverse Event|1|||
105859883|NCT02585934|365138576|FG000|Overall Study|Lost to Follow-up|2|||
105859884|NCT02585934|365138577|FG001|Overall Study|Lost to Follow-up|2|||
105859885|NCT02585934|365138576|FG000|Overall Study|Protocol Violation|14|||
105859886|NCT02585934|365138577|FG001|Overall Study|Protocol Violation|11|||
105859887|NCT02585934|365138576|FG000|Overall Study|Adverse Event|21|||
105859888|NCT02585934|365138577|FG001|Overall Study|Adverse Event|22|||
105859889|NCT02585934|365138576|FG000|Overall Study|Physician Decision|3|||
105859890|NCT02585934|365138577|FG001|Overall Study|Physician Decision|2|||
105859891|NCT02585934|365138576|FG000|Overall Study|Withdrawal by Subject|7|||
105859892|NCT02585934|365138577|FG001|Overall Study|Withdrawal by Subject|21|||
105859893|NCT02585934|365138576|FG000|Overall Study|Lack of Efficacy|2|||
105859894|NCT02585934|365138577|FG001|Overall Study|Lack of Efficacy|1|||
105859895|NCT02585934|365138576|FG000|Overall Study|Death|2|||
105859896|NCT02585934|365138577|FG001|Overall Study|Death|0|||
105859897|NCT02585934|365138576|FG000|Overall Study|Caregiver Withdrew Consent|7|||
105859898|NCT02585934|365138577|FG001|Overall Study|Caregiver Withdrew Consent|7|||
105859899|NCT02585934|365138576|FG000|Overall Study|Sponsor Termination|1|||
105859900|NCT02585934|365138577|FG001|Overall Study|Sponsor Termination|2|||
105859901|NCT02585934|365138576|FG000|Overall Study|Another Reason|10|||
105859902|NCT02585934|365138577|FG001|Overall Study|Another Reason|5|||
105859903|NCT02065700|365138579|FG000|Overall Study|Adverse Event|165|||
105859904|NCT02065700|365138580|FG001|Overall Study|Adverse Event|101|||
105859905|NCT02065700|365138579|FG000|Overall Study|Withdrawal by Subject|90|||
105859906|NCT02065700|365138580|FG001|Overall Study|Withdrawal by Subject|29|||
105859907|NCT02065700|365138579|FG000|Overall Study|Lost to Follow-up|12|||
105859908|NCT02065700|365138580|FG001|Overall Study|Lost to Follow-up|9|||
105859909|NCT02065700|365138579|FG000|Overall Study|Physician Decision|2|||
105859910|NCT02065700|365138580|FG001|Overall Study|Physician Decision|0|||
105859911|NCT02065700|365138579|FG000|Overall Study|Sponsor Request|38|||
105859912|NCT02065700|365138580|FG001|Overall Study|Sponsor Request|15|||
105859913|NCT02065700|365138579|FG000|Overall Study|Treatment Failure|3|||
105859914|NCT02065700|365138580|FG001|Overall Study|Treatment Failure|2|||
105859915|NCT02065700|365138579|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
105859916|NCT02065700|365138580|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
105859917|NCT02065700|365138579|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
105859918|NCT02065700|365138580|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
105859919|NCT02065700|365138579|FG000|Overall Study|Non-compliance with Study Procedures|2|||
105859920|NCT02065700|365138580|FG001|Overall Study|Non-compliance with Study Procedures|0|||
105859921|NCT02065700|365138579|FG000|Overall Study|Not Defined|21|||
105859922|NCT02065700|365138580|FG001|Overall Study|Not Defined|3|||
105859923|NCT03151408|365138581|FG000|Overall Study|Adverse Event|24|||
105859924|NCT03151408|365138582|FG001|Overall Study|Adverse Event|23|||
105859925|NCT03151408|365138581|FG000|Overall Study|Death|46|||
105859926|NCT03151408|365138582|FG001|Overall Study|Death|26|||
105859927|NCT03151408|365138581|FG000|Overall Study|Physician Decision|13|||
105859928|NCT03151408|365138582|FG001|Overall Study|Physician Decision|19|||
105859929|NCT03151408|365138581|FG000|Overall Study|Withdrawal by Subject|16|||
105859930|NCT03151408|365138582|FG001|Overall Study|Withdrawal by Subject|20|||
105859931|NCT03151408|365138581|FG000|Overall Study|Progressive disease|45|||
105859932|NCT03151408|365138582|FG001|Overall Study|Progressive disease|61|||
105859933|NCT03151408|365138581|FG000|Overall Study|non-compliance by patient|1|||
105859934|NCT03151408|365138582|FG001|Overall Study|non-compliance by patient|0|||
105859935|NCT03151408|365138581|FG000|Overall Study|other reasons|56|||
105859936|NCT03151408|365138582|FG001|Overall Study|other reasons|52|||
105859937|NCT03151408|365138581|FG000|Overall Study|randomized and not treated|2|||
105859938|NCT03151408|365138582|FG001|Overall Study|randomized and not treated|2|||
105859939|NCT00470067|365138585|FG000|Overall Study|Death|1|||
105859940|NCT00470067|365138585|FG000|Overall Study|Disease Progression|6|||
105859941|NCT00837473|365138586|FG000|Overall Study|Lost to Follow-up|1|||
105859942|NCT00837473|365138586|FG000|Overall Study|Withdrawal by Subject|2|||
105859943|NCT01635218|365138587|FG000|Overall Study|Lost to Follow-up|3|||
105859944|NCT01635218|365138588|FG001|Overall Study|Lost to Follow-up|7|||
105859945|NCT01635218|365138589|FG002|Overall Study|Lost to Follow-up|6|||
105859946|NCT03559400|365138590|FG000|Overall Study|Lost to Follow-up|9|||
105859947|NCT03559400|365138591|FG001|Overall Study|Lost to Follow-up|7|||
105859948|NCT03559400|365138590|FG000|Overall Study|Death|0|||
105859949|NCT03559400|365138591|FG001|Overall Study|Death|2|||
105859950|NCT01517373|365138600|FG000|Run-in Period|Death|1|||
105859951|NCT01517373|365138601|FG001|Run-in Period|Death|0|||
105859952|NCT01517373|365138602|FG002|Run-in Period|Death|0|||
105859953|NCT01517373|365138603|FG003|Run-in Period|Death|0|||
105859954|NCT01517373|365138604|FG004|Run-in Period|Death|0|||
105859955|NCT01517373|365138605|FG005|Run-in Period|Death|0|||
105859956|NCT01517373|365138600|FG000|Run-in Period|Adverse Event|5|||
105859957|NCT01517373|365138601|FG001|Run-in Period|Adverse Event|0|||
105859958|NCT01517373|365138602|FG002|Run-in Period|Adverse Event|0|||
105859959|NCT01517373|365138603|FG003|Run-in Period|Adverse Event|0|||
105859960|NCT01517373|365138604|FG004|Run-in Period|Adverse Event|0|||
105859961|NCT01517373|365138605|FG005|Run-in Period|Adverse Event|0|||
105859962|NCT01517373|365138600|FG000|Run-in Period|Did not meet eligibility criteria|34|||
105859963|NCT01517373|365138601|FG001|Run-in Period|Did not meet eligibility criteria|0|||
105859964|NCT01517373|365138602|FG002|Run-in Period|Did not meet eligibility criteria|0|||
105859965|NCT01517373|365138603|FG003|Run-in Period|Did not meet eligibility criteria|0|||
105859966|NCT01517373|365138604|FG004|Run-in Period|Did not meet eligibility criteria|0|||
105859967|NCT01517373|365138605|FG005|Run-in Period|Did not meet eligibility criteria|0|||
105859968|NCT01517373|365138600|FG000|Run-in Period|Lost to Follow-up|1|||
105859969|NCT01517373|365138601|FG001|Run-in Period|Lost to Follow-up|0|||
105859970|NCT01517373|365138602|FG002|Run-in Period|Lost to Follow-up|0|||
105859971|NCT01517373|365138603|FG003|Run-in Period|Lost to Follow-up|0|||
105859972|NCT01517373|365138604|FG004|Run-in Period|Lost to Follow-up|0|||
105859973|NCT01517373|365138605|FG005|Run-in Period|Lost to Follow-up|0|||
105859974|NCT01517373|365138600|FG000|Run-in Period|Withdrawal by Subject|12|||
106039482|NCT00423670|365810795|FG004|Follow-up Period|Lost to Follow-up|1|||
106039483|NCT00423670|365810796|FG005|Follow-up Period|Lost to Follow-up|0|||
106039484|NCT00423670|365810797|FG006|Follow-up Period|Lost to Follow-up|5|||
106039485|NCT00423670|365810798|FG007|Follow-up Period|Lost to Follow-up|0|||
106039486|NCT00423670|365810791|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
106039487|NCT00423670|365810792|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
106039488|NCT00423670|365810793|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
106039489|NCT00423670|365810794|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
106039490|NCT00423670|365810795|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
106039491|NCT00423670|365810796|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
106039492|NCT00423670|365810797|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
106039493|NCT00423670|365810798|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
106039494|NCT00423670|365810791|FG000|Follow-up Period|Non-compliance with protocol|2|||
106039495|NCT00423670|365810792|FG001|Follow-up Period|Non-compliance with protocol|0|||
106039496|NCT00423670|365810793|FG002|Follow-up Period|Non-compliance with protocol|1|||
106039497|NCT00423670|365810794|FG003|Follow-up Period|Non-compliance with protocol|1|||
106039498|NCT00423670|365810795|FG004|Follow-up Period|Non-compliance with protocol|0|||
106039499|NCT00423670|365810796|FG005|Follow-up Period|Non-compliance with protocol|0|||
106039500|NCT00423670|365810797|FG006|Follow-up Period|Non-compliance with protocol|3|||
106039501|NCT00423670|365810798|FG007|Follow-up Period|Non-compliance with protocol|2|||
106039502|NCT00900601|365810799|FG000|Overall Study|Physician Decision|1|||
106039503|NCT03026088|365810801|FG000|Overall Study|Study termination|20|||
106039504|NCT01869725|365810803|FG000|Overall Study|ineligible after registration|1|||
106039505|NCT01869725|365810803|FG000|Overall Study|Death|1|||
106039506|NCT01869725|365810803|FG000|Overall Study|Lost to Follow-up|2|||
106039507|NCT01143207|365810804|FG000|Overall Study|Lost to Follow-up|2|||
106039508|NCT01025154|365810806|FG000|Overall Study|Lost to Follow-up|1|||
106039509|NCT01025154|365810806|FG000|Overall Study|Withdrawal by Subject|1|||
106039510|NCT02545075|365810807|FG000|Randomization|Lost to Follow-up|0|||
106039511|NCT02545075|365810808|FG001|Randomization|Lost to Follow-up|1|||
106039512|NCT02545075|365810807|FG000|Randomization|Withdrawal by Subject|0|||
106039513|NCT02545075|365810808|FG001|Randomization|Withdrawal by Subject|6|||
106039514|NCT02545075|365810807|FG000|Treatment|Disease progression|71|||
106151724|NCT02590432|366215135|FG003|Double-blind Treatment Period|Adverse Event|12|||
105859975|NCT01517373|365138601|FG001|Run-in Period|Withdrawal by Subject|0|||
106039515|NCT02545075|365810808|FG001|Treatment|Disease progression|32|||
105859976|NCT01517373|365138602|FG002|Run-in Period|Withdrawal by Subject|0|||
105859977|NCT01517373|365138603|FG003|Run-in Period|Withdrawal by Subject|0|||
105859978|NCT01517373|365138604|FG004|Run-in Period|Withdrawal by Subject|0|||
105859979|NCT01517373|365138605|FG005|Run-in Period|Withdrawal by Subject|0|||
105859980|NCT01517373|365138600|FG000|Run-in Period|Sponsor Decision|3|||
105859981|NCT01517373|365138601|FG001|Run-in Period|Sponsor Decision|0|||
105859982|NCT01517373|365138602|FG002|Run-in Period|Sponsor Decision|0|||
106039516|NCT02545075|365810807|FG000|Treatment|Participant dicontinued study treatment|7|||
106039517|NCT02545075|365810808|FG001|Treatment|Participant dicontinued study treatment|9|||
106039518|NCT02545075|365810807|FG000|Treatment|Withdrawal by Subject|1|||
106039519|NCT02545075|365810808|FG001|Treatment|Withdrawal by Subject|0|||
106039520|NCT02545075|365810807|FG000|Treatment|Adverse event not related to study drug|1|||
106039521|NCT02545075|365810808|FG001|Treatment|Adverse event not related to study drug|0|||
105859983|NCT01517373|365138603|FG003|Run-in Period|Sponsor Decision|0|||
105859984|NCT01517373|365138604|FG004|Run-in Period|Sponsor Decision|0|||
105859985|NCT01517373|365138605|FG005|Run-in Period|Sponsor Decision|0|||
105859986|NCT01517373|365138600|FG000|Run-in Period|Other|1|||
105859987|NCT01517373|365138601|FG001|Run-in Period|Other|0|||
105859988|NCT01517373|365138602|FG002|Run-in Period|Other|0|||
105859989|NCT01517373|365138603|FG003|Run-in Period|Other|0|||
105859990|NCT01517373|365138604|FG004|Run-in Period|Other|0|||
105859991|NCT01517373|365138605|FG005|Run-in Period|Other|0|||
105859992|NCT01517373|365138600|FG000|Treatment Period|Adverse Event|0|||
105859993|NCT01517373|365138601|FG001|Treatment Period|Adverse Event|0|||
105859994|NCT01517373|365138602|FG002|Treatment Period|Adverse Event|0|||
105859995|NCT01517373|365138603|FG003|Treatment Period|Adverse Event|0|||
105859996|NCT01517373|365138604|FG004|Treatment Period|Adverse Event|0|||
105859997|NCT01517373|365138605|FG005|Treatment Period|Adverse Event|2|||
105859998|NCT01517373|365138600|FG000|Treatment Period|Lost to Follow-up|0|||
105859999|NCT01517373|365138601|FG001|Treatment Period|Lost to Follow-up|0|||
105860000|NCT01517373|365138602|FG002|Treatment Period|Lost to Follow-up|1|||
105860001|NCT01517373|365138603|FG003|Treatment Period|Lost to Follow-up|1|||
105860002|NCT01517373|365138604|FG004|Treatment Period|Lost to Follow-up|0|||
105860003|NCT01517373|365138605|FG005|Treatment Period|Lost to Follow-up|0|||
105860004|NCT01517373|365138600|FG000|Treatment Period|Withdrawal by Subject|0|||
105860005|NCT01517373|365138601|FG001|Treatment Period|Withdrawal by Subject|3|||
105860006|NCT01517373|365138602|FG002|Treatment Period|Withdrawal by Subject|2|||
105860007|NCT01517373|365138603|FG003|Treatment Period|Withdrawal by Subject|2|||
105860008|NCT01517373|365138604|FG004|Treatment Period|Withdrawal by Subject|2|||
105860009|NCT01517373|365138605|FG005|Treatment Period|Withdrawal by Subject|3|||
105860010|NCT01517373|365138600|FG000|Treatment Period|Other|0|||
106039522|NCT02545075|365810807|FG000|Treatment|Death|1|||
106039523|NCT02545075|365810808|FG001|Treatment|Death|0|||
106039524|NCT02545075|365810807|FG000|Treatment|Participant drug toxicity|1|||
106039525|NCT02545075|365810808|FG001|Treatment|Participant drug toxicity|0|||
106039526|NCT02545075|365810807|FG000|Treatment|Completed treatment|40|||
106039527|NCT02545075|365810808|FG001|Treatment|Completed treatment|12|||
106039528|NCT00736879|365810809|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
106039529|NCT00736879|365810810|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
106039530|NCT00736879|365810811|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
106039531|NCT00736879|365810812|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
106039532|NCT00736879|365810809|FG000|Double Blind Treatment Period|Adverse Event|0|||
106039533|NCT00736879|365810810|FG001|Double Blind Treatment Period|Adverse Event|1|||
106039534|NCT00736879|365810811|FG002|Double Blind Treatment Period|Adverse Event|1|||
106039535|NCT00736879|365810812|FG003|Double Blind Treatment Period|Adverse Event|0|||
106039536|NCT00736879|365810809|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
106039537|NCT00736879|365810810|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
106039538|NCT00736879|365810811|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
106039539|NCT00736879|365810812|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
106039540|NCT00736879|365810809|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
106039541|NCT00736879|365810810|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
106039542|NCT00736879|365810811|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
106039543|NCT00736879|365810812|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
106039544|NCT00736879|365810809|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
106039545|NCT00736879|365810810|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
106039546|NCT00736879|365810811|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
106039547|NCT00736879|365810812|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
106039548|NCT00736879|365810809|FG000|Double Blind Treatment Period|No longer met criteria|0|||
106039549|NCT00736879|365810810|FG001|Double Blind Treatment Period|No longer met criteria|1|||
106039550|NCT00736879|365810811|FG002|Double Blind Treatment Period|No longer met criteria|0|||
106039551|NCT00736879|365810812|FG003|Double Blind Treatment Period|No longer met criteria|0|||
106039552|NCT00736879|365810809|FG000|Double Blind Treatment Period|non-specified|0|||
106039553|NCT00736879|365810810|FG001|Double Blind Treatment Period|non-specified|1|||
106039554|NCT00736879|365810811|FG002|Double Blind Treatment Period|non-specified|0|||
105860011|NCT01517373|365138601|FG001|Treatment Period|Other|0|||
105860012|NCT01517373|365138602|FG002|Treatment Period|Other|0|||
106039555|NCT00736879|365810812|FG003|Double Blind Treatment Period|non-specified|0|||
106039556|NCT00736879|365810809|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
106039557|NCT00736879|365810810|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
106039558|NCT00736879|365810811|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
106039559|NCT00736879|365810812|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
105860013|NCT01517373|365138603|FG003|Treatment Period|Other|0|||
106039560|NCT00736879|365810809|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
106039561|NCT00736879|365810810|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
106039562|NCT00736879|365810811|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
106039563|NCT00736879|365810812|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
106039564|NCT00735254|365810817|FG000|Overall Study|Protocol Violation|1|||
105860014|NCT01517373|365138604|FG004|Treatment Period|Other|1|||
105860015|NCT01517373|365138605|FG005|Treatment Period|Other|0|||
105860016|NCT01517373|365138600|FG000|Treatment Period|Protocol Violation|0|||
105860017|NCT01517373|365138601|FG001|Treatment Period|Protocol Violation|0|||
105860018|NCT01517373|365138602|FG002|Treatment Period|Protocol Violation|0|||
105860019|NCT01517373|365138603|FG003|Treatment Period|Protocol Violation|0|||
105860020|NCT01517373|365138604|FG004|Treatment Period|Protocol Violation|1|||
105860021|NCT01517373|365138605|FG005|Treatment Period|Protocol Violation|0|||
105860022|NCT01517373|365138600|FG000|Treatment Period|Lack of Efficacy|0|||
105860023|NCT01517373|365138601|FG001|Treatment Period|Lack of Efficacy|1|||
105860024|NCT01517373|365138602|FG002|Treatment Period|Lack of Efficacy|1|||
105860025|NCT01517373|365138603|FG003|Treatment Period|Lack of Efficacy|3|||
105860026|NCT01517373|365138604|FG004|Treatment Period|Lack of Efficacy|2|||
105860027|NCT01517373|365138605|FG005|Treatment Period|Lack of Efficacy|0|||
105860028|NCT01517373|365138600|FG000|Treatment Period|Medication error without AEs|0|||
105860029|NCT01517373|365138601|FG001|Treatment Period|Medication error without AEs|0|||
105860030|NCT01517373|365138602|FG002|Treatment Period|Medication error without AEs|2|||
105860031|NCT01517373|365138603|FG003|Treatment Period|Medication error without AEs|1|||
105860032|NCT01517373|365138604|FG004|Treatment Period|Medication error without AEs|0|||
105860033|NCT01517373|365138605|FG005|Treatment Period|Medication error without AEs|2|||
105860034|NCT01085201|365138623|FG000|Overall Study|Scheduling conflict|1|||
105860035|NCT01085201|365138624|FG001|Overall Study|Scheduling conflict|0|||
105860036|NCT01085201|365138625|FG002|Overall Study|Scheduling conflict|1|||
105860037|NCT01085201|365138626|FG003|Overall Study|Scheduling conflict|0|||
105860038|NCT01085201|365138627|FG004|Overall Study|Scheduling conflict|0|||
105860039|NCT01085201|365138623|FG000|Overall Study|Unknown- no study drug|2|||
105860040|NCT01085201|365138624|FG001|Overall Study|Unknown- no study drug|0|||
105860041|NCT01085201|365138625|FG002|Overall Study|Unknown- no study drug|0|||
105860042|NCT01085201|365138626|FG003|Overall Study|Unknown- no study drug|0|||
105860043|NCT01085201|365138627|FG004|Overall Study|Unknown- no study drug|0|||
105860044|NCT01085201|365138623|FG000|Overall Study|Fond ineligible after consent|0|||
105860045|NCT01085201|365138624|FG001|Overall Study|Fond ineligible after consent|1|||
105860046|NCT01085201|365138625|FG002|Overall Study|Fond ineligible after consent|1|||
105860047|NCT01085201|365138626|FG003|Overall Study|Fond ineligible after consent|0|||
105860048|NCT01085201|365138627|FG004|Overall Study|Fond ineligible after consent|0|||
105860049|NCT00049530|365138632|FG000|Overall Study|Lack of Efficacy|25|||
105860050|NCT00049530|365138632|FG000|Overall Study|Adverse Event|2|||
105860051|NCT00049530|365138632|FG000|Overall Study|Death|1|||
105860052|NCT00049530|365138632|FG000|Overall Study|symptomatic deterioration|1|||
105860053|NCT00049530|365138632|FG000|Overall Study|ineligible|3|||
105860054|NCT01438996|365138633|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
105860055|NCT01438996|365138634|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
105860056|NCT01438996|365138635|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
105860057|NCT02540850|365138636|FG000|Overall Study|Lost to Follow-up|69|||
105860058|NCT02540850|365138637|FG001|Overall Study|Lost to Follow-up|66|||
105860059|NCT02540850|365138638|FG002|Overall Study|Lost to Follow-up|34|||
105860060|NCT03511326|365138639|FG000|Overall Study|Withdrawal by Subject|1|||
105860061|NCT04005352|365138640|FG000|Overall Study|Adverse Event|4|||
105860062|NCT04005352|365138641|FG001|Overall Study|Adverse Event|5|||
105860063|NCT04005352|365138640|FG000|Overall Study|Death|4|||
105860064|NCT04005352|365138641|FG001|Overall Study|Death|2|||
105860065|NCT04005352|365138640|FG000|Overall Study|Lost to Follow-up|6|||
105860066|NCT04005352|365138641|FG001|Overall Study|Lost to Follow-up|2|||
105860067|NCT04005352|365138640|FG000|Overall Study|Physician Decision|7|||
105860068|NCT04005352|365138641|FG001|Overall Study|Physician Decision|13|||
105860069|NCT04005352|365138640|FG000|Overall Study|Protocol Violation|0|||
105860070|NCT04005352|365138641|FG001|Overall Study|Protocol Violation|1|||
106039565|NCT00735254|365810818|FG001|Overall Study|Protocol Violation|1|||
106039566|NCT00735254|365810819|FG002|Overall Study|Protocol Violation|1|||
105860071|NCT04005352|365138640|FG000|Overall Study|Withdrawal by Subject|28|||
106039567|NCT00735254|365810820|FG003|Overall Study|Protocol Violation|0|||
106039568|NCT01251744|365810821|FG000|Overall Study|Lost to Follow-up|1|||
106039569|NCT01251744|365810822|FG001|Overall Study|Lost to Follow-up|0|||
106039570|NCT00559754|365810823|FG000|Overall Study|Disease progression|1|||
105860072|NCT04005352|365138641|FG001|Overall Study|Withdrawal by Subject|38|||
105860073|NCT02704403|365138642|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
105860074|NCT02704403|365138643|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
105860075|NCT02704403|365138642|FG000|Overall Study|Administrative reasons by sponsor|1251|||
106039571|NCT00559754|365810823|FG000|Overall Study|Adverse Event|5|||
106039572|NCT00559754|365810823|FG000|Overall Study|Protocol Violation|1|||
106039573|NCT00559754|365810823|FG000|Overall Study|Investigator criteria|2|||
106039574|NCT00559754|365810823|FG000|Overall Study|Withdrawal by Subject|2|||
106039575|NCT01068652|365810824|FG000|Overall Study|Adverse Event|4|||
106039576|NCT01068652|365810825|FG001|Overall Study|Adverse Event|0|||
106039577|NCT01068652|365810824|FG000|Overall Study|Lack of Efficacy|0|||
106039578|NCT01068652|365810825|FG001|Overall Study|Lack of Efficacy|2|||
106039579|NCT01068652|365810824|FG000|Overall Study|Lost to Follow-up|2|||
106039580|NCT01068652|365810825|FG001|Overall Study|Lost to Follow-up|1|||
106039581|NCT01068652|365810824|FG000|Overall Study|Protocol Violation|3|||
106039582|NCT01068652|365810825|FG001|Overall Study|Protocol Violation|6|||
106039583|NCT01068652|365810824|FG000|Overall Study|Withdrawal criteria|1|||
106039584|NCT01068652|365810825|FG001|Overall Study|Withdrawal criteria|2|||
106039585|NCT01068652|365810824|FG000|Overall Study|Patient was not eligible|1|||
106039586|NCT01068652|365810825|FG001|Overall Study|Patient was not eligible|0|||
106039587|NCT01068652|365810824|FG000|Overall Study|Unclassified|7|||
106039588|NCT01068652|365810825|FG001|Overall Study|Unclassified|4|||
106039589|NCT00214500|365810826|FG000|Treatment Period|Adverse Event|1|||
106039590|NCT00214500|365810826|FG000|Extension Period|Withdrawal by Subject|2|||
106039591|NCT00147251|365810827|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
106039592|NCT00147251|365810828|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
106039593|NCT01629706|365810829|FG000|Phase 1 PureVision|Screen Failure|4|||
106039594|NCT01629706|365810829|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
106039595|NCT01629706|365810829|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
106039596|NCT01629706|365810829|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
106039597|NCT01629706|365810829|FG000|Phase 2 Habitual|Screen Failure|6|||
106039598|NCT01629706|365810829|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
106039599|NCT01629706|365810829|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
106039600|NCT01629706|365810829|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
106039601|NCT01629706|365810829|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
106039602|NCT02537574|365810830|FG000|Overall Study|Adverse Event|1|||
106039603|NCT02537574|365810831|FG001|Overall Study|Adverse Event|3|||
106039604|NCT02537574|365810832|FG002|Overall Study|Adverse Event|2|||
106039605|NCT02537574|365810830|FG000|Overall Study|Lost to Follow-up|40|||
106039606|NCT02537574|365810831|FG001|Overall Study|Lost to Follow-up|51|||
106039607|NCT02537574|365810832|FG002|Overall Study|Lost to Follow-up|55|||
106039608|NCT02537574|365810830|FG000|Overall Study|Noncompliance with study drug|0|||
106039609|NCT02537574|365810831|FG001|Overall Study|Noncompliance with study drug|1|||
106039610|NCT02537574|365810832|FG002|Overall Study|Noncompliance with study drug|1|||
106039611|NCT02537574|365810830|FG000|Overall Study|Physician Decision|2|||
106039612|NCT02537574|365810831|FG001|Overall Study|Physician Decision|0|||
106039613|NCT02537574|365810832|FG002|Overall Study|Physician Decision|0|||
106039614|NCT02537574|365810830|FG000|Overall Study|Protocol Violation|4|||
106039615|NCT02537574|365810831|FG001|Overall Study|Protocol Violation|2|||
105860076|NCT02704403|365138643|FG001|Overall Study|Administrative reasons by sponsor|616|||
105860077|NCT02704403|365138642|FG000|Overall Study|Death|4|||
105860078|NCT02704403|365138643|FG001|Overall Study|Death|3|||
105860079|NCT02704403|365138642|FG000|Overall Study|Endpoint event|52|||
105860080|NCT02704403|365138643|FG001|Overall Study|Endpoint event|24|||
106039616|NCT02537574|365810832|FG002|Overall Study|Protocol Violation|3|||
106039617|NCT02537574|365810830|FG000|Overall Study|Withdrawal by Subject|37|||
106039618|NCT02537574|365810831|FG001|Overall Study|Withdrawal by Subject|27|||
106039619|NCT02537574|365810832|FG002|Overall Study|Withdrawal by Subject|29|||
106039620|NCT02537574|365810830|FG000|Overall Study|Lack of Efficacy|14|||
106039621|NCT02537574|365810831|FG001|Overall Study|Lack of Efficacy|16|||
106039622|NCT02537574|365810832|FG002|Overall Study|Lack of Efficacy|15|||
106039623|NCT02537574|365810830|FG000|Overall Study|Duplicate Patient|1|||
106039624|NCT02537574|365810831|FG001|Overall Study|Duplicate Patient|0|||
106039625|NCT02537574|365810832|FG002|Overall Study|Duplicate Patient|0|||
106039626|NCT02537574|365810830|FG000|Overall Study|Patient not Stable|0|||
106039627|NCT02537574|365810831|FG001|Overall Study|Patient not Stable|1|||
106039628|NCT02537574|365810832|FG002|Overall Study|Patient not Stable|0|||
106039629|NCT02537574|365810830|FG000|Overall Study|Incarceration|0|||
106039630|NCT02537574|365810831|FG001|Overall Study|Incarceration|1|||
106039631|NCT02537574|365810832|FG002|Overall Study|Incarceration|0|||
106039632|NCT02537574|365810830|FG000|Overall Study|Failed Naloxone Challenge|0|||
106039633|NCT02537574|365810831|FG001|Overall Study|Failed Naloxone Challenge|1|||
106039634|NCT02537574|365810832|FG002|Overall Study|Failed Naloxone Challenge|0|||
106039635|NCT02537574|365810830|FG000|Overall Study|Transportation Issues|0|||
106039636|NCT02537574|365810831|FG001|Overall Study|Transportation Issues|0|||
106039637|NCT02537574|365810832|FG002|Overall Study|Transportation Issues|1|||
106039638|NCT02537574|365810830|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
106039639|NCT02537574|365810831|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
106039640|NCT02537574|365810832|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
106039641|NCT02537574|365810830|FG000|Overall Study|Noncompliance with Protocol|0|||
105860081|NCT02704403|365138642|FG000|Overall Study|Lost to Follow-up|22|||
105860082|NCT02704403|365138643|FG001|Overall Study|Lost to Follow-up|11|||
106039642|NCT02537574|365810831|FG001|Overall Study|Noncompliance with Protocol|0|||
105860083|NCT02704403|365138642|FG000|Overall Study|Protocol Violation|15|||
105860084|NCT02704403|365138643|FG001|Overall Study|Protocol Violation|15|||
105860085|NCT02704403|365138642|FG000|Overall Study|Adverse Event|2|||
105860086|NCT02704403|365138643|FG001|Overall Study|Adverse Event|0|||
105860087|NCT02704403|365138642|FG000|Overall Study|Withdrawal by Subject|85|||
105860088|NCT02704403|365138643|FG001|Overall Study|Withdrawal by Subject|45|||
105860089|NCT02704403|365138642|FG000|Overall Study|Investigator decision|1|||
105860090|NCT02704403|365138643|FG001|Overall Study|Investigator decision|1|||
105860091|NCT02704403|365138642|FG000|Overall Study|Follow-up not possible|1|||
105860092|NCT02704403|365138643|FG001|Overall Study|Follow-up not possible|2|||
105860093|NCT01844856|365138644|FG000|Overall Study|Lost to Follow-up|15|||
105860094|NCT01844856|365138645|FG001|Overall Study|Lost to Follow-up|3|||
105860095|NCT01844856|365138644|FG000|Overall Study|Adverse Event|3|||
105860096|NCT01844856|365138645|FG001|Overall Study|Adverse Event|6|||
105860097|NCT01844856|365138644|FG000|Overall Study|Withdrawal by Subject|3|||
105860098|NCT01844856|365138645|FG001|Overall Study|Withdrawal by Subject|2|||
105860099|NCT01844856|365138644|FG000|Overall Study|Noncompliance|2|||
105860100|NCT01844856|365138645|FG001|Overall Study|Noncompliance|3|||
105860101|NCT01844856|365138644|FG000|Overall Study|Enterococcus Resistant|0|||
105860102|NCT01844856|365138645|FG001|Overall Study|Enterococcus Resistant|1|||
105860103|NCT01844856|365138644|FG000|Overall Study|Inadvertently Not Scheduled|1|||
105860104|NCT01844856|365138645|FG001|Overall Study|Inadvertently Not Scheduled|0|||
105860105|NCT01844856|365138644|FG000|Overall Study|Randomized but was a Screen Failure|0|||
105860106|NCT01844856|365138645|FG001|Overall Study|Randomized but was a Screen Failure|1|||
105860107|NCT05384171|365138646|FG000|Overall Study|Lost to Follow-up|9|||
105860108|NCT05384171|365138647|FG001|Overall Study|Lost to Follow-up|9|||
105860109|NCT05384171|365138646|FG000|Overall Study|Withdrawal by Subject|3|||
105860110|NCT05384171|365138647|FG001|Overall Study|Withdrawal by Subject|0|||
105860111|NCT00780910|365138648|FG000|Overall Study|Adverse Event|2|||
105860112|NCT00106964|365138649|FG000|Overall Study|Lost to Follow-up|8|||
105860113|NCT00106964|365138650|FG001|Overall Study|Lost to Follow-up|6|||
105860114|NCT00106964|365138651|FG002|Overall Study|Lost to Follow-up|2|||
105860115|NCT00106964|365138649|FG000|Overall Study|Pregnancy|2|||
105860116|NCT00106964|365138650|FG001|Overall Study|Pregnancy|3|||
105860117|NCT00106964|365138651|FG002|Overall Study|Pregnancy|2|||
105860118|NCT00106964|365138649|FG000|Overall Study|Death|1|||
105860119|NCT00106964|365138650|FG001|Overall Study|Death|1|||
105860120|NCT00106964|365138651|FG002|Overall Study|Death|0|||
105860121|NCT00106964|365138649|FG000|Overall Study|Incarceration|0|||
105860122|NCT00106964|365138650|FG001|Overall Study|Incarceration|1|||
105860123|NCT00106964|365138651|FG002|Overall Study|Incarceration|0|||
106039643|NCT02537574|365810832|FG002|Overall Study|Noncompliance with Protocol|1|||
106039644|NCT02663687|365810833|FG000|Overall Study|Adverse Event|1|||
106039645|NCT02663687|365810834|FG001|Overall Study|Adverse Event|0|||
106039646|NCT02663687|365810835|FG002|Overall Study|Adverse Event|0|||
106039647|NCT02663687|365810836|FG003|Overall Study|Adverse Event|0|||
106039648|NCT02663687|365810837|FG004|Overall Study|Adverse Event|0|||
106039649|NCT02663687|365810833|FG000|Overall Study|Other|1|||
106039650|NCT02663687|365810834|FG001|Overall Study|Other|0|||
106039651|NCT02663687|365810835|FG002|Overall Study|Other|1|||
106039652|NCT02663687|365810836|FG003|Overall Study|Other|0|||
106039653|NCT02663687|365810837|FG004|Overall Study|Other|0|||
106039654|NCT03880461|365810843|FG000|Overall Study|Determined ineligible after enrollment|45|||
106039655|NCT03880461|365810844|FG001|Overall Study|Determined ineligible after enrollment|44|||
106039656|NCT03880461|365810843|FG000|Overall Study|No weight measurement after enrollment|24|||
106039657|NCT03880461|365810844|FG001|Overall Study|No weight measurement after enrollment|17|||
106039658|NCT01822678|365810847|FG000|Overall Study|Withdrawal by Subject|5|||
106039659|NCT01822678|365810848|FG001|Overall Study|Withdrawal by Subject|4|||
105860124|NCT00106964|365138649|FG000|Overall Study|Site Funding Terminated|0|||
105860125|NCT00106964|365138650|FG001|Overall Study|Site Funding Terminated|1|||
105860126|NCT00106964|365138651|FG002|Overall Study|Site Funding Terminated|1|||
105860127|NCT00106964|365138649|FG000|Overall Study|Failure to adhere|2|||
105860128|NCT00106964|365138650|FG001|Overall Study|Failure to adhere|0|||
105860129|NCT00106964|365138651|FG002|Overall Study|Failure to adhere|0|||
105860130|NCT00106964|365138649|FG000|Overall Study|Did not meet eligibility criteria|0|||
105860131|NCT00106964|365138650|FG001|Overall Study|Did not meet eligibility criteria|2|||
105860132|NCT00106964|365138651|FG002|Overall Study|Did not meet eligibility criteria|2|||
105860133|NCT00106964|365138649|FG000|Overall Study|Required disallowed medication|0|||
106039660|NCT01822678|365810849|FG002|Overall Study|Withdrawal by Subject|4|||
106039661|NCT01822678|365810847|FG000|Overall Study|Adverse Event|4|||
105860134|NCT00106964|365138650|FG001|Overall Study|Required disallowed medication|1|||
105860135|NCT00106964|365138651|FG002|Overall Study|Required disallowed medication|0|||
106039662|NCT01822678|365810848|FG001|Overall Study|Adverse Event|3|||
106039663|NCT01822678|365810849|FG002|Overall Study|Adverse Event|1|||
105860136|NCT04746794|365138652|FG000|Overall Study|Did not complete any study assessment|50303|||
105860137|NCT04746794|365138653|FG001|Overall Study|Did not complete any study assessment|44997|||
105860138|NCT01422187|365138665|FG000|Overall Study|Personal reason|1|||
105860139|NCT01422187|365138666|FG001|Overall Study|Personal reason|0|||
105860140|NCT01422187|365138667|FG002|Overall Study|Personal reason|0|||
105860141|NCT01422187|365138665|FG000|Overall Study|Lost to Follow-up|0|||
105860142|NCT01422187|365138666|FG001|Overall Study|Lost to Follow-up|1|||
105860143|NCT01422187|365138667|FG002|Overall Study|Lost to Follow-up|0|||
105860144|NCT00168818|365138668|FG000|Overall Study|Adverse Event|23|||
105860145|NCT00168818|365138669|FG001|Overall Study|Adverse Event|29|||
105860146|NCT00168818|365138670|FG002|Overall Study|Adverse Event|31|||
105860147|NCT00168818|365138668|FG000|Overall Study|Protocol Violation|16|||
105860148|NCT00168818|365138669|FG001|Overall Study|Protocol Violation|11|||
105860149|NCT00168818|365138670|FG002|Overall Study|Protocol Violation|11|||
105860150|NCT00168818|365138668|FG000|Overall Study|Lost to Follow-up|13|||
105860151|NCT00168818|365138669|FG001|Overall Study|Lost to Follow-up|4|||
105860152|NCT00168818|365138670|FG002|Overall Study|Lost to Follow-up|15|||
105860153|NCT00168818|365138668|FG000|Overall Study|Withdrawal by Subject|43|||
106039664|NCT01822678|365810847|FG000|Overall Study|Lack of Efficacy|3|||
106039665|NCT01822678|365810848|FG001|Overall Study|Lack of Efficacy|6|||
106039666|NCT01822678|365810849|FG002|Overall Study|Lack of Efficacy|5|||
106039667|NCT01822678|365810847|FG000|Overall Study|Lost to Follow-up|0|||
106039668|NCT01822678|365810848|FG001|Overall Study|Lost to Follow-up|2|||
106039669|NCT01822678|365810849|FG002|Overall Study|Lost to Follow-up|1|||
106039670|NCT00764504|365810850|FG000|Overall Study|Death|12|||
106039671|NCT00764504|365810851|FG001|Overall Study|Death|6|||
106039672|NCT00764504|365810852|FG002|Overall Study|Death|13|||
106039673|NCT00764504|365810850|FG000|Overall Study|Revision of Device|12|||
106039674|NCT00764504|365810851|FG001|Overall Study|Revision of Device|23|||
106039675|NCT00764504|365810852|FG002|Overall Study|Revision of Device|14|||
106039676|NCT00764504|365810850|FG000|Overall Study|Physician Decision|1|||
106039677|NCT00764504|365810851|FG001|Overall Study|Physician Decision|0|||
106039678|NCT00764504|365810852|FG002|Overall Study|Physician Decision|0|||
106039679|NCT00764504|365810850|FG000|Overall Study|Withdrawal by Subject|1|||
106039680|NCT00764504|365810851|FG001|Overall Study|Withdrawal by Subject|7|||
106039681|NCT00764504|365810852|FG002|Overall Study|Withdrawal by Subject|4|||
106039682|NCT00764504|365810850|FG000|Overall Study|Lost to Follow-up|40|||
106039683|NCT00764504|365810851|FG001|Overall Study|Lost to Follow-up|34|||
106039684|NCT00764504|365810852|FG002|Overall Study|Lost to Follow-up|72|||
106039685|NCT01028378|365810853|FG000|Overall Study|Lost to Follow-up|12|||
106039686|NCT01028378|365810853|FG000|Overall Study|Withdrawal by Subject|1|||
106039687|NCT01028378|365810853|FG000|Overall Study|Adminstrative Reasons|4|||
106039688|NCT01465191|365810854|FG000|Overall Study|Protocol Violation|6|||
106039689|NCT01465191|365810855|FG001|Overall Study|Protocol Violation|3|||
106039690|NCT01465191|365810856|FG002|Overall Study|Protocol Violation|3|||
106039691|NCT01465191|365810854|FG000|Overall Study|Lost to Follow-up|3|||
106039692|NCT01465191|365810855|FG001|Overall Study|Lost to Follow-up|6|||
106039693|NCT01465191|365810856|FG002|Overall Study|Lost to Follow-up|4|||
106039694|NCT01298193|365810857|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
106039695|NCT01298193|365810857|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
106039696|NCT01298193|365810857|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
106039697|NCT01298193|365810857|FG000|Efficacy Phase (Second Cycle)|Death|1|||
106039698|NCT00107952|365810858|FG000|Overall Study|Death|75|||
106039699|NCT00107952|365810859|FG001|Overall Study|Death|61|||
106039700|NCT00107952|365810858|FG000|Overall Study|Lost to Follow-up|0|||
106039701|NCT00107952|365810859|FG001|Overall Study|Lost to Follow-up|3|||
106039702|NCT00107952|365810858|FG000|Overall Study|Withdrawal by Subject|9|||
106039703|NCT00107952|365810859|FG001|Overall Study|Withdrawal by Subject|6|||
106039704|NCT00107952|365810858|FG000|Overall Study|Other|2|||
106039705|NCT00107952|365810859|FG001|Overall Study|Other|5|||
106039706|NCT00107952|365810858|FG000|Overall Study|Never received study treatment|9|||
105860154|NCT00168818|365138669|FG001|Overall Study|Withdrawal by Subject|41|||
105860155|NCT00168818|365138670|FG002|Overall Study|Withdrawal by Subject|37|||
106039707|NCT00107952|365810859|FG001|Overall Study|Never received study treatment|6|||
105860156|NCT00168818|365138668|FG000|Overall Study|Other|22|||
105860157|NCT00168818|365138669|FG001|Overall Study|Other|24|||
105860158|NCT00168818|365138670|FG002|Overall Study|Other|30|||
106039708|NCT03475875|365810860|FG000|Period 1|Lost to Follow-up|1|||
106039709|NCT03475875|365810861|FG001|Period 1|Lost to Follow-up|0|||
106039710|NCT03475875|365810860|FG000|Period 1|Adverse Event|2|||
106039711|NCT03475875|365810861|FG001|Period 1|Adverse Event|1|||
106039712|NCT03475875|365810860|FG000|Period 2|Adverse Event|3|||
106039713|NCT03475875|365810861|FG001|Period 2|Adverse Event|0|||
106039714|NCT03475875|365810860|FG000|Period 2|Protocol Violation|0|||
105860159|NCT00168818|365138668|FG000|Treatment|Adverse Event|77|||
105860160|NCT00168818|365138669|FG001|Treatment|Adverse Event|89|||
105860161|NCT00168818|365138670|FG002|Treatment|Adverse Event|68|||
105860162|NCT00168818|365138668|FG000|Treatment|Protocol Violation|8|||
105860163|NCT00168818|365138669|FG001|Treatment|Protocol Violation|11|||
105860164|NCT00168818|365138670|FG002|Treatment|Protocol Violation|11|||
105860165|NCT00168818|365138668|FG000|Treatment|Lost to Follow-up|0|||
105860166|NCT00168818|365138669|FG001|Treatment|Lost to Follow-up|2|||
105860167|NCT00168818|365138670|FG002|Treatment|Lost to Follow-up|1|||
105860168|NCT00168818|365138668|FG000|Treatment|Withdrawal by Subject|25|||
105860169|NCT00168818|365138669|FG001|Treatment|Withdrawal by Subject|20|||
105860170|NCT00168818|365138670|FG002|Treatment|Withdrawal by Subject|22|||
105860171|NCT00168818|365138668|FG000|Treatment|Other|23|||
105860172|NCT00168818|365138669|FG001|Treatment|Other|29|||
105860173|NCT00168818|365138670|FG002|Treatment|Other|31|||
105860174|NCT02792699|365138673|FG000|Overall Study|Adverse Event|1|||
105860175|NCT02792699|365138674|FG001|Overall Study|Adverse Event|2|||
105860176|NCT02792699|365138675|FG002|Overall Study|Adverse Event|4|||
105860177|NCT02792699|365138673|FG000|Overall Study|Withdrawal by Subject|4|||
105860178|NCT02792699|365138674|FG001|Overall Study|Withdrawal by Subject|4|||
105860179|NCT02792699|365138675|FG002|Overall Study|Withdrawal by Subject|3|||
105860180|NCT02792699|365138673|FG000|Overall Study|Lost to Follow-up|0|||
105860181|NCT02792699|365138674|FG001|Overall Study|Lost to Follow-up|1|||
105860182|NCT02792699|365138675|FG002|Overall Study|Lost to Follow-up|2|||
105860183|NCT02792699|365138673|FG000|Overall Study|Physician Decision|2|||
105860184|NCT02792699|365138674|FG001|Overall Study|Physician Decision|0|||
105860185|NCT02792699|365138675|FG002|Overall Study|Physician Decision|0|||
105860186|NCT02792699|365138673|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
105860187|NCT02792699|365138674|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
105860188|NCT02792699|365138675|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
105860189|NCT02792699|365138673|FG000|Overall Study|Other|1|||
105860190|NCT02792699|365138674|FG001|Overall Study|Other|0|||
105860191|NCT02792699|365138675|FG002|Overall Study|Other|0|||
105860192|NCT03200912|365138676|FG000|Overall Study|Adverse Event|3|||
105860193|NCT03200912|365138677|FG001|Overall Study|Adverse Event|0|||
105860194|NCT03200912|365138678|FG002|Overall Study|Adverse Event|0|||
105860195|NCT03200912|365138676|FG000|Overall Study|Withdrawal by Subject|1|||
105860196|NCT03200912|365138677|FG001|Overall Study|Withdrawal by Subject|2|||
105860197|NCT03200912|365138678|FG002|Overall Study|Withdrawal by Subject|4|||
105860198|NCT03200912|365138676|FG000|Overall Study|Non-compliance with study drug|0|||
105860199|NCT03200912|365138677|FG001|Overall Study|Non-compliance with study drug|1|||
105860200|NCT03200912|365138678|FG002|Overall Study|Non-compliance with study drug|0|||
105860201|NCT00998309|365138680|FG000|Overall Study|Protocol Violation|4|||
105860202|NCT02871492|365138687|FG000|Overall Study|Lost to Follow-up|6|||
105860203|NCT02871492|365138688|FG001|Overall Study|Lost to Follow-up|3|||
105860204|NCT02871492|365138689|FG002|Overall Study|Lost to Follow-up|5|||
105860205|NCT02871492|365138687|FG000|Overall Study|Withdrawal by Subject|0|||
105860206|NCT02871492|365138688|FG001|Overall Study|Withdrawal by Subject|0|||
105860207|NCT02871492|365138689|FG002|Overall Study|Withdrawal by Subject|1|||
105860208|NCT02256436|365138690|FG000|Overall Study|Adverse Event|9|||
105860209|NCT02256436|365138691|FG001|Overall Study|Adverse Event|14|||
105860210|NCT02256436|365138690|FG000|Overall Study|Death|216|||
105860211|NCT02256436|365138691|FG001|Overall Study|Death|208|||
105860212|NCT02256436|365138690|FG000|Overall Study|Lost to Follow-up|1|||
105860213|NCT02256436|365138691|FG001|Overall Study|Lost to Follow-up|2|||
106039715|NCT03475875|365810861|FG001|Period 2|Protocol Violation|1|||
106039716|NCT01642407|365810862|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
106039717|NCT01642407|365810862|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
106039718|NCT01642407|365810862|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
106039719|NCT04718103|365810863|FG000|Overall Study|Adverse Event|1|||
106039720|NCT04718103|365810864|FG001|Overall Study|Adverse Event|1|||
106039721|NCT04718103|365810863|FG000|Overall Study|Lack of Efficacy|4|||
106039722|NCT04718103|365810864|FG001|Overall Study|Lack of Efficacy|1|||
106039723|NCT04718103|365810863|FG000|Overall Study|Lost to Follow-up|2|||
106039724|NCT04718103|365810864|FG001|Overall Study|Lost to Follow-up|2|||
106039725|NCT04718103|365810863|FG000|Overall Study|Physician Decision|2|||
106039726|NCT04718103|365810864|FG001|Overall Study|Physician Decision|0|||
106039727|NCT04718103|365810863|FG000|Overall Study|Pregnancy|0|||
106039728|NCT04718103|365810864|FG001|Overall Study|Pregnancy|1|||
105860214|NCT02256436|365138690|FG000|Overall Study|Physician Decision|1|||
105860215|NCT02256436|365138691|FG001|Overall Study|Physician Decision|0|||
105860216|NCT02256436|365138690|FG000|Overall Study|Protocol Violation|0|||
106039729|NCT04718103|365810863|FG000|Overall Study|Withdrawal by Subject|10|||
105860217|NCT02256436|365138691|FG001|Overall Study|Protocol Violation|1|||
105860218|NCT02256436|365138690|FG000|Overall Study|Withdrawal by Subject|26|||
105860219|NCT02256436|365138691|FG001|Overall Study|Withdrawal by Subject|10|||
105860220|NCT02256436|365138690|FG000|Overall Study|Transferred to Extension Study|11|||
105860221|NCT02256436|365138691|FG001|Overall Study|Transferred to Extension Study|23|||
106039730|NCT04718103|365810864|FG001|Overall Study|Withdrawal by Subject|6|||
105860222|NCT02256436|365138690|FG000|Overall Study|Did Not Continue on Extension Study|8|||
105860223|NCT02256436|365138691|FG001|Overall Study|Did Not Continue on Extension Study|12|||
105860224|NCT03583086|365138692|FG000|Overall Study|Death|2|||
105860225|NCT03583086|365138693|FG001|Overall Study|Death|6|||
105860226|NCT03583086|365138694|FG002|Overall Study|Death|12|||
105860227|NCT03583086|365138695|FG003|Overall Study|Death|10|||
105860228|NCT03583086|365138696|FG004|Overall Study|Death|14|||
105860229|NCT03583086|365138697|FG005|Overall Study|Death|14|||
105860230|NCT03583086|365138698|FG006|Overall Study|Death|4|||
105860231|NCT03583086|365138692|FG000|Overall Study|Withdrawal by Subject|0|||
105860232|NCT03583086|365138693|FG001|Overall Study|Withdrawal by Subject|0|||
105860233|NCT03583086|365138694|FG002|Overall Study|Withdrawal by Subject|1|||
105860234|NCT03583086|365138695|FG003|Overall Study|Withdrawal by Subject|0|||
105860235|NCT03583086|365138696|FG004|Overall Study|Withdrawal by Subject|0|||
105860236|NCT03583086|365138697|FG005|Overall Study|Withdrawal by Subject|0|||
105860237|NCT03583086|365138698|FG006|Overall Study|Withdrawal by Subject|1|||
105860238|NCT03583086|365138692|FG000|Overall Study|Refused follow-up|0|||
105860239|NCT03583086|365138693|FG001|Overall Study|Refused follow-up|0|||
105860240|NCT03583086|365138694|FG002|Overall Study|Refused follow-up|1|||
105860241|NCT03583086|365138695|FG003|Overall Study|Refused follow-up|0|||
105860242|NCT03583086|365138696|FG004|Overall Study|Refused follow-up|1|||
105860243|NCT03583086|365138697|FG005|Overall Study|Refused follow-up|0|||
105860244|NCT03583086|365138698|FG006|Overall Study|Refused follow-up|0|||
105860245|NCT03583086|365138692|FG000|Overall Study|Declining Performance Status|0|||
105860246|NCT03583086|365138693|FG001|Overall Study|Declining Performance Status|0|||
105860247|NCT03583086|365138694|FG002|Overall Study|Declining Performance Status|1|||
105860248|NCT03583086|365138695|FG003|Overall Study|Declining Performance Status|0|||
105860249|NCT03583086|365138696|FG004|Overall Study|Declining Performance Status|0|||
105860250|NCT03583086|365138697|FG005|Overall Study|Declining Performance Status|0|||
105860251|NCT03583086|365138698|FG006|Overall Study|Declining Performance Status|0|||
105860252|NCT03583086|365138692|FG000|Overall Study|Still on study|0|||
105860253|NCT03583086|365138693|FG001|Overall Study|Still on study|0|||
105860254|NCT03583086|365138694|FG002|Overall Study|Still on study|0|||
105860255|NCT03583086|365138695|FG003|Overall Study|Still on study|1|||
105860256|NCT03583086|365138696|FG004|Overall Study|Still on study|0|||
106039731|NCT04718103|365810863|FG000|Overall Study|Randomized, not treated|4|||
106039732|NCT04718103|365810864|FG001|Overall Study|Randomized, not treated|1|||
106039733|NCT04718103|365810863|FG000|Overall Study|GCP violations|7|||
106039734|NCT04718103|365810864|FG001|Overall Study|GCP violations|5|||
106039735|NCT02810340|365810865|FG000|Overall Study|Withdrawal by Subject|1|||
106039736|NCT02810340|365810866|FG001|Overall Study|Withdrawal by Subject|0|||
106039737|NCT02810340|365810867|FG002|Overall Study|Withdrawal by Subject|0|||
106039738|NCT02810340|365810865|FG000|Overall Study|Incarceration|0|||
106039739|NCT02810340|365810866|FG001|Overall Study|Incarceration|1|||
106039740|NCT02810340|365810867|FG002|Overall Study|Incarceration|0|||
106039741|NCT02810340|365810865|FG000|Overall Study|Lost to Follow-up|0|||
106039742|NCT02810340|365810866|FG001|Overall Study|Lost to Follow-up|0|||
106039743|NCT02810340|365810867|FG002|Overall Study|Lost to Follow-up|1|||
106039744|NCT04795622|365810868|FG000|Overall Study|Adverse Event|1|||
106039745|NCT04795622|365810869|FG001|Overall Study|Adverse Event|0|||
106039746|NCT04795622|365810868|FG000|Overall Study|Withdrawal by Subject|3|||
106039747|NCT04795622|365810869|FG001|Overall Study|Withdrawal by Subject|3|||
106039748|NCT04795622|365810868|FG000|Overall Study|Protocol Violation|0|||
106039749|NCT04795622|365810869|FG001|Overall Study|Protocol Violation|2|||
106039750|NCT04795622|365810868|FG000|Overall Study|Lost to Follow-up|2|||
106039751|NCT04795622|365810869|FG001|Overall Study|Lost to Follow-up|3|||
106039752|NCT04795622|365810868|FG000|Overall Study|Other|7|||
106039753|NCT04795622|365810869|FG001|Overall Study|Other|8|||
106039754|NCT02017171|365810870|FG000|Overall Study|Death|10|||
106039755|NCT02017171|365810871|FG001|Overall Study|Death|4|||
106039756|NCT02017171|365810870|FG000|Overall Study|Withdrawal by Subject|23|||
106039757|NCT02017171|365810871|FG001|Overall Study|Withdrawal by Subject|17|||
106039758|NCT02017171|365810870|FG000|Overall Study|Lost to Follow-up|21|||
105860257|NCT03583086|365138697|FG005|Overall Study|Still on study|0|||
105860258|NCT03583086|365138698|FG006|Overall Study|Still on study|1|||
106039759|NCT02017171|365810871|FG001|Overall Study|Lost to Follow-up|20|||
106039760|NCT02017171|365810870|FG000|Overall Study|ESKD|6|||
106039761|NCT02017171|365810871|FG001|Overall Study|ESKD|2|||
106039762|NCT02017171|365810870|FG000|Overall Study|Miscellaneous|2|||
105860259|NCT03583086|365138692|FG000|Overall Study|Disease progression|0|||
105860260|NCT03583086|365138693|FG001|Overall Study|Disease progression|0|||
105860261|NCT03583086|365138694|FG002|Overall Study|Disease progression|0|||
105860262|NCT03583086|365138695|FG003|Overall Study|Disease progression|0|||
105860263|NCT03583086|365138696|FG004|Overall Study|Disease progression|0|||
105860264|NCT03583086|365138697|FG005|Overall Study|Disease progression|0|||
105860265|NCT03583086|365138698|FG006|Overall Study|Disease progression|1|||
106039763|NCT02017171|365810871|FG001|Overall Study|Miscellaneous|3|||
106039764|NCT01369485|365810872|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
105860266|NCT03583086|365138692|FG000|Overall Study|Undergoing radiation therapy|0|||
105860267|NCT03583086|365138693|FG001|Overall Study|Undergoing radiation therapy|0|||
105860268|NCT03583086|365138694|FG002|Overall Study|Undergoing radiation therapy|0|||
105860269|NCT03583086|365138695|FG003|Overall Study|Undergoing radiation therapy|0|||
105860270|NCT03583086|365138696|FG004|Overall Study|Undergoing radiation therapy|0|||
105860271|NCT03583086|365138697|FG005|Overall Study|Undergoing radiation therapy|0|||
105860272|NCT03583086|365138698|FG006|Overall Study|Undergoing radiation therapy|1|||
105860273|NCT03583086|365138692|FG000|Overall Study|Lost to Follow-up|0|||
105860274|NCT03583086|365138693|FG001|Overall Study|Lost to Follow-up|0|||
105860275|NCT03583086|365138694|FG002|Overall Study|Lost to Follow-up|0|||
105860276|NCT03583086|365138695|FG003|Overall Study|Lost to Follow-up|0|||
105860277|NCT03583086|365138696|FG004|Overall Study|Lost to Follow-up|0|||
105860278|NCT03583086|365138697|FG005|Overall Study|Lost to Follow-up|1|||
105860279|NCT03583086|365138698|FG006|Overall Study|Lost to Follow-up|0|||
105860280|NCT03583086|365138692|FG000|Overall Study|Adverse Event|0|||
105860281|NCT03583086|365138693|FG001|Overall Study|Adverse Event|0|||
105860282|NCT03583086|365138694|FG002|Overall Study|Adverse Event|0|||
105860283|NCT03583086|365138695|FG003|Overall Study|Adverse Event|0|||
105860284|NCT03583086|365138696|FG004|Overall Study|Adverse Event|0|||
105860285|NCT03583086|365138697|FG005|Overall Study|Adverse Event|1|||
105860286|NCT03583086|365138698|FG006|Overall Study|Adverse Event|0|||
105860287|NCT01292226|365138702|FG000|Overall Study|Adverse Event|5|||
105860288|NCT01292226|365138702|FG000|Overall Study|Death|1|||
105860289|NCT01292226|365138702|FG000|Overall Study|Graft loss|1|||
105860290|NCT01292226|365138702|FG000|Overall Study|Protocol Violation|3|||
105860291|NCT01292226|365138702|FG000|Overall Study|Withdrawal by Subject|1|||
105860292|NCT01292226|365138702|FG000|Overall Study|Other|2|||
105860293|NCT01844505|365138703|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
105860294|NCT01844505|365138704|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
105860295|NCT01844505|365138705|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
105860296|NCT01844505|365138703|FG000|Treatment Period|Other Reasons|120|||
105860297|NCT01844505|365138704|FG001|Treatment Period|Other Reasons|136|||
105860298|NCT01844505|365138705|FG002|Treatment Period|Other Reasons|58|||
105860299|NCT01844505|365138703|FG000|Treatment Period|Lost to Follow-up|9|||
105860300|NCT01844505|365138704|FG001|Treatment Period|Lost to Follow-up|11|||
105860301|NCT01844505|365138705|FG002|Treatment Period|Lost to Follow-up|6|||
105860302|NCT01844505|365138703|FG000|Treatment Period|Death|175|||
105860303|NCT01844505|365138704|FG001|Treatment Period|Death|154|||
105860304|NCT01844505|365138705|FG002|Treatment Period|Death|228|||
105860305|NCT03503864|365138706|FG000|Overall Study|Protocol Violation|6|||
105860306|NCT03503864|365138706|FG000|Overall Study|Withdrawal by Subject|7|||
105860307|NCT04083781|365138707|FG000|Main Part|Physician Decision|0|||
105860308|NCT04083781|365138708|FG001|Main Part|Physician Decision|1|||
105860309|NCT04083781|365138709|FG002|Main Part|Physician Decision|2|||
105860310|NCT04083781|365138710|FG003|Main Part|Physician Decision|0|||
105860311|NCT04083781|365138707|FG000|Main Part|Death|1|||
105860312|NCT04083781|365138708|FG001|Main Part|Death|3|||
105860313|NCT04083781|365138709|FG002|Main Part|Death|1|||
105860314|NCT04083781|365138710|FG003|Main Part|Death|0|||
105860315|NCT04083781|365138707|FG000|Main Part|Withdrawal by Subject|5|||
105860316|NCT04083781|365138708|FG001|Main Part|Withdrawal by Subject|2|||
105860317|NCT04083781|365138709|FG002|Main Part|Withdrawal by Subject|3|||
105860318|NCT04083781|365138710|FG003|Main Part|Withdrawal by Subject|7|||
105860319|NCT04083781|365138707|FG000|Extension Part|Physician Decision|0|||
105860320|NCT04083781|365138708|FG001|Extension Part|Physician Decision|0|||
105860321|NCT04083781|365138709|FG002|Extension Part|Physician Decision|0|||
105860322|NCT04083781|365138710|FG003|Extension Part|Physician Decision|1|||
105860323|NCT04083781|365138707|FG000|Extension Part|Death|0|||
105860324|NCT04083781|365138708|FG001|Extension Part|Death|1|||
106039765|NCT01369485|365810873|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
106039766|NCT01369485|365810872|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
106039767|NCT01369485|365810873|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
105860325|NCT04083781|365138709|FG002|Extension Part|Death|0|||
105860326|NCT04083781|365138710|FG003|Extension Part|Death|1|||
105860327|NCT04083781|365138707|FG000|Extension Part|Withdrawal by Subject|0|||
105860328|NCT04083781|365138708|FG001|Extension Part|Withdrawal by Subject|1|||
105860329|NCT04083781|365138709|FG002|Extension Part|Withdrawal by Subject|0|||
105860330|NCT04083781|365138710|FG003|Extension Part|Withdrawal by Subject|0|||
105860331|NCT04083781|365138707|FG000|Extension Part|Ongoing|13|||
105860332|NCT04083781|365138708|FG001|Extension Part|Ongoing|25|||
105860333|NCT04083781|365138709|FG002|Extension Part|Ongoing|15|||
105860334|NCT04083781|365138710|FG003|Extension Part|Ongoing|51|||
105860335|NCT02639052|365138712|FG000|Overall Study|Lost to Follow-up|1|||
105860336|NCT02952898|365138713|FG000|Overall Study|Withdrawal by Subject|10|||
105860337|NCT02952898|365138714|FG001|Overall Study|Withdrawal by Subject|8|||
105860338|NCT02952898|365138715|FG002|Overall Study|Withdrawal by Subject|8|||
105860339|NCT02952898|365138713|FG000|Overall Study|Adverse Event|8|||
105860340|NCT02952898|365138714|FG001|Overall Study|Adverse Event|8|||
105860341|NCT02952898|365138715|FG002|Overall Study|Adverse Event|3|||
106039768|NCT01369485|365810872|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
105860342|NCT02952898|365138713|FG000|Overall Study|Lost to Follow-up|3|||
105860343|NCT02952898|365138714|FG001|Overall Study|Lost to Follow-up|2|||
105860344|NCT02952898|365138715|FG002|Overall Study|Lost to Follow-up|2|||
105860345|NCT02952898|365138713|FG000|Overall Study|Non-compliance with study drug|1|||
105860346|NCT02952898|365138714|FG001|Overall Study|Non-compliance with study drug|1|||
105860347|NCT02952898|365138715|FG002|Overall Study|Non-compliance with study drug|2|||
105860348|NCT02099682|365138716|FG000|Overall Study|Data Not Available|51|||
105860349|NCT02099682|365138716|FG000|Overall Study|Lost to Follow-up|31|||
105860350|NCT02099682|365138716|FG000|Overall Study|Other|29|||
105860351|NCT02212379|365138717|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
105860352|NCT02212379|365138717|FG000|From Baseline to Week 48|Adverse Event|7|||
105860353|NCT02212379|365138717|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
105860354|NCT02212379|365138717|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
105860355|NCT02212379|365138717|FG000|From Week 48 to Week 96|Adverse Event|1|||
105860356|NCT02212379|365138717|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
105860357|NCT04576923|365140348|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
105860358|NCT02679235|365140349|FG000|Overall Study|Withdrawal by Subject|3|||
105860359|NCT02679235|365140349|FG000|Overall Study|Adverse Event|1|||
105860360|NCT01161407|365140350|FG000|Overall Study|Protocol Violation|3|||
105860361|NCT01161407|365140351|FG001|Overall Study|Protocol Violation|1|||
105860362|NCT01635283|365140354|FG000|Overall Study|Tumor Progression|3|||
105860363|NCT01635283|365140354|FG000|Overall Study|Lost to Follow-up|1|||
105860364|NCT00927394|365140357|FG000|Overall Study|Adverse Event|14|||
105860365|NCT00927394|365140358|FG001|Overall Study|Adverse Event|9|||
105860366|NCT00927394|365140357|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
105860367|NCT00927394|365140358|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
105860368|NCT00927394|365140357|FG000|Overall Study|Withdrawal by Subject|20|||
105860369|NCT00927394|365140358|FG001|Overall Study|Withdrawal by Subject|24|||
105860370|NCT00927394|365140357|FG000|Overall Study|Lost to Follow-up|8|||
105860371|NCT00927394|365140358|FG001|Overall Study|Lost to Follow-up|14|||
105860372|NCT00927394|365140357|FG000|Overall Study|Administrative Problem|1|||
105860373|NCT00927394|365140358|FG001|Overall Study|Administrative Problem|0|||
105860374|NCT00927394|365140357|FG000|Overall Study|Death|1|||
105860375|NCT00927394|365140358|FG001|Overall Study|Death|1|||
105860376|NCT00927394|365140357|FG000|Overall Study|Protocol deviation|16|||
105860377|NCT00927394|365140358|FG001|Overall Study|Protocol deviation|13|||
105860378|NCT00927394|365140357|FG000|Overall Study|Randomized in error|0|||
105860379|NCT00927394|365140358|FG001|Overall Study|Randomized in error|1|||
105860380|NCT01329549|365140363|FG000|Overall Study|Withdrawal by Subject|1|||
105860381|NCT01329549|365140363|FG000|Overall Study|Adverse Event|1|||
105860382|NCT02695537|365140364|FG000|Overall Study|Adverse Event|3|||
105860383|NCT02695537|365140364|FG000|Overall Study|Lack of Efficacy|28|||
105860384|NCT02695537|365140364|FG000|Overall Study|Withdrawal by Subject|4|||
105860385|NCT02695537|365140364|FG000|Overall Study|Protocol Violation|3|||
105860386|NCT02794246|365140365|FG000|Overall Study|Withdrawal by Subject|2|||
105860387|NCT02794246|365140365|FG000|Overall Study|Physician Decision|4|||
105860388|NCT00715624|365140366|FG000|Overall Study|Adverse Event|12|||
105860389|NCT00715624|365140367|FG001|Overall Study|Adverse Event|37|||
105860390|NCT00715624|365140366|FG000|Overall Study|Lack of Efficacy|11|||
105860391|NCT00715624|365140367|FG001|Overall Study|Lack of Efficacy|11|||
105860392|NCT00715624|365140366|FG000|Overall Study|Lost to Follow-up|1|||
105860393|NCT00715624|365140367|FG001|Overall Study|Lost to Follow-up|2|||
105860394|NCT00715624|365140366|FG000|Overall Study|Protocol Violation|1|||
105860395|NCT00715624|365140367|FG001|Overall Study|Protocol Violation|0|||
105860396|NCT00715624|365140366|FG000|Overall Study|Withdrawal by Subject|11|||
105860397|NCT00715624|365140367|FG001|Overall Study|Withdrawal by Subject|25|||
105860398|NCT00715624|365140366|FG000|Overall Study|Familial and personal reasons|10|||
105860399|NCT00715624|365140367|FG001|Overall Study|Familial and personal reasons|22|||
105860400|NCT00715624|365140366|FG000|Overall Study|Poor compliance|6|||
105860401|NCT00715624|365140367|FG001|Overall Study|Poor compliance|13|||
105860402|NCT00715624|365140366|FG000|Overall Study|Sponsor decision|0|||
105860403|NCT00715624|365140367|FG001|Overall Study|Sponsor decision|4|||
105860404|NCT00715624|365140366|FG000|Overall Study|Incorrect randomization (not treated)|0|||
105860405|NCT00715624|365140367|FG001|Overall Study|Incorrect randomization (not treated)|1|||
105860406|NCT00715624|365140366|FG000|Overall Study|Other|0|||
105860407|NCT00715624|365140367|FG001|Overall Study|Other|1|||
105860408|NCT01338870|365140374|FG000|Overall Study|Lost to Follow-up|0|||
105860409|NCT01338870|365140375|FG001|Overall Study|Lost to Follow-up|0|||
105860410|NCT01338870|365140376|FG002|Overall Study|Lost to Follow-up|1|||
105860411|NCT01338870|365140377|FG003|Overall Study|Lost to Follow-up|0|||
105860412|NCT01338870|365140378|FG004|Overall Study|Lost to Follow-up|1|||
105860413|NCT01338870|365140379|FG005|Overall Study|Lost to Follow-up|0|||
105860414|NCT01338870|365140374|FG000|Overall Study|Withdrawal by Subject|2|||
105860415|NCT01338870|365140375|FG001|Overall Study|Withdrawal by Subject|3|||
105860416|NCT01338870|365140376|FG002|Overall Study|Withdrawal by Subject|4|||
106151725|NCT02590432|366215136|FG004|Double-blind Treatment Period|Adverse Event|6|||
105860417|NCT01338870|365140377|FG003|Overall Study|Withdrawal by Subject|0|||
105860418|NCT01338870|365140378|FG004|Overall Study|Withdrawal by Subject|0|||
105860419|NCT01338870|365140379|FG005|Overall Study|Withdrawal by Subject|2|||
105860420|NCT01338870|365140374|FG000|Overall Study|Other|3|||
105860421|NCT01338870|365140375|FG001|Overall Study|Other|3|||
105860422|NCT01338870|365140376|FG002|Overall Study|Other|3|||
105860423|NCT01338870|365140377|FG003|Overall Study|Other|2|||
105860424|NCT01338870|365140378|FG004|Overall Study|Other|0|||
105860425|NCT01338870|365140379|FG005|Overall Study|Other|2|||
105860426|NCT01338870|365140374|FG000|Overall Study|Protocol Violation|0|||
105860427|NCT01338870|365140375|FG001|Overall Study|Protocol Violation|2|||
105860428|NCT01338870|365140376|FG002|Overall Study|Protocol Violation|2|||
106039769|NCT01369485|365810873|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
106039770|NCT01369485|365810872|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
106039771|NCT01369485|365810873|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
106039772|NCT01369485|365810872|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
106039773|NCT01369485|365810873|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
105860429|NCT01338870|365140377|FG003|Overall Study|Protocol Violation|2|||
105860430|NCT01338870|365140378|FG004|Overall Study|Protocol Violation|1|||
105860431|NCT01338870|365140379|FG005|Overall Study|Protocol Violation|1|||
105860432|NCT01338870|365140374|FG000|Overall Study|Adverse Event|4|||
105860433|NCT01338870|365140375|FG001|Overall Study|Adverse Event|4|||
105860434|NCT01338870|365140376|FG002|Overall Study|Adverse Event|1|||
105860435|NCT01338870|365140377|FG003|Overall Study|Adverse Event|5|||
105860436|NCT01338870|365140378|FG004|Overall Study|Adverse Event|4|||
105860437|NCT01338870|365140379|FG005|Overall Study|Adverse Event|1|||
105860438|NCT01955083|365140380|FG000|Overall Study|Lost to Follow-up|1|||
105860439|NCT01955083|365140381|FG001|Overall Study|Lost to Follow-up|1|||
105860440|NCT00128830|365140382|FG000|Overall Study|Adverse Event|10|||
105860441|NCT00128830|365140382|FG000|Overall Study|Withdrawal by Subject|14|||
105860442|NCT00128830|365140382|FG000|Overall Study|Lost to Follow-up|4|||
105860443|NCT00128830|365140382|FG000|Overall Study|Reached a virologic endpoint|29|||
105860444|NCT00128830|365140382|FG000|Overall Study|Non-compliant|4|||
105860445|NCT00128830|365140382|FG000|Overall Study|Discontinued or ineligible for study|2|||
105860446|NCT00128830|365140382|FG000|Overall Study|Other|9|||
105860447|NCT02927366|365140385|FG000|Overall Study|Adverse Event|1|||
105860448|NCT02927366|365140386|FG001|Overall Study|Adverse Event|0|||
105860449|NCT02927366|365140385|FG000|Overall Study|Patient schedule|1|||
105860450|NCT02927366|365140386|FG001|Overall Study|Patient schedule|0|||
105860451|NCT00478426|365140387|FG000|Overall Study|Withdrawal by Subject|1|||
105860452|NCT00530218|365140390|FG000|Overall Study|CMV Not Detected|13|||
105860453|NCT00530218|365140390|FG000|Overall Study|Death|12|||
105860454|NCT03485365|365140392|FG000|Overall Study|Protocol Violation|0|||
105860455|NCT03485365|365140393|FG001|Overall Study|Protocol Violation|0|||
105860456|NCT03485365|365140394|FG002|Overall Study|Protocol Violation|0|||
105860457|NCT03485365|365140395|FG003|Overall Study|Protocol Violation|1|||
105860458|NCT03485365|365140396|FG004|Overall Study|Protocol Violation|0|||
105860459|NCT03485365|365140397|FG005|Overall Study|Protocol Violation|0|||
105860460|NCT03485365|365140398|FG006|Overall Study|Protocol Violation|1|||
105860461|NCT03485365|365140399|FG007|Overall Study|Protocol Violation|0|||
105860462|NCT03485365|365140400|FG008|Overall Study|Protocol Violation|0|||
105860463|NCT03136965|365140401|FG000|Overall Study|Lost to Follow-up|0|||
105860464|NCT03136965|365140402|FG001|Overall Study|Lost to Follow-up|1|||
105860465|NCT03136965|365140403|FG002|Overall Study|Lost to Follow-up|0|||
105860466|NCT03489109|365140404|FG000|Overall Study|Lost to Follow-up|1|||
105860467|NCT03489109|365140405|FG001|Overall Study|Lost to Follow-up|2|||
105860468|NCT02181790|365140408|FG000|Overall Study|study terminated|2|||
105860469|NCT02181790|365140409|FG001|Overall Study|study terminated|0|||
105860470|NCT00813800|365140416|FG000|Overall Study|Screen Failure after Consent|2|||
105860471|NCT00813800|365140416|FG000|Overall Study|Adverse Event|1|||
105860472|NCT00813800|365140416|FG000|Overall Study|Worsening of depression|2|||
105860473|NCT00813800|365140416|FG000|Overall Study|Physician Decision|1|||
105860474|NCT01860677|365140417|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
105860475|NCT01860677|365140418|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
106039774|NCT01369485|365810872|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
106039775|NCT01369485|365810873|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
105860476|NCT00642278|365140421|FG000|Overall Study|Adverse Event|2|||
106039776|NCT01369485|365810872|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
106039777|NCT01369485|365810873|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
106039778|NCT01369485|365810872|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
106151726|NCT02590432|366215137|FG005|Double-blind Treatment Period|Adverse Event|22|||
105860477|NCT00642278|365140422|FG001|Overall Study|Adverse Event|1|||
105860478|NCT00642278|365140423|FG002|Overall Study|Adverse Event|3|||
105860479|NCT00642278|365140424|FG003|Overall Study|Adverse Event|1|||
105860480|NCT00642278|365140425|FG004|Overall Study|Adverse Event|2|||
105860481|NCT00642278|365140426|FG005|Overall Study|Adverse Event|2|||
105860482|NCT00642278|365140427|FG006|Overall Study|Adverse Event|0|||
105860483|NCT00642278|365140421|FG000|Overall Study|Lack of Efficacy|0|||
105860484|NCT00642278|365140422|FG001|Overall Study|Lack of Efficacy|1|||
105860485|NCT00642278|365140423|FG002|Overall Study|Lack of Efficacy|0|||
105860486|NCT00642278|365140424|FG003|Overall Study|Lack of Efficacy|0|||
105860487|NCT00642278|365140425|FG004|Overall Study|Lack of Efficacy|0|||
105860488|NCT00642278|365140426|FG005|Overall Study|Lack of Efficacy|0|||
105860489|NCT00642278|365140427|FG006|Overall Study|Lack of Efficacy|0|||
105860490|NCT00642278|365140421|FG000|Overall Study|Lost to Follow-up|5|||
105860491|NCT00642278|365140422|FG001|Overall Study|Lost to Follow-up|1|||
105860492|NCT00642278|365140423|FG002|Overall Study|Lost to Follow-up|0|||
105860493|NCT00642278|365140424|FG003|Overall Study|Lost to Follow-up|1|||
105860494|NCT00642278|365140425|FG004|Overall Study|Lost to Follow-up|0|||
105860495|NCT00642278|365140426|FG005|Overall Study|Lost to Follow-up|1|||
105860496|NCT00642278|365140427|FG006|Overall Study|Lost to Follow-up|1|||
105860497|NCT00642278|365140421|FG000|Overall Study|Physician Decision|0|||
105860498|NCT00642278|365140422|FG001|Overall Study|Physician Decision|0|||
105860499|NCT00642278|365140423|FG002|Overall Study|Physician Decision|0|||
105860500|NCT00642278|365140424|FG003|Overall Study|Physician Decision|1|||
105860501|NCT00642278|365140425|FG004|Overall Study|Physician Decision|0|||
105860502|NCT00642278|365140426|FG005|Overall Study|Physician Decision|0|||
105860503|NCT00642278|365140427|FG006|Overall Study|Physician Decision|0|||
105860504|NCT00642278|365140421|FG000|Overall Study|Protocol Violation|0|||
105860505|NCT00642278|365140422|FG001|Overall Study|Protocol Violation|0|||
105860506|NCT00642278|365140423|FG002|Overall Study|Protocol Violation|1|||
105860507|NCT00642278|365140424|FG003|Overall Study|Protocol Violation|1|||
105860508|NCT00642278|365140425|FG004|Overall Study|Protocol Violation|0|||
105860509|NCT00642278|365140426|FG005|Overall Study|Protocol Violation|1|||
105860510|NCT00642278|365140427|FG006|Overall Study|Protocol Violation|2|||
105860511|NCT00642278|365140421|FG000|Overall Study|Withdrawal by Subject|1|||
105860512|NCT00642278|365140422|FG001|Overall Study|Withdrawal by Subject|1|||
105860513|NCT00642278|365140423|FG002|Overall Study|Withdrawal by Subject|1|||
105860514|NCT00642278|365140424|FG003|Overall Study|Withdrawal by Subject|3|||
105860515|NCT00642278|365140425|FG004|Overall Study|Withdrawal by Subject|6|||
105860516|NCT00642278|365140426|FG005|Overall Study|Withdrawal by Subject|2|||
105860517|NCT00642278|365140427|FG006|Overall Study|Withdrawal by Subject|2|||
105860518|NCT00642278|365140421|FG000|Overall Study|Noncompliance with study drug regimen|0|||
105860519|NCT00642278|365140422|FG001|Overall Study|Noncompliance with study drug regimen|0|||
105860520|NCT00642278|365140423|FG002|Overall Study|Noncompliance with study drug regimen|0|||
105860521|NCT00642278|365140424|FG003|Overall Study|Noncompliance with study drug regimen|1|||
105860522|NCT00642278|365140425|FG004|Overall Study|Noncompliance with study drug regimen|0|||
105860523|NCT00642278|365140426|FG005|Overall Study|Noncompliance with study drug regimen|0|||
105860524|NCT00642278|365140427|FG006|Overall Study|Noncompliance with study drug regimen|0|||
105860525|NCT00642278|365140421|FG000|Overall Study|Other|2|||
105860526|NCT00642278|365140422|FG001|Overall Study|Other|1|||
105860527|NCT00642278|365140423|FG002|Overall Study|Other|0|||
105860528|NCT00642278|365140424|FG003|Overall Study|Other|1|||
105860529|NCT00642278|365140425|FG004|Overall Study|Other|0|||
105860530|NCT00642278|365140426|FG005|Overall Study|Other|1|||
105860531|NCT00642278|365140427|FG006|Overall Study|Other|0|||
105860532|NCT03713619|365140428|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
105860533|NCT03713619|365140429|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105860534|NCT03713619|365140430|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
105860535|NCT03713619|365140431|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105860536|NCT03713619|365140432|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105860537|NCT03713619|365140428|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
105860538|NCT03713619|365140429|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105860539|NCT03713619|365140430|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105860540|NCT03713619|365140431|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
105860541|NCT03713619|365140432|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
105860542|NCT03713619|365140428|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
105860543|NCT03713619|365140429|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
105860544|NCT03713619|365140430|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
105860545|NCT03713619|365140431|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
105860546|NCT03713619|365140432|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
105860547|NCT03713619|365140428|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
105860548|NCT03713619|365140429|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105860549|NCT03713619|365140430|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105860550|NCT03713619|365140431|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105860551|NCT03713619|365140432|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105860552|NCT03713619|365140428|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
106039779|NCT01369485|365810873|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
105860553|NCT03713619|365140429|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
105860554|NCT03713619|365140430|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
105860555|NCT03713619|365140431|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
106039780|NCT01369485|365810872|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
105860556|NCT03713619|365140432|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
105860557|NCT03713619|365140428|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
105860558|NCT03713619|365140429|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
105860559|NCT03713619|365140430|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
105860560|NCT03713619|365140431|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
105860561|NCT03713619|365140432|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
105860562|NCT03713619|365140428|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
105860563|NCT03713619|365140429|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
105860564|NCT03713619|365140430|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
105860565|NCT03713619|365140431|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
105860566|NCT03713619|365140432|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
105860567|NCT03713619|365140428|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
105860568|NCT03713619|365140429|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
105860569|NCT03713619|365140430|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
105860570|NCT03713619|365140431|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
105860571|NCT03713619|365140432|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
105860572|NCT03713619|365140428|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
105860573|NCT03713619|365140429|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105860574|NCT03713619|365140430|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105860575|NCT03713619|365140431|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
105860576|NCT03713619|365140432|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105860577|NCT03713619|365140428|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
105860578|NCT03713619|365140429|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
105860579|NCT03713619|365140430|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
105860580|NCT03713619|365140431|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
105860581|NCT03713619|365140432|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
105860582|NCT03713619|365140428|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
105860583|NCT03713619|365140429|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
105860584|NCT03713619|365140430|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
105860585|NCT03713619|365140431|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
105860586|NCT03713619|365140432|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
105860587|NCT03713619|365140428|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
105860588|NCT03713619|365140429|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
105860589|NCT03713619|365140430|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
105860590|NCT03713619|365140431|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
105860591|NCT03713619|365140432|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
105860592|NCT03713619|365140428|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
105860593|NCT03713619|365140429|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
105860594|NCT03713619|365140430|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
105860595|NCT03713619|365140431|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
105860596|NCT03713619|365140432|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
105860597|NCT04642365|365140438|FG000|Overall Study|Death|3|||
105860598|NCT04642365|365140439|FG001|Overall Study|Death|2|||
105860599|NCT04642365|365140440|FG002|Overall Study|Death|4|||
105860600|NCT04642365|365140441|FG003|Overall Study|Death|5|||
105860601|NCT04642365|365140442|FG004|Overall Study|Death|5|||
105860602|NCT04642365|365140443|FG005|Overall Study|Death|3|||
105860603|NCT04642365|365140444|FG006|Overall Study|Death|2|||
105860604|NCT04642365|365140445|FG007|Overall Study|Death|1|||
105860605|NCT04642365|365140438|FG000|Overall Study|Physician Decision|1|||
106039781|NCT01369485|365810873|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
106039782|NCT01369485|365810872|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
106039783|NCT01369485|365810873|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
106039784|NCT03370289|365810874|FG000|Overall Study|Screen Failure|1|||
106039785|NCT03370289|365810874|FG000|Overall Study|Sample Size Sufficient|4|||
106039786|NCT00704808|365810876|FG000|Overall Study|Discontinued prior to starting treatment|14|||
106039787|NCT00704808|365810876|FG000|Overall Study|Death|7|||
106039788|NCT00704808|365810876|FG000|Overall Study|Tumor progression|80|||
106039789|NCT00704808|365810876|FG000|Overall Study|Patient's decision|11|||
106039790|NCT00704808|365810876|FG000|Overall Study|Early therapy discontinuation|16|||
106039791|NCT00704808|365810876|FG000|Overall Study|Adverse Event|1|||
106151727|NCT02590432|366215138|FG006|Double-blind Treatment Period|Adverse Event|20|||
106151728|NCT02590432|366215139|FG007|Double-blind Treatment Period|Adverse Event|0|||
105860606|NCT04642365|365140439|FG001|Overall Study|Physician Decision|0|||
105860607|NCT04642365|365140440|FG002|Overall Study|Physician Decision|0|||
106039792|NCT00704808|365810876|FG000|Overall Study|Lost to Follow-up|1|||
106039793|NCT00704808|365810876|FG000|Overall Study|Treatment change|1|||
105860608|NCT04642365|365140441|FG003|Overall Study|Physician Decision|0|||
105860609|NCT04642365|365140442|FG004|Overall Study|Physician Decision|0|||
105860610|NCT04642365|365140443|FG005|Overall Study|Physician Decision|0|||
105860611|NCT04642365|365140444|FG006|Overall Study|Physician Decision|0|||
106039794|NCT01309308|365810877|FG000|Overall Study|Lost to Follow-up|6|||
105860612|NCT04642365|365140445|FG007|Overall Study|Physician Decision|0|||
105860613|NCT04642365|365140438|FG000|Overall Study|Progressive Disease|1|||
105860614|NCT04642365|365140439|FG001|Overall Study|Progressive Disease|1|||
105860615|NCT04642365|365140440|FG002|Overall Study|Progressive Disease|1|||
105860616|NCT04642365|365140441|FG003|Overall Study|Progressive Disease|0|||
105860617|NCT04642365|365140442|FG004|Overall Study|Progressive Disease|0|||
105860618|NCT04642365|365140443|FG005|Overall Study|Progressive Disease|0|||
105860619|NCT04642365|365140444|FG006|Overall Study|Progressive Disease|1|||
105860620|NCT04642365|365140445|FG007|Overall Study|Progressive Disease|0|||
105860621|NCT04642365|365140438|FG000|Overall Study|Study Terminated By Sponsor|0|||
105860622|NCT04642365|365140439|FG001|Overall Study|Study Terminated By Sponsor|2|||
105860623|NCT04642365|365140440|FG002|Overall Study|Study Terminated By Sponsor|1|||
105860624|NCT04642365|365140441|FG003|Overall Study|Study Terminated By Sponsor|1|||
105860625|NCT04642365|365140442|FG004|Overall Study|Study Terminated By Sponsor|1|||
105860626|NCT04642365|365140443|FG005|Overall Study|Study Terminated By Sponsor|2|||
105860627|NCT04642365|365140444|FG006|Overall Study|Study Terminated By Sponsor|2|||
105860628|NCT04642365|365140445|FG007|Overall Study|Study Terminated By Sponsor|1|||
105860629|NCT04642365|365140438|FG000|Overall Study|Symptomatic Deterioration|1|||
105860630|NCT04642365|365140439|FG001|Overall Study|Symptomatic Deterioration|1|||
105860631|NCT04642365|365140440|FG002|Overall Study|Symptomatic Deterioration|0|||
105860632|NCT04642365|365140441|FG003|Overall Study|Symptomatic Deterioration|0|||
105860633|NCT04642365|365140442|FG004|Overall Study|Symptomatic Deterioration|0|||
105860634|NCT04642365|365140443|FG005|Overall Study|Symptomatic Deterioration|1|||
105860635|NCT04642365|365140444|FG006|Overall Study|Symptomatic Deterioration|0|||
105860636|NCT04642365|365140445|FG007|Overall Study|Symptomatic Deterioration|0|||
105860637|NCT04642365|365140438|FG000|Overall Study|Withdrawal by Subject|0|||
105860638|NCT04642365|365140439|FG001|Overall Study|Withdrawal by Subject|0|||
105860639|NCT04642365|365140440|FG002|Overall Study|Withdrawal by Subject|1|||
105860640|NCT04642365|365140441|FG003|Overall Study|Withdrawal by Subject|1|||
105860641|NCT04642365|365140442|FG004|Overall Study|Withdrawal by Subject|0|||
105860642|NCT04642365|365140443|FG005|Overall Study|Withdrawal by Subject|0|||
105860643|NCT04642365|365140444|FG006|Overall Study|Withdrawal by Subject|2|||
105860644|NCT04642365|365140445|FG007|Overall Study|Withdrawal by Subject|0|||
105860645|NCT04642365|365140438|FG000|Overall Study|Adverse Event|0|||
105860646|NCT04642365|365140439|FG001|Overall Study|Adverse Event|0|||
105860647|NCT04642365|365140440|FG002|Overall Study|Adverse Event|0|||
105860648|NCT04642365|365140441|FG003|Overall Study|Adverse Event|0|||
105860649|NCT04642365|365140442|FG004|Overall Study|Adverse Event|0|||
105860650|NCT04642365|365140443|FG005|Overall Study|Adverse Event|0|||
105860651|NCT04642365|365140444|FG006|Overall Study|Adverse Event|0|||
105860652|NCT04642365|365140445|FG007|Overall Study|Adverse Event|1|||
105860653|NCT01144715|365140446|FG000|Overall Study|Lost to Follow-up|2|||
105860654|NCT01144715|365140447|FG001|Overall Study|Lost to Follow-up|1|||
105860655|NCT01144715|365140446|FG000|Overall Study|Withdrawal by Subject|2|||
105860656|NCT01144715|365140447|FG001|Overall Study|Withdrawal by Subject|1|||
105860657|NCT01144715|365140446|FG000|Overall Study|Adverse Event|0|||
105860658|NCT01144715|365140447|FG001|Overall Study|Adverse Event|1|||
105860659|NCT06281171|365140448|FG000|Timepoint 2|Lost to Follow-up|6|||
106039795|NCT01309308|365810878|FG001|Overall Study|Lost to Follow-up|4|||
106039796|NCT02280473|365810879|FG000|Overall Study|Adverse Event|1|||
106039797|NCT02280473|365810880|FG001|Overall Study|Adverse Event|1|||
106039798|NCT02280473|365810879|FG000|Overall Study|Lack of Efficacy|0|||
106039799|NCT02280473|365810880|FG001|Overall Study|Lack of Efficacy|1|||
106039800|NCT02280473|365810879|FG000|Overall Study|Lost to Follow-up|0|||
106039801|NCT02280473|365810880|FG001|Overall Study|Lost to Follow-up|1|||
106039802|NCT01280955|365810885|FG000|Overall Study|Death|2|||
106039803|NCT01280955|365810885|FG000|Overall Study|Withdrawal by Subject|1|||
106039804|NCT02961218|365810886|FG000|Overall Study|Lost to Follow-up|0|||
106039805|NCT02961218|365810887|FG001|Overall Study|Lost to Follow-up|2|||
106151729|NCT02590432|366215140|FG008|Double-blind Treatment Period|Adverse Event|0|||
106151730|NCT02590432|366215132|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
106151731|NCT02590432|366215133|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
105860660|NCT06281171|365140449|FG001|Timepoint 2|Lost to Follow-up|4|||
105860661|NCT06281171|365140448|FG000|Timepoint 3|Lost to Follow-up|0|||
105860662|NCT06281171|365140449|FG001|Timepoint 3|Lost to Follow-up|5|||
105860663|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
105860664|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
105860665|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
105860666|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
105860667|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
105860668|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
106039806|NCT02961218|365810886|FG000|Overall Study|Physician Decision|0|||
106151732|NCT02590432|366215134|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
105860669|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
105860670|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
105860671|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
106039807|NCT02961218|365810887|FG001|Overall Study|Physician Decision|2|||
106039808|NCT02961218|365810886|FG000|Overall Study|Subject/Guardian Decision|3|||
106039809|NCT02961218|365810887|FG001|Overall Study|Subject/Guardian Decision|1|||
106039810|NCT01721070|365810893|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
106039811|NCT01226043|365810894|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
106039812|NCT01226043|365810895|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
106039813|NCT01226043|365810896|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
106039814|NCT01226043|365810897|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
106039815|NCT01226043|365810894|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
106039816|NCT01226043|365810895|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
106039817|NCT01226043|365810896|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
106039818|NCT01226043|365810897|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
106039819|NCT01226043|365810894|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
106039820|NCT01226043|365810895|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
106039821|NCT01226043|365810896|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
106039822|NCT01226043|365810897|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
106039823|NCT01226043|365810894|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
105860672|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
105860673|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
105860674|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
105860675|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
105860676|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
105860677|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
105860678|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
105860679|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
105860680|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
105860681|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
105860682|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
105860683|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
105860684|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
105860685|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
105860686|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
105860687|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
105860688|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
105860689|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
105860690|NCT02552212|365140450|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
105860691|NCT02552212|365140451|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
105860692|NCT02552212|365140452|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
105860693|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
105860694|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
105860695|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
105860696|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
105860697|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
105860698|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
105860699|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
105860700|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
105860701|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
105860702|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
105860703|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
105860704|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
105860705|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
105860706|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
105860707|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
105860708|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
105860709|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
105860710|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
105860711|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
105860712|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
105860713|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
105860714|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
105860715|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
106039824|NCT01226043|365810895|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
105860716|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
106039825|NCT01226043|365810896|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
106039826|NCT01226043|365810897|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
106039827|NCT01226043|365810894|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
105860717|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
105860718|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
105860719|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
105860720|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
105860721|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
105860722|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
105860723|NCT02552212|365140450|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
105860724|NCT02552212|365140451|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
105860725|NCT02552212|365140452|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
105860726|NCT05038800|365140458|FG000|Overall Study|Death|1|||
105860727|NCT05038800|365140459|FG001|Overall Study|Death|1|||
105860728|NCT05038800|365140460|FG002|Overall Study|Death|5|||
105860729|NCT05038800|365140461|FG003|Overall Study|Death|3|||
105860730|NCT05038800|365140462|FG004|Overall Study|Death|1|||
105860731|NCT05038800|365140458|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105860732|NCT05038800|365140459|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105860733|NCT05038800|365140460|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105860734|NCT05038800|365140461|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
105860735|NCT05038800|365140462|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
105860736|NCT05038800|365140458|FG000|Overall Study|Lack of Efficacy|0|||
105860737|NCT05038800|365140459|FG001|Overall Study|Lack of Efficacy|0|||
105860738|NCT05038800|365140460|FG002|Overall Study|Lack of Efficacy|0|||
105860739|NCT05038800|365140461|FG003|Overall Study|Lack of Efficacy|0|||
105860740|NCT05038800|365140462|FG004|Overall Study|Lack of Efficacy|1|||
105860741|NCT01102374|365140470|FG000|Overall Study|Death|9|||
105860742|NCT01102374|365140471|FG001|Overall Study|Death|13|||
105860743|NCT01102374|365140470|FG000|Overall Study|Lost to Follow-up|7|||
105860744|NCT01102374|365140471|FG001|Overall Study|Lost to Follow-up|6|||
105860745|NCT00418821|365140472|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
106039828|NCT01226043|365810895|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
106039829|NCT01226043|365810896|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
106039830|NCT01226043|365810897|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
106039831|NCT01226043|365810894|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
106039832|NCT01226043|365810895|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
106039833|NCT01226043|365810896|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
106039834|NCT01226043|365810897|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
106039835|NCT01226043|365810894|FG000|6-week Re-randomization Phase|Adverse Event|0|||
106039836|NCT01226043|365810895|FG001|6-week Re-randomization Phase|Adverse Event|0|||
106039837|NCT01226043|365810896|FG002|6-week Re-randomization Phase|Adverse Event|1|||
106039838|NCT01226043|365810897|FG003|6-week Re-randomization Phase|Adverse Event|1|||
106039839|NCT01226043|365810894|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
106039840|NCT01226043|365810895|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
106039841|NCT01226043|365810896|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
106039842|NCT01226043|365810897|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
106039843|NCT01226043|365810894|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
106039844|NCT01226043|365810895|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
106039845|NCT01226043|365810896|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
106039846|NCT01226043|365810897|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
106039847|NCT01226043|365810894|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
106039848|NCT01226043|365810895|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
106039849|NCT01226043|365810896|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
106039850|NCT01226043|365810897|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
106039851|NCT01226043|365810894|FG000|6-week Re-randomization Phase|Physician Decision|0|||
106039852|NCT01226043|365810895|FG001|6-week Re-randomization Phase|Physician Decision|0|||
106039853|NCT01226043|365810896|FG002|6-week Re-randomization Phase|Physician Decision|3|||
106039854|NCT01226043|365810897|FG003|6-week Re-randomization Phase|Physician Decision|2|||
106039855|NCT01226043|365810894|FG000|6-week Re-randomization Phase|completed in error|0|||
106039856|NCT01226043|365810895|FG001|6-week Re-randomization Phase|completed in error|0|||
106039857|NCT01226043|365810896|FG002|6-week Re-randomization Phase|completed in error|0|||
106039858|NCT01226043|365810897|FG003|6-week Re-randomization Phase|completed in error|1|||
105860746|NCT02011386|365140473|FG000|Overall Study|Non-compliance|2|||
106039859|NCT01226043|365810894|FG000|30-week Observational Phase|Adverse Event|0|||
105860747|NCT02011386|365140473|FG000|Overall Study|Lack of Efficacy|3|||
105860748|NCT04619992|365140474|FG000|Overall Study|Withdrawal by Subject|1|||
105860749|NCT04619992|365140475|FG001|Overall Study|Withdrawal by Subject|0|||
105860750|NCT03255655|365140476|FG000|Overall Study|Lost to Follow-up|7|||
105860751|NCT03255655|365140477|FG001|Overall Study|Lost to Follow-up|4|||
106039860|NCT01226043|365810895|FG001|30-week Observational Phase|Adverse Event|0|||
106039861|NCT01226043|365810896|FG002|30-week Observational Phase|Adverse Event|1|||
106039862|NCT01226043|365810897|FG003|30-week Observational Phase|Adverse Event|1|||
105860752|NCT04428333|365140478|FG000|Overall Study|Physician Decision|5|||
106039863|NCT01226043|365810894|FG000|30-week Observational Phase|Protocol Violation|0|||
106039864|NCT01226043|365810895|FG001|30-week Observational Phase|Protocol Violation|0|||
106039865|NCT01226043|365810896|FG002|30-week Observational Phase|Protocol Violation|0|||
106039866|NCT01226043|365810897|FG003|30-week Observational Phase|Protocol Violation|1|||
106039867|NCT01226043|365810894|FG000|30-week Observational Phase|Lost to Follow-up|0|||
106039868|NCT01226043|365810895|FG001|30-week Observational Phase|Lost to Follow-up|0|||
106039869|NCT01226043|365810896|FG002|30-week Observational Phase|Lost to Follow-up|2|||
106039870|NCT01226043|365810897|FG003|30-week Observational Phase|Lost to Follow-up|2|||
106039871|NCT01226043|365810894|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
105860753|NCT04428333|365140479|FG001|Overall Study|Physician Decision|6|||
105860754|NCT04428333|365140478|FG000|Overall Study|Withdrawal by Subject|1|||
105860755|NCT04428333|365140479|FG001|Overall Study|Withdrawal by Subject|3|||
105860756|NCT04428333|365140478|FG000|Overall Study|Study Terminated By Sponsor|14|||
105860757|NCT04428333|365140479|FG001|Overall Study|Study Terminated By Sponsor|16|||
105860758|NCT00758680|365140481|FG000|Overall Study|Adverse Event|0|||
105860759|NCT00758680|365140482|FG001|Overall Study|Adverse Event|0|||
105860760|NCT00758680|365140483|FG002|Overall Study|Adverse Event|0|||
105860761|NCT00758680|365140484|FG003|Overall Study|Adverse Event|0|||
105860762|NCT00758680|365140485|FG004|Overall Study|Adverse Event|0|||
105860763|NCT00758680|365140486|FG005|Overall Study|Adverse Event|0|||
105860764|NCT00758680|365140487|FG006|Overall Study|Adverse Event|0|||
105860765|NCT00758680|365140488|FG007|Overall Study|Adverse Event|1|||
105860766|NCT00758680|365140489|FG008|Overall Study|Adverse Event|0|||
105860767|NCT00758680|365140490|FG009|Overall Study|Adverse Event|1|||
105860768|NCT00758680|365140481|FG000|Overall Study|Laboratory Adverse Event|0|||
105860769|NCT00758680|365140482|FG001|Overall Study|Laboratory Adverse Event|0|||
105860770|NCT00758680|365140483|FG002|Overall Study|Laboratory Adverse Event|0|||
105860771|NCT00758680|365140484|FG003|Overall Study|Laboratory Adverse Event|0|||
106039872|NCT01226043|365810895|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
106039873|NCT01226043|365810896|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
106039874|NCT01226043|365810897|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
106039875|NCT01226043|365810894|FG000|30-week Observational Phase|Physician Decision|0|||
106039876|NCT01226043|365810895|FG001|30-week Observational Phase|Physician Decision|0|||
106039877|NCT01226043|365810896|FG002|30-week Observational Phase|Physician Decision|2|||
106039878|NCT01226043|365810897|FG003|30-week Observational Phase|Physician Decision|2|||
106039879|NCT00910988|365810898|FG000|Overall Study|Lost to Follow-up|2|||
106039880|NCT00910988|365810899|FG001|Overall Study|Lost to Follow-up|4|||
106039881|NCT00910988|365810900|FG002|Overall Study|Lost to Follow-up|3|||
106039882|NCT00910988|365810901|FG003|Overall Study|Lost to Follow-up|0|||
106039883|NCT00973349|365810902|FG000|Overall Study|Adverse Event|0|||
106039884|NCT00973349|365810903|FG001|Overall Study|Adverse Event|0|||
106039885|NCT00973349|365810904|FG002|Overall Study|Adverse Event|0|||
106039886|NCT00973349|365810905|FG003|Overall Study|Adverse Event|0|||
106039887|NCT00973349|365810906|FG004|Overall Study|Adverse Event|1|||
106039888|NCT00973349|365810907|FG005|Overall Study|Adverse Event|0|||
106039889|NCT00973349|365810908|FG006|Overall Study|Adverse Event|0|||
106039890|NCT00973349|365810909|FG007|Overall Study|Adverse Event|0|||
106039891|NCT00973349|365810910|FG008|Overall Study|Adverse Event|1|||
106039892|NCT00973349|365810911|FG009|Overall Study|Adverse Event|0|||
105860772|NCT00758680|365140485|FG004|Overall Study|Laboratory Adverse Event|0|||
105860773|NCT00758680|365140486|FG005|Overall Study|Laboratory Adverse Event|0|||
105860774|NCT00758680|365140487|FG006|Overall Study|Laboratory Adverse Event|0|||
105860775|NCT00758680|365140488|FG007|Overall Study|Laboratory Adverse Event|0|||
105860776|NCT00758680|365140489|FG008|Overall Study|Laboratory Adverse Event|1|||
105860777|NCT00758680|365140490|FG009|Overall Study|Laboratory Adverse Event|0|||
106039893|NCT00973349|365810912|FG010|Overall Study|Adverse Event|0|||
106039894|NCT00973349|365810913|FG011|Overall Study|Adverse Event|0|||
106039895|NCT00973349|365810914|FG012|Overall Study|Adverse Event|0|||
106039896|NCT00973349|365810915|FG013|Overall Study|Adverse Event|0|||
106039897|NCT00973349|365810916|FG014|Overall Study|Adverse Event|1|||
105860778|NCT00758680|365140481|FG000|Overall Study|Withdrawal by Subject|0|||
105860779|NCT00758680|365140482|FG001|Overall Study|Withdrawal by Subject|0|||
105860780|NCT00758680|365140483|FG002|Overall Study|Withdrawal by Subject|0|||
105860781|NCT00758680|365140484|FG003|Overall Study|Withdrawal by Subject|0|||
105860782|NCT00758680|365140485|FG004|Overall Study|Withdrawal by Subject|0|||
105860783|NCT00758680|365140486|FG005|Overall Study|Withdrawal by Subject|0|||
105860784|NCT00758680|365140487|FG006|Overall Study|Withdrawal by Subject|1|||
106039898|NCT00973349|365810917|FG015|Overall Study|Adverse Event|0|||
106039899|NCT00973349|365810902|FG000|Overall Study|Withdrawal by Subject|1|||
106039900|NCT00973349|365810903|FG001|Overall Study|Withdrawal by Subject|2|||
106039901|NCT00973349|365810904|FG002|Overall Study|Withdrawal by Subject|2|||
106039902|NCT00973349|365810905|FG003|Overall Study|Withdrawal by Subject|3|||
106039903|NCT00973349|365810906|FG004|Overall Study|Withdrawal by Subject|2|||
106039904|NCT00973349|365810907|FG005|Overall Study|Withdrawal by Subject|0|||
106039905|NCT00973349|365810908|FG006|Overall Study|Withdrawal by Subject|2|||
105860785|NCT00758680|365140488|FG007|Overall Study|Withdrawal by Subject|0|||
105860786|NCT00758680|365140489|FG008|Overall Study|Withdrawal by Subject|1|||
105860787|NCT00758680|365140490|FG009|Overall Study|Withdrawal by Subject|0|||
105860788|NCT02351960|365140491|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
105860789|NCT02351960|365140492|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
105860790|NCT02351960|365140491|FG000|Overall Study|Voluntary Withdrawal|5|||
105860791|NCT02351960|365140492|FG001|Overall Study|Voluntary Withdrawal|4|||
105860792|NCT02351960|365140491|FG000|Overall Study|Significant Protocol Deviation|0|||
105860793|NCT02351960|365140492|FG001|Overall Study|Significant Protocol Deviation|5|||
105860794|NCT00103610|365140493|FG000|Overall Study|Entered Rescue Procedure|10|||
105860795|NCT00103610|365140494|FG001|Overall Study|Entered Rescue Procedure|52|||
105860796|NCT00103610|365140493|FG000|Overall Study|Death|16|||
105860797|NCT00103610|365140494|FG001|Overall Study|Death|12|||
105860798|NCT00103610|365140493|FG000|Overall Study|Elective Withdrawal|4|||
105860799|NCT00103610|365140494|FG001|Overall Study|Elective Withdrawal|0|||
105860800|NCT00103610|365140493|FG000|Overall Study|Lost to Follow-up|3|||
105860801|NCT00103610|365140494|FG001|Overall Study|Lost to Follow-up|1|||
105860802|NCT00103610|365140493|FG000|Overall Study|Adverse Event|2|||
105860803|NCT00103610|365140494|FG001|Overall Study|Adverse Event|2|||
105860804|NCT00103610|365140493|FG000|Overall Study|Other|2|||
105860805|NCT00103610|365140494|FG001|Overall Study|Other|7|||
105860806|NCT00103610|365140493|FG000|Overall Study|Failed mobilization|1|||
105860807|NCT00103610|365140494|FG001|Overall Study|Failed mobilization|5|||
105860808|NCT00103610|365140493|FG000|Overall Study|Noncompliance|0|||
105860809|NCT00103610|365140494|FG001|Overall Study|Noncompliance|1|||
105860810|NCT00725205|365140495|FG000|Overall Study|Adverse Event|22|||
105860811|NCT00725205|365140495|FG000|Overall Study|Investigator Discontinued|1|||
105860812|NCT00725205|365140495|FG000|Overall Study|Non-compliance With Protocol|14|||
105860813|NCT00725205|365140495|FG000|Overall Study|Other|8|||
105860814|NCT00725205|365140495|FG000|Overall Study|Protocol Defined Clinical Event|1|||
105860815|NCT00725205|365140495|FG000|Overall Study|Treatment Failure|41|||
105860816|NCT02105974|365140496|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
105860817|NCT02105974|365140497|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
105860818|NCT02105974|365140498|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
105860819|NCT02105974|365140496|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
105860820|NCT02105974|365140497|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
105860821|NCT02105974|365140498|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
105860822|NCT02105974|365140496|FG000|2 Week Run-in Period|Adverse Event|6|||
105860823|NCT02105974|365140497|FG001|2 Week Run-in Period|Adverse Event|0|||
105860824|NCT02105974|365140498|FG002|2 Week Run-in Period|Adverse Event|0|||
105860825|NCT02105974|365140496|FG000|2 Week Run-in Period|Study closed/terminated|1|||
105860826|NCT02105974|365140497|FG001|2 Week Run-in Period|Study closed/terminated|0|||
105860827|NCT02105974|365140498|FG002|2 Week Run-in Period|Study closed/terminated|0|||
105860828|NCT02105974|365140496|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
105860829|NCT02105974|365140497|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
105860830|NCT02105974|365140498|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
105860831|NCT02105974|365140496|FG000|2 Week Run-in Period|Withdrew consent|23|||
105860832|NCT02105974|365140497|FG001|2 Week Run-in Period|Withdrew consent|0|||
105860833|NCT02105974|365140498|FG002|2 Week Run-in Period|Withdrew consent|0|||
105860834|NCT02105974|365140496|FG000|2 Week Run-in Period|Investigator discretion|8|||
105860835|NCT02105974|365140497|FG001|2 Week Run-in Period|Investigator discretion|0|||
105860836|NCT02105974|365140498|FG002|2 Week Run-in Period|Investigator discretion|0|||
105860837|NCT02105974|365140496|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
105860838|NCT02105974|365140497|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
105860839|NCT02105974|365140498|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
105860840|NCT02105974|365140496|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
105860841|NCT02105974|365140497|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
105860842|NCT02105974|365140498|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
105860843|NCT02105974|365140496|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
105860844|NCT02105974|365140497|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
105860845|NCT02105974|365140498|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
105860846|NCT02105974|365140496|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
105860847|NCT02105974|365140497|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
105860848|NCT02105974|365140498|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
105860849|NCT02105974|365140496|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
105860850|NCT02105974|365140497|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
105860851|NCT02105974|365140498|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
105860852|NCT02105974|365140496|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
105860853|NCT02105974|365140497|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
105860854|NCT02105974|365140498|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
105860855|NCT02105974|365140496|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
105860856|NCT02105974|365140497|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
105860857|NCT02105974|365140498|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
105860858|NCT00461253|365141997|FG000|Overall Study|Death|985|||
105860859|NCT00461253|365141998|FG001|Overall Study|Death|0|||
105860860|NCT00461253|365141997|FG000|Overall Study|Protocol Violation|613|||
105860861|NCT00461253|365141998|FG001|Overall Study|Protocol Violation|236|||
105860862|NCT00461253|365141997|FG000|Overall Study|no response|2609|||
105860863|NCT00461253|365141998|FG001|Overall Study|no response|11789|||
105860864|NCT00461253|365141997|FG000|Overall Study|administrative|773|||
105860865|NCT00461253|365141998|FG001|Overall Study|administrative|7773|||
105860866|NCT05307510|365141999|FG000|Overall Study|Lost to Follow-up|3|||
105860867|NCT05307510|365142000|FG001|Overall Study|Lost to Follow-up|6|||
105860868|NCT05307510|365141999|FG000|Overall Study|Withdrawal by Subject|0|||
105860869|NCT05307510|365142000|FG001|Overall Study|Withdrawal by Subject|1|||
105860870|NCT01957397|365142001|FG000|Test Period 1|sudden leakage/small bag|1|||
105860871|NCT01957397|365142002|FG001|Test Period 1|sudden leakage/small bag|1|||
105860872|NCT01957397|365142001|FG000|Test Period 1|Withdrawal by Subject|1|||
105860873|NCT01957397|365142002|FG001|Test Period 1|Withdrawal by Subject|0|||
105860874|NCT01957397|365142001|FG000|Test Period 2|Adverse Event|0|||
105860875|NCT01957397|365142002|FG001|Test Period 2|Adverse Event|1|||
105860876|NCT01957397|365142001|FG000|Test Period 3|Adverse Event|1|||
105860877|NCT01957397|365142002|FG001|Test Period 3|Adverse Event|2|||
105860878|NCT01957397|365142001|FG000|Test Period 3|the adhesive did not work|1|||
105860879|NCT01957397|365142002|FG001|Test Period 3|the adhesive did not work|0|||
105860880|NCT02618759|365142003|FG000|Overall Study|Lost to Follow-up|0|||
105860881|NCT02618759|365142004|FG001|Overall Study|Lost to Follow-up|1|||
105860882|NCT02618759|365142003|FG000|Overall Study|Withdrawal by Subject|1|||
105860883|NCT02618759|365142004|FG001|Overall Study|Withdrawal by Subject|0|||
105860884|NCT02618759|365142003|FG000|Overall Study|Other Reasons|1|||
105860885|NCT02618759|365142004|FG001|Overall Study|Other Reasons|4|||
105860886|NCT04933968|365142005|FG000|Overall Study|Adverse Event|0|||
105860887|NCT04933968|365142006|FG001|Overall Study|Adverse Event|0|||
105860888|NCT04933968|365142007|FG002|Overall Study|Adverse Event|1|||
105860889|NCT04933968|365142008|FG003|Overall Study|Adverse Event|1|||
105860890|NCT04933968|365142009|FG004|Overall Study|Adverse Event|0|||
105860891|NCT04933968|365142010|FG005|Overall Study|Adverse Event|0|||
105860892|NCT04933968|365142005|FG000|Overall Study|Lost to Follow-up|1|||
105860893|NCT04933968|365142006|FG001|Overall Study|Lost to Follow-up|0|||
105860894|NCT04933968|365142007|FG002|Overall Study|Lost to Follow-up|1|||
105860895|NCT04933968|365142008|FG003|Overall Study|Lost to Follow-up|0|||
105860896|NCT04933968|365142009|FG004|Overall Study|Lost to Follow-up|0|||
105860897|NCT04933968|365142010|FG005|Overall Study|Lost to Follow-up|0|||
105860898|NCT04933968|365142005|FG000|Overall Study|Randomized not treated|1|||
105860899|NCT04933968|365142006|FG001|Overall Study|Randomized not treated|0|||
105860900|NCT04933968|365142007|FG002|Overall Study|Randomized not treated|0|||
105860901|NCT04933968|365142008|FG003|Overall Study|Randomized not treated|0|||
105860902|NCT04933968|365142009|FG004|Overall Study|Randomized not treated|0|||
105860903|NCT04933968|365142010|FG005|Overall Study|Randomized not treated|0|||
105860904|NCT04933968|365142005|FG000|Overall Study|Sponsor terminated study|0|||
105860905|NCT04933968|365142006|FG001|Overall Study|Sponsor terminated study|0|||
105860906|NCT04933968|365142007|FG002|Overall Study|Sponsor terminated study|0|||
105860907|NCT04933968|365142008|FG003|Overall Study|Sponsor terminated study|1|||
105860908|NCT04933968|365142009|FG004|Overall Study|Sponsor terminated study|2|||
105860909|NCT04933968|365142010|FG005|Overall Study|Sponsor terminated study|0|||
105860910|NCT04933968|365142005|FG000|Overall Study|Other|0|||
105860911|NCT04933968|365142006|FG001|Overall Study|Other|0|||
105860912|NCT04933968|365142007|FG002|Overall Study|Other|0|||
105860913|NCT04933968|365142008|FG003|Overall Study|Other|1|||
106039906|NCT00973349|365810909|FG007|Overall Study|Withdrawal by Subject|2|||
105860914|NCT04933968|365142009|FG004|Overall Study|Other|0|||
105860915|NCT04933968|365142010|FG005|Overall Study|Other|0|||
105860916|NCT04933968|365142005|FG000|Overall Study|Missing|1|||
105860917|NCT04933968|365142006|FG001|Overall Study|Missing|3|||
105860918|NCT04933968|365142007|FG002|Overall Study|Missing|2|||
105860919|NCT04933968|365142008|FG003|Overall Study|Missing|1|||
105860920|NCT04933968|365142009|FG004|Overall Study|Missing|1|||
105860921|NCT04933968|365142010|FG005|Overall Study|Missing|0|||
105860922|NCT01724489|365142011|FG000|Overall Study|Adverse Event|8|||
105860923|NCT01724489|365142012|FG001|Overall Study|Adverse Event|3|||
105860924|NCT01724489|365142011|FG000|Overall Study|Surgery, medication|1|||
105860925|NCT01724489|365142012|FG001|Overall Study|Surgery, medication|1|||
105860926|NCT01724489|365142011|FG000|Overall Study|Lost to Follow-up|1|||
106039907|NCT00973349|365810910|FG008|Overall Study|Withdrawal by Subject|0|||
106039908|NCT00973349|365810911|FG009|Overall Study|Withdrawal by Subject|2|||
105860927|NCT01724489|365142012|FG001|Overall Study|Lost to Follow-up|2|||
105860928|NCT01724489|365142011|FG000|Overall Study|Withdrawal by Subject|6|||
105860929|NCT01724489|365142012|FG001|Overall Study|Withdrawal by Subject|6|||
105860930|NCT00923273|365142013|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
105860931|NCT00923273|365142014|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
105860932|NCT00923273|365142015|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
105860933|NCT00923273|365142016|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
105860934|NCT00923273|365142017|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
105860935|NCT00923273|365142013|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
105860936|NCT00923273|365142014|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
105860937|NCT00923273|365142015|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
105860938|NCT00923273|365142016|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
105860939|NCT00923273|365142017|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
105860940|NCT01544179|365142018|FG000|Overall Study|Death|50|||
105860941|NCT01544179|365142019|FG001|Overall Study|Death|37|||
105860942|NCT01544179|365142018|FG000|Overall Study|Lost to Follow-up|0|||
105860943|NCT01544179|365142019|FG001|Overall Study|Lost to Follow-up|1|||
105860944|NCT01544179|365142018|FG000|Overall Study|Adverse Event|0|||
105860945|NCT01544179|365142019|FG001|Overall Study|Adverse Event|1|||
105860946|NCT01544179|365142018|FG000|Overall Study|Withdrawal by Subject|12|||
105860947|NCT01544179|365142019|FG001|Overall Study|Withdrawal by Subject|7|||
105860948|NCT01544179|365142018|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
105860949|NCT01544179|365142019|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105860950|NCT01305044|365142020|FG000|Overall Study|Withdrawal by Subject|3|||
105860951|NCT01305044|365142021|FG001|Overall Study|Withdrawal by Subject|6|||
105860952|NCT04497948|365142022|FG000|Overall Study|Death|2|||
105860953|NCT00849186|365142025|FG000|Overall Study|Adverse Event|2|||
105860954|NCT00849186|365142025|FG000|Overall Study|Withdrawal by Subject|1|||
105860955|NCT00849186|365142025|FG000|Overall Study|not treated|6|||
105860956|NCT00849186|365142025|FG000|Overall Study|Other|1|||
105860957|NCT02861014|365142028|FG000|Primary Analysis|Adverse Event|7|||
105860958|NCT02861014|365142028|FG000|Primary Analysis|Death|1|||
105860959|NCT02861014|365142028|FG000|Primary Analysis|Lack of Efficacy|3|||
105860960|NCT02861014|365142028|FG000|Primary Analysis|Physician Decision|2|||
105860961|NCT02861014|365142028|FG000|Primary Analysis|Pregnancy|4|||
105860962|NCT02861014|365142028|FG000|Primary Analysis|Protocol Violation|2|||
105860963|NCT02861014|365142028|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
105860964|NCT02861014|365142028|FG000|Primary Analysis|Withdrawal by Subject|14|||
105860965|NCT02861014|365142028|FG000|Primary Analysis|Commercial ocrelizumab|3|||
105860966|NCT02861014|365142028|FG000|Safety Follow-up|Adverse Event|1|||
105860967|NCT02861014|365142028|FG000|Safety Follow-up|Pregnancy|1|||
105860968|NCT02861014|365142028|FG000|Safety Follow-up|Withdrawal by Subject|9|||
105860969|NCT02861014|365142028|FG000|Safety Follow-up|Study terminated by sponsor|1|||
105860970|NCT02861014|365142028|FG000|Safety Follow-up|Physician Decision|1|||
106039909|NCT00973349|365810912|FG010|Overall Study|Withdrawal by Subject|0|||
106039910|NCT00973349|365810913|FG011|Overall Study|Withdrawal by Subject|1|||
106039911|NCT00973349|365810914|FG012|Overall Study|Withdrawal by Subject|0|||
106039912|NCT00973349|365810915|FG013|Overall Study|Withdrawal by Subject|0|||
106039913|NCT00973349|365810916|FG014|Overall Study|Withdrawal by Subject|0|||
106039914|NCT00973349|365810917|FG015|Overall Study|Withdrawal by Subject|0|||
106039915|NCT00973349|365810902|FG000|Overall Study|Lost to Follow-up|3|||
106039916|NCT00973349|365810903|FG001|Overall Study|Lost to Follow-up|1|||
106039917|NCT00973349|365810904|FG002|Overall Study|Lost to Follow-up|2|||
106039918|NCT00973349|365810905|FG003|Overall Study|Lost to Follow-up|2|||
106039919|NCT00973349|365810906|FG004|Overall Study|Lost to Follow-up|1|||
106039920|NCT00973349|365810907|FG005|Overall Study|Lost to Follow-up|3|||
106039921|NCT00973349|365810908|FG006|Overall Study|Lost to Follow-up|0|||
106039922|NCT00973349|365810909|FG007|Overall Study|Lost to Follow-up|1|||
106039923|NCT00973349|365810910|FG008|Overall Study|Lost to Follow-up|2|||
106039924|NCT00973349|365810911|FG009|Overall Study|Lost to Follow-up|1|||
106039925|NCT00973349|365810912|FG010|Overall Study|Lost to Follow-up|0|||
106039926|NCT00973349|365810913|FG011|Overall Study|Lost to Follow-up|1|||
106039927|NCT00973349|365810914|FG012|Overall Study|Lost to Follow-up|0|||
106039928|NCT00973349|365810915|FG013|Overall Study|Lost to Follow-up|0|||
106039929|NCT00973349|365810916|FG014|Overall Study|Lost to Follow-up|0|||
106039930|NCT00973349|365810917|FG015|Overall Study|Lost to Follow-up|1|||
105860971|NCT02861014|365142028|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
105860972|NCT02861014|365142028|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
105860973|NCT04058067|365142029|FG000|Overall Study|Adverse Event|2|||
105860974|NCT04058067|365142030|FG001|Overall Study|Adverse Event|0|||
105860975|NCT04058067|365142029|FG000|Overall Study|Death|0|||
105860976|NCT04058067|365142030|FG001|Overall Study|Death|1|||
105860977|NCT04058067|365142029|FG000|Overall Study|Physician Decision|3|||
106039931|NCT00973349|365810902|FG000|Overall Study|Inappropriate enrolment|0|||
105860978|NCT04058067|365142030|FG001|Overall Study|Physician Decision|1|||
105860979|NCT04058067|365142029|FG000|Overall Study|Protocol Violation|0|||
105860980|NCT04058067|365142030|FG001|Overall Study|Protocol Violation|1|||
105860981|NCT04058067|365142029|FG000|Overall Study|Withdrawal by Subject|7|||
106039932|NCT00973349|365810903|FG001|Overall Study|Inappropriate enrolment|0|||
106039933|NCT00973349|365810904|FG002|Overall Study|Inappropriate enrolment|1|||
106039934|NCT00973349|365810905|FG003|Overall Study|Inappropriate enrolment|0|||
106151733|NCT02590432|366215135|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
105860982|NCT04058067|365142030|FG001|Overall Study|Withdrawal by Subject|8|||
105860983|NCT00417170|365142031|FG000|Overall Study|Adverse Event|1|||
105860984|NCT00417170|365142032|FG001|Overall Study|Adverse Event|1|||
105860985|NCT00417170|365142031|FG000|Overall Study|Withdrawal by Subject|1|||
105860986|NCT00417170|365142032|FG001|Overall Study|Withdrawal by Subject|1|||
105860987|NCT00417170|365142031|FG000|Overall Study|Lost to Follow-up|0|||
105860988|NCT00417170|365142032|FG001|Overall Study|Lost to Follow-up|1|||
105860989|NCT05005312|365142033|FG000|Overall Study|Enrolled, but not treated|0|||
105860990|NCT05005312|365142034|FG001|Overall Study|Enrolled, but not treated|1|||
105860991|NCT00851318|365142035|FG000|Overall Study|Withdrawal by Subject|7|||
105860992|NCT00851318|365142036|FG001|Overall Study|Withdrawal by Subject|1|||
105860993|NCT00851318|365142037|FG002|Overall Study|Withdrawal by Subject|5|||
105860994|NCT00851318|365142038|FG003|Overall Study|Withdrawal by Subject|3|||
105860995|NCT00851318|365142035|FG000|Overall Study|Adverse Event|13|||
105860996|NCT00851318|365142036|FG001|Overall Study|Adverse Event|2|||
105860997|NCT00851318|365142037|FG002|Overall Study|Adverse Event|9|||
105860998|NCT00851318|365142038|FG003|Overall Study|Adverse Event|12|||
105860999|NCT00851318|365142035|FG000|Overall Study|Pregnancy|0|||
105861000|NCT00851318|365142036|FG001|Overall Study|Pregnancy|0|||
105861001|NCT00851318|365142037|FG002|Overall Study|Pregnancy|1|||
105861002|NCT00851318|365142038|FG003|Overall Study|Pregnancy|1|||
105861003|NCT00851318|365142035|FG000|Overall Study|Lack of Efficacy|8|||
105861004|NCT00851318|365142036|FG001|Overall Study|Lack of Efficacy|2|||
105861005|NCT00851318|365142037|FG002|Overall Study|Lack of Efficacy|4|||
105861006|NCT00851318|365142038|FG003|Overall Study|Lack of Efficacy|2|||
105861007|NCT00851318|365142035|FG000|Overall Study|Non-compliance with Study Procedures|2|||
105861008|NCT00851318|365142036|FG001|Overall Study|Non-compliance with Study Procedures|0|||
105861009|NCT00851318|365142037|FG002|Overall Study|Non-compliance with Study Procedures|1|||
105861010|NCT00851318|365142038|FG003|Overall Study|Non-compliance with Study Procedures|0|||
105861011|NCT00851318|365142035|FG000|Overall Study|Physician Decision|0|||
105861012|NCT00851318|365142036|FG001|Overall Study|Physician Decision|0|||
105861013|NCT00851318|365142037|FG002|Overall Study|Physician Decision|1|||
105861014|NCT00851318|365142038|FG003|Overall Study|Physician Decision|1|||
105861015|NCT01001988|365142045|FG000|Overall Study|Protocol Violation|84|||
105861016|NCT01001988|365142045|FG000|Overall Study|Withdrawal by Subject|18|||
105861017|NCT01001988|365142045|FG000|Overall Study|Lost to Follow-up|15|||
105861018|NCT01756079|365142055|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
105861019|NCT01756079|365142055|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
106039935|NCT00973349|365810906|FG004|Overall Study|Inappropriate enrolment|0|||
106039936|NCT00973349|365810907|FG005|Overall Study|Inappropriate enrolment|0|||
106039937|NCT00973349|365810908|FG006|Overall Study|Inappropriate enrolment|0|||
106039938|NCT00973349|365810909|FG007|Overall Study|Inappropriate enrolment|0|||
106039939|NCT00973349|365810910|FG008|Overall Study|Inappropriate enrolment|0|||
106039940|NCT00973349|365810911|FG009|Overall Study|Inappropriate enrolment|2|||
106039941|NCT00973349|365810912|FG010|Overall Study|Inappropriate enrolment|0|||
106039942|NCT00973349|365810913|FG011|Overall Study|Inappropriate enrolment|0|||
106039943|NCT00973349|365810914|FG012|Overall Study|Inappropriate enrolment|1|||
106039944|NCT00973349|365810915|FG013|Overall Study|Inappropriate enrolment|0|||
106039945|NCT00973349|365810916|FG014|Overall Study|Inappropriate enrolment|1|||
106039946|NCT00973349|365810917|FG015|Overall Study|Inappropriate enrolment|1|||
105861020|NCT01756079|365142055|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
105861021|NCT01756079|365142055|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
105861022|NCT01756079|365142055|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
105861023|NCT03207243|365142058|FG000|Overall Study|Adverse Event|2|||
105861024|NCT03207243|365142059|FG001|Overall Study|Adverse Event|2|||
105861025|NCT03207243|365142058|FG000|Overall Study|Loss of Asthma Control|47|||
105861026|NCT03207243|365142059|FG001|Overall Study|Loss of Asthma Control|31|||
105861027|NCT03207243|365142058|FG000|Overall Study|Withdrawal by Subject|2|||
105861028|NCT03207243|365142059|FG001|Overall Study|Withdrawal by Subject|4|||
105861029|NCT03207243|365142058|FG000|Overall Study|Physician Decision|1|||
105861030|NCT03207243|365142059|FG001|Overall Study|Physician Decision|1|||
105861031|NCT03207243|365142058|FG000|Overall Study|Lost to Follow-up|0|||
105861032|NCT03207243|365142059|FG001|Overall Study|Lost to Follow-up|1|||
105861033|NCT03207243|365142058|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
105861034|NCT03207243|365142059|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
105861035|NCT03207243|365142058|FG000|Overall Study|Protocol Violation|0|||
105861036|NCT03207243|365142059|FG001|Overall Study|Protocol Violation|3|||
105861037|NCT02552303|365142066|FG000|Allocation|Withdrawal by Subject|2|||
105861038|NCT02552303|365142067|FG001|Allocation|Withdrawal by Subject|1|||
105861039|NCT02552303|365142068|FG002|Allocation|Withdrawal by Subject|1|||
105861040|NCT02552303|365142069|FG003|Allocation|Withdrawal by Subject|1|||
106039947|NCT00973349|365810902|FG000|Overall Study|Protocol Violation|0|||
106039948|NCT00973349|365810903|FG001|Overall Study|Protocol Violation|0|||
105861041|NCT02552303|365142066|FG000|Allocation|ineligible|1|||
105861042|NCT02552303|365142067|FG001|Allocation|ineligible|1|||
105861043|NCT02552303|365142068|FG002|Allocation|ineligible|0|||
105861044|NCT02552303|365142069|FG003|Allocation|ineligible|0|||
105861045|NCT02552303|365142066|FG000|Follow-Up|Lost to Follow-up|0|||
105861046|NCT02552303|365142067|FG001|Follow-Up|Lost to Follow-up|0|||
105861047|NCT02552303|365142068|FG002|Follow-Up|Lost to Follow-up|1|||
105861048|NCT02552303|365142069|FG003|Follow-Up|Lost to Follow-up|0|||
105861049|NCT02552303|365142066|FG000|Follow-Up|ineligible|0|||
105861050|NCT02552303|365142067|FG001|Follow-Up|ineligible|2|||
105861051|NCT02552303|365142068|FG002|Follow-Up|ineligible|0|||
105861052|NCT02552303|365142069|FG003|Follow-Up|ineligible|0|||
105861053|NCT01377987|365142070|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
105861054|NCT01377987|365142071|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
105861055|NCT04015908|365142072|FG000|Overall Study|Lost to Follow-up|0|||
105861056|NCT04015908|365142073|FG001|Overall Study|Lost to Follow-up|1|||
105861057|NCT00856375|365142076|FG000|Overall Study|Other|0|||
105861058|NCT00856375|365142077|FG001|Overall Study|Other|1|||
105861059|NCT00856375|365142076|FG000|Overall Study|Death|32|||
105861060|NCT00856375|365142077|FG001|Overall Study|Death|30|||
105861061|NCT00856375|365142076|FG000|Overall Study|Sponsor Terminated Study|7|||
105861062|NCT00856375|365142077|FG001|Overall Study|Sponsor Terminated Study|7|||
105861063|NCT00856375|365142076|FG000|Overall Study|Withdrawal by Subject|2|||
105861064|NCT00856375|365142077|FG001|Overall Study|Withdrawal by Subject|1|||
105861065|NCT00856375|365142076|FG000|Overall Study|Lost to Follow-up|1|||
105861066|NCT00856375|365142077|FG001|Overall Study|Lost to Follow-up|2|||
105861067|NCT02227446|365142080|FG000|Overall Study|not eligible post randomization|18|||
105861068|NCT02227446|365142081|FG001|Overall Study|not eligible post randomization|29|||
105861069|NCT02227446|365142080|FG000|Overall Study|Withdrawal by Subject|4|||
105861070|NCT02227446|365142081|FG001|Overall Study|Withdrawal by Subject|5|||
105861071|NCT04623086|365142082|FG000|Overall Study|Withdrawal by Subject|0|||
105861072|NCT04623086|365142083|FG001|Overall Study|Withdrawal by Subject|0|||
105861073|NCT04623086|365142084|FG002|Overall Study|Withdrawal by Subject|10|||
105861074|NCT02538965|365142085|FG000|Treatment Period|Other = Death due to disease progression|1|||
105861075|NCT02538965|365142085|FG000|Treatment Period|Adverse Event|2|||
105861076|NCT02538965|365142085|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
105861077|NCT02538965|365142085|FG000|Treatment Period|Treatment Failure|9|||
105861078|NCT02538965|365142085|FG000|Treatment Period|Disease Progression|1|||
105861079|NCT02538965|365142085|FG000|Treatment Period|Physician Decision|2|||
105861080|NCT02538965|365142085|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
105861081|NCT02538965|365142085|FG000|Follow-Up Period|Withdrawal by Parent|4|||
105861082|NCT00875797|365142086|FG000|Overall Study|Protocol Violation|6|||
105861083|NCT00875797|365142087|FG001|Overall Study|Protocol Violation|3|||
105861084|NCT03016975|365142098|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
105861085|NCT03016975|365142099|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
105861086|NCT03016975|365142100|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
105861087|NCT03016975|365142098|FG000|At 6 Months Follow-up|Death|2|||
105861088|NCT03016975|365142099|FG001|At 6 Months Follow-up|Death|0|||
105861089|NCT03016975|365142100|FG002|At 6 Months Follow-up|Death|0|||
105861090|NCT03016975|365142098|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
105861091|NCT03016975|365142099|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
105861092|NCT03016975|365142100|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
105861093|NCT03016975|365142098|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
105861094|NCT03016975|365142099|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
105861095|NCT03016975|365142100|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
105861096|NCT03016975|365142098|FG000|At 6 Months Follow-up|Aborted implant|1|||
105861097|NCT03016975|365142099|FG001|At 6 Months Follow-up|Aborted implant|0|||
105861098|NCT03016975|365142100|FG002|At 6 Months Follow-up|Aborted implant|0|||
105861099|NCT03016975|365142098|FG000|At 2 Year Follow-up|Death|1|||
105861100|NCT03016975|365142099|FG001|At 2 Year Follow-up|Death|0|||
105861101|NCT03016975|365142100|FG002|At 2 Year Follow-up|Death|0|||
106151734|NCT02590432|366215136|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
106151735|NCT02590432|366215137|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
106151736|NCT02590432|366215138|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
106151737|NCT02590432|366215139|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
106151738|NCT02590432|366215140|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
105861102|NCT03016975|365142098|FG000|At 3 Year Follow-up|Death|1|||
105861103|NCT03016975|365142099|FG001|At 3 Year Follow-up|Death|0|||
105861104|NCT03016975|365142100|FG002|At 3 Year Follow-up|Death|0|||
105861105|NCT03016975|365142098|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
105861106|NCT03016975|365142099|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
105861107|NCT03016975|365142100|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
105861108|NCT03016975|365142098|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
105861109|NCT03016975|365142099|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
105861110|NCT03016975|365142100|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
105861111|NCT01590797|365142101|FG000|Overall Study|Adverse Event|4|||
105861112|NCT01590797|365142102|FG001|Overall Study|Adverse Event|3|||
105861113|NCT01590797|365142101|FG000|Overall Study|Lack of Efficacy|0|||
105861114|NCT01590797|365142102|FG001|Overall Study|Lack of Efficacy|2|||
105861115|NCT01590797|365142101|FG000|Overall Study|Lost to Follow-up|0|||
106039949|NCT00973349|365810904|FG002|Overall Study|Protocol Violation|0|||
106039950|NCT00973349|365810905|FG003|Overall Study|Protocol Violation|0|||
106039951|NCT00973349|365810906|FG004|Overall Study|Protocol Violation|0|||
106039952|NCT00973349|365810907|FG005|Overall Study|Protocol Violation|0|||
106039953|NCT00973349|365810908|FG006|Overall Study|Protocol Violation|0|||
106039954|NCT00973349|365810909|FG007|Overall Study|Protocol Violation|0|||
106039955|NCT00973349|365810910|FG008|Overall Study|Protocol Violation|1|||
106039956|NCT00973349|365810911|FG009|Overall Study|Protocol Violation|0|||
106039957|NCT00973349|365810912|FG010|Overall Study|Protocol Violation|0|||
106039958|NCT00973349|365810913|FG011|Overall Study|Protocol Violation|0|||
106039959|NCT00973349|365810914|FG012|Overall Study|Protocol Violation|0|||
106039960|NCT00973349|365810915|FG013|Overall Study|Protocol Violation|0|||
106039961|NCT00973349|365810916|FG014|Overall Study|Protocol Violation|0|||
106039962|NCT00973349|365810917|FG015|Overall Study|Protocol Violation|0|||
106039963|NCT00973349|365810902|FG000|Overall Study|Unable to classify|0|||
106039964|NCT00973349|365810903|FG001|Overall Study|Unable to classify|0|||
106039965|NCT00973349|365810904|FG002|Overall Study|Unable to classify|0|||
106039966|NCT00973349|365810905|FG003|Overall Study|Unable to classify|0|||
106039967|NCT00973349|365810906|FG004|Overall Study|Unable to classify|1|||
106039968|NCT00973349|365810907|FG005|Overall Study|Unable to classify|1|||
106039969|NCT00973349|365810908|FG006|Overall Study|Unable to classify|0|||
106039970|NCT00973349|365810909|FG007|Overall Study|Unable to classify|0|||
106039971|NCT00973349|365810910|FG008|Overall Study|Unable to classify|0|||
106039972|NCT00973349|365810911|FG009|Overall Study|Unable to classify|1|||
106039973|NCT00973349|365810912|FG010|Overall Study|Unable to classify|0|||
106039974|NCT00973349|365810913|FG011|Overall Study|Unable to classify|0|||
106039975|NCT00973349|365810914|FG012|Overall Study|Unable to classify|0|||
106039976|NCT00973349|365810915|FG013|Overall Study|Unable to classify|0|||
106039977|NCT00973349|365810916|FG014|Overall Study|Unable to classify|0|||
106039978|NCT00973349|365810917|FG015|Overall Study|Unable to classify|0|||
106039979|NCT02734433|365810919|FG000|Overall Study|Disease progression|1|||
106039980|NCT02734433|365810920|FG001|Overall Study|Disease progression|5|||
106039981|NCT02734433|365810919|FG000|Overall Study|Clinical progression|0|||
106039982|NCT02734433|365810920|FG001|Overall Study|Clinical progression|1|||
106039983|NCT02734433|365810919|FG000|Overall Study|Withdrawal by Subject|1|||
106039984|NCT02734433|365810920|FG001|Overall Study|Withdrawal by Subject|2|||
106039985|NCT02750943|365810921|FG000|Overall Study|Lost to Follow-up|1|||
106039986|NCT02750943|365810922|FG001|Overall Study|Lost to Follow-up|2|||
106039987|NCT02750943|365810921|FG000|Overall Study|Withdrawal by Subject|5|||
106039988|NCT02750943|365810922|FG001|Overall Study|Withdrawal by Subject|7|||
106039989|NCT00171054|365810923|FG000|Overall Study|Protocol Violation|1|||
106039990|NCT00171054|365810924|FG001|Overall Study|Protocol Violation|2|||
106039991|NCT00171054|365810923|FG000|Overall Study|Patient withdrew consent|1|||
106039992|NCT00171054|365810924|FG001|Overall Study|Patient withdrew consent|0|||
106039993|NCT00171054|365810923|FG000|Overall Study|Lost to Follow-up|0|||
106039994|NCT00171054|365810924|FG001|Overall Study|Lost to Follow-up|1|||
106039995|NCT00171054|365810923|FG000|Overall Study|Adverse Event|8|||
106039996|NCT00171054|365810924|FG001|Overall Study|Adverse Event|8|||
106039997|NCT00171054|365810923|FG000|Overall Study|Condition no longer required study drug|0|||
106039998|NCT00171054|365810924|FG001|Overall Study|Condition no longer required study drug|1|||
106039999|NCT05597020|365810929|FG000|Washout|Forbidden medication|2|||
106040000|NCT05597020|365810930|FG001|Washout|Forbidden medication|0|||
106040001|NCT05597020|365810929|FG000|Treatment Period II|Advice from primary care physician|1|||
106040002|NCT05597020|365810930|FG001|Treatment Period II|Advice from primary care physician|0|||
106040003|NCT05597020|365810929|FG000|Treatment Period II|Subject lost investigational product|1|||
106040004|NCT05597020|365810930|FG001|Treatment Period II|Subject lost investigational product|0|||
106040005|NCT05597020|365810929|FG000|Treatment Period II|Private reasons|0|||
106040006|NCT05597020|365810930|FG001|Treatment Period II|Private reasons|1|||
106040007|NCT02718300|365810933|FG000|Overall Study|Death|4|||
106040008|NCT02718300|365810934|FG001|Overall Study|Death|5|||
106040009|NCT02718300|365810935|FG002|Overall Study|Death|17|||
106040010|NCT02718300|365810933|FG000|Overall Study|Lost to Follow-up|1|||
106040011|NCT02718300|365810934|FG001|Overall Study|Lost to Follow-up|0|||
106040012|NCT02718300|365810935|FG002|Overall Study|Lost to Follow-up|2|||
106040013|NCT02718300|365810933|FG000|Overall Study|Physician Decision|1|||
106040014|NCT02718300|365810934|FG001|Overall Study|Physician Decision|0|||
106040015|NCT02718300|365810935|FG002|Overall Study|Physician Decision|2|||
106040016|NCT02718300|365810933|FG000|Overall Study|Study Terminated by Sponsor|6|||
106040017|NCT02718300|365810934|FG001|Overall Study|Study Terminated by Sponsor|3|||
106040018|NCT02718300|365810935|FG002|Overall Study|Study Terminated by Sponsor|4|||
106040019|NCT02718300|365810933|FG000|Overall Study|Withdrawal by Subject|0|||
106040020|NCT02718300|365810934|FG001|Overall Study|Withdrawal by Subject|4|||
106040021|NCT02718300|365810935|FG002|Overall Study|Withdrawal by Subject|3|||
106040022|NCT02718300|365810933|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
106040023|NCT02718300|365810934|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
106040024|NCT02718300|365810935|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
106040025|NCT01994590|365812587|FG000|Overall Study|Adverse Event|1|||
106040026|NCT01994590|365812587|FG000|Overall Study|Trial Terminated|1|||
106040027|NCT00510874|365812588|FG000|Overall Study|Withdrawal by Subject|1|||
106040028|NCT00510874|365812589|FG001|Overall Study|Withdrawal by Subject|1|||
106040029|NCT00510874|365812590|FG002|Overall Study|Withdrawal by Subject|0|||
106040030|NCT00510874|365812591|FG003|Overall Study|Withdrawal by Subject|0|||
106040031|NCT00510874|365812592|FG004|Overall Study|Withdrawal by Subject|3|||
106040032|NCT00510874|365812593|FG005|Overall Study|Withdrawal by Subject|0|||
106040033|NCT00510874|365812594|FG006|Overall Study|Withdrawal by Subject|0|||
106040034|NCT00510874|365812588|FG000|Overall Study|Lost to Follow-up|2|||
106040035|NCT00510874|365812589|FG001|Overall Study|Lost to Follow-up|3|||
106040036|NCT00510874|365812590|FG002|Overall Study|Lost to Follow-up|1|||
106040037|NCT00510874|365812591|FG003|Overall Study|Lost to Follow-up|3|||
106040038|NCT00510874|365812592|FG004|Overall Study|Lost to Follow-up|4|||
106040039|NCT00510874|365812593|FG005|Overall Study|Lost to Follow-up|0|||
106040040|NCT00510874|365812594|FG006|Overall Study|Lost to Follow-up|1|||
106040041|NCT01739400|365812595|FG000|Overall Study|Physician Decision|3|||
106040042|NCT01739400|365812596|FG001|Overall Study|Physician Decision|0|||
106040043|NCT01739400|365812595|FG000|Overall Study|Lost to Follow-up|2|||
106040044|NCT01739400|365812596|FG001|Overall Study|Lost to Follow-up|0|||
106040045|NCT01739400|365812595|FG000|Overall Study|Death|5|||
106040046|NCT01739400|365812596|FG001|Overall Study|Death|2|||
106040047|NCT01739400|365812595|FG000|Overall Study|Withdrawal by Subject|7|||
106040048|NCT01739400|365812596|FG001|Overall Study|Withdrawal by Subject|7|||
106040049|NCT01347307|365812599|FG000|Overall Study|Death|0|||
106040050|NCT01347307|365812600|FG001|Overall Study|Death|4|||
106040051|NCT01347307|365812599|FG000|Overall Study|Physician Decision|0|||
106040052|NCT01347307|365812600|FG001|Overall Study|Physician Decision|1|||
106040053|NCT02237911|365812605|FG000|Overall Study|Withdrawal by Subject|4|||
106040054|NCT02237911|365812606|FG001|Overall Study|Withdrawal by Subject|7|||
106040055|NCT02237911|365812607|FG002|Overall Study|Withdrawal by Subject|2|||
106040056|NCT02237911|365812605|FG000|Overall Study|Lost to Follow-up|3|||
106040057|NCT02237911|365812606|FG001|Overall Study|Lost to Follow-up|1|||
106040058|NCT02237911|365812607|FG002|Overall Study|Lost to Follow-up|1|||
106040059|NCT00053365|365812608|FG000|Overall Study|Incorrect cell type|1|||
106040060|NCT00053365|365812608|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
106040061|NCT00053365|365812608|FG000|Overall Study|Never treated|4|||
106040062|NCT00958789|365812609|FG000|Overall Study|Death|5|||
106040063|NCT00958789|365812609|FG000|Overall Study|Lost to Follow-up|14|||
106040064|NCT00958789|365812609|FG000|Overall Study|Withdrawal by Subject|17|||
106040065|NCT00958789|365812609|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
106040066|NCT00958789|365812609|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
106040067|NCT00958789|365812609|FG000|Overall Study|Subject terminated|2|||
106040068|NCT00958789|365812609|FG000|Overall Study|Revision|7|||
106040069|NCT00478881|365812610|FG000|Overall Study|Adverse Event|31|||
106040070|NCT00478881|365812611|FG001|Overall Study|Adverse Event|12|||
106040071|NCT00478881|365812610|FG000|Overall Study|Lack of Efficacy|0|||
106040072|NCT00478881|365812611|FG001|Overall Study|Lack of Efficacy|3|||
106040073|NCT00478881|365812610|FG000|Overall Study|Lost to Follow-up|0|||
106040074|NCT00478881|365812611|FG001|Overall Study|Lost to Follow-up|1|||
106040075|NCT00478881|365812610|FG000|Overall Study|Protocol Violation|2|||
106040076|NCT00478881|365812611|FG001|Overall Study|Protocol Violation|2|||
106040077|NCT00478881|365812610|FG000|Overall Study|Withdrawal by Subject|6|||
106040078|NCT00478881|365812611|FG001|Overall Study|Withdrawal by Subject|2|||
106040079|NCT00478881|365812610|FG000|Overall Study|Non-Compliance with Study Medication|0|||
106040080|NCT00478881|365812611|FG001|Overall Study|Non-Compliance with Study Medication|2|||
106040081|NCT00721123|365812612|FG000|Overall Study|Adverse Event|96|||
106040082|NCT00721123|365812612|FG000|Overall Study|Death|10|||
106040083|NCT00721123|365812612|FG000|Overall Study|Insufficient Therapeutic Response|21|||
106040084|NCT00721123|365812612|FG000|Overall Study|Protocol Violation|1|||
106040085|NCT00721123|365812612|FG000|Overall Study|Refused Treatment|41|||
106040086|NCT00721123|365812612|FG000|Overall Study|Failure to Return|9|||
106040087|NCT00721123|365812612|FG000|Overall Study|Withdrawal by Subject|5|||
106151739|NCT02590432|366215132|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
105861116|NCT01590797|365142102|FG001|Overall Study|Lost to Follow-up|1|||
106040088|NCT03954041|365812616|FG000|Overall Study|Lost to Follow-up|3|||
106040089|NCT03954041|365812617|FG001|Overall Study|Lost to Follow-up|3|||
106040090|NCT03954041|365812618|FG002|Overall Study|Lost to Follow-up|6|||
106040091|NCT03954041|365812616|FG000|Overall Study|Death|4|||
106040092|NCT03954041|365812617|FG001|Overall Study|Death|0|||
106040093|NCT03954041|365812618|FG002|Overall Study|Death|1|||
106040094|NCT03954041|365812616|FG000|Overall Study|Death by neurologic criteria|0|||
106040095|NCT03954041|365812617|FG001|Overall Study|Death by neurologic criteria|0|||
106040096|NCT03954041|365812618|FG002|Overall Study|Death by neurologic criteria|1|||
106040097|NCT03954041|365812616|FG000|Overall Study|Reason not specified|7|||
106040098|NCT03954041|365812617|FG001|Overall Study|Reason not specified|4|||
106040099|NCT03954041|365812618|FG002|Overall Study|Reason not specified|2|||
106040100|NCT03954041|365812616|FG000|Overall Study|Withdrew prior to dosing|4|||
106040101|NCT03954041|365812617|FG001|Overall Study|Withdrew prior to dosing|2|||
106040102|NCT03954041|365812618|FG002|Overall Study|Withdrew prior to dosing|0|||
106040103|NCT03468985|365812619|FG000|Overall Study|Adverse Event|0|||
106040104|NCT03468985|365812620|FG001|Overall Study|Adverse Event|2|||
106040105|NCT03468985|365812621|FG002|Overall Study|Adverse Event|0|||
106040106|NCT03468985|365812622|FG003|Overall Study|Adverse Event|0|||
106040107|NCT03468985|365812619|FG000|Overall Study|Withdrawal by Subject|0|||
106040108|NCT03468985|365812620|FG001|Overall Study|Withdrawal by Subject|0|||
106040109|NCT03468985|365812621|FG002|Overall Study|Withdrawal by Subject|0|||
106040110|NCT03468985|365812622|FG003|Overall Study|Withdrawal by Subject|1|||
106040111|NCT01315236|365812623|FG000|Double-blind Phase|Death|1|||
106040112|NCT01315236|365812624|FG001|Double-blind Phase|Death|0|||
106040113|NCT01315236|365812623|FG000|Double-blind Phase|Adverse Event|1|||
106040114|NCT01315236|365812624|FG001|Double-blind Phase|Adverse Event|0|||
106040115|NCT01315236|365812623|FG000|Double-blind Phase|Withdrawal of Consent|1|||
106040116|NCT01315236|365812624|FG001|Double-blind Phase|Withdrawal of Consent|0|||
106040117|NCT01315236|365812623|FG000|Double-blind Phase|Lost to Follow-up|1|||
106040118|NCT01315236|365812624|FG001|Double-blind Phase|Lost to Follow-up|0|||
106040119|NCT01315236|365812623|FG000|Open-label Phase|Death|1|||
106040120|NCT01315236|365812624|FG001|Open-label Phase|Death|0|||
106040121|NCT01315236|365812623|FG000|Open-label Phase|Adverse Event|0|||
105861117|NCT01590797|365142101|FG000|Overall Study|Protocol Violation|4|||
105861118|NCT01590797|365142102|FG001|Overall Study|Protocol Violation|1|||
105861119|NCT01590797|365142101|FG000|Overall Study|Withdrawal by Subject|7|||
105861120|NCT01590797|365142102|FG001|Overall Study|Withdrawal by Subject|5|||
105861121|NCT01590797|365142101|FG000|Overall Study|Other Protocol Specified Criteria|2|||
105861122|NCT01590797|365142102|FG001|Overall Study|Other Protocol Specified Criteria|4|||
105861123|NCT00901576|365142108|FG000|Second Intervention|Withdrawal by Subject|0|||
105861124|NCT00901576|365142109|FG001|Second Intervention|Withdrawal by Subject|0|||
105861125|NCT00901576|365142110|FG002|Second Intervention|Withdrawal by Subject|0|||
105861126|NCT00901576|365142111|FG003|Second Intervention|Withdrawal by Subject|1|||
105861127|NCT00901576|365142112|FG004|Second Intervention|Withdrawal by Subject|0|||
105861128|NCT00901576|365142113|FG005|Second Intervention|Withdrawal by Subject|1|||
105861129|NCT00901576|365142108|FG000|Second Intervention|Physician Decision|1|||
105861130|NCT00901576|365142109|FG001|Second Intervention|Physician Decision|0|||
105861131|NCT00901576|365142110|FG002|Second Intervention|Physician Decision|0|||
105861132|NCT00901576|365142111|FG003|Second Intervention|Physician Decision|0|||
105861133|NCT00901576|365142112|FG004|Second Intervention|Physician Decision|0|||
105861134|NCT00901576|365142113|FG005|Second Intervention|Physician Decision|0|||
105861135|NCT01559389|365142114|FG000|Overall Study|Withdrawal by Subject|20|||
105861136|NCT01559389|365142115|FG001|Overall Study|Withdrawal by Subject|20|||
105861137|NCT02252406|365142116|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
105861138|NCT02252406|365142117|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
105861139|NCT02252406|365142116|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
105861140|NCT02252406|365142117|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
105861141|NCT02252406|365142116|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
105861142|NCT02252406|365142117|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
106040122|NCT01315236|365812624|FG001|Open-label Phase|Adverse Event|1|||
106040123|NCT01315236|365812623|FG000|Open-label Phase|Other|0|||
105861143|NCT02252406|365142116|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
105861144|NCT02252406|365142117|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
105861145|NCT02252406|365142116|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
105861146|NCT02252406|365142117|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
105861147|NCT01696279|365142120|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
106040124|NCT01315236|365812624|FG001|Open-label Phase|Other|1|||
106040125|NCT01315236|365812623|FG000|12-Month Follow-up Period|Death|0|||
106040126|NCT01315236|365812624|FG001|12-Month Follow-up Period|Death|1|||
106040127|NCT01315236|365812623|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
106040128|NCT01315236|365812624|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
106040129|NCT00057954|365812625|FG000|Overall Study|Death|1|||
106040130|NCT00057954|365812625|FG000|Overall Study|Disease progression|1|||
106040131|NCT02147184|365812630|FG000|Overall Study|Lost to Follow-up|28|||
106040132|NCT02147184|365812631|FG001|Overall Study|Lost to Follow-up|15|||
106040133|NCT02147184|365812630|FG000|Overall Study|Study Burden|11|||
106040134|NCT02147184|365812631|FG001|Overall Study|Study Burden|7|||
106040135|NCT02147184|365812630|FG000|Overall Study|Pregnancy|6|||
106040136|NCT02147184|365812631|FG001|Overall Study|Pregnancy|0|||
106040137|NCT02147184|365812630|FG000|Overall Study|Moved out of state|3|||
106040138|NCT02147184|365812631|FG001|Overall Study|Moved out of state|3|||
106040139|NCT02147184|365812630|FG000|Overall Study|Physician Decision|0|||
105861148|NCT01696279|365142121|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
105861149|NCT01696279|365142122|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
105861150|NCT01696279|365142123|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
105861151|NCT01696279|365142120|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
105861152|NCT01696279|365142121|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
105861153|NCT01696279|365142122|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
105861154|NCT01696279|365142123|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
105861155|NCT01696279|365142120|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
105861156|NCT01696279|365142121|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
105861157|NCT01696279|365142122|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
105861158|NCT01696279|365142123|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
105861159|NCT01696279|365142120|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
105861160|NCT01696279|365142121|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
105861161|NCT01696279|365142122|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
105861162|NCT01696279|365142123|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
105861163|NCT01696279|365142120|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
105861164|NCT01696279|365142121|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
105861165|NCT01696279|365142122|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
105861166|NCT01696279|365142123|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
105861167|NCT01696279|365142120|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
105861168|NCT01696279|365142121|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
105861169|NCT01696279|365142122|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
105861170|NCT01696279|365142123|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
105861171|NCT01696279|365142120|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
105861172|NCT01696279|365142121|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
105861173|NCT01696279|365142122|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
105861174|NCT01696279|365142123|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
105861175|NCT01696279|365142120|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
105861176|NCT01696279|365142121|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
105861177|NCT01696279|365142122|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
105861178|NCT01696279|365142123|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
105861179|NCT01696279|365142120|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
105861180|NCT01696279|365142121|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
105861181|NCT01696279|365142122|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
105861182|NCT01696279|365142123|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
105861183|NCT01696279|365142120|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
105861184|NCT01696279|365142121|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
105861185|NCT01696279|365142122|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
105861186|NCT01696279|365142123|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
105861187|NCT01696279|365142120|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
105861188|NCT01696279|365142121|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
105861189|NCT01696279|365142122|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
105861190|NCT01696279|365142123|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
105861191|NCT00396812|365142124|FG000|Overall Study|Physician Decision|1|||
105861192|NCT03796039|365142126|FG000|Overall Study|Death|2|||
106040140|NCT02147184|365812631|FG001|Overall Study|Physician Decision|2|||
106040141|NCT02147184|365812630|FG000|Overall Study|Other|1|||
106040142|NCT02147184|365812631|FG001|Overall Study|Other|0|||
106040143|NCT03595774|365812633|FG000|Overall Study|Adverse Event|1|||
106040144|NCT03595774|365812634|FG001|Overall Study|Adverse Event|0|||
106040145|NCT03595774|365812635|FG002|Overall Study|Adverse Event|1|||
106040146|NCT03595774|365812636|FG003|Overall Study|Adverse Event|0|||
106040147|NCT03595774|365812633|FG000|Overall Study|screen failure|0|||
106040148|NCT03595774|365812634|FG001|Overall Study|screen failure|1|||
106040149|NCT03595774|365812635|FG002|Overall Study|screen failure|0|||
106040150|NCT03595774|365812636|FG003|Overall Study|screen failure|1|||
106040151|NCT00751621|365812637|FG000|Overall Study|Adverse Event|1|||
106040152|NCT00751621|365812637|FG000|Overall Study|Withdrawal by Subject|1|||
106040153|NCT00751621|365812637|FG000|Overall Study|Subject moved to another country|1|||
105861193|NCT03796039|365142127|FG001|Overall Study|Death|1|||
105861194|NCT03796039|365142126|FG000|Overall Study|Withdrawal by Subject|7|||
105861195|NCT03796039|365142127|FG001|Overall Study|Withdrawal by Subject|4|||
105861196|NCT02910063|365142130|FG000|Phase 2|Withdrawal by Subject|3|||
105861197|NCT02910063|365142131|FG001|Phase 2|Withdrawal by Subject|0|||
105861198|NCT02910063|365142132|FG002|Phase 2|Withdrawal by Subject|0|||
105861199|NCT02910063|365142130|FG000|Phase 2|Lost to Follow-up|1|||
105861200|NCT02910063|365142131|FG001|Phase 2|Lost to Follow-up|0|||
105861201|NCT02910063|365142132|FG002|Phase 2|Lost to Follow-up|0|||
105861202|NCT02910063|365142130|FG000|Phase 2|Death|24|||
105861203|NCT02910063|365142131|FG001|Phase 2|Death|0|||
105861204|NCT02910063|365142132|FG002|Phase 2|Death|0|||
105861205|NCT04693416|365142133|FG000|Overall Study|Lost to Follow-up|13|||
105861206|NCT04693416|365142134|FG001|Overall Study|Lost to Follow-up|0|||
105861207|NCT00369317|365142135|FG000|Overall Study|Adverse Event|3|||
105861208|NCT00369317|365142135|FG000|Overall Study|Death|1|||
105861209|NCT00369317|365142135|FG000|Overall Study|Lack of Efficacy|5|||
105861210|NCT00369317|365142135|FG000|Overall Study|Physician Decision|2|||
105861211|NCT00369317|365142135|FG000|Overall Study|Withdrawal by Subject|8|||
105861212|NCT00369317|365142135|FG000|Overall Study|Ineligible|1|||
105861213|NCT01104792|365142149|FG000|Overall Study|Adverse Event|77|||
105861214|NCT01104792|365142149|FG000|Overall Study|Insufficient Therapeutic Response|22|||
105861215|NCT01104792|365142149|FG000|Overall Study|Protocol Violation|45|||
105861216|NCT01104792|365142149|FG000|Overall Study|Withdrawal of Consent|179|||
105861217|NCT01104792|365142149|FG000|Overall Study|Lost to Follow-up|43|||
105861218|NCT01104792|365142149|FG000|Overall Study|Reasons Not Specified|27|||
105861219|NCT01104792|365142149|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
105861220|NCT02071849|365142150|FG000|6-month Primary Endpoint|Did not receive device|4|||
105861221|NCT02071849|365142150|FG000|6-month Primary Endpoint|Adverse Event|1|||
105861222|NCT02071849|365142150|FG000|2-year Extended Follow-up|Adverse Event|1|||
105861223|NCT05065567|365142151|FG000|Overall Study|Lost to Follow-up|10|||
105861224|NCT05065567|365142152|FG001|Overall Study|Lost to Follow-up|9|||
105861225|NCT05065567|365142153|FG002|Overall Study|Lost to Follow-up|6|||
105861226|NCT03510598|365143171|FG000|Overall Study|Withdrawal by Subject|1|||
105861227|NCT00359801|365143177|FG000|Overall Study|Lost to Follow-up|72|||
105861228|NCT00359801|365143178|FG001|Overall Study|Lost to Follow-up|58|||
105861229|NCT00359801|365143177|FG000|Overall Study|Withdrawal by Subject|143|||
105861230|NCT00359801|365143178|FG001|Overall Study|Withdrawal by Subject|96|||
105861231|NCT00359801|365143177|FG000|Overall Study|Other|66|||
105861232|NCT00359801|365143178|FG001|Overall Study|Other|46|||
105861233|NCT00359801|365143177|FG000|Overall Study|Final Status Unknown: missing data|7|||
105861234|NCT00359801|365143178|FG001|Overall Study|Final Status Unknown: missing data|4|||
105861235|NCT00359801|365143177|FG000|Overall Study|Sponsor Decision|17|||
105861236|NCT00359801|365143178|FG001|Overall Study|Sponsor Decision|16|||
105861237|NCT00754650|365143188|FG000|Overall Study|Disease Progression|2|||
105861238|NCT03323437|365143192|FG000|Overall Study|Withdrawal by Subject|0|||
105861239|NCT03323437|365143193|FG001|Overall Study|Withdrawal by Subject|4|||
105861240|NCT00605540|365143194|FG000|Overall Study|Death|15|||
105861241|NCT00605540|365143194|FG000|Overall Study|Lost to Follow-up|23|||
105861242|NCT00094861|365143197|FG000|Overall Study|Adverse Event|5|||
105861243|NCT00094861|365143198|FG001|Overall Study|Adverse Event|2|||
105861244|NCT00094861|365143197|FG000|Overall Study|Withdrawal by Subject|5|||
105861245|NCT00094861|365143198|FG001|Overall Study|Withdrawal by Subject|3|||
105861246|NCT00094861|365143197|FG000|Overall Study|Physician Decision|1|||
105861247|NCT00094861|365143198|FG001|Overall Study|Physician Decision|1|||
105861248|NCT00094861|365143197|FG000|Overall Study|Lost to Follow-up|0|||
105861249|NCT00094861|365143198|FG001|Overall Study|Lost to Follow-up|1|||
105861250|NCT00094861|365143197|FG000|Overall Study|Death|4|||
105861251|NCT00094861|365143198|FG001|Overall Study|Death|2|||
105861252|NCT00094861|365143197|FG000|Overall Study|Other|3|||
105861253|NCT00094861|365143198|FG001|Overall Study|Other|0|||
105861254|NCT02383810|365143200|FG000|Overall Study|Physician Decision|1|||
105861255|NCT02383810|365143201|FG001|Overall Study|Physician Decision|1|||
105861256|NCT02383810|365143202|FG002|Overall Study|Physician Decision|0|||
105861257|NCT02383810|365143203|FG003|Overall Study|Physician Decision|0|||
105861258|NCT02383810|365143204|FG004|Overall Study|Physician Decision|0|||
105861259|NCT02383810|365143205|FG005|Overall Study|Physician Decision|0|||
105861260|NCT02383810|365143206|FG006|Overall Study|Physician Decision|0|||
105861261|NCT02383810|365143207|FG007|Overall Study|Physician Decision|0|||
105861262|NCT02383810|365143200|FG000|Overall Study|Withdrawal by Subject|2|||
105861263|NCT02383810|365143201|FG001|Overall Study|Withdrawal by Subject|3|||
105861264|NCT02383810|365143202|FG002|Overall Study|Withdrawal by Subject|3|||
105861265|NCT02383810|365143203|FG003|Overall Study|Withdrawal by Subject|3|||
105861266|NCT02383810|365143204|FG004|Overall Study|Withdrawal by Subject|0|||
105861267|NCT02383810|365143205|FG005|Overall Study|Withdrawal by Subject|0|||
105861268|NCT02383810|365143206|FG006|Overall Study|Withdrawal by Subject|0|||
106040154|NCT00751621|365812637|FG000|Overall Study|Poor adherence to asthma treatment|1|||
106040155|NCT03343067|365812638|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
106040156|NCT03343067|365812639|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
106040157|NCT03343067|365812640|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
106040158|NCT00116168|365812641|FG000|Overall Study|Lost to Follow-up|6|||
106040159|NCT00116168|365812642|FG001|Overall Study|Lost to Follow-up|5|||
106040160|NCT00116168|365812643|FG002|Overall Study|Lost to Follow-up|0|||
106040161|NCT00116168|365812644|FG003|Overall Study|Lost to Follow-up|0|||
106040162|NCT00117286|365812645|FG000|Overall Study|Adverse Event|12|||
106040163|NCT00117286|365812646|FG001|Overall Study|Adverse Event|6|||
106040164|NCT00117286|365812645|FG000|Overall Study|Lost to Follow-up|2|||
106040165|NCT00117286|365812646|FG001|Overall Study|Lost to Follow-up|0|||
106040166|NCT00117286|365812645|FG000|Overall Study|Protocol Violation|3|||
106040167|NCT00117286|365812646|FG001|Overall Study|Protocol Violation|3|||
106040168|NCT00117286|365812645|FG000|Overall Study|Withdrawal by Subject|6|||
106040169|NCT00117286|365812646|FG001|Overall Study|Withdrawal by Subject|2|||
106040170|NCT00117286|365812645|FG000|Overall Study|Physician Decision|3|||
106040171|NCT00117286|365812646|FG001|Overall Study|Physician Decision|7|||
106040172|NCT00117286|365812645|FG000|Overall Study|Lack of Efficacy|2|||
106040173|NCT00117286|365812646|FG001|Overall Study|Lack of Efficacy|1|||
106040174|NCT00117286|365812645|FG000|Overall Study|Research site closing|0|||
106040175|NCT00117286|365812646|FG001|Overall Study|Research site closing|2|||
106040176|NCT00048061|365812648|FG000|Overall Study|Adverse Event|41|||
106040177|NCT00048061|365812649|FG001|Overall Study|Adverse Event|32|||
106040178|NCT00048061|365812650|FG002|Overall Study|Adverse Event|44|||
106040179|NCT00048061|365812651|FG003|Overall Study|Adverse Event|37|||
106040180|NCT00048061|365812648|FG000|Overall Study|Lost to Follow-up|3|||
106040181|NCT00048061|365812649|FG001|Overall Study|Lost to Follow-up|2|||
106040182|NCT00048061|365812650|FG002|Overall Study|Lost to Follow-up|4|||
106040183|NCT00048061|365812651|FG003|Overall Study|Lost to Follow-up|5|||
106040184|NCT00048061|365812648|FG000|Overall Study|Withdrawal by Subject|20|||
106040185|NCT00048061|365812649|FG001|Overall Study|Withdrawal by Subject|29|||
106040186|NCT00048061|365812650|FG002|Overall Study|Withdrawal by Subject|29|||
106040187|NCT00048061|365812651|FG003|Overall Study|Withdrawal by Subject|32|||
105861269|NCT02383810|365143207|FG007|Overall Study|Withdrawal by Subject|0|||
105861270|NCT02383810|365143200|FG000|Overall Study|Adverse Event|0|||
105861271|NCT02383810|365143201|FG001|Overall Study|Adverse Event|2|||
105861272|NCT02383810|365143202|FG002|Overall Study|Adverse Event|4|||
105861273|NCT02383810|365143203|FG003|Overall Study|Adverse Event|5|||
105861274|NCT02383810|365143204|FG004|Overall Study|Adverse Event|0|||
105861275|NCT02383810|365143205|FG005|Overall Study|Adverse Event|1|||
105861276|NCT02383810|365143206|FG006|Overall Study|Adverse Event|1|||
105861277|NCT02383810|365143207|FG007|Overall Study|Adverse Event|0|||
105861278|NCT02383810|365143200|FG000|Overall Study|Lost to Follow-up|0|||
105861279|NCT02383810|365143201|FG001|Overall Study|Lost to Follow-up|1|||
105861280|NCT02383810|365143202|FG002|Overall Study|Lost to Follow-up|0|||
105861281|NCT02383810|365143203|FG003|Overall Study|Lost to Follow-up|1|||
105861282|NCT02383810|365143204|FG004|Overall Study|Lost to Follow-up|0|||
105861283|NCT02383810|365143205|FG005|Overall Study|Lost to Follow-up|0|||
105861284|NCT02383810|365143206|FG006|Overall Study|Lost to Follow-up|0|||
105861285|NCT02383810|365143207|FG007|Overall Study|Lost to Follow-up|0|||
105861286|NCT02383810|365143200|FG000|Overall Study|other|0|||
105861287|NCT02383810|365143201|FG001|Overall Study|other|0|||
105861288|NCT02383810|365143202|FG002|Overall Study|other|0|||
105861289|NCT02383810|365143203|FG003|Overall Study|other|2|||
105861290|NCT02383810|365143204|FG004|Overall Study|other|0|||
105861291|NCT02383810|365143205|FG005|Overall Study|other|0|||
105861292|NCT02383810|365143206|FG006|Overall Study|other|0|||
105861293|NCT02383810|365143207|FG007|Overall Study|other|0|||
105861294|NCT02383810|365143200|FG000|Overall Study|subject did not receive study treatment|0|||
105861295|NCT02383810|365143201|FG001|Overall Study|subject did not receive study treatment|1|||
105861296|NCT02383810|365143202|FG002|Overall Study|subject did not receive study treatment|0|||
105861297|NCT02383810|365143203|FG003|Overall Study|subject did not receive study treatment|0|||
105861298|NCT02383810|365143204|FG004|Overall Study|subject did not receive study treatment|0|||
105861299|NCT02383810|365143205|FG005|Overall Study|subject did not receive study treatment|0|||
105861300|NCT02383810|365143206|FG006|Overall Study|subject did not receive study treatment|0|||
106040188|NCT00048061|365812648|FG000|Overall Study|Did not follow-up|5|||
106040189|NCT00048061|365812649|FG001|Overall Study|Did not follow-up|5|||
106040190|NCT00048061|365812650|FG002|Overall Study|Did not follow-up|4|||
106040191|NCT00048061|365812651|FG003|Overall Study|Did not follow-up|5|||
106040192|NCT00048061|365812648|FG000|Overall Study|Early improvement|6|||
106040193|NCT00048061|365812649|FG001|Overall Study|Early improvement|5|||
105861301|NCT02383810|365143207|FG007|Overall Study|subject did not receive study treatment|0|||
106040194|NCT00048061|365812650|FG002|Overall Study|Early improvement|3|||
106040195|NCT00048061|365812651|FG003|Overall Study|Early improvement|0|||
106040196|NCT03555435|365812652|FG000|Overall Study|Lost to Follow-up|17|||
106040197|NCT03555435|365812653|FG001|Overall Study|Lost to Follow-up|19|||
106040198|NCT03555435|365812654|FG002|Overall Study|Lost to Follow-up|8|||
106040199|NCT00943124|365812655|FG000|Period 1|Withdrawal by Subject|1|||
106040200|NCT00943124|365812656|FG001|Period 1|Withdrawal by Subject|1|||
106040201|NCT00943124|365812655|FG000|Period 1|Did Not Follow Study Procedures|1|||
106040202|NCT00943124|365812656|FG001|Period 1|Did Not Follow Study Procedures|0|||
106040203|NCT00943124|365812655|FG000|Period 1|Personal Reasons|0|||
106040204|NCT00943124|365812656|FG001|Period 1|Personal Reasons|1|||
106040205|NCT04010539|365812657|FG000|Overall Study|Withdrawal by Subject|4|||
106040206|NCT04010539|365812658|FG001|Overall Study|Withdrawal by Subject|1|||
106040207|NCT04010539|365812657|FG000|Overall Study|Physician Decision|0|||
106040208|NCT04010539|365812658|FG001|Overall Study|Physician Decision|2|||
106040209|NCT04010539|365812657|FG000|Overall Study|Lost to Follow-up|10|||
106040210|NCT04010539|365812658|FG001|Overall Study|Lost to Follow-up|14|||
106040211|NCT04010539|365812657|FG000|Overall Study|Adverse Event|3|||
106040212|NCT04010539|365812658|FG001|Overall Study|Adverse Event|0|||
106040213|NCT04010539|365812657|FG000|Overall Study|Participant Did Not Receive IP|0|||
106040214|NCT04010539|365812658|FG001|Overall Study|Participant Did Not Receive IP|1|||
106040215|NCT04010539|365812657|FG000|Overall Study|Protocol Deviation|0|||
106040216|NCT04010539|365812658|FG001|Overall Study|Protocol Deviation|1|||
106040217|NCT04010539|365812657|FG000|Overall Study|Randomized in Error/ Mistake|2|||
106040218|NCT04010539|365812658|FG001|Overall Study|Randomized in Error/ Mistake|0|||
106040219|NCT04010539|365812657|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
106040220|NCT04010539|365812658|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
106040221|NCT00249288|365812659|FG000|Overall Study|Lost to Follow-up|3|||
106040222|NCT00249288|365812660|FG001|Overall Study|Lost to Follow-up|3|||
106040223|NCT00249288|365812659|FG000|Overall Study|Withdrawal by Subject|2|||
106040224|NCT00249288|365812660|FG001|Overall Study|Withdrawal by Subject|2|||
106040225|NCT04025710|365812661|FG000|Overall Study|Death|3|||
106040226|NCT04025710|365812661|FG000|Overall Study|Lost to Follow-up|5|||
106040227|NCT04025710|365812661|FG000|Overall Study|Withdrawal by Subject|1|||
106040228|NCT04025710|365812661|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
106040229|NCT04025710|365812661|FG000|Overall Study|Drop-out according to protocol|34|||
106040230|NCT00381381|365812665|FG000|Overall Study|Adverse Event|3|||
106040231|NCT00381381|365812665|FG000|Overall Study|Lost to Follow-up|52|||
106040232|NCT00381381|365812665|FG000|Overall Study|Withdrawal by Subject|9|||
106040233|NCT01070043|365812681|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
106040234|NCT01070043|365812682|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
106040235|NCT01070043|365812683|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
106040236|NCT01070043|365812681|FG000|Double-Blind Treatment|Adverse Event|0|||
106040237|NCT01070043|365812682|FG001|Double-Blind Treatment|Adverse Event|0|||
106040238|NCT01070043|365812683|FG002|Double-Blind Treatment|Adverse Event|2|||
106040239|NCT01912963|365812684|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
106040240|NCT01912963|365812685|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
106040241|NCT01912963|365812686|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
106040242|NCT01912963|365812684|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
106040243|NCT01912963|365812685|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
106040244|NCT01912963|365812686|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
106040245|NCT01912963|365812684|FG000|Overall Study|Adverse Event|0|||
106040246|NCT01912963|365812685|FG001|Overall Study|Adverse Event|1|||
106040247|NCT01912963|365812686|FG002|Overall Study|Adverse Event|1|||
106040248|NCT01912963|365812684|FG000|Overall Study|Withdrawal by Subject|0|||
106040249|NCT01912963|365812685|FG001|Overall Study|Withdrawal by Subject|1|||
106040250|NCT01912963|365812686|FG002|Overall Study|Withdrawal by Subject|0|||
106040251|NCT01912963|365812684|FG000|Overall Study|Sought treatment locally|0|||
106040252|NCT01912963|365812685|FG001|Overall Study|Sought treatment locally|1|||
106040253|NCT01912963|365812686|FG002|Overall Study|Sought treatment locally|0|||
106040254|NCT00473746|365812687|FG000|Period 1 (Phase 1)|Adverse Event|1|||
106040255|NCT00473746|365812688|FG001|Period 1 (Phase 1)|Adverse Event|0|||
106040256|NCT00473746|365812689|FG002|Period 1 (Phase 1)|Adverse Event|0|||
106040257|NCT00473746|365812690|FG003|Period 1 (Phase 1)|Adverse Event|0|||
106040258|NCT00473746|365812691|FG004|Period 1 (Phase 1)|Adverse Event|0|||
106040259|NCT00473746|365812687|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
106040260|NCT00473746|365812688|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
106040261|NCT00473746|365812689|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
106040262|NCT00473746|365812690|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
106040263|NCT00473746|365812691|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
106040264|NCT00473746|365812687|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
106040265|NCT00473746|365812688|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
106040266|NCT00473746|365812689|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
106040267|NCT00473746|365812690|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
106040268|NCT00473746|365812691|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
106040269|NCT00473746|365812687|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
106040270|NCT00473746|365812688|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
106040271|NCT00473746|365812689|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
106040272|NCT00473746|365812690|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
106040273|NCT00473746|365812691|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
106040274|NCT00473746|365812687|FG000|Period 1 (Phase 1)|Reason not specified|0|||
106040275|NCT00473746|365812688|FG001|Period 1 (Phase 1)|Reason not specified|1|||
106040276|NCT00473746|365812689|FG002|Period 1 (Phase 1)|Reason not specified|0|||
106040277|NCT00473746|365812690|FG003|Period 1 (Phase 1)|Reason not specified|0|||
106040278|NCT00473746|365812691|FG004|Period 1 (Phase 1)|Reason not specified|0|||
106040279|NCT00473746|365812687|FG000|Period 2 (Phase 2)|Adverse Event|0|||
106040280|NCT00473746|365812688|FG001|Period 2 (Phase 2)|Adverse Event|0|||
106040281|NCT00473746|365812689|FG002|Period 2 (Phase 2)|Adverse Event|0|||
106040282|NCT00473746|365812690|FG003|Period 2 (Phase 2)|Adverse Event|0|||
106040283|NCT00473746|365812691|FG004|Period 2 (Phase 2)|Adverse Event|3|||
106040284|NCT00473746|365812687|FG000|Period 2 (Phase 2)|Death|0|||
106040285|NCT00473746|365812688|FG001|Period 2 (Phase 2)|Death|0|||
106040286|NCT00473746|365812689|FG002|Period 2 (Phase 2)|Death|0|||
106040287|NCT00473746|365812690|FG003|Period 2 (Phase 2)|Death|0|||
106040288|NCT00473746|365812691|FG004|Period 2 (Phase 2)|Death|1|||
106040289|NCT00473746|365812687|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
106040290|NCT00473746|365812688|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
106040291|NCT00473746|365812689|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
106040292|NCT00473746|365812690|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
106040293|NCT00473746|365812691|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
106040294|NCT00473746|365812687|FG000|Period 2 (Phase 2)|Reason not specified|0|||
106040295|NCT00473746|365812688|FG001|Period 2 (Phase 2)|Reason not specified|0|||
106040296|NCT00473746|365812689|FG002|Period 2 (Phase 2)|Reason not specified|0|||
106040297|NCT00473746|365812690|FG003|Period 2 (Phase 2)|Reason not specified|0|||
106040298|NCT00473746|365812691|FG004|Period 2 (Phase 2)|Reason not specified|3|||
106040299|NCT00667420|365812695|FG000|Overall Study|Adverse Event|2|||
106040300|NCT00667420|365812695|FG000|Overall Study|Lack of Efficacy|5|||
106040301|NCT00667420|365812695|FG000|Overall Study|Physician Decision|1|||
106040302|NCT00667420|365812695|FG000|Overall Study|Withdrawal by Subject|2|||
106040303|NCT01982331|365812698|FG000|Received Vaccination 2|Adverse Event|1|||
106040304|NCT01982331|365812699|FG001|Received Vaccination 2|Adverse Event|2|||
106040305|NCT01982331|365812698|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
106040306|NCT01982331|365812699|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
106040307|NCT01982331|365812698|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
106040308|NCT01982331|365812699|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
106040309|NCT04223232|365812707|FG000|Overall Study|Withdrawal by Subject|1|||
106040310|NCT01278160|365812724|FG000|Overall Study|Adverse Event|1|||
106040311|NCT01278160|365812725|FG001|Overall Study|Adverse Event|1|||
106040312|NCT01278160|365812724|FG000|Overall Study|Lost to Follow-up|0|||
106040313|NCT01278160|365812725|FG001|Overall Study|Lost to Follow-up|1|||
106040314|NCT01278160|365812724|FG000|Overall Study|Withdrawal by Subject|3|||
106040315|NCT01278160|365812725|FG001|Overall Study|Withdrawal by Subject|2|||
106040316|NCT01278160|365812724|FG000|Overall Study|Unclassified|1|||
106040317|NCT01278160|365812725|FG001|Overall Study|Unclassified|2|||
106040318|NCT02819518|365812727|FG000|Overall Study|Death|9|||
106040319|NCT02819518|365812728|FG001|Overall Study|Death|12|||
106040320|NCT02819518|365812729|FG002|Overall Study|Death|9|||
106040321|NCT02819518|365812730|FG003|Overall Study|Death|475|||
106040322|NCT02819518|365812731|FG004|Overall Study|Death|244|||
106040323|NCT02819518|365812727|FG000|Overall Study|Withdrawal by Subject|0|||
106040324|NCT02819518|365812728|FG001|Overall Study|Withdrawal by Subject|0|||
106040325|NCT02819518|365812729|FG002|Overall Study|Withdrawal by Subject|0|||
106040326|NCT02819518|365812730|FG003|Overall Study|Withdrawal by Subject|25|||
106040327|NCT02819518|365812731|FG004|Overall Study|Withdrawal by Subject|8|||
106040328|NCT02819518|365812727|FG000|Overall Study|Lost to Follow-up|0|||
106040329|NCT02819518|365812728|FG001|Overall Study|Lost to Follow-up|0|||
106040330|NCT02819518|365812729|FG002|Overall Study|Lost to Follow-up|0|||
106040331|NCT02819518|365812730|FG003|Overall Study|Lost to Follow-up|0|||
106040332|NCT02819518|365812731|FG004|Overall Study|Lost to Follow-up|1|||
106040333|NCT02819518|365812727|FG000|Overall Study|Sponsor Decision|1|||
106040334|NCT02819518|365812728|FG001|Overall Study|Sponsor Decision|1|||
106040335|NCT02819518|365812729|FG002|Overall Study|Sponsor Decision|0|||
106040336|NCT02819518|365812730|FG003|Overall Study|Sponsor Decision|34|||
106040337|NCT02819518|365812731|FG004|Overall Study|Sponsor Decision|17|||
106040338|NCT02819518|365812727|FG000|Overall Study|Transferred to extension study|1|||
106040339|NCT02819518|365812728|FG001|Overall Study|Transferred to extension study|1|||
106040340|NCT02819518|365812729|FG002|Overall Study|Transferred to extension study|1|||
106040341|NCT02819518|365812730|FG003|Overall Study|Transferred to extension study|32|||
106040342|NCT02819518|365812731|FG004|Overall Study|Transferred to extension study|11|||
106040343|NCT00880165|365812732|FG000|Overall Study|Withdrawal by Subject|27|||
106040344|NCT00880165|365812733|FG001|Overall Study|Withdrawal by Subject|23|||
106040345|NCT00880165|365812732|FG000|Overall Study|Not diagnosed with OSA|14|||
106040346|NCT00880165|365812733|FG001|Overall Study|Not diagnosed with OSA|8|||
106040347|NCT00880165|365812732|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
106040348|NCT00880165|365812733|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
106040349|NCT00880165|365812732|FG000|Overall Study|Lost to follow|9|||
106040350|NCT00880165|365812733|FG001|Overall Study|Lost to follow|15|||
106040351|NCT00739596|365812738|FG000|Overall Study|Adverse Event|12|||
106040352|NCT00739596|365812739|FG001|Overall Study|Adverse Event|6|||
106040353|NCT00739596|365812738|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
106040354|NCT00739596|365812739|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
106040355|NCT00739596|365812738|FG000|Overall Study|Patient Withdrew Consent|8|||
106040356|NCT00739596|365812739|FG001|Overall Study|Patient Withdrew Consent|8|||
106040357|NCT00739596|365812738|FG000|Overall Study|Lost to Follow-up|0|||
106040358|NCT00739596|365812739|FG001|Overall Study|Lost to Follow-up|2|||
106040359|NCT00739596|365812738|FG000|Overall Study|Protocol Deviation|1|||
106040360|NCT00739596|365812739|FG001|Overall Study|Protocol Deviation|1|||
106040361|NCT00908011|365812740|FG000|Overall Study|Withdrawal by Subject|2|||
106040362|NCT00908011|365812741|FG001|Overall Study|Withdrawal by Subject|2|||
106040363|NCT02301988|365812748|FG000|Overall Study|Withdrawal by Subject|2|||
106040364|NCT02301988|365812749|FG001|Overall Study|Withdrawal by Subject|1|||
106040365|NCT02301988|365812748|FG000|Overall Study|Physician Decision|2|||
106040366|NCT02301988|365812749|FG001|Overall Study|Physician Decision|2|||
106040367|NCT02301988|365812748|FG000|Overall Study|Unknown Reason|1|||
106040368|NCT02301988|365812749|FG001|Overall Study|Unknown Reason|3|||
106040369|NCT02301988|365812748|FG000|Overall Study|Lack of Efficacy|3|||
106040370|NCT02301988|365812749|FG001|Overall Study|Lack of Efficacy|2|||
106040371|NCT02301988|365812748|FG000|Overall Study|Death|1|||
106040372|NCT02301988|365812749|FG001|Overall Study|Death|0|||
106040373|NCT02301988|365812748|FG000|Overall Study|Adverse Event|1|||
106040374|NCT02301988|365812749|FG001|Overall Study|Adverse Event|1|||
106040375|NCT02898116|365812750|FG000|Overall Study|Adverse Event|1|||
106040376|NCT02898116|365812750|FG000|Overall Study|Progressive disease|1|||
106040377|NCT05169567|365812761|FG000|Overall Study|On study treatment|116|||
106040378|NCT05169567|365812762|FG001|Overall Study|On study treatment|128|||
106040379|NCT05169567|365812761|FG000|Overall Study|Lost to Follow-up|1|||
106040380|NCT05169567|365812762|FG001|Overall Study|Lost to Follow-up|0|||
106040381|NCT05169567|365812761|FG000|Overall Study|Withdrawal by Subject|25|||
106040382|NCT05169567|365812762|FG001|Overall Study|Withdrawal by Subject|21|||
106040383|NCT04078178|365813828|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
106040384|NCT04078178|365813829|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
106040385|NCT04078178|365813828|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
106040386|NCT04078178|365813829|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
106040387|NCT04078178|365813828|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
106040388|NCT04078178|365813829|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
106040389|NCT04078178|365813828|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
106040390|NCT04078178|365813829|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
106040391|NCT04078178|365813828|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
106040392|NCT04078178|365813829|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
106040393|NCT00089284|365813831|FG000|Overall Study|Adverse event before starting treatment|0|||
106040394|NCT00089284|365813832|FG001|Overall Study|Adverse event before starting treatment|0|||
106040395|NCT00089284|365813833|FG002|Overall Study|Adverse event before starting treatment|0|||
106040396|NCT00089284|365813834|FG003|Overall Study|Adverse event before starting treatment|0|||
106040397|NCT00089284|365813835|FG004|Overall Study|Adverse event before starting treatment|0|||
106040398|NCT00089284|365813836|FG005|Overall Study|Adverse event before starting treatment|0|||
106040399|NCT00089284|365813837|FG006|Overall Study|Adverse event before starting treatment|1|||
106040400|NCT00287079|365813845|FG000|Overall Study|Qualifying relapse|12|||
106040401|NCT00287079|365813846|FG001|Overall Study|Qualifying relapse|1|||
106040402|NCT00287079|365813845|FG000|Overall Study|Non-qualifying relapse|1|||
106040403|NCT00287079|365813846|FG001|Overall Study|Non-qualifying relapse|0|||
106040404|NCT00287079|365813845|FG000|Overall Study|Adverse Event|5|||
106040405|NCT00287079|365813846|FG001|Overall Study|Adverse Event|0|||
106040406|NCT00287079|365813845|FG000|Overall Study|Protocol Violation|1|||
106040407|NCT00287079|365813846|FG001|Overall Study|Protocol Violation|0|||
106040408|NCT00287079|365813845|FG000|Overall Study|Other|3|||
106040409|NCT00287079|365813846|FG001|Overall Study|Other|0|||
106040410|NCT03282565|365813847|FG000|Overall Study|COVID-19 Research Shutdown|0|||
106040411|NCT03282565|365813848|FG001|Overall Study|COVID-19 Research Shutdown|2|||
106040412|NCT03282565|365813849|FG002|Overall Study|COVID-19 Research Shutdown|2|||
106040413|NCT01134315|365813851|FG000|Overall Study|Adverse Event|1|||
106040414|NCT01134315|365813852|FG001|Overall Study|Adverse Event|2|||
106040415|NCT01134315|365813851|FG000|Overall Study|Other Reason|8|||
106040416|NCT01134315|365813852|FG001|Overall Study|Other Reason|17|||
106040417|NCT03960554|365813853|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
106040418|NCT03960554|365813854|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
106040419|NCT01810432|365813857|FG000|Washout|Protocol Violation|0|||
106040420|NCT01810432|365813858|FG001|Washout|Protocol Violation|1|||
106040421|NCT01810432|365813857|FG000|Washout|Adverse Event|1|||
106040422|NCT01810432|365813858|FG001|Washout|Adverse Event|0|||
106040423|NCT01810432|365813857|FG000|Period 2|Withdrawal by Subject|2|||
106040424|NCT01810432|365813858|FG001|Period 2|Withdrawal by Subject|1|||
106040425|NCT01810432|365813857|FG000|Period 2|Physician Decision|1|||
106040426|NCT01810432|365813858|FG001|Period 2|Physician Decision|0|||
106040427|NCT01810432|365813857|FG000|Period 2|Lost to Follow-up|1|||
106040428|NCT01810432|365813858|FG001|Period 2|Lost to Follow-up|1|||
106040429|NCT02360111|365813859|FG000|Overall Study|Death|2|||
106040430|NCT01933217|365813862|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
106040431|NCT01933217|365813863|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
106040432|NCT01933217|365813862|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
106040433|NCT01933217|365813863|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
106040434|NCT03923738|365813866|FG000|Period 1|Adverse Event|1|||
106040435|NCT03923738|365813866|FG000|Period 1|Withdrawal by Subject|1|||
106040436|NCT03583164|365813868|FG000|Overall Study|Death in Main Phase|35|||
106040437|NCT03583164|365813868|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
106040438|NCT03583164|365813868|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
106040439|NCT03583164|365813868|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
106040440|NCT03583164|365813868|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
106040441|NCT03583164|365813868|FG000|Overall Study|Physician decision in Main Phase|1|||
106040442|NCT03583164|365813868|FG000|Overall Study|Physician decision in Extended Phase|2|||
106040443|NCT03583164|365813868|FG000|Overall Study|Death in Extended Phase|13|||
106040444|NCT03583164|365813868|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
106040445|NCT03583164|365813868|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
106040446|NCT03583164|365813868|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
106040447|NCT03583164|365813868|FG000|Overall Study|Treatment failure in Main Phase|2|||
106040448|NCT03583164|365813868|FG000|Overall Study|Treatment failure in Extended Phase|4|||
106040449|NCT03583164|365813868|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
106040450|NCT03583164|365813868|FG000|Overall Study|Other not specified reason in Main Phase|2|||
106040451|NCT02943460|365813872|FG000|Blinded Study Phase|Adverse Event|3|||
106040452|NCT02943460|365813873|FG001|Blinded Study Phase|Adverse Event|0|||
106040453|NCT02943460|365813874|FG002|Blinded Study Phase|Adverse Event|0|||
106040454|NCT02943460|365813872|FG000|Blinded Study Phase|Withdrew Consent|0|||
106040455|NCT02943460|365813873|FG001|Blinded Study Phase|Withdrew Consent|1|||
106040456|NCT02943460|365813874|FG002|Blinded Study Phase|Withdrew Consent|0|||
106040457|NCT02943460|365813872|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
106040458|NCT02943460|365813873|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
106040459|NCT02943460|365813874|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
106040460|NCT02943460|365813872|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
106040461|NCT02943460|365813873|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
106040462|NCT02943460|365813874|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
106040463|NCT02943460|365813872|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
106040464|NCT02943460|365813873|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
106040465|NCT02943460|365813874|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
106040466|NCT01323946|365813875|FG000|Overall Study|Lost to Follow-up|0|||
106040467|NCT01323946|365813876|FG001|Overall Study|Lost to Follow-up|1|||
106040468|NCT01323946|365813877|FG002|Overall Study|Lost to Follow-up|0|||
106040469|NCT01323946|365813875|FG000|Overall Study|Parents refused the last blood draw|1|||
106040470|NCT01323946|365813876|FG001|Overall Study|Parents refused the last blood draw|0|||
106040471|NCT01323946|365813877|FG002|Overall Study|Parents refused the last blood draw|0|||
106040472|NCT01323946|365813875|FG000|Overall Study|Withdrawal by Subject|2|||
106040473|NCT01323946|365813876|FG001|Overall Study|Withdrawal by Subject|2|||
106040474|NCT01323946|365813877|FG002|Overall Study|Withdrawal by Subject|0|||
106040475|NCT01243671|365813880|FG000|Overall Study|Adverse Event|3|||
106040476|NCT01243671|365813880|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
106040477|NCT01243671|365813880|FG000|Overall Study|Other|1|||
106040478|NCT00925990|365813881|FG000|Overall Study|Adverse Event|1|||
106040479|NCT00925990|365813882|FG001|Overall Study|Adverse Event|3|||
106040480|NCT00925990|365813881|FG000|Overall Study|Withdrawal by Subject|2|||
106040481|NCT00925990|365813882|FG001|Overall Study|Withdrawal by Subject|2|||
106040482|NCT00925990|365813881|FG000|Overall Study|Lost to Follow-up|1|||
106040483|NCT00925990|365813882|FG001|Overall Study|Lost to Follow-up|3|||
106040484|NCT00925990|365813881|FG000|Overall Study|Physician Decision|1|||
106040485|NCT00925990|365813882|FG001|Overall Study|Physician Decision|1|||
106040486|NCT00925990|365813881|FG000|Overall Study|moved out of state, missed medication|0|||
106040487|NCT00925990|365813882|FG001|Overall Study|moved out of state, missed medication|2|||
106040488|NCT02169284|365813885|FG000|Overall Study|Physician Decision|0|||
106040489|NCT02169284|365813886|FG001|Overall Study|Physician Decision|1|||
106040490|NCT00573248|365813887|FG000|Overall Study|scheduling conflicts|15|||
106040491|NCT00573248|365813888|FG001|Overall Study|scheduling conflicts|11|||
106040492|NCT03583073|365813889|FG000|Overall Study|Lost to Follow-up|8|||
106040493|NCT03583073|365813890|FG001|Overall Study|Lost to Follow-up|12|||
106040494|NCT02495233|365813899|FG000|Overall Study|Miscellaneous|0|||
106040495|NCT02495233|365813900|FG001|Overall Study|Miscellaneous|1|||
106040496|NCT04950166|365813901|FG000|Overall Study|Withdrawal by Subject|1|||
106040497|NCT05896748|365813902|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
106040498|NCT05896748|365813902|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
106040499|NCT05896748|365813902|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
106040500|NCT05896748|365813902|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
106040501|NCT05896748|365813902|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
106040502|NCT02325791|365813904|FG000|Overall Study|Adverse Event|0|||
106040503|NCT02325791|365813905|FG001|Overall Study|Adverse Event|1|||
106040504|NCT02325791|365813906|FG002|Overall Study|Adverse Event|1|||
106040505|NCT02325791|365813907|FG003|Overall Study|Adverse Event|0|||
106040506|NCT02325791|365813904|FG000|Overall Study|Death|0|||
106040507|NCT02325791|365813905|FG001|Overall Study|Death|3|||
106040508|NCT02325791|365813906|FG002|Overall Study|Death|0|||
106040509|NCT02325791|365813907|FG003|Overall Study|Death|1|||
106040510|NCT02325791|365813904|FG000|Overall Study|Lost to Follow-up|0|||
106040511|NCT02325791|365813905|FG001|Overall Study|Lost to Follow-up|15|||
106040512|NCT02325791|365813906|FG002|Overall Study|Lost to Follow-up|14|||
106040513|NCT02325791|365813907|FG003|Overall Study|Lost to Follow-up|9|||
106040514|NCT02325791|365813904|FG000|Overall Study|Physician Decision|0|||
106040515|NCT02325791|365813905|FG001|Overall Study|Physician Decision|1|||
106040516|NCT02325791|365813906|FG002|Overall Study|Physician Decision|1|||
106040517|NCT02325791|365813907|FG003|Overall Study|Physician Decision|0|||
106040518|NCT02325791|365813904|FG000|Overall Study|Protocol Violation|0|||
106040519|NCT02325791|365813905|FG001|Overall Study|Protocol Violation|0|||
106040520|NCT02325791|365813906|FG002|Overall Study|Protocol Violation|1|||
106040521|NCT02325791|365813907|FG003|Overall Study|Protocol Violation|0|||
106040522|NCT02325791|365813904|FG000|Overall Study|Withdrawal by Subject|0|||
106040523|NCT02325791|365813905|FG001|Overall Study|Withdrawal by Subject|5|||
106040524|NCT02325791|365813906|FG002|Overall Study|Withdrawal by Subject|8|||
106040525|NCT02325791|365813907|FG003|Overall Study|Withdrawal by Subject|16|||
106040526|NCT03953183|365813908|FG000|Overall Study|Physician Decision|0|||
106040527|NCT03953183|365813909|FG001|Overall Study|Physician Decision|1|||
106040528|NCT03953183|365813908|FG000|Overall Study|Withdrawal by Subject|0|||
106040529|NCT03953183|365813909|FG001|Overall Study|Withdrawal by Subject|1|||
106040530|NCT04508140|365813910|FG000|Overall Study|Adverse Event|2|||
106040531|NCT04508140|365813911|FG001|Overall Study|Adverse Event|2|||
106040532|NCT04508140|365813910|FG000|Overall Study|Withdrawal by Subject|0|||
106040533|NCT04508140|365813911|FG001|Overall Study|Withdrawal by Subject|2|||
106040534|NCT04508140|365813910|FG000|Overall Study|progressive disease|9|||
106040535|NCT04508140|365813911|FG001|Overall Study|progressive disease|3|||
106040536|NCT01115803|365813912|FG000|Overall Study|Withdrawal by Subject|0|||
106040537|NCT01115803|365813913|FG001|Overall Study|Withdrawal by Subject|0|||
106040538|NCT01115803|365813914|FG002|Overall Study|Withdrawal by Subject|0|||
106040539|NCT01115803|365813915|FG003|Overall Study|Withdrawal by Subject|0|||
106040540|NCT01115803|365813916|FG004|Overall Study|Withdrawal by Subject|0|||
106040541|NCT01115803|365813917|FG005|Overall Study|Withdrawal by Subject|0|||
106040542|NCT01115803|365813918|FG006|Overall Study|Withdrawal by Subject|1|||
106040543|NCT01115803|365813912|FG000|Overall Study|Lost to Follow-up|0|||
106040544|NCT01115803|365813913|FG001|Overall Study|Lost to Follow-up|0|||
106040545|NCT01115803|365813914|FG002|Overall Study|Lost to Follow-up|1|||
106040546|NCT01115803|365813915|FG003|Overall Study|Lost to Follow-up|0|||
106040547|NCT01115803|365813916|FG004|Overall Study|Lost to Follow-up|0|||
106040548|NCT01115803|365813917|FG005|Overall Study|Lost to Follow-up|0|||
106040549|NCT01115803|365813918|FG006|Overall Study|Lost to Follow-up|0|||
106040550|NCT01115803|365813912|FG000|Overall Study|Progressive Disease during Cycle1|0|||
106040551|NCT01115803|365813913|FG001|Overall Study|Progressive Disease during Cycle1|0|||
106040552|NCT01115803|365813914|FG002|Overall Study|Progressive Disease during Cycle1|0|||
106040553|NCT01115803|365813915|FG003|Overall Study|Progressive Disease during Cycle1|0|||
106040554|NCT01115803|365813916|FG004|Overall Study|Progressive Disease during Cycle1|0|||
106040555|NCT01115803|365813917|FG005|Overall Study|Progressive Disease during Cycle1|0|||
106040556|NCT01115803|365813918|FG006|Overall Study|Progressive Disease during Cycle1|1|||
106040557|NCT03059446|365813919|FG000|Overall Study|Adverse Event|11|||
106040558|NCT03059446|365813919|FG000|Overall Study|Withdrawal of Consent|16|||
106151740|NCT02590432|366215133|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
105861302|NCT00282919|365143210|FG000|Overall Study|Lack of Efficacy|4|||
106040559|NCT03059446|365813919|FG000|Overall Study|Lost to Follow-up|3|||
106040560|NCT03059446|365813919|FG000|Overall Study|Protocol Violation|1|||
106040561|NCT03059446|365813919|FG000|Overall Study|Study Terminated by Sponsor|131|||
106040562|NCT03059446|365813919|FG000|Overall Study|Reason not Specified|5|||
106040563|NCT02992132|365813920|FG000|Overall Study|Adverse Event|4|||
106040564|NCT02992132|365813921|FG001|Overall Study|Adverse Event|1|||
106040565|NCT02992132|365813922|FG002|Overall Study|Adverse Event|3|||
106040566|NCT02992132|365813920|FG000|Overall Study|Lack of Efficacy|2|||
106040567|NCT02992132|365813921|FG001|Overall Study|Lack of Efficacy|0|||
106040568|NCT02992132|365813922|FG002|Overall Study|Lack of Efficacy|0|||
106040569|NCT02992132|365813920|FG000|Overall Study|Non-compliance with study drug|2|||
105861303|NCT00282919|365143210|FG000|Overall Study|Withdrawal by Subject|1|||
105861304|NCT00282919|365143210|FG000|Overall Study|Asymptomatic Parasitemia|2|||
105861305|NCT01433549|365143213|FG000|Phase 2: Second Study Product|Adverse Event|0|||
105861306|NCT01433549|365143214|FG001|Phase 2: Second Study Product|Adverse Event|1|||
105861307|NCT01696058|365143218|FG000|Overall Study|Adverse Event|21|||
105861308|NCT01696058|365143219|FG001|Overall Study|Adverse Event|11|||
105861309|NCT01696058|365143218|FG000|Overall Study|Lack of Efficacy|2|||
105861310|NCT01696058|365143219|FG001|Overall Study|Lack of Efficacy|3|||
105861311|NCT01696058|365143218|FG000|Overall Study|Protocol Violation|9|||
105861312|NCT01696058|365143219|FG001|Overall Study|Protocol Violation|3|||
105861313|NCT01696058|365143218|FG000|Overall Study|Lost to Follow-up|2|||
105861314|NCT01696058|365143219|FG001|Overall Study|Lost to Follow-up|5|||
105861315|NCT01696058|365143218|FG000|Overall Study|Withdrawal by Subject|4|||
105861316|NCT01696058|365143219|FG001|Overall Study|Withdrawal by Subject|6|||
105861317|NCT01696058|365143218|FG000|Overall Study|Other reason prematurely discontinued|5|||
105861318|NCT01696058|365143219|FG001|Overall Study|Other reason prematurely discontinued|3|||
105861319|NCT02549027|365143224|FG000|Washout After Period 4|Withdrawal by Subject|0|||
105861320|NCT02549027|365143225|FG001|Washout After Period 4|Withdrawal by Subject|1|||
105861321|NCT02549027|365143226|FG002|Washout After Period 4|Withdrawal by Subject|1|||
105861322|NCT02549027|365143227|FG003|Washout After Period 4|Withdrawal by Subject|1|||
105861323|NCT02549027|365143228|FG004|Washout After Period 4|Withdrawal by Subject|0|||
105861324|NCT02549027|365143229|FG005|Washout After Period 4|Withdrawal by Subject|0|||
105861325|NCT02549027|365143224|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105861326|NCT02549027|365143225|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
106040570|NCT02992132|365813921|FG001|Overall Study|Non-compliance with study drug|0|||
106040571|NCT02992132|365813922|FG002|Overall Study|Non-compliance with study drug|0|||
106040572|NCT02992132|365813920|FG000|Overall Study|Progressive disease|1|||
106040573|NCT02992132|365813921|FG001|Overall Study|Progressive disease|0|||
106040574|NCT02992132|365813922|FG002|Overall Study|Progressive disease|0|||
106040575|NCT02992132|365813920|FG000|Overall Study|Protocol Violation|2|||
106040576|NCT02992132|365813921|FG001|Overall Study|Protocol Violation|2|||
106040577|NCT02992132|365813922|FG002|Overall Study|Protocol Violation|0|||
106040578|NCT02992132|365813920|FG000|Overall Study|Caregiver withdrew consent|2|||
106040579|NCT02992132|365813921|FG001|Overall Study|Caregiver withdrew consent|3|||
106040580|NCT02992132|365813922|FG002|Overall Study|Caregiver withdrew consent|2|||
106040581|NCT02992132|365813920|FG000|Overall Study|Withdrawal by Subject|0|||
106040582|NCT02992132|365813921|FG001|Overall Study|Withdrawal by Subject|2|||
106040583|NCT02992132|365813922|FG002|Overall Study|Withdrawal by Subject|1|||
106040584|NCT02992132|365813920|FG000|Overall Study|Physician Decision|0|||
106040585|NCT02992132|365813921|FG001|Overall Study|Physician Decision|0|||
106040586|NCT02992132|365813922|FG002|Overall Study|Physician Decision|1|||
106040587|NCT01610271|365813930|FG000|Overall Study|Surgery not complete|0|||
106040588|NCT01610271|365813931|FG001|Overall Study|Surgery not complete|1|||
106040589|NCT01610271|365813930|FG000|Overall Study|Prosthesis not implanted|2|||
106040590|NCT01610271|365813931|FG001|Overall Study|Prosthesis not implanted|3|||
106040591|NCT01927341|365815790|FG000|Phase 1b|Lost to Follow-up|1|||
106040592|NCT01927341|365815791|FG001|Phase 1b|Lost to Follow-up|0|||
106040593|NCT01927341|365815792|FG002|Phase 1b|Lost to Follow-up|0|||
106040594|NCT01927341|365815793|FG003|Phase 1b|Lost to Follow-up|0|||
106040595|NCT01927341|365815794|FG004|Phase 1b|Lost to Follow-up|0|||
106040596|NCT01927341|365815790|FG000|Phase 1b|Death|2|||
106040597|NCT01927341|365815791|FG001|Phase 1b|Death|0|||
106040598|NCT01927341|365815792|FG002|Phase 1b|Death|0|||
106040599|NCT01927341|365815793|FG003|Phase 1b|Death|0|||
106040600|NCT01927341|365815794|FG004|Phase 1b|Death|0|||
105861327|NCT02549027|365143226|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105861328|NCT02549027|365143227|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105861329|NCT02549027|365143228|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
105861330|NCT02549027|365143229|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
105861331|NCT02186834|365143230|FG000|Dose Escalation|Death|0|||
105861332|NCT02186834|365143231|FG001|Dose Escalation|Death|0|||
105861333|NCT02186834|365143232|FG002|Dose Escalation|Death|0|||
106040601|NCT01927341|365815790|FG000|Phase 1b|Follow-up completed|7|||
106040602|NCT01927341|365815791|FG001|Phase 1b|Follow-up completed|0|||
106151741|NCT02590432|366215134|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
105861334|NCT02186834|365143233|FG003|Dose Escalation|Death|1|||
105861335|NCT02186834|365143234|FG004|Dose Escalation|Death|0|||
105861336|NCT02186834|365143235|FG005|Dose Escalation|Death|0|||
105861337|NCT02186834|365143230|FG000|Treatment at RP2D|Died prior to treatment|0|||
105861338|NCT02186834|365143231|FG001|Treatment at RP2D|Died prior to treatment|0|||
106040603|NCT01927341|365815792|FG002|Phase 1b|Follow-up completed|0|||
106040604|NCT01927341|365815793|FG003|Phase 1b|Follow-up completed|0|||
106040605|NCT01927341|365815794|FG004|Phase 1b|Follow-up completed|0|||
106040606|NCT01927341|365815790|FG000|Phase 2|Lost to Follow-up|0|||
106040607|NCT01927341|365815791|FG001|Phase 2|Lost to Follow-up|1|||
106040608|NCT01927341|365815792|FG002|Phase 2|Lost to Follow-up|0|||
106040609|NCT01927341|365815793|FG003|Phase 2|Lost to Follow-up|0|||
106040610|NCT01927341|365815794|FG004|Phase 2|Lost to Follow-up|0|||
106040611|NCT01927341|365815790|FG000|Phase 2|Participant withdrew consent|0|||
106040612|NCT01927341|365815791|FG001|Phase 2|Participant withdrew consent|2|||
106040613|NCT01927341|365815792|FG002|Phase 2|Participant withdrew consent|1|||
106040614|NCT01927341|365815793|FG003|Phase 2|Participant withdrew consent|2|||
106040615|NCT01927341|365815794|FG004|Phase 2|Participant withdrew consent|3|||
106040616|NCT01927341|365815790|FG000|Phase 2|Death|0|||
106040617|NCT01927341|365815791|FG001|Phase 2|Death|4|||
106040618|NCT01927341|365815792|FG002|Phase 2|Death|0|||
106040619|NCT01927341|365815793|FG003|Phase 2|Death|3|||
106040620|NCT01927341|365815794|FG004|Phase 2|Death|2|||
106040621|NCT01927341|365815790|FG000|Phase 2|New cancer therapy|0|||
106040622|NCT01927341|365815791|FG001|Phase 2|New cancer therapy|1|||
106040623|NCT01927341|365815792|FG002|Phase 2|New cancer therapy|0|||
106040624|NCT01927341|365815793|FG003|Phase 2|New cancer therapy|4|||
106040625|NCT01927341|365815794|FG004|Phase 2|New cancer therapy|1|||
106040626|NCT01927341|365815790|FG000|Phase 2|Disease progression|0|||
106040627|NCT01927341|365815791|FG001|Phase 2|Disease progression|1|||
106040628|NCT01927341|365815792|FG002|Phase 2|Disease progression|1|||
106040629|NCT01927341|365815793|FG003|Phase 2|Disease progression|1|||
106040630|NCT01927341|365815794|FG004|Phase 2|Disease progression|0|||
106040631|NCT01927341|365815790|FG000|Phase 2|Follow-up completed|0|||
106040632|NCT01927341|365815791|FG001|Phase 2|Follow-up completed|6|||
106040633|NCT01927341|365815792|FG002|Phase 2|Follow-up completed|3|||
106040634|NCT01927341|365815793|FG003|Phase 2|Follow-up completed|5|||
106040635|NCT01927341|365815794|FG004|Phase 2|Follow-up completed|2|||
106040636|NCT01104701|365815795|FG000|Overall Study|Withdrawal by Subject|0|||
106040637|NCT01104701|365815796|FG001|Overall Study|Withdrawal by Subject|1|||
106040638|NCT01104701|365815797|FG002|Overall Study|Withdrawal by Subject|2|||
106040639|NCT01104701|365815798|FG003|Overall Study|Withdrawal by Subject|1|||
106040640|NCT01104701|365815795|FG000|Overall Study|Adverse Event|0|||
106040641|NCT01104701|365815796|FG001|Overall Study|Adverse Event|0|||
106040642|NCT01104701|365815797|FG002|Overall Study|Adverse Event|0|||
106040643|NCT01104701|365815798|FG003|Overall Study|Adverse Event|1|||
106040644|NCT01104701|365815795|FG000|Overall Study|Physician Decision|0|||
106040645|NCT01104701|365815796|FG001|Overall Study|Physician Decision|2|||
106040646|NCT01104701|365815797|FG002|Overall Study|Physician Decision|0|||
106040647|NCT01104701|365815798|FG003|Overall Study|Physician Decision|0|||
106040648|NCT02582255|365815799|FG000|Overall Study|Protocol Violation|0|||
106040649|NCT02582255|365815800|FG001|Overall Study|Protocol Violation|3|||
106040650|NCT02294773|365815801|FG000|Overall Study|Withdrawal by Subject|0|||
106040651|NCT02294773|365815802|FG001|Overall Study|Withdrawal by Subject|2|||
106040652|NCT01865084|365815803|FG000|Double Blind Period (DB)|Adverse Event|2|||
106040653|NCT01865084|365815804|FG001|Double Blind Period (DB)|Adverse Event|2|||
106040654|NCT01865084|365815805|FG002|Double Blind Period (DB)|Adverse Event|1|||
106040655|NCT01865084|365815803|FG000|Double Blind Period (DB)|Protocol Violation|0|||
106040656|NCT01865084|365815804|FG001|Double Blind Period (DB)|Protocol Violation|0|||
106040657|NCT01865084|365815805|FG002|Double Blind Period (DB)|Protocol Violation|1|||
106040658|NCT01865084|365815803|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
106040659|NCT01865084|365815804|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
106040660|NCT01865084|365815805|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
106040661|NCT01865084|365815803|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
106040662|NCT01865084|365815804|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
106040663|NCT01865084|365815805|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
106040664|NCT01865084|365815803|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
106040665|NCT01865084|365815804|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
106040666|NCT01865084|365815805|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
106040667|NCT01865084|365815803|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
106040668|NCT01865084|365815804|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
106040669|NCT01865084|365815805|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
106040670|NCT01865084|365815803|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
106040671|NCT01865084|365815804|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
106040672|NCT01865084|365815805|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
106040673|NCT01865084|365815803|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
106040674|NCT01865084|365815804|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
106040675|NCT01865084|365815805|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
106040676|NCT01865084|365815803|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
106040677|NCT01865084|365815804|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
106040678|NCT01865084|365815805|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
106040679|NCT03052764|365815806|FG000|Double-Blind Treatment Period|Adverse Event|2|||
106040680|NCT03052764|365815807|FG001|Double-Blind Treatment Period|Adverse Event|0|||
106040681|NCT03052764|365815806|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
106040682|NCT03052764|365815807|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
106040683|NCT03052764|365815806|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
106040684|NCT03052764|365815807|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
106040685|NCT03052764|365815806|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
106040686|NCT03052764|365815807|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
106040687|NCT03052764|365815806|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
106040688|NCT03052764|365815807|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
106040689|NCT00096954|365815811|FG000|Overall Study|Adverse Event|3|||
106040690|NCT00096954|365815812|FG001|Overall Study|Adverse Event|1|||
106040691|NCT00096954|365815811|FG000|Overall Study|Withdrawal by Subject|9|||
106040692|NCT00096954|365815812|FG001|Overall Study|Withdrawal by Subject|8|||
106040693|NCT00096954|365815811|FG000|Overall Study|Physician Decision|1|||
106040694|NCT00096954|365815812|FG001|Overall Study|Physician Decision|1|||
106040695|NCT00096954|365815811|FG000|Overall Study|Sponsors Decision|1|||
106040696|NCT00096954|365815812|FG001|Overall Study|Sponsors Decision|1|||
106040697|NCT00096954|365815811|FG000|Overall Study|Pregnancy|1|||
106040698|NCT00096954|365815812|FG001|Overall Study|Pregnancy|1|||
106040699|NCT00096954|365815811|FG000|Overall Study|Initiation of immunotherapy|1|||
106040700|NCT00096954|365815812|FG001|Overall Study|Initiation of immunotherapy|0|||
106040701|NCT00096954|365815811|FG000|Overall Study|Non-compliance|0|||
106040702|NCT00096954|365815812|FG001|Overall Study|Non-compliance|3|||
106040703|NCT00096954|365815811|FG000|Overall Study|Lost to Follow-up|8|||
106040704|NCT00096954|365815812|FG001|Overall Study|Lost to Follow-up|5|||
106040705|NCT02095223|365815813|FG000|Overall Study|Withdrawal by Subject|1|||
106040706|NCT02095223|365815814|FG001|Overall Study|Withdrawal by Subject|0|||
106040707|NCT03607422|365815815|FG000|Overall Study|Adverse Event|7|||
106040708|NCT03607422|365815816|FG001|Overall Study|Adverse Event|3|||
106040709|NCT03607422|365815817|FG002|Overall Study|Adverse Event|2|||
106040710|NCT03607422|365815818|FG003|Overall Study|Adverse Event|0|||
106040711|NCT03607422|365815819|FG004|Overall Study|Adverse Event|2|||
106040712|NCT03607422|365815820|FG005|Overall Study|Adverse Event|0|||
106040713|NCT03607422|365815815|FG000|Overall Study|Withdrawal by Subject|11|||
106040714|NCT03607422|365815816|FG001|Overall Study|Withdrawal by Subject|3|||
106040715|NCT03607422|365815817|FG002|Overall Study|Withdrawal by Subject|6|||
106040716|NCT03607422|365815818|FG003|Overall Study|Withdrawal by Subject|2|||
106040717|NCT03607422|365815819|FG004|Overall Study|Withdrawal by Subject|0|||
106040718|NCT03607422|365815820|FG005|Overall Study|Withdrawal by Subject|0|||
106040719|NCT03607422|365815815|FG000|Overall Study|Lost to Follow-up|0|||
106040720|NCT03607422|365815816|FG001|Overall Study|Lost to Follow-up|0|||
106040721|NCT03607422|365815817|FG002|Overall Study|Lost to Follow-up|1|||
106040722|NCT03607422|365815818|FG003|Overall Study|Lost to Follow-up|0|||
106040723|NCT03607422|365815819|FG004|Overall Study|Lost to Follow-up|0|||
106040724|NCT03607422|365815820|FG005|Overall Study|Lost to Follow-up|0|||
106040725|NCT03607422|365815815|FG000|Overall Study|Other|12|||
106040726|NCT03607422|365815816|FG001|Overall Study|Other|4|||
106040727|NCT03607422|365815817|FG002|Overall Study|Other|1|||
106040728|NCT03607422|365815818|FG003|Overall Study|Other|2|||
106040729|NCT03607422|365815819|FG004|Overall Study|Other|0|||
106040730|NCT03607422|365815820|FG005|Overall Study|Other|2|||
106040731|NCT03607422|365815815|FG000|Overall Study|Ongoing at Time of Analysis|8|||
106040732|NCT03607422|365815816|FG001|Overall Study|Ongoing at Time of Analysis|0|||
106040733|NCT03607422|365815817|FG002|Overall Study|Ongoing at Time of Analysis|2|||
106040734|NCT03607422|365815818|FG003|Overall Study|Ongoing at Time of Analysis|1|||
106040735|NCT03607422|365815819|FG004|Overall Study|Ongoing at Time of Analysis|1|||
106040736|NCT03607422|365815820|FG005|Overall Study|Ongoing at Time of Analysis|1|||
106040737|NCT04478123|365815821|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
106040738|NCT04478123|365815821|FG000|Overall Study|NE|1|||
106040739|NCT01801072|365815822|FG000|Overall Study|Lost to Follow-up|17|||
106040740|NCT01801072|365815823|FG001|Overall Study|Lost to Follow-up|14|||
106040741|NCT01801072|365815822|FG000|Overall Study|Physician Decision|2|||
106040742|NCT01801072|365815823|FG001|Overall Study|Physician Decision|3|||
106040743|NCT01801072|365815822|FG000|Overall Study|Withdrawal by Subject|1|||
106040744|NCT01801072|365815823|FG001|Overall Study|Withdrawal by Subject|0|||
106040745|NCT01801072|365815822|FG000|Overall Study|Protocol Violation|2|||
106040746|NCT01801072|365815823|FG001|Overall Study|Protocol Violation|0|||
106040747|NCT01801072|365815822|FG000|Overall Study|Death|7|||
106151742|NCT02590432|366215135|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
106040748|NCT01801072|365815823|FG001|Overall Study|Death|8|||
106040749|NCT03693170|365815824|FG000|Overall Study|Disease Progression|48|||
106040750|NCT03693170|365815824|FG000|Overall Study|Adverse Event|16|||
106040751|NCT03693170|365815824|FG000|Overall Study|Physician Decision|6|||
106040752|NCT03693170|365815824|FG000|Overall Study|Protocol Violation|2|||
106040753|NCT03693170|365815824|FG000|Overall Study|Death|1|||
106040754|NCT03693170|365815824|FG000|Overall Study|Non compliance with study drug|1|||
106040755|NCT03693170|365815824|FG000|Overall Study|Withdrawal by Subject|1|||
106040756|NCT02247531|365815825|FG000|Overall Study|Adverse Event|3|||
106040757|NCT02247531|365815826|FG001|Overall Study|Adverse Event|4|||
106040758|NCT02247531|365815827|FG002|Overall Study|Adverse Event|9|||
106040759|NCT02247531|365815825|FG000|Overall Study|Death|8|||
106040760|NCT02247531|365815826|FG001|Overall Study|Death|9|||
106040761|NCT02247531|365815827|FG002|Overall Study|Death|5|||
106040762|NCT02247531|365815825|FG000|Overall Study|Lost to Follow-up|1|||
105861339|NCT02186834|365143232|FG002|Treatment at RP2D|Died prior to treatment|0|||
105861340|NCT02186834|365143233|FG003|Treatment at RP2D|Died prior to treatment|0|||
105861341|NCT02186834|365143234|FG004|Treatment at RP2D|Died prior to treatment|0|||
105861342|NCT02186834|365143235|FG005|Treatment at RP2D|Died prior to treatment|1|||
106040763|NCT02247531|365815826|FG001|Overall Study|Lost to Follow-up|8|||
106040764|NCT02247531|365815827|FG002|Overall Study|Lost to Follow-up|3|||
106040765|NCT02247531|365815825|FG000|Overall Study|Non-compliance|2|||
106040766|NCT02247531|365815826|FG001|Overall Study|Non-compliance|2|||
106040767|NCT02247531|365815827|FG002|Overall Study|Non-compliance|0|||
106040768|NCT02247531|365815825|FG000|Overall Study|Withdrawal by Subject|26|||
106040769|NCT02247531|365815826|FG001|Overall Study|Withdrawal by Subject|31|||
106040770|NCT02247531|365815827|FG002|Overall Study|Withdrawal by Subject|25|||
106040771|NCT02247531|365815825|FG000|Overall Study|Study Terminated by Sponsor|64|||
106040772|NCT02247531|365815826|FG001|Overall Study|Study Terminated by Sponsor|66|||
106040773|NCT02247531|365815827|FG002|Overall Study|Study Terminated by Sponsor|62|||
106040774|NCT02247531|365815825|FG000|Overall Study|Physician Decision|0|||
106040775|NCT02247531|365815826|FG001|Overall Study|Physician Decision|2|||
106040776|NCT02247531|365815827|FG002|Overall Study|Physician Decision|2|||
106040777|NCT02247531|365815825|FG000|Overall Study|Unspecified Reason|2|||
106040778|NCT02247531|365815826|FG001|Overall Study|Unspecified Reason|3|||
106040779|NCT02247531|365815827|FG002|Overall Study|Unspecified Reason|4|||
106040780|NCT04123665|365815828|FG000|Overall Study|Withdrawal by Subject|7|||
106040781|NCT04123665|365815829|FG001|Overall Study|Withdrawal by Subject|0|||
106040782|NCT04123665|365815828|FG000|Overall Study|Lost to Follow-up|1|||
106040783|NCT04123665|365815829|FG001|Overall Study|Lost to Follow-up|0|||
106040784|NCT03646643|365815836|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
106040785|NCT03646643|365815837|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
106040786|NCT03646643|365815836|FG000|Overall Study|Lost to Follow-up|0|||
106040787|NCT03646643|365815837|FG001|Overall Study|Lost to Follow-up|1|||
106040788|NCT04521777|365815838|FG000|Overall Study|Death|2|||
106040789|NCT04521777|365815838|FG000|Overall Study|Withdrawal by Subject|2|||
106040790|NCT00145600|365815841|FG000|Overall Study|Death|1|||
106040791|NCT00145600|365815842|FG001|Overall Study|Death|2|||
105861343|NCT01755767|365143242|FG000|Overall Study|Progressive Disease|8|||
105861344|NCT01755767|365143243|FG001|Overall Study|Progressive Disease|7|||
105861345|NCT01755767|365143244|FG002|Overall Study|Progressive Disease|91|||
105861346|NCT01755767|365143245|FG003|Overall Study|Progressive Disease|43|||
105861347|NCT01755767|365143242|FG000|Overall Study|Clinical Disease Progression|4|||
105861348|NCT01755767|365143243|FG001|Overall Study|Clinical Disease Progression|2|||
105861349|NCT01755767|365143244|FG002|Overall Study|Clinical Disease Progression|29|||
105861350|NCT01755767|365143245|FG003|Overall Study|Clinical Disease Progression|20|||
105861351|NCT01755767|365143242|FG000|Overall Study|Radiographic Disease Progression|9|||
105861352|NCT01755767|365143243|FG001|Overall Study|Radiographic Disease Progression|4|||
105861353|NCT01755767|365143244|FG002|Overall Study|Radiographic Disease Progression|44|||
105861354|NCT01755767|365143245|FG003|Overall Study|Radiographic Disease Progression|27|||
105861355|NCT01755767|365143242|FG000|Overall Study|Adverse Event|6|||
105861356|NCT01755767|365143243|FG001|Overall Study|Adverse Event|0|||
105861357|NCT01755767|365143244|FG002|Overall Study|Adverse Event|28|||
105861358|NCT01755767|365143245|FG003|Overall Study|Adverse Event|11|||
105861359|NCT01755767|365143242|FG000|Overall Study|Death|1|||
105861360|NCT01755767|365143243|FG001|Overall Study|Death|2|||
105861361|NCT01755767|365143244|FG002|Overall Study|Death|15|||
105861362|NCT01755767|365143245|FG003|Overall Study|Death|4|||
105861363|NCT01755767|365143242|FG000|Overall Study|Subject Decision|0|||
105861364|NCT01755767|365143243|FG001|Overall Study|Subject Decision|0|||
105861365|NCT01755767|365143244|FG002|Overall Study|Subject Decision|10|||
105861366|NCT01755767|365143245|FG003|Overall Study|Subject Decision|3|||
105861367|NCT01755767|365143242|FG000|Overall Study|Withdrawal by Subject|0|||
105861368|NCT01755767|365143243|FG001|Overall Study|Withdrawal by Subject|0|||
105861369|NCT01755767|365143244|FG002|Overall Study|Withdrawal by Subject|2|||
105861370|NCT01755767|365143245|FG003|Overall Study|Withdrawal by Subject|1|||
105861371|NCT01755767|365143242|FG000|Overall Study|Other|0|||
105861372|NCT01755767|365143243|FG001|Overall Study|Other|0|||
105861373|NCT01755767|365143244|FG002|Overall Study|Other|2|||
105861374|NCT01755767|365143245|FG003|Overall Study|Other|3|||
105861375|NCT01755767|365143242|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
105861376|NCT01755767|365143243|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
105861377|NCT01755767|365143244|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
105861378|NCT01755767|365143245|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
106040792|NCT00145600|365815843|FG002|Overall Study|Death|2|||
106040793|NCT00145600|365815844|FG003|Overall Study|Death|6|||
106040794|NCT00145600|365815841|FG000|Overall Study|Ineligible|3|||
106040795|NCT00145600|365815842|FG001|Overall Study|Ineligible|0|||
106040796|NCT00145600|365815843|FG002|Overall Study|Ineligible|1|||
106040797|NCT00145600|365815844|FG003|Overall Study|Ineligible|5|||
106040798|NCT00145600|365815841|FG000|Overall Study|Lost to Follow-up|2|||
105861379|NCT02121392|365143249|FG000|Prior to Intervention|Protocol Violation|40|||
106040799|NCT00145600|365815842|FG001|Overall Study|Lost to Follow-up|6|||
105861380|NCT02121392|365143250|FG001|Prior to Intervention|Protocol Violation|35|||
105861381|NCT02121392|365143249|FG000|Prior to Intervention|Withdrawal by Subject|8|||
105861382|NCT02121392|365143250|FG001|Prior to Intervention|Withdrawal by Subject|6|||
105861383|NCT02121392|365143249|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
105861384|NCT02121392|365143250|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
105861385|NCT02121392|365143249|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
105861386|NCT02121392|365143250|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
105861387|NCT01352416|365143251|FG000|Overall Study|Physician Decision|1|||
105861388|NCT01352416|365143252|FG001|Overall Study|Physician Decision|2|||
105861389|NCT01352416|365143253|FG002|Overall Study|Physician Decision|2|||
105861390|NCT01352416|365143254|FG003|Overall Study|Physician Decision|1|||
105861391|NCT02730351|365143256|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
105861392|NCT02730351|365143257|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
105861393|NCT02730351|365143256|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
105861394|NCT02730351|365143257|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
105861395|NCT02730351|365143256|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
105861396|NCT02730351|365143257|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
105861397|NCT02730351|365143256|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
105861398|NCT02730351|365143257|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
105861399|NCT02730351|365143256|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
105861400|NCT02730351|365143257|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
105861401|NCT02257385|365143258|FG000|Overall Study|Adverse Event|12|||
105861402|NCT02257385|365143259|FG001|Overall Study|Adverse Event|8|||
105861403|NCT02257385|365143258|FG000|Overall Study|Lack of Efficacy|1|||
105861404|NCT02257385|365143259|FG001|Overall Study|Lack of Efficacy|2|||
105861405|NCT02257385|365143258|FG000|Overall Study|Protocol Violation|5|||
105861406|NCT02257385|365143259|FG001|Overall Study|Protocol Violation|7|||
105861407|NCT02257385|365143258|FG000|Overall Study|Lost to Follow-up|0|||
105861408|NCT02257385|365143259|FG001|Overall Study|Lost to Follow-up|1|||
105861409|NCT02257385|365143258|FG000|Overall Study|Withdrawal by Subject|4|||
105861410|NCT02257385|365143259|FG001|Overall Study|Withdrawal by Subject|4|||
105861411|NCT02087189|365143260|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
105861412|NCT02774642|365143267|FG000|Overall Study|Lost to Follow-up|9|||
105861413|NCT02774642|365143268|FG001|Overall Study|Lost to Follow-up|7|||
105861414|NCT03553576|365143269|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
105861415|NCT03553576|365143270|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
105861416|NCT03553576|365143269|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
105861417|NCT03553576|365143270|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
105861418|NCT03553576|365143269|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
105861419|NCT03553576|365143270|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
106040800|NCT00145600|365815843|FG002|Overall Study|Lost to Follow-up|2|||
106040801|NCT00145600|365815844|FG003|Overall Study|Lost to Follow-up|4|||
106040802|NCT00145600|365815841|FG000|Overall Study|Noncompliance|1|||
106040803|NCT00145600|365815842|FG001|Overall Study|Noncompliance|0|||
106040804|NCT00145600|365815843|FG002|Overall Study|Noncompliance|0|||
106040805|NCT00145600|365815844|FG003|Overall Study|Noncompliance|0|||
106040806|NCT00145600|365815841|FG000|Overall Study|Withdrawal by Subject|1|||
106040807|NCT00145600|365815842|FG001|Overall Study|Withdrawal by Subject|2|||
106040808|NCT00145600|365815843|FG002|Overall Study|Withdrawal by Subject|0|||
106040809|NCT00145600|365815844|FG003|Overall Study|Withdrawal by Subject|1|||
106040810|NCT05128773|365815847|FG000|Overall Study|Sponsor decision to terminate study|3|||
106040811|NCT02476422|365815848|FG000|Overall Study|Subject/guardian decision|0|||
106040812|NCT02476422|365815849|FG001|Overall Study|Subject/guardian decision|1|||
106040813|NCT00760214|365815850|FG000|Overall Study|Adverse Event|8|||
106040814|NCT00760214|365815851|FG001|Overall Study|Adverse Event|9|||
106040815|NCT00760214|365815852|FG002|Overall Study|Adverse Event|12|||
106040816|NCT00760214|365815850|FG000|Overall Study|Protocol Violation|3|||
106040817|NCT00760214|365815851|FG001|Overall Study|Protocol Violation|0|||
106151743|NCT02590432|366215136|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
105861420|NCT03553576|365143269|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
105861421|NCT03553576|365143270|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
105861422|NCT03553576|365143269|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
105861423|NCT03553576|365143270|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
105861424|NCT03553576|365143269|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
105861425|NCT03553576|365143270|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
106040818|NCT00760214|365815852|FG002|Overall Study|Protocol Violation|3|||
106040819|NCT00760214|365815850|FG000|Overall Study|Lost to Follow-up|0|||
106040820|NCT00760214|365815851|FG001|Overall Study|Lost to Follow-up|0|||
106040821|NCT00760214|365815852|FG002|Overall Study|Lost to Follow-up|1|||
106040822|NCT00760214|365815850|FG000|Overall Study|Withdrawal by Subject|12|||
106040823|NCT00760214|365815851|FG001|Overall Study|Withdrawal by Subject|14|||
106040824|NCT00760214|365815852|FG002|Overall Study|Withdrawal by Subject|13|||
106040825|NCT00760214|365815850|FG000|Overall Study|Lack of Efficacy|3|||
106040826|NCT00760214|365815851|FG001|Overall Study|Lack of Efficacy|2|||
106040827|NCT00760214|365815852|FG002|Overall Study|Lack of Efficacy|4|||
106040828|NCT00760214|365815850|FG000|Overall Study|Pregnancy|0|||
106040829|NCT00760214|365815851|FG001|Overall Study|Pregnancy|0|||
106040830|NCT00760214|365815852|FG002|Overall Study|Pregnancy|1|||
106040831|NCT00760214|365815850|FG000|Overall Study|Physician Decision|1|||
105861426|NCT03553576|365143269|FG000|Overall Study|Physician Decision|2|||
105861427|NCT03553576|365143270|FG001|Overall Study|Physician Decision|5|||
105861428|NCT01671332|365143271|FG000|Overall Study|Withdrawal by Subject|1|||
105861429|NCT01671332|365143272|FG001|Overall Study|Withdrawal by Subject|1|||
105861430|NCT00205803|365143273|FG000|Infant Series|Lost to Follow-up|10|||
105861431|NCT00205803|365143274|FG001|Infant Series|Lost to Follow-up|4|||
105861432|NCT00205803|365143273|FG000|Infant Series|Withdrawal by Subject|2|||
105861433|NCT00205803|365143274|FG001|Infant Series|Withdrawal by Subject|5|||
105861434|NCT00205803|365143273|FG000|Infant Series|Physician Decision|3|||
105861435|NCT00205803|365143274|FG001|Infant Series|Physician Decision|1|||
105861436|NCT00205803|365143273|FG000|Infant Series|Protocol Violation|1|||
105861437|NCT00205803|365143274|FG001|Infant Series|Protocol Violation|0|||
105861438|NCT00205803|365143273|FG000|Infant Series|Lost Kaiser coverage|0|||
105861439|NCT00205803|365143274|FG001|Infant Series|Lost Kaiser coverage|1|||
105861440|NCT00205803|365143273|FG000|Infant Series|Non-compliant|1|||
105861441|NCT00205803|365143274|FG001|Infant Series|Non-compliant|0|||
105861442|NCT00205803|365143273|FG000|Infant Series|Sponsor request|1|||
105861443|NCT00205803|365143274|FG001|Infant Series|Sponsor request|0|||
105861444|NCT00205803|365143273|FG000|After Infant Series|Adverse Event|1|||
105861445|NCT00205803|365143274|FG001|After Infant Series|Adverse Event|1|||
105861446|NCT00205803|365143273|FG000|After Infant Series|Protocol Violation|1|||
105861447|NCT00205803|365143274|FG001|After Infant Series|Protocol Violation|1|||
105861448|NCT00205803|365143273|FG000|After Infant Series|Lost to Follow-up|2|||
105861449|NCT00205803|365143274|FG001|After Infant Series|Lost to Follow-up|1|||
105861450|NCT00205803|365143273|FG000|After Infant Series|Physician Decision|3|||
105861451|NCT00205803|365143274|FG001|After Infant Series|Physician Decision|2|||
105861452|NCT00205803|365143273|FG000|After Infant Series|Withdrawal by Subject|1|||
105861453|NCT00205803|365143274|FG001|After Infant Series|Withdrawal by Subject|4|||
105861454|NCT00205803|365143273|FG000|After Infant Series|Other|10|||
105861455|NCT00205803|365143274|FG001|After Infant Series|Other|4|||
105861456|NCT00205803|365143273|FG000|Toddler Dose|Lost to Follow-up|2|||
105861457|NCT00205803|365143274|FG001|Toddler Dose|Lost to Follow-up|3|||
105861458|NCT02369458|365143277|FG000|Overall Study|Determined to be not eligible|1|||
105861459|NCT02369458|365143278|FG001|Overall Study|Determined to be not eligible|0|||
105861460|NCT00121134|365143279|FG000|Overall Study|Progression of Disease|5|||
105861461|NCT00121134|365143280|FG001|Overall Study|Progression of Disease|3|||
105861462|NCT00121134|365143281|FG002|Overall Study|Progression of Disease|4|||
105861463|NCT00121134|365143282|FG003|Overall Study|Progression of Disease|2|||
105861464|NCT00121134|365143279|FG000|Overall Study|Toxicity|4|||
105861465|NCT00121134|365143280|FG001|Overall Study|Toxicity|7|||
105861466|NCT00121134|365143281|FG002|Overall Study|Toxicity|13|||
105861467|NCT00121134|365143282|FG003|Overall Study|Toxicity|5|||
105861468|NCT00121134|365143279|FG000|Overall Study|Physician Decision|6|||
106040832|NCT00760214|365815851|FG001|Overall Study|Physician Decision|1|||
106040833|NCT00760214|365815852|FG002|Overall Study|Physician Decision|1|||
106040834|NCT00760214|365815850|FG000|Overall Study|Other|3|||
106040835|NCT00760214|365815851|FG001|Overall Study|Other|4|||
105861469|NCT00121134|365143280|FG001|Overall Study|Physician Decision|4|||
105861470|NCT00121134|365143281|FG002|Overall Study|Physician Decision|4|||
105861471|NCT00121134|365143282|FG003|Overall Study|Physician Decision|1|||
105861472|NCT00121134|365143279|FG000|Overall Study|Treatment Delay|1|||
105861473|NCT00121134|365143280|FG001|Overall Study|Treatment Delay|0|||
105861474|NCT00121134|365143281|FG002|Overall Study|Treatment Delay|0|||
105861475|NCT00121134|365143282|FG003|Overall Study|Treatment Delay|0|||
105861476|NCT00121134|365143279|FG000|Overall Study|Intercurrent Illness|0|||
105861477|NCT00121134|365143280|FG001|Overall Study|Intercurrent Illness|0|||
105861478|NCT00121134|365143281|FG002|Overall Study|Intercurrent Illness|0|||
105861479|NCT00121134|365143282|FG003|Overall Study|Intercurrent Illness|1|||
105861480|NCT00121134|365143279|FG000|Overall Study|Patient Personal Reasons|0|||
105861481|NCT00121134|365143280|FG001|Overall Study|Patient Personal Reasons|1|||
106040836|NCT00760214|365815852|FG002|Overall Study|Other|6|||
105861482|NCT00121134|365143281|FG002|Overall Study|Patient Personal Reasons|0|||
105861483|NCT00121134|365143282|FG003|Overall Study|Patient Personal Reasons|0|||
105861484|NCT00658021|365143284|FG000|28-Week Treatment Period|Adverse Event|3|||
105861485|NCT00658021|365143285|FG001|28-Week Treatment Period|Adverse Event|1|||
105861486|NCT00658021|365143286|FG002|28-Week Treatment Period|Adverse Event|0|||
105861487|NCT00658021|365143284|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
106040837|NCT02694523|365815856|FG000|Part A|Adverse Event|7|||
106040838|NCT02694523|365815857|FG001|Part A|Adverse Event|3|||
106040839|NCT02694523|365815858|FG002|Part A|Adverse Event|0|||
106040840|NCT02694523|365815859|FG003|Part A|Adverse Event|0|||
106040841|NCT02694523|365815860|FG004|Part A|Adverse Event|0|||
106040842|NCT02694523|365815861|FG005|Part A|Adverse Event|0|||
106040843|NCT02694523|365815862|FG006|Part A|Adverse Event|0|||
106040844|NCT02694523|365815856|FG000|Part A|Protocol Violation|1|||
106040845|NCT02694523|365815857|FG001|Part A|Protocol Violation|0|||
106040846|NCT02694523|365815858|FG002|Part A|Protocol Violation|0|||
106040847|NCT02694523|365815859|FG003|Part A|Protocol Violation|0|||
106040848|NCT02694523|365815860|FG004|Part A|Protocol Violation|0|||
106040849|NCT02694523|365815861|FG005|Part A|Protocol Violation|0|||
106040850|NCT02694523|365815862|FG006|Part A|Protocol Violation|0|||
106040851|NCT02694523|365815856|FG000|Part A|Lost to Follow-up|1|||
106040852|NCT02694523|365815857|FG001|Part A|Lost to Follow-up|2|||
106040853|NCT02694523|365815858|FG002|Part A|Lost to Follow-up|0|||
106040854|NCT02694523|365815859|FG003|Part A|Lost to Follow-up|0|||
106040855|NCT02694523|365815860|FG004|Part A|Lost to Follow-up|0|||
106040856|NCT02694523|365815861|FG005|Part A|Lost to Follow-up|0|||
106040857|NCT02694523|365815862|FG006|Part A|Lost to Follow-up|0|||
106040858|NCT02694523|365815856|FG000|Part A|Withdrawal by Subject|3|||
106040859|NCT02694523|365815857|FG001|Part A|Withdrawal by Subject|1|||
106040860|NCT02694523|365815858|FG002|Part A|Withdrawal by Subject|0|||
106040861|NCT02694523|365815859|FG003|Part A|Withdrawal by Subject|0|||
106040862|NCT02694523|365815860|FG004|Part A|Withdrawal by Subject|0|||
106040863|NCT02694523|365815861|FG005|Part A|Withdrawal by Subject|0|||
106040864|NCT02694523|365815862|FG006|Part A|Withdrawal by Subject|0|||
106040865|NCT02694523|365815856|FG000|Part A|Other|1|||
106040866|NCT02694523|365815857|FG001|Part A|Other|1|||
106040867|NCT02694523|365815858|FG002|Part A|Other|0|||
106040868|NCT02694523|365815859|FG003|Part A|Other|0|||
106040869|NCT02694523|365815860|FG004|Part A|Other|0|||
106040870|NCT02694523|365815861|FG005|Part A|Other|0|||
106040871|NCT02694523|365815862|FG006|Part A|Other|0|||
106040872|NCT02694523|365815856|FG000|Part B|Adverse Event|0|||
106040873|NCT02694523|365815857|FG001|Part B|Adverse Event|0|||
106040874|NCT02694523|365815858|FG002|Part B|Adverse Event|7|||
106040875|NCT02694523|365815859|FG003|Part B|Adverse Event|1|||
106040876|NCT02694523|365815860|FG004|Part B|Adverse Event|1|||
106040877|NCT02694523|365815861|FG005|Part B|Adverse Event|2|||
106040878|NCT02694523|365815862|FG006|Part B|Adverse Event|0|||
106040879|NCT02694523|365815856|FG000|Part B|Protocol Violation|0|||
106040880|NCT02694523|365815857|FG001|Part B|Protocol Violation|0|||
106040881|NCT02694523|365815858|FG002|Part B|Protocol Violation|1|||
106040882|NCT02694523|365815859|FG003|Part B|Protocol Violation|0|||
106040883|NCT02694523|365815860|FG004|Part B|Protocol Violation|0|||
106040884|NCT02694523|365815861|FG005|Part B|Protocol Violation|0|||
106040885|NCT02694523|365815862|FG006|Part B|Protocol Violation|0|||
106040886|NCT02694523|365815856|FG000|Part B|Lost to Follow-up|0|||
106040887|NCT02694523|365815857|FG001|Part B|Lost to Follow-up|0|||
106040888|NCT02694523|365815858|FG002|Part B|Lost to Follow-up|2|||
106040889|NCT02694523|365815859|FG003|Part B|Lost to Follow-up|3|||
106040890|NCT02694523|365815860|FG004|Part B|Lost to Follow-up|2|||
106040891|NCT02694523|365815861|FG005|Part B|Lost to Follow-up|0|||
106040892|NCT02694523|365815862|FG006|Part B|Lost to Follow-up|1|||
106151744|NCT02590432|366215137|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
106151745|NCT02590432|366215138|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
106040893|NCT02694523|365815856|FG000|Part B|Withdrawal by Subject|0|||
106040894|NCT02694523|365815857|FG001|Part B|Withdrawal by Subject|0|||
106040895|NCT02694523|365815858|FG002|Part B|Withdrawal by Subject|9|||
106040896|NCT02694523|365815859|FG003|Part B|Withdrawal by Subject|0|||
106040897|NCT02694523|365815860|FG004|Part B|Withdrawal by Subject|1|||
106040898|NCT02694523|365815861|FG005|Part B|Withdrawal by Subject|3|||
106040899|NCT02694523|365815862|FG006|Part B|Withdrawal by Subject|0|||
106040900|NCT02694523|365815856|FG000|Part B|Other|0|||
106040901|NCT02694523|365815857|FG001|Part B|Other|0|||
106040902|NCT02694523|365815858|FG002|Part B|Other|1|||
106040903|NCT02694523|365815859|FG003|Part B|Other|0|||
106040904|NCT02694523|365815860|FG004|Part B|Other|0|||
106040905|NCT02694523|365815861|FG005|Part B|Other|0|||
106040906|NCT02694523|365815862|FG006|Part B|Other|1|||
106040907|NCT01272661|365815864|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
106040908|NCT01272661|365815865|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
106040909|NCT01272661|365815866|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
106040910|NCT04137224|365815867|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
106040911|NCT04137224|365815868|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
106151746|NCT02590432|366215139|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
106151747|NCT02590432|366215140|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
106151748|NCT02590432|366215132|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
106151749|NCT02590432|366215133|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
106151750|NCT02590432|366215134|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
106151751|NCT02590432|366215135|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
106151752|NCT02590432|366215136|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
105861488|NCT00658021|365143285|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
105861489|NCT00658021|365143286|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
105861490|NCT00658021|365143284|FG000|28-Week Treatment Period|Protocol Violation|0|||
105861491|NCT00658021|365143285|FG001|28-Week Treatment Period|Protocol Violation|2|||
105861492|NCT00658021|365143286|FG002|28-Week Treatment Period|Protocol Violation|1|||
105861493|NCT00658021|365143284|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
105861494|NCT00658021|365143285|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
105861495|NCT00658021|365143286|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
105861496|NCT00658021|365143284|FG000|28-Week Treatment Period|Physician Decision|1|||
105861497|NCT00658021|365143285|FG001|28-Week Treatment Period|Physician Decision|2|||
105861498|NCT00658021|365143286|FG002|28-Week Treatment Period|Physician Decision|1|||
105861499|NCT00658021|365143284|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
105861500|NCT00658021|365143285|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
105861501|NCT00658021|365143286|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
105861502|NCT00658021|365143284|FG000|28-Week Treatment Period|Loss of glucose control|1|||
105861503|NCT00658021|365143285|FG001|28-Week Treatment Period|Loss of glucose control|1|||
105861504|NCT00658021|365143286|FG002|28-Week Treatment Period|Loss of glucose control|10|||
105861505|NCT00658021|365143284|FG000|28-Week Treatment Period|Other|2|||
105861506|NCT00658021|365143285|FG001|28-Week Treatment Period|Other|3|||
105861507|NCT00658021|365143286|FG002|28-Week Treatment Period|Other|1|||
105861508|NCT00658021|365143284|FG000|28-Week Treatment Period|Did not receive treatment|2|||
105861509|NCT00658021|365143285|FG001|28-Week Treatment Period|Did not receive treatment|0|||
105861510|NCT00658021|365143286|FG002|28-Week Treatment Period|Did not receive treatment|0|||
105861511|NCT00658021|365143284|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
105861512|NCT00658021|365143285|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
105861513|NCT00658021|365143286|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
105861514|NCT00658021|365143284|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
105861515|NCT00658021|365143285|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
105861516|NCT00658021|365143286|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
105861517|NCT01806506|365143287|FG000|Overall Study|Lost to Follow-up|2|||
105861518|NCT01806506|365143288|FG001|Overall Study|Lost to Follow-up|1|||
105861519|NCT04614246|365143289|FG000|Overall Study|Adverse Event|0|||
105861520|NCT04614246|365143290|FG001|Overall Study|Adverse Event|1|||
105861521|NCT04614246|365143291|FG002|Overall Study|Adverse Event|1|||
105861522|NCT04614246|365143292|FG003|Overall Study|Adverse Event|2|||
105861523|NCT04614246|365143293|FG004|Overall Study|Adverse Event|1|||
105861524|NCT04614246|365143289|FG000|Overall Study|Lost to Follow-up|0|||
105861525|NCT04614246|365143290|FG001|Overall Study|Lost to Follow-up|1|||
105861526|NCT04614246|365143291|FG002|Overall Study|Lost to Follow-up|0|||
105861527|NCT04614246|365143292|FG003|Overall Study|Lost to Follow-up|1|||
105861528|NCT04614246|365143293|FG004|Overall Study|Lost to Follow-up|3|||
105861529|NCT04614246|365143289|FG000|Overall Study|Other reason|0|||
105861530|NCT04614246|365143290|FG001|Overall Study|Other reason|1|||
105861531|NCT04614246|365143291|FG002|Overall Study|Other reason|2|||
105861532|NCT04614246|365143292|FG003|Overall Study|Other reason|0|||
105861533|NCT04614246|365143293|FG004|Overall Study|Other reason|0|||
105861534|NCT04614246|365143289|FG000|Overall Study|Withdrawal by Subject|4|||
105861535|NCT04614246|365143290|FG001|Overall Study|Withdrawal by Subject|2|||
105861536|NCT04614246|365143291|FG002|Overall Study|Withdrawal by Subject|4|||
105861537|NCT04614246|365143292|FG003|Overall Study|Withdrawal by Subject|3|||
105861538|NCT04614246|365143293|FG004|Overall Study|Withdrawal by Subject|4|||
105861539|NCT04614246|365143289|FG000|Overall Study|Physician Decision|0|||
105861540|NCT04614246|365143290|FG001|Overall Study|Physician Decision|2|||
106040912|NCT04137224|365815867|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
106040913|NCT04137224|365815868|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
106040914|NCT04137224|365815867|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
106040915|NCT04137224|365815868|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
105861541|NCT04614246|365143291|FG002|Overall Study|Physician Decision|1|||
105861542|NCT04614246|365143292|FG003|Overall Study|Physician Decision|0|||
105861543|NCT04614246|365143293|FG004|Overall Study|Physician Decision|0|||
105861544|NCT04614246|365143289|FG000|Overall Study|Study terminated by sponsor|10|||
105861545|NCT04614246|365143290|FG001|Overall Study|Study terminated by sponsor|15|||
105861546|NCT04614246|365143291|FG002|Overall Study|Study terminated by sponsor|12|||
105861547|NCT04614246|365143292|FG003|Overall Study|Study terminated by sponsor|13|||
105861548|NCT04614246|365143293|FG004|Overall Study|Study terminated by sponsor|9|||
105861549|NCT04614246|365143289|FG000|Overall Study|Pregnancy|2|||
105861550|NCT04614246|365143290|FG001|Overall Study|Pregnancy|0|||
105861551|NCT04614246|365143291|FG002|Overall Study|Pregnancy|1|||
105861552|NCT04614246|365143292|FG003|Overall Study|Pregnancy|0|||
105861553|NCT04614246|365143293|FG004|Overall Study|Pregnancy|0|||
105861554|NCT05819203|365143298|FG000|Overall Study|Protocol Violation|1|||
105861555|NCT05819203|365143299|FG001|Overall Study|Protocol Violation|2|||
105861556|NCT05819203|365143298|FG000|Overall Study|Withdrawal by Subject|1|||
106151753|NCT02590432|366215137|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
105861557|NCT05819203|365143299|FG001|Overall Study|Withdrawal by Subject|0|||
105861558|NCT00477633|365143300|FG000|Overall Study|Did not receive treatment|23|||
105861559|NCT00477633|365143300|FG000|Overall Study|Adverse Event|143|||
105861560|NCT00477633|365143300|FG000|Overall Study|Pregnancy|23|||
105861561|NCT00477633|365143300|FG000|Overall Study|Lost to Follow-up|271|||
105861562|NCT00477633|365143300|FG000|Overall Study|Withdrawal by Subject|149|||
105861563|NCT00477633|365143300|FG000|Overall Study|Protocol Violation|25|||
105861564|NCT00477633|365143300|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
105861565|NCT00213135|365145576|FG000|Overall Study|Adverse Event|9|||
105861566|NCT00213135|365145577|FG001|Overall Study|Adverse Event|5|||
105861567|NCT00213135|365145578|FG002|Overall Study|Adverse Event|5|||
105861568|NCT00213135|365145576|FG000|Overall Study|Lost to Follow-up|11|||
105861569|NCT00213135|365145577|FG001|Overall Study|Lost to Follow-up|8|||
105861570|NCT00213135|365145578|FG002|Overall Study|Lost to Follow-up|4|||
105861571|NCT00213135|365145576|FG000|Overall Study|Protocol Violation|4|||
105861572|NCT00213135|365145577|FG001|Overall Study|Protocol Violation|4|||
105861573|NCT00213135|365145578|FG002|Overall Study|Protocol Violation|10|||
105861574|NCT00213135|365145576|FG000|Overall Study|Death|1|||
105861575|NCT00213135|365145577|FG001|Overall Study|Death|1|||
105861576|NCT00213135|365145578|FG002|Overall Study|Death|2|||
105861577|NCT00213135|365145576|FG000|Overall Study|Disease progression|4|||
105861578|NCT00213135|365145577|FG001|Overall Study|Disease progression|5|||
105861579|NCT00213135|365145578|FG002|Overall Study|Disease progression|21|||
105861580|NCT00213135|365145576|FG000|Overall Study|Other|21|||
105861581|NCT00213135|365145577|FG001|Overall Study|Other|12|||
105861582|NCT00213135|365145578|FG002|Overall Study|Other|15|||
105861583|NCT01908907|365145579|FG000|Overall Study|Physician Decision|1|||
105861584|NCT01908907|365145580|FG001|Overall Study|Physician Decision|0|||
105861585|NCT01908907|365145579|FG000|Overall Study|Protocol Violation|1|||
105861586|NCT01908907|365145580|FG001|Overall Study|Protocol Violation|0|||
105861587|NCT00749892|365145581|FG000|Overall Study|Withdrawal by Subject|3|||
105861588|NCT04581369|365145582|FG000|Overall Study|Death|7|||
105861589|NCT04581369|365145583|FG001|Overall Study|Death|6|||
105861590|NCT04581369|365145584|FG002|Overall Study|Death|0|||
105861591|NCT04581369|365145582|FG000|Overall Study|Lost to Follow-up|7|||
105861592|NCT04581369|365145583|FG001|Overall Study|Lost to Follow-up|3|||
105861593|NCT04581369|365145584|FG002|Overall Study|Lost to Follow-up|0|||
105861594|NCT04581369|365145582|FG000|Overall Study|liver transplant|2|||
105861595|NCT04581369|365145583|FG001|Overall Study|liver transplant|2|||
105861596|NCT04581369|365145584|FG002|Overall Study|liver transplant|0|||
105861597|NCT04581369|365145582|FG000|Overall Study|transitioned to hospice care|0|||
105861598|NCT04581369|365145583|FG001|Overall Study|transitioned to hospice care|5|||
105861599|NCT04581369|365145584|FG002|Overall Study|transitioned to hospice care|0|||
105861600|NCT02473523|365145585|FG000|Overall Study|Death|1|||
105861601|NCT02473523|365145585|FG000|Overall Study|Lost to Follow-up|1|||
105861602|NCT01111825|365145586|FG000|Overall Study|Withdrawal by Subject|0|||
105861603|NCT01111825|365145587|FG001|Overall Study|Withdrawal by Subject|0|||
105861604|NCT01111825|365145588|FG002|Overall Study|Withdrawal by Subject|1|||
105861605|NCT01111825|365145589|FG003|Overall Study|Withdrawal by Subject|0|||
105861606|NCT01111825|365145586|FG000|Overall Study|Lost to Follow-up|0|||
105861607|NCT01111825|365145587|FG001|Overall Study|Lost to Follow-up|0|||
105861608|NCT01111825|365145588|FG002|Overall Study|Lost to Follow-up|3|||
105861609|NCT01111825|365145589|FG003|Overall Study|Lost to Follow-up|1|||
105861610|NCT01111825|365145586|FG000|Overall Study|Adverse Event|2|||
105861611|NCT01111825|365145587|FG001|Overall Study|Adverse Event|1|||
105861612|NCT01111825|365145588|FG002|Overall Study|Adverse Event|4|||
105861613|NCT01111825|365145589|FG003|Overall Study|Adverse Event|0|||
105861614|NCT01111825|365145586|FG000|Overall Study|Disease Progression|1|||
105861615|NCT01111825|365145587|FG001|Overall Study|Disease Progression|0|||
105861616|NCT01111825|365145588|FG002|Overall Study|Disease Progression|0|||
105861617|NCT01111825|365145589|FG003|Overall Study|Disease Progression|0|||
105861618|NCT01111825|365145586|FG000|Overall Study|Discontinuation by Sponsor|0|||
105861619|NCT01111825|365145587|FG001|Overall Study|Discontinuation by Sponsor|0|||
105861620|NCT01111825|365145588|FG002|Overall Study|Discontinuation by Sponsor|0|||
105861621|NCT01111825|365145589|FG003|Overall Study|Discontinuation by Sponsor|20|||
105861622|NCT01191944|365145590|FG000|Overall Study|Adverse Event|11|||
105861623|NCT01191944|365145591|FG001|Overall Study|Adverse Event|12|||
105861624|NCT01191944|365145590|FG000|Overall Study|Protocol Violation|1|||
105861625|NCT01191944|365145591|FG001|Overall Study|Protocol Violation|2|||
105861626|NCT01191944|365145590|FG000|Overall Study|Withdrawal by Subject|4|||
105861627|NCT01191944|365145591|FG001|Overall Study|Withdrawal by Subject|2|||
105861628|NCT01191944|365145590|FG000|Overall Study|Other|1|||
105861629|NCT01191944|365145591|FG001|Overall Study|Other|3|||
105861630|NCT00469144|365145594|FG000|Overall Study|Death|0|||
105861631|NCT00469144|365145595|FG001|Overall Study|Death|1|||
105861632|NCT00469144|365145594|FG000|Overall Study|No Response|5|||
105861633|NCT00469144|365145595|FG001|Overall Study|No Response|5|||
105861634|NCT00469144|365145594|FG000|Overall Study|Progressive Disease|1|||
105861635|NCT00469144|365145595|FG001|Overall Study|Progressive Disease|0|||
105861636|NCT00603837|365145596|FG000|Overall Study|Physician Decision|3|||
105861637|NCT00603837|365145597|FG001|Overall Study|Physician Decision|0|||
106040916|NCT01646073|365815871|FG000|Period A (12 Weeks)|Adverse Event|0|||
106040917|NCT01646073|365815872|FG001|Period A (12 Weeks)|Adverse Event|2|||
106040918|NCT01646073|365815871|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
106040919|NCT01646073|365815872|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
106040920|NCT01646073|365815871|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
106040921|NCT01646073|365815872|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
106040922|NCT01646073|365815871|FG000|Period A (12 Weeks)|Protocol Violation|0|||
106040923|NCT01646073|365815872|FG001|Period A (12 Weeks)|Protocol Violation|1|||
106040924|NCT01646073|365815871|FG000|Period A (12 Weeks)|Other|0|||
106040925|NCT01646073|365815872|FG001|Period A (12 Weeks)|Other|1|||
106040926|NCT01646073|365815871|FG000|Period B (12 Weeks)|Adverse Event|0|||
106040927|NCT01646073|365815872|FG001|Period B (12 Weeks)|Adverse Event|7|||
106040928|NCT01646073|365815871|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
106040929|NCT01646073|365815872|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
106040930|NCT01646073|365815871|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
106040931|NCT01646073|365815872|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
106040932|NCT00566501|365815873|FG000|Overall Study|Adverse Event|68|||
106040933|NCT00566501|365815874|FG001|Overall Study|Adverse Event|59|||
106040934|NCT00566501|365815873|FG000|Overall Study|Medication Non-compliance|5|||
106040935|NCT00566501|365815874|FG001|Overall Study|Medication Non-compliance|0|||
106040936|NCT00566501|365815873|FG000|Overall Study|Protocol Violation|2|||
106040937|NCT00566501|365815874|FG001|Overall Study|Protocol Violation|2|||
106040938|NCT00566501|365815873|FG000|Overall Study|Request of Investigator or Sponsor|6|||
106040939|NCT00566501|365815874|FG001|Overall Study|Request of Investigator or Sponsor|7|||
106040940|NCT00566501|365815873|FG000|Overall Study|Withdrawal by Subject|33|||
106040941|NCT00566501|365815874|FG001|Overall Study|Withdrawal by Subject|30|||
106040942|NCT00566501|365815873|FG000|Overall Study|Lack of Efficacy|8|||
106040943|NCT00566501|365815874|FG001|Overall Study|Lack of Efficacy|3|||
106040944|NCT00566501|365815873|FG000|Overall Study|Other|25|||
106040945|NCT00566501|365815874|FG001|Overall Study|Other|21|||
106040946|NCT00679055|365815878|FG000|Overall Study|Adverse Event|0|||
106040947|NCT00679055|365815879|FG001|Overall Study|Adverse Event|1|||
106040948|NCT00679055|365815878|FG000|Overall Study|Other|0|||
106040949|NCT00679055|365815879|FG001|Overall Study|Other|3|||
106040950|NCT00679055|365815878|FG000|Overall Study|Study Terminated|2|||
106040951|NCT00679055|365815879|FG001|Overall Study|Study Terminated|1|||
106040952|NCT01400815|365815880|FG000|Overall Study|Adverse Event|3|||
106040953|NCT01400815|365815881|FG001|Overall Study|Adverse Event|0|||
106040954|NCT01400815|365815880|FG000|Overall Study|Death|0|||
106040955|NCT01400815|365815881|FG001|Overall Study|Death|1|||
106040956|NCT01400815|365815880|FG000|Overall Study|Lost to Follow-up|18|||
106040957|NCT01400815|365815881|FG001|Overall Study|Lost to Follow-up|11|||
106040958|NCT01400815|365815880|FG000|Overall Study|Protocol Violation|0|||
106040959|NCT01400815|365815881|FG001|Overall Study|Protocol Violation|1|||
106040960|NCT01400815|365815880|FG000|Overall Study|Physician Decision|1|||
106040961|NCT01400815|365815881|FG001|Overall Study|Physician Decision|0|||
106040962|NCT01400815|365815880|FG000|Overall Study|Withdrawal by Subject|15|||
106040963|NCT01400815|365815881|FG001|Overall Study|Withdrawal by Subject|8|||
106040964|NCT01400815|365815880|FG000|Overall Study|Subject in jail|1|||
106040965|NCT01400815|365815881|FG001|Overall Study|Subject in jail|0|||
106040966|NCT01199731|365815888|FG000|Overall Study|Adverse Event|0|||
106040967|NCT01199731|365815889|FG001|Overall Study|Adverse Event|1|||
106040968|NCT01199731|365815890|FG002|Overall Study|Adverse Event|0|||
106040969|NCT01199731|365815888|FG000|Overall Study|Study closed/terminated|7|||
106040970|NCT01199731|365815889|FG001|Overall Study|Study closed/terminated|9|||
106040971|NCT01199731|365815890|FG002|Overall Study|Study closed/terminated|7|||
106040972|NCT01199731|365815888|FG000|Overall Study|Lost to Follow-up|0|||
106040973|NCT01199731|365815889|FG001|Overall Study|Lost to Follow-up|0|||
106040974|NCT01199731|365815890|FG002|Overall Study|Lost to Follow-up|2|||
106040975|NCT01199731|365815888|FG000|Overall Study|Physician Decision|0|||
106040976|NCT01199731|365815889|FG001|Overall Study|Physician Decision|1|||
106151754|NCT02590432|366215138|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
106151755|NCT02590432|366215139|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
105861638|NCT00229723|365145598|FG000|Concomitant Phase|Adverse Event|4|||
106040977|NCT01199731|365815890|FG002|Overall Study|Physician Decision|1|||
106040978|NCT01199731|365815888|FG000|Overall Study|Withdrawal by Subject|2|||
106040979|NCT01199731|365815889|FG001|Overall Study|Withdrawal by Subject|0|||
106040980|NCT01199731|365815890|FG002|Overall Study|Withdrawal by Subject|0|||
106040981|NCT02448810|365815891|FG000|Overall Study|Adverse Event|0|||
106040982|NCT02448810|365815892|FG001|Overall Study|Adverse Event|0|||
106040983|NCT02448810|365815893|FG002|Overall Study|Adverse Event|1|||
106040984|NCT02448810|365815894|FG003|Overall Study|Adverse Event|0|||
106040985|NCT02448810|365815895|FG004|Overall Study|Adverse Event|0|||
106040986|NCT02448810|365815896|FG005|Overall Study|Adverse Event|0|||
106040987|NCT02448810|365815897|FG006|Overall Study|Adverse Event|0|||
106040988|NCT02448810|365815898|FG007|Overall Study|Adverse Event|0|||
106040989|NCT02448810|365815891|FG000|Overall Study|Withdrawal by Subject|0|||
106040990|NCT02448810|365815892|FG001|Overall Study|Withdrawal by Subject|0|||
106040991|NCT02448810|365815893|FG002|Overall Study|Withdrawal by Subject|1|||
105861639|NCT00229723|365145599|FG001|Concomitant Phase|Adverse Event|2|||
105861640|NCT00229723|365145600|FG002|Concomitant Phase|Adverse Event|5|||
105861641|NCT00229723|365145601|FG003|Concomitant Phase|Adverse Event|2|||
105861642|NCT00229723|365145602|FG004|Concomitant Phase|Adverse Event|0|||
105861643|NCT00229723|365145603|FG005|Concomitant Phase|Adverse Event|1|||
105861644|NCT00229723|365145604|FG006|Concomitant Phase|Adverse Event|2|||
105861645|NCT00229723|365145598|FG000|Concomitant Phase|Objective disease progression|0|||
105861646|NCT00229723|365145599|FG001|Concomitant Phase|Objective disease progression|0|||
105861647|NCT00229723|365145600|FG002|Concomitant Phase|Objective disease progression|0|||
105861648|NCT00229723|365145601|FG003|Concomitant Phase|Objective disease progression|0|||
105861649|NCT00229723|365145602|FG004|Concomitant Phase|Objective disease progression|0|||
105861650|NCT00229723|365145603|FG005|Concomitant Phase|Objective disease progression|0|||
105861651|NCT00229723|365145604|FG006|Concomitant Phase|Objective disease progression|0|||
105861652|NCT00229723|365145598|FG000|Concomitant Phase|Clinical progression|0|||
105861653|NCT00229723|365145599|FG001|Concomitant Phase|Clinical progression|0|||
105861654|NCT00229723|365145600|FG002|Concomitant Phase|Clinical progression|0|||
105861655|NCT00229723|365145601|FG003|Concomitant Phase|Clinical progression|0|||
105861656|NCT00229723|365145602|FG004|Concomitant Phase|Clinical progression|0|||
105861657|NCT00229723|365145603|FG005|Concomitant Phase|Clinical progression|0|||
105861658|NCT00229723|365145604|FG006|Concomitant Phase|Clinical progression|1|||
105861659|NCT00229723|365145598|FG000|Concomitant Phase|Lost to Follow-up|0|||
105861660|NCT00229723|365145599|FG001|Concomitant Phase|Lost to Follow-up|0|||
105861661|NCT00229723|365145600|FG002|Concomitant Phase|Lost to Follow-up|0|||
105861662|NCT00229723|365145601|FG003|Concomitant Phase|Lost to Follow-up|0|||
105861663|NCT00229723|365145602|FG004|Concomitant Phase|Lost to Follow-up|1|||
105861664|NCT00229723|365145603|FG005|Concomitant Phase|Lost to Follow-up|0|||
105861665|NCT00229723|365145604|FG006|Concomitant Phase|Lost to Follow-up|0|||
105861666|NCT00229723|365145598|FG000|Concomitant Phase|Informed consent withdrawn|3|||
105861667|NCT00229723|365145599|FG001|Concomitant Phase|Informed consent withdrawn|2|||
105861668|NCT00229723|365145600|FG002|Concomitant Phase|Informed consent withdrawn|0|||
105861669|NCT00229723|365145601|FG003|Concomitant Phase|Informed consent withdrawn|2|||
105861670|NCT00229723|365145602|FG004|Concomitant Phase|Informed consent withdrawn|0|||
105861671|NCT00229723|365145603|FG005|Concomitant Phase|Informed consent withdrawn|0|||
105861672|NCT00229723|365145604|FG006|Concomitant Phase|Informed consent withdrawn|0|||
105861673|NCT00229723|365145598|FG000|Concomitant Phase|Severe non-compliance|0|||
105861674|NCT00229723|365145599|FG001|Concomitant Phase|Severe non-compliance|1|||
105861675|NCT00229723|365145600|FG002|Concomitant Phase|Severe non-compliance|0|||
105861676|NCT00229723|365145601|FG003|Concomitant Phase|Severe non-compliance|0|||
106040992|NCT02448810|365815894|FG003|Overall Study|Withdrawal by Subject|0|||
106040993|NCT02448810|365815895|FG004|Overall Study|Withdrawal by Subject|3|||
106040994|NCT02448810|365815896|FG005|Overall Study|Withdrawal by Subject|5|||
106040995|NCT02448810|365815897|FG006|Overall Study|Withdrawal by Subject|0|||
106040996|NCT02448810|365815898|FG007|Overall Study|Withdrawal by Subject|2|||
106040997|NCT02448810|365815891|FG000|Overall Study|Other (study terminated by sponsor)|0|||
106040998|NCT02448810|365815892|FG001|Overall Study|Other (study terminated by sponsor)|0|||
106040999|NCT02448810|365815893|FG002|Overall Study|Other (study terminated by sponsor)|0|||
106041000|NCT02448810|365815894|FG003|Overall Study|Other (study terminated by sponsor)|0|||
106041001|NCT02448810|365815895|FG004|Overall Study|Other (study terminated by sponsor)|4|||
106041002|NCT02448810|365815896|FG005|Overall Study|Other (study terminated by sponsor)|2|||
106041003|NCT02448810|365815897|FG006|Overall Study|Other (study terminated by sponsor)|2|||
106041004|NCT02448810|365815898|FG007|Overall Study|Other (study terminated by sponsor)|1|||
106041005|NCT02448810|365815891|FG000|Overall Study|Death|1|||
106041006|NCT02448810|365815892|FG001|Overall Study|Death|0|||
106041007|NCT02448810|365815893|FG002|Overall Study|Death|1|||
106041008|NCT02448810|365815894|FG003|Overall Study|Death|0|||
106041009|NCT02448810|365815895|FG004|Overall Study|Death|1|||
105861677|NCT00229723|365145602|FG004|Concomitant Phase|Severe non-compliance|1|||
105861678|NCT00229723|365145603|FG005|Concomitant Phase|Severe non-compliance|0|||
105861679|NCT00229723|365145604|FG006|Concomitant Phase|Severe non-compliance|0|||
105861680|NCT00229723|365145598|FG000|Concomitant Phase|Other|3|||
105861681|NCT00229723|365145599|FG001|Concomitant Phase|Other|0|||
105861682|NCT00229723|365145600|FG002|Concomitant Phase|Other|1|||
105861683|NCT00229723|365145601|FG003|Concomitant Phase|Other|1|||
105861684|NCT00229723|365145602|FG004|Concomitant Phase|Other|0|||
105861685|NCT00229723|365145603|FG005|Concomitant Phase|Other|2|||
105861686|NCT00229723|365145604|FG006|Concomitant Phase|Other|0|||
105861687|NCT00229723|365145598|FG000|Maintenance Phase|Adverse Event|7|||
105861688|NCT00229723|365145599|FG001|Maintenance Phase|Adverse Event|2|||
105861689|NCT00229723|365145600|FG002|Maintenance Phase|Adverse Event|1|||
105861690|NCT00229723|365145601|FG003|Maintenance Phase|Adverse Event|4|||
105861691|NCT00229723|365145602|FG004|Maintenance Phase|Adverse Event|7|||
105861692|NCT00229723|365145603|FG005|Maintenance Phase|Adverse Event|5|||
105861693|NCT00229723|365145604|FG006|Maintenance Phase|Adverse Event|2|||
106041010|NCT02448810|365815896|FG005|Overall Study|Death|0|||
106041011|NCT02448810|365815897|FG006|Overall Study|Death|0|||
106041012|NCT02448810|365815898|FG007|Overall Study|Death|0|||
106041013|NCT02448810|365815891|FG000|Overall Study|Other (Progressive disease)|2|||
105861694|NCT00229723|365145598|FG000|Maintenance Phase|Objective disease progression|5|||
105861695|NCT00229723|365145599|FG001|Maintenance Phase|Objective disease progression|5|||
105861696|NCT00229723|365145600|FG002|Maintenance Phase|Objective disease progression|3|||
105861697|NCT00229723|365145601|FG003|Maintenance Phase|Objective disease progression|6|||
105861698|NCT00229723|365145602|FG004|Maintenance Phase|Objective disease progression|2|||
105861699|NCT00229723|365145603|FG005|Maintenance Phase|Objective disease progression|9|||
105861700|NCT00229723|365145604|FG006|Maintenance Phase|Objective disease progression|5|||
105861701|NCT00229723|365145598|FG000|Maintenance Phase|Clinical progression|4|||
105861702|NCT00229723|365145599|FG001|Maintenance Phase|Clinical progression|1|||
105861703|NCT00229723|365145600|FG002|Maintenance Phase|Clinical progression|2|||
105861704|NCT00229723|365145601|FG003|Maintenance Phase|Clinical progression|2|||
105861705|NCT00229723|365145602|FG004|Maintenance Phase|Clinical progression|1|||
105861706|NCT00229723|365145603|FG005|Maintenance Phase|Clinical progression|1|||
105861707|NCT00229723|365145604|FG006|Maintenance Phase|Clinical progression|1|||
105861708|NCT00229723|365145598|FG000|Maintenance Phase|Lost to Follow-up|0|||
105861709|NCT00229723|365145599|FG001|Maintenance Phase|Lost to Follow-up|1|||
105861710|NCT00229723|365145600|FG002|Maintenance Phase|Lost to Follow-up|2|||
105861711|NCT00229723|365145601|FG003|Maintenance Phase|Lost to Follow-up|2|||
105861712|NCT00229723|365145602|FG004|Maintenance Phase|Lost to Follow-up|0|||
105861713|NCT00229723|365145603|FG005|Maintenance Phase|Lost to Follow-up|0|||
105861714|NCT00229723|365145604|FG006|Maintenance Phase|Lost to Follow-up|1|||
105861715|NCT00229723|365145598|FG000|Maintenance Phase|Informed consent withdrawn|1|||
105861716|NCT00229723|365145599|FG001|Maintenance Phase|Informed consent withdrawn|0|||
105861717|NCT00229723|365145600|FG002|Maintenance Phase|Informed consent withdrawn|0|||
105861718|NCT00229723|365145601|FG003|Maintenance Phase|Informed consent withdrawn|1|||
105861719|NCT00229723|365145602|FG004|Maintenance Phase|Informed consent withdrawn|1|||
105861720|NCT00229723|365145603|FG005|Maintenance Phase|Informed consent withdrawn|1|||
105861721|NCT00229723|365145604|FG006|Maintenance Phase|Informed consent withdrawn|0|||
105861722|NCT00229723|365145598|FG000|Maintenance Phase|Severe non-compliance|3|||
105861723|NCT00229723|365145599|FG001|Maintenance Phase|Severe non-compliance|1|||
105861724|NCT00229723|365145600|FG002|Maintenance Phase|Severe non-compliance|0|||
105861725|NCT00229723|365145601|FG003|Maintenance Phase|Severe non-compliance|0|||
105861726|NCT00229723|365145602|FG004|Maintenance Phase|Severe non-compliance|1|||
105861727|NCT00229723|365145603|FG005|Maintenance Phase|Severe non-compliance|0|||
105861728|NCT00229723|365145604|FG006|Maintenance Phase|Severe non-compliance|0|||
105861729|NCT00229723|365145598|FG000|Maintenance Phase|Other|5|||
105861730|NCT00229723|365145599|FG001|Maintenance Phase|Other|4|||
105861731|NCT00229723|365145600|FG002|Maintenance Phase|Other|1|||
105861732|NCT00229723|365145601|FG003|Maintenance Phase|Other|2|||
105861733|NCT00229723|365145602|FG004|Maintenance Phase|Other|3|||
105861734|NCT00229723|365145603|FG005|Maintenance Phase|Other|3|||
105861735|NCT00229723|365145604|FG006|Maintenance Phase|Other|1|||
105861736|NCT01346293|365145610|FG000|Overall Study|Protocol Violation|30|||
105861737|NCT01346293|365145611|FG001|Overall Study|Protocol Violation|9|||
105861738|NCT01346293|365145610|FG000|Overall Study|Lost to Follow-up|21|||
105861739|NCT01346293|365145611|FG001|Overall Study|Lost to Follow-up|8|||
105861740|NCT01346293|365145610|FG000|Overall Study|Withdrawal by Subject|15|||
105861741|NCT01346293|365145611|FG001|Overall Study|Withdrawal by Subject|4|||
105861742|NCT01346293|365145610|FG000|Overall Study|Other|1|||
105861743|NCT01346293|365145611|FG001|Overall Study|Other|0|||
105861744|NCT02015065|365145614|FG000|Overall Study|Death on study|1|||
105861745|NCT02015065|365145615|FG001|Overall Study|Death on study|2|||
105861746|NCT02015065|365145616|FG002|Overall Study|Death on study|1|||
105861747|NCT04106661|365145651|FG000|Overall Study|Protocol Violation|3|||
105861748|NCT04106661|365145652|FG001|Overall Study|Protocol Violation|0|||
105861749|NCT04106661|365145651|FG000|Overall Study|Scheduling difficulties|1|||
105861750|NCT04106661|365145652|FG001|Overall Study|Scheduling difficulties|1|||
105861751|NCT00233402|365145653|FG000|Overall Study|No pathology data|12|||
105861752|NCT00233402|365145654|FG001|Overall Study|No pathology data|9|||
105861753|NCT00233402|365145653|FG000|Overall Study|No Ta/T1|89|||
105861754|NCT00233402|365145654|FG001|Overall Study|No Ta/T1|94|||
105861755|NCT00233402|365145653|FG000|Overall Study|Lost to follow up etc|3|||
105861756|NCT00233402|365145654|FG001|Overall Study|Lost to follow up etc|21|||
105861757|NCT00838435|365145657|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
105861758|NCT00838435|365145657|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
105861759|NCT00838435|365145657|FG000|Part 2 (7 Years)|Adverse Event|2|||
105861760|NCT00838435|365145657|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
106041014|NCT02448810|365815892|FG001|Overall Study|Other (Progressive disease)|2|||
106041015|NCT02448810|365815893|FG002|Overall Study|Other (Progressive disease)|0|||
106041016|NCT02448810|365815894|FG003|Overall Study|Other (Progressive disease)|3|||
106041017|NCT02448810|365815895|FG004|Overall Study|Other (Progressive disease)|23|||
106041018|NCT02448810|365815896|FG005|Overall Study|Other (Progressive disease)|9|||
106041019|NCT02448810|365815897|FG006|Overall Study|Other (Progressive disease)|14|||
106041020|NCT02448810|365815898|FG007|Overall Study|Other (Progressive disease)|5|||
106041021|NCT02448810|365815891|FG000|Overall Study|Lost to Follow-up|0|||
106041022|NCT02448810|365815892|FG001|Overall Study|Lost to Follow-up|1|||
106041023|NCT02448810|365815893|FG002|Overall Study|Lost to Follow-up|0|||
106041024|NCT02448810|365815894|FG003|Overall Study|Lost to Follow-up|0|||
106041025|NCT02448810|365815895|FG004|Overall Study|Lost to Follow-up|0|||
106041026|NCT02448810|365815896|FG005|Overall Study|Lost to Follow-up|0|||
106041027|NCT02448810|365815897|FG006|Overall Study|Lost to Follow-up|0|||
106041028|NCT02448810|365815898|FG007|Overall Study|Lost to Follow-up|0|||
106041029|NCT02448810|365815891|FG000|Overall Study|Other (unspecified)|0|||
106041030|NCT02448810|365815892|FG001|Overall Study|Other (unspecified)|0|||
106041031|NCT02448810|365815893|FG002|Overall Study|Other (unspecified)|0|||
106041032|NCT02448810|365815894|FG003|Overall Study|Other (unspecified)|0|||
106041033|NCT02448810|365815895|FG004|Overall Study|Other (unspecified)|0|||
106041034|NCT02448810|365815896|FG005|Overall Study|Other (unspecified)|0|||
106041035|NCT02448810|365815897|FG006|Overall Study|Other (unspecified)|2|||
106041036|NCT02448810|365815898|FG007|Overall Study|Other (unspecified)|0|||
106041037|NCT00568685|365815901|FG000|Overall Study|Adverse Event|2|||
106041038|NCT00568685|365815902|FG001|Overall Study|Adverse Event|3|||
106041039|NCT00568685|365815903|FG002|Overall Study|Adverse Event|3|||
106041040|NCT00568685|365815901|FG000|Overall Study|Withdrawal by Subject|7|||
106041041|NCT00568685|365815902|FG001|Overall Study|Withdrawal by Subject|2|||
106041042|NCT00568685|365815903|FG002|Overall Study|Withdrawal by Subject|2|||
106041043|NCT00568685|365815901|FG000|Overall Study|Protocol Violation|1|||
106041044|NCT00568685|365815902|FG001|Overall Study|Protocol Violation|0|||
106041045|NCT00568685|365815903|FG002|Overall Study|Protocol Violation|0|||
106041046|NCT01462227|365815904|FG000|Second Assignment|Lost to Follow-up|1|||
106041047|NCT01462227|365815905|FG001|Second Assignment|Lost to Follow-up|0|||
106041048|NCT01462227|365815906|FG002|Second Assignment|Lost to Follow-up|0|||
106041049|NCT01462227|365815907|FG003|Second Assignment|Lost to Follow-up|0|||
106041050|NCT01462227|365815904|FG000|Second Assignment|Protocol Violation|0|||
106041051|NCT01462227|365815905|FG001|Second Assignment|Protocol Violation|1|||
106041052|NCT01462227|365815906|FG002|Second Assignment|Protocol Violation|1|||
106041053|NCT01462227|365815907|FG003|Second Assignment|Protocol Violation|0|||
106041054|NCT02393690|365815908|FG000|Overall Study|Ineligible|0|||
106041055|NCT02393690|365815909|FG001|Overall Study|Ineligible|1|||
106041056|NCT00591266|365815910|FG000|Overall Study|Adverse Event|2|||
106041057|NCT00591266|365815911|FG001|Overall Study|Adverse Event|2|||
106041058|NCT00591266|365815912|FG002|Overall Study|Adverse Event|3|||
106041059|NCT00591266|365815910|FG000|Overall Study|Lost to Follow-up|0|||
106041060|NCT00591266|365815911|FG001|Overall Study|Lost to Follow-up|1|||
106041061|NCT00591266|365815912|FG002|Overall Study|Lost to Follow-up|0|||
106041062|NCT00591266|365815910|FG000|Overall Study|Protocol Violation|0|||
106041063|NCT00591266|365815911|FG001|Overall Study|Protocol Violation|0|||
106041064|NCT00591266|365815912|FG002|Overall Study|Protocol Violation|1|||
106041065|NCT00591266|365815910|FG000|Overall Study|Withdrawal by Subject|6|||
106041066|NCT00591266|365815911|FG001|Overall Study|Withdrawal by Subject|2|||
106041067|NCT00591266|365815912|FG002|Overall Study|Withdrawal by Subject|5|||
105861761|NCT00838435|365145657|FG000|Part 2 (7 Years)|Physician Decision|1|||
106041068|NCT00591266|365815910|FG000|Overall Study|Lack of Efficacy|0|||
106041069|NCT00591266|365815911|FG001|Overall Study|Lack of Efficacy|2|||
106041070|NCT00591266|365815912|FG002|Overall Study|Lack of Efficacy|0|||
106041071|NCT00591266|365815910|FG000|Overall Study|Other|1|||
106151756|NCT02590432|366215140|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
106151757|NCT02590432|366215132|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
106151758|NCT02590432|366215133|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
106041072|NCT00591266|365815911|FG001|Overall Study|Other|4|||
106041073|NCT00591266|365815912|FG002|Overall Study|Other|5|||
106041074|NCT00901927|365815915|FG000|Overall Study|Lack of Efficacy|1|||
106041075|NCT00901927|365815915|FG000|Overall Study|Protocol Violation|3|||
106041076|NCT00901927|365815915|FG000|Overall Study|Withdrawal by Subject|2|||
106041077|NCT00586846|365815916|FG000|Overall Study|Physician Decision|1|||
106041078|NCT00586846|365815916|FG000|Overall Study|Death|1|||
106041079|NCT00586846|365815916|FG000|Overall Study|Evaluable for Toxicity Only|4|||
106041080|NCT01697358|365815920|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
106041081|NCT01697358|365815921|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
106041082|NCT01697358|365815920|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
106041083|NCT01697358|365815921|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
106041084|NCT01697358|365815920|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
106041085|NCT01697358|365815921|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
106041086|NCT01697358|365815920|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
106041087|NCT01697358|365815921|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
106041088|NCT01697358|365815920|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
106041089|NCT01697358|365815921|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
106041090|NCT01697358|365815920|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
106041091|NCT01697358|365815921|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
106041092|NCT01697358|365815920|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
106041093|NCT01697358|365815921|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
106041094|NCT01697358|365815920|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
106041095|NCT01697358|365815921|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
106041096|NCT01697358|365815920|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
106041097|NCT01697358|365815921|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
106041098|NCT01697358|365815920|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
106041099|NCT01697358|365815921|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
106041100|NCT03538431|365815922|FG000|Overall Study|Physician Decision|0|||
106041101|NCT03538431|365815923|FG001|Overall Study|Physician Decision|1|||
106041102|NCT03538431|365815922|FG000|Overall Study|Withdrawal by Subject|1|||
106041103|NCT03538431|365815923|FG001|Overall Study|Withdrawal by Subject|0|||
106041104|NCT00620464|365815924|FG000|Overall Study|Adverse Event|15|||
106041105|NCT00620464|365815925|FG001|Overall Study|Adverse Event|17|||
106041106|NCT00620464|365815924|FG000|Overall Study|Lost to Follow-up|1|||
106041107|NCT00620464|365815925|FG001|Overall Study|Lost to Follow-up|1|||
106041108|NCT00620464|365815924|FG000|Overall Study|Planning Pregnancy|1|||
106041109|NCT00620464|365815925|FG001|Overall Study|Planning Pregnancy|4|||
106041110|NCT00620464|365815924|FG000|Overall Study|Personal|2|||
106041111|NCT00620464|365815925|FG001|Overall Study|Personal|2|||
106041112|NCT00620464|365815924|FG000|Overall Study|Used prohibited medication|1|||
106041113|NCT00620464|365815925|FG001|Overall Study|Used prohibited medication|0|||
106041114|NCT00586066|365815926|FG000|Overall Study|Lost to Follow-up|6|||
106041115|NCT00586066|365815927|FG001|Overall Study|Lost to Follow-up|3|||
106041116|NCT00586066|365815926|FG000|Overall Study|Lack of Efficacy|5|||
106041117|NCT00586066|365815927|FG001|Overall Study|Lack of Efficacy|3|||
106041118|NCT00586066|365815926|FG000|Overall Study|Adverse Event|2|||
106041119|NCT00586066|365815927|FG001|Overall Study|Adverse Event|2|||
106041120|NCT00586066|365815926|FG000|Overall Study|Physician Decision|1|||
106041121|NCT00586066|365815927|FG001|Overall Study|Physician Decision|0|||
106041122|NCT00586066|365815926|FG000|Overall Study|Withdrawal of consent|4|||
106041123|NCT00586066|365815927|FG001|Overall Study|Withdrawal of consent|2|||
106041124|NCT00410202|365815930|FG000|On-Treatment|Continuing treatment|69|||
106041125|NCT00410202|365815931|FG001|On-Treatment|Continuing treatment|71|||
106041126|NCT00410202|365815932|FG002|On-Treatment|Continuing treatment|66|||
106041127|NCT00410202|365815930|FG000|On-Treatment|Adverse Event|1|||
106041128|NCT00410202|365815931|FG001|On-Treatment|Adverse Event|3|||
106041129|NCT00410202|365815932|FG002|On-Treatment|Adverse Event|2|||
106041130|NCT00410202|365815930|FG000|On-Treatment|Death|1|||
106041131|NCT00410202|365815931|FG001|On-Treatment|Death|0|||
106041132|NCT00410202|365815932|FG002|On-Treatment|Death|0|||
106041133|NCT00410202|365815930|FG000|On-Treatment|Lost to Follow-up|1|||
106041134|NCT00410202|365815931|FG001|On-Treatment|Lost to Follow-up|0|||
106041135|NCT00410202|365815932|FG002|On-Treatment|Lost to Follow-up|1|||
106041136|NCT00410202|365815930|FG000|On-Treatment|Lack of Efficacy|1|||
106041137|NCT00410202|365815931|FG001|On-Treatment|Lack of Efficacy|4|||
106041138|NCT00410202|365815932|FG002|On-Treatment|Lack of Efficacy|0|||
106041139|NCT00410202|365815930|FG000|On-Treatment|Withdrawal by Subject|2|||
106041140|NCT00410202|365815931|FG001|On-Treatment|Withdrawal by Subject|1|||
106041141|NCT00410202|365815932|FG002|On-Treatment|Withdrawal by Subject|1|||
106041142|NCT00410202|365815930|FG000|On-Treatment|Other Reason|0|||
106041143|NCT00410202|365815931|FG001|On-Treatment|Other Reason|0|||
106041144|NCT00410202|365815932|FG002|On-Treatment|Other Reason|1|||
106041145|NCT00410202|365815930|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
106041146|NCT00410202|365815931|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
106151759|NCT02590432|366215134|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
106151760|NCT02590432|366215135|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
106041147|NCT00410202|365815932|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
106041148|NCT00410202|365815930|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
106041149|NCT00410202|365815931|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
106041150|NCT00410202|365815932|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
106041151|NCT00410202|365815930|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
106041152|NCT00410202|365815931|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
106041153|NCT00410202|365815932|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
106041154|NCT03139279|365815933|FG000|Overall Study|Physician Decision|2|||
106041155|NCT03139279|365815934|FG001|Overall Study|Physician Decision|0|||
106041156|NCT03139279|365815933|FG000|Overall Study|Protocol Violation|5|||
106041157|NCT03139279|365815934|FG001|Overall Study|Protocol Violation|4|||
106041158|NCT03139279|365815933|FG000|Overall Study|Withdrawal by Subject|0|||
106041159|NCT03139279|365815934|FG001|Overall Study|Withdrawal by Subject|2|||
106041160|NCT01369615|365815935|FG000|Overall Study|Withdrawal by Subject|0|||
106041161|NCT01369615|365815936|FG001|Overall Study|Withdrawal by Subject|1|||
106041162|NCT01369615|365815935|FG000|Overall Study|Lost to Follow-up|0|||
106041163|NCT01369615|365815936|FG001|Overall Study|Lost to Follow-up|1|||
106041164|NCT04263454|365815937|FG000|Overall Study|Adverse Event|0|||
106041165|NCT04263454|365815938|FG001|Overall Study|Adverse Event|2|||
106041166|NCT04263454|365815937|FG000|Overall Study|Physician Decision|3|||
106041167|NCT04263454|365815938|FG001|Overall Study|Physician Decision|5|||
106041168|NCT04263454|365815937|FG000|Overall Study|Poor Data Quality|0|||
106041169|NCT04263454|365815938|FG001|Overall Study|Poor Data Quality|1|||
106041170|NCT02676466|365815939|FG000|Overall Study|Death|0|||
106041171|NCT02676466|365815940|FG001|Overall Study|Death|2|||
106041172|NCT02676466|365815941|FG002|Overall Study|Death|1|||
106041173|NCT02676466|365815942|FG003|Overall Study|Death|0|||
106041174|NCT02676466|365815943|FG004|Overall Study|Death|0|||
106041175|NCT02676466|365815944|FG005|Overall Study|Death|0|||
106041176|NCT02676466|365815945|FG006|Overall Study|Death|0|||
106041177|NCT02676466|365815946|FG007|Overall Study|Death|0|||
106041178|NCT02676466|365815939|FG000|Overall Study|Withdrawal by Subject|4|||
106041179|NCT02676466|365815940|FG001|Overall Study|Withdrawal by Subject|3|||
106041180|NCT02676466|365815941|FG002|Overall Study|Withdrawal by Subject|1|||
106041181|NCT02676466|365815942|FG003|Overall Study|Withdrawal by Subject|0|||
106041182|NCT02676466|365815943|FG004|Overall Study|Withdrawal by Subject|3|||
106041183|NCT02676466|365815944|FG005|Overall Study|Withdrawal by Subject|1|||
106041184|NCT02676466|365815945|FG006|Overall Study|Withdrawal by Subject|1|||
106041185|NCT02676466|365815946|FG007|Overall Study|Withdrawal by Subject|1|||
106041186|NCT01178073|365815949|FG000|Overall Study|Adverse Event|34|||
106041187|NCT01178073|365815950|FG001|Overall Study|Adverse Event|27|||
106041188|NCT01178073|365815951|FG002|Overall Study|Adverse Event|24|||
106041189|NCT01178073|365815949|FG000|Overall Study|Protocol Violation|1|||
106041190|NCT01178073|365815950|FG001|Overall Study|Protocol Violation|1|||
106041191|NCT01178073|365815951|FG002|Overall Study|Protocol Violation|1|||
106041192|NCT01178073|365815949|FG000|Overall Study|Lost to Follow-up|2|||
106041193|NCT01178073|365815950|FG001|Overall Study|Lost to Follow-up|0|||
106041194|NCT01178073|365815951|FG002|Overall Study|Lost to Follow-up|3|||
106041195|NCT01178073|365815949|FG000|Overall Study|Physician Decision|14|||
106041196|NCT01178073|365815950|FG001|Overall Study|Physician Decision|10|||
106041197|NCT01178073|365815951|FG002|Overall Study|Physician Decision|10|||
106041198|NCT01178073|365815949|FG000|Overall Study|Withdrawal by Subject|10|||
106041199|NCT01178073|365815950|FG001|Overall Study|Withdrawal by Subject|6|||
106041200|NCT01178073|365815951|FG002|Overall Study|Withdrawal by Subject|8|||
106041201|NCT01178073|365815949|FG000|Overall Study|Missing Completion Status|1|||
106041202|NCT01178073|365815950|FG001|Overall Study|Missing Completion Status|0|||
106041203|NCT01178073|365815951|FG002|Overall Study|Missing Completion Status|0|||
106041204|NCT00986479|365815956|FG000|Period 1|Improved mood|1|||
106041205|NCT00986479|365815957|FG001|Period 1|Improved mood|0|||
106041206|NCT00986479|365815956|FG000|Period 1|Administrative reasons|1|||
106041207|NCT00986479|365815957|FG001|Period 1|Administrative reasons|0|||
106041208|NCT01702571|365815961|FG000|Overall Study|Death|1067|||
106041209|NCT01702571|365815962|FG001|Overall Study|Death|76|||
106041210|NCT01702571|365815961|FG000|Overall Study|Lost to Follow-up|144|||
106041211|NCT01702571|365815962|FG001|Overall Study|Lost to Follow-up|10|||
106041212|NCT01702571|365815961|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
106041213|NCT01702571|365815962|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
106041214|NCT01702571|365815961|FG000|Overall Study|Investigator Decision|5|||
106041215|NCT01702571|365815962|FG001|Overall Study|Investigator Decision|0|||
106041216|NCT01702571|365815961|FG000|Overall Study|Not Classifiable|1|||
106041217|NCT01702571|365815962|FG001|Overall Study|Not Classifiable|0|||
106041218|NCT01702571|365815961|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
106041219|NCT01702571|365815962|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
106041220|NCT01702571|365815961|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
106041221|NCT01702571|365815962|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
106041222|NCT01702571|365815961|FG000|Overall Study|Progressive Disease|3|||
106041223|NCT01702571|365815962|FG001|Overall Study|Progressive Disease|0|||
106041224|NCT01702571|365815961|FG000|Overall Study|Protocol Violation|2|||
106041225|NCT01702571|365815962|FG001|Overall Study|Protocol Violation|0|||
106041226|NCT01702571|365815961|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
106041227|NCT01702571|365815962|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
106041228|NCT01702571|365815961|FG000|Overall Study|Termination By Sponsor|4|||
106041229|NCT01702571|365815962|FG001|Overall Study|Termination By Sponsor|0|||
106041230|NCT01702571|365815961|FG000|Overall Study|Withdrawal by Subject|177|||
106041231|NCT01702571|365815962|FG001|Overall Study|Withdrawal by Subject|29|||
106041232|NCT03004443|365815963|FG000|Overall Study|Pregnancy|0|||
106041233|NCT03004443|365815964|FG001|Overall Study|Pregnancy|1|||
106041234|NCT00828854|365815965|FG000|Overall Study|Disease Progression|17|||
106041235|NCT00828854|365815965|FG000|Overall Study|Adverse Event|9|||
106041236|NCT00828854|365815965|FG000|Overall Study|Reason not Specified|1|||
106041237|NCT00667602|365815967|FG000|Overall Study|Withdrawal by Subject|4|||
106041238|NCT00667602|365815968|FG001|Overall Study|Withdrawal by Subject|9|||
106041239|NCT00667602|365815969|FG002|Overall Study|Withdrawal by Subject|10|||
106041240|NCT00667602|365815967|FG000|Overall Study|Lost to Follow-up|4|||
106041241|NCT00667602|365815968|FG001|Overall Study|Lost to Follow-up|5|||
106041242|NCT00667602|365815969|FG002|Overall Study|Lost to Follow-up|6|||
106041243|NCT00667602|365815967|FG000|Overall Study|Administrative reason|0|||
106041244|NCT00667602|365815968|FG001|Overall Study|Administrative reason|0|||
106041245|NCT00667602|365815969|FG002|Overall Study|Administrative reason|2|||
106041246|NCT00667602|365815967|FG000|Overall Study|Protocol Violation|0|||
106041247|NCT00667602|365815968|FG001|Overall Study|Protocol Violation|1|||
106041248|NCT00667602|365815969|FG002|Overall Study|Protocol Violation|0|||
106041249|NCT00406718|365815970|FG000|Overall Study|Withdrawal by Subject|2|||
105861762|NCT00838435|365145657|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
105861763|NCT00838435|365145657|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
105861764|NCT00895414|365145658|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
105861765|NCT00895414|365145659|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
105861766|NCT00895414|365145658|FG000|First Intervention (14 Days)|Physician Decision|0|||
105861767|NCT00895414|365145659|FG001|First Intervention (14 Days)|Physician Decision|1|||
106041250|NCT00406718|365815971|FG001|Overall Study|Withdrawal by Subject|9|||
106041251|NCT00406718|365815972|FG002|Overall Study|Withdrawal by Subject|4|||
106041252|NCT00406718|365815970|FG000|Overall Study|Lost to Follow-up|2|||
106041253|NCT00406718|365815971|FG001|Overall Study|Lost to Follow-up|5|||
106041254|NCT00406718|365815972|FG002|Overall Study|Lost to Follow-up|4|||
106041255|NCT03187756|365815973|FG000|Overall Study|Termination of study|4|||
106041256|NCT00084838|365817291|FG000|Overall Study|Death|1|||
106041257|NCT00084838|365817291|FG000|Overall Study|Adverse Event|2|||
106041258|NCT00084838|365817291|FG000|Overall Study|Withdrawal by Subject|1|||
106041259|NCT00084838|365817291|FG000|Overall Study|Progressive Disease|4|||
106041260|NCT00084838|365817291|FG000|Overall Study|Pt Non-Compliance|1|||
106041261|NCT00084838|365817291|FG000|Overall Study|Ineligible|4|||
106041262|NCT00122278|365817292|FG000|Overall Study|Lost to Follow-up|2|||
106041263|NCT00122278|365817293|FG001|Overall Study|Lost to Follow-up|0|||
106041264|NCT01002482|365817294|FG000|Overall Study|Withdrawal by Subject|14|||
106041265|NCT01002482|365817295|FG001|Overall Study|Withdrawal by Subject|21|||
106041266|NCT01002482|365817294|FG000|Overall Study|Included twice|1|||
106041267|NCT01002482|365817295|FG001|Overall Study|Included twice|0|||
106041268|NCT05108922|365817299|FG000|Overall Study|Adverse Event|2|||
106041269|NCT05108922|365817300|FG001|Overall Study|Adverse Event|3|||
105861768|NCT00252239|365145660|FG000|Overall Study|Withdrawal by Subject|1|||
105861769|NCT00252239|365145661|FG001|Overall Study|Withdrawal by Subject|0|||
105861770|NCT00252239|365145662|FG002|Overall Study|Withdrawal by Subject|0|||
105861771|NCT00252239|365145663|FG003|Overall Study|Withdrawal by Subject|1|||
105861772|NCT00252239|365145660|FG000|Overall Study|Lost to Follow-up|0|||
105861773|NCT00252239|365145661|FG001|Overall Study|Lost to Follow-up|0|||
105861774|NCT00252239|365145662|FG002|Overall Study|Lost to Follow-up|2|||
105861775|NCT00252239|365145663|FG003|Overall Study|Lost to Follow-up|0|||
105861776|NCT00789737|365145668|FG000|Overall Study|Withdrawal by Subject|13|||
105861777|NCT00789737|365145669|FG001|Overall Study|Withdrawal by Subject|22|||
105861778|NCT00789737|365145668|FG000|Overall Study|Lost to Follow-up|10|||
105861779|NCT00789737|365145669|FG001|Overall Study|Lost to Follow-up|14|||
105861780|NCT00789737|365145668|FG000|Overall Study|Adverse Event|8|||
105861781|NCT00789737|365145669|FG001|Overall Study|Adverse Event|8|||
105861782|NCT00789737|365145668|FG000|Overall Study|Protocol Violation|3|||
105861783|NCT00789737|365145669|FG001|Overall Study|Protocol Violation|0|||
105861784|NCT00789737|365145668|FG000|Overall Study|Lack of Efficacy|3|||
105861785|NCT00789737|365145669|FG001|Overall Study|Lack of Efficacy|0|||
105861786|NCT00789737|365145668|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
105861787|NCT00789737|365145669|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
105861788|NCT00789737|365145668|FG000|Overall Study|Other|11|||
105861789|NCT00789737|365145669|FG001|Overall Study|Other|7|||
105861790|NCT01189487|365145676|FG000|Overall Study|Lack of Efficacy|2|||
106041270|NCT05108922|365817299|FG000|Overall Study|Lost to Follow-up|2|||
106041271|NCT05108922|365817300|FG001|Overall Study|Lost to Follow-up|1|||
105861791|NCT01189487|365145676|FG000|Overall Study|Adverse Event|1|||
105861792|NCT00587990|365145677|FG000|Overall Study|Death|0|||
105861793|NCT00587990|365145678|FG001|Overall Study|Death|0|||
105861794|NCT00587990|365145679|FG002|Overall Study|Death|1|||
105861795|NCT04630158|365145680|FG000|Overall Study|Adverse Event|1|||
106041272|NCT05108922|365817299|FG000|Overall Study|Inadvertent enrollment|0|||
106041273|NCT05108922|365817300|FG001|Overall Study|Inadvertent enrollment|1|||
106041274|NCT05108922|365817299|FG000|Overall Study|Physician Decision|2|||
106041275|NCT05108922|365817300|FG001|Overall Study|Physician Decision|3|||
106041276|NCT05108922|365817299|FG000|Overall Study|Protocol deviation|1|||
106041277|NCT05108922|365817300|FG001|Overall Study|Protocol deviation|0|||
106041278|NCT05108922|365817299|FG000|Overall Study|Screen failure|1|||
106041279|NCT05108922|365817300|FG001|Overall Study|Screen failure|0|||
106041280|NCT05108922|365817299|FG000|Overall Study|Withdrawal by Subject|11|||
106041281|NCT05108922|365817300|FG001|Overall Study|Withdrawal by Subject|8|||
105861796|NCT04630158|365145681|FG001|Overall Study|Adverse Event|1|||
105861797|NCT04630158|365145682|FG002|Overall Study|Adverse Event|1|||
105861798|NCT04630158|365145680|FG000|Overall Study|Physician Decision|0|||
105861799|NCT04630158|365145681|FG001|Overall Study|Physician Decision|2|||
105861800|NCT04630158|365145682|FG002|Overall Study|Physician Decision|0|||
105861801|NCT04630158|365145680|FG000|Overall Study|Protocol Violation|1|||
105861802|NCT04630158|365145681|FG001|Overall Study|Protocol Violation|0|||
105861803|NCT04630158|365145682|FG002|Overall Study|Protocol Violation|1|||
105861804|NCT04630158|365145680|FG000|Overall Study|Withdrawal by Subject|2|||
105861805|NCT04630158|365145681|FG001|Overall Study|Withdrawal by Subject|1|||
105861806|NCT04630158|365145682|FG002|Overall Study|Withdrawal by Subject|2|||
105861807|NCT02754856|365145683|FG000|Overall Study|Withdrawal by Subject|1|||
105861808|NCT04868968|365145690|FG000|Overall Study|Lost to Follow-up|1|||
105861809|NCT00384930|365145691|FG000|Overall Study|Adverse Event|5|||
105861810|NCT00384930|365145692|FG001|Overall Study|Adverse Event|4|||
105861811|NCT00384930|365145693|FG002|Overall Study|Adverse Event|12|||
105861812|NCT00384930|365145694|FG003|Overall Study|Adverse Event|11|||
105861813|NCT00384930|365145695|FG004|Overall Study|Adverse Event|14|||
105861814|NCT00384930|365145691|FG000|Overall Study|Entry Criteria Not Met|2|||
105861815|NCT00384930|365145692|FG001|Overall Study|Entry Criteria Not Met|6|||
105861816|NCT00384930|365145693|FG002|Overall Study|Entry Criteria Not Met|7|||
105861817|NCT00384930|365145694|FG003|Overall Study|Entry Criteria Not Met|8|||
105861818|NCT00384930|365145695|FG004|Overall Study|Entry Criteria Not Met|4|||
105861819|NCT00384930|365145691|FG000|Overall Study|Lack of Efficacy|1|||
105861820|NCT00384930|365145692|FG001|Overall Study|Lack of Efficacy|1|||
105861821|NCT00384930|365145693|FG002|Overall Study|Lack of Efficacy|2|||
105861822|NCT00384930|365145694|FG003|Overall Study|Lack of Efficacy|1|||
105861823|NCT00384930|365145695|FG004|Overall Study|Lack of Efficacy|2|||
105861824|NCT00384930|365145691|FG000|Overall Study|Lost to Follow-up|5|||
105861825|NCT00384930|365145692|FG001|Overall Study|Lost to Follow-up|3|||
105861826|NCT00384930|365145693|FG002|Overall Study|Lost to Follow-up|0|||
105861827|NCT00384930|365145694|FG003|Overall Study|Lost to Follow-up|4|||
105861828|NCT00384930|365145695|FG004|Overall Study|Lost to Follow-up|6|||
105861829|NCT00384930|365145691|FG000|Overall Study|Physician Decision|0|||
105861830|NCT00384930|365145692|FG001|Overall Study|Physician Decision|1|||
105861831|NCT00384930|365145693|FG002|Overall Study|Physician Decision|1|||
105861832|NCT00384930|365145694|FG003|Overall Study|Physician Decision|0|||
105861833|NCT00384930|365145695|FG004|Overall Study|Physician Decision|1|||
105861834|NCT00384930|365145691|FG000|Overall Study|Protocol Violation|1|||
105861835|NCT00384930|365145692|FG001|Overall Study|Protocol Violation|0|||
105861836|NCT00384930|365145693|FG002|Overall Study|Protocol Violation|1|||
105861837|NCT00384930|365145694|FG003|Overall Study|Protocol Violation|6|||
105861838|NCT00384930|365145695|FG004|Overall Study|Protocol Violation|4|||
105861839|NCT00384930|365145691|FG000|Overall Study|Sponsor Decision|3|||
105861840|NCT00384930|365145692|FG001|Overall Study|Sponsor Decision|4|||
105861841|NCT00384930|365145693|FG002|Overall Study|Sponsor Decision|0|||
105861842|NCT00384930|365145694|FG003|Overall Study|Sponsor Decision|5|||
105861843|NCT00384930|365145695|FG004|Overall Study|Sponsor Decision|0|||
105861844|NCT00384930|365145691|FG000|Overall Study|Withdrawal by Subject|9|||
105861845|NCT00384930|365145692|FG001|Overall Study|Withdrawal by Subject|7|||
105861846|NCT00384930|365145693|FG002|Overall Study|Withdrawal by Subject|7|||
105861847|NCT00384930|365145694|FG003|Overall Study|Withdrawal by Subject|6|||
105861848|NCT00384930|365145695|FG004|Overall Study|Withdrawal by Subject|16|||
105861849|NCT00384930|365145691|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
105861850|NCT00384930|365145692|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
105861851|NCT00384930|365145693|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
105861852|NCT00384930|365145694|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
105861853|NCT00384930|365145695|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
105861854|NCT01147107|365145696|FG000|Overall Study|Lack of Efficacy|5|||
105861855|NCT01147107|365145697|FG001|Overall Study|Lack of Efficacy|0|||
105861856|NCT01147107|365145696|FG000|Overall Study|Withdrawal by Subject|1|||
105861857|NCT01147107|365145697|FG001|Overall Study|Withdrawal by Subject|1|||
105861858|NCT04988087|365145705|FG000|Overall Study|Adverse Event|4|||
105861859|NCT04988087|365145706|FG001|Overall Study|Adverse Event|0|||
105861860|NCT04988087|365145707|FG002|Overall Study|Adverse Event|0|||
105861861|NCT04988087|365145708|FG003|Overall Study|Adverse Event|0|||
105861862|NCT04988087|365145705|FG000|Overall Study|Withdrawal by Subject|1|||
105861863|NCT04988087|365145706|FG001|Overall Study|Withdrawal by Subject|1|||
105861864|NCT04988087|365145707|FG002|Overall Study|Withdrawal by Subject|0|||
105861865|NCT04988087|365145708|FG003|Overall Study|Withdrawal by Subject|0|||
105861866|NCT04988087|365145705|FG000|Overall Study|Technical problems|7|||
105861867|NCT04988087|365145706|FG001|Overall Study|Technical problems|9|||
105861868|NCT04988087|365145707|FG002|Overall Study|Technical problems|1|||
105861869|NCT04988087|365145708|FG003|Overall Study|Technical problems|2|||
105861870|NCT02458287|365145709|FG000|Overall Study|Adverse Event|0|||
105861871|NCT02458287|365145710|FG001|Overall Study|Adverse Event|0|||
105861872|NCT02458287|365145711|FG002|Overall Study|Adverse Event|0|||
106041282|NCT01854658|365817301|FG000|Overall Study|Protocol Violation|6|||
106041283|NCT01854658|365817302|FG001|Overall Study|Protocol Violation|2|||
106041284|NCT01854658|365817303|FG002|Overall Study|Protocol Violation|2|||
106041285|NCT01854658|365817304|FG003|Overall Study|Protocol Violation|1|||
106041286|NCT01854658|365817301|FG000|Overall Study|Physician Decision|7|||
106041287|NCT01854658|365817302|FG001|Overall Study|Physician Decision|5|||
106041288|NCT01854658|365817303|FG002|Overall Study|Physician Decision|2|||
106041289|NCT01854658|365817304|FG003|Overall Study|Physician Decision|4|||
106041290|NCT01854658|365817301|FG000|Overall Study|Lost to Follow-up|8|||
106041291|NCT01854658|365817302|FG001|Overall Study|Lost to Follow-up|9|||
106041292|NCT01854658|365817303|FG002|Overall Study|Lost to Follow-up|8|||
106041293|NCT01854658|365817304|FG003|Overall Study|Lost to Follow-up|4|||
106041294|NCT01854658|365817301|FG000|Overall Study|Withdrawal by Subject|28|||
106041295|NCT01854658|365817302|FG001|Overall Study|Withdrawal by Subject|21|||
106041296|NCT01854658|365817303|FG002|Overall Study|Withdrawal by Subject|29|||
106041297|NCT01854658|365817304|FG003|Overall Study|Withdrawal by Subject|15|||
106041298|NCT01854658|365817301|FG000|Overall Study|Protocol-specified criteria|15|||
106041299|NCT01854658|365817302|FG001|Overall Study|Protocol-specified criteria|15|||
106041300|NCT01854658|365817303|FG002|Overall Study|Protocol-specified criteria|10|||
106041301|NCT01854658|365817304|FG003|Overall Study|Protocol-specified criteria|7|||
106041302|NCT01854658|365817301|FG000|Overall Study|Lack of Efficacy|3|||
106041303|NCT01854658|365817302|FG001|Overall Study|Lack of Efficacy|8|||
106041304|NCT01854658|365817303|FG002|Overall Study|Lack of Efficacy|4|||
106041305|NCT01854658|365817304|FG003|Overall Study|Lack of Efficacy|7|||
106041306|NCT01854658|365817301|FG000|Overall Study|Adverse Event|21|||
106041307|NCT01854658|365817302|FG001|Overall Study|Adverse Event|14|||
106041308|NCT01854658|365817303|FG002|Overall Study|Adverse Event|23|||
106041309|NCT01854658|365817304|FG003|Overall Study|Adverse Event|19|||
106041310|NCT01854658|365817301|FG000|Overall Study|Administrative reasons|5|||
106041311|NCT01854658|365817302|FG001|Overall Study|Administrative reasons|1|||
106041312|NCT01854658|365817303|FG002|Overall Study|Administrative reasons|2|||
106041313|NCT01854658|365817304|FG003|Overall Study|Administrative reasons|2|||
106041314|NCT04444895|365817305|FG000|Overall Study|Adverse Event|2|||
106041315|NCT04444895|365817305|FG000|Overall Study|Lost to Follow-up|2|||
106041316|NCT04444895|365817305|FG000|Overall Study|Withdrawal by Subject|5|||
106041317|NCT01795638|365817306|FG000|Overall Study|Death|0|||
106041318|NCT01795638|365817307|FG001|Overall Study|Death|3|||
106041319|NCT01795638|365817306|FG000|Overall Study|transferred to quaternary hospital|2|||
106041320|NCT01795638|365817307|FG001|Overall Study|transferred to quaternary hospital|3|||
106041321|NCT01795638|365817306|FG000|Overall Study|Protocol Violation|3|||
106041322|NCT01795638|365817307|FG001|Overall Study|Protocol Violation|0|||
106041323|NCT01795638|365817306|FG000|Overall Study|discharged from hospital|7|||
106041324|NCT01795638|365817307|FG001|Overall Study|discharged from hospital|5|||
106041325|NCT01795638|365817306|FG000|Overall Study|Withdrawal by Subject|1|||
106041326|NCT01795638|365817307|FG001|Overall Study|Withdrawal by Subject|0|||
106041327|NCT03875118|365817308|FG000|Overall Study|Withdrawal by Subject|4|||
106041328|NCT03875118|365817309|FG001|Overall Study|Withdrawal by Subject|4|||
106041329|NCT01442038|365817310|FG000|Overall Study|Death|35|||
106041330|NCT01442038|365817311|FG001|Overall Study|Death|29|||
106041331|NCT01442038|365817310|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
106041332|NCT01442038|365817311|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
106041333|NCT01442038|365817310|FG000|Overall Study|Participant Withdrew Consent|137|||
106041334|NCT01442038|365817311|FG001|Overall Study|Participant Withdrew Consent|102|||
106041335|NCT01442038|365817310|FG000|Overall Study|Lost to Follow-up|37|||
106041336|NCT01442038|365817311|FG001|Overall Study|Lost to Follow-up|51|||
106041337|NCT01442038|365817310|FG000|Overall Study|Adverse Event|26|||
106041338|NCT01442038|365817311|FG001|Overall Study|Adverse Event|15|||
106041339|NCT01442038|365817310|FG000|Overall Study|Protocol Deviation|9|||
106041340|NCT01442038|365817311|FG001|Overall Study|Protocol Deviation|20|||
106041341|NCT01442038|365817310|FG000|Overall Study|Investigator's Discretion|13|||
106041342|NCT01442038|365817311|FG001|Overall Study|Investigator's Discretion|16|||
106041343|NCT01442038|365817310|FG000|Overall Study|Study Terminated By Sponsor|2|||
106041344|NCT01442038|365817311|FG001|Overall Study|Study Terminated By Sponsor|3|||
106041345|NCT04622735|365817315|FG000|Overall Study|Lost to Follow-up|1|||
106041346|NCT04622735|365817316|FG001|Overall Study|Lost to Follow-up|2|||
106041347|NCT04622735|365817317|FG002|Overall Study|Lost to Follow-up|1|||
106041348|NCT04622735|365817315|FG000|Overall Study|Adverse Event|0|||
106041349|NCT04622735|365817316|FG001|Overall Study|Adverse Event|0|||
106041350|NCT04622735|365817317|FG002|Overall Study|Adverse Event|1|||
106041351|NCT04622735|365817315|FG000|Overall Study|Protocol Violation|1|||
106041352|NCT04622735|365817316|FG001|Overall Study|Protocol Violation|0|||
106041353|NCT04622735|365817317|FG002|Overall Study|Protocol Violation|0|||
106041354|NCT05007717|365817318|FG000|Overall Study|Death|3|||
106041355|NCT05007717|365817319|FG001|Overall Study|Death|2|||
106041356|NCT05314478|365817320|FG000|Overall Study|Physician Decision|1|||
106041357|NCT04060862|365817323|FG000|Overall Study|Symptomatic Deterioration|1|||
106041358|NCT04060862|365817323|FG000|Overall Study|Un-specified|6|||
106041359|NCT04060862|365817323|FG000|Overall Study|Progressive disease|12|||
106041360|NCT04060862|365817323|FG000|Overall Study|Physician Decision|1|||
106041361|NCT01325623|365817324|FG000|Overall Study|Withdrawal by Subject|3|||
106041362|NCT03875768|365817327|FG000|Overall Study|Lost to Follow-up|16|||
106041363|NCT03875768|365817328|FG001|Overall Study|Lost to Follow-up|13|||
106041364|NCT03875768|365817327|FG000|Overall Study|Withdrawal by Subject|10|||
106041365|NCT03875768|365817328|FG001|Overall Study|Withdrawal by Subject|21|||
106041366|NCT03875768|365817327|FG000|Overall Study|Did not complete assessment|21|||
106041367|NCT03875768|365817328|FG001|Overall Study|Did not complete assessment|12|||
106041368|NCT03875768|365817327|FG000|Overall Study|Became ineligible|1|||
106041369|NCT03875768|365817328|FG001|Overall Study|Became ineligible|0|||
106041370|NCT00777205|365817331|FG000|Overall Study|Lost to Follow-up|25|||
106041371|NCT00777205|365817332|FG001|Overall Study|Lost to Follow-up|9|||
106041372|NCT00777205|365817331|FG000|Overall Study|Withdrawal by Subject|6|||
106041373|NCT00777205|365817332|FG001|Overall Study|Withdrawal by Subject|4|||
106041374|NCT00777205|365817331|FG000|Overall Study|Death|0|||
106041375|NCT00777205|365817332|FG001|Overall Study|Death|2|||
106041376|NCT00777205|365817331|FG000|Overall Study|Protocol Violation|0|||
106041377|NCT00777205|365817332|FG001|Overall Study|Protocol Violation|56|||
106041378|NCT03053271|365817335|FG000|Overall Study|Did not meet randomization criteria|3|||
106041379|NCT03053271|365817335|FG000|Overall Study|Withdrawal by Subject|1|||
106041380|NCT03114488|365817336|FG000|Time Period 2|Withdrawal by Subject|1|||
106041381|NCT03114488|365817337|FG001|Time Period 2|Withdrawal by Subject|3|||
106041382|NCT01225887|365817339|FG000|Overall Study|Ineligible:required test not done|2|||
106041383|NCT01225887|365817339|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
106041384|NCT01225887|365817339|FG000|Overall Study|Ineligible:inadequate pathology|2|||
106041385|NCT02869438|365817340|FG000|Overall Study|Lost to Follow-up|1|||
106041386|NCT02869438|365817341|FG001|Overall Study|Lost to Follow-up|0|||
106041387|NCT02869438|365817340|FG000|Overall Study|Adverse Event|1|||
106041388|NCT02869438|365817341|FG001|Overall Study|Adverse Event|0|||
106041389|NCT02869438|365817340|FG000|Overall Study|Withdrawal by Subject|1|||
106041390|NCT02869438|365817341|FG001|Overall Study|Withdrawal by Subject|2|||
106041391|NCT01669928|365817342|FG000|First Intervention|Withdrawal by Subject|3|||
106041392|NCT01669928|365817343|FG001|First Intervention|Withdrawal by Subject|5|||
106041393|NCT00057876|365817346|FG000|Overall Study|Adverse Event|8|||
106041394|NCT00057876|365817347|FG001|Overall Study|Adverse Event|8|||
106041395|NCT00057876|365817346|FG000|Overall Study|Death|2|||
106041396|NCT00057876|365817347|FG001|Overall Study|Death|1|||
106041397|NCT00057876|365817346|FG000|Overall Study|Withdrawal by Subject|5|||
106041398|NCT00057876|365817347|FG001|Overall Study|Withdrawal by Subject|6|||
106041399|NCT00057876|365817346|FG000|Overall Study|Lack of Efficacy|10|||
106041400|NCT00057876|365817347|FG001|Overall Study|Lack of Efficacy|8|||
106041401|NCT00057876|365817346|FG000|Overall Study|Ineligible|1|||
106041402|NCT00057876|365817347|FG001|Overall Study|Ineligible|2|||
106041403|NCT00057876|365817346|FG000|Overall Study|other reason|2|||
106041404|NCT00057876|365817347|FG001|Overall Study|other reason|2|||
106041405|NCT00057876|365817346|FG000|Overall Study|other complicating disease|1|||
106041406|NCT00057876|365817347|FG001|Overall Study|other complicating disease|0|||
106041407|NCT01368432|365817350|FG000|Overall Study|Lost to Follow-up|0|||
106041408|NCT01368432|365817351|FG001|Overall Study|Lost to Follow-up|1|||
106041409|NCT01130103|365817357|FG000|Randomized Treatment|Adverse Event|1|||
106041410|NCT01130103|365817358|FG001|Randomized Treatment|Adverse Event|1|||
106041411|NCT01130103|365817357|FG000|Randomized Treatment|Lost to Follow-up|1|||
106041412|NCT01130103|365817358|FG001|Randomized Treatment|Lost to Follow-up|0|||
106041413|NCT01130103|365817357|FG000|Randomized Treatment|Protocol Violation|3|||
106041414|NCT01130103|365817358|FG001|Randomized Treatment|Protocol Violation|2|||
106041415|NCT01130103|365817357|FG000|Randomized Treatment|Withdrawal by Subject|1|||
106041416|NCT01130103|365817358|FG001|Randomized Treatment|Withdrawal by Subject|2|||
106041417|NCT01130103|365817357|FG000|Maintenance Treatment|Lack of Efficacy|0|||
106041418|NCT01130103|365817358|FG001|Maintenance Treatment|Lack of Efficacy|1|||
106041419|NCT01130103|365817357|FG000|Maintenance Treatment|Lost to Follow-up|1|||
106041420|NCT01130103|365817358|FG001|Maintenance Treatment|Lost to Follow-up|1|||
106041421|NCT01130103|365817357|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
106041422|NCT01130103|365817358|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
106041423|NCT01916967|365817360|FG000|Overall Study|Adverse Event|0|||
106041424|NCT01916967|365817361|FG001|Overall Study|Adverse Event|0|||
106041425|NCT01916967|365817362|FG002|Overall Study|Adverse Event|2|||
106041426|NCT01916967|365817360|FG000|Overall Study|Lack of Efficacy|0|||
106041427|NCT01916967|365817361|FG001|Overall Study|Lack of Efficacy|0|||
106041428|NCT01916967|365817362|FG002|Overall Study|Lack of Efficacy|6|||
106041429|NCT01916967|365817360|FG000|Overall Study|Physician Decision|0|||
106041430|NCT01916967|365817361|FG001|Overall Study|Physician Decision|0|||
106041431|NCT01916967|365817362|FG002|Overall Study|Physician Decision|1|||
106041432|NCT01916967|365817360|FG000|Overall Study|Protocol Violation|0|||
106041433|NCT01916967|365817361|FG001|Overall Study|Protocol Violation|1|||
106041434|NCT01916967|365817362|FG002|Overall Study|Protocol Violation|0|||
106041435|NCT01437878|365817369|FG000|Overall Study|Withdrawal by Subject|1|||
106041436|NCT01437878|365817370|FG001|Overall Study|Withdrawal by Subject|0|||
106041437|NCT01528215|365817373|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
106041438|NCT01528215|365817374|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
106041439|NCT01528215|365817373|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
106041440|NCT01528215|365817374|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
106041441|NCT01528215|365817373|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
106041442|NCT01528215|365817374|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
106041443|NCT01528215|365817373|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
106041444|NCT01528215|365817374|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
106041445|NCT01147172|365817375|FG000|Overall Study|Withdrawal by Subject|2|||
106041446|NCT01147172|365817375|FG000|Overall Study|Lost to Follow-up|2|||
106041447|NCT03488927|365817376|FG000|Overall Study|Withdrawal by Subject|44|||
106041448|NCT03488927|365817377|FG001|Overall Study|Withdrawal by Subject|118|||
106041449|NCT03488927|365817378|FG002|Overall Study|Withdrawal by Subject|217|||
106041450|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
106041451|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
106041452|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Death|1|||
106041453|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Death|0|||
106041454|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
106041455|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
106041456|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
106041457|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
106041458|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
106041459|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
106041460|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
106041461|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
106041462|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
106041463|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
106041464|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
106041465|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
106041466|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
106041467|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
106041468|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
106041469|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
106041470|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
106041471|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
106041472|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
106041473|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
106041474|NCT02927262|365817381|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
106041475|NCT02927262|365817382|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
106041476|NCT02927262|365817381|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
106041477|NCT02927262|365817382|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
106041478|NCT02927262|365817381|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
106041479|NCT02927262|365817382|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
106041480|NCT02927262|365817381|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
106041481|NCT02927262|365817382|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
106041482|NCT00923936|365817383|FG000|Overall Study|progressive disease on study|2|||
106041483|NCT00923936|365817384|FG001|Overall Study|progressive disease on study|1|||
106041484|NCT00923936|365817383|FG000|Overall Study|Adverse Event|2|||
106041485|NCT00923936|365817384|FG001|Overall Study|Adverse Event|1|||
106041486|NCT00923936|365817383|FG000|Overall Study|Lost to follow up|2|||
106041487|NCT00923936|365817384|FG001|Overall Study|Lost to follow up|0|||
106041488|NCT00923936|365817383|FG000|Overall Study|Continuing in follow up period|2|||
106041489|NCT00923936|365817384|FG001|Overall Study|Continuing in follow up period|1|||
106041490|NCT05298306|365817386|FG000|Overall Study|Physician Decision|0|||
106041491|NCT05298306|365817387|FG001|Overall Study|Physician Decision|0|||
106041492|NCT05298306|365817388|FG002|Overall Study|Physician Decision|0|||
106041493|NCT05298306|365817389|FG003|Overall Study|Physician Decision|1|||
106041494|NCT05298306|365817390|FG004|Overall Study|Physician Decision|0|||
106041495|NCT05298306|365817391|FG005|Overall Study|Physician Decision|0|||
106041496|NCT00467610|365817396|FG000|Overall Study|Withdrawal by Subject|1|||
106041497|NCT03971071|365817403|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
106041498|NCT03971071|365817404|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
106041499|NCT03971071|365817405|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
106041500|NCT03971071|365817406|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
106041501|NCT03971071|365817407|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
106041502|NCT03971071|365817403|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
106041503|NCT03971071|365817404|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
106041504|NCT03971071|365817405|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
106041505|NCT03971071|365817406|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
106041506|NCT03971071|365817407|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
106041507|NCT03971071|365817403|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
106041508|NCT03971071|365817404|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
106041509|NCT03971071|365817405|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
106041510|NCT03971071|365817406|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
106041511|NCT03971071|365817407|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
106041512|NCT03971071|365817403|FG000|Open-label Treatment Period|Sponsor decision|0|||
106041513|NCT03971071|365817404|FG001|Open-label Treatment Period|Sponsor decision|0|||
106041514|NCT03971071|365817405|FG002|Open-label Treatment Period|Sponsor decision|0|||
106041515|NCT03971071|365817406|FG003|Open-label Treatment Period|Sponsor decision|0|||
106041516|NCT03971071|365817407|FG004|Open-label Treatment Period|Sponsor decision|1|||
106041517|NCT03971071|365817403|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
106041518|NCT03971071|365817404|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
106041519|NCT03971071|365817405|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
106041520|NCT03971071|365817406|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
106041521|NCT03971071|365817407|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
106041522|NCT03971071|365817403|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
106041523|NCT03971071|365817404|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
106041524|NCT03971071|365817405|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
106041525|NCT03971071|365817406|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
106041526|NCT03971071|365817407|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
106041527|NCT00292318|365817408|FG000|Overall Study|Study terminated by officials|2|||
106041528|NCT00292318|365817409|FG001|Overall Study|Study terminated by officials|1|||
106041529|NCT00771316|365817410|FG000|Overall Study|Adverse Event|0|||
106041530|NCT00771316|365817411|FG001|Overall Study|Adverse Event|1|||
106041531|NCT00771316|365817410|FG000|Overall Study|Patient withdrew consent|1|||
106041532|NCT00771316|365817411|FG001|Overall Study|Patient withdrew consent|0|||
106041533|NCT00771316|365817410|FG000|Overall Study|Discontinued due to early termination|1|||
106041534|NCT00771316|365817411|FG001|Overall Study|Discontinued due to early termination|0|||
106041535|NCT01626495|365817412|FG000|Overall Study|Adverse Event|3|||
106041536|NCT01626495|365817412|FG000|Overall Study|Disease progression|27|||
106041537|NCT01626495|365817412|FG000|Overall Study|Withdrawal by Subject|1|||
106041538|NCT01626495|365817412|FG000|Overall Study|Administrative problem|1|||
106041539|NCT01626495|365817412|FG000|Overall Study|Death|2|||
106041540|NCT01626495|365817412|FG000|Overall Study|Physician Decision|1|||
106041541|NCT01626495|365817412|FG000|Overall Study|New cancer therapy|16|||
106041542|NCT01626495|365817412|FG000|Overall Study|Manufacturing failure|1|||
106041543|NCT00445978|365817413|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
106041544|NCT00445978|365817413|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
106041545|NCT00445978|365817413|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
106041546|NCT00445978|365817413|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
106041547|NCT00445978|365817413|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
106041548|NCT00445978|365817413|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
106041549|NCT00445978|365817413|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
106041550|NCT00445978|365817413|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
106041551|NCT00445978|365817413|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
106041552|NCT03438383|365817417|FG000|Overall Study|Protocol Violation|9|||
106041553|NCT03438383|365817418|FG001|Overall Study|Protocol Violation|3|||
106041554|NCT00843726|365817419|FG000|Overall Study|Death|1|||
106041555|NCT00843726|365817420|FG001|Overall Study|Death|0|||
106041556|NCT00843726|365817419|FG000|Overall Study|Withdrawal by Subject|0|||
106041557|NCT00843726|365817420|FG001|Overall Study|Withdrawal by Subject|1|||
106041558|NCT00072176|365817421|FG000|Overall Study|Withdrawal by Subject|1|||
106041559|NCT00072176|365817422|FG001|Overall Study|Withdrawal by Subject|0|||
106041560|NCT00072176|365817421|FG000|Overall Study|Protocol Violation|0|||
106041561|NCT00072176|365817422|FG001|Overall Study|Protocol Violation|1|||
106041562|NCT02891161|365817425|FG000|Study Treatment|Disease Progression|2|||
106041563|NCT02891161|365817426|FG001|Study Treatment|Disease Progression|4|||
106041564|NCT02891161|365817425|FG000|Study Treatment|AE/Side Effects/Complications|1|||
106041565|NCT02891161|365817426|FG001|Study Treatment|AE/Side Effects/Complications|5|||
106041566|NCT02891161|365817425|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
106041567|NCT02891161|365817426|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
106041568|NCT02891161|365817425|FG000|Follow up|Death|4|||
106041569|NCT02891161|365817426|FG001|Follow up|Death|8|||
106041570|NCT02891161|365817425|FG000|Follow up|Refused to Follow up|0|||
106041571|NCT02891161|365817426|FG001|Follow up|Refused to Follow up|2|||
106041572|NCT02891161|365817425|FG000|Follow up|Symptomatic deterioration|0|||
106041573|NCT02891161|365817426|FG001|Follow up|Symptomatic deterioration|1|||
106041574|NCT02891161|365817425|FG000|Follow up|Study terminated|0|||
106041575|NCT02891161|365817426|FG001|Follow up|Study terminated|6|||
106041576|NCT05069259|365817427|FG000|Overall Study|Withdrawal by Subject|1|||
106041577|NCT05069259|365817427|FG000|Overall Study|Sponsor decision|1|||
106041578|NCT00215683|365819035|FG000|Overall Study|Adverse Event|15|||
106041579|NCT00215683|365819036|FG001|Overall Study|Adverse Event|16|||
106041580|NCT00215683|365819037|FG002|Overall Study|Adverse Event|15|||
106041581|NCT00215683|365819035|FG000|Overall Study|Lack of Efficacy|5|||
106041582|NCT00215683|365819036|FG001|Overall Study|Lack of Efficacy|1|||
106041583|NCT00215683|365819037|FG002|Overall Study|Lack of Efficacy|2|||
106041584|NCT00215683|365819035|FG000|Overall Study|Lost to Follow-up|0|||
106041585|NCT00215683|365819036|FG001|Overall Study|Lost to Follow-up|2|||
106041586|NCT00215683|365819037|FG002|Overall Study|Lost to Follow-up|1|||
106041587|NCT00215683|365819035|FG000|Overall Study|Withdrawal by Subject|9|||
106041588|NCT00215683|365819036|FG001|Overall Study|Withdrawal by Subject|4|||
106041589|NCT00215683|365819037|FG002|Overall Study|Withdrawal by Subject|13|||
106041590|NCT00215683|365819035|FG000|Overall Study|Physician Decision|0|||
106041591|NCT00215683|365819036|FG001|Overall Study|Physician Decision|0|||
106041592|NCT00215683|365819037|FG002|Overall Study|Physician Decision|1|||
106041593|NCT00215683|365819035|FG000|Overall Study|Difficult to attend visits|0|||
106041594|NCT00215683|365819036|FG001|Overall Study|Difficult to attend visits|1|||
106041595|NCT00215683|365819037|FG002|Overall Study|Difficult to attend visits|0|||
106041596|NCT00215683|365819035|FG000|Overall Study|No study drug available|0|||
106041597|NCT00215683|365819036|FG001|Overall Study|No study drug available|1|||
106041598|NCT00215683|365819037|FG002|Overall Study|No study drug available|0|||
106041599|NCT00215683|365819035|FG000|Overall Study|Intermittent therapy required|0|||
106041600|NCT00215683|365819036|FG001|Overall Study|Intermittent therapy required|1|||
106041601|NCT00215683|365819037|FG002|Overall Study|Intermittent therapy required|0|||
106041602|NCT00422097|365819044|FG000|Dose Level 2|Still on treatment|0|||
106041603|NCT00422097|365819045|FG001|Dose Level 2|Still on treatment|1|||
106041604|NCT00422097|365819046|FG002|Dose Level 2|Still on treatment|0|||
106041605|NCT00422097|365819047|FG003|Dose Level 2|Still on treatment|0|||
106041606|NCT00422097|365819048|FG004|Dose Level 2|Still on treatment|0|||
106041607|NCT00422097|365819049|FG005|Dose Level 2|Still on treatment|0|||
106041608|NCT00422097|365819050|FG006|Dose Level 2|Still on treatment|0|||
106041609|NCT00422097|365819051|FG007|Dose Level 2|Still on treatment|0|||
106041610|NCT02923427|365819052|FG000|Overall Study|convert to laparatomy|2|||
106041611|NCT02923427|365819053|FG001|Overall Study|convert to laparatomy|2|||
106041612|NCT02923427|365819052|FG000|Overall Study|destaturation|1|||
106041613|NCT02923427|365819053|FG001|Overall Study|destaturation|0|||
106041614|NCT02923427|365819052|FG000|Overall Study|can not replace LMA|1|||
106041615|NCT02923427|365819053|FG001|Overall Study|can not replace LMA|0|||
106041616|NCT01229397|365819054|FG000|Overall Study|Withdrawal by Subject|3|||
106041617|NCT01229397|365819055|FG001|Overall Study|Withdrawal by Subject|3|||
106041618|NCT01229397|365819054|FG000|Overall Study|Lost to Follow-up|7|||
106041619|NCT01229397|365819055|FG001|Overall Study|Lost to Follow-up|6|||
106041620|NCT01229397|365819054|FG000|Overall Study|Migrated/moved from study area|1|||
106041621|NCT01229397|365819055|FG001|Overall Study|Migrated/moved from study area|0|||
106041622|NCT00950911|365819056|FG000|Overall Study|Adverse Event|0|||
106041623|NCT00950911|365819057|FG001|Overall Study|Adverse Event|2|||
106041624|NCT00950911|365819056|FG000|Overall Study|Death|4|||
106041625|NCT00950911|365819057|FG001|Overall Study|Death|6|||
106041626|NCT00950911|365819056|FG000|Overall Study|Disease progression|2|||
106041627|NCT00950911|365819057|FG001|Overall Study|Disease progression|2|||
106041628|NCT00950911|365819056|FG000|Overall Study|Consent withdrawn|1|||
106041629|NCT00950911|365819057|FG001|Overall Study|Consent withdrawn|3|||
106041630|NCT00950911|365819056|FG000|Overall Study|Administrative decision|3|||
106041631|NCT00950911|365819057|FG001|Overall Study|Administrative decision|1|||
106041632|NCT00950911|365819056|FG000|Overall Study|Ineligibility determined|1|||
106041633|NCT00950911|365819057|FG001|Overall Study|Ineligibility determined|0|||
106041634|NCT00950911|365819056|FG000|Overall Study|Noncompliance|1|||
106041635|NCT00950911|365819057|FG001|Overall Study|Noncompliance|0|||
106041636|NCT00950911|365819056|FG000|Overall Study|Poor performance status|0|||
106041637|NCT00950911|365819057|FG001|Overall Study|Poor performance status|1|||
106041638|NCT02180165|365819062|FG000|Overall Study|Not Treated|0|||
106041639|NCT02180165|365819063|FG001|Overall Study|Not Treated|0|||
106041640|NCT02180165|365819064|FG002|Overall Study|Not Treated|1|||
106041641|NCT02180165|365819065|FG003|Overall Study|Not Treated|0|||
106041642|NCT02180165|365819062|FG000|Overall Study|Adverse Event|7|||
106041643|NCT02180165|365819063|FG001|Overall Study|Adverse Event|0|||
106041644|NCT02180165|365819064|FG002|Overall Study|Adverse Event|18|||
106041645|NCT02180165|365819065|FG003|Overall Study|Adverse Event|3|||
106041646|NCT02180165|365819062|FG000|Overall Study|Lack of Efficacy|0|||
106041647|NCT02180165|365819063|FG001|Overall Study|Lack of Efficacy|1|||
106041648|NCT02180165|365819064|FG002|Overall Study|Lack of Efficacy|3|||
106041649|NCT02180165|365819065|FG003|Overall Study|Lack of Efficacy|2|||
106041650|NCT02180165|365819062|FG000|Overall Study|Physician Decision|1|||
106041651|NCT02180165|365819063|FG001|Overall Study|Physician Decision|0|||
106041652|NCT02180165|365819064|FG002|Overall Study|Physician Decision|5|||
105861873|NCT02458287|365145712|FG003|Overall Study|Adverse Event|1|||
105861874|NCT02458287|365145709|FG000|Overall Study|Lost to Follow-up|0|||
105861875|NCT02458287|365145710|FG001|Overall Study|Lost to Follow-up|1|||
105861876|NCT02458287|365145711|FG002|Overall Study|Lost to Follow-up|1|||
105861877|NCT02458287|365145712|FG003|Overall Study|Lost to Follow-up|0|||
105861878|NCT02458287|365145709|FG000|Overall Study|Protocol Violation|0|||
105861879|NCT02458287|365145710|FG001|Overall Study|Protocol Violation|1|||
105861880|NCT02458287|365145711|FG002|Overall Study|Protocol Violation|0|||
105861881|NCT02458287|365145712|FG003|Overall Study|Protocol Violation|0|||
105861882|NCT02458287|365145709|FG000|Overall Study|Withdrawal by Subject|0|||
105861883|NCT02458287|365145710|FG001|Overall Study|Withdrawal by Subject|2|||
105861884|NCT02458287|365145711|FG002|Overall Study|Withdrawal by Subject|2|||
105861885|NCT02458287|365145712|FG003|Overall Study|Withdrawal by Subject|1|||
105861886|NCT02458287|365145709|FG000|Overall Study|Relocated Out of State|0|||
105861887|NCT02458287|365145710|FG001|Overall Study|Relocated Out of State|0|||
105861888|NCT02458287|365145711|FG002|Overall Study|Relocated Out of State|0|||
105861889|NCT02458287|365145712|FG003|Overall Study|Relocated Out of State|1|||
105861890|NCT02752087|365145713|FG000|Washout|Physician Decision|1|||
105861891|NCT02752087|365145714|FG001|Washout|Physician Decision|0|||
105861892|NCT02613182|365145715|FG000|Overall Study|Death|6|||
105861893|NCT02613182|365145715|FG000|Overall Study|Physician Decision|1|||
105861894|NCT02613182|365145715|FG000|Overall Study|Study Terminated by Sponsor|21|||
105861895|NCT02613182|365145715|FG000|Overall Study|Withdrawal by Subject|6|||
105861896|NCT00843635|365145716|FG000|Overall Study|Adverse Event|2|||
105861897|NCT00843635|365145717|FG001|Overall Study|Adverse Event|2|||
105861898|NCT00843635|365145718|FG002|Overall Study|Adverse Event|0|||
105861899|NCT01547130|365145719|FG000|Overall Study|Lost to Follow-up|9|||
105861900|NCT01547130|365145720|FG001|Overall Study|Lost to Follow-up|5|||
105861901|NCT03496610|365145721|FG000|Overall Study|Lost to Follow-up|3|||
105861902|NCT03496610|365145722|FG001|Overall Study|Lost to Follow-up|2|||
105861903|NCT03496610|365145721|FG000|Overall Study|Physician Decision|1|||
105861904|NCT03496610|365145722|FG001|Overall Study|Physician Decision|0|||
105861905|NCT03496610|365145721|FG000|Overall Study|Withdrawal by Subject|1|||
105861906|NCT03496610|365145722|FG001|Overall Study|Withdrawal by Subject|0|||
105861907|NCT02714426|365145723|FG000|Overall Study|Withdrawal by Subject|2|||
105861908|NCT02714426|365145724|FG001|Overall Study|Withdrawal by Subject|2|||
105861909|NCT04435184|365145725|FG000|Overall Study|follow-up blood draws missing|3|||
105861910|NCT04435184|365145726|FG001|Overall Study|follow-up blood draws missing|5|||
105861911|NCT00025259|365145731|FG000|Overall Study|Death|1|||
105861912|NCT00025259|365145732|FG001|Overall Study|Death|3|||
105861913|NCT00025259|365145733|FG002|Overall Study|Death|0|||
105861914|NCT00025259|365145734|FG003|Overall Study|Death|3|||
105861915|NCT00025259|365145735|FG004|Overall Study|Death|0|||
105861916|NCT00025259|365145736|FG005|Overall Study|Death|1|||
105861917|NCT00025259|365145737|FG006|Overall Study|Death|2|||
105861918|NCT00025259|365145731|FG000|Overall Study|Lack of Efficacy|2|||
105861919|NCT00025259|365145732|FG001|Overall Study|Lack of Efficacy|46|||
105861920|NCT00025259|365145733|FG002|Overall Study|Lack of Efficacy|60|||
105861921|NCT00025259|365145734|FG003|Overall Study|Lack of Efficacy|78|||
105861922|NCT00025259|365145735|FG004|Overall Study|Lack of Efficacy|11|||
105861923|NCT00025259|365145736|FG005|Overall Study|Lack of Efficacy|30|||
105861924|NCT00025259|365145737|FG006|Overall Study|Lack of Efficacy|38|||
105861925|NCT00025259|365145731|FG000|Overall Study|Lost to Follow-up|2|||
105861926|NCT00025259|365145732|FG001|Overall Study|Lost to Follow-up|9|||
105861927|NCT00025259|365145733|FG002|Overall Study|Lost to Follow-up|13|||
106041653|NCT02180165|365819065|FG003|Overall Study|Physician Decision|0|||
106041654|NCT02180165|365819062|FG000|Overall Study|Withdrawal by Subject|3|||
106041655|NCT02180165|365819063|FG001|Overall Study|Withdrawal by Subject|0|||
105861928|NCT00025259|365145734|FG003|Overall Study|Lost to Follow-up|13|||
105861929|NCT00025259|365145735|FG004|Overall Study|Lost to Follow-up|1|||
105861930|NCT00025259|365145736|FG005|Overall Study|Lost to Follow-up|3|||
105861931|NCT00025259|365145737|FG006|Overall Study|Lost to Follow-up|1|||
105861932|NCT00025259|365145731|FG000|Overall Study|Physician Decision|12|||
105861933|NCT00025259|365145732|FG001|Overall Study|Physician Decision|1|||
105861934|NCT00025259|365145733|FG002|Overall Study|Physician Decision|0|||
106041656|NCT02180165|365819064|FG002|Overall Study|Withdrawal by Subject|2|||
106041657|NCT02180165|365819065|FG003|Overall Study|Withdrawal by Subject|1|||
105861935|NCT00025259|365145734|FG003|Overall Study|Physician Decision|5|||
105861936|NCT00025259|365145735|FG004|Overall Study|Physician Decision|4|||
105861937|NCT00025259|365145736|FG005|Overall Study|Physician Decision|2|||
105861938|NCT00025259|365145737|FG006|Overall Study|Physician Decision|1|||
105861939|NCT00025259|365145731|FG000|Overall Study|Protocol Violation|3|||
105861940|NCT00025259|365145732|FG001|Overall Study|Protocol Violation|2|||
105861941|NCT00025259|365145733|FG002|Overall Study|Protocol Violation|2|||
105861942|NCT00025259|365145734|FG003|Overall Study|Protocol Violation|1|||
106041658|NCT04697056|365819066|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
106041659|NCT04697056|365819067|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
106041660|NCT01925274|365819068|FG000|Overall Study|Death|1|||
106041661|NCT01925274|365819069|FG001|Overall Study|Death|0|||
105861943|NCT00025259|365145735|FG004|Overall Study|Protocol Violation|2|||
105861944|NCT00025259|365145736|FG005|Overall Study|Protocol Violation|1|||
105861945|NCT00025259|365145737|FG006|Overall Study|Protocol Violation|3|||
105861946|NCT00025259|365145731|FG000|Overall Study|Withdrawal by Subject|9|||
105861947|NCT00025259|365145732|FG001|Overall Study|Withdrawal by Subject|27|||
105861948|NCT00025259|365145733|FG002|Overall Study|Withdrawal by Subject|6|||
105861949|NCT00025259|365145734|FG003|Overall Study|Withdrawal by Subject|14|||
105861950|NCT00025259|365145735|FG004|Overall Study|Withdrawal by Subject|11|||
105861951|NCT00025259|365145736|FG005|Overall Study|Withdrawal by Subject|8|||
105861952|NCT00025259|365145737|FG006|Overall Study|Withdrawal by Subject|3|||
105861953|NCT00025259|365145731|FG000|Overall Study|Ineligible|14|||
105861954|NCT00025259|365145732|FG001|Overall Study|Ineligible|1|||
105861955|NCT00025259|365145733|FG002|Overall Study|Ineligible|0|||
105861956|NCT00025259|365145734|FG003|Overall Study|Ineligible|0|||
105861957|NCT00025259|365145735|FG004|Overall Study|Ineligible|6|||
105861958|NCT00025259|365145736|FG005|Overall Study|Ineligible|0|||
105861959|NCT00025259|365145737|FG006|Overall Study|Ineligible|1|||
105861960|NCT00025259|365145731|FG000|Overall Study|Randomization error|1|||
105861961|NCT00025259|365145732|FG001|Overall Study|Randomization error|0|||
105861962|NCT00025259|365145733|FG002|Overall Study|Randomization error|0|||
105861963|NCT00025259|365145734|FG003|Overall Study|Randomization error|0|||
105861964|NCT00025259|365145735|FG004|Overall Study|Randomization error|1|||
105861965|NCT00025259|365145736|FG005|Overall Study|Randomization error|7|||
105861966|NCT00025259|365145737|FG006|Overall Study|Randomization error|2|||
105861967|NCT00025259|365145731|FG000|Overall Study|Adverse Event|1|||
105861968|NCT00025259|365145732|FG001|Overall Study|Adverse Event|0|||
105861969|NCT00025259|365145733|FG002|Overall Study|Adverse Event|0|||
105861970|NCT00025259|365145734|FG003|Overall Study|Adverse Event|0|||
105861971|NCT00025259|365145735|FG004|Overall Study|Adverse Event|0|||
105861972|NCT00025259|365145736|FG005|Overall Study|Adverse Event|0|||
105861973|NCT00025259|365145737|FG006|Overall Study|Adverse Event|0|||
105861974|NCT00474266|365145738|FG000|Overall Study|Withdrawal by Subject|7|||
105861975|NCT00474266|365145739|FG001|Overall Study|Withdrawal by Subject|20|||
105861976|NCT00474266|365145740|FG002|Overall Study|Withdrawal by Subject|4|||
105861977|NCT00474266|365145741|FG003|Overall Study|Withdrawal by Subject|7|||
105861978|NCT01449370|365145742|FG000|Overall Study|Disease Progression|5|||
105861979|NCT01449370|365145743|FG001|Overall Study|Disease Progression|4|||
105861980|NCT01449370|365145744|FG002|Overall Study|Disease Progression|8|||
105861981|NCT01449370|365145745|FG003|Overall Study|Disease Progression|3|||
105861982|NCT01449370|365145746|FG004|Overall Study|Disease Progression|3|||
105861983|NCT01449370|365145747|FG005|Overall Study|Disease Progression|3|||
105861984|NCT01449370|365145748|FG006|Overall Study|Disease Progression|3|||
105861985|NCT01449370|365145749|FG007|Overall Study|Disease Progression|2|||
105861986|NCT01449370|365145750|FG008|Overall Study|Disease Progression|9|||
105861987|NCT01449370|365145751|FG009|Overall Study|Disease Progression|1|||
105861988|NCT01449370|365145752|FG010|Overall Study|Disease Progression|3|||
105861989|NCT01449370|365145753|FG011|Overall Study|Disease Progression|3|||
105861990|NCT01449370|365145754|FG012|Overall Study|Disease Progression|2|||
105861991|NCT01449370|365145755|FG013|Overall Study|Disease Progression|8|||
105861992|NCT01449370|365145756|FG014|Overall Study|Disease Progression|3|||
105861993|NCT01449370|365145757|FG015|Overall Study|Disease Progression|1|||
105861994|NCT01449370|365145758|FG016|Overall Study|Disease Progression|4|||
105861995|NCT01449370|365145759|FG017|Overall Study|Disease Progression|3|||
105861996|NCT01449370|365145760|FG018|Overall Study|Disease Progression|1|||
105861997|NCT01449370|365145761|FG019|Overall Study|Disease Progression|2|||
105861998|NCT01449370|365145762|FG020|Overall Study|Disease Progression|5|||
105861999|NCT01449370|365145763|FG021|Overall Study|Disease Progression|2|||
105862000|NCT01449370|365145764|FG022|Overall Study|Disease Progression|3|||
105862001|NCT01449370|365145765|FG023|Overall Study|Disease Progression|7|||
106041662|NCT01925274|365819070|FG002|Overall Study|Death|0|||
106041663|NCT01925274|365819068|FG000|Overall Study|Lost to Follow-up|0|||
106041664|NCT01925274|365819069|FG001|Overall Study|Lost to Follow-up|1|||
106041665|NCT01925274|365819070|FG002|Overall Study|Lost to Follow-up|0|||
105862002|NCT01449370|365145766|FG024|Overall Study|Disease Progression|3|||
105862003|NCT01449370|365145742|FG000|Overall Study|Adverse Event|1|||
105862004|NCT01449370|365145743|FG001|Overall Study|Adverse Event|2|||
105862005|NCT01449370|365145744|FG002|Overall Study|Adverse Event|0|||
105862006|NCT01449370|365145745|FG003|Overall Study|Adverse Event|1|||
105862007|NCT01449370|365145746|FG004|Overall Study|Adverse Event|0|||
105862008|NCT01449370|365145747|FG005|Overall Study|Adverse Event|0|||
105862009|NCT01449370|365145748|FG006|Overall Study|Adverse Event|0|||
105862010|NCT01449370|365145749|FG007|Overall Study|Adverse Event|0|||
105862011|NCT01449370|365145750|FG008|Overall Study|Adverse Event|1|||
106041666|NCT01925274|365819068|FG000|Overall Study|Withdrawal by Subject|1|||
106041667|NCT01925274|365819069|FG001|Overall Study|Withdrawal by Subject|2|||
106041668|NCT01925274|365819070|FG002|Overall Study|Withdrawal by Subject|0|||
106041669|NCT01925274|365819068|FG000|Overall Study|Study terminated by sponsor|4|||
106041670|NCT01925274|365819069|FG001|Overall Study|Study terminated by sponsor|0|||
106041671|NCT01925274|365819070|FG002|Overall Study|Study terminated by sponsor|0|||
106041672|NCT01925274|365819068|FG000|Overall Study|Protocol amendment|1|||
106041673|NCT01925274|365819069|FG001|Overall Study|Protocol amendment|3|||
106041674|NCT01925274|365819070|FG002|Overall Study|Protocol amendment|6|||
106041675|NCT04327674|365819071|FG000|Overall Study|Protocol Violation|19|||
106041676|NCT01008150|365819073|FG000|Overall Study|did not receive study drug|1|||
106041677|NCT01008150|365819074|FG001|Overall Study|did not receive study drug|1|||
106041678|NCT01008150|365819075|FG002|Overall Study|did not receive study drug|1|||
106041679|NCT01008150|365819076|FG003|Overall Study|did not receive study drug|0|||
106041680|NCT00737438|365819080|FG000|Overall Study|Withdrawal by Subject|2|||
106041681|NCT00737438|365819080|FG000|Overall Study|Patient ineligible|1|||
106041682|NCT02791594|365819086|FG000|Overall Study|Physician Decision|2|||
106041683|NCT03845543|365819087|FG000|Overall Study|Death|25|||
106041684|NCT03845543|365819087|FG000|Overall Study|Withdrawal by Subject|2|||
106041685|NCT03845543|365819087|FG000|Overall Study|Lost to Follow-up|12|||
106041686|NCT03845543|365819087|FG000|Overall Study|Adverse Event|17|||
106041687|NCT00857415|365819088|FG000|Overall Study|Image acquisition failure|2|||
106041688|NCT00857415|365819089|FG001|Overall Study|Image acquisition failure|0|||
106041689|NCT00857415|365819088|FG000|Overall Study|Invalid image or not imaged|3|||
106041690|NCT00857415|365819089|FG001|Overall Study|Invalid image or not imaged|0|||
106041691|NCT00857415|365819088|FG000|Overall Study|Subject still living at end of study|110|||
106041692|NCT00857415|365819089|FG001|Overall Study|Subject still living at end of study|0|||
106041693|NCT00857415|365819088|FG000|Overall Study|Deceased with no autopsy|2|||
106041694|NCT00857415|365819089|FG001|Overall Study|Deceased with no autopsy|0|||
106041695|NCT01484132|365819096|FG000|Overall Study|Lost to Follow-up|8|||
106041696|NCT01484132|365819096|FG000|Overall Study|Difficulty with time commitment|2|||
106041697|NCT01484132|365819096|FG000|Overall Study|Ineligible|1|||
106041698|NCT01484132|365819096|FG000|Overall Study|No pre-treatment urine sample collected|1|||
106041699|NCT01484132|365819096|FG000|Overall Study|No post-treatment urine sample collected|10|||
106041700|NCT00764491|365819098|FG000|Overall Study|Lost to Follow-up|35|||
106041701|NCT00764491|365819099|FG001|Overall Study|Lost to Follow-up|17|||
106041702|NCT04209348|365819103|FG000|Overall Study|Lost to Follow-up|1|||
106041703|NCT04209348|365819104|FG001|Overall Study|Lost to Follow-up|0|||
106041704|NCT02035475|365819105|FG000|Overall Study|Withdrawal by Subject|4|||
106041705|NCT02035475|365819105|FG000|Overall Study|Physician Decision|1|||
106041706|NCT02035475|365819105|FG000|Overall Study|Equipment Error|1|||
106041707|NCT01231347|365819106|FG000|Overall Study|Full Consent withdrawn|19|||
106041708|NCT01231347|365819107|FG001|Overall Study|Full Consent withdrawn|19|||
106041709|NCT01231347|365819108|FG002|Overall Study|Full Consent withdrawn|11|||
106041710|NCT01231347|365819106|FG000|Overall Study|Lost to Follow-up|4|||
106041711|NCT01231347|365819107|FG001|Overall Study|Lost to Follow-up|2|||
106041712|NCT01231347|365819108|FG002|Overall Study|Lost to Follow-up|2|||
106041713|NCT01231347|365819106|FG000|Overall Study|Death|202|||
106041714|NCT01231347|365819107|FG001|Overall Study|Death|210|||
106041715|NCT01231347|365819108|FG002|Overall Study|Death|101|||
106041716|NCT01231347|365819106|FG000|Overall Study|other event|7|||
106041717|NCT01231347|365819107|FG001|Overall Study|other event|9|||
106041718|NCT01231347|365819108|FG002|Overall Study|other event|3|||
106041719|NCT01977937|365819109|FG000|Overall Study|Withdrawal by Subject|2|||
106041720|NCT01977937|365819110|FG001|Overall Study|Withdrawal by Subject|1|||
106041721|NCT01977937|365819109|FG000|Overall Study|Adverse Event|1|||
106041722|NCT01977937|365819110|FG001|Overall Study|Adverse Event|0|||
106041723|NCT01977937|365819109|FG000|Overall Study|Physician Decision|0|||
106041724|NCT01977937|365819110|FG001|Overall Study|Physician Decision|1|||
106041725|NCT00915356|365819111|FG000|Overall Study|Withdrawal by Subject|1|||
106041726|NCT00915356|365819112|FG001|Overall Study|Withdrawal by Subject|0|||
106041727|NCT00915356|365819113|FG002|Overall Study|Withdrawal by Subject|0|||
106041728|NCT00915356|365819114|FG003|Overall Study|Withdrawal by Subject|0|||
106041729|NCT00915356|365819115|FG004|Overall Study|Withdrawal by Subject|0|||
106041730|NCT00191646|365819119|FG000|Overall Study|Toxicity|26|||
106041731|NCT00191646|365819120|FG001|Overall Study|Toxicity|37|||
106041732|NCT00191646|365819119|FG000|Overall Study|Disease Progression|5|||
106041733|NCT00191646|365819120|FG001|Overall Study|Disease Progression|6|||
106041734|NCT00191646|365819119|FG000|Overall Study|Physician Decision|20|||
106041735|NCT00191646|365819120|FG001|Overall Study|Physician Decision|11|||
106041736|NCT00191646|365819119|FG000|Overall Study|Withdrawal by Subject|58|||
106041737|NCT00191646|365819120|FG001|Overall Study|Withdrawal by Subject|39|||
106041738|NCT00191646|365819119|FG000|Overall Study|Protocol Violation|5|||
106041739|NCT00191646|365819120|FG001|Overall Study|Protocol Violation|7|||
106041740|NCT00191646|365819119|FG000|Overall Study|Death|6|||
106041741|NCT00191646|365819120|FG001|Overall Study|Death|8|||
106041742|NCT00191646|365819119|FG000|Overall Study|Other|33|||
106041743|NCT00191646|365819120|FG001|Overall Study|Other|34|||
106041744|NCT00191646|365819119|FG000|Overall Study|Missing Data|18|||
106041745|NCT00191646|365819120|FG001|Overall Study|Missing Data|11|||
106041746|NCT03131453|365819129|FG000|Overall Study|Study terminated by Sponsor|424|||
106041747|NCT03131453|365819130|FG001|Overall Study|Study terminated by Sponsor|222|||
106041748|NCT03131453|365819131|FG002|Overall Study|Study terminated by Sponsor|438|||
106041749|NCT03131453|365819129|FG000|Overall Study|Withdrawal by Subject|18|||
106041750|NCT03131453|365819130|FG001|Overall Study|Withdrawal by Subject|7|||
106041751|NCT03131453|365819131|FG002|Overall Study|Withdrawal by Subject|13|||
106041752|NCT03131453|365819129|FG000|Overall Study|Adverse Event|10|||
106041753|NCT03131453|365819130|FG001|Overall Study|Adverse Event|3|||
106041754|NCT03131453|365819131|FG002|Overall Study|Adverse Event|3|||
106041755|NCT03131453|365819129|FG000|Overall Study|Lost to Follow-up|1|||
106041756|NCT03131453|365819130|FG001|Overall Study|Lost to Follow-up|0|||
106041757|NCT03131453|365819131|FG002|Overall Study|Lost to Follow-up|1|||
106041758|NCT03131453|365819129|FG000|Overall Study|Physician Decision|1|||
106041759|NCT03131453|365819130|FG001|Overall Study|Physician Decision|0|||
106041760|NCT03131453|365819131|FG002|Overall Study|Physician Decision|1|||
106041761|NCT03131453|365819129|FG000|Overall Study|Non-compliance with study treatment|1|||
106041762|NCT03131453|365819130|FG001|Overall Study|Non-compliance with study treatment|0|||
106041763|NCT03131453|365819131|FG002|Overall Study|Non-compliance with study treatment|0|||
106041764|NCT03131453|365819129|FG000|Overall Study|Technical problems|1|||
106041765|NCT03131453|365819130|FG001|Overall Study|Technical problems|0|||
106041766|NCT03131453|365819131|FG002|Overall Study|Technical problems|0|||
106041767|NCT03131453|365819129|FG000|Overall Study|Protocol deviation|0|||
106041768|NCT03131453|365819130|FG001|Overall Study|Protocol deviation|1|||
106041769|NCT03131453|365819131|FG002|Overall Study|Protocol deviation|0|||
106041770|NCT01822496|365819135|FG000|Overall Study|Protocol Violation|2|||
106041771|NCT01822496|365819136|FG001|Overall Study|Protocol Violation|2|||
106041772|NCT01822496|365819137|FG002|Overall Study|Protocol Violation|0|||
106041773|NCT01822496|365819138|FG003|Overall Study|Protocol Violation|1|||
106041774|NCT01822496|365819135|FG000|Overall Study|Withdrawal by Subject|0|||
106041775|NCT01822496|365819136|FG001|Overall Study|Withdrawal by Subject|0|||
106041776|NCT01822496|365819137|FG002|Overall Study|Withdrawal by Subject|0|||
106041777|NCT01822496|365819138|FG003|Overall Study|Withdrawal by Subject|3|||
106041778|NCT02766465|365819139|FG000|Overall Study|Withdrawal by Subject|0|||
106041779|NCT02766465|365819140|FG001|Overall Study|Withdrawal by Subject|10|||
106041780|NCT02711345|365819141|FG000|Overall Study|Adverse Event|0|||
106041781|NCT02711345|365819142|FG001|Overall Study|Adverse Event|0|||
106041782|NCT02711345|365819143|FG002|Overall Study|Adverse Event|0|||
106041783|NCT02711345|365819144|FG003|Overall Study|Adverse Event|1|||
106041784|NCT02711345|365819145|FG004|Overall Study|Adverse Event|1|||
106041785|NCT02711345|365819146|FG005|Overall Study|Adverse Event|2|||
106041786|NCT02711345|365819147|FG006|Overall Study|Adverse Event|1|||
106041787|NCT02711345|365819148|FG007|Overall Study|Adverse Event|0|||
106041788|NCT02711345|365819149|FG008|Overall Study|Adverse Event|0|||
106041789|NCT02711345|365819150|FG009|Overall Study|Adverse Event|2|||
106041790|NCT02711345|365819141|FG000|Overall Study|Physician Decision|0|||
106041791|NCT02711345|365819142|FG001|Overall Study|Physician Decision|0|||
106041792|NCT02711345|365819143|FG002|Overall Study|Physician Decision|1|||
106041793|NCT02711345|365819144|FG003|Overall Study|Physician Decision|0|||
106041794|NCT02711345|365819145|FG004|Overall Study|Physician Decision|0|||
106041795|NCT02711345|365819146|FG005|Overall Study|Physician Decision|0|||
106041796|NCT02711345|365819147|FG006|Overall Study|Physician Decision|0|||
106041797|NCT02711345|365819148|FG007|Overall Study|Physician Decision|0|||
106041798|NCT02711345|365819149|FG008|Overall Study|Physician Decision|1|||
106041799|NCT02711345|365819150|FG009|Overall Study|Physician Decision|0|||
106041800|NCT02711345|365819141|FG000|Overall Study|Progressive disease|1|||
106041801|NCT02711345|365819142|FG001|Overall Study|Progressive disease|3|||
106041802|NCT02711345|365819143|FG002|Overall Study|Progressive disease|5|||
106041803|NCT02711345|365819144|FG003|Overall Study|Progressive disease|3|||
106041804|NCT02711345|365819145|FG004|Overall Study|Progressive disease|7|||
106151761|NCT02590432|366215136|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
105862012|NCT01449370|365145751|FG009|Overall Study|Adverse Event|1|||
106041805|NCT02711345|365819146|FG005|Overall Study|Progressive disease|2|||
106041806|NCT02711345|365819147|FG006|Overall Study|Progressive disease|8|||
106041807|NCT02711345|365819148|FG007|Overall Study|Progressive disease|4|||
106041808|NCT02711345|365819149|FG008|Overall Study|Progressive disease|5|||
106041809|NCT02711345|365819150|FG009|Overall Study|Progressive disease|6|||
106041810|NCT02711345|365819141|FG000|Overall Study|Subject/guardian decision|0|||
106041811|NCT02711345|365819142|FG001|Overall Study|Subject/guardian decision|0|||
106041812|NCT02711345|365819143|FG002|Overall Study|Subject/guardian decision|0|||
106041813|NCT02711345|365819144|FG003|Overall Study|Subject/guardian decision|0|||
106041814|NCT02711345|365819145|FG004|Overall Study|Subject/guardian decision|0|||
106041815|NCT02711345|365819146|FG005|Overall Study|Subject/guardian decision|2|||
106041816|NCT02711345|365819147|FG006|Overall Study|Subject/guardian decision|3|||
106041817|NCT02711345|365819148|FG007|Overall Study|Subject/guardian decision|1|||
105862013|NCT01449370|365145752|FG010|Overall Study|Adverse Event|0|||
106041818|NCT02711345|365819149|FG008|Overall Study|Subject/guardian decision|0|||
106041819|NCT02711345|365819150|FG009|Overall Study|Subject/guardian decision|4|||
106041820|NCT02711345|365819141|FG000|Overall Study|Death|1|||
106041821|NCT02711345|365819142|FG001|Overall Study|Death|0|||
106041822|NCT02711345|365819143|FG002|Overall Study|Death|0|||
106041823|NCT02711345|365819144|FG003|Overall Study|Death|0|||
106041824|NCT02711345|365819145|FG004|Overall Study|Death|0|||
106041825|NCT02711345|365819146|FG005|Overall Study|Death|0|||
106041826|NCT02711345|365819147|FG006|Overall Study|Death|0|||
106041827|NCT02711345|365819148|FG007|Overall Study|Death|1|||
106041828|NCT02711345|365819149|FG008|Overall Study|Death|0|||
106041829|NCT02711345|365819150|FG009|Overall Study|Death|0|||
106041830|NCT01011738|365819151|FG000|Overall Study|Death|12|||
106041831|NCT01011738|365819152|FG001|Overall Study|Death|3|||
106041832|NCT01011738|365819153|FG002|Overall Study|Death|0|||
106041833|NCT01011738|365819151|FG000|Overall Study|Unknown reasons|312|||
106041834|NCT01011738|365819152|FG001|Overall Study|Unknown reasons|291|||
106041835|NCT01011738|365819153|FG002|Overall Study|Unknown reasons|17|||
106041836|NCT02567552|365819158|FG000|Overall Study|Adverse Event|0|||
106041837|NCT02567552|365819159|FG001|Overall Study|Adverse Event|1|||
106041838|NCT05521906|365819162|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
106041839|NCT05521906|365819163|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
106041840|NCT03350620|365819164|FG000|Stage 2|Adverse Event|0|||
106041841|NCT03350620|365819165|FG001|Stage 2|Adverse Event|1|||
106041842|NCT03350620|365819166|FG002|Stage 2|Adverse Event|1|||
106041843|NCT03350620|365819164|FG000|Stage 2|Lack of Efficacy|0|||
106041844|NCT03350620|365819165|FG001|Stage 2|Lack of Efficacy|2|||
106041845|NCT03350620|365819166|FG002|Stage 2|Lack of Efficacy|0|||
106041846|NCT03350620|365819164|FG000|Stage 2|Lost to Follow-up|1|||
106041847|NCT03350620|365819165|FG001|Stage 2|Lost to Follow-up|2|||
106041848|NCT03350620|365819166|FG002|Stage 2|Lost to Follow-up|2|||
106041849|NCT03350620|365819164|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
106041850|NCT03350620|365819165|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
106041851|NCT03350620|365819166|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
106041852|NCT03507400|365819170|FG000|Overall Study|discontinued|5|||
106041853|NCT03507400|365819171|FG001|Overall Study|discontinued|1|||
106041854|NCT03507400|365819170|FG000|Overall Study|Lost to Follow-up|8|||
106041855|NCT03507400|365819171|FG001|Overall Study|Lost to Follow-up|6|||
106041856|NCT03507400|365819170|FG000|Overall Study|Protocol Violation|0|||
106041857|NCT03507400|365819171|FG001|Overall Study|Protocol Violation|1|||
106041858|NCT02445391|365819172|FG000|Overall Study|No active protocol treatment|3|||
106041859|NCT02445391|365819173|FG001|Overall Study|No active protocol treatment|0|||
106041860|NCT02445391|365819174|FG002|Overall Study|No active protocol treatment|0|||
106041861|NCT02445391|365819172|FG000|Overall Study|Adverse Event|0|||
106041862|NCT02445391|365819173|FG001|Overall Study|Adverse Event|21|||
106041863|NCT02445391|365819174|FG002|Overall Study|Adverse Event|12|||
106041864|NCT02445391|365819172|FG000|Overall Study|Alternative therapy|0|||
106041865|NCT02445391|365819173|FG001|Overall Study|Alternative therapy|0|||
106041866|NCT02445391|365819174|FG002|Overall Study|Alternative therapy|1|||
106041867|NCT02445391|365819172|FG000|Overall Study|Disease progression|0|||
106041868|NCT02445391|365819173|FG001|Overall Study|Disease progression|7|||
106041869|NCT02445391|365819174|FG002|Overall Study|Disease progression|22|||
106041870|NCT02445391|365819172|FG000|Overall Study|Complicating disease|0|||
106041871|NCT02445391|365819173|FG001|Overall Study|Complicating disease|2|||
106041872|NCT02445391|365819174|FG002|Overall Study|Complicating disease|1|||
106041873|NCT02445391|365819172|FG000|Overall Study|Withdrawal by Subject|0|||
106041874|NCT02445391|365819173|FG001|Overall Study|Withdrawal by Subject|4|||
106041875|NCT02445391|365819174|FG002|Overall Study|Withdrawal by Subject|9|||
106041876|NCT02445391|365819172|FG000|Overall Study|Financial issue|0|||
106041877|NCT02445391|365819173|FG001|Overall Study|Financial issue|0|||
106041878|NCT02445391|365819174|FG002|Overall Study|Financial issue|2|||
106041879|NCT02445391|365819172|FG000|Overall Study|Still on treatment|0|||
106041880|NCT02445391|365819173|FG001|Overall Study|Still on treatment|7|||
106041881|NCT02445391|365819174|FG002|Overall Study|Still on treatment|16|||
106041882|NCT02445391|365819172|FG000|Overall Study|Not start protocol therapy|0|||
106041883|NCT02445391|365819173|FG001|Overall Study|Not start protocol therapy|12|||
106041884|NCT02445391|365819174|FG002|Overall Study|Not start protocol therapy|9|||
106041885|NCT00560885|365819175|FG000|Overall Study|Death|7|||
106041886|NCT00560885|365819175|FG000|Overall Study|Withdrawal by Subject|1|||
106041887|NCT02887859|365819177|FG000|Overall Study|Ongoing|6|||
106041888|NCT02887859|365819177|FG000|Overall Study|Adverse Event|7|||
106041889|NCT02887859|365819177|FG000|Overall Study|Death|1|||
106041890|NCT02887859|365819177|FG000|Overall Study|Physician Decision|1|||
106151762|NCT02590432|366215137|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
106041891|NCT05419908|365819179|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
106041892|NCT05419908|365819180|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
106041893|NCT05419908|365819179|FG000|Overall Study|Serious Adverse Event|0|||
106041894|NCT05419908|365819180|FG001|Overall Study|Serious Adverse Event|2|||
106041895|NCT05419908|365819179|FG000|Overall Study|Withdrawal by Subject|2|||
106041896|NCT05419908|365819180|FG001|Overall Study|Withdrawal by Subject|0|||
106041897|NCT05419908|365819179|FG000|Overall Study|Miscellaneous|1|||
106041898|NCT05419908|365819180|FG001|Overall Study|Miscellaneous|1|||
106041899|NCT01554397|365819183|FG000|Overall Study|Withdrawal by Subject|1|||
106041900|NCT01554397|365819184|FG001|Overall Study|Withdrawal by Subject|0|||
106041901|NCT01554397|365819183|FG000|Overall Study|Ineligible|7|||
106041902|NCT01554397|365819184|FG001|Overall Study|Ineligible|0|||
106041903|NCT02160782|365820431|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
106041904|NCT02160782|365820432|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
106041905|NCT02160782|365820433|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
105862014|NCT01449370|365145753|FG011|Overall Study|Adverse Event|0|||
106041906|NCT02160782|365820434|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
106041907|NCT02160782|365820435|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
106041908|NCT02160782|365820431|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
106041909|NCT02160782|365820432|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
106041910|NCT02160782|365820433|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
106041911|NCT02160782|365820434|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
106041912|NCT02160782|365820435|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
106041913|NCT02160782|365820431|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
106041914|NCT02160782|365820432|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
106041915|NCT02160782|365820433|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
106041916|NCT02160782|365820434|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
106041917|NCT02160782|365820435|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
106041918|NCT02160782|365820431|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
106041919|NCT02160782|365820432|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
106041920|NCT02160782|365820433|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
106041921|NCT02160782|365820434|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
106041922|NCT02160782|365820435|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
106041923|NCT02160782|365820431|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
106041924|NCT02160782|365820432|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
106041925|NCT02160782|365820433|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
106041926|NCT02160782|365820434|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
106041927|NCT02160782|365820435|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
106041928|NCT02160782|365820431|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
106041929|NCT02160782|365820432|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
106041930|NCT02160782|365820433|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
106041931|NCT02160782|365820434|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
106041932|NCT02160782|365820435|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
106041933|NCT02160782|365820431|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
106041934|NCT02160782|365820432|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
106041935|NCT02160782|365820433|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
106041936|NCT02160782|365820434|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
106041937|NCT02160782|365820435|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
106041938|NCT01397201|365820437|FG000|Overall Study|Not treated|0|||
106041939|NCT01397201|365820438|FG001|Overall Study|Not treated|0|||
106041940|NCT01397201|365820439|FG002|Overall Study|Not treated|1|||
106041941|NCT01397201|365820440|FG003|Overall Study|Not treated|0|||
106041942|NCT01397201|365820441|FG004|Overall Study|Not treated|0|||
106041943|NCT01397201|365820437|FG000|Overall Study|Not yet defined|3|||
106041944|NCT01397201|365820438|FG001|Overall Study|Not yet defined|6|||
106041945|NCT01397201|365820439|FG002|Overall Study|Not yet defined|5|||
106041946|NCT01397201|365820440|FG003|Overall Study|Not yet defined|5|||
106041947|NCT01397201|365820441|FG004|Overall Study|Not yet defined|4|||
106041948|NCT01397201|365820437|FG000|Overall Study|Adverse Event|2|||
106041949|NCT01397201|365820438|FG001|Overall Study|Adverse Event|0|||
106041950|NCT01397201|365820439|FG002|Overall Study|Adverse Event|0|||
106041951|NCT01397201|365820440|FG003|Overall Study|Adverse Event|0|||
106041952|NCT01397201|365820441|FG004|Overall Study|Adverse Event|0|||
106041953|NCT03437512|365820442|FG000|Randomized|Withdrawal by Subject|0|||
106041954|NCT03437512|365820443|FG001|Randomized|Withdrawal by Subject|2|||
106041955|NCT03437512|365820442|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
106041956|NCT03437512|365820443|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
106041957|NCT04493333|365820444|FG000|Overall Study|Withdrawal by Subject|1|||
106041958|NCT04493333|365820445|FG001|Overall Study|Withdrawal by Subject|1|||
105862015|NCT01449370|365145754|FG012|Overall Study|Adverse Event|0|||
105862016|NCT01449370|365145755|FG013|Overall Study|Adverse Event|2|||
105862017|NCT01449370|365145756|FG014|Overall Study|Adverse Event|0|||
105862018|NCT01449370|365145757|FG015|Overall Study|Adverse Event|1|||
105862019|NCT01449370|365145758|FG016|Overall Study|Adverse Event|0|||
105862020|NCT01449370|365145759|FG017|Overall Study|Adverse Event|0|||
105862021|NCT01449370|365145760|FG018|Overall Study|Adverse Event|1|||
105862022|NCT01449370|365145761|FG019|Overall Study|Adverse Event|1|||
105862023|NCT01449370|365145762|FG020|Overall Study|Adverse Event|0|||
105862024|NCT01449370|365145763|FG021|Overall Study|Adverse Event|1|||
105862025|NCT01449370|365145764|FG022|Overall Study|Adverse Event|0|||
105862026|NCT01449370|365145765|FG023|Overall Study|Adverse Event|1|||
105862027|NCT01449370|365145766|FG024|Overall Study|Adverse Event|3|||
105862028|NCT01449370|365145742|FG000|Overall Study|Participant Decision|0|||
105862029|NCT01449370|365145743|FG001|Overall Study|Participant Decision|0|||
105862030|NCT01449370|365145744|FG002|Overall Study|Participant Decision|0|||
105862031|NCT01449370|365145745|FG003|Overall Study|Participant Decision|0|||
105862032|NCT01449370|365145746|FG004|Overall Study|Participant Decision|0|||
105862033|NCT01449370|365145747|FG005|Overall Study|Participant Decision|0|||
105862034|NCT01449370|365145748|FG006|Overall Study|Participant Decision|0|||
105862035|NCT01449370|365145749|FG007|Overall Study|Participant Decision|1|||
105862036|NCT01449370|365145750|FG008|Overall Study|Participant Decision|1|||
105862037|NCT01449370|365145751|FG009|Overall Study|Participant Decision|0|||
105862038|NCT01449370|365145752|FG010|Overall Study|Participant Decision|0|||
105862039|NCT01449370|365145753|FG011|Overall Study|Participant Decision|0|||
105862040|NCT01449370|365145754|FG012|Overall Study|Participant Decision|1|||
105862041|NCT01449370|365145755|FG013|Overall Study|Participant Decision|1|||
105862042|NCT01449370|365145756|FG014|Overall Study|Participant Decision|0|||
105862043|NCT01449370|365145757|FG015|Overall Study|Participant Decision|1|||
106151763|NCT02590432|366215138|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
106151764|NCT02590432|366215139|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
106151765|NCT02590432|366215140|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
106151766|NCT02590432|366215132|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
106151767|NCT02590432|366215133|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
105862044|NCT01449370|365145758|FG016|Overall Study|Participant Decision|3|||
105862045|NCT01449370|365145759|FG017|Overall Study|Participant Decision|0|||
105862046|NCT01449370|365145760|FG018|Overall Study|Participant Decision|1|||
105862047|NCT01449370|365145761|FG019|Overall Study|Participant Decision|0|||
106151768|NCT02590432|366215134|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
106151769|NCT02590432|366215135|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
106151770|NCT02590432|366215136|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
106151771|NCT02590432|366215137|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
106151772|NCT02590432|366215138|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
106151773|NCT02590432|366215139|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
106151774|NCT02590432|366215140|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
106151775|NCT02590432|366215132|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
106151776|NCT02590432|366215133|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
106151777|NCT02590432|366215134|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
106151778|NCT02590432|366215135|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
106151779|NCT02590432|366215136|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
106151780|NCT02590432|366215137|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
106151781|NCT02590432|366215138|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
106151782|NCT02590432|366215139|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
106151783|NCT02590432|366215140|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
106151784|NCT02590432|366215132|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
106151785|NCT02590432|366215133|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
106151786|NCT02590432|366215134|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
106151787|NCT02590432|366215135|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
106151788|NCT02590432|366215136|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
106151789|NCT02590432|366215137|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
106151790|NCT02590432|366215138|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
106151791|NCT02590432|366215139|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
106151792|NCT02590432|366215140|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
106151793|NCT02590432|366215132|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
105862048|NCT01449370|365145762|FG020|Overall Study|Participant Decision|0|||
105862049|NCT01449370|365145763|FG021|Overall Study|Participant Decision|1|||
105862050|NCT01449370|365145764|FG022|Overall Study|Participant Decision|0|||
105862051|NCT01449370|365145765|FG023|Overall Study|Participant Decision|0|||
105862052|NCT01449370|365145766|FG024|Overall Study|Participant Decision|1|||
105862053|NCT01449370|365145742|FG000|Overall Study|Lost to Follow-up|0|||
105862054|NCT01449370|365145743|FG001|Overall Study|Lost to Follow-up|0|||
106151794|NCT02590432|366215133|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
106151795|NCT02590432|366215134|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
106151796|NCT02590432|366215135|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
106151797|NCT02590432|366215136|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
106151798|NCT02590432|366215137|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
106151799|NCT02590432|366215138|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
106151800|NCT02590432|366215139|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
106151801|NCT02590432|366215140|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
106151802|NCT02590432|366215132|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
106151803|NCT02590432|366215133|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
106151804|NCT02590432|366215134|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
106151805|NCT02590432|366215135|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
106151806|NCT02590432|366215136|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
106151807|NCT02590432|366215137|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
106151808|NCT02590432|366215138|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
106151809|NCT02590432|366215139|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
106151810|NCT02590432|366215140|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
106151811|NCT02590432|366215132|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
106151812|NCT02590432|366215133|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
106151813|NCT02590432|366215134|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
106151814|NCT02590432|366215135|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
106151815|NCT02590432|366215136|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
106151816|NCT02590432|366215137|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
106151817|NCT02590432|366215138|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
106151818|NCT02590432|366215139|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
106151819|NCT02590432|366215140|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
106151820|NCT02590432|366215132|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
106151821|NCT02590432|366215133|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
106151822|NCT02590432|366215134|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
106151823|NCT02590432|366215135|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
106151824|NCT02590432|366215136|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
106151825|NCT02590432|366215137|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
106151826|NCT02590432|366215138|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
106151827|NCT02590432|366215139|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
106151828|NCT02590432|366215140|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
106151829|NCT04788641|366215145|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
106151830|NCT04788641|366215146|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
106151831|NCT04788641|366215147|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
106151832|NCT04788641|366215148|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
106151833|NCT04788641|366215145|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
106151834|NCT04788641|366215146|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
106151835|NCT04788641|366215147|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
106151836|NCT04788641|366215148|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
106151837|NCT04788641|366215145|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
106151838|NCT04788641|366215146|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
106151839|NCT04788641|366215147|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
106151840|NCT04788641|366215148|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
106151841|NCT02740231|366215149|FG000|Overall Study|Withdrawal by Subject|1|||
106151842|NCT02740231|366215150|FG001|Overall Study|Withdrawal by Subject|1|||
106151843|NCT02740231|366215151|FG002|Overall Study|Withdrawal by Subject|1|||
106151844|NCT02740231|366215152|FG003|Overall Study|Withdrawal by Subject|0|||
105862055|NCT01449370|365145744|FG002|Overall Study|Lost to Follow-up|0|||
105862056|NCT01449370|365145745|FG003|Overall Study|Lost to Follow-up|0|||
106151845|NCT02740231|366215149|FG000|Overall Study|Lack of Efficacy|0|||
106151846|NCT02740231|366215150|FG001|Overall Study|Lack of Efficacy|1|||
106151847|NCT02740231|366215151|FG002|Overall Study|Lack of Efficacy|0|||
106151848|NCT02740231|366215152|FG003|Overall Study|Lack of Efficacy|4|||
106151849|NCT02740231|366215149|FG000|Overall Study|Lost to Follow-up|1|||
106151850|NCT02740231|366215150|FG001|Overall Study|Lost to Follow-up|3|||
106151851|NCT02740231|366215151|FG002|Overall Study|Lost to Follow-up|0|||
106151852|NCT02740231|366215152|FG003|Overall Study|Lost to Follow-up|3|||
106151853|NCT02740231|366215149|FG000|Overall Study|Adverse Event|0|||
106151854|NCT02740231|366215150|FG001|Overall Study|Adverse Event|1|||
106151855|NCT02740231|366215151|FG002|Overall Study|Adverse Event|0|||
106151856|NCT02740231|366215152|FG003|Overall Study|Adverse Event|1|||
106151857|NCT00243503|366215153|FG000|Overall Study|Adverse Event|11|||
106151858|NCT00243503|366215153|FG000|Overall Study|Withdrawal by Subject|1|||
106151859|NCT00243503|366215153|FG000|Overall Study|Lack of Efficacy|44|||
106151860|NCT00243503|366215153|FG000|Overall Study|Death|1|||
106151861|NCT00243503|366215153|FG000|Overall Study|Other|1|||
106151862|NCT02538900|366215154|FG000|Overall Study|Death|2|||
106151863|NCT02538900|366215155|FG001|Overall Study|Death|2|||
106151864|NCT02538900|366215156|FG002|Overall Study|Death|2|||
106151865|NCT02538900|366215154|FG000|Overall Study|Withdrawal by Subject|18|||
106151866|NCT02538900|366215155|FG001|Overall Study|Withdrawal by Subject|16|||
106151867|NCT02538900|366215156|FG002|Overall Study|Withdrawal by Subject|15|||
106151868|NCT02874534|366215157|FG000|Overall Study|Withdrawal by Subject|5|||
106151869|NCT02874534|366215158|FG001|Overall Study|Withdrawal by Subject|8|||
106151870|NCT02874534|366215157|FG000|Overall Study|Lost to Follow-up|2|||
106151871|NCT02874534|366215158|FG001|Overall Study|Lost to Follow-up|2|||
106151872|NCT02874534|366215157|FG000|Overall Study|Ongoing in study|1|||
106151873|NCT02874534|366215158|FG001|Overall Study|Ongoing in study|1|||
106151874|NCT04431726|366215162|FG000|Overall Study|Ongoing in the Study|55|||
106151875|NCT01102231|366215163|FG000|Overall Study|Protocol Violation|3|||
106151876|NCT01102231|366215163|FG000|Overall Study|Lack of Efficacy|2|||
106151877|NCT01102231|366215163|FG000|Overall Study|Death|2|||
106151878|NCT01102231|366215163|FG000|Overall Study|Adverse Event|3|||
106151879|NCT01102231|366215163|FG000|Overall Study|Withdrawal by Subject|1|||
106151880|NCT01102231|366215163|FG000|Overall Study|Did not received the treatment|4|||
106151881|NCT00296036|366215164|FG000|Overall Study|Withdrawal by Subject|1|||
106151882|NCT00296036|366215165|FG001|Overall Study|Withdrawal by Subject|0|||
106151883|NCT00296036|366215166|FG002|Overall Study|Withdrawal by Subject|2|||
106151884|NCT00296036|366215167|FG003|Overall Study|Withdrawal by Subject|1|||
106151885|NCT00296036|366215168|FG004|Overall Study|Withdrawal by Subject|2|||
106151886|NCT00296036|366215169|FG005|Overall Study|Withdrawal by Subject|1|||
106151887|NCT00296036|366215164|FG000|Overall Study|Protocol Violation|0|||
106151888|NCT00296036|366215165|FG001|Overall Study|Protocol Violation|0|||
106151889|NCT00296036|366215166|FG002|Overall Study|Protocol Violation|0|||
106151890|NCT00296036|366215167|FG003|Overall Study|Protocol Violation|0|||
106151891|NCT00296036|366215168|FG004|Overall Study|Protocol Violation|0|||
106151892|NCT00296036|366215169|FG005|Overall Study|Protocol Violation|3|||
106151893|NCT00604669|366215170|FG000|Overall Study|lack of information in chart|7|||
106151894|NCT01695954|366215171|FG000|Overall Study|Withdrawal by Subject|4|||
106151895|NCT01695954|366215172|FG001|Overall Study|Withdrawal by Subject|0|||
106151896|NCT01695954|366215171|FG000|Overall Study|Adverse Event|0|||
106151897|NCT01695954|366215172|FG001|Overall Study|Adverse Event|2|||
106151898|NCT01340066|366215173|FG000|Placebo Run in Period|Screen Failures|27|||
106151899|NCT01340066|366215174|FG001|Placebo Run in Period|Screen Failures|0|||
106151900|NCT01340066|366215175|FG002|Placebo Run in Period|Screen Failures|0|||
106151901|NCT01340066|366215173|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
106151902|NCT01340066|366215174|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
106151903|NCT01340066|366215175|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
106151904|NCT01340066|366215173|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
106151905|NCT01340066|366215174|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
106151906|NCT01340066|366215175|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
106151907|NCT01340066|366215173|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
106151908|NCT01340066|366215174|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
106151909|NCT01340066|366215175|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
106151910|NCT02789020|366215176|FG000|Overall Study|Withdrawal by Subject|6|||
106151911|NCT02789020|366215177|FG001|Overall Study|Withdrawal by Subject|5|||
106151912|NCT00595413|366215188|FG000|Overall Study|Adverse Event|0|||
106151913|NCT00595413|366215189|FG001|Overall Study|Adverse Event|2|||
106151914|NCT00595413|366215190|FG002|Overall Study|Adverse Event|1|||
106151915|NCT00595413|366215191|FG003|Overall Study|Adverse Event|1|||
106151916|NCT00595413|366215188|FG000|Overall Study|Lost to Follow-up|2|||
106151917|NCT00595413|366215189|FG001|Overall Study|Lost to Follow-up|2|||
106151918|NCT00595413|366215190|FG002|Overall Study|Lost to Follow-up|1|||
106151919|NCT00595413|366215191|FG003|Overall Study|Lost to Follow-up|3|||
106151920|NCT00595413|366215188|FG000|Overall Study|Death|0|||
106151921|NCT00595413|366215189|FG001|Overall Study|Death|0|||
106151922|NCT00595413|366215190|FG002|Overall Study|Death|1|||
106151923|NCT00595413|366215191|FG003|Overall Study|Death|0|||
106151924|NCT00595413|366215188|FG000|Overall Study|Other|5|||
106151925|NCT00595413|366215189|FG001|Overall Study|Other|1|||
106151926|NCT00595413|366215190|FG002|Overall Study|Other|5|||
106151927|NCT00595413|366215191|FG003|Overall Study|Other|0|||
106151928|NCT03233633|366215201|FG000|Overall Study|Adverse Event|2|||
106151929|NCT03233633|366215201|FG000|Overall Study|Less Than 3 Days of Data|6|||
106151930|NCT01198145|366215202|FG000|Overall Study|Withdrawal by Subject|1|||
106151931|NCT01198145|366215203|FG001|Overall Study|Withdrawal by Subject|1|||
106151932|NCT00603954|366215204|FG000|Overall Study|Protocol Violation|1|||
106151933|NCT00603954|366215205|FG001|Overall Study|Protocol Violation|2|||
106151934|NCT03380390|366215206|FG000|Overall Study|Adverse Event|3|||
106151935|NCT02886286|366215207|FG000|Overall Study|pump motor stall|0|||
106151936|NCT02886286|366215208|FG001|Overall Study|pump motor stall|1|||
106151937|NCT01127373|366215209|FG000|Overall Study|Not Treated|3|||
106151938|NCT01127373|366215209|FG000|Overall Study|Lost to Follow-up|7|||
106151939|NCT01127373|366215209|FG000|Overall Study|Withdrawal by Subject|1|||
106151940|NCT01127373|366215209|FG000|Overall Study|Disease progression|1|||
106151941|NCT02477605|366215212|FG000|Overall Study|Discontinued prior to treatment|1|||
106151942|NCT02477605|366215213|FG001|Overall Study|Discontinued prior to treatment|0|||
106151943|NCT02477605|366215212|FG000|Overall Study|Lost to Follow-up|0|||
106151944|NCT02477605|366215213|FG001|Overall Study|Lost to Follow-up|2|||
106151945|NCT02477605|366215212|FG000|Overall Study|Withdrawal by Subject|0|||
106151946|NCT02477605|366215213|FG001|Overall Study|Withdrawal by Subject|1|||
106151947|NCT02477605|366215212|FG000|Overall Study|Administered gas during surgery|0|||
106151948|NCT02477605|366215213|FG001|Overall Study|Administered gas during surgery|1|||
106151949|NCT02794480|366215214|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
106151950|NCT02794480|366215215|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
106151951|NCT02794480|366215216|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
106151952|NCT02794480|366215217|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
106151953|NCT02794480|366215214|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
106151954|NCT02794480|366215215|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
106151955|NCT02794480|366215216|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
106151956|NCT02794480|366215217|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
106151957|NCT02794480|366215214|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
106151958|NCT02794480|366215215|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
106151959|NCT02794480|366215216|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
106151960|NCT02794480|366215217|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
106151961|NCT02794480|366215214|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
106151962|NCT02794480|366215215|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
106151963|NCT02794480|366215216|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
106151964|NCT02794480|366215217|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
106151965|NCT02794480|366215214|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
106151966|NCT02794480|366215215|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
106151967|NCT02794480|366215216|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
106151968|NCT02794480|366215217|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
106151969|NCT00262301|366215218|FG000|Double-blind Phase|Lost to Follow-up|1|||
106151970|NCT00262301|366215219|FG001|Double-blind Phase|Lost to Follow-up|0|||
106151971|NCT00262301|366215220|FG002|Double-blind Phase|Lost to Follow-up|0|||
106151972|NCT00262301|366215218|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
106151973|NCT00262301|366215219|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
106151974|NCT00262301|366215220|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
106151975|NCT03101930|366215221|FG000|Overall Study|Withdrawal by Subject|2|||
106151976|NCT03101930|366215222|FG001|Overall Study|Withdrawal by Subject|1|||
106151977|NCT03101930|366215223|FG002|Overall Study|Withdrawal by Subject|2|||
106151978|NCT01084707|366215224|FG000|Overall Study|Withdrawal by Subject|6|||
106151979|NCT04154384|366215232|FG000|Overall Study|Lost to Follow-up|24|||
106151980|NCT04154384|366215233|FG001|Overall Study|Lost to Follow-up|33|||
106151981|NCT04154384|366215234|FG002|Overall Study|Lost to Follow-up|0|||
106151982|NCT04154384|366215232|FG000|Overall Study|Withdrawal by Subject|7|||
106151983|NCT04154384|366215233|FG001|Overall Study|Withdrawal by Subject|18|||
106151984|NCT04154384|366215234|FG002|Overall Study|Withdrawal by Subject|0|||
106151985|NCT04154384|366215232|FG000|Overall Study|Missing outcome data|1|||
106151986|NCT04154384|366215233|FG001|Overall Study|Missing outcome data|0|||
106151987|NCT04154384|366215234|FG002|Overall Study|Missing outcome data|0|||
106151988|NCT01136876|366215235|FG000|Overall Study|Lost to Follow-up|0|||
106151989|NCT01136876|366215236|FG001|Overall Study|Lost to Follow-up|1|||
106151990|NCT01136876|366215235|FG000|Overall Study|Physician Decision|3|||
106151991|NCT01136876|366215236|FG001|Overall Study|Physician Decision|5|||
106151992|NCT01136876|366215235|FG000|Overall Study|Missing NGAL measurement|2|||
106151993|NCT01136876|366215236|FG001|Overall Study|Missing NGAL measurement|5|||
106151994|NCT05048186|366215237|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
106151995|NCT05048186|366215238|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
106151996|NCT05048186|366215237|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
106151997|NCT05048186|366215238|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
106151998|NCT01094184|366215241|FG000|Overall Study|Death|35|||
106151999|NCT01094184|366215242|FG001|Overall Study|Death|11|||
106152000|NCT03988842|366215243|FG000|Overall Study|Death|1|||
106152001|NCT01976312|366215244|FG000|Overall Study|Pregnancy|0|||
106152002|NCT01976312|366215245|FG001|Overall Study|Pregnancy|1|||
106152003|NCT01976312|366215244|FG000|Overall Study|Lost to Follow-up|2|||
106152004|NCT01976312|366215245|FG001|Overall Study|Lost to Follow-up|0|||
106152005|NCT01976312|366215244|FG000|Overall Study|Withdrawal by Subject|7|||
106152006|NCT01976312|366215245|FG001|Overall Study|Withdrawal by Subject|2|||
106152007|NCT01976312|366215244|FG000|Overall Study|Adverse Event|6|||
106152008|NCT01976312|366215245|FG001|Overall Study|Adverse Event|6|||
106152009|NCT01976312|366215244|FG000|Overall Study|Protocol Violation|2|||
106152010|NCT01976312|366215245|FG001|Overall Study|Protocol Violation|0|||
106152011|NCT04043455|366216994|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
106152012|NCT04043455|366216995|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
106152013|NCT04043455|366216996|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
106152014|NCT04043455|366216997|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
106152015|NCT04043455|366216998|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
106152016|NCT04043455|366216999|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
106152017|NCT04043455|366216994|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
106152018|NCT04043455|366216995|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
106152019|NCT04043455|366216996|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
106152020|NCT04043455|366216997|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
106152021|NCT04043455|366216998|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
106152022|NCT04043455|366216999|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
106152023|NCT04043455|366216994|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
106152024|NCT04043455|366216995|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
106152025|NCT04043455|366216996|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
106152026|NCT04043455|366216997|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
106152027|NCT04043455|366216998|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
106152028|NCT04043455|366216999|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
106152029|NCT04043455|366216994|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
106152030|NCT04043455|366216995|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
106152031|NCT04043455|366216996|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
106152032|NCT04043455|366216997|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
106152033|NCT04043455|366216998|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
106152034|NCT04043455|366216999|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
106152035|NCT04043455|366216994|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
106152036|NCT04043455|366216995|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
106152037|NCT04043455|366216996|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
106152038|NCT04043455|366216997|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
106152039|NCT04043455|366216998|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
106152040|NCT04043455|366216999|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
106152041|NCT04043455|366216994|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
106152042|NCT04043455|366216995|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
106152043|NCT04043455|366216996|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
106152044|NCT04043455|366216997|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
106152045|NCT04043455|366216998|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
106152046|NCT04043455|366216999|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
106152047|NCT04043455|366216994|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
106041959|NCT04493333|365820444|FG000|Overall Study|Ineligible|0|||
106041960|NCT04493333|365820445|FG001|Overall Study|Ineligible|1|||
106041961|NCT04493333|365820444|FG000|Overall Study|Noncompliance|2|||
106041962|NCT04493333|365820445|FG001|Overall Study|Noncompliance|1|||
106041963|NCT00674973|365820448|FG000|Overall Study|Insufficient Therapeutic Response|77|||
106041964|NCT00674973|365820449|FG001|Overall Study|Insufficient Therapeutic Response|72|||
106041965|NCT00674973|365820448|FG000|Overall Study|Refused Treatment|1|||
106041966|NCT00674973|365820449|FG001|Overall Study|Refused Treatment|5|||
106041967|NCT00674973|365820448|FG000|Overall Study|Failure to Return|1|||
106041968|NCT00674973|365820449|FG001|Overall Study|Failure to Return|0|||
106041969|NCT00674973|365820448|FG000|Overall Study|Adverse Event|2|||
106041970|NCT00674973|365820449|FG001|Overall Study|Adverse Event|9|||
106041971|NCT00674973|365820448|FG000|Overall Study|Death|19|||
106041972|NCT00674973|365820449|FG001|Overall Study|Death|15|||
106041973|NCT00674973|365820448|FG000|Overall Study|Protocol Violation|0|||
106041974|NCT00674973|365820449|FG001|Overall Study|Protocol Violation|1|||
106041975|NCT00451451|365820450|FG000|Overall Study|Adverse Event|11|||
106041976|NCT00451451|365820451|FG001|Overall Study|Adverse Event|21|||
106041977|NCT00451451|365820452|FG002|Overall Study|Adverse Event|26|||
106041978|NCT00451451|365820453|FG003|Overall Study|Adverse Event|10|||
106041979|NCT00451451|365820450|FG000|Overall Study|Lost to Follow-up|11|||
106041980|NCT00451451|365820451|FG001|Overall Study|Lost to Follow-up|9|||
106041981|NCT00451451|365820452|FG002|Overall Study|Lost to Follow-up|8|||
106041982|NCT00451451|365820453|FG003|Overall Study|Lost to Follow-up|11|||
106041983|NCT00451451|365820450|FG000|Overall Study|Consent Withdrawn|14|||
106041984|NCT00451451|365820451|FG001|Overall Study|Consent Withdrawn|9|||
106041985|NCT00451451|365820452|FG002|Overall Study|Consent Withdrawn|17|||
106041986|NCT00451451|365820453|FG003|Overall Study|Consent Withdrawn|17|||
106041987|NCT00451451|365820450|FG000|Overall Study|Investigator Decision|6|||
106041988|NCT00451451|365820451|FG001|Overall Study|Investigator Decision|2|||
106041989|NCT00451451|365820452|FG002|Overall Study|Investigator Decision|1|||
106041990|NCT00451451|365820453|FG003|Overall Study|Investigator Decision|2|||
106041991|NCT00451451|365820450|FG000|Overall Study|Subject Non-Compliance|8|||
106041992|NCT00451451|365820451|FG001|Overall Study|Subject Non-Compliance|4|||
106041993|NCT00451451|365820452|FG002|Overall Study|Subject Non-Compliance|3|||
106152048|NCT04043455|366216995|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
106152049|NCT04043455|366216996|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
106152050|NCT04043455|366216997|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
106152051|NCT04043455|366216998|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
106152052|NCT04043455|366216999|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
106152053|NCT04043455|366216994|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
106152054|NCT04043455|366216995|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
106152055|NCT04043455|366216996|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
106152056|NCT04043455|366216997|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
106152057|NCT04043455|366216998|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
106152058|NCT04043455|366216999|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
106152059|NCT04043455|366216994|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
106152060|NCT04043455|366216995|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
106152061|NCT04043455|366216996|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
106152062|NCT04043455|366216997|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
106152063|NCT04043455|366216998|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
106152064|NCT04043455|366216999|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
106152065|NCT04043455|366216994|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
106152066|NCT04043455|366216995|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
106152067|NCT04043455|366216996|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
106152068|NCT04043455|366216997|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
106152069|NCT04043455|366216998|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
106152070|NCT04043455|366216999|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
106152071|NCT04043455|366216994|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
106152072|NCT04043455|366216995|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
106152073|NCT04043455|366216996|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
106152074|NCT04043455|366216997|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
106152075|NCT04043455|366216998|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
106152076|NCT04043455|366216999|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
106152077|NCT04688450|366217002|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
106152078|NCT04688450|366217002|FG000|Overall Study|Withdrawal by Subject|1|||
106152079|NCT02544074|366217005|FG000|Overall Study|Withdrawal by Subject|0|||
106152080|NCT02544074|366217006|FG001|Overall Study|Withdrawal by Subject|1|||
106152081|NCT02544074|366217007|FG002|Overall Study|Withdrawal by Subject|0|||
106152082|NCT02544074|366217008|FG003|Overall Study|Withdrawal by Subject|0|||
106152083|NCT02544074|366217009|FG004|Overall Study|Withdrawal by Subject|0|||
106152084|NCT02544074|366217010|FG005|Overall Study|Withdrawal by Subject|0|||
106152085|NCT02544074|366217011|FG006|Overall Study|Withdrawal by Subject|0|||
106152086|NCT02544074|366217012|FG007|Overall Study|Withdrawal by Subject|0|||
106152087|NCT02544074|366217013|FG008|Overall Study|Withdrawal by Subject|0|||
106152088|NCT02544074|366217014|FG009|Overall Study|Withdrawal by Subject|0|||
106152089|NCT02544074|366217015|FG010|Overall Study|Withdrawal by Subject|0|||
106152090|NCT02544074|366217016|FG011|Overall Study|Withdrawal by Subject|0|||
106152091|NCT02544074|366217017|FG012|Overall Study|Withdrawal by Subject|0|||
106041994|NCT00451451|365820453|FG003|Overall Study|Subject Non-Compliance|3|||
106041995|NCT00451451|365820450|FG000|Overall Study|Death|1|||
106041996|NCT00451451|365820451|FG001|Overall Study|Death|0|||
106041997|NCT00451451|365820452|FG002|Overall Study|Death|0|||
106041998|NCT00451451|365820453|FG003|Overall Study|Death|1|||
105862057|NCT01449370|365145746|FG004|Overall Study|Lost to Follow-up|0|||
106041999|NCT00451451|365820450|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
106042000|NCT00451451|365820451|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
106042001|NCT00451451|365820452|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
106042002|NCT00451451|365820453|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
106042003|NCT05036369|365820454|FG000|Overall Study|Run In non compliance|1|||
106042004|NCT05036369|365820455|FG001|Overall Study|Run In non compliance|2|||
106042005|NCT05036369|365820454|FG000|Overall Study|Change in eligibility criteria|0|||
106042006|NCT05036369|365820455|FG001|Overall Study|Change in eligibility criteria|1|||
106042007|NCT03332771|365820456|FG000|Overall Study|Adverse Event|6|||
106042008|NCT03332771|365820457|FG001|Overall Study|Adverse Event|4|||
106042009|NCT03332771|365820458|FG002|Overall Study|Adverse Event|1|||
106042010|NCT03332771|365820459|FG003|Overall Study|Adverse Event|3|||
106042011|NCT03332771|365820456|FG000|Overall Study|Poor Compliance to Protocol|0|||
106042012|NCT03332771|365820457|FG001|Overall Study|Poor Compliance to Protocol|1|||
106042013|NCT03332771|365820458|FG002|Overall Study|Poor Compliance to Protocol|0|||
106042014|NCT03332771|365820459|FG003|Overall Study|Poor Compliance to Protocol|1|||
106042015|NCT03332771|365820456|FG000|Overall Study|Lost to Follow-up|2|||
106042016|NCT03332771|365820457|FG001|Overall Study|Lost to Follow-up|2|||
106042017|NCT03332771|365820458|FG002|Overall Study|Lost to Follow-up|1|||
106042018|NCT03332771|365820459|FG003|Overall Study|Lost to Follow-up|2|||
106042019|NCT03332771|365820456|FG000|Overall Study|At the Participant's own request|20|||
106042020|NCT03332771|365820457|FG001|Overall Study|At the Participant's own request|26|||
106042021|NCT03332771|365820458|FG002|Overall Study|At the Participant's own request|14|||
106042022|NCT03332771|365820459|FG003|Overall Study|At the Participant's own request|23|||
106042023|NCT03332771|365820456|FG000|Overall Study|Reason Not Specified|6|||
106042024|NCT03332771|365820457|FG001|Overall Study|Reason Not Specified|18|||
106042025|NCT03332771|365820458|FG002|Overall Study|Reason Not Specified|16|||
106042026|NCT03332771|365820459|FG003|Overall Study|Reason Not Specified|19|||
106042027|NCT03906461|365820460|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
106042028|NCT03906461|365820460|FG000|Completed 12-month Follow-up|Missed Visit|6|||
106042029|NCT01920555|365820461|FG000|Overall Study|Physician Decision|1|||
106042030|NCT01920555|365820462|FG001|Overall Study|Physician Decision|2|||
106042031|NCT01920555|365820463|FG002|Overall Study|Physician Decision|1|||
106042032|NCT01920555|365820464|FG003|Overall Study|Physician Decision|2|||
106042033|NCT01920555|365820465|FG004|Overall Study|Physician Decision|0|||
106042034|NCT01920555|365820461|FG000|Overall Study|Lack of Efficacy|2|||
106042035|NCT01920555|365820462|FG001|Overall Study|Lack of Efficacy|0|||
106042036|NCT01920555|365820463|FG002|Overall Study|Lack of Efficacy|0|||
106042037|NCT01920555|365820464|FG003|Overall Study|Lack of Efficacy|0|||
106042038|NCT01920555|365820465|FG004|Overall Study|Lack of Efficacy|0|||
106042039|NCT01920555|365820461|FG000|Overall Study|Travel Difficulties|1|||
106042040|NCT01920555|365820462|FG001|Overall Study|Travel Difficulties|1|||
106042041|NCT01920555|365820463|FG002|Overall Study|Travel Difficulties|0|||
106042042|NCT01920555|365820464|FG003|Overall Study|Travel Difficulties|0|||
106042043|NCT01920555|365820465|FG004|Overall Study|Travel Difficulties|1|||
106042044|NCT01920555|365820461|FG000|Overall Study|Lost to Follow-up|0|||
106042045|NCT01920555|365820462|FG001|Overall Study|Lost to Follow-up|1|||
106042046|NCT01920555|365820463|FG002|Overall Study|Lost to Follow-up|0|||
106042047|NCT01920555|365820464|FG003|Overall Study|Lost to Follow-up|1|||
106042048|NCT01920555|365820465|FG004|Overall Study|Lost to Follow-up|0|||
106042049|NCT00697073|365820466|FG000|Overall Study|Withdrawal by Subject|2|||
106042050|NCT00697073|365820466|FG000|Overall Study|Pregnancy|1|||
106042051|NCT00697073|365820466|FG000|Overall Study|non compliance and other|6|||
106042052|NCT03061097|365820469|FG000|Overall Study|Withdrawal by Subject|0|||
106042053|NCT03061097|365820470|FG001|Overall Study|Withdrawal by Subject|3|||
106042054|NCT01845818|365820471|FG000|Overall Study|Withdrawal by Subject|0|||
106042055|NCT01845818|365820472|FG001|Overall Study|Withdrawal by Subject|1|||
106042056|NCT01845818|365820471|FG000|Overall Study|Lost to Follow-up|7|||
106042057|NCT01845818|365820472|FG001|Overall Study|Lost to Follow-up|5|||
106042058|NCT01845818|365820471|FG000|Overall Study|Administrative Reasons|3|||
106042059|NCT01845818|365820472|FG001|Overall Study|Administrative Reasons|1|||
106042060|NCT01845818|365820471|FG000|Overall Study|Serious Adverse Event|1|||
106042061|NCT01845818|365820472|FG001|Overall Study|Serious Adverse Event|1|||
106042062|NCT01845818|365820471|FG000|Overall Study|Other|25|||
106042063|NCT01845818|365820472|FG001|Overall Study|Other|8|||
106042064|NCT01845818|365820471|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
106042065|NCT01845818|365820472|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
106042066|NCT01845818|365820471|FG000|Overall Study|No Follow-Up Data Available|4|||
106042067|NCT01845818|365820472|FG001|Overall Study|No Follow-Up Data Available|1|||
106042068|NCT00595465|365820473|FG000|Overall Study|Adverse Event|4|||
106042069|NCT00595465|365820474|FG001|Overall Study|Adverse Event|3|||
106042070|NCT00595465|365820475|FG002|Overall Study|Adverse Event|3|||
106042071|NCT00595465|365820473|FG000|Overall Study|Pregnancy|0|||
106042072|NCT00595465|365820474|FG001|Overall Study|Pregnancy|0|||
106042073|NCT00595465|365820475|FG002|Overall Study|Pregnancy|1|||
106042074|NCT00595465|365820473|FG000|Overall Study|Protocol Violation|2|||
106042075|NCT00595465|365820474|FG001|Overall Study|Protocol Violation|1|||
106042076|NCT00595465|365820475|FG002|Overall Study|Protocol Violation|0|||
106042077|NCT00595465|365820473|FG000|Overall Study|Lost to Follow-up|0|||
106042078|NCT00595465|365820474|FG001|Overall Study|Lost to Follow-up|0|||
106042079|NCT00595465|365820475|FG002|Overall Study|Lost to Follow-up|2|||
106042080|NCT00595465|365820473|FG000|Overall Study|administrative reason|0|||
106042081|NCT00595465|365820474|FG001|Overall Study|administrative reason|0|||
106042082|NCT00595465|365820475|FG002|Overall Study|administrative reason|1|||
106042083|NCT03228420|365820476|FG000|Overall Study|Lost to Follow-up|5|||
106042084|NCT03228420|365820477|FG001|Overall Study|Lost to Follow-up|3|||
106042085|NCT03228420|365820476|FG000|Overall Study|Withdrawal by Subject|10|||
106042086|NCT03228420|365820477|FG001|Overall Study|Withdrawal by Subject|0|||
106042087|NCT03228420|365820476|FG000|Overall Study|Adverse Event|5|||
106042088|NCT03228420|365820477|FG001|Overall Study|Adverse Event|2|||
106042089|NCT01298531|365820478|FG000|Overall Study|Lack of Efficacy|0|||
106042090|NCT01298531|365820479|FG001|Overall Study|Lack of Efficacy|1|||
106042091|NCT01298531|365820478|FG000|Overall Study|Lost to Follow-up|2|||
106042092|NCT01298531|365820479|FG001|Overall Study|Lost to Follow-up|0|||
106042093|NCT01298531|365820478|FG000|Overall Study|Protocol Violation|1|||
106042094|NCT01298531|365820479|FG001|Overall Study|Protocol Violation|1|||
106042095|NCT01298531|365820478|FG000|Overall Study|Adverse Event|4|||
106042096|NCT01298531|365820479|FG001|Overall Study|Adverse Event|3|||
106042097|NCT01298531|365820478|FG000|Overall Study|Does not meet entrance criteria|0|||
106042098|NCT01298531|365820479|FG001|Overall Study|Does not meet entrance criteria|1|||
106042099|NCT01298531|365820478|FG000|Overall Study|Other|2|||
106042100|NCT01298531|365820479|FG001|Overall Study|Other|1|||
106042101|NCT02213042|365820482|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
106042102|NCT02213042|365820483|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
106042103|NCT02213042|365820484|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
106042104|NCT02213042|365820482|FG000|Overall Study|Adverse Event|2|||
106042105|NCT02213042|365820483|FG001|Overall Study|Adverse Event|1|||
106042106|NCT02213042|365820484|FG002|Overall Study|Adverse Event|0|||
106042107|NCT02213042|365820482|FG000|Overall Study|Withdrawal by Subject|0|||
106042108|NCT02213042|365820483|FG001|Overall Study|Withdrawal by Subject|1|||
106042109|NCT02213042|365820484|FG002|Overall Study|Withdrawal by Subject|1|||
106042110|NCT02213042|365820482|FG000|Overall Study|Protocol Violation|1|||
106042111|NCT02213042|365820483|FG001|Overall Study|Protocol Violation|0|||
106042112|NCT02213042|365820484|FG002|Overall Study|Protocol Violation|0|||
106042113|NCT02213042|365820482|FG000|Overall Study|Investigator discretion|0|||
106042114|NCT02213042|365820483|FG001|Overall Study|Investigator discretion|0|||
106042115|NCT02213042|365820484|FG002|Overall Study|Investigator discretion|1|||
106042116|NCT01539642|365820485|FG000|Overall Study|Lack of Efficacy|20|||
106042117|NCT01539642|365820486|FG001|Overall Study|Lack of Efficacy|18|||
106042118|NCT01539642|365820485|FG000|Overall Study|Patient ready for early discharge|8|||
106042119|NCT01539642|365820486|FG001|Overall Study|Patient ready for early discharge|7|||
106042120|NCT01539642|365820485|FG000|Overall Study|Adverse Event|6|||
106042121|NCT01539642|365820486|FG001|Overall Study|Adverse Event|4|||
106042122|NCT01539642|365820485|FG000|Overall Study|Withdrawal by Subject|2|||
106042123|NCT01539642|365820486|FG001|Overall Study|Withdrawal by Subject|2|||
106042124|NCT02556203|365820487|FG000|Overall Study|Withdrawal by Subject|21|||
106042125|NCT02556203|365820488|FG001|Overall Study|Withdrawal by Subject|21|||
106042126|NCT02556203|365820487|FG000|Overall Study|Lost to Follow-up|5|||
106042127|NCT02556203|365820488|FG001|Overall Study|Lost to Follow-up|5|||
106042128|NCT02556203|365820487|FG000|Overall Study|Adverse Event|1|||
106042129|NCT02556203|365820488|FG001|Overall Study|Adverse Event|0|||
106042130|NCT00580970|365820492|FG000|Pre-treatment|Non-compliance|1|||
106042131|NCT00580970|365820492|FG000|Treatment (Lovastatin)|Non-compliance|6|||
106042132|NCT00580970|365820492|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
106042133|NCT00580970|365820492|FG000|Treatment (Lovastatin)|Physician Decision|4|||
106042134|NCT00580970|365820492|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
106042135|NCT00580970|365820492|FG000|Treatment (Lovastatin)|Death|1|||
106042136|NCT01086423|365820493|FG000|Overall Study|Protocol Violation|0|||
106042137|NCT01086423|365820494|FG001|Overall Study|Protocol Violation|0|||
106042138|NCT01086423|365820495|FG002|Overall Study|Protocol Violation|1|||
106042139|NCT01086423|365820493|FG000|Overall Study|Migrated/moved from study area|2|||
106042140|NCT01086423|365820494|FG001|Overall Study|Migrated/moved from study area|0|||
106042141|NCT01086423|365820495|FG002|Overall Study|Migrated/moved from study area|4|||
106042142|NCT01086423|365820493|FG000|Overall Study|Adverse event, fatal|1|||
106042143|NCT01086423|365820494|FG001|Overall Study|Adverse event, fatal|1|||
106042144|NCT01086423|365820495|FG002|Overall Study|Adverse event, fatal|0|||
106042145|NCT01086423|365820493|FG000|Overall Study|Adverse event, non-fatal|2|||
106042146|NCT01086423|365820494|FG001|Overall Study|Adverse event, non-fatal|1|||
106042147|NCT01086423|365820495|FG002|Overall Study|Adverse event, non-fatal|0|||
106042148|NCT01086423|365820493|FG000|Overall Study|Withdrawal by Subject|5|||
106042149|NCT01086423|365820494|FG001|Overall Study|Withdrawal by Subject|1|||
106042150|NCT01086423|365820495|FG002|Overall Study|Withdrawal by Subject|3|||
106042151|NCT01086423|365820493|FG000|Overall Study|Lost to Follow-up|0|||
106042152|NCT01086423|365820494|FG001|Overall Study|Lost to Follow-up|0|||
106042153|NCT01086423|365820495|FG002|Overall Study|Lost to Follow-up|1|||
106042154|NCT02456103|365820498|FG000|Overall Study|Study Closure|207|||
106042155|NCT02456103|365820498|FG000|Overall Study|Physician Decision|1|||
106042156|NCT02456103|365820498|FG000|Overall Study|Required prohibited medications|5|||
106042157|NCT02456103|365820498|FG000|Overall Study|Protocol Violation|1|||
106042158|NCT02456103|365820498|FG000|Overall Study|Adverse Event|5|||
106042159|NCT02456103|365820498|FG000|Overall Study|Abnormal Laboratory Value|2|||
106042160|NCT02456103|365820498|FG000|Overall Study|Lost to Follow-up|1|||
106042161|NCT02456103|365820498|FG000|Overall Study|Withdrawal by Subject|24|||
106042162|NCT00470847|365820506|FG000|Overall Study|Pt still receiving treatment|1|||
106042163|NCT02808650|365820509|FG000|Overall Study|Death|0|||
106042164|NCT02808650|365820510|FG001|Overall Study|Death|0|||
106042165|NCT02808650|365820511|FG002|Overall Study|Death|0|||
106042166|NCT02808650|365820512|FG003|Overall Study|Death|0|||
106042167|NCT02808650|365820513|FG004|Overall Study|Death|1|||
106042168|NCT02808650|365820509|FG000|Overall Study|Lack of Efficacy|5|||
106042169|NCT02808650|365820510|FG001|Overall Study|Lack of Efficacy|5|||
106042170|NCT02808650|365820511|FG002|Overall Study|Lack of Efficacy|6|||
106042171|NCT02808650|365820512|FG003|Overall Study|Lack of Efficacy|5|||
106042172|NCT02808650|365820513|FG004|Overall Study|Lack of Efficacy|4|||
106042173|NCT02808650|365820509|FG000|Overall Study|Physician Decision|1|||
106042174|NCT02808650|365820510|FG001|Overall Study|Physician Decision|1|||
106042175|NCT02808650|365820511|FG002|Overall Study|Physician Decision|0|||
106042176|NCT02808650|365820512|FG003|Overall Study|Physician Decision|0|||
106042177|NCT02808650|365820513|FG004|Overall Study|Physician Decision|0|||
106042178|NCT02808650|365820509|FG000|Overall Study|Withdrawal by Subject|0|||
106042179|NCT02808650|365820510|FG001|Overall Study|Withdrawal by Subject|0|||
106042180|NCT02808650|365820511|FG002|Overall Study|Withdrawal by Subject|0|||
106042181|NCT02808650|365820512|FG003|Overall Study|Withdrawal by Subject|1|||
106042182|NCT02808650|365820513|FG004|Overall Study|Withdrawal by Subject|1|||
106042183|NCT01638819|365820515|FG000|Overall Study|Lost to Follow-up|1|||
106042184|NCT01638819|365820516|FG001|Overall Study|Lost to Follow-up|0|||
106042185|NCT03911154|365820517|FG000|Overall Study|Withdrawal by Subject|1|||
106042186|NCT02322021|365820518|FG000|Core Phase|Adverse Event|1|||
106042187|NCT02322021|365820519|FG001|Core Phase|Adverse Event|3|||
106042188|NCT02322021|365820520|FG002|Core Phase|Adverse Event|4|||
106042189|NCT02322021|365820521|FG003|Core Phase|Adverse Event|2|||
106042190|NCT02322021|365820522|FG004|Core Phase|Adverse Event|0|||
106042191|NCT02322021|365820518|FG000|Core Phase|Participant Choice|4|||
106042192|NCT02322021|365820519|FG001|Core Phase|Participant Choice|5|||
106042193|NCT02322021|365820520|FG002|Core Phase|Participant Choice|4|||
106042194|NCT02322021|365820521|FG003|Core Phase|Participant Choice|2|||
106042195|NCT02322021|365820522|FG004|Core Phase|Participant Choice|0|||
106042196|NCT02322021|365820518|FG000|Core Phase|Lost to Follow-up|0|||
106042197|NCT02322021|365820519|FG001|Core Phase|Lost to Follow-up|0|||
106152092|NCT02544074|366217018|FG013|Overall Study|Withdrawal by Subject|0|||
106152093|NCT02544074|366217019|FG014|Overall Study|Withdrawal by Subject|0|||
106152094|NCT02544074|366217020|FG015|Overall Study|Withdrawal by Subject|0|||
106042198|NCT02322021|365820520|FG002|Core Phase|Lost to Follow-up|0|||
106042199|NCT02322021|365820521|FG003|Core Phase|Lost to Follow-up|1|||
106042200|NCT02322021|365820522|FG004|Core Phase|Lost to Follow-up|0|||
106042201|NCT02322021|365820518|FG000|Core Phase|Other|0|||
106042202|NCT02322021|365820519|FG001|Core Phase|Other|0|||
106042203|NCT02322021|365820520|FG002|Core Phase|Other|1|||
106042204|NCT02322021|365820521|FG003|Core Phase|Other|0|||
106042205|NCT02322021|365820522|FG004|Core Phase|Other|0|||
106042206|NCT02322021|365820518|FG000|Extension Phase|Adverse Event|0|||
106042207|NCT02322021|365820519|FG001|Extension Phase|Adverse Event|0|||
106042208|NCT02322021|365820520|FG002|Extension Phase|Adverse Event|0|||
106042209|NCT02322021|365820521|FG003|Extension Phase|Adverse Event|0|||
106042210|NCT02322021|365820522|FG004|Extension Phase|Adverse Event|3|||
106042211|NCT02322021|365820518|FG000|Extension Phase|Participant Choice|0|||
106042212|NCT02322021|365820519|FG001|Extension Phase|Participant Choice|0|||
106042213|NCT02322021|365820520|FG002|Extension Phase|Participant Choice|0|||
106042214|NCT02322021|365820521|FG003|Extension Phase|Participant Choice|0|||
106042215|NCT02322021|365820522|FG004|Extension Phase|Participant Choice|6|||
106042216|NCT02322021|365820518|FG000|Extension Phase|Other|0|||
106042217|NCT02322021|365820519|FG001|Extension Phase|Other|0|||
106042218|NCT02322021|365820520|FG002|Extension Phase|Other|0|||
106042219|NCT02322021|365820521|FG003|Extension Phase|Other|0|||
106042220|NCT02322021|365820522|FG004|Extension Phase|Other|3|||
106042221|NCT02322021|365820518|FG000|Extension Phase|Lost to Follow-up|0|||
106042222|NCT02322021|365820519|FG001|Extension Phase|Lost to Follow-up|0|||
106042223|NCT02322021|365820520|FG002|Extension Phase|Lost to Follow-up|0|||
106042224|NCT02322021|365820521|FG003|Extension Phase|Lost to Follow-up|0|||
106042225|NCT02322021|365820522|FG004|Extension Phase|Lost to Follow-up|1|||
106042226|NCT02322021|365820518|FG000|Extension Phase|Study terminated by sponsor|0|||
106042227|NCT02322021|365820519|FG001|Extension Phase|Study terminated by sponsor|0|||
106042228|NCT02322021|365820520|FG002|Extension Phase|Study terminated by sponsor|0|||
106042229|NCT02322021|365820521|FG003|Extension Phase|Study terminated by sponsor|0|||
106042230|NCT02322021|365820522|FG004|Extension Phase|Study terminated by sponsor|28|||
106042231|NCT02047227|365820523|FG000|Overall Study|Adverse Event|2|||
106042232|NCT02047227|365820524|FG001|Overall Study|Adverse Event|4|||
106042233|NCT02047227|365820523|FG000|Overall Study|Lost to Follow-up|0|||
106042234|NCT02047227|365820524|FG001|Overall Study|Lost to Follow-up|3|||
106042235|NCT02047227|365820523|FG000|Overall Study|Protocol Violation|1|||
106042236|NCT02047227|365820524|FG001|Overall Study|Protocol Violation|0|||
106042237|NCT02047227|365820523|FG000|Overall Study|Spontaneous pregnancy|1|||
106042238|NCT02047227|365820524|FG001|Overall Study|Spontaneous pregnancy|0|||
106042239|NCT02047227|365820523|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
106042240|NCT02047227|365820524|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
106042241|NCT02047227|365820523|FG000|Overall Study|No oocytes retrieved|21|||
106042242|NCT02047227|365820524|FG001|Overall Study|No oocytes retrieved|20|||
106042243|NCT02047227|365820523|FG000|Overall Study|No fertilization|61|||
106042244|NCT02047227|365820524|FG001|Overall Study|No fertilization|51|||
106042245|NCT02047227|365820523|FG000|Overall Study|Intention to freeze all embryos|1|||
106042246|NCT02047227|365820524|FG001|Overall Study|Intention to freeze all embryos|0|||
106042247|NCT02047227|365820523|FG000|Overall Study|All embryos discarded|12|||
106042248|NCT02047227|365820524|FG001|Overall Study|All embryos discarded|11|||
106042249|NCT02047227|365820523|FG000|Overall Study|Other|10|||
106042250|NCT02047227|365820524|FG001|Overall Study|Other|9|||
106042251|NCT00299182|365820525|FG000|Overall Study|Withdrawal by Subject|0|||
106042252|NCT00299182|365820526|FG001|Overall Study|Withdrawal by Subject|0|||
106042253|NCT00299182|365820527|FG002|Overall Study|Withdrawal by Subject|1|||
106042254|NCT00299182|365820528|FG003|Overall Study|Withdrawal by Subject|0|||
106042255|NCT00299182|365820529|FG004|Overall Study|Withdrawal by Subject|1|||
106042256|NCT00299182|365820530|FG005|Overall Study|Withdrawal by Subject|2|||
106042257|NCT00299182|365820531|FG006|Overall Study|Withdrawal by Subject|0|||
106042258|NCT00299182|365820525|FG000|Overall Study|Chemotherapy Changed|0|||
106042259|NCT00299182|365820526|FG001|Overall Study|Chemotherapy Changed|0|||
106042260|NCT00299182|365820527|FG002|Overall Study|Chemotherapy Changed|1|||
106042261|NCT00299182|365820528|FG003|Overall Study|Chemotherapy Changed|0|||
106042262|NCT00299182|365820529|FG004|Overall Study|Chemotherapy Changed|1|||
106042263|NCT00299182|365820530|FG005|Overall Study|Chemotherapy Changed|0|||
106042264|NCT00299182|365820531|FG006|Overall Study|Chemotherapy Changed|1|||
106042265|NCT00299182|365820525|FG000|Overall Study|Adverse Event|0|||
106152095|NCT02544074|366217021|FG016|Overall Study|Withdrawal by Subject|0|||
106152096|NCT02544074|366217022|FG017|Overall Study|Withdrawal by Subject|0|||
106152097|NCT02544074|366217023|FG018|Overall Study|Withdrawal by Subject|0|||
106152098|NCT02544074|366217024|FG019|Overall Study|Withdrawal by Subject|0|||
106152099|NCT02544074|366217025|FG020|Overall Study|Withdrawal by Subject|0|||
106152100|NCT02544074|366217005|FG000|Overall Study|Tablet error|0|||
106152101|NCT02544074|366217006|FG001|Overall Study|Tablet error|0|||
106042266|NCT00299182|365820526|FG001|Overall Study|Adverse Event|0|||
106042267|NCT00299182|365820527|FG002|Overall Study|Adverse Event|0|||
106042268|NCT00299182|365820528|FG003|Overall Study|Adverse Event|0|||
106042269|NCT00299182|365820529|FG004|Overall Study|Adverse Event|0|||
106042270|NCT00299182|365820530|FG005|Overall Study|Adverse Event|1|||
106042271|NCT00299182|365820531|FG006|Overall Study|Adverse Event|0|||
106042272|NCT00299182|365820525|FG000|Overall Study|Not Eligible|0|||
106042273|NCT00299182|365820526|FG001|Overall Study|Not Eligible|0|||
106042274|NCT00299182|365820527|FG002|Overall Study|Not Eligible|0|||
106042275|NCT00299182|365820528|FG003|Overall Study|Not Eligible|0|||
106042276|NCT00299182|365820529|FG004|Overall Study|Not Eligible|1|||
106042277|NCT00299182|365820530|FG005|Overall Study|Not Eligible|0|||
106042278|NCT00299182|365820531|FG006|Overall Study|Not Eligible|0|||
106152102|NCT02544074|366217007|FG002|Overall Study|Tablet error|0|||
106042279|NCT02001181|365820533|FG000|Overall Study|Adverse Event|0|||
106042280|NCT02001181|365820534|FG001|Overall Study|Adverse Event|2|||
105862058|NCT01449370|365145747|FG005|Overall Study|Lost to Follow-up|0|||
105862059|NCT01449370|365145748|FG006|Overall Study|Lost to Follow-up|0|||
105862060|NCT01449370|365145749|FG007|Overall Study|Lost to Follow-up|0|||
105862061|NCT01449370|365145750|FG008|Overall Study|Lost to Follow-up|0|||
105862062|NCT01449370|365145751|FG009|Overall Study|Lost to Follow-up|0|||
105862063|NCT01449370|365145752|FG010|Overall Study|Lost to Follow-up|0|||
106042281|NCT02001181|365820533|FG000|Overall Study|Lost to Follow-up|1|||
106042282|NCT02001181|365820534|FG001|Overall Study|Lost to Follow-up|0|||
106042283|NCT02001181|365820533|FG000|Overall Study|Withdrawal by Subject|0|||
106042284|NCT02001181|365820534|FG001|Overall Study|Withdrawal by Subject|1|||
106042285|NCT01090973|365820538|FG000|Overall Study|Disease progression|1|||
106042286|NCT02027376|365820540|FG000|Overall Study|Death|1|||
106042287|NCT02027376|365820541|FG001|Overall Study|Death|0|||
106042288|NCT02027376|365820542|FG002|Overall Study|Death|0|||
106042289|NCT02520661|365820546|FG000|Overall Study|Lost to Follow-up|7|||
106042290|NCT02520661|365820547|FG001|Overall Study|Lost to Follow-up|3|||
106042291|NCT02520661|365820546|FG000|Overall Study|Admitted from ED|49|||
106042292|NCT02520661|365820547|FG001|Overall Study|Admitted from ED|48|||
106042293|NCT02520661|365820546|FG000|Overall Study|ED greater than 24 hours|29|||
106042294|NCT02520661|365820547|FG001|Overall Study|ED greater than 24 hours|38|||
106042295|NCT02520661|365820546|FG000|Overall Study|other ineligibility|14|||
106042296|NCT02520661|365820547|FG001|Overall Study|other ineligibility|22|||
106042297|NCT02520661|365820546|FG000|Overall Study|Withdrawal by Subject|7|||
106042298|NCT02520661|365820547|FG001|Overall Study|Withdrawal by Subject|16|||
106042299|NCT02919696|365820550|FG000|Overall Study|Adverse Event|1|||
106042300|NCT02919696|365820551|FG001|Overall Study|Adverse Event|2|||
106042301|NCT02919696|365820550|FG000|Overall Study|Withdrawal by Subject|2|||
106042302|NCT02919696|365820551|FG001|Overall Study|Withdrawal by Subject|1|||
106042303|NCT02919696|365820550|FG000|Overall Study|Sponsor Decision|1|||
106042304|NCT02919696|365820551|FG001|Overall Study|Sponsor Decision|1|||
106042305|NCT02919696|365820550|FG000|Overall Study|Never Treated|0|||
106042306|NCT02919696|365820551|FG001|Overall Study|Never Treated|1|||
106042307|NCT00945555|365820552|FG000|Overall Study|Referred to another hospital|5|||
106042308|NCT00945555|365820552|FG000|Overall Study|Worsening condition, intensive care unit|1|||
106042309|NCT00945555|365820552|FG000|Overall Study|Withdrawal by Subject|2|||
106042310|NCT00945555|365820552|FG000|Overall Study|Participant continued treatment at home|1|||
106042311|NCT00945555|365820552|FG000|Overall Study|Death|18|||
106042312|NCT00945555|365820552|FG000|Overall Study|Other|1|||
106042313|NCT04399837|365820553|FG000|Overall Study|Other than listed|0|||
106042314|NCT04399837|365820554|FG001|Overall Study|Other than listed|2|||
106152103|NCT02544074|366217008|FG003|Overall Study|Tablet error|0|||
106042315|NCT04399837|365820555|FG002|Overall Study|Other than listed|2|||
106042316|NCT04399837|365820556|FG003|Overall Study|Other than listed|3|||
106042317|NCT04399837|365820553|FG000|Overall Study|Withdrawal by Subject|1|||
106042318|NCT04399837|365820554|FG001|Overall Study|Withdrawal by Subject|2|||
106042319|NCT04399837|365820555|FG002|Overall Study|Withdrawal by Subject|1|||
106042320|NCT04399837|365820556|FG003|Overall Study|Withdrawal by Subject|1|||
106042321|NCT03805646|365820557|FG000|Overall Study|Death|40|||
106042322|NCT03805646|365820558|FG001|Overall Study|Death|49|||
106042323|NCT03805646|365820557|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
106042324|NCT03805646|365820558|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
106042325|NCT05430022|365820561|FG000|Overall Study|Withdrawal by Subject|4|||
106042326|NCT05430022|365820562|FG001|Overall Study|Withdrawal by Subject|4|||
106042327|NCT02719327|365820564|FG000|Overall Study|Withdrawal by Subject|11|||
106152104|NCT02544074|366217009|FG004|Overall Study|Tablet error|0|||
106152105|NCT02544074|366217010|FG005|Overall Study|Tablet error|1|||
105862064|NCT01449370|365145753|FG011|Overall Study|Lost to Follow-up|0|||
106042328|NCT02719327|365820565|FG001|Overall Study|Withdrawal by Subject|8|||
106042329|NCT03148275|365820568|FG000|Overall Study|Death|6|||
106042330|NCT03148275|365820568|FG000|Overall Study|Adverse Event|3|||
106042331|NCT03148275|365820568|FG000|Overall Study|Liver transplant|2|||
106042332|NCT03148275|365820568|FG000|Overall Study|Patient decision|5|||
106042333|NCT03148275|365820568|FG000|Overall Study|transition to commercial drug|1|||
106042334|NCT03148275|365820568|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
106042335|NCT01083485|365822176|FG000|Overall Study|Adverse Event|0|||
106042336|NCT01083485|365822177|FG001|Overall Study|Adverse Event|1|||
106042337|NCT01083485|365822176|FG000|Overall Study|Protocol Violation|1|||
106042338|NCT01083485|365822177|FG001|Overall Study|Protocol Violation|0|||
106042339|NCT01083485|365822176|FG000|Overall Study|Withdrawal by Subject|5|||
106042340|NCT01083485|365822177|FG001|Overall Study|Withdrawal by Subject|2|||
106042341|NCT01083485|365822176|FG000|Overall Study|Other|1|||
106042342|NCT01083485|365822177|FG001|Overall Study|Other|0|||
106042343|NCT00537238|365822178|FG000|Overall Study|Death|1|||
106042344|NCT00537238|365822179|FG001|Overall Study|Death|2|||
106042345|NCT00537238|365822178|FG000|Overall Study|Adverse Event|31|||
106042346|NCT00537238|365822179|FG001|Overall Study|Adverse Event|22|||
106042347|NCT00537238|365822178|FG000|Overall Study|Lack of Efficacy|20|||
106042348|NCT00537238|365822179|FG001|Overall Study|Lack of Efficacy|21|||
106042349|NCT00537238|365822178|FG000|Overall Study|Lost to Follow-up|12|||
106042350|NCT00537238|365822179|FG001|Overall Study|Lost to Follow-up|8|||
105862065|NCT01449370|365145754|FG012|Overall Study|Lost to Follow-up|0|||
105862066|NCT01449370|365145755|FG013|Overall Study|Lost to Follow-up|0|||
105862067|NCT01449370|365145756|FG014|Overall Study|Lost to Follow-up|0|||
105862068|NCT01449370|365145757|FG015|Overall Study|Lost to Follow-up|0|||
105862069|NCT01449370|365145758|FG016|Overall Study|Lost to Follow-up|0|||
105862070|NCT01449370|365145759|FG017|Overall Study|Lost to Follow-up|0|||
105862071|NCT01449370|365145760|FG018|Overall Study|Lost to Follow-up|0|||
105862072|NCT01449370|365145761|FG019|Overall Study|Lost to Follow-up|0|||
105862073|NCT01449370|365145762|FG020|Overall Study|Lost to Follow-up|1|||
105862074|NCT01449370|365145763|FG021|Overall Study|Lost to Follow-up|0|||
105862075|NCT01449370|365145764|FG022|Overall Study|Lost to Follow-up|0|||
105862076|NCT01449370|365145765|FG023|Overall Study|Lost to Follow-up|0|||
105862077|NCT01449370|365145766|FG024|Overall Study|Lost to Follow-up|0|||
105862078|NCT01449370|365145742|FG000|Overall Study|Other|0|||
105862079|NCT01449370|365145743|FG001|Overall Study|Other|0|||
105862080|NCT01449370|365145744|FG002|Overall Study|Other|0|||
105862081|NCT01449370|365145745|FG003|Overall Study|Other|0|||
105862082|NCT01449370|365145746|FG004|Overall Study|Other|0|||
105862083|NCT01449370|365145747|FG005|Overall Study|Other|0|||
105862084|NCT01449370|365145748|FG006|Overall Study|Other|0|||
105862085|NCT01449370|365145749|FG007|Overall Study|Other|0|||
105862086|NCT01449370|365145750|FG008|Overall Study|Other|1|||
105862087|NCT01449370|365145751|FG009|Overall Study|Other|1|||
105862088|NCT01449370|365145752|FG010|Overall Study|Other|0|||
105862089|NCT01449370|365145753|FG011|Overall Study|Other|0|||
105862090|NCT01449370|365145754|FG012|Overall Study|Other|0|||
105862091|NCT01449370|365145755|FG013|Overall Study|Other|0|||
105862092|NCT01449370|365145756|FG014|Overall Study|Other|0|||
105862093|NCT01449370|365145757|FG015|Overall Study|Other|0|||
105862094|NCT01449370|365145758|FG016|Overall Study|Other|0|||
105862095|NCT01449370|365145759|FG017|Overall Study|Other|0|||
105862096|NCT01449370|365145760|FG018|Overall Study|Other|0|||
105862097|NCT01449370|365145761|FG019|Overall Study|Other|0|||
105862098|NCT01449370|365145762|FG020|Overall Study|Other|0|||
105862099|NCT01449370|365145763|FG021|Overall Study|Other|0|||
105862100|NCT01449370|365145764|FG022|Overall Study|Other|1|||
105862101|NCT01449370|365145765|FG023|Overall Study|Other|1|||
105862102|NCT01449370|365145766|FG024|Overall Study|Other|0|||
105862103|NCT01449370|365145742|FG000|Overall Study|Medication Prohibited by Protocol|0|||
105862104|NCT01449370|365145743|FG001|Overall Study|Medication Prohibited by Protocol|0|||
105862105|NCT01449370|365145744|FG002|Overall Study|Medication Prohibited by Protocol|0|||
105862106|NCT01449370|365145745|FG003|Overall Study|Medication Prohibited by Protocol|0|||
105862107|NCT01449370|365145746|FG004|Overall Study|Medication Prohibited by Protocol|0|||
105862108|NCT01449370|365145747|FG005|Overall Study|Medication Prohibited by Protocol|0|||
105862109|NCT01449370|365145748|FG006|Overall Study|Medication Prohibited by Protocol|0|||
105862110|NCT01449370|365145749|FG007|Overall Study|Medication Prohibited by Protocol|0|||
105862111|NCT01449370|365145750|FG008|Overall Study|Medication Prohibited by Protocol|0|||
105862112|NCT01449370|365145751|FG009|Overall Study|Medication Prohibited by Protocol|0|||
105862113|NCT01449370|365145752|FG010|Overall Study|Medication Prohibited by Protocol|0|||
105862114|NCT01449370|365145753|FG011|Overall Study|Medication Prohibited by Protocol|0|||
105862115|NCT01449370|365145754|FG012|Overall Study|Medication Prohibited by Protocol|0|||
105862116|NCT01449370|365145755|FG013|Overall Study|Medication Prohibited by Protocol|0|||
105862117|NCT01449370|365145756|FG014|Overall Study|Medication Prohibited by Protocol|0|||
105862118|NCT01449370|365145757|FG015|Overall Study|Medication Prohibited by Protocol|0|||
105862119|NCT01449370|365145758|FG016|Overall Study|Medication Prohibited by Protocol|0|||
105862120|NCT01449370|365145759|FG017|Overall Study|Medication Prohibited by Protocol|0|||
105862121|NCT01449370|365145760|FG018|Overall Study|Medication Prohibited by Protocol|0|||
105862122|NCT01449370|365145761|FG019|Overall Study|Medication Prohibited by Protocol|0|||
105862123|NCT01449370|365145762|FG020|Overall Study|Medication Prohibited by Protocol|0|||
105862124|NCT01449370|365145763|FG021|Overall Study|Medication Prohibited by Protocol|0|||
106042351|NCT00537238|365822178|FG000|Overall Study|Withdrawal by Subject|51|||
106042352|NCT00537238|365822179|FG001|Overall Study|Withdrawal by Subject|47|||
106042353|NCT00537238|365822178|FG000|Overall Study|Protocol Violation|15|||
106042354|NCT00537238|365822179|FG001|Overall Study|Protocol Violation|19|||
105862125|NCT01449370|365145764|FG022|Overall Study|Medication Prohibited by Protocol|0|||
105862126|NCT01449370|365145765|FG023|Overall Study|Medication Prohibited by Protocol|1|||
105862127|NCT01449370|365145766|FG024|Overall Study|Medication Prohibited by Protocol|0|||
105862128|NCT01449370|365145742|FG000|Overall Study|Death|0|||
105862129|NCT01449370|365145743|FG001|Overall Study|Death|0|||
105862130|NCT01449370|365145744|FG002|Overall Study|Death|0|||
105862131|NCT01449370|365145745|FG003|Overall Study|Death|0|||
105862132|NCT01449370|365145746|FG004|Overall Study|Death|0|||
106042355|NCT00537238|365822178|FG000|Overall Study|Does not meet entrance criteria|0|||
105862133|NCT01449370|365145747|FG005|Overall Study|Death|0|||
105862134|NCT01449370|365145748|FG006|Overall Study|Death|0|||
105862135|NCT01449370|365145749|FG007|Overall Study|Death|0|||
105862136|NCT01449370|365145750|FG008|Overall Study|Death|0|||
105862137|NCT01449370|365145751|FG009|Overall Study|Death|0|||
106042356|NCT00537238|365822179|FG001|Overall Study|Does not meet entrance criteria|2|||
106042357|NCT00537238|365822178|FG000|Overall Study|Other|44|||
106042358|NCT00537238|365822179|FG001|Overall Study|Other|52|||
106042359|NCT00426231|365822182|FG000|Overall Study|Withdrawal by Subject|9|||
106042360|NCT00426231|365822183|FG001|Overall Study|Withdrawal by Subject|12|||
106042361|NCT03911713|365822190|FG000|Overall Study|Lost to Follow-up|0|||
106042362|NCT03911713|365822191|FG001|Overall Study|Lost to Follow-up|2|||
106042363|NCT03911713|365822192|FG002|Overall Study|Lost to Follow-up|0|||
106042364|NCT03911713|365822193|FG003|Overall Study|Lost to Follow-up|0|||
106042365|NCT03911713|365822194|FG004|Overall Study|Lost to Follow-up|0|||
106042366|NCT03911713|365822190|FG000|Overall Study|Other|0|||
106042367|NCT03911713|365822191|FG001|Overall Study|Other|0|||
106042368|NCT03911713|365822192|FG002|Overall Study|Other|0|||
106042369|NCT03911713|365822193|FG003|Overall Study|Other|1|||
106042370|NCT03911713|365822194|FG004|Overall Study|Other|0|||
106042371|NCT03911713|365822190|FG000|Overall Study|Randomized, Never Dosed|1|||
106042372|NCT03911713|365822191|FG001|Overall Study|Randomized, Never Dosed|0|||
106042373|NCT03911713|365822192|FG002|Overall Study|Randomized, Never Dosed|0|||
106042374|NCT03911713|365822193|FG003|Overall Study|Randomized, Never Dosed|1|||
106042375|NCT03911713|365822194|FG004|Overall Study|Randomized, Never Dosed|0|||
106042376|NCT04447417|365822197|FG000|Overall Study|Withdrawal by Subject|1|||
106042377|NCT04447417|365822198|FG001|Overall Study|Withdrawal by Subject|0|||
106042378|NCT04447417|365822197|FG000|Overall Study|Failure to meet inclusion criteria|1|||
106042379|NCT04447417|365822198|FG001|Overall Study|Failure to meet inclusion criteria|0|||
106042380|NCT04447417|365822197|FG000|Overall Study|Lost to Follow-up|1|||
106042381|NCT04447417|365822198|FG001|Overall Study|Lost to Follow-up|0|||
106042382|NCT03265665|365822199|FG000|24-week Data Collection|Withdrawal by Subject|2|||
106042383|NCT03265665|365822200|FG001|24-week Data Collection|Withdrawal by Subject|2|||
106042384|NCT03265665|365822199|FG000|24-week Data Collection|Lost to Follow-up|4|||
106042385|NCT03265665|365822200|FG001|24-week Data Collection|Lost to Follow-up|5|||
106042386|NCT03265665|365822199|FG000|36-week Data Collection|Lost to Follow-up|6|||
106042387|NCT03265665|365822200|FG001|36-week Data Collection|Lost to Follow-up|8|||
106042388|NCT01614600|365822201|FG000|Overall Study|Unacceptable fit|1|||
106042389|NCT01614600|365822201|FG000|Overall Study|Discomfort|1|||
106042390|NCT01614600|365822201|FG000|Overall Study|Unable to remove lens at the end of day|1|||
106042391|NCT01614600|365822201|FG000|Overall Study|Protocol deviation|1|||
106042392|NCT02437513|365822202|FG000|Overall Study|Withdrawal by Subject|2|||
106042393|NCT02423109|365822205|FG000|Lens 1|Adverse Event|1|||
106042394|NCT02423109|365822206|FG001|Lens 1|Adverse Event|0|||
106042395|NCT03956056|365822207|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
106042396|NCT03956056|365822207|FG000|Overall Study|Lack of Efficacy|1|||
106042397|NCT03347188|365822208|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
106042398|NCT03347188|365822209|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
106042399|NCT03347188|365822208|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
106042400|NCT03347188|365822209|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
106042401|NCT03347188|365822208|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
106042402|NCT03347188|365822209|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
106042403|NCT03347188|365822208|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
106042404|NCT03347188|365822209|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
106042405|NCT03347188|365822208|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
106042406|NCT03347188|365822209|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
106042407|NCT03347188|365822208|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
106042408|NCT03347188|365822209|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
106042409|NCT03347188|365822208|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
106042410|NCT03347188|365822209|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
106042411|NCT03347188|365822208|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
106042412|NCT03347188|365822209|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
106042413|NCT01193660|365822210|FG000|Overall Study|Withdrawal by Subject|2|||
106042414|NCT01193660|365822211|FG001|Overall Study|Withdrawal by Subject|3|||
106042415|NCT01193660|365822212|FG002|Overall Study|Withdrawal by Subject|1|||
106042416|NCT01193660|365822210|FG000|Overall Study|Death|1|||
106042417|NCT01193660|365822211|FG001|Overall Study|Death|0|||
106152106|NCT02544074|366217011|FG006|Overall Study|Tablet error|0|||
106042418|NCT01193660|365822212|FG002|Overall Study|Death|0|||
106042419|NCT01193660|365822210|FG000|Overall Study|Physician Decision|1|||
106042420|NCT01193660|365822211|FG001|Overall Study|Physician Decision|0|||
106042421|NCT01193660|365822212|FG002|Overall Study|Physician Decision|1|||
106042422|NCT03403374|365822213|FG000|Overall Study|Lost to Follow-up|1|||
106042423|NCT00195273|365822214|FG000|Overall Study|Adverse Event|9|||
106042424|NCT00195273|365822215|FG001|Overall Study|Adverse Event|9|||
106042425|NCT00195273|365822214|FG000|Overall Study|Protocol deviation|0|||
106042426|NCT00195273|365822215|FG001|Overall Study|Protocol deviation|1|||
106042427|NCT00195273|365822214|FG000|Overall Study|Lack of Efficacy|3|||
106042428|NCT00195273|365822215|FG001|Overall Study|Lack of Efficacy|1|||
106042429|NCT00195273|365822214|FG000|Overall Study|Procedural complications|9|||
106042430|NCT00195273|365822215|FG001|Overall Study|Procedural complications|3|||
106042431|NCT01680965|365822216|FG000|Overall Study|Death|0|||
106042432|NCT01680965|365822217|FG001|Overall Study|Death|0|||
106042433|NCT01680965|365822218|FG002|Overall Study|Death|0|||
106042434|NCT01680965|365822219|FG003|Overall Study|Death|6|||
106042435|NCT02595970|365822220|FG000|Overall Study|Withdrawal by Subject|2|||
106042436|NCT02595970|365822220|FG000|Overall Study|Physician Decision|2|||
106042437|NCT02595970|365822220|FG000|Overall Study|Protocol Violation|4|||
106042438|NCT02595970|365822220|FG000|Overall Study|Adverse Event|5|||
106042439|NCT02595970|365822220|FG000|Overall Study|Lack of Efficacy|7|||
106042440|NCT01886716|365822223|FG000|Week 1|Lost to Follow-up|0|||
106042441|NCT01886716|365822224|FG001|Week 1|Lost to Follow-up|0|||
106042442|NCT01886716|365822225|FG002|Week 1|Lost to Follow-up|2|||
106042443|NCT01886716|365822226|FG003|Week 1|Lost to Follow-up|2|||
106042444|NCT01886716|365822223|FG000|Week 2|Lost to Follow-up|3|||
106042445|NCT01886716|365822224|FG001|Week 2|Lost to Follow-up|2|||
106042446|NCT01886716|365822225|FG002|Week 2|Lost to Follow-up|1|||
106042447|NCT01886716|365822226|FG003|Week 2|Lost to Follow-up|3|||
106042448|NCT01886716|365822223|FG000|Week 3|Lost to Follow-up|1|||
106042449|NCT01886716|365822224|FG001|Week 3|Lost to Follow-up|1|||
106042450|NCT01886716|365822225|FG002|Week 3|Lost to Follow-up|0|||
106042451|NCT01886716|365822226|FG003|Week 3|Lost to Follow-up|1|||
106042452|NCT00736957|365822227|FG000|Overall Study|Adverse Event|43|||
106042453|NCT00736957|365822227|FG000|Overall Study|Withdrawal by Subject|49|||
106042454|NCT00736957|365822227|FG000|Overall Study|violation of eligibility criteria|2|||
106042455|NCT00736957|365822227|FG000|Overall Study|did not attend hospital appointments|1|||
106042456|NCT00736957|365822227|FG000|Overall Study|not eligible for Treatment Period I|22|||
106042457|NCT00736957|365822227|FG000|Overall Study|Physician Decision|5|||
106042458|NCT02231918|365822228|FG000|Overall Study|Withdrawal by Subject|0|||
106042459|NCT02231918|365822229|FG001|Overall Study|Withdrawal by Subject|1|||
106042460|NCT02231918|365822230|FG002|Overall Study|Withdrawal by Subject|0|||
106042461|NCT02231918|365822228|FG000|Overall Study|Adverse Event|0|||
106042462|NCT02231918|365822229|FG001|Overall Study|Adverse Event|0|||
106042463|NCT02231918|365822230|FG002|Overall Study|Adverse Event|1|||
106042464|NCT02395666|365822231|FG000|Overall Study|Physician Decision|3|||
106042465|NCT02395666|365822232|FG001|Overall Study|Physician Decision|0|||
106042466|NCT02395666|365822231|FG000|Overall Study|Lost to Follow-up|1|||
106042467|NCT02395666|365822232|FG001|Overall Study|Lost to Follow-up|0|||
106042468|NCT02395666|365822231|FG000|Overall Study|Withdrawal by Subject|2|||
106042469|NCT02395666|365822232|FG001|Overall Study|Withdrawal by Subject|1|||
106042470|NCT01092507|365822233|FG000|Overall Study|Withdrawal by Subject|2|||
106042471|NCT01092507|365822234|FG001|Overall Study|Withdrawal by Subject|0|||
106042472|NCT02486302|365822236|FG000|Overall Study|Discontinued prematurely|410|||
106042473|NCT02486302|365822236|FG000|Overall Study|Documentation not completed|255|||
106042474|NCT02486302|365822236|FG000|Overall Study|Excluded due to legal reasons|8|||
106042475|NCT02486302|365822236|FG000|Overall Study|Not treated|3|||
106042476|NCT01871142|365822237|FG000|Overall Study|Adverse Event|1|||
106042477|NCT00085709|365822238|FG000|Overall Study|Adverse Event|8|||
106042478|NCT00085709|365822239|FG001|Overall Study|Adverse Event|0|||
106042479|NCT00085709|365822238|FG000|Overall Study|Death|8|||
106042480|NCT00085709|365822239|FG001|Overall Study|Death|2|||
106042481|NCT00085709|365822238|FG000|Overall Study|Refusal unrelated to adverse events|1|||
106042482|NCT00085709|365822239|FG001|Overall Study|Refusal unrelated to adverse events|2|||
106042483|NCT00085709|365822238|FG000|Overall Study|Progression|3|||
106042484|NCT00085709|365822239|FG001|Overall Study|Progression|4|||
106042485|NCT00085709|365822238|FG000|Overall Study|Not protocol specified|12|||
106042486|NCT00085709|365822239|FG001|Overall Study|Not protocol specified|22|||
106042487|NCT00085709|365822238|FG000|Overall Study|Not eligible|19|||
106042488|NCT00085709|365822239|FG001|Overall Study|Not eligible|19|||
106042489|NCT00085709|365822238|FG000|Overall Study|Withdrawal by Subject|2|||
106042490|NCT00085709|365822239|FG001|Overall Study|Withdrawal by Subject|1|||
106042491|NCT03793556|365822240|FG000|Overall Study|Withdrawal by Subject|12|||
106042492|NCT03793556|365822241|FG001|Overall Study|Withdrawal by Subject|1|||
106042493|NCT03793556|365822240|FG000|Overall Study|Lost to Follow-up|1|||
106042494|NCT03793556|365822241|FG001|Overall Study|Lost to Follow-up|1|||
106042495|NCT04416633|365822242|FG000|Overall Study|Death|1|||
106042496|NCT04416633|365822242|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
106042497|NCT04416633|365822242|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
106042498|NCT04416633|365822242|FG000|Overall Study|Adverse Event|6|||
106042499|NCT04416633|365822242|FG000|Overall Study|Withdrawal by Subject|6|||
106042500|NCT04612790|365822243|FG000|DB Period (Up to 36 Weeks)|Death|1|||
106042501|NCT04612790|365822244|FG001|DB Period (Up to 36 Weeks)|Death|1|||
106042502|NCT04612790|365822245|FG002|DB Period (Up to 36 Weeks)|Death|0|||
106042503|NCT04612790|365822246|FG003|DB Period (Up to 36 Weeks)|Death|0|||
106042504|NCT04612790|365822243|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
106042505|NCT04612790|365822244|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
106042506|NCT04612790|365822245|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
106042507|NCT04612790|365822246|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
106042508|NCT04612790|365822243|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
106042509|NCT04612790|365822244|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
106042510|NCT04612790|365822245|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
106042511|NCT04612790|365822246|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
106042512|NCT04612790|365822243|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
106042513|NCT04612790|365822244|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
106042514|NCT04612790|365822245|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
106042515|NCT04612790|365822246|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
106042516|NCT04612790|365822243|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
106042517|NCT04612790|365822244|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
106042518|NCT04612790|365822245|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
106042519|NCT04612790|365822246|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
106042520|NCT04612790|365822243|FG000|DB Period (Up to 36 Weeks)|Other|1|||
106042521|NCT04612790|365822244|FG001|DB Period (Up to 36 Weeks)|Other|0|||
106042522|NCT04612790|365822245|FG002|DB Period (Up to 36 Weeks)|Other|0|||
106042523|NCT04612790|365822246|FG003|DB Period (Up to 36 Weeks)|Other|0|||
106042524|NCT04612790|365822243|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
106042525|NCT04612790|365822244|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
106042526|NCT04612790|365822245|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
106042527|NCT04612790|365822246|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
106042528|NCT04612790|365822243|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
106042529|NCT04612790|365822244|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
106042530|NCT04612790|365822245|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
106042531|NCT04612790|365822246|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
106042532|NCT04612790|365822243|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
106042533|NCT04612790|365822244|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
106042534|NCT04612790|365822245|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
106042535|NCT04612790|365822246|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
106042536|NCT04612790|365822243|FG000|OLE Period (Up to 1 Year)|Other|0|||
106042537|NCT04612790|365822244|FG001|OLE Period (Up to 1 Year)|Other|0|||
106042538|NCT04612790|365822245|FG002|OLE Period (Up to 1 Year)|Other|0|||
106042539|NCT04612790|365822246|FG003|OLE Period (Up to 1 Year)|Other|1|||
106042540|NCT02063880|365822252|FG000|Overall Study|Death|21|||
106042541|NCT02063880|365822253|FG001|Overall Study|Death|18|||
106042542|NCT02063880|365822252|FG000|Overall Study|Lost to Follow-up|7|||
106042543|NCT02063880|365822253|FG001|Overall Study|Lost to Follow-up|7|||
106042544|NCT02063880|365822252|FG000|Overall Study|Ineligible|0|||
106042545|NCT02063880|365822253|FG001|Overall Study|Ineligible|2|||
106042546|NCT02106910|365822254|FG000|Overall Study|Lost to Follow-up|1|||
106042547|NCT02106910|365822255|FG001|Overall Study|Lost to Follow-up|1|||
106042548|NCT01859143|365822258|FG000|Overall Study|Lost to Follow-up|2|||
106042549|NCT01859143|365822259|FG001|Overall Study|Lost to Follow-up|0|||
106042550|NCT01675427|365822260|FG000|Overall Study|Withdrawal by Subject|7|||
106042551|NCT01675427|365822260|FG000|Overall Study|Participant Refused Sample Collection|18|||
106042552|NCT01675427|365822260|FG000|Overall Study|Sample not Collected by Mistake|2|||
106042553|NCT01675427|365822260|FG000|Overall Study|Lost to Follow-up|5|||
106042554|NCT01675427|365822260|FG000|Overall Study|Other|2|||
106042555|NCT00629772|365822263|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
106042556|NCT00629772|365822264|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
106042557|NCT00629772|365822263|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
106042558|NCT00629772|365822264|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
106042559|NCT00853073|365822265|FG000|Overall Study|Withdrawal by Subject|3|||
106042560|NCT00853073|365822266|FG001|Overall Study|Withdrawal by Subject|2|||
106042561|NCT02028871|365822269|FG000|Overall Study|Positive urine drug screen|1|||
106042562|NCT02028871|365822270|FG001|Overall Study|Positive urine drug screen|1|||
106042563|NCT02028871|365822269|FG000|Overall Study|Withdrawal by Subject|1|||
106042564|NCT02028871|365822270|FG001|Overall Study|Withdrawal by Subject|2|||
106042565|NCT02028871|365822269|FG000|Overall Study|IV placement difficulty|1|||
106042566|NCT02028871|365822270|FG001|Overall Study|IV placement difficulty|0|||
106042567|NCT02028871|365822269|FG000|Overall Study|Current Illness|1|||
106042568|NCT02028871|365822270|FG001|Overall Study|Current Illness|0|||
106042569|NCT00532155|365822271|FG000|Overall Study|Adverse Event|66|||
106042570|NCT00532155|365822272|FG001|Overall Study|Adverse Event|123|||
106042571|NCT00532155|365822271|FG000|Overall Study|Lack of Efficacy|332|||
106042572|NCT00532155|365822272|FG001|Overall Study|Lack of Efficacy|255|||
106042573|NCT00532155|365822271|FG000|Overall Study|Protocol Violation|1|||
106042574|NCT00532155|365822272|FG001|Overall Study|Protocol Violation|3|||
106042575|NCT00532155|365822271|FG000|Overall Study|Lost to Follow-up|2|||
106042576|NCT00532155|365822272|FG001|Overall Study|Lost to Follow-up|0|||
106042577|NCT00532155|365822271|FG000|Overall Study|Physician Decision|16|||
106042578|NCT00532155|365822272|FG001|Overall Study|Physician Decision|15|||
106042579|NCT00532155|365822271|FG000|Overall Study|Withdrawal by Subject|23|||
106042580|NCT00532155|365822272|FG001|Overall Study|Withdrawal by Subject|44|||
106042581|NCT00532155|365822271|FG000|Overall Study|Consent withdrawn|5|||
105862138|NCT01449370|365145752|FG010|Overall Study|Death|0|||
106042582|NCT00532155|365822272|FG001|Overall Study|Consent withdrawn|7|||
106042583|NCT00532155|365822271|FG000|Overall Study|Moved|1|||
106042584|NCT00532155|365822272|FG001|Overall Study|Moved|0|||
105862139|NCT01449370|365145753|FG011|Overall Study|Death|0|||
105862140|NCT01449370|365145754|FG012|Overall Study|Death|0|||
105862141|NCT01449370|365145755|FG013|Overall Study|Death|0|||
105862142|NCT01449370|365145756|FG014|Overall Study|Death|0|||
105862143|NCT01449370|365145757|FG015|Overall Study|Death|0|||
105862144|NCT01449370|365145758|FG016|Overall Study|Death|0|||
105862145|NCT01449370|365145759|FG017|Overall Study|Death|0|||
105862146|NCT01449370|365145760|FG018|Overall Study|Death|0|||
105862147|NCT01449370|365145761|FG019|Overall Study|Death|0|||
105862148|NCT01449370|365145762|FG020|Overall Study|Death|0|||
105862149|NCT01449370|365145763|FG021|Overall Study|Death|0|||
105862150|NCT01449370|365145764|FG022|Overall Study|Death|0|||
105862151|NCT01449370|365145765|FG023|Overall Study|Death|0|||
105862152|NCT01449370|365145766|FG024|Overall Study|Death|1|||
105862153|NCT00863772|365145767|FG000|Overall Study|Adverse Event|1|||
105862154|NCT00863772|365145768|FG001|Overall Study|Adverse Event|4|||
105862155|NCT00863772|365145769|FG002|Overall Study|Adverse Event|0|||
105862156|NCT00863772|365145767|FG000|Overall Study|Lack of Efficacy|4|||
105862157|NCT00863772|365145768|FG001|Overall Study|Lack of Efficacy|2|||
105862158|NCT00863772|365145769|FG002|Overall Study|Lack of Efficacy|4|||
105862159|NCT00863772|365145767|FG000|Overall Study|Lost to Follow-up|5|||
105862160|NCT00863772|365145768|FG001|Overall Study|Lost to Follow-up|1|||
105862161|NCT00863772|365145769|FG002|Overall Study|Lost to Follow-up|1|||
105862162|NCT00863772|365145767|FG000|Overall Study|Protocol Violation|2|||
105862163|NCT00863772|365145768|FG001|Overall Study|Protocol Violation|0|||
105862164|NCT00863772|365145769|FG002|Overall Study|Protocol Violation|2|||
105862165|NCT00863772|365145767|FG000|Overall Study|Withdrawal by Subject|4|||
105862166|NCT00863772|365145768|FG001|Overall Study|Withdrawal by Subject|7|||
105862167|NCT00863772|365145769|FG002|Overall Study|Withdrawal by Subject|5|||
105862168|NCT00863772|365145767|FG000|Overall Study|Study terminated by sponsor|44|||
105862169|NCT00863772|365145768|FG001|Overall Study|Study terminated by sponsor|45|||
105862170|NCT00863772|365145769|FG002|Overall Study|Study terminated by sponsor|36|||
105862171|NCT00863772|365145767|FG000|Overall Study|Entered extension study|6|||
105862172|NCT00863772|365145768|FG001|Overall Study|Entered extension study|4|||
105862173|NCT00863772|365145769|FG002|Overall Study|Entered extension study|9|||
105862174|NCT00863772|365145767|FG000|Overall Study|Other|1|||
105862175|NCT00863772|365145768|FG001|Overall Study|Other|2|||
105862176|NCT00863772|365145769|FG002|Overall Study|Other|4|||
105862177|NCT00863772|365145767|FG000|Overall Study|Randomized but not Treated|1|||
105862178|NCT00863772|365145768|FG001|Overall Study|Randomized but not Treated|0|||
105862179|NCT00863772|365145769|FG002|Overall Study|Randomized but not Treated|0|||
105862180|NCT00534404|365145770|FG000|Overall Study|Death|0|||
105862181|NCT00534404|365145771|FG001|Overall Study|Death|0|||
105862182|NCT00534404|365145772|FG002|Overall Study|Death|2|||
105862183|NCT00534404|365145770|FG000|Overall Study|Withdrawal by Subject|8|||
105862184|NCT00534404|365145771|FG001|Overall Study|Withdrawal by Subject|2|||
105862185|NCT00534404|365145772|FG002|Overall Study|Withdrawal by Subject|38|||
105862186|NCT00534404|365145770|FG000|Overall Study|Removed by study staff|2|||
105862187|NCT00534404|365145771|FG001|Overall Study|Removed by study staff|3|||
105862188|NCT00534404|365145772|FG002|Overall Study|Removed by study staff|1|||
105862189|NCT00534404|365145770|FG000|Overall Study|Lost to Follow-up|170|||
105862190|NCT00534404|365145771|FG001|Overall Study|Lost to Follow-up|138|||
105862191|NCT00534404|365145772|FG002|Overall Study|Lost to Follow-up|201|||
105862192|NCT00896480|365145775|FG000|Overall Study|Disease progression/recurrence|21|||
105862193|NCT00090363|365145776|FG000|Overall Study|Lost to Follow-up|1|||
105862194|NCT00090363|365145777|FG001|Overall Study|Lost to Follow-up|2|||
105862195|NCT00090363|365145778|FG002|Overall Study|Lost to Follow-up|1|||
105862196|NCT00090363|365145776|FG000|Overall Study|Withdrawal by Subject|7|||
105862197|NCT00090363|365145777|FG001|Overall Study|Withdrawal by Subject|7|||
105862198|NCT00090363|365145778|FG002|Overall Study|Withdrawal by Subject|6|||
105862199|NCT00090363|365145776|FG000|Overall Study|Study-specific discontinuation criteria|75|||
105862200|NCT00090363|365145777|FG001|Overall Study|Study-specific discontinuation criteria|74|||
105862201|NCT00090363|365145778|FG002|Overall Study|Study-specific discontinuation criteria|62|||
105862202|NCT00090363|365145776|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105862203|NCT00090363|365145777|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
105862204|NCT00090363|365145778|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105862205|NCT00090363|365145776|FG000|Overall Study|Consent expired|7|||
106042585|NCT00532155|365822271|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
106042586|NCT00532155|365822272|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
105862206|NCT00090363|365145777|FG001|Overall Study|Consent expired|10|||
106042587|NCT00532155|365822271|FG000|Overall Study|Occurence of a second cancer|0|||
105862207|NCT00090363|365145778|FG002|Overall Study|Consent expired|9|||
105862208|NCT00090363|365145776|FG000|Overall Study|Reasons not specified|2|||
105862209|NCT00090363|365145777|FG001|Overall Study|Reasons not specified|1|||
105862210|NCT00090363|365145778|FG002|Overall Study|Reasons not specified|1|||
105862211|NCT00090363|365145776|FG000|Overall Study|Continuing on study off treatment|14|||
105862212|NCT00090363|365145777|FG001|Overall Study|Continuing on study off treatment|13|||
106042588|NCT00532155|365822272|FG001|Overall Study|Occurence of a second cancer|1|||
106042589|NCT00532155|365822271|FG000|Overall Study|Occurence of a secondary cancer|0|||
106042590|NCT00532155|365822272|FG001|Overall Study|Occurence of a secondary cancer|1|||
106042591|NCT00532155|365822271|FG000|Overall Study|Promotor ended study|1|||
106042592|NCT00532155|365822272|FG001|Overall Study|Promotor ended study|0|||
106042593|NCT00532155|365822271|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
106042594|NCT00532155|365822272|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
106042595|NCT00532155|365822271|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
106042596|NCT00532155|365822272|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
106042597|NCT00532155|365822271|FG000|Overall Study|Study stopped|1|||
106042598|NCT00532155|365822272|FG001|Overall Study|Study stopped|0|||
106042599|NCT00532155|365822271|FG000|Overall Study|Study terminated by sponsor|1|||
106042600|NCT00532155|365822272|FG001|Overall Study|Study terminated by sponsor|0|||
106042601|NCT00532155|365822271|FG000|Overall Study|Study termination stop further treatment|4|||
106042602|NCT00532155|365822272|FG001|Overall Study|Study termination stop further treatment|0|||
106042603|NCT00532155|365822271|FG000|Overall Study|Did not receive study medication|2|||
106042604|NCT00532155|365822272|FG001|Overall Study|Did not receive study medication|6|||
106042605|NCT00304239|365822287|FG000|Overall Study|Protocol Deviations/Violations|15|||
106042606|NCT00304239|365822288|FG001|Overall Study|Protocol Deviations/Violations|0|||
106042607|NCT00304239|365822287|FG000|Overall Study|Adverse Event|2|||
106042608|NCT00304239|365822288|FG001|Overall Study|Adverse Event|0|||
106042609|NCT02979197|365822289|FG000|Overall Study|Adverse Event|4|||
106042610|NCT02979197|365822290|FG001|Overall Study|Adverse Event|2|||
106042611|NCT02979197|365822291|FG002|Overall Study|Adverse Event|0|||
106042612|NCT02979197|365822289|FG000|Overall Study|Protocol Violation|0|||
106042613|NCT02979197|365822290|FG001|Overall Study|Protocol Violation|1|||
106042614|NCT02979197|365822291|FG002|Overall Study|Protocol Violation|0|||
106042615|NCT02979197|365822289|FG000|Overall Study|Subject unable to commit to study dates|0|||
106042616|NCT02979197|365822290|FG001|Overall Study|Subject unable to commit to study dates|1|||
106042617|NCT02979197|365822291|FG002|Overall Study|Subject unable to commit to study dates|0|||
106042618|NCT01898208|365822294|FG000|Overall Study|Positive blood culture|17|||
106042619|NCT01898208|365822295|FG001|Overall Study|Positive blood culture|23|||
106042620|NCT01898208|365822296|FG002|Overall Study|Positive blood culture|15|||
106042621|NCT01898208|365822294|FG000|Overall Study|Death/comfort care within 24 hours|10|||
106042622|NCT01898208|365822295|FG001|Overall Study|Death/comfort care within 24 hours|9|||
106042623|NCT01898208|365822296|FG002|Overall Study|Death/comfort care within 24 hours|8|||
106042624|NCT01898208|365822294|FG000|Overall Study|Negative Gram Stain|6|||
106042625|NCT01898208|365822295|FG001|Overall Study|Negative Gram Stain|9|||
106042626|NCT01898208|365822296|FG002|Overall Study|Negative Gram Stain|6|||
106042627|NCT01898208|365822294|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
106042628|NCT01898208|365822295|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
106042629|NCT01898208|365822296|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
106042630|NCT01898208|365822294|FG000|Overall Study|System/Technical Error|1|||
106042631|NCT01898208|365822295|FG001|Overall Study|System/Technical Error|2|||
106042632|NCT01898208|365822296|FG002|Overall Study|System/Technical Error|3|||
106042633|NCT01898208|365822294|FG000|Overall Study|Lost to Follow-up|3|||
106042634|NCT01898208|365822295|FG001|Overall Study|Lost to Follow-up|1|||
106042635|NCT01898208|365822296|FG002|Overall Study|Lost to Follow-up|1|||
106042636|NCT05182125|365822297|FG000|Overall Study|Withdrawal by Subject|0|||
106042637|NCT05182125|365822298|FG001|Overall Study|Withdrawal by Subject|0|||
106042638|NCT05182125|365822299|FG002|Overall Study|Withdrawal by Subject|0|||
106042639|NCT05182125|365822300|FG003|Overall Study|Withdrawal by Subject|0|||
106042640|NCT05182125|365822301|FG004|Overall Study|Withdrawal by Subject|2|||
106042641|NCT05182125|365822302|FG005|Overall Study|Withdrawal by Subject|0|||
106042642|NCT05182125|365822297|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
106042643|NCT05182125|365822298|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
106042644|NCT05182125|365822299|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
106042645|NCT05182125|365822300|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
106042646|NCT05182125|365822301|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
106042647|NCT05182125|365822302|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
106042648|NCT05182125|365822297|FG000|Overall Study|Death|0|||
106042649|NCT05182125|365822298|FG001|Overall Study|Death|0|||
106042650|NCT05182125|365822299|FG002|Overall Study|Death|0|||
106042651|NCT05182125|365822300|FG003|Overall Study|Death|0|||
106042652|NCT05182125|365822301|FG004|Overall Study|Death|1|||
106042653|NCT05182125|365822302|FG005|Overall Study|Death|0|||
106042654|NCT05182125|365822297|FG000|Overall Study|Health Contact Follow-up|5|||
106042655|NCT05182125|365822298|FG001|Overall Study|Health Contact Follow-up|5|||
106042656|NCT05182125|365822299|FG002|Overall Study|Health Contact Follow-up|2|||
106042657|NCT05182125|365822300|FG003|Overall Study|Health Contact Follow-up|9|||
106042658|NCT05182125|365822301|FG004|Overall Study|Health Contact Follow-up|7|||
106042659|NCT05182125|365822302|FG005|Overall Study|Health Contact Follow-up|2|||
106042660|NCT02435069|365822303|FG000|Dose Response - First Intervention|Adverse Event|0|||
106042661|NCT02435069|365822304|FG001|Dose Response - First Intervention|Adverse Event|1|||
106042662|NCT02435069|365822305|FG002|Dose Response - First Intervention|Adverse Event|1|||
106042663|NCT02435069|365822306|FG003|Dose Response - First Intervention|Adverse Event|0|||
106042664|NCT02435069|365822307|FG004|Dose Response - First Intervention|Adverse Event|0|||
106042665|NCT02435069|365822303|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
106042666|NCT02435069|365822304|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
106042667|NCT02435069|365822305|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
106042668|NCT02435069|365822306|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
106042669|NCT02435069|365822307|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
106042670|NCT02349542|365822308|FG000|Overall Study|Withdrawal by Subject|5|||
106042671|NCT00932737|365822309|FG000|Overall Study|Not treated in second episode|1|||
106042672|NCT00932737|365822310|FG001|Overall Study|Not treated in second episode|0|||
106042673|NCT00932737|365822309|FG000|Overall Study|Adverse Event|0|||
106042674|NCT00932737|365822310|FG001|Overall Study|Adverse Event|1|||
106042675|NCT05156073|365822311|FG000|Overall Study|Patient canceled appointment with PCP|1|||
106042676|NCT04996797|365822315|FG000|Overall Study|Adverse Event|0|||
106042677|NCT04996797|365822316|FG001|Overall Study|Adverse Event|2|||
106042678|NCT04996797|365822317|FG002|Overall Study|Adverse Event|0|||
106042679|NCT04996797|365822318|FG003|Overall Study|Adverse Event|1|||
106042680|NCT04996797|365822315|FG000|Overall Study|Lack of Efficacy|0|||
106042681|NCT04996797|365822316|FG001|Overall Study|Lack of Efficacy|2|||
106042682|NCT04996797|365822317|FG002|Overall Study|Lack of Efficacy|0|||
106042683|NCT04996797|365822318|FG003|Overall Study|Lack of Efficacy|0|||
106042684|NCT04996797|365822315|FG000|Overall Study|Prohibited Medication|0|||
106042685|NCT04996797|365822316|FG001|Overall Study|Prohibited Medication|1|||
106042686|NCT04996797|365822317|FG002|Overall Study|Prohibited Medication|0|||
106042687|NCT04996797|365822318|FG003|Overall Study|Prohibited Medication|0|||
106042688|NCT04996797|365822315|FG000|Overall Study|Ongoing|68|||
106042689|NCT04996797|365822316|FG001|Overall Study|Ongoing|60|||
106042690|NCT04996797|365822317|FG002|Overall Study|Ongoing|22|||
106042691|NCT04996797|365822318|FG003|Overall Study|Ongoing|20|||
106042692|NCT04996797|365822315|FG000|Overall Study|Withdrawal by Subject|0|||
106042693|NCT04996797|365822316|FG001|Overall Study|Withdrawal by Subject|2|||
106042694|NCT04996797|365822317|FG002|Overall Study|Withdrawal by Subject|0|||
106042695|NCT04996797|365822318|FG003|Overall Study|Withdrawal by Subject|0|||
106042696|NCT04176705|365822319|FG000|Overall Study|Withdrawal by Subject|4|||
106042697|NCT04176705|365822320|FG001|Overall Study|Withdrawal by Subject|4|||
106042698|NCT04176705|365822319|FG000|Overall Study|Death|1|||
106042699|NCT04176705|365822320|FG001|Overall Study|Death|1|||
106042700|NCT04176705|365822319|FG000|Overall Study|Lost to Follow-up|3|||
106042701|NCT04176705|365822320|FG001|Overall Study|Lost to Follow-up|3|||
106042702|NCT03360747|365822327|FG000|Overall Study|Voluntary Withdrawal|1|||
106042703|NCT03104374|365822328|FG000|Overall Study|Adverse Event|7|||
106042704|NCT03104374|365822329|FG001|Overall Study|Adverse Event|6|||
106042705|NCT03104374|365822330|FG002|Overall Study|Adverse Event|12|||
106042706|NCT03104374|365822331|FG003|Overall Study|Adverse Event|15|||
106042707|NCT03104374|365822328|FG000|Overall Study|Withdrawal by Subject|18|||
106042708|NCT03104374|365822329|FG001|Overall Study|Withdrawal by Subject|10|||
106042709|NCT03104374|365822330|FG002|Overall Study|Withdrawal by Subject|10|||
106042710|NCT03104374|365822331|FG003|Overall Study|Withdrawal by Subject|17|||
106042711|NCT03104374|365822328|FG000|Overall Study|Lost to Follow-up|4|||
106042712|NCT03104374|365822329|FG001|Overall Study|Lost to Follow-up|4|||
106042713|NCT03104374|365822330|FG002|Overall Study|Lost to Follow-up|6|||
106042714|NCT03104374|365822331|FG003|Overall Study|Lost to Follow-up|8|||
106042715|NCT03104374|365822328|FG000|Overall Study|Lack of Efficacy|6|||
106042716|NCT03104374|365822329|FG001|Overall Study|Lack of Efficacy|7|||
106042717|NCT03104374|365822330|FG002|Overall Study|Lack of Efficacy|12|||
106042718|NCT03104374|365822331|FG003|Overall Study|Lack of Efficacy|6|||
106042719|NCT03104374|365822328|FG000|Overall Study|Other|2|||
106042720|NCT03104374|365822329|FG001|Overall Study|Other|2|||
106042721|NCT03104374|365822330|FG002|Overall Study|Other|4|||
106042722|NCT03104374|365822331|FG003|Overall Study|Other|7|||
106042723|NCT03803683|365822337|FG000|Overall Study|Lost to Follow-up|41|||
106042724|NCT03803683|365822338|FG001|Overall Study|Lost to Follow-up|18|||
106042725|NCT03803683|365822339|FG002|Overall Study|Lost to Follow-up|12|||
106042726|NCT03803683|365822337|FG000|Overall Study|Withdrawal by Subject|9|||
106042727|NCT03803683|365822338|FG001|Overall Study|Withdrawal by Subject|1|||
106042728|NCT03803683|365822339|FG002|Overall Study|Withdrawal by Subject|4|||
106042729|NCT00107783|365824051|FG000|Overall Study|Adverse Event|0|||
106042730|NCT00107783|365824052|FG001|Overall Study|Adverse Event|2|||
106042731|NCT00107783|365824051|FG000|Overall Study|Death|0|||
106042732|NCT00107783|365824052|FG001|Overall Study|Death|1|||
106042733|NCT00107783|365824051|FG000|Overall Study|Withdrawal by Subject|2|||
106042734|NCT00107783|365824052|FG001|Overall Study|Withdrawal by Subject|0|||
106042735|NCT00107783|365824051|FG000|Overall Study|Second hip replacement|1|||
106042736|NCT00107783|365824052|FG001|Overall Study|Second hip replacement|1|||
106042737|NCT04879225|365824053|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
106042738|NCT04879225|365824053|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
106042739|NCT02367131|365824059|FG000|Overall Study|Adverse Event|64|||
106042740|NCT02367131|365824059|FG000|Overall Study|No visit since the first visit|3|||
106042741|NCT02367131|365824059|FG000|Overall Study|Request by patient|53|||
106042742|NCT02367131|365824059|FG000|Overall Study|Improvement/remission|2|||
106042743|NCT02367131|365824059|FG000|Overall Study|No change/progressive disease|78|||
106042744|NCT02367131|365824059|FG000|Overall Study|Other than stated above|20|||
106042745|NCT02367131|365824059|FG000|Overall Study|Not treated|2|||
106042746|NCT02572388|365824060|FG000|Overall Study|Withdrawal by Subject|1|||
106042747|NCT02572388|365824061|FG001|Overall Study|Withdrawal by Subject|1|||
106042748|NCT02572388|365824062|FG002|Overall Study|Withdrawal by Subject|2|||
106042749|NCT02572388|365824063|FG003|Overall Study|Withdrawal by Subject|2|||
106042750|NCT02360995|365824064|FG000|Overall Study|Lost to Follow-up|2|||
106042751|NCT02360995|365824065|FG001|Overall Study|Lost to Follow-up|0|||
106042752|NCT02360995|365824066|FG002|Overall Study|Lost to Follow-up|2|||
106042753|NCT02360995|365824064|FG000|Overall Study|Withdrawal by Subject|0|||
106042754|NCT02360995|365824065|FG001|Overall Study|Withdrawal by Subject|1|||
106042755|NCT02360995|365824066|FG002|Overall Study|Withdrawal by Subject|0|||
106042756|NCT00810108|365824067|FG000|Overall Study|Withdrawal by Subject|1|||
106042757|NCT00810108|365824068|FG001|Overall Study|Withdrawal by Subject|0|||
106042758|NCT00137631|365824071|FG000|Overall Study|Lost to Follow-up|37|||
106042759|NCT00137631|365824072|FG001|Overall Study|Lost to Follow-up|41|||
106042760|NCT02611960|365824073|FG000|Overall Study|Adverse Event|7|||
106042761|NCT02611960|365824074|FG001|Overall Study|Adverse Event|8|||
106042762|NCT02611960|365824073|FG000|Overall Study|Death|98|||
106042763|NCT02611960|365824074|FG001|Overall Study|Death|92|||
106042764|NCT02611960|365824073|FG000|Overall Study|Withdrawal by Subject|1|||
106042765|NCT02611960|365824074|FG001|Overall Study|Withdrawal by Subject|5|||
106042766|NCT02611960|365824073|FG000|Overall Study|Sponsor Decision|11|||
106042767|NCT02611960|365824074|FG001|Overall Study|Sponsor Decision|11|||
106042768|NCT01409434|365824087|FG000|Overall Study|Protocol Violation|4|||
106042769|NCT02436304|365824090|FG000|Overall Study|Lost to Follow-up|0|||
106042770|NCT02436304|365824091|FG001|Overall Study|Lost to Follow-up|1|||
106042771|NCT02436304|365824092|FG002|Overall Study|Lost to Follow-up|0|||
106042772|NCT02436304|365824090|FG000|Overall Study|Withdrawal by Subject|0|||
106042773|NCT02436304|365824091|FG001|Overall Study|Withdrawal by Subject|1|||
106042774|NCT02436304|365824092|FG002|Overall Study|Withdrawal by Subject|0|||
106042775|NCT02436304|365824090|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
106042776|NCT02436304|365824091|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
106042777|NCT02436304|365824092|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
106042778|NCT01229371|365824093|FG000|Overall Study|Withdrawal by Subject|0|||
106042779|NCT01229371|365824094|FG001|Overall Study|Withdrawal by Subject|1|||
106042780|NCT01229371|365824095|FG002|Overall Study|Withdrawal by Subject|0|||
106042781|NCT01229371|365824096|FG003|Overall Study|Withdrawal by Subject|0|||
106042782|NCT04073368|365824097|FG000|Overall Study|Adverse Event|2|||
106042783|NCT04073368|365824098|FG001|Overall Study|Adverse Event|0|||
106042784|NCT04073368|365824099|FG002|Overall Study|Adverse Event|1|||
106042785|NCT04073368|365824100|FG003|Overall Study|Adverse Event|1|||
106042786|NCT04073368|365824097|FG000|Overall Study|Withdrawal by Subject|2|||
106042787|NCT04073368|365824098|FG001|Overall Study|Withdrawal by Subject|2|||
106042788|NCT04073368|365824099|FG002|Overall Study|Withdrawal by Subject|1|||
106042789|NCT04073368|365824100|FG003|Overall Study|Withdrawal by Subject|1|||
106042790|NCT04073368|365824097|FG000|Overall Study|Lost to Follow-up|1|||
106042791|NCT04073368|365824098|FG001|Overall Study|Lost to Follow-up|1|||
106042792|NCT04073368|365824099|FG002|Overall Study|Lost to Follow-up|1|||
106042793|NCT04073368|365824100|FG003|Overall Study|Lost to Follow-up|0|||
106042794|NCT04073368|365824097|FG000|Overall Study|Protocol Violation|0|||
106042795|NCT04073368|365824098|FG001|Overall Study|Protocol Violation|1|||
106042796|NCT04073368|365824099|FG002|Overall Study|Protocol Violation|0|||
106152107|NCT02544074|366217012|FG007|Overall Study|Tablet error|0|||
106152108|NCT02544074|366217013|FG008|Overall Study|Tablet error|0|||
106152109|NCT02544074|366217014|FG009|Overall Study|Tablet error|1|||
106152110|NCT02544074|366217015|FG010|Overall Study|Tablet error|0|||
106042797|NCT04073368|365824100|FG003|Overall Study|Protocol Violation|0|||
106042798|NCT04073368|365824097|FG000|Overall Study|Subject noncompliance|7|||
106042799|NCT04073368|365824098|FG001|Overall Study|Subject noncompliance|4|||
106042800|NCT04073368|365824099|FG002|Overall Study|Subject noncompliance|0|||
106042801|NCT04073368|365824100|FG003|Overall Study|Subject noncompliance|0|||
106042802|NCT00761579|365824101|FG000|Overall Study|Adverse Event|10|||
106042803|NCT00761579|365824101|FG000|Overall Study|Death|2|||
106042804|NCT00761579|365824101|FG000|Overall Study|Lack of Efficacy|21|||
106042805|NCT00761579|365824101|FG000|Overall Study|Lost to Follow-up|16|||
106042806|NCT00761579|365824101|FG000|Overall Study|Pregnancy|1|||
106042807|NCT00761579|365824101|FG000|Overall Study|Withdrawal by Subject|34|||
106042808|NCT00761579|365824101|FG000|Overall Study|Lack of compliance|2|||
106042809|NCT00761579|365824101|FG000|Overall Study|Protocol deviation|1|||
106042810|NCT00761579|365824101|FG000|Overall Study|Drug overdose|1|||
106042811|NCT00761579|365824101|FG000|Overall Study|Aggravation of depression|1|||
106152111|NCT02544074|366217016|FG011|Overall Study|Tablet error|0|||
106042812|NCT00761579|365824101|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
106042813|NCT00761579|365824101|FG000|Overall Study|Lost survey form|1|||
106042814|NCT00761579|365824101|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
106042815|NCT03611010|365824102|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
106042816|NCT03611010|365824103|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
106042817|NCT03611010|365824104|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
106042818|NCT03611010|365824105|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
106042819|NCT00598702|365824106|FG000|Overall Study|Other|0|||
106042820|NCT00598702|365824107|FG001|Overall Study|Other|2|||
106042821|NCT00598702|365824108|FG002|Overall Study|Other|0|||
106042822|NCT00598702|365824109|FG003|Overall Study|Other|0|||
106042823|NCT00598702|365824110|FG004|Overall Study|Other|0|||
106042824|NCT00598702|365824111|FG005|Overall Study|Other|1|||
106042825|NCT00598702|365824112|FG006|Overall Study|Other|0|||
106042826|NCT00598702|365824113|FG007|Overall Study|Other|0|||
106042827|NCT00598702|365824106|FG000|Overall Study|Early discharge from hospital|0|||
106042828|NCT00598702|365824107|FG001|Overall Study|Early discharge from hospital|0|||
106042829|NCT00598702|365824108|FG002|Overall Study|Early discharge from hospital|2|||
106042830|NCT00598702|365824109|FG003|Overall Study|Early discharge from hospital|5|||
106042831|NCT00598702|365824110|FG004|Overall Study|Early discharge from hospital|0|||
106042832|NCT00598702|365824111|FG005|Overall Study|Early discharge from hospital|10|||
106042833|NCT00598702|365824112|FG006|Overall Study|Early discharge from hospital|1|||
106042834|NCT00598702|365824113|FG007|Overall Study|Early discharge from hospital|0|||
106042835|NCT00598702|365824106|FG000|Overall Study|Adverse Event|0|||
106042836|NCT00598702|365824107|FG001|Overall Study|Adverse Event|0|||
106042837|NCT00598702|365824108|FG002|Overall Study|Adverse Event|0|||
106042838|NCT00598702|365824109|FG003|Overall Study|Adverse Event|1|||
106042839|NCT00598702|365824110|FG004|Overall Study|Adverse Event|0|||
106042840|NCT00598702|365824111|FG005|Overall Study|Adverse Event|0|||
106042841|NCT00598702|365824112|FG006|Overall Study|Adverse Event|0|||
106042842|NCT00598702|365824113|FG007|Overall Study|Adverse Event|0|||
106042843|NCT00598702|365824106|FG000|Overall Study|Withdrawal by Subject|0|||
106042844|NCT00598702|365824107|FG001|Overall Study|Withdrawal by Subject|0|||
106042845|NCT00598702|365824108|FG002|Overall Study|Withdrawal by Subject|0|||
106042846|NCT00598702|365824109|FG003|Overall Study|Withdrawal by Subject|1|||
106042847|NCT00598702|365824110|FG004|Overall Study|Withdrawal by Subject|1|||
106042848|NCT00598702|365824111|FG005|Overall Study|Withdrawal by Subject|0|||
106042849|NCT00598702|365824112|FG006|Overall Study|Withdrawal by Subject|0|||
106042850|NCT00598702|365824113|FG007|Overall Study|Withdrawal by Subject|0|||
106042851|NCT00598702|365824106|FG000|Overall Study|Physician Decision|0|||
106042852|NCT00598702|365824107|FG001|Overall Study|Physician Decision|0|||
106042853|NCT00598702|365824108|FG002|Overall Study|Physician Decision|0|||
106042854|NCT00598702|365824109|FG003|Overall Study|Physician Decision|0|||
106042855|NCT00598702|365824110|FG004|Overall Study|Physician Decision|1|||
106042856|NCT00598702|365824111|FG005|Overall Study|Physician Decision|0|||
106042857|NCT00598702|365824112|FG006|Overall Study|Physician Decision|0|||
106042858|NCT00598702|365824113|FG007|Overall Study|Physician Decision|0|||
106042859|NCT00598702|365824106|FG000|Overall Study|Dose limiting toxicity|0|||
106042860|NCT00598702|365824107|FG001|Overall Study|Dose limiting toxicity|0|||
106042861|NCT00598702|365824108|FG002|Overall Study|Dose limiting toxicity|0|||
106042862|NCT00598702|365824109|FG003|Overall Study|Dose limiting toxicity|1|||
106042863|NCT00598702|365824110|FG004|Overall Study|Dose limiting toxicity|1|||
106042864|NCT00598702|365824111|FG005|Overall Study|Dose limiting toxicity|1|||
106042865|NCT00598702|365824112|FG006|Overall Study|Dose limiting toxicity|0|||
106042866|NCT00598702|365824113|FG007|Overall Study|Dose limiting toxicity|0|||
106042867|NCT00567593|365824116|FG000|Overall Study|Adverse Event|1|||
106042868|NCT00567593|365824116|FG000|Overall Study|Physician Decision|1|||
106042869|NCT04087213|365824117|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
106042870|NCT04087213|365824117|FG000|In-Facility Introduction|Adverse Event|1|||
106042871|NCT04087213|365824117|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
106042872|NCT04087213|365824117|FG000|Assisted Evaluable Period|Personal reasons|3|||
106042873|NCT04087213|365824117|FG000|Transition Period B|Renal Transplantation|1|||
106042874|NCT00700570|365824125|FG000|Overall Study|Adverse Event|2|||
106042875|NCT00700570|365824126|FG001|Overall Study|Adverse Event|6|||
106042876|NCT00700570|365824125|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
106042877|NCT00700570|365824126|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
106042878|NCT00700570|365824125|FG000|Overall Study|Disease Progression|8|||
106042879|NCT00700570|365824126|FG001|Overall Study|Disease Progression|11|||
106042880|NCT00700570|365824125|FG000|Overall Study|Withdrawal by Subject|1|||
106042881|NCT00700570|365824126|FG001|Overall Study|Withdrawal by Subject|6|||
106042882|NCT01031381|365824129|FG000|Overall Study|Physician Decision|3|||
106042883|NCT01031381|365824129|FG000|Overall Study|Withdrawal by Subject|6|||
106042884|NCT01461980|365824130|FG000|Overall Study|Other|9|||
106042885|NCT01461980|365824131|FG001|Overall Study|Other|8|||
106042886|NCT01461980|365824132|FG002|Overall Study|Other|6|||
106042887|NCT01461980|365824130|FG000|Overall Study|Medication error|7|||
106042888|NCT01461980|365824131|FG001|Overall Study|Medication error|5|||
106042889|NCT01461980|365824132|FG002|Overall Study|Medication error|6|||
106042890|NCT01461980|365824130|FG000|Overall Study|Adverse Event|12|||
106042891|NCT01461980|365824131|FG001|Overall Study|Adverse Event|5|||
106042892|NCT01461980|365824132|FG002|Overall Study|Adverse Event|6|||
106042893|NCT01461980|365824130|FG000|Overall Study|Protocol Violation|12|||
106042894|NCT01461980|365824131|FG001|Overall Study|Protocol Violation|19|||
106042895|NCT01461980|365824132|FG002|Overall Study|Protocol Violation|16|||
106042896|NCT01461980|365824130|FG000|Overall Study|No longer meets eligibility criteria|18|||
106042897|NCT01461980|365824131|FG001|Overall Study|No longer meets eligibility criteria|9|||
106042898|NCT01461980|365824132|FG002|Overall Study|No longer meets eligibility criteria|19|||
106042899|NCT01461980|365824130|FG000|Overall Study|Lost to Follow-up|52|||
106042900|NCT01461980|365824131|FG001|Overall Study|Lost to Follow-up|53|||
106042901|NCT01461980|365824132|FG002|Overall Study|Lost to Follow-up|51|||
106042902|NCT01461980|365824130|FG000|Overall Study|No longer willing to participate|52|||
106042903|NCT01461980|365824131|FG001|Overall Study|No longer willing to participate|38|||
106042904|NCT01461980|365824132|FG002|Overall Study|No longer willing to participate|54|||
106042905|NCT01461980|365824130|FG000|Overall Study|Randomized but not vaccinated|4|||
106042906|NCT01461980|365824131|FG001|Overall Study|Randomized but not vaccinated|8|||
106042907|NCT01461980|365824132|FG002|Overall Study|Randomized but not vaccinated|7|||
106042908|NCT00122109|365824134|FG000|Overall Study|Did not meet criteria|6|||
106042909|NCT00122109|365824135|FG001|Overall Study|Did not meet criteria|7|||
106042910|NCT02642029|365824136|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
106042911|NCT02642029|365824137|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
106042912|NCT02642029|365824138|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
106042913|NCT02642029|365824139|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
106042914|NCT02642029|365824140|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
106042915|NCT02642029|365824141|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
106042916|NCT02642029|365824136|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
106042917|NCT02642029|365824137|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
106042918|NCT02642029|365824138|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
106042919|NCT02642029|365824139|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
106042920|NCT02642029|365824140|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
106042921|NCT02642029|365824141|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
106042922|NCT02642029|365824136|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
106042923|NCT02642029|365824137|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
106042924|NCT02642029|365824138|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
106042925|NCT02642029|365824139|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
106042926|NCT02642029|365824140|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
106042927|NCT02642029|365824141|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
106042928|NCT02642029|365824136|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
106042929|NCT02642029|365824137|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
106042930|NCT02642029|365824138|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
106042931|NCT02642029|365824139|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
106042932|NCT02642029|365824140|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
106042933|NCT02642029|365824141|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
106042934|NCT02642029|365824136|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
106042935|NCT02642029|365824137|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
106042936|NCT02642029|365824138|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
106042937|NCT02642029|365824139|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
106042938|NCT02642029|365824140|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
106042939|NCT02642029|365824141|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
106042940|NCT02642029|365824136|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
106042941|NCT02642029|365824137|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
106042942|NCT02642029|365824138|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
106042943|NCT02642029|365824139|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
106042944|NCT02642029|365824140|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
106042945|NCT02642029|365824141|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
106042946|NCT00267189|365824142|FG000|Overall Study|Patient withdrew consent|1|||
106042947|NCT00267189|365824143|FG001|Overall Study|Patient withdrew consent|1|||
106152112|NCT02544074|366217017|FG012|Overall Study|Tablet error|0|||
106152113|NCT02544074|366217018|FG013|Overall Study|Tablet error|0|||
106152114|NCT02544074|366217019|FG014|Overall Study|Tablet error|0|||
106152115|NCT02544074|366217020|FG015|Overall Study|Tablet error|0|||
106152116|NCT02544074|366217021|FG016|Overall Study|Tablet error|0|||
106152117|NCT02544074|366217022|FG017|Overall Study|Tablet error|0|||
106042948|NCT00267189|365824142|FG000|Overall Study|Death|1|||
106042949|NCT00267189|365824143|FG001|Overall Study|Death|0|||
106042950|NCT00267189|365824142|FG000|Overall Study|Missing|3|||
106042951|NCT00267189|365824143|FG001|Overall Study|Missing|0|||
106042952|NCT02477839|365824144|FG000|Overall Study|Adverse Event|0|||
105862213|NCT00090363|365145778|FG002|Overall Study|Continuing on study off treatment|16|||
105862214|NCT04572893|365145781|FG000|Part A|Adverse Event|1|||
105862215|NCT04572893|365145782|FG001|Part A|Adverse Event|0|||
105862216|NCT04572893|365145783|FG002|Part A|Adverse Event|0|||
105862217|NCT04572893|365145784|FG003|Part A|Adverse Event|0|||
105862218|NCT04572893|365145785|FG004|Part A|Adverse Event|0|||
105862219|NCT04572893|365145786|FG005|Part A|Adverse Event|0|||
105862220|NCT04572893|365145787|FG006|Part A|Adverse Event|0|||
105862221|NCT04572893|365145781|FG000|Part B|Withdrawal by Subject|0|||
105862222|NCT04572893|365145782|FG001|Part B|Withdrawal by Subject|0|||
105862223|NCT04572893|365145783|FG002|Part B|Withdrawal by Subject|0|||
105862224|NCT04572893|365145784|FG003|Part B|Withdrawal by Subject|0|||
105862225|NCT04572893|365145785|FG004|Part B|Withdrawal by Subject|0|||
105862226|NCT04572893|365145786|FG005|Part B|Withdrawal by Subject|1|||
105862227|NCT04572893|365145787|FG006|Part B|Withdrawal by Subject|0|||
105862228|NCT04572893|365145781|FG000|Part B|Study terminated by sponsor|0|||
105862229|NCT04572893|365145782|FG001|Part B|Study terminated by sponsor|0|||
105862230|NCT04572893|365145783|FG002|Part B|Study terminated by sponsor|0|||
105862231|NCT04572893|365145784|FG003|Part B|Study terminated by sponsor|0|||
105862232|NCT04572893|365145785|FG004|Part B|Study terminated by sponsor|7|||
105862233|NCT04572893|365145786|FG005|Part B|Study terminated by sponsor|5|||
105862234|NCT04572893|365145787|FG006|Part B|Study terminated by sponsor|3|||
105862235|NCT04572893|365145781|FG000|Part B|Lost to Follow-up|0|||
105862236|NCT04572893|365145782|FG001|Part B|Lost to Follow-up|0|||
105862237|NCT04572893|365145783|FG002|Part B|Lost to Follow-up|0|||
105862238|NCT04572893|365145784|FG003|Part B|Lost to Follow-up|0|||
105862239|NCT04572893|365145785|FG004|Part B|Lost to Follow-up|0|||
105862240|NCT04572893|365145786|FG005|Part B|Lost to Follow-up|0|||
105862241|NCT04572893|365145787|FG006|Part B|Lost to Follow-up|1|||
105862242|NCT04572893|365145781|FG000|Part B|Adverse Event|0|||
105862243|NCT04572893|365145782|FG001|Part B|Adverse Event|0|||
105862244|NCT04572893|365145783|FG002|Part B|Adverse Event|0|||
105862245|NCT04572893|365145784|FG003|Part B|Adverse Event|0|||
105862246|NCT04572893|365145785|FG004|Part B|Adverse Event|1|||
105862247|NCT04572893|365145786|FG005|Part B|Adverse Event|1|||
105862248|NCT04572893|365145787|FG006|Part B|Adverse Event|0|||
105862249|NCT03301623|365145788|FG000|Overall Study|Death|3|||
105862250|NCT03301623|365145789|FG001|Overall Study|Death|1|||
105862251|NCT03301623|365145788|FG000|Overall Study|Withdrawal by Subject|11|||
105862252|NCT03301623|365145789|FG001|Overall Study|Withdrawal by Subject|13|||
105862253|NCT03301623|365145788|FG000|Overall Study|Lost to Follow-up|3|||
105862254|NCT03301623|365145789|FG001|Overall Study|Lost to Follow-up|1|||
105862255|NCT02203331|365145790|FG000|Overall Study|Pregnancy|1|||
105862256|NCT02203331|365145791|FG001|Overall Study|Pregnancy|0|||
105862257|NCT02203331|365145792|FG002|Overall Study|Pregnancy|0|||
105862258|NCT02203331|365145793|FG003|Overall Study|Pregnancy|0|||
105862259|NCT02203331|365145794|FG004|Overall Study|Pregnancy|2|||
105862260|NCT02203331|365145795|FG005|Overall Study|Pregnancy|0|||
106042953|NCT02477839|365824145|FG001|Overall Study|Adverse Event|1|||
106042954|NCT02477839|365824144|FG000|Overall Study|Protocol Violation|0|||
106042955|NCT02477839|365824145|FG001|Overall Study|Protocol Violation|2|||
106042956|NCT02477839|365824144|FG000|Overall Study|Withdrawal by Subject|3|||
106042957|NCT02477839|365824145|FG001|Overall Study|Withdrawal by Subject|3|||
106042958|NCT02477839|365824144|FG000|Overall Study|Participant had PGS during V6|0|||
106042959|NCT02477839|365824145|FG001|Overall Study|Participant had PGS during V6|1|||
106042960|NCT02477839|365824144|FG000|Overall Study|Parents decided to stop medication|0|||
106042961|NCT02477839|365824145|FG001|Overall Study|Parents decided to stop medication|1|||
105862261|NCT02203331|365145790|FG000|Overall Study|Withdrawal by Subject|1|||
105862262|NCT02203331|365145791|FG001|Overall Study|Withdrawal by Subject|0|||
105862263|NCT02203331|365145792|FG002|Overall Study|Withdrawal by Subject|1|||
105862264|NCT02203331|365145793|FG003|Overall Study|Withdrawal by Subject|0|||
105862265|NCT02203331|365145794|FG004|Overall Study|Withdrawal by Subject|0|||
105862266|NCT02203331|365145795|FG005|Overall Study|Withdrawal by Subject|3|||
105862267|NCT02203331|365145790|FG000|Overall Study|Adverse Event|4|||
105862268|NCT02203331|365145791|FG001|Overall Study|Adverse Event|8|||
106042962|NCT02477839|365824144|FG000|Overall Study|Lack of tolerability|0|||
106042963|NCT02477839|365824145|FG001|Overall Study|Lack of tolerability|1|||
106042964|NCT02477839|365824144|FG000|Overall Study|Exclusion criterion|0|||
105862269|NCT02203331|365145792|FG002|Overall Study|Adverse Event|3|||
105862270|NCT02203331|365145793|FG003|Overall Study|Adverse Event|4|||
105862271|NCT02203331|365145794|FG004|Overall Study|Adverse Event|3|||
105862272|NCT02203331|365145795|FG005|Overall Study|Adverse Event|3|||
105862273|NCT02203331|365145790|FG000|Overall Study|Other Reasons|1|||
105862274|NCT02203331|365145791|FG001|Overall Study|Other Reasons|2|||
105862275|NCT02203331|365145792|FG002|Overall Study|Other Reasons|0|||
105862276|NCT02203331|365145793|FG003|Overall Study|Other Reasons|2|||
105862277|NCT02203331|365145794|FG004|Overall Study|Other Reasons|0|||
105862278|NCT02203331|365145795|FG005|Overall Study|Other Reasons|0|||
105862279|NCT02203331|365145790|FG000|Overall Study|Lack of Efficacy|0|||
105862280|NCT02203331|365145791|FG001|Overall Study|Lack of Efficacy|2|||
105862281|NCT02203331|365145792|FG002|Overall Study|Lack of Efficacy|1|||
105862282|NCT02203331|365145793|FG003|Overall Study|Lack of Efficacy|0|||
105862283|NCT02203331|365145794|FG004|Overall Study|Lack of Efficacy|0|||
105862284|NCT02203331|365145795|FG005|Overall Study|Lack of Efficacy|1|||
105862285|NCT02203331|365145790|FG000|Overall Study|Protocol Violation|0|||
105862286|NCT02203331|365145791|FG001|Overall Study|Protocol Violation|2|||
105862287|NCT02203331|365145792|FG002|Overall Study|Protocol Violation|0|||
105862288|NCT02203331|365145793|FG003|Overall Study|Protocol Violation|1|||
105862289|NCT02203331|365145794|FG004|Overall Study|Protocol Violation|1|||
105862290|NCT02203331|365145795|FG005|Overall Study|Protocol Violation|0|||
105862291|NCT02203331|365145790|FG000|Overall Study|Lost to Follow-up|0|||
105862292|NCT02203331|365145791|FG001|Overall Study|Lost to Follow-up|0|||
105862293|NCT02203331|365145792|FG002|Overall Study|Lost to Follow-up|0|||
105862294|NCT02203331|365145793|FG003|Overall Study|Lost to Follow-up|0|||
105862295|NCT02203331|365145794|FG004|Overall Study|Lost to Follow-up|1|||
105862296|NCT02203331|365145795|FG005|Overall Study|Lost to Follow-up|0|||
105862297|NCT01374269|365145803|FG000|Overall Study|Withdrawal by Subject|4|||
105862298|NCT01374269|365145804|FG001|Overall Study|Withdrawal by Subject|0|||
105862299|NCT01374269|365145803|FG000|Overall Study|Lost to Follow-up|1|||
105862300|NCT01374269|365145804|FG001|Overall Study|Lost to Follow-up|3|||
105862301|NCT01374269|365145803|FG000|Overall Study|closed research|1|||
105862302|NCT01374269|365145804|FG001|Overall Study|closed research|2|||
105862303|NCT01987479|365145805|FG000|Overall Study|Protocol Violation|1|||
105862304|NCT01987479|365145805|FG000|Overall Study|Physician Decision|2|||
105862305|NCT01987479|365145805|FG000|Overall Study|Participant/legal guardian decision|1|||
105862306|NCT01987479|365145805|FG000|Overall Study|Other|5|||
105862307|NCT01987479|365145805|FG000|Overall Study|Lost to Follow-up|1|||
105862308|NCT01987479|365145805|FG000|Overall Study|Adverse Event|7|||
105862309|NCT04007991|365145806|FG000|Overall Study|Withdrawal by Subject|1|||
105862310|NCT04007991|365145807|FG001|Overall Study|Withdrawal by Subject|1|||
106042965|NCT02477839|365824145|FG001|Overall Study|Exclusion criterion|1|||
106042966|NCT01439568|365824150|FG000|Overall Study|Lost to Follow-up|1|||
106042967|NCT01439568|365824151|FG001|Overall Study|Lost to Follow-up|0|||
106042968|NCT01439568|365824150|FG000|Overall Study|Withdrawal by Subject|2|||
106042969|NCT01439568|365824151|FG001|Overall Study|Withdrawal by Subject|2|||
106042970|NCT01050543|365824154|FG000|Overall Study|Withdrawal by Subject|0|||
106042971|NCT01050543|365824155|FG001|Overall Study|Withdrawal by Subject|2|||
106042972|NCT01050543|365824154|FG000|Overall Study|Protocol Violation|0|||
106042973|NCT01050543|365824155|FG001|Overall Study|Protocol Violation|1|||
106042974|NCT01050543|365824154|FG000|Overall Study|Administrative|4|||
106042975|NCT01050543|365824155|FG001|Overall Study|Administrative|1|||
106042976|NCT00570765|365824156|FG000|DB Phase|Withdrawal by Subject|1|||
106042977|NCT00570765|365824157|FG001|DB Phase|Withdrawal by Subject|0|||
106042978|NCT00570765|365824158|FG002|DB Phase|Withdrawal by Subject|0|||
106042979|NCT00570765|365824159|FG003|DB Phase|Withdrawal by Subject|0|||
106042980|NCT00570765|365824156|FG000|DB Phase|Protocol Violation|0|||
106042981|NCT00570765|365824157|FG001|DB Phase|Protocol Violation|1|||
106042982|NCT00570765|365824158|FG002|DB Phase|Protocol Violation|0|||
106042983|NCT00570765|365824159|FG003|DB Phase|Protocol Violation|0|||
106042984|NCT00570765|365824156|FG000|DB Phase|Adverse Event|3|||
106042985|NCT00570765|365824157|FG001|DB Phase|Adverse Event|6|||
106042986|NCT00570765|365824158|FG002|DB Phase|Adverse Event|0|||
106042987|NCT00570765|365824159|FG003|DB Phase|Adverse Event|0|||
106042988|NCT00570765|365824156|FG000|DB Phase|Did Not Receive Study Drug|0|||
106042989|NCT00570765|365824157|FG001|DB Phase|Did Not Receive Study Drug|0|||
106042990|NCT00570765|365824158|FG002|DB Phase|Did Not Receive Study Drug|1|||
106042991|NCT00570765|365824159|FG003|DB Phase|Did Not Receive Study Drug|0|||
105862311|NCT04007991|365145806|FG000|Overall Study|Physician Decision|1|||
105862312|NCT04007991|365145807|FG001|Overall Study|Physician Decision|1|||
106042992|NCT00570765|365824156|FG000|LTSE Phase|Withdrawal by Subject|0|||
106042993|NCT00570765|365824157|FG001|LTSE Phase|Withdrawal by Subject|0|||
106042994|NCT00570765|365824158|FG002|LTSE Phase|Withdrawal by Subject|0|||
106042995|NCT00570765|365824159|FG003|LTSE Phase|Withdrawal by Subject|1|||
106042996|NCT00570765|365824156|FG000|LTSE Phase|Adverse Event|0|||
106042997|NCT00570765|365824157|FG001|LTSE Phase|Adverse Event|0|||
106042998|NCT00570765|365824158|FG002|LTSE Phase|Adverse Event|0|||
106042999|NCT00570765|365824159|FG003|LTSE Phase|Adverse Event|7|||
106152118|NCT02544074|366217023|FG018|Overall Study|Tablet error|0|||
105862313|NCT04007991|365145806|FG000|Overall Study|Non-compliance with Study Drug|0|||
105862314|NCT04007991|365145807|FG001|Overall Study|Non-compliance with Study Drug|1|||
105862315|NCT04007991|365145806|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
105862316|NCT04007991|365145807|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
105862317|NCT04007991|365145806|FG000|Overall Study|Adverse event, non-fatal|5|||
105862318|NCT04007991|365145807|FG001|Overall Study|Adverse event, non-fatal|0|||
105862319|NCT04007991|365145806|FG000|Overall Study|Lost to Follow-up|2|||
105862320|NCT04007991|365145807|FG001|Overall Study|Lost to Follow-up|1|||
106043000|NCT00570765|365824156|FG000|LTSE Phase|Physician Decision|0|||
106043001|NCT00570765|365824157|FG001|LTSE Phase|Physician Decision|0|||
106043002|NCT00570765|365824158|FG002|LTSE Phase|Physician Decision|0|||
106043003|NCT00570765|365824159|FG003|LTSE Phase|Physician Decision|4|||
106043004|NCT02517866|365824160|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
106043005|NCT02517866|365824161|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
106043006|NCT02517866|365824162|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
106043007|NCT02517866|365824160|FG000|Overall Study|Significant Protocol Deviation|4|||
106043008|NCT02517866|365824161|FG001|Overall Study|Significant Protocol Deviation|1|||
106043009|NCT02517866|365824162|FG002|Overall Study|Significant Protocol Deviation|0|||
106043010|NCT02517866|365824160|FG000|Overall Study|Lost to Follow-up|1|||
106043011|NCT02517866|365824161|FG001|Overall Study|Lost to Follow-up|0|||
106043012|NCT02517866|365824162|FG002|Overall Study|Lost to Follow-up|0|||
106043013|NCT02517866|365824160|FG000|Overall Study|Voluntary Withdrawal|2|||
106043014|NCT02517866|365824161|FG001|Overall Study|Voluntary Withdrawal|2|||
106043015|NCT02517866|365824162|FG002|Overall Study|Voluntary Withdrawal|0|||
106043016|NCT02517866|365824160|FG000|Overall Study|Investigator Decision|2|||
106043017|NCT02517866|365824161|FG001|Overall Study|Investigator Decision|1|||
106043018|NCT02517866|365824162|FG002|Overall Study|Investigator Decision|0|||
106043019|NCT02517866|365824160|FG000|Overall Study|Reason not specified|2|||
106043020|NCT02517866|365824161|FG001|Overall Study|Reason not specified|0|||
106043021|NCT02517866|365824162|FG002|Overall Study|Reason not specified|0|||
106043022|NCT01147640|365824164|FG000|Overall Study|Adverse Event|2|||
106043023|NCT01147640|365824165|FG001|Overall Study|Adverse Event|0|||
106043024|NCT01147640|365824164|FG000|Overall Study|Physician Decision|1|||
106043025|NCT01147640|365824165|FG001|Overall Study|Physician Decision|0|||
106043026|NCT01147640|365824164|FG000|Overall Study|Withdrawal by Subject|1|||
106043027|NCT01147640|365824165|FG001|Overall Study|Withdrawal by Subject|0|||
106043028|NCT01147640|365824164|FG000|Overall Study|Lost to Follow-up|0|||
106043029|NCT01147640|365824165|FG001|Overall Study|Lost to Follow-up|1|||
106043030|NCT01147640|365824164|FG000|Overall Study|Didn't meet eligibility criteria|1|||
106043031|NCT01147640|365824165|FG001|Overall Study|Didn't meet eligibility criteria|0|||
106043032|NCT03711266|365824166|FG000|Overall Study|Lost to Follow-up|10|||
106043033|NCT01954342|365824167|FG000|Overall Study|Missing data from 13-16week study visit|0|||
106043034|NCT01954342|365824168|FG001|Overall Study|Missing data from 13-16week study visit|0|||
106043035|NCT01954342|365824169|FG002|Overall Study|Missing data from 13-16week study visit|0|||
106043036|NCT01954342|365824170|FG003|Overall Study|Missing data from 13-16week study visit|1|||
106043037|NCT01954342|365824167|FG000|Overall Study|Miscarriage|0|||
106043038|NCT01954342|365824168|FG001|Overall Study|Miscarriage|0|||
106043039|NCT01954342|365824169|FG002|Overall Study|Miscarriage|0|||
106043040|NCT01954342|365824170|FG003|Overall Study|Miscarriage|3|||
106043041|NCT01954342|365824167|FG000|Overall Study|Lost to Follow-up|0|||
106043042|NCT01954342|365824168|FG001|Overall Study|Lost to Follow-up|0|||
106043043|NCT01954342|365824169|FG002|Overall Study|Lost to Follow-up|0|||
106043044|NCT01954342|365824170|FG003|Overall Study|Lost to Follow-up|5|||
106043045|NCT01954342|365824167|FG000|Overall Study|Preterm delivery|0|||
106043046|NCT01954342|365824168|FG001|Overall Study|Preterm delivery|0|||
106043047|NCT01954342|365824169|FG002|Overall Study|Preterm delivery|0|||
106043048|NCT01954342|365824170|FG003|Overall Study|Preterm delivery|3|||
106043049|NCT01954342|365824167|FG000|Overall Study|Pre-eclampsia|0|||
106043050|NCT01954342|365824168|FG001|Overall Study|Pre-eclampsia|0|||
106043051|NCT01954342|365824169|FG002|Overall Study|Pre-eclampsia|0|||
106043052|NCT01954342|365824170|FG003|Overall Study|Pre-eclampsia|4|||
106043053|NCT01954342|365824167|FG000|Overall Study|Unreliable Data|0|||
106043054|NCT01954342|365824168|FG001|Overall Study|Unreliable Data|0|||
106043055|NCT01954342|365824169|FG002|Overall Study|Unreliable Data|0|||
106043056|NCT01954342|365824170|FG003|Overall Study|Unreliable Data|2|||
106043057|NCT00437320|365824171|FG000|Overall Study|Participant request|2|||
106043058|NCT00437320|365824172|FG001|Overall Study|Participant request|1|||
106043059|NCT00437320|365824173|FG002|Overall Study|Participant request|4|||
106043060|NCT01938573|365824174|FG000|Overall Study|Lack of Efficacy|1|||
106043061|NCT01938573|365824175|FG001|Overall Study|Lack of Efficacy|0|||
106152119|NCT02544074|366217024|FG019|Overall Study|Tablet error|0|||
106152120|NCT02544074|366217025|FG020|Overall Study|Tablet error|0|||
106152121|NCT03954184|366217033|FG000|Overall Study|Lost to Follow-up|500|||
106152122|NCT03954184|366217034|FG001|Overall Study|Lost to Follow-up|0|||
106043062|NCT01938573|365824174|FG000|Overall Study|Operation at other hospital|1|||
106043063|NCT01938573|365824175|FG001|Overall Study|Operation at other hospital|0|||
106043064|NCT01756053|365824183|FG000|Period 1 (10 Days)|Protocol Violation|1|||
106043065|NCT01756053|365824184|FG001|Period 1 (10 Days)|Protocol Violation|1|||
106043066|NCT01756053|365824183|FG000|Period 2 (10 Days)|Protocol Violation|0|||
106043067|NCT01756053|365824184|FG001|Period 2 (10 Days)|Protocol Violation|2|||
106043068|NCT02038452|365824187|FG000|Overall Study|Withdrawal by Subject|7|||
106043069|NCT02038452|365824188|FG001|Overall Study|Withdrawal by Subject|9|||
106043070|NCT02038452|365824187|FG000|Overall Study|Lost to Follow-up|31|||
106043071|NCT02038452|365824188|FG001|Overall Study|Lost to Follow-up|28|||
106043072|NCT00237185|365824191|FG000|Core|Adverse Event|3|||
106043073|NCT00237185|365824192|FG001|Core|Adverse Event|4|||
106152123|NCT03398200|366217035|FG000|Overall Study|Withdrawal by Subject|0|||
106043074|NCT00237185|365824191|FG000|Core|Abnormal laboratory value|0|||
106043075|NCT00237185|365824192|FG001|Core|Abnormal laboratory value|4|||
106043076|NCT00237185|365824191|FG000|Core|Abnormal test procedure results|1|||
106043077|NCT00237185|365824192|FG001|Core|Abnormal test procedure results|0|||
106043078|NCT00237185|365824191|FG000|Core|Lack of Efficacy|30|||
106043079|NCT00237185|365824192|FG001|Core|Lack of Efficacy|23|||
106043080|NCT00237185|365824191|FG000|Core|Protocol Violation|1|||
106043081|NCT00237185|365824192|FG001|Core|Protocol Violation|1|||
106043082|NCT00237185|365824191|FG000|Core|Withdrawal by Subject|4|||
106043083|NCT00237185|365824192|FG001|Core|Withdrawal by Subject|4|||
106043084|NCT00237185|365824191|FG000|Core|Administrative problems|0|||
106043085|NCT00237185|365824192|FG001|Core|Administrative problems|1|||
106043086|NCT00237185|365824191|FG000|Core|Death|4|||
106043087|NCT00237185|365824192|FG001|Core|Death|0|||
106043088|NCT00237185|365824191|FG000|Core|Determined ineligible post randomization|1|||
106043089|NCT00237185|365824192|FG001|Core|Determined ineligible post randomization|0|||
106043090|NCT00237185|365824191|FG000|Extension|Adverse Event|1|||
106043091|NCT00237185|365824192|FG001|Extension|Adverse Event|0|||
106043092|NCT00237185|365824191|FG000|Extension|Abnormal laboratory value|0|||
106043093|NCT00237185|365824192|FG001|Extension|Abnormal laboratory value|1|||
106043094|NCT00237185|365824191|FG000|Extension|Lack of Efficacy|9|||
106043095|NCT00237185|365824192|FG001|Extension|Lack of Efficacy|14|||
106043096|NCT00237185|365824191|FG000|Extension|Condition no longer required study drug|0|||
106043097|NCT00237185|365824192|FG001|Extension|Condition no longer required study drug|1|||
106043098|NCT00237185|365824191|FG000|Extension|Withdrawal by Subject|3|||
106043099|NCT00237185|365824192|FG001|Extension|Withdrawal by Subject|2|||
106043100|NCT00237185|365824191|FG000|Extension|Lost to Follow-up|1|||
106043101|NCT00237185|365824192|FG001|Extension|Lost to Follow-up|0|||
106043102|NCT00237185|365824191|FG000|Extension|Administrative problems|1|||
106043103|NCT00237185|365824192|FG001|Extension|Administrative problems|0|||
106043104|NCT00237185|365824191|FG000|Extension|Death|1|||
106043105|NCT00237185|365824192|FG001|Extension|Death|1|||
106043106|NCT03643159|365824193|FG000|Overall Study|Adverse Event|1|||
106043107|NCT03643159|365824193|FG000|Overall Study|Withdrawal by Subject|1|||
106043108|NCT01631812|365824194|FG000|Overall Study|Adverse Event|25|||
106043109|NCT01631812|365824194|FG000|Overall Study|Lack of Efficacy|5|||
106043110|NCT01631812|365824194|FG000|Overall Study|Withdrawal by Subject|4|||
106043111|NCT01631812|365824194|FG000|Overall Study|Physician Decision|3|||
106043112|NCT00961649|365824196|FG000|Overall Study|Adverse Event|4|||
106043113|NCT00961649|365824197|FG001|Overall Study|Adverse Event|0|||
106043114|NCT00961649|365824198|FG002|Overall Study|Adverse Event|0|||
106043115|NCT00961649|365824199|FG003|Overall Study|Adverse Event|2|||
106043116|NCT00961649|365824196|FG000|Overall Study|Inadequate control of IOP|0|||
106043117|NCT00961649|365824197|FG001|Overall Study|Inadequate control of IOP|0|||
106043118|NCT00961649|365824198|FG002|Overall Study|Inadequate control of IOP|0|||
106043119|NCT00961649|365824199|FG003|Overall Study|Inadequate control of IOP|1|||
106043120|NCT00961649|365824196|FG000|Overall Study|Patient has travel plans during holidays|0|||
106043121|NCT00961649|365824197|FG001|Overall Study|Patient has travel plans during holidays|0|||
106043122|NCT00961649|365824198|FG002|Overall Study|Patient has travel plans during holidays|1|||
106043123|NCT00961649|365824199|FG003|Overall Study|Patient has travel plans during holidays|0|||
106043124|NCT00961649|365824196|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
106043125|NCT00961649|365824197|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
106043126|NCT00961649|365824198|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
106043127|NCT00961649|365824199|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
106043128|NCT00961649|365824196|FG000|Overall Study|Study terminated by sponsor|4|||
106043129|NCT00961649|365824197|FG001|Overall Study|Study terminated by sponsor|4|||
106043130|NCT00961649|365824198|FG002|Overall Study|Study terminated by sponsor|4|||
106043131|NCT00961649|365824199|FG003|Overall Study|Study terminated by sponsor|1|||
106043132|NCT01033851|365824200|FG000|Overall Study|Withdrawal by Subject|3|||
106043133|NCT01033851|365824201|FG001|Overall Study|Withdrawal by Subject|7|||
106043134|NCT03945266|365824206|FG000|Overall Study|Withdrawal by Subject|1|||
106043135|NCT03945266|365824207|FG001|Overall Study|Withdrawal by Subject|0|||
106043136|NCT03945266|365824206|FG000|Overall Study|Miscarriage|0|||
106043137|NCT03945266|365824207|FG001|Overall Study|Miscarriage|2|||
106043138|NCT03945266|365824206|FG000|Overall Study|Lost to Follow-up|1|||
106043139|NCT03945266|365824207|FG001|Overall Study|Lost to Follow-up|0|||
106043140|NCT02024555|365824208|FG000|Overall Study|Lost to Follow-up|1|||
106043141|NCT02024555|365824209|FG001|Overall Study|Lost to Follow-up|1|||
106043142|NCT02024555|365824208|FG000|Overall Study|Withdrawal by Subject|5|||
106043143|NCT02024555|365824209|FG001|Overall Study|Withdrawal by Subject|1|||
106043144|NCT04340193|365824210|FG000|Overall Study|Other reason|0|||
106043145|NCT04340193|365824211|FG001|Overall Study|Other reason|0|||
106043146|NCT04340193|365824212|FG002|Overall Study|Other reason|1|||
106043147|NCT04340193|365824210|FG000|Overall Study|Disease recurrence|0|||
106043148|NCT04340193|365824211|FG001|Overall Study|Disease recurrence|1|||
106043149|NCT04340193|365824212|FG002|Overall Study|Disease recurrence|0|||
106043150|NCT04340193|365824210|FG000|Overall Study|Study drug toxicity|1|||
106043151|NCT04340193|365824211|FG001|Overall Study|Study drug toxicity|0|||
106043152|NCT04340193|365824212|FG002|Overall Study|Study drug toxicity|0|||
106043153|NCT04340193|365824210|FG000|Overall Study|Disease progression|1|||
106043154|NCT04340193|365824211|FG001|Overall Study|Disease progression|2|||
106043155|NCT04340193|365824212|FG002|Overall Study|Disease progression|3|||
106043156|NCT04340193|365824210|FG000|Overall Study|Administrative reasons by sponsor|0|||
106043157|NCT04340193|365824211|FG001|Overall Study|Administrative reasons by sponsor|1|||
106043158|NCT04340193|365824212|FG002|Overall Study|Administrative reasons by sponsor|0|||
106043159|NCT04340193|365824210|FG000|Overall Study|Adverse Event|1|||
106043160|NCT04340193|365824211|FG001|Overall Study|Adverse Event|1|||
106043161|NCT04340193|365824212|FG002|Overall Study|Adverse Event|0|||
106043162|NCT03894046|365826411|FG000|Overall Study|Protocol Violation|1|||
106043163|NCT03894046|365826412|FG001|Overall Study|Protocol Violation|0|||
106043164|NCT03894046|365826413|FG002|Overall Study|Protocol Violation|0|||
106043165|NCT03894046|365826411|FG000|Overall Study|Adverse Event|0|||
106043166|NCT03894046|365826412|FG001|Overall Study|Adverse Event|1|||
106043167|NCT03894046|365826413|FG002|Overall Study|Adverse Event|0|||
106043168|NCT03894046|365826411|FG000|Overall Study|Withdrawal by Subject|2|||
106043169|NCT03894046|365826412|FG001|Overall Study|Withdrawal by Subject|3|||
106043170|NCT03894046|365826413|FG002|Overall Study|Withdrawal by Subject|1|||
106043171|NCT03894046|365826411|FG000|Overall Study|Death|15|||
106043172|NCT03894046|365826412|FG001|Overall Study|Death|21|||
106043173|NCT03894046|365826413|FG002|Overall Study|Death|4|||
106043174|NCT03894046|365826411|FG000|Overall Study|No growth of ABC|2|||
106043175|NCT03894046|365826412|FG001|Overall Study|No growth of ABC|1|||
106043176|NCT03894046|365826413|FG002|Overall Study|No growth of ABC|0|||
106043177|NCT03894046|365826411|FG000|Overall Study|Physician Decision|1|||
106043178|NCT03894046|365826412|FG001|Overall Study|Physician Decision|1|||
106043179|NCT03894046|365826413|FG002|Overall Study|Physician Decision|1|||
106043180|NCT03894046|365826411|FG000|Overall Study|Prohibited concomitant medication|1|||
106043181|NCT03894046|365826412|FG001|Overall Study|Prohibited concomitant medication|0|||
106043182|NCT03894046|365826413|FG002|Overall Study|Prohibited concomitant medication|0|||
106043183|NCT03894046|365826411|FG000|Overall Study|Transferred to other arm/group|1|||
106043184|NCT03894046|365826412|FG001|Overall Study|Transferred to other arm/group|1|||
106043185|NCT03894046|365826413|FG002|Overall Study|Transferred to other arm/group|0|||
106043186|NCT01973569|365826416|FG000|Overall Study|Adverse Event|9|||
106043187|NCT01973569|365826417|FG001|Overall Study|Adverse Event|2|||
106043188|NCT01973569|365826418|FG002|Overall Study|Adverse Event|4|||
106043189|NCT01973569|365826416|FG000|Overall Study|Protocol Violation|2|||
106043190|NCT01973569|365826417|FG001|Overall Study|Protocol Violation|1|||
106043191|NCT01973569|365826418|FG002|Overall Study|Protocol Violation|3|||
106043192|NCT01973569|365826416|FG000|Overall Study|Withdrawal by Subject|7|||
106043193|NCT01973569|365826417|FG001|Overall Study|Withdrawal by Subject|5|||
106043194|NCT01973569|365826418|FG002|Overall Study|Withdrawal by Subject|2|||
106043195|NCT01973569|365826416|FG000|Overall Study|Invasive dental treatment|3|||
106043196|NCT01973569|365826417|FG001|Overall Study|Invasive dental treatment|5|||
106043197|NCT01973569|365826418|FG002|Overall Study|Invasive dental treatment|6|||
106043198|NCT01973569|365826416|FG000|Overall Study|Prohibited concomitant d|1|||
106043199|NCT01973569|365826417|FG001|Overall Study|Prohibited concomitant d|5|||
106043200|NCT01973569|365826418|FG002|Overall Study|Prohibited concomitant d|0|||
106043201|NCT01973569|365826416|FG000|Overall Study|Disease progression|0|||
106043202|NCT01973569|365826417|FG001|Overall Study|Disease progression|3|||
106043203|NCT01973569|365826418|FG002|Overall Study|Disease progression|0|||
106043204|NCT01973569|365826416|FG000|Overall Study|Other|1|||
106043205|NCT01973569|365826417|FG001|Overall Study|Other|1|||
106043206|NCT01973569|365826418|FG002|Overall Study|Other|0|||
106043207|NCT01973569|365826416|FG000|Overall Study|Did not receive study drug|6|||
106043208|NCT01973569|365826417|FG001|Overall Study|Did not receive study drug|3|||
106043209|NCT01973569|365826418|FG002|Overall Study|Did not receive study drug|3|||
106043210|NCT01051466|365826419|FG000|Overall Study|Adverse Event|1|||
106043211|NCT01051466|365826420|FG001|Overall Study|Adverse Event|0|||
106043212|NCT01051466|365826419|FG000|Overall Study|Lost to Follow-up|1|||
106043213|NCT01051466|365826420|FG001|Overall Study|Lost to Follow-up|1|||
106043214|NCT01051466|365826419|FG000|Overall Study|Withdrawal by Subject|5|||
106043215|NCT01051466|365826420|FG001|Overall Study|Withdrawal by Subject|1|||
106043216|NCT01051466|365826419|FG000|Overall Study|Entry Criteria Not Met|0|||
106043217|NCT01051466|365826420|FG001|Overall Study|Entry Criteria Not Met|3|||
106043218|NCT01051466|365826419|FG000|Overall Study|Physician Decision|1|||
106043219|NCT01051466|365826420|FG001|Overall Study|Physician Decision|0|||
106043220|NCT00331864|365826432|FG000|Overall Study|Adverse Event|30|||
106043221|NCT00331864|365826433|FG001|Overall Study|Adverse Event|1|||
106043222|NCT00331864|365826432|FG000|Overall Study|Lack of Efficacy|4|||
106043223|NCT00331864|365826433|FG001|Overall Study|Lack of Efficacy|0|||
106043224|NCT00331864|365826432|FG000|Overall Study|Protocol Violation|3|||
106043225|NCT00331864|365826433|FG001|Overall Study|Protocol Violation|0|||
106043226|NCT00331864|365826432|FG000|Overall Study|Withdrawal by Subject|10|||
106043227|NCT00331864|365826433|FG001|Overall Study|Withdrawal by Subject|0|||
106043228|NCT00331864|365826432|FG000|Overall Study|Lost to Follow-up|4|||
106043229|NCT00331864|365826433|FG001|Overall Study|Lost to Follow-up|3|||
106043230|NCT00331864|365826432|FG000|Overall Study|Administrative Problems|1|||
106043231|NCT00331864|365826433|FG001|Overall Study|Administrative Problems|0|||
106043232|NCT00331864|365826432|FG000|Overall Study|Death|6|||
106043233|NCT00331864|365826433|FG001|Overall Study|Death|0|||
106043234|NCT00293215|365826434|FG000|Overall Study|Progressive disease|3|||
106043235|NCT00293215|365826435|FG001|Overall Study|Progressive disease|1|||
106043236|NCT00293215|365826434|FG000|Overall Study|Adverse Event|2|||
106043237|NCT00293215|365826435|FG001|Overall Study|Adverse Event|2|||
106043238|NCT05061966|365826436|FG000|Overall Study|Lost to Follow-up|13|||
106043239|NCT05061966|365826437|FG001|Overall Study|Lost to Follow-up|13|||
106043240|NCT00785928|365826440|FG000|Treatment Phase|Adverse Event|1|||
106043241|NCT00785928|365826441|FG001|Treatment Phase|Adverse Event|1|||
106043242|NCT00785928|365826442|FG002|Treatment Phase|Adverse Event|2|||
106043243|NCT00785928|365826443|FG003|Treatment Phase|Adverse Event|0|||
106043244|NCT00785928|365826444|FG004|Treatment Phase|Adverse Event|0|||
106043245|NCT00785928|365826445|FG005|Treatment Phase|Adverse Event|0|||
106043246|NCT00785928|365826446|FG006|Treatment Phase|Adverse Event|2|||
106043247|NCT00785928|365826440|FG000|Treatment Phase|Inadequate Response|0|||
106043248|NCT00785928|365826441|FG001|Treatment Phase|Inadequate Response|1|||
106043249|NCT00785928|365826442|FG002|Treatment Phase|Inadequate Response|0|||
106043250|NCT00785928|365826443|FG003|Treatment Phase|Inadequate Response|0|||
106043251|NCT00785928|365826444|FG004|Treatment Phase|Inadequate Response|0|||
106043252|NCT00785928|365826445|FG005|Treatment Phase|Inadequate Response|0|||
106043253|NCT00785928|365826446|FG006|Treatment Phase|Inadequate Response|0|||
106043254|NCT00785928|365826440|FG000|Treatment Phase|Lack of Efficacy|0|||
106043255|NCT00785928|365826441|FG001|Treatment Phase|Lack of Efficacy|1|||
106043256|NCT00785928|365826442|FG002|Treatment Phase|Lack of Efficacy|1|||
106043257|NCT00785928|365826443|FG003|Treatment Phase|Lack of Efficacy|0|||
106043258|NCT00785928|365826444|FG004|Treatment Phase|Lack of Efficacy|0|||
106043259|NCT00785928|365826445|FG005|Treatment Phase|Lack of Efficacy|0|||
106043260|NCT00785928|365826446|FG006|Treatment Phase|Lack of Efficacy|0|||
106043261|NCT00785928|365826440|FG000|Treatment Phase|Physician Decision|0|||
106043262|NCT00785928|365826441|FG001|Treatment Phase|Physician Decision|0|||
106043263|NCT00785928|365826442|FG002|Treatment Phase|Physician Decision|0|||
106043264|NCT00785928|365826443|FG003|Treatment Phase|Physician Decision|0|||
106043265|NCT00785928|365826444|FG004|Treatment Phase|Physician Decision|1|||
106043266|NCT00785928|365826445|FG005|Treatment Phase|Physician Decision|0|||
106043267|NCT00785928|365826446|FG006|Treatment Phase|Physician Decision|0|||
106043268|NCT00785928|365826440|FG000|Treatment Phase|Sponsor Decision|1|||
106043269|NCT00785928|365826441|FG001|Treatment Phase|Sponsor Decision|0|||
106043270|NCT00785928|365826442|FG002|Treatment Phase|Sponsor Decision|0|||
106043271|NCT00785928|365826443|FG003|Treatment Phase|Sponsor Decision|0|||
106043272|NCT00785928|365826444|FG004|Treatment Phase|Sponsor Decision|0|||
106043273|NCT00785928|365826445|FG005|Treatment Phase|Sponsor Decision|0|||
106043274|NCT00785928|365826446|FG006|Treatment Phase|Sponsor Decision|1|||
106043275|NCT00785928|365826440|FG000|Treatment Phase|Withdrawal by Subject|1|||
106043276|NCT00785928|365826441|FG001|Treatment Phase|Withdrawal by Subject|2|||
106043277|NCT00785928|365826442|FG002|Treatment Phase|Withdrawal by Subject|0|||
106043278|NCT00785928|365826443|FG003|Treatment Phase|Withdrawal by Subject|0|||
106043279|NCT00785928|365826444|FG004|Treatment Phase|Withdrawal by Subject|1|||
106043280|NCT00785928|365826445|FG005|Treatment Phase|Withdrawal by Subject|0|||
106043281|NCT00785928|365826446|FG006|Treatment Phase|Withdrawal by Subject|0|||
106043282|NCT02600351|365826454|FG000|Overall Study|Lack of Efficacy|3|||
106043283|NCT02600351|365826455|FG001|Overall Study|Lack of Efficacy|0|||
106043284|NCT02600351|365826456|FG002|Overall Study|Lack of Efficacy|5|||
106043285|NCT02600351|365826457|FG003|Overall Study|Lack of Efficacy|2|||
106043286|NCT02600351|365826454|FG000|Overall Study|Lost to Follow-up|1|||
106043287|NCT02600351|365826455|FG001|Overall Study|Lost to Follow-up|0|||
106043288|NCT02600351|365826456|FG002|Overall Study|Lost to Follow-up|0|||
106043289|NCT02600351|365826457|FG003|Overall Study|Lost to Follow-up|0|||
106152124|NCT03398200|366217036|FG001|Overall Study|Withdrawal by Subject|1|||
106152125|NCT03821844|366217039|FG000|Overall Study|Death|37|||
106152126|NCT03821844|366217040|FG001|Overall Study|Death|31|||
106152127|NCT03821844|366217039|FG000|Overall Study|Discharged|10|||
105862321|NCT00805467|365147947|FG000|Overall Study|Lack of Efficacy|0|||
105862322|NCT00805467|365147948|FG001|Overall Study|Lack of Efficacy|8|||
105862323|NCT00805467|365147949|FG002|Overall Study|Lack of Efficacy|13|||
105862324|NCT00805467|365147950|FG003|Overall Study|Lack of Efficacy|86|||
105862325|NCT00805467|365147947|FG000|Overall Study|Lost to Follow-up|0|||
106043290|NCT02600351|365826454|FG000|Overall Study|Randomized but Not Treated|1|||
106043291|NCT02600351|365826455|FG001|Overall Study|Randomized but Not Treated|0|||
106043292|NCT02600351|365826456|FG002|Overall Study|Randomized but Not Treated|1|||
106043293|NCT02600351|365826457|FG003|Overall Study|Randomized but Not Treated|3|||
106043294|NCT02413372|365826461|FG000|Treatment|Lost to Follow-up|0|||
106043295|NCT02413372|365826462|FG001|Treatment|Lost to Follow-up|2|||
106043296|NCT02413372|365826463|FG002|Treatment|Lost to Follow-up|1|||
106043297|NCT02413372|365826461|FG000|Treatment|Withdrawal by Subject|1|||
106043298|NCT02413372|365826462|FG001|Treatment|Withdrawal by Subject|0|||
106043299|NCT02413372|365826463|FG002|Treatment|Withdrawal by Subject|0|||
106043300|NCT02413372|365826461|FG000|Follow-up|Lost to Follow-up|1|||
106043301|NCT02413372|365826462|FG001|Follow-up|Lost to Follow-up|1|||
106152128|NCT03821844|366217040|FG001|Overall Study|Discharged|14|||
106043302|NCT02413372|365826463|FG002|Follow-up|Lost to Follow-up|0|||
106043303|NCT02413372|365826461|FG000|Follow-up|Subject Withdrew Consent|1|||
106043304|NCT02413372|365826462|FG001|Follow-up|Subject Withdrew Consent|0|||
106043305|NCT02413372|365826463|FG002|Follow-up|Subject Withdrew Consent|1|||
106043306|NCT02413372|365826461|FG000|Follow-up|Subject unable to return for visit|0|||
106043307|NCT02413372|365826462|FG001|Follow-up|Subject unable to return for visit|0|||
106043308|NCT02413372|365826463|FG002|Follow-up|Subject unable to return for visit|1|||
106043309|NCT04587271|365826465|FG000|Overall Study|Lost to Follow-up|2|||
106043310|NCT04587271|365826466|FG001|Overall Study|Lost to Follow-up|2|||
106043311|NCT04587271|365826467|FG002|Overall Study|Lost to Follow-up|0|||
106043312|NCT04587271|365826468|FG003|Overall Study|Lost to Follow-up|2|||
106043313|NCT04587271|365826469|FG004|Overall Study|Lost to Follow-up|2|||
106043314|NCT04587271|365826470|FG005|Overall Study|Lost to Follow-up|0|||
106043315|NCT04587271|365826465|FG000|Overall Study|Caregiver brought child to visits|0|||
106043316|NCT04587271|365826466|FG001|Overall Study|Caregiver brought child to visits|0|||
106043317|NCT04587271|365826467|FG002|Overall Study|Caregiver brought child to visits|0|||
106043318|NCT04587271|365826468|FG003|Overall Study|Caregiver brought child to visits|1|||
106043319|NCT04587271|365826469|FG004|Overall Study|Caregiver brought child to visits|0|||
106043320|NCT04587271|365826470|FG005|Overall Study|Caregiver brought child to visits|0|||
106043321|NCT02497612|365826472|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
106043322|NCT02497612|365826473|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
106043323|NCT02497612|365826474|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
106043324|NCT02497612|365826475|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
106043325|NCT02497612|365826472|FG000|Overall Study|Participant's request|2|||
106043326|NCT02497612|365826473|FG001|Overall Study|Participant's request|3|||
106043327|NCT02497612|365826474|FG002|Overall Study|Participant's request|4|||
106043328|NCT02497612|365826475|FG003|Overall Study|Participant's request|1|||
106152129|NCT03821844|366217039|FG000|Overall Study|Not present in facility at followup|2|||
106152130|NCT03821844|366217040|FG001|Overall Study|Not present in facility at followup|3|||
106152131|NCT02980276|366217041|FG000|Overall Study|Withdrawal by Subject|4|||
106152132|NCT02980276|366217042|FG001|Overall Study|Withdrawal by Subject|4|||
106152133|NCT02980276|366217041|FG000|Overall Study|Physician Decision|0|||
106152134|NCT02980276|366217042|FG001|Overall Study|Physician Decision|1|||
106152135|NCT02980276|366217041|FG000|Overall Study|Lost to Follow-up|18|||
106152136|NCT02980276|366217042|FG001|Overall Study|Lost to Follow-up|18|||
106152137|NCT02980276|366217041|FG000|Overall Study|Death|1|||
106152138|NCT02980276|366217042|FG001|Overall Study|Death|0|||
106152139|NCT02980276|366217041|FG000|Overall Study|Miscellaneous other|10|||
106152140|NCT02980276|366217042|FG001|Overall Study|Miscellaneous other|4|||
106152141|NCT03025789|366217052|FG000|Overall Study|Lack of Efficacy|6|||
106152142|NCT03025789|366217053|FG001|Overall Study|Lack of Efficacy|1|||
106152143|NCT03025789|366217052|FG000|Overall Study|Death|1|||
106152144|NCT03025789|366217053|FG001|Overall Study|Death|0|||
106152145|NCT03025789|366217052|FG000|Overall Study|Withdrawal by Subject|0|||
106152146|NCT03025789|366217053|FG001|Overall Study|Withdrawal by Subject|2|||
106152147|NCT03554265|366217054|FG000|Overall Study|Withdrawal by Subject|2|||
106152148|NCT03554265|366217055|FG001|Overall Study|Withdrawal by Subject|2|||
106152149|NCT03554265|366217056|FG002|Overall Study|Withdrawal by Subject|3|||
106152150|NCT03554265|366217054|FG000|Overall Study|Physician Decision|0|||
106152151|NCT03554265|366217055|FG001|Overall Study|Physician Decision|0|||
106152152|NCT03554265|366217056|FG002|Overall Study|Physician Decision|1|||
106152153|NCT02605837|366217059|FG000|Overall Study|Adverse Event|3|||
106152154|NCT02605837|366217060|FG001|Overall Study|Adverse Event|1|||
106152155|NCT02605837|366217059|FG000|Overall Study|Non-Compliance with Study Drug|0|||
106152156|NCT02605837|366217060|FG001|Overall Study|Non-Compliance with Study Drug|1|||
106152157|NCT02605837|366217059|FG000|Overall Study|Withdrawal by Subject|8|||
106152158|NCT02605837|366217060|FG001|Overall Study|Withdrawal by Subject|8|||
106152159|NCT02605837|366217059|FG000|Overall Study|Physician Decision|0|||
106152160|NCT02605837|366217060|FG001|Overall Study|Physician Decision|1|||
106152161|NCT05057897|366217062|FG000|Overall Study|Site closure|2|||
106152162|NCT05057897|366217063|FG001|Overall Study|Site closure|2|||
106152163|NCT05057897|366217062|FG000|Overall Study|Death|1|||
106152164|NCT05057897|366217063|FG001|Overall Study|Death|0|||
106152165|NCT01353313|366217064|FG000|Overall Study|Lost to Follow-up|22|||
106152166|NCT01353313|366217065|FG001|Overall Study|Lost to Follow-up|23|||
106152167|NCT01353313|366217064|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
106152168|NCT01353313|366217065|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
106152169|NCT05672667|366217066|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
106152170|NCT04524390|366217067|FG000|Double Blind|Consent Withdrawal by subject|2|||
106152171|NCT04524390|366217068|FG001|Double Blind|Consent Withdrawal by subject|1|||
106152172|NCT04524390|366217069|FG002|Double Blind|Consent Withdrawal by subject|0|||
106043329|NCT02497612|365826472|FG000|Overall Study|Investigator's judgement|1|||
106043330|NCT02497612|365826473|FG001|Overall Study|Investigator's judgement|0|||
106043331|NCT02497612|365826474|FG002|Overall Study|Investigator's judgement|0|||
106043332|NCT02497612|365826475|FG003|Overall Study|Investigator's judgement|2|||
105862326|NCT00805467|365147948|FG001|Overall Study|Lost to Follow-up|1|||
106043333|NCT02497612|365826472|FG000|Overall Study|Adverse Event|3|||
106043334|NCT02497612|365826473|FG001|Overall Study|Adverse Event|1|||
106043335|NCT02497612|365826474|FG002|Overall Study|Adverse Event|4|||
106043336|NCT02497612|365826475|FG003|Overall Study|Adverse Event|1|||
106043337|NCT02497612|365826472|FG000|Overall Study|Lost to Follow-up|1|||
106043338|NCT02497612|365826473|FG001|Overall Study|Lost to Follow-up|1|||
106043339|NCT02497612|365826474|FG002|Overall Study|Lost to Follow-up|0|||
106043340|NCT02497612|365826475|FG003|Overall Study|Lost to Follow-up|1|||
106043341|NCT02497612|365826472|FG000|Overall Study|Other unspecified|1|||
106043342|NCT02497612|365826473|FG001|Overall Study|Other unspecified|1|||
106043343|NCT02497612|365826474|FG002|Overall Study|Other unspecified|2|||
106043344|NCT02497612|365826475|FG003|Overall Study|Other unspecified|0|||
106043345|NCT02497612|365826472|FG000|Overall Study|Not eligible|1|||
106043346|NCT02497612|365826473|FG001|Overall Study|Not eligible|0|||
106043347|NCT02497612|365826474|FG002|Overall Study|Not eligible|0|||
106043348|NCT02497612|365826475|FG003|Overall Study|Not eligible|1|||
106043349|NCT00611533|365826476|FG000|First Intervention (6 Weeks)|Never started study|0|||
106043350|NCT00611533|365826477|FG001|First Intervention (6 Weeks)|Never started study|1|||
106043351|NCT00611533|365826476|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
106043352|NCT00611533|365826477|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
106043353|NCT00611533|365826476|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
106043354|NCT00611533|365826477|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
106043355|NCT03270644|365826484|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
106043356|NCT03270644|365826484|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
106043357|NCT00191906|365826485|FG000|Study Period II|Adverse Event|0|||
106043358|NCT00191906|365826486|FG001|Study Period II|Adverse Event|1|||
106043359|NCT00191906|365826487|FG002|Study Period II|Adverse Event|0|||
106043360|NCT00191906|365826488|FG003|Study Period II|Adverse Event|0|||
106043361|NCT00191906|365826485|FG000|Study Period II|Withdrawal by Subject|0|||
106043362|NCT00191906|365826486|FG001|Study Period II|Withdrawal by Subject|3|||
106043363|NCT00191906|365826487|FG002|Study Period II|Withdrawal by Subject|0|||
106043364|NCT00191906|365826488|FG003|Study Period II|Withdrawal by Subject|0|||
106043365|NCT00191906|365826485|FG000|Study Period II|Parent/Caregiver Decision|0|||
106043366|NCT00191906|365826486|FG001|Study Period II|Parent/Caregiver Decision|1|||
106043367|NCT00191906|365826487|FG002|Study Period II|Parent/Caregiver Decision|0|||
106043368|NCT00191906|365826488|FG003|Study Period II|Parent/Caregiver Decision|0|||
106043369|NCT00191906|365826485|FG000|Study Period II|Entry Criteria Exclusion|0|||
106043370|NCT00191906|365826486|FG001|Study Period II|Entry Criteria Exclusion|0|||
106043371|NCT00191906|365826487|FG002|Study Period II|Entry Criteria Exclusion|1|||
106043372|NCT00191906|365826488|FG003|Study Period II|Entry Criteria Exclusion|0|||
106043373|NCT00191906|365826485|FG000|Study Period III|Adverse Event|1|||
106043374|NCT00191906|365826486|FG001|Study Period III|Adverse Event|0|||
106043375|NCT00191906|365826487|FG002|Study Period III|Adverse Event|0|||
106043376|NCT00191906|365826488|FG003|Study Period III|Adverse Event|0|||
106043377|NCT00191906|365826485|FG000|Study Period III|Lost to Follow-up|0|||
106152173|NCT04524390|366217067|FG000|Double Blind|Adverse Event|5|||
106152174|NCT04524390|366217068|FG001|Double Blind|Adverse Event|3|||
106152175|NCT04524390|366217069|FG002|Double Blind|Adverse Event|0|||
106152176|NCT04524390|366217067|FG000|Double Blind|Liver Transplant|5|||
106152177|NCT04524390|366217068|FG001|Double Blind|Liver Transplant|6|||
106152178|NCT04524390|366217069|FG002|Double Blind|Liver Transplant|0|||
106152179|NCT04524390|366217067|FG000|Double Blind|Disease Progression|0|||
106152180|NCT04524390|366217068|FG001|Double Blind|Disease Progression|1|||
106152181|NCT04524390|366217069|FG002|Double Blind|Disease Progression|0|||
106152182|NCT04524390|366217067|FG000|Open-Label|Drug interruption criteria|0|||
106152183|NCT04524390|366217068|FG001|Open-Label|Drug interruption criteria|0|||
106152184|NCT04524390|366217069|FG002|Open-Label|Drug interruption criteria|1|||
106152185|NCT04524390|366217067|FG000|Open-Label|Liver Transplant|0|||
106152186|NCT04524390|366217068|FG001|Open-Label|Liver Transplant|0|||
106152187|NCT04524390|366217069|FG002|Open-Label|Liver Transplant|1|||
106152188|NCT04524390|366217067|FG000|Open-Label|Disease Progression|0|||
106152189|NCT04524390|366217068|FG001|Open-Label|Disease Progression|0|||
106152190|NCT04524390|366217069|FG002|Open-Label|Disease Progression|1|||
106152191|NCT04524390|366217067|FG000|Open-Label|Adverse Event|0|||
106152192|NCT04524390|366217068|FG001|Open-Label|Adverse Event|0|||
106152193|NCT04524390|366217069|FG002|Open-Label|Adverse Event|3|||
106152194|NCT04524390|366217067|FG000|Open-Label|Study Termination by sponsor|0|||
106043378|NCT00191906|365826486|FG001|Study Period III|Lost to Follow-up|1|||
106043379|NCT00191906|365826487|FG002|Study Period III|Lost to Follow-up|0|||
106043380|NCT00191906|365826488|FG003|Study Period III|Lost to Follow-up|0|||
106043381|NCT00191906|365826485|FG000|Study Period III|Parent/Caregiver Decision|1|||
106043382|NCT00191906|365826486|FG001|Study Period III|Parent/Caregiver Decision|0|||
106043383|NCT00191906|365826487|FG002|Study Period III|Parent/Caregiver Decision|0|||
106043384|NCT00191906|365826488|FG003|Study Period III|Parent/Caregiver Decision|0|||
106043385|NCT00191906|365826485|FG000|Study Period III|Lack of Efficacy|3|||
106043386|NCT00191906|365826486|FG001|Study Period III|Lack of Efficacy|3|||
106152195|NCT04524390|366217068|FG001|Open-Label|Study Termination by sponsor|0|||
106043387|NCT00191906|365826487|FG002|Study Period III|Lack of Efficacy|0|||
106043388|NCT00191906|365826488|FG003|Study Period III|Lack of Efficacy|0|||
106043389|NCT00333801|365826489|FG000|Overall Study|Moved to another state|5|||
106043390|NCT00333801|365826490|FG001|Overall Study|Moved to another state|3|||
106043391|NCT00333801|365826489|FG000|Overall Study|Lost to Follow-up|2|||
106043392|NCT00333801|365826490|FG001|Overall Study|Lost to Follow-up|0|||
106043393|NCT00333801|365826489|FG000|Overall Study|Incarcerated|1|||
106043394|NCT00333801|365826490|FG001|Overall Study|Incarcerated|2|||
106043395|NCT00333801|365826489|FG000|Overall Study|Withdrawal by Subject|0|||
106043396|NCT00333801|365826490|FG001|Overall Study|Withdrawal by Subject|1|||
106043397|NCT00809354|365826491|FG000|Overall Study|Adverse Event|32|||
106043398|NCT00809354|365826492|FG001|Overall Study|Adverse Event|45|||
106043399|NCT00809354|365826493|FG002|Overall Study|Adverse Event|37|||
106043400|NCT00809354|365826494|FG003|Overall Study|Adverse Event|53|||
106043401|NCT00809354|365826495|FG004|Overall Study|Adverse Event|26|||
106043402|NCT00809354|365826496|FG005|Overall Study|Adverse Event|33|||
106043403|NCT00809354|365826497|FG006|Overall Study|Adverse Event|44|||
106043404|NCT00809354|365826498|FG007|Overall Study|Adverse Event|40|||
106043405|NCT00809354|365826499|FG008|Overall Study|Adverse Event|46|||
106043406|NCT00809354|365826500|FG009|Overall Study|Adverse Event|26|||
106043407|NCT00809354|365826491|FG000|Overall Study|Lack of Efficacy|23|||
106043408|NCT00809354|365826492|FG001|Overall Study|Lack of Efficacy|23|||
106043409|NCT00809354|365826493|FG002|Overall Study|Lack of Efficacy|22|||
106043410|NCT00809354|365826494|FG003|Overall Study|Lack of Efficacy|15|||
106043411|NCT00809354|365826495|FG004|Overall Study|Lack of Efficacy|40|||
106043412|NCT00809354|365826496|FG005|Overall Study|Lack of Efficacy|19|||
106043413|NCT00809354|365826497|FG006|Overall Study|Lack of Efficacy|21|||
106043414|NCT00809354|365826498|FG007|Overall Study|Lack of Efficacy|15|||
106043415|NCT00809354|365826499|FG008|Overall Study|Lack of Efficacy|18|||
106043416|NCT00809354|365826500|FG009|Overall Study|Lack of Efficacy|38|||
106043417|NCT00809354|365826491|FG000|Overall Study|Lost to Follow-up|10|||
106043418|NCT00809354|365826492|FG001|Overall Study|Lost to Follow-up|11|||
106043419|NCT00809354|365826493|FG002|Overall Study|Lost to Follow-up|8|||
106043420|NCT00809354|365826494|FG003|Overall Study|Lost to Follow-up|13|||
106043421|NCT00809354|365826495|FG004|Overall Study|Lost to Follow-up|6|||
106043422|NCT00809354|365826496|FG005|Overall Study|Lost to Follow-up|2|||
106043423|NCT00809354|365826497|FG006|Overall Study|Lost to Follow-up|0|||
106043424|NCT00809354|365826498|FG007|Overall Study|Lost to Follow-up|5|||
106043425|NCT00809354|365826499|FG008|Overall Study|Lost to Follow-up|4|||
106043426|NCT00809354|365826500|FG009|Overall Study|Lost to Follow-up|0|||
106043427|NCT00809354|365826491|FG000|Overall Study|Protocol Violation|7|||
106043428|NCT00809354|365826492|FG001|Overall Study|Protocol Violation|14|||
106043429|NCT00809354|365826493|FG002|Overall Study|Protocol Violation|14|||
106043430|NCT00809354|365826494|FG003|Overall Study|Protocol Violation|12|||
106043431|NCT00809354|365826495|FG004|Overall Study|Protocol Violation|14|||
106043432|NCT00809354|365826496|FG005|Overall Study|Protocol Violation|6|||
106043433|NCT00809354|365826497|FG006|Overall Study|Protocol Violation|4|||
106043434|NCT00809354|365826498|FG007|Overall Study|Protocol Violation|6|||
106043435|NCT00809354|365826499|FG008|Overall Study|Protocol Violation|9|||
106043436|NCT00809354|365826500|FG009|Overall Study|Protocol Violation|3|||
106043437|NCT00809354|365826491|FG000|Overall Study|Withdrawal by Subject|32|||
106043438|NCT00809354|365826492|FG001|Overall Study|Withdrawal by Subject|27|||
106043439|NCT00809354|365826493|FG002|Overall Study|Withdrawal by Subject|31|||
106043440|NCT00809354|365826494|FG003|Overall Study|Withdrawal by Subject|33|||
106043441|NCT00809354|365826495|FG004|Overall Study|Withdrawal by Subject|34|||
106043442|NCT00809354|365826496|FG005|Overall Study|Withdrawal by Subject|29|||
106043443|NCT00809354|365826497|FG006|Overall Study|Withdrawal by Subject|27|||
106043444|NCT00809354|365826498|FG007|Overall Study|Withdrawal by Subject|19|||
106043445|NCT00809354|365826499|FG008|Overall Study|Withdrawal by Subject|18|||
106043446|NCT00809354|365826500|FG009|Overall Study|Withdrawal by Subject|20|||
106043447|NCT00809354|365826491|FG000|Overall Study|Other|10|||
106043448|NCT00809354|365826492|FG001|Overall Study|Other|2|||
106152196|NCT04524390|366217069|FG002|Open-Label|Study Termination by sponsor|45|||
106152197|NCT02837510|366217070|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
106152198|NCT02837510|366217071|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
106152199|NCT02837510|366217070|FG000|Washout (2 Weeks)|Adverse Event|0|||
106152200|NCT02837510|366217071|FG001|Washout (2 Weeks)|Adverse Event|1|||
106043449|NCT00809354|365826493|FG002|Overall Study|Other|7|||
106043450|NCT00809354|365826494|FG003|Overall Study|Other|10|||
106043451|NCT00809354|365826495|FG004|Overall Study|Other|5|||
106043452|NCT00809354|365826496|FG005|Overall Study|Other|3|||
106043453|NCT00809354|365826497|FG006|Overall Study|Other|2|||
106043454|NCT00809354|365826498|FG007|Overall Study|Other|3|||
106043455|NCT00809354|365826499|FG008|Overall Study|Other|4|||
106043456|NCT00809354|365826500|FG009|Overall Study|Other|3|||
106043457|NCT00809354|365826491|FG000|Overall Study|Study terminated by sponsor|138|||
106043458|NCT00809354|365826492|FG001|Overall Study|Study terminated by sponsor|134|||
106043459|NCT00809354|365826493|FG002|Overall Study|Study terminated by sponsor|129|||
106043460|NCT00809354|365826494|FG003|Overall Study|Study terminated by sponsor|120|||
106043461|NCT00809354|365826495|FG004|Overall Study|Study terminated by sponsor|126|||
106043462|NCT00809354|365826496|FG005|Overall Study|Study terminated by sponsor|133|||
106043463|NCT00809354|365826497|FG006|Overall Study|Study terminated by sponsor|124|||
106043464|NCT00809354|365826498|FG007|Overall Study|Study terminated by sponsor|148|||
106043465|NCT00809354|365826499|FG008|Overall Study|Study terminated by sponsor|127|||
106043466|NCT00809354|365826500|FG009|Overall Study|Study terminated by sponsor|135|||
106043467|NCT00809354|365826491|FG000|Overall Study|Withdrawn due to pregnancy|0|||
106043468|NCT00809354|365826492|FG001|Overall Study|Withdrawn due to pregnancy|1|||
106043469|NCT00809354|365826493|FG002|Overall Study|Withdrawn due to pregnancy|0|||
106043470|NCT00809354|365826494|FG003|Overall Study|Withdrawn due to pregnancy|0|||
106043471|NCT00809354|365826495|FG004|Overall Study|Withdrawn due to pregnancy|0|||
106043472|NCT00809354|365826496|FG005|Overall Study|Withdrawn due to pregnancy|0|||
106043473|NCT00809354|365826497|FG006|Overall Study|Withdrawn due to pregnancy|0|||
106043474|NCT00809354|365826498|FG007|Overall Study|Withdrawn due to pregnancy|0|||
106043475|NCT00809354|365826499|FG008|Overall Study|Withdrawn due to pregnancy|0|||
106043476|NCT00809354|365826500|FG009|Overall Study|Withdrawn due to pregnancy|0|||
106043477|NCT00809354|365826491|FG000|Overall Study|Randomized but not Treated|3|||
106043478|NCT00809354|365826492|FG001|Overall Study|Randomized but not Treated|1|||
106043479|NCT00809354|365826493|FG002|Overall Study|Randomized but not Treated|6|||
106043480|NCT00809354|365826494|FG003|Overall Study|Randomized but not Treated|0|||
106043481|NCT00809354|365826495|FG004|Overall Study|Randomized but not Treated|5|||
106043482|NCT00809354|365826496|FG005|Overall Study|Randomized but not Treated|0|||
106043483|NCT00809354|365826497|FG006|Overall Study|Randomized but not Treated|1|||
106043484|NCT00809354|365826498|FG007|Overall Study|Randomized but not Treated|1|||
106043485|NCT00809354|365826499|FG008|Overall Study|Randomized but not Treated|2|||
106043486|NCT00809354|365826500|FG009|Overall Study|Randomized but not Treated|1|||
106043487|NCT00809354|365826491|FG000|Overall Study|Death|0|||
106043488|NCT00809354|365826492|FG001|Overall Study|Death|0|||
106043489|NCT00809354|365826493|FG002|Overall Study|Death|0|||
106043490|NCT00809354|365826494|FG003|Overall Study|Death|0|||
106043491|NCT00809354|365826495|FG004|Overall Study|Death|0|||
106043492|NCT00809354|365826496|FG005|Overall Study|Death|0|||
106043493|NCT00809354|365826497|FG006|Overall Study|Death|0|||
106043494|NCT00809354|365826498|FG007|Overall Study|Death|1|||
106043495|NCT00809354|365826499|FG008|Overall Study|Death|0|||
106043496|NCT00809354|365826500|FG009|Overall Study|Death|0|||
106043497|NCT01332331|365826510|FG000|Overall Study|Lost to Follow-up|0|||
106043498|NCT01332331|365826511|FG001|Overall Study|Lost to Follow-up|1|||
106043499|NCT01332331|365826510|FG000|Overall Study|Adverse Event|1|||
106043500|NCT01332331|365826511|FG001|Overall Study|Adverse Event|1|||
106043501|NCT01332331|365826510|FG000|Overall Study|Physician Decision|1|||
106043502|NCT01332331|365826511|FG001|Overall Study|Physician Decision|0|||
106043503|NCT01123850|365826512|FG000|Overall Study|Slow enrollment|45|||
106043504|NCT01460368|365826520|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
106043505|NCT01460368|365826521|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
106043506|NCT01460368|365826522|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
106043507|NCT01460368|365826523|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
106043508|NCT01460368|365826524|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
106043509|NCT01460368|365826525|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
106043510|NCT01460368|365826526|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
106043511|NCT01460368|365826520|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
106043512|NCT01460368|365826521|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
106043513|NCT01460368|365826522|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
106043514|NCT01460368|365826523|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
106043515|NCT01460368|365826524|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
106043516|NCT01460368|365826525|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
106043517|NCT01460368|365826526|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
106043518|NCT01460368|365826520|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
106043519|NCT01460368|365826521|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
106043520|NCT01460368|365826522|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
106043521|NCT01460368|365826523|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
106043522|NCT01460368|365826524|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
106043523|NCT01460368|365826525|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
106043524|NCT01460368|365826526|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
106043525|NCT01460368|365826520|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
106043526|NCT01460368|365826521|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
106043527|NCT01460368|365826522|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
106043528|NCT01460368|365826523|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
106043529|NCT01460368|365826524|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
106043530|NCT01460368|365826525|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
106043531|NCT01460368|365826526|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
106043532|NCT01460368|365826520|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
106043533|NCT01460368|365826521|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
106043534|NCT01460368|365826522|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
106043535|NCT01460368|365826523|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
106043536|NCT01460368|365826524|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
106043537|NCT01460368|365826525|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
106043538|NCT01460368|365826526|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
106043539|NCT00973674|365826527|FG000|Overall Study|Protocol Violation|2|||
106043540|NCT00973674|365826528|FG001|Overall Study|Protocol Violation|0|||
106043541|NCT00747461|365826535|FG000|Overall Study|study terminated by sponsor|5|||
106043542|NCT01934972|365826536|FG000|Overall Study|Withdrawal by Subject|9|||
106043543|NCT01934972|365826537|FG001|Overall Study|Withdrawal by Subject|6|||
106043544|NCT02770170|365826539|FG000|Overall Study|Withdrawal by Subject|0|||
106043545|NCT02770170|365826540|FG001|Overall Study|Withdrawal by Subject|0|||
106043546|NCT02770170|365826541|FG002|Overall Study|Withdrawal by Subject|0|||
106043547|NCT02770170|365826542|FG003|Overall Study|Withdrawal by Subject|2|||
106043548|NCT02770170|365826539|FG000|Overall Study|due to pregnancy|1|||
106043549|NCT02770170|365826540|FG001|Overall Study|due to pregnancy|0|||
106043550|NCT02770170|365826541|FG002|Overall Study|due to pregnancy|0|||
106043551|NCT02770170|365826542|FG003|Overall Study|due to pregnancy|0|||
106043552|NCT02770170|365826539|FG000|Overall Study|Lack of Efficacy|2|||
106043553|NCT02770170|365826540|FG001|Overall Study|Lack of Efficacy|0|||
106043554|NCT02770170|365826541|FG002|Overall Study|Lack of Efficacy|0|||
106043555|NCT02770170|365826542|FG003|Overall Study|Lack of Efficacy|1|||
106043556|NCT02770170|365826539|FG000|Overall Study|Adverse Event|4|||
106043557|NCT02770170|365826540|FG001|Overall Study|Adverse Event|3|||
106043558|NCT02770170|365826541|FG002|Overall Study|Adverse Event|5|||
106043559|NCT02770170|365826542|FG003|Overall Study|Adverse Event|3|||
106043560|NCT02770170|365826539|FG000|Overall Study|due to disease worsening|0|||
106043561|NCT02770170|365826540|FG001|Overall Study|due to disease worsening|0|||
106043562|NCT02770170|365826541|FG002|Overall Study|due to disease worsening|0|||
106043563|NCT02770170|365826542|FG003|Overall Study|due to disease worsening|1|||
106043564|NCT01710046|365826543|FG000|Overall Study|Lost to Follow-up|1|||
106043565|NCT01710046|365826544|FG001|Overall Study|Lost to Follow-up|0|||
106043566|NCT02030938|365826545|FG000|Overall Study|Lost to Follow-up|4|||
106043567|NCT02030938|365826545|FG000|Overall Study|Withdrawal by Subject|1|||
106043568|NCT03954132|365826546|FG000|Overall Study|Adverse Event|2|||
106043569|NCT03954132|365826547|FG001|Overall Study|Adverse Event|0|||
106043570|NCT03954132|365826546|FG000|Overall Study|Patient's wish|5|||
106043571|NCT03954132|365826547|FG001|Overall Study|Patient's wish|0|||
106043572|NCT03954132|365826546|FG000|Overall Study|Lost to Follow-up|10|||
106043573|NCT03954132|365826547|FG001|Overall Study|Lost to Follow-up|0|||
106043574|NCT03954132|365826546|FG000|Overall Study|Screening failure|0|||
106043575|NCT03954132|365826547|FG001|Overall Study|Screening failure|1|||
106043576|NCT03954132|365826546|FG000|Overall Study|No registration after Visit 1|5|||
106043577|NCT03954132|365826547|FG001|Overall Study|No registration after Visit 1|2|||
106043578|NCT03954132|365826546|FG000|Overall Study|Other reason than listed|2|||
106043579|NCT03954132|365826547|FG001|Overall Study|Other reason than listed|2|||
106043580|NCT03954132|365826546|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
106043581|NCT03954132|365826547|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
106043582|NCT03954132|365826546|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
106043583|NCT03954132|365826547|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
106043584|NCT04128371|365826550|FG000|Overall Study|Lack of Efficacy|1|||
106043585|NCT01346969|365826551|FG000|Overall Study|Withdrawal by Subject|0|||
106043586|NCT01346969|365826552|FG001|Overall Study|Withdrawal by Subject|0|||
106043587|NCT01346969|365826553|FG002|Overall Study|Withdrawal by Subject|1|||
106043588|NCT01346969|365826554|FG003|Overall Study|Withdrawal by Subject|0|||
106043589|NCT01346969|365826551|FG000|Overall Study|Lost to Follow-up|1|||
106043590|NCT01346969|365826552|FG001|Overall Study|Lost to Follow-up|0|||
106043591|NCT01346969|365826553|FG002|Overall Study|Lost to Follow-up|2|||
106152201|NCT02837510|366217070|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
106152202|NCT02837510|366217071|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
106152203|NCT02837510|366217070|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
106043592|NCT01346969|365826554|FG003|Overall Study|Lost to Follow-up|0|||
106043593|NCT01346969|365826551|FG000|Overall Study|Physician Decision|0|||
106043594|NCT01346969|365826552|FG001|Overall Study|Physician Decision|0|||
106043595|NCT01346969|365826553|FG002|Overall Study|Physician Decision|0|||
106043596|NCT01346969|365826554|FG003|Overall Study|Physician Decision|1|||
106043597|NCT01346969|365826551|FG000|Overall Study|Randomized but not treated|1|||
106043598|NCT01346969|365826552|FG001|Overall Study|Randomized but not treated|0|||
106043599|NCT01346969|365826553|FG002|Overall Study|Randomized but not treated|0|||
106043600|NCT01346969|365826554|FG003|Overall Study|Randomized but not treated|0|||
106043601|NCT01686828|365826559|FG000|Overall Study|Physician Decision|1|||
106043602|NCT01686828|365826560|FG001|Overall Study|Physician Decision|0|||
106043603|NCT01686828|365826561|FG002|Overall Study|Physician Decision|0|||
106043604|NCT01686828|365826562|FG003|Overall Study|Physician Decision|0|||
106043605|NCT01686828|365826559|FG000|Overall Study|New Job|0|||
106043606|NCT01686828|365826560|FG001|Overall Study|New Job|1|||
106043607|NCT01686828|365826561|FG002|Overall Study|New Job|0|||
106043608|NCT01686828|365826562|FG003|Overall Study|New Job|0|||
106043609|NCT01686828|365826559|FG000|Overall Study|Weight Loss|0|||
106043610|NCT01686828|365826560|FG001|Overall Study|Weight Loss|0|||
106043611|NCT01686828|365826561|FG002|Overall Study|Weight Loss|1|||
106043612|NCT01686828|365826562|FG003|Overall Study|Weight Loss|0|||
106043613|NCT01558739|365826565|FG000|Overall Study|Adverse Event|7|||
106043614|NCT01558739|365826565|FG000|Overall Study|Withdrawal by Subject|2|||
106043615|NCT01558739|365826565|FG000|Overall Study|Death|3|||
106043616|NCT01558739|365826565|FG000|Overall Study|Disease Progression|4|||
106043617|NCT01558739|365826565|FG000|Overall Study|Protocol Violation|1|||
106043618|NCT03698331|365826568|FG000|Overall Study|Adverse Event|2|||
106043619|NCT03698331|365826569|FG001|Overall Study|Adverse Event|3|||
106043620|NCT03698331|365826568|FG000|Overall Study|Withdrawal by Subject|1|||
106043621|NCT03698331|365826569|FG001|Overall Study|Withdrawal by Subject|1|||
106043622|NCT03698331|365826568|FG000|Overall Study|Lost to Follow-up|0|||
106043623|NCT03698331|365826569|FG001|Overall Study|Lost to Follow-up|2|||
106043624|NCT03698331|365826568|FG000|Overall Study|Non-compliance with study drug|1|||
106043625|NCT03698331|365826569|FG001|Overall Study|Non-compliance with study drug|0|||
106043626|NCT02130024|365826572|FG000|Overall Study|Adverse Event|10|||
106043627|NCT02130024|365826573|FG001|Overall Study|Adverse Event|11|||
106043628|NCT02130024|365826572|FG000|Overall Study|Death|2|||
106043629|NCT02130024|365826573|FG001|Overall Study|Death|2|||
106043630|NCT02130024|365826572|FG000|Overall Study|Lost to Follow-up|1|||
106043631|NCT02130024|365826573|FG001|Overall Study|Lost to Follow-up|1|||
106043632|NCT02130024|365826572|FG000|Overall Study|Physician Decision|1|||
106043633|NCT02130024|365826573|FG001|Overall Study|Physician Decision|3|||
106043634|NCT02130024|365826572|FG000|Overall Study|Protocol Deviation|4|||
106043635|NCT02130024|365826573|FG001|Overall Study|Protocol Deviation|0|||
106043636|NCT02130024|365826572|FG000|Overall Study|Site Administration Problems|1|||
106043637|NCT02130024|365826573|FG001|Overall Study|Site Administration Problems|0|||
106043638|NCT02130024|365826572|FG000|Overall Study|Subject Withdrew Consent|6|||
106043639|NCT02130024|365826573|FG001|Overall Study|Subject Withdrew Consent|14|||
106043640|NCT01467583|365826574|FG000|Overall Study|Death|1|||
106043641|NCT01467583|365826575|FG001|Overall Study|Death|1|||
106043642|NCT01467583|365826576|FG002|Overall Study|Death|0|||
106043643|NCT01467583|365826574|FG000|Overall Study|Withdrawal by Subject|1|||
106043644|NCT01467583|365826575|FG001|Overall Study|Withdrawal by Subject|0|||
106043645|NCT01467583|365826576|FG002|Overall Study|Withdrawal by Subject|0|||
106043646|NCT01467583|365826574|FG000|Overall Study|Protocol Violation|0|||
106043647|NCT01467583|365826575|FG001|Overall Study|Protocol Violation|0|||
106043648|NCT01467583|365826576|FG002|Overall Study|Protocol Violation|2|||
106043649|NCT05274165|365826579|FG000|Overall Study|Withdrawal by Subject|3|||
106043650|NCT05274165|365826580|FG001|Overall Study|Withdrawal by Subject|3|||
106043651|NCT02484690|365826582|FG000|Overall Study|Adverse Event|1|||
106043652|NCT02484690|365826583|FG001|Overall Study|Adverse Event|3|||
106043653|NCT02484690|365826584|FG002|Overall Study|Adverse Event|0|||
106152204|NCT02837510|366217071|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
106152205|NCT02837510|366217070|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
106152206|NCT02837510|366217071|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
106152207|NCT02837510|366217070|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
106152208|NCT02837510|366217071|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
106043654|NCT02484690|365826585|FG003|Overall Study|Adverse Event|0|||
106043655|NCT02484690|365826586|FG004|Overall Study|Adverse Event|5|||
106043656|NCT02484690|365826582|FG000|Overall Study|Death|0|||
106043657|NCT02484690|365826583|FG001|Overall Study|Death|0|||
106043658|NCT02484690|365826584|FG002|Overall Study|Death|0|||
106043659|NCT02484690|365826585|FG003|Overall Study|Death|0|||
106043660|NCT02484690|365826586|FG004|Overall Study|Death|1|||
106043661|NCT02484690|365826582|FG000|Overall Study|Withdrawal by Subject|1|||
106043662|NCT02484690|365826583|FG001|Overall Study|Withdrawal by Subject|3|||
106043663|NCT02484690|365826584|FG002|Overall Study|Withdrawal by Subject|1|||
106043664|NCT02484690|365826585|FG003|Overall Study|Withdrawal by Subject|2|||
106043665|NCT02484690|365826586|FG004|Overall Study|Withdrawal by Subject|0|||
106043666|NCT02484690|365826582|FG000|Overall Study|Physician Decision|2|||
106043667|NCT02484690|365826583|FG001|Overall Study|Physician Decision|0|||
106043668|NCT02484690|365826584|FG002|Overall Study|Physician Decision|1|||
106043669|NCT02484690|365826585|FG003|Overall Study|Physician Decision|0|||
106043670|NCT02484690|365826586|FG004|Overall Study|Physician Decision|0|||
106043671|NCT02484690|365826582|FG000|Overall Study|Lost to Follow-up|0|||
106043672|NCT02484690|365826583|FG001|Overall Study|Lost to Follow-up|0|||
106043673|NCT02484690|365826584|FG002|Overall Study|Lost to Follow-up|1|||
106043674|NCT02484690|365826585|FG003|Overall Study|Lost to Follow-up|0|||
106043675|NCT02484690|365826586|FG004|Overall Study|Lost to Follow-up|0|||
106043676|NCT00589290|365826601|FG000|Overall Study|Withdrawal by Subject|1|||
106043677|NCT00976677|365826602|FG000|Overall Study|Adverse Event|1|||
106043678|NCT00976677|365826603|FG001|Overall Study|Adverse Event|0|||
106043679|NCT00976677|365826602|FG000|Overall Study|Withdrawal by Subject|0|||
106043680|NCT00976677|365826603|FG001|Overall Study|Withdrawal by Subject|2|||
106043681|NCT00976677|365826602|FG000|Overall Study|Disease progression|1|||
106043682|NCT00976677|365826603|FG001|Overall Study|Disease progression|1|||
106043683|NCT00976677|365826602|FG000|Overall Study|Trial unblinded|2|||
106043684|NCT00976677|365826603|FG001|Overall Study|Trial unblinded|2|||
106043685|NCT00976677|365826602|FG000|Overall Study|Unknown/Missing|1|||
106043686|NCT00976677|365826603|FG001|Overall Study|Unknown/Missing|0|||
106043687|NCT01555983|365826604|FG000|Overall Study|Withdrawal by Subject|1|||
106043688|NCT01555983|365826605|FG001|Overall Study|Withdrawal by Subject|0|||
106043689|NCT01555983|365826606|FG002|Overall Study|Withdrawal by Subject|0|||
106043690|NCT01555983|365826607|FG003|Overall Study|Withdrawal by Subject|0|||
106043691|NCT01555983|365826608|FG004|Overall Study|Withdrawal by Subject|1|||
106043692|NCT01555983|365826609|FG005|Overall Study|Withdrawal by Subject|1|||
106043693|NCT05246397|365828205|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
106043694|NCT00004635|365828210|FG000|Period One|refused|2|||
106043695|NCT00004635|365828211|FG001|Period One|refused|1|||
106043696|NCT00004635|365828210|FG000|Period One|Withdrawal by Subject|1|||
106043697|NCT00004635|365828211|FG001|Period One|Withdrawal by Subject|1|||
106043698|NCT00004635|365828210|FG000|Period One|Protocol Violation|1|||
106043699|NCT00004635|365828211|FG001|Period One|Protocol Violation|0|||
106043700|NCT00004635|365828210|FG000|Period One|PSA did not go <5 ng/mL|1|||
106043701|NCT00004635|365828211|FG001|Period One|PSA did not go <5 ng/mL|0|||
106043702|NCT00004635|365828210|FG000|Period One|second malignancy|1|||
106043703|NCT00004635|365828211|FG001|Period One|second malignancy|0|||
106043704|NCT00004635|365828210|FG000|Period One|progressed|0|||
106043705|NCT00004635|365828211|FG001|Period One|progressed|2|||
106043706|NCT00004635|365828210|FG000|Period One|health problem|0|||
106043707|NCT00004635|365828211|FG001|Period One|health problem|1|||
106043708|NCT00004635|365828210|FG000|Period One|discrepancy in data entry|0|||
106043709|NCT00004635|365828211|FG001|Period One|discrepancy in data entry|1|||
106043710|NCT00004635|365828210|FG000|Period Two|progression|2|||
106043711|NCT00004635|365828211|FG001|Period Two|progression|3|||
106043712|NCT00004635|365828210|FG000|Period Two|Adverse Event|1|||
106043713|NCT00004635|365828211|FG001|Period Two|Adverse Event|0|||
106043714|NCT00004635|365828210|FG000|Period Two|refused|0|||
106043715|NCT00004635|365828211|FG001|Period Two|refused|2|||
106043716|NCT00004635|365828210|FG000|Period Two|health problem|1|||
106043717|NCT00004635|365828211|FG001|Period Two|health problem|1|||
106043718|NCT00004635|365828210|FG000|Period Two|travel issues|0|||
106043719|NCT00004635|365828211|FG001|Period Two|travel issues|1|||
106043720|NCT00004635|365828210|FG000|Period Two|secondary malignancy|1|||
106043721|NCT00004635|365828211|FG001|Period Two|secondary malignancy|1|||
106043722|NCT00004635|365828210|FG000|Period Two|Lost to Follow-up|1|||
106043723|NCT00004635|365828211|FG001|Period Two|Lost to Follow-up|0|||
106043724|NCT00004635|365828210|FG000|Period Two|discrepancy in data entry|0|||
106043725|NCT00004635|365828211|FG001|Period Two|discrepancy in data entry|1|||
106043726|NCT00723398|365828212|FG000|Overall Study|Withdrawal by Subject|2|||
106043727|NCT00723398|365828213|FG001|Overall Study|Withdrawal by Subject|6|||
106043728|NCT00723398|365828214|FG002|Overall Study|Withdrawal by Subject|4|||
106043729|NCT00723398|365828215|FG003|Overall Study|Withdrawal by Subject|4|||
106043730|NCT00723398|365828216|FG004|Overall Study|Withdrawal by Subject|4|||
106043731|NCT00723398|365828212|FG000|Overall Study|Protocol Violation|2|||
106043732|NCT00723398|365828213|FG001|Overall Study|Protocol Violation|1|||
106043733|NCT00723398|365828214|FG002|Overall Study|Protocol Violation|5|||
106043734|NCT00723398|365828215|FG003|Overall Study|Protocol Violation|0|||
106043735|NCT00723398|365828216|FG004|Overall Study|Protocol Violation|0|||
106043736|NCT00723398|365828212|FG000|Overall Study|Physician Decision|2|||
106043737|NCT00723398|365828213|FG001|Overall Study|Physician Decision|2|||
106043738|NCT00723398|365828214|FG002|Overall Study|Physician Decision|5|||
106043739|NCT00723398|365828215|FG003|Overall Study|Physician Decision|0|||
106043740|NCT00723398|365828216|FG004|Overall Study|Physician Decision|1|||
106043741|NCT00723398|365828212|FG000|Overall Study|Adverse Event|0|||
106043742|NCT00723398|365828213|FG001|Overall Study|Adverse Event|5|||
106043743|NCT00723398|365828214|FG002|Overall Study|Adverse Event|3|||
106043744|NCT00723398|365828215|FG003|Overall Study|Adverse Event|1|||
106043745|NCT00723398|365828216|FG004|Overall Study|Adverse Event|4|||
106043746|NCT00723398|365828212|FG000|Overall Study|Lost to Follow-up|0|||
106043747|NCT00723398|365828213|FG001|Overall Study|Lost to Follow-up|1|||
106043748|NCT00723398|365828214|FG002|Overall Study|Lost to Follow-up|0|||
106043749|NCT00723398|365828215|FG003|Overall Study|Lost to Follow-up|0|||
106043750|NCT00723398|365828216|FG004|Overall Study|Lost to Follow-up|0|||
106043751|NCT03633617|365828217|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
106043752|NCT03633617|365828218|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
106043753|NCT03633617|365828219|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043754|NCT03633617|365828220|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043755|NCT03633617|365828221|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043756|NCT03633617|365828222|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043757|NCT03633617|365828223|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043758|NCT03633617|365828224|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043759|NCT03633617|365828225|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043760|NCT03633617|365828226|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043761|NCT03633617|365828227|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
106043762|NCT03633617|365828217|FG000|Part A|Unconfirmed early termination visit|1|||
106043763|NCT03633617|365828218|FG001|Part A|Unconfirmed early termination visit|0|||
106043764|NCT03633617|365828219|FG002|Part A|Unconfirmed early termination visit|0|||
106043765|NCT03633617|365828220|FG003|Part A|Unconfirmed early termination visit|0|||
106043766|NCT03633617|365828221|FG004|Part A|Unconfirmed early termination visit|0|||
106043767|NCT03633617|365828222|FG005|Part A|Unconfirmed early termination visit|0|||
106043768|NCT03633617|365828223|FG006|Part A|Unconfirmed early termination visit|0|||
106043769|NCT03633617|365828224|FG007|Part A|Unconfirmed early termination visit|0|||
106043770|NCT03633617|365828225|FG008|Part A|Unconfirmed early termination visit|0|||
106043771|NCT03633617|365828226|FG009|Part A|Unconfirmed early termination visit|0|||
106043772|NCT03633617|365828227|FG010|Part A|Unconfirmed early termination visit|0|||
106043773|NCT03633617|365828217|FG000|Part A|Adverse Event|0|||
106043774|NCT03633617|365828218|FG001|Part A|Adverse Event|1|||
106043775|NCT03633617|365828219|FG002|Part A|Adverse Event|0|||
106043776|NCT03633617|365828220|FG003|Part A|Adverse Event|0|||
106043777|NCT03633617|365828221|FG004|Part A|Adverse Event|0|||
105862327|NCT00805467|365147949|FG002|Overall Study|Lost to Follow-up|7|||
105862328|NCT00805467|365147950|FG003|Overall Study|Lost to Follow-up|21|||
105862329|NCT00805467|365147947|FG000|Overall Study|Withdrawal by Subject|0|||
105862330|NCT00805467|365147948|FG001|Overall Study|Withdrawal by Subject|6|||
105862331|NCT00805467|365147949|FG002|Overall Study|Withdrawal by Subject|45|||
105862332|NCT00805467|365147950|FG003|Overall Study|Withdrawal by Subject|50|||
105862333|NCT00805467|365147947|FG000|Overall Study|Protocol Violation|0|||
105862334|NCT00805467|365147948|FG001|Overall Study|Protocol Violation|3|||
105862335|NCT00805467|365147949|FG002|Overall Study|Protocol Violation|0|||
105862336|NCT00805467|365147950|FG003|Overall Study|Protocol Violation|5|||
105862337|NCT00805467|365147947|FG000|Overall Study|Adverse Event|0|||
105862338|NCT00805467|365147948|FG001|Overall Study|Adverse Event|13|||
105862339|NCT00805467|365147949|FG002|Overall Study|Adverse Event|26|||
105862340|NCT00805467|365147950|FG003|Overall Study|Adverse Event|57|||
105862341|NCT00805467|365147947|FG000|Overall Study|Death|0|||
105862342|NCT00805467|365147948|FG001|Overall Study|Death|2|||
105862343|NCT00805467|365147949|FG002|Overall Study|Death|7|||
105862344|NCT00805467|365147950|FG003|Overall Study|Death|5|||
105862345|NCT00805467|365147947|FG000|Overall Study|Physician Decision|0|||
105862346|NCT00805467|365147948|FG001|Overall Study|Physician Decision|1|||
105862347|NCT00805467|365147949|FG002|Overall Study|Physician Decision|2|||
105862348|NCT00805467|365147950|FG003|Overall Study|Physician Decision|6|||
105862349|NCT00805467|365147947|FG000|Overall Study|Not reported|0|||
105862350|NCT00805467|365147948|FG001|Overall Study|Not reported|0|||
105862351|NCT00805467|365147949|FG002|Overall Study|Not reported|3|||
105862352|NCT00805467|365147950|FG003|Overall Study|Not reported|7|||
105862353|NCT04975191|365147951|FG000|Overall Study|Protocol Violation|1|||
105862354|NCT04975191|365147952|FG001|Overall Study|Protocol Violation|2|||
105862355|NCT04975191|365147953|FG002|Overall Study|Protocol Violation|2|||
105862356|NCT04975191|365147954|FG003|Overall Study|Protocol Violation|2|||
105862357|NCT04975191|365147951|FG000|Overall Study|Lost to Follow-up|13|||
105862358|NCT04975191|365147952|FG001|Overall Study|Lost to Follow-up|3|||
105862359|NCT04975191|365147953|FG002|Overall Study|Lost to Follow-up|8|||
105862360|NCT04975191|365147954|FG003|Overall Study|Lost to Follow-up|8|||
105862361|NCT00402116|365147958|FG000|Overall Study|Jaw infection after surgery-other|1|||
105862362|NCT00402116|365147959|FG001|Overall Study|Jaw infection after surgery-other|0|||
105862363|NCT00402116|365147960|FG002|Overall Study|Jaw infection after surgery-other|0|||
105862364|NCT00402116|365147958|FG000|Overall Study|Withdrawal by Subject|1|||
105862365|NCT00402116|365147959|FG001|Overall Study|Withdrawal by Subject|0|||
105862366|NCT00402116|365147960|FG002|Overall Study|Withdrawal by Subject|5|||
105862367|NCT00402116|365147958|FG000|Overall Study|Treatment completed per protocol|1|||
105862368|NCT00402116|365147959|FG001|Overall Study|Treatment completed per protocol|1|||
105862369|NCT00402116|365147960|FG002|Overall Study|Treatment completed per protocol|2|||
105862370|NCT00402116|365147958|FG000|Overall Study|other complicating disease|0|||
105862371|NCT00402116|365147959|FG001|Overall Study|other complicating disease|0|||
105862372|NCT00402116|365147960|FG002|Overall Study|other complicating disease|2|||
106043778|NCT03633617|365828222|FG005|Part A|Adverse Event|0|||
106043779|NCT03633617|365828223|FG006|Part A|Adverse Event|0|||
106043780|NCT03633617|365828224|FG007|Part A|Adverse Event|0|||
106043781|NCT03633617|365828225|FG008|Part A|Adverse Event|0|||
106043782|NCT03633617|365828226|FG009|Part A|Adverse Event|0|||
106043783|NCT03633617|365828227|FG010|Part A|Adverse Event|0|||
106043784|NCT03633617|365828217|FG000|Part A|Pregnancy|1|||
106043785|NCT03633617|365828218|FG001|Part A|Pregnancy|0|||
106043786|NCT03633617|365828219|FG002|Part A|Pregnancy|0|||
106043787|NCT03633617|365828220|FG003|Part A|Pregnancy|0|||
106043788|NCT03633617|365828221|FG004|Part A|Pregnancy|0|||
106043789|NCT03633617|365828222|FG005|Part A|Pregnancy|0|||
106043790|NCT03633617|365828223|FG006|Part A|Pregnancy|0|||
106043791|NCT03633617|365828224|FG007|Part A|Pregnancy|0|||
106043792|NCT03633617|365828225|FG008|Part A|Pregnancy|0|||
106043793|NCT03633617|365828226|FG009|Part A|Pregnancy|0|||
106043794|NCT03633617|365828227|FG010|Part A|Pregnancy|0|||
106043795|NCT03633617|365828217|FG000|Part A|Withdrawal by Subject|0|||
106043796|NCT03633617|365828218|FG001|Part A|Withdrawal by Subject|1|||
106043797|NCT03633617|365828219|FG002|Part A|Withdrawal by Subject|0|||
106043798|NCT03633617|365828220|FG003|Part A|Withdrawal by Subject|0|||
106043799|NCT03633617|365828221|FG004|Part A|Withdrawal by Subject|0|||
106043800|NCT03633617|365828222|FG005|Part A|Withdrawal by Subject|0|||
106043801|NCT03633617|365828223|FG006|Part A|Withdrawal by Subject|0|||
106043802|NCT03633617|365828224|FG007|Part A|Withdrawal by Subject|0|||
106043803|NCT03633617|365828225|FG008|Part A|Withdrawal by Subject|0|||
106043804|NCT03633617|365828226|FG009|Part A|Withdrawal by Subject|0|||
106043805|NCT03633617|365828227|FG010|Part A|Withdrawal by Subject|0|||
106043806|NCT03633617|365828217|FG000|Part B|Adverse Event|0|||
106043807|NCT03633617|365828218|FG001|Part B|Adverse Event|0|||
106043808|NCT03633617|365828219|FG002|Part B|Adverse Event|2|||
106043809|NCT03633617|365828220|FG003|Part B|Adverse Event|2|||
106043810|NCT03633617|365828221|FG004|Part B|Adverse Event|1|||
106043811|NCT03633617|365828222|FG005|Part B|Adverse Event|0|||
106043812|NCT03633617|365828223|FG006|Part B|Adverse Event|0|||
106043813|NCT03633617|365828224|FG007|Part B|Adverse Event|0|||
106043814|NCT03633617|365828225|FG008|Part B|Adverse Event|0|||
106043815|NCT03633617|365828226|FG009|Part B|Adverse Event|0|||
106043816|NCT03633617|365828227|FG010|Part B|Adverse Event|0|||
106043817|NCT03633617|365828217|FG000|Part B|Withdrawal by Subject|0|||
106043818|NCT03633617|365828218|FG001|Part B|Withdrawal by Subject|0|||
106043819|NCT03633617|365828219|FG002|Part B|Withdrawal by Subject|1|||
106043820|NCT03633617|365828220|FG003|Part B|Withdrawal by Subject|0|||
106043821|NCT03633617|365828221|FG004|Part B|Withdrawal by Subject|2|||
106043822|NCT03633617|365828222|FG005|Part B|Withdrawal by Subject|0|||
106043823|NCT03633617|365828223|FG006|Part B|Withdrawal by Subject|0|||
106043824|NCT03633617|365828224|FG007|Part B|Withdrawal by Subject|0|||
106043825|NCT03633617|365828225|FG008|Part B|Withdrawal by Subject|0|||
106043826|NCT03633617|365828226|FG009|Part B|Withdrawal by Subject|0|||
106043827|NCT03633617|365828227|FG010|Part B|Withdrawal by Subject|0|||
106043828|NCT03633617|365828217|FG000|Part B|Lost to Follow-up|0|||
106043829|NCT03633617|365828218|FG001|Part B|Lost to Follow-up|0|||
106043830|NCT03633617|365828219|FG002|Part B|Lost to Follow-up|0|||
106043831|NCT03633617|365828220|FG003|Part B|Lost to Follow-up|0|||
106043832|NCT03633617|365828221|FG004|Part B|Lost to Follow-up|1|||
106043833|NCT03633617|365828222|FG005|Part B|Lost to Follow-up|0|||
106043834|NCT03633617|365828223|FG006|Part B|Lost to Follow-up|0|||
106043835|NCT03633617|365828224|FG007|Part B|Lost to Follow-up|0|||
106043836|NCT03633617|365828225|FG008|Part B|Lost to Follow-up|0|||
106043837|NCT03633617|365828226|FG009|Part B|Lost to Follow-up|0|||
106043838|NCT03633617|365828227|FG010|Part B|Lost to Follow-up|0|||
106043839|NCT03633617|365828217|FG000|Part B|Physician Decision|0|||
106043840|NCT03633617|365828218|FG001|Part B|Physician Decision|0|||
106043841|NCT03633617|365828219|FG002|Part B|Physician Decision|0|||
106043842|NCT03633617|365828220|FG003|Part B|Physician Decision|0|||
106043843|NCT03633617|365828221|FG004|Part B|Physician Decision|1|||
106043844|NCT03633617|365828222|FG005|Part B|Physician Decision|0|||
106043845|NCT03633617|365828223|FG006|Part B|Physician Decision|0|||
106043846|NCT03633617|365828224|FG007|Part B|Physician Decision|0|||
106043847|NCT03633617|365828225|FG008|Part B|Physician Decision|0|||
106043848|NCT03633617|365828226|FG009|Part B|Physician Decision|0|||
106043849|NCT03633617|365828227|FG010|Part B|Physician Decision|0|||
106043850|NCT03633617|365828217|FG000|Part B|COVID-19 Restrictions|0|||
106043851|NCT03633617|365828218|FG001|Part B|COVID-19 Restrictions|0|||
106043852|NCT03633617|365828219|FG002|Part B|COVID-19 Restrictions|1|||
106043853|NCT03633617|365828220|FG003|Part B|COVID-19 Restrictions|0|||
106043854|NCT03633617|365828221|FG004|Part B|COVID-19 Restrictions|0|||
106043855|NCT03633617|365828222|FG005|Part B|COVID-19 Restrictions|0|||
106043856|NCT03633617|365828223|FG006|Part B|COVID-19 Restrictions|0|||
106043857|NCT03633617|365828224|FG007|Part B|COVID-19 Restrictions|0|||
106043858|NCT03633617|365828225|FG008|Part B|COVID-19 Restrictions|0|||
106043859|NCT03633617|365828226|FG009|Part B|COVID-19 Restrictions|0|||
106043860|NCT03633617|365828227|FG010|Part B|COVID-19 Restrictions|0|||
106043861|NCT03633617|365828217|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
106043862|NCT03633617|365828218|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
106043863|NCT03633617|365828219|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
106043864|NCT03633617|365828220|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
106043865|NCT03633617|365828221|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
106097365|NCT03950739|366014391|FG000|Optional Extension Phase|Lost to Follow-up|2|||
105862373|NCT00402116|365147958|FG000|Overall Study|Disease Progression|0|||
105862374|NCT00402116|365147959|FG001|Overall Study|Disease Progression|4|||
105862375|NCT00402116|365147960|FG002|Overall Study|Disease Progression|38|||
105862376|NCT00402116|365147958|FG000|Overall Study|mistaken thrombocytopenia|0|||
105862377|NCT00402116|365147959|FG001|Overall Study|mistaken thrombocytopenia|0|||
105862378|NCT00402116|365147960|FG002|Overall Study|mistaken thrombocytopenia|1|||
105862379|NCT00402116|365147958|FG000|Overall Study|decline related hyponatremia/tumor|0|||
105862380|NCT00402116|365147959|FG001|Overall Study|decline related hyponatremia/tumor|0|||
105862381|NCT00402116|365147960|FG002|Overall Study|decline related hyponatremia/tumor|1|||
105862382|NCT00402116|365147958|FG000|Overall Study|Adverse Event|0|||
105862383|NCT00402116|365147959|FG001|Overall Study|Adverse Event|1|||
105862384|NCT00402116|365147960|FG002|Overall Study|Adverse Event|6|||
105862385|NCT02899195|365147961|FG000|Concurrent Durvalumab|Adverse Event|4|||
105862386|NCT02899195|365147961|FG000|Concurrent Durvalumab|Physician Decision|1|||
105862387|NCT02899195|365147961|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
105862388|NCT02899195|365147961|FG000|Concurrent Durvalumab|Progressive Disease|5|||
105862389|NCT02899195|365147961|FG000|Maintenance Durvalumab|Adverse Event|1|||
105862390|NCT02899195|365147961|FG000|Maintenance Durvalumab|Physician Decision|1|||
105862391|NCT02899195|365147961|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
105862392|NCT02899195|365147961|FG000|Maintenance Durvalumab|Progressive Disease|31|||
105862393|NCT01396512|365147963|FG000|Overall Study|Withdrawal by Subject|0|||
105862394|NCT01396512|365147964|FG001|Overall Study|Withdrawal by Subject|1|||
105862395|NCT01443728|365147972|FG000|Overall Study|Lost to Follow-up|2|||
105862396|NCT01443728|365147973|FG001|Overall Study|Lost to Follow-up|0|||
105862397|NCT01443728|365147972|FG000|Overall Study|Withdrawal by Subject|1|||
105862398|NCT01443728|365147973|FG001|Overall Study|Withdrawal by Subject|1|||
105862399|NCT01443728|365147972|FG000|Overall Study|Adverse Event|0|||
105862400|NCT01443728|365147973|FG001|Overall Study|Adverse Event|2|||
105862401|NCT00509366|365147979|FG000|Overall Study|Not Treated (Screen Failure)|1|||
105862402|NCT00509366|365147980|FG001|Overall Study|Not Treated (Screen Failure)|1|||
105862403|NCT00509366|365147981|FG002|Overall Study|Not Treated (Screen Failure)|1|||
105862404|NCT00509366|365147982|FG003|Overall Study|Not Treated (Screen Failure)|0|||
105862405|NCT00509366|365147983|FG004|Overall Study|Not Treated (Screen Failure)|0|||
105862406|NCT01473524|365147984|FG000|DB Phase|Adverse Event|4|||
105862407|NCT01473524|365147985|FG001|DB Phase|Adverse Event|8|||
105862408|NCT01473524|365147986|FG002|DB Phase|Adverse Event|2|||
105862409|NCT01473524|365147987|FG003|DB Phase|Adverse Event|0|||
105862410|NCT01473524|365147988|FG004|DB Phase|Adverse Event|0|||
105862411|NCT01473524|365147989|FG005|DB Phase|Adverse Event|0|||
105862412|NCT01473524|365147984|FG000|DB Phase|Death|1|||
105862413|NCT01473524|365147985|FG001|DB Phase|Death|0|||
105862414|NCT01473524|365147986|FG002|DB Phase|Death|0|||
105862415|NCT01473524|365147987|FG003|DB Phase|Death|0|||
105862416|NCT01473524|365147988|FG004|DB Phase|Death|0|||
105862417|NCT01473524|365147989|FG005|DB Phase|Death|0|||
105862418|NCT01473524|365147984|FG000|DB Phase|Withdrawal by Subject|2|||
105862419|NCT01473524|365147985|FG001|DB Phase|Withdrawal by Subject|1|||
105862420|NCT01473524|365147986|FG002|DB Phase|Withdrawal by Subject|1|||
105862421|NCT01473524|365147987|FG003|DB Phase|Withdrawal by Subject|0|||
105862422|NCT01473524|365147988|FG004|DB Phase|Withdrawal by Subject|0|||
105862423|NCT01473524|365147989|FG005|DB Phase|Withdrawal by Subject|0|||
105862424|NCT01473524|365147984|FG000|LTSE Phase|Withdrawal by Subject|0|||
105862425|NCT01473524|365147985|FG001|LTSE Phase|Withdrawal by Subject|0|||
105862426|NCT01473524|365147986|FG002|LTSE Phase|Withdrawal by Subject|0|||
105862427|NCT01473524|365147987|FG003|LTSE Phase|Withdrawal by Subject|3|||
105862428|NCT01473524|365147988|FG004|LTSE Phase|Withdrawal by Subject|3|||
105862429|NCT01473524|365147989|FG005|LTSE Phase|Withdrawal by Subject|6|||
105862430|NCT01473524|365147984|FG000|LTSE Phase|Death|0|||
105862431|NCT01473524|365147985|FG001|LTSE Phase|Death|0|||
106043866|NCT03633617|365828222|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105862432|NCT01473524|365147986|FG002|LTSE Phase|Death|0|||
105862433|NCT01473524|365147987|FG003|LTSE Phase|Death|0|||
105862434|NCT01473524|365147988|FG004|LTSE Phase|Death|1|||
106043867|NCT03633617|365828223|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105862435|NCT01473524|365147989|FG005|LTSE Phase|Death|0|||
105862436|NCT01473524|365147984|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
105862437|NCT01473524|365147985|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
106043868|NCT03633617|365828224|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
105862438|NCT01473524|365147986|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
105862439|NCT01473524|365147987|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
105862440|NCT01473524|365147988|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
105862441|NCT01473524|365147989|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
105862442|NCT01473524|365147984|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
105862443|NCT01473524|365147985|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
105862444|NCT01473524|365147986|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
105862445|NCT01473524|365147987|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
105862446|NCT01473524|365147988|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
106043869|NCT03633617|365828225|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
106043870|NCT03633617|365828226|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
106043871|NCT03633617|365828227|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
106043872|NCT03633617|365828217|FG000|Part C (& Follow-up)|Adverse Event|0|||
106043873|NCT03633617|365828218|FG001|Part C (& Follow-up)|Adverse Event|0|||
106043874|NCT03633617|365828219|FG002|Part C (& Follow-up)|Adverse Event|0|||
106043875|NCT03633617|365828220|FG003|Part C (& Follow-up)|Adverse Event|0|||
106043876|NCT03633617|365828221|FG004|Part C (& Follow-up)|Adverse Event|0|||
106043877|NCT03633617|365828222|FG005|Part C (& Follow-up)|Adverse Event|1|||
106043878|NCT03633617|365828223|FG006|Part C (& Follow-up)|Adverse Event|0|||
106043879|NCT03633617|365828224|FG007|Part C (& Follow-up)|Adverse Event|1|||
106043880|NCT03633617|365828225|FG008|Part C (& Follow-up)|Adverse Event|0|||
106043881|NCT03633617|365828226|FG009|Part C (& Follow-up)|Adverse Event|0|||
106043882|NCT03633617|365828227|FG010|Part C (& Follow-up)|Adverse Event|0|||
106043883|NCT03633617|365828217|FG000|Part C (& Follow-up)|Pregnancy|0|||
106043884|NCT03633617|365828218|FG001|Part C (& Follow-up)|Pregnancy|0|||
106043885|NCT03633617|365828219|FG002|Part C (& Follow-up)|Pregnancy|0|||
106043886|NCT03633617|365828220|FG003|Part C (& Follow-up)|Pregnancy|0|||
106043887|NCT03633617|365828221|FG004|Part C (& Follow-up)|Pregnancy|0|||
106043888|NCT03633617|365828222|FG005|Part C (& Follow-up)|Pregnancy|0|||
106043889|NCT03633617|365828223|FG006|Part C (& Follow-up)|Pregnancy|0|||
106043890|NCT03633617|365828224|FG007|Part C (& Follow-up)|Pregnancy|0|||
106043891|NCT03633617|365828225|FG008|Part C (& Follow-up)|Pregnancy|0|||
106043892|NCT03633617|365828226|FG009|Part C (& Follow-up)|Pregnancy|1|||
106043893|NCT03633617|365828227|FG010|Part C (& Follow-up)|Pregnancy|0|||
106043894|NCT03633617|365828217|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
106043895|NCT03633617|365828218|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
106043896|NCT03633617|365828219|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
106043897|NCT03633617|365828220|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
106043898|NCT03633617|365828221|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
106043899|NCT03633617|365828222|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
106043900|NCT03633617|365828223|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
106043901|NCT03633617|365828224|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
106043902|NCT03633617|365828225|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
106043903|NCT03633617|365828226|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
106043904|NCT03633617|365828227|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
106043905|NCT03633617|365828217|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
106043906|NCT03633617|365828218|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
106043907|NCT03633617|365828219|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
106043908|NCT03633617|365828220|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
106043909|NCT03633617|365828221|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
106043910|NCT03633617|365828222|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
106043911|NCT03633617|365828223|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
106043912|NCT03633617|365828224|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
106043913|NCT03633617|365828225|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
106043914|NCT03633617|365828226|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
106043915|NCT03633617|365828227|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
106043916|NCT03633617|365828217|FG000|Part C (& Follow-up)|Physician Decision|0|||
106043917|NCT03633617|365828218|FG001|Part C (& Follow-up)|Physician Decision|0|||
106043918|NCT03633617|365828219|FG002|Part C (& Follow-up)|Physician Decision|0|||
106043919|NCT03633617|365828220|FG003|Part C (& Follow-up)|Physician Decision|0|||
106043920|NCT03633617|365828221|FG004|Part C (& Follow-up)|Physician Decision|0|||
106043921|NCT03633617|365828222|FG005|Part C (& Follow-up)|Physician Decision|0|||
106043922|NCT03633617|365828223|FG006|Part C (& Follow-up)|Physician Decision|0|||
106043923|NCT03633617|365828224|FG007|Part C (& Follow-up)|Physician Decision|1|||
106043924|NCT03633617|365828225|FG008|Part C (& Follow-up)|Physician Decision|0|||
106043925|NCT03633617|365828226|FG009|Part C (& Follow-up)|Physician Decision|0|||
106043926|NCT03633617|365828227|FG010|Part C (& Follow-up)|Physician Decision|1|||
106043927|NCT03633617|365828217|FG000|Part C (& Follow-up)|COVID-19 related|0|||
106043928|NCT03633617|365828218|FG001|Part C (& Follow-up)|COVID-19 related|0|||
106043929|NCT03633617|365828219|FG002|Part C (& Follow-up)|COVID-19 related|0|||
106043930|NCT03633617|365828220|FG003|Part C (& Follow-up)|COVID-19 related|0|||
106043931|NCT03633617|365828221|FG004|Part C (& Follow-up)|COVID-19 related|0|||
106043932|NCT03633617|365828222|FG005|Part C (& Follow-up)|COVID-19 related|1|||
106043933|NCT03633617|365828223|FG006|Part C (& Follow-up)|COVID-19 related|0|||
106043934|NCT03633617|365828224|FG007|Part C (& Follow-up)|COVID-19 related|0|||
106043935|NCT03633617|365828225|FG008|Part C (& Follow-up)|COVID-19 related|0|||
106043936|NCT03633617|365828226|FG009|Part C (& Follow-up)|COVID-19 related|0|||
106043937|NCT03633617|365828227|FG010|Part C (& Follow-up)|COVID-19 related|0|||
106043938|NCT03633617|365828217|FG000|Part C (& Follow-up)|Protocol Violation|0|||
106043939|NCT03633617|365828218|FG001|Part C (& Follow-up)|Protocol Violation|0|||
106043940|NCT03633617|365828219|FG002|Part C (& Follow-up)|Protocol Violation|0|||
106043941|NCT03633617|365828220|FG003|Part C (& Follow-up)|Protocol Violation|0|||
106043942|NCT03633617|365828221|FG004|Part C (& Follow-up)|Protocol Violation|0|||
106043943|NCT03633617|365828222|FG005|Part C (& Follow-up)|Protocol Violation|0|||
106043944|NCT03633617|365828223|FG006|Part C (& Follow-up)|Protocol Violation|0|||
106043945|NCT03633617|365828224|FG007|Part C (& Follow-up)|Protocol Violation|0|||
106043946|NCT03633617|365828225|FG008|Part C (& Follow-up)|Protocol Violation|0|||
106043947|NCT03633617|365828226|FG009|Part C (& Follow-up)|Protocol Violation|3|||
106043948|NCT03633617|365828227|FG010|Part C (& Follow-up)|Protocol Violation|1|||
106043949|NCT03633617|365828217|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
106043950|NCT03633617|365828218|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
106043951|NCT03633617|365828219|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
106043952|NCT03633617|365828220|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
106043953|NCT03633617|365828221|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
106043954|NCT03633617|365828222|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
106043955|NCT03633617|365828223|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
106043956|NCT03633617|365828224|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
106043957|NCT03633617|365828225|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
106043958|NCT03633617|365828226|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
106043959|NCT03633617|365828227|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
106043960|NCT03257371|365828228|FG000|Overall Study|Lost to Follow-up|1|||
106043961|NCT02607930|365828234|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
106043962|NCT02607930|365828235|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
106043963|NCT02607930|365828236|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
105862447|NCT01473524|365147989|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
105862448|NCT01473524|365147984|FG000|LTSE Phase|Lost to Follow-up|0|||
105862449|NCT01473524|365147985|FG001|LTSE Phase|Lost to Follow-up|0|||
105862450|NCT01473524|365147986|FG002|LTSE Phase|Lost to Follow-up|0|||
105862451|NCT01473524|365147987|FG003|LTSE Phase|Lost to Follow-up|1|||
105862452|NCT01473524|365147988|FG004|LTSE Phase|Lost to Follow-up|3|||
105862453|NCT01473524|365147989|FG005|LTSE Phase|Lost to Follow-up|2|||
105862454|NCT01473524|365147984|FG000|LTSE Phase|Principal Investigator Decision|0|||
105862455|NCT01473524|365147985|FG001|LTSE Phase|Principal Investigator Decision|0|||
105862456|NCT01473524|365147986|FG002|LTSE Phase|Principal Investigator Decision|0|||
105862457|NCT01473524|365147987|FG003|LTSE Phase|Principal Investigator Decision|1|||
105862458|NCT01473524|365147988|FG004|LTSE Phase|Principal Investigator Decision|1|||
105862459|NCT01473524|365147989|FG005|LTSE Phase|Principal Investigator Decision|3|||
105862460|NCT01473524|365147984|FG000|LTSE Phase|Liver Transplantation|0|||
105862461|NCT01473524|365147985|FG001|LTSE Phase|Liver Transplantation|0|||
105862462|NCT01473524|365147986|FG002|LTSE Phase|Liver Transplantation|0|||
105862463|NCT01473524|365147987|FG003|LTSE Phase|Liver Transplantation|0|||
105862464|NCT01473524|365147988|FG004|LTSE Phase|Liver Transplantation|0|||
105862465|NCT01473524|365147989|FG005|LTSE Phase|Liver Transplantation|1|||
105862466|NCT01473524|365147984|FG000|LTSE Phase|Pregnancy|0|||
105862467|NCT01473524|365147985|FG001|LTSE Phase|Pregnancy|0|||
105862468|NCT01473524|365147986|FG002|LTSE Phase|Pregnancy|0|||
105862469|NCT01473524|365147987|FG003|LTSE Phase|Pregnancy|1|||
105862470|NCT01473524|365147988|FG004|LTSE Phase|Pregnancy|0|||
105862471|NCT01473524|365147989|FG005|LTSE Phase|Pregnancy|0|||
105862472|NCT01473524|365147984|FG000|LTSE Phase|Protocol Violation|0|||
105862473|NCT01473524|365147985|FG001|LTSE Phase|Protocol Violation|0|||
105862474|NCT01473524|365147986|FG002|LTSE Phase|Protocol Violation|0|||
105862475|NCT01473524|365147987|FG003|LTSE Phase|Protocol Violation|0|||
105862476|NCT01473524|365147988|FG004|LTSE Phase|Protocol Violation|0|||
105862477|NCT01473524|365147989|FG005|LTSE Phase|Protocol Violation|1|||
105862478|NCT02906358|365147990|FG000|Overall Study|Withdrawal by Subject|10|||
105862479|NCT02906358|365147991|FG001|Overall Study|Withdrawal by Subject|7|||
105862480|NCT02906358|365147990|FG000|Overall Study|Lost to Follow-up|12|||
105862481|NCT02906358|365147991|FG001|Overall Study|Lost to Follow-up|15|||
105862482|NCT02119819|365147992|FG000|Overall Study|Adverse Event|3|||
105862483|NCT02119819|365147993|FG001|Overall Study|Adverse Event|1|||
105862484|NCT02119819|365147994|FG002|Overall Study|Adverse Event|2|||
105862485|NCT02119819|365147995|FG003|Overall Study|Adverse Event|3|||
105862486|NCT02119819|365147996|FG004|Overall Study|Adverse Event|0|||
105862487|NCT02119819|365147997|FG005|Overall Study|Adverse Event|1|||
105862488|NCT02119819|365147992|FG000|Overall Study|Lack of Efficacy|0|||
105862489|NCT02119819|365147993|FG001|Overall Study|Lack of Efficacy|0|||
105862490|NCT02119819|365147994|FG002|Overall Study|Lack of Efficacy|0|||
105862491|NCT02119819|365147995|FG003|Overall Study|Lack of Efficacy|0|||
106152209|NCT03873779|366217072|FG000|Overall Study|Withdrawal by Subject|1|||
106152210|NCT02780388|366217073|FG000|Overall Study|Lost to Follow-up|0|||
105862492|NCT02119819|365147996|FG004|Overall Study|Lack of Efficacy|0|||
105862493|NCT02119819|365147997|FG005|Overall Study|Lack of Efficacy|1|||
105862494|NCT02119819|365147992|FG000|Overall Study|Lost to Follow-up|0|||
105862495|NCT02119819|365147993|FG001|Overall Study|Lost to Follow-up|0|||
105862496|NCT02119819|365147994|FG002|Overall Study|Lost to Follow-up|1|||
105862497|NCT02119819|365147995|FG003|Overall Study|Lost to Follow-up|2|||
105862498|NCT02119819|365147996|FG004|Overall Study|Lost to Follow-up|1|||
105862499|NCT02119819|365147997|FG005|Overall Study|Lost to Follow-up|2|||
106043964|NCT02607930|365828237|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
106043965|NCT02607930|365828234|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
106043966|NCT02607930|365828235|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
106043967|NCT02607930|365828236|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
106043968|NCT02607930|365828237|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
106043969|NCT02607930|365828234|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
106043970|NCT02607930|365828235|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
106043971|NCT02607930|365828236|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
106043972|NCT02607930|365828237|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
106043973|NCT02607930|365828234|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
106043974|NCT02607930|365828235|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
106043975|NCT02607930|365828236|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
106043976|NCT02607930|365828237|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
106043977|NCT02607930|365828234|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
106043978|NCT02607930|365828235|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
106043979|NCT02607930|365828236|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
106043980|NCT02607930|365828237|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
106043981|NCT02607930|365828234|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
106043982|NCT02607930|365828235|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
106043983|NCT02607930|365828236|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
106043984|NCT02607930|365828237|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
106043985|NCT02607930|365828234|FG000|Double-Blinded Treatment Phase|Death|2|||
106043986|NCT02607930|365828235|FG001|Double-Blinded Treatment Phase|Death|1|||
106043987|NCT02607930|365828236|FG002|Double-Blinded Treatment Phase|Death|0|||
106043988|NCT02607930|365828237|FG003|Double-Blinded Treatment Phase|Death|0|||
106043989|NCT02607930|365828234|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
106043990|NCT02607930|365828235|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
106043991|NCT02607930|365828236|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
106043992|NCT02607930|365828237|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
106043993|NCT02607930|365828234|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
106043994|NCT02607930|365828235|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
106043995|NCT02607930|365828236|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
106043996|NCT02607930|365828237|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
106043997|NCT02607930|365828234|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
106043998|NCT02607930|365828235|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
106043999|NCT02607930|365828236|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
106044000|NCT02607930|365828237|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
106044001|NCT02607930|365828234|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
106044002|NCT02607930|365828235|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
106044003|NCT02607930|365828236|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
106044004|NCT02607930|365828237|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
106044005|NCT02607930|365828234|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
106044006|NCT02607930|365828235|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
106044007|NCT02607930|365828236|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
106044008|NCT02607930|365828237|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
106044009|NCT02607930|365828234|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
106044010|NCT02607930|365828235|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
106044011|NCT02607930|365828236|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
105862500|NCT02119819|365147992|FG000|Overall Study|Physician Decision|1|||
105862501|NCT02119819|365147993|FG001|Overall Study|Physician Decision|1|||
105862502|NCT02119819|365147994|FG002|Overall Study|Physician Decision|0|||
105862503|NCT02119819|365147995|FG003|Overall Study|Physician Decision|0|||
105862504|NCT02119819|365147996|FG004|Overall Study|Physician Decision|0|||
105862505|NCT02119819|365147997|FG005|Overall Study|Physician Decision|1|||
105862506|NCT02119819|365147992|FG000|Overall Study|Withdrawal by Subject|5|||
105862507|NCT02119819|365147993|FG001|Overall Study|Withdrawal by Subject|3|||
105862508|NCT02119819|365147994|FG002|Overall Study|Withdrawal by Subject|0|||
105862509|NCT02119819|365147995|FG003|Overall Study|Withdrawal by Subject|0|||
105862510|NCT02119819|365147996|FG004|Overall Study|Withdrawal by Subject|6|||
105862511|NCT02119819|365147997|FG005|Overall Study|Withdrawal by Subject|10|||
105862512|NCT02119819|365147992|FG000|Overall Study|Jury Duty|0|||
105862513|NCT02119819|365147993|FG001|Overall Study|Jury Duty|0|||
105862514|NCT02119819|365147994|FG002|Overall Study|Jury Duty|1|||
105862515|NCT02119819|365147995|FG003|Overall Study|Jury Duty|0|||
106044012|NCT02607930|365828237|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
106044013|NCT02607930|365828234|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
105862516|NCT02119819|365147996|FG004|Overall Study|Jury Duty|0|||
105862517|NCT02119819|365147997|FG005|Overall Study|Jury Duty|0|||
105862518|NCT02119819|365147992|FG000|Overall Study|Protocol Violation|0|||
105862519|NCT02119819|365147993|FG001|Overall Study|Protocol Violation|0|||
105862520|NCT02119819|365147994|FG002|Overall Study|Protocol Violation|0|||
105862521|NCT02119819|365147995|FG003|Overall Study|Protocol Violation|1|||
106152211|NCT02780388|366217074|FG001|Overall Study|Lost to Follow-up|1|||
106044014|NCT02607930|365828235|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
106044015|NCT02607930|365828236|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
106044016|NCT02607930|365828237|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
106044017|NCT02607930|365828234|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
106044018|NCT02607930|365828235|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
106044019|NCT02607930|365828236|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
106044020|NCT02607930|365828237|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
106044021|NCT02607930|365828234|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
106044022|NCT02607930|365828235|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
106044023|NCT02607930|365828236|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
106044024|NCT02607930|365828237|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
106044025|NCT01649804|365828238|FG000|Overall Study|Administrative/Other|8|||
106044026|NCT00591344|365828239|FG000|Overall Study|Transportation issues|1|||
106044027|NCT00591344|365828240|FG001|Overall Study|Transportation issues|0|||
106044028|NCT00591344|365828239|FG000|Overall Study|Moved out of state|1|||
106044029|NCT00591344|365828240|FG001|Overall Study|Moved out of state|0|||
106044030|NCT00591344|365828239|FG000|Overall Study|Medical complications|1|||
106044031|NCT00591344|365828240|FG001|Overall Study|Medical complications|3|||
106044032|NCT00591344|365828239|FG000|Overall Study|Underwent DBS|2|||
106044033|NCT00591344|365828240|FG001|Overall Study|Underwent DBS|2|||
106044034|NCT00591344|365828239|FG000|Overall Study|Death|0|||
106044035|NCT00591344|365828240|FG001|Overall Study|Death|1|||
106044036|NCT00591344|365828239|FG000|Overall Study|Lost to Follow-up|0|||
106044037|NCT00591344|365828240|FG001|Overall Study|Lost to Follow-up|1|||
106044038|NCT00591344|365828239|FG000|Overall Study|Did not want to come off medication|0|||
106044039|NCT00591344|365828240|FG001|Overall Study|Did not want to come off medication|1|||
106044040|NCT00369707|365828241|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
106044041|NCT00369707|365828241|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
106044042|NCT00369707|365828241|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
106044043|NCT00369707|365828241|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
106044044|NCT00369707|365828241|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
106044045|NCT00369707|365828241|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
106044046|NCT00369707|365828241|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
106044047|NCT00369707|365828241|FG000|Follow up for 2 Years After Treatment|Death|1|||
106044048|NCT00369707|365828241|FG000|Follow up for 2 Years After Treatment|Other|2|||
106044049|NCT02046733|365828244|FG000|Overall Study|never initiated 'treatment visits'|6|||
106044050|NCT02046733|365828245|FG001|Overall Study|never initiated 'treatment visits'|0|||
106044051|NCT03605212|365828247|FG000|Treatment Period|Adverse Event|1|||
106044052|NCT03605212|365828248|FG001|Treatment Period|Adverse Event|0|||
106044053|NCT03605212|365828249|FG002|Treatment Period|Adverse Event|0|||
106044054|NCT03605212|365828250|FG003|Treatment Period|Adverse Event|0|||
106044055|NCT03605212|365828251|FG004|Treatment Period|Adverse Event|0|||
106044056|NCT03605212|365828247|FG000|Treatment Period|Physician Decision|0|||
106044057|NCT03605212|365828248|FG001|Treatment Period|Physician Decision|0|||
106044058|NCT03605212|365828249|FG002|Treatment Period|Physician Decision|0|||
106044059|NCT03605212|365828250|FG003|Treatment Period|Physician Decision|0|||
106044060|NCT03605212|365828251|FG004|Treatment Period|Physician Decision|1|||
106044061|NCT02083081|365828252|FG000|Overall Study|Lost to Follow-up|31|||
106044062|NCT02083081|365828253|FG001|Overall Study|Lost to Follow-up|9|||
106044063|NCT04041375|365828254|FG000|Intervention Phase|Withdrawal by Subject|2|||
106044064|NCT04041375|365828255|FG001|Intervention Phase|Withdrawal by Subject|2|||
106044065|NCT04041375|365828254|FG000|Follow-up Phase|Death|2|||
106044066|NCT04041375|365828255|FG001|Follow-up Phase|Death|0|||
106044067|NCT04041375|365828254|FG000|Follow-up Phase|Lost to Follow-up|2|||
106044068|NCT04041375|365828255|FG001|Follow-up Phase|Lost to Follow-up|1|||
106044069|NCT04041375|365828254|FG000|Follow-up Phase|Too ill|3|||
106044070|NCT04041375|365828255|FG001|Follow-up Phase|Too ill|0|||
106044071|NCT01230710|365828258|FG000|Overall Study|Disease Progression|41|||
106044072|NCT01230710|365828258|FG000|Overall Study|Lost to Follow-up|3|||
106044073|NCT01230710|365828258|FG000|Overall Study|Death|4|||
106044074|NCT01230710|365828258|FG000|Overall Study|Withdrawal of Consent|1|||
106044075|NCT00395733|365828259|FG000|Period 2|Withdrawal by Subject|1|||
106044076|NCT00395733|365828260|FG001|Period 2|Withdrawal by Subject|2|||
106044077|NCT00395733|365828259|FG000|Period 2|Protocol Violation|0|||
106044078|NCT00395733|365828260|FG001|Period 2|Protocol Violation|1|||
106044079|NCT00395733|365828259|FG000|Period 2|Adverse Event|0|||
106152212|NCT02780388|366217075|FG002|Overall Study|Lost to Follow-up|0|||
106152213|NCT02780388|366217076|FG003|Overall Study|Lost to Follow-up|0|||
106044080|NCT00395733|365828260|FG001|Period 2|Adverse Event|2|||
106044081|NCT00395733|365828259|FG000|Period 2|Technical problems|1|||
106044082|NCT00395733|365828260|FG001|Period 2|Technical problems|0|||
106044083|NCT01104155|365828261|FG000|Overall Study|Adverse Event|15|||
106044084|NCT01104155|365828262|FG001|Overall Study|Adverse Event|8|||
106044085|NCT01104155|365828261|FG000|Overall Study|Participant choice|6|||
106044086|NCT01104155|365828262|FG001|Overall Study|Participant choice|5|||
106044087|NCT01104155|365828261|FG000|Overall Study|Withdrawal of consent|1|||
106044088|NCT01104155|365828262|FG001|Overall Study|Withdrawal of consent|1|||
106044089|NCT01104155|365828261|FG000|Overall Study|Other|3|||
106044090|NCT01104155|365828262|FG001|Overall Study|Other|4|||
106044091|NCT02787551|365828265|FG000|Core Period: 26 Weeks|Adverse Event|10|||
106044092|NCT02787551|365828266|FG001|Core Period: 26 Weeks|Adverse Event|0|||
106044093|NCT02787551|365828265|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
106044094|NCT02787551|365828266|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
106044095|NCT02787551|365828265|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
106044096|NCT02787551|365828266|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
106044097|NCT02787551|365828265|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
106044098|NCT02787551|365828266|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
106044099|NCT02787551|365828265|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
106044100|NCT02787551|365828266|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
106044101|NCT02787551|365828265|FG000|Core Period: 26 Weeks|Other than specified|3|||
106044102|NCT02787551|365828266|FG001|Core Period: 26 Weeks|Other than specified|1|||
106044103|NCT02787551|365828265|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
106044104|NCT02787551|365828266|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
106044105|NCT02787551|365828265|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
106044106|NCT02787551|365828266|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
106044107|NCT02787551|365828265|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
106044108|NCT02787551|365828266|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
106044109|NCT03799211|365828267|FG000|Overall Study|Lost to Follow-up|2|||
106044110|NCT03799211|365828268|FG001|Overall Study|Lost to Follow-up|13|||
106044111|NCT03799211|365828267|FG000|Overall Study|Withdrawal by Subject|2|||
106044112|NCT03799211|365828268|FG001|Overall Study|Withdrawal by Subject|0|||
106044113|NCT01672736|365828269|FG000|Overall Study|Available drug expired on 31 May 16|3|||
106044114|NCT05394350|365828270|FG000|Overall Study|Death|2|||
106044115|NCT05394350|365828271|FG001|Overall Study|Death|2|||
106044116|NCT05394350|365828272|FG002|Overall Study|Death|4|||
106044117|NCT05394350|365828273|FG003|Overall Study|Death|0|||
106044118|NCT05394350|365828274|FG004|Overall Study|Death|1|||
106044119|NCT05394350|365828275|FG005|Overall Study|Death|0|||
106044120|NCT05394350|365828270|FG000|Overall Study|Study terminated by sponsor|1|||
106044121|NCT05394350|365828271|FG001|Overall Study|Study terminated by sponsor|1|||
106044122|NCT05394350|365828272|FG002|Overall Study|Study terminated by sponsor|7|||
106044123|NCT05394350|365828273|FG003|Overall Study|Study terminated by sponsor|3|||
106044124|NCT05394350|365828274|FG004|Overall Study|Study terminated by sponsor|2|||
106044125|NCT05394350|365828275|FG005|Overall Study|Study terminated by sponsor|4|||
106044126|NCT01336569|365828276|FG000|Overall Study|Lost to Follow-up|4|||
106044127|NCT03452228|365828279|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
106044128|NCT03452228|365828280|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
106044129|NCT03452228|365828281|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
106044130|NCT03452228|365828279|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
106044131|NCT03452228|365828280|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
106044132|NCT03452228|365828281|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
106044133|NCT03452228|365828279|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
106044134|NCT03452228|365828280|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
106044135|NCT03452228|365828281|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
106044136|NCT03452228|365828279|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
106044137|NCT03452228|365828280|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
106044138|NCT03452228|365828281|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
106044139|NCT03800173|365828284|FG000|Overall Study|Lost to Follow-up|0|||
106044140|NCT03800173|365828285|FG001|Overall Study|Lost to Follow-up|0|||
106044141|NCT03800173|365828286|FG002|Overall Study|Lost to Follow-up|0|||
106044142|NCT03800173|365828287|FG003|Overall Study|Lost to Follow-up|0|||
106044143|NCT03800173|365828288|FG004|Overall Study|Lost to Follow-up|1|||
106044144|NCT00936611|365828289|FG000|Overall Study|Progressive Disease|3|||
106044145|NCT00936611|365828289|FG000|Overall Study|New Systemic Therapy|22|||
106044146|NCT00936611|365828289|FG000|Overall Study|Lost to Follow-up|1|||
106044147|NCT00936611|365828289|FG000|Overall Study|Withdrawal by Subject|2|||
106044148|NCT00936611|365828289|FG000|Overall Study|Still on Follow-up|1|||
106044149|NCT00936611|365828289|FG000|Overall Study|Still on Active Therapy|7|||
106044150|NCT00936611|365828289|FG000|Overall Study|Ineligible for Study Drug|3|||
106044151|NCT02507973|365828290|FG000|Overall Study|Adverse Event|1|||
106044152|NCT01565642|365828291|FG000|Overall Study|Withdrawal by Subject|2|||
106044153|NCT01565642|365828292|FG001|Overall Study|Withdrawal by Subject|1|||
106044154|NCT02955797|365828293|FG000|Overall Study|Protocol Violation|1|||
106044155|NCT02955797|365828294|FG001|Overall Study|Protocol Violation|0|||
106044156|NCT02955797|365828295|FG002|Overall Study|Protocol Violation|0|||
106044157|NCT02955797|365828296|FG003|Overall Study|Protocol Violation|1|||
106044158|NCT02955797|365828293|FG000|Overall Study|Withdrawal by Subject|2|||
106044159|NCT02955797|365828294|FG001|Overall Study|Withdrawal by Subject|2|||
106152214|NCT02780388|366217077|FG004|Overall Study|Lost to Follow-up|0|||
106044160|NCT02955797|365828295|FG002|Overall Study|Withdrawal by Subject|0|||
106044161|NCT02955797|365828296|FG003|Overall Study|Withdrawal by Subject|1|||
106044162|NCT02955797|365828293|FG000|Overall Study|Lost to Follow-up|0|||
106044163|NCT02955797|365828294|FG001|Overall Study|Lost to Follow-up|1|||
106044164|NCT02955797|365828295|FG002|Overall Study|Lost to Follow-up|0|||
106044165|NCT02955797|365828296|FG003|Overall Study|Lost to Follow-up|0|||
106044166|NCT04043728|365828301|FG000|Overall Study|Lost to Follow-up|1|||
106044167|NCT04043728|365828302|FG001|Overall Study|Lost to Follow-up|2|||
106044168|NCT04043728|365828303|FG002|Overall Study|Lost to Follow-up|0|||
106044169|NCT02436681|365828306|FG000|Overall Study|Lost to Follow-up|10|||
106044170|NCT02436681|365828306|FG000|Overall Study|Withdrawal by Subject|2|||
106044171|NCT02436681|365828306|FG000|Overall Study|Death|2|||
106044172|NCT01163266|365828307|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
106044173|NCT01163266|365828308|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
106044174|NCT01163266|365828309|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
106044175|NCT01163266|365828307|FG000|Overall Study|Lack of Efficacy|1|||
106044176|NCT01163266|365828308|FG001|Overall Study|Lack of Efficacy|3|||
106044177|NCT01163266|365828309|FG002|Overall Study|Lack of Efficacy|1|||
106044178|NCT01163266|365828307|FG000|Overall Study|Noncompliance with Study Drug|0|||
106044179|NCT01163266|365828308|FG001|Overall Study|Noncompliance with Study Drug|2|||
106044180|NCT01163266|365828309|FG002|Overall Study|Noncompliance with Study Drug|0|||
106044181|NCT01163266|365828307|FG000|Overall Study|Protocol Deviations|2|||
106044182|NCT01163266|365828308|FG001|Overall Study|Protocol Deviations|2|||
106044183|NCT01163266|365828309|FG002|Overall Study|Protocol Deviations|5|||
106044184|NCT01163266|365828307|FG000|Overall Study|Withdrawal of Consent|5|||
106044185|NCT01163266|365828308|FG001|Overall Study|Withdrawal of Consent|7|||
106044186|NCT01163266|365828309|FG002|Overall Study|Withdrawal of Consent|3|||
106044187|NCT01163266|365828307|FG000|Overall Study|Lost to Follow-up|7|||
106044188|NCT01163266|365828308|FG001|Overall Study|Lost to Follow-up|7|||
106044189|NCT01163266|365828309|FG002|Overall Study|Lost to Follow-up|10|||
106044190|NCT01163266|365828307|FG000|Overall Study|Other|1|||
106044191|NCT01163266|365828308|FG001|Overall Study|Other|1|||
106044192|NCT01163266|365828309|FG002|Overall Study|Other|2|||
106044193|NCT02586064|365828310|FG000|Overall Study|Other Obligations|6|||
106044194|NCT02586064|365828311|FG001|Overall Study|Other Obligations|6|||
106044195|NCT02586064|365828310|FG000|Overall Study|Other|3|||
106044196|NCT02586064|365828311|FG001|Overall Study|Other|7|||
106044197|NCT02586064|365828310|FG000|Overall Study|Never Started|3|||
106044198|NCT02586064|365828311|FG001|Overall Study|Never Started|3|||
106044199|NCT02586064|365828310|FG000|Overall Study|Lost Interest|1|||
106044200|NCT02586064|365828311|FG001|Overall Study|Lost Interest|4|||
106044201|NCT02586064|365828310|FG000|Overall Study|Miscellaneous Life Issues|0|||
106044202|NCT02586064|365828311|FG001|Overall Study|Miscellaneous Life Issues|5|||
106044203|NCT02586064|365828310|FG000|Overall Study|Infrequent Attendance|2|||
106044204|NCT02586064|365828311|FG001|Overall Study|Infrequent Attendance|1|||
106044205|NCT02586064|365828310|FG000|Overall Study|Timed Out|2|||
106044206|NCT02586064|365828311|FG001|Overall Study|Timed Out|0|||
106044207|NCT02586064|365828310|FG000|Overall Study|AUD relapse|0|||
106044208|NCT02586064|365828311|FG001|Overall Study|AUD relapse|2|||
106044209|NCT02586064|365828310|FG000|Overall Study|Legal Issue|1|||
106044210|NCT02586064|365828311|FG001|Overall Study|Legal Issue|0|||
106044211|NCT04308304|365828312|FG000|Overall Study|Withdrawal by Subject|4|||
106044212|NCT04308304|365828313|FG001|Overall Study|Withdrawal by Subject|0|||
106044213|NCT04308304|365828312|FG000|Overall Study|Protocol Violation|1|||
106044214|NCT04308304|365828313|FG001|Overall Study|Protocol Violation|0|||
106044215|NCT02906332|365828320|FG000|Overall Study|Withdrawal by Subject|1|||
106044216|NCT02949700|365828321|FG000|Phase I|Withdrawal by Subject|1|||
106044217|NCT02949700|365828322|FG001|Phase I|Withdrawal by Subject|1|||
106044218|NCT02949700|365828323|FG002|Phase I|Withdrawal by Subject|0|||
106044219|NCT02949700|365828324|FG003|Phase I|Withdrawal by Subject|0|||
106044220|NCT02949700|365828321|FG000|Phase I|Protocol Violation|1|||
106044221|NCT02949700|365828322|FG001|Phase I|Protocol Violation|0|||
106152215|NCT02780388|366217073|FG000|Overall Study|Withdrawal by Subject|1|||
106044222|NCT02949700|365828323|FG002|Phase I|Protocol Violation|0|||
106044223|NCT02949700|365828324|FG003|Phase I|Protocol Violation|0|||
106044224|NCT02949700|365828321|FG000|Phase II|Withdrawal by Subject|0|||
106152216|NCT02780388|366217074|FG001|Overall Study|Withdrawal by Subject|1|||
106044225|NCT02949700|365828322|FG001|Phase II|Withdrawal by Subject|0|||
106044226|NCT02949700|365828323|FG002|Phase II|Withdrawal by Subject|0|||
106044227|NCT02949700|365828324|FG003|Phase II|Withdrawal by Subject|2|||
106044228|NCT02949700|365828321|FG000|Phase II|Protocol Violation|0|||
106044229|NCT02949700|365828322|FG001|Phase II|Protocol Violation|0|||
106044230|NCT02949700|365828323|FG002|Phase II|Protocol Violation|1|||
106044231|NCT02949700|365828324|FG003|Phase II|Protocol Violation|3|||
106044232|NCT01193842|365828328|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
106044233|NCT01193842|365828329|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
106044234|NCT01193842|365828330|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
106044235|NCT01193842|365828331|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
106044236|NCT01193842|365828332|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
106044237|NCT01193842|365828328|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
106044238|NCT01193842|365828329|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
106044239|NCT01193842|365828330|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
106044240|NCT01193842|365828331|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
106044241|NCT01193842|365828332|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
106044242|NCT01193842|365828328|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
106044243|NCT01193842|365828329|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
106044244|NCT01193842|365828330|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
106044245|NCT01193842|365828331|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
106044246|NCT01193842|365828332|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
106044247|NCT01193842|365828328|FG000|Phase II: Randomized Groups|Death|0|||
106044248|NCT01193842|365828329|FG001|Phase II: Randomized Groups|Death|0|||
106044249|NCT01193842|365828330|FG002|Phase II: Randomized Groups|Death|0|||
106044250|NCT01193842|365828331|FG003|Phase II: Randomized Groups|Death|1|||
106044251|NCT01193842|365828332|FG004|Phase II: Randomized Groups|Death|1|||
106044252|NCT01193842|365828328|FG000|Phase II: Randomized Groups|Adverse Event|0|||
106044253|NCT01193842|365828329|FG001|Phase II: Randomized Groups|Adverse Event|0|||
106044254|NCT01193842|365828330|FG002|Phase II: Randomized Groups|Adverse Event|0|||
106044255|NCT01193842|365828331|FG003|Phase II: Randomized Groups|Adverse Event|5|||
106044256|NCT01193842|365828332|FG004|Phase II: Randomized Groups|Adverse Event|3|||
106044257|NCT01193842|365828328|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
106044258|NCT01193842|365828329|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
106044259|NCT01193842|365828330|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
106044260|NCT01193842|365828331|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
106044261|NCT01193842|365828332|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
106044262|NCT01193842|365828328|FG000|Phase II: Randomized Groups|Ineligible|0|||
106044263|NCT01193842|365828329|FG001|Phase II: Randomized Groups|Ineligible|0|||
106044264|NCT01193842|365828330|FG002|Phase II: Randomized Groups|Ineligible|0|||
106044265|NCT01193842|365828331|FG003|Phase II: Randomized Groups|Ineligible|0|||
106044266|NCT01193842|365828332|FG004|Phase II: Randomized Groups|Ineligible|1|||
106044267|NCT01193842|365828328|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
106044268|NCT01193842|365828329|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
106044269|NCT01193842|365828330|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
106044270|NCT01193842|365828331|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
106044271|NCT01193842|365828332|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
106044272|NCT01759511|365828333|FG000|Overall Study|Adverse Event|4|||
106044273|NCT01759511|365828333|FG000|Overall Study|Death|2|||
106044274|NCT01759511|365828333|FG000|Overall Study|Lack of Efficacy|2|||
106044275|NCT01759511|365828333|FG000|Overall Study|Physician Decision|1|||
106044276|NCT01759511|365828333|FG000|Overall Study|Progressive Disease|5|||
106044277|NCT01759511|365828333|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
106044278|NCT01759511|365828333|FG000|Overall Study|Study Terminated by Sponsor|13|||
106044279|NCT01759511|365828333|FG000|Overall Study|Withdrawal by Subject|3|||
106044280|NCT04916769|365828334|FG000|Period 1|Physician Decision|0|||
106044281|NCT04916769|365828335|FG001|Period 1|Physician Decision|0|||
106044282|NCT04916769|365828336|FG002|Period 1|Physician Decision|0|||
106044283|NCT04916769|365828337|FG003|Period 1|Physician Decision|0|||
106044284|NCT04916769|365828338|FG004|Period 1|Physician Decision|0|||
106044285|NCT04916769|365828339|FG005|Period 1|Physician Decision|1|||
106044286|NCT04916769|365828334|FG000|Period 2|Physician Decision|0|||
106044287|NCT04916769|365828335|FG001|Period 2|Physician Decision|1|||
106044288|NCT04916769|365828336|FG002|Period 2|Physician Decision|0|||
106044289|NCT04916769|365828337|FG003|Period 2|Physician Decision|0|||
106044290|NCT04916769|365828338|FG004|Period 2|Physician Decision|0|||
106044291|NCT04916769|365828339|FG005|Period 2|Physician Decision|0|||
106044292|NCT05736224|365828340|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
106044293|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
106044294|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
106044295|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
106044296|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
106044297|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
106044298|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
106044299|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
106044300|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
106044301|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
106044302|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
106044303|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
106044304|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
106044305|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
106044306|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
106044307|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
106044308|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
106044309|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
106044310|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
106044311|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
106044312|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
106044313|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
106044314|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
106044315|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
106044316|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
106044317|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
106044318|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
106044319|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
106044320|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
106044321|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
106044322|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
106044323|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
106044324|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
106044325|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
106044326|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
106044327|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
106044328|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
106044329|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
106044330|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
106044331|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
106044332|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
106044333|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
106044334|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
106044335|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
106044336|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
106044337|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
106044338|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
106044339|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
106044340|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
106044341|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
106044342|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
106044343|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
106044344|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
106044345|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
106044346|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
106044347|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
106044348|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
106044349|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
106044350|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
106044351|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
106044352|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
106044353|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
106044354|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
106044355|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
106044356|NCT04526509|365828341|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
106044357|NCT04526509|365828342|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
106044358|NCT04526509|365828343|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
106044359|NCT04526509|365828344|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
106044360|NCT04526509|365828345|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
106044361|NCT04526509|365828346|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
106044362|NCT04526509|365828347|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
106044363|NCT04526509|365828341|FG000|Enrolled|Study Terminated by Sponsor|0|||
106044364|NCT04526509|365828342|FG001|Enrolled|Study Terminated by Sponsor|0|||
106044365|NCT04526509|365828343|FG002|Enrolled|Study Terminated by Sponsor|0|||
106044366|NCT04526509|365828344|FG003|Enrolled|Study Terminated by Sponsor|0|||
106044367|NCT04526509|365828345|FG004|Enrolled|Study Terminated by Sponsor|0|||
106044368|NCT04526509|365828346|FG005|Enrolled|Study Terminated by Sponsor|0|||
106044369|NCT04526509|365828347|FG006|Enrolled|Study Terminated by Sponsor|1|||
106044370|NCT04526509|365828341|FG000|Enrolled|Death prior to lymphodepletion|0|||
106044371|NCT04526509|365828342|FG001|Enrolled|Death prior to lymphodepletion|0|||
106044372|NCT04526509|365828343|FG002|Enrolled|Death prior to lymphodepletion|0|||
106044373|NCT04526509|365828344|FG003|Enrolled|Death prior to lymphodepletion|1|||
106044374|NCT04526509|365828345|FG004|Enrolled|Death prior to lymphodepletion|0|||
106044375|NCT04526509|365828346|FG005|Enrolled|Death prior to lymphodepletion|0|||
106044376|NCT04526509|365828347|FG006|Enrolled|Death prior to lymphodepletion|0|||
106044377|NCT04526509|365828341|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
106044378|NCT04526509|365828342|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
106044379|NCT04526509|365828343|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
106044380|NCT04526509|365828344|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
106044381|NCT04526509|365828345|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
106044382|NCT04526509|365828346|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
106044383|NCT04526509|365828347|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
106044384|NCT04526509|365828341|FG000|Enrolled|Physician Decision|0|||
106044385|NCT04526509|365828342|FG001|Enrolled|Physician Decision|1|||
106044386|NCT04526509|365828343|FG002|Enrolled|Physician Decision|0|||
106044387|NCT04526509|365828344|FG003|Enrolled|Physician Decision|0|||
106044388|NCT04526509|365828345|FG004|Enrolled|Physician Decision|0|||
106044389|NCT04526509|365828346|FG005|Enrolled|Physician Decision|0|||
106044390|NCT04526509|365828347|FG006|Enrolled|Physician Decision|0|||
106044391|NCT02612129|365828348|FG000|Single Dose Treatment Period|Screening Failure|1|||
106044392|NCT02612129|365828349|FG001|Single Dose Treatment Period|Screening Failure|0|||
106044393|NCT02612129|365828350|FG002|Single Dose Treatment Period|Screening Failure|0|||
106044394|NCT02612129|365828348|FG000|Continuous Treatment Period|Early Escape|0|||
106044395|NCT02612129|365828349|FG001|Continuous Treatment Period|Early Escape|2|||
106044396|NCT02612129|365828350|FG002|Continuous Treatment Period|Early Escape|0|||
106044397|NCT02612129|365828348|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
106044398|NCT02612129|365828349|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
106044399|NCT02612129|365828350|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
106044400|NCT02612129|365828348|FG000|Continuous Treatment Period|Safety Reasons|0|||
106044401|NCT02612129|365828349|FG001|Continuous Treatment Period|Safety Reasons|3|||
106044402|NCT02612129|365828350|FG002|Continuous Treatment Period|Safety Reasons|0|||
106044403|NCT02612129|365828348|FG000|Continuous Treatment Period|Death|0|||
106044404|NCT02612129|365828349|FG001|Continuous Treatment Period|Death|1|||
106044405|NCT02612129|365828350|FG002|Continuous Treatment Period|Death|0|||
106044406|NCT02612129|365828348|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
106044407|NCT02612129|365828349|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
106044408|NCT02612129|365828350|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
106044409|NCT01067976|365828351|FG000|Overall Study|Study drug never administered|20|||
106044410|NCT01067976|365828351|FG000|Overall Study|Study prematurely discontinued|2|||
106044411|NCT04449861|365828352|FG000|Overall Study|Withdrawal by Subject|4|||
106044412|NCT04449861|365828352|FG000|Overall Study|Lost to Follow-up|5|||
106044413|NCT04449861|365828352|FG000|Overall Study|Death|112|||
106044414|NCT05268055|365828353|FG000|Overall Study|Lost to Follow-up|68|||
106044415|NCT05268055|365828354|FG001|Overall Study|Lost to Follow-up|68|||
106044416|NCT05268055|365828353|FG000|Overall Study|Withdrawal by Subject|12|||
106044417|NCT05268055|365828354|FG001|Overall Study|Withdrawal by Subject|8|||
106044418|NCT06238362|365828355|FG000|Overall Study|Insufficient total sleep time|1|||
106044419|NCT06238362|365828356|FG001|Overall Study|Insufficient total sleep time|0|||
106044420|NCT06238362|365828355|FG000|Overall Study|Inadequate signal quality|1|||
106044421|NCT06238362|365828356|FG001|Overall Study|Inadequate signal quality|0|||
106044422|NCT05136690|365828357|FG000|Period 1|Withdrawal by Subject|0|||
106044423|NCT05136690|365828358|FG001|Period 1|Withdrawal by Subject|1|||
106044424|NCT05136690|365828357|FG000|Period 2|Lost to Follow-up|0|||
106044425|NCT05136690|365828358|FG001|Period 2|Lost to Follow-up|3|||
106044426|NCT05136690|365828357|FG000|Period 2|Withdrawal by Subject|0|||
106044427|NCT05136690|365828358|FG001|Period 2|Withdrawal by Subject|1|||
106044428|NCT00891462|365829659|FG000|Overall Study|Withdrawal by Subject|9|||
106044429|NCT00891462|365829660|FG001|Overall Study|Withdrawal by Subject|6|||
106044430|NCT00891462|365829661|FG002|Overall Study|Withdrawal by Subject|7|||
106044431|NCT00891462|365829659|FG000|Overall Study|Adverse Event|7|||
106044432|NCT00891462|365829660|FG001|Overall Study|Adverse Event|8|||
106044433|NCT00891462|365829661|FG002|Overall Study|Adverse Event|7|||
106044434|NCT00891462|365829659|FG000|Overall Study|Lack of Efficacy|10|||
106044435|NCT00891462|365829660|FG001|Overall Study|Lack of Efficacy|5|||
106044436|NCT00891462|365829661|FG002|Overall Study|Lack of Efficacy|1|||
106044437|NCT00891462|365829659|FG000|Overall Study|COPD exacerbation|7|||
106044438|NCT00891462|365829660|FG001|Overall Study|COPD exacerbation|4|||
106044439|NCT00891462|365829661|FG002|Overall Study|COPD exacerbation|1|||
106044440|NCT00891462|365829659|FG000|Overall Study|Other Reason|2|||
106044441|NCT00891462|365829660|FG001|Overall Study|Other Reason|5|||
106044442|NCT00891462|365829661|FG002|Overall Study|Other Reason|3|||
106044443|NCT00891462|365829659|FG000|Overall Study|Protocol Violation|2|||
106044444|NCT00891462|365829660|FG001|Overall Study|Protocol Violation|1|||
106044445|NCT00891462|365829661|FG002|Overall Study|Protocol Violation|3|||
106044446|NCT00891462|365829659|FG000|Overall Study|Inclusion/exclusion criteria|0|||
106044447|NCT00891462|365829660|FG001|Overall Study|Inclusion/exclusion criteria|2|||
106044448|NCT00891462|365829661|FG002|Overall Study|Inclusion/exclusion criteria|2|||
106044449|NCT00891462|365829659|FG000|Overall Study|Lost to Follow-up|0|||
106044450|NCT00891462|365829660|FG001|Overall Study|Lost to Follow-up|2|||
106044451|NCT00891462|365829661|FG002|Overall Study|Lost to Follow-up|0|||
106044452|NCT00100178|365829674|FG000|Overall Study|Lost to Follow-up|0|||
106044453|NCT00100178|365829675|FG001|Overall Study|Lost to Follow-up|6|||
106044454|NCT00100178|365829676|FG002|Overall Study|Lost to Follow-up|5|||
106044455|NCT00100178|365829674|FG000|Overall Study|Adverse Event|2|||
106044456|NCT00100178|365829675|FG001|Overall Study|Adverse Event|2|||
106044457|NCT00100178|365829676|FG002|Overall Study|Adverse Event|1|||
106044458|NCT00100178|365829674|FG000|Overall Study|Withdrawal by Subject|1|||
106044459|NCT00100178|365829675|FG001|Overall Study|Withdrawal by Subject|1|||
106044460|NCT00100178|365829676|FG002|Overall Study|Withdrawal by Subject|1|||
106044461|NCT00100178|365829674|FG000|Overall Study|Physician Decision|6|||
106044462|NCT00100178|365829675|FG001|Overall Study|Physician Decision|1|||
106044463|NCT00100178|365829676|FG002|Overall Study|Physician Decision|3|||
106044464|NCT03198078|365829677|FG000|Overall Study|Adverse Event|0|||
106044465|NCT03198078|365829678|FG001|Overall Study|Adverse Event|1|||
106044466|NCT03198078|365829679|FG002|Overall Study|Adverse Event|2|||
106044467|NCT03198078|365829677|FG000|Overall Study|Lack of Efficacy|0|||
106044468|NCT03198078|365829678|FG001|Overall Study|Lack of Efficacy|0|||
106044469|NCT03198078|365829679|FG002|Overall Study|Lack of Efficacy|3|||
106044470|NCT03198078|365829677|FG000|Overall Study|Lost to Follow-up|1|||
106044471|NCT03198078|365829678|FG001|Overall Study|Lost to Follow-up|0|||
106044472|NCT03198078|365829679|FG002|Overall Study|Lost to Follow-up|0|||
106044473|NCT03198078|365829677|FG000|Overall Study|Pregnancy|0|||
106044474|NCT03198078|365829678|FG001|Overall Study|Pregnancy|1|||
106044475|NCT03198078|365829679|FG002|Overall Study|Pregnancy|0|||
106044476|NCT03198078|365829677|FG000|Overall Study|Withdrawal by Subject|1|||
106044477|NCT03198078|365829678|FG001|Overall Study|Withdrawal by Subject|0|||
106044478|NCT03198078|365829679|FG002|Overall Study|Withdrawal by Subject|2|||
106044479|NCT03198078|365829677|FG000|Overall Study|Withdrawal by Caregiver|1|||
106044480|NCT03198078|365829678|FG001|Overall Study|Withdrawal by Caregiver|3|||
106044481|NCT03198078|365829679|FG002|Overall Study|Withdrawal by Caregiver|5|||
106044482|NCT01578330|365829680|FG000|Overall Study|Adverse Event|2|||
106044483|NCT01578330|365829680|FG000|Overall Study|Protocol Violation|5|||
106044484|NCT01134731|365829681|FG000|Overall Study|Adverse Event|3|||
106044485|NCT01134731|365829682|FG001|Overall Study|Adverse Event|2|||
106044486|NCT01134731|365829683|FG002|Overall Study|Adverse Event|1|||
106044487|NCT01134731|365829681|FG000|Overall Study|Physician Decision|2|||
106044488|NCT01134731|365829682|FG001|Overall Study|Physician Decision|2|||
106044489|NCT01134731|365829683|FG002|Overall Study|Physician Decision|2|||
106044490|NCT01134731|365829681|FG000|Overall Study|Lack of Efficacy|0|||
106044491|NCT01134731|365829682|FG001|Overall Study|Lack of Efficacy|0|||
106044492|NCT01134731|365829683|FG002|Overall Study|Lack of Efficacy|1|||
106044493|NCT01134731|365829681|FG000|Overall Study|Withdrawal by Subject|3|||
106044494|NCT01134731|365829682|FG001|Overall Study|Withdrawal by Subject|3|||
106044495|NCT01134731|365829683|FG002|Overall Study|Withdrawal by Subject|1|||
106044496|NCT01134731|365829681|FG000|Overall Study|Lost to Follow-up|5|||
106044497|NCT01134731|365829682|FG001|Overall Study|Lost to Follow-up|4|||
106044498|NCT01134731|365829683|FG002|Overall Study|Lost to Follow-up|3|||
106044499|NCT00676338|365829684|FG000|Overall Study|Adverse Event|6|||
106044500|NCT00676338|365829685|FG001|Overall Study|Adverse Event|6|||
106044501|NCT00676338|365829686|FG002|Overall Study|Adverse Event|5|||
106044502|NCT00676338|365829687|FG003|Overall Study|Adverse Event|1|||
106044503|NCT00676338|365829684|FG000|Overall Study|Lost to Follow-up|4|||
106044504|NCT00676338|365829685|FG001|Overall Study|Lost to Follow-up|1|||
106044505|NCT00676338|365829686|FG002|Overall Study|Lost to Follow-up|3|||
106044506|NCT00676338|365829687|FG003|Overall Study|Lost to Follow-up|4|||
106044507|NCT00676338|365829684|FG000|Overall Study|Physician Decision|3|||
106044508|NCT00676338|365829685|FG001|Overall Study|Physician Decision|3|||
106044509|NCT00676338|365829686|FG002|Overall Study|Physician Decision|2|||
106044510|NCT00676338|365829687|FG003|Overall Study|Physician Decision|3|||
106044511|NCT00676338|365829684|FG000|Overall Study|Protocol Violation|5|||
106044512|NCT00676338|365829685|FG001|Overall Study|Protocol Violation|9|||
106044513|NCT00676338|365829686|FG002|Overall Study|Protocol Violation|2|||
106044514|NCT00676338|365829687|FG003|Overall Study|Protocol Violation|5|||
106044515|NCT00676338|365829684|FG000|Overall Study|Withdrawal by Subject|17|||
106044516|NCT00676338|365829685|FG001|Overall Study|Withdrawal by Subject|9|||
106044517|NCT00676338|365829686|FG002|Overall Study|Withdrawal by Subject|12|||
106044518|NCT00676338|365829687|FG003|Overall Study|Withdrawal by Subject|6|||
106044519|NCT00676338|365829684|FG000|Overall Study|Entry Criteria Not Met|0|||
106044520|NCT00676338|365829685|FG001|Overall Study|Entry Criteria Not Met|2|||
106044521|NCT00676338|365829686|FG002|Overall Study|Entry Criteria Not Met|1|||
106044522|NCT00676338|365829687|FG003|Overall Study|Entry Criteria Not Met|1|||
106044523|NCT00676338|365829684|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
106044524|NCT00676338|365829685|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
106044525|NCT00676338|365829686|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
106044526|NCT00676338|365829687|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
106044527|NCT00412542|365829688|FG000|Overall Study|Withdrawal by Subject|0|||
106044528|NCT00412542|365829689|FG001|Overall Study|Withdrawal by Subject|2|||
106044529|NCT00412542|365829688|FG000|Overall Study|Not Eligible|0|||
106044530|NCT00412542|365829689|FG001|Overall Study|Not Eligible|1|||
106044531|NCT03387683|365829690|FG000|Overall Study|In receipt of disallowed medication|1|||
106044532|NCT03387683|365829691|FG001|Overall Study|In receipt of disallowed medication|0|||
106044533|NCT03387683|365829690|FG000|Overall Study|Did not receive treatment|1|||
106044534|NCT03387683|365829691|FG001|Overall Study|Did not receive treatment|0|||
106044535|NCT01495975|365829696|FG000|Overall Study|Lost to Follow-up|1|||
106044536|NCT01495975|365829697|FG001|Overall Study|Lost to Follow-up|0|||
106044537|NCT04810481|365829703|FG000|Overall Study|Disqualified data sets|10|||
106044538|NCT04810481|365829704|FG001|Overall Study|Disqualified data sets|28|||
106044539|NCT00285818|365829705|FG000|Overall Study|Withdrawal by Subject|3|||
106044540|NCT00285818|365829706|FG001|Overall Study|Withdrawal by Subject|2|||
106044541|NCT00285818|365829705|FG000|Overall Study|Lost to Follow-up|1|||
106044542|NCT00285818|365829706|FG001|Overall Study|Lost to Follow-up|0|||
106044543|NCT00199875|365829710|FG000|Overall Study|Withdrawal by Subject|0|||
106044544|NCT00199875|365829711|FG001|Overall Study|Withdrawal by Subject|0|||
106044545|NCT00199875|365829712|FG002|Overall Study|Withdrawal by Subject|0|||
106044546|NCT00199875|365829713|FG003|Overall Study|Withdrawal by Subject|0|||
106044547|NCT00199875|365829714|FG004|Overall Study|Withdrawal by Subject|1|||
106044548|NCT01024231|365829715|FG000|Overall Study|Other Reasons|1|||
106044549|NCT01024231|365829716|FG001|Overall Study|Other Reasons|2|||
106044550|NCT01024231|365829717|FG002|Overall Study|Other Reasons|0|||
106044551|NCT01024231|365829718|FG003|Overall Study|Other Reasons|0|||
106044552|NCT01024231|365829719|FG004|Overall Study|Other Reasons|2|||
106044553|NCT01024231|365829720|FG005|Overall Study|Other Reasons|0|||
106044554|NCT01024231|365829721|FG006|Overall Study|Other Reasons|1|||
106044555|NCT01024231|365829715|FG000|Overall Study|Maximum Clinical Benefit|1|||
106044556|NCT01024231|365829716|FG001|Overall Study|Maximum Clinical Benefit|2|||
106044557|NCT01024231|365829717|FG002|Overall Study|Maximum Clinical Benefit|0|||
106044558|NCT01024231|365829718|FG003|Overall Study|Maximum Clinical Benefit|1|||
106044559|NCT01024231|365829719|FG004|Overall Study|Maximum Clinical Benefit|1|||
106044560|NCT01024231|365829720|FG005|Overall Study|Maximum Clinical Benefit|0|||
106044561|NCT01024231|365829721|FG006|Overall Study|Maximum Clinical Benefit|0|||
106044562|NCT01024231|365829715|FG000|Overall Study|Disease Progression|3|||
106044563|NCT01024231|365829716|FG001|Overall Study|Disease Progression|1|||
106044564|NCT01024231|365829717|FG002|Overall Study|Disease Progression|3|||
106044565|NCT01024231|365829718|FG003|Overall Study|Disease Progression|0|||
106044566|NCT01024231|365829719|FG004|Overall Study|Disease Progression|4|||
106044567|NCT01024231|365829720|FG005|Overall Study|Disease Progression|11|||
106044568|NCT01024231|365829721|FG006|Overall Study|Disease Progression|6|||
106044569|NCT01024231|365829715|FG000|Overall Study|AE unrelated to Study Drug|0|||
106044570|NCT01024231|365829716|FG001|Overall Study|AE unrelated to Study Drug|1|||
106044571|NCT01024231|365829717|FG002|Overall Study|AE unrelated to Study Drug|0|||
106044572|NCT01024231|365829718|FG003|Overall Study|AE unrelated to Study Drug|0|||
106044573|NCT01024231|365829719|FG004|Overall Study|AE unrelated to Study Drug|0|||
106044574|NCT01024231|365829720|FG005|Overall Study|AE unrelated to Study Drug|0|||
106044575|NCT01024231|365829721|FG006|Overall Study|AE unrelated to Study Drug|0|||
106044576|NCT01024231|365829715|FG000|Overall Study|No longer meets criteria|0|||
106044577|NCT01024231|365829716|FG001|Overall Study|No longer meets criteria|0|||
106044578|NCT01024231|365829717|FG002|Overall Study|No longer meets criteria|0|||
106044579|NCT01024231|365829718|FG003|Overall Study|No longer meets criteria|0|||
106044580|NCT01024231|365829719|FG004|Overall Study|No longer meets criteria|1|||
106044581|NCT01024231|365829720|FG005|Overall Study|No longer meets criteria|0|||
106044582|NCT01024231|365829721|FG006|Overall Study|No longer meets criteria|1|||
106044583|NCT01024231|365829715|FG000|Overall Study|Study Drug Toxicity|1|||
106044584|NCT01024231|365829716|FG001|Overall Study|Study Drug Toxicity|6|||
106044585|NCT01024231|365829717|FG002|Overall Study|Study Drug Toxicity|6|||
106044586|NCT01024231|365829718|FG003|Overall Study|Study Drug Toxicity|4|||
106044587|NCT01024231|365829719|FG004|Overall Study|Study Drug Toxicity|2|||
106044588|NCT01024231|365829720|FG005|Overall Study|Study Drug Toxicity|0|||
106044589|NCT01024231|365829721|FG006|Overall Study|Study Drug Toxicity|7|||
106044590|NCT01024231|365829715|FG000|Overall Study|Death|6|||
106044591|NCT01024231|365829716|FG001|Overall Study|Death|2|||
106044592|NCT01024231|365829717|FG002|Overall Study|Death|1|||
106044593|NCT01024231|365829718|FG003|Overall Study|Death|0|||
106044594|NCT01024231|365829719|FG004|Overall Study|Death|4|||
106044595|NCT01024231|365829720|FG005|Overall Study|Death|3|||
106044596|NCT01024231|365829721|FG006|Overall Study|Death|5|||
106044597|NCT01024231|365829715|FG000|Overall Study|Lost to Follow-up|0|||
106044598|NCT01024231|365829716|FG001|Overall Study|Lost to Follow-up|0|||
106044599|NCT01024231|365829717|FG002|Overall Study|Lost to Follow-up|0|||
106044600|NCT01024231|365829718|FG003|Overall Study|Lost to Follow-up|0|||
106044601|NCT01024231|365829719|FG004|Overall Study|Lost to Follow-up|0|||
106044602|NCT01024231|365829720|FG005|Overall Study|Lost to Follow-up|0|||
106044603|NCT01024231|365829721|FG006|Overall Study|Lost to Follow-up|1|||
106044604|NCT01024231|365829715|FG000|Overall Study|Withdrew Consent|0|||
106044605|NCT01024231|365829716|FG001|Overall Study|Withdrew Consent|1|||
106044606|NCT01024231|365829717|FG002|Overall Study|Withdrew Consent|0|||
106044607|NCT01024231|365829718|FG003|Overall Study|Withdrew Consent|0|||
106044608|NCT01024231|365829719|FG004|Overall Study|Withdrew Consent|0|||
106044609|NCT01024231|365829720|FG005|Overall Study|Withdrew Consent|0|||
106044610|NCT01024231|365829721|FG006|Overall Study|Withdrew Consent|0|||
106044611|NCT01024231|365829715|FG000|Overall Study|Continuing on Treatment|0|||
106044612|NCT01024231|365829716|FG001|Overall Study|Continuing on Treatment|0|||
106044613|NCT01024231|365829717|FG002|Overall Study|Continuing on Treatment|0|||
106044614|NCT01024231|365829718|FG003|Overall Study|Continuing on Treatment|0|||
106044615|NCT01024231|365829719|FG004|Overall Study|Continuing on Treatment|3|||
106044616|NCT01024231|365829720|FG005|Overall Study|Continuing on Treatment|2|||
106044617|NCT01024231|365829721|FG006|Overall Study|Continuing on Treatment|0|||
106044618|NCT01013350|365829722|FG000|Overall Study|Lost to Follow-up|15|||
106044619|NCT01013350|365829723|FG001|Overall Study|Lost to Follow-up|95|||
106044620|NCT01013350|365829722|FG000|Overall Study|Adverse Event|0|||
106044621|NCT01013350|365829723|FG001|Overall Study|Adverse Event|1|||
106044622|NCT01013350|365829722|FG000|Overall Study|Physician Decision|4|||
106044623|NCT01013350|365829723|FG001|Overall Study|Physician Decision|20|||
106044624|NCT01013350|365829722|FG000|Overall Study|Withdrawal by Subject|15|||
106044625|NCT01013350|365829723|FG001|Overall Study|Withdrawal by Subject|38|||
106044626|NCT01013350|365829722|FG000|Overall Study|Death|3|||
106044627|NCT01013350|365829723|FG001|Overall Study|Death|5|||
106044628|NCT01013350|365829722|FG000|Overall Study|Participant entered interventional study|0|||
106044629|NCT01013350|365829723|FG001|Overall Study|Participant entered interventional study|8|||
106044630|NCT01013350|365829722|FG000|Overall Study|Other|1|||
106044631|NCT01013350|365829723|FG001|Overall Study|Other|25|||
106044632|NCT02019277|365829724|FG000|Overall Study|Withdrawal by Subject|3|||
106044633|NCT02019277|365829724|FG000|Overall Study|Death|7|||
106044634|NCT02019277|365829724|FG000|Overall Study|Did no Cooperate|1|||
106044635|NCT02019277|365829724|FG000|Overall Study|Adverse Event|1|||
106044636|NCT02633501|365829726|FG000|Overall Study|Adverse Event|0|||
106044637|NCT02633501|365829727|FG001|Overall Study|Adverse Event|0|||
106044638|NCT02633501|365829728|FG002|Overall Study|Adverse Event|1|||
106044639|NCT02633501|365829729|FG003|Overall Study|Adverse Event|0|||
106044640|NCT02633501|365829730|FG004|Overall Study|Adverse Event|1|||
106044641|NCT02633501|365829731|FG005|Overall Study|Adverse Event|1|||
106044642|NCT02633501|365829726|FG000|Overall Study|Withdrawal by Subject|2|||
106044643|NCT02633501|365829727|FG001|Overall Study|Withdrawal by Subject|1|||
106044644|NCT02633501|365829728|FG002|Overall Study|Withdrawal by Subject|2|||
106044645|NCT02633501|365829729|FG003|Overall Study|Withdrawal by Subject|2|||
106044646|NCT02633501|365829730|FG004|Overall Study|Withdrawal by Subject|1|||
106044647|NCT02633501|365829731|FG005|Overall Study|Withdrawal by Subject|3|||
106044648|NCT02633501|365829726|FG000|Overall Study|Various other reasons|0|||
106044649|NCT02633501|365829727|FG001|Overall Study|Various other reasons|2|||
106044650|NCT02633501|365829728|FG002|Overall Study|Various other reasons|4|||
106044651|NCT02633501|365829729|FG003|Overall Study|Various other reasons|1|||
106044652|NCT02633501|365829730|FG004|Overall Study|Various other reasons|7|||
106044653|NCT02633501|365829731|FG005|Overall Study|Various other reasons|11|||
106044654|NCT02633501|365829726|FG000|Overall Study|Lost to Follow-up|0|||
106044655|NCT02633501|365829727|FG001|Overall Study|Lost to Follow-up|0|||
106044656|NCT02633501|365829728|FG002|Overall Study|Lost to Follow-up|0|||
106044657|NCT02633501|365829729|FG003|Overall Study|Lost to Follow-up|1|||
106044658|NCT02633501|365829730|FG004|Overall Study|Lost to Follow-up|2|||
106044659|NCT02633501|365829731|FG005|Overall Study|Lost to Follow-up|0|||
106044660|NCT02963935|365829739|FG000|Overall Study|Adverse Event|12|||
106044661|NCT02963935|365829740|FG001|Overall Study|Adverse Event|6|||
106044662|NCT02963935|365829739|FG000|Overall Study|Protocol Violation|2|||
106044663|NCT02963935|365829740|FG001|Overall Study|Protocol Violation|1|||
106044664|NCT02963935|365829739|FG000|Overall Study|Lack of Efficacy|0|||
106044665|NCT02963935|365829740|FG001|Overall Study|Lack of Efficacy|2|||
106044666|NCT02963935|365829739|FG000|Overall Study|Lost to Follow-up|1|||
106044667|NCT02963935|365829740|FG001|Overall Study|Lost to Follow-up|6|||
106044668|NCT02963935|365829739|FG000|Overall Study|Unclassified|13|||
106044669|NCT02963935|365829740|FG001|Overall Study|Unclassified|22|||
106044670|NCT00464269|365829741|FG000|Overall Study|Lack of Efficacy|1|||
106044671|NCT00464269|365829742|FG001|Overall Study|Lack of Efficacy|0|||
106044672|NCT00464269|365829743|FG002|Overall Study|Lack of Efficacy|0|||
106044673|NCT00464269|365829744|FG003|Overall Study|Lack of Efficacy|0|||
106044674|NCT00464269|365829741|FG000|Overall Study|Lost to Follow-up|0|||
106044675|NCT00464269|365829742|FG001|Overall Study|Lost to Follow-up|4|||
106044676|NCT00464269|365829743|FG002|Overall Study|Lost to Follow-up|0|||
106044677|NCT00464269|365829744|FG003|Overall Study|Lost to Follow-up|1|||
106044678|NCT00464269|365829741|FG000|Overall Study|Withdrawal by Subject|0|||
106044679|NCT00464269|365829742|FG001|Overall Study|Withdrawal by Subject|2|||
106044680|NCT00464269|365829743|FG002|Overall Study|Withdrawal by Subject|1|||
106044681|NCT00464269|365829744|FG003|Overall Study|Withdrawal by Subject|1|||
106044682|NCT00464269|365829741|FG000|Overall Study|Other reason|3|||
106044683|NCT00464269|365829742|FG001|Overall Study|Other reason|3|||
106044684|NCT00464269|365829743|FG002|Overall Study|Other reason|1|||
106044685|NCT00464269|365829744|FG003|Overall Study|Other reason|1|||
106044686|NCT00464269|365829741|FG000|Overall Study|AE, serious fatal|0|||
106044687|NCT00464269|365829742|FG001|Overall Study|AE, serious fatal|0|||
106044688|NCT00464269|365829743|FG002|Overall Study|AE, serious fatal|1|||
106044689|NCT00464269|365829744|FG003|Overall Study|AE, serious fatal|1|||
106044690|NCT00464269|365829741|FG000|Overall Study|SAE, non-fatal|0|||
106044691|NCT00464269|365829742|FG001|Overall Study|SAE, non-fatal|0|||
106044692|NCT00464269|365829743|FG002|Overall Study|SAE, non-fatal|0|||
106044693|NCT00464269|365829744|FG003|Overall Study|SAE, non-fatal|1|||
106044694|NCT00464269|365829741|FG000|Overall Study|AE, non-serious non-fatal|2|||
106044695|NCT00464269|365829742|FG001|Overall Study|AE, non-serious non-fatal|8|||
106044696|NCT00464269|365829743|FG002|Overall Study|AE, non-serious non-fatal|3|||
106044697|NCT00464269|365829744|FG003|Overall Study|AE, non-serious non-fatal|4|||
106044698|NCT00464269|365829741|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
106044699|NCT00464269|365829742|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
106044700|NCT00464269|365829743|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
106044701|NCT00464269|365829744|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
106152217|NCT02780388|366217075|FG002|Overall Study|Withdrawal by Subject|0|||
106152218|NCT02780388|366217076|FG003|Overall Study|Withdrawal by Subject|0|||
106044702|NCT02149875|365829745|FG000|Overall Study|Lost to Follow-up|3|||
106044703|NCT02149875|365829746|FG001|Overall Study|Lost to Follow-up|4|||
106044704|NCT02149875|365829747|FG002|Overall Study|Lost to Follow-up|5|||
106044705|NCT02149875|365829745|FG000|Overall Study|Withdrawal by Subject|3|||
106044706|NCT02149875|365829746|FG001|Overall Study|Withdrawal by Subject|2|||
106044707|NCT02149875|365829747|FG002|Overall Study|Withdrawal by Subject|2|||
106044708|NCT02149875|365829745|FG000|Overall Study|Physician Decision|1|||
106044709|NCT02149875|365829746|FG001|Overall Study|Physician Decision|2|||
106044710|NCT02149875|365829747|FG002|Overall Study|Physician Decision|2|||
106044711|NCT01032174|365829748|FG000|Overall Study|Adverse Event|0|||
106044712|NCT01032174|365829749|FG001|Overall Study|Adverse Event|1|||
106044713|NCT02713204|365829750|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
106044714|NCT02713204|365829751|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
106044715|NCT02713204|365829752|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
106044716|NCT02713204|365829753|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
106044717|NCT02713204|365829754|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
106044718|NCT02713204|365829755|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
106044719|NCT02713204|365829756|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
106044720|NCT02713204|365829757|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
106044721|NCT02713204|365829750|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
106044722|NCT02713204|365829751|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
106044723|NCT02713204|365829752|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
106044724|NCT02713204|365829753|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
106044725|NCT02713204|365829754|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
106044726|NCT02713204|365829755|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
106044727|NCT02713204|365829756|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
106044728|NCT02713204|365829757|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
106044729|NCT02713204|365829750|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
106044730|NCT02713204|365829751|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
106044731|NCT02713204|365829752|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
106044732|NCT02713204|365829753|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
106044733|NCT02713204|365829754|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
106044734|NCT02713204|365829755|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
106044735|NCT02713204|365829756|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
106044736|NCT02713204|365829757|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
106044737|NCT02713204|365829750|FG000|From Week 12 up to Week 36|Adverse Event|1|||
106044738|NCT02713204|365829751|FG001|From Week 12 up to Week 36|Adverse Event|0|||
106044739|NCT02713204|365829752|FG002|From Week 12 up to Week 36|Adverse Event|0|||
106044740|NCT02713204|365829753|FG003|From Week 12 up to Week 36|Adverse Event|1|||
106044741|NCT02713204|365829754|FG004|From Week 12 up to Week 36|Adverse Event|1|||
106044742|NCT02713204|365829755|FG005|From Week 12 up to Week 36|Adverse Event|0|||
106044743|NCT02713204|365829756|FG006|From Week 12 up to Week 36|Adverse Event|2|||
106044744|NCT02713204|365829757|FG007|From Week 12 up to Week 36|Adverse Event|1|||
106044745|NCT02713204|365829750|FG000|From Week 12 up to Week 36|Death|0|||
106044746|NCT02713204|365829751|FG001|From Week 12 up to Week 36|Death|0|||
106044747|NCT02713204|365829752|FG002|From Week 12 up to Week 36|Death|0|||
106044748|NCT02713204|365829753|FG003|From Week 12 up to Week 36|Death|1|||
106044749|NCT02713204|365829754|FG004|From Week 12 up to Week 36|Death|0|||
106044750|NCT02713204|365829755|FG005|From Week 12 up to Week 36|Death|1|||
106044751|NCT02713204|365829756|FG006|From Week 12 up to Week 36|Death|0|||
106044752|NCT02713204|365829757|FG007|From Week 12 up to Week 36|Death|3|||
106044753|NCT02713204|365829750|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
106044754|NCT02713204|365829751|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
106044755|NCT02713204|365829752|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
106044756|NCT02713204|365829753|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
106044757|NCT02713204|365829754|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
106044758|NCT02713204|365829755|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
106044759|NCT02713204|365829756|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
106044760|NCT02713204|365829757|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
106044761|NCT02713204|365829750|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
106044762|NCT02713204|365829751|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
106044763|NCT02713204|365829752|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
106044764|NCT02713204|365829753|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
106044765|NCT02713204|365829754|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
106044766|NCT02713204|365829755|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
106044767|NCT02713204|365829756|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
106044768|NCT02713204|365829757|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
106044769|NCT04251273|365829760|FG000|Overall Study|Lost to Follow-up|331|||
106044770|NCT04251273|365829761|FG001|Overall Study|Lost to Follow-up|290|||
106044771|NCT02081183|365829762|FG000|Overall Study|Lost to Follow-up|0|||
106044772|NCT02081183|365829763|FG001|Overall Study|Lost to Follow-up|1|||
106044773|NCT02081183|365829762|FG000|Overall Study|Protocol Violation|1|||
106044774|NCT02081183|365829763|FG001|Overall Study|Protocol Violation|0|||
106044775|NCT02081183|365829762|FG000|Overall Study|Other|3|||
106152219|NCT02780388|366217077|FG004|Overall Study|Withdrawal by Subject|0|||
106152220|NCT04527146|366217078|FG000|Overall Study|Withdrawal by Subject|12|||
106152221|NCT04527146|366217079|FG001|Overall Study|Withdrawal by Subject|15|||
106044776|NCT02081183|365829763|FG001|Overall Study|Other|3|||
106044777|NCT01528033|365829764|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
106044778|NCT01528033|365829765|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
106044779|NCT01528033|365829764|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
106044780|NCT01528033|365829765|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
106044781|NCT01528033|365829764|FG000|Primary Endpoint Assessment ITT|Death|2|||
106044782|NCT01528033|365829765|FG001|Primary Endpoint Assessment ITT|Death|2|||
106044783|NCT01528033|365829764|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
106044784|NCT01528033|365829765|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
106044785|NCT01528033|365829764|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
106044786|NCT01528033|365829765|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
106044787|NCT01528033|365829764|FG000|Follow Up|No data available|46|||
106044788|NCT01528033|365829765|FG001|Follow Up|No data available|44|||
106044789|NCT00543543|365829766|FG000|Base Study|Adverse Event|1|||
106044790|NCT00543543|365829767|FG001|Base Study|Adverse Event|11|||
106044791|NCT00543543|365829768|FG002|Base Study|Adverse Event|0|||
106044792|NCT00543543|365829769|FG003|Base Study|Adverse Event|5|||
106044793|NCT00543543|365829766|FG000|Base Study|Lost to Follow-up|12|||
106044794|NCT00543543|365829767|FG001|Base Study|Lost to Follow-up|749|||
106044795|NCT00543543|365829768|FG002|Base Study|Lost to Follow-up|9|||
106044796|NCT00543543|365829769|FG003|Base Study|Lost to Follow-up|701|||
106044797|NCT00543543|365829766|FG000|Base Study|Physician Decision|0|||
106044798|NCT00543543|365829767|FG001|Base Study|Physician Decision|4|||
106044799|NCT00543543|365829768|FG002|Base Study|Physician Decision|0|||
106044800|NCT00543543|365829769|FG003|Base Study|Physician Decision|7|||
106044801|NCT00543543|365829766|FG000|Base Study|Protocol Violation|0|||
106044802|NCT00543543|365829767|FG001|Base Study|Protocol Violation|6|||
106044803|NCT00543543|365829768|FG002|Base Study|Protocol Violation|0|||
106044804|NCT00543543|365829769|FG003|Base Study|Protocol Violation|6|||
106044805|NCT00543543|365829766|FG000|Base Study|Withdrawal by Subject|7|||
106044806|NCT00543543|365829767|FG001|Base Study|Withdrawal by Subject|482|||
106044807|NCT00543543|365829768|FG002|Base Study|Withdrawal by Subject|5|||
106044808|NCT00543543|365829769|FG003|Base Study|Withdrawal by Subject|503|||
106044809|NCT00543543|365829766|FG000|Extension Study|Adverse Event|0|||
106044810|NCT00543543|365829767|FG001|Extension Study|Adverse Event|0|||
106044811|NCT00543543|365829768|FG002|Extension Study|Adverse Event|0|||
106044812|NCT00543543|365829769|FG003|Extension Study|Adverse Event|5|||
106044813|NCT00543543|365829766|FG000|Extension Study|Lost to Follow-up|0|||
106044814|NCT00543543|365829767|FG001|Extension Study|Lost to Follow-up|0|||
106044815|NCT00543543|365829768|FG002|Extension Study|Lost to Follow-up|0|||
106044816|NCT00543543|365829769|FG003|Extension Study|Lost to Follow-up|77|||
106044817|NCT00543543|365829766|FG000|Extension Study|Physician Decision|0|||
106044818|NCT00543543|365829767|FG001|Extension Study|Physician Decision|0|||
106044819|NCT00543543|365829768|FG002|Extension Study|Physician Decision|0|||
106044820|NCT00543543|365829769|FG003|Extension Study|Physician Decision|7|||
106044821|NCT00543543|365829766|FG000|Extension Study|Pregnancy|0|||
106044822|NCT00543543|365829767|FG001|Extension Study|Pregnancy|0|||
106044823|NCT00543543|365829768|FG002|Extension Study|Pregnancy|0|||
106044824|NCT00543543|365829769|FG003|Extension Study|Pregnancy|6|||
106044825|NCT00543543|365829766|FG000|Extension Study|Protocol Violation|0|||
106044826|NCT00543543|365829767|FG001|Extension Study|Protocol Violation|0|||
106044827|NCT00543543|365829768|FG002|Extension Study|Protocol Violation|0|||
106044828|NCT00543543|365829769|FG003|Extension Study|Protocol Violation|11|||
106044829|NCT00543543|365829766|FG000|Extension Study|Withdrawal by Subject|0|||
106044830|NCT00543543|365829767|FG001|Extension Study|Withdrawal by Subject|0|||
106044831|NCT00543543|365829768|FG002|Extension Study|Withdrawal by Subject|0|||
106044832|NCT00543543|365829769|FG003|Extension Study|Withdrawal by Subject|120|||
106044833|NCT04815031|365829771|FG000|Overall Study|No adverse event information (missing information)|33|||
106044834|NCT04502979|365829772|FG000|Overall Study|Lost to Follow-up|1|||
106044835|NCT04502979|365829773|FG001|Overall Study|Lost to Follow-up|3|||
106044836|NCT04502979|365829772|FG000|Overall Study|Withdrawal by Subject|2|||
106044837|NCT04502979|365829773|FG001|Overall Study|Withdrawal by Subject|1|||
105862522|NCT02119819|365147996|FG004|Overall Study|Protocol Violation|0|||
105862523|NCT02119819|365147997|FG005|Overall Study|Protocol Violation|0|||
106044838|NCT03331250|365829774|FG000|Overall Study|Withdrawal by Subject|1|||
106044839|NCT00761631|365829775|FG000|Overall Study|Parent/legal guardian request|8|||
106044840|NCT00761631|365829776|FG001|Overall Study|Parent/legal guardian request|3|||
106044841|NCT00761631|365829777|FG002|Overall Study|Parent/legal guardian request|8|||
106044842|NCT00761631|365829778|FG003|Overall Study|Parent/legal guardian request|0|||
106044843|NCT00761631|365829779|FG004|Overall Study|Parent/legal guardian request|5|||
106044844|NCT00761631|365829780|FG005|Overall Study|Parent/legal guardian request|0|||
106044845|NCT00761631|365829775|FG000|Overall Study|Lost to Follow-up|2|||
106044846|NCT00761631|365829776|FG001|Overall Study|Lost to Follow-up|4|||
106044847|NCT00761631|365829777|FG002|Overall Study|Lost to Follow-up|7|||
106044848|NCT00761631|365829778|FG003|Overall Study|Lost to Follow-up|1|||
106044849|NCT00761631|365829779|FG004|Overall Study|Lost to Follow-up|6|||
106044850|NCT00761631|365829780|FG005|Overall Study|Lost to Follow-up|1|||
106044851|NCT00761631|365829775|FG000|Overall Study|Protocol Violation|2|||
106044852|NCT00761631|365829776|FG001|Overall Study|Protocol Violation|0|||
106044853|NCT00761631|365829777|FG002|Overall Study|Protocol Violation|0|||
106044854|NCT00761631|365829778|FG003|Overall Study|Protocol Violation|1|||
106044855|NCT00761631|365829779|FG004|Overall Study|Protocol Violation|5|||
106044856|NCT00761631|365829780|FG005|Overall Study|Protocol Violation|1|||
106044857|NCT00761631|365829775|FG000|Overall Study|Randomized, not treated|1|||
106044858|NCT00761631|365829776|FG001|Overall Study|Randomized, not treated|0|||
105862524|NCT02119819|365147992|FG000|Overall Study|Left the city to get a job|0|||
106044859|NCT00761631|365829777|FG002|Overall Study|Randomized, not treated|0|||
106044860|NCT00761631|365829778|FG003|Overall Study|Randomized, not treated|0|||
106044861|NCT00761631|365829779|FG004|Overall Study|Randomized, not treated|0|||
106044862|NCT00761631|365829780|FG005|Overall Study|Randomized, not treated|0|||
106044863|NCT00761631|365829775|FG000|Overall Study|Failed to return|1|||
106044864|NCT00761631|365829776|FG001|Overall Study|Failed to return|0|||
106044865|NCT00761631|365829777|FG002|Overall Study|Failed to return|1|||
106044866|NCT00761631|365829778|FG003|Overall Study|Failed to return|1|||
106044867|NCT00761631|365829779|FG004|Overall Study|Failed to return|5|||
106044868|NCT00761631|365829780|FG005|Overall Study|Failed to return|2|||
106044869|NCT00761631|365829775|FG000|Overall Study|Physician Decision|1|||
106044870|NCT00761631|365829776|FG001|Overall Study|Physician Decision|0|||
106044871|NCT00761631|365829777|FG002|Overall Study|Physician Decision|0|||
106044872|NCT00761631|365829778|FG003|Overall Study|Physician Decision|0|||
106044873|NCT00761631|365829779|FG004|Overall Study|Physician Decision|0|||
106044874|NCT00761631|365829780|FG005|Overall Study|Physician Decision|0|||
106044875|NCT00761631|365829775|FG000|Overall Study|Other|0|||
106044876|NCT00761631|365829776|FG001|Overall Study|Other|0|||
106044877|NCT00761631|365829777|FG002|Overall Study|Other|0|||
106044878|NCT00761631|365829778|FG003|Overall Study|Other|0|||
106044879|NCT00761631|365829779|FG004|Overall Study|Other|1|||
106044880|NCT00761631|365829780|FG005|Overall Study|Other|1|||
106044881|NCT00289016|365829781|FG000|Overall Study|Disease Progression|29|||
106044882|NCT00289016|365829781|FG000|Overall Study|Death|2|||
106044883|NCT00289016|365829781|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
106044884|NCT00289016|365829781|FG000|Overall Study|Withdrawal by Subject|2|||
106044885|NCT00289016|365829781|FG000|Overall Study|Adverse Event|1|||
106044886|NCT00289016|365829781|FG000|Overall Study|Other|1|||
106044887|NCT03553927|365829782|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
106044888|NCT03553927|365829783|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
106044889|NCT03553927|365829782|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
106044890|NCT03553927|365829783|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
106044891|NCT02423772|365829784|FG000|Overall Study|Lost to Follow-up|3|||
106044892|NCT02423772|365829785|FG001|Overall Study|Lost to Follow-up|3|||
106044893|NCT02423772|365829784|FG000|Overall Study|Did not begin intervention|2|||
106044894|NCT02423772|365829785|FG001|Overall Study|Did not begin intervention|5|||
106044895|NCT01066000|365829792|FG000|Overall Study|Protocol Violation|4|||
106044896|NCT01066000|365829792|FG000|Overall Study|Death|3|||
106044897|NCT01066000|365829792|FG000|Overall Study|Withdrawal by Subject|1|||
106044898|NCT01066000|365829792|FG000|Overall Study|Adverse Event|1|||
106044899|NCT01386008|365829793|FG000|Overall Study|exited w/o incident /study discontinued|17|||
106044900|NCT01386008|365829793|FG000|Overall Study|Adverse Event|3|||
106044901|NCT00423722|365831219|FG000|Overall Study|Death|4|||
106044902|NCT00423722|365831220|FG001|Overall Study|Death|4|||
106044903|NCT00423722|365831219|FG000|Overall Study|Declined to participate|2|||
106044904|NCT00423722|365831220|FG001|Overall Study|Declined to participate|3|||
106044905|NCT00423722|365831219|FG000|Overall Study|Unable to complete questionnaires|4|||
106044906|NCT00423722|365831220|FG001|Overall Study|Unable to complete questionnaires|4|||
106044907|NCT00423722|365831219|FG000|Overall Study|Withdrawal by Subject|4|||
106044908|NCT00423722|365831220|FG001|Overall Study|Withdrawal by Subject|2|||
106044909|NCT00257608|365831223|FG000|Chemotherapy Phase|Adverse Event|138|||
106044910|NCT00257608|365831224|FG001|Chemotherapy Phase|Adverse Event|0|||
106044911|NCT00257608|365831225|FG002|Chemotherapy Phase|Adverse Event|0|||
106044912|NCT00257608|365831223|FG000|Chemotherapy Phase|Disease progression|139|||
106044913|NCT00257608|365831224|FG001|Chemotherapy Phase|Disease progression|0|||
106044914|NCT00257608|365831225|FG002|Chemotherapy Phase|Disease progression|0|||
106044915|NCT00257608|365831223|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
106044916|NCT00257608|365831224|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
106044917|NCT00257608|365831225|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
106044918|NCT00257608|365831223|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
106044919|NCT00257608|365831224|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
106044920|NCT00257608|365831225|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
106044921|NCT00257608|365831223|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
106044922|NCT00257608|365831224|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
106044923|NCT00257608|365831225|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
106044924|NCT00257608|365831223|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
106044925|NCT00257608|365831224|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
106044926|NCT00257608|365831225|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
106044927|NCT00257608|365831223|FG000|Chemotherapy Phase|Physician Decision|28|||
106044928|NCT00257608|365831224|FG001|Chemotherapy Phase|Physician Decision|0|||
106044929|NCT00257608|365831225|FG002|Chemotherapy Phase|Physician Decision|0|||
106044930|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Adverse Event|0|||
106044931|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Adverse Event|34|||
106044932|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Adverse Event|38|||
106044933|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Disease progression|0|||
106044934|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Disease progression|204|||
106044935|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Disease progression|168|||
106044936|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
106044937|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
106044938|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
106044939|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
106044940|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
106044941|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
106044942|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
106044943|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
106044944|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
106044945|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
106044946|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
106044947|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
106044948|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
106044949|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
106044950|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
106044951|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Physician Decision|0|||
106044952|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Physician Decision|8|||
106044953|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Physician Decision|11|||
106044954|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
106044955|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
106044956|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
106044957|NCT00257608|365831223|FG000|Post Chemotherapy Phase|Not treated|0|||
106044958|NCT00257608|365831224|FG001|Post Chemotherapy Phase|Not treated|4|||
106044959|NCT00257608|365831225|FG002|Post Chemotherapy Phase|Not treated|7|||
106044960|NCT00518687|365831226|FG000|Overall Study|Adverse Event|201|||
106044961|NCT00518687|365831227|FG001|Overall Study|Adverse Event|177|||
106044962|NCT00518687|365831226|FG000|Overall Study|Lost to Follow-up|144|||
106044963|NCT00518687|365831227|FG001|Overall Study|Lost to Follow-up|155|||
106044964|NCT00518687|365831226|FG000|Overall Study|Physician Decision|42|||
106044965|NCT00518687|365831227|FG001|Overall Study|Physician Decision|48|||
106044966|NCT00518687|365831226|FG000|Overall Study|Progressive disease|2|||
106044967|NCT00518687|365831227|FG001|Overall Study|Progressive disease|2|||
106044968|NCT00518687|365831226|FG000|Overall Study|Protocol Violation|8|||
106044969|NCT00518687|365831227|FG001|Overall Study|Protocol Violation|10|||
106044970|NCT00518687|365831226|FG000|Overall Study|Study terminated by sponsor|930|||
106044971|NCT00518687|365831227|FG001|Overall Study|Study terminated by sponsor|918|||
106044972|NCT00518687|365831226|FG000|Overall Study|Withdrawal by Subject|110|||
106044973|NCT00518687|365831227|FG001|Overall Study|Withdrawal by Subject|110|||
106044974|NCT01846104|365831229|FG000|Overall Study|Withdrawal by Subject|1|||
106044975|NCT00851630|365831230|FG000|Overall Study|Death|2|||
106044976|NCT00851630|365831231|FG001|Overall Study|Death|1|||
106044977|NCT00851630|365831230|FG000|Overall Study|Clinical failure|0|||
106044978|NCT00851630|365831231|FG001|Overall Study|Clinical failure|1|||
106044979|NCT02349061|365831236|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
106044980|NCT02349061|365831237|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
106044981|NCT02349061|365831238|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
106044982|NCT02349061|365831236|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
106044983|NCT02349061|365831237|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
106044984|NCT02349061|365831238|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
106044985|NCT02349061|365831236|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
106044986|NCT02349061|365831237|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
106044987|NCT02349061|365831238|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
106044988|NCT02349061|365831236|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
106044989|NCT02349061|365831237|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
106044990|NCT02349061|365831238|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
106044991|NCT02349061|365831236|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
106044992|NCT02349061|365831237|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
106044993|NCT02349061|365831238|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
106044994|NCT02349061|365831236|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
106044995|NCT02349061|365831237|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
106044996|NCT02349061|365831238|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
106044997|NCT02349061|365831236|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
106044998|NCT02349061|365831237|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
106044999|NCT02349061|365831238|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
106045000|NCT02349061|365831236|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
105862525|NCT02119819|365147993|FG001|Overall Study|Left the city to get a job|0|||
105862526|NCT02119819|365147994|FG002|Overall Study|Left the city to get a job|0|||
106045001|NCT02349061|365831237|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
106045002|NCT02349061|365831238|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
106045003|NCT02349061|365831236|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
106045004|NCT02349061|365831237|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
105862527|NCT02119819|365147995|FG003|Overall Study|Left the city to get a job|1|||
105862528|NCT02119819|365147996|FG004|Overall Study|Left the city to get a job|0|||
106045005|NCT02349061|365831238|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
105862529|NCT02119819|365147997|FG005|Overall Study|Left the city to get a job|0|||
106045006|NCT02349061|365831236|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
106045007|NCT02349061|365831237|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
106045008|NCT02349061|365831238|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
106045009|NCT02349061|365831236|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
106045010|NCT02349061|365831237|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
106045011|NCT02349061|365831238|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
106045012|NCT02349061|365831236|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
106045013|NCT02349061|365831237|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
106045014|NCT02349061|365831238|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
106045015|NCT02349061|365831236|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
106045016|NCT02349061|365831237|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
106045017|NCT02349061|365831238|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
106045018|NCT00398411|365831239|FG000|Overall Study|Death|0|||
106045019|NCT00398411|365831240|FG001|Overall Study|Death|1|||
106045020|NCT01397162|365831241|FG000|Overall Study|Adverse Event|4|||
106045021|NCT01397162|365831242|FG001|Overall Study|Adverse Event|0|||
106045022|NCT01397162|365831243|FG002|Overall Study|Adverse Event|0|||
106045023|NCT01397162|365831244|FG003|Overall Study|Adverse Event|0|||
106045024|NCT01397162|365831245|FG004|Overall Study|Adverse Event|0|||
106045025|NCT01397162|365831241|FG000|Overall Study|Not yet defined|3|||
106045026|NCT01397162|365831242|FG001|Overall Study|Not yet defined|4|||
106045027|NCT01397162|365831243|FG002|Overall Study|Not yet defined|3|||
106045028|NCT01397162|365831244|FG003|Overall Study|Not yet defined|5|||
106045029|NCT01397162|365831245|FG004|Overall Study|Not yet defined|3|||
106045030|NCT02339285|365831246|FG000|Overall Study|Withdrawal by Subject|0|||
106045031|NCT02339285|365831247|FG001|Overall Study|Withdrawal by Subject|1|||
106045032|NCT02339285|365831248|FG002|Overall Study|Withdrawal by Subject|1|||
106045033|NCT02339285|365831246|FG000|Overall Study|Lost to Follow-up|1|||
106045034|NCT02339285|365831247|FG001|Overall Study|Lost to Follow-up|1|||
106045035|NCT02339285|365831248|FG002|Overall Study|Lost to Follow-up|1|||
106045036|NCT02339285|365831246|FG000|Overall Study|Protocol Deviation|0|||
106045037|NCT02339285|365831247|FG001|Overall Study|Protocol Deviation|1|||
106045038|NCT02339285|365831248|FG002|Overall Study|Protocol Deviation|0|||
106045039|NCT00401531|365831251|FG000|Overall Study|Adverse Event|2|||
106045040|NCT00401531|365831252|FG001|Overall Study|Adverse Event|0|||
106045041|NCT00401531|365831251|FG000|Overall Study|Protocol Violation|3|||
106045042|NCT00401531|365831252|FG001|Overall Study|Protocol Violation|7|||
106045043|NCT00401531|365831251|FG000|Overall Study|Lost to Follow-up|1|||
106045044|NCT00401531|365831252|FG001|Overall Study|Lost to Follow-up|1|||
106045045|NCT00401531|365831251|FG000|Overall Study|Withdrawal by Subject|3|||
106045046|NCT00401531|365831252|FG001|Overall Study|Withdrawal by Subject|2|||
106045047|NCT00282412|365831253|FG000|Overall Study|Death|2|||
106045048|NCT01858376|365831256|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
106045049|NCT00108433|365831257|FG000|Overall Study|Lack of Efficacy|1|||
106045050|NCT00108433|365831258|FG001|Overall Study|Lack of Efficacy|2|||
106045051|NCT00108433|365831257|FG000|Overall Study|Death|3|||
106045052|NCT00108433|365831258|FG001|Overall Study|Death|0|||
106045053|NCT00108433|365831257|FG000|Overall Study|Adverse Event|3|||
106045054|NCT00108433|365831258|FG001|Overall Study|Adverse Event|1|||
106045055|NCT00108433|365831257|FG000|Overall Study|Other|14|||
106045056|NCT00108433|365831258|FG001|Overall Study|Other|14|||
106045057|NCT02203071|365831259|FG000|Overall Study|Lost to Follow-up|3|||
106045058|NCT02203071|365831260|FG001|Overall Study|Lost to Follow-up|1|||
106045059|NCT03589469|365831263|FG000|Overall Study|Withdrawal by Subject|8|||
106045060|NCT03589469|365831263|FG000|Overall Study|Physician Decision|20|||
106045061|NCT03589469|365831263|FG000|Overall Study|Death|97|||
106045062|NCT03589469|365831263|FG000|Overall Study|Lost to Follow-up|8|||
106045063|NCT03589469|365831263|FG000|Overall Study|Miscellaneous|1|||
106045064|NCT02202837|365831264|FG000|Overall Study|Enbrel treatment discontinued|36|||
106045065|NCT02202837|365831265|FG001|Overall Study|Enbrel treatment discontinued|4|||
106045066|NCT02202837|365831264|FG000|Overall Study|Other|10|||
106045067|NCT02202837|365831265|FG001|Overall Study|Other|0|||
106045068|NCT02202837|365831264|FG000|Overall Study|Lost to Follow-up|7|||
106045069|NCT02202837|365831265|FG001|Overall Study|Lost to Follow-up|1|||
106045070|NCT01364649|365831275|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
106045071|NCT01364649|365831276|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
106045072|NCT01364649|365831275|FG000|Overall Study|Lack of Efficacy|6|||
106045073|NCT01364649|365831276|FG001|Overall Study|Lack of Efficacy|0|||
106045074|NCT01364649|365831275|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
106045075|NCT01364649|365831276|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
106045076|NCT01364649|365831275|FG000|Overall Study|Protocol Deviations|4|||
106045077|NCT01364649|365831276|FG001|Overall Study|Protocol Deviations|8|||
106045078|NCT01364649|365831275|FG000|Overall Study|Withdrawal of Consent|9|||
106045079|NCT01364649|365831276|FG001|Overall Study|Withdrawal of Consent|7|||
106045080|NCT01364649|365831275|FG000|Overall Study|Lost to Follow-up|12|||
106045081|NCT01364649|365831276|FG001|Overall Study|Lost to Follow-up|13|||
106045082|NCT01364649|365831275|FG000|Overall Study|Other|4|||
106045083|NCT01364649|365831276|FG001|Overall Study|Other|1|||
106045084|NCT02468232|365831277|FG000|Core Part of Study|Adverse Event|0|||
106045085|NCT02468232|365831278|FG001|Core Part of Study|Adverse Event|1|||
106045086|NCT02468232|365831279|FG002|Core Part of Study|Adverse Event|0|||
106045087|NCT02468232|365831280|FG003|Core Part of Study|Adverse Event|0|||
106045088|NCT02468232|365831277|FG000|Core Part of Study|Death|20|||
106045089|NCT02468232|365831278|FG001|Core Part of Study|Death|17|||
106045090|NCT02468232|365831279|FG002|Core Part of Study|Death|0|||
106045091|NCT02468232|365831280|FG003|Core Part of Study|Death|0|||
106045092|NCT02468232|365831277|FG000|Core Part of Study|Technical Problems|1|||
106045093|NCT02468232|365831278|FG001|Core Part of Study|Technical Problems|1|||
106045094|NCT02468232|365831279|FG002|Core Part of Study|Technical Problems|0|||
106045095|NCT02468232|365831280|FG003|Core Part of Study|Technical Problems|0|||
106045096|NCT02468232|365831277|FG000|OLE Part of Study|Adverse Event|0|||
106045097|NCT02468232|365831278|FG001|OLE Part of Study|Adverse Event|0|||
106045098|NCT02468232|365831279|FG002|OLE Part of Study|Adverse Event|4|||
106045099|NCT02468232|365831280|FG003|OLE Part of Study|Adverse Event|5|||
106045100|NCT02468232|365831277|FG000|OLE Part of Study|Death|0|||
106045101|NCT02468232|365831278|FG001|OLE Part of Study|Death|0|||
106045102|NCT02468232|365831279|FG002|OLE Part of Study|Death|4|||
106045103|NCT02468232|365831280|FG003|OLE Part of Study|Death|2|||
106045104|NCT02468232|365831277|FG000|OLE Part of Study|Physician Decision|0|||
106045105|NCT02468232|365831278|FG001|OLE Part of Study|Physician Decision|0|||
106045106|NCT02468232|365831279|FG002|OLE Part of Study|Physician Decision|4|||
106045107|NCT02468232|365831280|FG003|OLE Part of Study|Physician Decision|0|||
106045108|NCT02468232|365831277|FG000|OLE Part of Study|Subject/Guardian decision|0|||
106045109|NCT02468232|365831278|FG001|OLE Part of Study|Subject/Guardian decision|0|||
106045110|NCT02468232|365831279|FG002|OLE Part of Study|Subject/Guardian decision|2|||
106045111|NCT02468232|365831280|FG003|OLE Part of Study|Subject/Guardian decision|5|||
106045112|NCT02764333|365831283|FG000|Overall Study|Ineligible|1|||
106045113|NCT00902668|365831286|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
106045114|NCT02024529|365831289|FG000|Overall Study|Withdrawal by Subject|11|||
106045115|NCT02024529|365831290|FG001|Overall Study|Withdrawal by Subject|21|||
106045116|NCT02024529|365831289|FG000|Overall Study|Lost to Follow-up|2|||
106045117|NCT02024529|365831290|FG001|Overall Study|Lost to Follow-up|4|||
106045118|NCT00354614|365831291|FG000|Overall Study|Lack of Efficacy|28|||
106045119|NCT01676727|365831292|FG000|Overall Study|Death|18|||
106045120|NCT01676727|365831292|FG000|Overall Study|Withdrawal by Subject|6|||
106045121|NCT01676727|365831292|FG000|Overall Study|Screening failure|5|||
106045122|NCT01676727|365831292|FG000|Overall Study|Not willing to attend 1-year visit|2|||
106045123|NCT01676727|365831292|FG000|Overall Study|Valve explanted|1|||
106045124|NCT02122458|365831295|FG000|Overall Study|Withdrawal by Subject|0|||
106045125|NCT02122458|365831296|FG001|Overall Study|Withdrawal by Subject|0|||
106045126|NCT02122458|365831297|FG002|Overall Study|Withdrawal by Subject|0|||
106045127|NCT02122458|365831298|FG003|Overall Study|Withdrawal by Subject|4|||
106045128|NCT02122458|365831299|FG004|Overall Study|Withdrawal by Subject|4|||
106045129|NCT02122458|365831300|FG005|Overall Study|Withdrawal by Subject|4|||
106045130|NCT02122458|365831301|FG006|Overall Study|Withdrawal by Subject|0|||
106045131|NCT02122458|365831295|FG000|Overall Study|Lost to Follow-up|1|||
106045132|NCT02122458|365831296|FG001|Overall Study|Lost to Follow-up|3|||
106045133|NCT02122458|365831297|FG002|Overall Study|Lost to Follow-up|0|||
106045134|NCT02122458|365831298|FG003|Overall Study|Lost to Follow-up|7|||
106045135|NCT02122458|365831299|FG004|Overall Study|Lost to Follow-up|5|||
106045136|NCT02122458|365831300|FG005|Overall Study|Lost to Follow-up|15|||
106045137|NCT02122458|365831301|FG006|Overall Study|Lost to Follow-up|1|||
106045138|NCT02122458|365831295|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
106045139|NCT02122458|365831296|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
106045140|NCT02122458|365831297|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
106045141|NCT02122458|365831298|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
106045142|NCT02122458|365831299|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
106045143|NCT02122458|365831300|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
106045144|NCT02122458|365831301|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
106045145|NCT02122458|365831295|FG000|Overall Study|Adverse Event|1|||
106045146|NCT02122458|365831296|FG001|Overall Study|Adverse Event|0|||
106045147|NCT02122458|365831297|FG002|Overall Study|Adverse Event|0|||
106045148|NCT02122458|365831298|FG003|Overall Study|Adverse Event|0|||
106045149|NCT02122458|365831299|FG004|Overall Study|Adverse Event|0|||
106045150|NCT02122458|365831300|FG005|Overall Study|Adverse Event|0|||
106045151|NCT02122458|365831301|FG006|Overall Study|Adverse Event|0|||
106045152|NCT02122458|365831295|FG000|Overall Study|Experimental Error|0|||
106045153|NCT02122458|365831296|FG001|Overall Study|Experimental Error|0|||
106045154|NCT02122458|365831297|FG002|Overall Study|Experimental Error|0|||
106045155|NCT02122458|365831298|FG003|Overall Study|Experimental Error|0|||
106045156|NCT02122458|365831299|FG004|Overall Study|Experimental Error|3|||
106045157|NCT02122458|365831300|FG005|Overall Study|Experimental Error|0|||
106045158|NCT02122458|365831301|FG006|Overall Study|Experimental Error|0|||
106045159|NCT02122458|365831295|FG000|Overall Study|Deployed or Moved|0|||
106045160|NCT02122458|365831296|FG001|Overall Study|Deployed or Moved|0|||
106045161|NCT02122458|365831297|FG002|Overall Study|Deployed or Moved|0|||
106045162|NCT02122458|365831298|FG003|Overall Study|Deployed or Moved|0|||
106045163|NCT02122458|365831299|FG004|Overall Study|Deployed or Moved|1|||
106045164|NCT02122458|365831300|FG005|Overall Study|Deployed or Moved|0|||
106045165|NCT02122458|365831301|FG006|Overall Study|Deployed or Moved|0|||
106045166|NCT02122458|365831295|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
106045167|NCT02122458|365831296|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
106045168|NCT02122458|365831297|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
106045169|NCT02122458|365831298|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
106045170|NCT02122458|365831299|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
106045171|NCT02122458|365831300|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
106045172|NCT02122458|365831301|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
106045173|NCT02122458|365831295|FG000|Overall Study|Noncompliance|0|||
106045174|NCT02122458|365831296|FG001|Overall Study|Noncompliance|1|||
106045175|NCT02122458|365831297|FG002|Overall Study|Noncompliance|0|||
106045176|NCT02122458|365831298|FG003|Overall Study|Noncompliance|0|||
106045177|NCT02122458|365831299|FG004|Overall Study|Noncompliance|0|||
106045178|NCT02122458|365831300|FG005|Overall Study|Noncompliance|0|||
106045179|NCT02122458|365831301|FG006|Overall Study|Noncompliance|0|||
106045180|NCT03161093|365831304|FG000|Overall Study|Protocol Violation|11|||
106045181|NCT03161093|365831305|FG001|Overall Study|Protocol Violation|14|||
106045182|NCT03161093|365831306|FG002|Overall Study|Protocol Violation|6|||
106045183|NCT03161093|365831307|FG003|Overall Study|Protocol Violation|13|||
106045184|NCT03161093|365831308|FG004|Overall Study|Protocol Violation|1|||
106045185|NCT03161093|365831309|FG005|Overall Study|Protocol Violation|0|||
106045186|NCT03161093|365831304|FG000|Overall Study|Adverse Event|5|||
106045187|NCT03161093|365831305|FG001|Overall Study|Adverse Event|21|||
106045188|NCT03161093|365831306|FG002|Overall Study|Adverse Event|16|||
106045189|NCT03161093|365831307|FG003|Overall Study|Adverse Event|35|||
106045190|NCT03161093|365831308|FG004|Overall Study|Adverse Event|2|||
106045191|NCT03161093|365831309|FG005|Overall Study|Adverse Event|1|||
106045192|NCT03161093|365831304|FG000|Overall Study|Lack of Efficacy|9|||
106045193|NCT03161093|365831305|FG001|Overall Study|Lack of Efficacy|13|||
106045194|NCT03161093|365831306|FG002|Overall Study|Lack of Efficacy|9|||
106045195|NCT03161093|365831307|FG003|Overall Study|Lack of Efficacy|24|||
106045196|NCT03161093|365831308|FG004|Overall Study|Lack of Efficacy|4|||
106045197|NCT03161093|365831309|FG005|Overall Study|Lack of Efficacy|1|||
106045198|NCT03161093|365831304|FG000|Overall Study|Physician Decision|0|||
106045199|NCT03161093|365831305|FG001|Overall Study|Physician Decision|1|||
106045200|NCT03161093|365831306|FG002|Overall Study|Physician Decision|0|||
106045201|NCT03161093|365831307|FG003|Overall Study|Physician Decision|2|||
106045202|NCT03161093|365831308|FG004|Overall Study|Physician Decision|17|||
106045203|NCT03161093|365831309|FG005|Overall Study|Physician Decision|15|||
106045204|NCT03161093|365831304|FG000|Overall Study|Withdrawal by Subject|24|||
106045205|NCT03161093|365831305|FG001|Overall Study|Withdrawal by Subject|73|||
106045206|NCT03161093|365831306|FG002|Overall Study|Withdrawal by Subject|44|||
106045207|NCT03161093|365831307|FG003|Overall Study|Withdrawal by Subject|97|||
106045208|NCT03161093|365831308|FG004|Overall Study|Withdrawal by Subject|11|||
106045209|NCT03161093|365831309|FG005|Overall Study|Withdrawal by Subject|10|||
106045210|NCT03161093|365831304|FG000|Overall Study|Lost to Follow-up|3|||
106045211|NCT03161093|365831305|FG001|Overall Study|Lost to Follow-up|12|||
106045212|NCT03161093|365831306|FG002|Overall Study|Lost to Follow-up|4|||
106045213|NCT03161093|365831307|FG003|Overall Study|Lost to Follow-up|7|||
106045214|NCT03161093|365831308|FG004|Overall Study|Lost to Follow-up|8|||
106045215|NCT03161093|365831309|FG005|Overall Study|Lost to Follow-up|13|||
106045216|NCT03161093|365831304|FG000|Overall Study|Death|3|||
106045217|NCT03161093|365831305|FG001|Overall Study|Death|9|||
106045218|NCT03161093|365831306|FG002|Overall Study|Death|7|||
106045219|NCT03161093|365831307|FG003|Overall Study|Death|9|||
106045220|NCT03161093|365831308|FG004|Overall Study|Death|0|||
106045221|NCT03161093|365831309|FG005|Overall Study|Death|0|||
106045222|NCT03161093|365831304|FG000|Overall Study|Unknown - Not reported|0|||
106045223|NCT03161093|365831305|FG001|Overall Study|Unknown - Not reported|1|||
106045224|NCT03161093|365831306|FG002|Overall Study|Unknown - Not reported|0|||
106045225|NCT03161093|365831307|FG003|Overall Study|Unknown - Not reported|0|||
106045226|NCT03161093|365831308|FG004|Overall Study|Unknown - Not reported|0|||
106045227|NCT03161093|365831309|FG005|Overall Study|Unknown - Not reported|1|||
106045228|NCT03643575|365831312|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
106045229|NCT03643575|365831313|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
106045230|NCT03643575|365831314|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
106045231|NCT03643575|365831315|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
106045232|NCT03643575|365831316|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
106045233|NCT03643575|365831317|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
106045234|NCT03643575|365831312|FG000|Washout: 7 Days|Adverse Event|1|||
106045235|NCT03643575|365831313|FG001|Washout: 7 Days|Adverse Event|0|||
106045236|NCT03643575|365831314|FG002|Washout: 7 Days|Adverse Event|0|||
106045237|NCT03643575|365831315|FG003|Washout: 7 Days|Adverse Event|0|||
106045238|NCT03643575|365831316|FG004|Washout: 7 Days|Adverse Event|0|||
106045239|NCT03643575|365831317|FG005|Washout: 7 Days|Adverse Event|0|||
106045240|NCT03643575|365831312|FG000|Washout: 7 Days|Non compliance check in|0|||
106045241|NCT03643575|365831313|FG001|Washout: 7 Days|Non compliance check in|1|||
106045242|NCT03643575|365831314|FG002|Washout: 7 Days|Non compliance check in|0|||
106045243|NCT03643575|365831315|FG003|Washout: 7 Days|Non compliance check in|0|||
106045244|NCT03643575|365831316|FG004|Washout: 7 Days|Non compliance check in|0|||
106045245|NCT03643575|365831317|FG005|Washout: 7 Days|Non compliance check in|0|||
106045246|NCT01309165|365831318|FG000|Overall Study|Lost to Follow-up|4|||
106045247|NCT01309165|365831319|FG001|Overall Study|Lost to Follow-up|3|||
106045248|NCT01309165|365831318|FG000|Overall Study|Return to work|1|||
106045249|NCT01309165|365831319|FG001|Overall Study|Return to work|2|||
106045250|NCT01309165|365831318|FG000|Overall Study|Left country|0|||
106045251|NCT01309165|365831319|FG001|Overall Study|Left country|1|||
106045252|NCT01309165|365831318|FG000|Overall Study|No transportation|0|||
106045253|NCT01309165|365831319|FG001|Overall Study|No transportation|1|||
106045254|NCT01309165|365831318|FG000|Overall Study|Admitted to hospital for second stroke|1|||
106045255|NCT01309165|365831319|FG001|Overall Study|Admitted to hospital for second stroke|0|||
106045256|NCT01497275|365831321|FG000|Overall Study|Death|1|||
106045257|NCT01497275|365831321|FG000|Overall Study|Adverse Event|1|||
106045258|NCT01950169|365831322|FG000|Overall Study|Withdrawal by Subject|2|||
106045259|NCT01950169|365831323|FG001|Overall Study|Withdrawal by Subject|8|||
106045260|NCT01950169|365831324|FG002|Overall Study|Withdrawal by Subject|1|||
106045261|NCT01950169|365831322|FG000|Overall Study|Death|1|||
106045262|NCT01950169|365831323|FG001|Overall Study|Death|0|||
106045263|NCT01950169|365831324|FG002|Overall Study|Death|0|||
106045264|NCT01739309|365831328|FG000|Overall Study|Adverse Event|1|||
106045265|NCT01739309|365831328|FG000|Overall Study|Withdrawal by Subject|1|||
106045266|NCT00986830|365831329|FG000|Overall Study|Death|1|||
106045267|NCT00986830|365831329|FG000|Overall Study|Lost to Follow-up|1|||
106045268|NCT00986830|365831329|FG000|Overall Study|Lack of Efficacy|1|||
106045269|NCT00986830|365831329|FG000|Overall Study|Unable to access sinus with device|5|||
106045270|NCT00808483|365831332|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
106045271|NCT00808483|365831333|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
106045272|NCT00808483|365831332|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
106045273|NCT00808483|365831333|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
106045274|NCT00808483|365831332|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
106045275|NCT00808483|365831333|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
106045276|NCT00850070|365831334|FG000|Overall Study|Lack of Efficacy|1|||
106045277|NCT00850070|365831335|FG001|Overall Study|Lack of Efficacy|1|||
106045278|NCT00850070|365831334|FG000|Overall Study|Adverse Event|2|||
106045279|NCT00850070|365831335|FG001|Overall Study|Adverse Event|0|||
106045280|NCT01254292|365831338|FG000|Comparative Phase|Adverse Event|25|||
106045281|NCT01254292|365831339|FG001|Comparative Phase|Adverse Event|25|||
106045282|NCT01254292|365831338|FG000|Comparative Phase|Lost to Follow-up|3|||
106045283|NCT01254292|365831339|FG001|Comparative Phase|Lost to Follow-up|21|||
106045284|NCT01254292|365831338|FG000|Comparative Phase|Pregnancy|2|||
106045285|NCT01254292|365831339|FG001|Comparative Phase|Pregnancy|6|||
106045286|NCT01254292|365831338|FG000|Comparative Phase|Withdrawal by Subject|20|||
106045287|NCT01254292|365831339|FG001|Comparative Phase|Withdrawal by Subject|21|||
106045288|NCT01254292|365831338|FG000|Comparative Phase|Protocol Violation|1|||
106045289|NCT01254292|365831339|FG001|Comparative Phase|Protocol Violation|2|||
106045290|NCT01254292|365831338|FG000|Comparative Phase|Wish for pregnancy|4|||
106045291|NCT01254292|365831339|FG001|Comparative Phase|Wish for pregnancy|6|||
106045292|NCT01254292|365831338|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
106045293|NCT01254292|365831339|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
106045294|NCT01254292|365831338|FG000|LCS12 Extension Phase|Adverse Event|9|||
106045295|NCT01254292|365831339|FG001|LCS12 Extension Phase|Adverse Event|0|||
106045296|NCT01254292|365831338|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
106045297|NCT01254292|365831339|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
106045298|NCT01254292|365831338|FG000|LCS12 Extension Phase|Other unknown|4|||
106045299|NCT01254292|365831339|FG001|LCS12 Extension Phase|Other unknown|0|||
106045300|NCT01254292|365831338|FG000|LCS12 Extension Phase|Pregnancy|2|||
106045301|NCT01254292|365831339|FG001|LCS12 Extension Phase|Pregnancy|0|||
106045302|NCT01254292|365831338|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
106045303|NCT01254292|365831339|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
106045304|NCT00669396|365831340|FG000|Overall Study|Lost to Follow-up|10|||
106045305|NCT00669396|365831341|FG001|Overall Study|Lost to Follow-up|12|||
106045306|NCT02128932|365831342|FG000|Overall Study|Withdrawal by Subject|11|||
106045307|NCT02128932|365831343|FG001|Overall Study|Withdrawal by Subject|7|||
106045308|NCT02128932|365831344|FG002|Overall Study|Withdrawal by Subject|8|||
106045309|NCT02128932|365831342|FG000|Overall Study|Death|2|||
106045310|NCT02128932|365831343|FG001|Overall Study|Death|0|||
106045311|NCT02128932|365831344|FG002|Overall Study|Death|2|||
106045312|NCT02128932|365831342|FG000|Overall Study|Lost to Follow-up|2|||
106045313|NCT02128932|365831343|FG001|Overall Study|Lost to Follow-up|1|||
106045314|NCT02128932|365831344|FG002|Overall Study|Lost to Follow-up|1|||
106045315|NCT02128932|365831342|FG000|Overall Study|No reason for withdrawal|12|||
106045316|NCT02128932|365831343|FG001|Overall Study|No reason for withdrawal|11|||
106045317|NCT02128932|365831344|FG002|Overall Study|No reason for withdrawal|7|||
106045318|NCT01361568|365831345|FG000|Overall Study|Adverse Event|0|||
106045319|NCT01361568|365831346|FG001|Overall Study|Adverse Event|0|||
106045320|NCT01361568|365831347|FG002|Overall Study|Adverse Event|0|||
106045321|NCT01361568|365831348|FG003|Overall Study|Adverse Event|0|||
106045322|NCT01361568|365831349|FG004|Overall Study|Adverse Event|1|||
106045323|NCT01361568|365831350|FG005|Overall Study|Adverse Event|0|||
106045324|NCT01361568|365831345|FG000|Overall Study|Physician Decision|0|||
106045325|NCT01361568|365831346|FG001|Overall Study|Physician Decision|0|||
106045326|NCT01361568|365831347|FG002|Overall Study|Physician Decision|0|||
106045327|NCT01361568|365831348|FG003|Overall Study|Physician Decision|0|||
106045328|NCT01361568|365831349|FG004|Overall Study|Physician Decision|0|||
106045329|NCT01361568|365831350|FG005|Overall Study|Physician Decision|1|||
106045330|NCT01361568|365831345|FG000|Overall Study|Withdrawal by Subject|2|||
106045331|NCT01361568|365831346|FG001|Overall Study|Withdrawal by Subject|1|||
106045332|NCT01361568|365831347|FG002|Overall Study|Withdrawal by Subject|0|||
106045333|NCT01361568|365831348|FG003|Overall Study|Withdrawal by Subject|0|||
106045334|NCT01361568|365831349|FG004|Overall Study|Withdrawal by Subject|0|||
106045335|NCT01361568|365831350|FG005|Overall Study|Withdrawal by Subject|1|||
106045336|NCT00657358|365831355|FG000|Overall Study|Lack of Efficacy|6|||
106045337|NCT01254630|365831356|FG000|Overall Study|Adverse Event|36|||
106045338|NCT01254630|365831357|FG001|Overall Study|Adverse Event|15|||
106045339|NCT01254630|365831358|FG002|Overall Study|Adverse Event|40|||
106045340|NCT01254630|365831359|FG003|Overall Study|Adverse Event|8|||
106045341|NCT01254630|365831356|FG000|Overall Study|Death|461|||
106045342|NCT01254630|365831357|FG001|Overall Study|Death|151|||
106045343|NCT01254630|365831358|FG002|Overall Study|Death|478|||
106045344|NCT01254630|365831359|FG003|Overall Study|Death|139|||
106045345|NCT01254630|365831356|FG000|Overall Study|Lost to Follow-up|80|||
106045346|NCT01254630|365831357|FG001|Overall Study|Lost to Follow-up|26|||
106045347|NCT01254630|365831358|FG002|Overall Study|Lost to Follow-up|89|||
106045348|NCT01254630|365831359|FG003|Overall Study|Lost to Follow-up|32|||
106045349|NCT01254630|365831356|FG000|Overall Study|Physician Decision|24|||
106045350|NCT01254630|365831357|FG001|Overall Study|Physician Decision|8|||
106045351|NCT01254630|365831358|FG002|Overall Study|Physician Decision|16|||
106045352|NCT01254630|365831359|FG003|Overall Study|Physician Decision|7|||
106045353|NCT01254630|365831356|FG000|Overall Study|Withdrawal by Subject|201|||
106045354|NCT01254630|365831357|FG001|Overall Study|Withdrawal by Subject|94|||
106045355|NCT01254630|365831358|FG002|Overall Study|Withdrawal by Subject|188|||
106045356|NCT01254630|365831359|FG003|Overall Study|Withdrawal by Subject|89|||
106045357|NCT01254630|365831356|FG000|Overall Study|Study terminated by sponsor|0|||
106045358|NCT01254630|365831357|FG001|Overall Study|Study terminated by sponsor|994|||
106045359|NCT01254630|365831358|FG002|Overall Study|Study terminated by sponsor|0|||
106045360|NCT01254630|365831359|FG003|Overall Study|Study terminated by sponsor|1010|||
106045361|NCT01254630|365831356|FG000|Overall Study|Status not recorded|0|||
106045362|NCT01254630|365831357|FG001|Overall Study|Status not recorded|0|||
106045363|NCT01254630|365831358|FG002|Overall Study|Status not recorded|1|||
106045364|NCT01254630|365831359|FG003|Overall Study|Status not recorded|0|||
106045365|NCT02186873|365833174|FG000|Overall Study|Adverse Event|1|||
106045366|NCT02186873|365833175|FG001|Overall Study|Adverse Event|3|||
106045367|NCT02186873|365833174|FG000|Overall Study|Lack of Efficacy|0|||
106045368|NCT02186873|365833175|FG001|Overall Study|Lack of Efficacy|1|||
106045369|NCT02186873|365833174|FG000|Overall Study|Lost to Follow-up|1|||
106045370|NCT02186873|365833175|FG001|Overall Study|Lost to Follow-up|2|||
106045371|NCT02186873|365833174|FG000|Overall Study|Withdrawal by Subject|7|||
106045372|NCT02186873|365833175|FG001|Overall Study|Withdrawal by Subject|2|||
106045373|NCT01824342|365833180|FG000|Overall Study|Withdrawal by Subject|0|||
106045374|NCT01824342|365833181|FG001|Overall Study|Withdrawal by Subject|3|||
106045375|NCT01824342|365833180|FG000|Overall Study|Adverse Event|1|||
106045376|NCT01824342|365833181|FG001|Overall Study|Adverse Event|1|||
106045377|NCT01824342|365833180|FG000|Overall Study|Disease Progression|1|||
106045378|NCT01824342|365833181|FG001|Overall Study|Disease Progression|1|||
106045379|NCT01824342|365833180|FG000|Overall Study|Physician Decision|5|||
106045380|NCT01824342|365833181|FG001|Overall Study|Physician Decision|0|||
106045381|NCT01824342|365833180|FG000|Overall Study|Death|2|||
106045382|NCT01824342|365833181|FG001|Overall Study|Death|0|||
106045383|NCT04195906|365833182|FG000|Part 1|Adverse Event|3|||
106045384|NCT04195906|365833183|FG001|Part 1|Adverse Event|7|||
106045385|NCT04195906|365833182|FG000|Part 1|Withdrawal by Subject|0|||
106045386|NCT04195906|365833183|FG001|Part 1|Withdrawal by Subject|1|||
106045387|NCT04195906|365833182|FG000|Part 2|Adverse Event|1|||
106045388|NCT04195906|365833183|FG001|Part 2|Adverse Event|1|||
106045389|NCT04195906|365833182|FG000|Part 2|Withdrawal by Subject|0|||
106045390|NCT04195906|365833183|FG001|Part 2|Withdrawal by Subject|3|||
106045391|NCT04195906|365833182|FG000|Part 2|Other|1|||
106045392|NCT04195906|365833183|FG001|Part 2|Other|3|||
106045393|NCT02281773|365833186|FG000|Overall Study|Adverse Event|6|||
106045394|NCT02281773|365833187|FG001|Overall Study|Adverse Event|1|||
106045395|NCT02281773|365833188|FG002|Overall Study|Adverse Event|4|||
106045396|NCT02281773|365833189|FG003|Overall Study|Adverse Event|8|||
105862530|NCT02699684|365147999|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
105862531|NCT02699684|365148000|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
105862532|NCT01145508|365148001|FG000|Overall Study|Adverse Event|1|||
105862533|NCT01145508|365148002|FG001|Overall Study|Adverse Event|0|||
105862534|NCT01145508|365148001|FG000|Overall Study|Death|1|||
105862535|NCT01145508|365148002|FG001|Overall Study|Death|0|||
105862536|NCT01145508|365148001|FG000|Overall Study|Physician Decision|2|||
105862537|NCT01145508|365148002|FG001|Overall Study|Physician Decision|1|||
105862538|NCT01145508|365148001|FG000|Overall Study|Never started treatment|1|||
106045397|NCT02281773|365833190|FG004|Overall Study|Adverse Event|9|||
106045398|NCT02281773|365833186|FG000|Overall Study|Protocol Violation|1|||
106045399|NCT02281773|365833187|FG001|Overall Study|Protocol Violation|0|||
106045400|NCT02281773|365833188|FG002|Overall Study|Protocol Violation|0|||
106045401|NCT02281773|365833189|FG003|Overall Study|Protocol Violation|2|||
106045402|NCT02281773|365833190|FG004|Overall Study|Protocol Violation|2|||
106045403|NCT02281773|365833186|FG000|Overall Study|Lost to Follow-up|2|||
106045404|NCT02281773|365833187|FG001|Overall Study|Lost to Follow-up|2|||
106045405|NCT02281773|365833188|FG002|Overall Study|Lost to Follow-up|6|||
106045406|NCT02281773|365833189|FG003|Overall Study|Lost to Follow-up|2|||
106045407|NCT02281773|365833190|FG004|Overall Study|Lost to Follow-up|10|||
106045408|NCT02281773|365833186|FG000|Overall Study|Withdrawal by Subject|2|||
106045409|NCT02281773|365833187|FG001|Overall Study|Withdrawal by Subject|8|||
106045410|NCT02281773|365833188|FG002|Overall Study|Withdrawal by Subject|6|||
106045411|NCT02281773|365833189|FG003|Overall Study|Withdrawal by Subject|6|||
106045412|NCT02281773|365833190|FG004|Overall Study|Withdrawal by Subject|8|||
106045413|NCT02281773|365833186|FG000|Overall Study|Other Reason|0|||
106045414|NCT02281773|365833187|FG001|Overall Study|Other Reason|4|||
106045415|NCT02281773|365833188|FG002|Overall Study|Other Reason|2|||
106045416|NCT02281773|365833189|FG003|Overall Study|Other Reason|3|||
106045417|NCT02281773|365833190|FG004|Overall Study|Other Reason|1|||
106045418|NCT00385762|365833197|FG000|Overall Study|Adverse Event|1|||
106045419|NCT00385762|365833197|FG000|Overall Study|Lost to Follow-up|1|||
106045420|NCT00313300|365833198|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
106045421|NCT00313300|365833199|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
106045422|NCT00313300|365833200|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
106045423|NCT00313300|365833201|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
106045424|NCT00313300|365833202|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
106045425|NCT00313300|365833198|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
106045426|NCT00313300|365833199|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
106045427|NCT00313300|365833200|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
106045428|NCT00313300|365833201|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
106045429|NCT00313300|365833202|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
106045430|NCT00313300|365833198|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
106045431|NCT00313300|365833199|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
106045432|NCT00313300|365833200|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
106045433|NCT00313300|365833201|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
106045434|NCT00313300|365833202|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
106045435|NCT00313300|365833198|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
106045436|NCT00313300|365833199|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
106045437|NCT00313300|365833200|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
106045438|NCT00313300|365833201|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
106045439|NCT00313300|365833202|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
106045440|NCT00313300|365833198|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
106045441|NCT00313300|365833199|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
106045442|NCT00313300|365833200|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
106045443|NCT00313300|365833201|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
106045444|NCT00313300|365833202|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
106045445|NCT00313300|365833198|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
106045446|NCT00313300|365833199|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
106045447|NCT00313300|365833200|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
106045448|NCT00313300|365833201|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
106045449|NCT00313300|365833202|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
106045450|NCT00313300|365833198|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
106045451|NCT00313300|365833199|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
106045452|NCT00313300|365833200|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
106045453|NCT00313300|365833201|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
106045454|NCT00313300|365833202|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
105862539|NCT01145508|365148002|FG001|Overall Study|Never started treatment|1|||
105862540|NCT02045147|365148003|FG000|Overall Study|Withdrawal by Subject|2|||
105862541|NCT02045147|365148004|FG001|Overall Study|Withdrawal by Subject|0|||
106045455|NCT00313300|365833198|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
105862542|NCT02045147|365148005|FG002|Overall Study|Withdrawal by Subject|0|||
105862543|NCT02045147|365148006|FG003|Overall Study|Withdrawal by Subject|0|||
105862544|NCT02045147|365148007|FG004|Overall Study|Withdrawal by Subject|0|||
105862545|NCT02045147|365148008|FG005|Overall Study|Withdrawal by Subject|0|||
105862546|NCT02045147|365148009|FG006|Overall Study|Withdrawal by Subject|0|||
105862547|NCT02045147|365148010|FG007|Overall Study|Withdrawal by Subject|1|||
105862548|NCT02045147|365148003|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
105862549|NCT02045147|365148004|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
105862550|NCT02045147|365148005|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
105862551|NCT02045147|365148006|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
105862552|NCT02045147|365148007|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
105862553|NCT02045147|365148008|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
105862554|NCT02045147|365148009|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
105862555|NCT02045147|365148010|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
105862556|NCT04839692|365148011|FG000|Overall Study|Withdrawal by Subject|0|||
105862557|NCT04839692|365148012|FG001|Overall Study|Withdrawal by Subject|3|||
105862558|NCT04839692|365148011|FG000|Overall Study|Physician Decision|1|||
105862559|NCT04839692|365148012|FG001|Overall Study|Physician Decision|0|||
105862560|NCT03146962|365148013|FG000|Overall Study|Lost to Follow-up|1|||
105862561|NCT03146962|365148014|FG001|Overall Study|Lost to Follow-up|1|||
105862562|NCT03146962|365148015|FG002|Overall Study|Lost to Follow-up|0|||
105862563|NCT03146962|365148016|FG003|Overall Study|Lost to Follow-up|0|||
105862564|NCT03146962|365148017|FG004|Overall Study|Lost to Follow-up|0|||
105862565|NCT03146962|365148018|FG005|Overall Study|Lost to Follow-up|0|||
105862566|NCT03146962|365148019|FG006|Overall Study|Lost to Follow-up|0|||
105862567|NCT03146962|365148020|FG007|Overall Study|Lost to Follow-up|0|||
105862568|NCT03146962|365148021|FG008|Overall Study|Lost to Follow-up|0|||
105862569|NCT03146962|365148022|FG009|Overall Study|Lost to Follow-up|0|||
105862570|NCT03146962|365148013|FG000|Overall Study|Adverse Event|0|||
105862571|NCT03146962|365148014|FG001|Overall Study|Adverse Event|3|||
105862572|NCT03146962|365148015|FG002|Overall Study|Adverse Event|0|||
105862573|NCT03146962|365148016|FG003|Overall Study|Adverse Event|0|||
105862574|NCT03146962|365148017|FG004|Overall Study|Adverse Event|0|||
105862575|NCT03146962|365148018|FG005|Overall Study|Adverse Event|0|||
105862576|NCT03146962|365148019|FG006|Overall Study|Adverse Event|0|||
105862577|NCT03146962|365148020|FG007|Overall Study|Adverse Event|1|||
105862578|NCT03146962|365148021|FG008|Overall Study|Adverse Event|0|||
105862579|NCT03146962|365148022|FG009|Overall Study|Adverse Event|0|||
105862580|NCT03146962|365148013|FG000|Overall Study|Withdrawal by Subject|0|||
105862581|NCT03146962|365148014|FG001|Overall Study|Withdrawal by Subject|0|||
105862582|NCT03146962|365148015|FG002|Overall Study|Withdrawal by Subject|0|||
105862583|NCT03146962|365148016|FG003|Overall Study|Withdrawal by Subject|0|||
105862584|NCT03146962|365148017|FG004|Overall Study|Withdrawal by Subject|1|||
105862585|NCT03146962|365148018|FG005|Overall Study|Withdrawal by Subject|0|||
105862586|NCT03146962|365148019|FG006|Overall Study|Withdrawal by Subject|0|||
105862587|NCT03146962|365148020|FG007|Overall Study|Withdrawal by Subject|0|||
105862588|NCT03146962|365148021|FG008|Overall Study|Withdrawal by Subject|0|||
105862589|NCT03146962|365148022|FG009|Overall Study|Withdrawal by Subject|0|||
105862590|NCT03146962|365148013|FG000|Overall Study|Death|0|||
105862591|NCT03146962|365148014|FG001|Overall Study|Death|1|||
105862592|NCT03146962|365148015|FG002|Overall Study|Death|0|||
105862593|NCT03146962|365148016|FG003|Overall Study|Death|0|||
105862594|NCT03146962|365148017|FG004|Overall Study|Death|0|||
105862595|NCT03146962|365148018|FG005|Overall Study|Death|0|||
105862596|NCT03146962|365148019|FG006|Overall Study|Death|0|||
105862597|NCT03146962|365148020|FG007|Overall Study|Death|0|||
105862598|NCT03146962|365148021|FG008|Overall Study|Death|0|||
105862599|NCT03146962|365148022|FG009|Overall Study|Death|0|||
105862600|NCT03146962|365148013|FG000|Overall Study|COVID Precautions|1|||
105862601|NCT03146962|365148014|FG001|Overall Study|COVID Precautions|0|||
105862602|NCT03146962|365148015|FG002|Overall Study|COVID Precautions|0|||
105862603|NCT03146962|365148016|FG003|Overall Study|COVID Precautions|0|||
105862604|NCT03146962|365148017|FG004|Overall Study|COVID Precautions|0|||
105862605|NCT03146962|365148018|FG005|Overall Study|COVID Precautions|0|||
105862606|NCT03146962|365148019|FG006|Overall Study|COVID Precautions|0|||
105862607|NCT03146962|365148020|FG007|Overall Study|COVID Precautions|0|||
105862608|NCT03146962|365148021|FG008|Overall Study|COVID Precautions|0|||
105862609|NCT03146962|365148022|FG009|Overall Study|COVID Precautions|0|||
105862610|NCT03146962|365148013|FG000|Overall Study|Physician Decision|0|||
105862611|NCT03146962|365148014|FG001|Overall Study|Physician Decision|0|||
105862612|NCT03146962|365148015|FG002|Overall Study|Physician Decision|0|||
105862613|NCT03146962|365148016|FG003|Overall Study|Physician Decision|0|||
105862614|NCT03146962|365148017|FG004|Overall Study|Physician Decision|0|||
105862615|NCT03146962|365148018|FG005|Overall Study|Physician Decision|0|||
105862616|NCT03146962|365148019|FG006|Overall Study|Physician Decision|0|||
106045456|NCT00313300|365833199|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
106045457|NCT00313300|365833200|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
106045458|NCT00313300|365833201|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
106045459|NCT00313300|365833202|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
106045460|NCT00313300|365833198|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
106045461|NCT00313300|365833199|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
106045462|NCT00313300|365833200|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
106045463|NCT00313300|365833201|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
106045464|NCT00313300|365833202|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
106045465|NCT00313300|365833198|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
106045466|NCT00313300|365833199|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
106045467|NCT00313300|365833200|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
106045468|NCT00313300|365833201|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
106045469|NCT00313300|365833202|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
106045470|NCT00313300|365833198|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
106045471|NCT00313300|365833199|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
106045472|NCT00313300|365833200|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
106045473|NCT00313300|365833201|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
106045474|NCT00313300|365833202|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
106045475|NCT00313300|365833198|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
106045476|NCT00313300|365833199|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
106045477|NCT00313300|365833200|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
106045478|NCT00313300|365833201|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
106045479|NCT00313300|365833202|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
106045480|NCT00313300|365833198|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
106045481|NCT00313300|365833199|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
106045482|NCT00313300|365833200|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
106045483|NCT00313300|365833201|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
106045484|NCT00313300|365833202|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
106045485|NCT00313300|365833198|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
106045486|NCT00313300|365833199|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
106045487|NCT00313300|365833200|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
106045488|NCT00313300|365833201|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
106045489|NCT00313300|365833202|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
106045490|NCT00313300|365833198|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
106045491|NCT00313300|365833199|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
106045492|NCT00313300|365833200|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
106045493|NCT00313300|365833201|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
106045494|NCT00313300|365833202|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
106045495|NCT00313300|365833198|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
106045496|NCT00313300|365833199|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
106045497|NCT00313300|365833200|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
106045498|NCT00313300|365833201|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
106045499|NCT00313300|365833202|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
106045500|NCT00313300|365833198|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
106045501|NCT00313300|365833199|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
106045502|NCT00313300|365833200|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
106045503|NCT00313300|365833201|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
106045504|NCT00313300|365833202|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
106045505|NCT00313300|365833198|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
106045506|NCT00313300|365833199|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
106045507|NCT00313300|365833200|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
106045508|NCT00313300|365833201|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
106045509|NCT00313300|365833202|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
106045510|NCT00313300|365833198|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
106045511|NCT00313300|365833199|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
106045512|NCT00313300|365833200|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
106045513|NCT00313300|365833201|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
106045514|NCT00313300|365833202|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
106045515|NCT00313300|365833198|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
106045516|NCT00313300|365833199|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
106045517|NCT00313300|365833200|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
106045518|NCT00313300|365833201|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
106045519|NCT00313300|365833202|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
106045520|NCT00313300|365833198|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
106045521|NCT00313300|365833199|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
106045522|NCT00313300|365833200|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
106045523|NCT00313300|365833201|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
106045524|NCT00313300|365833202|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
106045525|NCT00428792|365833203|FG000|Overall Study|Lack of Efficacy|1|||
106045526|NCT00428792|365833204|FG001|Overall Study|Lack of Efficacy|3|||
106045527|NCT00428792|365833203|FG000|Overall Study|Lost to Follow-up|0|||
106045528|NCT00428792|365833204|FG001|Overall Study|Lost to Follow-up|1|||
106045529|NCT04171765|365833205|FG000|Overall Study|Adverse Event|2|||
106045530|NCT04171765|365833206|FG001|Overall Study|Adverse Event|0|||
106045531|NCT04171765|365833207|FG002|Overall Study|Adverse Event|1|||
106045532|NCT04171765|365833208|FG003|Overall Study|Adverse Event|0|||
106045533|NCT04171765|365833205|FG000|Overall Study|Lost to Follow-up|0|||
106045534|NCT04171765|365833206|FG001|Overall Study|Lost to Follow-up|2|||
106045535|NCT04171765|365833207|FG002|Overall Study|Lost to Follow-up|2|||
106045536|NCT04171765|365833208|FG003|Overall Study|Lost to Follow-up|2|||
106045537|NCT04171765|365833205|FG000|Overall Study|Week 58 visit missed|0|||
106045538|NCT04171765|365833206|FG001|Overall Study|Week 58 visit missed|0|||
106045539|NCT04171765|365833207|FG002|Overall Study|Week 58 visit missed|1|||
106045540|NCT04171765|365833208|FG003|Overall Study|Week 58 visit missed|0|||
106045541|NCT04171765|365833205|FG000|Overall Study|Study terminated by sponsor|2|||
106045542|NCT04171765|365833206|FG001|Overall Study|Study terminated by sponsor|0|||
106045543|NCT04171765|365833207|FG002|Overall Study|Study terminated by sponsor|0|||
106045544|NCT04171765|365833208|FG003|Overall Study|Study terminated by sponsor|0|||
106045545|NCT04171765|365833205|FG000|Overall Study|Withdrawal by Subject|1|||
106045546|NCT04171765|365833206|FG001|Overall Study|Withdrawal by Subject|0|||
106045547|NCT04171765|365833207|FG002|Overall Study|Withdrawal by Subject|0|||
106045548|NCT04171765|365833208|FG003|Overall Study|Withdrawal by Subject|3|||
106045549|NCT01500031|365833209|FG000|Overall Study|Death|1|||
106045550|NCT01500031|365833209|FG000|Overall Study|Withdrawal by Subject|4|||
106045551|NCT00091442|365833210|FG000|Overall Study|Progressive Disease|220|||
106045552|NCT00091442|365833211|FG001|Overall Study|Progressive Disease|189|||
106045553|NCT00091442|365833210|FG000|Overall Study|Physician Decision|61|||
106045554|NCT00091442|365833211|FG001|Overall Study|Physician Decision|58|||
106045555|NCT00091442|365833210|FG000|Overall Study|Withdrawal by Subject|38|||
106045556|NCT00091442|365833211|FG001|Overall Study|Withdrawal by Subject|46|||
106045557|NCT00091442|365833210|FG000|Overall Study|Adverse Event|29|||
106045558|NCT00091442|365833211|FG001|Overall Study|Adverse Event|48|||
106045559|NCT00091442|365833210|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
106045560|NCT00091442|365833211|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
106045561|NCT00091442|365833210|FG000|Overall Study|Death|9|||
106045562|NCT00091442|365833211|FG001|Overall Study|Death|7|||
106045563|NCT00091442|365833210|FG000|Overall Study|Lost to Follow-up|1|||
106045564|NCT00091442|365833211|FG001|Overall Study|Lost to Follow-up|3|||
106045565|NCT00091442|365833210|FG000|Overall Study|Other|2|||
106045566|NCT00091442|365833211|FG001|Overall Study|Other|6|||
106045567|NCT00131508|365833214|FG000|Overall Study|Disease progression|0|||
106045568|NCT00131508|365833215|FG001|Overall Study|Disease progression|2|||
106045569|NCT00131508|365833214|FG000|Overall Study|Non-Compliance|2|||
106045570|NCT00131508|365833215|FG001|Overall Study|Non-Compliance|4|||
106045571|NCT00131508|365833214|FG000|Overall Study|Withdrawal by Subject|1|||
106045572|NCT00131508|365833215|FG001|Overall Study|Withdrawal by Subject|2|||
106045573|NCT03080454|365833216|FG000|Baseline|Adverse Event|2|||
106045574|NCT03080454|365833216|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
106045575|NCT03080454|365833216|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
106045576|NCT00694707|365833218|FG000|Overall Study|Did Not Receive Treatment|0|||
106045577|NCT00694707|365833219|FG001|Overall Study|Did Not Receive Treatment|0|||
106045578|NCT00694707|365833220|FG002|Overall Study|Did Not Receive Treatment|1|||
106045579|NCT00694707|365833221|FG003|Overall Study|Did Not Receive Treatment|1|||
106045580|NCT00694707|365833222|FG004|Overall Study|Did Not Receive Treatment|1|||
106045581|NCT00694707|365833218|FG000|Overall Study|Adverse Event|22|||
106045582|NCT00694707|365833219|FG001|Overall Study|Adverse Event|14|||
106045583|NCT00694707|365833220|FG002|Overall Study|Adverse Event|8|||
106045584|NCT00694707|365833221|FG003|Overall Study|Adverse Event|12|||
106045585|NCT00694707|365833222|FG004|Overall Study|Adverse Event|13|||
106045586|NCT00694707|365833218|FG000|Overall Study|Insufficient Therapeutic Response|33|||
105862617|NCT03146962|365148020|FG007|Overall Study|Physician Decision|0|||
105862618|NCT03146962|365148021|FG008|Overall Study|Physician Decision|0|||
105862619|NCT03146962|365148022|FG009|Overall Study|Physician Decision|1|||
106045587|NCT00694707|365833219|FG001|Overall Study|Insufficient Therapeutic Response|18|||
106045588|NCT00694707|365833220|FG002|Overall Study|Insufficient Therapeutic Response|17|||
106045589|NCT00694707|365833221|FG003|Overall Study|Insufficient Therapeutic Response|15|||
106045590|NCT00694707|365833222|FG004|Overall Study|Insufficient Therapeutic Response|10|||
106045591|NCT00694707|365833218|FG000|Overall Study|Protocol Violation|1|||
106045592|NCT00694707|365833219|FG001|Overall Study|Protocol Violation|2|||
106045593|NCT00694707|365833220|FG002|Overall Study|Protocol Violation|1|||
106045594|NCT00694707|365833221|FG003|Overall Study|Protocol Violation|3|||
106045595|NCT00694707|365833222|FG004|Overall Study|Protocol Violation|1|||
105862620|NCT03146962|365148013|FG000|Overall Study|Started New Treatment|0|||
106045596|NCT00694707|365833218|FG000|Overall Study|Withdrawal of Consent|14|||
106045597|NCT00694707|365833219|FG001|Overall Study|Withdrawal of Consent|18|||
106045598|NCT00694707|365833220|FG002|Overall Study|Withdrawal of Consent|22|||
106045599|NCT00694707|365833221|FG003|Overall Study|Withdrawal of Consent|16|||
106045600|NCT00694707|365833222|FG004|Overall Study|Withdrawal of Consent|15|||
106045601|NCT00694707|365833218|FG000|Overall Study|Lost to Follow-up|0|||
106045602|NCT00694707|365833219|FG001|Overall Study|Lost to Follow-up|1|||
106045603|NCT00694707|365833220|FG002|Overall Study|Lost to Follow-up|2|||
106045604|NCT00694707|365833221|FG003|Overall Study|Lost to Follow-up|0|||
106045605|NCT00694707|365833222|FG004|Overall Study|Lost to Follow-up|0|||
106045606|NCT00694707|365833218|FG000|Overall Study|Jeopardizing Parole Status|1|||
106045607|NCT00694707|365833219|FG001|Overall Study|Jeopardizing Parole Status|0|||
106045608|NCT00694707|365833220|FG002|Overall Study|Jeopardizing Parole Status|0|||
106045609|NCT00694707|365833221|FG003|Overall Study|Jeopardizing Parole Status|0|||
106045610|NCT00694707|365833222|FG004|Overall Study|Jeopardizing Parole Status|0|||
106045611|NCT00694707|365833218|FG000|Overall Study|Death in the Family|1|||
106045612|NCT00694707|365833219|FG001|Overall Study|Death in the Family|0|||
106045613|NCT00694707|365833220|FG002|Overall Study|Death in the Family|0|||
106045614|NCT00694707|365833221|FG003|Overall Study|Death in the Family|0|||
106045615|NCT00694707|365833222|FG004|Overall Study|Death in the Family|0|||
106045616|NCT00694707|365833218|FG000|Overall Study|Arrest by Police|0|||
106045617|NCT00694707|365833219|FG001|Overall Study|Arrest by Police|1|||
106045618|NCT00694707|365833220|FG002|Overall Study|Arrest by Police|0|||
106045619|NCT00694707|365833221|FG003|Overall Study|Arrest by Police|0|||
106045620|NCT00694707|365833222|FG004|Overall Study|Arrest by Police|0|||
106045621|NCT00694707|365833218|FG000|Overall Study|Administrative Reasons|0|||
106045622|NCT00694707|365833219|FG001|Overall Study|Administrative Reasons|1|||
106045623|NCT00694707|365833220|FG002|Overall Study|Administrative Reasons|0|||
106045624|NCT00694707|365833221|FG003|Overall Study|Administrative Reasons|2|||
106045625|NCT00694707|365833222|FG004|Overall Study|Administrative Reasons|0|||
106045626|NCT00694707|365833218|FG000|Overall Study|Notification of Past Head Injury|0|||
106045627|NCT00694707|365833219|FG001|Overall Study|Notification of Past Head Injury|0|||
106045628|NCT00694707|365833220|FG002|Overall Study|Notification of Past Head Injury|0|||
106045629|NCT00694707|365833221|FG003|Overall Study|Notification of Past Head Injury|1|||
106045630|NCT00694707|365833222|FG004|Overall Study|Notification of Past Head Injury|0|||
106045631|NCT04674644|365833236|FG000|Overall Study|with missing data|37|||
106045632|NCT03277690|365833237|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
106045633|NCT03277690|365833238|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
106045634|NCT03277690|365833237|FG000|Dose Titration and Maintenance|Physician Decision|1|||
106045635|NCT03277690|365833238|FG001|Dose Titration and Maintenance|Physician Decision|0|||
106045636|NCT03277690|365833237|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
106045637|NCT03277690|365833238|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
106045638|NCT03277690|365833237|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
106045639|NCT03277690|365833238|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
106045640|NCT03277690|365833237|FG000|Dose Titration and Maintenance|Adverse Event|15|||
106045641|NCT03277690|365833238|FG001|Dose Titration and Maintenance|Adverse Event|0|||
106045642|NCT03277690|365833237|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
106045643|NCT03277690|365833238|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
106045644|NCT03277690|365833237|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
106045645|NCT03277690|365833238|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
106045646|NCT01691898|365833239|FG000|Overall Study|Death|34|||
105862621|NCT03146962|365148014|FG001|Overall Study|Started New Treatment|1|||
105862622|NCT03146962|365148015|FG002|Overall Study|Started New Treatment|0|||
106045647|NCT01691898|365833240|FG001|Overall Study|Death|32|||
106045648|NCT01691898|365833241|FG002|Overall Study|Death|6|||
106045649|NCT01691898|365833242|FG003|Overall Study|Death|3|||
106045650|NCT01691898|365833243|FG004|Overall Study|Death|8|||
106045651|NCT01691898|365833244|FG005|Overall Study|Death|31|||
106045652|NCT01691898|365833239|FG000|Overall Study|Adverse Event|0|||
106045653|NCT01691898|365833240|FG001|Overall Study|Adverse Event|1|||
106045654|NCT01691898|365833241|FG002|Overall Study|Adverse Event|0|||
106045655|NCT01691898|365833242|FG003|Overall Study|Adverse Event|1|||
106045656|NCT01691898|365833243|FG004|Overall Study|Adverse Event|1|||
106045657|NCT01691898|365833244|FG005|Overall Study|Adverse Event|0|||
106045658|NCT01691898|365833239|FG000|Overall Study|Progression of Disease|1|||
106045659|NCT01691898|365833240|FG001|Overall Study|Progression of Disease|2|||
106045660|NCT01691898|365833241|FG002|Overall Study|Progression of Disease|1|||
105862623|NCT03146962|365148016|FG003|Overall Study|Started New Treatment|0|||
106045661|NCT01691898|365833242|FG003|Overall Study|Progression of Disease|0|||
106045662|NCT01691898|365833243|FG004|Overall Study|Progression of Disease|0|||
105862624|NCT03146962|365148017|FG004|Overall Study|Started New Treatment|0|||
106045663|NCT01691898|365833244|FG005|Overall Study|Progression of Disease|1|||
106045664|NCT01691898|365833239|FG000|Overall Study|Lost to Follow-up|3|||
105862625|NCT03146962|365148018|FG005|Overall Study|Started New Treatment|0|||
105862626|NCT03146962|365148019|FG006|Overall Study|Started New Treatment|0|||
105862627|NCT03146962|365148020|FG007|Overall Study|Started New Treatment|0|||
106045665|NCT01691898|365833240|FG001|Overall Study|Lost to Follow-up|1|||
106045666|NCT01691898|365833241|FG002|Overall Study|Lost to Follow-up|0|||
106045667|NCT01691898|365833242|FG003|Overall Study|Lost to Follow-up|0|||
106045668|NCT01691898|365833243|FG004|Overall Study|Lost to Follow-up|1|||
106045669|NCT01691898|365833244|FG005|Overall Study|Lost to Follow-up|0|||
106045670|NCT01691898|365833239|FG000|Overall Study|Withdrawal by Subject|9|||
106045671|NCT01691898|365833240|FG001|Overall Study|Withdrawal by Subject|8|||
106045672|NCT01691898|365833241|FG002|Overall Study|Withdrawal by Subject|2|||
106045673|NCT01691898|365833242|FG003|Overall Study|Withdrawal by Subject|1|||
106045674|NCT01691898|365833243|FG004|Overall Study|Withdrawal by Subject|3|||
106045675|NCT01691898|365833244|FG005|Overall Study|Withdrawal by Subject|3|||
106045676|NCT01691898|365833239|FG000|Overall Study|Non-Compliance|0|||
106045677|NCT01691898|365833240|FG001|Overall Study|Non-Compliance|0|||
106045678|NCT01691898|365833241|FG002|Overall Study|Non-Compliance|0|||
106045679|NCT01691898|365833242|FG003|Overall Study|Non-Compliance|0|||
106045680|NCT01691898|365833243|FG004|Overall Study|Non-Compliance|1|||
106045681|NCT01691898|365833244|FG005|Overall Study|Non-Compliance|0|||
106045682|NCT00747812|365833245|FG000|Overall Study|Research Site Staff Relocation|5|||
106045683|NCT00747812|365833246|FG001|Overall Study|Research Site Staff Relocation|3|||
106045684|NCT01986140|365833247|FG000|Overall Study|Withdrawal by Subject|31|||
106045685|NCT01986140|365833248|FG001|Overall Study|Withdrawal by Subject|25|||
106045686|NCT01986140|365833247|FG000|Overall Study|alternative treatment|1|||
106045687|NCT01986140|365833248|FG001|Overall Study|alternative treatment|1|||
106045688|NCT01986140|365833247|FG000|Overall Study|found not eligible|3|||
106045689|NCT01986140|365833248|FG001|Overall Study|found not eligible|0|||
106045690|NCT01986140|365833247|FG000|Overall Study|Adverse Event|0|||
106045691|NCT01986140|365833248|FG001|Overall Study|Adverse Event|1|||
106045692|NCT01986140|365833247|FG000|Overall Study|progression disease|0|||
106045693|NCT01986140|365833248|FG001|Overall Study|progression disease|1|||
106045694|NCT04738734|365833249|FG000|Overall Study|Withdrawal by Subject|2|||
106045695|NCT04738734|365833250|FG001|Overall Study|Withdrawal by Subject|4|||
106045696|NCT04738734|365833249|FG000|Overall Study|Lost to Follow-up|5|||
106045697|NCT04738734|365833250|FG001|Overall Study|Lost to Follow-up|2|||
106045698|NCT04738734|365833249|FG000|Overall Study|Physician Decision|0|||
106045699|NCT04738734|365833250|FG001|Overall Study|Physician Decision|1|||
106045700|NCT04738734|365833249|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
106045701|NCT04738734|365833250|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
106045702|NCT02939079|365833251|FG000|Overall Study|Adverse Event|2|||
106045703|NCT02939079|365833252|FG001|Overall Study|Adverse Event|1|||
106045704|NCT02939079|365833251|FG000|Overall Study|Lost to Follow-up|0|||
106045705|NCT02939079|365833252|FG001|Overall Study|Lost to Follow-up|2|||
106045706|NCT02939079|365833251|FG000|Overall Study|Protocol Violation|1|||
106045707|NCT02939079|365833252|FG001|Overall Study|Protocol Violation|0|||
106045708|NCT02939079|365833251|FG000|Overall Study|Withdrawal by Subject|0|||
106045709|NCT02939079|365833252|FG001|Overall Study|Withdrawal by Subject|1|||
106045710|NCT02939079|365833251|FG000|Overall Study|relapse during the study|1|||
106045711|NCT02939079|365833252|FG001|Overall Study|relapse during the study|1|||
106045712|NCT04093414|365833253|FG000|3 Month Follow up|Physician Decision|0|||
106045713|NCT04093414|365833254|FG001|3 Month Follow up|Physician Decision|1|||
106045714|NCT04093414|365833253|FG000|6month Follow up|Physician Decision|1|||
106045715|NCT04093414|365833254|FG001|6month Follow up|Physician Decision|3|||
106045716|NCT02337738|365833256|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
106045717|NCT02337738|365833257|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
106045718|NCT02337738|365833258|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
106045719|NCT02337738|365833256|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
106045720|NCT02337738|365833257|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
106045721|NCT02337738|365833258|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
106045722|NCT02337738|365833256|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
106045723|NCT02337738|365833257|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
106045724|NCT02337738|365833258|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
106045725|NCT02337738|365833256|FG000|Overall Study|Voluntary Withdrawal|10|||
106045726|NCT02337738|365833257|FG001|Overall Study|Voluntary Withdrawal|5|||
106045727|NCT02337738|365833258|FG002|Overall Study|Voluntary Withdrawal|2|||
106045728|NCT02337738|365833256|FG000|Overall Study|Lack of Efficacy|2|||
106045729|NCT02337738|365833257|FG001|Overall Study|Lack of Efficacy|4|||
106045730|NCT02337738|365833258|FG002|Overall Study|Lack of Efficacy|0|||
106045731|NCT02337738|365833256|FG000|Overall Study|Investigator's Judgment|1|||
106045732|NCT02337738|365833257|FG001|Overall Study|Investigator's Judgment|1|||
106045733|NCT02337738|365833258|FG002|Overall Study|Investigator's Judgment|3|||
106045734|NCT00406354|365833259|FG000|All Randomized Patients|Protocol Violation|0|||
106045735|NCT00406354|365833260|FG001|All Randomized Patients|Protocol Violation|0|||
106045736|NCT00406354|365833261|FG002|All Randomized Patients|Protocol Violation|1|||
106045737|NCT00406354|365833259|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
106045738|NCT00406354|365833260|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
106045739|NCT00406354|365833261|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
106045740|NCT00406354|365833259|FG000|All Randomized and Treated Patients|Adverse Event|6|||
106045741|NCT00406354|365833260|FG001|All Randomized and Treated Patients|Adverse Event|2|||
106045742|NCT00406354|365833261|FG002|All Randomized and Treated Patients|Adverse Event|1|||
106045743|NCT00406354|365833259|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
106045744|NCT00406354|365833260|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
106045745|NCT00406354|365833261|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
106045746|NCT00406354|365833259|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
106045747|NCT00406354|365833260|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
106045748|NCT00406354|365833261|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
106045749|NCT00406354|365833259|FG000|All Randomized and Treated Patients|Physician Decision|0|||
106045750|NCT00406354|365833260|FG001|All Randomized and Treated Patients|Physician Decision|0|||
106045751|NCT00406354|365833261|FG002|All Randomized and Treated Patients|Physician Decision|1|||
106045752|NCT05055128|365833262|FG000|Overall Study|Adverse Event|0|||
106045753|NCT05055128|365833263|FG001|Overall Study|Adverse Event|0|||
106045754|NCT05055128|365833264|FG002|Overall Study|Adverse Event|0|||
106045755|NCT05055128|365833265|FG003|Overall Study|Adverse Event|1|||
106045756|NCT05055128|365833266|FG004|Overall Study|Adverse Event|1|||
106045757|NCT05055128|365833262|FG000|Overall Study|Protocol Violation|0|||
106045758|NCT05055128|365833263|FG001|Overall Study|Protocol Violation|0|||
106045759|NCT05055128|365833264|FG002|Overall Study|Protocol Violation|0|||
106045760|NCT05055128|365833265|FG003|Overall Study|Protocol Violation|1|||
106045761|NCT05055128|365833266|FG004|Overall Study|Protocol Violation|0|||
106045762|NCT05055128|365833262|FG000|Overall Study|Withdrawal by Subject|5|||
106045763|NCT05055128|365833263|FG001|Overall Study|Withdrawal by Subject|2|||
106045764|NCT05055128|365833264|FG002|Overall Study|Withdrawal by Subject|2|||
106045765|NCT05055128|365833265|FG003|Overall Study|Withdrawal by Subject|4|||
106045766|NCT05055128|365833266|FG004|Overall Study|Withdrawal by Subject|2|||
106045767|NCT05055128|365833262|FG000|Overall Study|Randomized By Mistake|0|||
106045768|NCT05055128|365833263|FG001|Overall Study|Randomized By Mistake|1|||
106045769|NCT05055128|365833264|FG002|Overall Study|Randomized By Mistake|0|||
106045770|NCT05055128|365833265|FG003|Overall Study|Randomized By Mistake|0|||
106045771|NCT05055128|365833266|FG004|Overall Study|Randomized By Mistake|0|||
106045772|NCT05055128|365833262|FG000|Overall Study|Other|1|||
106045773|NCT05055128|365833263|FG001|Overall Study|Other|0|||
106045774|NCT05055128|365833264|FG002|Overall Study|Other|0|||
106045775|NCT05055128|365833265|FG003|Overall Study|Other|0|||
106045776|NCT05055128|365833266|FG004|Overall Study|Other|0|||
106045777|NCT02639546|365833267|FG000|Overall Study|Death|2|||
106045778|NCT02639546|365833268|FG001|Overall Study|Death|2|||
106045779|NCT02639546|365833269|FG002|Overall Study|Death|1|||
106045780|NCT02639546|365833270|FG003|Overall Study|Death|2|||
106045781|NCT02639546|365833271|FG004|Overall Study|Death|2|||
106045782|NCT02639546|365833272|FG005|Overall Study|Death|2|||
106045783|NCT02639546|365833273|FG006|Overall Study|Death|0|||
106045784|NCT02639546|365833274|FG007|Overall Study|Death|0|||
106045785|NCT02639546|365833267|FG000|Overall Study|Lost to Follow-up|0|||
106045786|NCT02639546|365833268|FG001|Overall Study|Lost to Follow-up|0|||
106045787|NCT02639546|365833269|FG002|Overall Study|Lost to Follow-up|1|||
106045788|NCT02639546|365833270|FG003|Overall Study|Lost to Follow-up|0|||
106045789|NCT02639546|365833271|FG004|Overall Study|Lost to Follow-up|1|||
106045790|NCT02639546|365833272|FG005|Overall Study|Lost to Follow-up|1|||
106045791|NCT02639546|365833273|FG006|Overall Study|Lost to Follow-up|0|||
106045792|NCT02639546|365833274|FG007|Overall Study|Lost to Follow-up|1|||
106045793|NCT02639546|365833267|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
106045794|NCT02639546|365833268|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
106045795|NCT02639546|365833269|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
106045796|NCT02639546|365833270|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
106045797|NCT02639546|365833271|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
106045798|NCT02639546|365833272|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
106045799|NCT02639546|365833273|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
106045800|NCT02639546|365833274|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
106045801|NCT02639546|365833267|FG000|Overall Study|Study Terminated By Sponsor|0|||
106045802|NCT02639546|365833268|FG001|Overall Study|Study Terminated By Sponsor|2|||
106045803|NCT02639546|365833269|FG002|Overall Study|Study Terminated By Sponsor|3|||
106045804|NCT02639546|365833270|FG003|Overall Study|Study Terminated By Sponsor|4|||
106045805|NCT02639546|365833271|FG004|Overall Study|Study Terminated By Sponsor|4|||
106045806|NCT02639546|365833272|FG005|Overall Study|Study Terminated By Sponsor|3|||
106045807|NCT02639546|365833273|FG006|Overall Study|Study Terminated By Sponsor|3|||
106045808|NCT02639546|365833274|FG007|Overall Study|Study Terminated By Sponsor|9|||
106045809|NCT02639546|365833267|FG000|Overall Study|Withdrawal by Subject|2|||
106045810|NCT02639546|365833268|FG001|Overall Study|Withdrawal by Subject|2|||
106045811|NCT02639546|365833269|FG002|Overall Study|Withdrawal by Subject|1|||
106045812|NCT02639546|365833270|FG003|Overall Study|Withdrawal by Subject|0|||
106045813|NCT02639546|365833271|FG004|Overall Study|Withdrawal by Subject|0|||
106045814|NCT02639546|365833272|FG005|Overall Study|Withdrawal by Subject|1|||
106045815|NCT02639546|365833273|FG006|Overall Study|Withdrawal by Subject|2|||
106045816|NCT02639546|365833274|FG007|Overall Study|Withdrawal by Subject|1|||
106045817|NCT01385371|365833275|FG000|Overall Study|Adverse Event|54|||
106045818|NCT01385371|365833276|FG001|Overall Study|Adverse Event|19|||
106045819|NCT01385371|365833275|FG000|Overall Study|Lost to Follow-up|16|||
106045820|NCT01385371|365833276|FG001|Overall Study|Lost to Follow-up|16|||
106045821|NCT01385371|365833275|FG000|Overall Study|Withdrawal by Subject|52|||
106045822|NCT01385371|365833276|FG001|Overall Study|Withdrawal by Subject|39|||
106045823|NCT01385371|365833275|FG000|Overall Study|Protocol Violation|25|||
106045824|NCT01385371|365833276|FG001|Overall Study|Protocol Violation|21|||
106045825|NCT01385371|365833275|FG000|Overall Study|Administrative|2|||
106045826|NCT01385371|365833276|FG001|Overall Study|Administrative|2|||
106045827|NCT00702689|365833277|FG000|Overall Study|Withdrawal by Subject|4|||
106045828|NCT00702689|365833277|FG000|Overall Study|Recurrent malignancy|1|||
106045829|NCT00702689|365833277|FG000|Overall Study|Adverse Event|1|||
106045830|NCT01281137|365833278|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
106045831|NCT01281137|365833279|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
106045832|NCT01281137|365833278|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
106045833|NCT01281137|365833279|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
106045834|NCT01281137|365833278|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
106045835|NCT01281137|365833279|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
106045836|NCT01281137|365833278|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
106045837|NCT01281137|365833279|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
106045838|NCT01281137|365833278|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
106045839|NCT01281137|365833279|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
106045840|NCT04402060|365833280|FG000|Overall Study|Death|1|||
106045841|NCT04402060|365833281|FG001|Overall Study|Death|12|||
106045842|NCT04402060|365833282|FG002|Overall Study|Death|7|||
106045843|NCT04402060|365833280|FG000|Overall Study|Adverse Event|0|||
106045844|NCT04402060|365833281|FG001|Overall Study|Adverse Event|0|||
106045845|NCT04402060|365833282|FG002|Overall Study|Adverse Event|1|||
106045846|NCT04402060|365833280|FG000|Overall Study|Withdrawal by Subject|0|||
106045847|NCT04402060|365833281|FG001|Overall Study|Withdrawal by Subject|1|||
106045848|NCT04402060|365833282|FG002|Overall Study|Withdrawal by Subject|2|||
106045849|NCT04402060|365833280|FG000|Overall Study|Sponsor Request|0|||
106045850|NCT04402060|365833281|FG001|Overall Study|Sponsor Request|2|||
106045851|NCT04402060|365833282|FG002|Overall Study|Sponsor Request|0|||
106045852|NCT04402060|365833280|FG000|Overall Study|Physician Decision|0|||
106045853|NCT04402060|365833281|FG001|Overall Study|Physician Decision|0|||
106045854|NCT04402060|365833282|FG002|Overall Study|Physician Decision|1|||
106045855|NCT04402060|365833280|FG000|Overall Study|Other|0|||
106045856|NCT04402060|365833281|FG001|Overall Study|Other|1|||
106045857|NCT04402060|365833282|FG002|Overall Study|Other|0|||
106045858|NCT02155881|365833290|FG000|Overall Study|Withdrawal by Subject|0|||
106045859|NCT02155881|365833291|FG001|Overall Study|Withdrawal by Subject|2|||
106045860|NCT02155881|365833290|FG000|Overall Study|Inappropriately randomized|2|||
106045861|NCT02155881|365833291|FG001|Overall Study|Inappropriately randomized|2|||
106045862|NCT03780543|365833293|FG000|Overall Study|Adverse Event|1|||
106045863|NCT03780543|365833294|FG001|Overall Study|Adverse Event|0|||
106045864|NCT03780543|365833295|FG002|Overall Study|Adverse Event|2|||
106045865|NCT03780543|365833293|FG000|Overall Study|Lost to Follow-up|2|||
106045866|NCT03780543|365833294|FG001|Overall Study|Lost to Follow-up|0|||
106045867|NCT03780543|365833295|FG002|Overall Study|Lost to Follow-up|1|||
106045868|NCT03780543|365833293|FG000|Overall Study|Study terminated by Sponsor|8|||
106045869|NCT03780543|365833294|FG001|Overall Study|Study terminated by Sponsor|7|||
106045870|NCT03780543|365833295|FG002|Overall Study|Study terminated by Sponsor|13|||
106045871|NCT03780543|365833293|FG000|Overall Study|Withdrawal by Subject|1|||
106045872|NCT03780543|365833294|FG001|Overall Study|Withdrawal by Subject|8|||
106045873|NCT03780543|365833295|FG002|Overall Study|Withdrawal by Subject|1|||
106045874|NCT03780543|365833293|FG000|Overall Study|Noncompliance with study drug|1|||
106045875|NCT03780543|365833294|FG001|Overall Study|Noncompliance with study drug|0|||
106045876|NCT03780543|365833295|FG002|Overall Study|Noncompliance with study drug|0|||
106045877|NCT03841448|365833297|FG000|Double-blind Treatment (DBT) Period|Death|1|||
106045878|NCT03841448|365833298|FG001|Double-blind Treatment (DBT) Period|Death|1|||
106045879|NCT03841448|365833299|FG002|Double-blind Treatment (DBT) Period|Death|0|||
106045880|NCT03841448|365833300|FG003|Double-blind Treatment (DBT) Period|Death|0|||
106045881|NCT03841448|365833297|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
106045882|NCT03841448|365833298|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
106045883|NCT03841448|365833299|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
106045884|NCT03841448|365833300|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
106045885|NCT03841448|365833297|FG000|Open-Label Extension (OLE) Period|Death|0|||
106045886|NCT03841448|365833298|FG001|Open-Label Extension (OLE) Period|Death|0|||
106045887|NCT03841448|365833299|FG002|Open-Label Extension (OLE) Period|Death|0|||
106045888|NCT03841448|365833300|FG003|Open-Label Extension (OLE) Period|Death|1|||
106045889|NCT03841448|365833297|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
106045890|NCT03841448|365833298|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
106045891|NCT03841448|365833299|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
106045892|NCT03841448|365833300|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
106045893|NCT03841448|365833297|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
106045894|NCT03841448|365833298|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
106045895|NCT03841448|365833299|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
106045896|NCT03841448|365833300|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
106045897|NCT03841448|365833297|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
106045898|NCT03841448|365833298|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
106045899|NCT03841448|365833299|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
106045900|NCT03841448|365833300|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
106045901|NCT02840721|365833301|FG000|Treatment Period|Adverse Event|1|||
106045902|NCT02840721|365833301|FG000|Follow-Up|Lack of Efficacy|1|||
106045903|NCT02840721|365833301|FG000|Follow-Up|Withdrawal by Subject|4|||
106045904|NCT02840721|365833301|FG000|Follow-Up|Withdrawal of Consent|2|||
106045905|NCT01967173|365833302|FG000|Overall Study|Lost to Follow-up|5|||
106045906|NCT01967173|365833303|FG001|Overall Study|Lost to Follow-up|3|||
106045907|NCT01967173|365833304|FG002|Overall Study|Lost to Follow-up|2|||
106045908|NCT01967173|365833305|FG003|Overall Study|Lost to Follow-up|4|||
106045909|NCT01967173|365833306|FG004|Overall Study|Lost to Follow-up|8|||
106045910|NCT01967173|365833307|FG005|Overall Study|Lost to Follow-up|12|||
106045911|NCT01967173|365833308|FG006|Overall Study|Lost to Follow-up|6|||
106045912|NCT01967173|365833309|FG007|Overall Study|Lost to Follow-up|8|||
106045913|NCT01967173|365833302|FG000|Overall Study|Physician Decision|2|||
106045914|NCT01967173|365833303|FG001|Overall Study|Physician Decision|0|||
106045915|NCT01967173|365833304|FG002|Overall Study|Physician Decision|2|||
106045916|NCT01967173|365833305|FG003|Overall Study|Physician Decision|1|||
106045917|NCT01967173|365833306|FG004|Overall Study|Physician Decision|1|||
106045918|NCT01967173|365833307|FG005|Overall Study|Physician Decision|1|||
106045919|NCT01967173|365833308|FG006|Overall Study|Physician Decision|1|||
106045920|NCT01967173|365833309|FG007|Overall Study|Physician Decision|0|||
106045921|NCT01967173|365833302|FG000|Overall Study|Lack of Efficacy|2|||
106045922|NCT01967173|365833303|FG001|Overall Study|Lack of Efficacy|0|||
106045923|NCT01967173|365833304|FG002|Overall Study|Lack of Efficacy|2|||
106045924|NCT01967173|365833305|FG003|Overall Study|Lack of Efficacy|2|||
106045925|NCT01967173|365833306|FG004|Overall Study|Lack of Efficacy|0|||
106045926|NCT01967173|365833307|FG005|Overall Study|Lack of Efficacy|1|||
106045927|NCT01967173|365833308|FG006|Overall Study|Lack of Efficacy|0|||
106045928|NCT01967173|365833309|FG007|Overall Study|Lack of Efficacy|2|||
106045929|NCT01967173|365833302|FG000|Overall Study|Pregnancy|0|||
106045930|NCT01967173|365833303|FG001|Overall Study|Pregnancy|0|||
106045931|NCT01967173|365833304|FG002|Overall Study|Pregnancy|0|||
106045932|NCT01967173|365833305|FG003|Overall Study|Pregnancy|0|||
106045933|NCT01967173|365833306|FG004|Overall Study|Pregnancy|0|||
106045934|NCT01967173|365833307|FG005|Overall Study|Pregnancy|0|||
106045935|NCT01967173|365833308|FG006|Overall Study|Pregnancy|1|||
106045936|NCT01967173|365833309|FG007|Overall Study|Pregnancy|1|||
106045937|NCT01967173|365833302|FG000|Overall Study|Adverse Event|0|||
106045938|NCT01967173|365833303|FG001|Overall Study|Adverse Event|0|||
106045939|NCT01967173|365833304|FG002|Overall Study|Adverse Event|0|||
106045940|NCT01967173|365833305|FG003|Overall Study|Adverse Event|0|||
106045941|NCT01967173|365833306|FG004|Overall Study|Adverse Event|0|||
106045942|NCT01967173|365833307|FG005|Overall Study|Adverse Event|0|||
106045943|NCT01967173|365833308|FG006|Overall Study|Adverse Event|0|||
106045944|NCT01967173|365833309|FG007|Overall Study|Adverse Event|1|||
106045945|NCT01967173|365833302|FG000|Overall Study|Withdrawal by Subject|15|||
106045946|NCT01967173|365833303|FG001|Overall Study|Withdrawal by Subject|14|||
106045947|NCT01967173|365833304|FG002|Overall Study|Withdrawal by Subject|10|||
106045948|NCT01967173|365833305|FG003|Overall Study|Withdrawal by Subject|7|||
106045949|NCT01967173|365833306|FG004|Overall Study|Withdrawal by Subject|8|||
106045950|NCT01967173|365833307|FG005|Overall Study|Withdrawal by Subject|9|||
106045951|NCT01967173|365833308|FG006|Overall Study|Withdrawal by Subject|10|||
106045952|NCT01967173|365833309|FG007|Overall Study|Withdrawal by Subject|12|||
106045953|NCT04122534|365833317|FG000|Overall Study|Lost to Follow-up|4|||
106045954|NCT00810355|365833322|FG000|Overall Study|Lost to Follow-up|13|||
106045955|NCT00810355|365833323|FG001|Overall Study|Lost to Follow-up|17|||
106045956|NCT00810355|365833324|FG002|Overall Study|Lost to Follow-up|11|||
106045957|NCT00810355|365833322|FG000|Overall Study|Withdrawal by Subject|1|||
106045958|NCT00810355|365833323|FG001|Overall Study|Withdrawal by Subject|0|||
106045959|NCT00810355|365833324|FG002|Overall Study|Withdrawal by Subject|0|||
106045960|NCT00397215|365833329|FG000|Month 0 (Day 0)|Adverse Event|0|||
106045961|NCT00397215|365833330|FG001|Month 0 (Day 0)|Adverse Event|1|||
106045962|NCT00397215|365833331|FG002|Month 0 (Day 0)|Adverse Event|0|||
106045963|NCT00397215|365833332|FG003|Month 0 (Day 0)|Adverse Event|0|||
106045964|NCT00397215|365833329|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
106045965|NCT00397215|365833330|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
106045966|NCT00397215|365833331|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
106045967|NCT00397215|365833332|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
106045968|NCT00397215|365833329|FG000|Month 0 (Day 0)|Other|4|||
106045969|NCT00397215|365833330|FG001|Month 0 (Day 0)|Other|1|||
106045970|NCT00397215|365833331|FG002|Month 0 (Day 0)|Other|3|||
106045971|NCT00397215|365833332|FG003|Month 0 (Day 0)|Other|3|||
106045972|NCT00397215|365833329|FG000|Month 6 (Day 180)|Adverse Event|0|||
106045973|NCT00397215|365833330|FG001|Month 6 (Day 180)|Adverse Event|3|||
106045974|NCT00397215|365833331|FG002|Month 6 (Day 180)|Adverse Event|2|||
106045975|NCT00397215|365833332|FG003|Month 6 (Day 180)|Adverse Event|0|||
106045976|NCT00397215|365833329|FG000|Month 6 (Day 180)|Other|2|||
106045977|NCT00397215|365833330|FG001|Month 6 (Day 180)|Other|0|||
106045978|NCT00397215|365833331|FG002|Month 6 (Day 180)|Other|3|||
106045979|NCT00397215|365833332|FG003|Month 6 (Day 180)|Other|0|||
106045980|NCT00423514|365833333|FG000|Overall Study|Ineligible|1|||
106045981|NCT00423514|365833334|FG001|Overall Study|Ineligible|0|||
106045982|NCT03685123|365833335|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
106045983|NCT03685123|365833336|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
106045984|NCT03685123|365833337|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
106045985|NCT03685123|365833335|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
106045986|NCT03685123|365833336|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
106045987|NCT03685123|365833337|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
106045988|NCT03685123|365833335|FG000|Weight Loss Phase|Lost to Follow-up|1|||
106045989|NCT03685123|365833336|FG001|Weight Loss Phase|Lost to Follow-up|0|||
106045990|NCT03685123|365833337|FG002|Weight Loss Phase|Lost to Follow-up|0|||
106045991|NCT03685123|365833335|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
106045992|NCT03685123|365833336|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
106045993|NCT03685123|365833337|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
106045994|NCT03685123|365833335|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
106045995|NCT03685123|365833336|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
106045996|NCT03685123|365833337|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
106045997|NCT03685123|365833335|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
106045998|NCT03685123|365833336|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
106045999|NCT03685123|365833337|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
106046000|NCT02959983|365833338|FG000|Overall Study|Protocol Violation|0|||
106046001|NCT02959983|365833339|FG001|Overall Study|Protocol Violation|1|||
106046002|NCT02959983|365833338|FG000|Overall Study|Lack of Efficacy|0|||
106046003|NCT02959983|365833339|FG001|Overall Study|Lack of Efficacy|1|||
106046004|NCT02959983|365833338|FG000|Overall Study|Lost to Follow-up|12|||
106046005|NCT02959983|365833339|FG001|Overall Study|Lost to Follow-up|9|||
106046006|NCT02959983|365833338|FG000|Overall Study|Other|1|||
106046007|NCT02959983|365833339|FG001|Overall Study|Other|1|||
106046008|NCT02959983|365833338|FG000|Overall Study|Physician Decision|1|||
106046009|NCT02959983|365833339|FG001|Overall Study|Physician Decision|0|||
106046010|NCT02959983|365833338|FG000|Overall Study|Adverse Event|5|||
106046011|NCT02959983|365833339|FG001|Overall Study|Adverse Event|1|||
106046012|NCT02959983|365833338|FG000|Overall Study|Withdrawal by Subject|7|||
106046013|NCT02959983|365833339|FG001|Overall Study|Withdrawal by Subject|12|||
106046014|NCT00484094|365833340|FG000|Overall Study|Discontinued|39|||
106046015|NCT00484094|365833340|FG000|Overall Study|Other|3|||
106046016|NCT00165984|365833344|FG000|Overall Study|Death|15|||
106046017|NCT01414608|365833345|FG000|Overall Study|Ineligible|5|||
106046018|NCT01414608|365833346|FG001|Overall Study|Ineligible|2|||
106046019|NCT04478266|365833347|FG000|Overall Study|Adverse Event|20|||
106046020|NCT04478266|365833348|FG001|Overall Study|Adverse Event|21|||
106046021|NCT04478266|365833347|FG000|Overall Study|Progressive disease|146|||
106046022|NCT04478266|365833348|FG001|Overall Study|Progressive disease|168|||
106046023|NCT04478266|365833347|FG000|Overall Study|Poor compliance to protocol|1|||
106046024|NCT04478266|365833348|FG001|Overall Study|Poor compliance to protocol|0|||
106046025|NCT04478266|365833347|FG000|Overall Study|Withdrawal by Subject|19|||
106046026|NCT04478266|365833348|FG001|Overall Study|Withdrawal by Subject|16|||
106046027|NCT04478266|365833347|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
106046028|NCT04478266|365833348|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
106046029|NCT04478266|365833347|FG000|Overall Study|Study terminated by sponsor|33|||
106046030|NCT04478266|365833348|FG001|Overall Study|Study terminated by sponsor|35|||
106046031|NCT04478266|365833347|FG000|Overall Study|Other: unspecified|5|||
106046032|NCT04478266|365833348|FG001|Overall Study|Other: unspecified|7|||
106046033|NCT04478266|365833347|FG000|Overall Study|Randomized but not treated|1|||
106046034|NCT04478266|365833348|FG001|Overall Study|Randomized but not treated|1|||
106046035|NCT03001882|365833349|FG000|Overall Study|Death|1|||
106046036|NCT03001882|365833350|FG001|Overall Study|Death|0|||
106046037|NCT03001882|365833351|FG002|Overall Study|Death|0|||
106046038|NCT03001882|365833352|FG003|Overall Study|Death|3|||
106046039|NCT03001882|365833349|FG000|Overall Study|Participant withdrew consent|0|||
106046040|NCT03001882|365833350|FG001|Overall Study|Participant withdrew consent|1|||
106046041|NCT03001882|365833351|FG002|Overall Study|Participant withdrew consent|0|||
106046042|NCT03001882|365833352|FG003|Overall Study|Participant withdrew consent|5|||
106046043|NCT03001882|365833349|FG000|Overall Study|Other reasons|1|||
106046044|NCT03001882|365833350|FG001|Overall Study|Other reasons|2|||
106046045|NCT03001882|365833351|FG002|Overall Study|Other reasons|0|||
106046046|NCT03001882|365833352|FG003|Overall Study|Other reasons|5|||
106046047|NCT03001882|365833349|FG000|Overall Study|Administrative reason by sponsor|0|||
106046048|NCT03001882|365833350|FG001|Overall Study|Administrative reason by sponsor|0|||
106046049|NCT03001882|365833351|FG002|Overall Study|Administrative reason by sponsor|0|||
106046050|NCT03001882|365833352|FG003|Overall Study|Administrative reason by sponsor|1|||
106046051|NCT03001882|365833349|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
106046052|NCT03001882|365833350|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
106046053|NCT03001882|365833351|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
106046054|NCT03001882|365833352|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
106046055|NCT03001882|365833349|FG000|Overall Study|Not reported|0|||
106046056|NCT03001882|365833350|FG001|Overall Study|Not reported|0|||
106046057|NCT03001882|365833351|FG002|Overall Study|Not reported|0|||
106046058|NCT03001882|365833352|FG003|Overall Study|Not reported|6|||
106046059|NCT03001882|365833349|FG000|Overall Study|Maximum clinical benefit|2|||
106046060|NCT03001882|365833350|FG001|Overall Study|Maximum clinical benefit|3|||
106046061|NCT03001882|365833351|FG002|Overall Study|Maximum clinical benefit|0|||
106046062|NCT03001882|365833352|FG003|Overall Study|Maximum clinical benefit|10|||
106046063|NCT03001882|365833349|FG000|Overall Study|AE unrelated to study drug|3|||
106046064|NCT03001882|365833350|FG001|Overall Study|AE unrelated to study drug|3|||
106046065|NCT03001882|365833351|FG002|Overall Study|AE unrelated to study drug|0|||
106046066|NCT03001882|365833352|FG003|Overall Study|AE unrelated to study drug|11|||
106046067|NCT03001882|365833349|FG000|Overall Study|Study Drug Toxicity|8|||
106046068|NCT03001882|365833350|FG001|Overall Study|Study Drug Toxicity|5|||
106046069|NCT03001882|365833351|FG002|Overall Study|Study Drug Toxicity|0|||
106046070|NCT03001882|365833352|FG003|Overall Study|Study Drug Toxicity|37|||
106046071|NCT03001882|365833349|FG000|Overall Study|Disease progression|16|||
106046072|NCT03001882|365833350|FG001|Overall Study|Disease progression|14|||
106046073|NCT03001882|365833351|FG002|Overall Study|Disease progression|1|||
106046074|NCT03001882|365833352|FG003|Overall Study|Disease progression|90|||
106046075|NCT01897714|365835266|FG000|Phase I (Dose Escalation)|Disease progression|3|||
106046076|NCT01897714|365835267|FG001|Phase I (Dose Escalation)|Disease progression|5|||
106046077|NCT01897714|365835268|FG002|Phase I (Dose Escalation)|Disease progression|1|||
106046078|NCT01897714|365835269|FG003|Phase I (Dose Escalation)|Disease progression|3|||
106046079|NCT01897714|365835270|FG004|Phase I (Dose Escalation)|Disease progression|0|||
106046080|NCT01897714|365835271|FG005|Phase I (Dose Escalation)|Disease progression|0|||
106046081|NCT01897714|365835266|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
106046082|NCT01897714|365835267|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
106046083|NCT01897714|365835268|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
106046084|NCT01897714|365835269|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
106046085|NCT01897714|365835270|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
106046086|NCT01897714|365835271|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
106046087|NCT01897714|365835266|FG000|Phase I (Dose Escalation)|Other|0|||
106046088|NCT01897714|365835267|FG001|Phase I (Dose Escalation)|Other|1|||
106046089|NCT01897714|365835268|FG002|Phase I (Dose Escalation)|Other|0|||
106046090|NCT01897714|365835269|FG003|Phase I (Dose Escalation)|Other|0|||
106046091|NCT01897714|365835270|FG004|Phase I (Dose Escalation)|Other|0|||
106046092|NCT01897714|365835271|FG005|Phase I (Dose Escalation)|Other|0|||
106046093|NCT01897714|365835266|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
106046094|NCT01897714|365835267|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
106046095|NCT01897714|365835268|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
106046096|NCT01897714|365835269|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
106046097|NCT01897714|365835270|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
106046098|NCT01897714|365835271|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
106046099|NCT01897714|365835266|FG000|Phase II (MTD)|Lost to Follow-up|0|||
106046100|NCT01897714|365835267|FG001|Phase II (MTD)|Lost to Follow-up|0|||
106046101|NCT01897714|365835268|FG002|Phase II (MTD)|Lost to Follow-up|0|||
106046102|NCT01897714|365835269|FG003|Phase II (MTD)|Lost to Follow-up|0|||
106046103|NCT01897714|365835270|FG004|Phase II (MTD)|Lost to Follow-up|1|||
106046104|NCT01897714|365835271|FG005|Phase II (MTD)|Lost to Follow-up|0|||
106046105|NCT01897714|365835266|FG000|Phase II (MTD)|Death|0|||
106046106|NCT01897714|365835267|FG001|Phase II (MTD)|Death|0|||
106046107|NCT01897714|365835268|FG002|Phase II (MTD)|Death|0|||
106046108|NCT01897714|365835269|FG003|Phase II (MTD)|Death|0|||
106046109|NCT01897714|365835270|FG004|Phase II (MTD)|Death|25|||
106046110|NCT01897714|365835271|FG005|Phase II (MTD)|Death|10|||
106046111|NCT01897714|365835266|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
106046112|NCT01897714|365835267|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
106046113|NCT01897714|365835268|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
106046114|NCT01897714|365835269|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
106046115|NCT01897714|365835270|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
106046116|NCT01897714|365835271|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
106046117|NCT01897714|365835266|FG000|Phase II (MTD)|Other|0|||
106046118|NCT01897714|365835267|FG001|Phase II (MTD)|Other|0|||
106046119|NCT01897714|365835268|FG002|Phase II (MTD)|Other|0|||
106046120|NCT01897714|365835269|FG003|Phase II (MTD)|Other|0|||
106046121|NCT01897714|365835270|FG004|Phase II (MTD)|Other|3|||
106046122|NCT01897714|365835271|FG005|Phase II (MTD)|Other|0|||
106046123|NCT00392015|365835273|FG000|Overall Study|Lost to Follow-up|2|||
106046124|NCT00392015|365835274|FG001|Overall Study|Lost to Follow-up|0|||
106046125|NCT00392015|365835275|FG002|Overall Study|Lost to Follow-up|2|||
106046126|NCT00392015|365835276|FG003|Overall Study|Lost to Follow-up|1|||
106046127|NCT00392015|365835277|FG004|Overall Study|Lost to Follow-up|1|||
106046128|NCT00392015|365835278|FG005|Overall Study|Lost to Follow-up|0|||
106046129|NCT00392015|365835273|FG000|Overall Study|Withdrawal by Subject|0|||
106046130|NCT00392015|365835274|FG001|Overall Study|Withdrawal by Subject|0|||
106046131|NCT00392015|365835275|FG002|Overall Study|Withdrawal by Subject|2|||
106046132|NCT00392015|365835276|FG003|Overall Study|Withdrawal by Subject|0|||
106046133|NCT00392015|365835277|FG004|Overall Study|Withdrawal by Subject|0|||
106046134|NCT00392015|365835278|FG005|Overall Study|Withdrawal by Subject|0|||
106046135|NCT00392015|365835273|FG000|Overall Study|Adverse Event|0|||
106046136|NCT00392015|365835274|FG001|Overall Study|Adverse Event|0|||
106046137|NCT00392015|365835275|FG002|Overall Study|Adverse Event|0|||
106046138|NCT00392015|365835276|FG003|Overall Study|Adverse Event|0|||
106046139|NCT00392015|365835277|FG004|Overall Study|Adverse Event|1|||
106046140|NCT00392015|365835278|FG005|Overall Study|Adverse Event|0|||
106046141|NCT00392015|365835273|FG000|Overall Study|Previous trial recipient|0|||
106046142|NCT00392015|365835274|FG001|Overall Study|Previous trial recipient|0|||
106046143|NCT00392015|365835275|FG002|Overall Study|Previous trial recipient|0|||
106046144|NCT00392015|365835276|FG003|Overall Study|Previous trial recipient|0|||
106046145|NCT00392015|365835277|FG004|Overall Study|Previous trial recipient|1|||
106046146|NCT00392015|365835278|FG005|Overall Study|Previous trial recipient|0|||
106046147|NCT02598960|365835279|FG000|Treatment Period|Disease Progression|4|||
106046148|NCT02598960|365835280|FG001|Treatment Period|Disease Progression|4|||
106046149|NCT02598960|365835281|FG002|Treatment Period|Disease Progression|4|||
106046150|NCT02598960|365835282|FG003|Treatment Period|Disease Progression|6|||
106046151|NCT02598960|365835283|FG004|Treatment Period|Disease Progression|8|||
106046152|NCT02598960|365835284|FG005|Treatment Period|Disease Progression|2|||
106046153|NCT02598960|365835285|FG006|Treatment Period|Disease Progression|2|||
106046154|NCT02598960|365835286|FG007|Treatment Period|Disease Progression|3|||
106046155|NCT02598960|365835287|FG008|Treatment Period|Disease Progression|7|||
106046156|NCT02598960|365835288|FG009|Treatment Period|Disease Progression|9|||
106046157|NCT02598960|365835289|FG010|Treatment Period|Disease Progression|7|||
106046158|NCT02598960|365835290|FG011|Treatment Period|Disease Progression|143|||
106046159|NCT02598960|365835291|FG012|Treatment Period|Disease Progression|23|||
106046160|NCT02598960|365835279|FG000|Treatment Period|Study drug toxicity|0|||
106046161|NCT02598960|365835280|FG001|Treatment Period|Study drug toxicity|0|||
106046162|NCT02598960|365835281|FG002|Treatment Period|Study drug toxicity|0|||
106046163|NCT02598960|365835282|FG003|Treatment Period|Study drug toxicity|0|||
106046164|NCT02598960|365835283|FG004|Treatment Period|Study drug toxicity|0|||
106046165|NCT02598960|365835284|FG005|Treatment Period|Study drug toxicity|0|||
106046166|NCT02598960|365835285|FG006|Treatment Period|Study drug toxicity|0|||
106046167|NCT02598960|365835286|FG007|Treatment Period|Study drug toxicity|0|||
106046168|NCT02598960|365835287|FG008|Treatment Period|Study drug toxicity|0|||
106046169|NCT02598960|365835288|FG009|Treatment Period|Study drug toxicity|1|||
106046170|NCT02598960|365835289|FG010|Treatment Period|Study drug toxicity|0|||
106046171|NCT02598960|365835290|FG011|Treatment Period|Study drug toxicity|3|||
106046172|NCT02598960|365835291|FG012|Treatment Period|Study drug toxicity|0|||
106046173|NCT02598960|365835279|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
106046174|NCT02598960|365835280|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
106046175|NCT02598960|365835281|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
106046176|NCT02598960|365835282|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
106046177|NCT02598960|365835283|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
106046178|NCT02598960|365835284|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
106046179|NCT02598960|365835285|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
106046180|NCT02598960|365835286|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
106046181|NCT02598960|365835287|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
106046182|NCT02598960|365835288|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
106046183|NCT02598960|365835289|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
106046184|NCT02598960|365835290|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
106046185|NCT02598960|365835291|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
106046186|NCT02598960|365835279|FG000|Treatment Period|participant request to discontinue|0|||
106046187|NCT02598960|365835280|FG001|Treatment Period|participant request to discontinue|1|||
106046188|NCT02598960|365835281|FG002|Treatment Period|participant request to discontinue|0|||
106046189|NCT02598960|365835282|FG003|Treatment Period|participant request to discontinue|0|||
106046190|NCT02598960|365835283|FG004|Treatment Period|participant request to discontinue|1|||
106046191|NCT02598960|365835284|FG005|Treatment Period|participant request to discontinue|0|||
106046192|NCT02598960|365835285|FG006|Treatment Period|participant request to discontinue|0|||
106046193|NCT02598960|365835286|FG007|Treatment Period|participant request to discontinue|0|||
106046194|NCT02598960|365835287|FG008|Treatment Period|participant request to discontinue|0|||
106046195|NCT02598960|365835288|FG009|Treatment Period|participant request to discontinue|0|||
106046196|NCT02598960|365835289|FG010|Treatment Period|participant request to discontinue|1|||
106046197|NCT02598960|365835290|FG011|Treatment Period|participant request to discontinue|4|||
106046198|NCT02598960|365835291|FG012|Treatment Period|participant request to discontinue|0|||
106046199|NCT02598960|365835279|FG000|Treatment Period|participant withdrew consent|0|||
106046200|NCT02598960|365835280|FG001|Treatment Period|participant withdrew consent|0|||
106046201|NCT02598960|365835281|FG002|Treatment Period|participant withdrew consent|0|||
106046202|NCT02598960|365835282|FG003|Treatment Period|participant withdrew consent|0|||
106046203|NCT02598960|365835283|FG004|Treatment Period|participant withdrew consent|0|||
106046204|NCT02598960|365835284|FG005|Treatment Period|participant withdrew consent|0|||
106046205|NCT02598960|365835285|FG006|Treatment Period|participant withdrew consent|0|||
106046206|NCT02598960|365835286|FG007|Treatment Period|participant withdrew consent|0|||
106046207|NCT02598960|365835287|FG008|Treatment Period|participant withdrew consent|0|||
106046208|NCT02598960|365835288|FG009|Treatment Period|participant withdrew consent|0|||
106046209|NCT02598960|365835289|FG010|Treatment Period|participant withdrew consent|0|||
106046210|NCT02598960|365835290|FG011|Treatment Period|participant withdrew consent|3|||
106046211|NCT02598960|365835291|FG012|Treatment Period|participant withdrew consent|0|||
106046212|NCT02598960|365835279|FG000|Treatment Period|No longer meets study criteria|0|||
106046213|NCT02598960|365835280|FG001|Treatment Period|No longer meets study criteria|0|||
106046214|NCT02598960|365835281|FG002|Treatment Period|No longer meets study criteria|0|||
106046215|NCT02598960|365835282|FG003|Treatment Period|No longer meets study criteria|0|||
106046216|NCT02598960|365835283|FG004|Treatment Period|No longer meets study criteria|0|||
106046217|NCT02598960|365835284|FG005|Treatment Period|No longer meets study criteria|0|||
106046218|NCT02598960|365835285|FG006|Treatment Period|No longer meets study criteria|0|||
106046219|NCT02598960|365835286|FG007|Treatment Period|No longer meets study criteria|0|||
106046220|NCT02598960|365835287|FG008|Treatment Period|No longer meets study criteria|0|||
106046221|NCT02598960|365835288|FG009|Treatment Period|No longer meets study criteria|0|||
106046222|NCT02598960|365835289|FG010|Treatment Period|No longer meets study criteria|0|||
106046223|NCT02598960|365835290|FG011|Treatment Period|No longer meets study criteria|1|||
106046224|NCT02598960|365835291|FG012|Treatment Period|No longer meets study criteria|0|||
106046225|NCT02598960|365835279|FG000|Treatment Period|Other Reasons|0|||
106046226|NCT02598960|365835280|FG001|Treatment Period|Other Reasons|0|||
106046227|NCT02598960|365835281|FG002|Treatment Period|Other Reasons|0|||
106046228|NCT02598960|365835282|FG003|Treatment Period|Other Reasons|0|||
106046229|NCT02598960|365835283|FG004|Treatment Period|Other Reasons|0|||
106046230|NCT02598960|365835284|FG005|Treatment Period|Other Reasons|0|||
106046231|NCT02598960|365835285|FG006|Treatment Period|Other Reasons|0|||
106046232|NCT02598960|365835286|FG007|Treatment Period|Other Reasons|0|||
106046233|NCT02598960|365835287|FG008|Treatment Period|Other Reasons|0|||
106046234|NCT02598960|365835288|FG009|Treatment Period|Other Reasons|0|||
106046235|NCT02598960|365835289|FG010|Treatment Period|Other Reasons|0|||
106046236|NCT02598960|365835290|FG011|Treatment Period|Other Reasons|0|||
106046237|NCT02598960|365835291|FG012|Treatment Period|Other Reasons|1|||
106046238|NCT02598960|365835279|FG000|Participants Entering Follow Up Period|Death|1|||
106046239|NCT02598960|365835280|FG001|Participants Entering Follow Up Period|Death|0|||
106046240|NCT02598960|365835281|FG002|Participants Entering Follow Up Period|Death|0|||
106046241|NCT02598960|365835282|FG003|Participants Entering Follow Up Period|Death|0|||
106046242|NCT02598960|365835283|FG004|Participants Entering Follow Up Period|Death|0|||
106046243|NCT02598960|365835284|FG005|Participants Entering Follow Up Period|Death|0|||
106046244|NCT02598960|365835285|FG006|Participants Entering Follow Up Period|Death|0|||
106046245|NCT02598960|365835286|FG007|Participants Entering Follow Up Period|Death|0|||
106046246|NCT02598960|365835287|FG008|Participants Entering Follow Up Period|Death|0|||
106046247|NCT02598960|365835288|FG009|Participants Entering Follow Up Period|Death|1|||
106046248|NCT02598960|365835289|FG010|Participants Entering Follow Up Period|Death|0|||
106046249|NCT02598960|365835290|FG011|Participants Entering Follow Up Period|Death|11|||
106046250|NCT02598960|365835291|FG012|Participants Entering Follow Up Period|Death|2|||
106046251|NCT02598960|365835279|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046252|NCT02598960|365835280|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046253|NCT02598960|365835281|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046254|NCT02598960|365835282|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046255|NCT02598960|365835283|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046256|NCT02598960|365835284|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046257|NCT02598960|365835285|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046258|NCT02598960|365835286|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046259|NCT02598960|365835287|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046260|NCT02598960|365835288|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046261|NCT02598960|365835289|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046262|NCT02598960|365835290|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
106046263|NCT02598960|365835291|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
106046264|NCT02598960|365835279|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
106046265|NCT02598960|365835280|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
106046266|NCT02598960|365835281|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
106046267|NCT02598960|365835282|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
106046268|NCT02598960|365835283|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
106046269|NCT02598960|365835284|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
106046270|NCT02598960|365835285|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
106046271|NCT02598960|365835286|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
106046272|NCT02598960|365835287|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
106046273|NCT02598960|365835288|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
106046274|NCT02598960|365835289|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
106046275|NCT02598960|365835290|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
106046276|NCT02598960|365835291|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
106046277|NCT02598960|365835279|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046278|NCT02598960|365835280|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046279|NCT02598960|365835281|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046280|NCT02598960|365835282|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046281|NCT02598960|365835283|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046282|NCT02598960|365835284|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046283|NCT02598960|365835285|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046284|NCT02598960|365835286|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046285|NCT02598960|365835287|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046286|NCT02598960|365835288|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046287|NCT02598960|365835289|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046288|NCT02598960|365835290|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
106046289|NCT02598960|365835291|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
106046290|NCT02598960|365835279|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
106046291|NCT02598960|365835280|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
106046292|NCT02598960|365835281|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
106046293|NCT02598960|365835282|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
106046294|NCT02598960|365835283|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
106046295|NCT02598960|365835284|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
106046296|NCT02598960|365835285|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
106046297|NCT02598960|365835286|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
106046298|NCT02598960|365835287|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
106046299|NCT02598960|365835288|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
106046300|NCT02598960|365835289|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
106046301|NCT02598960|365835290|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
106046302|NCT02598960|365835291|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
106046303|NCT01507298|365835297|FG000|Overall Study|Protocol Violation|0|||
106046304|NCT01507298|365835298|FG001|Overall Study|Protocol Violation|6|||
106046305|NCT00734474|365835299|FG000|Overall Study|Entry Criteria Not Met|0|||
106046306|NCT00734474|365835300|FG001|Overall Study|Entry Criteria Not Met|0|||
106046307|NCT00734474|365835301|FG002|Overall Study|Entry Criteria Not Met|5|||
106046308|NCT00734474|365835302|FG003|Overall Study|Entry Criteria Not Met|0|||
106046309|NCT00734474|365835303|FG004|Overall Study|Entry Criteria Not Met|3|||
106046310|NCT00734474|365835304|FG005|Overall Study|Entry Criteria Not Met|1|||
106046311|NCT00734474|365835305|FG006|Overall Study|Entry Criteria Not Met|0|||
106046312|NCT00734474|365835306|FG007|Overall Study|Entry Criteria Not Met|1|||
106046313|NCT00734474|365835307|FG008|Overall Study|Entry Criteria Not Met|1|||
106046314|NCT00734474|365835299|FG000|Overall Study|Lost to Follow-up|1|||
106046315|NCT00734474|365835300|FG001|Overall Study|Lost to Follow-up|0|||
106046316|NCT00734474|365835301|FG002|Overall Study|Lost to Follow-up|13|||
106046317|NCT00734474|365835302|FG003|Overall Study|Lost to Follow-up|0|||
106046318|NCT00734474|365835303|FG004|Overall Study|Lost to Follow-up|11|||
106046319|NCT00734474|365835304|FG005|Overall Study|Lost to Follow-up|1|||
106046320|NCT00734474|365835305|FG006|Overall Study|Lost to Follow-up|0|||
106046321|NCT00734474|365835306|FG007|Overall Study|Lost to Follow-up|9|||
106046322|NCT00734474|365835307|FG008|Overall Study|Lost to Follow-up|4|||
106046323|NCT00734474|365835299|FG000|Overall Study|Withdrawal by Subject|2|||
106046324|NCT00734474|365835300|FG001|Overall Study|Withdrawal by Subject|1|||
106046325|NCT00734474|365835301|FG002|Overall Study|Withdrawal by Subject|18|||
106046326|NCT00734474|365835302|FG003|Overall Study|Withdrawal by Subject|0|||
106046327|NCT00734474|365835303|FG004|Overall Study|Withdrawal by Subject|24|||
106046328|NCT00734474|365835304|FG005|Overall Study|Withdrawal by Subject|2|||
106046329|NCT00734474|365835305|FG006|Overall Study|Withdrawal by Subject|0|||
106046330|NCT00734474|365835306|FG007|Overall Study|Withdrawal by Subject|36|||
106046331|NCT00734474|365835307|FG008|Overall Study|Withdrawal by Subject|21|||
106046332|NCT00734474|365835299|FG000|Overall Study|Physician Decision|0|||
106046333|NCT00734474|365835300|FG001|Overall Study|Physician Decision|0|||
106046334|NCT00734474|365835301|FG002|Overall Study|Physician Decision|4|||
106046335|NCT00734474|365835302|FG003|Overall Study|Physician Decision|1|||
106046336|NCT00734474|365835303|FG004|Overall Study|Physician Decision|11|||
106046337|NCT00734474|365835304|FG005|Overall Study|Physician Decision|0|||
106046338|NCT00734474|365835305|FG006|Overall Study|Physician Decision|0|||
106046339|NCT00734474|365835306|FG007|Overall Study|Physician Decision|9|||
106046340|NCT00734474|365835307|FG008|Overall Study|Physician Decision|9|||
106046341|NCT00734474|365835299|FG000|Overall Study|Adverse Event|4|||
106046342|NCT00734474|365835300|FG001|Overall Study|Adverse Event|4|||
106046343|NCT00734474|365835301|FG002|Overall Study|Adverse Event|63|||
106046344|NCT00734474|365835302|FG003|Overall Study|Adverse Event|1|||
106046345|NCT00734474|365835303|FG004|Overall Study|Adverse Event|64|||
106046346|NCT00734474|365835304|FG005|Overall Study|Adverse Event|0|||
106046347|NCT00734474|365835305|FG006|Overall Study|Adverse Event|1|||
106046348|NCT00734474|365835306|FG007|Overall Study|Adverse Event|65|||
106046349|NCT00734474|365835307|FG008|Overall Study|Adverse Event|39|||
106046350|NCT00734474|365835299|FG000|Overall Study|Protocol Violation|0|||
106046351|NCT00734474|365835300|FG001|Overall Study|Protocol Violation|0|||
106046352|NCT00734474|365835301|FG002|Overall Study|Protocol Violation|4|||
106046353|NCT00734474|365835302|FG003|Overall Study|Protocol Violation|0|||
106046354|NCT00734474|365835303|FG004|Overall Study|Protocol Violation|3|||
106046355|NCT00734474|365835304|FG005|Overall Study|Protocol Violation|0|||
106046356|NCT00734474|365835305|FG006|Overall Study|Protocol Violation|0|||
106046357|NCT00734474|365835306|FG007|Overall Study|Protocol Violation|3|||
106046358|NCT00734474|365835307|FG008|Overall Study|Protocol Violation|1|||
106046359|NCT00734474|365835299|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
106046360|NCT00734474|365835300|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
106046361|NCT00734474|365835301|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
106046362|NCT00734474|365835302|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
106046363|NCT00734474|365835303|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
106046364|NCT00734474|365835304|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
106046365|NCT00734474|365835305|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
106046366|NCT00734474|365835306|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
106046367|NCT00734474|365835307|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
106046368|NCT00734474|365835299|FG000|Overall Study|Sponsor Decision|0|||
106046369|NCT00734474|365835300|FG001|Overall Study|Sponsor Decision|0|||
106046370|NCT00734474|365835301|FG002|Overall Study|Sponsor Decision|0|||
106046371|NCT00734474|365835302|FG003|Overall Study|Sponsor Decision|0|||
106046372|NCT00734474|365835303|FG004|Overall Study|Sponsor Decision|2|||
106046373|NCT00734474|365835304|FG005|Overall Study|Sponsor Decision|0|||
106046374|NCT00734474|365835305|FG006|Overall Study|Sponsor Decision|0|||
106046375|NCT00734474|365835306|FG007|Overall Study|Sponsor Decision|0|||
106046376|NCT00734474|365835307|FG008|Overall Study|Sponsor Decision|0|||
106046377|NCT00734474|365835299|FG000|Overall Study|Death|0|||
106046378|NCT00734474|365835300|FG001|Overall Study|Death|0|||
106046379|NCT00734474|365835301|FG002|Overall Study|Death|1|||
106046380|NCT00734474|365835302|FG003|Overall Study|Death|0|||
106046381|NCT00734474|365835303|FG004|Overall Study|Death|0|||
106046382|NCT00734474|365835304|FG005|Overall Study|Death|0|||
106046383|NCT00734474|365835305|FG006|Overall Study|Death|0|||
106046384|NCT00734474|365835306|FG007|Overall Study|Death|2|||
106046385|NCT00734474|365835307|FG008|Overall Study|Death|1|||
106046386|NCT00734474|365835299|FG000|Overall Study|Lack of Efficacy|0|||
106046387|NCT00734474|365835300|FG001|Overall Study|Lack of Efficacy|0|||
106046388|NCT00734474|365835301|FG002|Overall Study|Lack of Efficacy|4|||
106046389|NCT00734474|365835302|FG003|Overall Study|Lack of Efficacy|0|||
106046390|NCT00734474|365835303|FG004|Overall Study|Lack of Efficacy|0|||
106046391|NCT00734474|365835304|FG005|Overall Study|Lack of Efficacy|0|||
106046392|NCT00734474|365835305|FG006|Overall Study|Lack of Efficacy|0|||
106046393|NCT00734474|365835306|FG007|Overall Study|Lack of Efficacy|4|||
106046394|NCT00734474|365835307|FG008|Overall Study|Lack of Efficacy|6|||
106046395|NCT04622306|365835308|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
106046396|NCT04622306|365835309|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
106046397|NCT04622306|365835310|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
106046398|NCT04622306|365835311|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
106046399|NCT04622306|365835312|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
106046400|NCT04622306|365835313|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
106046401|NCT04622306|365835308|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
106046402|NCT04622306|365835309|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
106046403|NCT04622306|365835310|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
106046404|NCT04622306|365835311|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
106046405|NCT04622306|365835312|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
106046406|NCT04622306|365835313|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
106046407|NCT00617851|365835314|FG000|Overall Study|Death|0|||
106046408|NCT00617851|365835315|FG001|Overall Study|Death|0|||
106046409|NCT00617851|365835316|FG002|Overall Study|Death|0|||
106046410|NCT00617851|365835317|FG003|Overall Study|Death|1|||
106046411|NCT00617851|365835314|FG000|Overall Study|Withdrawal by Subject|14|||
106046412|NCT00617851|365835315|FG001|Overall Study|Withdrawal by Subject|7|||
106046413|NCT00617851|365835316|FG002|Overall Study|Withdrawal by Subject|12|||
106046414|NCT00617851|365835317|FG003|Overall Study|Withdrawal by Subject|4|||
106046415|NCT00617851|365835314|FG000|Overall Study|Lost to Follow-up|27|||
106046416|NCT00617851|365835315|FG001|Overall Study|Lost to Follow-up|29|||
106046417|NCT00617851|365835316|FG002|Overall Study|Lost to Follow-up|31|||
106046418|NCT00617851|365835317|FG003|Overall Study|Lost to Follow-up|19|||
106046419|NCT00617851|365835314|FG000|Overall Study|Inappropriate Enrollment|5|||
106046420|NCT00617851|365835315|FG001|Overall Study|Inappropriate Enrollment|4|||
106046421|NCT00617851|365835316|FG002|Overall Study|Inappropriate Enrollment|1|||
106046422|NCT00617851|365835317|FG003|Overall Study|Inappropriate Enrollment|1|||
106046423|NCT00617851|365835314|FG000|Overall Study|Unable to classify|1|||
106046424|NCT00617851|365835315|FG001|Overall Study|Unable to classify|0|||
106046425|NCT00617851|365835316|FG002|Overall Study|Unable to classify|1|||
106046426|NCT00617851|365835317|FG003|Overall Study|Unable to classify|0|||
106046427|NCT01200524|365835318|FG000|Overall Study|Withdrawal by Subject|1|||
106046428|NCT01200524|365835319|FG001|Overall Study|Withdrawal by Subject|1|||
106046429|NCT01200524|365835320|FG002|Overall Study|Withdrawal by Subject|3|||
106046430|NCT01200524|365835318|FG000|Overall Study|Adverse Event|1|||
106046431|NCT01200524|365835319|FG001|Overall Study|Adverse Event|0|||
106046432|NCT01200524|365835320|FG002|Overall Study|Adverse Event|0|||
106046433|NCT01200524|365835318|FG000|Overall Study|Non availability of study nurse|0|||
106046434|NCT01200524|365835319|FG001|Overall Study|Non availability of study nurse|0|||
106046435|NCT01200524|365835320|FG002|Overall Study|Non availability of study nurse|1|||
106046436|NCT00615108|365835323|FG000|Overall Study|Adverse Event|122|||
106046437|NCT00615108|365835323|FG000|Overall Study|Other|370|||
106046438|NCT00615108|365835323|FG000|Overall Study|Lost to Follow-up|15|||
106046439|NCT01914757|365835324|FG000|Overall Study|Severe non-compliance to protocol|3|||
106046440|NCT01914757|365835325|FG001|Overall Study|Severe non-compliance to protocol|1|||
106046441|NCT01914757|365835326|FG002|Overall Study|Severe non-compliance to protocol|2|||
106046442|NCT01914757|365835324|FG000|Overall Study|Lost to Follow-up|5|||
106046443|NCT01914757|365835325|FG001|Overall Study|Lost to Follow-up|8|||
106046444|NCT01914757|365835326|FG002|Overall Study|Lost to Follow-up|6|||
106046445|NCT01914757|365835324|FG000|Overall Study|Withdrawal by Subject|15|||
106046446|NCT01914757|365835325|FG001|Overall Study|Withdrawal by Subject|27|||
106046447|NCT01914757|365835326|FG002|Overall Study|Withdrawal by Subject|19|||
106046448|NCT01914757|365835324|FG000|Overall Study|Death|2|||
106046449|NCT01914757|365835325|FG001|Overall Study|Death|2|||
106046450|NCT01914757|365835326|FG002|Overall Study|Death|1|||
106046451|NCT01914757|365835324|FG000|Overall Study|Adverse Event|4|||
106046452|NCT01914757|365835325|FG001|Overall Study|Adverse Event|3|||
106046453|NCT01914757|365835326|FG002|Overall Study|Adverse Event|4|||
106046454|NCT01914757|365835324|FG000|Overall Study|Study specific withdrawal criteria|0|||
106046455|NCT01914757|365835325|FG001|Overall Study|Study specific withdrawal criteria|1|||
106046456|NCT01914757|365835326|FG002|Overall Study|Study specific withdrawal criteria|0|||
106046457|NCT01914757|365835324|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
106046458|NCT01914757|365835325|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
106046459|NCT01914757|365835326|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
106046460|NCT01914757|365835324|FG000|Overall Study|Other reasons|5|||
106046461|NCT01914757|365835325|FG001|Overall Study|Other reasons|9|||
106046462|NCT01914757|365835326|FG002|Overall Study|Other reasons|4|||
106046463|NCT05021081|365835327|FG000|Phase 2|Subject enrolled in error|1|||
106046464|NCT05021081|365835328|FG001|Phase 2|Subject enrolled in error|1|||
106046465|NCT05021081|365835329|FG002|Phase 2|Subject enrolled in error|0|||
106046466|NCT00369122|365835330|FG000|Overall Study|Ineligible|10|||
106046467|NCT00369122|365835330|FG000|Overall Study|No protocol treatment|1|||
106046468|NCT00631696|365835335|FG000|Overall Study|Entered, not randomized to treatment|1|||
106046469|NCT00631696|365835336|FG001|Overall Study|Entered, not randomized to treatment|1|||
106046470|NCT00631696|365835335|FG000|Overall Study|Discontinued after database release date|1|||
106046471|NCT00631696|365835336|FG001|Overall Study|Discontinued after database release date|0|||
106046472|NCT00631696|365835335|FG000|Overall Study|Follow up after database release date|1|||
106046473|NCT00631696|365835336|FG001|Overall Study|Follow up after database release date|0|||
106046474|NCT00631696|365835335|FG000|Overall Study|Lost to Follow-up|7|||
106046475|NCT00631696|365835336|FG001|Overall Study|Lost to Follow-up|10|||
106046476|NCT00631696|365835335|FG000|Overall Study|Withdrawal by Subject|2|||
106046477|NCT00631696|365835336|FG001|Overall Study|Withdrawal by Subject|9|||
106046478|NCT00631696|365835335|FG000|Overall Study|Other|8|||
106046479|NCT00631696|365835336|FG001|Overall Study|Other|8|||
106046480|NCT00631696|365835335|FG000|Overall Study|Protocol Violation|9|||
106046481|NCT00631696|365835336|FG001|Overall Study|Protocol Violation|9|||
106046482|NCT00631696|365835335|FG000|Overall Study|Study terminated by sponsor|3|||
106046483|NCT00631696|365835336|FG001|Overall Study|Study terminated by sponsor|3|||
106046484|NCT00631696|365835335|FG000|Overall Study|Adverse Event|5|||
106046485|NCT00631696|365835336|FG001|Overall Study|Adverse Event|0|||
106046486|NCT01426438|365835337|FG000|Overall Study|Lost to Follow-up|1|||
106046487|NCT01426438|365835338|FG001|Overall Study|Lost to Follow-up|3|||
106046488|NCT01426438|365835337|FG000|Overall Study|Off study Treatment|9|||
106046489|NCT01426438|365835338|FG001|Overall Study|Off study Treatment|3|||
106046490|NCT01426438|365835337|FG000|Overall Study|Poor scan quality|3|||
106046491|NCT01426438|365835338|FG001|Overall Study|Poor scan quality|2|||
106046492|NCT01426438|365835337|FG000|Overall Study|Missed Scan|2|||
106046493|NCT01426438|365835338|FG001|Overall Study|Missed Scan|2|||
106046494|NCT00697788|365835339|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
106046495|NCT00697788|365835340|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
106046496|NCT00697788|365835341|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
106046497|NCT00697788|365835342|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
106046498|NCT00697788|365835343|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
106046499|NCT00697788|365835344|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
106046500|NCT00697788|365835345|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
106046501|NCT00697788|365835346|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
106046502|NCT00697788|365835339|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
106046503|NCT00697788|365835340|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
106046504|NCT00697788|365835341|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
106046505|NCT00697788|365835342|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
106046506|NCT00697788|365835343|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
106046507|NCT00697788|365835344|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
106046508|NCT00697788|365835345|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
106046509|NCT00697788|365835346|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
106046510|NCT02833350|365835347|FG000|Overall Study|Adverse Event|0|||
106046511|NCT02833350|365835348|FG001|Overall Study|Adverse Event|3|||
106046512|NCT02833350|365835349|FG002|Overall Study|Adverse Event|4|||
106046513|NCT02833350|365835350|FG003|Overall Study|Adverse Event|4|||
106046514|NCT02833350|365835351|FG004|Overall Study|Adverse Event|1|||
106046515|NCT02833350|365835352|FG005|Overall Study|Adverse Event|0|||
106046516|NCT02833350|365835353|FG006|Overall Study|Adverse Event|1|||
106046517|NCT02833350|365835347|FG000|Overall Study|Death|0|||
106046518|NCT02833350|365835348|FG001|Overall Study|Death|0|||
106046519|NCT02833350|365835349|FG002|Overall Study|Death|1|||
106046520|NCT02833350|365835350|FG003|Overall Study|Death|0|||
106046521|NCT02833350|365835351|FG004|Overall Study|Death|0|||
106046522|NCT02833350|365835352|FG005|Overall Study|Death|0|||
106046523|NCT02833350|365835353|FG006|Overall Study|Death|0|||
106046524|NCT02833350|365835347|FG000|Overall Study|Lack of Efficacy|0|||
106046525|NCT02833350|365835348|FG001|Overall Study|Lack of Efficacy|2|||
106046526|NCT02833350|365835349|FG002|Overall Study|Lack of Efficacy|1|||
106046527|NCT02833350|365835350|FG003|Overall Study|Lack of Efficacy|4|||
106046528|NCT02833350|365835351|FG004|Overall Study|Lack of Efficacy|0|||
106046529|NCT02833350|365835352|FG005|Overall Study|Lack of Efficacy|1|||
106046530|NCT02833350|365835353|FG006|Overall Study|Lack of Efficacy|1|||
106046531|NCT02833350|365835347|FG000|Overall Study|Lost to Follow-up|0|||
106046532|NCT02833350|365835348|FG001|Overall Study|Lost to Follow-up|1|||
106046533|NCT02833350|365835349|FG002|Overall Study|Lost to Follow-up|0|||
106046534|NCT02833350|365835350|FG003|Overall Study|Lost to Follow-up|0|||
106046535|NCT02833350|365835351|FG004|Overall Study|Lost to Follow-up|0|||
106046536|NCT02833350|365835352|FG005|Overall Study|Lost to Follow-up|0|||
106046537|NCT02833350|365835353|FG006|Overall Study|Lost to Follow-up|1|||
106046538|NCT02833350|365835347|FG000|Overall Study|Withdrawal by Subject|3|||
106046539|NCT02833350|365835348|FG001|Overall Study|Withdrawal by Subject|3|||
106046540|NCT02833350|365835349|FG002|Overall Study|Withdrawal by Subject|2|||
106046541|NCT02833350|365835350|FG003|Overall Study|Withdrawal by Subject|0|||
106046542|NCT02833350|365835351|FG004|Overall Study|Withdrawal by Subject|2|||
106046543|NCT02833350|365835352|FG005|Overall Study|Withdrawal by Subject|0|||
106046544|NCT02833350|365835353|FG006|Overall Study|Withdrawal by Subject|2|||
106046545|NCT01788046|365835354|FG000|Overall Study|Withdrawal by Subject|12|||
106046546|NCT01788046|365835355|FG001|Overall Study|Withdrawal by Subject|12|||
106046547|NCT01788046|365835354|FG000|Overall Study|Lost to Follow-up|12|||
106046548|NCT01788046|365835355|FG001|Overall Study|Lost to Follow-up|19|||
106046549|NCT01788046|365835354|FG000|Overall Study|Death|7|||
106046550|NCT01788046|365835355|FG001|Overall Study|Death|5|||
106046551|NCT01788046|365835354|FG000|Overall Study|Protocol Specified Criteria|25|||
106046552|NCT01788046|365835355|FG001|Overall Study|Protocol Specified Criteria|1|||
106046553|NCT02124161|365835360|FG000|Overall Study|Other unspecified|0|||
106046554|NCT02124161|365835361|FG001|Overall Study|Other unspecified|1|||
105862628|NCT03146962|365148021|FG008|Overall Study|Started New Treatment|0|||
105862629|NCT03146962|365148022|FG009|Overall Study|Started New Treatment|0|||
105862630|NCT00264550|365148025|FG000|Overall Study|Death|0|||
105862631|NCT00264550|365148026|FG001|Overall Study|Death|3|||
105862632|NCT00264550|365148027|FG002|Overall Study|Death|0|||
105862633|NCT00264550|365148028|FG003|Overall Study|Death|0|||
105862634|NCT00264550|365148025|FG000|Overall Study|Lost to Follow-up|3|||
105862635|NCT00264550|365148026|FG001|Overall Study|Lost to Follow-up|1|||
105862636|NCT00264550|365148027|FG002|Overall Study|Lost to Follow-up|1|||
105862637|NCT00264550|365148028|FG003|Overall Study|Lost to Follow-up|1|||
105862638|NCT00264550|365148025|FG000|Overall Study|Adverse Event|23|||
105862639|NCT00264550|365148026|FG001|Overall Study|Adverse Event|18|||
105862640|NCT00264550|365148027|FG002|Overall Study|Adverse Event|9|||
105862641|NCT00264550|365148028|FG003|Overall Study|Adverse Event|14|||
105862642|NCT00264550|365148025|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
105862643|NCT00264550|365148026|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
105862644|NCT00264550|365148027|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
105862645|NCT00264550|365148028|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
105862646|NCT00264550|365148025|FG000|Overall Study|Discontinued oral study agent|0|||
105862647|NCT00264550|365148026|FG001|Overall Study|Discontinued oral study agent|1|||
105862648|NCT00264550|365148027|FG002|Overall Study|Discontinued oral study agent|0|||
105862649|NCT00264550|365148028|FG003|Overall Study|Discontinued oral study agent|0|||
105862650|NCT00264550|365148025|FG000|Overall Study|Other|13|||
105862651|NCT00264550|365148026|FG001|Overall Study|Other|7|||
105862652|NCT00264550|365148027|FG002|Overall Study|Other|3|||
105862653|NCT00264550|365148028|FG003|Overall Study|Other|9|||
105862654|NCT02242045|365148031|FG000|Overall Study|Investigator's Discretion|1|||
105862655|NCT02242045|365148031|FG000|Overall Study|Progressive Disease|2|||
105862656|NCT02242045|365148031|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
105862657|NCT02242045|365148031|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
105862658|NCT02954991|365148032|FG000|Overall Study|Death|92|||
105862659|NCT02954991|365148033|FG001|Overall Study|Death|11|||
105862660|NCT02954991|365148034|FG002|Overall Study|Death|2|||
105862661|NCT02954991|365148032|FG000|Overall Study|Lost to Follow-up|3|||
105862662|NCT02954991|365148033|FG001|Overall Study|Lost to Follow-up|2|||
105862663|NCT02954991|365148034|FG002|Overall Study|Lost to Follow-up|0|||
105862664|NCT02954991|365148032|FG000|Overall Study|Withdrawal by Subject|9|||
105862665|NCT02954991|365148033|FG001|Overall Study|Withdrawal by Subject|8|||
105862666|NCT02954991|365148034|FG002|Overall Study|Withdrawal by Subject|1|||
105862667|NCT02954991|365148032|FG000|Overall Study|Study Terminated by Sponsor|18|||
105862668|NCT02954991|365148033|FG001|Overall Study|Study Terminated by Sponsor|10|||
105862669|NCT02954991|365148034|FG002|Overall Study|Study Terminated by Sponsor|1|||
105862670|NCT02954991|365148032|FG000|Overall Study|Miscellaneous|2|||
105862671|NCT02954991|365148033|FG001|Overall Study|Miscellaneous|1|||
105862672|NCT02954991|365148034|FG002|Overall Study|Miscellaneous|1|||
105862673|NCT01994291|365148037|FG000|Overall Study|Adverse Event|4|||
105862674|NCT01994291|365148038|FG001|Overall Study|Adverse Event|1|||
105862675|NCT01994291|365148039|FG002|Overall Study|Adverse Event|3|||
105862676|NCT01994291|365148037|FG000|Overall Study|Lost to Follow-up|1|||
105862677|NCT01994291|365148038|FG001|Overall Study|Lost to Follow-up|1|||
105862678|NCT01994291|365148039|FG002|Overall Study|Lost to Follow-up|0|||
105862679|NCT01994291|365148037|FG000|Overall Study|Does not meet entrance criteria|1|||
105862680|NCT01994291|365148038|FG001|Overall Study|Does not meet entrance criteria|0|||
105862681|NCT01994291|365148039|FG002|Overall Study|Does not meet entrance criteria|0|||
105862682|NCT01994291|365148037|FG000|Overall Study|Medication error without associated AE|1|||
105862683|NCT01994291|365148038|FG001|Overall Study|Medication error without associated AE|0|||
105862684|NCT01994291|365148039|FG002|Overall Study|Medication error without associated AE|1|||
105862685|NCT01994291|365148037|FG000|Overall Study|Protocol Violation|1|||
105862686|NCT01994291|365148038|FG001|Overall Study|Protocol Violation|0|||
105862687|NCT01994291|365148039|FG002|Overall Study|Protocol Violation|0|||
105862688|NCT01994291|365148037|FG000|Overall Study|Withdrawal by Subject|6|||
105862689|NCT01994291|365148038|FG001|Overall Study|Withdrawal by Subject|3|||
105862690|NCT01994291|365148039|FG002|Overall Study|Withdrawal by Subject|5|||
105862691|NCT01994291|365148037|FG000|Overall Study|Other|1|||
105862692|NCT01994291|365148038|FG001|Overall Study|Other|2|||
105862693|NCT01994291|365148039|FG002|Overall Study|Other|0|||
105862694|NCT00741286|365148042|FG000|Overall Study|Lost to Follow-up|15|||
105862695|NCT00741286|365148043|FG001|Overall Study|Lost to Follow-up|10|||
105862696|NCT00741286|365148042|FG000|Overall Study|Adverse Event|1|||
105862697|NCT00741286|365148043|FG001|Overall Study|Adverse Event|6|||
105862698|NCT00741286|365148042|FG000|Overall Study|Protocol Violation|3|||
105862699|NCT00741286|365148043|FG001|Overall Study|Protocol Violation|2|||
106046555|NCT02124161|365835360|FG000|Overall Study|Death|1|||
105862700|NCT00741286|365148042|FG000|Overall Study|Primary Outcome|1|||
105862701|NCT00741286|365148043|FG001|Overall Study|Primary Outcome|1|||
105862702|NCT01831258|365148045|FG000|Overall Study|Withdrawal by Subject|2|||
105862703|NCT01831258|365148046|FG001|Overall Study|Withdrawal by Subject|1|||
105862704|NCT01831258|365148045|FG000|Overall Study|Lost to Follow-up|3|||
106046556|NCT02124161|365835361|FG001|Overall Study|Death|0|||
106046557|NCT02124161|365835360|FG000|Overall Study|Protocol Violation|2|||
106046558|NCT02124161|365835361|FG001|Overall Study|Protocol Violation|1|||
106046559|NCT02124161|365835360|FG000|Overall Study|Withdrawal by Subject|1|||
106046560|NCT02124161|365835361|FG001|Overall Study|Withdrawal by Subject|2|||
106046561|NCT02124161|365835360|FG000|Overall Study|Adverse Event|2|||
106046562|NCT02124161|365835361|FG001|Overall Study|Adverse Event|0|||
106046563|NCT02124161|365835360|FG000|Overall Study|Does not meet entrance criteria|2|||
106046564|NCT02124161|365835361|FG001|Overall Study|Does not meet entrance criteria|3|||
106046565|NCT02124161|365835360|FG000|Overall Study|No longer meets eligibility criteria|5|||
106046566|NCT02124161|365835361|FG001|Overall Study|No longer meets eligibility criteria|4|||
106046567|NCT02124161|365835360|FG000|Overall Study|Lost to Follow-up|3|||
106046568|NCT02124161|365835361|FG001|Overall Study|Lost to Follow-up|4|||
106046569|NCT01856907|365835362|FG000|Overall Study|Pregnancy|0|||
106046570|NCT01856907|365835363|FG001|Overall Study|Pregnancy|1|||
106046571|NCT01856907|365835364|FG002|Overall Study|Pregnancy|0|||
106046572|NCT01856907|365835362|FG000|Overall Study|Pregnancy|0|||
106046573|NCT01856907|365835363|FG001|Overall Study|Pregnancy|1|||
106046574|NCT01856907|365835364|FG002|Overall Study|Pregnancy|0|||
106046575|NCT01856907|365835362|FG000|Overall Study|Withdrawal by Subject|0|||
106046576|NCT01856907|365835363|FG001|Overall Study|Withdrawal by Subject|1|||
106046577|NCT01856907|365835364|FG002|Overall Study|Withdrawal by Subject|0|||
106046578|NCT01797731|365835365|FG000|Overall Study|Didn't have proper radiographs required|3|||
106046579|NCT01797731|365835366|FG001|Overall Study|Didn't have proper radiographs required|3|||
106046580|NCT01604408|365835367|FG000|Treatment Period 1|Protocol Violation|0|||
106046581|NCT01604408|365835368|FG001|Treatment Period 1|Protocol Violation|1|||
106046582|NCT01604408|365835367|FG000|Treatment Period 2|Withdrawal by Subject|1|||
106046583|NCT01604408|365835368|FG001|Treatment Period 2|Withdrawal by Subject|1|||
106046584|NCT01604408|365835367|FG000|Treatment Period 2|Protocol Violation|1|||
106046585|NCT01604408|365835368|FG001|Treatment Period 2|Protocol Violation|0|||
106046586|NCT01604408|365835367|FG000|Treatment Period 2|Adverse Event|0|||
106046587|NCT01604408|365835368|FG001|Treatment Period 2|Adverse Event|1|||
106046588|NCT01604408|365835367|FG000|Treatment Period 3|Protocol Violation|1|||
106046589|NCT01604408|365835368|FG001|Treatment Period 3|Protocol Violation|1|||
106046590|NCT01604408|365835367|FG000|Treatment Period 3|Adverse Event|0|||
106046591|NCT01604408|365835368|FG001|Treatment Period 3|Adverse Event|3|||
106046592|NCT01604408|365835367|FG000|Treatment Period 3|Withdrawal by Subject|3|||
106046593|NCT01604408|365835368|FG001|Treatment Period 3|Withdrawal by Subject|1|||
106046594|NCT01604408|365835367|FG000|Treatment Period 3|Sponsor Decision|1|||
106046595|NCT01604408|365835368|FG001|Treatment Period 3|Sponsor Decision|0|||
106046596|NCT01604408|365835367|FG000|Treatment Period 4|Death|1|||
106046597|NCT01604408|365835368|FG001|Treatment Period 4|Death|0|||
106046598|NCT01604408|365835367|FG000|Treatment Period 4|Withdrawal by Subject|2|||
106046599|NCT01604408|365835368|FG001|Treatment Period 4|Withdrawal by Subject|1|||
106046600|NCT01604408|365835367|FG000|Treatment Period 4|Adverse Event|0|||
106046601|NCT01604408|365835368|FG001|Treatment Period 4|Adverse Event|1|||
106046602|NCT01604408|365835367|FG000|Treatment Period 5|Adverse Event|4|||
106046603|NCT01604408|365835368|FG001|Treatment Period 5|Adverse Event|0|||
106046604|NCT01604408|365835367|FG000|Treatment Period 6|Lost to Follow-up|0|||
106046605|NCT01604408|365835368|FG001|Treatment Period 6|Lost to Follow-up|1|||
106046606|NCT01604408|365835367|FG000|Treatment Period 6|Adverse Event|2|||
106046607|NCT01604408|365835368|FG001|Treatment Period 6|Adverse Event|0|||
106046608|NCT01604408|365835367|FG000|Treatment Period 6|Sponsor decision|0|||
106046609|NCT01604408|365835368|FG001|Treatment Period 6|Sponsor decision|1|||
106046610|NCT01604408|365835367|FG000|Observation Period|Adverse Event|1|||
106046611|NCT01604408|365835368|FG001|Observation Period|Adverse Event|1|||
106046612|NCT01604408|365835367|FG000|Observation Period|Withdrawal by Subject|0|||
106046613|NCT01604408|365835368|FG001|Observation Period|Withdrawal by Subject|2|||
106046614|NCT00917501|365835370|FG000|Overall Study|Lost to Follow-up|4|||
106046615|NCT00917501|365835371|FG001|Overall Study|Lost to Follow-up|1|||
106046616|NCT00917501|365835370|FG000|Overall Study|Withdrawal by Subject|3|||
106046617|NCT00917501|365835371|FG001|Overall Study|Withdrawal by Subject|1|||
106046618|NCT00917501|365835370|FG000|Overall Study|Lack of Efficacy|1|||
106046619|NCT00917501|365835371|FG001|Overall Study|Lack of Efficacy|2|||
106046620|NCT00917501|365835370|FG000|Overall Study|trouble swollowing capsules|0|||
106046621|NCT00917501|365835371|FG001|Overall Study|trouble swollowing capsules|1|||
106046622|NCT03342963|365835372|FG000|Overall Study|Adverse Event|1|||
106046623|NCT03342963|365835373|FG001|Overall Study|Adverse Event|2|||
106046624|NCT03342963|365835374|FG002|Overall Study|Adverse Event|0|||
106046625|NCT03342963|365835375|FG003|Overall Study|Adverse Event|0|||
106046626|NCT03342963|365835372|FG000|Overall Study|Withdrawal by Subject|1|||
106046627|NCT03342963|365835373|FG001|Overall Study|Withdrawal by Subject|0|||
106046628|NCT03342963|365835374|FG002|Overall Study|Withdrawal by Subject|0|||
106046629|NCT03342963|365835375|FG003|Overall Study|Withdrawal by Subject|0|||
106046630|NCT00722423|365835378|FG000|Overall Study|Protocol Violation|0|||
106046631|NCT00722423|365835379|FG001|Overall Study|Protocol Violation|1|||
106046632|NCT05447897|365835380|FG000|Overall Study|Did not participate in survey|2|||
106046633|NCT04553679|365835381|FG000|Overall Study|Withdrawal by Subject|2|||
106046634|NCT04553679|365835382|FG001|Overall Study|Withdrawal by Subject|0|||
106046635|NCT04553679|365835381|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
106046636|NCT04553679|365835382|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
106046637|NCT01453725|365835383|FG000|Overall Study|Adverse Event|3|||
106046638|NCT01453725|365835384|FG001|Overall Study|Adverse Event|3|||
106046639|NCT01453725|365835383|FG000|Overall Study|Lost to Follow-up|4|||
106046640|NCT01453725|365835384|FG001|Overall Study|Lost to Follow-up|0|||
106046641|NCT01453725|365835383|FG000|Overall Study|Non-compliance With Protocol|1|||
106046642|NCT01453725|365835384|FG001|Overall Study|Non-compliance With Protocol|2|||
106046643|NCT01453725|365835383|FG000|Overall Study|Protocol Violation|1|||
106046644|NCT01453725|365835384|FG001|Overall Study|Protocol Violation|0|||
106046645|NCT01453725|365835383|FG000|Overall Study|Withdrawal by Subject|2|||
106046646|NCT01453725|365835384|FG001|Overall Study|Withdrawal by Subject|3|||
106046647|NCT01453725|365835383|FG000|Overall Study|Pregnancy Wish|0|||
106046648|NCT01453725|365835384|FG001|Overall Study|Pregnancy Wish|2|||
106046649|NCT01453725|365835383|FG000|Overall Study|Pregnancy|1|||
106046650|NCT01453725|365835384|FG001|Overall Study|Pregnancy|0|||
106046651|NCT01453725|365835383|FG000|Overall Study|Physician Decision|1|||
106046652|NCT01453725|365835384|FG001|Overall Study|Physician Decision|1|||
106046653|NCT04289623|365835385|FG000|Wave 1 Emails|Email was not delivered|268|||
106046654|NCT04289623|365835386|FG001|Wave 1 Emails|Email was not delivered|257|||
106046655|NCT04289623|365835387|FG002|Wave 1 Emails|Email was not delivered|0|||
106046656|NCT04289623|365835388|FG003|Wave 1 Emails|Email was not delivered|0|||
106046657|NCT04289623|365835389|FG004|Wave 1 Emails|Email was not delivered|0|||
106046658|NCT04289623|365835390|FG005|Wave 1 Emails|Email was not delivered|0|||
106046659|NCT00875979|365835391|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
106046660|NCT00875979|365835392|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
106046661|NCT00875979|365835391|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
106046662|NCT00875979|365835392|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
106046663|NCT00875979|365835391|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
106046664|NCT00875979|365835392|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
106046665|NCT00875979|365835391|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
106046666|NCT00875979|365835392|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
106046667|NCT00875979|365835391|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
106046668|NCT00875979|365835392|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
106046669|NCT00875979|365835391|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
106046670|NCT00875979|365835392|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
106046671|NCT00875979|365835391|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
106046672|NCT00875979|365835392|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
106046673|NCT00875979|365835391|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
106046674|NCT00875979|365835392|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
106046675|NCT00875979|365835391|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
106046676|NCT00875979|365835392|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
106046677|NCT01772160|365835393|FG000|Overall Study|Death|3|||
106046678|NCT01772160|365835393|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
106046679|NCT01772160|365835393|FG000|Overall Study|Consent withdrawal|3|||
106046680|NCT01772160|365835393|FG000|Overall Study|Migrated / moved from the study area|4|||
106046681|NCT01772160|365835393|FG000|Overall Study|Lost to Follow-up|30|||
106046682|NCT01772160|365835393|FG000|Overall Study|Other|5|||
106046683|NCT01069627|365835395|FG000|Overall Study|Disease progression|7|||
106046684|NCT01069627|365835395|FG000|Overall Study|Adverse Event|12|||
106046685|NCT01069627|365835395|FG000|Overall Study|Protocol Violation|1|||
106046686|NCT00386607|365835398|FG000|Core|Adverse Event|40|||
106046687|NCT00386607|365835399|FG001|Core|Adverse Event|0|||
106046688|NCT00386607|365835398|FG000|Core|Abnormal laboratory value(s)|3|||
106046689|NCT00386607|365835399|FG001|Core|Abnormal laboratory value(s)|0|||
106046690|NCT00386607|365835398|FG000|Core|Unsatisfactory therapeutic effect|23|||
106046691|NCT00386607|365835399|FG001|Core|Unsatisfactory therapeutic effect|0|||
106046692|NCT00386607|365835398|FG000|Core|Condition no longer requires study drug|4|||
106046693|NCT00386607|365835399|FG001|Core|Condition no longer requires study drug|0|||
106046694|NCT00386607|365835398|FG000|Core|Patient withdrew consent|15|||
106046695|NCT00386607|365835399|FG001|Core|Patient withdrew consent|0|||
106046696|NCT00386607|365835398|FG000|Core|Lost to Follow-up|23|||
106046697|NCT00386607|365835399|FG001|Core|Lost to Follow-up|0|||
106046698|NCT00386607|365835398|FG000|Core|Administrative problems|1|||
106046699|NCT00386607|365835399|FG001|Core|Administrative problems|0|||
106046700|NCT00386607|365835398|FG000|Core|Protocol Deviation|6|||
106046701|NCT00386607|365835399|FG001|Core|Protocol Deviation|0|||
106046702|NCT00386607|365835398|FG000|Extension|Adverse Event|0|||
106046703|NCT00386607|365835399|FG001|Extension|Adverse Event|6|||
106046704|NCT00386607|365835398|FG000|Extension|Abnormal laboratory value(s)|0|||
106046705|NCT00386607|365835399|FG001|Extension|Abnormal laboratory value(s)|1|||
106046706|NCT00386607|365835398|FG000|Extension|Administrative problems|0|||
106046707|NCT00386607|365835399|FG001|Extension|Administrative problems|1|||
105862705|NCT01831258|365148046|FG001|Overall Study|Lost to Follow-up|2|||
105862706|NCT00253448|365148055|FG000|Overall Study|Withdrawal by Subject|1|||
105862707|NCT00000620|365148058|FG000|Overall Study|Death|86|||
105862708|NCT00000620|365148059|FG001|Overall Study|Death|67|||
105862709|NCT00000620|365148060|FG002|Overall Study|Death|112|||
105862710|NCT00000620|365148061|FG003|Overall Study|Death|126|||
105862711|NCT00000620|365148062|FG004|Overall Study|Death|64|||
105862712|NCT00000620|365148063|FG005|Overall Study|Death|77|||
105862713|NCT00000620|365148064|FG006|Overall Study|Death|91|||
105862714|NCT00000620|365148065|FG007|Overall Study|Death|95|||
105862715|NCT00000620|365148058|FG000|Overall Study|Lost to Follow-up|14|||
105862716|NCT00000620|365148059|FG001|Overall Study|Lost to Follow-up|14|||
105862717|NCT00000620|365148060|FG002|Overall Study|Lost to Follow-up|14|||
105862718|NCT00000620|365148061|FG003|Overall Study|Lost to Follow-up|14|||
105862719|NCT00000620|365148062|FG004|Overall Study|Lost to Follow-up|15|||
105862720|NCT00000620|365148063|FG005|Overall Study|Lost to Follow-up|15|||
105862721|NCT00000620|365148064|FG006|Overall Study|Lost to Follow-up|13|||
105862722|NCT00000620|365148065|FG007|Overall Study|Lost to Follow-up|14|||
105862723|NCT00000620|365148058|FG000|Overall Study|Withdrawal by Subject|40|||
105862724|NCT00000620|365148059|FG001|Overall Study|Withdrawal by Subject|27|||
105862725|NCT00000620|365148060|FG002|Overall Study|Withdrawal by Subject|28|||
105862726|NCT00000620|365148061|FG003|Overall Study|Withdrawal by Subject|27|||
105862727|NCT00000620|365148062|FG004|Overall Study|Withdrawal by Subject|30|||
105862728|NCT00000620|365148063|FG005|Overall Study|Withdrawal by Subject|32|||
105862729|NCT00000620|365148064|FG006|Overall Study|Withdrawal by Subject|32|||
105862730|NCT00000620|365148065|FG007|Overall Study|Withdrawal by Subject|21|||
105862731|NCT00000620|365148058|FG000|Overall Study|missed closeout visit|22|||
105862732|NCT00000620|365148059|FG001|Overall Study|missed closeout visit|28|||
105862733|NCT00000620|365148060|FG002|Overall Study|missed closeout visit|16|||
105862734|NCT00000620|365148061|FG003|Overall Study|missed closeout visit|11|||
105862735|NCT00000620|365148062|FG004|Overall Study|missed closeout visit|26|||
105862736|NCT00000620|365148063|FG005|Overall Study|missed closeout visit|28|||
105862737|NCT00000620|365148064|FG006|Overall Study|missed closeout visit|13|||
105862738|NCT00000620|365148065|FG007|Overall Study|missed closeout visit|16|||
105862739|NCT01609023|365148077|FG000|Overall Study|Lack of Efficacy|3|||
105862740|NCT01609023|365148077|FG000|Overall Study|Withdrawal by Subject|4|||
105862741|NCT01609023|365148077|FG000|Overall Study|Lost to Follow-up|8|||
105862742|NCT01609023|365148077|FG000|Overall Study|Toxicity|3|||
105862743|NCT01609023|365148077|FG000|Overall Study|Disease progression|10|||
105862744|NCT01609023|365148077|FG000|Overall Study|Physician Decision|2|||
105862745|NCT01609023|365148077|FG000|Overall Study|Death|2|||
105862746|NCT01609023|365148077|FG000|Overall Study|Personal reasons|1|||
105862747|NCT00171951|365148078|FG000|Overall Study|Adverse Event|1|||
105862748|NCT00171951|365148078|FG000|Overall Study|Abnormal Laboratory Values|2|||
105862749|NCT00171951|365148078|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
105862750|NCT00171951|365148078|FG000|Overall Study|Participants Withdrew Consent|3|||
105862751|NCT00171951|365148078|FG000|Overall Study|New Cancer Therapy|5|||
105862752|NCT00171951|365148078|FG000|Overall Study|Reason not Specified|2|||
105862753|NCT00315731|365148079|FG000|Overall Study|Lost to Follow-up|1|||
105862754|NCT00315731|365148079|FG000|Overall Study|Death|5|||
105862755|NCT04400682|365148080|FG000|Period 1|Withdrawal by Subject|1|||
105862756|NCT04400682|365148081|FG001|Period 1|Withdrawal by Subject|4|||
105862757|NCT04784533|365148088|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
105862758|NCT04784533|365148089|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
106046708|NCT00386607|365835398|FG000|Extension|Lost to Follow-up|0|||
105862759|NCT04784533|365148090|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105862760|NCT04784533|365148091|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105862761|NCT04784533|365148092|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105862762|NCT04784533|365148093|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105862763|NCT04784533|365148094|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105862764|NCT04784533|365148095|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105862765|NCT04784533|365148096|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105862766|NCT04784533|365148097|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
105862767|NCT04784533|365148088|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
105862768|NCT04784533|365148089|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
105862769|NCT04784533|365148090|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105862770|NCT04784533|365148091|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105862771|NCT04784533|365148092|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105862772|NCT04784533|365148093|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105862773|NCT04784533|365148094|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
105862774|NCT04784533|365148095|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
106046709|NCT00386607|365835399|FG001|Extension|Lost to Follow-up|3|||
105862775|NCT04784533|365148096|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
106046710|NCT00386607|365835398|FG000|Extension|Patient withdrew consent|0|||
106046711|NCT00386607|365835399|FG001|Extension|Patient withdrew consent|5|||
106046712|NCT00386607|365835398|FG000|Extension|Unsatisfactory therapeutic effect|0|||
106046713|NCT00386607|365835399|FG001|Extension|Unsatisfactory therapeutic effect|1|||
106046714|NCT01262573|365835400|FG000|Overall Study|Withdrawal by Subject|0|||
106046715|NCT01262573|365835401|FG001|Overall Study|Withdrawal by Subject|1|||
106046716|NCT01986907|365835404|FG000|Overall Study|Adverse Event|11|||
106046717|NCT01986907|365835404|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
106046718|NCT01986907|365835404|FG000|Overall Study|Protocol Violation|4|||
106046719|NCT01986907|365835404|FG000|Overall Study|Withdrawal by Subject|76|||
106046720|NCT01986907|365835404|FG000|Overall Study|Lost to Follow-up|38|||
106046721|NCT01986907|365835404|FG000|Overall Study|Death|9|||
106046722|NCT00810693|365835407|FG000|Treatment Period|Adverse Event|8|||
106046723|NCT00810693|365835408|FG001|Treatment Period|Adverse Event|1|||
106046724|NCT00810693|365835409|FG002|Treatment Period|Adverse Event|7|||
106046725|NCT00810693|365835407|FG000|Treatment Period|Death|0|||
106046726|NCT00810693|365835408|FG001|Treatment Period|Death|1|||
106046727|NCT00810693|365835409|FG002|Treatment Period|Death|2|||
106046728|NCT00810693|365835407|FG000|Treatment Period|Lack of Efficacy|0|||
106046729|NCT00810693|365835408|FG001|Treatment Period|Lack of Efficacy|0|||
106046730|NCT00810693|365835409|FG002|Treatment Period|Lack of Efficacy|1|||
106046731|NCT00810693|365835407|FG000|Treatment Period|Lost to Follow-up|1|||
106046732|NCT00810693|365835408|FG001|Treatment Period|Lost to Follow-up|0|||
106046733|NCT00810693|365835409|FG002|Treatment Period|Lost to Follow-up|0|||
106046734|NCT00810693|365835407|FG000|Treatment Period|Non-compliance|1|||
106046735|NCT00810693|365835408|FG001|Treatment Period|Non-compliance|0|||
106046736|NCT00810693|365835409|FG002|Treatment Period|Non-compliance|0|||
106046737|NCT00810693|365835407|FG000|Treatment Period|Protocol Violation|1|||
106046738|NCT00810693|365835408|FG001|Treatment Period|Protocol Violation|2|||
106046739|NCT00810693|365835409|FG002|Treatment Period|Protocol Violation|2|||
106046740|NCT00810693|365835407|FG000|Treatment Period|Withdrawal by Subject|6|||
106046741|NCT00810693|365835408|FG001|Treatment Period|Withdrawal by Subject|2|||
106046742|NCT00810693|365835409|FG002|Treatment Period|Withdrawal by Subject|3|||
106046743|NCT00810693|365835407|FG000|Treatment Period|Not treated|0|||
106046744|NCT00810693|365835408|FG001|Treatment Period|Not treated|1|||
106046745|NCT00810693|365835409|FG002|Treatment Period|Not treated|1|||
106046746|NCT00810693|365835407|FG000|Follow-up Period (FUP)|Adverse Event|3|||
106046747|NCT00810693|365835408|FG001|Follow-up Period (FUP)|Adverse Event|1|||
106046748|NCT00810693|365835409|FG002|Follow-up Period (FUP)|Adverse Event|1|||
106046749|NCT00810693|365835407|FG000|Follow-up Period (FUP)|Death|2|||
106046750|NCT00810693|365835408|FG001|Follow-up Period (FUP)|Death|0|||
106046751|NCT00810693|365835409|FG002|Follow-up Period (FUP)|Death|1|||
106046752|NCT00810693|365835407|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
106046753|NCT00810693|365835408|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
106046754|NCT00810693|365835409|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
106046755|NCT00810693|365835407|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
106046756|NCT00810693|365835408|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
106046757|NCT00810693|365835409|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
106046758|NCT00810693|365835407|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
106046759|NCT00810693|365835408|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
106046760|NCT00810693|365835409|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
106046761|NCT02805972|365835410|FG000|Washout Period|Lost to Follow-up|3|||
106046762|NCT02805972|365835411|FG001|Washout Period|Lost to Follow-up|0|||
106046763|NCT00331422|365835412|FG000|Overall Study|Did not receive entire study regimen|5|||
106046764|NCT00467857|365835416|FG000|Overall Study|Adverse Event|1|||
106046765|NCT00467857|365835417|FG001|Overall Study|Adverse Event|0|||
106046766|NCT00467857|365835416|FG000|Overall Study|Withdrew consent|2|||
106046767|NCT00467857|365835417|FG001|Overall Study|Withdrew consent|0|||
106046768|NCT00467857|365835416|FG000|Overall Study|Death|0|||
106046769|NCT00467857|365835417|FG001|Overall Study|Death|1|||
106046770|NCT00467857|365835416|FG000|Overall Study|Discharged from court service|0|||
106046771|NCT00467857|365835417|FG001|Overall Study|Discharged from court service|1|||
106046772|NCT00467857|365835416|FG000|Overall Study|Emergency care required|0|||
106046773|NCT00467857|365835417|FG001|Overall Study|Emergency care required|1|||
106046774|NCT00467857|365835416|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
106046775|NCT00467857|365835417|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
106046776|NCT00467857|365835416|FG000|Overall Study|Discontinuation reason missing|0|||
106046777|NCT00467857|365835417|FG001|Overall Study|Discontinuation reason missing|3|||
106046778|NCT03386474|365835420|FG000|Overall Study|Death|1|||
106046779|NCT03386474|365835421|FG001|Overall Study|Death|0|||
106046780|NCT03386474|365835420|FG000|Overall Study|Adverse Event|0|||
106046781|NCT03386474|365835421|FG001|Overall Study|Adverse Event|1|||
106046782|NCT02282358|365835422|FG000|Overall Study|Nonevaluable|1|||
106046783|NCT00910273|365835423|FG000|Overall Study|Lack of Efficacy|6|||
106046784|NCT00910273|365835424|FG001|Overall Study|Lack of Efficacy|9|||
106046785|NCT00910273|365835423|FG000|Overall Study|Adverse Event|1|||
106046786|NCT00910273|365835424|FG001|Overall Study|Adverse Event|1|||
106046787|NCT00910273|365835423|FG000|Overall Study|Withdrawal by Subject|1|||
106046788|NCT00910273|365835424|FG001|Overall Study|Withdrawal by Subject|0|||
106046789|NCT00910273|365835423|FG000|Overall Study|Discontinuation of study by sponsor|8|||
106046790|NCT00910273|365835424|FG001|Overall Study|Discontinuation of study by sponsor|2|||
106046791|NCT00910273|365835423|FG000|Overall Study|Protocol Violation|1|||
105862776|NCT04784533|365148097|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
106046792|NCT00910273|365835424|FG001|Overall Study|Protocol Violation|0|||
106046793|NCT00910273|365835423|FG000|Overall Study|Lost to Follow-up|1|||
106046794|NCT00910273|365835424|FG001|Overall Study|Lost to Follow-up|1|||
106046795|NCT04357782|365835425|FG000|Overall Study|Discharged from hospital|1|||
106046796|NCT04357782|365835426|FG001|Overall Study|Discharged from hospital|0|||
106046797|NCT04357782|365835425|FG000|Overall Study|Death|0|||
106046798|NCT04357782|365835426|FG001|Overall Study|Death|2|||
106046799|NCT00968864|365835427|FG000|Overall Study|Protocol exception/ not evaluable|1|||
106046800|NCT02020577|365835429|FG000|Overall Study|Progressive disease|3|||
106046801|NCT02020577|365835430|FG001|Overall Study|Progressive disease|38|||
106046802|NCT02020577|365835429|FG000|Overall Study|Other AE or clinical progression|0|||
106046803|NCT02020577|365835430|FG001|Overall Study|Other AE or clinical progression|15|||
106046804|NCT02020577|365835429|FG000|Overall Study|Withdrawal by Subject|0|||
106046805|NCT02020577|365835430|FG001|Overall Study|Withdrawal by Subject|1|||
106046806|NCT02020577|365835429|FG000|Overall Study|Other than stated above|0|||
105862777|NCT04784533|365148088|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105862778|NCT04784533|365148089|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
105862779|NCT04784533|365148090|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105862780|NCT04784533|365148091|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105862781|NCT04784533|365148092|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105862782|NCT04784533|365148093|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105862783|NCT04784533|365148094|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105862784|NCT04784533|365148095|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
106046807|NCT02020577|365835430|FG001|Overall Study|Other than stated above|1|||
106046808|NCT01758523|365835431|FG000|Overall Study|Adverse Event|2|||
106046809|NCT01758523|365835432|FG001|Overall Study|Adverse Event|1|||
106046810|NCT01758523|365835431|FG000|Overall Study|Lack of Efficacy|4|||
106046811|NCT01758523|365835432|FG001|Overall Study|Lack of Efficacy|2|||
106046812|NCT01758523|365835431|FG000|Overall Study|Lost to Follow-up|3|||
106046813|NCT01758523|365835432|FG001|Overall Study|Lost to Follow-up|4|||
106046814|NCT01758523|365835431|FG000|Overall Study|Withdrawal by Subject|12|||
106046815|NCT01758523|365835432|FG001|Overall Study|Withdrawal by Subject|7|||
106046816|NCT00621959|365835433|FG000|Overall Study|Adverse Event|4|||
106046817|NCT00621959|365835434|FG001|Overall Study|Adverse Event|2|||
106046818|NCT00621959|365835433|FG000|Overall Study|Lack of Efficacy|1|||
106046819|NCT00621959|365835434|FG001|Overall Study|Lack of Efficacy|1|||
106046820|NCT00621959|365835433|FG000|Overall Study|Lost to Follow-up|0|||
106046821|NCT00621959|365835434|FG001|Overall Study|Lost to Follow-up|2|||
106046822|NCT00621959|365835433|FG000|Overall Study|Withdrawal by Subject|1|||
106046823|NCT00621959|365835434|FG001|Overall Study|Withdrawal by Subject|1|||
106046824|NCT00621959|365835433|FG000|Overall Study|Other|1|||
106046825|NCT00621959|365835434|FG001|Overall Study|Other|3|||
106046826|NCT00590135|365835435|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
106046827|NCT02764697|365835438|FG000|Overall Study|Lack of Efficacy|3|||
106046828|NCT01736124|365835439|FG000|Post-intervention Assessment|Death|2|||
106046829|NCT01736124|365835440|FG001|Post-intervention Assessment|Death|2|||
106046830|NCT01736124|365835439|FG000|Post-intervention Assessment|lost computer access|1|||
106046831|NCT01736124|365835440|FG001|Post-intervention Assessment|lost computer access|1|||
106046832|NCT01736124|365835439|FG000|Post-intervention Assessment|Moved away|3|||
106046833|NCT01736124|365835440|FG001|Post-intervention Assessment|Moved away|1|||
106046834|NCT01736124|365835439|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
106046835|NCT01736124|365835440|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
106046836|NCT01736124|365835439|FG000|Post-intervention Assessment|Illness|3|||
106046837|NCT01736124|365835440|FG001|Post-intervention Assessment|Illness|2|||
106046838|NCT01736124|365835439|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
106046839|NCT01736124|365835440|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
106046840|NCT01736124|365835439|FG000|Post-intervention Assessment|Temporarily away|3|||
106046841|NCT01736124|365835440|FG001|Post-intervention Assessment|Temporarily away|1|||
106046842|NCT01736124|365835439|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
106046843|NCT01736124|365835440|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
106046844|NCT01736124|365835439|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
106046845|NCT01736124|365835440|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
106046846|NCT01736124|365835439|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
106046847|NCT01736124|365835440|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
106046848|NCT01736124|365835439|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
106046849|NCT01736124|365835440|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
106046850|NCT01736124|365835439|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
105862785|NCT04784533|365148096|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105862786|NCT04784533|365148097|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
105862787|NCT04784533|365148088|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
105862788|NCT04784533|365148089|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862789|NCT04784533|365148090|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862790|NCT04784533|365148091|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862791|NCT04784533|365148092|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862792|NCT04784533|365148093|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862793|NCT04784533|365148094|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862794|NCT04784533|365148095|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862795|NCT04784533|365148096|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862796|NCT04784533|365148097|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
105862797|NCT04784533|365148088|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
105862798|NCT04784533|365148089|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
105862799|NCT04784533|365148090|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105862800|NCT04784533|365148091|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105862801|NCT04784533|365148092|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105862802|NCT04784533|365148093|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105862803|NCT04784533|365148094|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105862804|NCT04784533|365148095|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105862805|NCT04784533|365148096|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105862806|NCT04784533|365148097|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
105862807|NCT04784533|365148088|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
105862808|NCT04784533|365148089|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
105862809|NCT04784533|365148090|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105862810|NCT04784533|365148091|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105862811|NCT04784533|365148092|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105862812|NCT04784533|365148093|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105862813|NCT04784533|365148094|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105862814|NCT04784533|365148095|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105862815|NCT04784533|365148096|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105862816|NCT04784533|365148097|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
105862817|NCT04784533|365148088|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862818|NCT04784533|365148089|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862819|NCT04784533|365148090|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
105862820|NCT04784533|365148091|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862821|NCT04784533|365148092|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862822|NCT04784533|365148093|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862823|NCT04784533|365148094|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862824|NCT04784533|365148095|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862825|NCT04784533|365148096|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862826|NCT04784533|365148097|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
105862827|NCT04784533|365148088|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862828|NCT04784533|365148089|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862829|NCT04784533|365148090|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862830|NCT04784533|365148091|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862831|NCT04784533|365148092|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862832|NCT04784533|365148093|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862833|NCT04784533|365148094|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862834|NCT04784533|365148095|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862835|NCT04784533|365148096|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
105862836|NCT04784533|365148097|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
105862837|NCT04784533|365148088|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105862838|NCT04784533|365148089|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105862839|NCT04784533|365148090|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105862840|NCT04784533|365148091|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105862841|NCT04784533|365148092|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105862842|NCT04784533|365148093|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105862843|NCT04784533|365148094|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105862844|NCT04784533|365148095|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
105862845|NCT04784533|365148096|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
105862846|NCT04784533|365148097|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
105862847|NCT03597464|365148098|FG000|Overall Study|Withdrawal by Subject|4|||
105862848|NCT03597464|365148099|FG001|Overall Study|Withdrawal by Subject|5|||
105862849|NCT03597464|365148098|FG000|Overall Study|Lost to Follow-up|3|||
105862850|NCT03597464|365148099|FG001|Overall Study|Lost to Follow-up|1|||
105862851|NCT03597464|365148098|FG000|Overall Study|Pregnancy|3|||
105862852|NCT03597464|365148099|FG001|Overall Study|Pregnancy|1|||
106046851|NCT01736124|365835440|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
106046852|NCT01736124|365835439|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
106046853|NCT01736124|365835440|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
106046854|NCT01736124|365835439|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
106046855|NCT01736124|365835440|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
106046856|NCT01736124|365835439|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
106046857|NCT01736124|365835440|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
106046858|NCT01736124|365835439|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
106046859|NCT01736124|365835440|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
106046860|NCT04223973|365835441|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
106046861|NCT04223973|365835442|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
106046862|NCT04223973|365835441|FG000|Overall Study|Adverse Event|4|||
106046863|NCT04223973|365835442|FG001|Overall Study|Adverse Event|0|||
106046864|NCT04223973|365835441|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
106046865|NCT04223973|365835442|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
106046866|NCT04223973|365835441|FG000|Overall Study|Physician Decision|1|||
106046867|NCT04223973|365835442|FG001|Overall Study|Physician Decision|1|||
106046868|NCT04223973|365835441|FG000|Overall Study|Withdrawal by Subject|0|||
106046869|NCT04223973|365835442|FG001|Overall Study|Withdrawal by Subject|1|||
106046870|NCT03672643|365835444|FG000|Overall Study|Adverse Event|3|||
106046871|NCT03672643|365835444|FG000|Overall Study|Death|2|||
106046872|NCT03672643|365835444|FG000|Overall Study|Withdrawal by Subject|1|||
106046873|NCT03672643|365835444|FG000|Overall Study|Progressive disease|11|||
106046874|NCT03672643|365835444|FG000|Overall Study|Global deterioration of health status|1|||
106046875|NCT03672643|365835444|FG000|Overall Study|Refused further treatment|7|||
106046876|NCT03672643|365835444|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
106046877|NCT02557295|365835445|FG000|Overall Study|Withdrawal by Subject|9|||
106046878|NCT02557295|365835446|FG001|Overall Study|Withdrawal by Subject|2|||
106046879|NCT02557295|365835447|FG002|Overall Study|Withdrawal by Subject|4|||
106046880|NCT02557295|365835448|FG003|Overall Study|Withdrawal by Subject|0|||
106046881|NCT02557295|365835449|FG004|Overall Study|Withdrawal by Subject|0|||
106046882|NCT02557295|365835450|FG005|Overall Study|Withdrawal by Subject|0|||
106046883|NCT02557295|365835451|FG006|Overall Study|Withdrawal by Subject|15|||
106046884|NCT02557295|365835452|FG007|Overall Study|Withdrawal by Subject|1|||
106046885|NCT02557295|365835453|FG008|Overall Study|Withdrawal by Subject|3|||
106046886|NCT02557295|365835445|FG000|Overall Study|Disease Progression|0|||
106046887|NCT02557295|365835446|FG001|Overall Study|Disease Progression|0|||
106046888|NCT02557295|365835447|FG002|Overall Study|Disease Progression|0|||
106046889|NCT02557295|365835448|FG003|Overall Study|Disease Progression|0|||
106046890|NCT02557295|365835449|FG004|Overall Study|Disease Progression|0|||
106046891|NCT02557295|365835450|FG005|Overall Study|Disease Progression|0|||
106046892|NCT02557295|365835451|FG006|Overall Study|Disease Progression|1|||
106046893|NCT02557295|365835452|FG007|Overall Study|Disease Progression|0|||
106046894|NCT02557295|365835453|FG008|Overall Study|Disease Progression|0|||
106046895|NCT02557295|365835445|FG000|Overall Study|Lack of Efficacy|24|||
106046896|NCT02557295|365835446|FG001|Overall Study|Lack of Efficacy|1|||
106046897|NCT02557295|365835447|FG002|Overall Study|Lack of Efficacy|3|||
106046898|NCT02557295|365835448|FG003|Overall Study|Lack of Efficacy|0|||
106046899|NCT02557295|365835449|FG004|Overall Study|Lack of Efficacy|0|||
106046900|NCT02557295|365835450|FG005|Overall Study|Lack of Efficacy|0|||
106046901|NCT02557295|365835451|FG006|Overall Study|Lack of Efficacy|12|||
106046902|NCT02557295|365835452|FG007|Overall Study|Lack of Efficacy|1|||
106046903|NCT02557295|365835453|FG008|Overall Study|Lack of Efficacy|0|||
106046904|NCT02557295|365835445|FG000|Overall Study|Adverse Event|16|||
106046905|NCT02557295|365835446|FG001|Overall Study|Adverse Event|2|||
106046906|NCT02557295|365835447|FG002|Overall Study|Adverse Event|3|||
106046907|NCT02557295|365835448|FG003|Overall Study|Adverse Event|0|||
106046908|NCT02557295|365835449|FG004|Overall Study|Adverse Event|0|||
106046909|NCT02557295|365835450|FG005|Overall Study|Adverse Event|0|||
106046910|NCT02557295|365835451|FG006|Overall Study|Adverse Event|2|||
106046911|NCT02557295|365835452|FG007|Overall Study|Adverse Event|1|||
106046912|NCT02557295|365835453|FG008|Overall Study|Adverse Event|1|||
106046913|NCT02557295|365835445|FG000|Overall Study|Lost to Follow-up|4|||
106046914|NCT02557295|365835446|FG001|Overall Study|Lost to Follow-up|0|||
106046915|NCT02557295|365835447|FG002|Overall Study|Lost to Follow-up|0|||
106046916|NCT02557295|365835448|FG003|Overall Study|Lost to Follow-up|0|||
106046917|NCT02557295|365835449|FG004|Overall Study|Lost to Follow-up|0|||
106046918|NCT02557295|365835450|FG005|Overall Study|Lost to Follow-up|0|||
106046919|NCT02557295|365835451|FG006|Overall Study|Lost to Follow-up|9|||
106046920|NCT02557295|365835452|FG007|Overall Study|Lost to Follow-up|0|||
105862853|NCT03597464|365148098|FG000|Overall Study|Lack of Efficacy|2|||
105862854|NCT03597464|365148099|FG001|Overall Study|Lack of Efficacy|0|||
106046921|NCT02557295|365835453|FG008|Overall Study|Lost to Follow-up|0|||
106046922|NCT02557295|365835445|FG000|Overall Study|Study Close|54|||
106046923|NCT02557295|365835446|FG001|Overall Study|Study Close|3|||
106046924|NCT02557295|365835447|FG002|Overall Study|Study Close|5|||
106046925|NCT02557295|365835448|FG003|Overall Study|Study Close|3|||
106046926|NCT02557295|365835449|FG004|Overall Study|Study Close|0|||
106046927|NCT02557295|365835450|FG005|Overall Study|Study Close|0|||
106046928|NCT02557295|365835451|FG006|Overall Study|Study Close|37|||
106046929|NCT02557295|365835452|FG007|Overall Study|Study Close|3|||
106046930|NCT02557295|365835453|FG008|Overall Study|Study Close|19|||
106046931|NCT02557295|365835445|FG000|Overall Study|except for study close|4|||
106046932|NCT02557295|365835446|FG001|Overall Study|except for study close|0|||
106046933|NCT02557295|365835447|FG002|Overall Study|except for study close|0|||
106046934|NCT02557295|365835448|FG003|Overall Study|except for study close|0|||
106046935|NCT02557295|365835449|FG004|Overall Study|except for study close|0|||
106046936|NCT02557295|365835450|FG005|Overall Study|except for study close|0|||
106046937|NCT02557295|365835451|FG006|Overall Study|except for study close|5|||
106046938|NCT02557295|365835452|FG007|Overall Study|except for study close|1|||
106046939|NCT02557295|365835453|FG008|Overall Study|except for study close|0|||
106046940|NCT00566111|365835454|FG000|Overall Study|Adverse Event|0|||
106046941|NCT00566111|365835455|FG001|Overall Study|Adverse Event|2|||
106046942|NCT02171065|365837712|FG000|Overall Study|Withdrawal by Subject|1|||
106046943|NCT02171065|365837713|FG001|Overall Study|Withdrawal by Subject|0|||
106046944|NCT02171065|365837714|FG002|Overall Study|Withdrawal by Subject|0|||
106046945|NCT02171065|365837712|FG000|Overall Study|Lost to Follow-up|0|||
106046946|NCT02171065|365837713|FG001|Overall Study|Lost to Follow-up|0|||
106046947|NCT02171065|365837714|FG002|Overall Study|Lost to Follow-up|1|||
106046948|NCT00531934|365837715|FG000|Overall Study|Adverse Event|4|||
106046949|NCT00531934|365837716|FG001|Overall Study|Adverse Event|8|||
106046950|NCT00531934|365837715|FG000|Overall Study|Progression|52|||
106046951|NCT00531934|365837716|FG001|Overall Study|Progression|42|||
106046952|NCT00531934|365837715|FG000|Overall Study|Death|7|||
106046953|NCT00531934|365837716|FG001|Overall Study|Death|10|||
106046954|NCT00531934|365837715|FG000|Overall Study|Withdrawal by Subject|1|||
106046955|NCT00531934|365837716|FG001|Overall Study|Withdrawal by Subject|1|||
106046956|NCT00531934|365837715|FG000|Overall Study|Other|2|||
106046957|NCT00531934|365837716|FG001|Overall Study|Other|2|||
106046958|NCT02925923|365837717|FG000|Overall Study|blood samples hemolyzed|0|||
106046959|NCT02925923|365837718|FG001|Overall Study|blood samples hemolyzed|2|||
106046960|NCT04806503|365837720|FG000|Overall Study|Lost to Follow-up|0|||
106046961|NCT04806503|365837721|FG001|Overall Study|Lost to Follow-up|0|||
106046962|NCT04806503|365837722|FG002|Overall Study|Lost to Follow-up|1|||
106046963|NCT04806503|365837723|FG003|Overall Study|Lost to Follow-up|0|||
106046964|NCT04806503|365837724|FG004|Overall Study|Lost to Follow-up|0|||
106046965|NCT04806503|365837720|FG000|Overall Study|Withdrawal by Subject|1|||
106046966|NCT04806503|365837721|FG001|Overall Study|Withdrawal by Subject|0|||
106046967|NCT04806503|365837722|FG002|Overall Study|Withdrawal by Subject|1|||
106046968|NCT04806503|365837723|FG003|Overall Study|Withdrawal by Subject|1|||
106046969|NCT04806503|365837724|FG004|Overall Study|Withdrawal by Subject|1|||
106046970|NCT04806503|365837720|FG000|Overall Study|Adverse Event|1|||
106046971|NCT04806503|365837721|FG001|Overall Study|Adverse Event|1|||
106046972|NCT04806503|365837722|FG002|Overall Study|Adverse Event|0|||
106046973|NCT04806503|365837723|FG003|Overall Study|Adverse Event|1|||
106046974|NCT04806503|365837724|FG004|Overall Study|Adverse Event|0|||
106046975|NCT02008318|365837729|FG000|Overall Study|Adverse Event|4|||
106046976|NCT02008318|365837730|FG001|Overall Study|Adverse Event|0|||
106046977|NCT02008318|365837729|FG000|Overall Study|Physician Decision|2|||
106046978|NCT02008318|365837730|FG001|Overall Study|Physician Decision|0|||
106046979|NCT02008318|365837729|FG000|Overall Study|Progressive Disease|2|||
106046980|NCT02008318|365837730|FG001|Overall Study|Progressive Disease|0|||
106046981|NCT02008318|365837729|FG000|Overall Study|Protocol Violation|1|||
106046982|NCT02008318|365837730|FG001|Overall Study|Protocol Violation|1|||
106046983|NCT02008318|365837729|FG000|Overall Study|Withdrawal by Subject|3|||
106046984|NCT02008318|365837730|FG001|Overall Study|Withdrawal by Subject|0|||
106046985|NCT00371826|365837731|FG000|Core Phase (12 Months)|Adverse Event|15|||
106046986|NCT00371826|365837732|FG001|Core Phase (12 Months)|Adverse Event|4|||
106046987|NCT00371826|365837733|FG002|Core Phase (12 Months)|Adverse Event|9|||
106046988|NCT00371826|365837731|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
106046989|NCT00371826|365837732|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
106046990|NCT00371826|365837733|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
106046991|NCT00371826|365837731|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
106046992|NCT00371826|365837732|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
106046993|NCT00371826|365837733|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
106046994|NCT00371826|365837731|FG000|Core Phase (12 Months)|Protocol Violation|1|||
106046995|NCT00371826|365837732|FG001|Core Phase (12 Months)|Protocol Violation|0|||
106046996|NCT00371826|365837733|FG002|Core Phase (12 Months)|Protocol Violation|1|||
106046997|NCT00371826|365837731|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
106046998|NCT00371826|365837732|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
106046999|NCT00371826|365837733|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
106047000|NCT00371826|365837731|FG000|Core Phase (12 Months)|Administrative problems|1|||
106047001|NCT00371826|365837732|FG001|Core Phase (12 Months)|Administrative problems|0|||
106047002|NCT00371826|365837733|FG002|Core Phase (12 Months)|Administrative problems|8|||
106047003|NCT00371826|365837731|FG000|Core Phase (12 Months)|Graft Loss|0|||
106047004|NCT00371826|365837732|FG001|Core Phase (12 Months)|Graft Loss|1|||
106047005|NCT00371826|365837733|FG002|Core Phase (12 Months)|Graft Loss|0|||
106047006|NCT00371826|365837731|FG000|Extension Phase (24 Months)|Adverse Event|4|||
106047007|NCT00371826|365837732|FG001|Extension Phase (24 Months)|Adverse Event|5|||
106047008|NCT00371826|365837733|FG002|Extension Phase (24 Months)|Adverse Event|0|||
106047009|NCT00371826|365837731|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
106047010|NCT00371826|365837732|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
106047011|NCT00371826|365837733|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
106047012|NCT00371826|365837731|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
106047013|NCT00371826|365837732|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
106047014|NCT00371826|365837733|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
106047015|NCT00371826|365837731|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
106047016|NCT00371826|365837732|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
106047017|NCT00371826|365837733|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
106047018|NCT00371826|365837731|FG000|Extension Phase (24 Months)|Administrative problems|0|||
106047019|NCT00371826|365837732|FG001|Extension Phase (24 Months)|Administrative problems|0|||
106047020|NCT00371826|365837733|FG002|Extension Phase (24 Months)|Administrative problems|2|||
106047021|NCT02104752|365837736|FG000|Overall Study|Withdrawal by Subject|1|||
106047022|NCT02104752|365837737|FG001|Overall Study|Withdrawal by Subject|0|||
106047023|NCT02104752|365837736|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
106047024|NCT02104752|365837737|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
106047025|NCT00573183|365837738|FG000|Overall Study|Lost to Follow-up|52|||
106047026|NCT00573183|365837739|FG001|Overall Study|Lost to Follow-up|50|||
106047027|NCT00573183|365837738|FG000|Overall Study|Withdrawal by Subject|8|||
106047028|NCT00573183|365837739|FG001|Overall Study|Withdrawal by Subject|2|||
106047029|NCT00573183|365837738|FG000|Overall Study|Death|0|||
106047030|NCT00573183|365837739|FG001|Overall Study|Death|1|||
106047031|NCT00573183|365837738|FG000|Overall Study|Adverse Event|2|||
106047032|NCT00573183|365837739|FG001|Overall Study|Adverse Event|0|||
106047033|NCT00573183|365837738|FG000|Overall Study|Incarceration|5|||
106047034|NCT00573183|365837739|FG001|Overall Study|Incarceration|8|||
106047035|NCT00573183|365837738|FG000|Overall Study|Other|5|||
106047036|NCT00573183|365837739|FG001|Overall Study|Other|2|||
106047037|NCT00850343|365837740|FG000|Overall Study|Withdrawal by Subject|11|||
106047038|NCT00850343|365837741|FG001|Overall Study|Withdrawal by Subject|0|||
106047039|NCT00850343|365837742|FG002|Overall Study|Withdrawal by Subject|3|||
106047040|NCT00850343|365837743|FG003|Overall Study|Withdrawal by Subject|2|||
106047041|NCT00850343|365837740|FG000|Overall Study|Adverse Event|15|||
106047042|NCT00850343|365837741|FG001|Overall Study|Adverse Event|2|||
106047043|NCT00850343|365837742|FG002|Overall Study|Adverse Event|6|||
106047044|NCT00850343|365837743|FG003|Overall Study|Adverse Event|6|||
106047045|NCT00850343|365837740|FG000|Overall Study|Pregnancy|0|||
106047046|NCT00850343|365837741|FG001|Overall Study|Pregnancy|0|||
106047047|NCT00850343|365837742|FG002|Overall Study|Pregnancy|0|||
106047048|NCT00850343|365837743|FG003|Overall Study|Pregnancy|1|||
106047049|NCT00850343|365837740|FG000|Overall Study|Lack of Efficacy|17|||
106047050|NCT00850343|365837741|FG001|Overall Study|Lack of Efficacy|0|||
106047051|NCT00850343|365837742|FG002|Overall Study|Lack of Efficacy|3|||
106047052|NCT00850343|365837743|FG003|Overall Study|Lack of Efficacy|2|||
106047053|NCT00850343|365837740|FG000|Overall Study|Non-compliance with Study Procedures|1|||
106047054|NCT00850343|365837741|FG001|Overall Study|Non-compliance with Study Procedures|0|||
105862855|NCT03597464|365148098|FG000|Overall Study|Physician Decision|2|||
105862856|NCT03597464|365148099|FG001|Overall Study|Physician Decision|2|||
105862857|NCT03597464|365148098|FG000|Overall Study|Protocol Violation|1|||
105862858|NCT03597464|365148099|FG001|Overall Study|Protocol Violation|1|||
105862859|NCT03597464|365148098|FG000|Overall Study|Adverse Event|0|||
105862860|NCT03597464|365148099|FG001|Overall Study|Adverse Event|2|||
105862861|NCT03597464|365148098|FG000|Overall Study|Death|0|||
105862862|NCT03597464|365148099|FG001|Overall Study|Death|3|||
105862863|NCT02542605|365148100|FG000|Part B: Challenge Phase|Sponsor decision|1|||
105862864|NCT02542605|365148101|FG001|Part B: Challenge Phase|Sponsor decision|0|||
105862865|NCT02542605|365148102|FG002|Part B: Challenge Phase|Sponsor decision|0|||
105862866|NCT02542605|365148100|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
105862867|NCT02542605|365148101|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
105862868|NCT02542605|365148102|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
105862869|NCT04102189|365148103|FG000|Overall Study|Withdrawal by Subject|1|||
106047055|NCT00850343|365837742|FG002|Overall Study|Non-compliance with Study Procedures|1|||
106047056|NCT00850343|365837743|FG003|Overall Study|Non-compliance with Study Procedures|1|||
106047057|NCT00850343|365837740|FG000|Overall Study|Physician Decision|2|||
106047058|NCT00850343|365837741|FG001|Overall Study|Physician Decision|1|||
105862870|NCT04102189|365148104|FG001|Overall Study|Withdrawal by Subject|2|||
105862871|NCT04102189|365148103|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105862872|NCT04102189|365148104|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105862873|NCT04102189|365148103|FG000|Overall Study|Lost to Follow-up|1|||
105862874|NCT04102189|365148104|FG001|Overall Study|Lost to Follow-up|0|||
105862875|NCT00143247|365148105|FG000|Overall Study|Death|8|||
105862876|NCT00143247|365148105|FG000|Overall Study|Adverse Event|19|||
105862877|NCT00143247|365148105|FG000|Overall Study|Lack of Efficacy|3|||
105862878|NCT00143247|365148105|FG000|Overall Study|Withdrawal by Subject|55|||
105862879|NCT00143247|365148105|FG000|Overall Study|Study terminated by sponsor|31|||
105862880|NCT00143247|365148105|FG000|Overall Study|Protocol Violation|15|||
105862881|NCT00143247|365148105|FG000|Overall Study|Lost to Follow-up|12|||
105862882|NCT00143247|365148105|FG000|Overall Study|following inaccurate lab adverse event|1|||
105862883|NCT00143247|365148105|FG000|Overall Study|Other|12|||
105862884|NCT02766283|365148111|FG000|Overall Study|Lost to Follow-up|27|||
105862885|NCT00340678|365148112|FG000|Overall Study|Lost to Follow-up|1|||
105862886|NCT00340678|365148113|FG001|Overall Study|Lost to Follow-up|0|||
105862887|NCT00340678|365148114|FG002|Overall Study|Lost to Follow-up|0|||
106047059|NCT00850343|365837742|FG002|Overall Study|Physician Decision|1|||
106047060|NCT00850343|365837743|FG003|Overall Study|Physician Decision|1|||
106047061|NCT02570074|365837744|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
106047062|NCT02570074|365837745|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
106047063|NCT00246753|365837747|FG000|Overall Study|Withdrawal by Subject|2|||
106047064|NCT00246753|365837747|FG000|Overall Study|Physician Decision|2|||
106047065|NCT00246753|365837747|FG000|Overall Study|Adverse Event|2|||
106047066|NCT00246753|365837747|FG000|Overall Study|Unacceptable toxicity|2|||
106047067|NCT02478632|365837750|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
106047068|NCT02478632|365837751|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
106047069|NCT02478632|365837750|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
106047070|NCT02478632|365837751|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
106047071|NCT02478632|365837750|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
106047072|NCT02478632|365837751|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
106047073|NCT00864721|365837755|FG000|Overall Study|Patient request|11|||
106047074|NCT00864721|365837755|FG000|Overall Study|Hospitalized|1|||
106047075|NCT00864721|365837755|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
106047076|NCT00864721|365837755|FG000|Overall Study|Adverse Event|21|||
106047077|NCT02651467|365837756|FG000|Overall Study|Withdrawal by Subject|0|||
106047078|NCT02651467|365837757|FG001|Overall Study|Withdrawal by Subject|0|||
106047079|NCT02651467|365837758|FG002|Overall Study|Withdrawal by Subject|2|||
106047080|NCT02651467|365837756|FG000|Overall Study|Other (Not specified)|1|||
106047081|NCT02651467|365837757|FG001|Overall Study|Other (Not specified)|0|||
106047082|NCT02651467|365837758|FG002|Overall Study|Other (Not specified)|2|||
106047083|NCT01890746|365837761|FG000|Overall Study|Death|39|||
106047084|NCT01890746|365837762|FG001|Overall Study|Death|30|||
106047085|NCT01890746|365837761|FG000|Overall Study|Adverse Event|1|||
106047086|NCT01890746|365837762|FG001|Overall Study|Adverse Event|0|||
106047087|NCT01890746|365837761|FG000|Overall Study|Lost to Follow-up|4|||
106047088|NCT01890746|365837762|FG001|Overall Study|Lost to Follow-up|1|||
106047089|NCT01890746|365837761|FG000|Overall Study|Physician Decision|3|||
106047090|NCT01890746|365837762|FG001|Overall Study|Physician Decision|2|||
106047091|NCT01890746|365837761|FG000|Overall Study|Withdrawal by Subject|5|||
106047092|NCT01890746|365837762|FG001|Overall Study|Withdrawal by Subject|8|||
106047093|NCT05095454|365837764|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
106047094|NCT05095454|365837765|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
106047095|NCT01708161|365837775|FG000|Overall Study|Adverse Event|1|||
106047096|NCT01708161|365837776|FG001|Overall Study|Adverse Event|3|||
106047097|NCT01708161|365837777|FG002|Overall Study|Adverse Event|4|||
106047098|NCT01708161|365837778|FG003|Overall Study|Adverse Event|2|||
106047099|NCT01708161|365837779|FG004|Overall Study|Adverse Event|3|||
106047100|NCT01708161|365837780|FG005|Overall Study|Adverse Event|0|||
106047101|NCT01708161|365837775|FG000|Overall Study|Death|0|||
106047102|NCT01708161|365837776|FG001|Overall Study|Death|0|||
106047103|NCT01708161|365837777|FG002|Overall Study|Death|0|||
106047104|NCT01708161|365837778|FG003|Overall Study|Death|1|||
106047105|NCT01708161|365837779|FG004|Overall Study|Death|0|||
106047106|NCT01708161|365837780|FG005|Overall Study|Death|1|||
106047107|NCT01708161|365837775|FG000|Overall Study|Withdrawal by Subject|0|||
106047108|NCT01708161|365837776|FG001|Overall Study|Withdrawal by Subject|1|||
106047109|NCT01708161|365837777|FG002|Overall Study|Withdrawal by Subject|1|||
106047110|NCT01708161|365837778|FG003|Overall Study|Withdrawal by Subject|0|||
105862888|NCT00340678|365148115|FG003|Overall Study|Lost to Follow-up|0|||
105862889|NCT00721227|365148116|FG000|Overall Study|Lost to Follow-up|3|||
105862890|NCT00721227|365148117|FG001|Overall Study|Lost to Follow-up|0|||
105862891|NCT00721227|365148116|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
106047111|NCT01708161|365837779|FG004|Overall Study|Withdrawal by Subject|0|||
106047112|NCT01708161|365837780|FG005|Overall Study|Withdrawal by Subject|0|||
106047113|NCT01708161|365837775|FG000|Overall Study|Administrative problems|0|||
106047114|NCT01708161|365837776|FG001|Overall Study|Administrative problems|1|||
106047115|NCT01708161|365837777|FG002|Overall Study|Administrative problems|0|||
106047116|NCT01708161|365837778|FG003|Overall Study|Administrative problems|0|||
106047117|NCT01708161|365837779|FG004|Overall Study|Administrative problems|0|||
106047118|NCT01708161|365837780|FG005|Overall Study|Administrative problems|0|||
106047119|NCT01708161|365837775|FG000|Overall Study|Disease progression|3|||
106047120|NCT01708161|365837776|FG001|Overall Study|Disease progression|5|||
106047121|NCT01708161|365837777|FG002|Overall Study|Disease progression|5|||
106047122|NCT01708161|365837778|FG003|Overall Study|Disease progression|13|||
106047123|NCT01708161|365837779|FG004|Overall Study|Disease progression|3|||
106047124|NCT01708161|365837780|FG005|Overall Study|Disease progression|0|||
106047125|NCT01268150|365837781|FG000|Treatment Phase|Progression of disease|18|||
106047126|NCT01268150|365837781|FG000|Treatment Phase|Adverse Event|3|||
106047127|NCT01268150|365837781|FG000|Treatment Phase|Withdrawal by Subject|3|||
106047128|NCT01268150|365837781|FG000|Treatment Phase|Other|4|||
106047129|NCT01268150|365837781|FG000|Extension Phase|Adverse Event|3|||
106047130|NCT01268150|365837781|FG000|Extension Phase|Disease progression|18|||
106047131|NCT01268150|365837781|FG000|Extension Phase|Other|6|||
106047132|NCT02435147|365837785|FG000|Overall Study|non-evaluable DXA scan|11|||
106047133|NCT00471146|365837786|FG000|Overall Study|Adverse Event|32|||
106047134|NCT00471146|365837787|FG001|Overall Study|Adverse Event|33|||
106047135|NCT00471146|365837786|FG000|Overall Study|Withdrawal by Subject|14|||
106047136|NCT00471146|365837787|FG001|Overall Study|Withdrawal by Subject|11|||
106047137|NCT00471146|365837786|FG000|Overall Study|Death|11|||
106047138|NCT00471146|365837787|FG001|Overall Study|Death|12|||
106047139|NCT00471146|365837786|FG000|Overall Study|Lost to Follow-up|4|||
106047140|NCT00471146|365837787|FG001|Overall Study|Lost to Follow-up|2|||
106047141|NCT00471146|365837786|FG000|Overall Study|Protocol Violation|2|||
106047142|NCT00471146|365837787|FG001|Overall Study|Protocol Violation|2|||
106047143|NCT00471146|365837786|FG000|Overall Study|Objective progression or relapse|84|||
106047144|NCT00471146|365837787|FG001|Overall Study|Objective progression or relapse|87|||
106047145|NCT00471146|365837786|FG000|Overall Study|Global deterioration of health status|12|||
106047146|NCT00471146|365837787|FG001|Overall Study|Global deterioration of health status|14|||
106047147|NCT00471146|365837786|FG000|Overall Study|Randomized but not treated|9|||
106047148|NCT00471146|365837787|FG001|Overall Study|Randomized but not treated|8|||
106047149|NCT00471146|365837786|FG000|Overall Study|Other|4|||
106047150|NCT00471146|365837787|FG001|Overall Study|Other|5|||
106047151|NCT02853344|365837792|FG000|Overall Study|Lost to Follow-up|1|||
106047152|NCT02853344|365837793|FG001|Overall Study|Lost to Follow-up|1|||
106047153|NCT02853344|365837792|FG000|Overall Study|Withdrawal by Subject|2|||
106047154|NCT02853344|365837793|FG001|Overall Study|Withdrawal by Subject|4|||
106047155|NCT02853344|365837792|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
106047156|NCT02853344|365837793|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
106047157|NCT02853344|365837792|FG000|Overall Study|Death|70|||
106047158|NCT02853344|365837793|FG001|Overall Study|Death|112|||
106047159|NCT02913612|365837794|FG000|Overall Study|Lost to Follow-up|6|||
106047160|NCT02913612|365837795|FG001|Overall Study|Lost to Follow-up|5|||
106047161|NCT02913612|365837796|FG002|Overall Study|Lost to Follow-up|2|||
106047162|NCT02913612|365837797|FG003|Overall Study|Lost to Follow-up|0|||
106047163|NCT02913612|365837794|FG000|Overall Study|Physician Decision|1|||
106047164|NCT02913612|365837795|FG001|Overall Study|Physician Decision|4|||
106047165|NCT02913612|365837796|FG002|Overall Study|Physician Decision|1|||
106047166|NCT02913612|365837797|FG003|Overall Study|Physician Decision|0|||
106047167|NCT02913612|365837794|FG000|Overall Study|Withdrawal by Subject|2|||
106047168|NCT02913612|365837795|FG001|Overall Study|Withdrawal by Subject|4|||
106047169|NCT02913612|365837796|FG002|Overall Study|Withdrawal by Subject|0|||
106047170|NCT02913612|365837797|FG003|Overall Study|Withdrawal by Subject|0|||
106047171|NCT02913612|365837794|FG000|Overall Study|Hemangioma resolved|1|||
106047172|NCT02913612|365837795|FG001|Overall Study|Hemangioma resolved|0|||
106047173|NCT02913612|365837796|FG002|Overall Study|Hemangioma resolved|0|||
106047174|NCT02913612|365837797|FG003|Overall Study|Hemangioma resolved|0|||
106047175|NCT02913612|365837794|FG000|Overall Study|Local IRB decision|1|||
106047176|NCT02913612|365837795|FG001|Overall Study|Local IRB decision|0|||
106047177|NCT02913612|365837796|FG002|Overall Study|Local IRB decision|0|||
106047178|NCT02913612|365837797|FG003|Overall Study|Local IRB decision|0|||
106047179|NCT02913612|365837794|FG000|Overall Study|Study drug non-compliance|1|||
106047180|NCT02913612|365837795|FG001|Overall Study|Study drug non-compliance|1|||
106047181|NCT02913612|365837796|FG002|Overall Study|Study drug non-compliance|0|||
106047182|NCT02913612|365837797|FG003|Overall Study|Study drug non-compliance|0|||
106047183|NCT02913612|365837794|FG000|Overall Study|Insurance issues|0|||
106047184|NCT02913612|365837795|FG001|Overall Study|Insurance issues|1|||
106047185|NCT02913612|365837796|FG002|Overall Study|Insurance issues|0|||
106047186|NCT02913612|365837797|FG003|Overall Study|Insurance issues|0|||
106047187|NCT02913612|365837794|FG000|Overall Study|Needed to treat second hemangioma|0|||
106047188|NCT02913612|365837795|FG001|Overall Study|Needed to treat second hemangioma|1|||
106047189|NCT02913612|365837796|FG002|Overall Study|Needed to treat second hemangioma|0|||
106047190|NCT02913612|365837797|FG003|Overall Study|Needed to treat second hemangioma|0|||
106047191|NCT02913612|365837794|FG000|Overall Study|Study completion criteria not met|0|||
106047192|NCT02913612|365837795|FG001|Overall Study|Study completion criteria not met|1|||
106047193|NCT02913612|365837796|FG002|Overall Study|Study completion criteria not met|0|||
106047194|NCT02913612|365837797|FG003|Overall Study|Study completion criteria not met|0|||
106047195|NCT02913612|365837794|FG000|Overall Study|Ineligible|0|||
106047196|NCT02913612|365837795|FG001|Overall Study|Ineligible|1|||
106047197|NCT02913612|365837796|FG002|Overall Study|Ineligible|0|||
106047198|NCT02913612|365837797|FG003|Overall Study|Ineligible|0|||
106047199|NCT00071396|365837798|FG000|Overall Study|Withdrawal by Subject|1|||
106047200|NCT00071396|365837798|FG000|Overall Study|Physician Decision|2|||
106047201|NCT03082261|365837799|FG000|Overall Study|Death|4|||
106047202|NCT03082261|365837799|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
106047203|NCT03082261|365837799|FG000|Overall Study|Insurance denial|1|||
105862892|NCT00721227|365148117|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
105862893|NCT00996892|365148118|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
105862894|NCT00996892|365148119|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
105862895|NCT00996892|365148120|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
105862896|NCT00996892|365148121|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
105862897|NCT00996892|365148122|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
105862898|NCT00996892|365148123|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
105862899|NCT00996892|365148124|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
105862900|NCT00996892|365148125|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
105862901|NCT00996892|365148126|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
105862902|NCT00996892|365148127|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
105862903|NCT00996892|365148128|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
105862904|NCT00996892|365148129|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
105862905|NCT00996892|365148130|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
105862906|NCT00996892|365148131|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
105862907|NCT00996892|365148132|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
105862908|NCT00996892|365148133|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
105862909|NCT00996892|365148134|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
105862910|NCT00996892|365148135|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
105862911|NCT00996892|365148136|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
105862912|NCT00996892|365148137|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
105862913|NCT00996892|365148118|FG000|Dose-Escalation Stage 1|Death|1|||
105862914|NCT00996892|365148119|FG001|Dose-Escalation Stage 1|Death|0|||
105862915|NCT00996892|365148120|FG002|Dose-Escalation Stage 1|Death|0|||
105862916|NCT00996892|365148121|FG003|Dose-Escalation Stage 1|Death|0|||
105862917|NCT00996892|365148122|FG004|Dose-Escalation Stage 1|Death|0|||
105862918|NCT00996892|365148123|FG005|Dose-Escalation Stage 1|Death|1|||
105862919|NCT00996892|365148124|FG006|Dose-Escalation Stage 1|Death|0|||
105862920|NCT00996892|365148125|FG007|Dose-Escalation Stage 1|Death|0|||
105862921|NCT00996892|365148126|FG008|Dose-Escalation Stage 1|Death|0|||
105862922|NCT00996892|365148127|FG009|Dose-Escalation Stage 1|Death|0|||
105862923|NCT00996892|365148128|FG010|Dose-Escalation Stage 1|Death|0|||
105862924|NCT00996892|365148129|FG011|Dose-Escalation Stage 1|Death|0|||
105862925|NCT00996892|365148130|FG012|Dose-Escalation Stage 1|Death|0|||
105862926|NCT00996892|365148131|FG013|Dose-Escalation Stage 1|Death|0|||
105862927|NCT00996892|365148132|FG014|Dose-Escalation Stage 1|Death|0|||
105862928|NCT00996892|365148133|FG015|Dose-Escalation Stage 1|Death|0|||
105862929|NCT00996892|365148134|FG016|Dose-Escalation Stage 1|Death|0|||
105862930|NCT00996892|365148135|FG017|Dose-Escalation Stage 1|Death|0|||
105862931|NCT00996892|365148136|FG018|Dose-Escalation Stage 1|Death|0|||
105862932|NCT00996892|365148137|FG019|Dose-Escalation Stage 1|Death|0|||
105862933|NCT00996892|365148118|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
105862934|NCT00996892|365148119|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
105862935|NCT00996892|365148120|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
105862936|NCT00996892|365148121|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
105862937|NCT00996892|365148122|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
105862938|NCT00996892|365148123|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
105862939|NCT00996892|365148124|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
105862940|NCT00996892|365148125|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
105862941|NCT00996892|365148126|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
105862942|NCT00996892|365148127|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
106047204|NCT03082261|365837799|FG000|Overall Study|Peripheral lead added|1|||
106047205|NCT03082261|365837799|FG000|Overall Study|Withdrawal by Subject|40|||
105862943|NCT00996892|365148128|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
105862944|NCT00996892|365148129|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
106047206|NCT03082261|365837799|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
105862945|NCT00996892|365148130|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
106047207|NCT03082261|365837799|FG000|Overall Study|Subject implanted with device other than study device|1|||
105862946|NCT00996892|365148131|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
105862947|NCT00996892|365148132|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
105862948|NCT00996892|365148133|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
105862949|NCT00996892|365148134|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
105862950|NCT00996892|365148135|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
105862951|NCT00996892|365148136|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
106047208|NCT03082261|365837799|FG000|Overall Study|Lost to Follow-up|14|||
106047209|NCT03082261|365837799|FG000|Overall Study|Subject moved to a different state|1|||
106047210|NCT03082261|365837799|FG000|Overall Study|Subject non-compliance|2|||
106047211|NCT03082261|365837799|FG000|Overall Study|Subject participation terminated by investigator|9|||
106047212|NCT03082261|365837799|FG000|Overall Study|Subject participation terminated by sponsor|4|||
106047213|NCT03082261|365837799|FG000|Overall Study|System explant|19|||
106047214|NCT03082261|365837799|FG000|Overall Study|Unable to place lead(s)|2|||
106047215|NCT03082261|365837799|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
106047216|NCT00839852|365837800|FG000|Overall Study|Adverse Event|10|||
106047217|NCT00839852|365837800|FG000|Overall Study|Insufficient Therapeutic Response|3|||
106047218|NCT00839852|365837800|FG000|Overall Study|Protocol Violation|9|||
106047219|NCT00839852|365837800|FG000|Overall Study|Withdrawal of Consent|16|||
106047220|NCT00839852|365837800|FG000|Overall Study|Lost to Follow-up|7|||
106047221|NCT00839852|365837800|FG000|Overall Study|Lack of Compliance While in Jail|1|||
106047222|NCT00839852|365837800|FG000|Overall Study|Pregnancy|1|||
106047223|NCT04545554|365837801|FG000|Overall Study|Withdrawal by Subject|0|||
106047224|NCT04545554|365837802|FG001|Overall Study|Withdrawal by Subject|0|||
106047225|NCT04545554|365837803|FG002|Overall Study|Withdrawal by Subject|0|||
106047226|NCT04545554|365837804|FG003|Overall Study|Withdrawal by Subject|1|||
106047227|NCT04545554|365837805|FG004|Overall Study|Withdrawal by Subject|0|||
106047228|NCT04545554|365837806|FG005|Overall Study|Withdrawal by Subject|0|||
106047229|NCT02478372|365837811|FG000|Overall Study|Protocol Violation|12|||
106047230|NCT02478372|365837812|FG001|Overall Study|Protocol Violation|8|||
106047231|NCT02478372|365837811|FG000|Overall Study|Lost to Follow-up|1|||
106047232|NCT02478372|365837812|FG001|Overall Study|Lost to Follow-up|4|||
106047233|NCT02478372|365837811|FG000|Overall Study|Death|0|||
106047234|NCT02478372|365837812|FG001|Overall Study|Death|2|||
106047235|NCT00116428|365837813|FG000|Overall Study|Withdrawal by Subject|2|||
106047236|NCT00116428|365837814|FG001|Overall Study|Withdrawal by Subject|5|||
106047237|NCT00116428|365837813|FG000|Overall Study|Did not meet inclusion criteria|1|||
106047238|NCT00116428|365837814|FG001|Overall Study|Did not meet inclusion criteria|0|||
106047239|NCT01297920|365837816|FG000|Overall Study|Adverse Event|42|||
106047240|NCT01297920|365837817|FG001|Overall Study|Adverse Event|10|||
106047241|NCT01297920|365837818|FG002|Overall Study|Adverse Event|38|||
106047242|NCT01297920|365837816|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
106047243|NCT01297920|365837817|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
106047244|NCT01297920|365837818|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
106047245|NCT01297920|365837816|FG000|Overall Study|Noncompliance|1|||
106047246|NCT01297920|365837817|FG001|Overall Study|Noncompliance|0|||
106047247|NCT01297920|365837818|FG002|Overall Study|Noncompliance|0|||
106047248|NCT01297920|365837816|FG000|Overall Study|Protocol Violation|1|||
106047249|NCT01297920|365837817|FG001|Overall Study|Protocol Violation|3|||
106047250|NCT01297920|365837818|FG002|Overall Study|Protocol Violation|0|||
106047251|NCT01297920|365837816|FG000|Overall Study|Inadequate Control of IOP|7|||
106047252|NCT01297920|365837817|FG001|Overall Study|Inadequate Control of IOP|9|||
106047253|NCT01297920|365837818|FG002|Overall Study|Inadequate Control of IOP|17|||
106047254|NCT01297920|365837816|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
106047255|NCT01297920|365837817|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
106047256|NCT01297920|365837818|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
106047257|NCT00516074|365837831|FG000|Overall Study|Adverse Event|0|||
106047258|NCT00516074|365837832|FG001|Overall Study|Adverse Event|1|||
106047259|NCT00516074|365837831|FG000|Overall Study|Subject Decision|4|||
106047260|NCT00516074|365837832|FG001|Overall Study|Subject Decision|2|||
106047261|NCT00516074|365837831|FG000|Overall Study|Loss of Glucose Control|2|||
106047262|NCT00516074|365837832|FG001|Overall Study|Loss of Glucose Control|0|||
106047263|NCT00338104|365837833|FG000|Overall Study|Protocol Violation|2|||
106047264|NCT00338104|365837834|FG001|Overall Study|Protocol Violation|1|||
106047265|NCT00338104|365837835|FG002|Overall Study|Protocol Violation|3|||
106047266|NCT02215096|365837838|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
106047267|NCT02215096|365837839|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
106047268|NCT02215096|365837840|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
106047269|NCT02215096|365837841|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
106047270|NCT02215096|365837842|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
106047271|NCT02215096|365837838|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
106047272|NCT02215096|365837839|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
106047273|NCT02215096|365837840|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
106047274|NCT02215096|365837841|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
106047275|NCT02215096|365837842|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
106047276|NCT02215096|365837838|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
106047277|NCT02215096|365837839|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
106047278|NCT02215096|365837840|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
106047279|NCT02215096|365837841|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
106047280|NCT02215096|365837842|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
106047281|NCT02215096|365837838|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
106047282|NCT02215096|365837839|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
106047283|NCT02215096|365837840|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
106047284|NCT02215096|365837841|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
106047285|NCT02215096|365837842|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
106047286|NCT01903031|365837843|FG000|Overall Study|Not Able to Attend Clinic|1|||
106047287|NCT01903031|365837844|FG001|Overall Study|Not Able to Attend Clinic|1|||
106047288|NCT01903031|365837845|FG002|Overall Study|Not Able to Attend Clinic|0|||
106047289|NCT01903031|365837843|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
106047290|NCT01903031|365837844|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
106047291|NCT01903031|365837845|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
106047292|NCT01903031|365837843|FG000|Overall Study|Adverse Event|0|||
106047293|NCT01903031|365837844|FG001|Overall Study|Adverse Event|1|||
106047294|NCT01903031|365837845|FG002|Overall Study|Adverse Event|0|||
106047295|NCT01903031|365837843|FG000|Overall Study|Withdrawal by Subject|0|||
106047296|NCT01903031|365837844|FG001|Overall Study|Withdrawal by Subject|1|||
106047297|NCT01903031|365837845|FG002|Overall Study|Withdrawal by Subject|1|||
106047298|NCT01903031|365837843|FG000|Overall Study|Protocol Violation|0|||
106047299|NCT01903031|365837844|FG001|Overall Study|Protocol Violation|0|||
106047300|NCT01903031|365837845|FG002|Overall Study|Protocol Violation|2|||
106047301|NCT01903031|365837843|FG000|Overall Study|Lost to Follow-up|0|||
106047302|NCT01903031|365837844|FG001|Overall Study|Lost to Follow-up|0|||
106047303|NCT01903031|365837845|FG002|Overall Study|Lost to Follow-up|1|||
106047304|NCT01903031|365837843|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
106047305|NCT01903031|365837844|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
106047306|NCT01903031|365837845|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
106047307|NCT03896165|365837846|FG000|Overall Study|Withdrawal by Subject|2|||
106047308|NCT01811225|365837847|FG000|Treatment Period 1|Adverse Event|2|||
106047309|NCT01811225|365837848|FG001|Treatment Period 1|Adverse Event|3|||
106047310|NCT01811225|365837847|FG000|Treatment Period 1|Lost to Follow-up|12|||
106047311|NCT01811225|365837848|FG001|Treatment Period 1|Lost to Follow-up|8|||
106047312|NCT01811225|365837847|FG000|Treatment Period 1|transporation|1|||
106047313|NCT01811225|365837848|FG001|Treatment Period 1|transporation|0|||
106047314|NCT01811225|365837847|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
106047315|NCT01811225|365837848|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
106047316|NCT01811225|365837847|FG000|Treatment Period 2|Lost to Follow-up|1|||
106047317|NCT01811225|365837848|FG001|Treatment Period 2|Lost to Follow-up|2|||
106047318|NCT01811225|365837847|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
106047319|NCT01811225|365837848|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
106047320|NCT03181893|365837849|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047321|NCT03181893|365837850|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
106047322|NCT03181893|365837851|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047323|NCT03181893|365837852|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047324|NCT03181893|365837853|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047325|NCT03181893|365837854|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047326|NCT03181893|365837855|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047327|NCT03181893|365837856|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047328|NCT03181893|365837857|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047329|NCT03181893|365837858|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047330|NCT03181893|365837859|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
106047331|NCT03181893|365837849|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
106047332|NCT03181893|365837850|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
106047333|NCT03181893|365837851|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047334|NCT03181893|365837852|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047335|NCT03181893|365837853|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047336|NCT03181893|365837854|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047337|NCT03181893|365837855|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047338|NCT03181893|365837856|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047339|NCT03181893|365837857|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047340|NCT03181893|365837858|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047341|NCT03181893|365837859|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
106047342|NCT03181893|365837849|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
106047343|NCT03181893|365837850|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
106047344|NCT03181893|365837851|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
106047345|NCT03181893|365837852|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
106047346|NCT03181893|365837853|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
106047347|NCT03181893|365837854|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
105862952|NCT00996892|365148137|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
106047348|NCT03181893|365837855|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
106047349|NCT03181893|365837856|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
106047350|NCT03181893|365837857|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
106047351|NCT03181893|365837858|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
106047352|NCT03181893|365837859|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
106047353|NCT03181893|365837849|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047354|NCT03181893|365837850|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047355|NCT03181893|365837851|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047356|NCT03181893|365837852|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047357|NCT03181893|365837853|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047358|NCT03181893|365837854|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047359|NCT03181893|365837855|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047360|NCT03181893|365837856|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047361|NCT03181893|365837857|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047362|NCT03181893|365837858|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
106047363|NCT03181893|365837859|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
106047364|NCT03181893|365837849|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047365|NCT03181893|365837850|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047366|NCT03181893|365837851|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047367|NCT03181893|365837852|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047368|NCT03181893|365837853|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047369|NCT03181893|365837854|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047370|NCT03181893|365837855|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047371|NCT03181893|365837856|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047372|NCT03181893|365837857|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047373|NCT03181893|365837858|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
106047374|NCT03181893|365837859|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
106047375|NCT02158975|365837860|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
106047376|NCT03000569|365837861|FG000|Overall Study|Withdrawal by Subject|1|||
106047377|NCT03000569|365837862|FG001|Overall Study|Withdrawal by Subject|0|||
106047378|NCT02298023|365837865|FG000|Overall Study|Withdrawal by Subject|1|||
106047379|NCT02298023|365837866|FG001|Overall Study|Withdrawal by Subject|0|||
106047380|NCT02298023|365837867|FG002|Overall Study|Withdrawal by Subject|0|||
106047381|NCT00569270|365837868|FG000|Period: First Intervention|Protocol Violation|0|||
106047382|NCT00569270|365837869|FG001|Period: First Intervention|Protocol Violation|1|||
106047383|NCT00586625|365837870|FG000|Overall Study|Adverse Event|6|||
106047384|NCT00586625|365837871|FG001|Overall Study|Adverse Event|6|||
106047385|NCT00586625|365837870|FG000|Overall Study|Protocol Violation|3|||
106047386|NCT00586625|365837871|FG001|Overall Study|Protocol Violation|0|||
106047387|NCT00586625|365837870|FG000|Overall Study|Withdrawal by Subject|32|||
106047388|NCT00586625|365837871|FG001|Overall Study|Withdrawal by Subject|10|||
106047389|NCT00586625|365837870|FG000|Overall Study|Subject non-compliance|0|||
106047390|NCT00586625|365837871|FG001|Overall Study|Subject non-compliance|1|||
106047391|NCT00586625|365837870|FG000|Overall Study|Subject unable to return for visit|2|||
106047392|NCT00586625|365837871|FG001|Overall Study|Subject unable to return for visit|0|||
106047393|NCT02728596|365837872|FG000|Overall Study|Refusal unrelated to adverse event|3|||
106047394|NCT02728596|365837873|FG001|Overall Study|Refusal unrelated to adverse event|6|||
106047395|NCT02728596|365837874|FG002|Overall Study|Refusal unrelated to adverse event|7|||
106047396|NCT02728596|365837875|FG003|Overall Study|Refusal unrelated to adverse event|7|||
106047397|NCT02728596|365837872|FG000|Overall Study|Death|44|||
106047398|NCT02728596|365837873|FG001|Overall Study|Death|42|||
106047399|NCT02728596|365837874|FG002|Overall Study|Death|123|||
106047400|NCT02728596|365837875|FG003|Overall Study|Death|68|||
106047401|NCT00241358|365837876|FG000|Overall Study|Determined to be not ineligible|0|||
106047402|NCT00241358|365837877|FG001|Overall Study|Determined to be not ineligible|1|||
106047403|NCT00241358|365837878|FG002|Overall Study|Determined to be not ineligible|1|||
106047404|NCT02663908|365837881|FG000|Overall Study|Withdrawal by Subject|8|||
106047405|NCT02663908|365837882|FG001|Overall Study|Withdrawal by Subject|5|||
106047406|NCT02663908|365837881|FG000|Overall Study|Lost to Follow-up|1|||
106047407|NCT02663908|365837882|FG001|Overall Study|Lost to Follow-up|5|||
106047408|NCT02663908|365837881|FG000|Overall Study|Adverse Event|13|||
106047409|NCT02663908|365837882|FG001|Overall Study|Adverse Event|11|||
106047410|NCT02663908|365837881|FG000|Overall Study|Protocol Violation|1|||
106047411|NCT02663908|365837882|FG001|Overall Study|Protocol Violation|2|||
106047412|NCT02663908|365837881|FG000|Overall Study|Lack of therapeutic response|2|||
106047413|NCT02663908|365837882|FG001|Overall Study|Lack of therapeutic response|0|||
106047414|NCT02663908|365837881|FG000|Overall Study|COVID-19|1|||
106047415|NCT02663908|365837882|FG001|Overall Study|COVID-19|0|||
106047416|NCT02663908|365837881|FG000|Overall Study|Site closed|1|||
106047417|NCT02663908|365837882|FG001|Overall Study|Site closed|0|||
106047418|NCT02663908|365837881|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
106047419|NCT02663908|365837882|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
106047420|NCT02663908|365837881|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
106047421|NCT02663908|365837882|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
106047422|NCT02663908|365837881|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
106047423|NCT02663908|365837882|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
106047424|NCT02663908|365837881|FG000|Overall Study|Death|1|||
106047425|NCT02663908|365837882|FG001|Overall Study|Death|0|||
106047426|NCT02663908|365837881|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
106047427|NCT02663908|365837882|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
106047428|NCT02663908|365837881|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
106047429|NCT02663908|365837882|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
106047430|NCT00347360|365837894|FG000|Overall Study|Adverse Event|1|||
106047431|NCT00347360|365837895|FG001|Overall Study|Adverse Event|2|||
106047432|NCT00347360|365837896|FG002|Overall Study|Adverse Event|0|||
106047433|NCT00347360|365837897|FG003|Overall Study|Adverse Event|4|||
106047434|NCT00347360|365837898|FG004|Overall Study|Adverse Event|1|||
106047435|NCT00347360|365837899|FG005|Overall Study|Adverse Event|2|||
106047436|NCT00347360|365837900|FG006|Overall Study|Adverse Event|2|||
106047437|NCT00347360|365837901|FG007|Overall Study|Adverse Event|0|||
106047438|NCT00347360|365837902|FG008|Overall Study|Adverse Event|2|||
106047439|NCT00347360|365837903|FG009|Overall Study|Adverse Event|3|||
106047440|NCT00347360|365837904|FG010|Overall Study|Adverse Event|3|||
106047441|NCT00347360|365837905|FG011|Overall Study|Adverse Event|1|||
106047442|NCT00347360|365837906|FG012|Overall Study|Adverse Event|3|||
106047443|NCT00347360|365837907|FG013|Overall Study|Adverse Event|2|||
106047444|NCT00347360|365837908|FG014|Overall Study|Adverse Event|2|||
106047445|NCT00347360|365837894|FG000|Overall Study|Lost to Follow-up|0|||
106047446|NCT00347360|365837895|FG001|Overall Study|Lost to Follow-up|0|||
106047447|NCT00347360|365837896|FG002|Overall Study|Lost to Follow-up|0|||
106047448|NCT00347360|365837897|FG003|Overall Study|Lost to Follow-up|2|||
106047449|NCT00347360|365837898|FG004|Overall Study|Lost to Follow-up|1|||
106047450|NCT00347360|365837899|FG005|Overall Study|Lost to Follow-up|1|||
106047451|NCT00347360|365837900|FG006|Overall Study|Lost to Follow-up|0|||
106047452|NCT00347360|365837901|FG007|Overall Study|Lost to Follow-up|1|||
106047453|NCT00347360|365837902|FG008|Overall Study|Lost to Follow-up|1|||
106047454|NCT00347360|365837903|FG009|Overall Study|Lost to Follow-up|2|||
106047455|NCT00347360|365837904|FG010|Overall Study|Lost to Follow-up|0|||
106047456|NCT00347360|365837905|FG011|Overall Study|Lost to Follow-up|0|||
106047457|NCT00347360|365837906|FG012|Overall Study|Lost to Follow-up|1|||
106047458|NCT00347360|365837907|FG013|Overall Study|Lost to Follow-up|0|||
106047459|NCT00347360|365837908|FG014|Overall Study|Lost to Follow-up|0|||
106047460|NCT00347360|365837894|FG000|Overall Study|Protocol Violation|2|||
106047461|NCT00347360|365837895|FG001|Overall Study|Protocol Violation|3|||
106047462|NCT00347360|365837896|FG002|Overall Study|Protocol Violation|1|||
106047463|NCT00347360|365837897|FG003|Overall Study|Protocol Violation|2|||
106047464|NCT00347360|365837898|FG004|Overall Study|Protocol Violation|1|||
106047465|NCT00347360|365837899|FG005|Overall Study|Protocol Violation|2|||
106047466|NCT00347360|365837900|FG006|Overall Study|Protocol Violation|0|||
106047467|NCT00347360|365837901|FG007|Overall Study|Protocol Violation|0|||
106047468|NCT00347360|365837902|FG008|Overall Study|Protocol Violation|1|||
106047469|NCT00347360|365837903|FG009|Overall Study|Protocol Violation|2|||
106047470|NCT00347360|365837904|FG010|Overall Study|Protocol Violation|0|||
106047471|NCT00347360|365837905|FG011|Overall Study|Protocol Violation|0|||
106047472|NCT00347360|365837906|FG012|Overall Study|Protocol Violation|0|||
106047473|NCT00347360|365837907|FG013|Overall Study|Protocol Violation|1|||
106047474|NCT00347360|365837908|FG014|Overall Study|Protocol Violation|0|||
106047475|NCT00347360|365837894|FG000|Overall Study|Withdrawal by Subject|0|||
106047476|NCT00347360|365837895|FG001|Overall Study|Withdrawal by Subject|1|||
106047477|NCT00347360|365837896|FG002|Overall Study|Withdrawal by Subject|2|||
106047478|NCT00347360|365837897|FG003|Overall Study|Withdrawal by Subject|4|||
106047479|NCT00347360|365837898|FG004|Overall Study|Withdrawal by Subject|1|||
106047480|NCT00347360|365837899|FG005|Overall Study|Withdrawal by Subject|2|||
106047481|NCT00347360|365837900|FG006|Overall Study|Withdrawal by Subject|1|||
106047482|NCT00347360|365837901|FG007|Overall Study|Withdrawal by Subject|1|||
106047483|NCT00347360|365837902|FG008|Overall Study|Withdrawal by Subject|1|||
106047484|NCT00347360|365837903|FG009|Overall Study|Withdrawal by Subject|1|||
106047485|NCT00347360|365837904|FG010|Overall Study|Withdrawal by Subject|0|||
106047486|NCT00347360|365837905|FG011|Overall Study|Withdrawal by Subject|3|||
106047487|NCT00347360|365837906|FG012|Overall Study|Withdrawal by Subject|4|||
106047488|NCT00347360|365837907|FG013|Overall Study|Withdrawal by Subject|2|||
106047489|NCT00347360|365837908|FG014|Overall Study|Withdrawal by Subject|1|||
106047490|NCT00347360|365837894|FG000|Overall Study|Lack of Efficacy|1|||
106047491|NCT00347360|365837895|FG001|Overall Study|Lack of Efficacy|1|||
106047492|NCT00347360|365837896|FG002|Overall Study|Lack of Efficacy|3|||
106047493|NCT00347360|365837897|FG003|Overall Study|Lack of Efficacy|1|||
106047494|NCT00347360|365837898|FG004|Overall Study|Lack of Efficacy|0|||
106047495|NCT00347360|365837899|FG005|Overall Study|Lack of Efficacy|1|||
106047496|NCT00347360|365837900|FG006|Overall Study|Lack of Efficacy|0|||
106047497|NCT00347360|365837901|FG007|Overall Study|Lack of Efficacy|1|||
106047498|NCT00347360|365837902|FG008|Overall Study|Lack of Efficacy|1|||
106047499|NCT00347360|365837903|FG009|Overall Study|Lack of Efficacy|0|||
106047500|NCT00347360|365837904|FG010|Overall Study|Lack of Efficacy|0|||
106047501|NCT00347360|365837905|FG011|Overall Study|Lack of Efficacy|0|||
106047502|NCT00347360|365837906|FG012|Overall Study|Lack of Efficacy|0|||
106047503|NCT00347360|365837907|FG013|Overall Study|Lack of Efficacy|0|||
106047504|NCT00347360|365837908|FG014|Overall Study|Lack of Efficacy|0|||
106047505|NCT00347360|365837894|FG000|Overall Study|Reason not listed/blank|1|||
106047506|NCT00347360|365837895|FG001|Overall Study|Reason not listed/blank|0|||
106047507|NCT00347360|365837896|FG002|Overall Study|Reason not listed/blank|0|||
106047508|NCT00347360|365837897|FG003|Overall Study|Reason not listed/blank|0|||
106047509|NCT00347360|365837898|FG004|Overall Study|Reason not listed/blank|0|||
106047510|NCT00347360|365837899|FG005|Overall Study|Reason not listed/blank|0|||
106047511|NCT00347360|365837900|FG006|Overall Study|Reason not listed/blank|1|||
106047512|NCT00347360|365837901|FG007|Overall Study|Reason not listed/blank|0|||
106047513|NCT00347360|365837902|FG008|Overall Study|Reason not listed/blank|0|||
106047514|NCT00347360|365837903|FG009|Overall Study|Reason not listed/blank|0|||
106047515|NCT00347360|365837904|FG010|Overall Study|Reason not listed/blank|0|||
106047516|NCT00347360|365837905|FG011|Overall Study|Reason not listed/blank|0|||
106047517|NCT00347360|365837906|FG012|Overall Study|Reason not listed/blank|0|||
106047518|NCT00347360|365837907|FG013|Overall Study|Reason not listed/blank|1|||
106047519|NCT00347360|365837908|FG014|Overall Study|Reason not listed/blank|0|||
106047520|NCT00347360|365837894|FG000|Overall Study|Per sponsors instruction|0|||
106047521|NCT00347360|365837895|FG001|Overall Study|Per sponsors instruction|1|||
106047522|NCT00347360|365837896|FG002|Overall Study|Per sponsors instruction|0|||
106047523|NCT00347360|365837897|FG003|Overall Study|Per sponsors instruction|0|||
106047524|NCT00347360|365837898|FG004|Overall Study|Per sponsors instruction|0|||
106047525|NCT00347360|365837899|FG005|Overall Study|Per sponsors instruction|0|||
106047526|NCT00347360|365837900|FG006|Overall Study|Per sponsors instruction|0|||
106047527|NCT00347360|365837901|FG007|Overall Study|Per sponsors instruction|0|||
106047528|NCT00347360|365837902|FG008|Overall Study|Per sponsors instruction|0|||
106047529|NCT00347360|365837903|FG009|Overall Study|Per sponsors instruction|0|||
106047530|NCT00347360|365837904|FG010|Overall Study|Per sponsors instruction|0|||
106047531|NCT00347360|365837905|FG011|Overall Study|Per sponsors instruction|0|||
106047532|NCT00347360|365837906|FG012|Overall Study|Per sponsors instruction|0|||
106047533|NCT00347360|365837907|FG013|Overall Study|Per sponsors instruction|0|||
106047534|NCT00347360|365837908|FG014|Overall Study|Per sponsors instruction|0|||
106047535|NCT00347360|365837894|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
106047536|NCT00347360|365837895|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
106047537|NCT00347360|365837896|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
106047538|NCT00347360|365837897|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
106047539|NCT00347360|365837898|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
106047540|NCT00347360|365837899|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
106047541|NCT00347360|365837900|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
106047542|NCT00347360|365837901|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
106047543|NCT00347360|365837902|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
106047544|NCT00347360|365837903|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
106047545|NCT00347360|365837904|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
106047546|NCT00347360|365837905|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
106047547|NCT00347360|365837906|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
106047548|NCT00347360|365837907|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
106047549|NCT00347360|365837908|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
106047550|NCT00347360|365837894|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
106047551|NCT00347360|365837895|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
106047552|NCT00347360|365837896|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
106047553|NCT00347360|365837897|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
106047554|NCT00347360|365837898|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
106047555|NCT00347360|365837899|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
106047556|NCT00347360|365837900|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
106047557|NCT00347360|365837901|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
106047558|NCT00347360|365837902|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
106047559|NCT00347360|365837903|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
106047560|NCT00347360|365837904|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
106047561|NCT00347360|365837905|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
106047562|NCT00347360|365837906|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
106047563|NCT00347360|365837907|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
106047564|NCT00347360|365837908|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
106047565|NCT00347360|365837894|FG000|Overall Study|Abnormal lab values|0|||
106047566|NCT00347360|365837895|FG001|Overall Study|Abnormal lab values|0|||
106047567|NCT00347360|365837896|FG002|Overall Study|Abnormal lab values|0|||
106047568|NCT00347360|365837897|FG003|Overall Study|Abnormal lab values|0|||
106047569|NCT00347360|365837898|FG004|Overall Study|Abnormal lab values|0|||
106047570|NCT00347360|365837899|FG005|Overall Study|Abnormal lab values|0|||
106047571|NCT00347360|365837900|FG006|Overall Study|Abnormal lab values|1|||
106047572|NCT00347360|365837901|FG007|Overall Study|Abnormal lab values|0|||
106047573|NCT00347360|365837902|FG008|Overall Study|Abnormal lab values|0|||
106047574|NCT00347360|365837903|FG009|Overall Study|Abnormal lab values|0|||
106047575|NCT00347360|365837904|FG010|Overall Study|Abnormal lab values|0|||
106047576|NCT00347360|365837905|FG011|Overall Study|Abnormal lab values|0|||
106047577|NCT00347360|365837906|FG012|Overall Study|Abnormal lab values|0|||
106047578|NCT00347360|365837907|FG013|Overall Study|Abnormal lab values|0|||
106047579|NCT00347360|365837908|FG014|Overall Study|Abnormal lab values|0|||
106047580|NCT00347360|365837894|FG000|Overall Study|PI recommended early withdrawal|0|||
106047581|NCT00347360|365837895|FG001|Overall Study|PI recommended early withdrawal|0|||
106047582|NCT00347360|365837896|FG002|Overall Study|PI recommended early withdrawal|0|||
106047583|NCT00347360|365837897|FG003|Overall Study|PI recommended early withdrawal|0|||
106047584|NCT00347360|365837898|FG004|Overall Study|PI recommended early withdrawal|0|||
106047585|NCT00347360|365837899|FG005|Overall Study|PI recommended early withdrawal|0|||
106047586|NCT00347360|365837900|FG006|Overall Study|PI recommended early withdrawal|0|||
106047587|NCT00347360|365837901|FG007|Overall Study|PI recommended early withdrawal|0|||
106047588|NCT00347360|365837902|FG008|Overall Study|PI recommended early withdrawal|0|||
106047589|NCT00347360|365837903|FG009|Overall Study|PI recommended early withdrawal|1|||
106047590|NCT00347360|365837904|FG010|Overall Study|PI recommended early withdrawal|0|||
106047591|NCT00347360|365837905|FG011|Overall Study|PI recommended early withdrawal|0|||
106047592|NCT00347360|365837906|FG012|Overall Study|PI recommended early withdrawal|0|||
106047593|NCT00347360|365837907|FG013|Overall Study|PI recommended early withdrawal|0|||
106047594|NCT00347360|365837908|FG014|Overall Study|PI recommended early withdrawal|0|||
106047595|NCT00347360|365837894|FG000|Overall Study|Did not meet criteria before ABPM|0|||
106047596|NCT00347360|365837895|FG001|Overall Study|Did not meet criteria before ABPM|0|||
106047597|NCT00347360|365837896|FG002|Overall Study|Did not meet criteria before ABPM|0|||
106047598|NCT00347360|365837897|FG003|Overall Study|Did not meet criteria before ABPM|0|||
106047599|NCT00347360|365837898|FG004|Overall Study|Did not meet criteria before ABPM|0|||
106047600|NCT00347360|365837899|FG005|Overall Study|Did not meet criteria before ABPM|0|||
106047601|NCT00347360|365837900|FG006|Overall Study|Did not meet criteria before ABPM|0|||
106047602|NCT00347360|365837901|FG007|Overall Study|Did not meet criteria before ABPM|0|||
106047603|NCT00347360|365837902|FG008|Overall Study|Did not meet criteria before ABPM|0|||
106047604|NCT00347360|365837903|FG009|Overall Study|Did not meet criteria before ABPM|0|||
106047605|NCT00347360|365837904|FG010|Overall Study|Did not meet criteria before ABPM|1|||
106047606|NCT00347360|365837905|FG011|Overall Study|Did not meet criteria before ABPM|0|||
106047607|NCT00347360|365837906|FG012|Overall Study|Did not meet criteria before ABPM|0|||
106047608|NCT00347360|365837907|FG013|Overall Study|Did not meet criteria before ABPM|0|||
106047609|NCT00347360|365837908|FG014|Overall Study|Did not meet criteria before ABPM|0|||
106047610|NCT00347360|365837894|FG000|Overall Study|Randomized in error|0|||
106047611|NCT00347360|365837895|FG001|Overall Study|Randomized in error|0|||
106047612|NCT00347360|365837896|FG002|Overall Study|Randomized in error|0|||
106047613|NCT00347360|365837897|FG003|Overall Study|Randomized in error|0|||
106047614|NCT00347360|365837898|FG004|Overall Study|Randomized in error|0|||
106047615|NCT00347360|365837899|FG005|Overall Study|Randomized in error|0|||
106047616|NCT00347360|365837900|FG006|Overall Study|Randomized in error|0|||
106047617|NCT00347360|365837901|FG007|Overall Study|Randomized in error|0|||
106047618|NCT00347360|365837902|FG008|Overall Study|Randomized in error|0|||
106047619|NCT00347360|365837903|FG009|Overall Study|Randomized in error|0|||
106047620|NCT00347360|365837904|FG010|Overall Study|Randomized in error|0|||
106047621|NCT00347360|365837905|FG011|Overall Study|Randomized in error|1|||
106047622|NCT00347360|365837906|FG012|Overall Study|Randomized in error|0|||
106047623|NCT00347360|365837907|FG013|Overall Study|Randomized in error|0|||
106047624|NCT00347360|365837908|FG014|Overall Study|Randomized in error|0|||
106047625|NCT00347360|365837894|FG000|Overall Study|Failed inclusion criteria #4|0|||
106047626|NCT00347360|365837895|FG001|Overall Study|Failed inclusion criteria #4|0|||
106047627|NCT00347360|365837896|FG002|Overall Study|Failed inclusion criteria #4|0|||
106047628|NCT00347360|365837897|FG003|Overall Study|Failed inclusion criteria #4|0|||
106047629|NCT00347360|365837898|FG004|Overall Study|Failed inclusion criteria #4|0|||
106047630|NCT00347360|365837899|FG005|Overall Study|Failed inclusion criteria #4|0|||
106047631|NCT00347360|365837900|FG006|Overall Study|Failed inclusion criteria #4|0|||
106047632|NCT00347360|365837901|FG007|Overall Study|Failed inclusion criteria #4|0|||
106047633|NCT00347360|365837902|FG008|Overall Study|Failed inclusion criteria #4|0|||
106047634|NCT00347360|365837903|FG009|Overall Study|Failed inclusion criteria #4|0|||
106047635|NCT00347360|365837904|FG010|Overall Study|Failed inclusion criteria #4|0|||
106047636|NCT00347360|365837905|FG011|Overall Study|Failed inclusion criteria #4|1|||
106047637|NCT00347360|365837906|FG012|Overall Study|Failed inclusion criteria #4|0|||
106047638|NCT00347360|365837907|FG013|Overall Study|Failed inclusion criteria #4|0|||
106047639|NCT00347360|365837908|FG014|Overall Study|Failed inclusion criteria #4|0|||
106047640|NCT00347360|365837894|FG000|Overall Study|Prolonged duration between visits|0|||
106047641|NCT00347360|365837895|FG001|Overall Study|Prolonged duration between visits|0|||
106047642|NCT00347360|365837896|FG002|Overall Study|Prolonged duration between visits|0|||
106047643|NCT00347360|365837897|FG003|Overall Study|Prolonged duration between visits|0|||
106047644|NCT00347360|365837898|FG004|Overall Study|Prolonged duration between visits|0|||
106047645|NCT00347360|365837899|FG005|Overall Study|Prolonged duration between visits|0|||
106047646|NCT00347360|365837900|FG006|Overall Study|Prolonged duration between visits|0|||
106047647|NCT00347360|365837901|FG007|Overall Study|Prolonged duration between visits|0|||
106047648|NCT00347360|365837902|FG008|Overall Study|Prolonged duration between visits|0|||
106047649|NCT00347360|365837903|FG009|Overall Study|Prolonged duration between visits|0|||
106047650|NCT00347360|365837904|FG010|Overall Study|Prolonged duration between visits|0|||
106047651|NCT00347360|365837905|FG011|Overall Study|Prolonged duration between visits|0|||
106047652|NCT00347360|365837906|FG012|Overall Study|Prolonged duration between visits|1|||
106047653|NCT00347360|365837907|FG013|Overall Study|Prolonged duration between visits|0|||
106047654|NCT00347360|365837908|FG014|Overall Study|Prolonged duration between visits|0|||
106047655|NCT00347360|365837894|FG000|Overall Study|Subject left town, ran out of study drug|0|||
106047656|NCT00347360|365837895|FG001|Overall Study|Subject left town, ran out of study drug|0|||
106047657|NCT00347360|365837896|FG002|Overall Study|Subject left town, ran out of study drug|0|||
106047658|NCT00347360|365837897|FG003|Overall Study|Subject left town, ran out of study drug|0|||
106047659|NCT00347360|365837898|FG004|Overall Study|Subject left town, ran out of study drug|0|||
106047660|NCT00347360|365837899|FG005|Overall Study|Subject left town, ran out of study drug|0|||
106047661|NCT00347360|365837900|FG006|Overall Study|Subject left town, ran out of study drug|0|||
106047662|NCT00347360|365837901|FG007|Overall Study|Subject left town, ran out of study drug|0|||
106047663|NCT00347360|365837902|FG008|Overall Study|Subject left town, ran out of study drug|0|||
106047664|NCT00347360|365837903|FG009|Overall Study|Subject left town, ran out of study drug|0|||
106047665|NCT00347360|365837904|FG010|Overall Study|Subject left town, ran out of study drug|0|||
106047666|NCT00347360|365837905|FG011|Overall Study|Subject left town, ran out of study drug|0|||
106047667|NCT00347360|365837906|FG012|Overall Study|Subject left town, ran out of study drug|0|||
106047668|NCT00347360|365837907|FG013|Overall Study|Subject left town, ran out of study drug|1|||
106047669|NCT00347360|365837908|FG014|Overall Study|Subject left town, ran out of study drug|0|||
106047670|NCT00347360|365837894|FG000|Overall Study|Subject refuse to sign updated consent|0|||
106047671|NCT00347360|365837895|FG001|Overall Study|Subject refuse to sign updated consent|0|||
106047672|NCT00347360|365837896|FG002|Overall Study|Subject refuse to sign updated consent|0|||
106047673|NCT00347360|365837897|FG003|Overall Study|Subject refuse to sign updated consent|0|||
106047674|NCT00347360|365837898|FG004|Overall Study|Subject refuse to sign updated consent|0|||
106047675|NCT00347360|365837899|FG005|Overall Study|Subject refuse to sign updated consent|0|||
106047676|NCT00347360|365837900|FG006|Overall Study|Subject refuse to sign updated consent|0|||
106047677|NCT00347360|365837901|FG007|Overall Study|Subject refuse to sign updated consent|0|||
106047678|NCT00347360|365837902|FG008|Overall Study|Subject refuse to sign updated consent|0|||
106047679|NCT00347360|365837903|FG009|Overall Study|Subject refuse to sign updated consent|0|||
106047680|NCT00347360|365837904|FG010|Overall Study|Subject refuse to sign updated consent|0|||
106047681|NCT00347360|365837905|FG011|Overall Study|Subject refuse to sign updated consent|0|||
106047682|NCT00347360|365837906|FG012|Overall Study|Subject refuse to sign updated consent|0|||
106047683|NCT00347360|365837907|FG013|Overall Study|Subject refuse to sign updated consent|0|||
106047684|NCT00347360|365837908|FG014|Overall Study|Subject refuse to sign updated consent|1|||
106047685|NCT00347360|365837894|FG000|Overall Study|Visits conflicted with new job|0|||
106047686|NCT00347360|365837895|FG001|Overall Study|Visits conflicted with new job|0|||
106047687|NCT00347360|365837896|FG002|Overall Study|Visits conflicted with new job|0|||
106047688|NCT00347360|365837897|FG003|Overall Study|Visits conflicted with new job|0|||
106047689|NCT00347360|365837898|FG004|Overall Study|Visits conflicted with new job|0|||
106047690|NCT00347360|365837899|FG005|Overall Study|Visits conflicted with new job|0|||
106047691|NCT00347360|365837900|FG006|Overall Study|Visits conflicted with new job|1|||
106047692|NCT00347360|365837901|FG007|Overall Study|Visits conflicted with new job|0|||
106047693|NCT00347360|365837902|FG008|Overall Study|Visits conflicted with new job|0|||
106047694|NCT00347360|365837903|FG009|Overall Study|Visits conflicted with new job|0|||
106047695|NCT00347360|365837904|FG010|Overall Study|Visits conflicted with new job|0|||
106047696|NCT00347360|365837905|FG011|Overall Study|Visits conflicted with new job|0|||
106047697|NCT00347360|365837906|FG012|Overall Study|Visits conflicted with new job|0|||
106047698|NCT00347360|365837907|FG013|Overall Study|Visits conflicted with new job|0|||
106047699|NCT00347360|365837908|FG014|Overall Study|Visits conflicted with new job|0|||
106047700|NCT00913380|365837909|FG000|Clinical Outcomes|Lost to Follow-up|6|||
106047701|NCT00913380|365837910|FG001|Clinical Outcomes|Lost to Follow-up|6|||
106047702|NCT00316719|365839780|FG000|Overall Study|Adverse Event|0|||
106047703|NCT00316719|365839781|FG001|Overall Study|Adverse Event|6|||
106047704|NCT00316719|365839780|FG000|Overall Study|Consent withdrawn|2|||
106047705|NCT00316719|365839781|FG001|Overall Study|Consent withdrawn|0|||
106047706|NCT02742441|365839784|FG000|Overall Study|Lost to Follow-up|4|||
106047707|NCT02742441|365839785|FG001|Overall Study|Lost to Follow-up|4|||
106047708|NCT02742441|365839784|FG000|Overall Study|Withdrawal by Subject|2|||
106047709|NCT02742441|365839785|FG001|Overall Study|Withdrawal by Subject|2|||
106047710|NCT02742441|365839784|FG000|Overall Study|Adverse Event|0|||
106047711|NCT02742441|365839785|FG001|Overall Study|Adverse Event|2|||
106047712|NCT02975336|365839789|FG000|DBPC (52 Weeks)|Adverse Event|16|||
106047713|NCT02975336|365839790|FG001|DBPC (52 Weeks)|Adverse Event|17|||
106047714|NCT02975336|365839791|FG002|DBPC (52 Weeks)|Adverse Event|13|||
106047715|NCT02975336|365839792|FG003|DBPC (52 Weeks)|Adverse Event|18|||
106047716|NCT02975336|365839793|FG004|DBPC (52 Weeks)|Adverse Event|0|||
106047717|NCT02975336|365839794|FG005|DBPC (52 Weeks)|Adverse Event|0|||
106047718|NCT02975336|365839795|FG006|DBPC (52 Weeks)|Adverse Event|0|||
106047719|NCT02975336|365839796|FG007|DBPC (52 Weeks)|Adverse Event|0|||
106047720|NCT02975336|365839789|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
106047721|NCT02975336|365839790|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
106047722|NCT02975336|365839791|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
106047723|NCT02975336|365839792|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
106047724|NCT02975336|365839793|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
106047725|NCT02975336|365839794|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
106047726|NCT02975336|365839795|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
106047727|NCT02975336|365839796|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
106047728|NCT02975336|365839789|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
106047729|NCT02975336|365839790|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
106047730|NCT02975336|365839791|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
106047731|NCT02975336|365839792|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
106047732|NCT02975336|365839793|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
106047733|NCT02975336|365839794|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
106047734|NCT02975336|365839795|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
106047735|NCT02975336|365839796|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
106047736|NCT02975336|365839789|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
106047737|NCT02975336|365839790|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
106047738|NCT02975336|365839791|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
106047739|NCT02975336|365839792|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
106047740|NCT02975336|365839793|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
106047741|NCT02975336|365839794|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
106047742|NCT02975336|365839795|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
106047743|NCT02975336|365839796|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
106047744|NCT02975336|365839789|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
106047745|NCT02975336|365839790|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
106047746|NCT02975336|365839791|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
106047747|NCT02975336|365839792|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
106047748|NCT02975336|365839793|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
106047749|NCT02975336|365839794|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
106047750|NCT02975336|365839795|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
106047751|NCT02975336|365839796|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
106047752|NCT02975336|365839789|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
106047753|NCT02975336|365839790|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
106047754|NCT02975336|365839791|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
106047755|NCT02975336|365839792|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
106047756|NCT02975336|365839793|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
106047757|NCT02975336|365839794|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
106047758|NCT02975336|365839795|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
106047759|NCT02975336|365839796|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
106047760|NCT02975336|365839789|FG000|LTE (104 Weeks)|Adverse Event|0|||
106047761|NCT02975336|365839790|FG001|LTE (104 Weeks)|Adverse Event|0|||
106047762|NCT02975336|365839791|FG002|LTE (104 Weeks)|Adverse Event|0|||
106047763|NCT02975336|365839792|FG003|LTE (104 Weeks)|Adverse Event|0|||
106047764|NCT02975336|365839793|FG004|LTE (104 Weeks)|Adverse Event|7|||
106047765|NCT02975336|365839794|FG005|LTE (104 Weeks)|Adverse Event|4|||
106047766|NCT02975336|365839795|FG006|LTE (104 Weeks)|Adverse Event|2|||
106047767|NCT02975336|365839796|FG007|LTE (104 Weeks)|Adverse Event|0|||
106047768|NCT02975336|365839789|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
106047769|NCT02975336|365839790|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
106047770|NCT02975336|365839791|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
106047771|NCT02975336|365839792|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
106047772|NCT02975336|365839793|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
106047773|NCT02975336|365839794|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
106047774|NCT02975336|365839795|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
106047775|NCT02975336|365839796|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
106047776|NCT02975336|365839789|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
106047777|NCT02975336|365839790|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
106047778|NCT02975336|365839791|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
106047779|NCT02975336|365839792|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
106047780|NCT02975336|365839793|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
106047781|NCT02975336|365839794|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
106047782|NCT02975336|365839795|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
106047783|NCT02975336|365839796|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
106047784|NCT02975336|365839789|FG000|LTE (104 Weeks)|Other|0|||
106047785|NCT02975336|365839790|FG001|LTE (104 Weeks)|Other|0|||
106047786|NCT02975336|365839791|FG002|LTE (104 Weeks)|Other|0|||
106047787|NCT02975336|365839792|FG003|LTE (104 Weeks)|Other|0|||
106047788|NCT02975336|365839793|FG004|LTE (104 Weeks)|Other|55|||
106047789|NCT02975336|365839794|FG005|LTE (104 Weeks)|Other|63|||
105862953|NCT00996892|365148118|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
106047790|NCT02975336|365839795|FG006|LTE (104 Weeks)|Other|76|||
106047791|NCT02975336|365839796|FG007|LTE (104 Weeks)|Other|72|||
106047792|NCT01863953|365839797|FG000|Overall Study|Adverse Event|0|||
106047793|NCT01863953|365839798|FG001|Overall Study|Adverse Event|0|||
106047794|NCT01863953|365839799|FG002|Overall Study|Adverse Event|1|||
106047795|NCT05439941|365839802|FG000|Overall Study|Lack of Efficacy|8|||
106047796|NCT05439941|365839803|FG001|Overall Study|Lack of Efficacy|5|||
106047797|NCT05439941|365839804|FG002|Overall Study|Lack of Efficacy|3|||
106047798|NCT05439941|365839802|FG000|Overall Study|Treatment Failure|0|||
106047799|NCT05439941|365839803|FG001|Overall Study|Treatment Failure|1|||
106047800|NCT05439941|365839804|FG002|Overall Study|Treatment Failure|0|||
106047801|NCT05439941|365839802|FG000|Overall Study|Adverse Event|1|||
106047802|NCT05439941|365839803|FG001|Overall Study|Adverse Event|3|||
106047803|NCT05439941|365839804|FG002|Overall Study|Adverse Event|0|||
106047804|NCT05439941|365839802|FG000|Overall Study|Adverse Event - Parent Study|1|||
106047805|NCT05439941|365839803|FG001|Overall Study|Adverse Event - Parent Study|0|||
106047806|NCT05439941|365839804|FG002|Overall Study|Adverse Event - Parent Study|0|||
106047807|NCT05439941|365839802|FG000|Overall Study|Pregnancy|1|||
106047808|NCT05439941|365839803|FG001|Overall Study|Pregnancy|0|||
106047809|NCT05439941|365839804|FG002|Overall Study|Pregnancy|0|||
106047810|NCT05439941|365839802|FG000|Overall Study|Withdrawal by Subject|9|||
106047811|NCT05439941|365839803|FG001|Overall Study|Withdrawal by Subject|6|||
106047812|NCT05439941|365839804|FG002|Overall Study|Withdrawal by Subject|10|||
106047813|NCT05439941|365839802|FG000|Overall Study|Non-Compliance|1|||
106047814|NCT05439941|365839803|FG001|Overall Study|Non-Compliance|1|||
106047815|NCT05439941|365839804|FG002|Overall Study|Non-Compliance|1|||
106047816|NCT05439941|365839802|FG000|Overall Study|Lost to Follow-up|2|||
106047817|NCT05439941|365839803|FG001|Overall Study|Lost to Follow-up|2|||
106047818|NCT05439941|365839804|FG002|Overall Study|Lost to Follow-up|0|||
106047819|NCT05439941|365839802|FG000|Overall Study|Physician Decision|1|||
106047820|NCT05439941|365839803|FG001|Overall Study|Physician Decision|0|||
106047821|NCT05439941|365839804|FG002|Overall Study|Physician Decision|0|||
106047822|NCT05439941|365839802|FG000|Overall Study|Trial Termination by Sponsor|78|||
106047823|NCT05439941|365839803|FG001|Overall Study|Trial Termination by Sponsor|83|||
106047824|NCT05439941|365839804|FG002|Overall Study|Trial Termination by Sponsor|65|||
106047825|NCT05439941|365839802|FG000|Overall Study|Other than Reasons Listed|2|||
106047826|NCT05439941|365839803|FG001|Overall Study|Other than Reasons Listed|1|||
106047827|NCT05439941|365839804|FG002|Overall Study|Other than Reasons Listed|0|||
106047828|NCT00231842|365839805|FG000|Overall Study|Withdrawal by Subject|3|||
106047829|NCT00231842|365839805|FG000|Overall Study|Did not complete the last 3 cycle|8|||
106047830|NCT02422303|365839806|FG000|Overall Study|Lost to Follow-up|1|||
106047831|NCT02422303|365839807|FG001|Overall Study|Lost to Follow-up|1|||
105862954|NCT00996892|365148119|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
105862955|NCT00996892|365148120|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862956|NCT00996892|365148121|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
105862957|NCT00996892|365148122|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
105862958|NCT00996892|365148123|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
105862959|NCT00996892|365148124|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
105862960|NCT00996892|365148125|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862961|NCT00996892|365148126|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862962|NCT00996892|365148127|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862963|NCT00996892|365148128|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862964|NCT00996892|365148129|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862965|NCT00996892|365148130|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862966|NCT00996892|365148131|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862967|NCT00996892|365148132|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862968|NCT00996892|365148133|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862969|NCT00996892|365148134|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
106047832|NCT02899299|365839809|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
106047833|NCT02899299|365839810|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
106047834|NCT02899299|365839809|FG000|Pre-treatment|Participant withdrew consent|1|||
106047835|NCT02899299|365839810|FG001|Pre-treatment|Participant withdrew consent|11|||
105862970|NCT00996892|365148135|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
106047836|NCT02899299|365839809|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
106047837|NCT02899299|365839810|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
106047838|NCT02899299|365839809|FG000|Pre-treatment|Not reported|0|||
106047839|NCT02899299|365839810|FG001|Pre-treatment|Not reported|1|||
106047840|NCT02899299|365839809|FG000|Treatment|Disease Progression|182|||
106047841|NCT02899299|365839810|FG001|Treatment|Disease Progression|43|||
106047842|NCT02899299|365839809|FG000|Treatment|Study Drug Toxicity|60|||
106047843|NCT02899299|365839810|FG001|Treatment|Study Drug Toxicity|24|||
106047844|NCT02899299|365839809|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
106047845|NCT02899299|365839810|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
106047846|NCT02899299|365839809|FG000|Treatment|Participant request to discontinue Study treatment|4|||
106047847|NCT02899299|365839810|FG001|Treatment|Participant request to discontinue Study treatment|10|||
106047848|NCT02899299|365839809|FG000|Treatment|Participant withdrew consent|6|||
106047849|NCT02899299|365839810|FG001|Treatment|Participant withdrew consent|3|||
106047850|NCT02899299|365839809|FG000|Treatment|Lost to Follow-up|0|||
106047851|NCT02899299|365839810|FG001|Treatment|Lost to Follow-up|2|||
106047852|NCT02899299|365839809|FG000|Treatment|Maximum Clinical Benefit|11|||
106047853|NCT02899299|365839810|FG001|Treatment|Maximum Clinical Benefit|2|||
106047854|NCT02899299|365839809|FG000|Treatment|Poor/Non-compliance|1|||
106047855|NCT02899299|365839810|FG001|Treatment|Poor/Non-compliance|0|||
106047856|NCT02899299|365839809|FG000|Treatment|Participant no longer meets Study criteria|4|||
106047857|NCT02899299|365839810|FG001|Treatment|Participant no longer meets Study criteria|0|||
106047858|NCT02899299|365839809|FG000|Treatment|Administrative reason by Sponsor|2|||
106047859|NCT02899299|365839810|FG001|Treatment|Administrative reason by Sponsor|0|||
106047860|NCT02899299|365839809|FG000|Treatment|Other reasons|12|||
106047861|NCT02899299|365839810|FG001|Treatment|Other reasons|2|||
106047862|NCT02899299|365839809|FG000|Treatment|Not reported|7|||
106047863|NCT02899299|365839810|FG001|Treatment|Not reported|0|||
106047864|NCT02336373|365839811|FG000|Overall Study|Protocol closed early|4|||
106047865|NCT02336373|365839811|FG000|Overall Study|Physician Decision|14|||
106047866|NCT01868503|365839816|FG000|Overall Study|Withdrawal by Subject|1|||
106047867|NCT01868503|365839816|FG000|Overall Study|Protocol Violation|1|||
106047868|NCT00408629|365839817|FG000|Overall Study|Adverse Event|13|||
106047869|NCT00408629|365839818|FG001|Overall Study|Adverse Event|27|||
106047870|NCT00408629|365839817|FG000|Overall Study|Withdrawal by Subject|8|||
106047871|NCT00408629|365839818|FG001|Overall Study|Withdrawal by Subject|4|||
106047872|NCT00408629|365839817|FG000|Overall Study|Lost to Follow-up|1|||
106047873|NCT00408629|365839818|FG001|Overall Study|Lost to Follow-up|1|||
106047874|NCT00408629|365839817|FG000|Overall Study|Lack of Efficacy|63|||
106047875|NCT00408629|365839818|FG001|Overall Study|Lack of Efficacy|73|||
106047876|NCT00408629|365839817|FG000|Overall Study|Protocol Violation|1|||
106047877|NCT00408629|365839818|FG001|Overall Study|Protocol Violation|5|||
106047878|NCT00408629|365839817|FG000|Overall Study|Miscellaneous|11|||
106047879|NCT00408629|365839818|FG001|Overall Study|Miscellaneous|15|||
106047880|NCT01031706|365839827|FG000|Overall Study|Adverse Event|1|||
106047881|NCT01031706|365839828|FG001|Overall Study|Adverse Event|0|||
106047882|NCT01031706|365839827|FG000|Overall Study|Withdrawal by Subject|1|||
106047883|NCT01031706|365839828|FG001|Overall Study|Withdrawal by Subject|1|||
106047884|NCT03626168|365839829|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
106047885|NCT03626168|365839830|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
106047886|NCT03626168|365839829|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
106047887|NCT03626168|365839830|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
106047888|NCT03626168|365839829|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
106047889|NCT03626168|365839830|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
106047890|NCT03758443|365839831|FG000|Induction Period|Adverse Event|2|||
106047891|NCT03758443|365839832|FG001|Induction Period|Adverse Event|4|||
106047892|NCT03758443|365839833|FG002|Induction Period|Adverse Event|2|||
106047893|NCT03758443|365839834|FG003|Induction Period|Adverse Event|3|||
106047894|NCT03758443|365839831|FG000|Induction Period|Physician Decision|1|||
106047895|NCT03758443|365839832|FG001|Induction Period|Physician Decision|1|||
106047896|NCT03758443|365839833|FG002|Induction Period|Physician Decision|3|||
106047897|NCT03758443|365839834|FG003|Induction Period|Physician Decision|0|||
106047898|NCT03758443|365839831|FG000|Induction Period|Protocol Violation|0|||
106047899|NCT03758443|365839832|FG001|Induction Period|Protocol Violation|0|||
106047900|NCT03758443|365839833|FG002|Induction Period|Protocol Violation|0|||
106047901|NCT03758443|365839834|FG003|Induction Period|Protocol Violation|1|||
106047902|NCT03758443|365839831|FG000|Induction Period|Withdrawal by Subject|3|||
106047903|NCT03758443|365839832|FG001|Induction Period|Withdrawal by Subject|2|||
106047904|NCT03758443|365839833|FG002|Induction Period|Withdrawal by Subject|2|||
106047905|NCT03758443|365839834|FG003|Induction Period|Withdrawal by Subject|4|||
106047906|NCT03758443|365839831|FG000|Extended Induction Period|Adverse Event|1|||
106047907|NCT03758443|365839832|FG001|Extended Induction Period|Adverse Event|1|||
106047908|NCT03758443|365839833|FG002|Extended Induction Period|Adverse Event|0|||
106047909|NCT03758443|365839834|FG003|Extended Induction Period|Adverse Event|1|||
106047910|NCT03758443|365839831|FG000|Extended Induction Period|Lost to Follow-up|1|||
106047911|NCT03758443|365839832|FG001|Extended Induction Period|Lost to Follow-up|0|||
106047912|NCT03758443|365839833|FG002|Extended Induction Period|Lost to Follow-up|0|||
106047913|NCT03758443|365839834|FG003|Extended Induction Period|Lost to Follow-up|0|||
106047914|NCT03758443|365839831|FG000|Extended Induction Period|Physician Decision|2|||
106047915|NCT03758443|365839832|FG001|Extended Induction Period|Physician Decision|1|||
106047916|NCT03758443|365839833|FG002|Extended Induction Period|Physician Decision|2|||
106047917|NCT03758443|365839834|FG003|Extended Induction Period|Physician Decision|2|||
106047918|NCT03758443|365839831|FG000|Extended Induction Period|Protocol Violation|0|||
106047919|NCT03758443|365839832|FG001|Extended Induction Period|Protocol Violation|0|||
106047920|NCT03758443|365839833|FG002|Extended Induction Period|Protocol Violation|0|||
106047921|NCT03758443|365839834|FG003|Extended Induction Period|Protocol Violation|1|||
106047922|NCT03758443|365839831|FG000|Extended Induction Period|Withdrawal by Subject|8|||
106047923|NCT03758443|365839832|FG001|Extended Induction Period|Withdrawal by Subject|1|||
106047924|NCT03758443|365839833|FG002|Extended Induction Period|Withdrawal by Subject|7|||
106047925|NCT03758443|365839834|FG003|Extended Induction Period|Withdrawal by Subject|3|||
106047926|NCT03758443|365839831|FG000|Extended Induction Period|Miscellaneous|1|||
106047927|NCT03758443|365839832|FG001|Extended Induction Period|Miscellaneous|0|||
106047928|NCT03758443|365839833|FG002|Extended Induction Period|Miscellaneous|0|||
106047929|NCT03758443|365839834|FG003|Extended Induction Period|Miscellaneous|0|||
106047930|NCT03758443|365839831|FG000|Maintenance Period|Adverse Event|1|||
106047931|NCT03758443|365839832|FG001|Maintenance Period|Adverse Event|2|||
106047932|NCT03758443|365839833|FG002|Maintenance Period|Adverse Event|0|||
106047933|NCT03758443|365839834|FG003|Maintenance Period|Adverse Event|0|||
106047934|NCT03758443|365839831|FG000|Maintenance Period|Lost to Follow-up|0|||
106047935|NCT03758443|365839832|FG001|Maintenance Period|Lost to Follow-up|0|||
106047936|NCT03758443|365839833|FG002|Maintenance Period|Lost to Follow-up|0|||
106047937|NCT03758443|365839834|FG003|Maintenance Period|Lost to Follow-up|1|||
106047938|NCT03758443|365839831|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
106047939|NCT03758443|365839832|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
106047940|NCT03758443|365839833|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
106047941|NCT03758443|365839834|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
106047942|NCT03758443|365839831|FG000|Maintenance Period|Protocol Violation|0|||
106047943|NCT03758443|365839832|FG001|Maintenance Period|Protocol Violation|1|||
106047944|NCT03758443|365839833|FG002|Maintenance Period|Protocol Violation|0|||
106047945|NCT03758443|365839834|FG003|Maintenance Period|Protocol Violation|0|||
106047946|NCT03758443|365839831|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
106047947|NCT03758443|365839832|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
106047948|NCT03758443|365839833|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
106047949|NCT03758443|365839834|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
106047950|NCT03758443|365839831|FG000|Maintenance Period|Withdrawal by Subject|1|||
106047951|NCT03758443|365839832|FG001|Maintenance Period|Withdrawal by Subject|0|||
106047952|NCT03758443|365839833|FG002|Maintenance Period|Withdrawal by Subject|1|||
106047953|NCT03758443|365839834|FG003|Maintenance Period|Withdrawal by Subject|1|||
106047954|NCT03758443|365839831|FG000|Maintenance Period|Miscellaneous|0|||
106047955|NCT03758443|365839832|FG001|Maintenance Period|Miscellaneous|0|||
106047956|NCT03758443|365839833|FG002|Maintenance Period|Miscellaneous|1|||
106047957|NCT03758443|365839834|FG003|Maintenance Period|Miscellaneous|0|||
106047958|NCT00216476|365839837|FG000|Overall Study|Withdrawal by Subject|59|||
106047959|NCT00216476|365839838|FG001|Overall Study|Withdrawal by Subject|72|||
106047960|NCT00216476|365839839|FG002|Overall Study|Withdrawal by Subject|9|||
106047961|NCT00216476|365839837|FG000|Overall Study|Lost to Follow-up|10|||
106047962|NCT00216476|365839838|FG001|Overall Study|Lost to Follow-up|9|||
106047963|NCT00216476|365839839|FG002|Overall Study|Lost to Follow-up|1|||
106047964|NCT00216476|365839837|FG000|Overall Study|Adverse Event|6|||
106047965|NCT00216476|365839838|FG001|Overall Study|Adverse Event|10|||
106047966|NCT00216476|365839839|FG002|Overall Study|Adverse Event|1|||
106047967|NCT00216476|365839837|FG000|Overall Study|Lack of Efficacy|4|||
106047968|NCT00216476|365839838|FG001|Overall Study|Lack of Efficacy|3|||
106047969|NCT00216476|365839839|FG002|Overall Study|Lack of Efficacy|0|||
106047970|NCT00216476|365839837|FG000|Overall Study|Death|2|||
106047971|NCT00216476|365839838|FG001|Overall Study|Death|0|||
106047972|NCT00216476|365839839|FG002|Overall Study|Death|0|||
106047973|NCT00216476|365839837|FG000|Overall Study|Pregnancy|0|||
106047974|NCT00216476|365839838|FG001|Overall Study|Pregnancy|1|||
106047975|NCT00216476|365839839|FG002|Overall Study|Pregnancy|1|||
106047976|NCT00216476|365839837|FG000|Overall Study|Other|0|||
106047977|NCT00216476|365839838|FG001|Overall Study|Other|0|||
106047978|NCT00216476|365839839|FG002|Overall Study|Other|1|||
106047979|NCT00216476|365839837|FG000|Overall Study|Refuses Injection|11|||
106047980|NCT00216476|365839838|FG001|Overall Study|Refuses Injection|0|||
106047981|NCT00216476|365839839|FG002|Overall Study|Refuses Injection|0|||
106047982|NCT00216476|365839837|FG000|Overall Study|No Further Need for Treatment|3|||
106047983|NCT00216476|365839838|FG001|Overall Study|No Further Need for Treatment|4|||
106047984|NCT00216476|365839839|FG002|Overall Study|No Further Need for Treatment|1|||
106047985|NCT00216476|365839837|FG000|Overall Study|Non-compliance|0|||
106047986|NCT00216476|365839838|FG001|Overall Study|Non-compliance|4|||
106047987|NCT00216476|365839839|FG002|Overall Study|Non-compliance|1|||
106047988|NCT00216476|365839837|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
106047989|NCT00216476|365839838|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
106047990|NCT00216476|365839839|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
106047991|NCT00216476|365839837|FG000|Overall Study|Administrative Reasons|1|||
106047992|NCT00216476|365839838|FG001|Overall Study|Administrative Reasons|1|||
106047993|NCT00216476|365839839|FG002|Overall Study|Administrative Reasons|0|||
106047994|NCT00216476|365839837|FG000|Overall Study|Protocol Deviation|5|||
106047995|NCT00216476|365839838|FG001|Overall Study|Protocol Deviation|1|||
106047996|NCT00216476|365839839|FG002|Overall Study|Protocol Deviation|0|||
106047997|NCT00216476|365839837|FG000|Overall Study|Patient Moved|2|||
106047998|NCT00216476|365839838|FG001|Overall Study|Patient Moved|2|||
106047999|NCT00216476|365839839|FG002|Overall Study|Patient Moved|0|||
106048000|NCT01522248|365839842|FG000|Overall Study|Lost to Follow-up|1|||
106048001|NCT01522248|365839843|FG001|Overall Study|Lost to Follow-up|0|||
106048002|NCT03719586|365839844|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
106048003|NCT03719586|365839845|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
106048004|NCT03719586|365839846|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
106048005|NCT03719586|365839847|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
106048006|NCT00538291|365839849|FG000|Overall Study|Adverse Event|2|||
106048007|NCT00538291|365839849|FG000|Overall Study|Withdrawal by Subject|1|||
106048008|NCT01904058|365839850|FG000|Overall Study|Adverse Event|2|||
106048009|NCT01904058|365839851|FG001|Overall Study|Adverse Event|0|||
106048010|NCT01904058|365839852|FG002|Overall Study|Adverse Event|0|||
106048011|NCT01904058|365839853|FG003|Overall Study|Adverse Event|0|||
106048012|NCT01904058|365839850|FG000|Overall Study|Withdrawal by Subject|1|||
106048013|NCT01904058|365839851|FG001|Overall Study|Withdrawal by Subject|0|||
106048014|NCT01904058|365839852|FG002|Overall Study|Withdrawal by Subject|1|||
106048015|NCT01904058|365839853|FG003|Overall Study|Withdrawal by Subject|0|||
106048016|NCT01904058|365839850|FG000|Overall Study|Pregnancy|0|||
106048017|NCT01904058|365839851|FG001|Overall Study|Pregnancy|0|||
106048018|NCT01904058|365839852|FG002|Overall Study|Pregnancy|0|||
106048019|NCT01904058|365839853|FG003|Overall Study|Pregnancy|1|||
106048020|NCT03096483|365839854|FG000|Overall Study|Withdrawal by site|1|||
106048021|NCT01609231|365839860|FG000|Overall Study|Adverse Event|1|||
106048022|NCT01609231|365839861|FG001|Overall Study|Adverse Event|3|||
106048023|NCT01609231|365839860|FG000|Overall Study|Physician Decision|1|||
106048024|NCT01609231|365839861|FG001|Overall Study|Physician Decision|0|||
106048025|NCT01609231|365839860|FG000|Overall Study|Withdrawal by Subject|1|||
106048026|NCT01609231|365839861|FG001|Overall Study|Withdrawal by Subject|0|||
106048027|NCT00113087|365839866|FG000|Overall Study|Death or Transplant|14|||
106048028|NCT00113087|365839867|FG001|Overall Study|Death or Transplant|16|||
106048029|NCT00113087|365839866|FG000|Overall Study|Family or MD withdrew subject|10|||
106048030|NCT00113087|365839867|FG001|Overall Study|Family or MD withdrew subject|5|||
106048031|NCT02761733|365839868|FG000|Overall Study|Death|3|||
106048032|NCT02761733|365839869|FG001|Overall Study|Death|5|||
106048033|NCT02761733|365839870|FG002|Overall Study|Death|1|||
106048034|NCT02761733|365839871|FG003|Overall Study|Death|1|||
106048035|NCT02761733|365839868|FG000|Overall Study|Lost to Follow-up|6|||
106048036|NCT02761733|365839869|FG001|Overall Study|Lost to Follow-up|7|||
106048037|NCT02761733|365839870|FG002|Overall Study|Lost to Follow-up|0|||
106048038|NCT02761733|365839871|FG003|Overall Study|Lost to Follow-up|3|||
106048039|NCT02761733|365839868|FG000|Overall Study|Physician Decision|4|||
106048040|NCT02761733|365839869|FG001|Overall Study|Physician Decision|0|||
106048041|NCT02761733|365839870|FG002|Overall Study|Physician Decision|0|||
106048042|NCT02761733|365839871|FG003|Overall Study|Physician Decision|0|||
106048043|NCT02761733|365839868|FG000|Overall Study|Withdrawal by Subject|2|||
106048044|NCT02761733|365839869|FG001|Overall Study|Withdrawal by Subject|0|||
106048045|NCT02761733|365839870|FG002|Overall Study|Withdrawal by Subject|0|||
106048046|NCT02761733|365839871|FG003|Overall Study|Withdrawal by Subject|0|||
106048047|NCT02761733|365839868|FG000|Overall Study|Discharged from Study Site|10|||
106048048|NCT02761733|365839869|FG001|Overall Study|Discharged from Study Site|9|||
106048049|NCT02761733|365839870|FG002|Overall Study|Discharged from Study Site|25|||
106048050|NCT02761733|365839871|FG003|Overall Study|Discharged from Study Site|11|||
106048051|NCT02761733|365839868|FG000|Overall Study|Cognitive Impairment|5|||
106048052|NCT02761733|365839869|FG001|Overall Study|Cognitive Impairment|0|||
106048053|NCT02761733|365839870|FG002|Overall Study|Cognitive Impairment|1|||
106048054|NCT02761733|365839871|FG003|Overall Study|Cognitive Impairment|0|||
106048055|NCT00474760|365839874|FG000|Overall Study|Death|0|||
106048056|NCT00474760|365839875|FG001|Overall Study|Death|0|||
106048057|NCT00474760|365839876|FG002|Overall Study|Death|0|||
106048058|NCT00474760|365839877|FG003|Overall Study|Death|0|||
106048059|NCT00474760|365839878|FG004|Overall Study|Death|2|||
106048060|NCT00474760|365839879|FG005|Overall Study|Death|0|||
106048061|NCT00474760|365839880|FG006|Overall Study|Death|0|||
106048062|NCT00474760|365839874|FG000|Overall Study|Adverse Event|0|||
106048063|NCT00474760|365839875|FG001|Overall Study|Adverse Event|0|||
106048064|NCT00474760|365839876|FG002|Overall Study|Adverse Event|0|||
106048065|NCT00474760|365839877|FG003|Overall Study|Adverse Event|0|||
106048066|NCT00474760|365839878|FG004|Overall Study|Adverse Event|1|||
106048067|NCT00474760|365839879|FG005|Overall Study|Adverse Event|7|||
106048068|NCT00474760|365839880|FG006|Overall Study|Adverse Event|0|||
106048069|NCT00474760|365839874|FG000|Overall Study|Laboratory abnormality|0|||
106048070|NCT00474760|365839875|FG001|Overall Study|Laboratory abnormality|0|||
106048071|NCT00474760|365839876|FG002|Overall Study|Laboratory abnormality|0|||
106048072|NCT00474760|365839877|FG003|Overall Study|Laboratory abnormality|0|||
106048073|NCT00474760|365839878|FG004|Overall Study|Laboratory abnormality|0|||
106048074|NCT00474760|365839879|FG005|Overall Study|Laboratory abnormality|1|||
106048075|NCT00474760|365839880|FG006|Overall Study|Laboratory abnormality|0|||
106048076|NCT00474760|365839874|FG000|Overall Study|Withdrawal by Subject|0|||
106048077|NCT00474760|365839875|FG001|Overall Study|Withdrawal by Subject|0|||
106048078|NCT00474760|365839876|FG002|Overall Study|Withdrawal by Subject|0|||
106048079|NCT00474760|365839877|FG003|Overall Study|Withdrawal by Subject|1|||
106048080|NCT00474760|365839878|FG004|Overall Study|Withdrawal by Subject|0|||
106048081|NCT00474760|365839879|FG005|Overall Study|Withdrawal by Subject|1|||
106048082|NCT00474760|365839880|FG006|Overall Study|Withdrawal by Subject|1|||
106048083|NCT00474760|365839874|FG000|Overall Study|Other|0|||
106048084|NCT00474760|365839875|FG001|Overall Study|Other|1|||
106048085|NCT00474760|365839876|FG002|Overall Study|Other|0|||
106048086|NCT00474760|365839877|FG003|Overall Study|Other|0|||
106048087|NCT00474760|365839878|FG004|Overall Study|Other|1|||
106048088|NCT00474760|365839879|FG005|Overall Study|Other|0|||
106048089|NCT00474760|365839880|FG006|Overall Study|Other|0|||
106048090|NCT00474760|365839874|FG000|Overall Study|Progressive disease|3|||
106048091|NCT00474760|365839875|FG001|Overall Study|Progressive disease|2|||
106048092|NCT00474760|365839876|FG002|Overall Study|Progressive disease|3|||
106048093|NCT00474760|365839877|FG003|Overall Study|Progressive disease|2|||
106048094|NCT00474760|365839878|FG004|Overall Study|Progressive disease|8|||
106048095|NCT00474760|365839879|FG005|Overall Study|Progressive disease|20|||
106048096|NCT00474760|365839880|FG006|Overall Study|Progressive disease|7|||
106048097|NCT00474760|365839874|FG000|Overall Study|Terminated by sponsor|0|||
106048098|NCT00474760|365839875|FG001|Overall Study|Terminated by sponsor|0|||
106048099|NCT00474760|365839876|FG002|Overall Study|Terminated by sponsor|0|||
106048100|NCT00474760|365839877|FG003|Overall Study|Terminated by sponsor|0|||
106048101|NCT00474760|365839878|FG004|Overall Study|Terminated by sponsor|0|||
106048102|NCT00474760|365839879|FG005|Overall Study|Terminated by sponsor|0|||
106048103|NCT00474760|365839880|FG006|Overall Study|Terminated by sponsor|2|||
106048104|NCT04295772|365839881|FG000|Overall Study|Protocol Violation|1|||
106048105|NCT04295772|365839882|FG001|Overall Study|Protocol Violation|0|||
106048106|NCT04295772|365839881|FG000|Overall Study|Ongoing for safety monitoring|14|||
106048107|NCT04295772|365839882|FG001|Overall Study|Ongoing for safety monitoring|1|||
106048108|NCT04295772|365839881|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
106048109|NCT04295772|365839882|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
106048110|NCT03608254|365839896|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
106048111|NCT03608254|365839896|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
106048112|NCT00579098|365839897|FG000|Overall Study|Lost to Follow-up|2|||
106048113|NCT00579098|365839898|FG001|Overall Study|Lost to Follow-up|0|||
106048114|NCT00579098|365839897|FG000|Overall Study|Adverse Event|2|||
106048115|NCT00579098|365839898|FG001|Overall Study|Adverse Event|3|||
106048116|NCT00579098|365839897|FG000|Overall Study|Withdrawal by Subject|2|||
106048117|NCT00579098|365839898|FG001|Overall Study|Withdrawal by Subject|3|||
106048118|NCT00579098|365839897|FG000|Overall Study|AF returned after ablation|3|||
106048119|NCT00579098|365839898|FG001|Overall Study|AF returned after ablation|2|||
106048120|NCT00066729|365839899|FG000|Overall Study|Lost to Follow-up|1|||
106048121|NCT00066729|365839899|FG000|Overall Study|Disease progression|1|||
106048122|NCT00633750|365839905|FG000|Overall Study|Adverse Event|2|||
106048123|NCT00633750|365839905|FG000|Overall Study|Withdrawal by Subject|3|||
106048124|NCT00447005|365839907|FG000|Overall Study|Adverse Event|1|||
106048125|NCT00447005|365839907|FG000|Overall Study|Lack of Efficacy|11|||
106048126|NCT00492531|365839908|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
106048127|NCT00492531|365839909|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
106048128|NCT02628938|365839910|FG000|Overall Study|Did not attend the follow up recall|2|||
106048129|NCT02628938|365839911|FG001|Overall Study|Did not attend the follow up recall|2|||
106048130|NCT02628938|365839912|FG002|Overall Study|Did not attend the follow up recall|1|||
106048131|NCT02628938|365839910|FG000|Overall Study|Failure to comply with the instructions|3|||
106048132|NCT02628938|365839911|FG001|Overall Study|Failure to comply with the instructions|0|||
106048133|NCT02628938|365839912|FG002|Overall Study|Failure to comply with the instructions|3|||
106048134|NCT03113916|365839913|FG000|Overall Study|Withdrawal by Subject|9|||
106048135|NCT03113916|365839914|FG001|Overall Study|Withdrawal by Subject|7|||
106048136|NCT03113916|365839913|FG000|Overall Study|Pregnancy|1|||
106048137|NCT03113916|365839914|FG001|Overall Study|Pregnancy|3|||
106048138|NCT03113916|365839913|FG000|Overall Study|Lost to Follow-up|1|||
106048139|NCT03113916|365839914|FG001|Overall Study|Lost to Follow-up|2|||
106048140|NCT04729621|365839920|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
106048141|NCT04729621|365839921|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
106048142|NCT04729621|365839922|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
106048143|NCT04729621|365839923|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
106048144|NCT04729621|365839924|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
106048145|NCT04729621|365839920|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
106048146|NCT04729621|365839921|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
106048147|NCT04729621|365839922|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
106048148|NCT04729621|365839923|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
106048149|NCT04729621|365839924|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
106048150|NCT04729621|365839920|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
106048151|NCT04729621|365839921|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
106048152|NCT04729621|365839922|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
106048153|NCT04729621|365839923|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
106048154|NCT04729621|365839924|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
106048155|NCT04729621|365839920|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
106048156|NCT04729621|365839921|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
106048157|NCT04729621|365839922|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
106048158|NCT04729621|365839923|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
106048159|NCT04729621|365839924|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
106048160|NCT04729621|365839920|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
106048161|NCT04729621|365839921|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
106048162|NCT04729621|365839922|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
106048163|NCT04729621|365839923|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
106048164|NCT04729621|365839924|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
106048165|NCT04729621|365839920|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
106048166|NCT04729621|365839921|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
106048167|NCT04729621|365839922|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
106048168|NCT04729621|365839923|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
106048169|NCT04729621|365839924|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
106048170|NCT03439657|365839925|FG000|Overall Study|Adverse Event|2|||
106048171|NCT03439657|365839926|FG001|Overall Study|Adverse Event|3|||
106048172|NCT03439657|365839925|FG000|Overall Study|Lost to Follow-up|1|||
106048173|NCT03439657|365839926|FG001|Overall Study|Lost to Follow-up|0|||
106048174|NCT03439657|365839925|FG000|Overall Study|Protocol Violation|1|||
106048175|NCT03439657|365839926|FG001|Overall Study|Protocol Violation|1|||
106048176|NCT03439657|365839925|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
106048177|NCT03439657|365839926|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
106048178|NCT03308786|365839928|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
106048179|NCT01999868|365839929|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
106048180|NCT01999868|365839930|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
106048181|NCT01999868|365839931|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
106048182|NCT01999868|365839929|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
106048183|NCT01999868|365839930|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
106048184|NCT01999868|365839931|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
106048185|NCT01999868|365839929|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
106048186|NCT01999868|365839930|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
106048187|NCT01999868|365839931|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
106048188|NCT01999868|365839929|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
106048189|NCT01999868|365839930|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
106048190|NCT01999868|365839931|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
106048191|NCT01999868|365839929|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
106048192|NCT01999868|365839930|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
106048193|NCT01999868|365839931|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
106048194|NCT01999868|365839929|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
106048195|NCT01999868|365839930|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
106048196|NCT01999868|365839931|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
106048197|NCT01999868|365839929|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
106048198|NCT01999868|365839930|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
106048199|NCT01999868|365839931|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
106048200|NCT01999868|365839929|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
106048201|NCT01999868|365839930|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
106048202|NCT01999868|365839931|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
106048203|NCT01999868|365839929|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
106048204|NCT01999868|365839930|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
106048205|NCT01999868|365839931|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
106048206|NCT01999868|365839929|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
106048207|NCT01999868|365839930|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
106048208|NCT01999868|365839931|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
106048209|NCT01999868|365839929|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
106048210|NCT01999868|365839930|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
106048211|NCT01999868|365839931|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
106048212|NCT01999868|365839929|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
106048213|NCT01999868|365839930|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
106048214|NCT01999868|365839931|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
106048215|NCT01999868|365839929|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
106048216|NCT01999868|365839930|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
106048217|NCT01999868|365839931|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
106048218|NCT01999868|365839929|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
106048219|NCT01999868|365839930|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
106048220|NCT01999868|365839931|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
106048221|NCT01999868|365839929|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
106048222|NCT01999868|365839930|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
106048223|NCT01999868|365839931|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
106048224|NCT01187433|365839935|FG000|Overall Study|Protocol Violation|6|||
106048225|NCT01187433|365839936|FG001|Overall Study|Protocol Violation|2|||
106048226|NCT01187433|365839935|FG000|Overall Study|Withdrawal by Subject|5|||
106048227|NCT01187433|365839936|FG001|Overall Study|Withdrawal by Subject|2|||
106048228|NCT00302107|365839937|FG000|Overall Study|Lost to Follow-up|6|||
106048229|NCT00302107|365839938|FG001|Overall Study|Lost to Follow-up|5|||
106048230|NCT00302107|365839937|FG000|Overall Study|Protocol Violation|1|||
106048231|NCT00302107|365839938|FG001|Overall Study|Protocol Violation|0|||
106048232|NCT00302107|365839937|FG000|Overall Study|Relocation|0|||
106048233|NCT00302107|365839938|FG001|Overall Study|Relocation|1|||
106048234|NCT00302107|365839937|FG000|Overall Study|Withdrawal by Subject|0|||
106048235|NCT00302107|365839938|FG001|Overall Study|Withdrawal by Subject|3|||
106048236|NCT00302107|365839937|FG000|Overall Study|Adverse Event|1|||
106048237|NCT00302107|365839938|FG001|Overall Study|Adverse Event|0|||
106048238|NCT01790932|365839939|FG000|Overall Study|Disease Progression|41|||
106048239|NCT01790932|365839939|FG000|Overall Study|Adverse Event|7|||
106048240|NCT01790932|365839939|FG000|Overall Study|Physician Decision|1|||
106048241|NCT01790932|365839939|FG000|Overall Study|Withdrawal by Subject|1|||
106048242|NCT00678080|365839940|FG000|Overall Study|Physician Decision|2|||
106048243|NCT00678080|365839941|FG001|Overall Study|Physician Decision|0|||
106048244|NCT00678080|365839940|FG000|Overall Study|Lost to Follow-up|1|||
106048245|NCT00678080|365839941|FG001|Overall Study|Lost to Follow-up|0|||
106048246|NCT00678080|365839940|FG000|Overall Study|Withdrawal by Subject|0|||
106048247|NCT00678080|365839941|FG001|Overall Study|Withdrawal by Subject|1|||
106048248|NCT01752985|365839942|FG000|Treatment Period|Subject request to discontinue treatment|1|||
106048249|NCT01752985|365839943|FG001|Treatment Period|Subject request to discontinue treatment|0|||
106048250|NCT01752985|365839944|FG002|Treatment Period|Subject request to discontinue treatment|1|||
106048251|NCT01752985|365839942|FG000|Treatment Period|Subject no longer meets study criteria|0|||
106048252|NCT01752985|365839943|FG001|Treatment Period|Subject no longer meets study criteria|1|||
106048253|NCT01752985|365839944|FG002|Treatment Period|Subject no longer meets study criteria|1|||
106048254|NCT01752985|365839942|FG000|Treatment Period|Adverse Event|2|||
106048255|NCT01752985|365839943|FG001|Treatment Period|Adverse Event|1|||
106048256|NCT01752985|365839944|FG002|Treatment Period|Adverse Event|2|||
106048257|NCT01752985|365839942|FG000|Treatment Period|Withdrawal by Subject|1|||
106048258|NCT01752985|365839943|FG001|Treatment Period|Withdrawal by Subject|1|||
106048259|NCT01752985|365839944|FG002|Treatment Period|Withdrawal by Subject|0|||
106048260|NCT01752985|365839942|FG000|Treatment Period|Lost to Follow-up|0|||
106048261|NCT01752985|365839943|FG001|Treatment Period|Lost to Follow-up|0|||
106048262|NCT01752985|365839944|FG002|Treatment Period|Lost to Follow-up|1|||
106097366|NCT03950739|366014391|FG000|Optional Extension Phase|Site Closure|2|||
106097367|NCT03950739|366014391|FG000|Optional Extension Phase|Pregnancy|1|||
106097368|NCT04139317|366014392|FG000|Overall Study|Adverse Event|10|||
106097369|NCT04139317|366014393|FG001|Overall Study|Adverse Event|2|||
106097370|NCT04139317|366014392|FG000|Overall Study|Death|6|||
106097371|NCT04139317|366014393|FG001|Overall Study|Death|4|||
106097372|NCT04139317|366014392|FG000|Overall Study|Lost to Follow-up|1|||
106097373|NCT04139317|366014393|FG001|Overall Study|Lost to Follow-up|0|||
106097374|NCT04139317|366014392|FG000|Overall Study|Physician Decision|3|||
106097375|NCT04139317|366014393|FG001|Overall Study|Physician Decision|1|||
106097376|NCT04139317|366014392|FG000|Overall Study|Progressive Disease|19|||
106097377|NCT04139317|366014393|FG001|Overall Study|Progressive Disease|9|||
106097378|NCT04139317|366014392|FG000|Overall Study|Subject Decision|2|||
106097379|NCT04139317|366014393|FG001|Overall Study|Subject Decision|2|||
106097380|NCT01715805|366014394|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
106097381|NCT01715805|366014395|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
106097382|NCT01715805|366014396|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
105862971|NCT00996892|365148136|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862972|NCT00996892|365148137|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
105862973|NCT00996892|365148118|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
105862974|NCT00996892|365148119|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
105862975|NCT00996892|365148120|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
105862976|NCT00996892|365148121|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
105862977|NCT00996892|365148122|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
105862978|NCT00996892|365148123|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
105862979|NCT00996892|365148124|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
105862980|NCT00996892|365148125|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
105862981|NCT00996892|365148126|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
105862982|NCT00996892|365148127|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
105862983|NCT00996892|365148128|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
105862984|NCT00996892|365148129|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
105862985|NCT00996892|365148130|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
105862986|NCT00996892|365148131|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
105862987|NCT00996892|365148132|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
105862988|NCT00996892|365148133|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
105862989|NCT00996892|365148134|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
105862990|NCT00996892|365148135|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
105862991|NCT00996892|365148136|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
105862992|NCT00996892|365148137|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
105862993|NCT00996892|365148118|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
105862994|NCT00996892|365148119|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
105862995|NCT00996892|365148120|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
105862996|NCT00996892|365148121|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
105862997|NCT00996892|365148122|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
105862998|NCT00996892|365148123|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
105862999|NCT00996892|365148124|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
105863000|NCT00996892|365148125|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
105863001|NCT00996892|365148126|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
105863002|NCT00996892|365148127|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
105863003|NCT00996892|365148128|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
105863004|NCT00996892|365148129|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
105863005|NCT00996892|365148130|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
105863006|NCT00996892|365148131|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
105863007|NCT00996892|365148132|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
105863008|NCT00996892|365148133|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
105863009|NCT00996892|365148134|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
105863010|NCT00996892|365148135|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
105863011|NCT00996892|365148136|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
105863012|NCT00996892|365148137|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
105863013|NCT00996892|365148118|FG000|Dose-Escalation Stage 1A|Death|0|||
105863014|NCT00996892|365148119|FG001|Dose-Escalation Stage 1A|Death|0|||
105863015|NCT00996892|365148120|FG002|Dose-Escalation Stage 1A|Death|0|||
105863016|NCT00996892|365148121|FG003|Dose-Escalation Stage 1A|Death|0|||
105863017|NCT00996892|365148122|FG004|Dose-Escalation Stage 1A|Death|0|||
105863018|NCT00996892|365148123|FG005|Dose-Escalation Stage 1A|Death|0|||
105863019|NCT00996892|365148124|FG006|Dose-Escalation Stage 1A|Death|0|||
105863020|NCT00996892|365148125|FG007|Dose-Escalation Stage 1A|Death|0|||
105863021|NCT00996892|365148126|FG008|Dose-Escalation Stage 1A|Death|0|||
105863022|NCT00996892|365148127|FG009|Dose-Escalation Stage 1A|Death|2|||
105863023|NCT00996892|365148128|FG010|Dose-Escalation Stage 1A|Death|0|||
105863024|NCT00996892|365148129|FG011|Dose-Escalation Stage 1A|Death|1|||
105863025|NCT00996892|365148130|FG012|Dose-Escalation Stage 1A|Death|1|||
105863026|NCT00996892|365148131|FG013|Dose-Escalation Stage 1A|Death|0|||
105863027|NCT00996892|365148132|FG014|Dose-Escalation Stage 1A|Death|0|||
105863028|NCT00996892|365148133|FG015|Dose-Escalation Stage 1A|Death|0|||
105863029|NCT00996892|365148134|FG016|Dose-Escalation Stage 1A|Death|0|||
105863030|NCT00996892|365148135|FG017|Dose-Escalation Stage 1A|Death|0|||
105863031|NCT00996892|365148136|FG018|Dose-Escalation Stage 1A|Death|0|||
105863032|NCT00996892|365148137|FG019|Dose-Escalation Stage 1A|Death|0|||
105863033|NCT00996892|365148118|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
105863034|NCT00996892|365148119|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
105863035|NCT00996892|365148120|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
105863036|NCT00996892|365148121|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
105863037|NCT00996892|365148122|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
105863038|NCT00996892|365148123|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
105863039|NCT00996892|365148124|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
105863040|NCT00996892|365148125|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
105863041|NCT00996892|365148126|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
106048263|NCT03673046|365842135|FG000|Overall Study|Adverse Event|1|||
106048264|NCT03673046|365842136|FG001|Overall Study|Adverse Event|1|||
106048265|NCT03673046|365842135|FG000|Overall Study|Withdrawal by Subject|8|||
106048266|NCT03673046|365842136|FG001|Overall Study|Withdrawal by Subject|2|||
106048267|NCT03817879|365842137|FG000|Overall Study|Drop out|5|||
106048268|NCT03817879|365842138|FG001|Overall Study|Drop out|12|||
106048269|NCT03817879|365842137|FG000|Overall Study|Withdrawal by Subject|0|||
106048270|NCT03817879|365842138|FG001|Overall Study|Withdrawal by Subject|1|||
106048271|NCT01896050|365842141|FG000|Overall Study|Adverse Event|37|||
106048272|NCT01896050|365842142|FG001|Overall Study|Adverse Event|2|||
106048273|NCT01896050|365842141|FG000|Overall Study|Death|1|||
106048274|NCT01896050|365842142|FG001|Overall Study|Death|0|||
106048275|NCT03693300|365842143|FG000|Overall Study|Withdrawal by Subject|6|||
106048276|NCT03693300|365842144|FG001|Overall Study|Withdrawal by Subject|0|||
106048277|NCT03693300|365842143|FG000|Overall Study|Death|50|||
106048278|NCT03693300|365842144|FG001|Overall Study|Death|2|||
106048279|NCT03693300|365842143|FG000|Overall Study|Lost to Follow-up|2|||
106048280|NCT03693300|365842144|FG001|Overall Study|Lost to Follow-up|0|||
106048281|NCT00150709|365842148|FG000|Overall Study|Protocol Violation|7|||
106048282|NCT00150709|365842149|FG001|Overall Study|Protocol Violation|8|||
106048283|NCT00150709|365842150|FG002|Overall Study|Protocol Violation|3|||
106048284|NCT00150709|365842151|FG003|Overall Study|Protocol Violation|1|||
106048285|NCT00150709|365842148|FG000|Overall Study|Adverse Event|8|||
106048286|NCT00150709|365842149|FG001|Overall Study|Adverse Event|2|||
106048287|NCT00150709|365842150|FG002|Overall Study|Adverse Event|2|||
106048288|NCT00150709|365842151|FG003|Overall Study|Adverse Event|3|||
106048289|NCT00150709|365842148|FG000|Overall Study|Lack of Efficacy|6|||
106048290|NCT00150709|365842149|FG001|Overall Study|Lack of Efficacy|11|||
106048291|NCT00150709|365842150|FG002|Overall Study|Lack of Efficacy|9|||
106048292|NCT00150709|365842151|FG003|Overall Study|Lack of Efficacy|0|||
106048293|NCT00150709|365842148|FG000|Overall Study|Withdrawal by Subject|7|||
106048294|NCT00150709|365842149|FG001|Overall Study|Withdrawal by Subject|10|||
106048295|NCT00150709|365842150|FG002|Overall Study|Withdrawal by Subject|5|||
106048296|NCT00150709|365842151|FG003|Overall Study|Withdrawal by Subject|0|||
106048297|NCT00150709|365842148|FG000|Overall Study|Lost to Follow-up|3|||
106048298|NCT00150709|365842149|FG001|Overall Study|Lost to Follow-up|2|||
106048299|NCT00150709|365842150|FG002|Overall Study|Lost to Follow-up|0|||
106048300|NCT00150709|365842151|FG003|Overall Study|Lost to Follow-up|0|||
106048301|NCT00150709|365842148|FG000|Overall Study|Sponsor decision|0|||
106048302|NCT00150709|365842149|FG001|Overall Study|Sponsor decision|0|||
106048303|NCT00150709|365842150|FG002|Overall Study|Sponsor decision|0|||
106048304|NCT00150709|365842151|FG003|Overall Study|Sponsor decision|1|||
106048305|NCT00150709|365842148|FG000|Overall Study|Site/Investigator discontinued the study|5|||
106048306|NCT00150709|365842149|FG001|Overall Study|Site/Investigator discontinued the study|5|||
106048307|NCT00150709|365842150|FG002|Overall Study|Site/Investigator discontinued the study|2|||
106048308|NCT00150709|365842151|FG003|Overall Study|Site/Investigator discontinued the study|0|||
106048309|NCT00150709|365842148|FG000|Overall Study|Decision of parent(s)|1|||
106048310|NCT00150709|365842149|FG001|Overall Study|Decision of parent(s)|2|||
106048311|NCT00150709|365842150|FG002|Overall Study|Decision of parent(s)|0|||
106048312|NCT00150709|365842151|FG003|Overall Study|Decision of parent(s)|0|||
106048313|NCT00150709|365842148|FG000|Overall Study|Decision of parent(s) and investigator|3|||
106048314|NCT00150709|365842149|FG001|Overall Study|Decision of parent(s) and investigator|0|||
106048315|NCT00150709|365842150|FG002|Overall Study|Decision of parent(s) and investigator|0|||
106048316|NCT00150709|365842151|FG003|Overall Study|Decision of parent(s) and investigator|0|||
106048317|NCT00150709|365842148|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
106048318|NCT00150709|365842149|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
106048319|NCT00150709|365842150|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
106048320|NCT00150709|365842151|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
106048321|NCT00150709|365842148|FG000|Overall Study|Investigator decision|1|||
106048322|NCT00150709|365842149|FG001|Overall Study|Investigator decision|0|||
106048323|NCT00150709|365842150|FG002|Overall Study|Investigator decision|0|||
106048324|NCT00150709|365842151|FG003|Overall Study|Investigator decision|1|||
106048325|NCT00150709|365842148|FG000|Overall Study|Subject relocated|2|||
106048326|NCT00150709|365842149|FG001|Overall Study|Subject relocated|2|||
106048327|NCT00150709|365842150|FG002|Overall Study|Subject relocated|1|||
106048328|NCT00150709|365842151|FG003|Overall Study|Subject relocated|0|||
106048329|NCT00150709|365842148|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
106048330|NCT00150709|365842149|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
106048331|NCT00150709|365842150|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
106048332|NCT00150709|365842151|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
106048333|NCT00150709|365842148|FG000|Overall Study|Convenience|0|||
106048334|NCT00150709|365842149|FG001|Overall Study|Convenience|1|||
106048335|NCT00150709|365842150|FG002|Overall Study|Convenience|0|||
106048336|NCT00150709|365842151|FG003|Overall Study|Convenience|0|||
106048337|NCT00150709|365842148|FG000|Overall Study|Subject entered new drug study|0|||
106048338|NCT00150709|365842149|FG001|Overall Study|Subject entered new drug study|1|||
106048339|NCT00150709|365842150|FG002|Overall Study|Subject entered new drug study|0|||
106048340|NCT00150709|365842151|FG003|Overall Study|Subject entered new drug study|0|||
106048341|NCT00150709|365842148|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
106048342|NCT00150709|365842149|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
106048343|NCT00150709|365842150|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
106048344|NCT00150709|365842151|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
106048345|NCT00150709|365842148|FG000|Overall Study|Lack of ease of swallowing|0|||
106048346|NCT00150709|365842149|FG001|Overall Study|Lack of ease of swallowing|1|||
106048347|NCT00150709|365842150|FG002|Overall Study|Lack of ease of swallowing|0|||
106048348|NCT00150709|365842151|FG003|Overall Study|Lack of ease of swallowing|0|||
106048349|NCT00825682|365842152|FG000|Overall Study|personal reasons/ inconvenience|13|||
106048350|NCT00825682|365842153|FG001|Overall Study|personal reasons/ inconvenience|5|||
106048351|NCT00866788|365842154|FG000|Overall Study|Adverse Event|0|||
106048352|NCT00866788|365842155|FG001|Overall Study|Adverse Event|2|||
106048353|NCT00866788|365842156|FG002|Overall Study|Adverse Event|0|||
106048354|NCT00866788|365842157|FG003|Overall Study|Adverse Event|1|||
106048355|NCT00866788|365842154|FG000|Overall Study|Lost to Follow-up|1|||
106048356|NCT00866788|365842155|FG001|Overall Study|Lost to Follow-up|1|||
106048357|NCT00866788|365842156|FG002|Overall Study|Lost to Follow-up|0|||
106048358|NCT00866788|365842157|FG003|Overall Study|Lost to Follow-up|2|||
106048359|NCT00866788|365842154|FG000|Overall Study|Withdrawal by Subject|2|||
106048360|NCT00866788|365842155|FG001|Overall Study|Withdrawal by Subject|1|||
106048361|NCT00866788|365842156|FG002|Overall Study|Withdrawal by Subject|0|||
106048362|NCT00866788|365842157|FG003|Overall Study|Withdrawal by Subject|1|||
106048363|NCT00866788|365842154|FG000|Overall Study|Pregnancy|0|||
106048364|NCT00866788|365842155|FG001|Overall Study|Pregnancy|1|||
106048365|NCT00866788|365842156|FG002|Overall Study|Pregnancy|0|||
106048366|NCT00866788|365842157|FG003|Overall Study|Pregnancy|0|||
106048367|NCT00866788|365842154|FG000|Overall Study|Disease progression|3|||
106048368|NCT00866788|365842155|FG001|Overall Study|Disease progression|1|||
106048369|NCT00866788|365842156|FG002|Overall Study|Disease progression|1|||
106048370|NCT00866788|365842157|FG003|Overall Study|Disease progression|0|||
106048371|NCT00866788|365842154|FG000|Overall Study|Physician Decision|0|||
106048372|NCT00866788|365842155|FG001|Overall Study|Physician Decision|0|||
106048373|NCT00866788|365842156|FG002|Overall Study|Physician Decision|1|||
106048374|NCT00866788|365842157|FG003|Overall Study|Physician Decision|1|||
106048375|NCT03689530|365842162|FG000|Overall Study|Withdrawal by Subject|53|||
106048376|NCT03689530|365842163|FG001|Overall Study|Withdrawal by Subject|16|||
106048377|NCT01392443|365842165|FG000|Overall Study|Disease progression|30|||
106048378|NCT01392443|365842165|FG000|Overall Study|Adverse Event|24|||
106048379|NCT01392443|365842165|FG000|Overall Study|Death|7|||
106048380|NCT01392443|365842165|FG000|Overall Study|Withdrawal by Subject|5|||
106048381|NCT01392443|365842165|FG000|Overall Study|Lost to Follow-up|1|||
106048382|NCT01392443|365842165|FG000|Overall Study|Protocol Violation|1|||
106048383|NCT01977794|365842168|FG000|Overall Study|Adverse Event|2|||
106048384|NCT01977794|365842169|FG001|Overall Study|Adverse Event|2|||
106048385|NCT01977794|365842168|FG000|Overall Study|Lost to Follow-up|2|||
106048386|NCT01977794|365842169|FG001|Overall Study|Lost to Follow-up|1|||
106048387|NCT01977794|365842168|FG000|Overall Study|Protocol Violation|1|||
106048388|NCT01977794|365842169|FG001|Overall Study|Protocol Violation|0|||
106048389|NCT01977794|365842168|FG000|Overall Study|Death|1|||
106048390|NCT01977794|365842169|FG001|Overall Study|Death|1|||
106048391|NCT01977794|365842168|FG000|Overall Study|Withdrew consent|2|||
106048392|NCT01977794|365842169|FG001|Overall Study|Withdrew consent|1|||
106048393|NCT01977794|365842168|FG000|Overall Study|Other|0|||
106048394|NCT01977794|365842169|FG001|Overall Study|Other|1|||
106048395|NCT00573937|365842172|FG000|Overall Study|Study Terminated|0|||
106048396|NCT00573937|365842173|FG001|Overall Study|Study Terminated|1|||
106048397|NCT02476201|365842174|FG000|Overall Study|Unable to program MPP|9|||
106048398|NCT02476201|365842174|FG000|Overall Study|Study echo not performed|5|||
106048399|NCT02476201|365842174|FG000|Overall Study|Adverse Event|4|||
106048400|NCT02476201|365842174|FG000|Overall Study|Death|2|||
106048401|NCT02476201|365842174|FG000|Overall Study|Lost to Follow-up|2|||
106048402|NCT02476201|365842174|FG000|Overall Study|MPP programmed to OFF|2|||
106048403|NCT02476201|365842174|FG000|Overall Study|Withdrawal by Subject|1|||
106048404|NCT02476201|365842174|FG000|Overall Study|Unsuccessful implant|1|||
106048405|NCT03650556|365842175|FG000|Overall Study|Death|2|||
106048406|NCT03650556|365842175|FG000|Overall Study|Withdrawal by Subject|20|||
106048407|NCT03650556|365842175|FG000|Overall Study|Physician Decision|2|||
106048408|NCT03650556|365842175|FG000|Overall Study|Lost to Follow-up|8|||
106048409|NCT03650556|365842175|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
106048410|NCT03650556|365842175|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
106048411|NCT00491764|365842176|FG000|Overall Study|Adverse Event|1|||
106048412|NCT00491764|365842177|FG001|Overall Study|Adverse Event|2|||
106048413|NCT00491764|365842178|FG002|Overall Study|Adverse Event|4|||
106048414|NCT00491764|365842179|FG003|Overall Study|Adverse Event|4|||
106048415|NCT00491764|365842180|FG004|Overall Study|Adverse Event|0|||
106048416|NCT00491764|365842181|FG005|Overall Study|Adverse Event|1|||
106048417|NCT00491764|365842176|FG000|Overall Study|Lost to Follow-up|0|||
106048418|NCT00491764|365842177|FG001|Overall Study|Lost to Follow-up|1|||
106048419|NCT00491764|365842178|FG002|Overall Study|Lost to Follow-up|0|||
106048420|NCT00491764|365842179|FG003|Overall Study|Lost to Follow-up|1|||
106048421|NCT00491764|365842180|FG004|Overall Study|Lost to Follow-up|0|||
106048422|NCT00491764|365842181|FG005|Overall Study|Lost to Follow-up|3|||
106048423|NCT00491764|365842176|FG000|Overall Study|Withdrawal by Subject|2|||
106048424|NCT00491764|365842177|FG001|Overall Study|Withdrawal by Subject|3|||
106048425|NCT00491764|365842178|FG002|Overall Study|Withdrawal by Subject|1|||
106048426|NCT00491764|365842179|FG003|Overall Study|Withdrawal by Subject|2|||
106048427|NCT00491764|365842180|FG004|Overall Study|Withdrawal by Subject|2|||
106048428|NCT00491764|365842181|FG005|Overall Study|Withdrawal by Subject|4|||
106048429|NCT00491764|365842176|FG000|Overall Study|Non Compliance with the Protocol|1|||
106048430|NCT00491764|365842177|FG001|Overall Study|Non Compliance with the Protocol|0|||
106048431|NCT00491764|365842178|FG002|Overall Study|Non Compliance with the Protocol|0|||
106048432|NCT00491764|365842179|FG003|Overall Study|Non Compliance with the Protocol|0|||
106048433|NCT00491764|365842180|FG004|Overall Study|Non Compliance with the Protocol|0|||
106048434|NCT00491764|365842181|FG005|Overall Study|Non Compliance with the Protocol|0|||
106048435|NCT00491764|365842176|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
106048436|NCT00491764|365842177|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
106048437|NCT00491764|365842178|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
106048438|NCT00491764|365842179|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
106048439|NCT00491764|365842180|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
106048440|NCT00491764|365842181|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
106048441|NCT00491764|365842176|FG000|Overall Study|Administrative|1|||
106048442|NCT00491764|365842177|FG001|Overall Study|Administrative|0|||
106048443|NCT00491764|365842178|FG002|Overall Study|Administrative|2|||
106048444|NCT00491764|365842179|FG003|Overall Study|Administrative|1|||
106048445|NCT00491764|365842180|FG004|Overall Study|Administrative|0|||
106048446|NCT00491764|365842181|FG005|Overall Study|Administrative|0|||
106048447|NCT01601132|365842182|FG000|Overall Study|Patient withdrew consent|1|||
106048448|NCT01601132|365842182|FG000|Overall Study|Protocol deviation|1|||
106048449|NCT02758171|365842186|FG000|Wash-out|Withdrawal by Subject|1|||
106048450|NCT02758171|365842187|FG001|Wash-out|Withdrawal by Subject|0|||
106048451|NCT02758171|365842186|FG000|Wash-out|Other reason|1|||
106048452|NCT02758171|365842187|FG001|Wash-out|Other reason|0|||
106048453|NCT01999114|365842188|FG000|Overall Study|Adverse Event|8|||
106048454|NCT01999114|365842189|FG001|Overall Study|Adverse Event|7|||
106048455|NCT01999114|365842190|FG002|Overall Study|Adverse Event|2|||
106048456|NCT01999114|365842191|FG003|Overall Study|Adverse Event|2|||
106048457|NCT01999114|365842192|FG004|Overall Study|Adverse Event|1|||
106048458|NCT01999114|365842188|FG000|Overall Study|Withdrawal by Subject|0|||
106048459|NCT01999114|365842189|FG001|Overall Study|Withdrawal by Subject|0|||
106048460|NCT01999114|365842190|FG002|Overall Study|Withdrawal by Subject|1|||
106048461|NCT01999114|365842191|FG003|Overall Study|Withdrawal by Subject|0|||
106048462|NCT01999114|365842192|FG004|Overall Study|Withdrawal by Subject|1|||
106048463|NCT01999114|365842188|FG000|Overall Study|Lost to Follow-up|0|||
106048464|NCT01999114|365842189|FG001|Overall Study|Lost to Follow-up|0|||
106048465|NCT01999114|365842190|FG002|Overall Study|Lost to Follow-up|1|||
106048466|NCT01999114|365842191|FG003|Overall Study|Lost to Follow-up|0|||
106048467|NCT01999114|365842192|FG004|Overall Study|Lost to Follow-up|0|||
106048468|NCT01999114|365842188|FG000|Overall Study|Administrative|0|||
106048469|NCT01999114|365842189|FG001|Overall Study|Administrative|0|||
106048470|NCT01999114|365842190|FG002|Overall Study|Administrative|1|||
106048471|NCT01999114|365842191|FG003|Overall Study|Administrative|1|||
106048472|NCT01999114|365842192|FG004|Overall Study|Administrative|2|||
106048473|NCT01189604|365842193|FG000|Overall Study|Impossible to visit|0|||
106048474|NCT01189604|365842194|FG001|Overall Study|Impossible to visit|0|||
106048475|NCT01189604|365842195|FG002|Overall Study|Impossible to visit|0|||
106048476|NCT01189604|365842196|FG003|Overall Study|Impossible to visit|0|||
106048477|NCT01189604|365842197|FG004|Overall Study|Impossible to visit|0|||
106048478|NCT01189604|365842198|FG005|Overall Study|Impossible to visit|1|||
106048479|NCT01189604|365842199|FG006|Overall Study|Impossible to visit|0|||
106048480|NCT01189604|365842193|FG000|Overall Study|Adverse Event|0|||
106048481|NCT01189604|365842194|FG001|Overall Study|Adverse Event|1|||
106048482|NCT01189604|365842195|FG002|Overall Study|Adverse Event|0|||
106048483|NCT01189604|365842196|FG003|Overall Study|Adverse Event|0|||
106048484|NCT01189604|365842197|FG004|Overall Study|Adverse Event|2|||
106048485|NCT01189604|365842198|FG005|Overall Study|Adverse Event|0|||
106048486|NCT01189604|365842199|FG006|Overall Study|Adverse Event|1|||
106048487|NCT01189604|365842193|FG000|Overall Study|Withdrawal by Subject|1|||
106048488|NCT01189604|365842194|FG001|Overall Study|Withdrawal by Subject|0|||
106048489|NCT01189604|365842195|FG002|Overall Study|Withdrawal by Subject|0|||
106048490|NCT01189604|365842196|FG003|Overall Study|Withdrawal by Subject|0|||
106048491|NCT01189604|365842197|FG004|Overall Study|Withdrawal by Subject|0|||
106048492|NCT01189604|365842198|FG005|Overall Study|Withdrawal by Subject|0|||
106048493|NCT01189604|365842199|FG006|Overall Study|Withdrawal by Subject|0|||
106048494|NCT02248701|365842200|FG000|Overall Study|Withdrawal by Subject|2|||
106048495|NCT02248701|365842201|FG001|Overall Study|Withdrawal by Subject|1|||
106048496|NCT02248701|365842200|FG000|Overall Study|Physician Decision|0|||
106048497|NCT02248701|365842201|FG001|Overall Study|Physician Decision|1|||
106048498|NCT02248701|365842200|FG000|Overall Study|Adverse Event|1|||
106048499|NCT02248701|365842201|FG001|Overall Study|Adverse Event|0|||
106048500|NCT02248701|365842200|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
106048501|NCT02248701|365842201|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
106048502|NCT05085730|365842202|FG000|Overall Study|Withdrawal by Subject|4|||
106048503|NCT05085730|365842202|FG000|Overall Study|Physician Decision|1|||
106048504|NCT02038881|365842203|FG000|Overall Study|Withdrawal by Subject|0|||
106048505|NCT02038881|365842204|FG001|Overall Study|Withdrawal by Subject|0|||
106048506|NCT02038881|365842205|FG002|Overall Study|Withdrawal by Subject|1|||
106048507|NCT02038881|365842203|FG000|Overall Study|Lost to Follow-up|2|||
106048508|NCT02038881|365842204|FG001|Overall Study|Lost to Follow-up|0|||
106048509|NCT02038881|365842205|FG002|Overall Study|Lost to Follow-up|0|||
106048510|NCT02038881|365842203|FG000|Overall Study|incarcerated|1|||
106048511|NCT02038881|365842204|FG001|Overall Study|incarcerated|0|||
106048512|NCT02038881|365842205|FG002|Overall Study|incarcerated|0|||
106048513|NCT00333840|365842206|FG000|First-line Treatment Period|Adverse Event|38|||
106048514|NCT00333840|365842207|FG001|First-line Treatment Period|Adverse Event|37|||
106048515|NCT00333840|365842208|FG002|First-line Treatment Period|Adverse Event|0|||
106048516|NCT00333840|365842209|FG003|First-line Treatment Period|Adverse Event|0|||
106048517|NCT00333840|365842206|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
106048518|NCT00333840|365842207|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
106048519|NCT00333840|365842208|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
106048520|NCT00333840|365842209|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
106048521|NCT00333840|365842206|FG000|First-line Treatment Period|Abnormal procedure|2|||
106048522|NCT00333840|365842207|FG001|First-line Treatment Period|Abnormal procedure|0|||
106048523|NCT00333840|365842208|FG002|First-line Treatment Period|Abnormal procedure|0|||
106048524|NCT00333840|365842209|FG003|First-line Treatment Period|Abnormal procedure|0|||
106048525|NCT00333840|365842206|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
106048526|NCT00333840|365842207|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
106048527|NCT00333840|365842208|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
106048528|NCT00333840|365842209|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
106048529|NCT00333840|365842206|FG000|First-line Treatment Period|No longer required study drug|21|||
106048530|NCT00333840|365842207|FG001|First-line Treatment Period|No longer required study drug|8|||
106048531|NCT00333840|365842208|FG002|First-line Treatment Period|No longer required study drug|0|||
106048532|NCT00333840|365842209|FG003|First-line Treatment Period|No longer required study drug|0|||
106048533|NCT00333840|365842206|FG000|First-line Treatment Period|Protocol Violation|17|||
106048534|NCT00333840|365842207|FG001|First-line Treatment Period|Protocol Violation|17|||
106048535|NCT00333840|365842208|FG002|First-line Treatment Period|Protocol Violation|0|||
106048536|NCT00333840|365842209|FG003|First-line Treatment Period|Protocol Violation|0|||
106048537|NCT00333840|365842206|FG000|First-line Treatment Period|Subject withdrew consent|57|||
106048538|NCT00333840|365842207|FG001|First-line Treatment Period|Subject withdrew consent|77|||
106048539|NCT00333840|365842208|FG002|First-line Treatment Period|Subject withdrew consent|0|||
106048540|NCT00333840|365842209|FG003|First-line Treatment Period|Subject withdrew consent|0|||
106048541|NCT00333840|365842206|FG000|First-line Treatment Period|Lost to Follow-up|15|||
106048542|NCT00333840|365842207|FG001|First-line Treatment Period|Lost to Follow-up|6|||
106048543|NCT00333840|365842208|FG002|First-line Treatment Period|Lost to Follow-up|0|||
106048544|NCT00333840|365842209|FG003|First-line Treatment Period|Lost to Follow-up|0|||
106048545|NCT00333840|365842206|FG000|First-line Treatment Period|Administrative problems|12|||
106048546|NCT00333840|365842207|FG001|First-line Treatment Period|Administrative problems|6|||
106048547|NCT00333840|365842208|FG002|First-line Treatment Period|Administrative problems|0|||
106048548|NCT00333840|365842209|FG003|First-line Treatment Period|Administrative problems|0|||
106048549|NCT00333840|365842206|FG000|First-line Treatment Period|Death|19|||
106048550|NCT00333840|365842207|FG001|First-line Treatment Period|Death|2|||
106048551|NCT00333840|365842208|FG002|First-line Treatment Period|Death|0|||
106048552|NCT00333840|365842209|FG003|First-line Treatment Period|Death|0|||
106048553|NCT00333840|365842206|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
106048554|NCT00333840|365842207|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
106048555|NCT00333840|365842208|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
106048556|NCT00333840|365842209|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
106048557|NCT00333840|365842206|FG000|Second-line Treatment Period|Adverse Event|0|||
106048558|NCT00333840|365842207|FG001|Second-line Treatment Period|Adverse Event|0|||
106048559|NCT00333840|365842208|FG002|Second-line Treatment Period|Adverse Event|3|||
106152222|NCT04527146|366217080|FG002|Overall Study|Withdrawal by Subject|7|||
105863042|NCT00996892|365148127|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
105863043|NCT00996892|365148128|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
105863044|NCT00996892|365148129|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
105863045|NCT00996892|365148130|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
105863046|NCT00996892|365148131|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
105863047|NCT00996892|365148132|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
105863048|NCT00996892|365148133|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
105863049|NCT00996892|365148134|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
105863050|NCT00996892|365148135|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
105863051|NCT00996892|365148136|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
105863052|NCT00996892|365148137|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
105863053|NCT00996892|365148118|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863054|NCT00996892|365148119|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863055|NCT00996892|365148120|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863056|NCT00996892|365148121|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863057|NCT00996892|365148122|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863058|NCT00996892|365148123|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863059|NCT00996892|365148124|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863060|NCT00996892|365148125|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863061|NCT00996892|365148126|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863062|NCT00996892|365148127|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
105863063|NCT00996892|365148128|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
105863064|NCT00996892|365148129|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
105863065|NCT00996892|365148130|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
105863066|NCT00996892|365148131|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863067|NCT00996892|365148132|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863068|NCT00996892|365148133|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863069|NCT00996892|365148134|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863070|NCT00996892|365148135|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863071|NCT00996892|365148136|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863072|NCT00996892|365148137|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
105863073|NCT00996892|365148118|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
105863074|NCT00996892|365148119|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
105863075|NCT00996892|365148120|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
105863076|NCT00996892|365148121|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
105863077|NCT00996892|365148122|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
105863078|NCT00996892|365148123|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
105863079|NCT00996892|365148124|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
105863080|NCT00996892|365148125|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
105863081|NCT00996892|365148126|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
105863082|NCT00996892|365148127|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
105863083|NCT00996892|365148128|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
105863084|NCT00996892|365148129|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
105863085|NCT00996892|365148130|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
105863086|NCT00996892|365148131|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
105863087|NCT00996892|365148132|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
105863088|NCT00996892|365148133|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
105863089|NCT00996892|365148134|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
105863090|NCT00996892|365148135|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
105863091|NCT00996892|365148136|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
105863092|NCT00996892|365148137|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
105863093|NCT00996892|365148118|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
105863094|NCT00996892|365148119|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
105863095|NCT00996892|365148120|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
105863096|NCT00996892|365148121|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
105863097|NCT00996892|365148122|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
105863098|NCT00996892|365148123|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
105863099|NCT00996892|365148124|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
105863100|NCT00996892|365148125|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
105863101|NCT00996892|365148126|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
105863102|NCT00996892|365148127|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
105863103|NCT00996892|365148128|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
105863104|NCT00996892|365148129|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
106048560|NCT00333840|365842209|FG003|Second-line Treatment Period|Adverse Event|34|||
105863105|NCT00996892|365148130|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
105863106|NCT00996892|365148131|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
105863107|NCT00996892|365148132|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
105863108|NCT00996892|365148133|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
105863109|NCT00996892|365148134|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
105863110|NCT00996892|365148135|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
105863111|NCT00996892|365148136|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
105863112|NCT00996892|365148137|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
105863113|NCT00996892|365148118|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
105863114|NCT00996892|365148119|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
105863115|NCT00996892|365148120|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
105863116|NCT00996892|365148121|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
105863117|NCT00996892|365148122|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
105863118|NCT00996892|365148123|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
105863119|NCT00996892|365148124|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
105863120|NCT00996892|365148125|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
105863121|NCT00996892|365148126|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
105863122|NCT00996892|365148127|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
105863123|NCT00996892|365148128|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
105863124|NCT00996892|365148129|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
105863125|NCT00996892|365148130|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
105863126|NCT00996892|365148131|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
105863127|NCT00996892|365148132|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
105863128|NCT00996892|365148133|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
105863129|NCT00996892|365148134|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
105863130|NCT00996892|365148135|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
105863131|NCT00996892|365148136|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
105863132|NCT00996892|365148137|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
105863133|NCT00996892|365148118|FG000|Expansion Stage 2|Adverse Event|0|||
105863134|NCT00996892|365148119|FG001|Expansion Stage 2|Adverse Event|0|||
105863135|NCT00996892|365148120|FG002|Expansion Stage 2|Adverse Event|0|||
105863136|NCT00996892|365148121|FG003|Expansion Stage 2|Adverse Event|0|||
105863137|NCT00996892|365148122|FG004|Expansion Stage 2|Adverse Event|0|||
105863138|NCT00996892|365148123|FG005|Expansion Stage 2|Adverse Event|0|||
105863139|NCT00996892|365148124|FG006|Expansion Stage 2|Adverse Event|0|||
105863140|NCT00996892|365148125|FG007|Expansion Stage 2|Adverse Event|0|||
105863141|NCT00996892|365148126|FG008|Expansion Stage 2|Adverse Event|0|||
105863142|NCT00996892|365148127|FG009|Expansion Stage 2|Adverse Event|0|||
106152223|NCT04527146|366217081|FG003|Overall Study|Withdrawal by Subject|16|||
106152224|NCT04527146|366217078|FG000|Overall Study|Lost to Follow-up|13|||
106152225|NCT04527146|366217079|FG001|Overall Study|Lost to Follow-up|9|||
106152226|NCT04527146|366217080|FG002|Overall Study|Lost to Follow-up|16|||
106152227|NCT04527146|366217081|FG003|Overall Study|Lost to Follow-up|13|||
106152228|NCT04527146|366217078|FG000|Overall Study|Death|0|||
106152229|NCT04527146|366217079|FG001|Overall Study|Death|1|||
106152230|NCT04527146|366217080|FG002|Overall Study|Death|1|||
106152231|NCT04527146|366217081|FG003|Overall Study|Death|0|||
106152232|NCT04527146|366217078|FG000|Overall Study|Adverse Event|0|||
106152233|NCT04527146|366217079|FG001|Overall Study|Adverse Event|0|||
106152234|NCT04527146|366217080|FG002|Overall Study|Adverse Event|1|||
106152235|NCT04527146|366217081|FG003|Overall Study|Adverse Event|0|||
106152236|NCT04527146|366217078|FG000|Overall Study|Ineligible after randomization|2|||
106152237|NCT04527146|366217079|FG001|Overall Study|Ineligible after randomization|0|||
106152238|NCT04527146|366217080|FG002|Overall Study|Ineligible after randomization|2|||
106152239|NCT04527146|366217081|FG003|Overall Study|Ineligible after randomization|2|||
106152240|NCT04527146|366217078|FG000|Overall Study|Moved to a different group|6|||
106152241|NCT04527146|366217079|FG001|Overall Study|Moved to a different group|3|||
106152242|NCT04527146|366217080|FG002|Overall Study|Moved to a different group|0|||
106152243|NCT04527146|366217081|FG003|Overall Study|Moved to a different group|2|||
106152244|NCT05107401|366217082|FG000|Overall Study|Lost to Follow-up|13|||
106152245|NCT05107401|366217083|FG001|Overall Study|Lost to Follow-up|12|||
106152246|NCT04878354|366217084|FG000|Overall Study|Adverse Event|4|||
106152247|NCT04878354|366217085|FG001|Overall Study|Adverse Event|13|||
106152248|NCT04878354|366217084|FG000|Overall Study|Withdrawal by Subject|14|||
106152249|NCT04878354|366217085|FG001|Overall Study|Withdrawal by Subject|12|||
106152250|NCT04878354|366217084|FG000|Overall Study|Lost to Follow-up|4|||
106152251|NCT04878354|366217085|FG001|Overall Study|Lost to Follow-up|1|||
106152252|NCT04878354|366217084|FG000|Overall Study|Lack of Efficacy|1|||
106152253|NCT04878354|366217085|FG001|Overall Study|Lack of Efficacy|0|||
106152254|NCT04878354|366217084|FG000|Overall Study|Protocol Violation|0|||
106152255|NCT04878354|366217085|FG001|Overall Study|Protocol Violation|1|||
106152256|NCT04878354|366217084|FG000|Overall Study|"Reason stated as other in CRF"|2|||
106152257|NCT04878354|366217085|FG001|Overall Study|"Reason stated as other in CRF"|3|||
106152258|NCT06194214|366217086|FG000|Overall Study|Adverse Event|1|||
106152259|NCT04608045|366217089|FG000|Overall Study|Physician Decision|1|||
106152260|NCT03517553|366217090|FG000|Overall Study|Withdrawal by Subject|2|||
106152261|NCT04048681|366217091|FG000|Overall Study|family emergency|0|||
106152262|NCT04048681|366217092|FG001|Overall Study|family emergency|0|||
106152263|NCT04048681|366217093|FG002|Overall Study|family emergency|0|||
106152264|NCT04048681|366217094|FG003|Overall Study|family emergency|1|||
106152265|NCT04048681|366217095|FG004|Overall Study|family emergency|0|||
106152266|NCT02647905|366217100|FG000|Overall Study|Lost to Follow-up|1|||
105863143|NCT00996892|365148128|FG010|Expansion Stage 2|Adverse Event|0|||
105863144|NCT00996892|365148129|FG011|Expansion Stage 2|Adverse Event|0|||
106048561|NCT00333840|365842206|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
106048562|NCT00333840|365842207|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
106048563|NCT00333840|365842208|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
106048564|NCT00333840|365842209|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
106048565|NCT00333840|365842206|FG000|Second-line Treatment Period|Abnormal procedure|0|||
106048566|NCT00333840|365842207|FG001|Second-line Treatment Period|Abnormal procedure|0|||
106048567|NCT00333840|365842208|FG002|Second-line Treatment Period|Abnormal procedure|0|||
106048568|NCT00333840|365842209|FG003|Second-line Treatment Period|Abnormal procedure|1|||
106048569|NCT00333840|365842206|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
106048570|NCT00333840|365842207|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
106048571|NCT00333840|365842208|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
106048572|NCT00333840|365842209|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
106048573|NCT00333840|365842206|FG000|Second-line Treatment Period|No longer required study drug|0|||
106048574|NCT00333840|365842207|FG001|Second-line Treatment Period|No longer required study drug|0|||
106048575|NCT00333840|365842208|FG002|Second-line Treatment Period|No longer required study drug|1|||
106048576|NCT00333840|365842209|FG003|Second-line Treatment Period|No longer required study drug|14|||
106048577|NCT00333840|365842206|FG000|Second-line Treatment Period|Protocol Violation|0|||
106048578|NCT00333840|365842207|FG001|Second-line Treatment Period|Protocol Violation|0|||
106048579|NCT00333840|365842208|FG002|Second-line Treatment Period|Protocol Violation|1|||
106048580|NCT00333840|365842209|FG003|Second-line Treatment Period|Protocol Violation|10|||
106048581|NCT00333840|365842206|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
106048582|NCT00333840|365842207|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
106048583|NCT00333840|365842208|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
106048584|NCT00333840|365842209|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
106048585|NCT00333840|365842206|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
106048586|NCT00333840|365842207|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
106048587|NCT00333840|365842208|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
106048588|NCT00333840|365842209|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
106048589|NCT00333840|365842206|FG000|Second-line Treatment Period|Administrative problems|0|||
106048590|NCT00333840|365842207|FG001|Second-line Treatment Period|Administrative problems|0|||
106048591|NCT00333840|365842208|FG002|Second-line Treatment Period|Administrative problems|0|||
106048592|NCT00333840|365842209|FG003|Second-line Treatment Period|Administrative problems|7|||
106048593|NCT00333840|365842206|FG000|Second-line Treatment Period|Death|0|||
106048594|NCT00333840|365842207|FG001|Second-line Treatment Period|Death|0|||
106048595|NCT00333840|365842208|FG002|Second-line Treatment Period|Death|0|||
106048596|NCT00333840|365842209|FG003|Second-line Treatment Period|Death|9|||
106048597|NCT02357979|365842210|FG000|Overall Study|Lost to Follow-up|5|||
106048598|NCT02357979|365842211|FG001|Overall Study|Lost to Follow-up|5|||
106048599|NCT00845858|365842212|FG000|Overall Study|Withdrawal by Subject|5|||
106048600|NCT00845858|365842213|FG001|Overall Study|Withdrawal by Subject|1|||
106048601|NCT00845858|365842214|FG002|Overall Study|Withdrawal by Subject|1|||
106048602|NCT00845858|365842212|FG000|Overall Study|Adverse Event|3|||
106048603|NCT00845858|365842213|FG001|Overall Study|Adverse Event|8|||
106048604|NCT00845858|365842214|FG002|Overall Study|Adverse Event|4|||
106048605|NCT00845858|365842212|FG000|Overall Study|Protocol Violation|0|||
106048606|NCT00845858|365842213|FG001|Overall Study|Protocol Violation|0|||
106048607|NCT00845858|365842214|FG002|Overall Study|Protocol Violation|1|||
106048608|NCT00845858|365842212|FG000|Overall Study|not eligible|0|||
106048609|NCT00845858|365842213|FG001|Overall Study|not eligible|3|||
106048610|NCT00845858|365842214|FG002|Overall Study|not eligible|2|||
106048611|NCT03945214|365842215|FG000|Overall Study|Lost to Follow-up|3|||
106048612|NCT03945214|365842216|FG001|Overall Study|Lost to Follow-up|4|||
106048613|NCT03945214|365842217|FG002|Overall Study|Lost to Follow-up|7|||
106048614|NCT03945214|365842218|FG003|Overall Study|Lost to Follow-up|4|||
106048615|NCT00880542|365842222|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
106048616|NCT00880542|365842222|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
106048617|NCT00880542|365842222|FG000|REP: Surgical Resection|progressive disease|1|||
106048618|NCT05047770|365842223|FG000|Overall Study|Withdrawal by Subject|15|||
106048619|NCT05047770|365842224|FG001|Overall Study|Withdrawal by Subject|10|||
106048620|NCT05047770|365842225|FG002|Overall Study|Withdrawal by Subject|6|||
106048621|NCT05047770|365842226|FG003|Overall Study|Withdrawal by Subject|12|||
105863145|NCT00996892|365148130|FG012|Expansion Stage 2|Adverse Event|0|||
105863146|NCT00996892|365148131|FG013|Expansion Stage 2|Adverse Event|0|||
105863147|NCT00996892|365148132|FG014|Expansion Stage 2|Adverse Event|0|||
105863148|NCT00996892|365148133|FG015|Expansion Stage 2|Adverse Event|0|||
105863149|NCT00996892|365148134|FG016|Expansion Stage 2|Adverse Event|0|||
105863150|NCT00996892|365148135|FG017|Expansion Stage 2|Adverse Event|0|||
105863151|NCT00996892|365148136|FG018|Expansion Stage 2|Adverse Event|3|||
105863152|NCT00996892|365148137|FG019|Expansion Stage 2|Adverse Event|0|||
105863153|NCT00996892|365148118|FG000|Expansion Stage 2|Death|0|||
105863154|NCT00996892|365148119|FG001|Expansion Stage 2|Death|0|||
105863155|NCT00996892|365148120|FG002|Expansion Stage 2|Death|0|||
105863156|NCT00996892|365148121|FG003|Expansion Stage 2|Death|0|||
105863157|NCT00996892|365148122|FG004|Expansion Stage 2|Death|0|||
105863158|NCT00996892|365148123|FG005|Expansion Stage 2|Death|0|||
105863159|NCT00996892|365148124|FG006|Expansion Stage 2|Death|0|||
105863160|NCT00996892|365148125|FG007|Expansion Stage 2|Death|0|||
105863161|NCT00996892|365148126|FG008|Expansion Stage 2|Death|0|||
105863162|NCT00996892|365148127|FG009|Expansion Stage 2|Death|0|||
105863163|NCT00996892|365148128|FG010|Expansion Stage 2|Death|0|||
105863164|NCT00996892|365148129|FG011|Expansion Stage 2|Death|0|||
105863165|NCT00996892|365148130|FG012|Expansion Stage 2|Death|0|||
105863166|NCT00996892|365148131|FG013|Expansion Stage 2|Death|0|||
105863167|NCT00996892|365148132|FG014|Expansion Stage 2|Death|0|||
105863168|NCT00996892|365148133|FG015|Expansion Stage 2|Death|0|||
105863169|NCT00996892|365148134|FG016|Expansion Stage 2|Death|0|||
105863170|NCT00996892|365148135|FG017|Expansion Stage 2|Death|0|||
105863171|NCT00996892|365148136|FG018|Expansion Stage 2|Death|2|||
105863172|NCT00996892|365148137|FG019|Expansion Stage 2|Death|0|||
105863173|NCT00996892|365148118|FG000|Expansion Stage 2|Physician Decision|0|||
105863174|NCT00996892|365148119|FG001|Expansion Stage 2|Physician Decision|0|||
105863175|NCT00996892|365148120|FG002|Expansion Stage 2|Physician Decision|0|||
105863176|NCT00996892|365148121|FG003|Expansion Stage 2|Physician Decision|0|||
105863177|NCT00996892|365148122|FG004|Expansion Stage 2|Physician Decision|0|||
105863178|NCT00996892|365148123|FG005|Expansion Stage 2|Physician Decision|0|||
105863179|NCT00996892|365148124|FG006|Expansion Stage 2|Physician Decision|0|||
105863180|NCT00996892|365148125|FG007|Expansion Stage 2|Physician Decision|0|||
105863181|NCT00996892|365148126|FG008|Expansion Stage 2|Physician Decision|0|||
105863182|NCT00996892|365148127|FG009|Expansion Stage 2|Physician Decision|0|||
105863183|NCT00996892|365148128|FG010|Expansion Stage 2|Physician Decision|0|||
105863184|NCT00996892|365148129|FG011|Expansion Stage 2|Physician Decision|0|||
105863185|NCT00996892|365148130|FG012|Expansion Stage 2|Physician Decision|0|||
105863186|NCT00996892|365148131|FG013|Expansion Stage 2|Physician Decision|0|||
105863187|NCT00996892|365148132|FG014|Expansion Stage 2|Physician Decision|0|||
105863188|NCT00996892|365148133|FG015|Expansion Stage 2|Physician Decision|0|||
105863189|NCT00996892|365148134|FG016|Expansion Stage 2|Physician Decision|0|||
105863190|NCT00996892|365148135|FG017|Expansion Stage 2|Physician Decision|0|||
105863191|NCT00996892|365148136|FG018|Expansion Stage 2|Physician Decision|1|||
105863192|NCT00996892|365148137|FG019|Expansion Stage 2|Physician Decision|0|||
105863193|NCT00996892|365148118|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
105863194|NCT00996892|365148119|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
105863195|NCT00996892|365148120|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
105863196|NCT00996892|365148121|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
105863197|NCT00996892|365148122|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
105863198|NCT00996892|365148123|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
105863199|NCT00996892|365148124|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
105863200|NCT00996892|365148125|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
105863201|NCT00996892|365148126|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
105863202|NCT00996892|365148127|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
105863203|NCT00996892|365148128|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
105863204|NCT00996892|365148129|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
105863205|NCT00996892|365148130|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
105863206|NCT00996892|365148131|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
105863207|NCT00996892|365148132|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
105863208|NCT00996892|365148133|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
105863209|NCT00996892|365148134|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
105863210|NCT00996892|365148135|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
105863211|NCT00996892|365148136|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
105863212|NCT00996892|365148137|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
105863213|NCT00996892|365148118|FG000|Expansion Stage 2|Disease Progression|0|||
105863214|NCT00996892|365148119|FG001|Expansion Stage 2|Disease Progression|0|||
105863215|NCT00996892|365148120|FG002|Expansion Stage 2|Disease Progression|0|||
105863216|NCT00996892|365148121|FG003|Expansion Stage 2|Disease Progression|0|||
105863217|NCT00996892|365148122|FG004|Expansion Stage 2|Disease Progression|0|||
106048622|NCT05047770|365842223|FG000|Overall Study|Lost to Follow-up|7|||
105863218|NCT00996892|365148123|FG005|Expansion Stage 2|Disease Progression|0|||
105863219|NCT00996892|365148124|FG006|Expansion Stage 2|Disease Progression|0|||
105863220|NCT00996892|365148125|FG007|Expansion Stage 2|Disease Progression|0|||
106048623|NCT05047770|365842224|FG001|Overall Study|Lost to Follow-up|5|||
106048624|NCT05047770|365842225|FG002|Overall Study|Lost to Follow-up|12|||
106048625|NCT05047770|365842226|FG003|Overall Study|Lost to Follow-up|13|||
106048626|NCT05047770|365842223|FG000|Overall Study|Other|1|||
106048627|NCT05047770|365842224|FG001|Overall Study|Other|0|||
106048628|NCT05047770|365842225|FG002|Overall Study|Other|1|||
106048629|NCT05047770|365842226|FG003|Overall Study|Other|0|||
106048630|NCT00074984|365842227|FG000|Overall Study|Death|1|||
106048631|NCT00074984|365842228|FG001|Overall Study|Death|2|||
106048632|NCT00074984|365842227|FG000|Overall Study|Withdrawal by Subject|2|||
106048633|NCT00074984|365842228|FG001|Overall Study|Withdrawal by Subject|3|||
106048634|NCT00074984|365842227|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
106048635|NCT00074984|365842228|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
106048636|NCT01436396|365842229|FG000|Overall Study|Protocol Violation|7|||
106048637|NCT01436396|365842230|FG001|Overall Study|Protocol Violation|5|||
106048638|NCT01436396|365842229|FG000|Overall Study|Adverse Event|1|||
106048639|NCT01436396|365842230|FG001|Overall Study|Adverse Event|2|||
106048640|NCT01436396|365842229|FG000|Overall Study|Withdrawal by Subject|19|||
106048641|NCT01436396|365842230|FG001|Overall Study|Withdrawal by Subject|29|||
106048642|NCT01436396|365842229|FG000|Overall Study|Serious adverse event|2|||
106048643|NCT01436396|365842230|FG001|Overall Study|Serious adverse event|3|||
106048644|NCT01436396|365842229|FG000|Overall Study|Lost to Follow-up|3|||
106048645|NCT01436396|365842230|FG001|Overall Study|Lost to Follow-up|3|||
106048646|NCT02264639|365842231|FG000|Overall Study|Death (after completing single-dose phase)|1|||
106048647|NCT02264639|365842232|FG001|Overall Study|Death (after completing single-dose phase)|0|||
106048648|NCT02264639|365842233|FG002|Overall Study|Death (after completing single-dose phase)|0|||
106048649|NCT02264639|365842234|FG003|Overall Study|Death (after completing single-dose phase)|0|||
106048650|NCT02264639|365842235|FG004|Overall Study|Death (after completing single-dose phase)|0|||
106048651|NCT02264639|365842231|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
106048652|NCT02264639|365842232|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
106048653|NCT02264639|365842233|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
106048654|NCT02264639|365842234|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
106048655|NCT02264639|365842235|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
106048656|NCT02264639|365842231|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
106048657|NCT02264639|365842232|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
106048658|NCT02264639|365842233|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
106048659|NCT02264639|365842234|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
106048660|NCT02264639|365842235|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
106048661|NCT02264639|365842231|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
106048662|NCT02264639|365842232|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
106048663|NCT02264639|365842233|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
106048664|NCT02264639|365842234|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
106048665|NCT02264639|365842235|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
106048666|NCT01180647|365842236|FG000|Overall Study|Lost to Follow-up|5|||
106048667|NCT01180647|365842237|FG001|Overall Study|Lost to Follow-up|6|||
106048668|NCT00494299|365842238|FG000|Overall Study|Adverse Event|93|||
106048669|NCT00494299|365842239|FG001|Overall Study|Adverse Event|13|||
106048670|NCT00494299|365842238|FG000|Overall Study|Lost to Follow-up|1|||
106048671|NCT00494299|365842239|FG001|Overall Study|Lost to Follow-up|0|||
106048672|NCT00494299|365842238|FG000|Overall Study|Physician Decision|0|||
106048673|NCT00494299|365842239|FG001|Overall Study|Physician Decision|2|||
106048674|NCT00494299|365842238|FG000|Overall Study|Protocol Violation|1|||
106048675|NCT00494299|365842239|FG001|Overall Study|Protocol Violation|2|||
106048676|NCT00494299|365842238|FG000|Overall Study|Withdrawal by Subject|8|||
106048677|NCT00494299|365842239|FG001|Overall Study|Withdrawal by Subject|3|||
106048678|NCT00494299|365842238|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
106048679|NCT00494299|365842239|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
106048680|NCT00494299|365842238|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
106048681|NCT00494299|365842239|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
106048682|NCT00494299|365842238|FG000|Overall Study|Site Closed by Sponsor|6|||
106048683|NCT00494299|365842239|FG001|Overall Study|Site Closed by Sponsor|0|||
106048684|NCT00494299|365842238|FG000|Overall Study|Protocol Driven Decision Point|11|||
106048685|NCT00494299|365842239|FG001|Overall Study|Protocol Driven Decision Point|22|||
106048686|NCT03212690|365842242|FG000|Overall Study|Protocol Violation|1|||
106048687|NCT02345226|365842243|FG000|Double-Blind Phase|Adverse Event|5|||
106048688|NCT02345226|365842244|FG001|Double-Blind Phase|Adverse Event|6|||
106048689|NCT02345226|365842243|FG000|Double-Blind Phase|Death|3|||
106048690|NCT02345226|365842244|FG001|Double-Blind Phase|Death|0|||
106048691|NCT02345226|365842243|FG000|Double-Blind Phase|Pregnancy|0|||
106048692|NCT02345226|365842244|FG001|Double-Blind Phase|Pregnancy|1|||
106048693|NCT02345226|365842243|FG000|Double-Blind Phase|Lack of Efficacy|1|||
106048694|NCT02345226|365842244|FG001|Double-Blind Phase|Lack of Efficacy|0|||
106048695|NCT02345226|365842243|FG000|Double-Blind Phase|Investigator's Discretion|4|||
106048696|NCT02345226|365842244|FG001|Double-Blind Phase|Investigator's Discretion|3|||
106048697|NCT02345226|365842243|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
106048698|NCT02345226|365842244|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
106048699|NCT02345226|365842243|FG000|Double-Blind Phase|Withdrew Consent|41|||
106048700|NCT02345226|365842244|FG001|Double-Blind Phase|Withdrew Consent|39|||
106048701|NCT02345226|365842243|FG000|Double-Blind Phase|Lost to Follow-up|12|||
106048702|NCT02345226|365842244|FG001|Double-Blind Phase|Lost to Follow-up|16|||
106152267|NCT02647905|366217100|FG000|Overall Study|Withdrawal by Subject|2|||
106152268|NCT00792636|366217101|FG000|Overall Study|Protocol Violation|17|||
106152269|NCT00792636|366217102|FG001|Overall Study|Protocol Violation|23|||
106152270|NCT00792636|366217103|FG002|Overall Study|Protocol Violation|20|||
106152271|NCT00792636|366217101|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
106152272|NCT00792636|366217102|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
106152273|NCT00792636|366217103|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
106152274|NCT00792636|366217101|FG000|Overall Study|Lost to Follow-up|13|||
106152275|NCT00792636|366217102|FG001|Overall Study|Lost to Follow-up|19|||
106152276|NCT00792636|366217103|FG002|Overall Study|Lost to Follow-up|14|||
106152277|NCT00792636|366217101|FG000|Overall Study|Withdrew Consent|10|||
106152278|NCT00792636|366217102|FG001|Overall Study|Withdrew Consent|13|||
106152279|NCT00792636|366217103|FG002|Overall Study|Withdrew Consent|9|||
106152280|NCT00792636|366217101|FG000|Overall Study|Lack of Efficacy|3|||
106152281|NCT00792636|366217102|FG001|Overall Study|Lack of Efficacy|4|||
106152282|NCT00792636|366217103|FG002|Overall Study|Lack of Efficacy|13|||
106152283|NCT00792636|366217101|FG000|Overall Study|Adverse Event|4|||
106152284|NCT00792636|366217102|FG001|Overall Study|Adverse Event|2|||
106152285|NCT00792636|366217103|FG002|Overall Study|Adverse Event|3|||
106152286|NCT00792636|366217101|FG000|Overall Study|Investigator Discretion|2|||
106152287|NCT00792636|366217102|FG001|Overall Study|Investigator Discretion|0|||
106152288|NCT00792636|366217103|FG002|Overall Study|Investigator Discretion|2|||
106152289|NCT01046136|366217104|FG000|Overall Study|Withdrawal by Subject|0|||
106152290|NCT01046136|366217105|FG001|Overall Study|Withdrawal by Subject|4|||
106152291|NCT01046136|366217104|FG000|Overall Study|Physician Decision|1|||
106152292|NCT01046136|366217105|FG001|Overall Study|Physician Decision|1|||
106152293|NCT01046136|366217104|FG000|Overall Study|Lost to Follow-up|3|||
106152294|NCT01046136|366217105|FG001|Overall Study|Lost to Follow-up|3|||
106152295|NCT04579250|366217106|FG000|Overall Study|Withdrawal by Subject|1|||
106152296|NCT04579250|366217107|FG001|Overall Study|Withdrawal by Subject|1|||
106152297|NCT04579250|366217108|FG002|Overall Study|Withdrawal by Subject|0|||
106152298|NCT04579250|366217106|FG000|Overall Study|Lost to Follow-up|1|||
106152299|NCT04579250|366217107|FG001|Overall Study|Lost to Follow-up|1|||
105863221|NCT00996892|365148126|FG008|Expansion Stage 2|Disease Progression|0|||
105863222|NCT00996892|365148127|FG009|Expansion Stage 2|Disease Progression|0|||
105863223|NCT00996892|365148128|FG010|Expansion Stage 2|Disease Progression|0|||
105863224|NCT00996892|365148129|FG011|Expansion Stage 2|Disease Progression|0|||
105863225|NCT00996892|365148130|FG012|Expansion Stage 2|Disease Progression|0|||
105863226|NCT00996892|365148131|FG013|Expansion Stage 2|Disease Progression|0|||
105863227|NCT00996892|365148132|FG014|Expansion Stage 2|Disease Progression|0|||
105863228|NCT00996892|365148133|FG015|Expansion Stage 2|Disease Progression|0|||
105863229|NCT00996892|365148134|FG016|Expansion Stage 2|Disease Progression|0|||
105863230|NCT00996892|365148135|FG017|Expansion Stage 2|Disease Progression|0|||
105863231|NCT00996892|365148136|FG018|Expansion Stage 2|Disease Progression|28|||
105863232|NCT00996892|365148137|FG019|Expansion Stage 2|Disease Progression|0|||
105863233|NCT00996892|365148118|FG000|Expansion Stage 2A|Adverse Event|0|||
105863234|NCT00996892|365148119|FG001|Expansion Stage 2A|Adverse Event|0|||
105863235|NCT00996892|365148120|FG002|Expansion Stage 2A|Adverse Event|0|||
105863236|NCT00996892|365148121|FG003|Expansion Stage 2A|Adverse Event|0|||
105863237|NCT00996892|365148122|FG004|Expansion Stage 2A|Adverse Event|0|||
105863238|NCT00996892|365148123|FG005|Expansion Stage 2A|Adverse Event|0|||
105863239|NCT00996892|365148124|FG006|Expansion Stage 2A|Adverse Event|0|||
105863240|NCT00996892|365148125|FG007|Expansion Stage 2A|Adverse Event|0|||
105863241|NCT00996892|365148126|FG008|Expansion Stage 2A|Adverse Event|0|||
105863242|NCT00996892|365148127|FG009|Expansion Stage 2A|Adverse Event|0|||
105863243|NCT00996892|365148128|FG010|Expansion Stage 2A|Adverse Event|0|||
105863244|NCT00996892|365148129|FG011|Expansion Stage 2A|Adverse Event|0|||
105863245|NCT00996892|365148130|FG012|Expansion Stage 2A|Adverse Event|0|||
105863246|NCT00996892|365148131|FG013|Expansion Stage 2A|Adverse Event|0|||
105863247|NCT00996892|365148132|FG014|Expansion Stage 2A|Adverse Event|0|||
105863248|NCT00996892|365148133|FG015|Expansion Stage 2A|Adverse Event|0|||
106152300|NCT04579250|366217108|FG002|Overall Study|Lost to Follow-up|0|||
106152301|NCT04579250|366217106|FG000|Overall Study|Moved from area|0|||
106152302|NCT04579250|366217107|FG001|Overall Study|Moved from area|1|||
106152303|NCT04579250|366217108|FG002|Overall Study|Moved from area|2|||
106152304|NCT02058108|366217109|FG000|Overall Study|Abnormal Laboratory Values|0|||
106152305|NCT02058108|366217110|FG001|Overall Study|Abnormal Laboratory Values|1|||
106152306|NCT02058108|366217109|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
105863249|NCT00996892|365148134|FG016|Expansion Stage 2A|Adverse Event|0|||
105863250|NCT00996892|365148135|FG017|Expansion Stage 2A|Adverse Event|0|||
105863251|NCT00996892|365148136|FG018|Expansion Stage 2A|Adverse Event|0|||
105863252|NCT00996892|365148137|FG019|Expansion Stage 2A|Adverse Event|8|||
105863253|NCT00996892|365148118|FG000|Expansion Stage 2A|Physician Decision|0|||
105863254|NCT00996892|365148119|FG001|Expansion Stage 2A|Physician Decision|0|||
105863255|NCT00996892|365148120|FG002|Expansion Stage 2A|Physician Decision|0|||
105863256|NCT00996892|365148121|FG003|Expansion Stage 2A|Physician Decision|0|||
105863257|NCT00996892|365148122|FG004|Expansion Stage 2A|Physician Decision|0|||
105863258|NCT00996892|365148123|FG005|Expansion Stage 2A|Physician Decision|0|||
105863259|NCT00996892|365148124|FG006|Expansion Stage 2A|Physician Decision|0|||
105863260|NCT00996892|365148125|FG007|Expansion Stage 2A|Physician Decision|0|||
105863261|NCT00996892|365148126|FG008|Expansion Stage 2A|Physician Decision|0|||
105863262|NCT00996892|365148127|FG009|Expansion Stage 2A|Physician Decision|0|||
105863263|NCT00996892|365148128|FG010|Expansion Stage 2A|Physician Decision|0|||
105863264|NCT00996892|365148129|FG011|Expansion Stage 2A|Physician Decision|0|||
105863265|NCT00996892|365148130|FG012|Expansion Stage 2A|Physician Decision|0|||
105863266|NCT00996892|365148131|FG013|Expansion Stage 2A|Physician Decision|0|||
105863267|NCT00996892|365148132|FG014|Expansion Stage 2A|Physician Decision|0|||
105863268|NCT00996892|365148133|FG015|Expansion Stage 2A|Physician Decision|0|||
105863269|NCT00996892|365148134|FG016|Expansion Stage 2A|Physician Decision|0|||
105863270|NCT00996892|365148135|FG017|Expansion Stage 2A|Physician Decision|0|||
105863271|NCT00996892|365148136|FG018|Expansion Stage 2A|Physician Decision|0|||
105863272|NCT00996892|365148137|FG019|Expansion Stage 2A|Physician Decision|2|||
105863273|NCT00996892|365148118|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
105863274|NCT00996892|365148119|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
105863275|NCT00996892|365148120|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
105863276|NCT00996892|365148121|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
105863277|NCT00996892|365148122|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
105863278|NCT00996892|365148123|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
105863279|NCT00996892|365148124|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
105863280|NCT00996892|365148125|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
105863281|NCT00996892|365148126|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
105863282|NCT00996892|365148127|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
105863283|NCT00996892|365148128|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
105863284|NCT00996892|365148129|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
105863285|NCT00996892|365148130|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
105863286|NCT00996892|365148131|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
105863287|NCT00996892|365148132|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
105863288|NCT00996892|365148133|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
105863289|NCT00996892|365148134|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
105863290|NCT00996892|365148135|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
105863291|NCT00996892|365148136|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
105863292|NCT00996892|365148137|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
105863293|NCT00996892|365148118|FG000|Expansion Stage 2A|Disease Progression|0|||
105863294|NCT00996892|365148119|FG001|Expansion Stage 2A|Disease Progression|0|||
105863295|NCT00996892|365148120|FG002|Expansion Stage 2A|Disease Progression|0|||
105863296|NCT00996892|365148121|FG003|Expansion Stage 2A|Disease Progression|0|||
105863297|NCT00996892|365148122|FG004|Expansion Stage 2A|Disease Progression|0|||
105863298|NCT00996892|365148123|FG005|Expansion Stage 2A|Disease Progression|0|||
105863299|NCT00996892|365148124|FG006|Expansion Stage 2A|Disease Progression|0|||
105863300|NCT00996892|365148125|FG007|Expansion Stage 2A|Disease Progression|0|||
105863301|NCT00996892|365148126|FG008|Expansion Stage 2A|Disease Progression|0|||
105863302|NCT00996892|365148127|FG009|Expansion Stage 2A|Disease Progression|0|||
105863303|NCT00996892|365148128|FG010|Expansion Stage 2A|Disease Progression|0|||
105863304|NCT00996892|365148129|FG011|Expansion Stage 2A|Disease Progression|0|||
105863305|NCT00996892|365148130|FG012|Expansion Stage 2A|Disease Progression|0|||
105863306|NCT00996892|365148131|FG013|Expansion Stage 2A|Disease Progression|0|||
105863307|NCT00996892|365148132|FG014|Expansion Stage 2A|Disease Progression|0|||
105863308|NCT00996892|365148133|FG015|Expansion Stage 2A|Disease Progression|0|||
105863309|NCT00996892|365148134|FG016|Expansion Stage 2A|Disease Progression|0|||
105863310|NCT00996892|365148135|FG017|Expansion Stage 2A|Disease Progression|0|||
105863311|NCT00996892|365148136|FG018|Expansion Stage 2A|Disease Progression|0|||
105863312|NCT00996892|365148137|FG019|Expansion Stage 2A|Disease Progression|31|||
105863313|NCT01653912|365148138|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105863314|NCT01653912|365148139|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
105863315|NCT01653912|365148140|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105863316|NCT01653912|365148141|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105863317|NCT01653912|365148142|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105863318|NCT01653912|365148143|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
105863319|NCT01653912|365148138|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105863320|NCT01653912|365148139|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105863321|NCT01653912|365148140|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
105863322|NCT01653912|365148141|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105863323|NCT01653912|365148142|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105863324|NCT01653912|365148143|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
105863325|NCT01653912|365148138|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
106048703|NCT02345226|365842243|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
106048704|NCT02345226|365842244|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
106048705|NCT02345226|365842243|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
106048706|NCT02345226|365842244|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
106048707|NCT03540030|365842250|FG000|Overall Study|Withdrawal by Subject|2|||
106048708|NCT03540030|365842251|FG001|Overall Study|Withdrawal by Subject|1|||
106048709|NCT03540030|365842250|FG000|Overall Study|screen fail|7|||
106048710|NCT03540030|365842251|FG001|Overall Study|screen fail|1|||
106048711|NCT03540030|365842250|FG000|Overall Study|never had surgery after signing consent|9|||
106048712|NCT03540030|365842251|FG001|Overall Study|never had surgery after signing consent|1|||
106048713|NCT03307785|365842252|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
106048714|NCT03307785|365842253|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
106048715|NCT03307785|365842254|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
106048716|NCT03307785|365842255|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
106048717|NCT03307785|365842256|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
106048718|NCT03307785|365842257|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
106048719|NCT03307785|365842258|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
106048720|NCT03307785|365842259|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
106048721|NCT03307785|365842260|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
106048722|NCT03307785|365842261|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
106048723|NCT03307785|365842262|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
106048724|NCT03307785|365842252|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
106048725|NCT03307785|365842253|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
106048726|NCT03307785|365842254|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048727|NCT03307785|365842255|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048728|NCT03307785|365842256|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048729|NCT03307785|365842257|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048730|NCT03307785|365842258|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048731|NCT03307785|365842259|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048732|NCT03307785|365842260|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048733|NCT03307785|365842261|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048734|NCT03307785|365842262|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
106048735|NCT03307785|365842252|FG000|Part A: Up to 28.5 Months|Death|4|||
106048736|NCT03307785|365842253|FG001|Part A: Up to 28.5 Months|Death|4|||
106048737|NCT03307785|365842254|FG002|Part A: Up to 28.5 Months|Death|0|||
106048738|NCT03307785|365842255|FG003|Part A: Up to 28.5 Months|Death|0|||
106048739|NCT03307785|365842256|FG004|Part A: Up to 28.5 Months|Death|0|||
106048740|NCT03307785|365842257|FG005|Part A: Up to 28.5 Months|Death|0|||
106048741|NCT03307785|365842258|FG006|Part A: Up to 28.5 Months|Death|0|||
106048742|NCT03307785|365842259|FG007|Part A: Up to 28.5 Months|Death|0|||
106048743|NCT03307785|365842260|FG008|Part A: Up to 28.5 Months|Death|0|||
106048744|NCT03307785|365842261|FG009|Part A: Up to 28.5 Months|Death|0|||
106048745|NCT03307785|365842262|FG010|Part A: Up to 28.5 Months|Death|0|||
106048746|NCT03307785|365842252|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
106048747|NCT03307785|365842253|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
106048748|NCT03307785|365842254|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
106048749|NCT03307785|365842255|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
106048750|NCT03307785|365842256|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
106048751|NCT03307785|365842257|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
106048752|NCT03307785|365842258|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
106048753|NCT03307785|365842259|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
106048754|NCT03307785|365842260|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
106048755|NCT03307785|365842261|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
106048756|NCT03307785|365842262|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
106048757|NCT03307785|365842252|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
106048758|NCT03307785|365842253|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
106048759|NCT03307785|365842254|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
106152307|NCT02058108|366217110|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
106152308|NCT02058108|366217109|FG000|Overall Study|No longer requires study drug|0|||
106152309|NCT02058108|366217110|FG001|Overall Study|No longer requires study drug|1|||
106152310|NCT02058108|366217109|FG000|Overall Study|Withdrawal by Subject|1|||
106048760|NCT03307785|365842255|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
106048761|NCT03307785|365842256|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
106048762|NCT03307785|365842257|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
106048763|NCT03307785|365842258|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
106152311|NCT02058108|366217110|FG001|Overall Study|Withdrawal by Subject|0|||
106152312|NCT02058108|366217109|FG000|Overall Study|Administrative problems|3|||
105863326|NCT01653912|365148139|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
106048764|NCT03307785|365842259|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
106048765|NCT03307785|365842260|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
106152313|NCT02058108|366217110|FG001|Overall Study|Administrative problems|3|||
106152314|NCT02058108|366217109|FG000|Overall Study|Protocol Violation|0|||
106048766|NCT03307785|365842261|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
106048767|NCT03307785|365842262|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
106048768|NCT03307785|365842252|FG000|Part B: Up to Approx. 66 Months|Death|0|||
106048769|NCT03307785|365842253|FG001|Part B: Up to Approx. 66 Months|Death|0|||
106048770|NCT03307785|365842254|FG002|Part B: Up to Approx. 66 Months|Death|7|||
106048771|NCT03307785|365842255|FG003|Part B: Up to Approx. 66 Months|Death|0|||
106048772|NCT03307785|365842256|FG004|Part B: Up to Approx. 66 Months|Death|0|||
106048773|NCT03307785|365842257|FG005|Part B: Up to Approx. 66 Months|Death|0|||
106048774|NCT03307785|365842258|FG006|Part B: Up to Approx. 66 Months|Death|0|||
106048775|NCT03307785|365842259|FG007|Part B: Up to Approx. 66 Months|Death|0|||
106048776|NCT03307785|365842260|FG008|Part B: Up to Approx. 66 Months|Death|0|||
106048777|NCT03307785|365842261|FG009|Part B: Up to Approx. 66 Months|Death|0|||
106048778|NCT03307785|365842262|FG010|Part B: Up to Approx. 66 Months|Death|0|||
106048779|NCT03307785|365842252|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048780|NCT03307785|365842253|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048781|NCT03307785|365842254|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
106048782|NCT03307785|365842255|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048783|NCT03307785|365842256|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048784|NCT03307785|365842257|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048785|NCT03307785|365842258|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048786|NCT03307785|365842259|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048787|NCT03307785|365842260|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048788|NCT03307785|365842261|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048789|NCT03307785|365842262|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
106048790|NCT03307785|365842252|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048791|NCT03307785|365842253|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048792|NCT03307785|365842254|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
106048793|NCT03307785|365842255|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048794|NCT03307785|365842256|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048795|NCT03307785|365842257|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048796|NCT03307785|365842258|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048797|NCT03307785|365842259|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048798|NCT03307785|365842260|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048799|NCT03307785|365842261|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048800|NCT03307785|365842262|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
106048801|NCT03307785|365842252|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048802|NCT03307785|365842253|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048803|NCT03307785|365842254|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
106048804|NCT03307785|365842255|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048805|NCT03307785|365842256|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048806|NCT03307785|365842257|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048807|NCT03307785|365842258|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048808|NCT03307785|365842259|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048809|NCT03307785|365842260|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048810|NCT03307785|365842261|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048811|NCT03307785|365842262|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
106048812|NCT03307785|365842252|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048813|NCT03307785|365842253|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048814|NCT03307785|365842254|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048815|NCT03307785|365842255|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
106048816|NCT03307785|365842256|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
106048817|NCT03307785|365842257|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048818|NCT03307785|365842258|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048819|NCT03307785|365842259|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048820|NCT03307785|365842260|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048821|NCT03307785|365842261|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048822|NCT03307785|365842262|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
106048823|NCT03307785|365842252|FG000|Part C: Up to Approx. 60 Months|Death|0|||
106048824|NCT03307785|365842253|FG001|Part C: Up to Approx. 60 Months|Death|0|||
106048825|NCT03307785|365842254|FG002|Part C: Up to Approx. 60 Months|Death|0|||
106048826|NCT03307785|365842255|FG003|Part C: Up to Approx. 60 Months|Death|2|||
106048827|NCT03307785|365842256|FG004|Part C: Up to Approx. 60 Months|Death|5|||
106048828|NCT03307785|365842257|FG005|Part C: Up to Approx. 60 Months|Death|0|||
106048829|NCT03307785|365842258|FG006|Part C: Up to Approx. 60 Months|Death|0|||
106152315|NCT02058108|366217110|FG001|Overall Study|Protocol Violation|1|||
105863327|NCT01653912|365148140|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
105863328|NCT01653912|365148141|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
105863329|NCT01653912|365148142|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
105863330|NCT01653912|365148143|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
105863331|NCT01653912|365148138|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863332|NCT01653912|365148139|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863333|NCT01653912|365148140|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863334|NCT01653912|365148141|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
105863335|NCT01653912|365148142|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863336|NCT01653912|365148143|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863337|NCT01653912|365148138|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105863338|NCT01653912|365148139|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105863339|NCT01653912|365148140|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105863340|NCT01653912|365148141|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105863341|NCT01653912|365148142|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
105863342|NCT01653912|365148143|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
105863343|NCT01653912|365148138|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105863344|NCT01653912|365148139|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105863345|NCT01653912|365148140|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105863346|NCT01653912|365148141|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105863347|NCT01653912|365148142|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
105863348|NCT01653912|365148143|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
105863349|NCT01653912|365148138|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863350|NCT01653912|365148139|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863351|NCT01653912|365148140|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863352|NCT01653912|365148141|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863353|NCT01653912|365148142|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
105863354|NCT01653912|365148143|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
105863355|NCT03654599|365148144|FG000|Overall Study|Lost to Follow-up|14|||
105863356|NCT03654599|365148145|FG001|Overall Study|Lost to Follow-up|12|||
105863357|NCT03654599|365148144|FG000|Overall Study|Death|8|||
105863358|NCT03654599|365148145|FG001|Overall Study|Death|6|||
105863359|NCT03654599|365148144|FG000|Overall Study|Withdrawal by Subject|6|||
105863360|NCT03654599|365148145|FG001|Overall Study|Withdrawal by Subject|4|||
105863361|NCT05314816|365148147|FG000|Overall Study|Lost to Follow-up|5|||
105863362|NCT05314816|365148148|FG001|Overall Study|Lost to Follow-up|0|||
105863363|NCT05314816|365148149|FG002|Overall Study|Lost to Follow-up|1|||
105863364|NCT05314816|365148147|FG000|Overall Study|Protocol Violation|13|||
105863365|NCT05314816|365148148|FG001|Overall Study|Protocol Violation|8|||
105863366|NCT05314816|365148149|FG002|Overall Study|Protocol Violation|0|||
105863367|NCT02925403|365150402|FG000|Overall Study|Lost to Follow-up|0|||
105863368|NCT02925403|365150403|FG001|Overall Study|Lost to Follow-up|1|||
105863369|NCT00459043|365150404|FG000|Overall Study|Withdrawal by Subject|1|||
105863370|NCT00459043|365150405|FG001|Overall Study|Withdrawal by Subject|0|||
105863371|NCT00369486|365150406|FG000|4-Week Visit|Missed visit|2|||
105863372|NCT00369486|365150407|FG001|4-Week Visit|Missed visit|2|||
105863373|NCT00369486|365150408|FG002|4-Week Visit|Missed visit|0|||
105863374|NCT00369486|365150409|FG003|4-Week Visit|Missed visit|2|||
105863375|NCT00369486|365150410|FG004|4-Week Visit|Missed visit|1|||
105863376|NCT00369486|365150406|FG000|4-Week Visit|Dropped|0|||
105863377|NCT00369486|365150407|FG001|4-Week Visit|Dropped|0|||
105863378|NCT00369486|365150408|FG002|4-Week Visit|Dropped|1|||
105863379|NCT00369486|365150409|FG003|4-Week Visit|Dropped|0|||
105863380|NCT00369486|365150410|FG004|4-Week Visit|Dropped|0|||
105863381|NCT00369486|365150406|FG000|8-Week Visit|Missed visit|0|||
105863382|NCT00369486|365150407|FG001|8-Week Visit|Missed visit|1|||
105863383|NCT00369486|365150408|FG002|8-Week Visit|Missed visit|0|||
105863384|NCT00369486|365150409|FG003|8-Week Visit|Missed visit|0|||
105863385|NCT00369486|365150410|FG004|8-Week Visit|Missed visit|1|||
105863386|NCT00369486|365150406|FG000|8-Week Visit|Dropped|0|||
105863387|NCT00369486|365150407|FG001|8-Week Visit|Dropped|0|||
105863388|NCT00369486|365150408|FG002|8-Week Visit|Dropped|0|||
105863389|NCT00369486|365150409|FG003|8-Week Visit|Dropped|1|||
105863390|NCT00369486|365150410|FG004|8-Week Visit|Dropped|0|||
105863391|NCT00369486|365150406|FG000|17-Week Visit|Missed visit|0|||
105863392|NCT00369486|365150407|FG001|17-Week Visit|Missed visit|0|||
105863393|NCT00369486|365150408|FG002|17-Week Visit|Missed visit|1|||
105863394|NCT00369486|365150409|FG003|17-Week Visit|Missed visit|1|||
105863395|NCT00369486|365150410|FG004|17-Week Visit|Missed visit|1|||
105863396|NCT00369486|365150406|FG000|34-Week Visit|Dropped|0|||
105863397|NCT00369486|365150407|FG001|34-Week Visit|Dropped|1|||
105863398|NCT00369486|365150408|FG002|34-Week Visit|Dropped|1|||
105863399|NCT00369486|365150409|FG003|34-Week Visit|Dropped|3|||
105863400|NCT00369486|365150410|FG004|34-Week Visit|Dropped|3|||
105863401|NCT00270855|365150411|FG000|Overall Study|Withdrawal by Subject|8|||
105863402|NCT00270855|365150412|FG001|Overall Study|Withdrawal by Subject|8|||
105863403|NCT03156504|365150416|FG000|Overall Study|Withdrawal by Subject|1|||
106048830|NCT03307785|365842259|FG007|Part C: Up to Approx. 60 Months|Death|0|||
106048831|NCT03307785|365842260|FG008|Part C: Up to Approx. 60 Months|Death|0|||
106048832|NCT03307785|365842261|FG009|Part C: Up to Approx. 60 Months|Death|0|||
106048833|NCT03307785|365842262|FG010|Part C: Up to Approx. 60 Months|Death|0|||
106048834|NCT03307785|365842252|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048835|NCT03307785|365842253|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048836|NCT03307785|365842254|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048837|NCT03307785|365842255|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
106048838|NCT03307785|365842256|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048839|NCT03307785|365842257|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048840|NCT03307785|365842258|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048841|NCT03307785|365842259|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048842|NCT03307785|365842260|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048843|NCT03307785|365842261|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048844|NCT03307785|365842262|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
106048845|NCT03307785|365842252|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048846|NCT03307785|365842253|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048847|NCT03307785|365842254|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048848|NCT03307785|365842255|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048849|NCT03307785|365842256|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
106048850|NCT03307785|365842257|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048851|NCT03307785|365842258|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048852|NCT03307785|365842259|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048853|NCT03307785|365842260|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048854|NCT03307785|365842261|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048855|NCT03307785|365842262|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
106048856|NCT03307785|365842252|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048857|NCT03307785|365842253|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048858|NCT03307785|365842254|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048859|NCT03307785|365842255|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048860|NCT03307785|365842256|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048861|NCT03307785|365842257|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
106048862|NCT03307785|365842258|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106152316|NCT00727909|366217116|FG000|Overall Study|Withdrawal by Subject|5|||
106152317|NCT00727909|366217117|FG001|Overall Study|Withdrawal by Subject|11|||
106152318|NCT00727909|366217118|FG002|Overall Study|Withdrawal by Subject|8|||
106152319|NCT00727909|366217119|FG003|Overall Study|Withdrawal by Subject|5|||
106152320|NCT00727909|366217116|FG000|Overall Study|Death|0|||
106152321|NCT00727909|366217117|FG001|Overall Study|Death|0|||
106152322|NCT00727909|366217118|FG002|Overall Study|Death|1|||
106152323|NCT00727909|366217119|FG003|Overall Study|Death|0|||
106152324|NCT00411151|366217120|FG000|Overall Study|Death|38|||
106152325|NCT00411151|366217120|FG000|Overall Study|Withdrawal by Subject|2|||
106152326|NCT00411151|366217120|FG000|Overall Study|Lost to Follow-up|2|||
106152327|NCT00411151|366217120|FG000|Overall Study|Protocol Violation|1|||
106152328|NCT00411151|366217120|FG000|Overall Study|Trial prematurely closed|4|||
106152329|NCT03756571|366217121|FG000|Overall Study|Lost to Follow-up|1|||
106152330|NCT03756571|366217122|FG001|Overall Study|Lost to Follow-up|1|||
106152331|NCT00998881|366217123|FG000|Overall Study|Adverse Event|2|||
106152332|NCT00998881|366217124|FG001|Overall Study|Adverse Event|2|||
106152333|NCT00998881|366217123|FG000|Overall Study|Lack of Efficacy|1|||
106152334|NCT00998881|366217124|FG001|Overall Study|Lack of Efficacy|0|||
106152335|NCT00998881|366217123|FG000|Overall Study|Physician Decision|3|||
106152336|NCT00998881|366217124|FG001|Overall Study|Physician Decision|0|||
106152337|NCT00998881|366217123|FG000|Overall Study|Withdrawal by Subject|1|||
106152338|NCT00998881|366217124|FG001|Overall Study|Withdrawal by Subject|0|||
106152339|NCT00998881|366217123|FG000|Overall Study|Personal matter|1|||
106152340|NCT00998881|366217124|FG001|Overall Study|Personal matter|0|||
106152341|NCT01619410|366217125|FG000|Overall Study|Lost to Follow-up|7|||
106152342|NCT01619410|366217126|FG001|Overall Study|Lost to Follow-up|4|||
106152343|NCT02412748|366217128|FG000|Overall Study|Lost to Follow-up|38|||
106152344|NCT02412748|366217129|FG001|Overall Study|Lost to Follow-up|39|||
106152345|NCT02742519|366217132|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
106152346|NCT02742519|366217133|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
106152347|NCT02742519|366217134|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
106152348|NCT02742519|366217132|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
106152349|NCT02742519|366217133|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
106152350|NCT02742519|366217134|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
106152351|NCT02742519|366217132|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
105863404|NCT03452137|365150417|FG000|Overall Study|Death|67|||
106048863|NCT03307785|365842259|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048864|NCT03307785|365842260|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048865|NCT03307785|365842261|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048866|NCT03307785|365842262|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
106048867|NCT03307785|365842252|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
106048868|NCT03307785|365842253|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
106048869|NCT03307785|365842254|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
106048870|NCT03307785|365842255|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
106048871|NCT03307785|365842256|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
106048872|NCT03307785|365842257|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
106048873|NCT03307785|365842258|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
106048874|NCT03307785|365842259|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
106048875|NCT03307785|365842260|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
106048876|NCT03307785|365842261|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
106048877|NCT03307785|365842262|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
106048878|NCT03307785|365842252|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048879|NCT03307785|365842253|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048880|NCT03307785|365842254|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048881|NCT03307785|365842255|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048882|NCT03307785|365842256|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048883|NCT03307785|365842257|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
106048884|NCT03307785|365842258|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048885|NCT03307785|365842259|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048886|NCT03307785|365842260|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048887|NCT03307785|365842261|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048888|NCT03307785|365842262|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
106048889|NCT03307785|365842252|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048890|NCT03307785|365842253|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048891|NCT03307785|365842254|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048892|NCT03307785|365842255|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048893|NCT03307785|365842256|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048894|NCT03307785|365842257|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
106048895|NCT03307785|365842258|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048896|NCT03307785|365842259|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048897|NCT03307785|365842260|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048898|NCT03307785|365842261|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048899|NCT03307785|365842262|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
106048900|NCT03307785|365842252|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048901|NCT03307785|365842253|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048902|NCT03307785|365842254|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048903|NCT03307785|365842255|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048904|NCT03307785|365842256|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048905|NCT03307785|365842257|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
106048906|NCT03307785|365842258|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048907|NCT03307785|365842259|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048908|NCT03307785|365842260|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048909|NCT03307785|365842261|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048910|NCT03307785|365842262|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
106048911|NCT03307785|365842252|FG000|Part E: Up to 4.4 Months|Death|0|||
106048912|NCT03307785|365842253|FG001|Part E: Up to 4.4 Months|Death|0|||
106048913|NCT03307785|365842254|FG002|Part E: Up to 4.4 Months|Death|0|||
106048914|NCT03307785|365842255|FG003|Part E: Up to 4.4 Months|Death|0|||
106048915|NCT03307785|365842256|FG004|Part E: Up to 4.4 Months|Death|0|||
106048916|NCT03307785|365842257|FG005|Part E: Up to 4.4 Months|Death|0|||
106048917|NCT03307785|365842258|FG006|Part E: Up to 4.4 Months|Death|1|||
106048918|NCT03307785|365842259|FG007|Part E: Up to 4.4 Months|Death|0|||
106048919|NCT03307785|365842260|FG008|Part E: Up to 4.4 Months|Death|0|||
106048920|NCT03307785|365842261|FG009|Part E: Up to 4.4 Months|Death|0|||
106048921|NCT03307785|365842262|FG010|Part E: Up to 4.4 Months|Death|0|||
106048922|NCT03307785|365842252|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
106048923|NCT03307785|365842253|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
106048924|NCT03307785|365842254|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
106048925|NCT03307785|365842255|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
106048926|NCT03307785|365842256|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
106048927|NCT03307785|365842257|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
106048928|NCT03307785|365842258|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
106048929|NCT03307785|365842259|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
106048930|NCT03307785|365842260|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
106048931|NCT03307785|365842261|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
106048932|NCT03307785|365842262|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
106048933|NCT03307785|365842252|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
106048934|NCT03307785|365842253|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
106048935|NCT03307785|365842254|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
106048936|NCT03307785|365842255|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
106048937|NCT03307785|365842256|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
106048938|NCT03307785|365842257|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
106048939|NCT03307785|365842258|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
106048940|NCT03307785|365842259|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
106048941|NCT03307785|365842260|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
106048942|NCT03307785|365842261|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
106048943|NCT03307785|365842262|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
106048944|NCT03666624|365842263|FG000|Overall Study|participant grieving over recent death of parent|1|||
106048945|NCT03666624|365842264|FG001|Overall Study|participant grieving over recent death of parent|0|||
106048946|NCT03021304|365842269|FG000|Overall Study|Lack of Efficacy|1|||
106048947|NCT04154930|365842276|FG000|Overall Study|Withdrawal by Subject|15|||
106048948|NCT04154930|365842277|FG001|Overall Study|Withdrawal by Subject|6|||
106048949|NCT04154930|365842276|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
106048950|NCT04154930|365842277|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
106048951|NCT04154930|365842276|FG000|Overall Study|Lost to Follow-up|14|||
106048952|NCT04154930|365842277|FG001|Overall Study|Lost to Follow-up|6|||
106048953|NCT04154930|365842276|FG000|Overall Study|Other|6|||
106048954|NCT04154930|365842277|FG001|Overall Study|Other|0|||
106048955|NCT00400764|365842279|FG000|Phase Ib|Adverse Event|1|||
106048956|NCT00400764|365842280|FG001|Phase Ib|Adverse Event|0|||
106048957|NCT00400764|365842281|FG002|Phase Ib|Adverse Event|0|||
106048958|NCT00400764|365842282|FG003|Phase Ib|Adverse Event|0|||
106048959|NCT00400764|365842283|FG004|Phase Ib|Adverse Event|0|||
106048960|NCT00400764|365842279|FG000|Phase Ib|Death|1|||
106048961|NCT00400764|365842280|FG001|Phase Ib|Death|0|||
106048962|NCT00400764|365842281|FG002|Phase Ib|Death|0|||
106048963|NCT00400764|365842282|FG003|Phase Ib|Death|0|||
106048964|NCT00400764|365842283|FG004|Phase Ib|Death|0|||
106048965|NCT00400764|365842279|FG000|Phase Ib|Disease Progression|4|||
106048966|NCT00400764|365842280|FG001|Phase Ib|Disease Progression|4|||
106048967|NCT00400764|365842281|FG002|Phase Ib|Disease Progression|0|||
106048968|NCT00400764|365842282|FG003|Phase Ib|Disease Progression|0|||
106048969|NCT00400764|365842283|FG004|Phase Ib|Disease Progression|0|||
106048970|NCT00400764|365842279|FG000|Phase II|Death|0|||
106048971|NCT00400764|365842280|FG001|Phase II|Death|0|||
106048972|NCT00400764|365842281|FG002|Phase II|Death|1|||
106048973|NCT00400764|365842282|FG003|Phase II|Death|2|||
106048974|NCT00400764|365842283|FG004|Phase II|Death|0|||
106048975|NCT00400764|365842279|FG000|Phase II|Lost to Follow-up|0|||
106048976|NCT00400764|365842280|FG001|Phase II|Lost to Follow-up|0|||
106048977|NCT00400764|365842281|FG002|Phase II|Lost to Follow-up|1|||
106048978|NCT00400764|365842282|FG003|Phase II|Lost to Follow-up|0|||
106048979|NCT00400764|365842283|FG004|Phase II|Lost to Follow-up|0|||
106048980|NCT00400764|365842279|FG000|Phase II|Physician Decision|0|||
106048981|NCT00400764|365842280|FG001|Phase II|Physician Decision|0|||
106048982|NCT00400764|365842281|FG002|Phase II|Physician Decision|1|||
106048983|NCT00400764|365842282|FG003|Phase II|Physician Decision|1|||
106048984|NCT00400764|365842283|FG004|Phase II|Physician Decision|0|||
106048985|NCT00400764|365842279|FG000|Phase II|Sponsor's decision to terminate|0|||
106048986|NCT00400764|365842280|FG001|Phase II|Sponsor's decision to terminate|0|||
106048987|NCT00400764|365842281|FG002|Phase II|Sponsor's decision to terminate|18|||
106048988|NCT00400764|365842282|FG003|Phase II|Sponsor's decision to terminate|22|||
106048989|NCT00400764|365842283|FG004|Phase II|Sponsor's decision to terminate|11|||
106048990|NCT00400764|365842279|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
106048991|NCT00400764|365842280|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
106048992|NCT00400764|365842281|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
106048993|NCT00400764|365842282|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
106048994|NCT00400764|365842283|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
106048995|NCT00400764|365842279|FG000|Phase II|Withdrawal by Subject|0|||
106048996|NCT00400764|365842280|FG001|Phase II|Withdrawal by Subject|0|||
106048997|NCT00400764|365842281|FG002|Phase II|Withdrawal by Subject|1|||
106048998|NCT00400764|365842282|FG003|Phase II|Withdrawal by Subject|1|||
106048999|NCT00400764|365842283|FG004|Phase II|Withdrawal by Subject|0|||
106049000|NCT00181155|365842288|FG000|Overall Study|Physician Decision|1|||
106049001|NCT00181155|365842289|FG001|Overall Study|Physician Decision|0|||
106049002|NCT00181155|365842288|FG000|Overall Study|Withdrawal by Subject|1|||
106049003|NCT00181155|365842289|FG001|Overall Study|Withdrawal by Subject|0|||
106049004|NCT01788228|365842294|FG000|Overall Study|Migrated/moved from study area|1|||
106049005|NCT01788228|365842295|FG001|Overall Study|Migrated/moved from study area|0|||
106049006|NCT02187744|365842296|FG000|Study|Participant refused further follow-up|1|||
106049007|NCT02187744|365842297|FG001|Study|Participant refused further follow-up|0|||
106049008|NCT02187744|365842296|FG000|Study|Other|2|||
106049009|NCT02187744|365842297|FG001|Study|Other|1|||
106049010|NCT02187744|365842296|FG000|Study|Lost to Follow-up|0|||
106049011|NCT02187744|365842297|FG001|Study|Lost to Follow-up|2|||
106049012|NCT02187744|365842296|FG000|Study|Related adverse event, not serious|0|||
106049013|NCT02187744|365842297|FG001|Study|Related adverse event, not serious|2|||
106049014|NCT02187744|365842296|FG000|Study|Death|1|||
106049015|NCT02187744|365842297|FG001|Study|Death|0|||
106049016|NCT02187744|365842296|FG000|Study|Related adverse event, serious non-fatal|0|||
106049017|NCT02187744|365842297|FG001|Study|Related adverse event, serious non-fatal|1|||
106049018|NCT02187744|365842296|FG000|Treatment|Death|1|||
106049019|NCT02187744|365842297|FG001|Treatment|Death|0|||
106049020|NCT02187744|365842296|FG000|Treatment|Related adverse event, serious non-fatal|0|||
106049021|NCT02187744|365842297|FG001|Treatment|Related adverse event, serious non-fatal|1|||
106049022|NCT02187744|365842296|FG000|Treatment|Related adverse event, not serious|0|||
106049023|NCT02187744|365842297|FG001|Treatment|Related adverse event, not serious|2|||
106049024|NCT02187744|365842296|FG000|Treatment|Lost to Follow-up|0|||
106049025|NCT02187744|365842297|FG001|Treatment|Lost to Follow-up|1|||
106049026|NCT02187744|365842296|FG000|Treatment|Other|2|||
106049027|NCT02187744|365842297|FG001|Treatment|Other|0|||
106049028|NCT02187744|365842296|FG000|Treatment|Participant refused continued treatment|1|||
106049029|NCT02187744|365842297|FG001|Treatment|Participant refused continued treatment|1|||
106049030|NCT01972568|365842298|FG000|Overall Study|Other events|3|||
106049031|NCT01972568|365842299|FG001|Overall Study|Other events|0|||
106049032|NCT01972568|365842300|FG002|Overall Study|Other events|0|||
106049033|NCT01972568|365842298|FG000|Overall Study|Lack of Efficacy|0|||
106049034|NCT01972568|365842299|FG001|Overall Study|Lack of Efficacy|1|||
106049035|NCT01972568|365842300|FG002|Overall Study|Lack of Efficacy|2|||
106049036|NCT01972568|365842298|FG000|Overall Study|Protocol Violation|1|||
106049037|NCT01972568|365842299|FG001|Overall Study|Protocol Violation|2|||
106049038|NCT01972568|365842300|FG002|Overall Study|Protocol Violation|2|||
106049039|NCT01972568|365842298|FG000|Overall Study|Withdrawal by Subject|6|||
106049040|NCT01972568|365842299|FG001|Overall Study|Withdrawal by Subject|3|||
106049041|NCT01972568|365842300|FG002|Overall Study|Withdrawal by Subject|7|||
106049042|NCT01972568|365842298|FG000|Overall Study|Lost to Follow-up|1|||
106049043|NCT01972568|365842299|FG001|Overall Study|Lost to Follow-up|0|||
106049044|NCT01972568|365842300|FG002|Overall Study|Lost to Follow-up|0|||
106049045|NCT01972568|365842298|FG000|Overall Study|Adverse Event|5|||
106049046|NCT01972568|365842299|FG001|Overall Study|Adverse Event|6|||
106049047|NCT01972568|365842300|FG002|Overall Study|Adverse Event|5|||
106049048|NCT02572401|365842302|FG000|Overall Study|Lost to Follow-up|5|||
106049049|NCT02572401|365842303|FG001|Overall Study|Lost to Follow-up|8|||
106049050|NCT02572401|365842304|FG002|Overall Study|Lost to Follow-up|9|||
106049051|NCT02572401|365842305|FG003|Overall Study|Lost to Follow-up|9|||
106049052|NCT02572401|365842302|FG000|Overall Study|Death|0|||
106049053|NCT02572401|365842303|FG001|Overall Study|Death|0|||
106049054|NCT02572401|365842304|FG002|Overall Study|Death|0|||
106049055|NCT02572401|365842305|FG003|Overall Study|Death|1|||
106049056|NCT00370071|365842306|FG000|Overall Study|Withdrawal by Subject|2|||
106049057|NCT05147428|365842311|FG000|Overall Study|Removed prior to mailing|289|||
106049058|NCT05147428|365842312|FG001|Overall Study|Removed prior to mailing|306|||
106049059|NCT05147428|365842313|FG002|Overall Study|Removed prior to mailing|270|||
106049060|NCT05147428|365842311|FG000|Overall Study|Died or disenrolled during blackout period|239|||
106049061|NCT05147428|365842312|FG001|Overall Study|Died or disenrolled during blackout period|278|||
106049062|NCT05147428|365842313|FG002|Overall Study|Died or disenrolled during blackout period|273|||
106049063|NCT02180724|365843483|FG000|Overall Study|Death|26|||
106049064|NCT02180724|365843484|FG001|Overall Study|Death|1|||
106049065|NCT02180724|365843483|FG000|Overall Study|Lost to Follow-up|3|||
106049066|NCT02180724|365843484|FG001|Overall Study|Lost to Follow-up|1|||
106049067|NCT02180724|365843483|FG000|Overall Study|Withdrawal by Subject|4|||
106049068|NCT02180724|365843484|FG001|Overall Study|Withdrawal by Subject|2|||
106049069|NCT02180724|365843483|FG000|Overall Study|PI Decision|5|||
106049070|NCT02180724|365843484|FG001|Overall Study|PI Decision|2|||
106049071|NCT02180724|365843483|FG000|Overall Study|Study terminated by sponsor|54|||
106049072|NCT02180724|365843484|FG001|Overall Study|Study terminated by sponsor|8|||
106049073|NCT02206048|365843485|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
106049074|NCT00639678|365843486|FG000|Overall Study|Withdrawal by Subject|3|||
106049075|NCT00639678|365843487|FG001|Overall Study|Withdrawal by Subject|0|||
106049076|NCT00639678|365843488|FG002|Overall Study|Withdrawal by Subject|4|||
106049077|NCT00639678|365843489|FG003|Overall Study|Withdrawal by Subject|0|||
106049078|NCT00639678|365843486|FG000|Overall Study|Lost to Follow-up|1|||
106049079|NCT00639678|365843487|FG001|Overall Study|Lost to Follow-up|0|||
106049080|NCT00639678|365843488|FG002|Overall Study|Lost to Follow-up|6|||
106049081|NCT00639678|365843489|FG003|Overall Study|Lost to Follow-up|0|||
106049082|NCT00639678|365843486|FG000|Overall Study|Adverse Event|0|||
106049083|NCT00639678|365843487|FG001|Overall Study|Adverse Event|1|||
106049084|NCT00639678|365843488|FG002|Overall Study|Adverse Event|0|||
106049085|NCT00639678|365843489|FG003|Overall Study|Adverse Event|0|||
106049086|NCT00639678|365843486|FG000|Overall Study|Lack of Compliance|0|||
106049087|NCT00639678|365843487|FG001|Overall Study|Lack of Compliance|0|||
106049088|NCT00639678|365843488|FG002|Overall Study|Lack of Compliance|1|||
105863405|NCT03452137|365150418|FG001|Overall Study|Death|70|||
105863406|NCT03452137|365150417|FG000|Overall Study|Lost to Follow-up|4|||
105863407|NCT03452137|365150418|FG001|Overall Study|Lost to Follow-up|2|||
105863408|NCT03452137|365150417|FG000|Overall Study|Physician Decision|0|||
106049089|NCT00639678|365843489|FG003|Overall Study|Lack of Compliance|0|||
106049090|NCT01926015|365843490|FG000|Overall Study|Withdrawal by parent/guardian|0|||
106049091|NCT01926015|365843491|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106049092|NCT01926015|365843490|FG000|Overall Study|Randomized not treated|2|||
106049093|NCT01926015|365843491|FG001|Overall Study|Randomized not treated|0|||
106049094|NCT04015336|365843505|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
106049095|NCT01816074|365843506|FG000|Phase 1|Time commitment issues|0|||
106049096|NCT01816074|365843507|FG001|Phase 1|Time commitment issues|0|||
106049097|NCT01816074|365843508|FG002|Phase 1|Time commitment issues|1|||
106049098|NCT01816074|365843509|FG003|Phase 1|Time commitment issues|0|||
106049099|NCT01816074|365843506|FG000|Phase 2|Time commitment Issues|0|||
106049100|NCT01816074|365843507|FG001|Phase 2|Time commitment Issues|2|||
106049101|NCT01816074|365843508|FG002|Phase 2|Time commitment Issues|0|||
106049102|NCT01816074|365843509|FG003|Phase 2|Time commitment Issues|0|||
106049103|NCT01816074|365843506|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
106049104|NCT01816074|365843507|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
106049105|NCT01816074|365843508|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
106049106|NCT01816074|365843509|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
106049107|NCT01816074|365843506|FG000|Phase 2|Physician Decision|0|||
106049108|NCT01816074|365843507|FG001|Phase 2|Physician Decision|0|||
106049109|NCT01816074|365843508|FG002|Phase 2|Physician Decision|0|||
106049110|NCT01816074|365843509|FG003|Phase 2|Physician Decision|1|||
106049111|NCT01816074|365843506|FG000|Phase 2|Withdrawal by Subject|1|||
106049112|NCT01816074|365843507|FG001|Phase 2|Withdrawal by Subject|0|||
106049113|NCT01816074|365843508|FG002|Phase 2|Withdrawal by Subject|0|||
106049114|NCT01816074|365843509|FG003|Phase 2|Withdrawal by Subject|0|||
106049115|NCT01303861|365843526|FG000|Overall Study|Lost to Follow-up|34|||
106049116|NCT01303861|365843527|FG001|Overall Study|Lost to Follow-up|14|||
106049117|NCT01303861|365843528|FG002|Overall Study|Lost to Follow-up|27|||
106049118|NCT01303861|365843529|FG003|Overall Study|Lost to Follow-up|31|||
106049119|NCT01303861|365843526|FG000|Overall Study|Lack of Efficacy|3|||
106049120|NCT01303861|365843527|FG001|Overall Study|Lack of Efficacy|2|||
106049121|NCT01303861|365843528|FG002|Overall Study|Lack of Efficacy|1|||
106049122|NCT01303861|365843529|FG003|Overall Study|Lack of Efficacy|0|||
106049123|NCT01303861|365843526|FG000|Overall Study|Withdrawal by Subject|16|||
106049124|NCT01303861|365843527|FG001|Overall Study|Withdrawal by Subject|8|||
106049125|NCT01303861|365843528|FG002|Overall Study|Withdrawal by Subject|8|||
106049126|NCT01303861|365843529|FG003|Overall Study|Withdrawal by Subject|23|||
106049127|NCT01303861|365843526|FG000|Overall Study|Adverse Event|4|||
106049128|NCT01303861|365843527|FG001|Overall Study|Adverse Event|1|||
106049129|NCT01303861|365843528|FG002|Overall Study|Adverse Event|0|||
106049130|NCT01303861|365843529|FG003|Overall Study|Adverse Event|5|||
106049131|NCT01303861|365843526|FG000|Overall Study|Pregnancy|1|||
106049132|NCT01303861|365843527|FG001|Overall Study|Pregnancy|0|||
106049133|NCT01303861|365843528|FG002|Overall Study|Pregnancy|0|||
106049134|NCT01303861|365843529|FG003|Overall Study|Pregnancy|0|||
106049135|NCT00691301|365843531|FG000|Overall Study|Adverse Event|10|||
106049136|NCT00691301|365843531|FG000|Overall Study|Death|2|||
106049137|NCT00691301|365843531|FG000|Overall Study|Lack of Efficacy|32|||
106049138|NCT00691301|365843531|FG000|Overall Study|Withdrawal by Subject|4|||
106049139|NCT00691301|365843531|FG000|Overall Study|Concurrent illness|2|||
106049140|NCT00691301|365843531|FG000|Overall Study|other reason|3|||
106049141|NCT00691301|365843531|FG000|Overall Study|Did not initiate study treatment|1|||
106152352|NCT02742519|366217133|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
105863409|NCT03452137|365150418|FG001|Overall Study|Physician Decision|1|||
106049142|NCT01823146|365843535|FG000|Overall Study|Withdrawal by Subject|0|||
106049143|NCT01823146|365843536|FG001|Overall Study|Withdrawal by Subject|1|||
106049144|NCT01823146|365843535|FG000|Overall Study|Lost to Follow-up|2|||
106049145|NCT01823146|365843536|FG001|Overall Study|Lost to Follow-up|1|||
106049146|NCT01030536|365843540|FG000|Overall Study|Withdrawal by Subject|0|||
106049147|NCT01030536|365843541|FG001|Overall Study|Withdrawal by Subject|0|||
106049148|NCT01030536|365843542|FG002|Overall Study|Withdrawal by Subject|1|||
106049149|NCT01030536|365843543|FG003|Overall Study|Withdrawal by Subject|0|||
106049150|NCT01030536|365843544|FG004|Overall Study|Withdrawal by Subject|0|||
106049151|NCT01030536|365843540|FG000|Overall Study|undefined|1|||
105863410|NCT03452137|365150417|FG000|Overall Study|Study Terminated by Sponsor|120|||
106152353|NCT02742519|366217134|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
106049152|NCT01030536|365843541|FG001|Overall Study|undefined|0|||
106049153|NCT01030536|365843542|FG002|Overall Study|undefined|1|||
106049154|NCT01030536|365843543|FG003|Overall Study|undefined|1|||
105863411|NCT03452137|365150418|FG001|Overall Study|Study Terminated by Sponsor|121|||
105863412|NCT03452137|365150417|FG000|Overall Study|Withdrawal by Subject|12|||
105863413|NCT03452137|365150418|FG001|Overall Study|Withdrawal by Subject|9|||
105863414|NCT02864992|365150419|FG000|Overall Study|still on treatment|15|||
105863415|NCT02864992|365150420|FG001|Overall Study|still on treatment|1|||
105863416|NCT02864992|365150421|FG002|Overall Study|still on treatment|33|||
105863417|NCT00587860|365150422|FG000|Overall Study|Lost to Follow-up|2|||
105863418|NCT00587860|365150423|FG001|Overall Study|Lost to Follow-up|2|||
105863419|NCT00587860|365150422|FG000|Overall Study|Withdrawal by Subject|3|||
105863420|NCT00587860|365150423|FG001|Overall Study|Withdrawal by Subject|3|||
105863421|NCT00261443|365150424|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
105863422|NCT00261443|365150425|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
105863423|NCT00261443|365150426|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
105863424|NCT00261443|365150424|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
105863425|NCT00261443|365150425|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
105863426|NCT00261443|365150426|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
105863427|NCT00261443|365150424|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
105863428|NCT00261443|365150425|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
105863429|NCT00261443|365150426|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
105863430|NCT00261443|365150424|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
105863431|NCT00261443|365150425|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
105863432|NCT00261443|365150426|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
105863433|NCT00261443|365150424|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
105863434|NCT00261443|365150425|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
105863435|NCT00261443|365150426|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
105863436|NCT00261443|365150424|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
105863437|NCT00261443|365150425|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
105863438|NCT00261443|365150426|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
105863439|NCT00261443|365150424|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
105863440|NCT00261443|365150425|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
105863441|NCT00261443|365150426|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
105863442|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
105863443|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
105863444|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
105863445|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
105863446|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
105863447|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
105863448|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
105863449|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
105863450|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
105863451|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
105863452|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
105863453|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
105863454|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
105863455|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
105863456|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
105863457|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
105863458|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
105863459|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
105863460|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
105863461|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
105863462|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
105863463|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
105863464|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
105863465|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
106152354|NCT01227265|366217137|FG000|Overall Study|Did Not Receive Treatment|1|||
106152355|NCT01227265|366217138|FG001|Overall Study|Did Not Receive Treatment|2|||
106152356|NCT01227265|366217139|FG002|Overall Study|Did Not Receive Treatment|0|||
105863466|NCT00261443|365150424|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
105863467|NCT00261443|365150425|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
105863468|NCT00261443|365150426|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
105863469|NCT00261443|365150424|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
105863470|NCT00261443|365150425|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
105863471|NCT00261443|365150426|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
105863472|NCT00261443|365150424|FG000|3: Assessment of Relapse|Adverse Event|0|||
106152357|NCT01227265|366217137|FG000|Overall Study|Administrative|1|||
106152358|NCT01227265|366217138|FG001|Overall Study|Administrative|0|||
106049155|NCT01030536|365843544|FG004|Overall Study|undefined|0|||
106049156|NCT01030536|365843540|FG000|Overall Study|Adverse Event|0|||
106049157|NCT01030536|365843541|FG001|Overall Study|Adverse Event|3|||
106049158|NCT01030536|365843542|FG002|Overall Study|Adverse Event|1|||
106049159|NCT01030536|365843543|FG003|Overall Study|Adverse Event|0|||
106049160|NCT01030536|365843544|FG004|Overall Study|Adverse Event|1|||
106049161|NCT01030536|365843540|FG000|Overall Study|Progressive disease|6|||
106049162|NCT01030536|365843541|FG001|Overall Study|Progressive disease|2|||
106049163|NCT01030536|365843542|FG002|Overall Study|Progressive disease|3|||
106049164|NCT01030536|365843543|FG003|Overall Study|Progressive disease|2|||
106049165|NCT01030536|365843544|FG004|Overall Study|Progressive disease|0|||
106049166|NCT01030536|365843540|FG000|Overall Study|Death|0|||
106049167|NCT01030536|365843541|FG001|Overall Study|Death|1|||
106049168|NCT01030536|365843542|FG002|Overall Study|Death|0|||
106049169|NCT01030536|365843543|FG003|Overall Study|Death|0|||
106049170|NCT01030536|365843544|FG004|Overall Study|Death|0|||
106049171|NCT02410551|365843545|FG000|Overall Study|Adverse Event|1|||
106049172|NCT02410551|365843545|FG000|Overall Study|Withdrawal by Subject|1|||
106049173|NCT02410551|365843545|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
106049174|NCT01419626|365843546|FG000|Overall Study|Protocol Violation|3|||
106049175|NCT01419626|365843547|FG001|Overall Study|Protocol Violation|2|||
106049176|NCT01419626|365843548|FG002|Overall Study|Protocol Violation|2|||
106049177|NCT01419626|365843546|FG000|Overall Study|Withdrawal by Subject|1|||
106049178|NCT01419626|365843547|FG001|Overall Study|Withdrawal by Subject|0|||
106049179|NCT01419626|365843548|FG002|Overall Study|Withdrawal by Subject|0|||
106049180|NCT01419626|365843546|FG000|Overall Study|Lost to Follow-up|0|||
106049181|NCT01419626|365843547|FG001|Overall Study|Lost to Follow-up|1|||
106049182|NCT01419626|365843548|FG002|Overall Study|Lost to Follow-up|1|||
106049183|NCT01365052|365843549|FG000|Overall Study|Adverse Event|4|||
106049184|NCT01365052|365843550|FG001|Overall Study|Adverse Event|4|||
106049185|NCT01145625|365843553|FG000|Overall Study|Lost to Follow-up|8|||
106049186|NCT01145625|365843554|FG001|Overall Study|Lost to Follow-up|9|||
106049187|NCT01145625|365843553|FG000|Overall Study|Adverse Event|6|||
106049188|NCT01145625|365843554|FG001|Overall Study|Adverse Event|4|||
106049189|NCT01145625|365843553|FG000|Overall Study|Protocol Violation|3|||
106049190|NCT01145625|365843554|FG001|Overall Study|Protocol Violation|1|||
106049191|NCT01145625|365843553|FG000|Overall Study|Withdrawal by Subject|7|||
106049192|NCT01145625|365843554|FG001|Overall Study|Withdrawal by Subject|16|||
106049193|NCT01145625|365843553|FG000|Overall Study|Pregnancy|0|||
106049194|NCT01145625|365843554|FG001|Overall Study|Pregnancy|1|||
106049195|NCT04889222|365843558|FG000|Overall Study|Did not meet eligibility criteria|8|||
106049196|NCT04889222|365843558|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
106049197|NCT04889222|365843558|FG000|Overall Study|Did not proceed due to time constraints|5|||
106049198|NCT01206166|365843567|FG000|Overall Study|No evaluable data|2|||
106049199|NCT01206166|365843568|FG001|Overall Study|No evaluable data|3|||
106049200|NCT03576495|365843573|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
106049201|NCT03576495|365843574|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
106049202|NCT02635776|365843575|FG000|Overall Study|Physician Decision|1|||
106049203|NCT02635776|365843576|FG001|Overall Study|Physician Decision|0|||
106049204|NCT02635776|365843575|FG000|Overall Study|Adverse Event|51|||
106049205|NCT02635776|365843576|FG001|Overall Study|Adverse Event|3|||
106049206|NCT02635776|365843575|FG000|Overall Study|Withdrawal by Subject|41|||
106049207|NCT02635776|365843576|FG001|Overall Study|Withdrawal by Subject|7|||
106049208|NCT02635776|365843575|FG000|Overall Study|Lost to Follow-up|4|||
106049209|NCT02635776|365843576|FG001|Overall Study|Lost to Follow-up|0|||
106049210|NCT02635776|365843575|FG000|Overall Study|Other reasons|5|||
106049211|NCT02635776|365843576|FG001|Overall Study|Other reasons|1|||
106049212|NCT00660673|365843577|FG000|Overall Study|Adverse Event|84|||
106049213|NCT00660673|365843577|FG000|Overall Study|Lack of Efficacy|7|||
106049214|NCT00660673|365843577|FG000|Overall Study|Withdrawal by Subject|22|||
106049215|NCT00660673|365843577|FG000|Overall Study|Administrative|2|||
106049216|NCT00660673|365843577|FG000|Overall Study|Protocol Violation|2|||
106049217|NCT03208127|365843578|FG000|Overall Study|Death|1|||
106049218|NCT00843856|365843583|FG000|Overall Study|Lost to Follow-up|1|||
106049219|NCT00843856|365843584|FG001|Overall Study|Lost to Follow-up|2|||
106152359|NCT01227265|366217139|FG002|Overall Study|Administrative|2|||
106049220|NCT04032652|365843585|FG000|Overall Study|The study was terminated and the PI has|1|||
106049221|NCT04032652|365843586|FG001|Overall Study|The study was terminated and the PI has|1|||
106049222|NCT00450255|365843587|FG000|Overall Study|Prior RFA ablation of liver|1|||
106049223|NCT01696071|365843593|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
106049224|NCT01696071|365843594|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
106049225|NCT01441180|365843596|FG000|Overall Study|Lost to Follow-up|1|||
106049226|NCT01441180|365843597|FG001|Overall Study|Lost to Follow-up|1|||
106049227|NCT01441180|365843598|FG002|Overall Study|Lost to Follow-up|1|||
106049228|NCT01441180|365843596|FG000|Overall Study|Discontinued|0|||
106049229|NCT01441180|365843597|FG001|Overall Study|Discontinued|0|||
106049230|NCT01441180|365843598|FG002|Overall Study|Discontinued|2|||
106049231|NCT01402011|365843601|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
106152360|NCT01227265|366217137|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
106049232|NCT01402011|365843602|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
106049233|NCT01402011|365843603|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
106049234|NCT01402011|365843601|FG000|Active Treatment Period|Withdrawal by Subject|1|||
106049235|NCT01402011|365843602|FG001|Active Treatment Period|Withdrawal by Subject|3|||
106049236|NCT01402011|365843603|FG002|Active Treatment Period|Withdrawal by Subject|0|||
106049237|NCT01402011|365843601|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
106049238|NCT01402011|365843602|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
106049239|NCT01402011|365843603|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
106049240|NCT03730012|365843604|FG000|Overall Study|Adverse Event|0|||
106049241|NCT03730012|365843605|FG001|Overall Study|Adverse Event|1|||
106049242|NCT03730012|365843604|FG000|Overall Study|Lack of Efficacy|1|||
106049243|NCT03730012|365843605|FG001|Overall Study|Lack of Efficacy|5|||
106049244|NCT03730012|365843604|FG000|Overall Study|Withdrawal by Subject|0|||
106049245|NCT03730012|365843605|FG001|Overall Study|Withdrawal by Subject|1|||
106049246|NCT03730012|365843604|FG000|Overall Study|Miscellaneous|2|||
106049247|NCT03730012|365843605|FG001|Overall Study|Miscellaneous|1|||
106049248|NCT04680052|365845101|FG000|Overall Study|Ongoing|244|||
106049249|NCT04680052|365845102|FG001|Overall Study|Ongoing|229|||
106049250|NCT04680052|365845103|FG002|Overall Study|Ongoing|39|||
106049251|NCT04680052|365845104|FG003|Overall Study|Ongoing|46|||
106049252|NCT04680052|365845101|FG000|Overall Study|Death|15|||
106049253|NCT04680052|365845102|FG001|Overall Study|Death|22|||
106049254|NCT04680052|365845103|FG002|Overall Study|Death|7|||
106049255|NCT04680052|365845104|FG003|Overall Study|Death|1|||
106049256|NCT04680052|365845101|FG000|Overall Study|Lost to Follow-up|3|||
106049257|NCT04680052|365845102|FG001|Overall Study|Lost to Follow-up|2|||
106049258|NCT04680052|365845103|FG002|Overall Study|Lost to Follow-up|0|||
106049259|NCT04680052|365845104|FG003|Overall Study|Lost to Follow-up|1|||
106049260|NCT04680052|365845101|FG000|Overall Study|Withdrawal by Subject|11|||
106049261|NCT04680052|365845102|FG001|Overall Study|Withdrawal by Subject|19|||
106049262|NCT04680052|365845103|FG002|Overall Study|Withdrawal by Subject|7|||
106049263|NCT04680052|365845104|FG003|Overall Study|Withdrawal by Subject|5|||
106049264|NCT04680052|365845101|FG000|Overall Study|Missing|0|||
106049265|NCT04680052|365845102|FG001|Overall Study|Missing|1|||
106049266|NCT04680052|365845103|FG002|Overall Study|Missing|0|||
106049267|NCT04680052|365845104|FG003|Overall Study|Missing|0|||
106049268|NCT04680052|365845101|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
106049269|NCT04680052|365845102|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
106049270|NCT04680052|365845103|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
106049271|NCT04680052|365845104|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
106049272|NCT04680052|365845101|FG000|Overall Study|Physician Decision|0|||
106049273|NCT04680052|365845102|FG001|Overall Study|Physician Decision|1|||
106049274|NCT04680052|365845103|FG002|Overall Study|Physician Decision|0|||
106049275|NCT04680052|365845104|FG003|Overall Study|Physician Decision|0|||
106049276|NCT01644565|365845105|FG000|Overall Study|Undisclosed Medical History|1|||
106049277|NCT01644565|365845106|FG001|Overall Study|Undisclosed Medical History|0|||
106049278|NCT01644565|365845107|FG002|Overall Study|Undisclosed Medical History|0|||
106049279|NCT01644565|365845108|FG003|Overall Study|Undisclosed Medical History|0|||
106049280|NCT01644565|365845109|FG004|Overall Study|Undisclosed Medical History|0|||
106049281|NCT01644565|365845110|FG005|Overall Study|Undisclosed Medical History|0|||
106049282|NCT01644565|365845111|FG006|Overall Study|Undisclosed Medical History|0|||
106049283|NCT01644565|365845112|FG007|Overall Study|Undisclosed Medical History|0|||
106049284|NCT01644565|365845113|FG008|Overall Study|Undisclosed Medical History|0|||
106049285|NCT01644565|365845105|FG000|Overall Study|Lost to Follow-up|0|||
106049286|NCT01644565|365845106|FG001|Overall Study|Lost to Follow-up|0|||
106049287|NCT01644565|365845107|FG002|Overall Study|Lost to Follow-up|0|||
106049288|NCT01644565|365845108|FG003|Overall Study|Lost to Follow-up|1|||
106049289|NCT01644565|365845109|FG004|Overall Study|Lost to Follow-up|0|||
106049290|NCT01644565|365845110|FG005|Overall Study|Lost to Follow-up|0|||
106049291|NCT01644565|365845111|FG006|Overall Study|Lost to Follow-up|0|||
106049292|NCT01644565|365845112|FG007|Overall Study|Lost to Follow-up|2|||
106049293|NCT01644565|365845113|FG008|Overall Study|Lost to Follow-up|0|||
106049294|NCT01644565|365845105|FG000|Overall Study|Family emergency|0|||
106049295|NCT01644565|365845106|FG001|Overall Study|Family emergency|0|||
106049296|NCT01644565|365845107|FG002|Overall Study|Family emergency|0|||
106049297|NCT01644565|365845108|FG003|Overall Study|Family emergency|0|||
106049298|NCT01644565|365845109|FG004|Overall Study|Family emergency|1|||
106049299|NCT01644565|365845110|FG005|Overall Study|Family emergency|0|||
106049300|NCT01644565|365845111|FG006|Overall Study|Family emergency|0|||
106049301|NCT01644565|365845112|FG007|Overall Study|Family emergency|0|||
106049302|NCT01644565|365845113|FG008|Overall Study|Family emergency|0|||
106049303|NCT01644565|365845105|FG000|Overall Study|Relocation|0|||
106049304|NCT01644565|365845106|FG001|Overall Study|Relocation|0|||
106049305|NCT01644565|365845107|FG002|Overall Study|Relocation|0|||
106049306|NCT01644565|365845108|FG003|Overall Study|Relocation|0|||
106049307|NCT01644565|365845109|FG004|Overall Study|Relocation|0|||
106049308|NCT01644565|365845110|FG005|Overall Study|Relocation|0|||
106049309|NCT01644565|365845111|FG006|Overall Study|Relocation|0|||
106049310|NCT01644565|365845112|FG007|Overall Study|Relocation|0|||
106049311|NCT01644565|365845113|FG008|Overall Study|Relocation|1|||
106049312|NCT01313858|365845116|FG000|Overall Study|Premature Treatment Termination|251|||
106049313|NCT01313858|365845117|FG001|Overall Study|Premature Treatment Termination|219|||
106049314|NCT01313858|365845118|FG002|Overall Study|Premature Treatment Termination|191|||
106049315|NCT01313858|365845116|FG000|Overall Study|Lost to Follow-up|35|||
106049316|NCT01313858|365845117|FG001|Overall Study|Lost to Follow-up|51|||
106049317|NCT01313858|365845118|FG002|Overall Study|Lost to Follow-up|47|||
106049318|NCT02924571|365845119|FG000|Overall Study|Lost to Follow-up|1|||
106152361|NCT01227265|366217138|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
106152362|NCT01227265|366217139|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
105863473|NCT00261443|365150425|FG001|3: Assessment of Relapse|Adverse Event|15|||
105863474|NCT00261443|365150426|FG002|3: Assessment of Relapse|Adverse Event|19|||
105863475|NCT00261443|365150424|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
105863476|NCT00261443|365150425|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
105863477|NCT00261443|365150426|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
105863478|NCT00261443|365150424|FG000|3: Assessment of Relapse|Death|0|||
105863479|NCT00261443|365150425|FG001|3: Assessment of Relapse|Death|0|||
105863480|NCT00261443|365150426|FG002|3: Assessment of Relapse|Death|1|||
105863481|NCT00261443|365150424|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
105863482|NCT00261443|365150425|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
105863483|NCT00261443|365150426|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
105863484|NCT00261443|365150424|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
105863485|NCT00261443|365150425|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
105863486|NCT00261443|365150426|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
105863487|NCT00261443|365150424|FG000|3: Assessment of Relapse|Pregnancy|0|||
105863488|NCT00261443|365150425|FG001|3: Assessment of Relapse|Pregnancy|2|||
105863489|NCT00261443|365150426|FG002|3: Assessment of Relapse|Pregnancy|1|||
105863490|NCT00261443|365150424|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
105863491|NCT00261443|365150425|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
105863492|NCT00261443|365150426|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
105863493|NCT00261443|365150424|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
105863494|NCT00261443|365150425|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
105863495|NCT00261443|365150426|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
105863496|NCT00261443|365150424|FG000|3: Assessment of Relapse|Other Reasons|0|||
105863497|NCT00261443|365150425|FG001|3: Assessment of Relapse|Other Reasons|4|||
105863498|NCT00261443|365150426|FG002|3: Assessment of Relapse|Other Reasons|3|||
105863499|NCT00261443|365150424|FG000|4: Extension Phase|Adverse Event|0|||
105863500|NCT00261443|365150425|FG001|4: Extension Phase|Adverse Event|1|||
105863501|NCT00261443|365150426|FG002|4: Extension Phase|Adverse Event|0|||
105863502|NCT00261443|365150424|FG000|4: Extension Phase|Withdrawal by Subject|0|||
105863503|NCT00261443|365150425|FG001|4: Extension Phase|Withdrawal by Subject|1|||
105863504|NCT00261443|365150426|FG002|4: Extension Phase|Withdrawal by Subject|2|||
105863505|NCT00261443|365150424|FG000|4: Extension Phase|Lost to Follow-up|0|||
105863506|NCT00261443|365150425|FG001|4: Extension Phase|Lost to Follow-up|1|||
105863507|NCT00261443|365150426|FG002|4: Extension Phase|Lost to Follow-up|0|||
105863508|NCT02152605|365150429|FG000|Overall Study|Adverse Event|6|||
105863509|NCT02152605|365150430|FG001|Overall Study|Adverse Event|8|||
105863510|NCT02152605|365150429|FG000|Overall Study|Lack of Efficacy|7|||
105863511|NCT02152605|365150430|FG001|Overall Study|Lack of Efficacy|4|||
105863512|NCT02152605|365150429|FG000|Overall Study|Protocol deviation|1|||
105863513|NCT02152605|365150430|FG001|Overall Study|Protocol deviation|4|||
105863514|NCT02152605|365150429|FG000|Overall Study|Lost to Follow-up|1|||
105863515|NCT02152605|365150430|FG001|Overall Study|Lost to Follow-up|0|||
105863516|NCT02152605|365150429|FG000|Overall Study|Withdrew consent|4|||
105863517|NCT02152605|365150430|FG001|Overall Study|Withdrew consent|2|||
105863518|NCT02500043|365150433|FG000|Overall Study|Randomized, but not Treated|2|||
105863519|NCT02500043|365150434|FG001|Overall Study|Randomized, but not Treated|2|||
105863520|NCT02500043|365150433|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
105863521|NCT02500043|365150434|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
105863522|NCT02500043|365150433|FG000|Overall Study|Adverse Event|33|||
105863523|NCT02500043|365150434|FG001|Overall Study|Adverse Event|11|||
105863524|NCT02500043|365150433|FG000|Overall Study|Clinical Progression|54|||
105863525|NCT02500043|365150434|FG001|Overall Study|Clinical Progression|35|||
105863526|NCT02500043|365150433|FG000|Overall Study|Radiological Progression|192|||
105863527|NCT02500043|365150434|FG001|Overall Study|Radiological Progression|110|||
105863528|NCT02500043|365150433|FG000|Overall Study|Physician's Decision|11|||
105863529|NCT02500043|365150434|FG001|Overall Study|Physician's Decision|3|||
105863530|NCT02500043|365150433|FG000|Overall Study|Withdrawal by Subject|14|||
105863531|NCT02500043|365150434|FG001|Overall Study|Withdrawal by Subject|4|||
105863532|NCT02500043|365150433|FG000|Overall Study|Death|11|||
105863533|NCT02500043|365150434|FG001|Overall Study|Death|2|||
105863534|NCT02500043|365150433|FG000|Overall Study|Protocol Deviation|1|||
105863535|NCT02500043|365150434|FG001|Overall Study|Protocol Deviation|0|||
105863536|NCT04971187|365150435|FG000|Overall Study|Screen failures|2|||
106049319|NCT02924571|365845120|FG001|Overall Study|Lost to Follow-up|1|||
106049320|NCT02924571|365845121|FG002|Overall Study|Lost to Follow-up|0|||
106049321|NCT00463580|365845122|FG000|Overall Study|Lost to Follow-up|1|||
106049322|NCT00463580|365845123|FG001|Overall Study|Lost to Follow-up|0|||
106049323|NCT00463580|365845122|FG000|Overall Study|Schedule conflict|2|||
106049324|NCT00463580|365845123|FG001|Overall Study|Schedule conflict|0|||
106049325|NCT00463580|365845122|FG000|Overall Study|Medical/psychiatric complications|0|||
106049326|NCT00463580|365845123|FG001|Overall Study|Medical/psychiatric complications|2|||
106049327|NCT04638660|365845125|FG000|Overall Study|Withdrawal by Subject|2|||
106049328|NCT04638660|365845126|FG001|Overall Study|Withdrawal by Subject|0|||
106049329|NCT04638660|365845125|FG000|Overall Study|Lost to Follow-up|1|||
106049330|NCT04638660|365845126|FG001|Overall Study|Lost to Follow-up|0|||
106049331|NCT03917459|365845127|FG000|Overall Study|Adverse Event|1|||
106049332|NCT03917459|365845128|FG001|Overall Study|Adverse Event|0|||
106049333|NCT03917459|365845127|FG000|Overall Study|Withdrawal by Subject|0|||
106049334|NCT03917459|365845128|FG001|Overall Study|Withdrawal by Subject|1|||
106049335|NCT00736944|365845129|FG000|Induction|Death|1|||
106049336|NCT00736944|365845129|FG000|Definitive Treatment|Physician Decision|1|||
106049337|NCT05350410|365845130|FG000|Overall Study|Withdrawal by Subject|1|||
106049338|NCT00075218|365845138|FG000|Double-Blind Treatment|Adverse Event|23|||
106049339|NCT00075218|365845139|FG001|Double-Blind Treatment|Adverse Event|4|||
106049340|NCT00075218|365845140|FG002|Double-Blind Treatment|Adverse Event|0|||
106049341|NCT00075218|365845138|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
106049342|NCT00075218|365845139|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
106049343|NCT00075218|365845140|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
106049344|NCT00075218|365845138|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
106049345|NCT00075218|365845139|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
106049346|NCT00075218|365845140|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
106049347|NCT00075218|365845138|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
106049348|NCT00075218|365845139|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
106049349|NCT00075218|365845140|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
106049350|NCT00075218|365845138|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
106049351|NCT00075218|365845139|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
106049352|NCT00075218|365845140|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
106049353|NCT00075218|365845138|FG000|Double-Blind Treatment|No study medication taken|2|||
106049354|NCT00075218|365845139|FG001|Double-Blind Treatment|No study medication taken|0|||
106049355|NCT00075218|365845140|FG002|Double-Blind Treatment|No study medication taken|0|||
106049356|NCT00075218|365845138|FG000|Open-Label Treatment|Lack of Efficacy|0|||
106049357|NCT00075218|365845139|FG001|Open-Label Treatment|Lack of Efficacy|0|||
106049358|NCT00075218|365845140|FG002|Open-Label Treatment|Lack of Efficacy|174|||
106049359|NCT00075218|365845138|FG000|Open-Label Treatment|Adverse Event|0|||
106049360|NCT00075218|365845139|FG001|Open-Label Treatment|Adverse Event|0|||
106049361|NCT00075218|365845140|FG002|Open-Label Treatment|Adverse Event|51|||
106049362|NCT00075218|365845138|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
106049363|NCT00075218|365845139|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
106049364|NCT00075218|365845140|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
106049365|NCT00075218|365845138|FG000|Open-Label Treatment|Decision of Sponsor|0|||
106049366|NCT00075218|365845139|FG001|Open-Label Treatment|Decision of Sponsor|0|||
106049367|NCT00075218|365845140|FG002|Open-Label Treatment|Decision of Sponsor|8|||
106049368|NCT00075218|365845138|FG000|Open-Label Treatment|Protocol Violation|0|||
106049369|NCT00075218|365845139|FG001|Open-Label Treatment|Protocol Violation|0|||
106049370|NCT00075218|365845140|FG002|Open-Label Treatment|Protocol Violation|1|||
106049371|NCT00075218|365845138|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
106049372|NCT00075218|365845139|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
106049373|NCT00075218|365845140|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
106049374|NCT02601027|365845141|FG000|Registration to Surgery|Withdrawal by Subject|20|||
106049375|NCT02601027|365845142|FG001|Registration to Surgery|Withdrawal by Subject|10|||
106049376|NCT01393301|365845145|FG000|Overall Study|Lost to Follow-up|5|||
106049377|NCT01393301|365845146|FG001|Overall Study|Lost to Follow-up|3|||
106049378|NCT01393301|365845145|FG000|Overall Study|Withdrawal by Subject|2|||
106049379|NCT01393301|365845146|FG001|Overall Study|Withdrawal by Subject|0|||
106049380|NCT01393301|365845145|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
106049381|NCT01393301|365845146|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
106049382|NCT03840174|365845149|FG000|Overall Study|Withdrawal by Subject|1|||
106049383|NCT03840174|365845150|FG001|Overall Study|Withdrawal by Subject|0|||
106152363|NCT01227265|366217137|FG000|Overall Study|Protocol Violation|2|||
105863537|NCT02246114|365150442|FG000|Overall Study|miscarriage|1|||
106049384|NCT03840174|365845151|FG002|Overall Study|Withdrawal by Subject|0|||
106049385|NCT03840174|365845152|FG003|Overall Study|Withdrawal by Subject|0|||
106049386|NCT01065597|365845161|FG000|Overall Study|Adverse Event|1|||
106049387|NCT01719783|365845162|FG000|Dose 2|Physician Decision|1|||
106049388|NCT01719783|365845163|FG001|Dose 2|Physician Decision|0|||
106049389|NCT00932126|365845166|FG000|Overall Study|Adverse Event|0|||
106049390|NCT00932126|365845167|FG001|Overall Study|Adverse Event|0|||
106049391|NCT00932126|365845168|FG002|Overall Study|Adverse Event|0|||
106152364|NCT01227265|366217138|FG001|Overall Study|Protocol Violation|1|||
105863538|NCT02246114|365150443|FG001|Overall Study|miscarriage|0|||
106049392|NCT00932126|365845169|FG003|Overall Study|Adverse Event|0|||
106049393|NCT00932126|365845170|FG004|Overall Study|Adverse Event|0|||
106049394|NCT00932126|365845171|FG005|Overall Study|Adverse Event|0|||
106049395|NCT00932126|365845172|FG006|Overall Study|Adverse Event|1|||
106049396|NCT00932126|365845173|FG007|Overall Study|Adverse Event|2|||
106049397|NCT00932126|365845166|FG000|Overall Study|Protocol Violation|0|||
106049398|NCT00932126|365845167|FG001|Overall Study|Protocol Violation|0|||
106049399|NCT00932126|365845168|FG002|Overall Study|Protocol Violation|0|||
106049400|NCT00932126|365845169|FG003|Overall Study|Protocol Violation|0|||
106049401|NCT00932126|365845170|FG004|Overall Study|Protocol Violation|1|||
106152365|NCT01227265|366217139|FG002|Overall Study|Protocol Violation|0|||
105863539|NCT00811928|365150446|FG000|Overall Study|AEs and SAEs Including Death|7|||
105863540|NCT00811928|365150447|FG001|Overall Study|AEs and SAEs Including Death|11|||
105863541|NCT00811928|365150446|FG000|Overall Study|Withdrawal by Subject|18|||
105863542|NCT00811928|365150447|FG001|Overall Study|Withdrawal by Subject|12|||
105863543|NCT00811928|365150446|FG000|Overall Study|Did Not Take Study Drug|3|||
105863544|NCT00811928|365150447|FG001|Overall Study|Did Not Take Study Drug|0|||
105863545|NCT00811928|365150446|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
105863546|NCT00811928|365150447|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
105863547|NCT00811928|365150446|FG000|Overall Study|Investigator Decision|2|||
105863548|NCT00811928|365150447|FG001|Overall Study|Investigator Decision|1|||
105863549|NCT00811928|365150446|FG000|Overall Study|Poor Compliance|2|||
105863550|NCT00811928|365150447|FG001|Overall Study|Poor Compliance|5|||
105863551|NCT02533180|365150448|FG000|Overall Study|Death|0|||
105863552|NCT02533180|365150449|FG001|Overall Study|Death|2|||
105863553|NCT02533180|365150448|FG000|Overall Study|Lost to Follow-up|0|||
105863554|NCT02533180|365150449|FG001|Overall Study|Lost to Follow-up|1|||
105863555|NCT02533180|365150448|FG000|Overall Study|Physician Decision|0|||
105863556|NCT02533180|365150449|FG001|Overall Study|Physician Decision|1|||
105863557|NCT02533180|365150448|FG000|Overall Study|Withdrawal by Subject|2|||
105863558|NCT02533180|365150449|FG001|Overall Study|Withdrawal by Subject|5|||
105863559|NCT02533180|365150448|FG000|Overall Study|Screen Failure|37|||
105863560|NCT02533180|365150449|FG001|Overall Study|Screen Failure|0|||
105863561|NCT02533180|365150448|FG000|Overall Study|Protocol Deviation|0|||
105863562|NCT02533180|365150449|FG001|Overall Study|Protocol Deviation|1|||
105863563|NCT02533180|365150448|FG000|Overall Study|Non-compliance|0|||
105863564|NCT02533180|365150449|FG001|Overall Study|Non-compliance|1|||
105863565|NCT00447876|365150450|FG000|Overall Study|Withdrawal by Subject|1|||
105863566|NCT00447876|365150451|FG001|Overall Study|Withdrawal by Subject|4|||
105863567|NCT00447876|365150450|FG000|Overall Study|Lost to Follow-up|1|||
105863568|NCT00447876|365150451|FG001|Overall Study|Lost to Follow-up|0|||
105863569|NCT00447876|365150450|FG000|Overall Study|Deterioration of symptomology|1|||
105863570|NCT00447876|365150451|FG001|Overall Study|Deterioration of symptomology|0|||
105863571|NCT00314951|365150452|FG000|Treatment|Didn't meet criteria for mITT population|16|||
105863572|NCT00314951|365150453|FG001|Treatment|Didn't meet criteria for mITT population|11|||
105863573|NCT00314951|365150452|FG000|Follow-up|mITT failure|44|||
105863574|NCT00314951|365150453|FG001|Follow-up|mITT failure|34|||
105863575|NCT01228019|365150454|FG000|Overall Study|Dose Violation|70|||
105863576|NCT01228019|365150454|FG000|Overall Study|Duplicate enrollment|1|||
105863577|NCT01228019|365150454|FG000|Overall Study|Missing pre-treatment data|72|||
105863578|NCT01228019|365150454|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
105863579|NCT01228019|365150454|FG000|Overall Study|Violation of Entry Criterion|9|||
105863580|NCT00492778|365150455|FG000|Overall Study|Ineligible by Pathology Review|8|||
105863581|NCT00492778|365150456|FG001|Overall Study|Ineligible by Pathology Review|1|||
105863582|NCT03717012|365150457|FG000|Overall Study|Due to trial termination|1|||
105863583|NCT03717012|365150458|FG001|Overall Study|Due to trial termination|2|||
105863584|NCT03717012|365150457|FG000|Overall Study|Protocol Violation|0|||
106152366|NCT01227265|366217137|FG000|Overall Study|Withdrawal by Subject|7|||
106152367|NCT01227265|366217138|FG001|Overall Study|Withdrawal by Subject|7|||
105863585|NCT03717012|365150458|FG001|Overall Study|Protocol Violation|2|||
105863586|NCT03717012|365150457|FG000|Overall Study|Adverse Event|0|||
105863587|NCT03717012|365150458|FG001|Overall Study|Adverse Event|1|||
105863588|NCT03717012|365150457|FG000|Overall Study|Lung transplant|0|||
105863589|NCT03717012|365150458|FG001|Overall Study|Lung transplant|1|||
105863590|NCT00789035|365150459|FG000|Overall Study|Adverse Event|0|||
105863591|NCT00789035|365150460|FG001|Overall Study|Adverse Event|2|||
105863592|NCT00789035|365150461|FG002|Overall Study|Adverse Event|0|||
105863593|NCT00789035|365150462|FG003|Overall Study|Adverse Event|1|||
105863594|NCT00789035|365150463|FG004|Overall Study|Adverse Event|3|||
106049402|NCT00932126|365845171|FG005|Overall Study|Protocol Violation|0|||
106152368|NCT01227265|366217139|FG002|Overall Study|Withdrawal by Subject|3|||
105863595|NCT00789035|365150459|FG000|Overall Study|Lack of Efficacy|3|||
105863596|NCT00789035|365150460|FG001|Overall Study|Lack of Efficacy|0|||
105863597|NCT00789035|365150461|FG002|Overall Study|Lack of Efficacy|0|||
105863598|NCT00789035|365150462|FG003|Overall Study|Lack of Efficacy|0|||
106152369|NCT01227265|366217137|FG000|Overall Study|Lost to Follow-up|2|||
105863599|NCT00789035|365150463|FG004|Overall Study|Lack of Efficacy|2|||
106049403|NCT00932126|365845172|FG006|Overall Study|Protocol Violation|0|||
106049404|NCT00932126|365845173|FG007|Overall Study|Protocol Violation|0|||
106049405|NCT00932126|365845166|FG000|Overall Study|Withdrawal by Subject|0|||
106049406|NCT00932126|365845167|FG001|Overall Study|Withdrawal by Subject|0|||
106049407|NCT00932126|365845168|FG002|Overall Study|Withdrawal by Subject|1|||
106049408|NCT00932126|365845169|FG003|Overall Study|Withdrawal by Subject|0|||
106049409|NCT00932126|365845170|FG004|Overall Study|Withdrawal by Subject|0|||
106049410|NCT00932126|365845171|FG005|Overall Study|Withdrawal by Subject|0|||
106049411|NCT00932126|365845172|FG006|Overall Study|Withdrawal by Subject|0|||
106049412|NCT00932126|365845173|FG007|Overall Study|Withdrawal by Subject|1|||
106049413|NCT00932126|365845166|FG000|Overall Study|Objective progression or relapse|3|||
106049414|NCT00932126|365845167|FG001|Overall Study|Objective progression or relapse|3|||
106049415|NCT00932126|365845168|FG002|Overall Study|Objective progression or relapse|2|||
106049416|NCT00932126|365845169|FG003|Overall Study|Objective progression or relapse|3|||
106049417|NCT00932126|365845170|FG004|Overall Study|Objective progression or relapse|3|||
106049418|NCT00932126|365845171|FG005|Overall Study|Objective progression or relapse|3|||
106049419|NCT00932126|365845172|FG006|Overall Study|Objective progression or relapse|3|||
106049420|NCT00932126|365845173|FG007|Overall Study|Objective progression or relapse|5|||
106049421|NCT00932126|365845166|FG000|Overall Study|Other|0|||
106049422|NCT00932126|365845167|FG001|Overall Study|Other|0|||
106049423|NCT00932126|365845168|FG002|Overall Study|Other|0|||
106049424|NCT00932126|365845169|FG003|Overall Study|Other|0|||
106049425|NCT00932126|365845170|FG004|Overall Study|Other|1|||
106049426|NCT00932126|365845171|FG005|Overall Study|Other|0|||
106049427|NCT00932126|365845172|FG006|Overall Study|Other|1|||
106049428|NCT00932126|365845173|FG007|Overall Study|Other|2|||
106049429|NCT02716805|365845174|FG000|Overall Study|Progressive disease|2|||
106049430|NCT02716805|365845175|FG001|Overall Study|Progressive disease|0|||
106049431|NCT02716805|365845176|FG002|Overall Study|Progressive disease|0|||
106049432|NCT02716805|365845177|FG003|Overall Study|Progressive disease|0|||
106049433|NCT00066365|365845178|FG000|Overall Study|Adverse Event|1|||
106049434|NCT00066365|365845179|FG001|Overall Study|Adverse Event|0|||
106049435|NCT00066365|365845178|FG000|Overall Study|Lack of Efficacy|15|||
106049436|NCT00066365|365845179|FG001|Overall Study|Lack of Efficacy|12|||
106049437|NCT00066365|365845178|FG000|Overall Study|Physician Decision|1|||
106049438|NCT00066365|365845179|FG001|Overall Study|Physician Decision|0|||
106049439|NCT00066365|365845178|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
106049440|NCT00066365|365845179|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
106049441|NCT00066365|365845178|FG000|Overall Study|Ineligible|4|||
106049442|NCT00066365|365845179|FG001|Overall Study|Ineligible|2|||
106049443|NCT00239590|365845182|FG000|Randomized|Lost to Follow-up|0|||
106049444|NCT00239590|365845183|FG001|Randomized|Lost to Follow-up|1|||
106049445|NCT00239590|365845182|FG000|Randomized|Withdrawal by Subject|0|||
106049446|NCT00239590|365845183|FG001|Randomized|Withdrawal by Subject|1|||
106049447|NCT00239590|365845182|FG000|Completed Study Protocol|Adverse Event|1|||
106049448|NCT00239590|365845183|FG001|Completed Study Protocol|Adverse Event|1|||
106049449|NCT00239590|365845182|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
106049450|NCT00239590|365845183|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
106049451|NCT02058693|365845184|FG000|Phase 1|Withdrawal by Subject|3|||
106049452|NCT02058693|365845185|FG001|Phase 1|Withdrawal by Subject|2|||
106049453|NCT02058693|365845184|FG000|Phase 1|Adverse Event|0|||
106049454|NCT02058693|365845185|FG001|Phase 1|Adverse Event|1|||
106049455|NCT02058693|365845184|FG000|Phase 1|Lack of Efficacy|1|||
106049456|NCT02058693|365845185|FG001|Phase 1|Lack of Efficacy|0|||
106049457|NCT02058693|365845184|FG000|Phase 1|Physician Decision|1|||
106049458|NCT02058693|365845185|FG001|Phase 1|Physician Decision|1|||
106049459|NCT02058693|365845184|FG000|Phase 2|Withdrawal by Subject|0|||
106049460|NCT02058693|365845185|FG001|Phase 2|Withdrawal by Subject|2|||
106049461|NCT03344796|365845195|FG000|Overall Study|Lost to Follow-up|0|||
106049462|NCT03344796|365845196|FG001|Overall Study|Lost to Follow-up|0|||
106049463|NCT03344796|365845197|FG002|Overall Study|Lost to Follow-up|0|||
106049464|NCT03344796|365845198|FG003|Overall Study|Lost to Follow-up|0|||
106049465|NCT03344796|365845199|FG004|Overall Study|Lost to Follow-up|0|||
106049466|NCT03344796|365845200|FG005|Overall Study|Lost to Follow-up|2|||
106049467|NCT00242216|365845214|FG000|Overall Study|Lost to Follow-up|12|||
106049468|NCT00242216|365845215|FG001|Overall Study|Lost to Follow-up|17|||
106049469|NCT00242216|365845214|FG000|Overall Study|Death|4|||
106049470|NCT00242216|365845215|FG001|Overall Study|Death|2|||
106049471|NCT00242216|365845214|FG000|Overall Study|Lack of Efficacy|1|||
106049472|NCT00242216|365845215|FG001|Overall Study|Lack of Efficacy|2|||
106049473|NCT00242216|365845214|FG000|Overall Study|no medicaiton dispensed|1|||
105863600|NCT00789035|365150459|FG000|Overall Study|Protocol Violation|1|||
106049474|NCT00242216|365845215|FG001|Overall Study|no medicaiton dispensed|1|||
106049475|NCT02569671|365845216|FG000|Overall Study|Lost to Follow-up|2|||
106049476|NCT02569671|365845217|FG001|Overall Study|Lost to Follow-up|1|||
106049477|NCT02569671|365845216|FG000|Overall Study|Withdrawal by Subject|1|||
106049478|NCT02569671|365845217|FG001|Overall Study|Withdrawal by Subject|3|||
106049479|NCT05358444|365845218|FG000|Overall Study|Withdrawal by Subject|0|||
106049480|NCT05358444|365845219|FG001|Overall Study|Withdrawal by Subject|1|||
106049481|NCT05358444|365845218|FG000|Overall Study|Lost to Follow-up|0|||
106049482|NCT05358444|365845219|FG001|Overall Study|Lost to Follow-up|3|||
106049483|NCT01757535|365845220|FG000|Overall Study|Disease Relapse|151|||
106049484|NCT01757535|365845221|FG001|Overall Study|Disease Relapse|181|||
106049485|NCT01757535|365845220|FG000|Overall Study|Other Reasons|28|||
106049486|NCT01757535|365845221|FG001|Overall Study|Other Reasons|27|||
106049487|NCT01757535|365845220|FG000|Overall Study|Adverse Event|31|||
106049488|NCT01757535|365845221|FG001|Overall Study|Adverse Event|11|||
106049489|NCT01757535|365845220|FG000|Overall Study|Withdrew Consent|19|||
106049490|NCT01757535|365845221|FG001|Overall Study|Withdrew Consent|13|||
106049491|NCT01757535|365845220|FG000|Overall Study|Physician Decision|7|||
106049492|NCT01757535|365845221|FG001|Overall Study|Physician Decision|0|||
106049493|NCT01757535|365845220|FG000|Overall Study|Death|2|||
106049494|NCT01757535|365845221|FG001|Overall Study|Death|2|||
106049495|NCT03487549|365845224|FG000|Overall Study|Protocol Violation|0|||
106049496|NCT03487549|365845225|FG001|Overall Study|Protocol Violation|1|||
106049497|NCT03487549|365845224|FG000|Overall Study|Lost to Follow-up|2|||
106049498|NCT03487549|365845225|FG001|Overall Study|Lost to Follow-up|1|||
106049499|NCT03487549|365845224|FG000|Overall Study|Withdrawal by Subject|2|||
106049500|NCT03487549|365845225|FG001|Overall Study|Withdrawal by Subject|0|||
106049501|NCT02900976|365845226|FG000|Overall Study|Adverse Event|0|||
106049502|NCT02900976|365845227|FG001|Overall Study|Adverse Event|1|||
106049503|NCT02900976|365845226|FG000|Overall Study|Physician Decision|0|||
106049504|NCT02900976|365845227|FG001|Overall Study|Physician Decision|2|||
106049505|NCT02900976|365845226|FG000|Overall Study|Progressive disease|0|||
106049506|NCT02900976|365845227|FG001|Overall Study|Progressive disease|6|||
106049507|NCT04997304|365845229|FG000|Overall Study|Lost to Follow-up|11|||
106049508|NCT04997304|365845229|FG000|Overall Study|Death|1|||
106049509|NCT04997304|365845229|FG000|Overall Study|Withdrawal by Subject|14|||
106049510|NCT01453361|365845230|FG000|Overall Study|Disease Progression|6|||
106049511|NCT01453361|365845230|FG000|Overall Study|Screen-Failures|10|||
106049512|NCT03128047|365845231|FG000|Overall Study|Withdrawal by Subject|1|||
106049513|NCT02110238|365846656|FG000|12 Week Pivotal Phase|Adverse Event|3|||
106049514|NCT02110238|365846657|FG001|12 Week Pivotal Phase|Adverse Event|0|||
106049515|NCT02110238|365846656|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
106049516|NCT02110238|365846657|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
106152370|NCT01227265|366217138|FG001|Overall Study|Lost to Follow-up|0|||
106152371|NCT01227265|366217139|FG002|Overall Study|Lost to Follow-up|3|||
106152372|NCT01227265|366217137|FG000|Overall Study|Adverse Event|6|||
106152373|NCT01227265|366217138|FG001|Overall Study|Adverse Event|10|||
106152374|NCT01227265|366217139|FG002|Overall Study|Adverse Event|5|||
106152375|NCT03481816|366217141|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
106152376|NCT03481816|366217142|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
106152377|NCT03481816|366217141|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
106152378|NCT03481816|366217142|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
105863601|NCT00789035|365150460|FG001|Overall Study|Protocol Violation|0|||
105863602|NCT00789035|365150461|FG002|Overall Study|Protocol Violation|0|||
105863603|NCT00789035|365150462|FG003|Overall Study|Protocol Violation|0|||
105863604|NCT00789035|365150463|FG004|Overall Study|Protocol Violation|0|||
105863605|NCT00789035|365150459|FG000|Overall Study|Withdrawal by Subject|0|||
105863606|NCT00789035|365150460|FG001|Overall Study|Withdrawal by Subject|2|||
105863607|NCT00789035|365150461|FG002|Overall Study|Withdrawal by Subject|0|||
105863608|NCT00789035|365150462|FG003|Overall Study|Withdrawal by Subject|0|||
105863609|NCT00789035|365150463|FG004|Overall Study|Withdrawal by Subject|0|||
105863610|NCT00789035|365150459|FG000|Overall Study|Other reason not defined above|2|||
105863611|NCT00789035|365150460|FG001|Overall Study|Other reason not defined above|3|||
105863612|NCT00789035|365150461|FG002|Overall Study|Other reason not defined above|1|||
105863613|NCT00789035|365150462|FG003|Overall Study|Other reason not defined above|0|||
105863614|NCT00789035|365150463|FG004|Overall Study|Other reason not defined above|1|||
105863615|NCT00796107|365150471|FG000|Overall Study|Lack of Efficacy|1|||
105863616|NCT00796107|365150471|FG000|Overall Study|Progressive Disease|5|||
105863617|NCT01420965|365150476|FG000|Overall Study|Withdrawal by Subject|1|||
105863618|NCT01420965|365150477|FG001|Overall Study|Withdrawal by Subject|0|||
105863619|NCT01420965|365150478|FG002|Overall Study|Withdrawal by Subject|0|||
105863620|NCT01420965|365150476|FG000|Overall Study|Adverse Event|0|||
106152379|NCT03481816|366217141|FG000|Dose Expansion|Withdrawal by Subject|0|||
105863621|NCT01420965|365150477|FG001|Overall Study|Adverse Event|1|||
105863622|NCT01420965|365150478|FG002|Overall Study|Adverse Event|0|||
105863623|NCT00339144|365150479|FG000|Overall Study|Disease progression|5|||
105863624|NCT00339144|365150480|FG001|Overall Study|Disease progression|2|||
106049517|NCT02110238|365846656|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
106049518|NCT02110238|365846657|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
106049519|NCT02110238|365846656|FG000|12 Week Pivotal Phase|Physician Decision|0|||
106049520|NCT02110238|365846657|FG001|12 Week Pivotal Phase|Physician Decision|2|||
106152380|NCT03481816|366217142|FG001|Dose Expansion|Withdrawal by Subject|2|||
106152381|NCT03481816|366217141|FG000|Dose Expansion|Physician Decision|0|||
106049521|NCT02110238|365846656|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
106049522|NCT02110238|365846657|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
106049523|NCT02110238|365846656|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
106049524|NCT02110238|365846657|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
106049525|NCT02110238|365846656|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
106049526|NCT02110238|365846657|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
106049527|NCT02110238|365846656|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
106049528|NCT02110238|365846657|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
106049529|NCT02110238|365846656|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
106049530|NCT02110238|365846657|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
106049531|NCT02110238|365846656|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
106049532|NCT02110238|365846657|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
106049533|NCT02110238|365846656|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
106049534|NCT02110238|365846657|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
106049535|NCT01773733|365846658|FG000|Overall Study|Adverse Event|3286|||
106049536|NCT01773733|365846659|FG001|Overall Study|Adverse Event|540|||
106049537|NCT01773733|365846658|FG000|Overall Study|Pregnancy|28|||
106049538|NCT01773733|365846659|FG001|Overall Study|Pregnancy|0|||
106049539|NCT01773733|365846658|FG000|Overall Study|Other different categories of not compl|55415|||
106049540|NCT01773733|365846659|FG001|Overall Study|Other different categories of not compl|7781|||
105863625|NCT00339144|365150481|FG002|Overall Study|Disease progression|2|||
106049541|NCT03228433|365846660|FG000|Overall Study|Lost to Follow-up|1|||
106049542|NCT03228433|365846661|FG001|Overall Study|Lost to Follow-up|0|||
106049543|NCT03228433|365846662|FG002|Overall Study|Lost to Follow-up|0|||
106049544|NCT03228433|365846663|FG003|Overall Study|Lost to Follow-up|0|||
106049545|NCT03228433|365846664|FG004|Overall Study|Lost to Follow-up|0|||
106049546|NCT03228433|365846665|FG005|Overall Study|Lost to Follow-up|0|||
106049547|NCT03228433|365846660|FG000|Overall Study|Positive alcohol test|0|||
106049548|NCT03228433|365846661|FG001|Overall Study|Positive alcohol test|0|||
106049549|NCT03228433|365846662|FG002|Overall Study|Positive alcohol test|0|||
106049550|NCT03228433|365846663|FG003|Overall Study|Positive alcohol test|1|||
106049551|NCT03228433|365846664|FG004|Overall Study|Positive alcohol test|0|||
106049552|NCT03228433|365846665|FG005|Overall Study|Positive alcohol test|0|||
106049553|NCT00705289|365846666|FG000|Overall Study|Subject or treating physician's choice|131|||
106049554|NCT01330030|365846671|FG000|Overall Study|Lost to Follow-up|16|||
106049555|NCT01330030|365846672|FG001|Overall Study|Lost to Follow-up|17|||
106049556|NCT01146912|365846673|FG000|Overall Study|Already received influenza vaccination|817|||
106049557|NCT01146912|365846674|FG001|Overall Study|Already received influenza vaccination|822|||
106049558|NCT01146912|365846675|FG002|Overall Study|Already received influenza vaccination|13|||
106049559|NCT01146912|365846676|FG003|Overall Study|Already received influenza vaccination|15|||
106049560|NCT01146912|365846677|FG004|Overall Study|Already received influenza vaccination|41|||
106049561|NCT01146912|365846678|FG005|Overall Study|Already received influenza vaccination|61|||
106049562|NCT01146912|365846679|FG006|Overall Study|Already received influenza vaccination|56|||
106049563|NCT01146912|365846680|FG007|Overall Study|Already received influenza vaccination|0|||
106049564|NCT01146912|365846673|FG000|Overall Study|< 14 weeks gestational age|0|||
106049565|NCT01146912|365846674|FG001|Overall Study|< 14 weeks gestational age|0|||
106049566|NCT01146912|365846675|FG002|Overall Study|< 14 weeks gestational age|3|||
106049567|NCT01146912|365846676|FG003|Overall Study|< 14 weeks gestational age|2|||
106049568|NCT01146912|365846677|FG004|Overall Study|< 14 weeks gestational age|0|||
106049569|NCT01146912|365846678|FG005|Overall Study|< 14 weeks gestational age|0|||
106049570|NCT01146912|365846679|FG006|Overall Study|< 14 weeks gestational age|0|||
106049571|NCT01146912|365846680|FG007|Overall Study|< 14 weeks gestational age|0|||
106049572|NCT01146912|365846673|FG000|Overall Study|Duplicate patient|0|||
106049573|NCT01146912|365846674|FG001|Overall Study|Duplicate patient|0|||
106049574|NCT01146912|365846675|FG002|Overall Study|Duplicate patient|1|||
106049575|NCT01146912|365846676|FG003|Overall Study|Duplicate patient|0|||
106049576|NCT01146912|365846677|FG004|Overall Study|Duplicate patient|0|||
106049577|NCT01146912|365846678|FG005|Overall Study|Duplicate patient|0|||
106049578|NCT01146912|365846679|FG006|Overall Study|Duplicate patient|0|||
106049579|NCT01146912|365846680|FG007|Overall Study|Duplicate patient|0|||
106049580|NCT02609828|365846681|FG000|Overall Study|Adverse Event|8|||
106049581|NCT02609828|365846682|FG001|Overall Study|Adverse Event|1|||
106049582|NCT02609828|365846683|FG002|Overall Study|Adverse Event|0|||
106049583|NCT02609828|365846684|FG003|Overall Study|Adverse Event|6|||
106152382|NCT03481816|366217142|FG001|Dose Expansion|Physician Decision|5|||
106152383|NCT03892564|366217143|FG000|Overall Study|Withdrawal by Subject|2|||
106049584|NCT02609828|365846681|FG000|Overall Study|Death|15|||
106049585|NCT02609828|365846682|FG001|Overall Study|Death|1|||
106049586|NCT02609828|365846683|FG002|Overall Study|Death|1|||
106049587|NCT02609828|365846684|FG003|Overall Study|Death|19|||
106049588|NCT02609828|365846681|FG000|Overall Study|Insufficient clinical response|2|||
106049589|NCT02609828|365846682|FG001|Overall Study|Insufficient clinical response|1|||
106049590|NCT02609828|365846683|FG002|Overall Study|Insufficient clinical response|0|||
106049591|NCT02609828|365846684|FG003|Overall Study|Insufficient clinical response|0|||
106049592|NCT02609828|365846681|FG000|Overall Study|Lost to Follow-up|0|||
106049593|NCT02609828|365846682|FG001|Overall Study|Lost to Follow-up|0|||
106049594|NCT02609828|365846683|FG002|Overall Study|Lost to Follow-up|0|||
106049595|NCT02609828|365846684|FG003|Overall Study|Lost to Follow-up|1|||
106049596|NCT02609828|365846681|FG000|Overall Study|Protocol Violation|2|||
106049597|NCT02609828|365846682|FG001|Overall Study|Protocol Violation|0|||
106049598|NCT02609828|365846683|FG002|Overall Study|Protocol Violation|0|||
106049599|NCT02609828|365846684|FG003|Overall Study|Protocol Violation|1|||
106049600|NCT02609828|365846681|FG000|Overall Study|Withdrawal by Subject|12|||
106049601|NCT02609828|365846682|FG001|Overall Study|Withdrawal by Subject|1|||
106049602|NCT02609828|365846683|FG002|Overall Study|Withdrawal by Subject|0|||
106049603|NCT02609828|365846684|FG003|Overall Study|Withdrawal by Subject|10|||
106049604|NCT02609828|365846681|FG000|Overall Study|Other|3|||
106049605|NCT02609828|365846682|FG001|Overall Study|Other|0|||
106049606|NCT02609828|365846683|FG002|Overall Study|Other|0|||
106049607|NCT02609828|365846684|FG003|Overall Study|Other|6|||
106049608|NCT02609828|365846681|FG000|Overall Study|Randomized but not treated|1|||
106049609|NCT02609828|365846682|FG001|Overall Study|Randomized but not treated|0|||
106049610|NCT02609828|365846683|FG002|Overall Study|Randomized but not treated|0|||
106049611|NCT02609828|365846684|FG003|Overall Study|Randomized but not treated|0|||
106049612|NCT02980783|365846685|FG000|Overall Study|Lost to Follow-up|1|||
106049613|NCT02202980|365846686|FG000|Overall Study|Lack of Efficacy|1|||
106049614|NCT02202980|365846687|FG001|Overall Study|Lack of Efficacy|0|||
106049615|NCT02202980|365846688|FG002|Overall Study|Lack of Efficacy|7|||
106049616|NCT02202980|365846689|FG003|Overall Study|Lack of Efficacy|0|||
106049617|NCT02202980|365846690|FG004|Overall Study|Lack of Efficacy|3|||
106049618|NCT02202980|365846691|FG005|Overall Study|Lack of Efficacy|1|||
106049619|NCT02202980|365846692|FG006|Overall Study|Lack of Efficacy|11|||
106049620|NCT02202980|365846693|FG007|Overall Study|Lack of Efficacy|2|||
106049621|NCT02202980|365846694|FG008|Overall Study|Lack of Efficacy|2|||
106049622|NCT02202980|365846695|FG009|Overall Study|Lack of Efficacy|0|||
106049623|NCT02202980|365846696|FG010|Overall Study|Lack of Efficacy|0|||
106049624|NCT02202980|365846697|FG011|Overall Study|Lack of Efficacy|3|||
106049625|NCT02202980|365846698|FG012|Overall Study|Lack of Efficacy|10|||
106049626|NCT02202980|365846699|FG013|Overall Study|Lack of Efficacy|0|||
106049627|NCT02202980|365846686|FG000|Overall Study|Protocol Violation|0|||
106049628|NCT02202980|365846687|FG001|Overall Study|Protocol Violation|0|||
106049629|NCT02202980|365846688|FG002|Overall Study|Protocol Violation|0|||
106049630|NCT02202980|365846689|FG003|Overall Study|Protocol Violation|3|||
106049631|NCT02202980|365846690|FG004|Overall Study|Protocol Violation|3|||
106049632|NCT02202980|365846691|FG005|Overall Study|Protocol Violation|0|||
106049633|NCT02202980|365846692|FG006|Overall Study|Protocol Violation|0|||
106049634|NCT02202980|365846693|FG007|Overall Study|Protocol Violation|0|||
106049635|NCT02202980|365846694|FG008|Overall Study|Protocol Violation|0|||
106049636|NCT02202980|365846695|FG009|Overall Study|Protocol Violation|0|||
106049637|NCT02202980|365846696|FG010|Overall Study|Protocol Violation|0|||
106049638|NCT02202980|365846697|FG011|Overall Study|Protocol Violation|0|||
106049639|NCT02202980|365846698|FG012|Overall Study|Protocol Violation|0|||
106049640|NCT02202980|365846699|FG013|Overall Study|Protocol Violation|0|||
106049641|NCT02202980|365846686|FG000|Overall Study|Lost to Follow-up|0|||
106049642|NCT02202980|365846687|FG001|Overall Study|Lost to Follow-up|1|||
106049643|NCT02202980|365846688|FG002|Overall Study|Lost to Follow-up|1|||
106049644|NCT02202980|365846689|FG003|Overall Study|Lost to Follow-up|1|||
106049645|NCT02202980|365846690|FG004|Overall Study|Lost to Follow-up|0|||
106049646|NCT02202980|365846691|FG005|Overall Study|Lost to Follow-up|0|||
106049647|NCT02202980|365846692|FG006|Overall Study|Lost to Follow-up|0|||
106049648|NCT02202980|365846693|FG007|Overall Study|Lost to Follow-up|1|||
106049649|NCT02202980|365846694|FG008|Overall Study|Lost to Follow-up|1|||
106049650|NCT02202980|365846695|FG009|Overall Study|Lost to Follow-up|0|||
106049651|NCT02202980|365846696|FG010|Overall Study|Lost to Follow-up|0|||
106049652|NCT02202980|365846697|FG011|Overall Study|Lost to Follow-up|0|||
106049653|NCT02202980|365846698|FG012|Overall Study|Lost to Follow-up|1|||
106049654|NCT02202980|365846699|FG013|Overall Study|Lost to Follow-up|0|||
106049655|NCT02202980|365846686|FG000|Overall Study|Withdrew Consent|0|||
106049656|NCT02202980|365846687|FG001|Overall Study|Withdrew Consent|1|||
106049657|NCT02202980|365846688|FG002|Overall Study|Withdrew Consent|2|||
106049658|NCT02202980|365846689|FG003|Overall Study|Withdrew Consent|0|||
106049659|NCT02202980|365846690|FG004|Overall Study|Withdrew Consent|0|||
106049660|NCT02202980|365846691|FG005|Overall Study|Withdrew Consent|0|||
106049661|NCT02202980|365846692|FG006|Overall Study|Withdrew Consent|0|||
106049662|NCT02202980|365846693|FG007|Overall Study|Withdrew Consent|0|||
106049663|NCT02202980|365846694|FG008|Overall Study|Withdrew Consent|1|||
106049664|NCT02202980|365846695|FG009|Overall Study|Withdrew Consent|0|||
106049665|NCT02202980|365846696|FG010|Overall Study|Withdrew Consent|0|||
106049666|NCT02202980|365846697|FG011|Overall Study|Withdrew Consent|0|||
106049667|NCT02202980|365846698|FG012|Overall Study|Withdrew Consent|0|||
106049668|NCT02202980|365846699|FG013|Overall Study|Withdrew Consent|0|||
106049669|NCT01952145|365846700|FG000|Overall Study|Protocol Violation|2|||
106049670|NCT01952145|365846701|FG001|Overall Study|Protocol Violation|1|||
106049671|NCT01952145|365846700|FG000|Overall Study|Death|0|||
106049672|NCT01952145|365846701|FG001|Overall Study|Death|1|||
106049673|NCT01952145|365846700|FG000|Overall Study|Adverse Event|9|||
106049674|NCT01952145|365846701|FG001|Overall Study|Adverse Event|0|||
106049675|NCT01952145|365846700|FG000|Overall Study|Withdrawal Criteria|16|||
106049676|NCT01952145|365846701|FG001|Overall Study|Withdrawal Criteria|11|||
106049677|NCT01952145|365846700|FG000|Overall Study|Unclassified|1|||
106049678|NCT01952145|365846701|FG001|Overall Study|Unclassified|1|||
106049679|NCT02747875|365846702|FG000|Overall Study|Physician Decision|1|||
106049680|NCT02747875|365846703|FG001|Overall Study|Physician Decision|0|||
106049681|NCT02747875|365846702|FG000|Overall Study|Adverse Event|0|||
106049682|NCT02747875|365846703|FG001|Overall Study|Adverse Event|1|||
106049683|NCT02191137|365846704|FG000|Treatment|Death|4|||
106049684|NCT02191137|365846704|FG000|Treatment|Withdrawal by Subject|3|||
106049685|NCT02191137|365846704|FG000|Treatment|Adverse Event|2|||
106049686|NCT02191137|365846704|FG000|Treatment|Other|1|||
106049687|NCT02191137|365846704|FG000|Follow-up|Lost to Follow-up|2|||
106049688|NCT02191137|365846704|FG000|Follow-up|Ongoing/unknown|2|||
106049689|NCT02191137|365846704|FG000|Follow-up|Adverse Event|1|||
106049690|NCT00178633|365846705|FG000|Overall Study|Lost to Follow-up|6|||
106049691|NCT02590003|365846706|FG000|Overall Study|Death|1|||
106049692|NCT02590003|365846707|FG001|Overall Study|Death|2|||
106049693|NCT00696800|365846708|FG000|Overall Study|Adverse Event|16|||
106049694|NCT00696800|365846709|FG001|Overall Study|Adverse Event|3|||
106049695|NCT00696800|365846708|FG000|Overall Study|Insufficient compliance with medication|2|||
106049696|NCT00696800|365846709|FG001|Overall Study|Insufficient compliance with medication|1|||
106049697|NCT00696800|365846708|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
106049698|NCT00696800|365846709|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
106049699|NCT00696800|365846708|FG000|Overall Study|Insufficient ovarian response|4|||
106049700|NCT00696800|365846709|FG001|Overall Study|Insufficient ovarian response|1|||
106049701|NCT00696800|365846708|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
106049702|NCT00696800|365846709|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
106049703|NCT00696800|365846708|FG000|Overall Study|Too high ovarian response|6|||
106049704|NCT00696800|365846709|FG001|Overall Study|Too high ovarian response|1|||
106049705|NCT00696800|365846708|FG000|Overall Study|No/too few/bad quality oocytes|4|||
106049706|NCT00696800|365846709|FG001|Overall Study|No/too few/bad quality oocytes|3|||
106049707|NCT00696800|365846708|FG000|Overall Study|No/abnormal fertilization|11|||
106049708|NCT00696800|365846709|FG001|Overall Study|No/abnormal fertilization|13|||
106049709|NCT00696800|365846708|FG000|Overall Study|No/too few/bad quality embryos|24|||
106049710|NCT00696800|365846709|FG001|Overall Study|No/too few/bad quality embryos|18|||
106049711|NCT00696800|365846708|FG000|Overall Study|Other Reasons|5|||
106049712|NCT00696800|365846709|FG001|Overall Study|Other Reasons|3|||
106049713|NCT00696800|365846708|FG000|Overall Study|Not treated|1|||
106049714|NCT00696800|365846709|FG001|Overall Study|Not treated|2|||
106049715|NCT00762385|365846713|FG000|First Intervention|Lens Issue|1|||
106049716|NCT00762385|365846714|FG001|First Intervention|Lens Issue|1|||
106049717|NCT00762385|365846713|FG000|First Intervention|Lost to Follow-up|0|||
106049718|NCT00762385|365846714|FG001|First Intervention|Lost to Follow-up|2|||
106049719|NCT00762385|365846713|FG000|First Intervention|Ineligible|1|||
106049720|NCT00762385|365846714|FG001|First Intervention|Ineligible|0|||
106049721|NCT00762385|365846713|FG000|First Intervention|Protocol Violation|0|||
106049722|NCT00762385|365846714|FG001|First Intervention|Protocol Violation|1|||
106049723|NCT00762385|365846713|FG000|Second Intervention|Protocol Violation|3|||
106049724|NCT00762385|365846714|FG001|Second Intervention|Protocol Violation|3|||
106049725|NCT03863197|365846717|FG000|Overall Study|Lost to Follow-up|2|||
106049726|NCT03863197|365846718|FG001|Overall Study|Lost to Follow-up|3|||
106049727|NCT03863197|365846717|FG000|Overall Study|Withdrawal by Subject|4|||
106049728|NCT03863197|365846718|FG001|Overall Study|Withdrawal by Subject|0|||
106049729|NCT03863197|365846717|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
106049730|NCT03863197|365846718|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
106049731|NCT05338216|365846723|FG000|Overall Study|Withdrawal by Subject|1|||
106049732|NCT05338216|365846724|FG001|Overall Study|Withdrawal by Subject|1|||
106049733|NCT05224141|365846729|FG000|Overall Study|Ongoing|75|||
106049734|NCT05224141|365846730|FG001|Overall Study|Ongoing|88|||
106049735|NCT05224141|365846729|FG000|Overall Study|Withdrawal by Subject|2|||
106049736|NCT05224141|365846730|FG001|Overall Study|Withdrawal by Subject|4|||
106049737|NCT05224141|365846729|FG000|Overall Study|Death|153|||
106049738|NCT05224141|365846730|FG001|Overall Study|Death|138|||
106049739|NCT01781975|365846731|FG000|Overall Study|Death|1|||
106049740|NCT01781975|365846732|FG001|Overall Study|Death|0|||
106049741|NCT01781975|365846731|FG000|Overall Study|Withdrawal by Subject|1|||
106049742|NCT01781975|365846732|FG001|Overall Study|Withdrawal by Subject|1|||
106049743|NCT01622231|365846734|FG000|Overall Study|Physician Decision|1|||
106049744|NCT01622231|365846734|FG000|Overall Study|Withdrawal by Subject|1|||
106049745|NCT02404220|365846735|FG000|Overall Study|Adverse Event|0|||
106049746|NCT02404220|365846736|FG001|Overall Study|Adverse Event|0|||
106049747|NCT02404220|365846737|FG002|Overall Study|Adverse Event|1|||
106049748|NCT02404220|365846738|FG003|Overall Study|Adverse Event|0|||
106049749|NCT02404220|365846735|FG000|Overall Study|Death|5|||
106049750|NCT02404220|365846736|FG001|Overall Study|Death|5|||
106049751|NCT02404220|365846737|FG002|Overall Study|Death|3|||
106049752|NCT02404220|365846738|FG003|Overall Study|Death|8|||
106049753|NCT02404220|365846735|FG000|Overall Study|Progressive Disease|0|||
106049754|NCT02404220|365846736|FG001|Overall Study|Progressive Disease|0|||
106049755|NCT02404220|365846737|FG002|Overall Study|Progressive Disease|1|||
106049756|NCT02404220|365846738|FG003|Overall Study|Progressive Disease|1|||
106049757|NCT02404220|365846735|FG000|Overall Study|Study Terminated by Sponsor|0|||
106049758|NCT02404220|365846736|FG001|Overall Study|Study Terminated by Sponsor|0|||
106049759|NCT02404220|365846737|FG002|Overall Study|Study Terminated by Sponsor|2|||
106049760|NCT02404220|365846738|FG003|Overall Study|Study Terminated by Sponsor|1|||
106049761|NCT02404220|365846735|FG000|Overall Study|Withdrawal by Subject|0|||
106049762|NCT02404220|365846736|FG001|Overall Study|Withdrawal by Subject|1|||
106049763|NCT02404220|365846737|FG002|Overall Study|Withdrawal by Subject|0|||
106049764|NCT02404220|365846738|FG003|Overall Study|Withdrawal by Subject|0|||
106049765|NCT02404220|365846735|FG000|Overall Study|Enrolled but Never Treated|0|||
106049766|NCT02404220|365846736|FG001|Overall Study|Enrolled but Never Treated|2|||
106049767|NCT02404220|365846737|FG002|Overall Study|Enrolled but Never Treated|0|||
106049768|NCT02404220|365846738|FG003|Overall Study|Enrolled but Never Treated|0|||
106049769|NCT03469934|365846741|FG000|Overall Study|Withdrawal by Subject|0|||
106049770|NCT03469934|365846742|FG001|Overall Study|Withdrawal by Subject|1|||
106049771|NCT02589405|365846746|FG000|Overall Study|Adverse Event|3|||
106049772|NCT02589405|365846746|FG000|Overall Study|Withdrawal by Subject|1|||
106049773|NCT02905149|365846748|FG000|Overall Study|Lost to Follow-up|2|||
106049774|NCT02905149|365846749|FG001|Overall Study|Lost to Follow-up|0|||
106049775|NCT02329080|365846750|FG000|Overall Study|Adverse Event|1|||
106049776|NCT02329080|365846750|FG000|Overall Study|Death|4|||
106049777|NCT02329080|365846750|FG000|Overall Study|Lack of Efficacy|22|||
106049778|NCT02329080|365846750|FG000|Overall Study|Lost to Follow-up|1|||
106049779|NCT02329080|365846750|FG000|Overall Study|Physician Decision|2|||
106049780|NCT02329080|365846750|FG000|Overall Study|Partial response|4|||
106049781|NCT02329080|365846750|FG000|Overall Study|Complete response|4|||
106049782|NCT03725852|365846752|FG000|Overall Study|Death|1|||
106049783|NCT03725852|365846753|FG001|Overall Study|Death|0|||
106049784|NCT03725852|365846752|FG000|Overall Study|Withdrawal by Subject|1|||
106049785|NCT03725852|365846753|FG001|Overall Study|Withdrawal by Subject|0|||
106049786|NCT03725852|365846752|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
106049787|NCT03725852|365846753|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
106049788|NCT00753766|365846758|FG000|Overall Study|Physician Decision|1|||
106049789|NCT00753766|365846759|FG001|Overall Study|Physician Decision|0|||
106049790|NCT01313312|365846764|FG000|Overall Study|Adverse Event|5|||
106049791|NCT01313312|365846764|FG000|Overall Study|Withdrawal by Subject|18|||
106049792|NCT01313312|365846764|FG000|Overall Study|Lack of Efficacy|3|||
106049793|NCT01313312|365846764|FG000|Overall Study|Investigator Decision|1|||
106049794|NCT01313312|365846764|FG000|Overall Study|Observational Phase|1|||
106049795|NCT01313312|365846764|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
106049796|NCT01313312|365846764|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
106049797|NCT02846324|365846765|FG000|Overall Study|Other|1|||
106049798|NCT02846324|365846766|FG001|Overall Study|Other|0|||
106049799|NCT02846324|365846767|FG002|Overall Study|Other|0|||
106049800|NCT02846324|365846768|FG003|Overall Study|Other|0|||
106049801|NCT02846324|365846765|FG000|Overall Study|Withdrawal by Subject|1|||
106049802|NCT02846324|365846766|FG001|Overall Study|Withdrawal by Subject|0|||
106049803|NCT02846324|365846767|FG002|Overall Study|Withdrawal by Subject|4|||
106049804|NCT02846324|365846768|FG003|Overall Study|Withdrawal by Subject|0|||
106049805|NCT01927627|365846770|FG000|Overall Study|Adverse Event|3|||
106049806|NCT01927627|365846770|FG000|Overall Study|Lack of Efficacy|1|||
106049807|NCT01927627|365846770|FG000|Overall Study|Financial Concerns|1|||
106049808|NCT00788073|365846771|FG000|STX209 Then Placebo|Adverse Event|1|||
106049809|NCT00788073|365846772|FG001|STX209 Then Placebo|Adverse Event|0|||
106049810|NCT00788073|365846771|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
106049811|NCT00788073|365846772|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
106049812|NCT00788073|365846771|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
106049813|NCT00788073|365846772|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
106049814|NCT00788073|365846771|FG000|STX209 Then Placebo|unable to return due to travel|0|||
106049815|NCT00788073|365846772|FG001|STX209 Then Placebo|unable to return due to travel|1|||
106049816|NCT00788073|365846771|FG000|Placebo Then STX209|Adverse Event|2|||
106049817|NCT00788073|365846772|FG001|Placebo Then STX209|Adverse Event|0|||
106049818|NCT00788073|365846771|FG000|Placebo Then STX209|Protocol Violation|0|||
106049819|NCT00788073|365846772|FG001|Placebo Then STX209|Protocol Violation|1|||
106049820|NCT01786148|365846773|FG000|Overall Study|Lost to Follow-up|21|||
106049821|NCT01786148|365846774|FG001|Overall Study|Lost to Follow-up|13|||
106049822|NCT01786148|365846773|FG000|Overall Study|Death|0|||
106049823|NCT01786148|365846774|FG001|Overall Study|Death|1|||
106049824|NCT01786148|365846773|FG000|Overall Study|Withdrawal by Subject|0|||
106049825|NCT01786148|365846774|FG001|Overall Study|Withdrawal by Subject|7|||
106049826|NCT01786148|365846773|FG000|Overall Study|Incarceration|1|||
106049827|NCT01786148|365846774|FG001|Overall Study|Incarceration|1|||
106049828|NCT00806351|365846775|FG000|Overall Study|Death|5|||
106049829|NCT00806351|365846776|FG001|Overall Study|Death|4|||
106049830|NCT02059408|365846777|FG000|Overall Study|Did not get tested|0|||
106049831|NCT02059408|365846778|FG001|Overall Study|Did not get tested|330|||
106049832|NCT02059408|365846779|FG002|Overall Study|Did not get tested|358|||
106049833|NCT00508755|365846780|FG000|Overall Study|Withdrawal by Subject|1|||
106049834|NCT01681472|365846781|FG000|Overall Study|Adverse Event|0|||
106049835|NCT01681472|365846782|FG001|Overall Study|Adverse Event|1|||
106049836|NCT01681472|365846783|FG002|Overall Study|Adverse Event|0|||
106049837|NCT01681472|365846784|FG003|Overall Study|Adverse Event|0|||
106049838|NCT04057365|365846785|FG000|Overall Study|Withdrawal by Subject|2|||
106049839|NCT04057365|365846786|FG001|Overall Study|Withdrawal by Subject|0|||
106049840|NCT00437983|365846788|FG000|Overall Study|Adverse Event|6|||
106049841|NCT00437983|365846789|FG001|Overall Study|Adverse Event|6|||
106049842|NCT00437983|365846788|FG000|Overall Study|Protocol Violation|2|||
106049843|NCT00437983|365846789|FG001|Overall Study|Protocol Violation|1|||
106049844|NCT00437983|365846788|FG000|Overall Study|Withdrawal by Subject|5|||
106049845|NCT00437983|365846789|FG001|Overall Study|Withdrawal by Subject|6|||
106049846|NCT01999179|365846790|FG000|Overall Study|Adverse Event|1|||
106049847|NCT01999179|365846790|FG000|Overall Study|Lost to Follow-up|1|||
106049848|NCT01999179|365846790|FG000|Overall Study|Change in Therapy|3|||
106049849|NCT01999179|365846790|FG000|Overall Study|New catheter|2|||
106049850|NCT04439201|365846791|FG000|Overall Study|Ineligible|2|||
106049851|NCT04439201|365846791|FG000|Overall Study|Never start protocol therapy|1|||
106049852|NCT04439201|365846791|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
106049853|NCT04439201|365846791|FG000|Overall Study|Mutation status not confirmed|4|||
106049854|NCT04439201|365846791|FG000|Overall Study|Adverse Event|1|||
106049855|NCT04439201|365846791|FG000|Overall Study|Death|7|||
106049856|NCT04439201|365846791|FG000|Overall Study|Withdrawal by Subject|2|||
106049857|NCT04439201|365846791|FG000|Overall Study|Disease progression|20|||
106049858|NCT04439201|365846791|FG000|Overall Study|Alternative therapy|1|||
106049859|NCT04439201|365846791|FG000|Overall Study|Physician Decision|1|||
106049860|NCT03100149|365846794|FG000|Overall Study|Adverse Event|0|||
106049861|NCT03100149|365846795|FG001|Overall Study|Adverse Event|1|||
106049862|NCT03100149|365846796|FG002|Overall Study|Adverse Event|0|||
106049863|NCT03100149|365846794|FG000|Overall Study|Participant Moved out of Country|0|||
106049864|NCT03100149|365846795|FG001|Overall Study|Participant Moved out of Country|0|||
106049865|NCT03100149|365846796|FG002|Overall Study|Participant Moved out of Country|1|||
106049866|NCT03100149|365846794|FG000|Overall Study|Withdrawal by Subject|0|||
106049867|NCT03100149|365846795|FG001|Overall Study|Withdrawal by Subject|3|||
106049868|NCT03100149|365846796|FG002|Overall Study|Withdrawal by Subject|1|||
106049869|NCT00983437|365847846|FG000|Overall Study|Adverse Event|9|||
106049870|NCT00983437|365847846|FG000|Overall Study|Lack of Efficacy|1|||
106049871|NCT00983437|365847846|FG000|Overall Study|Withdrawal by Subject|8|||
106049872|NCT00983437|365847846|FG000|Overall Study|Noncompliance to Study Procedures|1|||
106049873|NCT00983437|365847846|FG000|Overall Study|Lost to Follow-up|2|||
106049874|NCT00983437|365847846|FG000|Overall Study|Other Reason|26|||
106049875|NCT01626456|365847849|FG000|Overall Study|Withdrawal by Subject|21|||
106049876|NCT01626456|365847850|FG001|Overall Study|Withdrawal by Subject|46|||
106049877|NCT01626456|365847849|FG000|Overall Study|Adverse Event|2|||
106049878|NCT01626456|365847850|FG001|Overall Study|Adverse Event|27|||
106049879|NCT01626456|365847849|FG000|Overall Study|Lost to Follow-up|2|||
106049880|NCT01626456|365847850|FG001|Overall Study|Lost to Follow-up|27|||
106049881|NCT01626456|365847849|FG000|Overall Study|Lack of Efficacy|6|||
106049882|NCT01626456|365847850|FG001|Overall Study|Lack of Efficacy|7|||
106049883|NCT01626456|365847849|FG000|Overall Study|Physician Decision|1|||
106049884|NCT01626456|365847850|FG001|Overall Study|Physician Decision|4|||
106049885|NCT01626456|365847849|FG000|Overall Study|Protocol Violation|1|||
106049886|NCT01626456|365847850|FG001|Overall Study|Protocol Violation|1|||
106049887|NCT01626456|365847849|FG000|Overall Study|Site Closure|2|||
106049888|NCT01626456|365847850|FG001|Overall Study|Site Closure|3|||
106049889|NCT01626456|365847849|FG000|Overall Study|Incarceration|0|||
106049890|NCT01626456|365847850|FG001|Overall Study|Incarceration|2|||
106049891|NCT00713323|365847851|FG000|Overall Study|Adverse Event|75|||
106049892|NCT00713323|365847851|FG000|Overall Study|Withdrawal by Subject|15|||
106049893|NCT00713323|365847851|FG000|Overall Study|Lost to Follow-up|11|||
106049894|NCT00713323|365847851|FG000|Overall Study|Lack of Efficacy|36|||
106049895|NCT00713323|365847851|FG000|Overall Study|Low creatine clearance at screening|1|||
106049896|NCT00713323|365847851|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
106049897|NCT00713323|365847851|FG000|Overall Study|Surgery cured allodynic pain|1|||
106049898|NCT00713323|365847851|FG000|Overall Study|Pain free|1|||
106049899|NCT00713323|365847851|FG000|Overall Study|Non-compliance|1|||
106049900|NCT00713323|365847851|FG000|Overall Study|Pain resolved|1|||
106049901|NCT00713323|365847851|FG000|Overall Study|Subject travelling to USA|1|||
106049902|NCT00713323|365847851|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
106049903|NCT00713323|365847851|FG000|Overall Study|Treatment that may interact with Sativex|1|||
106049904|NCT00506662|365847852|FG000|Overall Study|Adverse Event|0|||
106049905|NCT00506662|365847853|FG001|Overall Study|Adverse Event|2|||
106049906|NCT00506662|365847852|FG000|Overall Study|Lack of Efficacy|1|||
106049907|NCT00506662|365847853|FG001|Overall Study|Lack of Efficacy|0|||
106049908|NCT00506662|365847852|FG000|Overall Study|Protocol Violation|2|||
106049909|NCT00506662|365847853|FG001|Overall Study|Protocol Violation|4|||
106049910|NCT00506662|365847852|FG000|Overall Study|Trial terminated|10|||
106049911|NCT00506662|365847853|FG001|Overall Study|Trial terminated|16|||
106049912|NCT00506662|365847852|FG000|Overall Study|Not recorded|4|||
106049913|NCT00506662|365847853|FG001|Overall Study|Not recorded|6|||
106049914|NCT05096221|365847855|FG000|Part 2|Physician Decision|0|||
106049915|NCT05096221|365847856|FG001|Part 2|Physician Decision|1|||
106049916|NCT00434954|365847859|FG000|Overall Study|Adverse Event|17|||
106049917|NCT00434954|365847860|FG001|Overall Study|Adverse Event|2|||
106049918|NCT00434954|365847859|FG000|Overall Study|Entry criteria not met|14|||
106049919|NCT00434954|365847860|FG001|Overall Study|Entry criteria not met|16|||
106049920|NCT00434954|365847859|FG000|Overall Study|Lost to Follow-up|0|||
106049921|NCT00434954|365847860|FG001|Overall Study|Lost to Follow-up|1|||
106049922|NCT00434954|365847859|FG000|Overall Study|Physician Decision|6|||
106049923|NCT00434954|365847860|FG001|Overall Study|Physician Decision|3|||
106049924|NCT00434954|365847859|FG000|Overall Study|Protocol Violation|36|||
106049925|NCT00434954|365847860|FG001|Overall Study|Protocol Violation|27|||
106049926|NCT00434954|365847859|FG000|Overall Study|Sponsor decision|1|||
106049927|NCT00434954|365847860|FG001|Overall Study|Sponsor decision|0|||
106049928|NCT00434954|365847859|FG000|Overall Study|Subject decision|8|||
106049929|NCT00434954|365847860|FG001|Overall Study|Subject decision|22|||
106049930|NCT04891978|365847865|FG000|Baseline|Protocol Violation|2|||
106049931|NCT04891978|365847866|FG001|Baseline|Protocol Violation|1|||
106049932|NCT04891978|365847867|FG002|Baseline|Protocol Violation|0|||
106049933|NCT04891978|365847865|FG000|Baseline|Missing AIRQ|1|||
106049934|NCT04891978|365847866|FG001|Baseline|Missing AIRQ|0|||
106049935|NCT04891978|365847867|FG002|Baseline|Missing AIRQ|0|||
106049936|NCT04891978|365847865|FG000|Baseline|Did not attend a baseline visit|0|||
106049937|NCT04891978|365847866|FG001|Baseline|Did not attend a baseline visit|0|||
106049938|NCT04891978|365847867|FG002|Baseline|Did not attend a baseline visit|9|||
106049939|NCT01696695|365847868|FG000|Overall Study|Disease progression|373|||
106049940|NCT01696695|365847868|FG000|Overall Study|Death|29|||
106049941|NCT01696695|365847868|FG000|Overall Study|Adverse Event|74|||
106049942|NCT01696695|365847868|FG000|Overall Study|Withdrawal by Subject|92|||
106049943|NCT01696695|365847868|FG000|Overall Study|Lost to Follow-up|48|||
106049944|NCT01696695|365847868|FG000|Overall Study|Other|74|||
106049945|NCT01696695|365847868|FG000|Overall Study|Major Protocol Violation|192|||
106049946|NCT03570697|365847869|FG000|Overall Study|Lost to Follow-up|0|||
106049947|NCT03570697|365847870|FG001|Overall Study|Lost to Follow-up|1|||
106049948|NCT03570697|365847869|FG000|Overall Study|Death|2|||
106049949|NCT03570697|365847870|FG001|Overall Study|Death|0|||
106049950|NCT03570697|365847869|FG000|Overall Study|Withdrawal by Subject|4|||
106049951|NCT03570697|365847870|FG001|Overall Study|Withdrawal by Subject|2|||
106049952|NCT03173313|365847871|FG000|Overall Study|Lost to Follow-up|2|||
106049953|NCT03173313|365847872|FG001|Overall Study|Lost to Follow-up|3|||
106049954|NCT03173313|365847871|FG000|Overall Study|Withdrawal by Subject|0|||
106049955|NCT03173313|365847872|FG001|Overall Study|Withdrawal by Subject|1|||
106049956|NCT03173313|365847871|FG000|Overall Study|Death|5|||
106049957|NCT03173313|365847872|FG001|Overall Study|Death|0|||
106049958|NCT03173313|365847871|FG000|Overall Study|Physician Decision|1|||
106049959|NCT03173313|365847872|FG001|Overall Study|Physician Decision|0|||
106049960|NCT03173313|365847871|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
106049961|NCT03173313|365847872|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
106049962|NCT03173313|365847871|FG000|Overall Study|Bone Fracture|1|||
106049963|NCT03173313|365847872|FG001|Overall Study|Bone Fracture|0|||
106049964|NCT00413244|365847889|FG000|Overall Study|Withdrawal by Subject|10|||
106049965|NCT00413244|365847890|FG001|Overall Study|Withdrawal by Subject|1|||
106049966|NCT00446251|365847897|FG000|Overall Study|On-study Transplants|2|||
106049967|NCT00446251|365847897|FG000|Overall Study|Rituximab Infusion Reaction|2|||
106049968|NCT00446251|365847897|FG000|Overall Study|Lost to Follow-up|1|||
106049969|NCT01042678|365847901|FG000|Overall Study|Physician Decision|1|||
106049970|NCT01042678|365847902|FG001|Overall Study|Physician Decision|0|||
106049971|NCT01042678|365847903|FG002|Overall Study|Physician Decision|0|||
106049972|NCT01042678|365847904|FG003|Overall Study|Physician Decision|0|||
106049973|NCT01042678|365847905|FG004|Overall Study|Physician Decision|0|||
106049974|NCT01042678|365847906|FG005|Overall Study|Physician Decision|0|||
106049975|NCT01058655|365847910|FG000|Overall Study|Withdrawal by Subject|1|||
106049976|NCT01058655|365847911|FG001|Overall Study|Withdrawal by Subject|0|||
106049977|NCT01058655|365847912|FG002|Overall Study|Withdrawal by Subject|3|||
106049978|NCT01058655|365847913|FG003|Overall Study|Withdrawal by Subject|4|||
106049979|NCT01058655|365847910|FG000|Overall Study|Prolonged Treatment Delay|0|||
106049980|NCT01058655|365847911|FG001|Overall Study|Prolonged Treatment Delay|0|||
106049981|NCT01058655|365847912|FG002|Overall Study|Prolonged Treatment Delay|0|||
106049982|NCT01058655|365847913|FG003|Overall Study|Prolonged Treatment Delay|2|||
106049983|NCT01058655|365847910|FG000|Overall Study|Symptomatic Deterioration|0|||
106049984|NCT01058655|365847911|FG001|Overall Study|Symptomatic Deterioration|0|||
106049985|NCT01058655|365847912|FG002|Overall Study|Symptomatic Deterioration|0|||
106049986|NCT01058655|365847913|FG003|Overall Study|Symptomatic Deterioration|1|||
106049987|NCT01058655|365847910|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
106049988|NCT01058655|365847911|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
106049989|NCT01058655|365847912|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
106049990|NCT01058655|365847913|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
106049991|NCT01058655|365847910|FG000|Overall Study|Death|0|||
106049992|NCT01058655|365847911|FG001|Overall Study|Death|1|||
106049993|NCT01058655|365847912|FG002|Overall Study|Death|1|||
106049994|NCT01058655|365847913|FG003|Overall Study|Death|0|||
106049995|NCT01058655|365847910|FG000|Overall Study|Disease Progression|1|||
106049996|NCT01058655|365847911|FG001|Overall Study|Disease Progression|2|||
106049997|NCT01058655|365847912|FG002|Overall Study|Disease Progression|4|||
106049998|NCT01058655|365847913|FG003|Overall Study|Disease Progression|24|||
106049999|NCT01058655|365847910|FG000|Overall Study|Other|0|||
106050000|NCT01058655|365847911|FG001|Overall Study|Other|0|||
106050001|NCT01058655|365847912|FG002|Overall Study|Other|0|||
106050002|NCT01058655|365847913|FG003|Overall Study|Other|4|||
106050003|NCT04472429|365847916|FG000|Randomized Period|Ongoing|90|||
106050004|NCT04472429|365847917|FG001|Randomized Period|Ongoing|40|||
106050005|NCT04472429|365847918|FG002|Randomized Period|Ongoing|0|||
106050006|NCT04472429|365847916|FG000|Randomized Period|Death|52|||
106050007|NCT04472429|365847917|FG001|Randomized Period|Death|37|||
106050008|NCT04472429|365847918|FG002|Randomized Period|Death|0|||
106050009|NCT04472429|365847916|FG000|Randomized Period|Lost to Follow-up|4|||
106050010|NCT04472429|365847917|FG001|Randomized Period|Lost to Follow-up|0|||
106050011|NCT04472429|365847918|FG002|Randomized Period|Lost to Follow-up|0|||
106050012|NCT04472429|365847916|FG000|Randomized Period|Physician Decision|1|||
106050013|NCT04472429|365847917|FG001|Randomized Period|Physician Decision|2|||
106050014|NCT04472429|365847918|FG002|Randomized Period|Physician Decision|0|||
106050015|NCT04472429|365847916|FG000|Randomized Period|Withdrawal by Subject|6|||
106050016|NCT04472429|365847917|FG001|Randomized Period|Withdrawal by Subject|5|||
106050017|NCT04472429|365847918|FG002|Randomized Period|Withdrawal by Subject|0|||
106050018|NCT04472429|365847916|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
106050019|NCT04472429|365847917|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
106050020|NCT04472429|365847918|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
106050021|NCT04472429|365847916|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
106050022|NCT04472429|365847917|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
106050023|NCT04472429|365847918|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
106050024|NCT04472429|365847916|FG000|Open-label Monotherapy Period|Ongoing|0|||
106050025|NCT04472429|365847917|FG001|Open-label Monotherapy Period|Ongoing|0|||
106050026|NCT04472429|365847918|FG002|Open-label Monotherapy Period|Ongoing|32|||
106050027|NCT04472429|365847916|FG000|Open-label Monotherapy Period|Death|0|||
106050028|NCT04472429|365847917|FG001|Open-label Monotherapy Period|Death|0|||
106050029|NCT04472429|365847918|FG002|Open-label Monotherapy Period|Death|35|||
106050030|NCT04472429|365847916|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
106050031|NCT04472429|365847917|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
106050032|NCT04472429|365847918|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
106050033|NCT02319837|365847919|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
106050034|NCT02319837|365847920|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
106050035|NCT02319837|365847921|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
106050036|NCT02319837|365847919|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
106050037|NCT02319837|365847920|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
106050038|NCT02319837|365847921|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
106050039|NCT02319837|365847919|FG000|Study Treatment Phase|Adverse Event|73|||
106050040|NCT02319837|365847920|FG001|Study Treatment Phase|Adverse Event|36|||
106050041|NCT02319837|365847921|FG002|Study Treatment Phase|Adverse Event|63|||
106050042|NCT02319837|365847919|FG000|Study Treatment Phase|Development of castration resistance|0|||
106050043|NCT02319837|365847920|FG001|Study Treatment Phase|Development of castration resistance|2|||
106050044|NCT02319837|365847921|FG002|Study Treatment Phase|Development of castration resistance|0|||
106050045|NCT02319837|365847919|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
106050046|NCT02319837|365847920|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
106050047|NCT02319837|365847921|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
106050048|NCT02319837|365847919|FG000|Study Treatment Phase|Protocol Violation|2|||
106050049|NCT02319837|365847920|FG001|Study Treatment Phase|Protocol Violation|2|||
106050050|NCT02319837|365847921|FG002|Study Treatment Phase|Protocol Violation|1|||
106050051|NCT02319837|365847919|FG000|Study Treatment Phase|Lost to Follow-up|0|||
106050052|NCT02319837|365847920|FG001|Study Treatment Phase|Lost to Follow-up|1|||
106050053|NCT02319837|365847921|FG002|Study Treatment Phase|Lost to Follow-up|0|||
106050054|NCT02319837|365847919|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
106050055|NCT02319837|365847920|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
106050056|NCT02319837|365847921|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
106050057|NCT02319837|365847919|FG000|Study Treatment Phase|Other|0|||
106050058|NCT02319837|365847920|FG001|Study Treatment Phase|Other|1|||
106050059|NCT02319837|365847921|FG002|Study Treatment Phase|Other|0|||
106050060|NCT02319837|365847919|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
106050061|NCT02319837|365847920|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
106050062|NCT02319837|365847921|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
106050063|NCT02319837|365847919|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
106050064|NCT02319837|365847920|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
106050065|NCT02319837|365847921|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
106050066|NCT02319837|365847919|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
106050067|NCT02319837|365847920|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
106050068|NCT02319837|365847921|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
106050069|NCT02319837|365847919|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
106050070|NCT02319837|365847920|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
106050071|NCT02319837|365847921|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
106050072|NCT02319837|365847919|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
106050073|NCT02319837|365847920|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
106050074|NCT02319837|365847921|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
106050075|NCT02319837|365847919|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
106050076|NCT02319837|365847920|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
106050077|NCT02319837|365847921|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
106050078|NCT02319837|365847919|FG000|Long-Term Follow-Up Phase|Death|33|||
106050079|NCT02319837|365847920|FG001|Long-Term Follow-Up Phase|Death|54|||
106050080|NCT02319837|365847921|FG002|Long-Term Follow-Up Phase|Death|42|||
106050081|NCT04203797|365847922|FG000|Overall Study|Adverse Event|1|||
106050082|NCT04203797|365847923|FG001|Overall Study|Adverse Event|0|||
106050083|NCT04203797|365847922|FG000|Overall Study|Did not complete End of Study follow-up|1|||
106050084|NCT04203797|365847923|FG001|Overall Study|Did not complete End of Study follow-up|0|||
106050085|NCT00287365|365847924|FG000|Overall Study|sample not acquired|13|||
106050086|NCT01235689|365847925|FG000|Overall Study|Adverse Event|12|||
106050087|NCT01235689|365847926|FG001|Overall Study|Adverse Event|16|||
106050088|NCT01235689|365847925|FG000|Overall Study|Lack of Efficacy|12|||
106050089|NCT01235689|365847926|FG001|Overall Study|Lack of Efficacy|5|||
106050090|NCT01235689|365847925|FG000|Overall Study|Withdrawal by Subject|3|||
106050091|NCT01235689|365847926|FG001|Overall Study|Withdrawal by Subject|4|||
106050092|NCT01235689|365847925|FG000|Overall Study|Lost to Follow-up|1|||
106050093|NCT01235689|365847926|FG001|Overall Study|Lost to Follow-up|2|||
106050094|NCT01235689|365847925|FG000|Overall Study|Miscellaneous|1|||
106050095|NCT01235689|365847926|FG001|Overall Study|Miscellaneous|5|||
106050096|NCT00415168|365847927|FG000|Overall Study|Death|26|||
106050097|NCT00415168|365847927|FG000|Overall Study|Lost to Follow-up|3|||
106050098|NCT00415168|365847927|FG000|Overall Study|Physician Decision|13|||
106050099|NCT00415168|365847927|FG000|Overall Study|Sponsor Decision|4|||
106050100|NCT00415168|365847927|FG000|Overall Study|Withdrawal by Subject|6|||
106050101|NCT01484275|365847928|FG000|Overall Study|Study terminated by sponsor|28|||
106050102|NCT01484275|365847929|FG001|Overall Study|Study terminated by sponsor|32|||
106050103|NCT01484275|365847928|FG000|Overall Study|Other|10|||
106050104|NCT01484275|365847929|FG001|Overall Study|Other|0|||
106050105|NCT01484275|365847928|FG000|Overall Study|Death|3|||
106050106|NCT01484275|365847929|FG001|Overall Study|Death|4|||
106050107|NCT01484275|365847928|FG000|Overall Study|Withdrawal by Subject|1|||
106050108|NCT01484275|365847929|FG001|Overall Study|Withdrawal by Subject|5|||
106050109|NCT01484275|365847928|FG000|Overall Study|Lost to Follow-up|1|||
106050110|NCT01484275|365847929|FG001|Overall Study|Lost to Follow-up|1|||
106050111|NCT00389597|365847934|FG000|Overall Study|Lost to Follow-up|8|||
106050112|NCT00389597|365847935|FG001|Overall Study|Lost to Follow-up|6|||
106050113|NCT00389597|365847936|FG002|Overall Study|Lost to Follow-up|4|||
106050114|NCT00389597|365847937|FG003|Overall Study|Lost to Follow-up|6|||
106050115|NCT00003487|365847938|FG000|Overall Study|Not evaluable|2|||
106050116|NCT01548287|365847941|FG000|Screening|No reason provided|0|||
106050117|NCT01548287|365847942|FG001|Screening|No reason provided|0|||
106050118|NCT01548287|365847943|FG002|Screening|No reason provided|0|||
106050119|NCT01548287|365847944|FG003|Screening|No reason provided|0|||
106050120|NCT01548287|365847945|FG004|Screening|No reason provided|9|||
106050121|NCT01548287|365847941|FG000|Screening|Did not meet eligibility criteria|0|||
106050122|NCT01548287|365847942|FG001|Screening|Did not meet eligibility criteria|0|||
106050123|NCT01548287|365847943|FG002|Screening|Did not meet eligibility criteria|0|||
106050124|NCT01548287|365847944|FG003|Screening|Did not meet eligibility criteria|0|||
106050125|NCT01548287|365847945|FG004|Screening|Did not meet eligibility criteria|74|||
106050126|NCT01548287|365847941|FG000|Randomized Period|Did not meet inclusion criteria|0|||
106050127|NCT01548287|365847942|FG001|Randomized Period|Did not meet inclusion criteria|0|||
106050128|NCT01548287|365847943|FG002|Randomized Period|Did not meet inclusion criteria|2|||
106050129|NCT01548287|365847944|FG003|Randomized Period|Did not meet inclusion criteria|0|||
106050130|NCT01548287|365847945|FG004|Randomized Period|Did not meet inclusion criteria|0|||
106050131|NCT01548287|365847941|FG000|Randomized Period|Adverse Event|0|||
106050132|NCT01548287|365847942|FG001|Randomized Period|Adverse Event|2|||
106050133|NCT01548287|365847943|FG002|Randomized Period|Adverse Event|5|||
106050134|NCT01548287|365847944|FG003|Randomized Period|Adverse Event|0|||
106050135|NCT01548287|365847945|FG004|Randomized Period|Adverse Event|0|||
106050136|NCT00259610|365847946|FG000|Overall Study|Withdrawal by Subject|33|||
106050137|NCT00259610|365847947|FG001|Overall Study|Withdrawal by Subject|25|||
106050138|NCT00259610|365847948|FG002|Overall Study|Withdrawal by Subject|29|||
106050139|NCT00259610|365847949|FG003|Overall Study|Withdrawal by Subject|19|||
106050140|NCT00259610|365847946|FG000|Overall Study|Lost to Follow-up|19|||
106050141|NCT00259610|365847947|FG001|Overall Study|Lost to Follow-up|8|||
106050142|NCT00259610|365847948|FG002|Overall Study|Lost to Follow-up|18|||
106050143|NCT00259610|365847949|FG003|Overall Study|Lost to Follow-up|15|||
106050144|NCT00259610|365847946|FG000|Overall Study|Physician Decision|6|||
106050145|NCT00259610|365847947|FG001|Overall Study|Physician Decision|4|||
106050146|NCT00259610|365847948|FG002|Overall Study|Physician Decision|7|||
106050147|NCT00259610|365847949|FG003|Overall Study|Physician Decision|2|||
106050148|NCT00259610|365847946|FG000|Overall Study|Death|1|||
106050149|NCT00259610|365847947|FG001|Overall Study|Death|1|||
106050150|NCT00259610|365847948|FG002|Overall Study|Death|2|||
106050151|NCT00259610|365847949|FG003|Overall Study|Death|0|||
106050152|NCT00259610|365847946|FG000|Overall Study|non medical reason|6|||
106050153|NCT00259610|365847947|FG001|Overall Study|non medical reason|2|||
106050154|NCT00259610|365847948|FG002|Overall Study|non medical reason|10|||
106050155|NCT00259610|365847949|FG003|Overall Study|non medical reason|3|||
106050156|NCT00259610|365847946|FG000|Overall Study|Adverse Event|3|||
106050157|NCT00259610|365847947|FG001|Overall Study|Adverse Event|4|||
106050158|NCT00259610|365847948|FG002|Overall Study|Adverse Event|5|||
106050159|NCT00259610|365847949|FG003|Overall Study|Adverse Event|2|||
106050160|NCT00259610|365847946|FG000|Overall Study|Serious Adverse Event|8|||
106050161|NCT00259610|365847947|FG001|Overall Study|Serious Adverse Event|2|||
106050162|NCT00259610|365847948|FG002|Overall Study|Serious Adverse Event|2|||
106050163|NCT00259610|365847949|FG003|Overall Study|Serious Adverse Event|2|||
106050164|NCT00945893|365847951|FG000|Overall Study|Lost to Follow-up|2|||
106050165|NCT00945893|365847952|FG001|Overall Study|Lost to Follow-up|8|||
106050166|NCT00945893|365847951|FG000|Overall Study|Withdrawal of consent|1|||
106050167|NCT00945893|365847952|FG001|Overall Study|Withdrawal of consent|2|||
106050168|NCT03113071|365847953|FG000|Overall Study|Withdrawal by Subject|1|||
106050169|NCT03113071|365847954|FG001|Overall Study|Withdrawal by Subject|0|||
106050170|NCT02564796|365847955|FG000|Overall Study|Physician Decision|2|||
106050171|NCT02564796|365847956|FG001|Overall Study|Physician Decision|2|||
106050172|NCT00002651|365848991|FG000|Induction|Adverse Event|44|||
106050173|NCT00002651|365848992|FG001|Induction|Adverse Event|0|||
106050174|NCT00002651|365848993|FG002|Induction|Adverse Event|0|||
106050175|NCT00002651|365848991|FG000|Induction|Refusal unrelated to adverse event|50|||
106050176|NCT00002651|365848992|FG001|Induction|Refusal unrelated to adverse event|0|||
106050177|NCT00002651|365848993|FG002|Induction|Refusal unrelated to adverse event|0|||
106050178|NCT00002651|365848991|FG000|Induction|Progression/relapse|274|||
106050179|NCT00002651|365848992|FG001|Induction|Progression/relapse|0|||
106050180|NCT00002651|365848993|FG002|Induction|Progression/relapse|0|||
106050181|NCT00002651|365848991|FG000|Induction|Death|62|||
106050182|NCT00002651|365848992|FG001|Induction|Death|0|||
106050183|NCT00002651|365848993|FG002|Induction|Death|0|||
106050184|NCT00002651|365848991|FG000|Induction|Other|823|||
106050185|NCT00002651|365848992|FG001|Induction|Other|0|||
106050186|NCT00002651|365848993|FG002|Induction|Other|0|||
106050187|NCT00002651|365848991|FG000|Induction|not eligible|90|||
106050188|NCT00002651|365848992|FG001|Induction|not eligible|0|||
106050189|NCT00002651|365848993|FG002|Induction|not eligible|0|||
106050190|NCT00002651|365848991|FG000|Consolidation and Randomization|Adverse Event|0|||
106050191|NCT00002651|365848992|FG001|Consolidation and Randomization|Adverse Event|36|||
106050192|NCT00002651|365848993|FG002|Consolidation and Randomization|Adverse Event|14|||
106050193|NCT00002651|365848991|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
106050194|NCT00002651|365848992|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
106050195|NCT00002651|365848993|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
106050196|NCT00002651|365848991|FG000|Consolidation and Randomization|Progression/relapse|0|||
106050197|NCT00002651|365848992|FG001|Consolidation and Randomization|Progression/relapse|295|||
106050198|NCT00002651|365848993|FG002|Consolidation and Randomization|Progression/relapse|298|||
106050199|NCT00002651|365848991|FG000|Consolidation and Randomization|Death|0|||
106050200|NCT00002651|365848992|FG001|Consolidation and Randomization|Death|38|||
106050201|NCT00002651|365848993|FG002|Consolidation and Randomization|Death|48|||
106050202|NCT00002651|365848991|FG000|Consolidation and Randomization|Other|0|||
106050203|NCT00002651|365848992|FG001|Consolidation and Randomization|Other|314|||
106050204|NCT00002651|365848993|FG002|Consolidation and Randomization|Other|313|||
106050205|NCT00002651|365848991|FG000|Consolidation and Randomization|not eligible|0|||
106050206|NCT00002651|365848992|FG001|Consolidation and Randomization|not eligible|102|||
106050207|NCT00002651|365848993|FG002|Consolidation and Randomization|not eligible|112|||
106050208|NCT03750955|365848994|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
106050209|NCT03750955|365848995|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
106050210|NCT03750955|365848994|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
106050211|NCT03750955|365848995|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
106050212|NCT03345914|365848998|FG000|Overall Study|Transition to another study at week 16|80|||
106050213|NCT03345914|365848999|FG001|Overall Study|Transition to another study at week 16|86|||
106050214|NCT03345914|365849000|FG002|Overall Study|Transition to another study at week 16|78|||
106050215|NCT03345914|365848998|FG000|Overall Study|Transition to OLE during follow-up|37|||
106050216|NCT03345914|365848999|FG001|Overall Study|Transition to OLE during follow-up|33|||
106050217|NCT03345914|365849000|FG002|Overall Study|Transition to OLE during follow-up|39|||
106050218|NCT03345914|365848998|FG000|Overall Study|Physician Decision|0|||
106050219|NCT03345914|365848999|FG001|Overall Study|Physician Decision|1|||
106050220|NCT03345914|365849000|FG002|Overall Study|Physician Decision|1|||
106050221|NCT03345914|365848998|FG000|Overall Study|Withdrawal by Subject|5|||
106050222|NCT03345914|365848999|FG001|Overall Study|Withdrawal by Subject|1|||
106050223|NCT03345914|365849000|FG002|Overall Study|Withdrawal by Subject|2|||
106050224|NCT03345914|365848998|FG000|Overall Study|Other|1|||
106050225|NCT03345914|365848999|FG001|Overall Study|Other|1|||
106050226|NCT03345914|365849000|FG002|Overall Study|Other|1|||
106050227|NCT03345914|365848998|FG000|Overall Study|Ongoing|0|||
106050228|NCT03345914|365848999|FG001|Overall Study|Ongoing|0|||
106050229|NCT03345914|365849000|FG002|Overall Study|Ongoing|1|||
106050230|NCT01776840|365849002|FG000|Overall Study|Lost to Follow-up|12|||
106050231|NCT01776840|365849003|FG001|Overall Study|Lost to Follow-up|7|||
106050232|NCT01776840|365849002|FG000|Overall Study|Withdrawal by Subject|32|||
106050233|NCT01776840|365849003|FG001|Overall Study|Withdrawal by Subject|48|||
106050234|NCT01776840|365849002|FG000|Overall Study|Sponsor decision|89|||
106050235|NCT01776840|365849003|FG001|Overall Study|Sponsor decision|87|||
106050236|NCT03068455|365849005|FG000|Pre-treatment Period|Disease progression|0|||
106050237|NCT03068455|365849006|FG001|Pre-treatment Period|Disease progression|1|||
106050238|NCT03068455|365849005|FG000|Pre-treatment Period|Participant withdrew consent|1|||
106050239|NCT03068455|365849006|FG001|Pre-treatment Period|Participant withdrew consent|1|||
106050240|NCT03068455|365849005|FG000|Pre-treatment Period|Poor/non-compliance|0|||
106050241|NCT03068455|365849006|FG001|Pre-treatment Period|Poor/non-compliance|1|||
106050242|NCT03068455|365849005|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
106050243|NCT03068455|365849006|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
106050244|NCT03068455|365849005|FG000|Pre-treatment Period|Not reported|2|||
106050245|NCT03068455|365849006|FG001|Pre-treatment Period|Not reported|1|||
106050246|NCT03068455|365849005|FG000|Treatment Period|Disease progression|166|||
106050247|NCT03068455|365849006|FG001|Treatment Period|Disease progression|208|||
106050248|NCT03068455|365849005|FG000|Treatment Period|Study drug toxicity|317|||
106050249|NCT03068455|365849006|FG001|Treatment Period|Study drug toxicity|104|||
106050250|NCT03068455|365849005|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
106050251|NCT03068455|365849006|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
106050252|NCT03068455|365849005|FG000|Treatment Period|Participant request to stop therapy|33|||
106050253|NCT03068455|365849006|FG001|Treatment Period|Participant request to stop therapy|20|||
106050254|NCT03068455|365849005|FG000|Treatment Period|Participant withdrew consent|5|||
106050255|NCT03068455|365849006|FG001|Treatment Period|Participant withdrew consent|10|||
106050256|NCT03068455|365849005|FG000|Treatment Period|Poor/non-compliance|3|||
106050257|NCT03068455|365849006|FG001|Treatment Period|Poor/non-compliance|0|||
106050258|NCT03068455|365849005|FG000|Treatment Period|Participant no longer meets study criteria|1|||
106050259|NCT03068455|365849006|FG001|Treatment Period|Participant no longer meets study criteria|3|||
106050260|NCT03068455|365849005|FG000|Treatment Period|Other reasons|12|||
106050261|NCT03068455|365849006|FG001|Treatment Period|Other reasons|4|||
106050262|NCT00939640|365849010|FG000|Overall Study|Physician Decision|1|||
106050263|NCT02121522|365849012|FG000|Overall Study|Adverse Event|1|||
106050264|NCT02362269|365849017|FG000|Overall Study|Moved|1|||
106050265|NCT02362269|365849018|FG001|Overall Study|Moved|0|||
106050266|NCT02362269|365849017|FG000|Overall Study|Lost to Follow-up|0|||
106050267|NCT02362269|365849018|FG001|Overall Study|Lost to Follow-up|6|||
106050268|NCT00892047|365849019|FG000|Overall Study|Adverse Event|2|||
106050269|NCT00892047|365849020|FG001|Overall Study|Adverse Event|2|||
106050270|NCT00892047|365849019|FG000|Overall Study|subject burden|2|||
106050271|NCT00892047|365849020|FG001|Overall Study|subject burden|3|||
106050272|NCT00892047|365849019|FG000|Overall Study|Lack of Efficacy|0|||
106050273|NCT00892047|365849020|FG001|Overall Study|Lack of Efficacy|2|||
105863626|NCT00339144|365150479|FG000|Overall Study|Study drug toxicity|3|||
106050274|NCT01443078|365849022|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
106050275|NCT01443078|365849022|FG000|Overall Study|Withdrawal by Subject|1|||
106050276|NCT01443078|365849022|FG000|Overall Study|Patient had brain mets|1|||
106050277|NCT05213481|365849027|FG000|Overall Study|Adverse Event|3|||
106050278|NCT05213481|365849027|FG000|Overall Study|Lost to Follow-up|1|||
106050279|NCT03822182|365849033|FG000|Overall Study|Protocol Violation|0|||
106050280|NCT03822182|365849034|FG001|Overall Study|Protocol Violation|1|||
106050281|NCT03822182|365849035|FG002|Overall Study|Protocol Violation|1|||
106050282|NCT03855228|365849038|FG000|Overall Study|Adverse Event|2|||
106050283|NCT03855228|365849039|FG001|Overall Study|Adverse Event|4|||
106050284|NCT03855228|365849040|FG002|Overall Study|Adverse Event|4|||
106050285|NCT03855228|365849041|FG003|Overall Study|Adverse Event|8|||
106050286|NCT03855228|365849038|FG000|Overall Study|Treatment Failure|1|||
106050287|NCT03855228|365849039|FG001|Overall Study|Treatment Failure|2|||
106050288|NCT03855228|365849040|FG002|Overall Study|Treatment Failure|1|||
106050289|NCT03855228|365849041|FG003|Overall Study|Treatment Failure|8|||
106050290|NCT03855228|365849038|FG000|Overall Study|Lost to Follow-up|0|||
106050291|NCT03855228|365849039|FG001|Overall Study|Lost to Follow-up|0|||
106050292|NCT03855228|365849040|FG002|Overall Study|Lost to Follow-up|0|||
106050293|NCT03855228|365849041|FG003|Overall Study|Lost to Follow-up|1|||
106050294|NCT03855228|365849038|FG000|Overall Study|Protocol Violation|0|||
106050295|NCT03855228|365849039|FG001|Overall Study|Protocol Violation|1|||
106050296|NCT03855228|365849040|FG002|Overall Study|Protocol Violation|2|||
106050297|NCT03855228|365849041|FG003|Overall Study|Protocol Violation|1|||
106050298|NCT03855228|365849038|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
106050299|NCT03855228|365849039|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
106050300|NCT03855228|365849040|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
106050301|NCT03855228|365849041|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
106050302|NCT01893203|365849043|FG000|Overall Study|Withdrawal by Subject|1|||
106050303|NCT00722800|365849044|FG000|Overall Study|Withdrawal by Subject|1|||
106050304|NCT00722800|365849045|FG001|Overall Study|Withdrawal by Subject|0|||
106050305|NCT00722800|365849044|FG000|Overall Study|Physician Decision|1|||
106050306|NCT00722800|365849045|FG001|Overall Study|Physician Decision|0|||
106050307|NCT02130297|365849048|FG000|Overall Study|Lost to Follow-up|4|||
106050308|NCT01387789|365849049|FG000|Overall Study|Adverse Event|5|||
105863627|NCT00339144|365150480|FG001|Overall Study|Study drug toxicity|1|||
105863628|NCT00339144|365150481|FG002|Overall Study|Study drug toxicity|1|||
106050309|NCT01387789|365849049|FG000|Overall Study|Lack of Efficacy|2|||
106050310|NCT01387789|365849049|FG000|Overall Study|Lost to Follow-up|1|||
106050311|NCT00306189|365849050|FG000|Overall Study|Physician Decision|0|||
106050312|NCT00306189|365849051|FG001|Overall Study|Physician Decision|0|||
106050313|NCT00306189|365849052|FG002|Overall Study|Physician Decision|0|||
106050314|NCT00306189|365849053|FG003|Overall Study|Physician Decision|1|||
106050315|NCT00306189|365849050|FG000|Overall Study|Adverse Event|3|||
106050316|NCT00306189|365849051|FG001|Overall Study|Adverse Event|3|||
106050317|NCT00306189|365849052|FG002|Overall Study|Adverse Event|2|||
106050318|NCT00306189|365849053|FG003|Overall Study|Adverse Event|2|||
106050319|NCT00306189|365849050|FG000|Overall Study|Withdrawal by Subject|4|||
106050320|NCT00306189|365849051|FG001|Overall Study|Withdrawal by Subject|2|||
106050321|NCT00306189|365849052|FG002|Overall Study|Withdrawal by Subject|8|||
106050322|NCT00306189|365849053|FG003|Overall Study|Withdrawal by Subject|1|||
106050323|NCT00306189|365849050|FG000|Overall Study|Ineligibility determined|1|||
106050324|NCT00306189|365849051|FG001|Overall Study|Ineligibility determined|1|||
106050325|NCT00306189|365849052|FG002|Overall Study|Ineligibility determined|1|||
106050326|NCT00306189|365849053|FG003|Overall Study|Ineligibility determined|1|||
106050327|NCT00306189|365849050|FG000|Overall Study|Other|1|||
106050328|NCT00306189|365849051|FG001|Overall Study|Other|0|||
106050329|NCT00306189|365849052|FG002|Overall Study|Other|0|||
106050330|NCT00306189|365849053|FG003|Overall Study|Other|0|||
106050331|NCT01787331|365849056|FG000|Overall Study|Physician Decision|1|||
106050332|NCT01787331|365849056|FG000|Overall Study|Withdrawal by Subject|1|||
106050333|NCT03583697|365849058|FG000|Overall Study|Withdrawal by Subject|0|||
106050334|NCT03583697|365849059|FG001|Overall Study|Withdrawal by Subject|0|||
106050335|NCT03583697|365849060|FG002|Overall Study|Withdrawal by Subject|1|||
106050336|NCT03583697|365849058|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
106050337|NCT03583697|365849059|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
106050338|NCT03583697|365849060|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
106050339|NCT03607487|365849061|FG000|Overall Study|Withdrawal by Subject|2|||
106050340|NCT03607487|365849062|FG001|Overall Study|Withdrawal by Subject|0|||
106050341|NCT03607487|365849063|FG002|Overall Study|Withdrawal by Subject|0|||
106050342|NCT03607487|365849064|FG003|Overall Study|Withdrawal by Subject|1|||
106050343|NCT02867592|365849068|FG000|Overall Study|Adverse Event|3|||
106050344|NCT02867592|365849069|FG001|Overall Study|Adverse Event|0|||
106050345|NCT02867592|365849070|FG002|Overall Study|Adverse Event|2|||
106050346|NCT02867592|365849071|FG003|Overall Study|Adverse Event|1|||
106050347|NCT02867592|365849072|FG004|Overall Study|Adverse Event|1|||
106050348|NCT02867592|365849073|FG005|Overall Study|Adverse Event|5|||
106050349|NCT02867592|365849068|FG000|Overall Study|Death|0|||
106050350|NCT02867592|365849069|FG001|Overall Study|Death|0|||
106050351|NCT02867592|365849070|FG002|Overall Study|Death|0|||
106050352|NCT02867592|365849071|FG003|Overall Study|Death|1|||
106050353|NCT02867592|365849072|FG004|Overall Study|Death|0|||
106050354|NCT02867592|365849073|FG005|Overall Study|Death|1|||
106050355|NCT02867592|365849068|FG000|Overall Study|Lack of Efficacy|8|||
106050356|NCT02867592|365849069|FG001|Overall Study|Lack of Efficacy|10|||
106050357|NCT02867592|365849070|FG002|Overall Study|Lack of Efficacy|8|||
106050358|NCT02867592|365849071|FG003|Overall Study|Lack of Efficacy|8|||
106050359|NCT02867592|365849072|FG004|Overall Study|Lack of Efficacy|12|||
106050360|NCT02867592|365849073|FG005|Overall Study|Lack of Efficacy|17|||
106050361|NCT02867592|365849068|FG000|Overall Study|Physician Decision|1|||
106050362|NCT02867592|365849069|FG001|Overall Study|Physician Decision|2|||
106050363|NCT02867592|365849070|FG002|Overall Study|Physician Decision|2|||
106050364|NCT02867592|365849071|FG003|Overall Study|Physician Decision|0|||
106050365|NCT02867592|365849072|FG004|Overall Study|Physician Decision|5|||
106050366|NCT02867592|365849073|FG005|Overall Study|Physician Decision|1|||
106050367|NCT02867592|365849068|FG000|Overall Study|Protocol Violation|0|||
106050368|NCT02867592|365849069|FG001|Overall Study|Protocol Violation|0|||
106050369|NCT02867592|365849070|FG002|Overall Study|Protocol Violation|0|||
106050370|NCT02867592|365849071|FG003|Overall Study|Protocol Violation|0|||
106050371|NCT02867592|365849072|FG004|Overall Study|Protocol Violation|1|||
106050372|NCT02867592|365849073|FG005|Overall Study|Protocol Violation|1|||
106050373|NCT02867592|365849068|FG000|Overall Study|Withdrawal by Subject|0|||
106050374|NCT02867592|365849069|FG001|Overall Study|Withdrawal by Subject|1|||
106050375|NCT02867592|365849070|FG002|Overall Study|Withdrawal by Subject|0|||
106050376|NCT02867592|365849071|FG003|Overall Study|Withdrawal by Subject|1|||
106050377|NCT02867592|365849072|FG004|Overall Study|Withdrawal by Subject|3|||
106050378|NCT02867592|365849073|FG005|Overall Study|Withdrawal by Subject|3|||
106050379|NCT02867592|365849068|FG000|Overall Study|Ineligible|1|||
106050380|NCT02867592|365849069|FG001|Overall Study|Ineligible|1|||
106050381|NCT02867592|365849070|FG002|Overall Study|Ineligible|0|||
106050382|NCT02867592|365849071|FG003|Overall Study|Ineligible|0|||
106050383|NCT02867592|365849072|FG004|Overall Study|Ineligible|2|||
106050384|NCT02867592|365849073|FG005|Overall Study|Ineligible|0|||
106050385|NCT02867592|365849068|FG000|Overall Study|No Treatment|1|||
106050386|NCT02867592|365849069|FG001|Overall Study|No Treatment|0|||
106050387|NCT02867592|365849070|FG002|Overall Study|No Treatment|0|||
106050388|NCT02867592|365849071|FG003|Overall Study|No Treatment|0|||
106050389|NCT02867592|365849072|FG004|Overall Study|No Treatment|0|||
106050390|NCT02867592|365849073|FG005|Overall Study|No Treatment|0|||
106050391|NCT02867592|365849068|FG000|Overall Study|Still on Therapy|0|||
106050392|NCT02867592|365849069|FG001|Overall Study|Still on Therapy|0|||
106050393|NCT02867592|365849070|FG002|Overall Study|Still on Therapy|0|||
106050394|NCT02867592|365849071|FG003|Overall Study|Still on Therapy|0|||
106050395|NCT02867592|365849072|FG004|Overall Study|Still on Therapy|1|||
106050396|NCT02867592|365849073|FG005|Overall Study|Still on Therapy|0|||
106050397|NCT02867592|365849068|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
106050398|NCT02867592|365849069|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
106050399|NCT02867592|365849070|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
106050400|NCT02867592|365849071|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
106050401|NCT02867592|365849072|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
106050402|NCT02867592|365849073|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
106050403|NCT02867592|365849068|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
106050404|NCT02867592|365849069|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
106050405|NCT02867592|365849070|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
106050406|NCT02867592|365849071|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
106050407|NCT02867592|365849072|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
106050408|NCT02867592|365849073|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
106050409|NCT04560998|365849074|FG000|Overall Study|Withdrawal by Subject|18|||
106050410|NCT04560998|365849075|FG001|Overall Study|Withdrawal by Subject|12|||
106050411|NCT04560998|365849074|FG000|Overall Study|Lost to Follow-up|8|||
106050412|NCT04560998|365849075|FG001|Overall Study|Lost to Follow-up|5|||
106050413|NCT04560998|365849074|FG000|Overall Study|Physician Decision|4|||
106050414|NCT04560998|365849075|FG001|Overall Study|Physician Decision|0|||
106050415|NCT00717093|365850458|FG000|Overall Study|Adverse Event|19|||
106050416|NCT00717093|365850459|FG001|Overall Study|Adverse Event|9|||
106050417|NCT00717093|365850458|FG000|Overall Study|Lack of Efficacy|3|||
106050418|NCT00717093|365850459|FG001|Overall Study|Lack of Efficacy|13|||
106050419|NCT00717093|365850458|FG000|Overall Study|Lost to Follow-up|9|||
106050420|NCT00717093|365850459|FG001|Overall Study|Lost to Follow-up|6|||
106050421|NCT00717093|365850458|FG000|Overall Study|Withdrawal by Subject|12|||
106050422|NCT00717093|365850459|FG001|Overall Study|Withdrawal by Subject|19|||
106050423|NCT00717093|365850458|FG000|Overall Study|Other|0|||
106050424|NCT00717093|365850459|FG001|Overall Study|Other|1|||
106050425|NCT00717093|365850458|FG000|Overall Study|Randomized but not treated|1|||
106050426|NCT00717093|365850459|FG001|Overall Study|Randomized but not treated|0|||
106050427|NCT01560403|365850460|FG000|Overall Study|Lost to Follow-up|0|||
106050428|NCT01560403|365850461|FG001|Overall Study|Lost to Follow-up|1|||
106050429|NCT00094172|365850462|FG000|Overall Study|Adverse Event|0|||
106050430|NCT00094172|365850463|FG001|Overall Study|Adverse Event|1|||
106050431|NCT00094172|365850462|FG000|Overall Study|Lost to Follow-up|2|||
106050432|NCT00094172|365850463|FG001|Overall Study|Lost to Follow-up|0|||
106050433|NCT00094172|365850462|FG000|Overall Study|Protocol Violation|0|||
106050434|NCT00094172|365850463|FG001|Overall Study|Protocol Violation|1|||
106050435|NCT00094172|365850462|FG000|Overall Study|Withdrawal by Subject|10|||
106050436|NCT00094172|365850463|FG001|Overall Study|Withdrawal by Subject|5|||
106050437|NCT00094172|365850462|FG000|Overall Study|Primary endpoint met.|1|||
106050438|NCT00094172|365850463|FG001|Overall Study|Primary endpoint met.|0|||
106050439|NCT00094172|365850462|FG000|Overall Study|Started other MS therapy due to disease|1|||
106050440|NCT00094172|365850463|FG001|Overall Study|Started other MS therapy due to disease|0|||
106050441|NCT00533897|365850467|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
106050442|NCT00533897|365850468|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
106050443|NCT00533897|365850469|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
106050444|NCT00533897|365850470|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
106050445|NCT00533897|365850471|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
106050446|NCT00533897|365850472|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
106050447|NCT00533897|365850473|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
106050448|NCT00533897|365850474|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
106050449|NCT00533897|365850467|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
106050450|NCT00533897|365850468|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
106050451|NCT00533897|365850469|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
106050452|NCT00533897|365850470|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
106050453|NCT00533897|365850471|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
106050454|NCT00533897|365850472|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
106050455|NCT00533897|365850473|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
106050456|NCT00533897|365850474|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
106050457|NCT00533897|365850467|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
106050458|NCT00533897|365850468|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
106050459|NCT00533897|365850469|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
106050460|NCT00533897|365850470|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
106050461|NCT00533897|365850471|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
106050462|NCT00533897|365850472|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
106050463|NCT00533897|365850473|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
106050464|NCT00533897|365850474|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
106050465|NCT00533897|365850467|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
106050466|NCT00533897|365850468|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
106050467|NCT00533897|365850469|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
106050468|NCT00533897|365850470|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
106050469|NCT00533897|365850471|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
106050470|NCT00533897|365850472|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
106050471|NCT00533897|365850473|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
106050472|NCT00533897|365850474|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
106050473|NCT00533897|365850467|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
106050474|NCT00533897|365850468|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
106050475|NCT00533897|365850469|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
106050476|NCT00533897|365850470|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
106050477|NCT00533897|365850471|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
106050478|NCT00533897|365850472|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
106050479|NCT00533897|365850473|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
106050480|NCT00533897|365850474|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
106050481|NCT00533897|365850467|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
106050482|NCT00533897|365850468|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
106050483|NCT00533897|365850469|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
106050484|NCT00533897|365850470|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
106050485|NCT00533897|365850471|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
106050486|NCT00533897|365850472|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
106050487|NCT00533897|365850473|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
106050488|NCT00533897|365850474|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
106050489|NCT00533897|365850467|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
106050490|NCT00533897|365850468|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
106050491|NCT00533897|365850469|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
106050492|NCT00533897|365850470|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
106050493|NCT00533897|365850471|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
106050494|NCT00533897|365850472|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
106050495|NCT00533897|365850473|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
106050496|NCT00533897|365850474|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
106050497|NCT00533897|365850467|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
106050498|NCT00533897|365850468|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
106050499|NCT00533897|365850469|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
106050500|NCT00533897|365850470|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
106050501|NCT00533897|365850471|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
106050502|NCT00533897|365850472|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
106050503|NCT00533897|365850473|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
106050504|NCT00533897|365850474|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
106050505|NCT00533897|365850467|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
106050506|NCT00533897|365850468|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
106050507|NCT00533897|365850469|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
106050508|NCT00533897|365850470|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
106050509|NCT00533897|365850471|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
106050510|NCT00533897|365850472|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
106050511|NCT00533897|365850473|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
106050512|NCT00533897|365850474|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
106050513|NCT00533897|365850467|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
106050514|NCT00533897|365850468|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
106050515|NCT00533897|365850469|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
106050516|NCT00533897|365850470|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
106050517|NCT00533897|365850471|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
106050518|NCT00533897|365850472|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
106050519|NCT00533897|365850473|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
106050520|NCT00533897|365850474|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
106050521|NCT00533897|365850467|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
106050522|NCT00533897|365850468|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
106050523|NCT00533897|365850469|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
106050524|NCT00533897|365850470|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
106050525|NCT00533897|365850471|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
106050526|NCT00533897|365850472|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
106050527|NCT00533897|365850473|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
106050528|NCT00533897|365850474|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
106050529|NCT00533897|365850467|FG000|Long Term Extension (LTE)|Death|0|||
106050530|NCT00533897|365850468|FG001|Long Term Extension (LTE)|Death|0|||
106050531|NCT00533897|365850469|FG002|Long Term Extension (LTE)|Death|0|||
106050532|NCT00533897|365850470|FG003|Long Term Extension (LTE)|Death|0|||
106050533|NCT00533897|365850471|FG004|Long Term Extension (LTE)|Death|0|||
106050534|NCT00533897|365850472|FG005|Long Term Extension (LTE)|Death|0|||
106050535|NCT00533897|365850473|FG006|Long Term Extension (LTE)|Death|1|||
106050536|NCT00533897|365850474|FG007|Long Term Extension (LTE)|Death|3|||
106050537|NCT00533897|365850467|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
106050538|NCT00533897|365850468|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
106050539|NCT00533897|365850469|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
106050540|NCT00533897|365850470|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
106050541|NCT00533897|365850471|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
106050542|NCT00533897|365850472|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
106050543|NCT00533897|365850473|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
106050544|NCT00533897|365850474|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
106050545|NCT00533897|365850467|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
106050546|NCT00533897|365850468|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
106050547|NCT00533897|365850469|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
106050548|NCT00533897|365850470|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
106050549|NCT00533897|365850471|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
106050550|NCT00533897|365850472|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
106050551|NCT00533897|365850473|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
106152384|NCT01091168|366217146|FG000|Overall Study|Progressive disease|250|||
106152385|NCT01091168|366217147|FG001|Overall Study|Progressive disease|234|||
106152386|NCT01091168|366217146|FG000|Overall Study|Adverse Event|21|||
106050552|NCT00533897|365850474|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
106050553|NCT00533897|365850467|FG000|Long Term Extension (LTE)|Adverse Event|0|||
106050554|NCT00533897|365850468|FG001|Long Term Extension (LTE)|Adverse Event|0|||
106050555|NCT00533897|365850469|FG002|Long Term Extension (LTE)|Adverse Event|0|||
106050556|NCT00533897|365850470|FG003|Long Term Extension (LTE)|Adverse Event|0|||
106050557|NCT00533897|365850471|FG004|Long Term Extension (LTE)|Adverse Event|0|||
106050558|NCT00533897|365850472|FG005|Long Term Extension (LTE)|Adverse Event|0|||
106050559|NCT00533897|365850473|FG006|Long Term Extension (LTE)|Adverse Event|2|||
106152387|NCT01091168|366217147|FG001|Overall Study|Adverse Event|24|||
106050560|NCT00533897|365850474|FG007|Long Term Extension (LTE)|Adverse Event|5|||
106050561|NCT00533897|365850467|FG000|Long Term Extension (LTE)|Pregnancy|0|||
106050562|NCT00533897|365850468|FG001|Long Term Extension (LTE)|Pregnancy|0|||
106050563|NCT00533897|365850469|FG002|Long Term Extension (LTE)|Pregnancy|0|||
106050564|NCT00533897|365850470|FG003|Long Term Extension (LTE)|Pregnancy|0|||
106050565|NCT00533897|365850471|FG004|Long Term Extension (LTE)|Pregnancy|0|||
106050566|NCT00533897|365850472|FG005|Long Term Extension (LTE)|Pregnancy|0|||
106050567|NCT00533897|365850473|FG006|Long Term Extension (LTE)|Pregnancy|0|||
106050568|NCT00533897|365850474|FG007|Long Term Extension (LTE)|Pregnancy|2|||
106050569|NCT00533897|365850467|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
106050570|NCT00533897|365850468|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
106050571|NCT00533897|365850469|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
106050572|NCT00533897|365850470|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
106050573|NCT00533897|365850471|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
106050574|NCT00533897|365850472|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
106050575|NCT00533897|365850473|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
106050576|NCT00533897|365850474|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
106050577|NCT00533897|365850467|FG000|Long Term Extension (LTE)|Other|0|||
106050578|NCT00533897|365850468|FG001|Long Term Extension (LTE)|Other|0|||
106050579|NCT00533897|365850469|FG002|Long Term Extension (LTE)|Other|0|||
106050580|NCT00533897|365850470|FG003|Long Term Extension (LTE)|Other|0|||
106050581|NCT00533897|365850471|FG004|Long Term Extension (LTE)|Other|0|||
106050582|NCT00533897|365850472|FG005|Long Term Extension (LTE)|Other|0|||
106050583|NCT00533897|365850473|FG006|Long Term Extension (LTE)|Other|1|||
106050584|NCT00533897|365850474|FG007|Long Term Extension (LTE)|Other|6|||
106050585|NCT02555683|365850476|FG000|Overall Study|Physician Decision|1|||
106050586|NCT02555683|365850477|FG001|Overall Study|Physician Decision|0|||
106050587|NCT02555683|365850478|FG002|Overall Study|Physician Decision|2|||
106050588|NCT02555683|365850476|FG000|Overall Study|Lost to Follow-up|2|||
106050589|NCT02555683|365850477|FG001|Overall Study|Lost to Follow-up|1|||
106050590|NCT02555683|365850478|FG002|Overall Study|Lost to Follow-up|2|||
106050591|NCT02555683|365850476|FG000|Overall Study|Technical Problems|1|||
106050592|NCT02555683|365850477|FG001|Overall Study|Technical Problems|1|||
106050593|NCT02555683|365850478|FG002|Overall Study|Technical Problems|0|||
106050594|NCT02555683|365850476|FG000|Overall Study|Protocol deviation|0|||
106050595|NCT02555683|365850477|FG001|Overall Study|Protocol deviation|1|||
106050596|NCT02555683|365850478|FG002|Overall Study|Protocol deviation|0|||
106050597|NCT02555683|365850476|FG000|Overall Study|Lack of Efficacy|2|||
106050598|NCT02555683|365850477|FG001|Overall Study|Lack of Efficacy|0|||
106050599|NCT02555683|365850478|FG002|Overall Study|Lack of Efficacy|0|||
106050600|NCT02555683|365850476|FG000|Overall Study|Death|0|||
106050601|NCT02555683|365850477|FG001|Overall Study|Death|1|||
106050602|NCT02555683|365850478|FG002|Overall Study|Death|2|||
106050603|NCT02555683|365850476|FG000|Overall Study|Adverse Event|1|||
106050604|NCT02555683|365850477|FG001|Overall Study|Adverse Event|0|||
106050605|NCT02555683|365850478|FG002|Overall Study|Adverse Event|1|||
106050606|NCT02555683|365850476|FG000|Overall Study|Subject/guardian decision|12|||
106050607|NCT02555683|365850477|FG001|Overall Study|Subject/guardian decision|12|||
106050608|NCT02555683|365850478|FG002|Overall Study|Subject/guardian decision|22|||
106050609|NCT02555683|365850476|FG000|Overall Study|Death post Treatment/safety period|0|||
106050610|NCT02555683|365850477|FG001|Overall Study|Death post Treatment/safety period|1|||
106050611|NCT02555683|365850478|FG002|Overall Study|Death post Treatment/safety period|0|||
106050612|NCT05074667|365850479|FG000|Overall Study|Death|1|||
106050613|NCT05074667|365850479|FG000|Overall Study|Withdrawal by Subject|4|||
106050614|NCT05074667|365850479|FG000|Overall Study|Lost to Follow-up|10|||
106050615|NCT00491075|365850480|FG000|Overall Study|Withdrawal by Subject|1|||
106050616|NCT00491075|365850480|FG000|Overall Study|Physician Decision|1|||
106050617|NCT00827502|365850481|FG000|Overall Study|randomized but not treated|11|||
106050618|NCT00827502|365850481|FG000|Overall Study|Adverse Event|1|||
106152388|NCT01091168|366217146|FG000|Overall Study|Lost to Follow-up|0|||
106152389|NCT01091168|366217147|FG001|Overall Study|Lost to Follow-up|1|||
106050619|NCT00827502|365850481|FG000|Overall Study|Lost to Follow-up|4|||
106050620|NCT00827502|365850481|FG000|Overall Study|Withdrawal by Subject|5|||
106152390|NCT01091168|366217146|FG000|Overall Study|Physician, patient's decision, other|27|||
106050621|NCT04678661|365850482|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
106152391|NCT01091168|366217147|FG001|Overall Study|Physician, patient's decision, other|37|||
106152392|NCT04814186|366218767|FG000|Treatment Phase|Adverse Event|1|||
106050622|NCT04678661|365850483|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
106050623|NCT04678661|365850482|FG000|Overall Study|Protocol Violation|2|||
106050624|NCT04678661|365850483|FG001|Overall Study|Protocol Violation|0|||
106050625|NCT04678661|365850482|FG000|Overall Study|Withdrawal by Subject|1|||
106050626|NCT04678661|365850483|FG001|Overall Study|Withdrawal by Subject|0|||
106050627|NCT04678661|365850482|FG000|Overall Study|Lost to Follow-up|2|||
106050628|NCT04678661|365850483|FG001|Overall Study|Lost to Follow-up|0|||
106050629|NCT04678661|365850482|FG000|Overall Study|Death|2|||
106050630|NCT04678661|365850483|FG001|Overall Study|Death|0|||
106050631|NCT01705730|365850484|FG000|Overall Study|Lack of Efficacy|1|||
106050632|NCT01705730|365850484|FG000|Overall Study|Adverse Event|3|||
106050633|NCT01705730|365850484|FG000|Overall Study|Lost to Follow-up|1|||
106050634|NCT01705730|365850484|FG000|Overall Study|Reason not Specified|4|||
106050635|NCT00493025|365850485|FG000|Overall Study|Physician Decision|19|||
106050636|NCT01876420|365850488|FG000|Overall Study|Missed 30 day visit|1|||
106050637|NCT04457336|365850489|FG000|Period 2: Part A|Withdrawal by Subject|0|||
106050638|NCT04457336|365850490|FG001|Period 2: Part A|Withdrawal by Subject|1|||
106050639|NCT04457336|365850491|FG002|Period 2: Part A|Withdrawal by Subject|1|||
106050640|NCT04457336|365850492|FG003|Period 2: Part A|Withdrawal by Subject|1|||
106050641|NCT04457336|365850493|FG004|Period 2: Part A|Withdrawal by Subject|0|||
106050642|NCT04457336|365850494|FG005|Period 2: Part A|Withdrawal by Subject|0|||
106050643|NCT04457336|365850495|FG006|Period 2: Part A|Withdrawal by Subject|0|||
106050644|NCT04457336|365850496|FG007|Period 2: Part A|Withdrawal by Subject|0|||
106050645|NCT04457336|365850489|FG000|Period 2: Part A|Adverse Event|0|||
106050646|NCT04457336|365850490|FG001|Period 2: Part A|Adverse Event|0|||
106050647|NCT04457336|365850491|FG002|Period 2: Part A|Adverse Event|1|||
106050648|NCT04457336|365850492|FG003|Period 2: Part A|Adverse Event|1|||
106050649|NCT04457336|365850493|FG004|Period 2: Part A|Adverse Event|0|||
106050650|NCT04457336|365850494|FG005|Period 2: Part A|Adverse Event|0|||
106050651|NCT04457336|365850495|FG006|Period 2: Part A|Adverse Event|0|||
106050652|NCT04457336|365850496|FG007|Period 2: Part A|Adverse Event|0|||
106050653|NCT04457336|365850489|FG000|Period 2: Part A|Study Terminated|0|||
106050654|NCT04457336|365850490|FG001|Period 2: Part A|Study Terminated|0|||
106050655|NCT04457336|365850491|FG002|Period 2: Part A|Study Terminated|1|||
106050656|NCT04457336|365850492|FG003|Period 2: Part A|Study Terminated|0|||
106050657|NCT04457336|365850493|FG004|Period 2: Part A|Study Terminated|0|||
106050658|NCT04457336|365850494|FG005|Period 2: Part A|Study Terminated|0|||
106050659|NCT04457336|365850495|FG006|Period 2: Part A|Study Terminated|0|||
106050660|NCT04457336|365850496|FG007|Period 2: Part A|Study Terminated|0|||
106050661|NCT04457336|365850489|FG000|Period 2: Part A|Protocol Violation|0|||
106050662|NCT04457336|365850490|FG001|Period 2: Part A|Protocol Violation|1|||
106050663|NCT04457336|365850491|FG002|Period 2: Part A|Protocol Violation|0|||
106050664|NCT04457336|365850492|FG003|Period 2: Part A|Protocol Violation|0|||
106050665|NCT04457336|365850493|FG004|Period 2: Part A|Protocol Violation|0|||
106050666|NCT04457336|365850494|FG005|Period 2: Part A|Protocol Violation|0|||
106050667|NCT04457336|365850495|FG006|Period 2: Part A|Protocol Violation|0|||
106050668|NCT04457336|365850496|FG007|Period 2: Part A|Protocol Violation|0|||
106050669|NCT04457336|365850489|FG000|Period 2: Part A|Lost to Follow-up|0|||
106050670|NCT04457336|365850490|FG001|Period 2: Part A|Lost to Follow-up|1|||
106050671|NCT04457336|365850491|FG002|Period 2: Part A|Lost to Follow-up|0|||
106050672|NCT04457336|365850492|FG003|Period 2: Part A|Lost to Follow-up|0|||
106050673|NCT04457336|365850493|FG004|Period 2: Part A|Lost to Follow-up|0|||
106050674|NCT04457336|365850494|FG005|Period 2: Part A|Lost to Follow-up|0|||
106050675|NCT04457336|365850495|FG006|Period 2: Part A|Lost to Follow-up|0|||
106050676|NCT04457336|365850496|FG007|Period 2: Part A|Lost to Follow-up|0|||
106050677|NCT04457336|365850489|FG000|Period 2: Part A|Other|0|||
106050678|NCT04457336|365850490|FG001|Period 2: Part A|Other|1|||
106050679|NCT04457336|365850491|FG002|Period 2: Part A|Other|0|||
106050680|NCT04457336|365850492|FG003|Period 2: Part A|Other|0|||
106050681|NCT04457336|365850493|FG004|Period 2: Part A|Other|0|||
106050682|NCT04457336|365850494|FG005|Period 2: Part A|Other|0|||
106050683|NCT04457336|365850495|FG006|Period 2: Part A|Other|0|||
106050684|NCT04457336|365850496|FG007|Period 2: Part A|Other|0|||
106050685|NCT04457336|365850489|FG000|Period 2: Part A|Physician Decision|0|||
106050686|NCT04457336|365850490|FG001|Period 2: Part A|Physician Decision|0|||
106050687|NCT04457336|365850491|FG002|Period 2: Part A|Physician Decision|0|||
106050688|NCT04457336|365850492|FG003|Period 2: Part A|Physician Decision|1|||
106050689|NCT04457336|365850493|FG004|Period 2: Part A|Physician Decision|0|||
106050690|NCT04457336|365850494|FG005|Period 2: Part A|Physician Decision|0|||
106050691|NCT04457336|365850495|FG006|Period 2: Part A|Physician Decision|0|||
106050692|NCT04457336|365850496|FG007|Period 2: Part A|Physician Decision|0|||
106050693|NCT04457336|365850489|FG000|Period 3: Part B|Study Terminated|0|||
106050694|NCT04457336|365850490|FG001|Period 3: Part B|Study Terminated|0|||
106050695|NCT04457336|365850491|FG002|Period 3: Part B|Study Terminated|0|||
106050696|NCT04457336|365850492|FG003|Period 3: Part B|Study Terminated|0|||
106050697|NCT04457336|365850493|FG004|Period 3: Part B|Study Terminated|1|||
106050698|NCT04457336|365850494|FG005|Period 3: Part B|Study Terminated|10|||
106050699|NCT04457336|365850495|FG006|Period 3: Part B|Study Terminated|13|||
106050700|NCT04457336|365850496|FG007|Period 3: Part B|Study Terminated|0|||
106050701|NCT04457336|365850489|FG000|Period 3: Part B|Withdrawal by Subject|0|||
106050702|NCT04457336|365850490|FG001|Period 3: Part B|Withdrawal by Subject|0|||
106050703|NCT04457336|365850491|FG002|Period 3: Part B|Withdrawal by Subject|0|||
106050704|NCT04457336|365850492|FG003|Period 3: Part B|Withdrawal by Subject|0|||
106050705|NCT04457336|365850493|FG004|Period 3: Part B|Withdrawal by Subject|0|||
106050706|NCT04457336|365850494|FG005|Period 3: Part B|Withdrawal by Subject|1|||
106050707|NCT04457336|365850495|FG006|Period 3: Part B|Withdrawal by Subject|2|||
106050708|NCT04457336|365850496|FG007|Period 3: Part B|Withdrawal by Subject|0|||
106050709|NCT04457336|365850489|FG000|Period 4: Part C|Study Terminated|0|||
106050710|NCT04457336|365850490|FG001|Period 4: Part C|Study Terminated|0|||
106050711|NCT04457336|365850491|FG002|Period 4: Part C|Study Terminated|0|||
106050712|NCT04457336|365850492|FG003|Period 4: Part C|Study Terminated|0|||
106050713|NCT04457336|365850493|FG004|Period 4: Part C|Study Terminated|0|||
106050714|NCT04457336|365850494|FG005|Period 4: Part C|Study Terminated|0|||
106050715|NCT04457336|365850495|FG006|Period 4: Part C|Study Terminated|0|||
106050716|NCT04457336|365850496|FG007|Period 4: Part C|Study Terminated|30|||
106050717|NCT04457336|365850489|FG000|Period 4: Part C|Adverse Event|0|||
106050718|NCT04457336|365850490|FG001|Period 4: Part C|Adverse Event|0|||
106050719|NCT04457336|365850491|FG002|Period 4: Part C|Adverse Event|0|||
106050720|NCT04457336|365850492|FG003|Period 4: Part C|Adverse Event|0|||
106050721|NCT04457336|365850493|FG004|Period 4: Part C|Adverse Event|0|||
106050722|NCT04457336|365850494|FG005|Period 4: Part C|Adverse Event|0|||
106050723|NCT04457336|365850495|FG006|Period 4: Part C|Adverse Event|0|||
106050724|NCT04457336|365850496|FG007|Period 4: Part C|Adverse Event|2|||
106050725|NCT04457336|365850489|FG000|Period 4: Part C|Site Terminated|0|||
106050726|NCT04457336|365850490|FG001|Period 4: Part C|Site Terminated|0|||
106050727|NCT04457336|365850491|FG002|Period 4: Part C|Site Terminated|0|||
106050728|NCT04457336|365850492|FG003|Period 4: Part C|Site Terminated|0|||
106050729|NCT04457336|365850493|FG004|Period 4: Part C|Site Terminated|0|||
106050730|NCT04457336|365850494|FG005|Period 4: Part C|Site Terminated|0|||
106050731|NCT04457336|365850495|FG006|Period 4: Part C|Site Terminated|0|||
106050732|NCT04457336|365850496|FG007|Period 4: Part C|Site Terminated|1|||
106050733|NCT04457336|365850489|FG000|Period 4: Part C|Other|0|||
106050734|NCT04457336|365850490|FG001|Period 4: Part C|Other|0|||
106050735|NCT04457336|365850491|FG002|Period 4: Part C|Other|0|||
106050736|NCT04457336|365850492|FG003|Period 4: Part C|Other|0|||
106050737|NCT04457336|365850493|FG004|Period 4: Part C|Other|0|||
106050738|NCT04457336|365850494|FG005|Period 4: Part C|Other|0|||
106050739|NCT04457336|365850495|FG006|Period 4: Part C|Other|0|||
106050740|NCT04457336|365850496|FG007|Period 4: Part C|Other|2|||
106050741|NCT04457336|365850489|FG000|Period 4: Part C|Withdrawal by Subject|0|||
106050742|NCT04457336|365850490|FG001|Period 4: Part C|Withdrawal by Subject|0|||
106050743|NCT04457336|365850491|FG002|Period 4: Part C|Withdrawal by Subject|0|||
106050744|NCT04457336|365850492|FG003|Period 4: Part C|Withdrawal by Subject|0|||
106050745|NCT04457336|365850493|FG004|Period 4: Part C|Withdrawal by Subject|0|||
106050746|NCT04457336|365850494|FG005|Period 4: Part C|Withdrawal by Subject|0|||
106050747|NCT04457336|365850495|FG006|Period 4: Part C|Withdrawal by Subject|0|||
106050748|NCT04457336|365850496|FG007|Period 4: Part C|Withdrawal by Subject|3|||
106050749|NCT04545060|365850500|FG000|Overall Study|Adverse Event|0|||
106050750|NCT04545060|365850501|FG001|Overall Study|Adverse Event|1|||
106050751|NCT04545060|365850500|FG000|Overall Study|Death|0|||
106050752|NCT04545060|365850501|FG001|Overall Study|Death|5|||
106152393|NCT04814186|366218767|FG000|Treatment Phase|Death|6|||
105863629|NCT00339144|365150479|FG000|Overall Study|Participant's request to discontinuation|1|||
105863630|NCT00339144|365150480|FG001|Overall Study|Participant's request to discontinuation|0|||
105863631|NCT00339144|365150481|FG002|Overall Study|Participant's request to discontinuation|1|||
105863632|NCT01822366|365150485|FG000|Overall Study|Lost to Follow-up|5|||
105863633|NCT01822366|365150486|FG001|Overall Study|Lost to Follow-up|1|||
105863634|NCT01822366|365150487|FG002|Overall Study|Lost to Follow-up|5|||
105863635|NCT01822366|365150488|FG003|Overall Study|Lost to Follow-up|1|||
105863636|NCT01822366|365150485|FG000|Overall Study|Withdrawal by Subject|0|||
105863637|NCT01822366|365150486|FG001|Overall Study|Withdrawal by Subject|6|||
105863638|NCT01822366|365150487|FG002|Overall Study|Withdrawal by Subject|0|||
105863639|NCT01822366|365150488|FG003|Overall Study|Withdrawal by Subject|6|||
105863640|NCT01822366|365150485|FG000|Overall Study|Partial Intervention Completion|0|||
105863641|NCT01822366|365150486|FG001|Overall Study|Partial Intervention Completion|15|||
105863642|NCT01822366|365150487|FG002|Overall Study|Partial Intervention Completion|0|||
105863643|NCT01822366|365150488|FG003|Overall Study|Partial Intervention Completion|15|||
105863644|NCT01275430|365150490|FG000|Overall Study|Adverse Event|1|||
105863645|NCT01275430|365150490|FG000|Overall Study|No Contrast Injection|6|||
105863646|NCT01275430|365150490|FG000|Overall Study|Device Malfunction|1|||
105863647|NCT01275430|365150490|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
106050753|NCT04545060|365850500|FG000|Overall Study|Lost to Follow-up|10|||
106050754|NCT04545060|365850501|FG001|Overall Study|Lost to Follow-up|13|||
106050755|NCT04545060|365850500|FG000|Overall Study|Physician Decision|3|||
106050756|NCT04545060|365850501|FG001|Overall Study|Physician Decision|0|||
106050757|NCT04545060|365850500|FG000|Overall Study|Withdrawal by Subject|17|||
106050758|NCT04545060|365850501|FG001|Overall Study|Withdrawal by Subject|22|||
106050759|NCT00619177|365850502|FG000|Overall Study|Adverse Event|18|||
106050760|NCT00619177|365850502|FG000|Overall Study|Lost to Follow-up|2|||
106050761|NCT00619177|365850502|FG000|Overall Study|Lack of Efficacy|1|||
106050762|NCT00619177|365850502|FG000|Overall Study|Missing termination information|481|||
105863648|NCT04759768|365150491|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
105863649|NCT04759768|365150492|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
105863650|NCT04759768|365150491|FG000|Washout (7 Days)|Physician Decision|0|||
106050763|NCT00619177|365850502|FG000|Overall Study|Not specified reasons|6|||
106050764|NCT04203498|365850505|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
106050765|NCT04203498|365850506|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
106050766|NCT04203498|365850505|FG000|Overall Study|Withdrawal of patient consent|7|||
106050767|NCT04203498|365850506|FG001|Overall Study|Withdrawal of patient consent|2|||
106050768|NCT04203498|365850505|FG000|Overall Study|Adverse Event|4|||
106050769|NCT04203498|365850506|FG001|Overall Study|Adverse Event|1|||
106050770|NCT04203498|365850505|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
106050771|NCT04203498|365850506|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
106050772|NCT04203498|365850505|FG000|Overall Study|Did not receive IMP|2|||
106050773|NCT04203498|365850506|FG001|Overall Study|Did not receive IMP|0|||
106050774|NCT02106975|365850507|FG000|Overall Study|Death|25|||
106050775|NCT02106975|365850508|FG001|Overall Study|Death|39|||
106050776|NCT00005044|365850512|FG000|Overall Study|Protocol Violation|37|||
106050777|NCT00005044|365850513|FG001|Overall Study|Protocol Violation|46|||
106050778|NCT00005044|365850512|FG000|Overall Study|Withdrawal by Subject|1|||
106050779|NCT00005044|365850513|FG001|Overall Study|Withdrawal by Subject|5|||
106050780|NCT00005044|365850512|FG000|Overall Study|No protocol treatment|0|||
106050781|NCT00005044|365850513|FG001|Overall Study|No protocol treatment|1|||
106050782|NCT03546062|365850514|FG000|Overall Study|Adverse Event|6|||
106050783|NCT03546062|365850515|FG001|Overall Study|Adverse Event|5|||
106050784|NCT03546062|365850516|FG002|Overall Study|Adverse Event|8|||
106050785|NCT01449539|365850521|FG000|Overall Study|Withdrawal by Subject|3|||
106050786|NCT01449539|365850521|FG000|Overall Study|Toxicity not study related|1|||
106050787|NCT02993757|365850522|FG000|Overall Study|Non compliance with the protocol|155|||
106050788|NCT02993757|365850523|FG001|Overall Study|Non compliance with the protocol|170|||
106050789|NCT02993757|365850522|FG000|Overall Study|Lost to Follow-up|1|||
106050790|NCT02993757|365850523|FG001|Overall Study|Lost to Follow-up|0|||
106050791|NCT02993757|365850522|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
106050792|NCT02993757|365850523|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
106050793|NCT01534962|365850524|FG000|Overall Study|Randomized but did not start treatment|2|||
106050794|NCT01534962|365850525|FG001|Overall Study|Randomized but did not start treatment|0|||
106050795|NCT01534962|365850526|FG002|Overall Study|Randomized but did not start treatment|0|||
106050796|NCT01534962|365850527|FG003|Overall Study|Randomized but did not start treatment|1|||
106050797|NCT01534962|365850524|FG000|Overall Study|Discontinued at AF recurrence|35|||
106050798|NCT01534962|365850525|FG001|Overall Study|Discontinued at AF recurrence|26|||
106050799|NCT01534962|365850526|FG002|Overall Study|Discontinued at AF recurrence|24|||
106050800|NCT01534962|365850527|FG003|Overall Study|Discontinued at AF recurrence|31|||
106050801|NCT02935842|365850534|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
106050802|NCT02935842|365850535|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
106050803|NCT02935842|365850536|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
106050804|NCT02935842|365850537|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
106050805|NCT02935842|365850534|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
106050806|NCT02935842|365850535|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
106050807|NCT02935842|365850536|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
106050808|NCT02935842|365850537|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
106050809|NCT02935842|365850534|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
106050810|NCT02935842|365850535|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
106050811|NCT02935842|365850536|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
106050812|NCT02935842|365850537|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
106050813|NCT02935842|365850534|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
106050814|NCT02935842|365850535|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
106050815|NCT02935842|365850536|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
106050816|NCT02935842|365850537|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
106050817|NCT02935842|365850534|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
106050818|NCT02935842|365850535|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
106050819|NCT02935842|365850536|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
106050820|NCT02935842|365850537|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
106050821|NCT04545385|365850538|FG000|Overall Study|Withdrawal by Subject|2|||
106050822|NCT04545385|365850539|FG001|Overall Study|Withdrawal by Subject|0|||
106050823|NCT04545385|365850538|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
106050824|NCT04545385|365850539|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
106050825|NCT04545385|365850538|FG000|Overall Study|Study termination|10|||
106050826|NCT04545385|365850539|FG001|Overall Study|Study termination|10|||
106050827|NCT04545385|365850538|FG000|Overall Study|Sponsor decision|2|||
106050828|NCT04545385|365850539|FG001|Overall Study|Sponsor decision|2|||
106050829|NCT04545385|365850538|FG000|Overall Study|Other than specified|1|||
106050830|NCT04545385|365850539|FG001|Overall Study|Other than specified|0|||
106152394|NCT04814186|366218767|FG000|Treatment Phase|Withdrawal by Subject|2|||
106152395|NCT04814186|366218767|FG000|Treatment Phase|Other|1|||
106152396|NCT04814186|366218767|FG000|Follow-Up Phase|Adverse Event|1|||
106152397|NCT04814186|366218767|FG000|Follow-Up Phase|Death|6|||
106152398|NCT04814186|366218767|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
106152399|NCT04814186|366218767|FG000|Follow-Up Phase|Other|1|||
106050831|NCT02151110|365850540|FG000|Overall Study|Withdrawal by Subject|0|||
106050832|NCT02151110|365850541|FG001|Overall Study|Withdrawal by Subject|0|||
106050833|NCT02151110|365850542|FG002|Overall Study|Withdrawal by Subject|0|||
106050834|NCT02151110|365850543|FG003|Overall Study|Withdrawal by Subject|0|||
106050835|NCT02151110|365850544|FG004|Overall Study|Withdrawal by Subject|0|||
106050836|NCT02151110|365850545|FG005|Overall Study|Withdrawal by Subject|0|||
106050837|NCT02151110|365850546|FG006|Overall Study|Withdrawal by Subject|0|||
106050838|NCT02151110|365850547|FG007|Overall Study|Withdrawal by Subject|1|||
106050839|NCT02151110|365850540|FG000|Overall Study|Lost to Follow-up|0|||
106050840|NCT02151110|365850541|FG001|Overall Study|Lost to Follow-up|0|||
106050841|NCT02151110|365850542|FG002|Overall Study|Lost to Follow-up|0|||
106050842|NCT02151110|365850543|FG003|Overall Study|Lost to Follow-up|0|||
106050843|NCT02151110|365850544|FG004|Overall Study|Lost to Follow-up|0|||
106050844|NCT02151110|365850545|FG005|Overall Study|Lost to Follow-up|0|||
106050845|NCT02151110|365850546|FG006|Overall Study|Lost to Follow-up|0|||
106050846|NCT02151110|365850547|FG007|Overall Study|Lost to Follow-up|2|||
106050847|NCT00674362|365850550|FG000|Double Blind|Adverse Event|6|||
106050848|NCT00674362|365850551|FG001|Double Blind|Adverse Event|6|||
106050849|NCT00674362|365850550|FG000|Double Blind|Lack of Efficacy|2|||
106050850|NCT00674362|365850551|FG001|Double Blind|Lack of Efficacy|6|||
106050851|NCT00674362|365850550|FG000|Double Blind|Loss of efficacy|0|||
106050852|NCT00674362|365850551|FG001|Double Blind|Loss of efficacy|1|||
106050853|NCT00674362|365850550|FG000|Double Blind|Withdrawal by Subject|4|||
106050854|NCT00674362|365850551|FG001|Double Blind|Withdrawal by Subject|3|||
106050855|NCT00674362|365850550|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
106050856|NCT00674362|365850551|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
106050857|NCT00674362|365850550|FG000|Double Blind|Other: Surgery|0|||
106050858|NCT00674362|365850551|FG001|Double Blind|Other: Surgery|1|||
106050859|NCT00674362|365850550|FG000|Open Label|Adverse Event|1|||
106050860|NCT00674362|365850551|FG001|Open Label|Adverse Event|0|||
106050861|NCT00674362|365850550|FG000|Open Label|Other: Subject moved to extension study|1|||
106050862|NCT00674362|365850551|FG001|Open Label|Other: Subject moved to extension study|0|||
106050863|NCT00668707|365850552|FG000|Overall Study|Cancer Recurrence|58|||
106050864|NCT00668707|365850553|FG001|Overall Study|Cancer Recurrence|58|||
106050865|NCT00668707|365850552|FG000|Overall Study|Withdrawal by Subject|117|||
106050866|NCT00668707|365850553|FG001|Overall Study|Withdrawal by Subject|100|||
106050867|NCT00668707|365850552|FG000|Overall Study|Lost to Follow-up|3|||
106050868|NCT00668707|365850553|FG001|Overall Study|Lost to Follow-up|6|||
106050869|NCT00668707|365850552|FG000|Overall Study|Protocol Violation|10|||
106050870|NCT00668707|365850553|FG001|Overall Study|Protocol Violation|12|||
106050871|NCT00668707|365850552|FG000|Overall Study|Death|11|||
106050872|NCT00668707|365850553|FG001|Overall Study|Death|4|||
106050873|NCT03137537|365850558|FG000|Overall Study|Adverse Event|0|||
106050874|NCT03137537|365850559|FG001|Overall Study|Adverse Event|1|||
106050875|NCT00672646|365850560|FG000|Overall Study|Lost to Follow-up|0|||
106050876|NCT00672646|365850561|FG001|Overall Study|Lost to Follow-up|1|||
106050877|NCT00672646|365850562|FG002|Overall Study|Lost to Follow-up|2|||
106050878|NCT00672646|365850560|FG000|Overall Study|Withdrawal by Subject|0|||
106050879|NCT00672646|365850561|FG001|Overall Study|Withdrawal by Subject|0|||
106050880|NCT00672646|365850562|FG002|Overall Study|Withdrawal by Subject|1|||
106050881|NCT00453063|365850563|FG000|Overall Study|Adverse Event|1|||
106050882|NCT00453063|365850564|FG001|Overall Study|Adverse Event|2|||
106050883|NCT00453063|365850563|FG000|Overall Study|Withdrawal by Subject|1|||
106050884|NCT00453063|365850564|FG001|Overall Study|Withdrawal by Subject|1|||
106050885|NCT00453063|365850563|FG000|Overall Study|Protocol Violation|1|||
106050886|NCT00453063|365850564|FG001|Overall Study|Protocol Violation|0|||
106050887|NCT00289783|365850570|FG000|Primary Phase|Adverse Event|10|||
106050888|NCT00289783|365850571|FG001|Primary Phase|Adverse Event|1|||
106050889|NCT00289783|365850570|FG000|Primary Phase|Protocol Violation|27|||
106050890|NCT00289783|365850571|FG001|Primary Phase|Protocol Violation|6|||
106050891|NCT00289783|365850570|FG000|Primary Phase|Withdrawal by Subject|93|||
106050892|NCT00289783|365850571|FG001|Primary Phase|Withdrawal by Subject|40|||
106050893|NCT00289783|365850570|FG000|Primary Phase|Lost to Follow-up|60|||
106050894|NCT00289783|365850571|FG001|Primary Phase|Lost to Follow-up|14|||
106050895|NCT00289783|365850570|FG000|Primary Phase|Migration from the study area|26|||
106050896|NCT00289783|365850571|FG001|Primary Phase|Migration from the study area|10|||
106050897|NCT00289783|365850570|FG000|Primary Phase|Other|32|||
106050898|NCT00289783|365850571|FG001|Primary Phase|Other|12|||
106050899|NCT00289783|365850570|FG000|Fourth Dose Phase|Adverse Event|1|||
106050900|NCT00289783|365850571|FG001|Fourth Dose Phase|Adverse Event|0|||
106050901|NCT00289783|365850570|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
106050902|NCT00289783|365850571|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
106050903|NCT00289783|365850570|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
106050904|NCT00289783|365850571|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
106050905|NCT00289783|365850570|FG000|Fourth Dose Phase|Migration from the study area|1|||
106050906|NCT00289783|365850571|FG001|Fourth Dose Phase|Migration from the study area|1|||
106050907|NCT00289783|365850570|FG000|Fourth Dose Phase|Other|22|||
106050908|NCT00289783|365850571|FG001|Fourth Dose Phase|Other|10|||
106152400|NCT05665595|366218779|FG000|Overall Study|Ongoing|692|||
106050909|NCT00404235|365850572|FG000|Overall Study|Withdrawal by Subject|1|||
106050910|NCT00404235|365850573|FG001|Overall Study|Withdrawal by Subject|2|||
106050911|NCT00566995|365850574|FG000|Overall Study|Toxicity|4|||
106050912|NCT00566995|365850574|FG000|Overall Study|Withdrew consent|3|||
106050913|NCT01064310|365850575|FG000|Period 1|Adverse Event|7|||
106050914|NCT01064310|365850576|FG001|Period 1|Adverse Event|10|||
106050915|NCT01064310|365850577|FG002|Period 1|Adverse Event|0|||
106050916|NCT01064310|365850575|FG000|Period 1|Physician Decision|1|||
106050917|NCT01064310|365850576|FG001|Period 1|Physician Decision|0|||
106050918|NCT01064310|365850577|FG002|Period 1|Physician Decision|0|||
106050919|NCT01064310|365850575|FG000|Period 1|Withdrawal by Subject|2|||
106050920|NCT01064310|365850576|FG001|Period 1|Withdrawal by Subject|2|||
106050921|NCT01064310|365850577|FG002|Period 1|Withdrawal by Subject|0|||
106050922|NCT01064310|365850575|FG000|Period 1|Lack of Efficacy|3|||
106050923|NCT01064310|365850576|FG001|Period 1|Lack of Efficacy|5|||
106050924|NCT01064310|365850577|FG002|Period 1|Lack of Efficacy|0|||
106050925|NCT01064310|365850575|FG000|Period 1|Entered Open-label Period|1|||
106050926|NCT01064310|365850576|FG001|Period 1|Entered Open-label Period|1|||
106050927|NCT01064310|365850577|FG002|Period 1|Entered Open-label Period|0|||
106050928|NCT01064310|365850575|FG000|Period 2|Adverse Event|2|||
106050929|NCT01064310|365850576|FG001|Period 2|Adverse Event|1|||
106050930|NCT01064310|365850577|FG002|Period 2|Adverse Event|0|||
106050931|NCT01064310|365850575|FG000|Period 2|Physician Decision|0|||
106050932|NCT01064310|365850576|FG001|Period 2|Physician Decision|1|||
106050933|NCT01064310|365850577|FG002|Period 2|Physician Decision|0|||
106050934|NCT01064310|365850575|FG000|Period 2|Entered Open-label Period|1|||
105863651|NCT04759768|365150492|FG001|Washout (7 Days)|Physician Decision|1|||
105863652|NCT02996487|365150493|FG000|Overall Study|Lost to Follow-up|1|||
105863653|NCT02996487|365150494|FG001|Overall Study|Lost to Follow-up|1|||
105863654|NCT02996487|365150495|FG002|Overall Study|Lost to Follow-up|0|||
105863655|NCT02996487|365150493|FG000|Overall Study|Death|0|||
105863656|NCT02996487|365150494|FG001|Overall Study|Death|1|||
105863657|NCT02996487|365150495|FG002|Overall Study|Death|0|||
105863658|NCT02996487|365150493|FG000|Overall Study|Withdrawal by Subject|2|||
105863659|NCT02996487|365150494|FG001|Overall Study|Withdrawal by Subject|3|||
105863660|NCT02996487|365150495|FG002|Overall Study|Withdrawal by Subject|0|||
105863661|NCT02027428|365150496|FG000|Induction|Never treated|7|||
105863662|NCT02027428|365150497|FG001|Induction|Never treated|0|||
105863663|NCT02027428|365150498|FG002|Induction|Never treated|0|||
105863664|NCT02027428|365150496|FG000|Induction|Progressive disease|77|||
105863665|NCT02027428|365150497|FG001|Induction|Progressive disease|0|||
105863666|NCT02027428|365150498|FG002|Induction|Progressive disease|0|||
105863667|NCT02027428|365150496|FG000|Induction|Adverse Event|51|||
105863668|NCT02027428|365150497|FG001|Induction|Adverse Event|0|||
105863669|NCT02027428|365150498|FG002|Induction|Adverse Event|0|||
105863670|NCT02027428|365150496|FG000|Induction|Withdrawal by Subject|22|||
105863671|NCT02027428|365150497|FG001|Induction|Withdrawal by Subject|0|||
105863672|NCT02027428|365150498|FG002|Induction|Withdrawal by Subject|0|||
105863673|NCT02027428|365150496|FG000|Induction|Death|21|||
105863674|NCT02027428|365150497|FG001|Induction|Death|0|||
105863675|NCT02027428|365150498|FG002|Induction|Death|0|||
105863676|NCT02027428|365150496|FG000|Induction|Symptomatic deterioration|16|||
105863677|NCT02027428|365150497|FG001|Induction|Symptomatic deterioration|0|||
105863678|NCT02027428|365150498|FG002|Induction|Symptomatic deterioration|0|||
105863679|NCT02027428|365150496|FG000|Induction|Study terminated by sponsor|12|||
105863680|NCT02027428|365150497|FG001|Induction|Study terminated by sponsor|0|||
105863681|NCT02027428|365150498|FG002|Induction|Study terminated by sponsor|0|||
105863682|NCT02027428|365150496|FG000|Induction|Protocol Violation|1|||
106050935|NCT01064310|365850576|FG001|Period 2|Entered Open-label Period|0|||
106050936|NCT01064310|365850577|FG002|Period 2|Entered Open-label Period|0|||
106050937|NCT01064310|365850575|FG000|Period 2|Lack of Efficacy|1|||
106050938|NCT01064310|365850576|FG001|Period 2|Lack of Efficacy|4|||
105863683|NCT02027428|365150497|FG001|Induction|Protocol Violation|0|||
105863684|NCT02027428|365150498|FG002|Induction|Protocol Violation|0|||
106050939|NCT01064310|365850577|FG002|Period 2|Lack of Efficacy|0|||
106050940|NCT01064310|365850575|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
106050941|NCT01064310|365850576|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
106050942|NCT01064310|365850577|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
106050943|NCT01064310|365850575|FG000|Open Label Pazopinib|Adverse Event|0|||
105863685|NCT02027428|365150496|FG000|Induction|Miscellaneous|14|||
105863686|NCT02027428|365150497|FG001|Induction|Miscellaneous|0|||
105863687|NCT02027428|365150498|FG002|Induction|Miscellaneous|0|||
106050944|NCT01064310|365850576|FG001|Open Label Pazopinib|Adverse Event|0|||
106050945|NCT01064310|365850577|FG002|Open Label Pazopinib|Adverse Event|12|||
105863688|NCT02027428|365150496|FG000|Induction|Induction Treatment Ongoing|4|||
105863689|NCT02027428|365150497|FG001|Induction|Induction Treatment Ongoing|0|||
105863690|NCT02027428|365150498|FG002|Induction|Induction Treatment Ongoing|0|||
105863691|NCT02027428|365150496|FG000|Maintenance|Death|0|||
105863692|NCT02027428|365150497|FG001|Maintenance|Death|3|||
105863693|NCT02027428|365150498|FG002|Maintenance|Death|2|||
105863694|NCT02027428|365150496|FG000|Maintenance|Adverse Event|0|||
106050946|NCT01064310|365850575|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
106050947|NCT01064310|365850576|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
106050948|NCT01064310|365850577|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
106050949|NCT01064310|365850575|FG000|Open Label Pazopinib|Physician Decision|0|||
106050950|NCT01064310|365850576|FG001|Open Label Pazopinib|Physician Decision|0|||
106050951|NCT01064310|365850577|FG002|Open Label Pazopinib|Physician Decision|20|||
106050952|NCT03128411|365850580|FG000|Treatment Phase|Adverse Event|21|||
106050953|NCT03128411|365850580|FG000|Treatment Phase|Physician Decision|1|||
106050954|NCT03128411|365850580|FG000|Treatment Phase|Other|2|||
106050955|NCT03128411|365850580|FG000|Long Term Follow-up Phase|Death|2|||
106050956|NCT06934993|365850581|FG000|Overall Study|Withdrawal by Subject|29|||
106050957|NCT06934993|365850581|FG000|Overall Study|elevated postoperative creatinine level|11|||
106050958|NCT06934993|365850581|FG000|Overall Study|Death|3|||
106050959|NCT02400333|365852396|FG000|Overall Study|Withdrawal by Subject|0|||
106050960|NCT02400333|365852397|FG001|Overall Study|Withdrawal by Subject|1|||
106050961|NCT02400333|365852398|FG002|Overall Study|Withdrawal by Subject|0|||
106050962|NCT02400333|365852399|FG003|Overall Study|Withdrawal by Subject|1|||
106050963|NCT02400333|365852396|FG000|Overall Study|Protocol Violation|1|||
106050964|NCT02400333|365852397|FG001|Overall Study|Protocol Violation|0|||
106050965|NCT02400333|365852398|FG002|Overall Study|Protocol Violation|2|||
106050966|NCT02400333|365852399|FG003|Overall Study|Protocol Violation|1|||
106050967|NCT01890473|365852400|FG000|Overall Study|Lost to Follow-up|1|||
106050968|NCT01890473|365852401|FG001|Overall Study|Lost to Follow-up|0|||
106050969|NCT01890473|365852400|FG000|Overall Study|Poor/non-compliance|1|||
106050970|NCT01890473|365852401|FG001|Overall Study|Poor/non-compliance|0|||
106050971|NCT03166735|365852402|FG000|Overall Study|Not Treated|1|||
106050972|NCT03166735|365852403|FG001|Overall Study|Not Treated|0|||
106050973|NCT03166735|365852404|FG002|Overall Study|Not Treated|0|||
106050974|NCT03166735|365852405|FG003|Overall Study|Not Treated|0|||
106050975|NCT03166735|365852406|FG004|Overall Study|Not Treated|0|||
106050976|NCT03166735|365852402|FG000|Overall Study|follow-up not completed as planned|0|||
106050977|NCT03166735|365852403|FG001|Overall Study|follow-up not completed as planned|1|||
106050978|NCT03166735|365852404|FG002|Overall Study|follow-up not completed as planned|1|||
106050979|NCT03166735|365852405|FG003|Overall Study|follow-up not completed as planned|0|||
106050980|NCT03166735|365852406|FG004|Overall Study|follow-up not completed as planned|1|||
106050981|NCT03166735|365852402|FG000|Overall Study|Withdrawal by Subject|0|||
106050982|NCT03166735|365852403|FG001|Overall Study|Withdrawal by Subject|0|||
106050983|NCT03166735|365852404|FG002|Overall Study|Withdrawal by Subject|1|||
106050984|NCT03166735|365852405|FG003|Overall Study|Withdrawal by Subject|1|||
106050985|NCT03166735|365852406|FG004|Overall Study|Withdrawal by Subject|2|||
106050986|NCT03166735|365852402|FG000|Overall Study|Lost to Follow-up|0|||
106050987|NCT03166735|365852403|FG001|Overall Study|Lost to Follow-up|2|||
106050988|NCT03166735|365852404|FG002|Overall Study|Lost to Follow-up|1|||
106050989|NCT03166735|365852405|FG003|Overall Study|Lost to Follow-up|0|||
106050990|NCT03166735|365852406|FG004|Overall Study|Lost to Follow-up|1|||
106050991|NCT01020981|365852407|FG000|Overall Study|Did not return mailed survey|74|||
106050992|NCT01020981|365852408|FG001|Overall Study|Did not return mailed survey|58|||
106050993|NCT01020981|365852407|FG000|Overall Study|Survey returned undeliverable|8|||
106050994|NCT01020981|365852408|FG001|Overall Study|Survey returned undeliverable|32|||
106050995|NCT01020981|365852407|FG000|Overall Study|Participant declined to complete survey|2|||
106050996|NCT01020981|365852408|FG001|Overall Study|Participant declined to complete survey|0|||
106050997|NCT01086033|365852413|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
106050998|NCT01086033|365852413|FG000|Overall Study|Lost to Follow-up|86|||
106050999|NCT01086033|365852413|FG000|Overall Study|Adverse Event|42|||
106051000|NCT01086033|365852413|FG000|Overall Study|Withdrawal by Subject|41|||
106051001|NCT01086033|365852413|FG000|Overall Study|Other|14|||
106051002|NCT01086033|365852413|FG000|Overall Study|Other|13|||
106051003|NCT01086033|365852413|FG000|Overall Study|AE and Withdrew Consent|5|||
106051004|NCT01086033|365852413|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
106051005|NCT01086033|365852413|FG000|Overall Study|Withdrew consent and Other Reason|4|||
106051006|NCT01086033|365852413|FG000|Overall Study|AE and Lack of Efficacy|4|||
106051007|NCT01086033|365852413|FG000|Overall Study|Death|1|||
106051008|NCT01086033|365852413|FG000|Overall Study|AE and Lost to Follow-up|1|||
106051009|NCT01086033|365852413|FG000|Overall Study|AE and Other Reason|1|||
106051010|NCT01086033|365852413|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
106051011|NCT03355365|365852415|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
106051012|NCT03355365|365852416|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
106051013|NCT03355365|365852415|FG000|Year 1, First Intervention|Protocol Violation|1|||
106051014|NCT03355365|365852416|FG001|Year 1, First Intervention|Protocol Violation|0|||
106051015|NCT03355365|365852415|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
106051016|NCT03355365|365852416|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
106051017|NCT03355365|365852415|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
106051018|NCT03355365|365852416|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
106051019|NCT03355365|365852415|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
106051020|NCT03355365|365852416|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
106051021|NCT03355365|365852415|FG000|Year 2, Crossover Intervention|severe COVID|0|||
106051022|NCT03355365|365852416|FG001|Year 2, Crossover Intervention|severe COVID|1|||
106051023|NCT03355365|365852415|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
106051024|NCT03355365|365852416|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
106051025|NCT00885846|365852423|FG000|Overall Study|Withdrawal by Subject|2|||
106051026|NCT00885846|365852424|FG001|Overall Study|Withdrawal by Subject|5|||
106051027|NCT00885846|365852425|FG002|Overall Study|Withdrawal by Subject|2|||
106051028|NCT01081678|365852428|FG000|Overall Study|Ineligibility Determined|0|||
106051029|NCT01081678|365852429|FG001|Overall Study|Ineligibility Determined|0|||
106051030|NCT01081678|365852430|FG002|Overall Study|Ineligibility Determined|1|||
106051031|NCT01081678|365852431|FG003|Overall Study|Ineligibility Determined|1|||
106051032|NCT01081678|365852428|FG000|Overall Study|Noncompliance|3|||
106051033|NCT01081678|365852429|FG001|Overall Study|Noncompliance|4|||
106051034|NCT01081678|365852430|FG002|Overall Study|Noncompliance|5|||
106051035|NCT01081678|365852431|FG003|Overall Study|Noncompliance|2|||
106051036|NCT01081678|365852428|FG000|Overall Study|Adverse Event|2|||
106051037|NCT01081678|365852429|FG001|Overall Study|Adverse Event|1|||
106051038|NCT01081678|365852430|FG002|Overall Study|Adverse Event|2|||
106051039|NCT01081678|365852431|FG003|Overall Study|Adverse Event|2|||
106051040|NCT01081678|365852428|FG000|Overall Study|Withdrawal by Subject|15|||
106051041|NCT01081678|365852429|FG001|Overall Study|Withdrawal by Subject|7|||
106051042|NCT01081678|365852430|FG002|Overall Study|Withdrawal by Subject|17|||
106051043|NCT01081678|365852431|FG003|Overall Study|Withdrawal by Subject|14|||
106051044|NCT01081678|365852428|FG000|Overall Study|Administrative Decision|1|||
106051045|NCT01081678|365852429|FG001|Overall Study|Administrative Decision|0|||
106051046|NCT01081678|365852430|FG002|Overall Study|Administrative Decision|0|||
106051047|NCT01081678|365852431|FG003|Overall Study|Administrative Decision|1|||
106051048|NCT01081678|365852428|FG000|Overall Study|Lost to Follow-up|4|||
106051049|NCT01081678|365852429|FG001|Overall Study|Lost to Follow-up|1|||
106051050|NCT01081678|365852430|FG002|Overall Study|Lost to Follow-up|4|||
106051051|NCT01081678|365852431|FG003|Overall Study|Lost to Follow-up|3|||
106051052|NCT01081678|365852428|FG000|Overall Study|Death|2|||
106051053|NCT01081678|365852429|FG001|Overall Study|Death|2|||
106051054|NCT01081678|365852430|FG002|Overall Study|Death|2|||
106051055|NCT01081678|365852431|FG003|Overall Study|Death|6|||
106051056|NCT01081678|365852428|FG000|Overall Study|Other|0|||
106051057|NCT01081678|365852429|FG001|Overall Study|Other|1|||
106051058|NCT01081678|365852430|FG002|Overall Study|Other|0|||
106051059|NCT01081678|365852431|FG003|Overall Study|Other|0|||
106051060|NCT00963937|365852434|FG000|Overall Study|Protocol Violation|1|||
106051061|NCT00963937|365852435|FG001|Overall Study|Protocol Violation|1|||
106051062|NCT00963937|365852436|FG002|Overall Study|Protocol Violation|0|||
106051063|NCT00963937|365852434|FG000|Overall Study|Physician Decision|18|||
106051064|NCT00963937|365852435|FG001|Overall Study|Physician Decision|10|||
106051065|NCT00963937|365852436|FG002|Overall Study|Physician Decision|4|||
106051066|NCT02197520|365852437|FG000|Period 1|Withdrawal by Subject|1|||
106051067|NCT02197520|365852438|FG001|Period 1|Withdrawal by Subject|0|||
106051068|NCT02197520|365852437|FG000|Period 2|Adverse Event|0|||
106051069|NCT02197520|365852438|FG001|Period 2|Adverse Event|2|||
106051070|NCT02197520|365852437|FG000|Period 2|Withdrawal by Subject|1|||
106051071|NCT02197520|365852438|FG001|Period 2|Withdrawal by Subject|0|||
106051072|NCT01254331|365852439|FG000|Initial Phase|Adverse Event|3|||
106051073|NCT01254331|365852439|FG000|Initial Phase|Withdrawal by Subject|1|||
106051074|NCT01254331|365852439|FG000|Initial Phase|Pregnancy|1|||
106051075|NCT01254331|365852439|FG000|Extension Phase|Lack of Efficacy|1|||
106051076|NCT01254331|365852439|FG000|Extension Phase|Lost to Follow-up|3|||
106051077|NCT05306977|365852440|FG000|Overall Study|Withdrawal by Subject|1|||
106051078|NCT01612858|365852441|FG000|Overall Study|Withdrawal by Subject|5|||
106051079|NCT01612858|365852442|FG001|Overall Study|Withdrawal by Subject|1|||
106051080|NCT03988088|365852445|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
106051081|NCT03988088|365852446|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
106051082|NCT03988088|365852447|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
106051083|NCT03988088|365852448|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
106051084|NCT03988088|365852445|FG000|Open-Label Addendum|Lost to Follow-up|0|||
106051085|NCT03988088|365852446|FG001|Open-Label Addendum|Lost to Follow-up|0|||
106051086|NCT03988088|365852447|FG002|Open-Label Addendum|Lost to Follow-up|1|||
106051087|NCT03988088|365852448|FG003|Open-Label Addendum|Lost to Follow-up|0|||
106051088|NCT04431453|365852449|FG000|Overall Study|Withdrew Consent|0|||
106051089|NCT04431453|365852450|FG001|Overall Study|Withdrew Consent|1|||
106051090|NCT04431453|365852451|FG002|Overall Study|Withdrew Consent|0|||
106051091|NCT04431453|365852452|FG003|Overall Study|Withdrew Consent|2|||
106051092|NCT04431453|365852453|FG004|Overall Study|Withdrew Consent|0|||
106051093|NCT04431453|365852454|FG005|Overall Study|Withdrew Consent|0|||
106051094|NCT04431453|365852455|FG006|Overall Study|Withdrew Consent|0|||
106051095|NCT04431453|365852456|FG007|Overall Study|Withdrew Consent|0|||
106051096|NCT04431453|365852449|FG000|Overall Study|Death|1|||
106051097|NCT04431453|365852450|FG001|Overall Study|Death|0|||
106051098|NCT04431453|365852451|FG002|Overall Study|Death|0|||
106051099|NCT04431453|365852452|FG003|Overall Study|Death|0|||
106051100|NCT04431453|365852453|FG004|Overall Study|Death|0|||
106051101|NCT04431453|365852454|FG005|Overall Study|Death|0|||
106051102|NCT04431453|365852455|FG006|Overall Study|Death|0|||
106051103|NCT04431453|365852456|FG007|Overall Study|Death|1|||
106051104|NCT04431453|365852449|FG000|Overall Study|Lost to Follow-up|0|||
106051105|NCT04431453|365852450|FG001|Overall Study|Lost to Follow-up|0|||
106051106|NCT04431453|365852451|FG002|Overall Study|Lost to Follow-up|1|||
106051107|NCT04431453|365852452|FG003|Overall Study|Lost to Follow-up|1|||
106051108|NCT04431453|365852453|FG004|Overall Study|Lost to Follow-up|0|||
105863695|NCT02027428|365150497|FG001|Maintenance|Adverse Event|21|||
105863696|NCT02027428|365150498|FG002|Maintenance|Adverse Event|1|||
105863697|NCT02027428|365150496|FG000|Maintenance|Progressive disease|0|||
105863698|NCT02027428|365150497|FG001|Maintenance|Progressive disease|84|||
105863699|NCT02027428|365150498|FG002|Maintenance|Progressive disease|47|||
105863700|NCT02027428|365150496|FG000|Maintenance|Symptomatic deterioration|0|||
105863701|NCT02027428|365150497|FG001|Maintenance|Symptomatic deterioration|4|||
105863702|NCT02027428|365150498|FG002|Maintenance|Symptomatic deterioration|1|||
105863703|NCT02027428|365150496|FG000|Maintenance|Withdrawal by Subject|0|||
105863704|NCT02027428|365150497|FG001|Maintenance|Withdrawal by Subject|6|||
105863705|NCT02027428|365150498|FG002|Maintenance|Withdrawal by Subject|5|||
105863706|NCT02027428|365150496|FG000|Maintenance|Protocol Violation|0|||
105863707|NCT02027428|365150497|FG001|Maintenance|Protocol Violation|0|||
105863708|NCT02027428|365150498|FG002|Maintenance|Protocol Violation|1|||
105863709|NCT02027428|365150496|FG000|Maintenance|Other|0|||
105863710|NCT02027428|365150497|FG001|Maintenance|Other|6|||
105863711|NCT02027428|365150498|FG002|Maintenance|Other|3|||
105863712|NCT02027428|365150496|FG000|Survival Follow-up|Death|0|||
105863713|NCT02027428|365150497|FG001|Survival Follow-up|Death|78|||
105863714|NCT02027428|365150498|FG002|Survival Follow-up|Death|45|||
105863715|NCT02027428|365150496|FG000|Survival Follow-up|Lost to Follow-up|0|||
105863716|NCT02027428|365150497|FG001|Survival Follow-up|Lost to Follow-up|1|||
105863717|NCT02027428|365150498|FG002|Survival Follow-up|Lost to Follow-up|1|||
105863718|NCT02785952|365150502|FG000|Overall Study|Adverse Event|31|||
105863719|NCT02785952|365150503|FG001|Overall Study|Adverse Event|19|||
105863720|NCT02785952|365150502|FG000|Overall Study|Refusal unrelated to adverse events|10|||
105863721|NCT02785952|365150503|FG001|Overall Study|Refusal unrelated to adverse events|5|||
105863722|NCT02785952|365150502|FG000|Overall Study|Disease progression/relapse|61|||
105863723|NCT02785952|365150503|FG001|Overall Study|Disease progression/relapse|89|||
105863724|NCT02785952|365150502|FG000|Overall Study|Death|11|||
105863725|NCT02785952|365150503|FG001|Overall Study|Death|7|||
105863726|NCT02785952|365150502|FG000|Overall Study|Other- not protocol specified|6|||
105863727|NCT02785952|365150503|FG001|Overall Study|Other- not protocol specified|4|||
105863728|NCT02785952|365150502|FG000|Overall Study|On protocol treatment|6|||
105863729|NCT02785952|365150503|FG001|Overall Study|On protocol treatment|3|||
105863730|NCT01004003|365150505|FG000|Overall Study|Progressive disease|2|||
105863731|NCT01004003|365150506|FG001|Overall Study|Progressive disease|1|||
105863732|NCT01004003|365150507|FG002|Overall Study|Progressive disease|1|||
105863733|NCT01004003|365150508|FG003|Overall Study|Progressive disease|0|||
105863734|NCT01004003|365150509|FG004|Overall Study|Progressive disease|2|||
105863735|NCT01004003|365150510|FG005|Overall Study|Progressive disease|1|||
105863736|NCT01004003|365150511|FG006|Overall Study|Progressive disease|1|||
105863737|NCT01004003|365150512|FG007|Overall Study|Progressive disease|39|||
105863738|NCT01004003|365150513|FG008|Overall Study|Progressive disease|22|||
105863739|NCT01004003|365150505|FG000|Overall Study|Adverse Event|4|||
105863740|NCT01004003|365150506|FG001|Overall Study|Adverse Event|2|||
105863741|NCT01004003|365150507|FG002|Overall Study|Adverse Event|3|||
105863742|NCT01004003|365150508|FG003|Overall Study|Adverse Event|3|||
105863743|NCT01004003|365150509|FG004|Overall Study|Adverse Event|2|||
105863744|NCT01004003|365150510|FG005|Overall Study|Adverse Event|2|||
105863745|NCT01004003|365150511|FG006|Overall Study|Adverse Event|7|||
105863746|NCT01004003|365150512|FG007|Overall Study|Adverse Event|21|||
105863747|NCT01004003|365150513|FG008|Overall Study|Adverse Event|6|||
106051109|NCT04431453|365852454|FG005|Overall Study|Lost to Follow-up|0|||
106051110|NCT04431453|365852455|FG006|Overall Study|Lost to Follow-up|0|||
106051111|NCT04431453|365852456|FG007|Overall Study|Lost to Follow-up|0|||
106051112|NCT04431453|365852449|FG000|Overall Study|Enrolled but Never Treated|0|||
105863748|NCT01004003|365150505|FG000|Overall Study|Refused to continue taking trial med.|0|||
105863749|NCT01004003|365150506|FG001|Overall Study|Refused to continue taking trial med.|0|||
105863750|NCT01004003|365150507|FG002|Overall Study|Refused to continue taking trial med.|0|||
105863751|NCT01004003|365150508|FG003|Overall Study|Refused to continue taking trial med.|0|||
105863752|NCT01004003|365150509|FG004|Overall Study|Refused to continue taking trial med.|0|||
105863753|NCT01004003|365150510|FG005|Overall Study|Refused to continue taking trial med.|0|||
105863754|NCT01004003|365150511|FG006|Overall Study|Refused to continue taking trial med.|0|||
105863755|NCT01004003|365150512|FG007|Overall Study|Refused to continue taking trial med.|0|||
105863756|NCT01004003|365150513|FG008|Overall Study|Refused to continue taking trial med.|2|||
105863757|NCT01004003|365150505|FG000|Overall Study|Other|0|||
105863758|NCT01004003|365150506|FG001|Overall Study|Other|0|||
105863759|NCT01004003|365150507|FG002|Overall Study|Other|0|||
105863760|NCT01004003|365150508|FG003|Overall Study|Other|0|||
105863761|NCT01004003|365150509|FG004|Overall Study|Other|0|||
106051113|NCT04431453|365852450|FG001|Overall Study|Enrolled but Never Treated|0|||
106051114|NCT04431453|365852451|FG002|Overall Study|Enrolled but Never Treated|0|||
106051115|NCT04431453|365852452|FG003|Overall Study|Enrolled but Never Treated|0|||
106051116|NCT04431453|365852453|FG004|Overall Study|Enrolled but Never Treated|1|||
106051117|NCT04431453|365852454|FG005|Overall Study|Enrolled but Never Treated|0|||
106051118|NCT04431453|365852455|FG006|Overall Study|Enrolled but Never Treated|0|||
106051119|NCT04431453|365852456|FG007|Overall Study|Enrolled but Never Treated|0|||
106051120|NCT02762578|365852465|FG000|Overall Study|Adverse Event|1|||
106051121|NCT02762578|365852466|FG001|Overall Study|Adverse Event|6|||
106051122|NCT02762578|365852465|FG000|Overall Study|Protocol Violation|4|||
106051123|NCT02762578|365852466|FG001|Overall Study|Protocol Violation|2|||
106051124|NCT02762578|365852465|FG000|Overall Study|Withdrawal by Subject|4|||
106051125|NCT02762578|365852466|FG001|Overall Study|Withdrawal by Subject|2|||
106051126|NCT02762578|365852465|FG000|Overall Study|Unclassified|6|||
106051127|NCT02762578|365852466|FG001|Overall Study|Unclassified|0|||
106051128|NCT01090492|365852467|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
106051129|NCT01090492|365852468|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
106051130|NCT01090492|365852469|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
106051131|NCT01090492|365852470|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
106051132|NCT01090492|365852471|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
106051133|NCT01090492|365852472|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
106051134|NCT01090492|365852473|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
106051135|NCT01090492|365852474|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
106051136|NCT01090492|365852467|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
106051137|NCT01090492|365852468|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
106051138|NCT01090492|365852469|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
106051139|NCT01090492|365852470|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
106051140|NCT01090492|365852471|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
106051141|NCT01090492|365852472|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
106051142|NCT01090492|365852473|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
106051143|NCT01090492|365852474|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
106051144|NCT01090492|365852467|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051145|NCT01090492|365852468|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051146|NCT01090492|365852469|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
106051147|NCT01090492|365852470|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051148|NCT01090492|365852471|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051149|NCT01090492|365852472|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051150|NCT01090492|365852473|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051151|NCT01090492|365852474|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051152|NCT01090492|365852467|FG000|First Intervention Period (4 Weeks)|Other|0|||
106051153|NCT01090492|365852468|FG001|First Intervention Period (4 Weeks)|Other|0|||
106051154|NCT01090492|365852469|FG002|First Intervention Period (4 Weeks)|Other|1|||
106051155|NCT01090492|365852470|FG003|First Intervention Period (4 Weeks)|Other|1|||
106051156|NCT01090492|365852471|FG004|First Intervention Period (4 Weeks)|Other|2|||
106051157|NCT01090492|365852472|FG005|First Intervention Period (4 Weeks)|Other|0|||
106051158|NCT01090492|365852473|FG006|First Intervention Period (4 Weeks)|Other|0|||
106051159|NCT01090492|365852474|FG007|First Intervention Period (4 Weeks)|Other|0|||
106051160|NCT01090492|365852467|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
106051161|NCT01090492|365852468|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
106051162|NCT01090492|365852469|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
106051163|NCT01090492|365852470|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
106051164|NCT01090492|365852471|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
106051165|NCT01090492|365852472|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
106051166|NCT01090492|365852473|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
106051167|NCT01090492|365852474|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
106051168|NCT01090492|365852467|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
106051169|NCT01090492|365852468|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
106051170|NCT01090492|365852469|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
106051171|NCT01090492|365852470|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
106051172|NCT01090492|365852471|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
106051173|NCT01090492|365852472|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
106051174|NCT01090492|365852473|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
106051175|NCT01090492|365852474|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
106051176|NCT01090492|365852467|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
106051177|NCT01090492|365852468|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
106051178|NCT01090492|365852469|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
106051179|NCT01090492|365852470|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
105863762|NCT01004003|365150510|FG005|Overall Study|Other|1|||
106051180|NCT01090492|365852471|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
106051181|NCT01090492|365852472|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
106051182|NCT01090492|365852473|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
106051183|NCT01090492|365852474|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
106051184|NCT01090492|365852467|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
106051185|NCT01090492|365852468|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
106051186|NCT01090492|365852469|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
106051187|NCT01090492|365852470|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
106051188|NCT01090492|365852471|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
106051189|NCT01090492|365852472|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
106051190|NCT01090492|365852473|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
106051191|NCT01090492|365852474|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
106051192|NCT01090492|365852467|FG000|Second Intervention Period (4 Weeks)|Other|0|||
106051193|NCT01090492|365852468|FG001|Second Intervention Period (4 Weeks)|Other|1|||
106051194|NCT01090492|365852469|FG002|Second Intervention Period (4 Weeks)|Other|1|||
106051195|NCT01090492|365852470|FG003|Second Intervention Period (4 Weeks)|Other|0|||
106051196|NCT01090492|365852471|FG004|Second Intervention Period (4 Weeks)|Other|0|||
106051197|NCT01090492|365852472|FG005|Second Intervention Period (4 Weeks)|Other|0|||
106051198|NCT01090492|365852473|FG006|Second Intervention Period (4 Weeks)|Other|0|||
106051199|NCT01090492|365852474|FG007|Second Intervention Period (4 Weeks)|Other|0|||
106051200|NCT01090492|365852467|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
106051201|NCT01090492|365852468|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
106051202|NCT01090492|365852469|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
106051203|NCT01090492|365852470|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
106051204|NCT01090492|365852471|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
106051205|NCT01090492|365852472|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
106051206|NCT01090492|365852473|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
106051207|NCT01090492|365852474|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
106051208|NCT01090492|365852467|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051209|NCT01090492|365852468|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051210|NCT01090492|365852469|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051211|NCT01090492|365852470|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051212|NCT01090492|365852471|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051213|NCT01090492|365852472|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051214|NCT01090492|365852473|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
106051215|NCT01090492|365852474|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
106051216|NCT01768286|365852475|FG000|Overall Study|Randomized But Not Treated|0|||
106051217|NCT01768286|365852476|FG001|Overall Study|Randomized But Not Treated|0|||
106051218|NCT01768286|365852477|FG002|Overall Study|Randomized But Not Treated|1|||
106051219|NCT01768286|365852478|FG003|Overall Study|Randomized But Not Treated|0|||
106051220|NCT01768286|365852475|FG000|Overall Study|Lack of Efficacy|7|||
106051221|NCT01768286|365852476|FG001|Overall Study|Lack of Efficacy|4|||
106051222|NCT01768286|365852477|FG002|Overall Study|Lack of Efficacy|0|||
106051223|NCT01768286|365852478|FG003|Overall Study|Lack of Efficacy|1|||
106051224|NCT01768286|365852475|FG000|Overall Study|Withdrew Consent|0|||
106051225|NCT01768286|365852476|FG001|Overall Study|Withdrew Consent|0|||
106051226|NCT01768286|365852477|FG002|Overall Study|Withdrew Consent|1|||
106051227|NCT01768286|365852478|FG003|Overall Study|Withdrew Consent|0|||
106051228|NCT02083965|365852479|FG000|Treatment Period|Other|1|||
106051229|NCT02083965|365852480|FG001|Treatment Period|Other|0|||
106051230|NCT01602120|365852481|FG000|Overall Study|Adverse Event|3|||
106051231|NCT01602120|365852482|FG001|Overall Study|Adverse Event|6|||
106051232|NCT01602120|365852483|FG002|Overall Study|Adverse Event|0|||
106051233|NCT01602120|365852484|FG003|Overall Study|Adverse Event|2|||
106051234|NCT01602120|365852481|FG000|Overall Study|Death|0|||
106051235|NCT01602120|365852482|FG001|Overall Study|Death|4|||
106051236|NCT01602120|365852483|FG002|Overall Study|Death|0|||
106051237|NCT01602120|365852484|FG003|Overall Study|Death|0|||
106051238|NCT01602120|365852481|FG000|Overall Study|Lost to Follow-up|0|||
106051239|NCT01602120|365852482|FG001|Overall Study|Lost to Follow-up|1|||
106051240|NCT01602120|365852483|FG002|Overall Study|Lost to Follow-up|0|||
106051241|NCT01602120|365852484|FG003|Overall Study|Lost to Follow-up|1|||
106051242|NCT01602120|365852481|FG000|Overall Study|Protocol Violation|1|||
106051243|NCT01602120|365852482|FG001|Overall Study|Protocol Violation|1|||
106051244|NCT01602120|365852483|FG002|Overall Study|Protocol Violation|0|||
106051245|NCT01602120|365852484|FG003|Overall Study|Protocol Violation|0|||
106051246|NCT01602120|365852481|FG000|Overall Study|Non-compliance|0|||
106051247|NCT01602120|365852482|FG001|Overall Study|Non-compliance|3|||
106051248|NCT01602120|365852483|FG002|Overall Study|Non-compliance|0|||
106051249|NCT01602120|365852484|FG003|Overall Study|Non-compliance|1|||
106051250|NCT01602120|365852481|FG000|Overall Study|Withdrawal by Subject|8|||
106152401|NCT05665595|366218780|FG001|Overall Study|Ongoing|698|||
106152402|NCT05665595|366218779|FG000|Overall Study|Withdrawal by Subject|2|||
105863763|NCT01004003|365150511|FG006|Overall Study|Other|0|||
106051251|NCT01602120|365852482|FG001|Overall Study|Withdrawal by Subject|17|||
106051252|NCT01602120|365852483|FG002|Overall Study|Withdrawal by Subject|0|||
105863764|NCT01004003|365150512|FG007|Overall Study|Other|0|||
105863765|NCT01004003|365150513|FG008|Overall Study|Other|0|||
105863766|NCT02728843|365150519|FG000|Overall Study|Adverse Event|0|||
106051253|NCT01602120|365852484|FG003|Overall Study|Withdrawal by Subject|3|||
106051254|NCT01602120|365852481|FG000|Overall Study|Study Terminated by Sponsor|12|||
106051255|NCT01602120|365852482|FG001|Overall Study|Study Terminated by Sponsor|24|||
106051256|NCT01602120|365852483|FG002|Overall Study|Study Terminated by Sponsor|17|||
106051257|NCT01602120|365852484|FG003|Overall Study|Study Terminated by Sponsor|44|||
106051258|NCT01602120|365852481|FG000|Overall Study|Physician Decision|2|||
106051259|NCT01602120|365852482|FG001|Overall Study|Physician Decision|3|||
106051260|NCT01602120|365852483|FG002|Overall Study|Physician Decision|0|||
106051261|NCT01602120|365852484|FG003|Overall Study|Physician Decision|0|||
106051262|NCT01602120|365852481|FG000|Overall Study|Unspecified Reason|3|||
106051263|NCT01602120|365852482|FG001|Overall Study|Unspecified Reason|1|||
106051264|NCT01602120|365852483|FG002|Overall Study|Unspecified Reason|0|||
106051265|NCT01602120|365852484|FG003|Overall Study|Unspecified Reason|2|||
106051266|NCT01611155|365852485|FG000|Overall Study|Adverse Event|1|||
106051267|NCT01611155|365852486|FG001|Overall Study|Adverse Event|1|||
106051268|NCT01611155|365852485|FG000|Overall Study|Refused further treatment|6|||
106051269|NCT01611155|365852486|FG001|Overall Study|Refused further treatment|4|||
106051270|NCT01611155|365852485|FG000|Overall Study|Disease progression|1|||
106051271|NCT01611155|365852486|FG001|Overall Study|Disease progression|0|||
106051272|NCT01611155|365852485|FG000|Overall Study|Withdrawal by Subject|1|||
106051273|NCT01611155|365852486|FG001|Overall Study|Withdrawal by Subject|0|||
106051274|NCT01611155|365852485|FG000|Overall Study|Alternative treatment|0|||
106051275|NCT01611155|365852486|FG001|Overall Study|Alternative treatment|1|||
106051276|NCT01611155|365852485|FG000|Overall Study|Ineligible patient|0|||
106051277|NCT01611155|365852486|FG001|Overall Study|Ineligible patient|1|||
106051278|NCT02004522|365852488|FG000|Overall Study|Adverse Event|55|||
106051279|NCT02004522|365852489|FG001|Overall Study|Adverse Event|6|||
106051280|NCT02004522|365852488|FG000|Overall Study|Withdrawal by Subject|13|||
106051281|NCT02004522|365852489|FG001|Overall Study|Withdrawal by Subject|7|||
106051282|NCT02004522|365852488|FG000|Overall Study|Death|12|||
106051283|NCT02004522|365852489|FG001|Overall Study|Death|3|||
106051284|NCT02004522|365852488|FG000|Overall Study|Physician Decision|3|||
106051285|NCT02004522|365852489|FG001|Overall Study|Physician Decision|4|||
106051286|NCT02004522|365852488|FG000|Overall Study|Protocol Violation|1|||
106051287|NCT02004522|365852489|FG001|Overall Study|Protocol Violation|0|||
106051288|NCT02004522|365852488|FG000|Overall Study|Other is reason listed by PI|4|||
106051289|NCT02004522|365852489|FG001|Overall Study|Other is reason listed by PI|1|||
106051290|NCT02004522|365852488|FG000|Overall Study|Never Dosed|2|||
106051291|NCT02004522|365852489|FG001|Overall Study|Never Dosed|4|||
106051292|NCT02004522|365852488|FG000|Overall Study|Disease Progression|35|||
106051293|NCT02004522|365852489|FG001|Overall Study|Disease Progression|31|||
106051294|NCT02004522|365852488|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
106051295|NCT02004522|365852489|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
106051296|NCT00911547|365852491|FG000|Overall Study|Adverse Event|8|||
106051297|NCT00911547|365852492|FG001|Overall Study|Adverse Event|27|||
106051298|NCT00911547|365852493|FG002|Overall Study|Adverse Event|11|||
106051299|NCT00911547|365852494|FG003|Overall Study|Adverse Event|6|||
106051300|NCT00911547|365852491|FG000|Overall Study|Lost to Follow-up|0|||
106051301|NCT00911547|365852492|FG001|Overall Study|Lost to Follow-up|0|||
106051302|NCT00911547|365852493|FG002|Overall Study|Lost to Follow-up|2|||
106051303|NCT00911547|365852494|FG003|Overall Study|Lost to Follow-up|1|||
106051304|NCT00911547|365852491|FG000|Overall Study|Protocol Violation|0|||
106051305|NCT00911547|365852492|FG001|Overall Study|Protocol Violation|5|||
106051306|NCT00911547|365852493|FG002|Overall Study|Protocol Violation|5|||
106051307|NCT00911547|365852494|FG003|Overall Study|Protocol Violation|1|||
106051308|NCT00911547|365852491|FG000|Overall Study|Withdrawal by Subject|3|||
106051309|NCT00911547|365852492|FG001|Overall Study|Withdrawal by Subject|10|||
106051310|NCT00911547|365852493|FG002|Overall Study|Withdrawal by Subject|4|||
106051311|NCT00911547|365852494|FG003|Overall Study|Withdrawal by Subject|8|||
106051312|NCT00191269|365852495|FG000|Overall Study|Protocol Violation|0|||
106051313|NCT00191269|365852496|FG001|Overall Study|Protocol Violation|2|||
106051314|NCT00191269|365852495|FG000|Overall Study|Adverse Event|1|||
106051315|NCT00191269|365852496|FG001|Overall Study|Adverse Event|4|||
106051316|NCT00191269|365852495|FG000|Overall Study|Progression of Disease|4|||
106051317|NCT00191269|365852496|FG001|Overall Study|Progression of Disease|42|||
106051318|NCT00191269|365852495|FG000|Overall Study|Lack of Efficacy|1|||
106051319|NCT00191269|365852496|FG001|Overall Study|Lack of Efficacy|5|||
106051320|NCT00191269|365852495|FG000|Overall Study|Withdrawal by Subject|0|||
106051321|NCT00191269|365852496|FG001|Overall Study|Withdrawal by Subject|1|||
105863767|NCT02728843|365150520|FG001|Overall Study|Adverse Event|2|||
105863768|NCT02728843|365150521|FG002|Overall Study|Adverse Event|3|||
106051322|NCT00191269|365852495|FG000|Overall Study|Pathologic Aggrevation|0|||
106051323|NCT00191269|365852496|FG001|Overall Study|Pathologic Aggrevation|1|||
106051324|NCT00191269|365852495|FG000|Overall Study|Physician Decision|0|||
106051325|NCT00191269|365852496|FG001|Overall Study|Physician Decision|3|||
106051326|NCT01201785|365852497|FG000|Overall Study|Lost to Follow-up|16|||
106051327|NCT00915278|365852498|FG000|Overall Study|Death|1|||
106051328|NCT00915278|365852499|FG001|Overall Study|Death|0|||
106051329|NCT00915278|365852500|FG002|Overall Study|Death|0|||
106051330|NCT00915278|365852501|FG003|Overall Study|Death|0|||
106051331|NCT00915278|365852502|FG004|Overall Study|Death|0|||
106051332|NCT00915278|365852503|FG005|Overall Study|Death|0|||
106051333|NCT00915278|365852498|FG000|Overall Study|Lost to Follow-up|0|||
106051334|NCT00915278|365852499|FG001|Overall Study|Lost to Follow-up|1|||
106051335|NCT00915278|365852500|FG002|Overall Study|Lost to Follow-up|0|||
106051336|NCT00915278|365852501|FG003|Overall Study|Lost to Follow-up|0|||
106051337|NCT00915278|365852502|FG004|Overall Study|Lost to Follow-up|0|||
106051338|NCT00915278|365852503|FG005|Overall Study|Lost to Follow-up|0|||
106051339|NCT00915278|365852498|FG000|Overall Study|Withdrawal by Subject|0|||
106051340|NCT00915278|365852499|FG001|Overall Study|Withdrawal by Subject|1|||
106051341|NCT00915278|365852500|FG002|Overall Study|Withdrawal by Subject|0|||
106051342|NCT00915278|365852501|FG003|Overall Study|Withdrawal by Subject|0|||
106051343|NCT00915278|365852502|FG004|Overall Study|Withdrawal by Subject|1|||
106051344|NCT00915278|365852503|FG005|Overall Study|Withdrawal by Subject|4|||
106051345|NCT00915278|365852498|FG000|Overall Study|Adverse Event|4|||
106051346|NCT00915278|365852499|FG001|Overall Study|Adverse Event|1|||
106051347|NCT00915278|365852500|FG002|Overall Study|Adverse Event|0|||
106051348|NCT00915278|365852501|FG003|Overall Study|Adverse Event|0|||
106051349|NCT00915278|365852502|FG004|Overall Study|Adverse Event|0|||
106051350|NCT00915278|365852503|FG005|Overall Study|Adverse Event|0|||
106051351|NCT00915278|365852498|FG000|Overall Study|Progressive disease/clinical progression|0|||
106051352|NCT00915278|365852499|FG001|Overall Study|Progressive disease/clinical progression|0|||
106051353|NCT00915278|365852500|FG002|Overall Study|Progressive disease/clinical progression|0|||
106051354|NCT00915278|365852501|FG003|Overall Study|Progressive disease/clinical progression|3|||
106051355|NCT00915278|365852502|FG004|Overall Study|Progressive disease/clinical progression|1|||
106051356|NCT00915278|365852503|FG005|Overall Study|Progressive disease/clinical progression|2|||
106051357|NCT00915278|365852498|FG000|Overall Study|Infusion related AEs|0|||
106051358|NCT00915278|365852499|FG001|Overall Study|Infusion related AEs|0|||
106051359|NCT00915278|365852500|FG002|Overall Study|Infusion related AEs|0|||
106051360|NCT00915278|365852501|FG003|Overall Study|Infusion related AEs|0|||
106051361|NCT00915278|365852502|FG004|Overall Study|Infusion related AEs|0|||
106051362|NCT00915278|365852503|FG005|Overall Study|Infusion related AEs|2|||
106051363|NCT00915278|365852498|FG000|Overall Study|Admission to hospice|0|||
106051364|NCT00915278|365852499|FG001|Overall Study|Admission to hospice|0|||
106051365|NCT00915278|365852500|FG002|Overall Study|Admission to hospice|1|||
106051366|NCT00915278|365852501|FG003|Overall Study|Admission to hospice|0|||
106051367|NCT00915278|365852502|FG004|Overall Study|Admission to hospice|0|||
106051368|NCT00915278|365852503|FG005|Overall Study|Admission to hospice|0|||
106051369|NCT01128842|365852504|FG000|Overall Study|Adverse Event|1|||
106051370|NCT01128842|365852504|FG000|Overall Study|Disease Progression|6|||
106051371|NCT04528732|365852505|FG000|Overall Study|Death|1|||
106051372|NCT04528732|365852506|FG001|Overall Study|Death|0|||
106051373|NCT04528732|365852507|FG002|Overall Study|Death|1|||
106051374|NCT04528732|365852505|FG000|Overall Study|Lost to Follow-up|0|||
106051375|NCT04528732|365852506|FG001|Overall Study|Lost to Follow-up|1|||
106051376|NCT04528732|365852507|FG002|Overall Study|Lost to Follow-up|2|||
106051377|NCT00319501|365852508|FG000|Double-blind Period|Withdrawal by Subject|0|||
106051378|NCT00319501|365852509|FG001|Double-blind Period|Withdrawal by Subject|3|||
106051379|NCT00319501|365852508|FG000|Double-blind Period|Sponsor Request|1|||
106051380|NCT00319501|365852509|FG001|Double-blind Period|Sponsor Request|0|||
106051381|NCT00319501|365852508|FG000|Double-blind Period|Did not receive treatment|42|||
106051382|NCT00319501|365852509|FG001|Double-blind Period|Did not receive treatment|29|||
106051383|NCT00319501|365852508|FG000|Open-label Period|Adverse Event|5|||
106051384|NCT00319501|365852509|FG001|Open-label Period|Adverse Event|0|||
106051385|NCT00319501|365852508|FG000|Open-label Period|Protocol Violation|6|||
106051386|NCT00319501|365852509|FG001|Open-label Period|Protocol Violation|0|||
106051387|NCT00319501|365852508|FG000|Open-label Period|Withdrawal by Subject|38|||
106051388|NCT00319501|365852509|FG001|Open-label Period|Withdrawal by Subject|0|||
106051389|NCT00319501|365852508|FG000|Open-label Period|Principal Investigator decision|6|||
106051390|NCT00319501|365852509|FG001|Open-label Period|Principal Investigator decision|0|||
105863769|NCT02728843|365150522|FG003|Overall Study|Adverse Event|1|||
106051391|NCT00319501|365852508|FG000|Open-label Period|Sponsor request|12|||
106051392|NCT00319501|365852509|FG001|Open-label Period|Sponsor request|0|||
106051393|NCT00319501|365852508|FG000|Open-label Period|Lost to Follow-up|5|||
106051394|NCT00319501|365852509|FG001|Open-label Period|Lost to Follow-up|0|||
106051395|NCT00319501|365852508|FG000|Open-label Period|Did not receive treatment|33|||
106051396|NCT00319501|365852509|FG001|Open-label Period|Did not receive treatment|0|||
106051397|NCT00319501|365852508|FG000|Open-label Period|Other|11|||
106051398|NCT00319501|365852509|FG001|Open-label Period|Other|0|||
106051399|NCT00319501|365852508|FG000|Open-label Extension Period|Adverse Event|2|||
106051400|NCT00319501|365852509|FG001|Open-label Extension Period|Adverse Event|0|||
106051401|NCT00319501|365852508|FG000|Open-label Extension Period|Did not receive treatment|18|||
106051402|NCT00319501|365852509|FG001|Open-label Extension Period|Did not receive treatment|0|||
106051403|NCT00319501|365852508|FG000|Open-label Extension Period|Other|1|||
106051404|NCT00319501|365852509|FG001|Open-label Extension Period|Other|0|||
106051405|NCT00319501|365852508|FG000|Open-label Extension Period|Principal investigator decision|2|||
106051406|NCT00319501|365852509|FG001|Open-label Extension Period|Principal investigator decision|0|||
106051407|NCT00319501|365852508|FG000|Open-label Extension Period|Sponsor request|26|||
106051408|NCT00319501|365852509|FG001|Open-label Extension Period|Sponsor request|0|||
106051409|NCT00319501|365852508|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
106051410|NCT00319501|365852509|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
106051411|NCT00667875|365852511|FG000|Overall Study|Adverse Event|0|||
106051412|NCT00667875|365852512|FG001|Overall Study|Adverse Event|2|||
106051413|NCT00667875|365852513|FG002|Overall Study|Adverse Event|6|||
106051414|NCT00667875|365852511|FG000|Overall Study|Withdrawal by Subject|10|||
106051415|NCT00667875|365852512|FG001|Overall Study|Withdrawal by Subject|9|||
106051416|NCT00667875|365852513|FG002|Overall Study|Withdrawal by Subject|7|||
106051417|NCT01702961|365852514|FG000|Overall Study|Additional treatment|3|||
106051418|NCT01702961|365852514|FG000|Overall Study|Progressive disease|5|||
106051419|NCT01702961|365852514|FG000|Overall Study|Relapse|20|||
106051420|NCT01702961|365852514|FG000|Overall Study|Death|6|||
106051421|NCT01702961|365852514|FG000|Overall Study|Lost to Follow-up|2|||
106051422|NCT01702961|365852514|FG000|Overall Study|Ongoing|11|||
106051423|NCT02229383|365852515|FG000|Overall Study|Adverse Event|7|||
106051424|NCT02229383|365852516|FG001|Overall Study|Adverse Event|4|||
106051425|NCT02229383|365852515|FG000|Overall Study|Death|0|||
106051426|NCT02229383|365852516|FG001|Overall Study|Death|1|||
106051427|NCT02229383|365852515|FG000|Overall Study|Lost to Follow-up|5|||
106051428|NCT02229383|365852516|FG001|Overall Study|Lost to Follow-up|3|||
106051429|NCT02229383|365852515|FG000|Overall Study|Withdrawal by Subject|4|||
106051430|NCT02229383|365852516|FG001|Overall Study|Withdrawal by Subject|6|||
106051431|NCT02229383|365852515|FG000|Overall Study|Did not receive treatment|1|||
106051432|NCT02229383|365852516|FG001|Overall Study|Did not receive treatment|0|||
106051433|NCT02229383|365852515|FG000|Overall Study|Other|3|||
106051434|NCT02229383|365852516|FG001|Overall Study|Other|8|||
106051435|NCT01817530|365852522|FG000|Overall Study|Exclusionary Medication Received|0|||
106051436|NCT01817530|365852523|FG001|Overall Study|Exclusionary Medication Received|0|||
106051437|NCT01817530|365852524|FG002|Overall Study|Exclusionary Medication Received|0|||
106051438|NCT01817530|365852525|FG003|Overall Study|Exclusionary Medication Received|0|||
106051439|NCT01817530|365852526|FG004|Overall Study|Exclusionary Medication Received|1|||
106051440|NCT01817530|365852527|FG005|Overall Study|Exclusionary Medication Received|0|||
106051441|NCT01817530|365852528|FG006|Overall Study|Exclusionary Medication Received|0|||
106051442|NCT01817530|365852529|FG007|Overall Study|Exclusionary Medication Received|0|||
106051443|NCT01817530|365852522|FG000|Overall Study|Adverse Event|6|||
106051444|NCT01817530|365852523|FG001|Overall Study|Adverse Event|3|||
106051445|NCT01817530|365852524|FG002|Overall Study|Adverse Event|2|||
106051446|NCT01817530|365852525|FG003|Overall Study|Adverse Event|5|||
106051447|NCT01817530|365852526|FG004|Overall Study|Adverse Event|0|||
106051448|NCT01817530|365852527|FG005|Overall Study|Adverse Event|10|||
106051449|NCT01817530|365852528|FG006|Overall Study|Adverse Event|5|||
106051450|NCT01817530|365852529|FG007|Overall Study|Adverse Event|8|||
106051451|NCT01817530|365852522|FG000|Overall Study|Subject Noncompliant|3|||
106051452|NCT01817530|365852523|FG001|Overall Study|Subject Noncompliant|1|||
106051453|NCT01817530|365852524|FG002|Overall Study|Subject Noncompliant|0|||
106051454|NCT01817530|365852525|FG003|Overall Study|Subject Noncompliant|4|||
106051455|NCT01817530|365852526|FG004|Overall Study|Subject Noncompliant|0|||
106051456|NCT01817530|365852527|FG005|Overall Study|Subject Noncompliant|1|||
106051457|NCT01817530|365852528|FG006|Overall Study|Subject Noncompliant|1|||
106051458|NCT01817530|365852529|FG007|Overall Study|Subject Noncompliant|1|||
106051459|NCT01817530|365852522|FG000|Overall Study|Lack of Efficacy|1|||
106051460|NCT01817530|365852523|FG001|Overall Study|Lack of Efficacy|0|||
106051461|NCT01817530|365852524|FG002|Overall Study|Lack of Efficacy|0|||
106051462|NCT01817530|365852525|FG003|Overall Study|Lack of Efficacy|0|||
106051463|NCT01817530|365852526|FG004|Overall Study|Lack of Efficacy|0|||
106051464|NCT01817530|365852527|FG005|Overall Study|Lack of Efficacy|1|||
106051465|NCT01817530|365852528|FG006|Overall Study|Lack of Efficacy|0|||
106051466|NCT01817530|365852529|FG007|Overall Study|Lack of Efficacy|1|||
106051467|NCT01817530|365852522|FG000|Overall Study|Pregnancy|0|||
106051468|NCT01817530|365852523|FG001|Overall Study|Pregnancy|0|||
106051469|NCT01817530|365852524|FG002|Overall Study|Pregnancy|0|||
106051470|NCT01817530|365852525|FG003|Overall Study|Pregnancy|0|||
106051471|NCT01817530|365852526|FG004|Overall Study|Pregnancy|0|||
106051472|NCT01817530|365852527|FG005|Overall Study|Pregnancy|1|||
106051473|NCT01817530|365852528|FG006|Overall Study|Pregnancy|0|||
105863770|NCT02728843|365150523|FG004|Overall Study|Adverse Event|2|||
106051474|NCT01817530|365852529|FG007|Overall Study|Pregnancy|0|||
106051475|NCT01817530|365852522|FG000|Overall Study|Other|0|||
106051476|NCT01817530|365852523|FG001|Overall Study|Other|1|||
106051477|NCT01817530|365852524|FG002|Overall Study|Other|0|||
106051478|NCT01817530|365852525|FG003|Overall Study|Other|0|||
106051479|NCT01817530|365852526|FG004|Overall Study|Other|1|||
106051480|NCT01817530|365852527|FG005|Overall Study|Other|0|||
106051481|NCT01817530|365852528|FG006|Overall Study|Other|5|||
106051482|NCT01817530|365852529|FG007|Overall Study|Other|0|||
106051483|NCT01817530|365852522|FG000|Overall Study|Surgery or Invasive Intervention|1|||
106051484|NCT01817530|365852523|FG001|Overall Study|Surgery or Invasive Intervention|0|||
106051485|NCT01817530|365852524|FG002|Overall Study|Surgery or Invasive Intervention|0|||
106051486|NCT01817530|365852525|FG003|Overall Study|Surgery or Invasive Intervention|0|||
106051487|NCT01817530|365852526|FG004|Overall Study|Surgery or Invasive Intervention|1|||
106051488|NCT01817530|365852527|FG005|Overall Study|Surgery or Invasive Intervention|1|||
106051489|NCT01817530|365852528|FG006|Overall Study|Surgery or Invasive Intervention|1|||
106051490|NCT01817530|365852529|FG007|Overall Study|Surgery or Invasive Intervention|0|||
106051491|NCT01817530|365852522|FG000|Overall Study|Consent Withdrawn by Subject|3|||
106051492|NCT01817530|365852523|FG001|Overall Study|Consent Withdrawn by Subject|4|||
106051493|NCT01817530|365852524|FG002|Overall Study|Consent Withdrawn by Subject|7|||
106051494|NCT01817530|365852525|FG003|Overall Study|Consent Withdrawn by Subject|3|||
106051495|NCT01817530|365852526|FG004|Overall Study|Consent Withdrawn by Subject|5|||
106051496|NCT01817530|365852527|FG005|Overall Study|Consent Withdrawn by Subject|3|||
106051497|NCT01817530|365852528|FG006|Overall Study|Consent Withdrawn by Subject|3|||
106051498|NCT01817530|365852529|FG007|Overall Study|Consent Withdrawn by Subject|10|||
106051499|NCT01817530|365852522|FG000|Overall Study|Lost to Follow-up|1|||
106051500|NCT01817530|365852523|FG001|Overall Study|Lost to Follow-up|4|||
106051501|NCT01817530|365852524|FG002|Overall Study|Lost to Follow-up|2|||
106051502|NCT01817530|365852525|FG003|Overall Study|Lost to Follow-up|1|||
106051503|NCT01817530|365852526|FG004|Overall Study|Lost to Follow-up|3|||
106051504|NCT01817530|365852527|FG005|Overall Study|Lost to Follow-up|2|||
106051505|NCT01817530|365852528|FG006|Overall Study|Lost to Follow-up|8|||
106051506|NCT01817530|365852529|FG007|Overall Study|Lost to Follow-up|4|||
106051507|NCT02538029|365852530|FG000|Overall Study|unable to complete cognitive assessments|1|||
106051508|NCT02538029|365852531|FG001|Overall Study|unable to complete cognitive assessments|0|||
106051509|NCT02538029|365852532|FG002|Overall Study|unable to complete cognitive assessments|1|||
106051510|NCT00679432|365852533|FG000|Overall Study|Adverse Event|5|||
106051511|NCT00679432|365852534|FG001|Overall Study|Adverse Event|6|||
106051512|NCT00679432|365852535|FG002|Overall Study|Adverse Event|10|||
106051513|NCT00679432|365852536|FG003|Overall Study|Adverse Event|7|||
106051514|NCT00679432|365852533|FG000|Overall Study|Protocol Violation|1|||
106051515|NCT00679432|365852534|FG001|Overall Study|Protocol Violation|1|||
106051516|NCT00679432|365852535|FG002|Overall Study|Protocol Violation|2|||
106051517|NCT00679432|365852536|FG003|Overall Study|Protocol Violation|1|||
106051518|NCT00679432|365852533|FG000|Overall Study|Withdrawal by Subject|8|||
106051519|NCT00679432|365852534|FG001|Overall Study|Withdrawal by Subject|11|||
106051520|NCT00679432|365852535|FG002|Overall Study|Withdrawal by Subject|10|||
106051521|NCT00679432|365852536|FG003|Overall Study|Withdrawal by Subject|9|||
106051522|NCT00679432|365852533|FG000|Overall Study|Lost to Follow-up|1|||
106051523|NCT00679432|365852534|FG001|Overall Study|Lost to Follow-up|5|||
106051524|NCT00679432|365852535|FG002|Overall Study|Lost to Follow-up|4|||
106051525|NCT00679432|365852536|FG003|Overall Study|Lost to Follow-up|2|||
106051526|NCT00679432|365852533|FG000|Overall Study|Physician Decision|3|||
106051527|NCT00679432|365852534|FG001|Overall Study|Physician Decision|2|||
106051528|NCT00679432|365852535|FG002|Overall Study|Physician Decision|2|||
106051529|NCT00679432|365852536|FG003|Overall Study|Physician Decision|2|||
106051530|NCT00679432|365852533|FG000|Overall Study|Sponsor decision|1|||
106051531|NCT00679432|365852534|FG001|Overall Study|Sponsor decision|0|||
106051532|NCT00679432|365852535|FG002|Overall Study|Sponsor decision|0|||
106051533|NCT00679432|365852536|FG003|Overall Study|Sponsor decision|0|||
106051534|NCT00679432|365852533|FG000|Overall Study|Lack of Efficacy|13|||
106051535|NCT00679432|365852534|FG001|Overall Study|Lack of Efficacy|9|||
106051536|NCT00679432|365852535|FG002|Overall Study|Lack of Efficacy|14|||
106051537|NCT00679432|365852536|FG003|Overall Study|Lack of Efficacy|8|||
106051538|NCT00679432|365852533|FG000|Overall Study|Infectious colitis, normal histology|5|||
105863771|NCT02728843|365150519|FG000|Overall Study|Lack of Efficacy|0|||
106051539|NCT00679432|365852534|FG001|Overall Study|Infectious colitis, normal histology|4|||
106051540|NCT00679432|365852535|FG002|Overall Study|Infectious colitis, normal histology|8|||
106051541|NCT00679432|365852536|FG003|Overall Study|Infectious colitis, normal histology|3|||
106051542|NCT00679432|365852533|FG000|Overall Study|Randomization error, return to prior Rx|0|||
106051543|NCT00679432|365852534|FG001|Overall Study|Randomization error, return to prior Rx|0|||
106051544|NCT00679432|365852535|FG002|Overall Study|Randomization error, return to prior Rx|3|||
106051545|NCT00679432|365852536|FG003|Overall Study|Randomization error, return to prior Rx|0|||
106051546|NCT00594659|365852537|FG000|Overall Study|Lost to Follow-up|13|||
106051547|NCT00594659|365852538|FG001|Overall Study|Lost to Follow-up|9|||
106051548|NCT00594659|365852539|FG002|Overall Study|Lost to Follow-up|7|||
106051549|NCT00142298|365852540|FG000|Overall Study|Adverse Event|10|||
106051550|NCT00142298|365852541|FG001|Overall Study|Adverse Event|10|||
106051551|NCT00142298|365852542|FG002|Overall Study|Adverse Event|1|||
106051552|NCT00142298|365852543|FG003|Overall Study|Adverse Event|5|||
106051553|NCT00142298|365852544|FG004|Overall Study|Adverse Event|2|||
106051554|NCT00142298|365852545|FG005|Overall Study|Adverse Event|2|||
106051555|NCT00142298|365852546|FG006|Overall Study|Adverse Event|0|||
105863772|NCT02728843|365150520|FG001|Overall Study|Lack of Efficacy|1|||
105863773|NCT02728843|365150521|FG002|Overall Study|Lack of Efficacy|1|||
105863774|NCT02728843|365150522|FG003|Overall Study|Lack of Efficacy|0|||
105863775|NCT02728843|365150523|FG004|Overall Study|Lack of Efficacy|0|||
105863776|NCT02728843|365150519|FG000|Overall Study|Protocol Violation|2|||
105863777|NCT02728843|365150520|FG001|Overall Study|Protocol Violation|0|||
105863778|NCT02728843|365150521|FG002|Overall Study|Protocol Violation|4|||
105863779|NCT02728843|365150522|FG003|Overall Study|Protocol Violation|2|||
105863780|NCT02728843|365150523|FG004|Overall Study|Protocol Violation|2|||
105863781|NCT02728843|365150519|FG000|Overall Study|Withdrawal by Subject|1|||
105863782|NCT02728843|365150520|FG001|Overall Study|Withdrawal by Subject|0|||
105863783|NCT02728843|365150521|FG002|Overall Study|Withdrawal by Subject|0|||
105863784|NCT02728843|365150522|FG003|Overall Study|Withdrawal by Subject|1|||
105863785|NCT02728843|365150523|FG004|Overall Study|Withdrawal by Subject|0|||
105863786|NCT02728843|365150519|FG000|Overall Study|Use of rescue medication|0|||
105863787|NCT02728843|365150520|FG001|Overall Study|Use of rescue medication|2|||
105863788|NCT02728843|365150521|FG002|Overall Study|Use of rescue medication|0|||
105863789|NCT02728843|365150522|FG003|Overall Study|Use of rescue medication|2|||
105863790|NCT02728843|365150523|FG004|Overall Study|Use of rescue medication|1|||
105863791|NCT03371459|365150525|FG000|Washout|Lost to Follow-up|0|||
105863792|NCT03371459|365150526|FG001|Washout|Lost to Follow-up|1|||
105863793|NCT00351533|365150527|FG000|Overall Study|Extubated before first BAL|1|||
105863794|NCT00351533|365150528|FG001|Overall Study|Extubated before first BAL|0|||
105863795|NCT00351533|365150527|FG000|Overall Study|Lost to Follow-up|1|||
105863796|NCT00351533|365150528|FG001|Overall Study|Lost to Follow-up|3|||
105863797|NCT00351533|365150527|FG000|Overall Study|Physician Decision|0|||
105863798|NCT00351533|365150528|FG001|Overall Study|Physician Decision|1|||
105863799|NCT00351533|365150527|FG000|Overall Study|Withdrawal by Subject|0|||
105863800|NCT00351533|365150528|FG001|Overall Study|Withdrawal by Subject|1|||
105863801|NCT01589497|365150530|FG000|Overall Study|Withdrawal by Subject|0|||
105863802|NCT01589497|365150531|FG001|Overall Study|Withdrawal by Subject|1|||
105863803|NCT01589497|365150532|FG002|Overall Study|Withdrawal by Subject|0|||
105863804|NCT01589497|365150533|FG003|Overall Study|Withdrawal by Subject|1|||
105863805|NCT01589497|365150530|FG000|Overall Study|Death|1|||
105863806|NCT01589497|365150531|FG001|Overall Study|Death|0|||
105863807|NCT01589497|365150532|FG002|Overall Study|Death|0|||
105863808|NCT01589497|365150533|FG003|Overall Study|Death|0|||
105863809|NCT01589497|365150530|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
105863810|NCT01589497|365150531|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
105863811|NCT01589497|365150532|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
105863812|NCT01589497|365150533|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
105863813|NCT02092467|365150542|FG000|Overall Study|Death|49|||
105863814|NCT02092467|365150543|FG001|Overall Study|Death|66|||
105863815|NCT02092467|365150544|FG002|Overall Study|Death|38|||
105863816|NCT02092467|365150542|FG000|Overall Study|Lost to Follow-up|38|||
105863817|NCT02092467|365150543|FG001|Overall Study|Lost to Follow-up|35|||
105863818|NCT02092467|365150544|FG002|Overall Study|Lost to Follow-up|40|||
105863819|NCT02092467|365150542|FG000|Overall Study|Global Deterioration of Health Status|1|||
105863820|NCT02092467|365150543|FG001|Overall Study|Global Deterioration of Health Status|0|||
105863821|NCT02092467|365150544|FG002|Overall Study|Global Deterioration of Health Status|0|||
105863822|NCT02092467|365150542|FG000|Overall Study|Other|32|||
105863823|NCT02092467|365150543|FG001|Overall Study|Other|30|||
105863824|NCT02092467|365150544|FG002|Overall Study|Other|24|||
105863825|NCT02092467|365150542|FG000|Overall Study|Withdrawal by Subject|282|||
105863826|NCT02092467|365150543|FG001|Overall Study|Withdrawal by Subject|327|||
105863827|NCT02092467|365150544|FG002|Overall Study|Withdrawal by Subject|289|||
105863828|NCT02092467|365150542|FG000|Overall Study|Randomized but not treated|2|||
105863829|NCT02092467|365150543|FG001|Overall Study|Randomized but not treated|1|||
105863830|NCT02092467|365150544|FG002|Overall Study|Randomized but not treated|7|||
105863831|NCT01680497|365150545|FG000|Overall Study|Lost to Follow-up|2|||
105863832|NCT04844762|365150550|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863833|NCT04844762|365150551|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863834|NCT04844762|365150552|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
105863835|NCT04844762|365150553|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863836|NCT04844762|365150554|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863837|NCT04844762|365150555|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863838|NCT04844762|365150550|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
105863839|NCT04844762|365150551|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
105863840|NCT04844762|365150552|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
105863841|NCT04844762|365150553|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
105863842|NCT04844762|365150554|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
105863843|NCT04844762|365150555|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
106051556|NCT00142298|365852547|FG007|Overall Study|Adverse Event|0|||
106051557|NCT00142298|365852548|FG008|Overall Study|Adverse Event|0|||
106051558|NCT00142298|365852549|FG009|Overall Study|Adverse Event|0|||
106051559|NCT00142298|365852540|FG000|Overall Study|Clinical disease progression|1|||
106051560|NCT00142298|365852541|FG001|Overall Study|Clinical disease progression|0|||
106051561|NCT00142298|365852542|FG002|Overall Study|Clinical disease progression|0|||
106051562|NCT00142298|365852543|FG003|Overall Study|Clinical disease progression|0|||
106051563|NCT00142298|365852544|FG004|Overall Study|Clinical disease progression|0|||
106051564|NCT00142298|365852545|FG005|Overall Study|Clinical disease progression|0|||
106051565|NCT00142298|365852546|FG006|Overall Study|Clinical disease progression|0|||
106051566|NCT00142298|365852547|FG007|Overall Study|Clinical disease progression|0|||
106051567|NCT00142298|365852548|FG008|Overall Study|Clinical disease progression|0|||
106051568|NCT00142298|365852549|FG009|Overall Study|Clinical disease progression|0|||
106051569|NCT00142298|365852540|FG000|Overall Study|Death|1|||
106051570|NCT00142298|365852541|FG001|Overall Study|Death|1|||
106051571|NCT00142298|365852542|FG002|Overall Study|Death|1|||
106051572|NCT00142298|365852543|FG003|Overall Study|Death|0|||
106051573|NCT00142298|365852544|FG004|Overall Study|Death|0|||
106051574|NCT00142298|365852545|FG005|Overall Study|Death|6|||
106051575|NCT00142298|365852546|FG006|Overall Study|Death|0|||
106051576|NCT00142298|365852547|FG007|Overall Study|Death|0|||
106051577|NCT00142298|365852548|FG008|Overall Study|Death|0|||
106051578|NCT00142298|365852549|FG009|Overall Study|Death|0|||
106051579|NCT00142298|365852540|FG000|Overall Study|Lack of Efficacy|44|||
106051580|NCT00142298|365852541|FG001|Overall Study|Lack of Efficacy|62|||
106051581|NCT00142298|365852542|FG002|Overall Study|Lack of Efficacy|9|||
106051582|NCT00142298|365852543|FG003|Overall Study|Lack of Efficacy|12|||
106051583|NCT00142298|365852544|FG004|Overall Study|Lack of Efficacy|1|||
106051584|NCT00142298|365852545|FG005|Overall Study|Lack of Efficacy|0|||
106051585|NCT00142298|365852546|FG006|Overall Study|Lack of Efficacy|0|||
106051586|NCT00142298|365852547|FG007|Overall Study|Lack of Efficacy|1|||
106051587|NCT00142298|365852548|FG008|Overall Study|Lack of Efficacy|0|||
106051588|NCT00142298|365852549|FG009|Overall Study|Lack of Efficacy|0|||
106051589|NCT00142298|365852540|FG000|Overall Study|Non-compliance|15|||
106051590|NCT00142298|365852541|FG001|Overall Study|Non-compliance|13|||
106051591|NCT00142298|365852542|FG002|Overall Study|Non-compliance|0|||
106051592|NCT00142298|365852543|FG003|Overall Study|Non-compliance|6|||
106051593|NCT00142298|365852544|FG004|Overall Study|Non-compliance|1|||
106051594|NCT00142298|365852545|FG005|Overall Study|Non-compliance|0|||
106051595|NCT00142298|365852546|FG006|Overall Study|Non-compliance|0|||
106051596|NCT00142298|365852547|FG007|Overall Study|Non-compliance|3|||
106051597|NCT00142298|365852548|FG008|Overall Study|Non-compliance|3|||
106051598|NCT00142298|365852549|FG009|Overall Study|Non-compliance|0|||
106051599|NCT00142298|365852540|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
106051600|NCT00142298|365852541|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
106051601|NCT00142298|365852542|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
106051602|NCT00142298|365852543|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
106051603|NCT00142298|365852544|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
106051604|NCT00142298|365852545|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
106051605|NCT00142298|365852546|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
106051606|NCT00142298|365852547|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
106051607|NCT00142298|365852548|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
106051608|NCT00142298|365852549|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
106051609|NCT00142298|365852540|FG000|Overall Study|Pregnancy|4|||
106051610|NCT00142298|365852541|FG001|Overall Study|Pregnancy|4|||
106051611|NCT00142298|365852542|FG002|Overall Study|Pregnancy|2|||
106051612|NCT00142298|365852543|FG003|Overall Study|Pregnancy|3|||
106051613|NCT00142298|365852544|FG004|Overall Study|Pregnancy|0|||
106051614|NCT00142298|365852545|FG005|Overall Study|Pregnancy|0|||
106051615|NCT00142298|365852546|FG006|Overall Study|Pregnancy|0|||
106051616|NCT00142298|365852547|FG007|Overall Study|Pregnancy|0|||
106051617|NCT00142298|365852548|FG008|Overall Study|Pregnancy|1|||
106051618|NCT00142298|365852549|FG009|Overall Study|Pregnancy|0|||
106051619|NCT00142298|365852540|FG000|Overall Study|Virologic breakthrough|19|||
106051620|NCT00142298|365852541|FG001|Overall Study|Virologic breakthrough|23|||
106051621|NCT00142298|365852542|FG002|Overall Study|Virologic breakthrough|9|||
106051622|NCT00142298|365852543|FG003|Overall Study|Virologic breakthrough|7|||
106051623|NCT00142298|365852544|FG004|Overall Study|Virologic breakthrough|2|||
106051624|NCT00142298|365852545|FG005|Overall Study|Virologic breakthrough|3|||
106051625|NCT00142298|365852546|FG006|Overall Study|Virologic breakthrough|3|||
106051626|NCT00142298|365852547|FG007|Overall Study|Virologic breakthrough|0|||
106051627|NCT00142298|365852548|FG008|Overall Study|Virologic breakthrough|0|||
106051628|NCT00142298|365852549|FG009|Overall Study|Virologic breakthrough|0|||
106051629|NCT00142298|365852540|FG000|Overall Study|Other- not specified|0|||
106051630|NCT00142298|365852541|FG001|Overall Study|Other- not specified|3|||
106051631|NCT00142298|365852542|FG002|Overall Study|Other- not specified|0|||
106051632|NCT00142298|365852543|FG003|Overall Study|Other- not specified|1|||
106051633|NCT00142298|365852544|FG004|Overall Study|Other- not specified|0|||
106051634|NCT00142298|365852545|FG005|Overall Study|Other- not specified|0|||
105863844|NCT04844762|365150550|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863845|NCT04844762|365150551|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863846|NCT04844762|365150552|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105863847|NCT04844762|365150553|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
105863848|NCT04844762|365150554|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863849|NCT04844762|365150555|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105863850|NCT04844762|365150550|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863851|NCT04844762|365150551|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863852|NCT04844762|365150552|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
105863853|NCT04844762|365150553|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
105863854|NCT04844762|365150554|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
105863855|NCT04844762|365150555|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863856|NCT04844762|365150550|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
105863857|NCT04844762|365150551|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
105863858|NCT04844762|365150552|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863859|NCT04844762|365150553|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863860|NCT04844762|365150554|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863861|NCT04844762|365150555|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863862|NCT04844762|365150550|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105863863|NCT04844762|365150551|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863864|NCT04844762|365150552|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863865|NCT04844762|365150553|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863866|NCT04844762|365150554|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863867|NCT04844762|365150555|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
106051635|NCT00142298|365852546|FG006|Overall Study|Other- not specified|0|||
106051636|NCT00142298|365852547|FG007|Overall Study|Other- not specified|0|||
106051637|NCT00142298|365852548|FG008|Overall Study|Other- not specified|0|||
106051638|NCT00142298|365852549|FG009|Overall Study|Other- not specified|0|||
106051639|NCT00142298|365852540|FG000|Overall Study|Lost to Follow-up|0|||
106051640|NCT00142298|365852541|FG001|Overall Study|Lost to Follow-up|0|||
106051641|NCT00142298|365852542|FG002|Overall Study|Lost to Follow-up|0|||
106051642|NCT00142298|365852543|FG003|Overall Study|Lost to Follow-up|0|||
106051643|NCT00142298|365852544|FG004|Overall Study|Lost to Follow-up|0|||
106051644|NCT00142298|365852545|FG005|Overall Study|Lost to Follow-up|0|||
106051645|NCT00142298|365852546|FG006|Overall Study|Lost to Follow-up|2|||
106051646|NCT00142298|365852547|FG007|Overall Study|Lost to Follow-up|0|||
106051647|NCT00142298|365852548|FG008|Overall Study|Lost to Follow-up|0|||
106051648|NCT00142298|365852549|FG009|Overall Study|Lost to Follow-up|0|||
106051649|NCT00142298|365852540|FG000|Overall Study|Treatment Failure|0|||
106051650|NCT00142298|365852541|FG001|Overall Study|Treatment Failure|0|||
106051651|NCT00142298|365852542|FG002|Overall Study|Treatment Failure|0|||
106051652|NCT00142298|365852543|FG003|Overall Study|Treatment Failure|0|||
106051653|NCT00142298|365852544|FG004|Overall Study|Treatment Failure|0|||
106051654|NCT00142298|365852545|FG005|Overall Study|Treatment Failure|2|||
106051655|NCT00142298|365852546|FG006|Overall Study|Treatment Failure|2|||
106051656|NCT00142298|365852547|FG007|Overall Study|Treatment Failure|0|||
106051657|NCT00142298|365852548|FG008|Overall Study|Treatment Failure|0|||
106051658|NCT00142298|365852549|FG009|Overall Study|Treatment Failure|0|||
106051659|NCT01466153|365852550|FG000|Overall Study|Disease Progression|2|||
106051660|NCT01466153|365852551|FG001|Overall Study|Disease Progression|2|||
106051661|NCT01466153|365852552|FG002|Overall Study|Disease Progression|0|||
106051662|NCT01466153|365852550|FG000|Overall Study|Adverse Event|14|||
106051663|NCT01466153|365852551|FG001|Overall Study|Adverse Event|13|||
106051664|NCT01466153|365852552|FG002|Overall Study|Adverse Event|17|||
106051665|NCT01466153|365852550|FG000|Overall Study|Withdrawal of Consent|2|||
106051666|NCT01466153|365852551|FG001|Overall Study|Withdrawal of Consent|0|||
106051667|NCT01466153|365852552|FG002|Overall Study|Withdrawal of Consent|0|||
106051668|NCT01466153|365852550|FG000|Overall Study|Investigator Discretion|3|||
106051669|NCT01466153|365852551|FG001|Overall Study|Investigator Discretion|2|||
106051670|NCT01466153|365852552|FG002|Overall Study|Investigator Discretion|2|||
106051671|NCT01466153|365852550|FG000|Overall Study|Randomized-Not Treated|2|||
106051672|NCT01466153|365852551|FG001|Overall Study|Randomized-Not Treated|3|||
106051673|NCT01466153|365852552|FG002|Overall Study|Randomized-Not Treated|4|||
106051674|NCT01466153|365852550|FG000|Overall Study|Other-Unspecified|6|||
106051675|NCT01466153|365852551|FG001|Overall Study|Other-Unspecified|4|||
106051676|NCT01466153|365852552|FG002|Overall Study|Other-Unspecified|2|||
106051677|NCT01785069|365852556|FG000|Overall Study|Implanted with nonstudy device|1|||
106051678|NCT01785069|365852557|FG001|Overall Study|Implanted with nonstudy device|2|||
106051679|NCT01785069|365852558|FG002|Overall Study|Implanted with nonstudy device|1|||
106051680|NCT01785069|365852559|FG003|Overall Study|Implanted with nonstudy device|0|||
106051681|NCT01785069|365852556|FG000|Overall Study|Death|0|||
106051682|NCT01785069|365852557|FG001|Overall Study|Death|0|||
106051683|NCT01785069|365852558|FG002|Overall Study|Death|2|||
106051684|NCT01785069|365852559|FG003|Overall Study|Death|0|||
106051685|NCT01785069|365852556|FG000|Overall Study|Subject choice|2|||
106051686|NCT01785069|365852557|FG001|Overall Study|Subject choice|2|||
106051687|NCT01785069|365852558|FG002|Overall Study|Subject choice|0|||
105863868|NCT04844762|365150550|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863869|NCT04844762|365150551|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863870|NCT04844762|365150552|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863871|NCT04844762|365150553|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
105863872|NCT04844762|365150554|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
105863873|NCT04844762|365150555|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
106051688|NCT01785069|365852559|FG003|Overall Study|Subject choice|1|||
106051689|NCT01785069|365852556|FG000|Overall Study|Lost to Follow-up|1|||
106051690|NCT01785069|365852557|FG001|Overall Study|Lost to Follow-up|2|||
106051691|NCT01785069|365852558|FG002|Overall Study|Lost to Follow-up|4|||
106051692|NCT01785069|365852559|FG003|Overall Study|Lost to Follow-up|1|||
106051693|NCT01785069|365852556|FG000|Overall Study|Reason not Specified|1|||
106051694|NCT01785069|365852557|FG001|Overall Study|Reason not Specified|2|||
106051695|NCT01785069|365852558|FG002|Overall Study|Reason not Specified|1|||
106051696|NCT01785069|365852559|FG003|Overall Study|Reason not Specified|4|||
106051697|NCT01785069|365852556|FG000|Overall Study|Not evaluable|7|||
106051698|NCT01785069|365852557|FG001|Overall Study|Not evaluable|4|||
106051699|NCT01785069|365852558|FG002|Overall Study|Not evaluable|5|||
106051700|NCT01785069|365852559|FG003|Overall Study|Not evaluable|8|||
106051701|NCT00300274|365852560|FG000|Overall Study|Withdrawal by Subject|12|||
106051702|NCT00300274|365852561|FG001|Overall Study|Withdrawal by Subject|3|||
106051703|NCT00300274|365852562|FG002|Overall Study|Withdrawal by Subject|14|||
106051704|NCT00300274|365852560|FG000|Overall Study|Lost to Follow-up|3|||
106051705|NCT00300274|365852561|FG001|Overall Study|Lost to Follow-up|4|||
106051706|NCT00300274|365852562|FG002|Overall Study|Lost to Follow-up|5|||
106051707|NCT00300274|365852560|FG000|Overall Study|Death|31|||
106051708|NCT00300274|365852561|FG001|Overall Study|Death|20|||
106051709|NCT00300274|365852562|FG002|Overall Study|Death|25|||
106051710|NCT00300274|365852560|FG000|Overall Study|Re-transplant|0|||
106051711|NCT00300274|365852561|FG001|Overall Study|Re-transplant|0|||
106051712|NCT00300274|365852562|FG002|Overall Study|Re-transplant|1|||
106051713|NCT01980940|365852565|FG000|Overall Study|Protocol Violation|0|||
106051714|NCT01980940|365852566|FG001|Overall Study|Protocol Violation|0|||
106051715|NCT01980940|365852567|FG002|Overall Study|Protocol Violation|0|||
106051716|NCT01980940|365852568|FG003|Overall Study|Protocol Violation|0|||
106051717|NCT01980940|365852569|FG004|Overall Study|Protocol Violation|0|||
106051718|NCT01980940|365852570|FG005|Overall Study|Protocol Violation|2|||
106051719|NCT01980940|365852571|FG006|Overall Study|Protocol Violation|0|||
106051720|NCT01980940|365852572|FG007|Overall Study|Protocol Violation|0|||
106051721|NCT00660699|365852573|FG000|Overall Study|Withdrawal by Subject|2|||
106051722|NCT03320057|365854527|FG000|Overall Study|Lost to Follow-up|4|||
106051723|NCT03320057|365854528|FG001|Overall Study|Lost to Follow-up|17|||
106051724|NCT03320057|365854527|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
106051725|NCT03320057|365854528|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
106051726|NCT01367002|365854529|FG000|Overall Study|Withdrawal by Subject|1|||
106051727|NCT01367002|365854530|FG001|Overall Study|Withdrawal by Subject|0|||
106051728|NCT01367002|365854529|FG000|Overall Study|Physician Decision|0|||
106051729|NCT01367002|365854530|FG001|Overall Study|Physician Decision|2|||
106051730|NCT01543698|365854538|FG000|Phase 1b|Disease progression|2|||
106051731|NCT01543698|365854539|FG001|Phase 1b|Disease progression|4|||
106051732|NCT01543698|365854540|FG002|Phase 1b|Disease progression|3|||
106051733|NCT01543698|365854541|FG003|Phase 1b|Disease progression|2|||
106051734|NCT01543698|365854542|FG004|Phase 1b|Disease progression|10|||
106051735|NCT01543698|365854543|FG005|Phase 1b|Disease progression|6|||
106051736|NCT01543698|365854544|FG006|Phase 1b|Disease progression|5|||
106051737|NCT01543698|365854545|FG007|Phase 1b|Disease progression|3|||
106051738|NCT01543698|365854546|FG008|Phase 1b|Disease progression|4|||
106051739|NCT01543698|365854547|FG009|Phase 1b|Disease progression|5|||
106051740|NCT01543698|365854548|FG010|Phase 1b|Disease progression|1|||
106051741|NCT01543698|365854549|FG011|Phase 1b|Disease progression|0|||
106051742|NCT01543698|365854550|FG012|Phase 1b|Disease progression|0|||
106051743|NCT01543698|365854551|FG013|Phase 1b|Disease progression|0|||
106051744|NCT01543698|365854552|FG014|Phase 1b|Disease progression|0|||
106051745|NCT01543698|365854538|FG000|Phase 1b|Death|0|||
106051746|NCT01543698|365854539|FG001|Phase 1b|Death|0|||
106051747|NCT01543698|365854540|FG002|Phase 1b|Death|1|||
106051748|NCT01543698|365854541|FG003|Phase 1b|Death|1|||
106051749|NCT01543698|365854542|FG004|Phase 1b|Death|0|||
106051750|NCT01543698|365854543|FG005|Phase 1b|Death|0|||
106051751|NCT01543698|365854544|FG006|Phase 1b|Death|0|||
106051752|NCT01543698|365854545|FG007|Phase 1b|Death|0|||
106051753|NCT01543698|365854546|FG008|Phase 1b|Death|0|||
106051754|NCT01543698|365854547|FG009|Phase 1b|Death|0|||
106051755|NCT01543698|365854548|FG010|Phase 1b|Death|1|||
106051756|NCT01543698|365854549|FG011|Phase 1b|Death|0|||
106051757|NCT01543698|365854550|FG012|Phase 1b|Death|0|||
106051758|NCT01543698|365854551|FG013|Phase 1b|Death|0|||
106051759|NCT01543698|365854552|FG014|Phase 1b|Death|0|||
106051760|NCT01543698|365854538|FG000|Phase 1b|Withdrawal by Subject|0|||
106051761|NCT01543698|365854539|FG001|Phase 1b|Withdrawal by Subject|1|||
106051762|NCT01543698|365854540|FG002|Phase 1b|Withdrawal by Subject|0|||
106152403|NCT05665595|366218780|FG001|Overall Study|Withdrawal by Subject|2|||
106152404|NCT05665595|366218779|FG000|Overall Study|Lost to Follow-up|1|||
106152405|NCT05665595|366218780|FG001|Overall Study|Lost to Follow-up|0|||
106152406|NCT05665595|366218779|FG000|Overall Study|Death|6|||
106051763|NCT01543698|365854541|FG003|Phase 1b|Withdrawal by Subject|1|||
106051764|NCT01543698|365854542|FG004|Phase 1b|Withdrawal by Subject|0|||
106051765|NCT01543698|365854543|FG005|Phase 1b|Withdrawal by Subject|0|||
106051766|NCT01543698|365854544|FG006|Phase 1b|Withdrawal by Subject|1|||
106051767|NCT01543698|365854545|FG007|Phase 1b|Withdrawal by Subject|0|||
106051768|NCT01543698|365854546|FG008|Phase 1b|Withdrawal by Subject|0|||
106051769|NCT01543698|365854547|FG009|Phase 1b|Withdrawal by Subject|0|||
106051770|NCT01543698|365854548|FG010|Phase 1b|Withdrawal by Subject|0|||
106051771|NCT01543698|365854549|FG011|Phase 1b|Withdrawal by Subject|0|||
106051772|NCT01543698|365854550|FG012|Phase 1b|Withdrawal by Subject|0|||
106051773|NCT01543698|365854551|FG013|Phase 1b|Withdrawal by Subject|0|||
106051774|NCT01543698|365854552|FG014|Phase 1b|Withdrawal by Subject|0|||
106051775|NCT01543698|365854538|FG000|Phase 1b|Adverse Event|1|||
106051776|NCT01543698|365854539|FG001|Phase 1b|Adverse Event|0|||
106051777|NCT01543698|365854540|FG002|Phase 1b|Adverse Event|0|||
106051778|NCT01543698|365854541|FG003|Phase 1b|Adverse Event|1|||
106051779|NCT01543698|365854542|FG004|Phase 1b|Adverse Event|2|||
106051780|NCT01543698|365854543|FG005|Phase 1b|Adverse Event|2|||
106051781|NCT01543698|365854544|FG006|Phase 1b|Adverse Event|0|||
106051782|NCT01543698|365854545|FG007|Phase 1b|Adverse Event|0|||
106051783|NCT01543698|365854546|FG008|Phase 1b|Adverse Event|1|||
106051784|NCT01543698|365854547|FG009|Phase 1b|Adverse Event|1|||
106051785|NCT01543698|365854548|FG010|Phase 1b|Adverse Event|2|||
106051786|NCT01543698|365854549|FG011|Phase 1b|Adverse Event|0|||
106051787|NCT01543698|365854550|FG012|Phase 1b|Adverse Event|0|||
106051788|NCT01543698|365854551|FG013|Phase 1b|Adverse Event|0|||
106051789|NCT01543698|365854552|FG014|Phase 1b|Adverse Event|0|||
106051790|NCT01543698|365854538|FG000|Phase 1b|Administrative problems|1|||
106051791|NCT01543698|365854539|FG001|Phase 1b|Administrative problems|0|||
106051792|NCT01543698|365854540|FG002|Phase 1b|Administrative problems|0|||
106051793|NCT01543698|365854541|FG003|Phase 1b|Administrative problems|0|||
106051794|NCT01543698|365854542|FG004|Phase 1b|Administrative problems|1|||
106051795|NCT01543698|365854543|FG005|Phase 1b|Administrative problems|0|||
106051796|NCT01543698|365854544|FG006|Phase 1b|Administrative problems|0|||
106051797|NCT01543698|365854545|FG007|Phase 1b|Administrative problems|1|||
106051798|NCT01543698|365854546|FG008|Phase 1b|Administrative problems|0|||
106051799|NCT01543698|365854547|FG009|Phase 1b|Administrative problems|0|||
106051800|NCT01543698|365854548|FG010|Phase 1b|Administrative problems|2|||
106051801|NCT01543698|365854549|FG011|Phase 1b|Administrative problems|0|||
106051802|NCT01543698|365854550|FG012|Phase 1b|Administrative problems|0|||
106051803|NCT01543698|365854551|FG013|Phase 1b|Administrative problems|0|||
106051804|NCT01543698|365854552|FG014|Phase 1b|Administrative problems|0|||
106051805|NCT01543698|365854538|FG000|Phase 1b|Protocol Violation|2|||
106051806|NCT01543698|365854539|FG001|Phase 1b|Protocol Violation|0|||
106051807|NCT01543698|365854540|FG002|Phase 1b|Protocol Violation|0|||
106051808|NCT01543698|365854541|FG003|Phase 1b|Protocol Violation|0|||
106051809|NCT01543698|365854542|FG004|Phase 1b|Protocol Violation|0|||
106051810|NCT01543698|365854543|FG005|Phase 1b|Protocol Violation|0|||
106051811|NCT01543698|365854544|FG006|Phase 1b|Protocol Violation|0|||
106051812|NCT01543698|365854545|FG007|Phase 1b|Protocol Violation|0|||
106152407|NCT05665595|366218780|FG001|Overall Study|Death|1|||
106152408|NCT03237481|366218783|FG000|Overall Study|Lost to Follow-up|1|||
106051813|NCT01543698|365854546|FG008|Phase 1b|Protocol Violation|0|||
106051814|NCT01543698|365854547|FG009|Phase 1b|Protocol Violation|0|||
106152409|NCT03237481|366218784|FG001|Overall Study|Lost to Follow-up|0|||
106051815|NCT01543698|365854548|FG010|Phase 1b|Protocol Violation|0|||
106051816|NCT01543698|365854549|FG011|Phase 1b|Protocol Violation|0|||
106051817|NCT01543698|365854550|FG012|Phase 1b|Protocol Violation|0|||
106051818|NCT01543698|365854551|FG013|Phase 1b|Protocol Violation|0|||
106051819|NCT01543698|365854552|FG014|Phase 1b|Protocol Violation|0|||
106051820|NCT01543698|365854538|FG000|Phase 2|Protocol Violation|0|||
106051821|NCT01543698|365854539|FG001|Phase 2|Protocol Violation|0|||
106051822|NCT01543698|365854540|FG002|Phase 2|Protocol Violation|0|||
106051823|NCT01543698|365854541|FG003|Phase 2|Protocol Violation|0|||
106051824|NCT01543698|365854542|FG004|Phase 2|Protocol Violation|0|||
106051825|NCT01543698|365854543|FG005|Phase 2|Protocol Violation|0|||
106051826|NCT01543698|365854544|FG006|Phase 2|Protocol Violation|0|||
106051827|NCT01543698|365854545|FG007|Phase 2|Protocol Violation|0|||
106051828|NCT01543698|365854546|FG008|Phase 2|Protocol Violation|0|||
106152410|NCT03237481|366218785|FG002|Overall Study|Lost to Follow-up|0|||
105863874|NCT04844762|365150550|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
105863875|NCT04844762|365150551|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863876|NCT04844762|365150552|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863877|NCT04844762|365150553|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863878|NCT04844762|365150554|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863879|NCT04844762|365150555|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
105863880|NCT04844762|365150550|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105863881|NCT04844762|365150551|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863882|NCT04844762|365150552|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863883|NCT04844762|365150553|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863884|NCT04844762|365150554|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
105863885|NCT04844762|365150555|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
105863886|NCT04844762|365150550|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105863887|NCT04844762|365150551|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
105863888|NCT04844762|365150552|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105863889|NCT04844762|365150553|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105863890|NCT04844762|365150554|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105863891|NCT04844762|365150555|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
105863892|NCT04844762|365150550|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105863893|NCT04844762|365150551|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105863894|NCT04844762|365150552|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105863895|NCT04844762|365150553|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
105863896|NCT04844762|365150554|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105863897|NCT04844762|365150555|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
105863898|NCT02293863|365150557|FG000|Overall Study|Death|4|||
105863899|NCT02293863|365150558|FG001|Overall Study|Death|6|||
105863900|NCT02293863|365150559|FG002|Overall Study|Death|4|||
105863901|NCT02293863|365150557|FG000|Overall Study|Lost to Follow-up|2|||
105863902|NCT02293863|365150558|FG001|Overall Study|Lost to Follow-up|2|||
105863903|NCT02293863|365150559|FG002|Overall Study|Lost to Follow-up|2|||
105863904|NCT02293863|365150557|FG000|Overall Study|Withdrawal by Subject|3|||
105863905|NCT02293863|365150558|FG001|Overall Study|Withdrawal by Subject|3|||
105863906|NCT02293863|365150559|FG002|Overall Study|Withdrawal by Subject|1|||
105863907|NCT02293863|365150557|FG000|Overall Study|Reason Not Specified|0|||
105863908|NCT02293863|365150558|FG001|Overall Study|Reason Not Specified|2|||
105863909|NCT02293863|365150559|FG002|Overall Study|Reason Not Specified|2|||
105863910|NCT00174954|365150560|FG000|Overall Study|Adverse Event|2|||
105863911|NCT00174954|365150560|FG000|Overall Study|No tophi found in MRI|1|||
105863912|NCT00174954|365150560|FG000|Overall Study|Physician Decision|1|||
105863913|NCT02185053|365150561|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
105863914|NCT02185053|365150562|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
105863915|NCT02185053|365150563|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
105863916|NCT02185053|365150561|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
105863917|NCT02185053|365150562|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
105863918|NCT02185053|365150563|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
105863919|NCT02185053|365150561|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
105863920|NCT02185053|365150562|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
105863921|NCT02185053|365150563|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
105863922|NCT02185053|365150561|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
105863923|NCT02185053|365150562|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
105863924|NCT02185053|365150563|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
105863925|NCT02185053|365150561|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
105863926|NCT02185053|365150562|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
105863927|NCT02185053|365150563|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
105863928|NCT02185053|365150561|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
105863929|NCT02185053|365150562|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
105863930|NCT02185053|365150563|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
106051829|NCT01543698|365854547|FG009|Phase 2|Protocol Violation|0|||
106051830|NCT01543698|365854548|FG010|Phase 2|Protocol Violation|0|||
106051831|NCT01543698|365854549|FG011|Phase 2|Protocol Violation|0|||
105863931|NCT02185053|365150561|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
105863932|NCT02185053|365150562|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
105863933|NCT02185053|365150563|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
105863934|NCT02185053|365150561|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
105863935|NCT02185053|365150562|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
105863936|NCT02185053|365150563|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
105863937|NCT04123561|365150565|FG000|Overall Study|Lost to Follow-up|20|||
106051832|NCT01543698|365854550|FG012|Phase 2|Protocol Violation|1|||
106051833|NCT01543698|365854551|FG013|Phase 2|Protocol Violation|0|||
106051834|NCT01543698|365854552|FG014|Phase 2|Protocol Violation|0|||
106051835|NCT01543698|365854538|FG000|Phase 2|Disease progression|0|||
106051836|NCT01543698|365854539|FG001|Phase 2|Disease progression|0|||
106051837|NCT01543698|365854540|FG002|Phase 2|Disease progression|0|||
106051838|NCT01543698|365854541|FG003|Phase 2|Disease progression|0|||
106051839|NCT01543698|365854542|FG004|Phase 2|Disease progression|0|||
106051840|NCT01543698|365854543|FG005|Phase 2|Disease progression|0|||
106051841|NCT01543698|365854544|FG006|Phase 2|Disease progression|0|||
106051842|NCT01543698|365854545|FG007|Phase 2|Disease progression|0|||
106051843|NCT01543698|365854546|FG008|Phase 2|Disease progression|0|||
106051844|NCT01543698|365854547|FG009|Phase 2|Disease progression|0|||
106051845|NCT01543698|365854548|FG010|Phase 2|Disease progression|0|||
106051846|NCT01543698|365854549|FG011|Phase 2|Disease progression|10|||
106051847|NCT01543698|365854550|FG012|Phase 2|Disease progression|21|||
106051848|NCT01543698|365854551|FG013|Phase 2|Disease progression|30|||
106051849|NCT01543698|365854552|FG014|Phase 2|Disease progression|25|||
106051850|NCT01543698|365854538|FG000|Phase 2|Death|0|||
106051851|NCT01543698|365854539|FG001|Phase 2|Death|0|||
106051852|NCT01543698|365854540|FG002|Phase 2|Death|0|||
106051853|NCT01543698|365854541|FG003|Phase 2|Death|0|||
106051854|NCT01543698|365854542|FG004|Phase 2|Death|0|||
106051855|NCT01543698|365854543|FG005|Phase 2|Death|0|||
106051856|NCT01543698|365854544|FG006|Phase 2|Death|0|||
106051857|NCT01543698|365854545|FG007|Phase 2|Death|0|||
106051858|NCT01543698|365854546|FG008|Phase 2|Death|0|||
106051859|NCT01543698|365854547|FG009|Phase 2|Death|0|||
106051860|NCT01543698|365854548|FG010|Phase 2|Death|0|||
106051861|NCT01543698|365854549|FG011|Phase 2|Death|0|||
106051862|NCT01543698|365854550|FG012|Phase 2|Death|1|||
106051863|NCT01543698|365854551|FG013|Phase 2|Death|1|||
106051864|NCT01543698|365854552|FG014|Phase 2|Death|1|||
106051865|NCT01543698|365854538|FG000|Phase 2|Administrative problems|0|||
106051866|NCT01543698|365854539|FG001|Phase 2|Administrative problems|0|||
106051867|NCT01543698|365854540|FG002|Phase 2|Administrative problems|0|||
106051868|NCT01543698|365854541|FG003|Phase 2|Administrative problems|0|||
106051869|NCT01543698|365854542|FG004|Phase 2|Administrative problems|0|||
106051870|NCT01543698|365854543|FG005|Phase 2|Administrative problems|0|||
106051871|NCT01543698|365854544|FG006|Phase 2|Administrative problems|0|||
106051872|NCT01543698|365854545|FG007|Phase 2|Administrative problems|0|||
106051873|NCT01543698|365854546|FG008|Phase 2|Administrative problems|0|||
106051874|NCT01543698|365854547|FG009|Phase 2|Administrative problems|0|||
106051875|NCT01543698|365854548|FG010|Phase 2|Administrative problems|0|||
106051876|NCT01543698|365854549|FG011|Phase 2|Administrative problems|0|||
106051877|NCT01543698|365854550|FG012|Phase 2|Administrative problems|0|||
106051878|NCT01543698|365854551|FG013|Phase 2|Administrative problems|3|||
106051879|NCT01543698|365854552|FG014|Phase 2|Administrative problems|1|||
106051880|NCT01543698|365854538|FG000|Phase 2|Withdrawal by Subject|0|||
106051881|NCT01543698|365854539|FG001|Phase 2|Withdrawal by Subject|0|||
106051882|NCT01543698|365854540|FG002|Phase 2|Withdrawal by Subject|0|||
106051883|NCT01543698|365854541|FG003|Phase 2|Withdrawal by Subject|0|||
106051884|NCT01543698|365854542|FG004|Phase 2|Withdrawal by Subject|0|||
106051885|NCT01543698|365854543|FG005|Phase 2|Withdrawal by Subject|0|||
106051886|NCT01543698|365854544|FG006|Phase 2|Withdrawal by Subject|0|||
106051887|NCT01543698|365854545|FG007|Phase 2|Withdrawal by Subject|0|||
106051888|NCT01543698|365854546|FG008|Phase 2|Withdrawal by Subject|0|||
106051889|NCT01543698|365854547|FG009|Phase 2|Withdrawal by Subject|0|||
106051890|NCT01543698|365854548|FG010|Phase 2|Withdrawal by Subject|0|||
106051891|NCT01543698|365854549|FG011|Phase 2|Withdrawal by Subject|0|||
106051892|NCT01543698|365854550|FG012|Phase 2|Withdrawal by Subject|0|||
106051893|NCT01543698|365854551|FG013|Phase 2|Withdrawal by Subject|3|||
106051894|NCT01543698|365854552|FG014|Phase 2|Withdrawal by Subject|1|||
106051895|NCT01543698|365854538|FG000|Phase 2|Adverse Event|0|||
106051896|NCT01543698|365854539|FG001|Phase 2|Adverse Event|0|||
106051897|NCT01543698|365854540|FG002|Phase 2|Adverse Event|0|||
106051898|NCT01543698|365854541|FG003|Phase 2|Adverse Event|0|||
106051899|NCT01543698|365854542|FG004|Phase 2|Adverse Event|0|||
106051900|NCT01543698|365854543|FG005|Phase 2|Adverse Event|0|||
106051901|NCT01543698|365854544|FG006|Phase 2|Adverse Event|0|||
106152411|NCT03237481|366218783|FG000|Overall Study|Protocol Violation|1|||
106051902|NCT01543698|365854545|FG007|Phase 2|Adverse Event|0|||
106051903|NCT01543698|365854546|FG008|Phase 2|Adverse Event|0|||
106051904|NCT01543698|365854547|FG009|Phase 2|Adverse Event|0|||
106051905|NCT01543698|365854548|FG010|Phase 2|Adverse Event|0|||
106051906|NCT01543698|365854549|FG011|Phase 2|Adverse Event|1|||
106051907|NCT01543698|365854550|FG012|Phase 2|Adverse Event|3|||
106051908|NCT01543698|365854551|FG013|Phase 2|Adverse Event|5|||
106051909|NCT01543698|365854552|FG014|Phase 2|Adverse Event|14|||
106051910|NCT01516437|365854553|FG000|Overall Study|Reason not specified|0|||
106051911|NCT01516437|365854554|FG001|Overall Study|Reason not specified|0|||
106051912|NCT01516437|365854555|FG002|Overall Study|Reason not specified|1|||
106051913|NCT01516437|365854556|FG003|Overall Study|Reason not specified|1|||
106051914|NCT00217620|365854557|FG000|Overall Study|Adverse Event|2|||
106051915|NCT00217620|365854557|FG000|Overall Study|Progression|31|||
106051916|NCT00217620|365854557|FG000|Overall Study|Not Protocol Specified|4|||
106051917|NCT00217620|365854557|FG000|Overall Study|Ineligible|13|||
106051918|NCT00217620|365854557|FG000|Overall Study|Never received treatment|1|||
106051919|NCT04092582|365854567|FG000|Overall Study|Death|1|||
106051920|NCT04092582|365854568|FG001|Overall Study|Death|1|||
106051921|NCT04092582|365854567|FG000|Overall Study|Withdrawal by Subject|4|||
106051922|NCT04092582|365854568|FG001|Overall Study|Withdrawal by Subject|1|||
106051923|NCT04092582|365854567|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
106051924|NCT04092582|365854568|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
106051925|NCT00560105|365854571|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
106051926|NCT00560105|365854572|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
106051927|NCT02468674|365854573|FG000|Overall Study|Adverse Event|0|||
106051928|NCT02468674|365854574|FG001|Overall Study|Adverse Event|0|||
106051929|NCT02468674|365854575|FG002|Overall Study|Adverse Event|0|||
106051930|NCT02468674|365854576|FG003|Overall Study|Adverse Event|1|||
106051931|NCT02468674|365854577|FG004|Overall Study|Adverse Event|0|||
106051932|NCT02468674|365854578|FG005|Overall Study|Adverse Event|1|||
106051933|NCT02468674|365854579|FG006|Overall Study|Adverse Event|0|||
106051934|NCT02468674|365854580|FG007|Overall Study|Adverse Event|0|||
106051935|NCT02468674|365854581|FG008|Overall Study|Adverse Event|0|||
106051936|NCT02468674|365854573|FG000|Overall Study|Lost to Follow-up|1|||
106051937|NCT02468674|365854574|FG001|Overall Study|Lost to Follow-up|0|||
106051938|NCT02468674|365854575|FG002|Overall Study|Lost to Follow-up|0|||
106051939|NCT02468674|365854576|FG003|Overall Study|Lost to Follow-up|0|||
106051940|NCT02468674|365854577|FG004|Overall Study|Lost to Follow-up|0|||
106051941|NCT02468674|365854578|FG005|Overall Study|Lost to Follow-up|0|||
106051942|NCT02468674|365854579|FG006|Overall Study|Lost to Follow-up|0|||
106051943|NCT02468674|365854580|FG007|Overall Study|Lost to Follow-up|1|||
106051944|NCT02468674|365854581|FG008|Overall Study|Lost to Follow-up|1|||
106051945|NCT02468674|365854573|FG000|Overall Study|Physician Decision|0|||
106051946|NCT02468674|365854574|FG001|Overall Study|Physician Decision|0|||
106051947|NCT02468674|365854575|FG002|Overall Study|Physician Decision|0|||
106051948|NCT02468674|365854576|FG003|Overall Study|Physician Decision|0|||
106051949|NCT02468674|365854577|FG004|Overall Study|Physician Decision|0|||
106051950|NCT02468674|365854578|FG005|Overall Study|Physician Decision|0|||
106051951|NCT02468674|365854579|FG006|Overall Study|Physician Decision|1|||
106051952|NCT02468674|365854580|FG007|Overall Study|Physician Decision|0|||
106051953|NCT02468674|365854581|FG008|Overall Study|Physician Decision|0|||
106051954|NCT02468674|365854573|FG000|Overall Study|Patient/Guardian Decision|0|||
106051955|NCT02468674|365854574|FG001|Overall Study|Patient/Guardian Decision|0|||
106051956|NCT02468674|365854575|FG002|Overall Study|Patient/Guardian Decision|0|||
106051957|NCT02468674|365854576|FG003|Overall Study|Patient/Guardian Decision|0|||
106051958|NCT02468674|365854577|FG004|Overall Study|Patient/Guardian Decision|1|||
106051959|NCT02468674|365854578|FG005|Overall Study|Patient/Guardian Decision|0|||
106051960|NCT02468674|365854579|FG006|Overall Study|Patient/Guardian Decision|0|||
106051961|NCT02468674|365854580|FG007|Overall Study|Patient/Guardian Decision|2|||
106051962|NCT02468674|365854581|FG008|Overall Study|Patient/Guardian Decision|1|||
106051963|NCT02468674|365854573|FG000|Overall Study|Protocol Deviation|0|||
106051964|NCT02468674|365854574|FG001|Overall Study|Protocol Deviation|0|||
106051965|NCT02468674|365854575|FG002|Overall Study|Protocol Deviation|0|||
106051966|NCT02468674|365854576|FG003|Overall Study|Protocol Deviation|0|||
106051967|NCT02468674|365854577|FG004|Overall Study|Protocol Deviation|0|||
106051968|NCT02468674|365854578|FG005|Overall Study|Protocol Deviation|0|||
106051969|NCT02468674|365854579|FG006|Overall Study|Protocol Deviation|0|||
106051970|NCT02468674|365854580|FG007|Overall Study|Protocol Deviation|1|||
106051971|NCT02468674|365854581|FG008|Overall Study|Protocol Deviation|1|||
106051972|NCT02280304|365854582|FG000|Overall Study|Lost to Follow-up|7|||
106051973|NCT02280304|365854583|FG001|Overall Study|Lost to Follow-up|8|||
106051974|NCT01550289|365854584|FG000|Overall Study|Protocol Violation|1|||
106051975|NCT01550289|365854585|FG001|Overall Study|Protocol Violation|0|||
106051976|NCT01550289|365854584|FG000|Overall Study|Lost to Follow-up|1|||
106051977|NCT01550289|365854585|FG001|Overall Study|Lost to Follow-up|1|||
106051978|NCT01550289|365854584|FG000|Overall Study|Withdrawal by Subject|11|||
106051979|NCT01550289|365854585|FG001|Overall Study|Withdrawal by Subject|3|||
106152412|NCT03237481|366218784|FG001|Overall Study|Protocol Violation|0|||
106051980|NCT00040365|365854597|FG000|Overall Study|Death|1|||
106051981|NCT00040365|365854597|FG000|Overall Study|Progressive disease|7|||
106051982|NCT00040365|365854597|FG000|Overall Study|Lost to Follow-up|3|||
106051983|NCT01603355|365854598|FG000|Overall Study|Lack of Efficacy|2|||
106051984|NCT00612040|365854599|FG000|Overall Study|Adverse Event|0|||
106051985|NCT00612040|365854600|FG001|Overall Study|Adverse Event|2|||
106051986|NCT00612040|365854601|FG002|Overall Study|Adverse Event|1|||
106051987|NCT00612040|365854599|FG000|Overall Study|Protocol Violation|1|||
106051988|NCT00612040|365854600|FG001|Overall Study|Protocol Violation|2|||
106051989|NCT00612040|365854601|FG002|Overall Study|Protocol Violation|1|||
106051990|NCT00612040|365854599|FG000|Overall Study|Lack of Efficacy|2|||
106051991|NCT00612040|365854600|FG001|Overall Study|Lack of Efficacy|1|||
106051992|NCT00612040|365854601|FG002|Overall Study|Lack of Efficacy|0|||
106051993|NCT00612040|365854599|FG000|Overall Study|Unclassified|2|||
106051994|NCT00612040|365854600|FG001|Overall Study|Unclassified|2|||
106051995|NCT00612040|365854601|FG002|Overall Study|Unclassified|5|||
106152413|NCT03237481|366218785|FG002|Overall Study|Protocol Violation|0|||
105863938|NCT04123561|365150566|FG001|Overall Study|Lost to Follow-up|12|||
105863939|NCT04123561|365150567|FG002|Overall Study|Lost to Follow-up|5|||
105863940|NCT04123561|365150565|FG000|Overall Study|Withdrawal by Subject|9|||
105863941|NCT04123561|365150566|FG001|Overall Study|Withdrawal by Subject|7|||
105863942|NCT04123561|365150567|FG002|Overall Study|Withdrawal by Subject|9|||
105863943|NCT04123561|365150565|FG000|Overall Study|Lack of Efficacy|7|||
105863944|NCT04123561|365150566|FG001|Overall Study|Lack of Efficacy|8|||
105863945|NCT04123561|365150567|FG002|Overall Study|Lack of Efficacy|6|||
105863946|NCT04123561|365150565|FG000|Overall Study|Adverse Event|5|||
105863947|NCT04123561|365150566|FG001|Overall Study|Adverse Event|2|||
105863948|NCT04123561|365150567|FG002|Overall Study|Adverse Event|3|||
105863949|NCT04123561|365150565|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
105863950|NCT04123561|365150566|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
105863951|NCT04123561|365150567|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
105863952|NCT04123561|365150565|FG000|Overall Study|Death|0|||
105863953|NCT04123561|365150566|FG001|Overall Study|Death|0|||
105863954|NCT04123561|365150567|FG002|Overall Study|Death|1|||
105863955|NCT04123561|365150565|FG000|Overall Study|Protocol Violation|0|||
105863956|NCT04123561|365150566|FG001|Overall Study|Protocol Violation|1|||
105863957|NCT04123561|365150567|FG002|Overall Study|Protocol Violation|0|||
105863958|NCT02521376|365150568|FG000|Overall Study|Enrolled, But Not Treated|1|||
105863959|NCT02521376|365150569|FG001|Overall Study|Enrolled, But Not Treated|0|||
105863960|NCT02521376|365150570|FG002|Overall Study|Enrolled, But Not Treated|0|||
105863961|NCT02521376|365150571|FG003|Overall Study|Enrolled, But Not Treated|0|||
105863962|NCT02933255|365150582|FG000|Overall Study|Discontinued due to study closure.|1|||
105863963|NCT02933255|365150583|FG001|Overall Study|Discontinued due to study closure.|0|||
105863964|NCT00451178|365150584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
105863965|NCT00451178|365150585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
105863966|NCT00451178|365150584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
105863967|NCT00451178|365150585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
105863968|NCT00451178|365150584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
105863969|NCT00451178|365150585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
105863970|NCT00451178|365150584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
105863971|NCT00451178|365150585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
105863972|NCT00451178|365150584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
105863973|NCT00451178|365150585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
105863974|NCT00451178|365150584|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
105863975|NCT00451178|365150585|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
105863976|NCT00451178|365150584|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
105863977|NCT00451178|365150585|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
105863978|NCT00451178|365150584|FG000|Prior to Maintenance Therapy|PD|2|||
105863979|NCT00451178|365150585|FG001|Prior to Maintenance Therapy|PD|0|||
105863980|NCT00451178|365150584|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
105863981|NCT00451178|365150585|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
105863982|NCT00451178|365150584|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
105863983|NCT00451178|365150585|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
105863984|NCT00451178|365150584|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
105863985|NCT00451178|365150585|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
105863986|NCT00451178|365150584|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
105863987|NCT00451178|365150585|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
105863988|NCT00451178|365150584|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
105863989|NCT00451178|365150585|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
105863990|NCT00451178|365150584|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
105863991|NCT00451178|365150585|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
105863992|NCT00451178|365150584|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
105863993|NCT00451178|365150585|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
105863994|NCT00912912|365150586|FG000|Overall Study|Withdrawal by Subject|1|||
105863995|NCT00912912|365150586|FG000|Overall Study|Disease Progression|3|||
105863996|NCT00761657|365152726|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
105863997|NCT00761657|365152727|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
106152414|NCT03237481|366218783|FG000|Overall Study|Withdrawal by Subject|3|||
105863998|NCT00761657|365152728|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
105863999|NCT00761657|365152729|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
105864000|NCT00761657|365152730|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
105864001|NCT00761657|365152731|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
106152415|NCT03237481|366218784|FG001|Overall Study|Withdrawal by Subject|2|||
106152416|NCT03237481|366218785|FG002|Overall Study|Withdrawal by Subject|1|||
105864002|NCT00761657|365152732|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
105864003|NCT00761657|365152733|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
106152417|NCT01643070|366218786|FG000|Overall Study|Withdrawal by Subject|3|||
106152418|NCT01643070|366218787|FG001|Overall Study|Withdrawal by Subject|1|||
106051996|NCT04645953|365854602|FG000|Overall Study|Lost to Follow-up|2|||
106051997|NCT04645953|365854603|FG001|Overall Study|Lost to Follow-up|1|||
106051998|NCT04645953|365854604|FG002|Overall Study|Lost to Follow-up|1|||
106051999|NCT04645953|365854602|FG000|Overall Study|Withdrawal by Subject|0|||
106052000|NCT04645953|365854603|FG001|Overall Study|Withdrawal by Subject|1|||
106052001|NCT04645953|365854604|FG002|Overall Study|Withdrawal by Subject|0|||
106052002|NCT04645953|365854602|FG000|Overall Study|Physician Decision|0|||
106052003|NCT04645953|365854603|FG001|Overall Study|Physician Decision|1|||
106052004|NCT04645953|365854604|FG002|Overall Study|Physician Decision|0|||
106052005|NCT04645953|365854602|FG000|Overall Study|Discontinued Prior to Dosing|0|||
106052006|NCT04645953|365854603|FG001|Overall Study|Discontinued Prior to Dosing|0|||
106052007|NCT04645953|365854604|FG002|Overall Study|Discontinued Prior to Dosing|2|||
106052008|NCT03741062|365854606|FG000|Overall Study|Protocol Violation|1|||
106052009|NCT03741062|365854607|FG001|Overall Study|Protocol Violation|0|||
106052010|NCT00762229|365854613|FG000|Overall Study|Lost to Follow-up|1|||
106052011|NCT00762229|365854614|FG001|Overall Study|Lost to Follow-up|1|||
106052012|NCT00762229|365854613|FG000|Overall Study|did not recveive intervention|0|||
106052013|NCT00762229|365854614|FG001|Overall Study|did not recveive intervention|1|||
106052014|NCT00444912|365854617|FG000|Overall Study|Death|1|||
106052015|NCT00444912|365854618|FG001|Overall Study|Death|2|||
106052016|NCT00444912|365854617|FG000|Overall Study|Lost to Follow-up|1|||
106052017|NCT00444912|365854618|FG001|Overall Study|Lost to Follow-up|0|||
106052018|NCT00444912|365854617|FG000|Overall Study|Participant Failed Mobilization|1|||
106052019|NCT00444912|365854618|FG001|Overall Study|Participant Failed Mobilization|0|||
106052020|NCT01606007|365854619|FG000|Overall Study|Reason 'Other' in the protocol|0|||
106052021|NCT01606007|365854620|FG001|Overall Study|Reason 'Other' in the protocol|1|||
106052022|NCT01606007|365854621|FG002|Overall Study|Reason 'Other' in the protocol|1|||
106052023|NCT01606007|365854619|FG000|Overall Study|Pregnancy|0|||
106052024|NCT01606007|365854620|FG001|Overall Study|Pregnancy|1|||
106052025|NCT01606007|365854621|FG002|Overall Study|Pregnancy|1|||
106052026|NCT01606007|365854619|FG000|Overall Study|Withdrawal by Subject|8|||
106052027|NCT01606007|365854620|FG001|Overall Study|Withdrawal by Subject|6|||
106052028|NCT01606007|365854621|FG002|Overall Study|Withdrawal by Subject|1|||
106052029|NCT01606007|365854619|FG000|Overall Study|Adverse Event|0|||
106052030|NCT01606007|365854620|FG001|Overall Study|Adverse Event|1|||
106052031|NCT01606007|365854621|FG002|Overall Study|Adverse Event|1|||
106052032|NCT01606007|365854619|FG000|Overall Study|discontinue study treatment|0|||
106052033|NCT01606007|365854620|FG001|Overall Study|discontinue study treatment|2|||
106052034|NCT01606007|365854621|FG002|Overall Study|discontinue study treatment|1|||
106052035|NCT01606007|365854619|FG000|Overall Study|Lost to Follow-up|6|||
106052036|NCT01606007|365854620|FG001|Overall Study|Lost to Follow-up|8|||
106052037|NCT01606007|365854621|FG002|Overall Study|Lost to Follow-up|5|||
106052038|NCT01606007|365854619|FG000|Overall Study|Poor/Non-compliance|1|||
106052039|NCT01606007|365854620|FG001|Overall Study|Poor/Non-compliance|0|||
106052040|NCT01606007|365854621|FG002|Overall Study|Poor/Non-compliance|0|||
106052041|NCT03758066|365854622|FG000|Overall Study|Lost to Follow-up|14|||
106052042|NCT04138810|365854623|FG000|Overall Study|Withdrawal by Subject|0|||
106052043|NCT04138810|365854624|FG001|Overall Study|Withdrawal by Subject|1|||
106052044|NCT04138810|365854623|FG000|Overall Study|Subject cancelled surgery|1|||
106052045|NCT04138810|365854624|FG001|Overall Study|Subject cancelled surgery|0|||
106052046|NCT03478657|365854627|FG000|Overall Study|Withdrawal by Subject|0|||
106052047|NCT03478657|365854628|FG001|Overall Study|Withdrawal by Subject|1|||
106052048|NCT01702805|365854629|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
106052049|NCT01702805|365854630|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
106052050|NCT01702805|365854629|FG000|Overall Study|Incomplete Follow-up|18|||
106052051|NCT01702805|365854630|FG001|Overall Study|Incomplete Follow-up|15|||
106052052|NCT01702805|365854629|FG000|Overall Study|Vital Status Assessment Only|40|||
106052053|NCT01702805|365854630|FG001|Overall Study|Vital Status Assessment Only|39|||
106152419|NCT01643070|366218786|FG000|Overall Study|Death|1|||
106152420|NCT01643070|366218787|FG001|Overall Study|Death|0|||
106152421|NCT01643070|366218786|FG000|Overall Study|Pregressive disease|0|||
106152422|NCT01643070|366218787|FG001|Overall Study|Pregressive disease|2|||
106052054|NCT01702805|365854629|FG000|Overall Study|Lost to Follow-up|5|||
106052055|NCT01702805|365854630|FG001|Overall Study|Lost to Follow-up|5|||
106052056|NCT01540838|365854631|FG000|Overall Study|Open nasogastric tube|9|||
106052057|NCT01540838|365854632|FG001|Overall Study|Open nasogastric tube|7|||
106052058|NCT01540838|365854631|FG000|Overall Study|Treatment doses missing|8|||
106052059|NCT01540838|365854632|FG001|Overall Study|Treatment doses missing|12|||
106052060|NCT01540838|365854631|FG000|Overall Study|Additional antibiotic treatment|1|||
106052061|NCT01540838|365854632|FG001|Overall Study|Additional antibiotic treatment|2|||
106052062|NCT01540838|365854631|FG000|Overall Study|Died before treatment initiation|1|||
106052063|NCT01540838|365854632|FG001|Overall Study|Died before treatment initiation|1|||
106052064|NCT01540838|365854631|FG000|Overall Study|Not BM. Other treatment|3|||
106052065|NCT01540838|365854632|FG001|Overall Study|Not BM. Other treatment|1|||
106052066|NCT02130570|365854633|FG000|Overall Study|Death|3|||
106052067|NCT02130570|365854634|FG001|Overall Study|Death|5|||
106152423|NCT05644002|366218788|FG000|Overall Study|Lost to Follow-up|1|||
106052068|NCT02130570|365854633|FG000|Overall Study|Withdrawal by Subject|6|||
106052069|NCT02130570|365854634|FG001|Overall Study|Withdrawal by Subject|3|||
106052070|NCT02130570|365854633|FG000|Overall Study|Part of practice that discontinued study|0|||
106052071|NCT02130570|365854634|FG001|Overall Study|Part of practice that discontinued study|5|||
106052072|NCT01849783|365854635|FG000|Overall Study|Adverse Event|5|||
106052073|NCT01849783|365854635|FG000|Overall Study|Death|2|||
106052074|NCT01849783|365854635|FG000|Overall Study|Physician Decision|1|||
106052075|NCT01849783|365854635|FG000|Overall Study|Withdrawal by Subject|1|||
106052076|NCT01849783|365854635|FG000|Overall Study|Unable to comply|2|||
106052077|NCT01849783|365854635|FG000|Overall Study|Disease progression|11|||
106052078|NCT03948581|365854636|FG000|Overall Study|Lost to Follow-up|0|||
106052079|NCT03948581|365854637|FG001|Overall Study|Lost to Follow-up|1|||
106052080|NCT03641339|365854638|FG000|Overall Study|Physician Decision|1|||
106052081|NCT03641339|365854639|FG001|Overall Study|Physician Decision|0|||
106052082|NCT03641339|365854640|FG002|Overall Study|Physician Decision|0|||
106052083|NCT03641339|365854641|FG003|Overall Study|Physician Decision|0|||
106052084|NCT03641339|365854642|FG004|Overall Study|Physician Decision|0|||
106052085|NCT03641339|365854643|FG005|Overall Study|Physician Decision|0|||
106052086|NCT03641339|365854638|FG000|Overall Study|Withdrawal by Subject|0|||
106052087|NCT03641339|365854639|FG001|Overall Study|Withdrawal by Subject|2|||
106052088|NCT03641339|365854640|FG002|Overall Study|Withdrawal by Subject|0|||
106052089|NCT03641339|365854641|FG003|Overall Study|Withdrawal by Subject|2|||
106052090|NCT03641339|365854642|FG004|Overall Study|Withdrawal by Subject|0|||
106052091|NCT03641339|365854643|FG005|Overall Study|Withdrawal by Subject|1|||
106052092|NCT02571777|365854644|FG000|Overall Study|Subject/guardian decision|34|||
106052093|NCT02571777|365854645|FG001|Overall Study|Subject/guardian decision|26|||
106052094|NCT02571777|365854646|FG002|Overall Study|Subject/guardian decision|26|||
106052095|NCT02571777|365854647|FG003|Overall Study|Subject/guardian decision|25|||
106052096|NCT02571777|365854648|FG004|Overall Study|Subject/guardian decision|27|||
106052097|NCT02571777|365854644|FG000|Overall Study|Protocol Deviation|2|||
106052098|NCT02571777|365854645|FG001|Overall Study|Protocol Deviation|3|||
106052099|NCT02571777|365854646|FG002|Overall Study|Protocol Deviation|4|||
106052100|NCT02571777|365854647|FG003|Overall Study|Protocol Deviation|8|||
106052101|NCT02571777|365854648|FG004|Overall Study|Protocol Deviation|4|||
106052102|NCT02571777|365854644|FG000|Overall Study|Death|1|||
106052103|NCT02571777|365854645|FG001|Overall Study|Death|1|||
106052104|NCT02571777|365854646|FG002|Overall Study|Death|4|||
106052105|NCT02571777|365854647|FG003|Overall Study|Death|0|||
106052106|NCT02571777|365854648|FG004|Overall Study|Death|0|||
106052107|NCT02571777|365854644|FG000|Overall Study|Lost to Follow-up|1|||
106052108|NCT02571777|365854645|FG001|Overall Study|Lost to Follow-up|1|||
106052109|NCT02571777|365854646|FG002|Overall Study|Lost to Follow-up|2|||
106052110|NCT02571777|365854647|FG003|Overall Study|Lost to Follow-up|0|||
106052111|NCT02571777|365854648|FG004|Overall Study|Lost to Follow-up|1|||
106052112|NCT02571777|365854644|FG000|Overall Study|Physician Decision|1|||
106052113|NCT02571777|365854645|FG001|Overall Study|Physician Decision|7|||
106052114|NCT02571777|365854646|FG002|Overall Study|Physician Decision|5|||
106052115|NCT02571777|365854647|FG003|Overall Study|Physician Decision|2|||
106052116|NCT02571777|365854648|FG004|Overall Study|Physician Decision|4|||
106052117|NCT02571777|365854644|FG000|Overall Study|Pregnancy|0|||
106052118|NCT02571777|365854645|FG001|Overall Study|Pregnancy|0|||
106052119|NCT02571777|365854646|FG002|Overall Study|Pregnancy|0|||
106052120|NCT02571777|365854647|FG003|Overall Study|Pregnancy|2|||
106052121|NCT02571777|365854648|FG004|Overall Study|Pregnancy|0|||
106052122|NCT04515394|365854653|FG000|Overall Study|Participant did not receive treatment|1|||
106052123|NCT03330288|365854657|FG000|Overall Study|Other reason|1|||
106052124|NCT03330288|365854658|FG001|Overall Study|Other reason|1|||
106052125|NCT03330288|365854657|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
106152424|NCT05644002|366218789|FG001|Overall Study|Lost to Follow-up|2|||
106152425|NCT05644002|366218788|FG000|Overall Study|Withdrawal by Subject|0|||
106152426|NCT05644002|366218789|FG001|Overall Study|Withdrawal by Subject|1|||
105864004|NCT00761657|365152734|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
105864005|NCT00761657|365152726|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
106052126|NCT03330288|365854658|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
106052127|NCT03330288|365854657|FG000|Overall Study|Adverse Event|1|||
106052128|NCT03330288|365854658|FG001|Overall Study|Adverse Event|0|||
106052129|NCT03330288|365854657|FG000|Overall Study|Withdrawal by Subject|1|||
106052130|NCT03330288|365854658|FG001|Overall Study|Withdrawal by Subject|0|||
106052131|NCT03330288|365854657|FG000|Overall Study|Lost to Follow-up|26|||
106052132|NCT03330288|365854658|FG001|Overall Study|Lost to Follow-up|7|||
106052133|NCT01416272|365854659|FG000|Overall Study|Unacceptable distance visual acuity|2|||
106052134|NCT01416272|365854659|FG000|Overall Study|Lost to Follow-up|1|||
106052135|NCT01416272|365854659|FG000|Overall Study|Study related complaints|1|||
106052136|NCT02693119|365854660|FG000|Open-Label Period|Withdrawal by Subject|0|||
106052137|NCT02693119|365854661|FG001|Open-Label Period|Withdrawal by Subject|1|||
106052138|NCT02571075|365854664|FG000|Overall Study|Lost to Follow-up|20|||
106052139|NCT02571075|365854665|FG001|Overall Study|Lost to Follow-up|24|||
106052140|NCT02925117|365854668|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
106052141|NCT02925117|365854669|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
106052142|NCT02925117|365854670|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
106052143|NCT02925117|365854671|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
106052144|NCT02925117|365854672|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
106052145|NCT02925117|365854673|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
106052146|NCT02925117|365854674|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
106052147|NCT02925117|365854675|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
106052148|NCT02925117|365854676|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
106052149|NCT02925117|365854677|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
106052150|NCT02925117|365854678|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
106052151|NCT02925117|365854679|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
106052152|NCT02925117|365854668|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
106052153|NCT02925117|365854669|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
106052154|NCT02925117|365854670|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
106052155|NCT02925117|365854671|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052156|NCT02925117|365854672|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052157|NCT02925117|365854673|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052158|NCT02925117|365854674|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052159|NCT02925117|365854675|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052160|NCT02925117|365854676|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052161|NCT02925117|365854677|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052162|NCT02925117|365854678|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052163|NCT02925117|365854679|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
106052164|NCT02925117|365854668|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
106052165|NCT02925117|365854669|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
106052166|NCT02925117|365854670|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052167|NCT02925117|365854671|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052168|NCT02925117|365854672|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052169|NCT02925117|365854673|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052170|NCT02925117|365854674|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052171|NCT02925117|365854675|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052172|NCT02925117|365854676|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052173|NCT02925117|365854677|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052174|NCT02925117|365854678|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052175|NCT02925117|365854679|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
106052176|NCT02925117|365854668|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
106052177|NCT02925117|365854669|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
106052178|NCT02925117|365854670|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
106052179|NCT02925117|365854671|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
106052180|NCT02925117|365854672|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
106052181|NCT02925117|365854673|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
106052182|NCT02925117|365854674|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
106052183|NCT02925117|365854675|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
106052184|NCT02925117|365854676|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
106052185|NCT02925117|365854677|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
106052186|NCT02925117|365854678|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
106052187|NCT02925117|365854679|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
106052188|NCT02925117|365854668|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052189|NCT02925117|365854669|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052190|NCT02925117|365854670|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052191|NCT02925117|365854671|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052192|NCT02925117|365854672|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052193|NCT02925117|365854673|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
106052194|NCT02925117|365854674|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052195|NCT02925117|365854675|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052196|NCT02925117|365854676|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052197|NCT02925117|365854677|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
106052198|NCT02925117|365854678|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
106052199|NCT02925117|365854679|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
106052200|NCT02925117|365854668|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
106052201|NCT02925117|365854669|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
106052202|NCT02925117|365854670|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
106052203|NCT02925117|365854671|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
106052204|NCT02925117|365854672|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
106052205|NCT02925117|365854673|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
106052206|NCT02925117|365854674|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
106052207|NCT02925117|365854675|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
106052208|NCT02925117|365854676|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
106052209|NCT02925117|365854677|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
106052210|NCT02925117|365854678|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
106052211|NCT02925117|365854679|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
106052212|NCT02925117|365854668|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
106052213|NCT02925117|365854669|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
106152427|NCT04038957|366218791|FG000|Overall Study|Withdrawal by Subject|1|||
106052214|NCT02925117|365854670|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
106052215|NCT02925117|365854671|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
106052216|NCT02925117|365854672|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
106052217|NCT02925117|365854673|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
106052218|NCT02925117|365854674|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
106052219|NCT02925117|365854675|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
106052220|NCT02925117|365854676|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
106052221|NCT02925117|365854677|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
106052222|NCT02925117|365854678|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
106052223|NCT02925117|365854679|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
106052224|NCT02925117|365854668|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
106052225|NCT02925117|365854669|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
106052226|NCT02925117|365854670|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
106052227|NCT02925117|365854671|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
106052228|NCT02925117|365854672|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
106052229|NCT02925117|365854673|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
106052230|NCT02925117|365854674|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
106052231|NCT02925117|365854675|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
106052232|NCT02925117|365854676|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
106052233|NCT02925117|365854677|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
106052234|NCT02925117|365854678|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
106052235|NCT02925117|365854679|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
106052236|NCT00868608|365854682|FG000|Overall Study|Withdrawal by Subject|3|||
106052237|NCT00868608|365854683|FG001|Overall Study|Withdrawal by Subject|1|||
106052238|NCT00868608|365854684|FG002|Overall Study|Withdrawal by Subject|0|||
106052239|NCT00868608|365854682|FG000|Overall Study|Lost to Follow-up|3|||
106052240|NCT00868608|365854683|FG001|Overall Study|Lost to Follow-up|0|||
106052241|NCT00868608|365854684|FG002|Overall Study|Lost to Follow-up|1|||
106052242|NCT00868608|365854682|FG000|Overall Study|Death|16|||
106052243|NCT00868608|365854683|FG001|Overall Study|Death|2|||
106052244|NCT00868608|365854684|FG002|Overall Study|Death|4|||
106052245|NCT00868608|365854682|FG000|Overall Study|Other - Unspecified|1|||
106052246|NCT00868608|365854683|FG001|Overall Study|Other - Unspecified|0|||
106052247|NCT00868608|365854684|FG002|Overall Study|Other - Unspecified|0|||
106052248|NCT02369016|365854685|FG000|Overall Study|AE associated with clinical disease progression|2|||
106052249|NCT02369016|365854686|FG001|Overall Study|AE associated with clinical disease progression|1|||
106052250|NCT02369016|365854685|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
106052251|NCT02369016|365854686|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
106052252|NCT02369016|365854685|FG000|Overall Study|Progressive disease - clinical progression|1|||
106052253|NCT02369016|365854686|FG001|Overall Study|Progressive disease - clinical progression|4|||
106052254|NCT02369016|365854685|FG000|Overall Study|withdrawal by patient|4|||
106052255|NCT02369016|365854686|FG001|Overall Study|withdrawal by patient|0|||
106052256|NCT02369016|365854685|FG000|Overall Study|Progressive disease - radiological progression|6|||
106052257|NCT02369016|365854686|FG001|Overall Study|Progressive disease - radiological progression|2|||
106052258|NCT00293033|365854693|FG000|Open-label Titration Period|Adverse Event|10|||
106052259|NCT00293033|365854693|FG000|Open-label Titration Period|Death|3|||
106052260|NCT00293033|365854693|FG000|Open-label Titration Period|Lack of Efficacy|5|||
106052261|NCT00293033|365854693|FG000|Open-label Titration Period|Protocol Violation|2|||
106052262|NCT00293033|365854693|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
106052263|NCT00293033|365854693|FG000|Open-label Titration Period|Noncompliance and other|27|||
106052264|NCT00293033|365854693|FG000|Double-blind Treatment Period|Adverse Event|3|||
106052265|NCT00293033|365854693|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
106052266|NCT00293033|365854693|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
106052267|NCT00293033|365854693|FG000|Double-blind Treatment Period|Noncompliance|4|||
106052268|NCT00365508|365854699|FG000|Overall Study|Lost to Follow-up|139|||
106052269|NCT00365508|365854700|FG001|Overall Study|Lost to Follow-up|154|||
106052270|NCT03846804|365854703|FG000|Overall Study|Refused blood draw|1|||
106052271|NCT03846804|365854703|FG000|Overall Study|Protocol Violation|1|||
106052272|NCT01995825|365856085|FG000|Overall Study|Withdrawal by Subject|1|||
106052273|NCT01995825|365856086|FG001|Overall Study|Withdrawal by Subject|0|||
106052274|NCT01897454|365856089|FG000|Overall Study|Withdrawal by Subject|1|||
106052275|NCT01871532|365856090|FG000|Overall Study|Withdrawal by Subject|1|||
106052276|NCT01871532|365856091|FG001|Overall Study|Withdrawal by Subject|2|||
106052277|NCT00283400|365856092|FG000|Overall Study|Withdrawal by Subject|1|||
106052278|NCT00283400|365856093|FG001|Overall Study|Withdrawal by Subject|1|||
106052279|NCT00283400|365856094|FG002|Overall Study|Withdrawal by Subject|0|||
106052280|NCT00283400|365856095|FG003|Overall Study|Withdrawal by Subject|0|||
106052281|NCT00283400|365856092|FG000|Overall Study|Death|1|||
106052282|NCT00283400|365856093|FG001|Overall Study|Death|0|||
106052283|NCT00283400|365856094|FG002|Overall Study|Death|1|||
106052284|NCT00283400|365856095|FG003|Overall Study|Death|0|||
106052285|NCT01034631|365856097|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
106052286|NCT01034631|365856098|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
106052287|NCT01034631|365856099|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
106052288|NCT01034631|365856097|FG000|Phase II|Not Evaluable per protocol|0|||
106052289|NCT01034631|365856098|FG001|Phase II|Not Evaluable per protocol|0|||
106052290|NCT01034631|365856099|FG002|Phase II|Not Evaluable per protocol|2|||
106052291|NCT01034631|365856097|FG000|Phase II|Determined Ineligible per protocol|0|||
106052292|NCT01034631|365856098|FG001|Phase II|Determined Ineligible per protocol|1|||
106052293|NCT01034631|365856099|FG002|Phase II|Determined Ineligible per protocol|0|||
106052294|NCT00354744|365856100|FG000|Overall Study|Adverse Event|2|||
106052295|NCT00354744|365856100|FG000|Overall Study|Death|2|||
106052296|NCT00354744|365856100|FG000|Overall Study|Lack of Efficacy|11|||
106052297|NCT00354744|365856100|FG000|Overall Study|Lost to Follow-up|2|||
106052298|NCT00354744|365856100|FG000|Overall Study|Physician Decision|11|||
106052299|NCT00354744|365856100|FG000|Overall Study|Withdrawal by Subject|14|||
106052300|NCT01193530|365856102|FG000|Overall Study|Withdrawal by Subject|2|||
106052301|NCT01193530|365856103|FG001|Overall Study|Withdrawal by Subject|2|||
106052302|NCT01193530|365856102|FG000|Overall Study|Began Contraindicated Therapy|1|||
106052303|NCT01193530|365856103|FG001|Overall Study|Began Contraindicated Therapy|0|||
106052304|NCT01193530|365856102|FG000|Overall Study|Lost Light Box|0|||
106052305|NCT01193530|365856103|FG001|Overall Study|Lost Light Box|1|||
106052306|NCT01193530|365856102|FG000|Overall Study|Returned home - out of state|0|||
106052307|NCT01193530|365856103|FG001|Overall Study|Returned home - out of state|1|||
106052308|NCT01193530|365856102|FG000|Overall Study|Non-Compliance|0|||
106052309|NCT01193530|365856103|FG001|Overall Study|Non-Compliance|1|||
106052310|NCT04218695|365856104|FG000|Overall Study|Adverse Event|1|||
106052311|NCT04218695|365856105|FG001|Overall Study|Adverse Event|0|||
106052312|NCT00395304|365856106|FG000|Treatment Period 1|Withdrawal by Subject|0|||
106052313|NCT00395304|365856107|FG001|Treatment Period 1|Withdrawal by Subject|3|||
106052314|NCT00395304|365856108|FG002|Treatment Period 1|Withdrawal by Subject|0|||
106052315|NCT00395304|365856109|FG003|Treatment Period 1|Withdrawal by Subject|2|||
106052316|NCT00395304|365856110|FG004|Treatment Period 1|Withdrawal by Subject|1|||
106052317|NCT00395304|365856111|FG005|Treatment Period 1|Withdrawal by Subject|1|||
106052318|NCT00395304|365856106|FG000|Treatment Period 1|Lost to Follow-up|1|||
106052319|NCT00395304|365856107|FG001|Treatment Period 1|Lost to Follow-up|0|||
106052320|NCT00395304|365856108|FG002|Treatment Period 1|Lost to Follow-up|0|||
106052321|NCT00395304|365856109|FG003|Treatment Period 1|Lost to Follow-up|1|||
106052322|NCT00395304|365856110|FG004|Treatment Period 1|Lost to Follow-up|0|||
106052323|NCT00395304|365856111|FG005|Treatment Period 1|Lost to Follow-up|1|||
106052324|NCT00395304|365856106|FG000|Treatment Period 1|Physician Decision|0|||
106052325|NCT00395304|365856107|FG001|Treatment Period 1|Physician Decision|1|||
106052326|NCT00395304|365856108|FG002|Treatment Period 1|Physician Decision|0|||
106052327|NCT00395304|365856109|FG003|Treatment Period 1|Physician Decision|0|||
106052328|NCT00395304|365856110|FG004|Treatment Period 1|Physician Decision|0|||
106052329|NCT00395304|365856111|FG005|Treatment Period 1|Physician Decision|0|||
106052330|NCT00395304|365856106|FG000|Treatment Period 2|Withdrawal by Subject|0|||
106052331|NCT00395304|365856107|FG001|Treatment Period 2|Withdrawal by Subject|0|||
106052332|NCT00395304|365856108|FG002|Treatment Period 2|Withdrawal by Subject|0|||
106052333|NCT00395304|365856109|FG003|Treatment Period 2|Withdrawal by Subject|1|||
106052334|NCT00395304|365856110|FG004|Treatment Period 2|Withdrawal by Subject|0|||
106052335|NCT00395304|365856111|FG005|Treatment Period 2|Withdrawal by Subject|2|||
106052336|NCT00395304|365856106|FG000|Treatment Period 2|Lost to Follow-up|0|||
106052337|NCT00395304|365856107|FG001|Treatment Period 2|Lost to Follow-up|3|||
106052338|NCT00395304|365856108|FG002|Treatment Period 2|Lost to Follow-up|0|||
106052339|NCT00395304|365856109|FG003|Treatment Period 2|Lost to Follow-up|0|||
106052340|NCT00395304|365856110|FG004|Treatment Period 2|Lost to Follow-up|0|||
106052341|NCT00395304|365856111|FG005|Treatment Period 2|Lost to Follow-up|0|||
106052342|NCT00395304|365856106|FG000|Treatment Period 2|Physician Decision|0|||
106052343|NCT00395304|365856107|FG001|Treatment Period 2|Physician Decision|0|||
106052344|NCT00395304|365856108|FG002|Treatment Period 2|Physician Decision|1|||
106052345|NCT00395304|365856109|FG003|Treatment Period 2|Physician Decision|0|||
106052346|NCT00395304|365856110|FG004|Treatment Period 2|Physician Decision|0|||
106052347|NCT00395304|365856111|FG005|Treatment Period 2|Physician Decision|0|||
106052348|NCT00395304|365856106|FG000|Treatment Period 2|Other|0|||
106052349|NCT00395304|365856107|FG001|Treatment Period 2|Other|1|||
106052350|NCT00395304|365856108|FG002|Treatment Period 2|Other|0|||
106052351|NCT00395304|365856109|FG003|Treatment Period 2|Other|0|||
106052352|NCT00395304|365856110|FG004|Treatment Period 2|Other|0|||
106052353|NCT00395304|365856111|FG005|Treatment Period 2|Other|0|||
105864006|NCT00761657|365152727|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105864007|NCT00761657|365152728|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
106052354|NCT00395304|365856106|FG000|Treatment Period 3|Withdrawal by Subject|0|||
106052355|NCT00395304|365856107|FG001|Treatment Period 3|Withdrawal by Subject|0|||
106152428|NCT04038957|366218791|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
106052356|NCT00395304|365856108|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105864008|NCT00761657|365152729|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
106152429|NCT03088813|366218793|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
105864009|NCT00761657|365152730|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
106052357|NCT00395304|365856109|FG003|Treatment Period 3|Withdrawal by Subject|1|||
106052358|NCT00395304|365856110|FG004|Treatment Period 3|Withdrawal by Subject|0|||
106052359|NCT00395304|365856111|FG005|Treatment Period 3|Withdrawal by Subject|1|||
106052360|NCT00395304|365856106|FG000|Treatment Period 3|Lost to Follow-up|1|||
106052361|NCT00395304|365856107|FG001|Treatment Period 3|Lost to Follow-up|1|||
106052362|NCT00395304|365856108|FG002|Treatment Period 3|Lost to Follow-up|0|||
106052363|NCT00395304|365856109|FG003|Treatment Period 3|Lost to Follow-up|0|||
106052364|NCT00395304|365856110|FG004|Treatment Period 3|Lost to Follow-up|0|||
106052365|NCT00395304|365856111|FG005|Treatment Period 3|Lost to Follow-up|0|||
106052366|NCT00395304|365856106|FG000|Treatment Period 3|Physician Decision|0|||
106052367|NCT00395304|365856107|FG001|Treatment Period 3|Physician Decision|1|||
106052368|NCT00395304|365856108|FG002|Treatment Period 3|Physician Decision|0|||
106052369|NCT00395304|365856109|FG003|Treatment Period 3|Physician Decision|0|||
106052370|NCT00395304|365856110|FG004|Treatment Period 3|Physician Decision|0|||
106052371|NCT00395304|365856111|FG005|Treatment Period 3|Physician Decision|0|||
106052372|NCT00395304|365856106|FG000|Treatment Period 3|Other|0|||
106052373|NCT00395304|365856107|FG001|Treatment Period 3|Other|0|||
106052374|NCT00395304|365856108|FG002|Treatment Period 3|Other|0|||
106052375|NCT00395304|365856109|FG003|Treatment Period 3|Other|1|||
106052376|NCT00395304|365856110|FG004|Treatment Period 3|Other|0|||
106052377|NCT00395304|365856111|FG005|Treatment Period 3|Other|0|||
106052378|NCT00934089|365856113|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
106052379|NCT00934089|365856114|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
106052380|NCT00934089|365856113|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
106052381|NCT00934089|365856114|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
106052382|NCT01945281|365856115|FG000|Overall Study|Adverse Event|1|||
106052383|NCT01945281|365856116|FG001|Overall Study|Adverse Event|0|||
106052384|NCT01945281|365856115|FG000|Overall Study|Death|3|||
106052385|NCT01945281|365856116|FG001|Overall Study|Death|3|||
106052386|NCT01945281|365856115|FG000|Overall Study|Physician Decision|1|||
106052387|NCT01945281|365856116|FG001|Overall Study|Physician Decision|1|||
106052388|NCT01945281|365856115|FG000|Overall Study|Technical Problems|1|||
106052389|NCT01945281|365856116|FG001|Overall Study|Technical Problems|0|||
106052390|NCT04401423|365856117|FG000|Overall Study|Withdrawal by Subject|3|||
106052391|NCT04401423|365856118|FG001|Overall Study|Withdrawal by Subject|1|||
106052392|NCT04401423|365856117|FG000|Overall Study|Physician Decision|2|||
106052393|NCT04401423|365856118|FG001|Overall Study|Physician Decision|1|||
106052394|NCT00003473|365856119|FG000|Overall Study|Three patients were not evaluable.|3|||
106052395|NCT00799383|365856124|FG000|Overall Study|Protocol Violation|1|||
106052396|NCT00799383|365856125|FG001|Overall Study|Protocol Violation|1|||
106052397|NCT00799383|365856124|FG000|Overall Study|Adverse Event|0|||
106052398|NCT00799383|365856125|FG001|Overall Study|Adverse Event|1|||
106052399|NCT00799383|365856124|FG000|Overall Study|Lost to Follow-up|1|||
106052400|NCT00799383|365856125|FG001|Overall Study|Lost to Follow-up|2|||
106052401|NCT00799383|365856124|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
106052402|NCT00799383|365856125|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
106052403|NCT00799383|365856124|FG000|Overall Study|Withdrawal by Subject|0|||
106052404|NCT00799383|365856125|FG001|Overall Study|Withdrawal by Subject|1|||
106052405|NCT00926328|365856131|FG000|Overall Study|Lost to Follow-up|12|||
106052406|NCT00926328|365856132|FG001|Overall Study|Lost to Follow-up|14|||
106052407|NCT00289133|365856133|FG000|Overall Study|Non-study device implanted|12|||
106052408|NCT00289133|365856134|FG001|Overall Study|Non-study device implanted|0|||
106052409|NCT00289133|365856133|FG000|Overall Study|Protocol Violation|32|||
106052410|NCT00289133|365856134|FG001|Overall Study|Protocol Violation|38|||
106052411|NCT00289133|365856133|FG000|Overall Study|Withdrawal by Subject|9|||
106052412|NCT00289133|365856134|FG001|Overall Study|Withdrawal by Subject|10|||
106052413|NCT00289133|365856133|FG000|Overall Study|Death|5|||
106052414|NCT00289133|365856134|FG001|Overall Study|Death|10|||
106052415|NCT00289133|365856133|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
106052416|NCT00289133|365856134|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
106052417|NCT00289133|365856133|FG000|Overall Study|Physician Decision|41|||
106052418|NCT00289133|365856134|FG001|Overall Study|Physician Decision|45|||
106052419|NCT00289133|365856133|FG000|Overall Study|Revision|8|||
106052420|NCT00289133|365856134|FG001|Overall Study|Revision|6|||
106052421|NCT00289133|365856133|FG000|Overall Study|Lost to Follow-up|92|||
106052422|NCT00289133|365856134|FG001|Overall Study|Lost to Follow-up|115|||
106052423|NCT01749137|365856139|FG000|Overall Study|Adverse Event|4|||
106052424|NCT01749137|365856140|FG001|Overall Study|Adverse Event|4|||
106052425|NCT01749137|365856139|FG000|Overall Study|Lost to Follow-up|2|||
106052426|NCT01749137|365856140|FG001|Overall Study|Lost to Follow-up|3|||
106052427|NCT01749137|365856139|FG000|Overall Study|Physician Decision|1|||
106052428|NCT01749137|365856140|FG001|Overall Study|Physician Decision|0|||
106052429|NCT01749137|365856139|FG000|Overall Study|Withdrawal by Subject|8|||
106052430|NCT01749137|365856140|FG001|Overall Study|Withdrawal by Subject|4|||
106052431|NCT03372096|365856141|FG000|Overall Study|Study Closed|8|||
106052432|NCT00680017|365856144|FG000|Overall Study|Adverse Event|13|||
106052433|NCT00680017|365856145|FG001|Overall Study|Adverse Event|7|||
106052434|NCT00680017|365856144|FG000|Overall Study|Withdrawal by Subject|2|||
106052435|NCT00680017|365856145|FG001|Overall Study|Withdrawal by Subject|5|||
106052436|NCT00680017|365856144|FG000|Overall Study|Lost to Follow-up|2|||
106052437|NCT00680017|365856145|FG001|Overall Study|Lost to Follow-up|0|||
106052438|NCT01546207|365856146|FG000|Overall Study|Death|1|||
106052439|NCT01826604|365856147|FG000|Overall Study|Lost to Follow-up|8|||
106052440|NCT01826604|365856148|FG001|Overall Study|Lost to Follow-up|9|||
106052441|NCT03019185|365856149|FG000|Overall Study|Lost to Follow-up|3|||
106052442|NCT03019185|365856150|FG001|Overall Study|Lost to Follow-up|0|||
106052443|NCT03019185|365856151|FG002|Overall Study|Lost to Follow-up|2|||
106052444|NCT03019185|365856149|FG000|Overall Study|Withdrawal by Subject|1|||
106052445|NCT03019185|365856150|FG001|Overall Study|Withdrawal by Subject|1|||
106052446|NCT03019185|365856151|FG002|Overall Study|Withdrawal by Subject|0|||
106052447|NCT03019185|365856149|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
106052448|NCT03019185|365856150|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
106052449|NCT03019185|365856151|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
106052450|NCT03019185|365856149|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
106052451|NCT03019185|365856150|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
106052452|NCT03019185|365856151|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
106052453|NCT05154578|365856152|FG000|Overall Study|Withdrawal by Subject|2|||
106052454|NCT05154578|365856153|FG001|Overall Study|Withdrawal by Subject|3|||
106052455|NCT05154578|365856154|FG002|Overall Study|Withdrawal by Subject|2|||
106052456|NCT05154578|365856155|FG003|Overall Study|Withdrawal by Subject|4|||
106052457|NCT05154578|365856156|FG004|Overall Study|Withdrawal by Subject|0|||
106052458|NCT05154578|365856152|FG000|Overall Study|Lost to Follow-up|0|||
106052459|NCT05154578|365856153|FG001|Overall Study|Lost to Follow-up|1|||
106052460|NCT05154578|365856154|FG002|Overall Study|Lost to Follow-up|0|||
106052461|NCT05154578|365856155|FG003|Overall Study|Lost to Follow-up|3|||
106052462|NCT05154578|365856156|FG004|Overall Study|Lost to Follow-up|0|||
106052463|NCT05154578|365856152|FG000|Overall Study|Adverse Event|0|||
106052464|NCT05154578|365856153|FG001|Overall Study|Adverse Event|0|||
106052465|NCT05154578|365856154|FG002|Overall Study|Adverse Event|0|||
106052466|NCT05154578|365856155|FG003|Overall Study|Adverse Event|1|||
106052467|NCT05154578|365856156|FG004|Overall Study|Adverse Event|0|||
106052468|NCT05154578|365856152|FG000|Overall Study|Relocated to another province|0|||
106052469|NCT05154578|365856153|FG001|Overall Study|Relocated to another province|0|||
106052470|NCT05154578|365856154|FG002|Overall Study|Relocated to another province|1|||
106052471|NCT05154578|365856155|FG003|Overall Study|Relocated to another province|0|||
106052472|NCT05154578|365856156|FG004|Overall Study|Relocated to another province|1|||
106052473|NCT05154578|365856152|FG000|Overall Study|Baby loss|0|||
106052474|NCT05154578|365856153|FG001|Overall Study|Baby loss|1|||
106052475|NCT05154578|365856154|FG002|Overall Study|Baby loss|0|||
106052476|NCT05154578|365856155|FG003|Overall Study|Baby loss|0|||
106052477|NCT05154578|365856156|FG004|Overall Study|Baby loss|0|||
106052478|NCT04572633|365856157|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
106052479|NCT00894166|365856161|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
106052480|NCT00894166|365856162|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
106052481|NCT00894166|365856163|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
106052482|NCT00894166|365856164|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
106052483|NCT00894166|365856165|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
106052484|NCT00894166|365856166|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
106052485|NCT00894166|365856167|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
106052486|NCT00894166|365856168|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
106052487|NCT00894166|365856161|FG000|Overall Study|Death|0|||
106052488|NCT00894166|365856162|FG001|Overall Study|Death|0|||
106052489|NCT00894166|365856163|FG002|Overall Study|Death|0|||
106052490|NCT00894166|365856164|FG003|Overall Study|Death|1|||
106052491|NCT00894166|365856165|FG004|Overall Study|Death|0|||
106052492|NCT00894166|365856166|FG005|Overall Study|Death|0|||
106052493|NCT00894166|365856167|FG006|Overall Study|Death|0|||
106052494|NCT00894166|365856168|FG007|Overall Study|Death|0|||
106052495|NCT00142935|365856171|FG000|Overall Study|Other reason|1|||
106052496|NCT00142935|365856172|FG001|Overall Study|Other reason|1|||
106052497|NCT00142935|365856173|FG002|Overall Study|Other reason|1|||
106052498|NCT00142935|365856171|FG000|Overall Study|Lost to Follow-up|2|||
106052499|NCT00142935|365856172|FG001|Overall Study|Lost to Follow-up|5|||
106052500|NCT00142935|365856173|FG002|Overall Study|Lost to Follow-up|5|||
106052501|NCT00142935|365856171|FG000|Overall Study|Death|0|||
106052502|NCT00142935|365856172|FG001|Overall Study|Death|2|||
106052503|NCT00142935|365856173|FG002|Overall Study|Death|1|||
106052504|NCT01921387|365856174|FG000|Overall Study|Adverse Event|1|||
106052505|NCT01180985|365856175|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
106052506|NCT01180985|365856176|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
106052507|NCT00319553|365856177|FG000|Overall Study|Protocol Violation|1|||
106052508|NCT00319553|365856178|FG001|Overall Study|Protocol Violation|2|||
106052509|NCT00319553|365856177|FG000|Overall Study|Lost to Follow-up|2|||
106052510|NCT00319553|365856178|FG001|Overall Study|Lost to Follow-up|1|||
106052511|NCT00319553|365856177|FG000|Overall Study|Withdrawal by Subject|1|||
106052512|NCT00319553|365856178|FG001|Overall Study|Withdrawal by Subject|1|||
106052513|NCT01896102|365856179|FG000|Overall Study|Death|1|||
106052514|NCT01896102|365856179|FG000|Overall Study|Participant to receive allogenic transplant|2|||
106052515|NCT01281865|365856184|FG000|Overall Study|Adverse Event|1|||
106052516|NCT01281865|365856185|FG001|Overall Study|Adverse Event|1|||
106052517|NCT01281865|365856184|FG000|Overall Study|Withdrawal by Subject|1|||
106052518|NCT01281865|365856185|FG001|Overall Study|Withdrawal by Subject|0|||
106052519|NCT01281865|365856184|FG000|Overall Study|Lack of Efficacy|1|||
105864010|NCT00761657|365152731|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105864011|NCT00761657|365152732|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105864012|NCT00761657|365152733|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105864013|NCT00761657|365152734|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
105864014|NCT00761657|365152726|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
105864015|NCT00761657|365152727|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
105864016|NCT00761657|365152728|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
105864017|NCT00761657|365152729|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
105864018|NCT00761657|365152730|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
105864019|NCT00761657|365152731|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
105864020|NCT00761657|365152732|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
105864021|NCT00761657|365152733|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
105864022|NCT00761657|365152734|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
105864023|NCT00761657|365152726|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
105864024|NCT00761657|365152727|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
105864025|NCT00761657|365152728|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
105864026|NCT00761657|365152729|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
105864027|NCT00761657|365152730|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
105864028|NCT00761657|365152731|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
105864029|NCT00761657|365152732|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
105864030|NCT00761657|365152733|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
105864031|NCT00761657|365152734|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
105864032|NCT00478244|365152737|FG000|Overall Study|Did not receive transplant|1|||
105864033|NCT02929056|365152742|FG000|Overall Study|Lost to Follow-up|0|||
105864034|NCT02929056|365152743|FG001|Overall Study|Lost to Follow-up|1|||
105864035|NCT02245412|365152744|FG000|Treatment Period|Death|1|||
105864036|NCT02245412|365152745|FG001|Treatment Period|Death|1|||
105864037|NCT02245412|365152746|FG002|Treatment Period|Death|0|||
105864038|NCT02245412|365152744|FG000|Treatment Period|Physician Decision|1|||
105864039|NCT02245412|365152745|FG001|Treatment Period|Physician Decision|1|||
105864040|NCT02245412|365152746|FG002|Treatment Period|Physician Decision|0|||
105864041|NCT02245412|365152744|FG000|Treatment Period|Withdrawal by Subject|2|||
105864042|NCT02245412|365152745|FG001|Treatment Period|Withdrawal by Subject|1|||
105864043|NCT02245412|365152746|FG002|Treatment Period|Withdrawal by Subject|0|||
105864044|NCT02245412|365152744|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
105864045|NCT02245412|365152745|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
105864046|NCT02245412|365152746|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
105864047|NCT02245412|365152744|FG000|Follow-Up Period|Death|4|||
105864048|NCT02245412|365152745|FG001|Follow-Up Period|Death|2|||
105864049|NCT02245412|365152746|FG002|Follow-Up Period|Death|1|||
105864050|NCT02245412|365152744|FG000|Follow-Up Period|Physician Decision|1|||
105864051|NCT02245412|365152745|FG001|Follow-Up Period|Physician Decision|0|||
105864052|NCT02245412|365152746|FG002|Follow-Up Period|Physician Decision|0|||
105864053|NCT02245412|365152744|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
105864054|NCT02245412|365152745|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
105864055|NCT02245412|365152746|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
105864056|NCT03132155|365152747|FG000|Overall Study|Lack of Efficacy|6|||
105864057|NCT03132155|365152747|FG000|Overall Study|Lost to Follow-up|1|||
105864058|NCT03132155|365152747|FG000|Overall Study|Withdrawal by Subject|1|||
105864059|NCT01056289|365152748|FG000|Open-label Phase|Adverse Event|29|||
105864060|NCT01056289|365152749|FG001|Open-label Phase|Adverse Event|0|||
105864061|NCT01056289|365152750|FG002|Open-label Phase|Adverse Event|0|||
105864062|NCT01056289|365152751|FG003|Open-label Phase|Adverse Event|0|||
105864063|NCT01056289|365152748|FG000|Open-label Phase|Lost to Follow-up|30|||
105864064|NCT01056289|365152749|FG001|Open-label Phase|Lost to Follow-up|0|||
105864065|NCT01056289|365152750|FG002|Open-label Phase|Lost to Follow-up|0|||
105864066|NCT01056289|365152751|FG003|Open-label Phase|Lost to Follow-up|0|||
105864067|NCT01056289|365152748|FG000|Open-label Phase|Other|9|||
105864068|NCT01056289|365152749|FG001|Open-label Phase|Other|0|||
105864069|NCT01056289|365152750|FG002|Open-label Phase|Other|0|||
105864070|NCT01056289|365152751|FG003|Open-label Phase|Other|0|||
105864071|NCT01056289|365152748|FG000|Open-label Phase|Protocol Violation|6|||
105864072|NCT01056289|365152749|FG001|Open-label Phase|Protocol Violation|0|||
105864073|NCT01056289|365152750|FG002|Open-label Phase|Protocol Violation|0|||
105864074|NCT01056289|365152751|FG003|Open-label Phase|Protocol Violation|0|||
105864075|NCT01056289|365152748|FG000|Open-label Phase|Withdrawal by Subject|26|||
105864076|NCT01056289|365152749|FG001|Open-label Phase|Withdrawal by Subject|0|||
106052520|NCT01281865|365856185|FG001|Overall Study|Lack of Efficacy|0|||
106052521|NCT01007812|365856187|FG000|Period 1, One Week|Lost to Follow-up|0|||
106052522|NCT01007812|365856188|FG001|Period 1, One Week|Lost to Follow-up|1|||
106052523|NCT01007812|365856187|FG000|Period 1, One Week|Discomfort|1|||
106052524|NCT01007812|365856188|FG001|Period 1, One Week|Discomfort|0|||
106052525|NCT02499783|365856189|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
106052526|NCT02499783|365856190|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
106052527|NCT02499783|365856191|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
106052528|NCT02499783|365856189|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
106052529|NCT02499783|365856190|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
106052530|NCT02499783|365856191|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
106052531|NCT02499783|365856189|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
106052532|NCT02499783|365856190|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
106052533|NCT02499783|365856191|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
106052534|NCT02499783|365856189|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
106052535|NCT02499783|365856190|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
106052536|NCT02499783|365856191|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
106052537|NCT02499783|365856189|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
106052538|NCT02499783|365856190|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
106052539|NCT02499783|365856191|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
106052540|NCT02499783|365856189|FG000|DB Period: Weeks 0-8|Other|1|||
106052541|NCT02499783|365856190|FG001|DB Period: Weeks 0-8|Other|1|||
106052542|NCT02499783|365856191|FG002|DB Period: Weeks 0-8|Other|0|||
106052543|NCT02499783|365856189|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
106052544|NCT02499783|365856190|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
106052545|NCT02499783|365856191|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
106052546|NCT02499783|365856189|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
106052547|NCT02499783|365856190|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
106052548|NCT02499783|365856191|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
106052549|NCT02499783|365856189|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
106052550|NCT02499783|365856190|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
106052551|NCT02499783|365856191|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
106052552|NCT02499783|365856189|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
106052553|NCT02499783|365856190|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
106052554|NCT02499783|365856191|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
106052555|NCT01866293|365856192|FG000|Overall Study|Adverse Event|2|||
106052556|NCT00555971|365856193|FG000|Overall Study|Adverse Event|1|||
106052557|NCT00555971|365856194|FG001|Overall Study|Adverse Event|1|||
106052558|NCT00621582|365856198|FG000|Overall Study|Adverse Event|7|||
106052559|NCT00621582|365856198|FG000|Overall Study|Protocol Violation|57|||
106052560|NCT00621582|365856198|FG000|Overall Study|Lost to Follow-up|24|||
106052561|NCT00621582|365856198|FG000|Overall Study|issues not identified by investigators|18|||
106052562|NCT00957580|365856202|FG000|Overall Study|Ongoing at data cut-off|0|||
106052563|NCT00957580|365856203|FG001|Overall Study|Ongoing at data cut-off|1|||
106052564|NCT00957580|365856204|FG002|Overall Study|Ongoing at data cut-off|0|||
106052565|NCT00957580|365856202|FG000|Overall Study|Enrolled but not treated|0|||
106052566|NCT00957580|365856203|FG001|Overall Study|Enrolled but not treated|1|||
106052567|NCT00957580|365856204|FG002|Overall Study|Enrolled but not treated|0|||
106052568|NCT00191139|365856205|FG000|Overall Study|Adverse Event|2|||
106052569|NCT00191139|365856206|FG001|Overall Study|Adverse Event|6|||
106052570|NCT00191139|365856205|FG000|Overall Study|Death|2|||
106052571|NCT00191139|365856206|FG001|Overall Study|Death|0|||
106052572|NCT00191139|365856205|FG000|Overall Study|Withdrawal by Subject|0|||
106052573|NCT00191139|365856206|FG001|Overall Study|Withdrawal by Subject|3|||
106052574|NCT00191139|365856205|FG000|Overall Study|Disease Progression|0|||
106052575|NCT00191139|365856206|FG001|Overall Study|Disease Progression|1|||
106052576|NCT00191139|365856205|FG000|Overall Study|Other|1|||
106052577|NCT00191139|365856206|FG001|Overall Study|Other|2|||
106052578|NCT05248867|365856207|FG000|Double-blind Period|Lost to Follow-up|0|||
106052579|NCT05248867|365856208|FG001|Double-blind Period|Lost to Follow-up|3|||
106052580|NCT05248867|365856209|FG002|Double-blind Period|Lost to Follow-up|0|||
106052581|NCT05248867|365856210|FG003|Double-blind Period|Lost to Follow-up|0|||
105864077|NCT01056289|365152750|FG002|Open-label Phase|Withdrawal by Subject|0|||
105864078|NCT01056289|365152751|FG003|Open-label Phase|Withdrawal by Subject|0|||
105864079|NCT01056289|365152748|FG000|Open-label Phase|Lack of Efficacy|18|||
106052582|NCT05248867|365856211|FG004|Double-blind Period|Lost to Follow-up|0|||
106052583|NCT05248867|365856212|FG005|Double-blind Period|Lost to Follow-up|0|||
106052584|NCT05248867|365856207|FG000|Double-blind Period|Withdrawal by Subject|5|||
106052585|NCT05248867|365856208|FG001|Double-blind Period|Withdrawal by Subject|14|||
106052586|NCT05248867|365856209|FG002|Double-blind Period|Withdrawal by Subject|0|||
106052587|NCT05248867|365856210|FG003|Double-blind Period|Withdrawal by Subject|0|||
106052588|NCT05248867|365856211|FG004|Double-blind Period|Withdrawal by Subject|0|||
106052589|NCT05248867|365856212|FG005|Double-blind Period|Withdrawal by Subject|0|||
106052590|NCT05248867|365856207|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
106052591|NCT05248867|365856208|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
106052592|NCT05248867|365856209|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
106052593|NCT05248867|365856210|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
106052594|NCT05248867|365856211|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
106052595|NCT05248867|365856212|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
106052596|NCT05248867|365856207|FG000|Double-blind Period|Other, not specified|3|||
106052597|NCT05248867|365856208|FG001|Double-blind Period|Other, not specified|8|||
106052598|NCT05248867|365856209|FG002|Double-blind Period|Other, not specified|0|||
106052599|NCT05248867|365856210|FG003|Double-blind Period|Other, not specified|0|||
106052600|NCT05248867|365856211|FG004|Double-blind Period|Other, not specified|0|||
106052601|NCT05248867|365856212|FG005|Double-blind Period|Other, not specified|0|||
106052602|NCT05248867|365856207|FG000|Open-label Period|Withdrawal by Subject|0|||
106052603|NCT05248867|365856208|FG001|Open-label Period|Withdrawal by Subject|0|||
106052604|NCT05248867|365856209|FG002|Open-label Period|Withdrawal by Subject|3|||
106052605|NCT05248867|365856210|FG003|Open-label Period|Withdrawal by Subject|1|||
106052606|NCT05248867|365856211|FG004|Open-label Period|Withdrawal by Subject|7|||
106052607|NCT05248867|365856212|FG005|Open-label Period|Withdrawal by Subject|9|||
106052608|NCT05248867|365856207|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
106052609|NCT05248867|365856208|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
106052610|NCT05248867|365856209|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
106052611|NCT05248867|365856210|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
106052612|NCT05248867|365856211|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
106052613|NCT05248867|365856212|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
106052614|NCT05248867|365856207|FG000|Open-label Period|Lost to Follow-up|0|||
106052615|NCT05248867|365856208|FG001|Open-label Period|Lost to Follow-up|0|||
106052616|NCT05248867|365856209|FG002|Open-label Period|Lost to Follow-up|0|||
106052617|NCT05248867|365856210|FG003|Open-label Period|Lost to Follow-up|0|||
106052618|NCT05248867|365856211|FG004|Open-label Period|Lost to Follow-up|5|||
106052619|NCT05248867|365856212|FG005|Open-label Period|Lost to Follow-up|2|||
106052620|NCT05248867|365856207|FG000|Open-label Period|COVID-19 Infection|0|||
106052621|NCT05248867|365856208|FG001|Open-label Period|COVID-19 Infection|0|||
106052622|NCT05248867|365856209|FG002|Open-label Period|COVID-19 Infection|0|||
106052623|NCT05248867|365856210|FG003|Open-label Period|COVID-19 Infection|0|||
106052624|NCT05248867|365856211|FG004|Open-label Period|COVID-19 Infection|1|||
106052625|NCT05248867|365856212|FG005|Open-label Period|COVID-19 Infection|0|||
106052626|NCT05248867|365856207|FG000|Open-label Period|Other, not specified|0|||
106052627|NCT05248867|365856208|FG001|Open-label Period|Other, not specified|0|||
106052628|NCT05248867|365856209|FG002|Open-label Period|Other, not specified|0|||
106052629|NCT05248867|365856210|FG003|Open-label Period|Other, not specified|0|||
106052630|NCT05248867|365856211|FG004|Open-label Period|Other, not specified|4|||
106052631|NCT05248867|365856212|FG005|Open-label Period|Other, not specified|0|||
106052632|NCT04362072|365856218|FG000|Treatment|Adverse Event|1|||
106052633|NCT04362072|365856218|FG000|Treatment|Death|9|||
106052634|NCT04362072|365856218|FG000|Treatment|Physician Decision|2|||
106052635|NCT04362072|365856218|FG000|Treatment|Progressive disease|27|||
106052636|NCT04362072|365856218|FG000|Treatment|Withdrawal by Subject|4|||
106052637|NCT04362072|365856218|FG000|Treatment|Global deterioration of health status|1|||
106052638|NCT04362072|365856218|FG000|Treatment|Switched to commercial Lorlatinib|13|||
106052639|NCT04362072|365856218|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
106052640|NCT04362072|365856218|FG000|Treatment|Other|3|||
106052641|NCT04362072|365856218|FG000|Follow up|Death|2|||
106052642|NCT04362072|365856218|FG000|Follow up|Other|2|||
106052643|NCT01133522|365856219|FG000|Overall Study|Withdrawal by Subject|0|||
106052644|NCT01133522|365856220|FG001|Overall Study|Withdrawal by Subject|1|||
106052645|NCT01133522|365856221|FG002|Overall Study|Withdrawal by Subject|0|||
106052646|NCT01133522|365856222|FG003|Overall Study|Withdrawal by Subject|1|||
106052647|NCT01133522|365856223|FG004|Overall Study|Withdrawal by Subject|0|||
106052648|NCT01133522|365856224|FG005|Overall Study|Withdrawal by Subject|0|||
106052649|NCT01133522|365856225|FG006|Overall Study|Withdrawal by Subject|0|||
106052650|NCT01133522|365856226|FG007|Overall Study|Withdrawal by Subject|0|||
106052651|NCT01133522|365856227|FG008|Overall Study|Withdrawal by Subject|0|||
106052652|NCT01133522|365856228|FG009|Overall Study|Withdrawal by Subject|0|||
106052653|NCT01133522|365856219|FG000|Overall Study|Physician Decision|0|||
106052654|NCT01133522|365856220|FG001|Overall Study|Physician Decision|0|||
106052655|NCT01133522|365856221|FG002|Overall Study|Physician Decision|0|||
106052656|NCT01133522|365856222|FG003|Overall Study|Physician Decision|0|||
106052657|NCT01133522|365856223|FG004|Overall Study|Physician Decision|1|||
106052658|NCT01133522|365856224|FG005|Overall Study|Physician Decision|0|||
106052659|NCT01133522|365856225|FG006|Overall Study|Physician Decision|0|||
106052660|NCT01133522|365856226|FG007|Overall Study|Physician Decision|0|||
106052661|NCT01133522|365856227|FG008|Overall Study|Physician Decision|0|||
106052662|NCT01133522|365856228|FG009|Overall Study|Physician Decision|0|||
106052663|NCT00688753|365858049|FG000|Overall Study|Disease progression|55|||
106052664|NCT00688753|365858049|FG000|Overall Study|Missing|1|||
106052665|NCT00688753|365858049|FG000|Overall Study|Death|9|||
106052666|NCT00688753|365858049|FG000|Overall Study|Withdrawal by Subject|3|||
106052667|NCT00688753|365858049|FG000|Overall Study|Adverse Event|20|||
106052668|NCT00688753|365858049|FG000|Overall Study|Protocol Violation|1|||
106052669|NCT00688753|365858049|FG000|Overall Study|Lost to Follow-up|3|||
106052670|NCT05996718|365858050|FG000|Overall Study|Lost to Follow-up|3|||
106052671|NCT06956170|365858051|FG000|Overall Study|Death|2|||
106052672|NCT06956170|365858052|FG001|Overall Study|Death|1|||
106052673|NCT06956170|365858051|FG000|Overall Study|Withdrawal by Subject|1|||
106052674|NCT06956170|365858052|FG001|Overall Study|Withdrawal by Subject|0|||
106052675|NCT06956170|365858051|FG000|Overall Study|Ongoing|7|||
106052676|NCT06956170|365858052|FG001|Overall Study|Ongoing|10|||
106052677|NCT01385566|365858055|FG000|Overall Study|Lost to Follow-up|1|||
106052678|NCT01385566|365858056|FG001|Overall Study|Lost to Follow-up|0|||
106052679|NCT01385566|365858057|FG002|Overall Study|Lost to Follow-up|0|||
106052680|NCT01385566|365858058|FG003|Overall Study|Lost to Follow-up|0|||
106052681|NCT01385566|365858059|FG004|Overall Study|Lost to Follow-up|0|||
106052682|NCT01385566|365858060|FG005|Overall Study|Lost to Follow-up|0|||
106052683|NCT01385566|365858055|FG000|Overall Study|Withdrawal by Subject|0|||
106052684|NCT01385566|365858056|FG001|Overall Study|Withdrawal by Subject|0|||
106052685|NCT01385566|365858057|FG002|Overall Study|Withdrawal by Subject|0|||
106052686|NCT01385566|365858058|FG003|Overall Study|Withdrawal by Subject|1|||
106052687|NCT01385566|365858059|FG004|Overall Study|Withdrawal by Subject|0|||
106052688|NCT01385566|365858060|FG005|Overall Study|Withdrawal by Subject|0|||
106052689|NCT00403234|365858061|FG000|Overall Study|Withdrawal by Subject|0|||
106052690|NCT00403234|365858062|FG001|Overall Study|Withdrawal by Subject|1|||
106052691|NCT00403234|365858063|FG002|Overall Study|Withdrawal by Subject|0|||
106052692|NCT00403234|365858064|FG003|Overall Study|Withdrawal by Subject|0|||
106052693|NCT00403234|365858061|FG000|Overall Study|Adverse Event|1|||
106052694|NCT00403234|365858062|FG001|Overall Study|Adverse Event|0|||
106052695|NCT00403234|365858063|FG002|Overall Study|Adverse Event|1|||
106052696|NCT00403234|365858064|FG003|Overall Study|Adverse Event|0|||
106052697|NCT03281577|365858065|FG000|Overall Study|Adverse Event|0|||
106052698|NCT03281577|365858066|FG001|Overall Study|Adverse Event|0|||
106052699|NCT03281577|365858067|FG002|Overall Study|Adverse Event|0|||
106052700|NCT03281577|365858068|FG003|Overall Study|Adverse Event|1|||
106052701|NCT03281577|365858065|FG000|Overall Study|Withdrawal by Subject|1|||
106052702|NCT03281577|365858066|FG001|Overall Study|Withdrawal by Subject|0|||
106052703|NCT03281577|365858067|FG002|Overall Study|Withdrawal by Subject|0|||
106052704|NCT03281577|365858068|FG003|Overall Study|Withdrawal by Subject|0|||
106052705|NCT01606800|365858074|FG000|Overall Study|Adverse Event|3|||
106052706|NCT01606800|365858075|FG001|Overall Study|Adverse Event|1|||
106052707|NCT01606800|365858074|FG000|Overall Study|Participant withdrew consent|0|||
106052708|NCT01606800|365858075|FG001|Overall Study|Participant withdrew consent|1|||
106052709|NCT01606800|365858074|FG000|Overall Study|Missing completion status|2|||
106052710|NCT01606800|365858075|FG001|Overall Study|Missing completion status|0|||
106052711|NCT00042289|365858076|FG000|Overall Study|Lost to Follow-up|3|||
106052712|NCT00042289|365858077|FG001|Overall Study|Lost to Follow-up|0|||
106052713|NCT00042289|365858078|FG002|Overall Study|Lost to Follow-up|0|||
106052714|NCT00042289|365858079|FG003|Overall Study|Lost to Follow-up|1|||
106052715|NCT00042289|365858080|FG004|Overall Study|Lost to Follow-up|3|||
106052716|NCT00042289|365858081|FG005|Overall Study|Lost to Follow-up|3|||
106052717|NCT00042289|365858082|FG006|Overall Study|Lost to Follow-up|6|||
106052718|NCT00042289|365858083|FG007|Overall Study|Lost to Follow-up|1|||
106052719|NCT00042289|365858084|FG008|Overall Study|Lost to Follow-up|1|||
106052720|NCT00042289|365858085|FG009|Overall Study|Lost to Follow-up|0|||
106052721|NCT00042289|365858086|FG010|Overall Study|Lost to Follow-up|0|||
106052722|NCT00042289|365858087|FG011|Overall Study|Lost to Follow-up|0|||
106052723|NCT00042289|365858088|FG012|Overall Study|Lost to Follow-up|0|||
106052724|NCT00042289|365858089|FG013|Overall Study|Lost to Follow-up|0|||
106052725|NCT00042289|365858090|FG014|Overall Study|Lost to Follow-up|0|||
106052726|NCT00042289|365858091|FG015|Overall Study|Lost to Follow-up|1|||
106052727|NCT00042289|365858092|FG016|Overall Study|Lost to Follow-up|1|||
106052728|NCT00042289|365858093|FG017|Overall Study|Lost to Follow-up|0|||
106052729|NCT00042289|365858094|FG018|Overall Study|Lost to Follow-up|3|||
106052730|NCT00042289|365858095|FG019|Overall Study|Lost to Follow-up|2|||
106052731|NCT00042289|365858096|FG020|Overall Study|Lost to Follow-up|0|||
106052732|NCT00042289|365858097|FG021|Overall Study|Lost to Follow-up|0|||
106052733|NCT00042289|365858098|FG022|Overall Study|Lost to Follow-up|0|||
106052734|NCT00042289|365858099|FG023|Overall Study|Lost to Follow-up|0|||
106052735|NCT00042289|365858100|FG024|Overall Study|Lost to Follow-up|0|||
106052736|NCT00042289|365858101|FG025|Overall Study|Lost to Follow-up|0|||
106052737|NCT00042289|365858102|FG026|Overall Study|Lost to Follow-up|2|||
106052738|NCT00042289|365858103|FG027|Overall Study|Lost to Follow-up|2|||
106052739|NCT00042289|365858104|FG028|Overall Study|Lost to Follow-up|2|||
106052740|NCT00042289|365858105|FG029|Overall Study|Lost to Follow-up|0|||
106052741|NCT00042289|365858106|FG030|Overall Study|Lost to Follow-up|0|||
106052742|NCT00042289|365858107|FG031|Overall Study|Lost to Follow-up|2|||
106052743|NCT00042289|365858108|FG032|Overall Study|Lost to Follow-up|1|||
106052744|NCT00042289|365858109|FG033|Overall Study|Lost to Follow-up|1|||
106052745|NCT00042289|365858110|FG034|Overall Study|Lost to Follow-up|1|||
106052746|NCT00042289|365858111|FG035|Overall Study|Lost to Follow-up|2|||
106052747|NCT00042289|365858112|FG036|Overall Study|Lost to Follow-up|1|||
106052748|NCT00042289|365858113|FG037|Overall Study|Lost to Follow-up|1|||
106052749|NCT00042289|365858114|FG038|Overall Study|Lost to Follow-up|0|||
106052750|NCT00042289|365858115|FG039|Overall Study|Lost to Follow-up|5|||
106052751|NCT00042289|365858116|FG040|Overall Study|Lost to Follow-up|0|||
106052752|NCT00042289|365858117|FG041|Overall Study|Lost to Follow-up|2|||
106052753|NCT00042289|365858118|FG042|Overall Study|Lost to Follow-up|2|||
106052754|NCT00042289|365858119|FG043|Overall Study|Lost to Follow-up|0|||
106052755|NCT00042289|365858120|FG044|Overall Study|Lost to Follow-up|0|||
106052756|NCT00042289|365858121|FG045|Overall Study|Lost to Follow-up|1|||
106052757|NCT00042289|365858122|FG046|Overall Study|Lost to Follow-up|0|||
106052758|NCT00042289|365858076|FG000|Overall Study|Other reason|0|||
106052759|NCT00042289|365858077|FG001|Overall Study|Other reason|0|||
106052760|NCT00042289|365858078|FG002|Overall Study|Other reason|0|||
106052761|NCT00042289|365858079|FG003|Overall Study|Other reason|2|||
106052762|NCT00042289|365858080|FG004|Overall Study|Other reason|0|||
106052763|NCT00042289|365858081|FG005|Overall Study|Other reason|0|||
106052764|NCT00042289|365858082|FG006|Overall Study|Other reason|0|||
106052765|NCT00042289|365858083|FG007|Overall Study|Other reason|0|||
106052766|NCT00042289|365858084|FG008|Overall Study|Other reason|0|||
106052767|NCT00042289|365858085|FG009|Overall Study|Other reason|0|||
106052768|NCT00042289|365858086|FG010|Overall Study|Other reason|0|||
106052769|NCT00042289|365858087|FG011|Overall Study|Other reason|0|||
106052770|NCT00042289|365858088|FG012|Overall Study|Other reason|0|||
106052771|NCT00042289|365858089|FG013|Overall Study|Other reason|0|||
106052772|NCT00042289|365858090|FG014|Overall Study|Other reason|0|||
106052773|NCT00042289|365858091|FG015|Overall Study|Other reason|0|||
106052774|NCT00042289|365858092|FG016|Overall Study|Other reason|0|||
106052775|NCT00042289|365858093|FG017|Overall Study|Other reason|0|||
106052776|NCT00042289|365858094|FG018|Overall Study|Other reason|1|||
106052777|NCT00042289|365858095|FG019|Overall Study|Other reason|0|||
106052778|NCT00042289|365858096|FG020|Overall Study|Other reason|0|||
106052779|NCT00042289|365858097|FG021|Overall Study|Other reason|0|||
106052780|NCT00042289|365858098|FG022|Overall Study|Other reason|0|||
106052781|NCT00042289|365858099|FG023|Overall Study|Other reason|1|||
106052782|NCT00042289|365858100|FG024|Overall Study|Other reason|0|||
106052783|NCT00042289|365858101|FG025|Overall Study|Other reason|0|||
106052784|NCT00042289|365858102|FG026|Overall Study|Other reason|1|||
106052785|NCT00042289|365858103|FG027|Overall Study|Other reason|0|||
106052786|NCT00042289|365858104|FG028|Overall Study|Other reason|3|||
106052787|NCT00042289|365858105|FG029|Overall Study|Other reason|0|||
106052788|NCT00042289|365858106|FG030|Overall Study|Other reason|0|||
106052789|NCT00042289|365858107|FG031|Overall Study|Other reason|1|||
105864080|NCT01056289|365152749|FG001|Open-label Phase|Lack of Efficacy|0|||
105864081|NCT01056289|365152750|FG002|Open-label Phase|Lack of Efficacy|0|||
105864082|NCT01056289|365152751|FG003|Open-label Phase|Lack of Efficacy|0|||
105864083|NCT01056289|365152748|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
105864084|NCT01056289|365152749|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
105864085|NCT01056289|365152750|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
105864086|NCT01056289|365152751|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
105864087|NCT01056289|365152748|FG000|Double-blind Phase|Adverse Event|0|||
105864088|NCT01056289|365152749|FG001|Double-blind Phase|Adverse Event|1|||
105864089|NCT01056289|365152750|FG002|Double-blind Phase|Adverse Event|2|||
105864090|NCT01056289|365152751|FG003|Double-blind Phase|Adverse Event|1|||
105864091|NCT01056289|365152748|FG000|Double-blind Phase|Lost to Follow-up|0|||
105864092|NCT01056289|365152749|FG001|Double-blind Phase|Lost to Follow-up|2|||
105864093|NCT01056289|365152750|FG002|Double-blind Phase|Lost to Follow-up|2|||
105864094|NCT01056289|365152751|FG003|Double-blind Phase|Lost to Follow-up|2|||
105864095|NCT01056289|365152748|FG000|Double-blind Phase|Other|0|||
105864096|NCT01056289|365152749|FG001|Double-blind Phase|Other|0|||
105864097|NCT01056289|365152750|FG002|Double-blind Phase|Other|1|||
105864098|NCT01056289|365152751|FG003|Double-blind Phase|Other|2|||
105864099|NCT01056289|365152748|FG000|Double-blind Phase|Protocol Violation|0|||
105864100|NCT01056289|365152749|FG001|Double-blind Phase|Protocol Violation|0|||
106052790|NCT00042289|365858108|FG032|Overall Study|Other reason|0|||
106052791|NCT00042289|365858109|FG033|Overall Study|Other reason|1|||
106052792|NCT00042289|365858110|FG034|Overall Study|Other reason|0|||
106052793|NCT00042289|365858111|FG035|Overall Study|Other reason|2|||
106052794|NCT00042289|365858112|FG036|Overall Study|Other reason|0|||
106052795|NCT00042289|365858113|FG037|Overall Study|Other reason|0|||
106052796|NCT00042289|365858114|FG038|Overall Study|Other reason|0|||
106052797|NCT00042289|365858115|FG039|Overall Study|Other reason|0|||
106052798|NCT00042289|365858116|FG040|Overall Study|Other reason|0|||
106052799|NCT00042289|365858117|FG041|Overall Study|Other reason|0|||
106052800|NCT00042289|365858118|FG042|Overall Study|Other reason|0|||
106052801|NCT00042289|365858119|FG043|Overall Study|Other reason|1|||
106052802|NCT00042289|365858120|FG044|Overall Study|Other reason|0|||
106052803|NCT00042289|365858121|FG045|Overall Study|Other reason|0|||
106052804|NCT00042289|365858122|FG046|Overall Study|Other reason|0|||
106052805|NCT00042289|365858076|FG000|Overall Study|Severe debilitation, unable to continue|0|||
106052806|NCT00042289|365858077|FG001|Overall Study|Severe debilitation, unable to continue|0|||
106052807|NCT00042289|365858078|FG002|Overall Study|Severe debilitation, unable to continue|0|||
106052808|NCT00042289|365858079|FG003|Overall Study|Severe debilitation, unable to continue|0|||
106052809|NCT00042289|365858080|FG004|Overall Study|Severe debilitation, unable to continue|0|||
106052810|NCT00042289|365858081|FG005|Overall Study|Severe debilitation, unable to continue|0|||
106052811|NCT00042289|365858082|FG006|Overall Study|Severe debilitation, unable to continue|0|||
106052812|NCT00042289|365858083|FG007|Overall Study|Severe debilitation, unable to continue|0|||
106052813|NCT00042289|365858084|FG008|Overall Study|Severe debilitation, unable to continue|0|||
106052814|NCT00042289|365858085|FG009|Overall Study|Severe debilitation, unable to continue|0|||
106052815|NCT00042289|365858086|FG010|Overall Study|Severe debilitation, unable to continue|0|||
106052816|NCT00042289|365858087|FG011|Overall Study|Severe debilitation, unable to continue|0|||
106052817|NCT00042289|365858088|FG012|Overall Study|Severe debilitation, unable to continue|0|||
106052818|NCT00042289|365858089|FG013|Overall Study|Severe debilitation, unable to continue|0|||
106052819|NCT00042289|365858090|FG014|Overall Study|Severe debilitation, unable to continue|0|||
106052820|NCT00042289|365858091|FG015|Overall Study|Severe debilitation, unable to continue|0|||
106052821|NCT00042289|365858092|FG016|Overall Study|Severe debilitation, unable to continue|0|||
106052822|NCT00042289|365858093|FG017|Overall Study|Severe debilitation, unable to continue|0|||
106052823|NCT00042289|365858094|FG018|Overall Study|Severe debilitation, unable to continue|0|||
106052824|NCT00042289|365858095|FG019|Overall Study|Severe debilitation, unable to continue|0|||
106052825|NCT00042289|365858096|FG020|Overall Study|Severe debilitation, unable to continue|0|||
106052826|NCT00042289|365858097|FG021|Overall Study|Severe debilitation, unable to continue|1|||
106052827|NCT00042289|365858098|FG022|Overall Study|Severe debilitation, unable to continue|0|||
106052828|NCT00042289|365858099|FG023|Overall Study|Severe debilitation, unable to continue|1|||
106052829|NCT00042289|365858100|FG024|Overall Study|Severe debilitation, unable to continue|0|||
106052830|NCT00042289|365858101|FG025|Overall Study|Severe debilitation, unable to continue|0|||
106052831|NCT00042289|365858102|FG026|Overall Study|Severe debilitation, unable to continue|0|||
106052832|NCT00042289|365858103|FG027|Overall Study|Severe debilitation, unable to continue|1|||
106052833|NCT00042289|365858104|FG028|Overall Study|Severe debilitation, unable to continue|0|||
106052834|NCT00042289|365858105|FG029|Overall Study|Severe debilitation, unable to continue|0|||
106052835|NCT00042289|365858106|FG030|Overall Study|Severe debilitation, unable to continue|0|||
106052836|NCT00042289|365858107|FG031|Overall Study|Severe debilitation, unable to continue|1|||
106052837|NCT00042289|365858108|FG032|Overall Study|Severe debilitation, unable to continue|1|||
106052838|NCT00042289|365858109|FG033|Overall Study|Severe debilitation, unable to continue|0|||
106052839|NCT00042289|365858110|FG034|Overall Study|Severe debilitation, unable to continue|0|||
106052840|NCT00042289|365858111|FG035|Overall Study|Severe debilitation, unable to continue|0|||
106052841|NCT00042289|365858112|FG036|Overall Study|Severe debilitation, unable to continue|0|||
106052842|NCT00042289|365858113|FG037|Overall Study|Severe debilitation, unable to continue|0|||
106052843|NCT00042289|365858114|FG038|Overall Study|Severe debilitation, unable to continue|0|||
106052844|NCT00042289|365858115|FG039|Overall Study|Severe debilitation, unable to continue|0|||
106052845|NCT00042289|365858116|FG040|Overall Study|Severe debilitation, unable to continue|0|||
106052846|NCT00042289|365858117|FG041|Overall Study|Severe debilitation, unable to continue|0|||
106052847|NCT00042289|365858118|FG042|Overall Study|Severe debilitation, unable to continue|0|||
106052848|NCT00042289|365858119|FG043|Overall Study|Severe debilitation, unable to continue|0|||
106052849|NCT00042289|365858120|FG044|Overall Study|Severe debilitation, unable to continue|0|||
106052850|NCT00042289|365858121|FG045|Overall Study|Severe debilitation, unable to continue|0|||
106052851|NCT00042289|365858122|FG046|Overall Study|Severe debilitation, unable to continue|0|||
106052852|NCT00042289|365858076|FG000|Overall Study|Site closed|0|||
106052853|NCT00042289|365858077|FG001|Overall Study|Site closed|0|||
106052854|NCT00042289|365858078|FG002|Overall Study|Site closed|0|||
106052855|NCT00042289|365858079|FG003|Overall Study|Site closed|0|||
106052856|NCT00042289|365858080|FG004|Overall Study|Site closed|0|||
106052857|NCT00042289|365858081|FG005|Overall Study|Site closed|0|||
106052858|NCT00042289|365858082|FG006|Overall Study|Site closed|0|||
106052859|NCT00042289|365858083|FG007|Overall Study|Site closed|0|||
106052860|NCT00042289|365858084|FG008|Overall Study|Site closed|0|||
106052861|NCT00042289|365858085|FG009|Overall Study|Site closed|0|||
106052862|NCT00042289|365858086|FG010|Overall Study|Site closed|0|||
106052863|NCT00042289|365858087|FG011|Overall Study|Site closed|0|||
106052864|NCT00042289|365858088|FG012|Overall Study|Site closed|0|||
106052865|NCT00042289|365858089|FG013|Overall Study|Site closed|0|||
106052866|NCT00042289|365858090|FG014|Overall Study|Site closed|0|||
106052867|NCT00042289|365858091|FG015|Overall Study|Site closed|0|||
106052868|NCT00042289|365858092|FG016|Overall Study|Site closed|0|||
106052869|NCT00042289|365858093|FG017|Overall Study|Site closed|0|||
106052870|NCT00042289|365858094|FG018|Overall Study|Site closed|0|||
106052871|NCT00042289|365858095|FG019|Overall Study|Site closed|0|||
106052872|NCT00042289|365858096|FG020|Overall Study|Site closed|0|||
106052873|NCT00042289|365858097|FG021|Overall Study|Site closed|0|||
106152430|NCT03088813|366218794|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
106152431|NCT03088813|366218795|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
106152432|NCT03088813|366218796|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
105864101|NCT01056289|365152750|FG002|Double-blind Phase|Protocol Violation|1|||
105864102|NCT01056289|365152751|FG003|Double-blind Phase|Protocol Violation|1|||
105864103|NCT01056289|365152748|FG000|Double-blind Phase|Withdrawal by Subject|0|||
105864104|NCT01056289|365152749|FG001|Double-blind Phase|Withdrawal by Subject|0|||
105864105|NCT01056289|365152750|FG002|Double-blind Phase|Withdrawal by Subject|4|||
105864106|NCT01056289|365152751|FG003|Double-blind Phase|Withdrawal by Subject|2|||
105864107|NCT01056289|365152748|FG000|Double-blind Phase|Discontinuation symptom|0|||
105864108|NCT01056289|365152749|FG001|Double-blind Phase|Discontinuation symptom|1|||
105864109|NCT01056289|365152750|FG002|Double-blind Phase|Discontinuation symptom|2|||
105864110|NCT01056289|365152751|FG003|Double-blind Phase|Discontinuation symptom|2|||
105864111|NCT01056289|365152748|FG000|Double-blind Phase|Physician Decision|0|||
105864112|NCT01056289|365152749|FG001|Double-blind Phase|Physician Decision|0|||
105864113|NCT01056289|365152750|FG002|Double-blind Phase|Physician Decision|1|||
105864114|NCT01056289|365152751|FG003|Double-blind Phase|Physician Decision|0|||
105864115|NCT01392963|365152763|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
105864116|NCT01392963|365152764|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
105864117|NCT01392963|365152763|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
105864118|NCT01392963|365152764|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
105864119|NCT01392963|365152763|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
105864120|NCT01392963|365152764|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
105864121|NCT00450801|365152765|FG000|Overall Study|Death|1|||
105864122|NCT03772717|365152766|FG000|Overall Study|Withdrawal by Subject|2|||
105864123|NCT01810302|365152767|FG000|Overall Study|Death|1|||
105864124|NCT01810302|365152768|FG001|Overall Study|Death|0|||
105864125|NCT01810302|365152767|FG000|Overall Study|Physician Decision|0|||
105864126|NCT01810302|365152768|FG001|Overall Study|Physician Decision|1|||
105864127|NCT01371747|365152769|FG000|Overall Study|Adverse Event|4|||
105864128|NCT01371747|365152770|FG001|Overall Study|Adverse Event|2|||
105864129|NCT01371747|365152771|FG002|Overall Study|Adverse Event|7|||
105864130|NCT01371747|365152772|FG003|Overall Study|Adverse Event|2|||
105864131|NCT01371747|365152773|FG004|Overall Study|Adverse Event|2|||
105864132|NCT01371747|365152774|FG005|Overall Study|Adverse Event|2|||
105864133|NCT01371747|365152769|FG000|Overall Study|Death|1|||
105864134|NCT01371747|365152770|FG001|Overall Study|Death|0|||
105864135|NCT01371747|365152771|FG002|Overall Study|Death|4|||
105864136|NCT01371747|365152772|FG003|Overall Study|Death|1|||
105864137|NCT01371747|365152773|FG004|Overall Study|Death|2|||
105864138|NCT01371747|365152774|FG005|Overall Study|Death|0|||
105864139|NCT01371747|365152769|FG000|Overall Study|Abnormal Renal Function|0|||
105864140|NCT01371747|365152770|FG001|Overall Study|Abnormal Renal Function|2|||
105864141|NCT01371747|365152771|FG002|Overall Study|Abnormal Renal Function|0|||
105864142|NCT01371747|365152772|FG003|Overall Study|Abnormal Renal Function|1|||
105864143|NCT01371747|365152773|FG004|Overall Study|Abnormal Renal Function|0|||
105864144|NCT01371747|365152774|FG005|Overall Study|Abnormal Renal Function|1|||
105864145|NCT01371747|365152769|FG000|Overall Study|High Serum Potassium Results|1|||
105864146|NCT01371747|365152770|FG001|Overall Study|High Serum Potassium Results|1|||
106052874|NCT00042289|365858098|FG022|Overall Study|Site closed|0|||
106052875|NCT00042289|365858099|FG023|Overall Study|Site closed|0|||
106052876|NCT00042289|365858100|FG024|Overall Study|Site closed|0|||
106052877|NCT00042289|365858101|FG025|Overall Study|Site closed|0|||
106052878|NCT00042289|365858102|FG026|Overall Study|Site closed|0|||
106052879|NCT00042289|365858103|FG027|Overall Study|Site closed|0|||
106052880|NCT00042289|365858104|FG028|Overall Study|Site closed|0|||
106052881|NCT00042289|365858105|FG029|Overall Study|Site closed|0|||
106052882|NCT00042289|365858106|FG030|Overall Study|Site closed|0|||
106052883|NCT00042289|365858107|FG031|Overall Study|Site closed|3|||
106052884|NCT00042289|365858108|FG032|Overall Study|Site closed|0|||
106052885|NCT00042289|365858109|FG033|Overall Study|Site closed|0|||
106052886|NCT00042289|365858110|FG034|Overall Study|Site closed|0|||
106052887|NCT00042289|365858111|FG035|Overall Study|Site closed|0|||
106052888|NCT00042289|365858112|FG036|Overall Study|Site closed|1|||
106052889|NCT00042289|365858113|FG037|Overall Study|Site closed|0|||
106052890|NCT00042289|365858114|FG038|Overall Study|Site closed|0|||
106052891|NCT00042289|365858115|FG039|Overall Study|Site closed|0|||
106052892|NCT00042289|365858116|FG040|Overall Study|Site closed|0|||
106052893|NCT00042289|365858117|FG041|Overall Study|Site closed|0|||
106052894|NCT00042289|365858118|FG042|Overall Study|Site closed|1|||
105864147|NCT01371747|365152771|FG002|Overall Study|High Serum Potassium Results|1|||
106052895|NCT00042289|365858119|FG043|Overall Study|Site closed|0|||
106052896|NCT00042289|365858120|FG044|Overall Study|Site closed|0|||
105864148|NCT01371747|365152772|FG003|Overall Study|High Serum Potassium Results|2|||
105864149|NCT01371747|365152773|FG004|Overall Study|High Serum Potassium Results|0|||
105864150|NCT01371747|365152774|FG005|Overall Study|High Serum Potassium Results|2|||
105864151|NCT01371747|365152769|FG000|Overall Study|Low Serum Potassium Results|1|||
105864152|NCT01371747|365152770|FG001|Overall Study|Low Serum Potassium Results|1|||
106052897|NCT00042289|365858121|FG045|Overall Study|Site closed|0|||
106052898|NCT00042289|365858122|FG046|Overall Study|Site closed|0|||
106052899|NCT00042289|365858076|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
106052900|NCT00042289|365858077|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
106052901|NCT00042289|365858078|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
106052902|NCT00042289|365858079|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
106052903|NCT00042289|365858080|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
106052904|NCT00042289|365858081|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
106052905|NCT00042289|365858082|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
106052906|NCT00042289|365858083|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
106052907|NCT00042289|365858084|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
106052908|NCT00042289|365858085|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
106052909|NCT00042289|365858086|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
106052910|NCT00042289|365858087|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
106052911|NCT00042289|365858088|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
106052912|NCT00042289|365858089|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
106052913|NCT00042289|365858090|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
106052914|NCT00042289|365858091|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
106052915|NCT00042289|365858092|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
106052916|NCT00042289|365858093|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
106052917|NCT00042289|365858094|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
106052918|NCT00042289|365858095|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
106052919|NCT00042289|365858096|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
106052920|NCT00042289|365858097|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
106052921|NCT00042289|365858098|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
106052922|NCT00042289|365858099|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
106052923|NCT00042289|365858100|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
106052924|NCT00042289|365858101|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
106052925|NCT00042289|365858102|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
106052926|NCT00042289|365858103|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
106052927|NCT00042289|365858104|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
106052928|NCT00042289|365858105|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
106052929|NCT00042289|365858106|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
106052930|NCT00042289|365858107|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
106052931|NCT00042289|365858108|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
106052932|NCT00042289|365858109|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
106052933|NCT00042289|365858110|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
106052934|NCT00042289|365858111|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
106052935|NCT00042289|365858112|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
106052936|NCT00042289|365858113|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
106052937|NCT00042289|365858114|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
106052938|NCT00042289|365858115|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
106052939|NCT00042289|365858116|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
106052940|NCT00042289|365858117|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
106052941|NCT00042289|365858118|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
106052942|NCT00042289|365858119|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
106052943|NCT00042289|365858120|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
106052944|NCT00042289|365858121|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
106052945|NCT00042289|365858122|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
106052946|NCT00042289|365858076|FG000|Overall Study|Protocol Violation|0|||
106052947|NCT00042289|365858077|FG001|Overall Study|Protocol Violation|0|||
106052948|NCT00042289|365858078|FG002|Overall Study|Protocol Violation|0|||
106052949|NCT00042289|365858079|FG003|Overall Study|Protocol Violation|0|||
106052950|NCT00042289|365858080|FG004|Overall Study|Protocol Violation|0|||
106052951|NCT00042289|365858081|FG005|Overall Study|Protocol Violation|1|||
106052952|NCT00042289|365858082|FG006|Overall Study|Protocol Violation|0|||
106052953|NCT00042289|365858083|FG007|Overall Study|Protocol Violation|1|||
106052954|NCT00042289|365858084|FG008|Overall Study|Protocol Violation|0|||
106052955|NCT00042289|365858085|FG009|Overall Study|Protocol Violation|0|||
106052956|NCT00042289|365858086|FG010|Overall Study|Protocol Violation|0|||
106052957|NCT00042289|365858087|FG011|Overall Study|Protocol Violation|0|||
106052958|NCT00042289|365858088|FG012|Overall Study|Protocol Violation|0|||
106052959|NCT00042289|365858089|FG013|Overall Study|Protocol Violation|0|||
106052960|NCT00042289|365858090|FG014|Overall Study|Protocol Violation|0|||
106052961|NCT00042289|365858091|FG015|Overall Study|Protocol Violation|0|||
106052962|NCT00042289|365858092|FG016|Overall Study|Protocol Violation|0|||
106052963|NCT00042289|365858093|FG017|Overall Study|Protocol Violation|0|||
106052964|NCT00042289|365858094|FG018|Overall Study|Protocol Violation|0|||
106052965|NCT00042289|365858095|FG019|Overall Study|Protocol Violation|0|||
106052966|NCT00042289|365858096|FG020|Overall Study|Protocol Violation|0|||
106052967|NCT00042289|365858097|FG021|Overall Study|Protocol Violation|0|||
106052968|NCT00042289|365858098|FG022|Overall Study|Protocol Violation|0|||
106052969|NCT00042289|365858099|FG023|Overall Study|Protocol Violation|1|||
106052970|NCT00042289|365858100|FG024|Overall Study|Protocol Violation|1|||
106052971|NCT00042289|365858101|FG025|Overall Study|Protocol Violation|0|||
106052972|NCT00042289|365858102|FG026|Overall Study|Protocol Violation|2|||
106052973|NCT00042289|365858103|FG027|Overall Study|Protocol Violation|0|||
106052974|NCT00042289|365858104|FG028|Overall Study|Protocol Violation|0|||
106052975|NCT00042289|365858105|FG029|Overall Study|Protocol Violation|0|||
106052976|NCT00042289|365858106|FG030|Overall Study|Protocol Violation|1|||
106052977|NCT00042289|365858107|FG031|Overall Study|Protocol Violation|0|||
106052978|NCT00042289|365858108|FG032|Overall Study|Protocol Violation|0|||
106052979|NCT00042289|365858109|FG033|Overall Study|Protocol Violation|0|||
106052980|NCT00042289|365858110|FG034|Overall Study|Protocol Violation|0|||
106052981|NCT00042289|365858111|FG035|Overall Study|Protocol Violation|0|||
106052982|NCT00042289|365858112|FG036|Overall Study|Protocol Violation|0|||
106052983|NCT00042289|365858113|FG037|Overall Study|Protocol Violation|0|||
106052984|NCT00042289|365858114|FG038|Overall Study|Protocol Violation|0|||
106052985|NCT00042289|365858115|FG039|Overall Study|Protocol Violation|0|||
106052986|NCT00042289|365858116|FG040|Overall Study|Protocol Violation|0|||
106052987|NCT00042289|365858117|FG041|Overall Study|Protocol Violation|1|||
106052988|NCT00042289|365858118|FG042|Overall Study|Protocol Violation|1|||
106052989|NCT00042289|365858119|FG043|Overall Study|Protocol Violation|1|||
106052990|NCT00042289|365858120|FG044|Overall Study|Protocol Violation|0|||
106052991|NCT00042289|365858121|FG045|Overall Study|Protocol Violation|0|||
106052992|NCT00042289|365858122|FG046|Overall Study|Protocol Violation|0|||
106052993|NCT00042289|365858076|FG000|Overall Study|Withdrawal by Subject|4|||
106052994|NCT00042289|365858077|FG001|Overall Study|Withdrawal by Subject|1|||
106052995|NCT00042289|365858078|FG002|Overall Study|Withdrawal by Subject|0|||
106052996|NCT00042289|365858079|FG003|Overall Study|Withdrawal by Subject|2|||
105864153|NCT01371747|365152771|FG002|Overall Study|Low Serum Potassium Results|1|||
105864154|NCT01371747|365152772|FG003|Overall Study|Low Serum Potassium Results|1|||
105864155|NCT01371747|365152773|FG004|Overall Study|Low Serum Potassium Results|0|||
105864156|NCT01371747|365152774|FG005|Overall Study|Low Serum Potassium Results|3|||
105864157|NCT01371747|365152769|FG000|Overall Study|Protocol Violation|0|||
105864158|NCT01371747|365152770|FG001|Overall Study|Protocol Violation|0|||
105864159|NCT01371747|365152771|FG002|Overall Study|Protocol Violation|1|||
105864160|NCT01371747|365152772|FG003|Overall Study|Protocol Violation|0|||
105864161|NCT01371747|365152773|FG004|Overall Study|Protocol Violation|0|||
105864162|NCT01371747|365152774|FG005|Overall Study|Protocol Violation|0|||
105864163|NCT01371747|365152769|FG000|Overall Study|Non-Compliance|3|||
105864164|NCT01371747|365152770|FG001|Overall Study|Non-Compliance|4|||
105864165|NCT01371747|365152771|FG002|Overall Study|Non-Compliance|3|||
105864166|NCT01371747|365152772|FG003|Overall Study|Non-Compliance|0|||
105864167|NCT01371747|365152773|FG004|Overall Study|Non-Compliance|0|||
106052997|NCT00042289|365858080|FG004|Overall Study|Withdrawal by Subject|0|||
106052998|NCT00042289|365858081|FG005|Overall Study|Withdrawal by Subject|2|||
106052999|NCT00042289|365858082|FG006|Overall Study|Withdrawal by Subject|0|||
106053000|NCT00042289|365858083|FG007|Overall Study|Withdrawal by Subject|0|||
106053001|NCT00042289|365858084|FG008|Overall Study|Withdrawal by Subject|0|||
106053002|NCT00042289|365858085|FG009|Overall Study|Withdrawal by Subject|1|||
106053003|NCT00042289|365858086|FG010|Overall Study|Withdrawal by Subject|0|||
106053004|NCT00042289|365858087|FG011|Overall Study|Withdrawal by Subject|0|||
106053005|NCT00042289|365858088|FG012|Overall Study|Withdrawal by Subject|2|||
106053006|NCT00042289|365858089|FG013|Overall Study|Withdrawal by Subject|0|||
106053007|NCT00042289|365858090|FG014|Overall Study|Withdrawal by Subject|0|||
106053008|NCT00042289|365858091|FG015|Overall Study|Withdrawal by Subject|0|||
106053009|NCT00042289|365858092|FG016|Overall Study|Withdrawal by Subject|0|||
106053010|NCT00042289|365858093|FG017|Overall Study|Withdrawal by Subject|0|||
106053011|NCT00042289|365858094|FG018|Overall Study|Withdrawal by Subject|0|||
106053012|NCT00042289|365858095|FG019|Overall Study|Withdrawal by Subject|0|||
106053013|NCT00042289|365858096|FG020|Overall Study|Withdrawal by Subject|0|||
106053014|NCT00042289|365858097|FG021|Overall Study|Withdrawal by Subject|1|||
106053015|NCT00042289|365858098|FG022|Overall Study|Withdrawal by Subject|1|||
106152433|NCT03088813|366218793|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
106152434|NCT03088813|366218794|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
106053016|NCT00042289|365858099|FG023|Overall Study|Withdrawal by Subject|1|||
106053017|NCT00042289|365858100|FG024|Overall Study|Withdrawal by Subject|0|||
106053018|NCT00042289|365858101|FG025|Overall Study|Withdrawal by Subject|0|||
106053019|NCT00042289|365858102|FG026|Overall Study|Withdrawal by Subject|1|||
106053020|NCT00042289|365858103|FG027|Overall Study|Withdrawal by Subject|0|||
106053021|NCT00042289|365858104|FG028|Overall Study|Withdrawal by Subject|2|||
106053022|NCT00042289|365858105|FG029|Overall Study|Withdrawal by Subject|0|||
106053023|NCT00042289|365858106|FG030|Overall Study|Withdrawal by Subject|0|||
106053024|NCT00042289|365858107|FG031|Overall Study|Withdrawal by Subject|1|||
105864168|NCT01371747|365152774|FG005|Overall Study|Non-Compliance|1|||
105864169|NCT01371747|365152769|FG000|Overall Study|Physician Decision|0|||
105864170|NCT01371747|365152770|FG001|Overall Study|Physician Decision|0|||
106053025|NCT00042289|365858108|FG032|Overall Study|Withdrawal by Subject|2|||
106053026|NCT00042289|365858109|FG033|Overall Study|Withdrawal by Subject|1|||
106053027|NCT00042289|365858110|FG034|Overall Study|Withdrawal by Subject|0|||
106053028|NCT00042289|365858111|FG035|Overall Study|Withdrawal by Subject|0|||
106053029|NCT00042289|365858112|FG036|Overall Study|Withdrawal by Subject|0|||
106053030|NCT00042289|365858113|FG037|Overall Study|Withdrawal by Subject|1|||
106053031|NCT00042289|365858114|FG038|Overall Study|Withdrawal by Subject|0|||
106053032|NCT00042289|365858115|FG039|Overall Study|Withdrawal by Subject|0|||
106053033|NCT00042289|365858116|FG040|Overall Study|Withdrawal by Subject|0|||
106053034|NCT00042289|365858117|FG041|Overall Study|Withdrawal by Subject|0|||
106053035|NCT00042289|365858118|FG042|Overall Study|Withdrawal by Subject|1|||
106053036|NCT00042289|365858119|FG043|Overall Study|Withdrawal by Subject|0|||
106053037|NCT00042289|365858120|FG044|Overall Study|Withdrawal by Subject|0|||
106053038|NCT00042289|365858121|FG045|Overall Study|Withdrawal by Subject|0|||
106053039|NCT00042289|365858122|FG046|Overall Study|Withdrawal by Subject|0|||
106053040|NCT01687998|365858123|FG000|Overall Study|Withdrawal by Subject|49|||
106053041|NCT01687998|365858124|FG001|Overall Study|Withdrawal by Subject|51|||
106053042|NCT01687998|365858123|FG000|Overall Study|Known to be Alive at Study End|54|||
106053043|NCT01687998|365858124|FG001|Overall Study|Known to be Alive at Study End|62|||
106053044|NCT01687998|365858123|FG000|Overall Study|Lost to Follow-up|9|||
106053045|NCT01687998|365858124|FG001|Overall Study|Lost to Follow-up|7|||
106053046|NCT00717197|365858127|FG000|Overall Study|Unable to purchase study drug|5|||
106053047|NCT00717197|365858127|FG000|Overall Study|Tumor Progression|1|||
106053048|NCT00717197|365858127|FG000|Overall Study|Physician Decision|1|||
106053049|NCT00443261|365858130|FG000|Overall Study|Death|1|||
106053050|NCT01663532|365858132|FG000|Overall Study|Lost to Follow-up|9|||
106053051|NCT01663532|365858133|FG001|Overall Study|Lost to Follow-up|10|||
106053052|NCT01663532|365858132|FG000|Overall Study|Adverse Event|7|||
106053053|NCT01663532|365858133|FG001|Overall Study|Adverse Event|13|||
106053054|NCT01663532|365858132|FG000|Overall Study|Met Withdrawal Criteria|7|||
106053055|NCT01663532|365858133|FG001|Overall Study|Met Withdrawal Criteria|6|||
106053056|NCT01663532|365858132|FG000|Overall Study|Physician Decision|1|||
106053057|NCT01663532|365858133|FG001|Overall Study|Physician Decision|1|||
106053058|NCT01663532|365858132|FG000|Overall Study|Withdrawal by Subject|35|||
106053059|NCT01663532|365858133|FG001|Overall Study|Withdrawal by Subject|17|||
106053060|NCT01663532|365858132|FG000|Overall Study|Lack of Efficacy|15|||
106053061|NCT01663532|365858133|FG001|Overall Study|Lack of Efficacy|60|||
106053062|NCT03539081|365858140|FG000|Overall Study|Withdrawal by Subject|2|||
106053063|NCT03539081|365858141|FG001|Overall Study|Withdrawal by Subject|3|||
106053064|NCT03539081|365858142|FG002|Overall Study|Withdrawal by Subject|0|||
106053065|NCT03539081|365858140|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
106053066|NCT03539081|365858141|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
106053067|NCT03539081|365858142|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
106053068|NCT00739674|365858145|FG000|Overall Study|Screening failures|19|||
106053069|NCT00739674|365858146|FG001|Overall Study|Screening failures|17|||
106053070|NCT00739674|365858145|FG000|Overall Study|Site 212 removal|19|||
106053071|NCT00739674|365858146|FG001|Overall Study|Site 212 removal|13|||
106053072|NCT00739674|365858145|FG000|Overall Study|No follow-up data|33|||
106053073|NCT00739674|365858146|FG001|Overall Study|No follow-up data|18|||
106053074|NCT00739674|365858145|FG000|Overall Study|Dietician consultation >30 days|1|||
106053075|NCT00739674|365858146|FG001|Overall Study|Dietician consultation >30 days|9|||
106053076|NCT00739674|365858145|FG000|Overall Study|Adverse Event|22|||
106053077|NCT00739674|365858146|FG001|Overall Study|Adverse Event|13|||
106053078|NCT00739674|365858145|FG000|Overall Study|Death|1|||
106053079|NCT00739674|365858146|FG001|Overall Study|Death|0|||
106053080|NCT00739674|365858145|FG000|Overall Study|Lack of Efficacy|1|||
106053081|NCT00739674|365858146|FG001|Overall Study|Lack of Efficacy|0|||
106053082|NCT00739674|365858145|FG000|Overall Study|Lost to Follow-up|52|||
106053083|NCT00739674|365858146|FG001|Overall Study|Lost to Follow-up|30|||
106053084|NCT00739674|365858145|FG000|Overall Study|Protocol Violation|5|||
106053085|NCT00739674|365858146|FG001|Overall Study|Protocol Violation|5|||
106053086|NCT00739674|365858145|FG000|Overall Study|Withdrawal by Subject|9|||
106053087|NCT00739674|365858146|FG001|Overall Study|Withdrawal by Subject|9|||
106053088|NCT00739674|365858145|FG000|Overall Study|Reason missing|2|||
106053089|NCT00739674|365858146|FG001|Overall Study|Reason missing|0|||
106053090|NCT00739674|365858145|FG000|Overall Study|Clinic closed|6|||
106053091|NCT00739674|365858146|FG001|Overall Study|Clinic closed|4|||
106053092|NCT00739674|365858145|FG000|Overall Study|Patient moved|3|||
106053093|NCT00739674|365858146|FG001|Overall Study|Patient moved|2|||
106053094|NCT00739674|365858145|FG000|Overall Study|Non compliant|4|||
106152435|NCT03088813|366218795|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
106053095|NCT00739674|365858146|FG001|Overall Study|Non compliant|0|||
106053096|NCT00739674|365858145|FG000|Overall Study|Unable to attend visit|3|||
106053097|NCT00739674|365858146|FG001|Overall Study|Unable to attend visit|1|||
106053098|NCT00739674|365858145|FG000|Overall Study|Home monitoring off meds|1|||
106053099|NCT00739674|365858146|FG001|Overall Study|Home monitoring off meds|0|||
106053100|NCT00739674|365858145|FG000|Overall Study|Erectile dysfunction|0|||
106053101|NCT00739674|365858146|FG001|Overall Study|Erectile dysfunction|1|||
106053102|NCT01594281|365858147|FG000|Interventional Core Phase|Protocol Deviation|1|||
106053103|NCT01594281|365858148|FG001|Interventional Core Phase|Protocol Deviation|0|||
106053104|NCT01594281|365858149|FG002|Interventional Core Phase|Protocol Deviation|0|||
106053105|NCT01594281|365858147|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
106053106|NCT01594281|365858148|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
106053107|NCT01594281|365858149|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
106053108|NCT01594281|365858147|FG000|Interventional Core Phase|Death|1|||
106053109|NCT01594281|365858148|FG001|Interventional Core Phase|Death|1|||
106053110|NCT01594281|365858149|FG002|Interventional Core Phase|Death|2|||
106053111|NCT01594281|365858147|FG000|Interventional Core Phase|Lost to Follow-up|1|||
106053112|NCT01594281|365858148|FG001|Interventional Core Phase|Lost to Follow-up|4|||
106053113|NCT01594281|365858149|FG002|Interventional Core Phase|Lost to Follow-up|1|||
106053114|NCT01594281|365858147|FG000|Interventional Core Phase|Adverse Event|4|||
106053115|NCT01594281|365858148|FG001|Interventional Core Phase|Adverse Event|4|||
106053116|NCT01594281|365858149|FG002|Interventional Core Phase|Adverse Event|4|||
106053117|NCT01594281|365858147|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
106053118|NCT01594281|365858148|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
106053119|NCT01594281|365858149|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
106053120|NCT01594281|365858147|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
106053121|NCT01594281|365858148|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
106053122|NCT01594281|365858149|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
106053123|NCT01594281|365858147|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
106053124|NCT01594281|365858148|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
106053125|NCT01594281|365858149|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
106053126|NCT04805541|365858150|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
106053127|NCT04019288|365858151|FG000|Overall Study|Death|1|||
106053128|NCT04019288|365858152|FG001|Overall Study|Death|0|||
106053129|NCT04019288|365858153|FG002|Overall Study|Death|0|||
106053130|NCT01970397|365858154|FG000|Overall Study|Adverse Event|0|||
106053131|NCT01970397|365858155|FG001|Overall Study|Adverse Event|1|||
106053132|NCT01970397|365858154|FG000|Overall Study|Lost to Follow-up|0|||
106053133|NCT01970397|365858155|FG001|Overall Study|Lost to Follow-up|1|||
106053134|NCT01970397|365858154|FG000|Overall Study|Personal Reasons|1|||
106053135|NCT01970397|365858155|FG001|Overall Study|Personal Reasons|2|||
106053136|NCT01970397|365858154|FG000|Overall Study|Protocol Violation|1|||
106053137|NCT01970397|365858155|FG001|Overall Study|Protocol Violation|1|||
106053138|NCT00726986|365858156|FG000|Induction Phase|Adverse Event|4|||
106053139|NCT00726986|365858156|FG000|Induction Phase|Withdrawal by Subject|2|||
106053140|NCT00726986|365858156|FG000|Induction Phase|Death|2|||
106053141|NCT00726986|365858156|FG000|Induction Phase|Lack of Efficacy|5|||
106053142|NCT00726986|365858156|FG000|Induction Phase|Secondary Disease|2|||
106053143|NCT00726986|365858156|FG000|Maintenance Phase|Adverse Event|1|||
106053144|NCT00726986|365858156|FG000|Maintenance Phase|Lack of Efficacy|2|||
106053145|NCT00541931|365858157|FG000|Overall Study|Adverse Event|1|||
106053146|NCT00541931|365858158|FG001|Overall Study|Adverse Event|0|||
106053147|NCT00541931|365858157|FG000|Overall Study|Lost to Follow-up|3|||
106053148|NCT00541931|365858158|FG001|Overall Study|Lost to Follow-up|3|||
106053149|NCT00541931|365858157|FG000|Overall Study|Withdrawal by Subject|1|||
106053150|NCT00541931|365858158|FG001|Overall Study|Withdrawal by Subject|0|||
106053151|NCT00541931|365858157|FG000|Overall Study|Transportation Issue|0|||
106053152|NCT00541931|365858158|FG001|Overall Study|Transportation Issue|1|||
106053153|NCT01947582|365858164|FG000|Overall Study|Withdrawal by Subject|1|||
106053154|NCT01397890|365858165|FG000|Overall Study|Withdrawal by Subject|7|||
106053155|NCT01397890|365858166|FG001|Overall Study|Withdrawal by Subject|11|||
106053156|NCT01397890|365858165|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
106053157|NCT01397890|365858166|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
106053158|NCT01397890|365858165|FG000|Overall Study|Death|2|||
106053159|NCT01397890|365858166|FG001|Overall Study|Death|3|||
106053160|NCT01397890|365858165|FG000|Overall Study|Lost to Follow-up|1|||
106053161|NCT01397890|365858166|FG001|Overall Study|Lost to Follow-up|4|||
106053162|NCT01397890|365858165|FG000|Overall Study|Condition under Investigation Worsened|1|||
106053163|NCT01397890|365858166|FG001|Overall Study|Condition under Investigation Worsened|3|||
106053164|NCT01397890|365858165|FG000|Overall Study|Adverse Event|1|||
106053165|NCT01397890|365858166|FG001|Overall Study|Adverse Event|2|||
106053166|NCT01397890|365858165|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
106053167|NCT01397890|365858166|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
106053168|NCT01397890|365858165|FG000|Overall Study|Others|2|||
106053169|NCT01397890|365858166|FG001|Overall Study|Others|1|||
106053170|NCT04613375|365858167|FG000|Overall Study|Death|198|||
106053171|NCT04613375|365858167|FG000|Overall Study|Withdrawal by Subject|3|||
106053172|NCT03727230|365858168|FG000|Overall Study|Lost to Follow-up|12|||
106053173|NCT03417219|365858172|FG000|Overall Study|Lost to Follow-up|0|||
106053174|NCT03417219|365858173|FG001|Overall Study|Lost to Follow-up|3|||
106053175|NCT00675948|365858175|FG000|Overall Study|Adverse Event|23|||
106053176|NCT00675948|365858176|FG001|Overall Study|Adverse Event|1|||
106053177|NCT00675948|365858175|FG000|Overall Study|Lack of Efficacy|3|||
106053178|NCT00675948|365858176|FG001|Overall Study|Lack of Efficacy|0|||
106053179|NCT00675948|365858175|FG000|Overall Study|Withdrawal by Subject|7|||
106053180|NCT00675948|365858176|FG001|Overall Study|Withdrawal by Subject|0|||
106053181|NCT00675948|365858175|FG000|Overall Study|Lost to Follow-up|2|||
106053182|NCT00675948|365858176|FG001|Overall Study|Lost to Follow-up|0|||
106053183|NCT00675948|365858175|FG000|Overall Study|Protocol Violation|1|||
106053184|NCT00675948|365858176|FG001|Overall Study|Protocol Violation|0|||
106053185|NCT00675948|365858175|FG000|Overall Study|Pain under control|1|||
106053186|NCT00675948|365858176|FG001|Overall Study|Pain under control|0|||
106053187|NCT00675948|365858175|FG000|Overall Study|Sponsor decision|0|||
106053188|NCT00675948|365858176|FG001|Overall Study|Sponsor decision|1|||
106053189|NCT00675948|365858175|FG000|Overall Study|Patient died|1|||
106053190|NCT00675948|365858176|FG001|Overall Study|Patient died|0|||
106053191|NCT00675948|365858175|FG000|Overall Study|Patient unable to comply with diaries|1|||
106053192|NCT00675948|365858176|FG001|Overall Study|Patient unable to comply with diaries|0|||
106053193|NCT00675948|365858175|FG000|Overall Study|Patient feels unable to take medication|0|||
106053194|NCT00675948|365858176|FG001|Overall Study|Patient feels unable to take medication|1|||
106053195|NCT04377620|365858177|FG000|Overall Study|Death|42|||
106053196|NCT04377620|365858178|FG001|Overall Study|Death|48|||
106053197|NCT04377620|365858179|FG002|Overall Study|Death|36|||
106053198|NCT04377620|365858177|FG000|Overall Study|Withdrawal by Subject|0|||
106053199|NCT04377620|365858178|FG001|Overall Study|Withdrawal by Subject|2|||
106053200|NCT04377620|365858179|FG002|Overall Study|Withdrawal by Subject|0|||
106053201|NCT02527161|365858180|FG000|Overall Study|Failed MRI|52|||
106053202|NCT02527161|365858180|FG000|Overall Study|Withdrawal by Subject|19|||
106053203|NCT02527161|365858180|FG000|Overall Study|Delay in or unfit for surgery|16|||
106053204|NCT02527161|365858180|FG000|Overall Study|MRI contraindication|6|||
106053205|NCT02527161|365858180|FG000|Overall Study|Consent violation|4|||
106053206|NCT02527161|365858180|FG000|Overall Study|Only Recruited to Part A|27|||
106053207|NCT02527161|365858180|FG000|Overall Study|Physician Decision|1|||
106053208|NCT02527161|365858180|FG000|Overall Study|Adverse Event|1|||
106053209|NCT02527161|365858180|FG000|Overall Study|Lost to Follow-up|6|||
106053210|NCT02100514|365858181|FG000|Treatment Period|Adverse Event|0|||
106053211|NCT02100514|365858182|FG001|Treatment Period|Adverse Event|5|||
106053212|NCT02100514|365858183|FG002|Treatment Period|Adverse Event|0|||
106053213|NCT02100514|365858184|FG003|Treatment Period|Adverse Event|0|||
106053214|NCT02100514|365858185|FG004|Treatment Period|Adverse Event|0|||
106053215|NCT02100514|365858181|FG000|Treatment Period|Death|2|||
106053216|NCT02100514|365858182|FG001|Treatment Period|Death|2|||
106053217|NCT02100514|365858183|FG002|Treatment Period|Death|0|||
106053218|NCT02100514|365858184|FG003|Treatment Period|Death|0|||
106053219|NCT02100514|365858185|FG004|Treatment Period|Death|0|||
106053220|NCT02100514|365858181|FG000|Treatment Period|Lost to Follow-up|5|||
106053221|NCT02100514|365858182|FG001|Treatment Period|Lost to Follow-up|17|||
106053222|NCT02100514|365858183|FG002|Treatment Period|Lost to Follow-up|0|||
106053223|NCT02100514|365858184|FG003|Treatment Period|Lost to Follow-up|0|||
106053224|NCT02100514|365858185|FG004|Treatment Period|Lost to Follow-up|0|||
106053225|NCT02100514|365858181|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
106053226|NCT02100514|365858182|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
106053227|NCT02100514|365858183|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
106053228|NCT02100514|365858184|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
106053229|NCT02100514|365858185|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
106053230|NCT02100514|365858181|FG000|Treatment Period|Protocol Violation|1|||
106053231|NCT02100514|365858182|FG001|Treatment Period|Protocol Violation|1|||
106053232|NCT02100514|365858183|FG002|Treatment Period|Protocol Violation|0|||
106053233|NCT02100514|365858184|FG003|Treatment Period|Protocol Violation|0|||
106053234|NCT02100514|365858185|FG004|Treatment Period|Protocol Violation|0|||
106053235|NCT02100514|365858181|FG000|Treatment Period|Withdrawal by Subject|12|||
106053236|NCT02100514|365858182|FG001|Treatment Period|Withdrawal by Subject|37|||
106053237|NCT02100514|365858183|FG002|Treatment Period|Withdrawal by Subject|0|||
106053238|NCT02100514|365858184|FG003|Treatment Period|Withdrawal by Subject|0|||
106053239|NCT02100514|365858185|FG004|Treatment Period|Withdrawal by Subject|0|||
106053240|NCT02100514|365858181|FG000|Treatment Period|Other|9|||
106053241|NCT02100514|365858182|FG001|Treatment Period|Other|11|||
106053242|NCT02100514|365858183|FG002|Treatment Period|Other|0|||
106053243|NCT02100514|365858184|FG003|Treatment Period|Other|0|||
106053244|NCT02100514|365858185|FG004|Treatment Period|Other|0|||
106053245|NCT02100514|365858181|FG000|Extension Period|Withdrew consent|0|||
106053246|NCT02100514|365858182|FG001|Extension Period|Withdrew consent|0|||
106053247|NCT02100514|365858183|FG002|Extension Period|Withdrew consent|2|||
106053248|NCT02100514|365858184|FG003|Extension Period|Withdrew consent|0|||
106053249|NCT02100514|365858185|FG004|Extension Period|Withdrew consent|0|||
106053250|NCT00724932|365858186|FG000|Overall Study|Lost to Follow-up|1|||
106053251|NCT00724932|365858187|FG001|Overall Study|Lost to Follow-up|0|||
106053252|NCT00724932|365858186|FG000|Overall Study|Not treated|4|||
106053253|NCT00724932|365858187|FG001|Overall Study|Not treated|3|||
106053254|NCT02021331|365858188|FG000|Overall Study|Adverse Event|0|||
106053255|NCT02021331|365858189|FG001|Overall Study|Adverse Event|2|||
106053256|NCT03733470|365858197|FG000|Overall Study|PI Decision|1|||
106053257|NCT03733470|365858198|FG001|Overall Study|PI Decision|1|||
106053258|NCT00781274|365858201|FG000|Overall Study|Withdrawal by Subject|2|||
106053259|NCT02699593|365858203|FG000|Period 1|Unsatisfactory Visual Response|0|||
106053260|NCT02699593|365858204|FG001|Period 1|Unsatisfactory Visual Response|1|||
106053261|NCT02699593|365858203|FG000|Period 1|Torn Contact Len|4|||
106053262|NCT02699593|365858204|FG001|Period 1|Torn Contact Len|3|||
106053263|NCT02699593|365858203|FG000|Period 1|Protocol Violation|0|||
106053264|NCT02699593|365858204|FG001|Period 1|Protocol Violation|1|||
106053265|NCT02699593|365858203|FG000|Period 1|Withdrawal by Subject|0|||
106053266|NCT02699593|365858204|FG001|Period 1|Withdrawal by Subject|1|||
106053267|NCT02699593|365858203|FG000|Period 1|Adverse Event|1|||
106053268|NCT02699593|365858204|FG001|Period 1|Adverse Event|1|||
106053269|NCT02699593|365858203|FG000|Period 2|Adverse Event|1|||
106053270|NCT02699593|365858204|FG001|Period 2|Adverse Event|1|||
106053271|NCT02699593|365858203|FG000|Period 2|Lost Contact Lens|0|||
106053272|NCT02699593|365858204|FG001|Period 2|Lost Contact Lens|1|||
106053273|NCT02699593|365858203|FG000|Period 2|Torn Contact Lens|1|||
106053274|NCT02699593|365858204|FG001|Period 2|Torn Contact Lens|0|||
106053275|NCT04502433|365858205|FG000|Overall Study|Death|2|||
106053276|NCT04502433|365858206|FG001|Overall Study|Death|4|||
106053277|NCT04502433|365858205|FG000|Overall Study|Lost to Follow-up|1|||
106053278|NCT04502433|365858206|FG001|Overall Study|Lost to Follow-up|0|||
106053279|NCT04502433|365858205|FG000|Overall Study|Physician Decision|0|||
106053280|NCT04502433|365858206|FG001|Overall Study|Physician Decision|1|||
106053281|NCT02015754|365858209|FG000|Overall Study|Disease progression|5|||
106053282|NCT02015754|365858209|FG000|Overall Study|Change in treatment modality|5|||
106053283|NCT02015754|365858209|FG000|Overall Study|Lost to Follow-up|1|||
106053284|NCT00478231|365858216|FG000|Overall Study|Death|7|||
106053285|NCT00478231|365858216|FG000|Overall Study|Lack of Efficacy|47|||
106053286|NCT00478231|365858216|FG000|Overall Study|Lost to Follow-up|7|||
106053287|NCT00478231|365858216|FG000|Overall Study|Withdrawal by Subject|6|||
106053288|NCT00478231|365858216|FG000|Overall Study|Other|9|||
106053289|NCT00478231|365858216|FG000|Overall Study|Adverse Event|5|||
106053290|NCT00478231|365858216|FG000|Overall Study|Randomized, not treated|3|||
106053291|NCT02405780|365858221|FG000|Period I|Adverse Event|8|||
106053292|NCT02405780|365858222|FG001|Period I|Adverse Event|0|||
106053293|NCT02405780|365858223|FG002|Period I|Adverse Event|3|||
106053294|NCT02405780|365858224|FG003|Period I|Adverse Event|7|||
106053295|NCT02405780|365858221|FG000|Period I|Medical reasons|1|||
106053296|NCT02405780|365858222|FG001|Period I|Medical reasons|1|||
106053297|NCT02405780|365858223|FG002|Period I|Medical reasons|0|||
106053298|NCT02405780|365858224|FG003|Period I|Medical reasons|1|||
106053299|NCT02405780|365858221|FG000|Period I|Screening Failure|1|||
106053300|NCT02405780|365858222|FG001|Period I|Screening Failure|0|||
106053301|NCT02405780|365858223|FG002|Period I|Screening Failure|1|||
106053302|NCT02405780|365858224|FG003|Period I|Screening Failure|0|||
106053303|NCT02405780|365858221|FG000|Period I|Withdrawal by Subject|9|||
106053304|NCT02405780|365858222|FG001|Period I|Withdrawal by Subject|1|||
106053305|NCT02405780|365858223|FG002|Period I|Withdrawal by Subject|3|||
106053306|NCT02405780|365858224|FG003|Period I|Withdrawal by Subject|4|||
106053307|NCT02405780|365858221|FG000|Period I|Non-compliance with study procedures|8|||
106053308|NCT02405780|365858222|FG001|Period I|Non-compliance with study procedures|6|||
106053309|NCT02405780|365858223|FG002|Period I|Non-compliance with study procedures|8|||
106053310|NCT02405780|365858224|FG003|Period I|Non-compliance with study procedures|11|||
106053311|NCT02405780|365858221|FG000|Period II|Adverse Event|3|||
106053312|NCT02405780|365858222|FG001|Period II|Adverse Event|5|||
106053313|NCT02405780|365858223|FG002|Period II|Adverse Event|4|||
106053314|NCT02405780|365858224|FG003|Period II|Adverse Event|11|||
106053315|NCT02405780|365858221|FG000|Period II|Medical reason|0|||
106053316|NCT02405780|365858222|FG001|Period II|Medical reason|1|||
106053317|NCT02405780|365858223|FG002|Period II|Medical reason|0|||
106053318|NCT02405780|365858224|FG003|Period II|Medical reason|0|||
106053319|NCT02405780|365858221|FG000|Period II|Pregnancy|0|||
106053320|NCT02405780|365858222|FG001|Period II|Pregnancy|0|||
106053321|NCT02405780|365858223|FG002|Period II|Pregnancy|1|||
106053322|NCT02405780|365858224|FG003|Period II|Pregnancy|0|||
106053323|NCT02405780|365858221|FG000|Period II|Withdrawal by Subject|7|||
106053324|NCT02405780|365858222|FG001|Period II|Withdrawal by Subject|4|||
106152436|NCT03088813|366218796|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
106152437|NCT03088813|366218793|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
106152438|NCT03088813|366218794|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
106053325|NCT02405780|365858223|FG002|Period II|Withdrawal by Subject|0|||
106053326|NCT02405780|365858224|FG003|Period II|Withdrawal by Subject|3|||
106053327|NCT02405780|365858221|FG000|Period II|Non-compliance with study procedures|5|||
106053328|NCT02405780|365858222|FG001|Period II|Non-compliance with study procedures|2|||
106053329|NCT02405780|365858223|FG002|Period II|Non-compliance with study procedures|7|||
106053330|NCT02405780|365858224|FG003|Period II|Non-compliance with study procedures|4|||
106053331|NCT00923156|365858225|FG000|Overall Study|Adverse Event|0|||
106053332|NCT00923156|365858226|FG001|Overall Study|Adverse Event|2|||
106053333|NCT00923156|365858227|FG002|Overall Study|Adverse Event|1|||
106053334|NCT00923156|365858225|FG000|Overall Study|Abnormal laboratory values|0|||
106053335|NCT00923156|365858226|FG001|Overall Study|Abnormal laboratory values|0|||
106053336|NCT00923156|365858227|FG002|Overall Study|Abnormal laboratory values|1|||
106053337|NCT00923156|365858225|FG000|Overall Study|Withdrawal by Subject|0|||
106053338|NCT00923156|365858226|FG001|Overall Study|Withdrawal by Subject|1|||
106053339|NCT00923156|365858227|FG002|Overall Study|Withdrawal by Subject|0|||
106053340|NCT00923156|365858225|FG000|Overall Study|Death|0|||
106053341|NCT00923156|365858226|FG001|Overall Study|Death|1|||
106053342|NCT00923156|365858227|FG002|Overall Study|Death|0|||
106053343|NCT00923156|365858225|FG000|Overall Study|Lack of Efficacy|0|||
106053344|NCT00923156|365858226|FG001|Overall Study|Lack of Efficacy|0|||
106053345|NCT00923156|365858227|FG002|Overall Study|Lack of Efficacy|1|||
106053346|NCT00939770|365858230|FG000|Overall Study|Adverse Event|1|||
106053347|NCT00939770|365858231|FG001|Overall Study|Adverse Event|1|||
106053348|NCT00939770|365858232|FG002|Overall Study|Adverse Event|0|||
106053349|NCT00939770|365858233|FG003|Overall Study|Adverse Event|0|||
106053350|NCT00939770|365858234|FG004|Overall Study|Adverse Event|6|||
106053351|NCT00939770|365858235|FG005|Overall Study|Adverse Event|2|||
106053352|NCT00939770|365858236|FG006|Overall Study|Adverse Event|1|||
106053353|NCT00939770|365858237|FG007|Overall Study|Adverse Event|1|||
106053354|NCT00939770|365858230|FG000|Overall Study|Lack of Efficacy|4|||
106053355|NCT00939770|365858231|FG001|Overall Study|Lack of Efficacy|6|||
106053356|NCT00939770|365858232|FG002|Overall Study|Lack of Efficacy|13|||
106053357|NCT00939770|365858233|FG003|Overall Study|Lack of Efficacy|9|||
106053358|NCT00939770|365858234|FG004|Overall Study|Lack of Efficacy|16|||
106053359|NCT00939770|365858235|FG005|Overall Study|Lack of Efficacy|8|||
106053360|NCT00939770|365858236|FG006|Overall Study|Lack of Efficacy|11|||
106053361|NCT00939770|365858237|FG007|Overall Study|Lack of Efficacy|1|||
106053362|NCT00939770|365858230|FG000|Overall Study|Lost to Follow-up|0|||
106053363|NCT00939770|365858231|FG001|Overall Study|Lost to Follow-up|0|||
106053364|NCT00939770|365858232|FG002|Overall Study|Lost to Follow-up|0|||
106053365|NCT00939770|365858233|FG003|Overall Study|Lost to Follow-up|0|||
106053366|NCT00939770|365858234|FG004|Overall Study|Lost to Follow-up|1|||
106053367|NCT00939770|365858235|FG005|Overall Study|Lost to Follow-up|0|||
106053368|NCT00939770|365858236|FG006|Overall Study|Lost to Follow-up|0|||
106053369|NCT00939770|365858237|FG007|Overall Study|Lost to Follow-up|0|||
106053370|NCT00939770|365858230|FG000|Overall Study|Physician Decision|0|||
106053371|NCT00939770|365858231|FG001|Overall Study|Physician Decision|0|||
106053372|NCT00939770|365858232|FG002|Overall Study|Physician Decision|2|||
106053373|NCT00939770|365858233|FG003|Overall Study|Physician Decision|0|||
106053374|NCT00939770|365858234|FG004|Overall Study|Physician Decision|7|||
106053375|NCT00939770|365858235|FG005|Overall Study|Physician Decision|1|||
106053376|NCT00939770|365858236|FG006|Overall Study|Physician Decision|0|||
106053377|NCT00939770|365858237|FG007|Overall Study|Physician Decision|6|||
106053378|NCT00939770|365858230|FG000|Overall Study|Protocol Violation|0|||
106053379|NCT00939770|365858231|FG001|Overall Study|Protocol Violation|0|||
106053380|NCT00939770|365858232|FG002|Overall Study|Protocol Violation|0|||
106053381|NCT00939770|365858233|FG003|Overall Study|Protocol Violation|0|||
106053382|NCT00939770|365858234|FG004|Overall Study|Protocol Violation|1|||
106053383|NCT00939770|365858235|FG005|Overall Study|Protocol Violation|0|||
106053384|NCT00939770|365858236|FG006|Overall Study|Protocol Violation|0|||
106053385|NCT00939770|365858237|FG007|Overall Study|Protocol Violation|0|||
106053386|NCT00939770|365858230|FG000|Overall Study|Withdrawal by Subject|0|||
106053387|NCT00939770|365858231|FG001|Overall Study|Withdrawal by Subject|1|||
106053388|NCT00939770|365858232|FG002|Overall Study|Withdrawal by Subject|5|||
106053389|NCT00939770|365858233|FG003|Overall Study|Withdrawal by Subject|2|||
106053390|NCT00939770|365858234|FG004|Overall Study|Withdrawal by Subject|6|||
106053391|NCT00939770|365858235|FG005|Overall Study|Withdrawal by Subject|0|||
106053392|NCT00939770|365858236|FG006|Overall Study|Withdrawal by Subject|2|||
106053393|NCT00939770|365858237|FG007|Overall Study|Withdrawal by Subject|2|||
106053394|NCT04066023|365858238|FG000|Overall Study|Adverse Event|0|||
106053395|NCT04066023|365858239|FG001|Overall Study|Adverse Event|0|||
106053396|NCT04066023|365858240|FG002|Overall Study|Adverse Event|1|||
106053397|NCT04066023|365858238|FG000|Overall Study|Sponsor decision|3|||
106053398|NCT04066023|365858239|FG001|Overall Study|Sponsor decision|6|||
106053399|NCT04066023|365858240|FG002|Overall Study|Sponsor decision|2|||
106053400|NCT04066023|365858238|FG000|Overall Study|Physician Decision|0|||
106053401|NCT04066023|365858239|FG001|Overall Study|Physician Decision|0|||
106053402|NCT04066023|365858240|FG002|Overall Study|Physician Decision|1|||
106053403|NCT04066023|365858238|FG000|Overall Study|Lost to Follow-up|0|||
106053404|NCT04066023|365858239|FG001|Overall Study|Lost to Follow-up|1|||
106053405|NCT04066023|365858240|FG002|Overall Study|Lost to Follow-up|1|||
106053406|NCT04066023|365858238|FG000|Overall Study|Noncompliance|0|||
106053407|NCT04066023|365858239|FG001|Overall Study|Noncompliance|1|||
106053408|NCT04066023|365858240|FG002|Overall Study|Noncompliance|1|||
106053409|NCT03338010|365858241|FG000|Overall Study|Withdrawal by Subject|14|||
106053410|NCT03338010|365858242|FG001|Overall Study|Withdrawal by Subject|8|||
106053411|NCT03338010|365858241|FG000|Overall Study|Lost to Follow-up|4|||
106053412|NCT03338010|365858242|FG001|Overall Study|Lost to Follow-up|2|||
106053413|NCT03338010|365858241|FG000|Overall Study|Adverse Event|3|||
106053414|NCT03338010|365858242|FG001|Overall Study|Adverse Event|2|||
106053415|NCT03338010|365858241|FG000|Overall Study|Physician Decision|2|||
106053416|NCT03338010|365858242|FG001|Overall Study|Physician Decision|2|||
106053417|NCT03338010|365858241|FG000|Overall Study|Non-Compliance with Study Drug|0|||
106053418|NCT03338010|365858242|FG001|Overall Study|Non-Compliance with Study Drug|3|||
106053419|NCT03338010|365858241|FG000|Overall Study|Protocol Violation|0|||
106053420|NCT03338010|365858242|FG001|Overall Study|Protocol Violation|1|||
106053421|NCT02465515|365858247|FG000|Overall Study|Investigator site closed|4|||
106053422|NCT02465515|365858248|FG001|Overall Study|Investigator site closed|5|||
106053423|NCT02465515|365858247|FG000|Overall Study|Withdrawal by Subject|74|||
106053424|NCT02465515|365858248|FG001|Overall Study|Withdrawal by Subject|43|||
106053425|NCT02465515|365858247|FG000|Overall Study|Physician Decision|8|||
106053426|NCT02465515|365858248|FG001|Overall Study|Physician Decision|12|||
106053427|NCT02465515|365858247|FG000|Overall Study|Lost to Follow-up|68|||
106053428|NCT02465515|365858248|FG001|Overall Study|Lost to Follow-up|51|||
106053429|NCT00114530|365858249|FG000|Overall Study|Death|3|||
106053430|NCT00114530|365858250|FG001|Overall Study|Death|11|||
106053431|NCT00114530|365858249|FG000|Overall Study|Lost to Follow-up|1|||
106053432|NCT00114530|365858250|FG001|Overall Study|Lost to Follow-up|1|||
106053433|NCT00114530|365858249|FG000|Overall Study|Physician Decision|1|||
106053434|NCT00114530|365858250|FG001|Overall Study|Physician Decision|1|||
106053435|NCT00114530|365858249|FG000|Overall Study|Withdrawal by Subject|2|||
106053436|NCT00114530|365858250|FG001|Overall Study|Withdrawal by Subject|6|||
106053437|NCT00114530|365858249|FG000|Overall Study|Breast Cancer|1|||
106053438|NCT00114530|365858250|FG001|Overall Study|Breast Cancer|0|||
106053439|NCT00114530|365858249|FG000|Overall Study|Subject decision after endpoint failure|0|||
106053440|NCT00114530|365858250|FG001|Overall Study|Subject decision after endpoint failure|1|||
106053441|NCT00114530|365858249|FG000|Overall Study|Ineligible|1|||
106053442|NCT00114530|365858250|FG001|Overall Study|Ineligible|0|||
106053443|NCT00115739|365859211|FG000|Overall Study|Lost to Follow-up|3|||
106053444|NCT02025621|365859212|FG000|Overall Study|Withdrawal by Subject|1|||
106053445|NCT02025621|365859213|FG001|Overall Study|Withdrawal by Subject|0|||
106053446|NCT02025621|365859212|FG000|Overall Study|Death|0|||
106053447|NCT02025621|365859213|FG001|Overall Study|Death|1|||
106053448|NCT02025621|365859212|FG000|Overall Study|No longer eligible|10|||
106053449|NCT02025621|365859213|FG001|Overall Study|No longer eligible|15|||
106053450|NCT02025621|365859212|FG000|Overall Study|Surgery initiated before infusion|3|||
106053451|NCT02025621|365859213|FG001|Overall Study|Surgery initiated before infusion|3|||
106053452|NCT02587234|365859219|FG000|Overall Study|Withdrawal by Subject|1|||
106053453|NCT02587234|365859220|FG001|Overall Study|Withdrawal by Subject|1|||
106053454|NCT02587234|365859219|FG000|Overall Study|Lost to Follow-up|0|||
106053455|NCT02587234|365859220|FG001|Overall Study|Lost to Follow-up|2|||
106053456|NCT00064337|365859221|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
106053457|NCT00064337|365859221|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
106053458|NCT00064337|365859221|FG000|PBSCC or Induction/PBSCC|Progression|3|||
106053459|NCT00064337|365859221|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
106053460|NCT00064337|365859221|FG000|PBSCC or Induction/PBSCC|Death|2|||
106053461|NCT00064337|365859221|FG000|Transplant|Adverse Event|9|||
106053462|NCT00064337|365859221|FG000|Transplant|Not protocol-specified|5|||
106053463|NCT00064337|365859221|FG000|Transplant|Death|3|||
106053464|NCT00064337|365859221|FG000|Transplant|Patient Refusal|2|||
106053465|NCT00064337|365859221|FG000|Transplant|Progression|2|||
106053466|NCT00064337|365859221|FG000|Maintenance|Adverse Event|3|||
106053467|NCT00064337|365859221|FG000|Maintenance|Progression|2|||
106053468|NCT00064337|365859221|FG000|Maintenance|On treatment at time of analysis|2|||
106053469|NCT00064337|365859221|FG000|Maintenance|Not protocol-specified|2|||
106053470|NCT00064337|365859221|FG000|Maintenance|Death|1|||
106053471|NCT02279420|365859222|FG000|Overall Study|Lost to Follow-up|23|||
106053472|NCT03068130|365859225|FG000|Overall Study|Adverse Event|19|||
106152439|NCT03088813|366218795|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
106152440|NCT03088813|366218796|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
106053473|NCT03068130|365859225|FG000|Overall Study|Death|14|||
106053474|NCT03068130|365859225|FG000|Overall Study|Lost to Follow-up|4|||
106053475|NCT03068130|365859225|FG000|Overall Study|Withdrawal by Subject|26|||
106053476|NCT03068130|365859225|FG000|Overall Study|Administrative Reasons|3|||
106053477|NCT03068130|365859225|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
106053478|NCT03068130|365859225|FG000|Overall Study|Study terminated by sponsor|194|||
106053479|NCT02763462|365859231|FG000|Overall Study|Protocol Violation|6|||
106053480|NCT00129272|365859232|FG000|Overall Study|Lost to Follow-up|12|||
106053481|NCT00129272|365859233|FG001|Overall Study|Lost to Follow-up|11|||
106053482|NCT00129272|365859232|FG000|Overall Study|Withdrawal by Subject|5|||
106053483|NCT00129272|365859233|FG001|Overall Study|Withdrawal by Subject|11|||
106053484|NCT01706146|365859236|FG000|Overall Study|Withdrawal by Subject|1|||
106053485|NCT01706146|365859236|FG000|Overall Study|Adverse Event|3|||
106053486|NCT01706146|365859236|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
106053487|NCT02582983|365859237|FG000|Overall Study|Death|3|||
106053488|NCT02582983|365859237|FG000|Overall Study|Withdrawal by Subject|2|||
106053489|NCT02582983|365859237|FG000|Overall Study|Adverse Event|1|||
106053490|NCT05209360|365859238|FG000|Overall Study|Withdrawal by Subject|0|||
106053491|NCT05209360|365859239|FG001|Overall Study|Withdrawal by Subject|0|||
106053492|NCT05209360|365859240|FG002|Overall Study|Withdrawal by Subject|1|||
106053493|NCT05209360|365859241|FG003|Overall Study|Withdrawal by Subject|0|||
106053494|NCT05209360|365859242|FG004|Overall Study|Withdrawal by Subject|0|||
106053495|NCT05209360|365859243|FG005|Overall Study|Withdrawal by Subject|0|||
106053496|NCT01387932|365859246|FG000|Randomized and Treated|Physician Decision|3|||
106053497|NCT01387932|365859247|FG001|Randomized and Treated|Physician Decision|2|||
106053498|NCT01387932|365859246|FG000|Randomized and Treated|Withdrawal by Subject|4|||
106053499|NCT01387932|365859247|FG001|Randomized and Treated|Withdrawal by Subject|2|||
106053500|NCT01387932|365859246|FG000|Survival Follow-up|Liver Transplant|24|||
106053501|NCT01387932|365859247|FG001|Survival Follow-up|Liver Transplant|28|||
106053502|NCT01387932|365859246|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
106053503|NCT01387932|365859247|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
106053504|NCT01387932|365859246|FG000|Survival Follow-up|Withdrawal by Subject|2|||
106053505|NCT01387932|365859247|FG001|Survival Follow-up|Withdrawal by Subject|4|||
106053506|NCT01387932|365859246|FG000|Survival Follow-up|Lost to Follow-up|6|||
106053507|NCT01387932|365859247|FG001|Survival Follow-up|Lost to Follow-up|5|||
106053508|NCT02657369|365859248|FG000|Overall Study|Death|27|||
106053509|NCT02657369|365859248|FG000|Overall Study|Study terminated by sponsor|7|||
106053510|NCT00824720|365859249|FG000|Overall Study|failed plug insertion|3|||
106053511|NCT00824720|365859250|FG001|Overall Study|failed plug insertion|1|||
106053512|NCT00824720|365859251|FG002|Overall Study|failed plug insertion|0|||
106053513|NCT00824720|365859249|FG000|Overall Study|Protocol Violation|0|||
106053514|NCT00824720|365859250|FG001|Overall Study|Protocol Violation|0|||
106053515|NCT00824720|365859251|FG002|Overall Study|Protocol Violation|1|||
106053516|NCT02639065|365859252|FG000|Study Treatment|Disease Progression|13|||
106053517|NCT02639065|365859252|FG000|Study Treatment|Adverse Event|9|||
106053518|NCT02639065|365859252|FG000|Study Treatment|Withdrawal by Subject|1|||
106053519|NCT02639065|365859252|FG000|Follow up|Subject refused to follow up|1|||
106053520|NCT02639065|365859252|FG000|Follow up|Symptomatic Deterioration|2|||
106053521|NCT02639065|365859252|FG000|Follow up|Death|2|||
106053522|NCT02639065|365859252|FG000|Follow up|Study Terminated|1|||
106053523|NCT02639065|365859252|FG000|Follow up|Disease Progression|3|||
106053524|NCT00873015|365859253|FG000|Overall Study|Withdrawal by Subject|0|||
106053525|NCT00873015|365859254|FG001|Overall Study|Withdrawal by Subject|1|||
106053526|NCT00873015|365859255|FG002|Overall Study|Withdrawal by Subject|0|||
106053527|NCT00873015|365859256|FG003|Overall Study|Withdrawal by Subject|0|||
106053528|NCT00345839|365859257|FG000|Overall Study|Withdrawal by Subject|91|||
106053529|NCT00345839|365859258|FG001|Overall Study|Withdrawal by Subject|98|||
106053530|NCT00345839|365859257|FG000|Overall Study|Lost to Follow-up|58|||
106053531|NCT00345839|365859258|FG001|Overall Study|Lost to Follow-up|61|||
106053532|NCT02339584|365859264|FG000|Overall Study|Adverse Event|11|||
106053533|NCT02339584|365859265|FG001|Overall Study|Adverse Event|7|||
106053534|NCT02339584|365859264|FG000|Overall Study|Lack of Efficacy|0|||
106053535|NCT02339584|365859265|FG001|Overall Study|Lack of Efficacy|1|||
106053536|NCT02339584|365859264|FG000|Overall Study|Physician Decision|1|||
106053537|NCT02339584|365859265|FG001|Overall Study|Physician Decision|2|||
106053538|NCT02339584|365859264|FG000|Overall Study|Protocol Violation|1|||
106053539|NCT02339584|365859265|FG001|Overall Study|Protocol Violation|1|||
106053540|NCT02339584|365859264|FG000|Overall Study|Withdrawal by Subject|2|||
106053541|NCT02339584|365859265|FG001|Overall Study|Withdrawal by Subject|4|||
106053542|NCT04094883|365859266|FG000|Overall Study|Withdrawal by Subject|1|||
106053543|NCT00826943|365859267|FG000|Overall Study|Withdrawal by Subject|0|||
106053544|NCT00826943|365859268|FG001|Overall Study|Withdrawal by Subject|0|||
106053545|NCT00826943|365859269|FG002|Overall Study|Withdrawal by Subject|0|||
106053546|NCT00826943|365859270|FG003|Overall Study|Withdrawal by Subject|0|||
106053547|NCT00826943|365859271|FG004|Overall Study|Withdrawal by Subject|1|||
106053548|NCT00826943|365859272|FG005|Overall Study|Withdrawal by Subject|0|||
106053549|NCT01348165|365859273|FG000|Overall Study|Adverse Event|0|||
106053550|NCT01348165|365859274|FG001|Overall Study|Adverse Event|0|||
106053551|NCT01348165|365859275|FG002|Overall Study|Adverse Event|0|||
106053552|NCT01348165|365859276|FG003|Overall Study|Adverse Event|0|||
106053553|NCT01348165|365859277|FG004|Overall Study|Adverse Event|0|||
106053554|NCT01348165|365859278|FG005|Overall Study|Adverse Event|0|||
106053555|NCT01348165|365859279|FG006|Overall Study|Adverse Event|1|||
106053556|NCT01088997|365859284|FG000|Overall Study|Physician Decision|1|||
106053557|NCT01088997|365859285|FG001|Overall Study|Physician Decision|1|||
106053558|NCT01088997|365859284|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
106053559|NCT01088997|365859285|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
106053560|NCT01088997|365859284|FG000|Overall Study|Excluded prior to receiving drug|1|||
106053561|NCT01088997|365859285|FG001|Overall Study|Excluded prior to receiving drug|1|||
106053562|NCT03278873|365859290|FG000|Overall Study|Withdrawal by Subject|0|||
106053563|NCT03278873|365859291|FG001|Overall Study|Withdrawal by Subject|1|||
106053564|NCT03278873|365859292|FG002|Overall Study|Withdrawal by Subject|0|||
106053565|NCT03278873|365859293|FG003|Overall Study|Withdrawal by Subject|0|||
106053566|NCT03278873|365859290|FG000|Overall Study|Sponsor's decision|0|||
106053567|NCT03278873|365859291|FG001|Overall Study|Sponsor's decision|1|||
106053568|NCT03278873|365859292|FG002|Overall Study|Sponsor's decision|0|||
106053569|NCT03278873|365859293|FG003|Overall Study|Sponsor's decision|0|||
106053570|NCT03278873|365859290|FG000|Overall Study|Early Termination|2|||
106053571|NCT03278873|365859291|FG001|Overall Study|Early Termination|6|||
106053572|NCT03278873|365859292|FG002|Overall Study|Early Termination|0|||
106053573|NCT03278873|365859293|FG003|Overall Study|Early Termination|4|||
106053574|NCT03278873|365859290|FG000|Overall Study|Lost to Follow-up|0|||
106053575|NCT03278873|365859291|FG001|Overall Study|Lost to Follow-up|0|||
106053576|NCT03278873|365859292|FG002|Overall Study|Lost to Follow-up|2|||
106053577|NCT03278873|365859293|FG003|Overall Study|Lost to Follow-up|0|||
106053578|NCT03278873|365859290|FG000|Overall Study|The patient decided to withdraw via email|1|||
106053579|NCT03278873|365859291|FG001|Overall Study|The patient decided to withdraw via email|0|||
106053580|NCT03278873|365859292|FG002|Overall Study|The patient decided to withdraw via email|0|||
106053581|NCT03278873|365859293|FG003|Overall Study|The patient decided to withdraw via email|0|||
106053582|NCT03278873|365859290|FG000|Overall Study|The patient was unresponsive to contact|0|||
106053583|NCT03278873|365859291|FG001|Overall Study|The patient was unresponsive to contact|0|||
106053584|NCT03278873|365859292|FG002|Overall Study|The patient was unresponsive to contact|0|||
106053585|NCT03278873|365859293|FG003|Overall Study|The patient was unresponsive to contact|4|||
106053586|NCT03278873|365859290|FG000|Overall Study|The patient wished to participate no longer|0|||
106053587|NCT03278873|365859291|FG001|Overall Study|The patient wished to participate no longer|1|||
106053588|NCT03278873|365859292|FG002|Overall Study|The patient wished to participate no longer|0|||
106053589|NCT03278873|365859293|FG003|Overall Study|The patient wished to participate no longer|0|||
106053590|NCT03278873|365859290|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
106053591|NCT03278873|365859291|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
106053592|NCT03278873|365859292|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
106053593|NCT03278873|365859293|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
106053594|NCT05243641|365859295|FG000|Overall Study|Adverse Event|3|||
106053595|NCT05243641|365859296|FG001|Overall Study|Adverse Event|0|||
106053596|NCT05243641|365859297|FG002|Overall Study|Adverse Event|0|||
106053597|NCT05243641|365859298|FG003|Overall Study|Adverse Event|1|||
106053598|NCT05243641|365859299|FG004|Overall Study|Adverse Event|0|||
106053599|NCT05243641|365859300|FG005|Overall Study|Adverse Event|0|||
106053600|NCT05243641|365859295|FG000|Overall Study|Disease progression|4|||
106053601|NCT05243641|365859296|FG001|Overall Study|Disease progression|0|||
106053602|NCT05243641|365859297|FG002|Overall Study|Disease progression|0|||
106053603|NCT05243641|365859298|FG003|Overall Study|Disease progression|2|||
106053604|NCT05243641|365859299|FG004|Overall Study|Disease progression|0|||
106053605|NCT05243641|365859300|FG005|Overall Study|Disease progression|0|||
106053606|NCT05695209|365859301|FG000|3-months|Withdrawal by Subject|2|||
106053607|NCT05695209|365859302|FG001|3-months|Withdrawal by Subject|0|||
106053608|NCT05695209|365859301|FG000|3-months|Unable to contact for 3-month data collection|0|||
106053609|NCT05695209|365859302|FG001|3-months|Unable to contact for 3-month data collection|1|||
106053610|NCT05695209|365859301|FG000|6-months|Lost to Follow-up|1|||
106053611|NCT05695209|365859302|FG001|6-months|Lost to Follow-up|1|||
106053612|NCT04731363|365859314|FG000|Overall Study|Could not obtain samples|0|||
106053613|NCT04731363|365859315|FG001|Overall Study|Could not obtain samples|1|||
106053614|NCT04731363|365859316|FG002|Overall Study|Could not obtain samples|0|||
106053615|NCT04731363|365859317|FG003|Overall Study|Could not obtain samples|0|||
106053616|NCT04731363|365859314|FG000|Overall Study|Physician Decision|0|||
106053617|NCT04731363|365859315|FG001|Overall Study|Physician Decision|1|||
106053618|NCT04731363|365859316|FG002|Overall Study|Physician Decision|0|||
106053619|NCT04731363|365859317|FG003|Overall Study|Physician Decision|0|||
106053620|NCT00745823|365860668|FG000|Overall Study|Adverse Event|5|||
106053621|NCT00745823|365860669|FG001|Overall Study|Adverse Event|3|||
106053622|NCT00745823|365860668|FG000|Overall Study|Lack of Efficacy|20|||
106053623|NCT00745823|365860669|FG001|Overall Study|Lack of Efficacy|6|||
106053624|NCT00745823|365860668|FG000|Overall Study|Lost to Follow-up|10|||
106053625|NCT00745823|365860669|FG001|Overall Study|Lost to Follow-up|11|||
106053626|NCT00745823|365860668|FG000|Overall Study|Physician Decision|10|||
106053627|NCT00745823|365860669|FG001|Overall Study|Physician Decision|5|||
106152441|NCT03088813|366218793|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
106152442|NCT03088813|366218794|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
106152443|NCT03088813|366218795|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
106053628|NCT00745823|365860668|FG000|Overall Study|Pregnancy|0|||
106053629|NCT00745823|365860669|FG001|Overall Study|Pregnancy|4|||
106053630|NCT00745823|365860668|FG000|Overall Study|Withdrawal by Subject|14|||
106053631|NCT00745823|365860669|FG001|Overall Study|Withdrawal by Subject|8|||
106053632|NCT00745823|365860668|FG000|Overall Study|Study Terminated by Sponsor|326|||
106053633|NCT00745823|365860669|FG001|Overall Study|Study Terminated by Sponsor|349|||
106053634|NCT00982137|365860670|FG000|Overall Study|Lost to Follow-up|0|||
106053635|NCT00982137|365860671|FG001|Overall Study|Lost to Follow-up|0|||
106053636|NCT00982137|365860672|FG002|Overall Study|Lost to Follow-up|0|||
106053637|NCT00982137|365860673|FG003|Overall Study|Lost to Follow-up|1|||
106053638|NCT00982137|365860670|FG000|Overall Study|Withdrawal by Subject|0|||
106053639|NCT00982137|365860671|FG001|Overall Study|Withdrawal by Subject|1|||
106053640|NCT00982137|365860672|FG002|Overall Study|Withdrawal by Subject|0|||
106053641|NCT00982137|365860673|FG003|Overall Study|Withdrawal by Subject|0|||
106053642|NCT04669600|365860674|FG000|Overall Study|Withdrawal by Subject|1|||
106053643|NCT04669600|365860674|FG000|Overall Study|Other|6|||
106053644|NCT02955602|365860675|FG000|Overall Study|Adverse Event|0|||
106053645|NCT02955602|365860676|FG001|Overall Study|Adverse Event|3|||
106053646|NCT02955602|365860677|FG002|Overall Study|Adverse Event|0|||
106053647|NCT02955602|365860675|FG000|Overall Study|Withdrawal of informed consent|1|||
106053648|NCT02955602|365860676|FG001|Overall Study|Withdrawal of informed consent|3|||
106053649|NCT02955602|365860677|FG002|Overall Study|Withdrawal of informed consent|2|||
106053650|NCT02955602|365860675|FG000|Overall Study|Lost to Follow-up|0|||
106053651|NCT02955602|365860676|FG001|Overall Study|Lost to Follow-up|0|||
106053652|NCT02955602|365860677|FG002|Overall Study|Lost to Follow-up|1|||
106053653|NCT02955602|365860675|FG000|Overall Study|Other|0|||
106053654|NCT02955602|365860676|FG001|Overall Study|Other|1|||
106053655|NCT02955602|365860677|FG002|Overall Study|Other|3|||
106053656|NCT00844831|365860680|FG000|Overall Study|Withdrawal by Subject|4|||
106053657|NCT00844831|365860680|FG000|Overall Study|Adverse Event|1|||
106053658|NCT00844831|365860680|FG000|Overall Study|Physician Decision|1|||
106053659|NCT02550106|365860689|FG000|Overall Study|Adverse Event|1|||
106053660|NCT02550106|365860689|FG000|Overall Study|Lack of Efficacy|3|||
106053661|NCT02550106|365860689|FG000|Overall Study|Protocol Violation|6|||
106053662|NCT02550106|365860689|FG000|Overall Study|Withdrawal by Subject|2|||
106053663|NCT02195583|365860690|FG000|Overall Study|Lost to Follow-up|1|||
106053664|NCT02195583|365860690|FG000|Overall Study|Withdrawal by Subject|4|||
106053665|NCT02195583|365860690|FG000|Overall Study|Adverse Event|2|||
106053666|NCT02195583|365860690|FG000|Overall Study|Other Reason|2|||
106053667|NCT01709513|365860691|FG000|Overall Study|Randomized but not treated|0|||
106053668|NCT01709513|365860692|FG001|Overall Study|Randomized but not treated|1|||
106053669|NCT01709513|365860693|FG002|Overall Study|Randomized but not treated|0|||
106053670|NCT01709513|365860691|FG000|Overall Study|Adverse Event|16|||
106053671|NCT01709513|365860692|FG001|Overall Study|Adverse Event|31|||
106053672|NCT01709513|365860693|FG002|Overall Study|Adverse Event|23|||
106053673|NCT01709513|365860691|FG000|Overall Study|Poor compliance to protocol|2|||
106053674|NCT01709513|365860692|FG001|Overall Study|Poor compliance to protocol|0|||
106053675|NCT01709513|365860693|FG002|Overall Study|Poor compliance to protocol|0|||
106053676|NCT01709513|365860691|FG000|Overall Study|Other|3|||
106053677|NCT01709513|365860692|FG001|Overall Study|Other|11|||
106053678|NCT01709513|365860693|FG002|Overall Study|Other|7|||
106053679|NCT01543958|365860694|FG000|Overall Study|Loss to follow-up|3|||
106053680|NCT01543958|365860694|FG000|Overall Study|ART initiation|1|||
106053681|NCT03305575|365860699|FG000|Overall Study|Physician Decision|1|||
106053682|NCT03305575|365860700|FG001|Overall Study|Physician Decision|0|||
106053683|NCT01389817|365860703|FG000|Overall Study|Physician Decision|1|||
106053684|NCT01389817|365860704|FG001|Overall Study|Physician Decision|0|||
106053685|NCT01389817|365860703|FG000|Overall Study|Lost to Follow-up|1|||
106053686|NCT01389817|365860704|FG001|Overall Study|Lost to Follow-up|0|||
106053687|NCT01389817|365860703|FG000|Overall Study|Withdrawal by Subject|2|||
106053688|NCT01389817|365860704|FG001|Overall Study|Withdrawal by Subject|0|||
106053689|NCT03486223|365860705|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
106053690|NCT03486223|365860706|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
105864171|NCT01371747|365152771|FG002|Overall Study|Physician Decision|0|||
106053691|NCT01819831|365860707|FG000|Overall Study|Withdrawal by Subject|1|||
106053692|NCT03130257|365860714|FG000|Overall Study|Withdrawal by Subject|1|||
106053693|NCT03130257|365860715|FG001|Overall Study|Withdrawal by Subject|0|||
106053694|NCT03130257|365860716|FG002|Overall Study|Withdrawal by Subject|2|||
106053695|NCT00261807|365860717|FG000|Overall Study|Lost to Follow-up|2|||
105864172|NCT01371747|365152772|FG003|Overall Study|Physician Decision|0|||
106053696|NCT00261807|365860717|FG000|Overall Study|Adverse Event|2|||
106053697|NCT00261807|365860717|FG000|Overall Study|Death|1|||
105864173|NCT01371747|365152773|FG004|Overall Study|Physician Decision|1|||
106053698|NCT00261807|365860717|FG000|Overall Study|Protocol Violation|2|||
106053699|NCT01751178|365860721|FG000|Overall Study|Adverse Event|2|||
106053700|NCT01751178|365860722|FG001|Overall Study|Adverse Event|0|||
106053701|NCT01751178|365860723|FG002|Overall Study|Adverse Event|0|||
106053702|NCT01751178|365860721|FG000|Overall Study|Other Reason (unknown)|1|||
106053703|NCT01751178|365860722|FG001|Overall Study|Other Reason (unknown)|0|||
106053704|NCT01751178|365860723|FG002|Overall Study|Other Reason (unknown)|2|||
106053705|NCT00044083|365860725|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
106053706|NCT00044083|365860726|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
106053707|NCT00044083|365860725|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
106053708|NCT00044083|365860726|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
106053709|NCT00044083|365860725|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
106053710|NCT00044083|365860726|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
106053711|NCT00044083|365860725|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
106053712|NCT00044083|365860726|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
106053713|NCT00044083|365860725|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
106053714|NCT00044083|365860726|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
106053715|NCT00044083|365860725|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
106053716|NCT00044083|365860726|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
106053717|NCT00044083|365860725|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
106053718|NCT00044083|365860726|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
106053719|NCT00044083|365860725|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
106053720|NCT00044083|365860726|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
106053721|NCT00044083|365860725|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
106053722|NCT00044083|365860726|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
106053723|NCT00044083|365860725|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
106053724|NCT00044083|365860726|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
106053725|NCT00288054|365860731|FG000|Overall Study|Protocol Violation|2|||
106053726|NCT00288054|365860731|FG000|Overall Study|Lack of Efficacy|16|||
106053727|NCT00288054|365860731|FG000|Overall Study|Adverse Event|3|||
106053728|NCT00288054|365860731|FG000|Overall Study|Withdrawal by Subject|1|||
106053729|NCT00288054|365860731|FG000|Overall Study|Not protocol specified|2|||
106053730|NCT00289991|365860732|FG000|Overall Study|Death|35|||
106053731|NCT00289991|365860733|FG001|Overall Study|Death|38|||
106053732|NCT00289991|365860732|FG000|Overall Study|Adverse Event|15|||
106053733|NCT00289991|365860733|FG001|Overall Study|Adverse Event|13|||
106053734|NCT00289991|365860732|FG000|Overall Study|Failure of prophylaxis|1|||
106053735|NCT00289991|365860733|FG001|Overall Study|Failure of prophylaxis|1|||
106053736|NCT00289991|365860732|FG000|Overall Study|Fungal breakthrough infection|0|||
106053737|NCT00289991|365860733|FG001|Overall Study|Fungal breakthrough infection|1|||
106053738|NCT00289991|365860732|FG000|Overall Study|Lost to Follow-up|0|||
106053739|NCT00289991|365860733|FG001|Overall Study|Lost to Follow-up|1|||
106053740|NCT00289991|365860732|FG000|Overall Study|Withdrawal by Subject|2|||
106053741|NCT00289991|365860733|FG001|Overall Study|Withdrawal by Subject|12|||
106053742|NCT00289991|365860732|FG000|Overall Study|Other|5|||
106053743|NCT00289991|365860733|FG001|Overall Study|Other|14|||
106053744|NCT01786668|365860741|FG000|Overall Study|Adverse Event|0|||
106053745|NCT01786668|365860742|FG001|Overall Study|Adverse Event|1|||
106053746|NCT01786668|365860743|FG002|Overall Study|Adverse Event|1|||
106053747|NCT01786668|365860744|FG003|Overall Study|Adverse Event|2|||
106053748|NCT01786668|365860741|FG000|Overall Study|Withdrawal by Subject|0|||
106053749|NCT01786668|365860742|FG001|Overall Study|Withdrawal by Subject|0|||
106053750|NCT01786668|365860743|FG002|Overall Study|Withdrawal by Subject|3|||
106053751|NCT01786668|365860744|FG003|Overall Study|Withdrawal by Subject|1|||
106053752|NCT01786668|365860741|FG000|Overall Study|Pregnancy|0|||
106053753|NCT01786668|365860742|FG001|Overall Study|Pregnancy|0|||
106053754|NCT01786668|365860743|FG002|Overall Study|Pregnancy|0|||
106053755|NCT01786668|365860744|FG003|Overall Study|Pregnancy|1|||
106053756|NCT01786668|365860741|FG000|Overall Study|Lost to Follow-up|1|||
106053757|NCT01786668|365860742|FG001|Overall Study|Lost to Follow-up|0|||
106053758|NCT01786668|365860743|FG002|Overall Study|Lost to Follow-up|1|||
106053759|NCT01786668|365860744|FG003|Overall Study|Lost to Follow-up|0|||
106053760|NCT01091974|365860745|FG000|Overall Study|Did not start intervention|3|||
106053761|NCT01091974|365860746|FG001|Overall Study|Did not start intervention|1|||
106053762|NCT01091974|365860747|FG002|Overall Study|Did not start intervention|3|||
106053763|NCT01091974|365860748|FG003|Overall Study|Did not start intervention|1|||
106053764|NCT01091974|365860745|FG000|Overall Study|resumed sleep medication|0|||
106053765|NCT01091974|365860746|FG001|Overall Study|resumed sleep medication|0|||
106053766|NCT01091974|365860747|FG002|Overall Study|resumed sleep medication|1|||
106053767|NCT01091974|365860748|FG003|Overall Study|resumed sleep medication|2|||
106053768|NCT01091974|365860745|FG000|Overall Study|Withdrawal by Subject|1|||
106053769|NCT01091974|365860746|FG001|Overall Study|Withdrawal by Subject|3|||
106053770|NCT01091974|365860747|FG002|Overall Study|Withdrawal by Subject|2|||
106053771|NCT01091974|365860748|FG003|Overall Study|Withdrawal by Subject|2|||
106152444|NCT03088813|366218796|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
106053772|NCT01091974|365860745|FG000|Overall Study|side-effects|1|||
106053773|NCT01091974|365860746|FG001|Overall Study|side-effects|1|||
106053774|NCT01091974|365860747|FG002|Overall Study|side-effects|0|||
106053775|NCT01091974|365860748|FG003|Overall Study|side-effects|2|||
106053776|NCT00518284|365860757|FG000|Overall Study|Adverse Event|0|||
106053777|NCT00518284|365860758|FG001|Overall Study|Adverse Event|1|||
106053778|NCT00518284|365860759|FG002|Overall Study|Adverse Event|0|||
106053779|NCT00518284|365860760|FG003|Overall Study|Adverse Event|0|||
106053780|NCT00518284|365860757|FG000|Overall Study|Study Termination|0|||
106053781|NCT00518284|365860758|FG001|Overall Study|Study Termination|2|||
106053782|NCT00518284|365860759|FG002|Overall Study|Study Termination|1|||
106053783|NCT00518284|365860760|FG003|Overall Study|Study Termination|2|||
106053784|NCT03768414|365860761|FG000|Overall Study|Adverse Event or side effects|72|||
106053785|NCT03768414|365860762|FG001|Overall Study|Adverse Event or side effects|28|||
106053786|NCT03768414|365860761|FG000|Overall Study|Refusal unrelated to adverse event|33|||
106053787|NCT03768414|365860762|FG001|Overall Study|Refusal unrelated to adverse event|33|||
106053788|NCT03768414|365860761|FG000|Overall Study|Progression/relapse|132|||
106053789|NCT03768414|365860762|FG001|Overall Study|Progression/relapse|60|||
106053790|NCT03768414|365860761|FG000|Overall Study|Death|9|||
106053791|NCT03768414|365860762|FG001|Overall Study|Death|6|||
106053792|NCT03768414|365860761|FG000|Overall Study|Other - not protocol specified|45|||
106053793|NCT03768414|365860762|FG001|Overall Study|Other - not protocol specified|18|||
106053794|NCT03768414|365860761|FG000|Overall Study|Reason under review|3|||
106053795|NCT03768414|365860762|FG001|Overall Study|Reason under review|2|||
106053796|NCT04075266|365860763|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
106053797|NCT04075266|365860764|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
106053798|NCT04075266|365860763|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
106053799|NCT04075266|365860764|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
106053800|NCT01302834|365860765|FG000|Overall Study|Protocol Violation|17|||
106053801|NCT01302834|365860766|FG001|Overall Study|Protocol Violation|23|||
106053802|NCT01302834|365860765|FG000|Overall Study|HIV positive|1|||
106053803|NCT01302834|365860766|FG001|Overall Study|HIV positive|3|||
106053804|NCT01217801|365860767|FG000|Period 1|Protocol Violation|1|||
106053805|NCT01217801|365860768|FG001|Period 1|Protocol Violation|1|||
106053806|NCT01217801|365860767|FG000|Period 1|Withdrawal by Subject|0|||
106053807|NCT01217801|365860768|FG001|Period 1|Withdrawal by Subject|1|||
106053808|NCT05399641|365860769|FG000|Overall Study|Adverse Event|0|||
106053809|NCT05399641|365860770|FG001|Overall Study|Adverse Event|1|||
106053810|NCT05399641|365860771|FG002|Overall Study|Adverse Event|1|||
106053811|NCT05399641|365860769|FG000|Overall Study|Lost to Follow-up|1|||
106053812|NCT05399641|365860770|FG001|Overall Study|Lost to Follow-up|2|||
106053813|NCT05399641|365860771|FG002|Overall Study|Lost to Follow-up|2|||
106053814|NCT05399641|365860769|FG000|Overall Study|Physician Decision|1|||
106053815|NCT05399641|365860770|FG001|Overall Study|Physician Decision|3|||
106053816|NCT05399641|365860771|FG002|Overall Study|Physician Decision|3|||
106053817|NCT05399641|365860769|FG000|Overall Study|Withdrawal by Subject|4|||
106053818|NCT05399641|365860770|FG001|Overall Study|Withdrawal by Subject|11|||
106053819|NCT05399641|365860771|FG002|Overall Study|Withdrawal by Subject|7|||
106053820|NCT05399641|365860769|FG000|Overall Study|Reason not defined|3|||
106053821|NCT05399641|365860770|FG001|Overall Study|Reason not defined|5|||
106053822|NCT05399641|365860771|FG002|Overall Study|Reason not defined|6|||
106053823|NCT01300650|365860772|FG000|Overall Study|Adverse Event|1|||
106053824|NCT01201850|365860775|FG000|Overall Study|Tumor progression|4|||
106053825|NCT03386448|365860776|FG000|Overall Study|Adverse Event|0|||
106053826|NCT03386448|365860777|FG001|Overall Study|Adverse Event|2|||
106053827|NCT01146665|365860780|FG000|Overall Study|Withdrawal by Subject|10|||
106053828|NCT01146665|365860781|FG001|Overall Study|Withdrawal by Subject|16|||
106053829|NCT00816595|365860782|FG000|Overall Study|Withdrawal by Subject|2|||
106053830|NCT00816595|365860783|FG001|Overall Study|Withdrawal by Subject|0|||
106053831|NCT00751933|365860784|FG000|Overall Study|Withdrawal by Subject|0|||
106053832|NCT00751933|365860785|FG001|Overall Study|Withdrawal by Subject|1|||
106053833|NCT00751933|365860786|FG002|Overall Study|Withdrawal by Subject|0|||
106053834|NCT00751933|365860787|FG003|Overall Study|Withdrawal by Subject|0|||
106053835|NCT00751933|365860784|FG000|Overall Study|Physician Decision|0|||
106053836|NCT00751933|365860785|FG001|Overall Study|Physician Decision|0|||
106053837|NCT00751933|365860786|FG002|Overall Study|Physician Decision|1|||
106053838|NCT00751933|365860787|FG003|Overall Study|Physician Decision|1|||
106053839|NCT00001880|365860792|FG000|Overall Study|Death|14|||
106053840|NCT03298867|365860793|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
106053841|NCT03298867|365860794|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
106053842|NCT03298867|365860793|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
106053843|NCT03298867|365860794|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
106053844|NCT03298867|365860793|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
106053845|NCT03298867|365860794|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
106053846|NCT03298867|365860793|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
106053847|NCT03298867|365860794|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
106053848|NCT03298867|365860793|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
106053849|NCT03298867|365860794|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
106053850|NCT03298867|365860793|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
106053851|NCT03298867|365860794|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
106053852|NCT03298867|365860793|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
106053853|NCT03298867|365860794|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
106053854|NCT03298867|365860793|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
106053855|NCT03298867|365860794|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
106053856|NCT03298867|365860793|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
106053857|NCT03298867|365860794|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
106053858|NCT01382212|365860795|FG000|Overall Study|Kidney transplant|1|||
106053859|NCT01382212|365860795|FG000|Overall Study|Withdrew consent|1|||
106053860|NCT00743483|365860796|FG000|Baseline Period|Physician Decision|1|||
106053861|NCT00743483|365860796|FG000|Treatment Period|Adverse Event|1|||
106053862|NCT00228384|365860797|FG000|Overall Study|Death|9|||
106053863|NCT00228384|365860798|FG001|Overall Study|Death|3|||
106053864|NCT00228384|365860797|FG000|Overall Study|Lost to Follow-up|6|||
106053865|NCT00228384|365860798|FG001|Overall Study|Lost to Follow-up|10|||
106053866|NCT00228384|365860797|FG000|Overall Study|Surgical Intervention (bypass)|5|||
106053867|NCT00228384|365860798|FG001|Overall Study|Surgical Intervention (bypass)|5|||
106053868|NCT00228384|365860797|FG000|Overall Study|Withdrawal by Subject|9|||
106053869|NCT00228384|365860798|FG001|Overall Study|Withdrawal by Subject|10|||
106053870|NCT00228384|365860797|FG000|Overall Study|Physician Decision|0|||
106053871|NCT00228384|365860798|FG001|Overall Study|Physician Decision|1|||
106053872|NCT01084083|365860799|FG000|Overall Study|Adverse Event|5|||
106053873|NCT01084083|365860799|FG000|Overall Study|Death|1|||
106053874|NCT01084083|365860799|FG000|Overall Study|Withdrawal by Subject|2|||
106053875|NCT01084083|365860799|FG000|Overall Study|Complicating disease|1|||
106053876|NCT01084083|365860799|FG000|Overall Study|Other|2|||
106053877|NCT01084083|365860799|FG000|Overall Study|Never started assigned therapy|1|||
106053878|NCT01273597|365860800|FG000|Overall Study|Adverse Event|5|||
106053879|NCT01273597|365860800|FG000|Overall Study|Underwent Kidney Transplantation|2|||
106053880|NCT01273597|365860800|FG000|Overall Study|Reason Not Reported|1|||
106053881|NCT00873912|365860802|FG000|Overall Study|Withdrawal by Subject|1|||
106053882|NCT00873912|365860803|FG001|Overall Study|Withdrawal by Subject|0|||
106053883|NCT00873912|365860802|FG000|Overall Study|Lost to Follow-up|2|||
106053884|NCT00873912|365860803|FG001|Overall Study|Lost to Follow-up|0|||
106053885|NCT03749447|365862378|FG000|Overall Study|Adverse Event|11|||
106053886|NCT03749447|365862379|FG001|Overall Study|Adverse Event|3|||
106053887|NCT03749447|365862378|FG000|Overall Study|Death|1|||
106053888|NCT03749447|365862379|FG001|Overall Study|Death|1|||
106053889|NCT03749447|365862378|FG000|Overall Study|Lost to Follow-up|2|||
106053890|NCT03749447|365862379|FG001|Overall Study|Lost to Follow-up|2|||
106053891|NCT03749447|365862378|FG000|Overall Study|Reason Not Specified|0|||
106053892|NCT03749447|365862379|FG001|Overall Study|Reason Not Specified|3|||
106053893|NCT03749447|365862378|FG000|Overall Study|Physician Decision|4|||
106053894|NCT03749447|365862379|FG001|Overall Study|Physician Decision|3|||
106053895|NCT03749447|365862378|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
106053896|NCT03749447|365862379|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
106053897|NCT03749447|365862378|FG000|Overall Study|Study Terminated By Sponsor|112|||
106053898|NCT03749447|365862379|FG001|Overall Study|Study Terminated By Sponsor|105|||
106053899|NCT03749447|365862378|FG000|Overall Study|Withdrawal by Subject|12|||
106053900|NCT03749447|365862379|FG001|Overall Study|Withdrawal by Subject|6|||
106053901|NCT03749447|365862378|FG000|Overall Study|Non-compliance With Study Drug|0|||
106053902|NCT03749447|365862379|FG001|Overall Study|Non-compliance With Study Drug|1|||
106053903|NCT00967668|365862380|FG000|Overall Study|Withdrawal by Subject|13|||
106053904|NCT00967668|365862381|FG001|Overall Study|Withdrawal by Subject|8|||
106053905|NCT00967668|365862382|FG002|Overall Study|Withdrawal by Subject|8|||
106053906|NCT00967668|365862380|FG000|Overall Study|Death|0|||
106053907|NCT00967668|365862381|FG001|Overall Study|Death|2|||
106053908|NCT00967668|365862382|FG002|Overall Study|Death|4|||
106053909|NCT00967668|365862380|FG000|Overall Study|Removed due to behavior|1|||
106053910|NCT00967668|365862381|FG001|Overall Study|Removed due to behavior|1|||
106053911|NCT00967668|365862382|FG002|Overall Study|Removed due to behavior|2|||
106053912|NCT00967668|365862380|FG000|Overall Study|Refused Year 2|11|||
106053913|NCT00967668|365862381|FG001|Overall Study|Refused Year 2|6|||
106053914|NCT00967668|365862382|FG002|Overall Study|Refused Year 2|4|||
106053915|NCT00967668|365862380|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
106053916|NCT00967668|365862381|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
106053917|NCT00967668|365862382|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
106053918|NCT00967668|365862380|FG000|Overall Study|Lost to Follow-up|15|||
106053919|NCT00967668|365862381|FG001|Overall Study|Lost to Follow-up|9|||
106053920|NCT00967668|365862382|FG002|Overall Study|Lost to Follow-up|16|||
106053921|NCT00967668|365862380|FG000|Overall Study|Refused 12-mo assessment|3|||
106053922|NCT00967668|365862381|FG001|Overall Study|Refused 12-mo assessment|1|||
106053923|NCT00967668|365862382|FG002|Overall Study|Refused 12-mo assessment|9|||
106053924|NCT00967668|365862380|FG000|Overall Study|Pregnancy|1|||
106053925|NCT00967668|365862381|FG001|Overall Study|Pregnancy|0|||
106053926|NCT00967668|365862382|FG002|Overall Study|Pregnancy|0|||
106053927|NCT00709761|365862385|FG000|Overall Study|Withdrawal by Subject|8|||
106053928|NCT00709761|365862385|FG000|Overall Study|study closed/terminated|17|||
106053929|NCT00709761|365862385|FG000|Overall Study|Lost to Follow-up|2|||
106053930|NCT00259649|365862386|FG000|Overall Study|Lost to Follow-up|7|||
106053931|NCT00259649|365862386|FG000|Overall Study|irregular menses|3|||
106053932|NCT02200211|365862387|FG000|Overall Study|Lost to Follow-up|7|||
106053933|NCT02200211|365862388|FG001|Overall Study|Lost to Follow-up|7|||
106053934|NCT02200211|365862389|FG002|Overall Study|Lost to Follow-up|1|||
106053935|NCT02200211|365862390|FG003|Overall Study|Lost to Follow-up|2|||
106053936|NCT02200211|365862387|FG000|Overall Study|Withdrawal by Subject|1|||
106053937|NCT02200211|365862388|FG001|Overall Study|Withdrawal by Subject|0|||
106053938|NCT02200211|365862389|FG002|Overall Study|Withdrawal by Subject|0|||
106053939|NCT02200211|365862390|FG003|Overall Study|Withdrawal by Subject|0|||
106053940|NCT02469298|365862397|FG000|Overall Study|Protocol Violation|0|||
106053941|NCT02469298|365862398|FG001|Overall Study|Protocol Violation|1|||
106053942|NCT02469298|365862399|FG002|Overall Study|Protocol Violation|1|||
106053943|NCT02469298|365862400|FG003|Overall Study|Protocol Violation|0|||
106053944|NCT02469298|365862397|FG000|Overall Study|Lost to Follow-up|1|||
106053945|NCT02469298|365862398|FG001|Overall Study|Lost to Follow-up|0|||
106053946|NCT02469298|365862399|FG002|Overall Study|Lost to Follow-up|1|||
106053947|NCT02469298|365862400|FG003|Overall Study|Lost to Follow-up|0|||
106053948|NCT02469298|365862397|FG000|Overall Study|Physician Decision|0|||
106053949|NCT02469298|365862398|FG001|Overall Study|Physician Decision|0|||
106053950|NCT02469298|365862399|FG002|Overall Study|Physician Decision|0|||
106053951|NCT02469298|365862400|FG003|Overall Study|Physician Decision|1|||
106053952|NCT02469298|365862397|FG000|Overall Study|Withdrawal by Subject|0|||
106053953|NCT02469298|365862398|FG001|Overall Study|Withdrawal by Subject|0|||
106053954|NCT02469298|365862399|FG002|Overall Study|Withdrawal by Subject|0|||
106053955|NCT02469298|365862400|FG003|Overall Study|Withdrawal by Subject|1|||
106053956|NCT00787891|365862412|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
106053957|NCT00787891|365862413|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
106053958|NCT00787891|365862412|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
106053959|NCT00787891|365862413|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
106053960|NCT00787891|365862412|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
106053961|NCT00787891|365862413|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
106053962|NCT00787891|365862412|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
106053963|NCT00787891|365862413|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
106053964|NCT00787891|365862412|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
106053965|NCT00787891|365862413|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
106053966|NCT00787891|365862412|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
106053967|NCT00787891|365862413|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
106053968|NCT00787891|365862412|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
106053969|NCT00787891|365862413|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
106053970|NCT00787891|365862412|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
106053971|NCT00787891|365862413|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
106053972|NCT00787891|365862412|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
106053973|NCT00787891|365862413|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
106053974|NCT00787891|365862412|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
106053975|NCT00787891|365862413|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
106053976|NCT03797014|365862416|FG000|Overall Study|Withdrawal by Subject|1|||
106053977|NCT03797014|365862416|FG000|Overall Study|Lost to Follow-up|1|||
106053978|NCT03797014|365862416|FG000|Overall Study|Protocol Violation|1|||
106053979|NCT01434667|365862425|FG000|Overall Study|Lost to Follow-up|5|||
106053980|NCT01434667|365862426|FG001|Overall Study|Lost to Follow-up|10|||
106053981|NCT02165215|365862427|FG000|Induction Phase|Adverse Event|1|||
106053982|NCT02165215|365862428|FG001|Induction Phase|Adverse Event|0|||
106053983|NCT02165215|365862429|FG002|Induction Phase|Adverse Event|0|||
106053984|NCT02165215|365862427|FG000|Induction Phase|Withdrawal by Subject|10|||
106053985|NCT02165215|365862428|FG001|Induction Phase|Withdrawal by Subject|0|||
106053986|NCT02165215|365862429|FG002|Induction Phase|Withdrawal by Subject|0|||
106053987|NCT02165215|365862427|FG000|Induction Phase|Protocol Violation|1|||
106053988|NCT02165215|365862428|FG001|Induction Phase|Protocol Violation|0|||
106053989|NCT02165215|365862429|FG002|Induction Phase|Protocol Violation|0|||
106053990|NCT02165215|365862427|FG000|Induction Phase|Physician Decision|1|||
106053991|NCT02165215|365862428|FG001|Induction Phase|Physician Decision|0|||
106053992|NCT02165215|365862429|FG002|Induction Phase|Physician Decision|0|||
106053993|NCT02165215|365862427|FG000|Induction Phase|Lack of Efficacy|2|||
106053994|NCT02165215|365862428|FG001|Induction Phase|Lack of Efficacy|0|||
106053995|NCT02165215|365862429|FG002|Induction Phase|Lack of Efficacy|0|||
106053996|NCT02165215|365862427|FG000|Induction Phase|Non-Compliance|2|||
106053997|NCT02165215|365862428|FG001|Induction Phase|Non-Compliance|0|||
106053998|NCT02165215|365862429|FG002|Induction Phase|Non-Compliance|0|||
106053999|NCT02165215|365862427|FG000|Induction Phase|Lost to Follow-up|6|||
106054000|NCT02165215|365862428|FG001|Induction Phase|Lost to Follow-up|0|||
106054001|NCT02165215|365862429|FG002|Induction Phase|Lost to Follow-up|0|||
106054002|NCT02165215|365862427|FG000|Maintenance Phase|Withdrawal by Subject|0|||
106054003|NCT02165215|365862428|FG001|Maintenance Phase|Withdrawal by Subject|7|||
106054004|NCT02165215|365862429|FG002|Maintenance Phase|Withdrawal by Subject|3|||
106054005|NCT02165215|365862427|FG000|Maintenance Phase|Multiple reasons|0|||
106054006|NCT02165215|365862428|FG001|Maintenance Phase|Multiple reasons|2|||
106054007|NCT02165215|365862429|FG002|Maintenance Phase|Multiple reasons|1|||
106054008|NCT02165215|365862427|FG000|Maintenance Phase|Lost to Follow-up|0|||
106054009|NCT02165215|365862428|FG001|Maintenance Phase|Lost to Follow-up|2|||
106054010|NCT02165215|365862429|FG002|Maintenance Phase|Lost to Follow-up|0|||
106054011|NCT02165215|365862427|FG000|Maintenance Phase|Adverse Event|0|||
106054012|NCT02165215|365862428|FG001|Maintenance Phase|Adverse Event|1|||
106054013|NCT02165215|365862429|FG002|Maintenance Phase|Adverse Event|1|||
106054014|NCT01877265|365862430|FG000|Treatment Period 1|Sponsor Decision|0|||
106054015|NCT01877265|365862431|FG001|Treatment Period 1|Sponsor Decision|0|||
106054016|NCT01877265|365862432|FG002|Treatment Period 1|Sponsor Decision|1|||
106054017|NCT01877265|365862433|FG003|Treatment Period 1|Sponsor Decision|0|||
106054018|NCT01877265|365862434|FG004|Treatment Period 1|Sponsor Decision|0|||
106054019|NCT01877265|365862435|FG005|Treatment Period 1|Sponsor Decision|0|||
106054020|NCT01877265|365862430|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
106054021|NCT01877265|365862431|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
106054022|NCT01877265|365862432|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
106054023|NCT01877265|365862433|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
106054024|NCT01877265|365862434|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
106054025|NCT01877265|365862435|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
106054026|NCT01877265|365862430|FG000|Treatment Period 3|Lost to Follow-up|1|||
106054027|NCT01877265|365862431|FG001|Treatment Period 3|Lost to Follow-up|0|||
106054028|NCT01877265|365862432|FG002|Treatment Period 3|Lost to Follow-up|0|||
106054029|NCT01877265|365862433|FG003|Treatment Period 3|Lost to Follow-up|0|||
106054030|NCT01877265|365862434|FG004|Treatment Period 3|Lost to Follow-up|0|||
106054031|NCT01877265|365862435|FG005|Treatment Period 3|Lost to Follow-up|0|||
106054032|NCT03535844|365862442|FG000|Overall Study|Withdrawal by Subject|0|||
106054033|NCT03535844|365862443|FG001|Overall Study|Withdrawal by Subject|1|||
106054034|NCT00297830|365862444|FG000|6 Month Visit|Death|1|||
106054035|NCT00297830|365862445|FG001|6 Month Visit|Death|0|||
106054036|NCT00297830|365862446|FG002|6 Month Visit|Death|2|||
106054037|NCT00297830|365862444|FG000|6 Month Visit|Withdrawal by Subject|2|||
106054038|NCT00297830|365862445|FG001|6 Month Visit|Withdrawal by Subject|1|||
106054039|NCT00297830|365862446|FG002|6 Month Visit|Withdrawal by Subject|1|||
106054040|NCT00297830|365862444|FG000|6 Month Visit|Adverse Event|0|||
106054041|NCT00297830|365862445|FG001|6 Month Visit|Adverse Event|1|||
106054042|NCT00297830|365862446|FG002|6 Month Visit|Adverse Event|0|||
106054043|NCT00297830|365862444|FG000|12 Month Visit|Lost to Follow-up|1|||
106054044|NCT00297830|365862445|FG001|12 Month Visit|Lost to Follow-up|0|||
106054045|NCT00297830|365862446|FG002|12 Month Visit|Lost to Follow-up|0|||
106054046|NCT00297830|365862444|FG000|12 Month Visit|Adverse Event|0|||
106054047|NCT00297830|365862445|FG001|12 Month Visit|Adverse Event|3|||
106054048|NCT00297830|365862446|FG002|12 Month Visit|Adverse Event|0|||
106054049|NCT00297830|365862444|FG000|12 Month Visit|Withdrawal by Subject|0|||
106054050|NCT00297830|365862445|FG001|12 Month Visit|Withdrawal by Subject|3|||
106054051|NCT00297830|365862446|FG002|12 Month Visit|Withdrawal by Subject|0|||
106054052|NCT02835820|365862447|FG000|Overall Study|Baseline Screen Failure|0|||
106054053|NCT02835820|365862448|FG001|Overall Study|Baseline Screen Failure|3|||
106054054|NCT00590720|365862449|FG000|Overall Study|Lost to Follow-up|1|||
106054055|NCT00590720|365862450|FG001|Overall Study|Lost to Follow-up|0|||
106054056|NCT00590720|365862449|FG000|Overall Study|Withdrawal by Subject|0|||
106054057|NCT00590720|365862450|FG001|Overall Study|Withdrawal by Subject|1|||
106054058|NCT01001377|365862454|FG000|Overall Study|Ineligibility determined|2|||
106054059|NCT01001377|365862455|FG001|Overall Study|Ineligibility determined|0|||
106054060|NCT01001377|365862454|FG000|Overall Study|Withdrawal by Subject|19|||
106054061|NCT01001377|365862455|FG001|Overall Study|Withdrawal by Subject|20|||
106054062|NCT01001377|365862454|FG000|Overall Study|Lost to Follow-up|14|||
106054063|NCT01001377|365862455|FG001|Overall Study|Lost to Follow-up|17|||
106054064|NCT01001377|365862454|FG000|Overall Study|Death|391|||
106054065|NCT01001377|365862455|FG001|Overall Study|Death|384|||
106054066|NCT03039283|365862460|FG000|Overall Study|Protocol Violation|2|||
106054067|NCT01056653|365862461|FG000|Overall Study|Lost to Follow-up|0|||
106054068|NCT01056653|365862462|FG001|Overall Study|Lost to Follow-up|0|||
106054069|NCT01056653|365862463|FG002|Overall Study|Lost to Follow-up|2|||
106054070|NCT03094169|365862464|FG000|Overall Study|Lack of Efficacy|0|||
106054071|NCT03094169|365862465|FG001|Overall Study|Lack of Efficacy|0|||
106054072|NCT03094169|365862466|FG002|Overall Study|Lack of Efficacy|0|||
106054073|NCT03094169|365862467|FG003|Overall Study|Lack of Efficacy|0|||
106054074|NCT03094169|365862468|FG004|Overall Study|Lack of Efficacy|0|||
106054075|NCT03094169|365862469|FG005|Overall Study|Lack of Efficacy|0|||
106054076|NCT03094169|365862470|FG006|Overall Study|Lack of Efficacy|0|||
106054077|NCT03094169|365862471|FG007|Overall Study|Lack of Efficacy|21|||
106054078|NCT03094169|365862464|FG000|Overall Study|Adverse Event|0|||
106054079|NCT03094169|365862465|FG001|Overall Study|Adverse Event|0|||
106054080|NCT03094169|365862466|FG002|Overall Study|Adverse Event|0|||
106054081|NCT03094169|365862467|FG003|Overall Study|Adverse Event|0|||
106054082|NCT03094169|365862468|FG004|Overall Study|Adverse Event|0|||
106054083|NCT03094169|365862469|FG005|Overall Study|Adverse Event|0|||
106054084|NCT03094169|365862470|FG006|Overall Study|Adverse Event|0|||
106054085|NCT03094169|365862471|FG007|Overall Study|Adverse Event|2|||
106054086|NCT03094169|365862464|FG000|Overall Study|Withdrawal by Subject|0|||
106054087|NCT03094169|365862465|FG001|Overall Study|Withdrawal by Subject|0|||
106054088|NCT03094169|365862466|FG002|Overall Study|Withdrawal by Subject|0|||
106054089|NCT03094169|365862467|FG003|Overall Study|Withdrawal by Subject|0|||
106054090|NCT03094169|365862468|FG004|Overall Study|Withdrawal by Subject|0|||
106054091|NCT03094169|365862469|FG005|Overall Study|Withdrawal by Subject|0|||
106054092|NCT03094169|365862470|FG006|Overall Study|Withdrawal by Subject|1|||
106054093|NCT03094169|365862471|FG007|Overall Study|Withdrawal by Subject|1|||
106054094|NCT03094169|365862464|FG000|Overall Study|Trial Termination|0|||
106054095|NCT03094169|365862465|FG001|Overall Study|Trial Termination|0|||
106054096|NCT03094169|365862466|FG002|Overall Study|Trial Termination|0|||
106054097|NCT03094169|365862467|FG003|Overall Study|Trial Termination|0|||
106054098|NCT03094169|365862468|FG004|Overall Study|Trial Termination|0|||
106054099|NCT03094169|365862469|FG005|Overall Study|Trial Termination|0|||
106054100|NCT03094169|365862470|FG006|Overall Study|Trial Termination|0|||
106054101|NCT03094169|365862471|FG007|Overall Study|Trial Termination|1|||
106054102|NCT04930965|365862473|FG000|Overall Study|Lost to Follow-up|7|||
106054103|NCT04930965|365862474|FG001|Overall Study|Lost to Follow-up|5|||
106054104|NCT01010061|365862475|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
106054105|NCT01010061|365862476|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
106054106|NCT01010061|365862475|FG000|Overall Study|Disease Progression|2|||
106054107|NCT01010061|365862476|FG001|Overall Study|Disease Progression|8|||
106054108|NCT01010061|365862475|FG000|Overall Study|Withdrew Consent|5|||
106054109|NCT01010061|365862476|FG001|Overall Study|Withdrew Consent|1|||
106054110|NCT01010061|365862475|FG000|Overall Study|Death|3|||
106054111|NCT01010061|365862476|FG001|Overall Study|Death|6|||
106054112|NCT01010061|365862475|FG000|Overall Study|Administrative/Other|0|||
106054113|NCT01010061|365862476|FG001|Overall Study|Administrative/Other|1|||
106054114|NCT01010061|365862475|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
106054115|NCT01010061|365862476|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
106054116|NCT01010061|365862475|FG000|Overall Study|Insufficient Therapeutic Response|1|||
106054117|NCT01010061|365862476|FG001|Overall Study|Insufficient Therapeutic Response|5|||
106054118|NCT01010061|365862475|FG000|Overall Study|Violation of Selection Criteria|0|||
106054119|NCT01010061|365862476|FG001|Overall Study|Violation of Selection Criteria|1|||
106054120|NCT01010061|365862475|FG000|Overall Study|Did Not Receive Treatment|2|||
106054121|NCT01010061|365862476|FG001|Overall Study|Did Not Receive Treatment|2|||
106054122|NCT00329238|365862477|FG000|Overall Study|Adverse Event|147|||
106054123|NCT00329238|365862478|FG001|Overall Study|Adverse Event|129|||
106054124|NCT00329238|365862477|FG000|Overall Study|Protocol Violation|23|||
106054125|NCT00329238|365862478|FG001|Overall Study|Protocol Violation|34|||
106054126|NCT00329238|365862477|FG000|Overall Study|Lost to Follow-up|2|||
106054127|NCT00329238|365862478|FG001|Overall Study|Lost to Follow-up|6|||
106054128|NCT00329238|365862477|FG000|Overall Study|Withdrawal by Subject|64|||
106054129|NCT00329238|365862478|FG001|Overall Study|Withdrawal by Subject|58|||
106054130|NCT00329238|365862477|FG000|Overall Study|Other reason (not specified)|40|||
106054131|NCT00329238|365862478|FG001|Overall Study|Other reason (not specified)|54|||
106054132|NCT00801632|365862479|FG000|Overall Study|Re-transplant|1|||
106054133|NCT00968513|365862484|FG000|Overall Study|Death|4|||
106054134|NCT00968513|365862485|FG001|Overall Study|Death|10|||
106054135|NCT00968513|365862486|FG002|Overall Study|Death|15|||
106054136|NCT05537883|365862487|FG000|Overall Study|revisional surgery|4|||
106054137|NCT05537883|365862488|FG001|Overall Study|revisional surgery|2|||
106054138|NCT05537883|365862487|FG000|Overall Study|surgeries were cancelled|0|||
106054139|NCT05537883|365862488|FG001|Overall Study|surgeries were cancelled|2|||
106054140|NCT05537883|365862487|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
106054141|NCT05537883|365862488|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
106054142|NCT01328431|365862489|FG000|Baseline|Protocol Violation|0|||
106054143|NCT01328431|365862490|FG001|Baseline|Protocol Violation|2|||
106054144|NCT01328431|365862489|FG000|1 Month (1M)|Lost to Follow-up|55|||
106054145|NCT01328431|365862490|FG001|1 Month (1M)|Lost to Follow-up|58|||
106054146|NCT01328431|365862489|FG000|3 Month (3M)|Death|2|||
106054147|NCT01328431|365862490|FG001|3 Month (3M)|Death|2|||
106054148|NCT01328431|365862489|FG000|3 Month (3M)|Lost to Follow-up|75|||
106054149|NCT01328431|365862490|FG001|3 Month (3M)|Lost to Follow-up|70|||
106054150|NCT01328431|365862489|FG000|12 Month (12M)|Death|2|||
106054151|NCT01328431|365862490|FG001|12 Month (12M)|Death|6|||
106054152|NCT01328431|365862489|FG000|12 Month (12M)|Lost to Follow-up|82|||
106054153|NCT01328431|365862490|FG001|12 Month (12M)|Lost to Follow-up|91|||
106054154|NCT05379231|365862491|FG000|Home Visit|Withdrawal by Subject|2|||
106054155|NCT05379231|365862491|FG000|In-lab Visit|Withdrawal by Subject|2|||
106054156|NCT02296320|365862497|FG000|Overall Study|Withdrawal by Subject|4|||
106054157|NCT02296320|365862498|FG001|Overall Study|Withdrawal by Subject|0|||
106054158|NCT02296320|365862499|FG002|Overall Study|Withdrawal by Subject|2|||
106054159|NCT02296320|365862497|FG000|Overall Study|Death|24|||
106054160|NCT02296320|365862498|FG001|Overall Study|Death|3|||
106054161|NCT02296320|365862499|FG002|Overall Study|Death|27|||
106054162|NCT02296320|365862497|FG000|Overall Study|Lost to Follow-up|5|||
106054163|NCT02296320|365862498|FG001|Overall Study|Lost to Follow-up|2|||
106054164|NCT02296320|365862499|FG002|Overall Study|Lost to Follow-up|7|||
106054165|NCT02296320|365862497|FG000|Overall Study|Not treated|2|||
106054166|NCT02296320|365862498|FG001|Overall Study|Not treated|0|||
106054167|NCT02296320|365862499|FG002|Overall Study|Not treated|0|||
106054168|NCT02296320|365862497|FG000|Overall Study|Not - specified|0|||
106054169|NCT02296320|365862498|FG001|Overall Study|Not - specified|0|||
106054170|NCT02296320|365862499|FG002|Overall Study|Not - specified|1|||
106054171|NCT01306942|365862507|FG000|Phase I|Adverse Event|2|||
106054172|NCT01306942|365862508|FG001|Phase I|Adverse Event|2|||
106054173|NCT01306942|365862509|FG002|Phase I|Adverse Event|0|||
106054174|NCT01306942|365862510|FG003|Phase I|Adverse Event|0|||
106054175|NCT01306942|365862507|FG000|Phase I|Physician Decision|3|||
106054176|NCT01306942|365862508|FG001|Phase I|Physician Decision|1|||
106054177|NCT01306942|365862509|FG002|Phase I|Physician Decision|0|||
106054178|NCT01306942|365862510|FG003|Phase I|Physician Decision|0|||
106054179|NCT01306942|365862507|FG000|Phase II|Adverse Event|0|||
106054180|NCT01306942|365862508|FG001|Phase II|Adverse Event|0|||
106054181|NCT01306942|365862509|FG002|Phase II|Adverse Event|0|||
106054182|NCT01306942|365862510|FG003|Phase II|Adverse Event|6|||
106054183|NCT01306942|365862507|FG000|Phase II|Physician Decision|2|||
106054184|NCT01306942|365862508|FG001|Phase II|Physician Decision|0|||
106054185|NCT01306942|365862509|FG002|Phase II|Physician Decision|0|||
106054186|NCT01306942|365862510|FG003|Phase II|Physician Decision|5|||
106054187|NCT01306942|365862507|FG000|Phase II|Withdrawal by Subject|0|||
106054188|NCT01306942|365862508|FG001|Phase II|Withdrawal by Subject|0|||
106054189|NCT01306942|365862509|FG002|Phase II|Withdrawal by Subject|0|||
106054190|NCT01306942|365862510|FG003|Phase II|Withdrawal by Subject|2|||
106054191|NCT01306942|365862507|FG000|Phase II|Death|0|||
106054192|NCT01306942|365862508|FG001|Phase II|Death|0|||
106054193|NCT01306942|365862509|FG002|Phase II|Death|0|||
106054194|NCT01306942|365862510|FG003|Phase II|Death|1|||
106054195|NCT01306942|365862507|FG000|Phase II|Not finished treatment|0|||
106054196|NCT01306942|365862508|FG001|Phase II|Not finished treatment|0|||
106054197|NCT01306942|365862509|FG002|Phase II|Not finished treatment|0|||
106054198|NCT01306942|365862510|FG003|Phase II|Not finished treatment|1|||
106054199|NCT01306942|365862507|FG000|Phase II|Protocol Violation|0|||
106054200|NCT01306942|365862508|FG001|Phase II|Protocol Violation|0|||
106054201|NCT01306942|365862509|FG002|Phase II|Protocol Violation|0|||
106054202|NCT01306942|365862510|FG003|Phase II|Protocol Violation|1|||
106054203|NCT03953820|365862511|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
106054204|NCT03953820|365862512|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
106054205|NCT03953820|365862513|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
106054206|NCT03953820|365862511|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
106054207|NCT03953820|365862512|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
106054208|NCT03953820|365862513|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
106054209|NCT00087607|365862519|FG000|Overall Study|Adverse Event|14|||
106054210|NCT00087607|365862520|FG001|Overall Study|Adverse Event|24|||
106054211|NCT00087607|365862519|FG000|Overall Study|Death|0|||
106054212|NCT00087607|365862520|FG001|Overall Study|Death|1|||
106054213|NCT00087607|365862519|FG000|Overall Study|Insufficient Therapeutic Response|53|||
106054214|NCT00087607|365862520|FG001|Overall Study|Insufficient Therapeutic Response|42|||
106054215|NCT00087607|365862519|FG000|Overall Study|Failure to return|21|||
106054216|NCT00087607|365862520|FG001|Overall Study|Failure to return|17|||
106054217|NCT00087607|365862519|FG000|Overall Study|Withdrew Consent|12|||
106054218|NCT00087607|365862520|FG001|Overall Study|Withdrew Consent|16|||
106054219|NCT00087607|365862519|FG000|Overall Study|Administrative|12|||
106054220|NCT00087607|365862520|FG001|Overall Study|Administrative|12|||
106054221|NCT00087607|365862519|FG000|Overall Study|Refused Treatment|5|||
106054222|NCT00087607|365862520|FG001|Overall Study|Refused Treatment|7|||
106054223|NCT00087607|365862519|FG000|Overall Study|Other Protocol Violation|5|||
106054224|NCT00087607|365862520|FG001|Overall Study|Other Protocol Violation|2|||
106054225|NCT00087607|365862519|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
106054226|NCT00087607|365862520|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
106054227|NCT01253408|365862521|FG000|Overall Study|Adverse Event|0|||
106054228|NCT01253408|365862522|FG001|Overall Study|Adverse Event|1|||
106054229|NCT01253408|365862523|FG002|Overall Study|Adverse Event|0|||
106054230|NCT02094677|365862524|FG000|Overall Study|Screening|3|||
106054231|NCT02094677|365862525|FG001|Overall Study|Screening|1|||
106054232|NCT03253744|365862526|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
106054233|NCT03253744|365862527|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
106054234|NCT03253744|365862528|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
106054235|NCT03253744|365862529|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
106054236|NCT04698187|365862532|FG000|Overall Study|Withdrawal by Subject|7|||
106054237|NCT04698187|365862532|FG000|Overall Study|Death|21|||
106054238|NCT04698187|365862532|FG000|Overall Study|Sponsor Decision|15|||
106054239|NCT04698187|365862532|FG000|Overall Study|In-transit Disease|1|||
106054240|NCT02513394|365862534|FG000|Overall Study|Withdrawal by Subject|11|||
106054241|NCT02513394|365862535|FG001|Overall Study|Withdrawal by Subject|23|||
106054242|NCT02513394|365862534|FG000|Overall Study|Ineligible|1|||
106054243|NCT02513394|365862535|FG001|Overall Study|Ineligible|0|||
106054244|NCT01898806|365864030|FG000|Overall Study|Withdrawal by Subject|2|||
106054245|NCT01898806|365864030|FG000|Overall Study|Physician Decision|1|||
106054246|NCT03478930|365864040|FG000|Overall Study|Adverse Event|0|||
106054247|NCT03478930|365864041|FG001|Overall Study|Adverse Event|1|||
106054248|NCT03478930|365864040|FG000|Overall Study|Lack of Efficacy|3|||
106054249|NCT03478930|365864041|FG001|Overall Study|Lack of Efficacy|3|||
106054250|NCT03478930|365864040|FG000|Overall Study|Withdrawal by Subject|6|||
106054251|NCT03478930|365864041|FG001|Overall Study|Withdrawal by Subject|5|||
106054252|NCT04189081|365864042|FG000|Overall Study|Lost to Follow-up|1|||
106054253|NCT04189081|365864043|FG001|Overall Study|Lost to Follow-up|0|||
106054254|NCT04189081|365864044|FG002|Overall Study|Lost to Follow-up|0|||
106054255|NCT04189081|365864042|FG000|Overall Study|Withdrawal by Subject|0|||
106054256|NCT04189081|365864043|FG001|Overall Study|Withdrawal by Subject|0|||
106054257|NCT04189081|365864044|FG002|Overall Study|Withdrawal by Subject|1|||
106054258|NCT00705484|365864048|FG000|Overall Study|Adverse Event|28|||
106054259|NCT00705484|365864049|FG001|Overall Study|Adverse Event|27|||
106054260|NCT00705484|365864048|FG000|Overall Study|Lost to Follow-up|169|||
106054261|NCT00705484|365864049|FG001|Overall Study|Lost to Follow-up|250|||
106054262|NCT00705484|365864048|FG000|Overall Study|Withdrawal by Subject|96|||
106054263|NCT00705484|365864049|FG001|Overall Study|Withdrawal by Subject|72|||
106054264|NCT00705484|365864048|FG000|Overall Study|Administrative|89|||
106054265|NCT00705484|365864049|FG001|Overall Study|Administrative|59|||
106054266|NCT02197247|365864050|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
106054267|NCT02197247|365864050|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
106054268|NCT02197247|365864050|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
106054269|NCT02197247|365864050|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
106054270|NCT02197247|365864050|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
106054271|NCT02197247|365864050|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
106054272|NCT02197247|365864050|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
106054273|NCT02197247|365864050|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
106054274|NCT00702923|365864060|FG000|Overall Study|Adverse Event|1|||
106054275|NCT02002091|365864062|FG000|Screening|Lost to Follow-up|10|||
106054276|NCT02002091|365864063|FG001|Screening|Lost to Follow-up|12|||
106054277|NCT02002091|365864062|FG000|Screening|Death|3|||
106054278|NCT02002091|365864063|FG001|Screening|Death|2|||
106054279|NCT00369824|365864064|FG000|Overall Study|Adverse Event|0|||
106054280|NCT00369824|365864065|FG001|Overall Study|Adverse Event|2|||
106054281|NCT00369824|365864066|FG002|Overall Study|Adverse Event|0|||
106054282|NCT00369824|365864067|FG003|Overall Study|Adverse Event|0|||
106054283|NCT00369824|365864068|FG004|Overall Study|Adverse Event|1|||
106054284|NCT00369824|365864069|FG005|Overall Study|Adverse Event|0|||
106054285|NCT00369824|365864064|FG000|Overall Study|Protocol Violation|0|||
106054286|NCT00369824|365864065|FG001|Overall Study|Protocol Violation|1|||
106054287|NCT00369824|365864066|FG002|Overall Study|Protocol Violation|0|||
106054288|NCT00369824|365864067|FG003|Overall Study|Protocol Violation|1|||
106054289|NCT00369824|365864068|FG004|Overall Study|Protocol Violation|1|||
106054290|NCT00369824|365864069|FG005|Overall Study|Protocol Violation|0|||
106054291|NCT00369824|365864064|FG000|Overall Study|Withdrawal by Subject|9|||
106054292|NCT00369824|365864065|FG001|Overall Study|Withdrawal by Subject|5|||
106054293|NCT00369824|365864066|FG002|Overall Study|Withdrawal by Subject|5|||
106054294|NCT00369824|365864067|FG003|Overall Study|Withdrawal by Subject|4|||
106054295|NCT00369824|365864068|FG004|Overall Study|Withdrawal by Subject|6|||
106054296|NCT00369824|365864069|FG005|Overall Study|Withdrawal by Subject|2|||
106054297|NCT00369824|365864064|FG000|Overall Study|Lost to Follow-up|6|||
106054298|NCT00369824|365864065|FG001|Overall Study|Lost to Follow-up|11|||
106054299|NCT00369824|365864066|FG002|Overall Study|Lost to Follow-up|7|||
106054300|NCT00369824|365864067|FG003|Overall Study|Lost to Follow-up|8|||
106054301|NCT00369824|365864068|FG004|Overall Study|Lost to Follow-up|9|||
106054302|NCT00369824|365864069|FG005|Overall Study|Lost to Follow-up|6|||
106054303|NCT00369824|365864064|FG000|Overall Study|Other|0|||
106054304|NCT00369824|365864065|FG001|Overall Study|Other|0|||
106054305|NCT00369824|365864066|FG002|Overall Study|Other|0|||
106054306|NCT00369824|365864067|FG003|Overall Study|Other|2|||
106054307|NCT00369824|365864068|FG004|Overall Study|Other|1|||
106054308|NCT00369824|365864069|FG005|Overall Study|Other|3|||
106054309|NCT01390649|365864070|FG000|Overall Study|Physician Decision|1|||
106054310|NCT02217878|365864071|FG000|Overall Study|required morphine due to chest pain|1|||
106054311|NCT02217878|365864072|FG001|Overall Study|required morphine due to chest pain|2|||
106152445|NCT03088813|366218793|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
106152446|NCT03088813|366218794|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
106152447|NCT03088813|366218795|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
106152448|NCT03088813|366218796|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
106152449|NCT03088813|366218793|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
106152450|NCT03088813|366218794|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
106054312|NCT02217878|365864071|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
106054313|NCT02217878|365864072|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
106054314|NCT03516812|365864073|FG000|Overall Study|Adverse Event|4|||
106054315|NCT03516812|365864073|FG000|Overall Study|Lack of Efficacy|2|||
106054316|NCT00622401|365864074|FG000|Overall Study|Disease progression prior to treatment|3|||
106054317|NCT00622401|365864075|FG001|Overall Study|Disease progression prior to treatment|2|||
106054318|NCT00622401|365864076|FG002|Overall Study|Disease progression prior to treatment|0|||
106054319|NCT03087643|365864081|FG000|Overall Study|Withdrawal by Subject|2|||
106054320|NCT03087643|365864082|FG001|Overall Study|Withdrawal by Subject|4|||
106054321|NCT03087643|365864081|FG000|Overall Study|Death|2|||
106054322|NCT03087643|365864082|FG001|Overall Study|Death|2|||
106054323|NCT02083783|365864086|FG000|Overall Study|Withdrawal by Subject|1|||
106054324|NCT02083783|365864087|FG001|Overall Study|Withdrawal by Subject|0|||
106054325|NCT01427972|365864095|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054326|NCT01427972|365864096|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054327|NCT01427972|365864097|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054328|NCT01427972|365864098|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054329|NCT01427972|365864099|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054330|NCT01427972|365864100|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054331|NCT01427972|365864101|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054332|NCT01427972|365864102|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
106054333|NCT01427972|365864103|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054334|NCT01427972|365864104|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054335|NCT01427972|365864105|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054336|NCT01427972|365864106|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
106054337|NCT01427972|365864095|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054338|NCT01427972|365864096|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054339|NCT01427972|365864097|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054340|NCT01427972|365864098|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054341|NCT01427972|365864099|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054342|NCT01427972|365864100|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
106054343|NCT01427972|365864101|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054344|NCT01427972|365864102|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054345|NCT01427972|365864103|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054346|NCT01427972|365864104|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054347|NCT01427972|365864105|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054348|NCT01427972|365864106|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
106054349|NCT01427972|365864095|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054350|NCT01427972|365864096|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
106054351|NCT01427972|365864097|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054352|NCT01427972|365864098|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054353|NCT01427972|365864099|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054354|NCT01427972|365864100|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054355|NCT01427972|365864101|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054356|NCT01427972|365864102|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054357|NCT01427972|365864103|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054358|NCT01427972|365864104|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106152451|NCT03088813|366218795|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
106054359|NCT01427972|365864105|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054360|NCT01427972|365864106|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
106054361|NCT02021773|365864110|FG000|Overall Study|Adverse Event|1|||
106054362|NCT02021773|365864111|FG001|Overall Study|Adverse Event|4|||
106054363|NCT02021773|365864112|FG002|Overall Study|Adverse Event|3|||
106054364|NCT02021773|365864110|FG000|Overall Study|Lack of Efficacy|2|||
106152452|NCT03088813|366218796|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
106152453|NCT03088813|366218793|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
106152454|NCT03088813|366218794|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
106054365|NCT02021773|365864111|FG001|Overall Study|Lack of Efficacy|2|||
106054366|NCT02021773|365864112|FG002|Overall Study|Lack of Efficacy|2|||
106054367|NCT02021773|365864110|FG000|Overall Study|Protocol Violation|2|||
106054368|NCT02021773|365864111|FG001|Overall Study|Protocol Violation|3|||
106054369|NCT02021773|365864112|FG002|Overall Study|Protocol Violation|1|||
106054370|NCT02021773|365864110|FG000|Overall Study|Withdrawal by Subject|3|||
106054371|NCT02021773|365864111|FG001|Overall Study|Withdrawal by Subject|4|||
106054372|NCT02021773|365864112|FG002|Overall Study|Withdrawal by Subject|5|||
106054373|NCT02021773|365864110|FG000|Overall Study|Lost to Follow-up|1|||
106054374|NCT02021773|365864111|FG001|Overall Study|Lost to Follow-up|3|||
106054375|NCT02021773|365864112|FG002|Overall Study|Lost to Follow-up|0|||
106054376|NCT02021773|365864110|FG000|Overall Study|Reason not specified|3|||
106054377|NCT02021773|365864111|FG001|Overall Study|Reason not specified|0|||
106054378|NCT02021773|365864112|FG002|Overall Study|Reason not specified|0|||
106054379|NCT00799422|365864113|FG000|First Week of Wear|Lost to Follow-up|0|||
106054380|NCT00799422|365864114|FG001|First Week of Wear|Lost to Follow-up|0|||
106054381|NCT00799422|365864115|FG002|First Week of Wear|Lost to Follow-up|1|||
106054382|NCT00799422|365864116|FG003|First Week of Wear|Lost to Follow-up|0|||
106054383|NCT00799422|365864117|FG004|First Week of Wear|Lost to Follow-up|0|||
106054384|NCT00799422|365864118|FG005|First Week of Wear|Lost to Follow-up|0|||
106054385|NCT00799422|365864113|FG000|First Week of Wear|Adverse Event|0|||
106054386|NCT00799422|365864114|FG001|First Week of Wear|Adverse Event|0|||
106054387|NCT00799422|365864115|FG002|First Week of Wear|Adverse Event|0|||
106054388|NCT00799422|365864116|FG003|First Week of Wear|Adverse Event|1|||
106054389|NCT00799422|365864117|FG004|First Week of Wear|Adverse Event|0|||
106054390|NCT00799422|365864118|FG005|First Week of Wear|Adverse Event|0|||
106054391|NCT00530946|365864120|FG000|Overall Study|Adverse Event|1|||
106054392|NCT00530946|365864121|FG001|Overall Study|Adverse Event|2|||
106054393|NCT00530946|365864122|FG002|Overall Study|Adverse Event|1|||
106054394|NCT00530946|365864123|FG003|Overall Study|Adverse Event|1|||
106054395|NCT00530946|365864120|FG000|Overall Study|Protocol Violation|0|||
106054396|NCT00530946|365864121|FG001|Overall Study|Protocol Violation|0|||
106054397|NCT00530946|365864122|FG002|Overall Study|Protocol Violation|0|||
106054398|NCT00530946|365864123|FG003|Overall Study|Protocol Violation|1|||
106054399|NCT00530946|365864120|FG000|Overall Study|Noncompliance|1|||
106054400|NCT00530946|365864121|FG001|Overall Study|Noncompliance|0|||
106054401|NCT00530946|365864122|FG002|Overall Study|Noncompliance|0|||
106054402|NCT00530946|365864123|FG003|Overall Study|Noncompliance|0|||
106054403|NCT00282984|365864124|FG000|Overall Study|Death|2|||
106054404|NCT00282984|365864125|FG001|Overall Study|Death|5|||
106054405|NCT00282984|365864124|FG000|Overall Study|Adverse Event|8|||
106054406|NCT00282984|365864125|FG001|Overall Study|Adverse Event|5|||
106054407|NCT00282984|365864124|FG000|Overall Study|Lack of Efficacy|0|||
106054408|NCT00282984|365864125|FG001|Overall Study|Lack of Efficacy|2|||
106054409|NCT00282984|365864124|FG000|Overall Study|Lost to Follow-up|14|||
106054410|NCT00282984|365864125|FG001|Overall Study|Lost to Follow-up|10|||
106054411|NCT00282984|365864124|FG000|Overall Study|Withdrawal by Participant|22|||
106054412|NCT00282984|365864125|FG001|Overall Study|Withdrawal by Participant|34|||
106054413|NCT00282984|365864124|FG000|Overall Study|Participant stopped study medication|2|||
106054414|NCT00282984|365864125|FG001|Overall Study|Participant stopped study medication|2|||
106054415|NCT00282984|365864124|FG000|Overall Study|Participant only allowed phone follow-up|0|||
106054416|NCT00282984|365864125|FG001|Overall Study|Participant only allowed phone follow-up|1|||
106054417|NCT00282984|365864124|FG000|Overall Study|Participant used antipsychosis meds|0|||
106054418|NCT00282984|365864125|FG001|Overall Study|Participant used antipsychosis meds|1|||
106054419|NCT00282984|365864124|FG000|Overall Study|lack of motivation|1|||
106054420|NCT00282984|365864125|FG001|Overall Study|lack of motivation|0|||
106054421|NCT00282984|365864124|FG000|Overall Study|in prison|0|||
106054422|NCT00282984|365864125|FG001|Overall Study|in prison|1|||
106054423|NCT00282984|365864124|FG000|Overall Study|Protocol Violation|2|||
106054424|NCT00282984|365864125|FG001|Overall Study|Protocol Violation|0|||
106054425|NCT00190671|365864126|FG000|Overall Study|Satisfactory Response|4|||
106054426|NCT00190671|365864127|FG001|Overall Study|Satisfactory Response|7|||
106054427|NCT00190671|365864126|FG000|Overall Study|Lack of Efficacy|19|||
106054428|NCT00190671|365864127|FG001|Overall Study|Lack of Efficacy|24|||
106054429|NCT00190671|365864126|FG000|Overall Study|Death from Study Disease|1|||
106054430|NCT00190671|365864127|FG001|Overall Study|Death from Study Disease|1|||
106054431|NCT00190671|365864126|FG000|Overall Study|Adverse Event|3|||
106054432|NCT00190671|365864127|FG001|Overall Study|Adverse Event|2|||
106054433|NCT00190671|365864126|FG000|Overall Study|Clinical Relapse|0|||
106054434|NCT00190671|365864127|FG001|Overall Study|Clinical Relapse|1|||
106054435|NCT00190671|365864126|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
106054436|NCT00190671|365864127|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
106054437|NCT00190671|365864126|FG000|Overall Study|Death from Other Causes|0|||
106054438|NCT00190671|365864127|FG001|Overall Study|Death from Other Causes|2|||
106054439|NCT00190671|365864126|FG000|Overall Study|Protocol Violation|0|||
106054440|NCT00190671|365864127|FG001|Overall Study|Protocol Violation|1|||
106054441|NCT00190671|365864126|FG000|Overall Study|Withdrawal by Subject|0|||
106054442|NCT00190671|365864127|FG001|Overall Study|Withdrawal by Subject|2|||
106054443|NCT00457301|365864128|FG000|Overall Study|Withdrawal by Subject|3|||
106054444|NCT00457301|365864129|FG001|Overall Study|Withdrawal by Subject|3|||
106054445|NCT00457301|365864128|FG000|Overall Study|Censored out of the study|15|||
106054446|NCT00457301|365864129|FG001|Overall Study|Censored out of the study|14|||
106054447|NCT00457301|365864128|FG000|Overall Study|Death|5|||
106054448|NCT00457301|365864129|FG001|Overall Study|Death|7|||
106054449|NCT03322631|365864139|FG000|Overall Study|Withdrawal by Subject|0|||
106054450|NCT03322631|365864140|FG001|Overall Study|Withdrawal by Subject|1|||
106054451|NCT03322631|365864141|FG002|Overall Study|Withdrawal by Subject|0|||
106054452|NCT03322631|365864142|FG003|Overall Study|Withdrawal by Subject|0|||
106054453|NCT03322631|365864139|FG000|Overall Study|Adverse Event|0|||
106054454|NCT03322631|365864140|FG001|Overall Study|Adverse Event|0|||
106054455|NCT03322631|365864141|FG002|Overall Study|Adverse Event|1|||
106054456|NCT03322631|365864142|FG003|Overall Study|Adverse Event|0|||
106054457|NCT02412618|365864143|FG000|Overall Study|Withdrawal by Subject|1|||
106054458|NCT02412618|365864144|FG001|Overall Study|Withdrawal by Subject|1|||
106054459|NCT02412618|365864143|FG000|Overall Study|Expulsion|1|||
106054460|NCT02412618|365864144|FG001|Overall Study|Expulsion|1|||
106054461|NCT02378961|365864145|FG000|Overall Study|Lack of Efficacy|4|||
106054462|NCT02378961|365864146|FG001|Overall Study|Lack of Efficacy|2|||
106054463|NCT02378961|365864147|FG002|Overall Study|Lack of Efficacy|0|||
106054464|NCT02378961|365864148|FG003|Overall Study|Lack of Efficacy|1|||
106054465|NCT02378961|365864145|FG000|Overall Study|Death|0|||
106054466|NCT02378961|365864146|FG001|Overall Study|Death|0|||
106054467|NCT02378961|365864147|FG002|Overall Study|Death|1|||
106054468|NCT02378961|365864148|FG003|Overall Study|Death|0|||
106054469|NCT03408483|365864149|FG000|Overall Study|Physician Decision|3|||
106054470|NCT03408483|365864150|FG001|Overall Study|Physician Decision|3|||
106054471|NCT03408483|365864149|FG000|Overall Study|Lost to Follow-up|3|||
106054472|NCT03408483|365864150|FG001|Overall Study|Lost to Follow-up|0|||
106054473|NCT00291577|365864156|FG000|Overall Study|Adverse Event|1|||
106054474|NCT00291577|365864156|FG000|Overall Study|Other|4|||
106054475|NCT00291577|365864156|FG000|Overall Study|Withdrawal by Subject|2|||
106054476|NCT00291577|365864156|FG000|Overall Study|Lack of Efficacy|14|||
106054477|NCT04502693|365864157|FG000|Overall Study|Adverse Event|7|||
106054478|NCT04502693|365864158|FG001|Overall Study|Adverse Event|6|||
106054479|NCT04502693|365864159|FG002|Overall Study|Adverse Event|11|||
106054480|NCT04502693|365864160|FG003|Overall Study|Adverse Event|1|||
106054481|NCT04502693|365864157|FG000|Overall Study|Lost to Follow-up|32|||
106054482|NCT04502693|365864158|FG001|Overall Study|Lost to Follow-up|36|||
106054483|NCT04502693|365864159|FG002|Overall Study|Lost to Follow-up|69|||
106054484|NCT04502693|365864160|FG003|Overall Study|Lost to Follow-up|4|||
106054485|NCT04502693|365864157|FG000|Overall Study|Protocol Violation|8|||
106054486|NCT04502693|365864158|FG001|Overall Study|Protocol Violation|8|||
106054487|NCT04502693|365864159|FG002|Overall Study|Protocol Violation|16|||
106054488|NCT04502693|365864160|FG003|Overall Study|Protocol Violation|1|||
106054489|NCT04502693|365864157|FG000|Overall Study|Withdrawal by Subject|46|||
106054490|NCT04502693|365864158|FG001|Overall Study|Withdrawal by Subject|38|||
106054491|NCT04502693|365864159|FG002|Overall Study|Withdrawal by Subject|54|||
106054492|NCT04502693|365864160|FG003|Overall Study|Withdrawal by Subject|7|||
106054493|NCT04502693|365864157|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
106054494|NCT04502693|365864158|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
106054495|NCT04502693|365864159|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
106054496|NCT04502693|365864160|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
106054497|NCT04502693|365864157|FG000|Overall Study|Other|1|||
106054498|NCT04502693|365864158|FG001|Overall Study|Other|0|||
106054499|NCT04502693|365864159|FG002|Overall Study|Other|1|||
106054500|NCT04502693|365864160|FG003|Overall Study|Other|1|||
106054501|NCT00602797|365864161|FG000|Overall Study|Adverse Event|1|||
106054502|NCT01587001|365864162|FG000|Overall Study|Lost to Follow-up|2|||
106054503|NCT01587001|365864163|FG001|Overall Study|Lost to Follow-up|0|||
106054504|NCT01587001|365864162|FG000|Overall Study|Insufficient samples to complete testing|4|||
106054505|NCT01587001|365864163|FG001|Overall Study|Insufficient samples to complete testing|1|||
106054506|NCT01552694|365864166|FG000|Overall Study|Lost to Follow-up|0|||
106054507|NCT01552694|365864167|FG001|Overall Study|Lost to Follow-up|1|||
106054508|NCT01552694|365864166|FG000|Overall Study|Protocol Violation|0|||
106054509|NCT01552694|365864167|FG001|Overall Study|Protocol Violation|1|||
106054510|NCT03943147|365864168|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
106054511|NCT03943147|365864169|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
106054512|NCT03943147|365864168|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
106054513|NCT03943147|365864169|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
106054514|NCT03943147|365864168|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
106054515|NCT03943147|365864169|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
106054516|NCT03943147|365864168|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
106054517|NCT03943147|365864169|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
106054518|NCT03943147|365864168|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
106054519|NCT03943147|365864169|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
106054520|NCT03943147|365864168|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
106152455|NCT03088813|366218795|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
106152456|NCT03088813|366218796|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
106054521|NCT03943147|365864169|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
106152457|NCT03103321|366218797|FG000|Overall Study|Protocol Violation|1|||
106054522|NCT02756013|365864170|FG000|Overall Study|Adverse Event|1|||
106054523|NCT02756013|365864170|FG000|Overall Study|Hypersensitivity|1|||
106054524|NCT01318993|365864171|FG000|Overall Study|Adverse Event|53|||
105864174|NCT01371747|365152774|FG005|Overall Study|Physician Decision|0|||
105864175|NCT01371747|365152769|FG000|Overall Study|Withdrawal by Subject|6|||
105864176|NCT01371747|365152770|FG001|Overall Study|Withdrawal by Subject|12|||
105864177|NCT01371747|365152771|FG002|Overall Study|Withdrawal by Subject|5|||
106054525|NCT01318993|365864171|FG000|Overall Study|Lack of Efficacy|121|||
106054526|NCT01318993|365864171|FG000|Overall Study|Protocol Violation|3|||
106054527|NCT01318993|365864171|FG000|Overall Study|Protocol based stopping criteria|6|||
106054528|NCT01318993|365864171|FG000|Overall Study|Study closed or terminated|174|||
106054529|NCT01318993|365864171|FG000|Overall Study|Lost to Follow-up|4|||
106054530|NCT01318993|365864171|FG000|Overall Study|Physician Decision|13|||
106054531|NCT01318993|365864171|FG000|Overall Study|Withdrawal by Subject|24|||
106054532|NCT00629707|365864174|FG000|Overall Study|Withdrawal by Subject|0|||
106054533|NCT00629707|365864175|FG001|Overall Study|Withdrawal by Subject|1|||
106054534|NCT00629707|365864174|FG000|Overall Study|Physician Decision|0|||
106054535|NCT00629707|365864175|FG001|Overall Study|Physician Decision|1|||
106054536|NCT03724032|365864176|FG000|Overall Study|Physician Decision|1|||
106054537|NCT03724032|365864177|FG001|Overall Study|Physician Decision|0|||
106054538|NCT03724032|365864178|FG002|Overall Study|Physician Decision|0|||
106054539|NCT03724032|365864176|FG000|Overall Study|Protocol Violation|2|||
106054540|NCT03724032|365864177|FG001|Overall Study|Protocol Violation|2|||
106054541|NCT03724032|365864178|FG002|Overall Study|Protocol Violation|1|||
106054542|NCT03736447|365864179|FG000|Overall Study|Adverse Event|5|||
106054543|NCT03736447|365864180|FG001|Overall Study|Adverse Event|1|||
106054544|NCT03736447|365864179|FG000|Overall Study|Withdrawal by Subject|5|||
106054545|NCT03736447|365864180|FG001|Overall Study|Withdrawal by Subject|1|||
106054546|NCT03736447|365864179|FG000|Overall Study|Lost to Follow-up|1|||
106054547|NCT03736447|365864180|FG001|Overall Study|Lost to Follow-up|0|||
106054548|NCT03736447|365864179|FG000|Overall Study|Physician Decision|1|||
106054549|NCT03736447|365864180|FG001|Overall Study|Physician Decision|0|||
106054550|NCT03736447|365864179|FG000|Overall Study|Continued commitment to study treatment|3|||
105864178|NCT01371747|365152772|FG003|Overall Study|Withdrawal by Subject|2|||
105864179|NCT01371747|365152773|FG004|Overall Study|Withdrawal by Subject|2|||
105864180|NCT01371747|365152774|FG005|Overall Study|Withdrawal by Subject|4|||
105864181|NCT01371747|365152769|FG000|Overall Study|Other Reasons|2|||
105864182|NCT01371747|365152770|FG001|Overall Study|Other Reasons|1|||
105864183|NCT01371747|365152771|FG002|Overall Study|Other Reasons|2|||
105864184|NCT01371747|365152772|FG003|Overall Study|Other Reasons|0|||
105864185|NCT01371747|365152773|FG004|Overall Study|Other Reasons|0|||
105864186|NCT01371747|365152774|FG005|Overall Study|Other Reasons|1|||
105864187|NCT03092219|365152775|FG000|Overall Study|Protocol Violation|7|||
105864188|NCT03092219|365152776|FG001|Overall Study|Protocol Violation|4|||
105864189|NCT02856555|365152779|FG000|Overall Study|Adverse Event|1|||
105864190|NCT02856555|365152780|FG001|Overall Study|Adverse Event|0|||
105864191|NCT02856555|365152781|FG002|Overall Study|Adverse Event|0|||
105864192|NCT02856555|365152779|FG000|Overall Study|Lost to Follow-up|1|||
105864193|NCT02856555|365152780|FG001|Overall Study|Lost to Follow-up|3|||
105864194|NCT02856555|365152781|FG002|Overall Study|Lost to Follow-up|0|||
105864195|NCT02856555|365152779|FG000|Overall Study|Withdrawal by Subject|3|||
105864196|NCT02856555|365152780|FG001|Overall Study|Withdrawal by Subject|0|||
105864197|NCT02856555|365152781|FG002|Overall Study|Withdrawal by Subject|0|||
105864198|NCT02856555|365152779|FG000|Overall Study|Randomized but Never Treated|0|||
105864199|NCT02856555|365152780|FG001|Overall Study|Randomized but Never Treated|1|||
105864200|NCT02856555|365152781|FG002|Overall Study|Randomized but Never Treated|0|||
105864201|NCT02094417|365152782|FG000|Overall Study|Adverse Event|0|||
105864202|NCT02094417|365152783|FG001|Overall Study|Adverse Event|0|||
105864203|NCT02094417|365152784|FG002|Overall Study|Adverse Event|0|||
105864204|NCT02094417|365152785|FG003|Overall Study|Adverse Event|1|||
105864205|NCT02094417|365152782|FG000|Overall Study|Eligibility criteria|0|||
105864206|NCT02094417|365152783|FG001|Overall Study|Eligibility criteria|1|||
106054551|NCT03736447|365864180|FG001|Overall Study|Continued commitment to study treatment|0|||
106054552|NCT03736447|365864179|FG000|Overall Study|Taste aversion to study product|0|||
105864207|NCT02094417|365152784|FG002|Overall Study|Eligibility criteria|0|||
105864208|NCT02094417|365152785|FG003|Overall Study|Eligibility criteria|0|||
105864209|NCT02094417|365152782|FG000|Overall Study|No responder|4|||
105864210|NCT02094417|365152783|FG001|Overall Study|No responder|4|||
105864211|NCT02094417|365152784|FG002|Overall Study|No responder|4|||
105864212|NCT02094417|365152785|FG003|Overall Study|No responder|3|||
105864213|NCT02094417|365152782|FG000|Overall Study|Unable to conduct observations or assess|0|||
105864214|NCT02094417|365152783|FG001|Overall Study|Unable to conduct observations or assess|1|||
105864215|NCT02094417|365152784|FG002|Overall Study|Unable to conduct observations or assess|0|||
106054553|NCT03736447|365864180|FG001|Overall Study|Taste aversion to study product|1|||
106054554|NCT03302234|365864181|FG000|Overall Study|Death|191|||
106054555|NCT03302234|365864182|FG001|Overall Study|Death|192|||
106054556|NCT03302234|365864181|FG000|Overall Study|Withdrawal by Subject|2|||
106054557|NCT03302234|365864182|FG001|Overall Study|Withdrawal by Subject|2|||
106054558|NCT03302234|365864181|FG000|Overall Study|Sponsor Decision|90|||
106054559|NCT03302234|365864182|FG001|Overall Study|Sponsor Decision|89|||
106054560|NCT03302234|365864181|FG000|Overall Study|Laryngeal carcinoma|0|||
106054561|NCT03302234|365864182|FG001|Overall Study|Laryngeal carcinoma|1|||
106054562|NCT03302234|365864181|FG000|Overall Study|Not Reported|1|||
106054563|NCT03302234|365864182|FG001|Overall Study|Not Reported|0|||
106054564|NCT02610725|365864184|FG000|Overall Study|Lost to Follow-up|197|||
106054565|NCT02610725|365864184|FG000|Overall Study|self-reported contraindication|9|||
106054566|NCT02302807|365864189|FG000|Overall Study|Withdrawal by Subject|28|||
106054567|NCT02302807|365864190|FG001|Overall Study|Withdrawal by Subject|11|||
106054568|NCT02302807|365864189|FG000|Overall Study|Lost to Follow-up|4|||
106054569|NCT02302807|365864190|FG001|Overall Study|Lost to Follow-up|6|||
106054570|NCT02302807|365864189|FG000|Overall Study|Death|397|||
106054571|NCT02302807|365864190|FG001|Overall Study|Death|385|||
106054572|NCT02302807|365864189|FG000|Overall Study|Study Terminated By Sponsor|35|||
106054573|NCT02302807|365864190|FG001|Overall Study|Study Terminated By Sponsor|64|||
106054574|NCT02302807|365864189|FG000|Overall Study|Physician Decision|0|||
106054575|NCT02302807|365864190|FG001|Overall Study|Physician Decision|1|||
106054576|NCT02777333|365864193|FG000|Overall Study|Withdrawal by Subject|0|||
106054577|NCT02777333|365864194|FG001|Overall Study|Withdrawal by Subject|1|||
106054578|NCT02777333|365864193|FG000|Overall Study|Lost to Follow-up|0|||
106054579|NCT02777333|365864194|FG001|Overall Study|Lost to Follow-up|1|||
106054580|NCT03307967|365864195|FG000|Overall Study|Lost to Follow-up|4|||
106054581|NCT02801331|365864196|FG000|Overall Study|Transferred to another hospital|8|||
106054582|NCT02801331|365864197|FG001|Overall Study|Transferred to another hospital|7|||
106054583|NCT02801331|365864196|FG000|Overall Study|Withdrawal by Subject|0|||
106054584|NCT02801331|365864197|FG001|Overall Study|Withdrawal by Subject|4|||
106054585|NCT02801331|365864196|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
106054586|NCT02801331|365864197|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
106054587|NCT05475236|365864198|FG000|Overall Study|Withdrawal by Subject|0|||
106054588|NCT05475236|365864199|FG001|Overall Study|Withdrawal by Subject|1|||
106054589|NCT01798004|365865557|FG000|Overall Study|Death|2|||
106054590|NCT01798004|365865557|FG000|Overall Study|Lack of Efficacy|8|||
106054591|NCT01798004|365865557|FG000|Overall Study|Physician Decision|25|||
106054592|NCT01798004|365865557|FG000|Overall Study|Withdrawal by Subject|4|||
106054593|NCT01798004|365865557|FG000|Overall Study|Ineligible|4|||
106054594|NCT01798004|365865557|FG000|Overall Study|Patient/parent refusal|7|||
106054595|NCT01798004|365865557|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
106054596|NCT01798004|365865557|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
106054597|NCT01218113|365865560|FG000|Overall Study|Withdrawal by Subject|1|||
106054598|NCT01218113|365865561|FG001|Overall Study|Withdrawal by Subject|0|||
106054599|NCT01218113|365865562|FG002|Overall Study|Withdrawal by Subject|1|||
106054600|NCT01218113|365865560|FG000|Overall Study|Lost to Follow-up|4|||
106054601|NCT01218113|365865561|FG001|Overall Study|Lost to Follow-up|1|||
106054602|NCT01218113|365865562|FG002|Overall Study|Lost to Follow-up|4|||
106054603|NCT01218113|365865560|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
106054604|NCT01218113|365865561|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
106054605|NCT01218113|365865562|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
106054606|NCT04840615|365865564|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
106054607|NCT04840615|365865565|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
106054608|NCT04840615|365865566|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
106054609|NCT01918774|365865567|FG000|Overall Study|Lost prior to first CBTw session|4|||
106054610|NCT01918774|365865567|FG000|Overall Study|Lost to Follow-up|1|||
106054611|NCT01575769|365865570|FG000|Overall Study|Adverse Event|1|||
106054612|NCT01575769|365865570|FG000|Overall Study|Study terminated by sponsor|40|||
106054613|NCT01673867|365865571|FG000|Randomization|Adverse event unrelated to study drug|1|||
106054614|NCT01673867|365865572|FG001|Randomization|Adverse event unrelated to study drug|0|||
106054615|NCT01673867|365865571|FG000|Randomization|Participant request to discontinue study treatment|0|||
106054616|NCT01673867|365865572|FG001|Randomization|Participant request to discontinue study treatment|4|||
106054617|NCT01673867|365865571|FG000|Randomization|Withdrawal by participant|0|||
106054618|NCT01673867|365865572|FG001|Randomization|Withdrawal by participant|12|||
106054619|NCT01673867|365865571|FG000|Randomization|Lost to Follow-up|0|||
106054620|NCT01673867|365865572|FG001|Randomization|Lost to Follow-up|1|||
106054621|NCT01673867|365865571|FG000|Randomization|Participant no longer meets study criteria|4|||
106054622|NCT01673867|365865572|FG001|Randomization|Participant no longer meets study criteria|5|||
106054623|NCT01673867|365865571|FG000|Treatment|Disease Progression|208|||
106054624|NCT01673867|365865572|FG001|Treatment|Disease Progression|178|||
106054625|NCT01673867|365865571|FG000|Treatment|Study Drug Toxicity|23|||
106054626|NCT01673867|365865572|FG001|Treatment|Study Drug Toxicity|43|||
106054627|NCT01673867|365865571|FG000|Treatment|Death|2|||
106054628|NCT01673867|365865572|FG001|Treatment|Death|3|||
106054629|NCT01673867|365865571|FG000|Treatment|Adverse event unrelated to study drug|23|||
106054630|NCT01673867|365865572|FG001|Treatment|Adverse event unrelated to study drug|10|||
106054631|NCT01673867|365865571|FG000|Treatment|Participant request to discontinue study treatment|7|||
106152458|NCT03103321|366218798|FG001|Overall Study|Protocol Violation|1|||
106054632|NCT01673867|365865572|FG001|Treatment|Participant request to discontinue study treatment|17|||
106054633|NCT01673867|365865571|FG000|Treatment|Withdrawal by participant|5|||
106054634|NCT01673867|365865572|FG001|Treatment|Withdrawal by participant|5|||
106054635|NCT01673867|365865571|FG000|Treatment|Maximum clinical benefit|1|||
106054636|NCT01673867|365865572|FG001|Treatment|Maximum clinical benefit|10|||
106054637|NCT01673867|365865571|FG000|Treatment|Participant no longer meets study criteria|2|||
106054638|NCT01673867|365865572|FG001|Treatment|Participant no longer meets study criteria|0|||
106054639|NCT01673867|365865571|FG000|Treatment|Administrative reason by sponsor|3|||
106054640|NCT01673867|365865572|FG001|Treatment|Administrative reason by sponsor|0|||
106054641|NCT01673867|365865571|FG000|Treatment|Other reason|11|||
106054642|NCT01673867|365865572|FG001|Treatment|Other reason|2|||
106054643|NCT01513343|365865573|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
106054644|NCT01513343|365865574|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
106054645|NCT01513343|365865573|FG000|Post Data Collection|Dropped/withdrew from study|7|||
106054646|NCT01513343|365865574|FG001|Post Data Collection|Dropped/withdrew from study|1|||
106054647|NCT01513343|365865573|FG000|Post Data Collection|Lost to Follow-up|10|||
106054648|NCT01513343|365865574|FG001|Post Data Collection|Lost to Follow-up|23|||
106054649|NCT01513343|365865573|FG000|6-month Follow-up|Lost to Follow-up|28|||
106054650|NCT01513343|365865574|FG001|6-month Follow-up|Lost to Follow-up|17|||
106054651|NCT01513343|365865573|FG000|12-month Follow-up|Lost to Follow-up|10|||
106054652|NCT01513343|365865574|FG001|12-month Follow-up|Lost to Follow-up|3|||
106054653|NCT04160195|365865585|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
106054654|NCT04160195|365865586|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
106054655|NCT01867424|365865588|FG000|Overall Study|Patient noncompliance|2|||
106054656|NCT01867424|365865589|FG001|Overall Study|Patient noncompliance|1|||
106054657|NCT03639935|365865590|FG000|Overall Study|Death|3|||
106054658|NCT03639935|365865590|FG000|Overall Study|Adverse Event|1|||
106054659|NCT03066804|365865595|FG000|Overall Study|Physician Decision|0|||
106054660|NCT03066804|365865596|FG001|Overall Study|Physician Decision|4|||
106054661|NCT03066804|365865595|FG000|Overall Study|Death|23|||
106054662|NCT03066804|365865596|FG001|Overall Study|Death|17|||
106054663|NCT03066804|365865595|FG000|Overall Study|Withdrawal by Subject|19|||
106054664|NCT03066804|365865596|FG001|Overall Study|Withdrawal by Subject|25|||
106054665|NCT03066804|365865595|FG000|Overall Study|Lost to Follow-up|2|||
106054666|NCT03066804|365865596|FG001|Overall Study|Lost to Follow-up|0|||
106054667|NCT03066804|365865595|FG000|Overall Study|Adverse Event|2|||
106054668|NCT03066804|365865596|FG001|Overall Study|Adverse Event|3|||
106054669|NCT03066804|365865595|FG000|Overall Study|Technical problems|5|||
106054670|NCT03066804|365865596|FG001|Overall Study|Technical problems|1|||
106054671|NCT03470441|365865603|FG000|Overall Study|Death|0|||
106054672|NCT03470441|365865604|FG001|Overall Study|Death|1|||
106054673|NCT03470441|365865605|FG002|Overall Study|Death|1|||
106054674|NCT03470441|365865606|FG003|Overall Study|Death|0|||
106054675|NCT03470441|365865603|FG000|Overall Study|Adverse Event|0|||
106054676|NCT03470441|365865604|FG001|Overall Study|Adverse Event|0|||
106054677|NCT03470441|365865605|FG002|Overall Study|Adverse Event|0|||
106054678|NCT03470441|365865606|FG003|Overall Study|Adverse Event|1|||
106054679|NCT03470441|365865603|FG000|Overall Study|Withdrawal by Subject|1|||
106054680|NCT03470441|365865604|FG001|Overall Study|Withdrawal by Subject|4|||
106054681|NCT03470441|365865605|FG002|Overall Study|Withdrawal by Subject|1|||
106054682|NCT03470441|365865606|FG003|Overall Study|Withdrawal by Subject|3|||
106054683|NCT03706079|365865607|FG000|Predecessor Study|Death|0|||
106054684|NCT03706079|365865608|FG001|Predecessor Study|Death|2|||
106054685|NCT03706079|365865609|FG002|Predecessor Study|Death|0|||
106054686|NCT03706079|365865610|FG003|Predecessor Study|Death|1|||
106054687|NCT03706079|365865611|FG004|Predecessor Study|Death|0|||
106054688|NCT03706079|365865612|FG005|Predecessor Study|Death|0|||
106054689|NCT03706079|365865607|FG000|Predecessor Study|Lost to Follow-up|5|||
106054690|NCT03706079|365865608|FG001|Predecessor Study|Lost to Follow-up|2|||
106054691|NCT03706079|365865609|FG002|Predecessor Study|Lost to Follow-up|0|||
106054692|NCT03706079|365865610|FG003|Predecessor Study|Lost to Follow-up|0|||
106054693|NCT03706079|365865611|FG004|Predecessor Study|Lost to Follow-up|1|||
106054694|NCT03706079|365865612|FG005|Predecessor Study|Lost to Follow-up|0|||
106054695|NCT03706079|365865607|FG000|Predecessor Study|Withdrawal by Subject|8|||
106054696|NCT03706079|365865608|FG001|Predecessor Study|Withdrawal by Subject|15|||
106054697|NCT03706079|365865609|FG002|Predecessor Study|Withdrawal by Subject|0|||
106054698|NCT03706079|365865610|FG003|Predecessor Study|Withdrawal by Subject|5|||
106054699|NCT03706079|365865611|FG004|Predecessor Study|Withdrawal by Subject|2|||
106054700|NCT03706079|365865612|FG005|Predecessor Study|Withdrawal by Subject|0|||
106054701|NCT03706079|365865607|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
106054702|NCT03706079|365865608|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
106054703|NCT03706079|365865609|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
106152459|NCT03103321|366218799|FG002|Overall Study|Protocol Violation|1|||
106054704|NCT03706079|365865610|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
106054705|NCT03706079|365865611|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
106054706|NCT03706079|365865612|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
106054707|NCT03706079|365865607|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
106054708|NCT03706079|365865608|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
106054709|NCT03706079|365865609|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
106054710|NCT03706079|365865610|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
106054711|NCT03706079|365865611|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
106054712|NCT03706079|365865612|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
106054713|NCT03706079|365865607|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
106054714|NCT03706079|365865608|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
106054715|NCT03706079|365865609|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
106054716|NCT03706079|365865610|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
106054717|NCT03706079|365865611|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
106054718|NCT03706079|365865612|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
106054719|NCT03706079|365865607|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
106054720|NCT03706079|365865608|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
106054721|NCT03706079|365865609|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
106054722|NCT03706079|365865610|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
106054723|NCT03706079|365865611|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
106054724|NCT03706079|365865612|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
106054725|NCT03706079|365865607|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
106054726|NCT03706079|365865608|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
106054727|NCT03706079|365865609|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
106054728|NCT03706079|365865610|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
106054729|NCT03706079|365865611|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
106054730|NCT03706079|365865612|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
106054731|NCT03706079|365865607|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
106054732|NCT03706079|365865608|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
106054733|NCT03706079|365865609|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
106054734|NCT03706079|365865610|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
106054735|NCT03706079|365865611|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
106054736|NCT03706079|365865612|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
106054737|NCT03706079|365865607|FG000|Long Term Extension (DESTINATION)|Death|8|||
106054738|NCT03706079|365865608|FG001|Long Term Extension (DESTINATION)|Death|2|||
106054739|NCT03706079|365865609|FG002|Long Term Extension (DESTINATION)|Death|2|||
106054740|NCT03706079|365865610|FG003|Long Term Extension (DESTINATION)|Death|1|||
106054741|NCT03706079|365865611|FG004|Long Term Extension (DESTINATION)|Death|0|||
106054742|NCT03706079|365865612|FG005|Long Term Extension (DESTINATION)|Death|0|||
106054743|NCT05393895|365865613|FG000|Overall Study|Adverse Event|2|||
106054744|NCT05393895|365865614|FG001|Overall Study|Adverse Event|3|||
106054745|NCT05393895|365865613|FG000|Overall Study|Lost to Follow-up|4|||
106054746|NCT05393895|365865614|FG001|Overall Study|Lost to Follow-up|3|||
106054747|NCT05393895|365865613|FG000|Overall Study|Protocol Violation|1|||
106054748|NCT05393895|365865614|FG001|Overall Study|Protocol Violation|0|||
106054749|NCT05393895|365865613|FG000|Overall Study|Withdrawal by Subject|1|||
106054750|NCT05393895|365865614|FG001|Overall Study|Withdrawal by Subject|4|||
106054751|NCT01203098|365865619|FG000|Overall Study|Adverse Event|3|||
106054752|NCT01203098|365865620|FG001|Overall Study|Adverse Event|1|||
106054753|NCT01203098|365865621|FG002|Overall Study|Adverse Event|7|||
106054754|NCT01203098|365865619|FG000|Overall Study|Lost to Follow-up|0|||
106054755|NCT01203098|365865620|FG001|Overall Study|Lost to Follow-up|0|||
106054756|NCT01203098|365865621|FG002|Overall Study|Lost to Follow-up|1|||
106054757|NCT01203098|365865619|FG000|Overall Study|Physician Decision|2|||
106054758|NCT01203098|365865620|FG001|Overall Study|Physician Decision|2|||
106054759|NCT01203098|365865621|FG002|Overall Study|Physician Decision|0|||
106054760|NCT01203098|365865619|FG000|Overall Study|Withdrawal by Subject|1|||
106054761|NCT01203098|365865620|FG001|Overall Study|Withdrawal by Subject|1|||
106054762|NCT01203098|365865621|FG002|Overall Study|Withdrawal by Subject|3|||
106054763|NCT01447433|365865627|FG000|Overall Study|Lost to Follow-up|0|||
106054764|NCT01447433|365865628|FG001|Overall Study|Lost to Follow-up|2|||
106054765|NCT01447433|365865627|FG000|Overall Study|Withdrawal by Subject|3|||
106054766|NCT01447433|365865628|FG001|Overall Study|Withdrawal by Subject|3|||
106054767|NCT01447433|365865627|FG000|Overall Study|Protocol Violation|1|||
106054768|NCT01447433|365865628|FG001|Overall Study|Protocol Violation|1|||
106152460|NCT03103321|366218800|FG003|Overall Study|Protocol Violation|0|||
106152461|NCT04247542|366218801|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
106152462|NCT04247542|366218802|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
106054769|NCT04447794|365865629|FG000|Overall Study|Lost to Follow-up|2|||
106054770|NCT04447794|365865630|FG001|Overall Study|Lost to Follow-up|3|||
106054771|NCT04447794|365865631|FG002|Overall Study|Lost to Follow-up|8|||
106054772|NCT04447794|365865629|FG000|Overall Study|Withdrawal by Subject|1|||
106054773|NCT04447794|365865630|FG001|Overall Study|Withdrawal by Subject|1|||
106054774|NCT04447794|365865631|FG002|Overall Study|Withdrawal by Subject|0|||
106054775|NCT01964430|365865632|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
106054776|NCT01964430|365865633|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
106054777|NCT01964430|365865632|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
106054778|NCT01964430|365865633|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
106054779|NCT01964430|365865632|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
106054780|NCT01964430|365865633|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
106054781|NCT01964430|365865632|FG000|Treatment Period|Adverse Event|71|||
106054782|NCT01964430|365865633|FG001|Treatment Period|Adverse Event|37|||
106054783|NCT01964430|365865632|FG000|Treatment Period|Withdrawal by Subject|36|||
106054784|NCT01964430|365865633|FG001|Treatment Period|Withdrawal by Subject|27|||
106054785|NCT01964430|365865632|FG000|Treatment Period|Death|1|||
106054786|NCT01964430|365865633|FG001|Treatment Period|Death|3|||
106054787|NCT01964430|365865632|FG000|Treatment Period|Protocol Deviation|0|||
106054788|NCT01964430|365865633|FG001|Treatment Period|Protocol Deviation|1|||
106054789|NCT01964430|365865632|FG000|Treatment Period|Physician Decision|5|||
106054790|NCT01964430|365865633|FG001|Treatment Period|Physician Decision|4|||
106054791|NCT01964430|365865632|FG000|Treatment Period|Disease Relapse|28|||
106054792|NCT01964430|365865633|FG001|Treatment Period|Disease Relapse|38|||
106054793|NCT01964430|365865632|FG000|Treatment Period|Other reasons|1|||
106054794|NCT01964430|365865633|FG001|Treatment Period|Other reasons|3|||
106054795|NCT01350492|365865634|FG000|Intervention|Lost to Follow-up|2|||
106054796|NCT01350492|365865635|FG001|Intervention|Lost to Follow-up|5|||
106054797|NCT01350492|365865634|FG000|Intervention|Withdrawal by Subject|3|||
106054798|NCT01350492|365865635|FG001|Intervention|Withdrawal by Subject|1|||
106054799|NCT01350492|365865634|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
106054800|NCT01350492|365865635|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
106054801|NCT01350492|365865634|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
106054802|NCT01350492|365865635|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
106054803|NCT00913497|365865636|FG000|Overall Study|Adverse Event|1|||
106054804|NCT00913497|365865636|FG000|Overall Study|Withdrawal by Subject|2|||
106054805|NCT02801396|365865637|FG000|Period 1|Withdrawal by Subject|0|||
106054806|NCT02801396|365865638|FG001|Period 1|Withdrawal by Subject|0|||
106054807|NCT02801396|365865639|FG002|Period 1|Withdrawal by Subject|0|||
106054808|NCT02801396|365865640|FG003|Period 1|Withdrawal by Subject|0|||
106054809|NCT02801396|365865641|FG004|Period 1|Withdrawal by Subject|1|||
106054810|NCT02801396|365865642|FG005|Period 1|Withdrawal by Subject|0|||
106054811|NCT03208244|365865645|FG000|Overall Study|Death|1|||
106054812|NCT01874054|365865647|FG000|Overall Study|Withdrawal by Subject|3|||
106054813|NCT01874054|365865647|FG000|Overall Study|Study Termination by Sponsor|42|||
106054814|NCT01874054|365865647|FG000|Overall Study|Lost to Follow-up|5|||
106054815|NCT01874054|365865647|FG000|Overall Study|Death|5|||
106054816|NCT00334958|365865648|FG000|Overall Study|Medication Noncompliance|0|||
106054817|NCT00334958|365865649|FG001|Overall Study|Medication Noncompliance|3|||
106054818|NCT00334958|365865648|FG000|Overall Study|Protocol Violation|2|||
106054819|NCT00334958|365865649|FG001|Overall Study|Protocol Violation|2|||
106054820|NCT00334958|365865648|FG000|Overall Study|Request of the investigator or sponsor|0|||
106054821|NCT00334958|365865649|FG001|Overall Study|Request of the investigator or sponsor|1|||
106054822|NCT00334958|365865648|FG000|Overall Study|Withdrawal by Subject|7|||
106054823|NCT00334958|365865649|FG001|Overall Study|Withdrawal by Subject|4|||
106054824|NCT00334958|365865648|FG000|Overall Study|Adverse Event|27|||
106054825|NCT00334958|365865649|FG001|Overall Study|Adverse Event|12|||
106054826|NCT00334958|365865648|FG000|Overall Study|Other|1|||
106054827|NCT00334958|365865649|FG001|Overall Study|Other|2|||
106054828|NCT01218243|365865653|FG000|Overall Study|Lack of Efficacy|1|||
106054829|NCT01218243|365865654|FG001|Overall Study|Lack of Efficacy|1|||
106054830|NCT01218243|365865653|FG000|Overall Study|Lost to Follow-up|3|||
106054831|NCT01218243|365865654|FG001|Overall Study|Lost to Follow-up|3|||
106054832|NCT01218243|365865653|FG000|Overall Study|Protocol Violation|5|||
106054833|NCT01218243|365865654|FG001|Overall Study|Protocol Violation|10|||
106054834|NCT02243696|365865655|FG000|Overall Study|Death|282|||
106054835|NCT02243696|365865655|FG000|Overall Study|Withdrawal by Subject|79|||
106054836|NCT02243696|365865655|FG000|Overall Study|Lost to Follow-up|57|||
106054837|NCT02243696|365865655|FG000|Overall Study|Subject No Longer has Study System|42|||
106054838|NCT02243696|365865655|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
106054839|NCT02243696|365865655|FG000|Overall Study|Study Terminated for EP PASSION|961|||
106054840|NCT03035409|365865657|FG000|Overall Study|Adverse Event|5|||
106054841|NCT03035409|365865657|FG000|Overall Study|Death|2|||
106054842|NCT03035409|365865657|FG000|Overall Study|Withdrawal by Subject|2|||
106054843|NCT03035409|365865657|FG000|Overall Study|Non compliance|4|||
106054844|NCT03035409|365865657|FG000|Overall Study|Patient was jittery|1|||
106054845|NCT03035409|365865657|FG000|Overall Study|Did not like Questionnaire|1|||
106054846|NCT03035409|365865657|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
106054847|NCT03035409|365865657|FG000|Overall Study|Did not like taking drugs|1|||
106054848|NCT04523220|365865661|FG000|Main Treatment Period|Physician Decision|1|||
106054849|NCT04523220|365865662|FG001|Main Treatment Period|Physician Decision|1|||
106054850|NCT04523220|365865663|FG002|Main Treatment Period|Physician Decision|0|||
106054851|NCT04523220|365865661|FG000|Main Treatment Period|Other|5|||
106054852|NCT04523220|365865662|FG001|Main Treatment Period|Other|2|||
106054853|NCT04523220|365865663|FG002|Main Treatment Period|Other|4|||
106054854|NCT04523220|365865661|FG000|Main Treatment Period|Subject Decision|5|||
106054855|NCT04523220|365865662|FG001|Main Treatment Period|Subject Decision|7|||
106054856|NCT04523220|365865663|FG002|Main Treatment Period|Subject Decision|3|||
106054857|NCT04523220|365865661|FG000|Main Treatment Period|Death|5|||
106054858|NCT04523220|365865662|FG001|Main Treatment Period|Death|11|||
106054859|NCT04523220|365865663|FG002|Main Treatment Period|Death|4|||
106054860|NCT04523220|365865661|FG000|Main Treatment Period|Adverse Event|11|||
106054861|NCT04523220|365865662|FG001|Main Treatment Period|Adverse Event|9|||
105864216|NCT02094417|365152785|FG003|Overall Study|Unable to conduct observations or assess|0|||
105864217|NCT02094417|365152782|FG000|Overall Study|Withdrawal by Subject|1|||
105864218|NCT02094417|365152783|FG001|Overall Study|Withdrawal by Subject|2|||
105864219|NCT02094417|365152784|FG002|Overall Study|Withdrawal by Subject|1|||
105864220|NCT02094417|365152785|FG003|Overall Study|Withdrawal by Subject|3|||
105864221|NCT03333941|365152786|FG000|Overall Study|Lost to Follow-up|10|||
105864222|NCT03333941|365152786|FG000|Overall Study|Death|2|||
105864223|NCT03333941|365152786|FG000|Overall Study|Adverse Event|1|||
105864224|NCT00580788|365152787|FG000|Overall Study|Adverse Event|0|||
105864225|NCT00580788|365152788|FG001|Overall Study|Adverse Event|0|||
105864226|NCT00580788|365152789|FG002|Overall Study|Adverse Event|0|||
105864227|NCT00580788|365152790|FG003|Overall Study|Adverse Event|1|||
105864228|NCT01564537|365152791|FG000|Overall Study|Site Terminated by Sponsor|1|||
105864229|NCT01564537|365152792|FG001|Overall Study|Site Terminated by Sponsor|0|||
105864230|NCT01564537|365152791|FG000|Overall Study|Withdrawal by Subject|12|||
105864231|NCT01564537|365152792|FG001|Overall Study|Withdrawal by Subject|14|||
105864232|NCT01564537|365152791|FG000|Overall Study|Lost to Follow-up|7|||
105864233|NCT01564537|365152792|FG001|Overall Study|Lost to Follow-up|3|||
105864234|NCT01564537|365152791|FG000|Overall Study|Reason not specified|81|||
105864235|NCT01564537|365152792|FG001|Overall Study|Reason not specified|82|||
105864236|NCT00287586|365152794|FG000|Overall Study|Withdrew Consent|19|||
105864237|NCT00287586|365152795|FG001|Overall Study|Withdrew Consent|30|||
105864238|NCT00287586|365152794|FG000|Overall Study|Lost to Follow-up|5|||
105864239|NCT00287586|365152795|FG001|Overall Study|Lost to Follow-up|4|||
105864240|NCT00287586|365152794|FG000|Overall Study|Death|2|||
105864241|NCT00287586|365152795|FG001|Overall Study|Death|3|||
105864242|NCT00287586|365152794|FG000|Overall Study|Elevated Hematocrit|3|||
105864243|NCT00287586|365152795|FG001|Overall Study|Elevated Hematocrit|0|||
105864244|NCT00287586|365152794|FG000|Overall Study|Rash|3|||
105864245|NCT00287586|365152795|FG001|Overall Study|Rash|0|||
105864246|NCT00287586|365152794|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
105864247|NCT00287586|365152795|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
105864248|NCT00287586|365152794|FG000|Overall Study|Stroke|2|||
105864249|NCT00287586|365152795|FG001|Overall Study|Stroke|0|||
105864250|NCT00287586|365152794|FG000|Overall Study|Myocardial Infarction|1|||
105864251|NCT00287586|365152795|FG001|Overall Study|Myocardial Infarction|0|||
105864252|NCT00287586|365152794|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
105864253|NCT00287586|365152795|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
105864254|NCT00287586|365152794|FG000|Overall Study|Cognitive Impairment|1|||
105864255|NCT00287586|365152795|FG001|Overall Study|Cognitive Impairment|0|||
105864256|NCT00287586|365152794|FG000|Overall Study|Pancreatic Cancer|1|||
105864257|NCT00287586|365152795|FG001|Overall Study|Pancreatic Cancer|3|||
105864258|NCT00287586|365152794|FG000|Overall Study|Sleep Apnea|1|||
105864259|NCT00287586|365152795|FG001|Overall Study|Sleep Apnea|0|||
105864260|NCT00287586|365152794|FG000|Overall Study|Shoulder Pain|1|||
105864261|NCT00287586|365152795|FG001|Overall Study|Shoulder Pain|0|||
105864262|NCT00287586|365152794|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
105864263|NCT00287586|365152795|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
105864264|NCT00287586|365152794|FG000|Overall Study|Nonadherence|1|||
105864265|NCT00287586|365152795|FG001|Overall Study|Nonadherence|1|||
105864266|NCT00287586|365152794|FG000|Overall Study|Enrolled in Another Study|1|||
105864267|NCT00287586|365152795|FG001|Overall Study|Enrolled in Another Study|0|||
105864268|NCT00287586|365152794|FG000|Overall Study|Major Depression|0|||
105864269|NCT00287586|365152795|FG001|Overall Study|Major Depression|2|||
105864270|NCT00287586|365152794|FG000|Overall Study|Lung Cancer|0|||
105864271|NCT00287586|365152795|FG001|Overall Study|Lung Cancer|2|||
106054862|NCT04523220|365865663|FG002|Main Treatment Period|Adverse Event|9|||
106054863|NCT04523220|365865661|FG000|Main Treatment Period|Withdrawal by Subject|3|||
106054864|NCT04523220|365865662|FG001|Main Treatment Period|Withdrawal by Subject|3|||
105864272|NCT00287586|365152794|FG000|Overall Study|Elevated IPSS Score|0|||
105864273|NCT00287586|365152795|FG001|Overall Study|Elevated IPSS Score|1|||
105864274|NCT00287586|365152794|FG000|Overall Study|Retroperitoneal Cancer|0|||
105864275|NCT00287586|365152795|FG001|Overall Study|Retroperitoneal Cancer|1|||
105864276|NCT00287586|365152794|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
105864277|NCT00287586|365152795|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
105864278|NCT00287586|365152794|FG000|Overall Study|Mood Swings and Irritability|0|||
105864279|NCT00287586|365152795|FG001|Overall Study|Mood Swings and Irritability|1|||
105864280|NCT00287586|365152794|FG000|Overall Study|Bradycardia|0|||
105864281|NCT00287586|365152795|FG001|Overall Study|Bradycardia|1|||
105864282|NCT00287586|365152794|FG000|Overall Study|Itchy Swollen Eyes|0|||
105864283|NCT00287586|365152795|FG001|Overall Study|Itchy Swollen Eyes|1|||
105864284|NCT00287586|365152794|FG000|Overall Study|Recurrent Melanoma|0|||
105864285|NCT00287586|365152795|FG001|Overall Study|Recurrent Melanoma|1|||
105864286|NCT03743415|365152797|FG000|Overall Study|Death|5|||
105864287|NCT03743415|365152798|FG001|Overall Study|Death|3|||
105864288|NCT03743415|365152799|FG002|Overall Study|Death|1|||
105864289|NCT03743415|365152800|FG003|Overall Study|Death|4|||
105864290|NCT03743415|365152801|FG004|Overall Study|Death|0|||
105864291|NCT03743415|365152802|FG005|Overall Study|Death|0|||
105864292|NCT03743415|365152803|FG006|Overall Study|Death|0|||
105864293|NCT03743415|365152804|FG007|Overall Study|Death|0|||
105864294|NCT03743415|365152805|FG008|Overall Study|Death|1|||
105864295|NCT03743415|365152806|FG009|Overall Study|Death|0|||
105864296|NCT03743415|365152797|FG000|Overall Study|Withdrawal by Subject|1|||
105864297|NCT03743415|365152798|FG001|Overall Study|Withdrawal by Subject|0|||
105864298|NCT03743415|365152799|FG002|Overall Study|Withdrawal by Subject|4|||
105864299|NCT03743415|365152800|FG003|Overall Study|Withdrawal by Subject|5|||
105864300|NCT03743415|365152801|FG004|Overall Study|Withdrawal by Subject|5|||
105864301|NCT03743415|365152802|FG005|Overall Study|Withdrawal by Subject|2|||
105864302|NCT03743415|365152803|FG006|Overall Study|Withdrawal by Subject|2|||
105864303|NCT03743415|365152804|FG007|Overall Study|Withdrawal by Subject|5|||
105864304|NCT03743415|365152805|FG008|Overall Study|Withdrawal by Subject|9|||
105864305|NCT03743415|365152806|FG009|Overall Study|Withdrawal by Subject|10|||
105864306|NCT03743415|365152797|FG000|Overall Study|Lost to Follow-up|2|||
105864307|NCT03743415|365152798|FG001|Overall Study|Lost to Follow-up|0|||
105864308|NCT03743415|365152799|FG002|Overall Study|Lost to Follow-up|2|||
105864309|NCT03743415|365152800|FG003|Overall Study|Lost to Follow-up|1|||
105864310|NCT03743415|365152801|FG004|Overall Study|Lost to Follow-up|1|||
105864311|NCT03743415|365152802|FG005|Overall Study|Lost to Follow-up|0|||
105864312|NCT03743415|365152803|FG006|Overall Study|Lost to Follow-up|1|||
105864313|NCT03743415|365152804|FG007|Overall Study|Lost to Follow-up|4|||
105864314|NCT03743415|365152805|FG008|Overall Study|Lost to Follow-up|13|||
105864315|NCT03743415|365152806|FG009|Overall Study|Lost to Follow-up|13|||
105864316|NCT00926783|365152812|FG000|Overall Study|Incomplete CFAE Procedures|3|||
105864317|NCT00926783|365152813|FG001|Overall Study|Incomplete CFAE Procedures|3|||
105864318|NCT01439009|365152814|FG000|Overall Study|Physician Decision|5|||
105864319|NCT01439009|365152815|FG001|Overall Study|Physician Decision|3|||
105864320|NCT01439009|365152814|FG000|Overall Study|Protocol Violation|2|||
105864321|NCT01439009|365152815|FG001|Overall Study|Protocol Violation|0|||
105864322|NCT01439009|365152814|FG000|Overall Study|Deviation of exclusion criteria|1|||
105864323|NCT01439009|365152815|FG001|Overall Study|Deviation of exclusion criteria|0|||
105864324|NCT00696787|365152817|FG000|Overall Study|Adverse Event|1|||
105864325|NCT00696787|365152818|FG001|Overall Study|Adverse Event|0|||
105864326|NCT00696787|365152819|FG002|Overall Study|Adverse Event|6|||
105864327|NCT00696787|365152817|FG000|Overall Study|Discontinuation by Sponsor|9|||
105864328|NCT00696787|365152818|FG001|Overall Study|Discontinuation by Sponsor|13|||
105864329|NCT00696787|365152819|FG002|Overall Study|Discontinuation by Sponsor|14|||
105864330|NCT00696787|365152817|FG000|Overall Study|Lack of Efficacy|0|||
105864331|NCT00696787|365152818|FG001|Overall Study|Lack of Efficacy|1|||
105864332|NCT00696787|365152819|FG002|Overall Study|Lack of Efficacy|0|||
105864333|NCT00696787|365152817|FG000|Overall Study|Lost to Follow-up|4|||
105864334|NCT00696787|365152818|FG001|Overall Study|Lost to Follow-up|0|||
105864335|NCT00696787|365152819|FG002|Overall Study|Lost to Follow-up|3|||
105864336|NCT00696787|365152817|FG000|Overall Study|Withdrawal by Subject|0|||
105864337|NCT00696787|365152818|FG001|Overall Study|Withdrawal by Subject|3|||
105864338|NCT00696787|365152819|FG002|Overall Study|Withdrawal by Subject|2|||
105864339|NCT00696787|365152817|FG000|Overall Study|Failed to return|1|||
105864340|NCT00696787|365152818|FG001|Overall Study|Failed to return|3|||
105864341|NCT00696787|365152819|FG002|Overall Study|Failed to return|1|||
105864342|NCT01421511|365152823|FG000|Overall Study|Lost to Follow-up|11|||
105864343|NCT01421511|365152824|FG001|Overall Study|Lost to Follow-up|14|||
105864344|NCT01421511|365152823|FG000|Overall Study|Randomized but didn't receive study drug|1|||
105864345|NCT01421511|365152824|FG001|Overall Study|Randomized but didn't receive study drug|7|||
105864346|NCT01421511|365152823|FG000|Overall Study|Physician Decision|0|||
105864347|NCT01421511|365152824|FG001|Overall Study|Physician Decision|1|||
105864348|NCT01421511|365152823|FG000|Overall Study|Withdrawal by Subject|6|||
106054865|NCT04523220|365865663|FG002|Main Treatment Period|Withdrawal by Subject|4|||
105864349|NCT01421511|365152824|FG001|Overall Study|Withdrawal by Subject|5|||
105864350|NCT01421511|365152823|FG000|Overall Study|Death|1|||
105864351|NCT01421511|365152824|FG001|Overall Study|Death|1|||
105864352|NCT00976911|365152827|FG000|Overall Study|Withdrawal by Subject|4|||
105864353|NCT00976911|365152828|FG001|Overall Study|Withdrawal by Subject|6|||
105864354|NCT00976911|365152827|FG000|Overall Study|Death|138|||
105864355|NCT00976911|365152828|FG001|Overall Study|Death|126|||
105864356|NCT00976911|365152827|FG000|Overall Study|Adverse Event|0|||
105864357|NCT00976911|365152828|FG001|Overall Study|Adverse Event|1|||
105864358|NCT00976911|365152827|FG000|Overall Study|Protocol Violation|2|||
105864359|NCT00976911|365152828|FG001|Overall Study|Protocol Violation|0|||
105864360|NCT00976911|365152827|FG000|Overall Study|Other|8|||
105864361|NCT00976911|365152828|FG001|Overall Study|Other|9|||
105864362|NCT00976911|365152827|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
105864363|NCT00976911|365152828|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
105864364|NCT00576316|365152829|FG000|Overall Study|Adverse Event|9|||
105864365|NCT00576316|365152829|FG000|Overall Study|Withdrawal by Subject|2|||
105864366|NCT00576316|365152829|FG000|Overall Study|Protocol Violation|9|||
105864367|NCT04602546|365152830|FG000|Overall Study|Training|2|||
105864368|NCT04602546|365152831|FG001|Overall Study|Training|2|||
105864369|NCT04602546|365152832|FG002|Overall Study|Training|1|||
105864370|NCT04602546|365152833|FG003|Overall Study|Training|2|||
105864371|NCT04602546|365152834|FG004|Overall Study|Training|0|||
105864372|NCT04602546|365152830|FG000|Overall Study|Randomized with disqualified data|2|||
105864373|NCT04602546|365152831|FG001|Overall Study|Randomized with disqualified data|0|||
105864374|NCT04602546|365152832|FG002|Overall Study|Randomized with disqualified data|2|||
105864375|NCT04602546|365152833|FG003|Overall Study|Randomized with disqualified data|5|||
105864376|NCT04602546|365152834|FG004|Overall Study|Randomized with disqualified data|3|||
105864377|NCT00425373|365152898|FG000|Overall Study|Adverse Event|2|||
105864378|NCT00425373|365152899|FG001|Overall Study|Adverse Event|2|||
105864379|NCT00425373|365152900|FG002|Overall Study|Adverse Event|0|||
105864380|NCT00425373|365152901|FG003|Overall Study|Adverse Event|1|||
105864381|NCT00425373|365152902|FG004|Overall Study|Adverse Event|4|||
105864382|NCT00425373|365152903|FG005|Overall Study|Adverse Event|6|||
105864383|NCT00425373|365152904|FG006|Overall Study|Adverse Event|2|||
105864384|NCT00425373|365152905|FG007|Overall Study|Adverse Event|3|||
105864385|NCT00425373|365152906|FG008|Overall Study|Adverse Event|8|||
105864386|NCT00425373|365152898|FG000|Overall Study|Lost to Follow-up|0|||
105864387|NCT00425373|365152899|FG001|Overall Study|Lost to Follow-up|1|||
105864388|NCT00425373|365152900|FG002|Overall Study|Lost to Follow-up|0|||
105864389|NCT00425373|365152901|FG003|Overall Study|Lost to Follow-up|0|||
105864390|NCT00425373|365152902|FG004|Overall Study|Lost to Follow-up|1|||
105864391|NCT00425373|365152903|FG005|Overall Study|Lost to Follow-up|0|||
105864392|NCT00425373|365152904|FG006|Overall Study|Lost to Follow-up|0|||
105864393|NCT00425373|365152905|FG007|Overall Study|Lost to Follow-up|0|||
105864394|NCT00425373|365152906|FG008|Overall Study|Lost to Follow-up|0|||
105864395|NCT00425373|365152898|FG000|Overall Study|Protocol Violation|1|||
105864396|NCT00425373|365152899|FG001|Overall Study|Protocol Violation|0|||
105864397|NCT00425373|365152900|FG002|Overall Study|Protocol Violation|1|||
105864398|NCT00425373|365152901|FG003|Overall Study|Protocol Violation|0|||
105864399|NCT00425373|365152902|FG004|Overall Study|Protocol Violation|0|||
105864400|NCT00425373|365152903|FG005|Overall Study|Protocol Violation|0|||
105864401|NCT00425373|365152904|FG006|Overall Study|Protocol Violation|0|||
105864402|NCT00425373|365152905|FG007|Overall Study|Protocol Violation|5|||
105864403|NCT00425373|365152906|FG008|Overall Study|Protocol Violation|3|||
105864404|NCT00425373|365152898|FG000|Overall Study|Withdrawal by Subject|2|||
105864405|NCT00425373|365152899|FG001|Overall Study|Withdrawal by Subject|0|||
105864406|NCT00425373|365152900|FG002|Overall Study|Withdrawal by Subject|2|||
105864407|NCT00425373|365152901|FG003|Overall Study|Withdrawal by Subject|1|||
105864408|NCT00425373|365152902|FG004|Overall Study|Withdrawal by Subject|4|||
105864409|NCT00425373|365152903|FG005|Overall Study|Withdrawal by Subject|0|||
105864410|NCT00425373|365152904|FG006|Overall Study|Withdrawal by Subject|2|||
105864411|NCT00425373|365152905|FG007|Overall Study|Withdrawal by Subject|2|||
105864412|NCT00425373|365152906|FG008|Overall Study|Withdrawal by Subject|2|||
105864413|NCT00425373|365152898|FG000|Overall Study|Lack of Efficacy|0|||
105864414|NCT00425373|365152899|FG001|Overall Study|Lack of Efficacy|0|||
105864415|NCT00425373|365152900|FG002|Overall Study|Lack of Efficacy|0|||
105864416|NCT00425373|365152901|FG003|Overall Study|Lack of Efficacy|0|||
105864417|NCT00425373|365152902|FG004|Overall Study|Lack of Efficacy|1|||
105864418|NCT00425373|365152903|FG005|Overall Study|Lack of Efficacy|3|||
105864419|NCT00425373|365152904|FG006|Overall Study|Lack of Efficacy|3|||
105864420|NCT00425373|365152905|FG007|Overall Study|Lack of Efficacy|0|||
105864421|NCT00425373|365152906|FG008|Overall Study|Lack of Efficacy|5|||
105864422|NCT02309138|365152908|FG000|Overall Study|Withdrawal by Subject|44|||
105864423|NCT02309138|365152909|FG001|Overall Study|Withdrawal by Subject|15|||
105864424|NCT02309138|365152908|FG000|Overall Study|Protocol Violation|4|||
105864425|NCT02309138|365152909|FG001|Overall Study|Protocol Violation|2|||
105864426|NCT02309138|365152908|FG000|Overall Study|delivered before visit 2|0|||
105864427|NCT02309138|365152909|FG001|Overall Study|delivered before visit 2|1|||
105864428|NCT02564887|365152910|FG000|Overall Study|Lost to Follow-up|6|||
105864429|NCT02564887|365152911|FG001|Overall Study|Lost to Follow-up|0|||
105864430|NCT02052011|365152915|FG000|Overall Study|Lost to Follow-up|3|||
105864431|NCT02052011|365152916|FG001|Overall Study|Lost to Follow-up|0|||
105864432|NCT02052011|365152915|FG000|Overall Study|Withdrawal by Subject|1|||
105864433|NCT02052011|365152916|FG001|Overall Study|Withdrawal by Subject|2|||
105864434|NCT00735397|365152919|FG000|Overall Study|Adverse Event|194|||
105864435|NCT00735397|365152919|FG000|Overall Study|Lost to Follow-up|33|||
105864436|NCT00735397|365152919|FG000|Overall Study|Participant choice|252|||
105864437|NCT00735397|365152919|FG000|Overall Study|Inadequate therapeutic effect|202|||
105864438|NCT00735397|365152919|FG000|Overall Study|Administrative/Other|502|||
105864439|NCT01851330|365152920|FG000|Overall Study|Lack of Efficacy|10|||
105864440|NCT01851330|365152921|FG001|Overall Study|Lack of Efficacy|9|||
105864441|NCT01851330|365152922|FG002|Overall Study|Lack of Efficacy|2|||
105864442|NCT01851330|365152920|FG000|Overall Study|Lost to Follow-up|1|||
105864443|NCT01851330|365152921|FG001|Overall Study|Lost to Follow-up|6|||
105864444|NCT01851330|365152922|FG002|Overall Study|Lost to Follow-up|9|||
105864445|NCT01851330|365152920|FG000|Overall Study|Withdrew Consent|2|||
105864446|NCT01851330|365152921|FG001|Overall Study|Withdrew Consent|1|||
105864447|NCT01851330|365152922|FG002|Overall Study|Withdrew Consent|0|||
105864448|NCT01851330|365152920|FG000|Overall Study|Investigator's Discretion|0|||
105864449|NCT01851330|365152921|FG001|Overall Study|Investigator's Discretion|0|||
105864450|NCT01851330|365152922|FG002|Overall Study|Investigator's Discretion|1|||
105864451|NCT03421730|365152923|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864452|NCT03421730|365152924|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
105864453|NCT03421730|365152925|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864454|NCT03421730|365152926|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864455|NCT03421730|365152927|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864456|NCT03421730|365152928|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864457|NCT03421730|365152929|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864458|NCT03421730|365152930|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864459|NCT03421730|365152931|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864460|NCT03421730|365152932|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864461|NCT03421730|365152933|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864462|NCT03421730|365152934|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
105864463|NCT03421730|365152923|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864464|NCT03421730|365152924|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864465|NCT03421730|365152925|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
106054866|NCT04523220|365865661|FG000|Main Treatment Period|Study drug never adminstered|10|||
106054867|NCT04523220|365865662|FG001|Main Treatment Period|Study drug never adminstered|3|||
106054868|NCT04523220|365865663|FG002|Main Treatment Period|Study drug never adminstered|5|||
106054869|NCT04523220|365865661|FG000|Extension Treatment Period|Physician Decision|1|||
106054870|NCT04523220|365865662|FG001|Extension Treatment Period|Physician Decision|0|||
106054871|NCT04523220|365865663|FG002|Extension Treatment Period|Physician Decision|3|||
106054872|NCT04523220|365865661|FG000|Extension Treatment Period|Other|2|||
106054873|NCT04523220|365865662|FG001|Extension Treatment Period|Other|6|||
106054874|NCT04523220|365865663|FG002|Extension Treatment Period|Other|6|||
106054875|NCT04523220|365865661|FG000|Extension Treatment Period|Subject Decision|5|||
106054876|NCT04523220|365865662|FG001|Extension Treatment Period|Subject Decision|2|||
106054877|NCT04523220|365865663|FG002|Extension Treatment Period|Subject Decision|4|||
106054878|NCT04523220|365865661|FG000|Extension Treatment Period|Death|6|||
106054879|NCT04523220|365865662|FG001|Extension Treatment Period|Death|4|||
106054880|NCT04523220|365865663|FG002|Extension Treatment Period|Death|7|||
106054881|NCT04523220|365865661|FG000|Extension Treatment Period|Adverse Event|6|||
106054882|NCT04523220|365865662|FG001|Extension Treatment Period|Adverse Event|7|||
106054883|NCT04523220|365865663|FG002|Extension Treatment Period|Adverse Event|9|||
106152463|NCT04247542|366218803|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
106152464|NCT04247542|366218801|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
106152465|NCT04247542|366218802|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
106152466|NCT04247542|366218803|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
105864466|NCT03421730|365152926|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864467|NCT03421730|365152927|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
105864468|NCT03421730|365152928|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864469|NCT03421730|365152929|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864470|NCT03421730|365152930|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864471|NCT03421730|365152931|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
106054884|NCT04523220|365865661|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
106054885|NCT04523220|365865662|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
106054886|NCT04523220|365865663|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
106054887|NCT04523220|365865661|FG000|Extension Treatment Period|Study drug never administered|0|||
106054888|NCT04523220|365865662|FG001|Extension Treatment Period|Study drug never administered|1|||
106054889|NCT04523220|365865663|FG002|Extension Treatment Period|Study drug never administered|0|||
106054890|NCT00571948|365865664|FG000|Overall Study|Lost to Follow-up|2|||
106054891|NCT00571948|365865665|FG001|Overall Study|Lost to Follow-up|0|||
106054892|NCT00571948|365865664|FG000|Overall Study|Withdrawal by Subject|1|||
106054893|NCT00571948|365865665|FG001|Overall Study|Withdrawal by Subject|2|||
106054894|NCT00571948|365865664|FG000|Overall Study|Protocol Violation|3|||
106054895|NCT00571948|365865665|FG001|Overall Study|Protocol Violation|3|||
106054896|NCT00571948|365865664|FG000|Overall Study|infant refused study meal|3|||
106054897|NCT00571948|365865665|FG001|Overall Study|infant refused study meal|4|||
106054898|NCT00571948|365865664|FG000|Overall Study|Parent were afraid of blood colection|2|||
106054899|NCT00571948|365865665|FG001|Overall Study|Parent were afraid of blood colection|5|||
106054900|NCT00481078|365865666|FG000|Overall Study|Progression of disease|11|||
106054901|NCT00481078|365865667|FG001|Overall Study|Progression of disease|11|||
106054902|NCT00481078|365865666|FG000|Overall Study|Adverse Event|15|||
106054903|NCT00481078|365865667|FG001|Overall Study|Adverse Event|3|||
106054904|NCT00481078|365865666|FG000|Overall Study|Death|5|||
106054905|NCT00481078|365865667|FG001|Overall Study|Death|3|||
106054906|NCT00481078|365865666|FG000|Overall Study|Intercurrent illness|1|||
106054907|NCT00481078|365865667|FG001|Overall Study|Intercurrent illness|0|||
106054908|NCT00481078|365865666|FG000|Overall Study|Withdrawal by Subject|7|||
106054909|NCT00481078|365865667|FG001|Overall Study|Withdrawal by Subject|1|||
106054910|NCT00481078|365865666|FG000|Overall Study|Information not available|1|||
106054911|NCT00481078|365865667|FG001|Overall Study|Information not available|0|||
106054912|NCT00481078|365865666|FG000|Overall Study|Received other treatment|2|||
106054913|NCT00481078|365865667|FG001|Overall Study|Received other treatment|1|||
106054914|NCT00481078|365865666|FG000|Overall Study|Brain metastasis|0|||
106054915|NCT00481078|365865667|FG001|Overall Study|Brain metastasis|1|||
106054916|NCT01558271|365865668|FG000|Overall Study|Adverse Event|6|||
106054917|NCT01558271|365865669|FG001|Overall Study|Adverse Event|3|||
106054918|NCT01558271|365865670|FG002|Overall Study|Adverse Event|4|||
106054919|NCT01558271|365865668|FG000|Overall Study|Lost to Follow-up|1|||
106054920|NCT01558271|365865669|FG001|Overall Study|Lost to Follow-up|0|||
106054921|NCT01558271|365865670|FG002|Overall Study|Lost to Follow-up|0|||
106054922|NCT01558271|365865668|FG000|Overall Study|Protocol Violation|1|||
106054923|NCT01558271|365865669|FG001|Overall Study|Protocol Violation|0|||
106054924|NCT01558271|365865670|FG002|Overall Study|Protocol Violation|0|||
106054925|NCT01558271|365865668|FG000|Overall Study|Withdrawal by Subject|10|||
106054926|NCT01558271|365865669|FG001|Overall Study|Withdrawal by Subject|6|||
106054927|NCT01558271|365865670|FG002|Overall Study|Withdrawal by Subject|12|||
106054928|NCT01558271|365865668|FG000|Overall Study|Physician Decision|0|||
106054929|NCT01558271|365865669|FG001|Overall Study|Physician Decision|2|||
106054930|NCT01558271|365865670|FG002|Overall Study|Physician Decision|1|||
106054931|NCT01845831|365865671|FG000|Inpatient Phase|Withdrawal by Subject|1|||
106054932|NCT01845831|365865672|FG001|Inpatient Phase|Withdrawal by Subject|1|||
106054933|NCT01845831|365865673|FG002|Inpatient Phase|Withdrawal by Subject|0|||
106054934|NCT01845831|365865674|FG003|Inpatient Phase|Withdrawal by Subject|0|||
106054935|NCT01845831|365865675|FG004|Inpatient Phase|Withdrawal by Subject|0|||
106054936|NCT00074152|365865676|FG000|Overall Study|Death|21|||
106054937|NCT00074152|365865677|FG001|Overall Study|Death|9|||
106054938|NCT00074152|365865676|FG000|Overall Study|Lack of Efficacy|34|||
106054939|NCT00074152|365865677|FG001|Overall Study|Lack of Efficacy|24|||
106054940|NCT01197560|365865678|FG000|Overall Study|Adverse Event|6|||
106054941|NCT01197560|365865679|FG001|Overall Study|Adverse Event|8|||
106054942|NCT01197560|365865678|FG000|Overall Study|Death|3|||
106054943|NCT01197560|365865679|FG001|Overall Study|Death|5|||
106054944|NCT01197560|365865678|FG000|Overall Study|Withdrawal by Subject|1|||
106054945|NCT01197560|365865679|FG001|Overall Study|Withdrawal by Subject|1|||
106054946|NCT01197560|365865678|FG000|Overall Study|Disease progression|40|||
106054947|NCT01197560|365865679|FG001|Overall Study|Disease progression|35|||
106054948|NCT01197560|365865678|FG000|Overall Study|Miscellaneous|4|||
106054949|NCT01197560|365865679|FG001|Overall Study|Miscellaneous|3|||
106054950|NCT01197560|365865678|FG000|Overall Study|Missing|0|||
106054951|NCT01197560|365865679|FG001|Overall Study|Missing|1|||
106054952|NCT00382252|365865680|FG000|Overall Study|Death|4|||
106054953|NCT00382252|365865680|FG000|Overall Study|Protocol Violation|8|||
106054954|NCT00382252|365865680|FG000|Overall Study|Not treated by RFA|1|||
106054955|NCT01737697|365865683|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054956|NCT01737697|365865684|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
106054957|NCT01737697|365865685|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054958|NCT01737697|365865686|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
106054959|NCT01737697|365865687|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
106054960|NCT01737697|365865688|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054961|NCT01737697|365865689|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054962|NCT01737697|365865690|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054963|NCT01737697|365865691|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054964|NCT01737697|365865692|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054965|NCT01737697|365865693|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054966|NCT01737697|365865694|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054967|NCT01737697|365865695|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054968|NCT01737697|365865696|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054969|NCT01737697|365865697|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
106054970|NCT01737697|365865683|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
106054971|NCT01737697|365865684|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
106054972|NCT01737697|365865685|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
106054973|NCT01737697|365865686|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054974|NCT01737697|365865687|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054975|NCT01737697|365865688|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054976|NCT01737697|365865689|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054977|NCT01737697|365865690|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054978|NCT01737697|365865691|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054979|NCT01737697|365865692|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054980|NCT01737697|365865693|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054981|NCT01737697|365865694|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054982|NCT01737697|365865695|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054983|NCT01737697|365865696|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054984|NCT01737697|365865697|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
106054985|NCT01737697|365865683|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054986|NCT01737697|365865684|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054987|NCT01737697|365865685|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054988|NCT01737697|365865686|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
106054989|NCT01737697|365865687|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054990|NCT01737697|365865688|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054991|NCT01737697|365865689|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054992|NCT01737697|365865690|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054993|NCT01737697|365865691|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054994|NCT01737697|365865692|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054995|NCT01737697|365865693|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054996|NCT01737697|365865694|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054997|NCT01737697|365865695|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054998|NCT01737697|365865696|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
106054999|NCT01737697|365865697|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
106055000|NCT01737697|365865683|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055001|NCT01737697|365865684|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
106055002|NCT01737697|365865685|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055003|NCT01737697|365865686|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055004|NCT01737697|365865687|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055005|NCT01737697|365865688|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055006|NCT01737697|365865689|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055007|NCT01737697|365865690|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055008|NCT01737697|365865691|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055009|NCT01737697|365865692|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055010|NCT01737697|365865693|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055011|NCT01737697|365865694|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055012|NCT01737697|365865695|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055013|NCT01737697|365865696|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055014|NCT01737697|365865697|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
106055015|NCT01737697|365865683|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055016|NCT01737697|365865684|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055017|NCT01737697|365865685|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055018|NCT01737697|365865686|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055019|NCT01737697|365865687|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
106055020|NCT01737697|365865688|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055021|NCT01737697|365865689|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055022|NCT01737697|365865690|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055023|NCT01737697|365865691|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055024|NCT01737697|365865692|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055025|NCT01737697|365865693|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055026|NCT01737697|365865694|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055027|NCT01737697|365865695|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055028|NCT01737697|365865696|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055029|NCT01737697|365865697|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
106055030|NCT01737697|365865683|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055031|NCT01737697|365865684|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
106055032|NCT01737697|365865685|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
106055033|NCT01737697|365865686|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
105864472|NCT03421730|365152932|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864473|NCT03421730|365152933|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864474|NCT03421730|365152934|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
105864475|NCT02648932|365152935|FG000|Overall Study|No transplant|3|||
105864476|NCT02648932|365152936|FG001|Overall Study|No transplant|1|||
105864477|NCT01199016|365152937|FG000|Overall Study|No longer meets eligibility criteria|4|||
105864478|NCT01199016|365152937|FG000|Overall Study|Entrance criteria|5|||
105864479|NCT01199016|365152937|FG000|Overall Study|Protocol Violation|9|||
105864480|NCT01199016|365152937|FG000|Overall Study|Other|13|||
105864481|NCT01199016|365152937|FG000|Overall Study|Withdrawal by Subject|21|||
105864482|NCT01199016|365152937|FG000|Overall Study|Lost to Follow-up|25|||
105864483|NCT02960490|365152946|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
106055034|NCT01737697|365865687|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
106055035|NCT01737697|365865688|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055036|NCT01737697|365865689|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055037|NCT01737697|365865690|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055038|NCT01737697|365865691|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055039|NCT01737697|365865692|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055040|NCT01737697|365865693|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055041|NCT01737697|365865694|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055042|NCT01737697|365865695|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055043|NCT01737697|365865696|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055044|NCT01737697|365865697|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
106055045|NCT01737697|365865683|FG000|Subacute Phase|Adverse Event|0|||
106055046|NCT01737697|365865684|FG001|Subacute Phase|Adverse Event|0|||
106055047|NCT01737697|365865685|FG002|Subacute Phase|Adverse Event|0|||
106055048|NCT01737697|365865686|FG003|Subacute Phase|Adverse Event|0|||
106055049|NCT01737697|365865687|FG004|Subacute Phase|Adverse Event|0|||
106055050|NCT01737697|365865688|FG005|Subacute Phase|Adverse Event|1|||
106055051|NCT01737697|365865689|FG006|Subacute Phase|Adverse Event|1|||
106055052|NCT01737697|365865690|FG007|Subacute Phase|Adverse Event|1|||
106055053|NCT01737697|365865691|FG008|Subacute Phase|Adverse Event|1|||
106055054|NCT01737697|365865692|FG009|Subacute Phase|Adverse Event|1|||
106055055|NCT01737697|365865693|FG010|Subacute Phase|Adverse Event|4|||
106055056|NCT01737697|365865694|FG011|Subacute Phase|Adverse Event|1|||
106055057|NCT01737697|365865695|FG012|Subacute Phase|Adverse Event|1|||
106055058|NCT01737697|365865696|FG013|Subacute Phase|Adverse Event|0|||
106055059|NCT01737697|365865697|FG014|Subacute Phase|Adverse Event|0|||
106055060|NCT01737697|365865683|FG000|Subacute Phase|Withdrawal by Subject|0|||
106055061|NCT01737697|365865684|FG001|Subacute Phase|Withdrawal by Subject|0|||
106055062|NCT01737697|365865685|FG002|Subacute Phase|Withdrawal by Subject|0|||
106055063|NCT01737697|365865686|FG003|Subacute Phase|Withdrawal by Subject|0|||
106055064|NCT01737697|365865687|FG004|Subacute Phase|Withdrawal by Subject|0|||
106055065|NCT01737697|365865688|FG005|Subacute Phase|Withdrawal by Subject|1|||
106055066|NCT01737697|365865689|FG006|Subacute Phase|Withdrawal by Subject|0|||
106055067|NCT01737697|365865690|FG007|Subacute Phase|Withdrawal by Subject|2|||
106055068|NCT01737697|365865691|FG008|Subacute Phase|Withdrawal by Subject|0|||
106055069|NCT01737697|365865692|FG009|Subacute Phase|Withdrawal by Subject|1|||
106055070|NCT01737697|365865693|FG010|Subacute Phase|Withdrawal by Subject|0|||
106055071|NCT01737697|365865694|FG011|Subacute Phase|Withdrawal by Subject|1|||
106055072|NCT01737697|365865695|FG012|Subacute Phase|Withdrawal by Subject|1|||
106055073|NCT01737697|365865696|FG013|Subacute Phase|Withdrawal by Subject|1|||
106055074|NCT01737697|365865697|FG014|Subacute Phase|Withdrawal by Subject|0|||
106055075|NCT01737697|365865683|FG000|Subacute Phase|Lost to Follow-up|0|||
106055076|NCT01737697|365865684|FG001|Subacute Phase|Lost to Follow-up|0|||
106055077|NCT01737697|365865685|FG002|Subacute Phase|Lost to Follow-up|0|||
106055078|NCT01737697|365865686|FG003|Subacute Phase|Lost to Follow-up|0|||
106055079|NCT01737697|365865687|FG004|Subacute Phase|Lost to Follow-up|0|||
106055080|NCT01737697|365865688|FG005|Subacute Phase|Lost to Follow-up|0|||
106152467|NCT03438188|366218805|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
106152468|NCT03438188|366218806|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
105864484|NCT02960490|365152947|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
105864485|NCT02960490|365152948|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105864486|NCT02960490|365152949|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105864487|NCT02960490|365152950|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105864488|NCT02960490|365152951|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
106055081|NCT01737697|365865689|FG006|Subacute Phase|Lost to Follow-up|0|||
106055082|NCT01737697|365865690|FG007|Subacute Phase|Lost to Follow-up|0|||
106055083|NCT01737697|365865691|FG008|Subacute Phase|Lost to Follow-up|0|||
106055084|NCT01737697|365865692|FG009|Subacute Phase|Lost to Follow-up|0|||
106055085|NCT01737697|365865693|FG010|Subacute Phase|Lost to Follow-up|0|||
106055086|NCT01737697|365865694|FG011|Subacute Phase|Lost to Follow-up|0|||
105864489|NCT02960490|365152952|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
106055087|NCT01737697|365865695|FG012|Subacute Phase|Lost to Follow-up|0|||
106055088|NCT01737697|365865696|FG013|Subacute Phase|Lost to Follow-up|0|||
106055089|NCT01737697|365865697|FG014|Subacute Phase|Lost to Follow-up|1|||
106055090|NCT01737697|365865683|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
106055091|NCT01737697|365865684|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
106055092|NCT01737697|365865685|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
106055093|NCT01737697|365865686|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
106055094|NCT01737697|365865687|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
106055095|NCT01737697|365865688|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
106055096|NCT01737697|365865689|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
106055097|NCT01737697|365865690|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
106055098|NCT01737697|365865691|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
106055099|NCT01737697|365865692|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
106055100|NCT01737697|365865693|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
106055101|NCT01737697|365865694|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
106055102|NCT01737697|365865695|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
106055103|NCT01737697|365865696|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
106055104|NCT01737697|365865697|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
106055105|NCT01737697|365865683|FG000|Subacute Phase|Protocol Violation|0|||
106055106|NCT01737697|365865684|FG001|Subacute Phase|Protocol Violation|0|||
106055107|NCT01737697|365865685|FG002|Subacute Phase|Protocol Violation|0|||
106055108|NCT01737697|365865686|FG003|Subacute Phase|Protocol Violation|0|||
106055109|NCT01737697|365865687|FG004|Subacute Phase|Protocol Violation|0|||
106055110|NCT01737697|365865688|FG005|Subacute Phase|Protocol Violation|1|||
106055111|NCT01737697|365865689|FG006|Subacute Phase|Protocol Violation|0|||
106055112|NCT01737697|365865690|FG007|Subacute Phase|Protocol Violation|0|||
106055113|NCT01737697|365865691|FG008|Subacute Phase|Protocol Violation|0|||
106055114|NCT01737697|365865692|FG009|Subacute Phase|Protocol Violation|0|||
106055115|NCT01737697|365865693|FG010|Subacute Phase|Protocol Violation|1|||
106055116|NCT01737697|365865694|FG011|Subacute Phase|Protocol Violation|0|||
106055117|NCT01737697|365865695|FG012|Subacute Phase|Protocol Violation|0|||
106055118|NCT01737697|365865696|FG013|Subacute Phase|Protocol Violation|0|||
106055119|NCT01737697|365865697|FG014|Subacute Phase|Protocol Violation|0|||
106055120|NCT01737697|365865683|FG000|Subacute Phase|Physician Decision|0|||
106055121|NCT01737697|365865684|FG001|Subacute Phase|Physician Decision|0|||
106055122|NCT01737697|365865685|FG002|Subacute Phase|Physician Decision|0|||
106055123|NCT01737697|365865686|FG003|Subacute Phase|Physician Decision|0|||
106055124|NCT01737697|365865687|FG004|Subacute Phase|Physician Decision|0|||
106055125|NCT01737697|365865688|FG005|Subacute Phase|Physician Decision|0|||
106055126|NCT01737697|365865689|FG006|Subacute Phase|Physician Decision|0|||
106055127|NCT01737697|365865690|FG007|Subacute Phase|Physician Decision|0|||
106055128|NCT01737697|365865691|FG008|Subacute Phase|Physician Decision|1|||
106055129|NCT01737697|365865692|FG009|Subacute Phase|Physician Decision|0|||
106055130|NCT01737697|365865693|FG010|Subacute Phase|Physician Decision|0|||
106055131|NCT01737697|365865694|FG011|Subacute Phase|Physician Decision|0|||
106055132|NCT01737697|365865695|FG012|Subacute Phase|Physician Decision|0|||
106055133|NCT01737697|365865696|FG013|Subacute Phase|Physician Decision|0|||
106055134|NCT01737697|365865697|FG014|Subacute Phase|Physician Decision|0|||
106055135|NCT01737697|365865683|FG000|Subacute Phase|Death|0|||
106055136|NCT01737697|365865684|FG001|Subacute Phase|Death|0|||
106055137|NCT01737697|365865685|FG002|Subacute Phase|Death|0|||
106055138|NCT01737697|365865686|FG003|Subacute Phase|Death|0|||
106055139|NCT01737697|365865687|FG004|Subacute Phase|Death|0|||
106055140|NCT01737697|365865688|FG005|Subacute Phase|Death|0|||
106055141|NCT01737697|365865689|FG006|Subacute Phase|Death|0|||
106055142|NCT01737697|365865690|FG007|Subacute Phase|Death|0|||
106055143|NCT01737697|365865691|FG008|Subacute Phase|Death|0|||
106055144|NCT01737697|365865692|FG009|Subacute Phase|Death|0|||
106055145|NCT01737697|365865693|FG010|Subacute Phase|Death|1|||
106055146|NCT01737697|365865694|FG011|Subacute Phase|Death|0|||
106055147|NCT01737697|365865695|FG012|Subacute Phase|Death|0|||
106055148|NCT01737697|365865696|FG013|Subacute Phase|Death|0|||
106055149|NCT01737697|365865697|FG014|Subacute Phase|Death|0|||
106152469|NCT03438188|366218807|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
106055150|NCT04404361|365865700|FG000|Overall Study|Death|12|||
106055151|NCT04404361|365865701|FG001|Overall Study|Death|12|||
106055152|NCT04404361|365865700|FG000|Overall Study|Withdrawal by Subject|13|||
106055153|NCT04404361|365865701|FG001|Overall Study|Withdrawal by Subject|5|||
106055154|NCT04404361|365865700|FG000|Overall Study|Lost to Follow-up|6|||
106055155|NCT04404361|365865701|FG001|Overall Study|Lost to Follow-up|3|||
106055156|NCT04404361|365865700|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
106055157|NCT04404361|365865701|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
106055158|NCT02862171|365865702|FG000|Overall Study|Death|1|||
106055159|NCT02862171|365865702|FG000|Overall Study|Lost to Follow-up|13|||
106055160|NCT02862171|365865702|FG000|Overall Study|Withdrawal by Subject|57|||
106055161|NCT02862171|365865702|FG000|Overall Study|Non-compliance|4|||
106055162|NCT02862171|365865702|FG000|Overall Study|HIV-1 seroconversion|18|||
106055163|NCT00558558|365865703|FG000|Overall Study|Unable to swallow|1|||
106055164|NCT00558558|365865703|FG000|Overall Study|Withdrawal by Subject|1|||
106055165|NCT00558558|365865703|FG000|Overall Study|Lack of Efficacy|4|||
106055166|NCT05570500|365865708|FG000|Overall Study|Lost to Follow-up|7|||
106055167|NCT05570500|365865709|FG001|Overall Study|Lost to Follow-up|5|||
106055168|NCT01063868|365865710|FG000|Overall Study|Adverse Event|9|||
106055169|NCT01063868|365865711|FG001|Overall Study|Adverse Event|7|||
106055170|NCT01063868|365865710|FG000|Overall Study|Withdrawal by Subject|3|||
106055171|NCT01063868|365865711|FG001|Overall Study|Withdrawal by Subject|1|||
106055172|NCT01063868|365865710|FG000|Overall Study|Study Terminated By Sponsor|23|||
106055173|NCT01063868|365865711|FG001|Overall Study|Study Terminated By Sponsor|4|||
106055174|NCT04292743|365865712|FG000|Overall Study|Physician Decision|1|||
106055175|NCT04292743|365865713|FG001|Overall Study|Physician Decision|3|||
106055176|NCT04292743|365865714|FG002|Overall Study|Physician Decision|0|||
106055177|NCT04292743|365865715|FG003|Overall Study|Physician Decision|0|||
106055178|NCT04292743|365865712|FG000|Overall Study|Withdrawal by Subject|0|||
106055179|NCT04292743|365865713|FG001|Overall Study|Withdrawal by Subject|5|||
106055180|NCT04292743|365865714|FG002|Overall Study|Withdrawal by Subject|0|||
106055181|NCT04292743|365865715|FG003|Overall Study|Withdrawal by Subject|0|||
106055182|NCT04292743|365865712|FG000|Overall Study|Death|0|||
106055183|NCT04292743|365865713|FG001|Overall Study|Death|1|||
106055184|NCT04292743|365865714|FG002|Overall Study|Death|0|||
106055185|NCT04292743|365865715|FG003|Overall Study|Death|0|||
106055186|NCT04292743|365865712|FG000|Overall Study|Progression of Disease|2|||
106055187|NCT04292743|365865713|FG001|Overall Study|Progression of Disease|5|||
106055188|NCT04292743|365865714|FG002|Overall Study|Progression of Disease|0|||
106055189|NCT04292743|365865715|FG003|Overall Study|Progression of Disease|0|||
106055190|NCT04292743|365865712|FG000|Overall Study|No Treatment per protocol|0|||
106055191|NCT04292743|365865713|FG001|Overall Study|No Treatment per protocol|2|||
106055192|NCT04292743|365865714|FG002|Overall Study|No Treatment per protocol|0|||
105864490|NCT02960490|365152953|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105864491|NCT02960490|365152954|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105864492|NCT02960490|365152955|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
105864493|NCT02960490|365152946|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864494|NCT02960490|365152947|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
105864495|NCT02960490|365152948|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864496|NCT02960490|365152949|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864497|NCT02960490|365152950|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864498|NCT02960490|365152951|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864499|NCT02960490|365152952|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864500|NCT02960490|365152953|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864501|NCT02960490|365152954|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864502|NCT02960490|365152955|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
105864503|NCT02960490|365152946|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
105864504|NCT02960490|365152947|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
105864505|NCT02960490|365152948|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105864506|NCT02960490|365152949|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105864507|NCT02960490|365152950|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105864508|NCT02960490|365152951|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105864509|NCT02960490|365152952|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105864510|NCT02960490|365152953|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105864511|NCT02960490|365152954|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105864512|NCT02960490|365152955|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
105864513|NCT02960490|365152946|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
105864514|NCT02960490|365152947|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
105864515|NCT02960490|365152948|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105864516|NCT02960490|365152949|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105864517|NCT02960490|365152950|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105864518|NCT02960490|365152951|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105864519|NCT02960490|365152952|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105864520|NCT02960490|365152953|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105864521|NCT02960490|365152954|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
105864522|NCT02960490|365152955|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
106055193|NCT04292743|365865715|FG003|Overall Study|No Treatment per protocol|0|||
106055194|NCT05766423|365865716|FG000|Overall Study|Withdrawal by Subject|1|||
106055195|NCT05766423|365865717|FG001|Overall Study|Withdrawal by Subject|0|||
106055196|NCT05766423|365865716|FG000|Overall Study|Consented, not scheduled|3|||
106055197|NCT05766423|365865717|FG001|Overall Study|Consented, not scheduled|5|||
106055198|NCT02323113|365868136|FG000|Overall Study|Adverse Event|3|||
106055199|NCT02323113|365868137|FG001|Overall Study|Adverse Event|3|||
106055200|NCT02323113|365868138|FG002|Overall Study|Adverse Event|2|||
106055201|NCT02323113|365868139|FG003|Overall Study|Adverse Event|5|||
106055202|NCT02323113|365868140|FG004|Overall Study|Adverse Event|8|||
106055203|NCT02323113|365868141|FG005|Overall Study|Adverse Event|3|||
106055204|NCT02323113|365868142|FG006|Overall Study|Adverse Event|6|||
106055205|NCT02323113|365868143|FG007|Overall Study|Adverse Event|0|||
106055206|NCT02323113|365868136|FG000|Overall Study|Progressive Disease|0|||
106055207|NCT02323113|365868137|FG001|Overall Study|Progressive Disease|1|||
106055208|NCT02323113|365868138|FG002|Overall Study|Progressive Disease|1|||
106055209|NCT02323113|365868139|FG003|Overall Study|Progressive Disease|0|||
106055210|NCT02323113|365868140|FG004|Overall Study|Progressive Disease|0|||
106055211|NCT02323113|365868141|FG005|Overall Study|Progressive Disease|3|||
106055212|NCT02323113|365868142|FG006|Overall Study|Progressive Disease|0|||
106055213|NCT02323113|365868143|FG007|Overall Study|Progressive Disease|0|||
106055214|NCT02323113|365868136|FG000|Overall Study|Symptomatic Deterioration|0|||
106055215|NCT02323113|365868137|FG001|Overall Study|Symptomatic Deterioration|0|||
106055216|NCT02323113|365868138|FG002|Overall Study|Symptomatic Deterioration|1|||
106055217|NCT02323113|365868139|FG003|Overall Study|Symptomatic Deterioration|0|||
106055218|NCT02323113|365868140|FG004|Overall Study|Symptomatic Deterioration|1|||
106055219|NCT02323113|365868141|FG005|Overall Study|Symptomatic Deterioration|0|||
106055220|NCT02323113|365868142|FG006|Overall Study|Symptomatic Deterioration|0|||
106055221|NCT02323113|365868143|FG007|Overall Study|Symptomatic Deterioration|0|||
106055222|NCT02323113|365868136|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
106055223|NCT02323113|365868137|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
106055224|NCT02323113|365868138|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
106055225|NCT02323113|365868139|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
106055226|NCT02323113|365868140|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
106055227|NCT02323113|365868141|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
106055228|NCT02323113|365868142|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
106055229|NCT02323113|365868143|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
106055230|NCT02323113|365868136|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
106055231|NCT02323113|365868137|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
106055232|NCT02323113|365868138|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
106055233|NCT02323113|365868139|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
106055234|NCT02323113|365868140|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
106055235|NCT02323113|365868141|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
106055236|NCT02323113|365868142|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
106055237|NCT02323113|365868143|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
106055238|NCT00126191|365868148|FG000|Overall Study|Physician Decision|0|||
106055239|NCT00126191|365868149|FG001|Overall Study|Physician Decision|1|||
106055240|NCT00126191|365868148|FG000|Overall Study|Death|0|||
106055241|NCT00126191|365868149|FG001|Overall Study|Death|1|||
106055242|NCT03003390|365868150|FG000|Overall Study|Physician Decision|2|||
106055243|NCT03003390|365868151|FG001|Overall Study|Physician Decision|0|||
106055244|NCT03003390|365868150|FG000|Overall Study|Parent refused intervention|2|||
106055245|NCT03003390|365868151|FG001|Overall Study|Parent refused intervention|0|||
106055246|NCT01433991|365868152|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
106055247|NCT01433991|365868153|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
106055248|NCT01433991|365868154|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
106055249|NCT01433991|365868155|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
106055250|NCT01433991|365868152|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
106055251|NCT01433991|365868153|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
106055252|NCT01433991|365868154|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
106055253|NCT01433991|365868155|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
106055254|NCT01433991|365868152|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
106055255|NCT01433991|365868153|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
106055256|NCT01433991|365868154|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
106055257|NCT01433991|365868155|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
106055258|NCT01433991|365868152|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
106055259|NCT01433991|365868153|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
106055260|NCT01433991|365868154|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
106055261|NCT01433991|365868155|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
106055262|NCT01433991|365868152|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
106055263|NCT01433991|365868153|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
106055264|NCT01433991|365868154|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
105864523|NCT02960490|365152946|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
106055265|NCT01433991|365868155|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
106055266|NCT01433991|365868152|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
106055267|NCT01433991|365868153|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
106055268|NCT01433991|365868154|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
106055269|NCT01433991|365868155|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
106055270|NCT01433991|365868152|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
106055271|NCT01433991|365868153|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
106055272|NCT01433991|365868154|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
106055273|NCT01433991|365868155|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
106055274|NCT00612690|365868156|FG000|Overall Study|Lost to Follow-up|72|||
106055275|NCT00612690|365868157|FG001|Overall Study|Lost to Follow-up|98|||
106055276|NCT00612690|365868156|FG000|Overall Study|Withdrawal by Subject|32|||
106055277|NCT00612690|365868157|FG001|Overall Study|Withdrawal by Subject|20|||
106055278|NCT00612690|365868156|FG000|Overall Study|Withdrawal by Site|11|||
106055279|NCT00612690|365868157|FG001|Overall Study|Withdrawal by Site|0|||
106055280|NCT02980601|365868158|FG000|Overall Study|Lost to Follow-up|2|||
106055281|NCT02980601|365868159|FG001|Overall Study|Lost to Follow-up|2|||
106055282|NCT02980601|365868158|FG000|Overall Study|Death|0|||
106055283|NCT02980601|365868159|FG001|Overall Study|Death|1|||
106055284|NCT02980601|365868158|FG000|Overall Study|Graft loss|1|||
106055285|NCT02980601|365868159|FG001|Overall Study|Graft loss|0|||
106055286|NCT02980601|365868158|FG000|Overall Study|Failed to sign consent|2|||
106055287|NCT02980601|365868159|FG001|Overall Study|Failed to sign consent|0|||
106055288|NCT03000439|365868160|FG000|Open Label Part 1|Adverse Event|6|||
106055289|NCT03000439|365868161|FG001|Open Label Part 1|Adverse Event|0|||
106055290|NCT03000439|365868162|FG002|Open Label Part 1|Adverse Event|0|||
106055291|NCT03000439|365868163|FG003|Open Label Part 1|Adverse Event|0|||
106055292|NCT03000439|365868160|FG000|Open Label Part 1|Other|2|||
106055293|NCT03000439|365868161|FG001|Open Label Part 1|Other|0|||
106055294|NCT03000439|365868162|FG002|Open Label Part 1|Other|0|||
106055295|NCT03000439|365868163|FG003|Open Label Part 1|Other|0|||
106055296|NCT03000439|365868160|FG000|Open Label Part 1|Insufficient clinical response|16|||
106055297|NCT03000439|365868161|FG001|Open Label Part 1|Insufficient clinical response|0|||
106055298|NCT03000439|365868162|FG002|Open Label Part 1|Insufficient clinical response|0|||
106055299|NCT03000439|365868163|FG003|Open Label Part 1|Insufficient clinical response|0|||
106055300|NCT03000439|365868160|FG000|Open Label Part 2|Other|0|||
106055301|NCT03000439|365868161|FG001|Open Label Part 2|Other|5|||
106055302|NCT03000439|365868162|FG002|Open Label Part 2|Other|0|||
106055303|NCT03000439|365868163|FG003|Open Label Part 2|Other|0|||
106055304|NCT03000439|365868160|FG000|Open Label Part 2|Insufficient clinical response|0|||
106055305|NCT03000439|365868161|FG001|Open Label Part 2|Insufficient clinical response|12|||
106055306|NCT03000439|365868162|FG002|Open Label Part 2|Insufficient clinical response|0|||
106055307|NCT03000439|365868163|FG003|Open Label Part 2|Insufficient clinical response|0|||
106055308|NCT03000439|365868160|FG000|Double Blind Phase|Adverse Event|0|||
106055309|NCT03000439|365868161|FG001|Double Blind Phase|Adverse Event|0|||
106055310|NCT03000439|365868162|FG002|Double Blind Phase|Adverse Event|2|||
106055311|NCT03000439|365868163|FG003|Double Blind Phase|Adverse Event|1|||
106055312|NCT03000439|365868160|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
106055313|NCT03000439|365868161|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
106055314|NCT03000439|365868162|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
106055315|NCT03000439|365868163|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
106055316|NCT03000439|365868160|FG000|Double Blind Phase|Other|0|||
106055317|NCT03000439|365868161|FG001|Double Blind Phase|Other|0|||
106055318|NCT03000439|365868162|FG002|Double Blind Phase|Other|10|||
106055319|NCT03000439|365868163|FG003|Double Blind Phase|Other|11|||
106055320|NCT03000439|365868160|FG000|Double Blind Phase|Insufficient clinical response|0|||
106055321|NCT03000439|365868161|FG001|Double Blind Phase|Insufficient clinical response|0|||
106055322|NCT03000439|365868162|FG002|Double Blind Phase|Insufficient clinical response|0|||
106055323|NCT03000439|365868163|FG003|Double Blind Phase|Insufficient clinical response|2|||
106055324|NCT04487730|365868164|FG000|Overall Study|Withdrawal by Subject|3|||
106055325|NCT04487730|365868165|FG001|Overall Study|Withdrawal by Subject|1|||
106055326|NCT04487730|365868164|FG000|Overall Study|Lost to Follow-up|0|||
106055327|NCT04487730|365868165|FG001|Overall Study|Lost to Follow-up|1|||
106055328|NCT04487730|365868164|FG000|Overall Study|Physician Decision|0|||
106055329|NCT04487730|365868165|FG001|Overall Study|Physician Decision|1|||
106055330|NCT02954237|365868166|FG000|Overall Study|Withdrawal by Subject|25|||
106152470|NCT03438188|366218805|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
106152471|NCT03438188|366218806|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
106055331|NCT02954237|365868166|FG000|Overall Study|Missed visit|16|||
106055332|NCT02954237|365868166|FG000|Overall Study|Death|2|||
106055333|NCT00621985|365868167|FG000|Dexamethasone Admission|Adverse Event|1|||
106055334|NCT01153347|365868171|FG000|Overall Study|Withdrawal by Subject|7|||
106055335|NCT01153347|365868172|FG001|Overall Study|Withdrawal by Subject|7|||
106055336|NCT01153347|365868173|FG002|Overall Study|Withdrawal by Subject|7|||
106055337|NCT01153347|365868174|FG003|Overall Study|Withdrawal by Subject|7|||
106055338|NCT01153347|365868171|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
106055339|NCT01153347|365868172|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
106055340|NCT01153347|365868173|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
106055341|NCT01153347|365868174|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
106055342|NCT01153347|365868171|FG000|Overall Study|Adverse Event|3|||
106055343|NCT01153347|365868172|FG001|Overall Study|Adverse Event|9|||
106055344|NCT01153347|365868173|FG002|Overall Study|Adverse Event|21|||
106055345|NCT01153347|365868174|FG003|Overall Study|Adverse Event|7|||
106055346|NCT01153347|365868171|FG000|Overall Study|Severe non-compliance to protocol|6|||
106055347|NCT01153347|365868172|FG001|Overall Study|Severe non-compliance to protocol|7|||
106055348|NCT01153347|365868173|FG002|Overall Study|Severe non-compliance to protocol|4|||
106055349|NCT01153347|365868174|FG003|Overall Study|Severe non-compliance to protocol|3|||
106055350|NCT01153347|365868171|FG000|Overall Study|Condition under investigation worsened|1|||
106055351|NCT01153347|365868172|FG001|Overall Study|Condition under investigation worsened|1|||
106055352|NCT01153347|365868173|FG002|Overall Study|Condition under investigation worsened|0|||
106055353|NCT01153347|365868174|FG003|Overall Study|Condition under investigation worsened|0|||
106055354|NCT01153347|365868171|FG000|Overall Study|Lack of Efficacy|2|||
106055355|NCT01153347|365868172|FG001|Overall Study|Lack of Efficacy|2|||
106055356|NCT01153347|365868173|FG002|Overall Study|Lack of Efficacy|0|||
106055357|NCT01153347|365868174|FG003|Overall Study|Lack of Efficacy|4|||
106055358|NCT01153347|365868171|FG000|Overall Study|Study-specific withdrawal criteria|4|||
106055359|NCT01153347|365868172|FG001|Overall Study|Study-specific withdrawal criteria|3|||
106055360|NCT01153347|365868173|FG002|Overall Study|Study-specific withdrawal criteria|1|||
106055361|NCT01153347|365868174|FG003|Overall Study|Study-specific withdrawal criteria|2|||
106055362|NCT01153347|365868171|FG000|Overall Study|Lost to Follow-up|4|||
106055363|NCT01153347|365868172|FG001|Overall Study|Lost to Follow-up|9|||
106055364|NCT01153347|365868173|FG002|Overall Study|Lost to Follow-up|11|||
106055365|NCT01153347|365868174|FG003|Overall Study|Lost to Follow-up|8|||
106055366|NCT01153347|365868171|FG000|Overall Study|Other|5|||
106055367|NCT01153347|365868172|FG001|Overall Study|Other|5|||
106055368|NCT01153347|365868173|FG002|Overall Study|Other|4|||
106055369|NCT01153347|365868174|FG003|Overall Study|Other|0|||
106055370|NCT01153347|365868171|FG000|Overall Study|Death|1|||
106055371|NCT01153347|365868172|FG001|Overall Study|Death|0|||
106055372|NCT01153347|365868173|FG002|Overall Study|Death|0|||
106055373|NCT01153347|365868174|FG003|Overall Study|Death|0|||
106055374|NCT00224042|365868175|FG000|Overall Study|Adverse Event|2|||
106055375|NCT00224042|365868176|FG001|Overall Study|Adverse Event|1|||
106055376|NCT00224042|365868175|FG000|Overall Study|Protocol Violation|0|||
106055377|NCT00224042|365868176|FG001|Overall Study|Protocol Violation|1|||
106055378|NCT00224042|365868175|FG000|Overall Study|Physician Decision|0|||
106055379|NCT00224042|365868176|FG001|Overall Study|Physician Decision|1|||
106055380|NCT00224042|365868175|FG000|Overall Study|Did not meet lab incusion criteria|2|||
106055381|NCT00224042|365868176|FG001|Overall Study|Did not meet lab incusion criteria|3|||
106055382|NCT00224042|365868175|FG000|Overall Study|Other|2|||
106055383|NCT00224042|365868176|FG001|Overall Study|Other|0|||
106055384|NCT00160693|365868177|FG000|Overall Study|Adverse Event|97|||
106055385|NCT00160693|365868177|FG000|Overall Study|Lack of Efficacy|30|||
106055386|NCT00160693|365868177|FG000|Overall Study|Protocol Violation|24|||
106055387|NCT00160693|365868177|FG000|Overall Study|Lost to Follow-up|15|||
106055388|NCT00160693|365868177|FG000|Overall Study|Withdrawal by Subject|54|||
106055389|NCT00160693|365868177|FG000|Overall Study|Study terminated by sponsor|15|||
106055390|NCT00133952|365868178|FG000|Overall Study|Adverse Event|1|||
106055391|NCT00133952|365868179|FG001|Overall Study|Adverse Event|2|||
106055392|NCT00133952|365868178|FG000|Overall Study|Death|3|||
106055393|NCT00133952|365868179|FG001|Overall Study|Death|2|||
106055394|NCT00133952|365868178|FG000|Overall Study|Lost to Follow-up|9|||
106055395|NCT00133952|365868179|FG001|Overall Study|Lost to Follow-up|14|||
106055396|NCT00133952|365868178|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
106055397|NCT00133952|365868179|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
106055398|NCT00133952|365868178|FG000|Overall Study|Protocol Violation|1|||
106055399|NCT00133952|365868179|FG001|Overall Study|Protocol Violation|1|||
106055400|NCT00133952|365868178|FG000|Overall Study|Withdrawal by Subject|20|||
106055401|NCT00133952|365868179|FG001|Overall Study|Withdrawal by Subject|4|||
106055402|NCT00133952|365868178|FG000|Overall Study|Physician Decision|4|||
106055403|NCT00133952|365868179|FG001|Overall Study|Physician Decision|3|||
106055404|NCT00133952|365868178|FG000|Overall Study|Sponsor Decision|0|||
106055405|NCT00133952|365868179|FG001|Overall Study|Sponsor Decision|1|||
106055406|NCT02853604|365868181|FG000|Overall Study|Withdrawal by Subject|12|||
106055407|NCT02853604|365868182|FG001|Overall Study|Withdrawal by Subject|35|||
106055408|NCT02853604|365868181|FG000|Overall Study|Lost to Follow-up|4|||
106055409|NCT02853604|365868182|FG001|Overall Study|Lost to Follow-up|8|||
106055410|NCT02853604|365868181|FG000|Overall Study|Death|1|||
106055411|NCT02853604|365868182|FG001|Overall Study|Death|5|||
106055412|NCT02853604|365868181|FG000|Overall Study|Miscellaneous|11|||
106055413|NCT02853604|365868182|FG001|Overall Study|Miscellaneous|2|||
106055414|NCT02853604|365868181|FG000|Overall Study|Progressive Disease|0|||
106055415|NCT02853604|365868182|FG001|Overall Study|Progressive Disease|2|||
106055416|NCT04213079|365868183|FG000|Overall Study|Lost to Follow-up|0|||
106055417|NCT04213079|365868184|FG001|Overall Study|Lost to Follow-up|2|||
106055418|NCT02193867|365868186|FG000|Overall Study|Death|2|||
106055419|NCT02193867|365868186|FG000|Overall Study|Sponsor Study Termination|2|||
106055420|NCT03616600|365868187|FG000|Overall Study|Withdrawal by Subject|1|||
106055421|NCT03616600|365868188|FG001|Overall Study|Withdrawal by Subject|0|||
106055422|NCT05386680|365868189|FG000|Overall Study|Guardian decision|2|||
106055423|NCT01847274|365868190|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
106055424|NCT01847274|365868191|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
106055425|NCT01847274|365868192|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
106055426|NCT01847274|365868193|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
106055427|NCT01847274|365868194|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
106055428|NCT01847274|365868195|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
106055429|NCT01847274|365868196|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
106055430|NCT01847274|365868197|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
106055431|NCT01847274|365868198|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
106055432|NCT01847274|365868199|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
106055433|NCT01847274|365868200|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
106055434|NCT01847274|365868190|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
106055435|NCT01847274|365868191|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
106055436|NCT01847274|365868192|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
106055437|NCT01847274|365868193|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
106055438|NCT01847274|365868194|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
106055439|NCT01847274|365868195|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
106055440|NCT01847274|365868196|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
106055441|NCT01847274|365868197|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
106055442|NCT01847274|365868198|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
106055443|NCT01847274|365868199|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
106055444|NCT01847274|365868200|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
106055445|NCT01847274|365868190|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
106055446|NCT01847274|365868191|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
106055447|NCT01847274|365868192|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
106055448|NCT01847274|365868193|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
106055449|NCT01847274|365868194|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
106055450|NCT01847274|365868195|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
106055451|NCT01847274|365868196|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
106055452|NCT01847274|365868197|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
106055453|NCT01847274|365868198|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
106055454|NCT01847274|365868199|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
106055455|NCT01847274|365868200|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
106055456|NCT01847274|365868190|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055457|NCT01847274|365868191|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055458|NCT01847274|365868192|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055459|NCT01847274|365868193|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
106055460|NCT01847274|365868194|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055461|NCT01847274|365868195|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055462|NCT01847274|365868196|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055463|NCT01847274|365868197|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055464|NCT01847274|365868198|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055465|NCT01847274|365868199|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055466|NCT01847274|365868200|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
106055467|NCT01847274|365868190|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
106055468|NCT01847274|365868191|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
106055469|NCT01847274|365868192|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
106055470|NCT01847274|365868193|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
106055471|NCT01847274|365868194|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
106055472|NCT01847274|365868195|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
106055473|NCT01847274|365868196|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
106055474|NCT01847274|365868197|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
106055475|NCT01847274|365868198|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
106055476|NCT01847274|365868199|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
106055477|NCT01847274|365868200|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
106055478|NCT01847274|365868190|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
106055479|NCT01847274|365868191|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
106055480|NCT01847274|365868192|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
106055481|NCT01847274|365868193|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
106055482|NCT01847274|365868194|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
106055483|NCT01847274|365868195|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
106055484|NCT01847274|365868196|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
106055485|NCT01847274|365868197|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
106055486|NCT01847274|365868198|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
106055487|NCT01847274|365868199|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
106055488|NCT01847274|365868200|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
106055489|NCT01847274|365868190|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
106055490|NCT01847274|365868191|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
106055491|NCT01847274|365868192|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
106055492|NCT01847274|365868193|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
106055493|NCT01847274|365868194|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
106055494|NCT01847274|365868195|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
106055495|NCT01847274|365868196|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
106055496|NCT01847274|365868197|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
106055497|NCT01847274|365868198|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
106055498|NCT01847274|365868199|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
106055499|NCT01847274|365868200|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
106055500|NCT01847274|365868190|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055501|NCT01847274|365868191|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055502|NCT01847274|365868192|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055503|NCT01847274|365868193|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055504|NCT01847274|365868194|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055505|NCT01847274|365868195|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
106055506|NCT01847274|365868196|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055507|NCT01847274|365868197|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055508|NCT01847274|365868198|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055509|NCT01847274|365868199|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055510|NCT01847274|365868200|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
106055511|NCT01847274|365868190|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055512|NCT01847274|365868191|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055513|NCT01847274|365868192|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055514|NCT01847274|365868193|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055515|NCT01847274|365868194|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
106055516|NCT01847274|365868195|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055517|NCT01847274|365868196|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055518|NCT01847274|365868197|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055519|NCT01847274|365868198|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055520|NCT01847274|365868199|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055521|NCT01847274|365868200|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
106055522|NCT01847274|365868190|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055523|NCT01847274|365868191|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055524|NCT01847274|365868192|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055525|NCT01847274|365868193|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055526|NCT01847274|365868194|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055527|NCT01847274|365868195|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055528|NCT01847274|365868196|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
106055529|NCT01847274|365868197|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055530|NCT01847274|365868198|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055531|NCT01847274|365868199|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055532|NCT01847274|365868200|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
106055533|NCT01847274|365868190|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055534|NCT01847274|365868191|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106152472|NCT03438188|366218807|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
106152473|NCT03438188|366218805|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
106055535|NCT01847274|365868192|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055536|NCT01847274|365868193|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055537|NCT01847274|365868194|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055538|NCT01847274|365868195|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055539|NCT01847274|365868196|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
106055540|NCT01847274|365868197|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055541|NCT01847274|365868198|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055542|NCT01847274|365868199|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055543|NCT01847274|365868200|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
106055544|NCT01847274|365868190|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055545|NCT01847274|365868191|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055546|NCT01847274|365868192|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055547|NCT01847274|365868193|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055548|NCT01847274|365868194|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055549|NCT01847274|365868195|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055550|NCT01847274|365868196|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
106055551|NCT01847274|365868197|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055552|NCT01847274|365868198|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055553|NCT01847274|365868199|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055554|NCT01847274|365868200|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
106055555|NCT01847274|365868190|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
106055556|NCT01847274|365868191|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
106055557|NCT01847274|365868192|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
106055558|NCT01847274|365868193|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
106055559|NCT01847274|365868194|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
106055560|NCT01847274|365868195|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
106055561|NCT01847274|365868196|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
106055562|NCT01847274|365868197|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
106055563|NCT01847274|365868198|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
106055564|NCT01847274|365868199|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
106055565|NCT01847274|365868200|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
106055566|NCT01847274|365868190|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055567|NCT01847274|365868191|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055568|NCT01847274|365868192|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055569|NCT01847274|365868193|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055570|NCT01847274|365868194|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055571|NCT01847274|365868195|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055572|NCT01847274|365868196|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055573|NCT01847274|365868197|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
106055574|NCT01847274|365868198|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055575|NCT01847274|365868199|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
106055576|NCT01847274|365868200|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
106055577|NCT01847274|365868190|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
106055578|NCT01847274|365868191|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
106055579|NCT01847274|365868192|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
106055580|NCT01847274|365868193|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
106055581|NCT01847274|365868194|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
106055582|NCT01847274|365868195|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
106055583|NCT01847274|365868196|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
106055584|NCT01847274|365868197|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
106055585|NCT01847274|365868198|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
106055586|NCT01847274|365868199|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
106055587|NCT01847274|365868200|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
106055588|NCT01847274|365868190|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055589|NCT01847274|365868191|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055590|NCT01847274|365868192|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055591|NCT01847274|365868193|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055592|NCT01847274|365868194|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055593|NCT01847274|365868195|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055594|NCT01847274|365868196|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055595|NCT01847274|365868197|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106152474|NCT03438188|366218806|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
106055596|NCT01847274|365868198|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055597|NCT01847274|365868199|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
106055598|NCT01847274|365868200|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
106055599|NCT00601458|365868204|FG000|Overall Study|Dosing Error|1|||
106055600|NCT00601458|365868205|FG001|Overall Study|Dosing Error|0|||
106055601|NCT00601458|365868206|FG002|Overall Study|Dosing Error|0|||
106055602|NCT00601458|365868204|FG000|Overall Study|Incomplete Data|0|||
106055603|NCT00601458|365868205|FG001|Overall Study|Incomplete Data|2|||
106055604|NCT00601458|365868206|FG002|Overall Study|Incomplete Data|0|||
106055605|NCT00601458|365868204|FG000|Overall Study|Protocol Violation|3|||
106055606|NCT00601458|365868205|FG001|Overall Study|Protocol Violation|2|||
106055607|NCT00601458|365868206|FG002|Overall Study|Protocol Violation|1|||
106055608|NCT00601458|365868204|FG000|Overall Study|Early Termination|0|||
106055609|NCT00601458|365868205|FG001|Overall Study|Early Termination|1|||
106055610|NCT00601458|365868206|FG002|Overall Study|Early Termination|1|||
106055611|NCT03982368|365868207|FG000|Overall Study|Adverse Event|6|||
106055612|NCT03982368|365868208|FG001|Overall Study|Adverse Event|4|||
106055613|NCT03982368|365868209|FG002|Overall Study|Adverse Event|3|||
106055614|NCT03982368|365868207|FG000|Overall Study|Lost to Follow-up|2|||
106055615|NCT03982368|365868208|FG001|Overall Study|Lost to Follow-up|1|||
106055616|NCT03982368|365868209|FG002|Overall Study|Lost to Follow-up|0|||
106055617|NCT03982368|365868207|FG000|Overall Study|Withdrawal by Subject|1|||
106055618|NCT03982368|365868208|FG001|Overall Study|Withdrawal by Subject|2|||
106055619|NCT03982368|365868209|FG002|Overall Study|Withdrawal by Subject|0|||
106055620|NCT03982368|365868207|FG000|Overall Study|unknow|4|||
106055621|NCT03982368|365868208|FG001|Overall Study|unknow|0|||
106055622|NCT03982368|365868209|FG002|Overall Study|unknow|2|||
106055623|NCT05229406|365868212|FG000|Overall Study|Withdrawal by Subject|1|||
106055624|NCT05229406|365868213|FG001|Overall Study|Withdrawal by Subject|2|||
106055625|NCT01496807|365868217|FG000|Overall Study|Progressive Disease|21|||
106055626|NCT01496807|365868217|FG000|Overall Study|Participant preference/toxicity|8|||
106055627|NCT01496807|365868217|FG000|Overall Study|Change in diagnosis|1|||
106055628|NCT05466682|365868221|FG000|Overall Study|Withdrawal by Subject|0|||
106055629|NCT05466682|365868222|FG001|Overall Study|Withdrawal by Subject|2|||
106055630|NCT05466682|365868221|FG000|Overall Study|Lost to Follow-up|2|||
106055631|NCT05466682|365868222|FG001|Overall Study|Lost to Follow-up|1|||
106055632|NCT01697566|365868223|FG000|Overall Study|Withdrawal by Subject|0|||
106055633|NCT01697566|365868224|FG001|Overall Study|Withdrawal by Subject|0|||
106055634|NCT01697566|365868225|FG002|Overall Study|Withdrawal by Subject|1|||
106055635|NCT01697566|365868226|FG003|Overall Study|Withdrawal by Subject|1|||
106055636|NCT01697566|365868223|FG000|Overall Study|Final biopsy not obtained|0|||
106055637|NCT01697566|365868224|FG001|Overall Study|Final biopsy not obtained|0|||
106055638|NCT01697566|365868225|FG002|Overall Study|Final biopsy not obtained|1|||
106055639|NCT01697566|365868226|FG003|Overall Study|Final biopsy not obtained|0|||
106055640|NCT03095612|365868227|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
106055641|NCT03095612|365868228|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
106055642|NCT03095612|365868229|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
106055643|NCT03095612|365868230|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
106055644|NCT03095612|365868231|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
106055645|NCT03095612|365868232|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
106055646|NCT03095612|365868233|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
106055647|NCT00036270|365868236|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
106055648|NCT00036270|365868237|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
106055649|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
106055650|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
106152475|NCT03438188|366218807|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
106055651|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
106055652|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
106055653|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
106055654|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
106055655|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Other|277|||
106055656|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Other|288|||
106055657|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
106055658|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
106055659|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
106055660|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
106055661|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
106055662|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
106152476|NCT03438188|366218805|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
106055663|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
106055664|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
106055665|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
106055666|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
106055667|NCT00036270|365868236|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
106055668|NCT00036270|365868237|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
106055669|NCT02591290|365868242|FG000|Overall Study|Withdrawal by Subject|2|||
106055670|NCT02516163|365868243|FG000|Overall Study|Withdrawal by Subject|1|||
106055671|NCT02516163|365868243|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
106055672|NCT02516163|365868243|FG000|Overall Study|Unfit/delay in surgery|3|||
106055673|NCT02516163|365868243|FG000|Overall Study|Use of incorrect measurement technique|5|||
106055674|NCT02516163|365868243|FG000|Overall Study|Data not recorded|2|||
106055675|NCT02516163|365868243|FG000|Overall Study|MRI contraindication exclusion|6|||
106055676|NCT01370356|365868248|FG000|Overall Study|Death|1|||
106055677|NCT01370356|365868249|FG001|Overall Study|Death|0|||
106055678|NCT01370356|365868248|FG000|Overall Study|Lack of Efficacy|6|||
106055679|NCT01370356|365868249|FG001|Overall Study|Lack of Efficacy|28|||
106055680|NCT01370356|365868248|FG000|Overall Study|Lost to Follow-up|76|||
106055681|NCT01370356|365868249|FG001|Overall Study|Lost to Follow-up|81|||
106055682|NCT01370356|365868248|FG000|Overall Study|Withdrawal by Subject|54|||
106055683|NCT01370356|365868249|FG001|Overall Study|Withdrawal by Subject|59|||
106055684|NCT01370356|365868248|FG000|Overall Study|Reason not specified|39|||
106055685|NCT01370356|365868249|FG001|Overall Study|Reason not specified|43|||
106055686|NCT01370356|365868248|FG000|Overall Study|Protocol Violation|3|||
106055687|NCT01370356|365868249|FG001|Overall Study|Protocol Violation|3|||
106055688|NCT01370356|365868248|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
106055689|NCT01370356|365868249|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
106055690|NCT01370356|365868248|FG000|Overall Study|AE Not Related to Study Drug|1|||
106055691|NCT01370356|365868249|FG001|Overall Study|AE Not Related to Study Drug|4|||
106055692|NCT00205881|365868250|FG000|Overall Study|Withdrawal by Subject|16|||
106055693|NCT01658072|365868257|FG000|Overall Study|Protocol Violation|4|||
106055694|NCT01658072|365868258|FG001|Overall Study|Protocol Violation|2|||
106055695|NCT03385564|365868264|FG000|Overall Study|Adverse Event|0|||
106055696|NCT03385564|365868265|FG001|Overall Study|Adverse Event|0|||
106055697|NCT03385564|365868266|FG002|Overall Study|Adverse Event|3|||
106055698|NCT03385564|365868267|FG003|Overall Study|Adverse Event|3|||
106055699|NCT03385564|365868264|FG000|Overall Study|Other than listed|0|||
106055700|NCT03385564|365868265|FG001|Overall Study|Other than listed|0|||
106055701|NCT03385564|365868266|FG002|Overall Study|Other than listed|0|||
106055702|NCT03385564|365868267|FG003|Overall Study|Other than listed|5|||
106055703|NCT03385564|365868264|FG000|Overall Study|Withdrawal by Subject|0|||
106055704|NCT03385564|365868265|FG001|Overall Study|Withdrawal by Subject|1|||
106055705|NCT03385564|365868266|FG002|Overall Study|Withdrawal by Subject|1|||
106055706|NCT03385564|365868267|FG003|Overall Study|Withdrawal by Subject|0|||
106055707|NCT03385564|365868264|FG000|Overall Study|Lack of Efficacy|0|||
106055708|NCT03385564|365868265|FG001|Overall Study|Lack of Efficacy|0|||
106055709|NCT03385564|365868266|FG002|Overall Study|Lack of Efficacy|0|||
106055710|NCT03385564|365868267|FG003|Overall Study|Lack of Efficacy|1|||
106055711|NCT03385564|365868264|FG000|Overall Study|Death|0|||
106055712|NCT03385564|365868265|FG001|Overall Study|Death|0|||
106055713|NCT03385564|365868266|FG002|Overall Study|Death|1|||
106055714|NCT03385564|365868267|FG003|Overall Study|Death|0|||
106055715|NCT01546883|365868270|FG000|Overall Study|Withdrawal by Subject|3|||
106055716|NCT01546883|365868270|FG000|Overall Study|Adverse Event|4|||
106055717|NCT01546883|365868270|FG000|Overall Study|Lost to Follow-up|2|||
106055718|NCT01546883|365868270|FG000|Overall Study|early closure of study|2|||
106055719|NCT01546883|365868270|FG000|Overall Study|other unrelated illness|1|||
106055720|NCT00622284|365868276|FG000|Overall Study|Lack of Efficacy|45|||
106055721|NCT00622284|365868277|FG001|Overall Study|Lack of Efficacy|15|||
106055722|NCT00622284|365868276|FG000|Overall Study|Adverse Event|61|||
106055723|NCT00622284|365868277|FG001|Overall Study|Adverse Event|90|||
106055724|NCT00622284|365868276|FG000|Overall Study|Protocol Violation|12|||
105864524|NCT02960490|365152947|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
106055725|NCT00622284|365868277|FG001|Overall Study|Protocol Violation|5|||
106055726|NCT00622284|365868276|FG000|Overall Study|Lost to Follow-up|11|||
106055727|NCT00622284|365868277|FG001|Overall Study|Lost to Follow-up|13|||
106055728|NCT00622284|365868276|FG000|Overall Study|Withdrawal by Subject|27|||
106055729|NCT00622284|365868277|FG001|Overall Study|Withdrawal by Subject|24|||
106055730|NCT00622284|365868276|FG000|Overall Study|Other reason (not specified)|33|||
106055731|NCT00622284|365868277|FG001|Overall Study|Other reason (not specified)|24|||
106055732|NCT01844518|365868283|FG000|Overall Study|Adverse Event|7|||
106055733|NCT01844518|365868284|FG001|Overall Study|Adverse Event|1|||
106055734|NCT01844518|365868283|FG000|Overall Study|Lack of Efficacy|17|||
106055735|NCT01844518|365868284|FG001|Overall Study|Lack of Efficacy|5|||
106055736|NCT01844518|365868283|FG000|Overall Study|Participant's request to discontinue|4|||
106055737|NCT01844518|365868284|FG001|Overall Study|Participant's request to discontinue|1|||
106152477|NCT03438188|366218806|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
106152478|NCT03438188|366218807|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
105864525|NCT02960490|365152948|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
105864526|NCT02960490|365152949|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
105864527|NCT02960490|365152950|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105864528|NCT02960490|365152951|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
105864529|NCT02960490|365152952|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105864530|NCT02960490|365152953|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105864531|NCT02960490|365152954|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105864532|NCT02960490|365152955|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
105864533|NCT02960490|365152946|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105864534|NCT02960490|365152947|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105864535|NCT02960490|365152948|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
105864536|NCT02960490|365152949|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105864537|NCT02960490|365152950|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
105864538|NCT02960490|365152951|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105864539|NCT02960490|365152952|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105864540|NCT02960490|365152953|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105864541|NCT02960490|365152954|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105864542|NCT02960490|365152955|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
105864543|NCT02960490|365152946|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
105864544|NCT02960490|365152947|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
105864545|NCT02960490|365152948|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
105864546|NCT02960490|365152949|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
105864547|NCT02960490|365152950|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
105864548|NCT02960490|365152951|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
105864549|NCT02960490|365152952|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
105864550|NCT02960490|365152953|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
105864551|NCT02960490|365152954|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
105864552|NCT02960490|365152955|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
105864553|NCT02960490|365152946|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105864554|NCT02960490|365152947|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105864555|NCT02960490|365152948|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105864556|NCT02960490|365152949|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105864557|NCT02960490|365152950|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105864558|NCT02960490|365152951|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105864559|NCT02960490|365152952|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
105864560|NCT02960490|365152953|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
105864561|NCT02960490|365152954|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
105864562|NCT02960490|365152955|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
105864563|NCT02960490|365152946|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105864564|NCT02960490|365152947|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105864565|NCT02960490|365152948|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105864566|NCT02960490|365152949|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105864567|NCT02960490|365152950|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
106055738|NCT01844518|365868283|FG000|Overall Study|Poor/Non-compliance|1|||
106055739|NCT01844518|365868284|FG001|Overall Study|Poor/Non-compliance|0|||
106055740|NCT01844518|365868283|FG000|Overall Study|No Longer Met Study Criteria|2|||
106055741|NCT01844518|365868284|FG001|Overall Study|No Longer Met Study Criteria|0|||
106055742|NCT01844518|365868283|FG000|Overall Study|Withdrawal by Subject|9|||
106055743|NCT01844518|365868284|FG001|Overall Study|Withdrawal by Subject|0|||
106055744|NCT01844518|365868283|FG000|Overall Study|Pregnancy|1|||
106055745|NCT01844518|365868284|FG001|Overall Study|Pregnancy|0|||
106055746|NCT02010775|365868285|FG000|Overall Study|Adverse Event|0|||
106055747|NCT02010775|365868286|FG001|Overall Study|Adverse Event|0|||
106055748|NCT02010775|365868287|FG002|Overall Study|Adverse Event|0|||
106055749|NCT02010775|365868288|FG003|Overall Study|Adverse Event|0|||
106055750|NCT02010775|365868289|FG004|Overall Study|Adverse Event|1|||
106055751|NCT02010775|365868285|FG000|Overall Study|Pregnancy|0|||
106152479|NCT03438188|366218805|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
106152480|NCT03438188|366218806|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
105864568|NCT02960490|365152951|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105864569|NCT02960490|365152952|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
106055752|NCT02010775|365868286|FG001|Overall Study|Pregnancy|0|||
106055753|NCT02010775|365868287|FG002|Overall Study|Pregnancy|2|||
106055754|NCT02010775|365868288|FG003|Overall Study|Pregnancy|0|||
106055755|NCT02010775|365868289|FG004|Overall Study|Pregnancy|0|||
106055756|NCT02010775|365868285|FG000|Overall Study|Lost to Follow-up|2|||
106055757|NCT02010775|365868286|FG001|Overall Study|Lost to Follow-up|0|||
106055758|NCT02010775|365868287|FG002|Overall Study|Lost to Follow-up|0|||
106055759|NCT02010775|365868288|FG003|Overall Study|Lost to Follow-up|1|||
106055760|NCT02010775|365868289|FG004|Overall Study|Lost to Follow-up|1|||
106055761|NCT02010775|365868285|FG000|Overall Study|Personal Reasons|3|||
106055762|NCT02010775|365868286|FG001|Overall Study|Personal Reasons|3|||
106055763|NCT02010775|365868287|FG002|Overall Study|Personal Reasons|1|||
106055764|NCT02010775|365868288|FG003|Overall Study|Personal Reasons|2|||
106055765|NCT02010775|365868289|FG004|Overall Study|Personal Reasons|4|||
106055766|NCT00256750|365868290|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
106055767|NCT00256750|365868291|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
106055768|NCT00256750|365868292|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
106055769|NCT00256750|365868290|FG000|Transplanted Pre-Treatment|Other|2|||
106055770|NCT00256750|365868291|FG001|Transplanted Pre-Treatment|Other|0|||
106055771|NCT00256750|365868292|FG002|Transplanted Pre-Treatment|Other|0|||
106055772|NCT00256750|365868290|FG000|Transplanted Pre-Treatment|Death|1|||
106055773|NCT00256750|365868291|FG001|Transplanted Pre-Treatment|Death|0|||
106055774|NCT00256750|365868292|FG002|Transplanted Pre-Treatment|Death|0|||
106055775|NCT00256750|365868290|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
106055776|NCT00256750|365868291|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
106055777|NCT00256750|365868292|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
106055778|NCT00256750|365868290|FG000|Post-Transplant Treated (12 Months)|Death|3|||
106055779|NCT00256750|365868291|FG001|Post-Transplant Treated (12 Months)|Death|2|||
106055780|NCT00256750|365868292|FG002|Post-Transplant Treated (12 Months)|Death|4|||
106055781|NCT00256750|365868290|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
106055782|NCT00256750|365868291|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
106055783|NCT00256750|365868292|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
106055784|NCT00256750|365868290|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
106055785|NCT00256750|365868291|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
106055786|NCT00256750|365868292|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
106055787|NCT00256750|365868290|FG000|Post-Transplant Treated (12 Months)|Other|5|||
106055788|NCT00256750|365868291|FG001|Post-Transplant Treated (12 Months)|Other|4|||
106055789|NCT00256750|365868292|FG002|Post-Transplant Treated (12 Months)|Other|2|||
106055790|NCT00256750|365868290|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
106055791|NCT00256750|365868291|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
106055792|NCT00256750|365868292|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
106055793|NCT00256750|365868290|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
106055794|NCT00256750|365868291|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
106055795|NCT00256750|365868292|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
106055796|NCT00256750|365868290|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
106055797|NCT00256750|365868291|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
106055798|NCT00256750|365868292|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
106055799|NCT00256750|365868290|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
106055800|NCT00256750|365868291|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
106055801|NCT00256750|365868292|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
106055802|NCT00256750|365868290|FG000|Post-Transplant Treated (24 Months)|Death|3|||
106055803|NCT00256750|365868291|FG001|Post-Transplant Treated (24 Months)|Death|0|||
106055804|NCT00256750|365868292|FG002|Post-Transplant Treated (24 Months)|Death|0|||
106055805|NCT00256750|365868290|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
106055806|NCT00256750|365868291|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
106055807|NCT00256750|365868292|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
106055808|NCT00256750|365868290|FG000|Post-Transplant Treated (24 Months)|Other|2|||
106055809|NCT00256750|365868291|FG001|Post-Transplant Treated (24 Months)|Other|0|||
106055810|NCT00256750|365868292|FG002|Post-Transplant Treated (24 Months)|Other|1|||
106055811|NCT00256750|365868290|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
106055812|NCT00256750|365868291|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
106055813|NCT00256750|365868292|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
106055814|NCT00256750|365868290|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
106055815|NCT00256750|365868291|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
106055816|NCT00256750|365868292|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
106055817|NCT00256750|365868290|FG000|Post-Transplant Treated (36 Months)|Death|0|||
106055818|NCT00256750|365868291|FG001|Post-Transplant Treated (36 Months)|Death|2|||
106055819|NCT00256750|365868292|FG002|Post-Transplant Treated (36 Months)|Death|1|||
106055820|NCT00256750|365868290|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
106055821|NCT00256750|365868291|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
106055822|NCT00256750|365868292|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
106055823|NCT00256750|365868290|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
106055824|NCT00256750|365868291|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
106055825|NCT00256750|365868292|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
106055826|NCT00256750|365868290|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
106055827|NCT00256750|365868291|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
106055828|NCT00256750|365868292|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
106055829|NCT00256750|365868290|FG000|Post-Transplant Treated (36 Months)|Other|0|||
106055830|NCT00256750|365868291|FG001|Post-Transplant Treated (36 Months)|Other|1|||
106055831|NCT00256750|365868292|FG002|Post-Transplant Treated (36 Months)|Other|1|||
106055832|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
106055833|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
106055834|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
106055835|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
106055836|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
106055837|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
106055838|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
106055839|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
106055840|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
106055841|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
106055842|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
106055843|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
106055844|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
106055845|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
106055846|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
106055847|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
106055848|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
106055849|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
106055850|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
106055851|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
106055852|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
106055853|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
106055854|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
106055855|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
106055856|NCT00256750|365868290|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
106055857|NCT00256750|365868291|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
106055858|NCT00256750|365868292|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
106055859|NCT02006719|365868293|FG000|Overall Study|Withdrawal by Subject|10|||
106055860|NCT02006719|365868294|FG001|Overall Study|Withdrawal by Subject|2|||
106055861|NCT02006719|365868293|FG000|Overall Study|Lost to Follow-up|5|||
106055862|NCT02006719|365868294|FG001|Overall Study|Lost to Follow-up|1|||
106055863|NCT02006719|365868293|FG000|Overall Study|Protocol Violation|2|||
106055864|NCT02006719|365868294|FG001|Overall Study|Protocol Violation|0|||
106055865|NCT02006719|365868293|FG000|Overall Study|Adverse Event|1|||
106055866|NCT02006719|365868294|FG001|Overall Study|Adverse Event|1|||
106055867|NCT02006719|365868293|FG000|Overall Study|Other/Unknown|0|||
106055868|NCT02006719|365868294|FG001|Overall Study|Other/Unknown|1|||
106055869|NCT03547583|365868295|FG000|Overall Study|Adverse Event|16|||
106055870|NCT03547583|365868296|FG001|Overall Study|Adverse Event|11|||
106055871|NCT03547583|365868297|FG002|Overall Study|Adverse Event|10|||
106055872|NCT03547583|365868295|FG000|Overall Study|Death|11|||
106055873|NCT03547583|365868296|FG001|Overall Study|Death|7|||
106055874|NCT03547583|365868297|FG002|Overall Study|Death|4|||
106055875|NCT03547583|365868295|FG000|Overall Study|Lost to Follow-up|1|||
106055876|NCT03547583|365868296|FG001|Overall Study|Lost to Follow-up|0|||
106055877|NCT03547583|365868297|FG002|Overall Study|Lost to Follow-up|0|||
106055878|NCT03547583|365868295|FG000|Overall Study|Non-compliance with study drug|0|||
106055879|NCT03547583|365868296|FG001|Overall Study|Non-compliance with study drug|0|||
106055880|NCT03547583|365868297|FG002|Overall Study|Non-compliance with study drug|1|||
106055881|NCT03547583|365868295|FG000|Overall Study|Physician Decision|1|||
106055882|NCT03547583|365868296|FG001|Overall Study|Physician Decision|0|||
106055883|NCT03547583|365868297|FG002|Overall Study|Physician Decision|3|||
106055884|NCT03547583|365868295|FG000|Overall Study|Protocol Violation|2|||
106055885|NCT03547583|365868296|FG001|Overall Study|Protocol Violation|1|||
106055886|NCT03547583|365868297|FG002|Overall Study|Protocol Violation|1|||
106055887|NCT03547583|365868295|FG000|Overall Study|Withdrawal by Subject|12|||
106055888|NCT03547583|365868296|FG001|Overall Study|Withdrawal by Subject|19|||
106055889|NCT03547583|365868297|FG002|Overall Study|Withdrawal by Subject|10|||
106055890|NCT03547583|365868295|FG000|Overall Study|Other|2|||
106055891|NCT03547583|365868296|FG001|Overall Study|Other|2|||
106055892|NCT03547583|365868297|FG002|Overall Study|Other|3|||
106055893|NCT03329573|365868298|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
106055894|NCT03329573|365868299|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
106055895|NCT03329573|365868300|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
106055896|NCT03329573|365868301|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
106055897|NCT03329573|365868298|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
106055898|NCT03329573|365868299|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
106055899|NCT03329573|365868300|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
106055900|NCT03329573|365868301|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
106055901|NCT03329573|365868298|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
106055902|NCT03329573|365868299|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
106055903|NCT03329573|365868300|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
106055904|NCT03329573|365868301|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
106055905|NCT03329573|365868298|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
106055906|NCT03329573|365868299|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
106055907|NCT03329573|365868300|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
106055908|NCT03329573|365868301|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
106055909|NCT00837811|365868304|FG000|Overall Study|Adverse Event|4|||
106055910|NCT00837811|365868305|FG001|Overall Study|Adverse Event|6|||
106055911|NCT00837811|365868306|FG002|Overall Study|Adverse Event|0|||
106055912|NCT00837811|365868304|FG000|Overall Study|Death|1|||
106055913|NCT00837811|365868305|FG001|Overall Study|Death|1|||
106055914|NCT00837811|365868306|FG002|Overall Study|Death|0|||
106055915|NCT00837811|365868304|FG000|Overall Study|Lack of Efficacy|0|||
106055916|NCT00837811|365868305|FG001|Overall Study|Lack of Efficacy|11|||
106055917|NCT00837811|365868306|FG002|Overall Study|Lack of Efficacy|0|||
106055918|NCT00837811|365868304|FG000|Overall Study|Lost to Follow-up|1|||
106055919|NCT00837811|365868305|FG001|Overall Study|Lost to Follow-up|3|||
106055920|NCT00837811|365868306|FG002|Overall Study|Lost to Follow-up|0|||
106055921|NCT00837811|365868304|FG000|Overall Study|Physician Decision|0|||
106055922|NCT00837811|365868305|FG001|Overall Study|Physician Decision|2|||
106055923|NCT00837811|365868306|FG002|Overall Study|Physician Decision|1|||
106055924|NCT00837811|365868304|FG000|Overall Study|Withdrawal by Subject|1|||
106055925|NCT00837811|365868305|FG001|Overall Study|Withdrawal by Subject|9|||
106055926|NCT00837811|365868306|FG002|Overall Study|Withdrawal by Subject|0|||
106055927|NCT00837811|365868304|FG000|Overall Study|Sponsor Decision|0|||
106055928|NCT00837811|365868305|FG001|Overall Study|Sponsor Decision|2|||
106055929|NCT00837811|365868306|FG002|Overall Study|Sponsor Decision|0|||
106055930|NCT02915016|365868307|FG000|Overall Study|Lost to Follow-up|4|||
106055931|NCT02915016|365868308|FG001|Overall Study|Lost to Follow-up|2|||
106055932|NCT02915016|365868309|FG002|Overall Study|Lost to Follow-up|5|||
106055933|NCT02915016|365868310|FG003|Overall Study|Lost to Follow-up|3|||
106055934|NCT02915016|365868311|FG004|Overall Study|Lost to Follow-up|5|||
106055935|NCT02915016|365868312|FG005|Overall Study|Lost to Follow-up|2|||
106055936|NCT02915016|365868313|FG006|Overall Study|Lost to Follow-up|8|||
106055937|NCT02915016|365868314|FG007|Overall Study|Lost to Follow-up|2|||
106055938|NCT02915016|365868307|FG000|Overall Study|Physician Decision|0|||
106055939|NCT02915016|365868308|FG001|Overall Study|Physician Decision|0|||
106055940|NCT02915016|365868309|FG002|Overall Study|Physician Decision|1|||
106055941|NCT02915016|365868310|FG003|Overall Study|Physician Decision|0|||
106055942|NCT02915016|365868311|FG004|Overall Study|Physician Decision|0|||
106055943|NCT02915016|365868312|FG005|Overall Study|Physician Decision|1|||
106055944|NCT02915016|365868313|FG006|Overall Study|Physician Decision|2|||
106055945|NCT02915016|365868314|FG007|Overall Study|Physician Decision|0|||
106055946|NCT02915016|365868307|FG000|Overall Study|Withdrawal by Subject|2|||
106055947|NCT02915016|365868308|FG001|Overall Study|Withdrawal by Subject|0|||
106055948|NCT02915016|365868309|FG002|Overall Study|Withdrawal by Subject|1|||
106055949|NCT02915016|365868310|FG003|Overall Study|Withdrawal by Subject|0|||
106055950|NCT02915016|365868311|FG004|Overall Study|Withdrawal by Subject|1|||
106055951|NCT02915016|365868312|FG005|Overall Study|Withdrawal by Subject|3|||
106055952|NCT02915016|365868313|FG006|Overall Study|Withdrawal by Subject|1|||
106055953|NCT02915016|365868314|FG007|Overall Study|Withdrawal by Subject|1|||
106055954|NCT02915016|365868307|FG000|Overall Study|Elected not to continue|0|||
106055955|NCT02915016|365868308|FG001|Overall Study|Elected not to continue|0|||
106055956|NCT02915016|365868309|FG002|Overall Study|Elected not to continue|0|||
106055957|NCT02915016|365868310|FG003|Overall Study|Elected not to continue|1|||
106055958|NCT02915016|365868311|FG004|Overall Study|Elected not to continue|0|||
106055959|NCT02915016|365868312|FG005|Overall Study|Elected not to continue|0|||
106055960|NCT02915016|365868313|FG006|Overall Study|Elected not to continue|1|||
106055961|NCT02915016|365868314|FG007|Overall Study|Elected not to continue|0|||
106055962|NCT02915016|365868307|FG000|Overall Study|HIV infection|1|||
106055963|NCT02915016|365868308|FG001|Overall Study|HIV infection|1|||
106055964|NCT02915016|365868309|FG002|Overall Study|HIV infection|1|||
106055965|NCT02915016|365868310|FG003|Overall Study|HIV infection|0|||
106055966|NCT02915016|365868311|FG004|Overall Study|HIV infection|1|||
106055967|NCT02915016|365868312|FG005|Overall Study|HIV infection|0|||
106055968|NCT02915016|365868313|FG006|Overall Study|HIV infection|0|||
106055969|NCT02915016|365868314|FG007|Overall Study|HIV infection|0|||
106055970|NCT02915016|365868307|FG000|Overall Study|Participant unable to adhere|0|||
106055971|NCT02915016|365868308|FG001|Overall Study|Participant unable to adhere|0|||
106055972|NCT02915016|365868309|FG002|Overall Study|Participant unable to adhere|0|||
106055973|NCT02915016|365868310|FG003|Overall Study|Participant unable to adhere|0|||
106055974|NCT02915016|365868311|FG004|Overall Study|Participant unable to adhere|0|||
106055975|NCT02915016|365868312|FG005|Overall Study|Participant unable to adhere|0|||
106055976|NCT02915016|365868313|FG006|Overall Study|Participant unable to adhere|0|||
106055977|NCT02915016|365868314|FG007|Overall Study|Participant unable to adhere|1|||
106055978|NCT02578316|365868315|FG000|Extension Phase|Progression of disease|6|||
106055979|NCT02166905|365868316|FG000|Overall Study|Withdrawal by Subject|1|||
106055980|NCT02166905|365868317|FG001|Overall Study|Withdrawal by Subject|0|||
106055981|NCT02166905|365868318|FG002|Overall Study|Withdrawal by Subject|0|||
106055982|NCT02166905|365868319|FG003|Overall Study|Withdrawal by Subject|0|||
106055983|NCT02617628|365868320|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
106055984|NCT02617628|365868321|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
106055985|NCT03904043|365868323|FG000|Overall Study|Adverse Event|1|||
106055986|NCT03904043|365868324|FG001|Overall Study|Adverse Event|1|||
106055987|NCT03904043|365868323|FG000|Overall Study|Withdrawal by Subject|1|||
106055988|NCT03904043|365868324|FG001|Overall Study|Withdrawal by Subject|0|||
106055989|NCT03904043|365868323|FG000|Overall Study|Non-compliance|1|||
106055990|NCT03904043|365868324|FG001|Overall Study|Non-compliance|0|||
106055991|NCT03904043|365868323|FG000|Overall Study|Did not start treatment|1|||
106055992|NCT03904043|365868324|FG001|Overall Study|Did not start treatment|0|||
106055993|NCT05425745|365868329|FG000|Overall Study|Withdrawal of Consent|3|||
106055994|NCT05425745|365868330|FG001|Overall Study|Withdrawal of Consent|3|||
106055995|NCT05425745|365868329|FG000|Overall Study|Death|2|||
106055996|NCT05425745|365868330|FG001|Overall Study|Death|3|||
106055997|NCT05425745|365868329|FG000|Overall Study|Lost to Follow-up|1|||
106055998|NCT05425745|365868330|FG001|Overall Study|Lost to Follow-up|2|||
106055999|NCT05425745|365868329|FG000|Overall Study|Adverse Event|0|||
106056000|NCT05425745|365868330|FG001|Overall Study|Adverse Event|1|||
106056001|NCT05425745|365868329|FG000|Overall Study|Did not return for end of study visit|0|||
106056002|NCT05425745|365868330|FG001|Overall Study|Did not return for end of study visit|1|||
106056003|NCT05425745|365868329|FG000|Overall Study|End of study visit completed by phone|1|||
106056004|NCT05425745|365868330|FG001|Overall Study|End of study visit completed by phone|0|||
106056005|NCT05425745|365868329|FG000|Overall Study|Subject decision|1|||
106056006|NCT05425745|365868330|FG001|Overall Study|Subject decision|0|||
106056007|NCT01713686|365871029|FG000|Overall Study|Lost to Follow-up|9|||
106056008|NCT01713686|365871029|FG000|Overall Study|Withdrawal by Subject|6|||
106056009|NCT03187197|365871030|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
106056010|NCT03187197|365871031|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
106056011|NCT03187197|365871032|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
106056012|NCT03187197|365871030|FG000|Overall Study|Withdrawal by Subject|8|||
106056013|NCT03187197|365871031|FG001|Overall Study|Withdrawal by Subject|63|||
106056014|NCT03187197|365871032|FG002|Overall Study|Withdrawal by Subject|4|||
106056015|NCT03187197|365871030|FG000|Overall Study|Lost to Follow-up|1|||
106056016|NCT03187197|365871031|FG001|Overall Study|Lost to Follow-up|60|||
106056017|NCT03187197|365871032|FG002|Overall Study|Lost to Follow-up|7|||
106056018|NCT03187197|365871030|FG000|Overall Study|Adverse Event|6|||
106056019|NCT03187197|365871031|FG001|Overall Study|Adverse Event|29|||
106056020|NCT03187197|365871032|FG002|Overall Study|Adverse Event|0|||
106056021|NCT03187197|365871030|FG000|Overall Study|Death|0|||
106056022|NCT03187197|365871031|FG001|Overall Study|Death|11|||
106056023|NCT03187197|365871032|FG002|Overall Study|Death|0|||
106056024|NCT03187197|365871030|FG000|Overall Study|Administrative problem|1|||
106056025|NCT03187197|365871031|FG001|Overall Study|Administrative problem|1|||
106056026|NCT03187197|365871032|FG002|Overall Study|Administrative problem|0|||
106056027|NCT03187197|365871030|FG000|Overall Study|Reason not listed|2|||
106056028|NCT03187197|365871031|FG001|Overall Study|Reason not listed|54|||
106056029|NCT03187197|365871032|FG002|Overall Study|Reason not listed|1|||
106056030|NCT03187197|365871030|FG000|Overall Study|Missing|1|||
106056031|NCT03187197|365871031|FG001|Overall Study|Missing|32|||
106056032|NCT03187197|365871032|FG002|Overall Study|Missing|3|||
106056033|NCT03187197|365871030|FG000|Overall Study|Status missing|2|||
106056034|NCT03187197|365871031|FG001|Overall Study|Status missing|33|||
106056035|NCT03187197|365871032|FG002|Overall Study|Status missing|3|||
106056036|NCT03187197|365871030|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
106056037|NCT03187197|365871031|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
106056038|NCT03187197|365871032|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
106056039|NCT02385045|365871033|FG000|Overall Study|Endoscopy could not be completed|4|||
106056040|NCT00381485|365871034|FG000|Open-Label Run-In Period|Adverse Event|9|||
106056041|NCT00381485|365871035|FG001|Open-Label Run-In Period|Adverse Event|0|||
106056042|NCT00381485|365871036|FG002|Open-Label Run-In Period|Adverse Event|0|||
106056043|NCT00381485|365871037|FG003|Open-Label Run-In Period|Adverse Event|0|||
106056044|NCT00381485|365871034|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
106056045|NCT00381485|365871035|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
106056046|NCT00381485|365871036|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
106056047|NCT00381485|365871037|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
106056048|NCT00381485|365871034|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
106056049|NCT00381485|365871035|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
106056050|NCT00381485|365871036|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
106056051|NCT00381485|365871037|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
106056052|NCT00381485|365871034|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
106056053|NCT00381485|365871035|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
106056054|NCT00381485|365871036|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
106056055|NCT00381485|365871037|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
106056056|NCT00381485|365871034|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
106056057|NCT00381485|365871035|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
106056058|NCT00381485|365871036|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
105864570|NCT02960490|365152953|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
105864571|NCT02960490|365152954|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105864572|NCT02960490|365152955|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
105864573|NCT02960490|365152946|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105864574|NCT02960490|365152947|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105864575|NCT02960490|365152948|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105864576|NCT02960490|365152949|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105864577|NCT02960490|365152950|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105864578|NCT02960490|365152951|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
105864579|NCT02960490|365152952|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
105864580|NCT02960490|365152953|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
105864581|NCT02960490|365152954|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
105864582|NCT02960490|365152955|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
105864583|NCT02960490|365152946|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864584|NCT02960490|365152947|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864585|NCT02960490|365152948|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864586|NCT02960490|365152949|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864587|NCT02960490|365152950|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864588|NCT02960490|365152951|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864589|NCT02960490|365152952|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
105864590|NCT02960490|365152953|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864591|NCT02960490|365152954|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864592|NCT02960490|365152955|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
105864593|NCT02960490|365152946|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864594|NCT02960490|365152947|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864595|NCT02960490|365152948|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864596|NCT02960490|365152949|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864597|NCT02960490|365152950|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864598|NCT02960490|365152951|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864599|NCT02960490|365152952|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864600|NCT02960490|365152953|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
105864601|NCT02960490|365152954|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864602|NCT02960490|365152955|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
105864603|NCT02901548|365152956|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
105864604|NCT02368314|365152959|FG000|Overall Study|Withdrawal by Subject|2|||
105864605|NCT02368314|365152960|FG001|Overall Study|Withdrawal by Subject|1|||
105864606|NCT02368314|365152959|FG000|Overall Study|Adverse Event|1|||
105864607|NCT02368314|365152960|FG001|Overall Study|Adverse Event|2|||
105864608|NCT02114385|365152961|FG000|Overall Study|Withdrawal by Subject|3|||
105864609|NCT02114385|365152962|FG001|Overall Study|Withdrawal by Subject|2|||
105864610|NCT02114385|365152961|FG000|Overall Study|Lost to Follow-up|0|||
105864611|NCT02114385|365152962|FG001|Overall Study|Lost to Follow-up|6|||
105864612|NCT01890434|365152965|FG000|Overall Study|Adverse Event|8|||
105864613|NCT01890434|365152965|FG000|Overall Study|PCI at external hospital|1|||
105864614|NCT01890434|365152965|FG000|Overall Study|Assessment discrepancy|1|||
105864615|NCT01890434|365152965|FG000|Overall Study|CRC didn't contact participant for FU|1|||
105864616|NCT01890434|365152965|FG000|Overall Study|Could not get whole set of images|1|||
105864617|NCT01890434|365152965|FG000|Overall Study|Decline to return for GSPECT|1|||
105864618|NCT01890434|365152965|FG000|Overall Study|GSPECT at rest was not done|1|||
105864619|NCT01890434|365152965|FG000|Overall Study|Participant didn't complete MRI|1|||
105864620|NCT01890434|365152965|FG000|Overall Study|Uncontactable by phone|1|||
105864621|NCT01890434|365152965|FG000|Overall Study|Moved out of position|1|||
105864622|NCT01890434|365152965|FG000|Overall Study|Unable to contact|1|||
105864623|NCT01890434|365152965|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
105864624|NCT03280381|365152967|FG000|Overall Study|Physician Decision|0|||
105864625|NCT03280381|365152968|FG001|Overall Study|Physician Decision|2|||
105864626|NCT01141205|365152969|FG000|Overall Study|Physician Decision|1|||
105864627|NCT01141205|365152970|FG001|Overall Study|Physician Decision|1|||
105864628|NCT01141205|365152969|FG000|Overall Study|Lost to Follow-up|1|||
106056059|NCT00381485|365871037|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
105864629|NCT01141205|365152970|FG001|Overall Study|Lost to Follow-up|0|||
105864630|NCT01141205|365152969|FG000|Overall Study|Withdrawal by Subject|1|||
105864631|NCT01141205|365152970|FG001|Overall Study|Withdrawal by Subject|1|||
106056060|NCT00381485|365871034|FG000|Open-Label Run-In Period|Treatment failure|1|||
106056061|NCT00381485|365871035|FG001|Open-Label Run-In Period|Treatment failure|0|||
106056062|NCT00381485|365871036|FG002|Open-Label Run-In Period|Treatment failure|0|||
106056063|NCT00381485|365871037|FG003|Open-Label Run-In Period|Treatment failure|0|||
106056064|NCT00381485|365871034|FG000|Double-Blind Treatment Period|Adverse Event|0|||
106056065|NCT00381485|365871035|FG001|Double-Blind Treatment Period|Adverse Event|2|||
106056066|NCT00381485|365871036|FG002|Double-Blind Treatment Period|Adverse Event|2|||
106056067|NCT00381485|365871037|FG003|Double-Blind Treatment Period|Adverse Event|5|||
106056068|NCT00381485|365871034|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
106056069|NCT00381485|365871035|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
106056070|NCT00381485|365871036|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
106056071|NCT00381485|365871037|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
106056072|NCT00381485|365871034|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
106056073|NCT00381485|365871035|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
106056074|NCT00381485|365871036|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
106056075|NCT00381485|365871037|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
106056076|NCT00381485|365871034|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
106056077|NCT00381485|365871035|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
106056078|NCT00381485|365871036|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
106056079|NCT00381485|365871037|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
106056080|NCT00381485|365871034|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
106056081|NCT00381485|365871035|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
106056082|NCT00381485|365871036|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
106056083|NCT00381485|365871037|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
106056084|NCT00381485|365871034|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
106056085|NCT00381485|365871035|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
106056086|NCT00381485|365871036|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
106056087|NCT00381485|365871037|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
106056088|NCT00381485|365871034|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
106056089|NCT00381485|365871035|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
106056090|NCT00381485|365871036|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
106056091|NCT00381485|365871037|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
106056092|NCT00381485|365871034|FG000|Double-Blind Treatment Period|Administrative|0|||
106056093|NCT00381485|365871035|FG001|Double-Blind Treatment Period|Administrative|1|||
106056094|NCT00381485|365871036|FG002|Double-Blind Treatment Period|Administrative|0|||
106056095|NCT00381485|365871037|FG003|Double-Blind Treatment Period|Administrative|1|||
106056096|NCT01648101|365871044|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
106056097|NCT01648101|365871045|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
106056098|NCT01648101|365871046|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
106056099|NCT01648101|365871044|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
106056100|NCT01648101|365871045|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
106056101|NCT01648101|365871046|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
106056102|NCT01648101|365871044|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
106056103|NCT01648101|365871045|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
106056104|NCT01648101|365871046|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
106056105|NCT01648101|365871044|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
106056106|NCT01648101|365871045|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
106056107|NCT01648101|365871046|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
106056108|NCT01648101|365871044|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
106056109|NCT01648101|365871045|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
106056110|NCT01648101|365871046|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
106056111|NCT01648101|365871044|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
106056112|NCT01648101|365871045|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
106056113|NCT01648101|365871046|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
106056114|NCT01648101|365871044|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
106056115|NCT01648101|365871045|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
106056116|NCT01648101|365871046|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
106056117|NCT01648101|365871044|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
106056118|NCT01648101|365871045|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
105864632|NCT01267994|365152971|FG000|Overall Study|Adverse Event|2|||
106056119|NCT01648101|365871046|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
106056120|NCT01648101|365871044|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
106056121|NCT01648101|365871045|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
106056122|NCT01648101|365871046|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
106056123|NCT01648101|365871044|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
106056124|NCT01648101|365871045|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
106056125|NCT01648101|365871046|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
106056126|NCT01648101|365871044|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
106056127|NCT01648101|365871045|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
106056128|NCT01648101|365871046|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
106056129|NCT03311724|365871061|FG000|Overall Study|Physician Decision|0|||
106056130|NCT03311724|365871062|FG001|Overall Study|Physician Decision|0|||
106056131|NCT03311724|365871063|FG002|Overall Study|Physician Decision|0|||
106056132|NCT03311724|365871064|FG003|Overall Study|Physician Decision|1|||
106056133|NCT03311724|365871061|FG000|Overall Study|Protocol Violation|1|||
106056134|NCT03311724|365871062|FG001|Overall Study|Protocol Violation|0|||
106056135|NCT03311724|365871063|FG002|Overall Study|Protocol Violation|1|||
106056136|NCT03311724|365871064|FG003|Overall Study|Protocol Violation|0|||
106056137|NCT03311724|365871061|FG000|Overall Study|Withdrawal by Subject|1|||
106056138|NCT03311724|365871062|FG001|Overall Study|Withdrawal by Subject|1|||
106056139|NCT03311724|365871063|FG002|Overall Study|Withdrawal by Subject|0|||
106056140|NCT03311724|365871064|FG003|Overall Study|Withdrawal by Subject|0|||
106056141|NCT03311724|365871061|FG000|Overall Study|Lost to Follow-up|1|||
106056142|NCT03311724|365871062|FG001|Overall Study|Lost to Follow-up|0|||
106056143|NCT03311724|365871063|FG002|Overall Study|Lost to Follow-up|0|||
106056144|NCT03311724|365871064|FG003|Overall Study|Lost to Follow-up|0|||
106056145|NCT03311724|365871061|FG000|Overall Study|Sponsor Decision|0|||
106056146|NCT03311724|365871062|FG001|Overall Study|Sponsor Decision|0|||
106056147|NCT03311724|365871063|FG002|Overall Study|Sponsor Decision|1|||
106056148|NCT03311724|365871064|FG003|Overall Study|Sponsor Decision|0|||
106056149|NCT02370160|365871066|FG000|Overall Study|Death|3|||
106056150|NCT02370160|365871067|FG001|Overall Study|Death|4|||
106056151|NCT02370160|365871068|FG002|Overall Study|Death|1|||
106056152|NCT02871297|365871073|FG000|Overall Study|Adverse Event|34|||
106056153|NCT02871297|365871073|FG000|Overall Study|Lack of Efficacy|10|||
106056154|NCT02871297|365871073|FG000|Overall Study|Non-compliance with study drug|15|||
106056155|NCT02871297|365871073|FG000|Overall Study|Protocol Violation|3|||
106056156|NCT02871297|365871073|FG000|Overall Study|Withdrawal by Subject|20|||
106056157|NCT02871297|365871073|FG000|Overall Study|Lost to Follow-up|13|||
106056158|NCT02871297|365871073|FG000|Overall Study|Rolled over to 13546A|2|||
106056159|NCT02871297|365871073|FG000|Overall Study|Other than specified|39|||
106056160|NCT04115839|365871079|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
106056161|NCT04115839|365871080|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
106056162|NCT04115839|365871081|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
106056163|NCT04115839|365871082|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
106056164|NCT04115839|365871083|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
106056165|NCT04115839|365871084|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
106056166|NCT04115839|365871085|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
106056167|NCT04115839|365871079|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
106056168|NCT04115839|365871080|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
106056169|NCT04115839|365871081|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
106056170|NCT04115839|365871082|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
106056171|NCT04115839|365871083|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
106056172|NCT04115839|365871084|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
106056173|NCT04115839|365871085|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
106056174|NCT04115839|365871079|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
106056175|NCT04115839|365871080|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
106056176|NCT04115839|365871081|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
106056177|NCT04115839|365871082|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
106056178|NCT04115839|365871083|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
106056179|NCT04115839|365871084|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
106056180|NCT04115839|365871085|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
106056181|NCT04115839|365871079|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
106056182|NCT04115839|365871080|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
106056183|NCT04115839|365871081|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
106056184|NCT04115839|365871082|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
106056185|NCT04115839|365871083|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
106056186|NCT04115839|365871084|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
106056187|NCT04115839|365871085|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
106056188|NCT04115839|365871079|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
106056189|NCT04115839|365871080|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
106056190|NCT04115839|365871081|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
106056191|NCT04115839|365871082|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
106056192|NCT04115839|365871083|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
106056193|NCT04115839|365871084|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
106056194|NCT04115839|365871085|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
106056195|NCT04115839|365871079|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
106056196|NCT04115839|365871080|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
106056197|NCT04115839|365871081|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
106056198|NCT04115839|365871082|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
105864633|NCT02655666|365152972|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
105864634|NCT05199090|365152976|FG000|Overall Study|Adverse Event|1|||
105864635|NCT05199090|365152977|FG001|Overall Study|Adverse Event|4|||
105864636|NCT05199090|365152978|FG002|Overall Study|Adverse Event|0|||
105864637|NCT05199090|365152979|FG003|Overall Study|Adverse Event|0|||
106056199|NCT04115839|365871083|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
106056200|NCT04115839|365871084|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
105864638|NCT05199090|365152980|FG004|Overall Study|Adverse Event|0|||
105864639|NCT05199090|365152981|FG005|Overall Study|Adverse Event|0|||
105864640|NCT05199090|365152976|FG000|Overall Study|Lost to Follow-up|1|||
105864641|NCT05199090|365152977|FG001|Overall Study|Lost to Follow-up|0|||
105864642|NCT05199090|365152978|FG002|Overall Study|Lost to Follow-up|1|||
105864643|NCT05199090|365152979|FG003|Overall Study|Lost to Follow-up|4|||
105864644|NCT05199090|365152980|FG004|Overall Study|Lost to Follow-up|0|||
105864645|NCT05199090|365152981|FG005|Overall Study|Lost to Follow-up|5|||
105864646|NCT05199090|365152976|FG000|Overall Study|Physician Decision|0|||
105864647|NCT05199090|365152977|FG001|Overall Study|Physician Decision|0|||
105864648|NCT05199090|365152978|FG002|Overall Study|Physician Decision|0|||
105864649|NCT05199090|365152979|FG003|Overall Study|Physician Decision|0|||
105864650|NCT05199090|365152980|FG004|Overall Study|Physician Decision|0|||
106056201|NCT04115839|365871085|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
106056202|NCT02966028|365871086|FG000|Overall Study|Adverse Event|7|||
106056203|NCT02966028|365871087|FG001|Overall Study|Adverse Event|13|||
106056204|NCT02966028|365871088|FG002|Overall Study|Adverse Event|10|||
106056205|NCT02966028|365871086|FG000|Overall Study|Physician Decision|1|||
106056206|NCT02966028|365871087|FG001|Overall Study|Physician Decision|0|||
106056207|NCT02966028|365871088|FG002|Overall Study|Physician Decision|2|||
106056208|NCT02966028|365871086|FG000|Overall Study|Withdrawal by Subject|7|||
106056209|NCT02966028|365871087|FG001|Overall Study|Withdrawal by Subject|5|||
106056210|NCT02966028|365871088|FG002|Overall Study|Withdrawal by Subject|5|||
106056211|NCT02966028|365871086|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
106056212|NCT02966028|365871087|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
106056213|NCT02966028|365871088|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
106056214|NCT02034110|365871089|FG000|Overall Study|Physician Decision|0|||
106056215|NCT02034110|365871090|FG001|Overall Study|Physician Decision|0|||
106056216|NCT02034110|365871091|FG002|Overall Study|Physician Decision|0|||
106056217|NCT02034110|365871092|FG003|Overall Study|Physician Decision|0|||
106056218|NCT02034110|365871093|FG004|Overall Study|Physician Decision|2|||
106056219|NCT02034110|365871094|FG005|Overall Study|Physician Decision|0|||
106056220|NCT02034110|365871095|FG006|Overall Study|Physician Decision|1|||
106152481|NCT03438188|366218807|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
105864651|NCT05199090|365152981|FG005|Overall Study|Physician Decision|1|||
105864652|NCT05199090|365152976|FG000|Overall Study|Study terminated by sponsor|0|||
105864653|NCT05199090|365152977|FG001|Overall Study|Study terminated by sponsor|6|||
105864654|NCT05199090|365152978|FG002|Overall Study|Study terminated by sponsor|0|||
105864655|NCT05199090|365152979|FG003|Overall Study|Study terminated by sponsor|0|||
105864656|NCT05199090|365152980|FG004|Overall Study|Study terminated by sponsor|0|||
105864657|NCT05199090|365152981|FG005|Overall Study|Study terminated by sponsor|5|||
105864658|NCT05199090|365152976|FG000|Overall Study|Subject decision|0|||
105864659|NCT05199090|365152977|FG001|Overall Study|Subject decision|4|||
105864660|NCT05199090|365152978|FG002|Overall Study|Subject decision|0|||
105864661|NCT05199090|365152979|FG003|Overall Study|Subject decision|2|||
105864662|NCT05199090|365152980|FG004|Overall Study|Subject decision|5|||
105864663|NCT05199090|365152981|FG005|Overall Study|Subject decision|2|||
105864664|NCT02552732|365152982|FG000|Overall Study|Lost to Follow-up|2|||
105864665|NCT02552732|365152982|FG000|Overall Study|Physician Decision|1|||
105864666|NCT02552732|365152982|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
105864667|NCT02552732|365152982|FG000|Overall Study|Withdrawal by Subject|6|||
105864668|NCT03968978|365152983|FG000|Overall Study|Adverse Event|1|||
105864669|NCT03968978|365152984|FG001|Overall Study|Adverse Event|0|||
105864670|NCT03017612|365152985|FG000|Overall Study|Adverse Event|2|||
105864671|NCT01320150|365152986|FG000|Overall Study|Protocol Violation|15|||
106056221|NCT02034110|365871096|FG007|Overall Study|Physician Decision|0|||
106152482|NCT03456076|366218818|FG000|Overall Study|Withdrawal by Subject|5|||
105864672|NCT01320150|365152986|FG000|Overall Study|Withdrawal by Subject|5|||
105864673|NCT01320150|365152986|FG000|Overall Study|Death|2|||
106056222|NCT02034110|365871089|FG000|Overall Study|Lost to Follow-up|1|||
106056223|NCT02034110|365871090|FG001|Overall Study|Lost to Follow-up|0|||
106152483|NCT03456076|366218819|FG001|Overall Study|Withdrawal by Subject|9|||
106056224|NCT02034110|365871091|FG002|Overall Study|Lost to Follow-up|0|||
106056225|NCT02034110|365871092|FG003|Overall Study|Lost to Follow-up|0|||
105864674|NCT01320150|365152986|FG000|Overall Study|Lost to Follow-up|44|||
105864675|NCT02759692|365152987|FG000|Period 1|Test article no longer available|1|||
105864676|NCT02759692|365152988|FG001|Period 1|Test article no longer available|1|||
105864677|NCT02759692|365152987|FG000|Period 1|No longer meets eligibility criteria.|1|||
106056226|NCT02034110|365871093|FG004|Overall Study|Lost to Follow-up|1|||
106056227|NCT02034110|365871094|FG005|Overall Study|Lost to Follow-up|0|||
106056228|NCT02034110|365871095|FG006|Overall Study|Lost to Follow-up|1|||
106056229|NCT02034110|365871096|FG007|Overall Study|Lost to Follow-up|0|||
106056230|NCT02034110|365871089|FG000|Overall Study|Withdrawal by Subject|5|||
106056231|NCT02034110|365871090|FG001|Overall Study|Withdrawal by Subject|7|||
106056232|NCT02034110|365871091|FG002|Overall Study|Withdrawal by Subject|0|||
106056233|NCT02034110|365871092|FG003|Overall Study|Withdrawal by Subject|3|||
106056234|NCT02034110|365871093|FG004|Overall Study|Withdrawal by Subject|7|||
106056235|NCT02034110|365871094|FG005|Overall Study|Withdrawal by Subject|0|||
106056236|NCT02034110|365871095|FG006|Overall Study|Withdrawal by Subject|3|||
106056237|NCT02034110|365871096|FG007|Overall Study|Withdrawal by Subject|1|||
106056238|NCT02034110|365871089|FG000|Overall Study|Study closed by sponsor|6|||
106056239|NCT02034110|365871090|FG001|Overall Study|Study closed by sponsor|2|||
106056240|NCT02034110|365871091|FG002|Overall Study|Study closed by sponsor|0|||
106056241|NCT02034110|365871092|FG003|Overall Study|Study closed by sponsor|6|||
106056242|NCT02034110|365871093|FG004|Overall Study|Study closed by sponsor|7|||
106056243|NCT02034110|365871094|FG005|Overall Study|Study closed by sponsor|0|||
106056244|NCT02034110|365871095|FG006|Overall Study|Study closed by sponsor|42|||
106056245|NCT02034110|365871096|FG007|Overall Study|Study closed by sponsor|0|||
106056246|NCT00599924|365871097|FG000|Overall Study|Lack of Efficacy|3|||
106056247|NCT00599924|365871098|FG001|Overall Study|Lack of Efficacy|5|||
106056248|NCT00599924|365871099|FG002|Overall Study|Lack of Efficacy|1|||
106056249|NCT00599924|365871100|FG003|Overall Study|Lack of Efficacy|2|||
106056250|NCT00599924|365871101|FG004|Overall Study|Lack of Efficacy|3|||
106056251|NCT00599924|365871102|FG005|Overall Study|Lack of Efficacy|2|||
106056252|NCT00599924|365871103|FG006|Overall Study|Lack of Efficacy|0|||
106056253|NCT00599924|365871097|FG000|Overall Study|Adverse Event|0|||
106056254|NCT00599924|365871098|FG001|Overall Study|Adverse Event|0|||
106056255|NCT00599924|365871099|FG002|Overall Study|Adverse Event|0|||
106056256|NCT00599924|365871100|FG003|Overall Study|Adverse Event|2|||
106056257|NCT00599924|365871101|FG004|Overall Study|Adverse Event|0|||
106056258|NCT00599924|365871102|FG005|Overall Study|Adverse Event|0|||
106056259|NCT00599924|365871103|FG006|Overall Study|Adverse Event|2|||
106056260|NCT00599924|365871097|FG000|Overall Study|Death|0|||
106056261|NCT00599924|365871098|FG001|Overall Study|Death|0|||
106056262|NCT00599924|365871099|FG002|Overall Study|Death|0|||
106056263|NCT00599924|365871100|FG003|Overall Study|Death|2|||
106056264|NCT00599924|365871101|FG004|Overall Study|Death|0|||
106056265|NCT00599924|365871102|FG005|Overall Study|Death|2|||
106056266|NCT00599924|365871103|FG006|Overall Study|Death|1|||
106056267|NCT00599924|365871097|FG000|Overall Study|Protocol Violation|0|||
106056268|NCT00599924|365871098|FG001|Overall Study|Protocol Violation|0|||
106056269|NCT00599924|365871099|FG002|Overall Study|Protocol Violation|0|||
106056270|NCT00599924|365871100|FG003|Overall Study|Protocol Violation|1|||
106056271|NCT00599924|365871101|FG004|Overall Study|Protocol Violation|0|||
106056272|NCT00599924|365871102|FG005|Overall Study|Protocol Violation|0|||
106056273|NCT00599924|365871103|FG006|Overall Study|Protocol Violation|0|||
106056274|NCT00599924|365871097|FG000|Overall Study|Withdrawal by Subject|0|||
106056275|NCT00599924|365871098|FG001|Overall Study|Withdrawal by Subject|0|||
106056276|NCT00599924|365871099|FG002|Overall Study|Withdrawal by Subject|1|||
106056277|NCT00599924|365871100|FG003|Overall Study|Withdrawal by Subject|0|||
106056278|NCT00599924|365871101|FG004|Overall Study|Withdrawal by Subject|1|||
106056279|NCT00599924|365871102|FG005|Overall Study|Withdrawal by Subject|0|||
106056280|NCT00599924|365871103|FG006|Overall Study|Withdrawal by Subject|0|||
106056281|NCT00599924|365871097|FG000|Overall Study|Other|0|||
106056282|NCT00599924|365871098|FG001|Overall Study|Other|0|||
106056283|NCT00599924|365871099|FG002|Overall Study|Other|0|||
106056284|NCT00599924|365871100|FG003|Overall Study|Other|1|||
106056285|NCT00599924|365871101|FG004|Overall Study|Other|2|||
106056286|NCT00599924|365871102|FG005|Overall Study|Other|0|||
106056287|NCT00599924|365871103|FG006|Overall Study|Other|2|||
106056288|NCT00777608|365871108|FG000|Overall Study|Lost to Follow-up|1|||
106056289|NCT00777608|365871109|FG001|Overall Study|Lost to Follow-up|1|||
106056290|NCT00777608|365871108|FG000|Overall Study|Withdrawal by Subject|1|||
106056291|NCT00777608|365871109|FG001|Overall Study|Withdrawal by Subject|3|||
106056292|NCT00777608|365871108|FG000|Overall Study|Protocol Violation|1|||
106056293|NCT00777608|365871109|FG001|Overall Study|Protocol Violation|0|||
106056294|NCT00777608|365871108|FG000|Overall Study|Investigator Decision|1|||
106056295|NCT00777608|365871109|FG001|Overall Study|Investigator Decision|2|||
106056296|NCT01488370|365871112|FG000|Overall Study|Protocol Violation|0|||
106056297|NCT01488370|365871113|FG001|Overall Study|Protocol Violation|1|||
106056298|NCT01488370|365871114|FG002|Overall Study|Protocol Violation|1|||
106056299|NCT01471171|365871115|FG000|Treatment Period 1|Adverse Event|4|||
106056300|NCT01471171|365871116|FG001|Treatment Period 1|Adverse Event|1|||
106056301|NCT01471171|365871115|FG000|Treatment Period 2|Adverse Event|1|||
106056302|NCT01471171|365871116|FG001|Treatment Period 2|Adverse Event|0|||
106056303|NCT01243892|365871117|FG000|Overall Study|Did not meet eligibility criteria|2|||
106056304|NCT01243892|365871118|FG001|Overall Study|Did not meet eligibility criteria|0|||
106056305|NCT04171531|365871120|FG000|Overall Study|Lost to Follow-up|4|||
106056306|NCT04171531|365871121|FG001|Overall Study|Lost to Follow-up|5|||
106056307|NCT04171531|365871120|FG000|Overall Study|Consent only through 6 months|1|||
106056308|NCT04171531|365871121|FG001|Overall Study|Consent only through 6 months|1|||
106056309|NCT04171531|365871120|FG000|Overall Study|Insurance did not cover procedure|0|||
106056310|NCT04171531|365871121|FG001|Overall Study|Insurance did not cover procedure|1|||
106056311|NCT04171531|365871120|FG000|Overall Study|Physician Decision|0|||
106056312|NCT04171531|365871121|FG001|Overall Study|Physician Decision|3|||
106056313|NCT04171531|365871120|FG000|Overall Study|Withdrawal by Subject|1|||
106056314|NCT04171531|365871121|FG001|Overall Study|Withdrawal by Subject|5|||
106056315|NCT02099708|365871122|FG000|Overall Study|Data Not Available|30|||
106056316|NCT02099708|365871122|FG000|Overall Study|Lost to Follow-up|141|||
106056317|NCT02099708|365871122|FG000|Overall Study|Other|29|||
106056318|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
106056319|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
106056320|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
106056321|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
106056322|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
106056323|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
106056324|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
106056325|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
106056326|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
106056327|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
106056328|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
106056329|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
106056330|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
106056331|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
106056332|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
106056333|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
106056334|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
106056335|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
106056336|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
106056337|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
106056338|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
106056339|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
106056340|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
106056341|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
106056342|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
106056343|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
106056344|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
106056345|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
106056346|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
106056347|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
106056348|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
106056349|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
106056350|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
106056351|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
106056352|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
106056353|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
106056354|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
106056355|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
106056356|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
106056357|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
106152484|NCT03456076|366218818|FG000|Overall Study|Protocol deviation|0|||
106152485|NCT03456076|366218819|FG001|Overall Study|Protocol deviation|1|||
106056358|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
106056359|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
106056360|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
106056361|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
106056362|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
106056363|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
106056364|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
106056365|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
106056366|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
106152486|NCT03456076|366218818|FG000|Overall Study|Lost to Follow-up|0|||
106152487|NCT03456076|366218819|FG001|Overall Study|Lost to Follow-up|1|||
106152488|NCT03456076|366218818|FG000|Overall Study|Death|2|||
106152489|NCT03456076|366218819|FG001|Overall Study|Death|5|||
106056367|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
106056368|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
106056369|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
106056370|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
106056371|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
106056372|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
106056373|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
106056374|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
106056375|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
106056376|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
106056377|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
106056378|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
106056379|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
106056380|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
106056381|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
106056382|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
106056383|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
106056384|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
106056385|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
106056386|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
106056387|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
106056388|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Change of location|0|||
106056389|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Change of location|0|||
106056390|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Change of location|0|||
106056391|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Change of location|1|||
106056392|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Change of location|0|||
106056393|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
106056394|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
106056395|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
106056396|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
106056397|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
106056398|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
106056399|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
106056400|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
106056401|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
106056402|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
106056403|NCT00730405|365871126|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
106056404|NCT00730405|365871127|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
106056405|NCT00730405|365871128|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
106056406|NCT00730405|365871129|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
106056407|NCT00730405|365871130|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
106056408|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
106056409|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
106056410|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
106056411|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
106056412|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
106056413|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
106056414|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
106056415|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
106056416|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
106056417|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
106056418|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
106056419|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
106056420|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
106056421|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
106056422|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
106056423|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Death|0|||
106056424|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Death|1|||
106152490|NCT03456076|366218818|FG000|Overall Study|Study ongoing|123|||
106152491|NCT03456076|366218819|FG001|Overall Study|Study ongoing|111|||
106056425|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Death|0|||
106056426|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Death|1|||
106056427|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Death|0|||
106056428|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Change of location|1|||
106056429|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Change of location|1|||
106056430|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Change of location|0|||
106152492|NCT03112174|366218820|FG000|Overall Study|Withdrawal by Subject|3|||
106056431|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Change of location|1|||
106056432|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Change of location|0|||
106056433|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
106056434|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
106056435|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
106056436|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
106056437|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
106056438|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
106056439|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
106056440|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
106056441|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
106056442|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
106056443|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
106056444|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
106056445|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
106056446|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
106056447|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
106056448|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
106056449|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
106056450|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
106056451|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
106056452|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
106056453|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
106056454|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
106056455|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
106056456|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
106056457|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
106056458|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
106056459|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
106056460|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
106056461|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
106056462|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
106056463|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
106056464|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
106056465|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
106056466|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
106056467|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
106056468|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
106056469|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
106056470|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
106056471|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
106056472|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
106056473|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
106056474|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
106056475|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
106056476|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
106056477|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
106056478|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
106056479|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
106056480|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
106056481|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
106056482|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
106056483|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Missing|0|||
106056484|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Missing|0|||
106056485|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Missing|2|||
106056486|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Missing|0|||
106056487|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Missing|0|||
106056488|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
106056489|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
106056490|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
106056491|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
106056492|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
106056493|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
106056494|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
106056495|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
106056496|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
106056497|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
106056498|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
106056499|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
106056500|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
106056501|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
106056502|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
106056503|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
106056504|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
106056505|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
106056506|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
106056507|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
106056508|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
106056509|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
106056510|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
106056511|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
106056512|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
106056513|NCT00730405|365871126|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
106056514|NCT00730405|365871127|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
106056515|NCT00730405|365871128|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
106056516|NCT00730405|365871129|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
106056517|NCT00730405|365871130|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
106056518|NCT03851705|365871133|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
106056519|NCT03851705|365871134|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
106056520|NCT03851705|365871135|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
106056521|NCT03851705|365871136|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
106056522|NCT03851705|365871133|FG000|Part 1: Double-Blind Period|Other reason|1|||
106056523|NCT03851705|365871134|FG001|Part 1: Double-Blind Period|Other reason|0|||
106056524|NCT03851705|365871135|FG002|Part 1: Double-Blind Period|Other reason|0|||
106056525|NCT03851705|365871136|FG003|Part 1: Double-Blind Period|Other reason|0|||
106056526|NCT03851705|365871133|FG000|Part 2: Open-Label Period|Other reason|0|||
106056527|NCT03851705|365871134|FG001|Part 2: Open-Label Period|Other reason|0|||
106056528|NCT03851705|365871135|FG002|Part 2: Open-Label Period|Other reason|0|||
106056529|NCT03851705|365871136|FG003|Part 2: Open-Label Period|Other reason|1|||
106056530|NCT03851705|365871133|FG000|Part 2: Open-Label Period|Death|0|||
106056531|NCT03851705|365871134|FG001|Part 2: Open-Label Period|Death|0|||
106056532|NCT03851705|365871135|FG002|Part 2: Open-Label Period|Death|3|||
106056533|NCT03851705|365871136|FG003|Part 2: Open-Label Period|Death|0|||
106056534|NCT03851705|365871133|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
106056535|NCT03851705|365871134|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
106056536|NCT03851705|365871135|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
106056537|NCT03851705|365871136|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
106056538|NCT02256631|365871139|FG000|Overall Study|Lost to Follow-up|1|||
106056539|NCT02256631|365871140|FG001|Overall Study|Lost to Follow-up|1|||
106056540|NCT02256631|365871141|FG002|Overall Study|Lost to Follow-up|0|||
106056541|NCT02256631|365871142|FG003|Overall Study|Lost to Follow-up|2|||
106056542|NCT02256631|365871143|FG004|Overall Study|Lost to Follow-up|0|||
106056543|NCT02256631|365871144|FG005|Overall Study|Lost to Follow-up|4|||
106056544|NCT02256631|365871145|FG006|Overall Study|Lost to Follow-up|1|||
106056545|NCT02256631|365871139|FG000|Overall Study|Withdrawal by Subject|0|||
106056546|NCT02256631|365871140|FG001|Overall Study|Withdrawal by Subject|0|||
106056547|NCT02256631|365871141|FG002|Overall Study|Withdrawal by Subject|0|||
106056548|NCT02256631|365871142|FG003|Overall Study|Withdrawal by Subject|1|||
106056549|NCT02256631|365871143|FG004|Overall Study|Withdrawal by Subject|1|||
106056550|NCT02256631|365871144|FG005|Overall Study|Withdrawal by Subject|0|||
106056551|NCT02256631|365871145|FG006|Overall Study|Withdrawal by Subject|1|||
106056552|NCT02256631|365871139|FG000|Overall Study|Unable to get to clinic|0|||
106056553|NCT02256631|365871140|FG001|Overall Study|Unable to get to clinic|2|||
106056554|NCT02256631|365871141|FG002|Overall Study|Unable to get to clinic|0|||
106056555|NCT02256631|365871142|FG003|Overall Study|Unable to get to clinic|1|||
106056556|NCT02256631|365871143|FG004|Overall Study|Unable to get to clinic|0|||
106056557|NCT02256631|365871144|FG005|Overall Study|Unable to get to clinic|1|||
106056558|NCT02256631|365871145|FG006|Overall Study|Unable to get to clinic|2|||
106056559|NCT04967443|365871146|FG000|Open Label Treatment|Death|1|||
106056560|NCT04967443|365871147|FG001|Open Label Treatment|Death|0|||
106056561|NCT04967443|365871148|FG002|Open Label Treatment|Death|0|||
106056562|NCT04967443|365871149|FG003|Open Label Treatment|Death|0|||
106056563|NCT04967443|365871150|FG004|Open Label Treatment|Death|0|||
106056564|NCT04967443|365871151|FG005|Open Label Treatment|Death|0|||
106056565|NCT04967443|365871152|FG006|Open Label Treatment|Death|0|||
106056566|NCT04967443|365871153|FG007|Open Label Treatment|Death|0|||
106056567|NCT04967443|365871146|FG000|Open Label Treatment|Lost to Follow-up|0|||
106056568|NCT04967443|365871147|FG001|Open Label Treatment|Lost to Follow-up|0|||
106056569|NCT04967443|365871148|FG002|Open Label Treatment|Lost to Follow-up|1|||
106056570|NCT04967443|365871149|FG003|Open Label Treatment|Lost to Follow-up|0|||
106056571|NCT04967443|365871150|FG004|Open Label Treatment|Lost to Follow-up|0|||
106056572|NCT04967443|365871151|FG005|Open Label Treatment|Lost to Follow-up|0|||
106056573|NCT04967443|365871152|FG006|Open Label Treatment|Lost to Follow-up|0|||
106056574|NCT04967443|365871153|FG007|Open Label Treatment|Lost to Follow-up|0|||
106056575|NCT04967443|365871146|FG000|Open Label Treatment|Withdrawal by Subject|0|||
106056576|NCT04967443|365871147|FG001|Open Label Treatment|Withdrawal by Subject|1|||
106056577|NCT04967443|365871148|FG002|Open Label Treatment|Withdrawal by Subject|0|||
106056578|NCT04967443|365871149|FG003|Open Label Treatment|Withdrawal by Subject|1|||
106056579|NCT04967443|365871150|FG004|Open Label Treatment|Withdrawal by Subject|0|||
106056580|NCT04967443|365871151|FG005|Open Label Treatment|Withdrawal by Subject|1|||
106056581|NCT04967443|365871152|FG006|Open Label Treatment|Withdrawal by Subject|2|||
106056582|NCT04967443|365871153|FG007|Open Label Treatment|Withdrawal by Subject|3|||
106056583|NCT04967443|365871146|FG000|Follow-Up|Death|1|||
106056584|NCT04967443|365871147|FG001|Follow-Up|Death|0|||
106056585|NCT04967443|365871148|FG002|Follow-Up|Death|0|||
106056586|NCT04967443|365871149|FG003|Follow-Up|Death|0|||
106056587|NCT04967443|365871150|FG004|Follow-Up|Death|0|||
106056588|NCT04967443|365871151|FG005|Follow-Up|Death|0|||
106056589|NCT04967443|365871152|FG006|Follow-Up|Death|0|||
106056590|NCT04967443|365871153|FG007|Follow-Up|Death|0|||
106056591|NCT04967443|365871146|FG000|Follow-Up|Lost to Follow-up|0|||
106056592|NCT04967443|365871147|FG001|Follow-Up|Lost to Follow-up|0|||
106056593|NCT04967443|365871148|FG002|Follow-Up|Lost to Follow-up|1|||
106056594|NCT04967443|365871149|FG003|Follow-Up|Lost to Follow-up|1|||
106056595|NCT04967443|365871150|FG004|Follow-Up|Lost to Follow-up|0|||
106056596|NCT04967443|365871151|FG005|Follow-Up|Lost to Follow-up|0|||
106056597|NCT04967443|365871152|FG006|Follow-Up|Lost to Follow-up|0|||
106056598|NCT04967443|365871153|FG007|Follow-Up|Lost to Follow-up|0|||
106056599|NCT04967443|365871146|FG000|Follow-Up|Withdrawal by Subject|0|||
106056600|NCT04967443|365871147|FG001|Follow-Up|Withdrawal by Subject|1|||
106056601|NCT04967443|365871148|FG002|Follow-Up|Withdrawal by Subject|0|||
106056602|NCT04967443|365871149|FG003|Follow-Up|Withdrawal by Subject|1|||
106056603|NCT04967443|365871150|FG004|Follow-Up|Withdrawal by Subject|0|||
106056604|NCT04967443|365871151|FG005|Follow-Up|Withdrawal by Subject|1|||
106056605|NCT04967443|365871152|FG006|Follow-Up|Withdrawal by Subject|2|||
106056606|NCT04967443|365871153|FG007|Follow-Up|Withdrawal by Subject|3|||
106056607|NCT01654536|365871154|FG000|Overall Study|Lost to Follow-up|5|||
106056608|NCT01654536|365871155|FG001|Overall Study|Lost to Follow-up|5|||
106056609|NCT01654536|365871154|FG000|Overall Study|Physician Decision|12|||
106056610|NCT01654536|365871155|FG001|Overall Study|Physician Decision|8|||
106056611|NCT01654536|365871154|FG000|Overall Study|Withdrawal by Subject|27|||
106056612|NCT01654536|365871155|FG001|Overall Study|Withdrawal by Subject|25|||
106056613|NCT03334539|365871156|FG000|Overall Study|Adverse Event|3|||
106056614|NCT03334539|365871157|FG001|Overall Study|Adverse Event|5|||
106056615|NCT03334539|365871158|FG002|Overall Study|Adverse Event|0|||
106056616|NCT03334539|365871156|FG000|Overall Study|Withdrawal by Subject|0|||
106056617|NCT03334539|365871157|FG001|Overall Study|Withdrawal by Subject|1|||
106056618|NCT03334539|365871158|FG002|Overall Study|Withdrawal by Subject|1|||
106056619|NCT03334539|365871156|FG000|Overall Study|Administrative Reasons|1|||
106056620|NCT03334539|365871157|FG001|Overall Study|Administrative Reasons|0|||
106056621|NCT03334539|365871158|FG002|Overall Study|Administrative Reasons|0|||
106056622|NCT03334539|365871156|FG000|Overall Study|Hypertension Not Controlled|0|||
106056623|NCT03334539|365871157|FG001|Overall Study|Hypertension Not Controlled|1|||
106056624|NCT03334539|365871158|FG002|Overall Study|Hypertension Not Controlled|0|||
106056625|NCT00968201|365871159|FG000|Base Study - (Period II)|Adverse Event|8|||
106056626|NCT00968201|365871160|FG001|Base Study - (Period II)|Adverse Event|0|||
106056627|NCT00968201|365871161|FG002|Base Study - (Period II)|Adverse Event|16|||
106056628|NCT00968201|365871159|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
106056629|NCT00968201|365871160|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
106056630|NCT00968201|365871161|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
106056631|NCT00968201|365871159|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
106056632|NCT00968201|365871160|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
106056633|NCT00968201|365871161|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
106056634|NCT00968201|365871159|FG000|Base Study - (Period II)|Protocol Violation|12|||
106056635|NCT00968201|365871160|FG001|Base Study - (Period II)|Protocol Violation|0|||
106056636|NCT00968201|365871161|FG002|Base Study - (Period II)|Protocol Violation|12|||
106056637|NCT00968201|365871159|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
106056638|NCT00968201|365871160|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
106056639|NCT00968201|365871161|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
106056640|NCT00968201|365871159|FG000|Base Study - (Period II)|Site Error|0|||
106056641|NCT00968201|365871160|FG001|Base Study - (Period II)|Site Error|0|||
106056642|NCT00968201|365871161|FG002|Base Study - (Period II)|Site Error|1|||
106056643|NCT00968201|365871159|FG000|Extension Study - (Period III)|Adverse Event|0|||
106056644|NCT00968201|365871160|FG001|Extension Study - (Period III)|Adverse Event|5|||
106056645|NCT00968201|365871161|FG002|Extension Study - (Period III)|Adverse Event|22|||
106056646|NCT00968201|365871159|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
106056647|NCT00968201|365871160|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
106056648|NCT00968201|365871161|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
106056649|NCT00968201|365871159|FG000|Extension Study - (Period III)|Protocol Violation|0|||
106056650|NCT00968201|365871160|FG001|Extension Study - (Period III)|Protocol Violation|17|||
106056651|NCT00968201|365871161|FG002|Extension Study - (Period III)|Protocol Violation|14|||
106056652|NCT00968201|365871159|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
106056653|NCT00968201|365871160|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
106056654|NCT00968201|365871161|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
106056655|NCT00968201|365871159|FG000|Extension Study - (Period III)|Patient Relocated|0|||
106056656|NCT00968201|365871160|FG001|Extension Study - (Period III)|Patient Relocated|1|||
106056657|NCT00968201|365871161|FG002|Extension Study - (Period III)|Patient Relocated|1|||
106056658|NCT00968201|365871159|FG000|Extension Study - (Period III)|Noncompliance|0|||
106056659|NCT00968201|365871160|FG001|Extension Study - (Period III)|Noncompliance|0|||
106056660|NCT00968201|365871161|FG002|Extension Study - (Period III)|Noncompliance|3|||
106056661|NCT00968201|365871159|FG000|Extension Study - (Period III)|Other|0|||
106056662|NCT00968201|365871160|FG001|Extension Study - (Period III)|Other|0|||
106056663|NCT00968201|365871161|FG002|Extension Study - (Period III)|Other|2|||
106056664|NCT00968201|365871159|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
106056665|NCT00968201|365871160|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
106056666|NCT00968201|365871161|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
106056667|NCT02619175|365871164|FG000|Overall Study|Withdrawal by Subject|1|||
106056668|NCT02619175|365871165|FG001|Overall Study|Withdrawal by Subject|0|||
106056669|NCT02619175|365871164|FG000|Overall Study|foot pain|1|||
106056670|NCT02619175|365871165|FG001|Overall Study|foot pain|0|||
106056671|NCT00361569|365871166|FG000|Overall Study|Protocol Violation|3|||
106056672|NCT00361569|365871167|FG001|Overall Study|Protocol Violation|2|||
106056673|NCT00361569|365871168|FG002|Overall Study|Protocol Violation|4|||
106056674|NCT00361569|365871169|FG003|Overall Study|Protocol Violation|2|||
106056675|NCT00361569|365871166|FG000|Overall Study|Withdrawal by Subject|2|||
106056676|NCT00361569|365871167|FG001|Overall Study|Withdrawal by Subject|1|||
106056677|NCT00361569|365871168|FG002|Overall Study|Withdrawal by Subject|9|||
106056678|NCT00361569|365871169|FG003|Overall Study|Withdrawal by Subject|14|||
106056679|NCT00361569|365871166|FG000|Overall Study|Adverse Event|3|||
106056680|NCT00361569|365871167|FG001|Overall Study|Adverse Event|5|||
106056681|NCT00361569|365871168|FG002|Overall Study|Adverse Event|2|||
106056682|NCT00361569|365871169|FG003|Overall Study|Adverse Event|2|||
106056683|NCT00361569|365871166|FG000|Overall Study|Lost to Follow-up|2|||
106056684|NCT00361569|365871167|FG001|Overall Study|Lost to Follow-up|3|||
106056685|NCT00361569|365871168|FG002|Overall Study|Lost to Follow-up|3|||
106056686|NCT00361569|365871169|FG003|Overall Study|Lost to Follow-up|2|||
106056687|NCT00361569|365871166|FG000|Overall Study|Not specified by investigator|2|||
106056688|NCT00361569|365871167|FG001|Overall Study|Not specified by investigator|0|||
106056689|NCT00361569|365871168|FG002|Overall Study|Not specified by investigator|0|||
106056690|NCT00361569|365871169|FG003|Overall Study|Not specified by investigator|1|||
106056691|NCT04659161|365871170|FG000|Overall Study|Adverse Event|10|||
106056692|NCT04659161|365871171|FG001|Overall Study|Adverse Event|6|||
106056693|NCT04659161|365871170|FG000|Overall Study|Withdrawal by Subject|13|||
106056694|NCT04659161|365871171|FG001|Overall Study|Withdrawal by Subject|12|||
106056695|NCT04659161|365871170|FG000|Overall Study|Other|9|||
106056696|NCT04659161|365871171|FG001|Overall Study|Other|8|||
106056697|NCT01929343|365871174|FG000|Overall Study|Physician Decision|0|||
106056698|NCT01929343|365871175|FG001|Overall Study|Physician Decision|2|||
106056699|NCT01929343|365871176|FG002|Overall Study|Physician Decision|0|||
106056700|NCT01929343|365871174|FG000|Overall Study|Withdrawal by Subject|1|||
106056701|NCT01929343|365871175|FG001|Overall Study|Withdrawal by Subject|0|||
106056702|NCT01929343|365871176|FG002|Overall Study|Withdrawal by Subject|0|||
106056703|NCT03727347|365871177|FG000|Overall Study|Withdrawal by Subject|2|||
106056704|NCT03727347|365871177|FG000|Overall Study|Lost to Follow-up|1|||
106056705|NCT00211510|365871178|FG000|Overall Study|Physician Decision|3|||
106056706|NCT00211510|365871179|FG001|Overall Study|Physician Decision|1|||
106056707|NCT00211510|365871178|FG000|Overall Study|Withdrawal by Subject|3|||
106056708|NCT00211510|365871179|FG001|Overall Study|Withdrawal by Subject|1|||
106056709|NCT01487200|365871180|FG000|Overall Study|Withdrawal by Subject|0|||
106056710|NCT01487200|365871181|FG001|Overall Study|Withdrawal by Subject|1|||
106056711|NCT01487200|365871182|FG002|Overall Study|Withdrawal by Subject|0|||
106056712|NCT01487200|365871183|FG003|Overall Study|Withdrawal by Subject|0|||
106056713|NCT03288129|365871185|FG000|Overall Study|Adverse Event|10|||
106056714|NCT03288129|365871185|FG000|Overall Study|Lost to Follow-up|3|||
106056715|NCT03288129|365871185|FG000|Overall Study|Withdrawal by Subject|3|||
106056716|NCT03288129|365871185|FG000|Overall Study|Withdrawal of consent/assent|1|||
106056717|NCT03288129|365871185|FG000|Overall Study|Other|5|||
106056718|NCT02549937|365871189|FG000|Overall Study|Death|0|||
106056719|NCT02549937|365871190|FG001|Overall Study|Death|1|||
106056720|NCT02549937|365871191|FG002|Overall Study|Death|0|||
106056721|NCT02549937|365871192|FG003|Overall Study|Death|1|||
106056722|NCT02549937|365871193|FG004|Overall Study|Death|0|||
106056723|NCT02549937|365871194|FG005|Overall Study|Death|8|||
106056724|NCT02549937|365871195|FG006|Overall Study|Death|0|||
106056725|NCT02549937|365871196|FG007|Overall Study|Death|0|||
106056726|NCT02549937|365871197|FG008|Overall Study|Death|19|||
106056727|NCT02549937|365871189|FG000|Overall Study|No follow up required|3|||
106056728|NCT02549937|365871190|FG001|Overall Study|No follow up required|6|||
106056729|NCT02549937|365871191|FG002|Overall Study|No follow up required|3|||
106056730|NCT02549937|365871192|FG003|Overall Study|No follow up required|8|||
106056731|NCT02549937|365871193|FG004|Overall Study|No follow up required|12|||
106056732|NCT02549937|365871194|FG005|Overall Study|No follow up required|21|||
106056733|NCT02549937|365871195|FG006|Overall Study|No follow up required|9|||
106056734|NCT02549937|365871196|FG007|Overall Study|No follow up required|11|||
106056735|NCT02549937|365871197|FG008|Overall Study|No follow up required|0|||
106056736|NCT02549937|365871189|FG000|Overall Study|Other|0|||
106056737|NCT02549937|365871190|FG001|Overall Study|Other|0|||
106056738|NCT02549937|365871191|FG002|Overall Study|Other|0|||
106056739|NCT02549937|365871192|FG003|Overall Study|Other|0|||
106056740|NCT02549937|365871193|FG004|Overall Study|Other|1|||
106056741|NCT02549937|365871194|FG005|Overall Study|Other|0|||
106056742|NCT02549937|365871195|FG006|Overall Study|Other|3|||
106056743|NCT02549937|365871196|FG007|Overall Study|Other|2|||
106056744|NCT02549937|365871197|FG008|Overall Study|Other|3|||
106056745|NCT02549937|365871189|FG000|Overall Study|Lost to Follow-up|0|||
106056746|NCT02549937|365871190|FG001|Overall Study|Lost to Follow-up|0|||
106056747|NCT02549937|365871191|FG002|Overall Study|Lost to Follow-up|0|||
106056748|NCT02549937|365871192|FG003|Overall Study|Lost to Follow-up|0|||
106056749|NCT02549937|365871193|FG004|Overall Study|Lost to Follow-up|0|||
106056750|NCT02549937|365871194|FG005|Overall Study|Lost to Follow-up|0|||
106056751|NCT02549937|365871195|FG006|Overall Study|Lost to Follow-up|0|||
106056752|NCT02549937|365871196|FG007|Overall Study|Lost to Follow-up|0|||
106056753|NCT02549937|365871197|FG008|Overall Study|Lost to Follow-up|3|||
106056754|NCT02549937|365871189|FG000|Overall Study|Withdrawal by Subject|0|||
106056755|NCT02549937|365871190|FG001|Overall Study|Withdrawal by Subject|0|||
106056756|NCT02549937|365871191|FG002|Overall Study|Withdrawal by Subject|0|||
106056757|NCT02549937|365871192|FG003|Overall Study|Withdrawal by Subject|0|||
106056758|NCT02549937|365871193|FG004|Overall Study|Withdrawal by Subject|0|||
106056759|NCT02549937|365871194|FG005|Overall Study|Withdrawal by Subject|1|||
106056760|NCT02549937|365871195|FG006|Overall Study|Withdrawal by Subject|4|||
106056761|NCT02549937|365871196|FG007|Overall Study|Withdrawal by Subject|3|||
106056762|NCT02549937|365871197|FG008|Overall Study|Withdrawal by Subject|2|||
106056763|NCT02549937|365871189|FG000|Overall Study|Sponsor Decision|0|||
106056764|NCT02549937|365871190|FG001|Overall Study|Sponsor Decision|0|||
106056765|NCT02549937|365871191|FG002|Overall Study|Sponsor Decision|0|||
106056766|NCT02549937|365871192|FG003|Overall Study|Sponsor Decision|0|||
106056767|NCT02549937|365871193|FG004|Overall Study|Sponsor Decision|0|||
106056768|NCT02549937|365871194|FG005|Overall Study|Sponsor Decision|0|||
106056769|NCT02549937|365871195|FG006|Overall Study|Sponsor Decision|0|||
106056770|NCT02549937|365871196|FG007|Overall Study|Sponsor Decision|0|||
106056771|NCT02549937|365871197|FG008|Overall Study|Sponsor Decision|6|||
106056772|NCT00662012|365871198|FG000|Overall Study|Lost to Follow-up|85|||
106056773|NCT00662012|365871198|FG000|Overall Study|Death|1|||
106056774|NCT00662012|365871198|FG000|Overall Study|Withdrawal by Subject|1|||
106056775|NCT02144012|365871201|FG000|Overall Study|Adverse Event|1|||
106056776|NCT02144012|365871202|FG001|Overall Study|Adverse Event|0|||
106056777|NCT02144012|365871201|FG000|Overall Study|Death|1|||
106056778|NCT02144012|365871202|FG001|Overall Study|Death|0|||
106056779|NCT02144012|365871201|FG000|Overall Study|Withdrawal by Subject|11|||
106056780|NCT02144012|365871202|FG001|Overall Study|Withdrawal by Subject|3|||
106056781|NCT02144012|365871201|FG000|Overall Study|Study Terminated by Sponsor|18|||
106056782|NCT02144012|365871202|FG001|Overall Study|Study Terminated by Sponsor|12|||
106056783|NCT02144012|365871201|FG000|Overall Study|Other|3|||
106056784|NCT02144012|365871202|FG001|Overall Study|Other|0|||
106056785|NCT00317356|365871203|FG000|Overall Study|Adverse Event|0|||
106056786|NCT00317356|365871204|FG001|Overall Study|Adverse Event|0|||
106056787|NCT00317356|365871205|FG002|Overall Study|Adverse Event|1|||
106056788|NCT00317356|365871206|FG003|Overall Study|Adverse Event|0|||
106056789|NCT00317356|365871203|FG000|Overall Study|Lack of Efficacy|1|||
106056790|NCT00317356|365871204|FG001|Overall Study|Lack of Efficacy|1|||
106056791|NCT00317356|365871205|FG002|Overall Study|Lack of Efficacy|0|||
106056792|NCT00317356|365871206|FG003|Overall Study|Lack of Efficacy|3|||
106056793|NCT00317356|365871203|FG000|Overall Study|Physician Decision|0|||
106056794|NCT00317356|365871204|FG001|Overall Study|Physician Decision|1|||
106056795|NCT00317356|365871205|FG002|Overall Study|Physician Decision|0|||
106056796|NCT00317356|365871206|FG003|Overall Study|Physician Decision|0|||
106056797|NCT01949506|365871207|FG000|Overall Study|Physician Decision|1|||
106056798|NCT05059600|365871211|FG000|Overall Study|Enrolled but not Treated|10|||
106056799|NCT00621153|365871212|FG000|Overall Study|Safety Reason|8|||
106056800|NCT00621153|365871213|FG001|Overall Study|Safety Reason|7|||
106056801|NCT00621153|365871212|FG000|Overall Study|Adverse Event|3|||
106056802|NCT00621153|365871213|FG001|Overall Study|Adverse Event|2|||
106056803|NCT00621153|365871212|FG000|Overall Study|Lost to Follow-up|5|||
106056804|NCT00621153|365871213|FG001|Overall Study|Lost to Follow-up|1|||
106056805|NCT00621153|365871212|FG000|Overall Study|Withdrawal by Subject|4|||
106056806|NCT00621153|365871213|FG001|Overall Study|Withdrawal by Subject|5|||
106056807|NCT04212650|365871216|FG000|Overall Study|Withdrawal by Subject|1|||
106056808|NCT04212650|365871217|FG001|Overall Study|Withdrawal by Subject|0|||
106056809|NCT01446289|365871218|FG000|Overall Study|Withdrawal by Subject|1|||
106056810|NCT01446289|365871219|FG001|Overall Study|Withdrawal by Subject|0|||
106056811|NCT01446289|365871220|FG002|Overall Study|Withdrawal by Subject|1|||
106056812|NCT01446289|365871221|FG003|Overall Study|Withdrawal by Subject|0|||
106056813|NCT03919799|365871222|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
106056814|NCT03919799|365871223|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
106056815|NCT03919799|365871224|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
106056816|NCT03919799|365871225|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
106056817|NCT03919799|365871226|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
106056818|NCT03919799|365871222|FG000|DB Period (28 Weeks)|Adverse Event|1|||
106056819|NCT03919799|365871223|FG001|DB Period (28 Weeks)|Adverse Event|1|||
106056820|NCT03919799|365871224|FG002|DB Period (28 Weeks)|Adverse Event|1|||
106056821|NCT03919799|365871225|FG003|DB Period (28 Weeks)|Adverse Event|0|||
106056822|NCT03919799|365871226|FG004|DB Period (28 Weeks)|Adverse Event|0|||
106056823|NCT03919799|365871222|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
106056824|NCT03919799|365871223|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
106056825|NCT03919799|365871224|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
106056826|NCT03919799|365871225|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
106056827|NCT03919799|365871226|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
106056828|NCT03919799|365871222|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
106056829|NCT03919799|365871223|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
106056830|NCT03919799|365871224|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
106056831|NCT03919799|365871225|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
106056832|NCT03919799|365871226|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
106056833|NCT03919799|365871222|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
106056834|NCT03919799|365871223|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
106056835|NCT03919799|365871224|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
106056836|NCT03919799|365871225|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
106056837|NCT03919799|365871226|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
106056838|NCT01235351|365872874|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
106056839|NCT01235351|365872875|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
106056840|NCT01806298|365872879|FG000|Overall Study|Adverse Event|3|||
106056841|NCT01806298|365872879|FG000|Overall Study|Protocol Non-compliance|1|||
106056842|NCT01806298|365872879|FG000|Overall Study|Withdrawal by Subject|1|||
106056843|NCT01806298|365872879|FG000|Overall Study|Other|5|||
106056844|NCT03808545|365872880|FG000|Overall Study|Withdrawal by Subject|1|||
106056845|NCT03808545|365872881|FG001|Overall Study|Withdrawal by Subject|1|||
106056846|NCT00980057|365872882|FG000|Overall Study|Death|13|||
106056847|NCT00980057|365872883|FG001|Overall Study|Death|3|||
106056848|NCT00980057|365872882|FG000|Overall Study|Adverse Event|0|||
106056849|NCT00980057|365872883|FG001|Overall Study|Adverse Event|1|||
106056850|NCT00980057|365872882|FG000|Overall Study|Physician Decision|4|||
106056851|NCT00980057|365872883|FG001|Overall Study|Physician Decision|0|||
106056852|NCT00980057|365872882|FG000|Overall Study|Lost to Follow-up|1|||
106056853|NCT00980057|365872883|FG001|Overall Study|Lost to Follow-up|0|||
106056854|NCT00980057|365872882|FG000|Overall Study|Withdrawal by Subject|1|||
106056855|NCT00980057|365872883|FG001|Overall Study|Withdrawal by Subject|1|||
106056856|NCT00592384|365872887|FG000|Overall Study|Withdrawal by Subject|5|||
106056857|NCT00592384|365872888|FG001|Overall Study|Withdrawal by Subject|6|||
106056858|NCT00062374|365872889|FG000|Overall Study|Not treated|12|||
106056859|NCT03633695|365872895|FG000|Overall Study|Lost to Follow-up|4|||
106056860|NCT03633695|365872896|FG001|Overall Study|Lost to Follow-up|5|||
106056861|NCT03633695|365872895|FG000|Overall Study|Discontinued|8|||
106056862|NCT03633695|365872896|FG001|Overall Study|Discontinued|4|||
106056863|NCT00187486|365872897|FG000|Overall Study|Protocol Violation|1|||
106056864|NCT00684593|365872898|FG000|Overall Study|Adverse Event|0|||
106056865|NCT00684593|365872899|FG001|Overall Study|Adverse Event|2|||
106056866|NCT02380677|365872907|FG000|Overall Study|Adverse Event|0|||
106056867|NCT02380677|365872908|FG001|Overall Study|Adverse Event|0|||
106056868|NCT02380677|365872909|FG002|Overall Study|Adverse Event|0|||
106056869|NCT02380677|365872910|FG003|Overall Study|Adverse Event|1|||
106152493|NCT03112174|366218821|FG001|Overall Study|Withdrawal by Subject|0|||
106056870|NCT02380677|365872911|FG004|Overall Study|Adverse Event|1|||
106152494|NCT03112174|366218822|FG002|Overall Study|Withdrawal by Subject|11|||
106152495|NCT03112174|366218823|FG003|Overall Study|Withdrawal by Subject|9|||
106056871|NCT02380677|365872912|FG005|Overall Study|Adverse Event|4|||
106056872|NCT02380677|365872913|FG006|Overall Study|Adverse Event|2|||
106056873|NCT02380677|365872914|FG007|Overall Study|Adverse Event|2|||
106056874|NCT02380677|365872915|FG008|Overall Study|Adverse Event|2|||
106056875|NCT02380677|365872916|FG009|Overall Study|Adverse Event|1|||
106056876|NCT02380677|365872917|FG010|Overall Study|Adverse Event|2|||
106056877|NCT02380677|365872918|FG011|Overall Study|Adverse Event|1|||
106056878|NCT02380677|365872907|FG000|Overall Study|Physician Decision|1|||
106056879|NCT02380677|365872908|FG001|Overall Study|Physician Decision|0|||
106056880|NCT02380677|365872909|FG002|Overall Study|Physician Decision|1|||
106056881|NCT02380677|365872910|FG003|Overall Study|Physician Decision|1|||
106056882|NCT02380677|365872911|FG004|Overall Study|Physician Decision|0|||
106056883|NCT02380677|365872912|FG005|Overall Study|Physician Decision|0|||
106056884|NCT02380677|365872913|FG006|Overall Study|Physician Decision|0|||
106056885|NCT02380677|365872914|FG007|Overall Study|Physician Decision|0|||
106056886|NCT02380677|365872915|FG008|Overall Study|Physician Decision|0|||
106056887|NCT02380677|365872916|FG009|Overall Study|Physician Decision|0|||
106056888|NCT02380677|365872917|FG010|Overall Study|Physician Decision|0|||
106056889|NCT02380677|365872918|FG011|Overall Study|Physician Decision|0|||
106056890|NCT02380677|365872907|FG000|Overall Study|Lack of Efficacy|0|||
106056891|NCT02380677|365872908|FG001|Overall Study|Lack of Efficacy|1|||
106056892|NCT02380677|365872909|FG002|Overall Study|Lack of Efficacy|2|||
106056893|NCT02380677|365872910|FG003|Overall Study|Lack of Efficacy|0|||
106056894|NCT02380677|365872911|FG004|Overall Study|Lack of Efficacy|4|||
106056895|NCT02380677|365872912|FG005|Overall Study|Lack of Efficacy|1|||
106056896|NCT02380677|365872913|FG006|Overall Study|Lack of Efficacy|1|||
106056897|NCT02380677|365872914|FG007|Overall Study|Lack of Efficacy|2|||
106056898|NCT02380677|365872915|FG008|Overall Study|Lack of Efficacy|2|||
106056899|NCT02380677|365872916|FG009|Overall Study|Lack of Efficacy|0|||
106056900|NCT02380677|365872917|FG010|Overall Study|Lack of Efficacy|2|||
106056901|NCT02380677|365872918|FG011|Overall Study|Lack of Efficacy|1|||
106056902|NCT02380677|365872907|FG000|Overall Study|Withdrawal by Subject|0|||
106056903|NCT02380677|365872908|FG001|Overall Study|Withdrawal by Subject|0|||
106056904|NCT02380677|365872909|FG002|Overall Study|Withdrawal by Subject|0|||
106056905|NCT02380677|365872910|FG003|Overall Study|Withdrawal by Subject|0|||
106056906|NCT02380677|365872911|FG004|Overall Study|Withdrawal by Subject|0|||
106056907|NCT02380677|365872912|FG005|Overall Study|Withdrawal by Subject|0|||
106056908|NCT02380677|365872913|FG006|Overall Study|Withdrawal by Subject|0|||
106056909|NCT02380677|365872914|FG007|Overall Study|Withdrawal by Subject|0|||
106056910|NCT02380677|365872915|FG008|Overall Study|Withdrawal by Subject|0|||
106056911|NCT02380677|365872916|FG009|Overall Study|Withdrawal by Subject|1|||
106056912|NCT02380677|365872917|FG010|Overall Study|Withdrawal by Subject|0|||
106056913|NCT02380677|365872918|FG011|Overall Study|Withdrawal by Subject|3|||
106056914|NCT02380677|365872907|FG000|Overall Study|Other|0|||
106056915|NCT02380677|365872908|FG001|Overall Study|Other|0|||
106056916|NCT02380677|365872909|FG002|Overall Study|Other|0|||
106056917|NCT02380677|365872910|FG003|Overall Study|Other|1|||
106056918|NCT02380677|365872911|FG004|Overall Study|Other|1|||
106056919|NCT02380677|365872912|FG005|Overall Study|Other|1|||
106056920|NCT02380677|365872913|FG006|Overall Study|Other|0|||
106056921|NCT02380677|365872914|FG007|Overall Study|Other|0|||
106056922|NCT02380677|365872915|FG008|Overall Study|Other|0|||
106056923|NCT02380677|365872916|FG009|Overall Study|Other|0|||
106056924|NCT02380677|365872917|FG010|Overall Study|Other|0|||
106056925|NCT02380677|365872918|FG011|Overall Study|Other|0|||
106056926|NCT03217175|365872922|FG000|Overall Study|Physician Decision|4|||
106056927|NCT03217175|365872923|FG001|Overall Study|Physician Decision|1|||
106056928|NCT05035550|365872927|FG000|Overall Study|Withdrawal by Subject|3|||
106056929|NCT05035550|365872928|FG001|Overall Study|Withdrawal by Subject|0|||
106056930|NCT01396148|365872929|FG000|Overall Study|Patient Decision|1|||
106056931|NCT00840450|365872936|FG000|Overall Study|Adverse Event|1|||
106056932|NCT00840450|365872936|FG000|Overall Study|Lack of Efficacy|2|||
106056933|NCT02495168|365872937|FG000|Overall Study|Other than Specified|18|||
106152496|NCT03112174|366218824|FG004|Overall Study|Withdrawal by Subject|7|||
106152497|NCT03112174|366218820|FG000|Overall Study|Lost to Follow-up|1|||
106056934|NCT02495168|365872938|FG001|Overall Study|Other than Specified|22|||
106152498|NCT03112174|366218821|FG001|Overall Study|Lost to Follow-up|1|||
106152499|NCT03112174|366218822|FG002|Overall Study|Lost to Follow-up|2|||
106152500|NCT03112174|366218823|FG003|Overall Study|Lost to Follow-up|3|||
106152501|NCT03112174|366218824|FG004|Overall Study|Lost to Follow-up|2|||
106152502|NCT03112174|366218820|FG000|Overall Study|Death|8|||
106152503|NCT03112174|366218821|FG001|Overall Study|Death|3|||
106056935|NCT02495168|365872939|FG002|Overall Study|Other than Specified|5|||
106056936|NCT02495168|365872937|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
106056937|NCT02495168|365872938|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
106056938|NCT02495168|365872939|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
106056939|NCT02495168|365872937|FG000|Overall Study|Physician Decision|1|||
106056940|NCT02495168|365872938|FG001|Overall Study|Physician Decision|1|||
106056941|NCT02495168|365872939|FG002|Overall Study|Physician Decision|0|||
106056942|NCT02495168|365872937|FG000|Overall Study|Lost to Follow-up|10|||
106056943|NCT02495168|365872938|FG001|Overall Study|Lost to Follow-up|6|||
106056944|NCT02495168|365872939|FG002|Overall Study|Lost to Follow-up|1|||
106056945|NCT02495168|365872937|FG000|Overall Study|Withdrawal by Subject|1|||
106056946|NCT02495168|365872938|FG001|Overall Study|Withdrawal by Subject|4|||
106056947|NCT02495168|365872939|FG002|Overall Study|Withdrawal by Subject|2|||
106056948|NCT02495168|365872937|FG000|Overall Study|Protocol Violation|0|||
106056949|NCT02495168|365872938|FG001|Overall Study|Protocol Violation|10|||
106056950|NCT02495168|365872939|FG002|Overall Study|Protocol Violation|1|||
106056951|NCT02495168|365872937|FG000|Overall Study|Adverse Event|4|||
106056952|NCT02495168|365872938|FG001|Overall Study|Adverse Event|8|||
106056953|NCT02495168|365872939|FG002|Overall Study|Adverse Event|3|||
106056954|NCT02495168|365872937|FG000|Overall Study|Lack of Efficacy|0|||
106056955|NCT02495168|365872938|FG001|Overall Study|Lack of Efficacy|0|||
106056956|NCT02495168|365872939|FG002|Overall Study|Lack of Efficacy|3|||
106056957|NCT01976338|365872940|FG000|Overall Study|Physician Decision|0|||
106056958|NCT01976338|365872941|FG001|Overall Study|Physician Decision|1|||
106056959|NCT01976338|365872940|FG000|Overall Study|Lost to Follow-up|3|||
106056960|NCT01976338|365872941|FG001|Overall Study|Lost to Follow-up|0|||
106056961|NCT01976338|365872940|FG000|Overall Study|Withdrawal by Subject|5|||
106056962|NCT01976338|365872941|FG001|Overall Study|Withdrawal by Subject|2|||
106056963|NCT01976338|365872940|FG000|Overall Study|Adverse Event|5|||
106056964|NCT01976338|365872941|FG001|Overall Study|Adverse Event|1|||
106056965|NCT04390191|365872945|FG000|Overall Study|Withdrawal by Subject|1|||
106056966|NCT04390191|365872946|FG001|Overall Study|Withdrawal by Subject|0|||
106056967|NCT02794883|365872947|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
106056968|NCT02794883|365872948|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
106056969|NCT02794883|365872949|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
106056970|NCT02794883|365872947|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
106056971|NCT02794883|365872948|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
106056972|NCT02794883|365872949|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
106056973|NCT02794883|365872947|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
106056974|NCT02794883|365872948|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
106056975|NCT02794883|365872949|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
106056976|NCT02794883|365872947|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
106056977|NCT02794883|365872948|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
106056978|NCT02794883|365872949|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
106056979|NCT02794883|365872947|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
106056980|NCT02794883|365872948|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
106056981|NCT02794883|365872949|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
106056982|NCT02794883|365872947|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
106056983|NCT02794883|365872948|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
106056984|NCT02794883|365872949|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
106056985|NCT02794883|365872947|FG000|Follow-up Period (up to 2 Years)|Death|12|||
106056986|NCT02794883|365872948|FG001|Follow-up Period (up to 2 Years)|Death|10|||
106056987|NCT02794883|365872949|FG002|Follow-up Period (up to 2 Years)|Death|10|||
106056988|NCT03978832|365872950|FG000|Overall Study|Adverse Event|1|||
106056989|NCT03978832|365872950|FG000|Overall Study|Lost to Follow-up|1|||
106056990|NCT03978832|365872950|FG000|Overall Study|Withdrawal by Subject|6|||
106056991|NCT03978832|365872950|FG000|Overall Study|Physician Decision|2|||
106056992|NCT03978832|365872950|FG000|Overall Study|did not pass screening criteria|44|||
106056993|NCT02864498|365872955|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
106056994|NCT02864498|365872956|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
106056995|NCT02864498|365872957|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
106056996|NCT02864498|365872955|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
106056997|NCT02864498|365872956|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
106056998|NCT02864498|365872957|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
106056999|NCT02864498|365872955|FG000|Overall Study|Investigator Discretion|0|||
106057000|NCT02864498|365872956|FG001|Overall Study|Investigator Discretion|2|||
106057001|NCT02864498|365872957|FG002|Overall Study|Investigator Discretion|1|||
106057002|NCT02864498|365872955|FG000|Overall Study|Lost to Follow-up|8|||
106057003|NCT02864498|365872956|FG001|Overall Study|Lost to Follow-up|6|||
106057004|NCT02864498|365872957|FG002|Overall Study|Lost to Follow-up|3|||
106057005|NCT02864498|365872955|FG000|Overall Study|Lack of Efficacy|5|||
106057006|NCT02864498|365872956|FG001|Overall Study|Lack of Efficacy|3|||
106057007|NCT02864498|365872957|FG002|Overall Study|Lack of Efficacy|3|||
106057008|NCT02864498|365872955|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
106057009|NCT02864498|365872956|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
106057010|NCT02864498|365872957|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
106057011|NCT02864498|365872955|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
106057012|NCT02864498|365872956|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
106057013|NCT02864498|365872957|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
106057014|NCT02864498|365872955|FG000|Overall Study|Subject moved out of the country.|0|||
106057015|NCT02864498|365872956|FG001|Overall Study|Subject moved out of the country.|0|||
106057016|NCT02864498|365872957|FG002|Overall Study|Subject moved out of the country.|1|||
106057017|NCT01812174|365872958|FG000|Overall Study|Death|1|||
106057018|NCT01812174|365872959|FG001|Overall Study|Death|0|||
106057019|NCT01812174|365872958|FG000|Overall Study|Protocol Violation|2|||
106057020|NCT01812174|365872959|FG001|Overall Study|Protocol Violation|0|||
106057021|NCT02627144|365872965|FG000|Overall Study|Serious adverse event|32|||
106057022|NCT02627144|365872965|FG000|Overall Study|Cancer progression|171|||
106057023|NCT02627144|365872965|FG000|Overall Study|Death from cancer|20|||
106057024|NCT02627144|365872965|FG000|Overall Study|Death from other cause|8|||
106057025|NCT02627144|365872965|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
106057026|NCT02627144|365872965|FG000|Overall Study|Administrative reasons|65|||
106057027|NCT02627144|365872965|FG000|Overall Study|Lost to Follow-up|8|||
106057028|NCT02627144|365872965|FG000|Overall Study|Enrolled, not treated|6|||
105864678|NCT02759692|365152988|FG001|Period 1|No longer meets eligibility criteria.|0|||
105864679|NCT02759692|365152987|FG000|Period 1|Miss-Randomized|1|||
106057029|NCT02627144|365872965|FG000|Overall Study|Other|17|||
106057030|NCT00119106|365872966|FG000|Overall Study|HIV infected at baseline|179|||
106057031|NCT00119106|365872967|FG001|Overall Study|HIV infected at baseline|178|||
106057032|NCT00730132|365872968|FG000|Overall Study|Protocol Violation|154|||
106057033|NCT00730132|365872968|FG000|Overall Study|Death|1|||
106057034|NCT01051323|365872969|FG000|Overall Study|Discontinuation of treatment|103|||
106057035|NCT01051323|365872969|FG000|Overall Study|Transplantation|28|||
106057036|NCT01051323|365872969|FG000|Overall Study|Dialysis dependency|22|||
106057037|NCT01051323|365872969|FG000|Overall Study|Withdrawal by Subject|13|||
106057038|NCT01051323|365872969|FG000|Overall Study|Lost to Follow-up|31|||
106057039|NCT01051323|365872969|FG000|Overall Study|Death|129|||
106057040|NCT01051323|365872969|FG000|Overall Study|Hospitalization|28|||
106057041|NCT01051323|365872969|FG000|Overall Study|Other|148|||
106057042|NCT01051323|365872969|FG000|Overall Study|Missing|37|||
106057043|NCT01626391|365872970|FG000|Overall Study|Physician Decision|1|||
106057044|NCT01626391|365872971|FG001|Overall Study|Physician Decision|0|||
106057045|NCT01626391|365872970|FG000|Overall Study|Withdrawal by Subject|1|||
106057046|NCT01626391|365872971|FG001|Overall Study|Withdrawal by Subject|0|||
106057047|NCT00370032|365872974|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
106057048|NCT00370032|365872975|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
106057049|NCT00370032|365872974|FG000|Washout Period|Withdrawal by Subject|0|||
106057050|NCT00370032|365872975|FG001|Washout Period|Withdrawal by Subject|1|||
106057051|NCT00370032|365872974|FG000|Washout Period|Lost to Follow-up|0|||
106057052|NCT00370032|365872975|FG001|Washout Period|Lost to Follow-up|1|||
106057053|NCT00370032|365872974|FG000|Washout Period|Adverse Event|1|||
106057054|NCT00370032|365872975|FG001|Washout Period|Adverse Event|0|||
106057055|NCT00370032|365872974|FG000|Follow-up Period|Withdrawal by Subject|1|||
106057056|NCT00370032|365872975|FG001|Follow-up Period|Withdrawal by Subject|0|||
106057057|NCT02220205|365872976|FG000|Overall Study|Withdrawal by Subject|1|||
106057058|NCT02220205|365872977|FG001|Overall Study|Withdrawal by Subject|0|||
106057059|NCT01930123|365872978|FG000|Overall Study|Adverse Event|1|||
106057060|NCT01930123|365872979|FG001|Overall Study|Adverse Event|0|||
106057061|NCT01930123|365872978|FG000|Overall Study|Physician Decision|21|||
106057062|NCT01930123|365872979|FG001|Overall Study|Physician Decision|8|||
106057063|NCT01930123|365872978|FG000|Overall Study|Withdrawal by Subject|1|||
106057064|NCT01930123|365872979|FG001|Overall Study|Withdrawal by Subject|0|||
106057065|NCT01578187|365872980|FG000|Usability Phase|Withdrawal by Subject|1|||
106057066|NCT00496470|365872981|FG000|Overall Study|Adverse Event|8|||
106057067|NCT00496470|365872982|FG001|Overall Study|Adverse Event|10|||
106057068|NCT00496470|365872981|FG000|Overall Study|Withdrawal by Subject|5|||
106057069|NCT00496470|365872982|FG001|Overall Study|Withdrawal by Subject|12|||
106057070|NCT00496470|365872981|FG000|Overall Study|Incorrectly enrolled|13|||
106057071|NCT00496470|365872982|FG001|Overall Study|Incorrectly enrolled|5|||
106057072|NCT00496470|365872981|FG000|Overall Study|Other reason|0|||
106057073|NCT00496470|365872982|FG001|Overall Study|Other reason|2|||
106057074|NCT01709162|365872983|FG000|Overall Study|Disease progression|3|||
106057075|NCT01709162|365872984|FG001|Overall Study|Disease progression|3|||
106152504|NCT03112174|366218822|FG002|Overall Study|Death|67|||
106152505|NCT03112174|366218823|FG003|Overall Study|Death|73|||
106152506|NCT03112174|366218824|FG004|Overall Study|Death|18|||
106152507|NCT03112174|366218820|FG000|Overall Study|Other, Not Specified|1|||
106152508|NCT03112174|366218821|FG001|Overall Study|Other, Not Specified|0|||
106152509|NCT03112174|366218822|FG002|Overall Study|Other, Not Specified|1|||
106152510|NCT03112174|366218823|FG003|Overall Study|Other, Not Specified|2|||
105864680|NCT02759692|365152988|FG001|Period 1|Miss-Randomized|1|||
106057076|NCT01709162|365872983|FG000|Overall Study|Study drug toxicity|2|||
106057077|NCT01709162|365872984|FG001|Overall Study|Study drug toxicity|0|||
106057078|NCT01709162|365872983|FG000|Overall Study|Administrative reason by sponsor|0|||
106057079|NCT01709162|365872984|FG001|Overall Study|Administrative reason by sponsor|1|||
106057080|NCT01709162|365872983|FG000|Overall Study|Other|1|||
106057081|NCT01709162|365872984|FG001|Overall Study|Other|0|||
106057082|NCT01709162|365872983|FG000|Overall Study|Withdrawal by Subject|0|||
106057083|NCT01709162|365872984|FG001|Overall Study|Withdrawal by Subject|1|||
106057084|NCT03310021|365872985|FG000|Overall Study|Withdrawal by Subject|0|||
106057085|NCT03310021|365872986|FG001|Overall Study|Withdrawal by Subject|0|||
106057086|NCT03310021|365872987|FG002|Overall Study|Withdrawal by Subject|0|||
106057087|NCT03310021|365872988|FG003|Overall Study|Withdrawal by Subject|0|||
106057088|NCT03310021|365872989|FG004|Overall Study|Withdrawal by Subject|0|||
106057089|NCT03310021|365872990|FG005|Overall Study|Withdrawal by Subject|0|||
106057090|NCT03310021|365872991|FG006|Overall Study|Withdrawal by Subject|1|||
106057091|NCT03310021|365872992|FG007|Overall Study|Withdrawal by Subject|0|||
106057092|NCT03310021|365872993|FG008|Overall Study|Withdrawal by Subject|0|||
106057093|NCT03310021|365872994|FG009|Overall Study|Withdrawal by Subject|0|||
106057094|NCT03310021|365872995|FG010|Overall Study|Withdrawal by Subject|0|||
106057095|NCT03310021|365872996|FG011|Overall Study|Withdrawal by Subject|0|||
106057096|NCT03310021|365872997|FG012|Overall Study|Withdrawal by Subject|0|||
106057097|NCT03310021|365872998|FG013|Overall Study|Withdrawal by Subject|0|||
106057098|NCT03310021|365872999|FG014|Overall Study|Withdrawal by Subject|0|||
106057099|NCT03310021|365873000|FG015|Overall Study|Withdrawal by Subject|0|||
106057100|NCT03310021|365873001|FG016|Overall Study|Withdrawal by Subject|0|||
106057101|NCT03310021|365873002|FG017|Overall Study|Withdrawal by Subject|0|||
106057102|NCT03310021|365873003|FG018|Overall Study|Withdrawal by Subject|0|||
106057103|NCT03310021|365873004|FG019|Overall Study|Withdrawal by Subject|0|||
106057104|NCT03310021|365872985|FG000|Overall Study|Lost to Follow-up|0|||
106057105|NCT03310021|365872986|FG001|Overall Study|Lost to Follow-up|0|||
106057106|NCT03310021|365872987|FG002|Overall Study|Lost to Follow-up|0|||
106057107|NCT03310021|365872988|FG003|Overall Study|Lost to Follow-up|0|||
106057108|NCT03310021|365872989|FG004|Overall Study|Lost to Follow-up|0|||
106057109|NCT03310021|365872990|FG005|Overall Study|Lost to Follow-up|0|||
106057110|NCT03310021|365872991|FG006|Overall Study|Lost to Follow-up|0|||
106057111|NCT03310021|365872992|FG007|Overall Study|Lost to Follow-up|0|||
106057112|NCT03310021|365872993|FG008|Overall Study|Lost to Follow-up|0|||
106057113|NCT03310021|365872994|FG009|Overall Study|Lost to Follow-up|0|||
106057114|NCT03310021|365872995|FG010|Overall Study|Lost to Follow-up|1|||
106057115|NCT03310021|365872996|FG011|Overall Study|Lost to Follow-up|0|||
106057116|NCT03310021|365872997|FG012|Overall Study|Lost to Follow-up|0|||
106057117|NCT03310021|365872998|FG013|Overall Study|Lost to Follow-up|0|||
106057118|NCT03310021|365872999|FG014|Overall Study|Lost to Follow-up|0|||
106057119|NCT03310021|365873000|FG015|Overall Study|Lost to Follow-up|0|||
106057120|NCT03310021|365873001|FG016|Overall Study|Lost to Follow-up|0|||
106057121|NCT03310021|365873002|FG017|Overall Study|Lost to Follow-up|0|||
106057122|NCT03310021|365873003|FG018|Overall Study|Lost to Follow-up|0|||
106057123|NCT03310021|365873004|FG019|Overall Study|Lost to Follow-up|0|||
106057124|NCT01233258|365873005|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
106057125|NCT01233258|365873006|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
106057126|NCT01233258|365873007|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
106057127|NCT01233258|365873008|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
106057128|NCT01233258|365873009|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
106057129|NCT01233258|365873010|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
106057130|NCT01233258|365873005|FG000|First Intervention (6 Months)|Protocol Violation|0|||
106057131|NCT01233258|365873006|FG001|First Intervention (6 Months)|Protocol Violation|0|||
106057132|NCT01233258|365873007|FG002|First Intervention (6 Months)|Protocol Violation|1|||
106057133|NCT01233258|365873008|FG003|First Intervention (6 Months)|Protocol Violation|0|||
106057134|NCT01233258|365873009|FG004|First Intervention (6 Months)|Protocol Violation|0|||
106057135|NCT01233258|365873010|FG005|First Intervention (6 Months)|Protocol Violation|0|||
106057136|NCT01233258|365873005|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
106057137|NCT01233258|365873006|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
106057138|NCT01233258|365873007|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
106057139|NCT01233258|365873008|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
106057140|NCT01233258|365873009|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
106057141|NCT01233258|365873010|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
106057142|NCT00880009|365873011|FG000|Overall Study|Study terminated by sponsor|14|||
106057143|NCT00880009|365873011|FG000|Overall Study|Withdrawal by Subject|1|||
106057144|NCT00880009|365873011|FG000|Overall Study|Protocol Violation|1|||
106057145|NCT00390468|365873012|FG000|Overall Study|Protocol Violation|2|||
106057146|NCT00390468|365873012|FG000|Overall Study|Lack of Efficacy|1|||
106057147|NCT04974697|365873023|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
106057148|NCT04974697|365873023|FG000|Overall Study|Lens discomfort|1|||
106057149|NCT03706456|365873024|FG000|Overall Study|Adverse Event|1|||
106057150|NCT03706456|365873024|FG000|Overall Study|Lack of Efficacy|2|||
106057151|NCT02784431|365873025|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
106057152|NCT02784431|365873025|FG000|Overall Study|Early Study Termination|19|||
106152511|NCT03112174|366218824|FG004|Overall Study|Other, Not Specified|0|||
106152512|NCT03446157|366218825|FG000|Overall Study|Death|11|||
106152513|NCT03446157|366218826|FG001|Overall Study|Death|9|||
106152514|NCT03446157|366218825|FG000|Overall Study|Lost to Follow-up|0|||
106057153|NCT02795832|365873028|FG000|Overall Study|Adverse Event|0|||
106057154|NCT02795832|365873029|FG001|Overall Study|Adverse Event|0|||
106057155|NCT02795832|365873030|FG002|Overall Study|Adverse Event|0|||
106057156|NCT02795832|365873031|FG003|Overall Study|Adverse Event|0|||
106057157|NCT02795832|365873032|FG004|Overall Study|Adverse Event|0|||
106057158|NCT02795832|365873033|FG005|Overall Study|Adverse Event|3|||
106057159|NCT02605824|365873034|FG000|Overall Study|Physician Decision|1|||
106057160|NCT02605824|365873035|FG001|Overall Study|Physician Decision|0|||
106057161|NCT04112784|365873036|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
106057162|NCT04112784|365873036|FG000|Overall Study|Screen Failures|4|||
106057163|NCT00221403|365873037|FG000|Overall Study|Protocol Violation|1|||
106057164|NCT00221403|365873038|FG001|Overall Study|Protocol Violation|0|||
106057165|NCT00221403|365873039|FG002|Overall Study|Protocol Violation|0|||
106057166|NCT00221403|365873037|FG000|Overall Study|Physician Decision|1|||
106057167|NCT00221403|365873038|FG001|Overall Study|Physician Decision|0|||
106057168|NCT00221403|365873039|FG002|Overall Study|Physician Decision|0|||
106057169|NCT00221403|365873037|FG000|Overall Study|Withdrawal by Subject|0|||
106057170|NCT00221403|365873038|FG001|Overall Study|Withdrawal by Subject|3|||
106057171|NCT00221403|365873039|FG002|Overall Study|Withdrawal by Subject|0|||
106057172|NCT00221403|365873037|FG000|Overall Study|Lack of Efficacy|0|||
106057173|NCT00221403|365873038|FG001|Overall Study|Lack of Efficacy|1|||
106057174|NCT00221403|365873039|FG002|Overall Study|Lack of Efficacy|0|||
106057175|NCT00221403|365873037|FG000|Overall Study|Adverse Event|0|||
106057176|NCT00221403|365873038|FG001|Overall Study|Adverse Event|1|||
106057177|NCT00221403|365873039|FG002|Overall Study|Adverse Event|0|||
106057178|NCT02030041|365873042|FG000|Overall Study|Withdrawal by Subject|2|||
106057179|NCT02030041|365873043|FG001|Overall Study|Withdrawal by Subject|2|||
106057180|NCT02030041|365873044|FG002|Overall Study|Withdrawal by Subject|1|||
106057181|NCT05201703|365873045|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
106057182|NCT05201703|365873046|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
106057183|NCT05201703|365873045|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
106057184|NCT05201703|365873046|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
106057185|NCT00393029|365873047|FG000|Overall Study|Not treated|0|||
106057186|NCT00393029|365873048|FG001|Overall Study|Not treated|1|||
106057187|NCT03715530|365873049|FG000|Overall Study|Lost to Follow-up|3|||
106057188|NCT03715530|365873050|FG001|Overall Study|Lost to Follow-up|1|||
106057189|NCT03715530|365873051|FG002|Overall Study|Lost to Follow-up|2|||
106057190|NCT02197130|365873052|FG000|Overall Study|Adverse Event|13|||
106057191|NCT02197130|365873053|FG001|Overall Study|Adverse Event|4|||
106057192|NCT02197130|365873054|FG002|Overall Study|Adverse Event|23|||
106057193|NCT02197130|365873052|FG000|Overall Study|Death|0|||
106057194|NCT02197130|365873053|FG001|Overall Study|Death|1|||
106057195|NCT02197130|365873054|FG002|Overall Study|Death|0|||
106057196|NCT02197130|365873052|FG000|Overall Study|Lost to Follow-up|2|||
106057197|NCT02197130|365873053|FG001|Overall Study|Lost to Follow-up|0|||
106057198|NCT02197130|365873054|FG002|Overall Study|Lost to Follow-up|1|||
106057199|NCT02197130|365873052|FG000|Overall Study|Does not meet entrance criteria|0|||
106057200|NCT02197130|365873053|FG001|Overall Study|Does not meet entrance criteria|0|||
106057201|NCT02197130|365873054|FG002|Overall Study|Does not meet entrance criteria|1|||
106057202|NCT02197130|365873052|FG000|Overall Study|Withdrawal by Subject|0|||
106057203|NCT02197130|365873053|FG001|Overall Study|Withdrawal by Subject|3|||
106057204|NCT02197130|365873054|FG002|Overall Study|Withdrawal by Subject|4|||
106057205|NCT02197130|365873052|FG000|Overall Study|Other|1|||
106057206|NCT02197130|365873053|FG001|Overall Study|Other|0|||
106057207|NCT02197130|365873054|FG002|Overall Study|Other|3|||
106057208|NCT01594762|365873058|FG000|Overall Study|Withdrawal by Subject|1|||
106057209|NCT01594762|365873059|FG001|Overall Study|Withdrawal by Subject|0|||
106057210|NCT01594762|365873058|FG000|Overall Study|Lost to Follow-up|10|||
106057211|NCT01594762|365873059|FG001|Overall Study|Lost to Follow-up|10|||
106057212|NCT02216591|365873060|FG000|Overall Study|Lost to Follow-up|0|||
106057213|NCT02216591|365873061|FG001|Overall Study|Lost to Follow-up|1|||
106057214|NCT04518306|365873071|FG000|Double-Blind Period|Run in failure|0|||
106057215|NCT04518306|365873072|FG001|Double-Blind Period|Run in failure|0|||
106057216|NCT04518306|365873073|FG002|Double-Blind Period|Run in failure|1|||
106057217|NCT04518306|365873071|FG000|Double-Blind Period|Adverse Event|0|||
106057218|NCT04518306|365873072|FG001|Double-Blind Period|Adverse Event|2|||
106057219|NCT04518306|365873073|FG002|Double-Blind Period|Adverse Event|2|||
106057220|NCT04518306|365873071|FG000|Double-Blind Period|Lost to Follow-up|1|||
106057221|NCT04518306|365873072|FG001|Double-Blind Period|Lost to Follow-up|2|||
106057222|NCT04518306|365873073|FG002|Double-Blind Period|Lost to Follow-up|2|||
106057223|NCT04518306|365873071|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
106057224|NCT04518306|365873072|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
106057225|NCT04518306|365873073|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
106057226|NCT04518306|365873071|FG000|Double-Blind Period|Other|0|||
106152515|NCT03446157|366218826|FG001|Overall Study|Lost to Follow-up|1|||
106057227|NCT04518306|365873072|FG001|Double-Blind Period|Other|2|||
106057228|NCT04518306|365873073|FG002|Double-Blind Period|Other|0|||
106057229|NCT04518306|365873071|FG000|Double-Blind Period|Missing|0|||
106057230|NCT04518306|365873072|FG001|Double-Blind Period|Missing|1|||
106057231|NCT04518306|365873073|FG002|Double-Blind Period|Missing|0|||
106057232|NCT05372419|365873074|FG000|Overall Study|Protocol Deviation|1|||
106057233|NCT05372419|365873074|FG000|Overall Study|Withdrawal by Subject|5|||
106057234|NCT05372419|365873074|FG000|Overall Study|Lost to Follow-up|7|||
106057235|NCT02324569|365874272|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
106057236|NCT02324569|365874273|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
106057237|NCT02324569|365874272|FG000|Overall Study|Voluntary Withdrawal|3|||
106057238|NCT02324569|365874273|FG001|Overall Study|Voluntary Withdrawal|6|||
106057239|NCT02324569|365874272|FG000|Overall Study|Lack of Efficacy|2|||
106057240|NCT02324569|365874273|FG001|Overall Study|Lack of Efficacy|3|||
106057241|NCT02324569|365874272|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
106057242|NCT02324569|365874273|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
106057243|NCT02324569|365874272|FG000|Overall Study|Inconvenient Schedule|2|||
106057244|NCT02324569|365874273|FG001|Overall Study|Inconvenient Schedule|0|||
106057245|NCT03156543|365874274|FG000|Overall Study|Withdrawal by Subject|1|||
106057246|NCT03156543|365874275|FG001|Overall Study|Withdrawal by Subject|0|||
106057247|NCT00674700|365874276|FG000|Year 1|Adverse Event|17|||
106057248|NCT00674700|365874277|FG001|Year 1|Adverse Event|20|||
106057249|NCT00674700|365874278|FG002|Year 1|Adverse Event|5|||
106057250|NCT00674700|365874276|FG000|Year 1|Withdrawal by Subject|7|||
106057251|NCT00674700|365874277|FG001|Year 1|Withdrawal by Subject|7|||
106057252|NCT00674700|365874278|FG002|Year 1|Withdrawal by Subject|6|||
106057253|NCT00674700|365874276|FG000|Year 1|Any other reason not above-mentioned|7|||
106057254|NCT00674700|365874277|FG001|Year 1|Any other reason not above-mentioned|7|||
106057255|NCT00674700|365874278|FG002|Year 1|Any other reason not above-mentioned|6|||
106057256|NCT00674700|365874276|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
106057257|NCT00674700|365874277|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
106057258|NCT00674700|365874278|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
106057259|NCT00674700|365874276|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
106057260|NCT00674700|365874277|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
106057261|NCT00674700|365874278|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
106057262|NCT00674700|365874276|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
106057263|NCT00674700|365874277|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
106057264|NCT00674700|365874278|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
106057265|NCT02601469|365874279|FG000|Overall Study|Enrolled in Error|1|||
106057266|NCT02601469|365874280|FG001|Overall Study|Enrolled in Error|0|||
106057267|NCT00630396|365874288|FG000|Overall Study|Death|4|||
106057268|NCT00630396|365874288|FG000|Overall Study|Lost to Follow-up|3|||
106057269|NCT00056316|365874291|FG000|Overall Study|Withdrawal by Subject|2|||
106057270|NCT00056316|365874292|FG001|Overall Study|Withdrawal by Subject|2|||
106057271|NCT00056316|365874291|FG000|Overall Study|Death/NH placement of pt|1|||
106057272|NCT00056316|365874292|FG001|Overall Study|Death/NH placement of pt|1|||
106057273|NCT04980040|365874293|FG000|Overall Study|Violated the Inclusion Criteria|260|||
106057274|NCT04980040|365874293|FG000|Overall Study|Violated the Administration & Dosage|225|||
106057275|NCT04980040|365874293|FG000|Overall Study|Lost to Safety-Follow-up|4|||
106057276|NCT04980040|365874293|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
106057277|NCT02820753|365874294|FG000|2 Month|Withdrawal by Subject|3|||
106057278|NCT02820753|365874295|FG001|2 Month|Withdrawal by Subject|3|||
106057279|NCT02820753|365874294|FG000|2 Month|Lost to Follow-up|24|||
106057280|NCT02820753|365874295|FG001|2 Month|Lost to Follow-up|26|||
106057281|NCT02820753|365874294|FG000|2 Month|Stopped per NIH Hold|51|||
106057282|NCT02820753|365874295|FG001|2 Month|Stopped per NIH Hold|13|||
106057283|NCT02820753|365874294|FG000|6 Month|Withdrawal by Subject|2|||
106057284|NCT02820753|365874295|FG001|6 Month|Withdrawal by Subject|2|||
106057285|NCT02820753|365874294|FG000|6 Month|Lost to Follow-up|20|||
106057286|NCT02820753|365874295|FG001|6 Month|Lost to Follow-up|27|||
106057287|NCT02820753|365874294|FG000|6 Month|Stopped per NIH Hold|81|||
106057288|NCT02820753|365874295|FG001|6 Month|Stopped per NIH Hold|81|||
106057289|NCT02820753|365874294|FG000|6 Month|Death|0|||
106057290|NCT02820753|365874295|FG001|6 Month|Death|1|||
106057291|NCT02161731|365874299|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
106057292|NCT02161731|365874300|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
106057293|NCT02161731|365874299|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
106057294|NCT02161731|365874300|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
106057295|NCT01408485|365874301|FG000|Overall Study|Withdrawal by Subject|21|||
106057296|NCT00691015|365874302|FG000|Overall Study|Refused further treatment|1|||
106057297|NCT00618072|365874303|FG000|Overall Study|Lost to Follow-up|2|||
106057298|NCT00618072|365874304|FG001|Overall Study|Lost to Follow-up|0|||
106057299|NCT00618072|365874305|FG002|Overall Study|Lost to Follow-up|3|||
106057300|NCT00618072|365874303|FG000|Overall Study|Physician Decision|0|||
106057301|NCT00618072|365874304|FG001|Overall Study|Physician Decision|1|||
106057302|NCT00618072|365874305|FG002|Overall Study|Physician Decision|1|||
106057303|NCT02151591|365874306|FG000|Overall Study|Lost to Follow-up|6|||
106057304|NCT02151591|365874307|FG001|Overall Study|Lost to Follow-up|3|||
106057305|NCT00578812|365874308|FG000|Overall Study|Not treated|6|||
106057306|NCT00578812|365874309|FG001|Overall Study|Not treated|7|||
106057307|NCT01508650|365874317|FG000|Overall Study|Lost to Follow-up|0|||
106057308|NCT01508650|365874318|FG001|Overall Study|Lost to Follow-up|3|||
106057309|NCT00884312|365874319|FG000|Overall Study|Non-fatal Progressive Disease|0|||
106057310|NCT00884312|365874320|FG001|Overall Study|Non-fatal Progressive Disease|8|||
106057311|NCT00884312|365874319|FG000|Overall Study|Fatal Progressive Disease|0|||
106057312|NCT00884312|365874320|FG001|Overall Study|Fatal Progressive Disease|1|||
106057313|NCT00884312|365874319|FG000|Overall Study|Non-fatal Adverse Event|1|||
106057314|NCT00884312|365874320|FG001|Overall Study|Non-fatal Adverse Event|0|||
106057315|NCT00884312|365874319|FG000|Overall Study|Fatal Adverse Event|1|||
106057316|NCT00884312|365874320|FG001|Overall Study|Fatal Adverse Event|4|||
106057317|NCT00884312|365874319|FG000|Overall Study|Withdrawal by Subject|0|||
106057318|NCT00884312|365874320|FG001|Overall Study|Withdrawal by Subject|6|||
106057319|NCT00884312|365874319|FG000|Overall Study|Physician Decision|0|||
106057320|NCT00884312|365874320|FG001|Overall Study|Physician Decision|1|||
106057321|NCT00884312|365874319|FG000|Overall Study|Other|0|||
106057322|NCT00884312|365874320|FG001|Overall Study|Other|4|||
106057323|NCT00884312|365874319|FG000|Overall Study|Did Not Receive Study Drug|0|||
106057324|NCT00884312|365874320|FG001|Overall Study|Did Not Receive Study Drug|1|||
106057325|NCT03052725|365874322|FG000|Overall Study|Adverse Event|2|||
106057326|NCT03052725|365874323|FG001|Overall Study|Adverse Event|0|||
106057327|NCT03052725|365874322|FG000|Overall Study|Withdrawal by Subject|3|||
106057328|NCT03052725|365874323|FG001|Overall Study|Withdrawal by Subject|4|||
106057329|NCT03052725|365874322|FG000|Overall Study|Pregnancy|0|||
106057330|NCT03052725|365874323|FG001|Overall Study|Pregnancy|1|||
106057331|NCT03052725|365874322|FG000|Overall Study|Site closure|0|||
106057332|NCT03052725|365874323|FG001|Overall Study|Site closure|1|||
106057333|NCT03052725|365874322|FG000|Overall Study|Study terminated by sponsor|143|||
106057334|NCT03052725|365874323|FG001|Overall Study|Study terminated by sponsor|144|||
106057335|NCT00520936|365874324|FG000|Overall Study|Physician Decision|0|||
106057336|NCT00520936|365874325|FG001|Overall Study|Physician Decision|2|||
106057337|NCT00520936|365874326|FG002|Overall Study|Physician Decision|1|||
106057338|NCT00520936|365874327|FG003|Overall Study|Physician Decision|0|||
106057339|NCT00520936|365874328|FG004|Overall Study|Physician Decision|0|||
106057340|NCT00520936|365874329|FG005|Overall Study|Physician Decision|0|||
106057341|NCT00520936|365874330|FG006|Overall Study|Physician Decision|0|||
106057342|NCT00520936|365874331|FG007|Overall Study|Physician Decision|0|||
106057343|NCT00520936|365874324|FG000|Overall Study|Withdrawal by Subject|0|||
106057344|NCT00520936|365874325|FG001|Overall Study|Withdrawal by Subject|0|||
106057345|NCT00520936|365874326|FG002|Overall Study|Withdrawal by Subject|0|||
106057346|NCT00520936|365874327|FG003|Overall Study|Withdrawal by Subject|0|||
106057347|NCT00520936|365874328|FG004|Overall Study|Withdrawal by Subject|0|||
106057348|NCT00520936|365874329|FG005|Overall Study|Withdrawal by Subject|0|||
106057349|NCT00520936|365874330|FG006|Overall Study|Withdrawal by Subject|0|||
106057350|NCT00520936|365874331|FG007|Overall Study|Withdrawal by Subject|1|||
106057351|NCT00520936|365874324|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
106057352|NCT00520936|365874325|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
106057353|NCT00520936|365874326|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
106057354|NCT00520936|365874327|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
106057355|NCT00520936|365874328|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
106057356|NCT00520936|365874329|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
106057357|NCT00520936|365874330|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
106057358|NCT00520936|365874331|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
106057359|NCT00520936|365874324|FG000|Overall Study|Death|0|||
106057360|NCT00520936|365874325|FG001|Overall Study|Death|0|||
106057361|NCT00520936|365874326|FG002|Overall Study|Death|0|||
106057362|NCT00520936|365874327|FG003|Overall Study|Death|0|||
106057363|NCT00520936|365874328|FG004|Overall Study|Death|0|||
106057364|NCT00520936|365874329|FG005|Overall Study|Death|0|||
106057365|NCT00520936|365874330|FG006|Overall Study|Death|1|||
106057366|NCT00520936|365874331|FG007|Overall Study|Death|0|||
106057367|NCT00520936|365874324|FG000|Overall Study|Protocol Violation|0|||
106057368|NCT00520936|365874325|FG001|Overall Study|Protocol Violation|1|||
106057369|NCT00520936|365874326|FG002|Overall Study|Protocol Violation|1|||
106057370|NCT00520936|365874327|FG003|Overall Study|Protocol Violation|0|||
106057371|NCT00520936|365874328|FG004|Overall Study|Protocol Violation|1|||
106057372|NCT00520936|365874329|FG005|Overall Study|Protocol Violation|0|||
106057373|NCT00520936|365874330|FG006|Overall Study|Protocol Violation|1|||
106057374|NCT00520936|365874331|FG007|Overall Study|Protocol Violation|0|||
106057375|NCT03716024|365874332|FG000|Overall Study|Randomized, not Treated|7|||
106057376|NCT03716024|365874333|FG001|Overall Study|Randomized, not Treated|8|||
106057377|NCT03716024|365874332|FG000|Overall Study|Adverse Event|1|||
106057378|NCT03716024|365874333|FG001|Overall Study|Adverse Event|2|||
106057379|NCT03716024|365874332|FG000|Overall Study|Treatment Failure|1|||
106057380|NCT03716024|365874333|FG001|Overall Study|Treatment Failure|0|||
106057381|NCT03716024|365874332|FG000|Overall Study|Lost to Follow-up|2|||
106057382|NCT03716024|365874333|FG001|Overall Study|Lost to Follow-up|6|||
106057383|NCT03716024|365874332|FG000|Overall Study|Withdrawal by Subject|0|||
106057384|NCT03716024|365874333|FG001|Overall Study|Withdrawal by Subject|1|||
106057385|NCT03716024|365874332|FG000|Overall Study|Missing Reason|0|||
106057386|NCT03716024|365874333|FG001|Overall Study|Missing Reason|1|||
106057387|NCT00867568|365874334|FG000|Overall Study|Lack of Efficacy|10|||
106057388|NCT00867568|365874334|FG000|Overall Study|Adverse Event|4|||
106057389|NCT00867568|365874334|FG000|Overall Study|Withdrawal by Subject|1|||
106057390|NCT05275400|365874338|FG000|Treatment Period|Adverse Event|7|||
106057391|NCT05275400|365874339|FG001|Treatment Period|Adverse Event|1|||
106057392|NCT05275400|365874338|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
106057393|NCT05275400|365874339|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
106057394|NCT05275400|365874338|FG000|Treatment Period|Death|5|||
106057395|NCT05275400|365874339|FG001|Treatment Period|Death|2|||
106057396|NCT05275400|365874338|FG000|Treatment Period|Protocol Violation|1|||
106057397|NCT05275400|365874339|FG001|Treatment Period|Protocol Violation|0|||
106057398|NCT05275400|365874338|FG000|Treatment Period|Physician Decision|5|||
106057399|NCT05275400|365874339|FG001|Treatment Period|Physician Decision|4|||
106057400|NCT05275400|365874338|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
106057401|NCT05275400|365874339|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
106057402|NCT05275400|365874338|FG000|Treatment Period|Withdrawal by Subject|30|||
106057403|NCT05275400|365874339|FG001|Treatment Period|Withdrawal by Subject|12|||
106057404|NCT05275400|365874338|FG000|Treatment Period|Lost to Follow-up|1|||
106057405|NCT05275400|365874339|FG001|Treatment Period|Lost to Follow-up|5|||
106057406|NCT05275400|365874338|FG000|Treatment Period|Lack of Efficacy|1|||
106057407|NCT05275400|365874339|FG001|Treatment Period|Lack of Efficacy|0|||
106057408|NCT05275400|365874338|FG000|Treatment Period|Sponsor Decision|1|||
106057409|NCT05275400|365874339|FG001|Treatment Period|Sponsor Decision|0|||
106057410|NCT05275400|365874338|FG000|Follow-Up Period|Death|2|||
106057411|NCT05275400|365874339|FG001|Follow-Up Period|Death|0|||
106057412|NCT05275400|365874338|FG000|Follow-Up Period|Protocol Violation|1|||
106057413|NCT05275400|365874339|FG001|Follow-Up Period|Protocol Violation|0|||
106057414|NCT05275400|365874338|FG000|Follow-Up Period|Withdrawal by Subject|3|||
106057415|NCT05275400|365874339|FG001|Follow-Up Period|Withdrawal by Subject|0|||
106057416|NCT06333613|365874341|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
106057417|NCT00003479|365874342|FG000|Overall Study|Not evaluable|3|||
106057418|NCT01061177|365874344|FG000|Overall Study|Adverse Event|117|||
106057419|NCT01061177|365874344|FG000|Overall Study|Withdrawal by Subject|27|||
106057420|NCT01061177|365874344|FG000|Overall Study|Disease progression|17|||
106057421|NCT01061177|365874344|FG000|Overall Study|Protocol Violation|11|||
106057422|NCT01061177|365874344|FG000|Overall Study|Lost to Follow-up|9|||
106057423|NCT01061177|365874344|FG000|Overall Study|New cancer therapy|9|||
106057424|NCT01061177|365874344|FG000|Overall Study|Abnormal laboratory values|6|||
106057425|NCT01061177|365874344|FG000|Overall Study|Abnormal test procedure results|4|||
106057426|NCT01061177|365874344|FG000|Overall Study|Administratie problems|4|||
106057427|NCT01061177|365874344|FG000|Overall Study|Death|4|||
106057428|NCT02059395|365874345|FG000|Overall Study|Lost to Follow-up|2|||
106057429|NCT02059395|365874346|FG001|Overall Study|Lost to Follow-up|4|||
106057430|NCT01909674|365874347|FG000|Overall Study|Withdrawal by Subject|5|||
106057431|NCT01909674|365874348|FG001|Overall Study|Withdrawal by Subject|2|||
106057432|NCT02969369|365874349|FG000|Study|Adverse Event|1|||
106057433|NCT02969369|365874350|FG001|Study|Adverse Event|6|||
106057434|NCT02969369|365874349|FG000|Study|Lack of Efficacy|0|||
106057435|NCT02969369|365874350|FG001|Study|Lack of Efficacy|1|||
106057436|NCT02969369|365874349|FG000|Study|Lost to Follow-up|0|||
106057437|NCT02969369|365874350|FG001|Study|Lost to Follow-up|1|||
106057438|NCT02969369|365874349|FG000|Study|Withdrawal by Subject|3|||
106057439|NCT02969369|365874350|FG001|Study|Withdrawal by Subject|5|||
106057440|NCT02969369|365874349|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
106057441|NCT02969369|365874350|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
106057442|NCT02969369|365874349|FG000|Double-blind Period|Adverse Event|1|||
106057443|NCT02969369|365874350|FG001|Double-blind Period|Adverse Event|5|||
106057444|NCT02969369|365874349|FG000|Double-blind Period|Lost to Follow-up|0|||
106057445|NCT02969369|365874350|FG001|Double-blind Period|Lost to Follow-up|1|||
106057446|NCT02969369|365874349|FG000|Double-blind Period|Withdrawal by Subject|2|||
106057447|NCT02969369|365874350|FG001|Double-blind Period|Withdrawal by Subject|3|||
106057448|NCT02969369|365874349|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
106057449|NCT02969369|365874350|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
106057450|NCT02969369|365874349|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
106057451|NCT02969369|365874350|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
106057452|NCT02969369|365874349|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
106057453|NCT02969369|365874350|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
106057454|NCT02969369|365874349|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
106057455|NCT02969369|365874350|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
106057456|NCT02849678|365874351|FG000|Overall Study|Protocol Violation|3|||
106057457|NCT02849678|365874352|FG001|Overall Study|Protocol Violation|6|||
106057458|NCT01192516|365874353|FG000|Overall Study|Lost to Follow-up|7|||
106057459|NCT01192516|365874354|FG001|Overall Study|Lost to Follow-up|10|||
106057460|NCT01192516|365874355|FG002|Overall Study|Lost to Follow-up|7|||
106057461|NCT01192516|365874353|FG000|Overall Study|Withdrawal by Subject|4|||
106057462|NCT01192516|365874354|FG001|Overall Study|Withdrawal by Subject|4|||
106057463|NCT01192516|365874355|FG002|Overall Study|Withdrawal by Subject|1|||
106057464|NCT01192516|365874353|FG000|Overall Study|started new treatment|5|||
106057465|NCT01192516|365874354|FG001|Overall Study|started new treatment|1|||
106057466|NCT01192516|365874355|FG002|Overall Study|started new treatment|0|||
106057467|NCT01192516|365874353|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
106057468|NCT01192516|365874354|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
106057469|NCT01192516|365874355|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
106057470|NCT01256008|365874356|FG000|Overall Study|Lost to Follow-up|6|||
106057471|NCT01256008|365874357|FG001|Overall Study|Lost to Follow-up|4|||
106057472|NCT01256008|365874358|FG002|Overall Study|Lost to Follow-up|11|||
106057473|NCT01256008|365874356|FG000|Overall Study|Withdrawal by Subject|2|||
106057474|NCT01256008|365874357|FG001|Overall Study|Withdrawal by Subject|3|||
106057475|NCT01256008|365874358|FG002|Overall Study|Withdrawal by Subject|10|||
106057476|NCT02244606|365874359|FG000|Overall Study|Adverse Event|0|||
106057477|NCT02244606|365874360|FG001|Overall Study|Adverse Event|1|||
106057478|NCT02244606|365874361|FG002|Overall Study|Adverse Event|1|||
106057479|NCT02244606|365874362|FG003|Overall Study|Adverse Event|0|||
106057480|NCT02244606|365874359|FG000|Overall Study|Lost to Follow-up|2|||
106057481|NCT02244606|365874360|FG001|Overall Study|Lost to Follow-up|2|||
106057482|NCT02244606|365874361|FG002|Overall Study|Lost to Follow-up|1|||
106057483|NCT02244606|365874362|FG003|Overall Study|Lost to Follow-up|0|||
106057484|NCT02244606|365874359|FG000|Overall Study|Protocol Violation|0|||
106057485|NCT02244606|365874360|FG001|Overall Study|Protocol Violation|0|||
106057486|NCT02244606|365874361|FG002|Overall Study|Protocol Violation|0|||
106057487|NCT02244606|365874362|FG003|Overall Study|Protocol Violation|1|||
106057488|NCT02244606|365874359|FG000|Overall Study|Withdrawal by Subject|1|||
106057489|NCT02244606|365874360|FG001|Overall Study|Withdrawal by Subject|1|||
106057490|NCT02244606|365874361|FG002|Overall Study|Withdrawal by Subject|0|||
106057491|NCT02244606|365874362|FG003|Overall Study|Withdrawal by Subject|0|||
106057492|NCT02244606|365874359|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
106057493|NCT02244606|365874360|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
106152516|NCT03446157|366218825|FG000|Overall Study|Withdrawal by Subject|2|||
106152517|NCT03446157|366218826|FG001|Overall Study|Withdrawal by Subject|1|||
106152518|NCT02923180|366218836|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
106152519|NCT02923180|366218836|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
106152520|NCT05198310|366218837|FG000|Overall Study|Lost to Follow-up|0|||
106152521|NCT05198310|366218838|FG001|Overall Study|Lost to Follow-up|1|||
106152522|NCT05198310|366218839|FG002|Overall Study|Lost to Follow-up|0|||
106152523|NCT05198310|366218840|FG003|Overall Study|Lost to Follow-up|0|||
106152524|NCT05198310|366218841|FG004|Overall Study|Lost to Follow-up|0|||
106152525|NCT05198310|366218842|FG005|Overall Study|Lost to Follow-up|0|||
106152526|NCT05198310|366218843|FG006|Overall Study|Lost to Follow-up|0|||
106152527|NCT05198310|366218844|FG007|Overall Study|Lost to Follow-up|0|||
106152528|NCT05198310|366218837|FG000|Overall Study|Withdrawal by Subject|0|||
106152529|NCT05198310|366218838|FG001|Overall Study|Withdrawal by Subject|0|||
106057494|NCT02244606|365874361|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
106057495|NCT02244606|365874362|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
106057496|NCT00378378|365874363|FG000|Overall Study|Withdrawal by Subject|0|||
106057497|NCT00378378|365874364|FG001|Overall Study|Withdrawal by Subject|1|||
106057498|NCT00378378|365874365|FG002|Overall Study|Withdrawal by Subject|0|||
106057499|NCT00378378|365874363|FG000|Overall Study|Treatment Failure|0|||
106057500|NCT00378378|365874364|FG001|Overall Study|Treatment Failure|0|||
106057501|NCT00378378|365874365|FG002|Overall Study|Treatment Failure|1|||
106057502|NCT00378378|365874363|FG000|Overall Study|Non-compliance with protocol|0|||
106057503|NCT00378378|365874364|FG001|Overall Study|Non-compliance with protocol|0|||
106057504|NCT00378378|365874365|FG002|Overall Study|Non-compliance with protocol|1|||
106057505|NCT02228460|365874366|FG000|Overall Study|Adverse Event|1|||
106057506|NCT02228460|365874366|FG000|Overall Study|Lost to Follow-up|1|||
106057507|NCT01962896|365874377|FG000|Overall Study|Lack of Efficacy|4|||
106057508|NCT02837783|365874378|FG000|Overall Study|Adverse Event|1|||
106057509|NCT02837783|365874379|FG001|Overall Study|Adverse Event|0|||
106057510|NCT02837783|365874378|FG000|Overall Study|Other, Not Specified|1|||
106057511|NCT02837783|365874379|FG001|Overall Study|Other, Not Specified|2|||
106057512|NCT03338998|365874381|FG000|Treatment Period|Withdrawal by Subject|1|||
106057513|NCT03338998|365874382|FG001|Treatment Period|Withdrawal by Subject|1|||
106057514|NCT03338998|365874381|FG000|Treatment Period|Adverse Event|0|||
106057515|NCT03338998|365874382|FG001|Treatment Period|Adverse Event|2|||
106057516|NCT03338998|365874381|FG000|Treatment Period|Protocol deviation|1|||
106057517|NCT03338998|365874382|FG001|Treatment Period|Protocol deviation|0|||
106057518|NCT03338998|365874381|FG000|Treatment Period|Physician Decision|2|||
106057519|NCT03338998|365874382|FG001|Treatment Period|Physician Decision|0|||
106057520|NCT03338998|365874381|FG000|Treatment Period|Subject failed swallow test|4|||
106057521|NCT03338998|365874382|FG001|Treatment Period|Subject failed swallow test|0|||
106057522|NCT03338998|365874381|FG000|Safety Follow-Up Period|Adverse Event|0|||
106057523|NCT03338998|365874382|FG001|Safety Follow-Up Period|Adverse Event|1|||
106057524|NCT03338998|365874381|FG000|Safety Follow-Up Period|Protocol deviation|1|||
106057525|NCT03338998|365874382|FG001|Safety Follow-Up Period|Protocol deviation|0|||
106057526|NCT03338998|365874381|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
106057527|NCT03338998|365874382|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
106057528|NCT00039130|365874383|FG000|Overall Study|Adverse Event|11|||
106057529|NCT00039130|365874383|FG000|Overall Study|Death|9|||
106057530|NCT00039130|365874383|FG000|Overall Study|Withdrawal by Subject|3|||
106057531|NCT00039130|365874383|FG000|Overall Study|Progression|2|||
106057532|NCT00039130|365874383|FG000|Overall Study|Subsequent treatment|2|||
106057533|NCT00039130|365874383|FG000|Overall Study|Physician Decision|3|||
106057534|NCT00279305|365874386|FG000|Overall Study|Pregnancy|1|||
106057535|NCT00279305|365874387|FG001|Overall Study|Pregnancy|0|||
106057536|NCT00279305|365874386|FG000|Overall Study|Withdrawal by Subject|2|||
106057537|NCT00279305|365874387|FG001|Overall Study|Withdrawal by Subject|0|||
106057538|NCT00279305|365874386|FG000|Overall Study|Dificulting establishing IV|1|||
106057539|NCT00279305|365874387|FG001|Overall Study|Dificulting establishing IV|0|||
106057540|NCT00279305|365874386|FG000|Overall Study|FDA Safety Alert|4|||
106057541|NCT00279305|365874387|FG001|Overall Study|FDA Safety Alert|1|||
106057542|NCT03930797|365874390|FG000|Overall Study|Lost to Follow-up|3|||
106057543|NCT03930797|365874391|FG001|Overall Study|Lost to Follow-up|10|||
106057544|NCT04706091|365874392|FG000|Treatment 2|Withdrawal by Subject|1|||
106057545|NCT04706091|365874393|FG001|Treatment 2|Withdrawal by Subject|0|||
106057546|NCT02612727|365874394|FG000|Overall Study|Parent request|4|||
106057547|NCT02612727|365874395|FG001|Overall Study|Parent request|1|||
106057548|NCT02612727|365874394|FG000|Overall Study|Needed treatment incompatible with PT|1|||
106057549|NCT02612727|365874395|FG001|Overall Study|Needed treatment incompatible with PT|1|||
106057550|NCT02612727|365874394|FG000|Overall Study|Direct hyperbilirubinemia|0|||
106057551|NCT02612727|365874395|FG001|Overall Study|Direct hyperbilirubinemia|2|||
106057552|NCT00753415|365874399|FG000|Part A|Disease progression|1|||
106057553|NCT00753415|365874400|FG001|Part A|Disease progression|0|||
106057554|NCT00753415|365874401|FG002|Part A|Disease progression|1|||
106057555|NCT00753415|365874402|FG003|Part A|Disease progression|2|||
106057556|NCT00753415|365874403|FG004|Part A|Disease progression|0|||
106057557|NCT00753415|365874404|FG005|Part A|Disease progression|0|||
106057558|NCT00753415|365874405|FG006|Part A|Disease progression|0|||
106057559|NCT00753415|365874406|FG007|Part A|Disease progression|0|||
106057560|NCT00753415|365874407|FG008|Part A|Disease progression|0|||
106057561|NCT00753415|365874408|FG009|Part A|Disease progression|0|||
106057562|NCT00753415|365874399|FG000|Part A|Withdrawal by Subject|0|||
106057563|NCT00753415|365874400|FG001|Part A|Withdrawal by Subject|0|||
106152530|NCT05198310|366218839|FG002|Overall Study|Withdrawal by Subject|0|||
106057564|NCT00753415|365874401|FG002|Part A|Withdrawal by Subject|1|||
106057565|NCT00753415|365874402|FG003|Part A|Withdrawal by Subject|0|||
106057566|NCT00753415|365874403|FG004|Part A|Withdrawal by Subject|0|||
106057567|NCT00753415|365874404|FG005|Part A|Withdrawal by Subject|0|||
106057568|NCT00753415|365874405|FG006|Part A|Withdrawal by Subject|0|||
106057569|NCT00753415|365874406|FG007|Part A|Withdrawal by Subject|0|||
106057570|NCT00753415|365874407|FG008|Part A|Withdrawal by Subject|0|||
106057571|NCT00753415|365874408|FG009|Part A|Withdrawal by Subject|0|||
106057572|NCT00753415|365874399|FG000|Part B|Lost to Follow-up|0|||
106057573|NCT00753415|365874400|FG001|Part B|Lost to Follow-up|0|||
106057574|NCT00753415|365874401|FG002|Part B|Lost to Follow-up|0|||
106057575|NCT00753415|365874402|FG003|Part B|Lost to Follow-up|0|||
106057576|NCT00753415|365874403|FG004|Part B|Lost to Follow-up|0|||
106152531|NCT05198310|366218840|FG003|Overall Study|Withdrawal by Subject|2|||
106057577|NCT00753415|365874404|FG005|Part B|Lost to Follow-up|0|||
106057578|NCT00753415|365874405|FG006|Part B|Lost to Follow-up|0|||
106057579|NCT00753415|365874406|FG007|Part B|Lost to Follow-up|1|||
106057580|NCT00753415|365874407|FG008|Part B|Lost to Follow-up|1|||
106057581|NCT00753415|365874408|FG009|Part B|Lost to Follow-up|0|||
106057582|NCT00753415|365874399|FG000|Part B|Disease progression|0|||
106057583|NCT00753415|365874400|FG001|Part B|Disease progression|0|||
106057584|NCT00753415|365874401|FG002|Part B|Disease progression|0|||
106057585|NCT00753415|365874402|FG003|Part B|Disease progression|0|||
106057586|NCT00753415|365874403|FG004|Part B|Disease progression|0|||
106057587|NCT00753415|365874404|FG005|Part B|Disease progression|0|||
106057588|NCT00753415|365874405|FG006|Part B|Disease progression|0|||
106057589|NCT00753415|365874406|FG007|Part B|Disease progression|0|||
106057590|NCT00753415|365874407|FG008|Part B|Disease progression|2|||
106057591|NCT00753415|365874408|FG009|Part B|Disease progression|1|||
106057592|NCT01405456|365874413|FG000|Overall Study|Lost to Follow-up|2|||
106057593|NCT01405456|365874414|FG001|Overall Study|Lost to Follow-up|1|||
106057594|NCT01405456|365874413|FG000|Overall Study|Physician Decision|1|||
106057595|NCT01405456|365874414|FG001|Overall Study|Physician Decision|0|||
106057596|NCT00307294|365876020|FG000|Overall Study|Withdrawal by Subject|1|||
106057597|NCT01664533|365876021|FG000|Overall Study|Death|42|||
106057598|NCT01664533|365876021|FG000|Overall Study|Lost to Follow-up|3|||
106057599|NCT01664533|365876021|FG000|Overall Study|Study termination|9|||
106057600|NCT01664533|365876021|FG000|Overall Study|Protocol Violation|3|||
106057601|NCT00290888|365876023|FG000|Overall Study|Physician Decision|3|||
106057602|NCT00290888|365876024|FG001|Overall Study|Physician Decision|1|||
106057603|NCT01581931|365876025|FG000|Washout|Adverse Event|0|||
106057604|NCT01581931|365876026|FG001|Washout|Adverse Event|1|||
106057605|NCT00907777|365876027|FG000|Overall Study|Withdrawal by Subject|0|||
106057606|NCT00907777|365876028|FG001|Overall Study|Withdrawal by Subject|1|||
106057607|NCT03292588|365876031|FG000|Overall Study|Death|1|||
106057608|NCT03292588|365876032|FG001|Overall Study|Death|0|||
106057609|NCT03292588|365876031|FG000|Overall Study|Lost to Follow-up|12|||
106057610|NCT03292588|365876032|FG001|Overall Study|Lost to Follow-up|16|||
106057611|NCT03292588|365876031|FG000|Overall Study|Physician Decision|0|||
106057612|NCT03292588|365876032|FG001|Overall Study|Physician Decision|1|||
106057613|NCT03292588|365876031|FG000|Overall Study|Withdrawal by Subject|4|||
106057614|NCT03292588|365876032|FG001|Overall Study|Withdrawal by Subject|4|||
106057615|NCT03292588|365876031|FG000|Overall Study|Move out of town|1|||
106057616|NCT03292588|365876032|FG001|Overall Study|Move out of town|0|||
106057617|NCT03292588|365876031|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
106057618|NCT03292588|365876032|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
106057619|NCT03766581|365876033|FG000|Randomization|Other reasons|2|||
106057620|NCT03766581|365876034|FG001|Randomization|Other reasons|1|||
106057621|NCT03766581|365876035|FG002|Randomization|Other reasons|0|||
106057622|NCT03766581|365876036|FG003|Randomization|Other reasons|1|||
106057623|NCT03766581|365876037|FG004|Randomization|Other reasons|0|||
106057624|NCT03766581|365876038|FG005|Randomization|Other reasons|0|||
106057625|NCT03766581|365876039|FG006|Randomization|Other reasons|0|||
106057626|NCT03766581|365876040|FG007|Randomization|Other reasons|0|||
106057627|NCT03766581|365876033|FG000|Randomization|Participant no longer meets study criteria|5|||
106057628|NCT03766581|365876034|FG001|Randomization|Participant no longer meets study criteria|3|||
106057629|NCT03766581|365876035|FG002|Randomization|Participant no longer meets study criteria|4|||
106152532|NCT05198310|366218841|FG004|Overall Study|Withdrawal by Subject|0|||
106152533|NCT05198310|366218842|FG005|Overall Study|Withdrawal by Subject|2|||
106152534|NCT05198310|366218843|FG006|Overall Study|Withdrawal by Subject|1|||
106152535|NCT05198310|366218844|FG007|Overall Study|Withdrawal by Subject|3|||
106152536|NCT04950127|366218851|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
106152537|NCT04950127|366218852|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
106152538|NCT04950127|366218853|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
106152539|NCT04950127|366218854|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
106152540|NCT04950127|366218855|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
106152541|NCT04950127|366218856|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
106152542|NCT04950127|366218851|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
106152543|NCT04950127|366218852|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
106152544|NCT04950127|366218853|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
106152545|NCT04950127|366218854|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
106057630|NCT03766581|365876036|FG003|Randomization|Participant no longer meets study criteria|0|||
106057631|NCT03766581|365876037|FG004|Randomization|Participant no longer meets study criteria|2|||
106057632|NCT03766581|365876038|FG005|Randomization|Participant no longer meets study criteria|3|||
106057633|NCT03766581|365876039|FG006|Randomization|Participant no longer meets study criteria|0|||
106057634|NCT03766581|365876040|FG007|Randomization|Participant no longer meets study criteria|1|||
106057635|NCT03766581|365876033|FG000|Randomization|Participant request to discontinue study treatment|1|||
106057636|NCT03766581|365876034|FG001|Randomization|Participant request to discontinue study treatment|0|||
106152546|NCT04950127|366218855|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
106152547|NCT04950127|366218856|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
106152548|NCT04950127|366218851|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
106057637|NCT03766581|365876035|FG002|Randomization|Participant request to discontinue study treatment|0|||
106057638|NCT03766581|365876036|FG003|Randomization|Participant request to discontinue study treatment|0|||
106057639|NCT03766581|365876037|FG004|Randomization|Participant request to discontinue study treatment|1|||
106057640|NCT03766581|365876038|FG005|Randomization|Participant request to discontinue study treatment|2|||
106057641|NCT03766581|365876039|FG006|Randomization|Participant request to discontinue study treatment|0|||
106057642|NCT03766581|365876040|FG007|Randomization|Participant request to discontinue study treatment|0|||
106057643|NCT03766581|365876033|FG000|Randomization|Participant withdrew consent|1|||
106057644|NCT03766581|365876034|FG001|Randomization|Participant withdrew consent|0|||
106057645|NCT03766581|365876035|FG002|Randomization|Participant withdrew consent|1|||
106057646|NCT03766581|365876036|FG003|Randomization|Participant withdrew consent|2|||
106057647|NCT03766581|365876037|FG004|Randomization|Participant withdrew consent|1|||
106057648|NCT03766581|365876038|FG005|Randomization|Participant withdrew consent|1|||
106057649|NCT03766581|365876039|FG006|Randomization|Participant withdrew consent|0|||
106057650|NCT03766581|365876040|FG007|Randomization|Participant withdrew consent|0|||
106057651|NCT03766581|365876033|FG000|Treatment|Adverse Event|82|||
106057652|NCT03766581|365876034|FG001|Treatment|Adverse Event|44|||
106057653|NCT03766581|365876035|FG002|Treatment|Adverse Event|47|||
106057654|NCT03766581|365876036|FG003|Treatment|Adverse Event|46|||
106057655|NCT03766581|365876037|FG004|Treatment|Adverse Event|50|||
106057656|NCT03766581|365876038|FG005|Treatment|Adverse Event|77|||
106057657|NCT03766581|365876039|FG006|Treatment|Adverse Event|5|||
106057658|NCT03766581|365876040|FG007|Treatment|Adverse Event|2|||
106057659|NCT03766581|365876033|FG000|Treatment|Participant request to discontinue treatment|34|||
106057660|NCT03766581|365876034|FG001|Treatment|Participant request to discontinue treatment|6|||
106057661|NCT03766581|365876035|FG002|Treatment|Participant request to discontinue treatment|10|||
106057662|NCT03766581|365876036|FG003|Treatment|Participant request to discontinue treatment|10|||
106057663|NCT03766581|365876037|FG004|Treatment|Participant request to discontinue treatment|14|||
106057664|NCT03766581|365876038|FG005|Treatment|Participant request to discontinue treatment|15|||
106057665|NCT03766581|365876039|FG006|Treatment|Participant request to discontinue treatment|0|||
106057666|NCT03766581|365876040|FG007|Treatment|Participant request to discontinue treatment|1|||
106057667|NCT03766581|365876033|FG000|Treatment|Participant withdrew consent|11|||
106057668|NCT03766581|365876034|FG001|Treatment|Participant withdrew consent|4|||
106057669|NCT03766581|365876035|FG002|Treatment|Participant withdrew consent|5|||
106057670|NCT03766581|365876036|FG003|Treatment|Participant withdrew consent|5|||
106057671|NCT03766581|365876037|FG004|Treatment|Participant withdrew consent|4|||
106057672|NCT03766581|365876038|FG005|Treatment|Participant withdrew consent|4|||
106057673|NCT03766581|365876039|FG006|Treatment|Participant withdrew consent|0|||
106057674|NCT03766581|365876040|FG007|Treatment|Participant withdrew consent|0|||
106057675|NCT03766581|365876033|FG000|Treatment|Death|1|||
106057676|NCT03766581|365876034|FG001|Treatment|Death|0|||
106057677|NCT03766581|365876035|FG002|Treatment|Death|0|||
106057678|NCT03766581|365876036|FG003|Treatment|Death|0|||
106152549|NCT04950127|366218852|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
106152550|NCT04950127|366218853|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
106152551|NCT04950127|366218854|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
106152552|NCT04950127|366218855|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
106152553|NCT04950127|366218856|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
106152554|NCT04950127|366218851|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
106057679|NCT03766581|365876037|FG004|Treatment|Death|0|||
106057680|NCT03766581|365876038|FG005|Treatment|Death|0|||
106152555|NCT04950127|366218852|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
106152556|NCT04950127|366218853|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
106152557|NCT04950127|366218854|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
106152558|NCT04950127|366218855|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
106152559|NCT04950127|366218856|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
106152560|NCT04950127|366218851|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
106152561|NCT04950127|366218852|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
106152562|NCT04950127|366218853|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
106152563|NCT04950127|366218854|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
106152564|NCT04950127|366218855|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
106152565|NCT04950127|366218856|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
106152566|NCT03833167|366218861|FG000|Overall Study|Withdrawal by Subject|4|||
106152567|NCT03833167|366218862|FG001|Overall Study|Withdrawal by Subject|6|||
106152568|NCT03833167|366218861|FG000|Overall Study|Ongoing|186|||
106152569|NCT03833167|366218862|FG001|Overall Study|Ongoing|194|||
106152570|NCT03833167|366218861|FG000|Overall Study|Lost to Follow-up|1|||
106152571|NCT03833167|366218862|FG001|Overall Study|Lost to Follow-up|1|||
106152572|NCT03833167|366218861|FG000|Overall Study|Physician Decision|0|||
106152573|NCT03833167|366218862|FG001|Overall Study|Physician Decision|2|||
106152574|NCT03833167|366218861|FG000|Overall Study|Death|34|||
106057681|NCT03766581|365876039|FG006|Treatment|Death|0|||
106057682|NCT03766581|365876040|FG007|Treatment|Death|0|||
106057683|NCT03766581|365876033|FG000|Treatment|Lost to Follow-up|1|||
106057684|NCT03766581|365876034|FG001|Treatment|Lost to Follow-up|0|||
106152575|NCT03833167|366218862|FG001|Overall Study|Death|22|||
106152576|NCT03271489|366218864|FG000|Double-Blind (DB) Period|Adverse Event|4|||
106152577|NCT03271489|366218865|FG001|Double-Blind (DB) Period|Adverse Event|1|||
106152578|NCT03271489|366218864|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
106152579|NCT03271489|366218865|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
106152580|NCT03271489|366218864|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
106152581|NCT03271489|366218865|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
106152582|NCT03271489|366218864|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
105864681|NCT02759692|365152987|FG000|Period 2|Lost to Follow-up|1|||
106057685|NCT03766581|365876035|FG002|Treatment|Lost to Follow-up|0|||
106057686|NCT03766581|365876036|FG003|Treatment|Lost to Follow-up|1|||
106057687|NCT03766581|365876037|FG004|Treatment|Lost to Follow-up|0|||
106057688|NCT03766581|365876038|FG005|Treatment|Lost to Follow-up|0|||
106057689|NCT03766581|365876039|FG006|Treatment|Lost to Follow-up|0|||
106057690|NCT03766581|365876040|FG007|Treatment|Lost to Follow-up|0|||
106057691|NCT03766581|365876033|FG000|Treatment|Poor/Non compliance|2|||
106057692|NCT03766581|365876034|FG001|Treatment|Poor/Non compliance|2|||
106057693|NCT03766581|365876035|FG002|Treatment|Poor/Non compliance|1|||
106057694|NCT03766581|365876036|FG003|Treatment|Poor/Non compliance|1|||
106057695|NCT03766581|365876037|FG004|Treatment|Poor/Non compliance|1|||
106057696|NCT03766581|365876038|FG005|Treatment|Poor/Non compliance|1|||
106057697|NCT03766581|365876039|FG006|Treatment|Poor/Non compliance|0|||
106057698|NCT03766581|365876040|FG007|Treatment|Poor/Non compliance|0|||
106057699|NCT03766581|365876033|FG000|Treatment|Participant no longer meets study criteria|9|||
106057700|NCT03766581|365876034|FG001|Treatment|Participant no longer meets study criteria|1|||
106057701|NCT03766581|365876035|FG002|Treatment|Participant no longer meets study criteria|5|||
106057702|NCT03766581|365876036|FG003|Treatment|Participant no longer meets study criteria|4|||
106057703|NCT03766581|365876037|FG004|Treatment|Participant no longer meets study criteria|4|||
106057704|NCT03766581|365876038|FG005|Treatment|Participant no longer meets study criteria|4|||
106057705|NCT03766581|365876039|FG006|Treatment|Participant no longer meets study criteria|2|||
106057706|NCT03766581|365876040|FG007|Treatment|Participant no longer meets study criteria|0|||
106057707|NCT03766581|365876033|FG000|Treatment|Other reasons|13|||
106057708|NCT03766581|365876034|FG001|Treatment|Other reasons|8|||
106057709|NCT03766581|365876035|FG002|Treatment|Other reasons|3|||
106057710|NCT03766581|365876036|FG003|Treatment|Other reasons|7|||
106057711|NCT03766581|365876037|FG004|Treatment|Other reasons|3|||
106057712|NCT03766581|365876038|FG005|Treatment|Other reasons|3|||
106057713|NCT03766581|365876039|FG006|Treatment|Other reasons|0|||
106057714|NCT03766581|365876040|FG007|Treatment|Other reasons|0|||
106057715|NCT02269241|365876041|FG000|Overall Study|Lost to Follow-up|269|||
106057716|NCT02269241|365876041|FG000|Overall Study|Withdrawal by Subject|155|||
106057717|NCT02269241|365876041|FG000|Overall Study|Protocol Violation|1|||
106057718|NCT02269241|365876041|FG000|Overall Study|Physician Decision|7|||
106057719|NCT02269241|365876041|FG000|Overall Study|Pregnancy|15|||
106057720|NCT02269241|365876041|FG000|Overall Study|Wish for pregnancy|5|||
106057721|NCT02269241|365876041|FG000|Overall Study|Development of an exclusion criteria|16|||
106057722|NCT02269241|365876041|FG000|Overall Study|Adverse Event|113|||
106057723|NCT02269241|365876041|FG000|Overall Study|At the specific request of the sponsor|20|||
106057724|NCT02269241|365876041|FG000|Overall Study|Several reasons not classified|53|||
106057725|NCT02269241|365876041|FG000|Overall Study|Screening failures|546|||
106057726|NCT02270957|365876042|FG000|Overall Study|Lack of Efficacy|2|||
106057727|NCT02270957|365876043|FG001|Overall Study|Lack of Efficacy|4|||
106057728|NCT02270957|365876042|FG000|Overall Study|Adverse Event|2|||
106057729|NCT02270957|365876043|FG001|Overall Study|Adverse Event|0|||
106057730|NCT04343261|365876044|FG000|Overall Study|Adverse Event|1|||
106057731|NCT04343261|365876044|FG000|Overall Study|received inadequate amount of antibodies|7|||
106057732|NCT02585960|365876045|FG000|PK/Safety Assessment Period|Physician Decision|0|||
106057733|NCT02585960|365876046|FG001|PK/Safety Assessment Period|Physician Decision|1|||
106057734|NCT02585960|365876047|FG002|PK/Safety Assessment Period|Physician Decision|0|||
106057735|NCT02585960|365876045|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
106057736|NCT02585960|365876046|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
105864682|NCT02759692|365152988|FG001|Period 2|Lost to Follow-up|0|||
105864683|NCT02759692|365152987|FG000|Period 2|Test article no longer available|0|||
105864684|NCT02759692|365152988|FG001|Period 2|Test article no longer available|1|||
105864685|NCT03207867|365152989|FG000|Overall Study|Adverse Event|1|||
106057737|NCT02585960|365876047|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
106057738|NCT02585960|365876045|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
106057739|NCT02585960|365876046|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
106057740|NCT02585960|365876047|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
106057741|NCT02585960|365876045|FG000|PK/Safety Assessment Period|Other|4|||
106057742|NCT02585960|365876046|FG001|PK/Safety Assessment Period|Other|4|||
106057743|NCT02585960|365876047|FG002|PK/Safety Assessment Period|Other|0|||
106057744|NCT02585960|365876045|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
106057745|NCT02585960|365876046|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
106057746|NCT02585960|365876047|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
106057747|NCT02585960|365876045|FG000|PK/Safety Assessment Period|Screen Failure|0|||
106057748|NCT02585960|365876046|FG001|PK/Safety Assessment Period|Screen Failure|0|||
106057749|NCT02585960|365876047|FG002|PK/Safety Assessment Period|Screen Failure|1|||
106057750|NCT02585960|365876045|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
106057751|NCT02585960|365876046|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
106057752|NCT02585960|365876047|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
106057753|NCT02585960|365876045|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
106057754|NCT02585960|365876046|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
106057755|NCT02585960|365876047|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
106057756|NCT00489541|365876048|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
106057757|NCT00489541|365876049|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
106057758|NCT00489541|365876048|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
106057759|NCT00489541|365876049|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
106057760|NCT00489541|365876048|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
106057761|NCT00489541|365876049|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
106057762|NCT00489541|365876048|FG000|12-Month Clinical Follow-up|Death|3|||
106057763|NCT00489541|365876049|FG001|12-Month Clinical Follow-up|Death|2|||
106057764|NCT00489541|365876048|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
106057765|NCT00489541|365876049|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
106057766|NCT00489541|365876048|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
106057767|NCT00489541|365876049|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
106057768|NCT02128113|365876052|FG000|Overall Study|Withdrawal by Subject|3|||
106057769|NCT02128113|365876053|FG001|Overall Study|Withdrawal by Subject|1|||
106057770|NCT02128113|365876054|FG002|Overall Study|Withdrawal by Subject|0|||
106057771|NCT02128113|365876052|FG000|Overall Study|Protocol Violation|0|||
106057772|NCT02128113|365876053|FG001|Overall Study|Protocol Violation|1|||
106057773|NCT02128113|365876054|FG002|Overall Study|Protocol Violation|0|||
106057774|NCT02128113|365876052|FG000|Overall Study|Surgery cancelled|0|||
106057775|NCT02128113|365876053|FG001|Overall Study|Surgery cancelled|1|||
106057776|NCT02128113|365876054|FG002|Overall Study|Surgery cancelled|0|||
106057777|NCT02128113|365876052|FG000|Overall Study|Adverse Event|0|||
106057778|NCT02128113|365876053|FG001|Overall Study|Adverse Event|0|||
106057779|NCT02128113|365876054|FG002|Overall Study|Adverse Event|1|||
106057780|NCT00299104|365876055|FG000|Treatment Period|Adverse Event|14|||
106057781|NCT00299104|365876056|FG001|Treatment Period|Adverse Event|9|||
106057782|NCT00299104|365876057|FG002|Treatment Period|Adverse Event|7|||
106057783|NCT00299104|365876055|FG000|Treatment Period|Death|1|||
106057784|NCT00299104|365876056|FG001|Treatment Period|Death|1|||
106057785|NCT00299104|365876057|FG002|Treatment Period|Death|1|||
106057786|NCT00299104|365876055|FG000|Treatment Period|Insufficient therapeutic response|34|||
106057787|NCT00299104|365876056|FG001|Treatment Period|Insufficient therapeutic response|13|||
106057788|NCT00299104|365876057|FG002|Treatment Period|Insufficient therapeutic response|8|||
106057789|NCT00299104|365876055|FG000|Treatment Period|Failure to return|9|||
106057790|NCT00299104|365876056|FG001|Treatment Period|Failure to return|8|||
106057791|NCT00299104|365876057|FG002|Treatment Period|Failure to return|8|||
106057792|NCT00299104|365876055|FG000|Treatment Period|Violation of selection criteria|1|||
106057793|NCT00299104|365876056|FG001|Treatment Period|Violation of selection criteria|2|||
106057794|NCT00299104|365876057|FG002|Treatment Period|Violation of selection criteria|0|||
106057795|NCT00299104|365876055|FG000|Treatment Period|Protocol Violation|1|||
106057796|NCT00299104|365876056|FG001|Treatment Period|Protocol Violation|1|||
106057797|NCT00299104|365876057|FG002|Treatment Period|Protocol Violation|0|||
106057798|NCT00299104|365876055|FG000|Treatment Period|Refused treatment|9|||
106057799|NCT00299104|365876056|FG001|Treatment Period|Refused treatment|2|||
106057800|NCT00299104|365876057|FG002|Treatment Period|Refused treatment|2|||
106057801|NCT00299104|365876055|FG000|Treatment Period|Withdrew consent|14|||
106057802|NCT00299104|365876056|FG001|Treatment Period|Withdrew consent|19|||
106057803|NCT00299104|365876057|FG002|Treatment Period|Withdrew consent|9|||
106057804|NCT00299104|365876055|FG000|Treatment Period|Administrative reasons|106|||
106057805|NCT00299104|365876056|FG001|Treatment Period|Administrative reasons|120|||
106057806|NCT00299104|365876057|FG002|Treatment Period|Administrative reasons|137|||
106057807|NCT00299104|365876055|FG000|Safety Follow-Up (SFU) Period|Death|3|||
106057808|NCT00299104|365876056|FG001|Safety Follow-Up (SFU) Period|Death|2|||
106057809|NCT00299104|365876057|FG002|Safety Follow-Up (SFU) Period|Death|1|||
106057810|NCT00299104|365876055|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
106057811|NCT00299104|365876056|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
106057812|NCT00299104|365876057|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
106057813|NCT00299104|365876055|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
106057814|NCT00299104|365876056|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
106057815|NCT00299104|365876057|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
106057816|NCT00299104|365876055|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
106057817|NCT00299104|365876056|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
106057818|NCT00299104|365876057|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
106057819|NCT00299104|365876055|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
106057820|NCT00299104|365876056|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
106057821|NCT00299104|365876057|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
106057822|NCT00299104|365876055|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
106057823|NCT00299104|365876056|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
106057824|NCT00299104|365876057|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
106057825|NCT00299104|365876055|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
106057826|NCT00299104|365876056|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
106057827|NCT00299104|365876057|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
106057828|NCT00299104|365876055|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
106057829|NCT00299104|365876056|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
106057830|NCT00299104|365876057|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
106057831|NCT00587054|365876067|FG000|Overall Study|Patient not treated|9|||
106057832|NCT03648541|365876068|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
106057833|NCT03648541|365876069|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
106057834|NCT03648541|365876068|FG000|Re-induction Period Only|Lack of Efficacy|7|||
106057835|NCT03648541|365876069|FG001|Re-induction Period Only|Lack of Efficacy|0|||
106057836|NCT03648541|365876068|FG000|Maintenance Period Only|Missing|0|||
106057837|NCT03648541|365876069|FG001|Maintenance Period Only|Missing|1|||
106057838|NCT03648541|365876068|FG000|Maintenance Period Only|Other not listed below|0|||
106057839|NCT03648541|365876069|FG001|Maintenance Period Only|Other not listed below|4|||
106057840|NCT03648541|365876068|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
106057841|NCT03648541|365876069|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
106057842|NCT03648541|365876068|FG000|Maintenance Period Only|Protocol Violation|0|||
106057843|NCT03648541|365876069|FG001|Maintenance Period Only|Protocol Violation|1|||
106057844|NCT03648541|365876068|FG000|Maintenance Period Only|Lack of Efficacy|0|||
106057845|NCT03648541|365876069|FG001|Maintenance Period Only|Lack of Efficacy|18|||
106057846|NCT03648541|365876068|FG000|Maintenance Period Only|Adverse Event|0|||
106057847|NCT03648541|365876069|FG001|Maintenance Period Only|Adverse Event|4|||
106057848|NCT03648541|365876068|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
106057849|NCT03648541|365876069|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
106057850|NCT04623216|365876072|FG000|Overall Study|Death|5|||
106057851|NCT04623216|365876073|FG001|Overall Study|Death|2|||
106057852|NCT04623216|365876074|FG002|Overall Study|Death|0|||
106057853|NCT04623216|365876075|FG003|Overall Study|Death|0|||
106057854|NCT04623216|365876072|FG000|Overall Study|Terminated by Sponsor|3|||
106057855|NCT04623216|365876073|FG001|Overall Study|Terminated by Sponsor|2|||
106057856|NCT04623216|365876074|FG002|Overall Study|Terminated by Sponsor|2|||
106057857|NCT04623216|365876075|FG003|Overall Study|Terminated by Sponsor|0|||
106057858|NCT04623216|365876072|FG000|Overall Study|Physician Decision|1|||
106057859|NCT04623216|365876073|FG001|Overall Study|Physician Decision|0|||
106057860|NCT04623216|365876074|FG002|Overall Study|Physician Decision|0|||
106057861|NCT04623216|365876075|FG003|Overall Study|Physician Decision|0|||
106057862|NCT01651039|365876076|FG000|Overall Study|Non-evaluables|5|||
106057863|NCT01651039|365876076|FG000|Overall Study|Physician Decision|2|||
106057864|NCT01651039|365876076|FG000|Overall Study|Withdrawal by Subject|1|||
106057865|NCT01651039|365876076|FG000|Overall Study|Progressive Disease|22|||
106057866|NCT01539538|365876077|FG000|Overall Study|Adverse Event|13|||
106057867|NCT01539538|365876078|FG001|Overall Study|Adverse Event|18|||
106057868|NCT01539538|365876077|FG000|Overall Study|Lack of Efficacy|13|||
106057869|NCT01539538|365876078|FG001|Overall Study|Lack of Efficacy|16|||
106057870|NCT01539538|365876077|FG000|Overall Study|Withdrawal by Subject|2|||
106057871|NCT01539538|365876078|FG001|Overall Study|Withdrawal by Subject|3|||
106057872|NCT01539538|365876077|FG000|Overall Study|PCA no longer required or PCA problem|3|||
106057873|NCT01539538|365876078|FG001|Overall Study|PCA no longer required or PCA problem|7|||
106057874|NCT03600818|365876082|FG000|Overall Study|Adverse Event|4|||
106057875|NCT03600818|365876083|FG001|Overall Study|Adverse Event|7|||
106057876|NCT03600818|365876082|FG000|Overall Study|Lack of Efficacy|9|||
106057877|NCT03600818|365876083|FG001|Overall Study|Lack of Efficacy|4|||
106057878|NCT03600818|365876082|FG000|Overall Study|Withdrawal by Subject|4|||
106057879|NCT03600818|365876083|FG001|Overall Study|Withdrawal by Subject|3|||
106057880|NCT03600818|365876082|FG000|Overall Study|Other-unspecified|5|||
106057881|NCT03600818|365876083|FG001|Overall Study|Other-unspecified|3|||
106057882|NCT03600818|365876082|FG000|Overall Study|Randomized and not treated|0|||
106057883|NCT03600818|365876083|FG001|Overall Study|Randomized and not treated|1|||
106057884|NCT00847379|365876086|FG000|Overall Study|Study terminated by Sponsor|59|||
106057885|NCT00847379|365876087|FG001|Overall Study|Study terminated by Sponsor|57|||
106057886|NCT00847379|365876088|FG002|Overall Study|Study terminated by Sponsor|57|||
106057887|NCT00134082|365876089|FG000|Overall Study|Adverse Event|2|||
106057888|NCT00134082|365876089|FG000|Overall Study|Death|1|||
106057889|NCT00521014|365876090|FG000|Overall Study|Inevaluable, not treated|1|||
106057890|NCT00003499|365876098|FG000|Overall Study|Not evaluable|8|||
106057891|NCT01727297|365876099|FG000|Overall Study|Death|13|||
106057892|NCT01727297|365876100|FG001|Overall Study|Death|0|||
106057893|NCT01727297|365876099|FG000|Overall Study|Protocol Violation|1|||
106057894|NCT01727297|365876100|FG001|Overall Study|Protocol Violation|10|||
106057895|NCT01727297|365876099|FG000|Overall Study|Adverse Event|3|||
106057896|NCT01727297|365876100|FG001|Overall Study|Adverse Event|1|||
106057897|NCT01727297|365876099|FG000|Overall Study|Lost to Follow-up|11|||
106057898|NCT01727297|365876100|FG001|Overall Study|Lost to Follow-up|0|||
106057899|NCT01727297|365876099|FG000|Overall Study|Withdrawal by Subject|26|||
106057900|NCT01727297|365876100|FG001|Overall Study|Withdrawal by Subject|27|||
106057901|NCT01727297|365876099|FG000|Overall Study|Physician Decision|19|||
106057902|NCT01727297|365876100|FG001|Overall Study|Physician Decision|5|||
106057903|NCT01727297|365876099|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
106057904|NCT01727297|365876100|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
106057905|NCT03782792|365876103|FG000|Overall Study|Patient left the country|0|||
106057906|NCT03782792|365876104|FG001|Overall Study|Patient left the country|1|||
106057907|NCT03782792|365876103|FG000|Overall Study|Withdrawal by Subject|1|||
106057908|NCT03782792|365876104|FG001|Overall Study|Withdrawal by Subject|2|||
106057909|NCT00814164|365876105|FG000|Overall Study|Progression|7|||
106057910|NCT00814164|365876105|FG000|Overall Study|not stated|7|||
106057911|NCT00814164|365876105|FG000|Overall Study|Death|5|||
106057912|NCT01854710|365876112|FG000|Overall Study|Withdrawal by Subject|2|||
106057913|NCT01854710|365876113|FG001|Overall Study|Withdrawal by Subject|1|||
106057914|NCT01854710|365876114|FG002|Overall Study|Withdrawal by Subject|0|||
106057915|NCT01854710|365876115|FG003|Overall Study|Withdrawal by Subject|0|||
106057916|NCT01854710|365876116|FG004|Overall Study|Withdrawal by Subject|0|||
106057917|NCT01854710|365876117|FG005|Overall Study|Withdrawal by Subject|0|||
106057918|NCT01854710|365876112|FG000|Overall Study|CRI procedural error|2|||
106057919|NCT01854710|365876113|FG001|Overall Study|CRI procedural error|2|||
106057920|NCT01854710|365876114|FG002|Overall Study|CRI procedural error|2|||
106057921|NCT01854710|365876115|FG003|Overall Study|CRI procedural error|2|||
106057922|NCT01854710|365876116|FG004|Overall Study|CRI procedural error|2|||
106057923|NCT01854710|365876117|FG005|Overall Study|CRI procedural error|2|||
106057924|NCT05228132|365876122|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
106057925|NCT05228132|365876122|FG000|Overall Study|Adverse Event|3|||
106057926|NCT05228132|365876122|FG000|Overall Study|Lost to Follow-up|1|||
106057927|NCT05228132|365876122|FG000|Overall Study|Arteriovenous-fistula mature|1|||
106057928|NCT04270747|365876123|FG000|Through Week 16|Adverse Event|1|||
106057929|NCT04270747|365876124|FG001|Through Week 16|Adverse Event|2|||
106057930|NCT04270747|365876125|FG002|Through Week 16|Adverse Event|0|||
106057931|NCT04270747|365876123|FG000|Through Week 16|Death|0|||
106057932|NCT04270747|365876124|FG001|Through Week 16|Death|2|||
106057933|NCT04270747|365876125|FG002|Through Week 16|Death|0|||
106057934|NCT04270747|365876123|FG000|Through Week 16|Consent Withdrawn|3|||
106057935|NCT04270747|365876124|FG001|Through Week 16|Consent Withdrawn|3|||
106057936|NCT04270747|365876125|FG002|Through Week 16|Consent Withdrawn|0|||
106057937|NCT04270747|365876123|FG000|Through Week 16|Physician Decision|1|||
106057938|NCT04270747|365876124|FG001|Through Week 16|Physician Decision|1|||
106057939|NCT04270747|365876125|FG002|Through Week 16|Physician Decision|0|||
106057940|NCT04270747|365876123|FG000|Through Week 16|Lost to Follow-up|2|||
106057941|NCT04270747|365876124|FG001|Through Week 16|Lost to Follow-up|0|||
106057942|NCT04270747|365876125|FG002|Through Week 16|Lost to Follow-up|0|||
106057943|NCT04270747|365876123|FG000|Through Week 16|Protocol Violation|1|||
106057944|NCT04270747|365876124|FG001|Through Week 16|Protocol Violation|2|||
106057945|NCT04270747|365876125|FG002|Through Week 16|Protocol Violation|0|||
106057946|NCT04270747|365876123|FG000|Through Week 16|Protocol Specified Criteria|6|||
106057947|NCT04270747|365876124|FG001|Through Week 16|Protocol Specified Criteria|7|||
106057948|NCT04270747|365876125|FG002|Through Week 16|Protocol Specified Criteria|0|||
106057949|NCT04270747|365876123|FG000|Through Week 16|Miscellaneous|1|||
106057950|NCT04270747|365876124|FG001|Through Week 16|Miscellaneous|1|||
106057951|NCT04270747|365876125|FG002|Through Week 16|Miscellaneous|0|||
106057952|NCT04270747|365876123|FG000|Post Week 16|Adverse Event|7|||
106057953|NCT04270747|365876124|FG001|Post Week 16|Adverse Event|5|||
106057954|NCT04270747|365876125|FG002|Post Week 16|Adverse Event|1|||
106057955|NCT04270747|365876123|FG000|Post Week 16|Death|2|||
106057956|NCT04270747|365876124|FG001|Post Week 16|Death|0|||
106057957|NCT04270747|365876125|FG002|Post Week 16|Death|2|||
106057958|NCT04270747|365876123|FG000|Post Week 16|Consent Withdrawn|4|||
106057959|NCT04270747|365876124|FG001|Post Week 16|Consent Withdrawn|3|||
106057960|NCT04270747|365876125|FG002|Post Week 16|Consent Withdrawn|6|||
106057961|NCT04270747|365876123|FG000|Post Week 16|Physician Decision|3|||
106057962|NCT04270747|365876124|FG001|Post Week 16|Physician Decision|1|||
106057963|NCT04270747|365876125|FG002|Post Week 16|Physician Decision|1|||
106057964|NCT04270747|365876123|FG000|Post Week 16|Lost to Follow-up|2|||
106057965|NCT04270747|365876124|FG001|Post Week 16|Lost to Follow-up|1|||
106057966|NCT04270747|365876125|FG002|Post Week 16|Lost to Follow-up|0|||
106057967|NCT04270747|365876123|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
106057968|NCT04270747|365876124|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
106057969|NCT04270747|365876125|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
106057970|NCT04270747|365876123|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
106057971|NCT04270747|365876124|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
106057972|NCT04270747|365876125|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
106057973|NCT04270747|365876123|FG000|Post Week 16|Miscellaneous|1|||
106057974|NCT04270747|365876124|FG001|Post Week 16|Miscellaneous|0|||
106057975|NCT04270747|365876125|FG002|Post Week 16|Miscellaneous|1|||
106057976|NCT05025241|365876126|FG000|Screening|Failed Screening|5|||
106057977|NCT05025241|365876126|FG000|Treatment and Follow Up|Adverse Event|3|||
106057978|NCT04605484|365876127|FG000|Overall Study|Lost to Follow-up|0|||
106057979|NCT04605484|365876128|FG001|Overall Study|Lost to Follow-up|1|||
106057980|NCT04605484|365876129|FG002|Overall Study|Lost to Follow-up|1|||
106057981|NCT04605484|365876127|FG000|Overall Study|Other|0|||
106057982|NCT04605484|365876128|FG001|Overall Study|Other|1|||
106057983|NCT04605484|365876129|FG002|Overall Study|Other|0|||
106057984|NCT05683249|365876132|FG000|Overall Study|Adverse Event|3|||
106057985|NCT05683249|365876133|FG001|Overall Study|Adverse Event|1|||
106057986|NCT05683249|365876132|FG000|Overall Study|Lack of Efficacy|0|||
106057987|NCT05683249|365876133|FG001|Overall Study|Lack of Efficacy|2|||
106057988|NCT05683249|365876132|FG000|Overall Study|Lost to Follow-up|6|||
106057989|NCT05683249|365876133|FG001|Overall Study|Lost to Follow-up|5|||
106057990|NCT05683249|365876132|FG000|Overall Study|Non-compliance with Study Drug|2|||
106057991|NCT05683249|365876133|FG001|Overall Study|Non-compliance with Study Drug|0|||
106057992|NCT05683249|365876132|FG000|Overall Study|Protocol Violation|6|||
106057993|NCT05683249|365876133|FG001|Overall Study|Protocol Violation|3|||
106057994|NCT05683249|365876132|FG000|Overall Study|Withdrawal by Subject|9|||
106057995|NCT05683249|365876133|FG001|Overall Study|Withdrawal by Subject|8|||
106057996|NCT05683249|365876132|FG000|Overall Study|Other|0|||
106057997|NCT05683249|365876133|FG001|Overall Study|Other|2|||
106057998|NCT01217814|365876135|FG000|Overall Study|Adverse Event|1|||
106057999|NCT01217814|365876136|FG001|Overall Study|Adverse Event|1|||
106058000|NCT01217814|365876137|FG002|Overall Study|Adverse Event|0|||
106058001|NCT01217814|365876135|FG000|Overall Study|Lack of Efficacy|0|||
106058002|NCT01217814|365876136|FG001|Overall Study|Lack of Efficacy|0|||
106058003|NCT01217814|365876137|FG002|Overall Study|Lack of Efficacy|1|||
106058004|NCT00729651|365876138|FG000|Overall Study|Withdrawal by Subject|5|||
106058005|NCT00729651|365876139|FG001|Overall Study|Withdrawal by Subject|6|||
106058006|NCT00729651|365876138|FG000|Overall Study|Lost to Follow-up|5|||
106058007|NCT00729651|365876139|FG001|Overall Study|Lost to Follow-up|4|||
106058008|NCT00729651|365876138|FG000|Overall Study|Protocol Violation|0|||
106058009|NCT00729651|365876139|FG001|Overall Study|Protocol Violation|1|||
106058010|NCT00729651|365876138|FG000|Overall Study|Adverse Event|7|||
106058011|NCT00729651|365876139|FG001|Overall Study|Adverse Event|3|||
106058012|NCT00729651|365876138|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
106058013|NCT00729651|365876139|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
106058014|NCT00729651|365876138|FG000|Overall Study|Subject's private reason|2|||
106058015|NCT00729651|365876139|FG001|Overall Study|Subject's private reason|0|||
106058016|NCT02925494|365876140|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
106058017|NCT02925494|365876141|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
106058018|NCT02925494|365876142|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
106058019|NCT02925494|365876143|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
106058020|NCT02925494|365876140|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
106058021|NCT02925494|365876141|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
106058022|NCT02925494|365876142|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
106058023|NCT02925494|365876143|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
106058024|NCT02925494|365876140|FG000|Post-Treatment Follow-Up Period|Other|1|||
106058025|NCT02925494|365876141|FG001|Post-Treatment Follow-Up Period|Other|4|||
106058026|NCT02925494|365876142|FG002|Post-Treatment Follow-Up Period|Other|3|||
106058027|NCT02925494|365876143|FG003|Post-Treatment Follow-Up Period|Other|6|||
106058028|NCT02925494|365876140|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
106058029|NCT02925494|365876141|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
106058030|NCT02925494|365876142|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
106058031|NCT02925494|365876143|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
106058032|NCT02925494|365876140|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
105864686|NCT03207867|365152990|FG001|Overall Study|Adverse Event|0|||
105864687|NCT03207867|365152991|FG002|Overall Study|Adverse Event|1|||
106058033|NCT02925494|365876141|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
106058034|NCT02925494|365876142|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
106058035|NCT02925494|365876143|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
106058036|NCT02925494|365876140|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
106058037|NCT02925494|365876141|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
106058038|NCT02925494|365876142|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
106058039|NCT02925494|365876143|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
106058040|NCT02925494|365876140|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
106058041|NCT02925494|365876141|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
106058042|NCT02925494|365876142|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
106058043|NCT02925494|365876143|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
106058044|NCT01637272|365876145|FG000|Overall Study|Adverse Event|6|||
106058045|NCT01637272|365876145|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106058046|NCT01637272|365876145|FG000|Overall Study|Withdrawal by Subject|3|||
106058047|NCT01637272|365876145|FG000|Overall Study|Lost to Follow-up|2|||
106058048|NCT01637272|365876145|FG000|Overall Study|completed core, did not enter ext. phase|4|||
106058049|NCT01637272|365876145|FG000|Overall Study|Administrative problems|1|||
106058050|NCT01637272|365876145|FG000|Overall Study|Protocol Violation|2|||
106058051|NCT01496612|365876146|FG000|1st Intervention|Adverse Event|1|||
106058052|NCT01496612|365876147|FG001|1st Intervention|Adverse Event|0|||
106058053|NCT01496612|365876146|FG000|1st Intervention|Withdrawal by Subject|1|||
106058054|NCT01496612|365876147|FG001|1st Intervention|Withdrawal by Subject|0|||
106058055|NCT04584645|365876148|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
106058056|NCT04584645|365876149|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
106058057|NCT02439138|365876157|FG000|Overall Study|Adverse Event|1|||
106058058|NCT02439138|365876157|FG000|Overall Study|PI decision to terminate the study|2|||
106058059|NCT02521870|365876160|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058060|NCT02521870|365876161|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
106058061|NCT02521870|365876162|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058062|NCT02521870|365876163|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058063|NCT02521870|365876164|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058064|NCT02521870|365876165|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058065|NCT02521870|365876166|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058066|NCT02521870|365876167|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058067|NCT02521870|365876168|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058068|NCT02521870|365876169|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058069|NCT02521870|365876170|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058070|NCT02521870|365876171|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106058071|NCT02521870|365876160|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
106058072|NCT02521870|365876161|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
106058073|NCT02521870|365876162|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
106058074|NCT02521870|365876163|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
106058075|NCT02521870|365876164|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
106058076|NCT02521870|365876165|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
106058077|NCT02521870|365876166|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
106058078|NCT02521870|365876167|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
106058079|NCT02521870|365876168|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
106058080|NCT02521870|365876169|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
106058081|NCT02521870|365876170|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
106058082|NCT02521870|365876171|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
106058083|NCT02521870|365876160|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
106058084|NCT02521870|365876161|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
106058085|NCT02521870|365876162|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
106058086|NCT02521870|365876163|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
106058087|NCT02521870|365876164|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
106058088|NCT02521870|365876165|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
106058089|NCT02521870|365876166|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
106058090|NCT02521870|365876167|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
106058091|NCT02521870|365876168|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
106058092|NCT02521870|365876169|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
106058093|NCT02521870|365876170|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
106058094|NCT02521870|365876171|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
106058095|NCT02521870|365876160|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106058096|NCT02521870|365876161|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106152583|NCT03271489|366218865|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
106058097|NCT02521870|365876162|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106058098|NCT02521870|365876163|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106058099|NCT02521870|365876164|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
106058100|NCT02521870|365876165|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
106152584|NCT03271489|366218864|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
106058101|NCT02521870|365876166|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
106058102|NCT02521870|365876167|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106058103|NCT02521870|365876168|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
106058104|NCT02521870|365876169|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
106058105|NCT02521870|365876170|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
106058106|NCT02521870|365876171|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106058107|NCT02521870|365876160|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
106058108|NCT02521870|365876161|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
106058109|NCT02521870|365876162|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
106058110|NCT02521870|365876163|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
106058111|NCT02521870|365876164|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
106058112|NCT02521870|365876165|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
106058113|NCT02521870|365876166|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
106058114|NCT02521870|365876167|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
106058115|NCT02521870|365876168|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
106058116|NCT02521870|365876169|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
106058117|NCT02521870|365876170|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
106058118|NCT02521870|365876171|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
106058119|NCT02521870|365876160|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
106058120|NCT02521870|365876161|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
106058121|NCT02521870|365876162|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
106058122|NCT02521870|365876163|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
106058123|NCT02521870|365876164|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
106058124|NCT02521870|365876165|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
106058125|NCT02521870|365876166|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
106058126|NCT02521870|365876167|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
106058127|NCT02521870|365876168|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
106058128|NCT02521870|365876169|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
106058129|NCT02521870|365876170|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
106058130|NCT02521870|365876171|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
106058131|NCT02521870|365876160|FG000|Phase 2: Dose Expansion|Death|0|||
106058132|NCT02521870|365876161|FG001|Phase 2: Dose Expansion|Death|0|||
106058133|NCT02521870|365876162|FG002|Phase 2: Dose Expansion|Death|0|||
106058134|NCT02521870|365876163|FG003|Phase 2: Dose Expansion|Death|0|||
106058135|NCT02521870|365876164|FG004|Phase 2: Dose Expansion|Death|1|||
106058136|NCT02521870|365876165|FG005|Phase 2: Dose Expansion|Death|1|||
106058137|NCT02521870|365876166|FG006|Phase 2: Dose Expansion|Death|3|||
106058138|NCT02521870|365876167|FG007|Phase 2: Dose Expansion|Death|1|||
106058139|NCT02521870|365876168|FG008|Phase 2: Dose Expansion|Death|1|||
106058140|NCT02521870|365876169|FG009|Phase 2: Dose Expansion|Death|5|||
106058141|NCT02521870|365876170|FG010|Phase 2: Dose Expansion|Death|2|||
106058142|NCT02521870|365876171|FG011|Phase 2: Dose Expansion|Death|2|||
106058143|NCT02521870|365876160|FG000|Phase 2: Dose Expansion|Other|0|||
106058144|NCT02521870|365876161|FG001|Phase 2: Dose Expansion|Other|0|||
106058145|NCT02521870|365876162|FG002|Phase 2: Dose Expansion|Other|0|||
106058146|NCT02521870|365876163|FG003|Phase 2: Dose Expansion|Other|0|||
106058147|NCT02521870|365876164|FG004|Phase 2: Dose Expansion|Other|10|||
106058148|NCT02521870|365876165|FG005|Phase 2: Dose Expansion|Other|3|||
106058149|NCT02521870|365876166|FG006|Phase 2: Dose Expansion|Other|2|||
106058150|NCT02521870|365876167|FG007|Phase 2: Dose Expansion|Other|0|||
106058151|NCT02521870|365876168|FG008|Phase 2: Dose Expansion|Other|10|||
106058152|NCT02521870|365876169|FG009|Phase 2: Dose Expansion|Other|5|||
106058153|NCT02521870|365876170|FG010|Phase 2: Dose Expansion|Other|1|||
106058154|NCT02521870|365876171|FG011|Phase 2: Dose Expansion|Other|7|||
106058155|NCT02521870|365876160|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058156|NCT02521870|365876161|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058157|NCT02521870|365876162|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058158|NCT02521870|365876163|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058159|NCT02521870|365876164|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
106058160|NCT02521870|365876165|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058161|NCT02521870|365876166|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058162|NCT02521870|365876167|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058163|NCT02521870|365876168|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058164|NCT02521870|365876169|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058165|NCT02521870|365876170|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058166|NCT02521870|365876171|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106058167|NCT02521870|365876160|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106152585|NCT03271489|366218865|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
106058168|NCT02521870|365876161|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058169|NCT02521870|365876162|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058170|NCT02521870|365876163|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058171|NCT02521870|365876164|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
106058172|NCT02521870|365876165|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058173|NCT02521870|365876166|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058174|NCT02521870|365876167|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058175|NCT02521870|365876168|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058176|NCT02521870|365876169|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058177|NCT02521870|365876170|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058178|NCT02521870|365876171|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
106058179|NCT03200860|365876172|FG000|Overall Study|Withdrawal by Subject|1|||
106058180|NCT03200860|365876173|FG001|Overall Study|Withdrawal by Subject|0|||
106058181|NCT01744197|365876177|FG000|Overall Study|Received 1 patch|2|||
106058182|NCT01744197|365876178|FG001|Overall Study|Received 1 patch|1|||
106058183|NCT01744197|365876177|FG000|Overall Study|No patch received|2|||
106058184|NCT01744197|365876178|FG001|Overall Study|No patch received|2|||
106058185|NCT01325584|365876179|FG000|Overall Study|Death|1|||
106058186|NCT00887978|365876180|FG000|Overall Study|Adverse Event|18|||
106058187|NCT00887978|365876181|FG001|Overall Study|Adverse Event|5|||
106058188|NCT00887978|365876180|FG000|Overall Study|Clinical Worsening|4|||
106058189|NCT00887978|365876181|FG001|Overall Study|Clinical Worsening|4|||
106058190|NCT00887978|365876180|FG000|Overall Study|Death|2|||
106058191|NCT00887978|365876181|FG001|Overall Study|Death|3|||
106058192|NCT00887978|365876180|FG000|Overall Study|Withdrawal by Subject|1|||
106058193|NCT00887978|365876181|FG001|Overall Study|Withdrawal by Subject|2|||
106058194|NCT00887978|365876180|FG000|Overall Study|Lost to Follow-up|0|||
106058195|NCT00887978|365876181|FG001|Overall Study|Lost to Follow-up|1|||
106058196|NCT01473836|365877748|FG000|Overall Study|Adverse Event|4|||
106058197|NCT01473836|365877748|FG000|Overall Study|Lack of Efficacy|1|||
106058198|NCT01473836|365877748|FG000|Overall Study|Does not meet entrance criteria|1|||
106058199|NCT03291808|365877749|FG000|Overall Study|Lost to Follow-up|6|||
106058200|NCT03291808|365877749|FG000|Overall Study|Research burden|4|||
106058201|NCT00964860|365877756|FG000|Overall Study|Withdrawal by Subject|0|||
106058202|NCT00964860|365877757|FG001|Overall Study|Withdrawal by Subject|1|||
106058203|NCT03462082|365877761|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
106058204|NCT03462082|365877762|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
106058205|NCT03462082|365877763|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
106058206|NCT03462082|365877764|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
106058207|NCT03462082|365877765|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
106058208|NCT03462082|365877766|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
106058209|NCT03462082|365877767|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
106058210|NCT03462082|365877768|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
106058211|NCT00284050|365877769|FG000|Overall Study|Adverse Event|1|||
106058212|NCT00284050|365877770|FG001|Overall Study|Adverse Event|1|||
106058213|NCT00284050|365877771|FG002|Overall Study|Adverse Event|1|||
106058214|NCT00284050|365877769|FG000|Overall Study|Lack of Efficacy|0|||
106058215|NCT00284050|365877770|FG001|Overall Study|Lack of Efficacy|1|||
106058216|NCT00284050|365877771|FG002|Overall Study|Lack of Efficacy|3|||
106058217|NCT00284050|365877769|FG000|Overall Study|Protocol Violation|0|||
106058218|NCT00284050|365877770|FG001|Overall Study|Protocol Violation|1|||
106058219|NCT00284050|365877771|FG002|Overall Study|Protocol Violation|2|||
106058220|NCT00284050|365877769|FG000|Overall Study|Withdrawal by Subject|2|||
106058221|NCT00284050|365877770|FG001|Overall Study|Withdrawal by Subject|2|||
106058222|NCT00284050|365877771|FG002|Overall Study|Withdrawal by Subject|2|||
106058223|NCT00284050|365877769|FG000|Overall Study|Lost to Follow-up|1|||
106058224|NCT00284050|365877770|FG001|Overall Study|Lost to Follow-up|0|||
106058225|NCT00284050|365877771|FG002|Overall Study|Lost to Follow-up|1|||
106058226|NCT00284050|365877769|FG000|Overall Study|Death|1|||
106058227|NCT00284050|365877770|FG001|Overall Study|Death|0|||
106058228|NCT00284050|365877771|FG002|Overall Study|Death|0|||
106058229|NCT00166114|365877772|FG000|Overall Study|Protocol Violation|2|||
106058230|NCT00166114|365877773|FG001|Overall Study|Protocol Violation|1|||
106058231|NCT00166114|365877772|FG000|Overall Study|Withdrawal by Subject|10|||
106058232|NCT00166114|365877773|FG001|Overall Study|Withdrawal by Subject|4|||
106058233|NCT00166114|365877772|FG000|Overall Study|Adverse Event|2|||
106058234|NCT00166114|365877773|FG001|Overall Study|Adverse Event|1|||
106058235|NCT02548650|365877784|FG000|Triple Therapy|Adverse Event|1|||
106058236|NCT02548650|365877785|FG001|Triple Therapy|Adverse Event|0|||
106058237|NCT02548650|365877784|FG000|Triple Therapy|Withdrawal by Subject|0|||
106058238|NCT02548650|365877785|FG001|Triple Therapy|Withdrawal by Subject|4|||
106058239|NCT02548650|365877784|FG000|Double Therapy|Adverse Event|1|||
106058240|NCT02548650|365877785|FG001|Double Therapy|Adverse Event|1|||
106152586|NCT03271489|366218864|FG000|Double-Blind (DB) Period|Other|6|||
106058241|NCT02548650|365877784|FG000|Double Therapy|Withdrawal by Subject|0|||
106058242|NCT02548650|365877785|FG001|Double Therapy|Withdrawal by Subject|1|||
106058243|NCT01191801|365877786|FG000|Overall Study|Death|36|||
106058244|NCT01191801|365877787|FG001|Overall Study|Death|12|||
106058245|NCT01191801|365877786|FG000|Overall Study|Lack of Efficacy|176|||
106058246|NCT01191801|365877787|FG001|Overall Study|Lack of Efficacy|258|||
106058247|NCT01191801|365877786|FG000|Overall Study|Adverse Event|9|||
106058248|NCT01191801|365877787|FG001|Overall Study|Adverse Event|8|||
106058249|NCT01191801|365877786|FG000|Overall Study|Protocol Violation|2|||
106058250|NCT01191801|365877787|FG001|Overall Study|Protocol Violation|4|||
106058251|NCT01191801|365877786|FG000|Overall Study|Physician Decision|47|||
106058252|NCT01191801|365877787|FG001|Overall Study|Physician Decision|24|||
106058253|NCT01191801|365877786|FG000|Overall Study|Withdrawal by Subject|1|||
106058254|NCT01191801|365877787|FG001|Overall Study|Withdrawal by Subject|4|||
106058255|NCT01191801|365877786|FG000|Overall Study|Not Provided|45|||
106058256|NCT01191801|365877787|FG001|Overall Study|Not Provided|27|||
106058257|NCT02042183|365877792|FG000|Overall Study|Physician Decision|7|||
106058258|NCT02042183|365877793|FG001|Overall Study|Physician Decision|2|||
106058259|NCT02042183|365877792|FG000|Overall Study|Lack of Efficacy|4|||
106058260|NCT02042183|365877793|FG001|Overall Study|Lack of Efficacy|3|||
106058261|NCT02042183|365877792|FG000|Overall Study|Non-compliance with Study Drug|2|||
106058262|NCT02042183|365877793|FG001|Overall Study|Non-compliance with Study Drug|3|||
106058263|NCT02042183|365877792|FG000|Overall Study|Adverse Event|17|||
106058264|NCT02042183|365877793|FG001|Overall Study|Adverse Event|6|||
106058265|NCT02042183|365877792|FG000|Overall Study|Other|3|||
106058266|NCT02042183|365877793|FG001|Overall Study|Other|3|||
106058267|NCT02042183|365877792|FG000|Overall Study|Withdrawal by Subject|21|||
106058268|NCT02042183|365877793|FG001|Overall Study|Withdrawal by Subject|16|||
106058269|NCT02042183|365877792|FG000|Overall Study|Site Terminated by Sponsor|2|||
106058270|NCT02042183|365877793|FG001|Overall Study|Site Terminated by Sponsor|1|||
106058271|NCT02042183|365877792|FG000|Overall Study|Lost to Follow-up|9|||
106058272|NCT02042183|365877793|FG001|Overall Study|Lost to Follow-up|2|||
106058273|NCT00407797|365877798|FG000|Overall Study|Lost to Follow-up|2|||
106058274|NCT00407797|365877798|FG000|Overall Study|Adverse Event|6|||
106058275|NCT00407797|365877798|FG000|Overall Study|Other|7|||
106058276|NCT00407797|365877798|FG000|Overall Study|Withdrawal by Subject|3|||
106058277|NCT00553644|365877799|FG000|Overall Study|Adverse Event|17|||
106058278|NCT00553644|365877799|FG000|Overall Study|Withdrawal by Subject|4|||
106058279|NCT00553644|365877799|FG000|Overall Study|Physician Decision|1|||
106058280|NCT00553644|365877799|FG000|Overall Study|Alternative therapy|6|||
106058281|NCT01619423|365877800|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
106058282|NCT01619423|365877801|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
106058283|NCT01619423|365877802|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
106058284|NCT01619423|365877803|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
106058285|NCT00851747|365877806|FG000|Overall Study|Physician Decision|6|||
106058286|NCT00851747|365877807|FG001|Overall Study|Physician Decision|6|||
106058287|NCT00851747|365877808|FG002|Overall Study|Physician Decision|6|||
106058288|NCT02321800|365877809|FG000|Overall Study|Withdrawal by Subject|3|||
106058289|NCT02321800|365877810|FG001|Overall Study|Withdrawal by Subject|3|||
106058290|NCT02321800|365877809|FG000|Overall Study|Death|1|||
106058291|NCT02321800|365877810|FG001|Overall Study|Death|0|||
106058292|NCT02321800|365877809|FG000|Overall Study|Protocol Violation|1|||
106058293|NCT02321800|365877810|FG001|Overall Study|Protocol Violation|0|||
106058294|NCT02321800|365877809|FG000|Overall Study|Lost to Follow-up|10|||
106058295|NCT02321800|365877810|FG001|Overall Study|Lost to Follow-up|4|||
106058296|NCT02321800|365877809|FG000|Overall Study|Adverse Event|2|||
106058297|NCT02321800|365877810|FG001|Overall Study|Adverse Event|3|||
106058298|NCT02321800|365877809|FG000|Overall Study|Other, Miscellaneous|3|||
106058299|NCT02321800|365877810|FG001|Overall Study|Other, Miscellaneous|1|||
106058300|NCT02340975|365877811|FG000|Overall Study|Death|6|||
106058301|NCT02340975|365877812|FG001|Overall Study|Death|23|||
106058302|NCT02340975|365877813|FG002|Overall Study|Death|21|||
106058303|NCT02340975|365877814|FG003|Overall Study|Death|7|||
106058304|NCT02340975|365877815|FG004|Overall Study|Death|21|||
106058305|NCT02340975|365877816|FG005|Overall Study|Death|13|||
106058306|NCT02340975|365877811|FG000|Overall Study|Lost to Follow-up|0|||
106058307|NCT02340975|365877812|FG001|Overall Study|Lost to Follow-up|0|||
106058308|NCT02340975|365877813|FG002|Overall Study|Lost to Follow-up|0|||
106058309|NCT02340975|365877814|FG003|Overall Study|Lost to Follow-up|0|||
106058310|NCT02340975|365877815|FG004|Overall Study|Lost to Follow-up|2|||
106058311|NCT02340975|365877816|FG005|Overall Study|Lost to Follow-up|0|||
106058312|NCT02340975|365877811|FG000|Overall Study|Withdrawal by Subject|0|||
106058313|NCT02340975|365877812|FG001|Overall Study|Withdrawal by Subject|0|||
106058314|NCT02340975|365877813|FG002|Overall Study|Withdrawal by Subject|3|||
106058315|NCT02340975|365877814|FG003|Overall Study|Withdrawal by Subject|3|||
106058316|NCT02340975|365877815|FG004|Overall Study|Withdrawal by Subject|2|||
106058317|NCT02340975|365877816|FG005|Overall Study|Withdrawal by Subject|0|||
106058318|NCT02340975|365877811|FG000|Overall Study|Other|0|||
106058319|NCT02340975|365877812|FG001|Overall Study|Other|4|||
106058320|NCT02340975|365877813|FG002|Overall Study|Other|0|||
106058321|NCT02340975|365877814|FG003|Overall Study|Other|2|||
106058322|NCT02340975|365877815|FG004|Overall Study|Other|0|||
106058323|NCT02340975|365877816|FG005|Overall Study|Other|6|||
106058324|NCT00982878|365877820|FG000|Overall Study|Physician Decision|1|||
106058325|NCT03132220|365877821|FG000|Overall Study|Lost to Follow-up|17|||
106058326|NCT03132220|365877822|FG001|Overall Study|Lost to Follow-up|8|||
106058327|NCT03132220|365877821|FG000|Overall Study|Withdrawal by Subject|1|||
106058328|NCT03132220|365877822|FG001|Overall Study|Withdrawal by Subject|4|||
106058329|NCT01169493|365877823|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
106058330|NCT01169493|365877824|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
106058331|NCT01169493|365877825|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
106058332|NCT01169493|365877826|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
106058333|NCT01169493|365877827|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
106058334|NCT01169493|365877828|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
106058335|NCT01169493|365877823|FG000|Period 3 (6 Months)|Adverse Event|0|||
106058336|NCT01169493|365877824|FG001|Period 3 (6 Months)|Adverse Event|1|||
106058337|NCT01169493|365877825|FG002|Period 3 (6 Months)|Adverse Event|0|||
106058338|NCT01169493|365877826|FG003|Period 3 (6 Months)|Adverse Event|0|||
106058339|NCT01169493|365877827|FG004|Period 3 (6 Months)|Adverse Event|0|||
106058340|NCT01169493|365877828|FG005|Period 3 (6 Months)|Adverse Event|0|||
106058341|NCT01169493|365877823|FG000|Period 3 (6 Months)|Physician Decision|0|||
106058342|NCT01169493|365877824|FG001|Period 3 (6 Months)|Physician Decision|1|||
106058343|NCT01169493|365877825|FG002|Period 3 (6 Months)|Physician Decision|1|||
106058344|NCT01169493|365877826|FG003|Period 3 (6 Months)|Physician Decision|0|||
106058345|NCT01169493|365877827|FG004|Period 3 (6 Months)|Physician Decision|0|||
106058346|NCT01169493|365877828|FG005|Period 3 (6 Months)|Physician Decision|0|||
106058347|NCT01336764|365877829|FG000|Overall Study|Withdrawal by Subject|5|||
106058348|NCT01336764|365877830|FG001|Overall Study|Withdrawal by Subject|5|||
106058349|NCT01906008|365877835|FG000|Overall Study|Lost to Follow-up|2|||
106058350|NCT01906008|365877836|FG001|Overall Study|Lost to Follow-up|0|||
106058351|NCT01906008|365877835|FG000|Overall Study|Oxaliplatin toxicity|2|||
106058352|NCT01906008|365877836|FG001|Overall Study|Oxaliplatin toxicity|0|||
106058353|NCT01906008|365877835|FG000|Overall Study|Protocol Violation|0|||
106058354|NCT01906008|365877836|FG001|Overall Study|Protocol Violation|1|||
106058355|NCT01906008|365877835|FG000|Overall Study|Withdrawal by Subject|1|||
106058356|NCT01906008|365877836|FG001|Overall Study|Withdrawal by Subject|5|||
106058357|NCT01906008|365877835|FG000|Overall Study|Did not start study med|3|||
106058358|NCT01906008|365877836|FG001|Overall Study|Did not start study med|4|||
106058359|NCT01906008|365877835|FG000|Overall Study|Oxaliplatin stops|10|||
106058360|NCT01906008|365877836|FG001|Overall Study|Oxaliplatin stops|8|||
106058361|NCT01906008|365877835|FG000|Overall Study|Hospice|1|||
106058362|NCT01906008|365877836|FG001|Overall Study|Hospice|0|||
106058363|NCT01906008|365877835|FG000|Overall Study|Physician Decision|3|||
106058364|NCT01906008|365877836|FG001|Overall Study|Physician Decision|3|||
106058365|NCT01906008|365877835|FG000|Overall Study|Lack of compliance of study med|5|||
106058366|NCT01906008|365877836|FG001|Overall Study|Lack of compliance of study med|3|||
106058367|NCT01906008|365877835|FG000|Overall Study|Adverse Event|0|||
106058368|NCT01906008|365877836|FG001|Overall Study|Adverse Event|3|||
106058369|NCT00420927|365877838|FG000|Period 1|Adverse Event|19|||
106058370|NCT00420927|365877839|FG001|Period 1|Adverse Event|15|||
106058371|NCT00420927|365877840|FG002|Period 1|Adverse Event|0|||
106058372|NCT00420927|365877841|FG003|Period 1|Adverse Event|0|||
106058373|NCT00420927|365877842|FG004|Period 1|Adverse Event|0|||
106058374|NCT00420927|365877843|FG005|Period 1|Adverse Event|0|||
106058375|NCT00420927|365877844|FG006|Period 1|Adverse Event|0|||
106152587|NCT03271489|366218865|FG001|Double-Blind (DB) Period|Other|1|||
106152588|NCT03271489|366218864|FG000|Double-Blind (DB) Period|Missing|1|||
106152589|NCT03271489|366218865|FG001|Double-Blind (DB) Period|Missing|0|||
106152590|NCT03271489|366218864|FG000|Open-Label (OL) Period|Adverse Event|2|||
106152591|NCT03271489|366218865|FG001|Open-Label (OL) Period|Adverse Event|0|||
106152592|NCT03271489|366218864|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
106152593|NCT03271489|366218865|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
106152594|NCT03271489|366218864|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
106152595|NCT03271489|366218865|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
106152596|NCT03271489|366218864|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
106152597|NCT03271489|366218865|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
106152598|NCT03271489|366218864|FG000|Open-Label (OL) Period|No Specified|2|||
106152599|NCT03271489|366218865|FG001|Open-Label (OL) Period|No Specified|2|||
106152600|NCT03271489|366218864|FG000|Open-Label (OL) Period|Missing|2|||
106152601|NCT03271489|366218865|FG001|Open-Label (OL) Period|Missing|0|||
106152602|NCT03271489|366218864|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
106152603|NCT03271489|366218865|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
106152604|NCT03271489|366218864|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
106152605|NCT03271489|366218865|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
106058376|NCT00420927|365877838|FG000|Period 1|Withdrawal by Subject|7|||
106058377|NCT00420927|365877839|FG001|Period 1|Withdrawal by Subject|12|||
106058378|NCT00420927|365877840|FG002|Period 1|Withdrawal by Subject|0|||
106058379|NCT00420927|365877841|FG003|Period 1|Withdrawal by Subject|0|||
106058380|NCT00420927|365877842|FG004|Period 1|Withdrawal by Subject|0|||
106058381|NCT00420927|365877843|FG005|Period 1|Withdrawal by Subject|0|||
106058382|NCT00420927|365877844|FG006|Period 1|Withdrawal by Subject|0|||
106058383|NCT00420927|365877838|FG000|Period 1|Lost to Follow-up|8|||
106058384|NCT00420927|365877839|FG001|Period 1|Lost to Follow-up|6|||
106058385|NCT00420927|365877840|FG002|Period 1|Lost to Follow-up|0|||
106058386|NCT00420927|365877841|FG003|Period 1|Lost to Follow-up|0|||
106058387|NCT00420927|365877842|FG004|Period 1|Lost to Follow-up|0|||
106058388|NCT00420927|365877843|FG005|Period 1|Lost to Follow-up|0|||
106058389|NCT00420927|365877844|FG006|Period 1|Lost to Follow-up|0|||
106058390|NCT00420927|365877838|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
106058391|NCT00420927|365877839|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
106058392|NCT00420927|365877840|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
106058393|NCT00420927|365877841|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
106058394|NCT00420927|365877842|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
106058395|NCT00420927|365877843|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
106058396|NCT00420927|365877844|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
106058397|NCT00420927|365877838|FG000|Period 1|Death|2|||
106058398|NCT00420927|365877839|FG001|Period 1|Death|0|||
106058399|NCT00420927|365877840|FG002|Period 1|Death|0|||
106058400|NCT00420927|365877841|FG003|Period 1|Death|0|||
106058401|NCT00420927|365877842|FG004|Period 1|Death|0|||
106058402|NCT00420927|365877843|FG005|Period 1|Death|0|||
106058403|NCT00420927|365877844|FG006|Period 1|Death|0|||
106058404|NCT00420927|365877838|FG000|Period 1|Subject moved/relocated|0|||
106058405|NCT00420927|365877839|FG001|Period 1|Subject moved/relocated|2|||
106058406|NCT00420927|365877840|FG002|Period 1|Subject moved/relocated|0|||
106058407|NCT00420927|365877841|FG003|Period 1|Subject moved/relocated|0|||
106058408|NCT00420927|365877842|FG004|Period 1|Subject moved/relocated|0|||
106058409|NCT00420927|365877843|FG005|Period 1|Subject moved/relocated|0|||
106058410|NCT00420927|365877844|FG006|Period 1|Subject moved/relocated|0|||
106058411|NCT00420927|365877838|FG000|Period 1|Noncompliant with study drug|1|||
106058412|NCT00420927|365877839|FG001|Period 1|Noncompliant with study drug|1|||
106058413|NCT00420927|365877840|FG002|Period 1|Noncompliant with study drug|0|||
106058414|NCT00420927|365877841|FG003|Period 1|Noncompliant with study drug|0|||
106058415|NCT00420927|365877842|FG004|Period 1|Noncompliant with study drug|0|||
106058416|NCT00420927|365877843|FG005|Period 1|Noncompliant with study drug|0|||
106058417|NCT00420927|365877844|FG006|Period 1|Noncompliant with study drug|0|||
106058418|NCT00420927|365877838|FG000|Period 1|Randomization error|1|||
106058419|NCT00420927|365877839|FG001|Period 1|Randomization error|0|||
106058420|NCT00420927|365877840|FG002|Period 1|Randomization error|0|||
106058421|NCT00420927|365877841|FG003|Period 1|Randomization error|0|||
106058422|NCT00420927|365877842|FG004|Period 1|Randomization error|0|||
106058423|NCT00420927|365877843|FG005|Period 1|Randomization error|0|||
106058424|NCT00420927|365877844|FG006|Period 1|Randomization error|0|||
106058425|NCT00420927|365877838|FG000|Period 1|Suspected tuberculosis/positive test|1|||
106058426|NCT00420927|365877839|FG001|Period 1|Suspected tuberculosis/positive test|1|||
106058427|NCT00420927|365877840|FG002|Period 1|Suspected tuberculosis/positive test|0|||
106058428|NCT00420927|365877841|FG003|Period 1|Suspected tuberculosis/positive test|0|||
106058429|NCT00420927|365877842|FG004|Period 1|Suspected tuberculosis/positive test|0|||
106058430|NCT00420927|365877843|FG005|Period 1|Suspected tuberculosis/positive test|0|||
106058431|NCT00420927|365877844|FG006|Period 1|Suspected tuberculosis/positive test|0|||
106058432|NCT00420927|365877838|FG000|Period 1|Study site closure|0|||
106058433|NCT00420927|365877839|FG001|Period 1|Study site closure|1|||
106058434|NCT00420927|365877840|FG002|Period 1|Study site closure|0|||
106058435|NCT00420927|365877841|FG003|Period 1|Study site closure|0|||
106058436|NCT00420927|365877842|FG004|Period 1|Study site closure|0|||
106058437|NCT00420927|365877843|FG005|Period 1|Study site closure|0|||
106058438|NCT00420927|365877844|FG006|Period 1|Study site closure|0|||
106058439|NCT00420927|365877838|FG000|Period 1|Subject received new diagnosis|0|||
106058440|NCT00420927|365877839|FG001|Period 1|Subject received new diagnosis|2|||
106058441|NCT00420927|365877840|FG002|Period 1|Subject received new diagnosis|0|||
106058442|NCT00420927|365877841|FG003|Period 1|Subject received new diagnosis|0|||
106152606|NCT03271489|366218864|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
106152607|NCT03271489|366218865|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
105864688|NCT03207867|365152992|FG003|Overall Study|Adverse Event|0|||
106058443|NCT00420927|365877842|FG004|Period 1|Subject received new diagnosis|0|||
106058444|NCT00420927|365877843|FG005|Period 1|Subject received new diagnosis|0|||
106058445|NCT00420927|365877844|FG006|Period 1|Subject received new diagnosis|0|||
106058446|NCT00420927|365877838|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
106058447|NCT00420927|365877839|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
106058448|NCT00420927|365877840|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
106058449|NCT00420927|365877841|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
106058450|NCT00420927|365877842|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
106058451|NCT00420927|365877843|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
106058452|NCT00420927|365877844|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
106058453|NCT00420927|365877838|FG000|Period 1|Failed to meet entry criteria|8|||
106058454|NCT00420927|365877839|FG001|Period 1|Failed to meet entry criteria|7|||
106058455|NCT00420927|365877840|FG002|Period 1|Failed to meet entry criteria|0|||
106058456|NCT00420927|365877841|FG003|Period 1|Failed to meet entry criteria|0|||
106058457|NCT00420927|365877842|FG004|Period 1|Failed to meet entry criteria|0|||
106058458|NCT00420927|365877843|FG005|Period 1|Failed to meet entry criteria|0|||
106058459|NCT00420927|365877844|FG006|Period 1|Failed to meet entry criteria|0|||
106058460|NCT00420927|365877838|FG000|Period 1|Took prohibited medication|1|||
106058461|NCT00420927|365877839|FG001|Period 1|Took prohibited medication|3|||
106058462|NCT00420927|365877840|FG002|Period 1|Took prohibited medication|0|||
106058463|NCT00420927|365877841|FG003|Period 1|Took prohibited medication|0|||
106058464|NCT00420927|365877842|FG004|Period 1|Took prohibited medication|0|||
106058465|NCT00420927|365877843|FG005|Period 1|Took prohibited medication|0|||
106058466|NCT00420927|365877844|FG006|Period 1|Took prohibited medication|0|||
106058467|NCT00420927|365877838|FG000|Period 2|Adverse Event|0|||
106058468|NCT00420927|365877839|FG001|Period 2|Adverse Event|0|||
106058469|NCT00420927|365877840|FG002|Period 2|Adverse Event|7|||
106058470|NCT00420927|365877841|FG003|Period 2|Adverse Event|3|||
106058471|NCT00420927|365877842|FG004|Period 2|Adverse Event|17|||
106058472|NCT00420927|365877843|FG005|Period 2|Adverse Event|6|||
106058473|NCT00420927|365877844|FG006|Period 2|Adverse Event|20|||
106058474|NCT00420927|365877838|FG000|Period 2|Withdrawal by Subject|0|||
106058475|NCT00420927|365877839|FG001|Period 2|Withdrawal by Subject|0|||
106058476|NCT00420927|365877840|FG002|Period 2|Withdrawal by Subject|1|||
106058477|NCT00420927|365877841|FG003|Period 2|Withdrawal by Subject|3|||
106058478|NCT00420927|365877842|FG004|Period 2|Withdrawal by Subject|11|||
106058479|NCT00420927|365877843|FG005|Period 2|Withdrawal by Subject|2|||
106058480|NCT00420927|365877844|FG006|Period 2|Withdrawal by Subject|12|||
106058481|NCT00420927|365877838|FG000|Period 2|Lost to Follow-up|0|||
106058482|NCT00420927|365877839|FG001|Period 2|Lost to Follow-up|0|||
106058483|NCT00420927|365877840|FG002|Period 2|Lost to Follow-up|2|||
106058484|NCT00420927|365877841|FG003|Period 2|Lost to Follow-up|2|||
106058485|NCT00420927|365877842|FG004|Period 2|Lost to Follow-up|6|||
106058486|NCT00420927|365877843|FG005|Period 2|Lost to Follow-up|3|||
106058487|NCT00420927|365877844|FG006|Period 2|Lost to Follow-up|9|||
106058488|NCT00420927|365877838|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
106058489|NCT00420927|365877839|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
106058490|NCT00420927|365877840|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
106058491|NCT00420927|365877841|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
106058492|NCT00420927|365877842|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
106058493|NCT00420927|365877843|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
106058494|NCT00420927|365877844|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
106058495|NCT00420927|365877838|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
106058496|NCT00420927|365877839|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
106058497|NCT00420927|365877840|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
106058498|NCT00420927|365877841|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
106058499|NCT00420927|365877842|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
106058500|NCT00420927|365877843|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
106058501|NCT00420927|365877844|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
106058502|NCT00420927|365877838|FG000|Period 2|Subject unable to find transportation|0|||
106058503|NCT00420927|365877839|FG001|Period 2|Subject unable to find transportation|0|||
106058504|NCT00420927|365877840|FG002|Period 2|Subject unable to find transportation|0|||
106058505|NCT00420927|365877841|FG003|Period 2|Subject unable to find transportation|0|||
106058506|NCT00420927|365877842|FG004|Period 2|Subject unable to find transportation|0|||
106058507|NCT00420927|365877843|FG005|Period 2|Subject unable to find transportation|0|||
106058508|NCT00420927|365877844|FG006|Period 2|Subject unable to find transportation|1|||
106058509|NCT00420927|365877838|FG000|Period 2|Physician Decision|0|||
106058510|NCT00420927|365877839|FG001|Period 2|Physician Decision|0|||
106058511|NCT00420927|365877840|FG002|Period 2|Physician Decision|0|||
106058512|NCT00420927|365877841|FG003|Period 2|Physician Decision|0|||
106058513|NCT00420927|365877842|FG004|Period 2|Physician Decision|1|||
106058514|NCT00420927|365877843|FG005|Period 2|Physician Decision|1|||
106058515|NCT00420927|365877844|FG006|Period 2|Physician Decision|0|||
106058516|NCT00420927|365877838|FG000|Period 2|Sponsor decision|0|||
106058517|NCT00420927|365877839|FG001|Period 2|Sponsor decision|0|||
106152608|NCT03271489|366218864|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
106152609|NCT03271489|366218865|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
106152610|NCT03271489|366218864|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
106058518|NCT00420927|365877840|FG002|Period 2|Sponsor decision|1|||
106058519|NCT00420927|365877841|FG003|Period 2|Sponsor decision|0|||
106058520|NCT00420927|365877842|FG004|Period 2|Sponsor decision|0|||
106058521|NCT00420927|365877843|FG005|Period 2|Sponsor decision|0|||
106058522|NCT00420927|365877844|FG006|Period 2|Sponsor decision|1|||
106058523|NCT00420927|365877838|FG000|Period 2|Randomization error|0|||
106058524|NCT00420927|365877839|FG001|Period 2|Randomization error|0|||
106058525|NCT00420927|365877840|FG002|Period 2|Randomization error|0|||
106058526|NCT00420927|365877841|FG003|Period 2|Randomization error|0|||
106058527|NCT00420927|365877842|FG004|Period 2|Randomization error|1|||
106058528|NCT00420927|365877843|FG005|Period 2|Randomization error|1|||
106058529|NCT00420927|365877844|FG006|Period 2|Randomization error|0|||
106058530|NCT00420927|365877838|FG000|Period 2|Noncompliant with study drug|0|||
106058531|NCT00420927|365877839|FG001|Period 2|Noncompliant with study drug|0|||
106058532|NCT00420927|365877840|FG002|Period 2|Noncompliant with study drug|0|||
106058533|NCT00420927|365877841|FG003|Period 2|Noncompliant with study drug|1|||
106058534|NCT00420927|365877842|FG004|Period 2|Noncompliant with study drug|0|||
106058535|NCT00420927|365877843|FG005|Period 2|Noncompliant with study drug|0|||
106058536|NCT00420927|365877844|FG006|Period 2|Noncompliant with study drug|2|||
106058537|NCT00420927|365877838|FG000|Period 2|Methotrexate intolerance|0|||
106058538|NCT00420927|365877839|FG001|Period 2|Methotrexate intolerance|0|||
106058539|NCT00420927|365877840|FG002|Period 2|Methotrexate intolerance|0|||
106058540|NCT00420927|365877841|FG003|Period 2|Methotrexate intolerance|0|||
106058541|NCT00420927|365877842|FG004|Period 2|Methotrexate intolerance|0|||
106058542|NCT00420927|365877843|FG005|Period 2|Methotrexate intolerance|0|||
106058543|NCT00420927|365877844|FG006|Period 2|Methotrexate intolerance|1|||
106058544|NCT00420927|365877838|FG000|Period 2|Took prohibited medication|0|||
106058545|NCT00420927|365877839|FG001|Period 2|Took prohibited medication|0|||
106058546|NCT00420927|365877840|FG002|Period 2|Took prohibited medication|0|||
106058547|NCT00420927|365877841|FG003|Period 2|Took prohibited medication|0|||
106058548|NCT00420927|365877842|FG004|Period 2|Took prohibited medication|1|||
106058549|NCT00420927|365877843|FG005|Period 2|Took prohibited medication|0|||
106058550|NCT00420927|365877844|FG006|Period 2|Took prohibited medication|0|||
106058551|NCT03018704|365877845|FG000|Overall Study|Lost to Follow-up|1|||
106058552|NCT03018704|365877846|FG001|Overall Study|Lost to Follow-up|1|||
106058553|NCT00642460|365877847|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
106058554|NCT00642460|365877848|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
106058555|NCT00642460|365877849|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
106058556|NCT00642460|365877850|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
106058557|NCT00642460|365877851|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
106058558|NCT00642460|365877852|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
106058559|NCT00642460|365877847|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
106058560|NCT00642460|365877848|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
106058561|NCT00642460|365877849|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
106058562|NCT00642460|365877850|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
106058563|NCT00642460|365877851|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
106058564|NCT00642460|365877852|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
106058565|NCT00642460|365877847|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
106058566|NCT00642460|365877848|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
106058567|NCT00642460|365877849|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
106058568|NCT00642460|365877850|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
106058569|NCT00642460|365877851|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
106058570|NCT00642460|365877852|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
106058571|NCT00642460|365877847|FG000|Part II: Open-Label Up to Week 92|Death|0|||
106058572|NCT00642460|365877848|FG001|Part II: Open-Label Up to Week 92|Death|1|||
106058573|NCT00642460|365877849|FG002|Part II: Open-Label Up to Week 92|Death|0|||
106058574|NCT00642460|365877850|FG003|Part II: Open-Label Up to Week 92|Death|2|||
106058575|NCT00642460|365877851|FG004|Part II: Open-Label Up to Week 92|Death|0|||
106058576|NCT00642460|365877852|FG005|Part II: Open-Label Up to Week 92|Death|0|||
106058577|NCT00642460|365877847|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
106058578|NCT00642460|365877848|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
106058579|NCT00642460|365877849|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
106058580|NCT00642460|365877850|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
106058581|NCT00642460|365877851|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
106058582|NCT00642460|365877852|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
106058583|NCT00642460|365877847|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
106058584|NCT00642460|365877848|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
106058585|NCT00642460|365877849|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
106058586|NCT00642460|365877850|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
106058587|NCT00642460|365877851|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
106058588|NCT00642460|365877852|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
106058589|NCT00642460|365877847|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
106058590|NCT00642460|365877848|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
106058591|NCT00642460|365877849|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
106058592|NCT00642460|365877850|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
106058593|NCT00642460|365877851|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
106058594|NCT00642460|365877852|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
106152611|NCT03271489|366218865|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
106152612|NCT03271489|366218864|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
106152613|NCT03271489|366218865|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
106152614|NCT03271489|366218864|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
106152615|NCT03271489|366218865|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
106152616|NCT03271489|366218864|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
106058595|NCT00642460|365877847|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
106058596|NCT00642460|365877848|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
106058597|NCT00642460|365877849|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
106058598|NCT00642460|365877850|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
106058599|NCT00642460|365877851|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
106058600|NCT00642460|365877852|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
106058601|NCT00642460|365877847|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
106058602|NCT00642460|365877848|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
106058603|NCT00642460|365877849|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
106058604|NCT00642460|365877850|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
106058605|NCT00642460|365877851|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
106058606|NCT00642460|365877852|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
106058607|NCT00642460|365877847|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
106058608|NCT00642460|365877848|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
106058609|NCT00642460|365877849|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
106058610|NCT00642460|365877850|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
106058611|NCT00642460|365877851|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
106058612|NCT00642460|365877852|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
106058613|NCT00642460|365877847|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
106058614|NCT00642460|365877848|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
106058615|NCT00642460|365877849|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
106058616|NCT00642460|365877850|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
106058617|NCT00642460|365877851|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
106058618|NCT00642460|365877852|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
106058619|NCT00642460|365877847|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
106058620|NCT00642460|365877848|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
106058621|NCT00642460|365877849|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
106058622|NCT00642460|365877850|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
106058623|NCT00642460|365877851|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
106058624|NCT00642460|365877852|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
106058625|NCT00642460|365877847|FG000|Part III: Open-Label Up to Week 260|Other|0|||
106058626|NCT00642460|365877848|FG001|Part III: Open-Label Up to Week 260|Other|0|||
106058627|NCT00642460|365877849|FG002|Part III: Open-Label Up to Week 260|Other|0|||
106058628|NCT00642460|365877850|FG003|Part III: Open-Label Up to Week 260|Other|0|||
106058629|NCT00642460|365877851|FG004|Part III: Open-Label Up to Week 260|Other|2|||
106058630|NCT00642460|365877852|FG005|Part III: Open-Label Up to Week 260|Other|2|||
106058631|NCT00642460|365877847|FG000|Part III: Open-Label Up to Week 260|Death|0|||
106058632|NCT00642460|365877848|FG001|Part III: Open-Label Up to Week 260|Death|0|||
106058633|NCT00642460|365877849|FG002|Part III: Open-Label Up to Week 260|Death|0|||
106058634|NCT00642460|365877850|FG003|Part III: Open-Label Up to Week 260|Death|0|||
106058635|NCT00642460|365877851|FG004|Part III: Open-Label Up to Week 260|Death|0|||
106058636|NCT00642460|365877852|FG005|Part III: Open-Label Up to Week 260|Death|3|||
106058637|NCT00642460|365877847|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
106058638|NCT00642460|365877848|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
106058639|NCT00642460|365877849|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
106058640|NCT00642460|365877850|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
106058641|NCT00642460|365877851|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
106058642|NCT00642460|365877852|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
106058643|NCT00642460|365877847|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
106058644|NCT00642460|365877848|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
106058645|NCT00642460|365877849|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
106058646|NCT00642460|365877850|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
106058647|NCT00642460|365877851|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
106058648|NCT00642460|365877852|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
106058649|NCT02557646|365877855|FG000|Overall Study|Adverse Event|40|||
106058650|NCT02557646|365877855|FG000|Overall Study|Death|1|||
106058651|NCT02557646|365877855|FG000|Overall Study|Lack of Efficacy|186|||
106058652|NCT02557646|365877855|FG000|Overall Study|Withdrawal by Subject|18|||
106058653|NCT02557646|365877855|FG000|Overall Study|Lost to Follow-up|17|||
106058654|NCT02557646|365877855|FG000|Overall Study|Other|14|||
106058655|NCT00518986|365877856|FG000|Overall Study|Adverse Event|12|||
106058656|NCT00518986|365877857|FG001|Overall Study|Adverse Event|7|||
106058657|NCT00518986|365877856|FG000|Overall Study|Lack of Efficacy|0|||
106058658|NCT00518986|365877857|FG001|Overall Study|Lack of Efficacy|2|||
106058659|NCT00518986|365877856|FG000|Overall Study|Lost to Follow-up|3|||
106058660|NCT00518986|365877857|FG001|Overall Study|Lost to Follow-up|2|||
106058661|NCT00518986|365877856|FG000|Overall Study|Physician Decision|0|||
106058662|NCT00518986|365877857|FG001|Overall Study|Physician Decision|3|||
106058663|NCT00518986|365877856|FG000|Overall Study|Protocol Violation|5|||
106058664|NCT00518986|365877857|FG001|Overall Study|Protocol Violation|7|||
106058665|NCT00518986|365877856|FG000|Overall Study|Withdrawal by Subject|4|||
106152617|NCT03271489|366218865|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
106152618|NCT02860130|366218866|FG000|Overall Study|Adverse Event|2|||
106152619|NCT02860130|366218867|FG001|Overall Study|Adverse Event|3|||
106152620|NCT02860130|366218866|FG000|Overall Study|Protocol Violation|1|||
106152621|NCT02860130|366218867|FG001|Overall Study|Protocol Violation|1|||
106152622|NCT02860130|366218866|FG000|Overall Study|Withdrawal by Subject|0|||
106152623|NCT02860130|366218867|FG001|Overall Study|Withdrawal by Subject|2|||
106152624|NCT02860130|366218866|FG000|Overall Study|Physician Decision|2|||
106152625|NCT02860130|366218867|FG001|Overall Study|Physician Decision|2|||
106058666|NCT00518986|365877857|FG001|Overall Study|Withdrawal by Subject|4|||
106058667|NCT00518986|365877856|FG000|Overall Study|Non-Specific|2|||
106058668|NCT00518986|365877857|FG001|Overall Study|Non-Specific|1|||
106058669|NCT02088047|365877858|FG000|Overall Study|Withdrawal by Subject|1|||
106058670|NCT02088047|365877859|FG001|Overall Study|Withdrawal by Subject|0|||
106058671|NCT00660309|365877860|FG000|Overall Study|Adverse Event|2|||
106058672|NCT00660309|365877861|FG001|Overall Study|Adverse Event|0|||
106058673|NCT00660309|365877860|FG000|Overall Study|Withdrawal by Subject|0|||
106058674|NCT00660309|365877861|FG001|Overall Study|Withdrawal by Subject|3|||
106058675|NCT01442675|365877864|FG000|Overall Study|Protocol Violation|6|||
106058676|NCT01442675|365877864|FG000|Overall Study|Lost to Follow-up|2|||
106058677|NCT01442675|365877864|FG000|Overall Study|Withdrawal by Subject|4|||
106058678|NCT03366337|365877865|FG000|Overall Study|Lost to Follow-up|1|||
106058679|NCT03366337|365877866|FG001|Overall Study|Lost to Follow-up|0|||
106058680|NCT03366337|365877867|FG002|Overall Study|Lost to Follow-up|1|||
106058681|NCT03366337|365877868|FG003|Overall Study|Lost to Follow-up|0|||
106058682|NCT03366337|365877865|FG000|Overall Study|Withdrawal by Subject|2|||
106058683|NCT03366337|365877866|FG001|Overall Study|Withdrawal by Subject|0|||
106058684|NCT03366337|365877867|FG002|Overall Study|Withdrawal by Subject|1|||
106058685|NCT03366337|365877868|FG003|Overall Study|Withdrawal by Subject|1|||
106058686|NCT01537393|365877869|FG000|Overall Study|Exclude prior to study|32|||
106058687|NCT01537393|365877870|FG001|Overall Study|Exclude prior to study|44|||
106058688|NCT01537393|365877869|FG000|Overall Study|Death|20|||
106058689|NCT01537393|365877870|FG001|Overall Study|Death|32|||
106058690|NCT01537393|365877869|FG000|Overall Study|Withdrawal by Subject|18|||
106058691|NCT01537393|365877870|FG001|Overall Study|Withdrawal by Subject|17|||
106058692|NCT01537393|365877869|FG000|Overall Study|Lost to Follow-up|53|||
106058693|NCT01537393|365877870|FG001|Overall Study|Lost to Follow-up|48|||
106058694|NCT01537393|365877869|FG000|Overall Study|Failure - Regrafted|28|||
106058695|NCT01537393|365877870|FG001|Overall Study|Failure - Regrafted|43|||
106058696|NCT01537393|365877869|FG000|Overall Study|Failure - Not regrafted|2|||
106058697|NCT01537393|365877870|FG001|Overall Study|Failure - Not regrafted|6|||
106058698|NCT01537393|365877869|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
106058699|NCT01537393|365877870|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
106058700|NCT00459953|365877871|FG000|Overall Study|not analyzed-household member in study|1|||
106058701|NCT00459953|365877872|FG001|Overall Study|not analyzed-household member in study|1|||
106058702|NCT01049308|365877878|FG000|Pill Counts|Withdrawal by Subject|83|||
106058703|NCT03129100|365877879|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
106058704|NCT03129100|365877880|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
106058705|NCT03129100|365877881|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
106058706|NCT03129100|365877882|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
106058707|NCT03129100|365877883|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
106058708|NCT03129100|365877884|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
106058709|NCT03129100|365877885|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
106058710|NCT03129100|365877886|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
106058711|NCT03129100|365877887|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
106058712|NCT03129100|365877888|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
106058713|NCT03129100|365877889|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
106058714|NCT03129100|365877890|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
106058715|NCT03129100|365877891|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
106058716|NCT03129100|365877892|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
106152626|NCT02860130|366218866|FG000|Overall Study|Other|2|||
106152627|NCT02860130|366218867|FG001|Overall Study|Other|1|||
106058717|NCT03129100|365877893|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
106058718|NCT03129100|365877894|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
106058719|NCT03129100|365877895|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
106058720|NCT03129100|365877896|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
106152628|NCT03330795|366218868|FG000|Overall Study|Death|3|||
106058721|NCT03129100|365877897|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
106058722|NCT03129100|365877898|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
106058723|NCT03129100|365877899|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
106058724|NCT03129100|365877900|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
106058725|NCT03129100|365877901|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
106058726|NCT03129100|365877902|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
106058727|NCT03129100|365877903|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
106058728|NCT03129100|365877904|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
106058729|NCT03129100|365877879|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
106058730|NCT03129100|365877880|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058731|NCT03129100|365877881|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058732|NCT03129100|365877882|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058733|NCT03129100|365877883|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058734|NCT03129100|365877884|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058735|NCT03129100|365877885|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058736|NCT03129100|365877886|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058737|NCT03129100|365877887|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058738|NCT03129100|365877888|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058739|NCT03129100|365877889|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058740|NCT03129100|365877890|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058741|NCT03129100|365877891|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058742|NCT03129100|365877892|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058743|NCT03129100|365877893|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058744|NCT03129100|365877894|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058745|NCT03129100|365877895|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058746|NCT03129100|365877896|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058747|NCT03129100|365877897|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058748|NCT03129100|365877898|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058749|NCT03129100|365877899|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058750|NCT03129100|365877900|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058751|NCT03129100|365877901|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058752|NCT03129100|365877902|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058753|NCT03129100|365877903|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058754|NCT03129100|365877904|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
106058755|NCT03129100|365877879|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
106058756|NCT03129100|365877880|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
106058757|NCT03129100|365877881|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058758|NCT03129100|365877882|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058759|NCT03129100|365877883|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058760|NCT03129100|365877884|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058761|NCT03129100|365877885|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058762|NCT03129100|365877886|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058763|NCT03129100|365877887|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058764|NCT03129100|365877888|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058765|NCT03129100|365877889|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058766|NCT03129100|365877890|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058767|NCT03129100|365877891|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058768|NCT03129100|365877892|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058769|NCT03129100|365877893|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058770|NCT03129100|365877894|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058771|NCT03129100|365877895|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058772|NCT03129100|365877896|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058773|NCT03129100|365877897|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058774|NCT03129100|365877898|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
105864689|NCT03207867|365152993|FG004|Overall Study|Adverse Event|0|||
105864690|NCT03207867|365152994|FG005|Overall Study|Adverse Event|2|||
105864691|NCT03207867|365152995|FG006|Overall Study|Adverse Event|1|||
105864692|NCT03207867|365152996|FG007|Overall Study|Adverse Event|1|||
105864693|NCT03207867|365152997|FG008|Overall Study|Adverse Event|2|||
105864694|NCT03207867|365152998|FG009|Overall Study|Adverse Event|2|||
105864695|NCT03207867|365152999|FG010|Overall Study|Adverse Event|0|||
105864696|NCT03207867|365153000|FG011|Overall Study|Adverse Event|0|||
105864697|NCT03207867|365153001|FG012|Overall Study|Adverse Event|0|||
105864698|NCT03207867|365153002|FG013|Overall Study|Adverse Event|0|||
105864699|NCT03207867|365153003|FG014|Overall Study|Adverse Event|0|||
105864700|NCT03207867|365153004|FG015|Overall Study|Adverse Event|0|||
105864701|NCT03207867|365153005|FG016|Overall Study|Adverse Event|3|||
105864702|NCT03207867|365153006|FG017|Overall Study|Adverse Event|1|||
105864703|NCT03207867|365153007|FG018|Overall Study|Adverse Event|2|||
106058775|NCT03129100|365877899|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058776|NCT03129100|365877900|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058777|NCT03129100|365877901|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058778|NCT03129100|365877902|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058779|NCT03129100|365877903|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058780|NCT03129100|365877904|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
106058781|NCT03129100|365877879|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
105864704|NCT03207867|365153008|FG019|Overall Study|Adverse Event|1|||
105864705|NCT03207867|365153009|FG020|Overall Study|Adverse Event|0|||
106058782|NCT03129100|365877880|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
106058783|NCT03129100|365877881|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058784|NCT03129100|365877882|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058785|NCT03129100|365877883|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058786|NCT03129100|365877884|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058787|NCT03129100|365877885|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058788|NCT03129100|365877886|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058789|NCT03129100|365877887|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058790|NCT03129100|365877888|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058791|NCT03129100|365877889|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058792|NCT03129100|365877890|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106152629|NCT03330795|366218868|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
106152630|NCT05064735|366218869|FG000|Overall Study|Withdrawal by Subject|7|||
106152631|NCT05064735|366218870|FG001|Overall Study|Withdrawal by Subject|8|||
106152632|NCT05064735|366218869|FG000|Overall Study|Lost to Follow-up|7|||
106152633|NCT05064735|366218870|FG001|Overall Study|Lost to Follow-up|2|||
106152634|NCT05064735|366218869|FG000|Overall Study|Physician Decision|2|||
106152635|NCT05064735|366218870|FG001|Overall Study|Physician Decision|1|||
106152636|NCT05064735|366218869|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
106152637|NCT05064735|366218870|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
106152638|NCT05064735|366218869|FG000|Overall Study|Site Closure|7|||
106152639|NCT05064735|366218870|FG001|Overall Study|Site Closure|2|||
106152640|NCT04157348|366218871|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
106152641|NCT04157348|366218872|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
106058793|NCT03129100|365877891|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058794|NCT03129100|365877892|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058795|NCT03129100|365877893|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058796|NCT03129100|365877894|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058797|NCT03129100|365877895|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058798|NCT03129100|365877896|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058799|NCT03129100|365877897|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058800|NCT03129100|365877898|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058801|NCT03129100|365877899|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058802|NCT03129100|365877900|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058803|NCT03129100|365877901|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058804|NCT03129100|365877902|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058805|NCT03129100|365877903|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058806|NCT03129100|365877904|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
106058807|NCT03129100|365877879|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058808|NCT03129100|365877880|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
106058809|NCT03129100|365877881|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058810|NCT03129100|365877882|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058811|NCT03129100|365877883|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058812|NCT03129100|365877884|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058813|NCT03129100|365877885|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058814|NCT03129100|365877886|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058815|NCT03129100|365877887|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058816|NCT03129100|365877888|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058817|NCT03129100|365877889|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058818|NCT03129100|365877890|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058819|NCT03129100|365877891|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058820|NCT03129100|365877892|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058821|NCT03129100|365877893|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058822|NCT03129100|365877894|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058823|NCT03129100|365877895|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058824|NCT03129100|365877896|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058825|NCT03129100|365877897|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058826|NCT03129100|365877898|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058827|NCT03129100|365877899|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058828|NCT03129100|365877900|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058829|NCT03129100|365877901|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
106152642|NCT04157348|366218871|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
106152643|NCT04157348|366218872|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
106058830|NCT03129100|365877902|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058831|NCT03129100|365877903|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058832|NCT03129100|365877904|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
106058833|NCT03129100|365877879|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058834|NCT03129100|365877880|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058835|NCT03129100|365877881|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
106152644|NCT04157348|366218871|FG000|Double-blind Treatment Period|Adverse Event|0|||
106058836|NCT03129100|365877882|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
106058837|NCT03129100|365877883|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058838|NCT03129100|365877884|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
106058839|NCT03129100|365877885|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058840|NCT03129100|365877886|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058841|NCT03129100|365877887|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058842|NCT03129100|365877888|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058843|NCT03129100|365877889|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058844|NCT03129100|365877890|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058845|NCT03129100|365877891|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058846|NCT03129100|365877892|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058847|NCT03129100|365877893|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058848|NCT03129100|365877894|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058849|NCT03129100|365877895|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058850|NCT03129100|365877896|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058851|NCT03129100|365877897|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058852|NCT03129100|365877898|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058853|NCT03129100|365877899|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058854|NCT03129100|365877900|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058855|NCT03129100|365877901|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058856|NCT03129100|365877902|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058857|NCT03129100|365877903|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058858|NCT03129100|365877904|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
106058859|NCT03129100|365877879|FG000|Period2 Extension Period (Group A and B)|Death|0|||
106058860|NCT03129100|365877880|FG001|Period2 Extension Period (Group A and B)|Death|0|||
106058861|NCT03129100|365877881|FG002|Period2 Extension Period (Group A and B)|Death|1|||
106058862|NCT03129100|365877882|FG003|Period2 Extension Period (Group A and B)|Death|0|||
106058863|NCT03129100|365877883|FG004|Period2 Extension Period (Group A and B)|Death|0|||
106058864|NCT03129100|365877884|FG005|Period2 Extension Period (Group A and B)|Death|0|||
106058865|NCT03129100|365877885|FG006|Period2 Extension Period (Group A and B)|Death|0|||
106058866|NCT03129100|365877886|FG007|Period2 Extension Period (Group A and B)|Death|0|||
106058867|NCT03129100|365877887|FG008|Period2 Extension Period (Group A and B)|Death|0|||
106058868|NCT03129100|365877888|FG009|Period2 Extension Period (Group A and B)|Death|0|||
106058869|NCT03129100|365877889|FG010|Period2 Extension Period (Group A and B)|Death|0|||
106058870|NCT03129100|365877890|FG011|Period2 Extension Period (Group A and B)|Death|0|||
106058871|NCT03129100|365877891|FG012|Period2 Extension Period (Group A and B)|Death|0|||
106058872|NCT03129100|365877892|FG013|Period2 Extension Period (Group A and B)|Death|0|||
106058873|NCT03129100|365877893|FG014|Period2 Extension Period (Group A and B)|Death|0|||
106058874|NCT03129100|365877894|FG015|Period2 Extension Period (Group A and B)|Death|0|||
106058875|NCT03129100|365877895|FG016|Period2 Extension Period (Group A and B)|Death|0|||
106058876|NCT03129100|365877896|FG017|Period2 Extension Period (Group A and B)|Death|0|||
106058877|NCT03129100|365877897|FG018|Period2 Extension Period (Group A and B)|Death|0|||
106058878|NCT03129100|365877898|FG019|Period2 Extension Period (Group A and B)|Death|0|||
106058879|NCT03129100|365877899|FG020|Period2 Extension Period (Group A and B)|Death|0|||
106058880|NCT03129100|365877900|FG021|Period2 Extension Period (Group A and B)|Death|0|||
106058881|NCT03129100|365877901|FG022|Period2 Extension Period (Group A and B)|Death|0|||
106058882|NCT03129100|365877902|FG023|Period2 Extension Period (Group A and B)|Death|0|||
106058883|NCT03129100|365877903|FG024|Period2 Extension Period (Group A and B)|Death|0|||
106058884|NCT03129100|365877904|FG025|Period2 Extension Period (Group A and B)|Death|0|||
106058885|NCT03129100|365877879|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058886|NCT03129100|365877880|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058887|NCT03129100|365877881|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
106058888|NCT03129100|365877882|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
106058889|NCT03129100|365877883|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
106058890|NCT03129100|365877884|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
106058891|NCT03129100|365877885|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
106058892|NCT03129100|365877886|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058893|NCT03129100|365877887|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058894|NCT03129100|365877888|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058895|NCT03129100|365877889|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058896|NCT03129100|365877890|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058897|NCT03129100|365877891|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058898|NCT03129100|365877892|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058899|NCT03129100|365877893|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058900|NCT03129100|365877894|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106152645|NCT04157348|366218872|FG001|Double-blind Treatment Period|Adverse Event|1|||
106058901|NCT03129100|365877895|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058902|NCT03129100|365877896|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058903|NCT03129100|365877897|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058904|NCT03129100|365877898|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058905|NCT03129100|365877899|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058906|NCT03129100|365877900|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058907|NCT03129100|365877901|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058908|NCT03129100|365877902|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058909|NCT03129100|365877903|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058910|NCT03129100|365877904|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
106058911|NCT03129100|365877879|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058912|NCT03129100|365877880|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058913|NCT03129100|365877881|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
106058914|NCT03129100|365877882|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058915|NCT03129100|365877883|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058916|NCT03129100|365877884|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058917|NCT03129100|365877885|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058918|NCT03129100|365877886|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058919|NCT03129100|365877887|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058920|NCT03129100|365877888|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058921|NCT03129100|365877889|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058922|NCT03129100|365877890|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058923|NCT03129100|365877891|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058924|NCT03129100|365877892|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058925|NCT03129100|365877893|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058926|NCT03129100|365877894|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058927|NCT03129100|365877895|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058928|NCT03129100|365877896|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058929|NCT03129100|365877897|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058930|NCT03129100|365877898|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058931|NCT03129100|365877899|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058932|NCT03129100|365877900|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058933|NCT03129100|365877901|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058934|NCT03129100|365877902|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058935|NCT03129100|365877903|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058936|NCT03129100|365877904|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
106058937|NCT03129100|365877879|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058938|NCT03129100|365877880|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058939|NCT03129100|365877881|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
106058940|NCT03129100|365877882|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058941|NCT03129100|365877883|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058942|NCT03129100|365877884|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058943|NCT03129100|365877885|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058944|NCT03129100|365877886|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058945|NCT03129100|365877887|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058946|NCT03129100|365877888|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058947|NCT03129100|365877889|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058948|NCT03129100|365877890|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058949|NCT03129100|365877891|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058950|NCT03129100|365877892|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058951|NCT03129100|365877893|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058952|NCT03129100|365877894|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058953|NCT03129100|365877895|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058954|NCT03129100|365877896|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058955|NCT03129100|365877897|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058956|NCT03129100|365877898|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058957|NCT03129100|365877899|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058958|NCT03129100|365877900|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106152646|NCT04157348|366218871|FG000|Open-label Extension Period|Adverse Event|1|||
106152647|NCT04157348|366218872|FG001|Open-label Extension Period|Adverse Event|1|||
106152648|NCT04157348|366218871|FG000|Open-label Extension Period|Death|0|||
106152649|NCT04157348|366218872|FG001|Open-label Extension Period|Death|1|||
106152650|NCT04157348|366218871|FG000|Open-label Extension Period|Lack of Efficacy|2|||
106152651|NCT04157348|366218872|FG001|Open-label Extension Period|Lack of Efficacy|2|||
106058959|NCT03129100|365877901|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058960|NCT03129100|365877902|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058961|NCT03129100|365877903|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058962|NCT03129100|365877904|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
106058963|NCT03129100|365877879|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058964|NCT03129100|365877880|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058965|NCT03129100|365877881|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
106058966|NCT03129100|365877882|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058967|NCT03129100|365877883|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058968|NCT03129100|365877884|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058969|NCT03129100|365877885|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058970|NCT03129100|365877886|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058971|NCT03129100|365877887|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058972|NCT03129100|365877888|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058973|NCT03129100|365877889|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058974|NCT03129100|365877890|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058975|NCT03129100|365877891|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058976|NCT03129100|365877892|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058977|NCT03129100|365877893|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058978|NCT03129100|365877894|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058979|NCT03129100|365877895|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058980|NCT03129100|365877896|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058981|NCT03129100|365877897|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058982|NCT03129100|365877898|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058983|NCT03129100|365877899|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058984|NCT03129100|365877900|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058985|NCT03129100|365877901|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058986|NCT03129100|365877902|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058987|NCT03129100|365877903|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058988|NCT03129100|365877904|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
106058989|NCT03129100|365877879|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106058990|NCT03129100|365877880|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106058991|NCT03129100|365877881|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106058992|NCT03129100|365877882|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106058993|NCT03129100|365877883|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
106058994|NCT03129100|365877884|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
106058995|NCT03129100|365877885|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
106058996|NCT03129100|365877886|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106058997|NCT03129100|365877887|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106058998|NCT03129100|365877888|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106058999|NCT03129100|365877889|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059000|NCT03129100|365877890|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059001|NCT03129100|365877891|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059002|NCT03129100|365877892|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059003|NCT03129100|365877893|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059004|NCT03129100|365877894|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059005|NCT03129100|365877895|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059006|NCT03129100|365877896|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059007|NCT03129100|365877897|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059008|NCT03129100|365877898|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059009|NCT03129100|365877899|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059010|NCT03129100|365877900|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059011|NCT03129100|365877901|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059012|NCT03129100|365877902|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059013|NCT03129100|365877903|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059014|NCT03129100|365877904|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
106059015|NCT03129100|365877879|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059016|NCT03129100|365877880|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059017|NCT03129100|365877881|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059018|NCT03129100|365877882|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059019|NCT03129100|365877883|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059020|NCT03129100|365877884|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059021|NCT03129100|365877885|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059022|NCT03129100|365877886|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059023|NCT03129100|365877887|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059024|NCT03129100|365877888|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
106059025|NCT03129100|365877889|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059026|NCT03129100|365877890|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059027|NCT03129100|365877891|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059028|NCT03129100|365877892|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059029|NCT03129100|365877893|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059030|NCT03129100|365877894|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059031|NCT03129100|365877895|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059032|NCT03129100|365877896|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059033|NCT03129100|365877897|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059034|NCT03129100|365877898|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059035|NCT03129100|365877899|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059036|NCT03129100|365877900|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059037|NCT03129100|365877901|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059038|NCT03129100|365877902|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059039|NCT03129100|365877903|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059040|NCT03129100|365877904|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
106059041|NCT03129100|365877879|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059042|NCT03129100|365877880|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059043|NCT03129100|365877881|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059044|NCT03129100|365877882|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059045|NCT03129100|365877883|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059046|NCT03129100|365877884|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059047|NCT03129100|365877885|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059048|NCT03129100|365877886|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059049|NCT03129100|365877887|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059050|NCT03129100|365877888|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059051|NCT03129100|365877889|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059052|NCT03129100|365877890|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
106059053|NCT03129100|365877891|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059054|NCT03129100|365877892|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059055|NCT03129100|365877893|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059056|NCT03129100|365877894|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059057|NCT03129100|365877895|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059058|NCT03129100|365877896|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059059|NCT03129100|365877897|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059060|NCT03129100|365877898|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059061|NCT03129100|365877899|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059062|NCT03129100|365877900|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059063|NCT03129100|365877901|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059064|NCT03129100|365877902|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059065|NCT03129100|365877903|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106152652|NCT04157348|366218871|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
106152653|NCT04157348|366218872|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
106152654|NCT04157348|366218871|FG000|Open-label Extension Period|Ongoing|60|||
106152655|NCT04157348|366218872|FG001|Open-label Extension Period|Ongoing|57|||
106152656|NCT04157348|366218871|FG000|Open-label Extension Period|other reasons|1|||
106152657|NCT04157348|366218872|FG001|Open-label Extension Period|other reasons|1|||
106152658|NCT00567489|366218873|FG000|Overall Study|Adverse Event|6|||
106152659|NCT00567489|366218874|FG001|Overall Study|Adverse Event|14|||
106152660|NCT00567489|366218873|FG000|Overall Study|Physician Decision|0|||
106152661|NCT00567489|366218874|FG001|Overall Study|Physician Decision|4|||
106152662|NCT00567489|366218873|FG000|Overall Study|Withdrawal by Subject|0|||
106152663|NCT00567489|366218874|FG001|Overall Study|Withdrawal by Subject|2|||
106152664|NCT00567489|366218873|FG000|Overall Study|Renal Transplantation|0|||
106152665|NCT00567489|366218874|FG001|Overall Study|Renal Transplantation|3|||
106152666|NCT00567489|366218873|FG000|Overall Study|Other|1|||
106152667|NCT00567489|366218874|FG001|Overall Study|Other|0|||
106152668|NCT02671435|366218876|FG000|Overall Study|Death|1|||
106152669|NCT02671435|366218877|FG001|Overall Study|Death|3|||
106059066|NCT03129100|365877904|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
106059067|NCT03129100|365877879|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059068|NCT03129100|365877880|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059069|NCT03129100|365877881|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059070|NCT03129100|365877882|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059071|NCT03129100|365877883|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059072|NCT03129100|365877884|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059073|NCT03129100|365877885|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059074|NCT03129100|365877886|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059075|NCT03129100|365877887|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059076|NCT03129100|365877888|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059077|NCT03129100|365877889|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059078|NCT03129100|365877890|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
106059079|NCT03129100|365877891|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
106059080|NCT03129100|365877892|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
106059081|NCT03129100|365877893|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
106059082|NCT03129100|365877894|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059083|NCT03129100|365877895|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059084|NCT03129100|365877896|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059085|NCT03129100|365877897|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059086|NCT03129100|365877898|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059087|NCT03129100|365877899|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059088|NCT03129100|365877900|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059089|NCT03129100|365877901|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059090|NCT03129100|365877902|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059091|NCT03129100|365877903|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059092|NCT03129100|365877904|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
106059093|NCT03129100|365877879|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059094|NCT03129100|365877880|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059095|NCT03129100|365877881|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059096|NCT03129100|365877882|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059097|NCT03129100|365877883|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059098|NCT03129100|365877884|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059099|NCT03129100|365877885|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059100|NCT03129100|365877886|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059101|NCT03129100|365877887|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059102|NCT03129100|365877888|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059103|NCT03129100|365877889|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059104|NCT03129100|365877890|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
106059105|NCT03129100|365877891|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059106|NCT03129100|365877892|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
106059107|NCT03129100|365877893|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
106059108|NCT03129100|365877894|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059109|NCT03129100|365877895|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059110|NCT03129100|365877896|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059111|NCT03129100|365877897|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059112|NCT03129100|365877898|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059113|NCT03129100|365877899|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059114|NCT03129100|365877900|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059115|NCT03129100|365877901|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059116|NCT03129100|365877902|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059117|NCT03129100|365877903|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059118|NCT03129100|365877904|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
106059119|NCT03129100|365877879|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059120|NCT03129100|365877880|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059121|NCT03129100|365877881|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059122|NCT03129100|365877882|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059123|NCT03129100|365877883|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059124|NCT03129100|365877884|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059125|NCT03129100|365877885|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059126|NCT03129100|365877886|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059127|NCT03129100|365877887|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059128|NCT03129100|365877888|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059129|NCT03129100|365877889|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059130|NCT03129100|365877890|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059131|NCT03129100|365877891|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059132|NCT03129100|365877892|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059133|NCT03129100|365877893|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059134|NCT03129100|365877894|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
106059135|NCT03129100|365877895|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059136|NCT03129100|365877896|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059137|NCT03129100|365877897|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059138|NCT03129100|365877898|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059139|NCT03129100|365877899|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059140|NCT03129100|365877900|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059141|NCT03129100|365877901|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059142|NCT03129100|365877902|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059143|NCT03129100|365877903|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059144|NCT03129100|365877904|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
106059145|NCT03129100|365877879|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059146|NCT03129100|365877880|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059147|NCT03129100|365877881|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059148|NCT03129100|365877882|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059149|NCT03129100|365877883|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059150|NCT03129100|365877884|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059151|NCT03129100|365877885|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059152|NCT03129100|365877886|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059153|NCT03129100|365877887|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059154|NCT03129100|365877888|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059155|NCT03129100|365877889|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059156|NCT03129100|365877890|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059157|NCT03129100|365877891|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
106059158|NCT03129100|365877892|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059159|NCT03129100|365877893|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
106059160|NCT03129100|365877894|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
106059161|NCT03129100|365877895|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059162|NCT03129100|365877896|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059163|NCT03129100|365877897|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059164|NCT03129100|365877898|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059165|NCT03129100|365877899|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059166|NCT03129100|365877900|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059167|NCT03129100|365877901|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059168|NCT03129100|365877902|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059169|NCT03129100|365877903|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059170|NCT03129100|365877904|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
106059171|NCT03129100|365877879|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059172|NCT03129100|365877880|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059173|NCT03129100|365877881|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059174|NCT03129100|365877882|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059175|NCT03129100|365877883|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059176|NCT03129100|365877884|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059177|NCT03129100|365877885|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059178|NCT03129100|365877886|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059179|NCT03129100|365877887|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059180|NCT03129100|365877888|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059181|NCT03129100|365877889|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059182|NCT03129100|365877890|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059183|NCT03129100|365877891|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059184|NCT03129100|365877892|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059185|NCT03129100|365877893|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059186|NCT03129100|365877894|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059187|NCT03129100|365877895|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059188|NCT03129100|365877896|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
106059189|NCT03129100|365877897|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059190|NCT03129100|365877898|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
106059191|NCT03129100|365877899|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
105864706|NCT03207867|365153010|FG021|Overall Study|Adverse Event|0|||
106059192|NCT03129100|365877900|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059193|NCT03129100|365877901|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059194|NCT03129100|365877902|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059195|NCT03129100|365877903|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059196|NCT03129100|365877904|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
106059197|NCT03129100|365877879|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059198|NCT03129100|365877880|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059199|NCT03129100|365877881|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059200|NCT03129100|365877882|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106152670|NCT02671435|366218878|FG002|Overall Study|Death|0|||
106152671|NCT02671435|366218879|FG003|Overall Study|Death|16|||
106152672|NCT02671435|366218880|FG004|Overall Study|Death|14|||
106152673|NCT02671435|366218881|FG005|Overall Study|Death|29|||
106152674|NCT02671435|366218882|FG006|Overall Study|Death|34|||
106152675|NCT02671435|366218883|FG007|Overall Study|Death|28|||
106152676|NCT02671435|366218884|FG008|Overall Study|Death|19|||
106152677|NCT02671435|366218885|FG009|Overall Study|Death|10|||
106152678|NCT02671435|366218886|FG010|Overall Study|Death|8|||
106152679|NCT02671435|366218887|FG011|Overall Study|Death|29|||
106152680|NCT02671435|366218888|FG012|Overall Study|Death|29|||
106152681|NCT02671435|366218889|FG013|Overall Study|Death|29|||
106152682|NCT02671435|366218890|FG014|Overall Study|Death|27|||
106152683|NCT02671435|366218876|FG000|Overall Study|Lost to Follow-up|0|||
106152684|NCT02671435|366218877|FG001|Overall Study|Lost to Follow-up|0|||
106152685|NCT02671435|366218878|FG002|Overall Study|Lost to Follow-up|1|||
106152686|NCT02671435|366218879|FG003|Overall Study|Lost to Follow-up|0|||
106152687|NCT02671435|366218880|FG004|Overall Study|Lost to Follow-up|1|||
106152688|NCT02671435|366218881|FG005|Overall Study|Lost to Follow-up|1|||
106152689|NCT02671435|366218882|FG006|Overall Study|Lost to Follow-up|2|||
106152690|NCT02671435|366218883|FG007|Overall Study|Lost to Follow-up|2|||
106152691|NCT02671435|366218884|FG008|Overall Study|Lost to Follow-up|0|||
106152692|NCT02671435|366218885|FG009|Overall Study|Lost to Follow-up|2|||
106152693|NCT02671435|366218886|FG010|Overall Study|Lost to Follow-up|0|||
106152694|NCT02671435|366218887|FG011|Overall Study|Lost to Follow-up|3|||
106152695|NCT02671435|366218888|FG012|Overall Study|Lost to Follow-up|3|||
106152696|NCT02671435|366218889|FG013|Overall Study|Lost to Follow-up|2|||
106152697|NCT02671435|366218890|FG014|Overall Study|Lost to Follow-up|0|||
106152698|NCT02671435|366218876|FG000|Overall Study|Withdrawal by Subject|2|||
106152699|NCT02671435|366218877|FG001|Overall Study|Withdrawal by Subject|0|||
106152700|NCT02671435|366218878|FG002|Overall Study|Withdrawal by Subject|2|||
106152701|NCT02671435|366218879|FG003|Overall Study|Withdrawal by Subject|2|||
106152702|NCT02671435|366218880|FG004|Overall Study|Withdrawal by Subject|2|||
106152703|NCT02671435|366218881|FG005|Overall Study|Withdrawal by Subject|7|||
106152704|NCT02671435|366218882|FG006|Overall Study|Withdrawal by Subject|2|||
106152705|NCT02671435|366218883|FG007|Overall Study|Withdrawal by Subject|7|||
106152706|NCT02671435|366218884|FG008|Overall Study|Withdrawal by Subject|1|||
106152707|NCT02671435|366218885|FG009|Overall Study|Withdrawal by Subject|1|||
106152708|NCT02671435|366218886|FG010|Overall Study|Withdrawal by Subject|2|||
106152709|NCT02671435|366218887|FG011|Overall Study|Withdrawal by Subject|4|||
106152710|NCT02671435|366218888|FG012|Overall Study|Withdrawal by Subject|4|||
106152711|NCT02671435|366218889|FG013|Overall Study|Withdrawal by Subject|4|||
106152712|NCT02671435|366218890|FG014|Overall Study|Withdrawal by Subject|2|||
106152713|NCT02671435|366218876|FG000|Overall Study|Un-specified|0|||
106152714|NCT02671435|366218877|FG001|Overall Study|Un-specified|0|||
106152715|NCT02671435|366218878|FG002|Overall Study|Un-specified|0|||
106152716|NCT02671435|366218879|FG003|Overall Study|Un-specified|0|||
106152717|NCT02671435|366218880|FG004|Overall Study|Un-specified|1|||
106152718|NCT02671435|366218881|FG005|Overall Study|Un-specified|3|||
106152719|NCT02671435|366218882|FG006|Overall Study|Un-specified|2|||
106059201|NCT03129100|365877883|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106152720|NCT02671435|366218883|FG007|Overall Study|Un-specified|3|||
106152721|NCT02671435|366218884|FG008|Overall Study|Un-specified|0|||
106152722|NCT02671435|366218885|FG009|Overall Study|Un-specified|5|||
106152723|NCT02671435|366218886|FG010|Overall Study|Un-specified|8|||
106152724|NCT02671435|366218887|FG011|Overall Study|Un-specified|4|||
106152725|NCT02671435|366218888|FG012|Overall Study|Un-specified|5|||
106152726|NCT02671435|366218889|FG013|Overall Study|Un-specified|9|||
106152727|NCT02671435|366218890|FG014|Overall Study|Un-specified|8|||
106152728|NCT01721291|366218891|FG000|Overall Study|Withdrawal by Subject|1|||
106152729|NCT01721291|366218892|FG001|Overall Study|Withdrawal by Subject|0|||
106152730|NCT01721291|366218891|FG000|Overall Study|did not like the treatment|1|||
106152731|NCT01721291|366218892|FG001|Overall Study|did not like the treatment|0|||
106152732|NCT06450405|366218902|FG000|Overall Study|Study funding terminated.|0|||
106152733|NCT06450405|366218903|FG001|Overall Study|Study funding terminated.|2|||
106152734|NCT03529110|366219600|FG000|Overall Study|Progressive Disease|66|||
106152735|NCT03529110|366219601|FG001|Overall Study|Progressive Disease|158|||
106059202|NCT03129100|365877884|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106152736|NCT03529110|366219600|FG000|Overall Study|Clinical Progression|4|||
106152737|NCT03529110|366219601|FG001|Overall Study|Clinical Progression|12|||
106059203|NCT03129100|365877885|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059204|NCT03129100|365877886|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059205|NCT03129100|365877887|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059206|NCT03129100|365877888|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059207|NCT03129100|365877889|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059208|NCT03129100|365877890|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059209|NCT03129100|365877891|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059210|NCT03129100|365877892|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059211|NCT03129100|365877893|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059212|NCT03129100|365877894|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059213|NCT03129100|365877895|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059214|NCT03129100|365877896|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059215|NCT03129100|365877897|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059216|NCT03129100|365877898|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059217|NCT03129100|365877899|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
106059218|NCT03129100|365877900|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059219|NCT03129100|365877901|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059220|NCT03129100|365877902|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059221|NCT03129100|365877903|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059222|NCT03129100|365877904|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
106059223|NCT03129100|365877879|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
106059224|NCT03129100|365877880|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
106059225|NCT03129100|365877881|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
106059226|NCT03129100|365877882|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
106059227|NCT03129100|365877883|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
106059228|NCT03129100|365877884|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
106059229|NCT03129100|365877885|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
106059230|NCT03129100|365877886|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
106059231|NCT03129100|365877887|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
106059232|NCT03129100|365877888|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
106059233|NCT03129100|365877889|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
106059234|NCT03129100|365877890|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
106059235|NCT03129100|365877891|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
106059236|NCT03129100|365877892|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
106059237|NCT03129100|365877893|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
106059238|NCT03129100|365877894|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
106059239|NCT03129100|365877895|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
106059240|NCT03129100|365877896|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
106059241|NCT03129100|365877897|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
106059242|NCT03129100|365877898|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
106059243|NCT03129100|365877899|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
106059244|NCT03129100|365877900|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
106059245|NCT03129100|365877901|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
106059246|NCT03129100|365877902|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
106059247|NCT03129100|365877903|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
106059248|NCT03129100|365877904|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
106059249|NCT03129100|365877879|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059250|NCT03129100|365877880|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059251|NCT03129100|365877881|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059252|NCT03129100|365877882|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059253|NCT03129100|365877883|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059254|NCT03129100|365877884|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059255|NCT03129100|365877885|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059256|NCT03129100|365877886|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059257|NCT03129100|365877887|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059258|NCT03129100|365877888|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059259|NCT03129100|365877889|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059260|NCT03129100|365877890|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059261|NCT03129100|365877891|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059262|NCT03129100|365877892|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059263|NCT03129100|365877893|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059264|NCT03129100|365877894|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059265|NCT03129100|365877895|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059266|NCT03129100|365877896|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059267|NCT03129100|365877897|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059268|NCT03129100|365877898|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059269|NCT03129100|365877899|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
106059270|NCT03129100|365877900|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059271|NCT03129100|365877901|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059272|NCT03129100|365877902|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059273|NCT03129100|365877903|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059274|NCT03129100|365877904|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
106059275|NCT03129100|365877879|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
106059276|NCT03129100|365877880|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
106059277|NCT03129100|365877881|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
106059278|NCT03129100|365877882|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
106059279|NCT03129100|365877883|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
106059280|NCT03129100|365877884|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
106059281|NCT03129100|365877885|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
106059282|NCT03129100|365877886|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
106059283|NCT03129100|365877887|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
106059284|NCT03129100|365877888|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
106059285|NCT03129100|365877889|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
106059286|NCT03129100|365877890|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
106059287|NCT03129100|365877891|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
106059288|NCT03129100|365877892|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
106059289|NCT03129100|365877893|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
106059290|NCT03129100|365877894|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
106059291|NCT03129100|365877895|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
106059292|NCT03129100|365877896|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
106059293|NCT03129100|365877897|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
106059294|NCT03129100|365877898|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
106059295|NCT03129100|365877899|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
106059296|NCT03129100|365877900|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
106059297|NCT03129100|365877901|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
106059298|NCT03129100|365877902|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
106059299|NCT03129100|365877903|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
106059300|NCT03129100|365877904|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
106059301|NCT03129100|365877879|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059302|NCT03129100|365877880|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059303|NCT03129100|365877881|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059304|NCT03129100|365877882|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059305|NCT03129100|365877883|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059306|NCT03129100|365877884|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059307|NCT03129100|365877885|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059308|NCT03129100|365877886|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059309|NCT03129100|365877887|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059310|NCT03129100|365877888|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059311|NCT03129100|365877889|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059312|NCT03129100|365877890|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059313|NCT03129100|365877891|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059314|NCT03129100|365877892|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059315|NCT03129100|365877893|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059316|NCT03129100|365877894|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059317|NCT03129100|365877895|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059318|NCT03129100|365877896|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059319|NCT03129100|365877897|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059320|NCT03129100|365877898|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106152738|NCT03529110|366219600|FG000|Overall Study|Adverse Event|35|||
106152739|NCT03529110|366219601|FG001|Overall Study|Adverse Event|17|||
106152740|NCT03529110|366219600|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
106152741|NCT03529110|366219601|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
106152742|NCT03529110|366219600|FG000|Overall Study|Lack of Efficacy|3|||
106152743|NCT03529110|366219601|FG001|Overall Study|Lack of Efficacy|3|||
106059321|NCT03129100|365877899|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059322|NCT03129100|365877900|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059323|NCT03129100|365877901|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059324|NCT03129100|365877902|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
106059325|NCT03129100|365877903|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
106059326|NCT03129100|365877904|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
106059327|NCT03129100|365877879|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059328|NCT03129100|365877880|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059329|NCT03129100|365877881|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059330|NCT03129100|365877882|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059331|NCT03129100|365877883|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059332|NCT03129100|365877884|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059333|NCT03129100|365877885|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059334|NCT03129100|365877886|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059335|NCT03129100|365877887|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059336|NCT03129100|365877888|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059337|NCT03129100|365877889|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059338|NCT03129100|365877890|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059339|NCT03129100|365877891|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059340|NCT03129100|365877892|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059341|NCT03129100|365877893|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059342|NCT03129100|365877894|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059343|NCT03129100|365877895|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059344|NCT03129100|365877896|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059345|NCT03129100|365877897|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059346|NCT03129100|365877898|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059347|NCT03129100|365877899|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059348|NCT03129100|365877900|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059349|NCT03129100|365877901|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
106059350|NCT03129100|365877902|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
106059351|NCT03129100|365877903|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
106059352|NCT03129100|365877904|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
106059353|NCT03129100|365877879|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059354|NCT03129100|365877880|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059355|NCT03129100|365877881|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059356|NCT03129100|365877882|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059357|NCT03129100|365877883|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059358|NCT03129100|365877884|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059359|NCT03129100|365877885|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059360|NCT03129100|365877886|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059361|NCT03129100|365877887|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059362|NCT03129100|365877888|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059363|NCT03129100|365877889|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059364|NCT03129100|365877890|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059365|NCT03129100|365877891|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059366|NCT03129100|365877892|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059367|NCT03129100|365877893|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059368|NCT03129100|365877894|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059369|NCT03129100|365877895|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059370|NCT03129100|365877896|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059371|NCT03129100|365877897|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059372|NCT03129100|365877898|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059373|NCT03129100|365877899|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059374|NCT03129100|365877900|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059375|NCT03129100|365877901|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059376|NCT03129100|365877902|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059377|NCT03129100|365877903|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
106059378|NCT03129100|365877904|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
106059379|NCT03129100|365877879|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059380|NCT03129100|365877880|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059381|NCT03129100|365877881|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059382|NCT03129100|365877882|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059383|NCT03129100|365877883|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059384|NCT03129100|365877884|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059385|NCT03129100|365877885|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059386|NCT03129100|365877886|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059387|NCT03129100|365877887|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059388|NCT03129100|365877888|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059389|NCT03129100|365877889|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059390|NCT03129100|365877890|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059391|NCT03129100|365877891|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059392|NCT03129100|365877892|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059393|NCT03129100|365877893|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059394|NCT03129100|365877894|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059395|NCT03129100|365877895|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059396|NCT03129100|365877896|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106152744|NCT03529110|366219600|FG000|Overall Study|Physician Decision|2|||
106059397|NCT03129100|365877897|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059398|NCT03129100|365877898|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059399|NCT03129100|365877899|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059400|NCT03129100|365877900|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059401|NCT03129100|365877901|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059402|NCT03129100|365877902|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059403|NCT03129100|365877903|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
106059404|NCT03129100|365877904|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
106059405|NCT03129100|365877879|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
106059406|NCT03129100|365877880|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
106059407|NCT03129100|365877881|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
106059408|NCT03129100|365877882|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
106059409|NCT03129100|365877883|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
106059410|NCT03129100|365877884|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
106059411|NCT03129100|365877885|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
106059412|NCT03129100|365877886|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
106059413|NCT03129100|365877887|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
106059414|NCT03129100|365877888|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
106059415|NCT03129100|365877889|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
106059416|NCT03129100|365877890|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
106059417|NCT03129100|365877891|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
106059418|NCT03129100|365877892|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
106059419|NCT03129100|365877893|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
106059420|NCT03129100|365877894|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
106059421|NCT03129100|365877895|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
106059422|NCT03129100|365877896|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
106059423|NCT03129100|365877897|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
106059424|NCT03129100|365877898|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
106059425|NCT03129100|365877899|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
106059426|NCT03129100|365877900|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
106059427|NCT03129100|365877901|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
106059428|NCT03129100|365877902|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
106059429|NCT03129100|365877903|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
106059430|NCT03129100|365877904|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
106059431|NCT03845985|365877907|FG000|Overall Study|Lost to Follow-up|2|||
106059432|NCT03845985|365877908|FG001|Overall Study|Lost to Follow-up|1|||
106059433|NCT03845985|365877907|FG000|Overall Study|Physician Decision|1|||
106059434|NCT03845985|365877908|FG001|Overall Study|Physician Decision|0|||
106059435|NCT03845985|365877907|FG000|Overall Study|Withdrawal by Subject|4|||
106059436|NCT03845985|365877908|FG001|Overall Study|Withdrawal by Subject|1|||
106059437|NCT02695329|365877910|FG000|Overall Study|Adverse Event|1|||
106059438|NCT02695329|365877911|FG001|Overall Study|Adverse Event|0|||
106059439|NCT02695329|365877910|FG000|Overall Study|Poor X-ray quality for measurement|4|||
106059440|NCT02695329|365877911|FG001|Overall Study|Poor X-ray quality for measurement|5|||
106059441|NCT00843024|365877912|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
106059442|NCT00843024|365877913|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
106059443|NCT00843024|365877914|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
106059444|NCT00843024|365877915|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
106059445|NCT00843024|365877916|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
106059446|NCT00843024|365877917|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
106059447|NCT00843024|365877912|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
106059448|NCT00843024|365877913|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
106059449|NCT00843024|365877914|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
106059450|NCT00843024|365877915|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
106059451|NCT00843024|365877916|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
106059452|NCT00843024|365877917|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
106059453|NCT00843024|365877912|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
106059454|NCT00843024|365877913|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
106059455|NCT00843024|365877914|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
106059456|NCT00843024|365877915|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
106059457|NCT00843024|365877916|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
106059458|NCT00843024|365877917|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
106059459|NCT00843024|365877912|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
106059460|NCT00843024|365877913|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
106059461|NCT00843024|365877914|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
106059462|NCT00843024|365877915|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
106059463|NCT00843024|365877916|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
106059464|NCT00843024|365877917|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
106059465|NCT00843024|365877912|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
106059466|NCT00843024|365877913|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
106059467|NCT00843024|365877914|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
106059468|NCT00843024|365877915|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
106059469|NCT00843024|365877916|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
106059470|NCT00843024|365877917|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
106059471|NCT00843024|365877912|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
106059472|NCT00843024|365877913|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
106059473|NCT00843024|365877914|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
106059474|NCT00843024|365877915|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
106059475|NCT00843024|365877916|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
106059476|NCT00843024|365877917|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
106059477|NCT00843024|365877912|FG000|Single-blind Placebo Run-In Phase|Other|0|||
106059478|NCT00843024|365877913|FG001|Single-blind Placebo Run-In Phase|Other|1|||
106059479|NCT00843024|365877914|FG002|Single-blind Placebo Run-In Phase|Other|0|||
106059480|NCT00843024|365877915|FG003|Single-blind Placebo Run-In Phase|Other|0|||
106059481|NCT00843024|365877916|FG004|Single-blind Placebo Run-In Phase|Other|0|||
106059482|NCT00843024|365877917|FG005|Single-blind Placebo Run-In Phase|Other|0|||
106059483|NCT00843024|365877912|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
106059484|NCT00843024|365877913|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
106059485|NCT00843024|365877914|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
106059486|NCT00843024|365877915|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
106059487|NCT00843024|365877916|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
106059488|NCT00843024|365877917|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
106059489|NCT00843024|365877912|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
106059490|NCT00843024|365877913|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
106059491|NCT00843024|365877914|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
106059492|NCT00843024|365877915|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
106059493|NCT00843024|365877916|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
106059494|NCT00843024|365877917|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
106059495|NCT00843024|365877912|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
106059496|NCT00843024|365877913|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
106059497|NCT00843024|365877914|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
106059498|NCT00843024|365877915|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
106059499|NCT00843024|365877916|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
106059500|NCT00843024|365877917|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
106059501|NCT00843024|365877912|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
106059502|NCT00843024|365877913|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
106059503|NCT00843024|365877914|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
106059504|NCT00843024|365877915|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
106059505|NCT00843024|365877916|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
106059506|NCT00843024|365877917|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
106059507|NCT00843024|365877912|FG000|Double-blind Treatment Phase|Physician Decision|0|||
106059508|NCT00843024|365877913|FG001|Double-blind Treatment Phase|Physician Decision|0|||
106059509|NCT00843024|365877914|FG002|Double-blind Treatment Phase|Physician Decision|0|||
106059510|NCT00843024|365877915|FG003|Double-blind Treatment Phase|Physician Decision|3|||
106059511|NCT00843024|365877916|FG004|Double-blind Treatment Phase|Physician Decision|1|||
106059512|NCT00843024|365877917|FG005|Double-blind Treatment Phase|Physician Decision|1|||
106059513|NCT00843024|365877912|FG000|Double-blind Treatment Phase|Adverse Event|0|||
106059514|NCT00843024|365877913|FG001|Double-blind Treatment Phase|Adverse Event|0|||
106059515|NCT00843024|365877914|FG002|Double-blind Treatment Phase|Adverse Event|0|||
106059516|NCT00843024|365877915|FG003|Double-blind Treatment Phase|Adverse Event|0|||
106059517|NCT00843024|365877916|FG004|Double-blind Treatment Phase|Adverse Event|1|||
106059518|NCT00843024|365877917|FG005|Double-blind Treatment Phase|Adverse Event|1|||
106059519|NCT00843024|365877912|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
106059520|NCT00843024|365877913|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
106059521|NCT00843024|365877914|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
106059522|NCT00843024|365877915|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
106059523|NCT00843024|365877916|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
106059524|NCT00843024|365877917|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
106059525|NCT02615145|365877919|FG000|Overall Study|Did Not Start Treatment|0|||
106059526|NCT02615145|365877920|FG001|Overall Study|Did Not Start Treatment|0|||
106059527|NCT02615145|365877921|FG002|Overall Study|Did Not Start Treatment|1|||
106059528|NCT02615145|365877922|FG003|Overall Study|Did Not Start Treatment|1|||
106059529|NCT02615145|365877919|FG000|Overall Study|Failure to Return|20|||
106059530|NCT02615145|365877920|FG001|Overall Study|Failure to Return|10|||
106059531|NCT02615145|365877921|FG002|Overall Study|Failure to Return|7|||
106059532|NCT02615145|365877922|FG003|Overall Study|Failure to Return|0|||
106059533|NCT02615145|365877919|FG000|Overall Study|Death|2|||
106059534|NCT02615145|365877920|FG001|Overall Study|Death|3|||
106059535|NCT02615145|365877921|FG002|Overall Study|Death|0|||
106059536|NCT02615145|365877922|FG003|Overall Study|Death|0|||
106059537|NCT02615145|365877919|FG000|Overall Study|Other, Not Specified|5|||
106059538|NCT02615145|365877920|FG001|Overall Study|Other, Not Specified|2|||
106059539|NCT02615145|365877921|FG002|Overall Study|Other, Not Specified|0|||
106059540|NCT02615145|365877922|FG003|Overall Study|Other, Not Specified|0|||
106059541|NCT04600921|365877924|FG000|Overall Study|Withdrawal by Subject|3|||
106059542|NCT04600921|365877925|FG001|Overall Study|Withdrawal by Subject|5|||
106059543|NCT04600921|365877924|FG000|Overall Study|Death|0|||
106059544|NCT04600921|365877925|FG001|Overall Study|Death|1|||
106059545|NCT01892293|365879513|FG000|Overall Study|Apheresed but not treated|4|||
106059546|NCT02397278|365879516|FG000|Overall Study|Withdrawal by Subject|0|||
106059547|NCT02397278|365879517|FG001|Overall Study|Withdrawal by Subject|2|||
106059548|NCT02397278|365879516|FG000|Overall Study|Deemed ineligible following surgery|1|||
106059549|NCT02397278|365879517|FG001|Overall Study|Deemed ineligible following surgery|1|||
106059550|NCT00105469|365879518|FG000|Overall Study|Adverse Event|9|||
106059551|NCT00105469|365879519|FG001|Overall Study|Adverse Event|8|||
106059552|NCT00105469|365879518|FG000|Overall Study|Protocol Violation|4|||
106059553|NCT00105469|365879519|FG001|Overall Study|Protocol Violation|0|||
106059554|NCT00105469|365879518|FG000|Overall Study|Withdrawal by Subject|2|||
106059555|NCT00105469|365879519|FG001|Overall Study|Withdrawal by Subject|3|||
106059556|NCT00105469|365879518|FG000|Overall Study|Lost to Follow-up|1|||
106059557|NCT00105469|365879519|FG001|Overall Study|Lost to Follow-up|0|||
106059558|NCT00105469|365879518|FG000|Overall Study|Lack of Efficacy|2|||
106059559|NCT00105469|365879519|FG001|Overall Study|Lack of Efficacy|0|||
106059560|NCT00105469|365879518|FG000|Overall Study|Other Reason|4|||
106059561|NCT00105469|365879519|FG001|Overall Study|Other Reason|0|||
106059562|NCT01384760|365879535|FG000|Overall Study|Lost to Follow-up|0|||
106059563|NCT01384760|365879536|FG001|Overall Study|Lost to Follow-up|6|||
106059564|NCT01384760|365879535|FG000|Overall Study|Protocol Violation|16|||
106059565|NCT01384760|365879536|FG001|Overall Study|Protocol Violation|0|||
106059566|NCT01411774|365879537|FG000|Overall Study|Withdrawal by Subject|0|||
106059567|NCT01411774|365879538|FG001|Overall Study|Withdrawal by Subject|3|||
106059568|NCT00963547|365879539|FG000|Overall Study|Adverse Event|0|||
106059569|NCT00963547|365879540|FG001|Overall Study|Adverse Event|1|||
106059570|NCT00963547|365879541|FG002|Overall Study|Adverse Event|0|||
106059571|NCT00963547|365879542|FG003|Overall Study|Adverse Event|1|||
106059572|NCT00963547|365879543|FG004|Overall Study|Adverse Event|0|||
106059573|NCT00963547|365879544|FG005|Overall Study|Adverse Event|0|||
106059574|NCT00963547|365879545|FG006|Overall Study|Adverse Event|0|||
106059575|NCT00963547|365879539|FG000|Overall Study|Physician Decision|1|||
106059576|NCT00963547|365879540|FG001|Overall Study|Physician Decision|1|||
106059577|NCT00963547|365879541|FG002|Overall Study|Physician Decision|0|||
106059578|NCT00963547|365879542|FG003|Overall Study|Physician Decision|0|||
106059579|NCT00963547|365879543|FG004|Overall Study|Physician Decision|0|||
106059580|NCT00963547|365879544|FG005|Overall Study|Physician Decision|0|||
106059581|NCT00963547|365879545|FG006|Overall Study|Physician Decision|0|||
106059582|NCT00963547|365879539|FG000|Overall Study|Progressive Disease|3|||
106059583|NCT00963547|365879540|FG001|Overall Study|Progressive Disease|8|||
106059584|NCT00963547|365879541|FG002|Overall Study|Progressive Disease|9|||
106059585|NCT00963547|365879542|FG003|Overall Study|Progressive Disease|5|||
106059586|NCT00963547|365879543|FG004|Overall Study|Progressive Disease|0|||
106059587|NCT00963547|365879544|FG005|Overall Study|Progressive Disease|0|||
106059588|NCT00963547|365879545|FG006|Overall Study|Progressive Disease|0|||
106059589|NCT00963547|365879539|FG000|Overall Study|Withdrawal by Subject|0|||
106059590|NCT00963547|365879540|FG001|Overall Study|Withdrawal by Subject|0|||
106059591|NCT00963547|365879541|FG002|Overall Study|Withdrawal by Subject|3|||
106059592|NCT00963547|365879542|FG003|Overall Study|Withdrawal by Subject|0|||
106059593|NCT00963547|365879543|FG004|Overall Study|Withdrawal by Subject|0|||
106059594|NCT00963547|365879544|FG005|Overall Study|Withdrawal by Subject|0|||
106059595|NCT00963547|365879545|FG006|Overall Study|Withdrawal by Subject|0|||
106059596|NCT00963547|365879539|FG000|Overall Study|Reason Unknown|0|||
106059597|NCT00963547|365879540|FG001|Overall Study|Reason Unknown|1|||
106059598|NCT00963547|365879541|FG002|Overall Study|Reason Unknown|0|||
106059599|NCT00963547|365879542|FG003|Overall Study|Reason Unknown|0|||
106059600|NCT00963547|365879543|FG004|Overall Study|Reason Unknown|0|||
106059601|NCT00963547|365879544|FG005|Overall Study|Reason Unknown|0|||
106059602|NCT00963547|365879545|FG006|Overall Study|Reason Unknown|0|||
106059603|NCT01315678|365879552|FG000|Overall Study|Withdrawal by Subject|7|||
106059604|NCT01315678|365879553|FG001|Overall Study|Withdrawal by Subject|3|||
106059605|NCT01315678|365879552|FG000|Overall Study|Adverse Event|3|||
106059606|NCT01315678|365879553|FG001|Overall Study|Adverse Event|1|||
106059607|NCT01315678|365879552|FG000|Overall Study|Lost to Follow-up|1|||
106059608|NCT01315678|365879553|FG001|Overall Study|Lost to Follow-up|0|||
106059609|NCT01315678|365879552|FG000|Overall Study|similar reason to those listed above|3|||
106059610|NCT01315678|365879553|FG001|Overall Study|similar reason to those listed above|2|||
106059611|NCT01397084|365879554|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
106059612|NCT01397084|365879554|FG000|Overall Study|Protocol Violation|2|||
106059613|NCT01397084|365879554|FG000|Overall Study|Adverse Event|2|||
106059614|NCT01397084|365879554|FG000|Overall Study|Withdrawal by Subject|1|||
106059615|NCT01397084|365879554|FG000|Overall Study|Lost to Follow-up|1|||
106059616|NCT01397084|365879554|FG000|Overall Study|Used other proton pump inhibitor|1|||
106059617|NCT00790023|365879561|FG000|Overall Study|Adverse Event|2|||
106059618|NCT00790023|365879562|FG001|Overall Study|Adverse Event|1|||
106059619|NCT00790023|365879563|FG002|Overall Study|Adverse Event|4|||
106059620|NCT00790023|365879561|FG000|Overall Study|Protocol Violation|2|||
106059621|NCT00790023|365879562|FG001|Overall Study|Protocol Violation|4|||
106059622|NCT00790023|365879563|FG002|Overall Study|Protocol Violation|2|||
106059623|NCT00790023|365879561|FG000|Overall Study|Withdrawal by Subject|2|||
106059624|NCT00790023|365879562|FG001|Overall Study|Withdrawal by Subject|0|||
106059625|NCT00790023|365879563|FG002|Overall Study|Withdrawal by Subject|6|||
106152745|NCT03529110|366219601|FG001|Overall Study|Physician Decision|8|||
106152746|NCT03529110|366219600|FG000|Overall Study|Miscellaneous|2|||
106152747|NCT03529110|366219601|FG001|Overall Study|Miscellaneous|5|||
106152748|NCT01216176|366219602|FG000|Overall Study|Adverse Event|0|||
106152749|NCT01216176|366219603|FG001|Overall Study|Adverse Event|8|||
106152750|NCT01216176|366219604|FG002|Overall Study|Adverse Event|0|||
106152751|NCT01216176|366219602|FG000|Overall Study|Physician Decision|0|||
106152752|NCT01216176|366219603|FG001|Overall Study|Physician Decision|0|||
106152753|NCT01216176|366219604|FG002|Overall Study|Physician Decision|1|||
106152754|NCT04278586|366219605|FG000|Overall Study|Withdrawal by Subject|13|||
106152755|NCT04278586|366219606|FG001|Overall Study|Withdrawal by Subject|6|||
106152756|NCT04278586|366219605|FG000|Overall Study|Lost to Follow-up|37|||
106152757|NCT04278586|366219606|FG001|Overall Study|Lost to Follow-up|24|||
106152758|NCT05696080|366219607|FG000|Overall Study|Lost to Follow-up|2|||
106152759|NCT05696080|366219608|FG001|Overall Study|Lost to Follow-up|1|||
106152760|NCT05696080|366219607|FG000|Overall Study|Physician Decision|1|||
106152761|NCT05696080|366219608|FG001|Overall Study|Physician Decision|0|||
106152762|NCT05696080|366219607|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106152763|NCT05696080|366219608|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
106152764|NCT05696080|366219607|FG000|Overall Study|Withdrawal by Subject|12|||
106152765|NCT05696080|366219608|FG001|Overall Study|Withdrawal by Subject|0|||
106152766|NCT03397108|366219615|FG000|Overall Study|Lost to Follow-up|15|||
106152767|NCT03397108|366219616|FG001|Overall Study|Lost to Follow-up|0|||
106152768|NCT03397108|366219615|FG000|Overall Study|Insufficient milk production|3|||
106152769|NCT03397108|366219616|FG001|Overall Study|Insufficient milk production|2|||
106152770|NCT03397108|366219615|FG000|Overall Study|Withdrawal by Subject|2|||
106152771|NCT03397108|366219616|FG001|Overall Study|Withdrawal by Subject|0|||
106152772|NCT02562235|366219617|FG000|Overall Study|Adverse Event|3|||
106152773|NCT05096819|366219618|FG000|Overall Study|Withdrawal by Subject|3|||
106152774|NCT05096819|366219619|FG001|Overall Study|Withdrawal by Subject|0|||
106152775|NCT05307783|366219620|FG000|Overall Study|Death|7|||
106152776|NCT05307783|366219620|FG000|Overall Study|Lost to Follow-up|4|||
106152777|NCT02991807|366219621|FG000|Overall Study|Withdrawal by Subject|2|||
106152778|NCT02991807|366219622|FG001|Overall Study|Withdrawal by Subject|1|||
106152779|NCT02991807|366219621|FG000|Overall Study|Physician Decision|0|||
106152780|NCT02991807|366219622|FG001|Overall Study|Physician Decision|1|||
106152781|NCT02991807|366219621|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
106152782|NCT02991807|366219622|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
106152783|NCT02553642|366219623|FG000|Overall Study|Withdrawal by Subject|0|||
106152784|NCT02553642|366219624|FG001|Overall Study|Withdrawal by Subject|3|||
106152785|NCT02553642|366219623|FG000|Overall Study|Physician Decision|0|||
106152786|NCT02553642|366219624|FG001|Overall Study|Physician Decision|1|||
106152787|NCT02553642|366219623|FG000|Overall Study|Additional cancer dx|0|||
106152788|NCT02553642|366219624|FG001|Overall Study|Additional cancer dx|1|||
106152789|NCT02553642|366219623|FG000|Overall Study|Never started treatment|0|||
106152790|NCT02553642|366219624|FG001|Overall Study|Never started treatment|1|||
106059626|NCT00790023|365879561|FG000|Overall Study|Lost to Follow-up|0|||
106152791|NCT04437433|366219625|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
106059627|NCT00790023|365879562|FG001|Overall Study|Lost to Follow-up|0|||
106059628|NCT00790023|365879563|FG002|Overall Study|Lost to Follow-up|1|||
106152792|NCT04437433|366219626|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
106152793|NCT04437433|366219625|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
106152794|NCT04437433|366219626|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
106152795|NCT04437433|366219625|FG000|Overall Study|Adverse Event|9|||
106152796|NCT04437433|366219626|FG001|Overall Study|Adverse Event|0|||
106152797|NCT04437433|366219625|FG000|Overall Study|Lack of Efficacy|4|||
106059629|NCT00790023|365879561|FG000|Overall Study|Other|5|||
106059630|NCT00790023|365879562|FG001|Overall Study|Other|5|||
106059631|NCT00790023|365879563|FG002|Overall Study|Other|8|||
106059632|NCT00331682|365879564|FG000|Overall Study|Adverse Event|1|||
106059633|NCT03761277|365879565|FG000|Enrollment to Implant|Screen Failure|17|||
106059634|NCT03761277|365879565|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
106059635|NCT03761277|365879565|FG000|Enrollment to Implant|Physician Decision|2|||
106059636|NCT03761277|365879565|FG000|Enrollment to Implant|Site Closure|3|||
106059637|NCT03761277|365879565|FG000|Enrollment to Implant|Sponsor Request|2|||
106059638|NCT03761277|365879565|FG000|Post-Implant to 6 Months|Adverse Event|2|||
106059639|NCT03761277|365879565|FG000|Post-Implant to 6 Months|Death|1|||
106059640|NCT03761277|365879565|FG000|Post-Implant to 6 Months|Site Closure|2|||
106059641|NCT03761277|365879565|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
106059642|NCT03761277|365879565|FG000|6 Months to 12 Months|Physician Decision|2|||
106059643|NCT03761277|365879565|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
106059644|NCT00004978|365879566|FG000|Overall Study|Death|107|||
106059645|NCT00004978|365879567|FG001|Overall Study|Death|116|||
106059646|NCT00004978|365879566|FG000|Overall Study|Lost to Follow-up|101|||
106059647|NCT00004978|365879567|FG001|Overall Study|Lost to Follow-up|108|||
106059648|NCT00004978|365879566|FG000|Overall Study|Withdrawal by Subject|17|||
106059649|NCT00004978|365879567|FG001|Overall Study|Withdrawal by Subject|26|||
106059650|NCT00004978|365879566|FG000|Overall Study|site closure - not in analysis cohort|19|||
106059651|NCT00004978|365879567|FG001|Overall Study|site closure - not in analysis cohort|20|||
106059652|NCT01652703|365879568|FG000|Overall Study|Withdrawal by Subject|0|||
106059653|NCT01652703|365879569|FG001|Overall Study|Withdrawal by Subject|1|||
106059654|NCT01652703|365879570|FG002|Overall Study|Withdrawal by Subject|3|||
106059655|NCT01652703|365879571|FG003|Overall Study|Withdrawal by Subject|1|||
106059656|NCT01652703|365879572|FG004|Overall Study|Withdrawal by Subject|0|||
106059657|NCT01652703|365879573|FG005|Overall Study|Withdrawal by Subject|1|||
106059658|NCT01652703|365879568|FG000|Overall Study|Other|0|||
106059659|NCT01652703|365879569|FG001|Overall Study|Other|0|||
106059660|NCT01652703|365879570|FG002|Overall Study|Other|0|||
106059661|NCT01652703|365879571|FG003|Overall Study|Other|1|||
106059662|NCT01652703|365879572|FG004|Overall Study|Other|1|||
106059663|NCT01652703|365879573|FG005|Overall Study|Other|1|||
106059664|NCT03555591|365879574|FG000|Overall Study|Protocol Violation|77|||
106059665|NCT01532414|365879575|FG000|Overall Study|Lost to Follow-up|3|||
106059666|NCT01532414|365879576|FG001|Overall Study|Lost to Follow-up|0|||
106059667|NCT01532414|365879577|FG002|Overall Study|Lost to Follow-up|1|||
106059668|NCT01532414|365879575|FG000|Overall Study|Withdrawal by Subject|3|||
106059669|NCT01532414|365879576|FG001|Overall Study|Withdrawal by Subject|0|||
106059670|NCT01532414|365879577|FG002|Overall Study|Withdrawal by Subject|0|||
106059671|NCT01532414|365879575|FG000|Overall Study|No V6 semen sample|0|||
106059672|NCT01532414|365879576|FG001|Overall Study|No V6 semen sample|1|||
106059673|NCT01532414|365879577|FG002|Overall Study|No V6 semen sample|0|||
106059674|NCT01532414|365879575|FG000|Overall Study|Adverse Event|0|||
106059675|NCT01532414|365879576|FG001|Overall Study|Adverse Event|1|||
106059676|NCT01532414|365879577|FG002|Overall Study|Adverse Event|1|||
106059677|NCT01532414|365879575|FG000|Overall Study|Unable to complete 24 hour PK|0|||
106059678|NCT01532414|365879576|FG001|Overall Study|Unable to complete 24 hour PK|0|||
106152798|NCT04437433|366219626|FG001|Overall Study|Lack of Efficacy|0|||
106152799|NCT04437433|366219625|FG000|Overall Study|Withdrawal by Subject|4|||
106152800|NCT04437433|366219626|FG001|Overall Study|Withdrawal by Subject|1|||
106152801|NCT04437433|366219625|FG000|Overall Study|Protocol Deviation|0|||
106152802|NCT04437433|366219626|FG001|Overall Study|Protocol Deviation|1|||
106059679|NCT01532414|365879577|FG002|Overall Study|Unable to complete 24 hour PK|1|||
106059680|NCT01532414|365879575|FG000|Overall Study|Withdrawn by sponsor|1|||
106059681|NCT01532414|365879576|FG001|Overall Study|Withdrawn by sponsor|0|||
106059682|NCT01532414|365879577|FG002|Overall Study|Withdrawn by sponsor|0|||
106059683|NCT00903695|365879578|FG000|Overall Study|medical exclusion after 1st testing|1|||
106059684|NCT00903695|365879579|FG001|Overall Study|medical exclusion after 1st testing|0|||
106059685|NCT00903695|365879578|FG000|Overall Study|lung cancer|1|||
106059686|NCT00903695|365879579|FG001|Overall Study|lung cancer|0|||
106059687|NCT01751867|365879580|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
106059688|NCT01751867|365879581|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
106059689|NCT01751867|365879580|FG000|Overall Study|Diease Progression|4|||
106059690|NCT01751867|365879581|FG001|Overall Study|Diease Progression|18|||
106059691|NCT01751867|365879580|FG000|Overall Study|Adverse Event|8|||
106059692|NCT01751867|365879581|FG001|Overall Study|Adverse Event|15|||
106059693|NCT01751867|365879580|FG000|Overall Study|Poor Compliance|0|||
106059694|NCT01751867|365879581|FG001|Overall Study|Poor Compliance|5|||
106152803|NCT04437433|366219625|FG000|Overall Study|Other, not specified|0|||
106152804|NCT04437433|366219626|FG001|Overall Study|Other, not specified|1|||
106152805|NCT00894543|366219627|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
106152806|NCT00894543|366219628|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
106152807|NCT00894543|366219627|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
106152808|NCT00894543|366219628|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
106152809|NCT01532388|366219629|FG000|3-month Follow-up|Lost to Follow-up|68|||
106152810|NCT01532388|366219630|FG001|3-month Follow-up|Lost to Follow-up|68|||
106152811|NCT01532388|366219629|FG000|6-month Follow-up|Lost to Follow-up|74|||
106152812|NCT01532388|366219630|FG001|6-month Follow-up|Lost to Follow-up|66|||
106152813|NCT01532388|366219629|FG000|12-month Follow-up|Lost to Follow-up|69|||
106152814|NCT01532388|366219630|FG001|12-month Follow-up|Lost to Follow-up|67|||
106152815|NCT01772472|366219632|FG000|Overall Study|Death|126|||
106152816|NCT01772472|366219633|FG001|Overall Study|Death|94|||
106152817|NCT01772472|366219632|FG000|Overall Study|Lost to Follow-up|51|||
106152818|NCT01772472|366219633|FG001|Overall Study|Lost to Follow-up|50|||
106152819|NCT01772472|366219632|FG000|Overall Study|Other|9|||
106152820|NCT01772472|366219633|FG001|Overall Study|Other|7|||
106152821|NCT01772472|366219632|FG000|Overall Study|Physician Decision|1|||
106152822|NCT01772472|366219633|FG001|Overall Study|Physician Decision|7|||
106152823|NCT01772472|366219632|FG000|Overall Study|Withdrawal by Subject|115|||
106152824|NCT01772472|366219633|FG001|Overall Study|Withdrawal by Subject|90|||
106152825|NCT01772472|366219632|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
106152826|NCT01772472|366219633|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
106152827|NCT02697136|366219634|FG000|Overall Study|Adverse Event|3|||
106152828|NCT02697136|366219635|FG001|Overall Study|Adverse Event|0|||
106152829|NCT01426412|366219642|FG000|Overall Study|Withdrawal by Subject|1|||
106152830|NCT01426412|366219643|FG001|Overall Study|Withdrawal by Subject|0|||
106152831|NCT01426412|366219644|FG002|Overall Study|Withdrawal by Subject|0|||
106152832|NCT01426412|366219645|FG003|Overall Study|Withdrawal by Subject|0|||
106152833|NCT01426412|366219646|FG004|Overall Study|Withdrawal by Subject|1|||
106152834|NCT01426412|366219647|FG005|Overall Study|Withdrawal by Subject|0|||
106152835|NCT01426412|366219648|FG006|Overall Study|Withdrawal by Subject|0|||
106152836|NCT01426412|366219649|FG007|Overall Study|Withdrawal by Subject|3|||
106152837|NCT01426412|366219650|FG008|Overall Study|Withdrawal by Subject|1|||
106152838|NCT05450458|366219651|FG000|Overall Study|Lost to Follow-up|4|||
106152839|NCT04757610|366219654|FG000|Overall Study|Adverse Event|13|||
106152840|NCT04757610|366219655|FG001|Overall Study|Adverse Event|10|||
106152841|NCT04757610|366219656|FG002|Overall Study|Adverse Event|5|||
106152842|NCT04757610|366219654|FG000|Overall Study|Death|5|||
106152843|NCT04757610|366219655|FG001|Overall Study|Death|13|||
106152844|NCT04757610|366219656|FG002|Overall Study|Death|8|||
106152845|NCT04757610|366219654|FG000|Overall Study|Lack of Efficacy|1|||
106152846|NCT04757610|366219655|FG001|Overall Study|Lack of Efficacy|2|||
106152847|NCT04757610|366219656|FG002|Overall Study|Lack of Efficacy|3|||
106152848|NCT04757610|366219654|FG000|Overall Study|Lost to Follow-up|7|||
106152849|NCT04757610|366219655|FG001|Overall Study|Lost to Follow-up|2|||
106059695|NCT01751867|365879580|FG000|Overall Study|Withdrawal by Subject|3|||
106059696|NCT01751867|365879581|FG001|Overall Study|Withdrawal by Subject|1|||
106059697|NCT01751867|365879580|FG000|Overall Study|Physician Decision|4|||
106059698|NCT01751867|365879581|FG001|Overall Study|Physician Decision|7|||
106059699|NCT01751867|365879580|FG000|Overall Study|Protocol Violation|0|||
106059700|NCT01751867|365879581|FG001|Overall Study|Protocol Violation|2|||
106059701|NCT01751867|365879580|FG000|Overall Study|Death|0|||
106059702|NCT01751867|365879581|FG001|Overall Study|Death|5|||
106059703|NCT01751867|365879580|FG000|Overall Study|Other|11|||
106059704|NCT01751867|365879581|FG001|Overall Study|Other|37|||
106059705|NCT01751867|365879580|FG000|Overall Study|Randomized but not treated.|2|||
106059706|NCT01751867|365879581|FG001|Overall Study|Randomized but not treated.|1|||
106059707|NCT01806545|365879582|FG000|Overall Study|Adverse Event|2|||
106059708|NCT01806545|365879583|FG001|Overall Study|Adverse Event|3|||
106059709|NCT01806545|365879582|FG000|Overall Study|Lost to Follow-up|1|||
106059710|NCT01806545|365879583|FG001|Overall Study|Lost to Follow-up|0|||
106152850|NCT04757610|366219656|FG002|Overall Study|Lost to Follow-up|7|||
106152851|NCT04757610|366219654|FG000|Overall Study|Physician Decision|4|||
106152852|NCT04757610|366219655|FG001|Overall Study|Physician Decision|1|||
106152853|NCT04757610|366219656|FG002|Overall Study|Physician Decision|2|||
106059711|NCT01806545|365879582|FG000|Overall Study|Withdrawal by Subject|3|||
106059712|NCT01806545|365879583|FG001|Overall Study|Withdrawal by Subject|2|||
106059713|NCT01059825|365879585|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
106059714|NCT01059825|365879586|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
106152854|NCT04757610|366219654|FG000|Overall Study|Withdrawal by Subject|26|||
106152855|NCT04757610|366219655|FG001|Overall Study|Withdrawal by Subject|25|||
106152856|NCT04757610|366219656|FG002|Overall Study|Withdrawal by Subject|25|||
106152857|NCT04757610|366219654|FG000|Overall Study|Study Terminated by Sponsor|105|||
106152858|NCT04757610|366219655|FG001|Overall Study|Study Terminated by Sponsor|105|||
106152859|NCT04757610|366219656|FG002|Overall Study|Study Terminated by Sponsor|110|||
106059715|NCT01059825|365879587|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
106059716|NCT01059825|365879588|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
106059717|NCT01059825|365879589|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
106059718|NCT01059825|365879590|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
106059719|NCT01059825|365879591|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
106059720|NCT01059825|365879585|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
106059721|NCT01059825|365879586|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
106059722|NCT01059825|365879587|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
106059723|NCT01059825|365879588|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
106059724|NCT01059825|365879589|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
106059725|NCT01059825|365879590|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
105864707|NCT03207867|365153011|FG022|Overall Study|Adverse Event|0|||
105864708|NCT03207867|365153012|FG023|Overall Study|Adverse Event|0|||
106059726|NCT01059825|365879591|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
106059727|NCT01059825|365879585|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
106059728|NCT01059825|365879586|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
106059729|NCT01059825|365879587|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
106059730|NCT01059825|365879588|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
106059731|NCT01059825|365879589|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
106059732|NCT01059825|365879590|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
106059733|NCT01059825|365879591|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
106059734|NCT01059825|365879585|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
106059735|NCT01059825|365879586|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
106059736|NCT01059825|365879587|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
106059737|NCT01059825|365879588|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
106059738|NCT01059825|365879589|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
106059739|NCT01059825|365879590|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
106059740|NCT01059825|365879591|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
106059741|NCT01059825|365879585|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
106059742|NCT01059825|365879586|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
106059743|NCT01059825|365879587|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
106059744|NCT01059825|365879588|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
106059745|NCT01059825|365879589|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
106059746|NCT01059825|365879590|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
106059747|NCT01059825|365879591|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
106059748|NCT01059825|365879585|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
106059749|NCT01059825|365879586|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
106059750|NCT01059825|365879587|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
106059751|NCT01059825|365879588|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
106059752|NCT01059825|365879589|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
106059753|NCT01059825|365879590|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
106059754|NCT01059825|365879591|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
106059755|NCT01059825|365879585|FG000|Treatment Period|Lost to Follow-up|2|||
106059756|NCT01059825|365879586|FG001|Treatment Period|Lost to Follow-up|1|||
106059757|NCT01059825|365879587|FG002|Treatment Period|Lost to Follow-up|0|||
106059758|NCT01059825|365879588|FG003|Treatment Period|Lost to Follow-up|1|||
106059759|NCT01059825|365879589|FG004|Treatment Period|Lost to Follow-up|2|||
106059760|NCT01059825|365879590|FG005|Treatment Period|Lost to Follow-up|0|||
106059761|NCT01059825|365879591|FG006|Treatment Period|Lost to Follow-up|0|||
106059762|NCT01059825|365879585|FG000|Treatment Period|Withdrawal by Subject|3|||
106059763|NCT01059825|365879586|FG001|Treatment Period|Withdrawal by Subject|0|||
106059764|NCT01059825|365879587|FG002|Treatment Period|Withdrawal by Subject|1|||
106059765|NCT01059825|365879588|FG003|Treatment Period|Withdrawal by Subject|5|||
106059766|NCT01059825|365879589|FG004|Treatment Period|Withdrawal by Subject|4|||
106059767|NCT01059825|365879590|FG005|Treatment Period|Withdrawal by Subject|1|||
106059768|NCT01059825|365879591|FG006|Treatment Period|Withdrawal by Subject|0|||
106059769|NCT01059825|365879585|FG000|Treatment Period|Other reason not specified|1|||
106059770|NCT01059825|365879586|FG001|Treatment Period|Other reason not specified|2|||
106059771|NCT01059825|365879587|FG002|Treatment Period|Other reason not specified|1|||
106059772|NCT01059825|365879588|FG003|Treatment Period|Other reason not specified|2|||
106059773|NCT01059825|365879589|FG004|Treatment Period|Other reason not specified|0|||
106059774|NCT01059825|365879590|FG005|Treatment Period|Other reason not specified|0|||
106059775|NCT01059825|365879591|FG006|Treatment Period|Other reason not specified|0|||
106059776|NCT01059825|365879585|FG000|Treatment Period|Protocol Violation|0|||
106059777|NCT01059825|365879586|FG001|Treatment Period|Protocol Violation|0|||
106059778|NCT01059825|365879587|FG002|Treatment Period|Protocol Violation|1|||
106059779|NCT01059825|365879588|FG003|Treatment Period|Protocol Violation|1|||
106059780|NCT01059825|365879589|FG004|Treatment Period|Protocol Violation|1|||
106152860|NCT04757610|366219654|FG000|Overall Study|Randomized in Error|1|||
106152861|NCT04757610|366219655|FG001|Overall Study|Randomized in Error|0|||
106152862|NCT04757610|366219656|FG002|Overall Study|Randomized in Error|0|||
106059781|NCT01059825|365879590|FG005|Treatment Period|Protocol Violation|1|||
106059782|NCT01059825|365879591|FG006|Treatment Period|Protocol Violation|0|||
106059783|NCT01059825|365879585|FG000|Treatment Period|Adverse event related to study drug|1|||
106059784|NCT01059825|365879586|FG001|Treatment Period|Adverse event related to study drug|0|||
106059785|NCT01059825|365879587|FG002|Treatment Period|Adverse event related to study drug|1|||
106059786|NCT01059825|365879588|FG003|Treatment Period|Adverse event related to study drug|1|||
106059787|NCT01059825|365879589|FG004|Treatment Period|Adverse event related to study drug|0|||
106059788|NCT01059825|365879590|FG005|Treatment Period|Adverse event related to study drug|0|||
106059789|NCT01059825|365879591|FG006|Treatment Period|Adverse event related to study drug|0|||
106059790|NCT01059825|365879585|FG000|Treatment Period|Insufficient clinical response|3|||
106059791|NCT01059825|365879586|FG001|Treatment Period|Insufficient clinical response|0|||
106059792|NCT01059825|365879587|FG002|Treatment Period|Insufficient clinical response|0|||
106059793|NCT01059825|365879588|FG003|Treatment Period|Insufficient clinical response|0|||
106059794|NCT01059825|365879589|FG004|Treatment Period|Insufficient clinical response|0|||
106059795|NCT01059825|365879590|FG005|Treatment Period|Insufficient clinical response|0|||
106059796|NCT01059825|365879591|FG006|Treatment Period|Insufficient clinical response|0|||
106059797|NCT01059825|365879585|FG000|Treatment Period|Adverse event not related to study drug|0|||
106059798|NCT01059825|365879586|FG001|Treatment Period|Adverse event not related to study drug|1|||
106059799|NCT01059825|365879587|FG002|Treatment Period|Adverse event not related to study drug|2|||
106059800|NCT01059825|365879588|FG003|Treatment Period|Adverse event not related to study drug|1|||
106059801|NCT01059825|365879589|FG004|Treatment Period|Adverse event not related to study drug|1|||
106059802|NCT01059825|365879590|FG005|Treatment Period|Adverse event not related to study drug|1|||
106059803|NCT01059825|365879591|FG006|Treatment Period|Adverse event not related to study drug|0|||
106059804|NCT00429273|365879592|FG000|Overall Study|Lost to Follow-up|1|||
106059805|NCT00429273|365879593|FG001|Overall Study|Lost to Follow-up|2|||
106059806|NCT00429273|365879594|FG002|Overall Study|Lost to Follow-up|2|||
106059807|NCT00429273|365879592|FG000|Overall Study|Physician Decision|6|||
106059808|NCT00429273|365879593|FG001|Overall Study|Physician Decision|5|||
106059809|NCT00429273|365879594|FG002|Overall Study|Physician Decision|5|||
106059810|NCT00429273|365879592|FG000|Overall Study|Adverse Event|1|||
106059811|NCT00429273|365879593|FG001|Overall Study|Adverse Event|1|||
106059812|NCT00429273|365879594|FG002|Overall Study|Adverse Event|2|||
106059813|NCT01438957|365879595|FG000|Overall Study|Physician Decision|1|||
106059814|NCT01438957|365879596|FG001|Overall Study|Physician Decision|1|||
106059815|NCT01438957|365879597|FG002|Overall Study|Physician Decision|0|||
106059816|NCT01438957|365879598|FG003|Overall Study|Physician Decision|1|||
106059817|NCT01438957|365879599|FG004|Overall Study|Physician Decision|0|||
106059818|NCT00617123|365879602|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
106059819|NCT00617123|365879603|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
106059820|NCT00617123|365879602|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
106059821|NCT00617123|365879603|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
106059822|NCT00617123|365879602|FG000|Referral Screening Period|Adverse Event|0|||
106059823|NCT00617123|365879603|FG001|Referral Screening Period|Adverse Event|1|||
106059824|NCT00617123|365879602|FG000|Study Treatment Period|Withdrawal by Subject|8|||
106059825|NCT00617123|365879603|FG001|Study Treatment Period|Withdrawal by Subject|12|||
106059826|NCT00617123|365879602|FG000|Study Treatment Period|Adverse Event|7|||
106059827|NCT00617123|365879603|FG001|Study Treatment Period|Adverse Event|3|||
106059828|NCT00617123|365879602|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
106059829|NCT00617123|365879603|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
106059830|NCT00617123|365879602|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
106059831|NCT00617123|365879603|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
106059832|NCT00727025|365879607|FG000|Overall Study|Physician Decision|23|||
106059833|NCT02732119|365879610|FG000|Phase I|Adverse Event|1|||
106059834|NCT02732119|365879611|FG001|Phase I|Adverse Event|3|||
106059835|NCT02732119|365879612|FG002|Phase I|Adverse Event|1|||
106059836|NCT02732119|365879613|FG003|Phase I|Adverse Event|0|||
106059837|NCT02732119|365879614|FG004|Phase I|Adverse Event|0|||
106059838|NCT02732119|365879610|FG000|Phase I|Progressive disease|7|||
106059839|NCT02732119|365879611|FG001|Phase I|Progressive disease|3|||
106059840|NCT02732119|365879612|FG002|Phase I|Progressive disease|2|||
106059841|NCT02732119|365879613|FG003|Phase I|Progressive disease|0|||
106059842|NCT02732119|365879614|FG004|Phase I|Progressive disease|0|||
106059843|NCT02732119|365879610|FG000|Phase I|Protocol deviation|0|||
106059844|NCT02732119|365879611|FG001|Phase I|Protocol deviation|1|||
106059845|NCT02732119|365879612|FG002|Phase I|Protocol deviation|0|||
106059846|NCT02732119|365879613|FG003|Phase I|Protocol deviation|0|||
106059847|NCT02732119|365879614|FG004|Phase I|Protocol deviation|0|||
106059848|NCT02732119|365879610|FG000|Phase I|Physician Decision|0|||
106059849|NCT02732119|365879611|FG001|Phase I|Physician Decision|3|||
106059850|NCT02732119|365879612|FG002|Phase I|Physician Decision|4|||
106059851|NCT02732119|365879613|FG003|Phase I|Physician Decision|0|||
106059852|NCT02732119|365879614|FG004|Phase I|Physician Decision|0|||
106059853|NCT02732119|365879610|FG000|Phase II|Adverse Event|0|||
106059854|NCT02732119|365879611|FG001|Phase II|Adverse Event|0|||
106059855|NCT02732119|365879612|FG002|Phase II|Adverse Event|0|||
106059856|NCT02732119|365879613|FG003|Phase II|Adverse Event|3|||
106059857|NCT02732119|365879614|FG004|Phase II|Adverse Event|3|||
106059858|NCT02732119|365879610|FG000|Phase II|Death|0|||
106059859|NCT02732119|365879611|FG001|Phase II|Death|0|||
106059860|NCT02732119|365879612|FG002|Phase II|Death|0|||
106059861|NCT02732119|365879613|FG003|Phase II|Death|1|||
106059862|NCT02732119|365879614|FG004|Phase II|Death|0|||
106059863|NCT02732119|365879610|FG000|Phase II|Progressive dissease|0|||
106059864|NCT02732119|365879611|FG001|Phase II|Progressive dissease|0|||
106059865|NCT02732119|365879612|FG002|Phase II|Progressive dissease|0|||
106059866|NCT02732119|365879613|FG003|Phase II|Progressive dissease|30|||
106059867|NCT02732119|365879614|FG004|Phase II|Progressive dissease|23|||
106059868|NCT02732119|365879610|FG000|Phase II|Study terminated by sponsor|0|||
106059869|NCT02732119|365879611|FG001|Phase II|Study terminated by sponsor|0|||
106059870|NCT02732119|365879612|FG002|Phase II|Study terminated by sponsor|0|||
106059871|NCT02732119|365879613|FG003|Phase II|Study terminated by sponsor|2|||
106059872|NCT02732119|365879614|FG004|Phase II|Study terminated by sponsor|2|||
106059873|NCT02732119|365879610|FG000|Phase II|Other|0|||
106059874|NCT02732119|365879611|FG001|Phase II|Other|0|||
106059875|NCT02732119|365879612|FG002|Phase II|Other|0|||
106059876|NCT02732119|365879613|FG003|Phase II|Other|2|||
106059877|NCT02732119|365879614|FG004|Phase II|Other|0|||
106059878|NCT02732119|365879610|FG000|Phase II|Physician Decision|0|||
106059879|NCT02732119|365879611|FG001|Phase II|Physician Decision|0|||
106059880|NCT02732119|365879612|FG002|Phase II|Physician Decision|0|||
106059881|NCT02732119|365879613|FG003|Phase II|Physician Decision|8|||
106059882|NCT02732119|365879614|FG004|Phase II|Physician Decision|5|||
106059883|NCT02101060|365879615|FG000|Overall Study|Adverse Event|1|||
106059884|NCT02101060|365879616|FG001|Overall Study|Adverse Event|0|||
106059885|NCT02101060|365879615|FG000|Overall Study|Withdrawal by Subject|1|||
106059886|NCT02101060|365879616|FG001|Overall Study|Withdrawal by Subject|1|||
106059887|NCT02101060|365879615|FG000|Overall Study|Lost to Follow-up|3|||
106059888|NCT02101060|365879616|FG001|Overall Study|Lost to Follow-up|3|||
106059889|NCT00006237|365879617|FG000|Overall Study|Adverse Event|39|||
106059890|NCT00006237|365879618|FG001|Overall Study|Adverse Event|29|||
106059891|NCT00006237|365879617|FG000|Overall Study|Death|1|||
106059892|NCT00006237|365879618|FG001|Overall Study|Death|0|||
106059893|NCT00006237|365879617|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
106059894|NCT00006237|365879618|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
106059895|NCT00006237|365879617|FG000|Overall Study|Progression/relapse|54|||
106059896|NCT00006237|365879618|FG001|Overall Study|Progression/relapse|2|||
106059897|NCT00006237|365879617|FG000|Overall Study|Not eligible|9|||
106059898|NCT00006237|365879618|FG001|Overall Study|Not eligible|20|||
106059899|NCT00006237|365879617|FG000|Overall Study|Withdrawal by Subject|0|||
106059900|NCT00006237|365879618|FG001|Overall Study|Withdrawal by Subject|1|||
106059901|NCT00006237|365879617|FG000|Overall Study|Not protocol specified|14|||
106059902|NCT00006237|365879618|FG001|Overall Study|Not protocol specified|5|||
106059903|NCT00496054|365879625|FG000|Overall Study|Adverse Event|1|||
106059904|NCT00496054|365879625|FG000|Overall Study|Lost to Follow-up|7|||
106059905|NCT02207244|365879626|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
106059906|NCT02207244|365879627|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
106059907|NCT02207244|365879628|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
106059908|NCT02207244|365879629|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
106059909|NCT02207244|365879630|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
106059910|NCT02207244|365879631|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
106059911|NCT02207244|365879632|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
106059912|NCT02207244|365879633|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
106059913|NCT02207244|365879634|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
106059914|NCT02207244|365879635|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
106059915|NCT02207244|365879636|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
106059916|NCT02207244|365879626|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
106059917|NCT02207244|365879627|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106152863|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
106059918|NCT02207244|365879628|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
106059919|NCT02207244|365879629|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106059920|NCT02207244|365879630|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106059921|NCT02207244|365879631|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106059922|NCT02207244|365879632|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106059923|NCT02207244|365879633|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106059924|NCT02207244|365879634|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106059925|NCT02207244|365879635|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106059926|NCT02207244|365879636|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
106059927|NCT02207244|365879626|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
106059928|NCT02207244|365879627|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
106152864|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
106059929|NCT02207244|365879628|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
106059930|NCT02207244|365879629|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
106059931|NCT02207244|365879630|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
106059932|NCT02207244|365879631|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
106059933|NCT02207244|365879632|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
106059934|NCT02207244|365879633|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
106059935|NCT02207244|365879634|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
106059936|NCT02207244|365879635|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
106059937|NCT02207244|365879636|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
106059938|NCT02207244|365879626|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
106059939|NCT02207244|365879627|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
106059940|NCT02207244|365879628|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059941|NCT02207244|365879629|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059942|NCT02207244|365879630|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059943|NCT02207244|365879631|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059944|NCT02207244|365879632|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059945|NCT02207244|365879633|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059946|NCT02207244|365879634|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059947|NCT02207244|365879635|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059948|NCT02207244|365879636|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
106059949|NCT02207244|365879626|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
106059950|NCT02207244|365879627|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
106059951|NCT02207244|365879628|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
106059952|NCT02207244|365879629|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
106059953|NCT02207244|365879630|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
106059954|NCT02207244|365879631|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
106059955|NCT02207244|365879632|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
106059956|NCT02207244|365879633|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
106059957|NCT02207244|365879634|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
106059958|NCT02207244|365879635|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
106059959|NCT02207244|365879636|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
105864709|NCT03207867|365152989|FG000|Overall Study|Death|0|||
105864710|NCT03207867|365152990|FG001|Overall Study|Death|0|||
105864711|NCT03207867|365152991|FG002|Overall Study|Death|0|||
105864712|NCT03207867|365152992|FG003|Overall Study|Death|0|||
105864713|NCT03207867|365152993|FG004|Overall Study|Death|0|||
105864714|NCT03207867|365152994|FG005|Overall Study|Death|1|||
105864715|NCT03207867|365152995|FG006|Overall Study|Death|0|||
105864716|NCT03207867|365152996|FG007|Overall Study|Death|3|||
105864717|NCT03207867|365152997|FG008|Overall Study|Death|1|||
105864718|NCT03207867|365152998|FG009|Overall Study|Death|2|||
105864719|NCT03207867|365152999|FG010|Overall Study|Death|0|||
105864720|NCT03207867|365153000|FG011|Overall Study|Death|1|||
105864721|NCT03207867|365153001|FG012|Overall Study|Death|0|||
105864722|NCT03207867|365153002|FG013|Overall Study|Death|1|||
105864723|NCT03207867|365153003|FG014|Overall Study|Death|0|||
105864724|NCT03207867|365153004|FG015|Overall Study|Death|0|||
105864725|NCT03207867|365153005|FG016|Overall Study|Death|0|||
105864726|NCT03207867|365153006|FG017|Overall Study|Death|2|||
105864727|NCT03207867|365153007|FG018|Overall Study|Death|0|||
105864728|NCT03207867|365153008|FG019|Overall Study|Death|1|||
105864729|NCT03207867|365153009|FG020|Overall Study|Death|0|||
105864730|NCT03207867|365153010|FG021|Overall Study|Death|0|||
105864731|NCT03207867|365153011|FG022|Overall Study|Death|0|||
106059960|NCT02207244|365879626|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
106059961|NCT02207244|365879627|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
106059962|NCT02207244|365879628|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
106059963|NCT02207244|365879629|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
106059964|NCT02207244|365879630|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
106059965|NCT02207244|365879631|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
106059966|NCT02207244|365879632|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
106059967|NCT02207244|365879633|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
106059968|NCT02207244|365879634|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105864732|NCT03207867|365153012|FG023|Overall Study|Death|0|||
105864733|NCT03207867|365152989|FG000|Overall Study|Physician Decision|3|||
105864734|NCT03207867|365152990|FG001|Overall Study|Physician Decision|5|||
105864735|NCT03207867|365152991|FG002|Overall Study|Physician Decision|0|||
105864736|NCT03207867|365152992|FG003|Overall Study|Physician Decision|3|||
106059969|NCT02207244|365879635|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
105864737|NCT03207867|365152993|FG004|Overall Study|Physician Decision|2|||
105864738|NCT03207867|365152994|FG005|Overall Study|Physician Decision|0|||
105864739|NCT03207867|365152995|FG006|Overall Study|Physician Decision|0|||
106059970|NCT02207244|365879636|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
106059971|NCT02207244|365879626|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059972|NCT02207244|365879627|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
106059973|NCT02207244|365879628|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059974|NCT02207244|365879629|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059975|NCT02207244|365879630|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059976|NCT02207244|365879631|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059977|NCT02207244|365879632|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059978|NCT02207244|365879633|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059979|NCT02207244|365879634|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059980|NCT02207244|365879635|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059981|NCT02207244|365879636|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
106059982|NCT02207244|365879626|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059983|NCT02207244|365879627|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059984|NCT02207244|365879628|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059985|NCT02207244|365879629|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059986|NCT02207244|365879630|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
106059987|NCT02207244|365879631|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
106059988|NCT02207244|365879632|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059989|NCT02207244|365879633|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059990|NCT02207244|365879634|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059991|NCT02207244|365879635|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059992|NCT02207244|365879636|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
106059993|NCT02207244|365879626|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106059994|NCT02207244|365879627|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106059995|NCT02207244|365879628|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106059996|NCT02207244|365879629|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106059997|NCT02207244|365879630|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106059998|NCT02207244|365879631|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
106059999|NCT02207244|365879632|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106060000|NCT02207244|365879633|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106060001|NCT02207244|365879634|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106060002|NCT02207244|365879635|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106060003|NCT02207244|365879636|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
106060004|NCT02207244|365879626|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
106060005|NCT02207244|365879627|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
106060006|NCT02207244|365879628|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
106060007|NCT02207244|365879629|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
106060008|NCT02207244|365879630|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
106060009|NCT02207244|365879631|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
106060010|NCT02207244|365879632|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
106060011|NCT02207244|365879633|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
106060012|NCT02207244|365879634|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
106060013|NCT02207244|365879635|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
106060014|NCT02207244|365879636|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
106060015|NCT02207244|365879626|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
106060016|NCT02207244|365879627|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
106060017|NCT02207244|365879628|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
106060018|NCT02207244|365879629|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
106060019|NCT02207244|365879630|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
106060020|NCT02207244|365879631|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
106060021|NCT02207244|365879632|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
106060022|NCT02207244|365879633|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
106060023|NCT02207244|365879634|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
106060024|NCT02207244|365879635|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
106060025|NCT02207244|365879636|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
106060026|NCT02207244|365879626|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060027|NCT02207244|365879627|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060028|NCT02207244|365879628|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060029|NCT02207244|365879629|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
106060030|NCT02207244|365879630|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060031|NCT02207244|365879631|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
106060032|NCT02207244|365879632|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060033|NCT02207244|365879633|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060034|NCT02207244|365879634|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060035|NCT02207244|365879635|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060036|NCT02207244|365879636|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
106060037|NCT02207244|365879626|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060038|NCT02207244|365879627|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060039|NCT02207244|365879628|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060040|NCT02207244|365879629|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
106060041|NCT02207244|365879630|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060042|NCT02207244|365879631|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060043|NCT02207244|365879632|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060044|NCT02207244|365879633|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060045|NCT02207244|365879634|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060046|NCT02207244|365879635|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060047|NCT02207244|365879636|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
106060048|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
106060049|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
106060050|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
106060051|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
106060052|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
106060053|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
106060054|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
106060055|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
106060056|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
106060057|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
106060058|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
106060059|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060060|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060061|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060062|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060063|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060064|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060065|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060066|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
106060067|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060068|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060069|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
106060070|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
106060071|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
106060072|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
106060073|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
106060074|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
106060075|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
106060076|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
106060077|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
106060078|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
106060079|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
106060080|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
106060081|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
106060082|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
106060083|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
106152865|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
106152866|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
106152867|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
106152868|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
106152869|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
106152870|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
106152871|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
106152872|NCT03939312|366219659|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
106152873|NCT03939312|366219659|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
106152874|NCT03939312|366219659|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
106152875|NCT06024174|366219660|FG000|Overall Study|Other Reasons|1|||
106152876|NCT06024174|366219660|FG000|Overall Study|Study terminated by Sponsor|4|||
106152877|NCT05505045|366221974|FG000|Overall Study|Withdrawal by Subject|2|||
106152878|NCT05505045|366221975|FG001|Overall Study|Withdrawal by Subject|1|||
106152879|NCT01012817|366221976|FG000|Overall Study|Withdrawal by Subject|0|||
106152880|NCT01012817|366221977|FG001|Overall Study|Withdrawal by Subject|0|||
106152881|NCT01012817|366221978|FG002|Overall Study|Withdrawal by Subject|0|||
106152882|NCT01012817|366221979|FG003|Overall Study|Withdrawal by Subject|1|||
106152883|NCT01012817|366221980|FG004|Overall Study|Withdrawal by Subject|0|||
106152884|NCT01012817|366221981|FG005|Overall Study|Withdrawal by Subject|0|||
106152885|NCT01012817|366221982|FG006|Overall Study|Withdrawal by Subject|0|||
106152886|NCT01012817|366221983|FG007|Overall Study|Withdrawal by Subject|1|||
106152887|NCT01012817|366221984|FG008|Overall Study|Withdrawal by Subject|0|||
106152888|NCT01012817|366221985|FG009|Overall Study|Withdrawal by Subject|0|||
106152889|NCT01012817|366221986|FG010|Overall Study|Withdrawal by Subject|1|||
106152890|NCT01012817|366221987|FG011|Overall Study|Withdrawal by Subject|1|||
106152891|NCT01012817|366221988|FG012|Overall Study|Withdrawal by Subject|0|||
106152892|NCT01012817|366221989|FG013|Overall Study|Withdrawal by Subject|1|||
106152893|NCT01012817|366221976|FG000|Overall Study|Adverse Event|0|||
106152894|NCT01012817|366221977|FG001|Overall Study|Adverse Event|0|||
106152895|NCT01012817|366221978|FG002|Overall Study|Adverse Event|0|||
106152896|NCT01012817|366221979|FG003|Overall Study|Adverse Event|0|||
106152897|NCT01012817|366221980|FG004|Overall Study|Adverse Event|0|||
106152898|NCT01012817|366221981|FG005|Overall Study|Adverse Event|1|||
106152899|NCT01012817|366221982|FG006|Overall Study|Adverse Event|0|||
106152900|NCT01012817|366221983|FG007|Overall Study|Adverse Event|0|||
106152901|NCT01012817|366221984|FG008|Overall Study|Adverse Event|0|||
106152902|NCT01012817|366221985|FG009|Overall Study|Adverse Event|0|||
106152903|NCT01012817|366221986|FG010|Overall Study|Adverse Event|1|||
106152904|NCT01012817|366221987|FG011|Overall Study|Adverse Event|0|||
106152905|NCT01012817|366221988|FG012|Overall Study|Adverse Event|0|||
106152906|NCT01012817|366221989|FG013|Overall Study|Adverse Event|1|||
106152907|NCT01600014|366221990|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
106060084|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
106060085|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
106060086|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
106060087|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
106060088|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
106060089|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
106060090|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
106060091|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
106060092|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
106060093|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
106060094|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
106060095|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
106060096|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
106060097|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
106060098|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
106060099|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
106060100|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
106152908|NCT01600014|366221991|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
106152909|NCT01600014|366221990|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
106152910|NCT01600014|366221991|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
106152911|NCT01600014|366221990|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
106152912|NCT01600014|366221991|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
106060101|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
106060102|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
106152913|NCT01600014|366221990|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
106152914|NCT01600014|366221991|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
106152915|NCT01600014|366221990|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
106152916|NCT01600014|366221991|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
106152917|NCT01600014|366221990|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
106152918|NCT01600014|366221991|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
106152919|NCT01600014|366221990|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
106152920|NCT01600014|366221991|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
106152921|NCT01600014|366221990|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
106152922|NCT01600014|366221991|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
106152923|NCT01600014|366221990|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
106152924|NCT01600014|366221991|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
106152925|NCT01600014|366221990|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
106152926|NCT01600014|366221991|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
106152927|NCT01600014|366221990|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
106152928|NCT01600014|366221991|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
106152929|NCT01600014|366221990|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
106152930|NCT01600014|366221991|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
106152931|NCT01600014|366221990|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
106152932|NCT01600014|366221991|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
106152933|NCT01600014|366221990|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
106152934|NCT01600014|366221991|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
106152935|NCT01600014|366221990|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
106152936|NCT01600014|366221991|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
106152937|NCT01600014|366221990|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
106152938|NCT01600014|366221991|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
106152939|NCT01600014|366221990|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
106152940|NCT01600014|366221991|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
106152941|NCT03152786|366221995|FG000|Overall Study|Withdrawal by Subject|2|||
106152942|NCT03152786|366221996|FG001|Overall Study|Withdrawal by Subject|1|||
106152943|NCT04923347|366221997|FG000|Overall Study|Withdrawal by Subject|14|||
106152944|NCT03481660|366221998|FG000|Overall Study|Adverse Event|5|||
106152945|NCT03481660|366221999|FG001|Overall Study|Adverse Event|4|||
106152946|NCT03481660|366221998|FG000|Overall Study|Death|13|||
106152947|NCT03481660|366221999|FG001|Overall Study|Death|9|||
106152948|NCT03481660|366221998|FG000|Overall Study|Lost to Follow-up|2|||
106152949|NCT03481660|366221999|FG001|Overall Study|Lost to Follow-up|2|||
106152950|NCT03481660|366221998|FG000|Overall Study|Physician Decision|2|||
106152951|NCT03481660|366221999|FG001|Overall Study|Physician Decision|3|||
106152952|NCT03481660|366221998|FG000|Overall Study|Withdrawal by Subject|14|||
106152953|NCT03481660|366221999|FG001|Overall Study|Withdrawal by Subject|7|||
106152954|NCT01649271|366222000|FG000|Overall Study|Progressive disease|4|||
106152955|NCT01649271|366222001|FG001|Overall Study|Progressive disease|5|||
105864740|NCT03207867|365152996|FG007|Overall Study|Physician Decision|0|||
105864741|NCT03207867|365152997|FG008|Overall Study|Physician Decision|4|||
105864742|NCT03207867|365152998|FG009|Overall Study|Physician Decision|2|||
105864743|NCT03207867|365152999|FG010|Overall Study|Physician Decision|0|||
105864744|NCT03207867|365153000|FG011|Overall Study|Physician Decision|4|||
105864745|NCT03207867|365153001|FG012|Overall Study|Physician Decision|0|||
105864746|NCT03207867|365153002|FG013|Overall Study|Physician Decision|0|||
105864747|NCT03207867|365153003|FG014|Overall Study|Physician Decision|2|||
106152956|NCT01649271|366222000|FG000|Overall Study|Other Adverse Event|0|||
106152957|NCT01649271|366222001|FG001|Overall Study|Other Adverse Event|2|||
106152958|NCT01649271|366222000|FG000|Overall Study|Withdrawal by Subject|1|||
106152959|NCT01649271|366222001|FG001|Overall Study|Withdrawal by Subject|0|||
106152960|NCT01649271|366222000|FG000|Overall Study|Other than stated above|1|||
106152961|NCT01649271|366222001|FG001|Overall Study|Other than stated above|0|||
106152962|NCT04842500|366222004|FG000|Overall Study|Withdrawal by Subject|4|||
106152963|NCT04842500|366222005|FG001|Overall Study|Withdrawal by Subject|1|||
106152964|NCT04842500|366222006|FG002|Overall Study|Withdrawal by Subject|2|||
106152965|NCT04842500|366222007|FG003|Overall Study|Withdrawal by Subject|3|||
106152966|NCT04842500|366222004|FG000|Overall Study|Protocol Violation|1|||
106152967|NCT04842500|366222005|FG001|Overall Study|Protocol Violation|0|||
106152968|NCT04842500|366222006|FG002|Overall Study|Protocol Violation|0|||
106152969|NCT04842500|366222007|FG003|Overall Study|Protocol Violation|1|||
105864748|NCT03207867|365153004|FG015|Overall Study|Physician Decision|1|||
105864749|NCT03207867|365153005|FG016|Overall Study|Physician Decision|1|||
106152970|NCT05756075|366222010|FG000|Overall Study|Withdrawal by Subject|16|||
106152971|NCT05756075|366222011|FG001|Overall Study|Withdrawal by Subject|9|||
106152972|NCT00092534|366222012|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
105864750|NCT03207867|365153006|FG017|Overall Study|Physician Decision|2|||
106060103|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060104|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060105|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060106|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060107|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060108|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060109|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060110|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
106060111|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
106060112|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060113|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
106060114|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060115|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060116|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060117|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060118|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060119|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060120|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060121|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060122|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
106060123|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060124|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
106060125|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060126|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060127|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060128|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060129|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060130|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060131|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060132|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
106060133|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060134|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060135|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
106060136|NCT02207244|365879626|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060137|NCT02207244|365879627|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060138|NCT02207244|365879628|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060139|NCT02207244|365879629|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060140|NCT02207244|365879630|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060141|NCT02207244|365879631|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060142|NCT02207244|365879632|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
106060143|NCT02207244|365879633|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060144|NCT02207244|365879634|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060145|NCT02207244|365879635|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060146|NCT02207244|365879636|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
106060147|NCT02207244|365879626|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060148|NCT02207244|365879627|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060149|NCT02207244|365879628|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060150|NCT02207244|365879629|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060151|NCT02207244|365879630|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060152|NCT02207244|365879631|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060153|NCT02207244|365879632|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060154|NCT02207244|365879633|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060155|NCT02207244|365879634|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
106060156|NCT02207244|365879635|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
106060157|NCT02207244|365879636|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
106060158|NCT02207244|365879626|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
106060159|NCT02207244|365879627|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
106060160|NCT02207244|365879628|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
106060161|NCT02207244|365879629|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
105864751|NCT03207867|365153007|FG018|Overall Study|Physician Decision|1|||
105864752|NCT03207867|365153008|FG019|Overall Study|Physician Decision|3|||
105864753|NCT03207867|365153009|FG020|Overall Study|Physician Decision|0|||
105864754|NCT03207867|365153010|FG021|Overall Study|Physician Decision|0|||
106060162|NCT02207244|365879630|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
106060163|NCT02207244|365879631|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
106060164|NCT02207244|365879632|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
106060165|NCT02207244|365879633|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
106060166|NCT02207244|365879634|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
106060167|NCT02207244|365879635|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
106060168|NCT02207244|365879636|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
106060169|NCT02207244|365879626|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060170|NCT02207244|365879627|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060171|NCT02207244|365879628|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060172|NCT02207244|365879629|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060173|NCT02207244|365879630|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060174|NCT02207244|365879631|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060175|NCT02207244|365879632|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060176|NCT02207244|365879633|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060177|NCT02207244|365879634|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
106060178|NCT02207244|365879635|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
106060179|NCT02207244|365879636|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
106060180|NCT02207244|365879626|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060181|NCT02207244|365879627|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060182|NCT02207244|365879628|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060183|NCT02207244|365879629|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060184|NCT02207244|365879630|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060185|NCT02207244|365879631|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060186|NCT02207244|365879632|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060187|NCT02207244|365879633|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060188|NCT02207244|365879634|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
106060189|NCT02207244|365879635|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
106060190|NCT02207244|365879636|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
106060191|NCT02207244|365879626|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
106060192|NCT02207244|365879627|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
106060193|NCT02207244|365879628|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
106060194|NCT02207244|365879629|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
106060195|NCT02207244|365879630|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
106060196|NCT02207244|365879631|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
106060197|NCT02207244|365879632|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
106060198|NCT02207244|365879633|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
106060199|NCT02207244|365879634|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
106060200|NCT02207244|365879635|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
106060201|NCT02207244|365879636|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
106060202|NCT02207244|365879626|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
106060203|NCT02207244|365879627|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
106060204|NCT02207244|365879628|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
106060205|NCT02207244|365879629|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
106060206|NCT02207244|365879630|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
106060207|NCT02207244|365879631|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
106060208|NCT02207244|365879632|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
106060209|NCT02207244|365879633|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
106060210|NCT02207244|365879634|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
106060211|NCT02207244|365879635|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
106060212|NCT02207244|365879636|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
106060213|NCT02207244|365879626|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060214|NCT02207244|365879627|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060215|NCT02207244|365879628|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060216|NCT02207244|365879629|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060217|NCT02207244|365879630|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060218|NCT02207244|365879631|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060219|NCT02207244|365879632|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060220|NCT02207244|365879633|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060221|NCT02207244|365879634|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060222|NCT02207244|365879635|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
106060223|NCT02207244|365879636|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
106060224|NCT01866930|365879637|FG000|Treatment Period|Other|1|||
106060225|NCT01866930|365879638|FG001|Treatment Period|Other|0|||
106152973|NCT00092534|366222013|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
106152974|NCT00092534|366222014|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
106152975|NCT00092534|366222015|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
106152976|NCT00092534|366222016|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
106060226|NCT01866930|365879637|FG000|Treatment Period|Death|0|||
106060227|NCT01866930|365879638|FG001|Treatment Period|Death|2|||
106060228|NCT01866930|365879637|FG000|Treatment Period|Poor/non compliance|0|||
106152977|NCT00092534|366222012|FG000|Base Study Vaccination Period|Adverse Event|3|||
106152978|NCT00092534|366222013|FG001|Base Study Vaccination Period|Adverse Event|1|||
106152979|NCT00092534|366222014|FG002|Base Study Vaccination Period|Adverse Event|0|||
106152980|NCT00092534|366222015|FG003|Base Study Vaccination Period|Adverse Event|0|||
106152981|NCT00092534|366222016|FG004|Base Study Vaccination Period|Adverse Event|0|||
106152982|NCT00092534|366222012|FG000|Base Study Vaccination Period|Death|5|||
106152983|NCT00092534|366222013|FG001|Base Study Vaccination Period|Death|4|||
106152984|NCT00092534|366222014|FG002|Base Study Vaccination Period|Death|0|||
106152985|NCT00092534|366222015|FG003|Base Study Vaccination Period|Death|0|||
106152986|NCT00092534|366222016|FG004|Base Study Vaccination Period|Death|0|||
106152987|NCT00092534|366222012|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
106152988|NCT00092534|366222013|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
106152989|NCT00092534|366222014|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
106152990|NCT00092534|366222015|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
106152991|NCT00092534|366222016|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
106152992|NCT00092534|366222012|FG000|Base Study Vaccination Period|Physician Decision|1|||
106152993|NCT00092534|366222013|FG001|Base Study Vaccination Period|Physician Decision|0|||
106152994|NCT00092534|366222014|FG002|Base Study Vaccination Period|Physician Decision|0|||
106152995|NCT00092534|366222015|FG003|Base Study Vaccination Period|Physician Decision|0|||
106152996|NCT00092534|366222016|FG004|Base Study Vaccination Period|Physician Decision|0|||
106152997|NCT00092534|366222012|FG000|Base Study Vaccination Period|Pregnancy|9|||
106152998|NCT00092534|366222013|FG001|Base Study Vaccination Period|Pregnancy|7|||
106152999|NCT00092534|366222014|FG002|Base Study Vaccination Period|Pregnancy|0|||
106153000|NCT00092534|366222015|FG003|Base Study Vaccination Period|Pregnancy|0|||
106153001|NCT00092534|366222016|FG004|Base Study Vaccination Period|Pregnancy|0|||
106153002|NCT00092534|366222012|FG000|Base Study Vaccination Period|Protocol Violation|2|||
106153003|NCT00092534|366222013|FG001|Base Study Vaccination Period|Protocol Violation|1|||
106153004|NCT00092534|366222014|FG002|Base Study Vaccination Period|Protocol Violation|0|||
106153005|NCT00092534|366222015|FG003|Base Study Vaccination Period|Protocol Violation|0|||
106153006|NCT00092534|366222016|FG004|Base Study Vaccination Period|Protocol Violation|0|||
106153007|NCT00092534|366222012|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
106153008|NCT00092534|366222013|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
106153009|NCT00092534|366222014|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
106153010|NCT00092534|366222015|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
106153011|NCT00092534|366222016|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
106153012|NCT00092534|366222012|FG000|Base Study Vaccination Period|Moved|14|||
106153013|NCT00092534|366222013|FG001|Base Study Vaccination Period|Moved|12|||
106153014|NCT00092534|366222014|FG002|Base Study Vaccination Period|Moved|0|||
106153015|NCT00092534|366222015|FG003|Base Study Vaccination Period|Moved|0|||
106153016|NCT00092534|366222016|FG004|Base Study Vaccination Period|Moved|0|||
106153017|NCT00092534|366222012|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
106153018|NCT00092534|366222013|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
106153019|NCT00092534|366222014|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
106153020|NCT00092534|366222015|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
106153021|NCT00092534|366222016|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
106153022|NCT00092534|366222012|FG000|Base Study Vaccination Period|Travel|1|||
106153023|NCT00092534|366222013|FG001|Base Study Vaccination Period|Travel|0|||
106153024|NCT00092534|366222014|FG002|Base Study Vaccination Period|Travel|0|||
106153025|NCT00092534|366222015|FG003|Base Study Vaccination Period|Travel|0|||
106153026|NCT00092534|366222016|FG004|Base Study Vaccination Period|Travel|0|||
106153027|NCT00092534|366222012|FG000|Base Study Vaccination Period|Site Closed|0|||
106153028|NCT00092534|366222013|FG001|Base Study Vaccination Period|Site Closed|1|||
106153029|NCT00092534|366222014|FG002|Base Study Vaccination Period|Site Closed|0|||
106153030|NCT00092534|366222015|FG003|Base Study Vaccination Period|Site Closed|0|||
106153031|NCT00092534|366222016|FG004|Base Study Vaccination Period|Site Closed|0|||
106153032|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Adverse Event|2|||
106153033|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Adverse Event|4|||
106153034|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Adverse Event|0|||
106153035|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Adverse Event|0|||
106153036|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Adverse Event|0|||
106153037|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Death|2|||
106153038|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Death|1|||
106153039|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Death|0|||
106153040|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Death|0|||
106153041|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Death|0|||
106153042|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
106153043|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
106153044|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
106153045|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
106153046|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
106153047|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Pregnancy|6|||
106153048|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Pregnancy|10|||
106060229|NCT01866930|365879638|FG001|Treatment Period|Poor/non compliance|2|||
106060230|NCT01866930|365879637|FG000|Treatment Period|No longer meets study criteria|0|||
106060231|NCT01866930|365879638|FG001|Treatment Period|No longer meets study criteria|1|||
106060232|NCT01866930|365879637|FG000|Treatment Period|Withdrawal by Subject|2|||
106060233|NCT01866930|365879638|FG001|Treatment Period|Withdrawal by Subject|8|||
106060234|NCT01866930|365879637|FG000|Treatment Period|Lack of Efficacy|1|||
106060235|NCT01866930|365879638|FG001|Treatment Period|Lack of Efficacy|9|||
106060236|NCT01866930|365879637|FG000|Treatment Period|Adverse Event|4|||
105864755|NCT03207867|365153011|FG022|Overall Study|Physician Decision|0|||
106060237|NCT01866930|365879638|FG001|Treatment Period|Adverse Event|12|||
106060238|NCT01866930|365879637|FG000|Treatment Period|Lost to Follow-up|1|||
106060239|NCT01866930|365879638|FG001|Treatment Period|Lost to Follow-up|1|||
106060240|NCT01866930|365879637|FG000|Follow-up Period|Lost to Follow-up|1|||
106060241|NCT01866930|365879638|FG001|Follow-up Period|Lost to Follow-up|1|||
106060242|NCT01866930|365879637|FG000|Follow-up Period|Other|1|||
106060243|NCT01866930|365879638|FG001|Follow-up Period|Other|5|||
106060244|NCT01866930|365879637|FG000|Follow-up Period|No longer required per protocol|1|||
106060245|NCT01866930|365879638|FG001|Follow-up Period|No longer required per protocol|0|||
106060246|NCT01866930|365879637|FG000|Follow-up Period|Withdrawal by Subject|3|||
106060247|NCT01866930|365879638|FG001|Follow-up Period|Withdrawal by Subject|3|||
106060248|NCT03648983|365879639|FG000|Overall Study|Study was terminated due to PI departure|95|||
106060249|NCT03572062|365879640|FG000|Overall Study|Adverse Event|0|||
106060250|NCT03572062|365879641|FG001|Overall Study|Adverse Event|0|||
106060251|NCT03572062|365879642|FG002|Overall Study|Adverse Event|0|||
106060252|NCT03572062|365879643|FG003|Overall Study|Adverse Event|0|||
106060253|NCT03572062|365879644|FG004|Overall Study|Adverse Event|0|||
106060254|NCT03572062|365879645|FG005|Overall Study|Adverse Event|0|||
106060255|NCT03572062|365879646|FG006|Overall Study|Adverse Event|0|||
106060256|NCT03572062|365879647|FG007|Overall Study|Adverse Event|0|||
106060257|NCT03572062|365879648|FG008|Overall Study|Adverse Event|1|||
106060258|NCT03572062|365879649|FG009|Overall Study|Adverse Event|3|||
106060259|NCT03572062|365879640|FG000|Overall Study|Death|0|||
106060260|NCT03572062|365879641|FG001|Overall Study|Death|0|||
106060261|NCT03572062|365879642|FG002|Overall Study|Death|0|||
106060262|NCT03572062|365879643|FG003|Overall Study|Death|0|||
106060263|NCT03572062|365879644|FG004|Overall Study|Death|0|||
106060264|NCT03572062|365879645|FG005|Overall Study|Death|1|||
106060265|NCT03572062|365879646|FG006|Overall Study|Death|0|||
106060266|NCT03572062|365879647|FG007|Overall Study|Death|0|||
106060267|NCT03572062|365879648|FG008|Overall Study|Death|0|||
106060268|NCT03572062|365879649|FG009|Overall Study|Death|0|||
106060269|NCT03572062|365879640|FG000|Overall Study|Lost to Follow-up|0|||
106060270|NCT03572062|365879641|FG001|Overall Study|Lost to Follow-up|0|||
106060271|NCT03572062|365879642|FG002|Overall Study|Lost to Follow-up|0|||
106060272|NCT03572062|365879643|FG003|Overall Study|Lost to Follow-up|0|||
106060273|NCT03572062|365879644|FG004|Overall Study|Lost to Follow-up|0|||
106060274|NCT03572062|365879645|FG005|Overall Study|Lost to Follow-up|1|||
106060275|NCT03572062|365879646|FG006|Overall Study|Lost to Follow-up|1|||
106060276|NCT03572062|365879647|FG007|Overall Study|Lost to Follow-up|0|||
106060277|NCT03572062|365879648|FG008|Overall Study|Lost to Follow-up|0|||
106060278|NCT03572062|365879649|FG009|Overall Study|Lost to Follow-up|0|||
106060279|NCT03572062|365879640|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060280|NCT03572062|365879641|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060281|NCT03572062|365879642|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060282|NCT03572062|365879643|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060283|NCT03572062|365879644|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060284|NCT03572062|365879645|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060285|NCT03572062|365879646|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060286|NCT03572062|365879647|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060287|NCT03572062|365879648|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
106060288|NCT03572062|365879649|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
106060289|NCT03572062|365879640|FG000|Overall Study|Study Terminated By Sponsor|0|||
106153049|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Pregnancy|0|||
106153050|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Pregnancy|0|||
106153051|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Pregnancy|0|||
106060290|NCT03572062|365879641|FG001|Overall Study|Study Terminated By Sponsor|0|||
106060291|NCT03572062|365879642|FG002|Overall Study|Study Terminated By Sponsor|0|||
106060292|NCT03572062|365879643|FG003|Overall Study|Study Terminated By Sponsor|0|||
106060293|NCT03572062|365879644|FG004|Overall Study|Study Terminated By Sponsor|0|||
106060294|NCT03572062|365879645|FG005|Overall Study|Study Terminated By Sponsor|0|||
106060295|NCT03572062|365879646|FG006|Overall Study|Study Terminated By Sponsor|0|||
106060296|NCT03572062|365879647|FG007|Overall Study|Study Terminated By Sponsor|0|||
106060297|NCT03572062|365879648|FG008|Overall Study|Study Terminated By Sponsor|29|||
106060298|NCT03572062|365879649|FG009|Overall Study|Study Terminated By Sponsor|27|||
106060299|NCT03572062|365879640|FG000|Overall Study|Physician Decision|0|||
106060300|NCT03572062|365879641|FG001|Overall Study|Physician Decision|0|||
106060301|NCT03572062|365879642|FG002|Overall Study|Physician Decision|0|||
106153052|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
106153053|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
106153054|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
106153055|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
106153056|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
106153057|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
106153058|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
106153059|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
106153060|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
106153061|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
106153062|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Moved|62|||
106153063|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Moved|58|||
106153064|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Moved|0|||
106153065|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Moved|0|||
106153066|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Moved|0|||
106153067|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Travel|10|||
106153068|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Travel|7|||
106153069|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Travel|0|||
106153070|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Travel|0|||
106153071|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Travel|0|||
106153072|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Site Closed|0|||
106153073|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Site Closed|2|||
106153074|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Site Closed|0|||
106153075|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Site Closed|0|||
106153076|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Site Closed|0|||
106153077|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
106153078|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
106153079|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
106153080|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
106153081|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
106153082|NCT00092534|366222012|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
106153083|NCT00092534|366222013|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
106153084|NCT00092534|366222014|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
106153085|NCT00092534|366222015|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
106153086|NCT00092534|366222016|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
106153087|NCT00092534|366222012|FG000|Base Study EXT|Lost to Follow-up|0|||
106153088|NCT00092534|366222013|FG001|Base Study EXT|Lost to Follow-up|0|||
106153089|NCT00092534|366222014|FG002|Base Study EXT|Lost to Follow-up|41|||
106153090|NCT00092534|366222015|FG003|Base Study EXT|Lost to Follow-up|0|||
106153091|NCT00092534|366222016|FG004|Base Study EXT|Lost to Follow-up|0|||
106153092|NCT00092534|366222012|FG000|Base Study EXT|Physician Decision|0|||
106153093|NCT00092534|366222013|FG001|Base Study EXT|Physician Decision|0|||
106153094|NCT00092534|366222014|FG002|Base Study EXT|Physician Decision|1|||
106153095|NCT00092534|366222015|FG003|Base Study EXT|Physician Decision|0|||
106153096|NCT00092534|366222016|FG004|Base Study EXT|Physician Decision|0|||
106060302|NCT03572062|365879643|FG003|Overall Study|Physician Decision|0|||
106060303|NCT03572062|365879644|FG004|Overall Study|Physician Decision|0|||
106060304|NCT03572062|365879645|FG005|Overall Study|Physician Decision|0|||
106060305|NCT03572062|365879646|FG006|Overall Study|Physician Decision|0|||
106060306|NCT03572062|365879647|FG007|Overall Study|Physician Decision|0|||
106060307|NCT03572062|365879648|FG008|Overall Study|Physician Decision|1|||
106060308|NCT03572062|365879649|FG009|Overall Study|Physician Decision|0|||
106060309|NCT03572062|365879640|FG000|Overall Study|Withdrawal by Subject|0|||
106060310|NCT03572062|365879641|FG001|Overall Study|Withdrawal by Subject|0|||
106060311|NCT03572062|365879642|FG002|Overall Study|Withdrawal by Subject|0|||
106060312|NCT03572062|365879643|FG003|Overall Study|Withdrawal by Subject|0|||
106060313|NCT03572062|365879644|FG004|Overall Study|Withdrawal by Subject|0|||
106060314|NCT03572062|365879645|FG005|Overall Study|Withdrawal by Subject|0|||
106060315|NCT03572062|365879646|FG006|Overall Study|Withdrawal by Subject|0|||
106060316|NCT03572062|365879647|FG007|Overall Study|Withdrawal by Subject|0|||
106153097|NCT00092534|366222012|FG000|Base Study EXT|Pregnancy|0|||
106153098|NCT00092534|366222013|FG001|Base Study EXT|Pregnancy|0|||
106153099|NCT00092534|366222014|FG002|Base Study EXT|Pregnancy|12|||
106153100|NCT00092534|366222015|FG003|Base Study EXT|Pregnancy|0|||
106153101|NCT00092534|366222016|FG004|Base Study EXT|Pregnancy|0|||
106153102|NCT00092534|366222012|FG000|Base Study EXT|Withdrawal by Subject|0|||
106153103|NCT00092534|366222013|FG001|Base Study EXT|Withdrawal by Subject|0|||
106153104|NCT00092534|366222014|FG002|Base Study EXT|Withdrawal by Subject|18|||
106153105|NCT00092534|366222015|FG003|Base Study EXT|Withdrawal by Subject|0|||
106060317|NCT03572062|365879648|FG008|Overall Study|Withdrawal by Subject|0|||
106060318|NCT03572062|365879649|FG009|Overall Study|Withdrawal by Subject|1|||
106060319|NCT03572062|365879640|FG000|Overall Study|Randomized But Not Treated|0|||
106060320|NCT03572062|365879641|FG001|Overall Study|Randomized But Not Treated|0|||
106060321|NCT03572062|365879642|FG002|Overall Study|Randomized But Not Treated|0|||
106153106|NCT00092534|366222016|FG004|Base Study EXT|Withdrawal by Subject|0|||
106153107|NCT00092534|366222012|FG000|Base Study EXT|Participant moved|0|||
106153108|NCT00092534|366222013|FG001|Base Study EXT|Participant moved|0|||
106153109|NCT00092534|366222014|FG002|Base Study EXT|Participant moved|6|||
106153110|NCT00092534|366222015|FG003|Base Study EXT|Participant moved|0|||
106153111|NCT00092534|366222016|FG004|Base Study EXT|Participant moved|0|||
106153112|NCT00092534|366222012|FG000|Base Study EXT|Travel|0|||
106153113|NCT00092534|366222013|FG001|Base Study EXT|Travel|0|||
106153114|NCT00092534|366222014|FG002|Base Study EXT|Travel|2|||
106153115|NCT00092534|366222015|FG003|Base Study EXT|Travel|0|||
106153116|NCT00092534|366222016|FG004|Base Study EXT|Travel|0|||
106153117|NCT00092534|366222012|FG000|Base Study EXT|Site closed|0|||
106153118|NCT00092534|366222013|FG001|Base Study EXT|Site closed|0|||
106153119|NCT00092534|366222014|FG002|Base Study EXT|Site closed|21|||
106153120|NCT00092534|366222015|FG003|Base Study EXT|Site closed|0|||
106153121|NCT00092534|366222016|FG004|Base Study EXT|Site closed|0|||
106153122|NCT00092534|366222012|FG000|Base Study EXT|Study ended|0|||
106153123|NCT00092534|366222013|FG001|Base Study EXT|Study ended|0|||
106153124|NCT00092534|366222014|FG002|Base Study EXT|Study ended|29|||
106153125|NCT00092534|366222015|FG003|Base Study EXT|Study ended|0|||
105864756|NCT03207867|365153012|FG023|Overall Study|Physician Decision|0|||
106060322|NCT03572062|365879643|FG003|Overall Study|Randomized But Not Treated|0|||
106060323|NCT03572062|365879644|FG004|Overall Study|Randomized But Not Treated|1|||
106060324|NCT03572062|365879645|FG005|Overall Study|Randomized But Not Treated|2|||
106060325|NCT03572062|365879646|FG006|Overall Study|Randomized But Not Treated|0|||
106060326|NCT03572062|365879647|FG007|Overall Study|Randomized But Not Treated|1|||
106060327|NCT03572062|365879648|FG008|Overall Study|Randomized But Not Treated|0|||
106060328|NCT03572062|365879649|FG009|Overall Study|Randomized But Not Treated|0|||
106060329|NCT01269463|365879650|FG000|First Intervention|Withdrawal by Subject|1|||
106060330|NCT01269463|365879651|FG001|First Intervention|Withdrawal by Subject|0|||
106060331|NCT01269463|365879650|FG000|First Intervention|Adverse Event|1|||
106060332|NCT01269463|365879651|FG001|First Intervention|Adverse Event|0|||
106060333|NCT01269463|365879650|FG000|First Intervention|Lack of Efficacy|0|||
106060334|NCT01269463|365879651|FG001|First Intervention|Lack of Efficacy|1|||
106060335|NCT01269463|365879650|FG000|First Intervention|Physician Decision|0|||
106060336|NCT01269463|365879651|FG001|First Intervention|Physician Decision|1|||
106060337|NCT04051008|365879652|FG000|Overall Study|Withdrawal by Subject|2|||
106060338|NCT04051008|365879653|FG001|Overall Study|Withdrawal by Subject|0|||
106060339|NCT04051008|365879654|FG002|Overall Study|Withdrawal by Subject|1|||
106060340|NCT00458211|365879655|FG000|Overall Study|Lack of Efficacy|12|||
106060341|NCT00458211|365879655|FG000|Overall Study|Withdrawal by Subject|2|||
106060342|NCT00458211|365879655|FG000|Overall Study|Protocol Violation|2|||
106060343|NCT04342897|365879656|FG000|Overall Study|Death|7|||
106060344|NCT04342897|365879657|FG001|Overall Study|Death|4|||
106060345|NCT04342897|365879656|FG000|Overall Study|Lost to Follow-up|6|||
106060346|NCT04342897|365879657|FG001|Overall Study|Lost to Follow-up|6|||
106060347|NCT04342897|365879656|FG000|Overall Study|Withdrawal by Subject|1|||
106060348|NCT04342897|365879657|FG001|Overall Study|Withdrawal by Subject|2|||
106060349|NCT00838578|365879658|FG000|Overall Study|Protocol Violation|2|||
106060350|NCT02142959|365879659|FG000|Overall Study|Adverse Event|1|||
106060351|NCT02142959|365879660|FG001|Overall Study|Adverse Event|0|||
106060352|NCT02142959|365879661|FG002|Overall Study|Adverse Event|0|||
106060353|NCT02142959|365879659|FG000|Overall Study|Death|0|||
106060354|NCT02142959|365879660|FG001|Overall Study|Death|1|||
105864757|NCT03207867|365152989|FG000|Overall Study|Progressive Disease|7|||
106060355|NCT02142959|365879661|FG002|Overall Study|Death|0|||
106060356|NCT02142959|365879659|FG000|Overall Study|Withdrawal by Subject|3|||
106060357|NCT02142959|365879660|FG001|Overall Study|Withdrawal by Subject|1|||
106060358|NCT02142959|365879661|FG002|Overall Study|Withdrawal by Subject|3|||
106060359|NCT02142959|365879659|FG000|Overall Study|Administrative Reasons|1|||
106153126|NCT00092534|366222016|FG004|Base Study EXT|Study ended|0|||
106153127|NCT00092534|366222012|FG000|Base Study EXT|Protocol Violation|0|||
106153128|NCT00092534|366222013|FG001|Base Study EXT|Protocol Violation|0|||
106153129|NCT00092534|366222014|FG002|Base Study EXT|Protocol Violation|15|||
105864758|NCT03207867|365152990|FG001|Overall Study|Progressive Disease|7|||
105864759|NCT03207867|365152991|FG002|Overall Study|Progressive Disease|9|||
105864760|NCT03207867|365152992|FG003|Overall Study|Progressive Disease|10|||
106153130|NCT00092534|366222015|FG003|Base Study EXT|Protocol Violation|0|||
106060360|NCT02142959|365879660|FG001|Overall Study|Administrative Reasons|0|||
106060361|NCT02142959|365879661|FG002|Overall Study|Administrative Reasons|1|||
106060362|NCT02142959|365879659|FG000|Overall Study|Missing|0|||
106060363|NCT02142959|365879660|FG001|Overall Study|Missing|1|||
106060364|NCT02142959|365879661|FG002|Overall Study|Missing|0|||
106060365|NCT02142959|365879659|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
106153131|NCT00092534|366222016|FG004|Base Study EXT|Protocol Violation|0|||
105864761|NCT03207867|365152993|FG004|Overall Study|Progressive Disease|11|||
106060366|NCT02142959|365879660|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
106060367|NCT02142959|365879661|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
106060368|NCT02142959|365879659|FG000|Overall Study|Patient didn't complete end of study visit|0|||
106060369|NCT02142959|365879660|FG001|Overall Study|Patient didn't complete end of study visit|0|||
106060370|NCT02142959|365879661|FG002|Overall Study|Patient didn't complete end of study visit|1|||
106060371|NCT03667924|365879662|FG000|Baseline Completed|Lost to Follow-up|0|||
106060372|NCT03667924|365879663|FG001|Baseline Completed|Lost to Follow-up|2|||
106060373|NCT03667924|365879664|FG002|Baseline Completed|Lost to Follow-up|0|||
106060374|NCT03667924|365879662|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
106060375|NCT03667924|365879663|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
106060376|NCT03667924|365879664|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
106060377|NCT03667924|365879662|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
106060378|NCT03667924|365879663|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
106060379|NCT03667924|365879664|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
106060380|NCT03667924|365879662|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
106060381|NCT03667924|365879663|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
106060382|NCT03667924|365879664|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
106060383|NCT03667924|365879662|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
106060384|NCT03667924|365879663|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
106060385|NCT03667924|365879664|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
106060386|NCT03667924|365879662|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
106060387|NCT03667924|365879663|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
106060388|NCT03667924|365879664|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
106060389|NCT03667924|365879662|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
106060390|NCT03667924|365879663|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
106060391|NCT03667924|365879664|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
106060392|NCT03031678|365879665|FG000|Overall Study|Study closed prior to completion|1|||
106060393|NCT00439244|365879666|FG000|Overall Study|Adverse Event|5|||
106060394|NCT00439244|365879667|FG001|Overall Study|Adverse Event|2|||
106060395|NCT00439244|365879668|FG002|Overall Study|Adverse Event|3|||
106060396|NCT00439244|365879666|FG000|Overall Study|Withdrawal by Subject|3|||
106060397|NCT00439244|365879667|FG001|Overall Study|Withdrawal by Subject|1|||
106060398|NCT00439244|365879668|FG002|Overall Study|Withdrawal by Subject|2|||
106060399|NCT00439244|365879666|FG000|Overall Study|Lost to Follow-up|2|||
106060400|NCT00439244|365879667|FG001|Overall Study|Lost to Follow-up|1|||
106060401|NCT00439244|365879668|FG002|Overall Study|Lost to Follow-up|2|||
106060402|NCT00439244|365879666|FG000|Overall Study|Death|0|||
106060403|NCT00439244|365879667|FG001|Overall Study|Death|1|||
106060404|NCT00439244|365879668|FG002|Overall Study|Death|0|||
106060405|NCT00439244|365879666|FG000|Overall Study|Protocol Violation|0|||
106060406|NCT00439244|365879667|FG001|Overall Study|Protocol Violation|1|||
106060407|NCT00439244|365879668|FG002|Overall Study|Protocol Violation|0|||
106060408|NCT00439244|365879666|FG000|Overall Study|Administrative problems|1|||
106060409|NCT00439244|365879667|FG001|Overall Study|Administrative problems|0|||
106060410|NCT00439244|365879668|FG002|Overall Study|Administrative problems|0|||
106060411|NCT03918447|365879671|FG000|Overall Study|Death|1|||
106060412|NCT03918447|365879672|FG001|Overall Study|Death|0|||
106060413|NCT03918447|365879671|FG000|Overall Study|Lost to Follow-up|13|||
106060414|NCT03918447|365879672|FG001|Overall Study|Lost to Follow-up|6|||
106060415|NCT03918447|365879671|FG000|Overall Study|Withdrawal by Subject|19|||
106060416|NCT03918447|365879672|FG001|Overall Study|Withdrawal by Subject|17|||
106060417|NCT03918447|365879671|FG000|Overall Study|Study Terminated by Sponsor|195|||
106060418|NCT03918447|365879672|FG001|Overall Study|Study Terminated by Sponsor|197|||
106060419|NCT03918447|365879671|FG000|Overall Study|Reason not Specified|0|||
106060420|NCT03918447|365879672|FG001|Overall Study|Reason not Specified|1|||
106060421|NCT03278613|365879673|FG000|Overall Study|Lost to Follow-up|3|||
106060422|NCT03278613|365879674|FG001|Overall Study|Lost to Follow-up|1|||
106060423|NCT00540514|365881118|FG000|Overall Study|Still on treatment|3|||
106060424|NCT00540514|365881119|FG001|Overall Study|Still on treatment|0|||
106060425|NCT00540514|365881118|FG000|Overall Study|Unacceptable Toxicity|61|||
106060426|NCT00540514|365881119|FG001|Overall Study|Unacceptable Toxicity|62|||
106060427|NCT00540514|365881118|FG000|Overall Study|Adverse Event|20|||
106060428|NCT00540514|365881119|FG001|Overall Study|Adverse Event|24|||
106060429|NCT00540514|365881118|FG000|Overall Study|Physician Decision|86|||
106060430|NCT00540514|365881119|FG001|Overall Study|Physician Decision|99|||
106060431|NCT00540514|365881118|FG000|Overall Study|Protocol Deviation|3|||
106060432|NCT00540514|365881119|FG001|Overall Study|Protocol Deviation|4|||
106060433|NCT00540514|365881118|FG000|Overall Study|Lost to Follow-up|1|||
106060434|NCT00540514|365881119|FG001|Overall Study|Lost to Follow-up|1|||
106060435|NCT00540514|365881118|FG000|Overall Study|Withdrawal by Subject|65|||
106060436|NCT00540514|365881119|FG001|Overall Study|Withdrawal by Subject|67|||
106060437|NCT00540514|365881118|FG000|Overall Study|Excluded prior to treatment|7|||
106060438|NCT00540514|365881119|FG001|Overall Study|Excluded prior to treatment|7|||
106060439|NCT00540514|365881118|FG000|Overall Study|Paclitaxel not available|0|||
106060440|NCT00540514|365881119|FG001|Overall Study|Paclitaxel not available|2|||
106060441|NCT02501473|365881122|FG000|Overall Study|Study Terminated|2|||
106060442|NCT02501473|365881123|FG001|Overall Study|Study Terminated|3|||
106060443|NCT02501473|365881124|FG002|Overall Study|Study Terminated|7|||
106060444|NCT02501473|365881125|FG003|Overall Study|Study Terminated|9|||
106060445|NCT02501473|365881126|FG004|Overall Study|Study Terminated|2|||
106060446|NCT02501473|365881127|FG005|Overall Study|Study Terminated|10|||
106060447|NCT02501473|365881128|FG006|Overall Study|Study Terminated|1|||
106060448|NCT02501473|365881129|FG007|Overall Study|Study Terminated|0|||
106060449|NCT02501473|365881122|FG000|Overall Study|Withdrawal by Subject|0|||
106060450|NCT02501473|365881123|FG001|Overall Study|Withdrawal by Subject|0|||
106060451|NCT02501473|365881124|FG002|Overall Study|Withdrawal by Subject|3|||
106060452|NCT02501473|365881125|FG003|Overall Study|Withdrawal by Subject|3|||
106060453|NCT02501473|365881126|FG004|Overall Study|Withdrawal by Subject|2|||
106060454|NCT02501473|365881127|FG005|Overall Study|Withdrawal by Subject|2|||
106060455|NCT02501473|365881128|FG006|Overall Study|Withdrawal by Subject|0|||
106060456|NCT02501473|365881129|FG007|Overall Study|Withdrawal by Subject|0|||
106060457|NCT02501473|365881122|FG000|Overall Study|Death|0|||
106060458|NCT02501473|365881123|FG001|Overall Study|Death|0|||
106060459|NCT02501473|365881124|FG002|Overall Study|Death|1|||
106060460|NCT02501473|365881125|FG003|Overall Study|Death|1|||
106060461|NCT02501473|365881126|FG004|Overall Study|Death|0|||
106060462|NCT02501473|365881127|FG005|Overall Study|Death|1|||
106060463|NCT02501473|365881128|FG006|Overall Study|Death|0|||
106060464|NCT02501473|365881129|FG007|Overall Study|Death|0|||
106060465|NCT02501473|365881122|FG000|Overall Study|Lost to Follow-up|1|||
106060466|NCT02501473|365881123|FG001|Overall Study|Lost to Follow-up|0|||
106060467|NCT02501473|365881124|FG002|Overall Study|Lost to Follow-up|1|||
106060468|NCT02501473|365881125|FG003|Overall Study|Lost to Follow-up|0|||
106060469|NCT02501473|365881126|FG004|Overall Study|Lost to Follow-up|0|||
106060470|NCT02501473|365881127|FG005|Overall Study|Lost to Follow-up|1|||
106060471|NCT02501473|365881128|FG006|Overall Study|Lost to Follow-up|0|||
106060472|NCT02501473|365881129|FG007|Overall Study|Lost to Follow-up|0|||
106060473|NCT02501473|365881122|FG000|Overall Study|Reason not specified|0|||
106060474|NCT02501473|365881123|FG001|Overall Study|Reason not specified|0|||
106060475|NCT02501473|365881124|FG002|Overall Study|Reason not specified|1|||
106060476|NCT02501473|365881125|FG003|Overall Study|Reason not specified|1|||
106060477|NCT02501473|365881126|FG004|Overall Study|Reason not specified|0|||
106060478|NCT02501473|365881127|FG005|Overall Study|Reason not specified|0|||
106060479|NCT02501473|365881128|FG006|Overall Study|Reason not specified|0|||
106060480|NCT02501473|365881129|FG007|Overall Study|Reason not specified|0|||
106060481|NCT03364023|365881131|FG000|Overall Study|Lost to Follow-up|3|||
106060482|NCT03364023|365881131|FG000|Overall Study|Death|14|||
106060483|NCT02674529|365881132|FG000|Overall Study|Lost to Follow-up|1|||
106060484|NCT02674529|365881133|FG001|Overall Study|Lost to Follow-up|2|||
106060485|NCT02674529|365881132|FG000|Overall Study|Withdrawal by Subject|2|||
106060486|NCT02674529|365881133|FG001|Overall Study|Withdrawal by Subject|1|||
106060487|NCT02674529|365881132|FG000|Overall Study|Physician Decision|0|||
106060488|NCT02674529|365881133|FG001|Overall Study|Physician Decision|1|||
106060489|NCT02674529|365881132|FG000|Overall Study|Protocol Violation|0|||
106060490|NCT02674529|365881133|FG001|Overall Study|Protocol Violation|1|||
106060491|NCT02891850|365881134|FG000|Overall Study|Adverse Event|3|||
106060492|NCT02891850|365881135|FG001|Overall Study|Adverse Event|0|||
106060493|NCT02891850|365881134|FG000|Overall Study|Death|0|||
106060494|NCT02891850|365881135|FG001|Overall Study|Death|4|||
106060495|NCT02891850|365881134|FG000|Overall Study|Physician Decision|1|||
106060496|NCT02891850|365881135|FG001|Overall Study|Physician Decision|0|||
106060497|NCT02891850|365881134|FG000|Overall Study|Pregnancy|1|||
106060498|NCT02891850|365881135|FG001|Overall Study|Pregnancy|0|||
106060499|NCT02891850|365881134|FG000|Overall Study|Withdrawal by Subject|2|||
106060500|NCT02891850|365881135|FG001|Overall Study|Withdrawal by Subject|3|||
106060501|NCT03602482|365881140|FG000|Overall Study|Withdrawal by Subject|6|||
106060502|NCT03602482|365881141|FG001|Overall Study|Withdrawal by Subject|7|||
106060503|NCT03602482|365881142|FG002|Overall Study|Withdrawal by Subject|0|||
106060504|NCT03602482|365881143|FG003|Overall Study|Withdrawal by Subject|0|||
106060505|NCT03098550|365881148|FG000|Overall Study|Disease Progression|30|||
106060506|NCT03098550|365881149|FG001|Overall Study|Disease Progression|19|||
106060507|NCT03098550|365881150|FG002|Overall Study|Disease Progression|41|||
106060508|NCT03098550|365881148|FG000|Overall Study|Study Drug Toxicity|2|||
105864762|NCT03207867|365152994|FG005|Overall Study|Progressive Disease|10|||
106060509|NCT03098550|365881149|FG001|Overall Study|Study Drug Toxicity|1|||
106060510|NCT03098550|365881150|FG002|Overall Study|Study Drug Toxicity|0|||
106060511|NCT03098550|365881148|FG000|Overall Study|Death|1|||
106060512|NCT03098550|365881149|FG001|Overall Study|Death|0|||
106060513|NCT03098550|365881150|FG002|Overall Study|Death|0|||
106060514|NCT03098550|365881148|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
106153132|NCT00092534|366222012|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
106153133|NCT00092534|366222013|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
106153134|NCT00092534|366222014|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
106153135|NCT00092534|366222015|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
106153136|NCT00092534|366222016|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
106153137|NCT04065048|366222017|FG000|Overall Study|Withdrawal by Subject|1|||
106153138|NCT04065048|366222018|FG001|Overall Study|Withdrawal by Subject|2|||
106153139|NCT04065048|366222019|FG002|Overall Study|Withdrawal by Subject|1|||
106153140|NCT04065048|366222020|FG003|Overall Study|Withdrawal by Subject|1|||
106153141|NCT04065048|366222017|FG000|Overall Study|Adverse Event|1|||
106153142|NCT04065048|366222018|FG001|Overall Study|Adverse Event|0|||
106153143|NCT04065048|366222019|FG002|Overall Study|Adverse Event|1|||
106153144|NCT04065048|366222020|FG003|Overall Study|Adverse Event|0|||
106153145|NCT01998984|366222021|FG000|Overall Study|Adverse Event|0|||
106153146|NCT01998984|366222022|FG001|Overall Study|Adverse Event|0|||
106153147|NCT01998984|366222023|FG002|Overall Study|Adverse Event|0|||
106153148|NCT01998984|366222024|FG003|Overall Study|Adverse Event|1|||
106153149|NCT01998984|366222021|FG000|Overall Study|Lost to Follow-up|0|||
106153150|NCT01998984|366222022|FG001|Overall Study|Lost to Follow-up|1|||
106153151|NCT01998984|366222023|FG002|Overall Study|Lost to Follow-up|0|||
106153152|NCT01998984|366222024|FG003|Overall Study|Lost to Follow-up|1|||
106153153|NCT01998984|366222021|FG000|Overall Study|Withdrawal by Subject|0|||
106153154|NCT01998984|366222022|FG001|Overall Study|Withdrawal by Subject|0|||
106153155|NCT01998984|366222023|FG002|Overall Study|Withdrawal by Subject|1|||
106153156|NCT01998984|366222024|FG003|Overall Study|Withdrawal by Subject|0|||
106153157|NCT01998984|366222021|FG000|Overall Study|Other|0|||
106153158|NCT01998984|366222022|FG001|Overall Study|Other|0|||
106153159|NCT01998984|366222023|FG002|Overall Study|Other|0|||
106153160|NCT01998984|366222024|FG003|Overall Study|Other|1|||
106153161|NCT03845465|366222026|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
106153162|NCT03845465|366222027|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
106153163|NCT03845465|366222026|FG000|6-month Data Collection|Withdrawal by Subject|0|||
106153164|NCT03845465|366222027|FG001|6-month Data Collection|Withdrawal by Subject|2|||
106153165|NCT03845465|366222026|FG000|12-month Data Collection|Withdrawal by Subject|0|||
106153166|NCT03845465|366222027|FG001|12-month Data Collection|Withdrawal by Subject|2|||
106153167|NCT04907474|366222028|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
106153168|NCT04907474|366222029|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
106153169|NCT04714320|366222031|FG000|Overall Study|Voluntary Withdrawal|4|||
106153170|NCT04714320|366222032|FG001|Overall Study|Voluntary Withdrawal|1|||
106153171|NCT04714320|366222033|FG002|Overall Study|Voluntary Withdrawal|2|||
106153172|NCT04714320|366222031|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
106153173|NCT04714320|366222032|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
106153174|NCT04714320|366222033|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
106153175|NCT04714320|366222031|FG000|Overall Study|Reason Not Specified|1|||
106153176|NCT04714320|366222032|FG001|Overall Study|Reason Not Specified|3|||
106153177|NCT04714320|366222033|FG002|Overall Study|Reason Not Specified|3|||
106153178|NCT03299049|366222038|FG000|Overall Study|On-going|486|||
106153179|NCT03299049|366222039|FG001|Overall Study|On-going|481|||
106153180|NCT03299049|366222038|FG000|Overall Study|Withdrawal by Subject|6|||
106153181|NCT03299049|366222039|FG001|Overall Study|Withdrawal by Subject|21|||
106153182|NCT03299049|366222038|FG000|Overall Study|Physician Decision|5|||
106153183|NCT03299049|366222039|FG001|Overall Study|Physician Decision|1|||
106153184|NCT03299049|366222038|FG000|Overall Study|Lost to Follow-up|2|||
106153185|NCT03299049|366222039|FG001|Overall Study|Lost to Follow-up|0|||
106153186|NCT03299049|366222038|FG000|Overall Study|Pregnancy|1|||
106153187|NCT03299049|366222039|FG001|Overall Study|Pregnancy|3|||
106153188|NCT03299049|366222038|FG000|Overall Study|Protocol Violation|1|||
106153189|NCT03299049|366222039|FG001|Overall Study|Protocol Violation|1|||
106153190|NCT03299049|366222038|FG000|Overall Study|Lack of Efficacy|9|||
106153191|NCT03299049|366222039|FG001|Overall Study|Lack of Efficacy|3|||
106153192|NCT03299049|366222038|FG000|Overall Study|Adverse Event|12|||
106153193|NCT03299049|366222039|FG001|Overall Study|Adverse Event|13|||
106153194|NCT05369208|366222040|FG000|Core Phase|Prohibited Medication Required|2|||
106153195|NCT05369208|366222040|FG000|Core Phase|Adverse Event|1|||
106153196|NCT05369208|366222040|FG000|Core Phase|Lack of Efficacy|1|||
106153197|NCT04023526|366222041|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
106153198|NCT04023526|366222042|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
106153199|NCT04023526|366222041|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
106153200|NCT04023526|366222042|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
106153201|NCT05075408|366222043|FG000|Overall Study|Withdrawal by Subject|5|||
106153202|NCT05075408|366222044|FG001|Overall Study|Withdrawal by Subject|3|||
106153203|NCT05075408|366222045|FG002|Overall Study|Withdrawal by Subject|4|||
106153204|NCT05075408|366222043|FG000|Overall Study|Adverse Event|5|||
106153205|NCT05075408|366222044|FG001|Overall Study|Adverse Event|7|||
106153206|NCT05075408|366222045|FG002|Overall Study|Adverse Event|8|||
106060515|NCT03098550|365881149|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
106060516|NCT03098550|365881150|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
106060517|NCT03098550|365881148|FG000|Overall Study|Administrative reason by sponsor|0|||
106060518|NCT03098550|365881149|FG001|Overall Study|Administrative reason by sponsor|0|||
106060519|NCT03098550|365881150|FG002|Overall Study|Administrative reason by sponsor|1|||
106060520|NCT03098550|365881148|FG000|Overall Study|Other reasons|2|||
106060521|NCT03098550|365881149|FG001|Overall Study|Other reasons|0|||
106060522|NCT03098550|365881150|FG002|Overall Study|Other reasons|0|||
106060523|NCT02599129|365881152|FG000|Overall Study|Lack of Efficacy|2|||
106060524|NCT02599129|365881153|FG001|Overall Study|Lack of Efficacy|2|||
106060525|NCT02599129|365881152|FG000|Overall Study|Lost to Follow-up|1|||
106060526|NCT02599129|365881153|FG001|Overall Study|Lost to Follow-up|0|||
106060527|NCT02599129|365881152|FG000|Overall Study|Withdrawal by Subject|2|||
106060528|NCT02599129|365881153|FG001|Overall Study|Withdrawal by Subject|1|||
106060529|NCT01029795|365881156|FG000|Overall Study|Entry Criteria Not Met|2|||
106060530|NCT01029795|365881157|FG001|Overall Study|Entry Criteria Not Met|1|||
106060531|NCT01029795|365881156|FG000|Overall Study|Physician Decision|2|||
106060532|NCT01029795|365881157|FG001|Overall Study|Physician Decision|1|||
106060533|NCT01029795|365881156|FG000|Overall Study|Sponsor Decision|11|||
106060534|NCT01029795|365881157|FG001|Overall Study|Sponsor Decision|17|||
106060535|NCT01029795|365881156|FG000|Overall Study|Withdrawal by Subject|1|||
106060536|NCT01029795|365881157|FG001|Overall Study|Withdrawal by Subject|3|||
106060537|NCT03902574|365881158|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
106060538|NCT03902574|365881159|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
106060539|NCT03902574|365881160|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
106060540|NCT02064894|365881166|FG000|Overall Study|Withdrawal by Subject|43|||
106060541|NCT02064894|365881167|FG001|Overall Study|Withdrawal by Subject|102|||
106060542|NCT02064894|365881168|FG002|Overall Study|Withdrawal by Subject|115|||
106060543|NCT03521934|365881170|FG000|Overall Study|Death|65|||
106060544|NCT03521934|365881171|FG001|Overall Study|Death|73|||
106060545|NCT03521934|365881170|FG000|Overall Study|Withdrawal by Subject|18|||
106060546|NCT03521934|365881171|FG001|Overall Study|Withdrawal by Subject|23|||
106060547|NCT03521934|365881170|FG000|Overall Study|Site Terminated by Sponsor|39|||
106060548|NCT03521934|365881171|FG001|Overall Study|Site Terminated by Sponsor|35|||
106060549|NCT03521934|365881170|FG000|Overall Study|Study Terminated by Sponsor|483|||
106060550|NCT03521934|365881171|FG001|Overall Study|Study Terminated by Sponsor|477|||
106060551|NCT03521934|365881170|FG000|Overall Study|Reason not Specified|3|||
106060552|NCT03521934|365881171|FG001|Overall Study|Reason not Specified|6|||
106060553|NCT05131646|365881172|FG000|Overall Study|Withdrawal by Subject|1|||
106060554|NCT05131646|365881173|FG001|Overall Study|Withdrawal by Subject|0|||
106060555|NCT05131646|365881174|FG002|Overall Study|Withdrawal by Subject|0|||
106060556|NCT03266107|365881175|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
106060557|NCT03266107|365881175|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
106060558|NCT03266107|365881175|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
106060559|NCT03266107|365881175|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
106060560|NCT00299975|365881176|FG000|Overall Study|Adverse Event|1|||
106060561|NCT00299975|365881177|FG001|Overall Study|Adverse Event|0|||
106060562|NCT00299975|365881178|FG002|Overall Study|Adverse Event|2|||
106060563|NCT00299975|365881176|FG000|Overall Study|Pregnancy|0|||
106060564|NCT00299975|365881177|FG001|Overall Study|Pregnancy|0|||
106060565|NCT00299975|365881178|FG002|Overall Study|Pregnancy|1|||
106060566|NCT00299975|365881176|FG000|Overall Study|Lack of Efficacy|1|||
106060567|NCT00299975|365881177|FG001|Overall Study|Lack of Efficacy|0|||
106060568|NCT00299975|365881178|FG002|Overall Study|Lack of Efficacy|1|||
106060569|NCT00299975|365881176|FG000|Overall Study|Lost to Follow-up|1|||
106060570|NCT00299975|365881177|FG001|Overall Study|Lost to Follow-up|0|||
106060571|NCT00299975|365881178|FG002|Overall Study|Lost to Follow-up|0|||
106060572|NCT00299975|365881176|FG000|Overall Study|Withdrawal by Subject|0|||
106060573|NCT00299975|365881177|FG001|Overall Study|Withdrawal by Subject|1|||
106060574|NCT00299975|365881178|FG002|Overall Study|Withdrawal by Subject|3|||
106060575|NCT00299975|365881176|FG000|Overall Study|Physician Decision|0|||
106060576|NCT00299975|365881177|FG001|Overall Study|Physician Decision|0|||
106060577|NCT00299975|365881178|FG002|Overall Study|Physician Decision|1|||
106060578|NCT00171730|365881183|FG000|Overall Study|Adverse Event|3|||
106060579|NCT00171730|365881183|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
106060580|NCT00171730|365881183|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
106060581|NCT00171730|365881183|FG000|Overall Study|Withdrawal by Subject|3|||
106060582|NCT01366209|365881184|FG000|Overall Study|Adverse Event|6|||
106060583|NCT01366209|365881185|FG001|Overall Study|Adverse Event|7|||
106060584|NCT01366209|365881184|FG000|Overall Study|Withdrawal by Subject|4|||
106060585|NCT01366209|365881185|FG001|Overall Study|Withdrawal by Subject|4|||
106060586|NCT01366209|365881184|FG000|Overall Study|Death|12|||
106060587|NCT01366209|365881185|FG001|Overall Study|Death|19|||
106060588|NCT01366209|365881184|FG000|Overall Study|Lung transplantation|6|||
106060589|NCT01366209|365881185|FG001|Overall Study|Lung transplantation|1|||
106060590|NCT01366209|365881184|FG000|Overall Study|Lost to Follow-up|2|||
106060591|NCT01366209|365881185|FG001|Overall Study|Lost to Follow-up|1|||
106153207|NCT05075408|366222043|FG000|Overall Study|Protocol Violation|0|||
106153208|NCT05075408|366222044|FG001|Overall Study|Protocol Violation|1|||
106153209|NCT05075408|366222045|FG002|Overall Study|Protocol Violation|0|||
106153210|NCT05075408|366222043|FG000|Overall Study|Lost to Follow-up|2|||
106153211|NCT05075408|366222044|FG001|Overall Study|Lost to Follow-up|1|||
106153212|NCT05075408|366222045|FG002|Overall Study|Lost to Follow-up|1|||
106153213|NCT05075408|366222043|FG000|Overall Study|Physician Decision|1|||
106153214|NCT05075408|366222044|FG001|Overall Study|Physician Decision|0|||
106153215|NCT05075408|366222045|FG002|Overall Study|Physician Decision|0|||
106153216|NCT05075408|366222043|FG000|Overall Study|Other-unspecified|3|||
106153217|NCT05075408|366222044|FG001|Overall Study|Other-unspecified|2|||
106153218|NCT05075408|366222045|FG002|Overall Study|Other-unspecified|0|||
106060592|NCT01366209|365881184|FG000|Overall Study|Physician Decision|1|||
106060593|NCT01366209|365881185|FG001|Overall Study|Physician Decision|0|||
106060594|NCT01366209|365881184|FG000|Overall Study|Sponsors decision|0|||
106060595|NCT01366209|365881185|FG001|Overall Study|Sponsors decision|1|||
106060596|NCT01366209|365881184|FG000|Overall Study|Withdrew consent|4|||
106060597|NCT01366209|365881185|FG001|Overall Study|Withdrew consent|3|||
106060598|NCT01985867|365881186|FG000|Overall Study|Lost to Follow-up|3|||
106060599|NCT01985867|365881187|FG001|Overall Study|Lost to Follow-up|4|||
106060600|NCT01985867|365881186|FG000|Overall Study|Adverse Event|3|||
106060601|NCT01985867|365881187|FG001|Overall Study|Adverse Event|2|||
106060602|NCT01985867|365881186|FG000|Overall Study|Lack of Efficacy|1|||
106060603|NCT01985867|365881187|FG001|Overall Study|Lack of Efficacy|0|||
106060604|NCT02670837|365881188|FG000|Overall Study|Death|2|||
106060605|NCT02670837|365881189|FG001|Overall Study|Death|0|||
106060606|NCT02670837|365881190|FG002|Overall Study|Death|0|||
106060607|NCT01053221|365881191|FG000|Overall Study|The study was closed prematurely|5|||
106060608|NCT01053221|365881192|FG001|Overall Study|The study was closed prematurely|9|||
106060609|NCT02266225|365881195|FG000|Overall Study|Lost to Follow-up|2|||
106060610|NCT02266225|365881195|FG000|Overall Study|Death|1|||
106060611|NCT02266225|365881195|FG000|Overall Study|Withdrawal by Subject|13|||
106060612|NCT01465997|365881198|FG000|Overall Study|Adverse Event|12|||
106060613|NCT01465997|365881199|FG001|Overall Study|Adverse Event|22|||
106060614|NCT01465997|365881198|FG000|Overall Study|Lack of Efficacy|13|||
106060615|NCT01465997|365881199|FG001|Overall Study|Lack of Efficacy|1|||
106060616|NCT01465997|365881198|FG000|Overall Study|Protocol Violation|1|||
106060617|NCT01465997|365881199|FG001|Overall Study|Protocol Violation|4|||
106060618|NCT01465997|365881198|FG000|Overall Study|Lost to Follow-up|6|||
106060619|NCT01465997|365881199|FG001|Overall Study|Lost to Follow-up|9|||
106060620|NCT01465997|365881198|FG000|Overall Study|Withdrawal by Subject|32|||
106060621|NCT01465997|365881199|FG001|Overall Study|Withdrawal by Subject|35|||
106060622|NCT01465997|365881198|FG000|Overall Study|investigator's decision|1|||
106060623|NCT01465997|365881199|FG001|Overall Study|investigator's decision|1|||
106060624|NCT01465997|365881198|FG000|Overall Study|Death|0|||
106060625|NCT01465997|365881199|FG001|Overall Study|Death|1|||
106060626|NCT01465997|365881198|FG000|Overall Study|sponsor's decision|1|||
106060627|NCT01465997|365881199|FG001|Overall Study|sponsor's decision|1|||
106060628|NCT01465997|365881198|FG000|Overall Study|subject withdrew consent|1|||
106060629|NCT01465997|365881199|FG001|Overall Study|subject withdrew consent|0|||
106060630|NCT01465997|365881198|FG000|Overall Study|local lab unblinded site|1|||
106060631|NCT01465997|365881199|FG001|Overall Study|local lab unblinded site|0|||
106060632|NCT01465997|365881198|FG000|Overall Study|withdrew before follow-up|0|||
106060633|NCT01465997|365881199|FG001|Overall Study|withdrew before follow-up|13|||
106060634|NCT01465997|365881198|FG000|Overall Study|decision by site staff|0|||
106060635|NCT01465997|365881199|FG001|Overall Study|decision by site staff|1|||
106060636|NCT01465997|365881198|FG000|Overall Study|subject left participation SP0993|0|||
106060637|NCT01465997|365881199|FG001|Overall Study|subject left participation SP0993|1|||
106060638|NCT02246660|365881200|FG000|Overall Study|Withdrawal by Subject|0|||
106060639|NCT02246660|365881201|FG001|Overall Study|Withdrawal by Subject|1|||
106060640|NCT02246660|365881202|FG002|Overall Study|Withdrawal by Subject|0|||
106060641|NCT02246660|365881200|FG000|Overall Study|Death|0|||
106153219|NCT04540913|366222057|FG000|Overall Study|Withdrawal by Subject|14|||
106153220|NCT04540913|366222058|FG001|Overall Study|Withdrawal by Subject|3|||
106060642|NCT02246660|365881201|FG001|Overall Study|Death|0|||
106060643|NCT02246660|365881202|FG002|Overall Study|Death|1|||
106060644|NCT01919723|365881208|FG000|Overall Study|Blood Samples Hemolyzed|2|||
106060645|NCT01919723|365881209|FG001|Overall Study|Blood Samples Hemolyzed|2|||
106060646|NCT02573311|365881210|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
106060647|NCT02573311|365881211|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
106060648|NCT02573311|365881210|FG000|Disposition for Part 2|Physician Decision|25|||
106060649|NCT02573311|365881211|FG001|Disposition for Part 2|Physician Decision|7|||
106060650|NCT02573311|365881210|FG000|Disposition for Part 2|Adverse Event|36|||
106060651|NCT02573311|365881211|FG001|Disposition for Part 2|Adverse Event|5|||
106060652|NCT02573311|365881210|FG000|Disposition for Part 2|Lost to Follow-up|76|||
106060653|NCT02573311|365881211|FG001|Disposition for Part 2|Lost to Follow-up|7|||
106060654|NCT02573311|365881210|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
105864763|NCT03207867|365152995|FG006|Overall Study|Progressive Disease|9|||
106153221|NCT04468776|366222059|FG000|Overall Study|Lost to Follow-up|4|||
106060655|NCT02573311|365881211|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
106060656|NCT02573311|365881210|FG000|Disposition for Part 2|Investigator decision|0|||
106060657|NCT02573311|365881211|FG001|Disposition for Part 2|Investigator decision|1|||
106060658|NCT02573311|365881210|FG000|Disposition for Part 2|Other than specified above|13|||
106060659|NCT02573311|365881211|FG001|Disposition for Part 2|Other than specified above|3|||
106060660|NCT00160251|365881213|FG000|Prior to Amendment 2|Adverse Event|2|||
106060661|NCT00160251|365881214|FG001|Prior to Amendment 2|Adverse Event|1|||
106060662|NCT00160251|365881215|FG002|Prior to Amendment 2|Adverse Event|3|||
106060663|NCT00160251|365881216|FG003|Prior to Amendment 2|Adverse Event|1|||
106060664|NCT00160251|365881217|FG004|Prior to Amendment 2|Adverse Event|1|||
106060665|NCT00160251|365881218|FG005|Prior to Amendment 2|Adverse Event|1|||
106060666|NCT00160251|365881219|FG006|Prior to Amendment 2|Adverse Event|1|||
106060667|NCT00160251|365881220|FG007|Prior to Amendment 2|Adverse Event|0|||
106060668|NCT00160251|365881213|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
106060669|NCT00160251|365881214|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
106060670|NCT00160251|365881215|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
106060671|NCT00160251|365881216|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
106060672|NCT00160251|365881217|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
106060673|NCT00160251|365881218|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
106060674|NCT00160251|365881219|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
106060675|NCT00160251|365881220|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
106060676|NCT00160251|365881213|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
106060677|NCT00160251|365881214|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
106060678|NCT00160251|365881215|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
106060679|NCT00160251|365881216|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
106060680|NCT00160251|365881217|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
106060681|NCT00160251|365881218|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
106060682|NCT00160251|365881219|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
106060683|NCT00160251|365881220|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
106060684|NCT00160251|365881213|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
106060685|NCT00160251|365881214|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
106060686|NCT00160251|365881215|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
106060687|NCT00160251|365881216|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
106060688|NCT00160251|365881217|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
106060689|NCT00160251|365881218|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
106060690|NCT00160251|365881219|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
106060691|NCT00160251|365881220|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
106060692|NCT00160251|365881213|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
106060693|NCT00160251|365881214|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
106060694|NCT00160251|365881215|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
106060695|NCT00160251|365881216|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
106060696|NCT00160251|365881217|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
106060697|NCT00160251|365881218|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
106060698|NCT00160251|365881219|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
106060699|NCT00160251|365881220|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
106060700|NCT00160251|365881213|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
106060701|NCT00160251|365881214|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
106060702|NCT00160251|365881215|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
106060703|NCT00160251|365881216|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
106060704|NCT00160251|365881217|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
106060705|NCT00160251|365881218|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
106060706|NCT00160251|365881219|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
106060707|NCT00160251|365881220|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
106060708|NCT00160251|365881213|FG000|Post-amendment 2|Adverse Event|0|||
106060709|NCT00160251|365881214|FG001|Post-amendment 2|Adverse Event|0|||
106060710|NCT00160251|365881215|FG002|Post-amendment 2|Adverse Event|0|||
106060711|NCT00160251|365881216|FG003|Post-amendment 2|Adverse Event|0|||
106060712|NCT00160251|365881217|FG004|Post-amendment 2|Adverse Event|0|||
106060713|NCT00160251|365881218|FG005|Post-amendment 2|Adverse Event|0|||
106060714|NCT00160251|365881219|FG006|Post-amendment 2|Adverse Event|0|||
106060715|NCT00160251|365881220|FG007|Post-amendment 2|Adverse Event|20|||
106060716|NCT00160251|365881213|FG000|Post-amendment 2|Lack of Efficacy|0|||
106060717|NCT00160251|365881214|FG001|Post-amendment 2|Lack of Efficacy|0|||
106060718|NCT00160251|365881215|FG002|Post-amendment 2|Lack of Efficacy|0|||
106060719|NCT00160251|365881216|FG003|Post-amendment 2|Lack of Efficacy|0|||
106060720|NCT00160251|365881217|FG004|Post-amendment 2|Lack of Efficacy|0|||
106060721|NCT00160251|365881218|FG005|Post-amendment 2|Lack of Efficacy|0|||
106060722|NCT00160251|365881219|FG006|Post-amendment 2|Lack of Efficacy|0|||
106060723|NCT00160251|365881220|FG007|Post-amendment 2|Lack of Efficacy|24|||
106060724|NCT00160251|365881213|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
106060725|NCT00160251|365881214|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
106060726|NCT00160251|365881215|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
106060727|NCT00160251|365881216|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
106153222|NCT04468776|366222060|FG001|Overall Study|Lost to Follow-up|3|||
106153223|NCT04468776|366222061|FG002|Overall Study|Lost to Follow-up|4|||
106153224|NCT04468776|366222059|FG000|Overall Study|Withdrawal by Subject|1|||
106153225|NCT04468776|366222060|FG001|Overall Study|Withdrawal by Subject|10|||
106153226|NCT04468776|366222061|FG002|Overall Study|Withdrawal by Subject|4|||
106153227|NCT04468776|366222059|FG000|Overall Study|Physician Decision|0|||
106153228|NCT04468776|366222060|FG001|Overall Study|Physician Decision|1|||
106153229|NCT04468776|366222061|FG002|Overall Study|Physician Decision|1|||
106153230|NCT05613205|366222062|FG000|Overall Study|Lost to Follow-up|0|||
106153231|NCT05613205|366222063|FG001|Overall Study|Lost to Follow-up|0|||
106153232|NCT05613205|366222064|FG002|Overall Study|Lost to Follow-up|1|||
106153233|NCT05613205|366222065|FG003|Overall Study|Lost to Follow-up|1|||
106153234|NCT05613205|366222066|FG004|Overall Study|Lost to Follow-up|0|||
106153235|NCT05613205|366222062|FG000|Overall Study|Withdrawal by Subject|0|||
106153236|NCT05613205|366222063|FG001|Overall Study|Withdrawal by Subject|0|||
106153237|NCT05613205|366222064|FG002|Overall Study|Withdrawal by Subject|1|||
106153238|NCT05613205|366222065|FG003|Overall Study|Withdrawal by Subject|1|||
106153239|NCT05613205|366222066|FG004|Overall Study|Withdrawal by Subject|0|||
106153240|NCT05338086|366222069|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
106153241|NCT05338086|366222070|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
106153242|NCT05338086|366222071|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
106153243|NCT05338086|366222072|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
106153244|NCT05338086|366222073|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
106153245|NCT05338086|366222069|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
106153246|NCT05338086|366222070|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
106153247|NCT05338086|366222071|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
106153248|NCT05338086|366222072|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
106153249|NCT05338086|366222073|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
106153250|NCT05338086|366222069|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
106153251|NCT05338086|366222070|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
106153252|NCT05338086|366222071|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
106153253|NCT05338086|366222072|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
106153254|NCT05338086|366222073|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
106153255|NCT05338086|366222069|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
106153256|NCT05338086|366222070|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
106153257|NCT05338086|366222071|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
106153258|NCT05338086|366222072|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
106153259|NCT05338086|366222073|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
106153260|NCT05338086|366222069|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
106153261|NCT05338086|366222070|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
106153262|NCT05338086|366222071|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
106153263|NCT05338086|366222072|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
106153264|NCT05338086|366222073|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
106153265|NCT05338086|366222069|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
106153266|NCT05338086|366222070|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
106153267|NCT05338086|366222071|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
106153268|NCT05338086|366222072|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
106153269|NCT05338086|366222073|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
106153270|NCT05338086|366222069|FG000|Transition Period (M12 to M18)|Death|0|||
106153271|NCT05338086|366222070|FG001|Transition Period (M12 to M18)|Death|0|||
106153272|NCT05338086|366222071|FG002|Transition Period (M12 to M18)|Death|1|||
106153273|NCT05338086|366222072|FG003|Transition Period (M12 to M18)|Death|0|||
106153274|NCT05338086|366222073|FG004|Transition Period (M12 to M18)|Death|0|||
106153275|NCT05338086|366222069|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
106153276|NCT05338086|366222070|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
106153277|NCT05338086|366222071|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
106153278|NCT05338086|366222072|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
106153279|NCT05338086|366222073|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
106153280|NCT05338086|366222069|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
106153281|NCT05338086|366222070|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
106153282|NCT05338086|366222071|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
106153283|NCT05338086|366222072|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
106153284|NCT05338086|366222073|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
106153285|NCT05338086|366222069|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
106153286|NCT05338086|366222070|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
106153287|NCT05338086|366222071|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
106153288|NCT05338086|366222072|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
106060728|NCT00160251|365881217|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
106060729|NCT00160251|365881218|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
106060730|NCT00160251|365881219|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
106060731|NCT00160251|365881220|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
106060732|NCT00211809|365881223|FG000|Overall Study|Lack of Efficacy|1|||
106060733|NCT00211809|365881223|FG000|Overall Study|Lost to Follow-up|2|||
106060734|NCT00211809|365881223|FG000|Overall Study|Pregnancy|1|||
106060735|NCT00211809|365881223|FG000|Overall Study|side effects|2|||
106060736|NCT03681405|365881224|FG000|Overall Study|Found to be ineligible after randomized|1|||
106060737|NCT03681405|365881225|FG001|Overall Study|Found to be ineligible after randomized|0|||
106060738|NCT01032837|365881226|FG000|Overall Study|Adverse event/internal illness|0|||
106060739|NCT01032837|365881227|FG001|Overall Study|Adverse event/internal illness|1|||
106060740|NCT01032837|365881228|FG002|Overall Study|Adverse event/internal illness|0|||
106060741|NCT01032837|365881229|FG003|Overall Study|Adverse event/internal illness|1|||
106060742|NCT01032837|365881226|FG000|Overall Study|Withdrew consent|0|||
106060743|NCT01032837|365881227|FG001|Overall Study|Withdrew consent|2|||
106060744|NCT01032837|365881228|FG002|Overall Study|Withdrew consent|0|||
106060745|NCT01032837|365881229|FG003|Overall Study|Withdrew consent|1|||
106060746|NCT01032837|365881226|FG000|Overall Study|Failed to return|0|||
106060747|NCT01032837|365881227|FG001|Overall Study|Failed to return|0|||
106060748|NCT01032837|365881228|FG002|Overall Study|Failed to return|1|||
106060749|NCT01032837|365881229|FG003|Overall Study|Failed to return|0|||
106060750|NCT01032837|365881226|FG000|Overall Study|Refused treatment|0|||
106060751|NCT01032837|365881227|FG001|Overall Study|Refused treatment|0|||
106060752|NCT01032837|365881228|FG002|Overall Study|Refused treatment|0|||
106060753|NCT01032837|365881229|FG003|Overall Study|Refused treatment|1|||
106060754|NCT01782222|365881230|FG000|Overall Study|Adverse Event|4|||
106060755|NCT01782222|365881231|FG001|Overall Study|Adverse Event|5|||
106060756|NCT01782222|365881232|FG002|Overall Study|Adverse Event|3|||
106060757|NCT01782222|365881230|FG000|Overall Study|Lack of Efficacy|2|||
106060758|NCT01782222|365881231|FG001|Overall Study|Lack of Efficacy|1|||
106060759|NCT01782222|365881232|FG002|Overall Study|Lack of Efficacy|0|||
106060760|NCT01782222|365881230|FG000|Overall Study|Protocol Violation|1|||
106060761|NCT01782222|365881231|FG001|Overall Study|Protocol Violation|0|||
106060762|NCT01782222|365881232|FG002|Overall Study|Protocol Violation|0|||
106060763|NCT01782222|365881230|FG000|Overall Study|Withdrawal by Subject|1|||
106060764|NCT01782222|365881231|FG001|Overall Study|Withdrawal by Subject|4|||
106060765|NCT01782222|365881232|FG002|Overall Study|Withdrawal by Subject|1|||
106060766|NCT01782222|365881230|FG000|Overall Study|Moved to other state|0|||
106060767|NCT01782222|365881231|FG001|Overall Study|Moved to other state|1|||
106060768|NCT01782222|365881232|FG002|Overall Study|Moved to other state|0|||
106060769|NCT01846416|365881235|FG000|Treatment Phase|Death|2|||
106060770|NCT01846416|365881236|FG001|Treatment Phase|Death|9|||
106060771|NCT01846416|365881237|FG002|Treatment Phase|Death|1|||
106060772|NCT01846416|365881235|FG000|Treatment Phase|Withdrawal by Subject|2|||
106060773|NCT01846416|365881236|FG001|Treatment Phase|Withdrawal by Subject|4|||
106060774|NCT01846416|365881237|FG002|Treatment Phase|Withdrawal by Subject|2|||
106060775|NCT01846416|365881235|FG000|Treatment Phase|Other|1|||
106060776|NCT01846416|365881236|FG001|Treatment Phase|Other|5|||
106060777|NCT01846416|365881237|FG002|Treatment Phase|Other|1|||
106060778|NCT01846416|365881235|FG000|Treatment Phase|Physician Decision|1|||
106060779|NCT01846416|365881236|FG001|Treatment Phase|Physician Decision|2|||
106060780|NCT01846416|365881237|FG002|Treatment Phase|Physician Decision|0|||
106060781|NCT01846416|365881235|FG000|Treatment Phase|Adverse Event|3|||
106060782|NCT01846416|365881236|FG001|Treatment Phase|Adverse Event|4|||
106060783|NCT01846416|365881237|FG002|Treatment Phase|Adverse Event|0|||
106060784|NCT01846416|365881235|FG000|Treatment Phase|Non-compliance|0|||
106060785|NCT01846416|365881236|FG001|Treatment Phase|Non-compliance|2|||
106060786|NCT01846416|365881237|FG002|Treatment Phase|Non-compliance|0|||
106060787|NCT01846416|365881235|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
106060788|NCT01846416|365881236|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
106060789|NCT01846416|365881237|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
106060790|NCT01846416|365881235|FG000|Treatment Phase|Progressive Disease|21|||
106060791|NCT01846416|365881236|FG001|Treatment Phase|Progressive Disease|63|||
106060792|NCT01846416|365881237|FG002|Treatment Phase|Progressive Disease|9|||
106060793|NCT01846416|365881235|FG000|Survival Follow-up|Death|21|||
106060794|NCT01846416|365881236|FG001|Survival Follow-up|Death|62|||
106060795|NCT01846416|365881237|FG002|Survival Follow-up|Death|9|||
106060796|NCT01846416|365881235|FG000|Survival Follow-up|Lost to Follow-up|0|||
106060797|NCT01846416|365881236|FG001|Survival Follow-up|Lost to Follow-up|2|||
106060798|NCT01846416|365881237|FG002|Survival Follow-up|Lost to Follow-up|2|||
106060799|NCT01846416|365881235|FG000|Survival Follow-up|Withdrawal by Subject|2|||
106060800|NCT01846416|365881236|FG001|Survival Follow-up|Withdrawal by Subject|7|||
106060801|NCT01846416|365881237|FG002|Survival Follow-up|Withdrawal by Subject|0|||
106060802|NCT01846416|365881235|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
106060803|NCT01846416|365881236|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
106060804|NCT01846416|365881237|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
106060805|NCT01846416|365881235|FG000|Survival Follow-up|Other|3|||
106060806|NCT01846416|365881236|FG001|Survival Follow-up|Other|1|||
106060807|NCT01846416|365881237|FG002|Survival Follow-up|Other|1|||
106060808|NCT00833794|365881238|FG000|Open-label Phase|Adverse Event|225|||
106060809|NCT00833794|365881239|FG001|Open-label Phase|Adverse Event|0|||
106060810|NCT00833794|365881238|FG000|Open-label Phase|Lack of Efficacy|28|||
106060811|NCT00833794|365881239|FG001|Open-label Phase|Lack of Efficacy|0|||
106060812|NCT00833794|365881238|FG000|Open-label Phase|Withdrawal by Subject|48|||
106060813|NCT00833794|365881239|FG001|Open-label Phase|Withdrawal by Subject|0|||
106060814|NCT00833794|365881238|FG000|Open-label Phase|Physician Decision|20|||
106060815|NCT00833794|365881239|FG001|Open-label Phase|Physician Decision|0|||
106060816|NCT00833794|365881238|FG000|Open-label Phase|Administrative reason|1|||
106060817|NCT00833794|365881239|FG001|Open-label Phase|Administrative reason|0|||
106060818|NCT00833794|365881238|FG000|Open-label Phase|Protocol Violation|47|||
106060819|NCT00833794|365881239|FG001|Open-label Phase|Protocol Violation|0|||
106060820|NCT00833794|365881238|FG000|Open-label Phase|Did not complete wash-out period|12|||
106060821|NCT00833794|365881239|FG001|Open-label Phase|Did not complete wash-out period|0|||
106060822|NCT00833794|365881238|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
106060823|NCT00833794|365881239|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
106060824|NCT00833794|365881238|FG000|Double-blind Phase|Adverse Event|44|||
106060825|NCT00833794|365881239|FG001|Double-blind Phase|Adverse Event|11|||
106060826|NCT00833794|365881238|FG000|Double-blind Phase|Lack of Efficacy|34|||
106060827|NCT00833794|365881239|FG001|Double-blind Phase|Lack of Efficacy|22|||
106060828|NCT00833794|365881238|FG000|Double-blind Phase|Withdrawal by Subject|23|||
106060829|NCT00833794|365881239|FG001|Double-blind Phase|Withdrawal by Subject|6|||
106060830|NCT00833794|365881238|FG000|Double-blind Phase|Physician Decision|4|||
106060831|NCT00833794|365881239|FG001|Double-blind Phase|Physician Decision|7|||
106060832|NCT00833794|365881238|FG000|Double-blind Phase|Administrative reason|1|||
106060833|NCT00833794|365881239|FG001|Double-blind Phase|Administrative reason|3|||
106060834|NCT02007109|365881240|FG000|Overall Study|Diary not returned or excluded|102|||
106060835|NCT02007109|365881240|FG000|Overall Study|Excluded - Age<7yo|9|||
106060836|NCT01950741|365881241|FG000|Overall Study|Lost to Follow-up|1|||
106060837|NCT01950741|365881241|FG000|Overall Study|Death|1|||
106060838|NCT01950741|365881241|FG000|Overall Study|Withdrawal by Subject|1|||
106060839|NCT01858389|365881244|FG000|Overall Study|Death|1|||
106060840|NCT01858389|365881245|FG001|Overall Study|Death|3|||
106060841|NCT01858389|365881244|FG000|Overall Study|Study terminated by sponsor|0|||
106060842|NCT01858389|365881245|FG001|Overall Study|Study terminated by sponsor|2|||
106060843|NCT01858389|365881244|FG000|Overall Study|Withdrawal by Subject|0|||
106060844|NCT01858389|365881245|FG001|Overall Study|Withdrawal by Subject|1|||
106060845|NCT01858389|365881244|FG000|Overall Study|Progressive disease|10|||
106060846|NCT01858389|365881245|FG001|Overall Study|Progressive disease|11|||
106060847|NCT01858389|365881244|FG000|Overall Study|Other|2|||
106060848|NCT01858389|365881245|FG001|Overall Study|Other|4|||
106060849|NCT01858389|365881244|FG000|Overall Study|Adverse Event|3|||
106060850|NCT01858389|365881245|FG001|Overall Study|Adverse Event|1|||
106060851|NCT01858389|365881244|FG000|Overall Study|Did not receive treatment|0|||
106060852|NCT01858389|365881245|FG001|Overall Study|Did not receive treatment|3|||
106060853|NCT00844896|365881246|FG000|Overall Study|Lost to Follow-up|12|||
106060854|NCT00844896|365881247|FG001|Overall Study|Lost to Follow-up|16|||
106060855|NCT00844896|365881246|FG000|Overall Study|Parents did not have time to complete|0|||
106060856|NCT00844896|365881247|FG001|Overall Study|Parents did not have time to complete|1|||
106060857|NCT01835587|365881248|FG000|Overall Study|Disease Recurrence or Relapse|0|||
106060858|NCT01835587|365881249|FG001|Overall Study|Disease Recurrence or Relapse|3|||
106060859|NCT01835587|365881250|FG002|Overall Study|Disease Recurrence or Relapse|0|||
106060860|NCT01835587|365881251|FG003|Overall Study|Disease Recurrence or Relapse|3|||
106060861|NCT01835587|365881248|FG000|Overall Study|Withdrawal by Subject|2|||
106060862|NCT01835587|365881249|FG001|Overall Study|Withdrawal by Subject|0|||
106060863|NCT01835587|365881250|FG002|Overall Study|Withdrawal by Subject|0|||
106060864|NCT01835587|365881251|FG003|Overall Study|Withdrawal by Subject|3|||
106060865|NCT01835587|365881248|FG000|Overall Study|Adverse Event|0|||
106060866|NCT01835587|365881249|FG001|Overall Study|Adverse Event|0|||
106060867|NCT01835587|365881250|FG002|Overall Study|Adverse Event|2|||
106060868|NCT01835587|365881251|FG003|Overall Study|Adverse Event|2|||
106060869|NCT01835587|365881248|FG000|Overall Study|Death|0|||
106060870|NCT01835587|365881249|FG001|Overall Study|Death|0|||
106060871|NCT01835587|365881250|FG002|Overall Study|Death|0|||
106060872|NCT01835587|365881251|FG003|Overall Study|Death|1|||
106060873|NCT01835587|365881248|FG000|Overall Study|Miscellaneous|0|||
106060874|NCT01835587|365881249|FG001|Overall Study|Miscellaneous|1|||
106060875|NCT01835587|365881250|FG002|Overall Study|Miscellaneous|0|||
106060876|NCT01835587|365881251|FG003|Overall Study|Miscellaneous|0|||
106060877|NCT05255068|365882737|FG000|Overall Study|Lost to Follow-up|0|||
106060878|NCT05255068|365882738|FG001|Overall Study|Lost to Follow-up|1|||
106060879|NCT00911820|365882744|FG000|Overall Study|RECIST progression|12|||
106060880|NCT00911820|365882745|FG001|Overall Study|RECIST progression|8|||
106060881|NCT00911820|365882744|FG000|Overall Study|Adverse Event|8|||
106153289|NCT05338086|366222073|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
106060882|NCT00911820|365882745|FG001|Overall Study|Adverse Event|8|||
106060883|NCT00911820|365882744|FG000|Overall Study|Clinical Progression|7|||
106060884|NCT00911820|365882745|FG001|Overall Study|Clinical Progression|5|||
106060885|NCT00911820|365882744|FG000|Overall Study|Physician Decision|5|||
106060886|NCT00911820|365882745|FG001|Overall Study|Physician Decision|9|||
106060887|NCT00911820|365882744|FG000|Overall Study|Decline in Performance Status|4|||
106060888|NCT00911820|365882745|FG001|Overall Study|Decline in Performance Status|2|||
106060889|NCT00911820|365882744|FG000|Overall Study|Withdrawal by Subject|3|||
106060890|NCT00911820|365882745|FG001|Overall Study|Withdrawal by Subject|4|||
106060891|NCT00911820|365882744|FG000|Overall Study|Death|1|||
106060892|NCT00911820|365882745|FG001|Overall Study|Death|2|||
106060893|NCT00911820|365882744|FG000|Overall Study|Pursue surgery|1|||
106060894|NCT00911820|365882745|FG001|Overall Study|Pursue surgery|1|||
106060895|NCT00911820|365882744|FG000|Overall Study|Pursue Radiation|1|||
106060896|NCT00911820|365882745|FG001|Overall Study|Pursue Radiation|0|||
106060897|NCT00911820|365882744|FG000|Overall Study|Still on Therapy|2|||
106060898|NCT00911820|365882745|FG001|Overall Study|Still on Therapy|2|||
106060899|NCT00911820|365882744|FG000|Overall Study|Pathology Not Confirmed|1|||
106060900|NCT00911820|365882745|FG001|Overall Study|Pathology Not Confirmed|0|||
106060901|NCT00911820|365882744|FG000|Overall Study|Withdraw before Receive Treatment|0|||
106060902|NCT00911820|365882745|FG001|Overall Study|Withdraw before Receive Treatment|2|||
106060903|NCT02990910|365882749|FG000|Overall Study|Lack of Efficacy|6|||
106060904|NCT02990910|365882750|FG001|Overall Study|Lack of Efficacy|10|||
106060905|NCT02155608|365882758|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
106060906|NCT02155608|365882759|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
106060907|NCT02155608|365882758|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
106060908|NCT02155608|365882759|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
106060909|NCT01366521|365882761|FG000|Overall Study|Adverse Event|1|||
106060910|NCT01366521|365882762|FG001|Overall Study|Adverse Event|0|||
106060911|NCT01366521|365882763|FG002|Overall Study|Adverse Event|0|||
106060912|NCT01366521|365882764|FG003|Overall Study|Adverse Event|0|||
106060913|NCT01366521|365882761|FG000|Overall Study|Protocol Violation|0|||
106060914|NCT01366521|365882762|FG001|Overall Study|Protocol Violation|0|||
106060915|NCT01366521|365882763|FG002|Overall Study|Protocol Violation|1|||
106060916|NCT01366521|365882764|FG003|Overall Study|Protocol Violation|0|||
106060917|NCT01366521|365882761|FG000|Overall Study|Physician Decision|0|||
106060918|NCT01366521|365882762|FG001|Overall Study|Physician Decision|0|||
106060919|NCT01366521|365882763|FG002|Overall Study|Physician Decision|1|||
106060920|NCT01366521|365882764|FG003|Overall Study|Physician Decision|0|||
106060921|NCT01366521|365882761|FG000|Overall Study|Withdrawal by Subject|0|||
106060922|NCT01366521|365882762|FG001|Overall Study|Withdrawal by Subject|1|||
106060923|NCT01366521|365882763|FG002|Overall Study|Withdrawal by Subject|0|||
106060924|NCT01366521|365882764|FG003|Overall Study|Withdrawal by Subject|0|||
106060925|NCT00660023|365882765|FG000|Overall Study|Adverse Event|2|||
106060926|NCT00660023|365882765|FG000|Overall Study|Death|8|||
106060927|NCT00660023|365882765|FG000|Overall Study|Blood Transfusion|5|||
106060928|NCT00660023|365882765|FG000|Overall Study|Renal Transplantation|3|||
106060929|NCT00660023|365882765|FG000|Overall Study|Withdrawal by Subject|1|||
106060930|NCT00660023|365882765|FG000|Overall Study|Missed Pregnancy Test|1|||
106060931|NCT00660023|365882765|FG000|Overall Study|Other Screening Failure|9|||
106060932|NCT00684307|365882766|FG000|Overall Study|Adverse Event|11|||
106060933|NCT00684307|365882767|FG001|Overall Study|Adverse Event|6|||
106060934|NCT00684307|365882768|FG002|Overall Study|Adverse Event|15|||
106060935|NCT00684307|365882769|FG003|Overall Study|Adverse Event|16|||
106060936|NCT00684307|365882770|FG004|Overall Study|Adverse Event|8|||
106060937|NCT00684307|365882766|FG000|Overall Study|Development of increasing Liver Function|0|||
106060938|NCT00684307|365882767|FG001|Overall Study|Development of increasing Liver Function|2|||
106153290|NCT04840199|366222074|FG000|Overall Study|Study Terminated by Sponsor|8|||
106153291|NCT04840199|366222075|FG001|Overall Study|Study Terminated by Sponsor|9|||
106153292|NCT04840199|366222074|FG000|Overall Study|Lost to Follow-up|0|||
106060939|NCT00684307|365882768|FG002|Overall Study|Development of increasing Liver Function|0|||
106060940|NCT00684307|365882769|FG003|Overall Study|Development of increasing Liver Function|1|||
106060941|NCT00684307|365882770|FG004|Overall Study|Development of increasing Liver Function|0|||
106060942|NCT00684307|365882766|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
106060943|NCT00684307|365882767|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
106060944|NCT00684307|365882768|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
106060945|NCT00684307|365882769|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
106060946|NCT00684307|365882770|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
106060947|NCT00684307|365882766|FG000|Overall Study|Incorrect enrolment or randomization|4|||
106060948|NCT00684307|365882767|FG001|Overall Study|Incorrect enrolment or randomization|0|||
106060949|NCT00684307|365882768|FG002|Overall Study|Incorrect enrolment or randomization|0|||
106060950|NCT00684307|365882769|FG003|Overall Study|Incorrect enrolment or randomization|0|||
106060951|NCT00684307|365882770|FG004|Overall Study|Incorrect enrolment or randomization|0|||
106153293|NCT04840199|366222075|FG001|Overall Study|Lost to Follow-up|2|||
106060952|NCT00684307|365882766|FG000|Overall Study|Interupted IP for more than 7 days|0|||
106060953|NCT00684307|365882767|FG001|Overall Study|Interupted IP for more than 7 days|4|||
106060954|NCT00684307|365882768|FG002|Overall Study|Interupted IP for more than 7 days|1|||
106060955|NCT00684307|365882769|FG003|Overall Study|Interupted IP for more than 7 days|3|||
106060956|NCT00684307|365882770|FG004|Overall Study|Interupted IP for more than 7 days|3|||
106060957|NCT00684307|365882766|FG000|Overall Study|Severe non compliance to protocol|1|||
106060958|NCT00684307|365882767|FG001|Overall Study|Severe non compliance to protocol|0|||
106060959|NCT00684307|365882768|FG002|Overall Study|Severe non compliance to protocol|0|||
106060960|NCT00684307|365882769|FG003|Overall Study|Severe non compliance to protocol|1|||
106060961|NCT00684307|365882770|FG004|Overall Study|Severe non compliance to protocol|2|||
106060962|NCT00684307|365882766|FG000|Overall Study|Participant not willing to continue|7|||
106060963|NCT00684307|365882767|FG001|Overall Study|Participant not willing to continue|10|||
106060964|NCT00684307|365882768|FG002|Overall Study|Participant not willing to continue|11|||
106060965|NCT00684307|365882769|FG003|Overall Study|Participant not willing to continue|5|||
106060966|NCT00684307|365882770|FG004|Overall Study|Participant not willing to continue|8|||
106060967|NCT00684307|365882766|FG000|Overall Study|Criteria from the CSR|0|||
106060968|NCT00684307|365882767|FG001|Overall Study|Criteria from the CSR|0|||
106060969|NCT00684307|365882768|FG002|Overall Study|Criteria from the CSR|1|||
106060970|NCT00684307|365882769|FG003|Overall Study|Criteria from the CSR|3|||
106060971|NCT00684307|365882770|FG004|Overall Study|Criteria from the CSR|3|||
106060972|NCT00759031|365882771|FG000|First Intervention (1 Day)|Physician Decision|1|||
106060973|NCT00759031|365882772|FG001|First Intervention (1 Day)|Physician Decision|0|||
106060974|NCT00759031|365882771|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
106060975|NCT00759031|365882772|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
106060976|NCT00759031|365882771|FG000|First Intervention (1 Day)|Screening failure|1|||
106060977|NCT00759031|365882772|FG001|First Intervention (1 Day)|Screening failure|0|||
106060978|NCT04160091|365882773|FG000|Overall Study|Terminated by Sponsor|7|||
106060979|NCT04160091|365882774|FG001|Overall Study|Terminated by Sponsor|3|||
106060980|NCT04160091|365882775|FG002|Overall Study|Terminated by Sponsor|5|||
106060981|NCT04160091|365882776|FG003|Overall Study|Terminated by Sponsor|2|||
106060982|NCT04160091|365882773|FG000|Overall Study|Noncompliance|0|||
106060983|NCT04160091|365882774|FG001|Overall Study|Noncompliance|0|||
106060984|NCT04160091|365882775|FG002|Overall Study|Noncompliance|0|||
106060985|NCT04160091|365882776|FG003|Overall Study|Noncompliance|1|||
106060986|NCT04160091|365882773|FG000|Overall Study|Withdrawal by Subject|0|||
106060987|NCT04160091|365882774|FG001|Overall Study|Withdrawal by Subject|0|||
106060988|NCT04160091|365882775|FG002|Overall Study|Withdrawal by Subject|0|||
106060989|NCT04160091|365882776|FG003|Overall Study|Withdrawal by Subject|1|||
106060990|NCT00309387|365882782|FG000|Overall Study|Death|72|||
106060991|NCT00309387|365882783|FG001|Overall Study|Death|73|||
106060992|NCT00309387|365882782|FG000|Overall Study|Lost to Follow-up|70|||
106060993|NCT00309387|365882783|FG001|Overall Study|Lost to Follow-up|86|||
106060994|NCT04532164|365882785|FG000|Overall Study|Adverse Event|1|||
106060995|NCT04532164|365882785|FG000|Overall Study|Protocol Violation|5|||
106060996|NCT04532164|365882785|FG000|Overall Study|Lost to Follow-up|1|||
106060997|NCT04532164|365882785|FG000|Overall Study|Found to be Ineligible|3|||
106060998|NCT04532164|365882785|FG000|Overall Study|Withdrawal by Subject|14|||
106060999|NCT02483520|365882786|FG000|Overall Study|Lost to Follow-up|3|||
106061000|NCT02483520|365882787|FG001|Overall Study|Lost to Follow-up|4|||
106061001|NCT02483520|365882786|FG000|Overall Study|Withdrawal by Subject|4|||
106061002|NCT02483520|365882787|FG001|Overall Study|Withdrawal by Subject|14|||
106061003|NCT02483520|365882786|FG000|Overall Study|Hospitalized|2|||
106061004|NCT02483520|365882787|FG001|Overall Study|Hospitalized|3|||
106061005|NCT02483520|365882786|FG000|Overall Study|Moved to LTC|2|||
106061006|NCT02483520|365882787|FG001|Overall Study|Moved to LTC|3|||
106061007|NCT01401283|365882801|FG000|Overall Study|surgery cancelled|5|||
106061008|NCT01401283|365882802|FG001|Overall Study|surgery cancelled|8|||
106061009|NCT01401283|365882801|FG000|Overall Study|preoperative arrhythmia|5|||
106061010|NCT01401283|365882802|FG001|Overall Study|preoperative arrhythmia|0|||
106061011|NCT01401283|365882801|FG000|Overall Study|no central venous access|0|||
106061012|NCT01401283|365882802|FG001|Overall Study|no central venous access|1|||
105864764|NCT03207867|365152996|FG007|Overall Study|Progressive Disease|8|||
105864765|NCT03207867|365152997|FG008|Overall Study|Progressive Disease|19|||
106061013|NCT01401283|365882801|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
106061014|NCT01401283|365882802|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
106061015|NCT03489720|365882803|FG000|Overall Study|Withdrawal by Subject|2|||
106061016|NCT03489720|365882804|FG001|Overall Study|Withdrawal by Subject|0|||
106061017|NCT02170298|365882805|FG000|Overall Study|Withdrawal by Subject|0|||
106061018|NCT02170298|365882806|FG001|Overall Study|Withdrawal by Subject|1|||
106061019|NCT02170298|365882805|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
106061020|NCT02170298|365882806|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
106061021|NCT01513473|365882807|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
106061022|NCT01513473|365882808|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
106061023|NCT01513473|365882807|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
106061024|NCT01513473|365882808|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
106061025|NCT01513473|365882807|FG000|Main Trial (26 Weeks)|Unclassified|0|||
106061026|NCT01513473|365882808|FG001|Main Trial (26 Weeks)|Unclassified|2|||
106061027|NCT01513473|365882807|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
106061028|NCT01513473|365882808|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
106061029|NCT01513473|365882807|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
106061030|NCT01513473|365882808|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
106061031|NCT02709785|365882810|FG000|Overall Study|Withdrawal by Subject|1|||
106061032|NCT02709785|365882811|FG001|Overall Study|Withdrawal by Subject|2|||
106061033|NCT02709785|365882812|FG002|Overall Study|Withdrawal by Subject|1|||
106061034|NCT00582166|365882813|FG000|Overall Study|Death|1|||
106061035|NCT00582166|365882813|FG000|Overall Study|Ineligible pathology|1|||
106061036|NCT01606436|365882814|FG000|Overall Study|Withdrawal by Subject|0|||
106061037|NCT01606436|365882815|FG001|Overall Study|Withdrawal by Subject|0|||
106061038|NCT01606436|365882816|FG002|Overall Study|Withdrawal by Subject|1|||
106061039|NCT01606436|365882817|FG003|Overall Study|Withdrawal by Subject|1|||
106061040|NCT01606436|365882818|FG004|Overall Study|Withdrawal by Subject|1|||
106061041|NCT01606436|365882819|FG005|Overall Study|Withdrawal by Subject|0|||
106061042|NCT01606436|365882814|FG000|Overall Study|Adverse Event|0|||
106061043|NCT01606436|365882815|FG001|Overall Study|Adverse Event|0|||
106061044|NCT01606436|365882816|FG002|Overall Study|Adverse Event|1|||
106061045|NCT01606436|365882817|FG003|Overall Study|Adverse Event|0|||
106061046|NCT01606436|365882818|FG004|Overall Study|Adverse Event|0|||
106061047|NCT01606436|365882819|FG005|Overall Study|Adverse Event|0|||
106061048|NCT01606436|365882814|FG000|Overall Study|Sponsor Decision|0|||
106061049|NCT01606436|365882815|FG001|Overall Study|Sponsor Decision|0|||
106061050|NCT01606436|365882816|FG002|Overall Study|Sponsor Decision|0|||
106061051|NCT01606436|365882817|FG003|Overall Study|Sponsor Decision|1|||
106061052|NCT01606436|365882818|FG004|Overall Study|Sponsor Decision|0|||
106061053|NCT01606436|365882819|FG005|Overall Study|Sponsor Decision|0|||
106061054|NCT02289417|365882820|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
106061055|NCT02289417|365882821|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
106061056|NCT02289417|365882822|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
106061057|NCT02289417|365882823|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
106061058|NCT02289417|365882824|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
106061059|NCT02289417|365882825|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
106061060|NCT02289417|365882826|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
106061061|NCT02289417|365882827|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
106061062|NCT02289417|365882828|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
106061063|NCT02289417|365882820|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
106061064|NCT02289417|365882821|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
106061065|NCT02289417|365882822|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
106061066|NCT02289417|365882823|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
106061067|NCT02289417|365882824|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
106061068|NCT02289417|365882825|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
106061069|NCT02289417|365882826|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
106061070|NCT02289417|365882827|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
106061071|NCT02289417|365882828|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
106061072|NCT02289417|365882820|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
106061073|NCT02289417|365882821|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
106061074|NCT02289417|365882822|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
106061075|NCT02289417|365882823|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
106061076|NCT02289417|365882824|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
106061077|NCT02289417|365882825|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
106061078|NCT02289417|365882826|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
106061079|NCT02289417|365882827|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
106061080|NCT02289417|365882828|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
106061081|NCT02289417|365882820|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
106061082|NCT02289417|365882821|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
106061083|NCT02289417|365882822|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
106061084|NCT02289417|365882823|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
106061085|NCT02289417|365882824|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
106061086|NCT02289417|365882825|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
106061087|NCT02289417|365882826|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
106061088|NCT02289417|365882827|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
106061089|NCT02289417|365882828|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
106061090|NCT02289417|365882820|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
106061091|NCT02289417|365882821|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
106061092|NCT02289417|365882822|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
106061093|NCT02289417|365882823|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
106061094|NCT02289417|365882824|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
106061095|NCT02289417|365882825|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
106153294|NCT04840199|366222074|FG000|Overall Study|Withdrawal by Subject|2|||
106153295|NCT04840199|366222075|FG001|Overall Study|Withdrawal by Subject|0|||
106153296|NCT04840199|366222074|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
106153297|NCT04840199|366222075|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
106153298|NCT04440176|366222076|FG000|Overall Study|Withdrawal by Subject|5|||
106153299|NCT04440176|366222077|FG001|Overall Study|Withdrawal by Subject|3|||
106153300|NCT04440176|366222076|FG000|Overall Study|Withdrawal by parent/guardian|4|||
106153301|NCT04440176|366222077|FG001|Overall Study|Withdrawal by parent/guardian|5|||
106153302|NCT04440176|366222076|FG000|Overall Study|Adverse Event|2|||
106153303|NCT04440176|366222077|FG001|Overall Study|Adverse Event|6|||
106153304|NCT04440176|366222076|FG000|Overall Study|Lost to Follow-up|22|||
106153305|NCT04440176|366222077|FG001|Overall Study|Lost to Follow-up|23|||
106153306|NCT04440176|366222076|FG000|Overall Study|Medication error without associated adverse event|0|||
106153307|NCT04440176|366222077|FG001|Overall Study|Medication error without associated adverse event|1|||
106153308|NCT04440176|366222076|FG000|Overall Study|No longer met eligibility criteria|7|||
106153309|NCT04440176|366222077|FG001|Overall Study|No longer met eligibility criteria|1|||
106153310|NCT04440176|366222076|FG000|Overall Study|Other|1|||
106153311|NCT04440176|366222077|FG001|Overall Study|Other|2|||
106153312|NCT04440176|366222076|FG000|Overall Study|Protocol deviation|6|||
106153313|NCT04440176|366222077|FG001|Overall Study|Protocol deviation|8|||
106153314|NCT04440176|366222076|FG000|Overall Study|Randomized but not vaccinated|6|||
106153315|NCT04440176|366222077|FG001|Overall Study|Randomized but not vaccinated|3|||
106153316|NCT03656562|366222089|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
106153317|NCT03656562|366222090|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
106153318|NCT03656562|366222091|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
106153319|NCT03656562|366222092|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
106153320|NCT03656562|366222089|FG000|Overall Study|Physician Decision|1|||
106153321|NCT03656562|366222090|FG001|Overall Study|Physician Decision|2|||
106153322|NCT03656562|366222091|FG002|Overall Study|Physician Decision|0|||
106153323|NCT03656562|366222092|FG003|Overall Study|Physician Decision|0|||
106153324|NCT03656562|366222089|FG000|Overall Study|Subject Decision|3|||
106153325|NCT03656562|366222090|FG001|Overall Study|Subject Decision|5|||
106153326|NCT03656562|366222091|FG002|Overall Study|Subject Decision|0|||
106153327|NCT03656562|366222092|FG003|Overall Study|Subject Decision|2|||
106153328|NCT04112316|366222093|FG000|First Period (8 Weeks)|Protocol Violation|1|||
106153329|NCT04112316|366222094|FG001|First Period (8 Weeks)|Protocol Violation|0|||
106153330|NCT04112316|366222093|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
106153331|NCT04112316|366222094|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
106153332|NCT00567398|366222095|FG000|Overall Study|Adverse Event|6|||
106153333|NCT00567398|366222096|FG001|Overall Study|Adverse Event|14|||
106153334|NCT00567398|366222095|FG000|Overall Study|Physician Decision|0|||
106153335|NCT00567398|366222096|FG001|Overall Study|Physician Decision|4|||
106153336|NCT00567398|366222095|FG000|Overall Study|Withdrawal by Subject|0|||
106153337|NCT00567398|366222096|FG001|Overall Study|Withdrawal by Subject|2|||
106153338|NCT00567398|366222095|FG000|Overall Study|Renal Transplantation|0|||
106153339|NCT00567398|366222096|FG001|Overall Study|Renal Transplantation|3|||
106153340|NCT00567398|366222095|FG000|Overall Study|Other|1|||
106153341|NCT00567398|366222096|FG001|Overall Study|Other|0|||
105864766|NCT03207867|365152998|FG009|Overall Study|Progressive Disease|23|||
105864767|NCT03207867|365152999|FG010|Overall Study|Progressive Disease|2|||
105864768|NCT03207867|365153000|FG011|Overall Study|Progressive Disease|24|||
106061096|NCT02289417|365882826|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
106061097|NCT02289417|365882827|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
106061098|NCT02289417|365882828|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
106061099|NCT02289417|365882820|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
106061100|NCT02289417|365882821|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
106061101|NCT02289417|365882822|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
106061102|NCT02289417|365882823|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
106061103|NCT02289417|365882824|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
106061104|NCT02289417|365882825|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
106061105|NCT02289417|365882826|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
106061106|NCT02289417|365882827|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
106061107|NCT02289417|365882828|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
106153342|NCT05215847|366222097|FG000|Overall Study|Lost to Follow-up|1|||
106153343|NCT01121991|366222100|FG000|Overall Study|Lack of Ovarian Response|2|||
106153344|NCT01121991|366222100|FG000|Overall Study|No Oocytes Retrieved|3|||
105864769|NCT03207867|365153001|FG012|Overall Study|Progressive Disease|3|||
106153345|NCT01121991|366222100|FG000|Overall Study|No Fertilization|1|||
106153346|NCT00409838|366222107|FG000|Short-term Period|Adverse Event|0|||
106153347|NCT00409838|366222108|FG001|Short-term Period|Adverse Event|1|||
105864770|NCT03207867|365153002|FG013|Overall Study|Progressive Disease|11|||
105864771|NCT03207867|365153003|FG014|Overall Study|Progressive Disease|9|||
106061108|NCT02289417|365882820|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
106153348|NCT00409838|366222107|FG000|Short-term Period|Lost to Follow-up|0|||
106153349|NCT00409838|366222108|FG001|Short-term Period|Lost to Follow-up|1|||
106153350|NCT00409838|366222107|FG000|Short-term Period|Withdrawal by Subject|2|||
106153351|NCT00409838|366222108|FG001|Short-term Period|Withdrawal by Subject|3|||
106153352|NCT00409838|366222107|FG000|Short-term Period|Never Treated|1|||
106153353|NCT00409838|366222108|FG001|Short-term Period|Never Treated|0|||
106153354|NCT00409838|366222107|FG000|Long-term Extension Period|Adverse Event|10|||
106153355|NCT00409838|366222108|FG001|Long-term Extension Period|Adverse Event|0|||
106153356|NCT00409838|366222107|FG000|Long-term Extension Period|Death|1|||
106153357|NCT00409838|366222108|FG001|Long-term Extension Period|Death|0|||
106153358|NCT00409838|366222107|FG000|Long-term Extension Period|Lack of Efficacy|2|||
106153359|NCT00409838|366222108|FG001|Long-term Extension Period|Lack of Efficacy|0|||
106153360|NCT00409838|366222107|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
106153361|NCT00409838|366222108|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
106153362|NCT00409838|366222107|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
106153363|NCT00409838|366222108|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
106153364|NCT00409838|366222107|FG000|Long-term Extension Period|Pregnancy|1|||
106153365|NCT00409838|366222108|FG001|Long-term Extension Period|Pregnancy|0|||
106153366|NCT02006758|366222109|FG000|Overall Study|Protocol Violation|1|||
106153367|NCT02006758|366222109|FG000|Overall Study|Death|1|||
106153368|NCT02006758|366222109|FG000|Overall Study|Lost to Follow-up|4|||
106153369|NCT02006758|366222109|FG000|Overall Study|Withdrawal by Subject|4|||
106153370|NCT02006758|366222109|FG000|Overall Study|Procedurally excluded|1|||
106153371|NCT02006758|366222109|FG000|Overall Study|Other|2|||
106153372|NCT03283371|366222111|FG000|Placebo-controlled|Adverse Event|1|||
106153373|NCT03283371|366222112|FG001|Placebo-controlled|Adverse Event|1|||
106061109|NCT02289417|365882821|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
106061110|NCT02289417|365882822|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
106061111|NCT02289417|365882823|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
106061112|NCT02289417|365882824|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
106061113|NCT02289417|365882825|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
106061114|NCT02289417|365882826|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
106061115|NCT02289417|365882827|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
106061116|NCT02289417|365882828|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
106061117|NCT02289417|365882820|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
106061118|NCT02289417|365882821|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
106061119|NCT02289417|365882822|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
106061120|NCT02289417|365882823|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
106061121|NCT02289417|365882824|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
106061122|NCT02289417|365882825|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
106061123|NCT02289417|365882826|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
106061124|NCT02289417|365882827|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
106061125|NCT02289417|365882828|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
106061126|NCT02289417|365882820|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
106061127|NCT02289417|365882821|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
106061128|NCT02289417|365882822|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
106061129|NCT02289417|365882823|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
106061130|NCT02289417|365882824|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
106061131|NCT02289417|365882825|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
106061132|NCT02289417|365882826|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
106061133|NCT02289417|365882827|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
106061134|NCT02289417|365882828|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
106061135|NCT02289417|365882820|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
106061136|NCT02289417|365882821|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
106061137|NCT02289417|365882822|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
106061138|NCT02289417|365882823|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
106061139|NCT02289417|365882824|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
106153374|NCT03283371|366222113|FG002|Placebo-controlled|Adverse Event|0|||
106153375|NCT03283371|366222114|FG003|Placebo-controlled|Adverse Event|0|||
106153376|NCT03283371|366222111|FG000|Placebo-controlled|Lack of Efficacy|1|||
106153377|NCT03283371|366222112|FG001|Placebo-controlled|Lack of Efficacy|0|||
106153378|NCT03283371|366222113|FG002|Placebo-controlled|Lack of Efficacy|0|||
106153379|NCT03283371|366222114|FG003|Placebo-controlled|Lack of Efficacy|0|||
106153380|NCT03283371|366222111|FG000|Placebo-controlled|Withdrawal by Subject|1|||
106061140|NCT02289417|365882825|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
106153381|NCT03283371|366222112|FG001|Placebo-controlled|Withdrawal by Subject|1|||
106153382|NCT03283371|366222113|FG002|Placebo-controlled|Withdrawal by Subject|0|||
106153383|NCT03283371|366222114|FG003|Placebo-controlled|Withdrawal by Subject|0|||
106153384|NCT03283371|366222111|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
106153385|NCT03283371|366222112|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
106153386|NCT03283371|366222113|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
106153387|NCT03283371|366222114|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
106153388|NCT03283371|366222111|FG000|Open-label Phase|Adverse Event|0|||
106153389|NCT03283371|366222112|FG001|Open-label Phase|Adverse Event|0|||
106153390|NCT03283371|366222113|FG002|Open-label Phase|Adverse Event|2|||
106153391|NCT03283371|366222114|FG003|Open-label Phase|Adverse Event|0|||
106153392|NCT03283371|366222111|FG000|Open-label Phase|Withdrawal by Subject|0|||
106153393|NCT03283371|366222112|FG001|Open-label Phase|Withdrawal by Subject|0|||
106153394|NCT03283371|366222113|FG002|Open-label Phase|Withdrawal by Subject|1|||
106153395|NCT03283371|366222114|FG003|Open-label Phase|Withdrawal by Subject|0|||
106153396|NCT03283371|366222111|FG000|Open-label Phase|Other|0|||
106153397|NCT03283371|366222112|FG001|Open-label Phase|Other|0|||
106153398|NCT03283371|366222113|FG002|Open-label Phase|Other|1|||
106153399|NCT03283371|366222114|FG003|Open-label Phase|Other|1|||
106153400|NCT04600752|366222115|FG000|Overall Study|Physician Decision|0|||
106153401|NCT04600752|366222116|FG001|Overall Study|Physician Decision|0|||
106153402|NCT04600752|366222117|FG002|Overall Study|Physician Decision|1|||
106153403|NCT04600752|366222115|FG000|Overall Study|Adverse Event|0|||
106153404|NCT04600752|366222116|FG001|Overall Study|Adverse Event|1|||
106153405|NCT04600752|366222117|FG002|Overall Study|Adverse Event|0|||
106153406|NCT04600752|366222115|FG000|Overall Study|Withdrawal by Subject|2|||
106153407|NCT04600752|366222116|FG001|Overall Study|Withdrawal by Subject|1|||
106153408|NCT04600752|366222117|FG002|Overall Study|Withdrawal by Subject|0|||
106153409|NCT04600752|366222115|FG000|Overall Study|Lack of Efficacy|1|||
106153410|NCT04600752|366222116|FG001|Overall Study|Lack of Efficacy|0|||
106153411|NCT04600752|366222117|FG002|Overall Study|Lack of Efficacy|0|||
106153412|NCT00632203|366222120|FG000|Overall Study|Did not start study treatment|1|||
106153413|NCT00632203|366222121|FG001|Overall Study|Did not start study treatment|0|||
106153414|NCT00448669|366222131|FG000|Overall Study|Lost to Follow-up|52|||
106153415|NCT00448669|366222132|FG001|Overall Study|Lost to Follow-up|63|||
106153416|NCT00448669|366222131|FG000|Overall Study|Withdrawal by Subject|90|||
106153417|NCT00448669|366222132|FG001|Overall Study|Withdrawal by Subject|74|||
106153418|NCT00448669|366222131|FG000|Overall Study|Relocated|49|||
106153419|NCT00448669|366222132|FG001|Overall Study|Relocated|36|||
106153420|NCT00448669|366222131|FG000|Overall Study|Were withdrawn by investigator|10|||
106153421|NCT00448669|366222132|FG001|Overall Study|Were withdrawn by investigator|6|||
106153422|NCT00448669|366222131|FG000|Overall Study|Death|2|||
106153423|NCT00448669|366222132|FG001|Overall Study|Death|4|||
106153424|NCT00448669|366222131|FG000|Overall Study|Had other reasons|5|||
106153425|NCT00448669|366222132|FG001|Overall Study|Had other reasons|6|||
106153426|NCT00448669|366222131|FG000|Overall Study|HIV-infected at enrollment|1|||
106153427|NCT00448669|366222132|FG001|Overall Study|HIV-infected at enrollment|2|||
106153428|NCT00448669|366222131|FG000|Overall Study|Never started drug|9|||
106153429|NCT00448669|366222132|FG001|Overall Study|Never started drug|7|||
106153430|NCT03771352|366222136|FG000|Overall Study|Screen failure|2|||
106153431|NCT03771352|366222136|FG000|Overall Study|Withdrawal by Subject|2|||
106153432|NCT03338816|366222137|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
106153433|NCT03338816|366222138|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
106153434|NCT03338816|366222139|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
106153435|NCT03338816|366222140|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
106153436|NCT03338816|366222137|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
106153437|NCT03338816|366222138|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
106153438|NCT03338816|366222139|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
106153439|NCT03338816|366222140|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
106153440|NCT03338816|366222137|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
106153441|NCT03338816|366222138|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
106153442|NCT03338816|366222139|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
106153443|NCT03338816|366222140|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
106153444|NCT03338816|366222137|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
106153445|NCT03338816|366222138|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
106153446|NCT03338816|366222139|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
106153447|NCT03338816|366222140|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
106153448|NCT03338816|366222137|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
106153449|NCT03338816|366222138|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
106153450|NCT03338816|366222139|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
106153451|NCT03338816|366222140|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
106153452|NCT03338816|366222137|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
106153453|NCT03338816|366222138|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
106153454|NCT03338816|366222139|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
106153455|NCT03338816|366222140|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
106153456|NCT03338816|366222137|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
106153457|NCT03338816|366222138|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
106153458|NCT03338816|366222139|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
106061141|NCT02289417|365882826|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
106061142|NCT02289417|365882827|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
106061143|NCT02289417|365882828|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
106061144|NCT02289417|365882820|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
106061145|NCT02289417|365882821|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
106061146|NCT02289417|365882822|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
106061147|NCT02289417|365882823|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
106061148|NCT02289417|365882824|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
106061149|NCT02289417|365882825|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
106061150|NCT02289417|365882826|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
106061151|NCT02289417|365882827|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
106061152|NCT02289417|365882828|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
106061153|NCT02289417|365882820|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
106061154|NCT02289417|365882821|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
106061155|NCT02289417|365882822|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
106061156|NCT02289417|365882823|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
106061157|NCT02289417|365882824|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
106061158|NCT02289417|365882825|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
106061159|NCT02289417|365882826|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
106061160|NCT02289417|365882827|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
106061161|NCT02289417|365882828|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
106061162|NCT02289417|365882820|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
106061163|NCT02289417|365882821|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
106061164|NCT02289417|365882822|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
106061165|NCT02289417|365882823|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
106061166|NCT02289417|365882824|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
106061167|NCT02289417|365882825|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
106061168|NCT02289417|365882826|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
106061169|NCT02289417|365882827|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
106061170|NCT02289417|365882828|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
106061171|NCT02289417|365882820|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
106061172|NCT02289417|365882821|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
106061173|NCT02289417|365882822|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
106061174|NCT02289417|365882823|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
106061175|NCT02289417|365882824|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
106061176|NCT02289417|365882825|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
106061177|NCT02289417|365882826|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
106061178|NCT02289417|365882827|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
106061179|NCT02289417|365882828|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
106061180|NCT03926169|365882829|FG000|Period A|Adverse Event|2|||
106061181|NCT03926169|365882830|FG001|Period A|Adverse Event|2|||
106061182|NCT03926169|365882831|FG002|Period A|Adverse Event|1|||
106061183|NCT03926169|365882829|FG000|Period A|Withdrawal by Subject|2|||
106061184|NCT03926169|365882830|FG001|Period A|Withdrawal by Subject|2|||
106061185|NCT03926169|365882831|FG002|Period A|Withdrawal by Subject|2|||
106061186|NCT03926169|365882829|FG000|Period A|Lost to Follow-up|3|||
106061187|NCT03926169|365882830|FG001|Period A|Lost to Follow-up|1|||
106061188|NCT03926169|365882831|FG002|Period A|Lost to Follow-up|0|||
106061189|NCT03926169|365882829|FG000|Period A|Lack of Efficacy|0|||
106061190|NCT03926169|365882830|FG001|Period A|Lack of Efficacy|2|||
106061191|NCT03926169|365882831|FG002|Period A|Lack of Efficacy|2|||
106061192|NCT03926169|365882829|FG000|Period A|COVID-19 Infection|0|||
106061193|NCT03926169|365882830|FG001|Period A|COVID-19 Infection|1|||
106061194|NCT03926169|365882831|FG002|Period A|COVID-19 Infection|0|||
106153459|NCT03338816|366222140|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
106153460|NCT04238247|366222141|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
106153461|NCT04238247|366222142|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
106153462|NCT04238247|366222143|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
106153463|NCT04238247|366222144|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
106153464|NCT04238247|366222141|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
106061195|NCT03926169|365882829|FG000|Period A|COVID-19 Logistical Restrictions|0|||
106061196|NCT03926169|365882830|FG001|Period A|COVID-19 Logistical Restrictions|2|||
106153465|NCT04238247|366222142|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
106153466|NCT04238247|366222143|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
106061197|NCT03926169|365882831|FG002|Period A|COVID-19 Logistical Restrictions|1|||
106061198|NCT03926169|365882829|FG000|Period A|Other, Not Specified|1|||
106153467|NCT04238247|366222144|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
106061199|NCT03926169|365882830|FG001|Period A|Other, Not Specified|0|||
106061200|NCT03926169|365882831|FG002|Period A|Other, Not Specified|0|||
106061201|NCT03926169|365882829|FG000|Period B|Adverse Event|3|||
106061202|NCT03926169|365882830|FG001|Period B|Adverse Event|1|||
106061203|NCT03926169|365882831|FG002|Period B|Adverse Event|1|||
106061204|NCT03926169|365882829|FG000|Period B|Withdrawal by Subject|1|||
106061205|NCT03926169|365882830|FG001|Period B|Withdrawal by Subject|3|||
106061206|NCT03926169|365882831|FG002|Period B|Withdrawal by Subject|0|||
106061207|NCT03926169|365882829|FG000|Period B|Lack of Efficacy|3|||
106061208|NCT03926169|365882830|FG001|Period B|Lack of Efficacy|1|||
106061209|NCT03926169|365882831|FG002|Period B|Lack of Efficacy|1|||
106061210|NCT03926169|365882829|FG000|Period B|Lost to Follow-up|1|||
106061211|NCT03926169|365882830|FG001|Period B|Lost to Follow-up|1|||
106061212|NCT03926169|365882831|FG002|Period B|Lost to Follow-up|4|||
106061213|NCT03926169|365882829|FG000|Period B|Other, Not Specified|62|||
106061214|NCT03926169|365882830|FG001|Period B|Other, Not Specified|57|||
106061215|NCT03926169|365882831|FG002|Period B|Other, Not Specified|65|||
106061216|NCT01500694|365882835|FG000|Overall Study|Adverse Event|4|||
106061217|NCT01500694|365882836|FG001|Overall Study|Adverse Event|3|||
106061218|NCT01500694|365882835|FG000|Overall Study|Protocol Violation|0|||
106061219|NCT01500694|365882836|FG001|Overall Study|Protocol Violation|1|||
106061220|NCT01500694|365882835|FG000|Overall Study|Withdrawal by Subject|23|||
106061221|NCT01500694|365882836|FG001|Overall Study|Withdrawal by Subject|14|||
106061222|NCT01500694|365882835|FG000|Overall Study|Lost to Follow-up|2|||
106061223|NCT01500694|365882836|FG001|Overall Study|Lost to Follow-up|3|||
106061224|NCT01500694|365882835|FG000|Overall Study|Lack of Efficacy|14|||
106061225|NCT01500694|365882836|FG001|Overall Study|Lack of Efficacy|5|||
106061226|NCT01500694|365882835|FG000|Overall Study|Other|9|||
106061227|NCT01500694|365882836|FG001|Overall Study|Other|3|||
106061228|NCT00519831|365882841|FG000|Overall Study|Adverse Event|3|||
106061229|NCT00471328|365882842|FG000|Core Phase|Adverse Event|18|||
106061230|NCT00471328|365882843|FG001|Core Phase|Adverse Event|6|||
106061231|NCT00471328|365882842|FG000|Core Phase|Death|8|||
106061232|NCT00471328|365882843|FG001|Core Phase|Death|4|||
106061233|NCT00471328|365882842|FG000|Core Phase|Withdrawal by Subject|2|||
106061234|NCT00471328|365882843|FG001|Core Phase|Withdrawal by Subject|2|||
106061235|NCT00471328|365882842|FG000|Core Phase|Abnormal laboratory value|1|||
106061236|NCT00471328|365882843|FG001|Core Phase|Abnormal laboratory value|0|||
106061237|NCT00471328|365882842|FG000|Core Phase|Disease Progression|78|||
106061238|NCT00471328|365882843|FG001|Core Phase|Disease Progression|53|||
106061239|NCT00471328|365882842|FG000|Core Phase|Administrative Problem|0|||
106061240|NCT00471328|365882843|FG001|Core Phase|Administrative Problem|1|||
106061241|NCT00471328|365882842|FG000|Core Phase|Protocol Deviation|0|||
106061242|NCT00471328|365882843|FG001|Core Phase|Protocol Deviation|1|||
106061243|NCT00471328|365882842|FG000|Extension Phase|Adverse Event|3|||
106061244|NCT00471328|365882843|FG001|Extension Phase|Adverse Event|12|||
106061245|NCT00471328|365882842|FG000|Extension Phase|Withdrawal by Subject|0|||
106061246|NCT00471328|365882843|FG001|Extension Phase|Withdrawal by Subject|2|||
106061247|NCT00471328|365882842|FG000|Extension Phase|Death|1|||
106061248|NCT00471328|365882843|FG001|Extension Phase|Death|7|||
106061249|NCT00471328|365882842|FG000|Extension Phase|Protocol Deviation|3|||
106061250|NCT00471328|365882843|FG001|Extension Phase|Protocol Deviation|1|||
106061251|NCT00471328|365882842|FG000|Extension Phase|Treatment duration as per protocol|0|||
106061252|NCT00471328|365882843|FG001|Extension Phase|Treatment duration as per protocol|1|||
106061253|NCT00471328|365882842|FG000|Extension Phase|Disease Progression|32|||
106061254|NCT00471328|365882843|FG001|Extension Phase|Disease Progression|44|||
106061255|NCT00471328|365882842|FG000|Extension Phase|New cancer Therapy|1|||
106061256|NCT00471328|365882843|FG001|Extension Phase|New cancer Therapy|0|||
106061257|NCT00471328|365882842|FG000|Extension Phase|Administrative Problem|1|||
106061258|NCT00471328|365882843|FG001|Extension Phase|Administrative Problem|0|||
106061259|NCT02854631|365882844|FG000|Overall Study|Adverse Event|1|||
106061260|NCT02854631|365882845|FG001|Overall Study|Adverse Event|2|||
106061261|NCT02854631|365882844|FG000|Overall Study|Withdrew Consent|3|||
106061262|NCT02854631|365882845|FG001|Overall Study|Withdrew Consent|2|||
106061263|NCT02854631|365882844|FG000|Overall Study|Investigator's Discretion|2|||
106061264|NCT02854631|365882845|FG001|Overall Study|Investigator's Discretion|0|||
106061265|NCT02854631|365882844|FG000|Overall Study|Death|12|||
106061266|NCT02854631|365882845|FG001|Overall Study|Death|8|||
106061267|NCT02854631|365882844|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
106061268|NCT02854631|365882845|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
106061269|NCT02854631|365882844|FG000|Overall Study|Protocol Violation|0|||
106061270|NCT02854631|365882845|FG001|Overall Study|Protocol Violation|1|||
106061271|NCT02854631|365882844|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
106061272|NCT02854631|365882845|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
106061273|NCT02854631|365882844|FG000|Overall Study|Lost to Follow-up|4|||
106061274|NCT02854631|365882845|FG001|Overall Study|Lost to Follow-up|2|||
106061275|NCT01605877|365882849|FG000|Overall Study|Withdrawal by Subject|1|||
106061276|NCT00357968|365882854|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
106061277|NCT00357968|365882855|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
106061278|NCT00357968|365882854|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
106061279|NCT00357968|365882855|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
106061280|NCT00679302|365882858|FG000|Overall Study|Lost to Follow-up|8|||
106061281|NCT00679302|365882859|FG001|Overall Study|Lost to Follow-up|4|||
106061282|NCT00600483|365882860|FG000|Overall Study|Lost to Follow-up|26|||
106153468|NCT04238247|366222141|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
106153469|NCT04238247|366222142|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
106153470|NCT04238247|366222143|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
106153471|NCT04238247|366222144|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
106153472|NCT04238247|366222141|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
106153473|NCT04238247|366222142|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
106153474|NCT04238247|366222143|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
106153475|NCT04238247|366222144|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
106153476|NCT03092726|366222145|FG000|Overall Study|Adverse Event|3|||
106153477|NCT03092726|366222146|FG001|Overall Study|Adverse Event|10|||
106153478|NCT03092726|366222145|FG000|Overall Study|Lack of Efficacy|0|||
106153479|NCT03092726|366222146|FG001|Overall Study|Lack of Efficacy|1|||
106153480|NCT03092726|366222145|FG000|Overall Study|Lost to Follow-up|1|||
106153481|NCT03092726|366222146|FG001|Overall Study|Lost to Follow-up|0|||
106153482|NCT03092726|366222145|FG000|Overall Study|Withdrawal by Subject|5|||
106153483|NCT03092726|366222146|FG001|Overall Study|Withdrawal by Subject|3|||
106153484|NCT01948661|366222147|FG000|Overall Study|Withdrawal by Subject|2|||
106153485|NCT01948661|366222148|FG001|Overall Study|Withdrawal by Subject|4|||
106153486|NCT00632749|366222149|FG000|Overall Study|Progressive disease|3|||
106153487|NCT00632749|366222150|FG001|Overall Study|Progressive disease|2|||
106153488|NCT00632749|366222151|FG002|Overall Study|Progressive disease|2|||
106153489|NCT00632749|366222152|FG003|Overall Study|Progressive disease|2|||
106153490|NCT00632749|366222153|FG004|Overall Study|Progressive disease|4|||
106153491|NCT00632749|366222154|FG005|Overall Study|Progressive disease|4|||
106153492|NCT00632749|366222155|FG006|Overall Study|Progressive disease|3|||
106153493|NCT00632749|366222156|FG007|Overall Study|Progressive disease|2|||
106153494|NCT00632749|366222157|FG008|Overall Study|Progressive disease|3|||
106153495|NCT00632749|366222158|FG009|Overall Study|Progressive disease|2|||
106153496|NCT00632749|366222159|FG010|Overall Study|Progressive disease|4|||
106153497|NCT00632749|366222160|FG011|Overall Study|Progressive disease|3|||
106153498|NCT00632749|366222161|FG012|Overall Study|Progressive disease|2|||
106153499|NCT00632749|366222162|FG013|Overall Study|Progressive disease|4|||
106153500|NCT00632749|366222149|FG000|Overall Study|Other Adverse event|1|||
106153501|NCT00632749|366222150|FG001|Overall Study|Other Adverse event|1|||
106153502|NCT00632749|366222151|FG002|Overall Study|Other Adverse event|1|||
106153503|NCT00632749|366222152|FG003|Overall Study|Other Adverse event|1|||
106153504|NCT00632749|366222153|FG004|Overall Study|Other Adverse event|2|||
106153505|NCT00632749|366222154|FG005|Overall Study|Other Adverse event|4|||
106153506|NCT00632749|366222155|FG006|Overall Study|Other Adverse event|1|||
106153507|NCT00632749|366222156|FG007|Overall Study|Other Adverse event|2|||
106153508|NCT00632749|366222157|FG008|Overall Study|Other Adverse event|2|||
106153509|NCT00632749|366222158|FG009|Overall Study|Other Adverse event|0|||
106153510|NCT00632749|366222159|FG010|Overall Study|Other Adverse event|1|||
106153511|NCT00632749|366222160|FG011|Overall Study|Other Adverse event|0|||
106153512|NCT00632749|366222161|FG012|Overall Study|Other Adverse event|1|||
106153513|NCT00632749|366222162|FG013|Overall Study|Other Adverse event|0|||
106153514|NCT00632749|366222149|FG000|Overall Study|Refuse to continue medication|0|||
106153515|NCT00632749|366222150|FG001|Overall Study|Refuse to continue medication|0|||
106153516|NCT00632749|366222151|FG002|Overall Study|Refuse to continue medication|0|||
106153517|NCT00632749|366222152|FG003|Overall Study|Refuse to continue medication|1|||
106153518|NCT00632749|366222153|FG004|Overall Study|Refuse to continue medication|0|||
106153519|NCT00632749|366222154|FG005|Overall Study|Refuse to continue medication|0|||
106153520|NCT00632749|366222155|FG006|Overall Study|Refuse to continue medication|0|||
106153521|NCT00632749|366222156|FG007|Overall Study|Refuse to continue medication|0|||
106153522|NCT00632749|366222157|FG008|Overall Study|Refuse to continue medication|0|||
106153523|NCT00632749|366222158|FG009|Overall Study|Refuse to continue medication|1|||
106153524|NCT00632749|366222159|FG010|Overall Study|Refuse to continue medication|0|||
106153525|NCT00632749|366222160|FG011|Overall Study|Refuse to continue medication|0|||
106153526|NCT00632749|366222161|FG012|Overall Study|Refuse to continue medication|0|||
106153527|NCT00632749|366222162|FG013|Overall Study|Refuse to continue medication|0|||
106153528|NCT00632749|366222149|FG000|Overall Study|Reason other than those specified above|0|||
106153529|NCT00632749|366222150|FG001|Overall Study|Reason other than those specified above|2|||
106153530|NCT00632749|366222151|FG002|Overall Study|Reason other than those specified above|0|||
106153531|NCT00632749|366222152|FG003|Overall Study|Reason other than those specified above|0|||
106153532|NCT00632749|366222153|FG004|Overall Study|Reason other than those specified above|1|||
106153533|NCT00632749|366222154|FG005|Overall Study|Reason other than those specified above|0|||
106153534|NCT00632749|366222155|FG006|Overall Study|Reason other than those specified above|1|||
106153535|NCT00632749|366222156|FG007|Overall Study|Reason other than those specified above|0|||
106153536|NCT00632749|366222157|FG008|Overall Study|Reason other than those specified above|0|||
106153537|NCT00632749|366222158|FG009|Overall Study|Reason other than those specified above|0|||
106153538|NCT00632749|366222159|FG010|Overall Study|Reason other than those specified above|2|||
106153539|NCT00632749|366222160|FG011|Overall Study|Reason other than those specified above|1|||
106153540|NCT00632749|366222161|FG012|Overall Study|Reason other than those specified above|0|||
106153541|NCT00632749|366222162|FG013|Overall Study|Reason other than those specified above|2|||
106153542|NCT04218266|366222163|FG000|Overall Study|Death|1|||
106153543|NCT04218266|366222164|FG001|Overall Study|Death|2|||
106061283|NCT00600483|365882861|FG001|Overall Study|Lost to Follow-up|47|||
106061284|NCT00600483|365882860|FG000|Overall Study|Randomized but not treated|10|||
106061285|NCT00600483|365882861|FG001|Overall Study|Randomized but not treated|0|||
106061286|NCT02846779|365882875|FG000|Overall Study|Lost Enrollment|83|||
106061287|NCT02846779|365882876|FG001|Overall Study|Lost Enrollment|82|||
106061288|NCT02846779|365882877|FG002|Overall Study|Lost Enrollment|86|||
106061289|NCT02846779|365882875|FG000|Overall Study|Less than 31 days of follow-up|56|||
106061290|NCT02846779|365882876|FG001|Overall Study|Less than 31 days of follow-up|45|||
106061291|NCT02846779|365882877|FG002|Overall Study|Less than 31 days of follow-up|52|||
106061292|NCT00203996|365882878|FG000|Overall Study|Lost to Follow-up|0|||
106061293|NCT00203996|365882879|FG001|Overall Study|Lost to Follow-up|0|||
106061294|NCT00203996|365882880|FG002|Overall Study|Lost to Follow-up|0|||
106061295|NCT00203996|365882881|FG003|Overall Study|Lost to Follow-up|1|||
106061296|NCT00203996|365882882|FG004|Overall Study|Lost to Follow-up|0|||
106061297|NCT00203996|365882883|FG005|Overall Study|Lost to Follow-up|0|||
106061298|NCT00203996|365882884|FG006|Overall Study|Lost to Follow-up|0|||
106061299|NCT00203996|365882885|FG007|Overall Study|Lost to Follow-up|0|||
106061300|NCT00203996|365882886|FG008|Overall Study|Lost to Follow-up|0|||
106061301|NCT00203996|365882887|FG009|Overall Study|Lost to Follow-up|0|||
106061302|NCT00203996|365882878|FG000|Overall Study|Protocol Violation|0|||
106061303|NCT00203996|365882879|FG001|Overall Study|Protocol Violation|0|||
106061304|NCT00203996|365882880|FG002|Overall Study|Protocol Violation|0|||
106061305|NCT00203996|365882881|FG003|Overall Study|Protocol Violation|6|||
106061306|NCT00203996|365882882|FG004|Overall Study|Protocol Violation|1|||
106061307|NCT00203996|365882883|FG005|Overall Study|Protocol Violation|0|||
106061308|NCT00203996|365882884|FG006|Overall Study|Protocol Violation|0|||
106061309|NCT00203996|365882885|FG007|Overall Study|Protocol Violation|0|||
106061310|NCT00203996|365882886|FG008|Overall Study|Protocol Violation|0|||
106061311|NCT00203996|365882887|FG009|Overall Study|Protocol Violation|0|||
106061312|NCT00203996|365882878|FG000|Overall Study|Physician Decision|0|||
106061313|NCT00203996|365882879|FG001|Overall Study|Physician Decision|0|||
106061314|NCT00203996|365882880|FG002|Overall Study|Physician Decision|0|||
106061315|NCT00203996|365882881|FG003|Overall Study|Physician Decision|2|||
106061316|NCT00203996|365882882|FG004|Overall Study|Physician Decision|0|||
106061317|NCT00203996|365882883|FG005|Overall Study|Physician Decision|0|||
106061318|NCT00203996|365882884|FG006|Overall Study|Physician Decision|0|||
106061319|NCT00203996|365882885|FG007|Overall Study|Physician Decision|0|||
106061320|NCT00203996|365882886|FG008|Overall Study|Physician Decision|0|||
106061321|NCT00203996|365882887|FG009|Overall Study|Physician Decision|1|||
106061322|NCT00203996|365882878|FG000|Overall Study|CPAP machine malfunction|0|||
106061323|NCT00203996|365882879|FG001|Overall Study|CPAP machine malfunction|0|||
106061324|NCT00203996|365882880|FG002|Overall Study|CPAP machine malfunction|0|||
106061325|NCT00203996|365882881|FG003|Overall Study|CPAP machine malfunction|1|||
106061326|NCT00203996|365882882|FG004|Overall Study|CPAP machine malfunction|0|||
106061327|NCT00203996|365882883|FG005|Overall Study|CPAP machine malfunction|0|||
106061328|NCT00203996|365882884|FG006|Overall Study|CPAP machine malfunction|0|||
106061329|NCT00203996|365882885|FG007|Overall Study|CPAP machine malfunction|0|||
106061330|NCT00203996|365882886|FG008|Overall Study|CPAP machine malfunction|0|||
106061331|NCT00203996|365882887|FG009|Overall Study|CPAP machine malfunction|0|||
106061332|NCT00203996|365882878|FG000|Overall Study|Scheduling issue|0|||
106061333|NCT00203996|365882879|FG001|Overall Study|Scheduling issue|0|||
106061334|NCT00203996|365882880|FG002|Overall Study|Scheduling issue|0|||
106061335|NCT00203996|365882881|FG003|Overall Study|Scheduling issue|0|||
106061336|NCT00203996|365882882|FG004|Overall Study|Scheduling issue|0|||
106061337|NCT00203996|365882883|FG005|Overall Study|Scheduling issue|0|||
106061338|NCT00203996|365882884|FG006|Overall Study|Scheduling issue|0|||
106061339|NCT00203996|365882885|FG007|Overall Study|Scheduling issue|2|||
106061340|NCT00203996|365882886|FG008|Overall Study|Scheduling issue|0|||
106061341|NCT00203996|365882887|FG009|Overall Study|Scheduling issue|0|||
106061342|NCT03064451|365882888|FG000|Overall Study|Lost to Follow-up|1|||
106061343|NCT03064451|365882888|FG000|Overall Study|Mapping Failure|4|||
106061344|NCT03064451|365882888|FG000|Overall Study|Exited prior to procedure|8|||
106061345|NCT03064451|365882888|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
106061346|NCT00850564|365882889|FG000|Overall Study|Withdrawal by Subject|2|||
106153544|NCT04218266|366222165|FG002|Overall Study|Death|3|||
106061347|NCT05355805|365882890|FG000|Overall Study|Lost to Follow-up|6|||
106061348|NCT05355805|365882891|FG001|Overall Study|Lost to Follow-up|11|||
106061349|NCT05355805|365882892|FG002|Overall Study|Lost to Follow-up|10|||
106061350|NCT05355805|365882893|FG003|Overall Study|Lost to Follow-up|6|||
106061351|NCT05355805|365882890|FG000|Overall Study|Decision by Sponsor|0|||
106061352|NCT05355805|365882891|FG001|Overall Study|Decision by Sponsor|0|||
106061353|NCT05355805|365882892|FG002|Overall Study|Decision by Sponsor|1|||
106061354|NCT05355805|365882893|FG003|Overall Study|Decision by Sponsor|0|||
106061355|NCT05355805|365882890|FG000|Overall Study|Withdrawal by Subject|7|||
106061356|NCT05355805|365882891|FG001|Overall Study|Withdrawal by Subject|14|||
106061357|NCT05355805|365882892|FG002|Overall Study|Withdrawal by Subject|15|||
106061358|NCT05355805|365882893|FG003|Overall Study|Withdrawal by Subject|13|||
106061359|NCT02167893|365882896|FG000|Overall Study|Investigator transferred|85|||
106061360|NCT02167893|365882896|FG000|Overall Study|Investigator health reasons|10|||
106061361|NCT02167893|365882896|FG000|Overall Study|Case report forms not collected|68|||
106061362|NCT00410046|365884988|FG000|Overall Study|Adverse Event|3|||
106061363|NCT00410046|365884988|FG000|Overall Study|Withdrawal by Subject|1|||
106061364|NCT00410046|365884988|FG000|Overall Study|Lost to Follow-up|1|||
106061365|NCT01549860|365884989|FG000|Overall Study|Withdrawal by Subject|1|||
106061366|NCT01549860|365884990|FG001|Overall Study|Withdrawal by Subject|0|||
106061367|NCT01549860|365884989|FG000|Overall Study|Physician Decision|1|||
106061368|NCT01549860|365884990|FG001|Overall Study|Physician Decision|1|||
106061369|NCT00482612|365884991|FG000|In-treatment Period|No study medication administered|0|||
106061370|NCT00482612|365884992|FG001|In-treatment Period|No study medication administered|0|||
106061371|NCT00482612|365884993|FG002|In-treatment Period|No study medication administered|1|||
106061372|NCT00482612|365884994|FG003|In-treatment Period|No study medication administered|0|||
106061373|NCT00482612|365884991|FG000|Follow-up Period|Other|4|||
106061374|NCT00482612|365884992|FG001|Follow-up Period|Other|2|||
106061375|NCT00482612|365884993|FG002|Follow-up Period|Other|1|||
106061376|NCT00482612|365884994|FG003|Follow-up Period|Other|2|||
106061377|NCT00482612|365884991|FG000|Follow-up Period|Lack of compliance|0|||
106061378|NCT00482612|365884992|FG001|Follow-up Period|Lack of compliance|0|||
106061379|NCT00482612|365884993|FG002|Follow-up Period|Lack of compliance|1|||
106061380|NCT00482612|365884994|FG003|Follow-up Period|Lack of compliance|0|||
106061381|NCT00482612|365884991|FG000|Follow-up Period|Lost to Follow-up|0|||
106061382|NCT00482612|365884992|FG001|Follow-up Period|Lost to Follow-up|4|||
106061383|NCT00482612|365884993|FG002|Follow-up Period|Lost to Follow-up|2|||
106061384|NCT00482612|365884994|FG003|Follow-up Period|Lost to Follow-up|1|||
106061385|NCT00482612|365884991|FG000|Follow-up Period|Adverse Event|4|||
106061386|NCT00482612|365884992|FG001|Follow-up Period|Adverse Event|7|||
106061387|NCT00482612|365884993|FG002|Follow-up Period|Adverse Event|9|||
106061388|NCT00482612|365884994|FG003|Follow-up Period|Adverse Event|0|||
106061389|NCT00482612|365884991|FG000|Follow-up Period|Lack of Efficacy|2|||
106061390|NCT00482612|365884992|FG001|Follow-up Period|Lack of Efficacy|0|||
106061391|NCT00482612|365884993|FG002|Follow-up Period|Lack of Efficacy|1|||
106061392|NCT00482612|365884994|FG003|Follow-up Period|Lack of Efficacy|0|||
106061393|NCT00482612|365884991|FG000|Follow-up Period|Withdrawal by Subject|3|||
106061394|NCT00482612|365884992|FG001|Follow-up Period|Withdrawal by Subject|5|||
106061395|NCT00482612|365884993|FG002|Follow-up Period|Withdrawal by Subject|7|||
106061396|NCT00482612|365884994|FG003|Follow-up Period|Withdrawal by Subject|2|||
106061397|NCT00482612|365884991|FG000|Follow-up Period|Reasons not related to trial|1|||
106061398|NCT00482612|365884992|FG001|Follow-up Period|Reasons not related to trial|0|||
106061399|NCT00482612|365884993|FG002|Follow-up Period|Reasons not related to trial|1|||
106061400|NCT00482612|365884994|FG003|Follow-up Period|Reasons not related to trial|3|||
106061401|NCT00543140|365884995|FG000|Overall Study|Lost to Follow-up|33|||
106061402|NCT00543140|365884995|FG000|Overall Study|Withdrawal by Subject|13|||
106061403|NCT00543140|365884995|FG000|Overall Study|Protocol Violation|10|||
106061404|NCT00543140|365884995|FG000|Overall Study|Insufficient weight loss|10|||
106061405|NCT00543140|365884995|FG000|Overall Study|SAE leading to explant of SAGB|3|||
106061406|NCT00543140|365884995|FG000|Overall Study|Death|1|||
106061407|NCT00543140|365884995|FG000|Overall Study|Subject moved|1|||
106061408|NCT00543140|365884995|FG000|Overall Study|Conversion to different procedure|1|||
106061409|NCT02430311|365884996|FG000|Part A|Adverse Event|0|||
106061410|NCT02430311|365884997|FG001|Part A|Adverse Event|1|||
106061411|NCT02430311|365884996|FG000|Part A|Withdrawal by Subject|1|||
106061412|NCT02430311|365884997|FG001|Part A|Withdrawal by Subject|0|||
106061413|NCT02430311|365884996|FG000|Part B|Meet study-specific withdrawal criteria|6|||
106061414|NCT02430311|365884997|FG001|Part B|Meet study-specific withdrawal criteria|6|||
106061415|NCT02430311|365884996|FG000|Part B|Withdrawal by Subject|2|||
106061416|NCT02430311|365884997|FG001|Part B|Withdrawal by Subject|2|||
106061417|NCT02430311|365884996|FG000|Part B|Adverse Event|1|||
106061418|NCT02430311|365884997|FG001|Part B|Adverse Event|0|||
106061419|NCT02430311|365884996|FG000|Part B|Death|1|||
106061420|NCT02430311|365884997|FG001|Part B|Death|0|||
106061421|NCT03506815|365884998|FG000|Overall Study|Adverse Event|8|||
106061422|NCT03506815|365884999|FG001|Overall Study|Adverse Event|0|||
106061423|NCT03506815|365884998|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
106061424|NCT03506815|365884999|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
106061425|NCT03506815|365884998|FG000|Overall Study|Protocol Violation|1|||
106061426|NCT03506815|365884999|FG001|Overall Study|Protocol Violation|0|||
106061427|NCT03506815|365884998|FG000|Overall Study|Elective Surgery|1|||
106061428|NCT03506815|365884999|FG001|Overall Study|Elective Surgery|0|||
106061429|NCT00381095|365885006|FG000|Overall Study|Death|3|||
106061430|NCT00381095|365885007|FG001|Overall Study|Death|4|||
106061431|NCT00381095|365885006|FG000|Overall Study|Lack of Efficacy|2|||
106061432|NCT00381095|365885007|FG001|Overall Study|Lack of Efficacy|4|||
106061433|NCT00381095|365885006|FG000|Overall Study|Other|2|||
106061434|NCT00381095|365885007|FG001|Overall Study|Other|2|||
106061435|NCT00381095|365885006|FG000|Overall Study|Protocol Violation|1|||
106061436|NCT00381095|365885007|FG001|Overall Study|Protocol Violation|1|||
106061437|NCT00381095|365885006|FG000|Overall Study|Withdrawal by Subject|3|||
106061438|NCT00381095|365885007|FG001|Overall Study|Withdrawal by Subject|3|||
106061439|NCT00381095|365885006|FG000|Overall Study|Adverse Event|2|||
106061440|NCT00381095|365885007|FG001|Overall Study|Adverse Event|7|||
106061441|NCT01599234|365885008|FG000|Overall Study|Adverse Event|9|||
106061442|NCT01599234|365885009|FG001|Overall Study|Adverse Event|5|||
106061443|NCT01599234|365885008|FG000|Overall Study|Withdrawal by Subject|2|||
106061444|NCT01599234|365885009|FG001|Overall Study|Withdrawal by Subject|1|||
106061445|NCT01599234|365885008|FG000|Overall Study|Lost to Follow-up|1|||
106061446|NCT01599234|365885009|FG001|Overall Study|Lost to Follow-up|2|||
106061447|NCT01599234|365885008|FG000|Overall Study|Lack of Efficacy|2|||
106061448|NCT01599234|365885009|FG001|Overall Study|Lack of Efficacy|4|||
106061449|NCT01599234|365885008|FG000|Overall Study|Unable to operate spray|1|||
106061450|NCT01599234|365885009|FG001|Overall Study|Unable to operate spray|0|||
106061451|NCT01599234|365885008|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
106061452|NCT01599234|365885009|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
106061453|NCT01599234|365885008|FG000|Overall Study|Death|1|||
106061454|NCT01599234|365885009|FG001|Overall Study|Death|0|||
106061455|NCT01599234|365885008|FG000|Overall Study|Patient would not stop driving|1|||
106061456|NCT01599234|365885009|FG001|Overall Study|Patient would not stop driving|0|||
106061457|NCT01599234|365885008|FG000|Overall Study|Contra-indication discovered|0|||
106061458|NCT01599234|365885009|FG001|Overall Study|Contra-indication discovered|1|||
106061459|NCT01599234|365885008|FG000|Overall Study|Pregnancy|0|||
106061460|NCT01599234|365885009|FG001|Overall Study|Pregnancy|1|||
106061461|NCT04626297|365885019|FG000|Overall Study|Adverse Event|5|||
106061462|NCT04626297|365885020|FG001|Overall Study|Adverse Event|3|||
106061463|NCT04626297|365885019|FG000|Overall Study|Lost to Follow-up|7|||
106061464|NCT04626297|365885020|FG001|Overall Study|Lost to Follow-up|3|||
106061465|NCT04626297|365885019|FG000|Overall Study|Protocol Violation|5|||
106061466|NCT04626297|365885020|FG001|Overall Study|Protocol Violation|1|||
106061467|NCT04626297|365885019|FG000|Overall Study|Withdrawal by Subject|20|||
106061468|NCT04626297|365885020|FG001|Overall Study|Withdrawal by Subject|6|||
106061469|NCT04626297|365885019|FG000|Overall Study|Sponsor decision|2|||
106061470|NCT04626297|365885020|FG001|Overall Study|Sponsor decision|1|||
106061471|NCT00885105|365885021|FG000|Overall Study|Withdrawal by Subject|0|||
105864772|NCT03207867|365153004|FG015|Overall Study|Progressive Disease|5|||
105864773|NCT03207867|365153005|FG016|Overall Study|Progressive Disease|10|||
106061472|NCT00885105|365885022|FG001|Overall Study|Withdrawal by Subject|8|||
106061473|NCT00885105|365885021|FG000|Overall Study|Adverse Event|1|||
106061474|NCT00885105|365885022|FG001|Overall Study|Adverse Event|0|||
106061475|NCT00885105|365885021|FG000|Overall Study|Protocol Violation|0|||
106061476|NCT00885105|365885022|FG001|Overall Study|Protocol Violation|2|||
106061477|NCT03020160|365885023|FG000|Overall Study|Withdrawal by Subject|1|||
106061478|NCT03020160|365885024|FG001|Overall Study|Withdrawal by Subject|0|||
106061479|NCT01350414|365885031|FG000|Overall Study|Lost to Follow-up|13|||
106061480|NCT01350414|365885031|FG000|Overall Study|Withdrawal by Subject|4|||
106061481|NCT01350414|365885031|FG000|Overall Study|Physician Decision|2|||
106061482|NCT04016285|365885032|FG000|Overall Study|Did not progress to surgery|2|||
106061483|NCT04016285|365885033|FG001|Overall Study|Did not progress to surgery|5|||
106061484|NCT04016285|365885032|FG000|Overall Study|Failed to collect outcome data|5|||
106061485|NCT04016285|365885033|FG001|Overall Study|Failed to collect outcome data|3|||
106061486|NCT00460408|365885037|FG000|Overall Study|Adverse Event|1|||
106061487|NCT00460408|365885038|FG001|Overall Study|Adverse Event|0|||
106061488|NCT00460408|365885039|FG002|Overall Study|Adverse Event|0|||
106061489|NCT00460408|365885040|FG003|Overall Study|Adverse Event|0|||
106061490|NCT00460408|365885037|FG000|Overall Study|Death|7|||
106061491|NCT00460408|365885038|FG001|Overall Study|Death|0|||
106061492|NCT00460408|365885039|FG002|Overall Study|Death|0|||
105864774|NCT03207867|365153006|FG017|Overall Study|Progressive Disease|14|||
106061493|NCT00460408|365885040|FG003|Overall Study|Death|0|||
106061494|NCT00460408|365885037|FG000|Overall Study|Lost to Follow-up|11|||
106061495|NCT00460408|365885038|FG001|Overall Study|Lost to Follow-up|0|||
106061496|NCT00460408|365885039|FG002|Overall Study|Lost to Follow-up|1|||
106061497|NCT00460408|365885040|FG003|Overall Study|Lost to Follow-up|0|||
106061498|NCT00460408|365885037|FG000|Overall Study|Withdrawal by Subject|31|||
106061499|NCT00460408|365885038|FG001|Overall Study|Withdrawal by Subject|0|||
106061500|NCT00460408|365885039|FG002|Overall Study|Withdrawal by Subject|0|||
106061501|NCT00460408|365885040|FG003|Overall Study|Withdrawal by Subject|0|||
106153545|NCT04218266|366222163|FG000|Overall Study|Adverse Event|13|||
106061502|NCT00460408|365885037|FG000|Overall Study|Insufficient clinical response|5|||
106061503|NCT00460408|365885038|FG001|Overall Study|Insufficient clinical response|1|||
106061504|NCT00460408|365885039|FG002|Overall Study|Insufficient clinical response|5|||
106153546|NCT04218266|366222164|FG001|Overall Study|Adverse Event|14|||
106153547|NCT04218266|366222165|FG002|Overall Study|Adverse Event|11|||
106153548|NCT04218266|366222163|FG000|Overall Study|Other|7|||
106153549|NCT04218266|366222164|FG001|Overall Study|Other|5|||
106153550|NCT04218266|366222165|FG002|Overall Study|Other|14|||
106153551|NCT04218266|366222163|FG000|Overall Study|Physician Decision|1|||
106153552|NCT04218266|366222164|FG001|Overall Study|Physician Decision|3|||
106153553|NCT04218266|366222165|FG002|Overall Study|Physician Decision|2|||
106153554|NCT04218266|366222163|FG000|Overall Study|Non-compliance with study drug|0|||
106153555|NCT04218266|366222164|FG001|Overall Study|Non-compliance with study drug|0|||
106153556|NCT04218266|366222165|FG002|Overall Study|Non-compliance with study drug|1|||
106153557|NCT04218266|366222163|FG000|Overall Study|Withdrawal by Subject|1|||
106153558|NCT04218266|366222164|FG001|Overall Study|Withdrawal by Subject|3|||
106153559|NCT04218266|366222165|FG002|Overall Study|Withdrawal by Subject|1|||
106153560|NCT04218266|366222163|FG000|Overall Study|Study drug never administered|2|||
106153561|NCT04218266|366222164|FG001|Overall Study|Study drug never administered|0|||
106153562|NCT04218266|366222165|FG002|Overall Study|Study drug never administered|0|||
106153563|NCT04820686|366222168|FG000|Overall Study|Withdrawal by Subject|5|||
106153564|NCT04820686|366222169|FG001|Overall Study|Withdrawal by Subject|2|||
106153565|NCT04820686|366222170|FG002|Overall Study|Withdrawal by Subject|3|||
106153566|NCT04820686|366222168|FG000|Overall Study|Study Termination|25|||
106153567|NCT04820686|366222169|FG001|Overall Study|Study Termination|13|||
106153568|NCT04820686|366222170|FG002|Overall Study|Study Termination|14|||
106153569|NCT04820686|366222168|FG000|Overall Study|Adverse Event|0|||
106153570|NCT04820686|366222169|FG001|Overall Study|Adverse Event|1|||
106153571|NCT04820686|366222170|FG002|Overall Study|Adverse Event|0|||
106153572|NCT04567615|366222173|FG000|Randomization|Participant withdrew consent|1|||
106153573|NCT04567615|366222174|FG001|Randomization|Participant withdrew consent|0|||
106153574|NCT04567615|366222175|FG002|Randomization|Participant withdrew consent|0|||
106153575|NCT04567615|366222173|FG000|Randomization|Adverse event unrelated to study drug|0|||
106153576|NCT04567615|366222174|FG001|Randomization|Adverse event unrelated to study drug|1|||
106153577|NCT04567615|366222175|FG002|Randomization|Adverse event unrelated to study drug|0|||
106153578|NCT04567615|366222173|FG000|Treatment Period|Participant Withdrew Consent|2|||
106153579|NCT04567615|366222174|FG001|Treatment Period|Participant Withdrew Consent|5|||
106153580|NCT04567615|366222175|FG002|Treatment Period|Participant Withdrew Consent|1|||
106153581|NCT04567615|366222173|FG000|Treatment Period|Death|1|||
106153582|NCT04567615|366222174|FG001|Treatment Period|Death|2|||
106153583|NCT04567615|366222175|FG002|Treatment Period|Death|0|||
106153584|NCT04567615|366222173|FG000|Treatment Period|Lost to Follow-up|0|||
106153585|NCT04567615|366222174|FG001|Treatment Period|Lost to Follow-up|1|||
106153586|NCT04567615|366222175|FG002|Treatment Period|Lost to Follow-up|0|||
106153587|NCT04567615|366222173|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
106153588|NCT04567615|366222174|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
106153589|NCT04567615|366222175|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
106153590|NCT04567615|366222173|FG000|Treatment Period|Disease Progression|85|||
106153591|NCT04567615|366222174|FG001|Treatment Period|Disease Progression|63|||
106153592|NCT04567615|366222175|FG002|Treatment Period|Disease Progression|16|||
106153593|NCT04567615|366222173|FG000|Treatment Period|Study Drug Toxicity|3|||
106153594|NCT04567615|366222174|FG001|Treatment Period|Study Drug Toxicity|10|||
106153595|NCT04567615|366222175|FG002|Treatment Period|Study Drug Toxicity|4|||
106153596|NCT04567615|366222173|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
106153597|NCT04567615|366222174|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
106153598|NCT04567615|366222175|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
106153599|NCT04567615|366222173|FG000|Treatment Period|Other Reasons|1|||
106153600|NCT04567615|366222174|FG001|Treatment Period|Other Reasons|2|||
106153601|NCT04567615|366222175|FG002|Treatment Period|Other Reasons|0|||
106153602|NCT04567615|366222173|FG000|Treatment Period|Still On-going Treatment|21|||
106153603|NCT04567615|366222174|FG001|Treatment Period|Still On-going Treatment|22|||
106153604|NCT04567615|366222175|FG002|Treatment Period|Still On-going Treatment|2|||
106153605|NCT05134337|366223896|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
106153606|NCT05134337|366223897|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
106153607|NCT03398148|366223903|FG000|Substudy 1 Period 1|Adverse Event|5|||
106153608|NCT03398148|366223904|FG001|Substudy 1 Period 1|Adverse Event|2|||
106153609|NCT03398148|366223905|FG002|Substudy 1 Period 1|Adverse Event|2|||
106153610|NCT03398148|366223906|FG003|Substudy 1 Period 1|Adverse Event|0|||
106153611|NCT03398148|366223907|FG004|Substudy 1 Period 1|Adverse Event|8|||
106153612|NCT03398148|366223908|FG005|Substudy 1 Period 1|Adverse Event|0|||
106153613|NCT03398148|366223909|FG006|Substudy 1 Period 1|Adverse Event|0|||
106153614|NCT03398148|366223910|FG007|Substudy 1 Period 1|Adverse Event|0|||
106153615|NCT03398148|366223911|FG008|Substudy 1 Period 1|Adverse Event|0|||
106153616|NCT03398148|366223912|FG009|Substudy 1 Period 1|Adverse Event|0|||
106153617|NCT03398148|366223913|FG010|Substudy 1 Period 1|Adverse Event|0|||
106153618|NCT03398148|366223914|FG011|Substudy 1 Period 1|Adverse Event|0|||
106153619|NCT03398148|366223915|FG012|Substudy 1 Period 1|Adverse Event|0|||
106153620|NCT03398148|366223916|FG013|Substudy 1 Period 1|Adverse Event|0|||
106153621|NCT03398148|366223917|FG014|Substudy 1 Period 1|Adverse Event|0|||
106153622|NCT03398148|366223903|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
106153623|NCT03398148|366223904|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
106153624|NCT03398148|366223905|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106061505|NCT00460408|365885040|FG003|Overall Study|Insufficient clinical response|0|||
106061506|NCT00460408|365885037|FG000|Overall Study|Other|12|||
106061507|NCT00460408|365885038|FG001|Overall Study|Other|2|||
106061508|NCT00460408|365885039|FG002|Overall Study|Other|0|||
106061509|NCT00460408|365885040|FG003|Overall Study|Other|0|||
106061510|NCT00545168|365885047|FG000|Overall Study|Lost to Follow-up|5|||
106061511|NCT00545168|365885048|FG001|Overall Study|Lost to Follow-up|5|||
106061512|NCT00545168|365885049|FG002|Overall Study|Lost to Follow-up|5|||
106061513|NCT00545168|365885047|FG000|Overall Study|Withdrawal by Subject|9|||
106061514|NCT00545168|365885048|FG001|Overall Study|Withdrawal by Subject|0|||
106061515|NCT00545168|365885049|FG002|Overall Study|Withdrawal by Subject|13|||
106061516|NCT00545168|365885047|FG000|Overall Study|Protocol Violation|1|||
106061517|NCT00545168|365885048|FG001|Overall Study|Protocol Violation|0|||
106061518|NCT00545168|365885049|FG002|Overall Study|Protocol Violation|1|||
106061519|NCT00545168|365885047|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
106061520|NCT00545168|365885048|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
106061521|NCT00545168|365885049|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
106061522|NCT01218204|365885050|FG000|Part B Washout|Adverse Event|0|||
106061523|NCT01218204|365885051|FG001|Part B Washout|Adverse Event|1|||
106061524|NCT01218204|365885052|FG002|Part B Washout|Adverse Event|0|||
106061525|NCT01218204|365885053|FG003|Part B Washout|Adverse Event|0|||
106061526|NCT01218204|365885050|FG000|Part B Washout|Lost to Follow-up|0|||
106061527|NCT01218204|365885051|FG001|Part B Washout|Lost to Follow-up|2|||
106061528|NCT01218204|365885052|FG002|Part B Washout|Lost to Follow-up|0|||
106061529|NCT01218204|365885053|FG003|Part B Washout|Lost to Follow-up|0|||
106061530|NCT01218204|365885050|FG000|Part B Washout|Physician Decision|0|||
106061531|NCT01218204|365885051|FG001|Part B Washout|Physician Decision|14|||
106061532|NCT01218204|365885052|FG002|Part B Washout|Physician Decision|0|||
106061533|NCT01218204|365885053|FG003|Part B Washout|Physician Decision|0|||
106061534|NCT01218204|365885050|FG000|Part B Washout|Withdrawal by Subject|0|||
106061535|NCT01218204|365885051|FG001|Part B Washout|Withdrawal by Subject|14|||
106061536|NCT01218204|365885052|FG002|Part B Washout|Withdrawal by Subject|0|||
106061537|NCT01218204|365885053|FG003|Part B Washout|Withdrawal by Subject|0|||
106061538|NCT01218204|365885050|FG000|Part B Washout|Reached defined stopping criteria|0|||
106061539|NCT01218204|365885051|FG001|Part B Washout|Reached defined stopping criteria|2|||
106061540|NCT01218204|365885052|FG002|Part B Washout|Reached defined stopping criteria|0|||
106061541|NCT01218204|365885053|FG003|Part B Washout|Reached defined stopping criteria|0|||
106061542|NCT01218204|365885050|FG000|Part B Washout|Did not meet continuation criteria|0|||
106061543|NCT01218204|365885051|FG001|Part B Washout|Did not meet continuation criteria|112|||
106061544|NCT01218204|365885052|FG002|Part B Washout|Did not meet continuation criteria|0|||
106061545|NCT01218204|365885053|FG003|Part B Washout|Did not meet continuation criteria|0|||
106061546|NCT01218204|365885050|FG000|Part B Run-in|Adverse Event|0|||
106061547|NCT01218204|365885051|FG001|Part B Run-in|Adverse Event|0|||
106061548|NCT01218204|365885052|FG002|Part B Run-in|Adverse Event|1|||
106061549|NCT01218204|365885053|FG003|Part B Run-in|Adverse Event|0|||
106061550|NCT01218204|365885050|FG000|Part B Run-in|Protocol Violation|0|||
106061551|NCT01218204|365885051|FG001|Part B Run-in|Protocol Violation|0|||
106061552|NCT01218204|365885052|FG002|Part B Run-in|Protocol Violation|2|||
106061553|NCT01218204|365885053|FG003|Part B Run-in|Protocol Violation|0|||
106061554|NCT01218204|365885050|FG000|Part B Run-in|Withdrawal by Subject|0|||
106061555|NCT01218204|365885051|FG001|Part B Run-in|Withdrawal by Subject|0|||
106061556|NCT01218204|365885052|FG002|Part B Run-in|Withdrawal by Subject|3|||
106061557|NCT01218204|365885053|FG003|Part B Run-in|Withdrawal by Subject|0|||
106061558|NCT01218204|365885050|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
106061559|NCT01218204|365885051|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
106061560|NCT01218204|365885052|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
106061561|NCT01218204|365885053|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
106061562|NCT01218204|365885050|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
106153625|NCT03398148|366223906|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
106153626|NCT03398148|366223907|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
106153627|NCT03398148|366223908|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153628|NCT03398148|366223909|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153629|NCT03398148|366223910|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106061563|NCT01218204|365885051|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
106061564|NCT01218204|365885052|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
106061565|NCT01218204|365885053|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
106061566|NCT02573350|365885057|FG000|Overall Study|Lost to Follow-up|2|||
106061567|NCT02573350|365885058|FG001|Overall Study|Lost to Follow-up|1|||
106061568|NCT02573350|365885057|FG000|Overall Study|Adverse Event|3|||
106061569|NCT02573350|365885058|FG001|Overall Study|Adverse Event|4|||
106061570|NCT02573350|365885057|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
106061571|NCT02573350|365885058|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
105864775|NCT03207867|365153007|FG018|Overall Study|Progressive Disease|13|||
106061572|NCT02573350|365885057|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
106061573|NCT02573350|365885058|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
106061574|NCT02573350|365885057|FG000|Overall Study|Subject withdrew consent to participate|6|||
106061575|NCT02573350|365885058|FG001|Overall Study|Subject withdrew consent to participate|1|||
106061576|NCT02573350|365885057|FG000|Overall Study|Protocol Deviation|1|||
106061577|NCT02573350|365885058|FG001|Overall Study|Protocol Deviation|1|||
106061578|NCT00743340|365885059|FG000|Overall Study|Study medication non-compliance|1|||
105864776|NCT03207867|365153008|FG019|Overall Study|Progressive Disease|14|||
106061579|NCT00743340|365885059|FG000|Overall Study|Lost to Follow-up|1|||
106061580|NCT00743340|365885059|FG000|Overall Study|Withdrawal from the Study|5|||
106061581|NCT00743340|365885059|FG000|Overall Study|Protocol Violation|1|||
106061582|NCT00743340|365885059|FG000|Overall Study|Virologic failure|8|||
106061583|NCT00743340|365885059|FG000|Overall Study|Pregnancy|1|||
106061584|NCT00743340|365885059|FG000|Overall Study|Rolled over to other Gilead Study|23|||
106061585|NCT00743340|365885059|FG000|Overall Study|Participant Relocated|1|||
106061586|NCT02708121|365885060|FG000|Overall Study|Withdrawn by Study Team|1|||
106061587|NCT02708121|365885061|FG001|Overall Study|Withdrawn by Study Team|1|||
106061588|NCT02708121|365885060|FG000|Overall Study|Withdrawal by Subject|0|||
106061589|NCT02708121|365885061|FG001|Overall Study|Withdrawal by Subject|4|||
106061590|NCT00127660|365885062|FG000|Overall Study|Protocol Violation|3|||
106061591|NCT00127660|365885063|FG001|Overall Study|Protocol Violation|3|||
106061592|NCT00127660|365885064|FG002|Overall Study|Protocol Violation|5|||
106061593|NCT00127660|365885065|FG003|Overall Study|Protocol Violation|0|||
106061594|NCT01987505|365885066|FG000|Overall Study|Other|9|||
106061595|NCT01987505|365885066|FG000|Overall Study|Withdrawal by Subject|2|||
106061596|NCT01987505|365885066|FG000|Overall Study|Other Reason|2|||
106061597|NCT01987505|365885066|FG000|Overall Study|Lost to Follow-up|15|||
106061598|NCT01987505|365885066|FG000|Overall Study|Investigator Decision|2|||
106061599|NCT01987505|365885066|FG000|Overall Study|Death|4|||
106061600|NCT01833520|365885067|FG000|Overall Study|Lack of Efficacy|3|||
106061601|NCT01833520|365885068|FG001|Overall Study|Lack of Efficacy|3|||
106061602|NCT01833520|365885069|FG002|Overall Study|Lack of Efficacy|8|||
106061603|NCT01833520|365885070|FG003|Overall Study|Lack of Efficacy|3|||
106061604|NCT02743520|365885071|FG000|Overall Study|Withdrawal by Subject|1|||
106061605|NCT04983264|365885072|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
106061606|NCT04983264|365885073|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
106061607|NCT04983264|365885074|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
106061608|NCT04983264|365885072|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
106061609|NCT04983264|365885073|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
106061610|NCT04983264|365885074|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
106061611|NCT01124422|365885075|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
106061612|NCT01124422|365885076|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
106061613|NCT01124422|365885077|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
106061614|NCT01124422|365885075|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
106061615|NCT01124422|365885076|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
106061616|NCT01124422|365885077|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
106061617|NCT01124422|365885075|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
106061618|NCT01124422|365885076|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
106061619|NCT01124422|365885077|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
106061620|NCT01124422|365885075|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
106061621|NCT01124422|365885076|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
106153630|NCT03398148|366223911|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153631|NCT03398148|366223912|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153632|NCT03398148|366223913|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153633|NCT03398148|366223914|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153634|NCT03398148|366223915|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153635|NCT03398148|366223916|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153636|NCT03398148|366223917|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
106153637|NCT03398148|366223903|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
106153638|NCT03398148|366223904|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
106153639|NCT03398148|366223905|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
106153640|NCT03398148|366223906|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
106153641|NCT03398148|366223907|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
106153642|NCT03398148|366223908|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
106153643|NCT03398148|366223909|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
106153644|NCT03398148|366223910|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
106153645|NCT03398148|366223911|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
106153646|NCT03398148|366223912|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
106153647|NCT03398148|366223913|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
106153648|NCT03398148|366223914|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
106153649|NCT03398148|366223915|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
106153650|NCT03398148|366223916|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
106153651|NCT03398148|366223917|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
106153652|NCT03398148|366223903|FG000|Substudy 1 Period 1|Other|0|||
106153653|NCT03398148|366223904|FG001|Substudy 1 Period 1|Other|1|||
106153654|NCT03398148|366223905|FG002|Substudy 1 Period 1|Other|0|||
106061622|NCT01124422|365885077|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
106153655|NCT03398148|366223906|FG003|Substudy 1 Period 1|Other|0|||
106153656|NCT03398148|366223907|FG004|Substudy 1 Period 1|Other|3|||
106153657|NCT03398148|366223908|FG005|Substudy 1 Period 1|Other|0|||
106153658|NCT03398148|366223909|FG006|Substudy 1 Period 1|Other|0|||
106153659|NCT03398148|366223910|FG007|Substudy 1 Period 1|Other|0|||
106061623|NCT01124422|365885075|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
106061624|NCT01124422|365885076|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
106061625|NCT01124422|365885077|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
106061626|NCT01124422|365885075|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
106061627|NCT01124422|365885076|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
106061628|NCT01124422|365885077|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
106061629|NCT01124422|365885075|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
106061630|NCT01124422|365885076|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
106061631|NCT01124422|365885077|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
106061632|NCT01124422|365885075|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
106061633|NCT01124422|365885076|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
106061634|NCT01124422|365885077|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
106061635|NCT01124422|365885075|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
106061636|NCT01124422|365885076|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
106061637|NCT01124422|365885077|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
106061638|NCT01124422|365885075|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
106061639|NCT01124422|365885076|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
106061640|NCT01124422|365885077|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
106061641|NCT00938639|365885078|FG000|Overall Study|Moved away from study area|0|||
106061642|NCT00938639|365885079|FG001|Overall Study|Moved away from study area|1|||
106061643|NCT00938639|365885078|FG000|Overall Study|Lost to Follow-up|1|||
106061644|NCT00938639|365885079|FG001|Overall Study|Lost to Follow-up|2|||
106061645|NCT00938639|365885078|FG000|Overall Study|Family issues|1|||
106061646|NCT00938639|365885079|FG001|Overall Study|Family issues|1|||
106061647|NCT00938639|365885078|FG000|Overall Study|Participant noncompliance|1|||
106061648|NCT00938639|365885079|FG001|Overall Study|Participant noncompliance|0|||
106061649|NCT02509156|365885080|FG000|Randomized Phase|Death|1|||
106061650|NCT02509156|365885081|FG001|Randomized Phase|Death|0|||
106061651|NCT02509156|365885080|FG000|Randomized Phase|Withdrawal by Subject|1|||
106061652|NCT02509156|365885081|FG001|Randomized Phase|Withdrawal by Subject|1|||
106061653|NCT01083576|365885082|FG000|Overall Study|Treatment Failure|6|||
106061654|NCT01083576|365885083|FG001|Overall Study|Treatment Failure|1|||
106061655|NCT02547649|365885084|FG000|Overall Study|Lost to Follow-up|3|||
106061656|NCT02547649|365885085|FG001|Overall Study|Lost to Follow-up|1|||
106061657|NCT02547649|365885086|FG002|Overall Study|Lost to Follow-up|1|||
106061658|NCT02547649|365885084|FG000|Overall Study|Not vaccinated|0|||
106061659|NCT02547649|365885085|FG001|Overall Study|Not vaccinated|0|||
106061660|NCT02547649|365885086|FG002|Overall Study|Not vaccinated|1|||
106061661|NCT02547649|365885084|FG000|Overall Study|Withdrawal by Subject|0|||
106061662|NCT02547649|365885085|FG001|Overall Study|Withdrawal by Subject|4|||
106061663|NCT02547649|365885086|FG002|Overall Study|Withdrawal by Subject|2|||
106061664|NCT01484197|365885090|FG000|Treatment Period 1|Adverse Event|1|||
106061665|NCT01484197|365885091|FG001|Treatment Period 1|Adverse Event|0|||
106061666|NCT01484197|365885092|FG002|Treatment Period 1|Adverse Event|0|||
106061667|NCT01484197|365885093|FG003|Treatment Period 1|Adverse Event|0|||
106061668|NCT01484197|365885090|FG000|Treatment Period 2|Subject withdrew consent|0|||
106061669|NCT01484197|365885091|FG001|Treatment Period 2|Subject withdrew consent|0|||
106061670|NCT01484197|365885092|FG002|Treatment Period 2|Subject withdrew consent|0|||
106061671|NCT01484197|365885093|FG003|Treatment Period 2|Subject withdrew consent|1|||
106061672|NCT00320411|365885097|FG000|Overall Study|No investigational product admin.|4|||
106061673|NCT00752232|365885102|FG000|Overall Study|Protocol Violation|0|||
106061674|NCT00752232|365885103|FG001|Overall Study|Protocol Violation|0|||
106061675|NCT00752232|365885104|FG002|Overall Study|Protocol Violation|0|||
106061676|NCT00752232|365885105|FG003|Overall Study|Protocol Violation|0|||
106061677|NCT00752232|365885106|FG004|Overall Study|Protocol Violation|0|||
106061678|NCT00752232|365885107|FG005|Overall Study|Protocol Violation|1|||
106061679|NCT00752232|365885108|FG006|Overall Study|Protocol Violation|0|||
106061680|NCT00752232|365885102|FG000|Overall Study|Caregiver request|2|||
106061681|NCT00752232|365885103|FG001|Overall Study|Caregiver request|0|||
106061682|NCT00752232|365885104|FG002|Overall Study|Caregiver request|0|||
106061683|NCT00752232|365885105|FG003|Overall Study|Caregiver request|0|||
106061684|NCT00752232|365885106|FG004|Overall Study|Caregiver request|1|||
106061685|NCT00752232|365885107|FG005|Overall Study|Caregiver request|0|||
106061686|NCT00752232|365885108|FG006|Overall Study|Caregiver request|0|||
106061687|NCT00752232|365885102|FG000|Overall Study|Investigator request|0|||
106061688|NCT00752232|365885103|FG001|Overall Study|Investigator request|0|||
106061689|NCT00752232|365885104|FG002|Overall Study|Investigator request|0|||
106061690|NCT00752232|365885105|FG003|Overall Study|Investigator request|0|||
106061691|NCT00752232|365885106|FG004|Overall Study|Investigator request|1|||
106061692|NCT00752232|365885107|FG005|Overall Study|Investigator request|0|||
106061693|NCT00752232|365885108|FG006|Overall Study|Investigator request|0|||
106061694|NCT00752232|365885102|FG000|Overall Study|Subject request|0|||
106061695|NCT00752232|365885103|FG001|Overall Study|Subject request|0|||
106061696|NCT00752232|365885104|FG002|Overall Study|Subject request|1|||
106061697|NCT00752232|365885105|FG003|Overall Study|Subject request|0|||
106061698|NCT00752232|365885106|FG004|Overall Study|Subject request|0|||
106061699|NCT00752232|365885107|FG005|Overall Study|Subject request|0|||
106061700|NCT00752232|365885108|FG006|Overall Study|Subject request|0|||
106061701|NCT00752232|365885102|FG000|Overall Study|Group home admission|0|||
106061702|NCT00752232|365885103|FG001|Overall Study|Group home admission|0|||
106061703|NCT00752232|365885104|FG002|Overall Study|Group home admission|0|||
106061704|NCT00752232|365885105|FG003|Overall Study|Group home admission|1|||
106061705|NCT00752232|365885106|FG004|Overall Study|Group home admission|0|||
106061706|NCT00752232|365885107|FG005|Overall Study|Group home admission|0|||
106061707|NCT00752232|365885108|FG006|Overall Study|Group home admission|0|||
106061708|NCT00752232|365885102|FG000|Overall Study|Caregiver could not attend the subject|0|||
106061709|NCT00752232|365885103|FG001|Overall Study|Caregiver could not attend the subject|0|||
106061710|NCT00752232|365885104|FG002|Overall Study|Caregiver could not attend the subject|0|||
106061711|NCT00752232|365885105|FG003|Overall Study|Caregiver could not attend the subject|0|||
106061712|NCT00752232|365885106|FG004|Overall Study|Caregiver could not attend the subject|1|||
106061713|NCT00752232|365885107|FG005|Overall Study|Caregiver could not attend the subject|0|||
106061714|NCT00752232|365885108|FG006|Overall Study|Caregiver could not attend the subject|0|||
106061715|NCT02859454|365885109|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
106061716|NCT04294472|365885110|FG000|Overall Study|Adverse Event|0|||
106061717|NCT04294472|365885111|FG001|Overall Study|Adverse Event|1|||
106061718|NCT04294472|365885112|FG002|Overall Study|Adverse Event|1|||
106061719|NCT04294472|365885110|FG000|Overall Study|Randomized but not treated|0|||
106061720|NCT04294472|365885111|FG001|Overall Study|Randomized but not treated|1|||
106061721|NCT04294472|365885112|FG002|Overall Study|Randomized but not treated|1|||
106061722|NCT02268084|365885115|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
106061723|NCT02268084|365885116|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
106061724|NCT02268084|365885115|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
106061725|NCT02268084|365885116|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
106061726|NCT02603419|365885119|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
106061727|NCT02603419|365885120|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
106061728|NCT02603419|365885121|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
106061729|NCT02603419|365885122|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
106061730|NCT02603419|365885123|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
106061731|NCT02603419|365885124|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
106061732|NCT02603419|365885119|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
106061733|NCT02603419|365885120|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
106061734|NCT02603419|365885121|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
106061735|NCT02603419|365885122|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
106061736|NCT02603419|365885123|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
106061737|NCT02603419|365885124|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
106061738|NCT02603419|365885119|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
106061739|NCT02603419|365885120|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
106061740|NCT02603419|365885121|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
106061741|NCT02603419|365885122|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
106061742|NCT02603419|365885123|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
106061743|NCT02603419|365885124|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
106061744|NCT02603419|365885119|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
106061745|NCT02603419|365885120|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
106061746|NCT02603419|365885121|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
106061747|NCT02603419|365885122|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
106061748|NCT02603419|365885123|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
106061749|NCT02603419|365885124|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
106061750|NCT02603419|365885119|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
106061751|NCT02603419|365885120|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
106061752|NCT02603419|365885121|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
106061753|NCT02603419|365885122|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
106061754|NCT02603419|365885123|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
106061755|NCT02603419|365885124|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
106061756|NCT02603419|365885119|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
106061757|NCT02603419|365885120|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
106061758|NCT02603419|365885121|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
106061759|NCT02603419|365885122|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
106061760|NCT02603419|365885123|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
106061761|NCT02603419|365885124|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
106061762|NCT02603419|365885119|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
106061763|NCT02603419|365885120|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
106061764|NCT02603419|365885121|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
106061765|NCT02603419|365885122|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
106061766|NCT02603419|365885123|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
106061767|NCT02603419|365885124|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
106061768|NCT02603419|365885119|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
106061769|NCT02603419|365885120|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
106061770|NCT02603419|365885121|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
106061771|NCT02603419|365885122|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
106061772|NCT02603419|365885123|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
106061773|NCT02603419|365885124|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
106061774|NCT02603419|365885119|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
106061775|NCT02603419|365885120|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
106061776|NCT02603419|365885121|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
106061777|NCT02603419|365885122|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
106061778|NCT02603419|365885123|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
106061779|NCT02603419|365885124|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
106061780|NCT02603419|365885119|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
106061781|NCT02603419|365885120|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
106061782|NCT02603419|365885121|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
106061783|NCT02603419|365885122|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
106061784|NCT02603419|365885123|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
106061785|NCT02603419|365885124|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
106061786|NCT01683383|365885128|FG000|Overall Study|Infant was not transported|1|||
106061787|NCT01683383|365885129|FG001|Overall Study|Infant was not transported|0|||
106061788|NCT00855920|365885130|FG000|Overall Study|Protocol Violation|0|||
106061789|NCT00855920|365885131|FG001|Overall Study|Protocol Violation|0|||
106061790|NCT00855920|365885132|FG002|Overall Study|Protocol Violation|2|||
106061791|NCT00855920|365885130|FG000|Overall Study|Adverse Event|2|||
106061792|NCT00855920|365885131|FG001|Overall Study|Adverse Event|1|||
106061793|NCT00855920|365885132|FG002|Overall Study|Adverse Event|1|||
106061794|NCT00855920|365885130|FG000|Overall Study|Lack of Efficacy|2|||
106061795|NCT00855920|365885131|FG001|Overall Study|Lack of Efficacy|2|||
106061796|NCT00855920|365885132|FG002|Overall Study|Lack of Efficacy|2|||
106061797|NCT00855920|365885130|FG000|Overall Study|Withdrawal by Subject|2|||
106061798|NCT00855920|365885131|FG001|Overall Study|Withdrawal by Subject|3|||
106061799|NCT00855920|365885132|FG002|Overall Study|Withdrawal by Subject|2|||
106061800|NCT00855920|365885130|FG000|Overall Study|Lost to Follow-up|1|||
106061801|NCT00855920|365885131|FG001|Overall Study|Lost to Follow-up|0|||
106061802|NCT00855920|365885132|FG002|Overall Study|Lost to Follow-up|2|||
106061803|NCT00855920|365885130|FG000|Overall Study|Death|0|||
106061804|NCT00855920|365885131|FG001|Overall Study|Death|1|||
106061805|NCT00855920|365885132|FG002|Overall Study|Death|0|||
106061806|NCT00855920|365885130|FG000|Overall Study|Decision by the sponsor|0|||
106061807|NCT00855920|365885131|FG001|Overall Study|Decision by the sponsor|1|||
106061808|NCT00855920|365885132|FG002|Overall Study|Decision by the sponsor|1|||
106061809|NCT00855920|365885130|FG000|Overall Study|Other than specified above|1|||
106061810|NCT00855920|365885131|FG001|Overall Study|Other than specified above|1|||
106061811|NCT00855920|365885132|FG002|Overall Study|Other than specified above|1|||
106061812|NCT02496611|365885135|FG000|Overall Study|Lost to Follow-up|2|||
106061813|NCT02496611|365885136|FG001|Overall Study|Lost to Follow-up|1|||
106061814|NCT02496611|365885135|FG000|Overall Study|Withdrawal by Subject|5|||
106061815|NCT02496611|365885136|FG001|Overall Study|Withdrawal by Subject|2|||
106061816|NCT01365910|365885137|FG000|Overall Study|Withdrawal by Subject|7|||
106061817|NCT01365910|365885137|FG000|Overall Study|disease progression|18|||
106061818|NCT01365910|365885137|FG000|Overall Study|Adverse Event|3|||
106061819|NCT01365910|365885137|FG000|Overall Study|other complicating disease|1|||
106061820|NCT01365910|365885137|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
106061821|NCT02013791|365885138|FG000|Period 1|Lost to Follow-up|0|||
106061822|NCT02013791|365885139|FG001|Period 1|Lost to Follow-up|0|||
106061823|NCT02013791|365885140|FG002|Period 1|Lost to Follow-up|0|||
106061824|NCT02013791|365885141|FG003|Period 1|Lost to Follow-up|1|||
106061825|NCT02013791|365885142|FG004|Period 1|Lost to Follow-up|0|||
106061826|NCT02013791|365885143|FG005|Period 1|Lost to Follow-up|0|||
106061827|NCT02013791|365885144|FG006|Period 1|Lost to Follow-up|1|||
106153660|NCT03398148|366223911|FG008|Substudy 1 Period 1|Other|0|||
106153661|NCT03398148|366223912|FG009|Substudy 1 Period 1|Other|0|||
106153662|NCT03398148|366223913|FG010|Substudy 1 Period 1|Other|0|||
106153663|NCT03398148|366223914|FG011|Substudy 1 Period 1|Other|0|||
106153664|NCT03398148|366223915|FG012|Substudy 1 Period 1|Other|0|||
106153665|NCT03398148|366223916|FG013|Substudy 1 Period 1|Other|0|||
106153666|NCT03398148|366223917|FG014|Substudy 1 Period 1|Other|0|||
106153667|NCT03398148|366223903|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153668|NCT03398148|366223904|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153669|NCT03398148|366223905|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153670|NCT03398148|366223906|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153671|NCT03398148|366223907|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
106153672|NCT03398148|366223908|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153673|NCT03398148|366223909|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153674|NCT03398148|366223910|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153675|NCT03398148|366223911|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153676|NCT03398148|366223912|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153677|NCT03398148|366223913|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153678|NCT03398148|366223914|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153679|NCT03398148|366223915|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153680|NCT03398148|366223916|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153681|NCT03398148|366223917|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
106153682|NCT03398148|366223903|FG000|Substudy 1 Period 2|Adverse Event|0|||
106153683|NCT03398148|366223904|FG001|Substudy 1 Period 2|Adverse Event|0|||
106153684|NCT03398148|366223905|FG002|Substudy 1 Period 2|Adverse Event|0|||
106153685|NCT03398148|366223906|FG003|Substudy 1 Period 2|Adverse Event|0|||
106153686|NCT03398148|366223907|FG004|Substudy 1 Period 2|Adverse Event|0|||
106153687|NCT03398148|366223908|FG005|Substudy 1 Period 2|Adverse Event|2|||
106153688|NCT03398148|366223909|FG006|Substudy 1 Period 2|Adverse Event|4|||
106153689|NCT03398148|366223910|FG007|Substudy 1 Period 2|Adverse Event|0|||
106153690|NCT03398148|366223911|FG008|Substudy 1 Period 2|Adverse Event|0|||
106153691|NCT03398148|366223912|FG009|Substudy 1 Period 2|Adverse Event|0|||
106153692|NCT03398148|366223913|FG010|Substudy 1 Period 2|Adverse Event|0|||
106153693|NCT03398148|366223914|FG011|Substudy 1 Period 2|Adverse Event|0|||
106153694|NCT03398148|366223915|FG012|Substudy 1 Period 2|Adverse Event|0|||
106153695|NCT03398148|366223916|FG013|Substudy 1 Period 2|Adverse Event|0|||
106153696|NCT03398148|366223917|FG014|Substudy 1 Period 2|Adverse Event|0|||
106153697|NCT03398148|366223903|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153698|NCT03398148|366223904|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153699|NCT03398148|366223905|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153700|NCT03398148|366223906|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153701|NCT03398148|366223907|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153702|NCT03398148|366223908|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153703|NCT03398148|366223909|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
106153704|NCT03398148|366223910|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
106153705|NCT03398148|366223911|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153706|NCT03398148|366223912|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153707|NCT03398148|366223913|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153708|NCT03398148|366223914|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153709|NCT03398148|366223915|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153710|NCT03398148|366223916|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153711|NCT03398148|366223917|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
106153712|NCT03398148|366223903|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
106153713|NCT03398148|366223904|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
106153714|NCT03398148|366223905|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
106153715|NCT03398148|366223906|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
106153716|NCT03398148|366223907|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
106153717|NCT03398148|366223908|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
106153718|NCT03398148|366223909|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
106153719|NCT03398148|366223910|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
106153720|NCT03398148|366223911|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
106153721|NCT03398148|366223912|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
106153722|NCT03398148|366223913|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
106153723|NCT03398148|366223914|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
106153724|NCT03398148|366223915|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
106153725|NCT03398148|366223916|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
106153726|NCT03398148|366223917|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
106153727|NCT03398148|366223903|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153728|NCT03398148|366223904|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153729|NCT03398148|366223905|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153730|NCT03398148|366223906|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106061828|NCT02013791|365885145|FG007|Period 1|Lost to Follow-up|1|||
106061829|NCT02013791|365885146|FG008|Period 1|Lost to Follow-up|0|||
106061830|NCT02013791|365885138|FG000|Period 1|Other Miscellaneous Reasons|0|||
106061831|NCT02013791|365885139|FG001|Period 1|Other Miscellaneous Reasons|2|||
106061832|NCT02013791|365885140|FG002|Period 1|Other Miscellaneous Reasons|0|||
106061833|NCT02013791|365885141|FG003|Period 1|Other Miscellaneous Reasons|0|||
106061834|NCT02013791|365885142|FG004|Period 1|Other Miscellaneous Reasons|0|||
106061835|NCT02013791|365885143|FG005|Period 1|Other Miscellaneous Reasons|0|||
106061836|NCT02013791|365885144|FG006|Period 1|Other Miscellaneous Reasons|0|||
106061837|NCT02013791|365885145|FG007|Period 1|Other Miscellaneous Reasons|0|||
106061838|NCT02013791|365885146|FG008|Period 1|Other Miscellaneous Reasons|0|||
106061839|NCT01756898|365885147|FG000|Overall Study|Adverse Event|7|||
106061840|NCT01756898|365885148|FG001|Overall Study|Adverse Event|1|||
106061841|NCT01756898|365885149|FG002|Overall Study|Adverse Event|0|||
106061842|NCT01756898|365885150|FG003|Overall Study|Adverse Event|0|||
106061843|NCT01756898|365885147|FG000|Overall Study|Lack of Efficacy|4|||
106061844|NCT01756898|365885148|FG001|Overall Study|Lack of Efficacy|7|||
106061845|NCT01756898|365885149|FG002|Overall Study|Lack of Efficacy|6|||
106061846|NCT01756898|365885150|FG003|Overall Study|Lack of Efficacy|6|||
106061847|NCT01756898|365885147|FG000|Overall Study|Lost to Follow-up|2|||
106061848|NCT01756898|365885148|FG001|Overall Study|Lost to Follow-up|4|||
106061849|NCT01756898|365885149|FG002|Overall Study|Lost to Follow-up|2|||
106061850|NCT01756898|365885150|FG003|Overall Study|Lost to Follow-up|3|||
106061851|NCT01756898|365885147|FG000|Overall Study|Protocol Violation|1|||
106061852|NCT01756898|365885148|FG001|Overall Study|Protocol Violation|2|||
106061853|NCT01756898|365885149|FG002|Overall Study|Protocol Violation|2|||
106061854|NCT01756898|365885150|FG003|Overall Study|Protocol Violation|1|||
106061855|NCT01756898|365885147|FG000|Overall Study|Withdrew Consent|5|||
106061856|NCT01756898|365885148|FG001|Overall Study|Withdrew Consent|3|||
106061857|NCT01756898|365885149|FG002|Overall Study|Withdrew Consent|5|||
106061858|NCT01756898|365885150|FG003|Overall Study|Withdrew Consent|6|||
106061859|NCT01756898|365885147|FG000|Overall Study|Other|0|||
106061860|NCT01756898|365885148|FG001|Overall Study|Other|2|||
106061861|NCT01756898|365885149|FG002|Overall Study|Other|2|||
106061862|NCT01756898|365885150|FG003|Overall Study|Other|0|||
106061863|NCT02233647|365885151|FG000|Overall Study|Adverse Event|1|||
106061864|NCT01918085|365885154|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
106061865|NCT01918085|365885155|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
106061866|NCT02132130|365885157|FG000|Overall Study|Lost to Follow-up|0|||
106061867|NCT02132130|365885158|FG001|Overall Study|Lost to Follow-up|2|||
106061868|NCT02132130|365885159|FG002|Overall Study|Lost to Follow-up|0|||
106061869|NCT02132130|365885160|FG003|Overall Study|Lost to Follow-up|0|||
106061870|NCT02132130|365885157|FG000|Overall Study|Withdrawal by Subject|0|||
106061871|NCT02132130|365885158|FG001|Overall Study|Withdrawal by Subject|0|||
106061872|NCT02132130|365885159|FG002|Overall Study|Withdrawal by Subject|0|||
106061873|NCT02132130|365885160|FG003|Overall Study|Withdrawal by Subject|1|||
106061874|NCT03310775|365885165|FG000|Overall Study|Lost to Follow-up|2|||
106061875|NCT03310775|365885166|FG001|Overall Study|Lost to Follow-up|3|||
106061876|NCT03310775|365885165|FG000|Overall Study|aggravation of depression|0|||
106061877|NCT03310775|365885166|FG001|Overall Study|aggravation of depression|1|||
106061878|NCT02760069|365885172|FG000|Overall Study|Withdrawal by Subject|0|||
106061879|NCT02760069|365885173|FG001|Overall Study|Withdrawal by Subject|1|||
106061880|NCT02760069|365885174|FG002|Overall Study|Withdrawal by Subject|1|||
106061881|NCT04656691|365885175|FG000|Overall Study|Adverse Event|1|||
106061882|NCT00793403|365887085|FG000|Overall Study|Other|73|||
106061883|NCT01338792|365887090|FG000|Overall Study|Adverse Event|2|||
106061884|NCT01338792|365887090|FG000|Overall Study|Death|1|||
106061885|NCT01338792|365887090|FG000|Overall Study|Withdrawal by Subject|1|||
106061886|NCT00573469|365887091|FG000|Overall Study|Adverse Event|1|||
106061887|NCT00573469|365887092|FG001|Overall Study|Adverse Event|1|||
106061888|NCT00573469|365887093|FG002|Overall Study|Adverse Event|1|||
106061889|NCT00573469|365887091|FG000|Overall Study|Withdrawal by Subject|0|||
106061890|NCT00573469|365887092|FG001|Overall Study|Withdrawal by Subject|2|||
106061891|NCT00573469|365887093|FG002|Overall Study|Withdrawal by Subject|0|||
106061892|NCT00573469|365887091|FG000|Overall Study|Other|5|||
106061893|NCT00573469|365887092|FG001|Overall Study|Other|1|||
106061894|NCT00573469|365887093|FG002|Overall Study|Other|3|||
106061895|NCT02468414|365887094|FG000|Overall Study|Early Study Termination by Sponsor|1|||
106061896|NCT02468414|365887095|FG001|Overall Study|Early Study Termination by Sponsor|0|||
106061897|NCT02468414|365887094|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
106061898|NCT02468414|365887095|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
106061899|NCT02468414|365887094|FG000|Overall Study|Screen Failure|1|||
106061900|NCT02468414|365887095|FG001|Overall Study|Screen Failure|0|||
106061901|NCT02989194|365887096|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
106061902|NCT02989194|365887097|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
106061903|NCT02989194|365887098|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
106153731|NCT03398148|366223907|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153732|NCT03398148|366223908|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153733|NCT03398148|366223909|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
106153734|NCT03398148|366223910|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153735|NCT03398148|366223911|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105864777|NCT03207867|365153009|FG020|Overall Study|Progressive Disease|6|||
105864778|NCT03207867|365153010|FG021|Overall Study|Progressive Disease|3|||
105864779|NCT03207867|365153011|FG022|Overall Study|Progressive Disease|3|||
106061904|NCT02989194|365887096|FG000|Overall Study|Lost to Follow-up|0|||
106061905|NCT02989194|365887097|FG001|Overall Study|Lost to Follow-up|1|||
106061906|NCT02989194|365887098|FG002|Overall Study|Lost to Follow-up|0|||
106061907|NCT02989194|365887096|FG000|Overall Study|Withdrawal by Subject|0|||
106061908|NCT02989194|365887097|FG001|Overall Study|Withdrawal by Subject|1|||
106061909|NCT02989194|365887098|FG002|Overall Study|Withdrawal by Subject|0|||
106061910|NCT02670083|365887101|FG000|Overall Study|Adverse Event|16|||
106061911|NCT02670083|365887102|FG001|Overall Study|Adverse Event|13|||
106061912|NCT02670083|365887101|FG000|Overall Study|Death|4|||
106061913|NCT02670083|365887102|FG001|Overall Study|Death|6|||
106061914|NCT02670083|365887101|FG000|Overall Study|Lost to Follow-up|2|||
106061915|NCT02670083|365887102|FG001|Overall Study|Lost to Follow-up|2|||
106061916|NCT02670083|365887101|FG000|Overall Study|Multiple Reasons|9|||
106061917|NCT02670083|365887102|FG001|Overall Study|Multiple Reasons|9|||
106061918|NCT02670083|365887101|FG000|Overall Study|Physician Decision|0|||
106061919|NCT02670083|365887102|FG001|Overall Study|Physician Decision|2|||
106061920|NCT02670083|365887101|FG000|Overall Study|Study Terminated By Sponsor|257|||
106061921|NCT02670083|365887102|FG001|Overall Study|Study Terminated By Sponsor|254|||
106061922|NCT02670083|365887101|FG000|Overall Study|Symptomatic Deterioration|0|||
106061923|NCT02670083|365887102|FG001|Overall Study|Symptomatic Deterioration|2|||
106061924|NCT02670083|365887101|FG000|Overall Study|Withdrawal by Subject|32|||
106061925|NCT02670083|365887102|FG001|Overall Study|Withdrawal by Subject|31|||
106061926|NCT02670083|365887101|FG000|Overall Study|Non-Compliance With Study Drug|1|||
106061927|NCT02670083|365887102|FG001|Overall Study|Non-Compliance With Study Drug|0|||
106061928|NCT02014597|365887103|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
106061929|NCT02014597|365887104|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
106061930|NCT00617773|365887106|FG000|Overall Study|Physician Decision|1|||
106061931|NCT00617773|365887106|FG000|Overall Study|Lack of compliance with the protocol|1|||
106061932|NCT00617773|365887106|FG000|Overall Study|Withdrawal by Subject|1|||
106061933|NCT00617773|365887106|FG000|Overall Study|Death|1|||
106061934|NCT00617773|365887106|FG000|Overall Study|Progressive disease|19|||
106061935|NCT00617773|365887106|FG000|Overall Study|Protocol Violation|1|||
106061936|NCT01342796|365887109|FG000|Overall Study|Withdrawal by Subject|2|||
106061937|NCT01342796|365887110|FG001|Overall Study|Withdrawal by Subject|0|||
106061938|NCT01342796|365887109|FG000|Overall Study|Lost to Follow-up|0|||
106061939|NCT01342796|365887110|FG001|Overall Study|Lost to Follow-up|3|||
106061940|NCT01342796|365887109|FG000|Overall Study|Inappropriate enrollment|1|||
106061941|NCT01342796|365887110|FG001|Overall Study|Inappropriate enrollment|0|||
106061942|NCT02692716|365887112|FG000|Overall Study|Lost to Follow-up|2|||
106061943|NCT02692716|365887113|FG001|Overall Study|Lost to Follow-up|5|||
106061944|NCT02692716|365887112|FG000|Overall Study|Withdrawal by Subject|3|||
106061945|NCT02692716|365887113|FG001|Overall Study|Withdrawal by Subject|1|||
106061946|NCT02899988|365887114|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
106061947|NCT02899988|365887115|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
106061948|NCT02899988|365887116|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061949|NCT02899988|365887117|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061950|NCT02899988|365887118|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061951|NCT02899988|365887119|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061952|NCT02899988|365887120|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061953|NCT02899988|365887121|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061954|NCT02899988|365887122|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061955|NCT02899988|365887123|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061956|NCT02899988|365887124|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
106061957|NCT02899988|365887114|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
106061958|NCT02899988|365887115|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
106061959|NCT02899988|365887116|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
106061960|NCT02899988|365887117|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
106061961|NCT02899988|365887118|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
106061962|NCT02899988|365887119|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
106061963|NCT02899988|365887120|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
106061964|NCT02899988|365887121|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
106153736|NCT03398148|366223912|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
105864780|NCT03207867|365153012|FG023|Overall Study|Progressive Disease|3|||
106061965|NCT02899988|365887122|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
106061966|NCT02899988|365887123|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
106061967|NCT02899988|365887124|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
106061968|NCT02899988|365887114|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
106061969|NCT02899988|365887115|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
106061970|NCT02899988|365887116|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
106061971|NCT02899988|365887117|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
106061972|NCT02899988|365887118|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
106061973|NCT02899988|365887119|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
106061974|NCT02899988|365887120|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
106061975|NCT02899988|365887121|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
106061976|NCT02899988|365887122|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
106061977|NCT02899988|365887123|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
106061978|NCT02899988|365887124|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
106061979|NCT02899988|365887114|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
106061980|NCT02899988|365887115|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
106061981|NCT02899988|365887116|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
106061982|NCT02899988|365887117|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
106061983|NCT02899988|365887118|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
106061984|NCT02899988|365887119|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
106061985|NCT02899988|365887120|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
106061986|NCT02899988|365887121|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
106061987|NCT02899988|365887122|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
106061988|NCT02899988|365887123|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
106061989|NCT02899988|365887124|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
106061990|NCT02899988|365887114|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106061991|NCT02899988|365887115|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106061992|NCT02899988|365887116|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106061993|NCT02899988|365887117|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106061994|NCT02899988|365887118|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106061995|NCT02899988|365887119|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
106061996|NCT02899988|365887120|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106061997|NCT02899988|365887121|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
106061998|NCT02899988|365887122|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106061999|NCT02899988|365887123|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106062000|NCT02899988|365887124|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
106062001|NCT02899988|365887114|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
106062002|NCT02899988|365887115|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
106062003|NCT02899988|365887116|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
106062004|NCT02899988|365887117|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
106062005|NCT02899988|365887118|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
106062006|NCT02899988|365887119|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
106062007|NCT02899988|365887120|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
106062008|NCT02899988|365887121|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
106062009|NCT02899988|365887122|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
106062010|NCT02899988|365887123|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
106062011|NCT02899988|365887124|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
106062012|NCT04492618|365887125|FG000|Overall Study|Withdrawal by Subject|1|||
106062013|NCT02433483|365887128|FG000|Overall Study|Unacceptable toxicity|1|||
106062014|NCT02433483|365887128|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
106062015|NCT02485301|365887132|FG000|Overall Study|Serious Adverse Events|2|||
106062016|NCT02485301|365887133|FG001|Overall Study|Serious Adverse Events|1|||
106062017|NCT02485301|365887132|FG000|Overall Study|Protocol Violation|0|||
106062018|NCT02485301|365887133|FG001|Overall Study|Protocol Violation|1|||
106062019|NCT02485301|365887132|FG000|Overall Study|Withdrawal by Subject|6|||
106062020|NCT02485301|365887133|FG001|Overall Study|Withdrawal by Subject|7|||
106062021|NCT02485301|365887132|FG000|Overall Study|Migrated/moved from study area|10|||
106062022|NCT02485301|365887133|FG001|Overall Study|Migrated/moved from study area|19|||
106062023|NCT02485301|365887132|FG000|Overall Study|Lost to Follow-up|17|||
106062024|NCT02485301|365887133|FG001|Overall Study|Lost to Follow-up|17|||
106062025|NCT02485301|365887132|FG000|Overall Study|Other|3|||
106062026|NCT02485301|365887133|FG001|Overall Study|Other|4|||
106062027|NCT03342690|365887134|FG000|Overall Study|Missing Information|9|||
106062028|NCT03342690|365887134|FG000|Overall Study|Protocol Violation|16|||
106062029|NCT00549302|365887135|FG000|Double-Blind|Death|2|||
106062030|NCT00549302|365887136|FG001|Double-Blind|Death|9|||
106062031|NCT00549302|365887137|FG002|Double-Blind|Death|0|||
106062032|NCT00549302|365887135|FG000|Double-Blind|Adverse Event|3|||
106062033|NCT00549302|365887136|FG001|Double-Blind|Adverse Event|16|||
106062034|NCT00549302|365887137|FG002|Double-Blind|Adverse Event|0|||
106062035|NCT00549302|365887135|FG000|Double-Blind|Withdrawal by Subject|3|||
106062036|NCT00549302|365887136|FG001|Double-Blind|Withdrawal by Subject|8|||
106062037|NCT00549302|365887137|FG002|Double-Blind|Withdrawal by Subject|0|||
106062038|NCT00549302|365887135|FG000|Double-Blind|Investigator Decision|1|||
106062039|NCT00549302|365887136|FG001|Double-Blind|Investigator Decision|5|||
106062040|NCT00549302|365887137|FG002|Double-Blind|Investigator Decision|0|||
106153737|NCT03398148|366223913|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153738|NCT03398148|366223914|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153739|NCT03398148|366223915|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153740|NCT03398148|366223916|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153741|NCT03398148|366223917|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153742|NCT03398148|366223903|FG000|Substudy 1 Period 2|Other|0|||
106153743|NCT03398148|366223904|FG001|Substudy 1 Period 2|Other|0|||
106153744|NCT03398148|366223905|FG002|Substudy 1 Period 2|Other|0|||
106153745|NCT03398148|366223906|FG003|Substudy 1 Period 2|Other|0|||
106153746|NCT03398148|366223907|FG004|Substudy 1 Period 2|Other|0|||
106153747|NCT03398148|366223908|FG005|Substudy 1 Period 2|Other|0|||
106153748|NCT03398148|366223909|FG006|Substudy 1 Period 2|Other|1|||
106153749|NCT03398148|366223910|FG007|Substudy 1 Period 2|Other|0|||
106153750|NCT03398148|366223911|FG008|Substudy 1 Period 2|Other|0|||
106153751|NCT03398148|366223912|FG009|Substudy 1 Period 2|Other|0|||
106153752|NCT03398148|366223913|FG010|Substudy 1 Period 2|Other|0|||
106153753|NCT03398148|366223914|FG011|Substudy 1 Period 2|Other|0|||
106153754|NCT03398148|366223915|FG012|Substudy 1 Period 2|Other|0|||
106153755|NCT03398148|366223916|FG013|Substudy 1 Period 2|Other|0|||
106153756|NCT03398148|366223917|FG014|Substudy 1 Period 2|Other|0|||
106153757|NCT03398148|366223903|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153758|NCT03398148|366223904|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153759|NCT03398148|366223905|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153760|NCT03398148|366223906|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153761|NCT03398148|366223907|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153762|NCT03398148|366223908|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153763|NCT03398148|366223909|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
106153764|NCT03398148|366223910|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153765|NCT03398148|366223911|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153766|NCT03398148|366223912|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153767|NCT03398148|366223913|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153768|NCT03398148|366223914|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153769|NCT03398148|366223915|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153770|NCT03398148|366223916|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153771|NCT03398148|366223917|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
106153772|NCT03398148|366223903|FG000|Substudy 2 Period 1|Adverse Event|0|||
106153773|NCT03398148|366223904|FG001|Substudy 2 Period 1|Adverse Event|0|||
106153774|NCT03398148|366223905|FG002|Substudy 2 Period 1|Adverse Event|0|||
106153775|NCT03398148|366223906|FG003|Substudy 2 Period 1|Adverse Event|0|||
106153776|NCT03398148|366223907|FG004|Substudy 2 Period 1|Adverse Event|0|||
106153777|NCT03398148|366223908|FG005|Substudy 2 Period 1|Adverse Event|0|||
106153778|NCT03398148|366223909|FG006|Substudy 2 Period 1|Adverse Event|0|||
106153779|NCT03398148|366223910|FG007|Substudy 2 Period 1|Adverse Event|0|||
106153780|NCT03398148|366223911|FG008|Substudy 2 Period 1|Adverse Event|0|||
106153781|NCT03398148|366223912|FG009|Substudy 2 Period 1|Adverse Event|12|||
106153782|NCT03398148|366223913|FG010|Substudy 2 Period 1|Adverse Event|2|||
106153783|NCT03398148|366223914|FG011|Substudy 2 Period 1|Adverse Event|0|||
106153784|NCT03398148|366223915|FG012|Substudy 2 Period 1|Adverse Event|0|||
106153785|NCT03398148|366223916|FG013|Substudy 2 Period 1|Adverse Event|0|||
106153786|NCT03398148|366223917|FG014|Substudy 2 Period 1|Adverse Event|0|||
106153787|NCT03398148|366223903|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153788|NCT03398148|366223904|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153789|NCT03398148|366223905|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153790|NCT03398148|366223906|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153791|NCT03398148|366223907|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153792|NCT03398148|366223908|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153793|NCT03398148|366223909|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153794|NCT03398148|366223910|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153795|NCT03398148|366223911|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153796|NCT03398148|366223912|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
106153797|NCT03398148|366223913|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
106153798|NCT03398148|366223914|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153799|NCT03398148|366223915|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153800|NCT03398148|366223916|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106153801|NCT03398148|366223917|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
106062041|NCT00549302|365887135|FG000|Double-Blind|Sponsor Decision|0|||
106062042|NCT00549302|365887136|FG001|Double-Blind|Sponsor Decision|1|||
106062043|NCT00549302|365887137|FG002|Double-Blind|Sponsor Decision|0|||
106062044|NCT00549302|365887135|FG000|Double-Blind|Lost to Follow-up|1|||
106062045|NCT00549302|365887136|FG001|Double-Blind|Lost to Follow-up|2|||
106062046|NCT00549302|365887137|FG002|Double-Blind|Lost to Follow-up|0|||
106062047|NCT00549302|365887135|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
106062048|NCT00549302|365887136|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
106062049|NCT00549302|365887137|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
106062050|NCT00549302|365887135|FG000|Double-Blind|New condition or starts new therapy|0|||
106062051|NCT00549302|365887136|FG001|Double-Blind|New condition or starts new therapy|2|||
106062052|NCT00549302|365887137|FG002|Double-Blind|New condition or starts new therapy|0|||
106062053|NCT00549302|365887135|FG000|Open-Label|Adverse Event|0|||
106062054|NCT00549302|365887136|FG001|Open-Label|Adverse Event|0|||
106062055|NCT00549302|365887137|FG002|Open-Label|Adverse Event|11|||
106062056|NCT00549302|365887135|FG000|Open-Label|Death|0|||
106062057|NCT00549302|365887136|FG001|Open-Label|Death|0|||
106062058|NCT00549302|365887137|FG002|Open-Label|Death|40|||
106062059|NCT00549302|365887135|FG000|Open-Label|Investigator Decision|0|||
106062060|NCT00549302|365887136|FG001|Open-Label|Investigator Decision|0|||
106062061|NCT00549302|365887137|FG002|Open-Label|Investigator Decision|5|||
106062062|NCT00549302|365887135|FG000|Open-Label|Lost to Follow-up|0|||
106062063|NCT00549302|365887136|FG001|Open-Label|Lost to Follow-up|0|||
106062064|NCT00549302|365887137|FG002|Open-Label|Lost to Follow-up|2|||
106062065|NCT00549302|365887135|FG000|Open-Label|Other|0|||
106062066|NCT00549302|365887136|FG001|Open-Label|Other|0|||
106062067|NCT00549302|365887137|FG002|Open-Label|Other|3|||
106062068|NCT00549302|365887135|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
106062069|NCT00549302|365887136|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
106062070|NCT00549302|365887137|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
106062071|NCT00549302|365887135|FG000|Open-Label|Withdrawal by Subject|0|||
106062072|NCT00549302|365887136|FG001|Open-Label|Withdrawal by Subject|0|||
106062073|NCT00549302|365887137|FG002|Open-Label|Withdrawal by Subject|6|||
106062074|NCT03585504|365887138|FG000|Overall Study|Lost to Follow-up|26|||
106062075|NCT03585504|365887139|FG001|Overall Study|Lost to Follow-up|29|||
106062076|NCT01414114|365887140|FG000|Overall Study|Adverse Event|2|||
106062077|NCT01414114|365887140|FG000|Overall Study|Withdrawal by Subject|1|||
106153802|NCT03398148|366223903|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
106153803|NCT03398148|366223904|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
106153804|NCT03398148|366223905|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
106153805|NCT03398148|366223906|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
106153806|NCT03398148|366223907|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
106153807|NCT03398148|366223908|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
106153808|NCT03398148|366223909|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
106153809|NCT03398148|366223910|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
106153810|NCT03398148|366223911|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
106153811|NCT03398148|366223912|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
106153812|NCT03398148|366223913|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
106153813|NCT03398148|366223914|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
106153814|NCT03398148|366223915|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
106153815|NCT03398148|366223916|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
106153816|NCT03398148|366223917|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
106153817|NCT03398148|366223903|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153818|NCT03398148|366223904|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153819|NCT03398148|366223905|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153820|NCT03398148|366223906|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153821|NCT03398148|366223907|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153822|NCT03398148|366223908|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106062078|NCT01414114|365887140|FG000|Overall Study|Other|2|||
106062079|NCT00105482|365887141|FG000|Overall Study|Adverse Event|1|||
106062080|NCT00105482|365887142|FG001|Overall Study|Adverse Event|1|||
106062081|NCT00105482|365887141|FG000|Overall Study|Lost to Follow-up|26|||
106062082|NCT00105482|365887142|FG001|Overall Study|Lost to Follow-up|17|||
106153823|NCT03398148|366223909|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153824|NCT03398148|366223910|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153825|NCT03398148|366223911|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153826|NCT03398148|366223912|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106062083|NCT00105482|365887141|FG000|Overall Study|Withdrawal by Subject|0|||
106062084|NCT00105482|365887142|FG001|Overall Study|Withdrawal by Subject|1|||
106062085|NCT00105482|365887141|FG000|Overall Study|Lost Interest|29|||
106062086|NCT00105482|365887142|FG001|Overall Study|Lost Interest|32|||
106062087|NCT00105482|365887141|FG000|Overall Study|Scheduling Conflict|2|||
106062088|NCT00105482|365887142|FG001|Overall Study|Scheduling Conflict|3|||
106062089|NCT00105482|365887141|FG000|Overall Study|Withdrawn by PI|1|||
106062090|NCT00105482|365887142|FG001|Overall Study|Withdrawn by PI|1|||
106062091|NCT01749514|365887149|FG000|Overall Study|Lost to Follow-up|0|||
106062092|NCT01749514|365887150|FG001|Overall Study|Lost to Follow-up|0|||
106062093|NCT01749514|365887151|FG002|Overall Study|Lost to Follow-up|0|||
106062094|NCT01749514|365887152|FG003|Overall Study|Lost to Follow-up|0|||
106062095|NCT01749514|365887153|FG004|Overall Study|Lost to Follow-up|0|||
106062096|NCT01749514|365887154|FG005|Overall Study|Lost to Follow-up|0|||
106062097|NCT01749514|365887155|FG006|Overall Study|Lost to Follow-up|0|||
106062098|NCT01749514|365887156|FG007|Overall Study|Lost to Follow-up|1|||
106062099|NCT01749514|365887149|FG000|Overall Study|Withdrawal by Subject|0|||
106062100|NCT01749514|365887150|FG001|Overall Study|Withdrawal by Subject|0|||
106062101|NCT01749514|365887151|FG002|Overall Study|Withdrawal by Subject|0|||
106062102|NCT01749514|365887152|FG003|Overall Study|Withdrawal by Subject|0|||
106062103|NCT01749514|365887153|FG004|Overall Study|Withdrawal by Subject|0|||
106062104|NCT01749514|365887154|FG005|Overall Study|Withdrawal by Subject|1|||
106062105|NCT01749514|365887155|FG006|Overall Study|Withdrawal by Subject|0|||
106062106|NCT01749514|365887156|FG007|Overall Study|Withdrawal by Subject|1|||
106062107|NCT01749514|365887149|FG000|Overall Study|Not Reported|0|||
106062108|NCT01749514|365887150|FG001|Overall Study|Not Reported|0|||
106062109|NCT01749514|365887151|FG002|Overall Study|Not Reported|0|||
106062110|NCT01749514|365887152|FG003|Overall Study|Not Reported|0|||
106062111|NCT01749514|365887153|FG004|Overall Study|Not Reported|0|||
106062112|NCT01749514|365887154|FG005|Overall Study|Not Reported|0|||
106062113|NCT01749514|365887155|FG006|Overall Study|Not Reported|0|||
106062114|NCT01749514|365887156|FG007|Overall Study|Not Reported|5|||
106062115|NCT00010374|365887157|FG000|Overall Study|False positive phrenic nerve test|1|||
106062116|NCT01678911|365887161|FG000|Second Intervention|Lost to Follow-up|2|||
106062117|NCT01678911|365887162|FG001|Second Intervention|Lost to Follow-up|0|||
106062118|NCT00553514|365887163|FG000|Overall Study|Protocol deviation|0|||
106062119|NCT00553514|365887164|FG001|Overall Study|Protocol deviation|0|||
106062120|NCT00553514|365887165|FG002|Overall Study|Protocol deviation|0|||
106062121|NCT00553514|365887166|FG003|Overall Study|Protocol deviation|1|||
106062122|NCT00553514|365887167|FG004|Overall Study|Protocol deviation|0|||
106062123|NCT00553514|365887163|FG000|Overall Study|Lack of ovarian response|4|||
106062124|NCT00553514|365887164|FG001|Overall Study|Lack of ovarian response|5|||
106153827|NCT03398148|366223913|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
106153828|NCT03398148|366223914|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153829|NCT03398148|366223915|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153830|NCT03398148|366223916|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153831|NCT03398148|366223917|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
106153832|NCT03398148|366223903|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153833|NCT03398148|366223904|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153834|NCT03398148|366223905|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153835|NCT03398148|366223906|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153836|NCT03398148|366223907|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153837|NCT03398148|366223908|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153838|NCT03398148|366223909|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153839|NCT03398148|366223910|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153840|NCT03398148|366223911|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153841|NCT03398148|366223912|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153842|NCT03398148|366223913|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
106153843|NCT03398148|366223914|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153844|NCT03398148|366223915|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153845|NCT03398148|366223916|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153846|NCT03398148|366223917|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
106153847|NCT03398148|366223903|FG000|Substudy 2 Period 1|Other|0|||
106153848|NCT03398148|366223904|FG001|Substudy 2 Period 1|Other|0|||
106153849|NCT03398148|366223905|FG002|Substudy 2 Period 1|Other|0|||
106153850|NCT03398148|366223906|FG003|Substudy 2 Period 1|Other|0|||
106062125|NCT00553514|365887165|FG002|Overall Study|Lack of ovarian response|5|||
106062126|NCT00553514|365887166|FG003|Overall Study|Lack of ovarian response|5|||
106062127|NCT00553514|365887167|FG004|Overall Study|Lack of ovarian response|6|||
106062128|NCT00553514|365887163|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
106062129|NCT00553514|365887164|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
106062130|NCT00553514|365887165|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
106062131|NCT00553514|365887166|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
106153851|NCT03398148|366223907|FG004|Substudy 2 Period 1|Other|0|||
106153852|NCT03398148|366223908|FG005|Substudy 2 Period 1|Other|0|||
106062132|NCT00553514|365887167|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
106062133|NCT00553514|365887163|FG000|Overall Study|Risk of multiple pregnancy|0|||
106062134|NCT00553514|365887164|FG001|Overall Study|Risk of multiple pregnancy|2|||
106062135|NCT00553514|365887165|FG002|Overall Study|Risk of multiple pregnancy|0|||
106062136|NCT00553514|365887166|FG003|Overall Study|Risk of multiple pregnancy|1|||
106062137|NCT00553514|365887167|FG004|Overall Study|Risk of multiple pregnancy|0|||
106062138|NCT00553514|365887163|FG000|Overall Study|Other|1|||
106062139|NCT00553514|365887164|FG001|Overall Study|Other|1|||
106062140|NCT00553514|365887165|FG002|Overall Study|Other|0|||
106062141|NCT00553514|365887166|FG003|Overall Study|Other|0|||
106062142|NCT00553514|365887167|FG004|Overall Study|Other|1|||
106062143|NCT00040664|365887170|FG000|Overall Study|Adverse Event|12|||
106062144|NCT00040664|365887171|FG001|Overall Study|Adverse Event|3|||
106062145|NCT00040664|365887172|FG002|Overall Study|Adverse Event|2|||
106062146|NCT00040664|365887173|FG003|Overall Study|Adverse Event|7|||
106062147|NCT00040664|365887170|FG000|Overall Study|Lack of Efficacy|9|||
106062148|NCT00040664|365887171|FG001|Overall Study|Lack of Efficacy|2|||
106062149|NCT00040664|365887172|FG002|Overall Study|Lack of Efficacy|3|||
106062150|NCT00040664|365887173|FG003|Overall Study|Lack of Efficacy|4|||
106062151|NCT00040664|365887170|FG000|Overall Study|Insufficient CD4 response|1|||
106062152|NCT00040664|365887171|FG001|Overall Study|Insufficient CD4 response|0|||
106062153|NCT00040664|365887172|FG002|Overall Study|Insufficient CD4 response|1|||
106062154|NCT00040664|365887173|FG003|Overall Study|Insufficient CD4 response|0|||
106062155|NCT00040664|365887170|FG000|Overall Study|Lost to Follow-up|4|||
106062156|NCT00040664|365887171|FG001|Overall Study|Lost to Follow-up|2|||
106062157|NCT00040664|365887172|FG002|Overall Study|Lost to Follow-up|0|||
106062158|NCT00040664|365887173|FG003|Overall Study|Lost to Follow-up|2|||
106062159|NCT00040664|365887170|FG000|Overall Study|Protocol Violation|2|||
106062160|NCT00040664|365887171|FG001|Overall Study|Protocol Violation|1|||
106062161|NCT00040664|365887172|FG002|Overall Study|Protocol Violation|0|||
106062162|NCT00040664|365887173|FG003|Overall Study|Protocol Violation|1|||
106062163|NCT00040664|365887170|FG000|Overall Study|Withdrawal by Subject|7|||
106062164|NCT00040664|365887171|FG001|Overall Study|Withdrawal by Subject|0|||
106062165|NCT00040664|365887172|FG002|Overall Study|Withdrawal by Subject|3|||
106062166|NCT00040664|365887173|FG003|Overall Study|Withdrawal by Subject|4|||
106062167|NCT00040664|365887170|FG000|Overall Study|Pregnancy|3|||
106062168|NCT00040664|365887171|FG001|Overall Study|Pregnancy|0|||
106062169|NCT00040664|365887172|FG002|Overall Study|Pregnancy|0|||
106062170|NCT00040664|365887173|FG003|Overall Study|Pregnancy|3|||
106062171|NCT00040664|365887170|FG000|Overall Study|Medication adherence/compliance problems|8|||
106062172|NCT00040664|365887171|FG001|Overall Study|Medication adherence/compliance problems|2|||
106062173|NCT00040664|365887172|FG002|Overall Study|Medication adherence/compliance problems|1|||
106062174|NCT00040664|365887173|FG003|Overall Study|Medication adherence/compliance problems|5|||
106062175|NCT00040664|365887170|FG000|Overall Study|Poor taste|2|||
106062176|NCT00040664|365887171|FG001|Overall Study|Poor taste|0|||
106062177|NCT00040664|365887172|FG002|Overall Study|Poor taste|2|||
106062178|NCT00040664|365887173|FG003|Overall Study|Poor taste|0|||
106062179|NCT00040664|365887170|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
106062180|NCT00040664|365887171|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
106062181|NCT00040664|365887172|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
106062182|NCT00040664|365887173|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
106062183|NCT00040664|365887170|FG000|Overall Study|Change of formulation|2|||
106062184|NCT00040664|365887171|FG001|Overall Study|Change of formulation|2|||
106062185|NCT00040664|365887172|FG002|Overall Study|Change of formulation|0|||
106062186|NCT00040664|365887173|FG003|Overall Study|Change of formulation|0|||
106062187|NCT00040664|365887170|FG000|Overall Study|Non-viability of oral suspension|1|||
106062188|NCT00040664|365887171|FG001|Overall Study|Non-viability of oral suspension|0|||
106062189|NCT00040664|365887172|FG002|Overall Study|Non-viability of oral suspension|1|||
106062190|NCT00040664|365887173|FG003|Overall Study|Non-viability of oral suspension|0|||
106062191|NCT00640601|365887179|FG000|Overall Study|Adverse Event|43|||
106062192|NCT00640601|365887179|FG000|Overall Study|Withdrawal by Subject|20|||
106062193|NCT00640601|365887179|FG000|Overall Study|Protocol Violation|6|||
106062194|NCT00640601|365887179|FG000|Overall Study|Lack of Efficacy|16|||
106062195|NCT00640601|365887179|FG000|Overall Study|Lost to Follow-up|9|||
106062196|NCT00640601|365887179|FG000|Overall Study|Physician Decision|8|||
106062197|NCT00640601|365887179|FG000|Overall Study|treatment naive, combination therapy|10|||
106062198|NCT04786990|365887184|FG000|Overall Study|Withdrawal by Subject|1|||
106062199|NCT04786990|365887184|FG000|Overall Study|Adverse Event|1|||
106062200|NCT04786990|365887184|FG000|Overall Study|Lost to Follow-up|1|||
106062201|NCT04786990|365887184|FG000|Overall Study|Noncompliance|1|||
106062202|NCT04786990|365887184|FG000|Overall Study|Unable to complete site visits|1|||
106062203|NCT04786990|365887184|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
106062204|NCT02505867|365887185|FG000|Overall Study|Lack of Efficacy|6|||
106062205|NCT02505867|365887186|FG001|Overall Study|Lack of Efficacy|6|||
106062206|NCT01862874|365887187|FG000|Overall Study|Randomized not treated|1|||
106062207|NCT01862874|365887188|FG001|Overall Study|Randomized not treated|0|||
106062208|NCT01862874|365887187|FG000|Overall Study|Adverse Event|0|||
106062209|NCT01862874|365887188|FG001|Overall Study|Adverse Event|3|||
106062210|NCT01862874|365887187|FG000|Overall Study|Lost to Follow-up|26|||
106062211|NCT01862874|365887188|FG001|Overall Study|Lost to Follow-up|29|||
106062212|NCT01862874|365887187|FG000|Overall Study|Physician Decision|5|||
106062213|NCT01862874|365887188|FG001|Overall Study|Physician Decision|3|||
106062214|NCT01862874|365887187|FG000|Overall Study|Withdrawn by parent/guardian|1|||
106062215|NCT01862874|365887188|FG001|Overall Study|Withdrawn by parent/guardian|1|||
106062216|NCT01862874|365887187|FG000|Overall Study|Withdrawal by Subject|46|||
106062217|NCT01862874|365887188|FG001|Overall Study|Withdrawal by Subject|40|||
106062218|NCT01862874|365887187|FG000|Overall Study|Death|0|||
106062219|NCT01862874|365887188|FG001|Overall Study|Death|1|||
106062220|NCT01405742|365887199|FG000|Overall Study|Lost to Follow-up|1|||
106062221|NCT01405742|365887200|FG001|Overall Study|Lost to Follow-up|0|||
106062222|NCT03965962|365887202|FG000|Overall Study|Adverse Event|1|||
106062223|NCT03965962|365887203|FG001|Overall Study|Adverse Event|0|||
106062224|NCT03965962|365887204|FG002|Overall Study|Adverse Event|0|||
106062225|NCT03965962|365887205|FG003|Overall Study|Adverse Event|0|||
106062226|NCT03965962|365887202|FG000|Overall Study|Protocol Violation|21|||
106062227|NCT03965962|365887203|FG001|Overall Study|Protocol Violation|4|||
106062228|NCT03965962|365887204|FG002|Overall Study|Protocol Violation|10|||
106062229|NCT03965962|365887205|FG003|Overall Study|Protocol Violation|5|||
106062230|NCT03965962|365887202|FG000|Overall Study|Lost to Follow-up|0|||
106062231|NCT03965962|365887203|FG001|Overall Study|Lost to Follow-up|1|||
106062232|NCT03965962|365887204|FG002|Overall Study|Lost to Follow-up|0|||
106062233|NCT03965962|365887205|FG003|Overall Study|Lost to Follow-up|0|||
106062234|NCT03965962|365887202|FG000|Overall Study|Withdrawal by Subject|3|||
106062235|NCT03965962|365887203|FG001|Overall Study|Withdrawal by Subject|0|||
106062236|NCT03965962|365887204|FG002|Overall Study|Withdrawal by Subject|0|||
106062237|NCT03965962|365887205|FG003|Overall Study|Withdrawal by Subject|1|||
106062238|NCT02634320|365887213|FG000|Overall Study|Adverse Event|2|||
106062239|NCT02634320|365887213|FG000|Overall Study|Lost to Follow-up|3|||
106062240|NCT02634320|365887213|FG000|Overall Study|Moved out of area|2|||
106062241|NCT02634320|365887213|FG000|Overall Study|Out of window for study visits|1|||
106062242|NCT02634320|365887213|FG000|Overall Study|Protocol Violation|1|||
106062243|NCT02634320|365887213|FG000|Overall Study|Withdrawal by Subject|5|||
106062244|NCT02634320|365887213|FG000|Overall Study|Lack of Efficacy|2|||
106062245|NCT00687323|365887214|FG000|Overall Study|Death|25|||
106062246|NCT00687323|365887214|FG000|Overall Study|Withdrawal by Subject|1|||
106062247|NCT00687323|365887214|FG000|Overall Study|Excluded from efficacy evaluations|6|||
106062248|NCT00687323|365887214|FG000|Overall Study|Screen failure|148|||
106062249|NCT01782495|365887217|FG000|Overall Study|Adverse Event|0|||
106062250|NCT01782495|365887218|FG001|Overall Study|Adverse Event|0|||
106062251|NCT01782495|365887219|FG002|Overall Study|Adverse Event|0|||
106062252|NCT01782495|365887220|FG003|Overall Study|Adverse Event|0|||
106062253|NCT01782495|365887221|FG004|Overall Study|Adverse Event|0|||
106062254|NCT01782495|365887222|FG005|Overall Study|Adverse Event|0|||
106062255|NCT01782495|365887223|FG006|Overall Study|Adverse Event|0|||
106153853|NCT03398148|366223909|FG006|Substudy 2 Period 1|Other|0|||
105864781|NCT03207867|365152989|FG000|Overall Study|Patient/guardian Decision|0|||
105864782|NCT03207867|365152990|FG001|Overall Study|Patient/guardian Decision|0|||
105864783|NCT03207867|365152991|FG002|Overall Study|Patient/guardian Decision|1|||
105864784|NCT03207867|365152992|FG003|Overall Study|Patient/guardian Decision|1|||
105864785|NCT03207867|365152993|FG004|Overall Study|Patient/guardian Decision|1|||
105864786|NCT03207867|365152994|FG005|Overall Study|Patient/guardian Decision|2|||
105864787|NCT03207867|365152995|FG006|Overall Study|Patient/guardian Decision|1|||
105864788|NCT03207867|365152996|FG007|Overall Study|Patient/guardian Decision|0|||
105864789|NCT03207867|365152997|FG008|Overall Study|Patient/guardian Decision|1|||
105864790|NCT03207867|365152998|FG009|Overall Study|Patient/guardian Decision|0|||
105864791|NCT03207867|365152999|FG010|Overall Study|Patient/guardian Decision|0|||
105864792|NCT03207867|365153000|FG011|Overall Study|Patient/guardian Decision|1|||
105864793|NCT03207867|365153001|FG012|Overall Study|Patient/guardian Decision|0|||
105864794|NCT03207867|365153002|FG013|Overall Study|Patient/guardian Decision|1|||
105864795|NCT03207867|365153003|FG014|Overall Study|Patient/guardian Decision|2|||
105864796|NCT03207867|365153004|FG015|Overall Study|Patient/guardian Decision|0|||
105864797|NCT03207867|365153005|FG016|Overall Study|Patient/guardian Decision|1|||
105864798|NCT03207867|365153006|FG017|Overall Study|Patient/guardian Decision|3|||
105864799|NCT03207867|365153007|FG018|Overall Study|Patient/guardian Decision|4|||
105864800|NCT03207867|365153008|FG019|Overall Study|Patient/guardian Decision|1|||
105864801|NCT03207867|365153009|FG020|Overall Study|Patient/guardian Decision|0|||
106062256|NCT01782495|365887224|FG007|Overall Study|Adverse Event|2|||
106062257|NCT01782495|365887225|FG008|Overall Study|Adverse Event|0|||
106062258|NCT01782495|365887226|FG009|Overall Study|Adverse Event|0|||
106062259|NCT01782495|365887227|FG010|Overall Study|Adverse Event|0|||
105864802|NCT03207867|365153010|FG021|Overall Study|Patient/guardian Decision|0|||
105864803|NCT03207867|365153011|FG022|Overall Study|Patient/guardian Decision|0|||
106062260|NCT01782495|365887217|FG000|Overall Study|Withdrew Consent|0|||
106062261|NCT01782495|365887218|FG001|Overall Study|Withdrew Consent|1|||
106062262|NCT01782495|365887219|FG002|Overall Study|Withdrew Consent|0|||
106062263|NCT01782495|365887220|FG003|Overall Study|Withdrew Consent|0|||
106062264|NCT01782495|365887221|FG004|Overall Study|Withdrew Consent|0|||
106062265|NCT01782495|365887222|FG005|Overall Study|Withdrew Consent|0|||
106062266|NCT01782495|365887223|FG006|Overall Study|Withdrew Consent|0|||
106062267|NCT01782495|365887224|FG007|Overall Study|Withdrew Consent|1|||
106062268|NCT01782495|365887225|FG008|Overall Study|Withdrew Consent|0|||
106062269|NCT01782495|365887226|FG009|Overall Study|Withdrew Consent|0|||
106062270|NCT01782495|365887227|FG010|Overall Study|Withdrew Consent|0|||
106062271|NCT00580606|365887231|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
106062272|NCT00580606|365887232|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
106062273|NCT00580606|365887231|FG000|Open Label (OL)|Withdrawal by Subject|4|||
106062274|NCT00580606|365887232|FG001|Open Label (OL)|Withdrawal by Subject|6|||
106062275|NCT00580606|365887231|FG000|Open Label (OL)|Dosing Symptoms|0|||
106062276|NCT00580606|365887232|FG001|Open Label (OL)|Dosing Symptoms|1|||
106062277|NCT00580606|365887231|FG000|Open Label (OL)|Lost to Follow-up|0|||
106062278|NCT00580606|365887232|FG001|Open Label (OL)|Lost to Follow-up|1|||
106062279|NCT00580606|365887231|FG000|Open Label (OL)|Pregnancy|0|||
106062280|NCT00580606|365887232|FG001|Open Label (OL)|Pregnancy|1|||
106062281|NCT00580606|365887231|FG000|Open Label (OL)|Non-compliance|2|||
106062282|NCT00580606|365887232|FG001|Open Label (OL)|Non-compliance|0|||
106062283|NCT00580606|365887231|FG000|Open Label (OL)|Physician Decision|1|||
106062284|NCT00580606|365887232|FG001|Open Label (OL)|Physician Decision|1|||
106062285|NCT00580606|365887231|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
106062286|NCT00580606|365887232|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
106062287|NCT03655691|365887233|FG000|Overall Study|Adverse Event|0|||
106062288|NCT03655691|365887234|FG001|Overall Study|Adverse Event|0|||
106062289|NCT03655691|365887235|FG002|Overall Study|Adverse Event|1|||
106062290|NCT03655691|365887233|FG000|Overall Study|Lost to Follow-up|1|||
106062291|NCT03655691|365887234|FG001|Overall Study|Lost to Follow-up|1|||
106062292|NCT03655691|365887235|FG002|Overall Study|Lost to Follow-up|2|||
106062293|NCT03655691|365887233|FG000|Overall Study|Protocol Violation|0|||
106062294|NCT03655691|365887234|FG001|Overall Study|Protocol Violation|1|||
106062295|NCT03655691|365887235|FG002|Overall Study|Protocol Violation|0|||
106062296|NCT03655691|365887233|FG000|Overall Study|Withdrawal by Subject|1|||
106062297|NCT03655691|365887234|FG001|Overall Study|Withdrawal by Subject|1|||
106062298|NCT03655691|365887235|FG002|Overall Study|Withdrawal by Subject|0|||
106062299|NCT04557371|365887236|FG000|Overall Study|Covid-19-related|0|||
106062300|NCT04557371|365887237|FG001|Overall Study|Covid-19-related|1|||
106062301|NCT04557371|365887238|FG002|Overall Study|Covid-19-related|0|||
106062302|NCT04557371|365887236|FG000|Overall Study|Withdrawal by Subject|0|||
106062303|NCT04557371|365887237|FG001|Overall Study|Withdrawal by Subject|1|||
106062304|NCT04557371|365887238|FG002|Overall Study|Withdrawal by Subject|0|||
106062305|NCT04557371|365887236|FG000|Overall Study|Adverse Event|1|||
106062306|NCT04557371|365887237|FG001|Overall Study|Adverse Event|0|||
106062307|NCT04557371|365887238|FG002|Overall Study|Adverse Event|0|||
106062308|NCT01753856|365887239|FG000|Overall Study|Adverse Event|1|||
106062309|NCT01753856|365887240|FG001|Overall Study|Adverse Event|0|||
106062310|NCT01753856|365887239|FG000|Overall Study|Withdrawal by Subject|0|||
106062311|NCT01753856|365887240|FG001|Overall Study|Withdrawal by Subject|2|||
106062312|NCT01753856|365887239|FG000|Overall Study|Sponsor Decision|2|||
106153854|NCT03398148|366223910|FG007|Substudy 2 Period 1|Other|0|||
106153855|NCT03398148|366223911|FG008|Substudy 2 Period 1|Other|0|||
106153856|NCT03398148|366223912|FG009|Substudy 2 Period 1|Other|4|||
106153857|NCT03398148|366223913|FG010|Substudy 2 Period 1|Other|4|||
106153858|NCT03398148|366223914|FG011|Substudy 2 Period 1|Other|0|||
106153859|NCT03398148|366223915|FG012|Substudy 2 Period 1|Other|0|||
106153860|NCT03398148|366223916|FG013|Substudy 2 Period 1|Other|0|||
106153861|NCT03398148|366223917|FG014|Substudy 2 Period 1|Other|0|||
106153862|NCT03398148|366223903|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153863|NCT03398148|366223904|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153864|NCT03398148|366223905|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153865|NCT03398148|366223906|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153866|NCT03398148|366223907|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153867|NCT03398148|366223908|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153868|NCT03398148|366223909|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
106062313|NCT01753856|365887240|FG001|Overall Study|Sponsor Decision|0|||
106062314|NCT01943292|365888859|FG000|Overall Study|Withdrawal by Subject|1|||
106062315|NCT01943292|365888860|FG001|Overall Study|Withdrawal by Subject|0|||
106062316|NCT01943292|365888861|FG002|Overall Study|Withdrawal by Subject|0|||
106062317|NCT00638378|365888862|FG000|Overall Study|Death|2|||
106062318|NCT00638378|365888862|FG000|Overall Study|Adverse Event|1|||
106062319|NCT00638378|365888862|FG000|Overall Study|Disease progression|15|||
106062320|NCT00638378|365888862|FG000|Overall Study|Physician Decision|4|||
106062321|NCT00996216|365888863|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
106153869|NCT03398148|366223910|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153870|NCT03398148|366223911|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153871|NCT03398148|366223912|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153872|NCT03398148|366223913|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
106062322|NCT00996216|365888863|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
106062323|NCT00996216|365888863|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
106062324|NCT01852110|365888864|FG000|Overall Study|Adverse Event|12|||
106062325|NCT01852110|365888865|FG001|Overall Study|Adverse Event|5|||
106062326|NCT01852110|365888866|FG002|Overall Study|Adverse Event|0|||
106062327|NCT01852110|365888867|FG003|Overall Study|Adverse Event|0|||
106062328|NCT01852110|365888868|FG004|Overall Study|Adverse Event|0|||
106062329|NCT01852110|365888869|FG005|Overall Study|Adverse Event|0|||
106062330|NCT01852110|365888864|FG000|Overall Study|Lost to Follow-up|1|||
106062331|NCT01852110|365888865|FG001|Overall Study|Lost to Follow-up|3|||
106062332|NCT01852110|365888866|FG002|Overall Study|Lost to Follow-up|0|||
106062333|NCT01852110|365888867|FG003|Overall Study|Lost to Follow-up|0|||
106062334|NCT01852110|365888868|FG004|Overall Study|Lost to Follow-up|0|||
106062335|NCT01852110|365888869|FG005|Overall Study|Lost to Follow-up|0|||
106062336|NCT01852110|365888864|FG000|Overall Study|Non-compliance with Study Drug|2|||
106062337|NCT01852110|365888865|FG001|Overall Study|Non-compliance with Study Drug|1|||
106062338|NCT01852110|365888866|FG002|Overall Study|Non-compliance with Study Drug|0|||
106062339|NCT01852110|365888867|FG003|Overall Study|Non-compliance with Study Drug|0|||
106062340|NCT01852110|365888868|FG004|Overall Study|Non-compliance with Study Drug|0|||
106062341|NCT01852110|365888869|FG005|Overall Study|Non-compliance with Study Drug|0|||
106062342|NCT01852110|365888864|FG000|Overall Study|Physician Decision|1|||
106062343|NCT01852110|365888865|FG001|Overall Study|Physician Decision|0|||
106062344|NCT01852110|365888866|FG002|Overall Study|Physician Decision|0|||
106062345|NCT01852110|365888867|FG003|Overall Study|Physician Decision|0|||
106062346|NCT01852110|365888868|FG004|Overall Study|Physician Decision|0|||
106062347|NCT01852110|365888869|FG005|Overall Study|Physician Decision|0|||
106062348|NCT01852110|365888864|FG000|Overall Study|Protocol Violation|0|||
106062349|NCT01852110|365888865|FG001|Overall Study|Protocol Violation|1|||
106062350|NCT01852110|365888866|FG002|Overall Study|Protocol Violation|0|||
106062351|NCT01852110|365888867|FG003|Overall Study|Protocol Violation|0|||
106062352|NCT01852110|365888868|FG004|Overall Study|Protocol Violation|0|||
106062353|NCT01852110|365888869|FG005|Overall Study|Protocol Violation|0|||
106062354|NCT01852110|365888864|FG000|Overall Study|Study Terminated by Sponsor|30|||
106062355|NCT01852110|365888865|FG001|Overall Study|Study Terminated by Sponsor|32|||
106062356|NCT01852110|365888866|FG002|Overall Study|Study Terminated by Sponsor|0|||
106062357|NCT01852110|365888867|FG003|Overall Study|Study Terminated by Sponsor|0|||
106062358|NCT01852110|365888868|FG004|Overall Study|Study Terminated by Sponsor|0|||
106062359|NCT01852110|365888869|FG005|Overall Study|Study Terminated by Sponsor|0|||
106062360|NCT01852110|365888864|FG000|Overall Study|Withdrawal by Subject|4|||
106062361|NCT01852110|365888865|FG001|Overall Study|Withdrawal by Subject|4|||
106062362|NCT01852110|365888866|FG002|Overall Study|Withdrawal by Subject|0|||
106062363|NCT01852110|365888867|FG003|Overall Study|Withdrawal by Subject|0|||
106062364|NCT01852110|365888868|FG004|Overall Study|Withdrawal by Subject|0|||
106062365|NCT01852110|365888869|FG005|Overall Study|Withdrawal by Subject|0|||
106062366|NCT00842712|365888882|FG000|Safety Run-in Part|Adverse Event|0|||
106062367|NCT00842712|365888883|FG001|Safety Run-in Part|Adverse Event|1|||
106062368|NCT00842712|365888884|FG002|Safety Run-in Part|Adverse Event|0|||
106062369|NCT00842712|365888885|FG003|Safety Run-in Part|Adverse Event|0|||
106062370|NCT00842712|365888886|FG004|Safety Run-in Part|Adverse Event|0|||
106062371|NCT00842712|365888887|FG005|Safety Run-in Part|Adverse Event|0|||
106062372|NCT00842712|365888888|FG006|Safety Run-in Part|Adverse Event|0|||
106062373|NCT00842712|365888882|FG000|Safety Run-in Part|Progressive disease|3|||
106062374|NCT00842712|365888883|FG001|Safety Run-in Part|Progressive disease|1|||
106062375|NCT00842712|365888884|FG002|Safety Run-in Part|Progressive disease|0|||
106062376|NCT00842712|365888885|FG003|Safety Run-in Part|Progressive disease|1|||
106062377|NCT00842712|365888886|FG004|Safety Run-in Part|Progressive disease|0|||
106062378|NCT00842712|365888887|FG005|Safety Run-in Part|Progressive disease|0|||
106062379|NCT00842712|365888888|FG006|Safety Run-in Part|Progressive disease|0|||
106062380|NCT00842712|365888882|FG000|Randomized Part|Randomized but not treated|0|||
106062381|NCT00842712|365888883|FG001|Randomized Part|Randomized but not treated|0|||
106062382|NCT00842712|365888884|FG002|Randomized Part|Randomized but not treated|0|||
106062383|NCT00842712|365888885|FG003|Randomized Part|Randomized but not treated|0|||
106062384|NCT00842712|365888886|FG004|Randomized Part|Randomized but not treated|0|||
106062385|NCT00842712|365888887|FG005|Randomized Part|Randomized but not treated|1|||
106062386|NCT00842712|365888888|FG006|Randomized Part|Randomized but not treated|4|||
106062387|NCT00842712|365888882|FG000|Randomized Part|Ongoing at cut-off date|0|||
106062388|NCT00842712|365888883|FG001|Randomized Part|Ongoing at cut-off date|0|||
106062389|NCT00842712|365888884|FG002|Randomized Part|Ongoing at cut-off date|0|||
106062390|NCT00842712|365888885|FG003|Randomized Part|Ongoing at cut-off date|0|||
106062391|NCT00842712|365888886|FG004|Randomized Part|Ongoing at cut-off date|0|||
106062392|NCT00842712|365888887|FG005|Randomized Part|Ongoing at cut-off date|0|||
106062393|NCT00842712|365888888|FG006|Randomized Part|Ongoing at cut-off date|2|||
106062394|NCT02310568|365888890|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
106062395|NCT02310568|365888891|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
106062396|NCT02310568|365888892|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
106062397|NCT02310568|365888893|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
106062398|NCT02310568|365888894|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
106062399|NCT02310568|365888890|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
106062400|NCT02310568|365888891|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
106062401|NCT02310568|365888892|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
106153873|NCT03398148|366223914|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153874|NCT03398148|366223915|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153875|NCT03398148|366223916|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153876|NCT03398148|366223917|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
106153877|NCT03398148|366223903|FG000|Substudy 2 Period 2|Adverse Event|0|||
106153878|NCT03398148|366223904|FG001|Substudy 2 Period 2|Adverse Event|0|||
106153879|NCT03398148|366223905|FG002|Substudy 2 Period 2|Adverse Event|0|||
106153880|NCT03398148|366223906|FG003|Substudy 2 Period 2|Adverse Event|0|||
106153881|NCT03398148|366223907|FG004|Substudy 2 Period 2|Adverse Event|0|||
106153882|NCT03398148|366223908|FG005|Substudy 2 Period 2|Adverse Event|0|||
106153883|NCT03398148|366223909|FG006|Substudy 2 Period 2|Adverse Event|0|||
106153884|NCT03398148|366223910|FG007|Substudy 2 Period 2|Adverse Event|0|||
106153885|NCT03398148|366223911|FG008|Substudy 2 Period 2|Adverse Event|0|||
106153886|NCT03398148|366223912|FG009|Substudy 2 Period 2|Adverse Event|0|||
106153887|NCT03398148|366223913|FG010|Substudy 2 Period 2|Adverse Event|0|||
106153888|NCT03398148|366223914|FG011|Substudy 2 Period 2|Adverse Event|0|||
106153889|NCT03398148|366223915|FG012|Substudy 2 Period 2|Adverse Event|0|||
106153890|NCT03398148|366223916|FG013|Substudy 2 Period 2|Adverse Event|1|||
106153891|NCT03398148|366223917|FG014|Substudy 2 Period 2|Adverse Event|3|||
106153892|NCT03398148|366223903|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
106153893|NCT03398148|366223904|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
106153894|NCT03398148|366223905|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
106153895|NCT03398148|366223906|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
106153896|NCT03398148|366223907|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
106153897|NCT03398148|366223908|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
106153898|NCT03398148|366223909|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
106153899|NCT03398148|366223910|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
106153900|NCT03398148|366223911|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
106153901|NCT03398148|366223912|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
106153902|NCT03398148|366223913|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
106153903|NCT03398148|366223914|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
106153904|NCT03398148|366223915|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
106153905|NCT03398148|366223916|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
106153906|NCT03398148|366223917|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
106153907|NCT03398148|366223903|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106062402|NCT02310568|365888893|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
106062403|NCT02310568|365888894|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
106062404|NCT02310568|365888890|FG000|Stage 1 ( 4 Weeks)|Other|1|||
106062405|NCT02310568|365888891|FG001|Stage 1 ( 4 Weeks)|Other|1|||
106062406|NCT02310568|365888892|FG002|Stage 1 ( 4 Weeks)|Other|0|||
106062407|NCT02310568|365888893|FG003|Stage 1 ( 4 Weeks)|Other|0|||
106062408|NCT02310568|365888894|FG004|Stage 1 ( 4 Weeks)|Other|0|||
106062409|NCT02310568|365888890|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
106062410|NCT02310568|365888891|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
106062411|NCT02310568|365888892|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
106062412|NCT02310568|365888893|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
106062413|NCT02310568|365888894|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
106062414|NCT02310568|365888890|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
106062415|NCT02310568|365888891|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
106062416|NCT02310568|365888892|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
106062417|NCT02310568|365888893|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
106062418|NCT02310568|365888894|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
106062419|NCT02310568|365888890|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
106062420|NCT02310568|365888891|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
106062421|NCT02310568|365888892|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
106062422|NCT02310568|365888893|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
106062423|NCT02310568|365888894|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
106062424|NCT02310568|365888890|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
106062425|NCT02310568|365888891|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
106062426|NCT02310568|365888892|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
106062427|NCT02310568|365888893|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
106062428|NCT02310568|365888894|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
106153908|NCT03398148|366223904|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153909|NCT03398148|366223905|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153910|NCT03398148|366223906|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106062429|NCT02310568|365888890|FG000|Stage 2 (4 Weeks)|Other|0|||
106153911|NCT03398148|366223907|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153912|NCT03398148|366223908|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153913|NCT03398148|366223909|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153914|NCT03398148|366223910|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153915|NCT03398148|366223911|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
105864804|NCT03207867|365153012|FG023|Overall Study|Patient/guardian Decision|0|||
105864805|NCT01266031|365154699|FG000|Overall Study|Not treated|0|||
105864806|NCT01266031|365154700|FG001|Overall Study|Not treated|3|||
105864807|NCT01266031|365154701|FG002|Overall Study|Not treated|2|||
105864808|NCT01434810|365154706|FG000|Overall Study|Did not receive treatment|11|||
105864809|NCT01434810|365154707|FG001|Overall Study|Did not receive treatment|3|||
105864810|NCT01434810|365154706|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
105864811|NCT01434810|365154707|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
105864812|NCT04893018|365154708|FG000|Overall Study|Lost to Follow-up|1|||
105864813|NCT04893018|365154709|FG001|Overall Study|Lost to Follow-up|0|||
105864814|NCT04893018|365154708|FG000|Overall Study|Withdrawal by Subject|2|||
105864815|NCT04893018|365154709|FG001|Overall Study|Withdrawal by Subject|0|||
105864816|NCT04893018|365154708|FG000|Overall Study|Study Terminated|1|||
105864817|NCT04893018|365154709|FG001|Overall Study|Study Terminated|2|||
105864818|NCT03106987|365154712|FG000|Overall Study|Death|37|||
105864819|NCT03106987|365154713|FG001|Overall Study|Death|22|||
105864820|NCT03106987|365154714|FG002|Overall Study|Death|12|||
105864821|NCT03106987|365154715|FG003|Overall Study|Death|8|||
105864822|NCT03106987|365154712|FG000|Overall Study|Lost to Follow-up|2|||
105864823|NCT03106987|365154713|FG001|Overall Study|Lost to Follow-up|0|||
105864824|NCT03106987|365154714|FG002|Overall Study|Lost to Follow-up|2|||
106062430|NCT02310568|365888891|FG001|Stage 2 (4 Weeks)|Other|1|||
106062431|NCT02310568|365888892|FG002|Stage 2 (4 Weeks)|Other|1|||
106062432|NCT02310568|365888893|FG003|Stage 2 (4 Weeks)|Other|0|||
106062433|NCT02310568|365888894|FG004|Stage 2 (4 Weeks)|Other|0|||
106062434|NCT02310568|365888890|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
106062435|NCT02310568|365888891|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
106062436|NCT02310568|365888892|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
106062437|NCT02310568|365888893|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
106062438|NCT02310568|365888894|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
106062439|NCT02310568|365888890|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
106062440|NCT02310568|365888891|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
106062441|NCT02310568|365888892|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
106062442|NCT02310568|365888893|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
106062443|NCT02310568|365888894|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
106062444|NCT02310568|365888890|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
106062445|NCT02310568|365888891|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
106062446|NCT02310568|365888892|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
106062447|NCT02310568|365888893|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
106062448|NCT02310568|365888894|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
106062449|NCT00754624|365888901|FG000|Overall Study|Adverse Event|16|||
106062450|NCT00754624|365888901|FG000|Overall Study|Death|1|||
106062451|NCT00754624|365888901|FG000|Overall Study|Physician Decision|8|||
106062452|NCT00754624|365888901|FG000|Overall Study|Protocol Violation|1|||
106062453|NCT00754624|365888901|FG000|Overall Study|Withdrawal by Subject|28|||
106062454|NCT00754624|365888901|FG000|Overall Study|Various|12|||
106062455|NCT00754624|365888901|FG000|Overall Study|Lost to Follow-up|3|||
106062456|NCT00720434|365888902|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
106062457|NCT00720434|365888903|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
106062458|NCT00720434|365888904|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
106062459|NCT00720434|365888905|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
106062460|NCT00720434|365888902|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
106062461|NCT00720434|365888903|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
106062462|NCT00720434|365888904|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
106062463|NCT00720434|365888905|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
106062464|NCT00720434|365888902|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
106062465|NCT00720434|365888903|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
106062466|NCT00720434|365888904|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
106062467|NCT00720434|365888905|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
106062468|NCT00720434|365888902|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
106062469|NCT00720434|365888903|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
106062470|NCT00720434|365888904|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
106062471|NCT00720434|365888905|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
106062472|NCT00720434|365888902|FG000|Open-Label Period (Week 5-72)|Other|4|||
106062473|NCT00720434|365888903|FG001|Open-Label Period (Week 5-72)|Other|3|||
106062474|NCT00720434|365888904|FG002|Open-Label Period (Week 5-72)|Other|3|||
105864825|NCT03106987|365154715|FG003|Overall Study|Lost to Follow-up|2|||
105864826|NCT03106987|365154712|FG000|Overall Study|Withdrawal by Subject|5|||
105864827|NCT03106987|365154713|FG001|Overall Study|Withdrawal by Subject|1|||
105864828|NCT03106987|365154714|FG002|Overall Study|Withdrawal by Subject|4|||
105864829|NCT03106987|365154715|FG003|Overall Study|Withdrawal by Subject|1|||
105864830|NCT01307111|365154716|FG000|IUD Insertion|Lost to Follow-up|2|||
105864831|NCT01307111|365154717|FG001|IUD Insertion|Lost to Follow-up|0|||
105864832|NCT01307111|365154716|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
105864833|NCT01307111|365154717|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
105864834|NCT01068262|365154724|FG000|Overall Study|Adverse Event|2|||
106062475|NCT00720434|365888905|FG003|Open-Label Period (Week 5-72)|Other|2|||
106062476|NCT01104493|365888906|FG000|Overall Study|Lost to Follow-up|0|||
106062477|NCT01104493|365888907|FG001|Overall Study|Lost to Follow-up|2|||
106062478|NCT02782780|365888919|FG000|Overall Study|dropped out after randomization.|7|||
106062479|NCT02782780|365888920|FG001|Overall Study|dropped out after randomization.|5|||
106062480|NCT02782780|365888919|FG000|Overall Study|Protocol Violation|0|||
106062481|NCT02782780|365888920|FG001|Overall Study|Protocol Violation|2|||
106062482|NCT03562481|365888921|FG000|First Intervention|Lost to Follow-up|1|||
106062483|NCT03562481|365888922|FG001|First Intervention|Lost to Follow-up|0|||
106062484|NCT02664441|365888923|FG000|Randomization|Withdrawal by Subject|0|||
106062485|NCT02664441|365888924|FG001|Randomization|Withdrawal by Subject|1|||
106062486|NCT02664441|365888923|FG000|36-week Randomized Trial|Adverse Event|2|||
106062487|NCT02664441|365888924|FG001|36-week Randomized Trial|Adverse Event|0|||
106062488|NCT02664441|365888923|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
106062489|NCT02664441|365888924|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
106062490|NCT02664441|365888923|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
106062491|NCT02664441|365888924|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
106062492|NCT02664441|365888923|FG000|18-week Open Label Extension|Adverse Event|1|||
106062493|NCT02664441|365888924|FG001|18-week Open Label Extension|Adverse Event|0|||
106062494|NCT02664441|365888923|FG000|18-week Open Label Extension|Physician Decision|1|||
106062495|NCT02664441|365888924|FG001|18-week Open Label Extension|Physician Decision|0|||
106062496|NCT02664441|365888923|FG000|18-week Open Label Extension|Death|1|||
106062497|NCT02664441|365888924|FG001|18-week Open Label Extension|Death|0|||
106062498|NCT02664441|365888923|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
106062499|NCT02664441|365888924|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
106062500|NCT03654651|365888925|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
106062501|NCT03654651|365888926|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
106062502|NCT03510884|365888927|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
106062503|NCT03510884|365888928|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
106062504|NCT03510884|365888929|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
106062505|NCT03510884|365888930|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
106062506|NCT03510884|365888927|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
106062507|NCT03510884|365888928|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
106062508|NCT03510884|365888929|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
106062509|NCT03510884|365888930|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
106062510|NCT03510884|365888927|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
106062511|NCT03510884|365888928|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
106062512|NCT03510884|365888929|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
106062513|NCT03510884|365888930|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
106062514|NCT03510884|365888927|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
106062515|NCT03510884|365888928|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
106062516|NCT03510884|365888929|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
106062517|NCT03510884|365888930|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
106062518|NCT03510884|365888927|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
106062519|NCT03510884|365888928|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
106062520|NCT03510884|365888929|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
106062521|NCT03510884|365888930|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
106062522|NCT03510884|365888927|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
106062523|NCT03510884|365888928|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
106062524|NCT03510884|365888929|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
106062525|NCT03510884|365888930|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
106062526|NCT03510884|365888927|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
106062527|NCT03510884|365888928|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
106062528|NCT03510884|365888929|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
105864835|NCT01068262|365154725|FG001|Overall Study|Adverse Event|0|||
105864836|NCT01068262|365154726|FG002|Overall Study|Adverse Event|1|||
105864837|NCT01068262|365154727|FG003|Overall Study|Adverse Event|0|||
105864838|NCT01068262|365154724|FG000|Overall Study|Protocol Violation|1|||
105864839|NCT01068262|365154725|FG001|Overall Study|Protocol Violation|0|||
105864840|NCT01068262|365154726|FG002|Overall Study|Protocol Violation|0|||
105864841|NCT01068262|365154727|FG003|Overall Study|Protocol Violation|0|||
105864842|NCT01068262|365154724|FG000|Overall Study|Withdrawal by Subject|0|||
105864843|NCT01068262|365154725|FG001|Overall Study|Withdrawal by Subject|1|||
105864844|NCT01068262|365154726|FG002|Overall Study|Withdrawal by Subject|0|||
105864845|NCT01068262|365154727|FG003|Overall Study|Withdrawal by Subject|0|||
105864846|NCT00195338|365154729|FG000|Overall Study|Lost to Follow-up|2|||
105864847|NCT00195338|365154729|FG000|Overall Study|Adverse Event|5|||
105864848|NCT00195338|365154729|FG000|Overall Study|Lack of Efficacy|1|||
105864849|NCT00195338|365154729|FG000|Overall Study|Early closure of the site|4|||
105864850|NCT00005957|365154734|FG000|Overall Study|No treated|3|||
105864851|NCT00005957|365154735|FG001|Overall Study|No treated|9|||
105864852|NCT00005957|365154734|FG000|Overall Study|Crossover to the other arm|5|||
105864853|NCT00005957|365154735|FG001|Overall Study|Crossover to the other arm|19|||
105864854|NCT02047734|365154736|FG000|Overall Study|Adverse Event|18|||
105864855|NCT02047734|365154737|FG001|Overall Study|Adverse Event|13|||
105864856|NCT02047734|365154738|FG002|Overall Study|Adverse Event|13|||
105864857|NCT02047734|365154736|FG000|Overall Study|Lack of Efficacy|4|||
105864858|NCT02047734|365154737|FG001|Overall Study|Lack of Efficacy|5|||
105864859|NCT02047734|365154738|FG002|Overall Study|Lack of Efficacy|1|||
105864860|NCT02047734|365154736|FG000|Overall Study|Protocol Violation|3|||
105864861|NCT02047734|365154737|FG001|Overall Study|Protocol Violation|1|||
105864862|NCT02047734|365154738|FG002|Overall Study|Protocol Violation|1|||
105864863|NCT02047734|365154736|FG000|Overall Study|Lost to Follow-up|1|||
105864864|NCT02047734|365154737|FG001|Overall Study|Lost to Follow-up|4|||
105864865|NCT02047734|365154738|FG002|Overall Study|Lost to Follow-up|0|||
105864866|NCT02047734|365154736|FG000|Overall Study|Death|0|||
105864867|NCT02047734|365154737|FG001|Overall Study|Death|1|||
106062529|NCT03510884|365888930|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
106062530|NCT03510884|365888927|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
106062531|NCT03510884|365888928|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
106062532|NCT03510884|365888929|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
106062533|NCT03510884|365888930|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
106062534|NCT03510884|365888927|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
106062535|NCT03510884|365888928|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
106062536|NCT03510884|365888929|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
106062537|NCT03510884|365888930|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
106062538|NCT03510884|365888927|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
106062539|NCT03510884|365888928|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
106062540|NCT03510884|365888929|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
106062541|NCT03510884|365888930|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
106062542|NCT00856284|365888931|FG000|Overall Study|Hyperglycemic rescue|231|||
106062543|NCT00856284|365888932|FG001|Overall Study|Hyperglycemic rescue|201|||
106062544|NCT00856284|365888933|FG002|Overall Study|Hyperglycemic rescue|235|||
106062545|NCT00856284|365888931|FG000|Overall Study|Adverse Event|60|||
106062546|NCT00856284|365888932|FG001|Overall Study|Adverse Event|74|||
106062547|NCT00856284|365888933|FG002|Overall Study|Adverse Event|82|||
106062548|NCT00856284|365888931|FG000|Overall Study|Major protocol deviation|24|||
106062549|NCT00856284|365888932|FG001|Overall Study|Major protocol deviation|16|||
106062550|NCT00856284|365888933|FG002|Overall Study|Major protocol deviation|15|||
106062551|NCT00856284|365888931|FG000|Overall Study|Lost to Follow-up|20|||
106062552|NCT00856284|365888932|FG001|Overall Study|Lost to Follow-up|22|||
106062553|NCT00856284|365888933|FG002|Overall Study|Lost to Follow-up|28|||
106062554|NCT00856284|365888931|FG000|Overall Study|Voluntary withdrawal|48|||
106062555|NCT00856284|365888932|FG001|Overall Study|Voluntary withdrawal|52|||
106062556|NCT00856284|365888933|FG002|Overall Study|Voluntary withdrawal|62|||
106153916|NCT03398148|366223912|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153917|NCT03398148|366223913|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153918|NCT03398148|366223914|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
106153919|NCT03398148|366223915|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
106153920|NCT03398148|366223916|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
106153921|NCT03398148|366223917|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
106153922|NCT03398148|366223903|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
106153923|NCT03398148|366223904|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
106153924|NCT03398148|366223905|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
106153925|NCT03398148|366223906|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
105864868|NCT02047734|365154738|FG002|Overall Study|Death|0|||
105864869|NCT02047734|365154736|FG000|Overall Study|Withdrawal by Subject|30|||
105864870|NCT02047734|365154737|FG001|Overall Study|Withdrawal by Subject|31|||
105864871|NCT02047734|365154738|FG002|Overall Study|Withdrawal by Subject|19|||
105864872|NCT02047734|365154736|FG000|Overall Study|Physician Decision|7|||
106062557|NCT00856284|365888931|FG000|Overall Study|Pregnancy|1|||
106062558|NCT00856284|365888932|FG001|Overall Study|Pregnancy|2|||
106062559|NCT00856284|365888933|FG002|Overall Study|Pregnancy|0|||
106062560|NCT00856284|365888931|FG000|Overall Study|Investigator discretion|9|||
106062561|NCT00856284|365888932|FG001|Overall Study|Investigator discretion|8|||
106062562|NCT00856284|365888933|FG002|Overall Study|Investigator discretion|10|||
106062563|NCT00856284|365888931|FG000|Overall Study|Other|15|||
106062564|NCT00856284|365888932|FG001|Overall Study|Other|17|||
106062565|NCT00856284|365888933|FG002|Overall Study|Other|14|||
106062566|NCT00856284|365888931|FG000|Overall Study|Randomized in error|0|||
106062567|NCT00856284|365888932|FG001|Overall Study|Randomized in error|0|||
106062568|NCT00856284|365888933|FG002|Overall Study|Randomized in error|1|||
106062569|NCT05620563|365888936|FG000|Overall Study|Adverse Event|3|||
106062570|NCT05620563|365888937|FG001|Overall Study|Adverse Event|1|||
106062571|NCT05620563|365888936|FG000|Overall Study|Lost to Follow-up|0|||
106062572|NCT05620563|365888937|FG001|Overall Study|Lost to Follow-up|2|||
106062573|NCT05620563|365888936|FG000|Overall Study|Protocol Deviation|1|||
106062574|NCT05620563|365888937|FG001|Overall Study|Protocol Deviation|2|||
106062575|NCT05620563|365888936|FG000|Overall Study|Withdrawal by Subject|3|||
106062576|NCT05620563|365888937|FG001|Overall Study|Withdrawal by Subject|3|||
106062577|NCT05620563|365888936|FG000|Overall Study|Physician Decision|0|||
106062578|NCT05620563|365888937|FG001|Overall Study|Physician Decision|1|||
106062579|NCT00085631|365888938|FG000|Overall Study|Missing Data|4|||
106062580|NCT00085631|365888939|FG001|Overall Study|Missing Data|11|||
106062581|NCT00085631|365888940|FG002|Overall Study|Missing Data|7|||
106062582|NCT00411645|365888941|FG000|Overall Study|Consent Withdrawn|13|||
106062583|NCT00411645|365888942|FG001|Overall Study|Consent Withdrawn|22|||
106062584|NCT00411645|365888941|FG000|Overall Study|Death|56|||
106062585|NCT00411645|365888942|FG001|Overall Study|Death|135|||
106062586|NCT00411645|365888941|FG000|Overall Study|Investigator/Sponsor Decision|10|||
106062587|NCT00411645|365888942|FG001|Overall Study|Investigator/Sponsor Decision|7|||
106062588|NCT00411645|365888941|FG000|Overall Study|Lost to Follow-up|2|||
106062589|NCT00411645|365888942|FG001|Overall Study|Lost to Follow-up|0|||
106062590|NCT04118166|365888945|FG000|Overall Study|Adverse Event|1|||
106062591|NCT02288559|365888954|FG000|Overall Study|Adverse Event|1|||
106062592|NCT02288559|365888955|FG001|Overall Study|Adverse Event|1|||
106062593|NCT02288559|365888956|FG002|Overall Study|Adverse Event|5|||
106062594|NCT02288559|365888957|FG003|Overall Study|Adverse Event|0|||
106062595|NCT02288559|365888954|FG000|Overall Study|Death|0|||
106062596|NCT02288559|365888955|FG001|Overall Study|Death|0|||
106062597|NCT02288559|365888956|FG002|Overall Study|Death|1|||
106062598|NCT02288559|365888957|FG003|Overall Study|Death|0|||
106062599|NCT02288559|365888954|FG000|Overall Study|Lost to Follow-up|0|||
106062600|NCT02288559|365888955|FG001|Overall Study|Lost to Follow-up|0|||
106062601|NCT02288559|365888956|FG002|Overall Study|Lost to Follow-up|0|||
106062602|NCT02288559|365888957|FG003|Overall Study|Lost to Follow-up|1|||
106062603|NCT02288559|365888954|FG000|Overall Study|Withdrawal by Subject|0|||
106062604|NCT02288559|365888955|FG001|Overall Study|Withdrawal by Subject|0|||
106062605|NCT02288559|365888956|FG002|Overall Study|Withdrawal by Subject|2|||
106062606|NCT02288559|365888957|FG003|Overall Study|Withdrawal by Subject|1|||
106062607|NCT02288559|365888954|FG000|Overall Study|Reason Not Specified|0|||
106062608|NCT02288559|365888955|FG001|Overall Study|Reason Not Specified|0|||
106062609|NCT02288559|365888956|FG002|Overall Study|Reason Not Specified|3|||
106062610|NCT02288559|365888957|FG003|Overall Study|Reason Not Specified|0|||
106062611|NCT01402492|365888959|FG000|Overall Study|Withdrawal by Subject|17|||
106062612|NCT01402492|365888960|FG001|Overall Study|Withdrawal by Subject|11|||
106062613|NCT01402492|365888961|FG002|Overall Study|Withdrawal by Subject|11|||
106062614|NCT01402492|365888959|FG000|Overall Study|Adverse Event|2|||
106062615|NCT01402492|365888960|FG001|Overall Study|Adverse Event|3|||
106062616|NCT01402492|365888961|FG002|Overall Study|Adverse Event|4|||
106062617|NCT01402492|365888959|FG000|Overall Study|Physician Decision|0|||
106153926|NCT03398148|366223907|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
106153927|NCT03398148|366223908|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
106153928|NCT03398148|366223909|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
106153929|NCT03398148|366223910|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
106153930|NCT03398148|366223911|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
106062618|NCT01402492|365888960|FG001|Overall Study|Physician Decision|3|||
106062619|NCT01402492|365888961|FG002|Overall Study|Physician Decision|0|||
106062620|NCT01402492|365888959|FG000|Overall Study|Incarcerated (N=3)|2|||
106062621|NCT01402492|365888960|FG001|Overall Study|Incarcerated (N=3)|0|||
106062622|NCT01402492|365888961|FG002|Overall Study|Incarcerated (N=3)|1|||
106062623|NCT00673465|365888965|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062624|NCT00673465|365888966|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062625|NCT00673465|365888967|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062626|NCT00673465|365888968|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062627|NCT00673465|365888969|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
106062628|NCT00673465|365888970|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
106062629|NCT00673465|365888971|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
105864873|NCT02047734|365154737|FG001|Overall Study|Physician Decision|6|||
105864874|NCT02047734|365154738|FG002|Overall Study|Physician Decision|5|||
106062630|NCT00673465|365888972|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062631|NCT00673465|365888973|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062632|NCT00673465|365888974|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062633|NCT00673465|365888975|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062634|NCT00673465|365888976|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
106062635|NCT00673465|365888965|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062636|NCT00673465|365888966|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062637|NCT00673465|365888967|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062638|NCT00673465|365888968|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062639|NCT00673465|365888969|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
106062640|NCT00673465|365888970|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062641|NCT00673465|365888971|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062642|NCT00673465|365888972|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062643|NCT00673465|365888973|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062644|NCT00673465|365888974|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062645|NCT00673465|365888975|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062646|NCT00673465|365888976|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
106062647|NCT03944954|365888982|FG000|Overall Study|Withdrawal by Subject|22|||
106062648|NCT03944954|365888983|FG001|Overall Study|Withdrawal by Subject|4|||
106062649|NCT03944954|365888982|FG000|Overall Study|Lost to Follow-up|18|||
106062650|NCT03944954|365888983|FG001|Overall Study|Lost to Follow-up|0|||
106062651|NCT03944954|365888982|FG000|Overall Study|Failed Medical Screening|7|||
106062652|NCT03944954|365888983|FG001|Overall Study|Failed Medical Screening|0|||
106062653|NCT00371137|365888984|FG000|Overall Study|Adverse Event|20|||
106062654|NCT00371137|365888985|FG001|Overall Study|Adverse Event|35|||
106062655|NCT00371137|365888986|FG002|Overall Study|Adverse Event|42|||
106062656|NCT00371137|365888984|FG000|Overall Study|Withdrawal by Subject|11|||
106062657|NCT00371137|365888985|FG001|Overall Study|Withdrawal by Subject|10|||
106062658|NCT00371137|365888986|FG002|Overall Study|Withdrawal by Subject|15|||
106062659|NCT00371137|365888984|FG000|Overall Study|Lost to Follow-up|6|||
106062660|NCT00371137|365888985|FG001|Overall Study|Lost to Follow-up|3|||
106062661|NCT00371137|365888986|FG002|Overall Study|Lost to Follow-up|5|||
106062662|NCT00371137|365888984|FG000|Overall Study|Lack of Efficacy|30|||
106062663|NCT00371137|365888985|FG001|Overall Study|Lack of Efficacy|12|||
106062664|NCT00371137|365888986|FG002|Overall Study|Lack of Efficacy|13|||
106062665|NCT00371137|365888984|FG000|Overall Study|Sponsor Decision|2|||
106062666|NCT00371137|365888985|FG001|Overall Study|Sponsor Decision|1|||
106062667|NCT00371137|365888986|FG002|Overall Study|Sponsor Decision|2|||
106062668|NCT00371137|365888984|FG000|Overall Study|Physician Decision|1|||
106062669|NCT00371137|365888985|FG001|Overall Study|Physician Decision|1|||
106062670|NCT00371137|365888986|FG002|Overall Study|Physician Decision|1|||
106062671|NCT00371137|365888984|FG000|Overall Study|Protocol Violation|2|||
106062672|NCT00371137|365888985|FG001|Overall Study|Protocol Violation|1|||
106062673|NCT00371137|365888986|FG002|Overall Study|Protocol Violation|1|||
106062674|NCT03798483|365888987|FG000|Overall Study|Lost to Follow-up|2|||
106062675|NCT02643082|365888988|FG000|Period 1|Adverse Event|1|||
106062676|NCT02643082|365888989|FG001|Period 1|Adverse Event|0|||
106062677|NCT00276744|365888990|FG000|PART A|Reason unknown|98|||
106062678|NCT02725710|365888994|FG000|Overall Study|Lost to Follow-up|1|||
106062679|NCT02725710|365888995|FG001|Overall Study|Lost to Follow-up|0|||
106062680|NCT01666782|365888998|FG000|Overall Study|Received 2 doses of vaccine|0|||
106062681|NCT01666782|365888999|FG001|Overall Study|Received 2 doses of vaccine|1|||
106062682|NCT01666782|365888998|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
106062683|NCT01666782|365888999|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
106062684|NCT01691781|365889019|FG000|Overall Study|Withdrawal by Subject|4|||
106062685|NCT01691781|365889020|FG001|Overall Study|Withdrawal by Subject|3|||
106062686|NCT01691781|365889019|FG000|Overall Study|Physician Decision|1|||
106062687|NCT01691781|365889020|FG001|Overall Study|Physician Decision|1|||
106062688|NCT01691781|365889019|FG000|Overall Study|Protocol Violation|2|||
106062689|NCT01691781|365889020|FG001|Overall Study|Protocol Violation|2|||
106062690|NCT01691781|365889019|FG000|Overall Study|Adverse Event|0|||
106062691|NCT01691781|365889020|FG001|Overall Study|Adverse Event|1|||
106062692|NCT03978520|365889021|FG000|Overall Study|Adverse Event|2|||
106062693|NCT03978520|365889022|FG001|Overall Study|Adverse Event|5|||
106062694|NCT03978520|365889023|FG002|Overall Study|Adverse Event|3|||
106062695|NCT03978520|365889024|FG003|Overall Study|Adverse Event|5|||
106062696|NCT03978520|365889025|FG004|Overall Study|Adverse Event|6|||
105864875|NCT02047734|365154736|FG000|Overall Study|Miscellaneous|2|||
106062697|NCT03978520|365889021|FG000|Overall Study|Withdrawal by Subject|10|||
106062698|NCT03978520|365889022|FG001|Overall Study|Withdrawal by Subject|4|||
106062699|NCT03978520|365889023|FG002|Overall Study|Withdrawal by Subject|5|||
106062700|NCT03978520|365889024|FG003|Overall Study|Withdrawal by Subject|6|||
106062701|NCT03978520|365889025|FG004|Overall Study|Withdrawal by Subject|5|||
106062702|NCT03978520|365889021|FG000|Overall Study|Lost to Follow-up|2|||
106062703|NCT03978520|365889022|FG001|Overall Study|Lost to Follow-up|2|||
106062704|NCT03978520|365889023|FG002|Overall Study|Lost to Follow-up|2|||
106062705|NCT03978520|365889024|FG003|Overall Study|Lost to Follow-up|0|||
106062706|NCT03978520|365889025|FG004|Overall Study|Lost to Follow-up|1|||
106062707|NCT03978520|365889021|FG000|Overall Study|COVID-19 infection|0|||
106062708|NCT03978520|365889022|FG001|Overall Study|COVID-19 infection|1|||
106062709|NCT03978520|365889023|FG002|Overall Study|COVID-19 infection|0|||
106062710|NCT03978520|365889024|FG003|Overall Study|COVID-19 infection|0|||
106062711|NCT03978520|365889025|FG004|Overall Study|COVID-19 infection|0|||
106062712|NCT03978520|365889021|FG000|Overall Study|Other, not specified|9|||
106062713|NCT03978520|365889022|FG001|Overall Study|Other, not specified|4|||
106062714|NCT03978520|365889023|FG002|Overall Study|Other, not specified|1|||
106062715|NCT03978520|365889024|FG003|Overall Study|Other, not specified|1|||
106062716|NCT03978520|365889025|FG004|Overall Study|Other, not specified|2|||
106062717|NCT03978520|365889021|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
106062718|NCT03978520|365889022|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
106062719|NCT03978520|365889023|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
106062720|NCT03978520|365889024|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
106062721|NCT03978520|365889025|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
106062722|NCT00230607|365889026|FG000|Overall Study|Other|3|||
106062723|NCT01927367|365889029|FG000|Overall Study|Withdrawal by Subject|7|||
106062724|NCT01927367|365889030|FG001|Overall Study|Withdrawal by Subject|4|||
106062725|NCT01927367|365889029|FG000|Overall Study|No baseline data|0|||
106062726|NCT01927367|365889030|FG001|Overall Study|No baseline data|1|||
106062727|NCT00598832|365889031|FG000|Overall Study|Lack of Efficacy|3|||
106062728|NCT00598832|365889032|FG001|Overall Study|Lack of Efficacy|7|||
106062729|NCT00598832|365889031|FG000|Overall Study|Adverse Event|6|||
106062730|NCT00598832|365889032|FG001|Overall Study|Adverse Event|2|||
106062731|NCT00598832|365889031|FG000|Overall Study|Withdrawal by Subject|25|||
106062732|NCT00598832|365889032|FG001|Overall Study|Withdrawal by Subject|36|||
106062733|NCT00598832|365889031|FG000|Overall Study|Protocol Violation|0|||
106062734|NCT00598832|365889032|FG001|Overall Study|Protocol Violation|2|||
106062735|NCT00598832|365889031|FG000|Overall Study|Lost to Follow-up|24|||
106062736|NCT00598832|365889032|FG001|Overall Study|Lost to Follow-up|29|||
106062737|NCT00598832|365889031|FG000|Overall Study|Pregnancy|2|||
106062738|NCT00598832|365889032|FG001|Overall Study|Pregnancy|2|||
106062739|NCT00598832|365889031|FG000|Overall Study|Physician Decision|1|||
106062740|NCT00598832|365889032|FG001|Overall Study|Physician Decision|4|||
106062741|NCT00598832|365889031|FG000|Overall Study|Non compliance|1|||
106062742|NCT00598832|365889032|FG001|Overall Study|Non compliance|0|||
106062743|NCT03547687|365889034|FG000|Overall Study|Withdrawal by Subject|1|||
106062744|NCT03547687|365889034|FG000|Overall Study|Death|1|||
106062745|NCT00646776|365889037|FG000|Overall Study|Adverse Event|1|||
106062746|NCT00646776|365889038|FG001|Overall Study|Adverse Event|9|||
106062747|NCT00646776|365889037|FG000|Overall Study|Investigator discretion|0|||
106062748|NCT00646776|365889038|FG001|Overall Study|Investigator discretion|4|||
106062749|NCT00126568|365889041|FG000|Overall Study|Death|2|||
106062750|NCT02260921|365889043|FG000|Overall Study|Adverse Event|1|||
106062751|NCT02260921|365889044|FG001|Overall Study|Adverse Event|0|||
106062752|NCT02260921|365889043|FG000|Overall Study|Lost to Follow-up|4|||
106062753|NCT02260921|365889044|FG001|Overall Study|Lost to Follow-up|3|||
106062754|NCT02260921|365889043|FG000|Overall Study|Withdraw Consent|4|||
106062755|NCT02260921|365889044|FG001|Overall Study|Withdraw Consent|1|||
106062756|NCT02260921|365889043|FG000|Overall Study|Death|1|||
106062757|NCT02260921|365889044|FG001|Overall Study|Death|0|||
106062758|NCT02260921|365889043|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
106062759|NCT02260921|365889044|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
106062760|NCT01244425|365889045|FG000|Overall Study|Withdrawal by Subject|2|||
106062761|NCT01244425|365889046|FG001|Overall Study|Withdrawal by Subject|2|||
106062762|NCT01244425|365889045|FG000|Overall Study|Adverse Event|1|||
106062763|NCT01244425|365889046|FG001|Overall Study|Adverse Event|1|||
106062764|NCT01482884|365889049|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
106062765|NCT01482884|365889050|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
106062766|NCT01482884|365889049|FG000|Overall Study|Protocol Violation|1|||
106062767|NCT01482884|365889050|FG001|Overall Study|Protocol Violation|0|||
106062768|NCT01482884|365889049|FG000|Overall Study|Lost to Follow-up|2|||
106062769|NCT01482884|365889050|FG001|Overall Study|Lost to Follow-up|2|||
106062770|NCT01482884|365889049|FG000|Overall Study|Lack of Efficacy|0|||
106062771|NCT01482884|365889050|FG001|Overall Study|Lack of Efficacy|1|||
106062772|NCT01482884|365889049|FG000|Overall Study|Adverse Event|2|||
106062773|NCT01482884|365889050|FG001|Overall Study|Adverse Event|1|||
106062774|NCT01482884|365889049|FG000|Overall Study|Withdrawal by Subject|8|||
106062775|NCT01482884|365889050|FG001|Overall Study|Withdrawal by Subject|13|||
106062776|NCT04203238|365890607|FG000|Overall Study|Withdrawal by Subject|1|||
106062777|NCT04203238|365890608|FG001|Overall Study|Withdrawal by Subject|1|||
106062778|NCT04203238|365890607|FG000|Overall Study|Covid-19|3|||
106062779|NCT04203238|365890608|FG001|Overall Study|Covid-19|0|||
106062780|NCT01955733|365890609|FG000|Period 1|Lost to Follow-up|1|||
106062781|NCT01955733|365890610|FG001|Period 1|Lost to Follow-up|0|||
106062782|NCT01955733|365890611|FG002|Period 1|Lost to Follow-up|0|||
106062783|NCT01955733|365890609|FG000|Period 2|Adverse Event|1|||
106062784|NCT01955733|365890610|FG001|Period 2|Adverse Event|0|||
106062785|NCT01955733|365890611|FG002|Period 2|Adverse Event|0|||
106062786|NCT01955733|365890609|FG000|Period 2|Physician Decision|0|||
106062787|NCT01955733|365890610|FG001|Period 2|Physician Decision|0|||
106062788|NCT01955733|365890611|FG002|Period 2|Physician Decision|1|||
106062789|NCT01955733|365890609|FG000|Period 2|Withdrawal by Subject|1|||
106062790|NCT01955733|365890610|FG001|Period 2|Withdrawal by Subject|3|||
106062791|NCT01955733|365890611|FG002|Period 2|Withdrawal by Subject|2|||
106062792|NCT01955733|365890609|FG000|Period 2|Study terminated by sponsor|8|||
106062793|NCT01955733|365890610|FG001|Period 2|Study terminated by sponsor|14|||
106062794|NCT01955733|365890611|FG002|Period 2|Study terminated by sponsor|16|||
106062795|NCT01955733|365890609|FG000|Period 2|Lost to Follow-up|2|||
106062796|NCT01955733|365890610|FG001|Period 2|Lost to Follow-up|0|||
106062797|NCT01955733|365890611|FG002|Period 2|Lost to Follow-up|0|||
106062798|NCT01955733|365890609|FG000|Period 2|Other not defined above|0|||
106062799|NCT01955733|365890610|FG001|Period 2|Other not defined above|2|||
106062800|NCT01955733|365890611|FG002|Period 2|Other not defined above|2|||
106062801|NCT01134783|365890612|FG000|Overall Study|Pregnancy|16|||
106062802|NCT01134783|365890613|FG001|Overall Study|Pregnancy|8|||
106062803|NCT01134783|365890612|FG000|Overall Study|Withdrawal by Subject|15|||
106062804|NCT01134783|365890613|FG001|Overall Study|Withdrawal by Subject|9|||
106062805|NCT01134783|365890612|FG000|Overall Study|Lost to Follow-up|5|||
106062806|NCT01134783|365890613|FG001|Overall Study|Lost to Follow-up|20|||
106062807|NCT04221009|365890614|FG000|Overall Study|Withdrawal by Subject|4|||
106062808|NCT00793598|365890615|FG000|Overall Study|Patient Request|0|||
106062809|NCT00793598|365890616|FG001|Overall Study|Patient Request|1|||
106062810|NCT00793598|365890617|FG002|Overall Study|Patient Request|0|||
106062811|NCT00793598|365890618|FG003|Overall Study|Patient Request|0|||
106062812|NCT00793598|365890619|FG004|Overall Study|Patient Request|0|||
106062813|NCT00793598|365890620|FG005|Overall Study|Patient Request|0|||
106062814|NCT00793598|365890621|FG006|Overall Study|Patient Request|0|||
106062815|NCT00793598|365890622|FG007|Overall Study|Patient Request|0|||
106062816|NCT00793598|365890615|FG000|Overall Study|Protocol Violation|0|||
106062817|NCT00793598|365890616|FG001|Overall Study|Protocol Violation|0|||
106062818|NCT00793598|365890617|FG002|Overall Study|Protocol Violation|0|||
106062819|NCT00793598|365890618|FG003|Overall Study|Protocol Violation|0|||
106062820|NCT00793598|365890619|FG004|Overall Study|Protocol Violation|0|||
106062821|NCT00793598|365890620|FG005|Overall Study|Protocol Violation|0|||
106062822|NCT00793598|365890621|FG006|Overall Study|Protocol Violation|0|||
106062823|NCT00793598|365890622|FG007|Overall Study|Protocol Violation|1|||
106062824|NCT00793598|365890615|FG000|Overall Study|Subject not dosed|0|||
106062825|NCT00793598|365890616|FG001|Overall Study|Subject not dosed|0|||
106062826|NCT00793598|365890617|FG002|Overall Study|Subject not dosed|0|||
106062827|NCT00793598|365890618|FG003|Overall Study|Subject not dosed|0|||
106062828|NCT00793598|365890619|FG004|Overall Study|Subject not dosed|0|||
106062829|NCT00793598|365890620|FG005|Overall Study|Subject not dosed|1|||
106062830|NCT00793598|365890621|FG006|Overall Study|Subject not dosed|0|||
106062831|NCT00793598|365890622|FG007|Overall Study|Subject not dosed|0|||
106062832|NCT01438424|365890623|FG000|Overall Study|Continuing treatment|29|||
106062833|NCT01438424|365890623|FG000|Overall Study|Minimal virologic response|95|||
106062834|NCT01438424|365890623|FG000|Overall Study|Not identified|55|||
106062835|NCT01438424|365890623|FG000|Overall Study|Withdrawal by Subject|104|||
106062836|NCT01438424|365890623|FG000|Overall Study|Progression of chronic hepatitis B|22|||
106062837|NCT01438424|365890623|FG000|Overall Study|Death|22|||
106062838|NCT01438424|365890623|FG000|Overall Study|Adverse Event|17|||
106062839|NCT01438424|365890623|FG000|Overall Study|Lost to Follow-up|17|||
106062840|NCT01438424|365890623|FG000|Overall Study|Abnormal laboratory test result|14|||
106062841|NCT01438424|365890623|FG000|Overall Study|Need for drug prohibited by protocol|14|||
106062842|NCT01438424|365890623|FG000|Overall Study|Pregnancy|7|||
106062843|NCT01438424|365890623|FG000|Overall Study|No longer met inclusion criteria|1|||
106062844|NCT01438424|365890623|FG000|Overall Study|Participant noncompliance|20|||
106062845|NCT04232124|365890624|FG000|Overall Study|Lost to Follow-up|3|||
106062846|NCT02329730|365890630|FG000|Overall Study|Protocol Violation|0|||
106062847|NCT02329730|365890631|FG001|Overall Study|Protocol Violation|0|||
106062848|NCT02329730|365890632|FG002|Overall Study|Protocol Violation|0|||
106062849|NCT02329730|365890633|FG003|Overall Study|Protocol Violation|0|||
106062850|NCT02329730|365890634|FG004|Overall Study|Protocol Violation|2|||
106062851|NCT02329730|365890635|FG005|Overall Study|Protocol Violation|2|||
106062852|NCT02329730|365890636|FG006|Overall Study|Protocol Violation|0|||
106062853|NCT02329730|365890637|FG007|Overall Study|Protocol Violation|0|||
106062854|NCT02329730|365890638|FG008|Overall Study|Protocol Violation|0|||
106062855|NCT02329730|365890639|FG009|Overall Study|Protocol Violation|0|||
106062856|NCT02329730|365890640|FG010|Overall Study|Protocol Violation|0|||
106062857|NCT02329730|365890641|FG011|Overall Study|Protocol Violation|0|||
106062858|NCT02329730|365890630|FG000|Overall Study|Withdrawal by Subject|0|||
106062859|NCT02329730|365890631|FG001|Overall Study|Withdrawal by Subject|0|||
106153931|NCT03398148|366223912|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
106153932|NCT03398148|366223913|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
106153933|NCT03398148|366223914|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
106153934|NCT03398148|366223915|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
106153935|NCT03398148|366223916|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
106153936|NCT03398148|366223917|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
106153937|NCT03398148|366223903|FG000|Substudy 2 Period 2|Other|0|||
106153938|NCT03398148|366223904|FG001|Substudy 2 Period 2|Other|0|||
106153939|NCT03398148|366223905|FG002|Substudy 2 Period 2|Other|0|||
106153940|NCT03398148|366223906|FG003|Substudy 2 Period 2|Other|0|||
106153941|NCT03398148|366223907|FG004|Substudy 2 Period 2|Other|0|||
106153942|NCT03398148|366223908|FG005|Substudy 2 Period 2|Other|0|||
106153943|NCT03398148|366223909|FG006|Substudy 2 Period 2|Other|0|||
106153944|NCT03398148|366223910|FG007|Substudy 2 Period 2|Other|0|||
106153945|NCT03398148|366223911|FG008|Substudy 2 Period 2|Other|0|||
106153946|NCT03398148|366223912|FG009|Substudy 2 Period 2|Other|0|||
105864876|NCT02047734|365154737|FG001|Overall Study|Miscellaneous|4|||
106062860|NCT02329730|365890632|FG002|Overall Study|Withdrawal by Subject|0|||
106062861|NCT02329730|365890633|FG003|Overall Study|Withdrawal by Subject|0|||
106062862|NCT02329730|365890634|FG004|Overall Study|Withdrawal by Subject|1|||
106062863|NCT02329730|365890635|FG005|Overall Study|Withdrawal by Subject|0|||
106062864|NCT02329730|365890636|FG006|Overall Study|Withdrawal by Subject|1|||
106062865|NCT02329730|365890637|FG007|Overall Study|Withdrawal by Subject|1|||
106062866|NCT02329730|365890638|FG008|Overall Study|Withdrawal by Subject|1|||
106062867|NCT02329730|365890639|FG009|Overall Study|Withdrawal by Subject|1|||
106062868|NCT02329730|365890640|FG010|Overall Study|Withdrawal by Subject|0|||
106062869|NCT02329730|365890641|FG011|Overall Study|Withdrawal by Subject|0|||
106062870|NCT02154490|365890642|FG000|Overall Study|No tissue submitted|23|||
106062871|NCT02154490|365890642|FG000|Overall Study|No biomarker results|167|||
106062872|NCT02154490|365890642|FG000|Overall Study|Not assigned to a sub-study|270|||
106062873|NCT02154490|365890642|FG000|Overall Study|Did not register to a sub-study|749|||
106062874|NCT02057406|365890643|FG000|Overall Study|Physician Decision|0|||
106062875|NCT02057406|365890644|FG001|Overall Study|Physician Decision|0|||
106062876|NCT02057406|365890645|FG002|Overall Study|Physician Decision|2|||
106062877|NCT02057406|365890643|FG000|Overall Study|Withdrawal by Subject|0|||
106062878|NCT02057406|365890644|FG001|Overall Study|Withdrawal by Subject|2|||
106062879|NCT02057406|365890645|FG002|Overall Study|Withdrawal by Subject|0|||
106062880|NCT02057406|365890643|FG000|Overall Study|Lost to Follow-up|0|||
106062881|NCT02057406|365890644|FG001|Overall Study|Lost to Follow-up|0|||
106062882|NCT02057406|365890645|FG002|Overall Study|Lost to Follow-up|1|||
105864877|NCT02047734|365154738|FG002|Overall Study|Miscellaneous|6|||
106062883|NCT02057406|365890643|FG000|Overall Study|Death|1|||
106062884|NCT02057406|365890644|FG001|Overall Study|Death|0|||
106062885|NCT02057406|365890645|FG002|Overall Study|Death|0|||
106153947|NCT03398148|366223913|FG010|Substudy 2 Period 2|Other|0|||
105864878|NCT02047734|365154736|FG000|Overall Study|Did Not Receive Study Drug|2|||
105864879|NCT02047734|365154737|FG001|Overall Study|Did Not Receive Study Drug|4|||
105864880|NCT02047734|365154738|FG002|Overall Study|Did Not Receive Study Drug|1|||
105864881|NCT01174043|365154740|FG000|Overall Study|Disease progression|5|||
105864882|NCT01174043|365154740|FG000|Overall Study|Adverse Event|3|||
105864883|NCT01174043|365154740|FG000|Overall Study|Death|1|||
105864884|NCT01174043|365154740|FG000|Overall Study|Withdrawal by Subject|2|||
105864885|NCT00799825|365154741|FG000|Overall Study|Adverse Event|1|||
105864886|NCT00799825|365154741|FG000|Overall Study|Withdrawal by Subject|6|||
105864887|NCT00799825|365154741|FG000|Overall Study|Lost to Follow-up|38|||
105864888|NCT00799825|365154741|FG000|Overall Study|Pregnancy|3|||
105864889|NCT01085357|365154742|FG000|Overall Study|Adverse Event|1|||
105864890|NCT01085357|365154743|FG001|Overall Study|Adverse Event|1|||
105864891|NCT01085357|365154742|FG000|Overall Study|Subject Decision|4|||
105864892|NCT01085357|365154743|FG001|Overall Study|Subject Decision|3|||
105864893|NCT01085357|365154742|FG000|Overall Study|Investigator Decision|1|||
105864894|NCT01085357|365154743|FG001|Overall Study|Investigator Decision|1|||
105864895|NCT01085357|365154742|FG000|Overall Study|Death|11|||
105864896|NCT01085357|365154743|FG001|Overall Study|Death|1|||
105864897|NCT01085357|365154742|FG000|Overall Study|Lost to Follow-up|2|||
105864898|NCT01085357|365154743|FG001|Overall Study|Lost to Follow-up|0|||
105864899|NCT02439970|365154751|FG000|Overall Study|Study Terminated|2|||
105864900|NCT02439970|365154752|FG001|Overall Study|Study Terminated|3|||
106062886|NCT02057406|365890643|FG000|Overall Study|Protocol Violation|0|||
106062887|NCT02057406|365890644|FG001|Overall Study|Protocol Violation|1|||
106062888|NCT02057406|365890645|FG002|Overall Study|Protocol Violation|0|||
106062889|NCT02057406|365890643|FG000|Overall Study|Patient transportation issues|0|||
106062890|NCT02057406|365890644|FG001|Overall Study|Patient transportation issues|0|||
106153948|NCT03398148|366223914|FG011|Substudy 2 Period 2|Other|0|||
106153949|NCT03398148|366223915|FG012|Substudy 2 Period 2|Other|0|||
105864901|NCT01520870|365154753|FG000|Overall Study|Withdrawal by Subject|2|||
105864902|NCT02289456|365154754|FG000|Induction Period|Death|2|||
105864903|NCT02289456|365154754|FG000|Induction Period|Adverse Event|11|||
105864904|NCT02289456|365154754|FG000|Induction Period|Progressive Disease (PD)|4|||
106153950|NCT03398148|366223916|FG013|Substudy 2 Period 2|Other|1|||
106062891|NCT02057406|365890645|FG002|Overall Study|Patient transportation issues|1|||
106062892|NCT03824912|365890651|FG000|Overall Study|Lost to Follow-up|18|||
106062893|NCT03824912|365890652|FG001|Overall Study|Lost to Follow-up|15|||
106062894|NCT03824912|365890653|FG002|Overall Study|Lost to Follow-up|8|||
106062895|NCT03824912|365890651|FG000|Overall Study|Negative Baseline Culture Result|118|||
106062896|NCT03824912|365890652|FG001|Overall Study|Negative Baseline Culture Result|112|||
106062897|NCT03824912|365890653|FG002|Overall Study|Negative Baseline Culture Result|57|||
106062898|NCT03824912|365890651|FG000|Overall Study|Non-Compliance with Study Drug|0|||
106062899|NCT03824912|365890652|FG001|Overall Study|Non-Compliance with Study Drug|0|||
106062900|NCT03824912|365890653|FG002|Overall Study|Non-Compliance with Study Drug|1|||
106062901|NCT03824912|365890651|FG000|Overall Study|Protocol Violation|1|||
106062902|NCT03824912|365890652|FG001|Overall Study|Protocol Violation|4|||
106062903|NCT03824912|365890653|FG002|Overall Study|Protocol Violation|1|||
106062904|NCT03824912|365890651|FG000|Overall Study|Withdrawal by Subject|3|||
106062905|NCT03824912|365890652|FG001|Overall Study|Withdrawal by Subject|2|||
106062906|NCT03824912|365890653|FG002|Overall Study|Withdrawal by Subject|1|||
106062907|NCT03824912|365890651|FG000|Overall Study|Participation in another study|0|||
106062908|NCT03824912|365890652|FG001|Overall Study|Participation in another study|1|||
106062909|NCT03824912|365890653|FG002|Overall Study|Participation in another study|0|||
106062910|NCT04876274|365890654|FG000|Overall Study|Lost to Follow-up|9|||
106062911|NCT04876274|365890655|FG001|Overall Study|Lost to Follow-up|12|||
106062912|NCT03454893|365890656|FG000|Overall Study|Study Terminated by the Sponsor|5|||
106062913|NCT03454893|365890656|FG000|Overall Study|Did not pass screening|4|||
106062914|NCT01986985|365890662|FG000|Overall Study|Withdrawal by Subject|4|||
106062915|NCT01986985|365890662|FG000|Overall Study|Scan not completed due to malfunction|3|||
106062916|NCT04326231|365890663|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
106062917|NCT03303079|365890664|FG000|Overall Study|Adverse Event|0|||
106062918|NCT03303079|365890665|FG001|Overall Study|Adverse Event|1|||
106062919|NCT03303079|365890666|FG002|Overall Study|Adverse Event|3|||
106062920|NCT03303079|365890664|FG000|Overall Study|Protocol Violation|5|||
106062921|NCT03303079|365890665|FG001|Overall Study|Protocol Violation|4|||
106062922|NCT03303079|365890666|FG002|Overall Study|Protocol Violation|7|||
106062923|NCT03303079|365890664|FG000|Overall Study|Withdrawal by Subject|2|||
106062924|NCT03303079|365890665|FG001|Overall Study|Withdrawal by Subject|4|||
106062925|NCT03303079|365890666|FG002|Overall Study|Withdrawal by Subject|2|||
106062926|NCT03303079|365890664|FG000|Overall Study|Other than specified|0|||
106062927|NCT03303079|365890665|FG001|Overall Study|Other than specified|2|||
106062928|NCT03303079|365890666|FG002|Overall Study|Other than specified|0|||
106062929|NCT01314443|365890667|FG000|Overall Study|Withdrawal by Subject|2|||
106062930|NCT01314443|365890668|FG001|Overall Study|Withdrawal by Subject|1|||
106062931|NCT01314443|365890669|FG002|Overall Study|Withdrawal by Subject|1|||
106062932|NCT01314443|365890670|FG003|Overall Study|Withdrawal by Subject|1|||
106062933|NCT01314443|365890667|FG000|Overall Study|Protocol Violation|2|||
106062934|NCT01314443|365890668|FG001|Overall Study|Protocol Violation|2|||
106062935|NCT01314443|365890669|FG002|Overall Study|Protocol Violation|1|||
106062936|NCT01314443|365890670|FG003|Overall Study|Protocol Violation|1|||
106062937|NCT00449540|365890672|FG000|Pretreatment Phase|No migraine experienced|66|||
106062938|NCT00449540|365890673|FG001|Pretreatment Phase|No migraine experienced|0|||
106062939|NCT00449540|365890674|FG002|Pretreatment Phase|No migraine experienced|0|||
106062940|NCT00449540|365890672|FG000|Treatment Phase|did not experience or treat migraine|0|||
106062941|NCT00449540|365890673|FG001|Treatment Phase|did not experience or treat migraine|20|||
106062942|NCT00449540|365890674|FG002|Treatment Phase|did not experience or treat migraine|17|||
106062943|NCT00759954|365890680|FG000|Overall Study|Personal reason|1|||
106062944|NCT00759954|365890681|FG001|Overall Study|Personal reason|0|||
106062945|NCT00759954|365890680|FG000|Overall Study|Adverse Event|1|||
106062946|NCT00759954|365890681|FG001|Overall Study|Adverse Event|2|||
106062947|NCT02551731|365890684|FG000|Overall Study|Withdrawal by Subject|2|||
106062948|NCT01750242|365890685|FG000|Overall Study|Unreadable Images|3|||
106062949|NCT02069366|365890686|FG000|Overall Study|Lost to Follow-up|0|||
106062950|NCT02069366|365890687|FG001|Overall Study|Lost to Follow-up|0|||
106062951|NCT02069366|365890688|FG002|Overall Study|Lost to Follow-up|1|||
106062952|NCT02069366|365890689|FG003|Overall Study|Lost to Follow-up|0|||
106062953|NCT02069366|365890690|FG004|Overall Study|Lost to Follow-up|0|||
106062954|NCT02069366|365890691|FG005|Overall Study|Lost to Follow-up|2|||
106062955|NCT02069366|365890686|FG000|Overall Study|Protocol Violation|0|||
106062956|NCT02069366|365890687|FG001|Overall Study|Protocol Violation|0|||
106062957|NCT02069366|365890688|FG002|Overall Study|Protocol Violation|1|||
106062958|NCT02069366|365890689|FG003|Overall Study|Protocol Violation|0|||
106062959|NCT02069366|365890690|FG004|Overall Study|Protocol Violation|0|||
106062960|NCT02069366|365890691|FG005|Overall Study|Protocol Violation|0|||
106062961|NCT02069366|365890686|FG000|Overall Study|Withdrawal by Subject|1|||
106062962|NCT02069366|365890687|FG001|Overall Study|Withdrawal by Subject|0|||
106062963|NCT02069366|365890688|FG002|Overall Study|Withdrawal by Subject|1|||
106062964|NCT02069366|365890689|FG003|Overall Study|Withdrawal by Subject|2|||
106062965|NCT02069366|365890690|FG004|Overall Study|Withdrawal by Subject|0|||
106062966|NCT02069366|365890691|FG005|Overall Study|Withdrawal by Subject|0|||
106062967|NCT04649060|365890699|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
106062968|NCT04649060|365890700|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
106062969|NCT04649060|365890699|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
106062970|NCT04649060|365890700|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
106062971|NCT04649060|365890699|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
106062972|NCT04649060|365890700|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
106062973|NCT04649060|365890699|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
106062974|NCT04649060|365890700|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
106062975|NCT04649060|365890699|FG000|Arm A/Arm B Treatment|Patient Request|1|||
106062976|NCT04649060|365890700|FG001|Arm A/Arm B Treatment|Patient Request|0|||
106062977|NCT04649060|365890699|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
106062978|NCT04649060|365890700|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
106062979|NCT04649060|365890699|FG000|Arm A/Arm B Treatment|Other|1|||
105864905|NCT02289456|365154754|FG000|Induction Period|Symptomatic Deterioration|4|||
105864906|NCT02289456|365154754|FG000|Induction Period|Withdrawal by Subject|2|||
106062980|NCT04649060|365890700|FG001|Arm A/Arm B Treatment|Other|0|||
106062981|NCT04649060|365890699|FG000|Crossover (Arm B)|Adverse Event|0|||
106062982|NCT04649060|365890700|FG001|Crossover (Arm B)|Adverse Event|1|||
106062983|NCT04649060|365890699|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
106062984|NCT04649060|365890700|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
106062985|NCT02706691|365890701|FG000|Overall Study|Adverse Event|1|||
106062986|NCT03033394|365890702|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
106062987|NCT03033394|365890702|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
106062988|NCT03033394|365890702|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
106062989|NCT03033394|365890702|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
106062990|NCT03033394|365890702|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
106062991|NCT03167411|365890703|FG000|Overall Study|Adverse Event|0|||
106062992|NCT03167411|365890704|FG001|Overall Study|Adverse Event|1|||
106062993|NCT01830972|365890708|FG000|Part II|Withdrawal by Subject|2|||
106062994|NCT01830972|365890709|FG001|Part II|Withdrawal by Subject|2|||
106062995|NCT01830972|365890708|FG000|Part III|Withdrawal by Subject|1|||
106062996|NCT01830972|365890709|FG001|Part III|Withdrawal by Subject|0|||
106062997|NCT01830972|365890708|FG000|Part III|Noncompliance|1|||
106062998|NCT01830972|365890709|FG001|Part III|Noncompliance|0|||
106062999|NCT01830972|365890708|FG000|Part IV|Withdrawal by Subject|2|||
106063000|NCT01830972|365890709|FG001|Part IV|Withdrawal by Subject|1|||
106063001|NCT01830972|365890708|FG000|Part IV|Non-Compliance|1|||
106063002|NCT01830972|365890709|FG001|Part IV|Non-Compliance|0|||
106063003|NCT02117648|365890710|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
106063004|NCT02117648|365890710|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
106063005|NCT02117648|365890710|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
106063006|NCT02117648|365890710|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
106063007|NCT02117648|365890710|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
106063008|NCT02117648|365890710|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
106063009|NCT02117648|365890710|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
106063010|NCT02117648|365890710|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
106063011|NCT02117648|365890710|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
106063012|NCT02117648|365890710|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
106063013|NCT02117648|365890710|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
106063014|NCT01426373|365890711|FG000|Overall Study|Adverse Event|6|||
106063015|NCT01426373|365890711|FG000|Overall Study|Lost to Follow-up|14|||
106063016|NCT01426373|365890711|FG000|Overall Study|Participant Convenience|10|||
106063017|NCT01426373|365890711|FG000|Overall Study|Miscellaneous Reasons|4|||
106063018|NCT00587639|365890712|FG000|Overall Study|Withdrawal by Subject|1|||
106063019|NCT04997161|365890721|FG000|Overall Study|Study terminated by sponsor|3|||
106063020|NCT04502589|365890722|FG000|Overall Study|Physician Decision|1|||
106063021|NCT04502589|365890723|FG001|Overall Study|Physician Decision|0|||
106063022|NCT02532972|365890724|FG000|Overall Study|Withdrawal by Subject|1|||
106063023|NCT01417234|365890727|FG000|Overall Study|Subject non-compliant|3|||
106063024|NCT00023764|365890728|FG000|Overall Study|Other|1|||
106063025|NCT00023764|365890728|FG000|Overall Study|Adverse Event|4|||
106063026|NCT00023764|365890728|FG000|Overall Study|Withdrawal by Subject|1|||
106063027|NCT00023764|365890728|FG000|Overall Study|Progression of disease|6|||
106063028|NCT00023764|365890728|FG000|Overall Study|patient received other treatment|1|||
106063029|NCT00023764|365890728|FG000|Overall Study|delay in obtaining staging images|1|||
105864907|NCT02289456|365154754|FG000|Induction Period|Miscellaneous|1|||
106063030|NCT02407704|365890733|FG000|Overall Study|Lost to Follow-up|0|||
106063031|NCT02407704|365890734|FG001|Overall Study|Lost to Follow-up|0|||
106063032|NCT02407704|365890735|FG002|Overall Study|Lost to Follow-up|0|||
106063033|NCT02407704|365890736|FG003|Overall Study|Lost to Follow-up|2|||
106063034|NCT02407704|365890733|FG000|Overall Study|Protocol Violation|0|||
106063035|NCT02407704|365890734|FG001|Overall Study|Protocol Violation|0|||
106063036|NCT02407704|365890735|FG002|Overall Study|Protocol Violation|0|||
106063037|NCT02407704|365890736|FG003|Overall Study|Protocol Violation|1|||
106063038|NCT02407704|365890733|FG000|Overall Study|Withdrawal by Subject|0|||
106063039|NCT02407704|365890734|FG001|Overall Study|Withdrawal by Subject|0|||
106063040|NCT02407704|365890735|FG002|Overall Study|Withdrawal by Subject|1|||
106063041|NCT02407704|365890736|FG003|Overall Study|Withdrawal by Subject|0|||
106063042|NCT02730455|365890740|FG000|Overall Study|Death|5|||
106063043|NCT02730455|365890741|FG001|Overall Study|Death|6|||
106063044|NCT02730455|365890742|FG002|Overall Study|Death|4|||
106063045|NCT02730455|365890740|FG000|Overall Study|Consent withdrawn|2|||
106063046|NCT02730455|365890741|FG001|Overall Study|Consent withdrawn|4|||
106063047|NCT02730455|365890742|FG002|Overall Study|Consent withdrawn|1|||
106063048|NCT02730455|365890740|FG000|Overall Study|Lost to Follow-up|3|||
106063049|NCT02730455|365890741|FG001|Overall Study|Lost to Follow-up|1|||
106063050|NCT02730455|365890742|FG002|Overall Study|Lost to Follow-up|4|||
106063051|NCT02730455|365890740|FG000|Overall Study|Other|1|||
106063052|NCT02730455|365890741|FG001|Overall Study|Other|1|||
106063053|NCT02730455|365890742|FG002|Overall Study|Other|2|||
106063054|NCT02730455|365890740|FG000|Overall Study|Other|2|||
106063055|NCT02730455|365890741|FG001|Overall Study|Other|2|||
106063056|NCT02730455|365890742|FG002|Overall Study|Other|0|||
106063057|NCT05227027|365890749|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
106063058|NCT05227027|365890750|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
106063059|NCT01018186|365890751|FG000|2-week Run-in Period|Protocol Violation|1|||
106063060|NCT01018186|365890752|FG001|2-week Run-in Period|Protocol Violation|0|||
106063061|NCT01018186|365890753|FG002|2-week Run-in Period|Protocol Violation|0|||
106063062|NCT01018186|365890754|FG003|2-week Run-in Period|Protocol Violation|0|||
106063063|NCT01018186|365890751|FG000|2-week Run-in Period|Lost to Follow-up|2|||
106063064|NCT01018186|365890752|FG001|2-week Run-in Period|Lost to Follow-up|0|||
106063065|NCT01018186|365890753|FG002|2-week Run-in Period|Lost to Follow-up|0|||
106063066|NCT01018186|365890754|FG003|2-week Run-in Period|Lost to Follow-up|0|||
106063067|NCT01018186|365890751|FG000|2-week Run-in Period|Physician Decision|3|||
106063068|NCT01018186|365890752|FG001|2-week Run-in Period|Physician Decision|0|||
106063069|NCT01018186|365890753|FG002|2-week Run-in Period|Physician Decision|0|||
106063070|NCT01018186|365890754|FG003|2-week Run-in Period|Physician Decision|0|||
106063071|NCT01018186|365890751|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
106063072|NCT01018186|365890752|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
106063073|NCT01018186|365890753|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
106063074|NCT01018186|365890754|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
106063075|NCT01018186|365890751|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
106063076|NCT01018186|365890752|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
106063077|NCT01018186|365890753|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
106063078|NCT01018186|365890754|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
106063079|NCT01018186|365890751|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
106063080|NCT01018186|365890752|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
106063081|NCT01018186|365890753|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
106063082|NCT01018186|365890754|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
106063083|NCT01018186|365890751|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
106063084|NCT01018186|365890752|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
106063085|NCT01018186|365890753|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
106063086|NCT01018186|365890754|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
106063087|NCT01018186|365890751|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
106063088|NCT01018186|365890752|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
106063089|NCT01018186|365890753|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
106063090|NCT01018186|365890754|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
106063091|NCT01018186|365890751|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
106063092|NCT01018186|365890752|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
106063093|NCT01018186|365890753|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
106063094|NCT01018186|365890754|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
106063095|NCT01018186|365890751|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
106063096|NCT01018186|365890752|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
106063097|NCT01018186|365890753|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
106063098|NCT01018186|365890754|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
106063099|NCT01018186|365890751|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
106063100|NCT01018186|365890752|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
106063101|NCT01018186|365890753|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
106063102|NCT01018186|365890754|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
106063103|NCT01018186|365890751|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
106063104|NCT01018186|365890752|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
106063105|NCT01018186|365890753|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
106153951|NCT03398148|366223917|FG014|Substudy 2 Period 2|Other|1|||
106153952|NCT03398148|366223903|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
105864908|NCT02289456|365154754|FG000|Monotherapy Period|Death|1|||
105864909|NCT02289456|365154754|FG000|Monotherapy Period|Adverse Event|1|||
105864910|NCT02289456|365154754|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
106063106|NCT01018186|365890754|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
106063107|NCT03049280|365890755|FG000|Overall Study|Physician Decision|1|||
106063108|NCT03552198|365890756|FG000|Overall Study|Lost to Follow-up|42|||
106063109|NCT03552198|365890757|FG001|Overall Study|Lost to Follow-up|48|||
106063110|NCT03552198|365890758|FG002|Overall Study|Lost to Follow-up|15|||
106063111|NCT03552198|365890759|FG003|Overall Study|Lost to Follow-up|19|||
106063112|NCT03552198|365890756|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
106063113|NCT03552198|365890757|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
106063114|NCT03552198|365890758|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
106063115|NCT03552198|365890759|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
106063116|NCT03552198|365890756|FG000|Overall Study|Did not receive air alerts|1|||
106063117|NCT03552198|365890757|FG001|Overall Study|Did not receive air alerts|0|||
106063118|NCT03552198|365890758|FG002|Overall Study|Did not receive air alerts|0|||
106063119|NCT03552198|365890759|FG003|Overall Study|Did not receive air alerts|1|||
106063120|NCT03334448|365890762|FG000|Washout|Personal Reason|0|||
106063121|NCT03334448|365890763|FG001|Washout|Personal Reason|1|||
106063122|NCT03334448|365890764|FG002|Washout|Personal Reason|0|||
106063123|NCT03334448|365890765|FG003|Washout|Personal Reason|0|||
106063124|NCT03334448|365890762|FG000|Washout|Protocol Violation|0|||
106063125|NCT03334448|365890763|FG001|Washout|Protocol Violation|0|||
106063126|NCT03334448|365890764|FG002|Washout|Protocol Violation|0|||
106063127|NCT03334448|365890765|FG003|Washout|Protocol Violation|1|||
106063128|NCT03235154|365890766|FG000|Overall Study|Withdrawal by Subject|1|||
106063129|NCT03235154|365890766|FG000|Overall Study|Adverse Event|1|||
106063130|NCT03235154|365890766|FG000|Overall Study|Lost to Follow-up|2|||
106063131|NCT00996307|365890767|FG000|Overall Study|Adverse Event|0|||
106063132|NCT00996307|365890768|FG001|Overall Study|Adverse Event|1|||
106063133|NCT00996307|365890769|FG002|Overall Study|Adverse Event|0|||
106063134|NCT00996307|365890770|FG003|Overall Study|Adverse Event|0|||
106063135|NCT00996307|365890767|FG000|Overall Study|Withdrawal by Subject|3|||
106063136|NCT00996307|365890768|FG001|Overall Study|Withdrawal by Subject|2|||
106063137|NCT00996307|365890769|FG002|Overall Study|Withdrawal by Subject|5|||
106063138|NCT00996307|365890770|FG003|Overall Study|Withdrawal by Subject|5|||
106063139|NCT00996307|365890767|FG000|Overall Study|Lost to Follow-up|13|||
106063140|NCT00996307|365890768|FG001|Overall Study|Lost to Follow-up|13|||
106063141|NCT00996307|365890769|FG002|Overall Study|Lost to Follow-up|7|||
106063142|NCT00996307|365890770|FG003|Overall Study|Lost to Follow-up|15|||
106063143|NCT00996307|365890767|FG000|Overall Study|Administrative reason|0|||
106063144|NCT00996307|365890768|FG001|Overall Study|Administrative reason|1|||
106063145|NCT00996307|365890769|FG002|Overall Study|Administrative reason|0|||
106063146|NCT00996307|365890770|FG003|Overall Study|Administrative reason|0|||
106063147|NCT00996307|365890767|FG000|Overall Study|Unable to classify|4|||
106063148|NCT00996307|365890768|FG001|Overall Study|Unable to classify|0|||
106063149|NCT00996307|365890769|FG002|Overall Study|Unable to classify|2|||
106063150|NCT00996307|365890770|FG003|Overall Study|Unable to classify|1|||
106063151|NCT02850965|365890771|FG000|Overall Study|Other than listed|3|||
106063152|NCT02850965|365890772|FG001|Overall Study|Other than listed|4|||
106063153|NCT02850965|365890771|FG000|Overall Study|Protocol Violation|0|||
106063154|NCT02850965|365890772|FG001|Overall Study|Protocol Violation|2|||
106063155|NCT02850965|365890771|FG000|Overall Study|Lost to Follow-up|5|||
106063156|NCT02850965|365890772|FG001|Overall Study|Lost to Follow-up|3|||
106063157|NCT02850965|365890771|FG000|Overall Study|Lack of Efficacy|4|||
106063158|NCT02850965|365890772|FG001|Overall Study|Lack of Efficacy|8|||
106063159|NCT02850965|365890771|FG000|Overall Study|Adverse Event|3|||
106063160|NCT02850965|365890772|FG001|Overall Study|Adverse Event|2|||
106063161|NCT02850965|365890771|FG000|Overall Study|Withdrawal by Subject|3|||
106063162|NCT02850965|365890772|FG001|Overall Study|Withdrawal by Subject|4|||
106063163|NCT02850965|365890771|FG000|Overall Study|Physician Decision|0|||
106063164|NCT02850965|365890772|FG001|Overall Study|Physician Decision|1|||
106063165|NCT02850965|365890771|FG000|Overall Study|Randomized but not treated|0|||
106063166|NCT02850965|365890772|FG001|Overall Study|Randomized but not treated|1|||
106063167|NCT02788357|365890776|FG000|Overall Study|Lost to Follow-up|3|||
106063168|NCT02788357|365890777|FG001|Overall Study|Lost to Follow-up|0|||
106063169|NCT00927784|365890778|FG000|Overall Study|Death|1|||
105864911|NCT02289456|365154754|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
105864912|NCT02289456|365154754|FG000|Monotherapy Period|Withdrawal by Subject|2|||
106063170|NCT00927784|365890779|FG001|Overall Study|Death|0|||
106063171|NCT00927784|365890778|FG000|Overall Study|Withdrawal by Subject|1|||
106063172|NCT00927784|365890779|FG001|Overall Study|Withdrawal by Subject|0|||
105864913|NCT02289456|365154754|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
106063173|NCT00881712|365890780|FG000|Overall Study|Death|1|||
106063174|NCT00881712|365890781|FG001|Overall Study|Death|0|||
106063175|NCT00881712|365890782|FG002|Overall Study|Death|0|||
106063176|NCT00881712|365890780|FG000|Overall Study|Withdrawal by Subject|1|||
106063177|NCT00881712|365890781|FG001|Overall Study|Withdrawal by Subject|0|||
106063178|NCT00881712|365890782|FG002|Overall Study|Withdrawal by Subject|0|||
106063179|NCT01324999|365890783|FG000|Overall Study|Adverse Event|3|||
106063180|NCT01324999|365890783|FG000|Overall Study|Withdrawal by Subject|2|||
106063181|NCT00071513|365890784|FG000|Intervention Component|Withdrawal by Subject|2|||
106063182|NCT00071513|365890785|FG001|Intervention Component|Withdrawal by Subject|3|||
106063183|NCT00071513|365890784|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
106063184|NCT00071513|365890785|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
106063185|NCT01648205|365890791|FG000|Placebo|Pregnancy|1|||
106063186|NCT01648205|365890791|FG000|Placebo|Withdrawal by Subject|1|||
106063187|NCT01648205|365890791|FG000|Placebo|Protocol Violation|2|||
106063188|NCT01648205|365890791|FG000|Ranolazine|Death|1|||
106063189|NCT01648205|365890791|FG000|Ranolazine|Withdrawal by Subject|1|||
106063190|NCT01648205|365890791|FG000|Ranolazine|Protocol Violation|3|||
106063191|NCT02547454|365890792|FG000|Overall Study|Due to hemodialysis|53|||
106063192|NCT02547454|365890792|FG000|Overall Study|Due to transplantation|1|||
106063193|NCT02547454|365890792|FG000|Overall Study|Due to no further need to treat|4|||
106063194|NCT02547454|365890792|FG000|Overall Study|Death|38|||
106063195|NCT02547454|365890792|FG000|Overall Study|Lost to Follow-up|26|||
106063196|NCT02547454|365890792|FG000|Overall Study|Other|39|||
106063197|NCT02547454|365890792|FG000|Overall Study|No data|11|||
106063198|NCT00524368|365892655|FG000|Overall Study|Adverse Event|10|||
105864914|NCT02289456|365154754|FG000|Monotherapy Period|Miscellaneous|1|||
105864915|NCT02910011|365154757|FG000|Overall Study|Physician Decision|2|||
105864916|NCT01399658|365154758|FG000|Overall Study|Ineligible|1|||
105864917|NCT01399658|365154758|FG000|Overall Study|Machine Technical Issue|3|||
105864918|NCT01399658|365154758|FG000|Overall Study|Alternative therapy|1|||
105864919|NCT01399658|365154758|FG000|Overall Study|No reason given|1|||
105864920|NCT02460679|365154759|FG000|Overall Study|Investigator Decision|1|||
105864921|NCT02460679|365154759|FG000|Overall Study|Withdrawal by Subject|4|||
105864922|NCT00920790|365154760|FG000|Overall Study|aggravation of general condition|14|||
105864923|NCT01661062|365154761|FG000|Overall Study|Completed Treatment Off Study|3|||
105864924|NCT01661062|365154761|FG000|Overall Study|Withdrawal by Subject|2|||
105864925|NCT04411914|365154762|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
105864926|NCT04411914|365154763|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
105864927|NCT02681510|365154764|FG000|Overall Study|Withdrawal by Subject|1|||
105864928|NCT02681510|365154764|FG000|Overall Study|Lost to Follow-up|9|||
105864929|NCT04315506|365154768|FG000|Overall Study|Lost to Follow-up|74|||
105864930|NCT04315506|365154769|FG001|Overall Study|Lost to Follow-up|82|||
105864931|NCT04315506|365154768|FG000|Overall Study|Withdrawal by Subject|8|||
105864932|NCT04315506|365154769|FG001|Overall Study|Withdrawal by Subject|8|||
105864933|NCT04315506|365154768|FG000|Overall Study|Physician Decision|0|||
105864934|NCT04315506|365154769|FG001|Overall Study|Physician Decision|1|||
105864935|NCT01721317|365154770|FG000|Overall Study|Study Closed / Terminated|2|||
105864936|NCT01721317|365154771|FG001|Overall Study|Study Closed / Terminated|2|||
105864937|NCT01721317|365154770|FG000|Overall Study|Physician Decision|0|||
105864938|NCT01721317|365154771|FG001|Overall Study|Physician Decision|1|||
105864939|NCT01721317|365154770|FG000|Overall Study|Withdrawal by Subject|0|||
105864940|NCT01721317|365154771|FG001|Overall Study|Withdrawal by Subject|1|||
105864941|NCT03276078|365154776|FG000|Overall Study|Adverse Event|1|||
105864942|NCT01210612|365154778|FG000|Overall Study|Withdrawal by Subject|0|||
105864943|NCT01210612|365154779|FG001|Overall Study|Withdrawal by Subject|2|||
105864944|NCT01685840|365154780|FG000|Overall Study|Death|77|||
105864945|NCT01685840|365154781|FG001|Overall Study|Death|66|||
105864946|NCT01685840|365154780|FG000|Overall Study|Lost to Follow-up|27|||
105864947|NCT01685840|365154781|FG001|Overall Study|Lost to Follow-up|25|||
105864948|NCT01685840|365154780|FG000|Overall Study|Physician Decision|3|||
105864949|NCT01685840|365154781|FG001|Overall Study|Physician Decision|7|||
105864950|NCT01685840|365154780|FG000|Overall Study|Withdrawal by Subject|14|||
105864951|NCT01685840|365154781|FG001|Overall Study|Withdrawal by Subject|17|||
105864952|NCT01685840|365154780|FG000|Overall Study|Futility|197|||
105864953|NCT01685840|365154781|FG001|Overall Study|Futility|200|||
105864954|NCT01685840|365154780|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
105864955|NCT01685840|365154781|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
105864956|NCT00908310|365154785|FG000|Overall Study|Death|37|||
105864957|NCT00908310|365154785|FG000|Overall Study|Withdrawal by Subject|7|||
105864958|NCT00908310|365154785|FG000|Overall Study|Lost to Follow-up|7|||
105864959|NCT00908310|365154785|FG000|Overall Study|Screening failure|5|||
105864960|NCT00908310|365154785|FG000|Overall Study|Other reasons|4|||
105864961|NCT02800642|365154786|FG000|Overall Study|Death|3|||
105864962|NCT02800642|365154786|FG000|Overall Study|Other|10|||
105864963|NCT02800642|365154786|FG000|Overall Study|Physician Decision|2|||
105864964|NCT02800642|365154786|FG000|Overall Study|Adverse Event|6|||
105864965|NCT02800642|365154786|FG000|Overall Study|Withdrawal by Subject|3|||
105864966|NCT02800642|365154786|FG000|Overall Study|Lost to Follow-up|1|||
105864967|NCT01941498|365154787|FG000|Overall Study|Relocated out of state|1|||
105864968|NCT00447993|365154792|FG000|Overall Study|Lost to Follow-up|0|||
106063199|NCT00524368|365892656|FG001|Overall Study|Adverse Event|12|||
106063200|NCT00524368|365892655|FG000|Overall Study|Lost to Follow-up|9|||
105864969|NCT00447993|365154793|FG001|Overall Study|Lost to Follow-up|0|||
105864970|NCT00447993|365154794|FG002|Overall Study|Lost to Follow-up|2|||
105864971|NCT00447993|365154795|FG003|Overall Study|Lost to Follow-up|2|||
105864972|NCT00447993|365154792|FG000|Overall Study|Withdrawal by Subject|0|||
105864973|NCT00447993|365154793|FG001|Overall Study|Withdrawal by Subject|0|||
105864974|NCT00447993|365154794|FG002|Overall Study|Withdrawal by Subject|2|||
105864975|NCT00447993|365154795|FG003|Overall Study|Withdrawal by Subject|2|||
105864976|NCT03390426|365154796|FG000|Overall Study|Protocol Violation|0|||
105864977|NCT03390426|365154797|FG001|Overall Study|Protocol Violation|1|||
105864978|NCT00548093|365154800|FG000|Overall Study|Death|33|||
105864979|NCT00548093|365154801|FG001|Overall Study|Death|13|||
105864980|NCT00548093|365154800|FG000|Overall Study|Lost to Follow-up|3|||
105864981|NCT00548093|365154801|FG001|Overall Study|Lost to Follow-up|1|||
105864982|NCT00548093|365154800|FG000|Overall Study|Objective progression or relapse|1|||
105864983|NCT00548093|365154801|FG001|Overall Study|Objective progression or relapse|1|||
105864984|NCT00548093|365154800|FG000|Overall Study|Other|11|||
106063201|NCT00524368|365892656|FG001|Overall Study|Lost to Follow-up|13|||
106063202|NCT00524368|365892655|FG000|Overall Study|Withdrawal by Subject|4|||
106063203|NCT00524368|365892656|FG001|Overall Study|Withdrawal by Subject|5|||
106063204|NCT00524368|365892655|FG000|Overall Study|Non-compliant|8|||
106063205|NCT00524368|365892656|FG001|Overall Study|Non-compliant|9|||
106063206|NCT00524368|365892655|FG000|Overall Study|Reached a Virologic Endpoint|3|||
106063207|NCT00524368|365892656|FG001|Overall Study|Reached a Virologic Endpoint|2|||
106063208|NCT00524368|365892655|FG000|Overall Study|Sponsor's Decision|2|||
106063209|NCT00524368|365892656|FG001|Overall Study|Sponsor's Decision|0|||
106063210|NCT00524368|365892655|FG000|Overall Study|Ineligible to Continue the study|2|||
106063211|NCT00524368|365892656|FG001|Overall Study|Ineligible to Continue the study|5|||
106063212|NCT00524368|365892655|FG000|Overall Study|Other|3|||
106063213|NCT00524368|365892656|FG001|Overall Study|Other|2|||
106063214|NCT00733408|365892658|FG000|Overall Study|Adverse Event|4|||
106063215|NCT02239978|365892664|FG000|Overall Study|Withdrawal by Subject|2|||
106063216|NCT02239978|365892665|FG001|Overall Study|Withdrawal by Subject|0|||
106063217|NCT02345850|365892666|FG000|Overall Study|Not transplanted|10|||
106063218|NCT02345850|365892667|FG001|Overall Study|Not transplanted|5|||
106063219|NCT02345850|365892668|FG002|Overall Study|Not transplanted|4|||
106063220|NCT02345850|365892666|FG000|Overall Study|Lost to Follow-up|2|||
106063221|NCT02345850|365892667|FG001|Overall Study|Lost to Follow-up|3|||
106063222|NCT02345850|365892668|FG002|Overall Study|Lost to Follow-up|2|||
106063223|NCT02345850|365892666|FG000|Overall Study|Withdrawal by Subject|1|||
106063224|NCT02345850|365892667|FG001|Overall Study|Withdrawal by Subject|0|||
106063225|NCT02345850|365892668|FG002|Overall Study|Withdrawal by Subject|0|||
106063226|NCT02373202|365892669|FG000|Overall Study|Adverse Event|2|||
106063227|NCT02373202|365892670|FG001|Overall Study|Adverse Event|5|||
106063228|NCT02373202|365892671|FG002|Overall Study|Adverse Event|2|||
106063229|NCT02373202|365892672|FG003|Overall Study|Adverse Event|1|||
106063230|NCT02373202|365892669|FG000|Overall Study|Lack of Efficacy|0|||
106063231|NCT02373202|365892670|FG001|Overall Study|Lack of Efficacy|0|||
106063232|NCT02373202|365892671|FG002|Overall Study|Lack of Efficacy|1|||
106063233|NCT02373202|365892672|FG003|Overall Study|Lack of Efficacy|0|||
106063234|NCT02373202|365892669|FG000|Overall Study|Other|0|||
106063235|NCT02373202|365892670|FG001|Overall Study|Other|1|||
106063236|NCT02373202|365892671|FG002|Overall Study|Other|0|||
106063237|NCT02373202|365892672|FG003|Overall Study|Other|0|||
106063238|NCT00848081|365892674|FG000|Overall Study|Adverse Event|6|||
106063239|NCT00848081|365892675|FG001|Overall Study|Adverse Event|7|||
106063240|NCT00848081|365892674|FG000|Overall Study|Protocol Violation|8|||
106063241|NCT00848081|365892675|FG001|Overall Study|Protocol Violation|5|||
106063242|NCT00848081|365892674|FG000|Overall Study|Lost to Follow-up|1|||
105864985|NCT00548093|365154801|FG001|Overall Study|Other|1|||
105864986|NCT00548093|365154800|FG000|Overall Study|Withdrawal by Subject|1|||
106063243|NCT00848081|365892675|FG001|Overall Study|Lost to Follow-up|0|||
106063244|NCT00848081|365892674|FG000|Overall Study|Physician Decision|0|||
106063245|NCT00848081|365892675|FG001|Overall Study|Physician Decision|3|||
106063246|NCT00848081|365892674|FG000|Overall Study|Withdrawal by Subject|5|||
106063247|NCT00848081|365892675|FG001|Overall Study|Withdrawal by Subject|3|||
106063248|NCT00464087|365892679|FG000|Overall Study|No PCI per inclusion criteria|0|||
105864987|NCT00548093|365154801|FG001|Overall Study|Withdrawal by Subject|0|||
106063249|NCT00464087|365892680|FG001|Overall Study|No PCI per inclusion criteria|0|||
106063250|NCT00464087|365892681|FG002|Overall Study|No PCI per inclusion criteria|29|||
106063251|NCT00609492|365892683|FG000|Overall Study|Withdrawal by Subject|0|||
106063252|NCT00609492|365892684|FG001|Overall Study|Withdrawal by Subject|2|||
106063253|NCT00609492|365892685|FG002|Overall Study|Withdrawal by Subject|3|||
106063254|NCT00609492|365892683|FG000|Overall Study|Lost to Follow-up|1|||
106063255|NCT00609492|365892684|FG001|Overall Study|Lost to Follow-up|1|||
106063256|NCT00609492|365892685|FG002|Overall Study|Lost to Follow-up|4|||
106063257|NCT01224431|365892686|FG000|Overall Study|not randomized|0|||
106063258|NCT01224431|365892687|FG001|Overall Study|not randomized|4|||
106063259|NCT01224431|365892686|FG000|Overall Study|no video record|0|||
106063260|NCT01224431|365892687|FG001|Overall Study|no video record|1|||
106063261|NCT01413191|365892688|FG000|Overall Study|Lost to Follow-up|5|||
106063262|NCT01413191|365892688|FG000|Overall Study|Disease Progression|5|||
106063263|NCT01413191|365892688|FG000|Overall Study|Death|1|||
106063264|NCT01702454|365892689|FG000|Overall Study|Consent withdrawal|0|||
106063265|NCT01702454|365892690|FG001|Overall Study|Consent withdrawal|1|||
106063266|NCT01702454|365892689|FG000|Overall Study|Migrated/moved from study area|0|||
106063267|NCT01702454|365892690|FG001|Overall Study|Migrated/moved from study area|1|||
106063268|NCT01702454|365892689|FG000|Overall Study|Lost to Follow-up|3|||
106063269|NCT01702454|365892690|FG001|Overall Study|Lost to Follow-up|6|||
106063270|NCT01327885|365892695|FG000|Overall Study|Disease progression-according to RECIST|173|||
106063271|NCT01327885|365892696|FG001|Overall Study|Disease progression-according to RECIST|165|||
106063272|NCT01327885|365892695|FG000|Overall Study|Clinical progression|24|||
106063273|NCT01327885|365892696|FG001|Overall Study|Clinical progression|27|||
106063274|NCT01327885|365892695|FG000|Overall Study|Adverse Event|14|||
106063275|NCT01327885|365892696|FG001|Overall Study|Adverse Event|10|||
106063276|NCT01327885|365892695|FG000|Overall Study|Subject choice|5|||
106063277|NCT01327885|365892696|FG001|Overall Study|Subject choice|10|||
106063278|NCT01327885|365892695|FG000|Overall Study|Other|8|||
106063279|NCT01327885|365892696|FG001|Overall Study|Other|6|||
106063280|NCT01327885|365892695|FG000|Overall Study|Withdrawal of consent from study|3|||
106063281|NCT01327885|365892696|FG001|Overall Study|Withdrawal of consent from study|4|||
106063282|NCT01327885|365892695|FG000|Overall Study|Not treated|1|||
106063283|NCT01327885|365892696|FG001|Overall Study|Not treated|1|||
106063284|NCT01327885|365892695|FG000|Overall Study|Administrative decision|0|||
106063285|NCT01327885|365892696|FG001|Overall Study|Administrative decision|1|||
106063286|NCT04271605|365892699|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
106063287|NCT01349790|365892706|FG000|Overall Study|Investigator Judgement|3|||
106063288|NCT01349790|365892706|FG000|Overall Study|Death|2|||
106063289|NCT01349790|365892706|FG000|Overall Study|Withdrawal by Patient|2|||
106063290|NCT01349790|365892706|FG000|Overall Study|Adverse Event|1|||
106063291|NCT01349790|365892706|FG000|Overall Study|Lost to Follow-up|1|||
106063292|NCT02085785|365892709|FG000|Overall Study|Withdrawal by Subject|2|||
106063293|NCT02085785|365892710|FG001|Overall Study|Withdrawal by Subject|1|||
106063294|NCT02085785|365892709|FG000|Overall Study|Lost to Follow-up|0|||
106063295|NCT02085785|365892710|FG001|Overall Study|Lost to Follow-up|1|||
106063296|NCT00779467|365892711|FG000|Overall Study|Lack of Efficacy|11|||
106063297|NCT00779467|365892712|FG001|Overall Study|Lack of Efficacy|2|||
106063298|NCT00779467|365892713|FG002|Overall Study|Lack of Efficacy|6|||
106063299|NCT00779467|365892714|FG003|Overall Study|Lack of Efficacy|11|||
106063300|NCT00779467|365892711|FG000|Overall Study|failed inclusion criteria|3|||
106063301|NCT00779467|365892712|FG001|Overall Study|failed inclusion criteria|3|||
106063302|NCT00779467|365892713|FG002|Overall Study|failed inclusion criteria|1|||
106063303|NCT00779467|365892714|FG003|Overall Study|failed inclusion criteria|2|||
106063304|NCT00779467|365892711|FG000|Overall Study|missing data|1|||
106063305|NCT00779467|365892712|FG001|Overall Study|missing data|0|||
106063306|NCT00779467|365892713|FG002|Overall Study|missing data|1|||
106063307|NCT00779467|365892714|FG003|Overall Study|missing data|4|||
106063308|NCT00779467|365892711|FG000|Overall Study|technical issue|0|||
106063309|NCT00779467|365892712|FG001|Overall Study|technical issue|0|||
106063310|NCT00779467|365892713|FG002|Overall Study|technical issue|2|||
106063311|NCT00779467|365892714|FG003|Overall Study|technical issue|1|||
106063312|NCT00779467|365892711|FG000|Overall Study|unavailable research staff|0|||
105864988|NCT00548093|365154800|FG000|Overall Study|Completed post-treatment follow-up|1|||
106063313|NCT00779467|365892712|FG001|Overall Study|unavailable research staff|0|||
106063314|NCT00779467|365892713|FG002|Overall Study|unavailable research staff|0|||
106063315|NCT00779467|365892714|FG003|Overall Study|unavailable research staff|1|||
106063316|NCT02692703|365892715|FG000|Overall Study|Lost to Follow-up|1|||
106063317|NCT02692703|365892715|FG000|Overall Study|Other|1|||
106063318|NCT05048784|365892716|FG000|Period 1|Adverse Event|3|||
106063319|NCT05048784|365892717|FG001|Period 1|Adverse Event|1|||
106063320|NCT05048784|365892718|FG002|Period 1|Adverse Event|0|||
106063321|NCT05048784|365892719|FG003|Period 1|Adverse Event|0|||
106063322|NCT05048784|365892716|FG000|Period 2|Lost to Follow-up|0|||
106063323|NCT05048784|365892717|FG001|Period 2|Lost to Follow-up|1|||
106063324|NCT05048784|365892718|FG002|Period 2|Lost to Follow-up|0|||
106063325|NCT05048784|365892719|FG003|Period 2|Lost to Follow-up|0|||
106063326|NCT03519932|365892722|FG000|First Intervention|Adverse Event|1|||
106063327|NCT03519932|365892723|FG001|First Intervention|Adverse Event|3|||
106063328|NCT02254486|365892724|FG000|Overall Study|Adverse Event|1|||
106063329|NCT02254486|365892725|FG001|Overall Study|Adverse Event|1|||
106063330|NCT02254486|365892724|FG000|Overall Study|Lack of Efficacy|1|||
106063331|NCT02254486|365892725|FG001|Overall Study|Lack of Efficacy|0|||
106063332|NCT02254486|365892724|FG000|Overall Study|Lost to Follow-up|2|||
106063333|NCT02254486|365892725|FG001|Overall Study|Lost to Follow-up|4|||
106063334|NCT02254486|365892724|FG000|Overall Study|Protocol Violation|1|||
106063335|NCT02254486|365892725|FG001|Overall Study|Protocol Violation|2|||
106063336|NCT02254486|365892724|FG000|Overall Study|Withdrawal by Subject|17|||
106063337|NCT02254486|365892725|FG001|Overall Study|Withdrawal by Subject|15|||
106063338|NCT02254486|365892724|FG000|Overall Study|GFR<60mL/min|16|||
106063339|NCT02254486|365892725|FG001|Overall Study|GFR<60mL/min|21|||
106063340|NCT02254486|365892724|FG000|Overall Study|Various|12|||
106063341|NCT02254486|365892725|FG001|Overall Study|Various|12|||
106063342|NCT04166435|365892726|FG000|Overall Study|2 patients ineligible for response|2|||
106063343|NCT00267046|365892729|FG000|Overall Study|Disease progression|4|||
106063344|NCT00267046|365892730|FG001|Overall Study|Disease progression|2|||
106063345|NCT00267046|365892729|FG000|Overall Study|Chemotoxicity|2|||
106063346|NCT00267046|365892730|FG001|Overall Study|Chemotoxicity|0|||
106063347|NCT00267046|365892729|FG000|Overall Study|Open-label palifermin|2|||
106063348|NCT00267046|365892730|FG001|Overall Study|Open-label palifermin|7|||
106063349|NCT00267046|365892729|FG000|Overall Study|Surgery|3|||
106063350|NCT00267046|365892730|FG001|Overall Study|Surgery|1|||
106063351|NCT00267046|365892729|FG000|Overall Study|Withdrawal by Subject|1|||
106063352|NCT00267046|365892730|FG001|Overall Study|Withdrawal by Subject|0|||
106063353|NCT00267046|365892729|FG000|Overall Study|Radiation|0|||
106063354|NCT00267046|365892730|FG001|Overall Study|Radiation|1|||
106063355|NCT00865124|365892731|FG000|Overall Study|Physician Decision|2|||
106063356|NCT00865124|365892732|FG001|Overall Study|Physician Decision|1|||
106063357|NCT00865124|365892733|FG002|Overall Study|Physician Decision|0|||
106063358|NCT00865124|365892731|FG000|Overall Study|Withdrawn consent|2|||
106063359|NCT00865124|365892732|FG001|Overall Study|Withdrawn consent|0|||
106063360|NCT00865124|365892733|FG002|Overall Study|Withdrawn consent|0|||
106063361|NCT01425281|365892735|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
106063362|NCT01425281|365892736|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
106063363|NCT01425281|365892735|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
106063364|NCT01425281|365892736|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
106063365|NCT01425281|365892735|FG000|At 180-day Clinical Follow-up|Death|0|||
106063366|NCT01425281|365892736|FG001|At 180-day Clinical Follow-up|Death|1|||
106063367|NCT01425281|365892735|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
106063368|NCT01425281|365892736|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
106063369|NCT01425281|365892735|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
106063370|NCT01425281|365892736|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
106063371|NCT01425281|365892735|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
106063372|NCT01425281|365892736|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
106063373|NCT01425281|365892735|FG000|At 2-year Clinical Follow-up|Death|2|||
106063374|NCT01425281|365892736|FG001|At 2-year Clinical Follow-up|Death|0|||
106063375|NCT01425281|365892735|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
106063376|NCT01425281|365892736|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
106063377|NCT01425281|365892735|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
106063378|NCT01425281|365892736|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
106063379|NCT01425281|365892735|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
106063380|NCT01425281|365892736|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
106063381|NCT01425281|365892735|FG000|At 3-year Clinical Follow-up|Death|2|||
106063382|NCT01425281|365892736|FG001|At 3-year Clinical Follow-up|Death|3|||
106063383|NCT01425281|365892735|FG000|At 4-year Clinical Follow-up|Death|7|||
106063384|NCT01425281|365892736|FG001|At 4-year Clinical Follow-up|Death|3|||
106063385|NCT01425281|365892735|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
106063386|NCT01425281|365892736|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
106063387|NCT01425281|365892735|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
106063388|NCT01425281|365892736|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
106063389|NCT01425281|365892735|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
106063390|NCT01425281|365892736|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
106063391|NCT01425281|365892735|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
106063392|NCT01425281|365892736|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
106063393|NCT01425281|365892735|FG000|At 5-year Clinical Follow-up|Death|2|||
106063394|NCT01425281|365892736|FG001|At 5-year Clinical Follow-up|Death|0|||
106063395|NCT01425281|365892735|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
106063396|NCT01425281|365892736|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
106063397|NCT01425281|365892735|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
106063398|NCT01425281|365892736|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
106063399|NCT01425281|365892735|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
106063400|NCT01425281|365892736|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
106063401|NCT01979016|365892738|FG000|Overall Study|Withdrawal by Subject|2|||
106063402|NCT01979016|365892739|FG001|Overall Study|Withdrawal by Subject|0|||
106063403|NCT01979016|365892738|FG000|Overall Study|Adverse Event|0|||
106063404|NCT01979016|365892739|FG001|Overall Study|Adverse Event|1|||
106063405|NCT01828281|365892741|FG000|Overall Study|Withdrawal by Subject|1|||
106063406|NCT01828281|365892742|FG001|Overall Study|Withdrawal by Subject|0|||
106063407|NCT01442493|365892743|FG000|Overall Study|withdrawn from study|3|||
106063408|NCT01442493|365892744|FG001|Overall Study|withdrawn from study|2|||
106063409|NCT01961323|365892746|FG000|Overall Study|Withdrawal by Subject|7|||
106063410|NCT01961323|365892746|FG000|Overall Study|Lost to Follow-up|8|||
106063411|NCT01961323|365892746|FG000|Overall Study|screen failure|34|||
106063412|NCT03315208|365892747|FG000|Overall Study|Lost to Follow-up|11|||
106063413|NCT03315208|365892748|FG001|Overall Study|Lost to Follow-up|6|||
106063414|NCT03315208|365892747|FG000|Overall Study|Withdrawal by Subject|2|||
106063415|NCT03315208|365892748|FG001|Overall Study|Withdrawal by Subject|0|||
106063416|NCT02875860|365892754|FG000|Overall Study|Withdrawal by Subject|0|||
106063417|NCT02875860|365892755|FG001|Overall Study|Withdrawal by Subject|1|||
106063418|NCT02746874|365892756|FG000|Overall Study|Withdrawal by Subject|0|||
106063419|NCT02746874|365892757|FG001|Overall Study|Withdrawal by Subject|1|||
106063420|NCT02746874|365892756|FG000|Overall Study|Surgery Date Changed|0|||
106063421|NCT02746874|365892757|FG001|Overall Study|Surgery Date Changed|2|||
106063422|NCT01881776|365892758|FG000|Overall Study|Lost to Follow-up|1|||
106063423|NCT01881776|365892759|FG001|Overall Study|Lost to Follow-up|2|||
106063424|NCT01881776|365892760|FG002|Overall Study|Lost to Follow-up|1|||
106063425|NCT01881776|365892758|FG000|Overall Study|Protocol Violation|0|||
106063426|NCT01881776|365892759|FG001|Overall Study|Protocol Violation|2|||
106063427|NCT01881776|365892760|FG002|Overall Study|Protocol Violation|1|||
106063428|NCT02320149|365892761|FG000|Overall Study|Adverse Event|3|||
106063429|NCT02320149|365892762|FG001|Overall Study|Adverse Event|7|||
106063430|NCT02320149|365892761|FG000|Overall Study|Withdrawal of Consent|28|||
106063431|NCT02320149|365892762|FG001|Overall Study|Withdrawal of Consent|32|||
106063432|NCT02320149|365892761|FG000|Overall Study|Lost to Follow-up|21|||
106063433|NCT02320149|365892762|FG001|Overall Study|Lost to Follow-up|34|||
106063434|NCT02320149|365892761|FG000|Overall Study|Protocol Violation|2|||
106063435|NCT02320149|365892762|FG001|Overall Study|Protocol Violation|1|||
106063436|NCT02320149|365892761|FG000|Overall Study|Noncompliance with Study Treatment|7|||
106063437|NCT02320149|365892762|FG001|Overall Study|Noncompliance with Study Treatment|2|||
106063438|NCT02320149|365892761|FG000|Overall Study|Lack of Efficacy|0|||
106063439|NCT02320149|365892762|FG001|Overall Study|Lack of Efficacy|1|||
106063440|NCT02320149|365892761|FG000|Overall Study|Other Miscellaneous Reasons|2|||
106063441|NCT02320149|365892762|FG001|Overall Study|Other Miscellaneous Reasons|3|||
106063442|NCT00487747|365892766|FG000|Overall Study|Adverse Event|1|||
106063443|NCT00487747|365892766|FG000|Overall Study|Lost to Follow-up|9|||
106063444|NCT00487747|365892766|FG000|Overall Study|Lack of Efficacy|1|||
106063445|NCT02205814|365892795|FG000|Overall Study|Lost to Follow-up|0|||
106063446|NCT02205814|365892796|FG001|Overall Study|Lost to Follow-up|0|||
106063447|NCT02205814|365892797|FG002|Overall Study|Lost to Follow-up|0|||
106063448|NCT02205814|365892798|FG003|Overall Study|Lost to Follow-up|1|||
106063449|NCT02205814|365892795|FG000|Overall Study|Lack of Efficacy|1|||
106063450|NCT02205814|365892796|FG001|Overall Study|Lack of Efficacy|0|||
106063451|NCT02205814|365892797|FG002|Overall Study|Lack of Efficacy|1|||
106063452|NCT02205814|365892798|FG003|Overall Study|Lack of Efficacy|1|||
106063453|NCT02205814|365892795|FG000|Overall Study|Physician Decision|0|||
106063454|NCT02205814|365892796|FG001|Overall Study|Physician Decision|0|||
106153953|NCT03398148|366223904|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153954|NCT03398148|366223905|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153955|NCT03398148|366223906|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153956|NCT03398148|366223907|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
106063455|NCT02205814|365892797|FG002|Overall Study|Physician Decision|1|||
106063456|NCT02205814|365892798|FG003|Overall Study|Physician Decision|0|||
106063457|NCT02205814|365892795|FG000|Overall Study|Protocol Violation|1|||
106063458|NCT02205814|365892796|FG001|Overall Study|Protocol Violation|0|||
106063459|NCT02205814|365892797|FG002|Overall Study|Protocol Violation|0|||
106063460|NCT02205814|365892798|FG003|Overall Study|Protocol Violation|1|||
106063461|NCT02205814|365892795|FG000|Overall Study|Withdrawal by Subject|0|||
106063462|NCT02205814|365892796|FG001|Overall Study|Withdrawal by Subject|1|||
106063463|NCT02205814|365892797|FG002|Overall Study|Withdrawal by Subject|2|||
106063464|NCT02205814|365892798|FG003|Overall Study|Withdrawal by Subject|1|||
106063465|NCT02205814|365892795|FG000|Overall Study|not compliant with study procedures|0|||
106063466|NCT02205814|365892796|FG001|Overall Study|not compliant with study procedures|0|||
106063467|NCT02205814|365892797|FG002|Overall Study|not compliant with study procedures|1|||
106063468|NCT02205814|365892798|FG003|Overall Study|not compliant with study procedures|0|||
106063469|NCT04952402|365892799|FG000|Overall Study|Lost to Follow-up|1|||
106063470|NCT04952402|365892800|FG001|Overall Study|Lost to Follow-up|3|||
106063471|NCT04952402|365892799|FG000|Overall Study|Lack Of Venous Access|0|||
106063472|NCT04952402|365892800|FG001|Overall Study|Lack Of Venous Access|1|||
106063473|NCT01025752|365892801|FG000|Overall Study|Lost to Follow-up|7|||
106063474|NCT01025752|365892802|FG001|Overall Study|Lost to Follow-up|10|||
106063475|NCT01025752|365892801|FG000|Overall Study|Physician Decision|1|||
106063476|NCT01025752|365892802|FG001|Overall Study|Physician Decision|3|||
106063477|NCT01922089|365892804|FG000|Overall Study|Adverse Event|18|||
106063478|NCT01922089|365892805|FG001|Overall Study|Adverse Event|13|||
106063479|NCT01922089|365892804|FG000|Overall Study|Protocol Deviation|10|||
106063480|NCT01922089|365892805|FG001|Overall Study|Protocol Deviation|7|||
106063481|NCT01922089|365892804|FG000|Overall Study|Withdrawal by Subject|3|||
106063482|NCT01922089|365892805|FG001|Overall Study|Withdrawal by Subject|4|||
106063483|NCT01922089|365892804|FG000|Overall Study|administrative problems|4|||
106063484|NCT01922089|365892805|FG001|Overall Study|administrative problems|1|||
106063485|NCT01922089|365892804|FG000|Overall Study|Physician Decision|2|||
106063486|NCT01922089|365892805|FG001|Overall Study|Physician Decision|3|||
106063487|NCT01922089|365892804|FG000|Overall Study|Death|2|||
106063488|NCT01922089|365892805|FG001|Overall Study|Death|1|||
106063489|NCT01922089|365892804|FG000|Overall Study|Lost to Follow-up|0|||
106063490|NCT01922089|365892805|FG001|Overall Study|Lost to Follow-up|1|||
106063491|NCT00573534|365892806|FG000|Overall Study|oppositional behavior|3|||
106063492|NCT00001723|365892807|FG000|Overall Study|Lack of Efficacy|6|||
106063493|NCT00001723|365892808|FG001|Overall Study|Lack of Efficacy|7|||
106063494|NCT00001723|365892807|FG000|Overall Study|Lack of family interest|4|||
106063495|NCT00001723|365892808|FG001|Overall Study|Lack of family interest|5|||
106063496|NCT00001723|365892807|FG000|Overall Study|Lost to Follow-up|2|||
106063497|NCT00001723|365892808|FG001|Overall Study|Lost to Follow-up|2|||
106063498|NCT00001723|365892807|FG000|Overall Study|medication intolerance|1|||
106063499|NCT00001723|365892808|FG001|Overall Study|medication intolerance|2|||
106063500|NCT00536198|365892809|FG000|Overall Study|Lost to Follow-up|15|||
106063501|NCT00536198|365892810|FG001|Overall Study|Lost to Follow-up|14|||
106063502|NCT00536198|365892809|FG000|Overall Study|Withdrawal by Subject|16|||
106063503|NCT00536198|365892810|FG001|Overall Study|Withdrawal by Subject|12|||
106063504|NCT00536198|365892809|FG000|Overall Study|Adverse Event|2|||
106063505|NCT00536198|365892810|FG001|Overall Study|Adverse Event|2|||
106063506|NCT00536198|365892809|FG000|Overall Study|Rescue|3|||
106063507|NCT00536198|365892810|FG001|Overall Study|Rescue|9|||
106063508|NCT00536198|365892809|FG000|Overall Study|Pregnancy|1|||
106063509|NCT00536198|365892810|FG001|Overall Study|Pregnancy|1|||
106063510|NCT00536198|365892809|FG000|Overall Study|Protocol Violation|0|||
106063511|NCT00536198|365892810|FG001|Overall Study|Protocol Violation|1|||
106063512|NCT02848651|365892816|FG000|Overall Study|Death|85|||
106063513|NCT02848651|365892816|FG000|Overall Study|Lost to Follow-up|1|||
106063514|NCT02848651|365892816|FG000|Overall Study|Non-Compliance|1|||
106063515|NCT02848651|365892816|FG000|Overall Study|Symptomatic Deterioration|1|||
106063516|NCT02848651|365892816|FG000|Overall Study|Physician Decision|4|||
106063517|NCT02848651|365892816|FG000|Overall Study|Withdrawal by Subject|14|||
106063518|NCT00750204|365892821|FG000|Overall Study|study halted prematurely|1|||
106063519|NCT00750204|365892822|FG001|Overall Study|study halted prematurely|1|||
106063520|NCT01905657|365892823|FG000|Overall Study|Adverse Event|23|||
106063521|NCT01905657|365892824|FG001|Overall Study|Adverse Event|17|||
106063522|NCT01905657|365892825|FG002|Overall Study|Adverse Event|18|||
106063523|NCT01905657|365892823|FG000|Overall Study|Clinical Progression|103|||
106063524|NCT01905657|365892824|FG001|Overall Study|Clinical Progression|78|||
106063525|NCT01905657|365892825|FG002|Overall Study|Clinical Progression|59|||
106063526|NCT01905657|365892823|FG000|Overall Study|Death|40|||
106063527|NCT01905657|365892824|FG001|Overall Study|Death|43|||
106063528|NCT01905657|365892825|FG002|Overall Study|Death|47|||
106063529|NCT01905657|365892823|FG000|Overall Study|Excluded Medication|13|||
106063530|NCT01905657|365892824|FG001|Overall Study|Excluded Medication|16|||
106063531|NCT01905657|365892825|FG002|Overall Study|Excluded Medication|9|||
106063532|NCT01905657|365892823|FG000|Overall Study|Lost to Follow-up|1|||
106063533|NCT01905657|365892824|FG001|Overall Study|Lost to Follow-up|2|||
106063534|NCT01905657|365892825|FG002|Overall Study|Lost to Follow-up|1|||
106063535|NCT01905657|365892823|FG000|Overall Study|Physician Decision|5|||
106063536|NCT01905657|365892824|FG001|Overall Study|Physician Decision|8|||
106063537|NCT01905657|365892825|FG002|Overall Study|Physician Decision|12|||
106063538|NCT01905657|365892823|FG000|Overall Study|Protocol Violation|2|||
106063539|NCT01905657|365892824|FG001|Overall Study|Protocol Violation|1|||
106063540|NCT01905657|365892825|FG002|Overall Study|Protocol Violation|1|||
106063541|NCT01905657|365892823|FG000|Overall Study|Screen Failure|0|||
106063542|NCT01905657|365892824|FG001|Overall Study|Screen Failure|1|||
106063543|NCT01905657|365892825|FG002|Overall Study|Screen Failure|0|||
106063544|NCT01905657|365892823|FG000|Overall Study|Withdrawal by Subject|15|||
106063545|NCT01905657|365892824|FG001|Overall Study|Withdrawal by Subject|21|||
106063546|NCT01905657|365892825|FG002|Overall Study|Withdrawal by Subject|53|||
106063547|NCT01905657|365892823|FG000|Overall Study|Sponsor Decision|1|||
106063548|NCT01905657|365892824|FG001|Overall Study|Sponsor Decision|0|||
106063549|NCT01905657|365892825|FG002|Overall Study|Sponsor Decision|0|||
106063550|NCT01991067|365894842|FG000|Overall Study|Lost to Follow-up|6|||
106063551|NCT01991067|365894843|FG001|Overall Study|Lost to Follow-up|5|||
106063552|NCT01752907|365894845|FG000|Overall Study|Withdrawal by Subject|4|||
106063553|NCT01752907|365894846|FG001|Overall Study|Withdrawal by Subject|10|||
106063554|NCT01752907|365894845|FG000|Overall Study|Lost to Follow-up|2|||
106063555|NCT01752907|365894846|FG001|Overall Study|Lost to Follow-up|1|||
106063556|NCT01752907|365894845|FG000|Overall Study|Decision by Sponsor|6|||
106063557|NCT01752907|365894846|FG001|Overall Study|Decision by Sponsor|9|||
106063558|NCT02425046|365894847|FG000|Overall Study|Lost to Follow-up|52|||
106063559|NCT02425046|365894848|FG001|Overall Study|Lost to Follow-up|50|||
106063560|NCT02425046|365894849|FG002|Overall Study|Lost to Follow-up|56|||
106063561|NCT02425046|365894847|FG000|Overall Study|Withdrawal by Subject|16|||
106063562|NCT02425046|365894848|FG001|Overall Study|Withdrawal by Subject|12|||
106063563|NCT02425046|365894849|FG002|Overall Study|Withdrawal by Subject|0|||
106063564|NCT01831544|365894853|FG000|Overall Study|Death|1|||
106063565|NCT01831544|365894853|FG000|Overall Study|Still on original MVAD device|2|||
106063566|NCT01402544|365894865|FG000|Overall Study|Withdrawal by Subject|6|||
106063567|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Death|3|||
106063568|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Death|3|||
106063569|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Death|0|||
106063570|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Death|0|||
106063571|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
106063572|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
106063573|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
106063574|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
106063575|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
106063576|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
106063577|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
106063578|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
106063579|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
106063580|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
106063581|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
106063582|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
106063583|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
106063584|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
106063585|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
106063586|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
106063587|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
106063588|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
106063589|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
106063590|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
106063591|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
106063592|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
106063593|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
106063594|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
106063595|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Other|6|||
106063596|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Other|3|||
106063597|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Other|0|||
106063598|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Other|0|||
106063599|NCT02051608|365894867|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
106063600|NCT02051608|365894868|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
106063601|NCT02051608|365894869|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
106063602|NCT02051608|365894870|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
106063603|NCT02051608|365894867|FG000|Part 2: Open-label Extension|Adverse Event|0|||
106063604|NCT02051608|365894868|FG001|Part 2: Open-label Extension|Adverse Event|0|||
106063605|NCT02051608|365894869|FG002|Part 2: Open-label Extension|Adverse Event|6|||
106063606|NCT02051608|365894870|FG003|Part 2: Open-label Extension|Adverse Event|8|||
106063607|NCT02051608|365894867|FG000|Part 2: Open-label Extension|Death|0|||
106063608|NCT02051608|365894868|FG001|Part 2: Open-label Extension|Death|0|||
106063609|NCT02051608|365894869|FG002|Part 2: Open-label Extension|Death|7|||
106063610|NCT02051608|365894870|FG003|Part 2: Open-label Extension|Death|4|||
106063611|NCT02051608|365894867|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
106063612|NCT02051608|365894868|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
106063613|NCT02051608|365894869|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
106063614|NCT02051608|365894870|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
106063615|NCT02051608|365894867|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
106063616|NCT02051608|365894868|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
106063617|NCT02051608|365894869|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
106063618|NCT02051608|365894870|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
106063619|NCT02051608|365894867|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
106063620|NCT02051608|365894868|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
106063621|NCT02051608|365894869|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
106063622|NCT02051608|365894870|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
106063623|NCT02051608|365894867|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
106063624|NCT02051608|365894868|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
106063625|NCT02051608|365894869|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
106063626|NCT02051608|365894870|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
106063627|NCT02051608|365894867|FG000|Part 2: Open-label Extension|Physician Decision|0|||
106063628|NCT02051608|365894868|FG001|Part 2: Open-label Extension|Physician Decision|0|||
106063629|NCT02051608|365894869|FG002|Part 2: Open-label Extension|Physician Decision|8|||
106063630|NCT02051608|365894870|FG003|Part 2: Open-label Extension|Physician Decision|5|||
106063631|NCT02051608|365894867|FG000|Part 2: Open-label Extension|Other|0|||
106063632|NCT02051608|365894868|FG001|Part 2: Open-label Extension|Other|0|||
106063633|NCT02051608|365894869|FG002|Part 2: Open-label Extension|Other|9|||
106063634|NCT02051608|365894870|FG003|Part 2: Open-label Extension|Other|9|||
106063635|NCT03070782|365894873|FG000|Overall Study|Adverse Event|3|||
106063636|NCT03070782|365894874|FG001|Overall Study|Adverse Event|0|||
106063637|NCT03070782|365894875|FG002|Overall Study|Adverse Event|3|||
106063638|NCT03070782|365894876|FG003|Overall Study|Adverse Event|1|||
106063639|NCT03070782|365894877|FG004|Overall Study|Adverse Event|6|||
106063640|NCT03070782|365894878|FG005|Overall Study|Adverse Event|2|||
106063641|NCT03070782|365894873|FG000|Overall Study|Withdrawal by Subject|2|||
106063642|NCT03070782|365894874|FG001|Overall Study|Withdrawal by Subject|1|||
106063643|NCT03070782|365894875|FG002|Overall Study|Withdrawal by Subject|1|||
106063644|NCT03070782|365894876|FG003|Overall Study|Withdrawal by Subject|0|||
106063645|NCT03070782|365894877|FG004|Overall Study|Withdrawal by Subject|4|||
106063646|NCT03070782|365894878|FG005|Overall Study|Withdrawal by Subject|3|||
106063647|NCT03070782|365894873|FG000|Overall Study|Reason Not Specified|2|||
106063648|NCT03070782|365894874|FG001|Overall Study|Reason Not Specified|0|||
106063649|NCT03070782|365894875|FG002|Overall Study|Reason Not Specified|0|||
106063650|NCT03070782|365894876|FG003|Overall Study|Reason Not Specified|1|||
106063651|NCT03070782|365894877|FG004|Overall Study|Reason Not Specified|2|||
106063652|NCT03070782|365894878|FG005|Overall Study|Reason Not Specified|1|||
106063653|NCT03070782|365894873|FG000|Overall Study|Ineligibility|0|||
106063654|NCT03070782|365894874|FG001|Overall Study|Ineligibility|0|||
106063655|NCT03070782|365894875|FG002|Overall Study|Ineligibility|0|||
106063656|NCT03070782|365894876|FG003|Overall Study|Ineligibility|1|||
106063657|NCT03070782|365894877|FG004|Overall Study|Ineligibility|0|||
106063658|NCT03070782|365894878|FG005|Overall Study|Ineligibility|1|||
106063659|NCT03070782|365894873|FG000|Overall Study|Pregnancy|0|||
106063660|NCT03070782|365894874|FG001|Overall Study|Pregnancy|0|||
106063661|NCT03070782|365894875|FG002|Overall Study|Pregnancy|0|||
106063662|NCT03070782|365894876|FG003|Overall Study|Pregnancy|1|||
106063663|NCT03070782|365894877|FG004|Overall Study|Pregnancy|0|||
106063664|NCT03070782|365894878|FG005|Overall Study|Pregnancy|0|||
106063665|NCT03070782|365894873|FG000|Overall Study|Investigator Judgement|0|||
106063666|NCT03070782|365894874|FG001|Overall Study|Investigator Judgement|0|||
106063667|NCT03070782|365894875|FG002|Overall Study|Investigator Judgement|0|||
106063668|NCT03070782|365894876|FG003|Overall Study|Investigator Judgement|1|||
106063669|NCT03070782|365894877|FG004|Overall Study|Investigator Judgement|0|||
106063670|NCT03070782|365894878|FG005|Overall Study|Investigator Judgement|0|||
106063671|NCT01156311|365894882|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
106063672|NCT01156311|365894883|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
106063673|NCT01156311|365894884|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
106063674|NCT01156311|365894885|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
106063675|NCT01156311|365894882|FG000|2-Month Monotherapy Period|Physician Decision|0|||
106063676|NCT01156311|365894883|FG001|2-Month Monotherapy Period|Physician Decision|1|||
106063677|NCT01156311|365894884|FG002|2-Month Monotherapy Period|Physician Decision|0|||
105864989|NCT00548093|365154801|FG001|Overall Study|Completed post-treatment follow-up|0|||
105864990|NCT02516553|365154802|FG000|Overall Study|Progressive disease|2|||
105864991|NCT02516553|365154803|FG001|Overall Study|Progressive disease|2|||
106063678|NCT01156311|365894885|FG003|2-Month Monotherapy Period|Physician Decision|0|||
106063679|NCT01156311|365894882|FG000|2-Month Monotherapy Period|Other|1|||
106063680|NCT01156311|365894883|FG001|2-Month Monotherapy Period|Other|0|||
106063681|NCT01156311|365894884|FG002|2-Month Monotherapy Period|Other|0|||
106063682|NCT01156311|365894885|FG003|2-Month Monotherapy Period|Other|0|||
106063683|NCT01156311|365894882|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
106063684|NCT01156311|365894883|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
106063685|NCT01156311|365894884|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
106063686|NCT01156311|365894885|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
106063687|NCT01156311|365894882|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
106063688|NCT01156311|365894883|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
106063689|NCT01156311|365894884|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
106063690|NCT01156311|365894885|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
106063691|NCT01156311|365894882|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
106063692|NCT01156311|365894883|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
106063693|NCT01156311|365894884|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
106063694|NCT01156311|365894885|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
105864992|NCT02516553|365154804|FG002|Overall Study|Progressive disease|3|||
105864993|NCT02516553|365154805|FG003|Overall Study|Progressive disease|5|||
105864994|NCT02516553|365154806|FG004|Overall Study|Progressive disease|3|||
105864995|NCT02516553|365154807|FG005|Overall Study|Progressive disease|0|||
106063695|NCT01156311|365894882|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
106063696|NCT01156311|365894883|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
106063697|NCT01156311|365894884|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
106063698|NCT01156311|365894885|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
106063699|NCT01156311|365894882|FG000|6-month Add-on Therapy Period|Other|0|||
106063700|NCT01156311|365894883|FG001|6-month Add-on Therapy Period|Other|0|||
106063701|NCT01156311|365894884|FG002|6-month Add-on Therapy Period|Other|1|||
106063702|NCT01156311|365894885|FG003|6-month Add-on Therapy Period|Other|2|||
106063703|NCT01741701|365894886|FG000|Overall Study|Adverse Event|5|||
106063704|NCT01741701|365894887|FG001|Overall Study|Adverse Event|1|||
106063705|NCT01741701|365894886|FG000|Overall Study|Withdrawal by Subject|0|||
106063706|NCT01741701|365894887|FG001|Overall Study|Withdrawal by Subject|1|||
106063707|NCT00006903|365894888|FG000|Overall Study|Still receiving treatment|0|||
106063708|NCT00006903|365894889|FG001|Overall Study|Still receiving treatment|0|||
106063709|NCT00006903|365894890|FG002|Overall Study|Still receiving treatment|1|||
106063710|NCT00006903|365894888|FG000|Overall Study|Refused further treatment|0|||
106063711|NCT00006903|365894889|FG001|Overall Study|Refused further treatment|2|||
106063712|NCT00006903|365894890|FG002|Overall Study|Refused further treatment|1|||
106063713|NCT00006903|365894888|FG000|Overall Study|Adverse Event|0|||
106063714|NCT00006903|365894889|FG001|Overall Study|Adverse Event|0|||
106063715|NCT00006903|365894890|FG002|Overall Study|Adverse Event|1|||
106063716|NCT00006903|365894888|FG000|Overall Study|Death|0|||
106063717|NCT00006903|365894889|FG001|Overall Study|Death|1|||
106063718|NCT00006903|365894890|FG002|Overall Study|Death|0|||
106063719|NCT00006903|365894888|FG000|Overall Study|Patient never treated|0|||
106063720|NCT00006903|365894889|FG001|Overall Study|Patient never treated|0|||
106063721|NCT00006903|365894890|FG002|Overall Study|Patient never treated|1|||
106063722|NCT00006903|365894888|FG000|Overall Study|Ineligible|10|||
106063723|NCT00006903|365894889|FG001|Overall Study|Ineligible|1|||
106063724|NCT00006903|365894890|FG002|Overall Study|Ineligible|2|||
106063725|NCT01980992|365894893|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
106063726|NCT01980992|365894894|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
106063727|NCT01980992|365894893|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
106063728|NCT01980992|365894894|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
106063729|NCT01980992|365894893|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
106063730|NCT01980992|365894894|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
106063731|NCT01980992|365894893|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
106063732|NCT01980992|365894894|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
106063733|NCT01980992|365894893|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
106063734|NCT01980992|365894894|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
106063735|NCT01980992|365894893|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
106063736|NCT01980992|365894894|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
106063737|NCT02927431|365894895|FG000|Overall Study|Withdrawal by Subject|0|||
106063738|NCT02927431|365894896|FG001|Overall Study|Withdrawal by Subject|0|||
106063739|NCT02927431|365894897|FG002|Overall Study|Withdrawal by Subject|1|||
106063740|NCT02651922|365894900|FG000|Overall Study|due to exclusion criteria|2|||
106063741|NCT01829191|365894901|FG000|Overall Study|Relocation|0|||
106063742|NCT01829191|365894902|FG001|Overall Study|Relocation|1|||
106063743|NCT01829191|365894901|FG000|Overall Study|Lens discomfort|0|||
106063744|NCT01829191|365894902|FG001|Overall Study|Lens discomfort|3|||
106063745|NCT01829191|365894901|FG000|Overall Study|Lens handling difficulty|1|||
106063746|NCT01829191|365894902|FG001|Overall Study|Lens handling difficulty|4|||
106063747|NCT01829191|365894901|FG000|Overall Study|Protocol Violation|4|||
106063748|NCT01829191|365894902|FG001|Overall Study|Protocol Violation|1|||
106063749|NCT01829191|365894901|FG000|Overall Study|Withdrawal by Subject|2|||
106063750|NCT01829191|365894902|FG001|Overall Study|Withdrawal by Subject|3|||
106063751|NCT01829191|365894901|FG000|Overall Study|Lost to Follow-up|0|||
106063752|NCT01829191|365894902|FG001|Overall Study|Lost to Follow-up|1|||
106063753|NCT01829191|365894901|FG000|Overall Study|Subject was fit for ortho - k|0|||
106063754|NCT01829191|365894902|FG001|Overall Study|Subject was fit for ortho - k|1|||
106063755|NCT01907815|365894903|FG000|Overall Study|Withdrawal by Subject|1|||
106063756|NCT01907815|365894904|FG001|Overall Study|Withdrawal by Subject|0|||
106063757|NCT01276353|365894905|FG000|Double-blind|Adverse Event|2|||
106063758|NCT01276353|365894906|FG001|Double-blind|Adverse Event|0|||
106063759|NCT01276353|365894905|FG000|Double-blind|Withdrawal by Subject|1|||
106063760|NCT01276353|365894906|FG001|Double-blind|Withdrawal by Subject|0|||
106063761|NCT01276353|365894905|FG000|Extension|Adverse Event|2|||
106063762|NCT01276353|365894906|FG001|Extension|Adverse Event|5|||
106063763|NCT01276353|365894905|FG000|Extension|Withdrawal by Subject|1|||
106063764|NCT01276353|365894906|FG001|Extension|Withdrawal by Subject|2|||
106063765|NCT01276353|365894905|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
106063766|NCT01276353|365894906|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
106063767|NCT01276353|365894905|FG000|Extension|Physician Decision|1|||
106063768|NCT01276353|365894906|FG001|Extension|Physician Decision|0|||
106063769|NCT01276353|365894905|FG000|Extension|Prohibited concomitant medications|0|||
106063770|NCT01276353|365894906|FG001|Extension|Prohibited concomitant medications|1|||
106063771|NCT03402386|365894908|FG000|Overall Study|Adverse Event|3|||
106063772|NCT03402386|365894908|FG000|Overall Study|Physician Decision|1|||
106063773|NCT03402386|365894908|FG000|Overall Study|Difficult to control Hb|2|||
106063774|NCT01574326|365894909|FG000|Overall Study|Randomized but not treated|0|||
106063775|NCT01574326|365894910|FG001|Overall Study|Randomized but not treated|1|||
106063776|NCT01574326|365894909|FG000|Overall Study|Withdrawal by Participant|2|||
106063777|NCT01574326|365894910|FG001|Overall Study|Withdrawal by Participant|4|||
106063778|NCT01574326|365894909|FG000|Overall Study|Physician Decision|5|||
106063779|NCT01574326|365894910|FG001|Overall Study|Physician Decision|3|||
106063780|NCT01574326|365894909|FG000|Overall Study|Adverse Event|1|||
106063781|NCT01574326|365894910|FG001|Overall Study|Adverse Event|3|||
106063782|NCT01574326|365894909|FG000|Overall Study|Other: Mainly kidney transplant|8|||
106063783|NCT01574326|365894910|FG001|Overall Study|Other: Mainly kidney transplant|8|||
106063784|NCT02485574|365894915|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
106063785|NCT00555321|365894918|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
106063786|NCT00555321|365894919|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
106063787|NCT00555321|365894920|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
106063788|NCT00555321|365894921|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
106063789|NCT00555321|365894922|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
106063790|NCT00555321|365894918|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
106063791|NCT00555321|365894919|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
106063792|NCT00555321|365894920|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
106063793|NCT00555321|365894921|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
106063794|NCT00555321|365894922|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
106063795|NCT00555321|365894918|FG000|Treatment Phase up to 12-months|Death|2|||
106063796|NCT00555321|365894919|FG001|Treatment Phase up to 12-months|Death|1|||
106063797|NCT00555321|365894920|FG002|Treatment Phase up to 12-months|Death|4|||
106063798|NCT00555321|365894921|FG003|Treatment Phase up to 12-months|Death|0|||
106063799|NCT00555321|365894922|FG004|Treatment Phase up to 12-months|Death|0|||
106063800|NCT00555321|365894918|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
106063801|NCT00555321|365894919|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
106063802|NCT00555321|365894920|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
106063803|NCT00555321|365894921|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
106063804|NCT00555321|365894922|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
106063805|NCT00555321|365894918|FG000|Treatment Phase up to 12-months|Other Reason|1|||
106063806|NCT00555321|365894919|FG001|Treatment Phase up to 12-months|Other Reason|3|||
106063807|NCT00555321|365894920|FG002|Treatment Phase up to 12-months|Other Reason|2|||
106063808|NCT00555321|365894921|FG003|Treatment Phase up to 12-months|Other Reason|0|||
106063809|NCT00555321|365894922|FG004|Treatment Phase up to 12-months|Other Reason|0|||
106063810|NCT00555321|365894918|FG000|Treatment Phase up to 12-months|Never treated|2|||
106063811|NCT00555321|365894919|FG001|Treatment Phase up to 12-months|Never treated|3|||
106063812|NCT00555321|365894920|FG002|Treatment Phase up to 12-months|Never treated|1|||
106063813|NCT00555321|365894921|FG003|Treatment Phase up to 12-months|Never treated|0|||
106063814|NCT00555321|365894922|FG004|Treatment Phase up to 12-months|Never treated|4|||
106063815|NCT00555321|365894918|FG000|Long-term Extension Phase|Adverse Event|2|||
106153957|NCT03398148|366223908|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153958|NCT03398148|366223909|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153959|NCT03398148|366223910|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153960|NCT03398148|366223911|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153961|NCT03398148|366223912|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153962|NCT03398148|366223913|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153963|NCT03398148|366223914|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153964|NCT03398148|366223915|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
106153965|NCT03398148|366223916|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
106153966|NCT03398148|366223917|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
106153967|NCT02791230|366223918|FG000|Overall Study|Adverse Event|10|||
106153968|NCT02791230|366223919|FG001|Overall Study|Adverse Event|9|||
106153969|NCT02791230|366223920|FG002|Overall Study|Adverse Event|66|||
106153970|NCT02791230|366223918|FG000|Overall Study|Death|38|||
106153971|NCT02791230|366223919|FG001|Overall Study|Death|25|||
106153972|NCT02791230|366223920|FG002|Overall Study|Death|184|||
106153973|NCT02791230|366223918|FG000|Overall Study|Lack of Efficacy|1|||
106063816|NCT00555321|365894919|FG001|Long-term Extension Phase|Adverse Event|5|||
106063817|NCT00555321|365894920|FG002|Long-term Extension Phase|Adverse Event|2|||
106063818|NCT00555321|365894921|FG003|Long-term Extension Phase|Adverse Event|1|||
106063819|NCT00555321|365894922|FG004|Long-term Extension Phase|Adverse Event|0|||
106063820|NCT00555321|365894918|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
106063821|NCT00555321|365894919|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
106063822|NCT00555321|365894920|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
106063823|NCT00555321|365894921|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
106063824|NCT00555321|365894922|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
106063825|NCT00555321|365894918|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
106063826|NCT00555321|365894919|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
106063827|NCT00555321|365894920|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
106063828|NCT00555321|365894921|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
106063829|NCT00555321|365894922|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
106063830|NCT00555321|365894918|FG000|Long-term Extension Phase|Death|2|||
106063831|NCT00555321|365894919|FG001|Long-term Extension Phase|Death|0|||
106063832|NCT00555321|365894920|FG002|Long-term Extension Phase|Death|0|||
106063833|NCT00555321|365894921|FG003|Long-term Extension Phase|Death|3|||
106063834|NCT00555321|365894922|FG004|Long-term Extension Phase|Death|0|||
106063835|NCT00555321|365894918|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
106063836|NCT00555321|365894919|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
106063837|NCT00555321|365894920|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
106063838|NCT00555321|365894921|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
106063839|NCT00555321|365894922|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
106063840|NCT00555321|365894918|FG000|Long-term Extension Phase|Other Reason|1|||
106063841|NCT00555321|365894919|FG001|Long-term Extension Phase|Other Reason|0|||
106063842|NCT00555321|365894920|FG002|Long-term Extension Phase|Other Reason|2|||
106063843|NCT00555321|365894921|FG003|Long-term Extension Phase|Other Reason|0|||
106153974|NCT02791230|366223919|FG001|Overall Study|Lack of Efficacy|0|||
106153975|NCT02791230|366223920|FG002|Overall Study|Lack of Efficacy|3|||
106153976|NCT02791230|366223918|FG000|Overall Study|Lost to Follow-up|0|||
106153977|NCT02791230|366223919|FG001|Overall Study|Lost to Follow-up|0|||
106153978|NCT02791230|366223920|FG002|Overall Study|Lost to Follow-up|10|||
106063844|NCT00555321|365894922|FG004|Long-term Extension Phase|Other Reason|0|||
106063845|NCT00137046|365894923|FG000|Overall Study|Death|2|||
106063846|NCT00137046|365894924|FG001|Overall Study|Death|1|||
106063847|NCT00137046|365894923|FG000|Overall Study|Adverse Event|16|||
106063848|NCT00137046|365894924|FG001|Overall Study|Adverse Event|5|||
106063849|NCT00137046|365894923|FG000|Overall Study|Laboratory Abnormality|2|||
106063850|NCT00137046|365894924|FG001|Overall Study|Laboratory Abnormality|0|||
106063851|NCT00137046|365894923|FG000|Overall Study|Lack of Efficacy|13|||
106063852|NCT00137046|365894924|FG001|Overall Study|Lack of Efficacy|1|||
106063853|NCT00137046|365894923|FG000|Overall Study|Lost to Follow-up|8|||
106063854|NCT00137046|365894924|FG001|Overall Study|Lost to Follow-up|24|||
106063855|NCT00137046|365894923|FG000|Overall Study|Other|23|||
106063856|NCT00137046|365894924|FG001|Overall Study|Other|19|||
106063857|NCT00137046|365894923|FG000|Overall Study|Withdrawal by Subject|33|||
106063858|NCT00137046|365894924|FG001|Overall Study|Withdrawal by Subject|42|||
106063859|NCT00137046|365894923|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
106063860|NCT00137046|365894924|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
106063861|NCT00137046|365894923|FG000|Overall Study|Withdrew prior to study treatment|1|||
106063862|NCT00137046|365894924|FG001|Overall Study|Withdrew prior to study treatment|1|||
106063863|NCT01288469|365894925|FG000|Overall Study|Adverse Event|4|||
106063864|NCT01288469|365894926|FG001|Overall Study|Adverse Event|1|||
106063865|NCT01288469|365894927|FG002|Overall Study|Adverse Event|1|||
106063866|NCT01288469|365894925|FG000|Overall Study|Poor compliance to protocol|0|||
106063867|NCT01288469|365894926|FG001|Overall Study|Poor compliance to protocol|1|||
106063868|NCT01288469|365894927|FG002|Overall Study|Poor compliance to protocol|0|||
106063869|NCT01288469|365894925|FG000|Overall Study|Participant Moved|1|||
106063870|NCT01288469|365894926|FG001|Overall Study|Participant Moved|0|||
106063871|NCT01288469|365894927|FG002|Overall Study|Participant Moved|0|||
106063872|NCT01288469|365894925|FG000|Overall Study|Consent withdrawn by subject|1|||
106063873|NCT01288469|365894926|FG001|Overall Study|Consent withdrawn by subject|1|||
106063874|NCT01288469|365894927|FG002|Overall Study|Consent withdrawn by subject|1|||
106063875|NCT01288469|365894925|FG000|Overall Study|Exclusion criteria finally met|1|||
106063876|NCT01288469|365894926|FG001|Overall Study|Exclusion criteria finally met|0|||
106063877|NCT01288469|365894927|FG002|Overall Study|Exclusion criteria finally met|0|||
106063878|NCT03672747|365894932|FG000|Overall Study|Lost to Follow-up|1|||
106063879|NCT03672747|365894933|FG001|Overall Study|Lost to Follow-up|1|||
106063880|NCT03672747|365894934|FG002|Overall Study|Lost to Follow-up|2|||
106063881|NCT03672747|365894935|FG003|Overall Study|Lost to Follow-up|2|||
106063882|NCT03672747|365894936|FG004|Overall Study|Lost to Follow-up|2|||
106063883|NCT03672747|365894937|FG005|Overall Study|Lost to Follow-up|1|||
106063884|NCT03198234|365894938|FG000|Overall Study|Relapse of primary disease|0|||
106063885|NCT03198234|365894939|FG001|Overall Study|Relapse of primary disease|1|||
106063886|NCT03198234|365894940|FG002|Overall Study|Relapse of primary disease|0|||
106063887|NCT02622321|365894942|FG000|Overall Study|Withdrawal by Subject|2|||
106063888|NCT02622321|365894943|FG001|Overall Study|Withdrawal by Subject|0|||
106063889|NCT02622321|365894944|FG002|Overall Study|Withdrawal by Subject|0|||
106063890|NCT02622321|365894945|FG003|Overall Study|Withdrawal by Subject|0|||
106063891|NCT02622321|365894942|FG000|Overall Study|Death|0|||
106063892|NCT02622321|365894943|FG001|Overall Study|Death|0|||
106063893|NCT02622321|365894944|FG002|Overall Study|Death|1|||
106063894|NCT02622321|365894945|FG003|Overall Study|Death|0|||
106063895|NCT02622321|365894942|FG000|Overall Study|Physician Decision|1|||
106063896|NCT02622321|365894943|FG001|Overall Study|Physician Decision|0|||
106063897|NCT02622321|365894944|FG002|Overall Study|Physician Decision|0|||
106063898|NCT02622321|365894945|FG003|Overall Study|Physician Decision|0|||
106063899|NCT03694821|365894950|FG000|Overall Study|Study terminated|4|||
106063900|NCT03694821|365894951|FG001|Overall Study|Study terminated|8|||
106063901|NCT03694821|365894952|FG002|Overall Study|Study terminated|4|||
106063902|NCT00897104|365894953|FG000|Overall Study|Lost to Follow-up|12|||
106063903|NCT00897104|365894954|FG001|Overall Study|Lost to Follow-up|17|||
106063904|NCT00897104|365894955|FG002|Overall Study|Lost to Follow-up|2|||
106063905|NCT00897104|365894953|FG000|Overall Study|Pregnancy|0|||
106063906|NCT00897104|365894954|FG001|Overall Study|Pregnancy|1|||
106063907|NCT00897104|365894955|FG002|Overall Study|Pregnancy|0|||
106063908|NCT00897104|365894953|FG000|Overall Study|Protocol Violation|0|||
106063909|NCT00897104|365894954|FG001|Overall Study|Protocol Violation|1|||
106063910|NCT00897104|365894955|FG002|Overall Study|Protocol Violation|0|||
106063911|NCT00897104|365894953|FG000|Overall Study|Withdrawal by Subject|23|||
106063912|NCT00897104|365894954|FG001|Overall Study|Withdrawal by Subject|27|||
106063913|NCT00897104|365894955|FG002|Overall Study|Withdrawal by Subject|3|||
106153979|NCT02791230|366223918|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
106153980|NCT02791230|366223919|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
106063914|NCT00897104|365894953|FG000|Overall Study|Abnormal Prestudy Labs|2|||
106063915|NCT00897104|365894954|FG001|Overall Study|Abnormal Prestudy Labs|0|||
106063916|NCT00897104|365894955|FG002|Overall Study|Abnormal Prestudy Labs|0|||
106063917|NCT00897104|365894953|FG000|Overall Study|Abnormal Baseline ECG|2|||
106063918|NCT00897104|365894954|FG001|Overall Study|Abnormal Baseline ECG|2|||
106063919|NCT00897104|365894955|FG002|Overall Study|Abnormal Baseline ECG|0|||
106063920|NCT00897104|365894953|FG000|Overall Study|Need for Concom. Med.|0|||
106063921|NCT00897104|365894954|FG001|Overall Study|Need for Concom. Med.|1|||
106063922|NCT00897104|365894955|FG002|Overall Study|Need for Concom. Med.|1|||
106063923|NCT00897104|365894953|FG000|Overall Study|Lack of Migraine Attack|20|||
106063924|NCT00897104|365894954|FG001|Overall Study|Lack of Migraine Attack|22|||
106063925|NCT00897104|365894955|FG002|Overall Study|Lack of Migraine Attack|1|||
106063926|NCT00897104|365894953|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
106063927|NCT00897104|365894954|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
106063928|NCT00897104|365894955|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
106063929|NCT00897104|365894953|FG000|Overall Study|Other|3|||
106063930|NCT00897104|365894954|FG001|Overall Study|Other|0|||
106063931|NCT00897104|365894955|FG002|Overall Study|Other|0|||
106063932|NCT00897104|365894953|FG000|Overall Study|Protocol Violation|1|||
106063933|NCT00897104|365894954|FG001|Overall Study|Protocol Violation|0|||
106063934|NCT00897104|365894955|FG002|Overall Study|Protocol Violation|0|||
106063935|NCT00897104|365894953|FG000|Overall Study|Withdrawal by Subject|0|||
106063936|NCT00897104|365894954|FG001|Overall Study|Withdrawal by Subject|0|||
106063937|NCT00897104|365894955|FG002|Overall Study|Withdrawal by Subject|1|||
106063938|NCT01059799|365894958|FG000|Overall Study|Adverse Event|2|||
106063939|NCT01059799|365894959|FG001|Overall Study|Adverse Event|3|||
106063940|NCT01059799|365894958|FG000|Overall Study|Lack of Efficacy|1|||
106063941|NCT01059799|365894959|FG001|Overall Study|Lack of Efficacy|0|||
106063942|NCT01059799|365894958|FG000|Overall Study|Protocol Violation|3|||
106063943|NCT01059799|365894959|FG001|Overall Study|Protocol Violation|2|||
106063944|NCT01059799|365894958|FG000|Overall Study|Withdrawal criteria|13|||
106063945|NCT01059799|365894959|FG001|Overall Study|Withdrawal criteria|2|||
106063946|NCT01059799|365894958|FG000|Overall Study|Other|12|||
106063947|NCT01059799|365894959|FG001|Overall Study|Other|3|||
106063948|NCT00434330|365894962|FG000|Overall Study|Adverse Event|0|||
106063949|NCT00434330|365894963|FG001|Overall Study|Adverse Event|0|||
106063950|NCT00434330|365894964|FG002|Overall Study|Adverse Event|1|||
106063951|NCT00434330|365894965|FG003|Overall Study|Adverse Event|0|||
106063952|NCT00434330|365894966|FG004|Overall Study|Adverse Event|0|||
106063953|NCT00434330|365894967|FG005|Overall Study|Adverse Event|0|||
106063954|NCT00434330|365894962|FG000|Overall Study|Death|1|||
106063955|NCT00434330|365894963|FG001|Overall Study|Death|0|||
106063956|NCT00434330|365894964|FG002|Overall Study|Death|0|||
106063957|NCT00434330|365894965|FG003|Overall Study|Death|0|||
106063958|NCT00434330|365894966|FG004|Overall Study|Death|1|||
106063959|NCT00434330|365894967|FG005|Overall Study|Death|1|||
106063960|NCT00434330|365894962|FG000|Overall Study|Withdrawal by Subject|0|||
106063961|NCT00434330|365894963|FG001|Overall Study|Withdrawal by Subject|0|||
106063962|NCT00434330|365894964|FG002|Overall Study|Withdrawal by Subject|1|||
106063963|NCT00434330|365894965|FG003|Overall Study|Withdrawal by Subject|1|||
106063964|NCT00434330|365894966|FG004|Overall Study|Withdrawal by Subject|0|||
106063965|NCT00434330|365894967|FG005|Overall Study|Withdrawal by Subject|0|||
106063966|NCT00434330|365894962|FG000|Overall Study|Renal transplant|0|||
106063967|NCT00434330|365894963|FG001|Overall Study|Renal transplant|0|||
106063968|NCT00434330|365894964|FG002|Overall Study|Renal transplant|0|||
106063969|NCT00434330|365894965|FG003|Overall Study|Renal transplant|1|||
106063970|NCT00434330|365894966|FG004|Overall Study|Renal transplant|0|||
106063971|NCT00434330|365894967|FG005|Overall Study|Renal transplant|0|||
106063972|NCT00434330|365894962|FG000|Overall Study|Subject Not Compliant With Study|0|||
106063973|NCT00434330|365894963|FG001|Overall Study|Subject Not Compliant With Study|0|||
106063974|NCT00434330|365894964|FG002|Overall Study|Subject Not Compliant With Study|1|||
106063975|NCT00434330|365894965|FG003|Overall Study|Subject Not Compliant With Study|0|||
106063976|NCT00434330|365894966|FG004|Overall Study|Subject Not Compliant With Study|0|||
106063977|NCT00434330|365894967|FG005|Overall Study|Subject Not Compliant With Study|0|||
106063978|NCT04702997|365894973|FG000|Overall Study|Withdrawal by Subject|1|||
106063979|NCT04702997|365894974|FG001|Overall Study|Withdrawal by Subject|1|||
106063980|NCT03789318|365894977|FG000|Overall Study|Adverse Event|0|||
106063981|NCT03789318|365894978|FG001|Overall Study|Adverse Event|0|||
106063982|NCT03789318|365894979|FG002|Overall Study|Adverse Event|1|||
106063983|NCT03789318|365894980|FG003|Overall Study|Adverse Event|1|||
106063984|NCT03789318|365894981|FG004|Overall Study|Adverse Event|0|||
106063985|NCT03789318|365894977|FG000|Overall Study|Lost to Follow-up|0|||
106063986|NCT03789318|365894978|FG001|Overall Study|Lost to Follow-up|0|||
106063987|NCT03789318|365894979|FG002|Overall Study|Lost to Follow-up|1|||
106063988|NCT03789318|365894980|FG003|Overall Study|Lost to Follow-up|0|||
106063989|NCT03789318|365894981|FG004|Overall Study|Lost to Follow-up|0|||
106063990|NCT03789318|365894977|FG000|Overall Study|Withdrawal by Subject|0|||
106063991|NCT03789318|365894978|FG001|Overall Study|Withdrawal by Subject|0|||
106063992|NCT03789318|365894979|FG002|Overall Study|Withdrawal by Subject|1|||
106063993|NCT03789318|365894980|FG003|Overall Study|Withdrawal by Subject|0|||
106063994|NCT03789318|365894981|FG004|Overall Study|Withdrawal by Subject|0|||
106063995|NCT01535053|365894982|FG000|Overall Study|Ineligible|1|||
106063996|NCT01535053|365894983|FG001|Overall Study|Ineligible|2|||
106063997|NCT00512707|365894984|FG000|Overall Study|Lost to Follow-up|5|||
106063998|NCT00512707|365894985|FG001|Overall Study|Lost to Follow-up|11|||
106063999|NCT00512707|365894984|FG000|Overall Study|Developed skin irritation|2|||
106064000|NCT00512707|365894985|FG001|Overall Study|Developed skin irritation|1|||
106064001|NCT00512707|365894984|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
106064002|NCT00512707|365894985|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
106064003|NCT00512707|365894984|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
106064004|NCT00512707|365894985|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
106064005|NCT03700671|365894988|FG000|Overall Study|Lack of Efficacy|1|||
106064006|NCT03700671|365894989|FG001|Overall Study|Lack of Efficacy|2|||
106064007|NCT01937559|365894997|FG000|Overall Study|Physician Decision|3|||
106064008|NCT01937559|365894998|FG001|Overall Study|Physician Decision|3|||
106064009|NCT01937559|365894999|FG002|Overall Study|Physician Decision|0|||
106064010|NCT01937559|365894997|FG000|Overall Study|Withdrawal by Subject|6|||
106064011|NCT01937559|365894998|FG001|Overall Study|Withdrawal by Subject|4|||
106064012|NCT01937559|365894999|FG002|Overall Study|Withdrawal by Subject|0|||
106064013|NCT01937559|365894997|FG000|Overall Study|screen fail|2|||
106064014|NCT01937559|365894998|FG001|Overall Study|screen fail|4|||
106064015|NCT01937559|365894999|FG002|Overall Study|screen fail|0|||
106064016|NCT02879305|365895000|FG000|Overall Study|Investigator Site Closed|55|||
106064017|NCT02879305|365895001|FG001|Overall Study|Investigator Site Closed|57|||
106064018|NCT02879305|365895000|FG000|Overall Study|Withdrawal by Subject|44|||
106064019|NCT02879305|365895001|FG001|Overall Study|Withdrawal by Subject|42|||
106064020|NCT02879305|365895000|FG000|Overall Study|Lost to Follow-up|17|||
106064021|NCT02879305|365895001|FG001|Overall Study|Lost to Follow-up|12|||
106064022|NCT02879305|365895000|FG000|Overall Study|Other|1|||
106064023|NCT02879305|365895001|FG001|Overall Study|Other|0|||
106064024|NCT02961751|365896271|FG000|Overall Study|Lost to Follow-up|11|||
106064025|NCT02961751|365896271|FG000|Overall Study|Physician Decision|2|||
106064026|NCT02961751|365896271|FG000|Overall Study|Not Eligible at Enrollment|1|||
106064027|NCT02961751|365896271|FG000|Overall Study|Protocol Violation|1|||
106064028|NCT02392247|365896272|FG000|Overall Study|Withdrawal by Subject|1|||
106064029|NCT02392247|365896272|FG000|Overall Study|Surgery cancelled; no data|1|||
106064030|NCT03909295|365896273|FG000|Overall Study|Adverse Event|2|||
106064031|NCT03909295|365896273|FG000|Overall Study|Study terminated by sponsor|50|||
106064032|NCT01411228|365896274|FG000|Overall Study|Lost to Follow-up|0|||
106064033|NCT01411228|365896275|FG001|Overall Study|Lost to Follow-up|0|||
106064034|NCT01411228|365896276|FG002|Overall Study|Lost to Follow-up|1|||
106064035|NCT01411228|365896274|FG000|Overall Study|Withdrawal by Subject|1|||
106064036|NCT01411228|365896275|FG001|Overall Study|Withdrawal by Subject|0|||
106064037|NCT01411228|365896276|FG002|Overall Study|Withdrawal by Subject|0|||
106064038|NCT00931762|365896284|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
106064039|NCT00931762|365896284|FG000|Overall Study|Administrative Problems|5|||
106064040|NCT00931762|365896284|FG000|Overall Study|Death|1|||
106064041|NCT00931762|365896284|FG000|Overall Study|Disease Progression|3|||
106064042|NCT00931762|365896284|FG000|Overall Study|Adverse Event (s)|11|||
106064043|NCT00931762|365896284|FG000|Overall Study|Subject withdrew consent|13|||
106064044|NCT00799487|365896295|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
106064045|NCT00799487|365896296|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
106064046|NCT00799487|365896297|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
106064047|NCT00799487|365896295|FG000|Dose Adjustment Period|Adverse Event|2|||
106064048|NCT00799487|365896296|FG001|Dose Adjustment Period|Adverse Event|0|||
106064049|NCT00799487|365896297|FG002|Dose Adjustment Period|Adverse Event|0|||
106064050|NCT00799487|365896295|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
106064051|NCT00799487|365896296|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
106064052|NCT00799487|365896297|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
106064053|NCT00799487|365896295|FG000|Dose Adjustment Period|Investigator Discretion|2|||
106064054|NCT00799487|365896296|FG001|Dose Adjustment Period|Investigator Discretion|0|||
106064055|NCT00799487|365896297|FG002|Dose Adjustment Period|Investigator Discretion|0|||
106064056|NCT00799487|365896295|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
106064057|NCT00799487|365896296|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
106064058|NCT00799487|365896297|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
106064059|NCT00799487|365896295|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
106064060|NCT00799487|365896296|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
106064061|NCT00799487|365896297|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
106064062|NCT00799487|365896295|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
106064063|NCT00799487|365896296|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
106064064|NCT00799487|365896297|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
106064065|NCT00799487|365896295|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
106064066|NCT00799487|365896296|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
106064067|NCT00799487|365896297|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
106064068|NCT00799487|365896295|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
106064069|NCT00799487|365896296|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
106064070|NCT00799487|365896297|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
106064071|NCT00799487|365896295|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
106064072|NCT00799487|365896296|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
106064073|NCT00799487|365896297|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
106064074|NCT00799487|365896295|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
106064075|NCT00799487|365896296|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
106064076|NCT00799487|365896297|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
106064077|NCT00799487|365896295|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
106064078|NCT00799487|365896296|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
106064079|NCT00799487|365896297|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
106064080|NCT03263442|365896298|FG000|Inpatient Phase|Death|1|||
106064081|NCT03263442|365896299|FG001|Inpatient Phase|Death|0|||
106064082|NCT03263442|365896298|FG000|Inpatient Phase|Withdrawal by Subject|1|||
106064083|NCT03263442|365896299|FG001|Inpatient Phase|Withdrawal by Subject|0|||
106064084|NCT03263442|365896298|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
106064085|NCT03263442|365896299|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
106064086|NCT03263442|365896298|FG000|1-month Follow-Up|Lost to Follow-up|1|||
106064087|NCT03263442|365896299|FG001|1-month Follow-Up|Lost to Follow-up|0|||
106064088|NCT03263442|365896298|FG000|3-month Follow-Up|Lost to Follow-up|1|||
106064089|NCT03263442|365896299|FG001|3-month Follow-Up|Lost to Follow-up|3|||
106064090|NCT03263442|365896298|FG000|6-month Follow-Up|Lost to Follow-up|2|||
106064091|NCT03263442|365896299|FG001|6-month Follow-Up|Lost to Follow-up|2|||
106064092|NCT03518073|365896300|FG000|Overall Study|Adverse Event|2|||
106064093|NCT03518073|365896301|FG001|Overall Study|Adverse Event|4|||
106064094|NCT03518073|365896302|FG002|Overall Study|Adverse Event|2|||
106064095|NCT03518073|365896300|FG000|Overall Study|Death|2|||
106064096|NCT03518073|365896301|FG001|Overall Study|Death|1|||
106064097|NCT03518073|365896302|FG002|Overall Study|Death|3|||
106064098|NCT03518073|365896300|FG000|Overall Study|Lost to Follow-up|1|||
106064099|NCT03518073|365896301|FG001|Overall Study|Lost to Follow-up|0|||
106064100|NCT03518073|365896302|FG002|Overall Study|Lost to Follow-up|1|||
106064101|NCT03518073|365896300|FG000|Overall Study|Physician Decision|5|||
106064102|NCT03518073|365896301|FG001|Overall Study|Physician Decision|0|||
106064103|NCT03518073|365896302|FG002|Overall Study|Physician Decision|2|||
106064104|NCT03518073|365896300|FG000|Overall Study|Progressive disease|1|||
106064105|NCT03518073|365896301|FG001|Overall Study|Progressive disease|1|||
106064106|NCT03518073|365896302|FG002|Overall Study|Progressive disease|1|||
106064107|NCT03518073|365896300|FG000|Overall Study|Protocol Violation|1|||
106064108|NCT03518073|365896301|FG001|Overall Study|Protocol Violation|0|||
106064109|NCT03518073|365896302|FG002|Overall Study|Protocol Violation|0|||
106064110|NCT03518073|365896300|FG000|Overall Study|Withdrawal by Subject|30|||
106064111|NCT03518073|365896301|FG001|Overall Study|Withdrawal by Subject|34|||
106064112|NCT03518073|365896302|FG002|Overall Study|Withdrawal by Subject|29|||
106064113|NCT03518073|365896300|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
106064114|NCT03518073|365896301|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
106064115|NCT03518073|365896302|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
106064116|NCT03518073|365896300|FG000|Overall Study|Covid-19|1|||
106064117|NCT03518073|365896301|FG001|Overall Study|Covid-19|2|||
106064118|NCT03518073|365896302|FG002|Overall Study|Covid-19|1|||
106064119|NCT00065507|365896303|FG000|Overall Study|Death|16|||
106064120|NCT00065507|365896304|FG001|Overall Study|Death|17|||
106064121|NCT00065507|365896303|FG000|Overall Study|Adverse Event|4|||
106064122|NCT00065507|365896304|FG001|Overall Study|Adverse Event|3|||
106064123|NCT00065507|365896303|FG000|Overall Study|Lack of Efficacy|0|||
106064124|NCT00065507|365896304|FG001|Overall Study|Lack of Efficacy|6|||
106064125|NCT00065507|365896303|FG000|Overall Study|Poor/Non-compliance|3|||
106064126|NCT00065507|365896304|FG001|Overall Study|Poor/Non-compliance|2|||
106064127|NCT00065507|365896303|FG000|Overall Study|Lost to Follow-up|3|||
106064128|NCT00065507|365896304|FG001|Overall Study|Lost to Follow-up|0|||
106064129|NCT00065507|365896303|FG000|Overall Study|Subject Withdrew Consent|2|||
106064130|NCT00065507|365896304|FG001|Overall Study|Subject Withdrew Consent|1|||
106064131|NCT00065507|365896303|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
106064132|NCT00065507|365896304|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
106064133|NCT02489344|365896305|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
106064134|NCT02489344|365896305|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
106064135|NCT02489344|365896305|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
106064136|NCT02489344|365896305|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
106064137|NCT04273217|365896306|FG000|Overall Study|Lost to Follow-up|0|||
106064138|NCT04273217|365896307|FG001|Overall Study|Lost to Follow-up|0|||
106064139|NCT04273217|365896308|FG002|Overall Study|Lost to Follow-up|0|||
106064140|NCT04273217|365896309|FG003|Overall Study|Lost to Follow-up|0|||
106064141|NCT04273217|365896310|FG004|Overall Study|Lost to Follow-up|0|||
106064142|NCT04273217|365896311|FG005|Overall Study|Lost to Follow-up|1|||
106064143|NCT04273217|365896306|FG000|Overall Study|Participant non-compliance|0|||
106064144|NCT04273217|365896307|FG001|Overall Study|Participant non-compliance|0|||
106064145|NCT04273217|365896308|FG002|Overall Study|Participant non-compliance|0|||
106064146|NCT04273217|365896309|FG003|Overall Study|Participant non-compliance|0|||
106064147|NCT04273217|365896310|FG004|Overall Study|Participant non-compliance|1|||
106064148|NCT04273217|365896311|FG005|Overall Study|Participant non-compliance|0|||
106064149|NCT04273217|365896306|FG000|Overall Study|Positive urine drug screen|1|||
106064150|NCT04273217|365896307|FG001|Overall Study|Positive urine drug screen|0|||
106064151|NCT04273217|365896308|FG002|Overall Study|Positive urine drug screen|1|||
106064152|NCT04273217|365896309|FG003|Overall Study|Positive urine drug screen|0|||
106064153|NCT04273217|365896310|FG004|Overall Study|Positive urine drug screen|0|||
106064154|NCT04273217|365896311|FG005|Overall Study|Positive urine drug screen|1|||
106064155|NCT03042533|365896314|FG000|Overall Study|MD left program|1|||
106064156|NCT03042533|365896315|FG001|Overall Study|MD left program|4|||
106064157|NCT03042533|365896316|FG002|Overall Study|MD left program|1|||
106064158|NCT01948050|365896317|FG000|Overall Study|Withdrawal by Subject|0|||
106064159|NCT01948050|365896318|FG001|Overall Study|Withdrawal by Subject|1|||
106064160|NCT02005445|365896319|FG000|Overall Study|Dual study enrollment|0|||
106064161|NCT02005445|365896320|FG001|Overall Study|Dual study enrollment|1|||
106064162|NCT01111149|365896321|FG000|Overall Study|Protocol Violation|1|||
106064163|NCT01111149|365896322|FG001|Overall Study|Protocol Violation|1|||
106064164|NCT01111149|365896323|FG002|Overall Study|Protocol Violation|2|||
106064165|NCT01111149|365896321|FG000|Overall Study|Withdrawal by Subject|1|||
106064166|NCT01111149|365896322|FG001|Overall Study|Withdrawal by Subject|0|||
106064167|NCT01111149|365896323|FG002|Overall Study|Withdrawal by Subject|2|||
106064168|NCT00674661|365896326|FG000|Overall Study|Other|5|||
106064169|NCT00674661|365896327|FG001|Overall Study|Other|7|||
106064170|NCT00674661|365896326|FG000|Overall Study|Lost to Follow-up|6|||
106064171|NCT00674661|365896327|FG001|Overall Study|Lost to Follow-up|3|||
106064172|NCT00674661|365896326|FG000|Overall Study|Withdrawal by Subject|0|||
106064173|NCT00674661|365896327|FG001|Overall Study|Withdrawal by Subject|5|||
106064174|NCT02036294|365896332|FG000|Overall Study|Death|7|||
106064175|NCT02036294|365896333|FG001|Overall Study|Death|8|||
106064176|NCT02036294|365896332|FG000|Overall Study|Withdrawal by Subject|2|||
106064177|NCT02036294|365896333|FG001|Overall Study|Withdrawal by Subject|3|||
106064178|NCT00726661|365896334|FG000|Overall Study|Lost to Follow-up|36|||
106064179|NCT00726661|365896335|FG001|Overall Study|Lost to Follow-up|11|||
106064180|NCT00726661|365896334|FG000|Overall Study|Withdrawal by Subject|17|||
106064181|NCT00726661|365896335|FG001|Overall Study|Withdrawal by Subject|13|||
106064182|NCT00726661|365896334|FG000|Overall Study|Trial terminated by sponsor|214|||
106064183|NCT00726661|365896335|FG001|Overall Study|Trial terminated by sponsor|187|||
106064184|NCT00726661|365896334|FG000|Overall Study|Death|475|||
106064185|NCT00726661|365896335|FG001|Overall Study|Death|159|||
106064186|NCT00726661|365896334|FG000|Overall Study|Physician Decision|25|||
106064187|NCT00726661|365896335|FG001|Overall Study|Physician Decision|13|||
106064188|NCT00726661|365896334|FG000|Overall Study|Other|47|||
106064189|NCT00726661|365896335|FG001|Overall Study|Other|35|||
106064190|NCT00811473|365896336|FG000|Overall Study|Adverse Event|3|||
106064191|NCT00811473|365896337|FG001|Overall Study|Adverse Event|12|||
106064192|NCT00811473|365896336|FG000|Overall Study|Lost to Follow-up|5|||
106064193|NCT00811473|365896337|FG001|Overall Study|Lost to Follow-up|1|||
106064194|NCT00811473|365896336|FG000|Overall Study|Withdrawal by Subject|2|||
106064195|NCT00811473|365896337|FG001|Overall Study|Withdrawal by Subject|4|||
106064196|NCT00811473|365896336|FG000|Overall Study|Severe non-compliance to protocol|2|||
106064197|NCT00811473|365896337|FG001|Overall Study|Severe non-compliance to protocol|4|||
106064198|NCT00811473|365896336|FG000|Overall Study|Lack of therapeutic response|4|||
106064199|NCT00811473|365896337|FG001|Overall Study|Lack of therapeutic response|1|||
106064200|NCT00811473|365896336|FG000|Overall Study|Condition under investigation worsened|1|||
106064201|NCT00811473|365896337|FG001|Overall Study|Condition under investigation worsened|3|||
106064202|NCT00811473|365896336|FG000|Overall Study|Other 2|4|||
106064203|NCT00811473|365896337|FG001|Overall Study|Other 2|1|||
106064204|NCT00811473|365896336|FG000|Overall Study|Incorrect Enrollment|1|||
106064205|NCT00811473|365896337|FG001|Overall Study|Incorrect Enrollment|0|||
106064206|NCT00811473|365896336|FG000|Overall Study|Safety Reasons|1|||
106064207|NCT00811473|365896337|FG001|Overall Study|Safety Reasons|0|||
106064208|NCT00563381|365896343|FG000|Overall Study|Adverse Event|264|||
106064209|NCT00563381|365896344|FG001|Overall Study|Adverse Event|292|||
106064210|NCT00563381|365896343|FG000|Overall Study|Protocol Violation|66|||
106064211|NCT00563381|365896344|FG001|Overall Study|Protocol Violation|74|||
106064212|NCT00563381|365896343|FG000|Overall Study|Lost to Follow-up|7|||
106064213|NCT00563381|365896344|FG001|Overall Study|Lost to Follow-up|15|||
106064214|NCT00563381|365896343|FG000|Overall Study|Withdrawal by Subject|192|||
106064215|NCT00563381|365896344|FG001|Overall Study|Withdrawal by Subject|209|||
106064216|NCT00563381|365896343|FG000|Overall Study|Lack of Efficacy|32|||
106064217|NCT00563381|365896344|FG001|Overall Study|Lack of Efficacy|24|||
106064218|NCT00563381|365896343|FG000|Overall Study|Individual different reasons|24|||
106064219|NCT00563381|365896344|FG001|Overall Study|Individual different reasons|34|||
106064220|NCT00110149|365896345|FG000|Overall Study|Physician Decision|3|||
106064221|NCT00667368|365896346|FG000|Overall Study|Lost to Follow-up|176|||
106064222|NCT00667368|365896347|FG001|Overall Study|Lost to Follow-up|155|||
106064223|NCT00667368|365896346|FG000|Overall Study|Discontinued early|24|||
106064224|NCT00667368|365896347|FG001|Overall Study|Discontinued early|17|||
106064225|NCT02452398|365896350|FG000|Overall Study|Adverse Event|1|||
106064226|NCT02452398|365896350|FG000|Overall Study|Lost to Follow-up|28|||
106064227|NCT02452398|365896350|FG000|Overall Study|Physician Decision|2|||
106064228|NCT02452398|365896350|FG000|Overall Study|Withdrawal by Subject|6|||
106064229|NCT02452398|365896350|FG000|Overall Study|Moved away|4|||
106064230|NCT01957644|365896351|FG000|Overall Study|Adverse Event|4|||
106064231|NCT01957644|365896352|FG001|Overall Study|Adverse Event|2|||
106064232|NCT01957644|365896353|FG002|Overall Study|Adverse Event|0|||
106064233|NCT01957644|365896354|FG003|Overall Study|Adverse Event|0|||
106064234|NCT01957644|365896355|FG004|Overall Study|Adverse Event|1|||
106064235|NCT01957644|365896351|FG000|Overall Study|Progressive disease / relapse|0|||
106064236|NCT01957644|365896352|FG001|Overall Study|Progressive disease / relapse|1|||
106064237|NCT01957644|365896353|FG002|Overall Study|Progressive disease / relapse|0|||
106064238|NCT01957644|365896354|FG003|Overall Study|Progressive disease / relapse|1|||
106064239|NCT01957644|365896355|FG004|Overall Study|Progressive disease / relapse|0|||
106064240|NCT01957644|365896351|FG000|Overall Study|Other reason|1|||
106064241|NCT01957644|365896352|FG001|Overall Study|Other reason|2|||
106064242|NCT01957644|365896353|FG002|Overall Study|Other reason|1|||
106064243|NCT01957644|365896354|FG003|Overall Study|Other reason|1|||
106064244|NCT01957644|365896355|FG004|Overall Study|Other reason|0|||
106064245|NCT01957644|365896351|FG000|Overall Study|Withdrawal by Subject|1|||
106064246|NCT01957644|365896352|FG001|Overall Study|Withdrawal by Subject|0|||
106064247|NCT01957644|365896353|FG002|Overall Study|Withdrawal by Subject|0|||
106064248|NCT01957644|365896354|FG003|Overall Study|Withdrawal by Subject|0|||
106064249|NCT01957644|365896355|FG004|Overall Study|Withdrawal by Subject|0|||
106064250|NCT01957644|365896351|FG000|Overall Study|Protocol Violation|0|||
106064251|NCT01957644|365896352|FG001|Overall Study|Protocol Violation|1|||
106064252|NCT01957644|365896353|FG002|Overall Study|Protocol Violation|0|||
106064253|NCT01957644|365896354|FG003|Overall Study|Protocol Violation|0|||
106064254|NCT01957644|365896355|FG004|Overall Study|Protocol Violation|0|||
106064255|NCT04044716|365896356|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
106064256|NCT04044716|365896357|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
106064257|NCT04044716|365896358|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
106064258|NCT04044716|365896356|FG000|Overall Study|Lost to Follow-up|2|||
106064259|NCT04044716|365896357|FG001|Overall Study|Lost to Follow-up|3|||
106064260|NCT04044716|365896358|FG002|Overall Study|Lost to Follow-up|0|||
106064261|NCT01867021|365896365|FG000|Overall Study|Adverse Event|0|||
106064262|NCT01867021|365896366|FG001|Overall Study|Adverse Event|1|||
106064263|NCT01867021|365896365|FG000|Overall Study|Not Eligible|0|||
106064264|NCT01867021|365896366|FG001|Overall Study|Not Eligible|1|||
106064265|NCT01867021|365896365|FG000|Overall Study|Death|1|||
106064266|NCT01867021|365896366|FG001|Overall Study|Death|0|||
106064267|NCT01867021|365896365|FG000|Overall Study|Lost to Follow-up|0|||
106064268|NCT01867021|365896366|FG001|Overall Study|Lost to Follow-up|2|||
106064269|NCT01867021|365896365|FG000|Overall Study|Withdrawal by Subject|1|||
106064270|NCT01867021|365896366|FG001|Overall Study|Withdrawal by Subject|6|||
106064271|NCT03060629|365896367|FG000|Overall Study|Death|4|||
106064272|NCT03060629|365896368|FG001|Overall Study|Death|5|||
106064273|NCT03060629|365896367|FG000|Overall Study|Withdrawal by Subject|50|||
106064274|NCT03060629|365896368|FG001|Overall Study|Withdrawal by Subject|35|||
106064275|NCT03060629|365896367|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
106064276|NCT03060629|365896368|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
106064277|NCT03060629|365896367|FG000|Overall Study|Participant Relocate|15|||
106064278|NCT03060629|365896368|FG001|Overall Study|Participant Relocate|15|||
106064279|NCT03060629|365896367|FG000|Overall Study|Unable to Contact Participant|34|||
106064280|NCT03060629|365896368|FG001|Overall Study|Unable to Contact Participant|23|||
106064281|NCT03060629|365896367|FG000|Overall Study|Investigator Decision|7|||
106064282|NCT03060629|365896368|FG001|Overall Study|Investigator Decision|7|||
106064283|NCT03060629|365896367|FG000|Overall Study|Study Terminated by Sponsor|1100|||
106064284|NCT03060629|365896368|FG001|Overall Study|Study Terminated by Sponsor|1123|||
106064285|NCT03060629|365896367|FG000|Overall Study|Other|4|||
106064286|NCT03060629|365896368|FG001|Overall Study|Other|4|||
106064287|NCT01714635|365896370|FG000|Overall Study|Discontinued|1|||
106064288|NCT01714635|365896371|FG001|Overall Study|Discontinued|0|||
106064289|NCT01714635|365896372|FG002|Overall Study|Discontinued|2|||
106064290|NCT01714635|365896370|FG000|Overall Study|Missed 6-month exam|1|||
106064291|NCT01714635|365896371|FG001|Overall Study|Missed 6-month exam|0|||
106064292|NCT01714635|365896372|FG002|Overall Study|Missed 6-month exam|0|||
106064293|NCT02860169|365896373|FG000|Part A|Withdrawal by Subject|1|||
106064294|NCT02860169|365896373|FG000|Part A|Other (Screening failure)|6|||
106064295|NCT02860169|365896373|FG000|Part A|Other (Survey not completed)|3|||
106064296|NCT02860169|365896373|FG000|Part A|Other (did not completed consent)|1|||
106064297|NCT02860169|365896373|FG000|Part B|Other (Screening failure)|10|||
106064298|NCT02860169|365896373|FG000|Part B|Withdrawal by Subject|1|||
106064299|NCT02860169|365896373|FG000|Part C|Other (Screening failure)|1|||
106064300|NCT00241280|365896379|FG000|Overall Study|Adverse Event|2|||
106064301|NCT00241280|365896380|FG001|Overall Study|Adverse Event|6|||
106064302|NCT00241280|365896379|FG000|Overall Study|Discomfort|11|||
106064303|NCT00241280|365896380|FG001|Overall Study|Discomfort|16|||
106064304|NCT00241280|365896379|FG000|Overall Study|Pregnancy|1|||
106064305|NCT00241280|365896380|FG001|Overall Study|Pregnancy|5|||
106064306|NCT00241280|365896379|FG000|Overall Study|Lost to Follow-up|5|||
106064307|NCT00241280|365896380|FG001|Overall Study|Lost to Follow-up|8|||
106064308|NCT00241280|365896379|FG000|Overall Study|Withdrawal by Subject|7|||
106064309|NCT00241280|365896380|FG001|Overall Study|Withdrawal by Subject|4|||
106064310|NCT00241280|365896379|FG000|Overall Study|Protocol Violation|4|||
106064311|NCT00241280|365896380|FG001|Overall Study|Protocol Violation|10|||
106064312|NCT00241280|365896379|FG000|Overall Study|Relocation|4|||
106064313|NCT00241280|365896380|FG001|Overall Study|Relocation|4|||
106064314|NCT00241280|365896379|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
106064315|NCT00241280|365896380|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
106064316|NCT00241280|365896379|FG000|Overall Study|Unsatisfactory Visual Response|1|||
106064317|NCT00241280|365896380|FG001|Overall Study|Unsatisfactory Visual Response|1|||
106064318|NCT00241280|365896379|FG000|Overall Study|Diabetic|1|||
106064319|NCT00241280|365896380|FG001|Overall Study|Diabetic|0|||
106064320|NCT00241280|365896379|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
106064321|NCT00241280|365896380|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
106064322|NCT00241280|365896379|FG000|Overall Study|Dispensed incorrect test article|1|||
106064323|NCT00241280|365896380|FG001|Overall Study|Dispensed incorrect test article|2|||
106064324|NCT00241280|365896379|FG000|Overall Study|Unacceptable Fit|0|||
106064325|NCT00241280|365896380|FG001|Overall Study|Unacceptable Fit|1|||
106064326|NCT00241280|365896379|FG000|Overall Study|Scheduling Conflict|0|||
106064327|NCT00241280|365896380|FG001|Overall Study|Scheduling Conflict|2|||
106064328|NCT00241280|365896379|FG000|Overall Study|History of Ocular Surgery|0|||
106064329|NCT00241280|365896380|FG001|Overall Study|History of Ocular Surgery|1|||
106064330|NCT00241280|365896379|FG000|Overall Study|Coating on Lens|1|||
106064331|NCT00241280|365896380|FG001|Overall Study|Coating on Lens|0|||
106064332|NCT00241280|365896379|FG000|Overall Study|Excessive Dryness|0|||
106064333|NCT00241280|365896380|FG001|Overall Study|Excessive Dryness|1|||
106064334|NCT01958008|365896381|FG000|Overall Study|Worsening of disease under study|0|||
106064335|NCT01958008|365896382|FG001|Overall Study|Worsening of disease under study|0|||
106064336|NCT01958008|365896383|FG002|Overall Study|Worsening of disease under study|1|||
106064337|NCT01958008|365896384|FG003|Overall Study|Worsening of disease under study|0|||
106064338|NCT01958008|365896381|FG000|Overall Study|Other adverse event|1|||
106064339|NCT01958008|365896382|FG001|Overall Study|Other adverse event|0|||
106064340|NCT01958008|365896383|FG002|Overall Study|Other adverse event|0|||
106064341|NCT01958008|365896384|FG003|Overall Study|Other adverse event|0|||
106064342|NCT00965718|365896385|FG000|Overall Study|Withdrawal by Subject|4|||
106064343|NCT01634360|365896386|FG000|Overall Study|Adverse Event|10|||
106064344|NCT01634360|365896387|FG001|Overall Study|Adverse Event|34|||
106064345|NCT01634360|365896386|FG000|Overall Study|subject withdrew consent|13|||
106064346|NCT01634360|365896387|FG001|Overall Study|subject withdrew consent|23|||
106064347|NCT01634360|365896386|FG000|Overall Study|Protocol Violation|1|||
106064348|NCT01634360|365896387|FG001|Overall Study|Protocol Violation|1|||
106064349|NCT01634360|365896386|FG000|Overall Study|Lack of Efficacy|4|||
106064350|NCT01634360|365896387|FG001|Overall Study|Lack of Efficacy|14|||
105864996|NCT02516553|365154808|FG006|Overall Study|Progressive disease|5|||
106064351|NCT01634360|365896386|FG000|Overall Study|Other|3|||
106064352|NCT01634360|365896387|FG001|Overall Study|Other|20|||
106064353|NCT01634360|365896386|FG000|Overall Study|Study termination by sponsor|18|||
106064354|NCT01634360|365896387|FG001|Overall Study|Study termination by sponsor|44|||
106064355|NCT02671422|365896389|FG000|Overall Study|Lost to Follow-up|1|||
106064356|NCT02671422|365896389|FG000|Overall Study|Adverse Event|68|||
106064357|NCT02671422|365896389|FG000|Overall Study|Lack of Efficacy|1|||
106064358|NCT02671422|365896389|FG000|Overall Study|Lost to Follow-up|4|||
106064359|NCT02671422|365896389|FG000|Overall Study|Withdrawal by Subject|7|||
106064360|NCT02671422|365896389|FG000|Overall Study|Progressive Disease|156|||
106064361|NCT02671422|365896389|FG000|Overall Study|Worsening of Disease|4|||
106064362|NCT02671422|365896389|FG000|Overall Study|Sponsor decision|5|||
106064363|NCT02671422|365896389|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
106064364|NCT02671422|365896389|FG000|Overall Study|Not treated with Vargatef®|3|||
106064365|NCT02671422|365896389|FG000|Overall Study|Other not defined above|3|||
106064366|NCT03036072|365896390|FG000|Overall Study|Death|0|||
106064367|NCT03036072|365896391|FG001|Overall Study|Death|1|||
106064368|NCT03036072|365896390|FG000|Overall Study|Withdrawal by Subject|0|||
106064369|NCT03036072|365896391|FG001|Overall Study|Withdrawal by Subject|1|||
106064370|NCT03036072|365896390|FG000|Overall Study|Physician Decision|0|||
106064371|NCT03036072|365896391|FG001|Overall Study|Physician Decision|1|||
106064372|NCT00662363|365896392|FG000|Overall Study|Withdrawal by Subject|6|||
106064373|NCT00662363|365896393|FG001|Overall Study|Withdrawal by Subject|5|||
106064374|NCT00662363|365896392|FG000|Overall Study|Adverse Event|0|||
106064375|NCT00662363|365896393|FG001|Overall Study|Adverse Event|3|||
106064376|NCT00662363|365896392|FG000|Overall Study|Discharged early from rehab|4|||
106064377|NCT00662363|365896393|FG001|Overall Study|Discharged early from rehab|1|||
106064378|NCT00662363|365896392|FG000|Overall Study|Protocol Violation|1|||
106064379|NCT00662363|365896393|FG001|Overall Study|Protocol Violation|1|||
106064380|NCT04080297|365896395|FG000|Overall Study|Adverse Event|1|||
106064381|NCT04080297|365896396|FG001|Overall Study|Adverse Event|3|||
106064382|NCT04080297|365896395|FG000|Overall Study|concurrent illness|1|||
106064383|NCT04080297|365896396|FG001|Overall Study|concurrent illness|0|||
106064384|NCT02744391|365896397|FG000|Overall Study|Lost to Follow-up|9|||
106064385|NCT02744391|365896397|FG000|Overall Study|Physician Decision|2|||
106064386|NCT02744391|365896397|FG000|Overall Study|Withdrawal by Subject|3|||
106064387|NCT02700815|365899136|FG000|Overall Study|Adverse Event|0|||
106064388|NCT02700815|365899137|FG001|Overall Study|Adverse Event|6|||
106064389|NCT02700815|365899138|FG002|Overall Study|Adverse Event|2|||
106064390|NCT02700815|365899139|FG003|Overall Study|Adverse Event|3|||
106064391|NCT02700815|365899136|FG000|Overall Study|Lack of Efficacy|0|||
106064392|NCT02700815|365899137|FG001|Overall Study|Lack of Efficacy|0|||
106064393|NCT02700815|365899138|FG002|Overall Study|Lack of Efficacy|1|||
106064394|NCT02700815|365899139|FG003|Overall Study|Lack of Efficacy|2|||
106064395|NCT02700815|365899136|FG000|Overall Study|Lost to Follow-up|1|||
106064396|NCT02700815|365899137|FG001|Overall Study|Lost to Follow-up|0|||
106064397|NCT02700815|365899138|FG002|Overall Study|Lost to Follow-up|0|||
106064398|NCT02700815|365899139|FG003|Overall Study|Lost to Follow-up|1|||
106064399|NCT02700815|365899136|FG000|Overall Study|Refusal to continue medication|0|||
106064400|NCT02700815|365899137|FG001|Overall Study|Refusal to continue medication|1|||
106064401|NCT02700815|365899138|FG002|Overall Study|Refusal to continue medication|0|||
106064402|NCT02700815|365899139|FG003|Overall Study|Refusal to continue medication|1|||
106064403|NCT02700815|365899136|FG000|Overall Study|Withdrawal by Subject|0|||
106064404|NCT02700815|365899137|FG001|Overall Study|Withdrawal by Subject|0|||
106064405|NCT02700815|365899138|FG002|Overall Study|Withdrawal by Subject|1|||
106064406|NCT02700815|365899139|FG003|Overall Study|Withdrawal by Subject|0|||
106064407|NCT02927080|365899143|FG000|Overall Study|Withdrawal by Subject|0|||
106064408|NCT02927080|365899144|FG001|Overall Study|Withdrawal by Subject|0|||
106064409|NCT02927080|365899145|FG002|Overall Study|Withdrawal by Subject|0|||
106064410|NCT02927080|365899146|FG003|Overall Study|Withdrawal by Subject|0|||
106064411|NCT02927080|365899147|FG004|Overall Study|Withdrawal by Subject|1|||
106064412|NCT02927080|365899148|FG005|Overall Study|Withdrawal by Subject|0|||
106064413|NCT02927080|365899149|FG006|Overall Study|Withdrawal by Subject|1|||
106064414|NCT02927080|365899150|FG007|Overall Study|Withdrawal by Subject|1|||
106064415|NCT02927080|365899151|FG008|Overall Study|Withdrawal by Subject|0|||
106064416|NCT02927080|365899152|FG009|Overall Study|Withdrawal by Subject|2|||
106064417|NCT02927080|365899143|FG000|Overall Study|Willingness to comply with protocol|0|||
106064418|NCT02927080|365899144|FG001|Overall Study|Willingness to comply with protocol|0|||
106153981|NCT02791230|366223920|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
106153982|NCT02791230|366223918|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
106153983|NCT02791230|366223919|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
106153984|NCT02791230|366223920|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
106153985|NCT02791230|366223918|FG000|Overall Study|Study sites terminated by sponsor|1|||
106153986|NCT02791230|366223919|FG001|Overall Study|Study sites terminated by sponsor|0|||
106153987|NCT02791230|366223920|FG002|Overall Study|Study sites terminated by sponsor|5|||
106064419|NCT02927080|365899145|FG002|Overall Study|Willingness to comply with protocol|0|||
106064420|NCT02927080|365899146|FG003|Overall Study|Willingness to comply with protocol|0|||
106064421|NCT02927080|365899147|FG004|Overall Study|Willingness to comply with protocol|0|||
106153988|NCT02791230|366223918|FG000|Overall Study|Other|9|||
106153989|NCT02791230|366223919|FG001|Overall Study|Other|1|||
106153990|NCT02791230|366223920|FG002|Overall Study|Other|28|||
106153991|NCT02791230|366223918|FG000|Overall Study|Protocol Violation|0|||
106064422|NCT02927080|365899148|FG005|Overall Study|Willingness to comply with protocol|0|||
106064423|NCT02927080|365899149|FG006|Overall Study|Willingness to comply with protocol|0|||
106064424|NCT02927080|365899150|FG007|Overall Study|Willingness to comply with protocol|0|||
106064425|NCT02927080|365899151|FG008|Overall Study|Willingness to comply with protocol|0|||
106064426|NCT02927080|365899152|FG009|Overall Study|Willingness to comply with protocol|1|||
106064427|NCT02927080|365899143|FG000|Overall Study|Study terminated by Sponsor|0|||
106064428|NCT02927080|365899144|FG001|Overall Study|Study terminated by Sponsor|0|||
106064429|NCT02927080|365899145|FG002|Overall Study|Study terminated by Sponsor|0|||
106064430|NCT02927080|365899146|FG003|Overall Study|Study terminated by Sponsor|0|||
106064431|NCT02927080|365899147|FG004|Overall Study|Study terminated by Sponsor|0|||
106064432|NCT02927080|365899148|FG005|Overall Study|Study terminated by Sponsor|0|||
106064433|NCT02927080|365899149|FG006|Overall Study|Study terminated by Sponsor|6|||
106064434|NCT02927080|365899150|FG007|Overall Study|Study terminated by Sponsor|7|||
106064435|NCT02927080|365899151|FG008|Overall Study|Study terminated by Sponsor|2|||
106064436|NCT02927080|365899152|FG009|Overall Study|Study terminated by Sponsor|3|||
106064437|NCT02927080|365899143|FG000|Overall Study|Adverse Event|0|||
106064438|NCT02927080|365899144|FG001|Overall Study|Adverse Event|1|||
106064439|NCT02927080|365899145|FG002|Overall Study|Adverse Event|0|||
106064440|NCT02927080|365899146|FG003|Overall Study|Adverse Event|0|||
106153992|NCT02791230|366223919|FG001|Overall Study|Protocol Violation|0|||
106153993|NCT02791230|366223920|FG002|Overall Study|Protocol Violation|4|||
106153994|NCT02791230|366223918|FG000|Overall Study|Withdrawal by Subject|24|||
106153995|NCT02791230|366223919|FG001|Overall Study|Withdrawal by Subject|13|||
106153996|NCT02791230|366223920|FG002|Overall Study|Withdrawal by Subject|172|||
106153997|NCT02791230|366223918|FG000|Overall Study|Enrolled but not treated|0|||
106153998|NCT02791230|366223919|FG001|Overall Study|Enrolled but not treated|0|||
106153999|NCT02791230|366223920|FG002|Overall Study|Enrolled but not treated|5|||
106154000|NCT04201834|366223928|FG000|Overall Study|Screen fail|1|||
106154001|NCT00212355|366223929|FG000|Overall Study|Adverse Event|1|||
106154002|NCT00212355|366223929|FG000|Overall Study|Withdrawal by Subject|1|||
106154003|NCT00212355|366223929|FG000|Overall Study|A change of address|1|||
106154004|NCT04310735|366223934|FG000|Overall Study|Withdrawal by Subject|1|||
106154005|NCT04310735|366223935|FG001|Overall Study|Withdrawal by Subject|3|||
106154006|NCT04310735|366223936|FG002|Overall Study|Withdrawal by Subject|8|||
106154007|NCT04310735|366223934|FG000|Overall Study|Equipment malfunction|0|||
106154008|NCT04310735|366223935|FG001|Overall Study|Equipment malfunction|1|||
106154009|NCT04310735|366223936|FG002|Overall Study|Equipment malfunction|0|||
106154010|NCT03012841|366223937|FG000|Overall Study|Protocol Violation|0|||
106154011|NCT03012841|366223938|FG001|Overall Study|Protocol Violation|10|||
106154012|NCT03012841|366223937|FG000|Overall Study|Lost to Follow-up|6|||
106154013|NCT03012841|366223938|FG001|Overall Study|Lost to Follow-up|1|||
106154014|NCT03012841|366223937|FG000|Overall Study|Withdrawal by Subject|6|||
106154015|NCT03012841|366223938|FG001|Overall Study|Withdrawal by Subject|0|||
106154016|NCT03012841|366223937|FG000|Overall Study|Unable to complete 12 month visit|6|||
106154017|NCT03012841|366223938|FG001|Overall Study|Unable to complete 12 month visit|0|||
106154018|NCT03012841|366223937|FG000|Overall Study|Subject relocation|1|||
106154019|NCT03012841|366223938|FG001|Overall Study|Subject relocation|0|||
106154020|NCT03012841|366223937|FG000|Overall Study|Seasonal winter travel|1|||
106154021|NCT03012841|366223938|FG001|Overall Study|Seasonal winter travel|0|||
106154022|NCT03012841|366223937|FG000|Overall Study|Physician Decision|0|||
106154023|NCT03012841|366223938|FG001|Overall Study|Physician Decision|2|||
106154024|NCT03012841|366223937|FG000|Overall Study|No ablation performed|0|||
106154025|NCT03012841|366223938|FG001|Overall Study|No ablation performed|2|||
106154026|NCT03012841|366223937|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
106154027|NCT03012841|366223938|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
106154028|NCT03012841|366223937|FG000|Overall Study|Insurance change|0|||
106154029|NCT03012841|366223938|FG001|Overall Study|Insurance change|1|||
106154030|NCT03769168|366223939|FG000|Overall Study|Adverse Event|0|||
106154031|NCT03769168|366223940|FG001|Overall Study|Adverse Event|1|||
106154032|NCT03769168|366223939|FG000|Overall Study|Lack of Efficacy|2|||
106154033|NCT03769168|366223940|FG001|Overall Study|Lack of Efficacy|4|||
106154034|NCT03769168|366223939|FG000|Overall Study|Post study access to treatment|3|||
106154035|NCT03769168|366223940|FG001|Overall Study|Post study access to treatment|11|||
106154036|NCT03769168|366223939|FG000|Overall Study|Physician Decision|1|||
106154037|NCT03769168|366223940|FG001|Overall Study|Physician Decision|4|||
105864997|NCT02516553|365154809|FG007|Overall Study|Progressive disease|5|||
106154038|NCT03769168|366223939|FG000|Overall Study|Subject Decision|2|||
106154039|NCT03769168|366223940|FG001|Overall Study|Subject Decision|4|||
106154040|NCT03769168|366223939|FG000|Overall Study|Guardian decision|1|||
106154041|NCT03769168|366223940|FG001|Overall Study|Guardian decision|0|||
106154042|NCT05478525|366223941|FG000|Overall Study|Withdrawal by Subject|0|||
106064441|NCT02927080|365899147|FG004|Overall Study|Adverse Event|0|||
106064442|NCT02927080|365899148|FG005|Overall Study|Adverse Event|0|||
106064443|NCT02927080|365899149|FG006|Overall Study|Adverse Event|0|||
106154043|NCT05478525|366223942|FG001|Overall Study|Withdrawal by Subject|1|||
106154044|NCT05478525|366223943|FG002|Overall Study|Withdrawal by Subject|2|||
106154045|NCT05478525|366223944|FG003|Overall Study|Withdrawal by Subject|0|||
106154046|NCT05478525|366223941|FG000|Overall Study|COVID-19 Infection|2|||
106154047|NCT05478525|366223942|FG001|Overall Study|COVID-19 Infection|0|||
106154048|NCT05478525|366223943|FG002|Overall Study|COVID-19 Infection|1|||
106154049|NCT05478525|366223944|FG003|Overall Study|COVID-19 Infection|1|||
106154050|NCT04486716|366223945|FG000|Overall Study|Subject decision|6|||
106154051|NCT04486716|366223945|FG000|Overall Study|Adverse Event|5|||
106154052|NCT04486716|366223945|FG000|Overall Study|Lost to Follow-up|1|||
106154053|NCT04486716|366223945|FG000|Overall Study|Physician Decision|1|||
106154054|NCT04486716|366223945|FG000|Overall Study|Enrolled subjects not treated|9|||
106154055|NCT00410761|366223948|FG000|Overall Study|Adverse Event|29|||
106064444|NCT02927080|365899150|FG007|Overall Study|Adverse Event|1|||
106064445|NCT02927080|365899151|FG008|Overall Study|Adverse Event|0|||
106064446|NCT02927080|365899152|FG009|Overall Study|Adverse Event|1|||
106064447|NCT02927080|365899143|FG000|Overall Study|Other|0|||
106064448|NCT02927080|365899144|FG001|Overall Study|Other|0|||
106064449|NCT02927080|365899145|FG002|Overall Study|Other|0|||
106064450|NCT02927080|365899146|FG003|Overall Study|Other|0|||
106064451|NCT02927080|365899147|FG004|Overall Study|Other|0|||
106064452|NCT02927080|365899148|FG005|Overall Study|Other|0|||
106064453|NCT02927080|365899149|FG006|Overall Study|Other|1|||
106064454|NCT02927080|365899150|FG007|Overall Study|Other|0|||
106064455|NCT02927080|365899151|FG008|Overall Study|Other|1|||
106064456|NCT02927080|365899152|FG009|Overall Study|Other|0|||
106064457|NCT01199289|365899155|FG000|Overall Study|Ineligibility determined|2|||
106064458|NCT01199289|365899156|FG001|Overall Study|Ineligibility determined|1|||
106064459|NCT01199289|365899157|FG002|Overall Study|Ineligibility determined|0|||
106064460|NCT01199289|365899158|FG003|Overall Study|Ineligibility determined|0|||
106064461|NCT01199289|365899155|FG000|Overall Study|Protocol Violation|1|||
106064462|NCT01199289|365899156|FG001|Overall Study|Protocol Violation|0|||
106064463|NCT01199289|365899157|FG002|Overall Study|Protocol Violation|0|||
106064464|NCT01199289|365899158|FG003|Overall Study|Protocol Violation|1|||
106064465|NCT01199289|365899155|FG000|Overall Study|Noncompliance|1|||
106064466|NCT01199289|365899156|FG001|Overall Study|Noncompliance|0|||
106064467|NCT01199289|365899157|FG002|Overall Study|Noncompliance|2|||
106064468|NCT01199289|365899158|FG003|Overall Study|Noncompliance|0|||
106064469|NCT01199289|365899155|FG000|Overall Study|Adverse Event|0|||
106064470|NCT01199289|365899156|FG001|Overall Study|Adverse Event|3|||
106064471|NCT01199289|365899157|FG002|Overall Study|Adverse Event|1|||
106064472|NCT01199289|365899158|FG003|Overall Study|Adverse Event|4|||
106064473|NCT01199289|365899155|FG000|Overall Study|Full consent withdrawn|2|||
106064474|NCT01199289|365899156|FG001|Overall Study|Full consent withdrawn|2|||
106064475|NCT01199289|365899157|FG002|Overall Study|Full consent withdrawn|2|||
106064476|NCT01199289|365899158|FG003|Overall Study|Full consent withdrawn|3|||
106064477|NCT01199289|365899155|FG000|Overall Study|Administrative decision|0|||
106064478|NCT01199289|365899156|FG001|Overall Study|Administrative decision|0|||
106064479|NCT01199289|365899157|FG002|Overall Study|Administrative decision|0|||
106064480|NCT01199289|365899158|FG003|Overall Study|Administrative decision|1|||
106064481|NCT01199289|365899155|FG000|Overall Study|Lost to Follow-up|0|||
106064482|NCT01199289|365899156|FG001|Overall Study|Lost to Follow-up|0|||
106064483|NCT01199289|365899157|FG002|Overall Study|Lost to Follow-up|0|||
106064484|NCT01199289|365899158|FG003|Overall Study|Lost to Follow-up|1|||
106064485|NCT01199289|365899155|FG000|Overall Study|Protocol-specified criteria|3|||
105864998|NCT02516553|365154810|FG008|Overall Study|Progressive disease|11|||
105864999|NCT02516553|365154811|FG009|Overall Study|Progressive disease|3|||
106064486|NCT01199289|365899156|FG001|Overall Study|Protocol-specified criteria|0|||
106064487|NCT01199289|365899157|FG002|Overall Study|Protocol-specified criteria|0|||
106064488|NCT01199289|365899158|FG003|Overall Study|Protocol-specified criteria|1|||
106064489|NCT01199289|365899155|FG000|Overall Study|Pregnancy|0|||
106064490|NCT01199289|365899156|FG001|Overall Study|Pregnancy|1|||
106064491|NCT01199289|365899157|FG002|Overall Study|Pregnancy|0|||
106064492|NCT01199289|365899158|FG003|Overall Study|Pregnancy|1|||
106064493|NCT01946425|365899161|FG000|Overall Study|Protocol Violation|1|||
106064494|NCT01946425|365899162|FG001|Overall Study|Protocol Violation|0|||
106154056|NCT00410761|366223949|FG001|Overall Study|Adverse Event|3|||
106064495|NCT01946425|365899161|FG000|Overall Study|Withdrawal by Subject|1|||
106064496|NCT01946425|365899162|FG001|Overall Study|Withdrawal by Subject|0|||
106154057|NCT00410761|366223948|FG000|Overall Study|objective disease progression|71|||
106064497|NCT03247530|365899163|FG000|Overall Study|Withdrawal by caregiver|19|||
106064498|NCT03247530|365899164|FG001|Overall Study|Withdrawal by caregiver|8|||
106064499|NCT03247530|365899165|FG002|Overall Study|Withdrawal by caregiver|10|||
106064500|NCT03247530|365899163|FG000|Overall Study|Lost to Follow-up|3|||
106064501|NCT03247530|365899164|FG001|Overall Study|Lost to Follow-up|9|||
106064502|NCT03247530|365899165|FG002|Overall Study|Lost to Follow-up|6|||
106064503|NCT03247530|365899163|FG000|Overall Study|Adverse Event|2|||
106064504|NCT03247530|365899164|FG001|Overall Study|Adverse Event|5|||
105865000|NCT02516553|365154812|FG010|Overall Study|Progressive disease|10|||
105865001|NCT02516553|365154813|FG011|Overall Study|Progressive disease|8|||
106064505|NCT03247530|365899165|FG002|Overall Study|Adverse Event|2|||
106064506|NCT03247530|365899163|FG000|Overall Study|Failure to follow procedure|1|||
106064507|NCT03247530|365899164|FG001|Overall Study|Failure to follow procedure|1|||
106064508|NCT03247530|365899165|FG002|Overall Study|Failure to follow procedure|1|||
106064509|NCT03247530|365899163|FG000|Overall Study|Withdrawal by Subject|1|||
106064510|NCT03247530|365899164|FG001|Overall Study|Withdrawal by Subject|1|||
106064511|NCT03247530|365899165|FG002|Overall Study|Withdrawal by Subject|0|||
106064512|NCT03247530|365899163|FG000|Overall Study|Study medication misuse|0|||
106064513|NCT03247530|365899164|FG001|Overall Study|Study medication misuse|1|||
106064514|NCT03247530|365899165|FG002|Overall Study|Study medication misuse|0|||
106064515|NCT03247530|365899163|FG000|Overall Study|Other, multiple categories|1|||
106064516|NCT03247530|365899164|FG001|Overall Study|Other, multiple categories|3|||
106064517|NCT03247530|365899165|FG002|Overall Study|Other, multiple categories|1|||
106064518|NCT03274440|365899166|FG000|Overall Study|Time commitment too great|1|||
106064519|NCT03274440|365899167|FG001|Overall Study|Time commitment too great|0|||
106064520|NCT03274440|365899168|FG002|Overall Study|Time commitment too great|0|||
106064521|NCT03274440|365899169|FG003|Overall Study|Time commitment too great|1|||
106064522|NCT03274440|365899170|FG004|Overall Study|Time commitment too great|0|||
106064523|NCT03274440|365899171|FG005|Overall Study|Time commitment too great|0|||
106064524|NCT00390858|365899174|FG000|Overall Study|Adverse Event|6|||
106064525|NCT00390858|365899175|FG001|Overall Study|Adverse Event|2|||
106064526|NCT00390858|365899174|FG000|Overall Study|Lack of Efficacy|0|||
106064527|NCT00390858|365899175|FG001|Overall Study|Lack of Efficacy|1|||
106064528|NCT00390858|365899174|FG000|Overall Study|Withdrawal by Subject|3|||
106064529|NCT00390858|365899175|FG001|Overall Study|Withdrawal by Subject|4|||
106064530|NCT00142584|365899176|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
106064531|NCT00142584|365899177|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
106064532|NCT00142584|365899176|FG000|Overall Study|Withdrawal by Subject|30|||
106064533|NCT00142584|365899177|FG001|Overall Study|Withdrawal by Subject|16|||
106064534|NCT00142584|365899176|FG000|Overall Study|Lost to Follow-up|22|||
106064535|NCT00142584|365899177|FG001|Overall Study|Lost to Follow-up|12|||
106064536|NCT00142584|365899176|FG000|Overall Study|Adverse Event|14|||
106064537|NCT00142584|365899177|FG001|Overall Study|Adverse Event|5|||
106064538|NCT00142584|365899176|FG000|Overall Study|Protocol Violation|4|||
106064539|NCT00142584|365899177|FG001|Overall Study|Protocol Violation|7|||
106064540|NCT00142584|365899176|FG000|Overall Study|Treatment Failure|2|||
106064541|NCT00142584|365899177|FG001|Overall Study|Treatment Failure|0|||
106064542|NCT01074450|365899178|FG000|First Intervention|Emesis in Dosing Interval|0|||
106064543|NCT01074450|365899179|FG001|First Intervention|Emesis in Dosing Interval|2|||
106064544|NCT01074450|365899178|FG000|Second Intervention|Protocol Violation|1|||
106064545|NCT01074450|365899179|FG001|Second Intervention|Protocol Violation|0|||
106064546|NCT01074450|365899178|FG000|Second Intervention|Physician Decision|0|||
106064547|NCT01074450|365899179|FG001|Second Intervention|Physician Decision|1|||
106064548|NCT01113801|365899180|FG000|Overall Study|Adverse Event|4|||
106064549|NCT01113801|365899181|FG001|Overall Study|Adverse Event|0|||
106064550|NCT01113801|365899182|FG002|Overall Study|Adverse Event|2|||
106064551|NCT01113801|365899183|FG003|Overall Study|Adverse Event|6|||
106064552|NCT01113801|365899180|FG000|Overall Study|Death|4|||
106064553|NCT01113801|365899181|FG001|Overall Study|Death|5|||
106064554|NCT01113801|365899182|FG002|Overall Study|Death|3|||
106064555|NCT01113801|365899183|FG003|Overall Study|Death|4|||
106064556|NCT01113801|365899180|FG000|Overall Study|Protocol Violation|0|||
106064557|NCT01113801|365899181|FG001|Overall Study|Protocol Violation|1|||
106064558|NCT01113801|365899182|FG002|Overall Study|Protocol Violation|0|||
106154058|NCT00410761|366223949|FG001|Overall Study|objective disease progression|55|||
106154059|NCT00410761|366223948|FG000|Overall Study|Withdrawal by Subject|8|||
106154060|NCT00410761|366223949|FG001|Overall Study|Withdrawal by Subject|4|||
106154061|NCT00410761|366223948|FG000|Overall Study|Other|12|||
106154062|NCT00410761|366223949|FG001|Overall Study|Other|9|||
106154063|NCT00410761|366223948|FG000|Overall Study|Never received randomised treatment|0|||
106154064|NCT00410761|366223949|FG001|Overall Study|Never received randomised treatment|1|||
106064559|NCT01113801|365899183|FG003|Overall Study|Protocol Violation|0|||
106064560|NCT01113801|365899180|FG000|Overall Study|Withdrawal by Subject|9|||
106064561|NCT01113801|365899181|FG001|Overall Study|Withdrawal by Subject|7|||
106064562|NCT01113801|365899182|FG002|Overall Study|Withdrawal by Subject|7|||
106064563|NCT01113801|365899183|FG003|Overall Study|Withdrawal by Subject|8|||
106064564|NCT01113801|365899180|FG000|Overall Study|Physician Decision|2|||
106064565|NCT01113801|365899181|FG001|Overall Study|Physician Decision|2|||
106064566|NCT01113801|365899182|FG002|Overall Study|Physician Decision|3|||
106154065|NCT05386238|366223950|FG000|Overall Study|Lost to Follow-up|3|||
106154066|NCT05386238|366223951|FG001|Overall Study|Lost to Follow-up|2|||
106154067|NCT05386238|366223950|FG000|Overall Study|Withdrawal by Subject|0|||
106154068|NCT05386238|366223951|FG001|Overall Study|Withdrawal by Subject|1|||
106064567|NCT01113801|365899183|FG003|Overall Study|Physician Decision|3|||
106064568|NCT01113801|365899180|FG000|Overall Study|Sponsor Decision|15|||
106064569|NCT01113801|365899181|FG001|Overall Study|Sponsor Decision|21|||
106064570|NCT01113801|365899182|FG002|Overall Study|Sponsor Decision|20|||
106064571|NCT01113801|365899183|FG003|Overall Study|Sponsor Decision|15|||
106064572|NCT01113801|365899180|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
106064573|NCT01113801|365899181|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
106064574|NCT01113801|365899182|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
106064575|NCT01113801|365899183|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
106064576|NCT03414424|365899184|FG000|Overall Study|Screened out after consent|0|||
106064577|NCT03414424|365899185|FG001|Overall Study|Screened out after consent|2|||
106064578|NCT03414424|365899184|FG000|Overall Study|Lost to Follow-up|0|||
106064579|NCT03414424|365899185|FG001|Overall Study|Lost to Follow-up|1|||
106064580|NCT03527966|365899186|FG000|Overall Study|Lost to Follow-up|3|||
106064581|NCT03527966|365899187|FG001|Overall Study|Lost to Follow-up|0|||
106064582|NCT01506479|365899188|FG000|Overall Study|Lost to Follow-up|1|||
106064583|NCT01506479|365899189|FG001|Overall Study|Lost to Follow-up|2|||
106064584|NCT01506479|365899190|FG002|Overall Study|Lost to Follow-up|2|||
106064585|NCT01506479|365899188|FG000|Overall Study|Withdrawal by Subject|1|||
106064586|NCT01506479|365899189|FG001|Overall Study|Withdrawal by Subject|2|||
106064587|NCT01506479|365899190|FG002|Overall Study|Withdrawal by Subject|1|||
106064588|NCT01506479|365899188|FG000|Overall Study|Missing assessment|1|||
106064589|NCT01506479|365899189|FG001|Overall Study|Missing assessment|0|||
106064590|NCT01506479|365899190|FG002|Overall Study|Missing assessment|0|||
106064591|NCT01506479|365899188|FG000|Overall Study|Adverse Event|0|||
106064592|NCT01506479|365899189|FG001|Overall Study|Adverse Event|1|||
106064593|NCT01506479|365899190|FG002|Overall Study|Adverse Event|0|||
106064594|NCT00022633|365899192|FG000|Overall Study|Adverse Event|11|||
106064595|NCT00022633|365899193|FG001|Overall Study|Adverse Event|1|||
106064596|NCT00022633|365899192|FG000|Overall Study|Refusal unrelated to adverse event|1|||
106064597|NCT00022633|365899193|FG001|Overall Study|Refusal unrelated to adverse event|0|||
106064598|NCT00022633|365899192|FG000|Overall Study|Progression/relapse|9|||
106064599|NCT00022633|365899193|FG001|Overall Study|Progression/relapse|2|||
106064600|NCT00022633|365899192|FG000|Overall Study|Death|4|||
106064601|NCT00022633|365899193|FG001|Overall Study|Death|0|||
106064602|NCT00022633|365899192|FG000|Overall Study|Other - not protocol specified|3|||
106064603|NCT00022633|365899193|FG001|Overall Study|Other - not protocol specified|2|||
106064604|NCT00022633|365899192|FG000|Overall Study|Ineligible|4|||
106064605|NCT00022633|365899193|FG001|Overall Study|Ineligible|0|||
106064606|NCT00276159|365899194|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
106064607|NCT00372112|365899200|FG000|Overall Study|Adverse Event|0|||
106064608|NCT00372112|365899201|FG001|Overall Study|Adverse Event|1|||
106064609|NCT00372112|365899202|FG002|Overall Study|Adverse Event|1|||
106064610|NCT00372112|365899203|FG003|Overall Study|Adverse Event|1|||
106064611|NCT00372112|365899200|FG000|Overall Study|Withdrawal by Subject|0|||
106064612|NCT00372112|365899201|FG001|Overall Study|Withdrawal by Subject|0|||
106064613|NCT00372112|365899202|FG002|Overall Study|Withdrawal by Subject|2|||
106064614|NCT00372112|365899203|FG003|Overall Study|Withdrawal by Subject|1|||
106064615|NCT00372112|365899200|FG000|Overall Study|Exacerbation|0|||
106064616|NCT00372112|365899201|FG001|Overall Study|Exacerbation|0|||
106064617|NCT00372112|365899202|FG002|Overall Study|Exacerbation|0|||
106064618|NCT00372112|365899203|FG003|Overall Study|Exacerbation|1|||
106064619|NCT00372112|365899200|FG000|Overall Study|PR >240 at Visit 3|0|||
106064620|NCT00372112|365899201|FG001|Overall Study|PR >240 at Visit 3|0|||
106064621|NCT00372112|365899202|FG002|Overall Study|PR >240 at Visit 3|0|||
106064622|NCT00372112|365899203|FG003|Overall Study|PR >240 at Visit 3|1|||
106064623|NCT00372112|365899200|FG000|Overall Study|Hepatitis B|1|||
106064624|NCT00372112|365899201|FG001|Overall Study|Hepatitis B|0|||
106064625|NCT00372112|365899202|FG002|Overall Study|Hepatitis B|0|||
106064626|NCT00372112|365899203|FG003|Overall Study|Hepatitis B|0|||
106064627|NCT00372112|365899200|FG000|Overall Study|Other-protocol violation|0|||
106064628|NCT00372112|365899201|FG001|Overall Study|Other-protocol violation|0|||
106064629|NCT00372112|365899202|FG002|Overall Study|Other-protocol violation|1|||
106064630|NCT00372112|365899203|FG003|Overall Study|Other-protocol violation|0|||
106064631|NCT00356369|365899204|FG000|Active Phase|Withdrawal by Subject|2|||
106064632|NCT00356369|365899205|FG001|Active Phase|Withdrawal by Subject|1|||
106064633|NCT00429104|365899206|FG000|Overall Study|Protocol Violation|1|||
106064634|NCT01285310|365899209|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
106064635|NCT01285310|365899210|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
106064636|NCT01285310|365899211|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
106064637|NCT01285310|365899212|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
106064638|NCT01285310|365899213|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
106064639|NCT01285310|365899209|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
106064640|NCT01285310|365899210|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
106064641|NCT01285310|365899211|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
106064642|NCT01285310|365899212|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
106064643|NCT01285310|365899213|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
106064644|NCT01285310|365899209|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
106064645|NCT01285310|365899210|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
106064646|NCT01285310|365899211|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
106064647|NCT01285310|365899212|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
106064648|NCT01285310|365899213|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
106064649|NCT01285310|365899209|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
106064650|NCT01285310|365899210|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
106064651|NCT01285310|365899211|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
106064652|NCT01285310|365899212|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
106064653|NCT01285310|365899213|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
106064654|NCT01285310|365899209|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
106064655|NCT01285310|365899210|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
106064656|NCT01285310|365899211|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
106064657|NCT01285310|365899212|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
106064658|NCT01285310|365899213|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
106064659|NCT01285310|365899209|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
106064660|NCT01285310|365899210|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
106064661|NCT01285310|365899211|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
106064662|NCT01285310|365899212|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
106064663|NCT01285310|365899213|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
106064664|NCT01285310|365899209|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
106064665|NCT01285310|365899210|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
106064666|NCT01285310|365899211|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
106064667|NCT01285310|365899212|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
106064668|NCT01285310|365899213|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
106064669|NCT01285310|365899209|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
106064670|NCT01285310|365899210|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
106064671|NCT01285310|365899211|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
106064672|NCT01285310|365899212|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
106064673|NCT01285310|365899213|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
106064674|NCT01285310|365899209|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
106064675|NCT01285310|365899210|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
106064676|NCT01285310|365899211|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
106064677|NCT01285310|365899212|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
106064678|NCT01285310|365899213|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
106064679|NCT01285310|365899209|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
106064680|NCT01285310|365899210|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
106064681|NCT01285310|365899211|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
106064682|NCT01285310|365899212|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
106064683|NCT01285310|365899213|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
106064684|NCT01285310|365899209|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
106064685|NCT01285310|365899210|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
106064686|NCT01285310|365899211|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
106064687|NCT01285310|365899212|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
106064688|NCT01285310|365899213|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
106064689|NCT01285310|365899209|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
106064690|NCT01285310|365899210|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
106064691|NCT01285310|365899211|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
106064692|NCT01285310|365899212|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
106064693|NCT01285310|365899213|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
106064694|NCT01996982|365899216|FG000|Overall Study|PI/team left institution|7|||
106064695|NCT01896531|365899217|FG000|Overall Study|Death|57|||
106064696|NCT01896531|365899218|FG001|Overall Study|Death|59|||
106064697|NCT01896531|365899217|FG000|Overall Study|Lost to Follow-up|3|||
106064698|NCT01896531|365899218|FG001|Overall Study|Lost to Follow-up|0|||
106064699|NCT01896531|365899217|FG000|Overall Study|Non-compliance|0|||
106064700|NCT01896531|365899218|FG001|Overall Study|Non-compliance|1|||
106154069|NCT03899961|366223952|FG000|Overall Study|-delivery prior to|2|||
106154070|NCT03899961|366223953|FG001|Overall Study|-delivery prior to|7|||
106154071|NCT03899961|366223952|FG000|Overall Study|req general anesth|1|||
106064701|NCT01896531|365899217|FG000|Overall Study|Study Ended by Sponsor|7|||
106154072|NCT03899961|366223953|FG001|Overall Study|req general anesth|2|||
106154073|NCT03899961|366223952|FG000|Overall Study|capacity|5|||
105865002|NCT02516553|365154814|FG012|Overall Study|Progressive disease|8|||
106064702|NCT01896531|365899218|FG001|Overall Study|Study Ended by Sponsor|20|||
106064703|NCT01896531|365899217|FG000|Overall Study|Withdrawal by Subject|3|||
106064704|NCT01896531|365899218|FG001|Overall Study|Withdrawal by Subject|2|||
106064705|NCT01896531|365899217|FG000|Overall Study|Death Prior to Treatment|1|||
106154074|NCT03899961|366223953|FG001|Overall Study|capacity|6|||
106064706|NCT01896531|365899218|FG001|Overall Study|Death Prior to Treatment|0|||
106064707|NCT01195415|365899239|FG000|Overall Study|No repeat biopsy due to progression|2|||
106064708|NCT00533845|365899240|FG000|Overall Study|Physician Decision|1|||
106064709|NCT00533845|365899241|FG001|Overall Study|Physician Decision|0|||
106064710|NCT02659631|365899244|FG000|Overall Study|Lost to Follow-up|0|||
106064711|NCT02659631|365899245|FG001|Overall Study|Lost to Follow-up|0|||
106064712|NCT02659631|365899246|FG002|Overall Study|Lost to Follow-up|2|||
106064713|NCT02659631|365899247|FG003|Overall Study|Lost to Follow-up|0|||
106064714|NCT02659631|365899248|FG004|Overall Study|Lost to Follow-up|0|||
106064715|NCT02659631|365899249|FG005|Overall Study|Lost to Follow-up|1|||
106064716|NCT02659631|365899250|FG006|Overall Study|Lost to Follow-up|0|||
106064717|NCT02659631|365899251|FG007|Overall Study|Lost to Follow-up|0|||
106064718|NCT02659631|365899252|FG008|Overall Study|Lost to Follow-up|0|||
106064719|NCT02659631|365899253|FG009|Overall Study|Lost to Follow-up|0|||
106064720|NCT02659631|365899244|FG000|Overall Study|Withdrawal prior to treatment|0|||
106064721|NCT02659631|365899245|FG001|Overall Study|Withdrawal prior to treatment|0|||
106064722|NCT02659631|365899246|FG002|Overall Study|Withdrawal prior to treatment|0|||
106064723|NCT02659631|365899247|FG003|Overall Study|Withdrawal prior to treatment|0|||
106064724|NCT02659631|365899248|FG004|Overall Study|Withdrawal prior to treatment|1|||
106064725|NCT02659631|365899249|FG005|Overall Study|Withdrawal prior to treatment|0|||
106064726|NCT02659631|365899250|FG006|Overall Study|Withdrawal prior to treatment|0|||
106064727|NCT02659631|365899251|FG007|Overall Study|Withdrawal prior to treatment|0|||
106064728|NCT02659631|365899252|FG008|Overall Study|Withdrawal prior to treatment|0|||
106064729|NCT02659631|365899253|FG009|Overall Study|Withdrawal prior to treatment|0|||
106064730|NCT02659631|365899244|FG000|Overall Study|Participant refused further follow-up|0|||
106064731|NCT02659631|365899245|FG001|Overall Study|Participant refused further follow-up|0|||
106064732|NCT02659631|365899246|FG002|Overall Study|Participant refused further follow-up|0|||
106064733|NCT02659631|365899247|FG003|Overall Study|Participant refused further follow-up|1|||
106064734|NCT02659631|365899248|FG004|Overall Study|Participant refused further follow-up|0|||
106064735|NCT02659631|365899249|FG005|Overall Study|Participant refused further follow-up|0|||
106064736|NCT02659631|365899250|FG006|Overall Study|Participant refused further follow-up|0|||
106064737|NCT02659631|365899251|FG007|Overall Study|Participant refused further follow-up|0|||
106064738|NCT02659631|365899252|FG008|Overall Study|Participant refused further follow-up|1|||
106064739|NCT02659631|365899253|FG009|Overall Study|Participant refused further follow-up|0|||
106064740|NCT02659631|365899244|FG000|Overall Study|Death (follow-up phase)|1|||
106064741|NCT02659631|365899245|FG001|Overall Study|Death (follow-up phase)|2|||
106064742|NCT02659631|365899246|FG002|Overall Study|Death (follow-up phase)|1|||
106064743|NCT02659631|365899247|FG003|Overall Study|Death (follow-up phase)|1|||
106064744|NCT02659631|365899248|FG004|Overall Study|Death (follow-up phase)|3|||
106064745|NCT02659631|365899249|FG005|Overall Study|Death (follow-up phase)|2|||
106064746|NCT02659631|365899250|FG006|Overall Study|Death (follow-up phase)|0|||
106064747|NCT02659631|365899251|FG007|Overall Study|Death (follow-up phase)|3|||
106064748|NCT02659631|365899252|FG008|Overall Study|Death (follow-up phase)|1|||
106064749|NCT02659631|365899253|FG009|Overall Study|Death (follow-up phase)|0|||
106064750|NCT02659631|365899244|FG000|Overall Study|Death (treatment phase)|0|||
106064751|NCT02659631|365899245|FG001|Overall Study|Death (treatment phase)|0|||
106064752|NCT02659631|365899246|FG002|Overall Study|Death (treatment phase)|0|||
106064753|NCT02659631|365899247|FG003|Overall Study|Death (treatment phase)|0|||
106064754|NCT02659631|365899248|FG004|Overall Study|Death (treatment phase)|1|||
106064755|NCT02659631|365899249|FG005|Overall Study|Death (treatment phase)|0|||
106064756|NCT02659631|365899250|FG006|Overall Study|Death (treatment phase)|1|||
106064757|NCT02659631|365899251|FG007|Overall Study|Death (treatment phase)|0|||
106064758|NCT02659631|365899252|FG008|Overall Study|Death (treatment phase)|0|||
106064759|NCT02659631|365899253|FG009|Overall Study|Death (treatment phase)|0|||
106064760|NCT02377466|365899254|FG000|Overall Study|Other: Randomized and not treated|0|||
106154075|NCT03899961|366223952|FG000|Overall Study|Withdrawal by Subject|1|||
106154076|NCT03899961|366223953|FG001|Overall Study|Withdrawal by Subject|1|||
106154077|NCT03324984|366223960|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
106154078|NCT03324984|366223961|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
106064761|NCT02377466|365899255|FG001|Overall Study|Other: Randomized and not treated|2|||
106064762|NCT00005937|365899259|FG000|Overall Study|Lack of Efficacy|5|||
106064763|NCT00330616|365899261|FG000|Overall Study|Adverse Event|13|||
106064764|NCT00330616|365899261|FG000|Overall Study|Lack of Efficacy|1|||
106154079|NCT02152137|366223969|FG000|Overall Study|Withdrawal by Subject|1|||
106154080|NCT02152137|366223969|FG000|Overall Study|Originally assigned to Arm B|3|||
106154081|NCT01903811|366223976|FG000|Overall Study|No measurable disease|1|||
105865003|NCT02516553|365154815|FG013|Overall Study|Progressive disease|2|||
106064765|NCT00330616|365899261|FG000|Overall Study|Lost to Follow-up|2|||
106064766|NCT00330616|365899261|FG000|Overall Study|Withdrawal by Subject|4|||
106064767|NCT00330616|365899261|FG000|Overall Study|Other|1|||
106064768|NCT00255047|365899264|FG000|Overall Study|Serious Adverse Events|2|||
106064769|NCT00255047|365899265|FG001|Overall Study|Serious Adverse Events|1|||
106064770|NCT00255047|365899266|FG002|Overall Study|Serious Adverse Events|2|||
106064771|NCT00255047|365899267|FG003|Overall Study|Serious Adverse Events|1|||
106064772|NCT00255047|365899264|FG000|Overall Study|Adverse Event|0|||
106064773|NCT00255047|365899265|FG001|Overall Study|Adverse Event|3|||
106064774|NCT00255047|365899266|FG002|Overall Study|Adverse Event|2|||
106064775|NCT00255047|365899267|FG003|Overall Study|Adverse Event|1|||
106064776|NCT00255047|365899264|FG000|Overall Study|Protocol Violation|13|||
106064777|NCT00255047|365899265|FG001|Overall Study|Protocol Violation|13|||
106064778|NCT00255047|365899266|FG002|Overall Study|Protocol Violation|16|||
106064779|NCT00255047|365899267|FG003|Overall Study|Protocol Violation|20|||
106064780|NCT00255047|365899264|FG000|Overall Study|Lost to Follow-up|9|||
106064781|NCT00255047|365899265|FG001|Overall Study|Lost to Follow-up|8|||
106064782|NCT00255047|365899266|FG002|Overall Study|Lost to Follow-up|5|||
106064783|NCT00255047|365899267|FG003|Overall Study|Lost to Follow-up|6|||
106064784|NCT00255047|365899264|FG000|Overall Study|Withdrawal by Subject|24|||
106064785|NCT00255047|365899265|FG001|Overall Study|Withdrawal by Subject|23|||
106064786|NCT00255047|365899266|FG002|Overall Study|Withdrawal by Subject|25|||
106064787|NCT00255047|365899267|FG003|Overall Study|Withdrawal by Subject|18|||
106064788|NCT01574612|365899268|FG000|Overall Study|Adverse Event|3|||
106064789|NCT01574612|365899268|FG000|Overall Study|non compliant with drug|2|||
106064790|NCT01574612|365899268|FG000|Overall Study|Withdrawal by Subject|1|||
106064791|NCT01574612|365899268|FG000|Overall Study|Lost to Follow-up|2|||
106064792|NCT01585194|365899271|FG000|Overall Study|Withdrawal by Subject|1|||
106064793|NCT01585194|365899271|FG000|Overall Study|Physician Decision|2|||
106064794|NCT01585194|365899271|FG000|Overall Study|Lack of insurance|1|||
106064795|NCT02049957|365899274|FG000|Overall Study|Progressive Disease|5|||
106064796|NCT02049957|365899275|FG001|Overall Study|Progressive Disease|4|||
106064797|NCT02049957|365899276|FG002|Overall Study|Progressive Disease|2|||
106064798|NCT02049957|365899277|FG003|Overall Study|Progressive Disease|2|||
106064799|NCT02049957|365899278|FG004|Overall Study|Progressive Disease|6|||
106064800|NCT02049957|365899279|FG005|Overall Study|Progressive Disease|35|||
106064801|NCT02049957|365899280|FG006|Overall Study|Progressive Disease|7|||
106064802|NCT02049957|365899281|FG007|Overall Study|Progressive Disease|26|||
106064803|NCT02049957|365899282|FG008|Overall Study|Progressive Disease|6|||
106064804|NCT02049957|365899274|FG000|Overall Study|Adverse Event|1|||
106064805|NCT02049957|365899275|FG001|Overall Study|Adverse Event|1|||
106064806|NCT02049957|365899276|FG002|Overall Study|Adverse Event|1|||
106064807|NCT02049957|365899277|FG003|Overall Study|Adverse Event|0|||
106064808|NCT02049957|365899278|FG004|Overall Study|Adverse Event|0|||
106064809|NCT02049957|365899279|FG005|Overall Study|Adverse Event|5|||
106064810|NCT02049957|365899280|FG006|Overall Study|Adverse Event|0|||
106064811|NCT02049957|365899281|FG007|Overall Study|Adverse Event|6|||
106064812|NCT02049957|365899282|FG008|Overall Study|Adverse Event|1|||
106064813|NCT02049957|365899274|FG000|Overall Study|Study Terminated by Sponsor|0|||
106064814|NCT02049957|365899275|FG001|Overall Study|Study Terminated by Sponsor|1|||
106064815|NCT02049957|365899276|FG002|Overall Study|Study Terminated by Sponsor|0|||
106064816|NCT02049957|365899277|FG003|Overall Study|Study Terminated by Sponsor|0|||
106064817|NCT02049957|365899278|FG004|Overall Study|Study Terminated by Sponsor|0|||
106064818|NCT02049957|365899279|FG005|Overall Study|Study Terminated by Sponsor|0|||
106064819|NCT02049957|365899280|FG006|Overall Study|Study Terminated by Sponsor|1|||
106064820|NCT02049957|365899281|FG007|Overall Study|Study Terminated by Sponsor|0|||
106064821|NCT02049957|365899282|FG008|Overall Study|Study Terminated by Sponsor|0|||
106064822|NCT02049957|365899274|FG000|Overall Study|Withdrawal by Subject|0|||
106064823|NCT02049957|365899275|FG001|Overall Study|Withdrawal by Subject|0|||
106064824|NCT02049957|365899276|FG002|Overall Study|Withdrawal by Subject|0|||
106064825|NCT02049957|365899277|FG003|Overall Study|Withdrawal by Subject|1|||
106064826|NCT02049957|365899278|FG004|Overall Study|Withdrawal by Subject|0|||
106064827|NCT02049957|365899279|FG005|Overall Study|Withdrawal by Subject|2|||
106064828|NCT02049957|365899280|FG006|Overall Study|Withdrawal by Subject|0|||
106064829|NCT02049957|365899281|FG007|Overall Study|Withdrawal by Subject|3|||
106064830|NCT02049957|365899282|FG008|Overall Study|Withdrawal by Subject|1|||
106064831|NCT02049957|365899274|FG000|Overall Study|Physician Decision|0|||
106064832|NCT02049957|365899275|FG001|Overall Study|Physician Decision|0|||
106064833|NCT02049957|365899276|FG002|Overall Study|Physician Decision|0|||
106064834|NCT02049957|365899277|FG003|Overall Study|Physician Decision|0|||
106064835|NCT02049957|365899278|FG004|Overall Study|Physician Decision|0|||
105865004|NCT02516553|365154816|FG014|Overall Study|Progressive disease|2|||
105865005|NCT02516553|365154817|FG015|Overall Study|Progressive disease|2|||
105865006|NCT02516553|365154818|FG016|Overall Study|Progressive disease|1|||
106064836|NCT02049957|365899279|FG005|Overall Study|Physician Decision|1|||
106064837|NCT02049957|365899280|FG006|Overall Study|Physician Decision|0|||
106064838|NCT02049957|365899281|FG007|Overall Study|Physician Decision|0|||
106064839|NCT02049957|365899282|FG008|Overall Study|Physician Decision|0|||
106064840|NCT00191789|365899283|FG000|Overall Study|Adverse Event|5|||
106064841|NCT00191789|365899283|FG000|Overall Study|Patient: Satisfactory Response|5|||
106064842|NCT00191789|365899283|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
106064843|NCT00191789|365899283|FG000|Overall Study|Withdrawal by Subject|4|||
106064844|NCT00191789|365899283|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
106064845|NCT00191789|365899283|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
106064846|NCT00191789|365899283|FG000|Overall Study|Death - Not Study-Drug Related|1|||
106064847|NCT02326025|365899288|FG000|Overall Study|Adverse Event|3|||
106064848|NCT02326025|365899289|FG001|Overall Study|Adverse Event|0|||
106064849|NCT02326025|365899288|FG000|Overall Study|Physician Decision|1|||
106064850|NCT02326025|365899289|FG001|Overall Study|Physician Decision|2|||
106064851|NCT02326025|365899288|FG000|Overall Study|Physician and Participant Decision|1|||
106064852|NCT02326025|365899289|FG001|Overall Study|Physician and Participant Decision|0|||
106064853|NCT02326025|365899288|FG000|Overall Study|Withdrawal by Subject|0|||
106064854|NCT02326025|365899289|FG001|Overall Study|Withdrawal by Subject|2|||
106064855|NCT02326025|365899288|FG000|Overall Study|Protocol Violation|0|||
106064856|NCT02326025|365899289|FG001|Overall Study|Protocol Violation|1|||
106064857|NCT02170051|365899290|FG000|Overall Study|Withdrawal by Subject|10|||
106064858|NCT02170051|365899291|FG001|Overall Study|Withdrawal by Subject|10|||
106064859|NCT02170051|365899290|FG000|Overall Study|Lost to Follow-up|1|||
106064860|NCT02170051|365899291|FG001|Overall Study|Lost to Follow-up|3|||
106064861|NCT03428360|365899293|FG000|Overall Study|Informed consent withdrawn|5|||
106064862|NCT03428360|365899293|FG000|Overall Study|Withdrawal by Subject|4|||
106064863|NCT03428360|365899293|FG000|Overall Study|Lost to Follow-up|5|||
106064864|NCT03428360|365899293|FG000|Overall Study|Physician Decision|2|||
106064865|NCT03428360|365899293|FG000|Overall Study|Informed consent withdrawn|5|||
106064866|NCT03428360|365899293|FG000|Overall Study|Study terminated by sponsor|10|||
106064867|NCT03428360|365899293|FG000|Overall Study|Non-compliant with study|1|||
106064868|NCT03428360|365899293|FG000|Overall Study|Non-compliant with study drug|3|||
106064869|NCT03428360|365899293|FG000|Overall Study|Death|3|||
106064870|NCT03428360|365899293|FG000|Overall Study|Adverse Event|1|||
106064871|NCT03428360|365899293|FG000|Overall Study|Not on antiepileptic drug|1|||
106064872|NCT00867009|365899300|FG000|Induction Period|Nonserious Adverse Event|5|||
106064873|NCT00867009|365899300|FG000|Induction Period|Serious Adverse Event|10|||
106064874|NCT00867009|365899300|FG000|Induction Period|Death due to serious adverse event|6|||
106064875|NCT00867009|365899300|FG000|Induction Period|Death due to Study Disease|4|||
106064876|NCT00867009|365899300|FG000|Induction Period|Protocol Violation|1|||
106064877|NCT00867009|365899300|FG000|Induction Period|Withdrawal by Subject|8|||
106064878|NCT00867009|365899300|FG000|Induction Period|Physician Decision|3|||
106064879|NCT00867009|365899300|FG000|Induction Period|Progressive Disease (PD)|25|||
106064880|NCT00867009|365899300|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
106064881|NCT01850524|365899305|FG000|Overall Study|Lost to Follow-up|5|||
106064882|NCT01850524|365899306|FG001|Overall Study|Lost to Follow-up|10|||
106064883|NCT01850524|365899305|FG000|Overall Study|Withdrawal by Subject|24|||
106064884|NCT01850524|365899306|FG001|Overall Study|Withdrawal by Subject|22|||
106064885|NCT01850524|365899305|FG000|Overall Study|Reason not Specified|142|||
106064886|NCT01850524|365899306|FG001|Overall Study|Reason not Specified|141|||
106064887|NCT02743871|365899308|FG000|Overall Study|Lost to Follow-up|0|||
106064888|NCT02743871|365899309|FG001|Overall Study|Lost to Follow-up|0|||
106064889|NCT02743871|365899310|FG002|Overall Study|Lost to Follow-up|0|||
106064890|NCT02743871|365899311|FG003|Overall Study|Lost to Follow-up|1|||
106064891|NCT02743871|365899312|FG004|Overall Study|Lost to Follow-up|0|||
106064892|NCT02743871|365899313|FG005|Overall Study|Lost to Follow-up|0|||
106064893|NCT02743871|365899314|FG006|Overall Study|Lost to Follow-up|1|||
106064894|NCT02743871|365899315|FG007|Overall Study|Lost to Follow-up|0|||
106064895|NCT02743871|365899316|FG008|Overall Study|Lost to Follow-up|0|||
106064896|NCT02743871|365899317|FG009|Overall Study|Lost to Follow-up|0|||
106154082|NCT01903811|366223977|FG001|Overall Study|No measurable disease|1|||
106154083|NCT01903811|366223976|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
106154084|NCT01903811|366223977|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
106154085|NCT01903811|366223976|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
106154086|NCT01903811|366223977|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
106154087|NCT01903811|366223976|FG000|Overall Study|Withdrawal by Subject|0|||
106154088|NCT01903811|366223977|FG001|Overall Study|Withdrawal by Subject|1|||
106154089|NCT00979576|366223983|FG000|Combination Treatment Phase|Progressive disease|3|||
106154090|NCT00979576|366223984|FG001|Combination Treatment Phase|Progressive disease|1|||
106154091|NCT00979576|366223985|FG002|Combination Treatment Phase|Progressive disease|5|||
106154092|NCT00979576|366223983|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
106154093|NCT00979576|366223984|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
105865007|NCT02516553|365154819|FG017|Overall Study|Progressive disease|9|||
106064897|NCT02743871|365899318|FG010|Overall Study|Lost to Follow-up|0|||
106064898|NCT02743871|365899319|FG011|Overall Study|Lost to Follow-up|2|||
106064899|NCT02743871|365899320|FG012|Overall Study|Lost to Follow-up|0|||
106064900|NCT02743871|365899321|FG013|Overall Study|Lost to Follow-up|0|||
106064901|NCT02743871|365899308|FG000|Overall Study|Withdrawal by Subject|0|||
106064902|NCT02743871|365899309|FG001|Overall Study|Withdrawal by Subject|0|||
106064903|NCT02743871|365899310|FG002|Overall Study|Withdrawal by Subject|0|||
106064904|NCT02743871|365899311|FG003|Overall Study|Withdrawal by Subject|0|||
106064905|NCT02743871|365899312|FG004|Overall Study|Withdrawal by Subject|0|||
106064906|NCT02743871|365899313|FG005|Overall Study|Withdrawal by Subject|0|||
106064907|NCT02743871|365899314|FG006|Overall Study|Withdrawal by Subject|0|||
106064908|NCT02743871|365899315|FG007|Overall Study|Withdrawal by Subject|0|||
106064909|NCT02743871|365899316|FG008|Overall Study|Withdrawal by Subject|0|||
106064910|NCT02743871|365899317|FG009|Overall Study|Withdrawal by Subject|0|||
106064911|NCT02743871|365899318|FG010|Overall Study|Withdrawal by Subject|1|||
106064912|NCT02743871|365899319|FG011|Overall Study|Withdrawal by Subject|0|||
106064913|NCT02743871|365899320|FG012|Overall Study|Withdrawal by Subject|12|||
106064914|NCT02743871|365899321|FG013|Overall Study|Withdrawal by Subject|6|||
106064915|NCT02743871|365899308|FG000|Overall Study|Adverse Event|1|||
106064916|NCT02743871|365899309|FG001|Overall Study|Adverse Event|0|||
106064917|NCT02743871|365899310|FG002|Overall Study|Adverse Event|0|||
106064918|NCT02743871|365899311|FG003|Overall Study|Adverse Event|0|||
106064919|NCT02743871|365899312|FG004|Overall Study|Adverse Event|0|||
106064920|NCT02743871|365899313|FG005|Overall Study|Adverse Event|0|||
106064921|NCT02743871|365899314|FG006|Overall Study|Adverse Event|0|||
106064922|NCT02743871|365899315|FG007|Overall Study|Adverse Event|0|||
106064923|NCT02743871|365899316|FG008|Overall Study|Adverse Event|0|||
106064924|NCT02743871|365899317|FG009|Overall Study|Adverse Event|0|||
106064925|NCT02743871|365899318|FG010|Overall Study|Adverse Event|0|||
106064926|NCT02743871|365899319|FG011|Overall Study|Adverse Event|0|||
106064927|NCT02743871|365899320|FG012|Overall Study|Adverse Event|0|||
106064928|NCT02743871|365899321|FG013|Overall Study|Adverse Event|0|||
106064929|NCT02743871|365899308|FG000|Overall Study|Other|0|||
106064930|NCT02743871|365899309|FG001|Overall Study|Other|0|||
106064931|NCT02743871|365899310|FG002|Overall Study|Other|0|||
106064932|NCT02743871|365899311|FG003|Overall Study|Other|0|||
106064933|NCT02743871|365899312|FG004|Overall Study|Other|0|||
106064934|NCT02743871|365899313|FG005|Overall Study|Other|0|||
106064935|NCT02743871|365899314|FG006|Overall Study|Other|0|||
106064936|NCT02743871|365899315|FG007|Overall Study|Other|0|||
106064937|NCT02743871|365899316|FG008|Overall Study|Other|0|||
106064938|NCT02743871|365899317|FG009|Overall Study|Other|0|||
106064939|NCT02743871|365899318|FG010|Overall Study|Other|0|||
106064940|NCT02743871|365899319|FG011|Overall Study|Other|1|||
106064941|NCT02743871|365899320|FG012|Overall Study|Other|1|||
106064942|NCT02743871|365899321|FG013|Overall Study|Other|1|||
106064943|NCT02743871|365899308|FG000|Overall Study|Protocol Violation|0|||
106064944|NCT02743871|365899309|FG001|Overall Study|Protocol Violation|0|||
106064945|NCT02743871|365899310|FG002|Overall Study|Protocol Violation|0|||
106064946|NCT02743871|365899311|FG003|Overall Study|Protocol Violation|0|||
106064947|NCT02743871|365899312|FG004|Overall Study|Protocol Violation|0|||
106064948|NCT02743871|365899313|FG005|Overall Study|Protocol Violation|0|||
106064949|NCT02743871|365899314|FG006|Overall Study|Protocol Violation|0|||
106064950|NCT02743871|365899315|FG007|Overall Study|Protocol Violation|0|||
106064951|NCT02743871|365899316|FG008|Overall Study|Protocol Violation|0|||
106064952|NCT02743871|365899317|FG009|Overall Study|Protocol Violation|0|||
106064953|NCT02743871|365899318|FG010|Overall Study|Protocol Violation|0|||
106064954|NCT02743871|365899319|FG011|Overall Study|Protocol Violation|0|||
106064955|NCT02743871|365899320|FG012|Overall Study|Protocol Violation|2|||
106064956|NCT02743871|365899321|FG013|Overall Study|Protocol Violation|0|||
106064957|NCT04772755|365899325|FG000|Overall Study|Withdrawal by Subject|1|||
106064958|NCT04772755|365899326|FG001|Overall Study|Withdrawal by Subject|0|||
106064959|NCT04772755|365899325|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
106064960|NCT04772755|365899326|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
106064961|NCT01317160|365899328|FG000|Overall Study|Incorrect inclusion|1|||
106064962|NCT01317160|365899329|FG001|Overall Study|Incorrect inclusion|1|||
106064963|NCT01317160|365899328|FG000|Overall Study|Lost to Follow-up|3|||
106064964|NCT01317160|365899329|FG001|Overall Study|Lost to Follow-up|3|||
106064965|NCT01317160|365899328|FG000|Overall Study|Withdrawal by Subject|0|||
106064966|NCT01317160|365899329|FG001|Overall Study|Withdrawal by Subject|2|||
106064967|NCT01774968|365899333|FG000|Overall Study|Adverse Event|4|||
106064968|NCT01774968|365899334|FG001|Overall Study|Adverse Event|4|||
106064969|NCT01774968|365899333|FG000|Overall Study|Death|0|||
106064970|NCT01774968|365899334|FG001|Overall Study|Death|1|||
106064971|NCT01774968|365899333|FG000|Overall Study|Lost to Follow-up|1|||
106064972|NCT01774968|365899334|FG001|Overall Study|Lost to Follow-up|3|||
106064973|NCT01774968|365899333|FG000|Overall Study|Physician Decision|5|||
106154094|NCT00979576|366223985|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
106154095|NCT00979576|366223983|FG000|Combination Treatment Phase|Adverse Event|0|||
106064974|NCT01774968|365899334|FG001|Overall Study|Physician Decision|1|||
106064975|NCT01774968|365899333|FG000|Overall Study|Protocol Violation|14|||
106064976|NCT01774968|365899334|FG001|Overall Study|Protocol Violation|13|||
106064977|NCT01774968|365899333|FG000|Overall Study|Sponsor Decision|0|||
106064978|NCT01774968|365899334|FG001|Overall Study|Sponsor Decision|2|||
106064979|NCT01774968|365899333|FG000|Overall Study|Withdrawal by Subject|6|||
106064980|NCT01774968|365899334|FG001|Overall Study|Withdrawal by Subject|11|||
106064981|NCT03032705|365899335|FG000|Overall Study|Lost to Follow-up|16|||
106064982|NCT03032705|365899336|FG001|Overall Study|Lost to Follow-up|17|||
106064983|NCT03032705|365899335|FG000|Overall Study|did not quality|6|||
106064984|NCT03032705|365899336|FG001|Overall Study|did not quality|6|||
106064985|NCT00353262|365899337|FG000|Overall Study|Adverse Event|8|||
106064986|NCT00353262|365899337|FG000|Overall Study|Withdrawal by Subject|2|||
106064987|NCT00353262|365899337|FG000|Overall Study|Insufficient Therapeutic Response|13|||
106064988|NCT00353262|365899337|FG000|Overall Study|Progression|1|||
106064989|NCT00353262|365899337|FG000|Overall Study|Surgery|4|||
106064990|NCT00353262|365899337|FG000|Overall Study|Break from Chemotherapy|1|||
106064991|NCT02759471|365899338|FG000|Overall Study|discomfort|2|||
106064992|NCT03312933|365901791|FG000|Overall Study|Protocol Violation|15|||
106064993|NCT03312933|365901791|FG000|Overall Study|Lost to Follow-up|36|||
106064994|NCT03312933|365901791|FG000|Overall Study|Withdrawal by Subject|3|||
106064995|NCT00224055|365901797|FG000|Overall Study|Adverse Event|9|||
106064996|NCT00224055|365901798|FG001|Overall Study|Adverse Event|3|||
106064997|NCT00224055|365901797|FG000|Overall Study|Lost to Follow-up|1|||
106064998|NCT00224055|365901798|FG001|Overall Study|Lost to Follow-up|2|||
106064999|NCT00224055|365901797|FG000|Overall Study|Protocol Violation|1|||
106065000|NCT00224055|365901798|FG001|Overall Study|Protocol Violation|1|||
106065001|NCT00224055|365901797|FG000|Overall Study|Inclusion Violation|3|||
106065002|NCT00224055|365901798|FG001|Overall Study|Inclusion Violation|6|||
106065003|NCT00224055|365901797|FG000|Overall Study|Withdrawal by Subject|0|||
106065004|NCT00224055|365901798|FG001|Overall Study|Withdrawal by Subject|2|||
106065005|NCT00224055|365901797|FG000|Overall Study|Other|1|||
106065006|NCT00224055|365901798|FG001|Overall Study|Other|0|||
106065007|NCT02068443|365901799|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
106065008|NCT02068443|365901800|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
106065009|NCT02068443|365901801|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
106065010|NCT02068443|365901799|FG000|Overall Study|Voluntary Withdrawal|4|||
106065011|NCT02068443|365901800|FG001|Overall Study|Voluntary Withdrawal|0|||
106065012|NCT02068443|365901801|FG002|Overall Study|Voluntary Withdrawal|1|||
106065013|NCT02068443|365901799|FG000|Overall Study|Lack of Efficacy|2|||
106065014|NCT02068443|365901800|FG001|Overall Study|Lack of Efficacy|1|||
106065015|NCT02068443|365901801|FG002|Overall Study|Lack of Efficacy|0|||
106065016|NCT02068443|365901799|FG000|Overall Study|Other Reason Not Specified|1|||
106065017|NCT02068443|365901800|FG001|Overall Study|Other Reason Not Specified|0|||
106065018|NCT02068443|365901801|FG002|Overall Study|Other Reason Not Specified|0|||
106065019|NCT00664742|365901803|FG000|Overall Study|Withdrawn due to adverse events|3|||
106065020|NCT00664742|365901803|FG000|Overall Study|Withdrawal by Subject|31|||
106065021|NCT00664742|365901803|FG000|Overall Study|Lost to Follow-up|92|||
106065022|NCT02064868|365901806|FG000|Overall Study|Lost to Follow-up|14|||
106065023|NCT02064868|365901807|FG001|Overall Study|Lost to Follow-up|8|||
106065024|NCT02064868|365901806|FG000|Overall Study|Physician Decision|1|||
106065025|NCT02064868|365901807|FG001|Overall Study|Physician Decision|0|||
106065026|NCT02064868|365901806|FG000|Overall Study|Withdrawal by Subject|14|||
106065027|NCT02064868|365901807|FG001|Overall Study|Withdrawal by Subject|3|||
106065028|NCT02064868|365901806|FG000|Overall Study|Technical Problems or Missing|5|||
106065029|NCT02064868|365901807|FG001|Overall Study|Technical Problems or Missing|2|||
106065030|NCT03182829|365901808|FG000|Overall Study|Protocol Violation|12|||
106065031|NCT03182829|365901809|FG001|Overall Study|Protocol Violation|12|||
106065032|NCT03182829|365901808|FG000|Overall Study|Other|4|||
106065033|NCT03182829|365901809|FG001|Overall Study|Other|3|||
106065034|NCT02904512|365901810|FG000|Overall Study|Withdrawal by Subject|1|||
106065035|NCT02904512|365901811|FG001|Overall Study|Withdrawal by Subject|0|||
106065036|NCT02904512|365901810|FG000|Overall Study|Transferred to ICU|1|||
106065037|NCT02904512|365901811|FG001|Overall Study|Transferred to ICU|0|||
106065038|NCT02904512|365901810|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
106065039|NCT02904512|365901811|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
106065040|NCT02041286|365901812|FG000|Overall Study|Adverse Event|1|||
106065041|NCT00386776|365901817|FG000|Overall Study|Withdrawal by Subject|8|||
106065042|NCT02282020|365901818|FG000|Overall Study|Objective Disease Progression|128|||
106065043|NCT02282020|365901819|FG001|Overall Study|Objective Disease Progression|30|||
106065044|NCT02282020|365901818|FG000|Overall Study|Adverse Event|18|||
106065045|NCT02282020|365901819|FG001|Overall Study|Adverse Event|15|||
106065046|NCT02282020|365901818|FG000|Overall Study|Withdrawal by Subject|7|||
106065047|NCT02282020|365901819|FG001|Overall Study|Withdrawal by Subject|10|||
106065048|NCT02282020|365901818|FG000|Overall Study|Miscellaneous|5|||
106065049|NCT02282020|365901819|FG001|Overall Study|Miscellaneous|19|||
106065050|NCT02282020|365901818|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
106154096|NCT00979576|366223984|FG001|Combination Treatment Phase|Adverse Event|2|||
106154097|NCT00979576|366223985|FG002|Combination Treatment Phase|Adverse Event|2|||
106154098|NCT00979576|366223983|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
106154099|NCT00979576|366223984|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
106065051|NCT02282020|365901819|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
106065052|NCT02282020|365901818|FG000|Overall Study|Developed Discontinuation Criteria|0|||
106065053|NCT02282020|365901819|FG001|Overall Study|Developed Discontinuation Criteria|2|||
106065054|NCT02282020|365901818|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
106065055|NCT02282020|365901819|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
106065056|NCT01500629|365901820|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
106065057|NCT01500629|365901821|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
106065058|NCT00588848|365901822|FG000|Overall Study|Physician Decision|0|||
106065059|NCT00588848|365901823|FG001|Overall Study|Physician Decision|3|||
106065060|NCT02902965|365901824|FG000|Overall Study|Withdrawal by Subject|10|||
106065061|NCT03138889|365901825|FG000|Overall Study|Withdrawal by Subject|5|||
106065062|NCT03138889|365901826|FG001|Overall Study|Withdrawal by Subject|5|||
106065063|NCT03138889|365901827|FG002|Overall Study|Withdrawal by Subject|0|||
106065064|NCT03138889|365901828|FG003|Overall Study|Withdrawal by Subject|2|||
106065065|NCT03138889|365901829|FG004|Overall Study|Withdrawal by Subject|1|||
106065066|NCT03138889|365901830|FG005|Overall Study|Withdrawal by Subject|3|||
106065067|NCT03138889|365901831|FG006|Overall Study|Withdrawal by Subject|0|||
106065068|NCT03138889|365901832|FG007|Overall Study|Withdrawal by Subject|1|||
106065069|NCT01963403|365901833|FG000|Overall Study|Lost to Follow-up|2|||
106065070|NCT01963403|365901834|FG001|Overall Study|Lost to Follow-up|3|||
106065071|NCT01963403|365901833|FG000|Overall Study|Implant removal|0|||
106065072|NCT01963403|365901834|FG001|Overall Study|Implant removal|1|||
106065073|NCT00589914|365901839|FG000|Overall Study|Adverse Event|19|||
106065074|NCT00589914|365901840|FG001|Overall Study|Adverse Event|10|||
106065075|NCT00589914|365901839|FG000|Overall Study|Death|2|||
106065076|NCT00589914|365901840|FG001|Overall Study|Death|0|||
106065077|NCT00589914|365901839|FG000|Overall Study|Lack of Efficacy|40|||
106065078|NCT00589914|365901840|FG001|Overall Study|Lack of Efficacy|43|||
106065079|NCT00589914|365901839|FG000|Overall Study|Lost to Follow-up|11|||
106065080|NCT00589914|365901840|FG001|Overall Study|Lost to Follow-up|18|||
106065081|NCT00589914|365901839|FG000|Overall Study|Pregnancy|1|||
106065082|NCT00589914|365901840|FG001|Overall Study|Pregnancy|0|||
106065083|NCT00589914|365901839|FG000|Overall Study|Withdrawal by Subject|55|||
106065084|NCT00589914|365901840|FG001|Overall Study|Withdrawal by Subject|49|||
106065085|NCT00589914|365901839|FG000|Overall Study|Other|22|||
106065086|NCT00589914|365901840|FG001|Overall Study|Other|17|||
106065087|NCT00531050|365901841|FG000|Part 1: Period 1|Adverse Event|0|||
106065088|NCT00531050|365901842|FG001|Part 1: Period 1|Adverse Event|1|||
106065089|NCT00531050|365901843|FG002|Part 1: Period 1|Adverse Event|0|||
106065090|NCT00531050|365901844|FG003|Part 1: Period 1|Adverse Event|0|||
106065091|NCT00531050|365901845|FG004|Part 1: Period 1|Adverse Event|0|||
106065092|NCT00531050|365901846|FG005|Part 1: Period 1|Adverse Event|0|||
106154100|NCT00979576|366223985|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
106154101|NCT03271151|366223989|FG000|Overall Study|Lost to Follow-up|1|||
106154102|NCT03271151|366223990|FG001|Overall Study|Lost to Follow-up|3|||
106154103|NCT03271151|366223989|FG000|Overall Study|Withdrawal by Subject|1|||
106154104|NCT03271151|366223990|FG001|Overall Study|Withdrawal by Subject|0|||
106154105|NCT03575052|366223991|FG000|Overall Study|Adverse Event|6|||
106154106|NCT03575052|366223992|FG001|Overall Study|Adverse Event|10|||
106154107|NCT03575052|366223991|FG000|Overall Study|Not further specified|5|||
106154108|NCT03575052|366223992|FG001|Overall Study|Not further specified|7|||
106154109|NCT03575052|366223991|FG000|Overall Study|Withdrawal by Subject|5|||
106154110|NCT03575052|366223992|FG001|Overall Study|Withdrawal by Subject|6|||
105865008|NCT02516553|365154820|FG018|Overall Study|Progressive disease|12|||
105865009|NCT02516553|365154821|FG019|Overall Study|Progressive disease|7|||
105865010|NCT02516553|365154822|FG020|Overall Study|Progressive disease|16|||
105865011|NCT02516553|365154823|FG021|Overall Study|Progressive disease|18|||
105865012|NCT02516553|365154802|FG000|Overall Study|Dose limiting toxicity|0|||
105865013|NCT02516553|365154803|FG001|Overall Study|Dose limiting toxicity|0|||
105865014|NCT02516553|365154804|FG002|Overall Study|Dose limiting toxicity|0|||
105865015|NCT02516553|365154805|FG003|Overall Study|Dose limiting toxicity|0|||
105865016|NCT02516553|365154806|FG004|Overall Study|Dose limiting toxicity|3|||
105865017|NCT02516553|365154807|FG005|Overall Study|Dose limiting toxicity|1|||
105865018|NCT02516553|365154808|FG006|Overall Study|Dose limiting toxicity|1|||
105865019|NCT02516553|365154809|FG007|Overall Study|Dose limiting toxicity|0|||
105865020|NCT02516553|365154810|FG008|Overall Study|Dose limiting toxicity|1|||
105865021|NCT02516553|365154811|FG009|Overall Study|Dose limiting toxicity|0|||
105865022|NCT02516553|365154812|FG010|Overall Study|Dose limiting toxicity|0|||
106154111|NCT03575052|366223991|FG000|Overall Study|Lost to Follow-up|3|||
106154112|NCT03575052|366223992|FG001|Overall Study|Lost to Follow-up|0|||
106154113|NCT03575052|366223991|FG000|Overall Study|Death|2|||
106065093|NCT00531050|365901841|FG000|Part 1: Period 1|Protocol Deviation|0|||
106065094|NCT00531050|365901842|FG001|Part 1: Period 1|Protocol Deviation|0|||
106065095|NCT00531050|365901843|FG002|Part 1: Period 1|Protocol Deviation|0|||
106065096|NCT00531050|365901844|FG003|Part 1: Period 1|Protocol Deviation|1|||
106154114|NCT03575052|366223992|FG001|Overall Study|Death|1|||
106154115|NCT03575052|366223991|FG000|Overall Study|Lack of Efficacy|2|||
106154116|NCT03575052|366223992|FG001|Overall Study|Lack of Efficacy|1|||
106154117|NCT03575052|366223991|FG000|Overall Study|Study drug noncompliance|1|||
105865023|NCT02516553|365154813|FG011|Overall Study|Dose limiting toxicity|1|||
105865024|NCT02516553|365154814|FG012|Overall Study|Dose limiting toxicity|0|||
106065097|NCT00531050|365901845|FG004|Part 1: Period 1|Protocol Deviation|0|||
106065098|NCT00531050|365901846|FG005|Part 1: Period 1|Protocol Deviation|0|||
106065099|NCT00531050|365901841|FG000|Part 1: Period 3|Adverse Event|1|||
106065100|NCT00531050|365901842|FG001|Part 1: Period 3|Adverse Event|0|||
106065101|NCT00531050|365901843|FG002|Part 1: Period 3|Adverse Event|0|||
106065102|NCT00531050|365901844|FG003|Part 1: Period 3|Adverse Event|0|||
106154118|NCT03575052|366223992|FG001|Overall Study|Study drug noncompliance|2|||
106065103|NCT00531050|365901845|FG004|Part 1: Period 3|Adverse Event|0|||
106065104|NCT00531050|365901846|FG005|Part 1: Period 3|Adverse Event|0|||
106065105|NCT00531050|365901841|FG000|Part 2: Period 1|Adverse Event|0|||
106065106|NCT00531050|365901842|FG001|Part 2: Period 1|Adverse Event|0|||
106065107|NCT00531050|365901843|FG002|Part 2: Period 1|Adverse Event|0|||
106065108|NCT00531050|365901844|FG003|Part 2: Period 1|Adverse Event|0|||
106065109|NCT00531050|365901845|FG004|Part 2: Period 1|Adverse Event|0|||
106065110|NCT00531050|365901846|FG005|Part 2: Period 1|Adverse Event|1|||
106065111|NCT00531050|365901841|FG000|Part 2: Period 3|Abnormal test procedure|1|||
106065112|NCT00531050|365901842|FG001|Part 2: Period 3|Abnormal test procedure|0|||
106065113|NCT00531050|365901843|FG002|Part 2: Period 3|Abnormal test procedure|0|||
106065114|NCT00531050|365901844|FG003|Part 2: Period 3|Abnormal test procedure|0|||
106065115|NCT00531050|365901845|FG004|Part 2: Period 3|Abnormal test procedure|0|||
106065116|NCT00531050|365901846|FG005|Part 2: Period 3|Abnormal test procedure|1|||
106065117|NCT02233309|365901847|FG000|Overall Study|Physician Decision|5|||
106065118|NCT00232817|365901856|FG000|Overall Study|Protocol Violation|2|||
106065119|NCT00232817|365901857|FG001|Overall Study|Protocol Violation|1|||
106065120|NCT04481750|365901858|FG000|Period 1 (Fasted)|Adverse Event|0|||
106065121|NCT04481750|365901859|FG001|Period 1 (Fasted)|Adverse Event|0|||
106065122|NCT04481750|365901860|FG002|Period 1 (Fasted)|Adverse Event|1|||
106065123|NCT04481750|365901861|FG003|Period 1 (Fasted)|Adverse Event|0|||
106065124|NCT04481750|365901862|FG004|Period 1 (Fasted)|Adverse Event|0|||
106065125|NCT04481750|365901863|FG005|Period 1 (Fasted)|Adverse Event|0|||
106065126|NCT04481750|365901864|FG006|Period 1 (Fasted)|Adverse Event|0|||
106065127|NCT04481750|365901865|FG007|Period 1 (Fasted)|Adverse Event|0|||
106065128|NCT04481750|365901866|FG008|Period 1 (Fasted)|Adverse Event|0|||
106065129|NCT04481750|365901867|FG009|Period 1 (Fasted)|Adverse Event|0|||
106065130|NCT04481750|365901868|FG010|Period 1 (Fasted)|Adverse Event|0|||
106065131|NCT00475176|365901869|FG000|Overall Study|Adverse Event|2|||
106065132|NCT00475176|365901869|FG000|Overall Study|Withdrawal by Subject|1|||
106065133|NCT00475176|365901869|FG000|Overall Study|Protocol Violation|1|||
106065134|NCT02436889|365901870|FG000|Overall Study|No improvement in symptoms|1|||
106065135|NCT02436889|365901871|FG001|Overall Study|No improvement in symptoms|0|||
106065136|NCT02436889|365901870|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
106065137|NCT02436889|365901871|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
106065138|NCT01585428|365901872|FG000|Overall Study|Death during treatment|1|||
106065139|NCT01585428|365901873|FG001|Overall Study|Death during treatment|0|||
106065140|NCT01349803|365901874|FG000|Overall Study|Adverse Event|0|||
106065141|NCT01349803|365901875|FG001|Overall Study|Adverse Event|0|||
106065142|NCT01349803|365901876|FG002|Overall Study|Adverse Event|0|||
106065143|NCT01349803|365901877|FG003|Overall Study|Adverse Event|2|||
106065144|NCT01349803|365901874|FG000|Overall Study|Withdrawal by Subject|1|||
106065145|NCT01349803|365901875|FG001|Overall Study|Withdrawal by Subject|0|||
106065146|NCT01349803|365901876|FG002|Overall Study|Withdrawal by Subject|0|||
106065147|NCT01349803|365901877|FG003|Overall Study|Withdrawal by Subject|0|||
106065148|NCT01349803|365901874|FG000|Overall Study|Protocol-specified criteria|0|||
106065149|NCT01349803|365901875|FG001|Overall Study|Protocol-specified criteria|1|||
106065150|NCT01349803|365901876|FG002|Overall Study|Protocol-specified criteria|3|||
106065151|NCT01349803|365901877|FG003|Overall Study|Protocol-specified criteria|0|||
106065152|NCT02169739|365901878|FG000|Overall Study|Lost to Follow-up|0|||
106065153|NCT02169739|365901879|FG001|Overall Study|Lost to Follow-up|4|||
106065154|NCT01484873|365901880|FG000|Overall Study|Withdrawal by Subject|2|||
106065155|NCT00100815|365901881|FG000|Overall Study|Progression|24|||
106065156|NCT00100815|365901881|FG000|Overall Study|Adverse Event|18|||
106065157|NCT00100815|365901881|FG000|Overall Study|Death|4|||
106065158|NCT00100815|365901881|FG000|Overall Study|Other|3|||
106065159|NCT02564042|365901882|FG000|Overall Study|Adverse Event|4|||
106065160|NCT02564042|365901883|FG001|Overall Study|Adverse Event|4|||
106065161|NCT02564042|365901884|FG002|Overall Study|Adverse Event|3|||
106065162|NCT02564042|365901885|FG003|Overall Study|Adverse Event|0|||
106065163|NCT02564042|365901886|FG004|Overall Study|Adverse Event|0|||
106065164|NCT02564042|365901887|FG005|Overall Study|Adverse Event|1|||
106065165|NCT02564042|365901882|FG000|Overall Study|Lost to Follow-up|1|||
106065166|NCT02564042|365901883|FG001|Overall Study|Lost to Follow-up|1|||
106065167|NCT02564042|365901884|FG002|Overall Study|Lost to Follow-up|1|||
106065168|NCT02564042|365901885|FG003|Overall Study|Lost to Follow-up|0|||
106065169|NCT02564042|365901886|FG004|Overall Study|Lost to Follow-up|1|||
106065170|NCT02564042|365901887|FG005|Overall Study|Lost to Follow-up|1|||
106065171|NCT02564042|365901882|FG000|Overall Study|Physician Decision|1|||
106065172|NCT02564042|365901883|FG001|Overall Study|Physician Decision|0|||
106065173|NCT02564042|365901884|FG002|Overall Study|Physician Decision|0|||
106065174|NCT02564042|365901885|FG003|Overall Study|Physician Decision|1|||
106065175|NCT02564042|365901886|FG004|Overall Study|Physician Decision|0|||
106065176|NCT02564042|365901887|FG005|Overall Study|Physician Decision|0|||
106065177|NCT02564042|365901882|FG000|Overall Study|Withdrawal by Subject|5|||
106065178|NCT02564042|365901883|FG001|Overall Study|Withdrawal by Subject|3|||
106065179|NCT02564042|365901884|FG002|Overall Study|Withdrawal by Subject|2|||
106065180|NCT02564042|365901885|FG003|Overall Study|Withdrawal by Subject|2|||
106065181|NCT02564042|365901886|FG004|Overall Study|Withdrawal by Subject|10|||
106065182|NCT02564042|365901887|FG005|Overall Study|Withdrawal by Subject|12|||
106065183|NCT01549392|365901888|FG000|Overall Study|Withdrawal by Subject|1|||
106065184|NCT01549392|365901889|FG001|Overall Study|Withdrawal by Subject|0|||
106065185|NCT02743806|365901891|FG000|Overall Study|Adverse Event|9|||
106065186|NCT02743806|365901891|FG000|Overall Study|Lost to Follow-up|8|||
106065187|NCT02743806|365901891|FG000|Overall Study|Voluntary Withdrawal|54|||
106065188|NCT02743806|365901891|FG000|Overall Study|Study Termination|65|||
106065189|NCT02743806|365901891|FG000|Overall Study|Pregnancy|6|||
106065190|NCT02743806|365901891|FG000|Overall Study|No Longer Clinically Benefiting|27|||
106065191|NCT02743806|365901891|FG000|Overall Study|Reason Not Specified|12|||
106065192|NCT01475331|365901893|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
106065193|NCT01475331|365901894|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
106065194|NCT01475331|365901893|FG000|Overall Study|excessive main duct communication|1|||
106065195|NCT01475331|365901894|FG001|Overall Study|excessive main duct communication|1|||
106065196|NCT01475331|365901893|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
106065197|NCT01475331|365901894|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
106154119|NCT03575052|366223991|FG000|Overall Study|Protocol Violation|0|||
106154120|NCT03575052|366223992|FG001|Overall Study|Protocol Violation|2|||
106154121|NCT03575052|366223991|FG000|Overall Study|Physician Decision|1|||
106154122|NCT03575052|366223992|FG001|Overall Study|Physician Decision|0|||
106065198|NCT01475331|365901893|FG000|Overall Study|Sign of malignancy during the procedure|2|||
106065199|NCT01475331|365901894|FG001|Overall Study|Sign of malignancy during the procedure|0|||
106065200|NCT01475331|365901893|FG000|Overall Study|cyst found to be prohibitively small|0|||
106065201|NCT01475331|365901894|FG001|Overall Study|cyst found to be prohibitively small|1|||
106065202|NCT01525550|365901895|FG000|Overall Study|Lost to Follow-up|8|||
106065203|NCT01525550|365901896|FG001|Overall Study|Lost to Follow-up|2|||
106065204|NCT01525550|365901895|FG000|Overall Study|Death|19|||
106065205|NCT01525550|365901896|FG001|Overall Study|Death|28|||
106065206|NCT01525550|365901895|FG000|Overall Study|Other|0|||
106065207|NCT01525550|365901896|FG001|Overall Study|Other|4|||
106065208|NCT01525550|365901895|FG000|Overall Study|Sponsor's Decision|30|||
106065209|NCT01525550|365901896|FG001|Overall Study|Sponsor's Decision|11|||
106065210|NCT01525550|365901895|FG000|Overall Study|Withdrawal by Subject|4|||
106065211|NCT01525550|365901896|FG001|Overall Study|Withdrawal by Subject|0|||
106065212|NCT02289690|365901897|FG000|Overall Study|Adverse Event Related to Progression|0|||
106065213|NCT02289690|365901898|FG001|Overall Study|Adverse Event Related to Progression|1|||
106065214|NCT02289690|365901899|FG002|Overall Study|Adverse Event Related to Progression|1|||
106065215|NCT02289690|365901900|FG003|Overall Study|Adverse Event Related to Progression|0|||
106065216|NCT02289690|365901901|FG004|Overall Study|Adverse Event Related to Progression|1|||
106065217|NCT02289690|365901902|FG005|Overall Study|Adverse Event Related to Progression|0|||
106065218|NCT02289690|365901903|FG006|Overall Study|Adverse Event Related to Progression|1|||
106065219|NCT02289690|365901904|FG007|Overall Study|Adverse Event Related to Progression|0|||
106065220|NCT02289690|365901905|FG008|Overall Study|Adverse Event Related to Progression|0|||
106065221|NCT02289690|365901906|FG009|Overall Study|Adverse Event Related to Progression|0|||
106065222|NCT02289690|365901897|FG000|Overall Study|Withdrawal by Subject|1|||
106065223|NCT02289690|365901898|FG001|Overall Study|Withdrawal by Subject|0|||
106065224|NCT02289690|365901899|FG002|Overall Study|Withdrawal by Subject|0|||
106065225|NCT02289690|365901900|FG003|Overall Study|Withdrawal by Subject|0|||
106065226|NCT02289690|365901901|FG004|Overall Study|Withdrawal by Subject|1|||
106065227|NCT02289690|365901902|FG005|Overall Study|Withdrawal by Subject|1|||
106065228|NCT02289690|365901903|FG006|Overall Study|Withdrawal by Subject|0|||
106065229|NCT02289690|365901904|FG007|Overall Study|Withdrawal by Subject|0|||
106065230|NCT02289690|365901905|FG008|Overall Study|Withdrawal by Subject|4|||
106065231|NCT02289690|365901906|FG009|Overall Study|Withdrawal by Subject|2|||
106065232|NCT02289690|365901897|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
106065233|NCT02289690|365901898|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
106065234|NCT02289690|365901899|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
106065235|NCT02289690|365901900|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
106065236|NCT02289690|365901901|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
106065237|NCT02289690|365901902|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
106065238|NCT02289690|365901903|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
106065239|NCT02289690|365901904|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
106065240|NCT02289690|365901905|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
106065241|NCT02289690|365901906|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
106065242|NCT02289690|365901897|FG000|Overall Study|Lost to Follow-up|0|||
105865025|NCT02516553|365154815|FG013|Overall Study|Dose limiting toxicity|1|||
106065243|NCT02289690|365901898|FG001|Overall Study|Lost to Follow-up|0|||
105865026|NCT02516553|365154816|FG014|Overall Study|Dose limiting toxicity|0|||
105865027|NCT02516553|365154817|FG015|Overall Study|Dose limiting toxicity|0|||
105865028|NCT02516553|365154818|FG016|Overall Study|Dose limiting toxicity|1|||
105865029|NCT02516553|365154819|FG017|Overall Study|Dose limiting toxicity|1|||
105865030|NCT02516553|365154820|FG018|Overall Study|Dose limiting toxicity|0|||
105865031|NCT02516553|365154821|FG019|Overall Study|Dose limiting toxicity|2|||
105865032|NCT02516553|365154822|FG020|Overall Study|Dose limiting toxicity|0|||
105865033|NCT02516553|365154823|FG021|Overall Study|Dose limiting toxicity|0|||
105865034|NCT02516553|365154802|FG000|Overall Study|Other Adverse Events|0|||
105865035|NCT02516553|365154803|FG001|Overall Study|Other Adverse Events|0|||
105865036|NCT02516553|365154804|FG002|Overall Study|Other Adverse Events|0|||
105865037|NCT02516553|365154805|FG003|Overall Study|Other Adverse Events|1|||
105865038|NCT02516553|365154806|FG004|Overall Study|Other Adverse Events|0|||
105865039|NCT02516553|365154807|FG005|Overall Study|Other Adverse Events|1|||
105865040|NCT02516553|365154808|FG006|Overall Study|Other Adverse Events|0|||
105865041|NCT02516553|365154809|FG007|Overall Study|Other Adverse Events|0|||
105865042|NCT02516553|365154810|FG008|Overall Study|Other Adverse Events|0|||
106065244|NCT02289690|365901899|FG002|Overall Study|Lost to Follow-up|0|||
106065245|NCT02289690|365901900|FG003|Overall Study|Lost to Follow-up|0|||
106065246|NCT02289690|365901901|FG004|Overall Study|Lost to Follow-up|0|||
106065247|NCT02289690|365901902|FG005|Overall Study|Lost to Follow-up|0|||
106065248|NCT02289690|365901903|FG006|Overall Study|Lost to Follow-up|0|||
106065249|NCT02289690|365901904|FG007|Overall Study|Lost to Follow-up|1|||
106065250|NCT02289690|365901905|FG008|Overall Study|Lost to Follow-up|0|||
106065251|NCT02289690|365901906|FG009|Overall Study|Lost to Follow-up|2|||
106065252|NCT02289690|365901897|FG000|Overall Study|Death|0|||
106065253|NCT02289690|365901898|FG001|Overall Study|Death|0|||
106065254|NCT02289690|365901899|FG002|Overall Study|Death|0|||
106065255|NCT02289690|365901900|FG003|Overall Study|Death|0|||
106065256|NCT02289690|365901901|FG004|Overall Study|Death|0|||
106065257|NCT02289690|365901902|FG005|Overall Study|Death|0|||
106065258|NCT02289690|365901903|FG006|Overall Study|Death|0|||
106065259|NCT02289690|365901904|FG007|Overall Study|Death|49|||
106065260|NCT02289690|365901905|FG008|Overall Study|Death|45|||
106065261|NCT02289690|365901906|FG009|Overall Study|Death|41|||
106065262|NCT02289690|365901897|FG000|Overall Study|Sponsor Discontinued Study|0|||
106065263|NCT02289690|365901898|FG001|Overall Study|Sponsor Discontinued Study|0|||
106065264|NCT02289690|365901899|FG002|Overall Study|Sponsor Discontinued Study|0|||
106065265|NCT02289690|365901900|FG003|Overall Study|Sponsor Discontinued Study|0|||
106065266|NCT02289690|365901901|FG004|Overall Study|Sponsor Discontinued Study|0|||
106065267|NCT02289690|365901902|FG005|Overall Study|Sponsor Discontinued Study|0|||
106065268|NCT02289690|365901903|FG006|Overall Study|Sponsor Discontinued Study|0|||
106065269|NCT02289690|365901904|FG007|Overall Study|Sponsor Discontinued Study|9|||
106065270|NCT02289690|365901905|FG008|Overall Study|Sponsor Discontinued Study|7|||
106065271|NCT02289690|365901906|FG009|Overall Study|Sponsor Discontinued Study|15|||
106065272|NCT02289690|365901897|FG000|Overall Study|Other|0|||
106065273|NCT02289690|365901898|FG001|Overall Study|Other|0|||
106065274|NCT02289690|365901899|FG002|Overall Study|Other|0|||
106065275|NCT02289690|365901900|FG003|Overall Study|Other|1|||
106065276|NCT02289690|365901901|FG004|Overall Study|Other|1|||
106065277|NCT02289690|365901902|FG005|Overall Study|Other|0|||
106065278|NCT02289690|365901903|FG006|Overall Study|Other|1|||
106065279|NCT02289690|365901904|FG007|Overall Study|Other|2|||
106154123|NCT04093362|366223993|FG000|Overall Study|Study Termination|1|||
106065280|NCT02289690|365901905|FG008|Overall Study|Other|3|||
106065281|NCT02289690|365901906|FG009|Overall Study|Other|1|||
106154124|NCT04093362|366223994|FG001|Overall Study|Study Termination|1|||
106154125|NCT04093362|366223993|FG000|Overall Study|Withdrawal of Consent|1|||
106154126|NCT04093362|366223994|FG001|Overall Study|Withdrawal of Consent|0|||
106154127|NCT04093362|366223993|FG000|Overall Study|Death|1|||
106154128|NCT04093362|366223994|FG001|Overall Study|Death|3|||
106154129|NCT04093362|366223993|FG000|Overall Study|Reason not Specified|1|||
106154130|NCT04093362|366223994|FG001|Overall Study|Reason not Specified|2|||
106154131|NCT00753090|366223997|FG000|Overall Study|Withdrawal by Subject|10|||
106154132|NCT00753090|366223998|FG001|Overall Study|Withdrawal by Subject|10|||
106154133|NCT00753090|366223997|FG000|Overall Study|Death|17|||
106154134|NCT00753090|366223998|FG001|Overall Study|Death|6|||
105865043|NCT02516553|365154811|FG009|Overall Study|Other Adverse Events|1|||
105865044|NCT02516553|365154812|FG010|Overall Study|Other Adverse Events|3|||
105865045|NCT02516553|365154813|FG011|Overall Study|Other Adverse Events|2|||
105865046|NCT02516553|365154814|FG012|Overall Study|Other Adverse Events|0|||
105865047|NCT02516553|365154815|FG013|Overall Study|Other Adverse Events|1|||
105865048|NCT02516553|365154816|FG014|Overall Study|Other Adverse Events|0|||
105865049|NCT02516553|365154817|FG015|Overall Study|Other Adverse Events|0|||
106065282|NCT01988103|365901909|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
106065283|NCT01988103|365901910|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
106065284|NCT01988103|365901911|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
106154135|NCT00753090|366223997|FG000|Overall Study|Study Prosthesis Removed|12|||
106065285|NCT01988103|365901912|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
106065286|NCT01988103|365901913|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
106065287|NCT01988103|365901909|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
106065288|NCT01988103|365901910|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
106065289|NCT01988103|365901911|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
106065290|NCT01988103|365901912|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
106065291|NCT01988103|365901913|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
106065292|NCT01988103|365901909|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
106065293|NCT01988103|365901910|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
106065294|NCT01988103|365901911|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
106065295|NCT01988103|365901912|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
106065296|NCT01988103|365901913|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
106065297|NCT01988103|365901909|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
106065298|NCT01988103|365901910|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
106065299|NCT01988103|365901911|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
106065300|NCT01988103|365901912|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
106065301|NCT01988103|365901913|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
106065302|NCT01988103|365901909|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
106065303|NCT01988103|365901910|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
106065304|NCT01988103|365901911|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
106065305|NCT01988103|365901912|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
106065306|NCT01988103|365901913|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
106065307|NCT01988103|365901909|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
106065308|NCT01988103|365901910|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
106065309|NCT01988103|365901911|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
106065310|NCT01988103|365901912|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
106065311|NCT01988103|365901913|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
106065312|NCT01988103|365901909|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
106065313|NCT01988103|365901910|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
106065314|NCT01988103|365901911|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
106065315|NCT01988103|365901912|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
106065316|NCT01988103|365901913|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
106065317|NCT02289898|365901917|FG000|Overall Study|Death|5|||
106065318|NCT02289898|365901918|FG001|Overall Study|Death|4|||
106065319|NCT02289898|365901919|FG002|Overall Study|Death|3|||
106065320|NCT02289898|365901917|FG000|Overall Study|Physician Decision|2|||
106065321|NCT02289898|365901918|FG001|Overall Study|Physician Decision|5|||
106065322|NCT02289898|365901919|FG002|Overall Study|Physician Decision|2|||
106065323|NCT02289898|365901917|FG000|Overall Study|Withdrawal by Subject|0|||
106065324|NCT02289898|365901918|FG001|Overall Study|Withdrawal by Subject|4|||
106065325|NCT02289898|365901919|FG002|Overall Study|Withdrawal by Subject|1|||
106065326|NCT02289898|365901917|FG000|Overall Study|Adverse Event|3|||
106065327|NCT02289898|365901918|FG001|Overall Study|Adverse Event|5|||
106065328|NCT02289898|365901919|FG002|Overall Study|Adverse Event|5|||
106065329|NCT02289898|365901917|FG000|Overall Study|Disease progression|34|||
106065330|NCT02289898|365901918|FG001|Overall Study|Disease progression|28|||
106065331|NCT02289898|365901919|FG002|Overall Study|Disease progression|34|||
106065332|NCT02289898|365901917|FG000|Overall Study|Use of another anticancer therapy|0|||
106065333|NCT02289898|365901918|FG001|Overall Study|Use of another anticancer therapy|0|||
106065334|NCT02289898|365901919|FG002|Overall Study|Use of another anticancer therapy|1|||
106065335|NCT02289898|365901917|FG000|Overall Study|Other|8|||
106065336|NCT02289898|365901918|FG001|Overall Study|Other|7|||
106065337|NCT02289898|365901919|FG002|Overall Study|Other|10|||
106065338|NCT00644995|365901920|FG000|Overall Study|Lost to Follow-up|1|||
106065339|NCT00644995|365901921|FG001|Overall Study|Lost to Follow-up|4|||
106065340|NCT00644995|365901920|FG000|Overall Study|Refused|1|||
106065341|NCT00644995|365901921|FG001|Overall Study|Refused|0|||
106065342|NCT01601626|365901922|FG000|Overall Study|Death|1|||
106065343|NCT01601626|365901923|FG001|Overall Study|Death|1|||
106065344|NCT01601626|365901924|FG002|Overall Study|Death|1|||
106065345|NCT01601626|365901922|FG000|Overall Study|Lost to Follow-up|1|||
106065346|NCT01601626|365901923|FG001|Overall Study|Lost to Follow-up|2|||
106065347|NCT01601626|365901924|FG002|Overall Study|Lost to Follow-up|0|||
106065348|NCT01601626|365901922|FG000|Overall Study|Unable to Get to Clinic|0|||
106065349|NCT01601626|365901923|FG001|Overall Study|Unable to Get to Clinic|1|||
106065350|NCT01601626|365901924|FG002|Overall Study|Unable to Get to Clinic|0|||
106065351|NCT01601626|365901922|FG000|Overall Study|Withdrawal by Subject|0|||
106065352|NCT01601626|365901923|FG001|Overall Study|Withdrawal by Subject|1|||
106065353|NCT01601626|365901924|FG002|Overall Study|Withdrawal by Subject|1|||
106065354|NCT01601626|365901922|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
105865050|NCT02516553|365154818|FG016|Overall Study|Other Adverse Events|0|||
105865051|NCT02516553|365154819|FG017|Overall Study|Other Adverse Events|2|||
106065355|NCT01601626|365901923|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
106065356|NCT01601626|365901924|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
106065357|NCT02598076|365901925|FG000|Overall Study|Lost to Follow-up|2|||
106065358|NCT02598076|365901926|FG001|Overall Study|Lost to Follow-up|3|||
106065359|NCT01291173|365901927|FG000|Overall Study|Adverse Event|0|||
106065360|NCT01291173|365901928|FG001|Overall Study|Adverse Event|3|||
106065361|NCT01291173|365901929|FG002|Overall Study|Adverse Event|1|||
106065362|NCT01291173|365901930|FG003|Overall Study|Adverse Event|3|||
106065363|NCT01291173|365901927|FG000|Overall Study|Protocol Violation|7|||
106065364|NCT01291173|365901928|FG001|Overall Study|Protocol Violation|2|||
106065365|NCT01291173|365901929|FG002|Overall Study|Protocol Violation|2|||
106065366|NCT01291173|365901930|FG003|Overall Study|Protocol Violation|5|||
106065367|NCT01291173|365901927|FG000|Overall Study|Withdrawal by Subject|6|||
106065368|NCT01291173|365901928|FG001|Overall Study|Withdrawal by Subject|4|||
106065369|NCT01291173|365901929|FG002|Overall Study|Withdrawal by Subject|4|||
106065370|NCT01291173|365901930|FG003|Overall Study|Withdrawal by Subject|2|||
106065371|NCT01291173|365901927|FG000|Overall Study|Lost to Follow-up|4|||
106065372|NCT01291173|365901928|FG001|Overall Study|Lost to Follow-up|6|||
106065373|NCT01291173|365901929|FG002|Overall Study|Lost to Follow-up|3|||
106065374|NCT01291173|365901930|FG003|Overall Study|Lost to Follow-up|2|||
106065375|NCT01291173|365901927|FG000|Overall Study|Unable to meet visit schedule|0|||
106065376|NCT01291173|365901928|FG001|Overall Study|Unable to meet visit schedule|0|||
106065377|NCT01291173|365901929|FG002|Overall Study|Unable to meet visit schedule|1|||
106065378|NCT01291173|365901930|FG003|Overall Study|Unable to meet visit schedule|0|||
106065379|NCT01291173|365901927|FG000|Overall Study|Lack of compliance|0|||
106065380|NCT01291173|365901928|FG001|Overall Study|Lack of compliance|0|||
106065381|NCT01291173|365901929|FG002|Overall Study|Lack of compliance|0|||
106065382|NCT01291173|365901930|FG003|Overall Study|Lack of compliance|1|||
106065383|NCT01291173|365901927|FG000|Overall Study|Subject was unblinded|0|||
106065384|NCT01291173|365901928|FG001|Overall Study|Subject was unblinded|0|||
106065385|NCT01291173|365901929|FG002|Overall Study|Subject was unblinded|1|||
106065386|NCT01291173|365901930|FG003|Overall Study|Subject was unblinded|0|||
106065387|NCT01291173|365901927|FG000|Overall Study|Excluded therapy|0|||
106065388|NCT01291173|365901928|FG001|Overall Study|Excluded therapy|0|||
106065389|NCT01291173|365901929|FG002|Overall Study|Excluded therapy|1|||
106065390|NCT01291173|365901930|FG003|Overall Study|Excluded therapy|0|||
106065391|NCT01949051|365901931|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
106065392|NCT01949051|365901932|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
106065393|NCT01949051|365901933|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
106065394|NCT01949051|365901934|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
106065395|NCT01949051|365901935|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
106065396|NCT01949051|365901936|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
106065397|NCT01949051|365901931|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
106065398|NCT01949051|365901932|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
106065399|NCT01949051|365901933|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
106065400|NCT01949051|365901934|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
106065401|NCT01949051|365901935|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
106065402|NCT01949051|365901936|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
106065403|NCT01949051|365901931|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
106065404|NCT01949051|365901932|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
106065405|NCT01949051|365901933|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
106065406|NCT01949051|365901934|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
106065407|NCT01949051|365901935|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
106065408|NCT01949051|365901936|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
106065409|NCT01949051|365901931|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
106065410|NCT01949051|365901932|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
106065411|NCT01949051|365901933|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
106065412|NCT01949051|365901934|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
106065413|NCT01949051|365901935|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
106065414|NCT01949051|365901936|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
106065415|NCT01949051|365901931|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
106065416|NCT01949051|365901932|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
106065417|NCT01949051|365901933|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
106065418|NCT01949051|365901934|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
106065419|NCT01949051|365901935|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
106065420|NCT01949051|365901936|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
106065421|NCT00732615|365901937|FG000|Overall Study|Withdrawal by Subject|3|||
105865052|NCT02516553|365154820|FG018|Overall Study|Other Adverse Events|1|||
105865053|NCT02516553|365154821|FG019|Overall Study|Other Adverse Events|2|||
106065422|NCT00732615|365901938|FG001|Overall Study|Withdrawal by Subject|1|||
106065423|NCT00732615|365901937|FG000|Overall Study|Lost to Follow-up|0|||
106065424|NCT00732615|365901938|FG001|Overall Study|Lost to Follow-up|1|||
106065425|NCT00732615|365901937|FG000|Overall Study|Adverse Event|0|||
106065426|NCT00732615|365901938|FG001|Overall Study|Adverse Event|2|||
106065427|NCT00732615|365901937|FG000|Overall Study|Physician Decision|3|||
106065428|NCT00732615|365901938|FG001|Overall Study|Physician Decision|0|||
106065429|NCT00732615|365901937|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
106065430|NCT00732615|365901938|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
106065431|NCT01414075|365901939|FG000|Overall Study|Adverse Event|1|||
106065432|NCT01414075|365901940|FG001|Overall Study|Adverse Event|0|||
106065433|NCT01414075|365901941|FG002|Overall Study|Adverse Event|1|||
106065434|NCT01414075|365901942|FG003|Overall Study|Adverse Event|0|||
106065435|NCT01414075|365901939|FG000|Overall Study|Death|1|||
106065436|NCT01414075|365901940|FG001|Overall Study|Death|0|||
106065437|NCT01414075|365901941|FG002|Overall Study|Death|0|||
106065438|NCT01414075|365901942|FG003|Overall Study|Death|1|||
106065439|NCT01414075|365901939|FG000|Overall Study|Withdrawal by Subject|0|||
106065440|NCT01414075|365901940|FG001|Overall Study|Withdrawal by Subject|0|||
106065441|NCT01414075|365901941|FG002|Overall Study|Withdrawal by Subject|0|||
106065442|NCT01414075|365901942|FG003|Overall Study|Withdrawal by Subject|1|||
106065443|NCT01414075|365901939|FG000|Overall Study|Other than specified|1|||
106065444|NCT01414075|365901940|FG001|Overall Study|Other than specified|0|||
106065445|NCT01414075|365901941|FG002|Overall Study|Other than specified|1|||
106065446|NCT01414075|365901942|FG003|Overall Study|Other than specified|0|||
106065447|NCT00576927|365901943|FG000|Clinical Assessment|Lack of Efficacy|24|||
106065448|NCT00576927|365901943|FG000|Clinical Assessment|Death|1|||
106065449|NCT00576927|365901943|FG000|Clinical Assessment|Withdrawal by Subject|10|||
106065450|NCT00576927|365901943|FG000|Clinical Assessment|Physician Decision|1|||
106065451|NCT00576927|365901943|FG000|Baseline|Physician Decision|9|||
106065452|NCT00576927|365901943|FG000|Baseline|Medication Change by PCP of subject|1|||
106065453|NCT00576927|365901943|FG000|Baseline|Withdrawal by Subject|3|||
106065454|NCT00576927|365901943|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
106065455|NCT00576927|365901943|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
106065456|NCT00576927|365901943|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
106065457|NCT00576927|365901943|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
106065458|NCT00576927|365901943|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
106065459|NCT02999854|365901947|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
106065460|NCT02999854|365901948|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
106065461|NCT02999854|365901947|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
106065462|NCT02999854|365901948|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
106065463|NCT02999854|365901947|FG000|Active Study Phase (up to 18 Months)|Death|7|||
106065464|NCT02999854|365901948|FG001|Active Study Phase (up to 18 Months)|Death|5|||
106065465|NCT02999854|365901947|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
106065466|NCT02999854|365901948|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
106065467|NCT02999854|365901947|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
106065468|NCT02999854|365901948|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
106065469|NCT02999854|365901947|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
106065470|NCT02999854|365901948|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
106065471|NCT02999854|365901947|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
106154136|NCT00753090|366223998|FG001|Overall Study|Study Prosthesis Removed|3|||
106154137|NCT00753090|366223997|FG000|Overall Study|Lost to Follow-up|2|||
106154138|NCT00753090|366223998|FG001|Overall Study|Lost to Follow-up|2|||
106154139|NCT00753090|366223997|FG000|Overall Study|Other|127|||
106065472|NCT02999854|365901948|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
106065473|NCT02999854|365901947|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
106065474|NCT02999854|365901948|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
106065475|NCT01013701|365901951|FG000|Overall Study|study prematurely terminated|7|||
106065476|NCT03241342|365901952|FG000|Overall Study|Adverse Event|5|||
106065477|NCT03241342|365901953|FG001|Overall Study|Adverse Event|8|||
106065478|NCT03241342|365901954|FG002|Overall Study|Adverse Event|4|||
106065479|NCT03241342|365901952|FG000|Overall Study|Lack of Efficacy|0|||
106065480|NCT03241342|365901953|FG001|Overall Study|Lack of Efficacy|0|||
106065481|NCT03241342|365901954|FG002|Overall Study|Lack of Efficacy|1|||
106065482|NCT03241342|365901952|FG000|Overall Study|noncompliance with study drug|2|||
106065483|NCT03241342|365901953|FG001|Overall Study|noncompliance with study drug|1|||
106154140|NCT00753090|366223998|FG001|Overall Study|Other|75|||
106154141|NCT02201108|366223999|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
106154142|NCT02201108|366224000|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
106154143|NCT02201108|366224001|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
106154144|NCT02201108|366223999|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
106065484|NCT03241342|365901954|FG002|Overall Study|noncompliance with study drug|1|||
106065485|NCT03241342|365901952|FG000|Overall Study|sponsor decision|0|||
106065486|NCT03241342|365901953|FG001|Overall Study|sponsor decision|1|||
106065487|NCT03241342|365901954|FG002|Overall Study|sponsor decision|2|||
106065488|NCT03241342|365901952|FG000|Overall Study|not reported|15|||
106065489|NCT03241342|365901953|FG001|Overall Study|not reported|21|||
106065490|NCT03241342|365901954|FG002|Overall Study|not reported|19|||
106065491|NCT00556712|365901955|FG000|Overall Study|Adverse Event|7|||
106065492|NCT00556712|365901956|FG001|Overall Study|Adverse Event|19|||
106065493|NCT00556712|365901955|FG000|Overall Study|Death|5|||
106065494|NCT00556712|365901956|FG001|Overall Study|Death|10|||
106065495|NCT00556712|365901955|FG000|Overall Study|Progressive Disease|383|||
106065496|NCT00556712|365901956|FG001|Overall Study|Progressive Disease|320|||
106065497|NCT00556712|365901955|FG000|Overall Study|Protocol Violation|3|||
106065498|NCT00556712|365901956|FG001|Overall Study|Protocol Violation|2|||
106065499|NCT00556712|365901955|FG000|Overall Study|Refused Treatment|17|||
106065500|NCT00556712|365901956|FG001|Overall Study|Refused Treatment|16|||
106065501|NCT00556712|365901955|FG000|Overall Study|Failure to Return|2|||
106065502|NCT00556712|365901956|FG001|Overall Study|Failure to Return|3|||
106065503|NCT00556712|365901955|FG000|Overall Study|Other|2|||
106065504|NCT00556712|365901956|FG001|Overall Study|Other|2|||
106065505|NCT00556712|365901955|FG000|Overall Study|Ongoing at Data Cutoff|32|||
106065506|NCT00556712|365901956|FG001|Overall Study|Ongoing at Data Cutoff|66|||
106065507|NCT03915496|365901958|FG000|Overall Study|Adverse Event|2|||
106065508|NCT03915496|365901959|FG001|Overall Study|Adverse Event|1|||
106065509|NCT03915496|365901960|FG002|Overall Study|Adverse Event|2|||
106065510|NCT02480114|365901961|FG000|Overall Study|Not completing surveys|3|||
106065511|NCT02480114|365901962|FG001|Overall Study|Not completing surveys|2|||
106065512|NCT02480114|365901961|FG000|Overall Study|Withdrawal by Subject|2|||
106065513|NCT02480114|365901962|FG001|Overall Study|Withdrawal by Subject|4|||
106065514|NCT02480114|365901961|FG000|Overall Study|Disease progression|3|||
106065515|NCT02480114|365901962|FG001|Overall Study|Disease progression|0|||
106065516|NCT02480114|365901961|FG000|Overall Study|Improper completion of survey|1|||
106065517|NCT02480114|365901962|FG001|Overall Study|Improper completion of survey|1|||
106065518|NCT02480114|365901961|FG000|Overall Study|Not eligible|0|||
106065519|NCT02480114|365901962|FG001|Overall Study|Not eligible|1|||
106065520|NCT02663674|365901963|FG000|Overall Study|Lost to Follow-up|5|||
106065521|NCT02663674|365901964|FG001|Overall Study|Lost to Follow-up|4|||
106065522|NCT02663674|365901963|FG000|Overall Study|Withdrawal by Subject|1|||
106065523|NCT02663674|365901964|FG001|Overall Study|Withdrawal by Subject|4|||
106065524|NCT02663674|365901963|FG000|Overall Study|Physician Decision|1|||
106065525|NCT02663674|365901964|FG001|Overall Study|Physician Decision|1|||
106065526|NCT02663674|365901963|FG000|Overall Study|Other Event (Health Related)|0|||
106065527|NCT02663674|365901964|FG001|Overall Study|Other Event (Health Related)|1|||
106065528|NCT01031069|365901965|FG000|Overall Study|Serious Adverse Event|0|||
106065529|NCT01031069|365901966|FG001|Overall Study|Serious Adverse Event|1|||
106065530|NCT01031069|365901967|FG002|Overall Study|Serious Adverse Event|0|||
106065531|NCT01031069|365901968|FG003|Overall Study|Serious Adverse Event|0|||
106065532|NCT01031069|365901965|FG000|Overall Study|Withdrawal by Subject|2|||
106065533|NCT01031069|365901966|FG001|Overall Study|Withdrawal by Subject|3|||
106065534|NCT01031069|365901967|FG002|Overall Study|Withdrawal by Subject|18|||
106065535|NCT01031069|365901968|FG003|Overall Study|Withdrawal by Subject|18|||
106065536|NCT01031069|365901965|FG000|Overall Study|Migrated/moved from study area|1|||
106065537|NCT01031069|365901966|FG001|Overall Study|Migrated/moved from study area|2|||
106065538|NCT01031069|365901967|FG002|Overall Study|Migrated/moved from study area|1|||
106065539|NCT01031069|365901968|FG003|Overall Study|Migrated/moved from study area|1|||
106065540|NCT01031069|365901965|FG000|Overall Study|Lost to Follow-up|9|||
106065541|NCT01031069|365901966|FG001|Overall Study|Lost to Follow-up|5|||
106065542|NCT01031069|365901967|FG002|Overall Study|Lost to Follow-up|21|||
106065543|NCT01031069|365901968|FG003|Overall Study|Lost to Follow-up|15|||
106065544|NCT01031069|365901965|FG000|Overall Study|Other|0|||
106065545|NCT01031069|365901966|FG001|Overall Study|Other|0|||
106065546|NCT01031069|365901967|FG002|Overall Study|Other|1|||
106065547|NCT01031069|365901968|FG003|Overall Study|Other|0|||
106065548|NCT00477971|365901969|FG000|Overall Study|Disease progression|6|||
106065549|NCT00477971|365901970|FG001|Overall Study|Disease progression|0|||
106065550|NCT00477971|365901969|FG000|Overall Study|Withdrawal by Subject|3|||
106065551|NCT00477971|365901970|FG001|Overall Study|Withdrawal by Subject|1|||
106065552|NCT00477971|365901969|FG000|Overall Study|Adverse Event|3|||
106065553|NCT00477971|365901970|FG001|Overall Study|Adverse Event|0|||
106065554|NCT00477971|365901969|FG000|Overall Study|Death|2|||
106065555|NCT00477971|365901970|FG001|Overall Study|Death|4|||
106065556|NCT00477971|365901969|FG000|Overall Study|Alternative treatment|3|||
106065557|NCT00477971|365901970|FG001|Overall Study|Alternative treatment|1|||
106065558|NCT01404325|365903418|FG000|Overall Study|Lost to Follow-up|1|||
106065559|NCT01404325|365903419|FG001|Overall Study|Lost to Follow-up|0|||
106065560|NCT01404325|365903418|FG000|Overall Study|Death|2|||
106065561|NCT01404325|365903419|FG001|Overall Study|Death|0|||
106065562|NCT01404325|365903418|FG000|Overall Study|Graft loss/Retransplantation|1|||
106065563|NCT01404325|365903419|FG001|Overall Study|Graft loss/Retransplantation|0|||
106065564|NCT01404325|365903418|FG000|Overall Study|non-specified reason|0|||
106065565|NCT01404325|365903419|FG001|Overall Study|non-specified reason|2|||
106065566|NCT02141282|365903423|FG000|Overall Study|Adverse event, not related to progression|8|||
106065567|NCT02141282|365903424|FG001|Overall Study|Adverse event, not related to progression|1|||
106065568|NCT02141282|365903425|FG002|Overall Study|Adverse event, not related to progression|3|||
106065569|NCT02141282|365903426|FG003|Overall Study|Adverse event, not related to progression|1|||
106065570|NCT02141282|365903423|FG000|Overall Study|Adverse event, related to progression|1|||
106065571|NCT02141282|365903424|FG001|Overall Study|Adverse event, related to progression|0|||
106065572|NCT02141282|365903425|FG002|Overall Study|Adverse event, related to progression|2|||
106065573|NCT02141282|365903426|FG003|Overall Study|Adverse event, related to progression|0|||
106065574|NCT02141282|365903423|FG000|Overall Study|COVID-19 infection|1|||
106065575|NCT02141282|365903424|FG001|Overall Study|COVID-19 infection|0|||
106065576|NCT02141282|365903425|FG002|Overall Study|COVID-19 infection|0|||
106065577|NCT02141282|365903426|FG003|Overall Study|COVID-19 infection|0|||
106065578|NCT02141282|365903423|FG000|Overall Study|Lost to Follow-up|0|||
106065579|NCT02141282|365903424|FG001|Overall Study|Lost to Follow-up|0|||
106065580|NCT02141282|365903425|FG002|Overall Study|Lost to Follow-up|4|||
106065581|NCT02141282|365903426|FG003|Overall Study|Lost to Follow-up|2|||
106154145|NCT02201108|366224000|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
106154146|NCT02201108|366224001|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
106154147|NCT02201108|366223999|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
106154148|NCT02201108|366224000|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
106154149|NCT02201108|366224001|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
106154150|NCT02201108|366223999|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
106154151|NCT02201108|366224000|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
106154152|NCT02201108|366224001|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
106154153|NCT02201108|366223999|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
106154154|NCT02201108|366224000|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
106154155|NCT02201108|366224001|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
106154156|NCT02201108|366223999|FG000|Open Label Period (up to Week 192)|Other reason|4|||
106154157|NCT02201108|366224000|FG001|Open Label Period (up to Week 192)|Other reason|7|||
106154158|NCT02201108|366224001|FG002|Open Label Period (up to Week 192)|Other reason|0|||
106154159|NCT02201108|366223999|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
106154160|NCT02201108|366224000|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
106154161|NCT02201108|366224001|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
106154162|NCT02201108|366223999|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
106154163|NCT02201108|366224000|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
106154164|NCT02201108|366224001|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
106154165|NCT02201108|366223999|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
106154166|NCT02201108|366224000|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
106154167|NCT02201108|366224001|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
106154168|NCT04118452|366224011|FG000|Overall Study|Lost to Follow-up|5|||
106154169|NCT04118452|366224012|FG001|Overall Study|Lost to Follow-up|5|||
106154170|NCT04118452|366224011|FG000|Overall Study|Withdrawal by Subject|17|||
106154171|NCT04118452|366224012|FG001|Overall Study|Withdrawal by Subject|17|||
106154172|NCT04934722|366224013|FG000|Overall Study|Death|4|||
106154173|NCT04934722|366224014|FG001|Overall Study|Death|3|||
106154174|NCT04934722|366224013|FG000|Overall Study|Participants Ongoing|88|||
106154175|NCT04934722|366224014|FG001|Overall Study|Participants Ongoing|91|||
106065582|NCT02141282|365903423|FG000|Overall Study|Other, not specified|14|||
106065583|NCT02141282|365903424|FG001|Overall Study|Other, not specified|11|||
106065584|NCT02141282|365903425|FG002|Overall Study|Other, not specified|23|||
106065585|NCT02141282|365903426|FG003|Overall Study|Other, not specified|9|||
106154176|NCT04847999|366224015|FG000|Overall Study|Lost to Follow-up|0|||
106154177|NCT04847999|366224016|FG001|Overall Study|Lost to Follow-up|1|||
106154178|NCT02879448|366224017|FG000|Overall Study|Death|251|||
106154179|NCT02879448|366224018|FG001|Overall Study|Death|263|||
106154180|NCT02879448|366224017|FG000|Overall Study|Lost to Follow-up|23|||
106154181|NCT02879448|366224018|FG001|Overall Study|Lost to Follow-up|28|||
106154182|NCT02879448|366224017|FG000|Overall Study|Withdrawal by Subject|42|||
106154183|NCT02879448|366224018|FG001|Overall Study|Withdrawal by Subject|79|||
106154184|NCT02879448|366224017|FG000|Overall Study|Other Reasons|8|||
106154185|NCT02879448|366224018|FG001|Overall Study|Other Reasons|12|||
106154186|NCT03433339|366224019|FG000|Overall Study|Lost to Follow-up|2|||
106154187|NCT03433339|366224020|FG001|Overall Study|Lost to Follow-up|0|||
106154188|NCT03433339|366224019|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
106154189|NCT03433339|366224020|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
106154190|NCT03433339|366224019|FG000|Overall Study|Withdrawal by Subject|0|||
106154191|NCT03433339|366224020|FG001|Overall Study|Withdrawal by Subject|2|||
106154192|NCT05952076|366224021|FG000|Overall Study|Death|1|||
106065586|NCT02141282|365903423|FG000|Overall Study|Progressive disease, Richter's|4|||
106065587|NCT02141282|365903424|FG001|Overall Study|Progressive disease, Richter's|1|||
106065588|NCT02141282|365903425|FG002|Overall Study|Progressive disease, Richter's|1|||
106065589|NCT02141282|365903426|FG003|Overall Study|Progressive disease, Richter's|1|||
106065590|NCT02141282|365903423|FG000|Overall Study|Progressive disease per protocol|12|||
106065591|NCT02141282|365903424|FG001|Overall Study|Progressive disease per protocol|7|||
106065592|NCT02141282|365903425|FG002|Overall Study|Progressive disease per protocol|9|||
106065593|NCT02141282|365903426|FG003|Overall Study|Progressive disease per protocol|2|||
106065594|NCT02141282|365903423|FG000|Overall Study|Stem cell transplant|1|||
106065595|NCT02141282|365903424|FG001|Overall Study|Stem cell transplant|0|||
106065596|NCT02141282|365903425|FG002|Overall Study|Stem cell transplant|1|||
106065597|NCT02141282|365903426|FG003|Overall Study|Stem cell transplant|0|||
106065598|NCT02141282|365903423|FG000|Overall Study|Study terminated by Sponsor|0|||
106065599|NCT02141282|365903424|FG001|Overall Study|Study terminated by Sponsor|1|||
106065600|NCT02141282|365903425|FG002|Overall Study|Study terminated by Sponsor|0|||
106065601|NCT02141282|365903426|FG003|Overall Study|Study terminated by Sponsor|0|||
106065602|NCT02141282|365903423|FG000|Overall Study|Subject non-compliance|0|||
106065603|NCT02141282|365903424|FG001|Overall Study|Subject non-compliance|0|||
106065604|NCT02141282|365903425|FG002|Overall Study|Subject non-compliance|1|||
106065605|NCT02141282|365903426|FG003|Overall Study|Subject non-compliance|0|||
106065606|NCT02141282|365903423|FG000|Overall Study|Withdrew consent|2|||
106065607|NCT02141282|365903424|FG001|Overall Study|Withdrew consent|0|||
106065608|NCT02141282|365903425|FG002|Overall Study|Withdrew consent|4|||
106065609|NCT02141282|365903426|FG003|Overall Study|Withdrew consent|0|||
106065610|NCT01986855|365903427|FG000|Overall Study|Adverse Event|1|||
106065611|NCT01986855|365903428|FG001|Overall Study|Adverse Event|0|||
106065612|NCT01986855|365903429|FG002|Overall Study|Adverse Event|0|||
106065613|NCT01986855|365903427|FG000|Overall Study|Death|3|||
106065614|NCT01986855|365903428|FG001|Overall Study|Death|4|||
106065615|NCT01986855|365903429|FG002|Overall Study|Death|4|||
106065616|NCT01986855|365903427|FG000|Overall Study|Lost to Follow-up|2|||
106065617|NCT01986855|365903428|FG001|Overall Study|Lost to Follow-up|1|||
106065618|NCT01986855|365903429|FG002|Overall Study|Lost to Follow-up|0|||
106065619|NCT01986855|365903427|FG000|Overall Study|Screen Failure|0|||
106065620|NCT01986855|365903428|FG001|Overall Study|Screen Failure|1|||
106065621|NCT01986855|365903429|FG002|Overall Study|Screen Failure|0|||
106065622|NCT01986855|365903427|FG000|Overall Study|Participant Moved|0|||
106065623|NCT01986855|365903428|FG001|Overall Study|Participant Moved|0|||
106065624|NCT01986855|365903429|FG002|Overall Study|Participant Moved|2|||
106065625|NCT01986855|365903427|FG000|Overall Study|Withdrawal by Subject|7|||
106065626|NCT01986855|365903428|FG001|Overall Study|Withdrawal by Subject|8|||
106065627|NCT01986855|365903429|FG002|Overall Study|Withdrawal by Subject|5|||
106065628|NCT02450903|365903430|FG000|Overall Study|Adverse Event|3|||
106065629|NCT02450903|365903430|FG000|Overall Study|Progressive disease|15|||
106065630|NCT02450903|365903430|FG000|Overall Study|Switched to commercial drug|1|||
106065631|NCT02450903|365903430|FG000|Overall Study|Subject/guardian decision|1|||
106065632|NCT02825992|365903431|FG000|Overall Study|Withdrawal by Subject|4|||
106065633|NCT02825992|365903431|FG000|Overall Study|Lost to Follow-up|2|||
106065634|NCT02825992|365903431|FG000|Overall Study|Procedure terminated|2|||
106065635|NCT04067544|365903435|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
106065636|NCT00418314|365903436|FG000|Overall Study|Withdrawal by Subject|1|||
106065637|NCT00418314|365903437|FG001|Overall Study|Withdrawal by Subject|2|||
106065638|NCT01320085|365903438|FG000|Overall Study|Disease Progression|26|||
106065639|NCT01320085|365903439|FG001|Overall Study|Disease Progression|93|||
106065640|NCT01320085|365903440|FG002|Overall Study|Disease Progression|17|||
106065641|NCT01320085|365903438|FG000|Overall Study|Adverse Event|12|||
106065642|NCT01320085|365903439|FG001|Overall Study|Adverse Event|20|||
106065643|NCT01320085|365903440|FG002|Overall Study|Adverse Event|5|||
106065644|NCT01320085|365903438|FG000|Overall Study|Withdrawal by Subject|2|||
106065645|NCT01320085|365903439|FG001|Overall Study|Withdrawal by Subject|4|||
106065646|NCT01320085|365903440|FG002|Overall Study|Withdrawal by Subject|1|||
106065647|NCT01320085|365903438|FG000|Overall Study|Protocol Deviation|1|||
106065648|NCT01320085|365903439|FG001|Overall Study|Protocol Deviation|0|||
106065649|NCT01320085|365903440|FG002|Overall Study|Protocol Deviation|1|||
106065650|NCT01320085|365903438|FG000|Overall Study|Administrative problems|0|||
106065651|NCT01320085|365903439|FG001|Overall Study|Administrative problems|0|||
106065652|NCT01320085|365903440|FG002|Overall Study|Administrative problems|1|||
106065653|NCT03316131|365903441|FG000|Treatment Period 2|Protocol deviation|1|||
106065654|NCT03316131|365903442|FG001|Treatment Period 2|Protocol deviation|0|||
106065655|NCT01409564|365903443|FG000|Overall Study|low medication compliance|4|||
106065656|NCT01409564|365903444|FG001|Overall Study|low medication compliance|3|||
106065657|NCT01409564|365903443|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
106065658|NCT01409564|365903444|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
106065659|NCT00710710|365903446|FG000|Overall Study|Consent withdrawn|2|||
106065660|NCT00710710|365903447|FG001|Overall Study|Consent withdrawn|2|||
106065661|NCT00710710|365903446|FG000|Overall Study|Protocol Violation|0|||
106065662|NCT00710710|365903447|FG001|Overall Study|Protocol Violation|1|||
106065663|NCT00710710|365903446|FG000|Overall Study|Adverse Event|3|||
106065664|NCT00710710|365903447|FG001|Overall Study|Adverse Event|3|||
106065665|NCT00710710|365903446|FG000|Overall Study|Progressive disease|40|||
106065666|NCT00710710|365903447|FG001|Overall Study|Progressive disease|38|||
106065667|NCT03045328|365903448|FG000|Overall Study|Withdrawal by Subject|2|||
106065668|NCT00715078|365903451|FG000|Overall Study|Death|29|||
106065669|NCT00715078|365903452|FG001|Overall Study|Death|36|||
106065670|NCT00715078|365903453|FG002|Overall Study|Death|36|||
106065671|NCT00715078|365903451|FG000|Overall Study|Withdrawal by Subject|1|||
106065672|NCT00715078|365903452|FG001|Overall Study|Withdrawal by Subject|0|||
106065673|NCT00715078|365903453|FG002|Overall Study|Withdrawal by Subject|1|||
106065674|NCT00715078|365903451|FG000|Overall Study|Unable to start due to disease prog.|0|||
106065675|NCT00715078|365903452|FG001|Overall Study|Unable to start due to disease prog.|0|||
106065676|NCT00715078|365903453|FG002|Overall Study|Unable to start due to disease prog.|1|||
106065677|NCT02511184|365903454|FG000|Overall Study|Death|1|||
106065678|NCT02511184|365903455|FG001|Overall Study|Death|0|||
106065679|NCT02511184|365903454|FG000|Overall Study|Lost to Follow-up|0|||
106065680|NCT02511184|365903455|FG001|Overall Study|Lost to Follow-up|1|||
106065681|NCT02511184|365903454|FG000|Overall Study|Study terminated by sponsor|1|||
106065682|NCT02511184|365903455|FG001|Overall Study|Study terminated by sponsor|5|||
106065683|NCT02511184|365903454|FG000|Overall Study|Withdrawal by Subject|0|||
106065684|NCT02511184|365903455|FG001|Overall Study|Withdrawal by Subject|1|||
106065685|NCT00157950|365903456|FG000|Overall Study|Death|1|||
106065686|NCT00157950|365903457|FG001|Overall Study|Death|0|||
106065687|NCT02892760|365903461|FG000|Overall Study|Withdrawal by Subject|3|||
106065688|NCT00293254|365903469|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
106065689|NCT00293254|365903470|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
106065690|NCT00293254|365903469|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
106065691|NCT00293254|365903470|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
106065692|NCT00293254|365903469|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
106065693|NCT00293254|365903470|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
106065694|NCT00293254|365903469|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
106065695|NCT00293254|365903470|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
106065696|NCT00293254|365903469|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
106065697|NCT00293254|365903470|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
106065698|NCT00293254|365903469|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
106065699|NCT00293254|365903470|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
106065700|NCT00293254|365903469|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
106065701|NCT00293254|365903470|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
106065702|NCT00293254|365903469|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
106065703|NCT00293254|365903470|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
106065704|NCT00293254|365903469|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
106065705|NCT00293254|365903470|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
106065706|NCT00293254|365903469|FG000|Extension - Double-Blind Week 49-156|Death|4|||
106065707|NCT00293254|365903470|FG001|Extension - Double-Blind Week 49-156|Death|1|||
106065708|NCT00293254|365903469|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
106065709|NCT00293254|365903470|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
106065710|NCT00293254|365903469|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
106065711|NCT00293254|365903470|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
106065712|NCT00293254|365903469|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
106065713|NCT00293254|365903470|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
106065714|NCT00293254|365903469|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
106065715|NCT00293254|365903470|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
106065716|NCT00293254|365903469|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
106065717|NCT00293254|365903470|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
106065718|NCT00293254|365903469|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
106065719|NCT00293254|365903470|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
106065720|NCT00293254|365903469|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
106065721|NCT00293254|365903470|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
106065722|NCT00293254|365903469|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
106065723|NCT00293254|365903470|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
106065724|NCT00293254|365903469|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
106065725|NCT00293254|365903470|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
106065726|NCT00293254|365903469|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
106065727|NCT00293254|365903470|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
106065728|NCT00293254|365903469|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
106065729|NCT00293254|365903470|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
106065730|NCT00293254|365903469|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
106154193|NCT05952076|366224022|FG001|Overall Study|Death|1|||
106154194|NCT05952076|366224021|FG000|Overall Study|Lost to Follow-up|0|||
106065731|NCT00293254|365903470|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
106065732|NCT00293254|365903469|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
106065733|NCT00293254|365903470|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
106065734|NCT00293254|365903469|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
106065735|NCT00293254|365903470|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
106065736|NCT00293254|365903469|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
106065737|NCT00293254|365903470|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
106065738|NCT00293254|365903469|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
106065739|NCT00293254|365903470|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
106065740|NCT00293254|365903469|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
106065741|NCT00293254|365903470|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
106065742|NCT01463878|365903471|FG000|Overall Study|no longer met criteria for tube feed|2|||
106065743|NCT01463878|365903472|FG001|Overall Study|no longer met criteria for tube feed|2|||
106065744|NCT01034462|365903473|FG000|Overall Study|Adverse Event|7|||
106065745|NCT01034462|365903474|FG001|Overall Study|Adverse Event|17|||
106065746|NCT01034462|365903473|FG000|Overall Study|Lack of Efficacy|4|||
106065747|NCT01034462|365903474|FG001|Overall Study|Lack of Efficacy|4|||
106065748|NCT01034462|365903473|FG000|Overall Study|Protocol Violation|10|||
106065749|NCT01034462|365903474|FG001|Overall Study|Protocol Violation|7|||
106065750|NCT01034462|365903473|FG000|Overall Study|Withdrawal by Subject|9|||
106065751|NCT01034462|365903474|FG001|Overall Study|Withdrawal by Subject|8|||
106065752|NCT01034462|365903473|FG000|Overall Study|Lost to Follow-up|14|||
106065753|NCT01034462|365903474|FG001|Overall Study|Lost to Follow-up|16|||
106065754|NCT01034462|365903473|FG000|Overall Study|Other reasons|1|||
106065755|NCT01034462|365903474|FG001|Overall Study|Other reasons|2|||
106065756|NCT01594125|365903476|FG000|Overall Study|Withdrawal by Subject|1|||
106065757|NCT01594125|365903477|FG001|Overall Study|Withdrawal by Subject|0|||
106065758|NCT01594125|365903478|FG002|Overall Study|Withdrawal by Subject|0|||
106065759|NCT01594125|365903479|FG003|Overall Study|Withdrawal by Subject|1|||
106065760|NCT01594125|365903480|FG004|Overall Study|Withdrawal by Subject|0|||
106065761|NCT01594125|365903476|FG000|Overall Study|Progressive Disease|3|||
106065762|NCT01594125|365903477|FG001|Overall Study|Progressive Disease|12|||
106065763|NCT01594125|365903478|FG002|Overall Study|Progressive Disease|3|||
106065764|NCT01594125|365903479|FG003|Overall Study|Progressive Disease|3|||
106065765|NCT01594125|365903480|FG004|Overall Study|Progressive Disease|7|||
106065766|NCT00503009|365903481|FG000|Overall Study|Protocol Violation|1|||
106065767|NCT00503009|365903482|FG001|Overall Study|Protocol Violation|0|||
106065768|NCT00503009|365903483|FG002|Overall Study|Protocol Violation|1|||
106065769|NCT00503009|365903481|FG000|Overall Study|Withdrawal by Subject|0|||
106065770|NCT00503009|365903482|FG001|Overall Study|Withdrawal by Subject|1|||
106065771|NCT00503009|365903483|FG002|Overall Study|Withdrawal by Subject|1|||
106065772|NCT00503009|365903481|FG000|Overall Study|Physician Decision|0|||
106065773|NCT00503009|365903482|FG001|Overall Study|Physician Decision|1|||
106065774|NCT00503009|365903483|FG002|Overall Study|Physician Decision|1|||
106065775|NCT01356966|365903484|FG000|Overall Study|Withdrawal by Subject|1|||
106065776|NCT01356966|365903485|FG001|Overall Study|Withdrawal by Subject|2|||
106065777|NCT01356966|365903484|FG000|Overall Study|Physician Decision|1|||
106065778|NCT01356966|365903485|FG001|Overall Study|Physician Decision|0|||
106065779|NCT02066233|365903490|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
106065780|NCT02066233|365903491|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
106065781|NCT00103142|365903492|FG000|Overall Study|Adverse Event|1|||
106065782|NCT00103142|365903493|FG001|Overall Study|Adverse Event|0|||
106065783|NCT00103142|365903492|FG000|Overall Study|Progression of disease|2|||
106065784|NCT00103142|365903493|FG001|Overall Study|Progression of disease|1|||
106065785|NCT03227029|365903496|FG000|Overall Study|Child Wheezed (no treatment)|0|||
106065786|NCT03227029|365903497|FG001|Overall Study|Child Wheezed (no treatment)|1|||
106065787|NCT03227029|365903498|FG002|Overall Study|Child Wheezed (no treatment)|0|||
106065788|NCT03227029|365903496|FG000|Overall Study|No post RSV season visit due to COVID|3|||
106065789|NCT03227029|365903497|FG001|Overall Study|No post RSV season visit due to COVID|3|||
106065790|NCT03227029|365903498|FG002|Overall Study|No post RSV season visit due to COVID|2|||
106065791|NCT03227029|365903496|FG000|Overall Study|Not able to get to clinic|0|||
106065792|NCT03227029|365903497|FG001|Overall Study|Not able to get to clinic|0|||
106065793|NCT03227029|365903498|FG002|Overall Study|Not able to get to clinic|1|||
106065794|NCT03227029|365903496|FG000|Overall Study|Withdrawal by Subject|1|||
106065795|NCT03227029|365903497|FG001|Overall Study|Withdrawal by Subject|0|||
106065796|NCT03227029|365903498|FG002|Overall Study|Withdrawal by Subject|0|||
106065797|NCT03227029|365903496|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
106065798|NCT03227029|365903497|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
106065799|NCT03227029|365903498|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
106065800|NCT00558025|365903504|FG000|Overall Study|Adverse Event|1|||
106065801|NCT00558025|365903505|FG001|Overall Study|Adverse Event|1|||
106065802|NCT00558025|365903504|FG000|Overall Study|Withdrawal by Subject|2|||
105865054|NCT02516553|365154822|FG020|Overall Study|Other Adverse Events|2|||
105865055|NCT02516553|365154823|FG021|Overall Study|Other Adverse Events|1|||
105865056|NCT02516553|365154802|FG000|Overall Study|Refused to continue trial medication|0|||
105865057|NCT02516553|365154803|FG001|Overall Study|Refused to continue trial medication|0|||
105865058|NCT02516553|365154804|FG002|Overall Study|Refused to continue trial medication|0|||
105865059|NCT02516553|365154805|FG003|Overall Study|Refused to continue trial medication|0|||
105865060|NCT02516553|365154806|FG004|Overall Study|Refused to continue trial medication|0|||
105865061|NCT02516553|365154807|FG005|Overall Study|Refused to continue trial medication|0|||
105865062|NCT02516553|365154808|FG006|Overall Study|Refused to continue trial medication|0|||
105865063|NCT02516553|365154809|FG007|Overall Study|Refused to continue trial medication|0|||
105865064|NCT02516553|365154810|FG008|Overall Study|Refused to continue trial medication|0|||
105865065|NCT02516553|365154811|FG009|Overall Study|Refused to continue trial medication|0|||
105865066|NCT02516553|365154812|FG010|Overall Study|Refused to continue trial medication|1|||
105865067|NCT02516553|365154813|FG011|Overall Study|Refused to continue trial medication|0|||
105865068|NCT02516553|365154814|FG012|Overall Study|Refused to continue trial medication|0|||
105865069|NCT02516553|365154815|FG013|Overall Study|Refused to continue trial medication|0|||
105865070|NCT02516553|365154816|FG014|Overall Study|Refused to continue trial medication|0|||
105865071|NCT02516553|365154817|FG015|Overall Study|Refused to continue trial medication|0|||
105865072|NCT02516553|365154818|FG016|Overall Study|Refused to continue trial medication|0|||
105865073|NCT02516553|365154819|FG017|Overall Study|Refused to continue trial medication|0|||
105865074|NCT02516553|365154820|FG018|Overall Study|Refused to continue trial medication|1|||
105865075|NCT02516553|365154821|FG019|Overall Study|Refused to continue trial medication|0|||
105865076|NCT02516553|365154822|FG020|Overall Study|Refused to continue trial medication|0|||
105865077|NCT02516553|365154823|FG021|Overall Study|Refused to continue trial medication|1|||
105865078|NCT02516553|365154802|FG000|Overall Study|other reasons than listed|0|||
105865079|NCT02516553|365154803|FG001|Overall Study|other reasons than listed|0|||
105865080|NCT02516553|365154804|FG002|Overall Study|other reasons than listed|0|||
105865081|NCT02516553|365154805|FG003|Overall Study|other reasons than listed|0|||
105865082|NCT02516553|365154806|FG004|Overall Study|other reasons than listed|0|||
105865083|NCT02516553|365154807|FG005|Overall Study|other reasons than listed|0|||
105865084|NCT02516553|365154808|FG006|Overall Study|other reasons than listed|0|||
105865085|NCT02516553|365154809|FG007|Overall Study|other reasons than listed|1|||
105865086|NCT02516553|365154810|FG008|Overall Study|other reasons than listed|1|||
105865087|NCT02516553|365154811|FG009|Overall Study|other reasons than listed|0|||
105865088|NCT02516553|365154812|FG010|Overall Study|other reasons than listed|1|||
105865089|NCT02516553|365154813|FG011|Overall Study|other reasons than listed|1|||
105865090|NCT02516553|365154814|FG012|Overall Study|other reasons than listed|0|||
105865091|NCT02516553|365154815|FG013|Overall Study|other reasons than listed|0|||
105865092|NCT02516553|365154816|FG014|Overall Study|other reasons than listed|0|||
105865093|NCT02516553|365154817|FG015|Overall Study|other reasons than listed|0|||
105865094|NCT02516553|365154818|FG016|Overall Study|other reasons than listed|0|||
105865095|NCT02516553|365154819|FG017|Overall Study|other reasons than listed|0|||
105865096|NCT02516553|365154820|FG018|Overall Study|other reasons than listed|0|||
105865097|NCT02516553|365154821|FG019|Overall Study|other reasons than listed|0|||
105865098|NCT02516553|365154822|FG020|Overall Study|other reasons than listed|2|||
105865099|NCT02516553|365154823|FG021|Overall Study|other reasons than listed|2|||
105865100|NCT02924727|365154824|FG000|Overall Study|Withdrawal by Subject|2|||
105865101|NCT02924727|365154825|FG001|Overall Study|Withdrawal by Subject|4|||
105865102|NCT02924727|365154824|FG000|Overall Study|Lost to Follow-up|2|||
105865103|NCT02924727|365154825|FG001|Overall Study|Lost to Follow-up|5|||
105865104|NCT02924727|365154824|FG000|Overall Study|Death|221|||
105865105|NCT02924727|365154825|FG001|Overall Study|Death|247|||
105865106|NCT02924727|365154824|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
105865107|NCT02924727|365154825|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
105865108|NCT03052127|365154831|FG000|Overall Study|Withdrawal by Subject|0|||
105865109|NCT03052127|365154832|FG001|Overall Study|Withdrawal by Subject|0|||
105865110|NCT03052127|365154833|FG002|Overall Study|Withdrawal by Subject|0|||
105865111|NCT03052127|365154834|FG003|Overall Study|Withdrawal by Subject|0|||
105865112|NCT03052127|365154835|FG004|Overall Study|Withdrawal by Subject|0|||
105865113|NCT03052127|365154836|FG005|Overall Study|Withdrawal by Subject|0|||
105865114|NCT03052127|365154837|FG006|Overall Study|Withdrawal by Subject|0|||
105865115|NCT03052127|365154838|FG007|Overall Study|Withdrawal by Subject|1|||
106154195|NCT05952076|366224022|FG001|Overall Study|Lost to Follow-up|1|||
106154196|NCT04300231|366224028|FG000|Overall Study|Protocol Violation|4|||
106154197|NCT04300231|366224029|FG001|Overall Study|Protocol Violation|3|||
106154198|NCT04300231|366224030|FG002|Overall Study|Protocol Violation|0|||
106154199|NCT04300231|366224031|FG003|Overall Study|Protocol Violation|2|||
106154200|NCT04823611|366224032|FG000|Overall Study|Adverse Event|2|||
106154201|NCT04823611|366224033|FG001|Overall Study|Adverse Event|0|||
106154202|NCT04823611|366224034|FG002|Overall Study|Adverse Event|1|||
106154203|NCT04823611|366224035|FG003|Overall Study|Adverse Event|0|||
106154204|NCT04823611|366224036|FG004|Overall Study|Adverse Event|0|||
106154205|NCT04823611|366224037|FG005|Overall Study|Adverse Event|0|||
106154206|NCT04823611|366224038|FG006|Overall Study|Adverse Event|0|||
106154207|NCT01250769|366224040|FG000|Overall Study|Withdrawal by Subject|0|||
106154208|NCT01250769|366224041|FG001|Overall Study|Withdrawal by Subject|1|||
106154209|NCT01250769|366224042|FG002|Overall Study|Withdrawal by Subject|1|||
106154210|NCT01250769|366224043|FG003|Overall Study|Withdrawal by Subject|0|||
106154211|NCT01250769|366224040|FG000|Overall Study|Adverse Event|0|||
106154212|NCT01250769|366224041|FG001|Overall Study|Adverse Event|0|||
106154213|NCT01250769|366224042|FG002|Overall Study|Adverse Event|1|||
106154214|NCT01250769|366224043|FG003|Overall Study|Adverse Event|0|||
106154215|NCT04110054|366224044|FG000|Overall Study|COVID-19 reason other than AE|0|||
106154216|NCT04110054|366224045|FG001|Overall Study|COVID-19 reason other than AE|0|||
106154217|NCT04110054|366224046|FG002|Overall Study|COVID-19 reason other than AE|2|||
106154218|NCT04110054|366224047|FG003|Overall Study|COVID-19 reason other than AE|0|||
106154219|NCT04110054|366224044|FG000|Overall Study|Withdrawal by Subject|0|||
106065803|NCT00558025|365903505|FG001|Overall Study|Withdrawal by Subject|2|||
106065804|NCT00558025|365903504|FG000|Overall Study|Protocol Violation|1|||
106065805|NCT00558025|365903505|FG001|Overall Study|Protocol Violation|0|||
106065806|NCT01782859|365903506|FG000|Overall Study|Protocol Violation|6|||
106065807|NCT01782859|365903507|FG001|Overall Study|Protocol Violation|6|||
106065808|NCT01782859|365903506|FG000|Overall Study|Withdrawal by Subject|0|||
106065809|NCT01782859|365903507|FG001|Overall Study|Withdrawal by Subject|1|||
106065810|NCT01957553|365903508|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
106065811|NCT01957553|365903509|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
106065812|NCT01957553|365903508|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
106065813|NCT01957553|365903509|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
106065814|NCT01957553|365903508|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
106065815|NCT01957553|365903509|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
106065816|NCT01957553|365903508|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
106065817|NCT01957553|365903509|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
106065818|NCT01957553|365903508|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
106065819|NCT01957553|365903509|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
106065820|NCT01957553|365903508|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
106065821|NCT01957553|365903509|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
106065822|NCT01957553|365903508|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
106065823|NCT01957553|365903509|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
106065824|NCT01957553|365903508|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
106065825|NCT01957553|365903509|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
106065826|NCT01957553|365903508|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
106065827|NCT01957553|365903509|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
106065828|NCT00993291|365903510|FG000|Overall Study|Withdrawal by Subject|1|||
106065829|NCT00165776|365903518|FG000|Overall Study|Lack of Efficacy|0|||
106065830|NCT00165776|365903519|FG001|Overall Study|Lack of Efficacy|0|||
106154220|NCT04110054|366224045|FG001|Overall Study|Withdrawal by Subject|3|||
106154221|NCT04110054|366224046|FG002|Overall Study|Withdrawal by Subject|2|||
106154222|NCT04110054|366224047|FG003|Overall Study|Withdrawal by Subject|0|||
106154223|NCT04110054|366224044|FG000|Overall Study|Adverse Event|1|||
106154224|NCT04110054|366224045|FG001|Overall Study|Adverse Event|1|||
106154225|NCT04110054|366224046|FG002|Overall Study|Adverse Event|4|||
106154226|NCT04110054|366224047|FG003|Overall Study|Adverse Event|3|||
106154227|NCT01095796|366224048|FG000|Overall Study|Randomized but Not Treated|5|||
106154228|NCT01095796|366224049|FG001|Overall Study|Randomized but Not Treated|2|||
106154229|NCT01095796|366224048|FG000|Overall Study|Adverse Event|9|||
106154230|NCT01095796|366224049|FG001|Overall Study|Adverse Event|19|||
106154231|NCT01095796|366224048|FG000|Overall Study|Death|3|||
106154232|NCT01095796|366224049|FG001|Overall Study|Death|2|||
106154233|NCT01095796|366224048|FG000|Overall Study|Pregnancy|2|||
106154234|NCT01095796|366224049|FG001|Overall Study|Pregnancy|0|||
106154235|NCT01095796|366224048|FG000|Overall Study|Lack of Efficacy|5|||
106154236|NCT01095796|366224049|FG001|Overall Study|Lack of Efficacy|3|||
106154237|NCT01095796|366224048|FG000|Overall Study|Investigator's Discretion|7|||
106154238|NCT01095796|366224049|FG001|Overall Study|Investigator's Discretion|2|||
106154239|NCT01095796|366224048|FG000|Overall Study|Withdrew Consent|16|||
105865116|NCT03052127|365154839|FG008|Overall Study|Withdrawal by Subject|1|||
105865117|NCT03052127|365154840|FG009|Overall Study|Withdrawal by Subject|1|||
105865118|NCT03052127|365154841|FG010|Overall Study|Withdrawal by Subject|0|||
105865119|NCT03052127|365154842|FG011|Overall Study|Withdrawal by Subject|0|||
105865120|NCT03052127|365154831|FG000|Overall Study|Discontinuation by Sponsor|0|||
105865121|NCT03052127|365154832|FG001|Overall Study|Discontinuation by Sponsor|0|||
105865122|NCT03052127|365154833|FG002|Overall Study|Discontinuation by Sponsor|0|||
105865123|NCT03052127|365154834|FG003|Overall Study|Discontinuation by Sponsor|0|||
105865124|NCT03052127|365154835|FG004|Overall Study|Discontinuation by Sponsor|0|||
105865125|NCT03052127|365154836|FG005|Overall Study|Discontinuation by Sponsor|0|||
105865126|NCT03052127|365154837|FG006|Overall Study|Discontinuation by Sponsor|0|||
105865127|NCT03052127|365154838|FG007|Overall Study|Discontinuation by Sponsor|0|||
105865128|NCT03052127|365154839|FG008|Overall Study|Discontinuation by Sponsor|4|||
105865129|NCT03052127|365154840|FG009|Overall Study|Discontinuation by Sponsor|2|||
105865130|NCT03052127|365154841|FG010|Overall Study|Discontinuation by Sponsor|5|||
105865131|NCT03052127|365154842|FG011|Overall Study|Discontinuation by Sponsor|13|||
106065831|NCT00165776|365903520|FG002|Overall Study|Lack of Efficacy|0|||
106065832|NCT00165776|365903521|FG003|Overall Study|Lack of Efficacy|1|||
106065833|NCT00165776|365903518|FG000|Overall Study|Withdrawal by Subject|4|||
106065834|NCT00165776|365903519|FG001|Overall Study|Withdrawal by Subject|1|||
106065835|NCT00165776|365903520|FG002|Overall Study|Withdrawal by Subject|2|||
106065836|NCT00165776|365903521|FG003|Overall Study|Withdrawal by Subject|0|||
106065837|NCT00165776|365903518|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
106065838|NCT00165776|365903519|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
106065839|NCT00165776|365903520|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
106065840|NCT00165776|365903521|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
106065841|NCT04900220|365903522|FG000|Overall Study|Lost to Follow-up|1|||
106065842|NCT04900220|365903523|FG001|Overall Study|Lost to Follow-up|1|||
106065843|NCT01414855|365903526|FG000|Overall Study|Death|17|||
106065844|NCT01414855|365903526|FG000|Overall Study|Lost to Follow-up|5|||
106065845|NCT01414855|365903526|FG000|Overall Study|Withdrawal by Subject|7|||
106065846|NCT03128892|365903532|FG000|Overall Study|Withdrawal by Subject|2|||
106065847|NCT03128892|365903532|FG000|Overall Study|Physician Decision|1|||
106065848|NCT03171415|365903537|FG000|Overall Study|Lost to Follow-up|0|||
106065849|NCT03171415|365903538|FG001|Overall Study|Lost to Follow-up|0|||
106065850|NCT03171415|365903539|FG002|Overall Study|Lost to Follow-up|0|||
106065851|NCT03171415|365903540|FG003|Overall Study|Lost to Follow-up|0|||
106065852|NCT03171415|365903541|FG004|Overall Study|Lost to Follow-up|2|||
106065853|NCT01339429|365903544|FG000|Overall Study|Withdrawal by Subject|1|||
106065854|NCT01339429|365903544|FG000|Overall Study|Physician Decision|3|||
106154240|NCT01095796|366224049|FG001|Overall Study|Withdrew Consent|22|||
106154241|NCT01095796|366224048|FG000|Overall Study|Lost to Follow-up|27|||
106154242|NCT01095796|366224049|FG001|Overall Study|Lost to Follow-up|29|||
106154243|NCT01095796|366224048|FG000|Overall Study|Participant Noncompliance|5|||
106154244|NCT01095796|366224049|FG001|Overall Study|Participant Noncompliance|10|||
106154245|NCT01095796|366224048|FG000|Overall Study|Protocol Violation|1|||
106154246|NCT01095796|366224049|FG001|Overall Study|Protocol Violation|0|||
106154247|NCT01095796|366224048|FG000|Overall Study|Participant Transferred to Another Study|215|||
106154248|NCT01095796|366224049|FG001|Overall Study|Participant Transferred to Another Study|200|||
106154249|NCT04377308|366224050|FG000|Overall Study|Withdrawal by Subject|0|||
106154250|NCT04377308|366224051|FG001|Overall Study|Withdrawal by Subject|1|||
106154251|NCT01494922|366224052|FG000|Overall Study|Adverse Event|1|||
106154252|NCT02759016|366224053|FG000|Overall Study|Not treated with BI 836826|1|||
106154253|NCT02759016|366224054|FG001|Overall Study|Not treated with BI 836826|0|||
106154254|NCT02759016|366224053|FG000|Overall Study|Progressive disease|1|||
106154255|NCT02759016|366224054|FG001|Overall Study|Progressive disease|0|||
105865132|NCT03052127|365154831|FG000|Overall Study|Inability to comply with trial requirements|0|||
105865133|NCT03052127|365154832|FG001|Overall Study|Inability to comply with trial requirements|0|||
105865134|NCT03052127|365154833|FG002|Overall Study|Inability to comply with trial requirements|1|||
105865135|NCT03052127|365154834|FG003|Overall Study|Inability to comply with trial requirements|0|||
105865136|NCT03052127|365154835|FG004|Overall Study|Inability to comply with trial requirements|0|||
105865137|NCT03052127|365154836|FG005|Overall Study|Inability to comply with trial requirements|0|||
105865138|NCT03052127|365154837|FG006|Overall Study|Inability to comply with trial requirements|0|||
105865139|NCT03052127|365154838|FG007|Overall Study|Inability to comply with trial requirements|0|||
105865140|NCT03052127|365154839|FG008|Overall Study|Inability to comply with trial requirements|0|||
106065855|NCT01085591|365903545|FG000|Overall Study|Adverse Event|0|||
106065856|NCT01085591|365903546|FG001|Overall Study|Adverse Event|1|||
106065857|NCT01085591|365903547|FG002|Overall Study|Adverse Event|3|||
106065858|NCT01085591|365903545|FG000|Overall Study|Physician Decision|1|||
106065859|NCT01085591|365903546|FG001|Overall Study|Physician Decision|0|||
106065860|NCT01085591|365903547|FG002|Overall Study|Physician Decision|1|||
106154256|NCT02759016|366224053|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
106154257|NCT02759016|366224054|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
106154258|NCT02759016|366224053|FG000|Overall Study|Other not defined above|2|||
106154259|NCT02759016|366224054|FG001|Overall Study|Other not defined above|1|||
105865141|NCT03052127|365154840|FG009|Overall Study|Inability to comply with trial requirements|0|||
105865142|NCT03052127|365154841|FG010|Overall Study|Inability to comply with trial requirements|0|||
105865143|NCT03052127|365154842|FG011|Overall Study|Inability to comply with trial requirements|0|||
105865144|NCT03052127|365154831|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
105865145|NCT03052127|365154832|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105865146|NCT03052127|365154833|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105865147|NCT03052127|365154834|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105865148|NCT03052127|365154835|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
105865149|NCT03052127|365154836|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
105865150|NCT03052127|365154837|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
105865151|NCT03052127|365154838|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105865152|NCT03052127|365154839|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105865153|NCT03052127|365154840|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105865154|NCT03052127|365154841|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105865155|NCT03052127|365154842|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
105865156|NCT03694327|365154846|FG000|Overall Study|Lost to Follow-up|13|||
105865157|NCT03694327|365154847|FG001|Overall Study|Lost to Follow-up|23|||
105865158|NCT01982812|365154850|FG000|Overall Study|Death|1|||
105865159|NCT01982812|365154851|FG001|Overall Study|Death|5|||
105865160|NCT01982812|365154850|FG000|Overall Study|Adverse Event|0|||
105865161|NCT01982812|365154851|FG001|Overall Study|Adverse Event|5|||
105865162|NCT00307437|365154852|FG000|Controlled Period|Adverse Event|7|||
105865163|NCT00307437|365154853|FG001|Controlled Period|Adverse Event|2|||
106065861|NCT01085591|365903545|FG000|Overall Study|Withdrawal by Subject|0|||
106065862|NCT01085591|365903546|FG001|Overall Study|Withdrawal by Subject|2|||
106065863|NCT01085591|365903547|FG002|Overall Study|Withdrawal by Subject|1|||
106065864|NCT01085591|365903545|FG000|Overall Study|Lost to Follow-up|0|||
106065865|NCT01085591|365903546|FG001|Overall Study|Lost to Follow-up|1|||
106065866|NCT01085591|365903547|FG002|Overall Study|Lost to Follow-up|1|||
106154260|NCT02891915|366224057|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
106065867|NCT01085591|365903545|FG000|Overall Study|Protocol Violation|1|||
106154261|NCT02891915|366224058|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
106154262|NCT02891915|366224057|FG000|Overall Study|Withdrawal by Subject|3|||
106154263|NCT02891915|366224058|FG001|Overall Study|Withdrawal by Subject|3|||
106154264|NCT02891915|366224057|FG000|Overall Study|Became Ineligible After Enrollment|2|||
106154265|NCT02891915|366224058|FG001|Overall Study|Became Ineligible After Enrollment|1|||
106154266|NCT02891915|366224057|FG000|Overall Study|Lost to Follow-up|1|||
106154267|NCT02891915|366224058|FG001|Overall Study|Lost to Follow-up|4|||
106154268|NCT02891915|366224057|FG000|Overall Study|Physician Decision|1|||
106154269|NCT02891915|366224058|FG001|Overall Study|Physician Decision|0|||
106154270|NCT00709098|366224059|FG000|Double-blind Period|Withdrawal of consent|3|||
106154271|NCT00709098|366224060|FG001|Double-blind Period|Withdrawal of consent|3|||
106154272|NCT00709098|366224061|FG002|Double-blind Period|Withdrawal of consent|0|||
106154273|NCT00709098|366224059|FG000|Double-blind Period|Administrative reason|1|||
106154274|NCT00709098|366224060|FG001|Double-blind Period|Administrative reason|3|||
106154275|NCT00709098|366224061|FG002|Double-blind Period|Administrative reason|0|||
106154276|NCT00709098|366224059|FG000|Double-blind Period|Death|1|||
106154277|NCT00709098|366224060|FG001|Double-blind Period|Death|1|||
106154278|NCT00709098|366224061|FG002|Double-blind Period|Death|0|||
106154279|NCT00709098|366224059|FG000|Double-blind Period|Lost to Follow-up|1|||
106154280|NCT00709098|366224060|FG001|Double-blind Period|Lost to Follow-up|1|||
106154281|NCT00709098|366224061|FG002|Double-blind Period|Lost to Follow-up|0|||
106154282|NCT00709098|366224059|FG000|Open-label Period|Withdrawal of consent|0|||
106154283|NCT00709098|366224060|FG001|Open-label Period|Withdrawal of consent|0|||
106154284|NCT00709098|366224061|FG002|Open-label Period|Withdrawal of consent|7|||
105865164|NCT00307437|365154854|FG002|Controlled Period|Adverse Event|5|||
105865165|NCT00307437|365154855|FG003|Controlled Period|Adverse Event|0|||
105865166|NCT00307437|365154856|FG004|Controlled Period|Adverse Event|0|||
105865167|NCT00307437|365154857|FG005|Controlled Period|Adverse Event|0|||
105865168|NCT00307437|365154858|FG006|Controlled Period|Adverse Event|0|||
105865169|NCT00307437|365154852|FG000|Controlled Period|Death|0|||
105865170|NCT00307437|365154853|FG001|Controlled Period|Death|0|||
105865171|NCT00307437|365154854|FG002|Controlled Period|Death|1|||
105865172|NCT00307437|365154855|FG003|Controlled Period|Death|0|||
105865173|NCT00307437|365154856|FG004|Controlled Period|Death|0|||
106065868|NCT01085591|365903546|FG001|Overall Study|Protocol Violation|1|||
105865174|NCT00307437|365154857|FG005|Controlled Period|Death|0|||
105865175|NCT00307437|365154858|FG006|Controlled Period|Death|0|||
105865176|NCT00307437|365154852|FG000|Controlled Period|Lack of Efficacy|2|||
105865177|NCT00307437|365154853|FG001|Controlled Period|Lack of Efficacy|0|||
105865178|NCT00307437|365154854|FG002|Controlled Period|Lack of Efficacy|0|||
105865179|NCT00307437|365154855|FG003|Controlled Period|Lack of Efficacy|0|||
106065869|NCT01085591|365903547|FG002|Overall Study|Protocol Violation|1|||
106154285|NCT00709098|366224059|FG000|Open-label Period|Administrative reason|0|||
106154286|NCT00709098|366224060|FG001|Open-label Period|Administrative reason|0|||
106065870|NCT01085591|365903545|FG000|Overall Study|Other|0|||
106065871|NCT01085591|365903546|FG001|Overall Study|Other|1|||
106065872|NCT01085591|365903547|FG002|Overall Study|Other|0|||
106065873|NCT01085591|365903545|FG000|Overall Study|Not Properly Consented|1|||
106065874|NCT01085591|365903546|FG001|Overall Study|Not Properly Consented|0|||
106065875|NCT01085591|365903547|FG002|Overall Study|Not Properly Consented|0|||
106065876|NCT00459667|365903548|FG000|Overall Study|Adverse Event|9|||
106065877|NCT00459667|365903549|FG001|Overall Study|Adverse Event|12|||
106065878|NCT00459667|365903550|FG002|Overall Study|Adverse Event|8|||
106065879|NCT00459667|365903548|FG000|Overall Study|Lost to Follow-up|5|||
106065880|NCT00459667|365903549|FG001|Overall Study|Lost to Follow-up|9|||
106065881|NCT00459667|365903550|FG002|Overall Study|Lost to Follow-up|3|||
106065882|NCT00459667|365903548|FG000|Overall Study|Pregnancy|1|||
106065883|NCT00459667|365903549|FG001|Overall Study|Pregnancy|1|||
106065884|NCT00459667|365903550|FG002|Overall Study|Pregnancy|1|||
106065885|NCT00459667|365903548|FG000|Overall Study|Protocol Violation|1|||
106065886|NCT00459667|365903549|FG001|Overall Study|Protocol Violation|0|||
106065887|NCT00459667|365903550|FG002|Overall Study|Protocol Violation|0|||
106065888|NCT00459667|365903548|FG000|Overall Study|Withdrawal by Subject|3|||
106065889|NCT00459667|365903549|FG001|Overall Study|Withdrawal by Subject|5|||
106065890|NCT00459667|365903550|FG002|Overall Study|Withdrawal by Subject|5|||
106065891|NCT00459667|365903548|FG000|Overall Study|Other disease modifying treatment|1|||
106065892|NCT00459667|365903549|FG001|Overall Study|Other disease modifying treatment|2|||
106065893|NCT00459667|365903550|FG002|Overall Study|Other disease modifying treatment|1|||
106065894|NCT00459667|365903548|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
106065895|NCT00459667|365903549|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
106065896|NCT00459667|365903550|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
106065897|NCT00459667|365903548|FG000|Overall Study|No treatment administered|6|||
106065898|NCT00459667|365903549|FG001|Overall Study|No treatment administered|3|||
106065899|NCT00459667|365903550|FG002|Overall Study|No treatment administered|1|||
106065900|NCT04140292|365903551|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
106065901|NCT04140292|365903552|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
106065902|NCT00396591|365903553|FG000|Overall Study|Disease Progression|13|||
106065903|NCT00396591|365903553|FG000|Overall Study|Adverse Event|2|||
106065904|NCT00396591|365903553|FG000|Overall Study|Participant request|1|||
106065905|NCT01705652|365903558|FG000|Overall Study|Adverse Event|1|||
106065906|NCT01705652|365903559|FG001|Overall Study|Adverse Event|0|||
106065907|NCT01705652|365903558|FG000|Overall Study|Withdrawal by Subject|1|||
106065908|NCT01705652|365903559|FG001|Overall Study|Withdrawal by Subject|2|||
106065909|NCT01705652|365903558|FG000|Overall Study|non-compliance|1|||
106065910|NCT01705652|365903559|FG001|Overall Study|non-compliance|1|||
106065911|NCT03334903|365903560|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
106065912|NCT03334903|365903561|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
106065913|NCT03334903|365903560|FG000|Overall Study|Protocol Violation|1|||
106065914|NCT03334903|365903561|FG001|Overall Study|Protocol Violation|3|||
106065915|NCT03334903|365903560|FG000|Overall Study|Surgery postponed|1|||
106065916|NCT03334903|365903561|FG001|Overall Study|Surgery postponed|0|||
106065917|NCT03334903|365903560|FG000|Overall Study|Adverse Event|1|||
106065918|NCT03334903|365903561|FG001|Overall Study|Adverse Event|1|||
106065919|NCT03334903|365903560|FG000|Overall Study|Withdrawal by Subject|0|||
106065920|NCT03334903|365903561|FG001|Overall Study|Withdrawal by Subject|1|||
106065921|NCT00180414|365905398|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
106065922|NCT00180414|365905399|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
106065923|NCT01084174|365905404|FG000|Overall Study|gastrointestinal symptoms|1|||
106065924|NCT01084174|365905405|FG001|Overall Study|gastrointestinal symptoms|1|||
106065925|NCT01084174|365905404|FG000|Overall Study|Eosinophilic esophagitis|0|||
106065926|NCT01084174|365905405|FG001|Overall Study|Eosinophilic esophagitis|1|||
106065927|NCT01084174|365905404|FG000|Overall Study|Anaphylaxis|0|||
106065928|NCT01084174|365905405|FG001|Overall Study|Anaphylaxis|1|||
106065929|NCT01084174|365905404|FG000|Overall Study|Participant noncompliance|0|||
106065930|NCT01084174|365905405|FG001|Overall Study|Participant noncompliance|1|||
106065931|NCT00708162|365905406|FG000|Randomized Phase|Randomized but Not Treated|7|||
106065932|NCT00708162|365905407|FG001|Randomized Phase|Randomized but Not Treated|5|||
106065933|NCT00708162|365905406|FG000|Randomized Phase|Participant Noncompliance|40|||
106065934|NCT00708162|365905407|FG001|Randomized Phase|Participant Noncompliance|32|||
106065935|NCT00708162|365905406|FG000|Randomized Phase|Lost to Follow-up|34|||
106065936|NCT00708162|365905407|FG001|Randomized Phase|Lost to Follow-up|34|||
106065937|NCT00708162|365905406|FG000|Randomized Phase|Withdrew Consent|31|||
106065938|NCT00708162|365905407|FG001|Randomized Phase|Withdrew Consent|22|||
106065939|NCT00708162|365905406|FG000|Randomized Phase|Lack of Efficacy|14|||
106065940|NCT00708162|365905407|FG001|Randomized Phase|Lack of Efficacy|19|||
106065941|NCT00708162|365905406|FG000|Randomized Phase|Protocol Violation|10|||
106154287|NCT00709098|366224061|FG002|Open-label Period|Administrative reason|5|||
106154288|NCT00709098|366224059|FG000|Open-label Period|Death|0|||
106065942|NCT00708162|365905407|FG001|Randomized Phase|Protocol Violation|11|||
106154289|NCT00709098|366224060|FG001|Open-label Period|Death|0|||
105865180|NCT00307437|365154856|FG004|Controlled Period|Lack of Efficacy|0|||
106065943|NCT00708162|365905406|FG000|Randomized Phase|Adverse Event|8|||
106065944|NCT00708162|365905407|FG001|Randomized Phase|Adverse Event|12|||
106065945|NCT00708162|365905406|FG000|Randomized Phase|Investigator's Discretion|7|||
106065946|NCT00708162|365905407|FG001|Randomized Phase|Investigator's Discretion|10|||
106065947|NCT00708162|365905406|FG000|Randomized Phase|Death|2|||
106065948|NCT00708162|365905407|FG001|Randomized Phase|Death|9|||
106065949|NCT00708162|365905406|FG000|Randomized Phase|Pregnancy|3|||
106065950|NCT00708162|365905407|FG001|Randomized Phase|Pregnancy|0|||
106065951|NCT00708162|365905406|FG000|Open-Label Phase|Lost to Follow-up|10|||
106065952|NCT00708162|365905407|FG001|Open-Label Phase|Lost to Follow-up|8|||
106065953|NCT00708162|365905406|FG000|Open-Label Phase|Withdrew Consent|12|||
106065954|NCT00708162|365905407|FG001|Open-Label Phase|Withdrew Consent|6|||
106065955|NCT00708162|365905406|FG000|Open-Label Phase|Participant Noncompliance|7|||
106065956|NCT00708162|365905407|FG001|Open-Label Phase|Participant Noncompliance|7|||
106065957|NCT00708162|365905406|FG000|Open-Label Phase|Lack of Efficacy|7|||
106065958|NCT00708162|365905407|FG001|Open-Label Phase|Lack of Efficacy|4|||
106065959|NCT00708162|365905406|FG000|Open-Label Phase|Investigator's Discretion|3|||
106065960|NCT00708162|365905407|FG001|Open-Label Phase|Investigator's Discretion|2|||
106065961|NCT00708162|365905406|FG000|Open-Label Phase|Death|3|||
106065962|NCT00708162|365905407|FG001|Open-Label Phase|Death|1|||
106065963|NCT00708162|365905406|FG000|Open-Label Phase|Adverse Event|1|||
106065964|NCT00708162|365905407|FG001|Open-Label Phase|Adverse Event|2|||
106065965|NCT00708162|365905406|FG000|Open-Label Phase|Other|1|||
106065966|NCT00708162|365905407|FG001|Open-Label Phase|Other|0|||
106065967|NCT04577118|365905408|FG000|Overall Study|Withdrawal by Subject|4|||
106065968|NCT00333866|365905411|FG000|Overall Study|Adverse Event|23|||
106065969|NCT00333866|365905412|FG001|Overall Study|Adverse Event|37|||
106065970|NCT00333866|365905413|FG002|Overall Study|Adverse Event|38|||
106065971|NCT00333866|365905414|FG003|Overall Study|Adverse Event|47|||
106065972|NCT00333866|365905411|FG000|Overall Study|Other|3|||
106065973|NCT00333866|365905412|FG001|Overall Study|Other|2|||
106065974|NCT00333866|365905413|FG002|Overall Study|Other|2|||
106065975|NCT00333866|365905414|FG003|Overall Study|Other|2|||
106065976|NCT00333866|365905411|FG000|Overall Study|Lack of Efficacy|8|||
106065977|NCT00333866|365905412|FG001|Overall Study|Lack of Efficacy|6|||
106065978|NCT00333866|365905413|FG002|Overall Study|Lack of Efficacy|3|||
106065979|NCT00333866|365905414|FG003|Overall Study|Lack of Efficacy|5|||
106065980|NCT00333866|365905411|FG000|Overall Study|Lost to Follow-up|1|||
106065981|NCT00333866|365905412|FG001|Overall Study|Lost to Follow-up|2|||
106065982|NCT00333866|365905413|FG002|Overall Study|Lost to Follow-up|2|||
106065983|NCT00333866|365905414|FG003|Overall Study|Lost to Follow-up|2|||
106065984|NCT00333866|365905411|FG000|Overall Study|Withdrawal by Subject|8|||
106065985|NCT00333866|365905412|FG001|Overall Study|Withdrawal by Subject|14|||
106065986|NCT00333866|365905413|FG002|Overall Study|Withdrawal by Subject|4|||
106065987|NCT00333866|365905414|FG003|Overall Study|Withdrawal by Subject|9|||
106065988|NCT00333866|365905411|FG000|Overall Study|Randomized but not Treated|5|||
106065989|NCT00333866|365905412|FG001|Overall Study|Randomized but not Treated|3|||
106065990|NCT00333866|365905413|FG002|Overall Study|Randomized but not Treated|2|||
106065991|NCT00333866|365905414|FG003|Overall Study|Randomized but not Treated|1|||
106065992|NCT02710045|365905415|FG000|Overall Study|Death|1|||
106065993|NCT02710045|365905416|FG001|Overall Study|Death|2|||
106065994|NCT02710045|365905417|FG002|Overall Study|Death|0|||
106065995|NCT02710045|365905415|FG000|Overall Study|Withdrawal by Subject|6|||
106065996|NCT02710045|365905416|FG001|Overall Study|Withdrawal by Subject|6|||
106065997|NCT02710045|365905417|FG002|Overall Study|Withdrawal by Subject|2|||
106065998|NCT02710045|365905415|FG000|Overall Study|Protocol Violation|1|||
106065999|NCT02710045|365905416|FG001|Overall Study|Protocol Violation|2|||
106066000|NCT02710045|365905417|FG002|Overall Study|Protocol Violation|3|||
106066001|NCT02710045|365905415|FG000|Overall Study|Lost to Follow-up|3|||
106066002|NCT02710045|365905416|FG001|Overall Study|Lost to Follow-up|6|||
105865181|NCT00307437|365154857|FG005|Controlled Period|Lack of Efficacy|0|||
105865182|NCT00307437|365154858|FG006|Controlled Period|Lack of Efficacy|0|||
105865183|NCT00307437|365154852|FG000|Controlled Period|Lost to Follow-up|2|||
106066003|NCT02710045|365905417|FG002|Overall Study|Lost to Follow-up|7|||
106066004|NCT02710045|365905415|FG000|Overall Study|Physician Decision|0|||
106066005|NCT02710045|365905416|FG001|Overall Study|Physician Decision|0|||
106066006|NCT02710045|365905417|FG002|Overall Study|Physician Decision|1|||
106066007|NCT02710045|365905415|FG000|Overall Study|Poor Attendance|0|||
106066008|NCT02710045|365905416|FG001|Overall Study|Poor Attendance|1|||
106066009|NCT02710045|365905417|FG002|Overall Study|Poor Attendance|0|||
106066010|NCT01382446|365905418|FG000|Overall Study|Withdrawal by Subject|0|||
106066011|NCT01382446|365905419|FG001|Overall Study|Withdrawal by Subject|1|||
105865184|NCT00307437|365154853|FG001|Controlled Period|Lost to Follow-up|3|||
106066012|NCT01382446|365905418|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
106066013|NCT01382446|365905419|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
106066014|NCT02393547|365905420|FG000|Overall Study|Adverse Event|2|||
106066015|NCT02393547|365905420|FG000|Overall Study|Withdrawal by Subject|3|||
106066016|NCT02393547|365905420|FG000|Overall Study|Lost to Follow-up|1|||
106066017|NCT02707991|365905421|FG000|Overall Study|Protocol Violation|1|||
106066018|NCT02707991|365905422|FG001|Overall Study|Protocol Violation|0|||
106066019|NCT02707991|365905421|FG000|Overall Study|Became ineligible|0|||
106066020|NCT02707991|365905422|FG001|Overall Study|Became ineligible|1|||
106066021|NCT00143403|365905423|FG000|Overall Study|Adverse Event|3|||
106066022|NCT00143403|365905424|FG001|Overall Study|Adverse Event|8|||
106066023|NCT00143403|365905423|FG000|Overall Study|Death|1|||
106066024|NCT00143403|365905424|FG001|Overall Study|Death|0|||
106066025|NCT00143403|365905423|FG000|Overall Study|Withdrawal by Subject|3|||
106066026|NCT00143403|365905424|FG001|Overall Study|Withdrawal by Subject|12|||
106066027|NCT00143403|365905423|FG000|Overall Study|Relapse|15|||
106066028|NCT00143403|365905424|FG001|Overall Study|Relapse|7|||
106066029|NCT00143403|365905423|FG000|Overall Study|Protocol Violation|2|||
106066030|NCT00143403|365905424|FG001|Overall Study|Protocol Violation|2|||
106066031|NCT00143403|365905423|FG000|Overall Study|specified by site|4|||
106066032|NCT00143403|365905424|FG001|Overall Study|specified by site|9|||
106066033|NCT00143403|365905423|FG000|Overall Study|Randomized Not Treated|7|||
106066034|NCT00143403|365905424|FG001|Overall Study|Randomized Not Treated|8|||
106066035|NCT00514540|365905425|FG000|First-Line Chemo|Withdrawal by Subject|1|||
106066036|NCT00514540|365905425|FG000|First-Line Chemo|Protocol Violation|7|||
106066037|NCT00514540|365905425|FG000|Second-Line|Physician/Patient Decision|31|||
106066038|NCT00770289|365905428|FG000|Overall Study|Other|6|||
106066039|NCT02956486|365905429|FG000|Core Phase|Adverse Event|51|||
106066040|NCT02956486|365905430|FG001|Core Phase|Adverse Event|88|||
106066041|NCT02956486|365905431|FG002|Core Phase|Adverse Event|0|||
106066042|NCT02956486|365905429|FG000|Core Phase|Lost to Follow-up|8|||
106066043|NCT02956486|365905430|FG001|Core Phase|Lost to Follow-up|6|||
106066044|NCT02956486|365905431|FG002|Core Phase|Lost to Follow-up|0|||
106066045|NCT02956486|365905429|FG000|Core Phase|Inadequate therapeutic effect|4|||
106066046|NCT02956486|365905430|FG001|Core Phase|Inadequate therapeutic effect|5|||
106066047|NCT02956486|365905431|FG002|Core Phase|Inadequate therapeutic effect|0|||
106066048|NCT02956486|365905429|FG000|Core Phase|Withdrawal by Subject|101|||
106066049|NCT02956486|365905430|FG001|Core Phase|Withdrawal by Subject|104|||
106066050|NCT02956486|365905431|FG002|Core Phase|Withdrawal by Subject|0|||
106066051|NCT02956486|365905429|FG000|Core Phase|Study terminated by sponsor|888|||
106066052|NCT02956486|365905430|FG001|Core Phase|Study terminated by sponsor|848|||
106066053|NCT02956486|365905431|FG002|Core Phase|Study terminated by sponsor|0|||
106066054|NCT02956486|365905429|FG000|Core Phase|Other|27|||
106066055|NCT02956486|365905430|FG001|Core Phase|Other|18|||
106066056|NCT02956486|365905431|FG002|Core Phase|Other|0|||
106066057|NCT02956486|365905429|FG000|Core Phase|Not treated|0|||
106066058|NCT02956486|365905430|FG001|Core Phase|Not treated|3|||
106066059|NCT02956486|365905431|FG002|Core Phase|Not treated|0|||
106066060|NCT02956486|365905429|FG000|Extension Phase|Adverse Event|0|||
106066061|NCT02956486|365905430|FG001|Extension Phase|Adverse Event|0|||
106066062|NCT02956486|365905431|FG002|Extension Phase|Adverse Event|2|||
106066063|NCT02956486|365905429|FG000|Extension Phase|Study terminated by sponsor|0|||
106066064|NCT02956486|365905430|FG001|Extension Phase|Study terminated by sponsor|0|||
106066065|NCT02956486|365905431|FG002|Extension Phase|Study terminated by sponsor|16|||
106066066|NCT02956486|365905429|FG000|Extension Phase|Not Treated|0|||
106066067|NCT02956486|365905430|FG001|Extension Phase|Not Treated|0|||
106066068|NCT02956486|365905431|FG002|Extension Phase|Not Treated|1|||
106066069|NCT00422591|365905432|FG000|Overall Study|Physician Decision|4|||
106066070|NCT00422591|365905432|FG000|Overall Study|Withdrawal by Subject|2|||
106066071|NCT03566823|365905437|FG000|Overall Study|Lack of Efficacy|0|||
106066072|NCT03566823|365905438|FG001|Overall Study|Lack of Efficacy|1|||
106066073|NCT03566823|365905439|FG002|Overall Study|Lack of Efficacy|0|||
106066074|NCT03566823|365905437|FG000|Overall Study|Withdrawal by Subject|1|||
106066075|NCT03566823|365905438|FG001|Overall Study|Withdrawal by Subject|2|||
106066076|NCT03566823|365905439|FG002|Overall Study|Withdrawal by Subject|0|||
106066077|NCT03566823|365905437|FG000|Overall Study|Adverse Event|1|||
106066078|NCT03566823|365905438|FG001|Overall Study|Adverse Event|0|||
106066079|NCT03566823|365905439|FG002|Overall Study|Adverse Event|2|||
106066080|NCT02733367|365905440|FG000|Overall Study|Withdrawal by Subject|6|||
106066081|NCT01528254|365905441|FG000|Overall Study|Administrative problems|96|||
106066082|NCT01528254|365905442|FG001|Overall Study|Administrative problems|94|||
106066083|NCT01528254|365905441|FG000|Overall Study|Adverse Event|28|||
106066084|NCT01528254|365905442|FG001|Overall Study|Adverse Event|44|||
106066085|NCT01528254|365905441|FG000|Overall Study|Lost to Follow-up|17|||
106066086|NCT01528254|365905442|FG001|Overall Study|Lost to Follow-up|24|||
106066087|NCT01528254|365905441|FG000|Overall Study|Death|13|||
106066088|NCT01528254|365905442|FG001|Overall Study|Death|9|||
106066089|NCT01528254|365905441|FG000|Overall Study|Protocol deviation|9|||
106066090|NCT01528254|365905442|FG001|Overall Study|Protocol deviation|19|||
106066091|NCT01528254|365905441|FG000|Overall Study|New therapy for study indication|8|||
106066092|NCT01528254|365905442|FG001|Overall Study|New therapy for study indication|6|||
106066093|NCT01528254|365905441|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
106066094|NCT01528254|365905442|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
106066095|NCT01528254|365905441|FG000|Overall Study|Withdrawal by Subject|5|||
106066096|NCT01528254|365905442|FG001|Overall Study|Withdrawal by Subject|4|||
106066097|NCT01528254|365905441|FG000|Overall Study|Abnormal laboratory value(s)|3|||
106066098|NCT01528254|365905442|FG001|Overall Study|Abnormal laboratory value(s)|7|||
106066099|NCT01528254|365905441|FG000|Overall Study|Abnormal test procedure result(s)|1|||
106066100|NCT01528254|365905442|FG001|Overall Study|Abnormal test procedure result(s)|0|||
106066101|NCT01528254|365905441|FG000|Overall Study|No longer requires study drug|1|||
106066102|NCT01528254|365905442|FG001|Overall Study|No longer requires study drug|1|||
106066103|NCT01348347|365905443|FG000|Overall Study|Withdrawal by Subject|1|||
106066104|NCT01348347|365905444|FG001|Overall Study|Withdrawal by Subject|1|||
106066105|NCT01348347|365905445|FG002|Overall Study|Withdrawal by Subject|1|||
106066106|NCT01348347|365905443|FG000|Overall Study|Progressive disease|2|||
106066107|NCT01348347|365905444|FG001|Overall Study|Progressive disease|5|||
106066108|NCT01348347|365905445|FG002|Overall Study|Progressive disease|5|||
106066109|NCT00737282|365905446|FG000|Overall Study|Study prematurely terminated|175|||
106066110|NCT04903626|365905447|FG000|Overall Study|Lost to Follow-up|6|||
106066111|NCT04903626|365905447|FG000|Overall Study|Withdrawal by Subject|1|||
106066112|NCT04903626|365905447|FG000|Overall Study|Other, Not Specified|1|||
106066113|NCT00467259|365905450|FG000|Overall Study|Adverse Event|24|||
106066114|NCT00467259|365905451|FG001|Overall Study|Adverse Event|90|||
106066115|NCT00467259|365905450|FG000|Overall Study|Protocol Violation|1|||
106066116|NCT00467259|365905451|FG001|Overall Study|Protocol Violation|7|||
106066117|NCT00467259|365905450|FG000|Overall Study|Withdrawal by Subject|34|||
106066118|NCT00467259|365905451|FG001|Overall Study|Withdrawal by Subject|108|||
106066119|NCT00467259|365905450|FG000|Overall Study|Physician Decision|0|||
106066120|NCT00467259|365905451|FG001|Overall Study|Physician Decision|2|||
106066121|NCT00467259|365905450|FG000|Overall Study|Lost to Follow-up|14|||
106066122|NCT00467259|365905451|FG001|Overall Study|Lost to Follow-up|34|||
106066123|NCT00467259|365905450|FG000|Overall Study|Site Closed|2|||
106066124|NCT00467259|365905451|FG001|Overall Study|Site Closed|1|||
106066125|NCT01129960|365905452|FG000|Overall Study|Withdrawal by Subject|3|||
106066126|NCT01129960|365905453|FG001|Overall Study|Withdrawal by Subject|0|||
106066127|NCT01129960|365905454|FG002|Overall Study|Withdrawal by Subject|3|||
106066128|NCT01129960|365905455|FG003|Overall Study|Withdrawal by Subject|2|||
106066129|NCT01129960|365905452|FG000|Overall Study|Lack of Efficacy|1|||
106066130|NCT01129960|365905453|FG001|Overall Study|Lack of Efficacy|1|||
106066131|NCT01129960|365905454|FG002|Overall Study|Lack of Efficacy|1|||
106066132|NCT01129960|365905455|FG003|Overall Study|Lack of Efficacy|1|||
106066133|NCT01129960|365905452|FG000|Overall Study|Adverse Event|23|||
106066134|NCT01129960|365905453|FG001|Overall Study|Adverse Event|16|||
106066135|NCT01129960|365905454|FG002|Overall Study|Adverse Event|16|||
106066136|NCT01129960|365905455|FG003|Overall Study|Adverse Event|7|||
106066137|NCT01129960|365905452|FG000|Overall Study|Protocol Violation|1|||
106066138|NCT01129960|365905453|FG001|Overall Study|Protocol Violation|2|||
106066139|NCT01129960|365905454|FG002|Overall Study|Protocol Violation|3|||
106066140|NCT01129960|365905455|FG003|Overall Study|Protocol Violation|0|||
106066141|NCT01129960|365905452|FG000|Overall Study|Lost to Follow-up|0|||
106066142|NCT01129960|365905453|FG001|Overall Study|Lost to Follow-up|2|||
106066143|NCT01129960|365905454|FG002|Overall Study|Lost to Follow-up|3|||
106066144|NCT01129960|365905455|FG003|Overall Study|Lost to Follow-up|3|||
106066145|NCT01129960|365905452|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
106066146|NCT01129960|365905453|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
106066147|NCT01129960|365905454|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
106066148|NCT01129960|365905455|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
106066149|NCT01129960|365905452|FG000|Overall Study|Physician Decision|1|||
106066150|NCT01129960|365905453|FG001|Overall Study|Physician Decision|0|||
106066151|NCT01129960|365905454|FG002|Overall Study|Physician Decision|0|||
106066152|NCT01129960|365905455|FG003|Overall Study|Physician Decision|0|||
106066153|NCT01129960|365905452|FG000|Overall Study|Pregnancy|1|||
106066154|NCT01129960|365905453|FG001|Overall Study|Pregnancy|0|||
106066155|NCT01129960|365905454|FG002|Overall Study|Pregnancy|0|||
106066156|NCT01129960|365905455|FG003|Overall Study|Pregnancy|0|||
106066157|NCT01340898|365905456|FG000|Primary Phase|Serious Adverse Events|0|||
106066158|NCT01340898|365905457|FG001|Primary Phase|Serious Adverse Events|0|||
106066159|NCT01340898|365905458|FG002|Primary Phase|Serious Adverse Events|1|||
106066160|NCT01340898|365905456|FG000|Primary Phase|Withdrawal by Subject|8|||
106066161|NCT01340898|365905457|FG001|Primary Phase|Withdrawal by Subject|7|||
106066162|NCT01340898|365905458|FG002|Primary Phase|Withdrawal by Subject|5|||
106066163|NCT01340898|365905456|FG000|Primary Phase|Migrated/moved from study area|4|||
106066164|NCT01340898|365905457|FG001|Primary Phase|Migrated/moved from study area|1|||
106066165|NCT01340898|365905458|FG002|Primary Phase|Migrated/moved from study area|0|||
106066166|NCT01340898|365905456|FG000|Primary Phase|Lost to Follow-up|4|||
106066167|NCT01340898|365905457|FG001|Primary Phase|Lost to Follow-up|1|||
106066168|NCT01340898|365905458|FG002|Primary Phase|Lost to Follow-up|0|||
106066169|NCT01340898|365905456|FG000|Booster Phase|Withdrawal by Subject|3|||
106066170|NCT01340898|365905457|FG001|Booster Phase|Withdrawal by Subject|0|||
106066171|NCT01340898|365905458|FG002|Booster Phase|Withdrawal by Subject|4|||
106066172|NCT01340898|365905456|FG000|Booster Phase|Migrated/moved from study area|3|||
106066173|NCT01340898|365905457|FG001|Booster Phase|Migrated/moved from study area|0|||
106066174|NCT01340898|365905458|FG002|Booster Phase|Migrated/moved from study area|0|||
106066175|NCT01340898|365905456|FG000|Booster Phase|Lost to Follow-up|4|||
106066176|NCT01340898|365905457|FG001|Booster Phase|Lost to Follow-up|2|||
106066177|NCT01340898|365905458|FG002|Booster Phase|Lost to Follow-up|3|||
106066178|NCT02028065|365905460|FG000|Randomization Through Start Treatment|Not treated|1|||
106066179|NCT02028065|365905461|FG001|Randomization Through Start Treatment|Not treated|3|||
106066180|NCT02028065|365905462|FG002|Randomization Through Start Treatment|Not treated|3|||
106066181|NCT02028065|365905460|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
106066182|NCT02028065|365905461|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
106066183|NCT02028065|365905462|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
106066184|NCT02028065|365905460|FG000|Treatment Through Study Completion|Physician Decision|1|||
106066185|NCT02028065|365905461|FG001|Treatment Through Study Completion|Physician Decision|0|||
106066186|NCT02028065|365905462|FG002|Treatment Through Study Completion|Physician Decision|0|||
106066187|NCT02028065|365905460|FG000|Treatment Through Study Completion|Protocol Violation|1|||
106066188|NCT02028065|365905461|FG001|Treatment Through Study Completion|Protocol Violation|4|||
106066189|NCT02028065|365905462|FG002|Treatment Through Study Completion|Protocol Violation|0|||
106066190|NCT02028065|365905460|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
106066191|NCT02028065|365905461|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
106066192|NCT02028065|365905462|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
106066193|NCT02028065|365905460|FG000|Treatment Through Study Completion|Adverse Event|3|||
106066194|NCT02028065|365905461|FG001|Treatment Through Study Completion|Adverse Event|3|||
106066195|NCT02028065|365905462|FG002|Treatment Through Study Completion|Adverse Event|5|||
106066196|NCT04851314|365905463|FG000|Overall Study|Unable to complete research set-up procedures|0|||
106066197|NCT04851314|365905464|FG001|Overall Study|Unable to complete research set-up procedures|2|||
106066198|NCT04851314|365905463|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
106066199|NCT04851314|365905464|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
106066200|NCT00877383|365905465|FG000|Overall Study|Adverse Event|13|||
106066201|NCT00877383|365905466|FG001|Overall Study|Adverse Event|14|||
106066202|NCT00877383|365905465|FG000|Overall Study|Lost to Follow-up|5|||
106066203|NCT00877383|365905466|FG001|Overall Study|Lost to Follow-up|3|||
106066204|NCT00877383|365905465|FG000|Overall Study|Subject withdrew consent|3|||
106066205|NCT00877383|365905466|FG001|Overall Study|Subject withdrew consent|12|||
106066206|NCT00877383|365905465|FG000|Overall Study|Subject no longer requires study drug|2|||
106066207|NCT00877383|365905466|FG001|Overall Study|Subject no longer requires study drug|0|||
106066208|NCT00877383|365905465|FG000|Overall Study|Administrative problems|2|||
106066209|NCT00877383|365905466|FG001|Overall Study|Administrative problems|0|||
106066210|NCT00877383|365905465|FG000|Overall Study|Protocol deviation|2|||
106066211|NCT00877383|365905466|FG001|Overall Study|Protocol deviation|6|||
106066212|NCT00877383|365905465|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
106066213|NCT00877383|365905466|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
106066214|NCT00877383|365905465|FG000|Overall Study|Death|1|||
106066215|NCT00877383|365905466|FG001|Overall Study|Death|2|||
106066216|NCT04868890|365905467|FG000|Overall Study|Death|2|||
106066217|NCT04868890|365905468|FG001|Overall Study|Death|1|||
106066218|NCT04868890|365905467|FG000|Overall Study|Withdrawal by Subject|1|||
106066219|NCT04868890|365905468|FG001|Overall Study|Withdrawal by Subject|5|||
106066220|NCT03266094|365905469|FG000|Overall Study|Lost to Follow-up|1|||
106066221|NCT03266094|365905469|FG000|Overall Study|Withdrawal by Subject|1|||
106066222|NCT00459108|365905472|FG000|Overall Study|Withdrawal by Subject|5|||
106066223|NCT00459108|365905472|FG000|Overall Study|Adverse Event|3|||
106066224|NCT00459108|365905472|FG000|Overall Study|Death|2|||
106066225|NCT00459108|365905472|FG000|Overall Study|Progression|1|||
106066226|NCT00368355|365905473|FG000|Overall Study|Adverse Event|1|||
106066227|NCT00368355|365905474|FG001|Overall Study|Adverse Event|0|||
106066228|NCT00368355|365905473|FG000|Overall Study|Death|2|||
106066229|NCT00368355|365905474|FG001|Overall Study|Death|4|||
106066230|NCT00368355|365905473|FG000|Overall Study|Relapse|6|||
106066231|NCT00368355|365905474|FG001|Overall Study|Relapse|10|||
106066232|NCT00368355|365905473|FG000|Overall Study|Subsequent transplant|0|||
106066233|NCT00368355|365905474|FG001|Overall Study|Subsequent transplant|3|||
106066234|NCT00368355|365905473|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
106066235|NCT00368355|365905474|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
106066236|NCT01472081|365905476|FG000|Overall Study|Continuing treatment at time of analysis|1|||
106066237|NCT01472081|365905477|FG001|Overall Study|Continuing treatment at time of analysis|4|||
106066238|NCT01472081|365905478|FG002|Overall Study|Continuing treatment at time of analysis|1|||
106066239|NCT01472081|365905479|FG003|Overall Study|Continuing treatment at time of analysis|8|||
106066240|NCT01472081|365905480|FG004|Overall Study|Continuing treatment at time of analysis|9|||
106066241|NCT01472081|365905481|FG005|Overall Study|Continuing treatment at time of analysis|0|||
106066242|NCT01472081|365905476|FG000|Overall Study|Disease Progression|4|||
106066243|NCT01472081|365905477|FG001|Overall Study|Disease Progression|10|||
106066244|NCT01472081|365905478|FG002|Overall Study|Disease Progression|12|||
106066245|NCT01472081|365905479|FG003|Overall Study|Disease Progression|31|||
106154290|NCT00709098|366224061|FG002|Open-label Period|Death|1|||
106154291|NCT00709098|366224059|FG000|Open-label Period|Lost to Follow-up|0|||
106154292|NCT00709098|366224060|FG001|Open-label Period|Lost to Follow-up|0|||
106154293|NCT00709098|366224061|FG002|Open-label Period|Lost to Follow-up|1|||
106154294|NCT03582722|366224062|FG000|Overall Study|Lost to Follow-up|1|||
106154295|NCT03582722|366224063|FG001|Overall Study|Lost to Follow-up|4|||
106154296|NCT03582722|366224062|FG000|Overall Study|Withdrawal by Subject|3|||
106154297|NCT03582722|366224063|FG001|Overall Study|Withdrawal by Subject|3|||
106154298|NCT00788671|366225753|FG000|Overall Study|Death|2|||
106154299|NCT00788671|366225753|FG000|Overall Study|Unable to biopsy|1|||
106154300|NCT00788671|366225753|FG000|Overall Study|Withdrawal by Subject|4|||
106154301|NCT00788671|366225753|FG000|Overall Study|IUD expulsed|1|||
106154302|NCT00788671|366225753|FG000|Overall Study|Lost to follow up|2|||
106154303|NCT04104321|366225755|FG000|Overall Study|didn't take the study drug|3|||
106154304|NCT03481777|366225756|FG000|Overall Study|Withdrawal by Subject|36|||
106154305|NCT03481777|366225757|FG001|Overall Study|Withdrawal by Subject|31|||
106154306|NCT03481777|366225756|FG000|Overall Study|Non stroke = non target population|277|||
106154307|NCT03481777|366225757|FG001|Overall Study|Non stroke = non target population|254|||
106154308|NCT03683069|366225758|FG000|Overall Study|see limitations|12|||
106154309|NCT03683069|366225759|FG001|Overall Study|see limitations|13|||
106154310|NCT04941287|366225760|FG000|Overall Study|Rapid decline before starting treatment|3|||
106154311|NCT04941287|366225761|FG001|Overall Study|Rapid decline before starting treatment|1|||
106154312|NCT05104697|366225762|FG000|Overall Study|Withdrawal by Subject|0|||
106154313|NCT05104697|366225763|FG001|Overall Study|Withdrawal by Subject|1|||
106154314|NCT05056246|366225766|FG000|Overall Study|Adverse Event|0|||
106154315|NCT05056246|366225767|FG001|Overall Study|Adverse Event|0|||
106154316|NCT05056246|366225768|FG002|Overall Study|Adverse Event|0|||
106154317|NCT05056246|366225769|FG003|Overall Study|Adverse Event|0|||
106154318|NCT05056246|366225770|FG004|Overall Study|Adverse Event|1|||
106154319|NCT05056246|366225766|FG000|Overall Study|Lost to Follow-up|0|||
106154320|NCT05056246|366225767|FG001|Overall Study|Lost to Follow-up|0|||
106154321|NCT05056246|366225768|FG002|Overall Study|Lost to Follow-up|0|||
106154322|NCT05056246|366225769|FG003|Overall Study|Lost to Follow-up|2|||
106154323|NCT05056246|366225770|FG004|Overall Study|Lost to Follow-up|0|||
106154324|NCT05056246|366225766|FG000|Overall Study|Withdrawal by Subject|0|||
106154325|NCT05056246|366225767|FG001|Overall Study|Withdrawal by Subject|1|||
106154326|NCT05056246|366225768|FG002|Overall Study|Withdrawal by Subject|0|||
106154327|NCT05056246|366225769|FG003|Overall Study|Withdrawal by Subject|0|||
106154328|NCT05056246|366225770|FG004|Overall Study|Withdrawal by Subject|0|||
106066246|NCT01472081|365905480|FG004|Overall Study|Disease Progression|22|||
106066247|NCT01472081|365905481|FG005|Overall Study|Disease Progression|3|||
106154329|NCT03547908|366225776|FG000|Blinded Phase|Lost to Follow-up|3|||
106154330|NCT03547908|366225777|FG001|Blinded Phase|Lost to Follow-up|3|||
106066248|NCT01472081|365905476|FG000|Overall Study|Study drug toxicity|2|||
106066249|NCT01472081|365905477|FG001|Overall Study|Study drug toxicity|9|||
106066250|NCT01472081|365905478|FG002|Overall Study|Study drug toxicity|4|||
106066251|NCT01472081|365905479|FG003|Overall Study|Study drug toxicity|6|||
106066252|NCT01472081|365905480|FG004|Overall Study|Study drug toxicity|13|||
106066253|NCT01472081|365905481|FG005|Overall Study|Study drug toxicity|2|||
106066254|NCT01472081|365905476|FG000|Overall Study|Death|0|||
106066255|NCT01472081|365905477|FG001|Overall Study|Death|0|||
106066256|NCT01472081|365905478|FG002|Overall Study|Death|0|||
106066257|NCT01472081|365905479|FG003|Overall Study|Death|0|||
106066258|NCT01472081|365905480|FG004|Overall Study|Death|1|||
106066259|NCT01472081|365905481|FG005|Overall Study|Death|0|||
106066260|NCT01472081|365905476|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
106066261|NCT01472081|365905477|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
106066262|NCT01472081|365905478|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
106066263|NCT01472081|365905479|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
106066264|NCT01472081|365905480|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
106066265|NCT01472081|365905481|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
106066266|NCT01472081|365905476|FG000|Overall Study|Withdrawal by Subject|0|||
106066267|NCT01472081|365905477|FG001|Overall Study|Withdrawal by Subject|0|||
106066268|NCT01472081|365905478|FG002|Overall Study|Withdrawal by Subject|0|||
106066269|NCT01472081|365905479|FG003|Overall Study|Withdrawal by Subject|0|||
106066270|NCT01472081|365905480|FG004|Overall Study|Withdrawal by Subject|0|||
106066271|NCT01472081|365905481|FG005|Overall Study|Withdrawal by Subject|1|||
106066272|NCT01472081|365905476|FG000|Overall Study|Poor/non-compliance|0|||
106066273|NCT01472081|365905477|FG001|Overall Study|Poor/non-compliance|0|||
106066274|NCT01472081|365905478|FG002|Overall Study|Poor/non-compliance|1|||
106066275|NCT01472081|365905479|FG003|Overall Study|Poor/non-compliance|0|||
106066276|NCT01472081|365905480|FG004|Overall Study|Poor/non-compliance|1|||
106066277|NCT01472081|365905481|FG005|Overall Study|Poor/non-compliance|0|||
106066278|NCT01472081|365905476|FG000|Overall Study|No longer meets study criteria|0|||
106066279|NCT01472081|365905477|FG001|Overall Study|No longer meets study criteria|0|||
106066280|NCT01472081|365905478|FG002|Overall Study|No longer meets study criteria|1|||
106066281|NCT01472081|365905479|FG003|Overall Study|No longer meets study criteria|0|||
106066282|NCT01472081|365905480|FG004|Overall Study|No longer meets study criteria|0|||
106066283|NCT01472081|365905481|FG005|Overall Study|No longer meets study criteria|0|||
106066284|NCT01472081|365905476|FG000|Overall Study|Subject request to discontinue treatment|0|||
106066285|NCT01472081|365905477|FG001|Overall Study|Subject request to discontinue treatment|3|||
105865185|NCT00307437|365154854|FG002|Controlled Period|Lost to Follow-up|0|||
105865186|NCT00307437|365154855|FG003|Controlled Period|Lost to Follow-up|0|||
105865187|NCT00307437|365154856|FG004|Controlled Period|Lost to Follow-up|0|||
105865188|NCT00307437|365154857|FG005|Controlled Period|Lost to Follow-up|0|||
105865189|NCT00307437|365154858|FG006|Controlled Period|Lost to Follow-up|0|||
105865190|NCT00307437|365154852|FG000|Controlled Period|Other|5|||
105865191|NCT00307437|365154853|FG001|Controlled Period|Other|1|||
105865192|NCT00307437|365154854|FG002|Controlled Period|Other|3|||
105865193|NCT00307437|365154855|FG003|Controlled Period|Other|0|||
105865194|NCT00307437|365154856|FG004|Controlled Period|Other|0|||
105865195|NCT00307437|365154857|FG005|Controlled Period|Other|0|||
105865196|NCT00307437|365154858|FG006|Controlled Period|Other|0|||
105865197|NCT00307437|365154852|FG000|After Controlled Period|Adverse Event|0|||
105865198|NCT00307437|365154853|FG001|After Controlled Period|Adverse Event|0|||
105865199|NCT00307437|365154854|FG002|After Controlled Period|Adverse Event|0|||
105865200|NCT00307437|365154855|FG003|After Controlled Period|Adverse Event|18|||
105865201|NCT00307437|365154856|FG004|After Controlled Period|Adverse Event|16|||
105865202|NCT00307437|365154857|FG005|After Controlled Period|Adverse Event|31|||
105865203|NCT00307437|365154858|FG006|After Controlled Period|Adverse Event|40|||
105865204|NCT00307437|365154852|FG000|After Controlled Period|Death|0|||
105865205|NCT00307437|365154853|FG001|After Controlled Period|Death|0|||
105865206|NCT00307437|365154854|FG002|After Controlled Period|Death|0|||
105865207|NCT00307437|365154855|FG003|After Controlled Period|Death|3|||
105865208|NCT00307437|365154856|FG004|After Controlled Period|Death|1|||
105865209|NCT00307437|365154857|FG005|After Controlled Period|Death|1|||
105865210|NCT00307437|365154858|FG006|After Controlled Period|Death|3|||
105865211|NCT00307437|365154852|FG000|After Controlled Period|Lack of Efficacy|0|||
105865212|NCT00307437|365154853|FG001|After Controlled Period|Lack of Efficacy|0|||
105865213|NCT00307437|365154854|FG002|After Controlled Period|Lack of Efficacy|0|||
105865214|NCT00307437|365154855|FG003|After Controlled Period|Lack of Efficacy|15|||
105865215|NCT00307437|365154856|FG004|After Controlled Period|Lack of Efficacy|17|||
105865216|NCT00307437|365154857|FG005|After Controlled Period|Lack of Efficacy|37|||
105865217|NCT00307437|365154858|FG006|After Controlled Period|Lack of Efficacy|24|||
105865218|NCT00307437|365154852|FG000|After Controlled Period|Lost to Follow-up|0|||
105865219|NCT00307437|365154853|FG001|After Controlled Period|Lost to Follow-up|0|||
105865220|NCT00307437|365154854|FG002|After Controlled Period|Lost to Follow-up|0|||
105865221|NCT00307437|365154855|FG003|After Controlled Period|Lost to Follow-up|7|||
105865222|NCT00307437|365154856|FG004|After Controlled Period|Lost to Follow-up|12|||
105865223|NCT00307437|365154857|FG005|After Controlled Period|Lost to Follow-up|13|||
105865224|NCT00307437|365154858|FG006|After Controlled Period|Lost to Follow-up|18|||
105865225|NCT00307437|365154852|FG000|After Controlled Period|Other|0|||
105865226|NCT00307437|365154853|FG001|After Controlled Period|Other|0|||
105865227|NCT00307437|365154854|FG002|After Controlled Period|Other|0|||
105865228|NCT00307437|365154855|FG003|After Controlled Period|Other|15|||
105865229|NCT00307437|365154856|FG004|After Controlled Period|Other|9|||
105865230|NCT00307437|365154857|FG005|After Controlled Period|Other|40|||
105865231|NCT00307437|365154858|FG006|After Controlled Period|Other|28|||
105865232|NCT00509795|365154866|FG000|Overall Study|Adverse Event|4|||
105865233|NCT00509795|365154867|FG001|Overall Study|Adverse Event|3|||
105865234|NCT00509795|365154868|FG002|Overall Study|Adverse Event|5|||
105865235|NCT00509795|365154869|FG003|Overall Study|Adverse Event|4|||
105865236|NCT00509795|365154866|FG000|Overall Study|Death|3|||
105865237|NCT00509795|365154867|FG001|Overall Study|Death|1|||
105865238|NCT00509795|365154868|FG002|Overall Study|Death|2|||
106066286|NCT01472081|365905478|FG002|Overall Study|Subject request to discontinue treatment|1|||
106066287|NCT01472081|365905479|FG003|Overall Study|Subject request to discontinue treatment|1|||
106066288|NCT01472081|365905480|FG004|Overall Study|Subject request to discontinue treatment|0|||
106066289|NCT01472081|365905481|FG005|Overall Study|Subject request to discontinue treatment|0|||
106066290|NCT00847704|365905482|FG000|Overall Study|Withdrawal by Subject|1|||
106066291|NCT01962207|365905483|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
106066292|NCT01962207|365905484|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
105865239|NCT00509795|365154869|FG003|Overall Study|Death|7|||
105865240|NCT00509795|365154866|FG000|Overall Study|Lack of Efficacy|0|||
105865241|NCT00509795|365154867|FG001|Overall Study|Lack of Efficacy|0|||
105865242|NCT00509795|365154868|FG002|Overall Study|Lack of Efficacy|2|||
105865243|NCT00509795|365154869|FG003|Overall Study|Lack of Efficacy|2|||
105865244|NCT00509795|365154866|FG000|Overall Study|Lost to Follow-up|1|||
105865245|NCT00509795|365154867|FG001|Overall Study|Lost to Follow-up|2|||
105865246|NCT00509795|365154868|FG002|Overall Study|Lost to Follow-up|4|||
105865247|NCT00509795|365154869|FG003|Overall Study|Lost to Follow-up|4|||
105865248|NCT00509795|365154866|FG000|Overall Study|OTHER|1|||
105865249|NCT00509795|365154867|FG001|Overall Study|OTHER|0|||
105865250|NCT00509795|365154868|FG002|Overall Study|OTHER|4|||
105865251|NCT00509795|365154869|FG003|Overall Study|OTHER|1|||
105865252|NCT00509795|365154866|FG000|Overall Study|Protocol Violation|3|||
105865253|NCT00509795|365154867|FG001|Overall Study|Protocol Violation|0|||
105865254|NCT00509795|365154868|FG002|Overall Study|Protocol Violation|3|||
105865255|NCT00509795|365154869|FG003|Overall Study|Protocol Violation|1|||
106066293|NCT01962207|365905485|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
106066294|NCT01962207|365905486|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
106066295|NCT01962207|365905483|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
106066296|NCT01962207|365905484|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
106066297|NCT01962207|365905485|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
106066298|NCT01962207|365905486|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
106066299|NCT01962207|365905483|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
106066300|NCT01962207|365905484|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
106066301|NCT01962207|365905485|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
106066302|NCT01962207|365905486|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
106066303|NCT01962207|365905483|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
106066304|NCT01962207|365905484|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
106066305|NCT01962207|365905485|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
106154331|NCT03547908|366225778|FG002|Blinded Phase|Lost to Follow-up|0|||
106154332|NCT03547908|366225779|FG003|Blinded Phase|Lost to Follow-up|0|||
106154333|NCT03547908|366225776|FG000|Blinded Phase|Withdrew Consent|2|||
106154334|NCT03547908|366225777|FG001|Blinded Phase|Withdrew Consent|3|||
106154335|NCT03547908|366225778|FG002|Blinded Phase|Withdrew Consent|0|||
106154336|NCT03547908|366225779|FG003|Blinded Phase|Withdrew Consent|0|||
106154337|NCT03547908|366225776|FG000|Blinded Phase|Investigator's Discretion|2|||
106154338|NCT03547908|366225777|FG001|Blinded Phase|Investigator's Discretion|1|||
106154339|NCT03547908|366225778|FG002|Blinded Phase|Investigator's Discretion|0|||
106154340|NCT03547908|366225779|FG003|Blinded Phase|Investigator's Discretion|0|||
106154341|NCT03547908|366225776|FG000|Blinded Phase|Death|2|||
106154342|NCT03547908|366225777|FG001|Blinded Phase|Death|0|||
106154343|NCT03547908|366225778|FG002|Blinded Phase|Death|0|||
106154344|NCT03547908|366225779|FG003|Blinded Phase|Death|0|||
106154345|NCT03547908|366225776|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
106154346|NCT03547908|366225777|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
106154347|NCT03547908|366225778|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
106154348|NCT03547908|366225779|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
106154349|NCT03547908|366225776|FG000|Blinded Phase|Adverse Event|1|||
106154350|NCT03547908|366225777|FG001|Blinded Phase|Adverse Event|0|||
106154351|NCT03547908|366225778|FG002|Blinded Phase|Adverse Event|0|||
106154352|NCT03547908|366225779|FG003|Blinded Phase|Adverse Event|0|||
106154353|NCT03547908|366225776|FG000|Blinded Phase|Randomized But Never Treated|1|||
106154354|NCT03547908|366225777|FG001|Blinded Phase|Randomized But Never Treated|0|||
106154355|NCT03547908|366225778|FG002|Blinded Phase|Randomized But Never Treated|0|||
106154356|NCT03547908|366225779|FG003|Blinded Phase|Randomized But Never Treated|0|||
106154357|NCT03547908|366225776|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
106154358|NCT03547908|366225777|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
106154359|NCT03547908|366225778|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
106154360|NCT03547908|366225779|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
106154361|NCT03547908|366225776|FG000|Open-label Extension Phase|Death|0|||
106154362|NCT03547908|366225777|FG001|Open-label Extension Phase|Death|0|||
106154363|NCT03547908|366225778|FG002|Open-label Extension Phase|Death|1|||
106154364|NCT03547908|366225779|FG003|Open-label Extension Phase|Death|0|||
106154365|NCT03346538|366225780|FG000|Overall Study|Physician Decision|0|||
106154366|NCT03346538|366225781|FG001|Overall Study|Physician Decision|1|||
106154367|NCT03346538|366225782|FG002|Overall Study|Physician Decision|0|||
106154368|NCT03346538|366225780|FG000|Overall Study|Withdrawal by Subject|3|||
106154369|NCT03346538|366225781|FG001|Overall Study|Withdrawal by Subject|2|||
106154370|NCT03346538|366225782|FG002|Overall Study|Withdrawal by Subject|0|||
106154371|NCT03346538|366225780|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
106154372|NCT03346538|366225781|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
106154373|NCT03346538|366225782|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
106154374|NCT05419505|366225783|FG000|Overall Study|Adverse Event|0|||
106154375|NCT05419505|366225784|FG001|Overall Study|Adverse Event|0|||
106154376|NCT05419505|366225785|FG002|Overall Study|Adverse Event|0|||
106154377|NCT05419505|366225786|FG003|Overall Study|Adverse Event|1|||
106154378|NCT05419505|366225787|FG004|Overall Study|Adverse Event|0|||
106154379|NCT05419505|366225788|FG005|Overall Study|Adverse Event|0|||
106154380|NCT05419505|366225789|FG006|Overall Study|Adverse Event|0|||
106154381|NCT05419505|366225790|FG007|Overall Study|Adverse Event|0|||
106154382|NCT05419505|366225783|FG000|Overall Study|Withdrawal by Subject|1|||
106154383|NCT05419505|366225784|FG001|Overall Study|Withdrawal by Subject|2|||
106154384|NCT05419505|366225785|FG002|Overall Study|Withdrawal by Subject|0|||
106154385|NCT05419505|366225786|FG003|Overall Study|Withdrawal by Subject|0|||
106154386|NCT05419505|366225787|FG004|Overall Study|Withdrawal by Subject|0|||
106154387|NCT05419505|366225788|FG005|Overall Study|Withdrawal by Subject|0|||
105865256|NCT00509795|365154866|FG000|Overall Study|Withdrawal by Subject|10|||
106066306|NCT01962207|365905486|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
106066307|NCT01962207|365905483|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
106066308|NCT01962207|365905484|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
106066309|NCT01962207|365905485|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
106066310|NCT01962207|365905486|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
106066311|NCT01962207|365905483|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
106066312|NCT01962207|365905484|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
106066313|NCT01962207|365905485|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
106066314|NCT01962207|365905486|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
106066315|NCT02289079|365905489|FG000|Overall Study|Physician Decision|2|||
106066316|NCT02289079|365905490|FG001|Overall Study|Physician Decision|0|||
106066317|NCT02289079|365905489|FG000|Overall Study|Lost to Follow-up|0|||
106066318|NCT02289079|365905490|FG001|Overall Study|Lost to Follow-up|1|||
106066319|NCT00680043|365905491|FG000|Overall Study|Withdrawal by Subject|1|||
106066320|NCT00680043|365905492|FG001|Overall Study|Withdrawal by Subject|0|||
106066321|NCT00680043|365905493|FG002|Overall Study|Withdrawal by Subject|0|||
106066322|NCT00680043|365905491|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
106066323|NCT00680043|365905492|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
106066324|NCT00680043|365905493|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
106066325|NCT00680043|365905491|FG000|Overall Study|Renal Transplant|1|||
106066326|NCT00680043|365905492|FG001|Overall Study|Renal Transplant|0|||
106066327|NCT00680043|365905493|FG002|Overall Study|Renal Transplant|4|||
106066328|NCT02111850|365905495|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066329|NCT02111850|365905496|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066330|NCT02111850|365905497|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066331|NCT02111850|365905498|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066332|NCT02111850|365905499|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
106066333|NCT02111850|365905500|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066334|NCT02111850|365905501|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066335|NCT02111850|365905502|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066336|NCT02111850|365905503|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066337|NCT02111850|365905504|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066338|NCT02111850|365905505|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
106066339|NCT02625259|365905508|FG000|First Intervention (Day 1)|Other|0|||
106066340|NCT02625259|365905509|FG001|First Intervention (Day 1)|Other|0|||
106066341|NCT02625259|365905510|FG002|First Intervention (Day 1)|Other|1|||
106066342|NCT02625259|365905511|FG003|First Intervention (Day 1)|Other|0|||
106066343|NCT02625259|365905512|FG004|First Intervention (Day 1)|Other|0|||
106066344|NCT02625259|365905508|FG000|First Intervention (Day 1)|Adverse Event|2|||
106066345|NCT02625259|365905509|FG001|First Intervention (Day 1)|Adverse Event|1|||
106066346|NCT02625259|365905510|FG002|First Intervention (Day 1)|Adverse Event|0|||
106066347|NCT02625259|365905511|FG003|First Intervention (Day 1)|Adverse Event|0|||
106066348|NCT02625259|365905512|FG004|First Intervention (Day 1)|Adverse Event|0|||
106066349|NCT02625259|365905508|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
106066350|NCT02625259|365905509|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
106066351|NCT02625259|365905510|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
106066352|NCT02625259|365905511|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
106066353|NCT02625259|365905512|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
106066354|NCT00513474|365905513|FG000|Overall Study|Death|6|||
106066355|NCT00513474|365905514|FG001|Overall Study|Death|9|||
106066356|NCT00513474|365905513|FG000|Overall Study|Participant Withdrew Consent|1|||
106066357|NCT00513474|365905514|FG001|Overall Study|Participant Withdrew Consent|0|||
106066358|NCT03251079|365905520|FG000|Overall Study|Withdrawal by Subject|1|||
106066359|NCT01428453|365905523|FG000|Overall Study|Adverse Event|2|||
106066360|NCT01428453|365905524|FG001|Overall Study|Adverse Event|7|||
106066361|NCT01428453|365905523|FG000|Overall Study|Protocol Violation|1|||
106066362|NCT01428453|365905524|FG001|Overall Study|Protocol Violation|0|||
106066363|NCT01428453|365905523|FG000|Overall Study|Lost to Follow-up|0|||
106066364|NCT01428453|365905524|FG001|Overall Study|Lost to Follow-up|1|||
106066365|NCT01428453|365905523|FG000|Overall Study|Withdrawal by Subject|3|||
106066366|NCT01428453|365905524|FG001|Overall Study|Withdrawal by Subject|1|||
106066367|NCT02626520|365905526|FG000|Overall Study|Physician Decision|1|||
106066368|NCT02626520|365905527|FG001|Overall Study|Physician Decision|1|||
106066369|NCT02626520|365905526|FG000|Overall Study|Adverse Event|0|||
106066370|NCT02626520|365905527|FG001|Overall Study|Adverse Event|4|||
106066371|NCT02626520|365905526|FG000|Overall Study|Lack of Efficacy|0|||
106066372|NCT02626520|365905527|FG001|Overall Study|Lack of Efficacy|2|||
106066373|NCT02626520|365905526|FG000|Overall Study|Did not start protocol therapy|0|||
106066374|NCT02626520|365905527|FG001|Overall Study|Did not start protocol therapy|2|||
106154388|NCT05419505|366225789|FG006|Overall Study|Withdrawal by Subject|1|||
106066375|NCT02626520|365905526|FG000|Overall Study|Study terminated|0|||
106066376|NCT02626520|365905527|FG001|Overall Study|Study terminated|1|||
106066377|NCT01996709|365905528|FG000|Overall Study|Withdrawal by Subject|1|||
106066378|NCT01996709|365905529|FG001|Overall Study|Withdrawal by Subject|0|||
106066379|NCT01996709|365905528|FG000|Overall Study|Lost to Follow-up|3|||
106066380|NCT01996709|365905529|FG001|Overall Study|Lost to Follow-up|0|||
106066381|NCT01996709|365905528|FG000|Overall Study|Subject Non-Compliant|1|||
106066382|NCT01996709|365905529|FG001|Overall Study|Subject Non-Compliant|0|||
106066383|NCT01996709|365905528|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
106066384|NCT01996709|365905529|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
106066385|NCT02953314|365905530|FG000|Overall Study|Adverse Event|0|||
106066386|NCT02953314|365905531|FG001|Overall Study|Adverse Event|1|||
106066387|NCT02953314|365905530|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
106066388|NCT02953314|365905531|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
106066389|NCT00492115|365905532|FG000|Overall Study|Withdrawal by Subject|3|||
106066390|NCT00492115|365905533|FG001|Overall Study|Withdrawal by Subject|4|||
106066391|NCT03564145|365905534|FG000|Overall Study|Adverse Event|4|||
106066392|NCT03564145|365905534|FG000|Overall Study|Lost to Follow-up|21|||
106066393|NCT03564145|365905534|FG000|Overall Study|Protocol Violation|2|||
106066394|NCT03564145|365905534|FG000|Overall Study|Withdrawal by Subject|48|||
106066395|NCT03564145|365905534|FG000|Overall Study|Study Terminated by Sponsor|146|||
106066396|NCT03564145|365905534|FG000|Overall Study|Physician Decision|1|||
106066397|NCT03564145|365905534|FG000|Overall Study|Other Than Specified|1|||
106066398|NCT03564145|365905534|FG000|Overall Study|Pregnancy|1|||
106066399|NCT02045797|365905537|FG000|Overall Study|Adverse Event|3|||
106066400|NCT02045797|365905538|FG001|Overall Study|Adverse Event|1|||
106066401|NCT02045797|365905539|FG002|Overall Study|Adverse Event|0|||
106066402|NCT02045797|365905537|FG000|Overall Study|Lack of Efficacy|1|||
106066403|NCT02045797|365905538|FG001|Overall Study|Lack of Efficacy|0|||
106066404|NCT02045797|365905539|FG002|Overall Study|Lack of Efficacy|0|||
106066405|NCT02045797|365905537|FG000|Overall Study|Lost to Follow-up|2|||
106066406|NCT02045797|365905538|FG001|Overall Study|Lost to Follow-up|3|||
106066407|NCT02045797|365905539|FG002|Overall Study|Lost to Follow-up|1|||
106066408|NCT02045797|365905537|FG000|Overall Study|Physician Decision|0|||
106066409|NCT02045797|365905538|FG001|Overall Study|Physician Decision|1|||
106066410|NCT02045797|365905539|FG002|Overall Study|Physician Decision|0|||
106066411|NCT02045797|365905537|FG000|Overall Study|Withdrawal by Subject|1|||
106066412|NCT02045797|365905538|FG001|Overall Study|Withdrawal by Subject|2|||
106066413|NCT02045797|365905539|FG002|Overall Study|Withdrawal by Subject|0|||
106066414|NCT02200445|365905540|FG000|Overall Study|Lack of Efficacy|1|||
106066415|NCT02200445|365905541|FG001|Overall Study|Lack of Efficacy|2|||
106066416|NCT02200445|365905542|FG002|Overall Study|Lack of Efficacy|2|||
106066417|NCT02200445|365905540|FG000|Overall Study|Adverse Event|0|||
106066418|NCT02200445|365905541|FG001|Overall Study|Adverse Event|2|||
106066419|NCT02200445|365905542|FG002|Overall Study|Adverse Event|0|||
106066420|NCT01386554|365905543|FG000|Overall Study|Lost to Follow-up|0|||
106066421|NCT01386554|365905544|FG001|Overall Study|Lost to Follow-up|0|||
106066422|NCT01386554|365905545|FG002|Overall Study|Lost to Follow-up|1|||
106066423|NCT01386554|365905543|FG000|Overall Study|Adverse Event|2|||
106066424|NCT01386554|365905544|FG001|Overall Study|Adverse Event|5|||
106066425|NCT01386554|365905545|FG002|Overall Study|Adverse Event|2|||
106066426|NCT01386554|365905543|FG000|Overall Study|Progressive disease|1|||
106066427|NCT01386554|365905544|FG001|Overall Study|Progressive disease|2|||
106066428|NCT01386554|365905545|FG002|Overall Study|Progressive disease|2|||
106066429|NCT01386554|365905543|FG000|Overall Study|Administration of live vaccines|0|||
106066430|NCT01386554|365905544|FG001|Overall Study|Administration of live vaccines|1|||
106066431|NCT01386554|365905545|FG002|Overall Study|Administration of live vaccines|0|||
106066432|NCT01386554|365905543|FG000|Overall Study|Investigator discretion|0|||
106066433|NCT01386554|365905544|FG001|Overall Study|Investigator discretion|0|||
106066434|NCT01386554|365905545|FG002|Overall Study|Investigator discretion|1|||
106066435|NCT01386554|365905543|FG000|Overall Study|Reason not collected|0|||
106066436|NCT01386554|365905544|FG001|Overall Study|Reason not collected|1|||
106066437|NCT01386554|365905545|FG002|Overall Study|Reason not collected|0|||
106066438|NCT05286307|365905546|FG000|Overall Study|Incomplete outcome assessments|2|||
106066439|NCT05286307|365905547|FG001|Overall Study|Incomplete outcome assessments|1|||
106066440|NCT05286307|365905546|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
106066441|NCT05286307|365905547|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
106066442|NCT05286307|365905546|FG000|Overall Study|Lost to follow up at 6 months|25|||
106066443|NCT05286307|365905547|FG001|Overall Study|Lost to follow up at 6 months|35|||
106066444|NCT05286307|365905546|FG000|Overall Study|Study medication not available|1|||
106066445|NCT05286307|365905547|FG001|Overall Study|Study medication not available|1|||
106066446|NCT02554812|365905548|FG000|Overall Study|Adverse Event|2|||
106066447|NCT02554812|365905549|FG001|Overall Study|Adverse Event|5|||
106066448|NCT02554812|365905550|FG002|Overall Study|Adverse Event|3|||
106066449|NCT02554812|365905551|FG003|Overall Study|Adverse Event|0|||
106066450|NCT02554812|365905552|FG004|Overall Study|Adverse Event|5|||
106066451|NCT02554812|365905553|FG005|Overall Study|Adverse Event|0|||
106066452|NCT02554812|365905554|FG006|Overall Study|Adverse Event|1|||
106066453|NCT02554812|365905555|FG007|Overall Study|Adverse Event|6|||
106066454|NCT02554812|365905556|FG008|Overall Study|Adverse Event|2|||
106066455|NCT02554812|365905557|FG009|Overall Study|Adverse Event|2|||
106066456|NCT02554812|365905558|FG010|Overall Study|Adverse Event|1|||
106066457|NCT02554812|365905559|FG011|Overall Study|Adverse Event|2|||
106066458|NCT02554812|365905560|FG012|Overall Study|Adverse Event|0|||
106066459|NCT02554812|365905561|FG013|Overall Study|Adverse Event|3|||
106066460|NCT02554812|365905562|FG014|Overall Study|Adverse Event|2|||
106066461|NCT02554812|365905563|FG015|Overall Study|Adverse Event|1|||
106066462|NCT02554812|365905564|FG016|Overall Study|Adverse Event|0|||
106066463|NCT02554812|365905565|FG017|Overall Study|Adverse Event|1|||
106066464|NCT02554812|365905566|FG018|Overall Study|Adverse Event|0|||
106066465|NCT02554812|365905567|FG019|Overall Study|Adverse Event|0|||
106066466|NCT02554812|365905568|FG020|Overall Study|Adverse Event|0|||
106066467|NCT02554812|365905569|FG021|Overall Study|Adverse Event|2|||
106066468|NCT02554812|365905570|FG022|Overall Study|Adverse Event|1|||
106066469|NCT02554812|365905571|FG023|Overall Study|Adverse Event|1|||
106066470|NCT02554812|365905572|FG024|Overall Study|Adverse Event|1|||
106066471|NCT02554812|365905573|FG025|Overall Study|Adverse Event|2|||
106066472|NCT02554812|365905574|FG026|Overall Study|Adverse Event|1|||
106066473|NCT02554812|365905548|FG000|Overall Study|Death|1|||
106066474|NCT02554812|365905549|FG001|Overall Study|Death|2|||
106066475|NCT02554812|365905550|FG002|Overall Study|Death|2|||
106066476|NCT02554812|365905551|FG003|Overall Study|Death|2|||
106066477|NCT02554812|365905552|FG004|Overall Study|Death|0|||
106066478|NCT02554812|365905553|FG005|Overall Study|Death|1|||
106066479|NCT02554812|365905554|FG006|Overall Study|Death|1|||
106066480|NCT02554812|365905555|FG007|Overall Study|Death|1|||
106066481|NCT02554812|365905556|FG008|Overall Study|Death|0|||
106066482|NCT02554812|365905557|FG009|Overall Study|Death|0|||
106066483|NCT02554812|365905558|FG010|Overall Study|Death|0|||
106066484|NCT02554812|365905559|FG011|Overall Study|Death|0|||
106066485|NCT02554812|365905560|FG012|Overall Study|Death|0|||
106066486|NCT02554812|365905561|FG013|Overall Study|Death|0|||
106066487|NCT02554812|365905562|FG014|Overall Study|Death|1|||
106066488|NCT02554812|365905563|FG015|Overall Study|Death|1|||
106066489|NCT02554812|365905564|FG016|Overall Study|Death|1|||
106066490|NCT02554812|365905565|FG017|Overall Study|Death|0|||
105865257|NCT00509795|365154867|FG001|Overall Study|Withdrawal by Subject|5|||
105865258|NCT00509795|365154868|FG002|Overall Study|Withdrawal by Subject|7|||
105865259|NCT00509795|365154869|FG003|Overall Study|Withdrawal by Subject|8|||
105865260|NCT00338728|365154870|FG000|Overall Study|Screen Failure|14|||
105865261|NCT00993421|365154872|FG000|Overall Study|Adverse Event|2|||
105865262|NCT00993421|365154873|FG001|Overall Study|Adverse Event|7|||
105865263|NCT00993421|365154874|FG002|Overall Study|Adverse Event|6|||
105865264|NCT00993421|365154875|FG003|Overall Study|Adverse Event|9|||
105865265|NCT00993421|365154876|FG004|Overall Study|Adverse Event|5|||
105865266|NCT00993421|365154877|FG005|Overall Study|Adverse Event|7|||
105865267|NCT00993421|365154878|FG006|Overall Study|Adverse Event|1|||
105865268|NCT00993421|365154872|FG000|Overall Study|Sponsor Decision|36|||
105865269|NCT00993421|365154873|FG001|Overall Study|Sponsor Decision|31|||
105865270|NCT00993421|365154874|FG002|Overall Study|Sponsor Decision|28|||
105865271|NCT00993421|365154875|FG003|Overall Study|Sponsor Decision|30|||
105865272|NCT00993421|365154876|FG004|Overall Study|Sponsor Decision|38|||
105865273|NCT00993421|365154877|FG005|Overall Study|Sponsor Decision|30|||
105865274|NCT00993421|365154878|FG006|Overall Study|Sponsor Decision|29|||
105865275|NCT00993421|365154872|FG000|Overall Study|Lost to Follow-up|3|||
105865276|NCT00993421|365154873|FG001|Overall Study|Lost to Follow-up|5|||
105865277|NCT00993421|365154874|FG002|Overall Study|Lost to Follow-up|5|||
105865278|NCT00993421|365154875|FG003|Overall Study|Lost to Follow-up|0|||
105865279|NCT00993421|365154876|FG004|Overall Study|Lost to Follow-up|0|||
105865280|NCT00993421|365154877|FG005|Overall Study|Lost to Follow-up|0|||
105865281|NCT00993421|365154878|FG006|Overall Study|Lost to Follow-up|6|||
105865282|NCT00993421|365154872|FG000|Overall Study|Withdrawal by Subject|3|||
105865283|NCT00993421|365154873|FG001|Overall Study|Withdrawal by Subject|2|||
105865284|NCT00993421|365154874|FG002|Overall Study|Withdrawal by Subject|3|||
105865285|NCT00993421|365154875|FG003|Overall Study|Withdrawal by Subject|3|||
106066491|NCT02554812|365905566|FG018|Overall Study|Death|1|||
106066492|NCT02554812|365905567|FG019|Overall Study|Death|2|||
106066493|NCT02554812|365905568|FG020|Overall Study|Death|0|||
106066494|NCT02554812|365905569|FG021|Overall Study|Death|1|||
106066495|NCT02554812|365905570|FG022|Overall Study|Death|1|||
106066496|NCT02554812|365905571|FG023|Overall Study|Death|0|||
105865286|NCT00993421|365154876|FG004|Overall Study|Withdrawal by Subject|3|||
105865287|NCT00993421|365154877|FG005|Overall Study|Withdrawal by Subject|5|||
105865288|NCT00993421|365154878|FG006|Overall Study|Withdrawal by Subject|3|||
106066497|NCT02554812|365905572|FG024|Overall Study|Death|0|||
105865289|NCT00993421|365154872|FG000|Overall Study|Death|0|||
106066498|NCT02554812|365905573|FG025|Overall Study|Death|0|||
106066499|NCT02554812|365905574|FG026|Overall Study|Death|0|||
106066500|NCT02554812|365905548|FG000|Overall Study|Lost to Follow-up|0|||
106066501|NCT02554812|365905549|FG001|Overall Study|Lost to Follow-up|1|||
106066502|NCT02554812|365905550|FG002|Overall Study|Lost to Follow-up|0|||
106066503|NCT02554812|365905551|FG003|Overall Study|Lost to Follow-up|0|||
106066504|NCT02554812|365905552|FG004|Overall Study|Lost to Follow-up|0|||
106066505|NCT02554812|365905553|FG005|Overall Study|Lost to Follow-up|0|||
106066506|NCT02554812|365905554|FG006|Overall Study|Lost to Follow-up|0|||
106066507|NCT02554812|365905555|FG007|Overall Study|Lost to Follow-up|0|||
106066508|NCT02554812|365905556|FG008|Overall Study|Lost to Follow-up|0|||
106066509|NCT02554812|365905557|FG009|Overall Study|Lost to Follow-up|0|||
106066510|NCT02554812|365905558|FG010|Overall Study|Lost to Follow-up|0|||
106066511|NCT02554812|365905559|FG011|Overall Study|Lost to Follow-up|0|||
106066512|NCT02554812|365905560|FG012|Overall Study|Lost to Follow-up|0|||
106066513|NCT02554812|365905561|FG013|Overall Study|Lost to Follow-up|0|||
106066514|NCT02554812|365905562|FG014|Overall Study|Lost to Follow-up|0|||
106066515|NCT02554812|365905563|FG015|Overall Study|Lost to Follow-up|0|||
106066516|NCT02554812|365905564|FG016|Overall Study|Lost to Follow-up|0|||
106066517|NCT02554812|365905565|FG017|Overall Study|Lost to Follow-up|0|||
106066518|NCT02554812|365905566|FG018|Overall Study|Lost to Follow-up|0|||
106066519|NCT02554812|365905567|FG019|Overall Study|Lost to Follow-up|0|||
106066520|NCT02554812|365905568|FG020|Overall Study|Lost to Follow-up|0|||
106066521|NCT02554812|365905569|FG021|Overall Study|Lost to Follow-up|0|||
106066522|NCT02554812|365905570|FG022|Overall Study|Lost to Follow-up|0|||
106066523|NCT02554812|365905571|FG023|Overall Study|Lost to Follow-up|0|||
106066524|NCT02554812|365905572|FG024|Overall Study|Lost to Follow-up|0|||
106066525|NCT02554812|365905573|FG025|Overall Study|Lost to Follow-up|0|||
106066526|NCT02554812|365905574|FG026|Overall Study|Lost to Follow-up|0|||
106066527|NCT02554812|365905548|FG000|Overall Study|Global deterioration of health status|4|||
106066528|NCT02554812|365905549|FG001|Overall Study|Global deterioration of health status|3|||
106066529|NCT02554812|365905550|FG002|Overall Study|Global deterioration of health status|3|||
106066530|NCT02554812|365905551|FG003|Overall Study|Global deterioration of health status|2|||
106066531|NCT02554812|365905552|FG004|Overall Study|Global deterioration of health status|5|||
106066532|NCT02554812|365905553|FG005|Overall Study|Global deterioration of health status|0|||
106066533|NCT02554812|365905554|FG006|Overall Study|Global deterioration of health status|2|||
106066534|NCT02554812|365905555|FG007|Overall Study|Global deterioration of health status|1|||
106066535|NCT02554812|365905556|FG008|Overall Study|Global deterioration of health status|1|||
106066536|NCT02554812|365905557|FG009|Overall Study|Global deterioration of health status|1|||
106066537|NCT02554812|365905558|FG010|Overall Study|Global deterioration of health status|2|||
106066538|NCT02554812|365905559|FG011|Overall Study|Global deterioration of health status|1|||
106066539|NCT02554812|365905560|FG012|Overall Study|Global deterioration of health status|0|||
106066540|NCT02554812|365905561|FG013|Overall Study|Global deterioration of health status|0|||
106066541|NCT02554812|365905562|FG014|Overall Study|Global deterioration of health status|0|||
106066542|NCT02554812|365905563|FG015|Overall Study|Global deterioration of health status|1|||
106066543|NCT02554812|365905564|FG016|Overall Study|Global deterioration of health status|0|||
106066544|NCT02554812|365905565|FG017|Overall Study|Global deterioration of health status|0|||
106066545|NCT02554812|365905566|FG018|Overall Study|Global deterioration of health status|0|||
106066546|NCT02554812|365905567|FG019|Overall Study|Global deterioration of health status|0|||
106066547|NCT02554812|365905568|FG020|Overall Study|Global deterioration of health status|0|||
106066548|NCT02554812|365905569|FG021|Overall Study|Global deterioration of health status|0|||
106066549|NCT02554812|365905570|FG022|Overall Study|Global deterioration of health status|0|||
106066550|NCT02554812|365905571|FG023|Overall Study|Global deterioration of health status|0|||
106066551|NCT02554812|365905572|FG024|Overall Study|Global deterioration of health status|0|||
106066552|NCT02554812|365905573|FG025|Overall Study|Global deterioration of health status|0|||
106066553|NCT02554812|365905574|FG026|Overall Study|Global deterioration of health status|0|||
106066554|NCT02554812|365905548|FG000|Overall Study|Progressive disease|20|||
106066555|NCT02554812|365905549|FG001|Overall Study|Progressive disease|16|||
106066556|NCT02554812|365905550|FG002|Overall Study|Progressive disease|19|||
106066557|NCT02554812|365905551|FG003|Overall Study|Progressive disease|18|||
106066558|NCT02554812|365905552|FG004|Overall Study|Progressive disease|21|||
106066559|NCT02554812|365905553|FG005|Overall Study|Progressive disease|15|||
106066560|NCT02554812|365905554|FG006|Overall Study|Progressive disease|6|||
106066561|NCT02554812|365905555|FG007|Overall Study|Progressive disease|13|||
106066562|NCT02554812|365905556|FG008|Overall Study|Progressive disease|6|||
106066563|NCT02554812|365905557|FG009|Overall Study|Progressive disease|6|||
106066564|NCT02554812|365905558|FG010|Overall Study|Progressive disease|8|||
106066565|NCT02554812|365905559|FG011|Overall Study|Progressive disease|8|||
106066566|NCT02554812|365905560|FG012|Overall Study|Progressive disease|6|||
106066567|NCT02554812|365905561|FG013|Overall Study|Progressive disease|10|||
106066568|NCT02554812|365905562|FG014|Overall Study|Progressive disease|20|||
106066569|NCT02554812|365905563|FG015|Overall Study|Progressive disease|6|||
106066570|NCT02554812|365905564|FG016|Overall Study|Progressive disease|3|||
106066571|NCT02554812|365905565|FG017|Overall Study|Progressive disease|3|||
106066572|NCT02554812|365905566|FG018|Overall Study|Progressive disease|11|||
106066573|NCT02554812|365905567|FG019|Overall Study|Progressive disease|7|||
106066574|NCT02554812|365905568|FG020|Overall Study|Progressive disease|11|||
106066575|NCT02554812|365905569|FG021|Overall Study|Progressive disease|6|||
105865290|NCT00993421|365154873|FG001|Overall Study|Death|0|||
106066576|NCT02554812|365905570|FG022|Overall Study|Progressive disease|9|||
106066577|NCT02554812|365905571|FG023|Overall Study|Progressive disease|9|||
106066578|NCT02554812|365905572|FG024|Overall Study|Progressive disease|4|||
106066579|NCT02554812|365905573|FG025|Overall Study|Progressive disease|5|||
106066580|NCT02554812|365905574|FG026|Overall Study|Progressive disease|5|||
106066581|NCT02554812|365905548|FG000|Overall Study|Other|0|||
106066582|NCT02554812|365905549|FG001|Overall Study|Other|0|||
106066583|NCT02554812|365905550|FG002|Overall Study|Other|2|||
106066584|NCT02554812|365905551|FG003|Overall Study|Other|3|||
106066585|NCT02554812|365905552|FG004|Overall Study|Other|2|||
105865291|NCT00993421|365154874|FG002|Overall Study|Death|0|||
105865292|NCT00993421|365154875|FG003|Overall Study|Death|0|||
105865293|NCT00993421|365154876|FG004|Overall Study|Death|0|||
105865294|NCT00993421|365154877|FG005|Overall Study|Death|0|||
105865295|NCT00993421|365154878|FG006|Overall Study|Death|1|||
106066586|NCT02554812|365905553|FG005|Overall Study|Other|1|||
106066587|NCT02554812|365905554|FG006|Overall Study|Other|0|||
106066588|NCT02554812|365905555|FG007|Overall Study|Other|0|||
106066589|NCT02554812|365905556|FG008|Overall Study|Other|1|||
106066590|NCT02554812|365905557|FG009|Overall Study|Other|1|||
106066591|NCT02554812|365905558|FG010|Overall Study|Other|0|||
106066592|NCT02554812|365905559|FG011|Overall Study|Other|0|||
106066593|NCT02554812|365905560|FG012|Overall Study|Other|1|||
106066594|NCT02554812|365905561|FG013|Overall Study|Other|0|||
106066595|NCT02554812|365905562|FG014|Overall Study|Other|1|||
106066596|NCT02554812|365905563|FG015|Overall Study|Other|0|||
106066597|NCT02554812|365905564|FG016|Overall Study|Other|0|||
106066598|NCT02554812|365905565|FG017|Overall Study|Other|0|||
106066599|NCT02554812|365905566|FG018|Overall Study|Other|0|||
106066600|NCT02554812|365905567|FG019|Overall Study|Other|0|||
106066601|NCT02554812|365905568|FG020|Overall Study|Other|0|||
106066602|NCT02554812|365905569|FG021|Overall Study|Other|2|||
106066603|NCT02554812|365905570|FG022|Overall Study|Other|0|||
106066604|NCT02554812|365905571|FG023|Overall Study|Other|0|||
106066605|NCT02554812|365905572|FG024|Overall Study|Other|0|||
106066606|NCT02554812|365905573|FG025|Overall Study|Other|0|||
106066607|NCT02554812|365905574|FG026|Overall Study|Other|0|||
106066608|NCT02554812|365905548|FG000|Overall Study|Withdrawal by Subject|1|||
106066609|NCT02554812|365905549|FG001|Overall Study|Withdrawal by Subject|0|||
106066610|NCT02554812|365905550|FG002|Overall Study|Withdrawal by Subject|0|||
106066611|NCT02554812|365905551|FG003|Overall Study|Withdrawal by Subject|2|||
106066612|NCT02554812|365905552|FG004|Overall Study|Withdrawal by Subject|2|||
106066613|NCT02554812|365905553|FG005|Overall Study|Withdrawal by Subject|3|||
106066614|NCT02554812|365905554|FG006|Overall Study|Withdrawal by Subject|0|||
106066615|NCT02554812|365905555|FG007|Overall Study|Withdrawal by Subject|0|||
106066616|NCT02554812|365905556|FG008|Overall Study|Withdrawal by Subject|1|||
106066617|NCT02554812|365905557|FG009|Overall Study|Withdrawal by Subject|1|||
106066618|NCT02554812|365905558|FG010|Overall Study|Withdrawal by Subject|0|||
106066619|NCT02554812|365905559|FG011|Overall Study|Withdrawal by Subject|1|||
106066620|NCT02554812|365905560|FG012|Overall Study|Withdrawal by Subject|1|||
106066621|NCT02554812|365905561|FG013|Overall Study|Withdrawal by Subject|1|||
106066622|NCT02554812|365905562|FG014|Overall Study|Withdrawal by Subject|1|||
106066623|NCT02554812|365905563|FG015|Overall Study|Withdrawal by Subject|1|||
106066624|NCT02554812|365905564|FG016|Overall Study|Withdrawal by Subject|3|||
106066625|NCT02554812|365905565|FG017|Overall Study|Withdrawal by Subject|1|||
106066626|NCT02554812|365905566|FG018|Overall Study|Withdrawal by Subject|0|||
106066627|NCT02554812|365905567|FG019|Overall Study|Withdrawal by Subject|2|||
106066628|NCT02554812|365905568|FG020|Overall Study|Withdrawal by Subject|0|||
106066629|NCT02554812|365905569|FG021|Overall Study|Withdrawal by Subject|1|||
106066630|NCT02554812|365905570|FG022|Overall Study|Withdrawal by Subject|0|||
106066631|NCT02554812|365905571|FG023|Overall Study|Withdrawal by Subject|1|||
106066632|NCT02554812|365905572|FG024|Overall Study|Withdrawal by Subject|0|||
106066633|NCT02554812|365905573|FG025|Overall Study|Withdrawal by Subject|0|||
106066634|NCT02554812|365905574|FG026|Overall Study|Withdrawal by Subject|1|||
106066635|NCT02554812|365905548|FG000|Overall Study|Physician Decision|1|||
106066636|NCT02554812|365905549|FG001|Overall Study|Physician Decision|0|||
105865296|NCT00993421|365154872|FG000|Overall Study|Entry Criteria Exclusion|0|||
106066637|NCT02554812|365905550|FG002|Overall Study|Physician Decision|0|||
106066638|NCT02554812|365905551|FG003|Overall Study|Physician Decision|1|||
106066639|NCT02554812|365905552|FG004|Overall Study|Physician Decision|0|||
106066640|NCT02554812|365905553|FG005|Overall Study|Physician Decision|1|||
106066641|NCT02554812|365905554|FG006|Overall Study|Physician Decision|0|||
105865297|NCT00993421|365154873|FG001|Overall Study|Entry Criteria Exclusion|0|||
105865298|NCT00993421|365154874|FG002|Overall Study|Entry Criteria Exclusion|1|||
106066642|NCT02554812|365905555|FG007|Overall Study|Physician Decision|0|||
106066643|NCT02554812|365905556|FG008|Overall Study|Physician Decision|0|||
106066644|NCT02554812|365905557|FG009|Overall Study|Physician Decision|0|||
106066645|NCT02554812|365905558|FG010|Overall Study|Physician Decision|1|||
106066646|NCT02554812|365905559|FG011|Overall Study|Physician Decision|0|||
106066647|NCT02554812|365905560|FG012|Overall Study|Physician Decision|0|||
106066648|NCT02554812|365905561|FG013|Overall Study|Physician Decision|0|||
106066649|NCT02554812|365905562|FG014|Overall Study|Physician Decision|0|||
106066650|NCT02554812|365905563|FG015|Overall Study|Physician Decision|0|||
106066651|NCT02554812|365905564|FG016|Overall Study|Physician Decision|1|||
106066652|NCT02554812|365905565|FG017|Overall Study|Physician Decision|1|||
106066653|NCT02554812|365905566|FG018|Overall Study|Physician Decision|0|||
106066654|NCT02554812|365905567|FG019|Overall Study|Physician Decision|1|||
106066655|NCT02554812|365905568|FG020|Overall Study|Physician Decision|1|||
106066656|NCT02554812|365905569|FG021|Overall Study|Physician Decision|0|||
106066657|NCT02554812|365905570|FG022|Overall Study|Physician Decision|1|||
106066658|NCT02554812|365905571|FG023|Overall Study|Physician Decision|0|||
106066659|NCT02554812|365905572|FG024|Overall Study|Physician Decision|0|||
106066660|NCT02554812|365905573|FG025|Overall Study|Physician Decision|0|||
106066661|NCT02554812|365905574|FG026|Overall Study|Physician Decision|0|||
106066662|NCT02554812|365905548|FG000|Overall Study|Study terminated by sponsor|0|||
106066663|NCT02554812|365905549|FG001|Overall Study|Study terminated by sponsor|0|||
106066664|NCT02554812|365905550|FG002|Overall Study|Study terminated by sponsor|0|||
106066665|NCT02554812|365905551|FG003|Overall Study|Study terminated by sponsor|0|||
106066666|NCT02554812|365905552|FG004|Overall Study|Study terminated by sponsor|0|||
106066667|NCT02554812|365905553|FG005|Overall Study|Study terminated by sponsor|0|||
106066668|NCT02554812|365905554|FG006|Overall Study|Study terminated by sponsor|0|||
106066669|NCT02554812|365905555|FG007|Overall Study|Study terminated by sponsor|0|||
106066670|NCT02554812|365905556|FG008|Overall Study|Study terminated by sponsor|0|||
106066671|NCT02554812|365905557|FG009|Overall Study|Study terminated by sponsor|0|||
106066672|NCT02554812|365905558|FG010|Overall Study|Study terminated by sponsor|0|||
106066673|NCT02554812|365905559|FG011|Overall Study|Study terminated by sponsor|0|||
106066674|NCT02554812|365905560|FG012|Overall Study|Study terminated by sponsor|0|||
106066675|NCT02554812|365905561|FG013|Overall Study|Study terminated by sponsor|0|||
106066676|NCT02554812|365905562|FG014|Overall Study|Study terminated by sponsor|0|||
106066677|NCT02554812|365905563|FG015|Overall Study|Study terminated by sponsor|0|||
106066678|NCT02554812|365905564|FG016|Overall Study|Study terminated by sponsor|0|||
106066679|NCT02554812|365905565|FG017|Overall Study|Study terminated by sponsor|0|||
106066680|NCT02554812|365905566|FG018|Overall Study|Study terminated by sponsor|0|||
106066681|NCT02554812|365905567|FG019|Overall Study|Study terminated by sponsor|0|||
106066682|NCT02554812|365905568|FG020|Overall Study|Study terminated by sponsor|0|||
106066683|NCT02554812|365905569|FG021|Overall Study|Study terminated by sponsor|0|||
106066684|NCT02554812|365905570|FG022|Overall Study|Study terminated by sponsor|0|||
106066685|NCT02554812|365905571|FG023|Overall Study|Study terminated by sponsor|0|||
106066686|NCT02554812|365905572|FG024|Overall Study|Study terminated by sponsor|1|||
106066687|NCT02554812|365905573|FG025|Overall Study|Study terminated by sponsor|0|||
106066688|NCT02554812|365905574|FG026|Overall Study|Study terminated by sponsor|0|||
106066689|NCT02554812|365905548|FG000|Overall Study|No longer meets eligibility criteria|0|||
106066690|NCT02554812|365905549|FG001|Overall Study|No longer meets eligibility criteria|1|||
106066691|NCT02554812|365905550|FG002|Overall Study|No longer meets eligibility criteria|0|||
106066692|NCT02554812|365905551|FG003|Overall Study|No longer meets eligibility criteria|0|||
106154389|NCT05419505|366225790|FG007|Overall Study|Withdrawal by Subject|0|||
106066693|NCT02554812|365905552|FG004|Overall Study|No longer meets eligibility criteria|0|||
106066694|NCT02554812|365905553|FG005|Overall Study|No longer meets eligibility criteria|0|||
106066695|NCT02554812|365905554|FG006|Overall Study|No longer meets eligibility criteria|0|||
106066696|NCT02554812|365905555|FG007|Overall Study|No longer meets eligibility criteria|0|||
106066697|NCT02554812|365905556|FG008|Overall Study|No longer meets eligibility criteria|0|||
106066698|NCT02554812|365905557|FG009|Overall Study|No longer meets eligibility criteria|0|||
106066699|NCT02554812|365905558|FG010|Overall Study|No longer meets eligibility criteria|0|||
106066700|NCT02554812|365905559|FG011|Overall Study|No longer meets eligibility criteria|0|||
106066701|NCT02554812|365905560|FG012|Overall Study|No longer meets eligibility criteria|0|||
106066702|NCT02554812|365905561|FG013|Overall Study|No longer meets eligibility criteria|0|||
106066703|NCT02554812|365905562|FG014|Overall Study|No longer meets eligibility criteria|0|||
106066704|NCT02554812|365905563|FG015|Overall Study|No longer meets eligibility criteria|0|||
106066705|NCT02554812|365905564|FG016|Overall Study|No longer meets eligibility criteria|0|||
106066706|NCT02554812|365905565|FG017|Overall Study|No longer meets eligibility criteria|0|||
106066707|NCT02554812|365905566|FG018|Overall Study|No longer meets eligibility criteria|0|||
106066708|NCT02554812|365905567|FG019|Overall Study|No longer meets eligibility criteria|0|||
106066709|NCT02554812|365905568|FG020|Overall Study|No longer meets eligibility criteria|0|||
106066710|NCT02554812|365905569|FG021|Overall Study|No longer meets eligibility criteria|0|||
106066711|NCT02554812|365905570|FG022|Overall Study|No longer meets eligibility criteria|0|||
106066712|NCT02554812|365905571|FG023|Overall Study|No longer meets eligibility criteria|0|||
106154390|NCT05419505|366225783|FG000|Overall Study|Lost to Follow-up|2|||
106066713|NCT02554812|365905572|FG024|Overall Study|No longer meets eligibility criteria|0|||
106066714|NCT02554812|365905573|FG025|Overall Study|No longer meets eligibility criteria|0|||
106154391|NCT05419505|366225784|FG001|Overall Study|Lost to Follow-up|1|||
106154392|NCT05419505|366225785|FG002|Overall Study|Lost to Follow-up|0|||
106154393|NCT05419505|366225786|FG003|Overall Study|Lost to Follow-up|0|||
106154394|NCT05419505|366225787|FG004|Overall Study|Lost to Follow-up|1|||
106066715|NCT02554812|365905574|FG026|Overall Study|No longer meets eligibility criteria|0|||
106066716|NCT00531232|365906900|FG000|Overall Study|Investigator decision|0|||
106066717|NCT00531232|365906901|FG001|Overall Study|Investigator decision|0|||
106066718|NCT00531232|365906902|FG002|Overall Study|Investigator decision|4|||
106066719|NCT00531232|365906900|FG000|Overall Study|Participants refused further treatment|0|||
106066720|NCT00531232|365906901|FG001|Overall Study|Participants refused further treatment|1|||
106066721|NCT00531232|365906902|FG002|Overall Study|Participants refused further treatment|2|||
106066722|NCT00531232|365906900|FG000|Overall Study|Adverse events (AEs)|1|||
106066723|NCT00531232|365906901|FG001|Overall Study|Adverse events (AEs)|2|||
106066724|NCT00531232|365906902|FG002|Overall Study|Adverse events (AEs)|2|||
106066725|NCT00531232|365906900|FG000|Overall Study|Treatment failure|1|||
106066726|NCT00531232|365906901|FG001|Overall Study|Treatment failure|3|||
106066727|NCT00531232|365906902|FG002|Overall Study|Treatment failure|7|||
106066728|NCT00531232|365906900|FG000|Overall Study|Disease recurrence|0|||
106066729|NCT00531232|365906901|FG001|Overall Study|Disease recurrence|0|||
106066730|NCT00531232|365906902|FG002|Overall Study|Disease recurrence|1|||
106066731|NCT00531232|365906900|FG000|Overall Study|Deceased|2|||
106066732|NCT00531232|365906901|FG001|Overall Study|Deceased|2|||
106066733|NCT00531232|365906902|FG002|Overall Study|Deceased|2|||
106066734|NCT00531232|365906900|FG000|Overall Study|Withdrawal by Subject|0|||
106066735|NCT00531232|365906901|FG001|Overall Study|Withdrawal by Subject|1|||
106066736|NCT00531232|365906902|FG002|Overall Study|Withdrawal by Subject|2|||
106066737|NCT00531232|365906900|FG000|Overall Study|Other|0|||
106066738|NCT00531232|365906901|FG001|Overall Study|Other|0|||
106066739|NCT00531232|365906902|FG002|Overall Study|Other|5|||
106066740|NCT02762266|365906903|FG000|Overall Study|Physician Decision|2|||
106066741|NCT02762266|365906904|FG001|Overall Study|Physician Decision|0|||
106066742|NCT00463346|365906910|FG000|Overall Study|Withdrawal by Subject|3|||
106066743|NCT00463346|365906911|FG001|Overall Study|Withdrawal by Subject|3|||
106066744|NCT03641651|365906913|FG000|Overall Study|organizational issues at one study site|1|||
106066745|NCT03010254|365906914|FG000|Overall Study|Adverse Event|0|||
106066746|NCT03010254|365906915|FG001|Overall Study|Adverse Event|1|||
106066747|NCT03010254|365906914|FG000|Overall Study|Lost to Follow-up|4|||
106066748|NCT03010254|365906915|FG001|Overall Study|Lost to Follow-up|0|||
106066749|NCT03010254|365906914|FG000|Overall Study|Withdrawal by Subject|1|||
106066750|NCT03010254|365906915|FG001|Overall Study|Withdrawal by Subject|1|||
106066751|NCT03010254|365906914|FG000|Overall Study|Other|2|||
106066752|NCT03010254|365906915|FG001|Overall Study|Other|3|||
106066753|NCT00951665|365906916|FG000|Phase 1b|Adverse Event|2|||
106066754|NCT00951665|365906917|FG001|Phase 1b|Adverse Event|1|||
106066755|NCT00951665|365906918|FG002|Phase 1b|Adverse Event|0|||
106066756|NCT00951665|365906919|FG003|Phase 1b|Adverse Event|1|||
106066757|NCT00951665|365906920|FG004|Phase 1b|Adverse Event|0|||
106066758|NCT00951665|365906921|FG005|Phase 1b|Adverse Event|0|||
106066759|NCT00951665|365906916|FG000|Phase 1b|Death|1|||
106066760|NCT00951665|365906917|FG001|Phase 1b|Death|0|||
106066761|NCT00951665|365906918|FG002|Phase 1b|Death|2|||
106066762|NCT00951665|365906919|FG003|Phase 1b|Death|0|||
106066763|NCT00951665|365906920|FG004|Phase 1b|Death|0|||
106066764|NCT00951665|365906921|FG005|Phase 1b|Death|0|||
106066765|NCT00951665|365906916|FG000|Phase 1b|Physician Decision|4|||
106066766|NCT00951665|365906917|FG001|Phase 1b|Physician Decision|0|||
106066767|NCT00951665|365906918|FG002|Phase 1b|Physician Decision|1|||
106066768|NCT00951665|365906919|FG003|Phase 1b|Physician Decision|0|||
106066769|NCT00951665|365906920|FG004|Phase 1b|Physician Decision|0|||
106066770|NCT00951665|365906921|FG005|Phase 1b|Physician Decision|0|||
106066771|NCT00951665|365906916|FG000|Phase 1b|Withdrawal by Subject|0|||
106066772|NCT00951665|365906917|FG001|Phase 1b|Withdrawal by Subject|1|||
106066773|NCT00951665|365906918|FG002|Phase 1b|Withdrawal by Subject|0|||
106066774|NCT00951665|365906919|FG003|Phase 1b|Withdrawal by Subject|0|||
106066775|NCT00951665|365906920|FG004|Phase 1b|Withdrawal by Subject|0|||
106066776|NCT00951665|365906921|FG005|Phase 1b|Withdrawal by Subject|0|||
106066777|NCT00951665|365906916|FG000|Phase 1b|Disease Progression|13|||
106066778|NCT00951665|365906917|FG001|Phase 1b|Disease Progression|2|||
106066779|NCT00951665|365906918|FG002|Phase 1b|Disease Progression|14|||
106066780|NCT00951665|365906919|FG003|Phase 1b|Disease Progression|0|||
106066781|NCT00951665|365906920|FG004|Phase 1b|Disease Progression|0|||
106066782|NCT00951665|365906921|FG005|Phase 1b|Disease Progression|0|||
106066783|NCT00951665|365906916|FG000|Phase 1b|Protocol Violation|2|||
106066784|NCT00951665|365906917|FG001|Phase 1b|Protocol Violation|0|||
106066785|NCT00951665|365906918|FG002|Phase 1b|Protocol Violation|0|||
106066786|NCT00951665|365906919|FG003|Phase 1b|Protocol Violation|0|||
106066787|NCT00951665|365906920|FG004|Phase 1b|Protocol Violation|0|||
106066788|NCT00951665|365906921|FG005|Phase 1b|Protocol Violation|0|||
106066789|NCT00951665|365906916|FG000|Phase 2a|Adverse Event|0|||
106066790|NCT00951665|365906917|FG001|Phase 2a|Adverse Event|0|||
106066791|NCT00951665|365906918|FG002|Phase 2a|Adverse Event|0|||
106066792|NCT00951665|365906919|FG003|Phase 2a|Adverse Event|0|||
106066793|NCT00951665|365906920|FG004|Phase 2a|Adverse Event|2|||
106066794|NCT00951665|365906921|FG005|Phase 2a|Adverse Event|0|||
106066795|NCT00951665|365906916|FG000|Phase 2a|Death|0|||
106066796|NCT00951665|365906917|FG001|Phase 2a|Death|0|||
106066797|NCT00951665|365906918|FG002|Phase 2a|Death|0|||
106066798|NCT00951665|365906919|FG003|Phase 2a|Death|0|||
106066799|NCT00951665|365906920|FG004|Phase 2a|Death|1|||
106066800|NCT00951665|365906921|FG005|Phase 2a|Death|1|||
106066801|NCT00951665|365906916|FG000|Phase 2a|Lost to Follow-up|0|||
106066802|NCT00951665|365906917|FG001|Phase 2a|Lost to Follow-up|0|||
106066803|NCT00951665|365906918|FG002|Phase 2a|Lost to Follow-up|0|||
106066804|NCT00951665|365906919|FG003|Phase 2a|Lost to Follow-up|0|||
106066805|NCT00951665|365906920|FG004|Phase 2a|Lost to Follow-up|1|||
106066806|NCT00951665|365906921|FG005|Phase 2a|Lost to Follow-up|0|||
106066807|NCT00951665|365906916|FG000|Phase 2a|Physician Decision|0|||
106066808|NCT00951665|365906917|FG001|Phase 2a|Physician Decision|0|||
106066809|NCT00951665|365906918|FG002|Phase 2a|Physician Decision|0|||
106066810|NCT00951665|365906919|FG003|Phase 2a|Physician Decision|0|||
106066811|NCT00951665|365906920|FG004|Phase 2a|Physician Decision|0|||
106066812|NCT00951665|365906921|FG005|Phase 2a|Physician Decision|1|||
106066813|NCT00951665|365906916|FG000|Phase 2a|Withdrawal by Subject|0|||
106066814|NCT00951665|365906917|FG001|Phase 2a|Withdrawal by Subject|0|||
106066815|NCT00951665|365906918|FG002|Phase 2a|Withdrawal by Subject|0|||
106066816|NCT00951665|365906919|FG003|Phase 2a|Withdrawal by Subject|0|||
106154395|NCT05419505|366225788|FG005|Overall Study|Lost to Follow-up|2|||
106154396|NCT05419505|366225789|FG006|Overall Study|Lost to Follow-up|0|||
106154397|NCT05419505|366225790|FG007|Overall Study|Lost to Follow-up|1|||
106154398|NCT03358875|366225791|FG000|Overall Study|Death|409|||
106154399|NCT03358875|366225792|FG001|Overall Study|Death|223|||
106154400|NCT03358875|366225791|FG000|Overall Study|Study Closed by Sponsor|66|||
106154401|NCT03358875|366225792|FG001|Overall Study|Study Closed by Sponsor|29|||
106066817|NCT00951665|365906920|FG004|Phase 2a|Withdrawal by Subject|2|||
106066818|NCT00951665|365906921|FG005|Phase 2a|Withdrawal by Subject|0|||
106066819|NCT00951665|365906916|FG000|Phase 2a|Disease Progression|0|||
106066820|NCT00951665|365906917|FG001|Phase 2a|Disease Progression|0|||
106066821|NCT00951665|365906918|FG002|Phase 2a|Disease Progression|0|||
106066822|NCT00951665|365906919|FG003|Phase 2a|Disease Progression|0|||
106066823|NCT00951665|365906920|FG004|Phase 2a|Disease Progression|6|||
106066824|NCT00951665|365906921|FG005|Phase 2a|Disease Progression|5|||
106066825|NCT04317066|365906922|FG000|Overall Study|Sponsor decision|5|||
106066826|NCT04317066|365906922|FG000|Overall Study|Death|2|||
106066827|NCT03804879|365906930|FG000|Overall Study|Adverse Event|3|||
106066828|NCT03804879|365906931|FG001|Overall Study|Adverse Event|0|||
106066829|NCT03804879|365906930|FG000|Overall Study|Study Terminated By Sponsor|10|||
106066830|NCT03804879|365906931|FG001|Overall Study|Study Terminated By Sponsor|12|||
106066831|NCT03804879|365906930|FG000|Overall Study|Withdrawal by Subject|3|||
106154402|NCT03358875|366225791|FG000|Overall Study|Withdrawal by Subject|13|||
106154403|NCT03358875|366225792|FG001|Overall Study|Withdrawal by Subject|16|||
106154404|NCT03358875|366225791|FG000|Overall Study|Lost to Follow-up|13|||
106154405|NCT03358875|366225792|FG001|Overall Study|Lost to Follow-up|2|||
106154406|NCT03358875|366225791|FG000|Overall Study|Miscellaneous|33|||
106154407|NCT03358875|366225792|FG001|Overall Study|Miscellaneous|0|||
106154408|NCT03358875|366225791|FG000|Overall Study|Remained on Study|1|||
106066832|NCT03804879|365906931|FG001|Overall Study|Withdrawal by Subject|1|||
106066833|NCT00708643|365906932|FG000|Overall Study|Adverse Event|0|||
106066834|NCT00708643|365906933|FG001|Overall Study|Adverse Event|1|||
106066835|NCT00788151|365906934|FG000|Overall Study|Other adverse event|0|||
106066836|NCT00788151|365906935|FG001|Overall Study|Other adverse event|2|||
106066837|NCT00788151|365906934|FG000|Overall Study|Protocol Violation|0|||
106066838|NCT00788151|365906935|FG001|Overall Study|Protocol Violation|1|||
106066839|NCT00788151|365906934|FG000|Overall Study|Withdrawal by Subject|13|||
106154409|NCT03358875|366225792|FG001|Overall Study|Remained on Study|0|||
106154410|NCT04855760|366225793|FG000|Overall Study|Adverse Event|21|||
106154411|NCT04855760|366225793|FG000|Overall Study|Withdrawal by Subject|116|||
106154412|NCT04855760|366225793|FG000|Overall Study|Lack of Efficacy|21|||
106154413|NCT04855760|366225793|FG000|Overall Study|Lost to Follow-up|49|||
106154414|NCT04855760|366225793|FG000|Overall Study|Protocol Violation|2|||
106154415|NCT04855760|366225793|FG000|Overall Study|Physician Decision|5|||
106154416|NCT04855760|366225793|FG000|Overall Study|Pregnancy|1|||
106154417|NCT04855760|366225793|FG000|Overall Study|Non-Compliance with Study Drug|11|||
106154418|NCT04855760|366225793|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
106154419|NCT04855760|366225793|FG000|Overall Study|Study Completed by Sponsor|202|||
106154420|NCT04855760|366225793|FG000|Overall Study|Other|13|||
106154421|NCT04732494|366225810|FG000|Overall Study|Death|39|||
106154422|NCT04732494|366225811|FG001|Overall Study|Death|36|||
106154423|NCT04732494|366225810|FG000|Overall Study|Study Closed by Sponsor|20|||
106154424|NCT04732494|366225811|FG001|Overall Study|Study Closed by Sponsor|15|||
106154425|NCT04732494|366225810|FG000|Overall Study|Withdrawal by Subject|2|||
106154426|NCT04732494|366225811|FG001|Overall Study|Withdrawal by Subject|7|||
106154427|NCT04732494|366225810|FG000|Overall Study|Lost to Follow-up|1|||
106154428|NCT04732494|366225811|FG001|Overall Study|Lost to Follow-up|5|||
106154429|NCT03055858|366225812|FG000|Overall Study|Death|9|||
106154430|NCT03055858|366225812|FG000|Overall Study|Withdrawal by Subject|11|||
106154431|NCT03055858|366225812|FG000|Overall Study|Lost to Follow-up|6|||
106154432|NCT03055858|366225812|FG000|Overall Study|Missed Follow-Up Visits|18|||
106066840|NCT00788151|365906935|FG001|Overall Study|Withdrawal by Subject|6|||
106066841|NCT00788151|365906934|FG000|Overall Study|Enrolled but not treated|1|||
106066842|NCT00788151|365906935|FG001|Overall Study|Enrolled but not treated|1|||
106066843|NCT01647282|365906938|FG000|Overall Study|Physician Decision|7|||
106066844|NCT01647282|365906939|FG001|Overall Study|Physician Decision|5|||
106066845|NCT00227903|365906940|FG000|Overall Study|Withdrawal by Subject|2|||
106066846|NCT00227903|365906941|FG001|Overall Study|Withdrawal by Subject|5|||
106066847|NCT00227903|365906940|FG000|Overall Study|Subject moved out of area|1|||
106154433|NCT05288283|366225814|FG000|Overall Study|Study Terminated Early|1|||
106154434|NCT05288283|366225815|FG001|Overall Study|Study Terminated Early|1|||
106154435|NCT05086744|366225817|FG000|Part A|Adverse Event|0|||
106154436|NCT05086744|366225818|FG001|Part A|Adverse Event|1|||
106154437|NCT05086744|366225817|FG000|Part A|Lack of Efficacy|3|||
106066848|NCT00227903|365906941|FG001|Overall Study|Subject moved out of area|2|||
106066849|NCT00227903|365906940|FG000|Overall Study|Lost to Follow-up|1|||
106154438|NCT05086744|366225818|FG001|Part A|Lack of Efficacy|0|||
106154439|NCT05086744|366225817|FG000|Part A|Protocol deviation|1|||
106154440|NCT05086744|366225818|FG001|Part A|Protocol deviation|0|||
106154441|NCT05086744|366225817|FG000|Part A|Subject decision|1|||
106154442|NCT05086744|366225818|FG001|Part A|Subject decision|0|||
106154443|NCT05086744|366225817|FG000|Part B|Adverse Event|0|||
106154444|NCT05086744|366225818|FG001|Part B|Adverse Event|1|||
106154445|NCT05086744|366225817|FG000|Part B|Lack of Efficacy|0|||
106154446|NCT05086744|366225818|FG001|Part B|Lack of Efficacy|1|||
106154447|NCT05086744|366225817|FG000|Part B|Study terminated by sponsor|1|||
106154448|NCT05086744|366225818|FG001|Part B|Study terminated by sponsor|6|||
106154449|NCT05415436|366225819|FG000|Overall Study|Surgeon cancelled procedure|1|||
106154450|NCT05415436|366225820|FG001|Overall Study|Surgeon cancelled procedure|0|||
106154451|NCT05415436|366225819|FG000|Overall Study|Death|1|||
106154452|NCT05415436|366225820|FG001|Overall Study|Death|0|||
106154453|NCT01704079|366225824|FG000|Overall Study|Withdrawal by Subject|5|||
106154454|NCT01704079|366225825|FG001|Overall Study|Withdrawal by Subject|7|||
106154455|NCT01704079|366225824|FG000|Overall Study|Lost to Follow-up|2|||
106154456|NCT01704079|366225825|FG001|Overall Study|Lost to Follow-up|5|||
106154457|NCT01704079|366225824|FG000|Overall Study|Adverse Event|4|||
106154458|NCT01704079|366225825|FG001|Overall Study|Adverse Event|7|||
106154459|NCT01704079|366225824|FG000|Overall Study|Protocol Violation|1|||
105865299|NCT00993421|365154875|FG003|Overall Study|Entry Criteria Exclusion|3|||
105865300|NCT00993421|365154876|FG004|Overall Study|Entry Criteria Exclusion|0|||
105865301|NCT00993421|365154877|FG005|Overall Study|Entry Criteria Exclusion|1|||
105865302|NCT00993421|365154878|FG006|Overall Study|Entry Criteria Exclusion|0|||
105865303|NCT00993421|365154872|FG000|Overall Study|Physician Decision|0|||
105865304|NCT00993421|365154873|FG001|Overall Study|Physician Decision|0|||
105865305|NCT00993421|365154874|FG002|Overall Study|Physician Decision|0|||
105865306|NCT00993421|365154875|FG003|Overall Study|Physician Decision|0|||
105865307|NCT00993421|365154876|FG004|Overall Study|Physician Decision|0|||
105865308|NCT00993421|365154877|FG005|Overall Study|Physician Decision|1|||
105865309|NCT00993421|365154878|FG006|Overall Study|Physician Decision|1|||
105865310|NCT00993421|365154872|FG000|Overall Study|Protocol Violation|0|||
105865311|NCT00993421|365154873|FG001|Overall Study|Protocol Violation|0|||
105865312|NCT00993421|365154874|FG002|Overall Study|Protocol Violation|0|||
105865313|NCT00993421|365154875|FG003|Overall Study|Protocol Violation|0|||
105865314|NCT00993421|365154876|FG004|Overall Study|Protocol Violation|0|||
105865315|NCT00993421|365154877|FG005|Overall Study|Protocol Violation|2|||
105865316|NCT00993421|365154878|FG006|Overall Study|Protocol Violation|1|||
105865317|NCT02447744|365154879|FG000|Overall Study|Withdrawal by Subject|3|||
105865318|NCT02447744|365154880|FG001|Overall Study|Withdrawal by Subject|1|||
105865319|NCT02447744|365154879|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
105865320|NCT02447744|365154880|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
105865321|NCT03408639|365156761|FG000|Overall Study|Death|5|||
105865322|NCT03408639|365156762|FG001|Overall Study|Death|5|||
105865323|NCT03408639|365156761|FG000|Overall Study|Lost to Follow-up|1|||
105865324|NCT03408639|365156762|FG001|Overall Study|Lost to Follow-up|4|||
105865325|NCT03408639|365156761|FG000|Overall Study|Withdrawal by Subject|2|||
105865326|NCT03408639|365156762|FG001|Overall Study|Withdrawal by Subject|7|||
105865327|NCT03408639|365156761|FG000|Overall Study|Physician Decision|3|||
105865328|NCT03408639|365156762|FG001|Overall Study|Physician Decision|6|||
105865329|NCT02856802|365156765|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
105865330|NCT02856802|365156766|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
105865331|NCT02856802|365156765|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
106066850|NCT00227903|365906941|FG001|Overall Study|Lost to Follow-up|3|||
106066851|NCT00227903|365906940|FG000|Overall Study|Miscarriage|1|||
105865332|NCT02856802|365156766|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
106154460|NCT01704079|366225825|FG001|Overall Study|Protocol Violation|0|||
106154461|NCT01704079|366225824|FG000|Overall Study|Subject noncompliance|2|||
106154462|NCT01704079|366225825|FG001|Overall Study|Subject noncompliance|3|||
106154463|NCT01704079|366225824|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
106154464|NCT01704079|366225825|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
106154465|NCT05986565|366225828|FG000|Overall Study|Lost to Follow-up|8|||
106066852|NCT00227903|365906941|FG001|Overall Study|Miscarriage|0|||
106066853|NCT02345811|365906942|FG000|First Intervention|Withdrawal by Subject|1|||
106066854|NCT02345811|365906943|FG001|First Intervention|Withdrawal by Subject|1|||
106066855|NCT01244906|365906944|FG000|Overall Study|Death|2|||
106066856|NCT01244906|365906944|FG000|Overall Study|Progression of disease post treatment|6|||
106066857|NCT00849381|365906946|FG000|Overall Study|Adverse Event|1|||
106066858|NCT00849381|365906946|FG000|Overall Study|Lost to Follow-up|129|||
106066859|NCT00849381|365906946|FG000|Overall Study|Protocol Violation|5|||
106066860|NCT00849381|365906946|FG000|Overall Study|Withdrawal by Subject|6|||
106066861|NCT00849381|365906946|FG000|Overall Study|Other|4|||
106066862|NCT00723892|365906947|FG000|Overall Study|Participant not tracked|33|||
106066863|NCT00723892|365906948|FG001|Overall Study|Participant not tracked|35|||
106066864|NCT00723892|365906947|FG000|Overall Study|Virological criterion|24|||
106066865|NCT00723892|365906948|FG001|Overall Study|Virological criterion|9|||
106066866|NCT00723892|365906947|FG000|Overall Study|Withdrawal by Subject|6|||
106066867|NCT00723892|365906948|FG001|Overall Study|Withdrawal by Subject|9|||
106066868|NCT00723892|365906947|FG000|Overall Study|End planned|11|||
106066869|NCT00723892|365906948|FG001|Overall Study|End planned|7|||
106066870|NCT00723892|365906947|FG000|Overall Study|Bad tolerance|5|||
106066871|NCT00723892|365906948|FG001|Overall Study|Bad tolerance|5|||
106066872|NCT00723892|365906947|FG000|Overall Study|Multiple reasons|17|||
106066873|NCT00723892|365906948|FG001|Overall Study|Multiple reasons|12|||
106066874|NCT00723892|365906947|FG000|Overall Study|Other|6|||
106066875|NCT00723892|365906948|FG001|Overall Study|Other|3|||
106066876|NCT00723892|365906947|FG000|Overall Study|Study end|1|||
106066877|NCT00723892|365906948|FG001|Overall Study|Study end|3|||
106066878|NCT00723892|365906947|FG000|Overall Study|Weight loss|1|||
106066879|NCT00723892|365906948|FG001|Overall Study|Weight loss|3|||
106066880|NCT00723892|365906947|FG000|Overall Study|Alcohol abuse|0|||
106066881|NCT00723892|365906948|FG001|Overall Study|Alcohol abuse|1|||
106066882|NCT00723892|365906947|FG000|Overall Study|Intercurrent infection|2|||
106066883|NCT00723892|365906948|FG001|Overall Study|Intercurrent infection|0|||
106066884|NCT00723892|365906947|FG000|Overall Study|Drug addiction|1|||
106066885|NCT00723892|365906948|FG001|Overall Study|Drug addiction|0|||
106066886|NCT00303498|365906949|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
106066887|NCT00303498|365906950|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
106066888|NCT00303498|365906949|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
106066889|NCT00303498|365906950|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
106066890|NCT00303498|365906949|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
106066891|NCT00303498|365906950|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
106066892|NCT00303498|365906949|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
106066893|NCT00303498|365906950|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
106066894|NCT00303498|365906949|FG000|Run-In-Phase (10 Weeks)|Other|4|||
106066895|NCT00303498|365906950|FG001|Run-In-Phase (10 Weeks)|Other|1|||
106066896|NCT00303498|365906949|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
106066897|NCT00303498|365906950|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
106066898|NCT00303498|365906949|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
106066899|NCT00303498|365906950|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
106066900|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
106066901|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
106066902|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Death|1|||
106066903|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Death|0|||
106066904|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
106066905|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
106066906|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
106154466|NCT05986565|366225829|FG001|Overall Study|Lost to Follow-up|3|||
106154467|NCT05986565|366225828|FG000|Overall Study|Withdrawal by Subject|0|||
106154468|NCT05986565|366225829|FG001|Overall Study|Withdrawal by Subject|1|||
106154469|NCT03775109|366225830|FG000|Overall Study|Adverse Event|1|||
106154470|NCT03775109|366225831|FG001|Overall Study|Adverse Event|0|||
106154471|NCT03775109|366225830|FG000|Overall Study|COVID-19 outbreak|2|||
106154472|NCT03775109|366225831|FG001|Overall Study|COVID-19 outbreak|0|||
106154473|NCT03775109|366225830|FG000|Overall Study|Lost to Follow-up|0|||
106154474|NCT03775109|366225831|FG001|Overall Study|Lost to Follow-up|2|||
106154475|NCT03775109|366225830|FG000|Overall Study|Withdrawal by Subject|1|||
106154476|NCT03775109|366225831|FG001|Overall Study|Withdrawal by Subject|1|||
106154477|NCT03775109|366225830|FG000|Overall Study|Death|0|||
106154478|NCT03775109|366225831|FG001|Overall Study|Death|1|||
106154479|NCT03775109|366225830|FG000|Overall Study|Lack of Efficacy|1|||
106154480|NCT03775109|366225831|FG001|Overall Study|Lack of Efficacy|0|||
106154481|NCT03089398|366225835|FG000|Overall Study|Death|4|||
106154482|NCT03089398|366225836|FG001|Overall Study|Death|9|||
106154483|NCT03089398|366225835|FG000|Overall Study|Lost to Follow-up|21|||
106154484|NCT03089398|366225836|FG001|Overall Study|Lost to Follow-up|30|||
106154485|NCT03089398|366225835|FG000|Overall Study|Withdrawal by Subject|2|||
106154486|NCT03089398|366225836|FG001|Overall Study|Withdrawal by Subject|2|||
106066907|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
106066908|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
106066909|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
106066910|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
106066911|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
106066912|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Other|1|||
106066913|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Other|0|||
106066914|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
106066915|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
106066916|NCT00303498|365906949|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
106066917|NCT00303498|365906950|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
106066918|NCT02618434|365906951|FG000|Overall Study|Withdrawal by Subject|0|||
106066919|NCT02618434|365906952|FG001|Overall Study|Withdrawal by Subject|2|||
106066920|NCT02618434|365906953|FG002|Overall Study|Withdrawal by Subject|3|||
106066921|NCT02618434|365906951|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
106066922|NCT02618434|365906952|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
106066923|NCT02618434|365906953|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
106066924|NCT02618434|365906951|FG000|Overall Study|Lost to Follow-up|3|||
106066925|NCT02618434|365906952|FG001|Overall Study|Lost to Follow-up|1|||
106066926|NCT02618434|365906953|FG002|Overall Study|Lost to Follow-up|3|||
106066927|NCT02618434|365906951|FG000|Overall Study|Adverse Event|1|||
106066928|NCT02618434|365906952|FG001|Overall Study|Adverse Event|0|||
106066929|NCT02618434|365906953|FG002|Overall Study|Adverse Event|12|||
106066930|NCT02618434|365906951|FG000|Overall Study|Physician Decision|0|||
106066931|NCT02618434|365906952|FG001|Overall Study|Physician Decision|1|||
106066932|NCT02618434|365906953|FG002|Overall Study|Physician Decision|0|||
106066933|NCT02618434|365906951|FG000|Overall Study|Protocol Violation|0|||
106066934|NCT02618434|365906952|FG001|Overall Study|Protocol Violation|0|||
106066935|NCT02618434|365906953|FG002|Overall Study|Protocol Violation|1|||
106066936|NCT02618434|365906951|FG000|Overall Study|Other, Multiple categories|1|||
106066937|NCT02618434|365906952|FG001|Overall Study|Other, Multiple categories|1|||
106066938|NCT02618434|365906953|FG002|Overall Study|Other, Multiple categories|1|||
106066939|NCT03590041|365906954|FG000|Overall Study|Protocol Violation|4|||
106066940|NCT03590041|365906955|FG001|Overall Study|Protocol Violation|3|||
106066941|NCT03590041|365906954|FG000|Overall Study|No session data recorded|14|||
106066942|NCT03590041|365906955|FG001|Overall Study|No session data recorded|2|||
106066943|NCT02772081|365906958|FG000|Overall Study|Physician Decision|1|||
106066944|NCT02772081|365906959|FG001|Overall Study|Physician Decision|1|||
106066945|NCT02772081|365906958|FG000|Overall Study|Death|1|||
106066946|NCT02772081|365906959|FG001|Overall Study|Death|1|||
106066947|NCT00498602|365906962|FG000|Overall Study|Death|0|||
106066948|NCT00498602|365906963|FG001|Overall Study|Death|0|||
106066949|NCT00498602|365906964|FG002|Overall Study|Death|0|||
106066950|NCT00498602|365906965|FG003|Overall Study|Death|0|||
106066951|NCT00498602|365906966|FG004|Overall Study|Death|0|||
106066952|NCT00498602|365906967|FG005|Overall Study|Death|1|||
106066953|NCT00498602|365906968|FG006|Overall Study|Death|0|||
106066954|NCT00498602|365906962|FG000|Overall Study|Lack of Efficacy|1|||
106066955|NCT00498602|365906963|FG001|Overall Study|Lack of Efficacy|0|||
106066956|NCT00498602|365906964|FG002|Overall Study|Lack of Efficacy|0|||
106066957|NCT00498602|365906965|FG003|Overall Study|Lack of Efficacy|0|||
106066958|NCT00498602|365906966|FG004|Overall Study|Lack of Efficacy|0|||
106066959|NCT00498602|365906967|FG005|Overall Study|Lack of Efficacy|0|||
106066960|NCT00498602|365906968|FG006|Overall Study|Lack of Efficacy|0|||
106066961|NCT00498602|365906962|FG000|Overall Study|Lost to Follow-up|0|||
106066962|NCT00498602|365906963|FG001|Overall Study|Lost to Follow-up|2|||
106066963|NCT00498602|365906964|FG002|Overall Study|Lost to Follow-up|0|||
106066964|NCT00498602|365906965|FG003|Overall Study|Lost to Follow-up|2|||
106066965|NCT00498602|365906966|FG004|Overall Study|Lost to Follow-up|0|||
106154487|NCT02300298|366225837|FG000|Disposition for Nintedanib|Progressive disease|10|||
106154488|NCT02300298|366225838|FG001|Disposition for Nintedanib|Progressive disease|0|||
106154489|NCT02300298|366225837|FG000|Disposition for Docetaxel|Progressive disease|0|||
106154490|NCT02300298|366225838|FG001|Disposition for Docetaxel|Progressive disease|6|||
106154491|NCT02300298|366225837|FG000|Disposition for Docetaxel|other adverse event|0|||
106154492|NCT02300298|366225838|FG001|Disposition for Docetaxel|other adverse event|4|||
106154493|NCT00150813|366225839|FG000|Overall Study|Adverse Event|1|||
106154494|NCT00150813|366225839|FG000|Overall Study|Lack of Efficacy|1|||
106154495|NCT00150813|366225839|FG000|Overall Study|Lost to Follow-up|5|||
106066966|NCT00498602|365906967|FG005|Overall Study|Lost to Follow-up|0|||
106066967|NCT00498602|365906968|FG006|Overall Study|Lost to Follow-up|0|||
106066968|NCT00498602|365906962|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
106066969|NCT00498602|365906963|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
106066970|NCT00498602|365906964|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
106066971|NCT00498602|365906965|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
106154496|NCT00150813|366225839|FG000|Overall Study|Withdrawal by Subject|5|||
105865333|NCT02856802|365156765|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
105865334|NCT02856802|365156766|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
105865335|NCT02856802|365156765|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
105865336|NCT02856802|365156766|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
105865337|NCT02856802|365156765|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
105865338|NCT02856802|365156766|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
105865339|NCT02856802|365156765|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
106066972|NCT00498602|365906966|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
106066973|NCT00498602|365906967|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
106066974|NCT00498602|365906968|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
106066975|NCT00498602|365906962|FG000|Overall Study|AE not related to Study Drug|1|||
106066976|NCT00498602|365906963|FG001|Overall Study|AE not related to Study Drug|3|||
105865340|NCT02856802|365156766|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
105865341|NCT04138043|365156767|FG000|Overall Study|Withdrawal by Subject|0|||
105865342|NCT04138043|365156768|FG001|Overall Study|Withdrawal by Subject|1|||
105865343|NCT02755649|365156772|FG000|Overall Study|Transitioned into OLE study|99|||
105865344|NCT02755649|365156773|FG001|Overall Study|Transitioned into OLE study|98|||
105865345|NCT02755649|365156774|FG002|Overall Study|Transitioned into OLE study|100|||
105865346|NCT02755649|365156772|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
106066977|NCT00498602|365906964|FG002|Overall Study|AE not related to Study Drug|0|||
106066978|NCT00498602|365906965|FG003|Overall Study|AE not related to Study Drug|0|||
106066979|NCT00498602|365906966|FG004|Overall Study|AE not related to Study Drug|2|||
106066980|NCT00498602|365906967|FG005|Overall Study|AE not related to Study Drug|2|||
105865347|NCT02755649|365156773|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
105865348|NCT02755649|365156774|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
106066981|NCT00498602|365906968|FG006|Overall Study|AE not related to Study Drug|1|||
106066982|NCT00498602|365906962|FG000|Overall Study|Caregiver Request|2|||
106066983|NCT00498602|365906963|FG001|Overall Study|Caregiver Request|2|||
106066984|NCT00498602|365906964|FG002|Overall Study|Caregiver Request|2|||
106066985|NCT00498602|365906965|FG003|Overall Study|Caregiver Request|0|||
106066986|NCT00498602|365906966|FG004|Overall Study|Caregiver Request|1|||
106066987|NCT00498602|365906967|FG005|Overall Study|Caregiver Request|2|||
106066988|NCT00498602|365906968|FG006|Overall Study|Caregiver Request|0|||
106066989|NCT00498602|365906962|FG000|Overall Study|Investigator Request|0|||
106066990|NCT00498602|365906963|FG001|Overall Study|Investigator Request|0|||
106066991|NCT00498602|365906964|FG002|Overall Study|Investigator Request|1|||
106066992|NCT00498602|365906965|FG003|Overall Study|Investigator Request|0|||
106066993|NCT00498602|365906966|FG004|Overall Study|Investigator Request|0|||
106066994|NCT00498602|365906967|FG005|Overall Study|Investigator Request|0|||
106066995|NCT00498602|365906968|FG006|Overall Study|Investigator Request|0|||
106066996|NCT00498602|365906962|FG000|Overall Study|Subject Request|3|||
106066997|NCT00498602|365906963|FG001|Overall Study|Subject Request|0|||
106066998|NCT00498602|365906964|FG002|Overall Study|Subject Request|1|||
106066999|NCT00498602|365906965|FG003|Overall Study|Subject Request|1|||
106067000|NCT00498602|365906966|FG004|Overall Study|Subject Request|1|||
106067001|NCT00498602|365906967|FG005|Overall Study|Subject Request|4|||
106067002|NCT00498602|365906968|FG006|Overall Study|Subject Request|1|||
106067003|NCT00498602|365906962|FG000|Overall Study|Other|2|||
106067004|NCT00498602|365906963|FG001|Overall Study|Other|3|||
106067005|NCT00498602|365906964|FG002|Overall Study|Other|1|||
106067006|NCT00498602|365906965|FG003|Overall Study|Other|0|||
106067007|NCT00498602|365906966|FG004|Overall Study|Other|0|||
106067008|NCT00498602|365906967|FG005|Overall Study|Other|3|||
106067009|NCT00498602|365906968|FG006|Overall Study|Other|0|||
106067010|NCT03103919|365906972|FG000|Overall Study|Adverse Event|2|||
106067011|NCT03103919|365906973|FG001|Overall Study|Adverse Event|2|||
106067012|NCT00546637|365906974|FG000|Overall Study|Adverse Event|46|||
106067013|NCT00546637|365906975|FG001|Overall Study|Adverse Event|20|||
106067014|NCT00546637|365906974|FG000|Overall Study|Lack of Efficacy|5|||
106067015|NCT00546637|365906975|FG001|Overall Study|Lack of Efficacy|5|||
106067016|NCT00546637|365906974|FG000|Overall Study|Lost to Follow-up|2|||
106067017|NCT00546637|365906975|FG001|Overall Study|Lost to Follow-up|2|||
106067018|NCT00546637|365906974|FG000|Overall Study|Other|10|||
106067019|NCT00546637|365906975|FG001|Overall Study|Other|12|||
106067020|NCT00546637|365906974|FG000|Overall Study|Withdrawal by Subject|7|||
106067021|NCT00546637|365906975|FG001|Overall Study|Withdrawal by Subject|9|||
106067022|NCT00546637|365906974|FG000|Overall Study|Randomized, but not treated|3|||
106067023|NCT00546637|365906975|FG001|Overall Study|Randomized, but not treated|1|||
106067024|NCT03998189|365906976|FG000|Overall Study|Lack of Efficacy|0|||
106067025|NCT03998189|365906977|FG001|Overall Study|Lack of Efficacy|1|||
106067026|NCT02728895|365906979|FG000|Overall Study|Other|1|||
106067027|NCT02728895|365906980|FG001|Overall Study|Other|2|||
106067028|NCT02728895|365906979|FG000|Overall Study|Withdrawal by Subject|0|||
106067029|NCT02728895|365906980|FG001|Overall Study|Withdrawal by Subject|3|||
106067030|NCT01846507|365906981|FG000|Overall Study|Lost to Follow-up|4|||
106067031|NCT01846507|365906981|FG000|Overall Study|Protocol Violation|1|||
106067032|NCT01846507|365906981|FG000|Overall Study|Missing data|2|||
106067033|NCT04984993|365906982|FG000|Overall Study|Withdrawal by Subject|8|||
106067034|NCT04984993|365906983|FG001|Overall Study|Withdrawal by Subject|2|||
106067035|NCT04984993|365906982|FG000|Overall Study|Lost to Follow-up|2|||
106067036|NCT04984993|365906983|FG001|Overall Study|Lost to Follow-up|2|||
106067037|NCT04984993|365906982|FG000|Overall Study|Both patients moved to another country|4|||
106067038|NCT04984993|365906983|FG001|Overall Study|Both patients moved to another country|0|||
106067039|NCT02865187|365906986|FG000|Overall Study|Lost to Follow-up|12|||
106067040|NCT02865187|365906987|FG001|Overall Study|Lost to Follow-up|7|||
106067041|NCT02865187|365906986|FG000|Overall Study|Adverse Event|1|||
106067042|NCT02865187|365906987|FG001|Overall Study|Adverse Event|0|||
106067043|NCT01110707|365906988|FG000|Overall Study|Protocol Violation|0|||
106067044|NCT01110707|365906989|FG001|Overall Study|Protocol Violation|3|||
106067045|NCT00495170|365906996|FG000|Overall Study|Lost to Follow-up|9|||
106067046|NCT00495170|365906996|FG000|Overall Study|Withdrawal by Subject|3|||
106067047|NCT00495170|365906996|FG000|Overall Study|Inappropriate staging|8|||
106067048|NCT03557151|365907000|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
106067049|NCT03557151|365907001|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
106067050|NCT03557151|365907000|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
106067051|NCT03557151|365907001|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
106067052|NCT03557151|365907000|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
106067053|NCT03557151|365907001|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
106067054|NCT02810392|365907002|FG000|Overall Study|Subject too ill to continue|1|||
105865349|NCT02755649|365156772|FG000|Overall Study|Physician Decision|0|||
106067055|NCT02810392|365907003|FG001|Overall Study|Subject too ill to continue|0|||
106067056|NCT02810392|365907002|FG000|Overall Study|COVID 19 research restrictions|0|||
106067057|NCT02810392|365907003|FG001|Overall Study|COVID 19 research restrictions|1|||
106067058|NCT02056340|365907005|FG000|Overall Study|Lost to Follow-up|5|||
106067059|NCT02056340|365907006|FG001|Overall Study|Lost to Follow-up|5|||
106067060|NCT02056340|365907005|FG000|Overall Study|Withdrawal by Subject|2|||
106067061|NCT02056340|365907006|FG001|Overall Study|Withdrawal by Subject|6|||
106067062|NCT01214629|365907008|FG000|Overall Study|Progressive Disease|1|||
106067063|NCT01214629|365907009|FG001|Overall Study|Progressive Disease|1|||
106067064|NCT01214629|365907010|FG002|Overall Study|Progressive Disease|0|||
106067065|NCT01214629|365907011|FG003|Overall Study|Progressive Disease|1|||
106067066|NCT01214629|365907012|FG004|Overall Study|Progressive Disease|2|||
106067067|NCT01214629|365907013|FG005|Overall Study|Progressive Disease|3|||
106067068|NCT01214629|365907014|FG006|Overall Study|Progressive Disease|1|||
106067069|NCT01214629|365907015|FG007|Overall Study|Progressive Disease|1|||
106067070|NCT01214629|365907016|FG008|Overall Study|Progressive Disease|1|||
106067071|NCT01214629|365907017|FG009|Overall Study|Progressive Disease|5|||
106067072|NCT01214629|365907018|FG010|Overall Study|Progressive Disease|1|||
106067073|NCT01214629|365907008|FG000|Overall Study|Adverse Event|0|||
106067074|NCT01214629|365907009|FG001|Overall Study|Adverse Event|0|||
106067075|NCT01214629|365907010|FG002|Overall Study|Adverse Event|0|||
106067076|NCT01214629|365907011|FG003|Overall Study|Adverse Event|1|||
106067077|NCT01214629|365907012|FG004|Overall Study|Adverse Event|0|||
106067078|NCT01214629|365907013|FG005|Overall Study|Adverse Event|1|||
106067079|NCT01214629|365907014|FG006|Overall Study|Adverse Event|0|||
106067080|NCT01214629|365907015|FG007|Overall Study|Adverse Event|0|||
106067081|NCT01214629|365907016|FG008|Overall Study|Adverse Event|0|||
106067082|NCT01214629|365907017|FG009|Overall Study|Adverse Event|1|||
106067083|NCT01214629|365907018|FG010|Overall Study|Adverse Event|0|||
106067084|NCT01214629|365907008|FG000|Overall Study|Physician Decision|0|||
106067085|NCT01214629|365907009|FG001|Overall Study|Physician Decision|0|||
106067086|NCT01214629|365907010|FG002|Overall Study|Physician Decision|0|||
106067087|NCT01214629|365907011|FG003|Overall Study|Physician Decision|0|||
106067088|NCT01214629|365907012|FG004|Overall Study|Physician Decision|0|||
106067089|NCT01214629|365907013|FG005|Overall Study|Physician Decision|0|||
106067090|NCT01214629|365907014|FG006|Overall Study|Physician Decision|0|||
106067091|NCT01214629|365907015|FG007|Overall Study|Physician Decision|0|||
106067092|NCT01214629|365907016|FG008|Overall Study|Physician Decision|0|||
106067093|NCT01214629|365907017|FG009|Overall Study|Physician Decision|0|||
106067094|NCT01214629|365907018|FG010|Overall Study|Physician Decision|1|||
106067095|NCT01214629|365907008|FG000|Overall Study|Withdrawal by Subject|0|||
106067096|NCT01214629|365907009|FG001|Overall Study|Withdrawal by Subject|0|||
106067097|NCT01214629|365907010|FG002|Overall Study|Withdrawal by Subject|0|||
106067098|NCT01214629|365907011|FG003|Overall Study|Withdrawal by Subject|0|||
106067099|NCT01214629|365907012|FG004|Overall Study|Withdrawal by Subject|0|||
106067100|NCT01214629|365907013|FG005|Overall Study|Withdrawal by Subject|0|||
106067101|NCT01214629|365907014|FG006|Overall Study|Withdrawal by Subject|0|||
106067102|NCT01214629|365907015|FG007|Overall Study|Withdrawal by Subject|0|||
106067103|NCT01214629|365907016|FG008|Overall Study|Withdrawal by Subject|0|||
106067104|NCT01214629|365907017|FG009|Overall Study|Withdrawal by Subject|1|||
106067105|NCT01214629|365907018|FG010|Overall Study|Withdrawal by Subject|0|||
106067106|NCT02107482|365907020|FG000|Overall Study|inconveinence|2|||
106067107|NCT02107482|365907020|FG000|Overall Study|Lost to Follow-up|1|||
106067108|NCT02107482|365907020|FG000|Overall Study|Lack of Efficacy|1|||
106067109|NCT03473808|365907021|FG000|Overall Study|Withdrawal by Subject|1|||
106067110|NCT04059094|365907026|FG000|Overall Study|Adverse Event|0|||
106067111|NCT04059094|365907027|FG001|Overall Study|Adverse Event|0|||
106067112|NCT04059094|365907028|FG002|Overall Study|Adverse Event|0|||
106067113|NCT04059094|365907029|FG003|Overall Study|Adverse Event|0|||
106067114|NCT04059094|365907030|FG004|Overall Study|Adverse Event|1|||
106067115|NCT04059094|365907026|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
106067116|NCT04059094|365907027|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
106067117|NCT04059094|365907028|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
106067118|NCT04059094|365907029|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
106067119|NCT04059094|365907030|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
106067120|NCT03715764|365907031|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
106067121|NCT03715764|365907032|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
106067122|NCT03715764|365907031|FG000|3 Month Follow-up|Lost to Follow-up|2|||
106067123|NCT03715764|365907032|FG001|3 Month Follow-up|Lost to Follow-up|2|||
106067124|NCT03715764|365907031|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
106067125|NCT03715764|365907032|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
106067126|NCT03715764|365907031|FG000|6 Month Follow-up|Lost to Follow-up|3|||
106067127|NCT03715764|365907032|FG001|6 Month Follow-up|Lost to Follow-up|0|||
106067128|NCT03715764|365907031|FG000|12 Month Follow-up|Lost to Follow-up|2|||
106067129|NCT03715764|365907032|FG001|12 Month Follow-up|Lost to Follow-up|3|||
106067130|NCT03715764|365907031|FG000|12 Month Follow-up|Pregnancy|0|||
106067131|NCT03715764|365907032|FG001|12 Month Follow-up|Pregnancy|1|||
106067132|NCT03715764|365907031|FG000|12 Month Follow-up|Surgery|2|||
106067133|NCT03715764|365907032|FG001|12 Month Follow-up|Surgery|0|||
106067134|NCT03715764|365907031|FG000|12 Month Follow-up|Wrong address|1|||
106067135|NCT03715764|365907032|FG001|12 Month Follow-up|Wrong address|0|||
106067136|NCT03715764|365907031|FG000|12 Month Follow-up|No symptoms|1|||
106067137|NCT03715764|365907032|FG001|12 Month Follow-up|No symptoms|0|||
106067138|NCT03715764|365907031|FG000|12 Month Follow-up|Changed primary care centre|0|||
106067139|NCT03715764|365907032|FG001|12 Month Follow-up|Changed primary care centre|1|||
106067140|NCT00488345|365909065|FG000|Overall Study|Adverse Event|0|||
106067141|NCT00488345|365909066|FG001|Overall Study|Adverse Event|1|||
106067142|NCT00488345|365909067|FG002|Overall Study|Adverse Event|1|||
106067143|NCT00488345|365909065|FG000|Overall Study|Unable to administer antibiotics at home|0|||
106067144|NCT00488345|365909066|FG001|Overall Study|Unable to administer antibiotics at home|1|||
106067145|NCT00488345|365909067|FG002|Overall Study|Unable to administer antibiotics at home|0|||
106067146|NCT00488345|365909065|FG000|Overall Study|Institutional Review Board review|0|||
106067147|NCT00488345|365909066|FG001|Overall Study|Institutional Review Board review|0|||
106067148|NCT00488345|365909067|FG002|Overall Study|Institutional Review Board review|1|||
106067149|NCT00488345|365909065|FG000|Overall Study|Surgical team recommendation|0|||
106067150|NCT00488345|365909066|FG001|Overall Study|Surgical team recommendation|1|||
106067151|NCT00488345|365909067|FG002|Overall Study|Surgical team recommendation|0|||
106067152|NCT00488345|365909065|FG000|Overall Study|Parent/legal guardian request|0|||
106067153|NCT00488345|365909066|FG001|Overall Study|Parent/legal guardian request|1|||
106067154|NCT00488345|365909067|FG002|Overall Study|Parent/legal guardian request|1|||
106067155|NCT00696696|365909071|FG000|Overall Study|Adverse Event|5|||
106067156|NCT00696696|365909071|FG000|Overall Study|Withdrawal by Subject|8|||
106067157|NCT00696696|365909071|FG000|Overall Study|Physician Decision|2|||
106067158|NCT00696696|365909071|FG000|Overall Study|Death|3|||
106067159|NCT03055260|365909072|FG000|Overall Study|Withdrawal by Subject|1|||
106067160|NCT03055260|365909073|FG001|Overall Study|Withdrawal by Subject|0|||
106067161|NCT02642614|365909074|FG000|Overall Study|Adverse Event|1|||
106067162|NCT02642614|365909075|FG001|Overall Study|Adverse Event|1|||
106067163|NCT02642614|365909076|FG002|Overall Study|Adverse Event|2|||
106067164|NCT02642614|365909077|FG003|Overall Study|Adverse Event|2|||
106067165|NCT02642614|365909074|FG000|Overall Study|Lost to Follow-up|1|||
106067166|NCT02642614|365909075|FG001|Overall Study|Lost to Follow-up|0|||
106067167|NCT02642614|365909076|FG002|Overall Study|Lost to Follow-up|0|||
106067168|NCT02642614|365909077|FG003|Overall Study|Lost to Follow-up|0|||
106067169|NCT02642614|365909074|FG000|Overall Study|Withdrawal by Subject|1|||
106067170|NCT02642614|365909075|FG001|Overall Study|Withdrawal by Subject|1|||
106067171|NCT02642614|365909076|FG002|Overall Study|Withdrawal by Subject|0|||
106067172|NCT02642614|365909077|FG003|Overall Study|Withdrawal by Subject|0|||
106067173|NCT02279173|365909078|FG000|Overall Study|Protocol-specified Criteria|67|||
106067174|NCT02279173|365909078|FG000|Overall Study|Withdrawal by Subject|20|||
106067175|NCT02279173|365909078|FG000|Overall Study|Decision by Sponsor|4|||
106067176|NCT02279173|365909078|FG000|Overall Study|Lost to Follow-up|3|||
106067177|NCT01164956|365909079|FG000|Overall Study|Side Effects|1|||
106067178|NCT01164956|365909080|FG001|Overall Study|Side Effects|0|||
106067179|NCT01164956|365909081|FG002|Overall Study|Side Effects|1|||
106067180|NCT00967798|365909082|FG000|Overall Study|Withdrawal by Subject|5|||
106067181|NCT00967798|365909083|FG001|Overall Study|Withdrawal by Subject|2|||
106067182|NCT00967798|365909082|FG000|Overall Study|Lost to Follow-up|4|||
106067183|NCT00967798|365909083|FG001|Overall Study|Lost to Follow-up|1|||
106067184|NCT01287897|365909086|FG000|Overall Study|Adverse Event|5|||
106067185|NCT01287897|365909087|FG001|Overall Study|Adverse Event|3|||
106067186|NCT01287897|365909088|FG002|Overall Study|Adverse Event|6|||
106067187|NCT01287897|365909089|FG003|Overall Study|Adverse Event|4|||
106067188|NCT01287897|365909086|FG000|Overall Study|Lack of Efficacy|2|||
106067189|NCT01287897|365909087|FG001|Overall Study|Lack of Efficacy|0|||
106067190|NCT01287897|365909088|FG002|Overall Study|Lack of Efficacy|0|||
106067191|NCT01287897|365909089|FG003|Overall Study|Lack of Efficacy|0|||
106067192|NCT01287897|365909086|FG000|Overall Study|Protocol Violation|1|||
106067193|NCT01287897|365909087|FG001|Overall Study|Protocol Violation|1|||
106067194|NCT01287897|365909088|FG002|Overall Study|Protocol Violation|0|||
106067195|NCT01287897|365909089|FG003|Overall Study|Protocol Violation|1|||
106067196|NCT01287897|365909086|FG000|Overall Study|Lost to Follow-up|0|||
106067197|NCT01287897|365909087|FG001|Overall Study|Lost to Follow-up|0|||
106067198|NCT01287897|365909088|FG002|Overall Study|Lost to Follow-up|2|||
106067199|NCT01287897|365909089|FG003|Overall Study|Lost to Follow-up|0|||
106067200|NCT01287897|365909086|FG000|Overall Study|Withdrawal by Subject|1|||
106067201|NCT01287897|365909087|FG001|Overall Study|Withdrawal by Subject|5|||
106067202|NCT01287897|365909088|FG002|Overall Study|Withdrawal by Subject|3|||
106067203|NCT01287897|365909089|FG003|Overall Study|Withdrawal by Subject|2|||
106067204|NCT01287897|365909086|FG000|Overall Study|Not consented properly|0|||
106067205|NCT01287897|365909087|FG001|Overall Study|Not consented properly|1|||
106067206|NCT01287897|365909088|FG002|Overall Study|Not consented properly|0|||
106067207|NCT01287897|365909089|FG003|Overall Study|Not consented properly|0|||
106067208|NCT01287897|365909086|FG000|Overall Study|Not meeting entrance criteria|1|||
106067209|NCT01287897|365909087|FG001|Overall Study|Not meeting entrance criteria|1|||
106067210|NCT01287897|365909088|FG002|Overall Study|Not meeting entrance criteria|0|||
106067211|NCT01287897|365909089|FG003|Overall Study|Not meeting entrance criteria|0|||
106067212|NCT01287897|365909086|FG000|Overall Study|Other|1|||
106067213|NCT01287897|365909087|FG001|Overall Study|Other|0|||
106067214|NCT01287897|365909088|FG002|Overall Study|Other|1|||
106067215|NCT01287897|365909089|FG003|Overall Study|Other|0|||
106067216|NCT00249444|365909092|FG000|Overall Study|Lost to Follow-up|2|||
106067217|NCT00249444|365909093|FG001|Overall Study|Lost to Follow-up|2|||
106067218|NCT00249444|365909092|FG000|Overall Study|non-compliant|9|||
106067219|NCT00249444|365909093|FG001|Overall Study|non-compliant|11|||
106067220|NCT00249444|365909092|FG000|Overall Study|Adverse Event|1|||
106067221|NCT00249444|365909093|FG001|Overall Study|Adverse Event|1|||
106067222|NCT00249444|365909092|FG000|Overall Study|life event|0|||
106067223|NCT00249444|365909093|FG001|Overall Study|life event|1|||
106067224|NCT01499667|365909094|FG000|Overall Study|administrative problems|4|||
106067225|NCT01499667|365909095|FG001|Overall Study|administrative problems|5|||
106067226|NCT01499667|365909096|FG002|Overall Study|administrative problems|5|||
106067227|NCT01499667|365909094|FG000|Overall Study|Protocol Violation|1|||
106067228|NCT01499667|365909095|FG001|Overall Study|Protocol Violation|3|||
106067229|NCT01499667|365909096|FG002|Overall Study|Protocol Violation|2|||
106067230|NCT01499667|365909094|FG000|Overall Study|Adverse Event|0|||
106067231|NCT01499667|365909095|FG001|Overall Study|Adverse Event|2|||
106067232|NCT01499667|365909096|FG002|Overall Study|Adverse Event|2|||
106067233|NCT01499667|365909094|FG000|Overall Study|Withdrawal by Subject|2|||
106067234|NCT01499667|365909095|FG001|Overall Study|Withdrawal by Subject|1|||
106067235|NCT01499667|365909096|FG002|Overall Study|Withdrawal by Subject|1|||
106067236|NCT01499667|365909094|FG000|Overall Study|Lack of Efficacy|2|||
106067237|NCT01499667|365909095|FG001|Overall Study|Lack of Efficacy|0|||
106067238|NCT01499667|365909096|FG002|Overall Study|Lack of Efficacy|0|||
106067239|NCT02673489|365909097|FG000|Treatment Period|Lost to Follow-up|3|||
106067240|NCT02673489|365909098|FG001|Treatment Period|Lost to Follow-up|0|||
106067241|NCT02673489|365909097|FG000|Treatment Period|Participant request to discontinue|1|||
106067242|NCT02673489|365909098|FG001|Treatment Period|Participant request to discontinue|1|||
106067243|NCT02673489|365909097|FG000|Treatment Period|Participant moved to another province|1|||
106067244|NCT02673489|365909098|FG001|Treatment Period|Participant moved to another province|0|||
106067245|NCT02673489|365909097|FG000|Treatment Period|Participant was incarcerated|0|||
106067246|NCT02673489|365909098|FG001|Treatment Period|Participant was incarcerated|1|||
106067247|NCT02673489|365909097|FG000|Treatment Period|Adverse Event|0|||
106067248|NCT02673489|365909098|FG001|Treatment Period|Adverse Event|1|||
106067249|NCT02673489|365909097|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
106067250|NCT02673489|365909098|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
106067251|NCT02673489|365909097|FG000|Follow Up Period|Unable to return for follow-up|0|||
106067252|NCT02673489|365909098|FG001|Follow Up Period|Unable to return for follow-up|1|||
106067253|NCT02335489|365909099|FG000|Overall Study|Sponsor terminated study|4|||
106067254|NCT02335489|365909099|FG000|Overall Study|Lost to Follow-up|1|||
106067255|NCT02335489|365909099|FG000|Overall Study|Withdrawal by Subject|2|||
106067256|NCT02335489|365909099|FG000|Overall Study|Physician Decision|2|||
106067257|NCT02335489|365909099|FG000|Overall Study|Lack of Efficacy|1|||
106067258|NCT04483011|365909105|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
106067259|NCT04483011|365909106|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
106067260|NCT01853046|365909107|FG000|Overall Study|Withdrawal by Subject|1|||
106067261|NCT01853046|365909108|FG001|Overall Study|Withdrawal by Subject|1|||
106067262|NCT01853046|365909107|FG000|Overall Study|Adverse Event|4|||
106067263|NCT01853046|365909108|FG001|Overall Study|Adverse Event|2|||
106067264|NCT01853046|365909107|FG000|Overall Study|Disease progression|13|||
106067265|NCT01853046|365909108|FG001|Overall Study|Disease progression|3|||
106067266|NCT03635957|365909113|FG000|Run-In Period|Lost to Follow-up|1|||
106067267|NCT03635957|365909113|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
106067268|NCT00350636|365909114|FG000|Overall Study|Adverse Event|19|||
106067269|NCT00350636|365909115|FG001|Overall Study|Adverse Event|13|||
106067270|NCT00350636|365909114|FG000|Overall Study|Protocol Violation|1|||
106067271|NCT00350636|365909115|FG001|Overall Study|Protocol Violation|3|||
106067272|NCT00350636|365909114|FG000|Overall Study|Withdrawal by Subject|13|||
106067273|NCT00350636|365909115|FG001|Overall Study|Withdrawal by Subject|17|||
106067274|NCT00350636|365909114|FG000|Overall Study|Lost to Follow-up|9|||
105865350|NCT02755649|365156773|FG001|Overall Study|Physician Decision|0|||
105865351|NCT02755649|365156774|FG002|Overall Study|Physician Decision|2|||
105865352|NCT02755649|365156772|FG000|Overall Study|Withdrawal by Subject|0|||
105865353|NCT02755649|365156773|FG001|Overall Study|Withdrawal by Subject|1|||
105865354|NCT02755649|365156774|FG002|Overall Study|Withdrawal by Subject|0|||
105865355|NCT02755649|365156772|FG000|Overall Study|Undecided|1|||
105865356|NCT02755649|365156773|FG001|Overall Study|Undecided|0|||
105865357|NCT02755649|365156774|FG002|Overall Study|Undecided|0|||
106067275|NCT00350636|365909115|FG001|Overall Study|Lost to Follow-up|8|||
106067276|NCT00350636|365909114|FG000|Overall Study|Physician Decision|0|||
106067277|NCT00350636|365909115|FG001|Overall Study|Physician Decision|2|||
106067278|NCT00350636|365909114|FG000|Overall Study|Other|1|||
106067279|NCT00350636|365909115|FG001|Overall Study|Other|2|||
105865358|NCT01286753|365156775|FG000|Overall Study|Adverse Event|7|||
106067280|NCT01710033|365909116|FG000|Stage 2|Adverse Event|0|||
106067281|NCT01710033|365909117|FG001|Stage 2|Adverse Event|0|||
106067282|NCT01710033|365909118|FG002|Stage 2|Adverse Event|0|||
106067283|NCT01710033|365909119|FG003|Stage 2|Adverse Event|0|||
106067284|NCT01710033|365909120|FG004|Stage 2|Adverse Event|1|||
106067285|NCT02514447|365909121|FG000|Overall Study|Withdrawal by Subject|3|||
106067286|NCT02514447|365909122|FG001|Overall Study|Withdrawal by Subject|1|||
106067287|NCT02514447|365909123|FG002|Overall Study|Withdrawal by Subject|1|||
106067288|NCT02514447|365909124|FG003|Overall Study|Withdrawal by Subject|0|||
106067289|NCT02514447|365909125|FG004|Overall Study|Withdrawal by Subject|0|||
106067290|NCT02514447|365909126|FG005|Overall Study|Withdrawal by Subject|0|||
106067291|NCT02514447|365909127|FG006|Overall Study|Withdrawal by Subject|0|||
106067292|NCT02514447|365909128|FG007|Overall Study|Withdrawal by Subject|1|||
106067293|NCT02514447|365909129|FG008|Overall Study|Withdrawal by Subject|1|||
106067294|NCT02514447|365909121|FG000|Overall Study|Death|24|||
106067295|NCT02514447|365909122|FG001|Overall Study|Death|28|||
106067296|NCT02514447|365909123|FG002|Overall Study|Death|29|||
106067297|NCT02514447|365909124|FG003|Overall Study|Death|0|||
106067298|NCT02514447|365909125|FG004|Overall Study|Death|3|||
106067299|NCT02514447|365909126|FG005|Overall Study|Death|4|||
106067300|NCT02514447|365909127|FG006|Overall Study|Death|8|||
106067301|NCT02514447|365909128|FG007|Overall Study|Death|6|||
106067302|NCT02514447|365909129|FG008|Overall Study|Death|5|||
106067303|NCT02514447|365909121|FG000|Overall Study|Lost to Follow-up|1|||
106067304|NCT02514447|365909122|FG001|Overall Study|Lost to Follow-up|0|||
106067305|NCT02514447|365909123|FG002|Overall Study|Lost to Follow-up|0|||
106067306|NCT02514447|365909124|FG003|Overall Study|Lost to Follow-up|0|||
106067307|NCT02514447|365909125|FG004|Overall Study|Lost to Follow-up|0|||
106067308|NCT02514447|365909126|FG005|Overall Study|Lost to Follow-up|0|||
106067309|NCT02514447|365909127|FG006|Overall Study|Lost to Follow-up|0|||
106067310|NCT02514447|365909128|FG007|Overall Study|Lost to Follow-up|0|||
106067311|NCT02514447|365909129|FG008|Overall Study|Lost to Follow-up|1|||
106067312|NCT02514447|365909121|FG000|Overall Study|Sponsor Termination of Study|0|||
106067313|NCT02514447|365909122|FG001|Overall Study|Sponsor Termination of Study|1|||
106067314|NCT02514447|365909123|FG002|Overall Study|Sponsor Termination of Study|1|||
106067315|NCT02514447|365909124|FG003|Overall Study|Sponsor Termination of Study|0|||
106067316|NCT02514447|365909125|FG004|Overall Study|Sponsor Termination of Study|0|||
106067317|NCT02514447|365909126|FG005|Overall Study|Sponsor Termination of Study|0|||
106067318|NCT02514447|365909127|FG006|Overall Study|Sponsor Termination of Study|0|||
106067319|NCT02514447|365909128|FG007|Overall Study|Sponsor Termination of Study|0|||
106067320|NCT02514447|365909129|FG008|Overall Study|Sponsor Termination of Study|0|||
106067321|NCT02514447|365909121|FG000|Overall Study|Study completion per Investigator|1|||
106067322|NCT02514447|365909122|FG001|Overall Study|Study completion per Investigator|0|||
106067323|NCT02514447|365909123|FG002|Overall Study|Study completion per Investigator|1|||
106067324|NCT02514447|365909124|FG003|Overall Study|Study completion per Investigator|2|||
106067325|NCT02514447|365909125|FG004|Overall Study|Study completion per Investigator|0|||
106067326|NCT02514447|365909126|FG005|Overall Study|Study completion per Investigator|0|||
106067327|NCT02514447|365909127|FG006|Overall Study|Study completion per Investigator|0|||
106067328|NCT02514447|365909128|FG007|Overall Study|Study completion per Investigator|0|||
106067329|NCT02514447|365909129|FG008|Overall Study|Study completion per Investigator|1|||
106067330|NCT02877082|365909130|FG000|Overall Study|Trial was closed early|5|||
106067331|NCT03480750|365909133|FG000|Overall Study|Withdrawal by Subject|0|||
106067332|NCT03480750|365909134|FG001|Overall Study|Withdrawal by Subject|1|||
106067333|NCT03480750|365909135|FG002|Overall Study|Withdrawal by Subject|0|||
106067334|NCT03480750|365909136|FG003|Overall Study|Withdrawal by Subject|0|||
106067335|NCT03480750|365909137|FG004|Overall Study|Withdrawal by Subject|0|||
106067336|NCT03480750|365909138|FG005|Overall Study|Withdrawal by Subject|0|||
106067337|NCT03480750|365909133|FG000|Overall Study|The interruption in Trientine shippment|0|||
106067338|NCT03480750|365909134|FG001|Overall Study|The interruption in Trientine shippment|0|||
106067339|NCT03480750|365909135|FG002|Overall Study|The interruption in Trientine shippment|0|||
106067340|NCT03480750|365909136|FG003|Overall Study|The interruption in Trientine shippment|0|||
106067341|NCT03480750|365909137|FG004|Overall Study|The interruption in Trientine shippment|0|||
106067342|NCT03480750|365909138|FG005|Overall Study|The interruption in Trientine shippment|1|||
106067343|NCT01172847|365909143|FG000|Overall Study|Withdrawal by Subject|3|||
106067344|NCT01103284|365909144|FG000|Overall Study|Death|2|||
106067345|NCT01103284|365909145|FG001|Overall Study|Death|0|||
106067346|NCT01103284|365909144|FG000|Overall Study|Lost to Follow-up|9|||
106067347|NCT01103284|365909145|FG001|Overall Study|Lost to Follow-up|10|||
106067348|NCT01103284|365909144|FG000|Overall Study|Pregnancy|3|||
106067349|NCT01103284|365909145|FG001|Overall Study|Pregnancy|1|||
106067350|NCT01103284|365909144|FG000|Overall Study|Protocol Violation|12|||
106067351|NCT01103284|365909145|FG001|Overall Study|Protocol Violation|5|||
106067352|NCT01103284|365909144|FG000|Overall Study|Adverse Event|0|||
106067353|NCT01103284|365909145|FG001|Overall Study|Adverse Event|5|||
106067354|NCT01103284|365909144|FG000|Overall Study|Withdrawal by Subject|14|||
106067355|NCT01103284|365909145|FG001|Overall Study|Withdrawal by Subject|18|||
106067356|NCT01103284|365909144|FG000|Overall Study|Dermal Hypersensitivity|0|||
106067357|NCT01103284|365909145|FG001|Overall Study|Dermal Hypersensitivity|1|||
106067358|NCT01103284|365909144|FG000|Overall Study|Termination by the Sponsor|0|||
106067359|NCT01103284|365909145|FG001|Overall Study|Termination by the Sponsor|1|||
106067360|NCT01103284|365909144|FG000|Overall Study|Not described|2|||
106067361|NCT01103284|365909145|FG001|Overall Study|Not described|1|||
106067362|NCT01103284|365909144|FG000|Overall Study|Missing CRF entries for study completion|0|||
106067363|NCT01103284|365909145|FG001|Overall Study|Missing CRF entries for study completion|2|||
106067364|NCT04532099|365909146|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
106067365|NCT04532099|365909147|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
106067366|NCT04532099|365909148|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
106067367|NCT01870583|365909149|FG000|Overall Study|Protocol Violation|0|||
106154497|NCT00150813|366225839|FG000|Overall Study|Remission|3|||
106154498|NCT00150813|366225839|FG000|Overall Study|Planned pregancy|1|||
105865359|NCT01286753|365156776|FG001|Overall Study|Adverse Event|6|||
106067368|NCT01870583|365909150|FG001|Overall Study|Protocol Violation|5|||
106154499|NCT00150813|366225839|FG000|Overall Study|Switch to commercially available LEV|2|||
106154500|NCT03285763|366225840|FG000|Overall Study|Death|470|||
106154501|NCT03285763|366225840|FG000|Overall Study|Lost to Follow-up|18|||
106154502|NCT03285763|366225840|FG000|Overall Study|Physician Decision|2|||
106154503|NCT03285763|366225840|FG000|Overall Study|Study Terminated By Sponsor|79|||
106154504|NCT03285763|366225840|FG000|Overall Study|Withdrawal by Subject|33|||
106154505|NCT03624972|366225841|FG000|Overall Study|Lost to Follow-up|2|||
106154506|NCT03624972|366225842|FG001|Overall Study|Lost to Follow-up|0|||
106154507|NCT03624972|366225843|FG002|Overall Study|Lost to Follow-up|0|||
106154508|NCT03624972|366225841|FG000|Overall Study|Withdrawal by Subject|0|||
106154509|NCT03624972|366225842|FG001|Overall Study|Withdrawal by Subject|2|||
106067369|NCT01870583|365909151|FG002|Overall Study|Protocol Violation|3|||
106067370|NCT01870583|365909149|FG000|Overall Study|Lost to Follow-up|11|||
106067371|NCT01870583|365909150|FG001|Overall Study|Lost to Follow-up|13|||
106067372|NCT01870583|365909151|FG002|Overall Study|Lost to Follow-up|5|||
106067373|NCT00311623|365909159|FG000|Overall Study|Physician Decision|0|||
106067374|NCT00311623|365909160|FG001|Overall Study|Physician Decision|0|||
106067375|NCT00311623|365909161|FG002|Overall Study|Physician Decision|2|||
106067376|NCT01998633|365909164|FG000|Overall Study|Death|1|||
106067377|NCT00810407|365909165|FG000|Overall Study|Protocol Violation|3|||
106067378|NCT00810407|365909165|FG000|Overall Study|No Visit After First Day of Treatment|3|||
106067379|NCT02611778|365909166|FG000|Overall Study|Withdrawal by Subject|2|||
106067380|NCT02611778|365909167|FG001|Overall Study|Withdrawal by Subject|8|||
106067381|NCT02611778|365909166|FG000|Overall Study|Adverse Event|1|||
106067382|NCT02611778|365909167|FG001|Overall Study|Adverse Event|2|||
106067383|NCT02611778|365909166|FG000|Overall Study|Death|2|||
106067384|NCT02611778|365909167|FG001|Overall Study|Death|1|||
106067385|NCT02611778|365909166|FG000|Overall Study|Protocol Violation|1|||
106067386|NCT02611778|365909167|FG001|Overall Study|Protocol Violation|0|||
106067387|NCT02611778|365909166|FG000|Overall Study|Lost to Follow-up|3|||
106067388|NCT02611778|365909167|FG001|Overall Study|Lost to Follow-up|1|||
106067389|NCT02611778|365909166|FG000|Overall Study|Need for alternative treatment|1|||
106067390|NCT02611778|365909167|FG001|Overall Study|Need for alternative treatment|0|||
106067391|NCT02611778|365909166|FG000|Overall Study|Other Reason|2|||
106067392|NCT02611778|365909167|FG001|Overall Study|Other Reason|1|||
106067393|NCT02369341|365909168|FG000|Overall Study|Migrated/moved from study area|1|||
106067394|NCT02369341|365909169|FG001|Overall Study|Migrated/moved from study area|0|||
106067395|NCT02278263|365909170|FG000|Overall Study|Protocol Violation|7|||
106067396|NCT02278263|365909171|FG001|Overall Study|Protocol Violation|0|||
106067397|NCT02278263|365909172|FG002|Overall Study|Protocol Violation|9|||
106067398|NCT03108027|365909177|FG000|Period 1|Subject/Guardian Decision|0|||
106067399|NCT03108027|365909178|FG001|Period 1|Subject/Guardian Decision|0|||
106067400|NCT03108027|365909179|FG002|Period 1|Subject/Guardian Decision|0|||
106067401|NCT03108027|365909180|FG003|Period 1|Subject/Guardian Decision|2|||
106067402|NCT03108027|365909181|FG004|Period 1|Subject/Guardian Decision|0|||
106067403|NCT03108027|365909182|FG005|Period 1|Subject/Guardian Decision|0|||
106067404|NCT03108027|365909177|FG000|Period 3|Adverse Event|0|||
106067405|NCT03108027|365909178|FG001|Period 3|Adverse Event|1|||
106067406|NCT03108027|365909179|FG002|Period 3|Adverse Event|0|||
106067407|NCT03108027|365909180|FG003|Period 3|Adverse Event|0|||
106067408|NCT03108027|365909181|FG004|Period 3|Adverse Event|0|||
106067409|NCT03108027|365909182|FG005|Period 3|Adverse Event|0|||
106067410|NCT02426892|365909183|FG000|Overall Study|Adverse Event|2|||
106067411|NCT02426892|365909183|FG000|Overall Study|Lack of Efficacy|17|||
106067412|NCT02426892|365909183|FG000|Overall Study|Withdrawal by Subject|1|||
106067413|NCT01359449|365909184|FG000|Overall Study|Lost to Follow-up|1|||
106067414|NCT01359449|365909185|FG001|Overall Study|Lost to Follow-up|0|||
106067415|NCT01359449|365909184|FG000|Overall Study|Protocol Violation|0|||
106067416|NCT01359449|365909185|FG001|Overall Study|Protocol Violation|2|||
106067417|NCT01359449|365909184|FG000|Overall Study|Withdrawal by Subject|3|||
106067418|NCT01359449|365909185|FG001|Overall Study|Withdrawal by Subject|2|||
106067419|NCT02574247|365909188|FG000|Overall Study|Withdrawal by Subject|1|||
106067420|NCT02574247|365909189|FG001|Overall Study|Withdrawal by Subject|0|||
106067421|NCT02574247|365909190|FG002|Overall Study|Withdrawal by Subject|0|||
106067422|NCT02574247|365909188|FG000|Overall Study|Did not meet inclusion criteria|4|||
106067423|NCT02574247|365909189|FG001|Overall Study|Did not meet inclusion criteria|3|||
106067424|NCT02574247|365909190|FG002|Overall Study|Did not meet inclusion criteria|5|||
106067425|NCT03178773|365909191|FG000|Overall Study|Death|0|||
106067426|NCT03178773|365909192|FG001|Overall Study|Death|1|||
106067427|NCT03178773|365909191|FG000|Overall Study|Lost to Follow-up|29|||
106067428|NCT03178773|365909192|FG001|Overall Study|Lost to Follow-up|25|||
106067429|NCT03178773|365909191|FG000|Overall Study|Withdrawal by Subject|10|||
106067430|NCT03178773|365909192|FG001|Overall Study|Withdrawal by Subject|14|||
106067431|NCT03325075|365909195|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
106067432|NCT03325075|365909196|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
106067433|NCT03325075|365909197|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
106067434|NCT03325075|365909198|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
106067435|NCT03325075|365909195|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
106067436|NCT03325075|365909196|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
106067437|NCT03325075|365909197|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
106067438|NCT03325075|365909198|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
106067439|NCT03325075|365909195|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
106067440|NCT03325075|365909196|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
106067441|NCT03325075|365909197|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
106067442|NCT03325075|365909198|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
106067443|NCT00748033|365909199|FG000|Overall Study|Adverse Event|0|||
106067444|NCT00748033|365909200|FG001|Overall Study|Adverse Event|1|||
106067445|NCT02763189|365909201|FG000|Overall Study|Device failure|0|||
106067446|NCT02763189|365909202|FG001|Overall Study|Device failure|2|||
106067447|NCT02669433|365909210|FG000|Overall Study|Protocol Violation|0|||
106067448|NCT02669433|365909211|FG001|Overall Study|Protocol Violation|4|||
106067449|NCT02669433|365909212|FG002|Overall Study|Protocol Violation|1|||
106067450|NCT02669433|365909210|FG000|Overall Study|Disease Progression|1|||
106067451|NCT02669433|365909211|FG001|Overall Study|Disease Progression|0|||
106067452|NCT02669433|365909212|FG002|Overall Study|Disease Progression|0|||
106067453|NCT02669433|365909210|FG000|Overall Study|Physician Decision|1|||
106067454|NCT02669433|365909211|FG001|Overall Study|Physician Decision|1|||
106067455|NCT02669433|365909212|FG002|Overall Study|Physician Decision|0|||
106067456|NCT02669433|365909210|FG000|Overall Study|Adverse Event|6|||
106067457|NCT02669433|365909211|FG001|Overall Study|Adverse Event|7|||
106067458|NCT02669433|365909212|FG002|Overall Study|Adverse Event|10|||
106067459|NCT02669433|365909210|FG000|Overall Study|Sponsor Termination|1|||
106067460|NCT02669433|365909211|FG001|Overall Study|Sponsor Termination|0|||
106067461|NCT02669433|365909212|FG002|Overall Study|Sponsor Termination|1|||
106067462|NCT02669433|365909210|FG000|Overall Study|Withdrawal by Subject|5|||
106067463|NCT02669433|365909211|FG001|Overall Study|Withdrawal by Subject|1|||
106067464|NCT02669433|365909212|FG002|Overall Study|Withdrawal by Subject|0|||
106067465|NCT02669433|365909210|FG000|Overall Study|Withdrawal by Caregiver|1|||
106067466|NCT02669433|365909211|FG001|Overall Study|Withdrawal by Caregiver|0|||
106067467|NCT02669433|365909212|FG002|Overall Study|Withdrawal by Caregiver|2|||
106067468|NCT02669433|365909210|FG000|Overall Study|Death|0|||
106067469|NCT02669433|365909211|FG001|Overall Study|Death|1|||
106067470|NCT02669433|365909212|FG002|Overall Study|Death|1|||
106067471|NCT01721330|365909213|FG000|Overall Study|Withdrawal by Subject|0|||
106067472|NCT01721330|365909214|FG001|Overall Study|Withdrawal by Subject|1|||
106067473|NCT03358290|365909215|FG000|Overall Study|Study discontinued by Sponsor|0|||
106067474|NCT03358290|365909216|FG001|Overall Study|Study discontinued by Sponsor|1|||
106067475|NCT03358290|365909217|FG002|Overall Study|Study discontinued by Sponsor|1|||
106067476|NCT03358290|365909218|FG003|Overall Study|Study discontinued by Sponsor|0|||
106067477|NCT03358290|365909219|FG004|Overall Study|Study discontinued by Sponsor|0|||
106067478|NCT03358290|365909215|FG000|Overall Study|Adverse Event|0|||
106067479|NCT03358290|365909216|FG001|Overall Study|Adverse Event|0|||
106067480|NCT03358290|365909217|FG002|Overall Study|Adverse Event|1|||
106067481|NCT03358290|365909218|FG003|Overall Study|Adverse Event|2|||
106067482|NCT03358290|365909219|FG004|Overall Study|Adverse Event|0|||
106067483|NCT03358290|365909215|FG000|Overall Study|Withdrawal by Subject|0|||
106067484|NCT03358290|365909216|FG001|Overall Study|Withdrawal by Subject|0|||
106067485|NCT03358290|365909217|FG002|Overall Study|Withdrawal by Subject|0|||
106067486|NCT03358290|365909218|FG003|Overall Study|Withdrawal by Subject|0|||
106067487|NCT03358290|365909219|FG004|Overall Study|Withdrawal by Subject|1|||
106067488|NCT03406104|365909222|FG000|Overall Study|Lost to Follow-up|2|||
106067489|NCT03406104|365909222|FG000|Overall Study|Withdrawal by Subject|2|||
106067490|NCT03406104|365909222|FG000|Overall Study|due to Covid patient did not want to travel|1|||
106067491|NCT03406104|365909222|FG000|Overall Study|Death|2|||
106067492|NCT00818662|365909223|FG000|Overall Study|Adverse Event|5|||
106067493|NCT00818662|365909224|FG001|Overall Study|Adverse Event|14|||
106067494|NCT00818662|365909225|FG002|Overall Study|Adverse Event|4|||
106067495|NCT00818662|365909226|FG003|Overall Study|Adverse Event|3|||
106067496|NCT00818662|365909223|FG000|Overall Study|Withdrawal by Subject|5|||
106067497|NCT00818662|365909224|FG001|Overall Study|Withdrawal by Subject|4|||
106067498|NCT00818662|365909225|FG002|Overall Study|Withdrawal by Subject|2|||
106067499|NCT00818662|365909226|FG003|Overall Study|Withdrawal by Subject|2|||
106067500|NCT00818662|365909223|FG000|Overall Study|Death|1|||
106067501|NCT00818662|365909224|FG001|Overall Study|Death|3|||
106067502|NCT00818662|365909225|FG002|Overall Study|Death|0|||
106067503|NCT00818662|365909226|FG003|Overall Study|Death|0|||
106067504|NCT00818662|365909223|FG000|Overall Study|Physician Decision|1|||
106067505|NCT00818662|365909224|FG001|Overall Study|Physician Decision|0|||
106067506|NCT00818662|365909225|FG002|Overall Study|Physician Decision|0|||
106067507|NCT00818662|365909226|FG003|Overall Study|Physician Decision|0|||
106067508|NCT00818662|365909223|FG000|Overall Study|Lost to Follow-up|0|||
106067509|NCT00818662|365909224|FG001|Overall Study|Lost to Follow-up|0|||
106067510|NCT00818662|365909225|FG002|Overall Study|Lost to Follow-up|0|||
106067511|NCT00818662|365909226|FG003|Overall Study|Lost to Follow-up|1|||
106067512|NCT00818662|365909223|FG000|Overall Study|Unwilling or Unable to Participate|4|||
106067513|NCT00818662|365909224|FG001|Overall Study|Unwilling or Unable to Participate|6|||
106067514|NCT00818662|365909225|FG002|Overall Study|Unwilling or Unable to Participate|2|||
106067515|NCT00818662|365909226|FG003|Overall Study|Unwilling or Unable to Participate|4|||
106067516|NCT00818662|365909223|FG000|Overall Study|Protocol Violation|1|||
106067517|NCT00818662|365909224|FG001|Overall Study|Protocol Violation|1|||
106067518|NCT00818662|365909225|FG002|Overall Study|Protocol Violation|0|||
106067519|NCT00818662|365909226|FG003|Overall Study|Protocol Violation|0|||
106067520|NCT00818662|365909223|FG000|Overall Study|Requires a Prohibited Medication|1|||
106067521|NCT00818662|365909224|FG001|Overall Study|Requires a Prohibited Medication|0|||
106067522|NCT00818662|365909225|FG002|Overall Study|Requires a Prohibited Medication|0|||
106067523|NCT00818662|365909226|FG003|Overall Study|Requires a Prohibited Medication|0|||
106067524|NCT00818662|365909223|FG000|Overall Study|Safety Risk|1|||
106067525|NCT00818662|365909224|FG001|Overall Study|Safety Risk|1|||
106067526|NCT00818662|365909225|FG002|Overall Study|Safety Risk|0|||
106067527|NCT00818662|365909226|FG003|Overall Study|Safety Risk|1|||
106067528|NCT00818662|365909223|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
106067529|NCT00818662|365909224|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
106067530|NCT00818662|365909225|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
106067531|NCT00818662|365909226|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
106067532|NCT00818662|365909223|FG000|Overall Study|Participant's health declined|0|||
106067533|NCT00818662|365909224|FG001|Overall Study|Participant's health declined|0|||
106067534|NCT00818662|365909225|FG002|Overall Study|Participant's health declined|0|||
106067535|NCT00818662|365909226|FG003|Overall Study|Participant's health declined|1|||
106067536|NCT00818662|365909223|FG000|Overall Study|Caregiver to pursue other treatment|0|||
106067537|NCT00818662|365909224|FG001|Overall Study|Caregiver to pursue other treatment|1|||
106067538|NCT00818662|365909225|FG002|Overall Study|Caregiver to pursue other treatment|0|||
106067539|NCT00818662|365909226|FG003|Overall Study|Caregiver to pursue other treatment|0|||
106067540|NCT00818662|365909223|FG000|Overall Study|Moving out of state|0|||
106067541|NCT00818662|365909224|FG001|Overall Study|Moving out of state|0|||
106067542|NCT00818662|365909225|FG002|Overall Study|Moving out of state|0|||
106067543|NCT00818662|365909226|FG003|Overall Study|Moving out of state|1|||
106067544|NCT00818662|365909223|FG000|Overall Study|Declined move to another study site|1|||
106067545|NCT00818662|365909224|FG001|Overall Study|Declined move to another study site|0|||
106067546|NCT00818662|365909225|FG002|Overall Study|Declined move to another study site|0|||
106067547|NCT00818662|365909226|FG003|Overall Study|Declined move to another study site|0|||
106067548|NCT00818662|365909223|FG000|Overall Study|Change in living situation|0|||
106067549|NCT00818662|365909224|FG001|Overall Study|Change in living situation|0|||
106067550|NCT00818662|365909225|FG002|Overall Study|Change in living situation|0|||
106067551|NCT00818662|365909226|FG003|Overall Study|Change in living situation|1|||
106067552|NCT00818662|365909223|FG000|Overall Study|Study partner decision|0|||
106067553|NCT00818662|365909224|FG001|Overall Study|Study partner decision|0|||
106067554|NCT00818662|365909225|FG002|Overall Study|Study partner decision|0|||
106067555|NCT00818662|365909226|FG003|Overall Study|Study partner decision|1|||
106067556|NCT00818662|365909223|FG000|Overall Study|Admitted to long term nursing care|0|||
106067557|NCT00818662|365909224|FG001|Overall Study|Admitted to long term nursing care|1|||
106067558|NCT00818662|365909225|FG002|Overall Study|Admitted to long term nursing care|0|||
106067559|NCT00818662|365909226|FG003|Overall Study|Admitted to long term nursing care|0|||
106067560|NCT03021265|365909227|FG000|Overall Study|Adverse Event|29|||
106067561|NCT03021265|365909227|FG000|Overall Study|Lack of Efficacy|3|||
106067562|NCT03021265|365909227|FG000|Overall Study|Improved|17|||
106067563|NCT03021265|365909227|FG000|Overall Study|Lost to Follow-up|67|||
106067564|NCT03021265|365909227|FG000|Overall Study|No reason given|2|||
106067565|NCT03021265|365909227|FG000|Overall Study|No visit since the first visit|4|||
106067566|NCT00642941|365909228|FG000|Overall Study|Physician Decision|3|||
106067567|NCT00642941|365909229|FG001|Overall Study|Physician Decision|1|||
106067568|NCT00642941|365909230|FG002|Overall Study|Physician Decision|0|||
106067569|NCT00642941|365909231|FG003|Overall Study|Physician Decision|0|||
106067570|NCT00642941|365909232|FG004|Overall Study|Physician Decision|0|||
106067571|NCT00642941|365909233|FG005|Overall Study|Physician Decision|0|||
106067572|NCT00642941|365909234|FG006|Overall Study|Physician Decision|1|||
106067573|NCT00642941|365909235|FG007|Overall Study|Physician Decision|0|||
106067574|NCT00642941|365909236|FG008|Overall Study|Physician Decision|0|||
106067575|NCT00642941|365909237|FG009|Overall Study|Physician Decision|1|||
106067576|NCT00642941|365909238|FG010|Overall Study|Physician Decision|0|||
106067577|NCT00642941|365909239|FG011|Overall Study|Physician Decision|1|||
106067578|NCT00642941|365909228|FG000|Overall Study|Death|4|||
106067579|NCT00642941|365909229|FG001|Overall Study|Death|0|||
106067580|NCT00642941|365909230|FG002|Overall Study|Death|1|||
106067581|NCT00642941|365909231|FG003|Overall Study|Death|1|||
106067582|NCT00642941|365909232|FG004|Overall Study|Death|2|||
106067583|NCT00642941|365909233|FG005|Overall Study|Death|1|||
106067584|NCT00642941|365909234|FG006|Overall Study|Death|0|||
106067585|NCT00642941|365909235|FG007|Overall Study|Death|0|||
106067586|NCT00642941|365909236|FG008|Overall Study|Death|0|||
106067587|NCT00642941|365909237|FG009|Overall Study|Death|0|||
106067588|NCT00642941|365909238|FG010|Overall Study|Death|0|||
106067589|NCT00642941|365909239|FG011|Overall Study|Death|1|||
106067590|NCT00642941|365909228|FG000|Overall Study|Study closed by Sponsor|0|||
106067591|NCT00642941|365909229|FG001|Overall Study|Study closed by Sponsor|1|||
106067592|NCT00642941|365909230|FG002|Overall Study|Study closed by Sponsor|0|||
106067593|NCT00642941|365909231|FG003|Overall Study|Study closed by Sponsor|0|||
106067594|NCT00642941|365909232|FG004|Overall Study|Study closed by Sponsor|0|||
106067595|NCT00642941|365909233|FG005|Overall Study|Study closed by Sponsor|0|||
106067596|NCT00642941|365909234|FG006|Overall Study|Study closed by Sponsor|0|||
106067597|NCT00642941|365909235|FG007|Overall Study|Study closed by Sponsor|0|||
106067598|NCT00642941|365909236|FG008|Overall Study|Study closed by Sponsor|0|||
106067599|NCT00642941|365909237|FG009|Overall Study|Study closed by Sponsor|0|||
106067600|NCT00642941|365909238|FG010|Overall Study|Study closed by Sponsor|0|||
106067601|NCT00642941|365909239|FG011|Overall Study|Study closed by Sponsor|0|||
106067602|NCT00642941|365909228|FG000|Overall Study|Withdrawal by Subject|1|||
106067603|NCT00642941|365909229|FG001|Overall Study|Withdrawal by Subject|0|||
106067604|NCT00642941|365909230|FG002|Overall Study|Withdrawal by Subject|0|||
106067605|NCT00642941|365909231|FG003|Overall Study|Withdrawal by Subject|2|||
106067606|NCT00642941|365909232|FG004|Overall Study|Withdrawal by Subject|0|||
106067607|NCT00642941|365909233|FG005|Overall Study|Withdrawal by Subject|0|||
106067608|NCT00642941|365909234|FG006|Overall Study|Withdrawal by Subject|2|||
106067609|NCT00642941|365909235|FG007|Overall Study|Withdrawal by Subject|0|||
106067610|NCT00642941|365909236|FG008|Overall Study|Withdrawal by Subject|1|||
106067611|NCT00642941|365909237|FG009|Overall Study|Withdrawal by Subject|0|||
106067612|NCT00642941|365909238|FG010|Overall Study|Withdrawal by Subject|0|||
106067613|NCT00642941|365909239|FG011|Overall Study|Withdrawal by Subject|1|||
106067614|NCT00642941|365909228|FG000|Overall Study|Protocol Violation|0|||
106067615|NCT00642941|365909229|FG001|Overall Study|Protocol Violation|0|||
106067616|NCT00642941|365909230|FG002|Overall Study|Protocol Violation|0|||
106067617|NCT00642941|365909231|FG003|Overall Study|Protocol Violation|0|||
106067618|NCT00642941|365909232|FG004|Overall Study|Protocol Violation|0|||
106067619|NCT00642941|365909233|FG005|Overall Study|Protocol Violation|0|||
106067620|NCT00642941|365909234|FG006|Overall Study|Protocol Violation|1|||
106067621|NCT00642941|365909235|FG007|Overall Study|Protocol Violation|0|||
106067622|NCT00642941|365909236|FG008|Overall Study|Protocol Violation|0|||
106067623|NCT00642941|365909237|FG009|Overall Study|Protocol Violation|0|||
106067624|NCT00642941|365909238|FG010|Overall Study|Protocol Violation|0|||
106067625|NCT00642941|365909239|FG011|Overall Study|Protocol Violation|0|||
106067626|NCT00642941|365909228|FG000|Overall Study|Adverse Event|1|||
106067627|NCT00642941|365909229|FG001|Overall Study|Adverse Event|1|||
106067628|NCT00642941|365909230|FG002|Overall Study|Adverse Event|0|||
106067629|NCT00642941|365909231|FG003|Overall Study|Adverse Event|0|||
106067630|NCT00642941|365909232|FG004|Overall Study|Adverse Event|0|||
106067631|NCT00642941|365909233|FG005|Overall Study|Adverse Event|0|||
106067632|NCT00642941|365909234|FG006|Overall Study|Adverse Event|1|||
106067633|NCT00642941|365909235|FG007|Overall Study|Adverse Event|1|||
106067634|NCT00642941|365909236|FG008|Overall Study|Adverse Event|0|||
106067635|NCT00642941|365909237|FG009|Overall Study|Adverse Event|1|||
106067636|NCT00642941|365909238|FG010|Overall Study|Adverse Event|0|||
106067637|NCT00642941|365909239|FG011|Overall Study|Adverse Event|0|||
106067638|NCT00642941|365909228|FG000|Overall Study|Other|1|||
106067639|NCT00642941|365909229|FG001|Overall Study|Other|1|||
106067640|NCT00642941|365909230|FG002|Overall Study|Other|1|||
106067641|NCT00642941|365909231|FG003|Overall Study|Other|1|||
106067642|NCT00642941|365909232|FG004|Overall Study|Other|0|||
106067643|NCT00642941|365909233|FG005|Overall Study|Other|1|||
106067644|NCT00642941|365909234|FG006|Overall Study|Other|0|||
106067645|NCT00642941|365909235|FG007|Overall Study|Other|1|||
106067646|NCT00642941|365909236|FG008|Overall Study|Other|0|||
106067647|NCT00642941|365909237|FG009|Overall Study|Other|0|||
106067648|NCT00642941|365909238|FG010|Overall Study|Other|0|||
106067649|NCT00642941|365909239|FG011|Overall Study|Other|1|||
106067650|NCT00642941|365909228|FG000|Overall Study|Disease progression|60|||
106067651|NCT00642941|365909229|FG001|Overall Study|Disease progression|50|||
106067652|NCT00642941|365909230|FG002|Overall Study|Disease progression|5|||
106067653|NCT00642941|365909231|FG003|Overall Study|Disease progression|36|||
106067654|NCT00642941|365909232|FG004|Overall Study|Disease progression|23|||
106067655|NCT00642941|365909233|FG005|Overall Study|Disease progression|39|||
106067656|NCT00642941|365909234|FG006|Overall Study|Disease progression|18|||
106067657|NCT00642941|365909235|FG007|Overall Study|Disease progression|12|||
106067658|NCT00642941|365909236|FG008|Overall Study|Disease progression|10|||
106067659|NCT00642941|365909237|FG009|Overall Study|Disease progression|7|||
106067660|NCT00642941|365909238|FG010|Overall Study|Disease progression|12|||
106067661|NCT00642941|365909239|FG011|Overall Study|Disease progression|7|||
106067662|NCT01338493|365909240|FG000|Enrolled|Withdrawal by Subject|1|||
106067663|NCT01338493|365909240|FG000|Enrolled|Patient not implanted|4|||
106067664|NCT01338493|365909240|FG000|Discharge|Death|1|||
106067665|NCT01338493|365909240|FG000|Discharge|Missed visit|1|||
106067666|NCT01338493|365909240|FG000|6 Months Follow up|Lost to Follow-up|11|||
106067667|NCT01338493|365909240|FG000|6 Months Follow up|Missed visit|8|||
106067668|NCT01338493|365909240|FG000|12 Months Follow up|Lost to Follow-up|9|||
106067669|NCT01846611|365909242|FG000|Overall Study|Lost to Follow-up|4|||
106067670|NCT01846611|365909243|FG001|Overall Study|Lost to Follow-up|6|||
106067671|NCT01846611|365909242|FG000|Overall Study|Withdrawal by Subject|15|||
106067672|NCT01846611|365909243|FG001|Overall Study|Withdrawal by Subject|19|||
106067673|NCT01846611|365909242|FG000|Overall Study|Other|19|||
106067674|NCT01846611|365909243|FG001|Overall Study|Other|18|||
106067675|NCT00541034|365909244|FG000|Overall Study|Non-Compliance|3|||
106154510|NCT03624972|366225843|FG002|Overall Study|Withdrawal by Subject|0|||
106154511|NCT05444192|366225844|FG000|Overall Study|Lost to Follow-up|1|||
106067676|NCT00656474|365909245|FG000|Overall Study|Other Reason|1|||
106067677|NCT01614067|365909246|FG000|Overall Study|Pregnancy|1|||
106067678|NCT01614067|365909247|FG001|Overall Study|Pregnancy|0|||
106067679|NCT01614067|365909246|FG000|Overall Study|Physician Decision|6|||
106067680|NCT01614067|365909247|FG001|Overall Study|Physician Decision|5|||
106067681|NCT01614067|365909246|FG000|Overall Study|Withdrawal by Subject|0|||
106067682|NCT01614067|365909247|FG001|Overall Study|Withdrawal by Subject|1|||
106067683|NCT01614067|365909246|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
106067684|NCT01614067|365909247|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
106067685|NCT02062879|365909248|FG000|Overall Study|Withdrawal by Subject|4|||
106067686|NCT02062879|365909249|FG001|Overall Study|Withdrawal by Subject|1|||
106067687|NCT02998840|365909250|FG000|Overall Study|Lost to Follow-up|1|||
106067688|NCT02998840|365909251|FG001|Overall Study|Lost to Follow-up|1|||
106067689|NCT02998840|365909252|FG002|Overall Study|Lost to Follow-up|2|||
106067690|NCT02998840|365909253|FG003|Overall Study|Lost to Follow-up|3|||
106067691|NCT02998840|365909250|FG000|Overall Study|Withdrawal by Subject|1|||
106067692|NCT02998840|365909251|FG001|Overall Study|Withdrawal by Subject|1|||
106067693|NCT02998840|365909252|FG002|Overall Study|Withdrawal by Subject|0|||
106067694|NCT02998840|365909253|FG003|Overall Study|Withdrawal by Subject|1|||
106067695|NCT02998840|365909250|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
106067696|NCT02998840|365909251|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
106067697|NCT02998840|365909252|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
106067698|NCT02998840|365909253|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
106067699|NCT00982488|365910768|FG000|Overall Study|Administrative reason by sponsor|81|||
106067700|NCT00982488|365910769|FG001|Overall Study|Administrative reason by sponsor|3|||
106067701|NCT00982488|365910770|FG002|Overall Study|Administrative reason by sponsor|11|||
106067702|NCT00982488|365910771|FG003|Overall Study|Administrative reason by sponsor|0|||
105865360|NCT01286753|365156775|FG000|Overall Study|Progression|11|||
105865361|NCT01286753|365156776|FG001|Overall Study|Progression|13|||
105865362|NCT01286753|365156775|FG000|Overall Study|Refused Treatment|1|||
105865363|NCT01286753|365156776|FG001|Overall Study|Refused Treatment|0|||
105865364|NCT01286753|365156775|FG000|Overall Study|Withdrawal of Consent|0|||
105865365|NCT01286753|365156776|FG001|Overall Study|Withdrawal of Consent|2|||
105865366|NCT01286753|365156775|FG000|Overall Study|Discontinued to Join Extension Study|6|||
105865367|NCT01286753|365156776|FG001|Overall Study|Discontinued to Join Extension Study|4|||
105865368|NCT01286753|365156775|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
105865369|NCT01286753|365156776|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
105865370|NCT03301649|365156780|FG000|Overall Study|Need alternate therapy due to live lice|17|||
105865371|NCT03301649|365156781|FG001|Overall Study|Need alternate therapy due to live lice|25|||
105865372|NCT03301649|365156782|FG002|Overall Study|Need alternate therapy due to live lice|81|||
105865373|NCT03301649|365156780|FG000|Overall Study|Lost to Follow-up|11|||
105865374|NCT03301649|365156781|FG001|Overall Study|Lost to Follow-up|11|||
105865375|NCT03301649|365156782|FG002|Overall Study|Lost to Follow-up|3|||
105865376|NCT03301649|365156780|FG000|Overall Study|Protocol Violation|0|||
105865377|NCT03301649|365156781|FG001|Overall Study|Protocol Violation|1|||
105865378|NCT03301649|365156782|FG002|Overall Study|Protocol Violation|1|||
105865379|NCT03301649|365156780|FG000|Overall Study|Withdrawal by Subject|10|||
105865380|NCT03301649|365156781|FG001|Overall Study|Withdrawal by Subject|4|||
105865381|NCT03301649|365156782|FG002|Overall Study|Withdrawal by Subject|0|||
105865382|NCT03301649|365156780|FG000|Overall Study|Other than specified|5|||
105865383|NCT03301649|365156781|FG001|Overall Study|Other than specified|3|||
105865384|NCT03301649|365156782|FG002|Overall Study|Other than specified|0|||
105865385|NCT01403051|365156783|FG000|Overall Study|Protocol Violation|2|||
105865386|NCT01403051|365156784|FG001|Overall Study|Protocol Violation|0|||
105865387|NCT01403051|365156783|FG000|Overall Study|Death|1|||
105865388|NCT01403051|365156784|FG001|Overall Study|Death|0|||
105865389|NCT01403051|365156783|FG000|Overall Study|Withdrawal by Subject|2|||
105865390|NCT01403051|365156784|FG001|Overall Study|Withdrawal by Subject|1|||
105865391|NCT01403051|365156783|FG000|Overall Study|Lost to Follow-up|5|||
105865392|NCT01403051|365156784|FG001|Overall Study|Lost to Follow-up|5|||
105865393|NCT00459355|365156785|FG000|Overall Study|Subject no longer met inc criteria|20|||
105865394|NCT00459355|365156786|FG001|Overall Study|Subject no longer met inc criteria|18|||
105865395|NCT00129389|365156795|FG000|Overall Study|Adverse Event|19|||
105865396|NCT00129389|365156796|FG001|Overall Study|Adverse Event|87|||
105865397|NCT00129389|365156795|FG000|Overall Study|Death|0|||
105865398|NCT00129389|365156796|FG001|Overall Study|Death|1|||
105865399|NCT00129389|365156795|FG000|Overall Study|Lost to Follow-up|2|||
105865400|NCT00129389|365156796|FG001|Overall Study|Lost to Follow-up|1|||
106067703|NCT00982488|365910772|FG004|Overall Study|Administrative reason by sponsor|0|||
106067704|NCT00982488|365910768|FG000|Overall Study|Adverse event unrelated to study drug|5|||
106067705|NCT00982488|365910769|FG001|Overall Study|Adverse event unrelated to study drug|1|||
105865401|NCT00129389|365156795|FG000|Overall Study|Physician Decision|0|||
105865402|NCT00129389|365156796|FG001|Overall Study|Physician Decision|4|||
105865403|NCT00129389|365156795|FG000|Overall Study|Protocol Violation|0|||
105865404|NCT00129389|365156796|FG001|Overall Study|Protocol Violation|6|||
105865405|NCT00129389|365156795|FG000|Overall Study|Withdrawal by Subject|9|||
105865406|NCT00129389|365156796|FG001|Overall Study|Withdrawal by Subject|23|||
105865407|NCT00129389|365156795|FG000|Overall Study|Relapse|1|||
105865408|NCT00129389|365156796|FG001|Overall Study|Relapse|0|||
106067706|NCT00982488|365910770|FG002|Overall Study|Adverse event unrelated to study drug|0|||
106067707|NCT00982488|365910771|FG003|Overall Study|Adverse event unrelated to study drug|0|||
106067708|NCT00982488|365910772|FG004|Overall Study|Adverse event unrelated to study drug|0|||
106067709|NCT00982488|365910768|FG000|Overall Study|Death|11|||
106067710|NCT00982488|365910769|FG001|Overall Study|Death|0|||
106067711|NCT00982488|365910770|FG002|Overall Study|Death|2|||
106067712|NCT00982488|365910771|FG003|Overall Study|Death|0|||
106067713|NCT00982488|365910772|FG004|Overall Study|Death|0|||
106067714|NCT00982488|365910768|FG000|Overall Study|Disease progression|30|||
106067715|NCT00982488|365910769|FG001|Overall Study|Disease progression|5|||
106067716|NCT00982488|365910770|FG002|Overall Study|Disease progression|10|||
106067717|NCT00982488|365910771|FG003|Overall Study|Disease progression|1|||
106067718|NCT00982488|365910772|FG004|Overall Study|Disease progression|1|||
106067719|NCT00982488|365910768|FG000|Overall Study|Lost to Follow-up|1|||
106067720|NCT00982488|365910769|FG001|Overall Study|Lost to Follow-up|0|||
106067721|NCT00982488|365910770|FG002|Overall Study|Lost to Follow-up|0|||
106067722|NCT00982488|365910771|FG003|Overall Study|Lost to Follow-up|0|||
106067723|NCT00982488|365910772|FG004|Overall Study|Lost to Follow-up|0|||
106067724|NCT00982488|365910768|FG000|Overall Study|Maximum clinical benefit|1|||
106067725|NCT00982488|365910769|FG001|Overall Study|Maximum clinical benefit|1|||
106067726|NCT00982488|365910770|FG002|Overall Study|Maximum clinical benefit|1|||
106067727|NCT00982488|365910771|FG003|Overall Study|Maximum clinical benefit|0|||
106067728|NCT00982488|365910772|FG004|Overall Study|Maximum clinical benefit|0|||
106067729|NCT00982488|365910768|FG000|Overall Study|Other|15|||
106067730|NCT00982488|365910769|FG001|Overall Study|Other|1|||
106067731|NCT00982488|365910770|FG002|Overall Study|Other|3|||
106067732|NCT00982488|365910771|FG003|Overall Study|Other|1|||
106067733|NCT00982488|365910772|FG004|Overall Study|Other|0|||
106067734|NCT00982488|365910768|FG000|Overall Study|Poor compliance/noncompliance|0|||
106067735|NCT00982488|365910769|FG001|Overall Study|Poor compliance/noncompliance|1|||
106067736|NCT00982488|365910770|FG002|Overall Study|Poor compliance/noncompliance|0|||
106067737|NCT00982488|365910771|FG003|Overall Study|Poor compliance/noncompliance|0|||
106067738|NCT00982488|365910772|FG004|Overall Study|Poor compliance/noncompliance|0|||
106067739|NCT00982488|365910768|FG000|Overall Study|Stem cell transplant|2|||
106067740|NCT00982488|365910769|FG001|Overall Study|Stem cell transplant|0|||
106067741|NCT00982488|365910770|FG002|Overall Study|Stem cell transplant|0|||
106067742|NCT00982488|365910771|FG003|Overall Study|Stem cell transplant|1|||
106067743|NCT00982488|365910772|FG004|Overall Study|Stem cell transplant|0|||
106067744|NCT00982488|365910768|FG000|Overall Study|Study drug toxicity|34|||
106067745|NCT00982488|365910769|FG001|Overall Study|Study drug toxicity|1|||
106067746|NCT00982488|365910770|FG002|Overall Study|Study drug toxicity|6|||
106067747|NCT00982488|365910771|FG003|Overall Study|Study drug toxicity|0|||
106067748|NCT00982488|365910772|FG004|Overall Study|Study drug toxicity|0|||
106067749|NCT00982488|365910768|FG000|Overall Study|Withdrawal by Subject|5|||
106067750|NCT00982488|365910769|FG001|Overall Study|Withdrawal by Subject|1|||
106067751|NCT00982488|365910770|FG002|Overall Study|Withdrawal by Subject|1|||
106067752|NCT00982488|365910771|FG003|Overall Study|Withdrawal by Subject|0|||
106067753|NCT00982488|365910772|FG004|Overall Study|Withdrawal by Subject|0|||
106067754|NCT00001596|365910776|FG000|Overall Study|Death|1|||
106067755|NCT00001596|365910777|FG001|Overall Study|Death|0|||
106067756|NCT00001596|365910776|FG000|Overall Study|Withdrawal by Subject|3|||
106067757|NCT00001596|365910777|FG001|Overall Study|Withdrawal by Subject|1|||
106067758|NCT00001596|365910776|FG000|Overall Study|Study Termination|12|||
106067759|NCT00001596|365910777|FG001|Overall Study|Study Termination|9|||
106067760|NCT00001596|365910776|FG000|Overall Study|Adverse Event|1|||
106067761|NCT00001596|365910777|FG001|Overall Study|Adverse Event|0|||
106067762|NCT01572909|365910778|FG000|Overall Study|Adverse Event|7|||
106067763|NCT01572909|365910779|FG001|Overall Study|Adverse Event|2|||
106067764|NCT01572909|365910778|FG000|Overall Study|Death|3|||
106067765|NCT01572909|365910779|FG001|Overall Study|Death|1|||
105865409|NCT00129389|365156795|FG000|Overall Study|Not eligible|1|||
105865410|NCT00129389|365156796|FG001|Overall Study|Not eligible|2|||
105865411|NCT00129389|365156795|FG000|Overall Study|Crossed to the other arm|1|||
105865412|NCT00129389|365156796|FG001|Overall Study|Crossed to the other arm|16|||
105865413|NCT03760185|365156797|FG000|Overall Study|Lost to Follow-up|1|||
105865414|NCT03760185|365156798|FG001|Overall Study|Lost to Follow-up|1|||
106067766|NCT01572909|365910778|FG000|Overall Study|Lost to Follow-up|8|||
106067767|NCT01572909|365910779|FG001|Overall Study|Lost to Follow-up|7|||
106067768|NCT01572909|365910778|FG000|Overall Study|Physician Decision|1|||
106067769|NCT01572909|365910779|FG001|Overall Study|Physician Decision|1|||
106067770|NCT01572909|365910778|FG000|Overall Study|Technical Issues|1|||
106067771|NCT01572909|365910779|FG001|Overall Study|Technical Issues|0|||
106067772|NCT01572909|365910778|FG000|Overall Study|Withdrawal by Subject|12|||
106067773|NCT01572909|365910779|FG001|Overall Study|Withdrawal by Subject|11|||
105865415|NCT02111603|365156799|FG000|Overall Study|Withdrawal by Subject|1|||
105865416|NCT04611529|365156805|FG000|2-day Follow up|Lost to Follow-up|5|||
106067774|NCT01572909|365910778|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
106067775|NCT01572909|365910779|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
106154512|NCT05444192|366225845|FG001|Overall Study|Lost to Follow-up|0|||
105865417|NCT04611529|365156806|FG001|2-day Follow up|Lost to Follow-up|6|||
105865418|NCT04611529|365156807|FG002|2-day Follow up|Lost to Follow-up|3|||
105865419|NCT01775189|365156808|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105865420|NCT01775189|365156809|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
105865421|NCT01775189|365156810|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105865422|NCT01775189|365156811|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106067776|NCT00613938|365910784|FG000|Overall Study|Withdrawal by Subject|2|||
106067777|NCT00613938|365910785|FG001|Overall Study|Withdrawal by Subject|4|||
106067778|NCT00613938|365910786|FG002|Overall Study|Withdrawal by Subject|9|||
106067779|NCT00613938|365910787|FG003|Overall Study|Withdrawal by Subject|9|||
106067780|NCT00613938|365910784|FG000|Overall Study|Adverse Event|1|||
106067781|NCT00613938|365910785|FG001|Overall Study|Adverse Event|4|||
106067782|NCT00613938|365910786|FG002|Overall Study|Adverse Event|8|||
106067783|NCT00613938|365910787|FG003|Overall Study|Adverse Event|5|||
106067784|NCT00613938|365910784|FG000|Overall Study|Lack of Efficacy|16|||
106067785|NCT00613938|365910785|FG001|Overall Study|Lack of Efficacy|18|||
106067786|NCT00613938|365910786|FG002|Overall Study|Lack of Efficacy|5|||
106067787|NCT00613938|365910787|FG003|Overall Study|Lack of Efficacy|9|||
106067788|NCT00613938|365910784|FG000|Overall Study|Other|1|||
106067789|NCT00613938|365910785|FG001|Overall Study|Other|2|||
106067790|NCT00613938|365910786|FG002|Overall Study|Other|1|||
106067791|NCT00613938|365910787|FG003|Overall Study|Other|3|||
106067792|NCT04779489|365910788|FG000|Overall Study|Physician Decision|1|||
106067793|NCT02636868|365910789|FG000|Overall Study|Death|0|||
106067794|NCT02636868|365910790|FG001|Overall Study|Death|1|||
106067795|NCT02636868|365910791|FG002|Overall Study|Death|2|||
106067796|NCT03745937|365910792|FG000|Overall Study|Withdrawal by Subject|0|||
106067797|NCT03745937|365910793|FG001|Overall Study|Withdrawal by Subject|0|||
106067798|NCT03745937|365910794|FG002|Overall Study|Withdrawal by Subject|0|||
106067799|NCT03745937|365910795|FG003|Overall Study|Withdrawal by Subject|1|||
106067800|NCT03745937|365910792|FG000|Overall Study|Not-specifed|0|||
106067801|NCT03745937|365910793|FG001|Overall Study|Not-specifed|1|||
106067802|NCT03745937|365910794|FG002|Overall Study|Not-specifed|0|||
105865423|NCT01775189|365156812|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105865424|NCT01775189|365156813|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
105865425|NCT01775189|365156814|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
106067803|NCT03745937|365910795|FG003|Overall Study|Not-specifed|1|||
106067804|NCT02723084|365910796|FG000|Overall Study|Withdrawal by Subject|1|||
106067805|NCT02723084|365910797|FG001|Overall Study|Withdrawal by Subject|1|||
106067806|NCT02723084|365910796|FG000|Overall Study|Lost to Follow-up|3|||
106067807|NCT02723084|365910797|FG001|Overall Study|Lost to Follow-up|0|||
106067808|NCT00501293|365910798|FG000|Optimization Period|Enrolled in error|1|||
106067809|NCT00501293|365910799|FG001|Optimization Period|Enrolled in error|0|||
106067810|NCT00501293|365910798|FG000|Maintenance Period|Withdrawal by Subject|14|||
106067811|NCT00501293|365910799|FG001|Maintenance Period|Withdrawal by Subject|13|||
106067812|NCT00501293|365910798|FG000|Maintenance Period|Lost to Follow-up|12|||
106067813|NCT00501293|365910799|FG001|Maintenance Period|Lost to Follow-up|7|||
106067814|NCT00501293|365910798|FG000|Maintenance Period|Adverse Event|6|||
106067815|NCT00501293|365910799|FG001|Maintenance Period|Adverse Event|6|||
106067816|NCT00501293|365910798|FG000|Maintenance Period|Protocol Violation|2|||
106067817|NCT00501293|365910799|FG001|Maintenance Period|Protocol Violation|1|||
106067818|NCT00501293|365910798|FG000|Maintenance Period|Lack of Efficacy|4|||
106067819|NCT00501293|365910799|FG001|Maintenance Period|Lack of Efficacy|1|||
106067820|NCT00501293|365910798|FG000|Maintenance Period|Noncompliant with study medication|5|||
106067821|NCT00501293|365910799|FG001|Maintenance Period|Noncompliant with study medication|0|||
106067822|NCT00501293|365910798|FG000|Maintenance Period|Went into rehabilitation|1|||
106067823|NCT00501293|365910799|FG001|Maintenance Period|Went into rehabilitation|0|||
106067824|NCT00501293|365910798|FG000|Maintenance Period|Would not wear patch|1|||
106067825|NCT00501293|365910799|FG001|Maintenance Period|Would not wear patch|0|||
106067826|NCT00501293|365910798|FG000|Maintenance Period|Application site reaction|1|||
106067827|NCT00501293|365910799|FG001|Maintenance Period|Application site reaction|0|||
106067828|NCT00127712|365910801|FG000|Overall Study|Adverse Event|3|||
106067829|NCT00127712|365910802|FG001|Overall Study|Adverse Event|0|||
106067830|NCT00127712|365910801|FG000|Overall Study|Lack of GI access to continue|2|||
106067831|NCT00127712|365910802|FG001|Overall Study|Lack of GI access to continue|0|||
106067832|NCT01529346|365910808|FG000|Overall Study|Lost to Follow-up|2|||
106067833|NCT01529346|365910809|FG001|Overall Study|Lost to Follow-up|0|||
106067834|NCT01529346|365910810|FG002|Overall Study|Lost to Follow-up|1|||
106067835|NCT01529346|365910811|FG003|Overall Study|Lost to Follow-up|0|||
106067836|NCT01529346|365910812|FG004|Overall Study|Lost to Follow-up|0|||
106067837|NCT01529346|365910808|FG000|Overall Study|Other|0|||
106154513|NCT00650104|366225855|FG000|Overall Study|Adverse Event|17|||
106154514|NCT00650104|366225855|FG000|Overall Study|Death|2|||
106154515|NCT00650104|366225855|FG000|Overall Study|Withdrawal by Subject|11|||
106154516|NCT00650104|366225855|FG000|Overall Study|Physician Decision|7|||
106154517|NCT00650104|366225855|FG000|Overall Study|Lost to Follow-up|1|||
106154518|NCT00650104|366225855|FG000|Overall Study|Non-compliance|2|||
106067838|NCT01529346|365910809|FG001|Overall Study|Other|1|||
106067839|NCT01529346|365910810|FG002|Overall Study|Other|1|||
106067840|NCT01529346|365910811|FG003|Overall Study|Other|0|||
106067841|NCT01529346|365910812|FG004|Overall Study|Other|0|||
106067842|NCT02259582|365910813|FG000|Overall Study|Physician Decision|0|||
106067843|NCT02259582|365910814|FG001|Overall Study|Physician Decision|1|||
106067844|NCT02259582|365910815|FG002|Overall Study|Physician Decision|0|||
106067845|NCT02259582|365910813|FG000|Overall Study|Death|0|||
106067846|NCT02259582|365910814|FG001|Overall Study|Death|0|||
106067847|NCT02259582|365910815|FG002|Overall Study|Death|1|||
106067848|NCT02259582|365910813|FG000|Overall Study|Adverse Event|1|||
106067849|NCT02259582|365910814|FG001|Overall Study|Adverse Event|0|||
106067850|NCT02259582|365910815|FG002|Overall Study|Adverse Event|1|||
106067851|NCT02259582|365910813|FG000|Overall Study|Withdrawal by Subject|0|||
106067852|NCT02259582|365910814|FG001|Overall Study|Withdrawal by Subject|0|||
106067853|NCT02259582|365910815|FG002|Overall Study|Withdrawal by Subject|1|||
106067854|NCT02259582|365910813|FG000|Overall Study|Disease progression|14|||
106067855|NCT02259582|365910814|FG001|Overall Study|Disease progression|15|||
106067856|NCT02259582|365910815|FG002|Overall Study|Disease progression|17|||
106067857|NCT02259582|365910813|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
106067858|NCT02259582|365910814|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
106067859|NCT02259582|365910815|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
106067860|NCT00503308|365910816|FG000|Overall Study|Protocol Violation|2|||
106067861|NCT00503308|365910817|FG001|Overall Study|Protocol Violation|1|||
106067862|NCT03045081|365910818|FG000|Overall Study|Withdrawal by Subject|6|||
106067863|NCT03045081|365910819|FG001|Overall Study|Withdrawal by Subject|11|||
106067864|NCT02057198|365910820|FG000|Overall Study|Death|0|||
106067865|NCT02057198|365910821|FG001|Overall Study|Death|0|||
106067866|NCT02057198|365910822|FG002|Overall Study|Death|1|||
106067867|NCT02057198|365910820|FG000|Overall Study|Discharged early; lost to followup|0|||
106067868|NCT02057198|365910821|FG001|Overall Study|Discharged early; lost to followup|1|||
106067869|NCT02057198|365910822|FG002|Overall Study|Discharged early; lost to followup|0|||
106067870|NCT01163279|365910823|FG000|Overall Study|Withdrawal by Subject|2|||
106067871|NCT01163279|365910824|FG001|Overall Study|Withdrawal by Subject|0|||
106067872|NCT00453921|365910825|FG000|Overall Study|Withdrawal by Subject|1|||
106067873|NCT00453921|365910826|FG001|Overall Study|Withdrawal by Subject|1|||
106067874|NCT00453921|365910827|FG002|Overall Study|Withdrawal by Subject|1|||
106067875|NCT00453921|365910828|FG003|Overall Study|Withdrawal by Subject|1|||
106067876|NCT00453921|365910825|FG000|Overall Study|Lost to Follow-up|0|||
106067877|NCT00453921|365910826|FG001|Overall Study|Lost to Follow-up|0|||
106067878|NCT00453921|365910827|FG002|Overall Study|Lost to Follow-up|1|||
106067879|NCT00453921|365910828|FG003|Overall Study|Lost to Follow-up|0|||
106067880|NCT00174915|365910829|FG000|Overall Study|Lost to Follow-up|19|||
106067881|NCT00174915|365910830|FG001|Overall Study|Lost to Follow-up|17|||
106067882|NCT00174915|365910831|FG002|Overall Study|Lost to Follow-up|9|||
106067883|NCT00174915|365910832|FG003|Overall Study|Lost to Follow-up|17|||
106067884|NCT00174915|365910833|FG004|Overall Study|Lost to Follow-up|10|||
106067885|NCT00174915|365910829|FG000|Overall Study|Adverse Event|18|||
106067886|NCT00174915|365910830|FG001|Overall Study|Adverse Event|16|||
106067887|NCT00174915|365910831|FG002|Overall Study|Adverse Event|11|||
106067888|NCT00174915|365910832|FG003|Overall Study|Adverse Event|18|||
106067889|NCT00174915|365910833|FG004|Overall Study|Adverse Event|5|||
106067890|NCT00174915|365910829|FG000|Overall Study|Personal Reason(s)|16|||
106067891|NCT00174915|365910830|FG001|Overall Study|Personal Reason(s)|16|||
106067892|NCT00174915|365910831|FG002|Overall Study|Personal Reason(s)|9|||
106067893|NCT00174915|365910832|FG003|Overall Study|Personal Reason(s)|9|||
106067894|NCT00174915|365910833|FG004|Overall Study|Personal Reason(s)|9|||
106067895|NCT00174915|365910829|FG000|Overall Study|Other|15|||
106067896|NCT00174915|365910830|FG001|Overall Study|Other|8|||
106067897|NCT00174915|365910831|FG002|Overall Study|Other|6|||
106067898|NCT00174915|365910832|FG003|Overall Study|Other|5|||
106067899|NCT00174915|365910833|FG004|Overall Study|Other|3|||
106067900|NCT00174915|365910829|FG000|Overall Study|Gout Flare|13|||
106067901|NCT00174915|365910830|FG001|Overall Study|Gout Flare|6|||
106067902|NCT00174915|365910831|FG002|Overall Study|Gout Flare|8|||
106067903|NCT00174915|365910832|FG003|Overall Study|Gout Flare|1|||
106067904|NCT00174915|365910833|FG004|Overall Study|Gout Flare|0|||
106067905|NCT00174915|365910829|FG000|Overall Study|Protocol Violation|6|||
106067906|NCT00174915|365910830|FG001|Overall Study|Protocol Violation|3|||
106067907|NCT00174915|365910831|FG002|Overall Study|Protocol Violation|3|||
106067908|NCT00174915|365910832|FG003|Overall Study|Protocol Violation|6|||
106067909|NCT00174915|365910833|FG004|Overall Study|Protocol Violation|3|||
106067910|NCT00174915|365910829|FG000|Overall Study|Therapeutic Failure|6|||
106067911|NCT00174915|365910830|FG001|Overall Study|Therapeutic Failure|3|||
106067912|NCT00174915|365910831|FG002|Overall Study|Therapeutic Failure|2|||
106067913|NCT00174915|365910832|FG003|Overall Study|Therapeutic Failure|1|||
106067914|NCT00174915|365910833|FG004|Overall Study|Therapeutic Failure|3|||
106067915|NCT00460031|365910834|FG000|Overall Study|Adverse Event|5|||
106067916|NCT00460031|365910834|FG000|Overall Study|Withdrawal by Subject|5|||
106067917|NCT00460031|365910834|FG000|Overall Study|Death|1|||
106067918|NCT01770379|365910835|FG000|Overall Study|Technical issues|1|||
106067919|NCT01770379|365910836|FG001|Overall Study|Technical issues|0|||
106067920|NCT01770379|365910837|FG002|Overall Study|Technical issues|0|||
106067921|NCT01770379|365910835|FG000|Overall Study|Withdrawal by Subject|7|||
106067922|NCT01770379|365910836|FG001|Overall Study|Withdrawal by Subject|10|||
106067923|NCT01770379|365910837|FG002|Overall Study|Withdrawal by Subject|7|||
106067924|NCT01770379|365910835|FG000|Overall Study|study terminated by sponsor|22|||
106067925|NCT01770379|365910836|FG001|Overall Study|study terminated by sponsor|23|||
106067926|NCT01770379|365910837|FG002|Overall Study|study terminated by sponsor|22|||
106067927|NCT01770379|365910835|FG000|Overall Study|Protocol Violation|0|||
106067928|NCT01770379|365910836|FG001|Overall Study|Protocol Violation|1|||
106067929|NCT01770379|365910837|FG002|Overall Study|Protocol Violation|1|||
106067930|NCT01770379|365910835|FG000|Overall Study|Physician Decision|0|||
106067931|NCT01770379|365910836|FG001|Overall Study|Physician Decision|1|||
106067932|NCT01770379|365910837|FG002|Overall Study|Physician Decision|2|||
106067933|NCT01770379|365910835|FG000|Overall Study|Lost to Follow-up|0|||
106067934|NCT01770379|365910836|FG001|Overall Study|Lost to Follow-up|0|||
106067935|NCT01770379|365910837|FG002|Overall Study|Lost to Follow-up|2|||
106067936|NCT01770379|365910835|FG000|Overall Study|Lack of Efficacy|8|||
106067937|NCT01770379|365910836|FG001|Overall Study|Lack of Efficacy|6|||
106067938|NCT01770379|365910837|FG002|Overall Study|Lack of Efficacy|6|||
106067939|NCT01770379|365910835|FG000|Overall Study|Adverse Event|1|||
106067940|NCT01770379|365910836|FG001|Overall Study|Adverse Event|3|||
106067941|NCT01770379|365910837|FG002|Overall Study|Adverse Event|2|||
106067942|NCT00483379|365910841|FG000|Treatment Period|Adverse Event|1|||
106067943|NCT00483379|365910842|FG001|Treatment Period|Adverse Event|0|||
106067944|NCT00483379|365910841|FG000|Treatment Period|Withdrawal by Subject|1|||
106067945|NCT00483379|365910842|FG001|Treatment Period|Withdrawal by Subject|0|||
106067946|NCT04210310|365910844|FG000|Overall Study|Lost to Follow-up|32|||
106067947|NCT04210310|365910845|FG001|Overall Study|Lost to Follow-up|1|||
106067948|NCT01408914|365910851|FG000|Overall Study|Could not complete tx in protocol period|5|||
106067949|NCT01408914|365910852|FG001|Overall Study|Could not complete tx in protocol period|5|||
106067950|NCT01408914|365910853|FG002|Overall Study|Could not complete tx in protocol period|6|||
106067951|NCT01408914|365910851|FG000|Overall Study|Lost to Follow-up|4|||
106067952|NCT01408914|365910852|FG001|Overall Study|Lost to Follow-up|1|||
106067953|NCT01408914|365910853|FG002|Overall Study|Lost to Follow-up|2|||
106067954|NCT01408914|365910851|FG000|Overall Study|Physician Decision|1|||
106067955|NCT01408914|365910852|FG001|Overall Study|Physician Decision|1|||
106067956|NCT01408914|365910853|FG002|Overall Study|Physician Decision|0|||
106067957|NCT01408914|365910851|FG000|Overall Study|Withdrawal by Subject|1|||
106067958|NCT01408914|365910852|FG001|Overall Study|Withdrawal by Subject|0|||
106067959|NCT01408914|365910853|FG002|Overall Study|Withdrawal by Subject|1|||
106067960|NCT01408914|365910851|FG000|Overall Study|Moved out of study jurisdiction|1|||
106067961|NCT01408914|365910852|FG001|Overall Study|Moved out of study jurisdiction|1|||
106067962|NCT01408914|365910853|FG002|Overall Study|Moved out of study jurisdiction|0|||
106067963|NCT01408914|365910851|FG000|Overall Study|Late exclusion|0|||
106067964|NCT01408914|365910852|FG001|Overall Study|Late exclusion|3|||
106067965|NCT01408914|365910853|FG002|Overall Study|Late exclusion|3|||
106067966|NCT01408914|365910851|FG000|Overall Study|Change in local TB/HIV norms|0|||
106067967|NCT01408914|365910852|FG001|Overall Study|Change in local TB/HIV norms|1|||
106067968|NCT01408914|365910853|FG002|Overall Study|Change in local TB/HIV norms|1|||
106067969|NCT00137423|365910854|FG000|Overall Study|Adverse Event|7|||
106067970|NCT00137423|365910855|FG001|Overall Study|Adverse Event|9|||
106067971|NCT00137423|365910854|FG000|Overall Study|consent withdrawn|1|||
106067972|NCT00137423|365910855|FG001|Overall Study|consent withdrawn|1|||
106067973|NCT00137423|365910854|FG000|Overall Study|Lack of Efficacy|31|||
106067974|NCT00137423|365910855|FG001|Overall Study|Lack of Efficacy|33|||
106067975|NCT00137423|365910854|FG000|Overall Study|Death|0|||
106067976|NCT00137423|365910855|FG001|Overall Study|Death|1|||
106067977|NCT01928329|365910856|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
106067978|NCT01928329|365910857|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
106067979|NCT01928329|365910856|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
106067980|NCT01928329|365910857|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
106067981|NCT01928329|365910856|FG000|Overall Study|Adverse Event|5|||
106154519|NCT00650104|366225855|FG000|Overall Study|Sponsor Terminated Dosing|1|||
106154520|NCT00931710|366225856|FG000|Overall Study|Adverse Event|16|||
106067982|NCT01928329|365910857|FG001|Overall Study|Adverse Event|3|||
106067983|NCT01928329|365910856|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
106067984|NCT01928329|365910857|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
106067985|NCT01928329|365910856|FG000|Overall Study|Withdrawal by Subject|1|||
106067986|NCT01928329|365910857|FG001|Overall Study|Withdrawal by Subject|5|||
106067987|NCT01928329|365910856|FG000|Overall Study|Physician Decision|1|||
106154521|NCT00931710|366225857|FG001|Overall Study|Adverse Event|10|||
106154522|NCT00931710|366225856|FG000|Overall Study|Abnormal test procedure results|2|||
106067988|NCT01928329|365910857|FG001|Overall Study|Physician Decision|1|||
105865426|NCT01775189|365156808|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105865427|NCT01775189|365156809|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
105865428|NCT01775189|365156810|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105865429|NCT01775189|365156811|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105865430|NCT01775189|365156812|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
105865431|NCT01775189|365156813|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106067989|NCT03187262|365910858|FG000|Induction|Lack of Efficacy|2|||
106067990|NCT03187262|365910858|FG000|Induction|Progressive Disease|4|||
106067991|NCT03187262|365910858|FG000|Consolidation|Progressive Disease|5|||
106067992|NCT00278109|365910863|FG000|Overall Study|Adverse Event|3|||
106067993|NCT00278109|365910863|FG000|Overall Study|social circumstances|1|||
106067994|NCT02064166|365910864|FG000|Overall Study|Adverse Event|1|||
106067995|NCT02064166|365910865|FG001|Overall Study|Adverse Event|0|||
106067996|NCT01119131|365910874|FG000|Overall Study|Adverse Event|1|||
106067997|NCT01119131|365910875|FG001|Overall Study|Adverse Event|1|||
106067998|NCT01119131|365910876|FG002|Overall Study|Adverse Event|1|||
106067999|NCT01119131|365910874|FG000|Overall Study|Non-Compliance|1|||
106068000|NCT01119131|365910875|FG001|Overall Study|Non-Compliance|0|||
106068001|NCT01119131|365910876|FG002|Overall Study|Non-Compliance|4|||
106068002|NCT01119131|365910874|FG000|Overall Study|Physician Decision|0|||
106068003|NCT01119131|365910875|FG001|Overall Study|Physician Decision|0|||
106068004|NCT01119131|365910876|FG002|Overall Study|Physician Decision|1|||
106068005|NCT00909389|365910877|FG000|Overall Study|Adverse Event|6|||
106068006|NCT00909389|365910877|FG000|Overall Study|Death|4|||
106068007|NCT00909389|365910877|FG000|Overall Study|Poor Compliance|16|||
106068008|NCT00909389|365910877|FG000|Overall Study|Lost to Follow-up|4|||
106068009|NCT00909389|365910877|FG000|Overall Study|No Information|103|||
106068010|NCT04285879|365910880|FG000|Overall Study|Lost to Follow-up|1|||
106068011|NCT04285879|365910881|FG001|Overall Study|Lost to Follow-up|8|||
106068012|NCT04285879|365910880|FG000|Overall Study|medical/surgical exclusion|16|||
106068013|NCT04285879|365910881|FG001|Overall Study|medical/surgical exclusion|0|||
106068014|NCT00416078|365910884|FG000|Overall Study|Death|3|||
106068015|NCT00416078|365910885|FG001|Overall Study|Death|4|||
106068016|NCT00416078|365910884|FG000|Overall Study|Withdrawal by Subject|3|||
106068017|NCT00416078|365910885|FG001|Overall Study|Withdrawal by Subject|2|||
106068018|NCT00416078|365910884|FG000|Overall Study|Physician Decision|1|||
106068019|NCT00416078|365910885|FG001|Overall Study|Physician Decision|0|||
106068020|NCT00416078|365910884|FG000|Overall Study|Lost to Follow-up|4|||
106068021|NCT00416078|365910885|FG001|Overall Study|Lost to Follow-up|2|||
106068022|NCT01106898|365910887|FG000|Overall Study|Adverse Event|6|||
106068023|NCT01722071|365910888|FG000|Overall Study|Protocol Violation|1|||
106068024|NCT01722071|365910889|FG001|Overall Study|Protocol Violation|0|||
106068025|NCT02484729|365910892|FG000|Overall Study|Failure of IntelliCap Error|0|||
106068026|NCT02484729|365910893|FG001|Overall Study|Failure of IntelliCap Error|0|||
106068027|NCT02484729|365910894|FG002|Overall Study|Failure of IntelliCap Error|0|||
106068028|NCT02484729|365910895|FG003|Overall Study|Failure of IntelliCap Error|0|||
106068029|NCT02484729|365910896|FG004|Overall Study|Failure of IntelliCap Error|0|||
106068030|NCT02484729|365910897|FG005|Overall Study|Failure of IntelliCap Error|0|||
106068031|NCT02484729|365910898|FG006|Overall Study|Failure of IntelliCap Error|0|||
106068032|NCT02484729|365910899|FG007|Overall Study|Failure of IntelliCap Error|0|||
106068033|NCT02484729|365910900|FG008|Overall Study|Failure of IntelliCap Error|0|||
106068034|NCT02484729|365910901|FG009|Overall Study|Failure of IntelliCap Error|1|||
106068035|NCT03061331|365910902|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
106068036|NCT03061331|365910903|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
106068037|NCT00511667|365910904|FG000|Overall Study|Adverse Event|1|||
106068038|NCT00511667|365910905|FG001|Overall Study|Adverse Event|0|||
106068039|NCT00511667|365910904|FG000|Overall Study|Protocol Violation|1|||
106068040|NCT00511667|365910905|FG001|Overall Study|Protocol Violation|1|||
106068041|NCT00511667|365910904|FG000|Overall Study|Withdrawal by Subject|2|||
106068042|NCT00511667|365910905|FG001|Overall Study|Withdrawal by Subject|0|||
106068043|NCT00511667|365910904|FG000|Overall Study|Site terminated|6|||
106068044|NCT00511667|365910905|FG001|Overall Study|Site terminated|1|||
106068045|NCT00511667|365910904|FG000|Overall Study|Other|2|||
106068046|NCT00511667|365910905|FG001|Overall Study|Other|1|||
105865432|NCT01775189|365156814|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
106068047|NCT02699554|365912596|FG000|Overall Study|Lost to Follow-up|9|||
106068048|NCT02232425|365912608|FG000|Overall Study|Lost to Follow-up|6|||
106068049|NCT02232425|365912609|FG001|Overall Study|Lost to Follow-up|2|||
106068050|NCT02232425|365912608|FG000|Overall Study|Adverse Event|2|||
106068051|NCT02232425|365912609|FG001|Overall Study|Adverse Event|0|||
106068052|NCT02232425|365912608|FG000|Overall Study|Withdrawal by Subject|5|||
106068053|NCT02232425|365912609|FG001|Overall Study|Withdrawal by Subject|6|||
106068054|NCT02232425|365912608|FG000|Overall Study|Lack of Efficacy|1|||
106068055|NCT02232425|365912609|FG001|Overall Study|Lack of Efficacy|0|||
106068056|NCT03060447|365912610|FG000|Overall Study|Withdrawal by Subject|2|||
106068057|NCT03060447|365912611|FG001|Overall Study|Withdrawal by Subject|0|||
106068058|NCT04741074|365912618|FG000|Overall Study|Withdrawal by Subject|1|||
106068059|NCT04741074|365912619|FG001|Overall Study|Withdrawal by Subject|1|||
106068060|NCT04741074|365912618|FG000|Overall Study|Study terminated prematurely|1|||
106068061|NCT04741074|365912619|FG001|Overall Study|Study terminated prematurely|0|||
106068062|NCT02432846|365912620|FG000|Overall Study (4 Arms/Strata)|Death|3|||
106068063|NCT02432846|365912621|FG001|Overall Study (4 Arms/Strata)|Death|2|||
106068064|NCT02432846|365912622|FG002|Overall Study (4 Arms/Strata)|Death|4|||
106068065|NCT02432846|365912623|FG003|Overall Study (4 Arms/Strata)|Death|3|||
106068066|NCT02432846|365912624|FG004|Overall Study (4 Arms/Strata)|Death|0|||
106068067|NCT02432846|365912625|FG005|Overall Study (4 Arms/Strata)|Death|0|||
106068068|NCT02432846|365912620|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
106068069|NCT02432846|365912621|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
106068070|NCT02432846|365912622|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
106068071|NCT02432846|365912623|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
106068072|NCT02432846|365912624|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
106068073|NCT02432846|365912625|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
106068074|NCT02432846|365912620|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
106068075|NCT02432846|365912621|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
106068076|NCT02432846|365912622|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
106068077|NCT02432846|365912623|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
106068078|NCT02432846|365912624|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
106068079|NCT02432846|365912625|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
106068080|NCT02432846|365912620|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
106068081|NCT02432846|365912621|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
106068082|NCT02432846|365912622|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
106068083|NCT02432846|365912623|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
106068084|NCT02432846|365912624|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
106068085|NCT02432846|365912625|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
106068086|NCT02432846|365912620|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
106068087|NCT02432846|365912621|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
106068088|NCT02432846|365912622|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
106068089|NCT02432846|365912623|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
106068090|NCT02432846|365912624|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
106068091|NCT02432846|365912625|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
106068092|NCT02432846|365912620|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
106068093|NCT02432846|365912621|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
106068094|NCT02432846|365912622|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
106068095|NCT02432846|365912623|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
106068096|NCT02432846|365912624|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
106068097|NCT02432846|365912625|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
106068098|NCT02432846|365912620|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
106068099|NCT02432846|365912621|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
106068100|NCT02432846|365912622|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
106068101|NCT02432846|365912623|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
106068102|NCT02432846|365912624|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
106068103|NCT02432846|365912625|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
106068104|NCT02432846|365912620|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
106068105|NCT02432846|365912621|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
106068106|NCT02432846|365912622|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
106068107|NCT02432846|365912623|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
106068108|NCT02432846|365912624|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
106068109|NCT02432846|365912625|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
106068110|NCT02432846|365912620|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
106068111|NCT02432846|365912621|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
106068112|NCT02432846|365912622|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
106068113|NCT02432846|365912623|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
106068114|NCT02432846|365912624|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
106068115|NCT02432846|365912625|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
106068116|NCT02432846|365912620|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
106068117|NCT02432846|365912621|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
106068118|NCT02432846|365912622|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
106068119|NCT02432846|365912623|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
106068120|NCT02432846|365912624|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
106068121|NCT02432846|365912625|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
106068122|NCT02432846|365912620|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
106068123|NCT02432846|365912621|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
106068124|NCT02432846|365912622|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
106068125|NCT02432846|365912623|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
106068126|NCT02432846|365912624|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
106068127|NCT02432846|365912625|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
106068128|NCT02432846|365912620|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
106068129|NCT02432846|365912621|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
106068130|NCT02432846|365912622|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
106068131|NCT02432846|365912623|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
106068132|NCT02432846|365912624|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
106068133|NCT02432846|365912625|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
106068134|NCT02432846|365912620|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
106068135|NCT02432846|365912621|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
106068136|NCT02432846|365912622|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
106068137|NCT02432846|365912623|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
106068138|NCT02432846|365912624|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
106068139|NCT02432846|365912625|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
106068140|NCT02432846|365912620|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
106068141|NCT02432846|365912621|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
106068142|NCT02432846|365912622|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
106068143|NCT02432846|365912623|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
106068144|NCT02432846|365912624|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
106068145|NCT02432846|365912625|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
106068146|NCT00937157|365912629|FG000|Overall Study|Pregnancy|1|||
106068147|NCT00937157|365912629|FG000|Overall Study|Lost to Follow-up|3|||
106068148|NCT00469092|365912630|FG000|Overall Study|Adverse Event|5|||
106068149|NCT00469092|365912631|FG001|Overall Study|Adverse Event|4|||
106068150|NCT00469092|365912630|FG000|Overall Study|Lack of Efficacy|1|||
106068151|NCT00469092|365912631|FG001|Overall Study|Lack of Efficacy|0|||
106068152|NCT00469092|365912630|FG000|Overall Study|Lost to Follow-up|1|||
106068153|NCT00469092|365912631|FG001|Overall Study|Lost to Follow-up|2|||
106068154|NCT00469092|365912630|FG000|Overall Study|Protocol Violation|3|||
106068155|NCT00469092|365912631|FG001|Overall Study|Protocol Violation|3|||
106068156|NCT00469092|365912630|FG000|Overall Study|Withdrawal by Subject|4|||
106068157|NCT00469092|365912631|FG001|Overall Study|Withdrawal by Subject|4|||
106068158|NCT00469092|365912630|FG000|Overall Study|Withdrawal Criteria|3|||
106068159|NCT00469092|365912631|FG001|Overall Study|Withdrawal Criteria|4|||
106068160|NCT00469092|365912630|FG000|Overall Study|Incorrectly Randomised|4|||
106068161|NCT00469092|365912631|FG001|Overall Study|Incorrectly Randomised|3|||
106068162|NCT00469092|365912630|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
106068163|NCT00469092|365912631|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
106068164|NCT00469092|365912630|FG000|Overall Study|Use of lipid lowering drug|1|||
106068165|NCT00469092|365912631|FG001|Overall Study|Use of lipid lowering drug|0|||
106068166|NCT00469092|365912630|FG000|Overall Study|Hypoglycaemic Episodes|1|||
106068167|NCT00469092|365912631|FG001|Overall Study|Hypoglycaemic Episodes|1|||
106068168|NCT00469092|365912630|FG000|Overall Study|Abnormal lab value|1|||
106068169|NCT00469092|365912631|FG001|Overall Study|Abnormal lab value|0|||
106068170|NCT00469092|365912630|FG000|Overall Study|Use of Corticosteroid|1|||
106068171|NCT00469092|365912631|FG001|Overall Study|Use of Corticosteroid|0|||
106068172|NCT00450450|365912632|FG000|Overall Study|Death|1|||
106068173|NCT00450450|365912633|FG001|Overall Study|Death|3|||
106068174|NCT00450450|365912632|FG000|Overall Study|Relapse|2|||
106068175|NCT00450450|365912633|FG001|Overall Study|Relapse|0|||
106068176|NCT00450450|365912632|FG000|Overall Study|Missing Data|2|||
106068177|NCT00450450|365912633|FG001|Overall Study|Missing Data|0|||
106068178|NCT02024867|365912634|FG000|Overall Study|Protocol Violation|3|||
106068179|NCT02024867|365912635|FG001|Overall Study|Protocol Violation|3|||
106068180|NCT02024867|365912634|FG000|Overall Study|Lost to Follow-up|6|||
106068181|NCT02024867|365912635|FG001|Overall Study|Lost to Follow-up|4|||
106068182|NCT01086540|365912636|FG000|Overall Study|Death|3|||
106068183|NCT01086540|365912637|FG001|Overall Study|Death|1|||
106068184|NCT01086540|365912636|FG000|Overall Study|Physician Decision|2|||
106068185|NCT01086540|365912637|FG001|Overall Study|Physician Decision|1|||
106068186|NCT01086540|365912636|FG000|Overall Study|Addition of new therapy for PAH|1|||
106068187|NCT01086540|365912637|FG001|Overall Study|Addition of new therapy for PAH|0|||
106068188|NCT01998737|365912638|FG000|Overall Study|Corrupted database|23|||
106068189|NCT01998737|365912639|FG001|Overall Study|Corrupted database|0|||
106068190|NCT00227305|365912643|FG000|Overall Study|Adverse Event|40|||
106068191|NCT00227305|365912643|FG000|Overall Study|Withdrawal by Subject|42|||
106068192|NCT00227305|365912643|FG000|Overall Study|Lost to Follow-up|33|||
106068193|NCT00227305|365912643|FG000|Overall Study|Study specific discontinuation|13|||
106068194|NCT00227305|365912643|FG000|Overall Study|MOVED OUT OF AREA|3|||
106068195|NCT00227305|365912643|FG000|Overall Study|Lack of Efficacy|7|||
106068196|NCT00227305|365912643|FG000|Overall Study|Physician Decision|3|||
106068197|NCT00227305|365912643|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
106068198|NCT00227305|365912643|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
106068199|NCT00227305|365912643|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
106068200|NCT02118012|365912644|FG000|Overall Study|Adverse Event|0|||
106068201|NCT02118012|365912645|FG001|Overall Study|Adverse Event|1|||
106068202|NCT02118012|365912644|FG000|Overall Study|Physician Decision|0|||
106068203|NCT02118012|365912645|FG001|Overall Study|Physician Decision|1|||
106068204|NCT00268996|365912646|FG000|Overall Study|Adverse Event|11|||
106068205|NCT00268996|365912647|FG001|Overall Study|Adverse Event|7|||
106068206|NCT00268996|365912646|FG000|Overall Study|Lost to Follow-up|3|||
106068207|NCT00268996|365912647|FG001|Overall Study|Lost to Follow-up|1|||
106068208|NCT00268996|365912646|FG000|Overall Study|Withdrawal by Subject|5|||
106068209|NCT00268996|365912647|FG001|Overall Study|Withdrawal by Subject|11|||
106068210|NCT00268996|365912646|FG000|Overall Study|Non-compliance|1|||
106068211|NCT00268996|365912647|FG001|Overall Study|Non-compliance|0|||
106068212|NCT00268996|365912646|FG000|Overall Study|Other|1|||
106068213|NCT00268996|365912647|FG001|Overall Study|Other|1|||
106068214|NCT02733991|365912648|FG000|Overall Study|Adverse Event|1|||
106068215|NCT02733991|365912649|FG001|Overall Study|Adverse Event|0|||
106068216|NCT02733991|365912648|FG000|Overall Study|Withdrawal by Subject|0|||
106068217|NCT02733991|365912649|FG001|Overall Study|Withdrawal by Subject|5|||
106068218|NCT02268864|365912650|FG000|Overall Study|Withdrawal by Subject|2|||
106068219|NCT02268864|365912651|FG001|Overall Study|Withdrawal by Subject|0|||
106068220|NCT02268864|365912652|FG002|Overall Study|Withdrawal by Subject|0|||
106068221|NCT02268864|365912650|FG000|Overall Study|Death|0|||
106068222|NCT02268864|365912651|FG001|Overall Study|Death|1|||
106068223|NCT02268864|365912652|FG002|Overall Study|Death|0|||
106068224|NCT00680745|365912656|FG000|Overall Study|Withdrawal by Subject|8|||
106068225|NCT00680745|365912657|FG001|Overall Study|Withdrawal by Subject|3|||
106068226|NCT00680745|365912658|FG002|Overall Study|Withdrawal by Subject|2|||
106068227|NCT00680745|365912659|FG003|Overall Study|Withdrawal by Subject|8|||
106068228|NCT00680745|365912656|FG000|Overall Study|Lost to Follow-up|0|||
106068229|NCT00680745|365912657|FG001|Overall Study|Lost to Follow-up|1|||
106068230|NCT00680745|365912658|FG002|Overall Study|Lost to Follow-up|1|||
106068231|NCT00680745|365912659|FG003|Overall Study|Lost to Follow-up|0|||
106068232|NCT00680745|365912656|FG000|Overall Study|Death|1|||
106068233|NCT00680745|365912657|FG001|Overall Study|Death|0|||
106068234|NCT00680745|365912658|FG002|Overall Study|Death|1|||
106068235|NCT00680745|365912659|FG003|Overall Study|Death|0|||
106068236|NCT00680745|365912656|FG000|Overall Study|Adverse Event|5|||
106068237|NCT00680745|365912657|FG001|Overall Study|Adverse Event|3|||
106068238|NCT00680745|365912658|FG002|Overall Study|Adverse Event|3|||
106068239|NCT00680745|365912659|FG003|Overall Study|Adverse Event|3|||
106068240|NCT00680745|365912656|FG000|Overall Study|Poor/Non-compliance|0|||
106068241|NCT00680745|365912657|FG001|Overall Study|Poor/Non-compliance|3|||
106068242|NCT00680745|365912658|FG002|Overall Study|Poor/Non-compliance|0|||
106068243|NCT00680745|365912659|FG003|Overall Study|Poor/Non-compliance|0|||
106068244|NCT00680745|365912656|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
106068245|NCT00680745|365912657|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
106068246|NCT00680745|365912658|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
106068247|NCT00680745|365912659|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
106068248|NCT00680745|365912656|FG000|Overall Study|False Treatment|0|||
106068249|NCT00680745|365912657|FG001|Overall Study|False Treatment|1|||
106068250|NCT00680745|365912658|FG002|Overall Study|False Treatment|3|||
106068251|NCT00680745|365912659|FG003|Overall Study|False Treatment|0|||
106068252|NCT02101775|365912660|FG000|Overall Study|Adverse Event|4|||
106068253|NCT02101775|365912661|FG001|Overall Study|Adverse Event|0|||
106068254|NCT02101775|365912662|FG002|Overall Study|Adverse Event|0|||
106068255|NCT02101775|365912660|FG000|Overall Study|Admission to Hospital|0|||
106068256|NCT02101775|365912661|FG001|Overall Study|Admission to Hospital|1|||
106068257|NCT02101775|365912662|FG002|Overall Study|Admission to Hospital|0|||
106068258|NCT00730912|365912663|FG000|Overall Study|Discontinued|0|||
106068259|NCT00730912|365912664|FG001|Overall Study|Discontinued|0|||
106068260|NCT00730912|365912665|FG002|Overall Study|Discontinued|1|||
106068261|NCT01333059|365912666|FG000|Overall Study|Physician Decision|3|||
106068262|NCT01333059|365912667|FG001|Overall Study|Physician Decision|3|||
106068263|NCT01333059|365912666|FG000|Overall Study|Protocol Violation|3|||
106068264|NCT01333059|365912667|FG001|Overall Study|Protocol Violation|0|||
106068265|NCT01166763|365912668|FG000|Overall Study|Withdrawal by Subject|3|||
106068266|NCT04339296|365912669|FG000|Overall Study|Refuse to participate after allocation|1|||
106068267|NCT04339296|365912670|FG001|Overall Study|Refuse to participate after allocation|1|||
106068268|NCT04339296|365912669|FG000|Overall Study|Withdrew after completion of baseline|2|||
106068269|NCT04339296|365912670|FG001|Overall Study|Withdrew after completion of baseline|1|||
106068270|NCT04339296|365912669|FG000|Overall Study|Lost to Follow-up|0|||
106068271|NCT04339296|365912670|FG001|Overall Study|Lost to Follow-up|4|||
106068272|NCT04339296|365912669|FG000|Overall Study|Discontinued intervention|5|||
106068273|NCT04339296|365912670|FG001|Overall Study|Discontinued intervention|3|||
106068274|NCT00840294|365912674|FG000|Overall Study|Withdrawal by Subject|2|||
106068275|NCT00840294|365912675|FG001|Overall Study|Withdrawal by Subject|1|||
106068276|NCT00840294|365912674|FG000|Overall Study|Protocol Violation|1|||
106068277|NCT00840294|365912675|FG001|Overall Study|Protocol Violation|3|||
106068278|NCT00840294|365912674|FG000|Overall Study|Illness|0|||
106068279|NCT00840294|365912675|FG001|Overall Study|Illness|1|||
106068280|NCT01994629|365912676|FG000|Overall Study|Withdrawal by Subject|1|||
106068281|NCT01994629|365912677|FG001|Overall Study|Withdrawal by Subject|0|||
106068282|NCT01994629|365912676|FG000|Overall Study|Lost to Follow-up|0|||
106068283|NCT01994629|365912677|FG001|Overall Study|Lost to Follow-up|3|||
106068284|NCT01187043|365912678|FG000|Overall Study|Adverse Event|0|||
106068285|NCT01187043|365912679|FG001|Overall Study|Adverse Event|0|||
106068286|NCT01187043|365912680|FG002|Overall Study|Adverse Event|0|||
106068287|NCT01187043|365912681|FG003|Overall Study|Adverse Event|0|||
106068288|NCT01187043|365912682|FG004|Overall Study|Adverse Event|1|||
106068289|NCT01187043|365912678|FG000|Overall Study|Unable to make scheduled visits|1|||
106068290|NCT01187043|365912679|FG001|Overall Study|Unable to make scheduled visits|0|||
106068291|NCT01187043|365912680|FG002|Overall Study|Unable to make scheduled visits|4|||
106068292|NCT01187043|365912681|FG003|Overall Study|Unable to make scheduled visits|0|||
106068293|NCT01187043|365912682|FG004|Overall Study|Unable to make scheduled visits|1|||
106068294|NCT00383149|365912683|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
106068295|NCT00383149|365912683|FG000|Overall Study|Death|2|||
106068296|NCT00383149|365912683|FG000|Overall Study|Disease Progression|38|||
106068297|NCT00383149|365912683|FG000|Overall Study|Lost to Follow-up|1|||
106068298|NCT00383149|365912683|FG000|Overall Study|Other|1|||
106068299|NCT00383149|365912683|FG000|Overall Study|Study Drug Toxicity|4|||
106068300|NCT00383149|365912683|FG000|Overall Study|Request to Discontinue Treatment|4|||
106068301|NCT00383149|365912683|FG000|Overall Study|Participant Withdrew Consent|1|||
106068302|NCT00453544|365912694|FG000|Overall Study|Withdrawal by Subject|1|||
106068303|NCT00453544|365912695|FG001|Overall Study|Withdrawal by Subject|0|||
106068304|NCT00453544|365912696|FG002|Overall Study|Withdrawal by Subject|0|||
106068305|NCT00453544|365912697|FG003|Overall Study|Withdrawal by Subject|0|||
106068306|NCT00453544|365912694|FG000|Overall Study|Primary outcome measure not completed|1|||
106068307|NCT00453544|365912695|FG001|Overall Study|Primary outcome measure not completed|1|||
106068308|NCT00453544|365912696|FG002|Overall Study|Primary outcome measure not completed|0|||
106068309|NCT00453544|365912697|FG003|Overall Study|Primary outcome measure not completed|1|||
106068310|NCT02457910|365912698|FG000|Overall Study|Withdrawal by Subject|0|||
106068311|NCT02457910|365912699|FG001|Overall Study|Withdrawal by Subject|0|||
106068312|NCT02457910|365912700|FG002|Overall Study|Withdrawal by Subject|0|||
106068313|NCT02457910|365912701|FG003|Overall Study|Withdrawal by Subject|0|||
106068314|NCT02457910|365912702|FG004|Overall Study|Withdrawal by Subject|0|||
105865433|NCT01775189|365156808|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105865434|NCT01775189|365156809|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
105865435|NCT01775189|365156810|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
105865436|NCT01775189|365156811|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105865437|NCT01775189|365156812|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105865438|NCT01775189|365156813|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105865439|NCT01775189|365156814|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
105865440|NCT01775189|365156808|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105865441|NCT01775189|365156809|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105865442|NCT01775189|365156810|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105865443|NCT01775189|365156811|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105865444|NCT01775189|365156812|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105865445|NCT01775189|365156813|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
105865446|NCT01775189|365156814|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
105865447|NCT01775189|365156808|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105865448|NCT01775189|365156809|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105865449|NCT01775189|365156810|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
106068315|NCT02457910|365912703|FG005|Overall Study|Withdrawal by Subject|1|||
106068316|NCT02457910|365912698|FG000|Overall Study|Adverse Event|0|||
106068317|NCT02457910|365912699|FG001|Overall Study|Adverse Event|2|||
106068318|NCT02457910|365912700|FG002|Overall Study|Adverse Event|1|||
106068319|NCT02457910|365912701|FG003|Overall Study|Adverse Event|1|||
106068320|NCT02457910|365912702|FG004|Overall Study|Adverse Event|1|||
106068321|NCT02457910|365912703|FG005|Overall Study|Adverse Event|3|||
106068322|NCT02457910|365912698|FG000|Overall Study|Disease progression|3|||
106068323|NCT02457910|365912699|FG001|Overall Study|Disease progression|3|||
106068324|NCT02457910|365912700|FG002|Overall Study|Disease progression|1|||
105865450|NCT01775189|365156811|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
105865451|NCT01775189|365156812|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
106068325|NCT02457910|365912701|FG003|Overall Study|Disease progression|1|||
106068326|NCT02457910|365912702|FG004|Overall Study|Disease progression|4|||
106068327|NCT02457910|365912703|FG005|Overall Study|Disease progression|6|||
106068328|NCT02457910|365912698|FG000|Overall Study|Other complicating illness|0|||
105865452|NCT01775189|365156813|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105865453|NCT01775189|365156814|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
105865454|NCT01775189|365156808|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105865455|NCT01775189|365156809|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105865456|NCT01775189|365156810|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105865457|NCT01775189|365156811|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
105865458|NCT01775189|365156812|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105865459|NCT01775189|365156813|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
105865460|NCT01775189|365156814|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
105865461|NCT01275729|365156819|FG000|Overall Study|Death|3|||
105865462|NCT01275729|365156819|FG000|Overall Study|Withdrawal by Subject|1|||
105865463|NCT02842073|365156820|FG000|Overall Study|Withdrawal by Subject|1|||
105865464|NCT01333397|365156827|FG000|Overall Study|Lost to Follow-up|1|||
105865465|NCT01333397|365156828|FG001|Overall Study|Lost to Follow-up|0|||
105865466|NCT01333397|365156829|FG002|Overall Study|Lost to Follow-up|0|||
105865467|NCT01333397|365156830|FG003|Overall Study|Lost to Follow-up|1|||
105865468|NCT01333397|365156831|FG004|Overall Study|Lost to Follow-up|0|||
105865469|NCT04172597|365156832|FG000|Overall Study|Disease Progression|0|||
105865470|NCT04172597|365156833|FG001|Overall Study|Disease Progression|0|||
105865471|NCT04172597|365156834|FG002|Overall Study|Disease Progression|0|||
105865472|NCT04172597|365156835|FG003|Overall Study|Disease Progression|0|||
105865473|NCT04172597|365156836|FG004|Overall Study|Disease Progression|1|||
105865474|NCT00794339|365156837|FG000|Overall Study|Withdrawal by Subject|3|||
105865475|NCT00794339|365156837|FG000|Overall Study|Ineligible|4|||
105865476|NCT00794339|365156837|FG000|Overall Study|Tx prior to ATSM|3|||
105865477|NCT00794339|365156837|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
105865478|NCT00794339|365156837|FG000|Overall Study|Tx not per protocol|1|||
105865479|NCT03201445|365156842|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
105865480|NCT03201445|365156843|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
105865481|NCT03201445|365156842|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
105865482|NCT03201445|365156843|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
105865483|NCT03201445|365156842|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
105865484|NCT03201445|365156843|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
105865485|NCT03201445|365156842|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
105865486|NCT03201445|365156843|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
105865487|NCT03201445|365156842|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
105865488|NCT03201445|365156843|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
106068329|NCT02457910|365912699|FG001|Overall Study|Other complicating illness|0|||
106068330|NCT02457910|365912700|FG002|Overall Study|Other complicating illness|0|||
106068331|NCT02457910|365912701|FG003|Overall Study|Other complicating illness|0|||
106068332|NCT02457910|365912702|FG004|Overall Study|Other complicating illness|0|||
106068333|NCT02457910|365912703|FG005|Overall Study|Other complicating illness|1|||
106068334|NCT02457910|365912698|FG000|Overall Study|Death|0|||
106068335|NCT02457910|365912699|FG001|Overall Study|Death|0|||
106068336|NCT02457910|365912700|FG002|Overall Study|Death|1|||
106068337|NCT02457910|365912701|FG003|Overall Study|Death|0|||
106068338|NCT02457910|365912702|FG004|Overall Study|Death|0|||
106068339|NCT02457910|365912703|FG005|Overall Study|Death|0|||
106068340|NCT00619801|365912704|FG000|Overall Study|Lack of Efficacy|0|||
106068341|NCT00619801|365912705|FG001|Overall Study|Lack of Efficacy|1|||
106068342|NCT00619801|365912704|FG000|Overall Study|Withdrawal by Subject|1|||
106068343|NCT00619801|365912705|FG001|Overall Study|Withdrawal by Subject|1|||
106068344|NCT00619801|365912704|FG000|Overall Study|Loss of efficacy|0|||
106068345|NCT00619801|365912705|FG001|Overall Study|Loss of efficacy|1|||
106068346|NCT03721276|365912708|FG000|Overall Study|Lost to Follow-up|5|||
106068347|NCT03721276|365912709|FG001|Overall Study|Lost to Follow-up|3|||
106068348|NCT03721276|365912708|FG000|Overall Study|Adverse Event|0|||
106068349|NCT03721276|365912709|FG001|Overall Study|Adverse Event|1|||
106068350|NCT00450333|365912712|FG000|Overall Study|Study terminated|47|||
106068351|NCT00450333|365912713|FG001|Overall Study|Study terminated|54|||
106068352|NCT00450333|365912714|FG002|Overall Study|Study terminated|16|||
106068353|NCT00450333|365912715|FG003|Overall Study|Study terminated|21|||
106068354|NCT00450333|365912712|FG000|Overall Study|Adverse Event|1|||
106068355|NCT00450333|365912713|FG001|Overall Study|Adverse Event|7|||
106154523|NCT00931710|366225857|FG001|Overall Study|Abnormal test procedure results|0|||
106154524|NCT00931710|366225856|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
106154525|NCT00931710|366225857|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
106068356|NCT00450333|365912714|FG002|Overall Study|Adverse Event|2|||
106068357|NCT00450333|365912715|FG003|Overall Study|Adverse Event|2|||
106154526|NCT00931710|366225856|FG000|Overall Study|Patient withdrew consent|4|||
106154527|NCT00931710|366225857|FG001|Overall Study|Patient withdrew consent|9|||
106154528|NCT00931710|366225856|FG000|Overall Study|Lost to Follow-up|6|||
106154529|NCT00931710|366225857|FG001|Overall Study|Lost to Follow-up|5|||
105865489|NCT03201445|365156842|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
105865490|NCT03201445|365156843|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
105865491|NCT03201445|365156842|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
105865492|NCT03201445|365156843|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
106068358|NCT00450333|365912712|FG000|Overall Study|Protocol Violation|1|||
106068359|NCT00450333|365912713|FG001|Overall Study|Protocol Violation|0|||
106154530|NCT00931710|366225856|FG000|Overall Study|Protocol deviation|1|||
106154531|NCT00931710|366225857|FG001|Overall Study|Protocol deviation|2|||
106154532|NCT05623345|366225866|FG000|Overall Study|Withdrawal by Subject|14|||
106154533|NCT05623345|366225867|FG001|Overall Study|Withdrawal by Subject|0|||
106154534|NCT05623345|366225868|FG002|Overall Study|Withdrawal by Subject|9|||
106068360|NCT00450333|365912714|FG002|Overall Study|Protocol Violation|1|||
106068361|NCT00450333|365912715|FG003|Overall Study|Protocol Violation|0|||
106068362|NCT00450333|365912712|FG000|Overall Study|Withdrawal by Subject|1|||
106068363|NCT00450333|365912713|FG001|Overall Study|Withdrawal by Subject|0|||
106068364|NCT00450333|365912714|FG002|Overall Study|Withdrawal by Subject|3|||
106068365|NCT00450333|365912715|FG003|Overall Study|Withdrawal by Subject|0|||
106068366|NCT00450333|365912712|FG000|Overall Study|Kidney transplant|1|||
106068367|NCT00450333|365912713|FG001|Overall Study|Kidney transplant|0|||
106068368|NCT00450333|365912714|FG002|Overall Study|Kidney transplant|1|||
106068369|NCT00450333|365912715|FG003|Overall Study|Kidney transplant|3|||
106068370|NCT00450333|365912712|FG000|Overall Study|Death|3|||
106068371|NCT00450333|365912713|FG001|Overall Study|Death|2|||
106068372|NCT00450333|365912714|FG002|Overall Study|Death|2|||
106068373|NCT00450333|365912715|FG003|Overall Study|Death|2|||
106068374|NCT02196558|365912720|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
106068375|NCT02196558|365912721|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
106068376|NCT02196558|365912722|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
106068377|NCT02196558|365912720|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
106068378|NCT02196558|365912721|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
106068379|NCT02196558|365912722|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
106068380|NCT02196558|365912720|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
106068381|NCT02196558|365912721|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
106068382|NCT02196558|365912722|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
106068383|NCT02196558|365912720|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
106068384|NCT02196558|365912721|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
106068385|NCT02196558|365912722|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
106068386|NCT02196558|365912720|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
106068387|NCT02196558|365912721|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
106068388|NCT02196558|365912722|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
106068389|NCT02375113|365912723|FG000|Overall Study|Undisclosed Reason(s).|1|||
106068390|NCT02375113|365912724|FG001|Overall Study|Undisclosed Reason(s).|1|||
106068391|NCT02375113|365912723|FG000|Overall Study|Poor adherence (<70%).|1|||
106068392|NCT02375113|365912724|FG001|Overall Study|Poor adherence (<70%).|0|||
106068393|NCT02375113|365912723|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
106068394|NCT02375113|365912724|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
106068395|NCT00296374|365912731|FG000|Overall Study|Adverse Event|14|||
106068396|NCT00296374|365912732|FG001|Overall Study|Adverse Event|10|||
106068397|NCT00296374|365912733|FG002|Overall Study|Adverse Event|7|||
106068398|NCT00296374|365912731|FG000|Overall Study|Withdrawal by Subject|3|||
106068399|NCT00296374|365912732|FG001|Overall Study|Withdrawal by Subject|5|||
106068400|NCT00296374|365912733|FG002|Overall Study|Withdrawal by Subject|11|||
106068401|NCT00296374|365912731|FG000|Overall Study|Incorrect enrollment|3|||
106068402|NCT00296374|365912732|FG001|Overall Study|Incorrect enrollment|3|||
106068403|NCT00296374|365912733|FG002|Overall Study|Incorrect enrollment|4|||
106068404|NCT00296374|365912731|FG000|Overall Study|Protocol Violation|1|||
106068405|NCT00296374|365912732|FG001|Overall Study|Protocol Violation|2|||
106068406|NCT00296374|365912733|FG002|Overall Study|Protocol Violation|3|||
106068407|NCT00296374|365912731|FG000|Overall Study|Lost to Follow-up|3|||
106068408|NCT00296374|365912732|FG001|Overall Study|Lost to Follow-up|1|||
106068409|NCT00296374|365912733|FG002|Overall Study|Lost to Follow-up|1|||
106068410|NCT00296374|365912731|FG000|Overall Study|Relocated to another state|1|||
106068411|NCT00296374|365912732|FG001|Overall Study|Relocated to another state|0|||
106068412|NCT00296374|365912733|FG002|Overall Study|Relocated to another state|0|||
106068413|NCT00296374|365912731|FG000|Overall Study|Stopped drug before end of study visit|0|||
106068414|NCT00296374|365912732|FG001|Overall Study|Stopped drug before end of study visit|1|||
106068415|NCT00296374|365912733|FG002|Overall Study|Stopped drug before end of study visit|0|||
106068416|NCT00296374|365912731|FG000|Overall Study|Nephrologist introduced ACE|0|||
106068417|NCT00296374|365912732|FG001|Overall Study|Nephrologist introduced ACE|1|||
106068418|NCT00296374|365912733|FG002|Overall Study|Nephrologist introduced ACE|0|||
106068419|NCT00296374|365912731|FG000|Overall Study|Pregnancy|0|||
106068420|NCT00296374|365912732|FG001|Overall Study|Pregnancy|0|||
106068421|NCT00296374|365912733|FG002|Overall Study|Pregnancy|2|||
106068422|NCT00296374|365912731|FG000|Overall Study|Other|0|||
105865493|NCT03201445|365156842|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
105865494|NCT03201445|365156843|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
105865495|NCT03201445|365156842|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
106068423|NCT00296374|365912732|FG001|Overall Study|Other|0|||
105865496|NCT03201445|365156843|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
105865497|NCT03201445|365156842|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
105865498|NCT03201445|365156843|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
105865499|NCT03201445|365156842|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
105865500|NCT03201445|365156843|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
105865501|NCT03201445|365156842|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
105865502|NCT03201445|365156843|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
105865503|NCT03201445|365156842|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
105865504|NCT03201445|365156843|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
105865505|NCT03201445|365156842|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
105865506|NCT03201445|365156843|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
105865507|NCT03201445|365156842|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
105865508|NCT03201445|365156843|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
105865509|NCT03201445|365156842|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
105865510|NCT03201445|365156843|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
105865511|NCT03201445|365156842|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
105865512|NCT03201445|365156843|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
105865513|NCT03201445|365156842|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
105865514|NCT03201445|365156843|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
105865515|NCT03201445|365156842|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
105865516|NCT03201445|365156843|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
105865517|NCT03201445|365156842|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
105865518|NCT03201445|365156843|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
105865519|NCT03201445|365156842|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
105865520|NCT03201445|365156843|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
105865521|NCT02952586|365156844|FG000|Lead-In Phase (7 Days)|Death|0|||
105865522|NCT02952586|365156845|FG001|Lead-In Phase (7 Days)|Death|1|||
105865523|NCT02952586|365156844|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
105865524|NCT02952586|365156845|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
105865525|NCT02952586|365156844|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
105865526|NCT02952586|365156845|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
105865527|NCT02952586|365156844|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
105865528|NCT02952586|365156845|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
105865529|NCT02952586|365156844|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
105865530|NCT02952586|365156845|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
105865531|NCT02952586|365156844|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
105865532|NCT02952586|365156845|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
105865533|NCT02952586|365156844|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
105865534|NCT02952586|365156845|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
105865535|NCT02952586|365156844|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
105865536|NCT02952586|365156845|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
105865537|NCT02952586|365156844|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
105865538|NCT02952586|365156845|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
105865539|NCT02952586|365156844|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
105865540|NCT02952586|365156845|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
105865541|NCT02952586|365156844|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
105865542|NCT02952586|365156845|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
105865543|NCT02952586|365156844|FG000|CRT for Cisplatin (63 Days)|Death|3|||
105865544|NCT02952586|365156845|FG001|CRT for Cisplatin (63 Days)|Death|8|||
106068424|NCT00296374|365912733|FG002|Overall Study|Other|1|||
106068425|NCT01980875|365912737|FG000|Overall Study|Withdrew Consent|1|||
106068426|NCT01980875|365912738|FG001|Overall Study|Withdrew Consent|1|||
106068427|NCT01980875|365912739|FG002|Overall Study|Withdrew Consent|1|||
106068428|NCT01980875|365912737|FG000|Overall Study|Study Terminated by Sponsor|7|||
106068429|NCT01980875|365912738|FG001|Overall Study|Study Terminated by Sponsor|24|||
106068430|NCT01980875|365912739|FG002|Overall Study|Study Terminated by Sponsor|22|||
106068431|NCT01980875|365912737|FG000|Overall Study|Lost to Follow-up|0|||
106068432|NCT01980875|365912738|FG001|Overall Study|Lost to Follow-up|0|||
106068433|NCT01980875|365912739|FG002|Overall Study|Lost to Follow-up|1|||
106068434|NCT01189812|365912740|FG000|Overall Study|Withdrawal by Subject|2|||
106068435|NCT01189812|365912741|FG001|Overall Study|Withdrawal by Subject|3|||
106068436|NCT01189812|365912740|FG000|Overall Study|Adverse Event|1|||
106068437|NCT01189812|365912741|FG001|Overall Study|Adverse Event|0|||
106068438|NCT01189812|365912740|FG000|Overall Study|Out of Window|4|||
106068439|NCT01189812|365912741|FG001|Overall Study|Out of Window|3|||
106068440|NCT01189812|365912740|FG000|Overall Study|Moved out of State|1|||
106068441|NCT01189812|365912741|FG001|Overall Study|Moved out of State|2|||
106068442|NCT00616655|365912742|FG000|Overall Study|Adverse Event|10|||
106068443|NCT00616655|365912743|FG001|Overall Study|Adverse Event|7|||
105865545|NCT02952586|365156844|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
105865546|NCT02952586|365156845|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
105865547|NCT02952586|365156844|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
106068444|NCT00616655|365912744|FG002|Overall Study|Adverse Event|12|||
106068445|NCT00616655|365912742|FG000|Overall Study|Lack of Efficacy|5|||
106068446|NCT00616655|365912743|FG001|Overall Study|Lack of Efficacy|5|||
105865548|NCT02952586|365156845|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
106068447|NCT00616655|365912744|FG002|Overall Study|Lack of Efficacy|5|||
106068448|NCT00616655|365912742|FG000|Overall Study|Lost to Follow-up|3|||
105865549|NCT02952586|365156844|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
105865550|NCT02952586|365156845|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
105865551|NCT02952586|365156844|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
105865552|NCT02952586|365156845|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
105865553|NCT02952586|365156844|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
105865554|NCT02952586|365156845|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
105865555|NCT02952586|365156844|FG000|CRT for Cisplatin (63 Days)|Other|1|||
105865556|NCT02952586|365156845|FG001|CRT for Cisplatin (63 Days)|Other|1|||
106068449|NCT00616655|365912743|FG001|Overall Study|Lost to Follow-up|12|||
105865557|NCT02952586|365156844|FG000|CRT for IMRT (63 Days)|Death|5|||
106068450|NCT00616655|365912744|FG002|Overall Study|Lost to Follow-up|10|||
106068451|NCT00616655|365912742|FG000|Overall Study|Protocol Violation|2|||
106068452|NCT00616655|365912743|FG001|Overall Study|Protocol Violation|4|||
105865558|NCT02952586|365156845|FG001|CRT for IMRT (63 Days)|Death|8|||
105865559|NCT02952586|365156844|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
105865560|NCT02952586|365156845|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
105865561|NCT02952586|365156844|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
105865562|NCT02952586|365156845|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
105865563|NCT02952586|365156844|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
105865564|NCT02952586|365156845|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
105865565|NCT02952586|365156844|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
105865566|NCT02952586|365156845|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
105865567|NCT02952586|365156844|FG000|CRT for IMRT (63 Days)|Other|1|||
105865568|NCT02952586|365156845|FG001|CRT for IMRT (63 Days)|Other|0|||
105865569|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Death|17|||
105865570|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Death|11|||
105865571|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
105865572|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
105865573|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
105865574|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
105865575|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
105865576|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
105865577|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
105865578|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
105865579|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
105865580|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
105865581|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
105865582|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
105865583|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
105865584|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
105865585|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Other|2|||
105865586|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Other|1|||
105865587|NCT02952586|365156844|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
105865588|NCT02952586|365156845|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
105865589|NCT02952586|365156844|FG000|Follow-Up Phase (90 Days)|Death|12|||
105865590|NCT02952586|365156845|FG001|Follow-Up Phase (90 Days)|Death|10|||
105865591|NCT02952586|365156844|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
105865592|NCT02952586|365156845|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
105865593|NCT02952586|365156844|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
105865594|NCT02952586|365156845|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
105865595|NCT02952586|365156844|FG000|Follow-Up Phase (90 Days)|Other|7|||
105865596|NCT02952586|365156845|FG001|Follow-Up Phase (90 Days)|Other|5|||
105865597|NCT02952586|365156844|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
106068453|NCT00616655|365912744|FG002|Overall Study|Protocol Violation|3|||
106068454|NCT00616655|365912742|FG000|Overall Study|Withdrawal by Subject|9|||
106068455|NCT00616655|365912743|FG001|Overall Study|Withdrawal by Subject|7|||
106068456|NCT00616655|365912744|FG002|Overall Study|Withdrawal by Subject|11|||
106068457|NCT00616655|365912742|FG000|Overall Study|Does not meet in/ex criteria|0|||
106068458|NCT00616655|365912743|FG001|Overall Study|Does not meet in/ex criteria|0|||
106068459|NCT00616655|365912744|FG002|Overall Study|Does not meet in/ex criteria|2|||
106068460|NCT00616655|365912742|FG000|Overall Study|Other|6|||
106068461|NCT00616655|365912743|FG001|Overall Study|Other|6|||
106068462|NCT00616655|365912744|FG002|Overall Study|Other|5|||
106068463|NCT03605303|365912746|FG000|Period 1|Study Terminated|2|||
106068464|NCT03605303|365912747|FG001|Period 1|Study Terminated|1|||
106068465|NCT00423150|365912750|FG000|Overall Study|Adverse Event|11|||
106068466|NCT00423150|365912750|FG000|Overall Study|Progression of disease being studied|69|||
106068467|NCT00423150|365912750|FG000|Overall Study|Withdrawal by Subject|1|||
106068468|NCT00423150|365912750|FG000|Overall Study|Non-compliance with protocol|1|||
106154535|NCT05623345|366225869|FG003|Overall Study|Withdrawal by Subject|20|||
106154536|NCT05623345|366225866|FG000|Overall Study|Lost to Follow-up|3|||
106154537|NCT05623345|366225867|FG001|Overall Study|Lost to Follow-up|0|||
106154538|NCT05623345|366225868|FG002|Overall Study|Lost to Follow-up|7|||
106154539|NCT05623345|366225869|FG003|Overall Study|Lost to Follow-up|2|||
106154540|NCT05623345|366225866|FG000|Overall Study|Termination of Study By Sponsor|37|||
106154541|NCT05623345|366225867|FG001|Overall Study|Termination of Study By Sponsor|4|||
106154542|NCT05623345|366225868|FG002|Overall Study|Termination of Study By Sponsor|40|||
106154543|NCT05623345|366225869|FG003|Overall Study|Termination of Study By Sponsor|38|||
106154544|NCT01385176|366225870|FG000|Randomization Phase|Death|1|||
106154545|NCT01385176|366225871|FG001|Randomization Phase|Death|2|||
106154546|NCT01385176|366225870|FG000|6-18 Month All VNS Active|Death|1|||
106154547|NCT01385176|366225871|FG001|6-18 Month All VNS Active|Death|2|||
106154548|NCT01385176|366225870|FG000|6-18 Month All VNS Active|Physician Decision|0|||
106154549|NCT01385176|366225871|FG001|6-18 Month All VNS Active|Physician Decision|1|||
106154550|NCT01385176|366225870|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
106154551|NCT01385176|366225871|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
105865598|NCT02952586|365156845|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
105865599|NCT02952586|365156844|FG000|LT Follow-up (up to 45 Months)|Death|51|||
105865600|NCT02952586|365156845|FG001|LT Follow-up (up to 45 Months)|Death|31|||
105865601|NCT02952586|365156844|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
105865602|NCT02952586|365156845|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
105865603|NCT02952586|365156844|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
105865604|NCT02952586|365156845|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
105865605|NCT02952586|365156844|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
105865606|NCT02952586|365156845|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
105865607|NCT05320887|365156848|FG000|Overall Study|Lost to Follow-up|0|||
105865608|NCT05320887|365156849|FG001|Overall Study|Lost to Follow-up|3|||
105865609|NCT05320887|365156850|FG002|Overall Study|Lost to Follow-up|0|||
105865610|NCT05320887|365156851|FG003|Overall Study|Lost to Follow-up|0|||
105865611|NCT02620579|365156854|FG000|Overall Study|Physician Decision|0|||
106068469|NCT00423150|365912750|FG000|Overall Study|Administrative|4|||
106068470|NCT03204305|365912751|FG000|Overall Study|Lost to Follow-up|6|||
106068471|NCT03204305|365912752|FG001|Overall Study|Lost to Follow-up|4|||
106068472|NCT03204305|365912753|FG002|Overall Study|Lost to Follow-up|0|||
106068473|NCT03204305|365912754|FG003|Overall Study|Lost to Follow-up|0|||
106068474|NCT03204305|365912751|FG000|Overall Study|Physician Decision|1|||
106068475|NCT03204305|365912752|FG001|Overall Study|Physician Decision|0|||
106068476|NCT03204305|365912753|FG002|Overall Study|Physician Decision|0|||
106068477|NCT03204305|365912754|FG003|Overall Study|Physician Decision|0|||
106068478|NCT03204305|365912751|FG000|Overall Study|failure to place arterial line|2|||
106068479|NCT03204305|365912752|FG001|Overall Study|failure to place arterial line|1|||
106068480|NCT03204305|365912753|FG002|Overall Study|failure to place arterial line|0|||
106068481|NCT03204305|365912754|FG003|Overall Study|failure to place arterial line|0|||
106068482|NCT03204305|365912751|FG000|Overall Study|Withdrawal by Subject|2|||
106068483|NCT03204305|365912752|FG001|Overall Study|Withdrawal by Subject|0|||
106068484|NCT03204305|365912753|FG002|Overall Study|Withdrawal by Subject|0|||
106068485|NCT03204305|365912754|FG003|Overall Study|Withdrawal by Subject|0|||
106068486|NCT00455429|365912755|FG000|Overall Study|Study Terminated by Sponsor|0|||
106068487|NCT00455429|365912756|FG001|Overall Study|Study Terminated by Sponsor|0|||
106154552|NCT01385176|366225870|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
106154553|NCT01385176|366225871|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
106154554|NCT05384730|366225874|FG000|Overall Study|Adverse Event|1|||
106154555|NCT05384730|366225875|FG001|Overall Study|Adverse Event|0|||
106154556|NCT05384730|366225874|FG000|Overall Study|Lack of social support|2|||
106154557|NCT05384730|366225875|FG001|Overall Study|Lack of social support|0|||
106154558|NCT05384730|366225874|FG000|Overall Study|Hospital readmission|2|||
106154559|NCT05384730|366225875|FG001|Overall Study|Hospital readmission|0|||
106154560|NCT05384730|366225874|FG000|Overall Study|Disease progression|5|||
106154561|NCT05384730|366225875|FG001|Overall Study|Disease progression|0|||
106154562|NCT05384730|366225874|FG000|Overall Study|Overwhelmed with College commitments|0|||
106154563|NCT05384730|366225875|FG001|Overall Study|Overwhelmed with College commitments|2|||
106154564|NCT02638337|366225882|FG000|Overall Study|Adverse Event|6|||
106154565|NCT02638337|366225883|FG001|Overall Study|Adverse Event|10|||
106154566|NCT02638337|366225882|FG000|Overall Study|Protocol Violation|3|||
106154567|NCT02638337|366225883|FG001|Overall Study|Protocol Violation|0|||
106154568|NCT02638337|366225882|FG000|Overall Study|Withdrawal by Subject|13|||
106154569|NCT02638337|366225883|FG001|Overall Study|Withdrawal by Subject|16|||
106154570|NCT02638337|366225882|FG000|Overall Study|Lost to Follow-up|7|||
106154571|NCT02638337|366225883|FG001|Overall Study|Lost to Follow-up|7|||
106154572|NCT02638337|366225882|FG000|Overall Study|Other - Miscellaneous|4|||
106154573|NCT02638337|366225883|FG001|Overall Study|Other - Miscellaneous|3|||
106154574|NCT02965846|366225885|FG000|Overall Study|Lost to Follow-up|1|||
106154575|NCT02965846|366225886|FG001|Overall Study|Lost to Follow-up|0|||
106154576|NCT02965846|366225887|FG002|Overall Study|Lost to Follow-up|0|||
106154577|NCT02965846|366225885|FG000|Overall Study|Withdrawal by Subject|0|||
106154578|NCT02965846|366225886|FG001|Overall Study|Withdrawal by Subject|1|||
106154579|NCT02965846|366225887|FG002|Overall Study|Withdrawal by Subject|0|||
106154580|NCT02965846|366225885|FG000|Overall Study|Study Terminated By Sponsor|4|||
106154581|NCT02965846|366225886|FG001|Overall Study|Study Terminated By Sponsor|4|||
106154582|NCT02965846|366225887|FG002|Overall Study|Study Terminated By Sponsor|0|||
106154583|NCT02965846|366225885|FG000|Overall Study|Participants not randomized|0|||
106154584|NCT02965846|366225886|FG001|Overall Study|Participants not randomized|0|||
106154585|NCT02965846|366225887|FG002|Overall Study|Participants not randomized|33|||
106154586|NCT00879333|366225888|FG000|Overall Study|Adverse Event|94|||
105865612|NCT02620579|365156855|FG001|Overall Study|Physician Decision|0|||
106154587|NCT00879333|366225889|FG001|Overall Study|Adverse Event|34|||
105865613|NCT02620579|365156856|FG002|Overall Study|Physician Decision|0|||
106068488|NCT00455429|365912757|FG002|Overall Study|Study Terminated by Sponsor|0|||
106068489|NCT00455429|365912758|FG003|Overall Study|Study Terminated by Sponsor|3|||
106154588|NCT00879333|366225888|FG000|Overall Study|Abnormal Laboratory Value|1|||
106154589|NCT00879333|366225889|FG001|Overall Study|Abnormal Laboratory Value|0|||
106154590|NCT00879333|366225888|FG000|Overall Study|Withdrawal by Subject|20|||
106154591|NCT00879333|366225889|FG001|Overall Study|Withdrawal by Subject|7|||
106154592|NCT00879333|366225888|FG000|Overall Study|Lost to Follow-up|2|||
106154593|NCT00879333|366225889|FG001|Overall Study|Lost to Follow-up|1|||
106154594|NCT00879333|366225888|FG000|Overall Study|Administrative Problems|2|||
106154595|NCT00879333|366225889|FG001|Overall Study|Administrative Problems|0|||
106154596|NCT00879333|366225888|FG000|Overall Study|Death|16|||
106154597|NCT00879333|366225889|FG001|Overall Study|Death|5|||
106154598|NCT00879333|366225888|FG000|Overall Study|Disease Progression|292|||
106154599|NCT00879333|366225889|FG001|Overall Study|Disease Progression|169|||
106154600|NCT00879333|366225888|FG000|Overall Study|Protocol Violation|1|||
106154601|NCT00879333|366225889|FG001|Overall Study|Protocol Violation|1|||
106154602|NCT00951379|366225890|FG000|Overall Study|Adverse Event|4|||
106154603|NCT00951379|366225891|FG001|Overall Study|Adverse Event|1|||
106154604|NCT00951379|366225890|FG000|Overall Study|Withdrawal by Subject|1|||
106154605|NCT00951379|366225891|FG001|Overall Study|Withdrawal by Subject|0|||
106154606|NCT00951379|366225890|FG000|Overall Study|Noncompliance|1|||
106154607|NCT00951379|366225891|FG001|Overall Study|Noncompliance|0|||
106154608|NCT00951379|366225890|FG000|Overall Study|Disease Progression|0|||
106154609|NCT00951379|366225891|FG001|Overall Study|Disease Progression|1|||
106154610|NCT03069313|366225892|FG000|Overall Study|Adverse Event|5|||
106154611|NCT01011946|366225893|FG000|Overall Study|Transferred to another hospital|2|||
106154612|NCT01011946|366225893|FG000|Overall Study|No pathological lab value|1|||
106154613|NCT01424670|366225896|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
106154614|NCT01424670|366225897|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
106154615|NCT01424670|366225896|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
106154616|NCT01424670|366225897|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
106154617|NCT01424670|366225896|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
106154618|NCT01424670|366225897|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
106154619|NCT01424670|366225896|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
106154620|NCT01424670|366225897|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
106154621|NCT01424670|366225896|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
106154622|NCT01424670|366225897|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
106154623|NCT01424670|366225896|FG000|Continuation Period|Adverse Event|13|||
106154624|NCT01424670|366225897|FG001|Continuation Period|Adverse Event|5|||
106154625|NCT01424670|366225896|FG000|Continuation Period|Lost to Follow-up|2|||
105865614|NCT02620579|365156857|FG003|Overall Study|Physician Decision|1|||
105865615|NCT02620579|365156854|FG000|Overall Study|Withdrawal by Subject|0|||
105865616|NCT02620579|365156855|FG001|Overall Study|Withdrawal by Subject|1|||
105865617|NCT02620579|365156856|FG002|Overall Study|Withdrawal by Subject|1|||
105865618|NCT02620579|365156857|FG003|Overall Study|Withdrawal by Subject|0|||
105865619|NCT00958893|365156862|FG000|Overall Study|Study prematurely terminated|4|||
105865620|NCT01524978|365156864|FG000|Overall Study|Other|16|||
105865621|NCT01524978|365156865|FG001|Overall Study|Other|2|||
105865622|NCT01524978|365156866|FG002|Overall Study|Other|1|||
105865623|NCT01524978|365156867|FG003|Overall Study|Other|2|||
105865624|NCT01524978|365156868|FG004|Overall Study|Other|1|||
105865625|NCT01524978|365156869|FG005|Overall Study|Other|3|||
105865626|NCT01524978|365156870|FG006|Overall Study|Other|17|||
105865627|NCT01524978|365156871|FG007|Overall Study|Other|1|||
105865628|NCT01524978|365156872|FG008|Overall Study|Other|2|||
105865629|NCT01524978|365156873|FG009|Overall Study|Other|2|||
105865630|NCT01524978|365156874|FG010|Overall Study|Other|5|||
105865631|NCT01524978|365156864|FG000|Overall Study|Withdrawal by Subject|12|||
105865632|NCT01524978|365156865|FG001|Overall Study|Withdrawal by Subject|0|||
105865633|NCT01524978|365156866|FG002|Overall Study|Withdrawal by Subject|1|||
105865634|NCT01524978|365156867|FG003|Overall Study|Withdrawal by Subject|1|||
106154626|NCT01424670|366225897|FG001|Continuation Period|Lost to Follow-up|0|||
106154627|NCT01424670|366225896|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
105865635|NCT01524978|365156868|FG004|Overall Study|Withdrawal by Subject|3|||
105865636|NCT01524978|365156869|FG005|Overall Study|Withdrawal by Subject|1|||
105865637|NCT01524978|365156870|FG006|Overall Study|Withdrawal by Subject|6|||
105865638|NCT01524978|365156871|FG007|Overall Study|Withdrawal by Subject|2|||
105865639|NCT01524978|365156872|FG008|Overall Study|Withdrawal by Subject|4|||
105865640|NCT01524978|365156873|FG009|Overall Study|Withdrawal by Subject|0|||
105865641|NCT01524978|365156874|FG010|Overall Study|Withdrawal by Subject|5|||
105865642|NCT01524978|365156864|FG000|Overall Study|Lost to Follow-up|0|||
105865643|NCT01524978|365156865|FG001|Overall Study|Lost to Follow-up|0|||
105865644|NCT01524978|365156866|FG002|Overall Study|Lost to Follow-up|3|||
105865645|NCT01524978|365156867|FG003|Overall Study|Lost to Follow-up|0|||
105865646|NCT01524978|365156868|FG004|Overall Study|Lost to Follow-up|1|||
105865647|NCT01524978|365156869|FG005|Overall Study|Lost to Follow-up|1|||
105865648|NCT01524978|365156870|FG006|Overall Study|Lost to Follow-up|2|||
105865649|NCT01524978|365156871|FG007|Overall Study|Lost to Follow-up|0|||
105865650|NCT01524978|365156872|FG008|Overall Study|Lost to Follow-up|1|||
105865651|NCT01524978|365156873|FG009|Overall Study|Lost to Follow-up|1|||
105865652|NCT01524978|365156874|FG010|Overall Study|Lost to Follow-up|1|||
105865653|NCT01524978|365156864|FG000|Overall Study|Death|34|||
105865654|NCT01524978|365156865|FG001|Overall Study|Death|2|||
105865655|NCT01524978|365156866|FG002|Overall Study|Death|5|||
105865656|NCT01524978|365156867|FG003|Overall Study|Death|24|||
105865657|NCT01524978|365156868|FG004|Overall Study|Death|4|||
105865658|NCT01524978|365156869|FG005|Overall Study|Death|4|||
105865659|NCT01524978|365156870|FG006|Overall Study|Death|1|||
106068490|NCT00455429|365912755|FG000|Overall Study|Lost to Follow-up|1|||
106068491|NCT00455429|365912756|FG001|Overall Study|Lost to Follow-up|0|||
106068492|NCT00455429|365912757|FG002|Overall Study|Lost to Follow-up|0|||
106068493|NCT00455429|365912758|FG003|Overall Study|Lost to Follow-up|3|||
106068494|NCT00455429|365912755|FG000|Overall Study|Withdrawal by Subject|0|||
106068495|NCT00455429|365912756|FG001|Overall Study|Withdrawal by Subject|1|||
106068496|NCT00455429|365912757|FG002|Overall Study|Withdrawal by Subject|1|||
106068497|NCT00455429|365912758|FG003|Overall Study|Withdrawal by Subject|0|||
106068498|NCT00455429|365912755|FG000|Overall Study|Lack of Efficacy|0|||
106068499|NCT00455429|365912756|FG001|Overall Study|Lack of Efficacy|1|||
106068500|NCT00455429|365912757|FG002|Overall Study|Lack of Efficacy|0|||
106068501|NCT00455429|365912758|FG003|Overall Study|Lack of Efficacy|1|||
106068502|NCT00455429|365912755|FG000|Overall Study|Adverse Event|0|||
106068503|NCT00455429|365912756|FG001|Overall Study|Adverse Event|1|||
106068504|NCT00455429|365912757|FG002|Overall Study|Adverse Event|0|||
106068505|NCT00455429|365912758|FG003|Overall Study|Adverse Event|3|||
106068506|NCT00455429|365912755|FG000|Overall Study|Randomly assigned but not treated|0|||
106068507|NCT00455429|365912756|FG001|Overall Study|Randomly assigned but not treated|0|||
106068508|NCT00455429|365912757|FG002|Overall Study|Randomly assigned but not treated|0|||
106068509|NCT00455429|365912758|FG003|Overall Study|Randomly assigned but not treated|2|||
106068510|NCT00455429|365912755|FG000|Overall Study|Personal Reason|1|||
106068511|NCT00455429|365912756|FG001|Overall Study|Personal Reason|0|||
106068512|NCT00455429|365912757|FG002|Overall Study|Personal Reason|0|||
106068513|NCT00455429|365912758|FG003|Overall Study|Personal Reason|0|||
106068514|NCT00455429|365912755|FG000|Overall Study|Non-compliance|0|||
106068515|NCT00455429|365912756|FG001|Overall Study|Non-compliance|0|||
106068516|NCT00455429|365912757|FG002|Overall Study|Non-compliance|0|||
106068517|NCT00455429|365912758|FG003|Overall Study|Non-compliance|1|||
106068518|NCT00455429|365912755|FG000|Overall Study|Other|0|||
106068519|NCT00455429|365912756|FG001|Overall Study|Other|2|||
106068520|NCT00455429|365912757|FG002|Overall Study|Other|0|||
106068521|NCT00455429|365912758|FG003|Overall Study|Other|1|||
106068522|NCT01165554|365912759|FG000|Overall Study|Withdrawal by Subject|23|||
106068523|NCT02951156|365912760|FG000|Overall Study|Death|3|||
106068524|NCT02951156|365912761|FG001|Overall Study|Death|8|||
106068525|NCT02951156|365912762|FG002|Overall Study|Death|5|||
106068526|NCT02951156|365912760|FG000|Overall Study|Progressive disease|1|||
106068527|NCT02951156|365912761|FG001|Overall Study|Progressive disease|0|||
106068528|NCT02951156|365912762|FG002|Overall Study|Progressive disease|1|||
106068529|NCT02951156|365912760|FG000|Overall Study|Withdrawal by Subject|0|||
106068530|NCT02951156|365912761|FG001|Overall Study|Withdrawal by Subject|0|||
106068531|NCT02951156|365912762|FG002|Overall Study|Withdrawal by Subject|1|||
106068532|NCT02951156|365912760|FG000|Overall Study|Study terminated by sponsor|0|||
105865660|NCT01524978|365156871|FG007|Overall Study|Death|9|||
105865661|NCT01524978|365156872|FG008|Overall Study|Death|5|||
106068533|NCT02951156|365912761|FG001|Overall Study|Study terminated by sponsor|0|||
105865662|NCT01524978|365156873|FG009|Overall Study|Death|6|||
105865663|NCT01524978|365156874|FG010|Overall Study|Death|17|||
105865664|NCT02806024|365156875|FG000|Overall Study|Night Delivery|1|||
105865665|NCT02806024|365156876|FG001|Overall Study|Night Delivery|1|||
106068534|NCT02951156|365912762|FG002|Overall Study|Study terminated by sponsor|1|||
106068535|NCT02951156|365912760|FG000|Overall Study|Other|5|||
106068536|NCT02951156|365912761|FG001|Overall Study|Other|1|||
106068537|NCT02951156|365912762|FG002|Overall Study|Other|2|||
106068538|NCT02081690|365914541|FG000|Overall Study|Death|3|||
106068539|NCT02081690|365914541|FG000|Overall Study|Physician Decision|3|||
106068540|NCT02081690|365914541|FG000|Overall Study|Withdrawal by Subject|1|||
106068541|NCT00397982|365914543|FG000|Overall Study|Withdrawal by Subject|1|||
106068542|NCT00397982|365914543|FG000|Overall Study|Adverse Event|1|||
106068543|NCT00397982|365914543|FG000|Overall Study|noncompliance|1|||
106068544|NCT00397982|365914543|FG000|Overall Study|Unrelated health issues|1|||
106068545|NCT04244786|365914544|FG000|Overall Study|Adverse Event|0|||
106068546|NCT04244786|365914545|FG001|Overall Study|Adverse Event|0|||
106068547|NCT04244786|365914546|FG002|Overall Study|Adverse Event|2|||
106068548|NCT04244786|365914544|FG000|Overall Study|Withdrawal by Subject|0|||
106068549|NCT04244786|365914545|FG001|Overall Study|Withdrawal by Subject|0|||
106068550|NCT04244786|365914546|FG002|Overall Study|Withdrawal by Subject|5|||
106068551|NCT00623727|365914552|FG000|Double Blind (DB)|Adverse Event|1|||
106068552|NCT00623727|365914553|FG001|Double Blind (DB)|Adverse Event|3|||
106068553|NCT00623727|365914552|FG000|Double Blind (DB)|Physician Decision|0|||
106068554|NCT00623727|365914553|FG001|Double Blind (DB)|Physician Decision|1|||
106068555|NCT00623727|365914552|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
106068556|NCT00623727|365914553|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
106068557|NCT00623727|365914552|FG000|Double Blind (DB)|Lack of Efficacy|2|||
106068558|NCT00623727|365914553|FG001|Double Blind (DB)|Lack of Efficacy|2|||
106068559|NCT00623727|365914552|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
106068560|NCT00623727|365914553|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
106068561|NCT00623727|365914552|FG000|Double Blind (DB)|Lost to Follow-up|1|||
106068562|NCT00623727|365914553|FG001|Double Blind (DB)|Lost to Follow-up|1|||
106068563|NCT00623727|365914552|FG000|Double Blind (DB)|Protocol Violation|2|||
106068564|NCT00623727|365914553|FG001|Double Blind (DB)|Protocol Violation|2|||
106068565|NCT00623727|365914552|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
106068566|NCT00623727|365914553|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
106068567|NCT00623727|365914552|FG000|Open Label Follow-up|Study termination|0|||
106068568|NCT00623727|365914553|FG001|Open Label Follow-up|Study termination|6|||
106068569|NCT00623727|365914552|FG000|Open Label Follow-up|Participant convenience|0|||
106068570|NCT00623727|365914553|FG001|Open Label Follow-up|Participant convenience|1|||
106068571|NCT03220217|365914554|FG000|Overall Study|Withdrawal by Subject|0|||
106068572|NCT03220217|365914555|FG001|Overall Study|Withdrawal by Subject|1|||
106068573|NCT03220217|365914556|FG002|Overall Study|Withdrawal by Subject|0|||
106068574|NCT03220217|365914554|FG000|Overall Study|Subject Missed Procedure|0|||
106068575|NCT03220217|365914555|FG001|Overall Study|Subject Missed Procedure|0|||
106068576|NCT03220217|365914556|FG002|Overall Study|Subject Missed Procedure|1|||
106068577|NCT02734810|365914558|FG000|Overall Study|Adverse Event|1|||
106068578|NCT02734810|365914559|FG001|Overall Study|Adverse Event|0|||
106068579|NCT02734810|365914558|FG000|Overall Study|Lack of Efficacy|1|||
106068580|NCT02734810|365914559|FG001|Overall Study|Lack of Efficacy|0|||
106068581|NCT00903617|365914565|FG000|Overall Study|Adverse Event|0|||
106068582|NCT00903617|365914566|FG001|Overall Study|Adverse Event|1|||
106068583|NCT00903617|365914567|FG002|Overall Study|Adverse Event|1|||
106068584|NCT00903617|365914568|FG003|Overall Study|Adverse Event|0|||
106068585|NCT00903617|365914565|FG000|Overall Study|Protocol-defined stopping criteria|0|||
106068586|NCT00903617|365914566|FG001|Overall Study|Protocol-defined stopping criteria|2|||
106068587|NCT00903617|365914567|FG002|Overall Study|Protocol-defined stopping criteria|0|||
106068588|NCT00903617|365914568|FG003|Overall Study|Protocol-defined stopping criteria|0|||
106068589|NCT00903617|365914565|FG000|Overall Study|Lost to Follow-up|2|||
106068590|NCT00903617|365914566|FG001|Overall Study|Lost to Follow-up|0|||
106154628|NCT01424670|366225897|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
106154629|NCT01424670|366225896|FG000|Continuation Period|Physician Decision|5|||
106154630|NCT01424670|366225897|FG001|Continuation Period|Physician Decision|4|||
106154631|NCT01424670|366225896|FG000|Continuation Period|Withdrawal by Subject|13|||
106154632|NCT01424670|366225897|FG001|Continuation Period|Withdrawal by Subject|4|||
106154633|NCT00761189|366225898|FG000|Overall Study|Adverse Event|42|||
106068591|NCT00903617|365914567|FG002|Overall Study|Lost to Follow-up|1|||
106154634|NCT00761189|366225898|FG000|Overall Study|Lack of Efficacy|45|||
106154635|NCT00761189|366225898|FG000|Overall Study|Lost to Follow-up|36|||
106068592|NCT00903617|365914568|FG003|Overall Study|Lost to Follow-up|1|||
106068593|NCT00903617|365914565|FG000|Overall Study|Withdrawal by Subject|1|||
106068594|NCT00903617|365914566|FG001|Overall Study|Withdrawal by Subject|2|||
106068595|NCT00903617|365914567|FG002|Overall Study|Withdrawal by Subject|3|||
106068596|NCT00903617|365914568|FG003|Overall Study|Withdrawal by Subject|0|||
106154636|NCT00761189|366225898|FG000|Overall Study|Withdrawal by Subject|49|||
106154637|NCT00761189|366225898|FG000|Overall Study|Other|13|||
106068598|NCT01706003|365914570|FG000|Overall Study|Withdrawal by Subject|2|||
106068599|NCT01706003|365914571|FG001|Overall Study|Withdrawal by Subject|0|||
106068600|NCT01706003|365914570|FG000|Overall Study|Not scheduled|3|||
106154638|NCT03912831|366225899|FG000|Overall Study|Death|1|||
106154639|NCT03912831|366225900|FG001|Overall Study|Death|1|||
106068601|NCT01706003|365914571|FG001|Overall Study|Not scheduled|0|||
106068602|NCT01706003|365914570|FG000|Overall Study|Lost to Follow-up|6|||
106068603|NCT01706003|365914571|FG001|Overall Study|Lost to Follow-up|4|||
106068604|NCT00407563|365914572|FG000|Overall Study|Patient continues on treatment|1|||
106068605|NCT02507505|365914573|FG000|Overall Study|Withdrawal by Subject|13|||
106068606|NCT02507505|365914574|FG001|Overall Study|Withdrawal by Subject|11|||
106068607|NCT02507505|365914573|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
106068608|NCT02507505|365914574|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
106068609|NCT02507505|365914573|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
106068610|NCT02507505|365914574|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
106068611|NCT02507505|365914573|FG000|Overall Study|Death before receipt of anesthesia|0|||
106068612|NCT02507505|365914574|FG001|Overall Study|Death before receipt of anesthesia|1|||
106068613|NCT00254540|365914575|FG000|Overall Study|Adverse Event|6|||
106068614|NCT00254540|365914576|FG001|Overall Study|Adverse Event|7|||
106068615|NCT00254540|365914575|FG000|Overall Study|Lack of Efficacy|13|||
106154640|NCT03912831|366225901|FG002|Overall Study|Death|1|||
106068616|NCT00254540|365914576|FG001|Overall Study|Lack of Efficacy|13|||
106068617|NCT00254540|365914575|FG000|Overall Study|Death|0|||
106068618|NCT00254540|365914576|FG001|Overall Study|Death|1|||
106068619|NCT00254540|365914575|FG000|Overall Study|Laboratory Test Abnormality|0|||
106068620|NCT00254540|365914576|FG001|Overall Study|Laboratory Test Abnormality|1|||
106068621|NCT00225251|365914577|FG000|Overall Study|Withdrawal by Subject|1|||
106068622|NCT00225251|365914578|FG001|Overall Study|Withdrawal by Subject|1|||
106068623|NCT00592839|365914579|FG000|Overall Study|Withdrawal by Subject|1|||
106068624|NCT00592839|365914580|FG001|Overall Study|Withdrawal by Subject|1|||
106154641|NCT03912831|366225902|FG003|Overall Study|Death|1|||
106154642|NCT03912831|366225903|FG004|Overall Study|Death|1|||
106154643|NCT03912831|366225904|FG005|Overall Study|Death|1|||
106154644|NCT03912831|366225899|FG000|Overall Study|Reason not Specified|0|||
106154645|NCT03912831|366225900|FG001|Overall Study|Reason not Specified|0|||
106154646|NCT03912831|366225901|FG002|Overall Study|Reason not Specified|0|||
106154647|NCT03912831|366225902|FG003|Overall Study|Reason not Specified|0|||
106068625|NCT00592839|365914581|FG002|Overall Study|Withdrawal by Subject|3|||
106068626|NCT00592839|365914579|FG000|Overall Study|Protocol Violation|1|||
106068627|NCT00592839|365914580|FG001|Overall Study|Protocol Violation|1|||
106068628|NCT00592839|365914581|FG002|Overall Study|Protocol Violation|2|||
106068629|NCT00592839|365914579|FG000|Overall Study|Adverse Event|0|||
106068630|NCT00592839|365914580|FG001|Overall Study|Adverse Event|1|||
106068631|NCT00592839|365914581|FG002|Overall Study|Adverse Event|0|||
106068632|NCT00592839|365914579|FG000|Overall Study|Lost to Follow-up|0|||
106068633|NCT00592839|365914580|FG001|Overall Study|Lost to Follow-up|1|||
106068634|NCT00592839|365914581|FG002|Overall Study|Lost to Follow-up|1|||
106068635|NCT01313767|365914582|FG000|Overall Study|Adverse Event|1|||
106068636|NCT01313767|365914583|FG001|Overall Study|Adverse Event|0|||
106068637|NCT01313767|365914582|FG000|Overall Study|Lost to Follow-up|1|||
106068638|NCT01313767|365914583|FG001|Overall Study|Lost to Follow-up|0|||
106068639|NCT01313767|365914582|FG000|Overall Study|Withdrawal by Subject|2|||
106068640|NCT01313767|365914583|FG001|Overall Study|Withdrawal by Subject|1|||
106068641|NCT01313767|365914582|FG000|Overall Study|Protocol Violation|3|||
106154648|NCT03912831|366225903|FG004|Overall Study|Reason not Specified|1|||
106154649|NCT03912831|366225904|FG005|Overall Study|Reason not Specified|0|||
106154650|NCT03912831|366225899|FG000|Overall Study|Withdrawal by Participant|0|||
106154651|NCT03912831|366225900|FG001|Overall Study|Withdrawal by Participant|0|||
106154652|NCT03912831|366225901|FG002|Overall Study|Withdrawal by Participant|0|||
106154653|NCT03912831|366225902|FG003|Overall Study|Withdrawal by Participant|0|||
106154654|NCT03912831|366225903|FG004|Overall Study|Withdrawal by Participant|1|||
105865666|NCT02806024|365156875|FG000|Overall Study|DVT during antepartum admission|0|||
105865667|NCT02806024|365156876|FG001|Overall Study|DVT during antepartum admission|1|||
105865668|NCT02892149|365156877|FG000|Overall Study|Death|262|||
105865669|NCT02892149|365156878|FG001|Overall Study|Death|278|||
105865670|NCT02892149|365156877|FG000|Overall Study|Withdrawal by Subject|53|||
105865671|NCT02892149|365156878|FG001|Overall Study|Withdrawal by Subject|47|||
105865672|NCT02892149|365156877|FG000|Overall Study|Lost to Follow-up|37|||
105865673|NCT02892149|365156878|FG001|Overall Study|Lost to Follow-up|31|||
105865674|NCT03633825|365156883|FG000|Enrollment|Did not post on network|5066|||
105865675|NCT03633825|365156884|FG001|Enrollment|Did not post on network|5080|||
106068642|NCT01313767|365914583|FG001|Overall Study|Protocol Violation|1|||
106068643|NCT00082355|365914590|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
106068644|NCT00082355|365914590|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
106068645|NCT00082355|365914590|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
106154655|NCT03912831|366225904|FG005|Overall Study|Withdrawal by Participant|0|||
106068646|NCT00759863|365914592|FG000|Overall Study|Death, moved, or lost contact|20|||
106068647|NCT00759863|365914593|FG001|Overall Study|Death, moved, or lost contact|18|||
106068648|NCT00936910|365914594|FG000|Overall Study|Lack of Efficacy|3|||
106068649|NCT00412854|365914598|FG000|Overall Study|Withdrawn due to adverse events|1|||
106068650|NCT00412854|365914599|FG001|Overall Study|Withdrawn due to adverse events|5|||
106068651|NCT00412854|365914598|FG000|Overall Study|Withdrawn for other reasons|13|||
106068652|NCT00412854|365914599|FG001|Overall Study|Withdrawn for other reasons|11|||
106068653|NCT01485640|365914604|FG000|Overall Study|Adverse Event|10|||
106068654|NCT01485640|365914604|FG000|Overall Study|Lack of Efficacy|2|||
106068655|NCT01485640|365914604|FG000|Overall Study|Protocol Violation|1|||
106068656|NCT01485640|365914604|FG000|Overall Study|Withdrawal by Subject|14|||
106068657|NCT01485640|365914604|FG000|Overall Study|Terminated by Sponsor|95|||
106068658|NCT03020407|365914607|FG000|Overall Study|Withdrawal by Subject|2|||
106068659|NCT03020407|365914608|FG001|Overall Study|Withdrawal by Subject|1|||
106068660|NCT03020407|365914607|FG000|Overall Study|Lost to Follow-up|2|||
106068661|NCT03020407|365914608|FG001|Overall Study|Lost to Follow-up|3|||
106068662|NCT03020407|365914607|FG000|Overall Study|Protocol Violation|0|||
106068663|NCT03020407|365914608|FG001|Overall Study|Protocol Violation|1|||
106068664|NCT02355691|365914609|FG000|Overall Study|Loss of Research Personnel|7|||
106068665|NCT02355691|365914610|FG001|Overall Study|Loss of Research Personnel|9|||
106068666|NCT01042236|365914613|FG000|Treatment Period 1|Adverse Event|0|||
106068667|NCT01042236|365914614|FG001|Treatment Period 1|Adverse Event|1|||
106068668|NCT01042236|365914615|FG002|Treatment Period 1|Adverse Event|0|||
106068669|NCT01042236|365914616|FG003|Treatment Period 1|Adverse Event|0|||
106068670|NCT01042236|365914617|FG004|Treatment Period 1|Adverse Event|1|||
106068671|NCT01042236|365914618|FG005|Treatment Period 1|Adverse Event|0|||
106068672|NCT01042236|365914613|FG000|Treatment Period 3|Adverse Event|0|||
106068673|NCT01042236|365914614|FG001|Treatment Period 3|Adverse Event|0|||
106068674|NCT01042236|365914615|FG002|Treatment Period 3|Adverse Event|0|||
106068675|NCT01042236|365914616|FG003|Treatment Period 3|Adverse Event|1|||
106068676|NCT01042236|365914617|FG004|Treatment Period 3|Adverse Event|0|||
106068677|NCT01042236|365914618|FG005|Treatment Period 3|Adverse Event|0|||
106068678|NCT01042236|365914613|FG000|Treatment Period 3|Protocol Violation|0|||
106068679|NCT01042236|365914614|FG001|Treatment Period 3|Protocol Violation|0|||
106068680|NCT01042236|365914615|FG002|Treatment Period 3|Protocol Violation|0|||
106068681|NCT01042236|365914616|FG003|Treatment Period 3|Protocol Violation|1|||
106068682|NCT01042236|365914617|FG004|Treatment Period 3|Protocol Violation|0|||
106068683|NCT01042236|365914618|FG005|Treatment Period 3|Protocol Violation|0|||
106068684|NCT03232281|365914619|FG000|Overall Study|Adverse Event|1|||
106068685|NCT03232281|365914620|FG001|Overall Study|Adverse Event|1|||
106068686|NCT03232281|365914619|FG000|Overall Study|Withdrawal by Subject|5|||
106068687|NCT03232281|365914620|FG001|Overall Study|Withdrawal by Subject|4|||
106068688|NCT03232281|365914619|FG000|Overall Study|Protocol Deviation|1|||
106068689|NCT03232281|365914620|FG001|Overall Study|Protocol Deviation|1|||
106068690|NCT00462761|365914624|FG000|Overall Study|Adverse Event|6|||
106068691|NCT00462761|365914624|FG000|Overall Study|Withdrawal by Subject|9|||
106068692|NCT00462761|365914624|FG000|Overall Study|Physician Decision|5|||
106068693|NCT00462761|365914624|FG000|Overall Study|Disease progression|43|||
106068694|NCT00462761|365914624|FG000|Overall Study|Death|12|||
106068695|NCT00462761|365914624|FG000|Overall Study|Other|1|||
106068696|NCT01132482|365914627|FG000|Overall Study|Adverse Event|1|||
106068697|NCT01132482|365914628|FG001|Overall Study|Adverse Event|0|||
106068698|NCT01955161|365914629|FG000|Overall Study|Withdrawal before treatment|2|||
106068699|NCT01955161|365914630|FG001|Overall Study|Withdrawal before treatment|0|||
106068700|NCT01955161|365914631|FG002|Overall Study|Withdrawal before treatment|1|||
106068701|NCT01955161|365914629|FG000|Overall Study|Adverse Event|10|||
106068702|NCT01955161|365914630|FG001|Overall Study|Adverse Event|14|||
106068703|NCT01955161|365914631|FG002|Overall Study|Adverse Event|15|||
106068704|NCT01955161|365914629|FG000|Overall Study|Death|1|||
106068705|NCT01955161|365914630|FG001|Overall Study|Death|1|||
106068706|NCT01955161|365914631|FG002|Overall Study|Death|3|||
106068707|NCT01955161|365914629|FG000|Overall Study|Withdrawal by Subject|9|||
106068708|NCT01955161|365914630|FG001|Overall Study|Withdrawal by Subject|8|||
106068709|NCT01955161|365914631|FG002|Overall Study|Withdrawal by Subject|12|||
106068710|NCT01955161|365914629|FG000|Overall Study|Protocol Violation|2|||
106068711|NCT01955161|365914630|FG001|Overall Study|Protocol Violation|0|||
106068712|NCT01955161|365914631|FG002|Overall Study|Protocol Violation|0|||
106068713|NCT01955161|365914629|FG000|Overall Study|Other reason: physician decision|0|||
106068714|NCT01955161|365914630|FG001|Overall Study|Other reason: physician decision|1|||
106068715|NCT01955161|365914631|FG002|Overall Study|Other reason: physician decision|1|||
106068716|NCT01955161|365914629|FG000|Overall Study|Other reason: disallowed medication|1|||
106068717|NCT01955161|365914630|FG001|Overall Study|Other reason: disallowed medication|0|||
106068718|NCT01955161|365914631|FG002|Overall Study|Other reason: disallowed medication|1|||
106068719|NCT01955161|365914629|FG000|Overall Study|Other reason: caregiver unavailable|1|||
106068720|NCT01955161|365914630|FG001|Overall Study|Other reason: caregiver unavailable|0|||
106068721|NCT01955161|365914631|FG002|Overall Study|Other reason: caregiver unavailable|0|||
106068722|NCT01955161|365914629|FG000|Overall Study|Other reason: moved to nursing home|0|||
106068723|NCT01955161|365914630|FG001|Overall Study|Other reason: moved to nursing home|1|||
106154656|NCT03527160|366225905|FG000|Overall Study|No urine collected|13|||
106154657|NCT03527160|366225905|FG000|Overall Study|No clinical serum creatinine collected|6|||
106154658|NCT03527160|366225905|FG000|Overall Study|Did not meet inclusion|2|||
106154659|NCT03416023|366227517|FG000|Overall Study|Exclusion criteria failure|1|||
106154660|NCT03416023|366227517|FG000|Overall Study|Withdrawal by Subject|6|||
106154661|NCT03416023|366227517|FG000|Overall Study|Explanted|7|||
106154662|NCT03416023|366227517|FG000|Overall Study|Physician Decision|1|||
106154663|NCT03416023|366227517|FG000|Overall Study|Lost to Follow-up|1|||
106154664|NCT03416023|366227517|FG000|Overall Study|Death|1|||
106154665|NCT05510232|366227518|FG000|Overall Study|Withdrawal by Subject|2|||
106154666|NCT05510232|366227519|FG001|Overall Study|Withdrawal by Subject|7|||
106154667|NCT05510232|366227520|FG002|Overall Study|Withdrawal by Subject|6|||
106154668|NCT01631214|366227528|FG000|Overall Study|Withdrawal by Subject|276|||
106154669|NCT01631214|366227529|FG001|Overall Study|Withdrawal by Subject|290|||
106154670|NCT01631214|366227528|FG000|Overall Study|Death|113|||
106154671|NCT01631214|366227529|FG001|Overall Study|Death|106|||
106154672|NCT01631214|366227528|FG000|Overall Study|Lost to Follow-up|54|||
106154673|NCT01631214|366227529|FG001|Overall Study|Lost to Follow-up|40|||
106154674|NCT01631214|366227528|FG000|Overall Study|Adverse Event|45|||
106154675|NCT01631214|366227529|FG001|Overall Study|Adverse Event|45|||
106154676|NCT01631214|366227528|FG000|Overall Study|Other|22|||
106154677|NCT01631214|366227529|FG001|Overall Study|Other|19|||
106154678|NCT01631214|366227528|FG000|Overall Study|Noncompliance|16|||
106154679|NCT01631214|366227529|FG001|Overall Study|Noncompliance|15|||
106154680|NCT01631214|366227528|FG000|Overall Study|Requirement for Alternative Therapy|8|||
106154681|NCT01631214|366227529|FG001|Overall Study|Requirement for Alternative Therapy|3|||
106154682|NCT01631214|366227528|FG000|Overall Study|Protocol Deviation|4|||
106154683|NCT01631214|366227529|FG001|Overall Study|Protocol Deviation|3|||
106154684|NCT01631214|366227528|FG000|Overall Study|Ineligibility determined|5|||
106154685|NCT01631214|366227529|FG001|Overall Study|Ineligibility determined|2|||
106154686|NCT01631214|366227528|FG000|Overall Study|Administrative Decision|1|||
106154687|NCT01631214|366227529|FG001|Overall Study|Administrative Decision|0|||
106154688|NCT04143061|366227531|FG000|Overall Study|Protocol Deviation|0|||
106154689|NCT04143061|366227532|FG001|Overall Study|Protocol Deviation|0|||
106154690|NCT04143061|366227533|FG002|Overall Study|Protocol Deviation|0|||
106154691|NCT04143061|366227534|FG003|Overall Study|Protocol Deviation|0|||
106068724|NCT01955161|365914631|FG002|Overall Study|Other reason: moved to nursing home|0|||
106068725|NCT01955161|365914629|FG000|Overall Study|Other reason: insufficient compliance|0|||
106068726|NCT01955161|365914630|FG001|Overall Study|Other reason: insufficient compliance|0|||
106068727|NCT01955161|365914631|FG002|Overall Study|Other reason: insufficient compliance|1|||
106068728|NCT01955161|365914629|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
106068729|NCT01955161|365914630|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
106068730|NCT01955161|365914631|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
106068731|NCT01955161|365914629|FG000|Overall Study|Other reason: patient's will|0|||
106068732|NCT01955161|365914630|FG001|Overall Study|Other reason: patient's will|0|||
106068733|NCT01955161|365914631|FG002|Overall Study|Other reason: patient's will|1|||
106068734|NCT03683758|365914632|FG000|Overall Study|Non-study commitment conflict|1|||
106068735|NCT03683758|365914633|FG001|Overall Study|Non-study commitment conflict|3|||
106068736|NCT03683758|365914632|FG000|Overall Study|Illness preventing participation|1|||
106068737|NCT03683758|365914633|FG001|Overall Study|Illness preventing participation|0|||
106068738|NCT03683758|365914632|FG000|Overall Study|Adverse Event|1|||
106068739|NCT03683758|365914633|FG001|Overall Study|Adverse Event|0|||
106068740|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
106068741|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
106068742|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
106068743|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
106068744|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
106068745|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
106068746|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
106068747|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
106068748|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
106068749|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
106068750|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
106068751|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
106068752|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
106068753|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
106068754|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
106068755|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
106068756|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
106154692|NCT04143061|366227535|FG004|Overall Study|Protocol Deviation|0|||
106154693|NCT04143061|366227536|FG005|Overall Study|Protocol Deviation|0|||
106154694|NCT04143061|366227537|FG006|Overall Study|Protocol Deviation|5|||
106154695|NCT04143061|366227538|FG007|Overall Study|Protocol Deviation|5|||
106068757|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
106068758|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
106068759|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
106068760|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
106068761|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
106068762|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
106068763|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
106068764|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
106068765|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
106068766|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
106068767|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
106068768|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
106068769|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
106068770|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
106068771|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
106068772|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
106068773|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
106068774|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
106068775|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
106068776|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
106068777|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
106068778|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
106068779|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
106068780|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
106068781|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
106068782|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
106068783|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
106068784|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
106068785|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
106068786|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
106068787|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
106068788|NCT03720470|365914636|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
106068789|NCT03720470|365914637|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
106068790|NCT03720470|365914638|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
106068791|NCT03720470|365914639|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
106068792|NCT03720470|365914640|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
106068793|NCT03720470|365914641|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
106068794|NCT03720470|365914636|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
106068795|NCT03720470|365914637|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
106068796|NCT03720470|365914638|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
106068797|NCT03720470|365914639|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
106068798|NCT03720470|365914640|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
106068799|NCT03720470|365914641|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
106068800|NCT03720470|365914636|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
106068801|NCT03720470|365914637|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
106068802|NCT03720470|365914638|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
106068803|NCT03720470|365914639|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
106068804|NCT03720470|365914640|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
106068805|NCT03720470|365914641|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
106068806|NCT03720470|365914636|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
106068807|NCT03720470|365914637|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
106068808|NCT03720470|365914638|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
106068809|NCT03720470|365914639|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
106068810|NCT03720470|365914640|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
106068811|NCT03720470|365914641|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
106068812|NCT03720470|365914636|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
106068813|NCT03720470|365914637|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
106068814|NCT03720470|365914638|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
106068815|NCT03720470|365914639|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
106068816|NCT03720470|365914640|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
106068817|NCT03720470|365914641|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
106068818|NCT03720470|365914636|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
106068819|NCT03720470|365914637|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
105865676|NCT03633825|365156883|FG000|Enrollment|Post not classified as crisis|13967|||
105865677|NCT03633825|365156884|FG001|Enrollment|Post not classified as crisis|13757|||
105865678|NCT03633825|365156883|FG000|Follow up|Lost to Follow-up|478|||
106068820|NCT03720470|365914638|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
106068821|NCT03720470|365914639|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
106068822|NCT03720470|365914640|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
106068823|NCT03720470|365914641|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
106068824|NCT03720470|365914636|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
106068825|NCT03720470|365914637|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
106068826|NCT03720470|365914638|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
106068827|NCT03720470|365914639|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
106068828|NCT03720470|365914640|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
106068829|NCT03720470|365914641|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
106068830|NCT03720470|365914636|FG000|Treatment Period: Final 4 Weeks|Other|0|||
106068831|NCT03720470|365914637|FG001|Treatment Period: Final 4 Weeks|Other|1|||
106068832|NCT03720470|365914638|FG002|Treatment Period: Final 4 Weeks|Other|0|||
106068833|NCT03720470|365914639|FG003|Treatment Period: Final 4 Weeks|Other|2|||
106068834|NCT03720470|365914640|FG004|Treatment Period: Final 4 Weeks|Other|1|||
106068835|NCT03720470|365914641|FG005|Treatment Period: Final 4 Weeks|Other|0|||
106068836|NCT02411292|365914643|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
106068837|NCT02411292|365914643|FG000|Overall Study|Death|2|||
106068838|NCT02411292|365914643|FG000|Overall Study|Lost to Follow-up|3|||
106068839|NCT01829230|365914655|FG000|Overall Study|Protocol Violation|0|||
106068840|NCT01829230|365914656|FG001|Overall Study|Protocol Violation|2|||
106068841|NCT01829230|365914655|FG000|Overall Study|Withdrawal by Subject|0|||
106068842|NCT01829230|365914656|FG001|Overall Study|Withdrawal by Subject|1|||
106068843|NCT01829230|365914655|FG000|Overall Study|Lost to Follow-up|1|||
106068844|NCT01829230|365914656|FG001|Overall Study|Lost to Follow-up|1|||
106068845|NCT02157298|365914660|FG000|Overall Study|Adverse Event|1|||
106068846|NCT02157298|365914661|FG001|Overall Study|Adverse Event|0|||
106068847|NCT02157298|365914660|FG000|Overall Study|Subject no longer meets study criteria|1|||
106068848|NCT02157298|365914661|FG001|Overall Study|Subject no longer meets study criteria|2|||
106068849|NCT02157298|365914660|FG000|Overall Study|Poor/Non-compliance|1|||
106068850|NCT02157298|365914661|FG001|Overall Study|Poor/Non-compliance|0|||
106068851|NCT02157298|365914660|FG000|Overall Study|Withdrawal by Subject|1|||
106068852|NCT02157298|365914661|FG001|Overall Study|Withdrawal by Subject|0|||
106068853|NCT04387435|365914662|FG000|Overall Study|Physician Decision|1|||
106068854|NCT03855280|365914663|FG000|Treatment Phase|Adverse Event|1|||
106068855|NCT03855280|365914663|FG000|Treatment Phase|Withdrawal by Subject|1|||
106068856|NCT03855280|365914663|FG000|Continuation Phase|Protocol Violation|1|||
106068857|NCT03855280|365914663|FG000|Continuation Phase|Adverse Event|1|||
106068858|NCT03855280|365914663|FG000|Continuation Phase|Sponsor Concluded Study|1|||
106068859|NCT00461682|365914664|FG000|Overall Study|Protocol Violation|1|||
106068860|NCT00883116|365914665|FG000|Overall Study|Adverse event unrelated to study drug|5|||
106068861|NCT00883116|365914666|FG001|Overall Study|Adverse event unrelated to study drug|10|||
106068862|NCT00883116|365914665|FG000|Overall Study|Death|6|||
106068863|NCT00883116|365914666|FG001|Overall Study|Death|2|||
106068864|NCT00883116|365914665|FG000|Overall Study|Disease progression|130|||
106068865|NCT00883116|365914666|FG001|Overall Study|Disease progression|128|||
106068866|NCT00883116|365914665|FG000|Overall Study|Lost to Follow-up|0|||
106068867|NCT00883116|365914666|FG001|Overall Study|Lost to Follow-up|1|||
106068868|NCT00883116|365914665|FG000|Overall Study|Maximum clinical benefit|13|||
106068869|NCT00883116|365914666|FG001|Overall Study|Maximum clinical benefit|46|||
106068870|NCT00883116|365914665|FG000|Overall Study|Not identified|3|||
106068871|NCT00883116|365914666|FG001|Overall Study|Not identified|6|||
106068872|NCT00883116|365914665|FG000|Overall Study|Study drug toxicity|36|||
106068873|NCT00883116|365914666|FG001|Overall Study|Study drug toxicity|16|||
106068874|NCT00883116|365914665|FG000|Overall Study|Withdrawal by Subject|14|||
106068875|NCT00883116|365914666|FG001|Overall Study|Withdrawal by Subject|8|||
106068876|NCT00883116|365914665|FG000|Overall Study|No longer meets study criteria|2|||
106068877|NCT00883116|365914666|FG001|Overall Study|No longer meets study criteria|2|||
106068878|NCT01361464|365914668|FG000|Overall Study|Death|1|||
106068879|NCT01361464|365914668|FG000|Overall Study|Withdrawal by Subject|2|||
106068880|NCT04128267|365914672|FG000|Overall Study|Withdrawal by Subject|6|||
106068881|NCT04128267|365914672|FG000|Overall Study|Death|2|||
106068882|NCT04128267|365914672|FG000|Overall Study|Disease progression|1|||
106068883|NCT04128267|365914672|FG000|Overall Study|Participant had other medical issues|4|||
106068884|NCT04128267|365914672|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
106068885|NCT01698801|365914678|FG000|Treatment Phase|Adverse Event|4|||
106068886|NCT01698801|365914678|FG000|Treatment Phase|Protocol Violation|1|||
106068887|NCT01698801|365914678|FG000|Treatment Phase|Other|4|||
106068888|NCT01698801|365914678|FG000|Treatment Phase|Withdrawal by Subject|1|||
106068889|NCT01698801|365914678|FG000|Treatment Phase|Disease progression|1|||
106068890|NCT01698801|365914678|FG000|Follow Up Phase|Withdrawal by Subject|1|||
106068891|NCT01698801|365914678|FG000|Follow Up Phase|Death|4|||
106068892|NCT01505868|365914679|FG000|Overall Study|Withdrawal by Subject|1|||
106068893|NCT01505868|365914680|FG001|Overall Study|Withdrawal by Subject|0|||
105865679|NCT03633825|365156884|FG001|Follow up|Lost to Follow-up|450|||
106068894|NCT01505868|365914681|FG002|Overall Study|Withdrawal by Subject|0|||
106068895|NCT01505868|365914682|FG003|Overall Study|Withdrawal by Subject|0|||
106068896|NCT01505868|365914683|FG004|Overall Study|Withdrawal by Subject|0|||
106068897|NCT00553150|365914686|FG000|Overall Study|Withdrawal by Subject|0|||
106068898|NCT00553150|365914687|FG001|Overall Study|Withdrawal by Subject|0|||
106068899|NCT00553150|365914688|FG002|Overall Study|Withdrawal by Subject|0|||
106068900|NCT00553150|365914689|FG003|Overall Study|Withdrawal by Subject|2|||
106068901|NCT00553150|365914686|FG000|Overall Study|Protocol Violation|0|||
106068902|NCT00553150|365914687|FG001|Overall Study|Protocol Violation|0|||
106068903|NCT00553150|365914688|FG002|Overall Study|Protocol Violation|0|||
106068904|NCT00553150|365914689|FG003|Overall Study|Protocol Violation|1|||
106068905|NCT00553150|365914686|FG000|Overall Study|Ineligible|0|||
106068906|NCT00553150|365914687|FG001|Overall Study|Ineligible|0|||
106068907|NCT00553150|365914688|FG002|Overall Study|Ineligible|0|||
106068908|NCT00553150|365914689|FG003|Overall Study|Ineligible|1|||
106068909|NCT03338855|365914690|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
106068910|NCT03338855|365914691|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
106068911|NCT00665847|365914692|FG000|Overall Study|Adverse Event|8|||
106068912|NCT00665847|365914692|FG000|Overall Study|Withdrawal by Subject|2|||
106068913|NCT00665847|365914692|FG000|Overall Study|Subject non-compliant|8|||
106068914|NCT00665847|365914692|FG000|Overall Study|Subject reached a virologic endpoint|4|||
106068915|NCT00665847|365914692|FG000|Overall Study|Resistance to TMC125|1|||
106068916|NCT00665847|365914692|FG000|Overall Study|Subject ineligible to continue the trial|1|||
106068917|NCT00665847|365914692|FG000|Overall Study|Switch to Commercial Medication|1|||
106068918|NCT00195676|365914693|FG000|Period O - Open-label Treatment|Adverse Event|82|||
106068919|NCT00195676|365914693|FG000|Period O - Open-label Treatment|Death|6|||
106068920|NCT00195676|365914693|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
106068921|NCT00195676|365914693|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
106068922|NCT00195676|365914693|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
106068923|NCT00195676|365914693|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
106068924|NCT00195676|365914693|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
106068925|NCT00195676|365914693|FG000|Period O - Open-label Treatment|Other reasons|68|||
106068926|NCT00195676|365914693|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
106068927|NCT00195676|365914693|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
106068928|NCT00195676|365914693|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
106068929|NCT00195676|365914693|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
106068930|NCT00195676|365914693|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
106068931|NCT00195676|365914693|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
106068932|NCT00195676|365914693|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
106068933|NCT00195676|365914693|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
106068934|NCT00195676|365914693|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
106068935|NCT00195676|365914693|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
106068936|NCT00195676|365914693|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
106068937|NCT00195676|365914693|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
106068938|NCT00195676|365914693|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
106068939|NCT01026792|365914697|FG000|Overall Study|Protocol Violation|1|||
106068940|NCT00309842|365914698|FG000|Overall Study|Lost to Follow-up|1|||
106068941|NCT01765153|365914699|FG000|Training Phase 1|Format of intervention differed|1|||
106068942|NCT01765153|365914700|FG001|Training Phase 1|Format of intervention differed|0|||
106068943|NCT01765153|365914699|FG000|Training Phase 1|Poor participation in intervention|0|||
106068944|NCT01765153|365914700|FG001|Training Phase 1|Poor participation in intervention|1|||
106068945|NCT01765153|365914699|FG000|Rest Phase 1|Withdrawal by Subject|0|||
106068946|NCT01765153|365914700|FG001|Rest Phase 1|Withdrawal by Subject|1|||
106068947|NCT01765153|365914699|FG000|Training Phase 2|Withdrawal by Subject|0|||
106068948|NCT01765153|365914700|FG001|Training Phase 2|Withdrawal by Subject|1|||
106068949|NCT01765153|365914699|FG000|Rest Phase 2|Lost to Follow-up|2|||
106068950|NCT01765153|365914700|FG001|Rest Phase 2|Lost to Follow-up|1|||
106068951|NCT01394523|365915934|FG000|Overall Study|Unable to place block|1|||
106068952|NCT01394523|365915935|FG001|Overall Study|Unable to place block|0|||
106068953|NCT01394523|365915936|FG002|Overall Study|Unable to place block|0|||
106068954|NCT03226392|365915938|FG000|Overall Study|Protocol Deviation|1|||
106068955|NCT03226392|365915939|FG001|Overall Study|Protocol Deviation|0|||
106068956|NCT03226392|365915938|FG000|Overall Study|Physician Decision|1|||
106068957|NCT03226392|365915939|FG001|Overall Study|Physician Decision|0|||
106068958|NCT03226392|365915938|FG000|Overall Study|Lost to Follow-up|1|||
106068959|NCT03226392|365915939|FG001|Overall Study|Lost to Follow-up|0|||
106068960|NCT03226392|365915938|FG000|Overall Study|Adverse Event|1|||
106068961|NCT03226392|365915939|FG001|Overall Study|Adverse Event|0|||
106068962|NCT03226392|365915938|FG000|Overall Study|Technical Problems|0|||
106068963|NCT03226392|365915939|FG001|Overall Study|Technical Problems|2|||
106068964|NCT03226392|365915938|FG000|Overall Study|Subject/Guardian Decision|7|||
106068965|NCT03226392|365915939|FG001|Overall Study|Subject/Guardian Decision|6|||
105865680|NCT00879411|365156885|FG000|Overall Study|lost to follow-up (non-AE)|162|||
106068966|NCT02357901|365915940|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
106068967|NCT02357901|365915941|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
106068968|NCT02357901|365915942|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
106068969|NCT02357901|365915943|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
106068970|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
106068971|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
106068972|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
106068973|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
106068974|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
106068975|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
106068976|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
106068977|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
106068978|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
106068979|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
106068980|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
106068981|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
106068982|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
106068983|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
106068984|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
106068985|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
106068986|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
106068987|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
106068988|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
106068989|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
106068990|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
106068991|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
106068992|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
106068993|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
106068994|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
106068995|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
106068996|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
106068997|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
106068998|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
106068999|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
106069000|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
106069001|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
106069002|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
106069003|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
106069004|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
106069005|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
106069006|NCT02357901|365915940|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
106069007|NCT02357901|365915941|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
106069008|NCT02357901|365915942|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
106069009|NCT02357901|365915943|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
106069010|NCT02769247|365915944|FG000|Overall Study|Withdrawal by Subject|1|||
106069011|NCT02769247|365915945|FG001|Overall Study|Withdrawal by Subject|0|||
106069012|NCT02769247|365915946|FG002|Overall Study|Withdrawal by Subject|0|||
106069013|NCT02769247|365915947|FG003|Overall Study|Withdrawal by Subject|1|||
106069014|NCT02769247|365915944|FG000|Overall Study|Protocol Violation|0|||
106069015|NCT02769247|365915945|FG001|Overall Study|Protocol Violation|0|||
106069016|NCT02769247|365915946|FG002|Overall Study|Protocol Violation|1|||
106069017|NCT02769247|365915947|FG003|Overall Study|Protocol Violation|0|||
106069018|NCT02769247|365915944|FG000|Overall Study|Physician Decision|1|||
106069019|NCT02769247|365915945|FG001|Overall Study|Physician Decision|0|||
106069020|NCT02769247|365915946|FG002|Overall Study|Physician Decision|0|||
106069021|NCT02769247|365915947|FG003|Overall Study|Physician Decision|0|||
106069022|NCT00413192|365915948|FG000|Overall Study|Disease progression|26|||
106069023|NCT00413192|365915949|FG001|Overall Study|Disease progression|31|||
106069024|NCT00413192|365915950|FG002|Overall Study|Disease progression|16|||
106069025|NCT00413192|365915951|FG003|Overall Study|Disease progression|25|||
106069026|NCT00413192|365915948|FG000|Overall Study|Toxicity|3|||
106069027|NCT00413192|365915949|FG001|Overall Study|Toxicity|2|||
105865681|NCT01884337|365156886|FG000|Treatment|Adverse Event|2|||
105865682|NCT01884337|365156887|FG001|Treatment|Adverse Event|2|||
105865683|NCT01884337|365156886|FG000|Treatment|Subj. request to discont. treatment|2|||
105865684|NCT01884337|365156887|FG001|Treatment|Subj. request to discont. treatment|0|||
105865685|NCT01884337|365156886|FG000|Follow-up Period|Lost to Follow-up|1|||
105865686|NCT01884337|365156887|FG001|Follow-up Period|Lost to Follow-up|1|||
105865687|NCT00428116|365156888|FG000|Overall Study|Death|1|||
105865688|NCT00428116|365156889|FG001|Overall Study|Death|0|||
105865689|NCT00428116|365156888|FG000|Overall Study|Withdrawal by Subject|1|||
105865690|NCT00428116|365156889|FG001|Overall Study|Withdrawal by Subject|0|||
105865691|NCT00428116|365156888|FG000|Overall Study|Lost to Follow-up|1|||
105865692|NCT00428116|365156889|FG001|Overall Study|Lost to Follow-up|0|||
106069028|NCT00413192|365915950|FG002|Overall Study|Toxicity|2|||
106069029|NCT00413192|365915951|FG003|Overall Study|Toxicity|2|||
106069030|NCT00413192|365915948|FG000|Overall Study|Withdrawal by Subject|3|||
106069031|NCT00413192|365915949|FG001|Overall Study|Withdrawal by Subject|5|||
106069032|NCT00413192|365915950|FG002|Overall Study|Withdrawal by Subject|0|||
106069033|NCT00413192|365915951|FG003|Overall Study|Withdrawal by Subject|1|||
106069034|NCT00413192|365915948|FG000|Overall Study|Intercurrent illness|0|||
106069035|NCT00413192|365915949|FG001|Overall Study|Intercurrent illness|0|||
106069036|NCT00413192|365915950|FG002|Overall Study|Intercurrent illness|0|||
106069037|NCT00413192|365915951|FG003|Overall Study|Intercurrent illness|1|||
106069038|NCT00413192|365915948|FG000|Overall Study|Intercurrent death|0|||
106069039|NCT00413192|365915949|FG001|Overall Study|Intercurrent death|1|||
105865693|NCT02455518|365156890|FG000|Overall Study|Protocol Violation|0|||
105865694|NCT02455518|365156891|FG001|Overall Study|Protocol Violation|1|||
105865695|NCT02455518|365156892|FG002|Overall Study|Protocol Violation|1|||
105865696|NCT02455518|365156893|FG003|Overall Study|Protocol Violation|3|||
105865697|NCT03837743|365156894|FG000|Overall Study|Adverse Event|1|||
105865698|NCT03837743|365156894|FG000|Overall Study|Withdrawal by Subject|2|||
105865699|NCT03279692|365156895|FG000|Overall Study|Withdrawal by Subject|1|||
105865700|NCT05794503|365156896|FG000|Overall Study|Operation Cancelled|2|||
105865701|NCT05794503|365156897|FG001|Overall Study|Operation Cancelled|0|||
105865702|NCT05794503|365156896|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
105865703|NCT05794503|365156897|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
105865704|NCT05794503|365156896|FG000|Overall Study|Protocol Violation|1|||
105865705|NCT05794503|365156897|FG001|Overall Study|Protocol Violation|0|||
105865706|NCT01885195|365156898|FG000|Overall Study|Adverse Event|29|||
105865707|NCT01885195|365156898|FG000|Overall Study|Death|1|||
105865708|NCT01885195|365156898|FG000|Overall Study|Disease Progression|67|||
106069040|NCT00413192|365915950|FG002|Overall Study|Intercurrent death|0|||
106069041|NCT00413192|365915951|FG003|Overall Study|Intercurrent death|0|||
106069042|NCT00413192|365915948|FG000|Overall Study|Other|5|||
106069043|NCT00413192|365915949|FG001|Overall Study|Other|1|||
106069044|NCT00413192|365915950|FG002|Overall Study|Other|1|||
106069045|NCT00413192|365915951|FG003|Overall Study|Other|2|||
106069046|NCT00413192|365915948|FG000|Overall Study|Not treated|0|||
106069047|NCT00413192|365915949|FG001|Overall Study|Not treated|0|||
106069048|NCT00413192|365915950|FG002|Overall Study|Not treated|0|||
106069049|NCT00413192|365915951|FG003|Overall Study|Not treated|1|||
106069050|NCT02436356|365915952|FG000|Overall Study|Excluded by MRI Screening|0|||
106069051|NCT02436356|365915953|FG001|Overall Study|Excluded by MRI Screening|0|||
106069052|NCT02436356|365915954|FG002|Overall Study|Excluded by MRI Screening|2|||
106069053|NCT02436356|365915952|FG000|Overall Study|Lost to Follow-up|0|||
106069054|NCT02436356|365915953|FG001|Overall Study|Lost to Follow-up|1|||
106069055|NCT02436356|365915954|FG002|Overall Study|Lost to Follow-up|0|||
106069056|NCT02436356|365915952|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
106069057|NCT02436356|365915953|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
106069058|NCT02436356|365915954|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
106069059|NCT02436356|365915952|FG000|Overall Study|Excluded due to other medical conditions|3|||
106069060|NCT02436356|365915953|FG001|Overall Study|Excluded due to other medical conditions|0|||
106069061|NCT02436356|365915954|FG002|Overall Study|Excluded due to other medical conditions|0|||
106069062|NCT02436356|365915952|FG000|Overall Study|Withdrawal by Subject|1|||
106069063|NCT02436356|365915953|FG001|Overall Study|Withdrawal by Subject|0|||
106069064|NCT02436356|365915954|FG002|Overall Study|Withdrawal by Subject|0|||
106069065|NCT02968563|365915959|FG000|Overall Study|Adverse Event|0|||
106069066|NCT02968563|365915960|FG001|Overall Study|Adverse Event|6|||
106069067|NCT02968563|365915959|FG000|Overall Study|Death|1|||
106069068|NCT02968563|365915960|FG001|Overall Study|Death|1|||
106069069|NCT02968563|365915959|FG000|Overall Study|Lost to Follow-up|0|||
106069070|NCT02968563|365915960|FG001|Overall Study|Lost to Follow-up|1|||
106069071|NCT03992781|365915961|FG000|Overall Study|Lost to Follow-up|5|||
105865709|NCT01885195|365156898|FG000|Overall Study|Protocol Deviation|2|||
105865710|NCT01885195|365156898|FG000|Overall Study|Physician Decision|3|||
105865711|NCT01885195|365156898|FG000|Overall Study|Patient/guardian decision|8|||
106069072|NCT03992781|365915961|FG000|Overall Study|Adverse Event|1|||
105865712|NCT04597632|365156899|FG000|Overall Study|Withdrawal by Subject|10|||
105865713|NCT04597632|365156899|FG000|Overall Study|Lost to Follow-up|1|||
106069073|NCT03992781|365915961|FG000|Overall Study|Lack of Efficacy|5|||
106069074|NCT03287804|365915962|FG000|Overall Study|Death|1|||
106069075|NCT03287804|365915962|FG000|Overall Study|Physician Decision|2|||
106069076|NCT03287804|365915962|FG000|Overall Study|Progressive disease|8|||
106069077|NCT01275833|365915964|FG000|Overall Study|Study terminated|1|||
106069078|NCT01275833|365915965|FG001|Overall Study|Study terminated|1|||
106069079|NCT02914769|365915972|FG000|Overall Study|Protocol Violation|3|||
106069080|NCT02914769|365915973|FG001|Overall Study|Protocol Violation|2|||
106069081|NCT02914769|365915972|FG000|Overall Study|Withdrawal by Subject|0|||
106069082|NCT02914769|365915973|FG001|Overall Study|Withdrawal by Subject|1|||
106069083|NCT00742001|365915974|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
106069084|NCT00742001|365915975|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
106069085|NCT00742001|365915976|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
106069086|NCT02488681|365915982|FG000|Overall Study|Implant unsuccessful|7|||
106069087|NCT02604212|365915983|FG000|Overall Study|Study Terminated by Sponsor|2|||
106069088|NCT02604212|365915984|FG001|Overall Study|Study Terminated by Sponsor|1|||
106069089|NCT02604212|365915985|FG002|Overall Study|Study Terminated by Sponsor|3|||
106069090|NCT02604212|365915986|FG003|Overall Study|Study Terminated by Sponsor|3|||
106069091|NCT02604212|365915983|FG000|Overall Study|Withdrawal by Subject|0|||
106069092|NCT02604212|365915984|FG001|Overall Study|Withdrawal by Subject|0|||
106069093|NCT02604212|365915985|FG002|Overall Study|Withdrawal by Subject|1|||
106069094|NCT02604212|365915986|FG003|Overall Study|Withdrawal by Subject|0|||
106069095|NCT00451321|365915987|FG000|Overall Study|Lost to Follow-up|3|||
106069096|NCT00451321|365915988|FG001|Overall Study|Lost to Follow-up|3|||
106069097|NCT00451321|365915989|FG002|Overall Study|Lost to Follow-up|1|||
106069098|NCT00451321|365915990|FG003|Overall Study|Lost to Follow-up|3|||
106069099|NCT00451321|365915991|FG004|Overall Study|Lost to Follow-up|0|||
106069100|NCT00451321|365915992|FG005|Overall Study|Lost to Follow-up|1|||
106069101|NCT00451321|365915993|FG006|Overall Study|Lost to Follow-up|0|||
106069102|NCT00451321|365915994|FG007|Overall Study|Lost to Follow-up|0|||
106069103|NCT00451321|365915987|FG000|Overall Study|Withdrawal by Subject|3|||
106069104|NCT00451321|365915988|FG001|Overall Study|Withdrawal by Subject|1|||
106069105|NCT00451321|365915989|FG002|Overall Study|Withdrawal by Subject|0|||
106069106|NCT00451321|365915990|FG003|Overall Study|Withdrawal by Subject|4|||
106069107|NCT00451321|365915991|FG004|Overall Study|Withdrawal by Subject|0|||
106069108|NCT00451321|365915992|FG005|Overall Study|Withdrawal by Subject|0|||
106069109|NCT00451321|365915993|FG006|Overall Study|Withdrawal by Subject|0|||
106069110|NCT00451321|365915994|FG007|Overall Study|Withdrawal by Subject|0|||
106069111|NCT00451321|365915987|FG000|Overall Study|Study closed/terminated|1|||
106069112|NCT00451321|365915988|FG001|Overall Study|Study closed/terminated|1|||
106069113|NCT00451321|365915989|FG002|Overall Study|Study closed/terminated|17|||
106069114|NCT00451321|365915990|FG003|Overall Study|Study closed/terminated|5|||
106069115|NCT00451321|365915991|FG004|Overall Study|Study closed/terminated|7|||
106069116|NCT00451321|365915992|FG005|Overall Study|Study closed/terminated|7|||
106069117|NCT00451321|365915993|FG006|Overall Study|Study closed/terminated|5|||
106069118|NCT00451321|365915994|FG007|Overall Study|Study closed/terminated|3|||
106069119|NCT00451321|365915987|FG000|Overall Study|Sponsor decision to amend protocol|0|||
106069120|NCT00451321|365915988|FG001|Overall Study|Sponsor decision to amend protocol|0|||
106069121|NCT00451321|365915989|FG002|Overall Study|Sponsor decision to amend protocol|0|||
106069122|NCT00451321|365915990|FG003|Overall Study|Sponsor decision to amend protocol|0|||
106069123|NCT00451321|365915991|FG004|Overall Study|Sponsor decision to amend protocol|0|||
106069124|NCT00451321|365915992|FG005|Overall Study|Sponsor decision to amend protocol|1|||
106069125|NCT00451321|365915993|FG006|Overall Study|Sponsor decision to amend protocol|1|||
106069126|NCT00451321|365915994|FG007|Overall Study|Sponsor decision to amend protocol|3|||
106069127|NCT00003492|365916001|FG000|Overall Study|Not evaluable|6|||
106069128|NCT00597766|365916002|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
106069129|NCT00597766|365916003|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
106069130|NCT00597766|365916004|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
106069131|NCT00597766|365916002|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
106069132|NCT00597766|365916003|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
106069133|NCT00597766|365916004|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
106069134|NCT04256785|365916008|FG000|Overall Study|Adverse Event|8|||
106069135|NCT04256785|365916009|FG001|Overall Study|Adverse Event|6|||
106069136|NCT04256785|365916008|FG000|Overall Study|Lack of Efficacy|3|||
106069137|NCT04256785|365916009|FG001|Overall Study|Lack of Efficacy|4|||
106069138|NCT04256785|365916008|FG000|Overall Study|Lost to Follow-up|7|||
106069139|NCT04256785|365916009|FG001|Overall Study|Lost to Follow-up|7|||
106069140|NCT04256785|365916008|FG000|Overall Study|Protocol Violation|1|||
106069141|NCT04256785|365916009|FG001|Overall Study|Protocol Violation|0|||
106069142|NCT04256785|365916008|FG000|Overall Study|Withdrawal by Subject|4|||
106069143|NCT04256785|365916009|FG001|Overall Study|Withdrawal by Subject|1|||
106069144|NCT04256785|365916008|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
106069145|NCT04256785|365916009|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
106069146|NCT01558752|365916010|FG000|Overall Study|Physician Decision|2|||
106069147|NCT01558752|365916011|FG001|Overall Study|Physician Decision|0|||
106069148|NCT01170091|365916014|FG000|Overall Study|Missing efficacy evaluation|3|||
106069149|NCT01170091|365916014|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
106069150|NCT00969150|365916019|FG000|Overall Study|Adverse Event|4|||
106069151|NCT00969150|365916020|FG001|Overall Study|Adverse Event|14|||
106069152|NCT00969150|365916019|FG000|Overall Study|Lack of Efficacy|1|||
106069153|NCT00969150|365916020|FG001|Overall Study|Lack of Efficacy|1|||
106069154|NCT00969150|365916019|FG000|Overall Study|Protocol Violation|9|||
106069155|NCT00969150|365916020|FG001|Overall Study|Protocol Violation|12|||
106069156|NCT00969150|365916019|FG000|Overall Study|Withdrawal by Subject|13|||
106069157|NCT00969150|365916020|FG001|Overall Study|Withdrawal by Subject|9|||
106069158|NCT00969150|365916019|FG000|Overall Study|Lost to Follow-up|5|||
106069159|NCT00969150|365916020|FG001|Overall Study|Lost to Follow-up|4|||
106069160|NCT00969150|365916019|FG000|Overall Study|Other reasons|1|||
106069161|NCT00969150|365916020|FG001|Overall Study|Other reasons|0|||
106069162|NCT00391274|365916027|FG000|Overall Study|Death Due to Study Disease|55|||
106069163|NCT00391274|365916028|FG001|Overall Study|Death Due to Study Disease|45|||
106069164|NCT00391274|365916027|FG000|Overall Study|Lost to Follow-up|0|||
106069165|NCT00391274|365916028|FG001|Overall Study|Lost to Follow-up|3|||
106069166|NCT00391274|365916027|FG000|Overall Study|Physician Decision|4|||
106069167|NCT00391274|365916028|FG001|Overall Study|Physician Decision|2|||
106069168|NCT00391274|365916027|FG000|Overall Study|Withdrawal by Subject|0|||
106069169|NCT00391274|365916028|FG001|Overall Study|Withdrawal by Subject|3|||
106069170|NCT00391274|365916027|FG000|Overall Study|Death Due to Adverse Event|1|||
106069171|NCT00391274|365916028|FG001|Overall Study|Death Due to Adverse Event|3|||
106069172|NCT00391274|365916027|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
106069173|NCT00391274|365916028|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
106069174|NCT00391274|365916027|FG000|Overall Study|Death Not Study Related|0|||
106069175|NCT00391274|365916028|FG001|Overall Study|Death Not Study Related|1|||
106069176|NCT04501666|365916029|FG000|Overall Study|Physician Decision|0|||
106069177|NCT04501666|365916030|FG001|Overall Study|Physician Decision|1|||
106069178|NCT04501666|365916029|FG000|Overall Study|Adverse Event|12|||
106069179|NCT04501666|365916030|FG001|Overall Study|Adverse Event|4|||
106069180|NCT04501666|365916029|FG000|Overall Study|Subject's request|10|||
106069181|NCT04501666|365916030|FG001|Overall Study|Subject's request|6|||
106069182|NCT04501666|365916029|FG000|Overall Study|Protocol Deviation|2|||
106069183|NCT04501666|365916030|FG001|Overall Study|Protocol Deviation|1|||
106069184|NCT04501666|365916029|FG000|Overall Study|Other-- site permanently closing|0|||
106069185|NCT04501666|365916030|FG001|Overall Study|Other-- site permanently closing|1|||
106069186|NCT00894322|365916031|FG000|Overall Study|Withdrawal by Subject|1|||
106069187|NCT00894322|365916032|FG001|Overall Study|Withdrawal by Subject|0|||
106069188|NCT00894322|365916033|FG002|Overall Study|Withdrawal by Subject|0|||
106069189|NCT01686633|365916034|FG000|Overall Study|Lack of Efficacy|33|||
106069190|NCT01686633|365916035|FG001|Overall Study|Lack of Efficacy|13|||
106069191|NCT01686633|365916036|FG002|Overall Study|Lack of Efficacy|11|||
106069192|NCT01686633|365916034|FG000|Overall Study|Withdrawal by Subject|8|||
106069193|NCT01686633|365916035|FG001|Overall Study|Withdrawal by Subject|8|||
106069194|NCT01686633|365916036|FG002|Overall Study|Withdrawal by Subject|5|||
106069195|NCT01686633|365916034|FG000|Overall Study|Physician Decision|3|||
106069196|NCT01686633|365916035|FG001|Overall Study|Physician Decision|4|||
106069197|NCT01686633|365916036|FG002|Overall Study|Physician Decision|4|||
106069198|NCT01686633|365916034|FG000|Overall Study|Adverse Event|4|||
105865714|NCT04597632|365156899|FG000|Overall Study|Death|1|||
105865715|NCT04597632|365156899|FG000|Overall Study|Adverse Event|5|||
105865716|NCT01823835|365156900|FG000|Overall Study|Adverse Event|0|||
105865717|NCT01823835|365156901|FG001|Overall Study|Adverse Event|0|||
105865718|NCT01823835|365156902|FG002|Overall Study|Adverse Event|0|||
105865719|NCT01823835|365156903|FG003|Overall Study|Adverse Event|0|||
105865720|NCT01823835|365156904|FG004|Overall Study|Adverse Event|1|||
105865721|NCT01823835|365156905|FG005|Overall Study|Adverse Event|0|||
105865722|NCT01823835|365156906|FG006|Overall Study|Adverse Event|1|||
105865723|NCT01823835|365156907|FG007|Overall Study|Adverse Event|0|||
105865724|NCT01823835|365156908|FG008|Overall Study|Adverse Event|0|||
105865725|NCT01823835|365156909|FG009|Overall Study|Adverse Event|0|||
105865726|NCT01823835|365156910|FG010|Overall Study|Adverse Event|1|||
105865727|NCT01823835|365156911|FG011|Overall Study|Adverse Event|2|||
105865728|NCT01823835|365156912|FG012|Overall Study|Adverse Event|0|||
105865729|NCT01823835|365156913|FG013|Overall Study|Adverse Event|0|||
105865730|NCT01823835|365156914|FG014|Overall Study|Adverse Event|0|||
105865731|NCT01823835|365156900|FG000|Overall Study|Physician Decision|0|||
105865732|NCT01823835|365156901|FG001|Overall Study|Physician Decision|0|||
106069199|NCT01686633|365916035|FG001|Overall Study|Adverse Event|3|||
106069200|NCT01686633|365916036|FG002|Overall Study|Adverse Event|3|||
106069201|NCT01686633|365916034|FG000|Overall Study|Protocol Violation|2|||
105865733|NCT01823835|365156902|FG002|Overall Study|Physician Decision|0|||
105865734|NCT01823835|365156903|FG003|Overall Study|Physician Decision|0|||
105865735|NCT01823835|365156904|FG004|Overall Study|Physician Decision|0|||
105865736|NCT01823835|365156905|FG005|Overall Study|Physician Decision|0|||
105865737|NCT01823835|365156906|FG006|Overall Study|Physician Decision|0|||
105865738|NCT01823835|365156907|FG007|Overall Study|Physician Decision|0|||
106069202|NCT01686633|365916035|FG001|Overall Study|Protocol Violation|3|||
106069203|NCT01686633|365916036|FG002|Overall Study|Protocol Violation|0|||
106069204|NCT01686633|365916034|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
106069205|NCT01686633|365916035|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
106069206|NCT01686633|365916036|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
106069207|NCT01686633|365916034|FG000|Overall Study|Lost to Follow-up|0|||
106069208|NCT01686633|365916035|FG001|Overall Study|Lost to Follow-up|1|||
106069209|NCT01686633|365916036|FG002|Overall Study|Lost to Follow-up|1|||
106069210|NCT00056407|365916037|FG000|Overall Study|Adverse Event|282|||
106069211|NCT00056407|365916038|FG001|Overall Study|Adverse Event|364|||
106069212|NCT00056407|365916037|FG000|Overall Study|Withdrawal by Subject|377|||
106069213|NCT00056407|365916038|FG001|Overall Study|Withdrawal by Subject|361|||
106069214|NCT00056407|365916037|FG000|Overall Study|Lost to Follow-up|123|||
106069215|NCT00056407|365916038|FG001|Overall Study|Lost to Follow-up|113|||
106069216|NCT00056407|365916037|FG000|Overall Study|Protocol Violation|104|||
106069217|NCT00056407|365916038|FG001|Overall Study|Protocol Violation|95|||
106069218|NCT00056407|365916037|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
106069219|NCT00056407|365916038|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
106069220|NCT00056407|365916037|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
106069221|NCT00056407|365916038|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
106069222|NCT00056407|365916037|FG000|Overall Study|Missing|25|||
106069223|NCT00056407|365916038|FG001|Overall Study|Missing|34|||
106154696|NCT04143061|366227531|FG000|Overall Study|Withdrawal by Subject|2|||
106154697|NCT04143061|366227532|FG001|Overall Study|Withdrawal by Subject|0|||
106154698|NCT04143061|366227533|FG002|Overall Study|Withdrawal by Subject|0|||
106154699|NCT04143061|366227534|FG003|Overall Study|Withdrawal by Subject|0|||
106069224|NCT00651755|365916042|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
106069225|NCT00651755|365916043|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
106069226|NCT00651755|365916042|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
106069227|NCT00651755|365916043|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
106069228|NCT02587065|365916046|FG000|Overall Study|Adverse Event|14|||
106069229|NCT02587065|365916046|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
106069230|NCT02587065|365916046|FG000|Overall Study|Non-adherence to the Protocol|3|||
106069231|NCT02587065|365916046|FG000|Overall Study|Discontinuation of Study Medication|2|||
106069232|NCT02587065|365916046|FG000|Overall Study|Reason not Specified|3|||
106069233|NCT00670800|365917944|FG000|Overall Study|2 controls were insulin resistant|0|||
106069234|NCT00670800|365917945|FG001|Overall Study|2 controls were insulin resistant|2|||
106069235|NCT01853826|365917946|FG000|Overall Study|Patients who switched to commercial drug|11|||
106069236|NCT01853826|365917946|FG000|Overall Study|Patient refused to continue medication|21|||
106069237|NCT01853826|365917946|FG000|Overall Study|Lost to Follow-up|2|||
106069238|NCT01853826|365917946|FG000|Overall Study|Non-compliant with protocol|4|||
106069239|NCT01853826|365917946|FG000|Overall Study|Other adverse events (AE)|62|||
106069240|NCT01853826|365917946|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
106069241|NCT01853826|365917946|FG000|Overall Study|Progressive disease|342|||
106069242|NCT01853826|365917946|FG000|Overall Study|Other than listed|13|||
106069243|NCT01853826|365917946|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
106069244|NCT03204981|365917947|FG000|Overall Study|Physician Decision|2|||
106069245|NCT03204981|365917947|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
106069246|NCT03025542|365917948|FG000|Overall Study|Adverse Event|0|||
106069247|NCT03025542|365917949|FG001|Overall Study|Adverse Event|2|||
106069248|NCT03025542|365917948|FG000|Overall Study|Lost to Follow-up|1|||
106069249|NCT03025542|365917949|FG001|Overall Study|Lost to Follow-up|0|||
106069250|NCT03025542|365917948|FG000|Overall Study|Withdrawal by Subject|1|||
106069251|NCT03025542|365917949|FG001|Overall Study|Withdrawal by Subject|0|||
106069252|NCT05024058|365917950|FG000|Treatment|Study terminated by sponsor|5|||
106069253|NCT05024058|365917951|FG001|Treatment|Study terminated by sponsor|6|||
106069254|NCT05024058|365917952|FG002|Treatment|Study terminated by sponsor|4|||
106069255|NCT05024058|365917953|FG003|Treatment|Study terminated by sponsor|2|||
106069256|NCT05024058|365917954|FG004|Treatment|Study terminated by sponsor|3|||
106069257|NCT05024058|365917955|FG005|Treatment|Study terminated by sponsor|3|||
106069258|NCT05024058|365917956|FG006|Treatment|Study terminated by sponsor|1|||
106069259|NCT05024058|365917957|FG007|Treatment|Study terminated by sponsor|3|||
106069260|NCT05024058|365917958|FG008|Treatment|Study terminated by sponsor|6|||
106069261|NCT05024058|365917959|FG009|Treatment|Study terminated by sponsor|6|||
106069262|NCT05024058|365917950|FG000|Follow-up|Withdrawal by Subject|1|||
106069263|NCT05024058|365917951|FG001|Follow-up|Withdrawal by Subject|0|||
106069264|NCT05024058|365917952|FG002|Follow-up|Withdrawal by Subject|1|||
106154700|NCT04143061|366227535|FG004|Overall Study|Withdrawal by Subject|0|||
106069265|NCT05024058|365917953|FG003|Follow-up|Withdrawal by Subject|0|||
106069266|NCT05024058|365917954|FG004|Follow-up|Withdrawal by Subject|0|||
106069267|NCT05024058|365917955|FG005|Follow-up|Withdrawal by Subject|0|||
106154701|NCT04143061|366227536|FG005|Overall Study|Withdrawal by Subject|1|||
106069268|NCT05024058|365917956|FG006|Follow-up|Withdrawal by Subject|0|||
106069269|NCT05024058|365917957|FG007|Follow-up|Withdrawal by Subject|1|||
106069270|NCT05024058|365917958|FG008|Follow-up|Withdrawal by Subject|0|||
105865739|NCT01823835|365156908|FG008|Overall Study|Physician Decision|0|||
105865740|NCT01823835|365156909|FG009|Overall Study|Physician Decision|0|||
105865741|NCT01823835|365156910|FG010|Overall Study|Physician Decision|0|||
105865742|NCT01823835|365156911|FG011|Overall Study|Physician Decision|2|||
105865743|NCT01823835|365156912|FG012|Overall Study|Physician Decision|0|||
105865744|NCT01823835|365156913|FG013|Overall Study|Physician Decision|0|||
105865745|NCT01823835|365156914|FG014|Overall Study|Physician Decision|0|||
105865746|NCT01823835|365156900|FG000|Overall Study|Progressive Disease|3|||
105865747|NCT01823835|365156901|FG001|Overall Study|Progressive Disease|4|||
105865748|NCT01823835|365156902|FG002|Overall Study|Progressive Disease|3|||
106069271|NCT05024058|365917959|FG009|Follow-up|Withdrawal by Subject|1|||
106069272|NCT01104636|365917961|FG000|Overall Study|Lack of Efficacy|43|||
106069273|NCT01104636|365917961|FG000|Overall Study|Lost to Follow-up|24|||
106069274|NCT01104636|365917961|FG000|Overall Study|Withdrawal by Subject|4|||
106069275|NCT01104636|365917961|FG000|Overall Study|Other|43|||
106069276|NCT01104636|365917961|FG000|Overall Study|Study terminated by sponsor|1|||
106069277|NCT01104636|365917961|FG000|Overall Study|Pregnancy|2|||
106069278|NCT01104636|365917961|FG000|Overall Study|Adverse Event|40|||
106069279|NCT01104636|365917961|FG000|Overall Study|Ongoing|21|||
106069280|NCT00380978|365917963|FG000|Overall Study|Refused allocated intervention|0|||
106069281|NCT00380978|365917964|FG001|Overall Study|Refused allocated intervention|6|||
106069282|NCT00380978|365917963|FG000|Overall Study|Wrong study envelope|0|||
106069283|NCT00380978|365917964|FG001|Overall Study|Wrong study envelope|2|||
106069284|NCT00380978|365917963|FG000|Overall Study|Allocation prior to analgesia request|1|||
106069285|NCT00380978|365917964|FG001|Overall Study|Allocation prior to analgesia request|2|||
106069286|NCT00380978|365917963|FG000|Overall Study|Parous patient|1|||
106069287|NCT00380978|365917964|FG001|Overall Study|Parous patient|0|||
106069288|NCT02750592|365917966|FG000|Overall Study|Adverse Event|3|||
106069289|NCT02750592|365917966|FG000|Overall Study|Lack of Efficacy|2|||
106069290|NCT04782856|365917973|FG000|Overall Study|Withdrawal by Subject|0|||
106069291|NCT04782856|365917974|FG001|Overall Study|Withdrawal by Subject|1|||
106069292|NCT01912287|365917975|FG000|Overall Study|Ineligible|1|||
106069293|NCT01912287|365917976|FG001|Overall Study|Ineligible|0|||
106069294|NCT01912287|365917977|FG002|Overall Study|Ineligible|1|||
106069295|NCT01912287|365917975|FG000|Overall Study|No-show|0|||
106069296|NCT01912287|365917976|FG001|Overall Study|No-show|0|||
106069297|NCT01912287|365917977|FG002|Overall Study|No-show|1|||
106069298|NCT01912287|365917975|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
106069299|NCT01912287|365917976|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
106069300|NCT01912287|365917977|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
106069301|NCT01912287|365917975|FG000|Overall Study|Felt treatment no longer needed|0|||
106069302|NCT01912287|365917976|FG001|Overall Study|Felt treatment no longer needed|1|||
106069303|NCT01912287|365917977|FG002|Overall Study|Felt treatment no longer needed|0|||
106069304|NCT01912287|365917975|FG000|Overall Study|Life circumstances|4|||
106069305|NCT01912287|365917976|FG001|Overall Study|Life circumstances|2|||
106069306|NCT01912287|365917977|FG002|Overall Study|Life circumstances|0|||
106069307|NCT01912287|365917975|FG000|Overall Study|Lost Interest|1|||
106069308|NCT01912287|365917976|FG001|Overall Study|Lost Interest|0|||
106069309|NCT01912287|365917977|FG002|Overall Study|Lost Interest|0|||
106069310|NCT01912287|365917975|FG000|Overall Study|Uknown reason - subject drop out|5|||
106069311|NCT01912287|365917976|FG001|Overall Study|Uknown reason - subject drop out|7|||
106069312|NCT01912287|365917977|FG002|Overall Study|Uknown reason - subject drop out|3|||
106069313|NCT01912287|365917975|FG000|Overall Study|Missed Assesment|1|||
106069314|NCT01912287|365917976|FG001|Overall Study|Missed Assesment|1|||
106069315|NCT01912287|365917977|FG002|Overall Study|Missed Assesment|1|||
105865749|NCT01823835|365156903|FG003|Overall Study|Progressive Disease|6|||
105865750|NCT01823835|365156904|FG004|Overall Study|Progressive Disease|4|||
105865751|NCT01823835|365156905|FG005|Overall Study|Progressive Disease|6|||
105865752|NCT01823835|365156906|FG006|Overall Study|Progressive Disease|5|||
105865753|NCT01823835|365156907|FG007|Overall Study|Progressive Disease|3|||
105865754|NCT01823835|365156908|FG008|Overall Study|Progressive Disease|3|||
106069316|NCT01912287|365917975|FG000|Overall Study|Scheduling/change in availability|17|||
106069317|NCT01912287|365917976|FG001|Overall Study|Scheduling/change in availability|10|||
106069318|NCT01912287|365917977|FG002|Overall Study|Scheduling/change in availability|8|||
106069319|NCT00695396|365917978|FG000|Overall Study|Study Closed Prematurely|5|||
106069320|NCT00695396|365917979|FG001|Overall Study|Study Closed Prematurely|6|||
105865755|NCT01823835|365156909|FG009|Overall Study|Progressive Disease|18|||
105865756|NCT01823835|365156910|FG010|Overall Study|Progressive Disease|8|||
106069321|NCT00695396|365917980|FG002|Overall Study|Study Closed Prematurely|8|||
106154702|NCT04143061|366227537|FG006|Overall Study|Withdrawal by Subject|0|||
106069322|NCT00695396|365917978|FG000|Overall Study|Withdrawal by Subject|2|||
106069323|NCT00695396|365917979|FG001|Overall Study|Withdrawal by Subject|2|||
106069324|NCT00695396|365917980|FG002|Overall Study|Withdrawal by Subject|0|||
106069325|NCT01050257|365917982|FG000|Overall Study|Adverse Event|4|||
105865757|NCT01823835|365156911|FG011|Overall Study|Progressive Disease|46|||
105865758|NCT01823835|365156912|FG012|Overall Study|Progressive Disease|18|||
106069326|NCT01050257|365917983|FG001|Overall Study|Adverse Event|4|||
106069327|NCT01050257|365917984|FG002|Overall Study|Adverse Event|2|||
106154703|NCT04143061|366227538|FG007|Overall Study|Withdrawal by Subject|0|||
106154704|NCT04143061|366227531|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
106154705|NCT04143061|366227532|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
106154706|NCT04143061|366227533|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
106154707|NCT04143061|366227534|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
106154708|NCT04143061|366227535|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
106154709|NCT04143061|366227536|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
106154710|NCT04143061|366227537|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
106154711|NCT04143061|366227538|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
106154712|NCT03602014|366227539|FG000|Overall Study|Lost to Follow-up|2|||
106154713|NCT03602014|366227540|FG001|Overall Study|Lost to Follow-up|0|||
106154714|NCT03602014|366227541|FG002|Overall Study|Lost to Follow-up|0|||
106154715|NCT04533022|366227542|FG000|Overall Study|Withdrawal by Subject|15|||
106154716|NCT04533022|366227542|FG000|Overall Study|Adverse Event|6|||
106154717|NCT04533022|366227542|FG000|Overall Study|Death|1|||
106154718|NCT04533022|366227542|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
106154719|NCT04533022|366227542|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
106154720|NCT03289039|366227543|FG000|Overall Study|Withdrawal by Subject|0|||
106154721|NCT03289039|366227544|FG001|Overall Study|Withdrawal by Subject|1|||
106154722|NCT03289039|366227543|FG000|Overall Study|Became ineligible prior to treatment start|0|||
106154723|NCT03289039|366227544|FG001|Overall Study|Became ineligible prior to treatment start|1|||
106154724|NCT03289039|366227543|FG000|Overall Study|progressed before treatment start|1|||
106154725|NCT03289039|366227544|FG001|Overall Study|progressed before treatment start|0|||
106154726|NCT05113966|366227545|FG000|Overall Study|Death|21|||
106154727|NCT05113966|366227545|FG000|Overall Study|Study Terminated by Sponsor|9|||
106154728|NCT05058391|366227554|FG000|Overall Study|Adverse Event|1|||
106154729|NCT03584516|366227555|FG000|Part 1|Death|2|||
106154730|NCT03584516|366227556|FG001|Part 1|Death|3|||
106154731|NCT03584516|366227557|FG002|Part 1|Death|0|||
106154732|NCT03584516|366227558|FG003|Part 1|Death|0|||
106154733|NCT03584516|366227559|FG004|Part 1|Death|0|||
106154734|NCT03584516|366227560|FG005|Part 1|Death|0|||
106154735|NCT03584516|366227555|FG000|Part 1|Withdrawal by Subject|2|||
106154736|NCT03584516|366227556|FG001|Part 1|Withdrawal by Subject|0|||
106154737|NCT03584516|366227557|FG002|Part 1|Withdrawal by Subject|0|||
106154738|NCT03584516|366227558|FG003|Part 1|Withdrawal by Subject|0|||
106154739|NCT03584516|366227559|FG004|Part 1|Withdrawal by Subject|0|||
106154740|NCT03584516|366227560|FG005|Part 1|Withdrawal by Subject|0|||
106154741|NCT03584516|366227555|FG000|Part 1|Lost to Follow-up|1|||
106154742|NCT03584516|366227556|FG001|Part 1|Lost to Follow-up|0|||
106154743|NCT03584516|366227557|FG002|Part 1|Lost to Follow-up|0|||
106154744|NCT03584516|366227558|FG003|Part 1|Lost to Follow-up|0|||
106154745|NCT03584516|366227559|FG004|Part 1|Lost to Follow-up|0|||
106154746|NCT03584516|366227560|FG005|Part 1|Lost to Follow-up|0|||
106154747|NCT03584516|366227555|FG000|Part 1|Study Terminated by Sponsor|0|||
106154748|NCT03584516|366227556|FG001|Part 1|Study Terminated by Sponsor|2|||
106154749|NCT03584516|366227557|FG002|Part 1|Study Terminated by Sponsor|0|||
106154750|NCT03584516|366227558|FG003|Part 1|Study Terminated by Sponsor|0|||
106154751|NCT03584516|366227559|FG004|Part 1|Study Terminated by Sponsor|0|||
106154752|NCT03584516|366227560|FG005|Part 1|Study Terminated by Sponsor|0|||
106154753|NCT03584516|366227555|FG000|Part 1 Expansion|Death|0|||
106154754|NCT03584516|366227556|FG001|Part 1 Expansion|Death|0|||
106154755|NCT03584516|366227557|FG002|Part 1 Expansion|Death|9|||
106154756|NCT03584516|366227558|FG003|Part 1 Expansion|Death|8|||
106154757|NCT03584516|366227559|FG004|Part 1 Expansion|Death|4|||
106154758|NCT03584516|366227560|FG005|Part 1 Expansion|Death|5|||
106154759|NCT03584516|366227555|FG000|Part 1 Expansion|Lost to Follow-up|0|||
106154760|NCT03584516|366227556|FG001|Part 1 Expansion|Lost to Follow-up|0|||
106154761|NCT03584516|366227557|FG002|Part 1 Expansion|Lost to Follow-up|0|||
106154762|NCT03584516|366227558|FG003|Part 1 Expansion|Lost to Follow-up|1|||
106154763|NCT03584516|366227559|FG004|Part 1 Expansion|Lost to Follow-up|0|||
106154764|NCT03584516|366227560|FG005|Part 1 Expansion|Lost to Follow-up|0|||
106154765|NCT03584516|366227555|FG000|Part 1 Expansion|Physician Decision|0|||
105865759|NCT01823835|365156913|FG013|Overall Study|Progressive Disease|4|||
106154766|NCT03584516|366227556|FG001|Part 1 Expansion|Physician Decision|0|||
106154767|NCT03584516|366227557|FG002|Part 1 Expansion|Physician Decision|4|||
106154768|NCT03584516|366227558|FG003|Part 1 Expansion|Physician Decision|3|||
106154769|NCT03584516|366227559|FG004|Part 1 Expansion|Physician Decision|2|||
106154770|NCT03584516|366227560|FG005|Part 1 Expansion|Physician Decision|3|||
105865760|NCT01823835|365156914|FG014|Overall Study|Progressive Disease|6|||
105865761|NCT01823835|365156900|FG000|Overall Study|Study Termination|0|||
106154771|NCT03584516|366227555|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
106154772|NCT03584516|366227556|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
106154773|NCT03584516|366227557|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
106154774|NCT03584516|366227558|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
106154775|NCT03584516|366227559|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
106154776|NCT03584516|366227560|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
106154777|NCT03584516|366227555|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
106154778|NCT03584516|366227556|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
106154779|NCT03584516|366227557|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
106154780|NCT03584516|366227558|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
106154781|NCT03584516|366227559|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
106154782|NCT03584516|366227560|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
106154783|NCT03584516|366227555|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
106154784|NCT03584516|366227556|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
106154785|NCT03584516|366227557|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
106154786|NCT03584516|366227558|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
106154787|NCT03584516|366227559|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
106154788|NCT03584516|366227560|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
106154789|NCT03584516|366227555|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
106154790|NCT03584516|366227556|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
106154791|NCT03584516|366227557|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
106154792|NCT03584516|366227558|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
106154793|NCT03584516|366227559|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
106154794|NCT03584516|366227560|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
106154795|NCT03263026|366227566|FG000|Overall Study|Withdrawal by Subject|1|||
106154796|NCT03263026|366227567|FG001|Overall Study|Withdrawal by Subject|0|||
106154797|NCT03263026|366227566|FG000|Overall Study|Death|1|||
106154798|NCT03263026|366227567|FG001|Overall Study|Death|0|||
106154799|NCT03263026|366227566|FG000|Overall Study|Other/ Various|41|||
106154800|NCT03263026|366227567|FG001|Overall Study|Other/ Various|29|||
106154801|NCT04868110|366227568|FG000|Overall Study|Withdrawal by Subject|3|||
106154802|NCT04868110|366227569|FG001|Overall Study|Withdrawal by Subject|4|||
106154803|NCT03833245|366227570|FG000|Overall Study|Death|0|||
106154804|NCT03833245|366227571|FG001|Overall Study|Death|1|||
106154805|NCT05608005|366227583|FG000|Overall Study|Adverse Event|2|||
106154806|NCT05608005|366227584|FG001|Overall Study|Adverse Event|1|||
106154807|NCT05608005|366227585|FG002|Overall Study|Adverse Event|3|||
106154808|NCT05608005|366227583|FG000|Overall Study|Protocol Violation|2|||
106154809|NCT05608005|366227584|FG001|Overall Study|Protocol Violation|3|||
106154810|NCT05608005|366227585|FG002|Overall Study|Protocol Violation|0|||
106154811|NCT05608005|366227583|FG000|Overall Study|Withdrawal by Subject|10|||
106154812|NCT05608005|366227584|FG001|Overall Study|Withdrawal by Subject|12|||
106154813|NCT05608005|366227585|FG002|Overall Study|Withdrawal by Subject|4|||
106154814|NCT05608005|366227583|FG000|Overall Study|Lost to Follow-up|25|||
106154815|NCT05608005|366227584|FG001|Overall Study|Lost to Follow-up|27|||
106154816|NCT05608005|366227585|FG002|Overall Study|Lost to Follow-up|15|||
106154817|NCT05608005|366227583|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
106154818|NCT05608005|366227584|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
106154819|NCT05608005|366227585|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
106154820|NCT03739996|366227586|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
106154821|NCT03739996|366227586|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
106154822|NCT03739996|366227586|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
106154823|NCT03739996|366227586|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
106154824|NCT03739996|366227586|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
106154825|NCT03739996|366227586|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
106154826|NCT03739996|366227586|FG000|Step 3 (SOC ART)|Death|1|||
106154827|NCT03739996|366227586|FG000|Step 3 (SOC ART)|Participant moved|1|||
106154828|NCT05387447|366227587|FG000|Overall Study|Participants changed their minds about study participation.|3|||
106154829|NCT05387447|366227588|FG001|Overall Study|Participants changed their minds about study participation.|5|||
106154830|NCT01673984|366227589|FG000|Overall Study|Adverse Event|1|||
106154831|NCT01673984|366227590|FG001|Overall Study|Adverse Event|0|||
106154832|NCT01673984|366227589|FG000|Overall Study|Study termination|9|||
106154833|NCT01673984|366227590|FG001|Overall Study|Study termination|6|||
106154834|NCT05062265|366227591|FG000|Overall Study|Withdrawal by Subject|1|||
106154835|NCT05062265|366227592|FG001|Overall Study|Withdrawal by Subject|0|||
106154836|NCT02919449|366227596|FG000|Overall Study|Withdrawal by Subject|1|||
106154837|NCT02919449|366227596|FG000|Overall Study|Investigator decision|1|||
106154838|NCT05633407|366227597|FG000|Overall Study|Physician Decision|2|||
106154839|NCT05633407|366227598|FG001|Overall Study|Physician Decision|0|||
106154840|NCT05633407|366227597|FG000|Overall Study|Adverse Event|1|||
106154841|NCT05633407|366227598|FG001|Overall Study|Adverse Event|0|||
106154842|NCT05633407|366227597|FG000|Overall Study|Withdrawal by Subject|1|||
106154843|NCT05633407|366227598|FG001|Overall Study|Withdrawal by Subject|0|||
106154844|NCT05633407|366227597|FG000|Overall Study|Other|1|||
106154845|NCT05633407|366227598|FG001|Overall Study|Other|1|||
106154846|NCT02500758|366227599|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
106154847|NCT02500758|366227600|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
106154848|NCT02500758|366227599|FG000|Washout (1 Week)|Lost to Follow-up|2|||
106154849|NCT02500758|366227600|FG001|Washout (1 Week)|Lost to Follow-up|2|||
106154850|NCT02500758|366227599|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
106154851|NCT02500758|366227600|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
106154852|NCT02500758|366227599|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
106154853|NCT02500758|366227600|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
106154854|NCT02500758|366227599|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
106154855|NCT02500758|366227600|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
106154856|NCT03578536|366227601|FG000|Overall Study|Lost to Follow-up|1|||
106154857|NCT02063724|366227603|FG000|Overall Study|Disease progression|1|||
106154858|NCT04436107|366227604|FG000|Overall Study|Sponsor Ended Study|2|||
106154859|NCT04436107|366227605|FG001|Overall Study|Sponsor Ended Study|4|||
106154860|NCT04436107|366227606|FG002|Overall Study|Sponsor Ended Study|8|||
106154861|NCT04436107|366227607|FG003|Overall Study|Sponsor Ended Study|20|||
106069328|NCT01050257|365917982|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
106069329|NCT01050257|365917983|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
106069330|NCT01050257|365917984|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
106069331|NCT01050257|365917982|FG000|Overall Study|Withdrawal by Subject|0|||
106069332|NCT01050257|365917983|FG001|Overall Study|Withdrawal by Subject|3|||
106069333|NCT01050257|365917984|FG002|Overall Study|Withdrawal by Subject|0|||
106069334|NCT01050257|365917982|FG000|Overall Study|No reason specified|0|||
106069335|NCT01050257|365917983|FG001|Overall Study|No reason specified|0|||
106069336|NCT01050257|365917984|FG002|Overall Study|No reason specified|2|||
106069337|NCT01050257|365917982|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
106069338|NCT01050257|365917983|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
106069339|NCT01050257|365917984|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
106069340|NCT01050257|365917982|FG000|Overall Study|Violation criteria|0|||
106069341|NCT01050257|365917983|FG001|Overall Study|Violation criteria|1|||
106069342|NCT01050257|365917984|FG002|Overall Study|Violation criteria|0|||
106069343|NCT01050257|365917982|FG000|Overall Study|Failure to return|0|||
106069344|NCT01050257|365917983|FG001|Overall Study|Failure to return|2|||
106069345|NCT01050257|365917984|FG002|Overall Study|Failure to return|0|||
106069346|NCT01050257|365917982|FG000|Overall Study|Death|0|||
106069347|NCT01050257|365917983|FG001|Overall Study|Death|0|||
106154862|NCT04436107|366227604|FG000|Overall Study|Death|3|||
106154863|NCT04436107|366227605|FG001|Overall Study|Death|5|||
106069348|NCT01050257|365917984|FG002|Overall Study|Death|1|||
106069349|NCT00171223|365917985|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
106069350|NCT00171223|365917986|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
106069351|NCT00171223|365917987|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
106069352|NCT00171223|365917985|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
106069353|NCT00171223|365917986|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
106069354|NCT00171223|365917987|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
106069355|NCT00171223|365917985|FG000|Overall Study|Abnormal Procedure|1|||
106069356|NCT00171223|365917986|FG001|Overall Study|Abnormal Procedure|0|||
106069357|NCT00171223|365917987|FG002|Overall Study|Abnormal Procedure|0|||
106069358|NCT00171223|365917985|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
106069359|NCT00171223|365917986|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
106069360|NCT00171223|365917987|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
106069361|NCT00171223|365917985|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
106069362|NCT00171223|365917986|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
106069363|NCT00171223|365917987|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
106069364|NCT00171223|365917985|FG000|Overall Study|Protocol Violation|2|||
106069365|NCT00171223|365917986|FG001|Overall Study|Protocol Violation|2|||
106069366|NCT00171223|365917987|FG002|Overall Study|Protocol Violation|3|||
106069367|NCT00171223|365917985|FG000|Overall Study|Participant Withdrew Consent|12|||
106154864|NCT04436107|366227606|FG002|Overall Study|Death|3|||
106154865|NCT04436107|366227607|FG003|Overall Study|Death|18|||
106154866|NCT04436107|366227604|FG000|Overall Study|Withdrawal by Subject|1|||
106154867|NCT04436107|366227605|FG001|Overall Study|Withdrawal by Subject|1|||
106154868|NCT04436107|366227606|FG002|Overall Study|Withdrawal by Subject|0|||
106154869|NCT04436107|366227607|FG003|Overall Study|Withdrawal by Subject|1|||
106154870|NCT04287985|366227608|FG000|Overall Study|Adverse Event|1|||
106154871|NCT04287985|366227609|FG001|Overall Study|Adverse Event|0|||
106154872|NCT04287985|366227610|FG002|Overall Study|Adverse Event|0|||
106154873|NCT04287985|366227611|FG003|Overall Study|Adverse Event|0|||
106154874|NCT04287985|366227608|FG000|Overall Study|Protocol Violation|0|||
106154875|NCT04287985|366227609|FG001|Overall Study|Protocol Violation|1|||
106154876|NCT04287985|366227610|FG002|Overall Study|Protocol Violation|0|||
106154877|NCT04287985|366227611|FG003|Overall Study|Protocol Violation|0|||
106069368|NCT00171223|365917986|FG001|Overall Study|Participant Withdrew Consent|21|||
106069369|NCT00171223|365917987|FG002|Overall Study|Participant Withdrew Consent|15|||
106069370|NCT00171223|365917985|FG000|Overall Study|Lost to Follow-up|5|||
106069371|NCT00171223|365917986|FG001|Overall Study|Lost to Follow-up|2|||
106069372|NCT00171223|365917987|FG002|Overall Study|Lost to Follow-up|3|||
106154878|NCT04287985|366227608|FG000|Overall Study|Physician Decision|0|||
106154879|NCT04287985|366227609|FG001|Overall Study|Physician Decision|0|||
106069373|NCT00171223|365917985|FG000|Overall Study|Administrative Problems|4|||
106069374|NCT00171223|365917986|FG001|Overall Study|Administrative Problems|7|||
106069375|NCT00171223|365917987|FG002|Overall Study|Administrative Problems|6|||
106069376|NCT00171223|365917985|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
106069377|NCT00171223|365917986|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
106069378|NCT00171223|365917987|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
106069379|NCT00171223|365917985|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
106069380|NCT00171223|365917986|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
106069381|NCT00171223|365917987|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
106069382|NCT03311659|365917991|FG000|Overall Study|Protocol Violation|1|||
106069383|NCT01909479|365917992|FG000|From Baseline to Week 26|Adverse Event|3|||
106069384|NCT01909479|365917993|FG001|From Baseline to Week 26|Adverse Event|2|||
106069385|NCT01909479|365917992|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
106069386|NCT01909479|365917993|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
106069387|NCT01909479|365917992|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
106069388|NCT01909479|365917993|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
106069389|NCT01909479|365917992|FG000|26 - 52 Weeks|Adverse Event|0|||
106069390|NCT01909479|365917993|FG001|26 - 52 Weeks|Adverse Event|1|||
106069391|NCT01909479|365917992|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
106069392|NCT01909479|365917993|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
106069393|NCT01909479|365917992|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
106069394|NCT01909479|365917993|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
106069395|NCT01909479|365917992|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
106069396|NCT01909479|365917993|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
106069397|NCT01909479|365917992|FG000|52 Weeks to End of Study|Adverse Event|2|||
106069398|NCT01909479|365917993|FG001|52 Weeks to End of Study|Adverse Event|1|||
106069399|NCT01909479|365917992|FG000|52 Weeks to End of Study|Death|0|||
106069400|NCT01909479|365917993|FG001|52 Weeks to End of Study|Death|1|||
106069401|NCT01909479|365917992|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
106069402|NCT01909479|365917993|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
106069403|NCT01909479|365917992|FG000|52 Weeks to End of Study|Protocol Violation|1|||
106069404|NCT01909479|365917993|FG001|52 Weeks to End of Study|Protocol Violation|0|||
106069405|NCT01909479|365917992|FG000|52 Weeks to End of Study|Progressive disease|1|||
106069406|NCT01909479|365917993|FG001|52 Weeks to End of Study|Progressive disease|1|||
106069407|NCT01909479|365917992|FG000|52 Weeks to End of Study|Personal reasons|2|||
106069408|NCT01909479|365917993|FG001|52 Weeks to End of Study|Personal reasons|1|||
106069409|NCT01909479|365917992|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
106069410|NCT01909479|365917993|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
106069411|NCT01909479|365917992|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
106069412|NCT01909479|365917993|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
106069413|NCT01909479|365917992|FG000|52 Weeks to End of Study|Lack of contact|1|||
106069414|NCT01909479|365917993|FG001|52 Weeks to End of Study|Lack of contact|0|||
106069415|NCT01909479|365917992|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
106069416|NCT01909479|365917993|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
106069417|NCT01909479|365917992|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
106069418|NCT01909479|365917993|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
106069419|NCT04446377|365917994|FG000|Overall Study|Withdrawal by Subject|6|||
106069420|NCT04446377|365917995|FG001|Overall Study|Withdrawal by Subject|1|||
106069421|NCT04446377|365917994|FG000|Overall Study|Physician Decision|1|||
106069422|NCT04446377|365917995|FG001|Overall Study|Physician Decision|1|||
106069423|NCT04446377|365917994|FG000|Overall Study|Lost to Follow-up|0|||
106069424|NCT04446377|365917995|FG001|Overall Study|Lost to Follow-up|2|||
106069425|NCT04446377|365917994|FG000|Overall Study|Not eligible|0|||
106069426|NCT04446377|365917995|FG001|Overall Study|Not eligible|1|||
106069427|NCT00271609|365917998|FG000|Overall Study|Adverse Event|11|||
106069428|NCT00271609|365917999|FG001|Overall Study|Adverse Event|3|||
106069429|NCT00271609|365917998|FG000|Overall Study|Withdrawal by Subject|2|||
106069430|NCT00271609|365917999|FG001|Overall Study|Withdrawal by Subject|0|||
106069431|NCT03051607|365918000|FG000|Overall Study|Adverse Event|66|||
106154880|NCT04287985|366227610|FG002|Overall Study|Physician Decision|0|||
106154881|NCT04287985|366227611|FG003|Overall Study|Physician Decision|1|||
106154882|NCT04287985|366227608|FG000|Overall Study|Withdrawal by Subject|2|||
106154883|NCT04287985|366227609|FG001|Overall Study|Withdrawal by Subject|1|||
106154884|NCT04287985|366227610|FG002|Overall Study|Withdrawal by Subject|1|||
106069432|NCT03447990|365918001|FG000|Overall Study|Withdrawal by Subject|0|||
106069433|NCT03447990|365918002|FG001|Overall Study|Withdrawal by Subject|0|||
106069434|NCT03447990|365918003|FG002|Overall Study|Withdrawal by Subject|0|||
106069435|NCT03447990|365918004|FG003|Overall Study|Withdrawal by Subject|0|||
106069436|NCT03447990|365918005|FG004|Overall Study|Withdrawal by Subject|0|||
106069437|NCT03447990|365918006|FG005|Overall Study|Withdrawal by Subject|0|||
106069438|NCT03447990|365918007|FG006|Overall Study|Withdrawal by Subject|1|||
106069439|NCT03559257|365918008|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
106069440|NCT03559257|365918009|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
106069441|NCT03559257|365918008|FG000|Double Blind Treatment Period|Protocol Violation|1|||
106069442|NCT03559257|365918009|FG001|Double Blind Treatment Period|Protocol Violation|4|||
106069443|NCT03559257|365918008|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
106069444|NCT03559257|365918009|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
106069445|NCT03559257|365918008|FG000|Double Blind Treatment Period|Adverse Event|0|||
106069446|NCT03559257|365918009|FG001|Double Blind Treatment Period|Adverse Event|1|||
106069447|NCT03559257|365918008|FG000|Double Blind Treatment Period|Screen Failure|0|||
106069448|NCT03559257|365918009|FG001|Double Blind Treatment Period|Screen Failure|1|||
106069449|NCT03559257|365918008|FG000|Open-label Treatment Period|Adverse Event|1|||
106069450|NCT03559257|365918009|FG001|Open-label Treatment Period|Adverse Event|4|||
106069451|NCT03559257|365918008|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
106069452|NCT03559257|365918009|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
106069453|NCT03559257|365918008|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
106069454|NCT03559257|365918009|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
106069455|NCT03559257|365918008|FG000|Open-label Treatment Period|Protocol Violation|2|||
106069456|NCT03559257|365918009|FG001|Open-label Treatment Period|Protocol Violation|0|||
106069457|NCT03559257|365918008|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
106069458|NCT03559257|365918009|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
106069459|NCT03559257|365918008|FG000|Open-label Treatment Period|Physician Decision|0|||
106069460|NCT03559257|365918009|FG001|Open-label Treatment Period|Physician Decision|1|||
106069461|NCT02738450|365918010|FG000|Overall Study|Withdrawal by Subject|0|||
106069462|NCT02738450|365918011|FG001|Overall Study|Withdrawal by Subject|2|||
106069463|NCT02738450|365918012|FG002|Overall Study|Withdrawal by Subject|0|||
106069464|NCT03761147|365918013|FG000|Overall Study|Withdrawal by Subject|6|||
106069465|NCT03761147|365918014|FG001|Overall Study|Withdrawal by Subject|1|||
106069466|NCT03761147|365918013|FG000|Overall Study|Adverse Event|1|||
106069467|NCT03761147|365918014|FG001|Overall Study|Adverse Event|3|||
106069468|NCT03630120|365918015|FG000|Overall Study|Disease progression|0|||
106069469|NCT03630120|365918016|FG001|Overall Study|Disease progression|1|||
106069470|NCT03630120|365918017|FG002|Overall Study|Disease progression|1|||
106069471|NCT03630120|365918018|FG003|Overall Study|Disease progression|1|||
106069472|NCT01519960|365918019|FG000|Overall Study|Withdrawal from the study|26|||
106069473|NCT01519960|365918020|FG001|Overall Study|Withdrawal from the study|22|||
106069474|NCT01519960|365918021|FG002|Overall Study|Withdrawal from the study|5|||
106069475|NCT04351087|365918029|FG000|Overall Study|Lost to Follow-up|7|||
106069476|NCT04351087|365918030|FG001|Overall Study|Lost to Follow-up|3|||
106069477|NCT04351087|365918029|FG000|Overall Study|Withdrawal by Subject|3|||
106069478|NCT04351087|365918030|FG001|Overall Study|Withdrawal by Subject|4|||
106069479|NCT04351087|365918029|FG000|Overall Study|Lack of Efficacy|3|||
106069480|NCT04351087|365918030|FG001|Overall Study|Lack of Efficacy|2|||
106069481|NCT01603459|365918031|FG000|Overall Study|Adverse Event|5|||
106069482|NCT01603459|365918031|FG000|Overall Study|Withdrawal by Subject|5|||
106069483|NCT01603459|365918031|FG000|Overall Study|Lost to Follow-up|3|||
106069484|NCT01603459|365918031|FG000|Overall Study|Predefined discontinuation criteria|3|||
106069485|NCT01603459|365918031|FG000|Overall Study|Non-compliance|1|||
106069486|NCT01603459|365918031|FG000|Overall Study|Administrative reason|1|||
106069487|NCT00399360|365918033|FG000|Overall Study|Lost to Follow-up|2|||
106069488|NCT00399360|365918034|FG001|Overall Study|Lost to Follow-up|1|||
106069489|NCT00399360|365918035|FG002|Overall Study|Lost to Follow-up|2|||
106069490|NCT00399360|365918036|FG003|Overall Study|Lost to Follow-up|4|||
106069491|NCT00399360|365918033|FG000|Overall Study|Adverse Event|0|||
106069492|NCT00399360|365918034|FG001|Overall Study|Adverse Event|0|||
106069493|NCT00399360|365918035|FG002|Overall Study|Adverse Event|1|||
106069494|NCT00399360|365918036|FG003|Overall Study|Adverse Event|0|||
106069495|NCT00399360|365918033|FG000|Overall Study|Withdrawal by Subject|0|||
106069496|NCT00399360|365918034|FG001|Overall Study|Withdrawal by Subject|2|||
106069497|NCT00399360|365918035|FG002|Overall Study|Withdrawal by Subject|0|||
106069498|NCT00399360|365918036|FG003|Overall Study|Withdrawal by Subject|2|||
106069499|NCT00535223|365918037|FG000|Overall Study|Withdrawal by Subject|4|||
106069500|NCT00535223|365918038|FG001|Overall Study|Withdrawal by Subject|1|||
106069501|NCT02335099|365918039|FG000|Treatment|Withdrawal by Subject|1|||
106069502|NCT02335099|365918040|FG001|Treatment|Withdrawal by Subject|3|||
106069503|NCT02335099|365918039|FG000|Treatment|Lost to Follow-up|2|||
106069504|NCT02335099|365918040|FG001|Treatment|Lost to Follow-up|0|||
106069505|NCT02335099|365918039|FG000|Treatment|Death|1|||
106069506|NCT02335099|365918040|FG001|Treatment|Death|0|||
106069507|NCT02335099|365918039|FG000|Treatment|Adverse Event|1|||
106069508|NCT02335099|365918040|FG001|Treatment|Adverse Event|2|||
106069509|NCT02335099|365918039|FG000|Follow-up|Death|0|||
106069510|NCT02335099|365918040|FG001|Follow-up|Death|1|||
106069511|NCT03519347|365918041|FG000|Interventional Crossover Period 1|Death|0|||
106069512|NCT03519347|365918042|FG001|Interventional Crossover Period 1|Death|0|||
105865762|NCT01823835|365156901|FG001|Overall Study|Study Termination|0|||
106069513|NCT03519347|365918043|FG002|Interventional Crossover Period 1|Death|0|||
106069514|NCT03519347|365918044|FG003|Interventional Crossover Period 1|Death|1|||
106069515|NCT05517382|365918047|FG000|Overall Study|Lost to Follow-up|0|||
105865763|NCT01823835|365156902|FG002|Overall Study|Study Termination|0|||
105865764|NCT01823835|365156903|FG003|Overall Study|Study Termination|0|||
105865765|NCT01823835|365156904|FG004|Overall Study|Study Termination|1|||
105865766|NCT01823835|365156905|FG005|Overall Study|Study Termination|0|||
105865767|NCT01823835|365156906|FG006|Overall Study|Study Termination|0|||
105865768|NCT01823835|365156907|FG007|Overall Study|Study Termination|0|||
105865769|NCT01823835|365156908|FG008|Overall Study|Study Termination|0|||
105865770|NCT01823835|365156909|FG009|Overall Study|Study Termination|0|||
105865771|NCT01823835|365156910|FG010|Overall Study|Study Termination|0|||
106069516|NCT05517382|365918048|FG001|Overall Study|Lost to Follow-up|1|||
106069517|NCT01641692|365918049|FG000|Treatment Period 1|Adverse Event|1|||
106069518|NCT01641692|365918050|FG001|Treatment Period 1|Adverse Event|0|||
106069519|NCT01641692|365918051|FG002|Treatment Period 1|Adverse Event|0|||
106069520|NCT01641692|365918052|FG003|Treatment Period 1|Adverse Event|0|||
106069521|NCT01641692|365918053|FG004|Treatment Period 1|Adverse Event|0|||
106069522|NCT01641692|365918054|FG005|Treatment Period 1|Adverse Event|0|||
106069523|NCT01641692|365918055|FG006|Treatment Period 1|Adverse Event|0|||
106069524|NCT01641692|365918056|FG007|Treatment Period 1|Adverse Event|0|||
106069525|NCT01641692|365918049|FG000|Treatment Period 1|Lack of Efficacy|0|||
106069526|NCT01641692|365918050|FG001|Treatment Period 1|Lack of Efficacy|0|||
106069527|NCT01641692|365918051|FG002|Treatment Period 1|Lack of Efficacy|0|||
106069528|NCT01641692|365918052|FG003|Treatment Period 1|Lack of Efficacy|0|||
106069529|NCT01641692|365918053|FG004|Treatment Period 1|Lack of Efficacy|0|||
106069530|NCT01641692|365918054|FG005|Treatment Period 1|Lack of Efficacy|0|||
106069531|NCT01641692|365918055|FG006|Treatment Period 1|Lack of Efficacy|0|||
106069532|NCT01641692|365918056|FG007|Treatment Period 1|Lack of Efficacy|1|||
106069533|NCT01641692|365918049|FG000|Treatment Period 1|Protocol Violation|1|||
106069534|NCT01641692|365918050|FG001|Treatment Period 1|Protocol Violation|0|||
106069535|NCT01641692|365918051|FG002|Treatment Period 1|Protocol Violation|0|||
106069536|NCT01641692|365918052|FG003|Treatment Period 1|Protocol Violation|0|||
106069537|NCT01641692|365918053|FG004|Treatment Period 1|Protocol Violation|2|||
106069538|NCT01641692|365918054|FG005|Treatment Period 1|Protocol Violation|0|||
106069539|NCT01641692|365918055|FG006|Treatment Period 1|Protocol Violation|0|||
106069540|NCT01641692|365918056|FG007|Treatment Period 1|Protocol Violation|0|||
106069541|NCT01641692|365918049|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
106069542|NCT01641692|365918050|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
106069543|NCT01641692|365918051|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
106069544|NCT01641692|365918052|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
106069545|NCT01641692|365918053|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
106069546|NCT01641692|365918054|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
106069547|NCT01641692|365918055|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
106069548|NCT01641692|365918056|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
106069549|NCT01641692|365918049|FG000|Treatment Period 1|Lost to Follow-up|0|||
106069550|NCT01641692|365918050|FG001|Treatment Period 1|Lost to Follow-up|0|||
106069551|NCT01641692|365918051|FG002|Treatment Period 1|Lost to Follow-up|1|||
106069552|NCT01641692|365918052|FG003|Treatment Period 1|Lost to Follow-up|0|||
106069553|NCT01641692|365918053|FG004|Treatment Period 1|Lost to Follow-up|0|||
106069554|NCT01641692|365918054|FG005|Treatment Period 1|Lost to Follow-up|0|||
106069555|NCT01641692|365918055|FG006|Treatment Period 1|Lost to Follow-up|0|||
106069556|NCT01641692|365918056|FG007|Treatment Period 1|Lost to Follow-up|0|||
106069557|NCT01641692|365918049|FG000|Treatment Period 1|Physician Decision|0|||
106069558|NCT01641692|365918050|FG001|Treatment Period 1|Physician Decision|0|||
106069559|NCT01641692|365918051|FG002|Treatment Period 1|Physician Decision|0|||
106069560|NCT01641692|365918052|FG003|Treatment Period 1|Physician Decision|0|||
106069561|NCT01641692|365918053|FG004|Treatment Period 1|Physician Decision|1|||
105865772|NCT01823835|365156911|FG011|Overall Study|Study Termination|1|||
105865773|NCT01823835|365156912|FG012|Overall Study|Study Termination|0|||
105865774|NCT01823835|365156913|FG013|Overall Study|Study Termination|0|||
105865775|NCT01823835|365156914|FG014|Overall Study|Study Termination|0|||
106069562|NCT01641692|365918054|FG005|Treatment Period 1|Physician Decision|0|||
106069563|NCT01641692|365918055|FG006|Treatment Period 1|Physician Decision|0|||
106069564|NCT01641692|365918056|FG007|Treatment Period 1|Physician Decision|0|||
106069565|NCT01641692|365918049|FG000|Treatment Period 1|Withdrawal by Subject|0|||
106069566|NCT01641692|365918050|FG001|Treatment Period 1|Withdrawal by Subject|0|||
106069567|NCT01641692|365918051|FG002|Treatment Period 1|Withdrawal by Subject|0|||
106069568|NCT01641692|365918052|FG003|Treatment Period 1|Withdrawal by Subject|0|||
106069569|NCT01641692|365918053|FG004|Treatment Period 1|Withdrawal by Subject|0|||
106069570|NCT01641692|365918054|FG005|Treatment Period 1|Withdrawal by Subject|2|||
105865776|NCT01823835|365156900|FG000|Overall Study|Withdrawal by Subject|0|||
105865777|NCT01823835|365156901|FG001|Overall Study|Withdrawal by Subject|0|||
105865778|NCT01823835|365156902|FG002|Overall Study|Withdrawal by Subject|1|||
105865779|NCT01823835|365156903|FG003|Overall Study|Withdrawal by Subject|0|||
106154885|NCT04287985|366227611|FG003|Overall Study|Withdrawal by Subject|2|||
106154886|NCT04116736|366227612|FG000|Overall Study|Withdrew consent during study|3|||
106154887|NCT04116736|366227613|FG001|Overall Study|Withdrew consent during study|1|||
106154888|NCT04116736|366227612|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
106154889|NCT04116736|366227613|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
106154890|NCT04116736|366227612|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
106154891|NCT04116736|366227613|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
106154892|NCT04116736|366227612|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
106069571|NCT01641692|365918055|FG006|Treatment Period 1|Withdrawal by Subject|0|||
106069572|NCT01641692|365918056|FG007|Treatment Period 1|Withdrawal by Subject|1|||
106069573|NCT01641692|365918049|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
106069574|NCT01641692|365918050|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
106069575|NCT01641692|365918051|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
106069576|NCT01641692|365918052|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
106069577|NCT01641692|365918053|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
106069578|NCT01641692|365918054|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
106069579|NCT01641692|365918055|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
106069580|NCT01641692|365918056|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
106069581|NCT01641692|365918049|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106069582|NCT01641692|365918050|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106069583|NCT01641692|365918051|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106069584|NCT01641692|365918052|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106069585|NCT01641692|365918053|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106069586|NCT01641692|365918054|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106069587|NCT01641692|365918055|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
106069588|NCT01641692|365918056|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106069589|NCT01641692|365918049|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
106069590|NCT01641692|365918050|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069591|NCT01641692|365918051|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
106069592|NCT01641692|365918052|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
106069593|NCT01641692|365918053|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
106069594|NCT01641692|365918054|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069595|NCT01641692|365918055|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069596|NCT01641692|365918056|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
106069597|NCT01641692|365918049|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
106069598|NCT01641692|365918050|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
106069599|NCT01641692|365918051|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
106069600|NCT01641692|365918052|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
106069601|NCT01641692|365918053|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
106069602|NCT01641692|365918054|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
106069603|NCT01641692|365918055|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
106069604|NCT01641692|365918056|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
106069605|NCT01641692|365918049|FG000|Treatment Period 2|Lack of Efficacy|1|||
106069606|NCT01641692|365918050|FG001|Treatment Period 2|Lack of Efficacy|0|||
106069607|NCT01641692|365918051|FG002|Treatment Period 2|Lack of Efficacy|0|||
106069608|NCT01641692|365918052|FG003|Treatment Period 2|Lack of Efficacy|0|||
106069609|NCT01641692|365918053|FG004|Treatment Period 2|Lack of Efficacy|0|||
106069610|NCT01641692|365918054|FG005|Treatment Period 2|Lack of Efficacy|0|||
106069611|NCT01641692|365918055|FG006|Treatment Period 2|Lack of Efficacy|0|||
106069612|NCT01641692|365918056|FG007|Treatment Period 2|Lack of Efficacy|0|||
106069613|NCT01641692|365918049|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
106069614|NCT01641692|365918050|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
106069615|NCT01641692|365918051|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
106069616|NCT01641692|365918052|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
106069617|NCT01641692|365918053|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
106069618|NCT01641692|365918054|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
106069619|NCT01641692|365918055|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
106069620|NCT01641692|365918056|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
106069621|NCT01641692|365918049|FG000|Treatment Period 2|Lost to Follow-up|0|||
106069622|NCT01641692|365918050|FG001|Treatment Period 2|Lost to Follow-up|0|||
106069623|NCT01641692|365918051|FG002|Treatment Period 2|Lost to Follow-up|0|||
106069624|NCT01641692|365918052|FG003|Treatment Period 2|Lost to Follow-up|0|||
106069625|NCT01641692|365918053|FG004|Treatment Period 2|Lost to Follow-up|0|||
106154893|NCT04116736|366227613|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
106154894|NCT04116736|366227612|FG000|Overall Study|Subject was enrolled in error|2|||
106069626|NCT01641692|365918054|FG005|Treatment Period 2|Lost to Follow-up|1|||
106069627|NCT01641692|365918055|FG006|Treatment Period 2|Lost to Follow-up|0|||
106069628|NCT01641692|365918056|FG007|Treatment Period 2|Lost to Follow-up|0|||
106154895|NCT04116736|366227613|FG001|Overall Study|Subject was enrolled in error|0|||
106154896|NCT04116736|366227612|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
106154897|NCT04116736|366227613|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
106154898|NCT04116736|366227612|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
106154899|NCT04116736|366227613|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
106154900|NCT04116736|366227612|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
106154901|NCT04116736|366227613|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
106154902|NCT00274469|366227618|FG000|Overall Study|Death|63|||
106154903|NCT00274469|366227619|FG001|Overall Study|Death|74|||
106154904|NCT00274469|366227618|FG000|Overall Study|Did not consent to OS follow-up|16|||
106154905|NCT00274469|366227619|FG001|Overall Study|Did not consent to OS follow-up|19|||
106154906|NCT05512962|366227621|FG000|Overall Study|Withdrawal by Subject|1|||
106154907|NCT05512962|366227622|FG001|Overall Study|Withdrawal by Subject|0|||
106154908|NCT02811679|366227623|FG000|Overall Study|Adverse Event|1|||
106154909|NCT02811679|366227623|FG000|Overall Study|Lack of Efficacy|6|||
106154910|NCT02811679|366227623|FG000|Overall Study|Early study closure due to slow accrual|3|||
106154911|NCT03941860|366227624|FG000|Overall Study|Withdrawal by Subject|0|||
106154912|NCT03941860|366227625|FG001|Overall Study|Withdrawal by Subject|1|||
106154913|NCT02140645|366227627|FG000|Overall Study|Not linked|5489|||
106154914|NCT02140645|366227628|FG001|Overall Study|Not linked|61654|||
106154915|NCT02140645|366227629|FG002|Overall Study|Not linked|4236|||
106154916|NCT02140645|366227630|FG003|Overall Study|Not linked|13833|||
106154917|NCT02140645|366227631|FG004|Overall Study|Not linked|3286|||
106154918|NCT02140645|366227632|FG005|Overall Study|Not linked|70896|||
106154919|NCT03014453|366227633|FG000|Overall Study|Lost to Follow-up|12|||
106154920|NCT03014453|366227633|FG000|Overall Study|Discontinued GER|3|||
106154921|NCT03014453|366227633|FG000|Overall Study|Excluded|19|||
106154922|NCT03014453|366227633|FG000|Overall Study|Refused to take part in|37|||
106154923|NCT00593489|366227637|FG000|Allocation|did not attend workshop; allocation not|2|||
106154924|NCT00593489|366227638|FG001|Allocation|did not attend workshop; allocation not|1|||
106154925|NCT00611559|366227639|FG000|Overall Study|Lost to Follow-up|0|||
106154926|NCT00611559|366227640|FG001|Overall Study|Lost to Follow-up|1|||
106154927|NCT00611559|366227641|FG002|Overall Study|Lost to Follow-up|0|||
106154928|NCT00611559|366227639|FG000|Overall Study|Protocol Violation|1|||
106154929|NCT00611559|366227640|FG001|Overall Study|Protocol Violation|0|||
106154930|NCT00611559|366227641|FG002|Overall Study|Protocol Violation|1|||
106154931|NCT01872078|366227642|FG000|Overall Study|Adverse Event|0|||
106154932|NCT01872078|366227643|FG001|Overall Study|Adverse Event|0|||
106154933|NCT01872078|366227644|FG002|Overall Study|Adverse Event|1|||
106154934|NCT01872078|366227645|FG003|Overall Study|Adverse Event|0|||
106154935|NCT01872078|366227642|FG000|Overall Study|Dose administration non-compliance|0|||
106154936|NCT01872078|366227643|FG001|Overall Study|Dose administration non-compliance|0|||
106154937|NCT01872078|366227644|FG002|Overall Study|Dose administration non-compliance|0|||
106154938|NCT01872078|366227645|FG003|Overall Study|Dose administration non-compliance|1|||
106154939|NCT01872078|366227642|FG000|Overall Study|Protocol Violation|0|||
106154940|NCT01872078|366227643|FG001|Overall Study|Protocol Violation|0|||
106154941|NCT01872078|366227644|FG002|Overall Study|Protocol Violation|1|||
106154942|NCT01872078|366227645|FG003|Overall Study|Protocol Violation|0|||
106154943|NCT01872078|366227642|FG000|Overall Study|Withdrawal by Subject|0|||
106154944|NCT01872078|366227643|FG001|Overall Study|Withdrawal by Subject|0|||
106154945|NCT01872078|366227644|FG002|Overall Study|Withdrawal by Subject|1|||
106154946|NCT01872078|366227645|FG003|Overall Study|Withdrawal by Subject|0|||
106154947|NCT01872078|366227642|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
106154948|NCT01872078|366227643|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
106154949|NCT01872078|366227644|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
106154950|NCT01872078|366227645|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
106154951|NCT03580369|366227646|FG000|Overall Study|No treatment due to mis-randomization|1|||
106154952|NCT03580369|366227647|FG001|Overall Study|No treatment due to mis-randomization|0|||
106154953|NCT03580369|366227648|FG002|Overall Study|No treatment due to mis-randomization|0|||
106154954|NCT03580369|366227649|FG003|Overall Study|No treatment due to mis-randomization|0|||
106154955|NCT03580369|366227650|FG004|Overall Study|No treatment due to mis-randomization|3|||
106154956|NCT03580369|366227651|FG005|Overall Study|No treatment due to mis-randomization|0|||
106154957|NCT03580369|366227652|FG006|Overall Study|No treatment due to mis-randomization|0|||
106154958|NCT03580369|366227653|FG007|Overall Study|No treatment due to mis-randomization|0|||
106154959|NCT03580369|366227646|FG000|Overall Study|Reason unknown|0|||
106154960|NCT03580369|366227647|FG001|Overall Study|Reason unknown|0|||
106154961|NCT03580369|366227648|FG002|Overall Study|Reason unknown|1|||
106154962|NCT03580369|366227649|FG003|Overall Study|Reason unknown|0|||
106154963|NCT03580369|366227650|FG004|Overall Study|Reason unknown|0|||
106154964|NCT03580369|366227651|FG005|Overall Study|Reason unknown|0|||
106154965|NCT03580369|366227652|FG006|Overall Study|Reason unknown|0|||
106154966|NCT03580369|366227653|FG007|Overall Study|Reason unknown|0|||
106154967|NCT03580369|366227646|FG000|Overall Study|Technical problems|0|||
106154968|NCT03580369|366227647|FG001|Overall Study|Technical problems|0|||
106069629|NCT01641692|365918049|FG000|Treatment Period 2|Withdrawal by Subject|1|||
106069630|NCT01641692|365918050|FG001|Treatment Period 2|Withdrawal by Subject|0|||
106069631|NCT01641692|365918051|FG002|Treatment Period 2|Withdrawal by Subject|0|||
106069632|NCT01641692|365918052|FG003|Treatment Period 2|Withdrawal by Subject|0|||
106069633|NCT01641692|365918053|FG004|Treatment Period 2|Withdrawal by Subject|0|||
106069634|NCT01641692|365918054|FG005|Treatment Period 2|Withdrawal by Subject|1|||
106069635|NCT01641692|365918055|FG006|Treatment Period 2|Withdrawal by Subject|0|||
106069636|NCT01641692|365918056|FG007|Treatment Period 2|Withdrawal by Subject|1|||
106069637|NCT01641692|365918049|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069638|NCT01641692|365918050|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069639|NCT01641692|365918051|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069640|NCT01641692|365918052|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069641|NCT01641692|365918053|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
106069642|NCT01641692|365918054|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069643|NCT01641692|365918055|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
106069644|NCT01641692|365918056|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
106069645|NCT01641692|365918049|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106069646|NCT01641692|365918050|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106069647|NCT01641692|365918051|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
106069648|NCT01641692|365918052|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106069649|NCT01641692|365918053|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106069650|NCT01641692|365918054|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
106069651|NCT01641692|365918055|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106069652|NCT01641692|365918056|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
106069653|NCT01641692|365918049|FG000|Treatment Period 3|Adverse Event|0|||
106069654|NCT01641692|365918050|FG001|Treatment Period 3|Adverse Event|0|||
106069655|NCT01641692|365918051|FG002|Treatment Period 3|Adverse Event|0|||
106069656|NCT01641692|365918052|FG003|Treatment Period 3|Adverse Event|0|||
106069657|NCT01641692|365918053|FG004|Treatment Period 3|Adverse Event|0|||
106069658|NCT01641692|365918054|FG005|Treatment Period 3|Adverse Event|0|||
106069659|NCT01641692|365918055|FG006|Treatment Period 3|Adverse Event|1|||
106069660|NCT01641692|365918056|FG007|Treatment Period 3|Adverse Event|0|||
106069661|NCT01641692|365918049|FG000|Treatment Period 3|Protocol Violation|0|||
106069662|NCT01641692|365918050|FG001|Treatment Period 3|Protocol Violation|0|||
106069663|NCT01641692|365918051|FG002|Treatment Period 3|Protocol Violation|1|||
106069664|NCT01641692|365918052|FG003|Treatment Period 3|Protocol Violation|0|||
106069665|NCT01641692|365918053|FG004|Treatment Period 3|Protocol Violation|0|||
106069666|NCT01641692|365918054|FG005|Treatment Period 3|Protocol Violation|0|||
106069667|NCT01641692|365918055|FG006|Treatment Period 3|Protocol Violation|0|||
106069668|NCT01641692|365918056|FG007|Treatment Period 3|Protocol Violation|0|||
106069669|NCT01641692|365918049|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
106069670|NCT01641692|365918050|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
106069671|NCT01641692|365918051|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
106069672|NCT01641692|365918052|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
106069673|NCT01641692|365918053|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
106069674|NCT01641692|365918054|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
106069675|NCT01641692|365918055|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
106069676|NCT01641692|365918056|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
106069677|NCT01641692|365918049|FG000|Treatment Period 3|Lost to Follow-up|0|||
106069678|NCT01641692|365918050|FG001|Treatment Period 3|Lost to Follow-up|1|||
106069679|NCT01641692|365918051|FG002|Treatment Period 3|Lost to Follow-up|0|||
106069680|NCT01641692|365918052|FG003|Treatment Period 3|Lost to Follow-up|0|||
106069681|NCT01641692|365918053|FG004|Treatment Period 3|Lost to Follow-up|0|||
106069682|NCT01641692|365918054|FG005|Treatment Period 3|Lost to Follow-up|0|||
106069683|NCT01641692|365918055|FG006|Treatment Period 3|Lost to Follow-up|0|||
106069684|NCT01641692|365918056|FG007|Treatment Period 3|Lost to Follow-up|0|||
106069685|NCT01641692|365918049|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
106069686|NCT01641692|365918050|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
106069687|NCT01641692|365918051|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
106069688|NCT01641692|365918052|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
106154969|NCT03580369|366227648|FG002|Overall Study|Technical problems|0|||
106154970|NCT03580369|366227649|FG003|Overall Study|Technical problems|0|||
106069689|NCT01641692|365918053|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
106069690|NCT01641692|365918054|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
106069691|NCT01641692|365918055|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
106069692|NCT01641692|365918056|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
106069693|NCT01641692|365918049|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
106069694|NCT01641692|365918050|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
106069695|NCT01641692|365918051|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
106069696|NCT01641692|365918052|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
106154971|NCT03580369|366227650|FG004|Overall Study|Technical problems|1|||
106154972|NCT03580369|366227651|FG005|Overall Study|Technical problems|0|||
106154973|NCT03580369|366227652|FG006|Overall Study|Technical problems|2|||
106154974|NCT03580369|366227653|FG007|Overall Study|Technical problems|0|||
106154975|NCT03580369|366227646|FG000|Overall Study|Pregnancy|2|||
106154976|NCT03580369|366227647|FG001|Overall Study|Pregnancy|0|||
106069697|NCT01641692|365918053|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
106069698|NCT01641692|365918054|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
106069699|NCT01641692|365918055|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
106069700|NCT01641692|365918056|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
106069701|NCT01412021|365918061|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
106069702|NCT01412021|365918061|FG000|Overall Study|Treatment Prior to Approval|3|||
106069703|NCT01412021|365918061|FG000|Overall Study|Transferred to Other Hospital|9|||
106069704|NCT01166178|365918072|FG000|Overall Study|Withdrawal by Subject|1|||
106069705|NCT01166178|365918073|FG001|Overall Study|Withdrawal by Subject|0|||
106069706|NCT01166178|365918072|FG000|Overall Study|Study was terminated|20|||
106069707|NCT01166178|365918073|FG001|Overall Study|Study was terminated|8|||
106069708|NCT00484939|365918076|FG000|Overall Study|Death|9|||
106069709|NCT00484939|365918077|FG001|Overall Study|Death|13|||
106069710|NCT00484939|365918076|FG000|Overall Study|Adverse Event|22|||
106069711|NCT00484939|365918077|FG001|Overall Study|Adverse Event|12|||
106069712|NCT00484939|365918076|FG000|Overall Study|Patient Withdrew Consent|19|||
106069713|NCT00484939|365918077|FG001|Overall Study|Patient Withdrew Consent|10|||
106069714|NCT00484939|365918076|FG000|Overall Study|Protocol Violation|3|||
106069715|NCT00484939|365918077|FG001|Overall Study|Protocol Violation|3|||
106069716|NCT00484939|365918076|FG000|Overall Study|Lost to Follow-up|0|||
106069717|NCT00484939|365918077|FG001|Overall Study|Lost to Follow-up|3|||
106069718|NCT00484939|365918076|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
106069719|NCT00484939|365918077|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
106069720|NCT00484939|365918076|FG000|Overall Study|Disease progression|67|||
106069721|NCT00484939|365918077|FG001|Overall Study|Disease progression|88|||
106069722|NCT00484939|365918076|FG000|Overall Study|Screen Failure|2|||
106069723|NCT00484939|365918077|FG001|Overall Study|Screen Failure|2|||
106069724|NCT00484939|365918076|FG000|Overall Study|Reason Not Specified|11|||
106069725|NCT00484939|365918077|FG001|Overall Study|Reason Not Specified|6|||
106069726|NCT04948450|365918078|FG000|Overall Study|Return home|1|||
106069727|NCT04948450|365918079|FG001|Overall Study|Return home|3|||
106069728|NCT02677987|365918080|FG000|Overall Study|Withdrawal by Subject|3|||
106069729|NCT02677987|365918081|FG001|Overall Study|Withdrawal by Subject|0|||
106069730|NCT02677987|365918080|FG000|Overall Study|Lost to Follow-up|1|||
106069731|NCT02677987|365918081|FG001|Overall Study|Lost to Follow-up|0|||
106069732|NCT00101907|365918085|FG000|Overall Study|Adverse Event|1|||
106069733|NCT00101907|365918086|FG001|Overall Study|Adverse Event|0|||
106069734|NCT00101907|365918087|FG002|Overall Study|Adverse Event|0|||
106069735|NCT00101907|365918088|FG003|Overall Study|Adverse Event|0|||
106069736|NCT00101907|365918089|FG004|Overall Study|Adverse Event|0|||
106069737|NCT00101907|365918090|FG005|Overall Study|Adverse Event|0|||
106069738|NCT00101907|365918085|FG000|Overall Study|Death|0|||
106069739|NCT00101907|365918086|FG001|Overall Study|Death|1|||
106069740|NCT00101907|365918087|FG002|Overall Study|Death|0|||
106069741|NCT00101907|365918088|FG003|Overall Study|Death|0|||
106069742|NCT00101907|365918089|FG004|Overall Study|Death|3|||
106069743|NCT00101907|365918090|FG005|Overall Study|Death|0|||
106069744|NCT00101907|365918085|FG000|Overall Study|Physician Decision|0|||
106069745|NCT00101907|365918086|FG001|Overall Study|Physician Decision|0|||
106069746|NCT00101907|365918087|FG002|Overall Study|Physician Decision|0|||
106069747|NCT00101907|365918088|FG003|Overall Study|Physician Decision|1|||
106069748|NCT00101907|365918089|FG004|Overall Study|Physician Decision|1|||
106069749|NCT00101907|365918090|FG005|Overall Study|Physician Decision|0|||
106069750|NCT00101907|365918085|FG000|Overall Study|Withdrawal by Subject|1|||
106069751|NCT00101907|365918086|FG001|Overall Study|Withdrawal by Subject|0|||
106069752|NCT00101907|365918087|FG002|Overall Study|Withdrawal by Subject|1|||
106154977|NCT03580369|366227648|FG002|Overall Study|Pregnancy|3|||
106154978|NCT03580369|366227649|FG003|Overall Study|Pregnancy|0|||
106154979|NCT03580369|366227650|FG004|Overall Study|Pregnancy|2|||
106069753|NCT00101907|365918088|FG003|Overall Study|Withdrawal by Subject|0|||
106069754|NCT00101907|365918089|FG004|Overall Study|Withdrawal by Subject|1|||
106069755|NCT00101907|365918090|FG005|Overall Study|Withdrawal by Subject|0|||
106069756|NCT00673179|365918091|FG000|Overall Study|Toxicity/Complications|3|||
106069757|NCT00673179|365918092|FG001|Overall Study|Toxicity/Complications|0|||
106069758|NCT00624052|365918093|FG000|Overall Study|Adverse Event|7|||
106069759|NCT00624052|365918094|FG001|Overall Study|Adverse Event|6|||
106069760|NCT00624052|365918095|FG002|Overall Study|Adverse Event|0|||
106069761|NCT00624052|365918096|FG003|Overall Study|Adverse Event|3|||
106069762|NCT00624052|365918093|FG000|Overall Study|Lack of Efficacy|1|||
106069763|NCT00624052|365918094|FG001|Overall Study|Lack of Efficacy|1|||
106069764|NCT00624052|365918095|FG002|Overall Study|Lack of Efficacy|0|||
106069765|NCT00624052|365918096|FG003|Overall Study|Lack of Efficacy|0|||
106154980|NCT03580369|366227651|FG005|Overall Study|Pregnancy|0|||
106154981|NCT03580369|366227652|FG006|Overall Study|Pregnancy|0|||
106154982|NCT03580369|366227653|FG007|Overall Study|Pregnancy|0|||
106154983|NCT03580369|366227646|FG000|Overall Study|Lost to Follow-up|2|||
106154984|NCT03580369|366227647|FG001|Overall Study|Lost to Follow-up|0|||
106154985|NCT03580369|366227648|FG002|Overall Study|Lost to Follow-up|2|||
106154986|NCT03580369|366227649|FG003|Overall Study|Lost to Follow-up|0|||
106154987|NCT03580369|366227650|FG004|Overall Study|Lost to Follow-up|3|||
106154988|NCT03580369|366227651|FG005|Overall Study|Lost to Follow-up|0|||
106154989|NCT03580369|366227652|FG006|Overall Study|Lost to Follow-up|1|||
106154990|NCT03580369|366227653|FG007|Overall Study|Lost to Follow-up|0|||
106154991|NCT03580369|366227646|FG000|Overall Study|Physician Decision|4|||
106154992|NCT03580369|366227647|FG001|Overall Study|Physician Decision|0|||
106154993|NCT03580369|366227648|FG002|Overall Study|Physician Decision|4|||
106154994|NCT03580369|366227649|FG003|Overall Study|Physician Decision|1|||
106154995|NCT03580369|366227650|FG004|Overall Study|Physician Decision|1|||
106154996|NCT03580369|366227651|FG005|Overall Study|Physician Decision|0|||
106154997|NCT03580369|366227652|FG006|Overall Study|Physician Decision|0|||
106154998|NCT03580369|366227653|FG007|Overall Study|Physician Decision|0|||
106154999|NCT03580369|366227646|FG000|Overall Study|Lack of Efficacy|3|||
106155000|NCT03580369|366227647|FG001|Overall Study|Lack of Efficacy|0|||
106155001|NCT03580369|366227648|FG002|Overall Study|Lack of Efficacy|7|||
106155002|NCT03580369|366227649|FG003|Overall Study|Lack of Efficacy|0|||
106155003|NCT03580369|366227650|FG004|Overall Study|Lack of Efficacy|2|||
106155004|NCT03580369|366227651|FG005|Overall Study|Lack of Efficacy|0|||
106155005|NCT03580369|366227652|FG006|Overall Study|Lack of Efficacy|3|||
106155006|NCT03580369|366227653|FG007|Overall Study|Lack of Efficacy|0|||
106155007|NCT03580369|366227646|FG000|Overall Study|Protocol Violation|6|||
106155008|NCT03580369|366227647|FG001|Overall Study|Protocol Violation|0|||
106155009|NCT03580369|366227648|FG002|Overall Study|Protocol Violation|6|||
106155010|NCT03580369|366227649|FG003|Overall Study|Protocol Violation|1|||
106155011|NCT03580369|366227650|FG004|Overall Study|Protocol Violation|8|||
106155012|NCT03580369|366227651|FG005|Overall Study|Protocol Violation|2|||
106155013|NCT03580369|366227652|FG006|Overall Study|Protocol Violation|1|||
106155014|NCT03580369|366227653|FG007|Overall Study|Protocol Violation|0|||
106155015|NCT03580369|366227646|FG000|Overall Study|Adverse Event|7|||
106155016|NCT03580369|366227647|FG001|Overall Study|Adverse Event|0|||
106155017|NCT03580369|366227648|FG002|Overall Study|Adverse Event|14|||
106155018|NCT03580369|366227649|FG003|Overall Study|Adverse Event|1|||
106155019|NCT03580369|366227650|FG004|Overall Study|Adverse Event|6|||
106155020|NCT03580369|366227651|FG005|Overall Study|Adverse Event|0|||
106155021|NCT03580369|366227652|FG006|Overall Study|Adverse Event|1|||
106155022|NCT03580369|366227653|FG007|Overall Study|Adverse Event|0|||
106155023|NCT03580369|366227646|FG000|Overall Study|Withdrawal by Subject|19|||
106155024|NCT03580369|366227647|FG001|Overall Study|Withdrawal by Subject|0|||
106155025|NCT03580369|366227648|FG002|Overall Study|Withdrawal by Subject|17|||
106155026|NCT03580369|366227649|FG003|Overall Study|Withdrawal by Subject|0|||
106155027|NCT03580369|366227650|FG004|Overall Study|Withdrawal by Subject|16|||
106155028|NCT03580369|366227651|FG005|Overall Study|Withdrawal by Subject|1|||
106155029|NCT03580369|366227652|FG006|Overall Study|Withdrawal by Subject|7|||
106155030|NCT03580369|366227653|FG007|Overall Study|Withdrawal by Subject|0|||
106155031|NCT02119650|366227654|FG000|Overall Study|Adverse Event|3|||
106155032|NCT02119650|366227655|FG001|Overall Study|Adverse Event|4|||
106155033|NCT02119650|366227654|FG000|Overall Study|Subject decision|2|||
106155034|NCT02119650|366227655|FG001|Overall Study|Subject decision|3|||
106155035|NCT02119650|366227654|FG000|Overall Study|Disease progression|11|||
106155036|NCT02119650|366227655|FG001|Overall Study|Disease progression|14|||
106155037|NCT02119650|366227654|FG000|Overall Study|Death|5|||
106155038|NCT02119650|366227655|FG001|Overall Study|Death|1|||
106155039|NCT02119650|366227654|FG000|Overall Study|Noncompliance with study treatment|1|||
106155040|NCT02119650|366227655|FG001|Overall Study|Noncompliance with study treatment|1|||
106155041|NCT02119650|366227654|FG000|Overall Study|Study terminated by the sponsor|1|||
105865780|NCT01823835|365156904|FG004|Overall Study|Withdrawal by Subject|0|||
105865781|NCT01823835|365156905|FG005|Overall Study|Withdrawal by Subject|0|||
105865782|NCT01823835|365156906|FG006|Overall Study|Withdrawal by Subject|0|||
106155042|NCT02119650|366227655|FG001|Overall Study|Study terminated by the sponsor|0|||
106155043|NCT02119650|366227654|FG000|Overall Study|Physician Decision|0|||
106155044|NCT02119650|366227655|FG001|Overall Study|Physician Decision|2|||
106155045|NCT02119650|366227654|FG000|Overall Study|Multiple reasons for termination|2|||
105865783|NCT01823835|365156907|FG007|Overall Study|Withdrawal by Subject|0|||
106155046|NCT02119650|366227655|FG001|Overall Study|Multiple reasons for termination|1|||
106155047|NCT02910713|366227657|FG000|Overall Study|Protocol Violation|2|||
106155048|NCT02910713|366227657|FG000|Overall Study|Subject Choice|4|||
106155049|NCT02910713|366227657|FG000|Overall Study|Received One Application|10|||
106155050|NCT02910713|366227657|FG000|Overall Study|Received Neither Application|18|||
106155051|NCT02910713|366227657|FG000|Overall Study|Enrollment cap|7|||
106155052|NCT02910713|366227657|FG000|Overall Study|Investigator Discretion|1|||
106155053|NCT00186992|366229023|FG000|Overall Study|Withdrawal by Subject|5|||
106155054|NCT00186992|366229023|FG000|Overall Study|Physician's discretion|13|||
106155055|NCT00186992|366229023|FG000|Overall Study|PI Discretion|4|||
106069766|NCT00624052|365918093|FG000|Overall Study|Lost to Follow-up|2|||
106069767|NCT00624052|365918094|FG001|Overall Study|Lost to Follow-up|3|||
106069768|NCT00624052|365918095|FG002|Overall Study|Lost to Follow-up|1|||
106069769|NCT00624052|365918096|FG003|Overall Study|Lost to Follow-up|0|||
106069770|NCT00624052|365918093|FG000|Overall Study|Non compliant with the protocol|2|||
106069771|NCT00624052|365918094|FG001|Overall Study|Non compliant with the protocol|1|||
106069772|NCT00624052|365918095|FG002|Overall Study|Non compliant with the protocol|1|||
106069773|NCT00624052|365918096|FG003|Overall Study|Non compliant with the protocol|1|||
106069774|NCT00624052|365918093|FG000|Overall Study|Consent withdrawn|3|||
106069775|NCT00624052|365918094|FG001|Overall Study|Consent withdrawn|1|||
106069776|NCT00624052|365918095|FG002|Overall Study|Consent withdrawn|1|||
106069777|NCT00624052|365918096|FG003|Overall Study|Consent withdrawn|0|||
106069778|NCT00624052|365918093|FG000|Overall Study|Changed job/ran out if meds|0|||
106069779|NCT00624052|365918094|FG001|Overall Study|Changed job/ran out if meds|2|||
106069780|NCT00624052|365918095|FG002|Overall Study|Changed job/ran out if meds|0|||
106069781|NCT00624052|365918096|FG003|Overall Study|Changed job/ran out if meds|0|||
106069782|NCT01559012|365918097|FG000|Overall Study|Withdrawal by Subject|0|||
106069783|NCT01559012|365918098|FG001|Overall Study|Withdrawal by Subject|1|||
106069784|NCT04814433|365918100|FG000|Overall Study|Survey not returned|4|||
106069785|NCT04814433|365918101|FG001|Overall Study|Survey not returned|8|||
106069786|NCT04814433|365918102|FG002|Overall Study|Survey not returned|4|||
106069787|NCT04814433|365918103|FG003|Overall Study|Survey not returned|5|||
106069788|NCT04837131|365918104|FG000|Overall Study|Death|1|||
106069789|NCT04837131|365918104|FG000|Overall Study|Withdrawal by Subject|1|||
106069790|NCT04837131|365918104|FG000|Overall Study|Adverse Event|1|||
106069791|NCT04837131|365918104|FG000|Overall Study|Protocol Violation|1|||
106069792|NCT02496533|365918105|FG000|Overall Study|Lack of data on outcome|3|||
106069793|NCT02496533|365918106|FG001|Overall Study|Lack of data on outcome|0|||
106069794|NCT02496533|365918105|FG000|Overall Study|Patient did not complete all measures|0|||
106069795|NCT02496533|365918106|FG001|Overall Study|Patient did not complete all measures|4|||
106069796|NCT02496533|365918105|FG000|Overall Study|Late for radiologic testing|0|||
106069797|NCT02496533|365918106|FG001|Overall Study|Late for radiologic testing|2|||
106069798|NCT03482791|365918108|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
106069799|NCT03482791|365918109|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
106069800|NCT04219891|365918110|FG000|Overall Study|Lost to Follow-up|3|||
106069801|NCT04219891|365918110|FG000|Overall Study|Withdrawal by Subject|2|||
106069802|NCT01372501|365920337|FG000|Overall Study|Adverse Event|4|||
106069803|NCT01372501|365920337|FG000|Overall Study|Device migration|1|||
106069804|NCT01541969|365920338|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
106069805|NCT01541969|365920339|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
106069806|NCT01541969|365920338|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
106069807|NCT01541969|365920339|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
106069808|NCT01541969|365920338|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
106069809|NCT01541969|365920339|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
106069810|NCT01541969|365920338|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
106069811|NCT01541969|365920339|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
106069812|NCT01541969|365920338|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
106069813|NCT01541969|365920339|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
106069814|NCT01541969|365920338|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
106069815|NCT01541969|365920339|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
106069816|NCT01541969|365920338|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
106069817|NCT01541969|365920339|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
106069818|NCT01541969|365920338|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
106069819|NCT01541969|365920339|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
106069820|NCT01541969|365920338|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
106069821|NCT01541969|365920339|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
106069822|NCT01541969|365920338|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
106069823|NCT01541969|365920339|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
106069824|NCT02522286|365920340|FG000|Overall Study|Withdrawal by Subject|3|||
106069825|NCT02522286|365920341|FG001|Overall Study|Withdrawal by Subject|0|||
106069826|NCT02522286|365920342|FG002|Overall Study|Withdrawal by Subject|0|||
106069827|NCT02522286|365920343|FG003|Overall Study|Withdrawal by Subject|3|||
106069828|NCT01466348|365920344|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
106069829|NCT01466348|365920345|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
106069830|NCT03970733|365920346|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
106069831|NCT03970733|365920347|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
106069832|NCT03970733|365920348|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
106069833|NCT03970733|365920349|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
106069834|NCT03970733|365920350|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
106069835|NCT03970733|365920346|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
106069836|NCT03970733|365920347|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
106155056|NCT00186992|366229023|FG000|Overall Study|Ineligible|2|||
106155057|NCT00186992|366229023|FG000|Overall Study|Lost to Follow-up|2|||
106155058|NCT00186992|366229023|FG000|Overall Study|Still on Study|9|||
106155059|NCT05307978|366229024|FG000|Overall Study|Lost to Follow-up|0|||
106155060|NCT05307978|366229025|FG001|Overall Study|Lost to Follow-up|1|||
106155061|NCT05307978|366229026|FG002|Overall Study|Lost to Follow-up|0|||
106155062|NCT05307978|366229027|FG003|Overall Study|Lost to Follow-up|4|||
105865784|NCT01823835|365156908|FG008|Overall Study|Withdrawal by Subject|0|||
105865785|NCT01823835|365156909|FG009|Overall Study|Withdrawal by Subject|1|||
105865786|NCT01823835|365156910|FG010|Overall Study|Withdrawal by Subject|1|||
105865787|NCT01823835|365156911|FG011|Overall Study|Withdrawal by Subject|2|||
105865788|NCT01823835|365156912|FG012|Overall Study|Withdrawal by Subject|1|||
106155063|NCT05307978|366229028|FG004|Overall Study|Lost to Follow-up|0|||
106155064|NCT05307978|366229029|FG005|Overall Study|Lost to Follow-up|0|||
105865789|NCT01823835|365156913|FG013|Overall Study|Withdrawal by Subject|0|||
106155065|NCT05307978|366229030|FG006|Overall Study|Lost to Follow-up|1|||
106155066|NCT04396366|366229031|FG000|Overall Study|Adverse Event|1|||
105865790|NCT01823835|365156914|FG014|Overall Study|Withdrawal by Subject|0|||
105865791|NCT00919854|365156917|FG000|Overall Study|Adverse Event|1|||
105865792|NCT00985491|365156919|FG000|Overall Study|Adverse Event|8|||
105865793|NCT00985491|365156919|FG000|Overall Study|device migration|7|||
105865794|NCT00985491|365156919|FG000|Overall Study|Withdrawal by Subject|1|||
105865795|NCT00985491|365156919|FG000|Overall Study|implant failure|3|||
105865796|NCT04386616|365156924|FG000|Overall Study|Death|22|||
105865797|NCT04386616|365156925|FG001|Overall Study|Death|22|||
105865798|NCT04386616|365156926|FG002|Overall Study|Death|21|||
105865799|NCT04386616|365156924|FG000|Overall Study|Lost to Follow-up|5|||
106069837|NCT03970733|365920348|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
106069838|NCT03970733|365920349|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
106069839|NCT03970733|365920350|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
106069840|NCT03970733|365920346|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
106069841|NCT03970733|365920347|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
106069842|NCT03970733|365920348|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
105865800|NCT04386616|365156925|FG001|Overall Study|Lost to Follow-up|8|||
105865801|NCT04386616|365156926|FG002|Overall Study|Lost to Follow-up|6|||
105865802|NCT04386616|365156924|FG000|Overall Study|Withdrawal by Subject|2|||
105865803|NCT04386616|365156925|FG001|Overall Study|Withdrawal by Subject|4|||
105865804|NCT04386616|365156926|FG002|Overall Study|Withdrawal by Subject|1|||
105865805|NCT04386616|365156924|FG000|Overall Study|Adverse Event|1|||
105865806|NCT04386616|365156925|FG001|Overall Study|Adverse Event|1|||
105865807|NCT04386616|365156926|FG002|Overall Study|Adverse Event|0|||
105865808|NCT03449446|365156927|FG000|Overall Study|Randomized but Never Treated|0|||
105865809|NCT03449446|365156928|FG001|Overall Study|Randomized but Never Treated|0|||
105865810|NCT03449446|365156929|FG002|Overall Study|Randomized but Never Treated|1|||
105865811|NCT03449446|365156930|FG003|Overall Study|Randomized but Never Treated|1|||
106069843|NCT03970733|365920349|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
106069844|NCT03970733|365920350|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
106069845|NCT03970733|365920346|FG000|Main Study Phase (18 Months)|Other|1|||
106069846|NCT03970733|365920347|FG001|Main Study Phase (18 Months)|Other|1|||
106069847|NCT03970733|365920348|FG002|Main Study Phase (18 Months)|Other|0|||
106069848|NCT03970733|365920349|FG003|Main Study Phase (18 Months)|Other|0|||
106069849|NCT03970733|365920350|FG004|Main Study Phase (18 Months)|Other|0|||
106069850|NCT03970733|365920346|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
106069851|NCT03970733|365920347|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
106069852|NCT03970733|365920348|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
106069853|NCT03970733|365920349|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
106069854|NCT03970733|365920350|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
106069855|NCT02189473|365920354|FG000|Overall Study|Death|22|||
106069856|NCT02189473|365920355|FG001|Overall Study|Death|23|||
106069857|NCT02189473|365920354|FG000|Overall Study|Lost to Follow-up|1|||
106069858|NCT02189473|365920355|FG001|Overall Study|Lost to Follow-up|2|||
106069859|NCT04608500|365920358|FG000|Overall Study|Adverse Event|2|||
106069860|NCT04608500|365920359|FG001|Overall Study|Adverse Event|0|||
106069861|NCT04608500|365920358|FG000|Overall Study|Lost to Follow-up|15|||
106069862|NCT04608500|365920359|FG001|Overall Study|Lost to Follow-up|9|||
106069863|NCT04608500|365920358|FG000|Overall Study|Participant request|11|||
106069864|NCT04608500|365920359|FG001|Overall Study|Participant request|7|||
106069865|NCT04608500|365920358|FG000|Overall Study|Protocol Violation|1|||
106069866|NCT04608500|365920359|FG001|Overall Study|Protocol Violation|0|||
106069867|NCT04608500|365920358|FG000|Overall Study|Other|6|||
106069868|NCT04608500|365920359|FG001|Overall Study|Other|2|||
106069869|NCT00665353|365920366|FG000|Study Step 1|Adverse Event|1|||
106069870|NCT00665353|365920366|FG000|Study Step 1|Withdrawal by Subject|2|||
106069871|NCT00665353|365920366|FG000|Study Step 2|Lost to Follow-up|2|||
106069872|NCT00665353|365920366|FG000|Study Step 2|Lack of Efficacy|12|||
105865812|NCT03449446|365156931|FG004|Overall Study|Randomized but Never Treated|1|||
105865813|NCT03449446|365156932|FG005|Overall Study|Randomized but Never Treated|0|||
105865814|NCT03449446|365156933|FG006|Overall Study|Randomized but Never Treated|0|||
105865815|NCT03449446|365156927|FG000|Overall Study|Unknown Reason|33|||
105865816|NCT03449446|365156928|FG001|Overall Study|Unknown Reason|1|||
105865817|NCT03449446|365156929|FG002|Overall Study|Unknown Reason|1|||
105865818|NCT03449446|365156930|FG003|Overall Study|Unknown Reason|1|||
105865819|NCT03449446|365156931|FG004|Overall Study|Unknown Reason|2|||
105865820|NCT03449446|365156932|FG005|Overall Study|Unknown Reason|2|||
105865821|NCT03449446|365156933|FG006|Overall Study|Unknown Reason|0|||
106069873|NCT00573755|365920367|FG000|Overall Study|Still receiving treatment|1|||
106069874|NCT00573755|365920368|FG001|Overall Study|Still receiving treatment|0|||
106069875|NCT03724812|365920369|FG000|Overall Study|Missed Visit|1|||
105865822|NCT03449446|365156927|FG000|Overall Study|Withdrew Consent|1|||
106069876|NCT03724812|365920369|FG000|Overall Study|Death|2|||
105865823|NCT03449446|365156928|FG001|Overall Study|Withdrew Consent|3|||
105865824|NCT03449446|365156929|FG002|Overall Study|Withdrew Consent|1|||
106069877|NCT03724812|365920369|FG000|Overall Study|Withdrawal by Subject|1|||
106069878|NCT01030523|365920370|FG000|Initial Study (5 Years)|Death|1|||
106069879|NCT01030523|365920371|FG001|Initial Study (5 Years)|Death|0|||
106069880|NCT01030523|365920370|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
106069881|NCT01030523|365920371|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
106069882|NCT01030523|365920370|FG000|Initial Study (5 Years)|Implant failure|1|||
106069883|NCT01030523|365920371|FG001|Initial Study (5 Years)|Implant failure|0|||
106069884|NCT01030523|365920370|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
106069885|NCT01030523|365920371|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
106069886|NCT01030523|365920370|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
106069887|NCT01030523|365920371|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
106069888|NCT01030523|365920370|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
106069889|NCT01030523|365920371|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
106069890|NCT04475588|365920372|FG000|Overall Study|Adverse Event|2|||
106069891|NCT04475588|365920373|FG001|Overall Study|Adverse Event|0|||
106069892|NCT01465022|365920374|FG000|Overall Study|Lost to Follow-up|15|||
106069893|NCT01465022|365920375|FG001|Overall Study|Lost to Follow-up|14|||
106069894|NCT01465022|365920376|FG002|Overall Study|Lost to Follow-up|0|||
106069895|NCT01465022|365920374|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
106069896|NCT01465022|365920375|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
106069897|NCT01465022|365920376|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
106069898|NCT01465022|365920374|FG000|Overall Study|Not Randomized|0|||
106069899|NCT01465022|365920375|FG001|Overall Study|Not Randomized|0|||
106069900|NCT01465022|365920376|FG002|Overall Study|Not Randomized|70|||
106069901|NCT01528072|365920389|FG000|Overall Study|Withdrawal by Subject|5|||
106069902|NCT01528072|365920389|FG000|Overall Study|Physician Decision|1|||
106069903|NCT01528072|365920389|FG000|Overall Study|Determined not eligible by AEAC|1|||
106069904|NCT01528072|365920389|FG000|Overall Study|Missed Visit|2|||
105865825|NCT03449446|365156930|FG003|Overall Study|Withdrew Consent|4|||
105865826|NCT03449446|365156931|FG004|Overall Study|Withdrew Consent|4|||
105865827|NCT03449446|365156932|FG005|Overall Study|Withdrew Consent|4|||
105865828|NCT03449446|365156933|FG006|Overall Study|Withdrew Consent|1|||
105865829|NCT03449446|365156927|FG000|Overall Study|Adverse Event|1|||
105865830|NCT03449446|365156928|FG001|Overall Study|Adverse Event|2|||
105865831|NCT03449446|365156929|FG002|Overall Study|Adverse Event|1|||
105865832|NCT03449446|365156930|FG003|Overall Study|Adverse Event|0|||
105865833|NCT03449446|365156931|FG004|Overall Study|Adverse Event|0|||
105865834|NCT03449446|365156932|FG005|Overall Study|Adverse Event|2|||
105865835|NCT03449446|365156933|FG006|Overall Study|Adverse Event|0|||
105865836|NCT03449446|365156927|FG000|Overall Study|Lost to Follow-up|0|||
105865837|NCT03449446|365156928|FG001|Overall Study|Lost to Follow-up|0|||
105865838|NCT03449446|365156929|FG002|Overall Study|Lost to Follow-up|2|||
105865839|NCT03449446|365156930|FG003|Overall Study|Lost to Follow-up|1|||
105865840|NCT03449446|365156931|FG004|Overall Study|Lost to Follow-up|3|||
105865841|NCT03449446|365156932|FG005|Overall Study|Lost to Follow-up|0|||
105865842|NCT03449446|365156933|FG006|Overall Study|Lost to Follow-up|0|||
105865843|NCT03449446|365156927|FG000|Overall Study|Investigator's Discretion|0|||
105865844|NCT03449446|365156928|FG001|Overall Study|Investigator's Discretion|1|||
105865845|NCT03449446|365156929|FG002|Overall Study|Investigator's Discretion|1|||
105865846|NCT03449446|365156930|FG003|Overall Study|Investigator's Discretion|2|||
105865847|NCT03449446|365156931|FG004|Overall Study|Investigator's Discretion|0|||
105865848|NCT03449446|365156932|FG005|Overall Study|Investigator's Discretion|0|||
105865849|NCT03449446|365156933|FG006|Overall Study|Investigator's Discretion|0|||
106069905|NCT01528072|365920389|FG000|Overall Study|Lost to Follow-up|5|||
106069906|NCT01528072|365920389|FG000|Overall Study|Explanted|2|||
106069907|NCT01528072|365920389|FG000|Overall Study|Site Closure|4|||
106069908|NCT01528072|365920389|FG000|Overall Study|Death|2|||
106069909|NCT01528072|365920389|FG000|Overall Study|Early Termination of Study|52|||
105865850|NCT03449446|365156927|FG000|Overall Study|Non Compliance with Study Drug|1|||
105865851|NCT03449446|365156928|FG001|Overall Study|Non Compliance with Study Drug|0|||
105865852|NCT03449446|365156929|FG002|Overall Study|Non Compliance with Study Drug|0|||
105865853|NCT03449446|365156930|FG003|Overall Study|Non Compliance with Study Drug|0|||
106069910|NCT02529137|365920395|FG000|Overall Study|Discontinuation for different reasons|8|||
106069911|NCT02389998|365920396|FG000|Overall Study|car accident|1|||
106069912|NCT02389998|365920397|FG001|Overall Study|car accident|0|||
106069913|NCT03045887|365920398|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
106069914|NCT03045887|365920399|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
106069915|NCT03045887|365920400|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
106069916|NCT03045887|365920401|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
106069917|NCT03045887|365920402|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
105865854|NCT03449446|365156931|FG004|Overall Study|Non Compliance with Study Drug|0|||
105865855|NCT03449446|365156932|FG005|Overall Study|Non Compliance with Study Drug|0|||
105865856|NCT03449446|365156933|FG006|Overall Study|Non Compliance with Study Drug|0|||
105865857|NCT03449446|365156927|FG000|Overall Study|Protocol Violation|0|||
105865858|NCT03449446|365156928|FG001|Overall Study|Protocol Violation|0|||
105865859|NCT03449446|365156929|FG002|Overall Study|Protocol Violation|0|||
105865860|NCT03449446|365156930|FG003|Overall Study|Protocol Violation|0|||
105865861|NCT03449446|365156931|FG004|Overall Study|Protocol Violation|1|||
106069918|NCT03045887|365920403|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
106069919|NCT03045887|365920404|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
106069920|NCT03045887|365920405|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
106069921|NCT03045887|365920406|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
106069922|NCT03045887|365920407|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
106069923|NCT03045887|365920398|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069924|NCT03045887|365920399|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069925|NCT03045887|365920400|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069926|NCT03045887|365920401|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
106069927|NCT03045887|365920402|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069928|NCT03045887|365920403|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069929|NCT03045887|365920404|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069930|NCT03045887|365920405|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069931|NCT03045887|365920406|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069932|NCT03045887|365920407|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
106069933|NCT03045887|365920398|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
106069934|NCT03045887|365920399|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069935|NCT03045887|365920400|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069936|NCT03045887|365920401|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069937|NCT03045887|365920402|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069938|NCT03045887|365920403|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069939|NCT03045887|365920404|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069940|NCT03045887|365920405|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069941|NCT03045887|365920406|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069942|NCT03045887|365920407|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
106069943|NCT03045887|365920398|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
106069944|NCT03045887|365920399|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
106069945|NCT03045887|365920400|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
106069946|NCT03045887|365920401|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
106069947|NCT03045887|365920402|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
106069948|NCT03045887|365920403|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
106069949|NCT03045887|365920404|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
106069950|NCT03045887|365920405|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
106069951|NCT03045887|365920406|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
106069952|NCT03045887|365920407|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
106069953|NCT03045887|365920398|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069954|NCT03045887|365920399|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069955|NCT03045887|365920400|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069956|NCT03045887|365920401|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
106069957|NCT03045887|365920402|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069958|NCT03045887|365920403|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069959|NCT03045887|365920404|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069960|NCT03045887|365920405|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069961|NCT03045887|365920406|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069962|NCT03045887|365920407|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
106069963|NCT02132767|365920409|FG000|Overall Study|Death|3|||
106069964|NCT02132767|365920410|FG001|Overall Study|Death|2|||
106069965|NCT02132767|365920409|FG000|Overall Study|Withdrawal by Subject|10|||
106069966|NCT02132767|365920410|FG001|Overall Study|Withdrawal by Subject|9|||
106069967|NCT02132767|365920409|FG000|Overall Study|Lost to Follow-up|4|||
106069968|NCT02132767|365920410|FG001|Overall Study|Lost to Follow-up|4|||
106069969|NCT00778700|365920411|FG000|Overall Study|Adverse Event|6|||
106069970|NCT00778700|365920412|FG001|Overall Study|Adverse Event|1|||
106069971|NCT00778700|365920413|FG002|Overall Study|Adverse Event|3|||
106069972|NCT00778700|365920414|FG003|Overall Study|Adverse Event|5|||
106069973|NCT00778700|365920411|FG000|Overall Study|Protocol Violation|1|||
106069974|NCT00778700|365920412|FG001|Overall Study|Protocol Violation|1|||
106069975|NCT00778700|365920413|FG002|Overall Study|Protocol Violation|0|||
106069976|NCT00778700|365920414|FG003|Overall Study|Protocol Violation|0|||
106069977|NCT00778700|365920411|FG000|Overall Study|Subject Withdrew Consent|6|||
106069978|NCT00778700|365920412|FG001|Overall Study|Subject Withdrew Consent|4|||
106069979|NCT00778700|365920413|FG002|Overall Study|Subject Withdrew Consent|1|||
106069980|NCT00778700|365920414|FG003|Overall Study|Subject Withdrew Consent|4|||
106069981|NCT00778700|365920411|FG000|Overall Study|Lost to Follow-up|3|||
106069982|NCT00778700|365920412|FG001|Overall Study|Lost to Follow-up|1|||
106069983|NCT00778700|365920413|FG002|Overall Study|Lost to Follow-up|0|||
106069984|NCT00778700|365920414|FG003|Overall Study|Lost to Follow-up|1|||
106069985|NCT00778700|365920411|FG000|Overall Study|Reason not Specified|2|||
106069986|NCT00778700|365920412|FG001|Overall Study|Reason not Specified|0|||
106069987|NCT00778700|365920413|FG002|Overall Study|Reason not Specified|1|||
105865862|NCT03449446|365156932|FG005|Overall Study|Protocol Violation|1|||
106069988|NCT00778700|365920414|FG003|Overall Study|Reason not Specified|3|||
106155067|NCT04396366|366229032|FG001|Overall Study|Adverse Event|0|||
106155068|NCT02396199|366229041|FG000|Overall Study|Lost to Follow-up|1|||
106155069|NCT02396199|366229041|FG000|Overall Study|Death|4|||
106155070|NCT01064440|366229042|FG000|Overall Study|Lost to Follow-up|1|||
106155071|NCT01064440|366229043|FG001|Overall Study|Lost to Follow-up|1|||
106155072|NCT01064440|366229044|FG002|Overall Study|Lost to Follow-up|1|||
106155073|NCT01064440|366229042|FG000|Overall Study|Non-compliance|0|||
106155074|NCT01064440|366229043|FG001|Overall Study|Non-compliance|1|||
106155075|NCT01064440|366229044|FG002|Overall Study|Non-compliance|0|||
106155076|NCT01064440|366229042|FG000|Overall Study|Death|1|||
106155077|NCT01064440|366229043|FG001|Overall Study|Death|0|||
106155078|NCT01064440|366229044|FG002|Overall Study|Death|1|||
106155079|NCT01064440|366229042|FG000|Overall Study|Withdrawal by Subject|0|||
106155080|NCT01064440|366229043|FG001|Overall Study|Withdrawal by Subject|1|||
106155081|NCT01064440|366229044|FG002|Overall Study|Withdrawal by Subject|1|||
106155082|NCT01064440|366229042|FG000|Overall Study|Other: amputation|1|||
106155083|NCT01064440|366229043|FG001|Overall Study|Other: amputation|0|||
106155084|NCT01064440|366229044|FG002|Overall Study|Other: amputation|0|||
106155085|NCT04337372|366229045|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
106155086|NCT04337372|366229046|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
106155087|NCT04337372|366229047|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
106155088|NCT04337372|366229048|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
106155089|NCT04337372|366229045|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
106155090|NCT04337372|366229046|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
106155091|NCT04337372|366229047|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
106155092|NCT04337372|366229048|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
106155093|NCT04337372|366229045|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
106155094|NCT04337372|366229046|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
106155095|NCT04337372|366229047|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
106155096|NCT04337372|366229048|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
106155097|NCT04337372|366229045|FG000|Day 2: EEG Measures|Protocol Violation|6|||
106155098|NCT04337372|366229046|FG001|Day 2: EEG Measures|Protocol Violation|6|||
106155099|NCT04337372|366229047|FG002|Day 2: EEG Measures|Protocol Violation|5|||
106155100|NCT04337372|366229048|FG003|Day 2: EEG Measures|Protocol Violation|17|||
106155101|NCT04883645|366229049|FG000|Overall Study|Death|1|||
106155102|NCT03460236|366229050|FG000|Overall Study|failed radiographic screening|16|||
106155103|NCT03460236|366229050|FG000|Overall Study|Withdrawal by Subject|11|||
106155104|NCT05687903|366229051|FG000|Overall Study|Protocol Deviation|1|||
106155105|NCT05687903|366229052|FG001|Overall Study|Protocol Deviation|1|||
106155106|NCT05687903|366229053|FG002|Overall Study|Protocol Deviation|0|||
106155107|NCT05687903|366229054|FG003|Overall Study|Protocol Deviation|1|||
106155108|NCT05687903|366229055|FG004|Overall Study|Protocol Deviation|0|||
106155109|NCT03424811|366229056|FG000|Overall Study|Lost to Follow-up|9|||
106155110|NCT03424811|366229057|FG001|Overall Study|Lost to Follow-up|0|||
106155111|NCT02473250|366229058|FG000|Overall Study|Lost to Follow-up|10|||
106155112|NCT02473250|366229058|FG000|Overall Study|Physician Decision|5|||
106155113|NCT02473250|366229058|FG000|Overall Study|Did not tolerate medication washout|3|||
106155114|NCT02473250|366229058|FG000|Overall Study|Antidepressant effect of divalproex|2|||
106155115|NCT06066541|366229061|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
106155116|NCT06066541|366229062|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
106155117|NCT06066541|366229063|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
106155118|NCT06066541|366229064|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
106155119|NCT06066541|366229065|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
106155120|NCT06066541|366229066|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
106155121|NCT06066541|366229067|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
106155122|NCT06066541|366229061|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
106155123|NCT06066541|366229062|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
106155124|NCT06066541|366229063|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
106155125|NCT06066541|366229064|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
106155126|NCT06066541|366229065|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
106155127|NCT06066541|366229066|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
106155128|NCT06066541|366229067|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
106155129|NCT01898494|366229068|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
106155130|NCT01898494|366229069|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
106155131|NCT01898494|366229070|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
106155132|NCT01898494|366229071|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
106155133|NCT01898494|366229072|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
106155134|NCT01898494|366229068|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
106155135|NCT01898494|366229069|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
106155136|NCT01898494|366229070|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
106069989|NCT00778700|365920411|FG000|Overall Study|Other|0|||
106069990|NCT00778700|365920412|FG001|Overall Study|Other|0|||
106069991|NCT00778700|365920413|FG002|Overall Study|Other|1|||
106069992|NCT00778700|365920414|FG003|Overall Study|Other|0|||
106069993|NCT00491387|365920418|FG000|Overall Study|study terminated|20|||
106069994|NCT04267133|365920419|FG000|Overall Study|Withdrawal by Subject|1|||
106069995|NCT04267133|365920419|FG000|Overall Study|Adverse Event|4|||
106069996|NCT02150954|365920420|FG000|Overall Study|Protocol Violation|1|||
106069997|NCT02150954|365920421|FG001|Overall Study|Protocol Violation|0|||
106069998|NCT03318315|365920422|FG000|Overall Study|Lost to Follow-up|3|||
106069999|NCT03318315|365920423|FG001|Overall Study|Lost to Follow-up|2|||
106070000|NCT03318315|365920424|FG002|Overall Study|Lost to Follow-up|1|||
106070001|NCT03318315|365920422|FG000|Overall Study|Protocol Violation|1|||
106070002|NCT03318315|365920423|FG001|Overall Study|Protocol Violation|1|||
106070003|NCT03318315|365920424|FG002|Overall Study|Protocol Violation|1|||
106070004|NCT03318315|365920422|FG000|Overall Study|Withdrawal by Subject|0|||
106070005|NCT03318315|365920423|FG001|Overall Study|Withdrawal by Subject|0|||
106070006|NCT03318315|365920424|FG002|Overall Study|Withdrawal by Subject|2|||
106070007|NCT02631850|365920425|FG000|Treatment Period|Lost to Follow-up|0|||
106070008|NCT02631850|365920426|FG001|Treatment Period|Lost to Follow-up|1|||
106070009|NCT02631850|365920427|FG002|Treatment Period|Lost to Follow-up|0|||
106070010|NCT02631850|365920428|FG003|Treatment Period|Lost to Follow-up|0|||
106070011|NCT02631850|365920425|FG000|Treatment Period|Protocol Violation|1|||
106070012|NCT02631850|365920426|FG001|Treatment Period|Protocol Violation|0|||
106070013|NCT02631850|365920427|FG002|Treatment Period|Protocol Violation|0|||
106070014|NCT02631850|365920428|FG003|Treatment Period|Protocol Violation|0|||
106070015|NCT02631850|365920425|FG000|Treatment Period|Withdrawal by Subject|0|||
106070016|NCT02631850|365920426|FG001|Treatment Period|Withdrawal by Subject|5|||
106070017|NCT02631850|365920427|FG002|Treatment Period|Withdrawal by Subject|2|||
106070018|NCT02631850|365920428|FG003|Treatment Period|Withdrawal by Subject|2|||
106070019|NCT02631850|365920425|FG000|Treatment Period|Adverse Event|1|||
106070020|NCT02631850|365920426|FG001|Treatment Period|Adverse Event|0|||
106070021|NCT02631850|365920427|FG002|Treatment Period|Adverse Event|2|||
106070022|NCT02631850|365920428|FG003|Treatment Period|Adverse Event|3|||
106070023|NCT02631850|365920425|FG000|Treatment Period|Family medical issue|1|||
106070024|NCT02631850|365920426|FG001|Treatment Period|Family medical issue|0|||
106070025|NCT02631850|365920427|FG002|Treatment Period|Family medical issue|0|||
106070026|NCT02631850|365920428|FG003|Treatment Period|Family medical issue|0|||
106070027|NCT02631850|365920425|FG000|6 Month Follow up|Lost to Follow-up|5|||
106070028|NCT02631850|365920426|FG001|6 Month Follow up|Lost to Follow-up|8|||
106070029|NCT02631850|365920427|FG002|6 Month Follow up|Lost to Follow-up|3|||
106070030|NCT02631850|365920428|FG003|6 Month Follow up|Lost to Follow-up|5|||
106070031|NCT02631850|365920425|FG000|6 Month Follow up|Withdrawal by Subject|1|||
106070032|NCT02631850|365920426|FG001|6 Month Follow up|Withdrawal by Subject|0|||
106070033|NCT02631850|365920427|FG002|6 Month Follow up|Withdrawal by Subject|0|||
106070034|NCT02631850|365920428|FG003|6 Month Follow up|Withdrawal by Subject|2|||
106070035|NCT02631850|365920425|FG000|6 Month Follow up|Adverse Event|1|||
106070036|NCT02631850|365920426|FG001|6 Month Follow up|Adverse Event|4|||
106070037|NCT02631850|365920427|FG002|6 Month Follow up|Adverse Event|1|||
106070038|NCT02631850|365920428|FG003|6 Month Follow up|Adverse Event|3|||
106070039|NCT02631850|365920425|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
106070040|NCT02631850|365920426|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
105865863|NCT03449446|365156933|FG006|Overall Study|Protocol Violation|0|||
105865864|NCT03449446|365156927|FG000|Overall Study|Death|0|||
105865865|NCT03449446|365156928|FG001|Overall Study|Death|0|||
105865866|NCT03449446|365156929|FG002|Overall Study|Death|0|||
105865867|NCT03449446|365156930|FG003|Overall Study|Death|0|||
105865868|NCT03449446|365156931|FG004|Overall Study|Death|1|||
105865869|NCT03449446|365156932|FG005|Overall Study|Death|0|||
105865870|NCT03449446|365156933|FG006|Overall Study|Death|0|||
105865871|NCT01377012|365156934|FG000|Core Study|Study terminated by Sponsor|47|||
105865872|NCT01377012|365156935|FG001|Core Study|Study terminated by Sponsor|54|||
105865873|NCT01377012|365156936|FG002|Core Study|Study terminated by Sponsor|46|||
105865874|NCT01377012|365156934|FG000|Core Study|Technical problems|1|||
106070041|NCT02631850|365920427|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
106070042|NCT02631850|365920428|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
106070043|NCT01996826|365920437|FG000|Overall Study|Lost to Follow-up|6|||
106070044|NCT01996826|365920438|FG001|Overall Study|Lost to Follow-up|2|||
106070045|NCT01996826|365920437|FG000|Overall Study|Physician Decision|1|||
106070046|NCT01996826|365920438|FG001|Overall Study|Physician Decision|1|||
106070047|NCT00326950|365920439|FG000|Overall Study|Progressive Disease|1|||
106070048|NCT01454570|365920440|FG000|Overall Study|Withdrawal by Subject|2|||
105865875|NCT01377012|365156935|FG001|Core Study|Technical problems|0|||
105865876|NCT01377012|365156936|FG002|Core Study|Technical problems|0|||
105865877|NCT01377012|365156934|FG000|Core Study|Withdrawal by Subject|15|||
105865878|NCT01377012|365156935|FG001|Core Study|Withdrawal by Subject|23|||
106070049|NCT01454570|365920440|FG000|Overall Study|Screen Failure|7|||
106070050|NCT00003901|365920441|FG000|Overall Study|Adverse Event|1|||
106155137|NCT01898494|366229071|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
106155138|NCT01898494|366229072|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
106155139|NCT01898494|366229068|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
106155140|NCT01898494|366229069|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
106155141|NCT01898494|366229070|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
106155142|NCT01898494|366229071|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
106155143|NCT01898494|366229072|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
106155144|NCT01898494|366229068|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
106155145|NCT01898494|366229069|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
106155146|NCT01898494|366229070|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
106155147|NCT01898494|366229071|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
106155148|NCT01898494|366229072|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
106155149|NCT01898494|366229068|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
106155150|NCT01898494|366229069|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
106155151|NCT01898494|366229070|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
106155152|NCT01898494|366229071|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
106155153|NCT01898494|366229072|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
106155154|NCT01898494|366229068|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
106155155|NCT01898494|366229069|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
106155156|NCT01898494|366229070|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
106155157|NCT01898494|366229071|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
106155158|NCT01898494|366229072|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
106155159|NCT01898494|366229068|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
106155160|NCT01898494|366229069|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
106155161|NCT01898494|366229070|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
106155162|NCT01898494|366229071|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
106155163|NCT01898494|366229072|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
106155164|NCT01898494|366229068|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
106155165|NCT01898494|366229069|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
106155166|NCT01898494|366229070|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
106155167|NCT01898494|366229071|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
106155168|NCT01898494|366229072|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
106155169|NCT01898494|366229068|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
106155170|NCT01898494|366229069|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
106155171|NCT01898494|366229070|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
106155172|NCT01898494|366229071|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
106155173|NCT01898494|366229072|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
106155174|NCT01898494|366229068|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
106155175|NCT01898494|366229069|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
106155176|NCT01898494|366229070|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
106155177|NCT01898494|366229071|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
106155178|NCT01898494|366229072|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
106155179|NCT01898494|366229068|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
106155180|NCT01898494|366229069|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
106155181|NCT01898494|366229070|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
106155182|NCT01898494|366229071|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
106155183|NCT01898494|366229072|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
106155184|NCT01898494|366229068|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
106155185|NCT01898494|366229069|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
106155186|NCT01898494|366229070|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
106155187|NCT01898494|366229071|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
106155188|NCT01898494|366229072|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
106155189|NCT01898494|366229068|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
106155190|NCT01898494|366229069|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
106155191|NCT01898494|366229070|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
106155192|NCT01898494|366229071|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
106155193|NCT01898494|366229072|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
106155194|NCT01898494|366229068|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
106155195|NCT01898494|366229069|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
106155196|NCT01898494|366229070|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
106155197|NCT01898494|366229071|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
106155198|NCT01898494|366229072|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
106155199|NCT02819843|366229073|FG000|Overall Study|Disease progression before RT|0|||
106155200|NCT02819843|366229074|FG001|Overall Study|Disease progression before RT|1|||
106155201|NCT02163447|366229075|FG000|Overall Study|Withdrawal by Subject|2|||
106155202|NCT02163447|366229076|FG001|Overall Study|Withdrawal by Subject|0|||
106155203|NCT02163447|366229077|FG002|Overall Study|Withdrawal by Subject|1|||
106155204|NCT02163447|366229075|FG000|Overall Study|Lost to Follow-up|1|||
106155205|NCT02163447|366229076|FG001|Overall Study|Lost to Follow-up|3|||
106155206|NCT02163447|366229077|FG002|Overall Study|Lost to Follow-up|0|||
106155207|NCT02163447|366229075|FG000|Overall Study|Moved out of study area|2|||
106155208|NCT02163447|366229076|FG001|Overall Study|Moved out of study area|3|||
106155209|NCT02163447|366229077|FG002|Overall Study|Moved out of study area|2|||
106155210|NCT02163447|366229075|FG000|Overall Study|Became HIV infected at time of delivery|1|||
106155211|NCT02163447|366229076|FG001|Overall Study|Became HIV infected at time of delivery|0|||
106155212|NCT02163447|366229077|FG002|Overall Study|Became HIV infected at time of delivery|0|||
106155213|NCT02728557|366229082|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
106155214|NCT02728557|366229083|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
106155215|NCT02728557|366229082|FG000|Overall Study|Dissatisfaction with research tasks|0|||
106155216|NCT02728557|366229083|FG001|Overall Study|Dissatisfaction with research tasks|1|||
106155217|NCT02728557|366229082|FG000|Overall Study|Scheduling or change in availability|1|||
106155218|NCT02728557|366229083|FG001|Overall Study|Scheduling or change in availability|1|||
106155219|NCT01718743|366229084|FG000|Overall Study|Physician Decision|7|||
106155220|NCT01718743|366229084|FG000|Overall Study|Withdrawal by Subject|14|||
106155221|NCT01718743|366229084|FG000|Overall Study|Progressive Disease|22|||
106155222|NCT01718743|366229084|FG000|Overall Study|Toxicity|1|||
106155223|NCT01718743|366229084|FG000|Overall Study|Malignancy|1|||
106155224|NCT03897686|366229085|FG000|Overall Study|Protocol Violation|1|||
106155225|NCT03897686|366229086|FG001|Overall Study|Protocol Violation|1|||
106155226|NCT03897686|366229085|FG000|Overall Study|Withdrawal by Subject|1|||
106070051|NCT00003901|365920441|FG000|Overall Study|Withdrawal by Subject|1|||
106070052|NCT00003901|365920441|FG000|Overall Study|Ineligible|6|||
106070053|NCT00003901|365920441|FG000|Overall Study|CT Scan not within protocol requirement|2|||
106070054|NCT00003901|365920441|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
106070055|NCT00003901|365920441|FG000|Overall Study|Medical problems|6|||
106070056|NCT02141997|365920445|FG000|Overall Study|Adverse Event|0|||
106070057|NCT02141997|365920446|FG001|Overall Study|Adverse Event|2|||
106070058|NCT02141997|365920447|FG002|Overall Study|Adverse Event|0|||
106070059|NCT02141997|365920448|FG003|Overall Study|Adverse Event|1|||
106070060|NCT02141997|365920445|FG000|Overall Study|Participant noncompliance|1|||
106070061|NCT02141997|365920446|FG001|Overall Study|Participant noncompliance|0|||
106070062|NCT02141997|365920447|FG002|Overall Study|Participant noncompliance|0|||
106070063|NCT02141997|365920448|FG003|Overall Study|Participant noncompliance|0|||
106070064|NCT02141997|365920445|FG000|Overall Study|Withdrew consent|1|||
106070065|NCT02141997|365920446|FG001|Overall Study|Withdrew consent|0|||
106070066|NCT02141997|365920447|FG002|Overall Study|Withdrew consent|3|||
106070067|NCT02141997|365920448|FG003|Overall Study|Withdrew consent|0|||
106070068|NCT02141997|365920445|FG000|Overall Study|Other|1|||
106070069|NCT02141997|365920446|FG001|Overall Study|Other|4|||
106070070|NCT02141997|365920447|FG002|Overall Study|Other|0|||
106070071|NCT02141997|365920448|FG003|Overall Study|Other|0|||
106070072|NCT04105998|365920450|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
106070073|NCT04105998|365920451|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
106070074|NCT04053023|365920452|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
106070075|NCT04053023|365920453|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
106070076|NCT05778786|365920465|FG000|Period 1|COVID-19 Related|3|||
106070077|NCT05778786|365920466|FG001|Period 1|COVID-19 Related|3|||
106070078|NCT05778786|365920465|FG000|Period 1|Withdrew Consent during Study|1|||
106070079|NCT05778786|365920466|FG001|Period 1|Withdrew Consent during Study|0|||
106070080|NCT05778786|365920465|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
106070081|NCT05778786|365920466|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
106070082|NCT05778786|365920465|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
106070083|NCT05778786|365920466|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
106070084|NCT01848756|365920467|FG000|Overall Study|Adverse Event|1|||
106070085|NCT01848756|365920467|FG000|Overall Study|Withdrawal by Subject|1|||
106070086|NCT01848756|365920467|FG000|Overall Study|Enrolled in Error|1|||
106070087|NCT01173718|365920468|FG000|Overall Study|Death|17|||
106070088|NCT01173718|365920468|FG000|Overall Study|Abandonment of study graft|27|||
106070089|NCT02075658|365920469|FG000|Overall Study|Physician Decision|2|||
106070090|NCT02075658|365920470|FG001|Overall Study|Physician Decision|2|||
106070091|NCT01286012|365920471|FG000|Overall Study|Adverse Event|3|||
106070092|NCT01286012|365920472|FG001|Overall Study|Adverse Event|3|||
106070093|NCT01286012|365920471|FG000|Overall Study|Death|2|||
106070094|NCT01286012|365920472|FG001|Overall Study|Death|3|||
106070095|NCT01286012|365920471|FG000|Overall Study|Protocol Violation|1|||
106070096|NCT01286012|365920472|FG001|Overall Study|Protocol Violation|1|||
106070097|NCT01286012|365920471|FG000|Overall Study|Withdrawal by Subject|4|||
106070098|NCT01286012|365920472|FG001|Overall Study|Withdrawal by Subject|4|||
106070099|NCT01286012|365920471|FG000|Overall Study|Physician Decision|2|||
106070100|NCT01286012|365920472|FG001|Overall Study|Physician Decision|0|||
106070101|NCT01286012|365920471|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
106155227|NCT03897686|366229086|FG001|Overall Study|Withdrawal by Subject|1|||
106070102|NCT01286012|365920472|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
106070103|NCT01367158|365920475|FG000|Overall Study|Withdrew consent|0|||
106070104|NCT01367158|365920476|FG001|Overall Study|Withdrew consent|2|||
106070105|NCT01367158|365920477|FG002|Overall Study|Withdrew consent|1|||
106155228|NCT03416010|366229087|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
106155229|NCT03416010|366229088|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
106155230|NCT03416010|366229087|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
106155231|NCT03416010|366229088|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
106155232|NCT03416010|366229087|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
106155233|NCT03416010|366229088|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
106155234|NCT03416010|366229087|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
106155235|NCT03416010|366229088|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
106155236|NCT03416010|366229087|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
106155237|NCT03416010|366229088|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
106155238|NCT03416010|366229087|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
106155239|NCT03416010|366229088|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
106155240|NCT03416010|366229087|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
105865879|NCT01377012|365156936|FG002|Core Study|Withdrawal by Subject|18|||
105865880|NCT01377012|365156934|FG000|Core Study|Protocol Violation|7|||
105865881|NCT01377012|365156935|FG001|Core Study|Protocol Violation|3|||
105865882|NCT01377012|365156936|FG002|Core Study|Protocol Violation|2|||
105865883|NCT01377012|365156934|FG000|Core Study|Pregnancy|0|||
105865884|NCT01377012|365156935|FG001|Core Study|Pregnancy|0|||
105865885|NCT01377012|365156936|FG002|Core Study|Pregnancy|1|||
105865886|NCT01377012|365156934|FG000|Core Study|Physician Decision|5|||
105865887|NCT01377012|365156935|FG001|Core Study|Physician Decision|4|||
105865888|NCT01377012|365156936|FG002|Core Study|Physician Decision|10|||
105865889|NCT01377012|365156934|FG000|Core Study|Non-Compliant with study treatment|0|||
105865890|NCT01377012|365156935|FG001|Core Study|Non-Compliant with study treatment|0|||
105865891|NCT01377012|365156936|FG002|Core Study|Non-Compliant with study treatment|1|||
105865892|NCT01377012|365156934|FG000|Core Study|No Longer require treatment|0|||
105865893|NCT01377012|365156935|FG001|Core Study|No Longer require treatment|0|||
105865894|NCT01377012|365156936|FG002|Core Study|No Longer require treatment|1|||
105865895|NCT01377012|365156934|FG000|Core Study|Lost to Follow-up|7|||
105865896|NCT01377012|365156935|FG001|Core Study|Lost to Follow-up|5|||
105865897|NCT01377012|365156936|FG002|Core Study|Lost to Follow-up|4|||
105865898|NCT01377012|365156934|FG000|Core Study|Lack of Efficacy|41|||
105865899|NCT01377012|365156935|FG001|Core Study|Lack of Efficacy|28|||
105865900|NCT01377012|365156936|FG002|Core Study|Lack of Efficacy|37|||
105865901|NCT01377012|365156934|FG000|Core Study|Death|1|||
105865902|NCT01377012|365156935|FG001|Core Study|Death|1|||
105865903|NCT01377012|365156936|FG002|Core Study|Death|1|||
105865904|NCT01377012|365156934|FG000|Core Study|Adverse Event|10|||
105865905|NCT01377012|365156935|FG001|Core Study|Adverse Event|14|||
105865906|NCT01377012|365156936|FG002|Core Study|Adverse Event|13|||
105865907|NCT01377012|365156934|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
105865908|NCT01377012|365156935|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
105865909|NCT01377012|365156936|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
106070106|NCT01367158|365920478|FG003|Overall Study|Withdrew consent|0|||
106070107|NCT01367158|365920479|FG004|Overall Study|Withdrew consent|2|||
106070108|NCT01367158|365920480|FG005|Overall Study|Withdrew consent|0|||
106070109|NCT01367158|365920481|FG006|Overall Study|Withdrew consent|0|||
106070110|NCT01367158|365920482|FG007|Overall Study|Withdrew consent|1|||
106070111|NCT01367158|365920483|FG008|Overall Study|Withdrew consent|0|||
105865910|NCT01377012|365156934|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
105865911|NCT01377012|365156935|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
105865912|NCT01377012|365156936|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
105865913|NCT01377012|365156934|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
105865914|NCT01377012|365156935|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
105865915|NCT01377012|365156936|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
106070112|NCT01367158|365920484|FG009|Overall Study|Withdrew consent|0|||
106070113|NCT01367158|365920485|FG010|Overall Study|Withdrew consent|0|||
106070114|NCT01367158|365920475|FG000|Overall Study|Lost to Follow-up|0|||
106070115|NCT01367158|365920476|FG001|Overall Study|Lost to Follow-up|0|||
106070116|NCT01367158|365920477|FG002|Overall Study|Lost to Follow-up|0|||
106070117|NCT01367158|365920478|FG003|Overall Study|Lost to Follow-up|1|||
106070118|NCT01367158|365920479|FG004|Overall Study|Lost to Follow-up|0|||
106155241|NCT03416010|366229088|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
106155242|NCT03948763|366229089|FG000|Overall Study|Sponsor's decision|0|||
106155243|NCT03948763|366229090|FG001|Overall Study|Sponsor's decision|2|||
106155244|NCT03948763|366229091|FG002|Overall Study|Sponsor's decision|6|||
106155245|NCT03948763|366229092|FG003|Overall Study|Sponsor's decision|4|||
106155246|NCT03948763|366229093|FG004|Overall Study|Sponsor's decision|0|||
106155247|NCT03948763|366229089|FG000|Overall Study|Physician Decision|0|||
106155248|NCT03948763|366229090|FG001|Overall Study|Physician Decision|0|||
106155249|NCT03948763|366229091|FG002|Overall Study|Physician Decision|1|||
106155250|NCT03948763|366229092|FG003|Overall Study|Physician Decision|0|||
106155251|NCT03948763|366229093|FG004|Overall Study|Physician Decision|0|||
106155252|NCT03948763|366229089|FG000|Overall Study|Lost to Follow-up|0|||
106155253|NCT03948763|366229090|FG001|Overall Study|Lost to Follow-up|0|||
106155254|NCT03948763|366229091|FG002|Overall Study|Lost to Follow-up|0|||
106155255|NCT03948763|366229092|FG003|Overall Study|Lost to Follow-up|0|||
106155256|NCT03948763|366229093|FG004|Overall Study|Lost to Follow-up|1|||
106155257|NCT03948763|366229089|FG000|Overall Study|Death|2|||
106155258|NCT03948763|366229090|FG001|Overall Study|Death|12|||
106155259|NCT03948763|366229091|FG002|Overall Study|Death|13|||
106155260|NCT03948763|366229092|FG003|Overall Study|Death|10|||
106155261|NCT03948763|366229093|FG004|Overall Study|Death|11|||
106155262|NCT03948763|366229089|FG000|Overall Study|Withdrawal by Subject|1|||
106155263|NCT03948763|366229090|FG001|Overall Study|Withdrawal by Subject|1|||
106155264|NCT03948763|366229091|FG002|Overall Study|Withdrawal by Subject|0|||
106155265|NCT03948763|366229092|FG003|Overall Study|Withdrawal by Subject|2|||
106155266|NCT03948763|366229093|FG004|Overall Study|Withdrawal by Subject|4|||
106155267|NCT05386355|366229103|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
106155268|NCT05386355|366229104|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
106155269|NCT05386355|366229105|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
106155270|NCT05386355|366229106|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
106155271|NCT06023082|366229110|FG000|Overall Study|Withdrawal by Subject|2|||
106155272|NCT06023082|366229110|FG000|Overall Study|Lost to Follow-up|15|||
106155273|NCT06023082|366229110|FG000|Overall Study|Side effects|5|||
106155274|NCT05136404|366229111|FG000|Period 1|Adverse Event|0|||
106155275|NCT05136404|366229112|FG001|Period 1|Adverse Event|1|||
106155276|NCT05136404|366229113|FG002|Period 1|Adverse Event|1|||
106155277|NCT05136404|366229111|FG000|Period 2|Inappropriate Behavior|0|||
106155278|NCT05136404|366229112|FG001|Period 2|Inappropriate Behavior|0|||
106155279|NCT05136404|366229113|FG002|Period 2|Inappropriate Behavior|1|||
106155280|NCT05136404|366229111|FG000|Period 3|Adverse Event|0|||
106155281|NCT05136404|366229112|FG001|Period 3|Adverse Event|0|||
106155282|NCT05136404|366229113|FG002|Period 3|Adverse Event|1|||
106155283|NCT03347383|366229114|FG000|Overall Study|Death|39|||
106155284|NCT03347383|366229114|FG000|Overall Study|Withdrawal by Subject|3|||
106155285|NCT03347383|366229114|FG000|Overall Study|Lost to Follow-up|9|||
106155286|NCT05691452|366229115|FG000|Overall Study|Withdrawal by Subject|1|||
106155287|NCT05691452|366229116|FG001|Overall Study|Withdrawal by Subject|1|||
106155288|NCT05691452|366229117|FG002|Overall Study|Withdrawal by Subject|0|||
106155289|NCT05691452|366229115|FG000|Overall Study|Physician Decision|1|||
106155290|NCT05691452|366229116|FG001|Overall Study|Physician Decision|0|||
106155291|NCT05691452|366229117|FG002|Overall Study|Physician Decision|0|||
106155292|NCT05691452|366229115|FG000|Overall Study|Lost to Follow-up|0|||
106155293|NCT05691452|366229116|FG001|Overall Study|Lost to Follow-up|0|||
106155294|NCT05691452|366229117|FG002|Overall Study|Lost to Follow-up|1|||
106155295|NCT05691452|366229115|FG000|Overall Study|Adverse Event|0|||
106155296|NCT05691452|366229116|FG001|Overall Study|Adverse Event|0|||
106155297|NCT05691452|366229117|FG002|Overall Study|Adverse Event|1|||
106155298|NCT05054374|366229120|FG000|Overall Study|Withdrawal by Subject|1|||
106155299|NCT05054374|366229121|FG001|Overall Study|Withdrawal by Subject|0|||
106155300|NCT05054374|366229122|FG002|Overall Study|Withdrawal by Subject|0|||
106155301|NCT05054374|366229123|FG003|Overall Study|Withdrawal by Subject|0|||
106155302|NCT05054374|366229120|FG000|Overall Study|Progressive Disease|5|||
106155303|NCT05054374|366229121|FG001|Overall Study|Progressive Disease|0|||
106155304|NCT05054374|366229122|FG002|Overall Study|Progressive Disease|0|||
106155305|NCT05054374|366229123|FG003|Overall Study|Progressive Disease|0|||
106155306|NCT01376700|366229126|FG000|Overall Study|Sponsor terminated study early|8|||
106155307|NCT01376700|366229126|FG000|Overall Study|Low or high titer inhibitor|8|||
105865916|NCT01377012|365156934|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
106155308|NCT04251533|366229132|FG000|Overall Study|Progressive disease|33|||
106155309|NCT04251533|366229133|FG001|Overall Study|Progressive disease|29|||
106155310|NCT04251533|366229134|FG002|Overall Study|Progressive disease|22|||
106155311|NCT04251533|366229132|FG000|Overall Study|Death|5|||
106155312|NCT04251533|366229133|FG001|Overall Study|Death|1|||
106155313|NCT04251533|366229134|FG002|Overall Study|Death|3|||
106155314|NCT04251533|366229132|FG000|Overall Study|Physician Decision|3|||
106155315|NCT04251533|366229133|FG001|Overall Study|Physician Decision|2|||
106155316|NCT04251533|366229134|FG002|Overall Study|Physician Decision|4|||
106155317|NCT04251533|366229132|FG000|Overall Study|Participant decision|1|||
106155318|NCT04251533|366229133|FG001|Overall Study|Participant decision|3|||
106155319|NCT04251533|366229134|FG002|Overall Study|Participant decision|1|||
106155320|NCT04251533|366229132|FG000|Overall Study|Adverse Event|2|||
106155321|NCT04251533|366229133|FG001|Overall Study|Adverse Event|1|||
106155322|NCT04251533|366229134|FG002|Overall Study|Adverse Event|1|||
106155323|NCT04314895|366229135|FG000|Overall Study|Lost to Follow-up|1|||
106155324|NCT04314895|366229135|FG000|Overall Study|Death|10|||
106155325|NCT04314895|366229135|FG000|Overall Study|Physician Decision|2|||
106155326|NCT03361748|366229139|FG000|Overall Study|Death|77|||
106155327|NCT03361748|366229139|FG000|Overall Study|Lost to Follow-up|4|||
106155328|NCT03361748|366229139|FG000|Overall Study|Withdrawal by Subject|20|||
106155329|NCT05575076|366229140|FG000|Overall Study|Adverse Event|24|||
106155330|NCT05575076|366229140|FG000|Overall Study|Death|7|||
106155331|NCT05575076|366229140|FG000|Overall Study|Lost to Follow-up|16|||
106155332|NCT05575076|366229140|FG000|Overall Study|Non-Compliance|3|||
106155333|NCT05575076|366229140|FG000|Overall Study|Physician Decision|6|||
106155334|NCT05575076|366229140|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
106155335|NCT05575076|366229140|FG000|Overall Study|Withdrawal by Subject|71|||
106155336|NCT05575076|366229140|FG000|Overall Study|Study Terminated by Sponsor|630|||
106155337|NCT05575076|366229140|FG000|Overall Study|Other|17|||
106155338|NCT04093752|366229141|FG000|Overall Study|Adverse Event|7|||
106155339|NCT04093752|366229142|FG001|Overall Study|Adverse Event|19|||
106155340|NCT04093752|366229143|FG002|Overall Study|Adverse Event|18|||
106155341|NCT04093752|366229144|FG003|Overall Study|Adverse Event|4|||
106155342|NCT04093752|366229141|FG000|Overall Study|Withdrawal by Subject|6|||
106155343|NCT04093752|366229142|FG001|Overall Study|Withdrawal by Subject|6|||
106155344|NCT04093752|366229143|FG002|Overall Study|Withdrawal by Subject|8|||
106155345|NCT04093752|366229144|FG003|Overall Study|Withdrawal by Subject|20|||
106155346|NCT04093752|366229141|FG000|Overall Study|Lost to Follow-up|2|||
106155347|NCT04093752|366229142|FG001|Overall Study|Lost to Follow-up|1|||
106155348|NCT04093752|366229143|FG002|Overall Study|Lost to Follow-up|1|||
106155349|NCT04093752|366229144|FG003|Overall Study|Lost to Follow-up|1|||
106155350|NCT04093752|366229141|FG000|Overall Study|Death|0|||
106155351|NCT04093752|366229142|FG001|Overall Study|Death|0|||
106155352|NCT04093752|366229143|FG002|Overall Study|Death|1|||
106155353|NCT04093752|366229144|FG003|Overall Study|Death|2|||
106155354|NCT04093752|366229141|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
106155355|NCT04093752|366229142|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
106155356|NCT04093752|366229143|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
106155357|NCT04093752|366229144|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
106155358|NCT04093752|366229141|FG000|Overall Study|Covid 19|0|||
106155359|NCT04093752|366229142|FG001|Overall Study|Covid 19|0|||
106155360|NCT04093752|366229143|FG002|Overall Study|Covid 19|0|||
105865917|NCT01377012|365156935|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
105865918|NCT01377012|365156936|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
105865919|NCT01377012|365156934|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
105865920|NCT01377012|365156935|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
105865921|NCT01377012|365156936|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
105865922|NCT01377012|365156934|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
105865923|NCT01377012|365156935|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
105865924|NCT01377012|365156936|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
105865925|NCT00805961|365156939|FG000|Modality Therapy|Withdrawal by Subject|1|||
105865926|NCT00805961|365156939|FG000|Modality Therapy|Adverse Event|1|||
105865927|NCT00805961|365156939|FG000|Modality Therapy|Disease Progression|2|||
105865928|NCT00805961|365156939|FG000|Treatment-Free Interval|Adverse Event|3|||
105865929|NCT00805961|365156939|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
105865930|NCT00805961|365156939|FG000|Treatment-Free Interval|Physician Decision|1|||
105865931|NCT00805961|365156939|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
105865932|NCT00805961|365156939|FG000|Maintenance Treatment|Lack of Efficacy|13|||
105865933|NCT00805961|365156939|FG000|Maintenance Treatment|Intercurrent Illness|7|||
105865934|NCT00805961|365156939|FG000|Maintenance Treatment|Adverse Event|6|||
105865935|NCT00805961|365156939|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
105865936|NCT00805961|365156939|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
105865937|NCT00805961|365156939|FG000|Maintenance Treatment|Withdrawn Consent|1|||
105865938|NCT04380961|365156940|FG000|Overall Study|Lost to Follow-up|17|||
105865939|NCT04380961|365156941|FG001|Overall Study|Lost to Follow-up|11|||
105865940|NCT04380961|365156940|FG000|Overall Study|Withdrawal by Subject|3|||
105865941|NCT04380961|365156941|FG001|Overall Study|Withdrawal by Subject|0|||
105865942|NCT04380961|365156940|FG000|Overall Study|Death|22|||
105865943|NCT04380961|365156941|FG001|Overall Study|Death|16|||
105865944|NCT04380961|365156940|FG000|Overall Study|Other|1|||
106155361|NCT04093752|366229144|FG003|Overall Study|Covid 19|1|||
106155362|NCT04093752|366229141|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
106155363|NCT04093752|366229142|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
105865945|NCT04380961|365156941|FG001|Overall Study|Other|0|||
106070119|NCT01367158|365920480|FG005|Overall Study|Lost to Follow-up|2|||
106070120|NCT01367158|365920481|FG006|Overall Study|Lost to Follow-up|0|||
106070121|NCT01367158|365920482|FG007|Overall Study|Lost to Follow-up|1|||
106070122|NCT01367158|365920483|FG008|Overall Study|Lost to Follow-up|0|||
106070123|NCT01367158|365920484|FG009|Overall Study|Lost to Follow-up|0|||
106070124|NCT01367158|365920485|FG010|Overall Study|Lost to Follow-up|1|||
106070125|NCT01367158|365920475|FG000|Overall Study|Protocol Violation|0|||
106070126|NCT01367158|365920476|FG001|Overall Study|Protocol Violation|1|||
106070127|NCT01367158|365920477|FG002|Overall Study|Protocol Violation|0|||
106070128|NCT01367158|365920478|FG003|Overall Study|Protocol Violation|0|||
106070129|NCT01367158|365920479|FG004|Overall Study|Protocol Violation|0|||
106070130|NCT01367158|365920480|FG005|Overall Study|Protocol Violation|0|||
106070131|NCT01367158|365920481|FG006|Overall Study|Protocol Violation|0|||
106070132|NCT01367158|365920482|FG007|Overall Study|Protocol Violation|0|||
106070133|NCT01367158|365920483|FG008|Overall Study|Protocol Violation|0|||
106070134|NCT01367158|365920484|FG009|Overall Study|Protocol Violation|0|||
106070135|NCT01367158|365920485|FG010|Overall Study|Protocol Violation|0|||
105865946|NCT04380961|365156940|FG000|Overall Study|Randomized but Not Treated|1|||
105865947|NCT04380961|365156941|FG001|Overall Study|Randomized but Not Treated|2|||
105865948|NCT03316547|365156942|FG000|Overall Study|Death|3|||
105865949|NCT03316547|365156943|FG001|Overall Study|Death|1|||
105865950|NCT03316547|365156942|FG000|Overall Study|Lost to Follow-up|6|||
105865951|NCT03316547|365156943|FG001|Overall Study|Lost to Follow-up|6|||
105865952|NCT03316547|365156942|FG000|Overall Study|Withdrawal by Subject|3|||
105865953|NCT03316547|365156943|FG001|Overall Study|Withdrawal by Subject|2|||
105865954|NCT03316547|365156942|FG000|Overall Study|Transfer to another hospital|6|||
105865955|NCT03316547|365156943|FG001|Overall Study|Transfer to another hospital|4|||
105865956|NCT02017015|365159208|FG000|Overall Study|Adverse Event|9|||
105865957|NCT02017015|365159208|FG000|Overall Study|Withdrawal by Subject|21|||
105865958|NCT02017015|365159208|FG000|Overall Study|Death|4|||
105865959|NCT02017015|365159208|FG000|Overall Study|Progressive Disease|31|||
105865960|NCT02017015|365159208|FG000|Overall Study|Non-compliance with study drug|2|||
106070136|NCT02113956|365920486|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
106070137|NCT02113956|365920487|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
106070138|NCT02113956|365920486|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
106155364|NCT04093752|366229143|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
106155365|NCT04093752|366229144|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
106155366|NCT04093752|366229141|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
105865961|NCT02017015|365159208|FG000|Overall Study|Physician Decision|2|||
105865962|NCT01200069|365159209|FG000|Overall Study|Withdrawal by Subject|0|||
105865963|NCT01200069|365159210|FG001|Overall Study|Withdrawal by Subject|1|||
105865964|NCT03765788|365159218|FG000|Overall Study|Subject decision|2|||
105865965|NCT03765788|365159219|FG001|Overall Study|Subject decision|3|||
106070139|NCT02113956|365920487|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
106070140|NCT02113956|365920486|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
106155367|NCT04093752|366229142|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
106155368|NCT04093752|366229143|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
106155369|NCT04093752|366229144|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
106155370|NCT04093752|366229141|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
106155371|NCT04093752|366229142|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
106155372|NCT04093752|366229143|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
106155373|NCT04093752|366229144|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
106155374|NCT02376790|366229145|FG000|Overall Study|Withdrawal by Subject|43|||
106155375|NCT02376790|366229146|FG001|Overall Study|Withdrawal by Subject|36|||
106155376|NCT02376790|366229147|FG002|Overall Study|Withdrawal by Subject|37|||
106155377|NCT02376790|366229145|FG000|Overall Study|Decision by Sponsor|2|||
106155378|NCT02376790|366229146|FG001|Overall Study|Decision by Sponsor|1|||
106155379|NCT02376790|366229147|FG002|Overall Study|Decision by Sponsor|4|||
106155380|NCT02376790|366229145|FG000|Overall Study|Lost to Follow-up|15|||
106155381|NCT02376790|366229146|FG001|Overall Study|Lost to Follow-up|10|||
106155382|NCT02376790|366229147|FG002|Overall Study|Lost to Follow-up|12|||
106155383|NCT02829918|366229150|FG000|Overall Study|Death|2|||
106155384|NCT02829918|366229150|FG000|Overall Study|Withdrawal by Subject|4|||
106155385|NCT02829918|366229150|FG000|Overall Study|Adverse Event|1|||
105865966|NCT03765788|365159218|FG000|Overall Study|Physician Decision|2|||
106070141|NCT02113956|365920487|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
106070142|NCT01498458|365920488|FG000|Overall Study|Adverse Event|4|||
106070143|NCT01498458|365920488|FG000|Overall Study|Physician Decision|3|||
105865967|NCT03765788|365159219|FG001|Overall Study|Physician Decision|4|||
106155386|NCT02829918|366229150|FG000|Overall Study|Progression|1|||
106155387|NCT03767517|366229152|FG000|Overall Study|Lost to Follow-up|16|||
106155388|NCT03767517|366229153|FG001|Overall Study|Lost to Follow-up|10|||
105865968|NCT03765788|365159218|FG000|Overall Study|Death|0|||
105865969|NCT03765788|365159219|FG001|Overall Study|Death|1|||
105865970|NCT03765788|365159218|FG000|Overall Study|Lost to Follow-up|1|||
105865971|NCT03765788|365159219|FG001|Overall Study|Lost to Follow-up|0|||
106155389|NCT03767517|366229152|FG000|Overall Study|Death|2|||
106155390|NCT03767517|366229153|FG001|Overall Study|Death|3|||
106155391|NCT04774237|366229154|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
106155392|NCT04774237|366229155|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
106155393|NCT04774237|366229156|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
106155394|NCT04774237|366229157|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
106155395|NCT04774237|366229158|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
106155396|NCT04774237|366229159|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
106155397|NCT03744312|366230078|FG000|Overall Study|Withdrawal by Subject|0|||
106155398|NCT03744312|366230079|FG001|Overall Study|Withdrawal by Subject|1|||
106155399|NCT03744312|366230078|FG000|Overall Study|Screen fail|0|||
106155400|NCT03744312|366230079|FG001|Overall Study|Screen fail|1|||
106155401|NCT02392429|366230080|FG000|Screening|Screen failure|15|||
106155402|NCT02392429|366230080|FG000|Enrolled Participants|Ineligible due to disease|3|||
106155403|NCT02392429|366230080|FG000|Enrolled Participants|Withdrawal by Subject|4|||
106155404|NCT02392429|366230080|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
106155405|NCT02392429|366230080|FG000|Evaluable|Death|5|||
106155406|NCT02392429|366230080|FG000|Evaluable|Withdrawal by Subject|1|||
106155407|NCT02392429|366230080|FG000|Evaluable|Adverse Event|1|||
106155408|NCT02392429|366230080|FG000|Evaluable|remission bone marrow biopsy|3|||
106155409|NCT04607044|366230081|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
106155410|NCT04607044|366230081|FG000|Overall Study|Adverse Event|1|||
106155411|NCT04607044|366230081|FG000|Overall Study|Did not receive study device|3|||
106155412|NCT04607044|366230081|FG000|Overall Study|Death|1|||
106155413|NCT04059354|366230082|FG000|Overall Study|COVID-19 pandemic|3|||
106155414|NCT05403801|366230083|FG000|Overall Study|Withdrawal by Subject|2|||
106155415|NCT00739648|366230105|FG000|Overall Study|Adverse Event|3|||
106155416|NCT00739648|366230106|FG001|Overall Study|Adverse Event|15|||
106155417|NCT00739648|366230105|FG000|Overall Study|Withdrawal by Subject|13|||
106155418|NCT00739648|366230106|FG001|Overall Study|Withdrawal by Subject|25|||
106155419|NCT00739648|366230105|FG000|Overall Study|Lost to Follow-up|4|||
106155420|NCT00739648|366230106|FG001|Overall Study|Lost to Follow-up|7|||
106155421|NCT00739648|366230105|FG000|Overall Study|Death|2|||
106155422|NCT00739648|366230106|FG001|Overall Study|Death|0|||
106070144|NCT02406651|365920489|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
106070145|NCT02226003|365920491|FG000|Overall Study|Lost to Follow-up|2|||
106070146|NCT02226003|365920492|FG001|Overall Study|Lost to Follow-up|1|||
106070147|NCT02226003|365920493|FG002|Overall Study|Lost to Follow-up|3|||
106070148|NCT02226003|365920491|FG000|Overall Study|Withdrawal by Subject|0|||
106070149|NCT02226003|365920492|FG001|Overall Study|Withdrawal by Subject|0|||
106070150|NCT02226003|365920493|FG002|Overall Study|Withdrawal by Subject|3|||
106070151|NCT02738151|365920498|FG000|Overall Study|Randomized but not treated|4|||
106070152|NCT02738151|365920499|FG001|Overall Study|Randomized but not treated|1|||
106070153|NCT02738151|365920498|FG000|Overall Study|Adverse Event|4|||
106070154|NCT02738151|365920499|FG001|Overall Study|Adverse Event|5|||
106070155|NCT02738151|365920498|FG000|Overall Study|Hypoglycemia|0|||
106070156|NCT02738151|365920499|FG001|Overall Study|Hypoglycemia|1|||
106070157|NCT02738151|365920498|FG000|Overall Study|Poor Compliance to Protocol|4|||
106070158|NCT02738151|365920499|FG001|Overall Study|Poor Compliance to Protocol|3|||
106070159|NCT02738151|365920498|FG000|Overall Study|Other than specified above|11|||
106070160|NCT02738151|365920499|FG001|Overall Study|Other than specified above|21|||
106070161|NCT02921776|365920509|FG000|Overall Study|patient deterioration, fatigue|2|||
106070162|NCT02921776|365920510|FG001|Overall Study|patient deterioration, fatigue|6|||
106070163|NCT02921776|365920511|FG002|Overall Study|patient deterioration, fatigue|0|||
106070164|NCT02921776|365920512|FG003|Overall Study|patient deterioration, fatigue|0|||
106070165|NCT02921776|365920513|FG004|Overall Study|patient deterioration, fatigue|0|||
106070166|NCT02921776|365920514|FG005|Overall Study|patient deterioration, fatigue|0|||
106070167|NCT02921776|365920515|FG006|Overall Study|patient deterioration, fatigue|0|||
106070168|NCT02921776|365920516|FG007|Overall Study|patient deterioration, fatigue|0|||
106070169|NCT02921776|365920509|FG000|Overall Study|Withdrawal by Subject|0|||
106070170|NCT02921776|365920510|FG001|Overall Study|Withdrawal by Subject|2|||
106070171|NCT02921776|365920511|FG002|Overall Study|Withdrawal by Subject|0|||
106070172|NCT02921776|365920512|FG003|Overall Study|Withdrawal by Subject|1|||
106070173|NCT02921776|365920513|FG004|Overall Study|Withdrawal by Subject|1|||
106070174|NCT02921776|365920514|FG005|Overall Study|Withdrawal by Subject|0|||
106070175|NCT02921776|365920515|FG006|Overall Study|Withdrawal by Subject|8|||
106070176|NCT02921776|365920516|FG007|Overall Study|Withdrawal by Subject|1|||
106070177|NCT02921776|365920509|FG000|Overall Study|Death|0|||
106070178|NCT02921776|365920510|FG001|Overall Study|Death|0|||
106070179|NCT02921776|365920511|FG002|Overall Study|Death|0|||
106070180|NCT02921776|365920512|FG003|Overall Study|Death|2|||
106155423|NCT00739648|366230105|FG000|Overall Study|Do not know|4|||
106155424|NCT00739648|366230106|FG001|Overall Study|Do not know|6|||
106155425|NCT05110495|366230107|FG000|Overall Study|Lost to Follow-up|1|||
106155426|NCT05110495|366230107|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
106155427|NCT02630823|366230109|FG000|Overall Study|Withdrawal by Subject|1|||
106070181|NCT02921776|365920513|FG004|Overall Study|Death|0|||
106070182|NCT02921776|365920514|FG005|Overall Study|Death|0|||
106070183|NCT02921776|365920515|FG006|Overall Study|Death|0|||
106070184|NCT02921776|365920516|FG007|Overall Study|Death|0|||
106070185|NCT02921776|365920509|FG000|Overall Study|extubation or early discharge|0|||
106070186|NCT02921776|365920510|FG001|Overall Study|extubation or early discharge|0|||
106070187|NCT02921776|365920511|FG002|Overall Study|extubation or early discharge|0|||
106070188|NCT02921776|365920512|FG003|Overall Study|extubation or early discharge|5|||
106070189|NCT02921776|365920513|FG004|Overall Study|extubation or early discharge|5|||
106070190|NCT02921776|365920514|FG005|Overall Study|extubation or early discharge|0|||
106070191|NCT02921776|365920515|FG006|Overall Study|extubation or early discharge|0|||
106070192|NCT02921776|365920516|FG007|Overall Study|extubation or early discharge|0|||
106070193|NCT02921776|365920509|FG000|Overall Study|Lost to Follow-up|0|||
106070194|NCT02921776|365920510|FG001|Overall Study|Lost to Follow-up|0|||
106070195|NCT02921776|365920511|FG002|Overall Study|Lost to Follow-up|0|||
106070196|NCT02921776|365920512|FG003|Overall Study|Lost to Follow-up|0|||
106070197|NCT02921776|365920513|FG004|Overall Study|Lost to Follow-up|0|||
106070198|NCT02921776|365920514|FG005|Overall Study|Lost to Follow-up|2|||
106070199|NCT02921776|365920515|FG006|Overall Study|Lost to Follow-up|3|||
106070200|NCT02921776|365920516|FG007|Overall Study|Lost to Follow-up|6|||
106070201|NCT01581307|365920524|FG000|Overall Study|Withdrawal by Subject|1|||
106070202|NCT01894581|365920525|FG000|Overall Study|Withdrawal by Subject|2|||
106070203|NCT01894581|365920526|FG001|Overall Study|Withdrawal by Subject|3|||
106070204|NCT01894581|365920525|FG000|Overall Study|Screen Failure|3|||
106070205|NCT01894581|365920526|FG001|Overall Study|Screen Failure|4|||
106070206|NCT01252940|365920530|FG000|Main Study Phase|Randomized but not treated|4|||
106070207|NCT01252940|365920531|FG001|Main Study Phase|Randomized but not treated|2|||
106070208|NCT01252940|365920530|FG000|Main Study Phase|Adverse Event|3|||
106070209|NCT01252940|365920531|FG001|Main Study Phase|Adverse Event|1|||
106070210|NCT01252940|365920530|FG000|Main Study Phase|Lack of Efficacy|1|||
106070211|NCT01252940|365920531|FG001|Main Study Phase|Lack of Efficacy|0|||
106070212|NCT01252940|365920530|FG000|Main Study Phase|Lost to Follow-up|6|||
106070213|NCT01252940|365920531|FG001|Main Study Phase|Lost to Follow-up|1|||
106070214|NCT01252940|365920530|FG000|Main Study Phase|Physician Decision|1|||
106070215|NCT01252940|365920531|FG001|Main Study Phase|Physician Decision|0|||
106070216|NCT01252940|365920530|FG000|Main Study Phase|Protocol Violation|4|||
106070217|NCT01252940|365920531|FG001|Main Study Phase|Protocol Violation|2|||
106070218|NCT01252940|365920530|FG000|Main Study Phase|Withdrawal by Subject|6|||
106070219|NCT01252940|365920531|FG001|Main Study Phase|Withdrawal by Subject|5|||
106070220|NCT01252940|365920530|FG000|Main Study Phase|Subject Non-compliance|1|||
106070221|NCT01252940|365920531|FG001|Main Study Phase|Subject Non-compliance|1|||
106070222|NCT01252940|365920530|FG000|Extension Phase|Adverse Event|2|||
106070223|NCT01252940|365920531|FG001|Extension Phase|Adverse Event|1|||
106070224|NCT01252940|365920530|FG000|Extension Phase|Lack of Efficacy|1|||
106070225|NCT01252940|365920531|FG001|Extension Phase|Lack of Efficacy|0|||
106070226|NCT01252940|365920530|FG000|Extension Phase|Lost to Follow-up|5|||
106070227|NCT01252940|365920531|FG001|Extension Phase|Lost to Follow-up|0|||
106070228|NCT01252940|365920530|FG000|Extension Phase|Physician Decision|0|||
106070229|NCT01252940|365920531|FG001|Extension Phase|Physician Decision|1|||
106070230|NCT01252940|365920530|FG000|Extension Phase|Subject Non-compliance|1|||
106070231|NCT01252940|365920531|FG001|Extension Phase|Subject Non-compliance|0|||
106070232|NCT01252940|365920530|FG000|Extension Phase|Withdrawal by Subject|1|||
106070233|NCT01252940|365920531|FG001|Extension Phase|Withdrawal by Subject|1|||
106070234|NCT01344161|365920533|FG000|Overall Study|Lost to Follow-up|4|||
106070235|NCT01344161|365920534|FG001|Overall Study|Lost to Follow-up|1|||
106070236|NCT01344161|365920533|FG000|Overall Study|Pregnancy|0|||
106070237|NCT01344161|365920534|FG001|Overall Study|Pregnancy|1|||
106070238|NCT01344161|365920533|FG000|Overall Study|Protocol Violation|1|||
106070239|NCT01344161|365920534|FG001|Overall Study|Protocol Violation|1|||
106155428|NCT02630823|366230109|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
106155429|NCT03655132|366230110|FG000|Overall Study|Lost to Follow-up|2|||
106155430|NCT03655132|366230111|FG001|Overall Study|Lost to Follow-up|1|||
106155431|NCT03655132|366230110|FG000|Overall Study|Withdrawal by Subject|0|||
106155432|NCT03655132|366230111|FG001|Overall Study|Withdrawal by Subject|1|||
106155433|NCT03655132|366230110|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
106155434|NCT03655132|366230111|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
106155435|NCT05439603|366230112|FG000|Overall Study|met withdrawal criteria|2|||
106155436|NCT03101904|366230113|FG000|Wash Out (10 Days)|Adverse Event|1|||
106070240|NCT04690751|365920535|FG000|Overall Study|Protocol Violation|0|||
106155437|NCT03101904|366230114|FG001|Wash Out (10 Days)|Adverse Event|0|||
106155438|NCT03101904|366230113|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
106070241|NCT04690751|365920536|FG001|Overall Study|Protocol Violation|1|||
106155439|NCT03101904|366230114|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
106070242|NCT04690751|365920537|FG002|Overall Study|Protocol Violation|0|||
106070243|NCT04690751|365920538|FG003|Overall Study|Protocol Violation|1|||
106070244|NCT04690751|365920539|FG004|Overall Study|Protocol Violation|2|||
106070245|NCT04690751|365920540|FG005|Overall Study|Protocol Violation|0|||
106070246|NCT04690751|365920535|FG000|Overall Study|Adverse Event|0|||
106070247|NCT04690751|365920536|FG001|Overall Study|Adverse Event|0|||
106070248|NCT04690751|365920537|FG002|Overall Study|Adverse Event|1|||
106070249|NCT04690751|365920538|FG003|Overall Study|Adverse Event|0|||
106070250|NCT04690751|365920539|FG004|Overall Study|Adverse Event|0|||
106070251|NCT04690751|365920540|FG005|Overall Study|Adverse Event|0|||
106070252|NCT04690751|365920535|FG000|Overall Study|Positive urine drug screen test|0|||
106070253|NCT04690751|365920536|FG001|Overall Study|Positive urine drug screen test|0|||
106070254|NCT04690751|365920537|FG002|Overall Study|Positive urine drug screen test|0|||
106070255|NCT04690751|365920538|FG003|Overall Study|Positive urine drug screen test|0|||
106070256|NCT04690751|365920539|FG004|Overall Study|Positive urine drug screen test|1|||
106070257|NCT04690751|365920540|FG005|Overall Study|Positive urine drug screen test|0|||
106070258|NCT04364620|365920542|FG000|Overall Study|Disease Progression|20|||
106070259|NCT04364620|365920542|FG000|Overall Study|Adverse Event|5|||
106070260|NCT04364620|365920542|FG000|Overall Study|Physician Decision|4|||
106070261|NCT04364620|365920542|FG000|Overall Study|Death|3|||
106070262|NCT04364620|365920542|FG000|Overall Study|Other|2|||
106070263|NCT04364620|365920542|FG000|Overall Study|Withdrawal by Subject|1|||
106070264|NCT01881230|365921739|FG000|Overall Study|Death|2|||
106070265|NCT01881230|365921740|FG001|Overall Study|Death|0|||
106070266|NCT01881230|365921741|FG002|Overall Study|Death|1|||
106070267|NCT01881230|365921739|FG000|Overall Study|Adverse Event|9|||
106070268|NCT01881230|365921740|FG001|Overall Study|Adverse Event|13|||
106070269|NCT01881230|365921741|FG002|Overall Study|Adverse Event|12|||
106070270|NCT01881230|365921739|FG000|Overall Study|Progressive Disease|31|||
106070271|NCT01881230|365921740|FG001|Overall Study|Progressive Disease|35|||
106070272|NCT01881230|365921741|FG002|Overall Study|Progressive Disease|36|||
106070273|NCT01881230|365921739|FG000|Overall Study|Symptomatic Deterioration|3|||
106070274|NCT01881230|365921740|FG001|Overall Study|Symptomatic Deterioration|3|||
106070275|NCT01881230|365921741|FG002|Overall Study|Symptomatic Deterioration|1|||
106070276|NCT01881230|365921739|FG000|Overall Study|Withdrawal by Subject|6|||
106070277|NCT01881230|365921740|FG001|Overall Study|Withdrawal by Subject|4|||
106070278|NCT01881230|365921741|FG002|Overall Study|Withdrawal by Subject|6|||
106070279|NCT01881230|365921739|FG000|Overall Study|Physician Decision|4|||
106070280|NCT01881230|365921740|FG001|Overall Study|Physician Decision|3|||
106070281|NCT01881230|365921741|FG002|Overall Study|Physician Decision|6|||
106070282|NCT01881230|365921739|FG000|Overall Study|Non-Compliance with Study Drug|1|||
106070283|NCT01881230|365921740|FG001|Overall Study|Non-Compliance with Study Drug|2|||
106070284|NCT01881230|365921741|FG002|Overall Study|Non-Compliance with Study Drug|0|||
106070285|NCT01881230|365921739|FG000|Overall Study|Given Commercially Available Drug|0|||
106070286|NCT01881230|365921740|FG001|Overall Study|Given Commercially Available Drug|0|||
106070287|NCT01881230|365921741|FG002|Overall Study|Given Commercially Available Drug|2|||
106070288|NCT01881230|365921739|FG000|Overall Study|Protocol Violation|1|||
106070289|NCT01881230|365921740|FG001|Overall Study|Protocol Violation|1|||
106070290|NCT01881230|365921741|FG002|Overall Study|Protocol Violation|0|||
106070291|NCT01881230|365921739|FG000|Overall Study|Miscellaneous|3|||
106070292|NCT01881230|365921740|FG001|Overall Study|Miscellaneous|3|||
106070293|NCT01881230|365921741|FG002|Overall Study|Miscellaneous|0|||
106070294|NCT01881230|365921739|FG000|Overall Study|Untreated: Other|0|||
106070295|NCT01881230|365921740|FG001|Overall Study|Untreated: Other|0|||
106070296|NCT01881230|365921741|FG002|Overall Study|Untreated: Other|1|||
106070297|NCT01881230|365921739|FG000|Overall Study|Untreated: Death|0|||
106070298|NCT01881230|365921740|FG001|Overall Study|Untreated: Death|0|||
106070299|NCT01881230|365921741|FG002|Overall Study|Untreated: Death|1|||
106070300|NCT01881230|365921739|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
106070301|NCT01881230|365921740|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
106070302|NCT01881230|365921741|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
106070303|NCT00914810|365921744|FG000|Overall Study|Withdrawal by Subject|1|||
106070304|NCT00914810|365921745|FG001|Overall Study|Withdrawal by Subject|0|||
106070305|NCT00914810|365921744|FG000|Overall Study|Relocated out of state|1|||
106070306|NCT00914810|365921745|FG001|Overall Study|Relocated out of state|0|||
106070307|NCT00914810|365921744|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
106070308|NCT00914810|365921745|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
106070309|NCT02520011|365921746|FG000|Overall Study|Adverse Event|0|||
106070310|NCT02520011|365921747|FG001|Overall Study|Adverse Event|1|||
106070311|NCT02520011|365921748|FG002|Overall Study|Adverse Event|2|||
106070312|NCT02520011|365921746|FG000|Overall Study|Death|0|||
106070313|NCT02520011|365921747|FG001|Overall Study|Death|8|||
106070314|NCT02520011|365921748|FG002|Overall Study|Death|1|||
106070315|NCT02520011|365921746|FG000|Overall Study|Lack of Efficacy|4|||
106070316|NCT02520011|365921747|FG001|Overall Study|Lack of Efficacy|26|||
106070317|NCT02520011|365921748|FG002|Overall Study|Lack of Efficacy|4|||
106070318|NCT02520011|365921746|FG000|Overall Study|Physician Decision|0|||
106070319|NCT02520011|365921747|FG001|Overall Study|Physician Decision|2|||
106070320|NCT02520011|365921748|FG002|Overall Study|Physician Decision|0|||
106070321|NCT02520011|365921746|FG000|Overall Study|Withdrawal by Subject|1|||
105865972|NCT01924754|365159220|FG000|Overall Study|Lost to Follow-up|1|||
105865973|NCT01924754|365159221|FG001|Overall Study|Lost to Follow-up|2|||
106070322|NCT02520011|365921747|FG001|Overall Study|Withdrawal by Subject|3|||
106070323|NCT02520011|365921748|FG002|Overall Study|Withdrawal by Subject|0|||
106070324|NCT02520011|365921746|FG000|Overall Study|Protocol Deviation|0|||
106070325|NCT02520011|365921747|FG001|Overall Study|Protocol Deviation|1|||
106070326|NCT02520011|365921748|FG002|Overall Study|Protocol Deviation|0|||
106070327|NCT02520011|365921746|FG000|Overall Study|Patient went to hospice|0|||
106070328|NCT02520011|365921747|FG001|Overall Study|Patient went to hospice|1|||
106070329|NCT02520011|365921748|FG002|Overall Study|Patient went to hospice|0|||
106070330|NCT02520011|365921746|FG000|Overall Study|Progressive disease following response|0|||
106070331|NCT02520011|365921747|FG001|Overall Study|Progressive disease following response|4|||
106070332|NCT02520011|365921748|FG002|Overall Study|Progressive disease following response|2|||
106070333|NCT02632552|365921749|FG000|Overall Study|Lost to Follow-up|14|||
106070334|NCT02632552|365921750|FG001|Overall Study|Lost to Follow-up|8|||
106070335|NCT02632552|365921749|FG000|Overall Study|Withdrawal by Subject|2|||
106070336|NCT02632552|365921750|FG001|Overall Study|Withdrawal by Subject|0|||
106070337|NCT02632552|365921749|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
106070338|NCT02632552|365921750|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
106070339|NCT02063854|365921758|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
106070340|NCT02063854|365921759|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
106070341|NCT02063854|365921760|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
106070342|NCT02063854|365921761|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
106070343|NCT02063854|365921762|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
106070344|NCT02063854|365921763|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
106070345|NCT02063854|365921764|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
106070346|NCT02063854|365921758|FG000|Overall Study|Major Protocol Deviation|0|||
106155440|NCT02682316|366230115|FG000|Overall Study|Benign Final Pathology|27|||
106155441|NCT02682316|366230116|FG001|Overall Study|Benign Final Pathology|26|||
106155442|NCT02682316|366230115|FG000|Overall Study|Reoperation before 30 days|7|||
106155443|NCT02682316|366230116|FG001|Overall Study|Reoperation before 30 days|6|||
106155444|NCT02682316|366230115|FG000|Overall Study|Ineligible|1|||
106155445|NCT02682316|366230116|FG001|Overall Study|Ineligible|0|||
106155446|NCT02682316|366230115|FG000|Overall Study|Death|1|||
106155447|NCT02682316|366230116|FG001|Overall Study|Death|0|||
106155448|NCT02682316|366230115|FG000|Overall Study|Lost to Follow-up|7|||
106155449|NCT02682316|366230116|FG001|Overall Study|Lost to Follow-up|3|||
106155450|NCT01857934|366230117|FG000|Overall Study|Relapse or progression|2|||
106155451|NCT01857934|366230117|FG000|Overall Study|Unacceptable toxicity|3|||
106155452|NCT01857934|366230117|FG000|Overall Study|Unwillingness or inability to comply|2|||
106155453|NCT01857934|366230117|FG000|Overall Study|Physician Decision|3|||
106155454|NCT04703322|366230118|FG000|Overall Study|Ongoing|8|||
106155455|NCT04703322|366230118|FG000|Overall Study|Withdrawal by Subject|1|||
106155456|NCT01057433|366230119|FG000|Overall Study|Adverse Event|1|||
106155457|NCT01101451|366230122|FG000|Overall Study|Eligible and never treated|0|||
106155458|NCT01101451|366230123|FG001|Overall Study|Eligible and never treated|5|||
106155459|NCT01101451|366230122|FG000|Overall Study|Ineligible and treated|12|||
106155460|NCT01101451|366230123|FG001|Overall Study|Ineligible and treated|8|||
106155461|NCT01101451|366230122|FG000|Overall Study|Ineligible and never treated|2|||
106155462|NCT01101451|366230123|FG001|Overall Study|Ineligible and never treated|2|||
106155463|NCT02814838|366230130|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
106155464|NCT02814838|366230131|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
106155465|NCT02814838|366230130|FG000|Overall Study|Consent withdrawal|1|||
106155466|NCT02814838|366230131|FG001|Overall Study|Consent withdrawal|1|||
106155467|NCT00073749|366230132|FG000|Overall Study|Disease Progression|2|||
106155468|NCT00073749|366230133|FG001|Overall Study|Disease Progression|0|||
106155469|NCT00073749|366230134|FG002|Overall Study|Disease Progression|3|||
106155470|NCT00073749|366230135|FG003|Overall Study|Disease Progression|2|||
106155471|NCT00073749|366230136|FG004|Overall Study|Disease Progression|3|||
106155472|NCT00073749|366230137|FG005|Overall Study|Disease Progression|1|||
106155473|NCT00073749|366230138|FG006|Overall Study|Disease Progression|3|||
106155474|NCT00073749|366230132|FG000|Overall Study|Death|0|||
106155475|NCT00073749|366230133|FG001|Overall Study|Death|1|||
106155476|NCT00073749|366230134|FG002|Overall Study|Death|1|||
106155477|NCT00073749|366230135|FG003|Overall Study|Death|0|||
106155478|NCT00073749|366230136|FG004|Overall Study|Death|0|||
106155479|NCT00073749|366230137|FG005|Overall Study|Death|0|||
106155480|NCT00073749|366230138|FG006|Overall Study|Death|29|||
106155481|NCT00073749|366230132|FG000|Overall Study|Adverse Event|0|||
106155482|NCT00073749|366230133|FG001|Overall Study|Adverse Event|3|||
106070347|NCT02063854|365921759|FG001|Overall Study|Major Protocol Deviation|0|||
106070348|NCT02063854|365921760|FG002|Overall Study|Major Protocol Deviation|3|||
106155483|NCT00073749|366230134|FG002|Overall Study|Adverse Event|6|||
106155484|NCT00073749|366230135|FG003|Overall Study|Adverse Event|4|||
105865974|NCT01924754|365159222|FG002|Overall Study|Lost to Follow-up|1|||
105865975|NCT01924754|365159220|FG000|Overall Study|Pregnancy|0|||
105865976|NCT01924754|365159221|FG001|Overall Study|Pregnancy|1|||
105865977|NCT01924754|365159222|FG002|Overall Study|Pregnancy|2|||
105865978|NCT04974749|365159223|FG000|Overall Study|Withdrawal by Subject|2|||
105865979|NCT04974749|365159223|FG000|Overall Study|Gestation|1|||
105865980|NCT02640690|365159224|FG000|Overall Study|Lost to Follow-up|7|||
105865981|NCT02640690|365159225|FG001|Overall Study|Lost to Follow-up|7|||
105865982|NCT02640690|365159224|FG000|Overall Study|Withdrawal by Subject|16|||
105865983|NCT02640690|365159225|FG001|Overall Study|Withdrawal by Subject|20|||
105865984|NCT02640690|365159224|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
105865985|NCT02640690|365159225|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
105865986|NCT01118975|365159226|FG000|Overall Study|Adverse Event|0|||
105865987|NCT01118975|365159227|FG001|Overall Study|Adverse Event|1|||
105865988|NCT01371539|365159230|FG000|Period One: One Week|Lost to Follow-up|0|||
105865989|NCT01371539|365159231|FG001|Period One: One Week|Lost to Follow-up|1|||
105865990|NCT01371539|365159230|FG000|Period Two: One Week|Lost to Follow-up|0|||
105865991|NCT01371539|365159231|FG001|Period Two: One Week|Lost to Follow-up|1|||
105865992|NCT01371539|365159230|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
105865993|NCT01371539|365159231|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
105865994|NCT01371539|365159230|FG000|Period Two: One Week|Time/job conflict|0|||
105865995|NCT01371539|365159231|FG001|Period Two: One Week|Time/job conflict|1|||
106070349|NCT02063854|365921761|FG003|Overall Study|Major Protocol Deviation|0|||
106070350|NCT02063854|365921762|FG004|Overall Study|Major Protocol Deviation|0|||
106070351|NCT02063854|365921763|FG005|Overall Study|Major Protocol Deviation|0|||
106070352|NCT02063854|365921764|FG006|Overall Study|Major Protocol Deviation|0|||
106070353|NCT02063854|365921758|FG000|Overall Study|Voluntary Withdrawal|2|||
106070354|NCT02063854|365921759|FG001|Overall Study|Voluntary Withdrawal|0|||
106070355|NCT02063854|365921760|FG002|Overall Study|Voluntary Withdrawal|8|||
106070356|NCT02063854|365921761|FG003|Overall Study|Voluntary Withdrawal|1|||
106070357|NCT02063854|365921762|FG004|Overall Study|Voluntary Withdrawal|3|||
106070358|NCT02063854|365921763|FG005|Overall Study|Voluntary Withdrawal|6|||
106070359|NCT02063854|365921764|FG006|Overall Study|Voluntary Withdrawal|1|||
106070360|NCT02063854|365921758|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
106070361|NCT02063854|365921759|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
106070362|NCT02063854|365921760|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
106070363|NCT02063854|365921761|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
106070364|NCT02063854|365921762|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
106070365|NCT02063854|365921763|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
106070366|NCT02063854|365921764|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
106070367|NCT02063854|365921758|FG000|Overall Study|Reason Not Specified|1|||
106070368|NCT02063854|365921759|FG001|Overall Study|Reason Not Specified|0|||
106070369|NCT02063854|365921760|FG002|Overall Study|Reason Not Specified|0|||
106070370|NCT02063854|365921761|FG003|Overall Study|Reason Not Specified|0|||
106070371|NCT02063854|365921762|FG004|Overall Study|Reason Not Specified|0|||
106070372|NCT02063854|365921763|FG005|Overall Study|Reason Not Specified|0|||
106070373|NCT02063854|365921764|FG006|Overall Study|Reason Not Specified|0|||
106070374|NCT02063854|365921758|FG000|Overall Study|Did Not Receive Study Drug|0|||
106070375|NCT02063854|365921759|FG001|Overall Study|Did Not Receive Study Drug|0|||
106070376|NCT02063854|365921760|FG002|Overall Study|Did Not Receive Study Drug|0|||
106070377|NCT02063854|365921761|FG003|Overall Study|Did Not Receive Study Drug|0|||
106070378|NCT02063854|365921762|FG004|Overall Study|Did Not Receive Study Drug|0|||
106070379|NCT02063854|365921763|FG005|Overall Study|Did Not Receive Study Drug|1|||
106070380|NCT02063854|365921764|FG006|Overall Study|Did Not Receive Study Drug|0|||
106070381|NCT01462084|365921765|FG000|Overall Study|Withdrawal by Subject|1|||
106070382|NCT01462084|365921766|FG001|Overall Study|Withdrawal by Subject|0|||
106070383|NCT01462084|365921765|FG000|Overall Study|Protocol Violation|1|||
106070384|NCT01462084|365921766|FG001|Overall Study|Protocol Violation|1|||
106070385|NCT03538158|365921767|FG000|Overall Study|Lost to Follow-up|13|||
106070386|NCT03538158|365921768|FG001|Overall Study|Lost to Follow-up|7|||
106070387|NCT03538158|365921767|FG000|Overall Study|Withdrawal by Subject|2|||
106070388|NCT03538158|365921768|FG001|Overall Study|Withdrawal by Subject|1|||
106070389|NCT05089682|365921769|FG000|Overall Study|Withdrawal by Subject|2|||
106070390|NCT02255981|365921770|FG000|Overall Study|Lost to Follow-up|3|||
106070391|NCT02255981|365921770|FG000|Overall Study|Withdrawal by Subject|1|||
106070392|NCT00518323|365921771|FG000|Overall Study|Lack of Efficacy|14|||
106155485|NCT00073749|366230136|FG004|Overall Study|Adverse Event|2|||
106155486|NCT00073749|366230137|FG005|Overall Study|Adverse Event|1|||
106155487|NCT00073749|366230138|FG006|Overall Study|Adverse Event|0|||
106155488|NCT00073749|366230132|FG000|Overall Study|Physician Decision|0|||
105865996|NCT00196326|365159244|FG000|Overall Study|Did not meet protocol requirements|64|||
105865997|NCT00196326|365159244|FG000|Overall Study|Non-compliance with the protocol|81|||
105865998|NCT00196326|365159244|FG000|Overall Study|Physician Decision|3|||
105865999|NCT00196326|365159244|FG000|Overall Study|Withdrawal by Subject|225|||
105866000|NCT00196326|365159244|FG000|Overall Study|Adverse Event|253|||
105866001|NCT00196326|365159244|FG000|Overall Study|Pregnancy|34|||
105866002|NCT00196326|365159244|FG000|Overall Study|Lost to Follow-up|304|||
106070393|NCT00518323|365921772|FG001|Overall Study|Lack of Efficacy|2|||
106070394|NCT00518323|365921773|FG002|Overall Study|Lack of Efficacy|4|||
106070395|NCT00518323|365921774|FG003|Overall Study|Lack of Efficacy|20|||
106070396|NCT00518323|365921771|FG000|Overall Study|Withdrawal by Subject|1|||
106070397|NCT00518323|365921772|FG001|Overall Study|Withdrawal by Subject|2|||
106070398|NCT00518323|365921773|FG002|Overall Study|Withdrawal by Subject|4|||
106155489|NCT00073749|366230133|FG001|Overall Study|Physician Decision|0|||
106155490|NCT00073749|366230134|FG002|Overall Study|Physician Decision|1|||
106155491|NCT00073749|366230135|FG003|Overall Study|Physician Decision|0|||
106155492|NCT00073749|366230136|FG004|Overall Study|Physician Decision|0|||
106155493|NCT00073749|366230137|FG005|Overall Study|Physician Decision|2|||
106155494|NCT00073749|366230138|FG006|Overall Study|Physician Decision|0|||
106155495|NCT00073749|366230132|FG000|Overall Study|Withdrawal by Subject|0|||
106155496|NCT00073749|366230133|FG001|Overall Study|Withdrawal by Subject|1|||
106155497|NCT00073749|366230134|FG002|Overall Study|Withdrawal by Subject|0|||
106155498|NCT00073749|366230135|FG003|Overall Study|Withdrawal by Subject|0|||
106155499|NCT00073749|366230136|FG004|Overall Study|Withdrawal by Subject|1|||
106155500|NCT00073749|366230137|FG005|Overall Study|Withdrawal by Subject|0|||
106155501|NCT00073749|366230138|FG006|Overall Study|Withdrawal by Subject|2|||
106155502|NCT00073749|366230132|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
106155503|NCT00073749|366230133|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
106155504|NCT00073749|366230134|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
106155505|NCT00073749|366230135|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
106155506|NCT00073749|366230136|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
106155507|NCT00073749|366230137|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
106155508|NCT00073749|366230138|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
106155509|NCT00073749|366230132|FG000|Overall Study|Lost to Follow-up|0|||
106155510|NCT00073749|366230133|FG001|Overall Study|Lost to Follow-up|0|||
106155511|NCT00073749|366230134|FG002|Overall Study|Lost to Follow-up|0|||
106070399|NCT00518323|365921774|FG003|Overall Study|Withdrawal by Subject|2|||
106070400|NCT00518323|365921771|FG000|Overall Study|Lost to Follow-up|0|||
106070401|NCT00518323|365921772|FG001|Overall Study|Lost to Follow-up|2|||
106070402|NCT00518323|365921773|FG002|Overall Study|Lost to Follow-up|1|||
106070403|NCT00518323|365921774|FG003|Overall Study|Lost to Follow-up|3|||
106070404|NCT00518323|365921771|FG000|Overall Study|Adverse Event|1|||
106070405|NCT00518323|365921772|FG001|Overall Study|Adverse Event|1|||
106070406|NCT00518323|365921773|FG002|Overall Study|Adverse Event|1|||
106070407|NCT00518323|365921774|FG003|Overall Study|Adverse Event|0|||
106070408|NCT00518323|365921771|FG000|Overall Study|Prohibited medication and others|3|||
106070409|NCT00518323|365921772|FG001|Overall Study|Prohibited medication and others|1|||
106070410|NCT00518323|365921773|FG002|Overall Study|Prohibited medication and others|1|||
106070411|NCT00518323|365921774|FG003|Overall Study|Prohibited medication and others|0|||
106070412|NCT01266460|365921775|FG000|Overall Study|Adverse Event|3|||
106070413|NCT01266460|365921775|FG000|Overall Study|Withdrawal by Subject|5|||
106070414|NCT01266460|365921775|FG000|Overall Study|Disease Progression|18|||
106070415|NCT01266460|365921775|FG000|Overall Study|Not otherwise specified|8|||
106070416|NCT01132547|365921776|FG000|Overall Study|Withdrawal by Subject|3|||
106070417|NCT01132547|365921777|FG001|Overall Study|Withdrawal by Subject|1|||
106070418|NCT01132547|365921776|FG000|Overall Study|Death|1|||
106070419|NCT01132547|365921777|FG001|Overall Study|Death|0|||
106070420|NCT02617511|365921779|FG000|Overall Study|Withdrawal by Subject|1|||
106070421|NCT02617511|365921780|FG001|Overall Study|Withdrawal by Subject|0|||
106070422|NCT02580357|365921783|FG000|Overall Study|Lost to Follow-up|2|||
106070423|NCT02580357|365921784|FG001|Overall Study|Lost to Follow-up|0|||
106070424|NCT02580357|365921785|FG002|Overall Study|Lost to Follow-up|0|||
106070425|NCT02580357|365921783|FG000|Overall Study|Protocol Violation|1|||
106070426|NCT02580357|365921784|FG001|Overall Study|Protocol Violation|0|||
106070427|NCT02580357|365921785|FG002|Overall Study|Protocol Violation|0|||
106070428|NCT00720057|365921788|FG000|Overall Study|Lost to Follow-up|0|||
106070429|NCT00720057|365921789|FG001|Overall Study|Lost to Follow-up|2|||
106070430|NCT00720057|365921788|FG000|Overall Study|Protocol Violation|1|||
106070431|NCT00720057|365921789|FG001|Overall Study|Protocol Violation|0|||
106070432|NCT00720057|365921788|FG000|Overall Study|Withdrawal by Subject|0|||
106070433|NCT00720057|365921789|FG001|Overall Study|Withdrawal by Subject|1|||
106070434|NCT03165110|365921793|FG000|Overall Study|Anroid phone software incompatibility|1|||
106070435|NCT01679002|365921794|FG000|Overall Study|Adverse Event|1|||
106070436|NCT01679002|365921795|FG001|Overall Study|Adverse Event|1|||
106070437|NCT01679002|365921796|FG002|Overall Study|Adverse Event|0|||
106155512|NCT00073749|366230135|FG003|Overall Study|Lost to Follow-up|0|||
106155513|NCT00073749|366230136|FG004|Overall Study|Lost to Follow-up|0|||
106070438|NCT00613015|365921803|FG000|Overall Study|Lost to Follow-up|0|||
106070439|NCT00613015|365921804|FG001|Overall Study|Lost to Follow-up|1|||
106070440|NCT00613015|365921805|FG002|Overall Study|Lost to Follow-up|3|||
106155514|NCT00073749|366230137|FG005|Overall Study|Lost to Follow-up|0|||
106155515|NCT00073749|366230138|FG006|Overall Study|Lost to Follow-up|2|||
105866003|NCT00196326|365159244|FG000|Overall Study|Other|22|||
106155516|NCT00073749|366230132|FG000|Overall Study|Other|0|||
106155517|NCT00073749|366230133|FG001|Overall Study|Other|0|||
106070441|NCT00613015|365921806|FG003|Overall Study|Lost to Follow-up|3|||
106070442|NCT00613015|365921807|FG004|Overall Study|Lost to Follow-up|2|||
106070443|NCT00613015|365921808|FG005|Overall Study|Lost to Follow-up|3|||
106070444|NCT01179477|365921811|FG000|Overall Study|Death|542|||
106070445|NCT01179477|365921811|FG000|Overall Study|Unsuccessful implant|80|||
106070446|NCT01179477|365921811|FG000|Overall Study|Non-death withdrawal|438|||
106070447|NCT01179477|365921811|FG000|Overall Study|Did not complete final visit|27|||
106070448|NCT00071760|365921812|FG000|Overall Study|Adverse Event|2|||
106070449|NCT00071760|365921813|FG001|Overall Study|Adverse Event|1|||
106070450|NCT00071760|365921812|FG000|Overall Study|Lost to Follow-up|0|||
106070451|NCT00071760|365921813|FG001|Overall Study|Lost to Follow-up|3|||
106070452|NCT00071760|365921812|FG000|Overall Study|Protocol Violation|1|||
106070453|NCT00071760|365921813|FG001|Overall Study|Protocol Violation|0|||
106070454|NCT00071760|365921812|FG000|Overall Study|Withdrawal by Subject|0|||
106070455|NCT00071760|365921813|FG001|Overall Study|Withdrawal by Subject|1|||
106070456|NCT00071760|365921812|FG000|Overall Study|Insufficient Viral Load Response|1|||
106070457|NCT00071760|365921813|FG001|Overall Study|Insufficient Viral Load Response|1|||
106070458|NCT00071760|365921812|FG000|Overall Study|Lack of availability of RTV|1|||
106070459|NCT00071760|365921813|FG001|Overall Study|Lack of availability of RTV|0|||
105866004|NCT00741338|365159249|FG000|Overall Study|Adverse Event|0|||
105866005|NCT00741338|365159250|FG001|Overall Study|Adverse Event|1|||
105866006|NCT03593395|365159251|FG000|Overall Study|Lost to Follow-up|48|||
105866007|NCT03593395|365159252|FG001|Overall Study|Lost to Follow-up|3|||
105866008|NCT03593395|365159251|FG000|Overall Study|Withdrawal by Subject|5|||
105866009|NCT03593395|365159252|FG001|Overall Study|Withdrawal by Subject|24|||
105866010|NCT03593395|365159251|FG000|Overall Study|Death|2|||
105866011|NCT03593395|365159252|FG001|Overall Study|Death|3|||
105866012|NCT03593395|365159251|FG000|Overall Study|Physician Decision|0|||
105866013|NCT03593395|365159252|FG001|Overall Study|Physician Decision|6|||
106070460|NCT00071760|365921812|FG000|Overall Study|Physician Decision|2|||
106070461|NCT00071760|365921813|FG001|Overall Study|Physician Decision|1|||
106070462|NCT00071760|365921812|FG000|Overall Study|Relocation|0|||
106070463|NCT00071760|365921813|FG001|Overall Study|Relocation|1|||
106070464|NCT04120974|365921814|FG000|Overall Study|Death|1|||
105866014|NCT03593395|365159251|FG000|Overall Study|Participant Relocated|19|||
105866015|NCT03593395|365159252|FG001|Overall Study|Participant Relocated|3|||
105866016|NCT03593395|365159251|FG000|Overall Study|No Information|1|||
105866017|NCT03593395|365159252|FG001|Overall Study|No Information|7|||
105866018|NCT03713632|365159253|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
105866019|NCT03713632|365159254|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
105866020|NCT03713632|365159255|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
105866021|NCT03713632|365159256|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
105866022|NCT03713632|365159257|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
105866023|NCT03713632|365159253|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
105866024|NCT03713632|365159254|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
105866025|NCT03713632|365159255|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
105866026|NCT03713632|365159256|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105866027|NCT03713632|365159257|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
105866028|NCT03713632|365159253|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105866029|NCT03713632|365159254|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105866030|NCT03713632|365159255|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
105866031|NCT03713632|365159256|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
105866032|NCT03713632|365159257|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
105866033|NCT03713632|365159253|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
105866034|NCT03713632|365159254|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
105866035|NCT03713632|365159255|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
105866036|NCT03713632|365159256|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
105866037|NCT03713632|365159257|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
105866038|NCT03713632|365159253|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
105866039|NCT03713632|365159254|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105866040|NCT03713632|365159255|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
105866041|NCT03713632|365159256|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105866042|NCT03713632|365159257|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
105866043|NCT03713632|365159253|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
105866044|NCT03713632|365159254|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
106070465|NCT04120974|365921814|FG000|Overall Study|Physician Decision|1|||
106070466|NCT04120974|365921814|FG000|Overall Study|Lost to Follow-up|6|||
106070467|NCT03194321|365921822|FG000|Overall Study|Withdrawal by Subject|1|||
106070468|NCT03194321|365921822|FG000|Overall Study|Lost to Follow-up|1|||
106070469|NCT03194321|365921822|FG000|Overall Study|Travel for Follow-up|1|||
106070470|NCT03341533|365921825|FG000|Overall Study|Withdrawal by Subject|1|||
106070471|NCT03341533|365921826|FG001|Overall Study|Withdrawal by Subject|1|||
106070472|NCT03341533|365921825|FG000|Overall Study|Not eligible after randomization|2|||
106070473|NCT03341533|365921826|FG001|Overall Study|Not eligible after randomization|1|||
106155518|NCT00073749|366230134|FG002|Overall Study|Other|0|||
106155519|NCT00073749|366230135|FG003|Overall Study|Other|0|||
106155520|NCT00073749|366230136|FG004|Overall Study|Other|0|||
106155521|NCT00073749|366230137|FG005|Overall Study|Other|2|||
106155522|NCT00073749|366230138|FG006|Overall Study|Other|0|||
106155523|NCT04999592|366230140|FG000|Overall Study|Withdrawal by Subject|1|||
106155524|NCT04999592|366230141|FG001|Overall Study|Withdrawal by Subject|0|||
106155525|NCT01361711|366230142|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
106155526|NCT01361711|366230142|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
106155527|NCT01361711|366230142|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
106155528|NCT01361711|366230142|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
106155529|NCT01361711|366230142|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
106155530|NCT01361711|366230142|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
106155531|NCT01361711|366230142|FG000|Completed Week 18 of Treatment|Other|9|||
106155532|NCT01361711|366230142|FG000|10 Year Follow-up|Still in follow-up|22|||
106155533|NCT01361711|366230142|FG000|10 Year Follow-up|Death|7|||
106155534|NCT01361711|366230142|FG000|10 Year Follow-up|Developed new cancer|1|||
106155535|NCT01361711|366230142|FG000|10 Year Follow-up|Lost to Follow-up|2|||
106155536|NCT01361711|366230142|FG000|10 Year Follow-up|New treatment started|6|||
106155537|NCT01361711|366230142|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
106155538|NCT01361711|366230142|FG000|10 Year Follow-up|Progressive Disease|1|||
106155539|NCT04095104|366230143|FG000|Overall Study|Withdrawal by Subject|0|||
106155540|NCT04095104|366230144|FG001|Overall Study|Withdrawal by Subject|1|||
106155541|NCT03396588|366230146|FG000|Overall Study|Physician Decision|2|||
106155542|NCT03396588|366230147|FG001|Overall Study|Physician Decision|3|||
106155543|NCT05179395|366230148|FG000|Overall Study|Lack of Efficacy|1|||
106155544|NCT00812461|366230150|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
106155545|NCT00812461|366230151|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
106155546|NCT00812461|366230150|FG000|All Treated Patients|Adverse Event|8|||
106155547|NCT00812461|366230151|FG001|All Treated Patients|Adverse Event|15|||
106155548|NCT00812461|366230150|FG000|All Treated Patients|Lack of Efficacy|13|||
106155549|NCT00812461|366230151|FG001|All Treated Patients|Lack of Efficacy|7|||
106155550|NCT00812461|366230150|FG000|All Treated Patients|Non-compliance|6|||
106155551|NCT00812461|366230151|FG001|All Treated Patients|Non-compliance|9|||
106155552|NCT00812461|366230150|FG000|All Treated Patients|Protocol Violation|36|||
106155553|NCT00812461|366230151|FG001|All Treated Patients|Protocol Violation|27|||
106155554|NCT00812461|366230150|FG000|All Treated Patients|Withdrawal by Subject|45|||
106155555|NCT00812461|366230151|FG001|All Treated Patients|Withdrawal by Subject|54|||
106155556|NCT00812461|366230150|FG000|All Treated Patients|Lost to Follow-up|11|||
106155557|NCT00812461|366230151|FG001|All Treated Patients|Lost to Follow-up|14|||
106155558|NCT00812461|366230150|FG000|All Treated Patients|Other Reason|13|||
106155559|NCT00812461|366230151|FG001|All Treated Patients|Other Reason|21|||
106155560|NCT04442126|366230154|FG000|Overall Study|Withdrawal by Subject|0|||
106155561|NCT04442126|366230155|FG001|Overall Study|Withdrawal by Subject|0|||
106155562|NCT04442126|366230156|FG002|Overall Study|Withdrawal by Subject|0|||
106155563|NCT04442126|366230157|FG003|Overall Study|Withdrawal by Subject|2|||
106155564|NCT04442126|366230158|FG004|Overall Study|Withdrawal by Subject|1|||
106155565|NCT04442126|366230159|FG005|Overall Study|Withdrawal by Subject|0|||
106155566|NCT04442126|366230160|FG006|Overall Study|Withdrawal by Subject|1|||
106155567|NCT04442126|366230161|FG007|Overall Study|Withdrawal by Subject|1|||
106155568|NCT04442126|366230162|FG008|Overall Study|Withdrawal by Subject|3|||
106155569|NCT04442126|366230154|FG000|Overall Study|Death|1|||
106155570|NCT04442126|366230155|FG001|Overall Study|Death|0|||
106155571|NCT04442126|366230156|FG002|Overall Study|Death|0|||
106155572|NCT04442126|366230157|FG003|Overall Study|Death|1|||
106155573|NCT04442126|366230158|FG004|Overall Study|Death|2|||
106155574|NCT04442126|366230159|FG005|Overall Study|Death|2|||
106155575|NCT04442126|366230160|FG006|Overall Study|Death|4|||
106155576|NCT04442126|366230161|FG007|Overall Study|Death|1|||
106155577|NCT04442126|366230162|FG008|Overall Study|Death|5|||
106155578|NCT04442126|366230154|FG000|Overall Study|Study Terminated by Sponsor|0|||
106155579|NCT04442126|366230155|FG001|Overall Study|Study Terminated by Sponsor|0|||
106155580|NCT04442126|366230156|FG002|Overall Study|Study Terminated by Sponsor|0|||
106155581|NCT04442126|366230157|FG003|Overall Study|Study Terminated by Sponsor|0|||
106155582|NCT04442126|366230158|FG004|Overall Study|Study Terminated by Sponsor|0|||
106155583|NCT04442126|366230159|FG005|Overall Study|Study Terminated by Sponsor|1|||
106155584|NCT04442126|366230160|FG006|Overall Study|Study Terminated by Sponsor|4|||
106155585|NCT04442126|366230161|FG007|Overall Study|Study Terminated by Sponsor|2|||
106155586|NCT04442126|366230162|FG008|Overall Study|Study Terminated by Sponsor|10|||
106155587|NCT04442126|366230154|FG000|Overall Study|Lost to Follow-up|0|||
106155588|NCT04442126|366230155|FG001|Overall Study|Lost to Follow-up|0|||
106155589|NCT04442126|366230156|FG002|Overall Study|Lost to Follow-up|0|||
106155590|NCT04442126|366230157|FG003|Overall Study|Lost to Follow-up|0|||
106155591|NCT04442126|366230158|FG004|Overall Study|Lost to Follow-up|0|||
105866045|NCT03713632|365159255|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
105866046|NCT03713632|365159256|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
105866047|NCT03713632|365159257|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
105866048|NCT03713632|365159253|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
105866049|NCT03713632|365159254|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
105866050|NCT03713632|365159255|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
105866051|NCT03713632|365159256|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
105866052|NCT03713632|365159257|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
105866053|NCT03713632|365159253|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
105866054|NCT03713632|365159254|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
105866055|NCT03713632|365159255|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
105866056|NCT03713632|365159256|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
105866057|NCT03713632|365159257|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
105866058|NCT03713632|365159253|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
106155592|NCT04442126|366230159|FG005|Overall Study|Lost to Follow-up|0|||
105866059|NCT03713632|365159254|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
105866060|NCT03713632|365159255|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
105866061|NCT03713632|365159256|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
105866062|NCT03713632|365159257|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
105866063|NCT03713632|365159253|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
105866064|NCT03713632|365159254|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
105866065|NCT03713632|365159255|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
106070474|NCT02446990|365921834|FG000|Overall Study|Death|485|||
106070475|NCT02446990|365921835|FG001|Overall Study|Death|458|||
106070476|NCT02446990|365921834|FG000|Overall Study|Lost to Follow-up|3|||
106070477|NCT02446990|365921835|FG001|Overall Study|Lost to Follow-up|1|||
106070478|NCT02446990|365921834|FG000|Overall Study|Physician Decision|1|||
106070479|NCT02446990|365921835|FG001|Overall Study|Physician Decision|0|||
106070480|NCT02446990|365921834|FG000|Overall Study|Withdrawal by Subject|231|||
106155593|NCT04442126|366230160|FG006|Overall Study|Lost to Follow-up|0|||
106155594|NCT04442126|366230161|FG007|Overall Study|Lost to Follow-up|1|||
106155595|NCT04442126|366230162|FG008|Overall Study|Lost to Follow-up|2|||
106155596|NCT04442126|366230154|FG000|Overall Study|Progressive Disease|0|||
106155597|NCT04442126|366230155|FG001|Overall Study|Progressive Disease|1|||
106155598|NCT04442126|366230156|FG002|Overall Study|Progressive Disease|3|||
106155599|NCT04442126|366230157|FG003|Overall Study|Progressive Disease|0|||
106155600|NCT04442126|366230158|FG004|Overall Study|Progressive Disease|3|||
106155601|NCT04442126|366230159|FG005|Overall Study|Progressive Disease|0|||
106155602|NCT04442126|366230160|FG006|Overall Study|Progressive Disease|0|||
106155603|NCT04442126|366230161|FG007|Overall Study|Progressive Disease|0|||
106155604|NCT04442126|366230162|FG008|Overall Study|Progressive Disease|0|||
106155605|NCT04442126|366230154|FG000|Overall Study|Other|0|||
106155606|NCT04442126|366230155|FG001|Overall Study|Other|0|||
106155607|NCT04442126|366230156|FG002|Overall Study|Other|0|||
106155608|NCT04442126|366230157|FG003|Overall Study|Other|0|||
106155609|NCT04442126|366230158|FG004|Overall Study|Other|0|||
106155610|NCT04442126|366230159|FG005|Overall Study|Other|0|||
106155611|NCT04442126|366230160|FG006|Overall Study|Other|0|||
106155612|NCT04442126|366230161|FG007|Overall Study|Other|0|||
106155613|NCT04442126|366230162|FG008|Overall Study|Other|1|||
106155614|NCT04924062|366231278|FG000|Overall Study|Death|49|||
106155615|NCT04924062|366231279|FG001|Overall Study|Death|63|||
106155616|NCT04924062|366231278|FG000|Overall Study|Participant On-going|26|||
106155617|NCT04924062|366231279|FG001|Overall Study|Participant On-going|20|||
106155618|NCT04869982|366231282|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
106155619|NCT04869982|366231283|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
106070481|NCT02446990|365921835|FG001|Overall Study|Withdrawal by Subject|199|||
106070482|NCT01064401|365921836|FG000|Overall Study|Adverse Event|47|||
106070483|NCT01064401|365921837|FG001|Overall Study|Adverse Event|56|||
105866066|NCT03713632|365159256|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
105866067|NCT03713632|365159257|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
105866068|NCT03713632|365159253|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
106070484|NCT01064401|365921836|FG000|Overall Study|Lack of Efficacy|46|||
106070485|NCT01064401|365921837|FG001|Overall Study|Lack of Efficacy|23|||
106070486|NCT01064401|365921836|FG000|Overall Study|Lost to Follow-up|12|||
106070487|NCT01064401|365921837|FG001|Overall Study|Lost to Follow-up|9|||
106155620|NCT04869982|366231282|FG000|Overall Study|Migrated / moved from the study area|1|||
106155621|NCT04869982|366231283|FG001|Overall Study|Migrated / moved from the study area|1|||
106155622|NCT04869982|366231282|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
106070488|NCT01064401|365921836|FG000|Overall Study|Consent Withdrawn|98|||
106070489|NCT01064401|365921837|FG001|Overall Study|Consent Withdrawn|80|||
106155623|NCT04869982|366231283|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
106155624|NCT04869982|366231282|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
106155625|NCT04869982|366231283|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
106155626|NCT04869982|366231282|FG000|Overall Study|Solicited adverse event|2|||
106155627|NCT04869982|366231283|FG001|Overall Study|Solicited adverse event|1|||
106155628|NCT03021486|366231284|FG000|Overall Study|Withdrawal by Subject|1|||
106155629|NCT03021486|366231285|FG001|Overall Study|Withdrawal by Subject|1|||
106155630|NCT03021486|366231286|FG002|Overall Study|Withdrawal by Subject|3|||
106155631|NCT03021486|366231284|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
106155632|NCT03021486|366231285|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
106155633|NCT03021486|366231286|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
106155634|NCT03857620|366231287|FG000|Overall Study|Death|4|||
106155635|NCT03857620|366231288|FG001|Overall Study|Death|5|||
106155636|NCT03857620|366231289|FG002|Overall Study|Death|7|||
106155637|NCT03857620|366231287|FG000|Overall Study|Lost to Follow-up|2|||
106155638|NCT03857620|366231288|FG001|Overall Study|Lost to Follow-up|5|||
106155639|NCT03857620|366231289|FG002|Overall Study|Lost to Follow-up|3|||
106155640|NCT03857620|366231287|FG000|Overall Study|Disease progression or relapse after study registration|1|||
106155641|NCT03857620|366231288|FG001|Overall Study|Disease progression or relapse after study registration|5|||
106155642|NCT03857620|366231289|FG002|Overall Study|Disease progression or relapse after study registration|1|||
106155643|NCT03857620|366231287|FG000|Overall Study|Ineligible|5|||
106155644|NCT03857620|366231288|FG001|Overall Study|Ineligible|0|||
106155645|NCT03857620|366231289|FG002|Overall Study|Ineligible|2|||
106155646|NCT03857620|366231287|FG000|Overall Study|No malignancy|1|||
106155647|NCT03857620|366231288|FG001|Overall Study|No malignancy|0|||
106155648|NCT03857620|366231289|FG002|Overall Study|No malignancy|1|||
106155649|NCT03857620|366231287|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
106155650|NCT03857620|366231288|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
106155651|NCT03857620|366231289|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
106155652|NCT03857620|366231287|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
106155653|NCT03857620|366231288|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
106155654|NCT03857620|366231289|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
106155655|NCT03857620|366231287|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
106155656|NCT03857620|366231288|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
106155657|NCT03857620|366231289|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
106155658|NCT03857620|366231287|FG000|Overall Study|Surgery not performed, patient decision|0|||
106155659|NCT03857620|366231288|FG001|Overall Study|Surgery not performed, patient decision|3|||
106155660|NCT03857620|366231289|FG002|Overall Study|Surgery not performed, patient decision|1|||
106155661|NCT03857620|366231287|FG000|Overall Study|Surgery not performed, other reason|3|||
106155662|NCT03857620|366231288|FG001|Overall Study|Surgery not performed, other reason|1|||
106155663|NCT03857620|366231289|FG002|Overall Study|Surgery not performed, other reason|4|||
106155664|NCT03857620|366231287|FG000|Overall Study|Worsening performance status after surgery performed|0|||
106155665|NCT03857620|366231288|FG001|Overall Study|Worsening performance status after surgery performed|1|||
106155666|NCT03857620|366231289|FG002|Overall Study|Worsening performance status after surgery performed|1|||
106155667|NCT03055377|366231292|FG000|Treatment Phase|Lost to Follow-up|28|||
106155668|NCT03055377|366231293|FG001|Treatment Phase|Lost to Follow-up|24|||
106155669|NCT03055377|366231292|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
106155670|NCT03055377|366231293|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
106155671|NCT04586920|366231294|FG000|Overall Study|Lost to Follow-up|0|||
106155672|NCT04586920|366231295|FG001|Overall Study|Lost to Follow-up|0|||
105866069|NCT03713632|365159254|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
105866070|NCT03713632|365159255|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
105866071|NCT03713632|365159256|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
106155673|NCT04586920|366231296|FG002|Overall Study|Lost to Follow-up|0|||
105866072|NCT03713632|365159257|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
106155674|NCT04586920|366231297|FG003|Overall Study|Lost to Follow-up|0|||
106155675|NCT04586920|366231298|FG004|Overall Study|Lost to Follow-up|0|||
106155676|NCT04586920|366231299|FG005|Overall Study|Lost to Follow-up|0|||
106155677|NCT04586920|366231300|FG006|Overall Study|Lost to Follow-up|1|||
106155678|NCT04586920|366231301|FG007|Overall Study|Lost to Follow-up|1|||
106155679|NCT04586920|366231302|FG008|Overall Study|Lost to Follow-up|0|||
106155680|NCT04586920|366231303|FG009|Overall Study|Lost to Follow-up|1|||
106155681|NCT04586920|366231304|FG010|Overall Study|Lost to Follow-up|0|||
106155682|NCT04586920|366231305|FG011|Overall Study|Lost to Follow-up|0|||
106155683|NCT04586920|366231306|FG012|Overall Study|Lost to Follow-up|0|||
106155684|NCT04586920|366231307|FG013|Overall Study|Lost to Follow-up|1|||
106155685|NCT04586920|366231308|FG014|Overall Study|Lost to Follow-up|0|||
106155686|NCT04586920|366231309|FG015|Overall Study|Lost to Follow-up|0|||
106155687|NCT04586920|366231310|FG016|Overall Study|Lost to Follow-up|0|||
106155688|NCT04586920|366231311|FG017|Overall Study|Lost to Follow-up|0|||
106155689|NCT04586920|366231294|FG000|Overall Study|Withdrawal by Subject|0|||
106155690|NCT04586920|366231295|FG001|Overall Study|Withdrawal by Subject|0|||
106155691|NCT04586920|366231296|FG002|Overall Study|Withdrawal by Subject|0|||
106155692|NCT04586920|366231297|FG003|Overall Study|Withdrawal by Subject|0|||
106155693|NCT04586920|366231298|FG004|Overall Study|Withdrawal by Subject|0|||
106155694|NCT04586920|366231299|FG005|Overall Study|Withdrawal by Subject|0|||
106155695|NCT04586920|366231300|FG006|Overall Study|Withdrawal by Subject|0|||
106155696|NCT04586920|366231301|FG007|Overall Study|Withdrawal by Subject|1|||
106155697|NCT04586920|366231302|FG008|Overall Study|Withdrawal by Subject|0|||
106155698|NCT04586920|366231303|FG009|Overall Study|Withdrawal by Subject|1|||
106155699|NCT04586920|366231304|FG010|Overall Study|Withdrawal by Subject|0|||
106155700|NCT04586920|366231305|FG011|Overall Study|Withdrawal by Subject|1|||
106155701|NCT04586920|366231306|FG012|Overall Study|Withdrawal by Subject|0|||
106155702|NCT04586920|366231307|FG013|Overall Study|Withdrawal by Subject|0|||
106155703|NCT04586920|366231308|FG014|Overall Study|Withdrawal by Subject|0|||
106155704|NCT04586920|366231309|FG015|Overall Study|Withdrawal by Subject|0|||
106155705|NCT04586920|366231310|FG016|Overall Study|Withdrawal by Subject|0|||
106155706|NCT04586920|366231311|FG017|Overall Study|Withdrawal by Subject|0|||
106155707|NCT06143670|366231315|FG000|Overall Study|Lost to Follow-up|0|||
106155708|NCT06143670|366231316|FG001|Overall Study|Lost to Follow-up|1|||
106155709|NCT06143670|366231315|FG000|Overall Study|Withdrawal by Subject|3|||
106155710|NCT06143670|366231316|FG001|Overall Study|Withdrawal by Subject|0|||
106155711|NCT03747484|366231317|FG000|Overall Study|Lack of Efficacy|0|||
106155712|NCT03747484|366231318|FG001|Overall Study|Lack of Efficacy|1|||
106155713|NCT03747484|366231319|FG002|Overall Study|Lack of Efficacy|1|||
106155714|NCT03747484|366231320|FG003|Overall Study|Lack of Efficacy|2|||
106155715|NCT03747484|366231321|FG004|Overall Study|Lack of Efficacy|2|||
106155716|NCT04905407|366231322|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
106155717|NCT04905407|366231323|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
106155718|NCT04905407|366231324|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
106155719|NCT04905407|366231325|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
106155720|NCT04905407|366231322|FG000|Part 1 and Part 2|Death|7|||
106155721|NCT04905407|366231323|FG001|Part 1 and Part 2|Death|7|||
106155722|NCT04905407|366231324|FG002|Part 1 and Part 2|Death|7|||
106155723|NCT04905407|366231325|FG003|Part 1 and Part 2|Death|0|||
106155724|NCT04905407|366231322|FG000|Part 1 and Part 2|Other than specified|0|||
106155725|NCT04905407|366231323|FG001|Part 1 and Part 2|Other than specified|0|||
106155726|NCT04905407|366231324|FG002|Part 1 and Part 2|Other than specified|1|||
106155727|NCT04905407|366231325|FG003|Part 1 and Part 2|Other than specified|0|||
106155728|NCT04905407|366231322|FG000|Part 3|Death|0|||
106155729|NCT04905407|366231323|FG001|Part 3|Death|0|||
106155730|NCT04905407|366231324|FG002|Part 3|Death|0|||
106155731|NCT04905407|366231325|FG003|Part 3|Death|2|||
106155732|NCT05141903|366231334|FG000|Overall Study|Withdrawal by Subject|0|||
105866073|NCT03713632|365159253|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
105866074|NCT03713632|365159254|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
105866075|NCT03713632|365159255|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
105866076|NCT03713632|365159256|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
105866077|NCT03713632|365159257|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
105866078|NCT03713632|365159253|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
105866079|NCT03713632|365159254|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
106155733|NCT05141903|366231335|FG001|Overall Study|Withdrawal by Subject|1|||
106155734|NCT05141903|366231336|FG002|Overall Study|Withdrawal by Subject|1|||
106155735|NCT05141903|366231337|FG003|Overall Study|Withdrawal by Subject|0|||
106155736|NCT05141903|366231338|FG004|Overall Study|Withdrawal by Subject|0|||
106155737|NCT05141903|366231334|FG000|Overall Study|Other|1|||
106155738|NCT05141903|366231335|FG001|Overall Study|Other|1|||
106155739|NCT05141903|366231336|FG002|Overall Study|Other|0|||
106155740|NCT05141903|366231337|FG003|Overall Study|Other|0|||
106155741|NCT05141903|366231338|FG004|Overall Study|Other|0|||
106155742|NCT05418296|366231352|FG000|Overall Study|Withdrawal by Subject|4|||
106155743|NCT05418296|366231353|FG001|Overall Study|Withdrawal by Subject|1|||
106155744|NCT05382936|366231354|FG000|Overall Study|Progressive Disease|3|||
106155745|NCT05382936|366231355|FG001|Overall Study|Progressive Disease|5|||
106155746|NCT05382936|366231356|FG002|Overall Study|Progressive Disease|2|||
106155747|NCT05382936|366231357|FG003|Overall Study|Progressive Disease|5|||
106155748|NCT05382936|366231354|FG000|Overall Study|Adverse Event|0|||
106155749|NCT05382936|366231355|FG001|Overall Study|Adverse Event|1|||
106155750|NCT05382936|366231356|FG002|Overall Study|Adverse Event|1|||
106155751|NCT05382936|366231357|FG003|Overall Study|Adverse Event|0|||
106155752|NCT05382936|366231354|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
106155753|NCT05382936|366231355|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
106155754|NCT05382936|366231356|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
106155755|NCT05382936|366231357|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
106155756|NCT05382936|366231354|FG000|Overall Study|Withdrawal by Subject|0|||
106155757|NCT05382936|366231355|FG001|Overall Study|Withdrawal by Subject|0|||
106155758|NCT05382936|366231356|FG002|Overall Study|Withdrawal by Subject|1|||
106155759|NCT05382936|366231357|FG003|Overall Study|Withdrawal by Subject|1|||
106155760|NCT05927753|366231359|FG000|Overall Study|Withdrawal by Subject|0|||
106155761|NCT05927753|366231360|FG001|Overall Study|Withdrawal by Subject|2|||
106155762|NCT05927753|366231359|FG000|Overall Study|Physician Decision|0|||
106155763|NCT05927753|366231360|FG001|Overall Study|Physician Decision|1|||
106155764|NCT00601900|366231369|FG000|Overall Study|Withdrawal by Subject|0|||
106155765|NCT00601900|366231370|FG001|Overall Study|Withdrawal by Subject|3|||
106155766|NCT04450342|366231372|FG000|Overall Study|Adverse Event|1|||
106155767|NCT04450342|366231373|FG001|Overall Study|Adverse Event|1|||
106155768|NCT04450342|366231374|FG002|Overall Study|Adverse Event|0|||
106155769|NCT04450342|366231372|FG000|Overall Study|Device not used|1|||
106155770|NCT04450342|366231373|FG001|Overall Study|Device not used|0|||
106155771|NCT04450342|366231374|FG002|Overall Study|Device not used|0|||
106155772|NCT04450342|366231372|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
106155773|NCT04450342|366231373|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
106155774|NCT04450342|366231374|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
106155775|NCT04450342|366231372|FG000|Overall Study|Physician Decision|1|||
106155776|NCT04450342|366231373|FG001|Overall Study|Physician Decision|0|||
106155777|NCT04450342|366231374|FG002|Overall Study|Physician Decision|1|||
106155778|NCT04450342|366231372|FG000|Overall Study|Protocol Deviation|0|||
106155779|NCT04450342|366231373|FG001|Overall Study|Protocol Deviation|1|||
106155780|NCT04450342|366231374|FG002|Overall Study|Protocol Deviation|0|||
106155781|NCT04450342|366231372|FG000|Overall Study|Reoperation|1|||
106155782|NCT04450342|366231373|FG001|Overall Study|Reoperation|1|||
106155783|NCT04450342|366231374|FG002|Overall Study|Reoperation|0|||
106155784|NCT04450342|366231372|FG000|Overall Study|Screen Failures|0|||
106155785|NCT04450342|366231373|FG001|Overall Study|Screen Failures|0|||
106155786|NCT04450342|366231374|FG002|Overall Study|Screen Failures|2|||
106155787|NCT04450342|366231372|FG000|Overall Study|Site Terminated by Sponsor|1|||
106155788|NCT04450342|366231373|FG001|Overall Study|Site Terminated by Sponsor|1|||
106155789|NCT04450342|366231374|FG002|Overall Study|Site Terminated by Sponsor|1|||
106155790|NCT04450342|366231372|FG000|Overall Study|Study Terminated by Sponsor|31|||
106155791|NCT04450342|366231373|FG001|Overall Study|Study Terminated by Sponsor|29|||
106070490|NCT01064401|365921836|FG000|Overall Study|Investigator Decision|4|||
106070491|NCT01064401|365921837|FG001|Overall Study|Investigator Decision|6|||
106070492|NCT01064401|365921836|FG000|Overall Study|Death|4|||
106070493|NCT01064401|365921837|FG001|Overall Study|Death|0|||
106070494|NCT01064401|365921836|FG000|Overall Study|Pregnancy|4|||
106070495|NCT01064401|365921837|FG001|Overall Study|Pregnancy|7|||
106070496|NCT01064401|365921836|FG000|Overall Study|Noncompliance|7|||
106070497|NCT01064401|365921837|FG001|Overall Study|Noncompliance|8|||
106070498|NCT01064401|365921836|FG000|Overall Study|Site Closure|4|||
106070499|NCT01064401|365921837|FG001|Overall Study|Site Closure|5|||
106070500|NCT01064401|365921836|FG000|Overall Study|Other|2|||
106070501|NCT01064401|365921837|FG001|Overall Study|Other|1|||
106070502|NCT03158051|365921841|FG000|Overall Study|Lost to Follow-up|41|||
106070503|NCT03158051|365921842|FG001|Overall Study|Lost to Follow-up|47|||
106070504|NCT03158051|365921841|FG000|Overall Study|Physician Decision|6|||
106155792|NCT04450342|366231374|FG002|Overall Study|Study Terminated by Sponsor|6|||
106155793|NCT04450342|366231372|FG000|Overall Study|Withdrawal by Subject|0|||
106155794|NCT04450342|366231373|FG001|Overall Study|Withdrawal by Subject|1|||
106155795|NCT04450342|366231374|FG002|Overall Study|Withdrawal by Subject|2|||
106155796|NCT00220740|366231375|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
106155797|NCT00220740|366231376|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
106155798|NCT00220740|366231375|FG000|Efficacy Period|Adverse Event|1|||
106155799|NCT00220740|366231376|FG001|Efficacy Period|Adverse Event|1|||
106155800|NCT00220740|366231375|FG000|Efficacy Period|Withdrawal by Subject|1|||
106155801|NCT00220740|366231376|FG001|Efficacy Period|Withdrawal by Subject|0|||
106155802|NCT00220740|366231375|FG000|Efficacy Period|Protocol Violation|1|||
106155803|NCT00220740|366231376|FG001|Efficacy Period|Protocol Violation|0|||
106070505|NCT03158051|365921842|FG001|Overall Study|Physician Decision|7|||
106070506|NCT03158051|365921841|FG000|Overall Study|Withdrawal by Subject|24|||
106155804|NCT00220740|366231375|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
105866080|NCT03713632|365159255|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
105866081|NCT03713632|365159256|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
105866082|NCT03713632|365159257|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
105866083|NCT03713632|365159253|FG000|Treatment Period 2 (After Week 16)|Death|0|||
105866084|NCT03713632|365159254|FG001|Treatment Period 2 (After Week 16)|Death|1|||
105866085|NCT03713632|365159255|FG002|Treatment Period 2 (After Week 16)|Death|0|||
105866086|NCT03713632|365159256|FG003|Treatment Period 2 (After Week 16)|Death|0|||
105866087|NCT03713632|365159257|FG004|Treatment Period 2 (After Week 16)|Death|0|||
105866088|NCT03713632|365159253|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
106070507|NCT03158051|365921842|FG001|Overall Study|Withdrawal by Subject|15|||
106070508|NCT03158051|365921841|FG000|Overall Study|Death|0|||
106070509|NCT03158051|365921842|FG001|Overall Study|Death|1|||
106070510|NCT00323115|365921845|FG000|Vaccine Administration|Adverse Event|1|||
106070511|NCT00323115|365921845|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
106070512|NCT02005250|365921846|FG000|Overall Study|Lost to Follow-up|15|||
106070513|NCT02005250|365921847|FG001|Overall Study|Lost to Follow-up|5|||
106070514|NCT02588833|365921849|FG000|Part 1|Withdrawal by Subject|1|||
106070515|NCT02588833|365921850|FG001|Part 1|Withdrawal by Subject|0|||
106070516|NCT02588833|365921849|FG000|Part 2A|Physician Decision|0|||
106070517|NCT02588833|365921850|FG001|Part 2A|Physician Decision|1|||
106070518|NCT02588833|365921849|FG000|Part 2A|Withdrawal by Subject|0|||
106070519|NCT02588833|365921850|FG001|Part 2A|Withdrawal by Subject|1|||
106070520|NCT02588833|365921849|FG000|Part 2B|Adverse Event|0|||
106070521|NCT02588833|365921850|FG001|Part 2B|Adverse Event|1|||
106070522|NCT02588833|365921849|FG000|Part 2C|Adverse Event|0|||
106070523|NCT02588833|365921850|FG001|Part 2C|Adverse Event|1|||
106070524|NCT02588833|365921849|FG000|Part 2C|Withdrawal by Subject|0|||
106070525|NCT02588833|365921850|FG001|Part 2C|Withdrawal by Subject|1|||
106070526|NCT02588833|365921849|FG000|Part 3 (Safety Follow-up)|Other|0|||
106070527|NCT02588833|365921850|FG001|Part 3 (Safety Follow-up)|Other|2|||
106070528|NCT03649711|365921851|FG000|Overall Study|Adverse Event|0|||
106070529|NCT03649711|365921852|FG001|Overall Study|Adverse Event|1|||
106070530|NCT03649711|365921853|FG002|Overall Study|Adverse Event|0|||
106070531|NCT03649711|365921851|FG000|Overall Study|Kidney Transplant|1|||
106070532|NCT03649711|365921852|FG001|Overall Study|Kidney Transplant|0|||
106070533|NCT03649711|365921853|FG002|Overall Study|Kidney Transplant|0|||
106070534|NCT04007094|365921854|FG000|Overall Study|Lost to Follow-up|1|||
106070535|NCT04007094|365921855|FG001|Overall Study|Lost to Follow-up|1|||
106070536|NCT02946047|365921860|FG000|Overall Study|Adverse Event|1|||
106070537|NCT02946047|365921861|FG001|Overall Study|Adverse Event|0|||
106070538|NCT02946047|365921862|FG002|Overall Study|Adverse Event|0|||
106070539|NCT02946047|365921863|FG003|Overall Study|Adverse Event|0|||
106070540|NCT04350788|365921864|FG000|Overall Study|Lost to Follow-up|6|||
106070541|NCT04350788|365921865|FG001|Overall Study|Lost to Follow-up|2|||
106070542|NCT04350788|365921864|FG000|Overall Study|Withdrawal by Subject|2|||
106070543|NCT04350788|365921865|FG001|Overall Study|Withdrawal by Subject|4|||
106070544|NCT04350788|365921864|FG000|Overall Study|Protocol Violation|4|||
106070545|NCT04350788|365921865|FG001|Overall Study|Protocol Violation|0|||
106070546|NCT03615105|365921866|FG000|Overall Study|Protocol Violation|1|||
106070547|NCT03615105|365921867|FG001|Overall Study|Protocol Violation|0|||
106070548|NCT03615105|365921868|FG002|Overall Study|Protocol Violation|0|||
106070549|NCT03615105|365921866|FG000|Overall Study|Death|0|||
106070550|NCT03615105|365921867|FG001|Overall Study|Death|2|||
106070551|NCT03615105|365921868|FG002|Overall Study|Death|0|||
106070552|NCT00378209|365921874|FG000|Overall Study|Progressive disease|11|||
106070553|NCT00378209|365921874|FG000|Overall Study|Adverse Event|3|||
106070554|NCT00378209|365921874|FG000|Overall Study|Initiation of non-protocol therapy|3|||
106070555|NCT00378209|365921874|FG000|Overall Study|Physician Decision|3|||
106070556|NCT00378209|365921874|FG000|Overall Study|Death|1|||
106070557|NCT00378209|365921874|FG000|Overall Study|Treatment delay|1|||
106070558|NCT03313804|365921875|FG000|Treatment|Death|5|||
106070559|NCT03313804|365921875|FG000|Treatment|still on treatment|2|||
106070560|NCT03313804|365921875|FG000|Follow Up|still on follow up|3|||
106070561|NCT01502423|365921876|FG000|Overall Study|Withdrawal by Subject|0|||
106070562|NCT01502423|365921877|FG001|Overall Study|Withdrawal by Subject|1|||
106070563|NCT00415909|365923721|FG000|Overall Study|Withdrawal by Subject|2|||
106070564|NCT00415909|365923721|FG000|Overall Study|Death|1|||
105866089|NCT03713632|365159254|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
105866090|NCT03713632|365159255|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105866091|NCT03713632|365159256|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105866092|NCT03713632|365159257|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
105866093|NCT01098474|365159267|FG000|Active Phase|Other|0|||
106070565|NCT00312494|365923722|FG000|Overall Study|Randomized; not treated with study drug|9|||
106070566|NCT00312494|365923723|FG001|Overall Study|Randomized; not treated with study drug|10|||
106070567|NCT00312494|365923724|FG002|Overall Study|Randomized; not treated with study drug|5|||
106070568|NCT00312494|365923722|FG000|Overall Study|Adverse Event|33|||
106070569|NCT00312494|365923723|FG001|Overall Study|Adverse Event|15|||
106070570|NCT00312494|365923724|FG002|Overall Study|Adverse Event|11|||
106070571|NCT00312494|365923722|FG000|Overall Study|Lack of Efficacy|4|||
106155805|NCT00220740|366231376|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
106155806|NCT05268302|366231377|FG000|Overall Study|Death|0|||
106155807|NCT05268302|366231378|FG001|Overall Study|Death|1|||
106155808|NCT02516241|366231379|FG000|Overall Study|Death|255|||
106155809|NCT02516241|366231380|FG001|Overall Study|Death|262|||
106155810|NCT02516241|366231381|FG002|Overall Study|Death|270|||
106155811|NCT02516241|366231379|FG000|Overall Study|Lost to Follow-up|1|||
106155812|NCT02516241|366231380|FG001|Overall Study|Lost to Follow-up|1|||
106155813|NCT02516241|366231381|FG002|Overall Study|Lost to Follow-up|3|||
106155814|NCT02516241|366231379|FG000|Overall Study|Withdrawal by Subject|2|||
106155815|NCT02516241|366231380|FG001|Overall Study|Withdrawal by Subject|7|||
106155816|NCT02516241|366231381|FG002|Overall Study|Withdrawal by Subject|12|||
106155817|NCT02516241|366231379|FG000|Overall Study|participants ongoing at data cut-off|84|||
106155818|NCT02516241|366231380|FG001|Overall Study|participants ongoing at data cut-off|76|||
106155819|NCT02516241|366231381|FG002|Overall Study|participants ongoing at data cut-off|59|||
106155820|NCT05792423|366231387|FG000|Overall Study|Withdrawal by Subject|2|||
106155821|NCT02471638|366231388|FG000|Overall Study|Early Term Withdrawal|10|||
106155822|NCT03651895|366232756|FG000|First Drug Assignment|Adverse Event|4|||
106155823|NCT03651895|366232757|FG001|First Drug Assignment|Adverse Event|5|||
106155824|NCT03651895|366232756|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
106155825|NCT03651895|366232757|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
106155826|NCT02525692|366232761|FG000|Overall Study|Withdrawal by Subject|1|||
106155827|NCT02525692|366232762|FG001|Overall Study|Withdrawal by Subject|1|||
106155828|NCT02525692|366232763|FG002|Overall Study|Withdrawal by Subject|0|||
106155829|NCT02525692|366232764|FG003|Overall Study|Withdrawal by Subject|5|||
106155830|NCT02525692|366232765|FG004|Overall Study|Withdrawal by Subject|0|||
106155831|NCT02525692|366232766|FG005|Overall Study|Withdrawal by Subject|1|||
106155832|NCT02525692|366232761|FG000|Overall Study|Death|16|||
106155833|NCT02525692|366232762|FG001|Overall Study|Death|18|||
106155834|NCT02525692|366232763|FG002|Overall Study|Death|7|||
106155835|NCT02525692|366232764|FG003|Overall Study|Death|20|||
106155836|NCT02525692|366232765|FG004|Overall Study|Death|3|||
106155837|NCT02525692|366232766|FG005|Overall Study|Death|6|||
106155838|NCT02525692|366232761|FG000|Overall Study|Lost to Follow-up|0|||
106155839|NCT02525692|366232762|FG001|Overall Study|Lost to Follow-up|0|||
106155840|NCT02525692|366232763|FG002|Overall Study|Lost to Follow-up|1|||
106155841|NCT02525692|366232764|FG003|Overall Study|Lost to Follow-up|5|||
106155842|NCT02525692|366232765|FG004|Overall Study|Lost to Follow-up|0|||
106155843|NCT02525692|366232766|FG005|Overall Study|Lost to Follow-up|0|||
106155844|NCT04052516|366232767|FG000|Overall Study|Withdrawal by Subject|4|||
106155845|NCT04052516|366232768|FG001|Overall Study|Withdrawal by Subject|5|||
106155846|NCT04052516|366232769|FG002|Overall Study|Withdrawal by Subject|6|||
106155847|NCT04052516|366232767|FG000|Overall Study|Adverse Event|3|||
106155848|NCT04052516|366232768|FG001|Overall Study|Adverse Event|2|||
106155849|NCT04052516|366232769|FG002|Overall Study|Adverse Event|8|||
106155850|NCT04052516|366232767|FG000|Overall Study|Lost to Follow-up|2|||
106155851|NCT04052516|366232768|FG001|Overall Study|Lost to Follow-up|5|||
106155852|NCT04052516|366232769|FG002|Overall Study|Lost to Follow-up|3|||
106155853|NCT04052516|366232767|FG000|Overall Study|Protocol Violation|1|||
106155854|NCT04052516|366232768|FG001|Overall Study|Protocol Violation|1|||
106155855|NCT04052516|366232769|FG002|Overall Study|Protocol Violation|0|||
106155856|NCT04052516|366232767|FG000|Overall Study|Death|1|||
106155857|NCT04052516|366232768|FG001|Overall Study|Death|0|||
106155858|NCT04052516|366232769|FG002|Overall Study|Death|0|||
106155859|NCT04052516|366232767|FG000|Overall Study|Physician Decision|0|||
106155860|NCT04052516|366232768|FG001|Overall Study|Physician Decision|1|||
106155861|NCT04052516|366232769|FG002|Overall Study|Physician Decision|0|||
106155862|NCT04052516|366232767|FG000|Overall Study|Pregnancy|1|||
106155863|NCT04052516|366232768|FG001|Overall Study|Pregnancy|0|||
106155864|NCT04052516|366232769|FG002|Overall Study|Pregnancy|0|||
106155865|NCT04052516|366232767|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
106155866|NCT04052516|366232768|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
106155867|NCT04052516|366232769|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
106155868|NCT04052516|366232767|FG000|Overall Study|Reason not recorded|0|||
106155869|NCT04052516|366232768|FG001|Overall Study|Reason not recorded|1|||
106155870|NCT04052516|366232769|FG002|Overall Study|Reason not recorded|0|||
106155871|NCT03819686|366232770|FG000|Overall Study|Lost to Follow-up|2|||
106155872|NCT03819686|366232771|FG001|Overall Study|Lost to Follow-up|3|||
106155873|NCT03157167|366232772|FG000|Overall Study|Withdrawal by Subject|1|||
106155874|NCT03157167|366232773|FG001|Overall Study|Withdrawal by Subject|0|||
106155875|NCT03157167|366232774|FG002|Overall Study|Withdrawal by Subject|0|||
106155876|NCT02597946|366232779|FG000|Overall Study|Withdrawal by Subject|1|||
106155877|NCT02597946|366232779|FG000|Overall Study|Progressive disease|16|||
106155878|NCT02597946|366232779|FG000|Overall Study|Other than above|1|||
106155879|NCT04521478|366232783|FG000|Overall Study|Protocol Violation|2|||
106155880|NCT04521478|366232784|FG001|Overall Study|Protocol Violation|0|||
106155881|NCT04521478|366232785|FG002|Overall Study|Protocol Violation|1|||
106155882|NCT04521478|366232786|FG003|Overall Study|Protocol Violation|0|||
106155883|NCT04521478|366232787|FG004|Overall Study|Protocol Violation|0|||
106155884|NCT04521478|366232788|FG005|Overall Study|Protocol Violation|0|||
106155885|NCT04521478|366232783|FG000|Overall Study|Technical Problems|0|||
106155886|NCT04521478|366232784|FG001|Overall Study|Technical Problems|0|||
106155887|NCT04521478|366232785|FG002|Overall Study|Technical Problems|0|||
106155888|NCT04521478|366232786|FG003|Overall Study|Technical Problems|1|||
106155889|NCT04521478|366232787|FG004|Overall Study|Technical Problems|0|||
106155890|NCT04521478|366232788|FG005|Overall Study|Technical Problems|0|||
106155891|NCT04521478|366232783|FG000|Overall Study|Burden of Study Procedures|1|||
106155892|NCT04521478|366232784|FG001|Overall Study|Burden of Study Procedures|0|||
106155893|NCT04521478|366232785|FG002|Overall Study|Burden of Study Procedures|0|||
106155894|NCT04521478|366232786|FG003|Overall Study|Burden of Study Procedures|1|||
106155895|NCT04521478|366232787|FG004|Overall Study|Burden of Study Procedures|0|||
106155896|NCT04521478|366232788|FG005|Overall Study|Burden of Study Procedures|1|||
106155897|NCT04521478|366232783|FG000|Overall Study|Lack of Efficacy|0|||
106155898|NCT04521478|366232784|FG001|Overall Study|Lack of Efficacy|0|||
106155899|NCT04521478|366232785|FG002|Overall Study|Lack of Efficacy|0|||
106155900|NCT04521478|366232786|FG003|Overall Study|Lack of Efficacy|0|||
106155901|NCT04521478|366232787|FG004|Overall Study|Lack of Efficacy|1|||
106155902|NCT04521478|366232788|FG005|Overall Study|Lack of Efficacy|1|||
106155903|NCT04521478|366232783|FG000|Overall Study|Adverse Event|7|||
106155904|NCT04521478|366232784|FG001|Overall Study|Adverse Event|0|||
106155905|NCT04521478|366232785|FG002|Overall Study|Adverse Event|2|||
106155906|NCT04521478|366232786|FG003|Overall Study|Adverse Event|1|||
106155907|NCT04521478|366232787|FG004|Overall Study|Adverse Event|2|||
106155908|NCT04521478|366232788|FG005|Overall Study|Adverse Event|7|||
106155909|NCT04521478|366232783|FG000|Overall Study|No Reason Available|0|||
106155910|NCT04521478|366232784|FG001|Overall Study|No Reason Available|2|||
106155911|NCT04521478|366232785|FG002|Overall Study|No Reason Available|0|||
106155912|NCT04521478|366232786|FG003|Overall Study|No Reason Available|0|||
106155913|NCT04521478|366232787|FG004|Overall Study|No Reason Available|1|||
106155914|NCT04521478|366232788|FG005|Overall Study|No Reason Available|0|||
106155915|NCT04521478|366232783|FG000|Overall Study|Other than listed|3|||
106155916|NCT04521478|366232784|FG001|Overall Study|Other than listed|3|||
106155917|NCT04521478|366232785|FG002|Overall Study|Other than listed|3|||
106155918|NCT04521478|366232786|FG003|Overall Study|Other than listed|2|||
106155919|NCT04521478|366232787|FG004|Overall Study|Other than listed|3|||
106155920|NCT04521478|366232788|FG005|Overall Study|Other than listed|3|||
106155921|NCT04521478|366232783|FG000|Overall Study|Not treated|0|||
106155922|NCT04521478|366232784|FG001|Overall Study|Not treated|0|||
106155923|NCT04521478|366232785|FG002|Overall Study|Not treated|0|||
106155924|NCT04521478|366232786|FG003|Overall Study|Not treated|0|||
106155925|NCT04521478|366232787|FG004|Overall Study|Not treated|0|||
106155926|NCT04521478|366232788|FG005|Overall Study|Not treated|1|||
106155927|NCT03625882|366232789|FG000|Overall Study|Protocol Violation|3|||
106155928|NCT01938547|366232790|FG000|Overall Study|Physician Decision|1|||
106155929|NCT02840474|366232794|FG000|Overall Study|Lost to Follow-up|1|||
106155930|NCT02840474|366232795|FG001|Overall Study|Lost to Follow-up|0|||
106155931|NCT01757665|366232796|FG000|Overall Study|Still on Study - Visit Completed|240|||
106155932|NCT01757665|366232797|FG001|Overall Study|Still on Study - Visit Completed|30|||
106155933|NCT01757665|366232796|FG000|Overall Study|Still on Study - Visit Pending|398|||
106155934|NCT01757665|366232797|FG001|Overall Study|Still on Study - Visit Pending|40|||
106155935|NCT01757665|366232796|FG000|Overall Study|Still on Study - Missed Visit|14|||
106155936|NCT01757665|366232797|FG001|Overall Study|Still on Study - Missed Visit|1|||
106155937|NCT01757665|366232796|FG000|Overall Study|Death|25|||
106155938|NCT01757665|366232797|FG001|Overall Study|Death|8|||
106155939|NCT01757665|366232796|FG000|Overall Study|Explant|1|||
106155940|NCT01757665|366232797|FG001|Overall Study|Explant|2|||
106155941|NCT01757665|366232796|FG000|Overall Study|Withdrawal by Subject|10|||
106155942|NCT01757665|366232797|FG001|Overall Study|Withdrawal by Subject|0|||
106155943|NCT01757665|366232796|FG000|Overall Study|Lost to Follow-up|1|||
106155944|NCT01757665|366232797|FG001|Overall Study|Lost to Follow-up|1|||
106155945|NCT01757665|366232796|FG000|Overall Study|Not Implanted with Device|5|||
106155946|NCT01757665|366232797|FG001|Overall Study|Not Implanted with Device|1|||
106155947|NCT05816551|366232800|FG000|Overall Study|Withdrawal by Subject|0|||
106155948|NCT05816551|366232801|FG001|Overall Study|Withdrawal by Subject|1|||
106155949|NCT05816551|366232800|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
106155950|NCT05816551|366232801|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
106155951|NCT04419168|366232802|FG000|Overall Study|Protocol Violation|1|||
106155952|NCT04419168|366232803|FG001|Overall Study|Protocol Violation|1|||
106155953|NCT04419168|366232802|FG000|Overall Study|Lost to Follow-up|7|||
106155954|NCT04419168|366232803|FG001|Overall Study|Lost to Follow-up|7|||
106155955|NCT04419168|366232802|FG000|Overall Study|Missed 6-month Visit|48|||
106155956|NCT04419168|366232803|FG001|Overall Study|Missed 6-month Visit|45|||
106155957|NCT03113500|366232806|FG000|Overall Study|Withdrawal by Subject|1|||
106155958|NCT06311084|366232808|FG000|Overall Study|Lost to Follow-up|14|||
106155959|NCT02312960|366232813|FG000|Overall Study|Death|24|||
106155960|NCT02312960|366232814|FG001|Overall Study|Death|32|||
106155961|NCT02312960|366232815|FG002|Overall Study|Death|25|||
106155962|NCT02312960|366232816|FG003|Overall Study|Death|11|||
106155963|NCT02312960|366232817|FG004|Overall Study|Death|5|||
106155964|NCT02312960|366232818|FG005|Overall Study|Death|5|||
106155965|NCT02312960|366232819|FG006|Overall Study|Death|8|||
106155966|NCT02312960|366232820|FG007|Overall Study|Death|5|||
106155967|NCT02312960|366232821|FG008|Overall Study|Death|7|||
106155968|NCT02312960|366232822|FG009|Overall Study|Death|3|||
106155969|NCT02312960|366232823|FG010|Overall Study|Death|3|||
106155970|NCT02312960|366232824|FG011|Overall Study|Death|1|||
106155971|NCT02312960|366232825|FG012|Overall Study|Death|25|||
106155972|NCT02312960|366232826|FG013|Overall Study|Death|19|||
106155973|NCT02312960|366232813|FG000|Overall Study|Missing|0|||
106155974|NCT02312960|366232814|FG001|Overall Study|Missing|0|||
106155975|NCT02312960|366232815|FG002|Overall Study|Missing|2|||
106155976|NCT02312960|366232816|FG003|Overall Study|Missing|0|||
106155977|NCT02312960|366232817|FG004|Overall Study|Missing|0|||
106155978|NCT02312960|366232818|FG005|Overall Study|Missing|0|||
106155979|NCT02312960|366232819|FG006|Overall Study|Missing|0|||
106155980|NCT02312960|366232820|FG007|Overall Study|Missing|0|||
106155981|NCT02312960|366232821|FG008|Overall Study|Missing|0|||
106155982|NCT02312960|366232822|FG009|Overall Study|Missing|0|||
106155983|NCT02312960|366232823|FG010|Overall Study|Missing|0|||
105866094|NCT01098474|365159268|FG001|Active Phase|Other|0|||
106070572|NCT00312494|365923723|FG001|Overall Study|Lack of Efficacy|6|||
106070573|NCT00312494|365923724|FG002|Overall Study|Lack of Efficacy|8|||
106070574|NCT00312494|365923722|FG000|Overall Study|Laboratory abnormality|1|||
106070575|NCT00312494|365923723|FG001|Overall Study|Laboratory abnormality|0|||
106070576|NCT00312494|365923724|FG002|Overall Study|Laboratory abnormality|0|||
106070577|NCT00312494|365923722|FG000|Overall Study|Lost to Follow-up|8|||
106070578|NCT00312494|365923723|FG001|Overall Study|Lost to Follow-up|8|||
106070579|NCT00312494|365923724|FG002|Overall Study|Lost to Follow-up|8|||
106070580|NCT00312494|365923722|FG000|Overall Study|Withdrawal by Subject|6|||
106070581|NCT00312494|365923723|FG001|Overall Study|Withdrawal by Subject|9|||
106070582|NCT00312494|365923724|FG002|Overall Study|Withdrawal by Subject|10|||
106070583|NCT00312494|365923722|FG000|Overall Study|Other|10|||
106070584|NCT00312494|365923723|FG001|Overall Study|Other|10|||
106070585|NCT00312494|365923724|FG002|Overall Study|Other|1|||
106070586|NCT00702403|365923725|FG000|From Consent to Engraftment|Progressive leukemia|6|||
106070587|NCT00702403|365923725|FG000|From Consent to Engraftment|Critically ill|2|||
106070588|NCT00702403|365923725|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
106070589|NCT00702403|365923725|FG000|From Consent to Engraftment|Myocardial infarction|1|||
106070590|NCT00702403|365923725|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
106070591|NCT00702403|365923725|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
106070592|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
106070593|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
106070594|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Non-compliance|2|||
106070595|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
106070596|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
106070597|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Suicide|1|||
106070598|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
106070599|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
106070600|NCT00702403|365923725|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
106070601|NCT00858442|365923726|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
106070602|NCT00858442|365923727|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
106070603|NCT02016625|365923730|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
106070604|NCT02016625|365923731|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
106070605|NCT02016625|365923730|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
106070606|NCT02016625|365923731|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
106070607|NCT02016625|365923730|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
106070608|NCT02016625|365923731|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
106070609|NCT01729754|365923732|FG000|Part 1|Adverse Event|2|||
106070610|NCT01729754|365923733|FG001|Part 1|Adverse Event|0|||
106070611|NCT01729754|365923734|FG002|Part 1|Adverse Event|0|||
106070612|NCT01729754|365923735|FG003|Part 1|Adverse Event|1|||
106155984|NCT02312960|366232824|FG011|Overall Study|Missing|0|||
106155985|NCT02312960|366232825|FG012|Overall Study|Missing|0|||
106155986|NCT02312960|366232826|FG013|Overall Study|Missing|0|||
106155987|NCT02312960|366232813|FG000|Overall Study|Lost to Follow-up|0|||
106155988|NCT02312960|366232814|FG001|Overall Study|Lost to Follow-up|0|||
106155989|NCT02312960|366232815|FG002|Overall Study|Lost to Follow-up|1|||
106155990|NCT02312960|366232816|FG003|Overall Study|Lost to Follow-up|0|||
106155991|NCT02312960|366232817|FG004|Overall Study|Lost to Follow-up|0|||
106070613|NCT01729754|365923736|FG004|Part 1|Adverse Event|0|||
106070614|NCT01729754|365923737|FG005|Part 1|Adverse Event|0|||
106070615|NCT01729754|365923738|FG006|Part 1|Adverse Event|2|||
106070616|NCT01729754|365923739|FG007|Part 1|Adverse Event|0|||
106070617|NCT01729754|365923740|FG008|Part 1|Adverse Event|0|||
106070618|NCT01729754|365923741|FG009|Part 1|Adverse Event|5|||
106070619|NCT01729754|365923732|FG000|Part 1|Lack of Efficacy|1|||
106070620|NCT01729754|365923733|FG001|Part 1|Lack of Efficacy|0|||
106070621|NCT01729754|365923734|FG002|Part 1|Lack of Efficacy|0|||
106070622|NCT01729754|365923735|FG003|Part 1|Lack of Efficacy|0|||
106070623|NCT01729754|365923736|FG004|Part 1|Lack of Efficacy|0|||
106070624|NCT01729754|365923737|FG005|Part 1|Lack of Efficacy|0|||
106070625|NCT01729754|365923738|FG006|Part 1|Lack of Efficacy|2|||
106070626|NCT01729754|365923739|FG007|Part 1|Lack of Efficacy|0|||
106070627|NCT01729754|365923740|FG008|Part 1|Lack of Efficacy|0|||
106070628|NCT01729754|365923741|FG009|Part 1|Lack of Efficacy|0|||
106070629|NCT01729754|365923732|FG000|Part 1|Lost to Follow-up|1|||
106070630|NCT01729754|365923733|FG001|Part 1|Lost to Follow-up|0|||
106070631|NCT01729754|365923734|FG002|Part 1|Lost to Follow-up|0|||
106070632|NCT01729754|365923735|FG003|Part 1|Lost to Follow-up|2|||
106070633|NCT01729754|365923736|FG004|Part 1|Lost to Follow-up|0|||
106070634|NCT01729754|365923737|FG005|Part 1|Lost to Follow-up|0|||
106070635|NCT01729754|365923738|FG006|Part 1|Lost to Follow-up|3|||
106070636|NCT01729754|365923739|FG007|Part 1|Lost to Follow-up|0|||
106070637|NCT01729754|365923740|FG008|Part 1|Lost to Follow-up|0|||
106070638|NCT01729754|365923741|FG009|Part 1|Lost to Follow-up|3|||
106070639|NCT01729754|365923732|FG000|Part 1|Non-compliance with Study Drug|1|||
106070640|NCT01729754|365923733|FG001|Part 1|Non-compliance with Study Drug|0|||
106070641|NCT01729754|365923734|FG002|Part 1|Non-compliance with Study Drug|0|||
106070642|NCT01729754|365923735|FG003|Part 1|Non-compliance with Study Drug|0|||
106070643|NCT01729754|365923736|FG004|Part 1|Non-compliance with Study Drug|0|||
106070644|NCT01729754|365923737|FG005|Part 1|Non-compliance with Study Drug|0|||
106070645|NCT01729754|365923738|FG006|Part 1|Non-compliance with Study Drug|0|||
106070646|NCT01729754|365923739|FG007|Part 1|Non-compliance with Study Drug|0|||
106070647|NCT01729754|365923740|FG008|Part 1|Non-compliance with Study Drug|0|||
106070648|NCT01729754|365923741|FG009|Part 1|Non-compliance with Study Drug|0|||
106070649|NCT01729754|365923732|FG000|Part 1|Physician Decision|0|||
106070650|NCT01729754|365923733|FG001|Part 1|Physician Decision|0|||
106070651|NCT01729754|365923734|FG002|Part 1|Physician Decision|0|||
106070652|NCT01729754|365923735|FG003|Part 1|Physician Decision|0|||
106070653|NCT01729754|365923736|FG004|Part 1|Physician Decision|0|||
106070654|NCT01729754|365923737|FG005|Part 1|Physician Decision|0|||
106070655|NCT01729754|365923738|FG006|Part 1|Physician Decision|0|||
106070656|NCT01729754|365923739|FG007|Part 1|Physician Decision|0|||
106070657|NCT01729754|365923740|FG008|Part 1|Physician Decision|0|||
106070658|NCT01729754|365923741|FG009|Part 1|Physician Decision|4|||
106070659|NCT01729754|365923732|FG000|Part 1|Pregnancy|0|||
106070660|NCT01729754|365923733|FG001|Part 1|Pregnancy|0|||
106070661|NCT01729754|365923734|FG002|Part 1|Pregnancy|0|||
106070662|NCT01729754|365923735|FG003|Part 1|Pregnancy|1|||
106070663|NCT01729754|365923736|FG004|Part 1|Pregnancy|0|||
106070664|NCT01729754|365923737|FG005|Part 1|Pregnancy|0|||
106070665|NCT01729754|365923738|FG006|Part 1|Pregnancy|0|||
106070666|NCT01729754|365923739|FG007|Part 1|Pregnancy|0|||
106070667|NCT01729754|365923740|FG008|Part 1|Pregnancy|0|||
106070668|NCT01729754|365923741|FG009|Part 1|Pregnancy|1|||
106070669|NCT01729754|365923732|FG000|Part 1|Progressive Disease|0|||
106070670|NCT01729754|365923733|FG001|Part 1|Progressive Disease|0|||
106070671|NCT01729754|365923734|FG002|Part 1|Progressive Disease|0|||
106070672|NCT01729754|365923735|FG003|Part 1|Progressive Disease|0|||
106070673|NCT01729754|365923736|FG004|Part 1|Progressive Disease|0|||
106070674|NCT01729754|365923737|FG005|Part 1|Progressive Disease|0|||
106070675|NCT01729754|365923738|FG006|Part 1|Progressive Disease|0|||
106070676|NCT01729754|365923739|FG007|Part 1|Progressive Disease|0|||
106070677|NCT01729754|365923740|FG008|Part 1|Progressive Disease|0|||
106070678|NCT01729754|365923741|FG009|Part 1|Progressive Disease|1|||
106070679|NCT01729754|365923732|FG000|Part 1|Protocol Violation|2|||
106070680|NCT01729754|365923733|FG001|Part 1|Protocol Violation|0|||
106070681|NCT01729754|365923734|FG002|Part 1|Protocol Violation|0|||
106070682|NCT01729754|365923735|FG003|Part 1|Protocol Violation|1|||
106070683|NCT01729754|365923736|FG004|Part 1|Protocol Violation|0|||
106070684|NCT01729754|365923737|FG005|Part 1|Protocol Violation|0|||
106070685|NCT01729754|365923738|FG006|Part 1|Protocol Violation|1|||
106070686|NCT01729754|365923739|FG007|Part 1|Protocol Violation|0|||
106070687|NCT01729754|365923740|FG008|Part 1|Protocol Violation|0|||
106070688|NCT01729754|365923741|FG009|Part 1|Protocol Violation|0|||
106070689|NCT01729754|365923732|FG000|Part 1|Withdrawal by Subject|5|||
106070690|NCT01729754|365923733|FG001|Part 1|Withdrawal by Subject|0|||
106070691|NCT01729754|365923734|FG002|Part 1|Withdrawal by Subject|0|||
106070692|NCT01729754|365923735|FG003|Part 1|Withdrawal by Subject|7|||
106070693|NCT01729754|365923736|FG004|Part 1|Withdrawal by Subject|0|||
106070694|NCT01729754|365923737|FG005|Part 1|Withdrawal by Subject|0|||
106070695|NCT01729754|365923738|FG006|Part 1|Withdrawal by Subject|5|||
106070696|NCT01729754|365923739|FG007|Part 1|Withdrawal by Subject|0|||
106070697|NCT01729754|365923740|FG008|Part 1|Withdrawal by Subject|0|||
106070698|NCT01729754|365923741|FG009|Part 1|Withdrawal by Subject|6|||
106070699|NCT01729754|365923732|FG000|Part 1|Other Protocol Specified Criteria|2|||
106070700|NCT01729754|365923733|FG001|Part 1|Other Protocol Specified Criteria|0|||
106070701|NCT01729754|365923734|FG002|Part 1|Other Protocol Specified Criteria|0|||
106070702|NCT01729754|365923735|FG003|Part 1|Other Protocol Specified Criteria|0|||
106070703|NCT01729754|365923736|FG004|Part 1|Other Protocol Specified Criteria|0|||
106070704|NCT01729754|365923737|FG005|Part 1|Other Protocol Specified Criteria|0|||
106070705|NCT01729754|365923738|FG006|Part 1|Other Protocol Specified Criteria|1|||
106070706|NCT01729754|365923739|FG007|Part 1|Other Protocol Specified Criteria|0|||
106070707|NCT01729754|365923740|FG008|Part 1|Other Protocol Specified Criteria|0|||
106070708|NCT01729754|365923741|FG009|Part 1|Other Protocol Specified Criteria|4|||
106070709|NCT01729754|365923732|FG000|Part 2|Adverse Event|2|||
106070710|NCT01729754|365923733|FG001|Part 2|Adverse Event|0|||
106070711|NCT01729754|365923734|FG002|Part 2|Adverse Event|0|||
106070712|NCT01729754|365923735|FG003|Part 2|Adverse Event|0|||
106070713|NCT01729754|365923736|FG004|Part 2|Adverse Event|0|||
106070714|NCT01729754|365923737|FG005|Part 2|Adverse Event|0|||
106070715|NCT01729754|365923738|FG006|Part 2|Adverse Event|0|||
106070716|NCT01729754|365923739|FG007|Part 2|Adverse Event|0|||
106070717|NCT01729754|365923740|FG008|Part 2|Adverse Event|1|||
106070718|NCT01729754|365923741|FG009|Part 2|Adverse Event|2|||
106070719|NCT01729754|365923732|FG000|Part 2|Lack of Efficacy|0|||
106070720|NCT01729754|365923733|FG001|Part 2|Lack of Efficacy|0|||
106070721|NCT01729754|365923734|FG002|Part 2|Lack of Efficacy|0|||
106070722|NCT01729754|365923735|FG003|Part 2|Lack of Efficacy|0|||
106070723|NCT01729754|365923736|FG004|Part 2|Lack of Efficacy|0|||
106070724|NCT01729754|365923737|FG005|Part 2|Lack of Efficacy|0|||
106070725|NCT01729754|365923738|FG006|Part 2|Lack of Efficacy|0|||
106070726|NCT01729754|365923739|FG007|Part 2|Lack of Efficacy|0|||
106070727|NCT01729754|365923740|FG008|Part 2|Lack of Efficacy|2|||
106070728|NCT01729754|365923741|FG009|Part 2|Lack of Efficacy|2|||
106070729|NCT01729754|365923732|FG000|Part 2|Lost to Follow-up|0|||
106070730|NCT01729754|365923733|FG001|Part 2|Lost to Follow-up|0|||
106070731|NCT01729754|365923734|FG002|Part 2|Lost to Follow-up|0|||
106070732|NCT01729754|365923735|FG003|Part 2|Lost to Follow-up|2|||
106070733|NCT01729754|365923736|FG004|Part 2|Lost to Follow-up|0|||
106070734|NCT01729754|365923737|FG005|Part 2|Lost to Follow-up|0|||
106070735|NCT01729754|365923738|FG006|Part 2|Lost to Follow-up|0|||
106070736|NCT01729754|365923739|FG007|Part 2|Lost to Follow-up|1|||
106070737|NCT01729754|365923740|FG008|Part 2|Lost to Follow-up|0|||
106070738|NCT01729754|365923741|FG009|Part 2|Lost to Follow-up|2|||
106070739|NCT01729754|365923732|FG000|Part 2|Non-Compliance with Study Drug|0|||
106070740|NCT01729754|365923733|FG001|Part 2|Non-Compliance with Study Drug|0|||
106070741|NCT01729754|365923734|FG002|Part 2|Non-Compliance with Study Drug|0|||
106070742|NCT01729754|365923735|FG003|Part 2|Non-Compliance with Study Drug|0|||
106070743|NCT01729754|365923736|FG004|Part 2|Non-Compliance with Study Drug|0|||
106070744|NCT01729754|365923737|FG005|Part 2|Non-Compliance with Study Drug|0|||
106070745|NCT01729754|365923738|FG006|Part 2|Non-Compliance with Study Drug|0|||
106070746|NCT01729754|365923739|FG007|Part 2|Non-Compliance with Study Drug|0|||
106070747|NCT01729754|365923740|FG008|Part 2|Non-Compliance with Study Drug|0|||
106070748|NCT01729754|365923741|FG009|Part 2|Non-Compliance with Study Drug|1|||
106070749|NCT01729754|365923732|FG000|Part 2|Pregnancy|0|||
106070750|NCT01729754|365923733|FG001|Part 2|Pregnancy|0|||
106070751|NCT01729754|365923734|FG002|Part 2|Pregnancy|0|||
106070752|NCT01729754|365923735|FG003|Part 2|Pregnancy|1|||
106070753|NCT01729754|365923736|FG004|Part 2|Pregnancy|0|||
106070754|NCT01729754|365923737|FG005|Part 2|Pregnancy|0|||
106070755|NCT01729754|365923738|FG006|Part 2|Pregnancy|0|||
106070756|NCT01729754|365923739|FG007|Part 2|Pregnancy|0|||
106070757|NCT01729754|365923740|FG008|Part 2|Pregnancy|0|||
106070758|NCT01729754|365923741|FG009|Part 2|Pregnancy|1|||
106070759|NCT01729754|365923732|FG000|Part 2|Withdrawal by Subject|3|||
106070760|NCT01729754|365923733|FG001|Part 2|Withdrawal by Subject|0|||
106070761|NCT01729754|365923734|FG002|Part 2|Withdrawal by Subject|0|||
106070762|NCT01729754|365923735|FG003|Part 2|Withdrawal by Subject|2|||
106070763|NCT01729754|365923736|FG004|Part 2|Withdrawal by Subject|0|||
106070764|NCT01729754|365923737|FG005|Part 2|Withdrawal by Subject|0|||
106070765|NCT01729754|365923738|FG006|Part 2|Withdrawal by Subject|0|||
106070766|NCT01729754|365923739|FG007|Part 2|Withdrawal by Subject|1|||
106070767|NCT01729754|365923740|FG008|Part 2|Withdrawal by Subject|1|||
106070768|NCT01729754|365923741|FG009|Part 2|Withdrawal by Subject|4|||
106070769|NCT01729754|365923732|FG000|Part 2|Other Protocol Specified Criteria|1|||
106070770|NCT01729754|365923733|FG001|Part 2|Other Protocol Specified Criteria|0|||
106070771|NCT01729754|365923734|FG002|Part 2|Other Protocol Specified Criteria|0|||
106070772|NCT01729754|365923735|FG003|Part 2|Other Protocol Specified Criteria|0|||
106070773|NCT01729754|365923736|FG004|Part 2|Other Protocol Specified Criteria|0|||
106070774|NCT01729754|365923737|FG005|Part 2|Other Protocol Specified Criteria|0|||
106070775|NCT01729754|365923738|FG006|Part 2|Other Protocol Specified Criteria|0|||
106070776|NCT01729754|365923739|FG007|Part 2|Other Protocol Specified Criteria|1|||
106070777|NCT01729754|365923740|FG008|Part 2|Other Protocol Specified Criteria|0|||
106070778|NCT01729754|365923741|FG009|Part 2|Other Protocol Specified Criteria|0|||
106070779|NCT01729754|365923732|FG000|Part 3|Adverse Event|0|||
106070780|NCT01729754|365923733|FG001|Part 3|Adverse Event|0|||
106070781|NCT01729754|365923734|FG002|Part 3|Adverse Event|1|||
106070782|NCT01729754|365923735|FG003|Part 3|Adverse Event|0|||
106070783|NCT01729754|365923736|FG004|Part 3|Adverse Event|0|||
106070784|NCT01729754|365923737|FG005|Part 3|Adverse Event|5|||
106070785|NCT01729754|365923738|FG006|Part 3|Adverse Event|0|||
106070786|NCT01729754|365923739|FG007|Part 3|Adverse Event|0|||
106070787|NCT01729754|365923740|FG008|Part 3|Adverse Event|0|||
106070788|NCT01729754|365923741|FG009|Part 3|Adverse Event|3|||
106070789|NCT01729754|365923732|FG000|Part 3|Death|0|||
106070790|NCT01729754|365923733|FG001|Part 3|Death|0|||
106070791|NCT01729754|365923734|FG002|Part 3|Death|0|||
106070792|NCT01729754|365923735|FG003|Part 3|Death|0|||
106070793|NCT01729754|365923736|FG004|Part 3|Death|0|||
106070794|NCT01729754|365923737|FG005|Part 3|Death|2|||
106070795|NCT01729754|365923738|FG006|Part 3|Death|0|||
106070796|NCT01729754|365923739|FG007|Part 3|Death|0|||
106070797|NCT01729754|365923740|FG008|Part 3|Death|0|||
106070798|NCT01729754|365923741|FG009|Part 3|Death|0|||
106070799|NCT01729754|365923732|FG000|Part 3|Lack of Efficacy|0|||
106070800|NCT01729754|365923733|FG001|Part 3|Lack of Efficacy|0|||
106070801|NCT01729754|365923734|FG002|Part 3|Lack of Efficacy|0|||
106070802|NCT01729754|365923735|FG003|Part 3|Lack of Efficacy|0|||
106070803|NCT01729754|365923736|FG004|Part 3|Lack of Efficacy|2|||
106070804|NCT01729754|365923737|FG005|Part 3|Lack of Efficacy|0|||
106070805|NCT01729754|365923738|FG006|Part 3|Lack of Efficacy|0|||
106070806|NCT01729754|365923739|FG007|Part 3|Lack of Efficacy|0|||
106070807|NCT01729754|365923740|FG008|Part 3|Lack of Efficacy|0|||
106070808|NCT01729754|365923741|FG009|Part 3|Lack of Efficacy|4|||
106070809|NCT01729754|365923732|FG000|Part 3|Lost to Follow-up|0|||
106070810|NCT01729754|365923733|FG001|Part 3|Lost to Follow-up|1|||
106070811|NCT01729754|365923734|FG002|Part 3|Lost to Follow-up|2|||
106070812|NCT01729754|365923735|FG003|Part 3|Lost to Follow-up|0|||
106070813|NCT01729754|365923736|FG004|Part 3|Lost to Follow-up|0|||
106070814|NCT01729754|365923737|FG005|Part 3|Lost to Follow-up|3|||
106070815|NCT01729754|365923738|FG006|Part 3|Lost to Follow-up|0|||
106070816|NCT01729754|365923739|FG007|Part 3|Lost to Follow-up|0|||
106070817|NCT01729754|365923740|FG008|Part 3|Lost to Follow-up|1|||
106070818|NCT01729754|365923741|FG009|Part 3|Lost to Follow-up|0|||
106070819|NCT01729754|365923732|FG000|Part 3|Physician Decision|0|||
106070820|NCT01729754|365923733|FG001|Part 3|Physician Decision|0|||
106155992|NCT02312960|366232818|FG005|Overall Study|Lost to Follow-up|0|||
106155993|NCT02312960|366232819|FG006|Overall Study|Lost to Follow-up|1|||
106155994|NCT02312960|366232820|FG007|Overall Study|Lost to Follow-up|1|||
106155995|NCT02312960|366232821|FG008|Overall Study|Lost to Follow-up|0|||
106155996|NCT02312960|366232822|FG009|Overall Study|Lost to Follow-up|1|||
106155997|NCT02312960|366232823|FG010|Overall Study|Lost to Follow-up|0|||
106155998|NCT02312960|366232824|FG011|Overall Study|Lost to Follow-up|0|||
106155999|NCT02312960|366232825|FG012|Overall Study|Lost to Follow-up|1|||
106156000|NCT02312960|366232826|FG013|Overall Study|Lost to Follow-up|0|||
106156001|NCT02312960|366232813|FG000|Overall Study|Withdrawal by Subject|1|||
106156002|NCT02312960|366232814|FG001|Overall Study|Withdrawal by Subject|2|||
106156003|NCT02312960|366232815|FG002|Overall Study|Withdrawal by Subject|0|||
106156004|NCT02312960|366232816|FG003|Overall Study|Withdrawal by Subject|0|||
106156005|NCT02312960|366232817|FG004|Overall Study|Withdrawal by Subject|1|||
106156006|NCT02312960|366232818|FG005|Overall Study|Withdrawal by Subject|0|||
106156007|NCT02312960|366232819|FG006|Overall Study|Withdrawal by Subject|1|||
106156008|NCT02312960|366232820|FG007|Overall Study|Withdrawal by Subject|2|||
106156009|NCT02312960|366232821|FG008|Overall Study|Withdrawal by Subject|2|||
106156010|NCT02312960|366232822|FG009|Overall Study|Withdrawal by Subject|3|||
105866095|NCT01098474|365159269|FG002|Active Phase|Other|3|||
105866096|NCT01098474|365159270|FG003|Active Phase|Other|0|||
105866097|NCT01098474|365159271|FG004|Active Phase|Other|0|||
105866098|NCT01098474|365159272|FG005|Active Phase|Other|0|||
105866099|NCT01098474|365159267|FG000|Active Phase|Withdrawal by Subject|1|||
105866100|NCT01098474|365159268|FG001|Active Phase|Withdrawal by Subject|1|||
105866101|NCT01098474|365159269|FG002|Active Phase|Withdrawal by Subject|2|||
105866102|NCT01098474|365159270|FG003|Active Phase|Withdrawal by Subject|0|||
105866103|NCT01098474|365159271|FG004|Active Phase|Withdrawal by Subject|0|||
105866104|NCT01098474|365159272|FG005|Active Phase|Withdrawal by Subject|0|||
106070821|NCT01729754|365923734|FG002|Part 3|Physician Decision|1|||
106070822|NCT01729754|365923735|FG003|Part 3|Physician Decision|0|||
106070823|NCT01729754|365923736|FG004|Part 3|Physician Decision|0|||
106070824|NCT01729754|365923737|FG005|Part 3|Physician Decision|0|||
106070825|NCT01729754|365923738|FG006|Part 3|Physician Decision|0|||
106070826|NCT01729754|365923739|FG007|Part 3|Physician Decision|0|||
106070827|NCT01729754|365923740|FG008|Part 3|Physician Decision|0|||
106070828|NCT01729754|365923741|FG009|Part 3|Physician Decision|0|||
105866105|NCT01098474|365159267|FG000|Active Phase|Lost to Follow-up|1|||
105866106|NCT01098474|365159268|FG001|Active Phase|Lost to Follow-up|0|||
105866107|NCT01098474|365159269|FG002|Active Phase|Lost to Follow-up|0|||
106070829|NCT01729754|365923732|FG000|Part 3|Withdrawal by Subject|0|||
106070830|NCT01729754|365923733|FG001|Part 3|Withdrawal by Subject|4|||
106070831|NCT01729754|365923734|FG002|Part 3|Withdrawal by Subject|1|||
106070832|NCT01729754|365923735|FG003|Part 3|Withdrawal by Subject|0|||
106070833|NCT01729754|365923736|FG004|Part 3|Withdrawal by Subject|2|||
106070834|NCT01729754|365923737|FG005|Part 3|Withdrawal by Subject|1|||
105866108|NCT01098474|365159270|FG003|Active Phase|Lost to Follow-up|0|||
106070835|NCT01729754|365923738|FG006|Part 3|Withdrawal by Subject|0|||
106070836|NCT01729754|365923739|FG007|Part 3|Withdrawal by Subject|2|||
106070837|NCT01729754|365923740|FG008|Part 3|Withdrawal by Subject|0|||
106070838|NCT01729754|365923741|FG009|Part 3|Withdrawal by Subject|0|||
106070839|NCT01729754|365923732|FG000|Part 3|Other Protocol Specified Criteria|0|||
106070840|NCT01729754|365923733|FG001|Part 3|Other Protocol Specified Criteria|0|||
106070841|NCT01729754|365923734|FG002|Part 3|Other Protocol Specified Criteria|0|||
106070842|NCT01729754|365923735|FG003|Part 3|Other Protocol Specified Criteria|0|||
106070843|NCT01729754|365923736|FG004|Part 3|Other Protocol Specified Criteria|0|||
106070844|NCT01729754|365923737|FG005|Part 3|Other Protocol Specified Criteria|2|||
106070845|NCT01729754|365923738|FG006|Part 3|Other Protocol Specified Criteria|0|||
106070846|NCT01729754|365923739|FG007|Part 3|Other Protocol Specified Criteria|1|||
106070847|NCT01729754|365923740|FG008|Part 3|Other Protocol Specified Criteria|0|||
106070848|NCT01729754|365923741|FG009|Part 3|Other Protocol Specified Criteria|0|||
106070849|NCT00773292|365923742|FG000|Treatment 48 Weeks|Adverse Event|1|||
106070850|NCT00773292|365923742|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
106070851|NCT02385266|365923743|FG000|Overall Study|Withdrawal by Subject|1|||
106070852|NCT02385266|365923744|FG001|Overall Study|Withdrawal by Subject|3|||
106070853|NCT01851720|365923745|FG000|Overall Study|Lost to Follow-up|0|||
106070854|NCT01851720|365923746|FG001|Overall Study|Lost to Follow-up|1|||
106070855|NCT01327300|365923747|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
106070856|NCT01327300|365923748|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
106070857|NCT02082210|365923750|FG000|Overall Study|Death|0|||
106070858|NCT02082210|365923751|FG001|Overall Study|Death|0|||
106070859|NCT02082210|365923752|FG002|Overall Study|Death|1|||
106070860|NCT02082210|365923753|FG003|Overall Study|Death|1|||
106070861|NCT02082210|365923754|FG004|Overall Study|Death|1|||
106070862|NCT02082210|365923755|FG005|Overall Study|Death|0|||
106070863|NCT02082210|365923750|FG000|Overall Study|Withdrawal by Subject|0|||
106070864|NCT02082210|365923751|FG001|Overall Study|Withdrawal by Subject|0|||
106070865|NCT02082210|365923752|FG002|Overall Study|Withdrawal by Subject|0|||
106070866|NCT02082210|365923753|FG003|Overall Study|Withdrawal by Subject|1|||
106070867|NCT02082210|365923754|FG004|Overall Study|Withdrawal by Subject|2|||
106070868|NCT02082210|365923755|FG005|Overall Study|Withdrawal by Subject|2|||
106070869|NCT02082210|365923750|FG000|Overall Study|Clinical Progression|0|||
106070870|NCT02082210|365923751|FG001|Overall Study|Clinical Progression|0|||
106070871|NCT02082210|365923752|FG002|Overall Study|Clinical Progression|0|||
106070872|NCT02082210|365923753|FG003|Overall Study|Clinical Progression|1|||
106070873|NCT02082210|365923754|FG004|Overall Study|Clinical Progression|0|||
106070874|NCT02082210|365923755|FG005|Overall Study|Clinical Progression|0|||
106070875|NCT02082210|365923750|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
106070876|NCT02082210|365923751|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
106070877|NCT02082210|365923752|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
106070878|NCT02082210|365923753|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
106070879|NCT02082210|365923754|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
106070880|NCT02082210|365923755|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
106156011|NCT02312960|366232823|FG010|Overall Study|Withdrawal by Subject|0|||
106156012|NCT02312960|366232824|FG011|Overall Study|Withdrawal by Subject|0|||
106156013|NCT02312960|366232825|FG012|Overall Study|Withdrawal by Subject|2|||
106156014|NCT02312960|366232826|FG013|Overall Study|Withdrawal by Subject|0|||
106156015|NCT04820855|366232827|FG000|Overall Study|Lost to Follow-up|6|||
106156016|NCT04820855|366232828|FG001|Overall Study|Lost to Follow-up|9|||
106156017|NCT02437318|366232829|FG000|Overall Study|Progressive disease|207|||
106156018|NCT02437318|366232830|FG001|Overall Study|Progressive disease|240|||
106156019|NCT02437318|366232829|FG000|Overall Study|Subject/guardian decision|24|||
106156020|NCT02437318|366232830|FG001|Overall Study|Subject/guardian decision|11|||
106156021|NCT02437318|366232829|FG000|Overall Study|Physician Decision|29|||
106156022|NCT02437318|366232830|FG001|Overall Study|Physician Decision|22|||
106156023|NCT02437318|366232829|FG000|Overall Study|Adverse Event|14|||
105866109|NCT01098474|365159271|FG004|Active Phase|Lost to Follow-up|0|||
105866110|NCT01098474|365159272|FG005|Active Phase|Lost to Follow-up|0|||
106070881|NCT02082210|365923750|FG000|Overall Study|Physician Decision|0|||
106070882|NCT02082210|365923751|FG001|Overall Study|Physician Decision|0|||
106070883|NCT02082210|365923752|FG002|Overall Study|Physician Decision|1|||
106070884|NCT02082210|365923753|FG003|Overall Study|Physician Decision|1|||
106070885|NCT02082210|365923754|FG004|Overall Study|Physician Decision|0|||
106070886|NCT02082210|365923755|FG005|Overall Study|Physician Decision|0|||
106070887|NCT02419742|365923760|FG000|Overall Study|Adverse Event|2|||
106070888|NCT02419742|365923761|FG001|Overall Study|Adverse Event|0|||
106070889|NCT02419742|365923760|FG000|Overall Study|Disease Progression|0|||
106070890|NCT02419742|365923761|FG001|Overall Study|Disease Progression|1|||
106070891|NCT02419742|365923760|FG000|Overall Study|Withdrew Consent|2|||
106070892|NCT02419742|365923761|FG001|Overall Study|Withdrew Consent|1|||
106070893|NCT02419742|365923760|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
106156024|NCT02437318|366232830|FG001|Overall Study|Adverse Event|4|||
106156025|NCT02437318|366232829|FG000|Overall Study|Death|4|||
105866111|NCT01098474|365159267|FG000|Follow Up Phase|Travelled out of study area|0|||
105866112|NCT01098474|365159268|FG001|Follow Up Phase|Travelled out of study area|0|||
105866113|NCT01098474|365159269|FG002|Follow Up Phase|Travelled out of study area|0|||
105866114|NCT01098474|365159270|FG003|Follow Up Phase|Travelled out of study area|0|||
105866115|NCT01098474|365159271|FG004|Follow Up Phase|Travelled out of study area|1|||
105866116|NCT01098474|365159272|FG005|Follow Up Phase|Travelled out of study area|0|||
105866117|NCT01098474|365159267|FG000|Follow Up Phase|Other|0|||
105866118|NCT01098474|365159268|FG001|Follow Up Phase|Other|0|||
106070894|NCT02419742|365923761|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
106070895|NCT02672423|365923762|FG000|Period 1|Adverse Event|0|||
106070896|NCT02672423|365923763|FG001|Period 1|Adverse Event|0|||
106070897|NCT02672423|365923764|FG002|Period 1|Adverse Event|0|||
106070898|NCT02672423|365923765|FG003|Period 1|Adverse Event|0|||
106070899|NCT02672423|365923766|FG004|Period 1|Adverse Event|1|||
106070900|NCT02672423|365923767|FG005|Period 1|Adverse Event|0|||
106070901|NCT02672423|365923768|FG006|Period 1|Adverse Event|0|||
106070902|NCT02672423|365923769|FG007|Period 1|Adverse Event|0|||
106070903|NCT02672423|365923770|FG008|Period 1|Adverse Event|0|||
106070904|NCT02672423|365923771|FG009|Period 1|Adverse Event|0|||
106070905|NCT02672423|365923762|FG000|Period 2|Withdrawal by Subject|0|||
106070906|NCT02672423|365923763|FG001|Period 2|Withdrawal by Subject|0|||
106070907|NCT02672423|365923764|FG002|Period 2|Withdrawal by Subject|1|||
106070908|NCT02672423|365923765|FG003|Period 2|Withdrawal by Subject|0|||
106070909|NCT02672423|365923766|FG004|Period 2|Withdrawal by Subject|0|||
106070910|NCT02672423|365923767|FG005|Period 2|Withdrawal by Subject|0|||
106070911|NCT02672423|365923768|FG006|Period 2|Withdrawal by Subject|0|||
106070912|NCT02672423|365923769|FG007|Period 2|Withdrawal by Subject|0|||
106070913|NCT02672423|365923770|FG008|Period 2|Withdrawal by Subject|0|||
106070914|NCT02672423|365923771|FG009|Period 2|Withdrawal by Subject|0|||
106070915|NCT02672423|365923762|FG000|Period 3|Withdrawal by Subject|0|||
106070916|NCT02672423|365923763|FG001|Period 3|Withdrawal by Subject|0|||
106070917|NCT02672423|365923764|FG002|Period 3|Withdrawal by Subject|0|||
106070918|NCT02672423|365923765|FG003|Period 3|Withdrawal by Subject|0|||
106070919|NCT02672423|365923766|FG004|Period 3|Withdrawal by Subject|0|||
106070920|NCT02672423|365923767|FG005|Period 3|Withdrawal by Subject|0|||
106070921|NCT02672423|365923768|FG006|Period 3|Withdrawal by Subject|0|||
106070922|NCT02672423|365923769|FG007|Period 3|Withdrawal by Subject|1|||
106070923|NCT02672423|365923770|FG008|Period 3|Withdrawal by Subject|0|||
106070924|NCT02672423|365923771|FG009|Period 3|Withdrawal by Subject|0|||
106070925|NCT02672423|365923762|FG000|Period 3|Physician Decision|0|||
106070926|NCT02672423|365923763|FG001|Period 3|Physician Decision|0|||
106070927|NCT02672423|365923764|FG002|Period 3|Physician Decision|0|||
106070928|NCT02672423|365923765|FG003|Period 3|Physician Decision|0|||
106070929|NCT02672423|365923766|FG004|Period 3|Physician Decision|0|||
106070930|NCT02672423|365923767|FG005|Period 3|Physician Decision|1|||
106070931|NCT02672423|365923768|FG006|Period 3|Physician Decision|0|||
106070932|NCT02672423|365923769|FG007|Period 3|Physician Decision|0|||
106070933|NCT02672423|365923770|FG008|Period 3|Physician Decision|0|||
106070934|NCT02672423|365923771|FG009|Period 3|Physician Decision|0|||
106070935|NCT01046682|365923773|FG000|Overall Study|Adverse Event|2|||
106070936|NCT01046682|365923774|FG001|Overall Study|Adverse Event|0|||
106070937|NCT02864251|365923778|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
106070938|NCT02864251|365923779|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
106070939|NCT02864251|365923780|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
106070940|NCT02864251|365923778|FG000|Pre-Treatment|Withdrawal by Participant|0|||
106070941|NCT02864251|365923779|FG001|Pre-Treatment|Withdrawal by Participant|0|||
106070942|NCT02864251|365923780|FG002|Pre-Treatment|Withdrawal by Participant|4|||
106070943|NCT02864251|365923778|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
106070944|NCT02864251|365923779|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
106070945|NCT02864251|365923780|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
106070946|NCT02864251|365923778|FG000|Pre-Treatment|Other Reasons|0|||
106070947|NCT02864251|365923779|FG001|Pre-Treatment|Other Reasons|1|||
105866119|NCT01098474|365159269|FG002|Follow Up Phase|Other|0|||
105866120|NCT01098474|365159270|FG003|Follow Up Phase|Other|0|||
105866121|NCT01098474|365159271|FG004|Follow Up Phase|Other|0|||
106070948|NCT02864251|365923780|FG002|Pre-Treatment|Other Reasons|1|||
106070949|NCT02864251|365923778|FG000|Treatment|Disease Progression|109|||
105866122|NCT01098474|365159272|FG005|Follow Up Phase|Other|4|||
105866123|NCT01098474|365159267|FG000|Follow Up Phase|Withdrawal by Subject|0|||
106070950|NCT02864251|365923779|FG001|Treatment|Disease Progression|52|||
106070951|NCT02864251|365923780|FG002|Treatment|Disease Progression|101|||
106070952|NCT02864251|365923778|FG000|Treatment|Study Drug Toxicity|9|||
106070953|NCT02864251|365923779|FG001|Treatment|Study Drug Toxicity|4|||
106070954|NCT02864251|365923780|FG002|Treatment|Study Drug Toxicity|10|||
106070955|NCT02864251|365923778|FG000|Treatment|Death|0|||
106070956|NCT02864251|365923779|FG001|Treatment|Death|2|||
106070957|NCT02864251|365923780|FG002|Treatment|Death|3|||
106070958|NCT02864251|365923778|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
106070959|NCT02864251|365923779|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
106156026|NCT02437318|366232830|FG001|Overall Study|Death|4|||
106156027|NCT02437318|366232829|FG000|Overall Study|Protocol deviation|5|||
106156028|NCT02437318|366232830|FG001|Overall Study|Protocol deviation|7|||
106156029|NCT02437318|366232829|FG000|Overall Study|Sponsor decision|1|||
106156030|NCT02437318|366232830|FG001|Overall Study|Sponsor decision|0|||
106156031|NCT03526861|366232831|FG000|Initial Treatment Period|Not dosed|1|||
106156032|NCT03526861|366232832|FG001|Initial Treatment Period|Not dosed|1|||
106156033|NCT03526861|366232833|FG002|Initial Treatment Period|Not dosed|1|||
106156034|NCT03526861|366232834|FG003|Initial Treatment Period|Not dosed|0|||
106156035|NCT03526861|366232835|FG004|Initial Treatment Period|Not dosed|0|||
106156036|NCT03526861|366232836|FG005|Initial Treatment Period|Not dosed|0|||
106156037|NCT03526861|366232837|FG006|Initial Treatment Period|Not dosed|0|||
106156038|NCT03526861|366232838|FG007|Initial Treatment Period|Not dosed|0|||
106156039|NCT03526861|366232839|FG008|Initial Treatment Period|Not dosed|0|||
106156040|NCT03526861|366232831|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
106156041|NCT03526861|366232832|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
106156042|NCT03526861|366232833|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
106156043|NCT03526861|366232834|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156044|NCT03526861|366232835|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156045|NCT03526861|366232836|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156046|NCT03526861|366232837|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156047|NCT03526861|366232838|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156048|NCT03526861|366232839|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156049|NCT03526861|366232831|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
106156050|NCT03526861|366232832|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
106156051|NCT03526861|366232833|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
106156052|NCT03526861|366232834|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
106156053|NCT03526861|366232835|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
106156054|NCT03526861|366232836|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
106156055|NCT03526861|366232837|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
106156056|NCT03526861|366232838|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
106156057|NCT03526861|366232839|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
106156058|NCT03526861|366232831|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156059|NCT03526861|366232832|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156060|NCT03526861|366232833|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156061|NCT03526861|366232834|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
106156062|NCT03526861|366232835|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
106156063|NCT03526861|366232836|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156064|NCT03526861|366232837|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
106156065|NCT03526861|366232838|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156066|NCT03526861|366232839|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156067|NCT03526861|366232831|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
106156068|NCT03526861|366232832|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
106156069|NCT03526861|366232833|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
106156070|NCT03526861|366232834|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
106156071|NCT03526861|366232835|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
106156072|NCT03526861|366232836|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
106156073|NCT03526861|366232837|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
106156074|NCT03526861|366232838|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
106156075|NCT03526861|366232839|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
106156076|NCT03526861|366232831|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156077|NCT03526861|366232832|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156078|NCT03526861|366232833|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156079|NCT03526861|366232834|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
105866124|NCT01098474|365159268|FG001|Follow Up Phase|Withdrawal by Subject|0|||
105866125|NCT01098474|365159269|FG002|Follow Up Phase|Withdrawal by Subject|0|||
105866126|NCT01098474|365159270|FG003|Follow Up Phase|Withdrawal by Subject|2|||
105866127|NCT01098474|365159271|FG004|Follow Up Phase|Withdrawal by Subject|0|||
105866128|NCT01098474|365159272|FG005|Follow Up Phase|Withdrawal by Subject|1|||
105866129|NCT01098474|365159267|FG000|Follow Up Phase|Lost to Follow-up|0|||
105866130|NCT01098474|365159268|FG001|Follow Up Phase|Lost to Follow-up|0|||
105866131|NCT01098474|365159269|FG002|Follow Up Phase|Lost to Follow-up|0|||
105866132|NCT01098474|365159270|FG003|Follow Up Phase|Lost to Follow-up|0|||
105866133|NCT01098474|365159271|FG004|Follow Up Phase|Lost to Follow-up|1|||
105866134|NCT01098474|365159272|FG005|Follow Up Phase|Lost to Follow-up|0|||
105866135|NCT02685735|365159278|FG000|Overall Study|Missing construct or pain data|23|||
105866136|NCT02685735|365159279|FG001|Overall Study|Missing construct or pain data|22|||
105866137|NCT02165735|365159280|FG000|Overall Study|Lost to Follow-up|12|||
105866138|NCT02165735|365159281|FG001|Overall Study|Lost to Follow-up|10|||
105866139|NCT02165735|365159280|FG000|Overall Study|Withdrawal by Subject|3|||
105866140|NCT02165735|365159281|FG001|Overall Study|Withdrawal by Subject|0|||
106156080|NCT03526861|366232835|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156081|NCT03526861|366232836|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156082|NCT03526861|366232837|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156083|NCT03526861|366232838|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156084|NCT03526861|366232839|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156085|NCT03526861|366232831|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156086|NCT03526861|366232832|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156087|NCT03526861|366232833|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156088|NCT03526861|366232834|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
105866141|NCT02165735|365159280|FG000|Overall Study|Participant indicated lack of time|1|||
105866142|NCT02165735|365159281|FG001|Overall Study|Participant indicated lack of time|3|||
105866143|NCT02165735|365159280|FG000|Overall Study|Protocol Violation|0|||
105866144|NCT02165735|365159281|FG001|Overall Study|Protocol Violation|1|||
105866145|NCT02540083|365159282|FG000|Overall Study|Withdrawal by Subject|16|||
105866146|NCT01994850|365159291|FG000|Overall Study|Physician Decision|1|||
106070960|NCT02864251|365923780|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
106070961|NCT02864251|365923778|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
106070962|NCT02864251|365923779|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
106070963|NCT02864251|365923780|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
106070964|NCT02864251|365923778|FG000|Treatment|Withdrawal by Participant|8|||
106070965|NCT02864251|365923779|FG001|Treatment|Withdrawal by Participant|5|||
106070966|NCT02864251|365923780|FG002|Treatment|Withdrawal by Participant|13|||
106070967|NCT02864251|365923778|FG000|Treatment|Maximum Clinical Benefit|1|||
106070968|NCT02864251|365923779|FG001|Treatment|Maximum Clinical Benefit|0|||
106070969|NCT02864251|365923780|FG002|Treatment|Maximum Clinical Benefit|1|||
106070970|NCT02864251|365923778|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
106070971|NCT02864251|365923779|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
106070972|NCT02864251|365923780|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
106070973|NCT02864251|365923778|FG000|Treatment|Other Reasons|1|||
106070974|NCT02864251|365923779|FG001|Treatment|Other Reasons|1|||
106070975|NCT02864251|365923780|FG002|Treatment|Other Reasons|4|||
106070976|NCT02864251|365923778|FG000|Treatment|Administrative Reason by Sponsor|1|||
106070977|NCT02864251|365923779|FG001|Treatment|Administrative Reason by Sponsor|0|||
106070978|NCT02864251|365923780|FG002|Treatment|Administrative Reason by Sponsor|0|||
106070979|NCT01514760|365923781|FG000|Overall Study|Lost to Follow-up|2|||
106070980|NCT02092662|365923782|FG000|Overall Study|Lost to Follow-up|13|||
106070981|NCT02092662|365923783|FG001|Overall Study|Lost to Follow-up|0|||
106070982|NCT00772707|365923784|FG000|Overall Study|Withdrawn|3|||
106070983|NCT00885755|365923788|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
106070984|NCT00885755|365923789|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
106070985|NCT00885755|365923790|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
106070986|NCT00885755|365923788|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
106070987|NCT00885755|365923789|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
106070988|NCT00885755|365923790|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
106070989|NCT00885755|365923788|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
105866147|NCT01994850|365159291|FG000|Overall Study|Withdrawal by Subject|1|||
105866148|NCT02481869|365159292|FG000|Overall Study|Lost to Follow-up|3|||
105866149|NCT02481869|365159293|FG001|Overall Study|Lost to Follow-up|4|||
105866150|NCT02481869|365159292|FG000|Overall Study|Withdrawal by Subject|2|||
106070990|NCT00885755|365923789|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
106070991|NCT00885755|365923790|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
106070992|NCT00885755|365923788|FG000|Part I: Trastuzumab+Taxane|Death|0|||
106070993|NCT00885755|365923789|FG001|Part I: Trastuzumab+Taxane|Death|0|||
106070994|NCT00885755|365923790|FG002|Part I: Trastuzumab+Taxane|Death|1|||
106070995|NCT00885755|365923788|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
106070996|NCT00885755|365923789|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
106070997|NCT00885755|365923790|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
106070998|NCT03338062|365923791|FG000|Overall Study|Alternative Therapy|1|||
106070999|NCT03338062|365923792|FG001|Overall Study|Alternative Therapy|0|||
106071000|NCT01265849|365923793|FG000|Overall Study|Randomized//Treatment not initiated|1|||
106071001|NCT01265849|365923794|FG001|Overall Study|Randomized//Treatment not initiated|4|||
106071002|NCT01265849|365923795|FG002|Overall Study|Randomized//Treatment not initiated|0|||
106071003|NCT01265849|365923793|FG000|Overall Study|Physician Decision|1|||
106071004|NCT01265849|365923794|FG001|Overall Study|Physician Decision|2|||
106071005|NCT01265849|365923795|FG002|Overall Study|Physician Decision|0|||
106071006|NCT01265849|365923793|FG000|Overall Study|Lost to Follow-up|18|||
106071007|NCT01265849|365923794|FG001|Overall Study|Lost to Follow-up|15|||
106071008|NCT01265849|365923795|FG002|Overall Study|Lost to Follow-up|5|||
106071009|NCT01265849|365923793|FG000|Overall Study|Not otherwise specified|1|||
106071010|NCT01265849|365923794|FG001|Overall Study|Not otherwise specified|6|||
106071011|NCT01265849|365923795|FG002|Overall Study|Not otherwise specified|1|||
106071012|NCT01265849|365923793|FG000|Overall Study|Withdrawal by Subject|25|||
106071013|NCT01265849|365923794|FG001|Overall Study|Withdrawal by Subject|34|||
106071014|NCT01265849|365923795|FG002|Overall Study|Withdrawal by Subject|13|||
106071015|NCT03424265|365923796|FG000|Overall Study|screening failure|1|||
106071016|NCT03424265|365923797|FG001|Overall Study|screening failure|0|||
106071017|NCT03424265|365923796|FG000|Overall Study|Withdrawal by Subject|0|||
106071018|NCT03424265|365923797|FG001|Overall Study|Withdrawal by Subject|2|||
106071019|NCT00362115|365923798|FG000|Overall Study|Adverse Event|0|||
106071020|NCT00362115|365923799|FG001|Overall Study|Adverse Event|1|||
106071021|NCT00362115|365923800|FG002|Overall Study|Adverse Event|1|||
106071022|NCT00362115|365923801|FG003|Overall Study|Adverse Event|1|||
106071023|NCT00362115|365923802|FG004|Overall Study|Adverse Event|2|||
106071024|NCT00362115|365923803|FG005|Overall Study|Adverse Event|2|||
106071025|NCT00362115|365923804|FG006|Overall Study|Adverse Event|1|||
106071026|NCT00362115|365923798|FG000|Overall Study|Protocol Violation|0|||
106071027|NCT00362115|365923799|FG001|Overall Study|Protocol Violation|0|||
106071028|NCT00362115|365923800|FG002|Overall Study|Protocol Violation|0|||
106071029|NCT00362115|365923801|FG003|Overall Study|Protocol Violation|0|||
106071030|NCT00362115|365923802|FG004|Overall Study|Protocol Violation|0|||
106071031|NCT00362115|365923803|FG005|Overall Study|Protocol Violation|1|||
106071032|NCT00362115|365923804|FG006|Overall Study|Protocol Violation|0|||
106071033|NCT00362115|365923798|FG000|Overall Study|Lost to Follow-up|0|||
106071034|NCT00362115|365923799|FG001|Overall Study|Lost to Follow-up|1|||
106071035|NCT00362115|365923800|FG002|Overall Study|Lost to Follow-up|0|||
106071036|NCT00362115|365923801|FG003|Overall Study|Lost to Follow-up|0|||
106071037|NCT00362115|365923802|FG004|Overall Study|Lost to Follow-up|2|||
106071038|NCT00362115|365923803|FG005|Overall Study|Lost to Follow-up|0|||
106071039|NCT00362115|365923804|FG006|Overall Study|Lost to Follow-up|1|||
106071040|NCT00362115|365923798|FG000|Overall Study|Withdrawal by Subject|1|||
106071041|NCT00362115|365923799|FG001|Overall Study|Withdrawal by Subject|3|||
106071042|NCT00362115|365923800|FG002|Overall Study|Withdrawal by Subject|1|||
106071043|NCT00362115|365923801|FG003|Overall Study|Withdrawal by Subject|0|||
106071044|NCT00362115|365923802|FG004|Overall Study|Withdrawal by Subject|1|||
106071045|NCT00362115|365923803|FG005|Overall Study|Withdrawal by Subject|3|||
106071046|NCT00362115|365923804|FG006|Overall Study|Withdrawal by Subject|4|||
106071047|NCT00362115|365923798|FG000|Overall Study|Lack of Efficacy|1|||
106071048|NCT00362115|365923799|FG001|Overall Study|Lack of Efficacy|0|||
106071049|NCT00362115|365923800|FG002|Overall Study|Lack of Efficacy|5|||
106071050|NCT00362115|365923801|FG003|Overall Study|Lack of Efficacy|2|||
106071051|NCT00362115|365923802|FG004|Overall Study|Lack of Efficacy|2|||
106071052|NCT00362115|365923803|FG005|Overall Study|Lack of Efficacy|0|||
106071053|NCT00362115|365923804|FG006|Overall Study|Lack of Efficacy|3|||
106071054|NCT00362115|365923798|FG000|Overall Study|Physician Decision|0|||
106071055|NCT00362115|365923799|FG001|Overall Study|Physician Decision|0|||
106071056|NCT00362115|365923800|FG002|Overall Study|Physician Decision|0|||
105866151|NCT02481869|365159293|FG001|Overall Study|Withdrawal by Subject|0|||
105866152|NCT05445492|365159297|FG000|Overall Study|Physician Decision|1|||
105866153|NCT03348163|365159301|FG000|Overall Study|Withdrawal by Subject|2|||
105866154|NCT03348163|365159302|FG001|Overall Study|Withdrawal by Subject|0|||
106071057|NCT00362115|365923801|FG003|Overall Study|Physician Decision|0|||
106071058|NCT00362115|365923802|FG004|Overall Study|Physician Decision|0|||
106071059|NCT00362115|365923803|FG005|Overall Study|Physician Decision|0|||
106071060|NCT00362115|365923804|FG006|Overall Study|Physician Decision|3|||
106071061|NCT00362115|365923798|FG000|Overall Study|Other|0|||
106071062|NCT00362115|365923799|FG001|Overall Study|Other|1|||
106071063|NCT00362115|365923800|FG002|Overall Study|Other|0|||
106071064|NCT00362115|365923801|FG003|Overall Study|Other|1|||
106071065|NCT00362115|365923802|FG004|Overall Study|Other|0|||
106071066|NCT00362115|365923803|FG005|Overall Study|Other|1|||
106071067|NCT00362115|365923804|FG006|Overall Study|Other|0|||
106071068|NCT02188589|365923805|FG000|Overall Study|Withdrawal by Subject|5|||
106071069|NCT00975481|365923815|FG000|Second Intervention Period|Adverse Event|2|||
106071070|NCT00975481|365923816|FG001|Second Intervention Period|Adverse Event|1|||
106071071|NCT00975481|365923817|FG002|Second Intervention Period|Adverse Event|0|||
106071072|NCT00975481|365923818|FG003|Second Intervention Period|Adverse Event|0|||
106071073|NCT00975481|365923819|FG004|Second Intervention Period|Adverse Event|0|||
106071074|NCT00975481|365923820|FG005|Second Intervention Period|Adverse Event|0|||
106071075|NCT00975481|365923815|FG000|Second Intervention Period|Withdrawal by Subject|0|||
106071076|NCT00975481|365923816|FG001|Second Intervention Period|Withdrawal by Subject|0|||
106071077|NCT00975481|365923817|FG002|Second Intervention Period|Withdrawal by Subject|1|||
106071078|NCT00975481|365923818|FG003|Second Intervention Period|Withdrawal by Subject|0|||
106071079|NCT00975481|365923819|FG004|Second Intervention Period|Withdrawal by Subject|0|||
106071080|NCT00975481|365923820|FG005|Second Intervention Period|Withdrawal by Subject|0|||
106071081|NCT00975481|365923815|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
106071082|NCT00975481|365923816|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
106071083|NCT00975481|365923817|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
106071084|NCT00975481|365923818|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
106071085|NCT00975481|365923819|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
106071086|NCT00975481|365923820|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
106071087|NCT00975481|365923815|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
106071088|NCT00975481|365923816|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
106071089|NCT00975481|365923817|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
106071090|NCT00975481|365923818|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
106071091|NCT00975481|365923819|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
106071092|NCT00975481|365923820|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
106071093|NCT00643682|365923821|FG000|Overall Study|did not keep appointment|522|||
106071094|NCT00643682|365923822|FG001|Overall Study|did not keep appointment|509|||
106071095|NCT01408030|365923824|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
106071096|NCT01408030|365923825|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
106071097|NCT01408030|365923826|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
106071098|NCT01408030|365923827|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
106071099|NCT01408030|365923824|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
106071100|NCT01408030|365923825|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
106071101|NCT01408030|365923826|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
106071102|NCT01408030|365923827|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
106071103|NCT01408030|365923824|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
106071104|NCT01408030|365923825|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
106071105|NCT01408030|365923826|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
106071106|NCT01408030|365923827|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
106071107|NCT01408030|365923824|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
106071108|NCT01408030|365923825|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
106071109|NCT01408030|365923826|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
106071110|NCT01408030|365923827|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
106071111|NCT01408030|365923824|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
106071112|NCT01408030|365923825|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
106071113|NCT01408030|365923826|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
106071114|NCT01408030|365923827|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
106071115|NCT01408030|365923824|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
106071116|NCT01408030|365923825|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
106071117|NCT01408030|365923826|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
106071118|NCT01408030|365923827|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
106071119|NCT01408030|365923824|FG000|Observation Phase (Off Drug)|Other|1|||
106071120|NCT01408030|365923825|FG001|Observation Phase (Off Drug)|Other|1|||
106071121|NCT01408030|365923826|FG002|Observation Phase (Off Drug)|Other|1|||
106071122|NCT01408030|365923827|FG003|Observation Phase (Off Drug)|Other|1|||
106071123|NCT03755414|365923830|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
106071124|NCT03755414|365923831|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
106156089|NCT03526861|366232835|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156090|NCT03526861|366232836|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156091|NCT03526861|366232837|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156092|NCT03526861|366232838|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
106156093|NCT03526861|366232839|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
106156094|NCT03526861|366232831|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
106156095|NCT03526861|366232832|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
106156096|NCT03526861|366232833|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
106156097|NCT03526861|366232834|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
106156098|NCT03526861|366232835|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
106156099|NCT03526861|366232836|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
106156100|NCT03526861|366232837|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
106156101|NCT03526861|366232838|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
106156102|NCT03526861|366232839|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
106156103|NCT03526861|366232831|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156104|NCT03526861|366232832|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156105|NCT03526861|366232833|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156106|NCT03526861|366232834|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156107|NCT03526861|366232835|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156108|NCT03526861|366232836|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156109|NCT03526861|366232837|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156110|NCT03526861|366232838|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
106156111|NCT03526861|366232839|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
106156112|NCT03281291|366232840|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
106156113|NCT03281291|366232841|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
106156114|NCT03281291|366232842|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
106156115|NCT03281291|366232843|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
106156116|NCT03281291|366232844|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
106156117|NCT03281291|366232840|FG000|Overall Study|Protocol Deviation|2|||
106156118|NCT03281291|366232841|FG001|Overall Study|Protocol Deviation|0|||
106156119|NCT03281291|366232842|FG002|Overall Study|Protocol Deviation|1|||
106156120|NCT03281291|366232843|FG003|Overall Study|Protocol Deviation|2|||
106156121|NCT03281291|366232844|FG004|Overall Study|Protocol Deviation|1|||
106156122|NCT03281291|366232840|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
106156123|NCT03281291|366232841|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
106156124|NCT03281291|366232842|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
106156125|NCT03281291|366232843|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
106071125|NCT03755414|365923832|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
106071126|NCT03755414|365923830|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
106071127|NCT03755414|365923831|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
106071128|NCT03755414|365923832|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
106071129|NCT03755414|365923830|FG000|Overall Study|Non-compliance|0|||
106071130|NCT03755414|365923831|FG001|Overall Study|Non-compliance|1|||
106071131|NCT03755414|365923832|FG002|Overall Study|Non-compliance|0|||
106071132|NCT02153112|365923833|FG000|Overall Study|Adverse Event|0|||
106071133|NCT02153112|365923834|FG001|Overall Study|Adverse Event|0|||
106071134|NCT02153112|365923835|FG002|Overall Study|Adverse Event|1|||
106071135|NCT02153112|365923836|FG003|Overall Study|Adverse Event|0|||
106071136|NCT02153112|365923837|FG004|Overall Study|Adverse Event|0|||
106071137|NCT02153112|365923838|FG005|Overall Study|Adverse Event|0|||
106071138|NCT02153112|365923839|FG006|Overall Study|Adverse Event|0|||
106071139|NCT02153112|365923840|FG007|Overall Study|Adverse Event|0|||
106071140|NCT02153112|365923841|FG008|Overall Study|Adverse Event|0|||
106071141|NCT02153112|365923842|FG009|Overall Study|Adverse Event|0|||
106071142|NCT02153112|365923833|FG000|Overall Study|Lost to Follow-up|1|||
106071143|NCT02153112|365923834|FG001|Overall Study|Lost to Follow-up|1|||
106156126|NCT03281291|366232844|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
106156127|NCT03281291|366232840|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
106071144|NCT02153112|365923835|FG002|Overall Study|Lost to Follow-up|0|||
106071145|NCT02153112|365923836|FG003|Overall Study|Lost to Follow-up|0|||
106071146|NCT02153112|365923837|FG004|Overall Study|Lost to Follow-up|2|||
106071147|NCT02153112|365923838|FG005|Overall Study|Lost to Follow-up|1|||
106071148|NCT02153112|365923839|FG006|Overall Study|Lost to Follow-up|1|||
106071149|NCT02153112|365923840|FG007|Overall Study|Lost to Follow-up|0|||
106071150|NCT02153112|365923841|FG008|Overall Study|Lost to Follow-up|1|||
106071151|NCT02153112|365923842|FG009|Overall Study|Lost to Follow-up|1|||
106071152|NCT02153112|365923833|FG000|Overall Study|Withdrawal by Subject|3|||
106071153|NCT02153112|365923834|FG001|Overall Study|Withdrawal by Subject|1|||
106071154|NCT02153112|365923835|FG002|Overall Study|Withdrawal by Subject|2|||
106071155|NCT02153112|365923836|FG003|Overall Study|Withdrawal by Subject|2|||
106071156|NCT02153112|365923837|FG004|Overall Study|Withdrawal by Subject|1|||
106071157|NCT02153112|365923838|FG005|Overall Study|Withdrawal by Subject|1|||
106071158|NCT02153112|365923839|FG006|Overall Study|Withdrawal by Subject|7|||
106071159|NCT02153112|365923840|FG007|Overall Study|Withdrawal by Subject|2|||
106071160|NCT02153112|365923841|FG008|Overall Study|Withdrawal by Subject|13|||
106071161|NCT02153112|365923842|FG009|Overall Study|Withdrawal by Subject|12|||
106071162|NCT02153112|365923833|FG000|Overall Study|Reason not Specified|0|||
106071163|NCT02153112|365923834|FG001|Overall Study|Reason not Specified|0|||
106071164|NCT02153112|365923835|FG002|Overall Study|Reason not Specified|0|||
106071165|NCT02153112|365923836|FG003|Overall Study|Reason not Specified|0|||
106071166|NCT02153112|365923837|FG004|Overall Study|Reason not Specified|0|||
106071167|NCT02153112|365923838|FG005|Overall Study|Reason not Specified|0|||
106071168|NCT02153112|365923839|FG006|Overall Study|Reason not Specified|0|||
106071169|NCT02153112|365923840|FG007|Overall Study|Reason not Specified|0|||
106071170|NCT02153112|365923841|FG008|Overall Study|Reason not Specified|1|||
106071171|NCT02153112|365923842|FG009|Overall Study|Reason not Specified|1|||
106071172|NCT00561080|365923843|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
106071173|NCT00561080|365923844|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
106071174|NCT00561080|365923845|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
106071175|NCT00561080|365923843|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
106071176|NCT00561080|365923844|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
106071177|NCT00561080|365923845|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
106071178|NCT00561080|365923843|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
106071179|NCT00561080|365923844|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
106071180|NCT00561080|365923845|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
106071181|NCT00561080|365923843|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
106071182|NCT00561080|365923844|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
106071183|NCT00561080|365923845|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
106071184|NCT00561080|365923843|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
106071185|NCT00561080|365923844|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
106071186|NCT00561080|365923845|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
106071187|NCT00561080|365923843|FG000|Vaccination Period (up to Month 4)|Other|0|||
106071188|NCT00561080|365923844|FG001|Vaccination Period (up to Month 4)|Other|2|||
106071189|NCT00561080|365923845|FG002|Vaccination Period (up to Month 4)|Other|1|||
106071190|NCT00561080|365923843|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
106071191|NCT00561080|365923844|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
106071192|NCT00561080|365923845|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
106071193|NCT00561080|365923843|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
106071194|NCT00561080|365923844|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
106071195|NCT00561080|365923845|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
106071196|NCT00561080|365923843|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
106071197|NCT00561080|365923844|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
106071198|NCT00561080|365923845|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
106071199|NCT00561080|365923843|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
106156128|NCT03281291|366232841|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
106156129|NCT03281291|366232842|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
106156130|NCT03281291|366232843|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
105866155|NCT02756208|365159304|FG000|Overall Study|Withdrawal by Subject|1|||
105866156|NCT02756208|365159305|FG001|Overall Study|Withdrawal by Subject|0|||
106071200|NCT00561080|365923844|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
106071201|NCT00561080|365923845|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
106071202|NCT02154581|365923853|FG000|Overall Study|Lost to Follow-up|7|||
106071203|NCT02154581|365923854|FG001|Overall Study|Lost to Follow-up|8|||
106071204|NCT00741039|365923855|FG000|Overall Study|Patient non-compliance|2|||
106071205|NCT00741039|365923856|FG001|Overall Study|Patient non-compliance|0|||
106071206|NCT01288287|365923857|FG000|Overall Study|Lost to Follow-up|8|||
106071207|NCT01288287|365923857|FG000|Overall Study|Withdrawal by Subject|4|||
106156131|NCT03281291|366232844|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
106156132|NCT03281291|366232840|FG000|Overall Study|Lost to Follow-up|10|||
106156133|NCT03281291|366232841|FG001|Overall Study|Lost to Follow-up|10|||
106156134|NCT03281291|366232842|FG002|Overall Study|Lost to Follow-up|4|||
106156135|NCT03281291|366232843|FG003|Overall Study|Lost to Follow-up|6|||
106156136|NCT03281291|366232844|FG004|Overall Study|Lost to Follow-up|10|||
106156137|NCT03281291|366232840|FG000|Overall Study|Other|0|||
106156138|NCT03281291|366232841|FG001|Overall Study|Other|2|||
106156139|NCT03281291|366232842|FG002|Overall Study|Other|0|||
106156140|NCT03281291|366232843|FG003|Overall Study|Other|2|||
106156141|NCT03281291|366232844|FG004|Overall Study|Other|1|||
106156142|NCT01809691|366232845|FG000|Overall Study|Currently on Treatment|192|||
106156143|NCT01809691|366232846|FG001|Overall Study|Currently on Treatment|100|||
106156144|NCT01809691|366232845|FG000|Overall Study|No Protocol Treatment|10|||
106156145|NCT01809691|366232846|FG001|Overall Study|No Protocol Treatment|11|||
106156146|NCT01809691|366232845|FG000|Overall Study|Adverse Event|80|||
106156147|NCT01809691|366232846|FG001|Overall Study|Adverse Event|21|||
106156148|NCT01809691|366232845|FG000|Overall Study|Disease Progression|226|||
106156149|NCT01809691|366232846|FG001|Overall Study|Disease Progression|372|||
106156150|NCT01809691|366232845|FG000|Overall Study|Death|26|||
106156151|NCT01809691|366232846|FG001|Overall Study|Death|13|||
106156152|NCT01809691|366232845|FG000|Overall Study|Participant Refusal|70|||
106156153|NCT01809691|366232846|FG001|Overall Study|Participant Refusal|72|||
106156154|NCT01809691|366232845|FG000|Overall Study|Other, Not Specified|34|||
106156155|NCT01809691|366232846|FG001|Overall Study|Other, Not Specified|52|||
106156156|NCT03385629|366232847|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
106156157|NCT03385629|366232848|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
106156158|NCT03385629|366232847|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
106156159|NCT03385629|366232848|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
106156160|NCT03385629|366232847|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
106156161|NCT03385629|366232848|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
106156162|NCT03978871|366232850|FG000|Overall Study|Lost to Follow-up|11|||
106156163|NCT03978871|366232851|FG001|Overall Study|Lost to Follow-up|12|||
106156164|NCT04854096|366232855|FG000|Overall Study|Adverse Event|1|||
106156165|NCT04854096|366232856|FG001|Overall Study|Adverse Event|0|||
106156166|NCT04854096|366232855|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
106156167|NCT04854096|366232856|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
106156168|NCT04854096|366232855|FG000|Overall Study|Withdrawal by Subject|1|||
106156169|NCT04854096|366232856|FG001|Overall Study|Withdrawal by Subject|0|||
106156170|NCT04854096|366232855|FG000|Overall Study|Other reasons|1|||
106156171|NCT04854096|366232856|FG001|Overall Study|Other reasons|0|||
106156172|NCT02596126|366232857|FG000|Overall Study|Lost to Follow-up|12|||
106156173|NCT02596126|366232858|FG001|Overall Study|Lost to Follow-up|21|||
106156174|NCT02596126|366232857|FG000|Overall Study|Protocol Violation|7|||
106156175|NCT02596126|366232858|FG001|Overall Study|Protocol Violation|9|||
106156176|NCT02349412|366234139|FG000|Overall Study|Withdrawal by Subject|7|||
106156177|NCT02349412|366234140|FG001|Overall Study|Withdrawal by Subject|7|||
106156178|NCT03940703|366234143|FG000|Overall Study|Still under treatment|31|||
106156179|NCT03940703|366234144|FG001|Overall Study|Still under treatment|0|||
106156180|NCT05320432|366234161|FG000|Overall Study|Withdrawal by Subject|0|||
106156181|NCT05320432|366234162|FG001|Overall Study|Withdrawal by Subject|2|||
106156182|NCT03484702|366234163|FG000|Treatment Period|Death|3|||
106156183|NCT03484702|366234164|FG001|Treatment Period|Death|1|||
106156184|NCT03484702|366234165|FG002|Treatment Period|Death|0|||
106156185|NCT03484702|366234166|FG003|Treatment Period|Death|0|||
106156186|NCT03484702|366234167|FG004|Treatment Period|Death|0|||
106156187|NCT03484702|366234168|FG005|Treatment Period|Death|0|||
106156188|NCT03484702|366234163|FG000|Treatment Period|Adverse Event|1|||
106156189|NCT03484702|366234164|FG001|Treatment Period|Adverse Event|0|||
106156190|NCT03484702|366234165|FG002|Treatment Period|Adverse Event|0|||
106156191|NCT03484702|366234166|FG003|Treatment Period|Adverse Event|0|||
106156192|NCT03484702|366234167|FG004|Treatment Period|Adverse Event|0|||
106156193|NCT03484702|366234168|FG005|Treatment Period|Adverse Event|0|||
106156194|NCT03484702|366234163|FG000|Treatment Period|Participant Withdrew from Study|0|||
106156195|NCT03484702|366234164|FG001|Treatment Period|Participant Withdrew from Study|1|||
106156196|NCT03484702|366234165|FG002|Treatment Period|Participant Withdrew from Study|0|||
106156197|NCT03484702|366234166|FG003|Treatment Period|Participant Withdrew from Study|0|||
106156198|NCT03484702|366234167|FG004|Treatment Period|Participant Withdrew from Study|0|||
106156199|NCT03484702|366234168|FG005|Treatment Period|Participant Withdrew from Study|0|||
106156200|NCT03484702|366234163|FG000|Treatment Period|Physician Decision|0|||
106156201|NCT03484702|366234164|FG001|Treatment Period|Physician Decision|1|||
106156202|NCT03484702|366234165|FG002|Treatment Period|Physician Decision|0|||
106156203|NCT03484702|366234166|FG003|Treatment Period|Physician Decision|0|||
106156204|NCT03484702|366234167|FG004|Treatment Period|Physician Decision|0|||
106156205|NCT03484702|366234168|FG005|Treatment Period|Physician Decision|1|||
106156206|NCT04850807|366234171|FG000|Overall Study|Death|50|||
105866157|NCT02756208|365159306|FG002|Overall Study|Withdrawal by Subject|1|||
105866158|NCT02756208|365159307|FG003|Overall Study|Withdrawal by Subject|3|||
105866159|NCT02756208|365159304|FG000|Overall Study|Lost to Follow-up|3|||
105866160|NCT02756208|365159305|FG001|Overall Study|Lost to Follow-up|1|||
105866161|NCT02756208|365159306|FG002|Overall Study|Lost to Follow-up|1|||
105866162|NCT02756208|365159307|FG003|Overall Study|Lost to Follow-up|1|||
105866163|NCT02756208|365159304|FG000|Overall Study|Physician Decision|1|||
105866164|NCT02756208|365159305|FG001|Overall Study|Physician Decision|0|||
105866165|NCT02756208|365159306|FG002|Overall Study|Physician Decision|0|||
105866166|NCT02756208|365159307|FG003|Overall Study|Physician Decision|0|||
105866167|NCT02756208|365159304|FG000|Overall Study|Protocol Violation|0|||
105866168|NCT02756208|365159305|FG001|Overall Study|Protocol Violation|1|||
105866169|NCT02756208|365159306|FG002|Overall Study|Protocol Violation|0|||
105866170|NCT02756208|365159307|FG003|Overall Study|Protocol Violation|0|||
105866171|NCT04841577|365159309|FG000|Overall Study|Adverse Event|5|||
105866172|NCT04841577|365159310|FG001|Overall Study|Adverse Event|10|||
105866173|NCT04841577|365159309|FG000|Overall Study|Lost to Follow-up|8|||
105866174|NCT04841577|365159310|FG001|Overall Study|Lost to Follow-up|7|||
105866175|NCT04841577|365159309|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
105866176|NCT04841577|365159310|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
105866177|NCT04841577|365159309|FG000|Overall Study|Other|0|||
105866178|NCT04841577|365159310|FG001|Overall Study|Other|1|||
105866179|NCT00182325|365159311|FG000|Overall Study|Lost to Follow-up|7|||
105866180|NCT00182325|365159312|FG001|Overall Study|Lost to Follow-up|7|||
105866181|NCT00182325|365159311|FG000|Overall Study|Miscarriage|5|||
105866182|NCT00182325|365159312|FG001|Overall Study|Miscarriage|3|||
105866183|NCT00182325|365159311|FG000|Overall Study|Did not complete survey|22|||
105866184|NCT00182325|365159312|FG001|Overall Study|Did not complete survey|43|||
105866185|NCT01937871|365159313|FG000|Overall Study|Adverse Event|6|||
105866186|NCT01937871|365159314|FG001|Overall Study|Adverse Event|6|||
105866187|NCT01937871|365159315|FG002|Overall Study|Adverse Event|2|||
105866188|NCT01937871|365159313|FG000|Overall Study|Lost to Follow-up|8|||
105866189|NCT01937871|365159314|FG001|Overall Study|Lost to Follow-up|2|||
105866190|NCT01937871|365159315|FG002|Overall Study|Lost to Follow-up|4|||
105866191|NCT01937871|365159313|FG000|Overall Study|Withdrawal by Subject|9|||
105866192|NCT01937871|365159314|FG001|Overall Study|Withdrawal by Subject|6|||
105866193|NCT01937871|365159315|FG002|Overall Study|Withdrawal by Subject|4|||
105866194|NCT01937871|365159313|FG000|Overall Study|Physician Decision|0|||
105866195|NCT01937871|365159314|FG001|Overall Study|Physician Decision|1|||
105866196|NCT01937871|365159315|FG002|Overall Study|Physician Decision|0|||
105866197|NCT01937871|365159313|FG000|Overall Study|Entry Criteria Not Met|1|||
105866198|NCT01937871|365159314|FG001|Overall Study|Entry Criteria Not Met|2|||
105866199|NCT01937871|365159315|FG002|Overall Study|Entry Criteria Not Met|1|||
105866200|NCT01569295|365159321|FG000|Overall Study|Progressive Disease|75|||
105866201|NCT01569295|365159322|FG001|Overall Study|Progressive Disease|139|||
105866202|NCT01569295|365159321|FG000|Overall Study|Adverse Event|39|||
105866203|NCT01569295|365159322|FG001|Overall Study|Adverse Event|14|||
105866204|NCT01569295|365159321|FG000|Overall Study|Withdrawal by Subject|25|||
105866205|NCT01569295|365159322|FG001|Overall Study|Withdrawal by Subject|12|||
105866206|NCT01569295|365159321|FG000|Overall Study|Death|19|||
105866207|NCT01569295|365159322|FG001|Overall Study|Death|15|||
106071208|NCT01288287|365923857|FG000|Overall Study|Lack of Efficacy|13|||
106071209|NCT01288287|365923857|FG000|Overall Study|Other Reason|13|||
106071210|NCT01288287|365923857|FG000|Overall Study|Unknown Reason|1|||
106071211|NCT01288287|365923857|FG000|Overall Study|Unknown Status|7|||
106071212|NCT02225743|365923858|FG000|Overall Study|Withdrawal by Subject|18|||
106071213|NCT00445965|365923862|FG000|Overall Study|Adverse Event|2|||
106071214|NCT00445965|365923862|FG000|Overall Study|Physician Decision|1|||
106071215|NCT00445965|365923862|FG000|Overall Study|Enrolled but not treated|1|||
106071216|NCT00445965|365923862|FG000|Overall Study|Removed due to progressive disease|29|||
106071217|NCT00679263|365923863|FG000|Visit 2/Dose 1|Adverse Event|1|||
106071218|NCT00679263|365923864|FG001|Visit 2/Dose 1|Adverse Event|0|||
106156207|NCT04850807|366234172|FG001|Overall Study|Death|55|||
105866208|NCT01569295|365159321|FG000|Overall Study|Physician Decision|13|||
105866209|NCT01569295|365159322|FG001|Overall Study|Physician Decision|18|||
105866210|NCT01569295|365159321|FG000|Overall Study|Study Terminated by Sponsor|24|||
105866211|NCT01569295|365159322|FG001|Overall Study|Study Terminated by Sponsor|2|||
105866212|NCT01569295|365159321|FG000|Overall Study|Other Reason not Specified|3|||
105866213|NCT01569295|365159322|FG001|Overall Study|Other Reason not Specified|5|||
105866214|NCT01569295|365159321|FG000|Overall Study|Non-Compliance with Study Drug|6|||
105866215|NCT01569295|365159322|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105866216|NCT01569295|365159321|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
105866217|NCT01569295|365159322|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
105866218|NCT01569295|365159321|FG000|Overall Study|Lost to Follow-up|1|||
105866219|NCT01569295|365159322|FG001|Overall Study|Lost to Follow-up|1|||
105866220|NCT01038297|365159325|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
106071219|NCT00679263|365923865|FG002|Visit 2/Dose 1|Adverse Event|0|||
106071220|NCT00679263|365923863|FG000|Visit 2/Dose 1|subject not compliance|1|||
106156208|NCT04850807|366234171|FG000|Overall Study|Discharged|17|||
106071221|NCT00679263|365923864|FG001|Visit 2/Dose 1|subject not compliance|1|||
106071222|NCT00679263|365923865|FG002|Visit 2/Dose 1|subject not compliance|0|||
106071223|NCT01464346|365923871|FG000|Overall Study|Withdrawal by Subject|0|||
106071224|NCT01464346|365923872|FG001|Overall Study|Withdrawal by Subject|0|||
106071225|NCT01464346|365923873|FG002|Overall Study|Withdrawal by Subject|1|||
106071226|NCT02642432|365923874|FG000|Overall Study|Adverse Event|2|||
106071227|NCT02642432|365923874|FG000|Overall Study|Withdrew Consent|1|||
106071228|NCT02642432|365923874|FG000|Overall Study|Lost to Follow-up|2|||
106071229|NCT02642432|365923874|FG000|Overall Study|Other|3|||
106071230|NCT00733746|365923875|FG000|Overall Study|Ineligible|5|||
106071231|NCT02295995|365923876|FG000|Overall Study|Lost to Follow-up|5|||
106071232|NCT02295995|365923877|FG001|Overall Study|Lost to Follow-up|1|||
106071233|NCT02447081|365923878|FG000|Overall Study|Death|161|||
106071234|NCT02447081|365923878|FG000|Overall Study|Lost to Follow-up|36|||
106071235|NCT02447081|365923878|FG000|Overall Study|Visit not completed|17|||
106071236|NCT02447081|365923878|FG000|Overall Study|unsuccessful implant procedure|10|||
106071237|NCT02867709|365923881|FG000|Treatment Period|Adverse Event|1|||
106071238|NCT02867709|365923882|FG001|Treatment Period|Adverse Event|1|||
106071239|NCT02867709|365923883|FG002|Treatment Period|Adverse Event|2|||
106071240|NCT02867709|365923881|FG000|Treatment Period|Withdrawal of Consent|7|||
106071241|NCT02867709|365923882|FG001|Treatment Period|Withdrawal of Consent|9|||
106071242|NCT02867709|365923883|FG002|Treatment Period|Withdrawal of Consent|8|||
106071243|NCT02867709|365923881|FG000|Treatment Period|Lost to Follow-up|17|||
106071244|NCT02867709|365923882|FG001|Treatment Period|Lost to Follow-up|20|||
106071245|NCT02867709|365923883|FG002|Treatment Period|Lost to Follow-up|20|||
106071246|NCT02867709|365923881|FG000|Treatment Period|Lack of Qualifying Event|42|||
106071247|NCT02867709|365923882|FG001|Treatment Period|Lack of Qualifying Event|55|||
106071248|NCT02867709|365923883|FG002|Treatment Period|Lack of Qualifying Event|42|||
106071249|NCT02867709|365923881|FG000|Treatment Period|Protocol Violation|3|||
106071250|NCT02867709|365923882|FG001|Treatment Period|Protocol Violation|2|||
106071251|NCT02867709|365923883|FG002|Treatment Period|Protocol Violation|3|||
106071252|NCT02867709|365923881|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
106071253|NCT02867709|365923882|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
106071254|NCT02867709|365923883|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
106071255|NCT02867709|365923881|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
106071256|NCT02867709|365923882|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
106071257|NCT02867709|365923883|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
106071258|NCT02867709|365923881|FG000|Safety Follow-up Period|Pregnancy|0|||
106071259|NCT02867709|365923882|FG001|Safety Follow-up Period|Pregnancy|1|||
106071260|NCT02867709|365923883|FG002|Safety Follow-up Period|Pregnancy|0|||
106071261|NCT02867709|365923881|FG000|Safety Follow-up Period|Protocol Violation|0|||
106071262|NCT02867709|365923882|FG001|Safety Follow-up Period|Protocol Violation|1|||
106071263|NCT02867709|365923883|FG002|Safety Follow-up Period|Protocol Violation|1|||
106071264|NCT03245008|365923884|FG000|Overall Study|Adverse Event|15|||
106071265|NCT03245008|365923885|FG001|Overall Study|Adverse Event|18|||
106071266|NCT03245008|365923886|FG002|Overall Study|Adverse Event|15|||
106071267|NCT03245008|365923887|FG003|Overall Study|Adverse Event|0|||
106071268|NCT03245008|365923888|FG004|Overall Study|Adverse Event|1|||
106071269|NCT03245008|365923884|FG000|Overall Study|Lack of Efficacy|0|||
106071270|NCT03245008|365923885|FG001|Overall Study|Lack of Efficacy|1|||
106071271|NCT03245008|365923886|FG002|Overall Study|Lack of Efficacy|0|||
106071272|NCT03245008|365923887|FG003|Overall Study|Lack of Efficacy|0|||
106071273|NCT03245008|365923888|FG004|Overall Study|Lack of Efficacy|0|||
106071274|NCT03245008|365923884|FG000|Overall Study|Lost to Follow-up|4|||
106071275|NCT03245008|365923885|FG001|Overall Study|Lost to Follow-up|1|||
106071276|NCT03245008|365923886|FG002|Overall Study|Lost to Follow-up|0|||
106071277|NCT03245008|365923887|FG003|Overall Study|Lost to Follow-up|0|||
106071278|NCT03245008|365923888|FG004|Overall Study|Lost to Follow-up|1|||
106071279|NCT03245008|365923884|FG000|Overall Study|Physician Decision|1|||
106071280|NCT03245008|365923885|FG001|Overall Study|Physician Decision|3|||
106071281|NCT03245008|365923886|FG002|Overall Study|Physician Decision|4|||
106071282|NCT03245008|365923887|FG003|Overall Study|Physician Decision|0|||
106071283|NCT03245008|365923888|FG004|Overall Study|Physician Decision|0|||
106071284|NCT03245008|365923884|FG000|Overall Study|Protocol Violation|0|||
106071285|NCT03245008|365923885|FG001|Overall Study|Protocol Violation|1|||
106071286|NCT03245008|365923886|FG002|Overall Study|Protocol Violation|0|||
106071287|NCT03245008|365923887|FG003|Overall Study|Protocol Violation|0|||
106071288|NCT03245008|365923888|FG004|Overall Study|Protocol Violation|0|||
106071289|NCT03245008|365923884|FG000|Overall Study|Withdrawal by Subject|20|||
106071290|NCT03245008|365923885|FG001|Overall Study|Withdrawal by Subject|19|||
106071291|NCT03245008|365923886|FG002|Overall Study|Withdrawal by Subject|11|||
106071292|NCT03245008|365923887|FG003|Overall Study|Withdrawal by Subject|0|||
106071293|NCT03245008|365923888|FG004|Overall Study|Withdrawal by Subject|0|||
106071294|NCT03245008|365923884|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
106071295|NCT03245008|365923885|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
106071296|NCT03245008|365923886|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
106071297|NCT03245008|365923887|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
106071298|NCT03245008|365923888|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
106071299|NCT03245008|365923884|FG000|Overall Study|Failure to meet randomization criteria|0|||
106071300|NCT03245008|365923885|FG001|Overall Study|Failure to meet randomization criteria|1|||
106071301|NCT03245008|365923886|FG002|Overall Study|Failure to meet randomization criteria|0|||
106071302|NCT03245008|365923887|FG003|Overall Study|Failure to meet randomization criteria|1|||
106071303|NCT03245008|365923888|FG004|Overall Study|Failure to meet randomization criteria|0|||
106071304|NCT01786629|365925108|FG000|Overall Study|Lack of Efficacy|0|||
106071305|NCT01786629|365925109|FG001|Overall Study|Lack of Efficacy|4|||
106071306|NCT01786629|365925108|FG000|Overall Study|Adverse Event|0|||
105866221|NCT01038297|365159326|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
106071307|NCT01786629|365925109|FG001|Overall Study|Adverse Event|1|||
106071308|NCT02926924|365925110|FG000|Overall Study|withdrawal - reason unknown|0|||
106071309|NCT02926924|365925111|FG001|Overall Study|withdrawal - reason unknown|1|||
106071310|NCT00939809|365925115|FG000|Overall Study|Adverse Event|2|||
106071311|NCT00939809|365925115|FG000|Overall Study|Death|1|||
106071312|NCT04568590|365925116|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
106071313|NCT00202644|365925118|FG000|Overall Study|Adverse Event|12|||
106071314|NCT00202644|365925119|FG001|Overall Study|Adverse Event|13|||
106071315|NCT00202644|365925118|FG000|Overall Study|Withdrawal by Subject|8|||
106071316|NCT00202644|365925119|FG001|Overall Study|Withdrawal by Subject|6|||
106071317|NCT00202644|365925118|FG000|Overall Study|Lack of Efficacy|6|||
106071318|NCT00202644|365925119|FG001|Overall Study|Lack of Efficacy|6|||
106071319|NCT00202644|365925118|FG000|Overall Study|Lost to Follow-up|0|||
106071320|NCT00202644|365925119|FG001|Overall Study|Lost to Follow-up|1|||
106071321|NCT00202644|365925118|FG000|Overall Study|Other|9|||
106071322|NCT00202644|365925119|FG001|Overall Study|Other|1|||
106071323|NCT02784821|365925120|FG000|Overall Study|Death|0|||
106071324|NCT02784821|365925121|FG001|Overall Study|Death|5|||
106071325|NCT02784821|365925122|FG002|Overall Study|Death|4|||
106071326|NCT02784821|365925123|FG003|Overall Study|Death|5|||
106071327|NCT01277523|365925124|FG000|Overall Study|Adverse Event|1|||
106071328|NCT01277523|365925125|FG001|Overall Study|Adverse Event|0|||
106071329|NCT01277523|365925126|FG002|Overall Study|Adverse Event|0|||
106071330|NCT01277523|365925124|FG000|Overall Study|Protocol Violation|2|||
106071331|NCT01277523|365925125|FG001|Overall Study|Protocol Violation|0|||
106071332|NCT01277523|365925126|FG002|Overall Study|Protocol Violation|0|||
106071333|NCT01277523|365925124|FG000|Overall Study|Other Reason not Defined|0|||
106071334|NCT01277523|365925125|FG001|Overall Study|Other Reason not Defined|1|||
106071335|NCT01277523|365925126|FG002|Overall Study|Other Reason not Defined|0|||
106071336|NCT03020823|365925131|FG000|Overall Study|Physician Decision|4|||
106071337|NCT03020823|365925131|FG000|Overall Study|Lack of Efficacy|4|||
106071338|NCT03020823|365925131|FG000|Overall Study|Adverse Event|2|||
106071339|NCT03739112|365925132|FG000|Overall Study|Adverse Event|2|||
106071340|NCT03739112|365925133|FG001|Overall Study|Adverse Event|2|||
106071341|NCT03739112|365925132|FG000|Overall Study|Withdrawal by Subject|38|||
106071342|NCT03739112|365925133|FG001|Overall Study|Withdrawal by Subject|19|||
106071343|NCT03739112|365925132|FG000|Overall Study|Lost to Follow-up|31|||
106071344|NCT03739112|365925133|FG001|Overall Study|Lost to Follow-up|33|||
106071345|NCT03739112|365925132|FG000|Overall Study|Protocol Deviation|12|||
106071346|NCT03739112|365925133|FG001|Overall Study|Protocol Deviation|9|||
106071347|NCT03739112|365925132|FG000|Overall Study|Physician Decision|1|||
106071348|NCT03739112|365925133|FG001|Overall Study|Physician Decision|0|||
106071349|NCT03739112|365925132|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
106071350|NCT03739112|365925133|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
106071351|NCT03739112|365925132|FG000|Overall Study|Site went on hold|65|||
106071352|NCT03739112|365925133|FG001|Overall Study|Site went on hold|67|||
106071353|NCT03739112|365925132|FG000|Overall Study|Other than specified|8|||
106071354|NCT03739112|365925133|FG001|Overall Study|Other than specified|5|||
106071355|NCT03739112|365925132|FG000|Overall Study|Randomized but not vaccinated|31|||
106071356|NCT03739112|365925133|FG001|Overall Study|Randomized but not vaccinated|25|||
106071357|NCT01816893|365925134|FG000|Washout Period|Withdrawal by Subject|2|||
106071358|NCT01816893|365925135|FG001|Washout Period|Withdrawal by Subject|0|||
106071359|NCT03388138|365925136|FG000|Overall Study|Protocol Violation|1|||
106071360|NCT03388138|365925137|FG001|Overall Study|Protocol Violation|0|||
106071361|NCT01859494|365925138|FG000|Overall Study|Adverse Event|1|||
106071362|NCT01063764|365925139|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
106071363|NCT01063764|365925139|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
106071364|NCT01063764|365925139|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
106071365|NCT01063764|365925139|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
106071366|NCT01063764|365925139|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
106071367|NCT01063764|365925139|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
106071368|NCT01063764|365925139|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
106071369|NCT00697515|365925140|FG000|Dose Optimization Period|Adverse Event|4|||
105866222|NCT01038297|365159327|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
105866223|NCT01973595|365159328|FG000|Washout|Withdrawal by Subject|1|||
105866224|NCT01973595|365159329|FG001|Washout|Withdrawal by Subject|0|||
105866225|NCT01973595|365159330|FG002|Washout|Withdrawal by Subject|1|||
105866226|NCT01973595|365159331|FG003|Washout|Withdrawal by Subject|0|||
105866227|NCT02508935|365159332|FG000|Overall Study|Withdrawal by Subject|1|||
105866228|NCT02508935|365159332|FG000|Overall Study|Withdrawal by Caregiver|8|||
105866229|NCT02508935|365159332|FG000|Overall Study|Pain Score <4|1|||
106071370|NCT00697515|365925141|FG001|Dose Optimization Period|Adverse Event|0|||
106071371|NCT00697515|365925140|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
106071372|NCT00697515|365925141|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
106071373|NCT00697515|365925140|FG000|Dose Optimization Period|Lost to Follow-up|2|||
106071374|NCT00697515|365925141|FG001|Dose Optimization Period|Lost to Follow-up|0|||
106071375|NCT00697515|365925140|FG000|Dose Optimization Period|sponsor request|2|||
106071376|NCT00697515|365925141|FG001|Dose Optimization Period|sponsor request|0|||
106071377|NCT00697515|365925140|FG000|Dose Optimization Period|called to active duty|1|||
106071378|NCT00697515|365925141|FG001|Dose Optimization Period|called to active duty|0|||
106071379|NCT00697515|365925140|FG000|Dose Optimization Period|elevated QTc|1|||
106071380|NCT00697515|365925141|FG001|Dose Optimization Period|elevated QTc|0|||
106071381|NCT00697515|365925140|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
106071382|NCT00697515|365925141|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
106071383|NCT00697515|365925140|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
106071384|NCT00697515|365925141|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
106071385|NCT00697515|365925140|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
106071386|NCT00697515|365925141|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
106071387|NCT00697515|365925140|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
106071388|NCT00697515|365925141|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
106071389|NCT02436759|365925142|FG000|Overall Study|Adverse Event|3|||
106071390|NCT02436759|365925143|FG001|Overall Study|Adverse Event|0|||
106071391|NCT02436759|365925142|FG000|Overall Study|Protocol Violation|1|||
106071392|NCT02436759|365925143|FG001|Overall Study|Protocol Violation|0|||
106071393|NCT02436759|365925142|FG000|Overall Study|Withdrawal by Subject|0|||
106071394|NCT02436759|365925143|FG001|Overall Study|Withdrawal by Subject|1|||
106071395|NCT01231581|365925150|FG000|Overall Study|Lost to Follow-up|2|||
106071396|NCT01231581|365925151|FG001|Overall Study|Lost to Follow-up|2|||
106071397|NCT01231581|365925150|FG000|Overall Study|Withdrawal by Subject|6|||
106071398|NCT01231581|365925151|FG001|Overall Study|Withdrawal by Subject|9|||
106071399|NCT01231581|365925150|FG000|Overall Study|Study Closed/Terminated|6|||
106071400|NCT01231581|365925151|FG001|Overall Study|Study Closed/Terminated|5|||
106071401|NCT01231581|365925150|FG000|Overall Study|Death|65|||
106071402|NCT01231581|365925151|FG001|Overall Study|Death|64|||
106071403|NCT01231581|365925150|FG000|Overall Study|Ongoing|1|||
106071404|NCT01231581|365925151|FG001|Overall Study|Ongoing|0|||
105866230|NCT02508935|365159332|FG000|Overall Study|Emesis|3|||
106156209|NCT04850807|366234172|FG001|Overall Study|Discharged|13|||
106156210|NCT04850807|366234171|FG000|Overall Study|Incomplete baseline data|3|||
106156211|NCT04850807|366234172|FG001|Overall Study|Incomplete baseline data|2|||
106156212|NCT04716634|366234173|FG000|Overall Study|Death|24|||
106156213|NCT04716634|366234174|FG001|Overall Study|Death|24|||
106156214|NCT04716634|366234175|FG002|Overall Study|Death|8|||
106156215|NCT04716634|366234173|FG000|Overall Study|Closed by Sponsor|4|||
106156216|NCT04716634|366234174|FG001|Overall Study|Closed by Sponsor|4|||
106156217|NCT04716634|366234175|FG002|Overall Study|Closed by Sponsor|5|||
106156218|NCT04716634|366234173|FG000|Overall Study|Lost to Follow-up|1|||
106156219|NCT04716634|366234174|FG001|Overall Study|Lost to Follow-up|0|||
106156220|NCT04716634|366234175|FG002|Overall Study|Lost to Follow-up|1|||
106156221|NCT04716634|366234173|FG000|Overall Study|Withdrawal by Subject|0|||
106156222|NCT04716634|366234174|FG001|Overall Study|Withdrawal by Subject|0|||
106156223|NCT04716634|366234175|FG002|Overall Study|Withdrawal by Subject|1|||
106156224|NCT02187003|366234177|FG000|Overall Study|Adverse Event|2|||
106156225|NCT02187003|366234178|FG001|Overall Study|Adverse Event|0|||
106156226|NCT02187003|366234177|FG000|Overall Study|Lost to Follow-up|14|||
106156227|NCT02187003|366234178|FG001|Overall Study|Lost to Follow-up|10|||
106156228|NCT02187003|366234177|FG000|Overall Study|Withdrawal by Subject|3|||
106156229|NCT02187003|366234178|FG001|Overall Study|Withdrawal by Subject|7|||
106156230|NCT02187003|366234177|FG000|Overall Study|Protocol Violation|2|||
106156231|NCT02187003|366234178|FG001|Overall Study|Protocol Violation|4|||
106156232|NCT02187003|366234177|FG000|Overall Study|Other|5|||
106156233|NCT02187003|366234178|FG001|Overall Study|Other|5|||
106156234|NCT02187003|366234177|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
106156235|NCT02187003|366234178|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
106156236|NCT05063994|366234196|FG000|Cortef Run-In|Withdrawal of Consent|1|||
106156237|NCT05063994|366234197|FG001|Cortef Run-In|Withdrawal of Consent|0|||
106156238|NCT05063994|366234198|FG002|Cortef Run-In|Withdrawal of Consent|0|||
106156239|NCT05063994|366234196|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
106156240|NCT05063994|366234197|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
106156241|NCT05063994|366234198|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
106156242|NCT05063994|366234196|FG000|Treatment|Physician Decision|0|||
106156243|NCT05063994|366234197|FG001|Treatment|Physician Decision|0|||
106156244|NCT05063994|366234198|FG002|Treatment|Physician Decision|1|||
106156245|NCT05063994|366234196|FG000|Treatment|Withdrawal by Subject|0|||
106156246|NCT05063994|366234197|FG001|Treatment|Withdrawal by Subject|0|||
106156247|NCT05063994|366234198|FG002|Treatment|Withdrawal by Subject|1|||
106156248|NCT05063994|366234196|FG000|Treatment|Withdrawal of Consent|0|||
106156249|NCT05063994|366234197|FG001|Treatment|Withdrawal of Consent|0|||
106156250|NCT05063994|366234198|FG002|Treatment|Withdrawal of Consent|1|||
106156251|NCT04538417|366234200|FG000|Overall Study|Withdrawal by Subject|2|||
106156252|NCT02867384|366234216|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
106156253|NCT02867384|366234217|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
106156254|NCT02867384|366234218|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
106071405|NCT01124604|365925152|FG000|Overall Study|Adverse Event|10|||
106071406|NCT01124604|365925153|FG001|Overall Study|Adverse Event|1|||
106071407|NCT01124604|365925152|FG000|Overall Study|Lack of Efficacy|1|||
106071408|NCT01124604|365925153|FG001|Overall Study|Lack of Efficacy|0|||
106071409|NCT01124604|365925152|FG000|Overall Study|Withdrawal by Subject|4|||
106071410|NCT01124604|365925153|FG001|Overall Study|Withdrawal by Subject|0|||
106071411|NCT01124604|365925152|FG000|Overall Study|Disease Progression|0|||
106071412|NCT01124604|365925153|FG001|Overall Study|Disease Progression|1|||
106156255|NCT02867384|366234216|FG000|Overall Study|Progression/ Relapse|15|||
106156256|NCT02867384|366234217|FG001|Overall Study|Progression/ Relapse|19|||
106156257|NCT02867384|366234218|FG002|Overall Study|Progression/ Relapse|0|||
106156258|NCT02867384|366234216|FG000|Overall Study|Adverse Event|13|||
106156259|NCT02867384|366234217|FG001|Overall Study|Adverse Event|1|||
106156260|NCT02867384|366234218|FG002|Overall Study|Adverse Event|0|||
106156261|NCT02867384|366234216|FG000|Overall Study|Withdrawal by Subject|6|||
105866231|NCT02508935|365159332|FG000|Overall Study|Adverse Event|3|||
106071413|NCT01290666|365925154|FG000|Overall Study|Lost to Follow-up|11|||
106071414|NCT01290666|365925154|FG000|Overall Study|Withdrawal by Subject|23|||
106071415|NCT01290666|365925154|FG000|Overall Study|Early Termination of Study|4|||
106156262|NCT02867384|366234217|FG001|Overall Study|Withdrawal by Subject|5|||
106156263|NCT02867384|366234218|FG002|Overall Study|Withdrawal by Subject|0|||
106156264|NCT02867384|366234216|FG000|Overall Study|Physician Decision|1|||
106156265|NCT02867384|366234217|FG001|Overall Study|Physician Decision|2|||
106156266|NCT02867384|366234218|FG002|Overall Study|Physician Decision|0|||
106156267|NCT02867384|366234216|FG000|Overall Study|Patient compliance|1|||
106156268|NCT02867384|366234217|FG001|Overall Study|Patient compliance|0|||
106156269|NCT02867384|366234218|FG002|Overall Study|Patient compliance|0|||
106156270|NCT02867384|366234216|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
106156271|NCT02867384|366234217|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
106156272|NCT02867384|366234218|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
106071416|NCT00507442|365925159|FG000|Overall Study|Adverse Event|8|||
106071417|NCT00507442|365925160|FG001|Overall Study|Adverse Event|11|||
106071418|NCT00507442|365925161|FG002|Overall Study|Adverse Event|4|||
106071419|NCT00507442|365925162|FG003|Overall Study|Adverse Event|1|||
105866232|NCT02508935|365159332|FG000|Overall Study|Protocol Violation|1|||
106071420|NCT00507442|365925159|FG000|Overall Study|Protocol Violation|0|||
106071421|NCT00507442|365925160|FG001|Overall Study|Protocol Violation|1|||
106071422|NCT00507442|365925161|FG002|Overall Study|Protocol Violation|0|||
106071423|NCT00507442|365925162|FG003|Overall Study|Protocol Violation|0|||
106071424|NCT00507442|365925159|FG000|Overall Study|Lost to Follow-up|0|||
106071425|NCT00507442|365925160|FG001|Overall Study|Lost to Follow-up|0|||
106071426|NCT00507442|365925161|FG002|Overall Study|Lost to Follow-up|1|||
106071427|NCT00507442|365925162|FG003|Overall Study|Lost to Follow-up|0|||
106071428|NCT00507442|365925159|FG000|Overall Study|Physician Decision|0|||
106071429|NCT00507442|365925160|FG001|Overall Study|Physician Decision|2|||
106071430|NCT00507442|365925161|FG002|Overall Study|Physician Decision|4|||
106071431|NCT00507442|365925162|FG003|Overall Study|Physician Decision|1|||
106071432|NCT00507442|365925159|FG000|Overall Study|Progressive Disease|2|||
105866233|NCT02508935|365159332|FG000|Overall Study|Physician Decision|1|||
105866234|NCT02508935|365159332|FG000|Overall Study|Trial terminated by sponsor|5|||
105866235|NCT01814553|365159335|FG000|Overall Study|PD per clinical progression|6|||
105866236|NCT01814553|365159336|FG001|Overall Study|PD per clinical progression|8|||
105866237|NCT01814553|365159335|FG000|Overall Study|Other Adverse Event|4|||
105866238|NCT01814553|365159336|FG001|Overall Study|Other Adverse Event|5|||
105866239|NCT01814553|365159335|FG000|Overall Study|Withdrawal by Subject|1|||
105866240|NCT01814553|365159336|FG001|Overall Study|Withdrawal by Subject|1|||
105866241|NCT01814553|365159335|FG000|Overall Study|Other than stated|7|||
105866242|NCT01814553|365159336|FG001|Overall Study|Other than stated|8|||
105866243|NCT00086281|365159337|FG000|Phase 1|Adverse Event|0|||
105866244|NCT00086281|365159338|FG001|Phase 1|Adverse Event|0|||
105866245|NCT00086281|365159339|FG002|Phase 1|Adverse Event|0|||
105866246|NCT00086281|365159340|FG003|Phase 1|Adverse Event|0|||
105866247|NCT00086281|365159341|FG004|Phase 1|Adverse Event|0|||
105866248|NCT00086281|365159342|FG005|Phase 1|Adverse Event|0|||
105866249|NCT00086281|365159343|FG006|Phase 1|Adverse Event|0|||
105866250|NCT00086281|365159344|FG007|Phase 1|Adverse Event|0|||
105866251|NCT00086281|365159345|FG008|Phase 1|Adverse Event|0|||
105866252|NCT00086281|365159346|FG009|Phase 1|Adverse Event|1|||
105866253|NCT00086281|365159347|FG010|Phase 1|Adverse Event|2|||
105866254|NCT00086281|365159348|FG011|Phase 1|Adverse Event|1|||
105866255|NCT00086281|365159349|FG012|Phase 1|Adverse Event|1|||
105866256|NCT00086281|365159350|FG013|Phase 1|Adverse Event|1|||
105866257|NCT00086281|365159351|FG014|Phase 1|Adverse Event|2|||
105866258|NCT00086281|365159337|FG000|Phase 1|Protocol Violation|0|||
105866259|NCT00086281|365159338|FG001|Phase 1|Protocol Violation|0|||
105866260|NCT00086281|365159339|FG002|Phase 1|Protocol Violation|0|||
105866261|NCT00086281|365159340|FG003|Phase 1|Protocol Violation|0|||
105866262|NCT00086281|365159341|FG004|Phase 1|Protocol Violation|0|||
105866263|NCT00086281|365159342|FG005|Phase 1|Protocol Violation|0|||
105866264|NCT00086281|365159343|FG006|Phase 1|Protocol Violation|0|||
106071433|NCT00507442|365925160|FG001|Overall Study|Progressive Disease|4|||
106071434|NCT00507442|365925161|FG002|Overall Study|Progressive Disease|2|||
106071435|NCT00507442|365925162|FG003|Overall Study|Progressive Disease|0|||
106071436|NCT00507442|365925159|FG000|Overall Study|Withdrawal by Subject|4|||
106071437|NCT00507442|365925160|FG001|Overall Study|Withdrawal by Subject|4|||
106071438|NCT00507442|365925161|FG002|Overall Study|Withdrawal by Subject|2|||
106071439|NCT00507442|365925162|FG003|Overall Study|Withdrawal by Subject|1|||
106071440|NCT00507442|365925159|FG000|Overall Study|Other|2|||
106071441|NCT00507442|365925160|FG001|Overall Study|Other|5|||
106071442|NCT00507442|365925161|FG002|Overall Study|Other|2|||
106071443|NCT00507442|365925162|FG003|Overall Study|Other|2|||
106071444|NCT00536107|365925167|FG000|Overall Study|Death|5|||
106156273|NCT02867384|366234216|FG000|Overall Study|Never start treatment|0|||
106156274|NCT02867384|366234217|FG001|Overall Study|Never start treatment|0|||
105866265|NCT00086281|365159344|FG007|Phase 1|Protocol Violation|0|||
105866266|NCT00086281|365159345|FG008|Phase 1|Protocol Violation|0|||
105866267|NCT00086281|365159346|FG009|Phase 1|Protocol Violation|0|||
106156275|NCT02867384|366234218|FG002|Overall Study|Never start treatment|3|||
106156276|NCT03161379|366234223|FG000|Overall Study|Withdrawal by Subject|4|||
105866268|NCT00086281|365159347|FG010|Phase 1|Protocol Violation|1|||
105866269|NCT00086281|365159348|FG011|Phase 1|Protocol Violation|0|||
105866270|NCT00086281|365159349|FG012|Phase 1|Protocol Violation|0|||
106071445|NCT00536107|365925168|FG001|Overall Study|Death|1|||
106071446|NCT00536107|365925167|FG000|Overall Study|Incorrect enrolment|1|||
106071447|NCT00536107|365925168|FG001|Overall Study|Incorrect enrolment|0|||
106071448|NCT00536107|365925167|FG000|Overall Study|Withdrawal by Subject|0|||
105866271|NCT00086281|365159350|FG013|Phase 1|Protocol Violation|0|||
106071449|NCT00536107|365925168|FG001|Overall Study|Withdrawal by Subject|1|||
106071450|NCT00536107|365925167|FG000|Overall Study|Study Termination|2|||
106071451|NCT00536107|365925168|FG001|Overall Study|Study Termination|4|||
106071452|NCT02420691|365925169|FG000|Overall Study|Adverse Event|3|||
105866272|NCT00086281|365159351|FG014|Phase 1|Protocol Violation|0|||
105866273|NCT00086281|365159337|FG000|Phase 1|Serious Adverse Event|0|||
105866274|NCT00086281|365159338|FG001|Phase 1|Serious Adverse Event|0|||
105866275|NCT00086281|365159339|FG002|Phase 1|Serious Adverse Event|0|||
106071453|NCT02420691|365925169|FG000|Overall Study|Withdrawal by Subject|3|||
106071454|NCT00857220|365925171|FG000|Overall Study|Adverse Event|35|||
106071455|NCT00857220|365925171|FG000|Overall Study|Death|1|||
106071456|NCT00857220|365925171|FG000|Overall Study|Lack of Efficacy|11|||
106071457|NCT00857220|365925171|FG000|Overall Study|Lost to Follow-up|30|||
106071458|NCT00857220|365925171|FG000|Overall Study|Physician Decision|4|||
106071459|NCT00857220|365925171|FG000|Overall Study|Protocol Violation|16|||
106071460|NCT00857220|365925171|FG000|Overall Study|Withdrawal by Subject|67|||
106071461|NCT00857220|365925171|FG000|Overall Study|Clinical Hold|6|||
106071462|NCT00857220|365925171|FG000|Overall Study|Site Closed|5|||
106071463|NCT00857220|365925171|FG000|Overall Study|Miscellaneous|8|||
106071464|NCT02612428|365925172|FG000|VTL-308|Death|14|||
106071465|NCT02612428|365925173|FG001|VTL-308|Death|16|||
106071466|NCT02612428|365925172|FG000|VTL-308|Withdrawal by Subject|0|||
106071467|NCT02612428|365925173|FG001|VTL-308|Withdrawal by Subject|1|||
106071468|NCT02612428|365925172|FG000|VTL-308E|Death|9|||
106071469|NCT02612428|365925173|FG001|VTL-308E|Death|7|||
106071470|NCT02612428|365925172|FG000|VTL-308E|Lost to Follow-up|2|||
106071471|NCT02612428|365925173|FG001|VTL-308E|Lost to Follow-up|0|||
106071472|NCT02337907|365925176|FG000|Overall Study|Other than listed|1|||
106071473|NCT02337907|365925177|FG001|Overall Study|Other than listed|0|||
106071474|NCT02337907|365925178|FG002|Overall Study|Other than listed|0|||
105866276|NCT00086281|365159340|FG003|Phase 1|Serious Adverse Event|0|||
106071475|NCT02337907|365925179|FG003|Overall Study|Other than listed|1|||
106071476|NCT02337907|365925180|FG004|Overall Study|Other than listed|1|||
106071477|NCT02337907|365925181|FG005|Overall Study|Other than listed|0|||
106071478|NCT02337907|365925176|FG000|Overall Study|Withdrawal by Subject|2|||
106071479|NCT02337907|365925177|FG001|Overall Study|Withdrawal by Subject|3|||
106071480|NCT02337907|365925178|FG002|Overall Study|Withdrawal by Subject|0|||
106071481|NCT02337907|365925179|FG003|Overall Study|Withdrawal by Subject|2|||
106071482|NCT02337907|365925180|FG004|Overall Study|Withdrawal by Subject|5|||
105866277|NCT00086281|365159341|FG004|Phase 1|Serious Adverse Event|0|||
105866278|NCT00086281|365159342|FG005|Phase 1|Serious Adverse Event|0|||
105866279|NCT00086281|365159343|FG006|Phase 1|Serious Adverse Event|0|||
105866280|NCT00086281|365159344|FG007|Phase 1|Serious Adverse Event|0|||
105866281|NCT00086281|365159345|FG008|Phase 1|Serious Adverse Event|0|||
105866282|NCT00086281|365159346|FG009|Phase 1|Serious Adverse Event|0|||
105866283|NCT00086281|365159347|FG010|Phase 1|Serious Adverse Event|0|||
105866284|NCT00086281|365159348|FG011|Phase 1|Serious Adverse Event|0|||
105866285|NCT00086281|365159349|FG012|Phase 1|Serious Adverse Event|0|||
105866286|NCT00086281|365159350|FG013|Phase 1|Serious Adverse Event|0|||
105866287|NCT00086281|365159351|FG014|Phase 1|Serious Adverse Event|1|||
105866288|NCT00086281|365159337|FG000|Phase 2|Adverse Event|0|||
106071483|NCT02337907|365925181|FG005|Overall Study|Withdrawal by Subject|0|||
106071484|NCT02337907|365925176|FG000|Overall Study|Lost to Follow-up|0|||
106071485|NCT02337907|365925177|FG001|Overall Study|Lost to Follow-up|0|||
106071486|NCT02337907|365925178|FG002|Overall Study|Lost to Follow-up|0|||
106071487|NCT02337907|365925179|FG003|Overall Study|Lost to Follow-up|0|||
106071488|NCT02337907|365925180|FG004|Overall Study|Lost to Follow-up|0|||
106071489|NCT02337907|365925181|FG005|Overall Study|Lost to Follow-up|1|||
106071490|NCT02337907|365925176|FG000|Overall Study|Adverse Event|1|||
106071491|NCT02337907|365925177|FG001|Overall Study|Adverse Event|1|||
106071492|NCT02337907|365925178|FG002|Overall Study|Adverse Event|1|||
106071493|NCT02337907|365925179|FG003|Overall Study|Adverse Event|1|||
106156277|NCT03161379|366234223|FG000|Overall Study|disease progression during chemotherapy|5|||
106156278|NCT03161379|366234223|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
105866289|NCT00086281|365159338|FG001|Phase 2|Adverse Event|0|||
105866290|NCT00086281|365159339|FG002|Phase 2|Adverse Event|0|||
106071494|NCT02337907|365925180|FG004|Overall Study|Adverse Event|4|||
106071495|NCT02337907|365925181|FG005|Overall Study|Adverse Event|0|||
106071496|NCT01592344|365925186|FG000|Overall Study|Adverse Event|1|||
106071497|NCT01592344|365925187|FG001|Overall Study|Adverse Event|1|||
106071498|NCT01592344|365925186|FG000|Overall Study|Lack of Efficacy|1|||
106071499|NCT01592344|365925187|FG001|Overall Study|Lack of Efficacy|0|||
105866291|NCT00086281|365159340|FG003|Phase 2|Adverse Event|0|||
106071500|NCT01592344|365925186|FG000|Overall Study|not available at primary outcome visit|2|||
106071501|NCT01592344|365925187|FG001|Overall Study|not available at primary outcome visit|4|||
106071502|NCT00751348|365925189|FG000|Overall Study|Withdrawal by Subject|5|||
106071503|NCT00751348|365925190|FG001|Overall Study|Withdrawal by Subject|2|||
106071504|NCT00751348|365925189|FG000|Overall Study|Migration from study area|1|||
105866292|NCT00086281|365159341|FG004|Phase 2|Adverse Event|0|||
105866293|NCT00086281|365159342|FG005|Phase 2|Adverse Event|0|||
105866294|NCT00086281|365159343|FG006|Phase 2|Adverse Event|0|||
105866295|NCT00086281|365159344|FG007|Phase 2|Adverse Event|0|||
106071505|NCT00751348|365925190|FG001|Overall Study|Migration from study area|0|||
106071506|NCT02726074|365925191|FG000|Overall Study|Withdrawal by Subject|4|||
106071507|NCT02726074|365925191|FG000|Overall Study|Adverse Event|14|||
106071508|NCT02726074|365925191|FG000|Overall Study|Protocol Violation|3|||
106071509|NCT02726074|365925191|FG000|Overall Study|Lost to Follow-up|2|||
106071510|NCT02726074|365925191|FG000|Overall Study|Others|3|||
106071511|NCT00878709|365925195|FG000|Overall Study|Withdrawal by Subject|197|||
106071512|NCT00878709|365925196|FG001|Overall Study|Withdrawal by Subject|120|||
106071513|NCT00878709|365925195|FG000|Overall Study|Lost to Follow-up|35|||
106071514|NCT00878709|365925196|FG001|Overall Study|Lost to Follow-up|33|||
106071515|NCT00878709|365925195|FG000|Overall Study|Other Reasons|93|||
106071516|NCT00878709|365925196|FG001|Overall Study|Other Reasons|84|||
106071517|NCT01712854|365925197|FG000|Overall Study|Physician Decision|1|||
106071518|NCT00768300|365925207|FG000|Overall Study|Randomized but not treated|1|||
106071519|NCT00768300|365925208|FG001|Overall Study|Randomized but not treated|1|||
106071520|NCT00768300|365925207|FG000|Overall Study|Adverse Event|10|||
106071521|NCT00768300|365925208|FG001|Overall Study|Adverse Event|2|||
106071522|NCT00768300|365925207|FG000|Overall Study|Protocol Violation|6|||
106071523|NCT00768300|365925208|FG001|Overall Study|Protocol Violation|1|||
106071524|NCT00768300|365925207|FG000|Overall Study|Withdrawal by Subject|13|||
106071525|NCT00768300|365925208|FG001|Overall Study|Withdrawal by Subject|7|||
106071526|NCT00768300|365925207|FG000|Overall Study|Physician Decision|2|||
106071527|NCT00768300|365925208|FG001|Overall Study|Physician Decision|3|||
106071528|NCT00768300|365925207|FG000|Overall Study|Study discontinued by Sponsor|271|||
106071529|NCT00768300|365925208|FG001|Overall Study|Study discontinued by Sponsor|140|||
106071530|NCT00768300|365925207|FG000|Overall Study|Death|21|||
106071531|NCT00768300|365925208|FG001|Overall Study|Death|5|||
106071532|NCT00768300|365925207|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
106071533|NCT00768300|365925208|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
106071534|NCT00768300|365925207|FG000|Overall Study|Screen failure following randomization|1|||
106071535|NCT00768300|365925208|FG001|Overall Study|Screen failure following randomization|0|||
106071536|NCT00768300|365925207|FG000|Overall Study|Received lung transplant|1|||
106071537|NCT00768300|365925208|FG001|Overall Study|Received lung transplant|1|||
106071538|NCT00768300|365925207|FG000|Overall Study|Lost to Follow-up|0|||
106071539|NCT00768300|365925208|FG001|Overall Study|Lost to Follow-up|1|||
106071540|NCT00768300|365925207|FG000|Overall Study|Began prohibited concomitant medication|0|||
106071541|NCT00768300|365925208|FG001|Overall Study|Began prohibited concomitant medication|1|||
106071542|NCT00768300|365925207|FG000|Overall Study|Treated but never dosed with Study drug|1|||
106071543|NCT00768300|365925208|FG001|Overall Study|Treated but never dosed with Study drug|0|||
106071544|NCT00768300|365925207|FG000|Overall Study|Missing data|1|||
106071545|NCT00768300|365925208|FG001|Overall Study|Missing data|0|||
106071546|NCT01374087|365925209|FG000|Overall Study|Adverse Event|1|||
106071547|NCT01374087|365925210|FG001|Overall Study|Adverse Event|0|||
106071548|NCT01374087|365925209|FG000|Overall Study|Disease progression|2|||
106071549|NCT01374087|365925210|FG001|Overall Study|Disease progression|2|||
106071550|NCT01374087|365925209|FG000|Overall Study|Study discontinued|13|||
106071551|NCT01374087|365925210|FG001|Overall Study|Study discontinued|13|||
106071552|NCT01474876|365925216|FG000|Overall Study|Adverse Event|11|||
106071553|NCT01474876|365925217|FG001|Overall Study|Adverse Event|5|||
106071554|NCT01474876|365925218|FG002|Overall Study|Adverse Event|0|||
106071555|NCT01474876|365925216|FG000|Overall Study|Serious Adverse Event|2|||
106071556|NCT01474876|365925217|FG001|Overall Study|Serious Adverse Event|3|||
106071557|NCT01474876|365925218|FG002|Overall Study|Serious Adverse Event|0|||
106071558|NCT01474876|365925216|FG000|Overall Study|Lost to Follow-up|5|||
106071559|NCT01474876|365925217|FG001|Overall Study|Lost to Follow-up|4|||
106071560|NCT01474876|365925218|FG002|Overall Study|Lost to Follow-up|0|||
106156279|NCT03161379|366234223|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
106156280|NCT02549339|366234227|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
106156281|NCT02549339|366234228|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
106156282|NCT02549339|366234227|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
106156283|NCT02549339|366234228|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
106156284|NCT02549339|366234227|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
106156285|NCT02549339|366234228|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
106156286|NCT02549339|366234227|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
106156287|NCT02549339|366234228|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
106156288|NCT02549339|366234227|FG000|12-month Follow-up|Lack of Efficacy|0|||
106156289|NCT02549339|366234228|FG001|12-month Follow-up|Lack of Efficacy|2|||
106156290|NCT02549339|366234227|FG000|12-month Follow-up|Withdrawal by Subject|8|||
106156291|NCT02549339|366234228|FG001|12-month Follow-up|Withdrawal by Subject|3|||
106156292|NCT02549339|366234227|FG000|12-month Follow-up|Lost to Follow-up|1|||
106156293|NCT02549339|366234228|FG001|12-month Follow-up|Lost to Follow-up|3|||
106156294|NCT02549339|366234227|FG000|12-month Follow-up|Other|0|||
106156295|NCT02549339|366234228|FG001|12-month Follow-up|Other|3|||
106156296|NCT03016169|366234229|FG000|Overall Study|Lost to Follow-up|4|||
106156297|NCT03016169|366234229|FG000|Overall Study|Death|54|||
106156298|NCT03016169|366234229|FG000|Overall Study|Device Explant|11|||
106156299|NCT03016169|366234229|FG000|Overall Study|Withdrawal by Subject|19|||
106156300|NCT03016169|366234229|FG000|Overall Study|Other Reasons|1|||
105866296|NCT00086281|365159345|FG008|Phase 2|Adverse Event|0|||
105866297|NCT00086281|365159346|FG009|Phase 2|Adverse Event|0|||
105866298|NCT00086281|365159347|FG010|Phase 2|Adverse Event|0|||
105866299|NCT00086281|365159348|FG011|Phase 2|Adverse Event|0|||
105866300|NCT00086281|365159349|FG012|Phase 2|Adverse Event|1|||
105866301|NCT00086281|365159350|FG013|Phase 2|Adverse Event|1|||
105866302|NCT00086281|365159351|FG014|Phase 2|Adverse Event|0|||
105866303|NCT02290223|365159354|FG000|6 Months|Lost to Follow-up|9|||
105866304|NCT02290223|365159355|FG001|6 Months|Lost to Follow-up|6|||
105866305|NCT02290223|365159354|FG000|6 Months|Withdrawal by Subject|5|||
106071561|NCT01474876|365925216|FG000|Overall Study|Investigator's decision|28|||
106071562|NCT01474876|365925217|FG001|Overall Study|Investigator's decision|6|||
106071563|NCT01474876|365925218|FG002|Overall Study|Investigator's decision|0|||
106071564|NCT01474876|365925216|FG000|Overall Study|Patient's request|19|||
106071565|NCT01474876|365925217|FG001|Overall Study|Patient's request|5|||
106071566|NCT01474876|365925218|FG002|Overall Study|Patient's request|0|||
106071567|NCT01474876|365925216|FG000|Overall Study|Investigator's decision and pt request|1|||
106071568|NCT01474876|365925217|FG001|Overall Study|Investigator's decision and pt request|0|||
106071569|NCT01474876|365925218|FG002|Overall Study|Investigator's decision and pt request|0|||
106071570|NCT00853723|365925219|FG000|Overall Study|Adverse Event|3|||
106071571|NCT00853723|365925220|FG001|Overall Study|Adverse Event|4|||
106071572|NCT00853723|365925221|FG002|Overall Study|Adverse Event|1|||
106071573|NCT00853723|365925219|FG000|Overall Study|Withdrawal by Subject|2|||
106071574|NCT00853723|365925220|FG001|Overall Study|Withdrawal by Subject|1|||
106071575|NCT00853723|365925221|FG002|Overall Study|Withdrawal by Subject|0|||
106071576|NCT00853723|365925219|FG000|Overall Study|Protocol Violation|1|||
106071577|NCT00853723|365925220|FG001|Overall Study|Protocol Violation|2|||
106071578|NCT00853723|365925221|FG002|Overall Study|Protocol Violation|1|||
106071579|NCT01531387|365925222|FG000|Overall Study|Early termination of study|11|||
106071580|NCT01531387|365925223|FG001|Overall Study|Early termination of study|11|||
106071581|NCT03839212|365925224|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
106071582|NCT03999892|365925225|FG000|Overall Study|Lost to Follow-up|1|||
106071583|NCT00718328|365925227|FG000|Overall Study|Lost to Follow-up|1|||
106071584|NCT00718328|365925228|FG001|Overall Study|Lost to Follow-up|0|||
106071585|NCT00663052|365925229|FG000|Overall Study|Adverse Event|6|||
106071586|NCT00663052|365925230|FG001|Overall Study|Adverse Event|3|||
106071587|NCT00663052|365925229|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
106071588|NCT00663052|365925230|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
106071589|NCT00663052|365925229|FG000|Overall Study|Protocol Violation|1|||
106071590|NCT00663052|365925230|FG001|Overall Study|Protocol Violation|0|||
106071591|NCT00663052|365925229|FG000|Overall Study|Withdrawal by Subject|2|||
106071592|NCT00663052|365925230|FG001|Overall Study|Withdrawal by Subject|5|||
106071593|NCT00663052|365925229|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
106071594|NCT00663052|365925230|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
106071595|NCT00663052|365925229|FG000|Overall Study|Other|0|||
105866306|NCT02290223|365159355|FG001|6 Months|Withdrawal by Subject|0|||
105866307|NCT02290223|365159354|FG000|6 Months|deceased (not related to study)|2|||
105866308|NCT02290223|365159355|FG001|6 Months|deceased (not related to study)|0|||
106071596|NCT00663052|365925230|FG001|Overall Study|Other|1|||
106071597|NCT00567892|365925233|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
106071598|NCT00567892|365925234|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
106071599|NCT00567892|365925235|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
106071600|NCT00567892|365925236|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
106156301|NCT02592330|366234230|FG000|Overall Study|Withdrawal by Subject|1|||
106156302|NCT02592330|366234231|FG001|Overall Study|Withdrawal by Subject|0|||
106156303|NCT02592330|366234230|FG000|Overall Study|Failed Biopsy|1|||
106156304|NCT02592330|366234231|FG001|Overall Study|Failed Biopsy|0|||
106156305|NCT00920621|366234232|FG000|Overall Study|Lost to Follow-up|16|||
106156306|NCT00920621|366234233|FG001|Overall Study|Lost to Follow-up|17|||
106156307|NCT00920621|366234234|FG002|Overall Study|Lost to Follow-up|19|||
106156308|NCT00920621|366234235|FG003|Overall Study|Lost to Follow-up|21|||
106156309|NCT00920621|366234232|FG000|Overall Study|Fetal/neonatal deaths|16|||
106156310|NCT00920621|366234233|FG001|Overall Study|Fetal/neonatal deaths|14|||
106156311|NCT00920621|366234234|FG002|Overall Study|Fetal/neonatal deaths|16|||
106156312|NCT00920621|366234235|FG003|Overall Study|Fetal/neonatal deaths|14|||
106156313|NCT00920621|366234232|FG000|Overall Study|Blood sample not collected|22|||
106156314|NCT00920621|366234233|FG001|Overall Study|Blood sample not collected|14|||
106156315|NCT00920621|366234234|FG002|Overall Study|Blood sample not collected|0|||
106156316|NCT00920621|366234235|FG003|Overall Study|Blood sample not collected|0|||
106156317|NCT01566695|366234236|FG000|Overall Study|Lack of Efficacy|1|||
106156318|NCT01566695|366234237|FG001|Overall Study|Lack of Efficacy|0|||
106156319|NCT01566695|366234236|FG000|Overall Study|Adverse Event|3|||
106156320|NCT01566695|366234237|FG001|Overall Study|Adverse Event|0|||
106156321|NCT01566695|366234236|FG000|Overall Study|Death|79|||
106156322|NCT01566695|366234237|FG001|Overall Study|Death|86|||
106156323|NCT01566695|366234236|FG000|Overall Study|Withdrawal by Subject|13|||
106156324|NCT01566695|366234237|FG001|Overall Study|Withdrawal by Subject|12|||
106156325|NCT01566695|366234236|FG000|Overall Study|Lost to Follow-up|0|||
106156326|NCT01566695|366234237|FG001|Overall Study|Lost to Follow-up|3|||
106156327|NCT01566695|366234236|FG000|Overall Study|Other reasons|11|||
106156328|NCT01566695|366234237|FG001|Overall Study|Other reasons|8|||
106156329|NCT04285567|366234238|FG000|Overall Study|Death|3|||
106156330|NCT04285567|366234239|FG001|Overall Study|Death|3|||
106156331|NCT04285567|366234238|FG000|Overall Study|Lost to Follow-up|1|||
106156332|NCT04285567|366234239|FG001|Overall Study|Lost to Follow-up|1|||
106156333|NCT04285567|366234238|FG000|Overall Study|Reason Not Specified|1|||
106156334|NCT04285567|366234239|FG001|Overall Study|Reason Not Specified|1|||
106156335|NCT04285567|366234238|FG000|Overall Study|Physician Decision|2|||
106156336|NCT04285567|366234239|FG001|Overall Study|Physician Decision|1|||
106156337|NCT04285567|366234238|FG000|Overall Study|Withdrawal by Subject|2|||
106156338|NCT04285567|366234239|FG001|Overall Study|Withdrawal by Subject|6|||
106156339|NCT04285567|366234238|FG000|Overall Study|Adverse Event|1|||
106156340|NCT04285567|366234239|FG001|Overall Study|Adverse Event|0|||
106156341|NCT04285567|366234238|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
106156342|NCT04285567|366234239|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
106156343|NCT05319860|366234240|FG000|Overall Study|Death|1|||
106156344|NCT05319860|366234241|FG001|Overall Study|Death|1|||
106156345|NCT05319860|366234240|FG000|Overall Study|Lost to Follow-up|3|||
106156346|NCT05319860|366234241|FG001|Overall Study|Lost to Follow-up|1|||
106156347|NCT05319860|366234240|FG000|Overall Study|Withdrawal by Subject|1|||
106156348|NCT05319860|366234241|FG001|Overall Study|Withdrawal by Subject|7|||
106156349|NCT05038566|366235294|FG000|Overall Study|Technical Difficulties with the Device|0|||
106156350|NCT05038566|366235295|FG001|Overall Study|Technical Difficulties with the Device|1|||
106156351|NCT04842643|366235296|FG000|Overall Study|Physician Decision|1|||
106156352|NCT04842643|366235296|FG000|Overall Study|Other|1|||
106156353|NCT04511702|366235301|FG000|Overall Study|Lost to Follow-up|3|||
106156354|NCT04511702|366235302|FG001|Overall Study|Lost to Follow-up|0|||
106156355|NCT04511702|366235303|FG002|Overall Study|Lost to Follow-up|4|||
106156356|NCT04511702|366235301|FG000|Overall Study|Withdrawal by Subject|17|||
106156357|NCT04511702|366235302|FG001|Overall Study|Withdrawal by Subject|1|||
106156358|NCT04511702|366235303|FG002|Overall Study|Withdrawal by Subject|8|||
106156359|NCT01894061|366235304|FG000|Overall Study|Screen failure|1|||
106156360|NCT01894061|366235304|FG000|Overall Study|Withdrawal by Subject|1|||
106156361|NCT04402489|366235305|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
106156362|NCT04402489|366235306|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
106156363|NCT04402489|366235307|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
106156364|NCT04402489|366235308|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
106156365|NCT04402489|366235309|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
106156366|NCT04402489|366235305|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
106156367|NCT04402489|366235306|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
106156368|NCT04402489|366235307|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
106156369|NCT04402489|366235308|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
106156370|NCT04402489|366235309|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
106156371|NCT04402489|366235305|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
106156372|NCT04402489|366235306|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
106156373|NCT04402489|366235307|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
106156374|NCT04402489|366235308|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
106156375|NCT04402489|366235309|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
106071601|NCT00567892|365925233|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
106071602|NCT00567892|365925234|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
106071603|NCT00567892|365925235|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
106071604|NCT00567892|365925236|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
106071605|NCT01921179|365927336|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
106071606|NCT01921179|365927337|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
106071607|NCT01921179|365927336|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
106071608|NCT01921179|365927337|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
106071609|NCT03873987|365927340|FG000|Overall Study|Adverse Event|1|||
106071610|NCT03873987|365927341|FG001|Overall Study|Adverse Event|0|||
106071611|NCT03873987|365927340|FG000|Overall Study|staff was unable to start a new IV line|1|||
106071612|NCT03873987|365927341|FG001|Overall Study|staff was unable to start a new IV line|0|||
106071613|NCT03873987|365927340|FG000|Overall Study|Lost to Follow-up|0|||
106071614|NCT03873987|365927341|FG001|Overall Study|Lost to Follow-up|1|||
106071615|NCT01023581|365927344|FG000|Overall Study|Adverse Event|4|||
106071616|NCT01023581|365927345|FG001|Overall Study|Adverse Event|4|||
106071617|NCT01023581|365927346|FG002|Overall Study|Adverse Event|7|||
106071618|NCT01023581|365927347|FG003|Overall Study|Adverse Event|3|||
106071619|NCT01023581|365927348|FG004|Overall Study|Adverse Event|2|||
106071620|NCT01023581|365927349|FG005|Overall Study|Adverse Event|5|||
106071621|NCT01023581|365927350|FG006|Overall Study|Adverse Event|11|||
106071622|NCT01023581|365927344|FG000|Overall Study|Major protocol deviation|2|||
106071623|NCT01023581|365927345|FG001|Overall Study|Major protocol deviation|0|||
106071624|NCT01023581|365927346|FG002|Overall Study|Major protocol deviation|3|||
106071625|NCT01023581|365927347|FG003|Overall Study|Major protocol deviation|0|||
106071626|NCT01023581|365927348|FG004|Overall Study|Major protocol deviation|0|||
106071627|NCT01023581|365927349|FG005|Overall Study|Major protocol deviation|0|||
106071628|NCT01023581|365927350|FG006|Overall Study|Major protocol deviation|0|||
106071629|NCT01023581|365927344|FG000|Overall Study|Lost to Follow-up|4|||
106071630|NCT01023581|365927345|FG001|Overall Study|Lost to Follow-up|8|||
106071631|NCT01023581|365927346|FG002|Overall Study|Lost to Follow-up|7|||
106071632|NCT01023581|365927347|FG003|Overall Study|Lost to Follow-up|2|||
106071633|NCT01023581|365927348|FG004|Overall Study|Lost to Follow-up|5|||
106071634|NCT01023581|365927349|FG005|Overall Study|Lost to Follow-up|2|||
106071635|NCT01023581|365927350|FG006|Overall Study|Lost to Follow-up|2|||
106071636|NCT01023581|365927344|FG000|Overall Study|Withdrawal by Subject|13|||
106071637|NCT01023581|365927345|FG001|Overall Study|Withdrawal by Subject|8|||
106071638|NCT01023581|365927346|FG002|Overall Study|Withdrawal by Subject|16|||
106071639|NCT01023581|365927347|FG003|Overall Study|Withdrawal by Subject|10|||
106071640|NCT01023581|365927348|FG004|Overall Study|Withdrawal by Subject|6|||
106071641|NCT01023581|365927349|FG005|Overall Study|Withdrawal by Subject|8|||
106071642|NCT01023581|365927350|FG006|Overall Study|Withdrawal by Subject|5|||
106071643|NCT01023581|365927344|FG000|Overall Study|Pregnancy|0|||
106071644|NCT01023581|365927345|FG001|Overall Study|Pregnancy|0|||
106071645|NCT01023581|365927346|FG002|Overall Study|Pregnancy|0|||
106071646|NCT01023581|365927347|FG003|Overall Study|Pregnancy|2|||
106071647|NCT01023581|365927348|FG004|Overall Study|Pregnancy|0|||
106071648|NCT01023581|365927349|FG005|Overall Study|Pregnancy|1|||
106071649|NCT01023581|365927350|FG006|Overall Study|Pregnancy|0|||
106071650|NCT01023581|365927344|FG000|Overall Study|Lack of Efficacy|9|||
106071651|NCT01023581|365927345|FG001|Overall Study|Lack of Efficacy|3|||
106071652|NCT01023581|365927346|FG002|Overall Study|Lack of Efficacy|6|||
106071653|NCT01023581|365927347|FG003|Overall Study|Lack of Efficacy|2|||
106071654|NCT01023581|365927348|FG004|Overall Study|Lack of Efficacy|1|||
106071655|NCT01023581|365927349|FG005|Overall Study|Lack of Efficacy|2|||
106071656|NCT01023581|365927350|FG006|Overall Study|Lack of Efficacy|1|||
106071657|NCT01023581|365927344|FG000|Overall Study|Physician Decision|2|||
106071658|NCT01023581|365927345|FG001|Overall Study|Physician Decision|0|||
106071659|NCT01023581|365927346|FG002|Overall Study|Physician Decision|2|||
106071660|NCT01023581|365927347|FG003|Overall Study|Physician Decision|1|||
106071661|NCT01023581|365927348|FG004|Overall Study|Physician Decision|1|||
106071662|NCT01023581|365927349|FG005|Overall Study|Physician Decision|1|||
106071663|NCT01023581|365927350|FG006|Overall Study|Physician Decision|1|||
106071664|NCT01023581|365927344|FG000|Overall Study|Other|1|||
106071665|NCT01023581|365927345|FG001|Overall Study|Other|0|||
106071666|NCT01023581|365927346|FG002|Overall Study|Other|1|||
106071667|NCT01023581|365927347|FG003|Overall Study|Other|0|||
106071668|NCT01023581|365927348|FG004|Overall Study|Other|1|||
106071669|NCT01023581|365927349|FG005|Overall Study|Other|0|||
106071670|NCT01023581|365927350|FG006|Overall Study|Other|0|||
106071671|NCT01957462|365927353|FG000|Test Period 1|Withdrawal by Subject|1|||
106071672|NCT01957462|365927354|FG001|Test Period 1|Withdrawal by Subject|0|||
106071673|NCT01957462|365927353|FG000|Test Period 1|Adverse Event|1|||
106071674|NCT01957462|365927354|FG001|Test Period 1|Adverse Event|0|||
106071675|NCT03616912|365927355|FG000|Overall Study|Adverse Event|17|||
106071676|NCT03616912|365927356|FG001|Overall Study|Adverse Event|21|||
106071677|NCT03616912|365927357|FG002|Overall Study|Adverse Event|9|||
106071678|NCT03616912|365927358|FG003|Overall Study|Adverse Event|0|||
106071679|NCT03616912|365927359|FG004|Overall Study|Adverse Event|0|||
106071680|NCT03616912|365927360|FG005|Overall Study|Adverse Event|0|||
106071681|NCT03616912|365927355|FG000|Overall Study|Death|1|||
106071682|NCT03616912|365927356|FG001|Overall Study|Death|1|||
106071683|NCT03616912|365927357|FG002|Overall Study|Death|0|||
106071684|NCT03616912|365927358|FG003|Overall Study|Death|0|||
106071685|NCT03616912|365927359|FG004|Overall Study|Death|0|||
106071686|NCT03616912|365927360|FG005|Overall Study|Death|0|||
106071687|NCT03616912|365927355|FG000|Overall Study|Lack of Efficacy|13|||
106071688|NCT03616912|365927356|FG001|Overall Study|Lack of Efficacy|6|||
106071689|NCT03616912|365927357|FG002|Overall Study|Lack of Efficacy|8|||
106071690|NCT03616912|365927358|FG003|Overall Study|Lack of Efficacy|4|||
106071691|NCT03616912|365927359|FG004|Overall Study|Lack of Efficacy|5|||
106071692|NCT03616912|365927360|FG005|Overall Study|Lack of Efficacy|1|||
106071693|NCT03616912|365927355|FG000|Overall Study|Lost to Follow-up|1|||
106071694|NCT03616912|365927356|FG001|Overall Study|Lost to Follow-up|2|||
106071695|NCT03616912|365927357|FG002|Overall Study|Lost to Follow-up|3|||
106071696|NCT03616912|365927358|FG003|Overall Study|Lost to Follow-up|0|||
106071697|NCT03616912|365927359|FG004|Overall Study|Lost to Follow-up|0|||
106071698|NCT03616912|365927360|FG005|Overall Study|Lost to Follow-up|0|||
106071699|NCT03616912|365927355|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
106071700|NCT03616912|365927356|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
106071701|NCT03616912|365927357|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
106071702|NCT03616912|365927358|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
106071703|NCT03616912|365927359|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
106071704|NCT03616912|365927360|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
106071705|NCT03616912|365927355|FG000|Overall Study|Withdrawal by Subject|12|||
106071706|NCT03616912|365927356|FG001|Overall Study|Withdrawal by Subject|12|||
106071707|NCT03616912|365927357|FG002|Overall Study|Withdrawal by Subject|15|||
106071708|NCT03616912|365927358|FG003|Overall Study|Withdrawal by Subject|2|||
106071709|NCT03616912|365927359|FG004|Overall Study|Withdrawal by Subject|0|||
106071710|NCT03616912|365927360|FG005|Overall Study|Withdrawal by Subject|2|||
106071711|NCT03616912|365927355|FG000|Overall Study|Study Terminated by Sponsor|0|||
106071712|NCT03616912|365927356|FG001|Overall Study|Study Terminated by Sponsor|0|||
106071713|NCT03616912|365927357|FG002|Overall Study|Study Terminated by Sponsor|0|||
106071714|NCT03616912|365927358|FG003|Overall Study|Study Terminated by Sponsor|10|||
106071715|NCT03616912|365927359|FG004|Overall Study|Study Terminated by Sponsor|9|||
106071716|NCT03616912|365927360|FG005|Overall Study|Study Terminated by Sponsor|11|||
106071717|NCT03616912|365927355|FG000|Overall Study|Protocol Deviation|1|||
106071718|NCT03616912|365927356|FG001|Overall Study|Protocol Deviation|1|||
106071719|NCT03616912|365927357|FG002|Overall Study|Protocol Deviation|0|||
106071720|NCT03616912|365927358|FG003|Overall Study|Protocol Deviation|0|||
106071721|NCT03616912|365927359|FG004|Overall Study|Protocol Deviation|0|||
106156376|NCT04402489|366235305|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
106156377|NCT04402489|366235306|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
106156378|NCT04402489|366235307|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
106156379|NCT04402489|366235308|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
106156380|NCT04402489|366235309|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
106156381|NCT04402489|366235305|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
106156382|NCT04402489|366235306|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
106156383|NCT04402489|366235307|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
106156384|NCT04402489|366235308|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
106156385|NCT04402489|366235309|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
106156386|NCT04402489|366235305|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
106156387|NCT04402489|366235306|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
106156388|NCT04402489|366235307|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
106156389|NCT04402489|366235308|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
106156390|NCT04402489|366235309|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
106156391|NCT03192891|366235310|FG000|Overall Study|Lost to Follow-up|55|||
106156392|NCT02287311|366235321|FG000|Cohort 1: Dose Level 1|Death|2|||
106156393|NCT02287311|366235322|FG001|Cohort 1: Dose Level 1|Death|0|||
106156394|NCT02287311|366235323|FG002|Cohort 1: Dose Level 1|Death|0|||
106071722|NCT03616912|365927360|FG005|Overall Study|Protocol Deviation|0|||
106071723|NCT03616912|365927355|FG000|Overall Study|Pregnancy|1|||
106071724|NCT03616912|365927356|FG001|Overall Study|Pregnancy|0|||
106071725|NCT03616912|365927357|FG002|Overall Study|Pregnancy|4|||
106071726|NCT03616912|365927358|FG003|Overall Study|Pregnancy|0|||
106071727|NCT03616912|365927359|FG004|Overall Study|Pregnancy|0|||
106071728|NCT03616912|365927360|FG005|Overall Study|Pregnancy|0|||
106071729|NCT03616912|365927355|FG000|Overall Study|Protocol Violation|1|||
106071730|NCT03616912|365927356|FG001|Overall Study|Protocol Violation|0|||
106071731|NCT03616912|365927357|FG002|Overall Study|Protocol Violation|2|||
106071732|NCT03616912|365927358|FG003|Overall Study|Protocol Violation|0|||
106071733|NCT03616912|365927359|FG004|Overall Study|Protocol Violation|0|||
106071734|NCT03616912|365927360|FG005|Overall Study|Protocol Violation|0|||
106071735|NCT03616912|365927355|FG000|Overall Study|Physician Decision|2|||
106071736|NCT03616912|365927356|FG001|Overall Study|Physician Decision|0|||
106071737|NCT03616912|365927357|FG002|Overall Study|Physician Decision|0|||
106071738|NCT03616912|365927358|FG003|Overall Study|Physician Decision|0|||
106071739|NCT03616912|365927359|FG004|Overall Study|Physician Decision|1|||
106071740|NCT03616912|365927360|FG005|Overall Study|Physician Decision|0|||
106071741|NCT03616912|365927355|FG000|Overall Study|Randomized But Never Treated|0|||
106071742|NCT03616912|365927356|FG001|Overall Study|Randomized But Never Treated|2|||
106071743|NCT03616912|365927357|FG002|Overall Study|Randomized But Never Treated|0|||
106071744|NCT03616912|365927358|FG003|Overall Study|Randomized But Never Treated|0|||
106071745|NCT03616912|365927359|FG004|Overall Study|Randomized But Never Treated|0|||
106071746|NCT03616912|365927360|FG005|Overall Study|Randomized But Never Treated|0|||
106071747|NCT01652664|365927361|FG000|Overall Study|Treatment Failure|5|||
106071748|NCT01652664|365927362|FG001|Overall Study|Treatment Failure|1|||
106071749|NCT01652664|365927361|FG000|Overall Study|Inadequate IOP control|1|||
106071750|NCT01652664|365927362|FG001|Overall Study|Inadequate IOP control|0|||
106071751|NCT00076011|365927363|FG000|Overall Study|Death|1|||
106071752|NCT00076011|365927363|FG000|Overall Study|Adverse Event|10|||
106071753|NCT00076011|365927363|FG000|Overall Study|Lack of Efficacy|25|||
106071754|NCT00076011|365927363|FG000|Overall Study|Withdrawal by Subject|1|||
106071755|NCT00076011|365927363|FG000|Overall Study|Study terminated by sponsor|3|||
106071756|NCT00076011|365927363|FG000|Overall Study|Other|11|||
106071757|NCT00076011|365927363|FG000|Overall Study|Ongoing|1|||
106071758|NCT03164928|365927371|FG000|Overall Study|Lost to Follow-up|1|||
106071759|NCT03164928|365927372|FG001|Overall Study|Lost to Follow-up|0|||
106071760|NCT02211131|365927374|FG000|Overall Study|Death|26|||
106071761|NCT02211131|365927375|FG001|Overall Study|Death|16|||
106071762|NCT02211131|365927374|FG000|Overall Study|Lost to Follow-up|4|||
106071763|NCT02211131|365927375|FG001|Overall Study|Lost to Follow-up|3|||
106071764|NCT02211131|365927374|FG000|Overall Study|Decision by Sponsor|1|||
106071765|NCT02211131|365927375|FG001|Overall Study|Decision by Sponsor|1|||
106071766|NCT02211131|365927374|FG000|Overall Study|Withdrawal by Subject|3|||
106071767|NCT02211131|365927375|FG001|Overall Study|Withdrawal by Subject|8|||
106071768|NCT00371254|365927376|FG000|Overall Study|Disease progression|13|||
106071769|NCT00371254|365927377|FG001|Overall Study|Disease progression|13|||
106071770|NCT00371254|365927376|FG000|Overall Study|Study drug toxicity|3|||
106071771|NCT00371254|365927377|FG001|Overall Study|Study drug toxicity|5|||
106071772|NCT00371254|365927376|FG000|Overall Study|Subject request|5|||
106071773|NCT00371254|365927377|FG001|Overall Study|Subject request|0|||
106071774|NCT00371254|365927376|FG000|Overall Study|Investigator Decision|2|||
106071775|NCT00371254|365927377|FG001|Overall Study|Investigator Decision|0|||
106071776|NCT00371254|365927376|FG000|Overall Study|Adverse event unrelated to study drug|0|||
106071777|NCT00371254|365927377|FG001|Overall Study|Adverse event unrelated to study drug|1|||
106071778|NCT00371254|365927376|FG000|Overall Study|Lost to Follow-up|0|||
106071779|NCT00371254|365927377|FG001|Overall Study|Lost to Follow-up|1|||
106071780|NCT00371254|365927376|FG000|Overall Study|Withdrawal by Subject|0|||
106071781|NCT00371254|365927377|FG001|Overall Study|Withdrawal by Subject|1|||
106071782|NCT03329690|365927380|FG000|Overall Study|Progressive disease per RECIST|85|||
106071783|NCT03329690|365927381|FG001|Overall Study|Progressive disease per RECIST|44|||
106071784|NCT03329690|365927382|FG002|Overall Study|Progressive disease per RECIST|6|||
106071785|NCT03329690|365927383|FG003|Overall Study|Progressive disease per RECIST|16|||
106156395|NCT02287311|366235324|FG003|Cohort 1: Dose Level 1|Death|3|||
106156396|NCT02287311|366235325|FG004|Cohort 1: Dose Level 1|Death|0|||
106071786|NCT03329690|365927384|FG004|Overall Study|Progressive disease per RECIST|20|||
106071787|NCT03329690|365927380|FG000|Overall Study|Clinical progression|7|||
106071788|NCT03329690|365927381|FG001|Overall Study|Clinical progression|4|||
106071789|NCT03329690|365927382|FG002|Overall Study|Clinical progression|1|||
106071790|NCT03329690|365927383|FG003|Overall Study|Clinical progression|1|||
106071791|NCT03329690|365927384|FG004|Overall Study|Clinical progression|1|||
106071792|NCT03329690|365927380|FG000|Overall Study|Adverse Event|22|||
106071793|NCT03329690|365927381|FG001|Overall Study|Adverse Event|4|||
106071794|NCT03329690|365927382|FG002|Overall Study|Adverse Event|0|||
106071795|NCT03329690|365927383|FG003|Overall Study|Adverse Event|1|||
106071796|NCT03329690|365927384|FG004|Overall Study|Adverse Event|2|||
106071797|NCT03329690|365927380|FG000|Overall Study|Death|2|||
106071798|NCT03329690|365927381|FG001|Overall Study|Death|0|||
106071799|NCT03329690|365927382|FG002|Overall Study|Death|0|||
106071800|NCT03329690|365927383|FG003|Overall Study|Death|1|||
106071801|NCT03329690|365927384|FG004|Overall Study|Death|0|||
106071802|NCT03329690|365927380|FG000|Overall Study|Withdrawal by Subject|2|||
106071803|NCT03329690|365927381|FG001|Overall Study|Withdrawal by Subject|3|||
106071804|NCT03329690|365927382|FG002|Overall Study|Withdrawal by Subject|0|||
106156397|NCT02287311|366235326|FG005|Cohort 1: Dose Level 1|Death|0|||
106156398|NCT02287311|366235327|FG006|Cohort 1: Dose Level 1|Death|1|||
106156399|NCT02287311|366235328|FG007|Cohort 1: Dose Level 1|Death|0|||
106156400|NCT02287311|366235329|FG008|Cohort 1: Dose Level 1|Death|0|||
106156401|NCT02287311|366235321|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
106156402|NCT02287311|366235322|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
106156403|NCT02287311|366235323|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
106156404|NCT02287311|366235324|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
106156405|NCT02287311|366235325|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
106156406|NCT02287311|366235326|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
106156407|NCT02287311|366235327|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
106156408|NCT02287311|366235328|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
106156409|NCT02287311|366235329|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
106156410|NCT02287311|366235321|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
106156411|NCT02287311|366235322|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
106156412|NCT02287311|366235323|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
106156413|NCT02287311|366235324|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
106156414|NCT02287311|366235325|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
106156415|NCT02287311|366235326|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
106156416|NCT02287311|366235327|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
106156417|NCT02287311|366235328|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
106156418|NCT02287311|366235329|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
106156419|NCT02287311|366235321|FG000|Cohort 2: Dose Level 2|Death|0|||
106156420|NCT02287311|366235322|FG001|Cohort 2: Dose Level 2|Death|2|||
106156421|NCT02287311|366235323|FG002|Cohort 2: Dose Level 2|Death|0|||
106156422|NCT02287311|366235324|FG003|Cohort 2: Dose Level 2|Death|0|||
106156423|NCT02287311|366235325|FG004|Cohort 2: Dose Level 2|Death|2|||
106156424|NCT02287311|366235326|FG005|Cohort 2: Dose Level 2|Death|0|||
106156425|NCT02287311|366235327|FG006|Cohort 2: Dose Level 2|Death|0|||
106156426|NCT02287311|366235328|FG007|Cohort 2: Dose Level 2|Death|2|||
106156427|NCT02287311|366235329|FG008|Cohort 2: Dose Level 2|Death|0|||
106156428|NCT02287311|366235321|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
106156429|NCT02287311|366235322|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
106156430|NCT02287311|366235323|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
106156431|NCT02287311|366235324|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
106156432|NCT02287311|366235325|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
106156433|NCT02287311|366235326|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
106156434|NCT02287311|366235327|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
106156435|NCT02287311|366235328|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
106156436|NCT02287311|366235329|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
106156437|NCT02287311|366235321|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
106156438|NCT02287311|366235322|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
106156439|NCT02287311|366235323|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
106156440|NCT02287311|366235324|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
106156441|NCT02287311|366235325|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
106156442|NCT02287311|366235326|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
106156443|NCT02287311|366235327|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
106156444|NCT02287311|366235328|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
106156445|NCT02287311|366235329|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
106156446|NCT02287311|366235321|FG000|Cohort 3: Dose Level 3|Death|0|||
106156447|NCT02287311|366235322|FG001|Cohort 3: Dose Level 3|Death|0|||
106156448|NCT02287311|366235323|FG002|Cohort 3: Dose Level 3|Death|4|||
106156449|NCT02287311|366235324|FG003|Cohort 3: Dose Level 3|Death|0|||
106156450|NCT02287311|366235325|FG004|Cohort 3: Dose Level 3|Death|0|||
106156451|NCT02287311|366235326|FG005|Cohort 3: Dose Level 3|Death|4|||
106156452|NCT02287311|366235327|FG006|Cohort 3: Dose Level 3|Death|0|||
106156453|NCT02287311|366235328|FG007|Cohort 3: Dose Level 3|Death|0|||
106156454|NCT02287311|366235329|FG008|Cohort 3: Dose Level 3|Death|2|||
106156455|NCT02287311|366235321|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
105866309|NCT02290223|365159354|FG000|12 Months|Lost to Follow-up|16|||
106156456|NCT02287311|366235322|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
106156457|NCT02287311|366235323|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
106156458|NCT02287311|366235324|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
106156459|NCT02287311|366235325|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
106156460|NCT02287311|366235326|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
106156461|NCT02287311|366235327|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
106156462|NCT02287311|366235328|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
106156463|NCT02287311|366235329|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
106156464|NCT02287311|366235321|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
106156465|NCT02287311|366235322|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
106156466|NCT02287311|366235323|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
106156467|NCT02287311|366235324|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
106156468|NCT02287311|366235325|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
106156469|NCT02287311|366235326|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
106156470|NCT02287311|366235327|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
106156471|NCT02287311|366235328|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
106156472|NCT02287311|366235329|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
106156473|NCT05461131|366235330|FG000|Overall Study|Lost to Follow-up|0|||
106156474|NCT05461131|366235331|FG001|Overall Study|Lost to Follow-up|2|||
106156475|NCT03896516|366235332|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
106156476|NCT03896516|366235333|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
106156477|NCT03896516|366235332|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
106156478|NCT03896516|366235333|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
106156479|NCT03896516|366235332|FG000|Washout Period|Physician Decision|3|||
106156480|NCT03896516|366235333|FG001|Washout Period|Physician Decision|1|||
106156481|NCT03896516|366235332|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
106156482|NCT03896516|366235333|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
106156483|NCT03648840|366235336|FG000|First IV Infusion Session|Adverse Event|0|||
106156484|NCT03648840|366235337|FG001|First IV Infusion Session|Adverse Event|2|||
106156485|NCT03648840|366235336|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
106156486|NCT03648840|366235337|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
106156487|NCT03648840|366235336|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
106156488|NCT03648840|366235337|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
106156489|NCT03648840|366235336|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
106156490|NCT03648840|366235337|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
106156491|NCT04630262|366235339|FG000|Overall Study|Intraoperative Screen Failure|5|||
106156492|NCT04630262|366235339|FG000|Overall Study|Study terminated prematurely|71|||
106156493|NCT04630262|366235339|FG000|Overall Study|Withdrawal by Subject|2|||
106156494|NCT04630262|366235339|FG000|Overall Study|Physician Decision|2|||
106156495|NCT01195831|366235340|FG000|Overall Study|Lost to Follow-up|2|||
106156496|NCT01195831|366235341|FG001|Overall Study|Lost to Follow-up|4|||
106156497|NCT01195831|366235340|FG000|Overall Study|Withdrawal by Subject|2|||
106156498|NCT01195831|366235341|FG001|Overall Study|Withdrawal by Subject|2|||
106156499|NCT01195831|366235340|FG000|Overall Study|Adverse Event|4|||
106156500|NCT01195831|366235341|FG001|Overall Study|Adverse Event|2|||
106156501|NCT01195831|366235340|FG000|Overall Study|Protocol Violation|0|||
106156502|NCT01195831|366235341|FG001|Overall Study|Protocol Violation|2|||
106156503|NCT04638998|366235346|FG000|Overall Study|Withdrawal by Subject|1|||
106156504|NCT04638998|366235347|FG001|Overall Study|Withdrawal by Subject|3|||
106156505|NCT03692676|366235348|FG000|Overall Study|exclude patients with prior use|4424|||
106156506|NCT03692676|366235349|FG001|Overall Study|exclude patients with prior use|24726|||
106156507|NCT03692676|366235350|FG002|Overall Study|exclude patients with prior use|0|||
106156508|NCT03692676|366235351|FG003|Overall Study|exclude patients with prior use|0|||
106156509|NCT03692676|366235348|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
106156510|NCT03692676|366235349|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
106156511|NCT03692676|366235350|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
106156512|NCT03692676|366235351|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
106156513|NCT03692676|366235348|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
106156514|NCT03692676|366235349|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
106156515|NCT03692676|366235350|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
106156516|NCT03692676|366235351|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
106156517|NCT03692676|366235348|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
106156518|NCT03692676|366235349|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
106156519|NCT03692676|366235350|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
106156520|NCT03692676|366235351|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
106156521|NCT03692676|366235348|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
106156522|NCT03692676|366235349|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
106156523|NCT03692676|366235350|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
106156524|NCT03692676|366235351|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
106156525|NCT03692676|366235348|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
106156526|NCT03692676|366235349|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
106156527|NCT03692676|366235350|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
106156528|NCT03692676|366235351|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
106156529|NCT03692676|366235348|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
106156530|NCT03692676|366235349|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
106156531|NCT03692676|366235350|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
106156532|NCT03692676|366235351|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
106156533|NCT03692676|366235348|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
105866310|NCT02290223|365159355|FG001|12 Months|Lost to Follow-up|10|||
106156534|NCT03692676|366235349|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
106156535|NCT03692676|366235350|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
106071805|NCT03329690|365927383|FG003|Overall Study|Withdrawal by Subject|1|||
106071806|NCT03329690|365927384|FG004|Overall Study|Withdrawal by Subject|0|||
106071807|NCT03329690|365927380|FG000|Overall Study|Physician Decision|1|||
106071808|NCT03329690|365927381|FG001|Overall Study|Physician Decision|0|||
106071809|NCT03329690|365927382|FG002|Overall Study|Physician Decision|0|||
106071810|NCT03329690|365927383|FG003|Overall Study|Physician Decision|0|||
106071811|NCT03329690|365927384|FG004|Overall Study|Physician Decision|1|||
106071812|NCT03329690|365927380|FG000|Overall Study|Miscellaneous|6|||
106071813|NCT03329690|365927381|FG001|Overall Study|Miscellaneous|0|||
106071814|NCT03329690|365927382|FG002|Overall Study|Miscellaneous|0|||
106071815|NCT03329690|365927383|FG003|Overall Study|Miscellaneous|0|||
106071816|NCT03329690|365927384|FG004|Overall Study|Miscellaneous|0|||
106071817|NCT03329690|365927380|FG000|Overall Study|Did not receive treatment|1|||
106071818|NCT03329690|365927381|FG001|Overall Study|Did not receive treatment|0|||
106071819|NCT03329690|365927382|FG002|Overall Study|Did not receive treatment|0|||
106071820|NCT03329690|365927383|FG003|Overall Study|Did not receive treatment|1|||
106071821|NCT03329690|365927384|FG004|Overall Study|Did not receive treatment|0|||
106071822|NCT01852812|365927385|FG000|Overall Study|Adverse Event|0|||
106071823|NCT01852812|365927386|FG001|Overall Study|Adverse Event|0|||
106071824|NCT01852812|365927387|FG002|Overall Study|Adverse Event|1|||
106071825|NCT01852812|365927385|FG000|Overall Study|Non-compliance With Study Drug|0|||
106071826|NCT01852812|365927386|FG001|Overall Study|Non-compliance With Study Drug|1|||
106071827|NCT01852812|365927387|FG002|Overall Study|Non-compliance With Study Drug|0|||
106071828|NCT00949325|365927403|FG000|Overall Study|Adverse Event|0|||
106071829|NCT00949325|365927404|FG001|Overall Study|Adverse Event|2|||
106071830|NCT00949325|365927405|FG002|Overall Study|Adverse Event|0|||
106071831|NCT00791518|365927406|FG000|Overall Study|Protocol Violation|93|||
106071832|NCT01892501|365927407|FG000|Overall Study|Protocol Violation|2|||
106071833|NCT01892501|365927407|FG000|Overall Study|Puncture not carried out|9|||
106071834|NCT01892501|365927407|FG000|Overall Study|Radiological monitoring not carried out|5|||
106071835|NCT01892501|365927407|FG000|Overall Study|Non-contributory histological result|12|||
106071836|NCT02319031|365927408|FG000|Treatment Period|Death|1|||
106071837|NCT02319031|365927409|FG001|Treatment Period|Death|0|||
106071838|NCT00454987|365927410|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
106071839|NCT00454987|365927411|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
106071840|NCT00454987|365927412|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
106071841|NCT00454987|365927410|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
106071842|NCT00454987|365927411|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
106071843|NCT00454987|365927412|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
106071844|NCT00454987|365927410|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
106071845|NCT00454987|365927411|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
106071846|NCT00454987|365927412|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
106071847|NCT01476696|365927413|FG000|Overall Study|Sponsor decision|2|||
106071848|NCT01476696|365927414|FG001|Overall Study|Sponsor decision|1|||
106071849|NCT01476696|365927415|FG002|Overall Study|Sponsor decision|0|||
106071850|NCT01476696|365927413|FG000|Overall Study|Withdrawal by Subject|1|||
106071851|NCT01476696|365927414|FG001|Overall Study|Withdrawal by Subject|0|||
106071852|NCT01476696|365927415|FG002|Overall Study|Withdrawal by Subject|0|||
106071853|NCT03054870|365927418|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
106071854|NCT03054870|365927418|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
106071855|NCT02009046|365927419|FG000|Overall Study|Lost to Follow-up|256|||
106071856|NCT02009046|365927420|FG001|Overall Study|Lost to Follow-up|206|||
106071857|NCT01176266|365927421|FG000|Overall Study|Death|6|||
106071858|NCT01176266|365927421|FG000|Overall Study|Withdrawal by Subject|3|||
106071859|NCT00728130|365927423|FG000|Overall Study|Withdrawal by Subject|1|||
106071860|NCT00728130|365927423|FG000|Overall Study|Paperwork not completed in time|1|||
106071861|NCT00728130|365927423|FG000|Overall Study|Physician Decision|1|||
106071862|NCT05075850|365927430|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
106071863|NCT01154218|365927431|FG000|Third Intervention Period|Adverse Event|0|||
106071864|NCT01154218|365927432|FG001|Third Intervention Period|Adverse Event|1|||
106071865|NCT01154218|365927433|FG002|Third Intervention Period|Adverse Event|0|||
106071866|NCT01154218|365927434|FG003|Third Intervention Period|Adverse Event|0|||
106071867|NCT01154218|365927431|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
106071868|NCT01154218|365927432|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
106071869|NCT01154218|365927433|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
106071870|NCT01154218|365927434|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
106071871|NCT01154218|365927431|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
106071872|NCT01154218|365927432|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
106071873|NCT01154218|365927433|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
106071874|NCT01154218|365927434|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
106071875|NCT03089606|365927435|FG000|Overall Study|Progression after Cycle 1|1|||
106071876|NCT01826487|365927438|FG000|Overall Study|Adverse Event|1|||
106071877|NCT01826487|365927439|FG001|Overall Study|Adverse Event|1|||
106071878|NCT01826487|365927438|FG000|Overall Study|Lost to Follow-up|1|||
105866311|NCT02290223|365159354|FG000|12 Months|Refusal|0|||
105866312|NCT02290223|365159355|FG001|12 Months|Refusal|1|||
105866313|NCT01098487|365159357|FG000|Overall Study|Adverse Event|22|||
105866314|NCT01098487|365159357|FG000|Overall Study|Lack of Efficacy|11|||
105866315|NCT01098487|365159357|FG000|Overall Study|Withdrawal by Subject|7|||
105866316|NCT01098487|365159357|FG000|Overall Study|Lost to Follow-up|3|||
105866317|NCT01098487|365159357|FG000|Overall Study|Physician Decision|1|||
105866318|NCT01301729|365159358|FG000|Overall Study|Withdrawal by Subject|2|||
105866319|NCT01301729|365159358|FG000|Overall Study|Participant did not Return for Treatment|1|||
105866320|NCT01301729|365159358|FG000|Overall Study|Violated Selection Criteria|1|||
105866321|NCT01957176|365159361|FG000|Overall Study|Adverse Event|2|||
105866322|NCT01957176|365159362|FG001|Overall Study|Adverse Event|0|||
105866323|NCT01957176|365159361|FG000|Overall Study|Physician Decision|2|||
105866324|NCT01957176|365159362|FG001|Overall Study|Physician Decision|1|||
105866325|NCT01957176|365159361|FG000|Overall Study|Withdrawal by Subject|1|||
105866326|NCT01957176|365159362|FG001|Overall Study|Withdrawal by Subject|0|||
105866327|NCT01464931|365159363|FG000|Overall Study|Withdrawal by Subject|1|||
106071879|NCT01826487|365927439|FG001|Overall Study|Lost to Follow-up|0|||
106071880|NCT01826487|365927438|FG000|Overall Study|Withdrawal by Subject|1|||
106071881|NCT01826487|365927439|FG001|Overall Study|Withdrawal by Subject|3|||
106071882|NCT01826487|365927438|FG000|Overall Study|Protocol Violation|1|||
106071883|NCT01826487|365927439|FG001|Overall Study|Protocol Violation|1|||
106071884|NCT01092182|365927441|FG000|Overall Study|Death|0|||
106071885|NCT01092182|365927442|FG001|Overall Study|Death|5|||
106071886|NCT01092182|365927443|FG002|Overall Study|Death|3|||
106071887|NCT01092182|365927441|FG000|Overall Study|participant safety|1|||
106071888|NCT01092182|365927442|FG001|Overall Study|participant safety|2|||
106071889|NCT01092182|365927443|FG002|Overall Study|participant safety|0|||
106071890|NCT01092182|365927441|FG000|Overall Study|Physician Decision|0|||
106071891|NCT01092182|365927442|FG001|Overall Study|Physician Decision|6|||
106071892|NCT01092182|365927443|FG002|Overall Study|Physician Decision|0|||
106071893|NCT01092182|365927441|FG000|Overall Study|Did not meet criteria|0|||
106071894|NCT01092182|365927442|FG001|Overall Study|Did not meet criteria|0|||
106071895|NCT01092182|365927443|FG002|Overall Study|Did not meet criteria|25|||
106071896|NCT01092182|365927441|FG000|Overall Study|Non-compliance|0|||
106071897|NCT01092182|365927442|FG001|Overall Study|Non-compliance|3|||
106071898|NCT01092182|365927443|FG002|Overall Study|Non-compliance|0|||
106071899|NCT01092182|365927441|FG000|Overall Study|Participant refused follow-up|0|||
106071900|NCT01092182|365927442|FG001|Overall Study|Participant refused follow-up|2|||
106071901|NCT01092182|365927443|FG002|Overall Study|Participant refused follow-up|0|||
106071902|NCT02081079|365927444|FG000|Overall Study|Lack of Efficacy|3|||
106071903|NCT02081079|365927445|FG001|Overall Study|Lack of Efficacy|2|||
106071904|NCT02081079|365927444|FG000|Overall Study|Lost to Follow-up|1|||
106071905|NCT02081079|365927445|FG001|Overall Study|Lost to Follow-up|0|||
106071906|NCT00322842|365927446|FG000|Overall Study|Withdrawal by Subject|0|||
106071907|NCT00322842|365927447|FG001|Overall Study|Withdrawal by Subject|1|||
106071908|NCT00322842|365927446|FG000|Overall Study|Lost to Follow-up|0|||
106071909|NCT00322842|365927447|FG001|Overall Study|Lost to Follow-up|1|||
106071910|NCT00322842|365927446|FG000|Overall Study|Refused transplant|1|||
106071911|NCT00322842|365927447|FG001|Overall Study|Refused transplant|0|||
106071912|NCT00322842|365927446|FG000|Overall Study|Death|1|||
106071913|NCT00322842|365927447|FG001|Overall Study|Death|0|||
106071914|NCT02515045|365927448|FG000|Overall Study|Adverse Event|0|||
106071915|NCT02515045|365927449|FG001|Overall Study|Adverse Event|3|||
106071916|NCT02515045|365927450|FG002|Overall Study|Adverse Event|3|||
106071917|NCT02515045|365927448|FG000|Overall Study|Lost to Follow-up|0|||
106071918|NCT02515045|365927449|FG001|Overall Study|Lost to Follow-up|1|||
106071919|NCT02515045|365927450|FG002|Overall Study|Lost to Follow-up|1|||
106071920|NCT02068222|365927453|FG000|Overall Study|Lost to Follow-up|1|||
106071921|NCT03082599|365927454|FG000|Overall Study|Lost to Follow-up|1|||
106071922|NCT03082599|365927455|FG001|Overall Study|Lost to Follow-up|0|||
106071923|NCT00238121|365927456|FG000|Overall Study|Withdrawal by Subject|1|||
106071924|NCT00238121|365927457|FG001|Overall Study|Withdrawal by Subject|1|||
106071925|NCT00238121|365927456|FG000|Overall Study|Adverse Event|2|||
106071926|NCT00238121|365927457|FG001|Overall Study|Adverse Event|1|||
106071927|NCT03255382|365927458|FG000|Overall Study|Adverse Event|3|||
105866328|NCT01464931|365159364|FG001|Overall Study|Withdrawal by Subject|0|||
106071928|NCT03255382|365927459|FG001|Overall Study|Adverse Event|0|||
106071929|NCT03255382|365927458|FG000|Overall Study|Lost to Follow-up|2|||
106071930|NCT03255382|365927459|FG001|Overall Study|Lost to Follow-up|0|||
106071931|NCT03255382|365927458|FG000|Overall Study|Withdrawal by Subject|2|||
106071932|NCT03255382|365927459|FG001|Overall Study|Withdrawal by Subject|0|||
106071933|NCT03255382|365927458|FG000|Overall Study|Other|6|||
106071934|NCT03255382|365927459|FG001|Overall Study|Other|0|||
106071935|NCT02221284|365927464|FG000|Overall Study|Case Report Forms Uncollected|56|||
106071936|NCT02221284|365927464|FG000|Overall Study|Protocol Deviation|5|||
106071937|NCT01675128|365927469|FG000|Overall Study|Disease progression on study|1|||
105866329|NCT00839254|365159365|FG000|Overall Study|Protocol Violation|0|||
105866330|NCT00839254|365159366|FG001|Overall Study|Protocol Violation|1|||
105866331|NCT00839254|365159367|FG002|Overall Study|Protocol Violation|1|||
105866332|NCT00839254|365159368|FG003|Overall Study|Protocol Violation|1|||
105866333|NCT00839254|365159369|FG004|Overall Study|Protocol Violation|0|||
105866334|NCT00839254|365159370|FG005|Overall Study|Protocol Violation|0|||
105866335|NCT00839254|365159371|FG006|Overall Study|Protocol Violation|1|||
105866336|NCT00839254|365159372|FG007|Overall Study|Protocol Violation|2|||
105866337|NCT00839254|365159365|FG000|Overall Study|Physician Decision|0|||
105866338|NCT00839254|365159366|FG001|Overall Study|Physician Decision|1|||
105866339|NCT00839254|365159367|FG002|Overall Study|Physician Decision|0|||
105866340|NCT00839254|365159368|FG003|Overall Study|Physician Decision|0|||
105866341|NCT00839254|365159369|FG004|Overall Study|Physician Decision|0|||
105866342|NCT00839254|365159370|FG005|Overall Study|Physician Decision|0|||
105866343|NCT00839254|365159371|FG006|Overall Study|Physician Decision|0|||
105866344|NCT00839254|365159372|FG007|Overall Study|Physician Decision|1|||
105866345|NCT00839254|365159365|FG000|Overall Study|Wrong treatment number allocation|0|||
105866346|NCT00839254|365159366|FG001|Overall Study|Wrong treatment number allocation|1|||
105866347|NCT00839254|365159367|FG002|Overall Study|Wrong treatment number allocation|0|||
105866348|NCT00839254|365159368|FG003|Overall Study|Wrong treatment number allocation|0|||
105866349|NCT00839254|365159369|FG004|Overall Study|Wrong treatment number allocation|0|||
105866350|NCT00839254|365159370|FG005|Overall Study|Wrong treatment number allocation|1|||
105866351|NCT00839254|365159371|FG006|Overall Study|Wrong treatment number allocation|0|||
105866352|NCT00839254|365159372|FG007|Overall Study|Wrong treatment number allocation|0|||
105866353|NCT00839254|365159365|FG000|Overall Study|Adverse Event|12|||
105866354|NCT00839254|365159366|FG001|Overall Study|Adverse Event|6|||
105866355|NCT00839254|365159367|FG002|Overall Study|Adverse Event|3|||
105866356|NCT00839254|365159368|FG003|Overall Study|Adverse Event|5|||
105866357|NCT00839254|365159369|FG004|Overall Study|Adverse Event|2|||
105866358|NCT00839254|365159370|FG005|Overall Study|Adverse Event|1|||
105866359|NCT00839254|365159371|FG006|Overall Study|Adverse Event|0|||
105866360|NCT00839254|365159372|FG007|Overall Study|Adverse Event|1|||
105866361|NCT00839254|365159365|FG000|Overall Study|Withdrawal by Subject|87|||
105866362|NCT00839254|365159366|FG001|Overall Study|Withdrawal by Subject|53|||
105866363|NCT00839254|365159367|FG002|Overall Study|Withdrawal by Subject|54|||
105866364|NCT00839254|365159368|FG003|Overall Study|Withdrawal by Subject|32|||
105866365|NCT00839254|365159369|FG004|Overall Study|Withdrawal by Subject|27|||
106071938|NCT01675128|365927470|FG001|Overall Study|Disease progression on study|1|||
106071939|NCT01675128|365927471|FG002|Overall Study|Disease progression on study|1|||
106071940|NCT01675128|365927469|FG000|Overall Study|Refused further treatment|1|||
106071941|NCT01675128|365927470|FG001|Overall Study|Refused further treatment|0|||
106071942|NCT01675128|365927471|FG002|Overall Study|Refused further treatment|0|||
106071943|NCT01675128|365927469|FG000|Overall Study|Pulmonary complication; off study|0|||
106071944|NCT01675128|365927470|FG001|Overall Study|Pulmonary complication; off study|1|||
106071945|NCT01675128|365927471|FG002|Overall Study|Pulmonary complication; off study|0|||
106071946|NCT03011307|365927473|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
106071947|NCT03011307|365927474|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
106071948|NCT03011307|365927473|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
106071949|NCT03011307|365927474|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
106071950|NCT03011307|365927473|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
106071951|NCT03011307|365927474|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
106156536|NCT03692676|366235351|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
106156537|NCT03692676|366235348|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
106156538|NCT03692676|366235349|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
106156539|NCT03692676|366235350|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
106156540|NCT03692676|366235351|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
106156541|NCT03692676|366235348|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
106156542|NCT03692676|366235349|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
106156543|NCT03692676|366235350|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
105866366|NCT00839254|365159370|FG005|Overall Study|Withdrawal by Subject|15|||
105866367|NCT00839254|365159371|FG006|Overall Study|Withdrawal by Subject|22|||
105866368|NCT00839254|365159372|FG007|Overall Study|Withdrawal by Subject|9|||
105866369|NCT00839254|365159365|FG000|Overall Study|Wrong group allocation|0|||
106156544|NCT03692676|366235351|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
105866370|NCT00839254|365159366|FG001|Overall Study|Wrong group allocation|0|||
105866371|NCT00839254|365159367|FG002|Overall Study|Wrong group allocation|0|||
105866372|NCT00839254|365159368|FG003|Overall Study|Wrong group allocation|0|||
105866373|NCT00839254|365159369|FG004|Overall Study|Wrong group allocation|0|||
105866374|NCT00839254|365159370|FG005|Overall Study|Wrong group allocation|0|||
106071952|NCT01782664|365927475|FG000|Overall Study|Adverse Event|2|||
106071953|NCT01782664|365927476|FG001|Overall Study|Adverse Event|2|||
106071954|NCT01782664|365927477|FG002|Overall Study|Adverse Event|2|||
106071955|NCT01782664|365927478|FG003|Overall Study|Adverse Event|2|||
106071956|NCT01782664|365927479|FG004|Overall Study|Adverse Event|0|||
106071957|NCT01782664|365927480|FG005|Overall Study|Adverse Event|0|||
106071958|NCT01782664|365927475|FG000|Overall Study|Lack of Efficacy|2|||
106071959|NCT01782664|365927476|FG001|Overall Study|Lack of Efficacy|0|||
106071960|NCT01782664|365927477|FG002|Overall Study|Lack of Efficacy|2|||
106071961|NCT01782664|365927478|FG003|Overall Study|Lack of Efficacy|2|||
106071962|NCT01782664|365927479|FG004|Overall Study|Lack of Efficacy|0|||
106071963|NCT01782664|365927480|FG005|Overall Study|Lack of Efficacy|0|||
106071964|NCT01782664|365927475|FG000|Overall Study|Protocol Violation|0|||
106071965|NCT01782664|365927476|FG001|Overall Study|Protocol Violation|1|||
106071966|NCT01782664|365927477|FG002|Overall Study|Protocol Violation|0|||
106071967|NCT01782664|365927478|FG003|Overall Study|Protocol Violation|1|||
106071968|NCT01782664|365927479|FG004|Overall Study|Protocol Violation|0|||
106071969|NCT01782664|365927480|FG005|Overall Study|Protocol Violation|0|||
106071970|NCT01782664|365927475|FG000|Overall Study|Withdrawal by Subject|2|||
106071971|NCT01782664|365927476|FG001|Overall Study|Withdrawal by Subject|2|||
106071972|NCT01782664|365927477|FG002|Overall Study|Withdrawal by Subject|0|||
106071973|NCT01782664|365927478|FG003|Overall Study|Withdrawal by Subject|0|||
106071974|NCT01782664|365927479|FG004|Overall Study|Withdrawal by Subject|0|||
106071975|NCT01782664|365927480|FG005|Overall Study|Withdrawal by Subject|0|||
106071976|NCT00281684|365927482|FG000|Overall Study|Lost to Follow-up|0|||
106071977|NCT00281684|365927483|FG001|Overall Study|Lost to Follow-up|0|||
106071978|NCT00281684|365927484|FG002|Overall Study|Lost to Follow-up|1|||
106071979|NCT00281684|365927485|FG003|Overall Study|Lost to Follow-up|0|||
106071980|NCT00281684|365927482|FG000|Overall Study|Withdrawal by Subject|1|||
106071981|NCT00281684|365927483|FG001|Overall Study|Withdrawal by Subject|0|||
106071982|NCT00281684|365927484|FG002|Overall Study|Withdrawal by Subject|0|||
106071983|NCT00281684|365927485|FG003|Overall Study|Withdrawal by Subject|0|||
106071984|NCT00698581|365927488|FG000|Overall Study|Lack of Efficacy|23|||
106071985|NCT00698581|365927489|FG001|Overall Study|Lack of Efficacy|11|||
106071986|NCT00698581|365927488|FG000|Overall Study|Withdrawal by Subject|6|||
106071987|NCT00698581|365927489|FG001|Overall Study|Withdrawal by Subject|0|||
106071988|NCT00698581|365927488|FG000|Overall Study|Other reason|9|||
106071989|NCT00698581|365927489|FG001|Overall Study|Other reason|1|||
106071990|NCT00698581|365927488|FG000|Overall Study|SAE, non-fatal|1|||
106071991|NCT00698581|365927489|FG001|Overall Study|SAE, non-fatal|0|||
106071992|NCT00698581|365927488|FG000|Overall Study|AE, non-serious non-fatal|4|||
106071993|NCT00698581|365927489|FG001|Overall Study|AE, non-serious non-fatal|0|||
106071994|NCT00698581|365927488|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
106071995|NCT00698581|365927489|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
106071996|NCT00698581|365927488|FG000|Overall Study|AE of unknown type|1|||
106071997|NCT00698581|365927489|FG001|Overall Study|AE of unknown type|0|||
106071998|NCT01082965|365927490|FG000|Overall Study|Protocol Violation|0|||
106071999|NCT01082965|365927491|FG001|Overall Study|Protocol Violation|1|||
106072000|NCT01082965|365927490|FG000|Overall Study|Other|1|||
106072001|NCT01082965|365927491|FG001|Overall Study|Other|1|||
106072002|NCT00529542|365927492|FG000|Overall Study|Withdrawal by Subject|1|||
106072003|NCT00529542|365927493|FG001|Overall Study|Withdrawal by Subject|0|||
106072004|NCT00529542|365927492|FG000|Overall Study|Lost to Follow-up|0|||
106072005|NCT00529542|365927493|FG001|Overall Study|Lost to Follow-up|1|||
106072006|NCT00946712|365927494|FG000|Overall Study|Adverse Event|118|||
106072007|NCT00946712|365927495|FG001|Overall Study|Adverse Event|124|||
106072008|NCT00946712|365927494|FG000|Overall Study|Disease progression|308|||
105866375|NCT00839254|365159371|FG006|Overall Study|Wrong group allocation|1|||
105866376|NCT00839254|365159372|FG007|Overall Study|Wrong group allocation|0|||
105866377|NCT00839254|365159365|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
105866378|NCT00839254|365159366|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
105866379|NCT00839254|365159367|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
105866380|NCT00839254|365159368|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
105866381|NCT00839254|365159369|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
106072009|NCT00946712|365927495|FG001|Overall Study|Disease progression|404|||
106072010|NCT00946712|365927494|FG000|Overall Study|Death|21|||
106072011|NCT00946712|365927495|FG001|Overall Study|Death|22|||
106072012|NCT00946712|365927494|FG000|Overall Study|No treatment given|25|||
106072013|NCT00946712|365927495|FG001|Overall Study|No treatment given|29|||
106072014|NCT00946712|365927494|FG000|Overall Study|Other reasons|61|||
106072015|NCT00946712|365927495|FG001|Overall Study|Other reasons|73|||
106072016|NCT00946712|365927494|FG000|Overall Study|On Treatment|0|||
106072017|NCT00946712|365927495|FG001|Overall Study|On Treatment|4|||
106072018|NCT00946712|365927494|FG000|Overall Study|Ineligible|14|||
106072019|NCT00946712|365927495|FG001|Overall Study|Ineligible|6|||
106072020|NCT01523886|365927497|FG000|Overall Study|surgery cancelled|0|||
106072021|NCT01523886|365927498|FG001|Overall Study|surgery cancelled|1|||
106072022|NCT01852942|365929952|FG000|Overall Study|Physician Decision|1|||
106072023|NCT01852942|365929953|FG001|Overall Study|Physician Decision|0|||
105866382|NCT00839254|365159370|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
105866383|NCT00839254|365159371|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
105866384|NCT00839254|365159372|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
105866385|NCT00839254|365159365|FG000|Overall Study|Withdrawn due to non-compliance|2|||
105866386|NCT00839254|365159366|FG001|Overall Study|Withdrawn due to non-compliance|0|||
105866387|NCT00839254|365159367|FG002|Overall Study|Withdrawn due to non-compliance|0|||
105866388|NCT00839254|365159368|FG003|Overall Study|Withdrawn due to non-compliance|0|||
105866389|NCT00839254|365159369|FG004|Overall Study|Withdrawn due to non-compliance|0|||
105866390|NCT00839254|365159370|FG005|Overall Study|Withdrawn due to non-compliance|0|||
105866391|NCT00839254|365159371|FG006|Overall Study|Withdrawn due to non-compliance|0|||
105866392|NCT00839254|365159372|FG007|Overall Study|Withdrawn due to non-compliance|0|||
106072024|NCT01852942|365929952|FG000|Overall Study|Death|1|||
106072025|NCT01852942|365929953|FG001|Overall Study|Death|1|||
106072026|NCT01852942|365929952|FG000|Overall Study|Withdrawal by Subject|2|||
106072027|NCT01852942|365929953|FG001|Overall Study|Withdrawal by Subject|3|||
106072028|NCT01852942|365929952|FG000|Overall Study|Lost to Follow-up|1|||
106072029|NCT01852942|365929953|FG001|Overall Study|Lost to Follow-up|2|||
106072030|NCT02155738|365929961|FG000|Overall Study|Missing critical information|1|||
106072031|NCT02155738|365929962|FG001|Overall Study|Missing critical information|0|||
106072032|NCT02155738|365929963|FG002|Overall Study|Missing critical information|0|||
106072033|NCT02155738|365929964|FG003|Overall Study|Missing critical information|1|||
106072034|NCT02356783|365929965|FG000|Overall Study|Lost to Follow-up|1|||
106072035|NCT02356783|365929966|FG001|Overall Study|Lost to Follow-up|3|||
106072036|NCT02603809|365929967|FG000|Overall Study|Withdrawal by Subject|4|||
106072037|NCT02603809|365929968|FG001|Overall Study|Withdrawal by Subject|1|||
106072038|NCT02603809|365929969|FG002|Overall Study|Withdrawal by Subject|2|||
106072039|NCT02603809|365929970|FG003|Overall Study|Withdrawal by Subject|3|||
106072040|NCT02603809|365929971|FG004|Overall Study|Withdrawal by Subject|3|||
106072041|NCT02603809|365929972|FG005|Overall Study|Withdrawal by Subject|4|||
106072042|NCT02603809|365929967|FG000|Overall Study|Lost to Follow-up|2|||
106072043|NCT02603809|365929968|FG001|Overall Study|Lost to Follow-up|3|||
106072044|NCT02603809|365929969|FG002|Overall Study|Lost to Follow-up|1|||
106072045|NCT02603809|365929970|FG003|Overall Study|Lost to Follow-up|4|||
106072046|NCT02603809|365929971|FG004|Overall Study|Lost to Follow-up|2|||
106072047|NCT02603809|365929972|FG005|Overall Study|Lost to Follow-up|2|||
106072048|NCT02603809|365929967|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
106072049|NCT02603809|365929968|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
106072050|NCT02603809|365929969|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
106072051|NCT02603809|365929970|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
106072052|NCT02603809|365929971|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
106072053|NCT02603809|365929972|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
106072054|NCT02603809|365929967|FG000|Overall Study|Physician Decision|0|||
106072055|NCT02603809|365929968|FG001|Overall Study|Physician Decision|0|||
106072056|NCT02603809|365929969|FG002|Overall Study|Physician Decision|0|||
106072057|NCT02603809|365929970|FG003|Overall Study|Physician Decision|1|||
106072058|NCT02603809|365929971|FG004|Overall Study|Physician Decision|2|||
106072059|NCT02603809|365929972|FG005|Overall Study|Physician Decision|1|||
106072060|NCT02603809|365929967|FG000|Overall Study|Adverse Event|3|||
106072061|NCT02603809|365929968|FG001|Overall Study|Adverse Event|0|||
106072062|NCT02603809|365929969|FG002|Overall Study|Adverse Event|2|||
106072063|NCT02603809|365929970|FG003|Overall Study|Adverse Event|2|||
106072064|NCT02603809|365929971|FG004|Overall Study|Adverse Event|1|||
106072065|NCT02603809|365929972|FG005|Overall Study|Adverse Event|1|||
106072066|NCT02603809|365929967|FG000|Overall Study|Lack of Efficacy|0|||
106072067|NCT02603809|365929968|FG001|Overall Study|Lack of Efficacy|1|||
106072068|NCT02603809|365929969|FG002|Overall Study|Lack of Efficacy|0|||
106072069|NCT02603809|365929970|FG003|Overall Study|Lack of Efficacy|0|||
106072070|NCT02603809|365929971|FG004|Overall Study|Lack of Efficacy|0|||
106072071|NCT02603809|365929972|FG005|Overall Study|Lack of Efficacy|1|||
106072072|NCT00156533|365929973|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
106072073|NCT00156533|365929974|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
106072074|NCT00156533|365929975|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
106072075|NCT00156533|365929976|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
106072076|NCT00156533|365929973|FG000|Overall Study|Withdrawal by Subject|1|||
105866393|NCT00839254|365159365|FG000|Overall Study|Lost to Follow-up|51|||
105866394|NCT00839254|365159366|FG001|Overall Study|Lost to Follow-up|30|||
106072077|NCT00156533|365929974|FG001|Overall Study|Withdrawal by Subject|0|||
106072078|NCT00156533|365929975|FG002|Overall Study|Withdrawal by Subject|0|||
106072079|NCT00156533|365929976|FG003|Overall Study|Withdrawal by Subject|1|||
106072080|NCT00156533|365929973|FG000|Overall Study|Failed Screening|1|||
106072081|NCT00156533|365929974|FG001|Overall Study|Failed Screening|0|||
106072082|NCT00156533|365929975|FG002|Overall Study|Failed Screening|1|||
106072083|NCT00156533|365929976|FG003|Overall Study|Failed Screening|1|||
106072084|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
106072085|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
106072086|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
106072087|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
106072088|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
106072089|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
106072090|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
106072091|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
106072092|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
106072093|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
106072094|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
106072095|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
106072096|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
106072097|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
106072098|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
106072099|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
106072100|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
106072101|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
106072102|NCT00887354|365929977|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
106072103|NCT00887354|365929978|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
106072104|NCT00887354|365929977|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
106072105|NCT00887354|365929978|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
106072106|NCT00887354|365929977|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
106072107|NCT00887354|365929978|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
106156545|NCT03692676|366235348|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
106156546|NCT03692676|366235349|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
106156547|NCT03692676|366235350|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
106156548|NCT03692676|366235351|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
106156549|NCT03692676|366235348|FG000|Overall Study|Other|0|||
106156550|NCT03692676|366235349|FG001|Overall Study|Other|805|||
106156551|NCT03692676|366235350|FG002|Overall Study|Other|758|||
106156552|NCT03692676|366235351|FG003|Overall Study|Other|277|||
106156553|NCT03692676|366235348|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
106156554|NCT03692676|366235349|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
106156555|NCT03692676|366235350|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
106156556|NCT03692676|366235351|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
106156557|NCT04549168|366235352|FG000|Randomization Phase|Adverse Event|0|||
106156558|NCT04549168|366235353|FG001|Randomization Phase|Adverse Event|0|||
106156559|NCT04549168|366235354|FG002|Randomization Phase|Adverse Event|1|||
106156560|NCT04549168|366235352|FG000|Randomization Phase|Other|0|||
106156561|NCT04549168|366235353|FG001|Randomization Phase|Other|2|||
106156562|NCT04549168|366235354|FG002|Randomization Phase|Other|0|||
106156563|NCT04549168|366235352|FG000|Randomization Phase|Withdrawal by Subject|0|||
106156564|NCT04549168|366235353|FG001|Randomization Phase|Withdrawal by Subject|2|||
106156565|NCT04549168|366235354|FG002|Randomization Phase|Withdrawal by Subject|1|||
106072108|NCT00887354|365929977|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
106072109|NCT00887354|365929978|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
106072110|NCT00887354|365929977|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
106072111|NCT00887354|365929978|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
106072112|NCT00887354|365929977|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
106072113|NCT00887354|365929978|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
106072114|NCT02981342|365929980|FG000|Overall Study|Adverse Event|0|||
106072115|NCT02981342|365929981|FG001|Overall Study|Adverse Event|0|||
106072116|NCT02981342|365929982|FG002|Overall Study|Adverse Event|0|||
106072117|NCT02981342|365929983|FG003|Overall Study|Adverse Event|1|||
106072118|NCT02981342|365929980|FG000|Overall Study|Death|0|||
106072119|NCT02981342|365929981|FG001|Overall Study|Death|9|||
106072120|NCT02981342|365929982|FG002|Overall Study|Death|9|||
106072121|NCT02981342|365929983|FG003|Overall Study|Death|4|||
106072122|NCT02981342|365929980|FG000|Overall Study|Withdrawal by Subject|0|||
106072123|NCT02981342|365929981|FG001|Overall Study|Withdrawal by Subject|0|||
106072124|NCT02981342|365929982|FG002|Overall Study|Withdrawal by Subject|3|||
106072125|NCT02981342|365929983|FG003|Overall Study|Withdrawal by Subject|1|||
106072126|NCT02981342|365929980|FG000|Overall Study|Study closed by sponsor|0|||
106072127|NCT02981342|365929981|FG001|Overall Study|Study closed by sponsor|0|||
106072128|NCT02981342|365929982|FG002|Overall Study|Study closed by sponsor|1|||
106072129|NCT02981342|365929983|FG003|Overall Study|Study closed by sponsor|1|||
106156566|NCT04725240|366235359|FG000|Overall Study|Adverse Event|2|||
106156567|NCT03147287|366235362|FG000|Overall Study|Randomized Not Treated|2|||
105866395|NCT00839254|365159367|FG002|Overall Study|Lost to Follow-up|32|||
106072130|NCT02981342|365929980|FG000|Overall Study|Randomized, Never Treated|0|||
105866396|NCT00839254|365159368|FG003|Overall Study|Lost to Follow-up|24|||
105866397|NCT00839254|365159369|FG004|Overall Study|Lost to Follow-up|8|||
106072131|NCT02981342|365929981|FG001|Overall Study|Randomized, Never Treated|1|||
106072132|NCT02981342|365929982|FG002|Overall Study|Randomized, Never Treated|0|||
106072133|NCT02981342|365929983|FG003|Overall Study|Randomized, Never Treated|7|||
106072134|NCT02981342|365929980|FG000|Overall Study|Lost to Follow-up|0|||
106072135|NCT02981342|365929981|FG001|Overall Study|Lost to Follow-up|1|||
106072136|NCT02981342|365929982|FG002|Overall Study|Lost to Follow-up|0|||
106072137|NCT02981342|365929983|FG003|Overall Study|Lost to Follow-up|0|||
106072138|NCT01365507|365929984|FG000|Overall Study|Withdrawal Criteria|8|||
106072139|NCT01365507|365929985|FG001|Overall Study|Withdrawal Criteria|5|||
106072140|NCT01365507|365929984|FG000|Overall Study|Unclassified|1|||
106072141|NCT01365507|365929985|FG001|Overall Study|Unclassified|4|||
106072142|NCT00192504|365929990|FG000|Overall Study|Lost to Follow-up|1|||
106072143|NCT00192504|365929991|FG001|Overall Study|Lost to Follow-up|0|||
106072144|NCT00192504|365929992|FG002|Overall Study|Lost to Follow-up|0|||
106072145|NCT00192504|365929993|FG003|Overall Study|Lost to Follow-up|0|||
106072146|NCT00192504|365929990|FG000|Overall Study|Dosing window missed|0|||
106072147|NCT00192504|365929991|FG001|Overall Study|Dosing window missed|0|||
106072148|NCT00192504|365929992|FG002|Overall Study|Dosing window missed|1|||
106072149|NCT00192504|365929993|FG003|Overall Study|Dosing window missed|0|||
106072150|NCT00605813|365929994|FG000|Overall Study|Protocol Violation|25|||
106072151|NCT03989440|365929995|FG000|Overall Study|COVID-19 travel restrictions|0|||
106072152|NCT03989440|365929996|FG001|Overall Study|COVID-19 travel restrictions|0|||
106072153|NCT03989440|365929997|FG002|Overall Study|COVID-19 travel restrictions|1|||
106072154|NCT03989440|365929998|FG003|Overall Study|COVID-19 travel restrictions|0|||
106072155|NCT03989440|365929999|FG004|Overall Study|COVID-19 travel restrictions|0|||
106072156|NCT03989440|365930000|FG005|Overall Study|COVID-19 travel restrictions|0|||
106072157|NCT03989440|365929995|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
106072158|NCT03989440|365929996|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
106072159|NCT03989440|365929997|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
106072160|NCT03989440|365929998|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
106072161|NCT03989440|365929999|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
106072162|NCT03989440|365930000|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
106072163|NCT03265249|365930001|FG000|Overall Study|Withdrawal by Subject|0|||
106072164|NCT03265249|365930002|FG001|Overall Study|Withdrawal by Subject|1|||
106072165|NCT01614990|365930003|FG000|Overall Study|Protocol Violation|1|||
106072166|NCT01614990|365930004|FG001|Overall Study|Protocol Violation|1|||
106072167|NCT02794103|365930005|FG000|Overall Study|Loss to follow up due to high sedation|3|||
106072168|NCT01139450|365930006|FG000|Overall Study|Withdrawal by Subject|7|||
106072169|NCT01139450|365930007|FG001|Overall Study|Withdrawal by Subject|10|||
106072170|NCT01139450|365930008|FG002|Overall Study|Withdrawal by Subject|13|||
106072171|NCT01139450|365930006|FG000|Overall Study|Lack of Efficacy|3|||
106072172|NCT01139450|365930007|FG001|Overall Study|Lack of Efficacy|1|||
106072173|NCT01139450|365930008|FG002|Overall Study|Lack of Efficacy|8|||
106072174|NCT01139450|365930006|FG000|Overall Study|Protocol Violation|6|||
106072175|NCT01139450|365930007|FG001|Overall Study|Protocol Violation|5|||
106072176|NCT01139450|365930008|FG002|Overall Study|Protocol Violation|2|||
106072177|NCT01139450|365930006|FG000|Overall Study|Lost to Follow-up|9|||
106072178|NCT01139450|365930007|FG001|Overall Study|Lost to Follow-up|7|||
106072179|NCT01139450|365930008|FG002|Overall Study|Lost to Follow-up|11|||
106072180|NCT01139450|365930006|FG000|Overall Study|Administrative|0|||
106072181|NCT01139450|365930007|FG001|Overall Study|Administrative|0|||
106072182|NCT01139450|365930008|FG002|Overall Study|Administrative|1|||
106072183|NCT01139450|365930006|FG000|Overall Study|Adverse Event|2|||
106072184|NCT01139450|365930007|FG001|Overall Study|Adverse Event|2|||
106072185|NCT01139450|365930008|FG002|Overall Study|Adverse Event|3|||
106072186|NCT05333900|365930009|FG000|Overall Study|Protocol Violation|0|||
106072187|NCT05333900|365930010|FG001|Overall Study|Protocol Violation|1|||
106072188|NCT05333900|365930009|FG000|Overall Study|Withdrawal by Subject|0|||
106072189|NCT05333900|365930010|FG001|Overall Study|Withdrawal by Subject|1|||
106072190|NCT05333900|365930009|FG000|Overall Study|COVID-19 Pandemic|1|||
106072191|NCT05333900|365930010|FG001|Overall Study|COVID-19 Pandemic|1|||
106156568|NCT03147287|366235363|FG001|Overall Study|Randomized Not Treated|1|||
106156569|NCT03147287|366235364|FG002|Overall Study|Randomized Not Treated|1|||
106156570|NCT03147287|366235362|FG000|Overall Study|Progressive Disease RECIST|31|||
106156571|NCT03147287|366235363|FG001|Overall Study|Progressive Disease RECIST|72|||
106156572|NCT03147287|366235364|FG002|Overall Study|Progressive Disease RECIST|32|||
106072192|NCT00542919|365930011|FG000|Overall Study|Adverse Event|1|||
106072193|NCT00542919|365930012|FG001|Overall Study|Adverse Event|5|||
106072194|NCT00542919|365930013|FG002|Overall Study|Adverse Event|1|||
106072195|NCT00542919|365930011|FG000|Overall Study|Withdrawal by Subject|1|||
106072196|NCT00542919|365930012|FG001|Overall Study|Withdrawal by Subject|0|||
106072197|NCT00542919|365930013|FG002|Overall Study|Withdrawal by Subject|3|||
106072198|NCT00542919|365930011|FG000|Overall Study|Physician Decision|2|||
106072199|NCT00542919|365930012|FG001|Overall Study|Physician Decision|2|||
106072200|NCT00542919|365930013|FG002|Overall Study|Physician Decision|1|||
106156573|NCT03147287|366235362|FG000|Overall Study|Progressive Disease not RECIST|13|||
106156574|NCT03147287|366235363|FG001|Overall Study|Progressive Disease not RECIST|21|||
106156575|NCT03147287|366235364|FG002|Overall Study|Progressive Disease not RECIST|13|||
106156576|NCT03147287|366235362|FG000|Overall Study|Physician Decision|1|||
106156577|NCT03147287|366235363|FG001|Overall Study|Physician Decision|2|||
106156578|NCT03147287|366235364|FG002|Overall Study|Physician Decision|1|||
106156579|NCT03147287|366235362|FG000|Overall Study|Intercurrent illness|0|||
106156580|NCT03147287|366235363|FG001|Overall Study|Intercurrent illness|1|||
105866398|NCT00839254|365159370|FG005|Overall Study|Lost to Follow-up|8|||
105866399|NCT00839254|365159371|FG006|Overall Study|Lost to Follow-up|4|||
105866400|NCT00839254|365159372|FG007|Overall Study|Lost to Follow-up|2|||
105866401|NCT02359994|365159373|FG000|Overall Population Study|Adverse Event|1|||
106072201|NCT00542919|365930011|FG000|Overall Study|Sponsor Decision|1|||
106072202|NCT00542919|365930012|FG001|Overall Study|Sponsor Decision|0|||
106072203|NCT00542919|365930013|FG002|Overall Study|Sponsor Decision|0|||
106072204|NCT00542919|365930011|FG000|Overall Study|Lost to Follow-up|2|||
106072205|NCT00542919|365930012|FG001|Overall Study|Lost to Follow-up|0|||
106072206|NCT00542919|365930013|FG002|Overall Study|Lost to Follow-up|1|||
106072207|NCT00112502|365930019|FG000|Overall Study|Withdrawal by Subject|0|||
106072208|NCT00112502|365930020|FG001|Overall Study|Withdrawal by Subject|1|||
106072209|NCT00112502|365930021|FG002|Overall Study|Withdrawal by Subject|1|||
106072210|NCT00112502|365930022|FG003|Overall Study|Withdrawal by Subject|4|||
106072211|NCT00112502|365930023|FG004|Overall Study|Withdrawal by Subject|2|||
106072212|NCT00112502|365930024|FG005|Overall Study|Withdrawal by Subject|5|||
106072213|NCT00112502|365930025|FG006|Overall Study|Withdrawal by Subject|3|||
106072214|NCT00112502|365930026|FG007|Overall Study|Withdrawal by Subject|7|||
106072215|NCT02255500|365930027|FG000|Overall Study|Withdrawal by Subject|1|||
106072216|NCT02255500|365930028|FG001|Overall Study|Withdrawal by Subject|0|||
106072217|NCT02747420|365930029|FG000|Overall Study|Lost to Follow-up|4|||
106072218|NCT02747420|365930030|FG001|Overall Study|Lost to Follow-up|2|||
106072219|NCT02747420|365930029|FG000|Overall Study|Withdrawal by Subject|3|||
106072220|NCT02747420|365930030|FG001|Overall Study|Withdrawal by Subject|2|||
106072221|NCT05129488|365930031|FG000|Overall Study|Protocol Violation|3|||
106072222|NCT02608268|365930032|FG000|Overall Study|Adverse Event|0|||
106072223|NCT02608268|365930033|FG001|Overall Study|Adverse Event|0|||
106072224|NCT02608268|365930034|FG002|Overall Study|Adverse Event|1|||
106072225|NCT02608268|365930035|FG003|Overall Study|Adverse Event|0|||
106072226|NCT02608268|365930036|FG004|Overall Study|Adverse Event|0|||
106072227|NCT02608268|365930037|FG005|Overall Study|Adverse Event|0|||
106072228|NCT02608268|365930038|FG006|Overall Study|Adverse Event|0|||
106072229|NCT02608268|365930039|FG007|Overall Study|Adverse Event|0|||
106072230|NCT02608268|365930040|FG008|Overall Study|Adverse Event|0|||
106072231|NCT02608268|365930041|FG009|Overall Study|Adverse Event|0|||
106072232|NCT02608268|365930042|FG010|Overall Study|Adverse Event|0|||
106072233|NCT02608268|365930043|FG011|Overall Study|Adverse Event|0|||
106072234|NCT02608268|365930044|FG012|Overall Study|Adverse Event|2|||
106072235|NCT02608268|365930045|FG013|Overall Study|Adverse Event|0|||
106072236|NCT02608268|365930046|FG014|Overall Study|Adverse Event|0|||
106072237|NCT02608268|365930047|FG015|Overall Study|Adverse Event|0|||
106072238|NCT02608268|365930048|FG016|Overall Study|Adverse Event|0|||
106072239|NCT02608268|365930049|FG017|Overall Study|Adverse Event|0|||
106072240|NCT02608268|365930050|FG018|Overall Study|Adverse Event|0|||
106072241|NCT02608268|365930051|FG019|Overall Study|Adverse Event|0|||
106072242|NCT02608268|365930052|FG020|Overall Study|Adverse Event|1|||
106072243|NCT02608268|365930053|FG021|Overall Study|Adverse Event|1|||
106072244|NCT02608268|365930054|FG022|Overall Study|Adverse Event|0|||
106072245|NCT02608268|365930055|FG023|Overall Study|Adverse Event|0|||
106072246|NCT02608268|365930056|FG024|Overall Study|Adverse Event|1|||
106072247|NCT02608268|365930057|FG025|Overall Study|Adverse Event|0|||
106072248|NCT02608268|365930058|FG026|Overall Study|Adverse Event|0|||
106072249|NCT02608268|365930059|FG027|Overall Study|Adverse Event|0|||
106072250|NCT02608268|365930060|FG028|Overall Study|Adverse Event|1|||
106072251|NCT02608268|365930061|FG029|Overall Study|Adverse Event|0|||
106072252|NCT02608268|365930032|FG000|Overall Study|Death|1|||
106072253|NCT02608268|365930033|FG001|Overall Study|Death|0|||
106072254|NCT02608268|365930034|FG002|Overall Study|Death|0|||
106072255|NCT02608268|365930035|FG003|Overall Study|Death|0|||
106072256|NCT02608268|365930036|FG004|Overall Study|Death|0|||
106072257|NCT02608268|365930037|FG005|Overall Study|Death|0|||
106072258|NCT02608268|365930038|FG006|Overall Study|Death|0|||
106072259|NCT02608268|365930039|FG007|Overall Study|Death|0|||
106072260|NCT02608268|365930040|FG008|Overall Study|Death|1|||
106072261|NCT02608268|365930041|FG009|Overall Study|Death|1|||
106072262|NCT02608268|365930042|FG010|Overall Study|Death|0|||
106072263|NCT02608268|365930043|FG011|Overall Study|Death|0|||
106072264|NCT02608268|365930044|FG012|Overall Study|Death|0|||
106072265|NCT02608268|365930045|FG013|Overall Study|Death|0|||
106072266|NCT02608268|365930046|FG014|Overall Study|Death|0|||
106072267|NCT02608268|365930047|FG015|Overall Study|Death|1|||
106072268|NCT02608268|365930048|FG016|Overall Study|Death|0|||
106156581|NCT03147287|366235364|FG002|Overall Study|Intercurrent illness|0|||
106072269|NCT02608268|365930049|FG017|Overall Study|Death|1|||
106072270|NCT02608268|365930050|FG018|Overall Study|Death|0|||
106072271|NCT02608268|365930051|FG019|Overall Study|Death|1|||
106072272|NCT02608268|365930052|FG020|Overall Study|Death|1|||
106072273|NCT02608268|365930053|FG021|Overall Study|Death|0|||
106072274|NCT02608268|365930054|FG022|Overall Study|Death|0|||
106072275|NCT02608268|365930055|FG023|Overall Study|Death|0|||
106072276|NCT02608268|365930056|FG024|Overall Study|Death|1|||
106072277|NCT02608268|365930057|FG025|Overall Study|Death|2|||
106072278|NCT02608268|365930058|FG026|Overall Study|Death|0|||
106072279|NCT02608268|365930059|FG027|Overall Study|Death|1|||
106072280|NCT02608268|365930060|FG028|Overall Study|Death|4|||
106072281|NCT02608268|365930061|FG029|Overall Study|Death|0|||
106072282|NCT02608268|365930032|FG000|Overall Study|Physician Decision|0|||
106072283|NCT02608268|365930033|FG001|Overall Study|Physician Decision|0|||
106072284|NCT02608268|365930034|FG002|Overall Study|Physician Decision|0|||
106072285|NCT02608268|365930035|FG003|Overall Study|Physician Decision|0|||
106072286|NCT02608268|365930036|FG004|Overall Study|Physician Decision|0|||
106072287|NCT02608268|365930037|FG005|Overall Study|Physician Decision|0|||
106072288|NCT02608268|365930038|FG006|Overall Study|Physician Decision|0|||
106072289|NCT02608268|365930039|FG007|Overall Study|Physician Decision|0|||
106072290|NCT02608268|365930040|FG008|Overall Study|Physician Decision|0|||
106072291|NCT02608268|365930041|FG009|Overall Study|Physician Decision|0|||
106072292|NCT02608268|365930042|FG010|Overall Study|Physician Decision|1|||
106072293|NCT02608268|365930043|FG011|Overall Study|Physician Decision|0|||
106072294|NCT02608268|365930044|FG012|Overall Study|Physician Decision|0|||
106072295|NCT02608268|365930045|FG013|Overall Study|Physician Decision|1|||
106072296|NCT02608268|365930046|FG014|Overall Study|Physician Decision|0|||
106072297|NCT02608268|365930047|FG015|Overall Study|Physician Decision|0|||
106072298|NCT02608268|365930048|FG016|Overall Study|Physician Decision|0|||
106072299|NCT02608268|365930049|FG017|Overall Study|Physician Decision|0|||
106072300|NCT02608268|365930050|FG018|Overall Study|Physician Decision|0|||
106072301|NCT02608268|365930051|FG019|Overall Study|Physician Decision|0|||
106072302|NCT02608268|365930052|FG020|Overall Study|Physician Decision|0|||
106072303|NCT02608268|365930053|FG021|Overall Study|Physician Decision|0|||
106072304|NCT02608268|365930054|FG022|Overall Study|Physician Decision|1|||
106072305|NCT02608268|365930055|FG023|Overall Study|Physician Decision|1|||
106072306|NCT02608268|365930056|FG024|Overall Study|Physician Decision|1|||
106072307|NCT02608268|365930057|FG025|Overall Study|Physician Decision|0|||
106072308|NCT02608268|365930058|FG026|Overall Study|Physician Decision|0|||
106072309|NCT02608268|365930059|FG027|Overall Study|Physician Decision|2|||
106072310|NCT02608268|365930060|FG028|Overall Study|Physician Decision|1|||
106072311|NCT02608268|365930061|FG029|Overall Study|Physician Decision|1|||
106072312|NCT02608268|365930032|FG000|Overall Study|Progressive disease|12|||
106072313|NCT02608268|365930033|FG001|Overall Study|Progressive disease|8|||
106072314|NCT02608268|365930034|FG002|Overall Study|Progressive disease|13|||
106072315|NCT02608268|365930035|FG003|Overall Study|Progressive disease|5|||
106072316|NCT02608268|365930036|FG004|Overall Study|Progressive disease|2|||
106072317|NCT02608268|365930037|FG005|Overall Study|Progressive disease|4|||
106072318|NCT02608268|365930038|FG006|Overall Study|Progressive disease|6|||
106072319|NCT02608268|365930039|FG007|Overall Study|Progressive disease|2|||
106072320|NCT02608268|365930040|FG008|Overall Study|Progressive disease|5|||
106072321|NCT02608268|365930041|FG009|Overall Study|Progressive disease|6|||
106072322|NCT02608268|365930042|FG010|Overall Study|Progressive disease|5|||
106072323|NCT02608268|365930043|FG011|Overall Study|Progressive disease|5|||
106072324|NCT02608268|365930044|FG012|Overall Study|Progressive disease|4|||
106072325|NCT02608268|365930045|FG013|Overall Study|Progressive disease|11|||
106072326|NCT02608268|365930046|FG014|Overall Study|Progressive disease|6|||
106072327|NCT02608268|365930047|FG015|Overall Study|Progressive disease|3|||
106072328|NCT02608268|365930048|FG016|Overall Study|Progressive disease|5|||
106072329|NCT02608268|365930049|FG017|Overall Study|Progressive disease|5|||
106072330|NCT02608268|365930050|FG018|Overall Study|Progressive disease|5|||
106072331|NCT02608268|365930051|FG019|Overall Study|Progressive disease|2|||
106072332|NCT02608268|365930052|FG020|Overall Study|Progressive disease|10|||
106072333|NCT02608268|365930053|FG021|Overall Study|Progressive disease|4|||
106072334|NCT02608268|365930054|FG022|Overall Study|Progressive disease|5|||
106156582|NCT03147287|366235362|FG000|Overall Study|Withdrawal by Subject|2|||
106156583|NCT03147287|366235363|FG001|Overall Study|Withdrawal by Subject|3|||
106156584|NCT03147287|366235364|FG002|Overall Study|Withdrawal by Subject|2|||
106156585|NCT03147287|366235362|FG000|Overall Study|Patient Non-Compliance|0|||
106156586|NCT03147287|366235363|FG001|Overall Study|Patient Non-Compliance|2|||
106156587|NCT03147287|366235364|FG002|Overall Study|Patient Non-Compliance|0|||
106156588|NCT03147287|366235362|FG000|Overall Study|Patient moved|0|||
106156589|NCT03147287|366235363|FG001|Overall Study|Patient moved|1|||
106156590|NCT03147287|366235364|FG002|Overall Study|Patient moved|0|||
106156591|NCT03147287|366235362|FG000|Overall Study|Arm A crossover without PD|1|||
106156592|NCT03147287|366235363|FG001|Overall Study|Arm A crossover without PD|0|||
106156593|NCT03147287|366235364|FG002|Overall Study|Arm A crossover without PD|0|||
106156594|NCT03147287|366235362|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
106156595|NCT03147287|366235363|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
106156596|NCT03147287|366235364|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
106156597|NCT01820260|366235365|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156598|NCT01820260|366235366|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156599|NCT01820260|366235367|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156600|NCT01820260|366235368|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156601|NCT01820260|366235369|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156602|NCT01820260|366235370|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156603|NCT01820260|366235371|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
106156604|NCT01820260|366235372|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156605|NCT01820260|366235373|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156606|NCT01820260|366235374|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156607|NCT01820260|366235375|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156608|NCT01820260|366235376|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156609|NCT01820260|366235377|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156610|NCT01820260|366235378|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
106156611|NCT01820260|366235365|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156612|NCT01820260|366235366|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156613|NCT01820260|366235367|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156614|NCT01820260|366235368|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156615|NCT01820260|366235369|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156616|NCT01820260|366235370|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156617|NCT01820260|366235371|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156618|NCT01820260|366235372|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156619|NCT01820260|366235373|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156620|NCT01820260|366235374|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
106156621|NCT01820260|366235375|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156622|NCT01820260|366235376|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156623|NCT01820260|366235377|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156624|NCT01820260|366235378|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
106156625|NCT00616967|366235380|FG000|Overall Study|Withdrawal by Subject|0|||
106156626|NCT00616967|366235381|FG001|Overall Study|Withdrawal by Subject|0|||
106156627|NCT00616967|366235382|FG002|Overall Study|Withdrawal by Subject|1|||
106156628|NCT02249949|366235383|FG000|Overall Study|Cancelled prior to treatment|2|||
106156629|NCT05524233|366235401|FG000|Overall Study|Lost to Follow-up|2|||
106156630|NCT05524233|366235401|FG000|Overall Study|Adverse Event|2|||
106156631|NCT05524233|366235401|FG000|Overall Study|Withdrawal by Subject|1|||
105866402|NCT02359994|365159374|FG001|Overall Population Study|Adverse Event|1|||
106156632|NCT03453619|366235402|FG000|Core Study (Part A)|Physician Decision|0|||
106156633|NCT03453619|366235403|FG001|Core Study (Part A)|Physician Decision|0|||
106156634|NCT03453619|366235404|FG002|Core Study (Part A)|Physician Decision|2|||
106156635|NCT03453619|366235405|FG003|Core Study (Part A)|Physician Decision|0|||
106156636|NCT03453619|366235402|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
106156637|NCT03453619|366235403|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
106156638|NCT03453619|366235404|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
106156639|NCT03453619|366235405|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
106156640|NCT03453619|366235402|FG000|Core Study (Part A)|Other|0|||
106156641|NCT03453619|366235403|FG001|Core Study (Part A)|Other|1|||
106156642|NCT03453619|366235404|FG002|Core Study (Part A)|Other|0|||
106156643|NCT03453619|366235405|FG003|Core Study (Part A)|Other|0|||
106156644|NCT03453619|366235402|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
106156645|NCT03453619|366235403|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
106156646|NCT03453619|366235404|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
106156647|NCT03453619|366235405|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
106156648|NCT03453619|366235402|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
106156649|NCT03453619|366235403|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
106156650|NCT03453619|366235404|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
106156651|NCT03453619|366235405|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
106156652|NCT03453619|366235402|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
106156653|NCT03453619|366235403|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
106156654|NCT03453619|366235404|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
106156655|NCT03453619|366235405|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
106156656|NCT03453619|366235402|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
106156657|NCT03453619|366235403|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
106156658|NCT03453619|366235404|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
106156659|NCT03453619|366235405|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
106156660|NCT04089371|366235406|FG000|Overall Study|Withdrawal by Subject|0|||
106156661|NCT04089371|366235407|FG001|Overall Study|Withdrawal by Subject|1|||
106156662|NCT04089371|366235406|FG000|Overall Study|Study terminated early|0|||
106156663|NCT04089371|366235407|FG001|Overall Study|Study terminated early|9|||
106156664|NCT04382898|366235408|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
106156665|NCT04382898|366235409|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
106156666|NCT04382898|366235410|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
106156667|NCT04382898|366235411|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
106156668|NCT04382898|366235412|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
106156669|NCT04382898|366235408|FG000|Part 1: Dose Titration|Death|6|||
106156670|NCT04382898|366235409|FG001|Part 1: Dose Titration|Death|0|||
106156671|NCT04382898|366235410|FG002|Part 1: Dose Titration|Death|0|||
106156672|NCT04382898|366235411|FG003|Part 1: Dose Titration|Death|0|||
106156673|NCT04382898|366235412|FG004|Part 1: Dose Titration|Death|0|||
106156674|NCT04382898|366235408|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
106156675|NCT04382898|366235409|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
106156676|NCT04382898|366235410|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
106156677|NCT04382898|366235411|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
106156678|NCT04382898|366235412|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
106156679|NCT04382898|366235408|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
106156680|NCT04382898|366235409|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
106156681|NCT04382898|366235410|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
106156682|NCT04382898|366235411|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
106156683|NCT04382898|366235412|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
106156684|NCT04382898|366235408|FG000|Part 2: Dose Expansion|Death|0|||
106156685|NCT04382898|366235409|FG001|Part 2: Dose Expansion|Death|17|||
106156686|NCT04382898|366235410|FG002|Part 2: Dose Expansion|Death|13|||
106156687|NCT04382898|366235411|FG003|Part 2: Dose Expansion|Death|1|||
106156688|NCT04382898|366235412|FG004|Part 2: Dose Expansion|Death|0|||
106156689|NCT04382898|366235408|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
106156690|NCT04382898|366235409|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
106156691|NCT04382898|366235410|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
106156692|NCT04382898|366235411|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
106156693|NCT04382898|366235412|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
106156694|NCT04382898|366235408|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
106156695|NCT04382898|366235409|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
106156696|NCT04382898|366235410|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
106156697|NCT04382898|366235411|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
106156698|NCT04382898|366235412|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
106156699|NCT04382898|366235408|FG000|Part 2: Dose Expansion|Other|0|||
106156700|NCT04382898|366235409|FG001|Part 2: Dose Expansion|Other|0|||
106156701|NCT04382898|366235410|FG002|Part 2: Dose Expansion|Other|1|||
106156702|NCT04382898|366235411|FG003|Part 2: Dose Expansion|Other|0|||
106072335|NCT02608268|365930055|FG023|Overall Study|Progressive disease|5|||
106072336|NCT02608268|365930056|FG024|Overall Study|Progressive disease|3|||
106072337|NCT02608268|365930057|FG025|Overall Study|Progressive disease|11|||
106072338|NCT02608268|365930058|FG026|Overall Study|Progressive disease|16|||
106072339|NCT02608268|365930059|FG027|Overall Study|Progressive disease|11|||
106072340|NCT02608268|365930060|FG028|Overall Study|Progressive disease|10|||
106072341|NCT02608268|365930061|FG029|Overall Study|Progressive disease|15|||
106072342|NCT02608268|365930032|FG000|Overall Study|Subject/guardian decision|1|||
106072343|NCT02608268|365930033|FG001|Overall Study|Subject/guardian decision|1|||
106072344|NCT02608268|365930034|FG002|Overall Study|Subject/guardian decision|2|||
106072345|NCT02608268|365930035|FG003|Overall Study|Subject/guardian decision|0|||
106072346|NCT02608268|365930036|FG004|Overall Study|Subject/guardian decision|0|||
106072347|NCT02608268|365930037|FG005|Overall Study|Subject/guardian decision|0|||
106072348|NCT02608268|365930038|FG006|Overall Study|Subject/guardian decision|0|||
106072349|NCT02608268|365930039|FG007|Overall Study|Subject/guardian decision|0|||
106072350|NCT02608268|365930040|FG008|Overall Study|Subject/guardian decision|2|||
106072351|NCT02608268|365930041|FG009|Overall Study|Subject/guardian decision|2|||
106072352|NCT02608268|365930042|FG010|Overall Study|Subject/guardian decision|0|||
106072353|NCT02608268|365930043|FG011|Overall Study|Subject/guardian decision|1|||
106072354|NCT02608268|365930044|FG012|Overall Study|Subject/guardian decision|0|||
106072355|NCT02608268|365930045|FG013|Overall Study|Subject/guardian decision|1|||
106072356|NCT02608268|365930046|FG014|Overall Study|Subject/guardian decision|0|||
106072357|NCT02608268|365930047|FG015|Overall Study|Subject/guardian decision|1|||
106072358|NCT02608268|365930048|FG016|Overall Study|Subject/guardian decision|0|||
106072359|NCT02608268|365930049|FG017|Overall Study|Subject/guardian decision|0|||
106072360|NCT02608268|365930050|FG018|Overall Study|Subject/guardian decision|1|||
106072361|NCT02608268|365930051|FG019|Overall Study|Subject/guardian decision|0|||
106072362|NCT02608268|365930052|FG020|Overall Study|Subject/guardian decision|0|||
106072363|NCT02608268|365930053|FG021|Overall Study|Subject/guardian decision|0|||
106072364|NCT02608268|365930054|FG022|Overall Study|Subject/guardian decision|1|||
106072365|NCT02608268|365930055|FG023|Overall Study|Subject/guardian decision|0|||
106072366|NCT02608268|365930056|FG024|Overall Study|Subject/guardian decision|0|||
106072367|NCT02608268|365930057|FG025|Overall Study|Subject/guardian decision|1|||
106072368|NCT02608268|365930058|FG026|Overall Study|Subject/guardian decision|1|||
106072369|NCT02608268|365930059|FG027|Overall Study|Subject/guardian decision|1|||
106072370|NCT02608268|365930060|FG028|Overall Study|Subject/guardian decision|1|||
106072371|NCT02608268|365930061|FG029|Overall Study|Subject/guardian decision|0|||
106072372|NCT00265343|365930062|FG000|Overall Study|Adverse Event|10|||
106072373|NCT00265343|365930063|FG001|Overall Study|Adverse Event|7|||
106072374|NCT00265343|365930062|FG000|Overall Study|Withdrawal by Subject|3|||
106072375|NCT00265343|365930063|FG001|Overall Study|Withdrawal by Subject|9|||
106156703|NCT04382898|366235412|FG004|Part 2: Dose Expansion|Other|0|||
106156704|NCT04710576|366235413|FG000|Overall Study|Participants still in the study|73|||
106156705|NCT04710576|366235414|FG001|Overall Study|Participants still in the study|70|||
106156706|NCT04710576|366235415|FG002|Overall Study|Participants still in the study|60|||
106156707|NCT04710576|366235413|FG000|Overall Study|Death|2|||
106156708|NCT04710576|366235414|FG001|Overall Study|Death|7|||
106156709|NCT04710576|366235415|FG002|Overall Study|Death|12|||
106156710|NCT04710576|366235413|FG000|Overall Study|Withdrawal by Subject|4|||
106156711|NCT04710576|366235414|FG001|Overall Study|Withdrawal by Subject|3|||
106156712|NCT04710576|366235415|FG002|Overall Study|Withdrawal by Subject|7|||
106156713|NCT04710576|366235413|FG000|Overall Study|Sponsor decision|1|||
106156714|NCT04710576|366235414|FG001|Overall Study|Sponsor decision|0|||
106156715|NCT04710576|366235415|FG002|Overall Study|Sponsor decision|0|||
106156716|NCT04541706|366235422|FG000|Overall Study|Withdrawal by Subject|3|||
106156717|NCT04541706|366235422|FG000|Overall Study|Progressive disease|33|||
106156718|NCT04541706|366235422|FG000|Overall Study|Physician Decision|1|||
106156719|NCT04541706|366235422|FG000|Overall Study|Lost to Follow-up|2|||
106156720|NCT04541706|366235422|FG000|Overall Study|Death|5|||
106156721|NCT04541706|366235422|FG000|Overall Study|Adverse Event|1|||
106156722|NCT02365766|366235441|FG000|Overall Study|Withdrawal by Subject|0|||
106156723|NCT02365766|366235442|FG001|Overall Study|Withdrawal by Subject|0|||
106072376|NCT00265343|365930062|FG000|Overall Study|Other|8|||
106072377|NCT00265343|365930063|FG001|Overall Study|Other|3|||
106072378|NCT04865354|365930064|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
106072379|NCT04865354|365930065|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
106072380|NCT04865354|365930064|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
106072381|NCT04865354|365930065|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
106072382|NCT04865354|365930064|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
106072383|NCT04865354|365930065|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
106072384|NCT00706641|365930070|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
106156724|NCT02365766|366235443|FG002|Overall Study|Withdrawal by Subject|1|||
106156725|NCT02365766|366235441|FG000|Overall Study|Eligibility Criteria Not Met|0|||
106156726|NCT02365766|366235442|FG001|Overall Study|Eligibility Criteria Not Met|0|||
105866403|NCT02359994|365159373|FG000|Overall Population Study|Death|1|||
105866404|NCT02359994|365159374|FG001|Overall Population Study|Death|5|||
105866405|NCT02359994|365159373|FG000|Overall Population Study|Lost to Follow-up|1|||
105866406|NCT02359994|365159374|FG001|Overall Population Study|Lost to Follow-up|1|||
105866407|NCT02359994|365159373|FG000|Overall Population Study|Withdrawal by Subject|1|||
105866408|NCT02359994|365159374|FG001|Overall Population Study|Withdrawal by Subject|0|||
105866409|NCT02359994|365159373|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
105866410|NCT02359994|365159374|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
105866411|NCT02359994|365159373|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
105866412|NCT02359994|365159374|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
105866413|NCT02359994|365159373|FG000|Extended Oncology 24-Month Survival|Death|19|||
105866414|NCT02359994|365159374|FG001|Extended Oncology 24-Month Survival|Death|21|||
105866415|NCT02359994|365159373|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
105866416|NCT02359994|365159374|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
105866417|NCT02682927|365159380|FG000|Overall Study|Adverse Event|0|||
105866418|NCT02682927|365159381|FG001|Overall Study|Adverse Event|0|||
105866419|NCT02682927|365159382|FG002|Overall Study|Adverse Event|5|||
105866420|NCT02682927|365159383|FG003|Overall Study|Adverse Event|1|||
105866421|NCT02682927|365159384|FG004|Overall Study|Adverse Event|0|||
105866422|NCT02682927|365159385|FG005|Overall Study|Adverse Event|2|||
105866423|NCT02682927|365159380|FG000|Overall Study|Death|0|||
105866424|NCT02682927|365159381|FG001|Overall Study|Death|0|||
105866425|NCT02682927|365159382|FG002|Overall Study|Death|0|||
105866426|NCT02682927|365159383|FG003|Overall Study|Death|1|||
105866427|NCT02682927|365159384|FG004|Overall Study|Death|0|||
105866428|NCT02682927|365159385|FG005|Overall Study|Death|0|||
105866429|NCT02682927|365159380|FG000|Overall Study|Lack of Efficacy|1|||
105866430|NCT02682927|365159381|FG001|Overall Study|Lack of Efficacy|0|||
105866431|NCT02682927|365159382|FG002|Overall Study|Lack of Efficacy|0|||
105866432|NCT02682927|365159383|FG003|Overall Study|Lack of Efficacy|1|||
105866433|NCT02682927|365159384|FG004|Overall Study|Lack of Efficacy|0|||
105866434|NCT02682927|365159385|FG005|Overall Study|Lack of Efficacy|0|||
105866435|NCT02682927|365159380|FG000|Overall Study|Other|0|||
105866436|NCT02682927|365159381|FG001|Overall Study|Other|0|||
105866437|NCT02682927|365159382|FG002|Overall Study|Other|0|||
105866438|NCT02682927|365159383|FG003|Overall Study|Other|2|||
105866439|NCT02682927|365159384|FG004|Overall Study|Other|0|||
105866440|NCT02682927|365159385|FG005|Overall Study|Other|0|||
105866441|NCT02682927|365159380|FG000|Overall Study|Withdrawal by Subject|2|||
105866442|NCT02682927|365159381|FG001|Overall Study|Withdrawal by Subject|0|||
105866443|NCT02682927|365159382|FG002|Overall Study|Withdrawal by Subject|1|||
105866444|NCT02682927|365159383|FG003|Overall Study|Withdrawal by Subject|0|||
105866445|NCT02682927|365159384|FG004|Overall Study|Withdrawal by Subject|1|||
105866446|NCT02682927|365159385|FG005|Overall Study|Withdrawal by Subject|1|||
105866447|NCT01243775|365159398|FG000|Overall Study|Withdrawal by Subject|2|||
105866448|NCT05422625|365159399|FG000|Overall Study|Withdrawal by Subject|1|||
105866449|NCT05422625|365159400|FG001|Overall Study|Withdrawal by Subject|0|||
105866450|NCT04778904|365161010|FG000|Overall Study|Protocol Violation|1|||
106072385|NCT00706641|365930070|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
106072386|NCT00706641|365930070|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
106072387|NCT01012622|365930071|FG000|Overall Study|Withdrawal by Subject|6|||
106072388|NCT01012622|365930071|FG000|Overall Study|Lost to Follow-up|5|||
106072389|NCT01012622|365930071|FG000|Overall Study|Adverse Event|7|||
106072390|NCT01012622|365930071|FG000|Overall Study|non-compliance with the drug|9|||
106072391|NCT01012622|365930071|FG000|Overall Study|Other|1|||
106072392|NCT01012622|365930071|FG000|Overall Study|screening failure|1|||
106072393|NCT01012622|365930071|FG000|Overall Study|withdrawal of consent by a parent|2|||
106072394|NCT02535741|365930072|FG000|Overall Study|Adverse Event|3|||
106072395|NCT02535741|365930072|FG000|Overall Study|Withdrawal by Subject|9|||
106072396|NCT02535741|365930072|FG000|Overall Study|Lost to Follow-up|10|||
106072397|NCT02535741|365930072|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
105866451|NCT04778904|365161011|FG001|Overall Study|Protocol Violation|0|||
105866452|NCT04778904|365161012|FG002|Overall Study|Protocol Violation|0|||
105866453|NCT04778904|365161013|FG003|Overall Study|Protocol Violation|0|||
106072398|NCT02535741|365930072|FG000|Overall Study|Missing data|6|||
106072399|NCT00798369|365930073|FG000|Overall Study|Subject withdrew consent|0|||
106072400|NCT00798369|365930074|FG001|Overall Study|Subject withdrew consent|0|||
106072401|NCT00798369|365930075|FG002|Overall Study|Subject withdrew consent|1|||
106072402|NCT00798369|365930076|FG003|Overall Study|Subject withdrew consent|1|||
105866454|NCT04778904|365161010|FG000|Overall Study|Withdrawal by Subject|0|||
105866455|NCT04778904|365161011|FG001|Overall Study|Withdrawal by Subject|0|||
106072403|NCT00798369|365930077|FG004|Overall Study|Subject withdrew consent|0|||
106072404|NCT00798369|365930078|FG005|Overall Study|Subject withdrew consent|2|||
106072405|NCT00798369|365930073|FG000|Overall Study|Lost to Follow-up|1|||
106072406|NCT00798369|365930074|FG001|Overall Study|Lost to Follow-up|1|||
106156727|NCT02365766|366235443|FG002|Overall Study|Eligibility Criteria Not Met|1|||
106156728|NCT04401800|366235444|FG000|Overall Study|Death|17|||
106156729|NCT04401800|366235444|FG000|Overall Study|Lost to Follow-up|5|||
106156730|NCT04401800|366235444|FG000|Overall Study|Withdrawal by Subject|4|||
106156731|NCT05089734|366235445|FG000|Overall Study|Still on study|122|||
106156732|NCT05089734|366235446|FG001|Overall Study|Still on study|101|||
106156733|NCT05089734|366235445|FG000|Overall Study|Death|161|||
106156734|NCT05089734|366235446|FG001|Overall Study|Death|179|||
106156735|NCT05089734|366235445|FG000|Overall Study|Withdrew consent|11|||
106156736|NCT05089734|366235446|FG001|Overall Study|Withdrew consent|24|||
106156737|NCT05089734|366235445|FG000|Overall Study|Lost to Follow-up|5|||
106156738|NCT05089734|366235446|FG001|Overall Study|Lost to Follow-up|0|||
106156739|NCT03514017|366235447|FG000|Overall Study|Death|1|||
106156740|NCT03514017|366235447|FG000|Overall Study|Adverse Event|1|||
106156741|NCT04593472|366236521|FG000|Overall Study|Death|31|||
106156742|NCT04593472|366236522|FG001|Overall Study|Death|27|||
106156743|NCT04593472|366236521|FG000|Overall Study|Withdrawal by Subject|12|||
106156744|NCT04593472|366236522|FG001|Overall Study|Withdrawal by Subject|12|||
106156745|NCT04593472|366236521|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
106156746|NCT04593472|366236522|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
106156747|NCT04593472|366236521|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
106156748|NCT04593472|366236522|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
106156749|NCT04593472|366236521|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
106156750|NCT04593472|366236522|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
106156751|NCT04593472|366236521|FG000|Overall Study|Lost to Follow-up|0|||
106156752|NCT04593472|366236522|FG001|Overall Study|Lost to Follow-up|2|||
106156753|NCT04593472|366236521|FG000|Overall Study|Still collecting 24-month assessment|17|||
106156754|NCT04593472|366236522|FG001|Overall Study|Still collecting 24-month assessment|10|||
106156755|NCT04178733|366236523|FG000|Overall Study|Investigator Decision|0|||
106156756|NCT04178733|366236524|FG001|Overall Study|Investigator Decision|0|||
106156757|NCT04178733|366236525|FG002|Overall Study|Investigator Decision|0|||
106156758|NCT04178733|366236526|FG003|Overall Study|Investigator Decision|1|||
106156759|NCT04178733|366236527|FG004|Overall Study|Investigator Decision|2|||
106156760|NCT03391466|366236532|FG000|Overall Study|Death|82|||
106156761|NCT03391466|366236533|FG001|Overall Study|Death|85|||
106156762|NCT03391466|366236532|FG000|Overall Study|Still on study|93|||
106156763|NCT03391466|366236533|FG001|Overall Study|Still on study|74|||
106156764|NCT03391466|366236532|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
106156765|NCT03391466|366236533|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
106156766|NCT03391466|366236532|FG000|Overall Study|Lost to Follow-up|5|||
106156767|NCT03391466|366236533|FG001|Overall Study|Lost to Follow-up|5|||
106156768|NCT03391466|366236532|FG000|Overall Study|Investigator decision|0|||
106156769|NCT03391466|366236533|FG001|Overall Study|Investigator decision|1|||
106156770|NCT03391466|366236532|FG000|Overall Study|Other|0|||
106156771|NCT03391466|366236533|FG001|Overall Study|Other|1|||
106156772|NCT04490915|366236535|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
106156773|NCT04490915|366236536|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
106156774|NCT04490915|366236535|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
106156775|NCT04490915|366236536|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
106156776|NCT04490915|366236535|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
106156777|NCT04490915|366236536|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
106156778|NCT04490915|366236535|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
106156779|NCT04490915|366236536|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
106156780|NCT04490915|366236535|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
106156781|NCT04490915|366236536|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
106156782|NCT04490915|366236535|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
106156783|NCT04490915|366236536|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
106156784|NCT04490915|366236535|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
106156785|NCT04490915|366236536|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
106156786|NCT03052608|366236537|FG000|Treatment Phase|Adverse Event|10|||
106156787|NCT03052608|366236538|FG001|Treatment Phase|Adverse Event|12|||
106156788|NCT03052608|366236537|FG000|Treatment Phase|Death|6|||
106156789|NCT03052608|366236538|FG001|Treatment Phase|Death|4|||
106156790|NCT03052608|366236537|FG000|Treatment Phase|Withdrawal by Subject|4|||
106156791|NCT03052608|366236538|FG001|Treatment Phase|Withdrawal by Subject|12|||
106156792|NCT03052608|366236537|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
106156793|NCT03052608|366236538|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
106156794|NCT03052608|366236537|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
106156795|NCT03052608|366236538|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
106156796|NCT03052608|366236537|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
106156797|NCT03052608|366236538|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
106156798|NCT03052608|366236537|FG000|Treatment Phase|Ongoing|103|||
106072407|NCT00798369|365930075|FG002|Overall Study|Lost to Follow-up|1|||
106072408|NCT00798369|365930076|FG003|Overall Study|Lost to Follow-up|0|||
106072409|NCT00798369|365930077|FG004|Overall Study|Lost to Follow-up|1|||
106072410|NCT00798369|365930078|FG005|Overall Study|Lost to Follow-up|0|||
106072411|NCT00798369|365930073|FG000|Overall Study|Adminstrative problems|0|||
106072412|NCT00798369|365930074|FG001|Overall Study|Adminstrative problems|0|||
106072413|NCT00798369|365930075|FG002|Overall Study|Adminstrative problems|0|||
106072414|NCT00798369|365930076|FG003|Overall Study|Adminstrative problems|0|||
106072415|NCT00798369|365930077|FG004|Overall Study|Adminstrative problems|0|||
106072416|NCT00798369|365930078|FG005|Overall Study|Adminstrative problems|1|||
106072417|NCT04307446|365930081|FG000|Overall Study|Lost to Follow-up|2|||
106072418|NCT04307446|365930082|FG001|Overall Study|Lost to Follow-up|0|||
106072419|NCT00297037|365930084|FG000|Overall Study|Withdrawal by Subject|2|||
106072420|NCT00297037|365930085|FG001|Overall Study|Withdrawal by Subject|0|||
106072421|NCT05352815|365930086|FG000|Overall Study|Withdrawal by Subject|28|||
106072422|NCT05352815|365930087|FG001|Overall Study|Withdrawal by Subject|24|||
106072423|NCT05352815|365930086|FG000|Overall Study|Lost to Follow-up|4|||
106072424|NCT05352815|365930087|FG001|Overall Study|Lost to Follow-up|7|||
106072425|NCT05352815|365930086|FG000|Overall Study|Death|2|||
106072426|NCT05352815|365930087|FG001|Overall Study|Death|3|||
106072427|NCT05352815|365930086|FG000|Overall Study|Site closure|1|||
106072428|NCT05352815|365930087|FG001|Overall Study|Site closure|0|||
106072429|NCT00464568|365930089|FG000|Overall Study|Adverse Event|2|||
106072430|NCT01480076|365930097|FG000|Overall Study|Run-in Failure|52|||
106072431|NCT01480076|365930097|FG000|Overall Study|Adverse Event|39|||
106072432|NCT01480076|365930097|FG000|Overall Study|Death|2|||
106072433|NCT01480076|365930097|FG000|Overall Study|Disease Progression|5|||
106072434|NCT01480076|365930097|FG000|Overall Study|Non-compliance With Study Protocol|15|||
106072435|NCT01480076|365930097|FG000|Overall Study|Withdrawal by Subject|105|||
106072436|NCT01480076|365930097|FG000|Overall Study|Lost to Follow-up|7|||
106072437|NCT01480076|365930097|FG000|Overall Study|Investigator Decision|13|||
106072438|NCT01480076|365930097|FG000|Overall Study|Other|52|||
106072439|NCT02503332|365930098|FG000|Overall Study|Adverse Event|17|||
106072440|NCT02503332|365930099|FG001|Overall Study|Adverse Event|5|||
106072441|NCT02503332|365930100|FG002|Overall Study|Adverse Event|3|||
106072442|NCT02503332|365930101|FG003|Overall Study|Adverse Event|1|||
106072443|NCT02503332|365930098|FG000|Overall Study|Investigator's Decision|5|||
106072444|NCT02503332|365930099|FG001|Overall Study|Investigator's Decision|1|||
106072445|NCT02503332|365930100|FG002|Overall Study|Investigator's Decision|0|||
106072446|NCT02503332|365930101|FG003|Overall Study|Investigator's Decision|0|||
106072447|NCT02503332|365930098|FG000|Overall Study|Sponsor's Decision|1|||
106072448|NCT02503332|365930099|FG001|Overall Study|Sponsor's Decision|0|||
106072449|NCT02503332|365930100|FG002|Overall Study|Sponsor's Decision|0|||
106072450|NCT02503332|365930101|FG003|Overall Study|Sponsor's Decision|1|||
106072451|NCT02503332|365930098|FG000|Overall Study|Subject Request|6|||
106072452|NCT02503332|365930099|FG001|Overall Study|Subject Request|5|||
106072453|NCT02503332|365930100|FG002|Overall Study|Subject Request|2|||
106072454|NCT02503332|365930101|FG003|Overall Study|Subject Request|1|||
106072455|NCT02503332|365930098|FG000|Overall Study|Death|0|||
106072456|NCT02503332|365930099|FG001|Overall Study|Death|2|||
106072457|NCT02503332|365930100|FG002|Overall Study|Death|2|||
106072458|NCT02503332|365930101|FG003|Overall Study|Death|0|||
106072459|NCT02503332|365930098|FG000|Overall Study|Other|5|||
106072460|NCT02503332|365930099|FG001|Overall Study|Other|6|||
106072461|NCT02503332|365930100|FG002|Overall Study|Other|1|||
106072462|NCT02503332|365930101|FG003|Overall Study|Other|1|||
106072463|NCT00335972|365930104|FG000|Overall Study|not given treatments|0|||
106156799|NCT03052608|366236538|FG001|Treatment Phase|Ongoing|31|||
106156800|NCT03052608|366236537|FG000|Long-Term Follow-up Phase|Death|23|||
106156801|NCT03052608|366236538|FG001|Long-Term Follow-up Phase|Death|28|||
106156802|NCT03052608|366236537|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
106156803|NCT03052608|366236538|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
106156804|NCT03052608|366236537|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
106156805|NCT03052608|366236538|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
106156806|NCT03052608|366236537|FG000|Long-Term Follow-up Phase|Ongoing|122|||
106156807|NCT03052608|366236538|FG001|Long-Term Follow-up Phase|Ongoing|99|||
106072464|NCT00335972|365930105|FG001|Overall Study|not given treatments|3|||
106072465|NCT01524692|365930108|FG000|Overall Study|Withdrawal by Subject|3|||
106072466|NCT02039674|365930111|FG000|Overall Study|Adverse Event|0|||
106072467|NCT02039674|365930112|FG001|Overall Study|Adverse Event|0|||
106072468|NCT02039674|365930113|FG002|Overall Study|Adverse Event|0|||
106072469|NCT02039674|365930114|FG003|Overall Study|Adverse Event|1|||
106072470|NCT02039674|365930115|FG004|Overall Study|Adverse Event|0|||
106072471|NCT02039674|365930116|FG005|Overall Study|Adverse Event|0|||
106072472|NCT02039674|365930117|FG006|Overall Study|Adverse Event|0|||
106072473|NCT02039674|365930118|FG007|Overall Study|Adverse Event|0|||
106072474|NCT02039674|365930119|FG008|Overall Study|Adverse Event|2|||
106072475|NCT02039674|365930120|FG009|Overall Study|Adverse Event|1|||
106072476|NCT02039674|365930121|FG010|Overall Study|Adverse Event|0|||
105866456|NCT04778904|365161012|FG002|Overall Study|Withdrawal by Subject|1|||
105866457|NCT04778904|365161013|FG003|Overall Study|Withdrawal by Subject|0|||
105866458|NCT01582152|365161020|FG000|Overall Study|Disease Progression|4|||
105866459|NCT01582152|365161021|FG001|Overall Study|Disease Progression|5|||
105866460|NCT01582152|365161020|FG000|Overall Study|Adverse Event|2|||
105866461|NCT01582152|365161021|FG001|Overall Study|Adverse Event|1|||
105866462|NCT02794870|365161023|FG000|Overall Study|Withdrawal by Subject|2|||
105866463|NCT02794870|365161024|FG001|Overall Study|Withdrawal by Subject|0|||
105866464|NCT03336528|365161025|FG000|Overall Study|Protocol Violation|1|||
105866465|NCT03336528|365161026|FG001|Overall Study|Protocol Violation|1|||
105866466|NCT03336528|365161025|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
105866467|NCT03336528|365161026|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
105866468|NCT03336528|365161025|FG000|Overall Study|Did not receive study medication|1|||
106072477|NCT02039674|365930122|FG011|Overall Study|Adverse Event|2|||
106072478|NCT02039674|365930123|FG012|Overall Study|Adverse Event|3|||
106072479|NCT02039674|365930124|FG013|Overall Study|Adverse Event|1|||
106072480|NCT02039674|365930111|FG000|Overall Study|Death|2|||
106072481|NCT02039674|365930112|FG001|Overall Study|Death|0|||
106072482|NCT02039674|365930113|FG002|Overall Study|Death|2|||
106072483|NCT02039674|365930114|FG003|Overall Study|Death|3|||
106072484|NCT02039674|365930115|FG004|Overall Study|Death|0|||
106072485|NCT02039674|365930116|FG005|Overall Study|Death|0|||
106072486|NCT02039674|365930117|FG006|Overall Study|Death|1|||
106072487|NCT02039674|365930118|FG007|Overall Study|Death|0|||
106072488|NCT02039674|365930119|FG008|Overall Study|Death|2|||
106072489|NCT02039674|365930120|FG009|Overall Study|Death|0|||
106072490|NCT02039674|365930121|FG010|Overall Study|Death|1|||
106072491|NCT02039674|365930122|FG011|Overall Study|Death|3|||
106072492|NCT02039674|365930123|FG012|Overall Study|Death|2|||
106072493|NCT02039674|365930124|FG013|Overall Study|Death|8|||
106072494|NCT02039674|365930111|FG000|Overall Study|Excluded Medication|1|||
106072495|NCT02039674|365930112|FG001|Overall Study|Excluded Medication|1|||
106072496|NCT02039674|365930113|FG002|Overall Study|Excluded Medication|0|||
106072497|NCT02039674|365930114|FG003|Overall Study|Excluded Medication|1|||
106072498|NCT02039674|365930115|FG004|Overall Study|Excluded Medication|0|||
106072499|NCT02039674|365930116|FG005|Overall Study|Excluded Medication|1|||
106072500|NCT02039674|365930117|FG006|Overall Study|Excluded Medication|0|||
106072501|NCT02039674|365930118|FG007|Overall Study|Excluded Medication|0|||
106072502|NCT02039674|365930119|FG008|Overall Study|Excluded Medication|2|||
106072503|NCT02039674|365930120|FG009|Overall Study|Excluded Medication|3|||
106072504|NCT02039674|365930121|FG010|Overall Study|Excluded Medication|5|||
106072505|NCT02039674|365930122|FG011|Overall Study|Excluded Medication|6|||
106072506|NCT02039674|365930123|FG012|Overall Study|Excluded Medication|8|||
106072507|NCT02039674|365930124|FG013|Overall Study|Excluded Medication|3|||
106072508|NCT02039674|365930111|FG000|Overall Study|Lost to Follow-up|0|||
106072509|NCT02039674|365930112|FG001|Overall Study|Lost to Follow-up|0|||
106072510|NCT02039674|365930113|FG002|Overall Study|Lost to Follow-up|0|||
106072511|NCT02039674|365930114|FG003|Overall Study|Lost to Follow-up|0|||
106072512|NCT02039674|365930115|FG004|Overall Study|Lost to Follow-up|1|||
106072513|NCT02039674|365930116|FG005|Overall Study|Lost to Follow-up|1|||
106072514|NCT02039674|365930117|FG006|Overall Study|Lost to Follow-up|0|||
106072515|NCT02039674|365930118|FG007|Overall Study|Lost to Follow-up|0|||
106072516|NCT02039674|365930119|FG008|Overall Study|Lost to Follow-up|0|||
106072517|NCT02039674|365930120|FG009|Overall Study|Lost to Follow-up|0|||
106072518|NCT02039674|365930121|FG010|Overall Study|Lost to Follow-up|0|||
106072519|NCT02039674|365930122|FG011|Overall Study|Lost to Follow-up|2|||
106072520|NCT02039674|365930123|FG012|Overall Study|Lost to Follow-up|2|||
106072521|NCT02039674|365930124|FG013|Overall Study|Lost to Follow-up|1|||
106072522|NCT02039674|365930111|FG000|Overall Study|Physician Decision|0|||
106072523|NCT02039674|365930112|FG001|Overall Study|Physician Decision|0|||
106072524|NCT02039674|365930113|FG002|Overall Study|Physician Decision|0|||
106072525|NCT02039674|365930114|FG003|Overall Study|Physician Decision|0|||
106072526|NCT02039674|365930115|FG004|Overall Study|Physician Decision|0|||
106072527|NCT02039674|365930116|FG005|Overall Study|Physician Decision|0|||
106072528|NCT02039674|365930117|FG006|Overall Study|Physician Decision|0|||
106072529|NCT02039674|365930118|FG007|Overall Study|Physician Decision|0|||
106072530|NCT02039674|365930119|FG008|Overall Study|Physician Decision|0|||
105866469|NCT03336528|365161026|FG001|Overall Study|Did not receive study medication|2|||
105866470|NCT01753297|365161030|FG000|Overall Study|Lost to Follow-up|7|||
105866471|NCT01753297|365161031|FG001|Overall Study|Lost to Follow-up|2|||
105866472|NCT01753297|365161030|FG000|Overall Study|Withdrawal by Subject|26|||
106072531|NCT02039674|365930120|FG009|Overall Study|Physician Decision|0|||
106072532|NCT02039674|365930121|FG010|Overall Study|Physician Decision|0|||
106072533|NCT02039674|365930122|FG011|Overall Study|Physician Decision|1|||
106072534|NCT02039674|365930123|FG012|Overall Study|Physician Decision|1|||
106072535|NCT02039674|365930124|FG013|Overall Study|Physician Decision|0|||
106072536|NCT02039674|365930111|FG000|Overall Study|Progressive Disease|8|||
106072537|NCT02039674|365930112|FG001|Overall Study|Progressive Disease|8|||
106072538|NCT02039674|365930113|FG002|Overall Study|Progressive Disease|6|||
106072539|NCT02039674|365930114|FG003|Overall Study|Progressive Disease|7|||
106072540|NCT02039674|365930115|FG004|Overall Study|Progressive Disease|9|||
105866473|NCT01753297|365161031|FG001|Overall Study|Withdrawal by Subject|23|||
105866474|NCT01753297|365161030|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
105866475|NCT01753297|365161031|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
105866476|NCT01753297|365161030|FG000|Overall Study|Death|0|||
106156808|NCT02662062|366236542|FG000|Overall Study|Withdrawal by Subject|1|||
105866477|NCT01753297|365161031|FG001|Overall Study|Death|2|||
105866478|NCT01753297|365161030|FG000|Overall Study|Did not attend end of study visit|7|||
105866479|NCT01753297|365161031|FG001|Overall Study|Did not attend end of study visit|8|||
105866480|NCT01611857|365161034|FG000|Overall Study|Withdrawal by Subject|0|||
105866481|NCT01611857|365161035|FG001|Overall Study|Withdrawal by Subject|2|||
105866482|NCT00658879|365161042|FG000|Overall Study|Protocol Violation|1|||
105866483|NCT01645787|365161043|FG000|Washout (2 Weeks)|Adverse Event|1|||
106156809|NCT05406921|366236543|FG000|Overall Study|Withdrawal by Subject|25|||
106156810|NCT05406921|366236544|FG001|Overall Study|Withdrawal by Subject|0|||
106156811|NCT05406921|366236545|FG002|Overall Study|Withdrawal by Subject|25|||
106156812|NCT05406921|366236543|FG000|Overall Study|Protocol Violation|0|||
106156813|NCT05406921|366236544|FG001|Overall Study|Protocol Violation|12|||
106156814|NCT05406921|366236545|FG002|Overall Study|Protocol Violation|0|||
106156815|NCT00676715|366236549|FG000|Treatment Period (TP)|Adverse Event|0|||
106156816|NCT00676715|366236550|FG001|Treatment Period (TP)|Adverse Event|3|||
106156817|NCT00676715|366236551|FG002|Treatment Period (TP)|Adverse Event|2|||
106156818|NCT00676715|366236552|FG003|Treatment Period (TP)|Adverse Event|2|||
106156819|NCT00676715|366236549|FG000|Treatment Period (TP)|Death|0|||
106156820|NCT00676715|366236550|FG001|Treatment Period (TP)|Death|0|||
106156821|NCT00676715|366236551|FG002|Treatment Period (TP)|Death|1|||
106156822|NCT00676715|366236552|FG003|Treatment Period (TP)|Death|0|||
105866484|NCT01645787|365161044|FG001|Washout (2 Weeks)|Adverse Event|0|||
105866485|NCT02075515|365161045|FG000|Overall Study|Serious Adverse Event|1|||
105866486|NCT02075515|365161046|FG001|Overall Study|Serious Adverse Event|1|||
105866487|NCT02075515|365161047|FG002|Overall Study|Serious Adverse Event|1|||
106072541|NCT02039674|365930116|FG005|Overall Study|Progressive Disease|10|||
106072542|NCT02039674|365930117|FG006|Overall Study|Progressive Disease|1|||
106072543|NCT02039674|365930118|FG007|Overall Study|Progressive Disease|3|||
106072544|NCT02039674|365930119|FG008|Overall Study|Progressive Disease|6|||
106072545|NCT02039674|365930120|FG009|Overall Study|Progressive Disease|4|||
106072546|NCT02039674|365930121|FG010|Overall Study|Progressive Disease|0|||
106072547|NCT02039674|365930122|FG011|Overall Study|Progressive Disease|34|||
106072548|NCT02039674|365930123|FG012|Overall Study|Progressive Disease|34|||
106072549|NCT02039674|365930124|FG013|Overall Study|Progressive Disease|18|||
106072550|NCT02039674|365930111|FG000|Overall Study|Withdrawal by Subject|1|||
106072551|NCT02039674|365930112|FG001|Overall Study|Withdrawal by Subject|2|||
106072552|NCT02039674|365930113|FG002|Overall Study|Withdrawal by Subject|3|||
106072553|NCT02039674|365930114|FG003|Overall Study|Withdrawal by Subject|0|||
106072554|NCT02039674|365930115|FG004|Overall Study|Withdrawal by Subject|1|||
106072555|NCT02039674|365930116|FG005|Overall Study|Withdrawal by Subject|0|||
106072556|NCT02039674|365930117|FG006|Overall Study|Withdrawal by Subject|0|||
106072557|NCT02039674|365930118|FG007|Overall Study|Withdrawal by Subject|0|||
106072558|NCT02039674|365930119|FG008|Overall Study|Withdrawal by Subject|0|||
106072559|NCT02039674|365930120|FG009|Overall Study|Withdrawal by Subject|1|||
106072560|NCT02039674|365930121|FG010|Overall Study|Withdrawal by Subject|1|||
106072561|NCT02039674|365930122|FG011|Overall Study|Withdrawal by Subject|4|||
106072562|NCT02039674|365930123|FG012|Overall Study|Withdrawal by Subject|6|||
106072563|NCT02039674|365930124|FG013|Overall Study|Withdrawal by Subject|2|||
106072564|NCT02039674|365930111|FG000|Overall Study|Clinical Progression|0|||
106072565|NCT02039674|365930112|FG001|Overall Study|Clinical Progression|0|||
106072566|NCT02039674|365930113|FG002|Overall Study|Clinical Progression|0|||
106072567|NCT02039674|365930114|FG003|Overall Study|Clinical Progression|0|||
106072568|NCT02039674|365930115|FG004|Overall Study|Clinical Progression|0|||
106072569|NCT02039674|365930116|FG005|Overall Study|Clinical Progression|0|||
106072570|NCT02039674|365930117|FG006|Overall Study|Clinical Progression|1|||
106072571|NCT02039674|365930118|FG007|Overall Study|Clinical Progression|0|||
106072572|NCT02039674|365930119|FG008|Overall Study|Clinical Progression|0|||
106072573|NCT02039674|365930120|FG009|Overall Study|Clinical Progression|0|||
106072574|NCT02039674|365930121|FG010|Overall Study|Clinical Progression|0|||
106072575|NCT02039674|365930122|FG011|Overall Study|Clinical Progression|0|||
106072576|NCT02039674|365930123|FG012|Overall Study|Clinical Progression|1|||
106072577|NCT02039674|365930124|FG013|Overall Study|Clinical Progression|0|||
106072578|NCT02039674|365930111|FG000|Overall Study|Sponsor Decision|1|||
106072579|NCT02039674|365930112|FG001|Overall Study|Sponsor Decision|1|||
106072580|NCT02039674|365930113|FG002|Overall Study|Sponsor Decision|1|||
106072581|NCT02039674|365930114|FG003|Overall Study|Sponsor Decision|1|||
106072582|NCT02039674|365930115|FG004|Overall Study|Sponsor Decision|1|||
106072583|NCT02039674|365930116|FG005|Overall Study|Sponsor Decision|0|||
106072584|NCT02039674|365930117|FG006|Overall Study|Sponsor Decision|0|||
106072585|NCT02039674|365930118|FG007|Overall Study|Sponsor Decision|0|||
106072586|NCT02039674|365930119|FG008|Overall Study|Sponsor Decision|0|||
106072587|NCT02039674|365930120|FG009|Overall Study|Sponsor Decision|3|||
106072588|NCT02039674|365930121|FG010|Overall Study|Sponsor Decision|0|||
106072589|NCT02039674|365930122|FG011|Overall Study|Sponsor Decision|8|||
106072590|NCT02039674|365930123|FG012|Overall Study|Sponsor Decision|5|||
106072591|NCT02039674|365930124|FG013|Overall Study|Sponsor Decision|0|||
106072592|NCT02039674|365930111|FG000|Overall Study|Other|0|||
106072593|NCT02039674|365930112|FG001|Overall Study|Other|0|||
106072594|NCT02039674|365930113|FG002|Overall Study|Other|0|||
106072595|NCT02039674|365930114|FG003|Overall Study|Other|0|||
106072596|NCT02039674|365930115|FG004|Overall Study|Other|0|||
106072597|NCT02039674|365930116|FG005|Overall Study|Other|0|||
106072598|NCT02039674|365930117|FG006|Overall Study|Other|0|||
106072599|NCT02039674|365930118|FG007|Overall Study|Other|0|||
106072600|NCT02039674|365930119|FG008|Overall Study|Other|0|||
106072601|NCT02039674|365930120|FG009|Overall Study|Other|0|||
106072602|NCT02039674|365930121|FG010|Overall Study|Other|0|||
106072603|NCT02039674|365930122|FG011|Overall Study|Other|0|||
106072604|NCT02039674|365930123|FG012|Overall Study|Other|1|||
106072605|NCT02039674|365930124|FG013|Overall Study|Other|0|||
106072606|NCT01387347|365930125|FG000|Overall Study|Lost to Follow-up|2|||
106072607|NCT01387347|365930126|FG001|Overall Study|Lost to Follow-up|1|||
106072608|NCT00075582|365930127|FG000|Overall Study|Adverse Event|3|||
106072609|NCT00075582|365930128|FG001|Overall Study|Adverse Event|1|||
106072610|NCT00075582|365930127|FG000|Overall Study|Lack of Efficacy|4|||
106072611|NCT00075582|365930128|FG001|Overall Study|Lack of Efficacy|8|||
106072612|NCT00075582|365930127|FG000|Overall Study|Physician Decision|5|||
106072613|NCT00075582|365930128|FG001|Overall Study|Physician Decision|8|||
106072614|NCT00075582|365930127|FG000|Overall Study|Withdrawal by Subject|2|||
106072615|NCT00075582|365930128|FG001|Overall Study|Withdrawal by Subject|2|||
106072616|NCT00075582|365930127|FG000|Overall Study|Ineligible for study|36|||
106072617|NCT00075582|365930128|FG001|Overall Study|Ineligible for study|16|||
106072618|NCT00323492|365930133|FG000|Study Phase 1|Adverse Event|2|||
106072619|NCT00323492|365930134|FG001|Study Phase 1|Adverse Event|0|||
106072620|NCT00323492|365930135|FG002|Study Phase 1|Adverse Event|0|||
106072621|NCT00323492|365930133|FG000|Study Phase 2|Adverse Event|1|||
106072622|NCT00323492|365930134|FG001|Study Phase 2|Adverse Event|0|||
106072623|NCT00323492|365930135|FG002|Study Phase 2|Adverse Event|0|||
106072624|NCT00323492|365930133|FG000|Study Phase 2|Physician Decision|1|||
106072625|NCT00323492|365930134|FG001|Study Phase 2|Physician Decision|0|||
106072626|NCT00323492|365930135|FG002|Study Phase 2|Physician Decision|0|||
106072627|NCT00323492|365930133|FG000|Study Phase 2|Lost to Follow-up|1|||
106072628|NCT00323492|365930134|FG001|Study Phase 2|Lost to Follow-up|0|||
106072629|NCT00323492|365930135|FG002|Study Phase 2|Lost to Follow-up|0|||
106072630|NCT00323492|365930133|FG000|Study Phase 2|Withdrawal by Subject|0|||
106072631|NCT00323492|365930134|FG001|Study Phase 2|Withdrawal by Subject|1|||
106072632|NCT00323492|365930135|FG002|Study Phase 2|Withdrawal by Subject|0|||
106072633|NCT00323492|365930133|FG000|Study Phase 2|Noncompliance with study schedule|0|||
106072634|NCT00323492|365930134|FG001|Study Phase 2|Noncompliance with study schedule|0|||
106072635|NCT00323492|365930135|FG002|Study Phase 2|Noncompliance with study schedule|1|||
106072636|NCT00323492|365930133|FG000|Study Phase 2|Protocol Violation|1|||
106072637|NCT00323492|365930134|FG001|Study Phase 2|Protocol Violation|0|||
106072638|NCT00323492|365930135|FG002|Study Phase 2|Protocol Violation|0|||
106072639|NCT00994240|365930137|FG000|Overall Study|Lost to Follow-up|3|||
106072640|NCT00994240|365930138|FG001|Overall Study|Lost to Follow-up|2|||
106072641|NCT00994240|365930137|FG000|Overall Study|Withdrawal by Subject|1|||
106072642|NCT00994240|365930138|FG001|Overall Study|Withdrawal by Subject|0|||
106072643|NCT00994240|365930137|FG000|Overall Study|study termination|2|||
106072644|NCT00994240|365930138|FG001|Overall Study|study termination|3|||
106072645|NCT03760146|365930139|FG000|Overall Study|Adverse Event|11|||
106072646|NCT03760146|365930140|FG001|Overall Study|Adverse Event|8|||
106072647|NCT03760146|365930141|FG002|Overall Study|Adverse Event|0|||
106072648|NCT03760146|365930142|FG003|Overall Study|Adverse Event|0|||
106072649|NCT03760146|365930143|FG004|Overall Study|Adverse Event|0|||
106072650|NCT03760146|365930144|FG005|Overall Study|Adverse Event|0|||
106072651|NCT03760146|365930139|FG000|Overall Study|Death|1|||
106072652|NCT03760146|365930140|FG001|Overall Study|Death|0|||
106072653|NCT03760146|365930141|FG002|Overall Study|Death|0|||
106072654|NCT03760146|365930142|FG003|Overall Study|Death|0|||
106072655|NCT03760146|365930143|FG004|Overall Study|Death|0|||
106072656|NCT03760146|365930144|FG005|Overall Study|Death|0|||
106072657|NCT03760146|365930139|FG000|Overall Study|Lost to Follow-up|41|||
106072658|NCT03760146|365930140|FG001|Overall Study|Lost to Follow-up|28|||
106072659|NCT03760146|365930141|FG002|Overall Study|Lost to Follow-up|9|||
106072660|NCT03760146|365930142|FG003|Overall Study|Lost to Follow-up|2|||
106072661|NCT03760146|365930143|FG004|Overall Study|Lost to Follow-up|14|||
106072662|NCT03760146|365930144|FG005|Overall Study|Lost to Follow-up|8|||
106072663|NCT03760146|365930139|FG000|Overall Study|No longer met eligibility criteria|3|||
106072664|NCT03760146|365930140|FG001|Overall Study|No longer met eligibility criteria|9|||
106072665|NCT03760146|365930141|FG002|Overall Study|No longer met eligibility criteria|0|||
106072666|NCT03760146|365930142|FG003|Overall Study|No longer met eligibility criteria|0|||
106072667|NCT03760146|365930143|FG004|Overall Study|No longer met eligibility criteria|1|||
106072668|NCT03760146|365930144|FG005|Overall Study|No longer met eligibility criteria|0|||
106072669|NCT03760146|365930139|FG000|Overall Study|Protocol Violation|21|||
106072670|NCT03760146|365930140|FG001|Overall Study|Protocol Violation|13|||
106072671|NCT03760146|365930141|FG002|Overall Study|Protocol Violation|1|||
106072672|NCT03760146|365930142|FG003|Overall Study|Protocol Violation|0|||
106072673|NCT03760146|365930143|FG004|Overall Study|Protocol Violation|1|||
106072674|NCT03760146|365930144|FG005|Overall Study|Protocol Violation|0|||
106072675|NCT03760146|365930139|FG000|Overall Study|Withdrawal by Subject|19|||
106072676|NCT03760146|365930140|FG001|Overall Study|Withdrawal by Subject|20|||
106072677|NCT03760146|365930141|FG002|Overall Study|Withdrawal by Subject|1|||
106072678|NCT03760146|365930142|FG003|Overall Study|Withdrawal by Subject|0|||
106072679|NCT03760146|365930143|FG004|Overall Study|Withdrawal by Subject|1|||
106072680|NCT03760146|365930144|FG005|Overall Study|Withdrawal by Subject|0|||
106072681|NCT00449644|365930145|FG000|Overall Study|Adverse Event|0|||
106072682|NCT00449644|365930146|FG001|Overall Study|Adverse Event|0|||
106072683|NCT00449644|365930147|FG002|Overall Study|Adverse Event|3|||
106072684|NCT00449644|365930148|FG003|Overall Study|Adverse Event|5|||
106072685|NCT00449644|365930145|FG000|Overall Study|Death|1|||
106072686|NCT00449644|365930146|FG001|Overall Study|Death|0|||
106072687|NCT00449644|365930147|FG002|Overall Study|Death|6|||
106072688|NCT00449644|365930148|FG003|Overall Study|Death|1|||
106072689|NCT00449644|365930145|FG000|Overall Study|Lost to Follow-up|1|||
106072690|NCT00449644|365930146|FG001|Overall Study|Lost to Follow-up|1|||
106072691|NCT00449644|365930147|FG002|Overall Study|Lost to Follow-up|5|||
106072692|NCT00449644|365930148|FG003|Overall Study|Lost to Follow-up|3|||
106072693|NCT00449644|365930145|FG000|Overall Study|Pregnancy|0|||
106072694|NCT00449644|365930146|FG001|Overall Study|Pregnancy|0|||
106072695|NCT00449644|365930147|FG002|Overall Study|Pregnancy|3|||
106072696|NCT00449644|365930148|FG003|Overall Study|Pregnancy|2|||
106072697|NCT00449644|365930145|FG000|Overall Study|Protocol Violation|4|||
106072698|NCT00449644|365930146|FG001|Overall Study|Protocol Violation|4|||
106072699|NCT00449644|365930147|FG002|Overall Study|Protocol Violation|3|||
106072700|NCT00449644|365930148|FG003|Overall Study|Protocol Violation|7|||
106072701|NCT00449644|365930145|FG000|Overall Study|Withdrawal by Subject|3|||
106072702|NCT00449644|365930146|FG001|Overall Study|Withdrawal by Subject|4|||
106072703|NCT00449644|365930147|FG002|Overall Study|Withdrawal by Subject|6|||
106072704|NCT00449644|365930148|FG003|Overall Study|Withdrawal by Subject|7|||
106072705|NCT00449644|365930145|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
106156823|NCT00676715|366236549|FG000|Treatment Period (TP)|Failure to return|1|||
106156824|NCT00676715|366236550|FG001|Treatment Period (TP)|Failure to return|0|||
106156825|NCT00676715|366236551|FG002|Treatment Period (TP)|Failure to return|0|||
106156826|NCT00676715|366236552|FG003|Treatment Period (TP)|Failure to return|0|||
106156827|NCT00676715|366236549|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
106156828|NCT00676715|366236550|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
106156829|NCT00676715|366236551|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
106156830|NCT00676715|366236552|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
106156831|NCT00676715|366236549|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
106156832|NCT00676715|366236550|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
106156833|NCT00676715|366236551|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
106156834|NCT00676715|366236552|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
106156835|NCT00676715|366236549|FG000|Treatment Period (TP)|Withdrew consent|3|||
106156836|NCT00676715|366236550|FG001|Treatment Period (TP)|Withdrew consent|3|||
106156837|NCT00676715|366236551|FG002|Treatment Period (TP)|Withdrew consent|3|||
106156838|NCT00676715|366236552|FG003|Treatment Period (TP)|Withdrew consent|3|||
106156839|NCT00676715|366236549|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
106156840|NCT00676715|366236550|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
106156841|NCT00676715|366236551|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
106156842|NCT00676715|366236552|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
106156843|NCT00676715|366236549|FG000|Treatment Period (TP)|Administrative|0|||
106156844|NCT00676715|366236550|FG001|Treatment Period (TP)|Administrative|0|||
106156845|NCT00676715|366236551|FG002|Treatment Period (TP)|Administrative|0|||
106156846|NCT00676715|366236552|FG003|Treatment Period (TP)|Administrative|1|||
106156847|NCT00676715|366236549|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
106156848|NCT00676715|366236550|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
106156849|NCT00676715|366236551|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
106156850|NCT00676715|366236552|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
106156851|NCT00676715|366236549|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
106156852|NCT00676715|366236550|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
106156853|NCT00676715|366236551|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
106156854|NCT00676715|366236552|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
106156855|NCT00676715|366236549|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
106156856|NCT00676715|366236550|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
106156857|NCT00676715|366236551|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
106156858|NCT00676715|366236552|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
106072706|NCT00449644|365930146|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
106072707|NCT00449644|365930147|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
106072708|NCT00449644|365930148|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
106072709|NCT00449644|365930145|FG000|Overall Study|Other|1|||
106072710|NCT00449644|365930146|FG001|Overall Study|Other|4|||
106072711|NCT00449644|365930147|FG002|Overall Study|Other|1|||
106072712|NCT00449644|365930148|FG003|Overall Study|Other|0|||
106072713|NCT00449644|365930145|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
106072714|NCT00449644|365930146|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
106072715|NCT00449644|365930147|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
106072716|NCT00449644|365930148|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
106072717|NCT02291055|365930149|FG000|Overall Study|Death|2|||
106072718|NCT02291055|365930150|FG001|Overall Study|Death|2|||
106072719|NCT02291055|365930151|FG002|Overall Study|Death|5|||
106072720|NCT02291055|365930152|FG003|Overall Study|Death|8|||
106072721|NCT02291055|365930153|FG004|Overall Study|Death|12|||
106072722|NCT02291055|365930149|FG000|Overall Study|Lost to Follow-up|0|||
106072723|NCT02291055|365930150|FG001|Overall Study|Lost to Follow-up|0|||
106072724|NCT02291055|365930151|FG002|Overall Study|Lost to Follow-up|0|||
106072725|NCT02291055|365930152|FG003|Overall Study|Lost to Follow-up|1|||
106072726|NCT02291055|365930153|FG004|Overall Study|Lost to Follow-up|2|||
106072727|NCT02291055|365930149|FG000|Overall Study|Withdrawal by Subject|3|||
106072728|NCT02291055|365930150|FG001|Overall Study|Withdrawal by Subject|1|||
106072729|NCT02291055|365930151|FG002|Overall Study|Withdrawal by Subject|1|||
106072730|NCT02291055|365930152|FG003|Overall Study|Withdrawal by Subject|5|||
106072731|NCT02291055|365930153|FG004|Overall Study|Withdrawal by Subject|10|||
106072732|NCT02291055|365930149|FG000|Overall Study|Progressive Disease|0|||
106072733|NCT02291055|365930150|FG001|Overall Study|Progressive Disease|0|||
106072734|NCT02291055|365930151|FG002|Overall Study|Progressive Disease|1|||
106072735|NCT02291055|365930152|FG003|Overall Study|Progressive Disease|4|||
106072736|NCT02291055|365930153|FG004|Overall Study|Progressive Disease|2|||
106072737|NCT02291055|365930149|FG000|Overall Study|Study Terminated by Sponsor|0|||
106072738|NCT02291055|365930150|FG001|Overall Study|Study Terminated by Sponsor|0|||
106072739|NCT02291055|365930151|FG002|Overall Study|Study Terminated by Sponsor|0|||
106072740|NCT02291055|365930152|FG003|Overall Study|Study Terminated by Sponsor|5|||
106072741|NCT02291055|365930153|FG004|Overall Study|Study Terminated by Sponsor|1|||
106072742|NCT02291055|365930149|FG000|Overall Study|Other|0|||
106072743|NCT02291055|365930150|FG001|Overall Study|Other|2|||
106072744|NCT02291055|365930151|FG002|Overall Study|Other|1|||
106072745|NCT02291055|365930152|FG003|Overall Study|Other|4|||
106072746|NCT02291055|365930153|FG004|Overall Study|Other|0|||
106072747|NCT02910167|365930156|FG000|Overall Study|Adverse Event|1|||
106072748|NCT02910167|365930156|FG000|Overall Study|Lost to Follow-up|18|||
106072749|NCT04059146|365930157|FG000|Overall Study|Withdrawal by Subject|0|||
106072750|NCT04059146|365930158|FG001|Overall Study|Withdrawal by Subject|1|||
106072751|NCT01239368|365931875|FG000|Overall Study|Principal investigator discretion|1|||
106072752|NCT01239368|365931876|FG001|Overall Study|Principal investigator discretion|0|||
106072753|NCT01239368|365931877|FG002|Overall Study|Principal investigator discretion|0|||
106072754|NCT01239368|365931878|FG003|Overall Study|Principal investigator discretion|0|||
106072755|NCT01239368|365931879|FG004|Overall Study|Principal investigator discretion|1|||
106072756|NCT01239368|365931880|FG005|Overall Study|Principal investigator discretion|2|||
106072757|NCT01239368|365931881|FG006|Overall Study|Principal investigator discretion|0|||
106072758|NCT01239368|365931882|FG007|Overall Study|Principal investigator discretion|0|||
106072759|NCT01239368|365931883|FG008|Overall Study|Principal investigator discretion|0|||
106072760|NCT01239368|365931884|FG009|Overall Study|Principal investigator discretion|1|||
106072761|NCT01239368|365931875|FG000|Overall Study|Disease progression on study|1|||
106072762|NCT01239368|365931876|FG001|Overall Study|Disease progression on study|1|||
106072763|NCT01239368|365931877|FG002|Overall Study|Disease progression on study|1|||
106072764|NCT01239368|365931878|FG003|Overall Study|Disease progression on study|1|||
106072765|NCT01239368|365931879|FG004|Overall Study|Disease progression on study|4|||
106072766|NCT01239368|365931880|FG005|Overall Study|Disease progression on study|2|||
106072767|NCT01239368|365931881|FG006|Overall Study|Disease progression on study|5|||
106072768|NCT01239368|365931882|FG007|Overall Study|Disease progression on study|0|||
106072769|NCT01239368|365931883|FG008|Overall Study|Disease progression on study|0|||
106072770|NCT01239368|365931884|FG009|Overall Study|Disease progression on study|2|||
106072771|NCT01239368|365931875|FG000|Overall Study|Refused further treatment|0|||
106072772|NCT01239368|365931876|FG001|Overall Study|Refused further treatment|0|||
106072773|NCT01239368|365931877|FG002|Overall Study|Refused further treatment|0|||
106072774|NCT01239368|365931878|FG003|Overall Study|Refused further treatment|0|||
106072775|NCT01239368|365931879|FG004|Overall Study|Refused further treatment|0|||
106072776|NCT01239368|365931880|FG005|Overall Study|Refused further treatment|0|||
106072777|NCT01239368|365931881|FG006|Overall Study|Refused further treatment|0|||
106072778|NCT01239368|365931882|FG007|Overall Study|Refused further treatment|0|||
106072779|NCT01239368|365931883|FG008|Overall Study|Refused further treatment|0|||
106072780|NCT01239368|365931884|FG009|Overall Study|Refused further treatment|1|||
106072781|NCT01239368|365931875|FG000|Overall Study|Death|0|||
106072782|NCT01239368|365931876|FG001|Overall Study|Death|0|||
106072783|NCT01239368|365931877|FG002|Overall Study|Death|0|||
106072784|NCT01239368|365931878|FG003|Overall Study|Death|0|||
106072785|NCT01239368|365931879|FG004|Overall Study|Death|0|||
106072786|NCT01239368|365931880|FG005|Overall Study|Death|0|||
106072787|NCT01239368|365931881|FG006|Overall Study|Death|1|||
106072788|NCT01239368|365931882|FG007|Overall Study|Death|0|||
106072789|NCT01239368|365931883|FG008|Overall Study|Death|0|||
106072790|NCT01239368|365931884|FG009|Overall Study|Death|0|||
106072791|NCT01536379|365931886|FG000|Overall Study|Adverse Event|1|||
106072792|NCT01536379|365931887|FG001|Overall Study|Adverse Event|2|||
106072793|NCT01536379|365931886|FG000|Overall Study|Withdrawal by Subject|1|||
106072794|NCT01536379|365931887|FG001|Overall Study|Withdrawal by Subject|1|||
106072795|NCT02268409|365931891|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
106072796|NCT02268409|365931891|FG000|Overall Study|Death|1|||
106072797|NCT02268409|365931891|FG000|Overall Study|Lost to Follow-up|1|||
106072798|NCT02268409|365931891|FG000|Overall Study|Protocol Violation|3|||
106072799|NCT02268409|365931891|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
106072800|NCT02268409|365931891|FG000|Overall Study|Withdrawal by Subject|5|||
106072801|NCT01190254|365931896|FG000|Overall Study|Adverse Event|3|||
106072802|NCT01190254|365931897|FG001|Overall Study|Adverse Event|6|||
106072803|NCT01190254|365931898|FG002|Overall Study|Adverse Event|8|||
106072804|NCT01190254|365931896|FG000|Overall Study|Lack of Efficacy|7|||
106072805|NCT01190254|365931897|FG001|Overall Study|Lack of Efficacy|4|||
106072806|NCT01190254|365931898|FG002|Overall Study|Lack of Efficacy|5|||
106072807|NCT01190254|365931896|FG000|Overall Study|Lost to Follow-up|4|||
106072808|NCT01190254|365931897|FG001|Overall Study|Lost to Follow-up|2|||
106072809|NCT01190254|365931898|FG002|Overall Study|Lost to Follow-up|0|||
106072810|NCT01190254|365931896|FG000|Overall Study|Withdrawal by Subject|4|||
106072811|NCT01190254|365931897|FG001|Overall Study|Withdrawal by Subject|5|||
106072812|NCT01190254|365931898|FG002|Overall Study|Withdrawal by Subject|7|||
106072813|NCT01190254|365931896|FG000|Overall Study|Protocol Violation|2|||
106072814|NCT01190254|365931897|FG001|Overall Study|Protocol Violation|0|||
106072815|NCT01190254|365931898|FG002|Overall Study|Protocol Violation|2|||
106072816|NCT01190254|365931896|FG000|Overall Study|Did not meet protocol eligibility|1|||
106072817|NCT01190254|365931897|FG001|Overall Study|Did not meet protocol eligibility|0|||
106072818|NCT01190254|365931898|FG002|Overall Study|Did not meet protocol eligibility|0|||
106072819|NCT00489853|365931899|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
106072820|NCT00489853|365931900|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
106072821|NCT00489853|365931901|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
106072822|NCT00489853|365931899|FG000|Wash-out Period 1|Adverse Event|0|||
106072823|NCT00489853|365931900|FG001|Wash-out Period 1|Adverse Event|1|||
106072824|NCT00489853|365931901|FG002|Wash-out Period 1|Adverse Event|1|||
106072825|NCT00489853|365931899|FG000|Wash-out Period 1|Protocol Violation|0|||
106072826|NCT00489853|365931900|FG001|Wash-out Period 1|Protocol Violation|1|||
106072827|NCT00489853|365931901|FG002|Wash-out Period 1|Protocol Violation|1|||
106072828|NCT00489853|365931899|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
106072829|NCT00489853|365931900|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
106072830|NCT00489853|365931901|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
106072831|NCT00489853|365931899|FG000|Wash-out Period 2|Adverse Event|1|||
106072832|NCT00489853|365931900|FG001|Wash-out Period 2|Adverse Event|1|||
106072833|NCT00489853|365931901|FG002|Wash-out Period 2|Adverse Event|0|||
106072834|NCT00489853|365931899|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
106072835|NCT00489853|365931900|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
106072836|NCT00489853|365931901|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
106072837|NCT00489853|365931899|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
106072838|NCT00489853|365931900|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
106072839|NCT00489853|365931901|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
106072840|NCT04146545|365931903|FG000|Overall Study|deemed ineligible after randomization|1|||
106072841|NCT04146545|365931904|FG001|Overall Study|deemed ineligible after randomization|0|||
106072842|NCT04729127|365931907|FG000|Overall Study|Suspended/Terminated EI Services|4|||
106072843|NCT04729127|365931908|FG001|Overall Study|Suspended/Terminated EI Services|0|||
106072844|NCT04729127|365931909|FG002|Overall Study|Suspended/Terminated EI Services|4|||
106072845|NCT04729127|365931910|FG003|Overall Study|Suspended/Terminated EI Services|6|||
106072846|NCT04729127|365931911|FG004|Overall Study|Suspended/Terminated EI Services|0|||
106072847|NCT04729127|365931912|FG005|Overall Study|Suspended/Terminated EI Services|6|||
106072848|NCT04729127|365931913|FG006|Overall Study|Suspended/Terminated EI Services|2|||
106072849|NCT04729127|365931914|FG007|Overall Study|Suspended/Terminated EI Services|0|||
106072850|NCT04729127|365931915|FG008|Overall Study|Suspended/Terminated EI Services|2|||
106072851|NCT04729127|365931907|FG000|Overall Study|Withdrawal by Subject|1|||
106072852|NCT04729127|365931908|FG001|Overall Study|Withdrawal by Subject|0|||
106072853|NCT04729127|365931909|FG002|Overall Study|Withdrawal by Subject|1|||
106072854|NCT04729127|365931910|FG003|Overall Study|Withdrawal by Subject|0|||
106072855|NCT04729127|365931911|FG004|Overall Study|Withdrawal by Subject|0|||
106072856|NCT04729127|365931912|FG005|Overall Study|Withdrawal by Subject|0|||
106156859|NCT00676715|366236549|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
106156860|NCT00676715|366236550|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
106156861|NCT00676715|366236551|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
106156862|NCT00676715|366236552|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
106156863|NCT00676715|366236549|FG000|Treatment-free Period (TFP)|Death|1|||
106156864|NCT00676715|366236550|FG001|Treatment-free Period (TFP)|Death|1|||
106156865|NCT00676715|366236551|FG002|Treatment-free Period (TFP)|Death|1|||
106156866|NCT00676715|366236552|FG003|Treatment-free Period (TFP)|Death|0|||
106156867|NCT00676715|366236549|FG000|Open Label Extension (OLE)|Reason not provided|3|||
106156868|NCT00676715|366236550|FG001|Open Label Extension (OLE)|Reason not provided|4|||
106156869|NCT00676715|366236551|FG002|Open Label Extension (OLE)|Reason not provided|1|||
106156870|NCT00676715|366236552|FG003|Open Label Extension (OLE)|Reason not provided|4|||
106156871|NCT00676715|366236549|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
106156872|NCT00676715|366236550|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
106156873|NCT00676715|366236551|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
106156874|NCT00676715|366236552|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
106156875|NCT00676715|366236549|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
106156876|NCT00676715|366236550|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
106156877|NCT00676715|366236551|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
106156878|NCT00676715|366236552|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
106156879|NCT00676715|366236549|FG000|Open Label Extension (OLE)|Adverse Event|0|||
106156880|NCT00676715|366236550|FG001|Open Label Extension (OLE)|Adverse Event|3|||
106156881|NCT00676715|366236551|FG002|Open Label Extension (OLE)|Adverse Event|1|||
106156882|NCT00676715|366236552|FG003|Open Label Extension (OLE)|Adverse Event|0|||
106156883|NCT00676715|366236549|FG000|Open Label Extension (OLE)|Death|2|||
106156884|NCT00676715|366236550|FG001|Open Label Extension (OLE)|Death|0|||
106156885|NCT00676715|366236551|FG002|Open Label Extension (OLE)|Death|2|||
106156886|NCT00676715|366236552|FG003|Open Label Extension (OLE)|Death|2|||
106156887|NCT04831281|366236553|FG000|Overall Study|Adverse Event|1|||
106156888|NCT04831281|366236554|FG001|Overall Study|Adverse Event|0|||
106156889|NCT04831281|366236555|FG002|Overall Study|Adverse Event|3|||
106072857|NCT04729127|365931913|FG006|Overall Study|Withdrawal by Subject|0|||
106072858|NCT04729127|365931914|FG007|Overall Study|Withdrawal by Subject|0|||
106072859|NCT04729127|365931915|FG008|Overall Study|Withdrawal by Subject|0|||
106072860|NCT04729127|365931907|FG000|Overall Study|Switched Agency/Setting|1|||
106156890|NCT04831281|366236553|FG000|Overall Study|Withdrawal by Subject|0|||
106156891|NCT04831281|366236554|FG001|Overall Study|Withdrawal by Subject|1|||
106072861|NCT04729127|365931908|FG001|Overall Study|Switched Agency/Setting|0|||
106072862|NCT04729127|365931909|FG002|Overall Study|Switched Agency/Setting|1|||
106072863|NCT04729127|365931910|FG003|Overall Study|Switched Agency/Setting|1|||
106072864|NCT04729127|365931911|FG004|Overall Study|Switched Agency/Setting|0|||
106072865|NCT04729127|365931912|FG005|Overall Study|Switched Agency/Setting|1|||
106072866|NCT04729127|365931913|FG006|Overall Study|Switched Agency/Setting|1|||
106072867|NCT04729127|365931914|FG007|Overall Study|Switched Agency/Setting|0|||
106072868|NCT04729127|365931915|FG008|Overall Study|Switched Agency/Setting|1|||
106072869|NCT03662542|365931916|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
106072870|NCT03662542|365931917|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
106072871|NCT03662542|365931918|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
106072872|NCT03662542|365931919|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
106072873|NCT03662542|365931920|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
106072874|NCT03662542|365931921|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
106072875|NCT03662542|365931922|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
106072876|NCT03662542|365931923|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
106072877|NCT03662542|365931924|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
106072878|NCT03662542|365931916|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
106072879|NCT03662542|365931917|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
106072880|NCT03662542|365931918|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
106072881|NCT03662542|365931919|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
106072882|NCT03662542|365931920|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
106072883|NCT03662542|365931921|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
106072884|NCT03662542|365931922|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
106072885|NCT03662542|365931923|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
106072886|NCT03662542|365931924|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
106072887|NCT03662542|365931916|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
106072888|NCT03662542|365931917|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
106072889|NCT03662542|365931918|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
106072890|NCT03662542|365931919|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
106072891|NCT03662542|365931920|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
106072892|NCT03662542|365931921|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
106072893|NCT03662542|365931922|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
106072894|NCT03662542|365931923|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
106072895|NCT03662542|365931924|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
106072896|NCT03662542|365931916|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
106072897|NCT03662542|365931917|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
106072898|NCT03662542|365931918|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
106072899|NCT03662542|365931919|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
106072900|NCT03662542|365931920|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
106072901|NCT03662542|365931921|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
106072902|NCT03662542|365931922|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
106072903|NCT03662542|365931923|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
106072904|NCT03662542|365931924|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
106072905|NCT03662542|365931916|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
106072906|NCT03662542|365931917|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
106072907|NCT03662542|365931918|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
106072908|NCT03662542|365931919|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
106072909|NCT03662542|365931920|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
106072910|NCT03662542|365931921|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
106072911|NCT03662542|365931922|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
106072912|NCT03662542|365931923|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
106072913|NCT03662542|365931924|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
106072914|NCT03662542|365931916|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
106072915|NCT03662542|365931917|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
106072916|NCT03662542|365931918|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
106072917|NCT03662542|365931919|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
106156892|NCT04831281|366236555|FG002|Overall Study|Withdrawal by Subject|2|||
106156893|NCT04831281|366236553|FG000|Overall Study|Undetermined|1|||
106072918|NCT03662542|365931920|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
106072919|NCT03662542|365931921|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
106072920|NCT03662542|365931922|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
106072921|NCT03662542|365931923|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
106072922|NCT03662542|365931924|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
106072923|NCT03662542|365931916|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
106072924|NCT03662542|365931917|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
106072925|NCT03662542|365931918|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
106072926|NCT03662542|365931919|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
106156894|NCT04831281|366236554|FG001|Overall Study|Undetermined|1|||
106156895|NCT04831281|366236555|FG002|Overall Study|Undetermined|0|||
106156896|NCT05059262|366236556|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
106156897|NCT05059262|366236557|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
106156898|NCT05059262|366236556|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
106156899|NCT05059262|366236557|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
106156900|NCT05059262|366236556|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
106156901|NCT05059262|366236557|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
106156902|NCT05059262|366236556|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
106156903|NCT05059262|366236557|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
106156904|NCT05059262|366236556|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
106156905|NCT05059262|366236557|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
106156906|NCT05059262|366236556|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
106156907|NCT05059262|366236557|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
106156908|NCT05059262|366236556|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
106156909|NCT05059262|366236557|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
106156910|NCT05059262|366236556|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
106156911|NCT05059262|366236557|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
106156912|NCT05059262|366236556|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
106156913|NCT05059262|366236557|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
106156914|NCT04060355|366236560|FG000|Overall Study|Lost to Follow-up|41|||
106156915|NCT01707030|366236578|FG000|Overall Study|Death|1|||
106156916|NCT01707030|366236579|FG001|Overall Study|Death|1|||
106156917|NCT01707030|366236578|FG000|Overall Study|Withdrawal by Subject|2|||
106156918|NCT01707030|366236579|FG001|Overall Study|Withdrawal by Subject|3|||
106156919|NCT01707030|366236578|FG000|Overall Study|Lost to Follow-up|8|||
106156920|NCT01707030|366236579|FG001|Overall Study|Lost to Follow-up|13|||
106156921|NCT04258709|366236583|FG000|Overall Study|Lost to Follow-up|10|||
106156922|NCT04258709|366236584|FG001|Overall Study|Lost to Follow-up|4|||
106156923|NCT04258709|366236583|FG000|Overall Study|Withdrawal by Subject|1|||
106156924|NCT04258709|366236584|FG001|Overall Study|Withdrawal by Subject|0|||
106156925|NCT04258709|366236583|FG000|Overall Study|Fetal demise|0|||
106156926|NCT04258709|366236584|FG001|Overall Study|Fetal demise|1|||
106156927|NCT04258709|366236583|FG000|Overall Study|Protocol Violation|1|||
106156928|NCT04258709|366236584|FG001|Overall Study|Protocol Violation|1|||
106156929|NCT04263311|366236585|FG000|Overall Study|Lost to Follow-up|1|||
106156930|NCT04263311|366236586|FG001|Overall Study|Lost to Follow-up|2|||
106156931|NCT04263311|366236587|FG002|Overall Study|Lost to Follow-up|0|||
106156932|NCT04263311|366236585|FG000|Overall Study|Health Issues|1|||
106156933|NCT04263311|366236586|FG001|Overall Study|Health Issues|0|||
106156934|NCT04263311|366236587|FG002|Overall Study|Health Issues|0|||
106156935|NCT04263311|366236585|FG000|Overall Study|Left the country|1|||
106156936|NCT04263311|366236586|FG001|Overall Study|Left the country|0|||
106156937|NCT04263311|366236587|FG002|Overall Study|Left the country|0|||
106156938|NCT04263311|366236585|FG000|Overall Study|Unable to maintain time commitment|1|||
106156939|NCT04263311|366236586|FG001|Overall Study|Unable to maintain time commitment|0|||
106156940|NCT04263311|366236587|FG002|Overall Study|Unable to maintain time commitment|0|||
106156941|NCT04263311|366236585|FG000|Overall Study|No longer interested|1|||
106156942|NCT04263311|366236586|FG001|Overall Study|No longer interested|0|||
106156943|NCT04263311|366236587|FG002|Overall Study|No longer interested|0|||
106156944|NCT04263311|366236585|FG000|Overall Study|Ineligible post consent|0|||
106156945|NCT04263311|366236586|FG001|Overall Study|Ineligible post consent|0|||
106156946|NCT04263311|366236587|FG002|Overall Study|Ineligible post consent|5|||
106156947|NCT04673929|366236588|FG000|Overall Study|Death|73|||
106156948|NCT04673929|366236588|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
106156949|NCT04024813|366236589|FG000|Overall Study|Study terminated by Sponsor|1|||
106156950|NCT05633953|366236590|FG000|Overall Study|Adverse Event|7|||
106156951|NCT05633953|366236590|FG000|Overall Study|Death|30|||
106156952|NCT05633953|366236590|FG000|Overall Study|Lost to Follow-up|1|||
106156953|NCT05633953|366236590|FG000|Overall Study|Osilodrostat discontinued|4|||
106156954|NCT05633953|366236590|FG000|Overall Study|Physician Decision|1|||
106156955|NCT05633953|366236590|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
106156956|NCT05633953|366236590|FG000|Overall Study|Progressive disease|2|||
106156957|NCT03047928|366236591|FG000|Overall Study|Adverse Event|0|||
106156958|NCT03047928|366236592|FG001|Overall Study|Adverse Event|2|||
106156959|NCT03047928|366236593|FG002|Overall Study|Adverse Event|0|||
106156960|NCT03047928|366236591|FG000|Overall Study|Protocol Violation|0|||
106156961|NCT03047928|366236592|FG001|Overall Study|Protocol Violation|1|||
106156962|NCT03047928|366236593|FG002|Overall Study|Protocol Violation|0|||
106156963|NCT03047928|366236591|FG000|Overall Study|included in another protocol|0|||
106156964|NCT03047928|366236592|FG001|Overall Study|included in another protocol|1|||
106156965|NCT03047928|366236593|FG002|Overall Study|included in another protocol|0|||
106156966|NCT05324124|366236594|FG000|Period 1|Withdrawal by Subject|1|||
106156967|NCT05324124|366236595|FG001|Period 1|Withdrawal by Subject|0|||
106156968|NCT05324124|366236594|FG000|Period 1|Physician Decision|0|||
105866488|NCT02075515|365161045|FG000|Overall Study|Non-Serious Adverse Event|0|||
105866489|NCT02075515|365161046|FG001|Overall Study|Non-Serious Adverse Event|1|||
105866490|NCT02075515|365161047|FG002|Overall Study|Non-Serious Adverse Event|0|||
106072927|NCT03662542|365931920|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
106072928|NCT03662542|365931921|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
105866491|NCT02075515|365161045|FG000|Overall Study|Withdrawal by Subject|2|||
106072929|NCT03662542|365931922|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
106072930|NCT03662542|365931923|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
106072931|NCT03662542|365931924|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
106072932|NCT03662542|365931916|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
106072933|NCT03662542|365931917|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
106072934|NCT03662542|365931918|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
106072935|NCT03662542|365931919|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
106072936|NCT03662542|365931920|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
106072937|NCT03662542|365931921|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
106072938|NCT03662542|365931922|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
106072939|NCT03662542|365931923|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
106072940|NCT03662542|365931924|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
106072941|NCT03662542|365931916|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
106072942|NCT03662542|365931917|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
106072943|NCT03662542|365931918|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
106072944|NCT03662542|365931919|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
106072945|NCT03662542|365931920|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
106072946|NCT03662542|365931921|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
106072947|NCT03662542|365931922|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
106072948|NCT03662542|365931923|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
106072949|NCT03662542|365931924|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
106072950|NCT03662542|365931916|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
106072951|NCT03662542|365931917|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
106072952|NCT03662542|365931918|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
106072953|NCT03662542|365931919|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
106072954|NCT03662542|365931920|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
106072955|NCT03662542|365931921|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
106072956|NCT03662542|365931922|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
106072957|NCT03662542|365931923|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
106072958|NCT03662542|365931924|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
106072959|NCT03662542|365931916|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
106072960|NCT03662542|365931917|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
106072961|NCT03662542|365931918|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
106072962|NCT03662542|365931919|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
106072963|NCT03662542|365931920|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
106072964|NCT03662542|365931921|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
106072965|NCT03662542|365931922|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
106072966|NCT03662542|365931923|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
106072967|NCT03662542|365931924|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
106072968|NCT03662542|365931916|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
106072969|NCT03662542|365931917|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
106072970|NCT03662542|365931918|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
106072971|NCT03662542|365931919|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
106072972|NCT03662542|365931920|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
106072973|NCT03662542|365931921|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
106072974|NCT03662542|365931922|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
106072975|NCT03662542|365931923|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
106072976|NCT03662542|365931924|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
106072977|NCT03662542|365931916|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
106072978|NCT03662542|365931917|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
106072979|NCT03662542|365931918|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
106072980|NCT03662542|365931919|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
106072981|NCT03662542|365931920|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
106072982|NCT03662542|365931921|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
106072983|NCT03662542|365931922|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
106072984|NCT03662542|365931923|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
106072985|NCT03662542|365931924|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
106072986|NCT01727141|365931925|FG000|Overall Study|Physician Decision|0|||
106072987|NCT01727141|365931926|FG001|Overall Study|Physician Decision|1|||
106072988|NCT01727141|365931927|FG002|Overall Study|Physician Decision|0|||
106072989|NCT01727141|365931928|FG003|Overall Study|Physician Decision|2|||
106072990|NCT01727141|365931925|FG000|Overall Study|Lost to Follow-up|0|||
106072991|NCT01727141|365931926|FG001|Overall Study|Lost to Follow-up|2|||
106072992|NCT01727141|365931927|FG002|Overall Study|Lost to Follow-up|0|||
106072993|NCT01727141|365931928|FG003|Overall Study|Lost to Follow-up|0|||
106072994|NCT01727141|365931925|FG000|Overall Study|Death|0|||
106072995|NCT01727141|365931926|FG001|Overall Study|Death|1|||
106072996|NCT01727141|365931927|FG002|Overall Study|Death|1|||
106072997|NCT01727141|365931928|FG003|Overall Study|Death|1|||
106072998|NCT01727141|365931925|FG000|Overall Study|Protocol deviation|1|||
106072999|NCT01727141|365931926|FG001|Overall Study|Protocol deviation|1|||
106073000|NCT01727141|365931927|FG002|Overall Study|Protocol deviation|0|||
106073001|NCT01727141|365931928|FG003|Overall Study|Protocol deviation|1|||
106156969|NCT05324124|366236595|FG001|Period 1|Physician Decision|1|||
106156970|NCT02543281|366236598|FG000|Overall Study|Lost to Follow-up|0|||
106156971|NCT02543281|366236599|FG001|Overall Study|Lost to Follow-up|0|||
106156972|NCT02543281|366236600|FG002|Overall Study|Lost to Follow-up|1|||
106156973|NCT03763708|366236616|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
106156974|NCT03763708|366236617|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
106156975|NCT03763708|366236618|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
106156976|NCT03763708|366236619|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
106156977|NCT03763708|366236620|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
106156978|NCT03763708|366236621|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
106156979|NCT03763708|366236622|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
106156980|NCT03763708|366236623|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
106156981|NCT03763708|366236624|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
106156982|NCT03763708|366236616|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
106156983|NCT03763708|366236617|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
106156984|NCT03763708|366236618|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
106156985|NCT03763708|366236619|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
106156986|NCT03763708|366236620|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
106156987|NCT03763708|366236621|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
106156988|NCT03763708|366236622|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
106156989|NCT03763708|366236623|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
106156990|NCT03763708|366236624|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
106156991|NCT03763708|366236616|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
106156992|NCT03763708|366236617|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
106156993|NCT03763708|366236618|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
106156994|NCT03763708|366236619|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
106156995|NCT03763708|366236620|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
106156996|NCT03763708|366236621|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
106156997|NCT03763708|366236622|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
106156998|NCT03763708|366236623|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
106156999|NCT03763708|366236624|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
106157000|NCT03763708|366236616|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
106157001|NCT03763708|366236617|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
106157002|NCT03763708|366236618|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
106157003|NCT03763708|366236619|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
106157004|NCT03763708|366236620|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
106157005|NCT03763708|366236621|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
106157006|NCT03763708|366236622|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
106157007|NCT03763708|366236623|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
106157008|NCT03763708|366236624|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
106157009|NCT03763708|366236616|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
106157010|NCT03763708|366236617|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
106157011|NCT03763708|366236618|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
106157012|NCT03763708|366236619|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
106157013|NCT03763708|366236620|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
106157014|NCT03763708|366236621|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
106157015|NCT03763708|366236622|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
106157016|NCT03763708|366236623|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
106157017|NCT03763708|366236624|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
106157018|NCT03763708|366236616|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
106157019|NCT03763708|366236617|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
106157020|NCT03763708|366236618|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
106157021|NCT03763708|366236619|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
106157022|NCT03763708|366236620|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
106157023|NCT03763708|366236621|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
106157024|NCT03763708|366236622|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
106157025|NCT03763708|366236623|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
106157026|NCT03763708|366236624|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
106157027|NCT03763708|366236616|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
106157028|NCT03763708|366236617|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
106157029|NCT03763708|366236618|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
106157030|NCT03763708|366236619|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
106157031|NCT03763708|366236620|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
106157032|NCT03763708|366236621|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
106157033|NCT03763708|366236622|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
106157034|NCT03763708|366236623|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
106157035|NCT03763708|366236624|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
106157036|NCT03763708|366236616|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
106157037|NCT03763708|366236617|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
106073002|NCT01727141|365931925|FG000|Overall Study|Withdrawal by Subject|4|||
106073003|NCT01727141|365931926|FG001|Overall Study|Withdrawal by Subject|4|||
106073004|NCT01727141|365931927|FG002|Overall Study|Withdrawal by Subject|2|||
106073005|NCT01727141|365931928|FG003|Overall Study|Withdrawal by Subject|11|||
106073006|NCT02603432|365931929|FG000|Overall Study|Adverse Event|1|||
106073007|NCT02603432|365931930|FG001|Overall Study|Adverse Event|0|||
106073008|NCT02603432|365931929|FG000|Overall Study|Death|221|||
106073009|NCT02603432|365931930|FG001|Overall Study|Death|242|||
106073010|NCT02603432|365931929|FG000|Overall Study|Lost to Follow-up|3|||
106073011|NCT02603432|365931930|FG001|Overall Study|Lost to Follow-up|9|||
106073012|NCT02603432|365931929|FG000|Overall Study|Progressive Disease|7|||
106073013|NCT02603432|365931930|FG001|Overall Study|Progressive Disease|5|||
106073014|NCT02603432|365931929|FG000|Overall Study|Withdrawal by Subject|12|||
106073015|NCT02603432|365931930|FG001|Overall Study|Withdrawal by Subject|18|||
106073016|NCT02603432|365931929|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
106073017|NCT02603432|365931930|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
106073018|NCT02603432|365931929|FG000|Overall Study|Study terminated by sponsor|74|||
106073019|NCT02603432|365931930|FG001|Overall Study|Study terminated by sponsor|75|||
106073020|NCT02603432|365931929|FG000|Overall Study|Other|13|||
106073021|NCT02603432|365931930|FG001|Overall Study|Other|0|||
106073022|NCT02510794|365931933|FG000|Overall Study|Adverse Event|0|||
106073023|NCT02510794|365931934|FG001|Overall Study|Adverse Event|1|||
106073024|NCT02510794|365931935|FG002|Overall Study|Adverse Event|0|||
106073025|NCT02510794|365931936|FG003|Overall Study|Adverse Event|0|||
106073026|NCT02510794|365931933|FG000|Overall Study|Death|1|||
106073027|NCT02510794|365931934|FG001|Overall Study|Death|2|||
106073028|NCT02510794|365931935|FG002|Overall Study|Death|1|||
106073029|NCT02510794|365931936|FG003|Overall Study|Death|1|||
106073030|NCT02510794|365931933|FG000|Overall Study|Lack of Efficacy|3|||
106073031|NCT02510794|365931934|FG001|Overall Study|Lack of Efficacy|1|||
106073032|NCT02510794|365931935|FG002|Overall Study|Lack of Efficacy|1|||
106073033|NCT02510794|365931936|FG003|Overall Study|Lack of Efficacy|0|||
106073034|NCT02510794|365931933|FG000|Overall Study|Participant moved out of the area|0|||
106073035|NCT02510794|365931934|FG001|Overall Study|Participant moved out of the area|0|||
106073036|NCT02510794|365931935|FG002|Overall Study|Participant moved out of the area|0|||
106073037|NCT02510794|365931936|FG003|Overall Study|Participant moved out of the area|1|||
106073038|NCT02510794|365931933|FG000|Overall Study|Physician Decision|3|||
106073039|NCT02510794|365931934|FG001|Overall Study|Physician Decision|0|||
106073040|NCT02510794|365931935|FG002|Overall Study|Physician Decision|0|||
106073041|NCT02510794|365931936|FG003|Overall Study|Physician Decision|0|||
106073042|NCT02510794|365931933|FG000|Overall Study|Protocol Violation|0|||
106073043|NCT02510794|365931934|FG001|Overall Study|Protocol Violation|0|||
106073044|NCT02510794|365931935|FG002|Overall Study|Protocol Violation|1|||
106073045|NCT02510794|365931936|FG003|Overall Study|Protocol Violation|0|||
106073046|NCT02510794|365931933|FG000|Overall Study|Withdrawal by Subject|1|||
106073047|NCT02510794|365931934|FG001|Overall Study|Withdrawal by Subject|2|||
106073048|NCT02510794|365931935|FG002|Overall Study|Withdrawal by Subject|4|||
106073049|NCT02510794|365931936|FG003|Overall Study|Withdrawal by Subject|3|||
106073050|NCT04765358|365931939|FG000|Overall Study|Withdrawal by Subject|1|||
106073051|NCT02731729|365931940|FG000|Overall Study|Death|2|||
106073052|NCT02731729|365931941|FG001|Overall Study|Death|2|||
106073053|NCT02731729|365931940|FG000|Overall Study|Study terminated by Sponsor|6|||
106073054|NCT02731729|365931941|FG001|Overall Study|Study terminated by Sponsor|6|||
106073055|NCT02731729|365931940|FG000|Overall Study|Withdrawal by Subject|1|||
106073056|NCT02731729|365931941|FG001|Overall Study|Withdrawal by Subject|0|||
106073057|NCT00159588|365931942|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
106157038|NCT03763708|366236618|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
106157039|NCT03763708|366236619|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
106157040|NCT03763708|366236620|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
106157041|NCT03763708|366236621|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
106157042|NCT03763708|366236622|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
106157043|NCT03763708|366236623|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
106157044|NCT03763708|366236624|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
106157045|NCT03763708|366236616|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
106157046|NCT03763708|366236617|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
106157047|NCT03763708|366236618|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
106157048|NCT03763708|366236619|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
106157049|NCT03763708|366236620|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
106157050|NCT03763708|366236621|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
106157051|NCT03763708|366236622|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
106157052|NCT03763708|366236623|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
106157053|NCT03763708|366236624|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
106157054|NCT05215314|366236625|FG000|Overall Study|Lost to Follow-up|2|||
106073058|NCT00159588|365931943|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
106157055|NCT05215314|366236626|FG001|Overall Study|Lost to Follow-up|2|||
106157056|NCT05215314|366236625|FG000|Overall Study|Withdrawal by Subject|2|||
106073059|NCT00159588|365931944|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
106073060|NCT00952341|365931949|FG000|Cycle 1|Adverse Event|4|||
106073061|NCT00952341|365931950|FG001|Cycle 1|Adverse Event|1|||
106073062|NCT00952341|365931949|FG000|Cycle 1|Withdrawal by Subject|3|||
106073063|NCT00952341|365931950|FG001|Cycle 1|Withdrawal by Subject|8|||
106073064|NCT00952341|365931949|FG000|Cycle 1|Protocol Violation|2|||
106073065|NCT00952341|365931950|FG001|Cycle 1|Protocol Violation|1|||
105866492|NCT02075515|365161046|FG001|Overall Study|Withdrawal by Subject|0|||
105866493|NCT02075515|365161047|FG002|Overall Study|Withdrawal by Subject|1|||
106073066|NCT00952341|365931949|FG000|Cycle 1|Lost to Follow-up|11|||
105866494|NCT02075515|365161045|FG000|Overall Study|Lost to Follow-up|1|||
106073067|NCT00952341|365931950|FG001|Cycle 1|Lost to Follow-up|2|||
106073068|NCT00952341|365931949|FG000|Cycle 1|Physician Decision|0|||
106073069|NCT00952341|365931950|FG001|Cycle 1|Physician Decision|1|||
106073070|NCT00952341|365931949|FG000|Cycle 2|Withdrawal by Subject|1|||
106073071|NCT00952341|365931950|FG001|Cycle 2|Withdrawal by Subject|1|||
106073072|NCT00952341|365931949|FG000|Cycle 2|Protocol Violation|1|||
106073073|NCT00952341|365931950|FG001|Cycle 2|Protocol Violation|0|||
106073074|NCT00952341|365931949|FG000|Cycle 2|Lost to Follow-up|6|||
106073075|NCT00952341|365931950|FG001|Cycle 2|Lost to Follow-up|9|||
106073076|NCT00952341|365931949|FG000|Cycle 2|Physician Decision|1|||
106073077|NCT00952341|365931950|FG001|Cycle 2|Physician Decision|1|||
106073078|NCT00952341|365931949|FG000|Cycle 2|Progressive Disease|0|||
106073079|NCT00952341|365931950|FG001|Cycle 2|Progressive Disease|1|||
106073080|NCT02066467|365931951|FG000|Overall Study|Did not undergo implant procedure|24|||
106073081|NCT02066467|365931951|FG000|Overall Study|Attempted to implant withoput success|43|||
106073082|NCT02066467|365931951|FG000|Overall Study|Consent ineligible|1|||
106073083|NCT02066467|365931951|FG000|Overall Study|Death|54|||
106073084|NCT02066467|365931951|FG000|Overall Study|Lost to Follow-up|51|||
106073085|NCT02066467|365931951|FG000|Overall Study|Adverse Event|20|||
106073086|NCT02066467|365931951|FG000|Overall Study|Withdrawal by Subject|16|||
106073087|NCT02066467|365931951|FG000|Overall Study|Physician Decision|2|||
106073088|NCT02066467|365931951|FG000|Overall Study|Not defined|4|||
106073089|NCT00456521|365931952|FG000|Overall Study|Adverse Event|150|||
106073090|NCT00456521|365931953|FG001|Overall Study|Adverse Event|25|||
106073091|NCT00456521|365931952|FG000|Overall Study|Withdrawal by Subject|43|||
106073092|NCT00456521|365931953|FG001|Overall Study|Withdrawal by Subject|24|||
106073093|NCT00456521|365931952|FG000|Overall Study|Lost to Follow-up|22|||
106073094|NCT00456521|365931953|FG001|Overall Study|Lost to Follow-up|17|||
106073095|NCT00456521|365931952|FG000|Overall Study|Lack of Efficacy|3|||
106073096|NCT00456521|365931953|FG001|Overall Study|Lack of Efficacy|6|||
106073097|NCT00456521|365931952|FG000|Overall Study|Protocol Violation|4|||
106073098|NCT00456521|365931953|FG001|Overall Study|Protocol Violation|0|||
106157057|NCT05215314|366236626|FG001|Overall Study|Withdrawal by Subject|0|||
106157058|NCT05215314|366236625|FG000|Overall Study|Physician Decision|1|||
106157059|NCT05215314|366236626|FG001|Overall Study|Physician Decision|0|||
106157060|NCT03138512|366236627|FG000|Randomization|Participants withdrew consent|0|||
106157061|NCT03138512|366236628|FG001|Randomization|Participants withdrew consent|1|||
106157062|NCT03138512|366236629|FG002|Randomization|Participants withdrew consent|1|||
106157063|NCT03138512|366236630|FG003|Randomization|Participants withdrew consent|0|||
106157064|NCT03138512|366236631|FG004|Randomization|Participants withdrew consent|0|||
106157065|NCT03138512|366236627|FG000|Randomization|Participant no longer meets study criteria|0|||
106157066|NCT03138512|366236628|FG001|Randomization|Participant no longer meets study criteria|3|||
106157067|NCT03138512|366236629|FG002|Randomization|Participant no longer meets study criteria|1|||
106157068|NCT03138512|366236630|FG003|Randomization|Participant no longer meets study criteria|1|||
106157069|NCT03138512|366236631|FG004|Randomization|Participant no longer meets study criteria|3|||
106157070|NCT03138512|366236627|FG000|Randomization|Other reasons|1|||
106157071|NCT03138512|366236628|FG001|Randomization|Other reasons|0|||
106157072|NCT03138512|366236629|FG002|Randomization|Other reasons|0|||
106157073|NCT03138512|366236630|FG003|Randomization|Other reasons|0|||
106157074|NCT03138512|366236631|FG004|Randomization|Other reasons|0|||
106157075|NCT03138512|366236627|FG000|Treatment Part A|Disease recurrence|10|||
106157076|NCT03138512|366236628|FG001|Treatment Part A|Disease recurrence|20|||
106157077|NCT03138512|366236629|FG002|Treatment Part A|Disease recurrence|0|||
106157078|NCT03138512|366236630|FG003|Treatment Part A|Disease recurrence|0|||
106157079|NCT03138512|366236631|FG004|Treatment Part A|Disease recurrence|0|||
106157080|NCT03138512|366236627|FG000|Treatment Part A|Study Drug Toxicity|132|||
106157081|NCT03138512|366236628|FG001|Treatment Part A|Study Drug Toxicity|5|||
106157082|NCT03138512|366236629|FG002|Treatment Part A|Study Drug Toxicity|0|||
106157083|NCT03138512|366236630|FG003|Treatment Part A|Study Drug Toxicity|0|||
106157084|NCT03138512|366236631|FG004|Treatment Part A|Study Drug Toxicity|0|||
106157085|NCT03138512|366236627|FG000|Treatment Part A|Death|1|||
106073099|NCT00456521|365931952|FG000|Overall Study|Pregnancy|1|||
106073100|NCT00456521|365931953|FG001|Overall Study|Pregnancy|1|||
106073101|NCT00456521|365931952|FG000|Overall Study|Drug non-compliance, moved, other|26|||
106073102|NCT00456521|365931953|FG001|Overall Study|Drug non-compliance, moved, other|11|||
106073103|NCT01316276|365931954|FG000|Overall Study|Death|1|||
106073104|NCT01316276|365931954|FG000|Overall Study|Adverse Event|19|||
106073105|NCT01316276|365931954|FG000|Overall Study|Withdrawal of consent|24|||
106073106|NCT01316276|365931954|FG000|Overall Study|Lost to Follow-up|1|||
106073107|NCT01316276|365931954|FG000|Overall Study|Other|22|||
106073108|NCT00605475|365931955|FG000|Overall Study|Abnormal Laboratory Values|0|||
106073109|NCT00605475|365931956|FG001|Overall Study|Abnormal Laboratory Values|0|||
106073110|NCT00605475|365931957|FG002|Overall Study|Abnormal Laboratory Values|0|||
106157086|NCT03138512|366236628|FG001|Treatment Part A|Death|0|||
106157087|NCT03138512|366236629|FG002|Treatment Part A|Death|0|||
106157088|NCT03138512|366236630|FG003|Treatment Part A|Death|0|||
106157089|NCT03138512|366236631|FG004|Treatment Part A|Death|0|||
106157090|NCT03138512|366236627|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
106157091|NCT03138512|366236628|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
106073111|NCT00605475|365931958|FG003|Overall Study|Abnormal Laboratory Values|0|||
106073112|NCT00605475|365931959|FG004|Overall Study|Abnormal Laboratory Values|0|||
106073113|NCT00605475|365931960|FG005|Overall Study|Abnormal Laboratory Values|0|||
106073114|NCT00605475|365931961|FG006|Overall Study|Abnormal Laboratory Values|0|||
106073115|NCT00605475|365931962|FG007|Overall Study|Abnormal Laboratory Values|0|||
106073116|NCT00605475|365931963|FG008|Overall Study|Abnormal Laboratory Values|1|||
106073117|NCT00605475|365931964|FG009|Overall Study|Abnormal Laboratory Values|0|||
106073118|NCT00605475|365931955|FG000|Overall Study|Administrative problems|0|||
106073119|NCT00605475|365931956|FG001|Overall Study|Administrative problems|0|||
106073120|NCT00605475|365931957|FG002|Overall Study|Administrative problems|0|||
106073121|NCT00605475|365931958|FG003|Overall Study|Administrative problems|0|||
106073122|NCT00605475|365931959|FG004|Overall Study|Administrative problems|0|||
106073123|NCT00605475|365931960|FG005|Overall Study|Administrative problems|0|||
106073124|NCT00605475|365931961|FG006|Overall Study|Administrative problems|1|||
106073125|NCT00605475|365931962|FG007|Overall Study|Administrative problems|0|||
106073126|NCT00605475|365931963|FG008|Overall Study|Administrative problems|0|||
106073127|NCT00605475|365931964|FG009|Overall Study|Administrative problems|0|||
106073128|NCT00605475|365931955|FG000|Overall Study|Lost to Follow-up|0|||
106073129|NCT00605475|365931956|FG001|Overall Study|Lost to Follow-up|0|||
106073130|NCT00605475|365931957|FG002|Overall Study|Lost to Follow-up|0|||
106073131|NCT00605475|365931958|FG003|Overall Study|Lost to Follow-up|0|||
106073132|NCT00605475|365931959|FG004|Overall Study|Lost to Follow-up|0|||
106073133|NCT00605475|365931960|FG005|Overall Study|Lost to Follow-up|0|||
106073134|NCT00605475|365931961|FG006|Overall Study|Lost to Follow-up|0|||
106073135|NCT00605475|365931962|FG007|Overall Study|Lost to Follow-up|0|||
106073136|NCT00605475|365931963|FG008|Overall Study|Lost to Follow-up|1|||
106073137|NCT00605475|365931964|FG009|Overall Study|Lost to Follow-up|1|||
106073138|NCT00605475|365931955|FG000|Overall Study|Protocol Violation|0|||
106073139|NCT00605475|365931956|FG001|Overall Study|Protocol Violation|0|||
106073140|NCT00605475|365931957|FG002|Overall Study|Protocol Violation|0|||
106073141|NCT00605475|365931958|FG003|Overall Study|Protocol Violation|0|||
106073142|NCT00605475|365931959|FG004|Overall Study|Protocol Violation|1|||
106073143|NCT00605475|365931960|FG005|Overall Study|Protocol Violation|0|||
106073144|NCT00605475|365931961|FG006|Overall Study|Protocol Violation|0|||
106073145|NCT00605475|365931962|FG007|Overall Study|Protocol Violation|0|||
106073146|NCT00605475|365931963|FG008|Overall Study|Protocol Violation|0|||
106073147|NCT00605475|365931964|FG009|Overall Study|Protocol Violation|0|||
106073148|NCT00605475|365931955|FG000|Overall Study|Withdrawal by Subject|0|||
106073149|NCT00605475|365931956|FG001|Overall Study|Withdrawal by Subject|0|||
106073150|NCT00605475|365931957|FG002|Overall Study|Withdrawal by Subject|0|||
106073151|NCT00605475|365931958|FG003|Overall Study|Withdrawal by Subject|0|||
106073152|NCT00605475|365931959|FG004|Overall Study|Withdrawal by Subject|0|||
106073153|NCT00605475|365931960|FG005|Overall Study|Withdrawal by Subject|2|||
106073154|NCT00605475|365931961|FG006|Overall Study|Withdrawal by Subject|0|||
106073155|NCT00605475|365931962|FG007|Overall Study|Withdrawal by Subject|0|||
106073156|NCT00605475|365931963|FG008|Overall Study|Withdrawal by Subject|0|||
106073157|NCT00605475|365931964|FG009|Overall Study|Withdrawal by Subject|1|||
106073158|NCT00581776|365931969|FG000|Overall Study|Disease progression or no response|3|||
106073159|NCT00930579|365931974|FG000|Overall Study|Withdrawal by Subject|1|||
106073160|NCT00930579|365931974|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
106073161|NCT04356963|365931991|FG000|First Session|Withdrawal by Subject|1|||
106073162|NCT04356963|365931991|FG000|Second Session|Withdrawal by Subject|3|||
106073163|NCT04356963|365931991|FG000|Second Session|Lost to Follow-up|1|||
106073164|NCT04356963|365931991|FG000|Third Session|Lost to Follow-up|6|||
106073165|NCT04356963|365931991|FG000|Third Session|Withdrawal by Subject|1|||
106073166|NCT02410954|365931997|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
106073167|NCT02410954|365931998|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
106073168|NCT02410954|365931997|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
106073169|NCT02410954|365931998|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
106073170|NCT00304356|365932005|FG000|Nitazoxanide|Physician Decision|5|||
106073171|NCT00304356|365932005|FG000|Nitazoxanide|Physician Decision|1|||
106073172|NCT00304356|365932005|FG000|Nitazoxanide|number is 0|1|||
106073173|NCT00304356|365932005|FG000|Nitazoxanide|Physician Decision|1|||
105866495|NCT02075515|365161046|FG001|Overall Study|Lost to Follow-up|3|||
106073174|NCT00304356|365932005|FG000|Nitazoxanide|Physician Decision|1|||
106073175|NCT00304356|365932005|FG000|Nitazoxanide|Physician Decision|1|||
106073176|NCT02140567|365932006|FG000|Overall Study|Problems with recording equipment|6|||
106073177|NCT02385084|365932012|FG000|Period 2|Protocol Violation|0|||
105866496|NCT02075515|365161047|FG002|Overall Study|Lost to Follow-up|6|||
106073178|NCT02385084|365932013|FG001|Period 2|Protocol Violation|0|||
106073179|NCT02385084|365932014|FG002|Period 2|Protocol Violation|1|||
106073180|NCT02385084|365932015|FG003|Period 2|Protocol Violation|0|||
106073181|NCT02385084|365932016|FG004|Period 2|Protocol Violation|0|||
106073182|NCT02385084|365932017|FG005|Period 2|Protocol Violation|0|||
106073183|NCT00744627|365932023|FG000|Overall Study|Adverse Event|6|||
106073184|NCT00744627|365932024|FG001|Overall Study|Adverse Event|9|||
106073185|NCT00744627|365932023|FG000|Overall Study|Lack of Efficacy|7|||
106073186|NCT00744627|365932024|FG001|Overall Study|Lack of Efficacy|3|||
106073187|NCT00744627|365932023|FG000|Overall Study|Noncompliance|0|||
106073188|NCT00744627|365932024|FG001|Overall Study|Noncompliance|1|||
106073189|NCT00744627|365932023|FG000|Overall Study|Protocol Deviations|0|||
106073190|NCT00744627|365932024|FG001|Overall Study|Protocol Deviations|2|||
106073191|NCT00744627|365932023|FG000|Overall Study|Voluntary Withdrawal|9|||
106073192|NCT00744627|365932024|FG001|Overall Study|Voluntary Withdrawal|6|||
106073193|NCT00744627|365932023|FG000|Overall Study|Lost to Follow-up|2|||
106073194|NCT00744627|365932024|FG001|Overall Study|Lost to Follow-up|1|||
106073195|NCT00744627|365932023|FG000|Overall Study|Other|1|||
106073196|NCT00744627|365932024|FG001|Overall Study|Other|0|||
106073197|NCT04251221|365932025|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
106073198|NCT04251221|365932026|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
106073199|NCT01466387|365932027|FG000|Overall Study|Adverse Event|0|||
106073200|NCT01466387|365932028|FG001|Overall Study|Adverse Event|0|||
106073201|NCT01466387|365932029|FG002|Overall Study|Adverse Event|1|||
106073202|NCT01466387|365932030|FG003|Overall Study|Adverse Event|1|||
106073203|NCT01466387|365932031|FG004|Overall Study|Adverse Event|0|||
106073204|NCT01466387|365932032|FG005|Overall Study|Adverse Event|0|||
106073205|NCT01466387|365932027|FG000|Overall Study|Lost to Follow-up|0|||
106073206|NCT01466387|365932028|FG001|Overall Study|Lost to Follow-up|0|||
106073207|NCT01466387|365932029|FG002|Overall Study|Lost to Follow-up|0|||
106073208|NCT01466387|365932030|FG003|Overall Study|Lost to Follow-up|0|||
106073209|NCT01466387|365932031|FG004|Overall Study|Lost to Follow-up|0|||
106073210|NCT01466387|365932032|FG005|Overall Study|Lost to Follow-up|1|||
106073211|NCT01466387|365932027|FG000|Overall Study|Protocol Violation|1|||
106073212|NCT01466387|365932028|FG001|Overall Study|Protocol Violation|0|||
106073213|NCT01466387|365932029|FG002|Overall Study|Protocol Violation|0|||
106073214|NCT01466387|365932030|FG003|Overall Study|Protocol Violation|1|||
106073215|NCT01466387|365932031|FG004|Overall Study|Protocol Violation|0|||
106073216|NCT01466387|365932032|FG005|Overall Study|Protocol Violation|0|||
106073217|NCT00832585|365932033|FG000|Overall Study|Withdrawal by Subject|1|||
106073218|NCT00832585|365932033|FG000|Overall Study|Lost to Follow-up|1|||
106073219|NCT03526458|365932036|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
106073220|NCT03526458|365932037|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
106073221|NCT03526458|365932036|FG000|Overall Study|Stone passed, surgery cancelled|2|||
106073222|NCT03526458|365932037|FG001|Overall Study|Stone passed, surgery cancelled|1|||
106073223|NCT03526458|365932036|FG000|Overall Study|Withdrawal by Subject|1|||
106073224|NCT03526458|365932037|FG001|Overall Study|Withdrawal by Subject|0|||
106073225|NCT03526458|365932036|FG000|Overall Study|Physician Decision|2|||
106073226|NCT03526458|365932037|FG001|Overall Study|Physician Decision|1|||
106073227|NCT03526458|365932036|FG000|Overall Study|Lack of equipment|1|||
106073228|NCT03526458|365932037|FG001|Overall Study|Lack of equipment|1|||
106073229|NCT00271947|365932038|FG000|Overall Study|Lost to Follow-up|1|||
106073230|NCT04404855|365932039|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
106073231|NCT04404855|365932040|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
106073232|NCT01522365|365932041|FG000|Overall Study|Withdrawal by Subject|1|||
106073233|NCT01522365|365932042|FG001|Overall Study|Withdrawal by Subject|1|||
106073234|NCT01522365|365932041|FG000|Overall Study|Lost to Follow-up|1|||
106073235|NCT01522365|365932042|FG001|Overall Study|Lost to Follow-up|1|||
106073236|NCT02680639|365932058|FG000|Screening Period|Screen Failure|7|||
106073237|NCT02680639|365932059|FG001|Screening Period|Screen Failure|0|||
106073238|NCT02680639|365932060|FG002|Screening Period|Screen Failure|0|||
106073239|NCT00588822|365934034|FG000|Overall Study|progression of disease|8|||
106073240|NCT00004888|365934035|FG000|Overall Study|Adverse Event|5|||
106073241|NCT00004888|365934036|FG001|Overall Study|Adverse Event|10|||
106073242|NCT00004888|365934035|FG000|Overall Study|Withdrawal by Subject|0|||
106073243|NCT00004888|365934036|FG001|Overall Study|Withdrawal by Subject|3|||
106073244|NCT00004888|365934035|FG000|Overall Study|Physician Decision|1|||
106073245|NCT00004888|365934036|FG001|Overall Study|Physician Decision|1|||
106073246|NCT00004888|365934035|FG000|Overall Study|Progressive Disease|4|||
106073247|NCT00004888|365934036|FG001|Overall Study|Progressive Disease|9|||
106073248|NCT00004888|365934035|FG000|Overall Study|Death without progressive disease|0|||
106073249|NCT00004888|365934036|FG001|Overall Study|Death without progressive disease|1|||
106073250|NCT00004888|365934035|FG000|Overall Study|Toxic death|1|||
106073251|NCT00004888|365934036|FG001|Overall Study|Toxic death|0|||
106073252|NCT02174848|365934038|FG000|Overall Study|Adverse Event|2|||
106073253|NCT02174848|365934039|FG001|Overall Study|Adverse Event|1|||
106073254|NCT02174848|365934038|FG000|Overall Study|Withdrawal by Subject|3|||
106073255|NCT02174848|365934039|FG001|Overall Study|Withdrawal by Subject|3|||
106073256|NCT02174848|365934038|FG000|Overall Study|Lost to Follow-up|0|||
106073257|NCT02174848|365934039|FG001|Overall Study|Lost to Follow-up|1|||
106073258|NCT02174848|365934038|FG000|Overall Study|Worsening of disease|1|||
106073259|NCT02174848|365934039|FG001|Overall Study|Worsening of disease|1|||
106073260|NCT02174848|365934038|FG000|Overall Study|Unable to comply with study requirements|1|||
106073261|NCT02174848|365934039|FG001|Overall Study|Unable to comply with study requirements|0|||
106073262|NCT03239470|365934049|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
106157092|NCT03138512|366236629|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
105866497|NCT00378573|365161051|FG000|Treatment Period|Adverse Event|9|||
105866498|NCT00378573|365161051|FG000|Treatment Period|Physician Decision|1|||
105866499|NCT00378573|365161051|FG000|Treatment Period|Withdrawal by Subject|2|||
105866500|NCT00378573|365161051|FG000|Treatment Period|Disease Progression|4|||
105866501|NCT00378573|365161051|FG000|Treatment Period|Sponsor decision to close study|1|||
105866502|NCT00378573|365161051|FG000|Follow-up|Death|12|||
105866503|NCT00378573|365161051|FG000|Follow-up|Lost to Follow-up|1|||
105866504|NCT00378573|365161051|FG000|Follow-up|Withdrawal by Subject|1|||
105866505|NCT02862730|365161054|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
106073263|NCT03239470|365934050|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
106073264|NCT00922766|365934051|FG000|Overall Study|Death|3|||
106073265|NCT00922766|365934051|FG000|Overall Study|Withdrawal by Subject|2|||
106073266|NCT00922766|365934051|FG000|Overall Study|Other|1|||
105866506|NCT02862730|365161055|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105866507|NCT02862730|365161056|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
105866508|NCT02862730|365161057|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105866509|NCT02862730|365161058|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105866510|NCT02862730|365161059|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105866511|NCT02862730|365161060|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
105866512|NCT02862730|365161054|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
105866513|NCT02862730|365161055|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105866514|NCT02862730|365161056|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105866515|NCT02862730|365161057|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105866516|NCT02862730|365161058|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105866517|NCT02862730|365161059|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105866518|NCT02862730|365161060|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
105866519|NCT02862730|365161054|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105866520|NCT02862730|365161055|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105866521|NCT02862730|365161056|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
105866522|NCT02862730|365161057|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105866523|NCT02862730|365161058|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
105866524|NCT02862730|365161059|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105866525|NCT02862730|365161060|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
105866526|NCT02862730|365161054|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105866527|NCT02862730|365161055|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105866528|NCT02862730|365161056|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105866529|NCT02862730|365161057|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
105866530|NCT02862730|365161058|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105866531|NCT02862730|365161059|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105866532|NCT02862730|365161060|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
105866533|NCT03908437|365161061|FG000|Overall Study|Death|0|||
105866534|NCT03908437|365161062|FG001|Overall Study|Death|1|||
105866535|NCT03908437|365161061|FG000|Overall Study|Lost to Follow-up|31|||
105866536|NCT03908437|365161062|FG001|Overall Study|Lost to Follow-up|24|||
105866537|NCT00704132|365161063|FG000|Overall Study|Clinical Adverse Experience|1|||
105866538|NCT00704132|365161064|FG001|Overall Study|Clinical Adverse Experience|0|||
105866539|NCT00704132|365161063|FG000|Overall Study|Lack of Efficacy|0|||
105866540|NCT00704132|365161064|FG001|Overall Study|Lack of Efficacy|1|||
105866541|NCT00704132|365161063|FG000|Overall Study|Withdrawal by Subject|0|||
105866542|NCT00704132|365161064|FG001|Overall Study|Withdrawal by Subject|1|||
105866543|NCT03685344|365161065|FG000|Overall Study|Withdrawal by Subject|1|||
105866544|NCT03685344|365161066|FG001|Overall Study|Withdrawal by Subject|1|||
105866545|NCT03685344|365161067|FG002|Overall Study|Withdrawal by Subject|2|||
105866546|NCT03685344|365161068|FG003|Overall Study|Withdrawal by Subject|0|||
105866547|NCT03685344|365161065|FG000|Overall Study|Physician Decision|1|||
105866548|NCT03685344|365161066|FG001|Overall Study|Physician Decision|1|||
105866549|NCT03685344|365161067|FG002|Overall Study|Physician Decision|5|||
105866550|NCT03685344|365161068|FG003|Overall Study|Physician Decision|0|||
105866551|NCT03685344|365161065|FG000|Overall Study|Death|1|||
105866552|NCT03685344|365161066|FG001|Overall Study|Death|1|||
105866553|NCT03685344|365161067|FG002|Overall Study|Death|0|||
105866554|NCT03685344|365161068|FG003|Overall Study|Death|0|||
105866555|NCT00442962|365161069|FG000|Overall Study|Pregnancy|1|||
105866556|NCT00442962|365161069|FG000|Overall Study|Lost to Follow-up|7|||
105866557|NCT00191191|365161070|FG000|Overall Study|Entry Criteria Exclusion|2|||
105866558|NCT00191191|365161071|FG001|Overall Study|Entry Criteria Exclusion|0|||
105866559|NCT00191191|365161070|FG000|Overall Study|Treated with Another Systemic Agent|1|||
105866560|NCT00191191|365161071|FG001|Overall Study|Treated with Another Systemic Agent|1|||
105866561|NCT00191191|365161070|FG000|Overall Study|Adverse Event|11|||
105866562|NCT00191191|365161071|FG001|Overall Study|Adverse Event|21|||
105866563|NCT00191191|365161070|FG000|Overall Study|Progressive Disease|84|||
105866564|NCT00191191|365161071|FG001|Overall Study|Progressive Disease|72|||
106073267|NCT00922766|365934051|FG000|Overall Study|Adverse Event|1|||
106073268|NCT04014075|365934052|FG000|Overall Study|Progressive Disease|53|||
106073269|NCT04014075|365934052|FG000|Overall Study|Adverse Event|15|||
105866565|NCT00191191|365161070|FG000|Overall Study|Toxicity After Dose Reduction|7|||
105866566|NCT00191191|365161071|FG001|Overall Study|Toxicity After Dose Reduction|8|||
105866567|NCT00191191|365161070|FG000|Overall Study|Family/Caregiver Decision|5|||
105866568|NCT00191191|365161071|FG001|Overall Study|Family/Caregiver Decision|7|||
105866569|NCT00191191|365161070|FG000|Overall Study|Lost to Follow-up|1|||
105866570|NCT00191191|365161071|FG001|Overall Study|Lost to Follow-up|0|||
106073270|NCT04014075|365934052|FG000|Overall Study|Clinical Progression|4|||
105866571|NCT00191191|365161070|FG000|Overall Study|Physician Decision|3|||
105866572|NCT00191191|365161071|FG001|Overall Study|Physician Decision|2|||
105866573|NCT00191191|365161070|FG000|Overall Study|Good Clinical Practice Violation|0|||
105866574|NCT00191191|365161071|FG001|Overall Study|Good Clinical Practice Violation|1|||
106157093|NCT03138512|366236630|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
106157094|NCT03138512|366236631|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
106157095|NCT03138512|366236627|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
106157096|NCT03138512|366236628|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
106157097|NCT03138512|366236629|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
106157098|NCT03138512|366236630|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
106157099|NCT03138512|366236631|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
106157100|NCT03138512|366236627|FG000|Treatment Part A|Participant withdrew consent|2|||
106157101|NCT03138512|366236628|FG001|Treatment Part A|Participant withdrew consent|4|||
106157102|NCT03138512|366236629|FG002|Treatment Part A|Participant withdrew consent|0|||
106157103|NCT03138512|366236630|FG003|Treatment Part A|Participant withdrew consent|0|||
106157104|NCT03138512|366236631|FG004|Treatment Part A|Participant withdrew consent|0|||
106157105|NCT03138512|366236627|FG000|Treatment Part A|Lost to Follow-up|0|||
106157106|NCT03138512|366236628|FG001|Treatment Part A|Lost to Follow-up|1|||
106157107|NCT03138512|366236629|FG002|Treatment Part A|Lost to Follow-up|0|||
106157108|NCT03138512|366236630|FG003|Treatment Part A|Lost to Follow-up|0|||
106157109|NCT03138512|366236631|FG004|Treatment Part A|Lost to Follow-up|0|||
106157110|NCT03138512|366236627|FG000|Treatment Part A|Poor/non-compliance|1|||
106157111|NCT03138512|366236628|FG001|Treatment Part A|Poor/non-compliance|0|||
106157112|NCT03138512|366236629|FG002|Treatment Part A|Poor/non-compliance|0|||
106157113|NCT03138512|366236630|FG003|Treatment Part A|Poor/non-compliance|0|||
106157114|NCT03138512|366236631|FG004|Treatment Part A|Poor/non-compliance|0|||
106157115|NCT03138512|366236627|FG000|Treatment Part A|Pregnancy|0|||
106157116|NCT03138512|366236628|FG001|Treatment Part A|Pregnancy|1|||
106157117|NCT03138512|366236629|FG002|Treatment Part A|Pregnancy|0|||
106157118|NCT03138512|366236630|FG003|Treatment Part A|Pregnancy|0|||
106157119|NCT03138512|366236631|FG004|Treatment Part A|Pregnancy|0|||
106157120|NCT03138512|366236627|FG000|Treatment Part A|Other reasons|11|||
106157121|NCT03138512|366236628|FG001|Treatment Part A|Other reasons|8|||
106157122|NCT03138512|366236629|FG002|Treatment Part A|Other reasons|0|||
106157123|NCT03138512|366236630|FG003|Treatment Part A|Other reasons|0|||
106157124|NCT03138512|366236631|FG004|Treatment Part A|Other reasons|0|||
106157125|NCT03138512|366236627|FG000|Treatment Part B|Disease recurrence|0|||
106157126|NCT03138512|366236628|FG001|Treatment Part B|Disease recurrence|0|||
106157127|NCT03138512|366236629|FG002|Treatment Part B|Disease recurrence|6|||
106157128|NCT03138512|366236630|FG003|Treatment Part B|Disease recurrence|12|||
106157129|NCT03138512|366236631|FG004|Treatment Part B|Disease recurrence|10|||
106157130|NCT03138512|366236627|FG000|Treatment Part B|Study drug toxicity|0|||
106157131|NCT03138512|366236628|FG001|Treatment Part B|Study drug toxicity|0|||
106157132|NCT03138512|366236629|FG002|Treatment Part B|Study drug toxicity|63|||
106157133|NCT03138512|366236630|FG003|Treatment Part B|Study drug toxicity|3|||
106157134|NCT03138512|366236631|FG004|Treatment Part B|Study drug toxicity|45|||
106157135|NCT03138512|366236627|FG000|Treatment Part B|Death|0|||
106157136|NCT03138512|366236628|FG001|Treatment Part B|Death|0|||
106157137|NCT03138512|366236629|FG002|Treatment Part B|Death|1|||
106157138|NCT03138512|366236630|FG003|Treatment Part B|Death|0|||
106157139|NCT03138512|366236631|FG004|Treatment Part B|Death|0|||
106157140|NCT03138512|366236627|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
106157141|NCT03138512|366236628|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
106157142|NCT03138512|366236629|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
106157143|NCT03138512|366236630|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
106157144|NCT03138512|366236631|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
106157145|NCT03138512|366236627|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
106157146|NCT03138512|366236628|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
106157147|NCT03138512|366236629|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
106157148|NCT03138512|366236630|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
106157149|NCT03138512|366236631|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
106157150|NCT03138512|366236627|FG000|Treatment Part B|Participant withdrew consent|0|||
106157151|NCT03138512|366236628|FG001|Treatment Part B|Participant withdrew consent|0|||
106157152|NCT03138512|366236629|FG002|Treatment Part B|Participant withdrew consent|1|||
106157153|NCT03138512|366236630|FG003|Treatment Part B|Participant withdrew consent|1|||
106157154|NCT03138512|366236631|FG004|Treatment Part B|Participant withdrew consent|2|||
106157155|NCT03138512|366236627|FG000|Treatment Part B|Lost to Follow-up|0|||
106157156|NCT03138512|366236628|FG001|Treatment Part B|Lost to Follow-up|0|||
106157157|NCT03138512|366236629|FG002|Treatment Part B|Lost to Follow-up|0|||
106157158|NCT03138512|366236630|FG003|Treatment Part B|Lost to Follow-up|1|||
106157159|NCT03138512|366236631|FG004|Treatment Part B|Lost to Follow-up|0|||
106157160|NCT03138512|366236627|FG000|Treatment Part B|Poor/non-compliance|0|||
106157161|NCT03138512|366236628|FG001|Treatment Part B|Poor/non-compliance|0|||
106157162|NCT03138512|366236629|FG002|Treatment Part B|Poor/non-compliance|1|||
106157163|NCT03138512|366236630|FG003|Treatment Part B|Poor/non-compliance|1|||
106157164|NCT03138512|366236631|FG004|Treatment Part B|Poor/non-compliance|1|||
106073271|NCT04014075|365934052|FG000|Overall Study|Death|2|||
106073272|NCT04014075|365934052|FG000|Overall Study|Withdrawal by Subject|2|||
106073273|NCT04014075|365934052|FG000|Overall Study|Miscellaneous|2|||
106073274|NCT04014075|365934052|FG000|Overall Study|Physician Decision|1|||
106073275|NCT02622828|365934053|FG000|Overall Study|participant withdrew|3|||
106073276|NCT00666757|365934054|FG000|Overall Study|Lost to Follow-up|39|||
106073277|NCT00666757|365934055|FG001|Overall Study|Lost to Follow-up|35|||
106073278|NCT00666757|365934054|FG000|Overall Study|Protocol Violation|23|||
106073279|NCT00666757|365934055|FG001|Overall Study|Protocol Violation|24|||
106073280|NCT00666757|365934054|FG000|Overall Study|Adverse Event|22|||
106073281|NCT00666757|365934055|FG001|Overall Study|Adverse Event|12|||
106073282|NCT00666757|365934054|FG000|Overall Study|Withdrawal by Subject|13|||
106073283|NCT00666757|365934055|FG001|Overall Study|Withdrawal by Subject|17|||
106157165|NCT03138512|366236627|FG000|Treatment Part B|Other reasons|0|||
106157166|NCT03138512|366236628|FG001|Treatment Part B|Other reasons|0|||
106157167|NCT03138512|366236629|FG002|Treatment Part B|Other reasons|3|||
106157168|NCT03138512|366236630|FG003|Treatment Part B|Other reasons|1|||
106157169|NCT03138512|366236631|FG004|Treatment Part B|Other reasons|5|||
106157170|NCT03317405|366236632|FG000|Overall Study|Withdrawal by Subject|1|||
106157171|NCT03317405|366236633|FG001|Overall Study|Withdrawal by Subject|0|||
106157172|NCT03317405|366236634|FG002|Overall Study|Withdrawal by Subject|0|||
106157173|NCT03317405|366236632|FG000|Overall Study|Physician Decision|0|||
106157174|NCT03317405|366236633|FG001|Overall Study|Physician Decision|0|||
106157175|NCT03317405|366236634|FG002|Overall Study|Physician Decision|1|||
106157176|NCT03317405|366236632|FG000|Overall Study|Surgery Rescheduled|0|||
106157177|NCT03317405|366236633|FG001|Overall Study|Surgery Rescheduled|1|||
106157178|NCT03317405|366236634|FG002|Overall Study|Surgery Rescheduled|0|||
106157179|NCT05323084|366236635|FG000|Period 2 - Washout|Lost to Follow-up|0|||
106157180|NCT05323084|366236636|FG001|Period 2 - Washout|Lost to Follow-up|1|||
106157181|NCT04533347|366236643|FG000|Overall Study|Adverse Event|1|||
106157182|NCT04533347|366236644|FG001|Overall Study|Adverse Event|2|||
106157183|NCT04533347|366236643|FG000|Overall Study|Lost to Follow-up|2|||
106157184|NCT04533347|366236644|FG001|Overall Study|Lost to Follow-up|0|||
106157185|NCT04533347|366236643|FG000|Overall Study|Withdrawal by Subject|1|||
106157186|NCT04533347|366236644|FG001|Overall Study|Withdrawal by Subject|0|||
106157187|NCT03774082|366236648|FG000|Overall Study|Death|6|||
106157188|NCT03774082|366236649|FG001|Overall Study|Death|3|||
106157189|NCT03774082|366236650|FG002|Overall Study|Death|2|||
106157190|NCT03774082|366236648|FG000|Overall Study|Subject decision|0|||
106157191|NCT03774082|366236649|FG001|Overall Study|Subject decision|3|||
106157192|NCT03774082|366236650|FG002|Overall Study|Subject decision|0|||
106157193|NCT03774082|366236648|FG000|Overall Study|Lost to Follow-up|2|||
106157194|NCT03774082|366236649|FG001|Overall Study|Lost to Follow-up|0|||
106157195|NCT03774082|366236650|FG002|Overall Study|Lost to Follow-up|0|||
106157196|NCT03774082|366236648|FG000|Overall Study|Guardian decision|0|||
106157197|NCT03774082|366236649|FG001|Overall Study|Guardian decision|0|||
106157198|NCT03774082|366236650|FG002|Overall Study|Guardian decision|1|||
106157199|NCT03774082|366236648|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
106157200|NCT03774082|366236649|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
106157201|NCT03774082|366236650|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
106157202|NCT04173663|366237854|FG000|Overall Study|Withdrawal by Subject|1|||
106157203|NCT04173663|366237855|FG001|Overall Study|Withdrawal by Subject|6|||
106157204|NCT04173663|366237854|FG000|Overall Study|Lost to Follow-up|17|||
106157205|NCT04173663|366237855|FG001|Overall Study|Lost to Follow-up|24|||
106157206|NCT05919082|366237859|FG000|Overall Study|Adverse Event|3|||
106157207|NCT05919082|366237860|FG001|Overall Study|Adverse Event|0|||
106157208|NCT05919082|366237859|FG000|Overall Study|Lost to Follow-up|0|||
106157209|NCT05919082|366237860|FG001|Overall Study|Lost to Follow-up|1|||
106157210|NCT05919082|366237859|FG000|Overall Study|Withdrawal by Subject|8|||
106157211|NCT05919082|366237860|FG001|Overall Study|Withdrawal by Subject|9|||
106073284|NCT00666757|365934054|FG000|Overall Study|Lack of Efficacy|3|||
106073285|NCT00666757|365934055|FG001|Overall Study|Lack of Efficacy|6|||
106157212|NCT05919082|366237859|FG000|Overall Study|Lack of Efficacy|0|||
106157213|NCT05919082|366237860|FG001|Overall Study|Lack of Efficacy|1|||
106157214|NCT05919082|366237859|FG000|Overall Study|Investigator Decision|1|||
106157215|NCT05919082|366237860|FG001|Overall Study|Investigator Decision|0|||
106157216|NCT04833777|366237863|FG000|Overall Study|Lost to Follow-up|1|||
106157217|NCT04833777|366237864|FG001|Overall Study|Lost to Follow-up|0|||
106157218|NCT01180634|366237867|FG000|Overall Study|Adverse Event|4|||
106157219|NCT01180634|366237868|FG001|Overall Study|Adverse Event|1|||
106157220|NCT01180634|366237867|FG000|Overall Study|Miscellaneous|2|||
106157221|NCT01180634|366237868|FG001|Overall Study|Miscellaneous|0|||
106157222|NCT01180634|366237867|FG000|Overall Study|Withdrawal by Subject|4|||
106157223|NCT01180634|366237868|FG001|Overall Study|Withdrawal by Subject|0|||
106157224|NCT03692611|366237869|FG000|Overall Study|Found to be ineligible postrandomization|3|||
106073286|NCT00666757|365934054|FG000|Overall Study|Physician Decision|0|||
106157225|NCT03692611|366237870|FG001|Overall Study|Found to be ineligible postrandomization|0|||
105866575|NCT04238650|365161075|FG000|Overall Study|Withdrawal by Subject|0|||
105866576|NCT04238650|365161076|FG001|Overall Study|Withdrawal by Subject|1|||
105866577|NCT04289363|365161077|FG000|Overall Study|Lost to Follow-up|14|||
105866578|NCT04289363|365161078|FG001|Overall Study|Lost to Follow-up|0|||
105866579|NCT02585778|365161079|FG000|Overall Study|Adverse Event|17|||
105866580|NCT02585778|365161080|FG001|Overall Study|Adverse Event|4|||
106073287|NCT00666757|365934055|FG001|Overall Study|Physician Decision|2|||
106073288|NCT00666757|365934054|FG000|Overall Study|Sponsor decision|0|||
106073289|NCT00666757|365934055|FG001|Overall Study|Sponsor decision|1|||
106073290|NCT01649375|365934056|FG000|Up to Week 16|Adverse Event|2|||
106073291|NCT01649375|365934057|FG001|Up to Week 16|Adverse Event|5|||
106073292|NCT01649375|365934058|FG002|Up to Week 16|Adverse Event|4|||
106073293|NCT01649375|365934059|FG003|Up to Week 16|Adverse Event|0|||
106073294|NCT01649375|365934060|FG004|Up to Week 16|Adverse Event|0|||
106073295|NCT01649375|365934056|FG000|Up to Week 16|Lack of Efficacy|0|||
106073296|NCT01649375|365934057|FG001|Up to Week 16|Lack of Efficacy|0|||
106073297|NCT01649375|365934058|FG002|Up to Week 16|Lack of Efficacy|1|||
106073298|NCT01649375|365934059|FG003|Up to Week 16|Lack of Efficacy|0|||
106073299|NCT01649375|365934060|FG004|Up to Week 16|Lack of Efficacy|0|||
106073300|NCT01649375|365934056|FG000|Up to Week 16|Physician Decision|0|||
106073301|NCT01649375|365934057|FG001|Up to Week 16|Physician Decision|0|||
106073302|NCT01649375|365934058|FG002|Up to Week 16|Physician Decision|1|||
106073303|NCT01649375|365934059|FG003|Up to Week 16|Physician Decision|0|||
106073304|NCT01649375|365934060|FG004|Up to Week 16|Physician Decision|0|||
106073305|NCT01649375|365934056|FG000|Up to Week 16|Withdrawal by Subject|2|||
106073306|NCT01649375|365934057|FG001|Up to Week 16|Withdrawal by Subject|1|||
106073307|NCT01649375|365934058|FG002|Up to Week 16|Withdrawal by Subject|2|||
106073308|NCT01649375|365934059|FG003|Up to Week 16|Withdrawal by Subject|0|||
106073309|NCT01649375|365934060|FG004|Up to Week 16|Withdrawal by Subject|0|||
106073310|NCT01649375|365934056|FG000|Up to Week 16|Death|1|||
106073311|NCT01649375|365934057|FG001|Up to Week 16|Death|0|||
106073312|NCT01649375|365934058|FG002|Up to Week 16|Death|0|||
106073313|NCT01649375|365934059|FG003|Up to Week 16|Death|0|||
106073314|NCT01649375|365934060|FG004|Up to Week 16|Death|0|||
106073315|NCT01649375|365934056|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
106073316|NCT01649375|365934057|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
106073317|NCT01649375|365934058|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
105866581|NCT02585778|365161079|FG000|Overall Study|Participant did not wish to continue|9|||
105866582|NCT02585778|365161080|FG001|Overall Study|Participant did not wish to continue|4|||
105866583|NCT02585778|365161079|FG000|Overall Study|Poor compliance to study protocol|0|||
106073318|NCT01649375|365934059|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
106073319|NCT01649375|365934060|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
106073320|NCT01649375|365934056|FG000|Week 16 up to Week 260|Non-compliance|0|||
106073321|NCT01649375|365934057|FG001|Week 16 up to Week 260|Non-compliance|1|||
106073322|NCT01649375|365934058|FG002|Week 16 up to Week 260|Non-compliance|0|||
106073323|NCT01649375|365934059|FG003|Week 16 up to Week 260|Non-compliance|1|||
106073324|NCT01649375|365934060|FG004|Week 16 up to Week 260|Non-compliance|0|||
106073325|NCT01649375|365934056|FG000|Week 16 up to Week 260|Physician Decision|0|||
106073326|NCT01649375|365934057|FG001|Week 16 up to Week 260|Physician Decision|2|||
106073327|NCT01649375|365934058|FG002|Week 16 up to Week 260|Physician Decision|0|||
106073328|NCT01649375|365934059|FG003|Week 16 up to Week 260|Physician Decision|0|||
106073329|NCT01649375|365934060|FG004|Week 16 up to Week 260|Physician Decision|0|||
106073330|NCT01649375|365934056|FG000|Week 16 up to Week 260|Technical issues|0|||
106073331|NCT01649375|365934057|FG001|Week 16 up to Week 260|Technical issues|1|||
106073332|NCT01649375|365934058|FG002|Week 16 up to Week 260|Technical issues|0|||
106073333|NCT01649375|365934059|FG003|Week 16 up to Week 260|Technical issues|1|||
106073334|NCT01649375|365934060|FG004|Week 16 up to Week 260|Technical issues|0|||
106073335|NCT01649375|365934056|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
106073336|NCT01649375|365934057|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
106073337|NCT01649375|365934058|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
106073338|NCT01649375|365934059|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
106073339|NCT01649375|365934060|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
106073340|NCT01649375|365934056|FG000|Week 16 up to Week 260|Death|1|||
106073341|NCT01649375|365934057|FG001|Week 16 up to Week 260|Death|1|||
106073342|NCT01649375|365934058|FG002|Week 16 up to Week 260|Death|0|||
106073343|NCT01649375|365934059|FG003|Week 16 up to Week 260|Death|0|||
106073344|NCT01649375|365934060|FG004|Week 16 up to Week 260|Death|0|||
106073345|NCT01649375|365934056|FG000|Week 16 up to Week 260|Adverse Event|5|||
106073346|NCT01649375|365934057|FG001|Week 16 up to Week 260|Adverse Event|2|||
106073347|NCT01649375|365934058|FG002|Week 16 up to Week 260|Adverse Event|0|||
106073348|NCT01649375|365934059|FG003|Week 16 up to Week 260|Adverse Event|3|||
106073349|NCT01649375|365934060|FG004|Week 16 up to Week 260|Adverse Event|2|||
106073350|NCT01856790|365934061|FG000|Closed Loop Control|Withdrawal by Subject|2|||
106073351|NCT01856790|365934061|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
106073352|NCT02584504|365934062|FG000|Double-blind Treatment|Participant withdrew consent|0|||
106073353|NCT02584504|365934063|FG001|Double-blind Treatment|Participant withdrew consent|0|||
106073354|NCT02584504|365934064|FG002|Double-blind Treatment|Participant withdrew consent|1|||
106073355|NCT02584504|365934062|FG000|Double-blind Treatment|Adverse Event|0|||
106073356|NCT02584504|365934063|FG001|Double-blind Treatment|Adverse Event|1|||
106073357|NCT02584504|365934064|FG002|Double-blind Treatment|Adverse Event|0|||
106073358|NCT02584504|365934062|FG000|Double-blind Treatment|Family Matter|0|||
106073359|NCT02584504|365934063|FG001|Double-blind Treatment|Family Matter|1|||
106073360|NCT02584504|365934064|FG002|Double-blind Treatment|Family Matter|0|||
106073361|NCT02584504|365934062|FG000|Open-label Treatment|Participant withdrew consent|0|||
106073362|NCT02584504|365934063|FG001|Open-label Treatment|Participant withdrew consent|0|||
106073363|NCT02584504|365934064|FG002|Open-label Treatment|Participant withdrew consent|4|||
106073364|NCT02584504|365934062|FG000|Open-label Treatment|Adverse Event|2|||
106073365|NCT02584504|365934063|FG001|Open-label Treatment|Adverse Event|2|||
106073366|NCT02584504|365934064|FG002|Open-label Treatment|Adverse Event|3|||
106073367|NCT02584504|365934062|FG000|Open-label Treatment|Physician Decision|0|||
106073368|NCT02584504|365934063|FG001|Open-label Treatment|Physician Decision|1|||
106073369|NCT02584504|365934064|FG002|Open-label Treatment|Physician Decision|0|||
106073370|NCT02584504|365934062|FG000|Open-label Treatment|Entered but not treated|0|||
106073371|NCT02584504|365934063|FG001|Open-label Treatment|Entered but not treated|1|||
106073372|NCT02584504|365934064|FG002|Open-label Treatment|Entered but not treated|1|||
106073373|NCT04091646|365934065|FG000|Overall Study|Adverse Event|2|||
106073374|NCT04091646|365934066|FG001|Overall Study|Adverse Event|1|||
106073375|NCT04091646|365934065|FG000|Overall Study|Lost to Follow-up|6|||
106073376|NCT04091646|365934066|FG001|Overall Study|Lost to Follow-up|2|||
106073377|NCT04091646|365934065|FG000|Overall Study|Protocol Violation|0|||
106073378|NCT04091646|365934066|FG001|Overall Study|Protocol Violation|1|||
106073379|NCT04091646|365934065|FG000|Overall Study|Withdrawal by Subject|4|||
106073380|NCT04091646|365934066|FG001|Overall Study|Withdrawal by Subject|1|||
106073381|NCT04091646|365934065|FG000|Overall Study|Participant Incarcerated|1|||
106073382|NCT04091646|365934066|FG001|Overall Study|Participant Incarcerated|0|||
106073383|NCT03102918|365934068|FG000|Overall Study|Protocol Violation|1|||
106073384|NCT03102918|365934069|FG001|Overall Study|Protocol Violation|0|||
106073385|NCT01762943|365934070|FG000|Overall Study|Physician Decision|1|||
106073386|NCT01762943|365934071|FG001|Overall Study|Physician Decision|1|||
106073387|NCT01762943|365934070|FG000|Overall Study|Protocol Violation|1|||
106073388|NCT01762943|365934071|FG001|Overall Study|Protocol Violation|0|||
106073389|NCT01762943|365934070|FG000|Overall Study|Withdrawal by Subject|2|||
106073390|NCT01762943|365934071|FG001|Overall Study|Withdrawal by Subject|1|||
106073391|NCT00539838|365934072|FG000|Overall Study|Fail to return|2|||
106073392|NCT00539838|365934073|FG001|Overall Study|Fail to return|0|||
106073393|NCT00539838|365934074|FG002|Overall Study|Fail to return|0|||
106073394|NCT00539838|365934072|FG000|Overall Study|Withdrawal by Subject|0|||
106073395|NCT00539838|365934073|FG001|Overall Study|Withdrawal by Subject|4|||
106073396|NCT00539838|365934074|FG002|Overall Study|Withdrawal by Subject|0|||
106073397|NCT00539838|365934072|FG000|Overall Study|Death|0|||
106073398|NCT00539838|365934073|FG001|Overall Study|Death|2|||
106073399|NCT00539838|365934074|FG002|Overall Study|Death|0|||
106073400|NCT00539838|365934072|FG000|Overall Study|Did not cooperate|1|||
106073401|NCT00539838|365934073|FG001|Overall Study|Did not cooperate|0|||
106073402|NCT00539838|365934074|FG002|Overall Study|Did not cooperate|1|||
106073403|NCT00539838|365934072|FG000|Overall Study|Administrative|4|||
106073404|NCT00539838|365934073|FG001|Overall Study|Administrative|0|||
106073405|NCT00539838|365934074|FG002|Overall Study|Administrative|8|||
106073406|NCT02658890|365934080|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073407|NCT02658890|365934081|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073408|NCT02658890|365934082|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073409|NCT02658890|365934083|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073410|NCT02658890|365934084|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073411|NCT02658890|365934085|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073412|NCT02658890|365934086|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073413|NCT02658890|365934087|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073414|NCT02658890|365934088|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
106073415|NCT02658890|365934089|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073416|NCT02658890|365934090|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073417|NCT02658890|365934091|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073418|NCT02658890|365934092|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073419|NCT02658890|365934093|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073420|NCT02658890|365934094|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073421|NCT02658890|365934095|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073422|NCT02658890|365934096|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073423|NCT02658890|365934097|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073424|NCT02658890|365934098|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073425|NCT02658890|365934099|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106157226|NCT03713086|366237873|FG000|Overall Study|Withdrawal by Subject|0|||
106073426|NCT02658890|365934100|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105866584|NCT02585778|365161080|FG001|Overall Study|Poor compliance to study protocol|2|||
105866585|NCT02585778|365161079|FG000|Overall Study|Death|0|||
105866586|NCT02585778|365161080|FG001|Overall Study|Death|1|||
105866587|NCT02585778|365161079|FG000|Overall Study|Randomized but not treated|1|||
105866588|NCT02585778|365161080|FG001|Overall Study|Randomized but not treated|2|||
105866589|NCT02585778|365161079|FG000|Overall Study|Other than specified above|6|||
105866590|NCT02585778|365161080|FG001|Overall Study|Other than specified above|2|||
105866591|NCT00261950|365161081|FG000|Overall Study|Lost to Follow-up|2|||
105866592|NCT00261950|365161081|FG000|Overall Study|Death|6|||
105866593|NCT00261950|365161081|FG000|Overall Study|Withdrawal by Subject|5|||
105866594|NCT00261950|365161081|FG000|Overall Study|Other|1|||
105866595|NCT00261950|365161081|FG000|Overall Study|Physician Decision|1|||
105866596|NCT00261950|365161081|FG000|Overall Study|Protocol specified Criteria|11|||
105866597|NCT00810511|365161092|FG000|Overall Study|Protocol Violation|0|||
105866598|NCT00810511|365161093|FG001|Overall Study|Protocol Violation|1|||
105866599|NCT00810511|365161092|FG000|Overall Study|Lack of Efficacy|9|||
105866600|NCT00810511|365161093|FG001|Overall Study|Lack of Efficacy|1|||
105866601|NCT00810511|365161092|FG000|Overall Study|death in the family|0|||
105866602|NCT00810511|365161093|FG001|Overall Study|death in the family|1|||
105866603|NCT00810511|365161092|FG000|Overall Study|Lost to Follow-up|1|||
106073427|NCT02658890|365934101|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
105866604|NCT00810511|365161093|FG001|Overall Study|Lost to Follow-up|0|||
105866605|NCT00810511|365161092|FG000|Overall Study|deposits on contact lens|0|||
105866606|NCT00810511|365161093|FG001|Overall Study|deposits on contact lens|1|||
105866607|NCT00462904|365161094|FG000|Overall Study|Lost to Follow-up|1|||
106073428|NCT02658890|365934102|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073429|NCT02658890|365934103|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073430|NCT02658890|365934104|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073431|NCT02658890|365934105|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073432|NCT02658890|365934106|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073433|NCT02658890|365934080|FG000|Treatment Phase|Adverse Event|0|||
106073434|NCT02658890|365934081|FG001|Treatment Phase|Adverse Event|1|||
106073435|NCT02658890|365934082|FG002|Treatment Phase|Adverse Event|2|||
106073436|NCT02658890|365934083|FG003|Treatment Phase|Adverse Event|2|||
106073437|NCT02658890|365934084|FG004|Treatment Phase|Adverse Event|1|||
106073438|NCT02658890|365934085|FG005|Treatment Phase|Adverse Event|0|||
106073439|NCT02658890|365934086|FG006|Treatment Phase|Adverse Event|0|||
106073440|NCT02658890|365934087|FG007|Treatment Phase|Adverse Event|2|||
106073441|NCT02658890|365934088|FG008|Treatment Phase|Adverse Event|1|||
106073442|NCT02658890|365934089|FG009|Treatment Phase|Adverse Event|2|||
106073443|NCT02658890|365934090|FG010|Treatment Phase|Adverse Event|3|||
106073444|NCT02658890|365934091|FG011|Treatment Phase|Adverse Event|0|||
106073445|NCT02658890|365934092|FG012|Treatment Phase|Adverse Event|1|||
106073446|NCT02658890|365934093|FG013|Treatment Phase|Adverse Event|4|||
106073447|NCT02658890|365934094|FG014|Treatment Phase|Adverse Event|0|||
106073448|NCT02658890|365934095|FG015|Treatment Phase|Adverse Event|0|||
106073449|NCT02658890|365934096|FG016|Treatment Phase|Adverse Event|0|||
106073450|NCT02658890|365934097|FG017|Treatment Phase|Adverse Event|0|||
106073451|NCT02658890|365934098|FG018|Treatment Phase|Adverse Event|5|||
106073452|NCT02658890|365934099|FG019|Treatment Phase|Adverse Event|1|||
106073453|NCT02658890|365934100|FG020|Treatment Phase|Adverse Event|3|||
106073454|NCT02658890|365934101|FG021|Treatment Phase|Adverse Event|0|||
106073455|NCT02658890|365934102|FG022|Treatment Phase|Adverse Event|5|||
106073456|NCT02658890|365934103|FG023|Treatment Phase|Adverse Event|0|||
106073457|NCT02658890|365934104|FG024|Treatment Phase|Adverse Event|0|||
106073458|NCT02658890|365934105|FG025|Treatment Phase|Adverse Event|2|||
106073459|NCT02658890|365934106|FG026|Treatment Phase|Adverse Event|1|||
106073460|NCT02658890|365934080|FG000|Treatment Phase|Death|0|||
106073461|NCT02658890|365934081|FG001|Treatment Phase|Death|0|||
106073462|NCT02658890|365934082|FG002|Treatment Phase|Death|0|||
106073463|NCT02658890|365934083|FG003|Treatment Phase|Death|0|||
106073464|NCT02658890|365934084|FG004|Treatment Phase|Death|0|||
106073465|NCT02658890|365934085|FG005|Treatment Phase|Death|0|||
106073466|NCT02658890|365934086|FG006|Treatment Phase|Death|0|||
106073467|NCT02658890|365934087|FG007|Treatment Phase|Death|0|||
106157227|NCT03713086|366237874|FG001|Overall Study|Withdrawal by Subject|2|||
106073468|NCT02658890|365934088|FG008|Treatment Phase|Death|0|||
106073469|NCT02658890|365934089|FG009|Treatment Phase|Death|0|||
106073470|NCT02658890|365934090|FG010|Treatment Phase|Death|0|||
106073471|NCT02658890|365934091|FG011|Treatment Phase|Death|0|||
106073472|NCT02658890|365934092|FG012|Treatment Phase|Death|0|||
106157228|NCT03713086|366237875|FG002|Overall Study|Withdrawal by Subject|1|||
105866608|NCT00652340|365161095|FG000|Overall Study|Had not progressed.|4|||
105866609|NCT00652340|365161096|FG001|Overall Study|Had not progressed.|3|||
106073473|NCT02658890|365934093|FG013|Treatment Phase|Death|0|||
106073474|NCT02658890|365934094|FG014|Treatment Phase|Death|0|||
106073475|NCT02658890|365934095|FG015|Treatment Phase|Death|0|||
106073476|NCT02658890|365934096|FG016|Treatment Phase|Death|0|||
106073477|NCT02658890|365934097|FG017|Treatment Phase|Death|0|||
106073478|NCT02658890|365934098|FG018|Treatment Phase|Death|1|||
105866610|NCT00214383|365161097|FG000|Overall Study|Lost to Follow-up|16|||
106073479|NCT02658890|365934099|FG019|Treatment Phase|Death|0|||
106073480|NCT02658890|365934100|FG020|Treatment Phase|Death|0|||
106073481|NCT02658890|365934101|FG021|Treatment Phase|Death|0|||
106073482|NCT02658890|365934102|FG022|Treatment Phase|Death|0|||
106073483|NCT02658890|365934103|FG023|Treatment Phase|Death|0|||
106073484|NCT02658890|365934104|FG024|Treatment Phase|Death|0|||
106073485|NCT02658890|365934105|FG025|Treatment Phase|Death|0|||
106073486|NCT02658890|365934106|FG026|Treatment Phase|Death|0|||
106073487|NCT02658890|365934080|FG000|Treatment Phase|Lost to Follow-up|0|||
106073488|NCT02658890|365934081|FG001|Treatment Phase|Lost to Follow-up|0|||
106073489|NCT02658890|365934082|FG002|Treatment Phase|Lost to Follow-up|0|||
106073490|NCT02658890|365934083|FG003|Treatment Phase|Lost to Follow-up|0|||
106073491|NCT02658890|365934084|FG004|Treatment Phase|Lost to Follow-up|0|||
106073492|NCT02658890|365934085|FG005|Treatment Phase|Lost to Follow-up|0|||
106073493|NCT02658890|365934086|FG006|Treatment Phase|Lost to Follow-up|1|||
106073494|NCT02658890|365934087|FG007|Treatment Phase|Lost to Follow-up|0|||
106073495|NCT02658890|365934088|FG008|Treatment Phase|Lost to Follow-up|0|||
106073496|NCT02658890|365934089|FG009|Treatment Phase|Lost to Follow-up|0|||
106073497|NCT02658890|365934090|FG010|Treatment Phase|Lost to Follow-up|0|||
106073498|NCT02658890|365934091|FG011|Treatment Phase|Lost to Follow-up|0|||
106073499|NCT02658890|365934092|FG012|Treatment Phase|Lost to Follow-up|0|||
106073500|NCT02658890|365934093|FG013|Treatment Phase|Lost to Follow-up|0|||
106073501|NCT02658890|365934094|FG014|Treatment Phase|Lost to Follow-up|0|||
106073502|NCT02658890|365934095|FG015|Treatment Phase|Lost to Follow-up|0|||
106073503|NCT02658890|365934096|FG016|Treatment Phase|Lost to Follow-up|0|||
106073504|NCT02658890|365934097|FG017|Treatment Phase|Lost to Follow-up|0|||
106073505|NCT02658890|365934098|FG018|Treatment Phase|Lost to Follow-up|0|||
106073506|NCT02658890|365934099|FG019|Treatment Phase|Lost to Follow-up|0|||
106073507|NCT02658890|365934100|FG020|Treatment Phase|Lost to Follow-up|0|||
106073508|NCT02658890|365934101|FG021|Treatment Phase|Lost to Follow-up|0|||
106073509|NCT02658890|365934102|FG022|Treatment Phase|Lost to Follow-up|0|||
106073510|NCT02658890|365934103|FG023|Treatment Phase|Lost to Follow-up|0|||
106073511|NCT02658890|365934104|FG024|Treatment Phase|Lost to Follow-up|0|||
106073512|NCT02658890|365934105|FG025|Treatment Phase|Lost to Follow-up|0|||
106073513|NCT02658890|365934106|FG026|Treatment Phase|Lost to Follow-up|0|||
106073514|NCT02658890|365934080|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
106073515|NCT02658890|365934081|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
106073516|NCT02658890|365934082|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
106073517|NCT02658890|365934083|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
106073518|NCT02658890|365934084|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
106073519|NCT02658890|365934085|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
106073520|NCT02658890|365934086|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
106073521|NCT02658890|365934087|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
106073522|NCT02658890|365934088|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
106073523|NCT02658890|365934089|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
106073524|NCT02658890|365934090|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
106073525|NCT02658890|365934091|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
106073526|NCT02658890|365934092|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
106073527|NCT02658890|365934093|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
106073528|NCT02658890|365934094|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
106073529|NCT02658890|365934095|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
106073530|NCT02658890|365934096|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
106073531|NCT02658890|365934097|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
106073532|NCT02658890|365934098|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
106073533|NCT02658890|365934099|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
106073534|NCT02658890|365934100|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
106073535|NCT02658890|365934101|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
106073536|NCT02658890|365934102|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
106073537|NCT02658890|365934103|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
106073538|NCT02658890|365934104|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
106073539|NCT02658890|365934105|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
106073540|NCT02658890|365934106|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
106073541|NCT02658890|365934080|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
106157229|NCT03713086|366237876|FG003|Overall Study|Withdrawal by Subject|0|||
106157230|NCT03713086|366237873|FG000|Overall Study|Lost to Follow-up|0|||
106157231|NCT03713086|366237874|FG001|Overall Study|Lost to Follow-up|1|||
106157232|NCT03713086|366237875|FG002|Overall Study|Lost to Follow-up|0|||
106157233|NCT03713086|366237876|FG003|Overall Study|Lost to Follow-up|1|||
106157234|NCT05009251|366237877|FG000|Overall Study|Protocol Violation|100|||
106157235|NCT05009251|366237878|FG001|Overall Study|Protocol Violation|105|||
106157236|NCT05009251|366237879|FG002|Overall Study|Protocol Violation|119|||
106157237|NCT05009251|366237880|FG003|Overall Study|Protocol Violation|120|||
106157238|NCT05009251|366237881|FG004|Overall Study|Protocol Violation|119|||
106073542|NCT02658890|365934081|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
106073543|NCT02658890|365934082|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
106073544|NCT02658890|365934083|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
106073545|NCT02658890|365934084|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
106073546|NCT02658890|365934085|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
106073547|NCT02658890|365934086|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
106073548|NCT02658890|365934087|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
106073549|NCT02658890|365934088|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
106073550|NCT02658890|365934089|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
106073551|NCT02658890|365934090|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
106073552|NCT02658890|365934091|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
106073553|NCT02658890|365934092|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
106073554|NCT02658890|365934093|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
106073555|NCT02658890|365934094|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
106073556|NCT02658890|365934095|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
106073557|NCT02658890|365934096|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
106073558|NCT02658890|365934097|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
106073559|NCT02658890|365934098|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
106073560|NCT02658890|365934099|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
106073561|NCT02658890|365934100|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
106073562|NCT02658890|365934101|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
106073563|NCT02658890|365934102|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
106073564|NCT02658890|365934103|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
106073565|NCT02658890|365934104|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
106073566|NCT02658890|365934105|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
106073567|NCT02658890|365934106|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
106073568|NCT02658890|365934080|FG000|Treatment Phase|Other Reasons|0|||
106073569|NCT02658890|365934081|FG001|Treatment Phase|Other Reasons|0|||
106073570|NCT02658890|365934082|FG002|Treatment Phase|Other Reasons|0|||
106073571|NCT02658890|365934083|FG003|Treatment Phase|Other Reasons|0|||
106073572|NCT02658890|365934084|FG004|Treatment Phase|Other Reasons|0|||
106073573|NCT02658890|365934085|FG005|Treatment Phase|Other Reasons|0|||
106073574|NCT02658890|365934086|FG006|Treatment Phase|Other Reasons|1|||
106073575|NCT02658890|365934087|FG007|Treatment Phase|Other Reasons|0|||
106073576|NCT02658890|365934088|FG008|Treatment Phase|Other Reasons|1|||
106073577|NCT02658890|365934089|FG009|Treatment Phase|Other Reasons|0|||
106073578|NCT02658890|365934090|FG010|Treatment Phase|Other Reasons|0|||
106073579|NCT02658890|365934091|FG011|Treatment Phase|Other Reasons|0|||
106073580|NCT02658890|365934092|FG012|Treatment Phase|Other Reasons|0|||
106073581|NCT02658890|365934093|FG013|Treatment Phase|Other Reasons|2|||
106073582|NCT02658890|365934094|FG014|Treatment Phase|Other Reasons|0|||
106073583|NCT02658890|365934095|FG015|Treatment Phase|Other Reasons|0|||
106073584|NCT02658890|365934096|FG016|Treatment Phase|Other Reasons|0|||
106073585|NCT02658890|365934097|FG017|Treatment Phase|Other Reasons|0|||
106073586|NCT02658890|365934098|FG018|Treatment Phase|Other Reasons|1|||
106073587|NCT02658890|365934099|FG019|Treatment Phase|Other Reasons|0|||
106073588|NCT02658890|365934100|FG020|Treatment Phase|Other Reasons|0|||
106073589|NCT02658890|365934101|FG021|Treatment Phase|Other Reasons|0|||
106073590|NCT02658890|365934102|FG022|Treatment Phase|Other Reasons|0|||
106073591|NCT02658890|365934103|FG023|Treatment Phase|Other Reasons|0|||
106073592|NCT02658890|365934104|FG024|Treatment Phase|Other Reasons|1|||
106073593|NCT02658890|365934105|FG025|Treatment Phase|Other Reasons|0|||
106073594|NCT02658890|365934106|FG026|Treatment Phase|Other Reasons|1|||
106073595|NCT02658890|365934080|FG000|Treatment Phase|Progressive Disease|6|||
106073596|NCT02658890|365934081|FG001|Treatment Phase|Progressive Disease|7|||
106073597|NCT02658890|365934082|FG002|Treatment Phase|Progressive Disease|6|||
106073598|NCT02658890|365934083|FG003|Treatment Phase|Progressive Disease|12|||
106073599|NCT02658890|365934084|FG004|Treatment Phase|Progressive Disease|6|||
106073600|NCT02658890|365934085|FG005|Treatment Phase|Progressive Disease|18|||
106073601|NCT02658890|365934086|FG006|Treatment Phase|Progressive Disease|12|||
106073602|NCT02658890|365934087|FG007|Treatment Phase|Progressive Disease|19|||
106073603|NCT02658890|365934088|FG008|Treatment Phase|Progressive Disease|26|||
106073604|NCT02658890|365934089|FG009|Treatment Phase|Progressive Disease|8|||
106157239|NCT05009251|366237877|FG000|Overall Study|Death|25|||
106157240|NCT05009251|366237878|FG001|Overall Study|Death|22|||
106157241|NCT05009251|366237879|FG002|Overall Study|Death|24|||
106073605|NCT02658890|365934090|FG010|Treatment Phase|Progressive Disease|7|||
106073606|NCT02658890|365934091|FG011|Treatment Phase|Progressive Disease|9|||
106073607|NCT02658890|365934092|FG012|Treatment Phase|Progressive Disease|8|||
105866611|NCT00214383|365161098|FG001|Overall Study|Lost to Follow-up|26|||
105866612|NCT02125877|365161102|FG000|Overall Study|Physician Decision|1|||
106073608|NCT02658890|365934093|FG013|Treatment Phase|Progressive Disease|29|||
106073609|NCT02658890|365934094|FG014|Treatment Phase|Progressive Disease|6|||
106073610|NCT02658890|365934095|FG015|Treatment Phase|Progressive Disease|2|||
106073611|NCT02658890|365934096|FG016|Treatment Phase|Progressive Disease|32|||
106073612|NCT02658890|365934097|FG017|Treatment Phase|Progressive Disease|14|||
106073613|NCT02658890|365934098|FG018|Treatment Phase|Progressive Disease|40|||
106073614|NCT02658890|365934099|FG019|Treatment Phase|Progressive Disease|32|||
106073615|NCT02658890|365934100|FG020|Treatment Phase|Progressive Disease|19|||
106073616|NCT02658890|365934101|FG021|Treatment Phase|Progressive Disease|30|||
106073617|NCT02658890|365934102|FG022|Treatment Phase|Progressive Disease|15|||
106073618|NCT02658890|365934103|FG023|Treatment Phase|Progressive Disease|0|||
106073619|NCT02658890|365934104|FG024|Treatment Phase|Progressive Disease|0|||
106073620|NCT02658890|365934105|FG025|Treatment Phase|Progressive Disease|14|||
106073621|NCT02658890|365934106|FG026|Treatment Phase|Progressive Disease|11|||
106073622|NCT02658890|365934080|FG000|Treatment Phase|Study Drug Toxicity|0|||
106073623|NCT02658890|365934081|FG001|Treatment Phase|Study Drug Toxicity|0|||
106073624|NCT02658890|365934082|FG002|Treatment Phase|Study Drug Toxicity|2|||
106073625|NCT02658890|365934083|FG003|Treatment Phase|Study Drug Toxicity|0|||
106073626|NCT02658890|365934084|FG004|Treatment Phase|Study Drug Toxicity|0|||
106073627|NCT02658890|365934085|FG005|Treatment Phase|Study Drug Toxicity|0|||
106073628|NCT02658890|365934086|FG006|Treatment Phase|Study Drug Toxicity|0|||
105866613|NCT02125877|365161103|FG001|Overall Study|Physician Decision|0|||
106073629|NCT02658890|365934087|FG007|Treatment Phase|Study Drug Toxicity|0|||
106073630|NCT02658890|365934088|FG008|Treatment Phase|Study Drug Toxicity|3|||
106073631|NCT02658890|365934089|FG009|Treatment Phase|Study Drug Toxicity|0|||
106073632|NCT02658890|365934090|FG010|Treatment Phase|Study Drug Toxicity|1|||
106073633|NCT02658890|365934091|FG011|Treatment Phase|Study Drug Toxicity|1|||
106073634|NCT02658890|365934092|FG012|Treatment Phase|Study Drug Toxicity|2|||
106073635|NCT02658890|365934093|FG013|Treatment Phase|Study Drug Toxicity|9|||
106073636|NCT02658890|365934094|FG014|Treatment Phase|Study Drug Toxicity|0|||
106073637|NCT02658890|365934095|FG015|Treatment Phase|Study Drug Toxicity|1|||
106073638|NCT02658890|365934096|FG016|Treatment Phase|Study Drug Toxicity|1|||
106073639|NCT02658890|365934097|FG017|Treatment Phase|Study Drug Toxicity|0|||
106073640|NCT02658890|365934098|FG018|Treatment Phase|Study Drug Toxicity|8|||
106073641|NCT02658890|365934099|FG019|Treatment Phase|Study Drug Toxicity|3|||
106073642|NCT02658890|365934100|FG020|Treatment Phase|Study Drug Toxicity|2|||
106073643|NCT02658890|365934101|FG021|Treatment Phase|Study Drug Toxicity|0|||
106073644|NCT02658890|365934102|FG022|Treatment Phase|Study Drug Toxicity|8|||
106073645|NCT02658890|365934103|FG023|Treatment Phase|Study Drug Toxicity|0|||
106073646|NCT02658890|365934104|FG024|Treatment Phase|Study Drug Toxicity|0|||
106073647|NCT02658890|365934105|FG025|Treatment Phase|Study Drug Toxicity|2|||
106073648|NCT02658890|365934106|FG026|Treatment Phase|Study Drug Toxicity|0|||
106073649|NCT02658890|365934080|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073650|NCT02658890|365934081|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073651|NCT02658890|365934082|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073652|NCT02658890|365934083|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
106073653|NCT02658890|365934084|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073654|NCT02658890|365934085|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073655|NCT02658890|365934086|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073656|NCT02658890|365934087|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073657|NCT02658890|365934088|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073658|NCT02658890|365934089|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
106073659|NCT02658890|365934090|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073660|NCT02658890|365934091|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073661|NCT02658890|365934092|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073662|NCT02658890|365934093|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073663|NCT02658890|365934094|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073664|NCT02658890|365934095|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073665|NCT02658890|365934096|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073666|NCT02658890|365934097|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073667|NCT02658890|365934098|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
106073668|NCT02658890|365934099|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073669|NCT02658890|365934100|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073670|NCT02658890|365934101|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073671|NCT02658890|365934102|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
106073672|NCT02658890|365934103|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106157242|NCT05009251|366237880|FG003|Overall Study|Death|19|||
106157243|NCT05009251|366237881|FG004|Overall Study|Death|15|||
106157244|NCT03988634|366237882|FG000|Double-Blind|Adverse Event|4|||
106157245|NCT03988634|366237883|FG001|Double-Blind|Adverse Event|0|||
106157246|NCT03988634|366237884|FG002|Double-Blind|Adverse Event|0|||
106157247|NCT03988634|366237882|FG000|Double-Blind|Death|18|||
106157248|NCT03988634|366237883|FG001|Double-Blind|Death|26|||
106157249|NCT03988634|366237884|FG002|Double-Blind|Death|0|||
106157250|NCT03988634|366237882|FG000|Double-Blind|Lost to Follow-up|6|||
106157251|NCT03988634|366237883|FG001|Double-Blind|Lost to Follow-up|7|||
106157252|NCT03988634|366237884|FG002|Double-Blind|Lost to Follow-up|0|||
106157253|NCT03988634|366237882|FG000|Double-Blind|Physician Decision|9|||
106157254|NCT03988634|366237883|FG001|Double-Blind|Physician Decision|5|||
106157255|NCT03988634|366237884|FG002|Double-Blind|Physician Decision|0|||
106157256|NCT03988634|366237882|FG000|Double-Blind|Subject decision|24|||
106157257|NCT03988634|366237883|FG001|Double-Blind|Subject decision|13|||
106157258|NCT03988634|366237884|FG002|Double-Blind|Subject decision|0|||
106157259|NCT03988634|366237882|FG000|Open-Label|Adverse Event|0|||
106157260|NCT03988634|366237883|FG001|Open-Label|Adverse Event|0|||
106157261|NCT03988634|366237884|FG002|Open-Label|Adverse Event|7|||
106157262|NCT03988634|366237882|FG000|Open-Label|Physician Decision|0|||
106157263|NCT03988634|366237883|FG001|Open-Label|Physician Decision|0|||
106157264|NCT03988634|366237884|FG002|Open-Label|Physician Decision|1|||
106157265|NCT03988634|366237882|FG000|Open-Label|Technical problems|0|||
106157266|NCT03988634|366237883|FG001|Open-Label|Technical problems|0|||
106157267|NCT03988634|366237884|FG002|Open-Label|Technical problems|1|||
106157268|NCT05249439|366237889|FG000|Overall Study|Withdrawal by Subject|2|||
106157269|NCT05249439|366237890|FG001|Overall Study|Withdrawal by Subject|5|||
106157270|NCT05249439|366237889|FG000|Overall Study|Physician Decision|3|||
106157271|NCT05249439|366237890|FG001|Overall Study|Physician Decision|1|||
106157272|NCT03786783|366237891|FG000|Overall Study|Death|1|||
106157273|NCT03786783|366237891|FG000|Overall Study|Physician Decision|6|||
106157274|NCT03786783|366237891|FG000|Overall Study|Withdrawal by Subject|2|||
106157275|NCT03786783|366237891|FG000|Overall Study|Disease Progression|7|||
106157276|NCT03786783|366237891|FG000|Overall Study|Patient/Parent Refusal|4|||
106157277|NCT02910583|366237892|FG000|Overall Study|Death|7|||
106157278|NCT02910583|366237893|FG001|Overall Study|Death|3|||
106157279|NCT02910583|366237892|FG000|Overall Study|Lost to Follow-up|1|||
106157280|NCT02910583|366237893|FG001|Overall Study|Lost to Follow-up|0|||
106157281|NCT02910583|366237892|FG000|Overall Study|Withdrawal by Subject|12|||
106157282|NCT02910583|366237893|FG001|Overall Study|Withdrawal by Subject|8|||
106157283|NCT02910583|366237892|FG000|Overall Study|Other, Not Specified|6|||
106157284|NCT02910583|366237893|FG001|Overall Study|Other, Not Specified|3|||
106157285|NCT02097420|366237897|FG000|Overall Study|Death|6|||
106073673|NCT02658890|365934104|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106157286|NCT02097420|366237897|FG000|Overall Study|Valve explanted|13|||
106157287|NCT02097420|366237897|FG000|Overall Study|Other Reason|1|||
106157288|NCT01331005|366237898|FG000|Overall Study|Lost to Follow-up|2|||
106157289|NCT01331005|366237899|FG001|Overall Study|Lost to Follow-up|1|||
106157290|NCT01331005|366237898|FG000|Overall Study|Withdrawal by Subject|2|||
106157291|NCT01331005|366237899|FG001|Overall Study|Withdrawal by Subject|3|||
106157292|NCT02728076|366237900|FG000|Overall Study|Physician Decision|4|||
106157293|NCT05691309|366237901|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
106157294|NCT05691309|366237901|FG000|Overall Study|vancomycin levels not evaluable|2|||
106157295|NCT01140880|366237902|FG000|Overall Study|Death|0|||
106157296|NCT01140880|366237903|FG001|Overall Study|Death|1|||
106157297|NCT01140880|366237902|FG000|Overall Study|Withdrawal by Subject|6|||
106157298|NCT01140880|366237903|FG001|Overall Study|Withdrawal by Subject|3|||
106157299|NCT01140880|366237902|FG000|Overall Study|Lost to Follow-up|8|||
106157300|NCT01140880|366237903|FG001|Overall Study|Lost to Follow-up|10|||
106157301|NCT01140880|366237902|FG000|Overall Study|Protocol Violation|0|||
106157302|NCT01140880|366237903|FG001|Overall Study|Protocol Violation|30|||
106157303|NCT02724878|366237905|FG000|Overall Study|Still on Active Therapy|15|||
106157304|NCT02724878|366237905|FG000|Overall Study|Disease Progression|31|||
106157305|NCT02724878|366237905|FG000|Overall Study|Toxicity|5|||
106157306|NCT02724878|366237905|FG000|Overall Study|Death|1|||
106073674|NCT02658890|365934105|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106073675|NCT02658890|365934106|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
106157307|NCT02724878|366237905|FG000|Overall Study|Withdrawal by Subject|4|||
106157308|NCT02724878|366237905|FG000|Overall Study|Lost to Follow-up|2|||
106157309|NCT02724878|366237905|FG000|Overall Study|Protocol Violation|1|||
106157310|NCT02724878|366237905|FG000|Overall Study|Ineligible for Study Drug|5|||
106157311|NCT02724878|366237905|FG000|Overall Study|not started|1|||
106157312|NCT03090152|366237906|FG000|Overall Study|Withdrawal by Subject|0|||
106157313|NCT03090152|366237907|FG001|Overall Study|Withdrawal by Subject|2|||
106157314|NCT03090152|366237908|FG002|Overall Study|Withdrawal by Subject|1|||
106157315|NCT03090152|366237906|FG000|Overall Study|Surgery Canceled|1|||
106157316|NCT03090152|366237907|FG001|Overall Study|Surgery Canceled|0|||
106157317|NCT03090152|366237908|FG002|Overall Study|Surgery Canceled|0|||
106157318|NCT03090152|366237906|FG000|Overall Study|Epidural catheter could not be placed|0|||
106157319|NCT03090152|366237907|FG001|Overall Study|Epidural catheter could not be placed|2|||
106157320|NCT03090152|366237908|FG002|Overall Study|Epidural catheter could not be placed|0|||
106157321|NCT04838262|366237909|FG000|Overall Study|Withdrawal by Subject|9|||
106157322|NCT04838262|366237910|FG001|Overall Study|Withdrawal by Subject|4|||
106157323|NCT05082909|366237913|FG000|Overall Study|Protocol Violation|0|||
106157324|NCT05082909|366237914|FG001|Overall Study|Protocol Violation|0|||
106157325|NCT05082909|366237915|FG002|Overall Study|Protocol Violation|1|||
106157326|NCT05082909|366237916|FG003|Overall Study|Protocol Violation|0|||
106157327|NCT05082909|366237917|FG004|Overall Study|Protocol Violation|0|||
106157328|NCT05082909|366237918|FG005|Overall Study|Protocol Violation|0|||
106157329|NCT02729311|366237921|FG000|Overall Study|Withdrawal by Subject|8|||
106157330|NCT02729311|366237922|FG001|Overall Study|Withdrawal by Subject|2|||
106157331|NCT04950660|366237923|FG000|Overall Study|Protocol Violation|4|||
106157332|NCT04950660|366237924|FG001|Overall Study|Protocol Violation|2|||
106157333|NCT04950660|366237923|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
106157334|NCT04950660|366237924|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
106157335|NCT04950660|366237923|FG000|Overall Study|Withdrawal by Subject|0|||
106157336|NCT04950660|366237924|FG001|Overall Study|Withdrawal by Subject|1|||
106157337|NCT04950660|366237923|FG000|Overall Study|Hypotension|1|||
106157338|NCT04950660|366237924|FG001|Overall Study|Hypotension|0|||
106157339|NCT04783935|366237925|FG000|Overall Study|Withdrawal by Subject|6|||
106157340|NCT04783935|366237925|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
106157341|NCT04783935|366237925|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
106157342|NCT04783935|366237925|FG000|Overall Study|Lost to Follow-up|3|||
106157343|NCT04783935|366237925|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
106157344|NCT04245501|366237928|FG000|Overall Study|Adverse Event|2|||
106157345|NCT04245501|366237929|FG001|Overall Study|Adverse Event|0|||
106157346|NCT04245501|366237928|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
106157347|NCT04245501|366237929|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
106073676|NCT02658890|365934080|FG000|Treatment Phase|Withdrawal by Subject|0|||
106073677|NCT02658890|365934081|FG001|Treatment Phase|Withdrawal by Subject|1|||
106073678|NCT02658890|365934082|FG002|Treatment Phase|Withdrawal by Subject|0|||
106073679|NCT02658890|365934083|FG003|Treatment Phase|Withdrawal by Subject|0|||
106073680|NCT02658890|365934084|FG004|Treatment Phase|Withdrawal by Subject|0|||
106073681|NCT02658890|365934085|FG005|Treatment Phase|Withdrawal by Subject|0|||
106073682|NCT02658890|365934086|FG006|Treatment Phase|Withdrawal by Subject|1|||
106073683|NCT02658890|365934087|FG007|Treatment Phase|Withdrawal by Subject|0|||
106073684|NCT02658890|365934088|FG008|Treatment Phase|Withdrawal by Subject|0|||
106073685|NCT02658890|365934089|FG009|Treatment Phase|Withdrawal by Subject|1|||
106073686|NCT02658890|365934090|FG010|Treatment Phase|Withdrawal by Subject|0|||
106073687|NCT02658890|365934091|FG011|Treatment Phase|Withdrawal by Subject|0|||
106073688|NCT02658890|365934092|FG012|Treatment Phase|Withdrawal by Subject|1|||
106073689|NCT02658890|365934093|FG013|Treatment Phase|Withdrawal by Subject|3|||
106157348|NCT00512070|366237930|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
106157349|NCT00512070|366237931|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
106073690|NCT02658890|365934094|FG014|Treatment Phase|Withdrawal by Subject|0|||
106073691|NCT02658890|365934095|FG015|Treatment Phase|Withdrawal by Subject|0|||
106157350|NCT00512070|366237932|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
106157351|NCT00512070|366237930|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
106157352|NCT00512070|366237931|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
106157353|NCT00512070|366237932|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
106157354|NCT05337748|366237933|FG000|Overall Study|Withdrawal by Subject|1|||
106157355|NCT05337748|366237934|FG001|Overall Study|Withdrawal by Subject|0|||
106157356|NCT05337748|366237933|FG000|Overall Study|Death|1|||
106157357|NCT05337748|366237934|FG001|Overall Study|Death|0|||
106157358|NCT04321031|366237935|FG000|Overall Study|Adverse Event|0|||
106157359|NCT04321031|366237936|FG001|Overall Study|Adverse Event|2|||
106157360|NCT04321031|366237937|FG002|Overall Study|Adverse Event|2|||
106157361|NCT04321031|366237938|FG003|Overall Study|Adverse Event|2|||
106157362|NCT04321031|366237939|FG004|Overall Study|Adverse Event|2|||
106157363|NCT04321031|366237940|FG005|Overall Study|Adverse Event|2|||
106073692|NCT02658890|365934096|FG016|Treatment Phase|Withdrawal by Subject|1|||
106073693|NCT02658890|365934097|FG017|Treatment Phase|Withdrawal by Subject|0|||
106073694|NCT02658890|365934098|FG018|Treatment Phase|Withdrawal by Subject|4|||
106073695|NCT02658890|365934099|FG019|Treatment Phase|Withdrawal by Subject|3|||
106073696|NCT02658890|365934100|FG020|Treatment Phase|Withdrawal by Subject|0|||
106073697|NCT02658890|365934101|FG021|Treatment Phase|Withdrawal by Subject|4|||
106073698|NCT02658890|365934102|FG022|Treatment Phase|Withdrawal by Subject|1|||
106073699|NCT02658890|365934103|FG023|Treatment Phase|Withdrawal by Subject|1|||
106073700|NCT02658890|365934104|FG024|Treatment Phase|Withdrawal by Subject|0|||
106073701|NCT02658890|365934105|FG025|Treatment Phase|Withdrawal by Subject|0|||
106073702|NCT02658890|365934106|FG026|Treatment Phase|Withdrawal by Subject|0|||
106073703|NCT03090100|365934107|FG000|Overall Study|Adverse Event|9|||
106073704|NCT03090100|365934108|FG001|Overall Study|Adverse Event|11|||
106073705|NCT03090100|365934107|FG000|Overall Study|Pregnancy|1|||
106073706|NCT03090100|365934108|FG001|Overall Study|Pregnancy|1|||
106073707|NCT03090100|365934107|FG000|Overall Study|Lack of Efficacy|2|||
106073708|NCT03090100|365934108|FG001|Overall Study|Lack of Efficacy|7|||
106073709|NCT03090100|365934107|FG000|Overall Study|Lost to Follow-up|2|||
106073710|NCT03090100|365934108|FG001|Overall Study|Lost to Follow-up|2|||
106073711|NCT03090100|365934107|FG000|Overall Study|Withdrawal by Subject|7|||
106073712|NCT03090100|365934108|FG001|Overall Study|Withdrawal by Subject|19|||
106073713|NCT03090100|365934107|FG000|Overall Study|Protocol Violation|2|||
106073714|NCT03090100|365934108|FG001|Overall Study|Protocol Violation|6|||
106073715|NCT03090100|365934107|FG000|Overall Study|Non-compliance|2|||
106073716|NCT03090100|365934108|FG001|Overall Study|Non-compliance|0|||
106073717|NCT03090100|365934107|FG000|Overall Study|Other|2|||
106073718|NCT03090100|365934108|FG001|Overall Study|Other|2|||
106073719|NCT02596854|365934113|FG000|Overall Study|Withdrawn|8|||
106073720|NCT04461015|365934114|FG000|Overall Study|IV access lost during the study|0|||
106073721|NCT04461015|365934115|FG001|Overall Study|IV access lost during the study|1|||
106073722|NCT04461015|365934114|FG000|Overall Study|Withdrawal by Subject|0|||
106073723|NCT04461015|365934115|FG001|Overall Study|Withdrawal by Subject|1|||
106073724|NCT00405587|365934116|FG000|Overall Study|Death|0|||
106073725|NCT00405587|365934117|FG001|Overall Study|Death|0|||
106073726|NCT00405587|365934118|FG002|Overall Study|Death|0|||
106073727|NCT00405587|365934119|FG003|Overall Study|Death|1|||
106073728|NCT00405587|365934116|FG000|Overall Study|Disease Progression|22|||
106073729|NCT00405587|365934117|FG001|Overall Study|Disease Progression|23|||
106073730|NCT00405587|365934118|FG002|Overall Study|Disease Progression|21|||
106073731|NCT00405587|365934119|FG003|Overall Study|Disease Progression|17|||
106073732|NCT00405587|365934116|FG000|Overall Study|Physician Decision|3|||
106073733|NCT00405587|365934117|FG001|Overall Study|Physician Decision|2|||
106073734|NCT00405587|365934118|FG002|Overall Study|Physician Decision|0|||
106073735|NCT00405587|365934119|FG003|Overall Study|Physician Decision|0|||
106073736|NCT00405587|365934116|FG000|Overall Study|Adverse Event|1|||
106073737|NCT00405587|365934117|FG001|Overall Study|Adverse Event|0|||
106073738|NCT00405587|365934118|FG002|Overall Study|Adverse Event|0|||
106073739|NCT00405587|365934119|FG003|Overall Study|Adverse Event|0|||
106073740|NCT00405587|365934116|FG000|Overall Study|Lost to Follow-up|0|||
106073741|NCT00405587|365934117|FG001|Overall Study|Lost to Follow-up|1|||
106073742|NCT00405587|365934118|FG002|Overall Study|Lost to Follow-up|1|||
106073743|NCT00405587|365934119|FG003|Overall Study|Lost to Follow-up|0|||
106073744|NCT00405587|365934116|FG000|Overall Study|Radiation induced necrosis|0|||
106073745|NCT00405587|365934117|FG001|Overall Study|Radiation induced necrosis|1|||
106073746|NCT00405587|365934118|FG002|Overall Study|Radiation induced necrosis|0|||
106073747|NCT00405587|365934119|FG003|Overall Study|Radiation induced necrosis|0|||
106073748|NCT00405587|365934116|FG000|Overall Study|Withdrawal by Subject|0|||
106073749|NCT00405587|365934117|FG001|Overall Study|Withdrawal by Subject|0|||
106073750|NCT00405587|365934118|FG002|Overall Study|Withdrawal by Subject|0|||
106073751|NCT00405587|365934119|FG003|Overall Study|Withdrawal by Subject|2|||
106073752|NCT00405587|365934116|FG000|Overall Study|Participant not dosed|0|||
106073753|NCT00405587|365934117|FG001|Overall Study|Participant not dosed|1|||
106073754|NCT00405587|365934118|FG002|Overall Study|Participant not dosed|0|||
106073755|NCT00405587|365934119|FG003|Overall Study|Participant not dosed|0|||
106073756|NCT02532647|365934130|FG000|Overall Study|Did not receive trial medication|1|||
106073757|NCT02532647|365934131|FG001|Overall Study|Did not receive trial medication|0|||
106073758|NCT02532647|365934132|FG002|Overall Study|Did not receive trial medication|1|||
106073759|NCT02939560|365934133|FG000|Overall Study|Withdrawal by Subject|2|||
106073760|NCT02939560|365934133|FG000|Overall Study|Protocol Violation|1|||
106073761|NCT03340025|365934134|FG000|Overall Study|Lost to Follow-up|2|||
106073762|NCT03340025|365934135|FG001|Overall Study|Lost to Follow-up|2|||
106073763|NCT01413360|365934136|FG000|Overall Study|Lost to Follow-up|2|||
106073764|NCT01413360|365934136|FG000|Overall Study|Adverse Event|1|||
106073765|NCT02250443|365934140|FG000|Overall Study|Administrative problems|7|||
106073766|NCT02250443|365934140|FG000|Overall Study|Adverse Event|3|||
106073767|NCT02136576|365934147|FG000|Overall Study|Lost to Follow-up|2|||
106073768|NCT02136576|365934148|FG001|Overall Study|Lost to Follow-up|0|||
106157364|NCT04321031|366237941|FG006|Overall Study|Adverse Event|0|||
106157365|NCT04321031|366237935|FG000|Overall Study|Lost to Follow-up|0|||
106157366|NCT04321031|366237936|FG001|Overall Study|Lost to Follow-up|0|||
106157367|NCT04321031|366237937|FG002|Overall Study|Lost to Follow-up|0|||
106157368|NCT04321031|366237938|FG003|Overall Study|Lost to Follow-up|1|||
106157369|NCT04321031|366237939|FG004|Overall Study|Lost to Follow-up|0|||
106157370|NCT04321031|366237940|FG005|Overall Study|Lost to Follow-up|2|||
106157371|NCT04321031|366237941|FG006|Overall Study|Lost to Follow-up|1|||
106157372|NCT04321031|366237935|FG000|Overall Study|Withdrawal by Subject|2|||
106157373|NCT04321031|366237936|FG001|Overall Study|Withdrawal by Subject|2|||
106157374|NCT04321031|366237937|FG002|Overall Study|Withdrawal by Subject|1|||
106157375|NCT04321031|366237938|FG003|Overall Study|Withdrawal by Subject|3|||
106157376|NCT04321031|366237939|FG004|Overall Study|Withdrawal by Subject|1|||
106157377|NCT04321031|366237940|FG005|Overall Study|Withdrawal by Subject|0|||
106157378|NCT04321031|366237941|FG006|Overall Study|Withdrawal by Subject|1|||
106157379|NCT04321031|366237935|FG000|Overall Study|Non-compliance with study drug|0|||
106157380|NCT04321031|366237936|FG001|Overall Study|Non-compliance with study drug|0|||
106157381|NCT04321031|366237937|FG002|Overall Study|Non-compliance with study drug|0|||
106157382|NCT04321031|366237938|FG003|Overall Study|Non-compliance with study drug|0|||
106157383|NCT04321031|366237939|FG004|Overall Study|Non-compliance with study drug|0|||
106157384|NCT04321031|366237940|FG005|Overall Study|Non-compliance with study drug|1|||
106157385|NCT04321031|366237941|FG006|Overall Study|Non-compliance with study drug|0|||
106157386|NCT04321031|366237935|FG000|Overall Study|Other|0|||
106157387|NCT04321031|366237936|FG001|Overall Study|Other|0|||
106157388|NCT04321031|366237937|FG002|Overall Study|Other|0|||
106157389|NCT04321031|366237938|FG003|Overall Study|Other|1|||
106157390|NCT04321031|366237939|FG004|Overall Study|Other|0|||
106157391|NCT04321031|366237940|FG005|Overall Study|Other|0|||
106157392|NCT04321031|366237941|FG006|Overall Study|Other|0|||
106157393|NCT02900924|366237942|FG000|Overall Study|Death|52|||
106157394|NCT02900924|366237942|FG000|Overall Study|Lost to Follow-up|4|||
106157395|NCT02900924|366237942|FG000|Overall Study|Withdrawal by Subject|20|||
106157396|NCT02900924|366237942|FG000|Overall Study|Missed Visit|33|||
106157397|NCT03126019|366237944|FG000|Overall Study|Death|5|||
106157398|NCT03126019|366237945|FG001|Overall Study|Death|27|||
106157399|NCT03126019|366237944|FG000|Overall Study|Lost to Follow-up|2|||
106157400|NCT03126019|366237945|FG001|Overall Study|Lost to Follow-up|4|||
106157401|NCT03126019|366237944|FG000|Overall Study|Withdrawal by Subject|1|||
106157402|NCT03126019|366237945|FG001|Overall Study|Withdrawal by Subject|9|||
106157403|NCT03126019|366237944|FG000|Overall Study|Physician Decision|1|||
106157404|NCT03126019|366237945|FG001|Overall Study|Physician Decision|0|||
106157405|NCT03126019|366237944|FG000|Overall Study|Transitioned to Rollover Study|0|||
106157406|NCT03126019|366237945|FG001|Overall Study|Transitioned to Rollover Study|11|||
106157407|NCT03126019|366237944|FG000|Overall Study|Did Not Return to Site for Care|0|||
106157408|NCT03126019|366237945|FG001|Overall Study|Did Not Return to Site for Care|1|||
106157409|NCT03126019|366237944|FG000|Overall Study|Site Closed|0|||
106157410|NCT03126019|366237945|FG001|Overall Study|Site Closed|1|||
106157411|NCT02960893|366237947|FG000|Randomization Phase (8-week)|Adverse Event|5|||
106157412|NCT02960893|366237948|FG001|Randomization Phase (8-week)|Adverse Event|0|||
106157413|NCT02960893|366237947|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
106157414|NCT02960893|366237948|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
106157415|NCT02960893|366237947|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
106157416|NCT02960893|366237948|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
106157417|NCT02960893|366237947|FG000|Extension Phase (48-week)|Adverse Event|2|||
106157418|NCT02960893|366237948|FG001|Extension Phase (48-week)|Adverse Event|3|||
106157419|NCT02960893|366237947|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
106157420|NCT02960893|366237948|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
106157421|NCT02960893|366237947|FG000|Extension Phase (48-week)|Other Reason|2|||
106157422|NCT02960893|366237948|FG001|Extension Phase (48-week)|Other Reason|1|||
106157423|NCT02960893|366237947|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
106157424|NCT02960893|366237948|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
106157425|NCT02960893|366237947|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
106157426|NCT02960893|366237948|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
106157427|NCT04060654|366237953|FG000|Overall Study|Withdrawal by Subject|1|||
106157428|NCT04060654|366237953|FG000|Overall Study|Lost to Follow-up|5|||
106157429|NCT05609760|366237956|FG000|Overall Study|Lost to Follow-up|0|||
106157430|NCT05609760|366237957|FG001|Overall Study|Lost to Follow-up|1|||
106157431|NCT05609760|366237956|FG000|Overall Study|Withdrawal by Subject|1|||
106157432|NCT05609760|366237957|FG001|Overall Study|Withdrawal by Subject|0|||
106157433|NCT04049643|366237958|FG000|Overall Study|Lack of Efficacy|1|||
106157434|NCT04049643|366237959|FG001|Overall Study|Lack of Efficacy|1|||
106157435|NCT04049643|366237960|FG002|Overall Study|Lack of Efficacy|0|||
106157436|NCT04049643|366237958|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
106157437|NCT04049643|366237959|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
106157438|NCT04049643|366237960|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
106157439|NCT03930342|366237961|FG000|Overall Study|Lost to Follow-up|70|||
106157440|NCT03930342|366237962|FG001|Overall Study|Lost to Follow-up|77|||
106073769|NCT02136576|365934149|FG002|Overall Study|Lost to Follow-up|0|||
106073770|NCT02197806|365934150|FG000|Overall Study|Adverse Event|0|||
106073771|NCT02197806|365934151|FG001|Overall Study|Adverse Event|1|||
106073772|NCT02197806|365934152|FG002|Overall Study|Adverse Event|0|||
106073773|NCT02197806|365934153|FG003|Overall Study|Adverse Event|1|||
106073774|NCT00537381|365934155|FG000|Overall Study|Adverse Event|13|||
106073775|NCT00537381|365934156|FG001|Overall Study|Adverse Event|9|||
106073776|NCT00537381|365934155|FG000|Overall Study|Death|3|||
106073777|NCT00537381|365934156|FG001|Overall Study|Death|3|||
106073778|NCT00537381|365934155|FG000|Overall Study|Withdrawal by Subject|5|||
106073779|NCT00537381|365934156|FG001|Overall Study|Withdrawal by Subject|14|||
106073780|NCT00537381|365934155|FG000|Overall Study|Physician Decision|7|||
106073781|NCT00537381|365934156|FG001|Overall Study|Physician Decision|6|||
106073782|NCT00537381|365934155|FG000|Overall Study|Disease Progression|9|||
106073783|NCT00537381|365934156|FG001|Overall Study|Disease Progression|18|||
106073784|NCT00537381|365934155|FG000|Overall Study|Sponsor decision|14|||
106073785|NCT00537381|365934156|FG001|Overall Study|Sponsor decision|9|||
106073786|NCT00537381|365934155|FG000|Overall Study|Other|5|||
106073787|NCT00537381|365934156|FG001|Overall Study|Other|3|||
106073788|NCT02590939|365934157|FG000|Overall Study|Withdrawal by Subject|3|||
106073789|NCT02590939|365934158|FG001|Overall Study|Withdrawal by Subject|1|||
106073790|NCT02590939|365934157|FG000|Overall Study|Failed the nociceptive test|2|||
106073791|NCT02590939|365934158|FG001|Overall Study|Failed the nociceptive test|1|||
106073792|NCT00108160|365934163|FG000|Overall Study|Lost to Follow-up|25|||
106073793|NCT00108160|365934164|FG001|Overall Study|Lost to Follow-up|12|||
106073794|NCT00108160|365934163|FG000|Overall Study|Death|1|||
106073795|NCT00108160|365934164|FG001|Overall Study|Death|2|||
106073796|NCT00108160|365934163|FG000|Overall Study|Withdrawal by Subject|4|||
106073797|NCT00108160|365934164|FG001|Overall Study|Withdrawal by Subject|2|||
106073798|NCT00108160|365934163|FG000|Overall Study|Protocol Violation|9|||
106073799|NCT00108160|365934164|FG001|Overall Study|Protocol Violation|5|||
106073800|NCT00923559|365934167|FG000|Overall Study|Lost to Follow-up|2|||
106073801|NCT00923559|365934168|FG001|Overall Study|Lost to Follow-up|3|||
106073802|NCT01774786|365934170|FG000|Overall Study|Death|300|||
106073803|NCT01774786|365934171|FG001|Overall Study|Death|319|||
106073804|NCT01774786|365934170|FG000|Overall Study|Lost to Follow-up|6|||
106073805|NCT01774786|365934171|FG001|Overall Study|Lost to Follow-up|7|||
106073806|NCT01774786|365934170|FG000|Overall Study|Withdrawal by Subject|18|||
106073807|NCT01774786|365934171|FG001|Overall Study|Withdrawal by Subject|14|||
106073808|NCT01774786|365934170|FG000|Overall Study|Physician Decision|2|||
106073809|NCT01774786|365934171|FG001|Overall Study|Physician Decision|0|||
106073810|NCT01774786|365934170|FG000|Overall Study|Non-compliance|0|||
106073811|NCT01774786|365934171|FG001|Overall Study|Non-compliance|1|||
106073812|NCT01774786|365934170|FG000|Overall Study|Reason Not Specified|2|||
106073813|NCT01774786|365934171|FG001|Overall Study|Reason Not Specified|5|||
106073814|NCT02268812|365934172|FG000|Overall Study|Adverse Event|8|||
106073815|NCT02268812|365934173|FG001|Overall Study|Adverse Event|26|||
106073816|NCT02268812|365934174|FG002|Overall Study|Adverse Event|7|||
106073817|NCT02268812|365934175|FG003|Overall Study|Adverse Event|10|||
106073818|NCT02268812|365934172|FG000|Overall Study|Protocol deviation|0|||
106073819|NCT02268812|365934173|FG001|Overall Study|Protocol deviation|0|||
106073820|NCT02268812|365934174|FG002|Overall Study|Protocol deviation|1|||
106073821|NCT02268812|365934175|FG003|Overall Study|Protocol deviation|0|||
106073822|NCT02268812|365934172|FG000|Overall Study|Withdrawal by Subject|0|||
106073823|NCT02268812|365934173|FG001|Overall Study|Withdrawal by Subject|1|||
106073824|NCT02268812|365934174|FG002|Overall Study|Withdrawal by Subject|0|||
106073825|NCT02268812|365934175|FG003|Overall Study|Withdrawal by Subject|0|||
106073826|NCT02268812|365934172|FG000|Overall Study|Physician Decision|3|||
106073827|NCT02268812|365934173|FG001|Overall Study|Physician Decision|1|||
106073828|NCT02268812|365934174|FG002|Overall Study|Physician Decision|0|||
106073829|NCT02268812|365934175|FG003|Overall Study|Physician Decision|1|||
106073830|NCT02268812|365934172|FG000|Overall Study|Other|5|||
106073831|NCT02268812|365934173|FG001|Overall Study|Other|4|||
106073832|NCT02268812|365934174|FG002|Overall Study|Other|1|||
106073833|NCT02268812|365934175|FG003|Overall Study|Other|3|||
106073834|NCT05045144|365934176|FG000|Overall Study|Lost to Follow-up|3|||
106073835|NCT05045144|365934177|FG001|Overall Study|Lost to Follow-up|2|||
106073836|NCT05045144|365934178|FG002|Overall Study|Lost to Follow-up|3|||
106073837|NCT05045144|365934179|FG003|Overall Study|Lost to Follow-up|5|||
106073838|NCT05045144|365934180|FG004|Overall Study|Lost to Follow-up|13|||
106073839|NCT05045144|365934176|FG000|Overall Study|Withdrawal by Subject|0|||
106073840|NCT05045144|365934177|FG001|Overall Study|Withdrawal by Subject|1|||
106073841|NCT05045144|365934178|FG002|Overall Study|Withdrawal by Subject|0|||
106073842|NCT05045144|365934179|FG003|Overall Study|Withdrawal by Subject|0|||
106073843|NCT05045144|365934180|FG004|Overall Study|Withdrawal by Subject|0|||
106073844|NCT05045144|365934176|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106073845|NCT05045144|365934177|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106073846|NCT05045144|365934178|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
106073847|NCT05045144|365934179|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106073848|NCT05045144|365934180|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
106073849|NCT00768144|365934181|FG000|Overall Study|Adverse Event|13|||
106073850|NCT00768144|365934181|FG000|Overall Study|Progressive Disease|21|||
106073851|NCT00768144|365934181|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
106073852|NCT00768144|365934181|FG000|Overall Study|Pt Withdrew Consent|1|||
106073853|NCT03886220|365934182|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
106073854|NCT03886220|365934183|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
106073855|NCT03886220|365934182|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
106157441|NCT02651324|366239941|FG000|Overall Study|drug not administered, due dispensing issue|1|||
106157442|NCT02651324|366239942|FG001|Overall Study|drug not administered, due dispensing issue|0|||
106157443|NCT02029443|366239949|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
106157444|NCT02029443|366239950|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
106157445|NCT02029443|366239951|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
106157446|NCT02029443|366239952|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
106157447|NCT02029443|366239953|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
106157448|NCT02029443|366239949|FG000|Overall Study|Death|13|||
106157449|NCT02029443|366239950|FG001|Overall Study|Death|2|||
106157450|NCT02029443|366239951|FG002|Overall Study|Death|2|||
106157451|NCT02029443|366239952|FG003|Overall Study|Death|11|||
106157452|NCT02029443|366239953|FG004|Overall Study|Death|2|||
106157453|NCT02029443|366239949|FG000|Overall Study|Lost to Follow-up|1|||
106157454|NCT02029443|366239950|FG001|Overall Study|Lost to Follow-up|0|||
106157455|NCT02029443|366239951|FG002|Overall Study|Lost to Follow-up|1|||
106157456|NCT02029443|366239952|FG003|Overall Study|Lost to Follow-up|1|||
106157457|NCT02029443|366239953|FG004|Overall Study|Lost to Follow-up|0|||
106157458|NCT02029443|366239949|FG000|Overall Study|Started other anti-cancer therapy|17|||
106157459|NCT02029443|366239950|FG001|Overall Study|Started other anti-cancer therapy|4|||
106157460|NCT02029443|366239951|FG002|Overall Study|Started other anti-cancer therapy|7|||
106157461|NCT02029443|366239952|FG003|Overall Study|Started other anti-cancer therapy|9|||
106157462|NCT02029443|366239953|FG004|Overall Study|Started other anti-cancer therapy|3|||
106157463|NCT02029443|366239949|FG000|Overall Study|Withdrawal by Subject|3|||
106157464|NCT02029443|366239950|FG001|Overall Study|Withdrawal by Subject|1|||
106157465|NCT02029443|366239951|FG002|Overall Study|Withdrawal by Subject|1|||
106157466|NCT02029443|366239952|FG003|Overall Study|Withdrawal by Subject|1|||
106157467|NCT02029443|366239953|FG004|Overall Study|Withdrawal by Subject|0|||
106157468|NCT02029443|366239949|FG000|Overall Study|Other|6|||
106157469|NCT02029443|366239950|FG001|Overall Study|Other|6|||
106157470|NCT02029443|366239951|FG002|Overall Study|Other|4|||
106157471|NCT02029443|366239952|FG003|Overall Study|Other|2|||
106157472|NCT02029443|366239953|FG004|Overall Study|Other|0|||
106157473|NCT05021640|366239961|FG000|Overall Study|Lost to Follow-up|0|||
106157474|NCT05021640|366239962|FG001|Overall Study|Lost to Follow-up|0|||
106157475|NCT05021640|366239963|FG002|Overall Study|Lost to Follow-up|0|||
106157476|NCT05021640|366239964|FG003|Overall Study|Lost to Follow-up|0|||
106157477|NCT05021640|366239965|FG004|Overall Study|Lost to Follow-up|1|||
106157478|NCT04737772|366239966|FG000|Phase 2 Study|Lost to Follow-up|15|||
106157479|NCT04737772|366239967|FG001|Phase 2 Study|Lost to Follow-up|15|||
106157480|NCT04737772|366239966|FG000|Phase 2 Study|Withdrawal by Subject|0|||
106157481|NCT04737772|366239967|FG001|Phase 2 Study|Withdrawal by Subject|1|||
106157482|NCT04737772|366239966|FG000|Phase 2 Study|Did not take any coaching calls|4|||
106157483|NCT04737772|366239967|FG001|Phase 2 Study|Did not take any coaching calls|0|||
106157484|NCT04737772|366239966|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
106157485|NCT04737772|366239967|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
106157486|NCT04737772|366239966|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
106157487|NCT04737772|366239967|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
106157488|NCT04083235|366239970|FG000|Overall Study|Death|252|||
106157489|NCT04083235|366239971|FG001|Overall Study|Death|277|||
106157490|NCT04083235|366239970|FG000|Overall Study|Withdrawal by Subject|13|||
106157491|NCT04083235|366239971|FG001|Overall Study|Withdrawal by Subject|17|||
106157492|NCT04083235|366239970|FG000|Overall Study|Lost to Follow-up|1|||
106157493|NCT04083235|366239971|FG001|Overall Study|Lost to Follow-up|1|||
106157494|NCT04083235|366239970|FG000|Overall Study|Does not meet entry criteria|1|||
106073856|NCT03886220|365934183|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
106073857|NCT03886220|365934182|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
106157495|NCT04083235|366239971|FG001|Overall Study|Does not meet entry criteria|0|||
106157496|NCT04083235|366239970|FG000|Overall Study|Did not receive treatment|13|||
106157497|NCT04083235|366239971|FG001|Overall Study|Did not receive treatment|8|||
106157498|NCT04083235|366239970|FG000|Overall Study|Ongoing at the time of DCO|44|||
106157499|NCT04083235|366239971|FG001|Overall Study|Ongoing at the time of DCO|7|||
106157500|NCT00667251|366239972|FG000|Overall Study|Disease progression|232|||
106157501|NCT00667251|366239973|FG001|Overall Study|Disease progression|203|||
106157502|NCT00667251|366239972|FG000|Overall Study|Toxicity|44|||
106157503|NCT00667251|366239973|FG001|Overall Study|Toxicity|23|||
106157504|NCT00667251|366239972|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
106157505|NCT00667251|366239973|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
106157506|NCT00667251|366239972|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
106157507|NCT00667251|366239973|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
106157508|NCT00667251|366239972|FG000|Overall Study|Symptomatic progression|8|||
106157509|NCT00667251|366239973|FG001|Overall Study|Symptomatic progression|4|||
106157510|NCT00667251|366239972|FG000|Overall Study|Death|6|||
106157511|NCT00667251|366239973|FG001|Overall Study|Death|11|||
106157512|NCT00667251|366239972|FG000|Overall Study|Intercurrent illness|5|||
106157513|NCT00667251|366239973|FG001|Overall Study|Intercurrent illness|6|||
106157514|NCT00667251|366239972|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
106157515|NCT00667251|366239973|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
106157516|NCT00667251|366239972|FG000|Overall Study|Randomized not Treated|4|||
106157517|NCT00667251|366239973|FG001|Overall Study|Randomized not Treated|1|||
106157518|NCT02727699|366239974|FG000|Overall Study|Adverse Event|2|||
106157519|NCT02727699|366239975|FG001|Overall Study|Adverse Event|0|||
106157520|NCT02727699|366239974|FG000|Overall Study|Withdrawal by Subject|5|||
106157521|NCT02727699|366239975|FG001|Overall Study|Withdrawal by Subject|3|||
106157522|NCT02727699|366239974|FG000|Overall Study|Protocol Violation|0|||
106157523|NCT02727699|366239975|FG001|Overall Study|Protocol Violation|1|||
106157524|NCT02727699|366239974|FG000|Overall Study|Physician Decision|0|||
106157525|NCT02727699|366239975|FG001|Overall Study|Physician Decision|1|||
106157526|NCT02727699|366239974|FG000|Overall Study|Lost to Follow-up|1|||
106157527|NCT02727699|366239975|FG001|Overall Study|Lost to Follow-up|0|||
106157528|NCT02727699|366239974|FG000|Overall Study|Sponsor Decision|1|||
106157529|NCT02727699|366239975|FG001|Overall Study|Sponsor Decision|0|||
106157530|NCT05458011|366239982|FG000|DB Period (12 Weeks)|Adverse Event|2|||
106157531|NCT05458011|366239983|FG001|DB Period (12 Weeks)|Adverse Event|1|||
106157532|NCT05458011|366239984|FG002|DB Period (12 Weeks)|Adverse Event|1|||
106157533|NCT05458011|366239982|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
106157534|NCT05458011|366239983|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
106157535|NCT05458011|366239984|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
106157536|NCT05458011|366239982|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
106157537|NCT05458011|366239983|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
106157538|NCT05458011|366239984|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
106157539|NCT05458011|366239982|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
106157540|NCT05458011|366239983|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
106157541|NCT05458011|366239984|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
106157542|NCT05458011|366239982|FG000|OL Period (12 Weeks)|Adverse Event|1|||
106157543|NCT05458011|366239983|FG001|OL Period (12 Weeks)|Adverse Event|2|||
106157544|NCT05458011|366239984|FG002|OL Period (12 Weeks)|Adverse Event|1|||
106157545|NCT05458011|366239982|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
106157546|NCT05458011|366239983|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
106157547|NCT05458011|366239984|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
106157548|NCT02671903|366239985|FG000|Period 0 (Run-In)|Death|0|||
106157549|NCT02671903|366239986|FG001|Period 0 (Run-In)|Death|0|||
106157550|NCT02671903|366239987|FG002|Period 0 (Run-In)|Death|3|||
106157551|NCT02671903|366239985|FG000|Period 0 (Run-In)|Physician Decision|0|||
106157552|NCT02671903|366239986|FG001|Period 0 (Run-In)|Physician Decision|0|||
106157553|NCT02671903|366239987|FG002|Period 0 (Run-In)|Physician Decision|4|||
106157554|NCT02671903|366239985|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
106157555|NCT02671903|366239986|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
106157556|NCT02671903|366239987|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
106157557|NCT02671903|366239985|FG000|Period 0 (Run-In)|Protocol Violation|0|||
106157558|NCT02671903|366239986|FG001|Period 0 (Run-In)|Protocol Violation|0|||
106157559|NCT02671903|366239987|FG002|Period 0 (Run-In)|Protocol Violation|1|||
106157560|NCT02671903|366239985|FG000|Period 0 (Run-In)|Adverse Event|0|||
106157561|NCT02671903|366239986|FG001|Period 0 (Run-In)|Adverse Event|0|||
106157562|NCT02671903|366239987|FG002|Period 0 (Run-In)|Adverse Event|1|||
106157563|NCT02671903|366239985|FG000|Period 0 (Run-In)|Implantation Failure|0|||
105866614|NCT02125877|365161102|FG000|Overall Study|Death|0|||
106157564|NCT02671903|366239986|FG001|Period 0 (Run-In)|Implantation Failure|0|||
106157565|NCT02671903|366239987|FG002|Period 0 (Run-In)|Implantation Failure|2|||
106157566|NCT02671903|366239985|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
106157567|NCT02671903|366239986|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
106157568|NCT02671903|366239987|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
106157569|NCT02992925|366239988|FG000|Cohort 2|Physician Decision|0|||
106157570|NCT02992925|366239989|FG001|Cohort 2|Physician Decision|0|||
106157571|NCT02992925|366239990|FG002|Cohort 2|Physician Decision|1|||
106157572|NCT02992925|366239991|FG003|Cohort 2|Physician Decision|0|||
106157573|NCT02992925|366239988|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
106157574|NCT02992925|366239989|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
106157575|NCT02992925|366239990|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
106157576|NCT02992925|366239991|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
105866615|NCT02125877|365161103|FG001|Overall Study|Death|1|||
106073858|NCT03886220|365934183|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
106073859|NCT01319877|365934187|FG000|Overall Study|Lost to Follow-up|100|||
106073860|NCT01319877|365934188|FG001|Overall Study|Lost to Follow-up|37|||
106073861|NCT01319877|365934187|FG000|Overall Study|Physician Decision|2|||
106073862|NCT01319877|365934188|FG001|Overall Study|Physician Decision|0|||
106073863|NCT01319877|365934187|FG000|Overall Study|Disease Progression|2|||
106073864|NCT01319877|365934188|FG001|Overall Study|Disease Progression|2|||
106073865|NCT01319877|365934187|FG000|Overall Study|Withdrawal by Subject|0|||
106073866|NCT01319877|365934188|FG001|Overall Study|Withdrawal by Subject|1|||
106073867|NCT01319877|365934187|FG000|Overall Study|Reason Not Specified|4|||
106073868|NCT01319877|365934188|FG001|Overall Study|Reason Not Specified|5|||
106073869|NCT02347189|365934189|FG000|Overall Study|No implant attempted of study device|9|||
106073870|NCT02347189|365934189|FG000|Overall Study|No primary outcome data available|2|||
106073871|NCT00735878|365934191|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
106073872|NCT00735878|365934192|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
106073873|NCT00735878|365934193|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
106157577|NCT01804816|366239992|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
106157578|NCT01804816|366239992|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
106157579|NCT04421378|366239996|FG000|Overall Study|Adverse Event|2|||
106157580|NCT04421378|366239997|FG001|Overall Study|Adverse Event|7|||
106157581|NCT04421378|366239998|FG002|Overall Study|Adverse Event|0|||
106157582|NCT04421378|366239999|FG003|Overall Study|Adverse Event|1|||
106157583|NCT04421378|366240000|FG004|Overall Study|Adverse Event|0|||
106157584|NCT04421378|366239996|FG000|Overall Study|Physician Decision|1|||
106157585|NCT04421378|366239997|FG001|Overall Study|Physician Decision|2|||
106157586|NCT04421378|366239998|FG002|Overall Study|Physician Decision|0|||
106157587|NCT04421378|366239999|FG003|Overall Study|Physician Decision|0|||
106157588|NCT04421378|366240000|FG004|Overall Study|Physician Decision|0|||
106157589|NCT04421378|366239996|FG000|Overall Study|Progressive Disease|16|||
106157590|NCT04421378|366239997|FG001|Overall Study|Progressive Disease|4|||
106157591|NCT04421378|366239998|FG002|Overall Study|Progressive Disease|18|||
106157592|NCT04421378|366239999|FG003|Overall Study|Progressive Disease|11|||
106157593|NCT04421378|366240000|FG004|Overall Study|Progressive Disease|3|||
106157594|NCT04421378|366239996|FG000|Overall Study|Study Terminated by Sponsor|0|||
106157595|NCT04421378|366239997|FG001|Overall Study|Study Terminated by Sponsor|1|||
106157596|NCT04421378|366239998|FG002|Overall Study|Study Terminated by Sponsor|1|||
106157597|NCT04421378|366239999|FG003|Overall Study|Study Terminated by Sponsor|0|||
106157598|NCT04421378|366240000|FG004|Overall Study|Study Terminated by Sponsor|0|||
106157599|NCT04421378|366239996|FG000|Overall Study|Withdrawal by Subject|3|||
106157600|NCT04421378|366239997|FG001|Overall Study|Withdrawal by Subject|1|||
106157601|NCT04421378|366239998|FG002|Overall Study|Withdrawal by Subject|0|||
106157602|NCT04421378|366239999|FG003|Overall Study|Withdrawal by Subject|2|||
106157603|NCT04421378|366240000|FG004|Overall Study|Withdrawal by Subject|0|||
106157604|NCT04421378|366239996|FG000|Overall Study|Other|1|||
106157605|NCT04421378|366239997|FG001|Overall Study|Other|0|||
106157606|NCT04421378|366239998|FG002|Overall Study|Other|0|||
106157607|NCT04421378|366239999|FG003|Overall Study|Other|0|||
106157608|NCT04421378|366240000|FG004|Overall Study|Other|0|||
106157609|NCT04150718|366240001|FG000|Overall Study|Withdrawal by Subject|2|||
106157610|NCT04150718|366240002|FG001|Overall Study|Withdrawal by Subject|7|||
106157611|NCT04150718|366240003|FG002|Overall Study|Withdrawal by Subject|1|||
106157612|NCT04150718|366240001|FG000|Overall Study|Lost to Follow-up|1|||
106157613|NCT04150718|366240002|FG001|Overall Study|Lost to Follow-up|2|||
106157614|NCT04150718|366240003|FG002|Overall Study|Lost to Follow-up|0|||
106157615|NCT04150718|366240001|FG000|Overall Study|Ineligible|1|||
106157616|NCT04150718|366240002|FG001|Overall Study|Ineligible|0|||
106157617|NCT04150718|366240003|FG002|Overall Study|Ineligible|10|||
106157618|NCT03958955|366240004|FG000|Overall Study|Adverse Event|1|||
106157619|NCT02927769|366240006|FG000|Induction Phase|Study drug toxicity|1|||
106157620|NCT02927769|366240007|FG001|Induction Phase|Study drug toxicity|1|||
106157621|NCT02927769|366240006|FG000|Induction Phase|Disease progression|0|||
106157622|NCT02927769|366240007|FG001|Induction Phase|Disease progression|1|||
106157623|NCT02927769|366240006|FG000|Intensification Phase|Study drug toxicity|1|||
106157624|NCT02927769|366240007|FG001|Intensification Phase|Study drug toxicity|0|||
106157625|NCT02807636|366240008|FG000|Overall Study|Lost to Follow-up|10|||
106157626|NCT02807636|366240009|FG001|Overall Study|Lost to Follow-up|13|||
106157627|NCT02807636|366240010|FG002|Overall Study|Lost to Follow-up|6|||
106157628|NCT02807636|366240008|FG000|Overall Study|Protocol Deviation|1|||
106157629|NCT02807636|366240009|FG001|Overall Study|Protocol Deviation|0|||
106073874|NCT03320564|365934194|FG000|Overall Study|Protocol Violation|1|||
106073875|NCT00788827|365934195|FG000|Overall Study|Lack of Efficacy|2|||
106157630|NCT02807636|366240010|FG002|Overall Study|Protocol Deviation|0|||
106157631|NCT02807636|366240008|FG000|Overall Study|Symptomatic Deterioration|0|||
106157632|NCT02807636|366240009|FG001|Overall Study|Symptomatic Deterioration|1|||
106157633|NCT02807636|366240010|FG002|Overall Study|Symptomatic Deterioration|0|||
106157634|NCT02807636|366240008|FG000|Overall Study|Withdrawal by Subject|39|||
106157635|NCT02807636|366240009|FG001|Overall Study|Withdrawal by Subject|28|||
106157636|NCT02807636|366240010|FG002|Overall Study|Withdrawal by Subject|24|||
106157637|NCT02807636|366240008|FG000|Overall Study|Death|303|||
106157638|NCT02807636|366240009|FG001|Overall Study|Death|332|||
106157639|NCT02807636|366240010|FG002|Overall Study|Death|272|||
106157640|NCT02807636|366240008|FG000|Overall Study|Study Terminated By Sponsor|47|||
106157641|NCT02807636|366240009|FG001|Overall Study|Study Terminated By Sponsor|76|||
106157642|NCT02807636|366240010|FG002|Overall Study|Study Terminated By Sponsor|60|||
106073876|NCT03745144|365934199|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
106073877|NCT03745144|365934200|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
106073878|NCT03745144|365934201|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
106073879|NCT03745144|365934199|FG000|Period 1|Other|0|||
106073880|NCT03745144|365934200|FG001|Period 1|Other|0|||
106073881|NCT03745144|365934201|FG002|Period 1|Other|1|||
106073882|NCT03642717|365934202|FG000|Overall Study|Lost to Follow-up|2|||
106073883|NCT03642717|365934202|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
106073884|NCT03642717|365934202|FG000|Overall Study|Taken study drug prior to contract date|3|||
106073885|NCT00642668|365934207|FG000|Overall Study|Lost to Follow-up|1|||
106073886|NCT00642668|365934207|FG000|Overall Study|Adverse Event|2|||
106073887|NCT00642668|365934207|FG000|Overall Study|Death|2|||
106073888|NCT00642668|365934207|FG000|Overall Study|Insufficient Therapeutic Response|1|||
106073889|NCT00642668|365934207|FG000|Overall Study|Failure to Return|1|||
106073890|NCT00642668|365934207|FG000|Overall Study|Dialysis Initiation|5|||
106073891|NCT00642668|365934207|FG000|Overall Study|Blood Transfusion|2|||
106073892|NCT01177540|365934208|FG000|Overall Study|Adverse Event|1|||
106073893|NCT01177540|365934209|FG001|Overall Study|Adverse Event|0|||
106073894|NCT00302458|365934210|FG000|Overall Study|Lost to Follow-up|1|||
106073895|NCT00302458|365934210|FG000|Overall Study|Ineligible after screening|1|||
106073896|NCT00302458|365934210|FG000|Overall Study|Withdrawal by Subject|1|||
106073897|NCT04248933|365934212|FG000|Overall Study|Lost to Follow-up|9|||
106073898|NCT04248933|365934212|FG000|Overall Study|Withdrawal by Subject|2|||
106073899|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
106073900|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
106073901|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
106073902|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
106073903|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
106073904|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
106073905|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
106073906|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
106073907|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
106073908|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
106073909|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
106073910|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
106073911|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
106073912|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
106073913|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
106073914|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
106073915|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
106073916|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
106073917|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
106073918|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
106073919|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
106073920|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
106073921|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
106073922|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
106073923|NCT00277212|365936590|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
106073924|NCT00277212|365936591|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
106073925|NCT00277212|365936592|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
106073926|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
106073927|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
106073928|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
106073929|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
106073930|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
106073931|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
106073932|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
106073933|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
106073934|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
106073935|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
106073936|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
106073937|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
106073938|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
106073939|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
106073940|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
106073941|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
106073942|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
106073943|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
106157643|NCT02807636|366240008|FG000|Overall Study|Physician Decision|0|||
106157644|NCT02807636|366240009|FG001|Overall Study|Physician Decision|1|||
106157645|NCT02807636|366240010|FG002|Overall Study|Physician Decision|0|||
106157646|NCT03175029|366240011|FG000|Overall Study|Withdrawal by Subject|2|||
106157647|NCT03175029|366240012|FG001|Overall Study|Withdrawal by Subject|1|||
106157648|NCT03175029|366240011|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
106157649|NCT03175029|366240012|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
106157650|NCT02287610|366240013|FG000|Overall Study|Lost to Follow-up|3|||
106157651|NCT02287610|366240013|FG000|Overall Study|Withdrawal by Subject|8|||
106157652|NCT02287610|366240013|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
106157653|NCT06074523|366240033|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
106157654|NCT06074523|366240033|FG000|Overall Study|Withdrawal by Subject|1|||
106157655|NCT01426425|366240034|FG000|Overall Study|Exited prior to EP study|22|||
106157656|NCT01426425|366240034|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
106157657|NCT01426425|366240034|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
106157658|NCT03932682|366240037|FG000|Overall Study|Death|1|||
106157659|NCT03932682|366240038|FG001|Overall Study|Death|2|||
106157660|NCT03932682|366240037|FG000|Overall Study|Withdrawal by Subject|37|||
106157661|NCT03932682|366240038|FG001|Overall Study|Withdrawal by Subject|45|||
106157662|NCT03932682|366240037|FG000|Overall Study|Lost to Follow-up|19|||
106157663|NCT03932682|366240038|FG001|Overall Study|Lost to Follow-up|25|||
106157664|NCT03932682|366240037|FG000|Overall Study|Protocol Violation|0|||
106157665|NCT03932682|366240038|FG001|Overall Study|Protocol Violation|2|||
106157666|NCT03932682|366240037|FG000|Overall Study|Other|9|||
106157667|NCT03932682|366240038|FG001|Overall Study|Other|23|||
106157668|NCT05536440|366240041|FG000|Overall Study|Adverse Event|0|||
106157669|NCT05536440|366240042|FG001|Overall Study|Adverse Event|0|||
106157670|NCT05536440|366240043|FG002|Overall Study|Adverse Event|0|||
106157671|NCT05536440|366240044|FG003|Overall Study|Adverse Event|0|||
106157672|NCT05536440|366240045|FG004|Overall Study|Adverse Event|0|||
106157673|NCT05536440|366240046|FG005|Overall Study|Adverse Event|0|||
106157674|NCT05536440|366240047|FG006|Overall Study|Adverse Event|0|||
106157675|NCT05536440|366240048|FG007|Overall Study|Adverse Event|0|||
106157676|NCT05536440|366240049|FG008|Overall Study|Adverse Event|1|||
106157677|NCT05470400|366240050|FG000|Overall Study|Lost to Follow-up|0|||
106157678|NCT05470400|366240051|FG001|Overall Study|Lost to Follow-up|0|||
106157679|NCT05470400|366240052|FG002|Overall Study|Lost to Follow-up|0|||
106157680|NCT05470400|366240053|FG003|Overall Study|Lost to Follow-up|0|||
106157681|NCT05470400|366240054|FG004|Overall Study|Lost to Follow-up|0|||
106157682|NCT05470400|366240055|FG005|Overall Study|Lost to Follow-up|0|||
106157683|NCT05470400|366240056|FG006|Overall Study|Lost to Follow-up|0|||
106157684|NCT05470400|366240057|FG007|Overall Study|Lost to Follow-up|1|||
106157685|NCT05470400|366240050|FG000|Overall Study|Withdrawal by Subject|1|||
106157686|NCT05470400|366240051|FG001|Overall Study|Withdrawal by Subject|0|||
106157687|NCT05470400|366240052|FG002|Overall Study|Withdrawal by Subject|0|||
106157688|NCT05470400|366240053|FG003|Overall Study|Withdrawal by Subject|0|||
106157689|NCT05470400|366240054|FG004|Overall Study|Withdrawal by Subject|0|||
106157690|NCT05470400|366240055|FG005|Overall Study|Withdrawal by Subject|1|||
106157691|NCT05470400|366240056|FG006|Overall Study|Withdrawal by Subject|0|||
106157692|NCT05470400|366240057|FG007|Overall Study|Withdrawal by Subject|2|||
106157693|NCT05956002|366240059|FG000|Treatment Period 3|Adverse Event|0|||
106157694|NCT05956002|366240060|FG001|Treatment Period 3|Adverse Event|0|||
106157695|NCT05956002|366240061|FG002|Treatment Period 3|Adverse Event|1|||
106157696|NCT05956002|366240062|FG003|Treatment Period 3|Adverse Event|0|||
106157697|NCT05687916|366240065|FG000|Overall Study|Adverse Event|1|||
106157698|NCT05687916|366240066|FG001|Overall Study|Adverse Event|2|||
106157699|NCT05687916|366240067|FG002|Overall Study|Adverse Event|0|||
106157700|NCT05687916|366240065|FG000|Overall Study|Withdrawal by Subject|1|||
106157701|NCT05687916|366240066|FG001|Overall Study|Withdrawal by Subject|0|||
106157702|NCT05687916|366240067|FG002|Overall Study|Withdrawal by Subject|1|||
105866616|NCT02125877|365161102|FG000|Overall Study|Administrative problems|0|||
106157703|NCT05687916|366240065|FG000|Overall Study|Protocol Violation|0|||
106157704|NCT05687916|366240066|FG001|Overall Study|Protocol Violation|2|||
106157705|NCT05687916|366240067|FG002|Overall Study|Protocol Violation|1|||
106157706|NCT05687916|366240065|FG000|Overall Study|Reason not Specified|1|||
106157707|NCT05687916|366240066|FG001|Overall Study|Reason not Specified|0|||
106157708|NCT05687916|366240067|FG002|Overall Study|Reason not Specified|0|||
106157709|NCT04294225|366240068|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
106157710|NCT04294225|366240068|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
106157711|NCT04294225|366240068|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
106157712|NCT04294225|366240068|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
106157713|NCT04294225|366240068|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
106157714|NCT03738228|366240069|FG000|Overall Study|Never received study treatment|2|||
105866617|NCT02125877|365161103|FG001|Overall Study|Administrative problems|1|||
105866618|NCT02125877|365161102|FG000|Overall Study|Participant/guardian decision|0|||
105866619|NCT02125877|365161103|FG001|Overall Study|Participant/guardian decision|2|||
106157715|NCT03738228|366240070|FG001|Overall Study|Never received study treatment|2|||
106157716|NCT04927065|366240078|FG000|First Booster|Adverse Event|1|||
106157717|NCT04927065|366240079|FG001|First Booster|Adverse Event|0|||
106157718|NCT04927065|366240080|FG002|First Booster|Adverse Event|0|||
106157719|NCT04927065|366240081|FG003|First Booster|Adverse Event|0|||
106157720|NCT04927065|366240082|FG004|First Booster|Adverse Event|0|||
106157721|NCT04927065|366240083|FG005|First Booster|Adverse Event|0|||
106157722|NCT04927065|366240084|FG006|First Booster|Adverse Event|0|||
106157723|NCT04927065|366240085|FG007|First Booster|Adverse Event|1|||
106157724|NCT04927065|366240086|FG008|First Booster|Adverse Event|0|||
106157725|NCT04927065|366240087|FG009|First Booster|Adverse Event|0|||
106157726|NCT04927065|366240088|FG010|First Booster|Adverse Event|0|||
106157727|NCT04927065|366240089|FG011|First Booster|Adverse Event|0|||
106157728|NCT04927065|366240090|FG012|First Booster|Adverse Event|0|||
106157729|NCT04927065|366240091|FG013|First Booster|Adverse Event|0|||
106157730|NCT04927065|366240092|FG014|First Booster|Adverse Event|0|||
106157731|NCT04927065|366240093|FG015|First Booster|Adverse Event|0|||
106157732|NCT04927065|366240078|FG000|First Booster|Death|1|||
106157733|NCT04927065|366240079|FG001|First Booster|Death|0|||
106157734|NCT04927065|366240080|FG002|First Booster|Death|0|||
106157735|NCT04927065|366240081|FG003|First Booster|Death|1|||
106157736|NCT04927065|366240082|FG004|First Booster|Death|0|||
106157737|NCT04927065|366240083|FG005|First Booster|Death|1|||
106157738|NCT04927065|366240084|FG006|First Booster|Death|0|||
106157739|NCT04927065|366240085|FG007|First Booster|Death|0|||
106157740|NCT04927065|366240086|FG008|First Booster|Death|0|||
106157741|NCT04927065|366240087|FG009|First Booster|Death|0|||
106157742|NCT04927065|366240088|FG010|First Booster|Death|0|||
106157743|NCT04927065|366240089|FG011|First Booster|Death|0|||
106157744|NCT04927065|366240090|FG012|First Booster|Death|0|||
106157745|NCT04927065|366240091|FG013|First Booster|Death|0|||
106157746|NCT04927065|366240092|FG014|First Booster|Death|0|||
106157747|NCT04927065|366240093|FG015|First Booster|Death|0|||
106157748|NCT04927065|366240078|FG000|First Booster|Lost to Follow-up|8|||
106157749|NCT04927065|366240079|FG001|First Booster|Lost to Follow-up|20|||
106157750|NCT04927065|366240080|FG002|First Booster|Lost to Follow-up|0|||
106157751|NCT04927065|366240081|FG003|First Booster|Lost to Follow-up|11|||
106157752|NCT04927065|366240082|FG004|First Booster|Lost to Follow-up|43|||
106157753|NCT04927065|366240083|FG005|First Booster|Lost to Follow-up|30|||
106157754|NCT04927065|366240084|FG006|First Booster|Lost to Follow-up|28|||
106157755|NCT04927065|366240085|FG007|First Booster|Lost to Follow-up|23|||
106157756|NCT04927065|366240086|FG008|First Booster|Lost to Follow-up|4|||
106157757|NCT04927065|366240087|FG009|First Booster|Lost to Follow-up|15|||
106157758|NCT04927065|366240088|FG010|First Booster|Lost to Follow-up|0|||
106157759|NCT04927065|366240089|FG011|First Booster|Lost to Follow-up|0|||
106157760|NCT04927065|366240090|FG012|First Booster|Lost to Follow-up|0|||
106157761|NCT04927065|366240091|FG013|First Booster|Lost to Follow-up|0|||
106157762|NCT04927065|366240092|FG014|First Booster|Lost to Follow-up|0|||
106157763|NCT04927065|366240093|FG015|First Booster|Lost to Follow-up|0|||
106157764|NCT04927065|366240078|FG000|First Booster|Physician Decision|1|||
106157765|NCT04927065|366240079|FG001|First Booster|Physician Decision|0|||
106157766|NCT04927065|366240080|FG002|First Booster|Physician Decision|0|||
106157767|NCT04927065|366240081|FG003|First Booster|Physician Decision|3|||
106157768|NCT04927065|366240082|FG004|First Booster|Physician Decision|1|||
106157769|NCT04927065|366240083|FG005|First Booster|Physician Decision|1|||
106157770|NCT04927065|366240084|FG006|First Booster|Physician Decision|0|||
106157771|NCT04927065|366240085|FG007|First Booster|Physician Decision|3|||
106157772|NCT04927065|366240086|FG008|First Booster|Physician Decision|0|||
106157773|NCT04927065|366240087|FG009|First Booster|Physician Decision|0|||
106157774|NCT04927065|366240088|FG010|First Booster|Physician Decision|0|||
106157775|NCT04927065|366240089|FG011|First Booster|Physician Decision|0|||
106157776|NCT04927065|366240090|FG012|First Booster|Physician Decision|0|||
106157777|NCT04927065|366240091|FG013|First Booster|Physician Decision|0|||
106157778|NCT04927065|366240092|FG014|First Booster|Physician Decision|0|||
106157779|NCT04927065|366240093|FG015|First Booster|Physician Decision|0|||
106157780|NCT04927065|366240078|FG000|First Booster|Protocol Violation|4|||
106157781|NCT04927065|366240079|FG001|First Booster|Protocol Violation|4|||
106157782|NCT04927065|366240080|FG002|First Booster|Protocol Violation|0|||
106157783|NCT04927065|366240081|FG003|First Booster|Protocol Violation|3|||
106157784|NCT04927065|366240082|FG004|First Booster|Protocol Violation|0|||
106157785|NCT04927065|366240083|FG005|First Booster|Protocol Violation|0|||
106157786|NCT04927065|366240084|FG006|First Booster|Protocol Violation|0|||
106157787|NCT04927065|366240085|FG007|First Booster|Protocol Violation|2|||
106157788|NCT04927065|366240086|FG008|First Booster|Protocol Violation|0|||
106157789|NCT04927065|366240087|FG009|First Booster|Protocol Violation|0|||
106157790|NCT04927065|366240088|FG010|First Booster|Protocol Violation|0|||
106157791|NCT04927065|366240089|FG011|First Booster|Protocol Violation|0|||
106157792|NCT04927065|366240090|FG012|First Booster|Protocol Violation|0|||
106157793|NCT04927065|366240091|FG013|First Booster|Protocol Violation|0|||
106157794|NCT04927065|366240092|FG014|First Booster|Protocol Violation|0|||
106157795|NCT04927065|366240093|FG015|First Booster|Protocol Violation|0|||
106157796|NCT04927065|366240078|FG000|First Booster|Withdrawal by Subject|8|||
106157797|NCT04927065|366240079|FG001|First Booster|Withdrawal by Subject|23|||
106157798|NCT04927065|366240080|FG002|First Booster|Withdrawal by Subject|0|||
106157799|NCT04927065|366240081|FG003|First Booster|Withdrawal by Subject|19|||
106157800|NCT04927065|366240082|FG004|First Booster|Withdrawal by Subject|20|||
106157801|NCT04927065|366240083|FG005|First Booster|Withdrawal by Subject|15|||
106157802|NCT04927065|366240084|FG006|First Booster|Withdrawal by Subject|6|||
106157803|NCT04927065|366240085|FG007|First Booster|Withdrawal by Subject|24|||
106157804|NCT04927065|366240086|FG008|First Booster|Withdrawal by Subject|0|||
106157805|NCT04927065|366240087|FG009|First Booster|Withdrawal by Subject|4|||
106157806|NCT04927065|366240088|FG010|First Booster|Withdrawal by Subject|0|||
106157807|NCT04927065|366240089|FG011|First Booster|Withdrawal by Subject|0|||
106157808|NCT04927065|366240090|FG012|First Booster|Withdrawal by Subject|0|||
106157809|NCT04927065|366240091|FG013|First Booster|Withdrawal by Subject|0|||
106157810|NCT04927065|366240092|FG014|First Booster|Withdrawal by Subject|0|||
106157811|NCT04927065|366240093|FG015|First Booster|Withdrawal by Subject|0|||
106157812|NCT04927065|366240078|FG000|First Booster|Other Than Specified|1|||
106157813|NCT04927065|366240079|FG001|First Booster|Other Than Specified|1|||
106157814|NCT04927065|366240080|FG002|First Booster|Other Than Specified|0|||
106157815|NCT04927065|366240081|FG003|First Booster|Other Than Specified|1|||
106157816|NCT04927065|366240082|FG004|First Booster|Other Than Specified|2|||
106157817|NCT04927065|366240083|FG005|First Booster|Other Than Specified|3|||
106157818|NCT04927065|366240084|FG006|First Booster|Other Than Specified|2|||
106157819|NCT04927065|366240085|FG007|First Booster|Other Than Specified|6|||
106157820|NCT04927065|366240086|FG008|First Booster|Other Than Specified|0|||
106157821|NCT04927065|366240087|FG009|First Booster|Other Than Specified|4|||
106157822|NCT04927065|366240088|FG010|First Booster|Other Than Specified|0|||
106157823|NCT04927065|366240089|FG011|First Booster|Other Than Specified|0|||
106157824|NCT04927065|366240090|FG012|First Booster|Other Than Specified|0|||
106157825|NCT04927065|366240091|FG013|First Booster|Other Than Specified|0|||
106157826|NCT04927065|366240092|FG014|First Booster|Other Than Specified|0|||
106157827|NCT04927065|366240093|FG015|First Booster|Other Than Specified|0|||
106157828|NCT04927065|366240078|FG000|Second Booster|Death|0|||
106157829|NCT04927065|366240079|FG001|Second Booster|Death|0|||
106157830|NCT04927065|366240080|FG002|Second Booster|Death|0|||
106157831|NCT04927065|366240081|FG003|Second Booster|Death|0|||
106157832|NCT04927065|366240082|FG004|Second Booster|Death|0|||
106157833|NCT04927065|366240083|FG005|Second Booster|Death|0|||
106157834|NCT04927065|366240084|FG006|Second Booster|Death|0|||
106157835|NCT04927065|366240085|FG007|Second Booster|Death|0|||
106157836|NCT04927065|366240086|FG008|Second Booster|Death|0|||
106157837|NCT04927065|366240087|FG009|Second Booster|Death|0|||
106157838|NCT04927065|366240088|FG010|Second Booster|Death|2|||
106157839|NCT04927065|366240089|FG011|Second Booster|Death|0|||
106157840|NCT04927065|366240090|FG012|Second Booster|Death|2|||
106157841|NCT04927065|366240091|FG013|Second Booster|Death|2|||
106157842|NCT04927065|366240092|FG014|Second Booster|Death|0|||
106157843|NCT04927065|366240093|FG015|Second Booster|Death|0|||
106157844|NCT04927065|366240078|FG000|Second Booster|Lost to Follow-up|0|||
106157845|NCT04927065|366240079|FG001|Second Booster|Lost to Follow-up|0|||
106157846|NCT04927065|366240080|FG002|Second Booster|Lost to Follow-up|3|||
106157847|NCT04927065|366240081|FG003|Second Booster|Lost to Follow-up|0|||
106157848|NCT04927065|366240082|FG004|Second Booster|Lost to Follow-up|0|||
106157849|NCT04927065|366240083|FG005|Second Booster|Lost to Follow-up|0|||
106157850|NCT04927065|366240084|FG006|Second Booster|Lost to Follow-up|0|||
106157851|NCT04927065|366240085|FG007|Second Booster|Lost to Follow-up|0|||
106157852|NCT04927065|366240086|FG008|Second Booster|Lost to Follow-up|0|||
106157853|NCT04927065|366240087|FG009|Second Booster|Lost to Follow-up|0|||
106157854|NCT04927065|366240088|FG010|Second Booster|Lost to Follow-up|14|||
106157855|NCT04927065|366240089|FG011|Second Booster|Lost to Follow-up|10|||
106157856|NCT04927065|366240090|FG012|Second Booster|Lost to Follow-up|13|||
106157857|NCT04927065|366240091|FG013|Second Booster|Lost to Follow-up|16|||
106157858|NCT04927065|366240092|FG014|Second Booster|Lost to Follow-up|0|||
106157859|NCT04927065|366240093|FG015|Second Booster|Lost to Follow-up|0|||
106157860|NCT04927065|366240078|FG000|Second Booster|Physician Decision|0|||
106157861|NCT04927065|366240079|FG001|Second Booster|Physician Decision|0|||
106157862|NCT04927065|366240080|FG002|Second Booster|Physician Decision|0|||
106157863|NCT04927065|366240081|FG003|Second Booster|Physician Decision|0|||
106157864|NCT04927065|366240082|FG004|Second Booster|Physician Decision|0|||
106157865|NCT04927065|366240083|FG005|Second Booster|Physician Decision|0|||
106157866|NCT04927065|366240084|FG006|Second Booster|Physician Decision|0|||
106157867|NCT04927065|366240085|FG007|Second Booster|Physician Decision|0|||
106157868|NCT04927065|366240086|FG008|Second Booster|Physician Decision|0|||
106157869|NCT04927065|366240087|FG009|Second Booster|Physician Decision|0|||
106157870|NCT04927065|366240088|FG010|Second Booster|Physician Decision|0|||
106157871|NCT04927065|366240089|FG011|Second Booster|Physician Decision|3|||
106073944|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
106073945|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
106073946|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
106073947|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
106073948|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
106073949|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
106073950|NCT00277212|365936590|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
106073951|NCT00277212|365936591|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
106073952|NCT00277212|365936592|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
106073953|NCT03336216|365936593|FG000|Randomization|Not reported|2|||
106073954|NCT03336216|365936594|FG001|Randomization|Not reported|0|||
106073955|NCT03336216|365936595|FG002|Randomization|Not reported|1|||
106073956|NCT03336216|365936596|FG003|Randomization|Not reported|0|||
106073957|NCT03336216|365936593|FG000|Randomization|Other reasons|1|||
106073958|NCT03336216|365936594|FG001|Randomization|Other reasons|1|||
106073959|NCT03336216|365936595|FG002|Randomization|Other reasons|1|||
106073960|NCT03336216|365936596|FG003|Randomization|Other reasons|0|||
106073961|NCT03336216|365936593|FG000|Randomization|Participant no longer meets study criteria|0|||
106073962|NCT03336216|365936594|FG001|Randomization|Participant no longer meets study criteria|2|||
106073963|NCT03336216|365936595|FG002|Randomization|Participant no longer meets study criteria|4|||
106073964|NCT03336216|365936596|FG003|Randomization|Participant no longer meets study criteria|1|||
106073965|NCT03336216|365936593|FG000|Randomization|Lost to Follow-up|1|||
106073966|NCT03336216|365936594|FG001|Randomization|Lost to Follow-up|0|||
106073967|NCT03336216|365936595|FG002|Randomization|Lost to Follow-up|0|||
106073968|NCT03336216|365936596|FG003|Randomization|Lost to Follow-up|0|||
106073969|NCT03336216|365936593|FG000|Randomization|Participant withdrew consent|9|||
106073970|NCT03336216|365936594|FG001|Randomization|Participant withdrew consent|1|||
106073971|NCT03336216|365936595|FG002|Randomization|Participant withdrew consent|0|||
106073972|NCT03336216|365936596|FG003|Randomization|Participant withdrew consent|0|||
106073973|NCT03336216|365936593|FG000|Randomization|Adverse Event|1|||
106073974|NCT03336216|365936594|FG001|Randomization|Adverse Event|1|||
106073975|NCT03336216|365936595|FG002|Randomization|Adverse Event|0|||
106073976|NCT03336216|365936596|FG003|Randomization|Adverse Event|0|||
106073977|NCT03336216|365936593|FG000|Treatment|Adverse Event|2|||
106073978|NCT03336216|365936594|FG001|Treatment|Adverse Event|3|||
106073979|NCT03336216|365936595|FG002|Treatment|Adverse Event|4|||
106073980|NCT03336216|365936596|FG003|Treatment|Adverse Event|4|||
106073981|NCT03336216|365936593|FG000|Treatment|Participant request to discontinue treatment|2|||
106073982|NCT03336216|365936594|FG001|Treatment|Participant request to discontinue treatment|1|||
106073983|NCT03336216|365936595|FG002|Treatment|Participant request to discontinue treatment|2|||
106073984|NCT03336216|365936596|FG003|Treatment|Participant request to discontinue treatment|2|||
106073985|NCT03336216|365936593|FG000|Treatment|Participant withdrew consent|7|||
106073986|NCT03336216|365936594|FG001|Treatment|Participant withdrew consent|2|||
106073987|NCT03336216|365936595|FG002|Treatment|Participant withdrew consent|3|||
106073988|NCT03336216|365936596|FG003|Treatment|Participant withdrew consent|2|||
106073989|NCT03336216|365936593|FG000|Treatment|Death|2|||
106073990|NCT03336216|365936594|FG001|Treatment|Death|3|||
106073991|NCT03336216|365936595|FG002|Treatment|Death|3|||
106073992|NCT03336216|365936596|FG003|Treatment|Death|4|||
106073993|NCT03336216|365936593|FG000|Treatment|Participant no longer meets study criteria|0|||
106073994|NCT03336216|365936594|FG001|Treatment|Participant no longer meets study criteria|1|||
106073995|NCT03336216|365936595|FG002|Treatment|Participant no longer meets study criteria|0|||
106073996|NCT03336216|365936596|FG003|Treatment|Participant no longer meets study criteria|0|||
106073997|NCT03336216|365936593|FG000|Treatment|Other reasons|2|||
106073998|NCT03336216|365936594|FG001|Treatment|Other reasons|0|||
106073999|NCT03336216|365936595|FG002|Treatment|Other reasons|0|||
106074000|NCT03336216|365936596|FG003|Treatment|Other reasons|3|||
106074001|NCT03336216|365936593|FG000|Treatment|Disease progression|23|||
106074002|NCT03336216|365936594|FG001|Treatment|Disease progression|34|||
106074003|NCT03336216|365936595|FG002|Treatment|Disease progression|33|||
106074004|NCT03336216|365936596|FG003|Treatment|Disease progression|26|||
106074005|NCT03336216|365936593|FG000|Treatment|Study drug toxicity|0|||
105866620|NCT02125877|365161102|FG000|Overall Study|Withdrawal by Subject|2|||
106074006|NCT03336216|365936594|FG001|Treatment|Study drug toxicity|3|||
106074007|NCT03336216|365936595|FG002|Treatment|Study drug toxicity|2|||
106074008|NCT03336216|365936596|FG003|Treatment|Study drug toxicity|0|||
106074009|NCT03336216|365936593|FG000|Treatment|Adverse Event unrelated to study drug|1|||
106074010|NCT03336216|365936594|FG001|Treatment|Adverse Event unrelated to study drug|1|||
106074011|NCT03336216|365936595|FG002|Treatment|Adverse Event unrelated to study drug|1|||
106074012|NCT03336216|365936596|FG003|Treatment|Adverse Event unrelated to study drug|0|||
106074013|NCT03336216|365936593|FG000|Treatment|Disease Recurrence|1|||
106074014|NCT03336216|365936594|FG001|Treatment|Disease Recurrence|0|||
106074015|NCT03336216|365936595|FG002|Treatment|Disease Recurrence|0|||
106074016|NCT03336216|365936596|FG003|Treatment|Disease Recurrence|0|||
106074017|NCT05620576|365936597|FG000|Overall Study|Adverse Event|1|||
105866621|NCT02125877|365161103|FG001|Overall Study|Withdrawal by Subject|1|||
105866622|NCT02125877|365161102|FG000|Overall Study|Protocol deviation|4|||
105866623|NCT02125877|365161103|FG001|Overall Study|Protocol deviation|1|||
105866624|NCT02125877|365161102|FG000|Overall Study|Adverse Event|6|||
105866625|NCT02125877|365161103|FG001|Overall Study|Adverse Event|4|||
106074018|NCT05620576|365936598|FG001|Overall Study|Adverse Event|1|||
106074019|NCT05620576|365936597|FG000|Overall Study|Lost to Follow-up|3|||
106074020|NCT05620576|365936598|FG001|Overall Study|Lost to Follow-up|1|||
106074021|NCT05620576|365936597|FG000|Overall Study|Physician Decision|0|||
106074022|NCT05620576|365936598|FG001|Overall Study|Physician Decision|1|||
106074023|NCT05620576|365936597|FG000|Overall Study|Protocol Deviation|1|||
106074024|NCT05620576|365936598|FG001|Overall Study|Protocol Deviation|1|||
106074025|NCT05620576|365936597|FG000|Overall Study|Withdrawal by Subject|2|||
106074026|NCT05620576|365936598|FG001|Overall Study|Withdrawal by Subject|3|||
106074027|NCT03897179|365936602|FG000|Overall Study|Withdrawal by Subject|1|||
106074028|NCT00704535|365936603|FG000|Overall Study|Adverse Event|2|||
106074029|NCT00704535|365936603|FG000|Overall Study|Death|2|||
106074030|NCT00704535|365936603|FG000|Overall Study|Lost to Follow-up|8|||
106074031|NCT00704535|365936603|FG000|Overall Study|Protocol Violation|10|||
106074032|NCT00704535|365936603|FG000|Overall Study|Completed status not on Case Report Form|124|||
106074033|NCT02120950|365936604|FG000|Overall Study|Adverse Event|5|||
106074034|NCT02120950|365936605|FG001|Overall Study|Adverse Event|4|||
106074035|NCT02120950|365936606|FG002|Overall Study|Adverse Event|3|||
106074036|NCT02120950|365936604|FG000|Overall Study|Death|3|||
106074037|NCT02120950|365936605|FG001|Overall Study|Death|0|||
106074038|NCT02120950|365936606|FG002|Overall Study|Death|1|||
106074039|NCT02120950|365936604|FG000|Overall Study|Withdrawal by Subject|6|||
106074040|NCT02120950|365936605|FG001|Overall Study|Withdrawal by Subject|3|||
106074041|NCT02120950|365936606|FG002|Overall Study|Withdrawal by Subject|2|||
106074042|NCT02120950|365936604|FG000|Overall Study|Protocol Violation|1|||
106074043|NCT02120950|365936605|FG001|Overall Study|Protocol Violation|1|||
106074044|NCT02120950|365936606|FG002|Overall Study|Protocol Violation|7|||
106074045|NCT02120950|365936604|FG000|Overall Study|Other reasons|5|||
106074046|NCT02120950|365936605|FG001|Overall Study|Other reasons|4|||
106074047|NCT02120950|365936606|FG002|Overall Study|Other reasons|1|||
106074048|NCT02120950|365936604|FG000|Overall Study|Lost to Follow-up|0|||
106074049|NCT02120950|365936605|FG001|Overall Study|Lost to Follow-up|2|||
106074050|NCT02120950|365936606|FG002|Overall Study|Lost to Follow-up|1|||
106074051|NCT02424383|365936607|FG000|Overall Study|Withdrawal by Subject|32|||
106074052|NCT02424383|365936607|FG000|Overall Study|Death|170|||
106074053|NCT02424383|365936607|FG000|Overall Study|Sponsor's decision|3|||
106074054|NCT02424383|365936607|FG000|Overall Study|Investigator's decision|44|||
106157872|NCT04927065|366240090|FG012|Second Booster|Physician Decision|0|||
106157873|NCT04927065|366240091|FG013|Second Booster|Physician Decision|1|||
106157874|NCT04927065|366240092|FG014|Second Booster|Physician Decision|0|||
106157875|NCT04927065|366240093|FG015|Second Booster|Physician Decision|0|||
106157876|NCT04927065|366240078|FG000|Second Booster|Withdrawal by Subject|0|||
106157877|NCT04927065|366240079|FG001|Second Booster|Withdrawal by Subject|0|||
106157878|NCT04927065|366240080|FG002|Second Booster|Withdrawal by Subject|4|||
106157879|NCT04927065|366240081|FG003|Second Booster|Withdrawal by Subject|0|||
106157880|NCT04927065|366240082|FG004|Second Booster|Withdrawal by Subject|0|||
106157881|NCT04927065|366240083|FG005|Second Booster|Withdrawal by Subject|0|||
106157882|NCT04927065|366240084|FG006|Second Booster|Withdrawal by Subject|0|||
106157883|NCT04927065|366240085|FG007|Second Booster|Withdrawal by Subject|0|||
106157884|NCT04927065|366240086|FG008|Second Booster|Withdrawal by Subject|0|||
106157885|NCT04927065|366240087|FG009|Second Booster|Withdrawal by Subject|0|||
106157886|NCT04927065|366240088|FG010|Second Booster|Withdrawal by Subject|3|||
106157887|NCT04927065|366240089|FG011|Second Booster|Withdrawal by Subject|16|||
106157888|NCT04927065|366240090|FG012|Second Booster|Withdrawal by Subject|13|||
106157889|NCT04927065|366240091|FG013|Second Booster|Withdrawal by Subject|9|||
106157890|NCT04927065|366240092|FG014|Second Booster|Withdrawal by Subject|0|||
106157891|NCT04927065|366240093|FG015|Second Booster|Withdrawal by Subject|0|||
106157892|NCT04927065|366240078|FG000|Second Booster|Other Than Specified|0|||
106157893|NCT04927065|366240079|FG001|Second Booster|Other Than Specified|0|||
106157894|NCT04927065|366240080|FG002|Second Booster|Other Than Specified|0|||
106157895|NCT04927065|366240081|FG003|Second Booster|Other Than Specified|0|||
106157896|NCT04927065|366240082|FG004|Second Booster|Other Than Specified|0|||
106157897|NCT04927065|366240083|FG005|Second Booster|Other Than Specified|0|||
106157898|NCT04927065|366240084|FG006|Second Booster|Other Than Specified|0|||
106157899|NCT04927065|366240085|FG007|Second Booster|Other Than Specified|0|||
106157900|NCT04927065|366240086|FG008|Second Booster|Other Than Specified|0|||
106157901|NCT04927065|366240087|FG009|Second Booster|Other Than Specified|0|||
106157902|NCT04927065|366240088|FG010|Second Booster|Other Than Specified|1|||
106157903|NCT04927065|366240089|FG011|Second Booster|Other Than Specified|1|||
106157904|NCT04927065|366240090|FG012|Second Booster|Other Than Specified|4|||
106157905|NCT04927065|366240091|FG013|Second Booster|Other Than Specified|0|||
106157906|NCT04927065|366240092|FG014|Second Booster|Other Than Specified|0|||
106157907|NCT04927065|366240093|FG015|Second Booster|Other Than Specified|0|||
105866626|NCT00710866|365161108|FG000|Overall Study|Protocol Violation|5|||
106074055|NCT02424383|365936607|FG000|Overall Study|Lost to Follow-up|81|||
106074056|NCT02424383|365936607|FG000|Overall Study|Other|7|||
106074057|NCT02424383|365936607|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
106074058|NCT01589445|365936611|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
106074059|NCT01589445|365936611|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
106074060|NCT01589445|365936611|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
106074061|NCT01589445|365936611|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
106074062|NCT01589445|365936611|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
106074063|NCT01589445|365936611|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
106074064|NCT01589445|365936611|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
106074065|NCT01589445|365936611|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
106074066|NCT01589445|365936611|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
106074067|NCT01589445|365936611|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
106074068|NCT00325754|365936612|FG000|Overall Study|Adverse Event|4|||
106074069|NCT00325754|365936613|FG001|Overall Study|Adverse Event|1|||
106074070|NCT02246673|365936617|FG000|Overall Study|Sponsor Decision|1|||
106074071|NCT02246673|365936618|FG001|Overall Study|Sponsor Decision|0|||
106074072|NCT02246673|365936619|FG002|Overall Study|Sponsor Decision|0|||
106074073|NCT02246673|365936620|FG003|Overall Study|Sponsor Decision|0|||
106074074|NCT02246673|365936621|FG004|Overall Study|Sponsor Decision|0|||
106074075|NCT02246673|365936617|FG000|Overall Study|Withdrawal by Subject|0|||
106074076|NCT02246673|365936618|FG001|Overall Study|Withdrawal by Subject|0|||
106074077|NCT02246673|365936619|FG002|Overall Study|Withdrawal by Subject|0|||
106074078|NCT02246673|365936620|FG003|Overall Study|Withdrawal by Subject|0|||
106074079|NCT02246673|365936621|FG004|Overall Study|Withdrawal by Subject|1|||
106074080|NCT02246673|365936617|FG000|Overall Study|Lost to Follow-up|0|||
106074081|NCT02246673|365936618|FG001|Overall Study|Lost to Follow-up|0|||
106074082|NCT02246673|365936619|FG002|Overall Study|Lost to Follow-up|0|||
106074083|NCT02246673|365936620|FG003|Overall Study|Lost to Follow-up|1|||
106074084|NCT02246673|365936621|FG004|Overall Study|Lost to Follow-up|0|||
106074085|NCT02246673|365936617|FG000|Overall Study|Protocol Violation|0|||
106074086|NCT02246673|365936618|FG001|Overall Study|Protocol Violation|0|||
106074087|NCT02246673|365936619|FG002|Overall Study|Protocol Violation|0|||
106074088|NCT02246673|365936620|FG003|Overall Study|Protocol Violation|1|||
106074089|NCT02246673|365936621|FG004|Overall Study|Protocol Violation|0|||
106074090|NCT01928862|365936625|FG000|Overall Study|Lost to Follow-up|1|||
106074091|NCT01928862|365936626|FG001|Overall Study|Lost to Follow-up|0|||
106074092|NCT01928862|365936627|FG002|Overall Study|Lost to Follow-up|0|||
106074093|NCT01928862|365936628|FG003|Overall Study|Lost to Follow-up|0|||
106074094|NCT01928862|365936629|FG004|Overall Study|Lost to Follow-up|1|||
106074095|NCT02625090|365936630|FG000|Overall Study|Participant wants to be pregnant|2|||
106074096|NCT02625090|365936630|FG000|Overall Study|For the Promoter|1|||
106074097|NCT02625090|365936630|FG000|Overall Study|Sponsor's Decision|9|||
106074098|NCT02625090|365936630|FG000|Overall Study|Somnolence|1|||
106074099|NCT02625090|365936630|FG000|Overall Study|Study terminated by Sponsor|7|||
106074100|NCT02625090|365936630|FG000|Overall Study|Negative Benefit/Risk|1|||
106074101|NCT02625090|365936630|FG000|Overall Study|Protocol Deviation|2|||
106074102|NCT02625090|365936630|FG000|Overall Study|Lack of Efficacy|16|||
106074103|NCT02625090|365936630|FG000|Overall Study|Adverse Event|3|||
106074104|NCT04649164|365936631|FG000|Overall Study|Withdrawal by Subject|1|||
106074105|NCT04649164|365936632|FG001|Overall Study|Withdrawal by Subject|1|||
106074106|NCT04649164|365936633|FG002|Overall Study|Withdrawal by Subject|2|||
106074107|NCT04649164|365936631|FG000|Overall Study|Participant's care recipient expired|0|||
106074108|NCT04649164|365936632|FG001|Overall Study|Participant's care recipient expired|0|||
106074109|NCT04649164|365936633|FG002|Overall Study|Participant's care recipient expired|2|||
106074110|NCT01549964|365936636|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
106074111|NCT01549964|365936637|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
106074112|NCT01549964|365936638|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
106074113|NCT01549964|365936639|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
106074114|NCT01549964|365936636|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
106074115|NCT01549964|365936637|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
106074116|NCT01549964|365936638|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
106074117|NCT01549964|365936639|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
106074118|NCT01549964|365936636|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
106074119|NCT01549964|365936637|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
106074120|NCT01549964|365936638|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
106074121|NCT01549964|365936639|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
106074122|NCT01549964|365936636|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
106074123|NCT01549964|365936637|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
106074124|NCT01549964|365936638|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
106074125|NCT01549964|365936639|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
106074126|NCT01549964|365936636|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
106074127|NCT01549964|365936637|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
106074128|NCT01549964|365936638|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
106074129|NCT01549964|365936639|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
106074130|NCT01549964|365936636|FG000|24-Week Treatment Period|Other|1|||
106074131|NCT01549964|365936637|FG001|24-Week Treatment Period|Other|0|||
106074132|NCT01549964|365936638|FG002|24-Week Treatment Period|Other|1|||
106074133|NCT01549964|365936639|FG003|24-Week Treatment Period|Other|0|||
106074134|NCT01549964|365936636|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
106074135|NCT01549964|365936637|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
106074136|NCT01549964|365936638|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
106074137|NCT01549964|365936639|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
106074138|NCT01549964|365936636|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
106074139|NCT01549964|365936637|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
106074140|NCT01549964|365936638|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
106074141|NCT01549964|365936639|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
106074142|NCT01549964|365936636|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
106074143|NCT01549964|365936637|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
106074144|NCT01549964|365936638|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
106074145|NCT01549964|365936639|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
106074146|NCT01549964|365936636|FG000|80-Week Extension Period|Pregnancy|0|||
106074147|NCT01549964|365936637|FG001|80-Week Extension Period|Pregnancy|0|||
106074148|NCT01549964|365936638|FG002|80-Week Extension Period|Pregnancy|1|||
106074149|NCT01549964|365936639|FG003|80-Week Extension Period|Pregnancy|0|||
106074150|NCT01549964|365936636|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
106074151|NCT01549964|365936637|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
106074152|NCT01549964|365936638|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
106074153|NCT01549964|365936639|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
106074154|NCT01549964|365936636|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
106074155|NCT01549964|365936637|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
106074156|NCT01549964|365936638|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
106074157|NCT01549964|365936639|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
106074158|NCT01549964|365936636|FG000|80-Week Extension Period|Lost to Follow-up|1|||
106074159|NCT01549964|365936637|FG001|80-Week Extension Period|Lost to Follow-up|0|||
106074160|NCT01549964|365936638|FG002|80-Week Extension Period|Lost to Follow-up|2|||
106074161|NCT01549964|365936639|FG003|80-Week Extension Period|Lost to Follow-up|1|||
106074162|NCT01549964|365936636|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
106074163|NCT01549964|365936637|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
106074164|NCT01549964|365936638|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
106074165|NCT01549964|365936639|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
106074166|NCT02290821|365936640|FG000|Overall Study|Withdrawal by Subject|1|||
106074167|NCT02290821|365936641|FG001|Overall Study|Withdrawal by Subject|1|||
106074168|NCT02290821|365936640|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
106074169|NCT02290821|365936641|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
106074170|NCT02290821|365936640|FG000|Overall Study|Lost to Follow-up|3|||
106074171|NCT02290821|365936641|FG001|Overall Study|Lost to Follow-up|2|||
106074172|NCT02439320|365936644|FG000|Overall Study|Adverse Event|0|||
106074173|NCT02439320|365936645|FG001|Overall Study|Adverse Event|2|||
106074174|NCT02439320|365936646|FG002|Overall Study|Adverse Event|0|||
106074175|NCT02439320|365936644|FG000|Overall Study|Lost to Follow-up|37|||
106074176|NCT02439320|365936645|FG001|Overall Study|Lost to Follow-up|34|||
106074177|NCT02439320|365936646|FG002|Overall Study|Lost to Follow-up|42|||
106074178|NCT02439320|365936644|FG000|Overall Study|Death|0|||
106074179|NCT02439320|365936645|FG001|Overall Study|Death|1|||
106074180|NCT02439320|365936646|FG002|Overall Study|Death|0|||
106157908|NCT04927065|366240078|FG000|Third Booster|Lost to Follow-up|0|||
106157909|NCT04927065|366240079|FG001|Third Booster|Lost to Follow-up|0|||
106157910|NCT04927065|366240080|FG002|Third Booster|Lost to Follow-up|0|||
106157911|NCT04927065|366240081|FG003|Third Booster|Lost to Follow-up|0|||
106157912|NCT04927065|366240082|FG004|Third Booster|Lost to Follow-up|0|||
106157913|NCT04927065|366240083|FG005|Third Booster|Lost to Follow-up|0|||
106157914|NCT04927065|366240084|FG006|Third Booster|Lost to Follow-up|0|||
106157915|NCT04927065|366240085|FG007|Third Booster|Lost to Follow-up|0|||
106157916|NCT04927065|366240086|FG008|Third Booster|Lost to Follow-up|0|||
106157917|NCT04927065|366240087|FG009|Third Booster|Lost to Follow-up|0|||
106157918|NCT04927065|366240088|FG010|Third Booster|Lost to Follow-up|0|||
106157919|NCT04927065|366240089|FG011|Third Booster|Lost to Follow-up|0|||
106157920|NCT04927065|366240090|FG012|Third Booster|Lost to Follow-up|0|||
106157921|NCT04927065|366240091|FG013|Third Booster|Lost to Follow-up|0|||
106157922|NCT04927065|366240092|FG014|Third Booster|Lost to Follow-up|0|||
106074181|NCT02439320|365936644|FG000|Overall Study|Noncompliance with Protocol|10|||
106074182|NCT02439320|365936645|FG001|Overall Study|Noncompliance with Protocol|11|||
106074183|NCT02439320|365936646|FG002|Overall Study|Noncompliance with Protocol|7|||
106157923|NCT04927065|366240093|FG015|Third Booster|Lost to Follow-up|1|||
106157924|NCT04927065|366240078|FG000|Third Booster|Withdrawal by Subject|0|||
106074184|NCT02439320|365936644|FG000|Overall Study|Pregnancy|0|||
106074185|NCT02439320|365936645|FG001|Overall Study|Pregnancy|1|||
106074186|NCT02439320|365936646|FG002|Overall Study|Pregnancy|1|||
106074187|NCT02439320|365936644|FG000|Overall Study|Withdrawal by Subject|12|||
106074188|NCT02439320|365936645|FG001|Overall Study|Withdrawal by Subject|16|||
106074189|NCT02439320|365936646|FG002|Overall Study|Withdrawal by Subject|14|||
106074190|NCT02439320|365936644|FG000|Overall Study|Physician Decision|2|||
106074191|NCT02439320|365936645|FG001|Overall Study|Physician Decision|1|||
106074192|NCT02439320|365936646|FG002|Overall Study|Physician Decision|0|||
106074193|NCT02439320|365936644|FG000|Overall Study|Sponsor Request|0|||
106074194|NCT02439320|365936645|FG001|Overall Study|Sponsor Request|2|||
106074195|NCT02439320|365936646|FG002|Overall Study|Sponsor Request|1|||
106074196|NCT02439320|365936644|FG000|Overall Study|Randomization Failure|35|||
106074197|NCT02439320|365936645|FG001|Overall Study|Randomization Failure|46|||
106074198|NCT02439320|365936646|FG002|Overall Study|Randomization Failure|34|||
106074199|NCT02972632|365936647|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
106074200|NCT02972632|365936647|FG000|Overall Study|Lost to Follow-up|4|||
106074201|NCT02972632|365936647|FG000|Overall Study|Voluntary Withdrawal|10|||
106074202|NCT02418468|365936648|FG000|Overall Study|Adverse Event|1|||
106074203|NCT02418468|365936649|FG001|Overall Study|Adverse Event|0|||
106074204|NCT02418468|365936648|FG000|Overall Study|Withdrawal of informed consent|1|||
106074205|NCT02418468|365936649|FG001|Overall Study|Withdrawal of informed consent|1|||
106074206|NCT00481195|365936650|FG000|Overall Study|Adverse Event|16|||
106074207|NCT00481195|365936651|FG001|Overall Study|Adverse Event|11|||
106074208|NCT00481195|365936650|FG000|Overall Study|Lack of Efficacy|1|||
106074209|NCT00481195|365936651|FG001|Overall Study|Lack of Efficacy|3|||
106074210|NCT00481195|365936650|FG000|Overall Study|Lost to Follow-up|4|||
106074211|NCT00481195|365936651|FG001|Overall Study|Lost to Follow-up|6|||
106074212|NCT00481195|365936650|FG000|Overall Study|Physician Decision|3|||
106074213|NCT00481195|365936651|FG001|Overall Study|Physician Decision|1|||
106074214|NCT00481195|365936650|FG000|Overall Study|Protocol Violation|10|||
106074215|NCT00481195|365936651|FG001|Overall Study|Protocol Violation|7|||
106074216|NCT00481195|365936650|FG000|Overall Study|Withdrawal by Subject|3|||
106074217|NCT00481195|365936651|FG001|Overall Study|Withdrawal by Subject|9|||
106074218|NCT00481195|365936650|FG000|Overall Study|Miscellaneous|2|||
106074219|NCT00481195|365936651|FG001|Overall Study|Miscellaneous|2|||
106074220|NCT01488097|365936652|FG000|Overall Study|Lost to Follow-up|1|||
106074221|NCT00909779|365936653|FG000|Overall Study|Adverse Event|53|||
106074222|NCT00909779|365936654|FG001|Overall Study|Adverse Event|55|||
106074223|NCT00909779|365936653|FG000|Overall Study|Lack of Efficacy|7|||
106074224|NCT00909779|365936654|FG001|Overall Study|Lack of Efficacy|4|||
106074225|NCT00909779|365936653|FG000|Overall Study|Lost to Follow-up|19|||
106074226|NCT00909779|365936654|FG001|Overall Study|Lost to Follow-up|15|||
106074227|NCT00909779|365936653|FG000|Overall Study|Physician Decision|8|||
106074228|NCT00909779|365936654|FG001|Overall Study|Physician Decision|2|||
106074229|NCT00909779|365936653|FG000|Overall Study|Protocol Violation|2|||
106074230|NCT00909779|365936654|FG001|Overall Study|Protocol Violation|5|||
106074231|NCT00909779|365936653|FG000|Overall Study|Withdrawal by Subject|116|||
106074232|NCT00909779|365936654|FG001|Overall Study|Withdrawal by Subject|80|||
106074233|NCT00909779|365936653|FG000|Overall Study|Site Ceasing Operation|2|||
106074234|NCT00909779|365936654|FG001|Overall Study|Site Ceasing Operation|2|||
106074235|NCT00909779|365936653|FG000|Overall Study|Medical Monitor Decision|1|||
106074236|NCT00909779|365936654|FG001|Overall Study|Medical Monitor Decision|0|||
106074237|NCT00909779|365936653|FG000|Overall Study|Noncompliance|1|||
106074238|NCT00909779|365936654|FG001|Overall Study|Noncompliance|1|||
106074239|NCT00909779|365936653|FG000|Overall Study|Randomized in error|1|||
106074240|NCT00909779|365936654|FG001|Overall Study|Randomized in error|1|||
106074241|NCT02016482|365936657|FG000|Period A|Adverse Event|3|||
106074242|NCT02016482|365936658|FG001|Period A|Adverse Event|5|||
106074243|NCT02016482|365936657|FG000|Period A|Withdrawal by Subject|3|||
106074244|NCT02016482|365936658|FG001|Period A|Withdrawal by Subject|4|||
106074245|NCT02016482|365936657|FG000|Period A|Lost to Follow-up|3|||
106074246|NCT02016482|365936658|FG001|Period A|Lost to Follow-up|3|||
106074247|NCT02016482|365936657|FG000|Period A|Lack of Efficacy|2|||
106074248|NCT02016482|365936658|FG001|Period A|Lack of Efficacy|1|||
106074249|NCT02016482|365936657|FG000|Period A|Other|3|||
106074250|NCT02016482|365936658|FG001|Period A|Other|0|||
106074251|NCT02016482|365936657|FG000|Period A|Protocol Violation|0|||
106074252|NCT02016482|365936658|FG001|Period A|Protocol Violation|1|||
106074253|NCT02016482|365936657|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
106074254|NCT02016482|365936658|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
106074255|NCT02016482|365936657|FG000|Period B|Withdrawal by Subject|1|||
106074256|NCT02016482|365936658|FG001|Period B|Withdrawal by Subject|1|||
106074257|NCT02016482|365936657|FG000|Period B|Lost to Follow-up|2|||
106074258|NCT02016482|365936658|FG001|Period B|Lost to Follow-up|0|||
106074259|NCT02016482|365936657|FG000|Period B|Lack of Efficacy|6|||
106074260|NCT02016482|365936658|FG001|Period B|Lack of Efficacy|4|||
106074261|NCT02016482|365936657|FG000|Period B|Other|4|||
106074262|NCT02016482|365936658|FG001|Period B|Other|0|||
106074263|NCT02016482|365936657|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
106074264|NCT02016482|365936658|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
106074265|NCT02738333|365936659|FG000|Overall Study|Death|1|||
106074266|NCT02738333|365936660|FG001|Overall Study|Death|0|||
106074267|NCT02738333|365936661|FG002|Overall Study|Death|0|||
106074268|NCT02738333|365936659|FG000|Overall Study|Lost to Follow-up|1|||
106074269|NCT02738333|365936660|FG001|Overall Study|Lost to Follow-up|0|||
106074270|NCT02738333|365936661|FG002|Overall Study|Lost to Follow-up|0|||
105866627|NCT00710866|365161109|FG001|Overall Study|Protocol Violation|4|||
106074271|NCT02205333|365936675|FG000|Overall Study|Death|5|||
106074272|NCT02205333|365936676|FG001|Overall Study|Death|6|||
106074273|NCT02205333|365936677|FG002|Overall Study|Death|2|||
106074274|NCT02205333|365936678|FG003|Overall Study|Death|6|||
106074275|NCT02205333|365936679|FG004|Overall Study|Death|5|||
106074276|NCT02205333|365936680|FG005|Overall Study|Death|3|||
106074277|NCT02205333|365936681|FG006|Overall Study|Death|3|||
106074278|NCT02205333|365936682|FG007|Overall Study|Death|2|||
106074279|NCT02205333|365936683|FG008|Overall Study|Death|0|||
106074280|NCT02205333|365936675|FG000|Overall Study|Withdrawal by Subject|1|||
106074281|NCT02205333|365936676|FG001|Overall Study|Withdrawal by Subject|0|||
106074282|NCT02205333|365936677|FG002|Overall Study|Withdrawal by Subject|0|||
106074283|NCT02205333|365936678|FG003|Overall Study|Withdrawal by Subject|1|||
106074284|NCT02205333|365936679|FG004|Overall Study|Withdrawal by Subject|0|||
106074285|NCT02205333|365936680|FG005|Overall Study|Withdrawal by Subject|0|||
106074286|NCT02205333|365936681|FG006|Overall Study|Withdrawal by Subject|2|||
106074287|NCT02205333|365936682|FG007|Overall Study|Withdrawal by Subject|0|||
106074288|NCT02205333|365936683|FG008|Overall Study|Withdrawal by Subject|0|||
106074289|NCT01324388|365936684|FG000|Part 1 of Study|Adverse Event|2|||
106074290|NCT01324388|365936685|FG001|Part 1 of Study|Adverse Event|0|||
106074291|NCT01324388|365936686|FG002|Part 1 of Study|Adverse Event|0|||
106074292|NCT01324388|365936687|FG003|Part 1 of Study|Adverse Event|0|||
106074293|NCT01324388|365936684|FG000|Part 1 of Study|Protocol Violation|1|||
106074294|NCT01324388|365936685|FG001|Part 1 of Study|Protocol Violation|2|||
106074295|NCT01324388|365936686|FG002|Part 1 of Study|Protocol Violation|0|||
106074296|NCT01324388|365936687|FG003|Part 1 of Study|Protocol Violation|0|||
106074297|NCT01324388|365936684|FG000|Part 1 of Study|Physician Decision|1|||
106074298|NCT01324388|365936685|FG001|Part 1 of Study|Physician Decision|0|||
106074299|NCT01324388|365936686|FG002|Part 1 of Study|Physician Decision|0|||
106074300|NCT01324388|365936687|FG003|Part 1 of Study|Physician Decision|0|||
106074301|NCT01324388|365936684|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
106074302|NCT01324388|365936685|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
106074303|NCT01324388|365936686|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
106074304|NCT01324388|365936687|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
106074305|NCT01324388|365936684|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
106074306|NCT01324388|365936685|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
106074307|NCT01324388|365936686|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
106074308|NCT01324388|365936687|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
106074309|NCT02073279|365936691|FG000|Double-blind Period|Adverse Event|1|||
106074310|NCT02073279|365936692|FG001|Double-blind Period|Adverse Event|1|||
106074311|NCT02073279|365936691|FG000|Double-blind Period|Switched to another treatment|1|||
106074312|NCT02073279|365936692|FG001|Double-blind Period|Switched to another treatment|2|||
106074313|NCT02073279|365936691|FG000|Double-blind Period|Protocol Violation|0|||
106074314|NCT02073279|365936692|FG001|Double-blind Period|Protocol Violation|1|||
106074315|NCT02073279|365936691|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
106074316|NCT02073279|365936692|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
106074317|NCT02073279|365936691|FG000|Double-blind Period|Withdrawal by Subject|2|||
106074318|NCT02073279|365936692|FG001|Double-blind Period|Withdrawal by Subject|2|||
106074319|NCT02073279|365936691|FG000|Open-label Extension Period|Adverse Event|1|||
106074320|NCT02073279|365936692|FG001|Open-label Extension Period|Adverse Event|0|||
106074321|NCT02073279|365936691|FG000|Open-label Extension Period|Lack of Efficacy|1|||
106074322|NCT02073279|365936692|FG001|Open-label Extension Period|Lack of Efficacy|0|||
106074323|NCT02073279|365936691|FG000|Open-label Extension Period|Lost to Follow-up|0|||
106074324|NCT02073279|365936692|FG001|Open-label Extension Period|Lost to Follow-up|4|||
106074325|NCT02073279|365936691|FG000|Open-label Extension Period|Switched to another treatment|1|||
106074326|NCT02073279|365936692|FG001|Open-label Extension Period|Switched to another treatment|4|||
106074327|NCT02073279|365936691|FG000|Open-label Extension Period|Protocol Violation|0|||
106074328|NCT02073279|365936692|FG001|Open-label Extension Period|Protocol Violation|1|||
106074329|NCT02073279|365936691|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
106074330|NCT02073279|365936692|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
106074331|NCT02073279|365936691|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
106074332|NCT02073279|365936692|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
106074333|NCT01085097|365936693|FG000|Overall Study|Adverse Event|0|||
106074334|NCT01085097|365936694|FG001|Overall Study|Adverse Event|0|||
106074335|NCT01085097|365936695|FG002|Overall Study|Adverse Event|2|||
106074336|NCT01085097|365936693|FG000|Overall Study|Treatment failure|2|||
106074337|NCT01085097|365936694|FG001|Overall Study|Treatment failure|0|||
106074338|NCT01085097|365936695|FG002|Overall Study|Treatment failure|0|||
106074339|NCT00973479|365936698|FG000|Overall Study|Lost to Follow-up|0|||
106074340|NCT00973479|365936699|FG001|Overall Study|Lost to Follow-up|3|||
106074341|NCT00973479|365936698|FG000|Overall Study|Death|2|||
106074342|NCT00973479|365936699|FG001|Overall Study|Death|2|||
106074343|NCT00973479|365936698|FG000|Overall Study|Withdrawal by Subject|15|||
106074344|NCT00973479|365936699|FG001|Overall Study|Withdrawal by Subject|16|||
106074345|NCT00973479|365936698|FG000|Overall Study|Lack of Efficacy|5|||
106074346|NCT00973479|365936699|FG001|Overall Study|Lack of Efficacy|7|||
106074347|NCT00973479|365936698|FG000|Overall Study|Adverse Event|12|||
106074348|NCT00973479|365936699|FG001|Overall Study|Adverse Event|32|||
106074349|NCT00973479|365936698|FG000|Overall Study|Protocol Violation|2|||
106074350|NCT00973479|365936699|FG001|Overall Study|Protocol Violation|2|||
106074351|NCT00973479|365936698|FG000|Overall Study|Other|1|||
106074352|NCT00973479|365936699|FG001|Overall Study|Other|7|||
106074353|NCT00129129|365936700|FG000|Primary Phase|Adverse Event|2|||
106074354|NCT00129129|365936701|FG001|Primary Phase|Adverse Event|1|||
106074355|NCT00129129|365936702|FG002|Primary Phase|Adverse Event|0|||
106074356|NCT00129129|365936703|FG003|Primary Phase|Adverse Event|0|||
106074357|NCT00129129|365936704|FG004|Primary Phase|Adverse Event|0|||
106074358|NCT00129129|365936700|FG000|Primary Phase|Withdrawal by Subject|12|||
106074359|NCT00129129|365936701|FG001|Primary Phase|Withdrawal by Subject|10|||
106074360|NCT00129129|365936702|FG002|Primary Phase|Withdrawal by Subject|0|||
106074361|NCT00129129|365936703|FG003|Primary Phase|Withdrawal by Subject|0|||
106074362|NCT00129129|365936704|FG004|Primary Phase|Withdrawal by Subject|0|||
106074363|NCT00129129|365936700|FG000|Primary Phase|Migration from study area|1|||
106074364|NCT00129129|365936701|FG001|Primary Phase|Migration from study area|3|||
106074365|NCT00129129|365936702|FG002|Primary Phase|Migration from study area|0|||
106074366|NCT00129129|365936703|FG003|Primary Phase|Migration from study area|0|||
106074367|NCT00129129|365936704|FG004|Primary Phase|Migration from study area|0|||
106074368|NCT00129129|365936700|FG000|Primary Phase|Lost to Follow-up|8|||
106074369|NCT00129129|365936701|FG001|Primary Phase|Lost to Follow-up|6|||
106074370|NCT00129129|365936702|FG002|Primary Phase|Lost to Follow-up|0|||
106074371|NCT00129129|365936703|FG003|Primary Phase|Lost to Follow-up|0|||
106074372|NCT00129129|365936704|FG004|Primary Phase|Lost to Follow-up|0|||
106074373|NCT00129129|365936700|FG000|Primary Phase|Other|2|||
106074374|NCT00129129|365936701|FG001|Primary Phase|Other|5|||
106074375|NCT00129129|365936702|FG002|Primary Phase|Other|0|||
106074376|NCT00129129|365936703|FG003|Primary Phase|Other|0|||
106074377|NCT00129129|365936704|FG004|Primary Phase|Other|0|||
106074378|NCT00129129|365936700|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
106074379|NCT00129129|365936701|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
106074380|NCT00129129|365936702|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
106074381|NCT00129129|365936703|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
106074382|NCT00129129|365936704|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
106074383|NCT00129129|365936700|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
106074384|NCT00129129|365936701|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
106074385|NCT00129129|365936702|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
106074386|NCT00129129|365936703|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
106074387|NCT00129129|365936704|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
106074388|NCT00129129|365936700|FG000|Fourth Dose Phase|Migration from study area|0|||
106074389|NCT00129129|365936701|FG001|Fourth Dose Phase|Migration from study area|0|||
106074390|NCT00129129|365936702|FG002|Fourth Dose Phase|Migration from study area|0|||
106074391|NCT00129129|365936703|FG003|Fourth Dose Phase|Migration from study area|0|||
106074392|NCT00129129|365936704|FG004|Fourth Dose Phase|Migration from study area|2|||
106074393|NCT00129129|365936700|FG000|Fourth Dose Phase|Other|0|||
106074394|NCT00129129|365936701|FG001|Fourth Dose Phase|Other|0|||
106074395|NCT00129129|365936702|FG002|Fourth Dose Phase|Other|0|||
106074396|NCT00129129|365936703|FG003|Fourth Dose Phase|Other|1|||
106074397|NCT00129129|365936704|FG004|Fourth Dose Phase|Other|1|||
106074398|NCT00129129|365936700|FG000|Fourth Dose Phase|Protocol Violation|0|||
106074399|NCT00129129|365936701|FG001|Fourth Dose Phase|Protocol Violation|0|||
106157925|NCT04927065|366240079|FG001|Third Booster|Withdrawal by Subject|0|||
106157926|NCT04927065|366240080|FG002|Third Booster|Withdrawal by Subject|0|||
106074400|NCT00129129|365936702|FG002|Fourth Dose Phase|Protocol Violation|0|||
106074401|NCT00129129|365936703|FG003|Fourth Dose Phase|Protocol Violation|1|||
106074402|NCT00129129|365936704|FG004|Fourth Dose Phase|Protocol Violation|0|||
106074403|NCT02802592|365936706|FG000|Overall Study|Study terminated due to loss of funding|4|||
106074404|NCT04007523|365936707|FG000|Overall Study|Withdrawal by Subject|0|||
106074405|NCT04007523|365936708|FG001|Overall Study|Withdrawal by Subject|1|||
106074406|NCT04007523|365936709|FG002|Overall Study|Withdrawal by Subject|1|||
106074407|NCT04007523|365936710|FG003|Overall Study|Withdrawal by Subject|0|||
106074408|NCT04007523|365936707|FG000|Overall Study|ICU Transfer|0|||
106074409|NCT04007523|365936708|FG001|Overall Study|ICU Transfer|1|||
106074410|NCT04007523|365936709|FG002|Overall Study|ICU Transfer|0|||
106074411|NCT04007523|365936710|FG003|Overall Study|ICU Transfer|0|||
106074412|NCT04007523|365936707|FG000|Overall Study|COVID hospital closure|0|||
106074413|NCT04007523|365936708|FG001|Overall Study|COVID hospital closure|0|||
106074414|NCT04007523|365936709|FG002|Overall Study|COVID hospital closure|1|||
106074415|NCT04007523|365936710|FG003|Overall Study|COVID hospital closure|2|||
106074416|NCT04007523|365936707|FG000|Overall Study|Surgery cancelled|0|||
106074417|NCT04007523|365936708|FG001|Overall Study|Surgery cancelled|0|||
106074418|NCT04007523|365936709|FG002|Overall Study|Surgery cancelled|1|||
106074419|NCT04007523|365936710|FG003|Overall Study|Surgery cancelled|1|||
106074420|NCT02882854|365936711|FG000|Overall Study|Lost to Follow-up|1|||
106074421|NCT02882854|365936712|FG001|Overall Study|Lost to Follow-up|2|||
106074422|NCT02882854|365936711|FG000|Overall Study|Physician Decision|0|||
106074423|NCT02882854|365936712|FG001|Overall Study|Physician Decision|1|||
106074424|NCT01358357|365936715|FG000|Open Label Phase|Adverse Event|0|||
106074425|NCT01358357|365936716|FG001|Open Label Phase|Adverse Event|0|||
106074426|NCT01358357|365936717|FG002|Open Label Phase|Adverse Event|59|||
106074427|NCT01358357|365936715|FG000|Open Label Phase|Lack of Efficacy|0|||
106074428|NCT01358357|365936716|FG001|Open Label Phase|Lack of Efficacy|0|||
106074429|NCT01358357|365936717|FG002|Open Label Phase|Lack of Efficacy|107|||
106074430|NCT01358357|365936715|FG000|Open Label Phase|Lost to Follow-up|0|||
106074431|NCT01358357|365936716|FG001|Open Label Phase|Lost to Follow-up|0|||
106074432|NCT01358357|365936717|FG002|Open Label Phase|Lost to Follow-up|76|||
106074433|NCT01358357|365936715|FG000|Open Label Phase|Protocol Violation|0|||
106074434|NCT01358357|365936716|FG001|Open Label Phase|Protocol Violation|0|||
106074435|NCT01358357|365936717|FG002|Open Label Phase|Protocol Violation|45|||
106074436|NCT01358357|365936715|FG000|Open Label Phase|Withdrawal by Subject|0|||
106074437|NCT01358357|365936716|FG001|Open Label Phase|Withdrawal by Subject|0|||
106074438|NCT01358357|365936717|FG002|Open Label Phase|Withdrawal by Subject|112|||
106074439|NCT01358357|365936715|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
106074440|NCT01358357|365936716|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
106074441|NCT01358357|365936717|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
106074442|NCT01358357|365936715|FG000|Open Label Phase|Terminated at study completion|0|||
106074443|NCT01358357|365936716|FG001|Open Label Phase|Terminated at study completion|0|||
106074444|NCT01358357|365936717|FG002|Open Label Phase|Terminated at study completion|5|||
106074445|NCT01358357|365936715|FG000|Open Label Phase|Mood episode|0|||
106074446|NCT01358357|365936716|FG001|Open Label Phase|Mood episode|0|||
106074447|NCT01358357|365936717|FG002|Open Label Phase|Mood episode|42|||
106074448|NCT01358357|365936715|FG000|Double-Blind Phase|Adverse Event|8|||
106074449|NCT01358357|365936716|FG001|Double-Blind Phase|Adverse Event|5|||
106074450|NCT01358357|365936717|FG002|Double-Blind Phase|Adverse Event|0|||
106074451|NCT01358357|365936715|FG000|Double-Blind Phase|Lost to Follow-up|5|||
106074452|NCT01358357|365936716|FG001|Double-Blind Phase|Lost to Follow-up|7|||
106074453|NCT01358357|365936717|FG002|Double-Blind Phase|Lost to Follow-up|0|||
106074454|NCT01358357|365936715|FG000|Double-Blind Phase|Protocol Violation|1|||
106074455|NCT01358357|365936716|FG001|Double-Blind Phase|Protocol Violation|11|||
106074456|NCT01358357|365936717|FG002|Double-Blind Phase|Protocol Violation|0|||
106074457|NCT01358357|365936715|FG000|Double-Blind Phase|Protocol Violation|16|||
106074458|NCT01358357|365936716|FG001|Double-Blind Phase|Protocol Violation|12|||
106074459|NCT01358357|365936717|FG002|Double-Blind Phase|Protocol Violation|0|||
106074460|NCT01358357|365936715|FG000|Double-Blind Phase|Terminated at study completion|2|||
106074461|NCT01358357|365936716|FG001|Double-Blind Phase|Terminated at study completion|0|||
106074462|NCT01358357|365936717|FG002|Double-Blind Phase|Terminated at study completion|0|||
106074463|NCT01358357|365936715|FG000|Double-Blind Phase|Recurrence of mood event|48|||
106074464|NCT01358357|365936716|FG001|Double-Blind Phase|Recurrence of mood event|64|||
106074465|NCT01358357|365936717|FG002|Double-Blind Phase|Recurrence of mood event|0|||
106074466|NCT01358357|365936715|FG000|Double-Blind Phase|Administrative|0|||
106074467|NCT01358357|365936716|FG001|Double-Blind Phase|Administrative|1|||
106074468|NCT01358357|365936717|FG002|Double-Blind Phase|Administrative|0|||
106074469|NCT02268786|365936719|FG000|Overall Study|No Euploid Embryos available|42|||
106074470|NCT02268786|365936720|FG001|Overall Study|No Euploid Embryos available|0|||
106074471|NCT02268786|365936719|FG000|Overall Study|Withdrawal by Subject|7|||
106074472|NCT02268786|365936720|FG001|Overall Study|Withdrawal by Subject|14|||
106074473|NCT02268786|365936719|FG000|Overall Study|Thaw Failure|6|||
106074474|NCT02268786|365936720|FG001|Overall Study|Thaw Failure|4|||
105866628|NCT00710866|365161108|FG000|Overall Study|Withdrawal by Subject|2|||
106157927|NCT04927065|366240081|FG003|Third Booster|Withdrawal by Subject|0|||
106157928|NCT04927065|366240082|FG004|Third Booster|Withdrawal by Subject|0|||
106157929|NCT04927065|366240083|FG005|Third Booster|Withdrawal by Subject|0|||
106157930|NCT04927065|366240084|FG006|Third Booster|Withdrawal by Subject|0|||
106157931|NCT04927065|366240085|FG007|Third Booster|Withdrawal by Subject|0|||
106157932|NCT04927065|366240086|FG008|Third Booster|Withdrawal by Subject|0|||
106157933|NCT04927065|366240087|FG009|Third Booster|Withdrawal by Subject|0|||
106157934|NCT04927065|366240088|FG010|Third Booster|Withdrawal by Subject|0|||
106157935|NCT04927065|366240089|FG011|Third Booster|Withdrawal by Subject|0|||
106157936|NCT04927065|366240090|FG012|Third Booster|Withdrawal by Subject|0|||
106157937|NCT04927065|366240091|FG013|Third Booster|Withdrawal by Subject|0|||
106157938|NCT04927065|366240092|FG014|Third Booster|Withdrawal by Subject|0|||
106157939|NCT04927065|366240093|FG015|Third Booster|Withdrawal by Subject|1|||
106157940|NCT04588298|366240108|FG000|Overall Study|Adverse Event|0|||
106157941|NCT04588298|366240109|FG001|Overall Study|Adverse Event|0|||
106157942|NCT04588298|366240110|FG002|Overall Study|Adverse Event|1|||
106157943|NCT04588298|366240111|FG003|Overall Study|Adverse Event|0|||
106157944|NCT04588298|366240112|FG004|Overall Study|Adverse Event|2|||
106157945|NCT04588298|366240108|FG000|Overall Study|Withdrawal by Subject|1|||
106157946|NCT04588298|366240109|FG001|Overall Study|Withdrawal by Subject|0|||
106157947|NCT04588298|366240110|FG002|Overall Study|Withdrawal by Subject|0|||
106157948|NCT04588298|366240111|FG003|Overall Study|Withdrawal by Subject|1|||
106157949|NCT04588298|366240112|FG004|Overall Study|Withdrawal by Subject|0|||
106157950|NCT03846505|366240113|FG000|Treatment Phase|Withdrawal by Subject|9|||
106157951|NCT03846505|366240114|FG001|Treatment Phase|Withdrawal by Subject|11|||
106157952|NCT03846505|366240113|FG000|Treatment Phase|Lost to Follow-up|6|||
106157953|NCT03846505|366240114|FG001|Treatment Phase|Lost to Follow-up|2|||
106157954|NCT03846505|366240113|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
106157955|NCT03846505|366240114|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
106157956|NCT03846505|366240113|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
106157957|NCT03846505|366240114|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
106157958|NCT05520190|366240115|FG000|Overall Study|Lost to Follow-up|7|||
106157959|NCT05520190|366240115|FG000|Overall Study|Withdrawal by Subject|2|||
106157960|NCT03683719|366240116|FG000|Overall Study|Lack of Efficacy|1|||
106157961|NCT03683719|366240117|FG001|Overall Study|Lack of Efficacy|3|||
106157962|NCT03683719|366240118|FG002|Overall Study|Lack of Efficacy|4|||
106157963|NCT03683719|366240119|FG003|Overall Study|Lack of Efficacy|0|||
106157964|NCT03683719|366240120|FG004|Overall Study|Lack of Efficacy|4|||
106157965|NCT03683719|366240116|FG000|Overall Study|Adverse Event|6|||
106157966|NCT03683719|366240117|FG001|Overall Study|Adverse Event|6|||
106157967|NCT03683719|366240118|FG002|Overall Study|Adverse Event|0|||
106157968|NCT03683719|366240119|FG003|Overall Study|Adverse Event|1|||
106157969|NCT03683719|366240120|FG004|Overall Study|Adverse Event|3|||
106157970|NCT03683719|366240116|FG000|Overall Study|Withdrawal by Subject|4|||
106157971|NCT03683719|366240117|FG001|Overall Study|Withdrawal by Subject|4|||
106157972|NCT03683719|366240118|FG002|Overall Study|Withdrawal by Subject|3|||
106157973|NCT03683719|366240119|FG003|Overall Study|Withdrawal by Subject|5|||
106157974|NCT03683719|366240120|FG004|Overall Study|Withdrawal by Subject|5|||
106157975|NCT03683719|366240116|FG000|Overall Study|Lost to Follow-up|1|||
106157976|NCT03683719|366240117|FG001|Overall Study|Lost to Follow-up|0|||
106157977|NCT03683719|366240118|FG002|Overall Study|Lost to Follow-up|0|||
106157978|NCT03683719|366240119|FG003|Overall Study|Lost to Follow-up|1|||
106157979|NCT03683719|366240120|FG004|Overall Study|Lost to Follow-up|1|||
106157980|NCT03683719|366240116|FG000|Overall Study|Other personal reasons|0|||
106157981|NCT03683719|366240117|FG001|Overall Study|Other personal reasons|0|||
106157982|NCT03683719|366240118|FG002|Overall Study|Other personal reasons|1|||
106157983|NCT03683719|366240119|FG003|Overall Study|Other personal reasons|0|||
106157984|NCT03683719|366240120|FG004|Overall Study|Other personal reasons|1|||
106157985|NCT03907397|366240121|FG000|Overall Study|Lost to Follow-up|0|||
106157986|NCT03907397|366240122|FG001|Overall Study|Lost to Follow-up|1|||
106157987|NCT03907397|366240121|FG000|Overall Study|Physician Decision|2|||
106157988|NCT03907397|366240122|FG001|Overall Study|Physician Decision|1|||
106157989|NCT03907397|366240121|FG000|Overall Study|Withdrawal by Subject|5|||
106157990|NCT03907397|366240122|FG001|Overall Study|Withdrawal by Subject|4|||
106157991|NCT03907397|366240121|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
106157992|NCT03907397|366240122|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
106157993|NCT03376321|366241485|FG000|Overall Study|Other|5|||
106157994|NCT03376321|366241486|FG001|Overall Study|Other|1|||
106157995|NCT03376321|366241485|FG000|Overall Study|Withdrawal by Subject|8|||
106157996|NCT03376321|366241486|FG001|Overall Study|Withdrawal by Subject|14|||
106157997|NCT03376321|366241485|FG000|Overall Study|Lost to Follow-up|1|||
106157998|NCT03376321|366241486|FG001|Overall Study|Lost to Follow-up|7|||
106157999|NCT03376321|366241485|FG000|Overall Study|Death|4|||
106158000|NCT03376321|366241486|FG001|Overall Study|Death|0|||
106158001|NCT03376321|366241485|FG000|Overall Study|Randomized, not treated|5|||
106074475|NCT02268786|365936719|FG000|Overall Study|Protocol Violation|1|||
106074476|NCT02268786|365936720|FG001|Overall Study|Protocol Violation|0|||
106074477|NCT01150123|365936721|FG000|Overall Study|Withdrawal by Subject|1|||
106074478|NCT01150123|365936722|FG001|Overall Study|Withdrawal by Subject|1|||
106074479|NCT01150123|365936723|FG002|Overall Study|Withdrawal by Subject|2|||
106074480|NCT01150123|365936724|FG003|Overall Study|Withdrawal by Subject|1|||
106074481|NCT01150123|365936725|FG004|Overall Study|Withdrawal by Subject|1|||
106074482|NCT01150123|365936726|FG005|Overall Study|Withdrawal by Subject|1|||
106074483|NCT01150123|365936727|FG006|Overall Study|Withdrawal by Subject|0|||
106074484|NCT01150123|365936728|FG007|Overall Study|Withdrawal by Subject|3|||
106074485|NCT01150123|365936729|FG008|Overall Study|Withdrawal by Subject|2|||
106074486|NCT01150123|365936730|FG009|Overall Study|Withdrawal by Subject|0|||
106074487|NCT01150123|365936731|FG010|Overall Study|Withdrawal by Subject|1|||
106074488|NCT01150123|365936732|FG011|Overall Study|Withdrawal by Subject|0|||
106074489|NCT01150123|365936733|FG012|Overall Study|Withdrawal by Subject|1|||
106074490|NCT01150123|365936734|FG013|Overall Study|Withdrawal by Subject|0|||
106074491|NCT01150123|365936735|FG014|Overall Study|Withdrawal by Subject|0|||
106074492|NCT01150123|365936736|FG015|Overall Study|Withdrawal by Subject|1|||
106074493|NCT01150123|365936737|FG016|Overall Study|Withdrawal by Subject|0|||
106074494|NCT01150123|365936738|FG017|Overall Study|Withdrawal by Subject|1|||
106074495|NCT01150123|365936721|FG000|Overall Study|Lost to Follow-up|2|||
106074496|NCT01150123|365936722|FG001|Overall Study|Lost to Follow-up|1|||
106074497|NCT01150123|365936723|FG002|Overall Study|Lost to Follow-up|2|||
106074498|NCT01150123|365936724|FG003|Overall Study|Lost to Follow-up|2|||
106074499|NCT01150123|365936725|FG004|Overall Study|Lost to Follow-up|2|||
106074500|NCT01150123|365936726|FG005|Overall Study|Lost to Follow-up|5|||
106074501|NCT01150123|365936727|FG006|Overall Study|Lost to Follow-up|0|||
106074502|NCT01150123|365936728|FG007|Overall Study|Lost to Follow-up|0|||
106074503|NCT01150123|365936729|FG008|Overall Study|Lost to Follow-up|3|||
106074504|NCT01150123|365936730|FG009|Overall Study|Lost to Follow-up|1|||
106074505|NCT01150123|365936731|FG010|Overall Study|Lost to Follow-up|1|||
106074506|NCT01150123|365936732|FG011|Overall Study|Lost to Follow-up|1|||
106074507|NCT01150123|365936733|FG012|Overall Study|Lost to Follow-up|2|||
106074508|NCT01150123|365936734|FG013|Overall Study|Lost to Follow-up|0|||
106074509|NCT01150123|365936735|FG014|Overall Study|Lost to Follow-up|0|||
106074510|NCT01150123|365936736|FG015|Overall Study|Lost to Follow-up|0|||
106074511|NCT01150123|365936737|FG016|Overall Study|Lost to Follow-up|0|||
106074512|NCT01150123|365936738|FG017|Overall Study|Lost to Follow-up|0|||
106074513|NCT02171260|365936743|FG000|Overall Study|Death|0|||
106074514|NCT02171260|365936744|FG001|Overall Study|Death|0|||
106074515|NCT02171260|365936745|FG002|Overall Study|Death|0|||
106074516|NCT02171260|365936746|FG003|Overall Study|Death|1|||
106074517|NCT02171260|365936743|FG000|Overall Study|Physician Decision|1|||
106074518|NCT02171260|365936744|FG001|Overall Study|Physician Decision|0|||
106074519|NCT02171260|365936745|FG002|Overall Study|Physician Decision|1|||
106074520|NCT02171260|365936746|FG003|Overall Study|Physician Decision|0|||
106074521|NCT02171260|365936743|FG000|Overall Study|Withdrawal by Subject|1|||
106074522|NCT02171260|365936744|FG001|Overall Study|Withdrawal by Subject|0|||
106074523|NCT02171260|365936745|FG002|Overall Study|Withdrawal by Subject|0|||
106074524|NCT02171260|365936746|FG003|Overall Study|Withdrawal by Subject|0|||
106074525|NCT02171260|365936743|FG000|Overall Study|Evidence of progressive disease|4|||
106074526|NCT02171260|365936744|FG001|Overall Study|Evidence of progressive disease|6|||
106074527|NCT02171260|365936745|FG002|Overall Study|Evidence of progressive disease|4|||
106074528|NCT02171260|365936746|FG003|Overall Study|Evidence of progressive disease|4|||
106074529|NCT01062555|365936751|FG000|Phase 1|Death|10|||
106074530|NCT01062555|365936752|FG001|Phase 1|Death|17|||
106074531|NCT01062555|365936753|FG002|Phase 1|Death|0|||
106074532|NCT01062555|365936754|FG003|Phase 1|Death|0|||
106074533|NCT01062555|365936751|FG000|Phase 1|Graft Failure|12|||
106074534|NCT01062555|365936752|FG001|Phase 1|Graft Failure|8|||
106074535|NCT01062555|365936753|FG002|Phase 1|Graft Failure|0|||
106074536|NCT01062555|365936754|FG003|Phase 1|Graft Failure|0|||
106074537|NCT01062555|365936751|FG000|Phase 1|Withdrawal by Subject|1|||
106074538|NCT01062555|365936752|FG001|Phase 1|Withdrawal by Subject|1|||
106074539|NCT01062555|365936753|FG002|Phase 1|Withdrawal by Subject|0|||
106074540|NCT01062555|365936754|FG003|Phase 1|Withdrawal by Subject|0|||
106074541|NCT01062555|365936751|FG000|Phase 2|Death|0|||
106074542|NCT01062555|365936752|FG001|Phase 2|Death|0|||
106074543|NCT01062555|365936753|FG002|Phase 2|Death|8|||
106074544|NCT01062555|365936754|FG003|Phase 2|Death|3|||
106074545|NCT01062555|365936751|FG000|Phase 2|Graft failure|0|||
106074546|NCT01062555|365936752|FG001|Phase 2|Graft failure|0|||
106074547|NCT01062555|365936753|FG002|Phase 2|Graft failure|7|||
106074548|NCT01062555|365936754|FG003|Phase 2|Graft failure|4|||
106074549|NCT01062555|365936751|FG000|Phase 2|Withdrawal by Subject|0|||
106074550|NCT01062555|365936752|FG001|Phase 2|Withdrawal by Subject|0|||
106074551|NCT01062555|365936753|FG002|Phase 2|Withdrawal by Subject|0|||
106074552|NCT01062555|365936754|FG003|Phase 2|Withdrawal by Subject|7|||
106074553|NCT01062555|365936751|FG000|Phase 2|Protocol Violation|0|||
106074554|NCT01062555|365936752|FG001|Phase 2|Protocol Violation|0|||
106074555|NCT01062555|365936753|FG002|Phase 2|Protocol Violation|0|||
106074556|NCT01062555|365936754|FG003|Phase 2|Protocol Violation|3|||
106074557|NCT01062555|365936751|FG000|Phase 2|Physician Decision|0|||
106074558|NCT01062555|365936752|FG001|Phase 2|Physician Decision|0|||
106074559|NCT01062555|365936753|FG002|Phase 2|Physician Decision|0|||
106074560|NCT01062555|365936754|FG003|Phase 2|Physician Decision|17|||
106074561|NCT02486042|365936755|FG000|Overall Study|Physician Decision|1|||
106074562|NCT02486042|365936756|FG001|Overall Study|Physician Decision|7|||
106074563|NCT02486042|365936755|FG000|Overall Study|Hospital transfer|2|||
106074564|NCT02486042|365936756|FG001|Overall Study|Hospital transfer|2|||
106074565|NCT02486042|365936755|FG000|Overall Study|Withdrawal by Subject|0|||
106074566|NCT02486042|365936756|FG001|Overall Study|Withdrawal by Subject|2|||
106074567|NCT02968979|365936759|FG000|Overall Study|Protocol Violation|7|||
106074568|NCT02968979|365936759|FG000|Overall Study|Withdrawal by Subject|1|||
106074569|NCT01471379|365936760|FG000|Overall Study|Adverse Event|1|||
106074570|NCT01471379|365936761|FG001|Overall Study|Adverse Event|0|||
106074571|NCT01471379|365936762|FG002|Overall Study|Adverse Event|0|||
106074572|NCT01471379|365936760|FG000|Overall Study|Study terminated|0|||
106074573|NCT01471379|365936761|FG001|Overall Study|Study terminated|1|||
106074574|NCT01471379|365936762|FG002|Overall Study|Study terminated|0|||
106074575|NCT00352846|365936765|FG000|Overall Study|Disease progression|0|||
106074576|NCT00352846|365936766|FG001|Overall Study|Disease progression|2|||
106074577|NCT00352846|365936765|FG000|Overall Study|Withdrawal by Subject|3|||
106074578|NCT00352846|365936766|FG001|Overall Study|Withdrawal by Subject|8|||
106074579|NCT00352846|365936765|FG000|Overall Study|Ineligible|3|||
106074580|NCT00352846|365936766|FG001|Overall Study|Ineligible|2|||
106074581|NCT00352846|365936765|FG000|Overall Study|Non-compliance|2|||
106074582|NCT00352846|365936766|FG001|Overall Study|Non-compliance|0|||
106074583|NCT00352846|365936765|FG000|Overall Study|Death|0|||
106074584|NCT00352846|365936766|FG001|Overall Study|Death|1|||
106074585|NCT00729183|365936767|FG000|Overall Study|Adverse Event|11|||
106074586|NCT00729183|365936768|FG001|Overall Study|Adverse Event|5|||
106074587|NCT00729183|365936767|FG000|Overall Study|Lack of Efficacy|0|||
106074588|NCT00729183|365936768|FG001|Overall Study|Lack of Efficacy|1|||
106074589|NCT00729183|365936767|FG000|Overall Study|Lost to Follow-up|3|||
106074590|NCT00729183|365936768|FG001|Overall Study|Lost to Follow-up|1|||
106074591|NCT00729183|365936767|FG000|Overall Study|Physician Decision|1|||
106074592|NCT00729183|365936768|FG001|Overall Study|Physician Decision|1|||
106074593|NCT00729183|365936767|FG000|Overall Study|Protocol Violation|1|||
106074594|NCT00729183|365936768|FG001|Overall Study|Protocol Violation|0|||
106074595|NCT00729183|365936767|FG000|Overall Study|Withdrawal by Subject|9|||
106074596|NCT00729183|365936768|FG001|Overall Study|Withdrawal by Subject|7|||
106074597|NCT02466555|365936769|FG000|Overall Study|Lost to Follow-up|2|||
106074598|NCT01527682|365936776|FG000|Overall Study|Protocol Violation|8|||
106074599|NCT01120756|365936777|FG000|Overall Study|Withdrawal by Subject|1|||
106074600|NCT01120756|365936778|FG001|Overall Study|Withdrawal by Subject|1|||
106074601|NCT00896337|365936779|FG000|Overall Study|Death|7|||
106074602|NCT00896337|365936779|FG000|Overall Study|Withdrawal by Subject|7|||
106074603|NCT00896337|365936779|FG000|Overall Study|Lost to Follow-up|11|||
106074604|NCT04668950|365936780|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
106074605|NCT04668950|365936781|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
106074606|NCT04668950|365936780|FG000|Overall Study|Could not confirm started study medication|15|||
106074607|NCT04668950|365936781|FG001|Overall Study|Could not confirm started study medication|15|||
106074608|NCT04668950|365936780|FG000|Overall Study|Could not confirm baseline status|6|||
106074609|NCT04668950|365936781|FG001|Overall Study|Could not confirm baseline status|2|||
106074610|NCT04668950|365936780|FG000|Overall Study|Drop out and did not start medication|15|||
106074611|NCT04668950|365936781|FG001|Overall Study|Drop out and did not start medication|17|||
106074612|NCT04668950|365936780|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
106074613|NCT04668950|365936781|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
106074614|NCT04668950|365936780|FG000|Overall Study|Other|2|||
106074615|NCT04668950|365936781|FG001|Overall Study|Other|4|||
106074616|NCT00747435|365936785|FG000|Overall Study|Lost to Follow-up|2|||
106074617|NCT00747435|365936785|FG000|Overall Study|Withdrawal by Subject|3|||
106074618|NCT00747435|365936785|FG000|Overall Study|Still undergoing follow up|1|||
106158002|NCT03376321|366241486|FG001|Overall Study|Randomized, not treated|3|||
106158003|NCT04088630|366241487|FG000|Overall Study|Lost to Follow-up|3|||
106158004|NCT04088630|366241488|FG001|Overall Study|Lost to Follow-up|2|||
106158005|NCT04088630|366241489|FG002|Overall Study|Lost to Follow-up|6|||
106158006|NCT04088630|366241487|FG000|Overall Study|Death|3|||
106158007|NCT04088630|366241488|FG001|Overall Study|Death|1|||
106158008|NCT04088630|366241489|FG002|Overall Study|Death|1|||
106158009|NCT04088630|366241487|FG000|Overall Study|Physician Decision|0|||
106158010|NCT04088630|366241488|FG001|Overall Study|Physician Decision|1|||
106158011|NCT04088630|366241489|FG002|Overall Study|Physician Decision|1|||
106158012|NCT04034251|366241492|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
106158013|NCT04034251|366241493|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
106158014|NCT04034251|366241494|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
106158015|NCT05034952|366241495|FG000|Overall Study|Adverse Event|1|||
106158016|NCT05034952|366241496|FG001|Overall Study|Adverse Event|0|||
106158017|NCT05034952|366241497|FG002|Overall Study|Adverse Event|0|||
106158018|NCT05034952|366241498|FG003|Overall Study|Adverse Event|0|||
106158019|NCT05034952|366241495|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
106158020|NCT05034952|366241496|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
106158021|NCT05034952|366241497|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
106158022|NCT05034952|366241498|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
106158023|NCT05034952|366241495|FG000|Overall Study|Lost to Follow-up|1|||
106158024|NCT05034952|366241496|FG001|Overall Study|Lost to Follow-up|4|||
106158025|NCT05034952|366241497|FG002|Overall Study|Lost to Follow-up|3|||
105866629|NCT00710866|365161109|FG001|Overall Study|Withdrawal by Subject|1|||
106074619|NCT00066066|365938188|FG000|Overall Study|Lost to Follow-up|6|||
106074620|NCT00066066|365938189|FG001|Overall Study|Lost to Follow-up|4|||
106074621|NCT00066066|365938190|FG002|Overall Study|Lost to Follow-up|7|||
106074622|NCT00066066|365938191|FG003|Overall Study|Lost to Follow-up|4|||
106074623|NCT00066066|365938192|FG004|Overall Study|Lost to Follow-up|3|||
106074624|NCT00066066|365938193|FG005|Overall Study|Lost to Follow-up|5|||
106074625|NCT01254227|365938200|FG000|Overall Study|Withdrawal by Subject|6|||
106074626|NCT01254227|365938200|FG000|Overall Study|Lost to Follow-up|6|||
106074627|NCT01254227|365938200|FG000|Overall Study|Adverse Event|5|||
106074628|NCT01254227|365938200|FG000|Overall Study|Abnormal test procedure result|5|||
106158026|NCT05034952|366241498|FG003|Overall Study|Lost to Follow-up|3|||
106158027|NCT05034952|366241495|FG000|Overall Study|Other|0|||
106158028|NCT05034952|366241496|FG001|Overall Study|Other|0|||
106158029|NCT05034952|366241497|FG002|Overall Study|Other|0|||
106074629|NCT01254227|365938200|FG000|Overall Study|Administrative problems|2|||
106074630|NCT01254227|365938200|FG000|Overall Study|Death|1|||
106074631|NCT01254227|365938200|FG000|Overall Study|Protocol deviation|1|||
106074632|NCT05123222|365938201|FG000|Overall Study|Lost to Follow-up|2|||
106074633|NCT05123222|365938202|FG001|Overall Study|Lost to Follow-up|0|||
106074634|NCT05123222|365938203|FG002|Overall Study|Lost to Follow-up|0|||
106074635|NCT05123222|365938204|FG003|Overall Study|Lost to Follow-up|0|||
106074636|NCT05123222|365938201|FG000|Overall Study|Protocol Violation|0|||
106074637|NCT05123222|365938202|FG001|Overall Study|Protocol Violation|0|||
106074638|NCT05123222|365938203|FG002|Overall Study|Protocol Violation|1|||
106074639|NCT05123222|365938204|FG003|Overall Study|Protocol Violation|0|||
106074640|NCT01217060|365938205|FG000|Overall Study|Withdrawal by Subject|1|||
106074641|NCT02579265|365938206|FG000|Overall Study|Weaned off earlier than 28 days|44|||
106074642|NCT02579265|365938207|FG001|Overall Study|Weaned off earlier than 28 days|43|||
106074643|NCT02579265|365938206|FG000|Overall Study|Adverse Event|2|||
106074644|NCT02579265|365938207|FG001|Overall Study|Adverse Event|0|||
106074645|NCT02579265|365938206|FG000|Overall Study|Any other reason not specified|0|||
106074646|NCT02579265|365938207|FG001|Overall Study|Any other reason not specified|2|||
106074647|NCT02579265|365938206|FG000|Overall Study|Withdrawal by Subject|2|||
106074648|NCT02579265|365938207|FG001|Overall Study|Withdrawal by Subject|0|||
106074649|NCT02579265|365938206|FG000|Overall Study|Physician Decision|1|||
106074650|NCT02579265|365938207|FG001|Overall Study|Physician Decision|0|||
106074651|NCT02579265|365938206|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
106074652|NCT02579265|365938207|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
106074653|NCT04254978|365938213|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
106074654|NCT04254978|365938213|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
106074655|NCT04254978|365938213|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
106074656|NCT04254978|365938213|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
106074657|NCT04254978|365938213|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
106074658|NCT04254978|365938213|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
106074659|NCT00644969|365938214|FG000|Treatment Phase|Randomized, not treated|1|||
106074660|NCT00644969|365938215|FG001|Treatment Phase|Randomized, not treated|0|||
106074661|NCT00644969|365938214|FG000|Treatment Phase|Adverse Event|3|||
106074662|NCT00644969|365938215|FG001|Treatment Phase|Adverse Event|0|||
106074663|NCT00644969|365938214|FG000|Treatment Phase|Withdrawal by Subject|4|||
106074664|NCT00644969|365938215|FG001|Treatment Phase|Withdrawal by Subject|0|||
106074665|NCT00644969|365938214|FG000|Treatment Phase|Lost to Follow-up|2|||
106074666|NCT00644969|365938215|FG001|Treatment Phase|Lost to Follow-up|2|||
106074667|NCT00644969|365938214|FG000|Treatment Phase|Other|4|||
106074668|NCT00644969|365938215|FG001|Treatment Phase|Other|1|||
106074669|NCT00644969|365938214|FG000|Post Treatment Phase|Death|1|||
106074670|NCT00644969|365938215|FG001|Post Treatment Phase|Death|0|||
106074671|NCT00644969|365938214|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
106074672|NCT00644969|365938215|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
106074673|NCT00644969|365938214|FG000|Post Treatment Phase|Lost to Follow-up|4|||
106074674|NCT00644969|365938215|FG001|Post Treatment Phase|Lost to Follow-up|1|||
106074675|NCT00644969|365938214|FG000|Post Treatment Phase|Other|1|||
106074676|NCT00644969|365938215|FG001|Post Treatment Phase|Other|0|||
106074677|NCT02515942|365938216|FG000|Overall Study|Adverse Event|5|||
106074678|NCT02515942|365938217|FG001|Overall Study|Adverse Event|0|||
106074679|NCT02515942|365938218|FG002|Overall Study|Adverse Event|0|||
106074680|NCT02515942|365938216|FG000|Overall Study|Death|0|||
106074681|NCT02515942|365938217|FG001|Overall Study|Death|0|||
106074682|NCT02515942|365938218|FG002|Overall Study|Death|1|||
106074683|NCT02515942|365938216|FG000|Overall Study|Lack of Efficacy|0|||
106074684|NCT02515942|365938217|FG001|Overall Study|Lack of Efficacy|0|||
106074685|NCT02515942|365938218|FG002|Overall Study|Lack of Efficacy|1|||
106074686|NCT02515942|365938216|FG000|Overall Study|Lost to Follow-up|2|||
106074687|NCT02515942|365938217|FG001|Overall Study|Lost to Follow-up|0|||
106074688|NCT02515942|365938218|FG002|Overall Study|Lost to Follow-up|0|||
106074689|NCT02515942|365938216|FG000|Overall Study|Withdrawal by Subject|0|||
106074690|NCT02515942|365938217|FG001|Overall Study|Withdrawal by Subject|3|||
106074691|NCT02515942|365938218|FG002|Overall Study|Withdrawal by Subject|2|||
106074692|NCT03257631|365938219|FG000|Overall Study|Death|1|||
106074693|NCT03257631|365938220|FG001|Overall Study|Death|0|||
106074694|NCT03257631|365938221|FG002|Overall Study|Death|1|||
106074695|NCT03257631|365938222|FG003|Overall Study|Death|1|||
106074696|NCT03257631|365938219|FG000|Overall Study|Progressive Disease|10|||
106074697|NCT03257631|365938220|FG001|Overall Study|Progressive Disease|9|||
106074698|NCT03257631|365938221|FG002|Overall Study|Progressive Disease|17|||
106074699|NCT03257631|365938222|FG003|Overall Study|Progressive Disease|8|||
106074700|NCT03257631|365938219|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
106074701|NCT03257631|365938220|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
106074702|NCT03257631|365938221|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
106074703|NCT03257631|365938222|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
106074704|NCT03257631|365938219|FG000|Overall Study|Adverse Event|0|||
106074705|NCT03257631|365938220|FG001|Overall Study|Adverse Event|0|||
106074706|NCT03257631|365938221|FG002|Overall Study|Adverse Event|2|||
106158030|NCT05034952|366241498|FG003|Overall Study|Other|1|||
106158031|NCT00961571|366241501|FG000|Overall Study|Physician Decision|39|||
106158032|NCT04784559|366241518|FG000|Overall Study|Withdrawal by Subject|3|||
106158033|NCT04784559|366241519|FG001|Overall Study|Withdrawal by Subject|2|||
106158034|NCT04784559|366241520|FG002|Overall Study|Withdrawal by Subject|1|||
106158035|NCT04784559|366241518|FG000|Overall Study|Death|2|||
106158036|NCT04784559|366241519|FG001|Overall Study|Death|1|||
106158037|NCT04784559|366241520|FG002|Overall Study|Death|2|||
106158038|NCT04784559|366241518|FG000|Overall Study|Lost to Follow-up|0|||
106158039|NCT04784559|366241519|FG001|Overall Study|Lost to Follow-up|0|||
106158040|NCT04784559|366241520|FG002|Overall Study|Lost to Follow-up|2|||
106158041|NCT04784559|366241518|FG000|Overall Study|Participant worsened, PI decision|1|||
106158042|NCT04784559|366241519|FG001|Overall Study|Participant worsened, PI decision|0|||
106158043|NCT04784559|366241520|FG002|Overall Study|Participant worsened, PI decision|0|||
106158044|NCT04784559|366241518|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
106158045|NCT04784559|366241519|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
106158046|NCT04784559|366241520|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
106158047|NCT04784559|366241518|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
106158048|NCT04784559|366241519|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
106158049|NCT04784559|366241520|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
106158050|NCT04784559|366241518|FG000|Overall Study|Did not meet all inclusion criteria|0|||
106158051|NCT04784559|366241519|FG001|Overall Study|Did not meet all inclusion criteria|1|||
106158052|NCT04784559|366241520|FG002|Overall Study|Did not meet all inclusion criteria|0|||
106158053|NCT04784559|366241518|FG000|Overall Study|The participant was transferred to IRCU|0|||
106158054|NCT04784559|366241519|FG001|Overall Study|The participant was transferred to IRCU|1|||
106158055|NCT04784559|366241520|FG002|Overall Study|The participant was transferred to IRCU|0|||
106158056|NCT04784559|366241518|FG000|Overall Study|SAE|0|||
106158057|NCT04784559|366241519|FG001|Overall Study|SAE|1|||
106158058|NCT04784559|366241520|FG002|Overall Study|SAE|0|||
106158059|NCT04784559|366241518|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
106158060|NCT04784559|366241519|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
106158061|NCT04784559|366241520|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
106158062|NCT04179500|366241521|FG000|Treatment|Withdrawal by Subject|1|||
106158063|NCT04179500|366241521|FG000|Treatment|Adverse Event|2|||
106158064|NCT04179500|366241521|FG000|Treatment|pyrazinamide resistance|1|||
106158065|NCT02307565|366241525|FG000|Overall Study|Adverse Event|3|||
106158066|NCT02307565|366241526|FG001|Overall Study|Adverse Event|2|||
106158067|NCT02307565|366241525|FG000|Overall Study|Withdrawal by Subject|2|||
106158068|NCT02307565|366241526|FG001|Overall Study|Withdrawal by Subject|2|||
106158069|NCT04382404|366241527|FG000|Overall Study|Adverse Event|1|||
106158070|NCT04382404|366241527|FG000|Overall Study|Lost to Follow-up|2|||
106158071|NCT01580488|366241530|FG000|Overall Study|Withdrawal by Subject|1|||
106158072|NCT04936035|366241531|FG000|Overall Study|Adverse Event|0|||
106158073|NCT04936035|366241532|FG001|Overall Study|Adverse Event|1|||
106158074|NCT04936035|366241533|FG002|Overall Study|Adverse Event|0|||
106158075|NCT04936035|366241534|FG003|Overall Study|Adverse Event|0|||
106158076|NCT04936035|366241535|FG004|Overall Study|Adverse Event|0|||
106158077|NCT04936035|366241531|FG000|Overall Study|Death|0|||
106158078|NCT04936035|366241532|FG001|Overall Study|Death|0|||
106158079|NCT04936035|366241533|FG002|Overall Study|Death|0|||
106158080|NCT04936035|366241534|FG003|Overall Study|Death|1|||
106158081|NCT04936035|366241535|FG004|Overall Study|Death|0|||
106158082|NCT04936035|366241531|FG000|Overall Study|Lost to Follow-up|0|||
106158083|NCT04936035|366241532|FG001|Overall Study|Lost to Follow-up|1|||
106158084|NCT04936035|366241533|FG002|Overall Study|Lost to Follow-up|1|||
106158085|NCT04936035|366241534|FG003|Overall Study|Lost to Follow-up|2|||
106158086|NCT04936035|366241535|FG004|Overall Study|Lost to Follow-up|1|||
106158087|NCT04936035|366241531|FG000|Overall Study|Physician Decision|0|||
106158088|NCT04936035|366241532|FG001|Overall Study|Physician Decision|1|||
106158089|NCT04936035|366241533|FG002|Overall Study|Physician Decision|0|||
106158090|NCT04936035|366241534|FG003|Overall Study|Physician Decision|0|||
106158091|NCT04936035|366241535|FG004|Overall Study|Physician Decision|0|||
106158092|NCT04936035|366241531|FG000|Overall Study|Protocol Deviation|0|||
106158093|NCT04936035|366241532|FG001|Overall Study|Protocol Deviation|0|||
106158094|NCT04936035|366241533|FG002|Overall Study|Protocol Deviation|1|||
106158095|NCT04936035|366241534|FG003|Overall Study|Protocol Deviation|0|||
106158096|NCT04936035|366241535|FG004|Overall Study|Protocol Deviation|0|||
106158097|NCT04936035|366241531|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
106158098|NCT04936035|366241532|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
106158099|NCT04936035|366241533|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
106158100|NCT04936035|366241534|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
106158101|NCT04936035|366241535|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
106158102|NCT04936035|366241531|FG000|Overall Study|Reason Unknown|0|||
106158103|NCT04936035|366241532|FG001|Overall Study|Reason Unknown|0|||
106074707|NCT03257631|365938222|FG003|Overall Study|Adverse Event|0|||
106074708|NCT00902564|365938223|FG000|Overall Study|Withdrawal by Subject|2|||
106074709|NCT02474199|365938229|FG000|Overall Study|Lost to Follow-up|1|||
106074710|NCT02474199|365938230|FG001|Overall Study|Lost to Follow-up|0|||
106074711|NCT02474199|365938231|FG002|Overall Study|Lost to Follow-up|0|||
106074712|NCT02474199|365938232|FG003|Overall Study|Lost to Follow-up|0|||
106074713|NCT02474199|365938229|FG000|Overall Study|Withdrawal by Subject|1|||
106074714|NCT02474199|365938230|FG001|Overall Study|Withdrawal by Subject|2|||
106074715|NCT02474199|365938231|FG002|Overall Study|Withdrawal by Subject|0|||
106074716|NCT02474199|365938232|FG003|Overall Study|Withdrawal by Subject|1|||
106074717|NCT02474199|365938229|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
106074718|NCT02474199|365938230|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
106158104|NCT04936035|366241533|FG002|Overall Study|Reason Unknown|0|||
106158105|NCT04936035|366241534|FG003|Overall Study|Reason Unknown|0|||
106158106|NCT04936035|366241535|FG004|Overall Study|Reason Unknown|1|||
106158107|NCT04936035|366241531|FG000|Overall Study|Withdrawal by Subject|1|||
106158108|NCT04936035|366241532|FG001|Overall Study|Withdrawal by Subject|0|||
106158109|NCT04936035|366241533|FG002|Overall Study|Withdrawal by Subject|0|||
106158110|NCT04936035|366241534|FG003|Overall Study|Withdrawal by Subject|0|||
106158111|NCT04936035|366241535|FG004|Overall Study|Withdrawal by Subject|0|||
106158112|NCT04936035|366241531|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
106158113|NCT04936035|366241532|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
106158114|NCT04936035|366241533|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
106158115|NCT04936035|366241534|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
106158116|NCT04936035|366241535|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
106158117|NCT04936035|366241531|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
106158118|NCT04936035|366241532|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
106158119|NCT04936035|366241533|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
106158120|NCT04936035|366241534|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
106158121|NCT04936035|366241535|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
106158122|NCT04936035|366241531|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
106158123|NCT04936035|366241532|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
106158124|NCT04936035|366241533|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
106158125|NCT04936035|366241534|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
106158126|NCT04936035|366241535|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
106158127|NCT03792555|366241540|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
106158128|NCT03792555|366241541|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
106158129|NCT03792555|366241542|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
106158130|NCT03792555|366241540|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
106158131|NCT03792555|366241541|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
106158132|NCT03792555|366241542|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
106158133|NCT03792555|366241540|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
106158134|NCT03792555|366241541|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
106158135|NCT03792555|366241542|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
106158136|NCT04485039|366241546|FG000|TPOXX Only|Adverse Event|2|||
106158137|NCT04485039|366241546|FG000|TPOXX Only|Physician Decision|1|||
106158138|NCT04485039|366241546|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
106158139|NCT04485039|366241546|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
106158140|NCT04005716|366241547|FG000|Overall Study|Death|175|||
106158141|NCT04005716|366241548|FG001|Overall Study|Death|196|||
106158142|NCT04005716|366241547|FG000|Overall Study|Withdrawal by Subject|1|||
106097383|NCT01715805|366014397|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
106074719|NCT02474199|365938231|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
106074720|NCT02474199|365938232|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
106074721|NCT02474199|365938229|FG000|Overall Study|Did not meet eligibility criteria|0|||
106074722|NCT02474199|365938230|FG001|Overall Study|Did not meet eligibility criteria|0|||
106074723|NCT02474199|365938231|FG002|Overall Study|Did not meet eligibility criteria|2|||
106074724|NCT02474199|365938232|FG003|Overall Study|Did not meet eligibility criteria|2|||
106074725|NCT01660711|365938233|FG000|Overall Study|Adverse Event|7|||
106074726|NCT01660711|365938233|FG000|Overall Study|Withdrawal by Subject|1|||
106074727|NCT03253848|365938234|FG000|Overall Study|Adverse Event|7|||
106074728|NCT03253848|365938234|FG000|Overall Study|Death|5|||
106074729|NCT03253848|365938234|FG000|Overall Study|initiation of other treatments|3|||
106074730|NCT03253848|365938234|FG000|Overall Study|Other complicating disease|1|||
106074731|NCT03253848|365938234|FG000|Overall Study|Withdrawal by Subject|1|||
106074732|NCT03253848|365938234|FG000|Overall Study|Declining health|1|||
106074733|NCT04214288|365938237|FG000|Overall Study|Ongoing in the study|41|||
106074734|NCT04214288|365938238|FG001|Overall Study|Ongoing in the study|51|||
106074735|NCT04214288|365938239|FG002|Overall Study|Ongoing in the study|12|||
106074736|NCT04214288|365938240|FG003|Overall Study|Ongoing in the study|39|||
106074737|NCT04214288|365938237|FG000|Overall Study|Adverse Event|1|||
106074738|NCT04214288|365938238|FG001|Overall Study|Adverse Event|0|||
106074739|NCT04214288|365938239|FG002|Overall Study|Adverse Event|0|||
106074740|NCT04214288|365938240|FG003|Overall Study|Adverse Event|0|||
106074741|NCT04214288|365938237|FG000|Overall Study|Death|22|||
106074742|NCT04214288|365938238|FG001|Overall Study|Death|13|||
106074743|NCT04214288|365938239|FG002|Overall Study|Death|7|||
106074744|NCT04214288|365938240|FG003|Overall Study|Death|19|||
106074745|NCT04214288|365938237|FG000|Overall Study|Lost to Follow-up|1|||
106074746|NCT04214288|365938238|FG001|Overall Study|Lost to Follow-up|2|||
106074747|NCT04214288|365938239|FG002|Overall Study|Lost to Follow-up|1|||
106074748|NCT04214288|365938240|FG003|Overall Study|Lost to Follow-up|0|||
106074749|NCT04214288|365938237|FG000|Overall Study|Other|1|||
106074750|NCT04214288|365938238|FG001|Overall Study|Other|2|||
106074751|NCT04214288|365938239|FG002|Overall Study|Other|0|||
106074752|NCT04214288|365938240|FG003|Overall Study|Other|6|||
106074753|NCT04214288|365938237|FG000|Overall Study|Protocol Violation|0|||
106074754|NCT04214288|365938238|FG001|Overall Study|Protocol Violation|1|||
106074755|NCT04214288|365938239|FG002|Overall Study|Protocol Violation|0|||
106074756|NCT04214288|365938240|FG003|Overall Study|Protocol Violation|0|||
106074757|NCT04214288|365938237|FG000|Overall Study|Withdrawal by Subject|8|||
106074758|NCT04214288|365938238|FG001|Overall Study|Withdrawal by Subject|4|||
106074759|NCT04214288|365938239|FG002|Overall Study|Withdrawal by Subject|0|||
106074760|NCT04214288|365938240|FG003|Overall Study|Withdrawal by Subject|9|||
106074761|NCT00278954|365938241|FG000|Overall Study|Adverse Event|3|||
106074762|NCT00278954|365938241|FG000|Overall Study|Lost to Follow-up|1|||
106074763|NCT00278954|365938241|FG000|Overall Study|Withdrawal by Subject|1|||
106074764|NCT05071183|365938244|FG000|Overall Study|Death|1|||
106074765|NCT05071183|365938245|FG001|Overall Study|Death|2|||
106074766|NCT05071183|365938246|FG002|Overall Study|Death|0|||
106074767|NCT05071183|365938244|FG000|Overall Study|Other Reasons|1|||
106074768|NCT05071183|365938245|FG001|Overall Study|Other Reasons|3|||
106074769|NCT05071183|365938246|FG002|Overall Study|Other Reasons|2|||
106074770|NCT02046148|365938247|FG000|Overall Study|Lost to Follow-up|1|||
106074771|NCT02046148|365938248|FG001|Overall Study|Lost to Follow-up|1|||
106074772|NCT02046148|365938247|FG000|Overall Study|Withdrawal by Subject|0|||
106074773|NCT02046148|365938248|FG001|Overall Study|Withdrawal by Subject|2|||
106074774|NCT03412084|365938261|FG000|Overall Study|Withdrawal by Subject|2|||
106074775|NCT03412084|365938262|FG001|Overall Study|Withdrawal by Subject|0|||
106074776|NCT03412084|365938261|FG000|Overall Study|Participant moved|1|||
106074777|NCT03412084|365938262|FG001|Overall Study|Participant moved|0|||
106074778|NCT03412084|365938261|FG000|Overall Study|Lost to Follow-up|1|||
106074779|NCT03412084|365938262|FG001|Overall Study|Lost to Follow-up|1|||
106074780|NCT01478321|365938267|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
106074781|NCT01478321|365938267|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
106074782|NCT01478321|365938267|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
106074783|NCT01478321|365938267|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
106074784|NCT01478321|365938267|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
106074785|NCT01478321|365938267|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
106074786|NCT01478321|365938267|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
106074787|NCT01478321|365938267|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
106074788|NCT00634088|365938268|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
106074789|NCT00634088|365938269|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
106074790|NCT00634088|365938270|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
106074791|NCT00634088|365938271|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
106074792|NCT00634088|365938268|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
106074793|NCT00634088|365938269|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
106158143|NCT04005716|366241548|FG001|Overall Study|Withdrawal by Subject|6|||
106158144|NCT04005716|366241547|FG000|Overall Study|Lost to Follow-up|2|||
106158145|NCT04005716|366241548|FG001|Overall Study|Lost to Follow-up|2|||
106158146|NCT03892616|366241549|FG000|Washout Period 2|Met discontinuation criterion|0|||
106158147|NCT03892616|366241550|FG001|Washout Period 2|Met discontinuation criterion|0|||
106158148|NCT03892616|366241551|FG002|Washout Period 2|Met discontinuation criterion|0|||
106158149|NCT03892616|366241552|FG003|Washout Period 2|Met discontinuation criterion|0|||
106158150|NCT03892616|366241553|FG004|Washout Period 2|Met discontinuation criterion|0|||
106158151|NCT03892616|366241554|FG005|Washout Period 2|Met discontinuation criterion|0|||
106158152|NCT03892616|366241555|FG006|Washout Period 2|Met discontinuation criterion|0|||
106158153|NCT03892616|366241556|FG007|Washout Period 2|Met discontinuation criterion|0|||
106158154|NCT03892616|366241557|FG008|Washout Period 2|Met discontinuation criterion|1|||
106158155|NCT03892616|366241558|FG009|Washout Period 2|Met discontinuation criterion|0|||
106158156|NCT03892616|366241559|FG010|Washout Period 2|Met discontinuation criterion|0|||
106158157|NCT03892616|366241560|FG011|Washout Period 2|Met discontinuation criterion|0|||
106158158|NCT00378105|366241562|FG000|Overall Study|Adverse Event|3|||
106158159|NCT00378105|366241563|FG001|Overall Study|Adverse Event|1|||
106158160|NCT00378105|366241562|FG000|Overall Study|Withdrawal by Subject|3|||
106158161|NCT00378105|366241563|FG001|Overall Study|Withdrawal by Subject|3|||
106158162|NCT00378105|366241562|FG000|Overall Study|Death|1|||
106158163|NCT00378105|366241563|FG001|Overall Study|Death|0|||
106158164|NCT00378105|366241562|FG000|Overall Study|Going to transplant|7|||
106158165|NCT00378105|366241563|FG001|Overall Study|Going to transplant|8|||
106158166|NCT00378105|366241562|FG000|Overall Study|Progressive disease|3|||
106158167|NCT00378105|366241563|FG001|Overall Study|Progressive disease|3|||
106158168|NCT00378105|366241562|FG000|Overall Study|remain on study|3|||
106158169|NCT00378105|366241563|FG001|Overall Study|remain on study|11|||
106158170|NCT00378105|366241562|FG000|Overall Study|Physician Decision|0|||
106158171|NCT00378105|366241563|FG001|Overall Study|Physician Decision|2|||
106158172|NCT00378105|366241562|FG000|Overall Study|Going non-protocol therapy|0|||
106158173|NCT00378105|366241563|FG001|Overall Study|Going non-protocol therapy|1|||
106158174|NCT00378105|366241562|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
106158175|NCT00378105|366241563|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
106158176|NCT05192200|366241564|FG000|Treatment Period|Other|1|||
106158177|NCT05192200|366241564|FG000|Treatment Period|Lack of Efficacy|1|||
106158178|NCT05192200|366241564|FG000|Treatment Period|Withdrawal by Subject|1|||
106158179|NCT05192200|366241564|FG000|Follow-up|Withdrawal by Subject|1|||
106158180|NCT04241068|366241566|FG000|Core Treatment Period|Adverse Event|91|||
106158181|NCT04241068|366241566|FG000|Core Treatment Period|Change of Treatment|4|||
106158182|NCT04241068|366241566|FG000|Core Treatment Period|Consent Withdrawn|143|||
106158183|NCT04241068|366241566|FG000|Core Treatment Period|Death|26|||
106158184|NCT04241068|366241566|FG000|Core Treatment Period|Disease Progression|67|||
106158185|NCT04241068|366241566|FG000|Core Treatment Period|Investigator Decision|40|||
106158186|NCT04241068|366241566|FG000|Core Treatment Period|Loss of Capacity|9|||
106158187|NCT04241068|366241566|FG000|Core Treatment Period|Lost to Follow-up|11|||
106158188|NCT04241068|366241566|FG000|Core Treatment Period|Relocation|4|||
106158189|NCT04241068|366241566|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
106158190|NCT04241068|366241566|FG000|Core Treatment Period|Study Visit Burden|40|||
106158191|NCT04241068|366241566|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
106158192|NCT04241068|366241566|FG000|Core Treatment Period|Missing|2|||
106158193|NCT04241068|366241566|FG000|Core Treatment Period|Reason Not Specified|41|||
106158194|NCT04241068|366241566|FG000|LTE Period|Adverse Event|19|||
106158195|NCT04241068|366241566|FG000|LTE Period|Change of Treatment|1|||
106158196|NCT04241068|366241566|FG000|LTE Period|Consent Withdrawn|71|||
106158197|NCT04241068|366241566|FG000|LTE Period|Death|8|||
106158198|NCT04241068|366241566|FG000|LTE Period|Disease Progression|11|||
106158199|NCT04241068|366241566|FG000|LTE Period|Investigator Decision|12|||
106158200|NCT04241068|366241566|FG000|LTE Period|Loss of Capacity|2|||
106158201|NCT04241068|366241566|FG000|LTE Period|Lost to Follow-up|7|||
106158202|NCT04241068|366241566|FG000|LTE Period|Relocation|6|||
106158203|NCT04241068|366241566|FG000|LTE Period|Site Terminated by Sponsor|26|||
105866630|NCT00710866|365161108|FG000|Overall Study|Lost to Follow-up|1|||
105866631|NCT00710866|365161109|FG001|Overall Study|Lost to Follow-up|0|||
105866632|NCT00710866|365161108|FG000|Overall Study|Failed to meet eligibility|1|||
105866633|NCT00710866|365161109|FG001|Overall Study|Failed to meet eligibility|1|||
105866634|NCT04138823|365161111|FG000|Overall Study|Clinical disease progression|0|||
106158204|NCT04241068|366241566|FG000|LTE Period|Study Terminated by Sponsor|276|||
106158205|NCT04241068|366241566|FG000|LTE Period|Study Visit Burden|10|||
106158206|NCT04241068|366241566|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
106158207|NCT04241068|366241566|FG000|LTE Period|Reason Not Specified|65|||
106158208|NCT04831216|366241568|FG000|Overall Study|Lost to Follow-up|32|||
106158209|NCT02913872|366241573|FG000|Overall Study|Withdrawal by Subject|1|||
105866635|NCT04138823|365161112|FG001|Overall Study|Clinical disease progression|0|||
106158210|NCT04391894|366241574|FG000|Overall Study|Adverse Event|1|||
106158211|NCT04391894|366241575|FG001|Overall Study|Adverse Event|1|||
106158212|NCT04391894|366241576|FG002|Overall Study|Adverse Event|1|||
106158213|NCT04391894|366241577|FG003|Overall Study|Adverse Event|1|||
106074794|NCT00634088|365938270|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
106074795|NCT00634088|365938271|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
106074796|NCT00634088|365938268|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
106074797|NCT00634088|365938269|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
106074798|NCT00634088|365938270|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
106074799|NCT00634088|365938271|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
106074800|NCT00634088|365938268|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
106074801|NCT00634088|365938269|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
106074802|NCT00634088|365938270|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
106074803|NCT00634088|365938271|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
106074804|NCT00634088|365938268|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
106074805|NCT00634088|365938269|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
106074806|NCT00634088|365938270|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
106074807|NCT00634088|365938271|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
106074808|NCT00634088|365938268|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
106074809|NCT00634088|365938269|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
106074810|NCT00634088|365938270|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
106074811|NCT00634088|365938271|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
106074812|NCT04064294|365938272|FG000|Overall Study|Adverse Event|1|||
106074813|NCT04064294|365938273|FG001|Overall Study|Adverse Event|0|||
106074814|NCT04064294|365938274|FG002|Overall Study|Adverse Event|0|||
106074815|NCT03450707|365938275|FG000|Overall Study|Outside enrollment window|4|||
106074816|NCT03450707|365938276|FG001|Overall Study|Outside enrollment window|1|||
106074817|NCT03450707|365938275|FG000|Overall Study|Death|1|||
106074818|NCT03450707|365938276|FG001|Overall Study|Death|0|||
106074819|NCT03450707|365938275|FG000|Overall Study|Indication for thiamine|1|||
106074820|NCT03450707|365938276|FG001|Overall Study|Indication for thiamine|1|||
106074821|NCT03450707|365938275|FG000|Overall Study|Evidence of traumatic brain injury|1|||
106074822|NCT03450707|365938276|FG001|Overall Study|Evidence of traumatic brain injury|0|||
106074823|NCT03450707|365938275|FG000|Overall Study|Following commands|0|||
106074824|NCT03450707|365938276|FG001|Overall Study|Following commands|3|||
106074825|NCT03450707|365938275|FG000|Overall Study|Lactate < 3.5|0|||
106074826|NCT03450707|365938276|FG001|Overall Study|Lactate < 3.5|2|||
106074827|NCT03450707|365938275|FG000|Overall Study|Rearrest with ECMO|0|||
106074828|NCT03450707|365938276|FG001|Overall Study|Rearrest with ECMO|1|||
106074829|NCT03450707|365938275|FG000|Overall Study|Indication for thiamine + head CT results|0|||
106074830|NCT03450707|365938276|FG001|Overall Study|Indication for thiamine + head CT results|1|||
106074831|NCT03450707|365938275|FG000|Overall Study|Family/patient goals of care|0|||
106074832|NCT03450707|365938276|FG001|Overall Study|Family/patient goals of care|1|||
106074833|NCT03343483|365938277|FG000|Overall Study|Death|0|||
106074834|NCT03343483|365938278|FG001|Overall Study|Death|3|||
106074835|NCT03343483|365938277|FG000|Overall Study|Lost to Follow-up|9|||
106074836|NCT03343483|365938278|FG001|Overall Study|Lost to Follow-up|13|||
106074837|NCT03343483|365938277|FG000|Overall Study|Withdrawal by Subject|8|||
106074838|NCT03343483|365938278|FG001|Overall Study|Withdrawal by Subject|17|||
106074839|NCT01505608|365938279|FG000|Phase I|Lack of Efficacy|0|||
106074840|NCT01505608|365938280|FG001|Phase I|Lack of Efficacy|4|||
106074841|NCT01505608|365938279|FG000|Phase I|Adverse Event|0|||
106074842|NCT01505608|365938280|FG001|Phase I|Adverse Event|1|||
106074843|NCT01505608|365938279|FG000|Phase I|Withdrawal by Subject|0|||
106074844|NCT01505608|365938280|FG001|Phase I|Withdrawal by Subject|1|||
106074845|NCT01505608|365938279|FG000|Phase II|Lack of Efficacy|2|||
106074846|NCT01505608|365938280|FG001|Phase II|Lack of Efficacy|1|||
106074847|NCT01505608|365938279|FG000|Phase II|Protocol Violation|0|||
106074848|NCT01505608|365938280|FG001|Phase II|Protocol Violation|1|||
106074849|NCT01520363|365938289|FG000|Overall Study|Withdrawal by Subject|2|||
106074850|NCT01520363|365938290|FG001|Overall Study|Withdrawal by Subject|0|||
106074851|NCT01251380|365938293|FG000|Overall Study|Other (Not otherwise specified)|12|||
106074852|NCT01251380|365938293|FG000|Overall Study|Withdrawal by Subject|6|||
106074853|NCT01251380|365938293|FG000|Overall Study|Lack of Efficacy|1|||
106074854|NCT01251380|365938293|FG000|Overall Study|Adverse Event|1|||
106074855|NCT01251380|365938293|FG000|Overall Study|Lost to Follow-up|2|||
106074856|NCT03792672|365938294|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
106074857|NCT03792672|365938295|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
106074858|NCT03792672|365938296|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
106074859|NCT03792672|365938297|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
106074860|NCT03792672|365938298|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
106074861|NCT03792672|365938299|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
106074862|NCT03792672|365938294|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
106074863|NCT03792672|365938295|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
106074864|NCT03792672|365938296|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
106074865|NCT03792672|365938297|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
106074866|NCT03792672|365938298|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
106074867|NCT03792672|365938299|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
106074868|NCT03792672|365938294|FG000|Treatment Period 4 (2 Days)|Other|1|||
106074869|NCT03792672|365938295|FG001|Treatment Period 4 (2 Days)|Other|0|||
106074870|NCT03792672|365938296|FG002|Treatment Period 4 (2 Days)|Other|0|||
106074871|NCT03792672|365938297|FG003|Treatment Period 4 (2 Days)|Other|0|||
106074872|NCT03792672|365938298|FG004|Treatment Period 4 (2 Days)|Other|0|||
106074873|NCT03792672|365938299|FG005|Treatment Period 4 (2 Days)|Other|0|||
106074874|NCT01498952|365938303|FG000|Overall Study|Death|2|||
106074875|NCT01498952|365938304|FG001|Overall Study|Death|2|||
106074876|NCT01498952|365938305|FG002|Overall Study|Death|0|||
106074877|NCT01498952|365938306|FG003|Overall Study|Death|0|||
106074878|NCT01498952|365938307|FG004|Overall Study|Death|0|||
106074879|NCT00579826|365938310|FG000|Overall Study|Withdrawal by Subject|5|||
106074880|NCT00579826|365938311|FG001|Overall Study|Withdrawal by Subject|3|||
106074881|NCT03608774|365938312|FG000|Overall Study|Lost to Follow-up|5|||
106074882|NCT03608774|365938313|FG001|Overall Study|Lost to Follow-up|5|||
106074883|NCT03608774|365938312|FG000|Overall Study|Withdrawal by Subject|1|||
106074884|NCT03608774|365938313|FG001|Overall Study|Withdrawal by Subject|0|||
106074885|NCT03608774|365938312|FG000|Overall Study|Protocol Violation|1|||
106074886|NCT03608774|365938313|FG001|Overall Study|Protocol Violation|0|||
106074887|NCT03608774|365938312|FG000|Overall Study|Not eligible at enrollment|0|||
106074888|NCT03608774|365938313|FG001|Overall Study|Not eligible at enrollment|1|||
106074889|NCT03608774|365938312|FG000|Overall Study|Health related event|0|||
106074890|NCT03608774|365938313|FG001|Overall Study|Health related event|1|||
106074891|NCT01359254|365938314|FG000|Overall Study|Death|1|||
106074892|NCT01359254|365938315|FG001|Overall Study|Death|0|||
106074893|NCT03979638|365938317|FG000|Period 1|Physician Decision|1|||
106074894|NCT03979638|365938318|FG001|Period 1|Physician Decision|1|||
106074895|NCT03979638|365938317|FG000|Period 1|Withdrawal by Subject|4|||
106074896|NCT03979638|365938318|FG001|Period 1|Withdrawal by Subject|3|||
106074897|NCT03979638|365938317|FG000|Period 1|Study terminated by Sponsor|1|||
106074898|NCT03979638|365938318|FG001|Period 1|Study terminated by Sponsor|3|||
106074899|NCT03979638|365938317|FG000|Period 1|Protocol Violation|1|||
106074900|NCT03979638|365938318|FG001|Period 1|Protocol Violation|0|||
106074901|NCT03979638|365938317|FG000|Period 2|Study terminated by Sponsor|1|||
106074902|NCT03979638|365938318|FG001|Period 2|Study terminated by Sponsor|1|||
106074903|NCT00578942|365938319|FG000|Overall Study|Lost to Follow-up|1|||
106074904|NCT00600938|365938324|FG000|Core Study|Abnormal test procedure result(s)|3|||
106074905|NCT00600938|365938325|FG001|Core Study|Abnormal test procedure result(s)|2|||
106074906|NCT00600938|365938326|FG002|Core Study|Abnormal test procedure result(s)|0|||
106074907|NCT00600938|365938327|FG003|Core Study|Abnormal test procedure result(s)|0|||
106074908|NCT00600938|365938324|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
106074909|NCT00600938|365938325|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
106074910|NCT00600938|365938326|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
106074911|NCT00600938|365938327|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
106074912|NCT00600938|365938324|FG000|Core Study|Patient withdrew consent|7|||
106074913|NCT00600938|365938325|FG001|Core Study|Patient withdrew consent|12|||
106074914|NCT00600938|365938326|FG002|Core Study|Patient withdrew consent|0|||
106074915|NCT00600938|365938327|FG003|Core Study|Patient withdrew consent|0|||
106074916|NCT00600938|365938324|FG000|Core Study|Lost to Follow-up|3|||
106074917|NCT00600938|365938325|FG001|Core Study|Lost to Follow-up|2|||
106074918|NCT00600938|365938326|FG002|Core Study|Lost to Follow-up|0|||
106074919|NCT00600938|365938327|FG003|Core Study|Lost to Follow-up|0|||
106074920|NCT00600938|365938324|FG000|Core Study|Death|1|||
106074921|NCT00600938|365938325|FG001|Core Study|Death|1|||
106074922|NCT00600938|365938326|FG002|Core Study|Death|0|||
106074923|NCT00600938|365938327|FG003|Core Study|Death|0|||
106074924|NCT00600938|365938324|FG000|Core Study|Protocol Violation|1|||
106074925|NCT00600938|365938325|FG001|Core Study|Protocol Violation|2|||
106074926|NCT00600938|365938326|FG002|Core Study|Protocol Violation|0|||
106074927|NCT00600938|365938327|FG003|Core Study|Protocol Violation|0|||
106074928|NCT00600938|365938324|FG000|Extension Study|Adverse Event|1|||
106074929|NCT00600938|365938325|FG001|Extension Study|Adverse Event|0|||
106074930|NCT00600938|365938326|FG002|Extension Study|Adverse Event|2|||
106074931|NCT00600938|365938327|FG003|Extension Study|Adverse Event|0|||
106074932|NCT00600938|365938324|FG000|Extension Study|Abnormal test procedure results|0|||
106074933|NCT00600938|365938325|FG001|Extension Study|Abnormal test procedure results|1|||
106074934|NCT00600938|365938326|FG002|Extension Study|Abnormal test procedure results|1|||
106074935|NCT00600938|365938327|FG003|Extension Study|Abnormal test procedure results|1|||
106074936|NCT00600938|365938324|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
106074937|NCT00600938|365938325|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
106074938|NCT00600938|365938326|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
106074939|NCT00600938|365938327|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
106074940|NCT00600938|365938324|FG000|Extension Study|Withdrawal by Subject|2|||
106074941|NCT00600938|365938325|FG001|Extension Study|Withdrawal by Subject|2|||
106074942|NCT00600938|365938326|FG002|Extension Study|Withdrawal by Subject|3|||
106074943|NCT00600938|365938327|FG003|Extension Study|Withdrawal by Subject|0|||
106074944|NCT00600938|365938324|FG000|Extension Study|Lost to Follow-up|1|||
106074945|NCT00600938|365938325|FG001|Extension Study|Lost to Follow-up|1|||
106074946|NCT00600938|365938326|FG002|Extension Study|Lost to Follow-up|2|||
106074947|NCT00600938|365938327|FG003|Extension Study|Lost to Follow-up|0|||
106074948|NCT00600938|365938324|FG000|Extension Study|Death|1|||
106074949|NCT00600938|365938325|FG001|Extension Study|Death|0|||
106074950|NCT00600938|365938326|FG002|Extension Study|Death|0|||
106074951|NCT00600938|365938327|FG003|Extension Study|Death|0|||
106074952|NCT01124643|365938328|FG000|Overall Study|Death|1|||
106074953|NCT04220411|365938329|FG000|Overall Study|Adverse Event|0|||
106074954|NCT04220411|365938330|FG001|Overall Study|Adverse Event|0|||
106074955|NCT04220411|365938331|FG002|Overall Study|Adverse Event|0|||
106074956|NCT04220411|365938332|FG003|Overall Study|Adverse Event|1|||
106074957|NCT01063595|365938333|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
106074958|NCT01063595|365938334|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
106074959|NCT01063595|365938333|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
106074960|NCT01063595|365938334|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
106074961|NCT01063595|365938333|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
106074962|NCT01063595|365938334|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
106074963|NCT01063595|365938333|FG000|First Intervention|Adverse Event|1|||
106074964|NCT01063595|365938334|FG001|First Intervention|Adverse Event|4|||
106074965|NCT01063595|365938333|FG000|First Intervention|Withdrawal by Subject|1|||
106074966|NCT01063595|365938334|FG001|First Intervention|Withdrawal by Subject|0|||
106074967|NCT01063595|365938333|FG000|First Intervention|Reason not Specified|0|||
106074968|NCT01063595|365938334|FG001|First Intervention|Reason not Specified|1|||
106074969|NCT02678676|365938335|FG000|Overall Study|Death|619|||
106074970|NCT02678676|365938336|FG001|Overall Study|Death|649|||
106074971|NCT02678676|365938335|FG000|Overall Study|Withdrawal by Subject|13|||
106074972|NCT02678676|365938336|FG001|Overall Study|Withdrawal by Subject|5|||
106074973|NCT02678676|365938335|FG000|Overall Study|Lost to Follow-up|171|||
106074974|NCT02678676|365938336|FG001|Overall Study|Lost to Follow-up|151|||
106074975|NCT02678676|365938335|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
106074976|NCT02678676|365938336|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
106074977|NCT04327986|365938338|FG000|Overall Study|Physician Decision|2|||
106074978|NCT04327986|365938339|FG001|Overall Study|Physician Decision|0|||
106074979|NCT04327986|365938340|FG002|Overall Study|Physician Decision|0|||
106074980|NCT04327986|365938338|FG000|Overall Study|Death|1|||
106074981|NCT04327986|365938339|FG001|Overall Study|Death|0|||
106074982|NCT04327986|365938340|FG002|Overall Study|Death|0|||
106074983|NCT00006478|365939708|FG000|Overall Study|Vaccine could not be produced|1|||
106074984|NCT00006478|365939708|FG000|Overall Study|Physician Decision|6|||
106074985|NCT03161483|365939709|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
106074986|NCT03161483|365939710|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
106074987|NCT03161483|365939711|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
106074988|NCT03161483|365939712|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
106074989|NCT03161483|365939709|FG000|Treatment Period|Death|1|||
106074990|NCT03161483|365939710|FG001|Treatment Period|Death|0|||
106074991|NCT03161483|365939711|FG002|Treatment Period|Death|0|||
106074992|NCT03161483|365939712|FG003|Treatment Period|Death|0|||
106074993|NCT03161483|365939709|FG000|Treatment Period|Adverse Event|5|||
106074994|NCT03161483|365939710|FG001|Treatment Period|Adverse Event|2|||
105866636|NCT04138823|365161113|FG002|Overall Study|Clinical disease progression|1|||
106074995|NCT03161483|365939711|FG002|Treatment Period|Adverse Event|1|||
106074996|NCT03161483|365939712|FG003|Treatment Period|Adverse Event|11|||
106074997|NCT03161483|365939709|FG000|Treatment Period|Pregnancy|1|||
106074998|NCT03161483|365939710|FG001|Treatment Period|Pregnancy|0|||
106074999|NCT03161483|365939711|FG002|Treatment Period|Pregnancy|0|||
106075000|NCT03161483|365939712|FG003|Treatment Period|Pregnancy|0|||
106075001|NCT03161483|365939709|FG000|Treatment Period|Lack of Efficacy|0|||
106075002|NCT03161483|365939710|FG001|Treatment Period|Lack of Efficacy|0|||
106075003|NCT03161483|365939711|FG002|Treatment Period|Lack of Efficacy|0|||
106075004|NCT03161483|365939712|FG003|Treatment Period|Lack of Efficacy|1|||
106075005|NCT03161483|365939709|FG000|Treatment Period|Withdrawal by Subject|2|||
106075006|NCT03161483|365939710|FG001|Treatment Period|Withdrawal by Subject|5|||
106075007|NCT03161483|365939711|FG002|Treatment Period|Withdrawal by Subject|2|||
106075008|NCT03161483|365939712|FG003|Treatment Period|Withdrawal by Subject|6|||
106075009|NCT03161483|365939709|FG000|Treatment Period|Lost to Follow-up|0|||
106075010|NCT03161483|365939710|FG001|Treatment Period|Lost to Follow-up|0|||
106075011|NCT03161483|365939711|FG002|Treatment Period|Lost to Follow-up|0|||
106075012|NCT03161483|365939712|FG003|Treatment Period|Lost to Follow-up|1|||
106075013|NCT03161483|365939709|FG000|Treatment Period|Protocol Violation|0|||
106075014|NCT03161483|365939710|FG001|Treatment Period|Protocol Violation|0|||
106075015|NCT03161483|365939711|FG002|Treatment Period|Protocol Violation|0|||
106075016|NCT03161483|365939712|FG003|Treatment Period|Protocol Violation|1|||
106075017|NCT03161483|365939709|FG000|Treatment Period|Other reasons|1|||
106075018|NCT03161483|365939710|FG001|Treatment Period|Other reasons|1|||
106075019|NCT03161483|365939711|FG002|Treatment Period|Other reasons|0|||
106075020|NCT03161483|365939712|FG003|Treatment Period|Other reasons|0|||
106075021|NCT03261947|365939714|FG000|Overall Study|Death|10|||
106075022|NCT03261947|365939715|FG001|Overall Study|Death|13|||
106075023|NCT03261947|365939716|FG002|Overall Study|Death|17|||
106075024|NCT03261947|365939717|FG003|Overall Study|Death|12|||
106158214|NCT04391894|366241578|FG004|Overall Study|Adverse Event|1|||
106158215|NCT04391894|366241574|FG000|Overall Study|Lost to Follow-up|1|||
106158216|NCT04391894|366241575|FG001|Overall Study|Lost to Follow-up|0|||
106158217|NCT04391894|366241576|FG002|Overall Study|Lost to Follow-up|0|||
106158218|NCT04391894|366241577|FG003|Overall Study|Lost to Follow-up|0|||
106158219|NCT04391894|366241578|FG004|Overall Study|Lost to Follow-up|0|||
106158220|NCT04391894|366241574|FG000|Overall Study|Protocol Violation|0|||
106158221|NCT04391894|366241575|FG001|Overall Study|Protocol Violation|0|||
106158222|NCT04391894|366241576|FG002|Overall Study|Protocol Violation|0|||
106158223|NCT04391894|366241577|FG003|Overall Study|Protocol Violation|1|||
106158224|NCT04391894|366241578|FG004|Overall Study|Protocol Violation|0|||
106158225|NCT04391894|366241574|FG000|Overall Study|Withdrawal by Subject|2|||
106158226|NCT04391894|366241575|FG001|Overall Study|Withdrawal by Subject|0|||
106158227|NCT04391894|366241576|FG002|Overall Study|Withdrawal by Subject|3|||
106158228|NCT04391894|366241577|FG003|Overall Study|Withdrawal by Subject|0|||
106158229|NCT04391894|366241578|FG004|Overall Study|Withdrawal by Subject|1|||
106158230|NCT04391894|366241574|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
106158231|NCT04391894|366241575|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
106158232|NCT04391894|366241576|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
106158233|NCT04391894|366241577|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
106158234|NCT04391894|366241578|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
106158235|NCT02323321|366241579|FG000|Overall Study|Re-Transplant|1|||
106158236|NCT02323321|366241579|FG000|Overall Study|Death|12|||
106158237|NCT00446225|366241580|FG000|Overall Study|Protocol Violation|1|||
106158238|NCT00446225|366241581|FG001|Overall Study|Protocol Violation|0|||
106158239|NCT03150810|366241582|FG000|Overall Study|Death|4|||
106158240|NCT03150810|366241583|FG001|Overall Study|Death|8|||
106158241|NCT03150810|366241584|FG002|Overall Study|Death|7|||
106158242|NCT03150810|366241585|FG003|Overall Study|Death|2|||
106158243|NCT03150810|366241586|FG004|Overall Study|Death|2|||
106158244|NCT03150810|366241587|FG005|Overall Study|Death|10|||
106158245|NCT03150810|366241588|FG006|Overall Study|Death|8|||
106158246|NCT03150810|366241589|FG007|Overall Study|Death|6|||
106158247|NCT03150810|366241590|FG008|Overall Study|Death|18|||
106158248|NCT03150810|366241591|FG009|Overall Study|Death|3|||
106158249|NCT03150810|366241592|FG010|Overall Study|Death|19|||
106158250|NCT03150810|366241593|FG011|Overall Study|Death|1|||
106158251|NCT03150810|366241594|FG012|Overall Study|Death|19|||
106158252|NCT03150810|366241582|FG000|Overall Study|Withdrawal by Subject|0|||
106158253|NCT03150810|366241583|FG001|Overall Study|Withdrawal by Subject|1|||
106158254|NCT03150810|366241584|FG002|Overall Study|Withdrawal by Subject|1|||
106158255|NCT03150810|366241585|FG003|Overall Study|Withdrawal by Subject|1|||
106158256|NCT03150810|366241586|FG004|Overall Study|Withdrawal by Subject|0|||
106158257|NCT03150810|366241587|FG005|Overall Study|Withdrawal by Subject|0|||
106158258|NCT03150810|366241588|FG006|Overall Study|Withdrawal by Subject|2|||
106158259|NCT03150810|366241589|FG007|Overall Study|Withdrawal by Subject|0|||
106158260|NCT03150810|366241590|FG008|Overall Study|Withdrawal by Subject|2|||
106158261|NCT03150810|366241591|FG009|Overall Study|Withdrawal by Subject|0|||
106158262|NCT03150810|366241592|FG010|Overall Study|Withdrawal by Subject|1|||
106158263|NCT03150810|366241593|FG011|Overall Study|Withdrawal by Subject|0|||
106158264|NCT03150810|366241594|FG012|Overall Study|Withdrawal by Subject|1|||
106158265|NCT03150810|366241582|FG000|Overall Study|Sponsor Decision|0|||
106158266|NCT03150810|366241583|FG001|Overall Study|Sponsor Decision|2|||
106158267|NCT03150810|366241584|FG002|Overall Study|Sponsor Decision|0|||
106158268|NCT03150810|366241585|FG003|Overall Study|Sponsor Decision|0|||
106158269|NCT03150810|366241586|FG004|Overall Study|Sponsor Decision|1|||
106158270|NCT03150810|366241587|FG005|Overall Study|Sponsor Decision|1|||
106158271|NCT03150810|366241588|FG006|Overall Study|Sponsor Decision|0|||
106158272|NCT03150810|366241589|FG007|Overall Study|Sponsor Decision|0|||
106158273|NCT03150810|366241590|FG008|Overall Study|Sponsor Decision|1|||
106158274|NCT03150810|366241591|FG009|Overall Study|Sponsor Decision|0|||
106158275|NCT03150810|366241592|FG010|Overall Study|Sponsor Decision|0|||
106158276|NCT03150810|366241593|FG011|Overall Study|Sponsor Decision|0|||
106158277|NCT03150810|366241594|FG012|Overall Study|Sponsor Decision|5|||
106158278|NCT03150810|366241582|FG000|Overall Study|Lost to Follow-up|0|||
106158279|NCT03150810|366241583|FG001|Overall Study|Lost to Follow-up|1|||
106158280|NCT03150810|366241584|FG002|Overall Study|Lost to Follow-up|1|||
106158281|NCT03150810|366241585|FG003|Overall Study|Lost to Follow-up|0|||
106158282|NCT03150810|366241586|FG004|Overall Study|Lost to Follow-up|0|||
106158283|NCT03150810|366241587|FG005|Overall Study|Lost to Follow-up|0|||
106158284|NCT03150810|366241588|FG006|Overall Study|Lost to Follow-up|1|||
106158285|NCT03150810|366241589|FG007|Overall Study|Lost to Follow-up|0|||
106158286|NCT03150810|366241590|FG008|Overall Study|Lost to Follow-up|0|||
106158287|NCT03150810|366241591|FG009|Overall Study|Lost to Follow-up|0|||
106158288|NCT03150810|366241592|FG010|Overall Study|Lost to Follow-up|1|||
106158289|NCT03150810|366241593|FG011|Overall Study|Lost to Follow-up|0|||
106158290|NCT03150810|366241594|FG012|Overall Study|Lost to Follow-up|0|||
106158291|NCT03150810|366241582|FG000|Overall Study|Physician Decision|0|||
106158292|NCT03150810|366241583|FG001|Overall Study|Physician Decision|0|||
106158293|NCT03150810|366241584|FG002|Overall Study|Physician Decision|0|||
106075025|NCT03261947|365939718|FG004|Overall Study|Death|8|||
106075026|NCT03261947|365939714|FG000|Overall Study|Lost to Follow-up|0|||
106075027|NCT03261947|365939715|FG001|Overall Study|Lost to Follow-up|0|||
106075028|NCT03261947|365939716|FG002|Overall Study|Lost to Follow-up|2|||
106075029|NCT03261947|365939717|FG003|Overall Study|Lost to Follow-up|1|||
106075030|NCT03261947|365939718|FG004|Overall Study|Lost to Follow-up|0|||
106075031|NCT03261947|365939714|FG000|Overall Study|Withdrawal by Subject|0|||
106075032|NCT03261947|365939715|FG001|Overall Study|Withdrawal by Subject|0|||
106075033|NCT03261947|365939716|FG002|Overall Study|Withdrawal by Subject|3|||
106075034|NCT03261947|365939717|FG003|Overall Study|Withdrawal by Subject|0|||
106075035|NCT03261947|365939718|FG004|Overall Study|Withdrawal by Subject|1|||
106075036|NCT03261947|365939714|FG000|Overall Study|Site Terminated by Sponsor|0|||
106075037|NCT03261947|365939715|FG001|Overall Study|Site Terminated by Sponsor|0|||
106075038|NCT03261947|365939716|FG002|Overall Study|Site Terminated by Sponsor|4|||
106075039|NCT03261947|365939717|FG003|Overall Study|Site Terminated by Sponsor|7|||
106075040|NCT03261947|365939718|FG004|Overall Study|Site Terminated by Sponsor|5|||
106075041|NCT03261947|365939714|FG000|Overall Study|Reason not Specified|2|||
106075042|NCT03261947|365939715|FG001|Overall Study|Reason not Specified|0|||
106075043|NCT03261947|365939716|FG002|Overall Study|Reason not Specified|4|||
106075044|NCT03261947|365939717|FG003|Overall Study|Reason not Specified|1|||
106075045|NCT03261947|365939718|FG004|Overall Study|Reason not Specified|3|||
106075046|NCT00228917|365939719|FG000|Overall Study|Migrated/moved from study area|0|||
106075047|NCT00228917|365939720|FG001|Overall Study|Migrated/moved from study area|0|||
106075048|NCT00228917|365939721|FG002|Overall Study|Migrated/moved from study area|0|||
106075049|NCT00228917|365939722|FG003|Overall Study|Migrated/moved from study area|0|||
106075050|NCT00228917|365939723|FG004|Overall Study|Migrated/moved from study area|0|||
106075051|NCT00228917|365939724|FG005|Overall Study|Migrated/moved from study area|2|||
106075052|NCT00228917|365939725|FG006|Overall Study|Migrated/moved from study area|0|||
106075053|NCT00228917|365939726|FG007|Overall Study|Migrated/moved from study area|0|||
106075054|NCT00409617|365939727|FG000|Overall Study|Adverse Event|57|||
106075055|NCT00409617|365939727|FG000|Overall Study|Lack of Efficacy|54|||
106075056|NCT00409617|365939727|FG000|Overall Study|Lost to Follow-up|2|||
106075057|NCT00409617|365939727|FG000|Overall Study|Protocol Violation|24|||
106075058|NCT00409617|365939727|FG000|Overall Study|Withdrawal by Subject|8|||
106158294|NCT03150810|366241585|FG003|Overall Study|Physician Decision|0|||
106158295|NCT03150810|366241586|FG004|Overall Study|Physician Decision|0|||
106158296|NCT03150810|366241587|FG005|Overall Study|Physician Decision|1|||
106158297|NCT03150810|366241588|FG006|Overall Study|Physician Decision|1|||
106158298|NCT03150810|366241589|FG007|Overall Study|Physician Decision|0|||
106158299|NCT03150810|366241590|FG008|Overall Study|Physician Decision|0|||
106158300|NCT03150810|366241591|FG009|Overall Study|Physician Decision|0|||
106158301|NCT03150810|366241592|FG010|Overall Study|Physician Decision|0|||
106158302|NCT03150810|366241593|FG011|Overall Study|Physician Decision|0|||
106158303|NCT03150810|366241594|FG012|Overall Study|Physician Decision|0|||
106158304|NCT03150810|366241582|FG000|Overall Study|Site withdrawal from study|0|||
106158305|NCT03150810|366241583|FG001|Overall Study|Site withdrawal from study|1|||
106158306|NCT03150810|366241584|FG002|Overall Study|Site withdrawal from study|0|||
106158307|NCT03150810|366241585|FG003|Overall Study|Site withdrawal from study|0|||
106158308|NCT03150810|366241586|FG004|Overall Study|Site withdrawal from study|0|||
106158309|NCT03150810|366241587|FG005|Overall Study|Site withdrawal from study|0|||
106158310|NCT03150810|366241588|FG006|Overall Study|Site withdrawal from study|0|||
106158311|NCT03150810|366241589|FG007|Overall Study|Site withdrawal from study|0|||
106158312|NCT03150810|366241590|FG008|Overall Study|Site withdrawal from study|0|||
106158313|NCT03150810|366241591|FG009|Overall Study|Site withdrawal from study|1|||
106158314|NCT03150810|366241592|FG010|Overall Study|Site withdrawal from study|1|||
106158315|NCT03150810|366241593|FG011|Overall Study|Site withdrawal from study|0|||
106158316|NCT03150810|366241594|FG012|Overall Study|Site withdrawal from study|0|||
105866637|NCT04138823|365161111|FG000|Overall Study|Objective disease progression|3|||
106075059|NCT00409617|365939727|FG000|Overall Study|Administrative reasons|1|||
106075060|NCT00409617|365939727|FG000|Overall Study|Not described|14|||
106075061|NCT02063737|365939729|FG000|Overall Study|Lost to Follow-up|11|||
106075062|NCT02063737|365939730|FG001|Overall Study|Lost to Follow-up|4|||
106075063|NCT00149747|365939731|FG000|Overall Study|Death|1|||
106075064|NCT00149747|365939732|FG001|Overall Study|Death|0|||
106075065|NCT00149747|365939731|FG000|Overall Study|Withdrawal by Subject|3|||
106075066|NCT00149747|365939732|FG001|Overall Study|Withdrawal by Subject|3|||
106075067|NCT03373383|365939733|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
106158317|NCT03150810|366241582|FG000|Overall Study|Hospice|0|||
106158318|NCT03150810|366241583|FG001|Overall Study|Hospice|0|||
106158319|NCT03150810|366241584|FG002|Overall Study|Hospice|0|||
106158320|NCT03150810|366241585|FG003|Overall Study|Hospice|0|||
106158321|NCT03150810|366241586|FG004|Overall Study|Hospice|0|||
106158322|NCT03150810|366241587|FG005|Overall Study|Hospice|1|||
106075068|NCT03373383|365939734|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
106075069|NCT03373383|365939735|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
106075070|NCT03373383|365939736|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
106075071|NCT03373383|365939737|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
106075072|NCT03373383|365939733|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
106075073|NCT03373383|365939734|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
106075074|NCT03373383|365939735|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
106075075|NCT03373383|365939736|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
106075076|NCT03373383|365939737|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
106075077|NCT03373383|365939733|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
106075078|NCT03373383|365939734|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
106075079|NCT03373383|365939735|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
106075080|NCT03373383|365939736|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
106075081|NCT03373383|365939737|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
106075082|NCT03373383|365939733|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
106075083|NCT03373383|365939734|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
106075084|NCT03373383|365939735|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
106075085|NCT03373383|365939736|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
106075086|NCT03373383|365939737|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
106075087|NCT03373383|365939733|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
106075088|NCT03373383|365939734|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
106075089|NCT03373383|365939735|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
106075090|NCT03373383|365939736|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
106075091|NCT03373383|365939737|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
106075092|NCT03373383|365939733|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
106075093|NCT03373383|365939734|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
106075094|NCT03373383|365939735|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
106075095|NCT03373383|365939736|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
106075096|NCT03373383|365939737|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
106075097|NCT03373383|365939733|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
106075098|NCT03373383|365939734|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
106075099|NCT03373383|365939735|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
106075100|NCT03373383|365939736|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
106075101|NCT03373383|365939737|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
106075102|NCT03373383|365939733|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
106075103|NCT03373383|365939734|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
106075104|NCT03373383|365939735|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
106075105|NCT03373383|365939736|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
106075106|NCT03373383|365939737|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
106075107|NCT03373383|365939733|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
106075108|NCT03373383|365939734|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
106075109|NCT03373383|365939735|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
106075110|NCT03373383|365939736|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
106075111|NCT03373383|365939737|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
106075112|NCT02871739|365939739|FG000|Overall Study|Lost to Follow-up|3|||
106075113|NCT02871739|365939740|FG001|Overall Study|Lost to Follow-up|2|||
106075114|NCT02871739|365939741|FG002|Overall Study|Lost to Follow-up|0|||
106075115|NCT02871739|365939742|FG003|Overall Study|Lost to Follow-up|2|||
106075116|NCT03316885|365939743|FG000|Overall Study|Adverse Event|1|||
106075117|NCT03316885|365939743|FG000|Overall Study|Death|10|||
106075118|NCT03316885|365939743|FG000|Overall Study|Lost to Follow-up|4|||
106075119|NCT03316885|365939743|FG000|Overall Study|Withdrawal by Subject|9|||
106075120|NCT03316885|365939743|FG000|Overall Study|COVID related|8|||
106075121|NCT03190889|365939747|FG000|Overall Study|Lost to Follow-up|7|||
106075122|NCT03190889|365939748|FG001|Overall Study|Lost to Follow-up|7|||
106075123|NCT03190889|365939749|FG002|Overall Study|Lost to Follow-up|3|||
106075124|NCT03190889|365939747|FG000|Overall Study|Withdrawal by Subject|1|||
106075125|NCT03190889|365939748|FG001|Overall Study|Withdrawal by Subject|1|||
106158323|NCT03150810|366241588|FG006|Overall Study|Hospice|0|||
106158324|NCT03150810|366241589|FG007|Overall Study|Hospice|0|||
106158325|NCT03150810|366241590|FG008|Overall Study|Hospice|0|||
106158326|NCT03150810|366241591|FG009|Overall Study|Hospice|0|||
106075126|NCT03190889|365939749|FG002|Overall Study|Withdrawal by Subject|2|||
106075127|NCT03190889|365939747|FG000|Overall Study|Did not complete protocol|4|||
106075128|NCT03190889|365939748|FG001|Overall Study|Did not complete protocol|9|||
106075129|NCT03190889|365939749|FG002|Overall Study|Did not complete protocol|0|||
106075130|NCT03190889|365939747|FG000|Overall Study|COVID-19|1|||
106075131|NCT03190889|365939748|FG001|Overall Study|COVID-19|0|||
106075132|NCT03190889|365939749|FG002|Overall Study|COVID-19|2|||
106075133|NCT01709695|365939752|FG000|Overall Study|Withdrawal by Subject|1|||
106075134|NCT01709695|365939753|FG001|Overall Study|Withdrawal by Subject|1|||
106158327|NCT03150810|366241592|FG010|Overall Study|Hospice|0|||
106158328|NCT03150810|366241593|FG011|Overall Study|Hospice|0|||
106158329|NCT03150810|366241594|FG012|Overall Study|Hospice|0|||
106158330|NCT03150810|366241582|FG000|Overall Study|Participant relocated abroad.|0|||
106158331|NCT03150810|366241583|FG001|Overall Study|Participant relocated abroad.|0|||
106158332|NCT03150810|366241584|FG002|Overall Study|Participant relocated abroad.|0|||
106158333|NCT03150810|366241585|FG003|Overall Study|Participant relocated abroad.|0|||
106158334|NCT03150810|366241586|FG004|Overall Study|Participant relocated abroad.|0|||
106158335|NCT03150810|366241587|FG005|Overall Study|Participant relocated abroad.|1|||
106158336|NCT03150810|366241588|FG006|Overall Study|Participant relocated abroad.|0|||
106158337|NCT03150810|366241589|FG007|Overall Study|Participant relocated abroad.|0|||
106158338|NCT03150810|366241590|FG008|Overall Study|Participant relocated abroad.|0|||
106158339|NCT03150810|366241591|FG009|Overall Study|Participant relocated abroad.|0|||
106158340|NCT03150810|366241592|FG010|Overall Study|Participant relocated abroad.|0|||
106158341|NCT03150810|366241593|FG011|Overall Study|Participant relocated abroad.|0|||
106158342|NCT03150810|366241594|FG012|Overall Study|Participant relocated abroad.|0|||
106158343|NCT03150810|366241582|FG000|Overall Study|Transferred care to oncologist|0|||
106158344|NCT03150810|366241583|FG001|Overall Study|Transferred care to oncologist|0|||
106158345|NCT03150810|366241584|FG002|Overall Study|Transferred care to oncologist|0|||
106158346|NCT03150810|366241585|FG003|Overall Study|Transferred care to oncologist|0|||
106158347|NCT03150810|366241586|FG004|Overall Study|Transferred care to oncologist|0|||
106158348|NCT03150810|366241587|FG005|Overall Study|Transferred care to oncologist|0|||
106158349|NCT03150810|366241588|FG006|Overall Study|Transferred care to oncologist|2|||
106158350|NCT03150810|366241589|FG007|Overall Study|Transferred care to oncologist|0|||
106158351|NCT03150810|366241590|FG008|Overall Study|Transferred care to oncologist|0|||
106158352|NCT03150810|366241591|FG009|Overall Study|Transferred care to oncologist|0|||
106158353|NCT03150810|366241592|FG010|Overall Study|Transferred care to oncologist|0|||
106158354|NCT03150810|366241593|FG011|Overall Study|Transferred care to oncologist|0|||
106158355|NCT03150810|366241594|FG012|Overall Study|Transferred care to oncologist|0|||
106158356|NCT04925986|366241595|FG000|Overall Study|Death|0|||
106158357|NCT04925986|366241596|FG001|Overall Study|Death|0|||
106158358|NCT04925986|366241597|FG002|Overall Study|Death|2|||
106158359|NCT04925986|366241598|FG003|Overall Study|Death|0|||
106158360|NCT04925986|366241595|FG000|Overall Study|Lack of Efficacy|1|||
106158361|NCT04925986|366241596|FG001|Overall Study|Lack of Efficacy|2|||
106158362|NCT04925986|366241597|FG002|Overall Study|Lack of Efficacy|0|||
106158363|NCT04925986|366241598|FG003|Overall Study|Lack of Efficacy|1|||
106158364|NCT04925986|366241595|FG000|Overall Study|Withdrawal by Subject|0|||
106158365|NCT04925986|366241596|FG001|Overall Study|Withdrawal by Subject|0|||
106158366|NCT04925986|366241597|FG002|Overall Study|Withdrawal by Subject|1|||
106158367|NCT04925986|366241598|FG003|Overall Study|Withdrawal by Subject|2|||
106158368|NCT05351554|366241602|FG000|Overall Study|Study terminated by sponsor|1|||
106158369|NCT05093829|366241603|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
106158370|NCT05093829|366241604|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
106158371|NCT05093829|366241605|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
106158372|NCT05093829|366241606|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
106158373|NCT05093829|366241607|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
106158374|NCT05302596|366241608|FG000|Overall Study|Withdrawal by Subject|1|||
106158375|NCT05302596|366241609|FG001|Overall Study|Withdrawal by Subject|1|||
106158376|NCT03779204|366243373|FG000|Overall Study|Lost to Follow-up|2|||
106158377|NCT03779204|366243374|FG001|Overall Study|Lost to Follow-up|0|||
106158378|NCT02954341|366243375|FG000|Overall Study|Attempted Implant unsuccessful|5|||
106158379|NCT02954341|366243375|FG000|Overall Study|Death|90|||
106158380|NCT02954341|366243375|FG000|Overall Study|Withdrawal by Subject|4|||
106158381|NCT02954341|366243375|FG000|Overall Study|Physician Decision|13|||
106158382|NCT02954341|366243375|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
106158383|NCT02954341|366243375|FG000|Overall Study|Not implanted due to physician's decision|1|||
106158384|NCT02954341|366243375|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
106158385|NCT05227209|366243379|FG000|Overall Study|Adverse Event|11|||
106158386|NCT05227209|366243379|FG000|Overall Study|Lost to Follow-up|1|||
106158387|NCT05227209|366243379|FG000|Overall Study|Withdrawal by Subject|7|||
106158388|NCT05227209|366243379|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
106075135|NCT01228747|365939754|FG000|Overall Study|Adverse Event|8|||
106075136|NCT01228747|365939755|FG001|Overall Study|Adverse Event|4|||
106075137|NCT01228747|365939754|FG000|Overall Study|Lack of Efficacy|40|||
106075138|NCT01228747|365939755|FG001|Overall Study|Lack of Efficacy|27|||
106075139|NCT01228747|365939754|FG000|Overall Study|Protocol Violation|6|||
106075140|NCT01228747|365939755|FG001|Overall Study|Protocol Violation|5|||
106075141|NCT01228747|365939754|FG000|Overall Study|Lost to Follow-up|4|||
106075142|NCT01228747|365939755|FG001|Overall Study|Lost to Follow-up|3|||
106075143|NCT01228747|365939754|FG000|Overall Study|Withdrawal by Subject|5|||
106075144|NCT01228747|365939755|FG001|Overall Study|Withdrawal by Subject|1|||
106075145|NCT01228747|365939754|FG000|Overall Study|Other Reason|2|||
106075146|NCT01228747|365939755|FG001|Overall Study|Other Reason|5|||
106075147|NCT02036502|365939756|FG000|Part 1:Dose Determination/Escalation|Death|3|||
106075148|NCT02036502|365939757|FG001|Part 1:Dose Determination/Escalation|Death|2|||
106075149|NCT02036502|365939758|FG002|Part 1:Dose Determination/Escalation|Death|0|||
106075150|NCT02036502|365939759|FG003|Part 1:Dose Determination/Escalation|Death|0|||
106075151|NCT02036502|365939760|FG004|Part 1:Dose Determination/Escalation|Death|0|||
106075152|NCT02036502|365939761|FG005|Part 1:Dose Determination/Escalation|Death|0|||
106075153|NCT02036502|365939762|FG006|Part 1:Dose Determination/Escalation|Death|0|||
106075154|NCT02036502|365939763|FG007|Part 1:Dose Determination/Escalation|Death|0|||
106075155|NCT02036502|365939756|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
106158422|NCT05273749|366243384|FG000|Overall Study|Adverse Event|14|||
106158423|NCT05273749|366243385|FG001|Overall Study|Adverse Event|8|||
106158424|NCT05273749|366243384|FG000|Overall Study|Lack of Efficacy|2|||
106158425|NCT05273749|366243385|FG001|Overall Study|Lack of Efficacy|8|||
106158426|NCT05273749|366243384|FG000|Overall Study|Physician Decision|0|||
106158427|NCT05273749|366243385|FG001|Overall Study|Physician Decision|2|||
106158428|NCT05273749|366243384|FG000|Overall Study|Withdrawal by Subject|14|||
106158429|NCT05273749|366243385|FG001|Overall Study|Withdrawal by Subject|16|||
106158430|NCT05273749|366243384|FG000|Overall Study|Lost to Follow-up|10|||
106158431|NCT05273749|366243385|FG001|Overall Study|Lost to Follow-up|10|||
106158432|NCT05273749|366243384|FG000|Overall Study|Pregnancy|1|||
106158433|NCT05273749|366243385|FG001|Overall Study|Pregnancy|0|||
106158434|NCT05273749|366243384|FG000|Overall Study|Non-Compliance|3|||
106158435|NCT05273749|366243385|FG001|Overall Study|Non-Compliance|2|||
106158436|NCT05273749|366243384|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
106158437|NCT05273749|366243385|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
105866638|NCT04138823|365161112|FG001|Overall Study|Objective disease progression|2|||
106075156|NCT02036502|365939757|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
106075157|NCT02036502|365939758|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
106075158|NCT02036502|365939759|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
106075159|NCT02036502|365939760|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
106075160|NCT02036502|365939761|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
106158438|NCT04806594|366243386|FG000|Overall Study|Withdrawal by Subject|2|||
106158439|NCT04806594|366243386|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
106075161|NCT02036502|365939762|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
106075162|NCT02036502|365939763|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
106075163|NCT02036502|365939756|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
106075164|NCT02036502|365939757|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
106075165|NCT02036502|365939758|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
106075166|NCT02036502|365939759|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
106075167|NCT02036502|365939760|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
106075168|NCT02036502|365939761|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
106075169|NCT02036502|365939762|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
106075170|NCT02036502|365939763|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
106075171|NCT02036502|365939756|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
106075172|NCT02036502|365939757|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
106075173|NCT02036502|365939758|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
106075174|NCT02036502|365939759|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
106075175|NCT02036502|365939760|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
106075176|NCT02036502|365939761|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
106075177|NCT02036502|365939762|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
106075178|NCT02036502|365939763|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
106075179|NCT02036502|365939756|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
106075180|NCT02036502|365939757|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
106075181|NCT02036502|365939758|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
106075182|NCT02036502|365939759|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
106075183|NCT02036502|365939760|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
106075184|NCT02036502|365939761|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
106075185|NCT02036502|365939762|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
106075186|NCT02036502|365939763|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
106075187|NCT02036502|365939756|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
106075188|NCT02036502|365939757|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
106075189|NCT02036502|365939758|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
106075190|NCT02036502|365939759|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
106075191|NCT02036502|365939760|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
106075192|NCT02036502|365939761|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
106075193|NCT02036502|365939762|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
106075194|NCT02036502|365939763|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
106075195|NCT02036502|365939756|FG000|Part 2:Dose Confirmation|Death|0|||
106075196|NCT02036502|365939757|FG001|Part 2:Dose Confirmation|Death|0|||
106075197|NCT02036502|365939758|FG002|Part 2:Dose Confirmation|Death|1|||
106075198|NCT02036502|365939759|FG003|Part 2:Dose Confirmation|Death|0|||
106075199|NCT02036502|365939760|FG004|Part 2:Dose Confirmation|Death|0|||
106075200|NCT02036502|365939761|FG005|Part 2:Dose Confirmation|Death|0|||
106075201|NCT02036502|365939762|FG006|Part 2:Dose Confirmation|Death|0|||
106075202|NCT02036502|365939763|FG007|Part 2:Dose Confirmation|Death|0|||
106075203|NCT02036502|365939756|FG000|Part 2:Dose Confirmation|Not treated|0|||
106075204|NCT02036502|365939757|FG001|Part 2:Dose Confirmation|Not treated|0|||
106075205|NCT02036502|365939758|FG002|Part 2:Dose Confirmation|Not treated|0|||
106075206|NCT02036502|365939759|FG003|Part 2:Dose Confirmation|Not treated|1|||
106075207|NCT02036502|365939760|FG004|Part 2:Dose Confirmation|Not treated|0|||
106075208|NCT02036502|365939761|FG005|Part 2:Dose Confirmation|Not treated|0|||
106075209|NCT02036502|365939762|FG006|Part 2:Dose Confirmation|Not treated|0|||
106075210|NCT02036502|365939763|FG007|Part 2:Dose Confirmation|Not treated|0|||
106075211|NCT02036502|365939756|FG000|Part 3:Dose Expansion|Adverse Event|0|||
106075212|NCT02036502|365939757|FG001|Part 3:Dose Expansion|Adverse Event|0|||
106075213|NCT02036502|365939758|FG002|Part 3:Dose Expansion|Adverse Event|0|||
106075214|NCT02036502|365939759|FG003|Part 3:Dose Expansion|Adverse Event|0|||
106075215|NCT02036502|365939760|FG004|Part 3:Dose Expansion|Adverse Event|0|||
106075216|NCT02036502|365939761|FG005|Part 3:Dose Expansion|Adverse Event|4|||
106075217|NCT02036502|365939762|FG006|Part 3:Dose Expansion|Adverse Event|0|||
106075218|NCT02036502|365939763|FG007|Part 3:Dose Expansion|Adverse Event|2|||
106075219|NCT02036502|365939756|FG000|Part 3:Dose Expansion|Death|0|||
106075220|NCT02036502|365939757|FG001|Part 3:Dose Expansion|Death|0|||
106158440|NCT03143153|366243387|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
106158441|NCT03143153|366243388|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
106158442|NCT03143153|366243389|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
106158443|NCT03143153|366243387|FG000|Pre-Treatment|Participant withdrew consent|0|||
106158444|NCT03143153|366243388|FG001|Pre-Treatment|Participant withdrew consent|1|||
106158445|NCT03143153|366243389|FG002|Pre-Treatment|Participant withdrew consent|12|||
106158446|NCT03143153|366243387|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
106075221|NCT02036502|365939758|FG002|Part 3:Dose Expansion|Death|0|||
106075222|NCT02036502|365939759|FG003|Part 3:Dose Expansion|Death|0|||
106075223|NCT02036502|365939760|FG004|Part 3:Dose Expansion|Death|0|||
106075224|NCT02036502|365939761|FG005|Part 3:Dose Expansion|Death|24|||
106075225|NCT02036502|365939762|FG006|Part 3:Dose Expansion|Death|0|||
106075226|NCT02036502|365939763|FG007|Part 3:Dose Expansion|Death|3|||
106075227|NCT02036502|365939756|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
106075228|NCT02036502|365939757|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
106075229|NCT02036502|365939758|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
106075230|NCT02036502|365939759|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
106075231|NCT02036502|365939760|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
106075232|NCT02036502|365939761|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
106075233|NCT02036502|365939762|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
106075234|NCT02036502|365939763|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
106075235|NCT02036502|365939756|FG000|Part 3:Dose Expansion|Physician Decision|0|||
106075236|NCT02036502|365939757|FG001|Part 3:Dose Expansion|Physician Decision|0|||
106075237|NCT02036502|365939758|FG002|Part 3:Dose Expansion|Physician Decision|0|||
106075238|NCT02036502|365939759|FG003|Part 3:Dose Expansion|Physician Decision|0|||
106075239|NCT02036502|365939760|FG004|Part 3:Dose Expansion|Physician Decision|0|||
106075240|NCT02036502|365939761|FG005|Part 3:Dose Expansion|Physician Decision|1|||
106075241|NCT02036502|365939762|FG006|Part 3:Dose Expansion|Physician Decision|0|||
106075242|NCT02036502|365939763|FG007|Part 3:Dose Expansion|Physician Decision|0|||
106075243|NCT02036502|365939756|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
106075244|NCT02036502|365939757|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
106075245|NCT02036502|365939758|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
106075246|NCT02036502|365939759|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
106075247|NCT02036502|365939760|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
106075248|NCT02036502|365939761|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
106075249|NCT02036502|365939762|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
106075250|NCT02036502|365939763|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
106075251|NCT02036502|365939756|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
106075252|NCT02036502|365939757|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
106075253|NCT02036502|365939758|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
106075254|NCT02036502|365939759|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
106075255|NCT02036502|365939760|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
106075256|NCT02036502|365939761|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
106075257|NCT02036502|365939762|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
106075258|NCT02036502|365939763|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
106075259|NCT02036502|365939756|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
106075260|NCT02036502|365939757|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
106075261|NCT02036502|365939758|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
106075262|NCT02036502|365939759|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
106075263|NCT02036502|365939760|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
106075264|NCT02036502|365939761|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
106075265|NCT02036502|365939762|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
106075266|NCT02036502|365939763|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
106075267|NCT02036502|365939756|FG000|Part 3:Dose Expansion|Not Treated|0|||
106075268|NCT02036502|365939757|FG001|Part 3:Dose Expansion|Not Treated|0|||
106158447|NCT03143153|366243388|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
106158448|NCT03143153|366243389|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
106158449|NCT03143153|366243387|FG000|Pre-Treatment|Other Reasons|1|||
106158450|NCT03143153|366243388|FG001|Pre-Treatment|Other Reasons|2|||
106158451|NCT03143153|366243389|FG002|Pre-Treatment|Other Reasons|1|||
106158452|NCT03143153|366243387|FG000|Pre-Treatment|Disease Progression|1|||
106158453|NCT03143153|366243388|FG001|Pre-Treatment|Disease Progression|1|||
106158454|NCT03143153|366243389|FG002|Pre-Treatment|Disease Progression|2|||
106158455|NCT03143153|366243387|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
106158456|NCT03143153|366243388|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
106158457|NCT03143153|366243389|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
106158458|NCT03143153|366243387|FG000|Treatment|Disease progression|174|||
106158459|NCT03143153|366243388|FG001|Treatment|Disease progression|184|||
106158460|NCT03143153|366243389|FG002|Treatment|Disease progression|193|||
106158461|NCT03143153|366243387|FG000|Treatment|Study drug toxicity|59|||
106158462|NCT03143153|366243388|FG001|Treatment|Study drug toxicity|33|||
106158463|NCT03143153|366243389|FG002|Treatment|Study drug toxicity|40|||
106158464|NCT03143153|366243387|FG000|Treatment|Death|5|||
106158465|NCT03143153|366243388|FG001|Treatment|Death|3|||
106158466|NCT03143153|366243389|FG002|Treatment|Death|4|||
106075269|NCT02036502|365939758|FG002|Part 3:Dose Expansion|Not Treated|0|||
106075270|NCT02036502|365939759|FG003|Part 3:Dose Expansion|Not Treated|0|||
106075271|NCT02036502|365939760|FG004|Part 3:Dose Expansion|Not Treated|0|||
106075272|NCT02036502|365939761|FG005|Part 3:Dose Expansion|Not Treated|2|||
106075273|NCT02036502|365939762|FG006|Part 3:Dose Expansion|Not Treated|0|||
106075274|NCT02036502|365939763|FG007|Part 3:Dose Expansion|Not Treated|0|||
106075275|NCT03065244|365939770|FG000|Overall Study|Lost to Follow-up|1|||
106158467|NCT03143153|366243387|FG000|Treatment|Adverse event unrelated to study drug|19|||
106158468|NCT03143153|366243388|FG001|Treatment|Adverse event unrelated to study drug|28|||
106075276|NCT03065244|365939771|FG001|Overall Study|Lost to Follow-up|1|||
106075277|NCT03065244|365939770|FG000|Overall Study|Diagnosed with a different disease|1|||
106075278|NCT03065244|365939771|FG001|Overall Study|Diagnosed with a different disease|1|||
106075279|NCT03065244|365939770|FG000|Overall Study|Protocol Violation|0|||
106075280|NCT03065244|365939771|FG001|Overall Study|Protocol Violation|1|||
106075281|NCT03065244|365939770|FG000|Overall Study|Withdrawal by Subject|1|||
106075282|NCT03065244|365939771|FG001|Overall Study|Withdrawal by Subject|1|||
106075283|NCT03717480|365939772|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
106075284|NCT00329407|365939777|FG000|Overall Study|Withdrawal by Subject|1|||
106075285|NCT00978068|365939778|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
106075286|NCT00978068|365939779|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
106075287|NCT00978068|365939778|FG000|Overall Study|Death|1|||
106075288|NCT00978068|365939779|FG001|Overall Study|Death|2|||
106075289|NCT00978068|365939778|FG000|Overall Study|Lost to Follow-up|1|||
106075290|NCT00978068|365939779|FG001|Overall Study|Lost to Follow-up|2|||
106075291|NCT00978068|365939778|FG000|Overall Study|Physician Decision|0|||
106075292|NCT00978068|365939779|FG001|Overall Study|Physician Decision|1|||
106075293|NCT00978068|365939778|FG000|Overall Study|Unable to Comply with Study|0|||
106075294|NCT00978068|365939779|FG001|Overall Study|Unable to Comply with Study|2|||
106075295|NCT01165138|365939780|FG000|Overall Study|Adverse Event|0|||
106075296|NCT01165138|365939781|FG001|Overall Study|Adverse Event|1|||
106075297|NCT01165138|365939782|FG002|Overall Study|Adverse Event|0|||
106075298|NCT01165138|365939783|FG003|Overall Study|Adverse Event|2|||
106075299|NCT01165138|365939780|FG000|Overall Study|Lack of Efficacy|0|||
106075300|NCT01165138|365939781|FG001|Overall Study|Lack of Efficacy|32|||
106075301|NCT01165138|365939782|FG002|Overall Study|Lack of Efficacy|6|||
106075302|NCT01165138|365939783|FG003|Overall Study|Lack of Efficacy|7|||
106075303|NCT01165138|365939780|FG000|Overall Study|Protocol Violation|0|||
106075304|NCT01165138|365939781|FG001|Overall Study|Protocol Violation|7|||
106075305|NCT01165138|365939782|FG002|Overall Study|Protocol Violation|0|||
106075306|NCT01165138|365939783|FG003|Overall Study|Protocol Violation|2|||
106075307|NCT01165138|365939780|FG000|Overall Study|Lost to Follow-up|0|||
106075308|NCT01165138|365939781|FG001|Overall Study|Lost to Follow-up|0|||
106075309|NCT01165138|365939782|FG002|Overall Study|Lost to Follow-up|1|||
106075310|NCT01165138|365939783|FG003|Overall Study|Lost to Follow-up|2|||
106075311|NCT01165138|365939780|FG000|Overall Study|Physician Decision|0|||
106075312|NCT01165138|365939781|FG001|Overall Study|Physician Decision|6|||
106075313|NCT01165138|365939782|FG002|Overall Study|Physician Decision|7|||
106075314|NCT01165138|365939783|FG003|Overall Study|Physician Decision|6|||
106158469|NCT03143153|366243389|FG002|Treatment|Adverse event unrelated to study drug|12|||
106158470|NCT03143153|366243387|FG000|Treatment|Participant request to discontinue study treatment|13|||
106158471|NCT03143153|366243388|FG001|Treatment|Participant request to discontinue study treatment|15|||
106158472|NCT03143153|366243389|FG002|Treatment|Participant request to discontinue study treatment|20|||
106158473|NCT03143153|366243387|FG000|Treatment|Participant withdrew consent|3|||
106158474|NCT03143153|366243388|FG001|Treatment|Participant withdrew consent|4|||
106158475|NCT03143153|366243389|FG002|Treatment|Participant withdrew consent|12|||
106158476|NCT03143153|366243387|FG000|Treatment|Pregnancy|1|||
106158477|NCT03143153|366243388|FG001|Treatment|Pregnancy|0|||
106158478|NCT03143153|366243389|FG002|Treatment|Pregnancy|0|||
106158479|NCT03143153|366243387|FG000|Treatment|Maximum clinical benefit|1|||
106158480|NCT03143153|366243388|FG001|Treatment|Maximum clinical benefit|3|||
106158481|NCT03143153|366243389|FG002|Treatment|Maximum clinical benefit|4|||
106158482|NCT03143153|366243387|FG000|Treatment|Completed treatment as per Protocol|13|||
106158483|NCT03143153|366243388|FG001|Treatment|Completed treatment as per Protocol|8|||
106158484|NCT03143153|366243389|FG002|Treatment|Completed treatment as per Protocol|0|||
106158485|NCT03143153|366243387|FG000|Treatment|Other reasons|12|||
106158486|NCT03143153|366243388|FG001|Treatment|Other reasons|7|||
106158487|NCT03143153|366243389|FG002|Treatment|Other reasons|15|||
106158488|NCT03143153|366243387|FG000|Treatment|Not reported|1|||
106158489|NCT03143153|366243388|FG001|Treatment|Not reported|0|||
106158490|NCT03143153|366243389|FG002|Treatment|Not reported|0|||
106158491|NCT04318548|366243390|FG000|Overall Study|Adverse Event|0|||
106158492|NCT04318548|366243391|FG001|Overall Study|Adverse Event|0|||
106158493|NCT04318548|366243392|FG002|Overall Study|Adverse Event|1|||
106158494|NCT04318548|366243390|FG000|Overall Study|Lost to Follow-up|6|||
106158495|NCT04318548|366243391|FG001|Overall Study|Lost to Follow-up|13|||
106158496|NCT04318548|366243392|FG002|Overall Study|Lost to Follow-up|9|||
106075315|NCT01165138|365939780|FG000|Overall Study|Withdrawal by Subject|0|||
106075316|NCT01165138|365939781|FG001|Overall Study|Withdrawal by Subject|6|||
106075317|NCT01165138|365939782|FG002|Overall Study|Withdrawal by Subject|6|||
106075318|NCT01165138|365939783|FG003|Overall Study|Withdrawal by Subject|3|||
106075319|NCT03560531|365939784|FG000|Overall Study|Death|4|||
106075320|NCT03560531|365939785|FG001|Overall Study|Death|1|||
106075321|NCT03560531|365939786|FG002|Overall Study|Death|1|||
106075322|NCT03560531|365939787|FG003|Overall Study|Death|2|||
106075323|NCT03560531|365939788|FG004|Overall Study|Death|6|||
106075324|NCT03560531|365939789|FG005|Overall Study|Death|1|||
106158497|NCT04318548|366243390|FG000|Overall Study|Protocol Violation|1|||
106075325|NCT03560531|365939790|FG006|Overall Study|Death|4|||
106075326|NCT03560531|365939791|FG007|Overall Study|Death|8|||
106075327|NCT03560531|365939792|FG008|Overall Study|Death|1|||
106075328|NCT03560531|365939793|FG009|Overall Study|Death|3|||
106075329|NCT03560531|365939794|FG010|Overall Study|Death|2|||
106075330|NCT03560531|365939795|FG011|Overall Study|Death|0|||
106075331|NCT03560531|365939796|FG012|Overall Study|Death|4|||
106075332|NCT03560531|365939797|FG013|Overall Study|Death|1|||
106075333|NCT03560531|365939784|FG000|Overall Study|Lost to Follow-up|1|||
106075334|NCT03560531|365939785|FG001|Overall Study|Lost to Follow-up|1|||
106075335|NCT03560531|365939786|FG002|Overall Study|Lost to Follow-up|0|||
106075336|NCT03560531|365939787|FG003|Overall Study|Lost to Follow-up|0|||
106075337|NCT03560531|365939788|FG004|Overall Study|Lost to Follow-up|0|||
106075338|NCT03560531|365939789|FG005|Overall Study|Lost to Follow-up|0|||
106075339|NCT03560531|365939790|FG006|Overall Study|Lost to Follow-up|1|||
106075340|NCT03560531|365939791|FG007|Overall Study|Lost to Follow-up|0|||
106075341|NCT03560531|365939792|FG008|Overall Study|Lost to Follow-up|0|||
106075342|NCT03560531|365939793|FG009|Overall Study|Lost to Follow-up|0|||
106075343|NCT03560531|365939794|FG010|Overall Study|Lost to Follow-up|0|||
106075344|NCT03560531|365939795|FG011|Overall Study|Lost to Follow-up|0|||
106075345|NCT03560531|365939796|FG012|Overall Study|Lost to Follow-up|0|||
106075346|NCT03560531|365939797|FG013|Overall Study|Lost to Follow-up|0|||
106075347|NCT03560531|365939784|FG000|Overall Study|Withdrawal by Subject|1|||
106075348|NCT03560531|365939785|FG001|Overall Study|Withdrawal by Subject|0|||
106075349|NCT03560531|365939786|FG002|Overall Study|Withdrawal by Subject|0|||
106075350|NCT03560531|365939787|FG003|Overall Study|Withdrawal by Subject|0|||
106075351|NCT03560531|365939788|FG004|Overall Study|Withdrawal by Subject|0|||
106158498|NCT04318548|366243391|FG001|Overall Study|Protocol Violation|0|||
106158499|NCT04318548|366243392|FG002|Overall Study|Protocol Violation|2|||
106158500|NCT04318548|366243390|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
106158501|NCT04318548|366243391|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
106158502|NCT04318548|366243392|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
106158503|NCT04318548|366243390|FG000|Overall Study|Migrated / moved from the study area|0|||
106158504|NCT04318548|366243391|FG001|Overall Study|Migrated / moved from the study area|0|||
106158505|NCT04318548|366243392|FG002|Overall Study|Migrated / moved from the study area|1|||
106158506|NCT04318548|366243390|FG000|Overall Study|Other|1|||
106158507|NCT04318548|366243391|FG001|Overall Study|Other|2|||
106158508|NCT04318548|366243392|FG002|Overall Study|Other|3|||
106158509|NCT02530671|366243393|FG000|Overall Study|Lost to Follow-up|2|||
106158510|NCT02530671|366243394|FG001|Overall Study|Lost to Follow-up|0|||
106158511|NCT02530671|366243393|FG000|Overall Study|Withdrawal by Subject|1|||
106158512|NCT02530671|366243394|FG001|Overall Study|Withdrawal by Subject|0|||
106158513|NCT02736409|366243395|FG000|Overall Study|Withdrawal by Subject|4|||
106158514|NCT02736409|366243396|FG001|Overall Study|Withdrawal by Subject|2|||
106158515|NCT02736409|366243397|FG002|Overall Study|Withdrawal by Subject|17|||
106158516|NCT02736409|366243398|FG003|Overall Study|Withdrawal by Subject|3|||
106158517|NCT02736409|366243395|FG000|Overall Study|Non-Compliance with Study Drug|0|||
106158518|NCT02736409|366243396|FG001|Overall Study|Non-Compliance with Study Drug|0|||
106158519|NCT02736409|366243397|FG002|Overall Study|Non-Compliance with Study Drug|0|||
106158520|NCT02736409|366243398|FG003|Overall Study|Non-Compliance with Study Drug|1|||
106158521|NCT02736409|366243395|FG000|Overall Study|Adverse Event|0|||
106158522|NCT02736409|366243396|FG001|Overall Study|Adverse Event|1|||
106158523|NCT02736409|366243397|FG002|Overall Study|Adverse Event|5|||
106158524|NCT02736409|366243398|FG003|Overall Study|Adverse Event|4|||
106158525|NCT02736409|366243395|FG000|Overall Study|Other|0|||
106158526|NCT02736409|366243396|FG001|Overall Study|Other|0|||
106158527|NCT02736409|366243397|FG002|Overall Study|Other|1|||
106158528|NCT02736409|366243398|FG003|Overall Study|Other|1|||
106158529|NCT02736409|366243395|FG000|Overall Study|Pregnancy|0|||
106075352|NCT03560531|365939789|FG005|Overall Study|Withdrawal by Subject|0|||
106075353|NCT03560531|365939790|FG006|Overall Study|Withdrawal by Subject|0|||
106075354|NCT03560531|365939791|FG007|Overall Study|Withdrawal by Subject|3|||
106158530|NCT02736409|366243396|FG001|Overall Study|Pregnancy|0|||
106158531|NCT02736409|366243397|FG002|Overall Study|Pregnancy|1|||
106158532|NCT02736409|366243398|FG003|Overall Study|Pregnancy|0|||
106158533|NCT02736409|366243395|FG000|Overall Study|Lost to Follow-up|0|||
106075355|NCT03560531|365939792|FG008|Overall Study|Withdrawal by Subject|2|||
106075356|NCT03560531|365939793|FG009|Overall Study|Withdrawal by Subject|0|||
106075357|NCT03560531|365939794|FG010|Overall Study|Withdrawal by Subject|0|||
106075358|NCT03560531|365939795|FG011|Overall Study|Withdrawal by Subject|0|||
106158534|NCT02736409|366243396|FG001|Overall Study|Lost to Follow-up|0|||
106158535|NCT02736409|366243397|FG002|Overall Study|Lost to Follow-up|2|||
106075359|NCT03560531|365939796|FG012|Overall Study|Withdrawal by Subject|2|||
106075360|NCT03560531|365939797|FG013|Overall Study|Withdrawal by Subject|0|||
106075361|NCT03560531|365939784|FG000|Overall Study|Study end per-protocol|1|||
106075362|NCT03560531|365939785|FG001|Overall Study|Study end per-protocol|1|||
106075363|NCT03560531|365939786|FG002|Overall Study|Study end per-protocol|2|||
106075364|NCT03560531|365939787|FG003|Overall Study|Study end per-protocol|0|||
106075365|NCT03560531|365939788|FG004|Overall Study|Study end per-protocol|1|||
106075366|NCT03560531|365939789|FG005|Overall Study|Study end per-protocol|0|||
106075367|NCT03560531|365939790|FG006|Overall Study|Study end per-protocol|0|||
106075368|NCT03560531|365939791|FG007|Overall Study|Study end per-protocol|0|||
106075369|NCT03560531|365939792|FG008|Overall Study|Study end per-protocol|0|||
106075370|NCT03560531|365939793|FG009|Overall Study|Study end per-protocol|0|||
106075371|NCT03560531|365939794|FG010|Overall Study|Study end per-protocol|0|||
106075372|NCT03560531|365939795|FG011|Overall Study|Study end per-protocol|0|||
106075373|NCT03560531|365939796|FG012|Overall Study|Study end per-protocol|0|||
106075374|NCT03560531|365939797|FG013|Overall Study|Study end per-protocol|0|||
106075375|NCT03560531|365939784|FG000|Overall Study|Early study termination by sponsor|9|||
106075376|NCT03560531|365939785|FG001|Overall Study|Early study termination by sponsor|0|||
106075377|NCT03560531|365939786|FG002|Overall Study|Early study termination by sponsor|0|||
106075378|NCT03560531|365939787|FG003|Overall Study|Early study termination by sponsor|4|||
106075379|NCT03560531|365939788|FG004|Overall Study|Early study termination by sponsor|8|||
106075380|NCT03560531|365939789|FG005|Overall Study|Early study termination by sponsor|2|||
106075381|NCT03560531|365939790|FG006|Overall Study|Early study termination by sponsor|5|||
106075382|NCT03560531|365939791|FG007|Overall Study|Early study termination by sponsor|64|||
106075383|NCT03560531|365939792|FG008|Overall Study|Early study termination by sponsor|7|||
106075384|NCT03560531|365939793|FG009|Overall Study|Early study termination by sponsor|2|||
106075385|NCT03560531|365939794|FG010|Overall Study|Early study termination by sponsor|16|||
106075386|NCT03560531|365939795|FG011|Overall Study|Early study termination by sponsor|2|||
106075387|NCT03560531|365939796|FG012|Overall Study|Early study termination by sponsor|6|||
106075388|NCT03560531|365939797|FG013|Overall Study|Early study termination by sponsor|2|||
106075389|NCT04964128|365939798|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
106075390|NCT04964128|365939798|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
106075391|NCT02120794|365939799|FG000|Overall Study|Withdrawal by Subject|43|||
106075392|NCT02120794|365939799|FG000|Overall Study|Adverse Event|10|||
106075393|NCT02120794|365939799|FG000|Overall Study|Physician Decision|4|||
106075394|NCT02120794|365939799|FG000|Overall Study|Due to insurance coverage|1|||
106075395|NCT01148511|365939801|FG000|Exposed to Study Drug|Protocol Violation|2|||
106075396|NCT01148511|365939802|FG001|Exposed to Study Drug|Protocol Violation|0|||
106075397|NCT01148511|365939803|FG002|Exposed to Study Drug|Protocol Violation|0|||
106075398|NCT01148511|365939801|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
106075399|NCT01148511|365939802|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
106075400|NCT01148511|365939803|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
106075401|NCT01148511|365939801|FG000|Randomized|Adverse Event|0|||
106075402|NCT01148511|365939802|FG001|Randomized|Adverse Event|1|||
106075403|NCT01148511|365939803|FG002|Randomized|Adverse Event|0|||
106075404|NCT01148511|365939801|FG000|Randomized|Protocol Violation|0|||
106075405|NCT01148511|365939802|FG001|Randomized|Protocol Violation|2|||
106075406|NCT01148511|365939803|FG002|Randomized|Protocol Violation|1|||
106075407|NCT01148511|365939801|FG000|Randomized|Lost to Follow-up|0|||
106075408|NCT01148511|365939802|FG001|Randomized|Lost to Follow-up|1|||
106075409|NCT01148511|365939803|FG002|Randomized|Lost to Follow-up|1|||
106075410|NCT01148511|365939801|FG000|Randomized|Consent withdrawal|0|||
106075411|NCT01148511|365939802|FG001|Randomized|Consent withdrawal|5|||
106075412|NCT01148511|365939803|FG002|Randomized|Consent withdrawal|3|||
106075413|NCT01148511|365939801|FG000|Randomized|Other|0|||
106075414|NCT01148511|365939802|FG001|Randomized|Other|1|||
106075415|NCT01148511|365939803|FG002|Randomized|Other|1|||
106075416|NCT01200797|365939806|FG000|Overall Study|symptomatic deterioration|2|||
106075417|NCT01200797|365939806|FG000|Overall Study|Adverse Event|4|||
106075418|NCT01200797|365939806|FG000|Overall Study|Disease Progression|13|||
106075419|NCT01586819|365939807|FG000|Overall Study|Withdrawal by Subject|1|||
106075420|NCT01586819|365939808|FG001|Overall Study|Withdrawal by Subject|0|||
106075421|NCT02028988|365939818|FG000|Overall Study|Withdrawal by Subject|2|||
106075422|NCT01623596|365939821|FG000|Overall Study|Abnormal laboratory values|2|||
105866639|NCT04138823|365161113|FG002|Overall Study|Objective disease progression|5|||
106075423|NCT01623596|365939822|FG001|Overall Study|Abnormal laboratory values|0|||
106075424|NCT01623596|365939821|FG000|Overall Study|Administrative problems|9|||
106075425|NCT01623596|365939822|FG001|Overall Study|Administrative problems|13|||
106075426|NCT01623596|365939821|FG000|Overall Study|Adverse Event|20|||
106075427|NCT01623596|365939822|FG001|Overall Study|Adverse Event|29|||
106075428|NCT01623596|365939821|FG000|Overall Study|Death|0|||
106075429|NCT01623596|365939822|FG001|Overall Study|Death|2|||
106075430|NCT01623596|365939821|FG000|Overall Study|Lost to Follow-up|12|||
106075431|NCT01623596|365939822|FG001|Overall Study|Lost to Follow-up|16|||
106075432|NCT01623596|365939821|FG000|Overall Study|Withdrawal by Subject|13|||
106075433|NCT01623596|365939822|FG001|Overall Study|Withdrawal by Subject|31|||
106075434|NCT01623596|365939821|FG000|Overall Study|Patient no longer requires study drug|1|||
106075435|NCT01623596|365939822|FG001|Overall Study|Patient no longer requires study drug|0|||
106075436|NCT01623596|365939821|FG000|Overall Study|Protocol Violation|0|||
106075437|NCT01623596|365939822|FG001|Overall Study|Protocol Violation|6|||
106075438|NCT01623596|365939821|FG000|Overall Study|Lack of Efficacy|5|||
106075439|NCT01623596|365939822|FG001|Overall Study|Lack of Efficacy|3|||
106075440|NCT04056195|365939823|FG000|Overall Study|Adverse Event|1|||
106075441|NCT04056195|365939824|FG001|Overall Study|Adverse Event|0|||
106075442|NCT04056195|365939825|FG002|Overall Study|Adverse Event|0|||
106075443|NCT04056195|365939823|FG000|Overall Study|Withdrawal by Subject|0|||
106075444|NCT04056195|365939824|FG001|Overall Study|Withdrawal by Subject|1|||
106075445|NCT04056195|365939825|FG002|Overall Study|Withdrawal by Subject|1|||
106075446|NCT04056195|365939823|FG000|Overall Study|Physician Decision|1|||
106075447|NCT04056195|365939824|FG001|Overall Study|Physician Decision|1|||
106075448|NCT04056195|365939825|FG002|Overall Study|Physician Decision|1|||
106075449|NCT01342510|365939835|FG000|Overall Study|Protocol Violation|12|||
106075450|NCT01342510|365939836|FG001|Overall Study|Protocol Violation|6|||
106075451|NCT01342510|365939837|FG002|Overall Study|Protocol Violation|13|||
106075452|NCT01342510|365939838|FG003|Overall Study|Protocol Violation|11|||
106075453|NCT01449526|365939839|FG000|Overall Study|Lost to Follow-up|1|||
106075454|NCT01449526|365939840|FG001|Overall Study|Lost to Follow-up|2|||
106075455|NCT01449526|365939839|FG000|Overall Study|Withdrawal by Subject|1|||
106075456|NCT01449526|365939840|FG001|Overall Study|Withdrawal by Subject|1|||
106075457|NCT01449526|365939839|FG000|Overall Study|Symptoms/complaints|0|||
106075458|NCT01449526|365939840|FG001|Overall Study|Symptoms/complaints|1|||
106075459|NCT01449526|365939839|FG000|Overall Study|Lack of Motivation|0|||
106075460|NCT01449526|365939840|FG001|Overall Study|Lack of Motivation|1|||
106075461|NCT01449526|365939839|FG000|Overall Study|Cannot maintain visits|0|||
106075462|NCT01449526|365939840|FG001|Overall Study|Cannot maintain visits|1|||
106075463|NCT01400516|365939841|FG000|Primary Trial|Withdrawal by Subject|0|||
106075464|NCT01400516|365939842|FG001|Primary Trial|Withdrawal by Subject|2|||
106075465|NCT00549562|365939843|FG000|Overall Study|Adverse Event|1|||
106075466|NCT00549562|365939843|FG000|Overall Study|Lack of Efficacy|1|||
106075467|NCT02865915|365939846|FG000|Overall Study|Pregnancy|1|||
106075468|NCT02865915|365939847|FG001|Overall Study|Pregnancy|0|||
106075469|NCT02865915|365939846|FG000|Overall Study|Withdrawal by Subject|1|||
106075470|NCT02865915|365939847|FG001|Overall Study|Withdrawal by Subject|1|||
106075471|NCT02865915|365939846|FG000|Overall Study|Adverse Event|0|||
106075472|NCT02865915|365939847|FG001|Overall Study|Adverse Event|4|||
106075473|NCT02865915|365939846|FG000|Overall Study|Lost to Follow-up|0|||
106075474|NCT02865915|365939847|FG001|Overall Study|Lost to Follow-up|1|||
106075475|NCT02865915|365939846|FG000|Overall Study|Protocol Violation|0|||
106075476|NCT02865915|365939847|FG001|Overall Study|Protocol Violation|1|||
106075477|NCT02865915|365939846|FG000|Overall Study|Study terminated by sponsor|23|||
106075478|NCT02865915|365939847|FG001|Overall Study|Study terminated by sponsor|18|||
106075479|NCT02865915|365939846|FG000|Overall Study|Dosing group discontinued|0|||
106075480|NCT02865915|365939847|FG001|Overall Study|Dosing group discontinued|5|||
106075481|NCT03913091|365939851|FG000|Overall Study|Lost to Follow-up|18|||
106075482|NCT03913091|365939852|FG001|Overall Study|Lost to Follow-up|11|||
106075483|NCT03913091|365939851|FG000|Overall Study|Required additional meds/surgery|1|||
106075484|NCT03913091|365939852|FG001|Overall Study|Required additional meds/surgery|2|||
106075485|NCT03913091|365939851|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
106075486|NCT03913091|365939852|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
106075487|NCT00082433|365939853|FG000|Overall Study|Adverse Event|12|||
106075488|NCT00082433|365939854|FG001|Overall Study|Adverse Event|17|||
106075489|NCT00082433|365939853|FG000|Overall Study|Death|8|||
106075490|NCT00082433|365939854|FG001|Overall Study|Death|18|||
106075491|NCT00082433|365939853|FG000|Overall Study|Disease Progression/Relapse|270|||
106075492|NCT00082433|365939854|FG001|Overall Study|Disease Progression/Relapse|388|||
106075493|NCT00082433|365939853|FG000|Overall Study|Physician Decision|50|||
106075494|NCT00082433|365939854|FG001|Overall Study|Physician Decision|61|||
106075495|NCT00082433|365939853|FG000|Overall Study|Lost to Follow-up|1|||
106075496|NCT00082433|365939854|FG001|Overall Study|Lost to Follow-up|2|||
106075497|NCT00082433|365939853|FG000|Overall Study|Study Drug Toxicity|179|||
106075498|NCT00082433|365939854|FG001|Overall Study|Study Drug Toxicity|66|||
106075499|NCT00082433|365939853|FG000|Overall Study|Withdrawal by Subject|55|||
106075500|NCT00082433|365939854|FG001|Overall Study|Withdrawal by Subject|30|||
106075501|NCT00082433|365939853|FG000|Overall Study|Still On Treatment|2|||
106075502|NCT00082433|365939854|FG001|Overall Study|Still On Treatment|1|||
106075503|NCT00082433|365939853|FG000|Overall Study|Not Treated|12|||
106075504|NCT00082433|365939854|FG001|Overall Study|Not Treated|11|||
106075505|NCT00082433|365939853|FG000|Overall Study|Ineligible|2|||
106075506|NCT00082433|365939854|FG001|Overall Study|Ineligible|1|||
106075507|NCT00082433|365939853|FG000|Overall Study|Noncompliance|2|||
106075508|NCT00082433|365939854|FG001|Overall Study|Noncompliance|1|||
106075509|NCT00082433|365939853|FG000|Overall Study|New primary cancer|1|||
106075510|NCT00082433|365939854|FG001|Overall Study|New primary cancer|0|||
106075511|NCT00082433|365939853|FG000|Overall Study|Impending surgery|0|||
106075512|NCT00082433|365939854|FG001|Overall Study|Impending surgery|1|||
106075513|NCT01380184|365939858|FG000|Part 1 (19 Days)|Adverse Event|1|||
106075514|NCT01380184|365939858|FG000|Part 2|Adverse Event|5|||
106075515|NCT01380184|365939858|FG000|Part 2|Disease Progression|8|||
106075516|NCT01380184|365939858|FG000|Part 2|Lost to Follow-up|1|||
106075517|NCT02759120|365941048|FG000|Overall Study|Death|34|||
106075518|NCT02759120|365941049|FG001|Overall Study|Death|36|||
106075519|NCT02759120|365941048|FG000|Overall Study|Lost to Follow-up|4|||
106075520|NCT02759120|365941049|FG001|Overall Study|Lost to Follow-up|7|||
106075521|NCT02759120|365941048|FG000|Overall Study|Physician Decision|3|||
106075522|NCT02759120|365941049|FG001|Overall Study|Physician Decision|0|||
106075523|NCT02759120|365941048|FG000|Overall Study|Withdrawal by Subject|28|||
106075524|NCT02759120|365941049|FG001|Overall Study|Withdrawal by Subject|15|||
106075525|NCT02759120|365941048|FG000|Overall Study|Moved out of area|3|||
106075526|NCT02759120|365941049|FG001|Overall Study|Moved out of area|4|||
106075527|NCT02759120|365941048|FG000|Overall Study|Lung transplant|3|||
106075528|NCT02759120|365941049|FG001|Overall Study|Lung transplant|5|||
106075529|NCT02759120|365941048|FG000|Overall Study|Other reason not completed|10|||
106075530|NCT02759120|365941049|FG001|Overall Study|Other reason not completed|12|||
106075531|NCT03406858|365941050|FG000|Overall Study|Failure to receive treatment drug.|1|||
106075532|NCT03406858|365941050|FG000|Overall Study|ineligible|1|||
106075533|NCT05664490|365941054|FG000|Overall Study|Withdrawal by Subject|0|||
106075534|NCT05664490|365941055|FG001|Overall Study|Withdrawal by Subject|1|||
106075535|NCT05664490|365941054|FG000|Overall Study|Lost to Follow-up|14|||
106075536|NCT05664490|365941055|FG001|Overall Study|Lost to Follow-up|22|||
106075537|NCT02053753|365941056|FG000|Overall Study|Withdrawal by Subject|2|||
106075538|NCT02053753|365941057|FG001|Overall Study|Withdrawal by Subject|4|||
106075539|NCT02053753|365941056|FG000|Overall Study|Decision by Sponsor|1|||
106075540|NCT02053753|365941057|FG001|Overall Study|Decision by Sponsor|1|||
106075541|NCT02053753|365941056|FG000|Overall Study|Lost to Follow-up|4|||
106075542|NCT02053753|365941057|FG001|Overall Study|Lost to Follow-up|3|||
106075543|NCT01203072|365941058|FG000|Overall Study|Adverse Event|5|||
106075544|NCT01203072|365941059|FG001|Overall Study|Adverse Event|3|||
106075545|NCT01203072|365941060|FG002|Overall Study|Adverse Event|2|||
106075546|NCT01203072|365941061|FG003|Overall Study|Adverse Event|4|||
106075547|NCT01203072|365941062|FG004|Overall Study|Adverse Event|2|||
106075548|NCT01203072|365941058|FG000|Overall Study|Lack of Efficacy|1|||
106075549|NCT01203072|365941059|FG001|Overall Study|Lack of Efficacy|0|||
106075550|NCT01203072|365941060|FG002|Overall Study|Lack of Efficacy|0|||
106075551|NCT01203072|365941061|FG003|Overall Study|Lack of Efficacy|0|||
106075552|NCT01203072|365941062|FG004|Overall Study|Lack of Efficacy|0|||
106075553|NCT01203072|365941058|FG000|Overall Study|Lost to Follow-up|0|||
106075554|NCT01203072|365941059|FG001|Overall Study|Lost to Follow-up|1|||
106075555|NCT01203072|365941060|FG002|Overall Study|Lost to Follow-up|0|||
106075556|NCT01203072|365941061|FG003|Overall Study|Lost to Follow-up|0|||
106075557|NCT01203072|365941062|FG004|Overall Study|Lost to Follow-up|0|||
106075558|NCT01203072|365941058|FG000|Overall Study|Protocol Violation|2|||
106075559|NCT01203072|365941059|FG001|Overall Study|Protocol Violation|0|||
106075560|NCT01203072|365941060|FG002|Overall Study|Protocol Violation|0|||
106075561|NCT01203072|365941061|FG003|Overall Study|Protocol Violation|0|||
106075562|NCT01203072|365941062|FG004|Overall Study|Protocol Violation|1|||
106075563|NCT01203072|365941058|FG000|Overall Study|Withdrawal by Subject|2|||
106075564|NCT01203072|365941059|FG001|Overall Study|Withdrawal by Subject|2|||
106075565|NCT01203072|365941060|FG002|Overall Study|Withdrawal by Subject|1|||
106075566|NCT01203072|365941061|FG003|Overall Study|Withdrawal by Subject|2|||
106075567|NCT01203072|365941062|FG004|Overall Study|Withdrawal by Subject|3|||
106075568|NCT00337103|365941066|FG000|Overall Study|Progressive Disease|414|||
106075569|NCT00337103|365941067|FG001|Overall Study|Progressive Disease|410|||
106075570|NCT00337103|365941066|FG000|Overall Study|Adverse Event|45|||
106075571|NCT00337103|365941067|FG001|Overall Study|Adverse Event|59|||
106075572|NCT00337103|365941066|FG000|Overall Study|Subject Choice|34|||
106075573|NCT00337103|365941067|FG001|Overall Study|Subject Choice|27|||
106075574|NCT00337103|365941066|FG000|Overall Study|Clinical Progression|27|||
106075575|NCT00337103|365941067|FG001|Overall Study|Clinical Progression|24|||
106075576|NCT00337103|365941066|FG000|Overall Study|Physician Decision|15|||
106075577|NCT00337103|365941067|FG001|Overall Study|Physician Decision|14|||
106075578|NCT00337103|365941066|FG000|Overall Study|Withdrawal by Subject|8|||
106075579|NCT00337103|365941067|FG001|Overall Study|Withdrawal by Subject|5|||
106075580|NCT00337103|365941066|FG000|Overall Study|Other|5|||
106075581|NCT00337103|365941067|FG001|Overall Study|Other|6|||
106075582|NCT00337103|365941066|FG000|Overall Study|Entry Criteria Not Met|4|||
106158536|NCT02736409|366243398|FG003|Overall Study|Lost to Follow-up|1|||
106075583|NCT00337103|365941067|FG001|Overall Study|Entry Criteria Not Met|1|||
106075584|NCT00337103|365941066|FG000|Overall Study|Lost to Follow-up|1|||
106075585|NCT00337103|365941067|FG001|Overall Study|Lost to Follow-up|2|||
106075586|NCT00337103|365941066|FG000|Overall Study|Death|1|||
106075587|NCT00337103|365941067|FG001|Overall Study|Death|0|||
106158537|NCT02736409|366243395|FG000|Overall Study|Physician Decision|0|||
106075588|NCT01577758|365941068|FG000|Dose Escalation Phase|Adverse Event|0|||
106075589|NCT01577758|365941069|FG001|Dose Escalation Phase|Adverse Event|0|||
106075590|NCT01577758|365941070|FG002|Dose Escalation Phase|Adverse Event|0|||
106158538|NCT02736409|366243396|FG001|Overall Study|Physician Decision|0|||
106158539|NCT02736409|366243397|FG002|Overall Study|Physician Decision|0|||
106158540|NCT02736409|366243398|FG003|Overall Study|Physician Decision|2|||
106158541|NCT04390048|366243399|FG000|Overall Study|Withdrawal by Subject|1|||
106158542|NCT04390048|366243400|FG001|Overall Study|Withdrawal by Subject|3|||
106158543|NCT00170573|366243402|FG000|Overall Study|Violation of inclusion criteria|13|||
106158544|NCT05563246|366243405|FG000|Overall Study|Withdrawal by Subject|1|||
106158545|NCT05563246|366243406|FG001|Overall Study|Withdrawal by Subject|2|||
106158546|NCT05563246|366243407|FG002|Overall Study|Withdrawal by Subject|0|||
106158547|NCT05563246|366243408|FG003|Overall Study|Withdrawal by Subject|0|||
106158548|NCT05563246|366243405|FG000|Overall Study|Protocol Deviation|0|||
106158549|NCT05563246|366243406|FG001|Overall Study|Protocol Deviation|1|||
106158550|NCT05563246|366243407|FG002|Overall Study|Protocol Deviation|0|||
106158551|NCT05563246|366243408|FG003|Overall Study|Protocol Deviation|0|||
106158552|NCT05563246|366243405|FG000|Overall Study|Physician Decision|0|||
106158553|NCT05563246|366243406|FG001|Overall Study|Physician Decision|1|||
106158554|NCT05563246|366243407|FG002|Overall Study|Physician Decision|0|||
106158555|NCT05563246|366243408|FG003|Overall Study|Physician Decision|0|||
106158556|NCT05563246|366243405|FG000|Overall Study|Adverse Event|0|||
106158557|NCT05563246|366243406|FG001|Overall Study|Adverse Event|0|||
106158558|NCT05563246|366243407|FG002|Overall Study|Adverse Event|2|||
106158559|NCT05563246|366243408|FG003|Overall Study|Adverse Event|0|||
106158560|NCT05563246|366243405|FG000|Overall Study|Lost to Follow-up|0|||
106158561|NCT05563246|366243406|FG001|Overall Study|Lost to Follow-up|0|||
106158562|NCT05563246|366243407|FG002|Overall Study|Lost to Follow-up|1|||
106158563|NCT05563246|366243408|FG003|Overall Study|Lost to Follow-up|0|||
106158564|NCT03366649|366243413|FG000|Overall Study|Failed preoperative screening|4|||
106158565|NCT03366649|366243414|FG001|Overall Study|Failed preoperative screening|0|||
106158566|NCT03366649|366243415|FG002|Overall Study|Failed preoperative screening|0|||
106158567|NCT03366649|366243413|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
106158568|NCT03366649|366243414|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
106158569|NCT03366649|366243415|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
106158570|NCT03673111|366243423|FG000|Overall Study|Protocol Violation|0|||
106158571|NCT03673111|366243424|FG001|Overall Study|Protocol Violation|0|||
106158572|NCT03673111|366243425|FG002|Overall Study|Protocol Violation|0|||
106158573|NCT03673111|366243426|FG003|Overall Study|Protocol Violation|0|||
106158574|NCT03673111|366243427|FG004|Overall Study|Protocol Violation|0|||
106158575|NCT03673111|366243428|FG005|Overall Study|Protocol Violation|0|||
106158576|NCT03673111|366243429|FG006|Overall Study|Protocol Violation|0|||
106158577|NCT03673111|366243430|FG007|Overall Study|Protocol Violation|0|||
106158578|NCT03673111|366243431|FG008|Overall Study|Protocol Violation|0|||
106158579|NCT03673111|366243432|FG009|Overall Study|Protocol Violation|0|||
106158580|NCT03673111|366243433|FG010|Overall Study|Protocol Violation|1|||
106158581|NCT03673111|366243434|FG011|Overall Study|Protocol Violation|0|||
106158582|NCT03673111|366243435|FG012|Overall Study|Protocol Violation|0|||
106158583|NCT03673111|366243436|FG013|Overall Study|Protocol Violation|0|||
106158584|NCT03673111|366243423|FG000|Overall Study|Adverse Event|1|||
106158585|NCT03673111|366243424|FG001|Overall Study|Adverse Event|0|||
106158586|NCT03673111|366243425|FG002|Overall Study|Adverse Event|0|||
106158587|NCT03673111|366243426|FG003|Overall Study|Adverse Event|0|||
106158588|NCT03673111|366243427|FG004|Overall Study|Adverse Event|0|||
106158589|NCT03673111|366243428|FG005|Overall Study|Adverse Event|0|||
106158590|NCT03673111|366243429|FG006|Overall Study|Adverse Event|0|||
106158591|NCT03673111|366243430|FG007|Overall Study|Adverse Event|0|||
106158592|NCT03673111|366243431|FG008|Overall Study|Adverse Event|0|||
106158593|NCT03673111|366243432|FG009|Overall Study|Adverse Event|0|||
106158594|NCT03673111|366243433|FG010|Overall Study|Adverse Event|0|||
106158595|NCT03673111|366243434|FG011|Overall Study|Adverse Event|0|||
106158596|NCT03673111|366243435|FG012|Overall Study|Adverse Event|0|||
106158597|NCT03673111|366243436|FG013|Overall Study|Adverse Event|0|||
106158598|NCT01744782|366243439|FG000|Overall Study|Death|1|||
106158599|NCT04649359|366243440|FG000|Overall Study|Withdrawal by Subject|7|||
106158600|NCT04649359|366243441|FG001|Overall Study|Withdrawal by Subject|7|||
106158601|NCT04649359|366243440|FG000|Overall Study|Death|41|||
106158602|NCT04649359|366243441|FG001|Overall Study|Death|26|||
106158603|NCT04649359|366243440|FG000|Overall Study|Ongoing in the study|75|||
106158604|NCT04649359|366243441|FG001|Overall Study|Ongoing in the study|31|||
106158605|NCT02120456|366243442|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
106158606|NCT02120456|366243443|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
106158607|NCT02120456|366243444|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
106158608|NCT02120456|366243445|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
106158609|NCT02120456|366243446|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
106158610|NCT02120456|366243447|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
106158611|NCT02120456|366243448|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
106158612|NCT02120456|366243449|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
106158613|NCT02120456|366243450|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
106075591|NCT01577758|365941071|FG003|Dose Escalation Phase|Adverse Event|0|||
106075592|NCT01577758|365941072|FG004|Dose Escalation Phase|Adverse Event|0|||
106075593|NCT01577758|365941073|FG005|Dose Escalation Phase|Adverse Event|2|||
106075594|NCT01577758|365941074|FG006|Dose Escalation Phase|Adverse Event|1|||
106075595|NCT01577758|365941075|FG007|Dose Escalation Phase|Adverse Event|0|||
106075596|NCT01577758|365941068|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
106075597|NCT01577758|365941069|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
106075598|NCT01577758|365941070|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
106075599|NCT01577758|365941071|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
106075600|NCT01577758|365941072|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
106075601|NCT01577758|365941073|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
106075602|NCT01577758|365941074|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
106075603|NCT01577758|365941075|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
106075604|NCT01577758|365941068|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
106075605|NCT01577758|365941069|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
106075606|NCT01577758|365941070|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
106075607|NCT01577758|365941071|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
106075608|NCT01577758|365941072|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
106075609|NCT01577758|365941073|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
106075610|NCT01577758|365941074|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
106075611|NCT01577758|365941075|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
106075612|NCT01577758|365941068|FG000|Dose Escalation Phase|Progression Disease|2|||
106075613|NCT01577758|365941069|FG001|Dose Escalation Phase|Progression Disease|2|||
106075614|NCT01577758|365941070|FG002|Dose Escalation Phase|Progression Disease|1|||
106075615|NCT01577758|365941071|FG003|Dose Escalation Phase|Progression Disease|2|||
106075616|NCT01577758|365941072|FG004|Dose Escalation Phase|Progression Disease|5|||
106075617|NCT01577758|365941073|FG005|Dose Escalation Phase|Progression Disease|0|||
106075618|NCT01577758|365941074|FG006|Dose Escalation Phase|Progression Disease|0|||
106075619|NCT01577758|365941075|FG007|Dose Escalation Phase|Progression Disease|0|||
106075620|NCT01577758|365941068|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
106075621|NCT01577758|365941069|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
106075622|NCT01577758|365941070|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
106075623|NCT01577758|365941071|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
106075624|NCT01577758|365941072|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
106075625|NCT01577758|365941073|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
106075626|NCT01577758|365941074|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
106075627|NCT01577758|365941075|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
106075628|NCT01577758|365941068|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
106075629|NCT01577758|365941069|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
106075630|NCT01577758|365941070|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
106075631|NCT01577758|365941071|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
106075632|NCT01577758|365941072|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
106075633|NCT01577758|365941073|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
106075634|NCT01577758|365941074|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
106075635|NCT01577758|365941075|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
106075636|NCT01577758|365941068|FG000|mCRC Expansion Phase|Progression Disease|0|||
106075637|NCT01577758|365941069|FG001|mCRC Expansion Phase|Progression Disease|0|||
106075638|NCT01577758|365941070|FG002|mCRC Expansion Phase|Progression Disease|0|||
106075639|NCT01577758|365941071|FG003|mCRC Expansion Phase|Progression Disease|0|||
106075640|NCT01577758|365941072|FG004|mCRC Expansion Phase|Progression Disease|0|||
106075641|NCT01577758|365941073|FG005|mCRC Expansion Phase|Progression Disease|0|||
106075642|NCT01577758|365941074|FG006|mCRC Expansion Phase|Progression Disease|0|||
106075643|NCT01577758|365941075|FG007|mCRC Expansion Phase|Progression Disease|19|||
106075644|NCT04327999|365941076|FG000|Overall Study|Protocol Violation|1|||
106075645|NCT03925324|365941080|FG000|Overall Study|Death|1|||
106075646|NCT03925324|365941081|FG001|Overall Study|Death|1|||
106075647|NCT02689258|365941087|FG000|Overall Study|Subject Non-Compliance|0|||
106075648|NCT02689258|365941088|FG001|Overall Study|Subject Non-Compliance|1|||
106075649|NCT02689258|365941089|FG002|Overall Study|Subject Non-Compliance|0|||
106075650|NCT02689258|365941090|FG003|Overall Study|Subject Non-Compliance|0|||
106075651|NCT02689258|365941091|FG004|Overall Study|Subject Non-Compliance|0|||
106075652|NCT02689258|365941092|FG005|Overall Study|Subject Non-Compliance|0|||
106075653|NCT02689258|365941093|FG006|Overall Study|Subject Non-Compliance|0|||
106075654|NCT02689258|365941094|FG007|Overall Study|Subject Non-Compliance|0|||
106075655|NCT02689258|365941095|FG008|Overall Study|Subject Non-Compliance|0|||
106158614|NCT02120456|366243442|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
106075656|NCT02689258|365941096|FG009|Overall Study|Subject Non-Compliance|0|||
106075657|NCT02689258|365941097|FG010|Overall Study|Subject Non-Compliance|0|||
106075658|NCT02689258|365941098|FG011|Overall Study|Subject Non-Compliance|0|||
106075659|NCT02689258|365941087|FG000|Overall Study|Subject Refusal to Continue|0|||
106075660|NCT02689258|365941088|FG001|Overall Study|Subject Refusal to Continue|1|||
106075661|NCT02689258|365941089|FG002|Overall Study|Subject Refusal to Continue|0|||
106158615|NCT02120456|366243443|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
106075662|NCT02689258|365941090|FG003|Overall Study|Subject Refusal to Continue|0|||
106075663|NCT02689258|365941091|FG004|Overall Study|Subject Refusal to Continue|0|||
106075664|NCT02689258|365941092|FG005|Overall Study|Subject Refusal to Continue|0|||
106075665|NCT02689258|365941093|FG006|Overall Study|Subject Refusal to Continue|0|||
106075666|NCT02689258|365941094|FG007|Overall Study|Subject Refusal to Continue|0|||
106075667|NCT02689258|365941095|FG008|Overall Study|Subject Refusal to Continue|1|||
106075668|NCT02689258|365941096|FG009|Overall Study|Subject Refusal to Continue|0|||
106075669|NCT02689258|365941097|FG010|Overall Study|Subject Refusal to Continue|0|||
106075670|NCT02689258|365941098|FG011|Overall Study|Subject Refusal to Continue|1|||
106075671|NCT02689258|365941087|FG000|Overall Study|Other|0|||
106075672|NCT02689258|365941088|FG001|Overall Study|Other|2|||
106075673|NCT02689258|365941089|FG002|Overall Study|Other|0|||
106075674|NCT02689258|365941090|FG003|Overall Study|Other|0|||
106075675|NCT02689258|365941091|FG004|Overall Study|Other|1|||
106075676|NCT02689258|365941092|FG005|Overall Study|Other|0|||
106075677|NCT02689258|365941093|FG006|Overall Study|Other|0|||
106075678|NCT02689258|365941094|FG007|Overall Study|Other|0|||
106075679|NCT02689258|365941095|FG008|Overall Study|Other|1|||
106075680|NCT02689258|365941096|FG009|Overall Study|Other|0|||
106075681|NCT02689258|365941097|FG010|Overall Study|Other|0|||
106075682|NCT02689258|365941098|FG011|Overall Study|Other|0|||
106075683|NCT02159521|365941099|FG000|Overall Study|Enrolled but not treated|3|||
106075684|NCT02159521|365941099|FG000|Overall Study|Withdrawal by Subject|7|||
106075685|NCT02159521|365941099|FG000|Overall Study|Lost to Follow-up|6|||
106075686|NCT02159521|365941099|FG000|Overall Study|Death|1|||
106075687|NCT02159521|365941099|FG000|Overall Study|Other than specified|1|||
106075688|NCT04372602|365941108|FG000|Overall Study|Withdrawal by Subject|1|||
106075689|NCT04372602|365941109|FG001|Overall Study|Withdrawal by Subject|1|||
106075690|NCT04372602|365941108|FG000|Overall Study|Adverse Event|0|||
106075691|NCT04372602|365941109|FG001|Overall Study|Adverse Event|1|||
106075692|NCT04372602|365941108|FG000|Overall Study|Transitioned to comfort care|0|||
106075693|NCT04372602|365941109|FG001|Overall Study|Transitioned to comfort care|1|||
106075694|NCT00775437|365941110|FG000|Overall Study|Loss of efficacy|2|||
106075695|NCT00775437|365941110|FG000|Overall Study|Withdrawal by Subject|3|||
106075696|NCT00775437|365941110|FG000|Overall Study|Lost to Follow-up|1|||
106075697|NCT02907359|365941112|FG000|Overall Study|Death|234|||
106075698|NCT02907359|365941113|FG001|Overall Study|Death|117|||
106075699|NCT02907359|365941112|FG000|Overall Study|Withdrawal by Subject|6|||
106075700|NCT02907359|365941113|FG001|Overall Study|Withdrawal by Subject|11|||
106075701|NCT02907359|365941112|FG000|Overall Study|Lost to Follow-up|1|||
106075702|NCT02907359|365941113|FG001|Overall Study|Lost to Follow-up|0|||
106075703|NCT03131440|365941114|FG000|Overall Study|Withdrawal by Subject|1|||
106075704|NCT03131440|365941115|FG001|Overall Study|Withdrawal by Subject|3|||
106075705|NCT03131440|365941116|FG002|Overall Study|Withdrawal by Subject|0|||
106075706|NCT03131440|365941117|FG003|Overall Study|Withdrawal by Subject|0|||
106075707|NCT03131440|365941118|FG004|Overall Study|Withdrawal by Subject|1|||
106075708|NCT03131440|365941119|FG005|Overall Study|Withdrawal by Subject|0|||
106075709|NCT03131440|365941120|FG006|Overall Study|Withdrawal by Subject|0|||
106075710|NCT03131440|365941121|FG007|Overall Study|Withdrawal by Subject|1|||
106075711|NCT03131440|365941122|FG008|Overall Study|Withdrawal by Subject|1|||
106075712|NCT03131440|365941123|FG009|Overall Study|Withdrawal by Subject|1|||
106075713|NCT03131440|365941124|FG010|Overall Study|Withdrawal by Subject|0|||
106075714|NCT03131440|365941125|FG011|Overall Study|Withdrawal by Subject|1|||
106075715|NCT03131440|365941126|FG012|Overall Study|Withdrawal by Subject|1|||
106075716|NCT03131440|365941127|FG013|Overall Study|Withdrawal by Subject|0|||
106075717|NCT03131440|365941128|FG014|Overall Study|Withdrawal by Subject|1|||
106075718|NCT03131440|365941129|FG015|Overall Study|Withdrawal by Subject|0|||
106075719|NCT03131440|365941130|FG016|Overall Study|Withdrawal by Subject|0|||
106075720|NCT03131440|365941131|FG017|Overall Study|Withdrawal by Subject|0|||
106075721|NCT03131440|365941132|FG018|Overall Study|Withdrawal by Subject|1|||
106075722|NCT03131440|365941133|FG019|Overall Study|Withdrawal by Subject|0|||
106075723|NCT03131440|365941134|FG020|Overall Study|Withdrawal by Subject|1|||
106075724|NCT03131440|365941135|FG021|Overall Study|Withdrawal by Subject|1|||
106075725|NCT03131440|365941136|FG022|Overall Study|Withdrawal by Subject|1|||
106075726|NCT03131440|365941137|FG023|Overall Study|Withdrawal by Subject|0|||
106075727|NCT03131440|365941138|FG024|Overall Study|Withdrawal by Subject|0|||
106075728|NCT03131440|365941139|FG025|Overall Study|Withdrawal by Subject|0|||
106075729|NCT03131440|365941140|FG026|Overall Study|Withdrawal by Subject|0|||
106075730|NCT03131440|365941141|FG027|Overall Study|Withdrawal by Subject|0|||
106075731|NCT03131440|365941142|FG028|Overall Study|Withdrawal by Subject|0|||
106075732|NCT03131440|365941143|FG029|Overall Study|Withdrawal by Subject|0|||
106075733|NCT03131440|365941144|FG030|Overall Study|Withdrawal by Subject|1|||
106075734|NCT03131440|365941145|FG031|Overall Study|Withdrawal by Subject|0|||
106075735|NCT03131440|365941114|FG000|Overall Study|Lost to Follow-up|0|||
106075736|NCT03131440|365941115|FG001|Overall Study|Lost to Follow-up|0|||
106075737|NCT03131440|365941116|FG002|Overall Study|Lost to Follow-up|0|||
106075738|NCT03131440|365941117|FG003|Overall Study|Lost to Follow-up|0|||
106075739|NCT03131440|365941118|FG004|Overall Study|Lost to Follow-up|0|||
106075740|NCT03131440|365941119|FG005|Overall Study|Lost to Follow-up|1|||
106075741|NCT03131440|365941120|FG006|Overall Study|Lost to Follow-up|0|||
106075742|NCT03131440|365941121|FG007|Overall Study|Lost to Follow-up|0|||
106075743|NCT03131440|365941122|FG008|Overall Study|Lost to Follow-up|0|||
106075744|NCT03131440|365941123|FG009|Overall Study|Lost to Follow-up|0|||
106075745|NCT03131440|365941124|FG010|Overall Study|Lost to Follow-up|0|||
106075746|NCT03131440|365941125|FG011|Overall Study|Lost to Follow-up|0|||
106075747|NCT03131440|365941126|FG012|Overall Study|Lost to Follow-up|0|||
106075748|NCT03131440|365941127|FG013|Overall Study|Lost to Follow-up|0|||
106075749|NCT03131440|365941128|FG014|Overall Study|Lost to Follow-up|0|||
106075750|NCT03131440|365941129|FG015|Overall Study|Lost to Follow-up|0|||
106075751|NCT03131440|365941130|FG016|Overall Study|Lost to Follow-up|0|||
106075752|NCT03131440|365941131|FG017|Overall Study|Lost to Follow-up|0|||
106075753|NCT03131440|365941132|FG018|Overall Study|Lost to Follow-up|0|||
106075754|NCT03131440|365941133|FG019|Overall Study|Lost to Follow-up|2|||
106075755|NCT03131440|365941134|FG020|Overall Study|Lost to Follow-up|1|||
106075756|NCT03131440|365941135|FG021|Overall Study|Lost to Follow-up|0|||
106075757|NCT03131440|365941136|FG022|Overall Study|Lost to Follow-up|1|||
106075758|NCT03131440|365941137|FG023|Overall Study|Lost to Follow-up|0|||
106075759|NCT03131440|365941138|FG024|Overall Study|Lost to Follow-up|1|||
106075760|NCT03131440|365941139|FG025|Overall Study|Lost to Follow-up|0|||
106075761|NCT03131440|365941140|FG026|Overall Study|Lost to Follow-up|0|||
106075762|NCT03131440|365941141|FG027|Overall Study|Lost to Follow-up|2|||
106075763|NCT03131440|365941142|FG028|Overall Study|Lost to Follow-up|0|||
106075764|NCT03131440|365941143|FG029|Overall Study|Lost to Follow-up|2|||
106075765|NCT03131440|365941144|FG030|Overall Study|Lost to Follow-up|0|||
106075766|NCT03131440|365941145|FG031|Overall Study|Lost to Follow-up|0|||
106075767|NCT03131440|365941114|FG000|Overall Study|Death|0|||
106075768|NCT03131440|365941115|FG001|Overall Study|Death|0|||
106075769|NCT03131440|365941116|FG002|Overall Study|Death|0|||
106075770|NCT03131440|365941117|FG003|Overall Study|Death|0|||
106075771|NCT03131440|365941118|FG004|Overall Study|Death|0|||
106075772|NCT03131440|365941119|FG005|Overall Study|Death|0|||
106075773|NCT03131440|365941120|FG006|Overall Study|Death|0|||
106075774|NCT03131440|365941121|FG007|Overall Study|Death|0|||
106075775|NCT03131440|365941122|FG008|Overall Study|Death|0|||
106075776|NCT03131440|365941123|FG009|Overall Study|Death|0|||
106075777|NCT03131440|365941124|FG010|Overall Study|Death|0|||
106075778|NCT03131440|365941125|FG011|Overall Study|Death|0|||
106075779|NCT03131440|365941126|FG012|Overall Study|Death|0|||
106075780|NCT03131440|365941127|FG013|Overall Study|Death|0|||
106075781|NCT03131440|365941128|FG014|Overall Study|Death|0|||
106075782|NCT03131440|365941129|FG015|Overall Study|Death|0|||
106075783|NCT03131440|365941130|FG016|Overall Study|Death|0|||
106075784|NCT03131440|365941131|FG017|Overall Study|Death|0|||
106075785|NCT03131440|365941132|FG018|Overall Study|Death|0|||
106075786|NCT03131440|365941133|FG019|Overall Study|Death|0|||
106075787|NCT03131440|365941134|FG020|Overall Study|Death|0|||
106075788|NCT03131440|365941135|FG021|Overall Study|Death|0|||
106075789|NCT03131440|365941136|FG022|Overall Study|Death|0|||
106075790|NCT03131440|365941137|FG023|Overall Study|Death|0|||
106075791|NCT03131440|365941138|FG024|Overall Study|Death|0|||
106075792|NCT03131440|365941139|FG025|Overall Study|Death|1|||
106075793|NCT03131440|365941140|FG026|Overall Study|Death|0|||
106075794|NCT03131440|365941141|FG027|Overall Study|Death|0|||
106075795|NCT03131440|365941142|FG028|Overall Study|Death|0|||
106075796|NCT03131440|365941143|FG029|Overall Study|Death|0|||
106075797|NCT03131440|365941144|FG030|Overall Study|Death|0|||
106075798|NCT03131440|365941145|FG031|Overall Study|Death|0|||
106075799|NCT01405963|365941146|FG000|Overall Study|Moved Away|2|||
106075800|NCT01405963|365941147|FG001|Overall Study|Moved Away|0|||
106075801|NCT01405963|365941146|FG000|Overall Study|Adverse Event|0|||
106075802|NCT01405963|365941147|FG001|Overall Study|Adverse Event|1|||
106075803|NCT01405963|365941146|FG000|Overall Study|Lost to Follow-up|0|||
106075804|NCT01405963|365941147|FG001|Overall Study|Lost to Follow-up|1|||
106075805|NCT01498640|365941156|FG000|Overall Study|Lost to Follow-up|1|||
106075806|NCT01498640|365941156|FG000|Overall Study|Death|1|||
106075807|NCT01498640|365941156|FG000|Overall Study|Other|3|||
106075808|NCT04371380|365941157|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
106075809|NCT04371380|365941158|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
106075810|NCT04371380|365941159|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
106075811|NCT06049043|365941160|FG000|Overall Study|Lost to Follow-up|11|||
106075812|NCT06049043|365941161|FG001|Overall Study|Lost to Follow-up|9|||
106075813|NCT04180020|365941162|FG000|Overall Study|missed visit|18|||
106075814|NCT04180020|365941163|FG001|Overall Study|missed visit|16|||
106075815|NCT04180020|365941162|FG000|Overall Study|Death|2|||
106075816|NCT04180020|365941163|FG001|Overall Study|Death|3|||
106075817|NCT04180020|365941162|FG000|Overall Study|Withdrawal by Subject|1|||
106075818|NCT04180020|365941163|FG001|Overall Study|Withdrawal by Subject|5|||
106075819|NCT04180020|365941162|FG000|Overall Study|incarcerated|1|||
106075820|NCT04180020|365941163|FG001|Overall Study|incarcerated|1|||
106075821|NCT04180020|365941162|FG000|Overall Study|Physician Decision|0|||
106075822|NCT04180020|365941163|FG001|Overall Study|Physician Decision|2|||
106075823|NCT03774433|365941170|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
106075824|NCT01708174|365941171|FG000|Treatment Period|Withdrawal by Subject|1|||
106075825|NCT01708174|365941172|FG001|Treatment Period|Withdrawal by Subject|0|||
106075826|NCT01708174|365941173|FG002|Treatment Period|Withdrawal by Subject|0|||
106075827|NCT01708174|365941171|FG000|Treatment Period|Progressive disease|0|||
106075828|NCT01708174|365941172|FG001|Treatment Period|Progressive disease|1|||
106075829|NCT01708174|365941173|FG002|Treatment Period|Progressive disease|0|||
106075830|NCT01708174|365941171|FG000|Treatment Period|Death|0|||
106075831|NCT01708174|365941172|FG001|Treatment Period|Death|0|||
106075832|NCT01708174|365941173|FG002|Treatment Period|Death|1|||
106075833|NCT01708174|365941171|FG000|Treatment Period|Adverse Event|0|||
106075834|NCT01708174|365941172|FG001|Treatment Period|Adverse Event|1|||
106075835|NCT01708174|365941173|FG002|Treatment Period|Adverse Event|0|||
106075836|NCT01951157|365941174|FG000|Overall Study|Progressive Disease|12|||
106075837|NCT01951157|365941175|FG001|Overall Study|Progressive Disease|13|||
106075838|NCT01951157|365941176|FG002|Overall Study|Progressive Disease|10|||
106075839|NCT01951157|365941174|FG000|Overall Study|Treatment-unrelated AE|1|||
106075840|NCT01951157|365941175|FG001|Overall Study|Treatment-unrelated AE|0|||
106075841|NCT01951157|365941176|FG002|Overall Study|Treatment-unrelated AE|3|||
106158616|NCT02120456|366243444|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
106158617|NCT02120456|366243445|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
106158618|NCT02120456|366243446|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
106158619|NCT02120456|366243447|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
106158620|NCT02120456|366243448|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
106158621|NCT02120456|366243449|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
106158622|NCT02120456|366243450|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
106158623|NCT02120456|366243442|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
106158624|NCT02120456|366243443|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
106158625|NCT02120456|366243444|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
106158626|NCT02120456|366243445|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
106158627|NCT02120456|366243446|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
106158628|NCT02120456|366243447|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
106158629|NCT02120456|366243448|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
106158630|NCT02120456|366243449|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
106158631|NCT02120456|366243450|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
106158632|NCT02243709|366243453|FG000|Phase 1|Lost to Follow-up|0|||
106158633|NCT02243709|366243454|FG001|Phase 1|Lost to Follow-up|1|||
106158634|NCT02243709|366243453|FG000|Phase 1|Withdrawal by Subject|1|||
106158635|NCT02243709|366243454|FG001|Phase 1|Withdrawal by Subject|0|||
106158636|NCT02243709|366243453|FG000|Phase 1|Protocol Violation|0|||
106158637|NCT02243709|366243454|FG001|Phase 1|Protocol Violation|1|||
106158638|NCT02243709|366243453|FG000|Phase 1|Adverse Event|0|||
106158639|NCT02243709|366243454|FG001|Phase 1|Adverse Event|1|||
106158640|NCT01785719|366243458|FG000|4-week Baseline Evaluation|Physician Decision|1|||
106158641|NCT01785719|366243459|FG001|4-week Baseline Evaluation|Physician Decision|0|||
106158642|NCT01785719|366243458|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
106158643|NCT01785719|366243459|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
106158644|NCT01785719|366243458|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
106158645|NCT01785719|366243459|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
106158646|NCT01785719|366243458|FG000|4-week Baseline Evaluation|Pregnancy|0|||
106158647|NCT01785719|366243459|FG001|4-week Baseline Evaluation|Pregnancy|2|||
106158648|NCT01785719|366243458|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
106158649|NCT01785719|366243459|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
106158650|NCT01785719|366243458|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
106158651|NCT01785719|366243459|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
106158652|NCT01785719|366243458|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
106158653|NCT01785719|366243459|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
106158654|NCT01785719|366243458|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
106158655|NCT01785719|366243459|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
106158656|NCT01785719|366243458|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
106158657|NCT01785719|366243459|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
106158658|NCT01785719|366243458|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
106158659|NCT01785719|366243459|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
106158660|NCT01785719|366243458|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
106158661|NCT01785719|366243459|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
106158662|NCT01785719|366243458|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
106075842|NCT01951157|365941174|FG000|Overall Study|Study Termination|0|||
106075843|NCT01951157|365941175|FG001|Overall Study|Study Termination|0|||
106075844|NCT01951157|365941176|FG002|Overall Study|Study Termination|1|||
106075845|NCT01951157|365941174|FG000|Overall Study|Physician Decision|5|||
106075846|NCT01951157|365941175|FG001|Overall Study|Physician Decision|3|||
106158663|NCT01785719|366243459|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
106158664|NCT01785719|366243458|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
106158665|NCT01785719|366243459|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
106158666|NCT01785719|366243458|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
106158667|NCT01785719|366243459|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
106158668|NCT01785719|366243458|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
106075847|NCT01951157|365941176|FG002|Overall Study|Physician Decision|2|||
106075848|NCT01951157|365941174|FG000|Overall Study|Non-treatmentrelated death|2|||
106075849|NCT01951157|365941175|FG001|Overall Study|Non-treatmentrelated death|2|||
106075850|NCT01951157|365941176|FG002|Overall Study|Non-treatmentrelated death|2|||
106075851|NCT01951157|365941174|FG000|Overall Study|No treated|0|||
106075852|NCT01951157|365941175|FG001|Overall Study|No treated|1|||
106075853|NCT01951157|365941176|FG002|Overall Study|No treated|0|||
106075854|NCT01951157|365941174|FG000|Overall Study|Treatment-related AE|2|||
106075855|NCT01951157|365941175|FG001|Overall Study|Treatment-related AE|0|||
106075856|NCT01951157|365941176|FG002|Overall Study|Treatment-related AE|4|||
106075857|NCT01951157|365941174|FG000|Overall Study|Consent withdrawn by subject|0|||
106075858|NCT01951157|365941175|FG001|Overall Study|Consent withdrawn by subject|1|||
106075859|NCT01951157|365941176|FG002|Overall Study|Consent withdrawn by subject|3|||
106075860|NCT01951157|365941174|FG000|Overall Study|Treatment-related death|0|||
106075861|NCT01951157|365941175|FG001|Overall Study|Treatment-related death|2|||
106075862|NCT01951157|365941176|FG002|Overall Study|Treatment-related death|0|||
106075863|NCT00851799|365941178|FG000|Overall Study|Death|1|||
106075864|NCT00851799|365941179|FG001|Overall Study|Death|0|||
106075865|NCT00851799|365941180|FG002|Overall Study|Death|1|||
106075866|NCT00851799|365941178|FG000|Overall Study|Lost to Follow-up|5|||
106075867|NCT00851799|365941179|FG001|Overall Study|Lost to Follow-up|3|||
106075868|NCT00851799|365941180|FG002|Overall Study|Lost to Follow-up|10|||
106075869|NCT00851799|365941178|FG000|Overall Study|Not able to get to clinic|8|||
106075870|NCT00851799|365941179|FG001|Overall Study|Not able to get to clinic|5|||
106075871|NCT00851799|365941180|FG002|Overall Study|Not able to get to clinic|9|||
106075872|NCT00851799|365941178|FG000|Overall Study|Not willing to adhere to requirements|1|||
106075873|NCT00851799|365941179|FG001|Overall Study|Not willing to adhere to requirements|2|||
106075874|NCT00851799|365941180|FG002|Overall Study|Not willing to adhere to requirements|2|||
106075875|NCT00851799|365941178|FG000|Overall Study|Withdrew consent prior study completion|1|||
106075876|NCT00851799|365941179|FG001|Overall Study|Withdrew consent prior study completion|2|||
106075877|NCT00851799|365941180|FG002|Overall Study|Withdrew consent prior study completion|1|||
106075878|NCT00851799|365941178|FG000|Overall Study|Severe Debilitation|0|||
106075879|NCT00851799|365941179|FG001|Overall Study|Severe Debilitation|1|||
106075880|NCT00851799|365941180|FG002|Overall Study|Severe Debilitation|0|||
106075881|NCT00851799|365941178|FG000|Overall Study|Completed protocol due to pregnancy|0|||
106075882|NCT00851799|365941179|FG001|Overall Study|Completed protocol due to pregnancy|0|||
106075883|NCT00851799|365941180|FG002|Overall Study|Completed protocol due to pregnancy|1|||
106075884|NCT00026793|365941184|FG000|Overall Study|Death on study due to underlying disease|4|||
106075885|NCT00026793|365941184|FG000|Overall Study|Physician Decision|2|||
106075886|NCT00026793|365941184|FG000|Overall Study|Off study|2|||
106075887|NCT03323658|365941186|FG000|Overall Study|Adverse Event|0|||
106075888|NCT03323658|365941187|FG001|Overall Study|Adverse Event|1|||
106075889|NCT03323658|365941188|FG002|Overall Study|Adverse Event|0|||
106075890|NCT02276612|365941189|FG000|Overall Study|Death|1|||
106075891|NCT02276612|365941190|FG001|Overall Study|Death|0|||
106075892|NCT02276612|365941189|FG000|Overall Study|Pregnancy|1|||
106075893|NCT02276612|365941190|FG001|Overall Study|Pregnancy|0|||
106075894|NCT02276612|365941189|FG000|Overall Study|Withdrew Consent|1|||
106075895|NCT02276612|365941190|FG001|Overall Study|Withdrew Consent|0|||
106075896|NCT02276612|365941189|FG000|Overall Study|Lost to Follow-up|1|||
106075897|NCT02276612|365941190|FG001|Overall Study|Lost to Follow-up|0|||
106097384|NCT01715805|366014394|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
106097385|NCT01715805|366014395|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
106097386|NCT01715805|366014396|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
106097387|NCT01715805|366014397|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
106097388|NCT01715805|366014394|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
106097389|NCT01715805|366014395|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
106097390|NCT01715805|366014396|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
106097391|NCT01715805|366014397|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
106158669|NCT01785719|366243459|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
106158670|NCT03443323|366243460|FG000|Overall Study|Lost to Follow-up|2|||
106097392|NCT01715805|366014394|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
106097393|NCT01715805|366014395|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
106097394|NCT01715805|366014396|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
106097395|NCT01715805|366014397|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
106097396|NCT01715805|366014394|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
106075898|NCT04709575|365942711|FG000|Overall Study|Withdrawal by Subject|6|||
106075899|NCT04709575|365942712|FG001|Overall Study|Withdrawal by Subject|2|||
106075900|NCT04709575|365942711|FG000|Overall Study|Lost to Follow-up|2|||
106075901|NCT04709575|365942712|FG001|Overall Study|Lost to Follow-up|2|||
106075902|NCT04709575|365942711|FG000|Overall Study|Adverse Event|1|||
106075903|NCT04709575|365942712|FG001|Overall Study|Adverse Event|0|||
106075904|NCT04709575|365942711|FG000|Overall Study|Protocol Violation|1|||
106075905|NCT04709575|365942712|FG001|Overall Study|Protocol Violation|1|||
106075906|NCT03299842|365942717|FG000|Overall Study|Caregiver withdrew consent|2|||
106075907|NCT03299842|365942717|FG000|Overall Study|Child would not keep the watch on|3|||
106075908|NCT00136084|365942722|FG000|Overall Study|Death|12|||
106075909|NCT00136084|365942723|FG001|Overall Study|Death|5|||
106075910|NCT00136084|365942722|FG000|Overall Study|Unacceptable toxicity|8|||
106075911|NCT00136084|365942723|FG001|Overall Study|Unacceptable toxicity|11|||
106075912|NCT00136084|365942722|FG000|Overall Study|Relapse|20|||
106075913|NCT00136084|365942723|FG001|Overall Study|Relapse|23|||
106075914|NCT00136084|365942722|FG000|Overall Study|Lost to Follow-up|2|||
106075915|NCT00136084|365942723|FG001|Overall Study|Lost to Follow-up|0|||
106075916|NCT00136084|365942722|FG000|Overall Study|No Response|1|||
106075917|NCT00136084|365942723|FG001|Overall Study|No Response|2|||
106075918|NCT00136084|365942722|FG000|Overall Study|Withdrawal by Subject|5|||
106075919|NCT00136084|365942723|FG001|Overall Study|Withdrawal by Subject|1|||
106075920|NCT01275066|365942726|FG000|Overall Study|Withdrawal by Subject|0|||
106075921|NCT01275066|365942727|FG001|Overall Study|Withdrawal by Subject|0|||
106075922|NCT01275066|365942728|FG002|Overall Study|Withdrawal by Subject|1|||
106075923|NCT01275066|365942726|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
106075924|NCT01275066|365942727|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
106075925|NCT01275066|365942728|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
106075926|NCT03509675|365942730|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
106075927|NCT03509675|365942731|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
106075928|NCT03509675|365942730|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
106075929|NCT03509675|365942731|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
106075930|NCT03509675|365942730|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
106075931|NCT03509675|365942731|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
106075932|NCT03509675|365942730|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
106075933|NCT03509675|365942731|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
106075934|NCT02780804|365942734|FG000|Overall Study|Death|1|||
106075935|NCT02780804|365942735|FG001|Overall Study|Death|0|||
106075936|NCT02780804|365942736|FG002|Overall Study|Death|0|||
106075937|NCT02780804|365942734|FG000|Overall Study|Lack of Efficacy|5|||
106075938|NCT02780804|365942735|FG001|Overall Study|Lack of Efficacy|8|||
106075939|NCT02780804|365942736|FG002|Overall Study|Lack of Efficacy|4|||
106075940|NCT02780804|365942734|FG000|Overall Study|Physician Decision|0|||
106075941|NCT02780804|365942735|FG001|Overall Study|Physician Decision|0|||
106075942|NCT02780804|365942736|FG002|Overall Study|Physician Decision|2|||
106075943|NCT02780804|365942734|FG000|Overall Study|Withdrawal by Subject|0|||
106075944|NCT02780804|365942735|FG001|Overall Study|Withdrawal by Subject|1|||
106075945|NCT02780804|365942736|FG002|Overall Study|Withdrawal by Subject|0|||
106075946|NCT01723163|365942737|FG000|Treatment Phase|Withdrawal by Subject|14|||
106075947|NCT01723163|365942738|FG001|Treatment Phase|Withdrawal by Subject|6|||
106075948|NCT01723163|365942737|FG000|Treatment Phase|Withdrawal by PI|5|||
106075949|NCT01723163|365942738|FG001|Treatment Phase|Withdrawal by PI|1|||
106075950|NCT01723163|365942737|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
106075951|NCT01723163|365942738|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
106075952|NCT01723163|365942737|FG000|3-Month Follow-up|Unable to Contact|12|||
106075953|NCT01723163|365942738|FG001|3-Month Follow-up|Unable to Contact|19|||
106075954|NCT01723163|365942737|FG000|6-Month Follow-up|Death|1|||
106075955|NCT01723163|365942738|FG001|6-Month Follow-up|Death|0|||
106075956|NCT01723163|365942737|FG000|6-Month Follow-up|Unable to Contact|17|||
106075957|NCT01723163|365942738|FG001|6-Month Follow-up|Unable to Contact|15|||
106075958|NCT01723163|365942737|FG000|12-Month Follow-up|Death|1|||
106075959|NCT01723163|365942738|FG001|12-Month Follow-up|Death|0|||
106075960|NCT01723163|365942737|FG000|12-Month Follow-up|Unable to Contact|23|||
106075961|NCT01723163|365942738|FG001|12-Month Follow-up|Unable to Contact|28|||
106075962|NCT01859507|365942741|FG000|Overall Study|left the country|4|||
106075963|NCT02342704|365942744|FG000|Overall Study|Physician Decision|0|||
106075964|NCT02342704|365942745|FG001|Overall Study|Physician Decision|3|||
106075965|NCT02342704|365942744|FG000|Overall Study|Sponsor Termination|49|||
106075966|NCT02342704|365942745|FG001|Overall Study|Sponsor Termination|43|||
106075967|NCT02342704|365942744|FG000|Overall Study|Other|0|||
106075968|NCT02342704|365942745|FG001|Overall Study|Other|1|||
106075969|NCT02342704|365942744|FG000|Overall Study|Withdrawal by Subject|1|||
106075970|NCT02342704|365942745|FG001|Overall Study|Withdrawal by Subject|0|||
106075971|NCT02342704|365942744|FG000|Overall Study|Lost to Follow-up|2|||
106075972|NCT02342704|365942745|FG001|Overall Study|Lost to Follow-up|1|||
106075973|NCT02342704|365942744|FG000|Overall Study|Adverse Event|1|||
106075974|NCT02342704|365942745|FG001|Overall Study|Adverse Event|3|||
106075975|NCT00283439|365942746|FG000|Overall Study|Adverse Event|0|||
105866640|NCT02676765|365161122|FG000|Overall Study|Lost to Follow-up|0|||
106075976|NCT00283439|365942747|FG001|Overall Study|Adverse Event|0|||
106075977|NCT00283439|365942748|FG002|Overall Study|Adverse Event|0|||
106075978|NCT00283439|365942749|FG003|Overall Study|Adverse Event|1|||
106075979|NCT00283439|365942746|FG000|Overall Study|Death|0|||
106075980|NCT00283439|365942747|FG001|Overall Study|Death|0|||
106075981|NCT00283439|365942748|FG002|Overall Study|Death|1|||
106075982|NCT00283439|365942749|FG003|Overall Study|Death|0|||
106075983|NCT00283439|365942746|FG000|Overall Study|Disease progression|0|||
106075984|NCT00283439|365942747|FG001|Overall Study|Disease progression|1|||
106075985|NCT00283439|365942748|FG002|Overall Study|Disease progression|0|||
106075986|NCT00283439|365942749|FG003|Overall Study|Disease progression|0|||
106075987|NCT00283439|365942746|FG000|Overall Study|Requirement for alternative therapy|1|||
106075988|NCT00283439|365942747|FG001|Overall Study|Requirement for alternative therapy|2|||
106075989|NCT00283439|365942748|FG002|Overall Study|Requirement for alternative therapy|5|||
106075990|NCT00283439|365942749|FG003|Overall Study|Requirement for alternative therapy|2|||
106075991|NCT00283439|365942746|FG000|Overall Study|Stem cell transplant|6|||
106075992|NCT00283439|365942747|FG001|Overall Study|Stem cell transplant|6|||
106075993|NCT00283439|365942748|FG002|Overall Study|Stem cell transplant|4|||
106075994|NCT00283439|365942749|FG003|Overall Study|Stem cell transplant|3|||
106075995|NCT00283439|365942746|FG000|Overall Study|Treatment discontinued|0|||
106075996|NCT00283439|365942747|FG001|Overall Study|Treatment discontinued|2|||
106075997|NCT00283439|365942748|FG002|Overall Study|Treatment discontinued|1|||
106075998|NCT00283439|365942749|FG003|Overall Study|Treatment discontinued|3|||
106075999|NCT00283439|365942746|FG000|Overall Study|Other|1|||
106076000|NCT00283439|365942747|FG001|Overall Study|Other|0|||
106076001|NCT00283439|365942748|FG002|Overall Study|Other|0|||
106076002|NCT00283439|365942749|FG003|Overall Study|Other|0|||
106076003|NCT02506816|365942756|FG000|Overall Study|Adverse Event|3|||
106076004|NCT00218296|365942757|FG000|Overall Study|Lost to Follow-up|9|||
106076005|NCT00218296|365942758|FG001|Overall Study|Lost to Follow-up|7|||
106076006|NCT00218296|365942757|FG000|Overall Study|Withdrawal by Subject|36|||
106076007|NCT00218296|365942758|FG001|Overall Study|Withdrawal by Subject|47|||
106076008|NCT00218296|365942757|FG000|Overall Study|Randomized but did not enter treatment|66|||
106076009|NCT00218296|365942758|FG001|Overall Study|Randomized but did not enter treatment|67|||
106076010|NCT04164901|365942766|FG000|Overall Study|Withdrawal by Subject|4|||
106076011|NCT04164901|365942767|FG001|Overall Study|Withdrawal by Subject|4|||
106076012|NCT01817725|365942783|FG000|Overall Study|Withdrawal by Subject|1|||
106076013|NCT02286193|365942787|FG000|Overall Study|Referred: CRS unable to make contact|62|||
106076014|NCT02286193|365942787|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
106076015|NCT02286193|365942787|FG000|Overall Study|Referred: Declined service|38|||
106076016|NCT01232296|365942788|FG000|Overall Study|Adverse Event|24|||
106076017|NCT01232296|365942789|FG001|Overall Study|Adverse Event|12|||
106076018|NCT01232296|365942788|FG000|Overall Study|Physician Decision|1|||
106076019|NCT01232296|365942789|FG001|Overall Study|Physician Decision|1|||
106076020|NCT01232296|365942788|FG000|Overall Study|Progressive disease|43|||
106076021|NCT01232296|365942789|FG001|Overall Study|Progressive disease|61|||
106076022|NCT01232296|365942788|FG000|Overall Study|Study terminated by sponsor|0|||
106076023|NCT01232296|365942789|FG001|Overall Study|Study terminated by sponsor|1|||
106076024|NCT01232296|365942788|FG000|Overall Study|Technical problems|3|||
106076025|NCT01232296|365942789|FG001|Overall Study|Technical problems|0|||
106076026|NCT01232296|365942788|FG000|Overall Study|Subject/guardian decision|10|||
106076027|NCT01232296|365942789|FG001|Overall Study|Subject/guardian decision|2|||
106076028|NCT01232296|365942788|FG000|Overall Study|Death|1|||
106076029|NCT01232296|365942789|FG001|Overall Study|Death|6|||
106076030|NCT01289847|365942794|FG000|Overall Study|Patient could not comply with visits|1|||
106076031|NCT02404350|365942800|FG000|Overall Study|Adverse Event|2|||
106076032|NCT02404350|365942801|FG001|Overall Study|Adverse Event|2|||
106076033|NCT02404350|365942802|FG002|Overall Study|Adverse Event|3|||
106076034|NCT02404350|365942803|FG003|Overall Study|Adverse Event|9|||
106076035|NCT02404350|365942800|FG000|Overall Study|Lack of Efficacy|3|||
106076036|NCT02404350|365942801|FG001|Overall Study|Lack of Efficacy|1|||
106076037|NCT02404350|365942802|FG002|Overall Study|Lack of Efficacy|0|||
106076038|NCT02404350|365942803|FG003|Overall Study|Lack of Efficacy|3|||
106076039|NCT02404350|365942800|FG000|Overall Study|Lost to Follow-up|2|||
106076040|NCT02404350|365942801|FG001|Overall Study|Lost to Follow-up|0|||
106076041|NCT02404350|365942802|FG002|Overall Study|Lost to Follow-up|0|||
106076042|NCT02404350|365942803|FG003|Overall Study|Lost to Follow-up|1|||
106076043|NCT02404350|365942800|FG000|Overall Study|Physician Decision|1|||
106076044|NCT02404350|365942801|FG001|Overall Study|Physician Decision|0|||
106076045|NCT02404350|365942802|FG002|Overall Study|Physician Decision|0|||
106076046|NCT02404350|365942803|FG003|Overall Study|Physician Decision|2|||
106076047|NCT02404350|365942800|FG000|Overall Study|Pregnancy|0|||
106076048|NCT02404350|365942801|FG001|Overall Study|Pregnancy|0|||
106076049|NCT02404350|365942802|FG002|Overall Study|Pregnancy|0|||
106076050|NCT02404350|365942803|FG003|Overall Study|Pregnancy|1|||
106076051|NCT02404350|365942800|FG000|Overall Study|Withdrawal by Subject|7|||
106076052|NCT02404350|365942801|FG001|Overall Study|Withdrawal by Subject|3|||
106076053|NCT02404350|365942802|FG002|Overall Study|Withdrawal by Subject|3|||
106076054|NCT02404350|365942803|FG003|Overall Study|Withdrawal by Subject|19|||
106076055|NCT02404350|365942800|FG000|Overall Study|Due to Non-compliance with treatment|0|||
106076056|NCT02404350|365942801|FG001|Overall Study|Due to Non-compliance with treatment|0|||
106076057|NCT02404350|365942802|FG002|Overall Study|Due to Non-compliance with treatment|0|||
106076058|NCT02404350|365942803|FG003|Overall Study|Due to Non-compliance with treatment|1|||
106076059|NCT02404350|365942800|FG000|Overall Study|Due to Technical problems|0|||
106076060|NCT02404350|365942801|FG001|Overall Study|Due to Technical problems|0|||
106076061|NCT02404350|365942802|FG002|Overall Study|Due to Technical problems|0|||
106076062|NCT02404350|365942803|FG003|Overall Study|Due to Technical problems|1|||
106076063|NCT01364428|365942809|FG000|Overall Study|Adverse Event|1|||
106076064|NCT01364428|365942810|FG001|Overall Study|Adverse Event|2|||
106076065|NCT01364428|365942809|FG000|Overall Study|Protocol Violation|2|||
106076066|NCT01364428|365942810|FG001|Overall Study|Protocol Violation|0|||
106076067|NCT01364428|365942809|FG000|Overall Study|Withdrawal Criteria|14|||
106076068|NCT01364428|365942810|FG001|Overall Study|Withdrawal Criteria|10|||
106076069|NCT01364428|365942809|FG000|Overall Study|Other|3|||
106076070|NCT01364428|365942810|FG001|Overall Study|Other|3|||
106076071|NCT01987427|365942811|FG000|Overall Study|Adverse Event|4|||
106076072|NCT01987427|365942812|FG001|Overall Study|Adverse Event|2|||
106076073|NCT01987427|365942813|FG002|Overall Study|Adverse Event|8|||
106076074|NCT01987427|365942811|FG000|Overall Study|Lost to Follow-up|6|||
106076075|NCT01987427|365942812|FG001|Overall Study|Lost to Follow-up|6|||
106076076|NCT01987427|365942813|FG002|Overall Study|Lost to Follow-up|9|||
106076077|NCT01987427|365942811|FG000|Overall Study|Withdrawal by Subject|2|||
106076078|NCT01987427|365942812|FG001|Overall Study|Withdrawal by Subject|1|||
106076079|NCT01987427|365942813|FG002|Overall Study|Withdrawal by Subject|3|||
106076080|NCT01987427|365942811|FG000|Overall Study|Lack of Efficacy|1|||
106076081|NCT01987427|365942812|FG001|Overall Study|Lack of Efficacy|0|||
106076082|NCT01987427|365942813|FG002|Overall Study|Lack of Efficacy|0|||
106076083|NCT01987427|365942811|FG000|Overall Study|Other|1|||
106076084|NCT01987427|365942812|FG001|Overall Study|Other|1|||
106076085|NCT01987427|365942813|FG002|Overall Study|Other|0|||
106076086|NCT01073865|365942814|FG000|Overall Study|Reasons other than below|19|||
106076087|NCT01073865|365942815|FG001|Overall Study|Reasons other than below|31|||
106076088|NCT01073865|365942814|FG000|Overall Study|Lost to Follow-up|1|||
106076089|NCT01073865|365942815|FG001|Overall Study|Lost to Follow-up|1|||
106076090|NCT01073865|365942814|FG000|Overall Study|Death|3|||
106076091|NCT01073865|365942815|FG001|Overall Study|Death|2|||
106076092|NCT01073865|365942814|FG000|Overall Study|Withdrawal by Subject|5|||
106076093|NCT01073865|365942815|FG001|Overall Study|Withdrawal by Subject|5|||
106076094|NCT00743652|365942816|FG000|Overall Study|Parent/Legal Guardian Request|3|||
106076095|NCT00743652|365942817|FG001|Overall Study|Parent/Legal Guardian Request|2|||
106076096|NCT00743652|365942818|FG002|Overall Study|Parent/Legal Guardian Request|2|||
106076097|NCT00743652|365942819|FG003|Overall Study|Parent/Legal Guardian Request|2|||
106076098|NCT00743652|365942820|FG004|Overall Study|Parent/Legal Guardian Request|0|||
106076099|NCT00743652|365942816|FG000|Overall Study|Adverse Event|3|||
106076100|NCT00743652|365942817|FG001|Overall Study|Adverse Event|0|||
106076101|NCT00743652|365942818|FG002|Overall Study|Adverse Event|0|||
106076102|NCT00743652|365942819|FG003|Overall Study|Adverse Event|0|||
106076103|NCT00743652|365942820|FG004|Overall Study|Adverse Event|0|||
106076104|NCT00743652|365942816|FG000|Overall Study|Death|2|||
106076105|NCT00743652|365942817|FG001|Overall Study|Death|0|||
106076106|NCT00743652|365942818|FG002|Overall Study|Death|0|||
106076107|NCT00743652|365942819|FG003|Overall Study|Death|0|||
106076108|NCT00743652|365942820|FG004|Overall Study|Death|0|||
106076109|NCT00743652|365942816|FG000|Overall Study|Investigator Request|0|||
106076110|NCT00743652|365942817|FG001|Overall Study|Investigator Request|0|||
106076111|NCT00743652|365942818|FG002|Overall Study|Investigator Request|0|||
106076112|NCT00743652|365942819|FG003|Overall Study|Investigator Request|2|||
106076113|NCT00743652|365942820|FG004|Overall Study|Investigator Request|0|||
106076114|NCT00743652|365942816|FG000|Overall Study|Other|1|||
106076115|NCT00743652|365942817|FG001|Overall Study|Other|1|||
106076116|NCT00743652|365942818|FG002|Overall Study|Other|0|||
106076117|NCT00743652|365942819|FG003|Overall Study|Other|0|||
106076118|NCT00743652|365942820|FG004|Overall Study|Other|0|||
106076119|NCT00743652|365942816|FG000|Overall Study|Lost to Follow-up|1|||
106076120|NCT00743652|365942817|FG001|Overall Study|Lost to Follow-up|0|||
106076121|NCT00743652|365942818|FG002|Overall Study|Lost to Follow-up|0|||
106076122|NCT00743652|365942819|FG003|Overall Study|Lost to Follow-up|0|||
106076123|NCT00743652|365942820|FG004|Overall Study|Lost to Follow-up|0|||
106076124|NCT00805766|365942824|FG000|Screening Period|Adverse Event|1|||
106076125|NCT00805766|365942824|FG000|Screening Period|Lack of Efficacy|2|||
106076126|NCT00805766|365942824|FG000|Screening Period|Pregnancy|1|||
106076127|NCT00805766|365942824|FG000|Screening Period|Responder|2|||
106076128|NCT00805766|365942824|FG000|Increased Dose Period|Adverse Event|4|||
106076129|NCT00805766|365942824|FG000|Increased Dose Period|Lack of Efficacy|7|||
106076130|NCT00805766|365942824|FG000|Increased Dose Period|Pregnancy|1|||
106076131|NCT00805766|365942824|FG000|Increased Dose Period|Withdrawal by Subject|1|||
106076132|NCT00600756|365942825|FG000|Analysis After 6 Months|Adverse Event|43|||
106076133|NCT00600756|365942826|FG001|Analysis After 6 Months|Adverse Event|33|||
106076134|NCT00600756|365942825|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
106076135|NCT00600756|365942826|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
106076136|NCT00600756|365942825|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
106076137|NCT00600756|365942826|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
106076138|NCT00600756|365942825|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
106076139|NCT00600756|365942826|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
106076140|NCT00600756|365942825|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
106076141|NCT00600756|365942826|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
106076142|NCT00600756|365942825|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
106076143|NCT00600756|365942826|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
106076144|NCT00600756|365942825|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
106076145|NCT00600756|365942826|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
106076146|NCT00600756|365942825|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
106076147|NCT00600756|365942826|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
106076148|NCT00600756|365942825|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
106076149|NCT00600756|365942826|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
106076150|NCT00600756|365942825|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
106076151|NCT00600756|365942826|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
106076152|NCT00600756|365942825|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
106076153|NCT00600756|365942826|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
106076154|NCT00600756|365942825|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
106076155|NCT00600756|365942826|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
106076156|NCT00600756|365942825|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
106076157|NCT00600756|365942826|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
106076158|NCT00600756|365942825|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
106076159|NCT00600756|365942826|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
106076160|NCT01256593|365942827|FG000|Overall Study|Protocol Violation|26|||
106076161|NCT01256593|365942827|FG000|Overall Study|No Drug Administration Information|2|||
106076162|NCT01256593|365942827|FG000|Overall Study|No Visit After Treatment|186|||
106076163|NCT04414553|365942828|FG000|Overall Study|Lost to Follow-up|20|||
106076164|NCT04753164|365942829|FG000|Overall Study|Adverse Event|0|||
106076165|NCT04753164|365942830|FG001|Overall Study|Adverse Event|2|||
106076166|NCT04753164|365942829|FG000|Overall Study|Withdrawal by Subject|9|||
106076167|NCT04753164|365942830|FG001|Overall Study|Withdrawal by Subject|7|||
106076168|NCT04753164|365942829|FG000|Overall Study|Lost to Follow-up|6|||
106158671|NCT03443323|366243461|FG001|Overall Study|Lost to Follow-up|2|||
106158672|NCT03443323|366243460|FG000|Overall Study|PI withdrawal|1|||
106158673|NCT03443323|366243461|FG001|Overall Study|PI withdrawal|0|||
106158674|NCT04229992|366243463|FG000|Overall Study|Withdrawal by Subject|0|||
106158675|NCT04229992|366243464|FG001|Overall Study|Withdrawal by Subject|2|||
106158676|NCT04229992|366243465|FG002|Overall Study|Withdrawal by Subject|1|||
106158677|NCT04229992|366243466|FG003|Overall Study|Withdrawal by Subject|1|||
106158678|NCT04229992|366243463|FG000|Overall Study|Adverse Event|1|||
106158679|NCT04229992|366243464|FG001|Overall Study|Adverse Event|1|||
106158680|NCT04229992|366243465|FG002|Overall Study|Adverse Event|3|||
106158681|NCT04229992|366243466|FG003|Overall Study|Adverse Event|1|||
106158682|NCT04229992|366243463|FG000|Overall Study|Lost to Follow-up|0|||
106158683|NCT04229992|366243464|FG001|Overall Study|Lost to Follow-up|0|||
106158684|NCT04229992|366243465|FG002|Overall Study|Lost to Follow-up|0|||
106158685|NCT04229992|366243466|FG003|Overall Study|Lost to Follow-up|1|||
106158686|NCT02455557|366243467|FG000|Overall Study|Withdrawal by Subject|2|||
106158687|NCT03707951|366243468|FG000|Overall Study|Lost to Follow-up|8|||
106158688|NCT03707951|366243469|FG001|Overall Study|Lost to Follow-up|17|||
106158689|NCT03707951|366243468|FG000|Overall Study|Withdrawal by Subject|6|||
106158690|NCT03707951|366243469|FG001|Overall Study|Withdrawal by Subject|6|||
106158691|NCT04169373|366243470|FG000|Week 1 to Week 14|Adverse Event|1|||
106158692|NCT04169373|366243471|FG001|Week 1 to Week 14|Adverse Event|0|||
106158693|NCT04169373|366243472|FG002|Week 1 to Week 14|Adverse Event|1|||
106158694|NCT04169373|366243473|FG003|Week 1 to Week 14|Adverse Event|2|||
106158695|NCT04169373|366243470|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
106158696|NCT04169373|366243471|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
106158697|NCT04169373|366243472|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
106158698|NCT04169373|366243473|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
106158699|NCT04169373|366243470|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
106158700|NCT04169373|366243471|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
106158701|NCT04169373|366243472|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
106158702|NCT04169373|366243473|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
106158703|NCT04169373|366243470|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
106158704|NCT04169373|366243471|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
106158705|NCT04169373|366243472|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
106158706|NCT04169373|366243473|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
106158707|NCT04169373|366243470|FG000|Week 1 to Week 14|Other|1|||
106158708|NCT04169373|366243471|FG001|Week 1 to Week 14|Other|3|||
106076169|NCT04753164|365942830|FG001|Overall Study|Lost to Follow-up|6|||
106076170|NCT04753164|365942829|FG000|Overall Study|Other|12|||
106076171|NCT04753164|365942830|FG001|Overall Study|Other|5|||
106076172|NCT00694369|365942832|FG000|Overall Study|Adverse Event|0|||
106076173|NCT00694369|365942833|FG001|Overall Study|Adverse Event|1|||
106076174|NCT00694369|365942834|FG002|Overall Study|Adverse Event|0|||
106076175|NCT00694369|365942835|FG003|Overall Study|Adverse Event|1|||
106076176|NCT00694369|365942836|FG004|Overall Study|Adverse Event|3|||
106076177|NCT00694369|365942832|FG000|Overall Study|Lost to Follow-up|0|||
106076178|NCT00694369|365942833|FG001|Overall Study|Lost to Follow-up|0|||
106076179|NCT00694369|365942834|FG002|Overall Study|Lost to Follow-up|1|||
106076180|NCT00694369|365942835|FG003|Overall Study|Lost to Follow-up|1|||
106076181|NCT00694369|365942836|FG004|Overall Study|Lost to Follow-up|0|||
106076182|NCT00694369|365942832|FG000|Overall Study|Physician Decision|0|||
106076183|NCT00694369|365942833|FG001|Overall Study|Physician Decision|0|||
106076184|NCT00694369|365942834|FG002|Overall Study|Physician Decision|0|||
106076185|NCT00694369|365942835|FG003|Overall Study|Physician Decision|0|||
106076186|NCT00694369|365942836|FG004|Overall Study|Physician Decision|1|||
106076187|NCT00694369|365942832|FG000|Overall Study|Protocol Violation|0|||
106076188|NCT00694369|365942833|FG001|Overall Study|Protocol Violation|1|||
106076189|NCT00694369|365942834|FG002|Overall Study|Protocol Violation|0|||
106076190|NCT00694369|365942835|FG003|Overall Study|Protocol Violation|0|||
106076191|NCT00694369|365942836|FG004|Overall Study|Protocol Violation|0|||
106158709|NCT04169373|366243472|FG002|Week 1 to Week 14|Other|3|||
106158710|NCT04169373|366243473|FG003|Week 1 to Week 14|Other|5|||
106158711|NCT04169373|366243470|FG000|Week 14 to Week 52|Adverse Event|1|||
106158712|NCT04169373|366243471|FG001|Week 14 to Week 52|Adverse Event|0|||
106076192|NCT00694369|365942832|FG000|Overall Study|Withdrawal by Subject|1|||
106158713|NCT04169373|366243472|FG002|Week 14 to Week 52|Adverse Event|0|||
106158714|NCT04169373|366243473|FG003|Week 14 to Week 52|Adverse Event|1|||
106076193|NCT00694369|365942833|FG001|Overall Study|Withdrawal by Subject|1|||
106076194|NCT00694369|365942834|FG002|Overall Study|Withdrawal by Subject|1|||
106076195|NCT00694369|365942835|FG003|Overall Study|Withdrawal by Subject|1|||
106076196|NCT00694369|365942836|FG004|Overall Study|Withdrawal by Subject|2|||
106158715|NCT04169373|366243470|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
106158716|NCT04169373|366243471|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
106158717|NCT04169373|366243472|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
106158718|NCT04169373|366243473|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
106158719|NCT04169373|366243470|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
106158720|NCT04169373|366243471|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
106076197|NCT00907374|365942837|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
106076198|NCT00907374|365942838|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
106076199|NCT00439556|365942839|FG000|Overall Study|Patient was taken off study for non-comp|0|||
106076200|NCT00439556|365942840|FG001|Overall Study|Patient was taken off study for non-comp|1|||
106076201|NCT00439556|365942841|FG002|Overall Study|Patient was taken off study for non-comp|0|||
106076202|NCT03818516|365942842|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
106076203|NCT01183975|365942848|FG000|Overall Study|Lost to Follow-up|73|||
106076204|NCT00746941|365942849|FG000|Overall Study|Death|2|||
106076205|NCT00746941|365942850|FG001|Overall Study|Death|0|||
106076206|NCT00746941|365942851|FG002|Overall Study|Death|0|||
106076207|NCT00746941|365942852|FG003|Overall Study|Death|6|||
106076208|NCT00746941|365942849|FG000|Overall Study|Physician Decision|0|||
106076209|NCT00746941|365942850|FG001|Overall Study|Physician Decision|0|||
106076210|NCT00746941|365942851|FG002|Overall Study|Physician Decision|2|||
106076211|NCT00746941|365942852|FG003|Overall Study|Physician Decision|0|||
106076212|NCT00746941|365942849|FG000|Overall Study|Withdrawal by Subject|3|||
106158721|NCT04169373|366243472|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
106158722|NCT04169373|366243473|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
106158723|NCT04169373|366243470|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
106158724|NCT04169373|366243471|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
106158725|NCT04169373|366243472|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
106158726|NCT04169373|366243473|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
106158727|NCT04169373|366243470|FG000|Week 14 to Week 52|Other|4|||
106158728|NCT04169373|366243471|FG001|Week 14 to Week 52|Other|5|||
106158729|NCT04169373|366243472|FG002|Week 14 to Week 52|Other|4|||
106158730|NCT04169373|366243473|FG003|Week 14 to Week 52|Other|5|||
106158731|NCT04169373|366243470|FG000|Week 14 to Week 52|Ongoing|0|||
106158732|NCT04169373|366243471|FG001|Week 14 to Week 52|Ongoing|1|||
106158733|NCT04169373|366243472|FG002|Week 14 to Week 52|Ongoing|0|||
106076213|NCT00746941|365942850|FG001|Overall Study|Withdrawal by Subject|0|||
106158734|NCT04169373|366243473|FG003|Week 14 to Week 52|Ongoing|0|||
106158735|NCT04610892|366243474|FG000|Overall Study|Adverse Event|1|||
106158736|NCT04610892|366243475|FG001|Overall Study|Adverse Event|0|||
106076214|NCT00746941|365942851|FG002|Overall Study|Withdrawal by Subject|0|||
106076215|NCT00746941|365942852|FG003|Overall Study|Withdrawal by Subject|2|||
106076216|NCT00746941|365942849|FG000|Overall Study|Other, reason not provided|2|||
106076217|NCT00746941|365942850|FG001|Overall Study|Other, reason not provided|4|||
106076218|NCT00746941|365942851|FG002|Overall Study|Other, reason not provided|0|||
106076219|NCT00746941|365942852|FG003|Overall Study|Other, reason not provided|4|||
106076220|NCT00746941|365942849|FG000|Overall Study|Adverse Event|0|||
106076221|NCT00746941|365942850|FG001|Overall Study|Adverse Event|0|||
106076222|NCT00746941|365942851|FG002|Overall Study|Adverse Event|0|||
106076223|NCT00746941|365942852|FG003|Overall Study|Adverse Event|1|||
106076224|NCT00405548|365942862|FG000|Overall Study|Cognitive Memory problems on study day|1|||
106076225|NCT00405548|365942863|FG001|Overall Study|Cognitive Memory problems on study day|0|||
106076226|NCT00405548|365942862|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
106076227|NCT00405548|365942863|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
106076228|NCT00405548|365942862|FG000|Overall Study|Unable to self-administer shots|1|||
106076229|NCT00405548|365942863|FG001|Overall Study|Unable to self-administer shots|0|||
106076230|NCT00405548|365942862|FG000|Overall Study|Venous access failed during study day|1|||
106076231|NCT00405548|365942863|FG001|Overall Study|Venous access failed during study day|0|||
106076232|NCT00405548|365942862|FG000|Overall Study|Withdrawal by Subject|1|||
106076233|NCT00405548|365942863|FG001|Overall Study|Withdrawal by Subject|0|||
106076234|NCT03554291|365942864|FG000|Overall Study|Death|2|||
106076235|NCT03554291|365942865|FG001|Overall Study|Death|1|||
106076236|NCT03554291|365942864|FG000|Overall Study|Lost to Follow-up|1|||
106076237|NCT03554291|365942865|FG001|Overall Study|Lost to Follow-up|0|||
106076238|NCT03554291|365942864|FG000|Overall Study|Withdrawal by Subject|1|||
106076239|NCT03554291|365942865|FG001|Overall Study|Withdrawal by Subject|0|||
106076240|NCT03554291|365942864|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
106076241|NCT03554291|365942865|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
106076242|NCT02741700|365942869|FG000|Overall Study|Lost to Follow-up|17|||
106076243|NCT02741700|365942870|FG001|Overall Study|Lost to Follow-up|8|||
106158737|NCT04610892|366243476|FG002|Overall Study|Adverse Event|0|||
106158738|NCT04610892|366243477|FG003|Overall Study|Adverse Event|1|||
106158739|NCT04610892|366243478|FG004|Overall Study|Adverse Event|3|||
106158740|NCT04610892|366243474|FG000|Overall Study|Death|0|||
106158741|NCT04610892|366243475|FG001|Overall Study|Death|1|||
106158742|NCT04610892|366243476|FG002|Overall Study|Death|0|||
106158743|NCT04610892|366243477|FG003|Overall Study|Death|1|||
106158744|NCT04610892|366243478|FG004|Overall Study|Death|0|||
106158745|NCT04610892|366243474|FG000|Overall Study|Withdrawal by Subject|3|||
106158746|NCT04610892|366243475|FG001|Overall Study|Withdrawal by Subject|2|||
106076244|NCT02741700|365942869|FG000|Overall Study|Withdrawal by Subject|2|||
106076245|NCT02741700|365942870|FG001|Overall Study|Withdrawal by Subject|5|||
106158747|NCT04610892|366243476|FG002|Overall Study|Withdrawal by Subject|0|||
106158748|NCT04610892|366243477|FG003|Overall Study|Withdrawal by Subject|6|||
106076246|NCT02741700|365942869|FG000|Overall Study|Physician Decision|3|||
106076247|NCT02741700|365942870|FG001|Overall Study|Physician Decision|0|||
106076248|NCT02741700|365942869|FG000|Overall Study|Moved out of State|0|||
106076249|NCT02741700|365942870|FG001|Overall Study|Moved out of State|1|||
106076250|NCT02741700|365942869|FG000|Overall Study|Death|4|||
106076251|NCT02741700|365942870|FG001|Overall Study|Death|5|||
106076252|NCT04809220|365942871|FG000|Overall Study|Adverse Event|4|||
106158749|NCT04610892|366243478|FG004|Overall Study|Withdrawal by Subject|6|||
105866641|NCT02676765|365161123|FG001|Overall Study|Lost to Follow-up|1|||
106076253|NCT04809220|365942872|FG001|Overall Study|Adverse Event|0|||
106076254|NCT04809220|365942871|FG000|Overall Study|Death|1|||
106076255|NCT04809220|365942872|FG001|Overall Study|Death|0|||
106158750|NCT04610892|366243474|FG000|Overall Study|Subjects who did not receive treatment|1|||
106158751|NCT04610892|366243475|FG001|Overall Study|Subjects who did not receive treatment|0|||
106158752|NCT04610892|366243476|FG002|Overall Study|Subjects who did not receive treatment|0|||
106158753|NCT04610892|366243477|FG003|Overall Study|Subjects who did not receive treatment|0|||
106158754|NCT04610892|366243478|FG004|Overall Study|Subjects who did not receive treatment|2|||
106158755|NCT04896476|366243487|FG000|Overall Study|Withdrawal by Subject|1|||
106158756|NCT04896476|366243487|FG000|Overall Study|Lost to Follow-up|2|||
106158757|NCT03476187|366243488|FG000|Overall Study|Protocol Violation|7|||
106158758|NCT03476187|366243488|FG000|Overall Study|Physician Decision|5|||
106158759|NCT03135548|366243489|FG000|Overall Study|Lost to Follow-up|3|||
106158760|NCT03135548|366243490|FG001|Overall Study|Lost to Follow-up|0|||
106158761|NCT03135548|366243491|FG002|Overall Study|Lost to Follow-up|0|||
106158762|NCT03135548|366243489|FG000|Overall Study|Withdrawal by Subject|2|||
106158763|NCT03135548|366243490|FG001|Overall Study|Withdrawal by Subject|2|||
106158764|NCT03135548|366243491|FG002|Overall Study|Withdrawal by Subject|1|||
106158765|NCT03135548|366243489|FG000|Overall Study|Other than listed|0|||
106158766|NCT03135548|366243490|FG001|Overall Study|Other than listed|2|||
106158767|NCT03135548|366243491|FG002|Overall Study|Other than listed|2|||
106158768|NCT03924986|366243492|FG000|Overall Study|Death|57|||
106158769|NCT03924986|366243493|FG001|Overall Study|Death|66|||
106158770|NCT03924986|366243492|FG000|Overall Study|Study Concluded by Sponsor|51|||
106158771|NCT03924986|366243493|FG001|Overall Study|Study Concluded by Sponsor|41|||
106158772|NCT03924986|366243492|FG000|Overall Study|Withdrawal by Subject|15|||
106158773|NCT03924986|366243493|FG001|Overall Study|Withdrawal by Subject|20|||
106158774|NCT03924986|366243492|FG000|Overall Study|Lost to Follow-up|7|||
106158775|NCT03924986|366243493|FG001|Overall Study|Lost to Follow-up|5|||
106158776|NCT03924986|366243492|FG000|Overall Study|Miscellaneous|1|||
106158777|NCT03924986|366243493|FG001|Overall Study|Miscellaneous|0|||
106158778|NCT03056040|366243496|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
106158779|NCT03056040|366243497|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
106158780|NCT03056040|366243496|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
106158781|NCT03056040|366243497|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
106158782|NCT03056040|366243496|FG000|Primary Evaluation Period|Pregnancy|0|||
106158783|NCT03056040|366243497|FG001|Primary Evaluation Period|Pregnancy|1|||
106158784|NCT03056040|366243496|FG000|Primary Evaluation Period|Randomized, not treated|1|||
106158785|NCT03056040|366243497|FG001|Primary Evaluation Period|Randomized, not treated|1|||
106158786|NCT03056040|366243496|FG000|Extension Period|Physician Decision|3|||
106158787|NCT03056040|366243497|FG001|Extension Period|Physician Decision|3|||
106158788|NCT03056040|366243496|FG000|Extension Period|Lost to Follow-up|0|||
106158789|NCT03056040|366243497|FG001|Extension Period|Lost to Follow-up|1|||
106158790|NCT03056040|366243496|FG000|Extension Period|Death|0|||
106158791|NCT03056040|366243497|FG001|Extension Period|Death|3|||
106158792|NCT03056040|366243496|FG000|Extension Period|Withdrawal by Subject|1|||
106076256|NCT04809220|365942871|FG000|Overall Study|Lost to Follow-up|3|||
106076257|NCT04809220|365942872|FG001|Overall Study|Lost to Follow-up|0|||
106076258|NCT04809220|365942871|FG000|Overall Study|Physician Decision|0|||
106076259|NCT04809220|365942872|FG001|Overall Study|Physician Decision|1|||
106076260|NCT04809220|365942871|FG000|Overall Study|Withdrawal by Subject|9|||
106076261|NCT04809220|365942872|FG001|Overall Study|Withdrawal by Subject|5|||
106076262|NCT04809220|365942871|FG000|Overall Study|Due to long-term overseas business trips|1|||
106076263|NCT04809220|365942872|FG001|Overall Study|Due to long-term overseas business trips|0|||
106076264|NCT01644175|365942873|FG000|Overall Study|Randomized But Not Treated|0|||
106076265|NCT01644175|365942874|FG001|Overall Study|Randomized But Not Treated|2|||
106076266|NCT01644175|365942873|FG000|Overall Study|Adverse Event|8|||
106076267|NCT01644175|365942874|FG001|Overall Study|Adverse Event|13|||
106076268|NCT01644175|365942873|FG000|Overall Study|Death|1|||
106076269|NCT01644175|365942874|FG001|Overall Study|Death|2|||
106076270|NCT01644175|365942873|FG000|Overall Study|Poor compliance to protocol|9|||
106076271|NCT01644175|365942874|FG001|Overall Study|Poor compliance to protocol|10|||
106076272|NCT01644175|365942873|FG000|Overall Study|Physician Decision|1|||
106076273|NCT01644175|365942874|FG001|Overall Study|Physician Decision|2|||
106076274|NCT01644175|365942873|FG000|Overall Study|Participant Moved|1|||
106076275|NCT01644175|365942874|FG001|Overall Study|Participant Moved|2|||
106076276|NCT01644175|365942873|FG000|Overall Study|Consent withdrawn by participant|3|||
106076277|NCT01644175|365942874|FG001|Overall Study|Consent withdrawn by participant|4|||
106076278|NCT01644175|365942873|FG000|Overall Study|Related to Autoinjector Administration|2|||
106076279|NCT01644175|365942874|FG001|Overall Study|Related to Autoinjector Administration|1|||
106076280|NCT01644175|365942873|FG000|Overall Study|Last visit outside protocol visit window|4|||
106076281|NCT01644175|365942874|FG001|Overall Study|Last visit outside protocol visit window|11|||
106076282|NCT01644175|365942873|FG000|Overall Study|Selection criteria finally not met|0|||
106076283|NCT01644175|365942874|FG001|Overall Study|Selection criteria finally not met|1|||
106076284|NCT01644175|365942873|FG000|Overall Study|Site closure|2|||
106076285|NCT01644175|365942874|FG001|Overall Study|Site closure|2|||
106076286|NCT01644175|365942873|FG000|Overall Study|Lost to Follow-up|1|||
106076287|NCT01644175|365942874|FG001|Overall Study|Lost to Follow-up|0|||
106076288|NCT01644175|365942873|FG000|Overall Study|Other than specified above|0|||
106076289|NCT01644175|365942874|FG001|Overall Study|Other than specified above|3|||
106076290|NCT01070316|365942875|FG000|Extension Phase|Lack of Efficacy|3|||
106076291|NCT01070316|365942875|FG000|Extension Phase|Withdrawal by Subject|1|||
106076292|NCT00748215|365942878|FG000|Overall Study|Withdrawal by Subject|7|||
106076293|NCT00748215|365942879|FG001|Overall Study|Withdrawal by Subject|7|||
106076294|NCT00748215|365942878|FG000|Overall Study|Treatment change|2|||
106076295|NCT00748215|365942879|FG001|Overall Study|Treatment change|1|||
106076296|NCT00748215|365942878|FG000|Overall Study|Change in patient condition|0|||
106076297|NCT00748215|365942879|FG001|Overall Study|Change in patient condition|3|||
106076298|NCT00748215|365942878|FG000|Overall Study|Non-compliant|0|||
106076299|NCT00748215|365942879|FG001|Overall Study|Non-compliant|2|||
106076300|NCT00748215|365942878|FG000|Overall Study|Adverse Event|0|||
106076301|NCT00748215|365942879|FG001|Overall Study|Adverse Event|5|||
106076302|NCT00962104|365942880|FG000|Overall Study|Adverse Event|10|||
106076303|NCT00962104|365942881|FG001|Overall Study|Adverse Event|3|||
106076304|NCT00962104|365942880|FG000|Overall Study|Entry Criteria Not Met|1|||
106076305|NCT00962104|365942881|FG001|Overall Study|Entry Criteria Not Met|2|||
106076306|NCT00962104|365942880|FG000|Overall Study|Lack of Efficacy|0|||
106076307|NCT00962104|365942881|FG001|Overall Study|Lack of Efficacy|1|||
106076308|NCT00962104|365942880|FG000|Overall Study|Lost to Follow-up|10|||
106076309|NCT00962104|365942881|FG001|Overall Study|Lost to Follow-up|4|||
106076310|NCT00962104|365942880|FG000|Overall Study|Physician Decision|1|||
106158793|NCT03056040|366243497|FG001|Extension Period|Withdrawal by Subject|0|||
106158794|NCT03232138|366243511|FG000|Overall Study|Physician Decision|1|||
106158795|NCT03232138|366243512|FG001|Overall Study|Physician Decision|0|||
106158796|NCT03232138|366243511|FG000|Overall Study|Adverse Event|2|||
106076311|NCT00962104|365942881|FG001|Overall Study|Physician Decision|0|||
106076312|NCT00962104|365942880|FG000|Overall Study|Protocol Violation|6|||
106076313|NCT00962104|365942881|FG001|Overall Study|Protocol Violation|8|||
106076314|NCT00962104|365942880|FG000|Overall Study|Sponsor Decision|0|||
106076315|NCT00962104|365942881|FG001|Overall Study|Sponsor Decision|1|||
106076316|NCT00962104|365942880|FG000|Overall Study|Withdrawal by Subject|10|||
106158797|NCT03232138|366243512|FG001|Overall Study|Adverse Event|0|||
105866642|NCT02466685|365161124|FG000|Overall Study|Adverse Event|5|||
106076317|NCT00962104|365942881|FG001|Overall Study|Withdrawal by Subject|6|||
106076318|NCT00962104|365942880|FG000|Overall Study|Other|2|||
106076319|NCT00962104|365942881|FG001|Overall Study|Other|0|||
106076320|NCT03200899|365942882|FG000|Overall Study|Lost to Follow-up|10|||
106076321|NCT03200899|365942883|FG001|Overall Study|Lost to Follow-up|23|||
106076322|NCT03274986|365942884|FG000|Overall Study|Withdrawal by Subject|0|||
106076323|NCT03274986|365942885|FG001|Overall Study|Withdrawal by Subject|1|||
106076324|NCT03274986|365942884|FG000|Overall Study|Lost to Follow-up|0|||
106076325|NCT03274986|365942885|FG001|Overall Study|Lost to Follow-up|1|||
106076326|NCT01132495|365942886|FG000|Overall Study|Various reasons|40|||
106158798|NCT03232138|366243511|FG000|Overall Study|Withdrawal by Subject|1|||
106076327|NCT01132495|365942887|FG001|Overall Study|Various reasons|38|||
106076328|NCT01132495|365942888|FG002|Overall Study|Various reasons|20|||
106076329|NCT01132495|365942889|FG003|Overall Study|Various reasons|12|||
106076330|NCT04536727|365942890|FG000|Overall Study|Lost to Follow-up|1|||
106076331|NCT04536727|365942891|FG001|Overall Study|Lost to Follow-up|1|||
106076332|NCT04536727|365942890|FG000|Overall Study|Death|0|||
106076333|NCT04536727|365942891|FG001|Overall Study|Death|1|||
106076334|NCT00699972|365944463|FG000|Overall Study|Adverse Event|7|||
106076335|NCT00699972|365944464|FG001|Overall Study|Adverse Event|9|||
106076336|NCT00699972|365944465|FG002|Overall Study|Adverse Event|24|||
106076337|NCT00699972|365944463|FG000|Overall Study|Lost to Follow-up|0|||
106076338|NCT00699972|365944464|FG001|Overall Study|Lost to Follow-up|2|||
106076339|NCT00699972|365944465|FG002|Overall Study|Lost to Follow-up|0|||
106076340|NCT00699972|365944463|FG000|Overall Study|Withdrawal by Subject|3|||
106076341|NCT00699972|365944464|FG001|Overall Study|Withdrawal by Subject|7|||
106076342|NCT00699972|365944465|FG002|Overall Study|Withdrawal by Subject|4|||
106076343|NCT00699972|365944463|FG000|Overall Study|Lack of Efficacy|2|||
106076344|NCT00699972|365944464|FG001|Overall Study|Lack of Efficacy|0|||
106076345|NCT00699972|365944465|FG002|Overall Study|Lack of Efficacy|2|||
106076346|NCT00699972|365944463|FG000|Overall Study|Administrative/Other|3|||
106076347|NCT00699972|365944464|FG001|Overall Study|Administrative/Other|1|||
106076348|NCT00699972|365944465|FG002|Overall Study|Administrative/Other|4|||
106076349|NCT00699972|365944463|FG000|Overall Study|Randomized, Not Treated|1|||
106076350|NCT00699972|365944464|FG001|Overall Study|Randomized, Not Treated|0|||
106076351|NCT00699972|365944465|FG002|Overall Study|Randomized, Not Treated|1|||
106076352|NCT01852292|365944470|FG000|Overall Study|Untreated - did not receive study drug|3|||
106076353|NCT01852292|365944471|FG001|Overall Study|Untreated - did not receive study drug|1|||
106076354|NCT01852292|365944470|FG000|Overall Study|Death|9|||
106076355|NCT01852292|365944471|FG001|Overall Study|Death|8|||
106076356|NCT01852292|365944470|FG000|Overall Study|Patient/guardian decision|8|||
106076357|NCT01852292|365944471|FG001|Overall Study|Patient/guardian decision|4|||
106076358|NCT01852292|365944470|FG000|Overall Study|Adverse Event|8|||
106076359|NCT01852292|365944471|FG001|Overall Study|Adverse Event|11|||
106076360|NCT01852292|365944470|FG000|Overall Study|Physician Decision|6|||
106076361|NCT01852292|365944471|FG001|Overall Study|Physician Decision|2|||
106076362|NCT01852292|365944470|FG000|Overall Study|Protocol Violation|2|||
106076363|NCT01852292|365944471|FG001|Overall Study|Protocol Violation|0|||
106076364|NCT01852292|365944470|FG000|Overall Study|Non-compliance with study treatment|1|||
106076365|NCT01852292|365944471|FG001|Overall Study|Non-compliance with study treatment|0|||
106076366|NCT01852292|365944470|FG000|Overall Study|Study terminated by Sponsor|0|||
106076367|NCT01852292|365944471|FG001|Overall Study|Study terminated by Sponsor|1|||
106076368|NCT01852292|365944470|FG000|Overall Study|Progressive disease|42|||
106076369|NCT01852292|365944471|FG001|Overall Study|Progressive disease|52|||
106076370|NCT02388737|365944474|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
106076371|NCT02388737|365944475|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
106076372|NCT02388737|365944476|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
106076373|NCT02388737|365944474|FG000|Overall Study|Major Protocol Deviation|18|||
106076374|NCT02388737|365944475|FG001|Overall Study|Major Protocol Deviation|25|||
106076375|NCT02388737|365944476|FG002|Overall Study|Major Protocol Deviation|22|||
106076376|NCT02388737|365944474|FG000|Overall Study|Lost to Follow-up|5|||
106076377|NCT02388737|365944475|FG001|Overall Study|Lost to Follow-up|1|||
106076378|NCT02388737|365944476|FG002|Overall Study|Lost to Follow-up|4|||
106076379|NCT02388737|365944474|FG000|Overall Study|Voluntary Withdrawal|10|||
106076380|NCT02388737|365944475|FG001|Overall Study|Voluntary Withdrawal|18|||
106076381|NCT02388737|365944476|FG002|Overall Study|Voluntary Withdrawal|17|||
106076382|NCT02388737|365944474|FG000|Overall Study|Lack of Efficacy|3|||
106076383|NCT02388737|365944475|FG001|Overall Study|Lack of Efficacy|0|||
106076384|NCT02388737|365944476|FG002|Overall Study|Lack of Efficacy|3|||
106076385|NCT02388737|365944474|FG000|Overall Study|Reason Not Specified|5|||
106076386|NCT02388737|365944475|FG001|Overall Study|Reason Not Specified|5|||
106076387|NCT02388737|365944476|FG002|Overall Study|Reason Not Specified|4|||
106076388|NCT00838201|365944477|FG000|Overall Study|Investigator decision, or other reasons|2|||
106076389|NCT00838201|365944478|FG001|Overall Study|Investigator decision, or other reasons|3|||
106076390|NCT00838201|365944477|FG000|Overall Study|Noncompliance|0|||
106076391|NCT00838201|365944478|FG001|Overall Study|Noncompliance|1|||
106076392|NCT00838201|365944477|FG000|Overall Study|Administrative decision|1|||
106076393|NCT00838201|365944478|FG001|Overall Study|Administrative decision|2|||
106076394|NCT00838201|365944477|FG000|Overall Study|Disease progression|3|||
106076395|NCT00838201|365944478|FG001|Overall Study|Disease progression|3|||
106076396|NCT00838201|365944477|FG000|Overall Study|Consent withdrawn|16|||
106076397|NCT00838201|365944478|FG001|Overall Study|Consent withdrawn|19|||
106076398|NCT00838201|365944477|FG000|Overall Study|Lost to Follow-up|4|||
106076399|NCT00838201|365944478|FG001|Overall Study|Lost to Follow-up|3|||
106076400|NCT00838201|365944477|FG000|Overall Study|Adverse Event|5|||
106076401|NCT00838201|365944478|FG001|Overall Study|Adverse Event|9|||
106076402|NCT00838201|365944477|FG000|Overall Study|Death|11|||
106076403|NCT00838201|365944478|FG001|Overall Study|Death|13|||
106076404|NCT02558790|365944479|FG000|Overall Study|Lost to Follow-up|2|||
106076405|NCT02558790|365944479|FG000|Overall Study|Physician Decision|1|||
106076406|NCT02558790|365944479|FG000|Overall Study|Withdrawal by Subject|1|||
106076407|NCT02558790|365944479|FG000|Overall Study|Screen Fail|3|||
106076408|NCT05083442|365944480|FG000|Overall Study|Lost to Follow-up|1|||
106076409|NCT05083442|365944481|FG001|Overall Study|Lost to Follow-up|0|||
106076410|NCT05083442|365944480|FG000|Overall Study|Lack of Efficacy|0|||
106076411|NCT05083442|365944481|FG001|Overall Study|Lack of Efficacy|1|||
106076412|NCT05083442|365944480|FG000|Overall Study|Withdrawal by Subject|1|||
106158799|NCT03232138|366243512|FG001|Overall Study|Withdrawal by Subject|2|||
106158800|NCT05051124|366243513|FG000|Overall Study|Lost to Follow-up|2|||
106158801|NCT05051124|366243513|FG000|Overall Study|Withdrawal by Subject|1|||
106158802|NCT05051124|366243513|FG000|Overall Study|Residential relocation|2|||
106158803|NCT05051124|366243513|FG000|Overall Study|Death|1|||
106158804|NCT04924660|366243514|FG000|United States|Death|29|||
106158805|NCT04924660|366243515|FG001|United States|Death|32|||
106158806|NCT04924660|366243516|FG002|United States|Death|34|||
106158807|NCT04924660|366243517|FG003|United States|Death|25|||
106158808|NCT04924660|366243518|FG004|United States|Death|26|||
106158809|NCT04924660|366243519|FG005|United States|Death|23|||
106158810|NCT04924660|366243514|FG000|United States|Lost to Follow-up|15|||
106158811|NCT04924660|366243515|FG001|United States|Lost to Follow-up|10|||
106158812|NCT04924660|366243516|FG002|United States|Lost to Follow-up|13|||
106158813|NCT04924660|366243517|FG003|United States|Lost to Follow-up|5|||
106158814|NCT04924660|366243518|FG004|United States|Lost to Follow-up|19|||
106158815|NCT04924660|366243519|FG005|United States|Lost to Follow-up|20|||
106158816|NCT04924660|366243514|FG000|United States|Withdrawal by Subject|8|||
106158817|NCT04924660|366243515|FG001|United States|Withdrawal by Subject|3|||
106158818|NCT04924660|366243516|FG002|United States|Withdrawal by Subject|3|||
106158819|NCT04924660|366243517|FG003|United States|Withdrawal by Subject|3|||
106158820|NCT04924660|366243518|FG004|United States|Withdrawal by Subject|8|||
106158821|NCT04924660|366243519|FG005|United States|Withdrawal by Subject|4|||
106158822|NCT04924660|366243514|FG000|Spain|Death|0|||
106158823|NCT04924660|366243515|FG001|Spain|Death|0|||
106158824|NCT04924660|366243516|FG002|Spain|Death|0|||
106158825|NCT04924660|366243517|FG003|Spain|Death|0|||
106158826|NCT04924660|366243518|FG004|Spain|Death|0|||
106158827|NCT04924660|366243519|FG005|Spain|Death|2|||
106158828|NCT04924660|366243514|FG000|Spain|Lost to Follow-up|0|||
106158829|NCT04924660|366243515|FG001|Spain|Lost to Follow-up|0|||
106158830|NCT04924660|366243516|FG002|Spain|Lost to Follow-up|0|||
106158831|NCT04924660|366243517|FG003|Spain|Lost to Follow-up|0|||
106158832|NCT04924660|366243518|FG004|Spain|Lost to Follow-up|1|||
106158833|NCT04924660|366243519|FG005|Spain|Lost to Follow-up|0|||
106158834|NCT04924660|366243514|FG000|Brazil|Death|0|||
106158835|NCT04924660|366243515|FG001|Brazil|Death|0|||
106158836|NCT04924660|366243516|FG002|Brazil|Death|0|||
106158837|NCT04924660|366243517|FG003|Brazil|Death|0|||
106158838|NCT04924660|366243518|FG004|Brazil|Death|1|||
106158839|NCT04924660|366243519|FG005|Brazil|Death|0|||
106158840|NCT04924660|366243514|FG000|Italy|Lost to Follow-up|0|||
106158841|NCT04924660|366243515|FG001|Italy|Lost to Follow-up|0|||
106158842|NCT04924660|366243516|FG002|Italy|Lost to Follow-up|0|||
106158843|NCT04924660|366243517|FG003|Italy|Lost to Follow-up|0|||
106158844|NCT04924660|366243518|FG004|Italy|Lost to Follow-up|0|||
106158845|NCT04924660|366243519|FG005|Italy|Lost to Follow-up|1|||
106158846|NCT04924660|366243514|FG000|South Africa|Death|0|||
106158847|NCT04924660|366243515|FG001|South Africa|Death|0|||
106158848|NCT04924660|366243516|FG002|South Africa|Death|0|||
106158849|NCT04924660|366243517|FG003|South Africa|Death|0|||
106158850|NCT04924660|366243518|FG004|South Africa|Death|0|||
106158851|NCT04924660|366243519|FG005|South Africa|Death|1|||
106158852|NCT04924660|366243514|FG000|South Africa|Lost to Follow-up|0|||
106158853|NCT04924660|366243515|FG001|South Africa|Lost to Follow-up|0|||
106158854|NCT04924660|366243516|FG002|South Africa|Lost to Follow-up|0|||
106158855|NCT04924660|366243517|FG003|South Africa|Lost to Follow-up|0|||
106158856|NCT04924660|366243518|FG004|South Africa|Lost to Follow-up|0|||
106158857|NCT04924660|366243519|FG005|South Africa|Lost to Follow-up|1|||
106076413|NCT05083442|365944481|FG001|Overall Study|Withdrawal by Subject|3|||
106076414|NCT05083442|365944480|FG000|Overall Study|scheduling difficulties|1|||
106158858|NCT02962895|366243522|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
106158859|NCT02962895|366243523|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
106158860|NCT02962895|366243524|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
106158861|NCT02962895|366243525|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
106158862|NCT02962895|366243526|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
106158863|NCT02962895|366243527|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
106158864|NCT02962895|366243528|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
106158865|NCT02962895|366243522|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
106158866|NCT02962895|366243523|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
106158867|NCT02962895|366243524|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
106158868|NCT02962895|366243525|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
106076415|NCT05083442|365944481|FG001|Overall Study|scheduling difficulties|2|||
106076416|NCT03711162|365944482|FG000|Overall Study|Adverse Event|5|||
106076417|NCT03711162|365944483|FG001|Overall Study|Adverse Event|2|||
106076418|NCT03711162|365944484|FG002|Overall Study|Adverse Event|4|||
106076419|NCT03711162|365944482|FG000|Overall Study|Death|11|||
106076420|NCT03711162|365944483|FG001|Overall Study|Death|7|||
106076421|NCT03711162|365944484|FG002|Overall Study|Death|8|||
106076422|NCT03711162|365944482|FG000|Overall Study|Lost to Follow-up|1|||
106076423|NCT03711162|365944483|FG001|Overall Study|Lost to Follow-up|0|||
106076424|NCT03711162|365944484|FG002|Overall Study|Lost to Follow-up|1|||
106076425|NCT03711162|365944482|FG000|Overall Study|Study Terminated by Sponsor|139|||
106076426|NCT03711162|365944483|FG001|Overall Study|Study Terminated by Sponsor|152|||
106076427|NCT03711162|365944484|FG002|Overall Study|Study Terminated by Sponsor|146|||
106076428|NCT03711162|365944482|FG000|Overall Study|Withdrawal by Subject|17|||
106076429|NCT03711162|365944483|FG001|Overall Study|Withdrawal by Subject|10|||
106076430|NCT03711162|365944484|FG002|Overall Study|Withdrawal by Subject|10|||
106076431|NCT03711162|365944482|FG000|Overall Study|Miscellaneous|1|||
106076432|NCT03711162|365944483|FG001|Overall Study|Miscellaneous|2|||
106076433|NCT03711162|365944484|FG002|Overall Study|Miscellaneous|2|||
106076434|NCT03711162|365944482|FG000|Overall Study|Not Treated|1|||
106076435|NCT03711162|365944483|FG001|Overall Study|Not Treated|0|||
106076436|NCT03711162|365944484|FG002|Overall Study|Not Treated|1|||
106076437|NCT03711162|365944482|FG000|Overall Study|Physician Decision|0|||
106076438|NCT03711162|365944483|FG001|Overall Study|Physician Decision|2|||
106076439|NCT03711162|365944484|FG002|Overall Study|Physician Decision|0|||
106076440|NCT03711162|365944482|FG000|Overall Study|Lack of Efficacy|0|||
106076441|NCT03711162|365944483|FG001|Overall Study|Lack of Efficacy|0|||
106076442|NCT03711162|365944484|FG002|Overall Study|Lack of Efficacy|2|||
106076443|NCT03711162|365944482|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
106076444|NCT03711162|365944483|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
106076445|NCT03711162|365944484|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
106076446|NCT03034954|365944485|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
106076447|NCT03034954|365944486|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
106076448|NCT05228470|365944487|FG000|Overall Study|Death|6|||
106076449|NCT05228470|365944488|FG001|Overall Study|Death|11|||
106076450|NCT05228470|365944487|FG000|Overall Study|Withdrawal by Subject|1|||
106076451|NCT05228470|365944488|FG001|Overall Study|Withdrawal by Subject|8|||
106076452|NCT05228470|365944487|FG000|Overall Study|Ongoing|1|||
106076453|NCT05228470|365944488|FG001|Overall Study|Ongoing|11|||
106076454|NCT00588445|365944491|FG000|Overall Study|Protocol Violation|1|||
106158869|NCT02962895|366243526|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
106158870|NCT02962895|366243527|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
106158871|NCT02962895|366243528|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
106158872|NCT02962895|366243522|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
106158873|NCT02962895|366243523|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
106158874|NCT02962895|366243524|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
106158875|NCT02962895|366243525|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
106158876|NCT02962895|366243526|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
106158877|NCT02962895|366243527|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
106158878|NCT02962895|366243528|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
106158879|NCT02962895|366243522|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
106158880|NCT02962895|366243523|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
106158881|NCT02962895|366243524|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
106158882|NCT02962895|366243525|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
106158883|NCT02962895|366243526|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
106158884|NCT02962895|366243527|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
106158885|NCT02962895|366243528|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
106158886|NCT02962895|366243522|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
106158887|NCT02962895|366243523|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
106158888|NCT02962895|366243524|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
106158889|NCT02962895|366243525|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
106158890|NCT02962895|366243526|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
106158891|NCT02962895|366243527|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
106158892|NCT02962895|366243528|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
106158893|NCT02962895|366243522|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
105866643|NCT02466685|365161125|FG001|Overall Study|Adverse Event|2|||
106076455|NCT00588445|365944491|FG000|Overall Study|Withdrawal by Subject|3|||
106076456|NCT00588445|365944491|FG000|Overall Study|Disease Progression|1|||
106076457|NCT00588445|365944491|FG000|Overall Study|Not Treated|10|||
106076458|NCT03240133|365944492|FG000|Overall Study|Withdrawal by Subject|0|||
106076459|NCT03240133|365944493|FG001|Overall Study|Withdrawal by Subject|1|||
106076460|NCT03240133|365944494|FG002|Overall Study|Withdrawal by Subject|0|||
106076461|NCT03240133|365944492|FG000|Overall Study|Adverse Event|1|||
106076462|NCT03240133|365944493|FG001|Overall Study|Adverse Event|1|||
106076463|NCT03240133|365944494|FG002|Overall Study|Adverse Event|0|||
106076464|NCT03240133|365944492|FG000|Overall Study|Rash|1|||
106076465|NCT03240133|365944493|FG001|Overall Study|Rash|0|||
106076466|NCT03240133|365944494|FG002|Overall Study|Rash|0|||
106076467|NCT03240133|365944492|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
106076468|NCT03240133|365944493|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
106076469|NCT03240133|365944494|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
106076470|NCT03240133|365944492|FG000|Overall Study|Intercurrent illness.|0|||
106076471|NCT03240133|365944493|FG001|Overall Study|Intercurrent illness.|1|||
106076472|NCT03240133|365944494|FG002|Overall Study|Intercurrent illness.|0|||
106076473|NCT03240133|365944492|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
106076474|NCT03240133|365944493|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
106076475|NCT03240133|365944494|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
106076476|NCT00997503|365944495|FG000|Overall Study|Death|53|||
106076477|NCT00997503|365944495|FG000|Overall Study|Withdrawal by Subject|76|||
106076478|NCT00997503|365944495|FG000|Overall Study|Lost to Follow-up|33|||
106076479|NCT00997503|365944495|FG000|Overall Study|Adverse Event|3|||
106076480|NCT00997503|365944495|FG000|Overall Study|Physician Decision|10|||
106076481|NCT00997503|365944495|FG000|Overall Study|Missed 12-month follow-up|85|||
106076482|NCT00997503|365944495|FG000|Overall Study|Other reason|13|||
106076483|NCT00116831|365944496|FG000|Overall Study|Adverse Event|14|||
106076484|NCT00116831|365944497|FG001|Overall Study|Adverse Event|16|||
106076485|NCT00116831|365944496|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
106076486|NCT00116831|365944497|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
106076487|NCT00116831|365944496|FG000|Overall Study|Lost to Follow-up|8|||
106076488|NCT00116831|365944497|FG001|Overall Study|Lost to Follow-up|6|||
106076489|NCT00116831|365944496|FG000|Overall Study|Protocol Violation|3|||
106076490|NCT00116831|365944497|FG001|Overall Study|Protocol Violation|6|||
106076491|NCT00116831|365944496|FG000|Overall Study|Hypoglycaemic events|1|||
106076492|NCT00116831|365944497|FG001|Overall Study|Hypoglycaemic events|0|||
106076493|NCT00116831|365944496|FG000|Overall Study|Low haemoglobin on screening|1|||
106076494|NCT00116831|365944497|FG001|Overall Study|Low haemoglobin on screening|0|||
106076495|NCT00116831|365944496|FG000|Overall Study|Withdrawn investigational product|1|||
106076496|NCT00116831|365944497|FG001|Overall Study|Withdrawn investigational product|0|||
106076497|NCT00116831|365944496|FG000|Overall Study|Withdrawal by Subject|32|||
106076498|NCT00116831|365944497|FG001|Overall Study|Withdrawal by Subject|32|||
106076499|NCT00116831|365944496|FG000|Overall Study|Insufficient therapeutic effect|0|||
106076500|NCT00116831|365944497|FG001|Overall Study|Insufficient therapeutic effect|1|||
106076501|NCT00116831|365944496|FG000|Overall Study|Missing data for participant|1|||
106076502|NCT00116831|365944497|FG001|Overall Study|Missing data for participant|0|||
106076503|NCT01990495|365944499|FG000|Overall Study|Physician Decision|5|||
106076504|NCT01990495|365944500|FG001|Overall Study|Physician Decision|4|||
106076505|NCT01752855|365944501|FG000|Overall Study|Adverse Event|1|||
106076506|NCT01752855|365944502|FG001|Overall Study|Adverse Event|0|||
106076507|NCT01752855|365944501|FG000|Overall Study|Withdrew Consent|0|||
106076508|NCT01752855|365944502|FG001|Overall Study|Withdrew Consent|2|||
106076509|NCT01752855|365944501|FG000|Overall Study|Lack of Efficacy|0|||
106076510|NCT01752855|365944502|FG001|Overall Study|Lack of Efficacy|2|||
106076511|NCT03168464|365944505|FG000|Overall Study|Death|9|||
106076512|NCT03168464|365944505|FG000|Overall Study|Progression of disease|6|||
106076513|NCT00235872|365944518|FG000|Overall Study|Adverse Event|34|||
106076514|NCT00235872|365944518|FG000|Overall Study|Death|1|||
106076515|NCT00235872|365944518|FG000|Overall Study|Lost to Follow-up|1|||
106076516|NCT00235872|365944518|FG000|Overall Study|Withdrawal by Subject|50|||
106076517|NCT00235872|365944518|FG000|Overall Study|Administrative reason|61|||
106076518|NCT01446965|365944524|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
106076519|NCT01446965|365944525|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
106076520|NCT01446965|365944524|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
106076521|NCT01446965|365944525|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
106076522|NCT02023151|365944526|FG000|Overall Study|Lost to Follow-up|4|||
106076523|NCT02932904|365944532|FG000|Overall Study|Reason not Specified|1|||
106076524|NCT02932904|365944533|FG001|Overall Study|Reason not Specified|0|||
106076525|NCT02932904|365944534|FG002|Overall Study|Reason not Specified|2|||
106158894|NCT02962895|366243523|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
106076526|NCT02932904|365944535|FG003|Overall Study|Reason not Specified|2|||
106076527|NCT02932904|365944532|FG000|Overall Study|Noncompliance with Study Drug|2|||
106076528|NCT02932904|365944533|FG001|Overall Study|Noncompliance with Study Drug|3|||
106076529|NCT02932904|365944534|FG002|Overall Study|Noncompliance with Study Drug|3|||
106076530|NCT02932904|365944535|FG003|Overall Study|Noncompliance with Study Drug|4|||
106076531|NCT02932904|365944532|FG000|Overall Study|Pregnancy|0|||
106076532|NCT02932904|365944533|FG001|Overall Study|Pregnancy|1|||
106076533|NCT02932904|365944534|FG002|Overall Study|Pregnancy|1|||
105866644|NCT02466685|365161124|FG000|Overall Study|Lost to Follow-up|1|||
105866645|NCT02466685|365161125|FG001|Overall Study|Lost to Follow-up|1|||
105866646|NCT02466685|365161124|FG000|Overall Study|Withdrawal by Subject|1|||
105866647|NCT02466685|365161125|FG001|Overall Study|Withdrawal by Subject|0|||
105866648|NCT02466685|365161124|FG000|Overall Study|Physician Decision|1|||
105866649|NCT02466685|365161125|FG001|Overall Study|Physician Decision|1|||
105866650|NCT01128543|365161126|FG000|Overall Study|Withdrawal by Subject|3|||
105866651|NCT01128543|365161126|FG000|Overall Study|Protocol Violation|1|||
105866652|NCT02565511|365161127|FG000|Overall Study|Study terminated by Sponsor|35|||
105866653|NCT02565511|365161128|FG001|Overall Study|Study terminated by Sponsor|22|||
105866654|NCT02565511|365161129|FG002|Overall Study|Study terminated by Sponsor|235|||
105866655|NCT02565511|365161130|FG003|Overall Study|Study terminated by Sponsor|156|||
105866656|NCT02565511|365161127|FG000|Overall Study|Withdrawal by Subject|3|||
105866657|NCT02565511|365161128|FG001|Overall Study|Withdrawal by Subject|0|||
105866658|NCT02565511|365161129|FG002|Overall Study|Withdrawal by Subject|12|||
105866659|NCT02565511|365161130|FG003|Overall Study|Withdrawal by Subject|5|||
105866660|NCT02565511|365161127|FG000|Overall Study|Adverse Event|0|||
105866661|NCT02565511|365161128|FG001|Overall Study|Adverse Event|0|||
105866662|NCT02565511|365161129|FG002|Overall Study|Adverse Event|1|||
105866663|NCT02565511|365161130|FG003|Overall Study|Adverse Event|1|||
105866664|NCT02565511|365161127|FG000|Overall Study|Lost to Follow-up|4|||
105866665|NCT02565511|365161128|FG001|Overall Study|Lost to Follow-up|1|||
105866666|NCT02565511|365161129|FG002|Overall Study|Lost to Follow-up|0|||
105866667|NCT02565511|365161130|FG003|Overall Study|Lost to Follow-up|1|||
105866668|NCT02565511|365161127|FG000|Overall Study|Physician Decision|0|||
105866669|NCT02565511|365161128|FG001|Overall Study|Physician Decision|0|||
105866670|NCT02565511|365161129|FG002|Overall Study|Physician Decision|0|||
105866671|NCT02565511|365161130|FG003|Overall Study|Physician Decision|1|||
105866672|NCT02565511|365161127|FG000|Overall Study|Protocol deviation|0|||
105866673|NCT02565511|365161128|FG001|Overall Study|Protocol deviation|0|||
105866674|NCT02565511|365161129|FG002|Overall Study|Protocol deviation|3|||
105866675|NCT02565511|365161130|FG003|Overall Study|Protocol deviation|0|||
105866676|NCT04324021|365161139|FG000|Overall Study|Adverse Event|1|||
105866677|NCT04324021|365161140|FG001|Overall Study|Adverse Event|0|||
105866678|NCT04324021|365161141|FG002|Overall Study|Adverse Event|0|||
105866679|NCT04324021|365161139|FG000|Overall Study|Lack of Efficacy|0|||
105866680|NCT04324021|365161140|FG001|Overall Study|Lack of Efficacy|0|||
105866681|NCT04324021|365161141|FG002|Overall Study|Lack of Efficacy|1|||
105866682|NCT04324021|365161139|FG000|Overall Study|Death|1|||
105866683|NCT04324021|365161140|FG001|Overall Study|Death|1|||
105866684|NCT04324021|365161141|FG002|Overall Study|Death|0|||
105866685|NCT03097991|365161142|FG000|Overall Study|Didn't meet study criteria|8|||
105866686|NCT03097991|365161143|FG001|Overall Study|Didn't meet study criteria|0|||
105866687|NCT03097991|365161142|FG000|Overall Study|Withdrawal by Subject|12|||
105866688|NCT03097991|365161143|FG001|Overall Study|Withdrawal by Subject|6|||
105866689|NCT03097991|365161142|FG000|Overall Study|Death of Baby|3|||
105866690|NCT03097991|365161143|FG001|Overall Study|Death of Baby|1|||
105866691|NCT03097991|365161142|FG000|Overall Study|Lost to Follow-up|24|||
105866692|NCT03097991|365161143|FG001|Overall Study|Lost to Follow-up|38|||
105866693|NCT03097991|365161142|FG000|Overall Study|Adverse Event|3|||
105866694|NCT03097991|365161143|FG001|Overall Study|Adverse Event|5|||
105866695|NCT01755091|365161144|FG000|Overall Study|Withdrawal by Subject|6|||
105866696|NCT01755091|365161145|FG001|Overall Study|Withdrawal by Subject|1|||
105866697|NCT01755091|365161146|FG002|Overall Study|Withdrawal by Subject|3|||
105866698|NCT01755091|365161144|FG000|Overall Study|Adverse Event|1|||
105866699|NCT01755091|365161145|FG001|Overall Study|Adverse Event|1|||
105866700|NCT01755091|365161146|FG002|Overall Study|Adverse Event|1|||
106076534|NCT02932904|365944535|FG003|Overall Study|Pregnancy|0|||
106076535|NCT02932904|365944532|FG000|Overall Study|Study Termination|0|||
106076536|NCT02932904|365944533|FG001|Overall Study|Study Termination|1|||
106076537|NCT02932904|365944534|FG002|Overall Study|Study Termination|0|||
106076538|NCT02932904|365944535|FG003|Overall Study|Study Termination|0|||
106076539|NCT02932904|365944532|FG000|Overall Study|Voluntary Withdrawal|2|||
106076540|NCT02932904|365944533|FG001|Overall Study|Voluntary Withdrawal|1|||
106076541|NCT02932904|365944534|FG002|Overall Study|Voluntary Withdrawal|4|||
106076542|NCT02932904|365944535|FG003|Overall Study|Voluntary Withdrawal|2|||
106076543|NCT02932904|365944532|FG000|Overall Study|Lost to Follow-up|5|||
106076544|NCT02932904|365944533|FG001|Overall Study|Lost to Follow-up|3|||
105866701|NCT01755091|365161144|FG000|Overall Study|Lost to Follow-up|1|||
105866702|NCT01755091|365161145|FG001|Overall Study|Lost to Follow-up|0|||
105866703|NCT01755091|365161146|FG002|Overall Study|Lost to Follow-up|1|||
105866704|NCT01755091|365161144|FG000|Overall Study|Physician Decision|1|||
105866705|NCT01755091|365161145|FG001|Overall Study|Physician Decision|1|||
105866706|NCT01755091|365161146|FG002|Overall Study|Physician Decision|2|||
105866707|NCT03516513|365161147|FG000|Overall Study|Withdrawal by Subject|2|||
105866708|NCT03516513|365161148|FG001|Overall Study|Withdrawal by Subject|2|||
106076545|NCT02932904|365944534|FG002|Overall Study|Lost to Follow-up|6|||
105866709|NCT03516513|365161149|FG002|Overall Study|Withdrawal by Subject|0|||
105866710|NCT03516513|365161150|FG003|Overall Study|Withdrawal by Subject|0|||
106076546|NCT02932904|365944535|FG003|Overall Study|Lost to Follow-up|0|||
106076547|NCT02932904|365944532|FG000|Overall Study|Significant Protocol Deviation|2|||
106076548|NCT02932904|365944533|FG001|Overall Study|Significant Protocol Deviation|3|||
106076549|NCT02932904|365944534|FG002|Overall Study|Significant Protocol Deviation|6|||
106076550|NCT02932904|365944535|FG003|Overall Study|Significant Protocol Deviation|1|||
106076551|NCT02932904|365944532|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
106076552|NCT02932904|365944533|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
106076553|NCT02932904|365944534|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
106076554|NCT02932904|365944535|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
106076555|NCT02932904|365944532|FG000|Overall Study|Randomized But Not Treated|1|||
106076556|NCT02932904|365944533|FG001|Overall Study|Randomized But Not Treated|1|||
106076557|NCT02932904|365944534|FG002|Overall Study|Randomized But Not Treated|0|||
106076558|NCT02932904|365944535|FG003|Overall Study|Randomized But Not Treated|2|||
106076559|NCT01293240|365944538|FG000|Overall Study|Noncompliance|2|||
106076560|NCT04238728|365944544|FG000|Overall Study|Withdrawal by Subject|1|||
106076561|NCT04238728|365944544|FG000|Overall Study|Lost to Follow-up|2|||
106076562|NCT02818777|365944561|FG000|Overall Study|Adverse Event|3|||
106076563|NCT01418937|365944562|FG000|Overall Study|Lost to Follow-up|5|||
106076564|NCT01418937|365944562|FG000|Overall Study|Protocol Violation|1|||
106076565|NCT01418937|365944562|FG000|Overall Study|Pregnancy|1|||
106076566|NCT01418937|365944562|FG000|Overall Study|Withdrawal by Subject|1|||
106076567|NCT00856908|365944568|FG000|Overall Study|Lost to Follow-up|1|||
106076568|NCT00856908|365944569|FG001|Overall Study|Lost to Follow-up|0|||
106076569|NCT00451035|365944573|FG000|Overall Study|Disease progression|11|||
106076570|NCT00451035|365944573|FG000|Overall Study|Death|3|||
106076571|NCT00451035|365944573|FG000|Overall Study|New anti-neoplastic therapy|3|||
106076572|NCT01324349|365944577|FG000|Overall Study|Death|1|||
106076573|NCT01324349|365944578|FG001|Overall Study|Death|1|||
106076574|NCT01324349|365944577|FG000|Overall Study|Withdrawal by Subject|0|||
106076575|NCT01324349|365944578|FG001|Overall Study|Withdrawal by Subject|1|||
106076576|NCT01712256|365944579|FG000|Overall Study|Lost to Follow-up|1|||
106076577|NCT02013167|365944582|FG000|Overall Study|Withdrawal by Subject|15|||
106076578|NCT02013167|365944583|FG001|Overall Study|Withdrawal by Subject|14|||
106076579|NCT02013167|365944582|FG000|Overall Study|Sponsor Decision|1|||
106076580|NCT02013167|365944583|FG001|Overall Study|Sponsor Decision|3|||
106076581|NCT02013167|365944582|FG000|Overall Study|Lost to Follow-up|0|||
106076582|NCT02013167|365944583|FG001|Overall Study|Lost to Follow-up|1|||
106076583|NCT02013167|365944582|FG000|Overall Study|Death|85|||
106076584|NCT02013167|365944583|FG001|Overall Study|Death|160|||
106076585|NCT00842348|365944584|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
106076586|NCT00842348|365944585|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
106076587|NCT00842348|365944584|FG000|Study 729|Disease progression/death|19|||
106076588|NCT00842348|365944585|FG001|Study 729|Disease progression/death|30|||
106076589|NCT00842348|365944584|FG000|Study 729|Adverse Event|1|||
106076590|NCT00842348|365944585|FG001|Study 729|Adverse Event|1|||
106076591|NCT00842348|365944584|FG000|Study 729|Protocol Violation|1|||
106076592|NCT00842348|365944585|FG001|Study 729|Protocol Violation|1|||
106076593|NCT00842348|365944584|FG000|Study 729|Withdrawal by Subject|2|||
106076594|NCT00842348|365944585|FG001|Study 729|Withdrawal by Subject|4|||
106076595|NCT00842348|365944584|FG000|Study 729|Due to Sponsor stopping the study|1|||
106076596|NCT00842348|365944585|FG001|Study 729|Due to Sponsor stopping the study|1|||
106076597|NCT00842348|365944584|FG000|Study 729|Due to non-availability of IP|0|||
106076598|NCT00842348|365944585|FG001|Study 729|Due to non-availability of IP|1|||
106076599|NCT00842348|365944584|FG000|Study 729|Sponsor's decision|1|||
106076600|NCT00842348|365944585|FG001|Study 729|Sponsor's decision|0|||
106076601|NCT00842348|365944584|FG000|Study 729|Surgical resection|1|||
106076602|NCT00842348|365944585|FG001|Study 729|Surgical resection|0|||
106076603|NCT00603746|365944586|FG000|Overall Study|Adverse Event|2|||
106076604|NCT00603746|365944587|FG001|Overall Study|Adverse Event|3|||
106076605|NCT00603746|365944588|FG002|Overall Study|Adverse Event|0|||
106076606|NCT00603746|365944589|FG003|Overall Study|Adverse Event|1|||
106076607|NCT00603746|365944590|FG004|Overall Study|Adverse Event|0|||
106076608|NCT00603746|365944591|FG005|Overall Study|Adverse Event|4|||
106076609|NCT00603746|365944586|FG000|Overall Study|Lack of Efficacy|34|||
106076610|NCT00603746|365944587|FG001|Overall Study|Lack of Efficacy|11|||
106076611|NCT00603746|365944588|FG002|Overall Study|Lack of Efficacy|6|||
106158895|NCT02962895|366243524|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
106158896|NCT02962895|366243525|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
106158897|NCT02962895|366243526|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
106158898|NCT02962895|366243527|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
106158899|NCT02962895|366243528|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
106158900|NCT02962895|366243522|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
106158901|NCT02962895|366243523|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
106076612|NCT00603746|365944589|FG003|Overall Study|Lack of Efficacy|11|||
106076613|NCT00603746|365944590|FG004|Overall Study|Lack of Efficacy|12|||
106076614|NCT00603746|365944591|FG005|Overall Study|Lack of Efficacy|8|||
106076615|NCT00603746|365944586|FG000|Overall Study|Protocol Violation|0|||
105866711|NCT00345631|365161151|FG000|Overall Study|Withdrawal by Subject|1|||
105866712|NCT00345631|365161152|FG001|Overall Study|Withdrawal by Subject|0|||
105866713|NCT00345631|365161153|FG002|Overall Study|Withdrawal by Subject|1|||
105866714|NCT00345631|365161151|FG000|Overall Study|Adverse Event|0|||
105866715|NCT00345631|365161152|FG001|Overall Study|Adverse Event|1|||
105866716|NCT00345631|365161153|FG002|Overall Study|Adverse Event|0|||
105866717|NCT00345631|365161151|FG000|Overall Study|Lost to Follow-up|3|||
105866718|NCT00345631|365161152|FG001|Overall Study|Lost to Follow-up|7|||
105866719|NCT00345631|365161153|FG002|Overall Study|Lost to Follow-up|4|||
105866720|NCT00345631|365161151|FG000|Overall Study|Other reasons|0|||
105866721|NCT00345631|365161152|FG001|Overall Study|Other reasons|0|||
105866722|NCT00345631|365161153|FG002|Overall Study|Other reasons|1|||
105866723|NCT01130597|365161154|FG000|Overall Study|Protocol-specified (High K+)|1|||
105866724|NCT01130597|365161154|FG000|Overall Study|Adverse Event|4|||
105866725|NCT01130597|365161154|FG000|Overall Study|Death|1|||
105866726|NCT01130597|365161154|FG000|Overall Study|Protocol Violation|1|||
105866727|NCT03071276|365161155|FG000|Overall Study|Adverse Event|1|||
105866728|NCT03071276|365161155|FG000|Overall Study|Lack of Efficacy|14|||
105866729|NCT01590277|365161161|FG000|Overall Study|Withdrawal by Subject|3|||
105866730|NCT01590277|365161161|FG000|Overall Study|Withdrawal by Subject|2|||
105866731|NCT01590277|365161161|FG000|Overall Study|Withdrawal by Subject|1|||
105866732|NCT01590277|365161161|FG000|Overall Study|Withdrawal by Subject|1|||
105866733|NCT01450683|365161164|FG000|Overall Study|Adverse Event|2|||
105866734|NCT02126826|365162985|FG000|Overall Study|Withdrawal by Subject|0|||
105866735|NCT02126826|365162986|FG001|Overall Study|Withdrawal by Subject|0|||
105866736|NCT02126826|365162987|FG002|Overall Study|Withdrawal by Subject|0|||
105866737|NCT02126826|365162988|FG003|Overall Study|Withdrawal by Subject|1|||
105866738|NCT02126826|365162989|FG004|Overall Study|Withdrawal by Subject|0|||
105866739|NCT02126826|365162990|FG005|Overall Study|Withdrawal by Subject|0|||
105866740|NCT02126826|365162991|FG006|Overall Study|Withdrawal by Subject|0|||
105866741|NCT02717455|365162993|FG000|Overall Study|Adverse Event|1|||
105866742|NCT02717455|365162994|FG001|Overall Study|Adverse Event|0|||
105866743|NCT02717455|365162995|FG002|Overall Study|Adverse Event|0|||
105866744|NCT02717455|365162996|FG003|Overall Study|Adverse Event|2|||
105866745|NCT02717455|365162997|FG004|Overall Study|Adverse Event|2|||
105866746|NCT02717455|365162998|FG005|Overall Study|Adverse Event|2|||
105866747|NCT02717455|365162993|FG000|Overall Study|Withdrawal by Subject|1|||
105866748|NCT02717455|365162994|FG001|Overall Study|Withdrawal by Subject|1|||
105866749|NCT02717455|365162995|FG002|Overall Study|Withdrawal by Subject|0|||
105866750|NCT02717455|365162996|FG003|Overall Study|Withdrawal by Subject|2|||
105866751|NCT02717455|365162997|FG004|Overall Study|Withdrawal by Subject|2|||
105866752|NCT02717455|365162998|FG005|Overall Study|Withdrawal by Subject|1|||
105866753|NCT02717455|365162993|FG000|Overall Study|Death|1|||
105866754|NCT02717455|365162994|FG001|Overall Study|Death|0|||
105866755|NCT02717455|365162995|FG002|Overall Study|Death|0|||
105866756|NCT02717455|365162996|FG003|Overall Study|Death|0|||
105866757|NCT02717455|365162997|FG004|Overall Study|Death|1|||
105866758|NCT02717455|365162998|FG005|Overall Study|Death|0|||
105866759|NCT02717455|365162993|FG000|Overall Study|Did not receive study drug|0|||
105866760|NCT02717455|365162994|FG001|Overall Study|Did not receive study drug|0|||
105866761|NCT02717455|365162995|FG002|Overall Study|Did not receive study drug|0|||
105866762|NCT02717455|365162996|FG003|Overall Study|Did not receive study drug|1|||
105866763|NCT02717455|365162997|FG004|Overall Study|Did not receive study drug|0|||
105866764|NCT02717455|365162998|FG005|Overall Study|Did not receive study drug|1|||
105866765|NCT02717455|365162993|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105866766|NCT02717455|365162994|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105866767|NCT02717455|365162995|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105866768|NCT02717455|365162996|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105866769|NCT02717455|365162997|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
105866770|NCT02717455|365162998|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
105866771|NCT02717455|365162993|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
106158902|NCT02962895|366243524|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
105866772|NCT02717455|365162994|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
105866773|NCT02717455|365162995|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
105866774|NCT02717455|365162996|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
105866775|NCT02717455|365162997|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
105866776|NCT02717455|365162998|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
105866777|NCT05013008|365162999|FG000|Overall Study|Exclusion from mBFAS|5|||
105866778|NCT05013008|365163000|FG001|Overall Study|Exclusion from mBFAS|25|||
105866779|NCT02207634|365163004|FG000|Overall Study|Withdrawal by Subject|21|||
105866780|NCT02207634|365163005|FG001|Overall Study|Withdrawal by Subject|31|||
105866781|NCT02207634|365163004|FG000|Overall Study|Lost to Follow-up|1|||
106158903|NCT02962895|366243525|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
105866782|NCT02207634|365163005|FG001|Overall Study|Lost to Follow-up|0|||
105866783|NCT02077140|365163006|FG000|Overall Study|Lost to Follow-up|4|||
105866784|NCT02077140|365163007|FG001|Overall Study|Lost to Follow-up|1|||
105866785|NCT02077140|365163008|FG002|Overall Study|Lost to Follow-up|2|||
105866786|NCT02077140|365163009|FG003|Overall Study|Lost to Follow-up|2|||
105866787|NCT02077140|365163010|FG004|Overall Study|Lost to Follow-up|3|||
105866788|NCT02077140|365163006|FG000|Overall Study|Withdrawal by Subject|0|||
105866789|NCT02077140|365163007|FG001|Overall Study|Withdrawal by Subject|1|||
105866790|NCT02077140|365163008|FG002|Overall Study|Withdrawal by Subject|0|||
105866791|NCT02077140|365163009|FG003|Overall Study|Withdrawal by Subject|2|||
105866792|NCT02077140|365163010|FG004|Overall Study|Withdrawal by Subject|2|||
105866793|NCT00887289|365163011|FG000|Overall Study|Lack of Efficacy|14|||
105866794|NCT00887289|365163011|FG000|Overall Study|Adverse Event|27|||
105866795|NCT00887289|365163011|FG000|Overall Study|Withdrawal by Subject|26|||
105866796|NCT00887289|365163011|FG000|Overall Study|Lost to Follow-up|8|||
105866797|NCT00887289|365163011|FG000|Overall Study|Other|20|||
105866798|NCT00974922|365163012|FG000|Overall Study|study terminated|24|||
105866799|NCT00591773|365163013|FG000|Overall Study|Adverse Event|9|||
105866800|NCT00591773|365163014|FG001|Overall Study|Adverse Event|9|||
105866801|NCT00591773|365163015|FG002|Overall Study|Adverse Event|6|||
105866802|NCT00591773|365163013|FG000|Overall Study|Protocol Violation|2|||
105866803|NCT00591773|365163014|FG001|Overall Study|Protocol Violation|3|||
105866804|NCT00591773|365163015|FG002|Overall Study|Protocol Violation|0|||
105866805|NCT00591773|365163013|FG000|Overall Study|Lost to Follow-up|1|||
105866806|NCT00591773|365163014|FG001|Overall Study|Lost to Follow-up|4|||
105866807|NCT00591773|365163015|FG002|Overall Study|Lost to Follow-up|1|||
105866808|NCT00591773|365163013|FG000|Overall Study|Withdrawal by Subject|2|||
105866809|NCT00591773|365163014|FG001|Overall Study|Withdrawal by Subject|5|||
105866810|NCT00591773|365163015|FG002|Overall Study|Withdrawal by Subject|3|||
105866811|NCT00591773|365163013|FG000|Overall Study|Lack of Efficacy|1|||
105866812|NCT00591773|365163014|FG001|Overall Study|Lack of Efficacy|2|||
105866813|NCT00591773|365163015|FG002|Overall Study|Lack of Efficacy|2|||
105866814|NCT00591773|365163013|FG000|Overall Study|Other|1|||
105866815|NCT00591773|365163014|FG001|Overall Study|Other|1|||
105866816|NCT00591773|365163015|FG002|Overall Study|Other|4|||
105866817|NCT01009814|365163018|FG000|Overall Study|No longer met study criteria|1|||
105866818|NCT01009814|365163019|FG001|Overall Study|No longer met study criteria|1|||
105866819|NCT01009814|365163020|FG002|Overall Study|No longer met study criteria|0|||
105866820|NCT01009814|365163021|FG003|Overall Study|No longer met study criteria|0|||
105866821|NCT01009814|365163022|FG004|Overall Study|No longer met study criteria|0|||
105866822|NCT02135614|365163023|FG000|Overall Study|Randomized but Not Treated|2|||
105866823|NCT02135614|365163024|FG001|Overall Study|Randomized but Not Treated|1|||
105866824|NCT02135614|365163023|FG000|Overall Study|Adverse Event|0|||
105866825|NCT02135614|365163024|FG001|Overall Study|Adverse Event|1|||
105866826|NCT02135614|365163023|FG000|Overall Study|Death|1|||
106076616|NCT00603746|365944587|FG001|Overall Study|Protocol Violation|3|||
106076617|NCT00603746|365944588|FG002|Overall Study|Protocol Violation|1|||
106076618|NCT00603746|365944589|FG003|Overall Study|Protocol Violation|0|||
106076619|NCT00603746|365944590|FG004|Overall Study|Protocol Violation|1|||
106076620|NCT00603746|365944591|FG005|Overall Study|Protocol Violation|0|||
106076621|NCT00603746|365944586|FG000|Overall Study|Lost to Follow-up|0|||
106076622|NCT00603746|365944587|FG001|Overall Study|Lost to Follow-up|1|||
106076623|NCT00603746|365944588|FG002|Overall Study|Lost to Follow-up|1|||
106076624|NCT00603746|365944589|FG003|Overall Study|Lost to Follow-up|0|||
106076625|NCT00603746|365944590|FG004|Overall Study|Lost to Follow-up|0|||
106076626|NCT00603746|365944591|FG005|Overall Study|Lost to Follow-up|0|||
106076627|NCT00603746|365944586|FG000|Overall Study|Physician Decision|1|||
106076628|NCT00603746|365944587|FG001|Overall Study|Physician Decision|0|||
105866827|NCT02135614|365163024|FG001|Overall Study|Death|0|||
105866828|NCT02135614|365163023|FG000|Overall Study|Investigator's Discretion|0|||
105866829|NCT02135614|365163024|FG001|Overall Study|Investigator's Discretion|1|||
105866830|NCT02135614|365163023|FG000|Overall Study|Withdrew Consent|2|||
105866831|NCT02135614|365163024|FG001|Overall Study|Withdrew Consent|2|||
105866832|NCT02135614|365163023|FG000|Overall Study|Lost to Follow-up|3|||
105866833|NCT02135614|365163024|FG001|Overall Study|Lost to Follow-up|0|||
105866834|NCT02013817|365163026|FG000|Overall Study|Adverse Event|12|||
105866835|NCT02013817|365163026|FG000|Overall Study|Withdrawal by Subject|4|||
105866836|NCT02013817|365163026|FG000|Overall Study|Death|2|||
105866837|NCT02013817|365163026|FG000|Overall Study|Other|9|||
105866838|NCT02129608|365163027|FG000|Overall Study|Lost to Follow-up|0|||
106076629|NCT00603746|365944588|FG002|Overall Study|Physician Decision|0|||
105866839|NCT02129608|365163028|FG001|Overall Study|Lost to Follow-up|1|||
105866840|NCT02129608|365163029|FG002|Overall Study|Lost to Follow-up|1|||
105866841|NCT02129608|365163027|FG000|Overall Study|Withdrawal by Subject|0|||
105866842|NCT02129608|365163028|FG001|Overall Study|Withdrawal by Subject|0|||
105866843|NCT02129608|365163029|FG002|Overall Study|Withdrawal by Subject|2|||
105866844|NCT00451204|365163036|FG000|Overall Study|Adverse Event|4|||
105866845|NCT00451204|365163037|FG001|Overall Study|Adverse Event|6|||
106076630|NCT00603746|365944589|FG003|Overall Study|Physician Decision|0|||
106076631|NCT00603746|365944590|FG004|Overall Study|Physician Decision|1|||
106158904|NCT02962895|366243526|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
106158905|NCT02962895|366243527|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
106158906|NCT02962895|366243528|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
106158907|NCT02962895|366243522|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
106158908|NCT02962895|366243523|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
106158909|NCT02962895|366243524|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
106158910|NCT02962895|366243525|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
106158911|NCT02962895|366243526|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
106158912|NCT02962895|366243527|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
106158913|NCT02962895|366243528|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
106158914|NCT02962895|366243522|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
106158915|NCT02962895|366243523|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
106158916|NCT02962895|366243524|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
106158917|NCT02962895|366243525|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
106158918|NCT02962895|366243526|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
106158919|NCT02962895|366243527|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
106158920|NCT02962895|366243528|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
106158921|NCT02962895|366243522|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
106158922|NCT02962895|366243523|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
106158923|NCT02962895|366243524|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
106158924|NCT02962895|366243525|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
106158925|NCT02962895|366243526|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
106158926|NCT02962895|366243527|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
106158927|NCT02962895|366243528|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
106158928|NCT02962895|366243522|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
106158929|NCT02962895|366243523|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
106158930|NCT02962895|366243524|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
106158931|NCT02962895|366243525|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
106158932|NCT02962895|366243526|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
106158933|NCT02962895|366243527|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
106158934|NCT02962895|366243528|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
106158935|NCT02962895|366243522|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
106158936|NCT02962895|366243523|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
106158937|NCT02962895|366243524|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
106158938|NCT02962895|366243525|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
106158939|NCT02962895|366243526|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
106158940|NCT02962895|366243527|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
106158941|NCT02962895|366243528|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
106158942|NCT02962895|366243522|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
106158943|NCT02962895|366243523|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
106158944|NCT02962895|366243524|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
106158945|NCT02962895|366243525|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
106158946|NCT02962895|366243526|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
106158947|NCT02962895|366243527|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
106158948|NCT02962895|366243528|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
106158949|NCT02962895|366243522|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
106158950|NCT02962895|366243523|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
106158951|NCT02962895|366243524|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
106158952|NCT02962895|366243525|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
106158953|NCT02962895|366243526|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
106158954|NCT02962895|366243527|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
106158955|NCT02962895|366243528|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
106158956|NCT02979522|366243529|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
106158957|NCT02979522|366243530|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
106158958|NCT02979522|366243529|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
106158959|NCT02979522|366243530|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
106158960|NCT05282173|366243531|FG000|Overall Study|Missed|3|||
106158961|NCT05282173|366243532|FG001|Overall Study|Missed|2|||
106158962|NCT05282173|366243533|FG002|Overall Study|Missed|4|||
106158963|NCT03470922|366245281|FG000|Overall Study|Death|107|||
106158964|NCT03470922|366245282|FG001|Overall Study|Death|118|||
106158965|NCT03470922|366245281|FG000|Overall Study|Lost to Follow-up|5|||
106158966|NCT03470922|366245282|FG001|Overall Study|Lost to Follow-up|5|||
106158967|NCT03470922|366245281|FG000|Overall Study|Participant Withdrew Consent|4|||
106158968|NCT03470922|366245282|FG001|Overall Study|Participant Withdrew Consent|9|||
106158969|NCT03470922|366245281|FG000|Overall Study|Other reasons|1|||
106158970|NCT03470922|366245282|FG001|Overall Study|Other reasons|0|||
106158971|NCT03470922|366245281|FG000|Overall Study|Not reported|1|||
106158972|NCT03470922|366245282|FG001|Overall Study|Not reported|0|||
106158973|NCT03393975|366245283|FG000|Urgent Treatment Period|Physician Decision|0|||
106158974|NCT03393975|366245284|FG001|Urgent Treatment Period|Physician Decision|0|||
106158975|NCT03393975|366245285|FG002|Urgent Treatment Period|Physician Decision|0|||
106158976|NCT03393975|366245286|FG003|Urgent Treatment Period|Physician Decision|1|||
106158977|NCT03393975|366245283|FG000|Prophylaxis Period 1|Reason not Specified|0|||
106158978|NCT03393975|366245284|FG001|Prophylaxis Period 1|Reason not Specified|1|||
106158979|NCT03393975|366245285|FG002|Prophylaxis Period 1|Reason not Specified|0|||
106158980|NCT03393975|366245286|FG003|Prophylaxis Period 1|Reason not Specified|0|||
106158981|NCT03393975|366245283|FG000|Prophylaxis Period 2|Reason not Specified|0|||
106158982|NCT03393975|366245284|FG001|Prophylaxis Period 2|Reason not Specified|1|||
106158983|NCT03393975|366245285|FG002|Prophylaxis Period 2|Reason not Specified|0|||
106158984|NCT03393975|366245286|FG003|Prophylaxis Period 2|Reason not Specified|0|||
106158985|NCT04353661|366245287|FG000|Overall Study|Protocol Violation|0|||
106158986|NCT04353661|366245288|FG001|Overall Study|Protocol Violation|0|||
106158987|NCT04353661|366245289|FG002|Overall Study|Protocol Violation|1|||
106158988|NCT04353661|366245287|FG000|Overall Study|Study termination by the Sponsor|1|||
106076632|NCT00603746|365944591|FG005|Overall Study|Physician Decision|0|||
106076633|NCT00603746|365944586|FG000|Overall Study|Withdrawal by Subject|1|||
106076634|NCT00603746|365944587|FG001|Overall Study|Withdrawal by Subject|0|||
106076635|NCT00603746|365944588|FG002|Overall Study|Withdrawal by Subject|0|||
106076636|NCT00603746|365944589|FG003|Overall Study|Withdrawal by Subject|1|||
106076637|NCT00603746|365944590|FG004|Overall Study|Withdrawal by Subject|3|||
106076638|NCT00603746|365944591|FG005|Overall Study|Withdrawal by Subject|1|||
106076639|NCT01113879|365944594|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
106076640|NCT01113879|365944595|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
106076641|NCT04151290|365944604|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
106076642|NCT02141074|365944605|FG000|Pre-prophylaxis|Adverse Event|3|||
106076643|NCT02141074|365944606|FG001|Pre-prophylaxis|Adverse Event|0|||
106076644|NCT02141074|365944605|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
106076645|NCT02141074|365944606|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
106076646|NCT02141074|365944605|FG000|Prophylaxis|Adverse Event|0|||
106076647|NCT02141074|365944606|FG001|Prophylaxis|Adverse Event|4|||
106076648|NCT02141074|365944605|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
106076649|NCT02141074|365944606|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
106076650|NCT02141074|365944605|FG000|Prophylaxis|Withdrawal by Subject|0|||
106076651|NCT02141074|365944606|FG001|Prophylaxis|Withdrawal by Subject|1|||
106076652|NCT01077804|365944607|FG000|Overall Study|Unreachable|102|||
106076653|NCT01077804|365944607|FG000|Overall Study|Refused to continue|79|||
106076654|NCT01077804|365944607|FG000|Overall Study|Other|18|||
106076655|NCT00560950|365944608|FG000|Overall Study|Lost to Follow-up|1|||
106076656|NCT00560950|365944609|FG001|Overall Study|Lost to Follow-up|0|||
106076657|NCT01914666|365946423|FG000|Treatment Period|Lack of Efficacy|0|||
106076658|NCT01914666|365946424|FG001|Treatment Period|Lack of Efficacy|0|||
106076659|NCT01914666|365946425|FG002|Treatment Period|Lack of Efficacy|2|||
106076660|NCT01914666|365946423|FG000|Treatment Period|Adverse Event|10|||
106076661|NCT01914666|365946424|FG001|Treatment Period|Adverse Event|4|||
106076662|NCT01914666|365946425|FG002|Treatment Period|Adverse Event|2|||
106076663|NCT01914666|365946423|FG000|Treatment Period|Withdrawal by Subject|3|||
106076664|NCT01914666|365946424|FG001|Treatment Period|Withdrawal by Subject|2|||
106076665|NCT01914666|365946425|FG002|Treatment Period|Withdrawal by Subject|2|||
106076666|NCT01914666|365946423|FG000|Treatment Period|Physician Decision|0|||
106076667|NCT01914666|365946424|FG001|Treatment Period|Physician Decision|0|||
106076668|NCT01914666|365946425|FG002|Treatment Period|Physician Decision|2|||
106076669|NCT01176292|365946438|FG000|Overall Study|Lost to Follow-up|2|||
106076670|NCT01176292|365946439|FG001|Overall Study|Lost to Follow-up|4|||
106076671|NCT01176292|365946438|FG000|Overall Study|Adverse Event|1|||
106076672|NCT01176292|365946439|FG001|Overall Study|Adverse Event|1|||
106076673|NCT01176292|365946438|FG000|Overall Study|Physician Decision|0|||
106076674|NCT01176292|365946439|FG001|Overall Study|Physician Decision|2|||
106076675|NCT01176292|365946438|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
106076676|NCT01176292|365946439|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
106076677|NCT02945410|365946440|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
106076678|NCT02945410|365946441|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
106076679|NCT02945410|365946442|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
106076680|NCT02945410|365946443|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
106076681|NCT02945410|365946444|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
106076682|NCT02945410|365946445|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
106076683|NCT02945410|365946440|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
106076684|NCT02945410|365946441|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
106076685|NCT02945410|365946442|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
106076686|NCT02945410|365946443|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
106076687|NCT02945410|365946444|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
106076688|NCT02945410|365946445|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
106076689|NCT02945410|365946440|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
106158989|NCT04353661|366245288|FG001|Overall Study|Study termination by the Sponsor|1|||
105866846|NCT00451204|365163036|FG000|Overall Study|Lack of Efficacy|4|||
105866847|NCT00451204|365163037|FG001|Overall Study|Lack of Efficacy|4|||
105866848|NCT00451204|365163036|FG000|Overall Study|Lost to Follow-up|4|||
105866849|NCT00451204|365163037|FG001|Overall Study|Lost to Follow-up|4|||
105866850|NCT00451204|365163036|FG000|Overall Study|Protocol Violation|1|||
105866851|NCT00451204|365163037|FG001|Overall Study|Protocol Violation|0|||
105866852|NCT00451204|365163036|FG000|Overall Study|Patient refusal|8|||
105866853|NCT00451204|365163037|FG001|Overall Study|Patient refusal|4|||
105866854|NCT00451204|365163036|FG000|Overall Study|Other|1|||
105866855|NCT00451204|365163037|FG001|Overall Study|Other|2|||
105866856|NCT00230178|365163039|FG000|Overall Study|Adverse Event|1|||
105866857|NCT00230178|365163040|FG001|Overall Study|Adverse Event|5|||
105866858|NCT00230178|365163041|FG002|Overall Study|Adverse Event|2|||
105866859|NCT00230178|365163039|FG000|Overall Study|Withdrawal by Subject|0|||
105866860|NCT00230178|365163040|FG001|Overall Study|Withdrawal by Subject|0|||
105866861|NCT00230178|365163041|FG002|Overall Study|Withdrawal by Subject|1|||
105866862|NCT00230178|365163039|FG000|Overall Study|Various other reasons|3|||
105866863|NCT00230178|365163040|FG001|Overall Study|Various other reasons|2|||
105866864|NCT00230178|365163041|FG002|Overall Study|Various other reasons|4|||
105866865|NCT00582010|365163044|FG000|Overall Study|Death|0|||
105866866|NCT00582010|365163045|FG001|Overall Study|Death|1|||
105866867|NCT04414618|365163058|FG000|Overall Study|Death|3|||
105866868|NCT04414618|365163059|FG001|Overall Study|Death|3|||
105866869|NCT04414618|365163058|FG000|Overall Study|Withdrawal by Subject|2|||
105866870|NCT04414618|365163059|FG001|Overall Study|Withdrawal by Subject|1|||
105866871|NCT04414618|365163058|FG000|Overall Study|Lost to Follow-up|2|||
105866872|NCT04414618|365163059|FG001|Overall Study|Lost to Follow-up|3|||
105866873|NCT04414618|365163058|FG000|Overall Study|Physician Decision|1|||
105866874|NCT04414618|365163059|FG001|Overall Study|Physician Decision|0|||
105866875|NCT00362336|365163060|FG000|Overall Study|Serious Adverse Event|1|||
105866876|NCT00362336|365163061|FG001|Overall Study|Serious Adverse Event|0|||
105866877|NCT00362336|365163062|FG002|Overall Study|Serious Adverse Event|1|||
105866878|NCT00362336|365163060|FG000|Overall Study|Protocol Violation|0|||
105866879|NCT00362336|365163061|FG001|Overall Study|Protocol Violation|0|||
105866880|NCT00362336|365163062|FG002|Overall Study|Protocol Violation|1|||
105866881|NCT00362336|365163060|FG000|Overall Study|Lost to Follow-up|6|||
105866882|NCT00362336|365163061|FG001|Overall Study|Lost to Follow-up|4|||
105866883|NCT00362336|365163062|FG002|Overall Study|Lost to Follow-up|0|||
105866884|NCT00362336|365163060|FG000|Overall Study|Withdrawal by Subject|3|||
105866885|NCT00362336|365163061|FG001|Overall Study|Withdrawal by Subject|3|||
105866886|NCT00362336|365163062|FG002|Overall Study|Withdrawal by Subject|1|||
105866887|NCT02463357|365163063|FG000|Overall Study|Withdrawal by Subject|1|||
105866888|NCT02463357|365163064|FG001|Overall Study|Withdrawal by Subject|0|||
105866889|NCT02463357|365163065|FG002|Overall Study|Withdrawal by Subject|0|||
105866890|NCT02463357|365163066|FG003|Overall Study|Withdrawal by Subject|0|||
105866891|NCT02463357|365163067|FG004|Overall Study|Withdrawal by Subject|0|||
105866892|NCT02463357|365163063|FG000|Overall Study|Withdrawal by Subject|0|||
105866893|NCT02463357|365163064|FG001|Overall Study|Withdrawal by Subject|0|||
105866894|NCT02463357|365163065|FG002|Overall Study|Withdrawal by Subject|0|||
105866895|NCT02463357|365163066|FG003|Overall Study|Withdrawal by Subject|0|||
106076690|NCT02945410|365946441|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
106076691|NCT02945410|365946442|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
106076692|NCT02945410|365946443|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
106076693|NCT02945410|365946444|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
105866896|NCT02463357|365163067|FG004|Overall Study|Withdrawal by Subject|1|||
105866897|NCT01121562|365163068|FG000|Overall Study|Objective progression or relapse|8|||
105866898|NCT01121562|365163068|FG000|Overall Study|Withdrawal by Subject|1|||
105866899|NCT01121562|365163068|FG000|Overall Study|Adverse Event|1|||
105866900|NCT01121562|365163068|FG000|Overall Study|Sponsor Decision|1|||
105866901|NCT01121562|365163068|FG000|Overall Study|Met study discontinuation criteria|1|||
106076694|NCT02945410|365946445|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
106076695|NCT02476968|365946448|FG000|Overall Study|Other|0|||
106076696|NCT02476968|365946449|FG001|Overall Study|Other|2|||
105866902|NCT00616421|365163073|FG000|Overall Study|Withdrawal by Subject|9|||
106076697|NCT02476968|365946450|FG002|Overall Study|Other|0|||
105866903|NCT00616421|365163074|FG001|Overall Study|Withdrawal by Subject|11|||
105866904|NCT00616421|365163075|FG002|Overall Study|Withdrawal by Subject|8|||
105866905|NCT00616421|365163073|FG000|Overall Study|Lost to Follow-up|12|||
106076698|NCT02476968|365946448|FG000|Overall Study|Lost to Follow-up|10|||
106076699|NCT02476968|365946449|FG001|Overall Study|Lost to Follow-up|0|||
105866906|NCT00616421|365163074|FG001|Overall Study|Lost to Follow-up|26|||
105866907|NCT00616421|365163075|FG002|Overall Study|Lost to Follow-up|30|||
105866908|NCT00616421|365163073|FG000|Overall Study|Inappropriate enrollment|3|||
105866909|NCT00616421|365163074|FG001|Overall Study|Inappropriate enrollment|0|||
105866910|NCT00616421|365163075|FG002|Overall Study|Inappropriate enrollment|1|||
105866911|NCT00616421|365163073|FG000|Overall Study|Administrative reason|1|||
105866912|NCT00616421|365163074|FG001|Overall Study|Administrative reason|0|||
105866913|NCT00616421|365163075|FG002|Overall Study|Administrative reason|0|||
106076700|NCT02476968|365946450|FG002|Overall Study|Lost to Follow-up|1|||
106076701|NCT02476968|365946448|FG000|Overall Study|Death|48|||
106076702|NCT02476968|365946449|FG001|Overall Study|Death|8|||
106076703|NCT02476968|365946450|FG002|Overall Study|Death|1|||
106076704|NCT02476968|365946448|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
106076705|NCT02476968|365946449|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
106076706|NCT02476968|365946450|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
106076707|NCT02476968|365946448|FG000|Overall Study|Patient decision|37|||
106076708|NCT02476968|365946449|FG001|Overall Study|Patient decision|8|||
106076709|NCT02476968|365946450|FG002|Overall Study|Patient decision|0|||
106076710|NCT03848845|365946451|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
106076711|NCT03848845|365946452|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
106076712|NCT03848845|365946453|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
106076713|NCT03848845|365946454|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
106076714|NCT03848845|365946451|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
106076715|NCT03848845|365946452|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
106076716|NCT03848845|365946453|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
106076717|NCT03848845|365946454|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
106076718|NCT03848845|365946451|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
106076719|NCT03848845|365946452|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
106076720|NCT03848845|365946453|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
106076721|NCT03848845|365946454|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
106076722|NCT03848845|365946451|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
106076723|NCT03848845|365946452|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
106076724|NCT03848845|365946453|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
106158990|NCT04353661|366245289|FG002|Overall Study|Study termination by the Sponsor|1|||
106158991|NCT03131648|366245290|FG000|Initial Treatment Period|Not dosed|2|||
106158992|NCT03131648|366245291|FG001|Initial Treatment Period|Not dosed|2|||
106158993|NCT03131648|366245292|FG002|Initial Treatment Period|Not dosed|0|||
106158994|NCT03131648|366245293|FG003|Initial Treatment Period|Not dosed|0|||
106158995|NCT03131648|366245294|FG004|Initial Treatment Period|Not dosed|0|||
106158996|NCT03131648|366245295|FG005|Initial Treatment Period|Not dosed|0|||
106158997|NCT03131648|366245296|FG006|Initial Treatment Period|Not dosed|0|||
106158998|NCT03131648|366245297|FG007|Initial Treatment Period|Not dosed|0|||
106158999|NCT03131648|366245290|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
106159000|NCT03131648|366245291|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
106159001|NCT03131648|366245292|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
106159002|NCT03131648|366245293|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
106159003|NCT03131648|366245294|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
106159004|NCT03131648|366245295|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
106159005|NCT03131648|366245296|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
106159006|NCT03131648|366245297|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
106159007|NCT03131648|366245290|FG000|Open-label Treatment|Discontinued IMP|0|||
106159008|NCT03131648|366245291|FG001|Open-label Treatment|Discontinued IMP|0|||
106159009|NCT03131648|366245292|FG002|Open-label Treatment|Discontinued IMP|0|||
106159010|NCT03131648|366245293|FG003|Open-label Treatment|Discontinued IMP|0|||
106159011|NCT03131648|366245294|FG004|Open-label Treatment|Discontinued IMP|0|||
106159012|NCT03131648|366245295|FG005|Open-label Treatment|Discontinued IMP|0|||
106159013|NCT03131648|366245296|FG006|Open-label Treatment|Discontinued IMP|112|||
106159014|NCT03131648|366245297|FG007|Open-label Treatment|Discontinued IMP|0|||
106159015|NCT03131648|366245290|FG000|Open-label Treatment|Completed Week 50|0|||
106159016|NCT03131648|366245291|FG001|Open-label Treatment|Completed Week 50|0|||
106159017|NCT03131648|366245292|FG002|Open-label Treatment|Completed Week 50|0|||
106159018|NCT03131648|366245293|FG003|Open-label Treatment|Completed Week 50|0|||
106159019|NCT03131648|366245294|FG004|Open-label Treatment|Completed Week 50|0|||
106159020|NCT03131648|366245295|FG005|Open-label Treatment|Completed Week 50|0|||
106159021|NCT03131648|366245296|FG006|Open-label Treatment|Completed Week 50|6|||
106159022|NCT03131648|366245297|FG007|Open-label Treatment|Completed Week 50|0|||
106159023|NCT03131648|366245290|FG000|Maintenance Treatment Period|Not dosed|0|||
106159024|NCT03131648|366245291|FG001|Maintenance Treatment Period|Not dosed|0|||
106159025|NCT03131648|366245292|FG002|Maintenance Treatment Period|Not dosed|3|||
106159026|NCT03131648|366245293|FG003|Maintenance Treatment Period|Not dosed|2|||
106159027|NCT03131648|366245294|FG004|Maintenance Treatment Period|Not dosed|1|||
106159028|NCT03131648|366245295|FG005|Maintenance Treatment Period|Not dosed|0|||
106159029|NCT03131648|366245296|FG006|Maintenance Treatment Period|Not dosed|0|||
106159030|NCT03131648|366245297|FG007|Maintenance Treatment Period|Not dosed|0|||
106159031|NCT03131648|366245290|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
106159032|NCT03131648|366245291|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
106159033|NCT03131648|366245292|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
106159034|NCT03131648|366245293|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
106159035|NCT03131648|366245294|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
105866914|NCT00616421|365163073|FG000|Overall Study|Protocol Violation|0|||
105866915|NCT00616421|365163074|FG001|Overall Study|Protocol Violation|1|||
105866916|NCT00616421|365163075|FG002|Overall Study|Protocol Violation|2|||
105866917|NCT00616421|365163073|FG000|Overall Study|Unable to classify|1|||
105866918|NCT00616421|365163074|FG001|Overall Study|Unable to classify|0|||
105866919|NCT00616421|365163075|FG002|Overall Study|Unable to classify|0|||
105866920|NCT01495702|365163076|FG000|Randomized Phase|Randomized But Not Treated|1|||
105866921|NCT01495702|365163077|FG001|Randomized Phase|Randomized But Not Treated|4|||
105866922|NCT01495702|365163076|FG000|Randomized Phase|Adverse Event|2|||
105866923|NCT01495702|365163077|FG001|Randomized Phase|Adverse Event|2|||
105866924|NCT01495702|365163076|FG000|Randomized Phase|Death|1|||
105866925|NCT01495702|365163077|FG001|Randomized Phase|Death|0|||
105866926|NCT01495702|365163076|FG000|Randomized Phase|Lack of Efficacy|2|||
105866927|NCT01495702|365163077|FG001|Randomized Phase|Lack of Efficacy|0|||
105866928|NCT01495702|365163076|FG000|Randomized Phase|Investigators Discretion|2|||
105866929|NCT01495702|365163077|FG001|Randomized Phase|Investigators Discretion|0|||
105866930|NCT01495702|365163076|FG000|Randomized Phase|Withdrew Consent|10|||
105866931|NCT01495702|365163077|FG001|Randomized Phase|Withdrew Consent|18|||
105866932|NCT01495702|365163076|FG000|Randomized Phase|Lost to Follow-up|4|||
105866933|NCT01495702|365163077|FG001|Randomized Phase|Lost to Follow-up|3|||
105866934|NCT01495702|365163076|FG000|Randomized Phase|Participant Noncompliance|1|||
105866935|NCT01495702|365163077|FG001|Randomized Phase|Participant Noncompliance|0|||
105866936|NCT01495702|365163076|FG000|Randomized Phase|Protocol Violation|3|||
105866937|NCT01495702|365163077|FG001|Randomized Phase|Protocol Violation|1|||
105866938|NCT04152863|365163078|FG000|Overall Study|Death|13|||
105866939|NCT04152863|365163079|FG001|Overall Study|Death|12|||
105866940|NCT04152863|365163080|FG002|Overall Study|Death|7|||
105866941|NCT04152863|365163078|FG000|Overall Study|Physician Decision|1|||
105866942|NCT04152863|365163079|FG001|Overall Study|Physician Decision|1|||
105866943|NCT04152863|365163080|FG002|Overall Study|Physician Decision|1|||
105866944|NCT04152863|365163078|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
105866945|NCT04152863|365163079|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
105866946|NCT04152863|365163080|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
105866947|NCT04152863|365163078|FG000|Overall Study|Withdrawal by Subject|2|||
105866948|NCT04152863|365163079|FG001|Overall Study|Withdrawal by Subject|1|||
105866949|NCT04152863|365163080|FG002|Overall Study|Withdrawal by Subject|3|||
105866950|NCT02661217|365163087|FG000|Overall Study|Physician Decision|12|||
105866951|NCT02661217|365163088|FG001|Overall Study|Physician Decision|15|||
105866952|NCT02661217|365163087|FG000|Overall Study|Lost to Follow-up|1|||
105866953|NCT02661217|365163088|FG001|Overall Study|Lost to Follow-up|4|||
105866954|NCT02661217|365163087|FG000|Overall Study|Protocol Deviation|0|||
105866955|NCT02661217|365163088|FG001|Overall Study|Protocol Deviation|4|||
105866956|NCT02661217|365163087|FG000|Overall Study|Non-compliance with study treatment|5|||
105866957|NCT02661217|365163088|FG001|Overall Study|Non-compliance with study treatment|5|||
105866958|NCT02661217|365163087|FG000|Overall Study|Death|21|||
105866959|NCT02661217|365163088|FG001|Overall Study|Death|15|||
105866960|NCT02661217|365163087|FG000|Overall Study|Adverse Event|10|||
105866961|NCT02661217|365163088|FG001|Overall Study|Adverse Event|8|||
105866962|NCT02661217|365163087|FG000|Overall Study|Withdrawal by Subject|15|||
105866963|NCT02661217|365163088|FG001|Overall Study|Withdrawal by Subject|19|||
105866964|NCT02661217|365163087|FG000|Overall Study|Did not enter follow-up epoch|7|||
105866965|NCT02661217|365163088|FG001|Overall Study|Did not enter follow-up epoch|10|||
105866966|NCT02661217|365163087|FG000|Overall Study|Death - no study drug received|1|||
105866967|NCT02661217|365163088|FG001|Overall Study|Death - no study drug received|2|||
105866968|NCT02661217|365163087|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
105866969|NCT02661217|365163088|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
105866970|NCT01644617|365163089|FG000|Overall Study|Withdrawal by Subject|3|||
105866971|NCT01644617|365163090|FG001|Overall Study|Withdrawal by Subject|4|||
105866972|NCT01644617|365163091|FG002|Overall Study|Withdrawal by Subject|1|||
105866973|NCT01644617|365163089|FG000|Overall Study|Lost to Follow-up|0|||
105866974|NCT01644617|365163090|FG001|Overall Study|Lost to Follow-up|1|||
106076725|NCT03848845|365946454|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
105866975|NCT01644617|365163091|FG002|Overall Study|Lost to Follow-up|0|||
105866976|NCT01644617|365163089|FG000|Overall Study|Adverse Event|3|||
105866977|NCT01644617|365163090|FG001|Overall Study|Adverse Event|0|||
105866978|NCT01644617|365163091|FG002|Overall Study|Adverse Event|6|||
105866979|NCT00444587|365163095|FG000|Overall Study|Death|2|||
106076726|NCT02256891|365946457|FG000|Overall Study|Death|0|||
106076727|NCT02256891|365946458|FG001|Overall Study|Death|2|||
105866980|NCT00444587|365163096|FG001|Overall Study|Death|1|||
105866981|NCT00444587|365163095|FG000|Overall Study|Progression of the disease|73|||
106076728|NCT02256891|365946457|FG000|Overall Study|Lost to Follow-up|0|||
105866982|NCT00444587|365163096|FG001|Overall Study|Progression of the disease|8|||
105866983|NCT00444587|365163095|FG000|Overall Study|Refused treatment/did not cooperate|4|||
106076729|NCT02256891|365946458|FG001|Overall Study|Lost to Follow-up|3|||
105866984|NCT00444587|365163096|FG001|Overall Study|Refused treatment/did not cooperate|1|||
106076730|NCT02256891|365946457|FG000|Overall Study|Physician Decision|7|||
106076731|NCT02256891|365946458|FG001|Overall Study|Physician Decision|3|||
106076732|NCT02256891|365946457|FG000|Overall Study|Screen Fail|5|||
106076733|NCT02256891|365946458|FG001|Overall Study|Screen Fail|4|||
106076734|NCT02256891|365946457|FG000|Overall Study|Equipment Malfunction|0|||
106076735|NCT02256891|365946458|FG001|Overall Study|Equipment Malfunction|1|||
106076736|NCT00097721|365946463|FG000|Overall Study|Adverse Event|8|||
106076737|NCT00097721|365946464|FG001|Overall Study|Adverse Event|1|||
106076738|NCT00097721|365946463|FG000|Overall Study|Withdrawal by Subject|6|||
106076739|NCT00097721|365946464|FG001|Overall Study|Withdrawal by Subject|1|||
106076740|NCT00097721|365946463|FG000|Overall Study|Progressive Disease|55|||
106076741|NCT00097721|365946464|FG001|Overall Study|Progressive Disease|27|||
106076742|NCT00097721|365946463|FG000|Overall Study|Physician Decision|1|||
106076743|NCT00097721|365946464|FG001|Overall Study|Physician Decision|3|||
106076744|NCT00097721|365946463|FG000|Overall Study|Reason not given|1|||
106076745|NCT00097721|365946464|FG001|Overall Study|Reason not given|1|||
106076746|NCT00449956|365946465|FG000|Overall Study|Adverse Event|7|||
106076747|NCT00449956|365946466|FG001|Overall Study|Adverse Event|1|||
106076748|NCT00449956|365946467|FG002|Overall Study|Adverse Event|6|||
106076749|NCT00449956|365946465|FG000|Overall Study|Lack of Efficacy|0|||
106076750|NCT00449956|365946466|FG001|Overall Study|Lack of Efficacy|0|||
106076751|NCT00449956|365946467|FG002|Overall Study|Lack of Efficacy|1|||
106076752|NCT00449956|365946465|FG000|Overall Study|Protocol Violation|1|||
106076753|NCT00449956|365946466|FG001|Overall Study|Protocol Violation|1|||
106076754|NCT00449956|365946467|FG002|Overall Study|Protocol Violation|1|||
106076755|NCT00449956|365946465|FG000|Overall Study|Withdrawal by Subject|0|||
106076756|NCT00449956|365946466|FG001|Overall Study|Withdrawal by Subject|1|||
106076757|NCT00449956|365946467|FG002|Overall Study|Withdrawal by Subject|0|||
106076758|NCT00449956|365946465|FG000|Overall Study|Physician Decision|2|||
106076759|NCT00449956|365946466|FG001|Overall Study|Physician Decision|1|||
106076760|NCT00449956|365946467|FG002|Overall Study|Physician Decision|1|||
106076761|NCT02852265|365946468|FG000|3-month Follow-up|Lost to Follow-up|1|||
106076762|NCT02852265|365946469|FG001|3-month Follow-up|Lost to Follow-up|1|||
106076763|NCT01907828|365946487|FG000|Overall Study|Exclusion criteria not met|0|||
106076764|NCT01907828|365946488|FG001|Overall Study|Exclusion criteria not met|1|||
106076765|NCT01907828|365946487|FG000|Overall Study|Withdrawal by Subject|3|||
106076766|NCT01907828|365946488|FG001|Overall Study|Withdrawal by Subject|4|||
106076767|NCT01907828|365946487|FG000|Overall Study|Lost to Follow-up|3|||
106076768|NCT01907828|365946488|FG001|Overall Study|Lost to Follow-up|0|||
106076769|NCT01907828|365946487|FG000|Overall Study|Participant refused 24-month follow-up|1|||
106076770|NCT01907828|365946488|FG001|Overall Study|Participant refused 24-month follow-up|0|||
106076771|NCT01907828|365946487|FG000|Overall Study|Participant met exclusion criteria|0|||
106076772|NCT01907828|365946488|FG001|Overall Study|Participant met exclusion criteria|1|||
106076773|NCT02547129|365946489|FG000|Overall Study|Difficulty with ongoing infection|1|||
106076774|NCT02547129|365946490|FG001|Overall Study|Difficulty with ongoing infection|0|||
106076775|NCT00794196|365946492|FG000|Overall Study|Lost to Follow-up|5|||
106076776|NCT00794196|365946493|FG001|Overall Study|Lost to Follow-up|23|||
106076777|NCT00850395|365946498|FG000|Overall Study|Death|1|||
106076778|NCT00850395|365946498|FG000|Overall Study|Adverse Event|1|||
106076779|NCT00850395|365946498|FG000|Overall Study|Insufficient clinical response|3|||
106076780|NCT00850395|365946498|FG000|Overall Study|Other|5|||
106076781|NCT01354496|365946501|FG000|Period 1|Adverse Event|0|||
106076782|NCT01354496|365946502|FG001|Period 1|Adverse Event|0|||
106076783|NCT01354496|365946503|FG002|Period 1|Adverse Event|1|||
106076784|NCT01354496|365946504|FG003|Period 1|Adverse Event|0|||
106076785|NCT01354496|365946505|FG004|Period 1|Adverse Event|0|||
106076786|NCT01354496|365946506|FG005|Period 1|Adverse Event|0|||
106076787|NCT01354496|365946501|FG000|Period 1|Physician Decision|0|||
106076788|NCT01354496|365946502|FG001|Period 1|Physician Decision|0|||
106076789|NCT01354496|365946503|FG002|Period 1|Physician Decision|1|||
106076790|NCT01354496|365946504|FG003|Period 1|Physician Decision|0|||
106076791|NCT01354496|365946505|FG004|Period 1|Physician Decision|0|||
106076792|NCT01354496|365946506|FG005|Period 1|Physician Decision|0|||
106076793|NCT01354496|365946501|FG000|Period 2|Adverse Event|0|||
106076794|NCT01354496|365946502|FG001|Period 2|Adverse Event|0|||
106076795|NCT01354496|365946503|FG002|Period 2|Adverse Event|0|||
106076796|NCT01354496|365946504|FG003|Period 2|Adverse Event|1|||
106076797|NCT01354496|365946505|FG004|Period 2|Adverse Event|0|||
106076798|NCT01354496|365946506|FG005|Period 2|Adverse Event|0|||
106076799|NCT01354496|365946501|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
106076800|NCT01354496|365946502|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
106076801|NCT01354496|365946503|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
106076802|NCT01354496|365946504|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
106076803|NCT01354496|365946505|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
106076804|NCT01354496|365946506|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
106076805|NCT03216850|365946507|FG000|Overall Study|Pre-analytical error|6|||
106076806|NCT00500292|365946508|FG000|Overall Study|Adverse Event|3|||
106076807|NCT00500292|365946509|FG001|Overall Study|Adverse Event|6|||
106076808|NCT00500292|365946510|FG002|Overall Study|Adverse Event|4|||
106076809|NCT00500292|365946508|FG000|Overall Study|Condition under investigation worsened|21|||
106159036|NCT03131648|366245295|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
105866985|NCT00444587|365163095|FG000|Overall Study|Investigator decision|3|||
105866986|NCT00444587|365163096|FG001|Overall Study|Investigator decision|0|||
105866987|NCT00444587|365163095|FG000|Overall Study|Protocol Violation|1|||
105866988|NCT00444587|365163096|FG001|Overall Study|Protocol Violation|0|||
105866989|NCT00444587|365163095|FG000|Overall Study|Missing|0|||
106076810|NCT00500292|365946509|FG001|Overall Study|Condition under investigation worsened|23|||
106076811|NCT00500292|365946510|FG002|Overall Study|Condition under investigation worsened|19|||
106076812|NCT00500292|365946508|FG000|Overall Study|Withdrawal by Subject|0|||
106076813|NCT00500292|365946509|FG001|Overall Study|Withdrawal by Subject|1|||
106076814|NCT00500292|365946510|FG002|Overall Study|Withdrawal by Subject|0|||
106076815|NCT00500292|365946508|FG000|Overall Study|Other|1|||
106076816|NCT00500292|365946509|FG001|Overall Study|Other|1|||
106076817|NCT00500292|365946510|FG002|Overall Study|Other|4|||
106076818|NCT01894152|365946511|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
106076819|NCT00811577|365946512|FG000|Overall Study|Lost to Follow-up|7|||
106076820|NCT00811577|365946513|FG001|Overall Study|Lost to Follow-up|1|||
106076821|NCT00811577|365946512|FG000|Overall Study|Withdrawal by Subject|3|||
106076822|NCT00811577|365946513|FG001|Overall Study|Withdrawal by Subject|0|||
106076823|NCT04011410|365946516|FG000|Overall Study|Withdrawal by Subject|1|||
106076824|NCT01068509|365946517|FG000|Overall Study|Death|0|||
106076825|NCT01068509|365946518|FG001|Overall Study|Death|0|||
106076826|NCT01068509|365946519|FG002|Overall Study|Death|1|||
106076827|NCT01068509|365946517|FG000|Overall Study|Disease Progression|5|||
106076828|NCT01068509|365946518|FG001|Overall Study|Disease Progression|20|||
106076829|NCT01068509|365946519|FG002|Overall Study|Disease Progression|18|||
106076830|NCT01068509|365946517|FG000|Overall Study|Lost to Follow-up|1|||
106076831|NCT01068509|365946518|FG001|Overall Study|Lost to Follow-up|0|||
106076832|NCT01068509|365946519|FG002|Overall Study|Lost to Follow-up|0|||
106076833|NCT01068509|365946517|FG000|Overall Study|Withdrew Consent|0|||
106076834|NCT01068509|365946518|FG001|Overall Study|Withdrew Consent|1|||
106076835|NCT01068509|365946519|FG002|Overall Study|Withdrew Consent|2|||
106076836|NCT01068509|365946517|FG000|Overall Study|Reason Not Specified|0|||
106076837|NCT01068509|365946518|FG001|Overall Study|Reason Not Specified|1|||
106076838|NCT01068509|365946519|FG002|Overall Study|Reason Not Specified|0|||
106076839|NCT03465878|365946539|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
106076840|NCT03465878|365946540|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
106076841|NCT03465878|365946541|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
106076842|NCT03465878|365946542|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
106076843|NCT03465878|365946539|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
106076844|NCT03465878|365946540|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
106076845|NCT03465878|365946541|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
106076846|NCT03465878|365946542|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
106076847|NCT03465878|365946539|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
106076848|NCT03465878|365946540|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
106076849|NCT03465878|365946541|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
106076850|NCT03465878|365946542|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
106076851|NCT01524627|365946543|FG000|Overall Study|Physician Decision|0|||
106076852|NCT01524627|365946544|FG001|Overall Study|Physician Decision|1|||
106076853|NCT01524627|365946543|FG000|Overall Study|Lost to Follow-up|1|||
106076854|NCT01524627|365946544|FG001|Overall Study|Lost to Follow-up|1|||
106076855|NCT00969553|365946545|FG000|Overall Study|Progressive disease (PD)|2|||
106076856|NCT00969553|365946546|FG001|Overall Study|Progressive disease (PD)|2|||
106076857|NCT00969553|365946547|FG002|Overall Study|Progressive disease (PD)|6|||
106076858|NCT00969553|365946548|FG003|Overall Study|Progressive disease (PD)|9|||
106076859|NCT00969553|365946549|FG004|Overall Study|Progressive disease (PD)|2|||
106076860|NCT00969553|365946550|FG005|Overall Study|Progressive disease (PD)|4|||
106076861|NCT00969553|365946551|FG006|Overall Study|Progressive disease (PD)|2|||
106076862|NCT00969553|365946552|FG007|Overall Study|Progressive disease (PD)|12|||
106076863|NCT00969553|365946553|FG008|Overall Study|Progressive disease (PD)|3|||
106076864|NCT00969553|365946545|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
106076865|NCT00969553|365946546|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
106076866|NCT00969553|365946547|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
106076867|NCT00969553|365946548|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
106076868|NCT00969553|365946549|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
106076869|NCT00969553|365946550|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
106076870|NCT00969553|365946551|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
106076871|NCT00969553|365946552|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
106076872|NCT00969553|365946553|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
106076873|NCT00969553|365946545|FG000|Overall Study|Other Adverse Event|0|||
106076874|NCT00969553|365946546|FG001|Overall Study|Other Adverse Event|0|||
106159037|NCT03131648|366245296|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
105866990|NCT00444587|365163096|FG001|Overall Study|Missing|5|||
106159038|NCT03131648|366245297|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
105866991|NCT01720225|365163097|FG000|Overall Study|Withdrawal by Subject|0|||
105866992|NCT01720225|365163098|FG001|Overall Study|Withdrawal by Subject|1|||
105866993|NCT01720225|365163097|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
105866994|NCT01720225|365163098|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
105866995|NCT01372748|365163099|FG000|Overall Study|Lost to Follow-up|16|||
105866996|NCT01372748|365163100|FG001|Overall Study|Lost to Follow-up|34|||
105866997|NCT01372748|365163099|FG000|Overall Study|Withdrawal by Subject|7|||
106076875|NCT00969553|365946547|FG002|Overall Study|Other Adverse Event|0|||
106076876|NCT00969553|365946548|FG003|Overall Study|Other Adverse Event|1|||
106076877|NCT00969553|365946549|FG004|Overall Study|Other Adverse Event|0|||
106076878|NCT00969553|365946550|FG005|Overall Study|Other Adverse Event|0|||
106076879|NCT00969553|365946551|FG006|Overall Study|Other Adverse Event|1|||
106076880|NCT00969553|365946552|FG007|Overall Study|Other Adverse Event|0|||
106076881|NCT00969553|365946553|FG008|Overall Study|Other Adverse Event|0|||
106076882|NCT00969553|365946545|FG000|Overall Study|Refused cont. medication|1|||
106076883|NCT00969553|365946546|FG001|Overall Study|Refused cont. medication|1|||
106076884|NCT00969553|365946547|FG002|Overall Study|Refused cont. medication|0|||
106076885|NCT00969553|365946548|FG003|Overall Study|Refused cont. medication|2|||
106076886|NCT00969553|365946549|FG004|Overall Study|Refused cont. medication|0|||
106076887|NCT00969553|365946550|FG005|Overall Study|Refused cont. medication|0|||
106159039|NCT03131648|366245290|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
106159040|NCT03131648|366245291|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
106159041|NCT03131648|366245292|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
106159042|NCT03131648|366245293|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
106159043|NCT03131648|366245294|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
106159044|NCT03131648|366245295|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
106159045|NCT03131648|366245296|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
106159046|NCT03131648|366245297|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
106159047|NCT03131648|366245290|FG000|Maintenance Treatment Period|Completed Week 50|0|||
106159048|NCT03131648|366245291|FG001|Maintenance Treatment Period|Completed Week 50|0|||
106159049|NCT03131648|366245292|FG002|Maintenance Treatment Period|Completed Week 50|0|||
106159050|NCT03131648|366245293|FG003|Maintenance Treatment Period|Completed Week 50|0|||
106159051|NCT03131648|366245294|FG004|Maintenance Treatment Period|Completed Week 50|1|||
106159052|NCT03131648|366245295|FG005|Maintenance Treatment Period|Completed Week 50|0|||
106159053|NCT03131648|366245296|FG006|Maintenance Treatment Period|Completed Week 50|0|||
106159054|NCT03131648|366245297|FG007|Maintenance Treatment Period|Completed Week 50|0|||
106159055|NCT03131648|366245290|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
106159056|NCT03131648|366245291|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
106159057|NCT03131648|366245292|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
106159058|NCT03131648|366245293|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
106159059|NCT03131648|366245294|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
106159060|NCT03131648|366245295|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
106159061|NCT03131648|366245296|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
106159062|NCT03131648|366245297|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
106159063|NCT04956861|366245304|FG000|Overall Study|Withdrawal by Subject|4|||
106159064|NCT04956861|366245305|FG001|Overall Study|Withdrawal by Subject|4|||
106159065|NCT04956861|366245306|FG002|Overall Study|Withdrawal by Subject|2|||
106159066|NCT04956861|366245304|FG000|Overall Study|Physician Decision|4|||
106159067|NCT04956861|366245305|FG001|Overall Study|Physician Decision|5|||
106159068|NCT04956861|366245306|FG002|Overall Study|Physician Decision|1|||
106159069|NCT05229120|366245311|FG000|Overall Study|Withdrawal by Subject|8|||
106159070|NCT05862870|366245312|FG000|Overall Study|Lost to Follow-up|3|||
106159071|NCT02312557|366245315|FG000|Overall Study|Survival follow-up|4|||
106159072|NCT04237298|366245316|FG000|Overall Study|Lost to Follow-up|4|||
106159073|NCT04237298|366245317|FG001|Overall Study|Lost to Follow-up|5|||
106159074|NCT05247489|366245318|FG000|Overall Study|Lost to Follow-up|5|||
106159075|NCT05247489|366245319|FG001|Overall Study|Lost to Follow-up|1|||
106159076|NCT05247489|366245318|FG000|Overall Study|Withdrawal by Subject|6|||
106159077|NCT05247489|366245319|FG001|Overall Study|Withdrawal by Subject|7|||
106159078|NCT05247489|366245318|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
106159079|NCT05247489|366245319|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
106159080|NCT05247489|366245318|FG000|Overall Study|Left Country|1|||
106159081|NCT05247489|366245319|FG001|Overall Study|Left Country|0|||
106159082|NCT05247489|366245318|FG000|Overall Study|Noncompliance with Investigational Product|1|||
106159083|NCT05247489|366245319|FG001|Overall Study|Noncompliance with Investigational Product|0|||
106159084|NCT05247489|366245318|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
106159085|NCT05247489|366245319|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
106159086|NCT03771898|366245320|FG000|Overall Study|Adverse Event|1|||
106159087|NCT03771898|366245321|FG001|Overall Study|Adverse Event|0|||
106159088|NCT03771898|366245322|FG002|Overall Study|Adverse Event|0|||
105866998|NCT01372748|365163100|FG001|Overall Study|Withdrawal by Subject|5|||
106076888|NCT00969553|365946551|FG006|Overall Study|Refused cont. medication|0|||
106159089|NCT03771898|366245323|FG003|Overall Study|Adverse Event|0|||
106159090|NCT03771898|366245324|FG004|Overall Study|Adverse Event|0|||
106159091|NCT03771898|366245320|FG000|Overall Study|Lost to Follow-up|1|||
106159092|NCT03771898|366245321|FG001|Overall Study|Lost to Follow-up|1|||
106159093|NCT03771898|366245322|FG002|Overall Study|Lost to Follow-up|1|||
106159094|NCT03771898|366245323|FG003|Overall Study|Lost to Follow-up|0|||
106159095|NCT03771898|366245324|FG004|Overall Study|Lost to Follow-up|0|||
106159096|NCT03771898|366245320|FG000|Overall Study|Withdrawal by parent/guardian|1|||
106159097|NCT03771898|366245321|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106159098|NCT03771898|366245322|FG002|Overall Study|Withdrawal by parent/guardian|0|||
106159099|NCT03771898|366245323|FG003|Overall Study|Withdrawal by parent/guardian|0|||
106159100|NCT03771898|366245324|FG004|Overall Study|Withdrawal by parent/guardian|0|||
106159101|NCT03771898|366245320|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
106159102|NCT03771898|366245321|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
106159103|NCT03771898|366245322|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
106159104|NCT03771898|366245323|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
106159105|NCT03771898|366245324|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
106159106|NCT01415154|366245325|FG000|Overall Study|Lack of Efficacy|4|||
106159107|NCT01415154|366245326|FG001|Overall Study|Lack of Efficacy|5|||
106159108|NCT01415154|366245325|FG000|Overall Study|Withdrawal by Subject|7|||
106159109|NCT01415154|366245326|FG001|Overall Study|Withdrawal by Subject|8|||
106159110|NCT01415154|366245325|FG000|Overall Study|Lost to Follow-up|1|||
106159111|NCT01415154|366245326|FG001|Overall Study|Lost to Follow-up|4|||
106159112|NCT01415154|366245325|FG000|Overall Study|Protocol Violation|0|||
106159113|NCT01415154|366245326|FG001|Overall Study|Protocol Violation|1|||
106159114|NCT01415154|366245325|FG000|Overall Study|Satisfactory Response|0|||
106159115|NCT01415154|366245326|FG001|Overall Study|Satisfactory Response|1|||
106159116|NCT01415154|366245325|FG000|Overall Study|Adverse Event|1|||
106159117|NCT01415154|366245326|FG001|Overall Study|Adverse Event|1|||
106159118|NCT04556656|366245327|FG000|Overall Study|Withdrawal by Subject|14|||
106159119|NCT04556656|366245328|FG001|Overall Study|Withdrawal by Subject|12|||
106159120|NCT04556656|366245327|FG000|Overall Study|Physician Decision|1|||
106159121|NCT04556656|366245328|FG001|Overall Study|Physician Decision|0|||
106159122|NCT04556656|366245327|FG000|Overall Study|Adverse Event|4|||
106159123|NCT04556656|366245328|FG001|Overall Study|Adverse Event|7|||
106159124|NCT04556656|366245327|FG000|Overall Study|Death|4|||
106159125|NCT04556656|366245328|FG001|Overall Study|Death|0|||
106159126|NCT04556656|366245327|FG000|Overall Study|Lost to Follow-up|3|||
106159127|NCT04556656|366245328|FG001|Overall Study|Lost to Follow-up|2|||
106159128|NCT04556656|366245327|FG000|Overall Study|Not further specified|2|||
106159129|NCT04556656|366245328|FG001|Overall Study|Not further specified|1|||
106159130|NCT06283173|366245332|FG000|Overall Study|Did not show for first visit|10|||
106159131|NCT06283173|366245332|FG000|Overall Study|Lost to Follow-up|12|||
106159132|NCT06283173|366245332|FG000|Overall Study|Physician Decision|7|||
106159133|NCT03615326|366245339|FG000|Overall Study|Death|266|||
106159134|NCT03615326|366245340|FG001|Overall Study|Death|286|||
106159135|NCT03615326|366245341|FG002|Overall Study|Death|14|||
106159136|NCT03615326|366245342|FG003|Overall Study|Death|17|||
106159137|NCT03615326|366245339|FG000|Overall Study|Lost to Follow-up|0|||
106159138|NCT03615326|366245340|FG001|Overall Study|Lost to Follow-up|1|||
106159139|NCT03615326|366245341|FG002|Overall Study|Lost to Follow-up|0|||
106159140|NCT03615326|366245342|FG003|Overall Study|Lost to Follow-up|0|||
106159141|NCT03615326|366245339|FG000|Overall Study|Withdrawal by Subject|1|||
106159142|NCT03615326|366245340|FG001|Overall Study|Withdrawal by Subject|3|||
106159143|NCT03615326|366245341|FG002|Overall Study|Withdrawal by Subject|0|||
106159144|NCT03615326|366245342|FG003|Overall Study|Withdrawal by Subject|0|||
106159145|NCT03615326|366245339|FG000|Overall Study|Participants Ongoing|83|||
106159146|NCT03615326|366245340|FG001|Overall Study|Participants Ongoing|58|||
106159147|NCT03615326|366245341|FG002|Overall Study|Participants Ongoing|6|||
106159148|NCT03615326|366245342|FG003|Overall Study|Participants Ongoing|3|||
106159149|NCT01416831|366245343|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
106159150|NCT01416831|366245344|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
106159151|NCT03332017|366245348|FG000|Overall Study|Lost to Follow-up|1|||
106159152|NCT03332017|366245349|FG001|Overall Study|Lost to Follow-up|2|||
106159153|NCT03332017|366245348|FG000|Overall Study|Death|17|||
106159154|NCT03332017|366245349|FG001|Overall Study|Death|16|||
106159155|NCT03332017|366245348|FG000|Overall Study|Withdrawal by Subject|6|||
106159156|NCT03332017|366245349|FG001|Overall Study|Withdrawal by Subject|14|||
106159157|NCT03332017|366245348|FG000|Overall Study|Other|1|||
106159158|NCT03332017|366245349|FG001|Overall Study|Other|3|||
106159159|NCT03332017|366245348|FG000|Overall Study|Remained in Study (Ongoing)|47|||
106159160|NCT03332017|366245349|FG001|Overall Study|Remained in Study (Ongoing)|110|||
106159161|NCT01261312|366245350|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
106076889|NCT00969553|365946552|FG007|Overall Study|Refused cont. medication|1|||
106076890|NCT00969553|365946553|FG008|Overall Study|Refused cont. medication|0|||
106076891|NCT00969553|365946545|FG000|Overall Study|Not specified above|0|||
106076892|NCT00969553|365946546|FG001|Overall Study|Not specified above|0|||
106076893|NCT00969553|365946547|FG002|Overall Study|Not specified above|0|||
106076894|NCT00969553|365946548|FG003|Overall Study|Not specified above|4|||
106076895|NCT00969553|365946549|FG004|Overall Study|Not specified above|0|||
106076896|NCT00969553|365946550|FG005|Overall Study|Not specified above|0|||
106076897|NCT00969553|365946551|FG006|Overall Study|Not specified above|1|||
106076898|NCT00969553|365946552|FG007|Overall Study|Not specified above|1|||
106076899|NCT00969553|365946553|FG008|Overall Study|Not specified above|0|||
106076900|NCT02357147|365946555|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
106076901|NCT02357147|365946556|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
106076902|NCT02357147|365946555|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
106076903|NCT02357147|365946556|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
106076904|NCT02357147|365946555|FG000|Combination Treatment Phase|Investigator Discretion|1|||
106076905|NCT02357147|365946556|FG001|Combination Treatment Phase|Investigator Discretion|1|||
106076906|NCT02357147|365946555|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
106076907|NCT02357147|365946556|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
106076908|NCT02357147|365946555|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
106076909|NCT02357147|365946556|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
106076910|NCT02357147|365946555|FG000|Combination Treatment Phase|Adverse Event|12|||
106076911|NCT02357147|365946556|FG001|Combination Treatment Phase|Adverse Event|4|||
106076912|NCT02357147|365946555|FG000|Combination Treatment Phase|Death|1|||
106076913|NCT02357147|365946556|FG001|Combination Treatment Phase|Death|1|||
106076914|NCT02357147|365946555|FG000|Combination Treatment Phase|Sponsor Decision|0|||
106076915|NCT02357147|365946556|FG001|Combination Treatment Phase|Sponsor Decision|12|||
106076916|NCT02357147|365946555|FG000|Combination Treatment Phase|Other|1|||
106076917|NCT02357147|365946556|FG001|Combination Treatment Phase|Other|0|||
106076918|NCT02357147|365946555|FG000|Combination Treatment Phase|Not treated|0|||
106076919|NCT02357147|365946556|FG001|Combination Treatment Phase|Not treated|2|||
106076920|NCT02357147|365946555|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
106076921|NCT02357147|365946556|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
106076922|NCT02357147|365946555|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
106076923|NCT02357147|365946556|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
106076924|NCT02357147|365946555|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
106076925|NCT02357147|365946556|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
106076926|NCT02357147|365946555|FG000|Maintenance Treatment Phase|Adverse Event|0|||
106076927|NCT02357147|365946556|FG001|Maintenance Treatment Phase|Adverse Event|3|||
106076928|NCT02357147|365946555|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
106076929|NCT02357147|365946556|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
106076930|NCT02357147|365946555|FG000|Maintenance Treatment Phase|Not Treated|1|||
106076931|NCT02357147|365946556|FG001|Maintenance Treatment Phase|Not Treated|0|||
106076932|NCT00256698|365946557|FG000|Overall Study|Withdrawal by Subject|7|||
106076933|NCT00256698|365946558|FG001|Overall Study|Withdrawal by Subject|7|||
106159162|NCT01261312|366245351|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
106159163|NCT01261312|366245352|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
106159164|NCT01261312|366245353|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159165|NCT01261312|366245354|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159166|NCT01261312|366245355|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159167|NCT01261312|366245356|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159168|NCT01261312|366245357|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159169|NCT01261312|366245358|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159170|NCT01261312|366245359|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159171|NCT01261312|366245360|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159172|NCT01261312|366245361|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159173|NCT01261312|366245362|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
106159174|NCT01261312|366245350|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
106159175|NCT01261312|366245351|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
106159176|NCT01261312|366245352|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159177|NCT01261312|366245353|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159178|NCT01261312|366245354|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159179|NCT01261312|366245355|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159180|NCT01261312|366245356|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159181|NCT01261312|366245357|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106076934|NCT00256698|365946557|FG000|Overall Study|Adverse Event|13|||
106076935|NCT00256698|365946558|FG001|Overall Study|Adverse Event|6|||
106076936|NCT00256698|365946557|FG000|Overall Study|Protocol Violation|6|||
106076937|NCT00256698|365946558|FG001|Overall Study|Protocol Violation|5|||
106076938|NCT00256698|365946557|FG000|Overall Study|Lost to Follow-up|1|||
106076939|NCT00256698|365946558|FG001|Overall Study|Lost to Follow-up|3|||
106076940|NCT00256698|365946557|FG000|Overall Study|disease progression|97|||
106076941|NCT00256698|365946558|FG001|Overall Study|disease progression|105|||
106076942|NCT00256698|365946557|FG000|Overall Study|still ongoing at data cut-off|41|||
106076943|NCT00256698|365946558|FG001|Overall Study|still ongoing at data cut-off|46|||
106076944|NCT00256698|365946557|FG000|Overall Study|withdrawn due to osteoporosis|1|||
106076945|NCT00256698|365946558|FG001|Overall Study|withdrawn due to osteoporosis|0|||
106076946|NCT00256698|365946557|FG000|Overall Study|Prematurely Discontinued|1|||
106076947|NCT00256698|365946558|FG001|Overall Study|Prematurely Discontinued|0|||
106076948|NCT02620046|365946560|FG000|Overall Study|Adverse Event|22|||
106076949|NCT02620046|365946561|FG001|Overall Study|Adverse Event|42|||
106076950|NCT02620046|365946560|FG000|Overall Study|Lost to Follow-up|4|||
106076951|NCT02620046|365946561|FG001|Overall Study|Lost to Follow-up|10|||
106076952|NCT02620046|365946560|FG000|Overall Study|Withdrawal by Subject|36|||
106076953|NCT02620046|365946561|FG001|Overall Study|Withdrawal by Subject|66|||
106076954|NCT02620046|365946560|FG000|Overall Study|Site Termination|3|||
106076955|NCT02620046|365946561|FG001|Overall Study|Site Termination|3|||
106076956|NCT02620046|365946560|FG000|Overall Study|Pregnancy|3|||
106076957|NCT02620046|365946561|FG001|Overall Study|Pregnancy|7|||
106076958|NCT02620046|365946560|FG000|Overall Study|Lack of Efficacy|81|||
106076959|NCT02620046|365946561|FG001|Overall Study|Lack of Efficacy|146|||
106076960|NCT02620046|365946560|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
106076961|NCT02620046|365946561|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
106076962|NCT02620046|365946560|FG000|Overall Study|Reason Not Specified|13|||
106076963|NCT02620046|365946561|FG001|Overall Study|Reason Not Specified|21|||
106076964|NCT02620046|365946560|FG000|Overall Study|Significant Protocol Deviation|0|||
106076965|NCT02620046|365946561|FG001|Overall Study|Significant Protocol Deviation|1|||
106076966|NCT01064648|365946564|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
106076967|NCT01064648|365946565|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
106076968|NCT01064648|365946566|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
106076969|NCT01064648|365946567|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
106076970|NCT01064648|365946564|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
106076971|NCT01064648|365946565|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
106159182|NCT01261312|366245358|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159183|NCT01261312|366245359|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159184|NCT01261312|366245360|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159185|NCT01261312|366245361|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159186|NCT01261312|366245362|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
106159187|NCT01261312|366245350|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
106076972|NCT01064648|365946566|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
106076973|NCT01064648|365946567|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
106076974|NCT01064648|365946564|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
106076975|NCT01064648|365946565|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
106076976|NCT01064648|365946566|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
106076977|NCT01064648|365946567|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
106076978|NCT01064648|365946564|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
106076979|NCT01064648|365946565|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
106076980|NCT01064648|365946566|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
106076981|NCT01064648|365946567|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
106076982|NCT01064648|365946564|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
106076983|NCT01064648|365946565|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
106076984|NCT01064648|365946566|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
106076985|NCT01064648|365946567|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
106076986|NCT01064648|365946564|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
106076987|NCT01064648|365946565|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
106076988|NCT01064648|365946566|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
106076989|NCT01064648|365946567|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
106076990|NCT01064648|365946564|FG000|Phase II|Adverse Event|0|||
106076991|NCT01064648|365946565|FG001|Phase II|Adverse Event|0|||
106076992|NCT01064648|365946566|FG002|Phase II|Adverse Event|15|||
106076993|NCT01064648|365946567|FG003|Phase II|Adverse Event|8|||
106076994|NCT01064648|365946564|FG000|Phase II|Death|0|||
106076995|NCT01064648|365946565|FG001|Phase II|Death|0|||
106076996|NCT01064648|365946566|FG002|Phase II|Death|4|||
106076997|NCT01064648|365946567|FG003|Phase II|Death|5|||
106076998|NCT01064648|365946564|FG000|Phase II|Withdrawal by Subject|0|||
106076999|NCT01064648|365946565|FG001|Phase II|Withdrawal by Subject|0|||
106077000|NCT01064648|365946566|FG002|Phase II|Withdrawal by Subject|2|||
106159188|NCT01261312|366245351|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
106159189|NCT01261312|366245352|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106077001|NCT01064648|365946567|FG003|Phase II|Withdrawal by Subject|5|||
106077002|NCT01064648|365946564|FG000|Phase II|Progression|0|||
106077003|NCT01064648|365946565|FG001|Phase II|Progression|0|||
106077004|NCT01064648|365946566|FG002|Phase II|Progression|21|||
106077005|NCT01064648|365946567|FG003|Phase II|Progression|27|||
106077006|NCT01064648|365946564|FG000|Phase II|Non-protocol specified|0|||
106077007|NCT01064648|365946565|FG001|Phase II|Non-protocol specified|0|||
106077008|NCT01064648|365946566|FG002|Phase II|Non-protocol specified|5|||
106077009|NCT01064648|365946567|FG003|Phase II|Non-protocol specified|3|||
106077010|NCT01064648|365946564|FG000|Phase II|Under Review|0|||
106077011|NCT01064648|365946565|FG001|Phase II|Under Review|0|||
106077012|NCT01064648|365946566|FG002|Phase II|Under Review|2|||
106077013|NCT01064648|365946567|FG003|Phase II|Under Review|0|||
106077014|NCT06023394|365946568|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
106077015|NCT06023394|365946569|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
106077016|NCT06023394|365946568|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
106077017|NCT06023394|365946569|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
106077018|NCT06023394|365946568|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
106077019|NCT06023394|365946569|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
106077020|NCT06023394|365946568|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
106077021|NCT06023394|365946569|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
106077022|NCT02283788|365946570|FG000|Overall Study|Adverse Event|1|||
106077023|NCT02283788|365946571|FG001|Overall Study|Adverse Event|3|||
106077024|NCT02283788|365946572|FG002|Overall Study|Adverse Event|5|||
106077025|NCT02283788|365946573|FG003|Overall Study|Adverse Event|1|||
106077026|NCT02283788|365946570|FG000|Overall Study|Withdrawal by Subject|0|||
106077027|NCT02283788|365946571|FG001|Overall Study|Withdrawal by Subject|1|||
106077028|NCT02283788|365946572|FG002|Overall Study|Withdrawal by Subject|0|||
106077029|NCT02283788|365946573|FG003|Overall Study|Withdrawal by Subject|1|||
106077030|NCT00403273|365948252|FG000|Overall Study|Lost to Follow-up|3|||
106077031|NCT00403273|365948253|FG001|Overall Study|Lost to Follow-up|2|||
106077032|NCT00403273|365948252|FG000|Overall Study|Physician Decision|0|||
106077033|NCT00403273|365948253|FG001|Overall Study|Physician Decision|1|||
106077034|NCT00403273|365948252|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
106077035|NCT00403273|365948253|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
106077036|NCT03252522|365948258|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
106077037|NCT03252522|365948259|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
106077038|NCT03252522|365948260|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
106077039|NCT03252522|365948258|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
106077040|NCT03252522|365948259|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
106077041|NCT03252522|365948260|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
106077042|NCT03252522|365948258|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
106077043|NCT03252522|365948259|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
106077044|NCT03252522|365948260|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
106077045|NCT03252522|365948258|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
106077046|NCT03252522|365948259|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
106077047|NCT03252522|365948260|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
106077048|NCT03252522|365948258|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
106077049|NCT03252522|365948259|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
106077050|NCT03252522|365948260|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
106077051|NCT03252522|365948258|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
106077052|NCT03252522|365948259|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
106077053|NCT03252522|365948260|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
106077054|NCT03252522|365948258|FG000|Phase 2: Open Label|Adverse Event|0|||
106077055|NCT03252522|365948259|FG001|Phase 2: Open Label|Adverse Event|0|||
106077056|NCT03252522|365948260|FG002|Phase 2: Open Label|Adverse Event|2|||
106077057|NCT03252522|365948258|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
106159190|NCT01261312|366245353|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159191|NCT01261312|366245354|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159192|NCT01261312|366245355|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159193|NCT01261312|366245356|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106077058|NCT03252522|365948259|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
106077059|NCT03252522|365948260|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
106077060|NCT03026257|365948261|FG000|Overall Study|Adverse Event|3|||
106077061|NCT03026257|365948262|FG001|Overall Study|Adverse Event|0|||
106077062|NCT03026257|365948263|FG002|Overall Study|Adverse Event|0|||
106077063|NCT03026257|365948264|FG003|Overall Study|Adverse Event|0|||
106077064|NCT03026257|365948265|FG004|Overall Study|Adverse Event|0|||
106077065|NCT03026257|365948266|FG005|Overall Study|Adverse Event|0|||
106077066|NCT03026257|365948261|FG000|Overall Study|Lost to Follow-up|1|||
106077067|NCT03026257|365948262|FG001|Overall Study|Lost to Follow-up|0|||
106077068|NCT03026257|365948263|FG002|Overall Study|Lost to Follow-up|0|||
106159194|NCT01261312|366245357|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159195|NCT01261312|366245358|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159196|NCT01261312|366245359|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159197|NCT01261312|366245360|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159198|NCT01261312|366245361|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159199|NCT01261312|366245362|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
106159200|NCT01261312|366245350|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
106159201|NCT01261312|366245351|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
106159202|NCT01261312|366245352|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159203|NCT01261312|366245353|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159204|NCT01261312|366245354|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159205|NCT01261312|366245355|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159206|NCT01261312|366245356|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159207|NCT01261312|366245357|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159208|NCT01261312|366245358|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159209|NCT01261312|366245359|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159210|NCT01261312|366245360|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159211|NCT01261312|366245361|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159212|NCT01261312|366245362|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
106159213|NCT01261312|366245350|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
106159214|NCT01261312|366245351|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
106159215|NCT01261312|366245352|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
106159216|NCT01261312|366245353|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159217|NCT01261312|366245354|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159218|NCT01261312|366245355|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159219|NCT01261312|366245356|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159220|NCT01261312|366245357|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159221|NCT01261312|366245358|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159222|NCT01261312|366245359|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159223|NCT01261312|366245360|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159224|NCT01261312|366245361|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159225|NCT01261312|366245362|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
106159226|NCT01261312|366245350|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
106159227|NCT01261312|366245351|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
106159228|NCT01261312|366245352|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
106159229|NCT01261312|366245353|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159230|NCT01261312|366245354|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159231|NCT01261312|366245355|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159232|NCT01261312|366245356|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159233|NCT01261312|366245357|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159234|NCT01261312|366245358|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106077069|NCT03026257|365948264|FG003|Overall Study|Lost to Follow-up|0|||
106077070|NCT03026257|365948265|FG004|Overall Study|Lost to Follow-up|0|||
106077071|NCT03026257|365948266|FG005|Overall Study|Lost to Follow-up|0|||
106077072|NCT03026257|365948261|FG000|Overall Study|Protocol Violation|1|||
106077073|NCT03026257|365948262|FG001|Overall Study|Protocol Violation|0|||
106077074|NCT03026257|365948263|FG002|Overall Study|Protocol Violation|0|||
106077075|NCT03026257|365948264|FG003|Overall Study|Protocol Violation|1|||
106077076|NCT03026257|365948265|FG004|Overall Study|Protocol Violation|1|||
106077077|NCT03026257|365948266|FG005|Overall Study|Protocol Violation|0|||
106077078|NCT03026257|365948261|FG000|Overall Study|Withdrawal by Subject|1|||
106077079|NCT03026257|365948262|FG001|Overall Study|Withdrawal by Subject|1|||
106077080|NCT03026257|365948263|FG002|Overall Study|Withdrawal by Subject|0|||
106077081|NCT03026257|365948264|FG003|Overall Study|Withdrawal by Subject|0|||
106077082|NCT03026257|365948265|FG004|Overall Study|Withdrawal by Subject|0|||
106077083|NCT03026257|365948266|FG005|Overall Study|Withdrawal by Subject|0|||
106077084|NCT02181556|365948267|FG000|Overall Study|Withdrawal by Subject|1|||
106077085|NCT04380857|365948268|FG000|Overall Study|Lost to Follow-up|3|||
106077086|NCT04380857|365948269|FG001|Overall Study|Lost to Follow-up|3|||
106077087|NCT00394212|365948272|FG000|Overall Study|Lost to Follow-up|3|||
106077088|NCT00394212|365948273|FG001|Overall Study|Lost to Follow-up|0|||
106077089|NCT00394212|365948272|FG000|Overall Study|Withdrawal by Subject|4|||
106077090|NCT00394212|365948273|FG001|Overall Study|Withdrawal by Subject|1|||
106077091|NCT03569371|365948275|FG000|Overall Study|Lack of Efficacy|1|||
106077092|NCT03569371|365948275|FG000|Overall Study|Lost to Follow-up|1|||
106077093|NCT03569371|365948275|FG000|Overall Study|Adverse Event|1|||
106077094|NCT02404311|365948277|FG000|Part A: Month 0-18|Death|2|||
106077095|NCT02404311|365948278|FG001|Part A: Month 0-18|Death|0|||
106077096|NCT02404311|365948279|FG002|Part A: Month 0-18|Death|0|||
106077097|NCT02404311|365948280|FG003|Part A: Month 0-18|Death|0|||
106077098|NCT02404311|365948281|FG004|Part A: Month 0-18|Death|0|||
106077099|NCT02404311|365948277|FG000|Part A: Month 0-18|Physician Decision|1|||
106077100|NCT02404311|365948278|FG001|Part A: Month 0-18|Physician Decision|0|||
106077101|NCT02404311|365948279|FG002|Part A: Month 0-18|Physician Decision|0|||
106077102|NCT02404311|365948280|FG003|Part A: Month 0-18|Physician Decision|0|||
106077103|NCT02404311|365948281|FG004|Part A: Month 0-18|Physician Decision|0|||
106077104|NCT02404311|365948277|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
106077105|NCT02404311|365948278|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
106077106|NCT02404311|365948279|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
106077107|NCT02404311|365948280|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
106077108|NCT02404311|365948281|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
106077109|NCT02404311|365948277|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
106077110|NCT02404311|365948278|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
106077111|NCT02404311|365948279|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
106077112|NCT02404311|365948280|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
106077113|NCT02404311|365948281|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
106077114|NCT02404311|365948277|FG000|Part A: Month 0-18|HIV Infection|6|||
106077115|NCT02404311|365948278|FG001|Part A: Month 0-18|HIV Infection|2|||
106077116|NCT02404311|365948279|FG002|Part A: Month 0-18|HIV Infection|0|||
106077117|NCT02404311|365948280|FG003|Part A: Month 0-18|HIV Infection|0|||
106077118|NCT02404311|365948281|FG004|Part A: Month 0-18|HIV Infection|0|||
106077119|NCT02404311|365948277|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
106077120|NCT02404311|365948278|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
106077121|NCT02404311|365948279|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
106077122|NCT02404311|365948280|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
106077123|NCT02404311|365948281|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
106077124|NCT01539226|365948283|FG000|Overall Study|Withdrawal by Subject|24|||
106077125|NCT01539226|365948284|FG001|Overall Study|Withdrawal by Subject|54|||
106077126|NCT01539226|365948283|FG000|Overall Study|Lost to Follow-up|20|||
106077127|NCT01539226|365948284|FG001|Overall Study|Lost to Follow-up|54|||
106077128|NCT01539226|365948283|FG000|Overall Study|Death|1|||
106077129|NCT01539226|365948284|FG001|Overall Study|Death|2|||
106077130|NCT01539226|365948283|FG000|Overall Study|Adverse Event|2|||
106077131|NCT01539226|365948284|FG001|Overall Study|Adverse Event|0|||
106077132|NCT01539226|365948283|FG000|Overall Study|Pregnancy|13|||
106077133|NCT01539226|365948284|FG001|Overall Study|Pregnancy|29|||
106077134|NCT01539226|365948283|FG000|Overall Study|inappropriate enrollment|0|||
106077135|NCT01539226|365948284|FG001|Overall Study|inappropriate enrollment|1|||
106077136|NCT01539226|365948283|FG000|Overall Study|Multiple Reasons|3|||
106077137|NCT01539226|365948284|FG001|Overall Study|Multiple Reasons|1|||
106077138|NCT01539226|365948283|FG000|Overall Study|not HIV seroconversion-related|93|||
106077139|NCT01539226|365948284|FG001|Overall Study|not HIV seroconversion-related|176|||
106077140|NCT01539226|365948283|FG000|Overall Study|HIV seroconversion-related|55|||
106077141|NCT01539226|365948284|FG001|Overall Study|HIV seroconversion-related|80|||
106077142|NCT01539226|365948283|FG000|Overall Study|Non-compliance|6|||
106077143|NCT01539226|365948284|FG001|Overall Study|Non-compliance|8|||
106077144|NCT00430092|365948289|FG000|Overall Study|Adverse Event|0|||
106077145|NCT00430092|365948290|FG001|Overall Study|Adverse Event|0|||
106077146|NCT00430092|365948291|FG002|Overall Study|Adverse Event|1|||
106077147|NCT00430092|365948289|FG000|Overall Study|Lack of Efficacy|5|||
106077148|NCT00430092|365948290|FG001|Overall Study|Lack of Efficacy|2|||
106077149|NCT00430092|365948291|FG002|Overall Study|Lack of Efficacy|54|||
106077150|NCT00430092|365948289|FG000|Overall Study|Lost to Follow-up|1|||
106077151|NCT00430092|365948290|FG001|Overall Study|Lost to Follow-up|0|||
106077152|NCT00430092|365948291|FG002|Overall Study|Lost to Follow-up|0|||
106077153|NCT00430092|365948289|FG000|Overall Study|Protocol Violation|0|||
106077154|NCT00430092|365948290|FG001|Overall Study|Protocol Violation|1|||
106077155|NCT00430092|365948291|FG002|Overall Study|Protocol Violation|1|||
106077156|NCT00430092|365948289|FG000|Overall Study|Withdrawal by Subject|0|||
106077157|NCT00430092|365948290|FG001|Overall Study|Withdrawal by Subject|1|||
106077158|NCT00430092|365948291|FG002|Overall Study|Withdrawal by Subject|1|||
106077159|NCT01714310|365948299|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
106077160|NCT01714310|365948300|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
106077161|NCT01714310|365948301|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
106077162|NCT01714310|365948299|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
106077163|NCT01714310|365948300|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
106077164|NCT01714310|365948301|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
106077165|NCT01714310|365948299|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
106077166|NCT01714310|365948300|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
106077167|NCT01714310|365948301|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
106077168|NCT01714310|365948299|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
106077169|NCT01714310|365948300|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
106077170|NCT01714310|365948301|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
106077171|NCT01641367|365948309|FG000|Cohorts|Death|18|||
106077172|NCT01641367|365948310|FG001|Cohorts|Death|1|||
106077173|NCT01641367|365948311|FG002|Cohorts|Death|2|||
106077174|NCT01641367|365948312|FG003|Cohorts|Death|0|||
106077175|NCT01641367|365948313|FG004|Cohorts|Death|1|||
106077176|NCT01641367|365948314|FG005|Cohorts|Death|1|||
106077177|NCT01641367|365948315|FG006|Cohorts|Death|0|||
106077178|NCT01641367|365948316|FG007|Cohorts|Death|0|||
106077179|NCT01641367|365948309|FG000|Cohorts|Lost to Follow-up|16|||
106077180|NCT01641367|365948310|FG001|Cohorts|Lost to Follow-up|0|||
106077181|NCT01641367|365948311|FG002|Cohorts|Lost to Follow-up|2|||
106077182|NCT01641367|365948312|FG003|Cohorts|Lost to Follow-up|0|||
106077183|NCT01641367|365948313|FG004|Cohorts|Lost to Follow-up|2|||
106077184|NCT01641367|365948314|FG005|Cohorts|Lost to Follow-up|0|||
106077185|NCT01641367|365948315|FG006|Cohorts|Lost to Follow-up|0|||
106077186|NCT01641367|365948316|FG007|Cohorts|Lost to Follow-up|0|||
106159235|NCT01261312|366245359|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159236|NCT01261312|366245360|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159237|NCT01261312|366245361|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159238|NCT01261312|366245362|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
106159239|NCT01261312|366245350|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
106159240|NCT01261312|366245351|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159241|NCT01261312|366245352|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
106159242|NCT01261312|366245353|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159243|NCT01261312|366245354|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159244|NCT01261312|366245355|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159245|NCT01261312|366245356|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159246|NCT01261312|366245357|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159247|NCT01261312|366245358|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159248|NCT01261312|366245359|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159249|NCT01261312|366245360|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159250|NCT01261312|366245361|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159251|NCT01261312|366245362|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
106159252|NCT01261312|366245350|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159253|NCT01261312|366245351|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159254|NCT01261312|366245352|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159255|NCT01261312|366245353|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
106159256|NCT01261312|366245354|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
106159257|NCT01261312|366245355|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
106159258|NCT01261312|366245356|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159259|NCT01261312|366245357|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159260|NCT01261312|366245358|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159261|NCT01261312|366245359|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159262|NCT01261312|366245360|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159263|NCT01261312|366245361|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159264|NCT01261312|366245362|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
106159265|NCT01261312|366245350|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159266|NCT01261312|366245351|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159267|NCT01261312|366245352|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159268|NCT01261312|366245353|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159269|NCT01261312|366245354|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
106159270|NCT01261312|366245355|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
106159271|NCT01261312|366245356|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159272|NCT01261312|366245357|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159273|NCT01261312|366245358|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159274|NCT01261312|366245359|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159275|NCT01261312|366245360|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159276|NCT01261312|366245361|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159277|NCT01261312|366245362|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
106159278|NCT01261312|366245350|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159279|NCT01261312|366245351|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159280|NCT01261312|366245352|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159281|NCT01261312|366245353|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159282|NCT01261312|366245354|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
106159283|NCT01261312|366245355|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
106077187|NCT01641367|365948309|FG000|Randomized Adherence Intervention|Death|0|||
106077188|NCT01641367|365948310|FG001|Randomized Adherence Intervention|Death|0|||
106077189|NCT01641367|365948311|FG002|Randomized Adherence Intervention|Death|0|||
106077190|NCT01641367|365948312|FG003|Randomized Adherence Intervention|Death|0|||
106077191|NCT01641367|365948313|FG004|Randomized Adherence Intervention|Death|0|||
106077192|NCT01641367|365948314|FG005|Randomized Adherence Intervention|Death|0|||
106077193|NCT01641367|365948315|FG006|Randomized Adherence Intervention|Death|11|||
106077194|NCT01641367|365948316|FG007|Randomized Adherence Intervention|Death|12|||
106077195|NCT01641367|365948309|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
106077196|NCT01641367|365948310|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
106077197|NCT01641367|365948311|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
106077198|NCT01641367|365948312|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
106077199|NCT01641367|365948313|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
106077200|NCT01641367|365948314|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
106077201|NCT01641367|365948315|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
106077202|NCT01641367|365948316|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
106077203|NCT00654381|365948319|FG000|1st Stage|Adverse Event|3|||
106077204|NCT00654381|365948320|FG001|1st Stage|Adverse Event|3|||
106077205|NCT00654381|365948321|FG002|1st Stage|Adverse Event|3|||
106077206|NCT00654381|365948322|FG003|1st Stage|Adverse Event|3|||
106077207|NCT00654381|365948323|FG004|1st Stage|Adverse Event|2|||
106077208|NCT00654381|365948324|FG005|1st Stage|Adverse Event|1|||
106077209|NCT00654381|365948319|FG000|1st Stage|Withdrawal by Subject|0|||
106077210|NCT00654381|365948320|FG001|1st Stage|Withdrawal by Subject|0|||
106077211|NCT00654381|365948321|FG002|1st Stage|Withdrawal by Subject|0|||
106077212|NCT00654381|365948322|FG003|1st Stage|Withdrawal by Subject|1|||
106077213|NCT00654381|365948323|FG004|1st Stage|Withdrawal by Subject|0|||
106077214|NCT00654381|365948324|FG005|1st Stage|Withdrawal by Subject|1|||
106077215|NCT00654381|365948319|FG000|1st Stage|Investigator's decision|0|||
106077216|NCT00654381|365948320|FG001|1st Stage|Investigator's decision|0|||
106077217|NCT00654381|365948321|FG002|1st Stage|Investigator's decision|0|||
106077218|NCT00654381|365948322|FG003|1st Stage|Investigator's decision|1|||
106077219|NCT00654381|365948323|FG004|1st Stage|Investigator's decision|0|||
106077220|NCT00654381|365948324|FG005|1st Stage|Investigator's decision|0|||
106077221|NCT00654381|365948319|FG000|2nd Stage|Adverse Event|2|||
106077222|NCT00654381|365948320|FG001|2nd Stage|Adverse Event|0|||
106077223|NCT00654381|365948321|FG002|2nd Stage|Adverse Event|2|||
106077224|NCT00654381|365948322|FG003|2nd Stage|Adverse Event|3|||
106077225|NCT00654381|365948323|FG004|2nd Stage|Adverse Event|7|||
106077226|NCT00654381|365948324|FG005|2nd Stage|Adverse Event|2|||
106077227|NCT00654381|365948319|FG000|2nd Stage|Withdrawal by Subject|0|||
106077228|NCT00654381|365948320|FG001|2nd Stage|Withdrawal by Subject|0|||
106077229|NCT00654381|365948321|FG002|2nd Stage|Withdrawal by Subject|0|||
106077230|NCT00654381|365948322|FG003|2nd Stage|Withdrawal by Subject|0|||
106077231|NCT00654381|365948323|FG004|2nd Stage|Withdrawal by Subject|1|||
106077232|NCT00654381|365948324|FG005|2nd Stage|Withdrawal by Subject|1|||
106077233|NCT00654381|365948319|FG000|2nd Stage|Investigator's decision|0|||
106077234|NCT00654381|365948320|FG001|2nd Stage|Investigator's decision|0|||
106077235|NCT00654381|365948321|FG002|2nd Stage|Investigator's decision|1|||
106077236|NCT00654381|365948322|FG003|2nd Stage|Investigator's decision|1|||
106077237|NCT00654381|365948323|FG004|2nd Stage|Investigator's decision|0|||
106077238|NCT00654381|365948324|FG005|2nd Stage|Investigator's decision|0|||
106077239|NCT00654381|365948319|FG000|Extension Stage|Adverse Event|1|||
106077240|NCT00654381|365948320|FG001|Extension Stage|Adverse Event|2|||
106077241|NCT00654381|365948321|FG002|Extension Stage|Adverse Event|9|||
106077242|NCT00654381|365948322|FG003|Extension Stage|Adverse Event|7|||
106077243|NCT00654381|365948323|FG004|Extension Stage|Adverse Event|1|||
106077244|NCT00654381|365948324|FG005|Extension Stage|Adverse Event|1|||
106077245|NCT00654381|365948319|FG000|Extension Stage|Protocol Violation|0|||
106077246|NCT00654381|365948320|FG001|Extension Stage|Protocol Violation|0|||
106077247|NCT00654381|365948321|FG002|Extension Stage|Protocol Violation|0|||
106077248|NCT00654381|365948322|FG003|Extension Stage|Protocol Violation|1|||
106077249|NCT00654381|365948323|FG004|Extension Stage|Protocol Violation|0|||
106077250|NCT00654381|365948324|FG005|Extension Stage|Protocol Violation|0|||
106077251|NCT00654381|365948319|FG000|Extension Stage|Lack of Efficacy|0|||
106077252|NCT00654381|365948320|FG001|Extension Stage|Lack of Efficacy|0|||
106077253|NCT00654381|365948321|FG002|Extension Stage|Lack of Efficacy|1|||
106077254|NCT00654381|365948322|FG003|Extension Stage|Lack of Efficacy|0|||
106077255|NCT00654381|365948323|FG004|Extension Stage|Lack of Efficacy|0|||
106077256|NCT00654381|365948324|FG005|Extension Stage|Lack of Efficacy|0|||
106077257|NCT00654381|365948319|FG000|Extension Stage|Withdrawal by Subject|0|||
106077258|NCT00654381|365948320|FG001|Extension Stage|Withdrawal by Subject|0|||
106077259|NCT00654381|365948321|FG002|Extension Stage|Withdrawal by Subject|1|||
106077260|NCT00654381|365948322|FG003|Extension Stage|Withdrawal by Subject|1|||
106077261|NCT00654381|365948323|FG004|Extension Stage|Withdrawal by Subject|1|||
106077262|NCT00654381|365948324|FG005|Extension Stage|Withdrawal by Subject|1|||
106077263|NCT00654381|365948319|FG000|Extension Stage|Closure of the trial site|0|||
106077264|NCT00654381|365948320|FG001|Extension Stage|Closure of the trial site|0|||
106077265|NCT00654381|365948321|FG002|Extension Stage|Closure of the trial site|0|||
106077266|NCT00654381|365948322|FG003|Extension Stage|Closure of the trial site|0|||
106077267|NCT00654381|365948323|FG004|Extension Stage|Closure of the trial site|1|||
106077268|NCT00654381|365948324|FG005|Extension Stage|Closure of the trial site|1|||
106077269|NCT03100825|365948325|FG000|Overall Study|Participant/Guardian Decision|7|||
106077270|NCT03100825|365948325|FG000|Overall Study|Physician Decision|1|||
106077271|NCT02586493|365948331|FG000|Overall Study|Adverse Event|4|||
106077272|NCT02586493|365948331|FG000|Overall Study|Protocol Violation|6|||
106077273|NCT02586493|365948331|FG000|Overall Study|Lost to Follow-up|1|||
106077274|NCT02586493|365948331|FG000|Overall Study|Withdrawal by Subject|1|||
106077275|NCT01675882|365948332|FG000|Overall Study|Adverse Event|0|||
106077276|NCT01675882|365948333|FG001|Overall Study|Adverse Event|2|||
106077277|NCT01675882|365948334|FG002|Overall Study|Adverse Event|1|||
106077278|NCT01675882|365948335|FG003|Overall Study|Adverse Event|0|||
106077279|NCT01675882|365948332|FG000|Overall Study|Participant unwilling to continue|2|||
106077280|NCT01675882|365948333|FG001|Overall Study|Participant unwilling to continue|4|||
106077281|NCT01675882|365948334|FG002|Overall Study|Participant unwilling to continue|2|||
106077282|NCT01675882|365948335|FG003|Overall Study|Participant unwilling to continue|1|||
106077283|NCT01675882|365948332|FG000|Overall Study|Lost to Follow-up|0|||
106077284|NCT01675882|365948333|FG001|Overall Study|Lost to Follow-up|1|||
106077285|NCT01675882|365948334|FG002|Overall Study|Lost to Follow-up|0|||
106077286|NCT01675882|365948335|FG003|Overall Study|Lost to Follow-up|0|||
106077287|NCT01675882|365948332|FG000|Overall Study|Non-compliance|0|||
106077288|NCT01675882|365948333|FG001|Overall Study|Non-compliance|0|||
106077289|NCT01675882|365948334|FG002|Overall Study|Non-compliance|0|||
106077290|NCT01675882|365948335|FG003|Overall Study|Non-compliance|1|||
106077291|NCT00735371|365948337|FG000|Overall Study|Adverse Event|3|||
106077292|NCT00735371|365948338|FG001|Overall Study|Adverse Event|3|||
106077293|NCT00735371|365948339|FG002|Overall Study|Adverse Event|4|||
106077294|NCT00735371|365948340|FG003|Overall Study|Adverse Event|1|||
106077295|NCT00735371|365948337|FG000|Overall Study|Protocol Violation|2|||
106077296|NCT00735371|365948338|FG001|Overall Study|Protocol Violation|2|||
106077297|NCT00735371|365948339|FG002|Overall Study|Protocol Violation|0|||
106077298|NCT00735371|365948340|FG003|Overall Study|Protocol Violation|3|||
106077299|NCT00735371|365948337|FG000|Overall Study|Withdrawal by Subject|0|||
106077300|NCT00735371|365948338|FG001|Overall Study|Withdrawal by Subject|2|||
106077301|NCT00735371|365948339|FG002|Overall Study|Withdrawal by Subject|2|||
106077302|NCT00735371|365948340|FG003|Overall Study|Withdrawal by Subject|0|||
106077303|NCT00735371|365948337|FG000|Overall Study|Lost to Follow-up|1|||
106077304|NCT00735371|365948338|FG001|Overall Study|Lost to Follow-up|1|||
106077305|NCT00735371|365948339|FG002|Overall Study|Lost to Follow-up|3|||
106077306|NCT00735371|365948340|FG003|Overall Study|Lost to Follow-up|1|||
106077307|NCT00735371|365948337|FG000|Overall Study|Lack of Efficacy|4|||
106077308|NCT00735371|365948338|FG001|Overall Study|Lack of Efficacy|2|||
106077309|NCT00735371|365948339|FG002|Overall Study|Lack of Efficacy|0|||
106077310|NCT00735371|365948340|FG003|Overall Study|Lack of Efficacy|4|||
106077311|NCT00735371|365948337|FG000|Overall Study|Sponsor Decision|3|||
106077312|NCT00735371|365948338|FG001|Overall Study|Sponsor Decision|1|||
106077313|NCT00735371|365948339|FG002|Overall Study|Sponsor Decision|0|||
106077314|NCT00735371|365948340|FG003|Overall Study|Sponsor Decision|1|||
106077315|NCT00735371|365948337|FG000|Overall Study|Protocol Violation|0|||
106077316|NCT00735371|365948338|FG001|Overall Study|Protocol Violation|1|||
106077317|NCT00735371|365948339|FG002|Overall Study|Protocol Violation|2|||
106077318|NCT00735371|365948340|FG003|Overall Study|Protocol Violation|0|||
106077319|NCT00735371|365948337|FG000|Overall Study|Prior Vyvanse Exposure|1|||
106077320|NCT00735371|365948338|FG001|Overall Study|Prior Vyvanse Exposure|1|||
106077321|NCT00735371|365948339|FG002|Overall Study|Prior Vyvanse Exposure|0|||
106077322|NCT00735371|365948340|FG003|Overall Study|Prior Vyvanse Exposure|0|||
106077323|NCT00735371|365948337|FG000|Overall Study|Exclusion criteria|1|||
106077324|NCT00735371|365948338|FG001|Overall Study|Exclusion criteria|0|||
106077325|NCT00735371|365948339|FG002|Overall Study|Exclusion criteria|0|||
106077326|NCT00735371|365948340|FG003|Overall Study|Exclusion criteria|0|||
106077327|NCT00994448|365948341|FG000|Overall Study|Adverse Event|1|||
106077328|NCT00994448|365948342|FG001|Overall Study|Adverse Event|0|||
106159284|NCT01261312|366245356|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159285|NCT01261312|366245357|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159286|NCT01261312|366245358|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159287|NCT01261312|366245359|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106077329|NCT00994448|365948341|FG000|Overall Study|Lost to Follow-up|5|||
106077330|NCT00994448|365948342|FG001|Overall Study|Lost to Follow-up|1|||
106077331|NCT00994448|365948341|FG000|Overall Study|Withdrawal by Subject|1|||
106159288|NCT01261312|366245360|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159289|NCT01261312|366245361|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106077332|NCT00994448|365948342|FG001|Overall Study|Withdrawal by Subject|1|||
106077333|NCT00994448|365948341|FG000|Overall Study|Physician Decision|1|||
106077334|NCT00994448|365948342|FG001|Overall Study|Physician Decision|0|||
106077335|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
106077336|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
106077337|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
106077338|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
106077339|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
106077340|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
106077341|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
106077342|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
106077343|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
106077344|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
106077345|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
106077346|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
106077347|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
106077348|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
106077349|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
106077350|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
106077351|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
106077352|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
106077353|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Death|0|||
106077354|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Death|0|||
106077355|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Death|1|||
106077356|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Death|0|||
106077357|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Death|0|||
106077358|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Death|0|||
106077359|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Death|0|||
106077360|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Death|0|||
106077361|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Death|0|||
106077362|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
106077363|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
106077364|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
106077365|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
106077366|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
106077367|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
106077368|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
106077369|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
106077370|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
106077371|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
106077372|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
106077373|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
106077374|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
106077375|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
106077376|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
106077377|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
106077378|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
106077379|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
106077380|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
106077381|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
106077382|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
106077383|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
106077384|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
106077385|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
106077386|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
106077387|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
106077388|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
106077389|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
106077390|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
106077391|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
106077392|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
106077393|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
106077394|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
106077395|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
106077396|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
106077397|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
106077398|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
106077399|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
106077400|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
106077401|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
106077402|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
106077403|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
106077404|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
106077405|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
106159290|NCT01261312|366245362|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
106159291|NCT01261312|366245350|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159292|NCT01261312|366245351|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
106077406|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
105866999|NCT03993379|365163101|FG000|Overall Study|The study was terminated early due to business decision.|0|||
105867000|NCT03993379|365163102|FG001|Overall Study|The study was terminated early due to business decision.|2|||
106159293|NCT01261312|366245352|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159294|NCT01261312|366245353|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
106159295|NCT01261312|366245354|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
106159296|NCT01261312|366245355|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
106159297|NCT01261312|366245356|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159298|NCT01261312|366245357|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159299|NCT01261312|366245358|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159300|NCT01261312|366245359|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159301|NCT01261312|366245360|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159302|NCT01261312|366245361|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159303|NCT01261312|366245362|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
106159304|NCT01261312|366245350|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159305|NCT01261312|366245351|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159306|NCT01261312|366245352|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159307|NCT01261312|366245353|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159308|NCT01261312|366245354|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159309|NCT01261312|366245355|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
106159310|NCT01261312|366245356|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159311|NCT01261312|366245357|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159312|NCT01261312|366245358|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159313|NCT01261312|366245359|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159314|NCT01261312|366245360|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159315|NCT01261312|366245361|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159316|NCT01261312|366245362|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
106159317|NCT01261312|366245350|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159318|NCT01261312|366245351|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159319|NCT01261312|366245352|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159320|NCT01261312|366245353|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
106159321|NCT01261312|366245354|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
106159322|NCT01261312|366245355|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
106159323|NCT01261312|366245356|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159324|NCT01261312|366245357|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159325|NCT01261312|366245358|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159326|NCT01261312|366245359|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159327|NCT01261312|366245360|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159328|NCT01261312|366245361|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159329|NCT01261312|366245362|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
106159330|NCT01261312|366245350|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159331|NCT01261312|366245351|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159332|NCT01261312|366245352|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159333|NCT01261312|366245353|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
106159334|NCT01261312|366245354|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
106159335|NCT01261312|366245355|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
106159336|NCT01261312|366245356|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159337|NCT01261312|366245357|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159338|NCT01261312|366245358|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159339|NCT01261312|366245359|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159340|NCT01261312|366245360|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159341|NCT01261312|366245361|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159342|NCT01261312|366245362|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
106159343|NCT01261312|366245350|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159344|NCT01261312|366245351|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159345|NCT01261312|366245352|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159346|NCT01261312|366245353|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159347|NCT01261312|366245354|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159348|NCT01261312|366245355|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159349|NCT01261312|366245356|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
106159350|NCT01261312|366245357|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
106159351|NCT01261312|366245358|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
106159352|NCT01261312|366245359|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159353|NCT01261312|366245360|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159354|NCT01261312|366245361|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159355|NCT01261312|366245362|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
106159356|NCT01261312|366245350|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106159357|NCT01261312|366245351|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106159358|NCT01261312|366245352|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106077407|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
106077408|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
106077409|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
106077410|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
106077411|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
106077412|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
106077413|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
106077414|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
106077415|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
106077416|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
106077417|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
106077418|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
106077419|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
106077420|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
106077421|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
106077422|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
106077423|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
106077424|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
106077425|NCT00404352|365948349|FG000|Double Blind (up to 24 Month)|Other|0|||
106077426|NCT00404352|365948350|FG001|Double Blind (up to 24 Month)|Other|1|||
106077427|NCT00404352|365948351|FG002|Double Blind (up to 24 Month)|Other|0|||
106077428|NCT00404352|365948352|FG003|Double Blind (up to 24 Month)|Other|0|||
106077429|NCT00404352|365948353|FG004|Double Blind (up to 24 Month)|Other|0|||
106077430|NCT00404352|365948354|FG005|Double Blind (up to 24 Month)|Other|0|||
106077431|NCT00404352|365948355|FG006|Double Blind (up to 24 Month)|Other|0|||
106077432|NCT00404352|365948356|FG007|Double Blind (up to 24 Month)|Other|0|||
106077433|NCT00404352|365948357|FG008|Double Blind (up to 24 Month)|Other|0|||
106077434|NCT00404352|365948349|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
106077435|NCT00404352|365948350|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
106077436|NCT00404352|365948351|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
106077437|NCT00404352|365948352|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
106077438|NCT00404352|365948353|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
106077439|NCT00404352|365948354|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
106077440|NCT00404352|365948355|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
106077441|NCT00404352|365948356|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
106077442|NCT00404352|365948357|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
106077443|NCT00404352|365948349|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
106077444|NCT00404352|365948350|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
106077445|NCT00404352|365948351|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
106077446|NCT00404352|365948352|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
106077447|NCT00404352|365948353|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
106077448|NCT00404352|365948354|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
106077449|NCT00404352|365948355|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
106077450|NCT00404352|365948356|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
106077451|NCT00404352|365948357|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
106077452|NCT00404352|365948349|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
106077453|NCT00404352|365948350|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
106077454|NCT00404352|365948351|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
106077455|NCT00404352|365948352|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
106077456|NCT00404352|365948353|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
106077457|NCT00404352|365948354|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
106077458|NCT00404352|365948355|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
106077459|NCT00404352|365948356|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
106077460|NCT00404352|365948357|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
106077461|NCT00404352|365948349|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
106077462|NCT00404352|365948350|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
106077463|NCT00404352|365948351|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
106077464|NCT00404352|365948352|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
106077465|NCT00404352|365948353|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
106077466|NCT00404352|365948354|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
106077467|NCT00404352|365948355|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
106159359|NCT01261312|366245353|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106159360|NCT01261312|366245354|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106077468|NCT00404352|365948356|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
106077469|NCT00404352|365948357|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
106077470|NCT00404352|365948349|FG000|Open Label (up to 24 Month)|Disease progression|0|||
106077471|NCT00404352|365948350|FG001|Open Label (up to 24 Month)|Disease progression|0|||
106077472|NCT00404352|365948351|FG002|Open Label (up to 24 Month)|Disease progression|0|||
106077473|NCT00404352|365948352|FG003|Open Label (up to 24 Month)|Disease progression|1|||
106159361|NCT01261312|366245355|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106159362|NCT01261312|366245356|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106077474|NCT00404352|365948353|FG004|Open Label (up to 24 Month)|Disease progression|0|||
106077475|NCT00404352|365948354|FG005|Open Label (up to 24 Month)|Disease progression|0|||
106077476|NCT00404352|365948355|FG006|Open Label (up to 24 Month)|Disease progression|0|||
106077477|NCT00404352|365948356|FG007|Open Label (up to 24 Month)|Disease progression|0|||
106077478|NCT00404352|365948357|FG008|Open Label (up to 24 Month)|Disease progression|0|||
106077479|NCT00404352|365948349|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
106077480|NCT00404352|365948350|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
106077481|NCT00404352|365948351|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
106077482|NCT00404352|365948352|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
106077483|NCT00404352|365948353|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
106077484|NCT00404352|365948354|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
106077485|NCT00404352|365948355|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
106077486|NCT00404352|365948356|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
106077487|NCT00404352|365948357|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
106077488|NCT00404352|365948349|FG000|Open Label Extension (up to 36 Months)|Other|0|||
106077489|NCT00404352|365948350|FG001|Open Label Extension (up to 36 Months)|Other|0|||
106077490|NCT00404352|365948351|FG002|Open Label Extension (up to 36 Months)|Other|0|||
106077491|NCT00404352|365948352|FG003|Open Label Extension (up to 36 Months)|Other|0|||
106077492|NCT00404352|365948353|FG004|Open Label Extension (up to 36 Months)|Other|0|||
106077493|NCT00404352|365948354|FG005|Open Label Extension (up to 36 Months)|Other|0|||
106077494|NCT00404352|365948355|FG006|Open Label Extension (up to 36 Months)|Other|0|||
106077495|NCT00404352|365948356|FG007|Open Label Extension (up to 36 Months)|Other|0|||
106077496|NCT00404352|365948357|FG008|Open Label Extension (up to 36 Months)|Other|2|||
106077497|NCT03746522|365948358|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
106077498|NCT03746522|365948359|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
106077499|NCT03746522|365948360|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
106077500|NCT03746522|365948358|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
106077501|NCT03746522|365948359|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
106077502|NCT03746522|365948360|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
106077503|NCT03746522|365948358|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
106077504|NCT03746522|365948359|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
106077505|NCT03746522|365948360|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
106077506|NCT03746522|365948358|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
106077507|NCT03746522|365948359|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
106077508|NCT03746522|365948360|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
106077509|NCT03746522|365948358|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
106077510|NCT03746522|365948359|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
106077511|NCT03746522|365948360|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
106077512|NCT01479621|365948361|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
106077513|NCT01479621|365948362|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106077514|NCT01479621|365948363|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106077515|NCT01479621|365948364|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106077516|NCT01479621|365948365|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106077517|NCT01479621|365948366|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106077518|NCT01479621|365948367|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
106077519|NCT01479621|365948361|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
106077520|NCT01479621|365948362|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106077521|NCT01479621|365948363|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106077522|NCT01479621|365948364|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106077523|NCT01479621|365948365|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106077524|NCT01479621|365948366|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106077525|NCT01479621|365948367|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
106077526|NCT01479621|365948361|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
106077527|NCT01479621|365948362|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106077528|NCT01479621|365948363|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106077529|NCT01479621|365948364|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106077530|NCT01479621|365948365|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106077531|NCT01479621|365948366|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106077532|NCT01479621|365948367|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
106077533|NCT01479621|365948361|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
106077534|NCT01479621|365948362|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106077535|NCT01479621|365948363|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106077536|NCT01479621|365948364|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106077537|NCT01479621|365948365|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106077538|NCT01479621|365948366|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106077539|NCT01479621|365948367|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
106077540|NCT01479621|365948361|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
106159363|NCT01261312|366245357|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
106159364|NCT01261312|366245358|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
106159365|NCT01261312|366245359|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106159366|NCT01261312|366245360|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106159367|NCT01261312|366245361|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106159368|NCT01261312|366245362|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
106159369|NCT01261312|366245350|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159370|NCT01261312|366245351|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159371|NCT01261312|366245352|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159372|NCT01261312|366245353|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159373|NCT01261312|366245354|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159374|NCT01261312|366245355|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159375|NCT01261312|366245356|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
106159376|NCT01261312|366245357|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
106159377|NCT01261312|366245358|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
106159378|NCT01261312|366245359|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159379|NCT01261312|366245360|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159380|NCT01261312|366245361|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159381|NCT01261312|366245362|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
106159382|NCT01261312|366245350|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
106159383|NCT01261312|366245351|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
106159384|NCT01261312|366245352|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
106159385|NCT01261312|366245353|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
106159386|NCT01261312|366245354|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
106159387|NCT01261312|366245355|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
106159388|NCT01261312|366245356|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
106159389|NCT01261312|366245357|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
106159390|NCT01261312|366245358|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
106159391|NCT01261312|366245359|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
106159392|NCT01261312|366245360|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
106159393|NCT01261312|366245361|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
106159394|NCT01261312|366245362|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
106159395|NCT01261312|366245350|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159396|NCT01261312|366245351|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159397|NCT01261312|366245352|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159398|NCT01261312|366245353|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159399|NCT01261312|366245354|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159400|NCT01261312|366245355|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159401|NCT01261312|366245356|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
106159402|NCT01261312|366245357|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
106159403|NCT01261312|366245358|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
106159404|NCT01261312|366245359|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159405|NCT01261312|366245360|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159406|NCT01261312|366245361|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159407|NCT01261312|366245362|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
106159408|NCT01261312|366245350|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159409|NCT01261312|366245351|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159410|NCT01261312|366245352|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159411|NCT01261312|366245353|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159412|NCT01261312|366245354|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159413|NCT01261312|366245355|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159414|NCT01261312|366245356|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
106159415|NCT01261312|366245357|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
106159416|NCT01261312|366245358|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
106159417|NCT01261312|366245359|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159418|NCT01261312|366245360|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159419|NCT01261312|366245361|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159420|NCT01261312|366245362|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
106159421|NCT01261312|366245350|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159422|NCT01261312|366245351|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159423|NCT01261312|366245352|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159424|NCT01261312|366245353|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159425|NCT01261312|366245354|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159426|NCT01261312|366245355|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159427|NCT01261312|366245356|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
106077541|NCT01479621|365948362|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106077542|NCT01479621|365948363|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106077543|NCT01479621|365948364|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106077544|NCT01479621|365948365|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106077545|NCT01479621|365948366|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106077546|NCT01479621|365948367|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
106077547|NCT01479621|365948361|FG000|Treatment Period|Adverse Event|0|||
106077548|NCT01479621|365948362|FG001|Treatment Period|Adverse Event|0|||
106077549|NCT01479621|365948363|FG002|Treatment Period|Adverse Event|0|||
106077550|NCT01479621|365948364|FG003|Treatment Period|Adverse Event|0|||
106077551|NCT01479621|365948365|FG004|Treatment Period|Adverse Event|1|||
106077552|NCT01479621|365948366|FG005|Treatment Period|Adverse Event|2|||
106159428|NCT01261312|366245357|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
106159429|NCT01261312|366245358|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
106159430|NCT01261312|366245359|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159431|NCT01261312|366245360|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159432|NCT01261312|366245361|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159433|NCT01261312|366245362|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
106159434|NCT01261312|366245350|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159435|NCT01261312|366245351|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159436|NCT01261312|366245352|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159437|NCT01261312|366245353|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159438|NCT01261312|366245354|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159439|NCT01261312|366245355|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159440|NCT01261312|366245356|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159441|NCT01261312|366245357|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159442|NCT01261312|366245358|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
106159443|NCT01261312|366245359|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
106159444|NCT01261312|366245360|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
106159445|NCT01261312|366245361|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
106159446|NCT01261312|366245362|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
106159447|NCT01261312|366245350|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159448|NCT01261312|366245351|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159449|NCT01261312|366245352|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159450|NCT01261312|366245353|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159451|NCT01261312|366245354|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159452|NCT01261312|366245355|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159453|NCT01261312|366245356|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159454|NCT01261312|366245357|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159455|NCT01261312|366245358|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159456|NCT01261312|366245359|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
106159457|NCT01261312|366245360|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
106159458|NCT01261312|366245361|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
106159459|NCT01261312|366245362|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
106159460|NCT01261312|366245350|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159461|NCT01261312|366245351|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159462|NCT01261312|366245352|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159463|NCT01261312|366245353|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159464|NCT01261312|366245354|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159465|NCT01261312|366245355|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159466|NCT01261312|366245356|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159467|NCT01261312|366245357|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159468|NCT01261312|366245358|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
106159469|NCT01261312|366245359|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
106159470|NCT01261312|366245360|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
106159471|NCT01261312|366245361|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
106159472|NCT01261312|366245362|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
106077553|NCT01479621|365948367|FG006|Treatment Period|Adverse Event|2|||
106077554|NCT01479621|365948361|FG000|Treatment Period|Withdrawal by Subject|0|||
106077555|NCT01479621|365948362|FG001|Treatment Period|Withdrawal by Subject|4|||
106077556|NCT01479621|365948363|FG002|Treatment Period|Withdrawal by Subject|2|||
106077557|NCT01479621|365948364|FG003|Treatment Period|Withdrawal by Subject|2|||
106159473|NCT01261312|366245350|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106077558|NCT01479621|365948365|FG004|Treatment Period|Withdrawal by Subject|5|||
106077559|NCT01479621|365948366|FG005|Treatment Period|Withdrawal by Subject|5|||
106077560|NCT01479621|365948367|FG006|Treatment Period|Withdrawal by Subject|1|||
106077561|NCT01479621|365948361|FG000|Treatment Period|Physician Decision|0|||
106077562|NCT01479621|365948362|FG001|Treatment Period|Physician Decision|0|||
106077563|NCT01479621|365948363|FG002|Treatment Period|Physician Decision|0|||
106159474|NCT01261312|366245351|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106159475|NCT01261312|366245352|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106159476|NCT01261312|366245353|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106159477|NCT01261312|366245354|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106159478|NCT01261312|366245355|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106159479|NCT01261312|366245356|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106159480|NCT01261312|366245357|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106159481|NCT01261312|366245358|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
106159482|NCT01261312|366245359|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
106159483|NCT01261312|366245360|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
106159484|NCT01261312|366245361|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
106159485|NCT01261312|366245362|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
106159486|NCT01261312|366245350|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159487|NCT01261312|366245351|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159488|NCT01261312|366245352|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159489|NCT01261312|366245353|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159490|NCT01261312|366245354|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159491|NCT01261312|366245355|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159492|NCT01261312|366245356|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159493|NCT01261312|366245357|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159494|NCT01261312|366245358|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
106159495|NCT01261312|366245359|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
106159496|NCT01261312|366245360|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
106159497|NCT01261312|366245361|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
106159498|NCT01261312|366245362|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
106159499|NCT01261312|366245350|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159500|NCT01261312|366245351|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159501|NCT01261312|366245352|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159502|NCT01261312|366245353|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159503|NCT01261312|366245354|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159504|NCT01261312|366245355|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159505|NCT01261312|366245356|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159506|NCT01261312|366245357|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159507|NCT01261312|366245358|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
106159508|NCT01261312|366245359|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
106159509|NCT01261312|366245360|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
106159510|NCT01261312|366245361|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
106159511|NCT01261312|366245362|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
106159512|NCT01261312|366245350|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159513|NCT01261312|366245351|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159514|NCT01261312|366245352|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159515|NCT01261312|366245353|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159516|NCT01261312|366245354|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159517|NCT01261312|366245355|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159518|NCT01261312|366245356|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159519|NCT01261312|366245357|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159520|NCT01261312|366245358|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
106159521|NCT01261312|366245359|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
106159522|NCT01261312|366245360|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
106159523|NCT01261312|366245361|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
106159524|NCT01261312|366245362|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
106159525|NCT04812535|366245365|FG000|Overall Study|Withdrawal by Subject|0|||
106159526|NCT04812535|366245366|FG001|Overall Study|Withdrawal by Subject|0|||
106159527|NCT04812535|366245367|FG002|Overall Study|Withdrawal by Subject|0|||
106159528|NCT04812535|366245368|FG003|Overall Study|Withdrawal by Subject|1|||
106159529|NCT04812535|366245365|FG000|Overall Study|Death|7|||
106159530|NCT04812535|366245366|FG001|Overall Study|Death|2|||
106159531|NCT04812535|366245367|FG002|Overall Study|Death|4|||
106159532|NCT04812535|366245368|FG003|Overall Study|Death|1|||
106159533|NCT04812535|366245365|FG000|Overall Study|Due to premature study termination by sponsor|2|||
106159534|NCT04812535|366245366|FG001|Overall Study|Due to premature study termination by sponsor|0|||
106159535|NCT04812535|366245367|FG002|Overall Study|Due to premature study termination by sponsor|1|||
106159536|NCT04812535|366245368|FG003|Overall Study|Due to premature study termination by sponsor|3|||
106159537|NCT03436745|366245369|FG000|Overall Study|Ineligible|0|||
106159538|NCT03436745|366245370|FG001|Overall Study|Ineligible|0|||
106159539|NCT03436745|366245371|FG002|Overall Study|Ineligible|1|||
105867001|NCT03993379|365163103|FG002|Overall Study|The study was terminated early due to business decision.|0|||
106077564|NCT01479621|365948364|FG003|Treatment Period|Physician Decision|0|||
106077565|NCT01479621|365948365|FG004|Treatment Period|Physician Decision|1|||
106077566|NCT01479621|365948366|FG005|Treatment Period|Physician Decision|1|||
106077567|NCT01479621|365948367|FG006|Treatment Period|Physician Decision|0|||
106077568|NCT01479621|365948361|FG000|Treatment Period|Non-compliance to study drug|0|||
106077569|NCT01479621|365948362|FG001|Treatment Period|Non-compliance to study drug|1|||
106077570|NCT01479621|365948363|FG002|Treatment Period|Non-compliance to study drug|0|||
106077571|NCT01479621|365948364|FG003|Treatment Period|Non-compliance to study drug|0|||
106077572|NCT01479621|365948365|FG004|Treatment Period|Non-compliance to study drug|0|||
106077573|NCT01479621|365948366|FG005|Treatment Period|Non-compliance to study drug|0|||
106077574|NCT01479621|365948367|FG006|Treatment Period|Non-compliance to study drug|1|||
106077575|NCT01479621|365948361|FG000|Treatment Period|Protocol Violation|0|||
106077576|NCT01479621|365948362|FG001|Treatment Period|Protocol Violation|9|||
106077577|NCT01479621|365948363|FG002|Treatment Period|Protocol Violation|6|||
106077578|NCT01479621|365948364|FG003|Treatment Period|Protocol Violation|5|||
106077579|NCT01479621|365948365|FG004|Treatment Period|Protocol Violation|2|||
106077580|NCT01479621|365948366|FG005|Treatment Period|Protocol Violation|10|||
106077581|NCT01479621|365948367|FG006|Treatment Period|Protocol Violation|6|||
106077582|NCT01479621|365948361|FG000|Treatment Period|Pregnancy|0|||
106077583|NCT01479621|365948362|FG001|Treatment Period|Pregnancy|0|||
106077584|NCT01479621|365948363|FG002|Treatment Period|Pregnancy|2|||
106077585|NCT01479621|365948364|FG003|Treatment Period|Pregnancy|0|||
106077586|NCT01479621|365948365|FG004|Treatment Period|Pregnancy|0|||
106077587|NCT01479621|365948366|FG005|Treatment Period|Pregnancy|0|||
106077588|NCT01479621|365948367|FG006|Treatment Period|Pregnancy|0|||
106077589|NCT01479621|365948361|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
106077590|NCT01479621|365948362|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
106077591|NCT01479621|365948363|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
106077592|NCT01479621|365948364|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
106077593|NCT01479621|365948365|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
106077594|NCT01479621|365948366|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
106077595|NCT01479621|365948367|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
106077596|NCT01479621|365948361|FG000|Treatment Period|Lost to Follow-up|0|||
106077597|NCT01479621|365948362|FG001|Treatment Period|Lost to Follow-up|0|||
106077598|NCT01479621|365948363|FG002|Treatment Period|Lost to Follow-up|1|||
106077599|NCT01479621|365948364|FG003|Treatment Period|Lost to Follow-up|0|||
106077600|NCT01479621|365948365|FG004|Treatment Period|Lost to Follow-up|2|||
106077601|NCT01479621|365948366|FG005|Treatment Period|Lost to Follow-up|2|||
106077602|NCT01479621|365948367|FG006|Treatment Period|Lost to Follow-up|1|||
106077603|NCT01479621|365948361|FG000|Treatment Period|Met stopping criteria|0|||
106077604|NCT01479621|365948362|FG001|Treatment Period|Met stopping criteria|8|||
106077605|NCT01479621|365948363|FG002|Treatment Period|Met stopping criteria|7|||
106077606|NCT01479621|365948364|FG003|Treatment Period|Met stopping criteria|4|||
106077607|NCT01479621|365948365|FG004|Treatment Period|Met stopping criteria|9|||
106077608|NCT01479621|365948366|FG005|Treatment Period|Met stopping criteria|20|||
106077609|NCT01479621|365948367|FG006|Treatment Period|Met stopping criteria|6|||
106077610|NCT00453999|365948372|FG000|Overall Study|Adverse Event|1|||
106077611|NCT00453999|365948373|FG001|Overall Study|Adverse Event|2|||
106077612|NCT00453999|365948374|FG002|Overall Study|Adverse Event|1|||
106077613|NCT00453999|365948372|FG000|Overall Study|Lost to Follow-up|0|||
106077614|NCT00453999|365948373|FG001|Overall Study|Lost to Follow-up|1|||
106077615|NCT00453999|365948374|FG002|Overall Study|Lost to Follow-up|1|||
106159540|NCT03336333|366245372|FG000|Overall Study|Remained on study at time of data cut-off|202|||
106159541|NCT03336333|366245373|FG001|Overall Study|Remained on study at time of data cut-off|219|||
106159542|NCT03336333|366245374|FG002|Overall Study|Remained on study at time of data cut-off|102|||
106159543|NCT03336333|366245372|FG000|Overall Study|Death|14|||
106159544|NCT03336333|366245373|FG001|Overall Study|Death|16|||
106159545|NCT03336333|366245374|FG002|Overall Study|Death|8|||
106159546|NCT03336333|366245372|FG000|Overall Study|Withdrawal by Subject|16|||
106159547|NCT03336333|366245373|FG001|Overall Study|Withdrawal by Subject|5|||
106159548|NCT03336333|366245374|FG002|Overall Study|Withdrawal by Subject|1|||
106159549|NCT03336333|366245372|FG000|Overall Study|Physician Decision|5|||
106159550|NCT03336333|366245373|FG001|Overall Study|Physician Decision|1|||
106159551|NCT03336333|366245374|FG002|Overall Study|Physician Decision|0|||
106159552|NCT03336333|366245372|FG000|Overall Study|Lost to Follow-up|1|||
106159553|NCT03336333|366245373|FG001|Overall Study|Lost to Follow-up|0|||
106159554|NCT03336333|366245374|FG002|Overall Study|Lost to Follow-up|0|||
106159555|NCT03406871|366245375|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
106159556|NCT03406871|366245376|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
106159557|NCT03406871|366245377|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
106159558|NCT03406871|366245375|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
106159559|NCT03406871|366245376|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
106077616|NCT00453999|365948372|FG000|Overall Study|Withdrawal by Subject|2|||
106077617|NCT00453999|365948373|FG001|Overall Study|Withdrawal by Subject|1|||
106077618|NCT00453999|365948374|FG002|Overall Study|Withdrawal by Subject|1|||
106077619|NCT00453999|365948372|FG000|Overall Study|Subject Request|2|||
106077620|NCT00453999|365948373|FG001|Overall Study|Subject Request|1|||
106077621|NCT00453999|365948374|FG002|Overall Study|Subject Request|0|||
106077622|NCT00696137|365948375|FG000|Overall Study|Withdrawal by Subject|2|||
106077623|NCT02350309|365948382|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
106077624|NCT02350309|365948383|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
106077625|NCT02350309|365948384|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
106077626|NCT02350309|365948385|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
106077627|NCT02350309|365948386|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
106077628|NCT02350309|365948387|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
106077629|NCT02350309|365948382|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
106077630|NCT02350309|365948383|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
106077631|NCT02350309|365948384|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
106077632|NCT02350309|365948385|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
106077633|NCT02350309|365948386|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
106077634|NCT02350309|365948387|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
106077635|NCT00058825|365948390|FG000|Overall Study|Relapse|9|||
106077636|NCT00058825|365948390|FG000|Overall Study|Progressive Disease|5|||
106077637|NCT00058825|365948390|FG000|Overall Study|Graft Failure|5|||
106077638|NCT00058825|365948390|FG000|Overall Study|Death|3|||
106077639|NCT01640366|365948391|FG000|Overall Study|Withdrawal by Subject|1|||
106077640|NCT01640366|365948391|FG000|Overall Study|Protocol Violation|16|||
106077641|NCT01640366|365948391|FG000|Overall Study|Lost to Follow-up|5|||
106077642|NCT02739269|365948392|FG000|Overall Study|Protocol Violation|5|||
106077643|NCT02739269|365948393|FG001|Overall Study|Protocol Violation|0|||
106077644|NCT02739269|365948392|FG000|Overall Study|Cycle cancellation|2|||
106077645|NCT02739269|365948393|FG001|Overall Study|Cycle cancellation|2|||
106077646|NCT02739269|365948392|FG000|Overall Study|Withdrawal by Subject|0|||
106077647|NCT02739269|365948393|FG001|Overall Study|Withdrawal by Subject|2|||
106077648|NCT02357940|365948395|FG000|Overall Study|Adverse Event|0|||
106077649|NCT02357940|365948396|FG001|Overall Study|Adverse Event|1|||
106159560|NCT03406871|366245377|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
106159561|NCT03406871|366245375|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
106159562|NCT03406871|366245376|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
106159563|NCT03406871|366245377|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
106159564|NCT03406871|366245375|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
106159565|NCT03406871|366245376|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
106077650|NCT02357940|365948395|FG000|Overall Study|Investigator's judgement|0|||
106077651|NCT02357940|365948396|FG001|Overall Study|Investigator's judgement|1|||
106159566|NCT03406871|366245377|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
106159567|NCT03406871|366245375|FG000|Expansion Cohort(Final Analysis)|Death|0|||
106159568|NCT03406871|366245376|FG001|Expansion Cohort(Final Analysis)|Death|1|||
106159569|NCT03406871|366245377|FG002|Expansion Cohort(Final Analysis)|Death|0|||
106159570|NCT03406871|366245375|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
106159571|NCT03406871|366245376|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
106159572|NCT03406871|366245377|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
106159573|NCT02281955|366245381|FG000|Overall Study|Death|1|||
106159574|NCT04021602|366245389|FG000|Overall Study|Lost to Follow-up|3|||
106159575|NCT04021602|366245390|FG001|Overall Study|Lost to Follow-up|3|||
106159576|NCT04021602|366245391|FG002|Overall Study|Lost to Follow-up|1|||
106159577|NCT04021602|366245389|FG000|Overall Study|Adverse Event|1|||
106159578|NCT04021602|366245390|FG001|Overall Study|Adverse Event|0|||
106159579|NCT04021602|366245391|FG002|Overall Study|Adverse Event|1|||
106159580|NCT01748448|366245392|FG000|Treatment Period|Consent withdrawn by subject|1|||
106159581|NCT01748448|366245393|FG001|Treatment Period|Consent withdrawn by subject|0|||
106159582|NCT01748448|366245392|FG000|Treatment Period|Adverse Event|1|||
106159583|NCT01748448|366245393|FG001|Treatment Period|Adverse Event|0|||
106159584|NCT01748448|366245392|FG000|Treatment Period|Personal|0|||
106159585|NCT01748448|366245393|FG001|Treatment Period|Personal|1|||
106159586|NCT02689284|366245398|FG000|Overall Study|Adverse Event|1|||
106159587|NCT02689284|366245399|FG001|Overall Study|Adverse Event|8|||
106159588|NCT02689284|366245398|FG000|Overall Study|Death|0|||
106159589|NCT02689284|366245399|FG001|Overall Study|Death|1|||
106159590|NCT02689284|366245398|FG000|Overall Study|Physician Decision|1|||
106159591|NCT02689284|366245399|FG001|Overall Study|Physician Decision|2|||
106159592|NCT02689284|366245398|FG000|Overall Study|Withdrawal by Subject|0|||
106159593|NCT02689284|366245399|FG001|Overall Study|Withdrawal by Subject|1|||
106159594|NCT02689284|366245398|FG000|Overall Study|progression of cancer|1|||
106159595|NCT02689284|366245399|FG001|Overall Study|progression of cancer|72|||
106077652|NCT02641379|365948397|FG000|Overall Study|Exclusion criterion during screening|1|||
106077653|NCT02641379|365948398|FG001|Overall Study|Exclusion criterion during screening|0|||
106077654|NCT02641379|365948399|FG002|Overall Study|Exclusion criterion during screening|0|||
105867002|NCT03993379|365163104|FG003|Overall Study|The study was terminated early due to business decision.|0|||
105867003|NCT03993379|365163101|FG000|Overall Study|Withdrawal by Subject|0|||
106077655|NCT02641379|365948400|FG003|Overall Study|Exclusion criterion during screening|1|||
106077656|NCT02641379|365948401|FG004|Overall Study|Exclusion criterion during screening|2|||
106077657|NCT02641379|365948402|FG005|Overall Study|Exclusion criterion during screening|0|||
106077658|NCT02641379|365948403|FG006|Overall Study|Exclusion criterion during screening|0|||
106077659|NCT02641379|365948404|FG007|Overall Study|Exclusion criterion during screening|0|||
106077660|NCT02641379|365948405|FG008|Overall Study|Exclusion criterion during screening|0|||
106077661|NCT02641379|365948406|FG009|Overall Study|Exclusion criterion during screening|0|||
106077662|NCT02641379|365948407|FG010|Overall Study|Exclusion criterion during screening|0|||
106077663|NCT02641379|365948397|FG000|Overall Study|Withdrawal of informed consent|0|||
106077664|NCT02641379|365948398|FG001|Overall Study|Withdrawal of informed consent|1|||
106077665|NCT02641379|365948399|FG002|Overall Study|Withdrawal of informed consent|0|||
106077666|NCT02641379|365948400|FG003|Overall Study|Withdrawal of informed consent|0|||
106077667|NCT02641379|365948401|FG004|Overall Study|Withdrawal of informed consent|0|||
106077668|NCT02641379|365948402|FG005|Overall Study|Withdrawal of informed consent|0|||
106077669|NCT02641379|365948403|FG006|Overall Study|Withdrawal of informed consent|0|||
106077670|NCT02641379|365948404|FG007|Overall Study|Withdrawal of informed consent|1|||
106077671|NCT02641379|365948405|FG008|Overall Study|Withdrawal of informed consent|0|||
106077672|NCT02641379|365948406|FG009|Overall Study|Withdrawal of informed consent|0|||
106077673|NCT02641379|365948407|FG010|Overall Study|Withdrawal of informed consent|0|||
106077674|NCT02641379|365948397|FG000|Overall Study|Adverse Event|7|||
106077675|NCT02641379|365948398|FG001|Overall Study|Adverse Event|8|||
106077676|NCT02641379|365948399|FG002|Overall Study|Adverse Event|2|||
106077677|NCT02641379|365948400|FG003|Overall Study|Adverse Event|2|||
106077678|NCT02641379|365948401|FG004|Overall Study|Adverse Event|5|||
106077679|NCT02641379|365948402|FG005|Overall Study|Adverse Event|1|||
106077680|NCT02641379|365948403|FG006|Overall Study|Adverse Event|5|||
106077681|NCT02641379|365948404|FG007|Overall Study|Adverse Event|0|||
106077682|NCT02641379|365948405|FG008|Overall Study|Adverse Event|1|||
106077683|NCT02641379|365948406|FG009|Overall Study|Adverse Event|1|||
106077684|NCT02641379|365948407|FG010|Overall Study|Adverse Event|5|||
106077685|NCT02641379|365948397|FG000|Overall Study|Lack of Efficacy|0|||
106077686|NCT02641379|365948398|FG001|Overall Study|Lack of Efficacy|0|||
106077687|NCT02641379|365948399|FG002|Overall Study|Lack of Efficacy|2|||
106077688|NCT02641379|365948400|FG003|Overall Study|Lack of Efficacy|0|||
106077689|NCT02641379|365948401|FG004|Overall Study|Lack of Efficacy|0|||
106077690|NCT02641379|365948402|FG005|Overall Study|Lack of Efficacy|2|||
106077691|NCT02641379|365948403|FG006|Overall Study|Lack of Efficacy|0|||
106077692|NCT02641379|365948404|FG007|Overall Study|Lack of Efficacy|5|||
106077693|NCT02641379|365948405|FG008|Overall Study|Lack of Efficacy|0|||
106077694|NCT02641379|365948406|FG009|Overall Study|Lack of Efficacy|0|||
106077695|NCT02641379|365948407|FG010|Overall Study|Lack of Efficacy|0|||
106077696|NCT02641379|365948397|FG000|Overall Study|Participant unable to attend study visit|4|||
106077697|NCT02641379|365948398|FG001|Overall Study|Participant unable to attend study visit|10|||
106077698|NCT02641379|365948399|FG002|Overall Study|Participant unable to attend study visit|1|||
106077699|NCT02641379|365948400|FG003|Overall Study|Participant unable to attend study visit|2|||
106077700|NCT02641379|365948401|FG004|Overall Study|Participant unable to attend study visit|5|||
106077701|NCT02641379|365948402|FG005|Overall Study|Participant unable to attend study visit|1|||
106077702|NCT02641379|365948403|FG006|Overall Study|Participant unable to attend study visit|1|||
106077703|NCT02641379|365948404|FG007|Overall Study|Participant unable to attend study visit|1|||
105867004|NCT03993379|365163102|FG001|Overall Study|Withdrawal by Subject|1|||
106077704|NCT02641379|365948405|FG008|Overall Study|Participant unable to attend study visit|0|||
106077705|NCT02641379|365948406|FG009|Overall Study|Participant unable to attend study visit|2|||
106077706|NCT02641379|365948407|FG010|Overall Study|Participant unable to attend study visit|0|||
106077707|NCT02641379|365948397|FG000|Overall Study|Participant's compliance|0|||
106077708|NCT02641379|365948398|FG001|Overall Study|Participant's compliance|1|||
106077709|NCT02641379|365948399|FG002|Overall Study|Participant's compliance|0|||
106077710|NCT02641379|365948400|FG003|Overall Study|Participant's compliance|1|||
106077711|NCT02641379|365948401|FG004|Overall Study|Participant's compliance|0|||
106077712|NCT02641379|365948402|FG005|Overall Study|Participant's compliance|2|||
106077713|NCT02641379|365948403|FG006|Overall Study|Participant's compliance|0|||
106077714|NCT02641379|365948404|FG007|Overall Study|Participant's compliance|0|||
106077715|NCT02641379|365948405|FG008|Overall Study|Participant's compliance|1|||
106077716|NCT02641379|365948406|FG009|Overall Study|Participant's compliance|1|||
106077717|NCT02641379|365948407|FG010|Overall Study|Participant's compliance|1|||
106077718|NCT02641379|365948397|FG000|Overall Study|Participant cannot be reached|4|||
106077719|NCT02641379|365948398|FG001|Overall Study|Participant cannot be reached|4|||
106077720|NCT02641379|365948399|FG002|Overall Study|Participant cannot be reached|0|||
106077721|NCT02641379|365948400|FG003|Overall Study|Participant cannot be reached|8|||
106077722|NCT02641379|365948401|FG004|Overall Study|Participant cannot be reached|2|||
106077723|NCT02641379|365948402|FG005|Overall Study|Participant cannot be reached|1|||
105867005|NCT03993379|365163103|FG002|Overall Study|Withdrawal by Subject|0|||
105867006|NCT03993379|365163104|FG003|Overall Study|Withdrawal by Subject|0|||
106159596|NCT02689284|366245398|FG000|Overall Study|decreased heart function|0|||
106159597|NCT02689284|366245399|FG001|Overall Study|decreased heart function|1|||
106159598|NCT02689284|366245398|FG000|Overall Study|concern for anemia|0|||
106159599|NCT02689284|366245399|FG001|Overall Study|concern for anemia|1|||
106159600|NCT02689284|366245398|FG000|Overall Study|no measurable cancer for evaluation|0|||
106159601|NCT02689284|366245399|FG001|Overall Study|no measurable cancer for evaluation|1|||
106159602|NCT05592418|366245400|FG000|Overall Study|Adverse Event|1|||
106159603|NCT05592418|366245401|FG001|Overall Study|Adverse Event|0|||
106159604|NCT05592418|366245400|FG000|Overall Study|Lost to Follow-up|1|||
106159605|NCT05592418|366245401|FG001|Overall Study|Lost to Follow-up|3|||
106159606|NCT05592418|366245400|FG000|Overall Study|Withdrawal by Subject|2|||
106159607|NCT05592418|366245401|FG001|Overall Study|Withdrawal by Subject|7|||
106159608|NCT05569252|366245404|FG000|Overall Study|Adverse event (central vision loss)|1|||
106159609|NCT05569252|366245405|FG001|Overall Study|Adverse event (central vision loss)|0|||
106159610|NCT05569252|366245406|FG002|Overall Study|Adverse event (central vision loss)|0|||
106159611|NCT05569252|366245407|FG003|Overall Study|Adverse event (central vision loss)|0|||
106159612|NCT03665597|366245408|FG000|Period 1|Adverse Event|1|||
106159613|NCT03665597|366245409|FG001|Period 1|Adverse Event|0|||
106159614|NCT03665597|366245410|FG002|Period 1|Adverse Event|0|||
106159615|NCT03665597|366245411|FG003|Period 1|Adverse Event|1|||
106159616|NCT03665597|366245412|FG004|Period 1|Adverse Event|0|||
106159617|NCT03665597|366245413|FG005|Period 1|Adverse Event|0|||
106159618|NCT03665597|366245414|FG006|Period 1|Adverse Event|0|||
106159619|NCT03665597|366245408|FG000|Period 1|Screen Failure|0|||
106159620|NCT03665597|366245409|FG001|Period 1|Screen Failure|0|||
106159621|NCT03665597|366245410|FG002|Period 1|Screen Failure|0|||
106159622|NCT03665597|366245411|FG003|Period 1|Screen Failure|1|||
106159623|NCT03665597|366245412|FG004|Period 1|Screen Failure|0|||
106159624|NCT03665597|366245413|FG005|Period 1|Screen Failure|0|||
106159625|NCT03665597|366245414|FG006|Period 1|Screen Failure|0|||
106159626|NCT03665597|366245408|FG000|Period 1|Death|0|||
106159627|NCT03665597|366245409|FG001|Period 1|Death|0|||
106159628|NCT03665597|366245410|FG002|Period 1|Death|0|||
106159629|NCT03665597|366245411|FG003|Period 1|Death|0|||
106159630|NCT03665597|366245412|FG004|Period 1|Death|0|||
106159631|NCT03665597|366245413|FG005|Period 1|Death|0|||
106159632|NCT03665597|366245414|FG006|Period 1|Death|45|||
106159633|NCT03665597|366245408|FG000|Period 1|Withdrawal by Subject|0|||
106159634|NCT03665597|366245409|FG001|Period 1|Withdrawal by Subject|0|||
106159635|NCT03665597|366245410|FG002|Period 1|Withdrawal by Subject|0|||
106159636|NCT03665597|366245411|FG003|Period 1|Withdrawal by Subject|0|||
106159637|NCT03665597|366245412|FG004|Period 1|Withdrawal by Subject|0|||
106159638|NCT03665597|366245413|FG005|Period 1|Withdrawal by Subject|0|||
106159639|NCT03665597|366245414|FG006|Period 1|Withdrawal by Subject|5|||
106159640|NCT03665597|366245408|FG000|Period 2|Adverse Event|0|||
106159641|NCT03665597|366245409|FG001|Period 2|Adverse Event|0|||
106159642|NCT03665597|366245410|FG002|Period 2|Adverse Event|0|||
106159643|NCT03665597|366245411|FG003|Period 2|Adverse Event|0|||
106159644|NCT03665597|366245412|FG004|Period 2|Adverse Event|0|||
106159645|NCT03665597|366245413|FG005|Period 2|Adverse Event|1|||
106159646|NCT03665597|366245414|FG006|Period 2|Adverse Event|0|||
106159647|NCT03665597|366245408|FG000|Period 3|Adverse Event|0|||
106159648|NCT03665597|366245409|FG001|Period 3|Adverse Event|1|||
106159649|NCT03665597|366245410|FG002|Period 3|Adverse Event|0|||
106159650|NCT03665597|366245411|FG003|Period 3|Adverse Event|0|||
106159651|NCT03665597|366245412|FG004|Period 3|Adverse Event|0|||
106159652|NCT03665597|366245413|FG005|Period 3|Adverse Event|0|||
106159653|NCT03665597|366245414|FG006|Period 3|Adverse Event|0|||
106159654|NCT03665597|366245408|FG000|Period 3|Death|0|||
106159655|NCT03665597|366245409|FG001|Period 3|Death|0|||
106159656|NCT03665597|366245410|FG002|Period 3|Death|0|||
106159657|NCT03665597|366245411|FG003|Period 3|Death|0|||
106159658|NCT03665597|366245412|FG004|Period 3|Death|1|||
106159659|NCT03665597|366245413|FG005|Period 3|Death|0|||
106159660|NCT03665597|366245414|FG006|Period 3|Death|0|||
106159661|NCT03665597|366245408|FG000|Period 4|Adverse Event|2|||
106159662|NCT03665597|366245409|FG001|Period 4|Adverse Event|2|||
106159663|NCT03665597|366245410|FG002|Period 4|Adverse Event|2|||
106159664|NCT03665597|366245411|FG003|Period 4|Adverse Event|2|||
106159665|NCT03665597|366245412|FG004|Period 4|Adverse Event|1|||
106159666|NCT03665597|366245413|FG005|Period 4|Adverse Event|0|||
106159667|NCT03665597|366245414|FG006|Period 4|Adverse Event|0|||
106159668|NCT03665597|366245408|FG000|Period 4|Death|0|||
106159669|NCT03665597|366245409|FG001|Period 4|Death|0|||
106159670|NCT03665597|366245410|FG002|Period 4|Death|2|||
106159671|NCT03665597|366245411|FG003|Period 4|Death|0|||
106159672|NCT03665597|366245412|FG004|Period 4|Death|0|||
106159673|NCT03665597|366245413|FG005|Period 4|Death|0|||
106159674|NCT03665597|366245414|FG006|Period 4|Death|0|||
106159675|NCT03665597|366245408|FG000|Period 4|Physician Decision|1|||
106159676|NCT03665597|366245409|FG001|Period 4|Physician Decision|2|||
106159677|NCT03665597|366245410|FG002|Period 4|Physician Decision|0|||
106159678|NCT03665597|366245411|FG003|Period 4|Physician Decision|0|||
106159679|NCT03665597|366245412|FG004|Period 4|Physician Decision|0|||
106077724|NCT02641379|365948403|FG006|Overall Study|Participant cannot be reached|0|||
106077725|NCT02641379|365948404|FG007|Overall Study|Participant cannot be reached|1|||
106077726|NCT02641379|365948405|FG008|Overall Study|Participant cannot be reached|0|||
106077727|NCT02641379|365948406|FG009|Overall Study|Participant cannot be reached|2|||
106077728|NCT02641379|365948407|FG010|Overall Study|Participant cannot be reached|1|||
106077729|NCT02641379|365948397|FG000|Overall Study|PCR positive at Week 24|15|||
106077730|NCT02641379|365948398|FG001|Overall Study|PCR positive at Week 24|21|||
106077731|NCT02641379|365948399|FG002|Overall Study|PCR positive at Week 24|62|||
106077732|NCT02641379|365948400|FG003|Overall Study|PCR positive at Week 24|0|||
106077733|NCT02641379|365948401|FG004|Overall Study|PCR positive at Week 24|0|||
106077734|NCT02641379|365948402|FG005|Overall Study|PCR positive at Week 24|6|||
106077735|NCT02641379|365948403|FG006|Overall Study|PCR positive at Week 24|3|||
106077736|NCT02641379|365948404|FG007|Overall Study|PCR positive at Week 24|8|||
106077737|NCT02641379|365948405|FG008|Overall Study|PCR positive at Week 24|0|||
106077738|NCT02641379|365948406|FG009|Overall Study|PCR positive at Week 24|1|||
106077739|NCT02641379|365948407|FG010|Overall Study|PCR positive at Week 24|0|||
106077740|NCT02641379|365948397|FG000|Overall Study|PCR positive at follow up 2|1|||
106077741|NCT02641379|365948398|FG001|Overall Study|PCR positive at follow up 2|0|||
106077742|NCT02641379|365948399|FG002|Overall Study|PCR positive at follow up 2|0|||
106077743|NCT02641379|365948400|FG003|Overall Study|PCR positive at follow up 2|0|||
106077744|NCT02641379|365948401|FG004|Overall Study|PCR positive at follow up 2|0|||
106077745|NCT02641379|365948402|FG005|Overall Study|PCR positive at follow up 2|0|||
106077746|NCT02641379|365948403|FG006|Overall Study|PCR positive at follow up 2|0|||
106077747|NCT02641379|365948404|FG007|Overall Study|PCR positive at follow up 2|0|||
106077748|NCT02641379|365948405|FG008|Overall Study|PCR positive at follow up 2|0|||
106077749|NCT02641379|365948406|FG009|Overall Study|PCR positive at follow up 2|0|||
106077750|NCT02641379|365948407|FG010|Overall Study|PCR positive at follow up 2|0|||
106077751|NCT02641379|365948397|FG000|Overall Study|Participant showed relapse|1|||
106077752|NCT02641379|365948398|FG001|Overall Study|Participant showed relapse|0|||
106077753|NCT02641379|365948399|FG002|Overall Study|Participant showed relapse|0|||
106077754|NCT02641379|365948400|FG003|Overall Study|Participant showed relapse|0|||
106077755|NCT02641379|365948401|FG004|Overall Study|Participant showed relapse|0|||
106077756|NCT02641379|365948402|FG005|Overall Study|Participant showed relapse|0|||
106077757|NCT02641379|365948403|FG006|Overall Study|Participant showed relapse|1|||
106077758|NCT02641379|365948404|FG007|Overall Study|Participant showed relapse|0|||
106077759|NCT02641379|365948405|FG008|Overall Study|Participant showed relapse|0|||
106077760|NCT02641379|365948406|FG009|Overall Study|Participant showed relapse|0|||
106077761|NCT02641379|365948407|FG010|Overall Study|Participant showed relapse|0|||
106077762|NCT02641379|365948397|FG000|Overall Study|Participant stopped study/treatment|1|||
106077763|NCT02641379|365948398|FG001|Overall Study|Participant stopped study/treatment|3|||
106077764|NCT02641379|365948399|FG002|Overall Study|Participant stopped study/treatment|1|||
106077765|NCT02641379|365948400|FG003|Overall Study|Participant stopped study/treatment|0|||
106077766|NCT02641379|365948401|FG004|Overall Study|Participant stopped study/treatment|0|||
106077767|NCT02641379|365948402|FG005|Overall Study|Participant stopped study/treatment|1|||
106077768|NCT02641379|365948403|FG006|Overall Study|Participant stopped study/treatment|2|||
106077769|NCT02641379|365948404|FG007|Overall Study|Participant stopped study/treatment|0|||
106077770|NCT02641379|365948405|FG008|Overall Study|Participant stopped study/treatment|1|||
106077771|NCT02641379|365948406|FG009|Overall Study|Participant stopped study/treatment|0|||
106077772|NCT02641379|365948407|FG010|Overall Study|Participant stopped study/treatment|0|||
106077773|NCT02641379|365948397|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
106077774|NCT02641379|365948398|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
106077775|NCT02641379|365948399|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
106077776|NCT02641379|365948400|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
106077777|NCT02641379|365948401|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
106077778|NCT02641379|365948402|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
106077779|NCT02641379|365948403|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
106077780|NCT02641379|365948404|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
106077781|NCT02641379|365948405|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
106077782|NCT02641379|365948406|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
106077783|NCT02641379|365948407|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
106077784|NCT02641379|365948397|FG000|Overall Study|Financial problems|0|||
106077785|NCT02641379|365948398|FG001|Overall Study|Financial problems|1|||
106077786|NCT02641379|365948399|FG002|Overall Study|Financial problems|0|||
106077787|NCT02641379|365948400|FG003|Overall Study|Financial problems|0|||
106077788|NCT02641379|365948401|FG004|Overall Study|Financial problems|0|||
106077789|NCT02641379|365948402|FG005|Overall Study|Financial problems|0|||
106077790|NCT02641379|365948403|FG006|Overall Study|Financial problems|0|||
106077791|NCT02641379|365948404|FG007|Overall Study|Financial problems|0|||
106077792|NCT02641379|365948405|FG008|Overall Study|Financial problems|0|||
106077793|NCT02641379|365948406|FG009|Overall Study|Financial problems|0|||
106077794|NCT02641379|365948407|FG010|Overall Study|Financial problems|0|||
106077795|NCT02641379|365948397|FG000|Overall Study|PCR positive at Week 68|0|||
106077796|NCT02641379|365948398|FG001|Overall Study|PCR positive at Week 68|1|||
106077797|NCT02641379|365948399|FG002|Overall Study|PCR positive at Week 68|0|||
106077798|NCT02641379|365948400|FG003|Overall Study|PCR positive at Week 68|0|||
106077799|NCT02641379|365948401|FG004|Overall Study|PCR positive at Week 68|0|||
106077800|NCT02641379|365948402|FG005|Overall Study|PCR positive at Week 68|0|||
106077801|NCT02641379|365948403|FG006|Overall Study|PCR positive at Week 68|0|||
106077802|NCT02641379|365948404|FG007|Overall Study|PCR positive at Week 68|0|||
106077803|NCT02641379|365948405|FG008|Overall Study|PCR positive at Week 68|0|||
106077804|NCT02641379|365948406|FG009|Overall Study|PCR positive at Week 68|0|||
106077805|NCT02641379|365948407|FG010|Overall Study|PCR positive at Week 68|0|||
106077806|NCT02641379|365948397|FG000|Overall Study|PCR positive at Week 48|0|||
106077807|NCT02641379|365948398|FG001|Overall Study|PCR positive at Week 48|1|||
106077808|NCT02641379|365948399|FG002|Overall Study|PCR positive at Week 48|0|||
106159680|NCT03665597|366245413|FG005|Period 4|Physician Decision|0|||
106159681|NCT03665597|366245414|FG006|Period 4|Physician Decision|0|||
106159682|NCT04557124|366245415|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
106159683|NCT04557124|366245416|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
106159684|NCT04557124|366245415|FG000|Mid-point (1 Month)|Missed testing|5|||
106159685|NCT04557124|366245416|FG001|Mid-point (1 Month)|Missed testing|4|||
106159686|NCT04557124|366245415|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
106159687|NCT04557124|366245416|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
106159688|NCT04557124|366245415|FG000|Post-testing (2 Months)|Missed testing|1|||
106159689|NCT04557124|366245416|FG001|Post-testing (2 Months)|Missed testing|5|||
106159690|NCT04557124|366245415|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
106159691|NCT04557124|366245416|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
106159692|NCT04557124|366245415|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
106159693|NCT04557124|366245416|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
106159694|NCT03920111|366245419|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
106159695|NCT03920111|366245420|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
106159696|NCT03920111|366245421|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
106159697|NCT03110315|366245424|FG000|Overall Study|Withdrawal by Subject|1|||
106159698|NCT03110315|366245425|FG001|Overall Study|Withdrawal by Subject|0|||
106159699|NCT04176965|366245429|FG000|Overall Study|Death|1|||
106077809|NCT02641379|365948400|FG003|Overall Study|PCR positive at Week 48|0|||
106077810|NCT02641379|365948401|FG004|Overall Study|PCR positive at Week 48|0|||
106077811|NCT02641379|365948402|FG005|Overall Study|PCR positive at Week 48|0|||
106077812|NCT02641379|365948403|FG006|Overall Study|PCR positive at Week 48|0|||
106077813|NCT02641379|365948404|FG007|Overall Study|PCR positive at Week 48|0|||
106077814|NCT02641379|365948405|FG008|Overall Study|PCR positive at Week 48|0|||
106077815|NCT02641379|365948406|FG009|Overall Study|PCR positive at Week 48|0|||
106077816|NCT02641379|365948407|FG010|Overall Study|PCR positive at Week 48|0|||
106077817|NCT02641379|365948397|FG000|Overall Study|PCR not performed at Week 12|0|||
106077818|NCT02641379|365948398|FG001|Overall Study|PCR not performed at Week 12|0|||
106077819|NCT02641379|365948399|FG002|Overall Study|PCR not performed at Week 12|1|||
106077820|NCT02641379|365948400|FG003|Overall Study|PCR not performed at Week 12|0|||
106077821|NCT02641379|365948401|FG004|Overall Study|PCR not performed at Week 12|0|||
106077822|NCT02641379|365948402|FG005|Overall Study|PCR not performed at Week 12|0|||
106077823|NCT02641379|365948403|FG006|Overall Study|PCR not performed at Week 12|0|||
106077824|NCT02641379|365948404|FG007|Overall Study|PCR not performed at Week 12|0|||
106077825|NCT02641379|365948405|FG008|Overall Study|PCR not performed at Week 12|0|||
106077826|NCT02641379|365948406|FG009|Overall Study|PCR not performed at Week 12|0|||
106077827|NCT02641379|365948407|FG010|Overall Study|PCR not performed at Week 12|0|||
106077828|NCT02641379|365948397|FG000|Overall Study|No PCR at baseline|0|||
106077829|NCT02641379|365948398|FG001|Overall Study|No PCR at baseline|0|||
106077830|NCT02641379|365948399|FG002|Overall Study|No PCR at baseline|1|||
106077831|NCT02641379|365948400|FG003|Overall Study|No PCR at baseline|0|||
106077832|NCT02641379|365948401|FG004|Overall Study|No PCR at baseline|0|||
106077833|NCT02641379|365948402|FG005|Overall Study|No PCR at baseline|0|||
106077834|NCT02641379|365948403|FG006|Overall Study|No PCR at baseline|0|||
106077835|NCT02641379|365948404|FG007|Overall Study|No PCR at baseline|0|||
106077836|NCT02641379|365948405|FG008|Overall Study|No PCR at baseline|0|||
106077837|NCT02641379|365948406|FG009|Overall Study|No PCR at baseline|0|||
106077838|NCT02641379|365948407|FG010|Overall Study|No PCR at baseline|0|||
106077839|NCT02641379|365948397|FG000|Overall Study|PCR positive at Week 28|0|||
106077840|NCT02641379|365948398|FG001|Overall Study|PCR positive at Week 28|0|||
106077841|NCT02641379|365948399|FG002|Overall Study|PCR positive at Week 28|1|||
106077842|NCT02641379|365948400|FG003|Overall Study|PCR positive at Week 28|0|||
106077843|NCT02641379|365948401|FG004|Overall Study|PCR positive at Week 28|0|||
106077844|NCT02641379|365948402|FG005|Overall Study|PCR positive at Week 28|0|||
106077845|NCT02641379|365948403|FG006|Overall Study|PCR positive at Week 28|0|||
106077846|NCT02641379|365948404|FG007|Overall Study|PCR positive at Week 28|0|||
106159700|NCT04176965|366245430|FG001|Overall Study|Death|2|||
106077847|NCT02641379|365948405|FG008|Overall Study|PCR positive at Week 28|0|||
106077848|NCT02641379|365948406|FG009|Overall Study|PCR positive at Week 28|0|||
106077849|NCT02641379|365948407|FG010|Overall Study|PCR positive at Week 28|0|||
106077850|NCT02641379|365948397|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
106077851|NCT02641379|365948398|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
106077852|NCT02641379|365948399|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
106077853|NCT02641379|365948400|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
106077854|NCT02641379|365948401|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
106077855|NCT02641379|365948402|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
106077856|NCT02641379|365948403|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
106077857|NCT02641379|365948404|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
106077858|NCT02641379|365948405|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
106077859|NCT02641379|365948406|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
106077860|NCT02641379|365948407|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
106077861|NCT02641379|365948397|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
106077862|NCT02641379|365948398|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
106077863|NCT02641379|365948399|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
106077864|NCT02641379|365948400|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
106077865|NCT02641379|365948401|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
106077866|NCT02641379|365948402|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
106077867|NCT02641379|365948403|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
106077868|NCT02641379|365948404|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
106077869|NCT02641379|365948405|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
106077870|NCT02641379|365948406|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
106077871|NCT02641379|365948407|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
106077872|NCT02641379|365948397|FG000|Overall Study|Baseline viral load unavailable|0|||
106077873|NCT02641379|365948398|FG001|Overall Study|Baseline viral load unavailable|0|||
106077874|NCT02641379|365948399|FG002|Overall Study|Baseline viral load unavailable|0|||
106077875|NCT02641379|365948400|FG003|Overall Study|Baseline viral load unavailable|1|||
106077876|NCT02641379|365948401|FG004|Overall Study|Baseline viral load unavailable|0|||
106077877|NCT02641379|365948402|FG005|Overall Study|Baseline viral load unavailable|0|||
106077878|NCT02641379|365948403|FG006|Overall Study|Baseline viral load unavailable|0|||
106077879|NCT02641379|365948404|FG007|Overall Study|Baseline viral load unavailable|0|||
106077880|NCT02641379|365948405|FG008|Overall Study|Baseline viral load unavailable|0|||
106077881|NCT02641379|365948406|FG009|Overall Study|Baseline viral load unavailable|0|||
106077882|NCT02641379|365948407|FG010|Overall Study|Baseline viral load unavailable|0|||
106077883|NCT02641379|365948397|FG000|Overall Study|Blood could not be drawn|0|||
106077884|NCT02641379|365948398|FG001|Overall Study|Blood could not be drawn|0|||
106077885|NCT02641379|365948399|FG002|Overall Study|Blood could not be drawn|0|||
106077886|NCT02641379|365948400|FG003|Overall Study|Blood could not be drawn|0|||
106077887|NCT02641379|365948401|FG004|Overall Study|Blood could not be drawn|1|||
106077888|NCT02641379|365948402|FG005|Overall Study|Blood could not be drawn|0|||
106077889|NCT02641379|365948403|FG006|Overall Study|Blood could not be drawn|0|||
106077890|NCT02641379|365948404|FG007|Overall Study|Blood could not be drawn|0|||
106077891|NCT02641379|365948405|FG008|Overall Study|Blood could not be drawn|0|||
106077892|NCT02641379|365948406|FG009|Overall Study|Blood could not be drawn|0|||
106077893|NCT02641379|365948407|FG010|Overall Study|Blood could not be drawn|0|||
106077894|NCT02641379|365948397|FG000|Overall Study|Protocol Violation|0|||
106077895|NCT02641379|365948398|FG001|Overall Study|Protocol Violation|0|||
106077896|NCT02641379|365948399|FG002|Overall Study|Protocol Violation|0|||
106077897|NCT02641379|365948400|FG003|Overall Study|Protocol Violation|0|||
106077898|NCT02641379|365948401|FG004|Overall Study|Protocol Violation|2|||
106077899|NCT02641379|365948402|FG005|Overall Study|Protocol Violation|0|||
106077900|NCT02641379|365948403|FG006|Overall Study|Protocol Violation|0|||
106077901|NCT02641379|365948404|FG007|Overall Study|Protocol Violation|0|||
106077902|NCT02641379|365948405|FG008|Overall Study|Protocol Violation|1|||
106077903|NCT02641379|365948406|FG009|Overall Study|Protocol Violation|0|||
106077904|NCT02641379|365948407|FG010|Overall Study|Protocol Violation|0|||
106077905|NCT02641379|365948397|FG000|Overall Study|Participation in sili rescue study|0|||
106077906|NCT02641379|365948398|FG001|Overall Study|Participation in sili rescue study|0|||
106077907|NCT02641379|365948399|FG002|Overall Study|Participation in sili rescue study|0|||
106077908|NCT02641379|365948400|FG003|Overall Study|Participation in sili rescue study|0|||
106077909|NCT02641379|365948401|FG004|Overall Study|Participation in sili rescue study|0|||
106077910|NCT02641379|365948402|FG005|Overall Study|Participation in sili rescue study|1|||
106077911|NCT02641379|365948403|FG006|Overall Study|Participation in sili rescue study|0|||
106077912|NCT02641379|365948404|FG007|Overall Study|Participation in sili rescue study|0|||
106077913|NCT02641379|365948405|FG008|Overall Study|Participation in sili rescue study|0|||
106077914|NCT02641379|365948406|FG009|Overall Study|Participation in sili rescue study|0|||
106159701|NCT04176965|366245429|FG000|Overall Study|Lost to Follow-up|10|||
106077915|NCT02641379|365948407|FG010|Overall Study|Participation in sili rescue study|0|||
106077916|NCT02641379|365948397|FG000|Overall Study|Lost to Follow-up|0|||
106077917|NCT02641379|365948398|FG001|Overall Study|Lost to Follow-up|0|||
106077918|NCT02641379|365948399|FG002|Overall Study|Lost to Follow-up|0|||
106077919|NCT02641379|365948400|FG003|Overall Study|Lost to Follow-up|0|||
106077920|NCT02641379|365948401|FG004|Overall Study|Lost to Follow-up|0|||
106077921|NCT02641379|365948402|FG005|Overall Study|Lost to Follow-up|0|||
106077922|NCT02641379|365948403|FG006|Overall Study|Lost to Follow-up|0|||
106077923|NCT02641379|365948404|FG007|Overall Study|Lost to Follow-up|0|||
106077924|NCT02641379|365948405|FG008|Overall Study|Lost to Follow-up|1|||
106077925|NCT02641379|365948406|FG009|Overall Study|Lost to Follow-up|0|||
106077926|NCT02641379|365948407|FG010|Overall Study|Lost to Follow-up|0|||
106077927|NCT02641379|365948397|FG000|Overall Study|Source data not found|0|||
106077928|NCT02641379|365948398|FG001|Overall Study|Source data not found|0|||
106077929|NCT02641379|365948399|FG002|Overall Study|Source data not found|0|||
106077930|NCT02641379|365948400|FG003|Overall Study|Source data not found|0|||
106077931|NCT02641379|365948401|FG004|Overall Study|Source data not found|0|||
106077932|NCT02641379|365948402|FG005|Overall Study|Source data not found|1|||
106077933|NCT02641379|365948403|FG006|Overall Study|Source data not found|0|||
106077934|NCT02641379|365948404|FG007|Overall Study|Source data not found|0|||
106077935|NCT02641379|365948405|FG008|Overall Study|Source data not found|0|||
106077936|NCT02641379|365948406|FG009|Overall Study|Source data not found|0|||
106077937|NCT02641379|365948407|FG010|Overall Study|Source data not found|0|||
106077938|NCT02641379|365948397|FG000|Overall Study|Participant showed weight reduction|0|||
106077939|NCT02641379|365948398|FG001|Overall Study|Participant showed weight reduction|0|||
106077940|NCT02641379|365948399|FG002|Overall Study|Participant showed weight reduction|0|||
106077941|NCT02641379|365948400|FG003|Overall Study|Participant showed weight reduction|0|||
106077942|NCT02641379|365948401|FG004|Overall Study|Participant showed weight reduction|0|||
106077943|NCT02641379|365948402|FG005|Overall Study|Participant showed weight reduction|0|||
106077944|NCT02641379|365948403|FG006|Overall Study|Participant showed weight reduction|0|||
106077945|NCT02641379|365948404|FG007|Overall Study|Participant showed weight reduction|1|||
106077946|NCT02641379|365948405|FG008|Overall Study|Participant showed weight reduction|0|||
106077947|NCT02641379|365948406|FG009|Overall Study|Participant showed weight reduction|0|||
106077948|NCT02641379|365948407|FG010|Overall Study|Participant showed weight reduction|0|||
106077949|NCT02641379|365948397|FG000|Overall Study|Non-response Week 12|0|||
106077950|NCT02641379|365948398|FG001|Overall Study|Non-response Week 12|0|||
106077951|NCT02641379|365948399|FG002|Overall Study|Non-response Week 12|0|||
106077952|NCT02641379|365948400|FG003|Overall Study|Non-response Week 12|0|||
106077953|NCT02641379|365948401|FG004|Overall Study|Non-response Week 12|0|||
106077954|NCT02641379|365948402|FG005|Overall Study|Non-response Week 12|0|||
106077955|NCT02641379|365948403|FG006|Overall Study|Non-response Week 12|0|||
106077956|NCT02641379|365948404|FG007|Overall Study|Non-response Week 12|1|||
106077957|NCT02641379|365948405|FG008|Overall Study|Non-response Week 12|0|||
106077958|NCT02641379|365948406|FG009|Overall Study|Non-response Week 12|0|||
106077959|NCT02641379|365948407|FG010|Overall Study|Non-response Week 12|0|||
106077960|NCT02641379|365948397|FG000|Overall Study|No 2 Log drop at Week 12|0|||
106077961|NCT02641379|365948398|FG001|Overall Study|No 2 Log drop at Week 12|0|||
106077962|NCT02641379|365948399|FG002|Overall Study|No 2 Log drop at Week 12|0|||
106077963|NCT02641379|365948400|FG003|Overall Study|No 2 Log drop at Week 12|0|||
106077964|NCT02641379|365948401|FG004|Overall Study|No 2 Log drop at Week 12|0|||
106077965|NCT02641379|365948402|FG005|Overall Study|No 2 Log drop at Week 12|0|||
106077966|NCT02641379|365948403|FG006|Overall Study|No 2 Log drop at Week 12|0|||
106077967|NCT02641379|365948404|FG007|Overall Study|No 2 Log drop at Week 12|0|||
106077968|NCT02641379|365948405|FG008|Overall Study|No 2 Log drop at Week 12|0|||
106077969|NCT02641379|365948406|FG009|Overall Study|No 2 Log drop at Week 12|0|||
106077970|NCT02641379|365948407|FG010|Overall Study|No 2 Log drop at Week 12|1|||
106077971|NCT02641379|365948397|FG000|Overall Study|Negative PCR result|0|||
106077972|NCT02641379|365948398|FG001|Overall Study|Negative PCR result|0|||
106077973|NCT02641379|365948399|FG002|Overall Study|Negative PCR result|0|||
106077974|NCT02641379|365948400|FG003|Overall Study|Negative PCR result|0|||
106077975|NCT02641379|365948401|FG004|Overall Study|Negative PCR result|0|||
106077976|NCT02641379|365948402|FG005|Overall Study|Negative PCR result|0|||
106077977|NCT02641379|365948403|FG006|Overall Study|Negative PCR result|0|||
106077978|NCT02641379|365948404|FG007|Overall Study|Negative PCR result|0|||
106077979|NCT02641379|365948405|FG008|Overall Study|Negative PCR result|0|||
106077980|NCT02641379|365948406|FG009|Overall Study|Negative PCR result|1|||
106077981|NCT02641379|365948407|FG010|Overall Study|Negative PCR result|0|||
106077982|NCT02641379|365948397|FG000|Overall Study|Participant's PCR high|0|||
106077983|NCT02641379|365948398|FG001|Overall Study|Participant's PCR high|0|||
106077984|NCT02641379|365948399|FG002|Overall Study|Participant's PCR high|0|||
106077985|NCT02641379|365948400|FG003|Overall Study|Participant's PCR high|0|||
106077986|NCT02641379|365948401|FG004|Overall Study|Participant's PCR high|0|||
106077987|NCT02641379|365948402|FG005|Overall Study|Participant's PCR high|0|||
106077988|NCT02641379|365948403|FG006|Overall Study|Participant's PCR high|0|||
106077989|NCT02641379|365948404|FG007|Overall Study|Participant's PCR high|1|||
106077990|NCT02641379|365948405|FG008|Overall Study|Participant's PCR high|0|||
106077991|NCT02641379|365948406|FG009|Overall Study|Participant's PCR high|0|||
106077992|NCT02641379|365948407|FG010|Overall Study|Participant's PCR high|0|||
106077993|NCT02641379|365948397|FG000|Overall Study|Participant treated after Week 24|0|||
106077994|NCT02641379|365948398|FG001|Overall Study|Participant treated after Week 24|0|||
106077995|NCT02641379|365948399|FG002|Overall Study|Participant treated after Week 24|0|||
106077996|NCT02641379|365948400|FG003|Overall Study|Participant treated after Week 24|0|||
106159702|NCT04176965|366245430|FG001|Overall Study|Lost to Follow-up|2|||
106159703|NCT04176965|366245429|FG000|Overall Study|Withdrawal by Subject|6|||
106159704|NCT04176965|366245430|FG001|Overall Study|Withdrawal by Subject|1|||
106159705|NCT04209465|366245431|FG000|Overall Study|Adverse Event|0|||
106159706|NCT04209465|366245432|FG001|Overall Study|Adverse Event|0|||
106159707|NCT04209465|366245433|FG002|Overall Study|Adverse Event|0|||
106159708|NCT04209465|366245434|FG003|Overall Study|Adverse Event|0|||
106159709|NCT04209465|366245435|FG004|Overall Study|Adverse Event|0|||
106159710|NCT04209465|366245436|FG005|Overall Study|Adverse Event|1|||
106159711|NCT04209465|366245437|FG006|Overall Study|Adverse Event|0|||
106159712|NCT04209465|366245438|FG007|Overall Study|Adverse Event|0|||
106159713|NCT04209465|366245439|FG008|Overall Study|Adverse Event|1|||
106159714|NCT04209465|366245440|FG009|Overall Study|Adverse Event|0|||
106159715|NCT04209465|366245441|FG010|Overall Study|Adverse Event|2|||
106159716|NCT04209465|366245442|FG011|Overall Study|Adverse Event|1|||
106159717|NCT04209465|366245443|FG012|Overall Study|Adverse Event|1|||
106159718|NCT04209465|366245431|FG000|Overall Study|Death|1|||
106159719|NCT04209465|366245432|FG001|Overall Study|Death|0|||
106159720|NCT04209465|366245433|FG002|Overall Study|Death|0|||
106159721|NCT04209465|366245434|FG003|Overall Study|Death|0|||
106159722|NCT04209465|366245435|FG004|Overall Study|Death|2|||
106159723|NCT04209465|366245436|FG005|Overall Study|Death|7|||
106159724|NCT04209465|366245437|FG006|Overall Study|Death|2|||
106159725|NCT04209465|366245438|FG007|Overall Study|Death|2|||
106159726|NCT04209465|366245439|FG008|Overall Study|Death|1|||
106159727|NCT04209465|366245440|FG009|Overall Study|Death|1|||
106159728|NCT04209465|366245441|FG010|Overall Study|Death|1|||
106159729|NCT04209465|366245442|FG011|Overall Study|Death|0|||
106159730|NCT04209465|366245443|FG012|Overall Study|Death|10|||
106159731|NCT04209465|366245431|FG000|Overall Study|Physician Decision|0|||
106159732|NCT04209465|366245432|FG001|Overall Study|Physician Decision|1|||
106159733|NCT04209465|366245433|FG002|Overall Study|Physician Decision|0|||
106159734|NCT04209465|366245434|FG003|Overall Study|Physician Decision|0|||
106159735|NCT04209465|366245435|FG004|Overall Study|Physician Decision|0|||
106159736|NCT04209465|366245436|FG005|Overall Study|Physician Decision|0|||
106159737|NCT04209465|366245437|FG006|Overall Study|Physician Decision|0|||
106159738|NCT04209465|366245438|FG007|Overall Study|Physician Decision|0|||
106159739|NCT04209465|366245439|FG008|Overall Study|Physician Decision|0|||
106159740|NCT04209465|366245440|FG009|Overall Study|Physician Decision|0|||
106159741|NCT04209465|366245441|FG010|Overall Study|Physician Decision|0|||
106159742|NCT04209465|366245442|FG011|Overall Study|Physician Decision|0|||
106159743|NCT04209465|366245443|FG012|Overall Study|Physician Decision|0|||
106159744|NCT04209465|366245431|FG000|Overall Study|Progressive Disease|0|||
106159745|NCT04209465|366245432|FG001|Overall Study|Progressive Disease|0|||
106159746|NCT04209465|366245433|FG002|Overall Study|Progressive Disease|1|||
106159747|NCT04209465|366245434|FG003|Overall Study|Progressive Disease|2|||
106159748|NCT04209465|366245435|FG004|Overall Study|Progressive Disease|8|||
106159749|NCT04209465|366245436|FG005|Overall Study|Progressive Disease|5|||
106159750|NCT04209465|366245437|FG006|Overall Study|Progressive Disease|3|||
106159751|NCT04209465|366245438|FG007|Overall Study|Progressive Disease|4|||
106159752|NCT04209465|366245439|FG008|Overall Study|Progressive Disease|1|||
106159753|NCT04209465|366245440|FG009|Overall Study|Progressive Disease|3|||
106159754|NCT04209465|366245441|FG010|Overall Study|Progressive Disease|2|||
106159755|NCT04209465|366245442|FG011|Overall Study|Progressive Disease|1|||
106159756|NCT04209465|366245443|FG012|Overall Study|Progressive Disease|0|||
106159757|NCT04209465|366245431|FG000|Overall Study|Withdrawal by Subject|0|||
106159758|NCT04209465|366245432|FG001|Overall Study|Withdrawal by Subject|0|||
106159759|NCT04209465|366245433|FG002|Overall Study|Withdrawal by Subject|0|||
106159760|NCT04209465|366245434|FG003|Overall Study|Withdrawal by Subject|0|||
106159761|NCT04209465|366245435|FG004|Overall Study|Withdrawal by Subject|0|||
106159762|NCT04209465|366245436|FG005|Overall Study|Withdrawal by Subject|1|||
106159763|NCT04209465|366245437|FG006|Overall Study|Withdrawal by Subject|2|||
106159764|NCT04209465|366245438|FG007|Overall Study|Withdrawal by Subject|0|||
106159765|NCT04209465|366245439|FG008|Overall Study|Withdrawal by Subject|1|||
106159766|NCT04209465|366245440|FG009|Overall Study|Withdrawal by Subject|0|||
106159767|NCT04209465|366245441|FG010|Overall Study|Withdrawal by Subject|0|||
106159768|NCT04209465|366245442|FG011|Overall Study|Withdrawal by Subject|2|||
106159769|NCT04209465|366245443|FG012|Overall Study|Withdrawal by Subject|2|||
106159770|NCT04209465|366245431|FG000|Overall Study|Lost to Follow-up|0|||
106159771|NCT04209465|366245432|FG001|Overall Study|Lost to Follow-up|0|||
106159772|NCT04209465|366245433|FG002|Overall Study|Lost to Follow-up|0|||
106159773|NCT04209465|366245434|FG003|Overall Study|Lost to Follow-up|0|||
106159774|NCT04209465|366245435|FG004|Overall Study|Lost to Follow-up|0|||
106159775|NCT04209465|366245436|FG005|Overall Study|Lost to Follow-up|1|||
106159776|NCT04209465|366245437|FG006|Overall Study|Lost to Follow-up|0|||
106159777|NCT04209465|366245438|FG007|Overall Study|Lost to Follow-up|0|||
106159778|NCT04209465|366245439|FG008|Overall Study|Lost to Follow-up|1|||
106159779|NCT04209465|366245440|FG009|Overall Study|Lost to Follow-up|0|||
106159780|NCT04209465|366245441|FG010|Overall Study|Lost to Follow-up|0|||
106077997|NCT02641379|365948401|FG004|Overall Study|Participant treated after Week 24|0|||
106077998|NCT02641379|365948402|FG005|Overall Study|Participant treated after Week 24|0|||
106077999|NCT02641379|365948403|FG006|Overall Study|Participant treated after Week 24|0|||
106078000|NCT02641379|365948404|FG007|Overall Study|Participant treated after Week 24|0|||
106078001|NCT02641379|365948405|FG008|Overall Study|Participant treated after Week 24|1|||
106078002|NCT02641379|365948406|FG009|Overall Study|Participant treated after Week 24|0|||
106078003|NCT02641379|365948407|FG010|Overall Study|Participant treated after Week 24|0|||
106078004|NCT02641379|365948397|FG000|Overall Study|Missing PCR result at Week 8|0|||
106078005|NCT02641379|365948398|FG001|Overall Study|Missing PCR result at Week 8|0|||
106078006|NCT02641379|365948399|FG002|Overall Study|Missing PCR result at Week 8|0|||
106078007|NCT02641379|365948400|FG003|Overall Study|Missing PCR result at Week 8|0|||
106078008|NCT02641379|365948401|FG004|Overall Study|Missing PCR result at Week 8|0|||
106078009|NCT02641379|365948402|FG005|Overall Study|Missing PCR result at Week 8|0|||
106078010|NCT02641379|365948403|FG006|Overall Study|Missing PCR result at Week 8|0|||
106078011|NCT02641379|365948404|FG007|Overall Study|Missing PCR result at Week 8|0|||
106078012|NCT02641379|365948405|FG008|Overall Study|Missing PCR result at Week 8|0|||
106078013|NCT02641379|365948406|FG009|Overall Study|Missing PCR result at Week 8|1|||
106078014|NCT02641379|365948407|FG010|Overall Study|Missing PCR result at Week 8|0|||
106078015|NCT02641379|365948397|FG000|Overall Study|PCR positive|0|||
106078016|NCT02641379|365948398|FG001|Overall Study|PCR positive|0|||
106078017|NCT02641379|365948399|FG002|Overall Study|PCR positive|0|||
106078018|NCT02641379|365948400|FG003|Overall Study|PCR positive|0|||
106078019|NCT02641379|365948401|FG004|Overall Study|PCR positive|0|||
106078020|NCT02641379|365948402|FG005|Overall Study|PCR positive|0|||
106078021|NCT02641379|365948403|FG006|Overall Study|PCR positive|1|||
106078022|NCT02641379|365948404|FG007|Overall Study|PCR positive|0|||
106078023|NCT02641379|365948405|FG008|Overall Study|PCR positive|0|||
106078024|NCT02641379|365948406|FG009|Overall Study|PCR positive|0|||
106078025|NCT02641379|365948407|FG010|Overall Study|PCR positive|0|||
106078026|NCT04258605|365948408|FG000|Overall Study|Death|1|||
106078027|NCT04258605|365948409|FG001|Overall Study|Death|0|||
106078028|NCT04258605|365948408|FG000|Overall Study|Early study termination|21|||
106078029|NCT04258605|365948409|FG001|Overall Study|Early study termination|2|||
106078030|NCT00660348|365948418|FG000|Overall Study|Withdrawal by Subject|1|||
106078031|NCT00660348|365948419|FG001|Overall Study|Withdrawal by Subject|0|||
106078032|NCT02849548|365948420|FG000|Overall Study|Lost to Follow-up|1|||
106078033|NCT02849548|365948421|FG001|Overall Study|Lost to Follow-up|2|||
106078034|NCT02849548|365948420|FG000|Overall Study|Protocol Violation|1|||
106078035|NCT02849548|365948421|FG001|Overall Study|Protocol Violation|0|||
106078036|NCT00502697|365949884|FG000|Overall Study|Withdrawal by Subject|3|||
106078037|NCT00502697|365949885|FG001|Overall Study|Withdrawal by Subject|1|||
106078038|NCT00502697|365949884|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
106078039|NCT00502697|365949885|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
106078040|NCT00502697|365949884|FG000|Overall Study|found not to meet eligibility criteria|3|||
106078041|NCT00502697|365949885|FG001|Overall Study|found not to meet eligibility criteria|4|||
106078042|NCT00502697|365949884|FG000|Overall Study|did not meet assignment criteria|4|||
106078043|NCT00502697|365949885|FG001|Overall Study|did not meet assignment criteria|2|||
106078044|NCT01545817|365949887|FG000|Pazopanib|Disease progression|51|||
106078045|NCT01545817|365949888|FG001|Pazopanib|Disease progression|0|||
106078046|NCT01545817|365949887|FG000|Pazopanib|Adverse Event|19|||
106078047|NCT01545817|365949888|FG001|Pazopanib|Adverse Event|0|||
106078048|NCT01545817|365949887|FG000|Pazopanib|Other reason|4|||
106078049|NCT01545817|365949888|FG001|Pazopanib|Other reason|0|||
106078050|NCT01545817|365949887|FG000|Everolimus|Other reason|0|||
106078051|NCT01545817|365949888|FG001|Everolimus|Other reason|7|||
106078052|NCT01545817|365949887|FG000|Everolimus|Disease progression|0|||
106078053|NCT01545817|365949888|FG001|Everolimus|Disease progression|25|||
106078054|NCT01545817|365949887|FG000|Everolimus|Adverse Event|0|||
106078055|NCT01545817|365949888|FG001|Everolimus|Adverse Event|6|||
106078056|NCT00589108|365949889|FG000|Overall Study|Lost to Follow-up|1|||
106078057|NCT00589108|365949890|FG001|Overall Study|Lost to Follow-up|1|||
106078058|NCT00589108|365949891|FG002|Overall Study|Lost to Follow-up|1|||
106078059|NCT00589108|365949889|FG000|Overall Study|Death|3|||
106078060|NCT00589108|365949890|FG001|Overall Study|Death|3|||
106078061|NCT00589108|365949891|FG002|Overall Study|Death|4|||
106078062|NCT03256552|365949892|FG000|Overall Study|Protocol Violation|1|||
106078063|NCT03256552|365949892|FG000|Overall Study|Physician Decision|1|||
106078064|NCT03256552|365949892|FG000|Overall Study|Adverse Event|1|||
106078065|NCT03256552|365949892|FG000|Overall Study|Withdrawal by Subject|2|||
106078066|NCT02586012|365949893|FG000|Overall Study|Withdrawal by Subject|1|||
106078067|NCT02586012|365949894|FG001|Overall Study|Withdrawal by Subject|1|||
106078068|NCT02586012|365949895|FG002|Overall Study|Withdrawal by Subject|0|||
106078069|NCT02586012|365949896|FG003|Overall Study|Withdrawal by Subject|1|||
106078070|NCT02586012|365949897|FG004|Overall Study|Withdrawal by Subject|0|||
106078071|NCT02586012|365949898|FG005|Overall Study|Withdrawal by Subject|2|||
106078072|NCT02586012|365949893|FG000|Overall Study|Protocol Violation|0|||
106078073|NCT02586012|365949894|FG001|Overall Study|Protocol Violation|0|||
106078074|NCT02586012|365949895|FG002|Overall Study|Protocol Violation|0|||
106078075|NCT02586012|365949896|FG003|Overall Study|Protocol Violation|0|||
106078076|NCT02586012|365949897|FG004|Overall Study|Protocol Violation|0|||
106078077|NCT02586012|365949898|FG005|Overall Study|Protocol Violation|1|||
106078078|NCT02586012|365949893|FG000|Overall Study|study terminated|0|||
106078079|NCT02586012|365949894|FG001|Overall Study|study terminated|2|||
106078080|NCT02586012|365949895|FG002|Overall Study|study terminated|1|||
106078081|NCT02586012|365949896|FG003|Overall Study|study terminated|1|||
106078082|NCT02586012|365949897|FG004|Overall Study|study terminated|1|||
106078083|NCT02586012|365949898|FG005|Overall Study|study terminated|0|||
106078084|NCT00427635|365949901|FG000|Treatment Phase|Withdrawal by Subject|1|||
106078085|NCT00427635|365949902|FG001|Treatment Phase|Withdrawal by Subject|0|||
106078086|NCT00427635|365949901|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
106078087|NCT00427635|365949902|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
106078088|NCT03277846|365949903|FG000|Overall Study|Inpatient stay too brief|12|||
106078089|NCT03277846|365949904|FG001|Overall Study|Inpatient stay too brief|11|||
106078090|NCT01888497|365949906|FG000|Washout Period 1|Withdrawal by Subject|0|||
106078091|NCT01888497|365949907|FG001|Washout Period 1|Withdrawal by Subject|0|||
106078092|NCT01888497|365949908|FG002|Washout Period 1|Withdrawal by Subject|1|||
106078093|NCT01888497|365949909|FG003|Washout Period 1|Withdrawal by Subject|1|||
106078094|NCT01888497|365949906|FG000|Washout Period 2|Adverse Event|0|||
106078095|NCT01888497|365949907|FG001|Washout Period 2|Adverse Event|0|||
106078096|NCT01888497|365949908|FG002|Washout Period 2|Adverse Event|0|||
106078097|NCT01888497|365949909|FG003|Washout Period 2|Adverse Event|1|||
106078098|NCT01888497|365949906|FG000|Washout Period 2|Withdrawal by Subject|0|||
106078099|NCT01888497|365949907|FG001|Washout Period 2|Withdrawal by Subject|0|||
106078100|NCT01888497|365949908|FG002|Washout Period 2|Withdrawal by Subject|0|||
106078101|NCT01888497|365949909|FG003|Washout Period 2|Withdrawal by Subject|1|||
106078102|NCT04152447|365949910|FG000|Overall Study|Lost to Follow-up|1|||
106078103|NCT04152447|365949911|FG001|Overall Study|Lost to Follow-up|0|||
106078104|NCT04152447|365949910|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
106078105|NCT04152447|365949911|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
106078106|NCT04152447|365949910|FG000|Overall Study|Withdrawal by Subject|0|||
106078107|NCT04152447|365949911|FG001|Overall Study|Withdrawal by Subject|1|||
106078108|NCT04152447|365949910|FG000|Overall Study|Found ineligible after enrolling|1|||
106078109|NCT04152447|365949911|FG001|Overall Study|Found ineligible after enrolling|1|||
106078110|NCT04152447|365949910|FG000|Overall Study|Did not receive VR headset in time.|0|||
106078111|NCT04152447|365949911|FG001|Overall Study|Did not receive VR headset in time.|2|||
106078112|NCT03240575|365949912|FG000|Overall Study|Adverse Event|0|||
106078113|NCT03240575|365949913|FG001|Overall Study|Adverse Event|2|||
106078114|NCT03240575|365949914|FG002|Overall Study|Adverse Event|0|||
106078115|NCT03240575|365949915|FG003|Overall Study|Adverse Event|1|||
106078116|NCT03240575|365949912|FG000|Overall Study|Withdrawal by Subject|2|||
106078117|NCT03240575|365949913|FG001|Overall Study|Withdrawal by Subject|11|||
106078118|NCT03240575|365949914|FG002|Overall Study|Withdrawal by Subject|0|||
106078119|NCT03240575|365949915|FG003|Overall Study|Withdrawal by Subject|1|||
106078120|NCT03240575|365949912|FG000|Overall Study|Other|0|||
106078121|NCT03240575|365949913|FG001|Overall Study|Other|1|||
106078122|NCT03240575|365949914|FG002|Overall Study|Other|0|||
106078123|NCT03240575|365949915|FG003|Overall Study|Other|0|||
106078124|NCT04013191|365949916|FG000|Overall Study|Adverse Event|1|||
106078125|NCT04013191|365949917|FG001|Overall Study|Adverse Event|0|||
106078126|NCT02449239|365949918|FG000|Induction Phase|Lack of Efficacy|64|||
106078127|NCT02449239|365949918|FG000|Induction Phase|Adverse Event|1|||
106078128|NCT02449239|365949918|FG000|Induction Phase|Lost to Follow-up|1|||
106078129|NCT02449239|365949918|FG000|Induction Phase|Protocol Violation|1|||
106078130|NCT02449239|365949918|FG000|Induction Phase|Physician Decision|1|||
106078131|NCT02449239|365949918|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
106078132|NCT02449239|365949918|FG000|Induction Phase|Withdrawal by Subject|1|||
106078133|NCT02449239|365949918|FG000|Maintenance Month 3|Lack of Efficacy|14|||
106078134|NCT02449239|365949918|FG000|Maintenance Month 6|Lack of Efficacy|10|||
106078135|NCT02449239|365949918|FG000|Maintenance Month 6|Adverse Event|2|||
106078136|NCT02449239|365949918|FG000|Maintenance Month 6|Physician Decision|1|||
106078137|NCT02449239|365949918|FG000|Maintenance Month 9|Lack of Efficacy|2|||
106078138|NCT02449239|365949918|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
106078139|NCT02449239|365949918|FG000|Maintenance Month 12|Lack of Efficacy|5|||
106078140|NCT02449239|365949918|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
106078141|NCT02449239|365949918|FG000|Maintenance Month 12|Subject moved from area|1|||
106078142|NCT02449239|365949918|FG000|Maintenance Month 15|Lack of Efficacy|1|||
106078143|NCT02449239|365949918|FG000|Maintenance Month 21|Lack of Efficacy|1|||
106078144|NCT02449239|365949918|FG000|Maintenance Month 21|Sponsor decision|1|||
106078145|NCT01236755|365949922|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
106078146|NCT01236755|365949922|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
106078147|NCT01236755|365949922|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
106097397|NCT01715805|366014395|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
106078148|NCT01236755|365949922|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
106078149|NCT00110812|365949925|FG000|Main Study|Death|0|||
106078150|NCT00110812|365949926|FG001|Main Study|Death|0|||
106078151|NCT00110812|365949927|FG002|Main Study|Death|2|||
106078152|NCT00110812|365949925|FG000|Main Study|Withdrawal by Subject|0|||
106078153|NCT00110812|365949926|FG001|Main Study|Withdrawal by Subject|0|||
106078154|NCT00110812|365949927|FG002|Main Study|Withdrawal by Subject|1|||
106078155|NCT00110812|365949925|FG000|Main Study|Lost to Follow-up|8|||
106078156|NCT00110812|365949926|FG001|Main Study|Lost to Follow-up|11|||
106078157|NCT00110812|365949927|FG002|Main Study|Lost to Follow-up|10|||
106078158|NCT00110812|365949925|FG000|Extended Follow-up|Death|1|||
106078159|NCT00110812|365949926|FG001|Extended Follow-up|Death|0|||
106078160|NCT00110812|365949927|FG002|Extended Follow-up|Death|3|||
106078161|NCT00110812|365949925|FG000|Extended Follow-up|Withdrawal by Subject|0|||
106078162|NCT00110812|365949926|FG001|Extended Follow-up|Withdrawal by Subject|1|||
106078163|NCT00110812|365949927|FG002|Extended Follow-up|Withdrawal by Subject|0|||
106078164|NCT00110812|365949925|FG000|Extended Follow-up|Lost to Follow-up|1|||
106078165|NCT00110812|365949926|FG001|Extended Follow-up|Lost to Follow-up|3|||
106078166|NCT00110812|365949927|FG002|Extended Follow-up|Lost to Follow-up|1|||
106078167|NCT01344369|365949928|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
106078168|NCT01344369|365949929|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
106078169|NCT01344369|365949928|FG000|Washout of 28 Days|Physician Decision|0|||
106078170|NCT01344369|365949929|FG001|Washout of 28 Days|Physician Decision|1|||
106078171|NCT01344369|365949928|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
106078172|NCT01344369|365949929|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
106078173|NCT00380393|365949930|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
106078174|NCT00380393|365949931|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
106078175|NCT00380393|365949930|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
106078176|NCT00380393|365949931|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
106078177|NCT00380393|365949930|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
106078178|NCT00380393|365949931|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
106078179|NCT00380393|365949930|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
106078180|NCT00380393|365949931|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
106078181|NCT00380393|365949930|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
106078182|NCT00380393|365949931|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
106078183|NCT00380393|365949930|FG000|Month 14|Withdrawal by Subject|9|||
106078184|NCT00380393|365949931|FG001|Month 14|Withdrawal by Subject|7|||
106078185|NCT00380393|365949930|FG000|Month 14|Death|1|||
106078186|NCT00380393|365949931|FG001|Month 14|Death|0|||
106078187|NCT00380393|365949930|FG000|Month 14|Lost to Follow-up|0|||
106078188|NCT00380393|365949931|FG001|Month 14|Lost to Follow-up|1|||
106078189|NCT00380393|365949930|FG000|Month 14|Migrated/moved from study area|39|||
106078190|NCT00380393|365949931|FG001|Month 14|Migrated/moved from study area|42|||
106078191|NCT00380393|365949930|FG000|Month 14|Protocol Violation|2|||
106078192|NCT00380393|365949931|FG001|Month 14|Protocol Violation|0|||
106078193|NCT00380393|365949930|FG000|Month 14|Others|6|||
106078194|NCT00380393|365949931|FG001|Month 14|Others|6|||
106078195|NCT01454726|365949932|FG000|Overall Study|Withdrawal by Subject|0|||
106078196|NCT01454726|365949933|FG001|Overall Study|Withdrawal by Subject|1|||
106078197|NCT04200248|365949934|FG000|Overall Study|Personal reasons|0|||
106078198|NCT04200248|365949935|FG001|Overall Study|Personal reasons|0|||
106078199|NCT04200248|365949936|FG002|Overall Study|Personal reasons|1|||
106078200|NCT04200248|365949934|FG000|Overall Study|Discontinued prior to treatment|3|||
106078201|NCT04200248|365949935|FG001|Overall Study|Discontinued prior to treatment|3|||
106078202|NCT04200248|365949936|FG002|Overall Study|Discontinued prior to treatment|2|||
106078203|NCT04476030|365949939|FG000|Overall Study|Withdrawal by Subject|20|||
106078204|NCT04476030|365949940|FG001|Overall Study|Withdrawal by Subject|16|||
106078205|NCT04476030|365949939|FG000|Overall Study|Adverse Event|10|||
106078206|NCT04476030|365949940|FG001|Overall Study|Adverse Event|11|||
106078207|NCT04476030|365949939|FG000|Overall Study|Lost to Follow-up|7|||
106078208|NCT04476030|365949940|FG001|Overall Study|Lost to Follow-up|4|||
106078209|NCT04476030|365949939|FG000|Overall Study|Physician Decision|1|||
106078210|NCT04476030|365949940|FG001|Overall Study|Physician Decision|1|||
106078211|NCT04476030|365949939|FG000|Overall Study|Protocol Deviation|2|||
106078212|NCT04476030|365949940|FG001|Overall Study|Protocol Deviation|0|||
106159781|NCT04209465|366245442|FG011|Overall Study|Lost to Follow-up|1|||
106078213|NCT04476030|365949939|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
106078214|NCT04476030|365949940|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
106078215|NCT04476030|365949939|FG000|Overall Study|Randomized but not Dosed|2|||
106078216|NCT04476030|365949940|FG001|Overall Study|Randomized but not Dosed|8|||
106078217|NCT02347527|365949943|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
106078218|NCT02347527|365949944|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
106078219|NCT02347527|365949945|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
106078220|NCT02347527|365949946|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
106078221|NCT02347527|365949943|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
106159782|NCT04209465|366245443|FG012|Overall Study|Lost to Follow-up|0|||
106078222|NCT02347527|365949944|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
106078223|NCT02347527|365949945|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
106078224|NCT02347527|365949946|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
106078225|NCT02347527|365949943|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
106078226|NCT02347527|365949944|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
106078227|NCT02347527|365949945|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
106078228|NCT02347527|365949946|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
106078229|NCT02347527|365949943|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
106078230|NCT02347527|365949944|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
106078231|NCT02347527|365949945|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
106078232|NCT02347527|365949946|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
106078233|NCT02347527|365949943|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
106078234|NCT02347527|365949944|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
106078235|NCT02347527|365949945|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
106078236|NCT02347527|365949946|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
106078237|NCT00934544|365949947|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
106078238|NCT00934544|365949948|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
106078239|NCT00934544|365949949|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
106078240|NCT00934544|365949947|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
106078241|NCT00934544|365949948|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
106078242|NCT00934544|365949949|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
106078243|NCT00934544|365949947|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
106078244|NCT00934544|365949948|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
106078245|NCT00934544|365949949|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
106078246|NCT00934544|365949947|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
106078247|NCT00934544|365949948|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
106078248|NCT00934544|365949949|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
106078249|NCT00934544|365949947|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
106078250|NCT00934544|365949948|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
106078251|NCT00934544|365949949|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
106078252|NCT00934544|365949947|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
106078253|NCT00934544|365949948|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
106078254|NCT00934544|365949949|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
106078255|NCT00934544|365949947|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
106078256|NCT00934544|365949948|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
106078257|NCT00934544|365949949|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
106078258|NCT00934544|365949947|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
106078259|NCT00934544|365949948|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
106078260|NCT00934544|365949949|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
106078261|NCT00934544|365949947|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
106078262|NCT00934544|365949948|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
106078263|NCT00934544|365949949|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
106078264|NCT00934544|365949947|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
106078265|NCT00934544|365949948|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
106078266|NCT00934544|365949949|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
106078267|NCT00934544|365949947|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
106078268|NCT00934544|365949948|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
106078269|NCT00934544|365949949|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
106078270|NCT00934544|365949947|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
106078271|NCT00934544|365949948|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
106078272|NCT00934544|365949949|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
106078273|NCT00934544|365949947|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
106078274|NCT00934544|365949948|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
106078275|NCT00934544|365949949|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
106078276|NCT00934544|365949947|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
106078277|NCT00934544|365949948|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
106078278|NCT00934544|365949949|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
106078279|NCT00934544|365949947|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
106078280|NCT00934544|365949948|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
106078281|NCT00934544|365949949|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
106078282|NCT00934544|365949947|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
106078283|NCT00934544|365949948|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
106078284|NCT00934544|365949949|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
106078285|NCT00302003|365949950|FG000|Overall Study|Lack of Efficacy|62|||
106078286|NCT00302003|365949950|FG000|Overall Study|Lost to Follow-up|1|||
106078287|NCT00302003|365949950|FG000|Overall Study|Physician Decision|2|||
106078288|NCT00302003|365949950|FG000|Overall Study|Withdrawal by Subject|5|||
106078289|NCT00302003|365949950|FG000|Overall Study|Ineligible|9|||
106078290|NCT00302003|365949950|FG000|Overall Study|Protocol Violation|1|||
106078291|NCT02042924|365949951|FG000|Overall Study|Early Death|1|||
106078292|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
106078293|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
106078294|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
106078295|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
106078296|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
106078297|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
106078298|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
106078299|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
106078300|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
106078301|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
106078302|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
106078303|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
106078304|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
106078305|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
106078306|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
106078307|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
106078308|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
106078309|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
106078310|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
106078311|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
106159783|NCT04209465|366245431|FG000|Overall Study|Started new therapy|0|||
106159784|NCT04209465|366245432|FG001|Overall Study|Started new therapy|0|||
106159785|NCT04209465|366245433|FG002|Overall Study|Started new therapy|0|||
106159786|NCT04209465|366245434|FG003|Overall Study|Started new therapy|0|||
106159787|NCT04209465|366245435|FG004|Overall Study|Started new therapy|0|||
106159788|NCT04209465|366245436|FG005|Overall Study|Started new therapy|1|||
106159789|NCT04209465|366245437|FG006|Overall Study|Started new therapy|0|||
106159790|NCT04209465|366245438|FG007|Overall Study|Started new therapy|0|||
106159791|NCT04209465|366245439|FG008|Overall Study|Started new therapy|0|||
106159792|NCT04209465|366245440|FG009|Overall Study|Started new therapy|0|||
106159793|NCT04209465|366245441|FG010|Overall Study|Started new therapy|0|||
106159794|NCT04209465|366245442|FG011|Overall Study|Started new therapy|0|||
106159795|NCT04209465|366245443|FG012|Overall Study|Started new therapy|0|||
106159796|NCT04209465|366245431|FG000|Overall Study|Study terminated early by sponsor|0|||
106159797|NCT04209465|366245432|FG001|Overall Study|Study terminated early by sponsor|0|||
106159798|NCT04209465|366245433|FG002|Overall Study|Study terminated early by sponsor|0|||
106159799|NCT04209465|366245434|FG003|Overall Study|Study terminated early by sponsor|0|||
106159800|NCT04209465|366245435|FG004|Overall Study|Study terminated early by sponsor|0|||
106159801|NCT04209465|366245436|FG005|Overall Study|Study terminated early by sponsor|0|||
106159802|NCT04209465|366245437|FG006|Overall Study|Study terminated early by sponsor|3|||
106159803|NCT04209465|366245438|FG007|Overall Study|Study terminated early by sponsor|0|||
106159804|NCT04209465|366245439|FG008|Overall Study|Study terminated early by sponsor|0|||
106159805|NCT04209465|366245440|FG009|Overall Study|Study terminated early by sponsor|0|||
106078312|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
106078313|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
106078314|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
106159806|NCT04209465|366245441|FG010|Overall Study|Study terminated early by sponsor|0|||
106159807|NCT04209465|366245442|FG011|Overall Study|Study terminated early by sponsor|0|||
106159808|NCT04209465|366245443|FG012|Overall Study|Study terminated early by sponsor|3|||
106159809|NCT04209465|366245431|FG000|Overall Study|Other|0|||
106159810|NCT04209465|366245432|FG001|Overall Study|Other|0|||
106159811|NCT04209465|366245433|FG002|Overall Study|Other|0|||
106159812|NCT04209465|366245434|FG003|Overall Study|Other|0|||
106159813|NCT04209465|366245435|FG004|Overall Study|Other|0|||
106159814|NCT04209465|366245436|FG005|Overall Study|Other|0|||
106159815|NCT04209465|366245437|FG006|Overall Study|Other|0|||
106159816|NCT04209465|366245438|FG007|Overall Study|Other|0|||
106159817|NCT04209465|366245439|FG008|Overall Study|Other|1|||
106159818|NCT04209465|366245440|FG009|Overall Study|Other|0|||
106159819|NCT04209465|366245441|FG010|Overall Study|Other|0|||
106159820|NCT04209465|366245442|FG011|Overall Study|Other|0|||
106159821|NCT04209465|366245443|FG012|Overall Study|Other|0|||
105867007|NCT02422797|365163105|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
106159822|NCT05030233|366245444|FG000|Overall Study|withdrawn for transfer|1|||
106159823|NCT05030233|366245445|FG001|Overall Study|withdrawn for transfer|0|||
106159824|NCT03365882|366245446|FG000|Randomization|Still Receiving Protocol Treatment|2|||
106159825|NCT03365882|366245447|FG001|Randomization|Still Receiving Protocol Treatment|0|||
106159826|NCT03365882|366245446|FG000|Randomization|Adverse Event|1|||
106159827|NCT03365882|366245447|FG001|Randomization|Adverse Event|2|||
106159828|NCT03365882|366245446|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
106159829|NCT03365882|366245447|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
106159830|NCT03365882|366245446|FG000|Randomization|Progression/Relapse|21|||
106159831|NCT03365882|366245447|FG001|Randomization|Progression/Relapse|3|||
106159832|NCT03365882|366245446|FG000|Randomization|Death|1|||
106159833|NCT03365882|366245447|FG001|Randomization|Death|0|||
106159834|NCT03365882|366245446|FG000|Randomization|Other - Not Protocol Specified|1|||
106159835|NCT03365882|366245447|FG001|Randomization|Other - Not Protocol Specified|1|||
106159836|NCT03365882|366245446|FG000|Randomization|Major Protocol Deviation|0|||
106159837|NCT03365882|366245447|FG001|Randomization|Major Protocol Deviation|1|||
106159838|NCT03365882|366245446|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
106159839|NCT03365882|366245447|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
106159840|NCT03365882|366245446|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
106159841|NCT03365882|366245447|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
106159842|NCT03365882|366245446|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
106159843|NCT03365882|366245447|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
106159844|NCT03365882|366245446|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
106159845|NCT03365882|366245447|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
106159846|NCT04437615|366245448|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
106159847|NCT05374837|366247346|FG000|Overall Study|Lost to Follow-up|17|||
106159848|NCT05374837|366247347|FG001|Overall Study|Lost to Follow-up|18|||
106159849|NCT04401267|366247349|FG000|Overall Study|Death|0|||
106159850|NCT04401267|366247350|FG001|Overall Study|Death|1|||
106159851|NCT04401267|366247349|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
106159852|NCT04401267|366247350|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
106159853|NCT04401267|366247349|FG000|Overall Study|Found to be Ineligible|1|||
106159854|NCT04401267|366247350|FG001|Overall Study|Found to be Ineligible|0|||
106159855|NCT02995434|366247355|FG000|Overall Study|Adverse Event|1|||
106159856|NCT02995434|366247356|FG001|Overall Study|Adverse Event|0|||
106159857|NCT02995434|366247355|FG000|Overall Study|Withdrawal by Subject|6|||
106159858|NCT02995434|366247356|FG001|Overall Study|Withdrawal by Subject|3|||
106159859|NCT02506959|366247366|FG000|Overall Study|Physician Decision|2|||
106159860|NCT02506959|366247367|FG001|Overall Study|Physician Decision|1|||
106159861|NCT03338790|366247376|FG000|Overall Study|Disease Progression|65|||
106159862|NCT03338790|366247377|FG001|Overall Study|Disease Progression|43|||
106159863|NCT03338790|366247378|FG002|Overall Study|Disease Progression|50|||
106159864|NCT03338790|366247379|FG003|Overall Study|Disease Progression|37|||
106159865|NCT03338790|366247376|FG000|Overall Study|Study Drug Toxicity|9|||
106159866|NCT03338790|366247377|FG001|Overall Study|Study Drug Toxicity|8|||
106159867|NCT03338790|366247378|FG002|Overall Study|Study Drug Toxicity|15|||
106159868|NCT03338790|366247379|FG003|Overall Study|Study Drug Toxicity|0|||
106159869|NCT03338790|366247376|FG000|Overall Study|Death|1|||
106159870|NCT03338790|366247377|FG001|Overall Study|Death|1|||
106159871|NCT03338790|366247378|FG002|Overall Study|Death|1|||
106159872|NCT03338790|366247379|FG003|Overall Study|Death|0|||
106159873|NCT03338790|366247376|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
106159874|NCT03338790|366247377|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
106159875|NCT03338790|366247378|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
106159876|NCT03338790|366247379|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
106159877|NCT03338790|366247376|FG000|Overall Study|Participant request to discontinue study treatment|3|||
106159878|NCT03338790|366247377|FG001|Overall Study|Participant request to discontinue study treatment|3|||
106159879|NCT03338790|366247378|FG002|Overall Study|Participant request to discontinue study treatment|2|||
106159880|NCT03338790|366247379|FG003|Overall Study|Participant request to discontinue study treatment|1|||
106159881|NCT03338790|366247376|FG000|Overall Study|Poor/non-compliance|0|||
106159882|NCT03338790|366247377|FG001|Overall Study|Poor/non-compliance|1|||
106159883|NCT03338790|366247378|FG002|Overall Study|Poor/non-compliance|0|||
106159884|NCT03338790|366247379|FG003|Overall Study|Poor/non-compliance|0|||
106159885|NCT03338790|366247376|FG000|Overall Study|Participant withdrew consent|1|||
106159886|NCT03338790|366247377|FG001|Overall Study|Participant withdrew consent|0|||
106159887|NCT03338790|366247378|FG002|Overall Study|Participant withdrew consent|1|||
106159888|NCT03338790|366247379|FG003|Overall Study|Participant withdrew consent|1|||
106159889|NCT03338790|366247376|FG000|Overall Study|Other reasons|0|||
106159890|NCT03338790|366247377|FG001|Overall Study|Other reasons|5|||
106159891|NCT03338790|366247378|FG002|Overall Study|Other reasons|0|||
106159892|NCT03338790|366247379|FG003|Overall Study|Other reasons|2|||
106159893|NCT03338790|366247376|FG000|Overall Study|Not reported|0|||
106078315|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
106078316|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
106078317|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
106078318|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
106078319|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
106078320|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
106078321|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
106078322|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
106078323|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
106078324|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
106078325|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
106078326|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
106078327|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
106078328|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
106078329|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
106078330|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
106078331|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
106078332|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
106078333|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
106078334|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
106078335|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
106078336|NCT01218516|365949952|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
106078337|NCT01218516|365949953|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
106078338|NCT01218516|365949954|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
106078339|NCT01218516|365949955|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
106078340|NCT04033003|365949956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
106078341|NCT04033003|365949957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
106078342|NCT04033003|365949956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
106078343|NCT04033003|365949957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
106078344|NCT04033003|365949956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
106078345|NCT04033003|365949957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
106078346|NCT04033003|365949956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
106078347|NCT04033003|365949957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
106078348|NCT04033003|365949956|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
106078349|NCT04033003|365949957|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
106078350|NCT04033003|365949956|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
106078351|NCT04033003|365949957|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
106078352|NCT04033003|365949956|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
106078353|NCT04033003|365949957|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
106078354|NCT04033003|365949956|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
106078355|NCT04033003|365949957|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
106078356|NCT04033003|365949956|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
106078357|NCT04033003|365949957|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
106078358|NCT04033003|365949956|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
106078359|NCT04033003|365949957|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
106078360|NCT04033003|365949956|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
106078361|NCT04033003|365949957|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
106078362|NCT04033003|365949956|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
106078363|NCT04033003|365949957|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
106078364|NCT04033003|365949956|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
106078365|NCT04033003|365949957|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
106078366|NCT00240071|365949958|FG000|Overall Study|Withdrawal by Subject|3|||
106078367|NCT01344447|365949959|FG000|Overall Study|Adverse Event|1|||
106078368|NCT01344447|365949959|FG000|Overall Study|Protocol Violation|1|||
106078369|NCT01344447|365949959|FG000|Overall Study|Withdrawal by Subject|1|||
106078370|NCT01344447|365949959|FG000|Overall Study|The contrast was not seen|1|||
106078371|NCT01344447|365949959|FG000|Overall Study|Physician Decision|1|||
106078372|NCT01344447|365949959|FG000|Overall Study|MRA unsuccessful|1|||
106078373|NCT01344447|365949959|FG000|Overall Study|Bolus tracking failed|1|||
106078374|NCT01344447|365949959|FG000|Overall Study|Error of power injector|1|||
106078375|NCT02365636|365949960|FG000|Overall Study|Adverse Event|3|||
106078376|NCT02365636|365949961|FG001|Overall Study|Adverse Event|3|||
106078377|NCT02365636|365949962|FG002|Overall Study|Adverse Event|2|||
106078378|NCT02365636|365949960|FG000|Overall Study|Protocol Violation|1|||
106078379|NCT02365636|365949961|FG001|Overall Study|Protocol Violation|4|||
106078380|NCT02365636|365949962|FG002|Overall Study|Protocol Violation|0|||
106078381|NCT02365636|365949960|FG000|Overall Study|Lost to Follow-up|0|||
106159894|NCT03338790|366247377|FG001|Overall Study|Not reported|0|||
106159895|NCT03338790|366247378|FG002|Overall Study|Not reported|1|||
106159896|NCT03338790|366247379|FG003|Overall Study|Not reported|0|||
106159897|NCT03338790|366247376|FG000|Overall Study|Completed treatment period|1|||
106159898|NCT03338790|366247377|FG001|Overall Study|Completed treatment period|2|||
106159899|NCT03338790|366247378|FG002|Overall Study|Completed treatment period|0|||
106159900|NCT03338790|366247379|FG003|Overall Study|Completed treatment period|0|||
106159901|NCT02783300|366247380|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159902|NCT02783300|366247381|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159903|NCT02783300|366247382|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159904|NCT02783300|366247383|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159905|NCT02783300|366247384|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159906|NCT02783300|366247385|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159907|NCT02783300|366247386|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
106159908|NCT02783300|366247387|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159909|NCT02783300|366247388|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159910|NCT02783300|366247389|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159911|NCT02783300|366247390|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159912|NCT02783300|366247391|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159913|NCT02783300|366247392|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159914|NCT02783300|366247393|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159915|NCT02783300|366247394|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159916|NCT02783300|366247395|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159917|NCT02783300|366247396|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159918|NCT02783300|366247397|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159919|NCT02783300|366247398|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159920|NCT02783300|366247399|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159921|NCT02783300|366247400|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159922|NCT02783300|366247401|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159923|NCT02783300|366247402|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159924|NCT02783300|366247403|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159925|NCT02783300|366247404|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159926|NCT02783300|366247405|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159927|NCT02783300|366247406|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
106159928|NCT02783300|366247380|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159929|NCT02783300|366247381|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159930|NCT02783300|366247382|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159931|NCT02783300|366247383|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
106159932|NCT02783300|366247384|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106078382|NCT02365636|365949961|FG001|Overall Study|Lost to Follow-up|0|||
106078383|NCT02365636|365949962|FG002|Overall Study|Lost to Follow-up|1|||
106078384|NCT02365636|365949960|FG000|Overall Study|Other|2|||
106078385|NCT02365636|365949961|FG001|Overall Study|Other|0|||
106078386|NCT02365636|365949962|FG002|Overall Study|Other|0|||
106078387|NCT01454934|365949966|FG000|Overall Study|Clinical progression|28|||
106078388|NCT01454934|365949967|FG001|Overall Study|Clinical progression|25|||
106078389|NCT01454934|365949966|FG000|Overall Study|Other|6|||
106078390|NCT01454934|365949967|FG001|Overall Study|Other|17|||
106078391|NCT01454934|365949966|FG000|Overall Study|Adverse Event|28|||
106078392|NCT01454934|365949967|FG001|Overall Study|Adverse Event|24|||
106078393|NCT01454934|365949966|FG000|Overall Study|Withdrawn consent|2|||
106078394|NCT01454934|365949967|FG001|Overall Study|Withdrawn consent|5|||
106078395|NCT01454934|365949966|FG000|Overall Study|Withdrawal by Subject|11|||
106078396|NCT01454934|365949967|FG001|Overall Study|Withdrawal by Subject|15|||
106078397|NCT01454934|365949966|FG000|Overall Study|Disease progression|194|||
106078398|NCT01454934|365949967|FG001|Overall Study|Disease progression|181|||
106078399|NCT01454934|365949966|FG000|Overall Study|Lost to Follow-up|0|||
106078400|NCT01454934|365949967|FG001|Overall Study|Lost to Follow-up|1|||
106078401|NCT01454934|365949966|FG000|Overall Study|Not treated|1|||
106078402|NCT01454934|365949967|FG001|Overall Study|Not treated|2|||
106159933|NCT02783300|366247385|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159934|NCT02783300|366247386|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159935|NCT02783300|366247387|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159936|NCT02783300|366247388|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159937|NCT02783300|366247389|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159938|NCT02783300|366247390|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159939|NCT02783300|366247391|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159940|NCT02783300|366247392|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159941|NCT02783300|366247393|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159942|NCT02783300|366247394|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159943|NCT02783300|366247395|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159944|NCT02783300|366247396|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159945|NCT02783300|366247397|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159946|NCT02783300|366247398|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159947|NCT02783300|366247399|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159948|NCT02783300|366247400|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159949|NCT02783300|366247401|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159950|NCT02783300|366247402|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159951|NCT02783300|366247403|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159952|NCT02783300|366247404|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159953|NCT02783300|366247405|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159954|NCT02783300|366247406|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
106159955|NCT02783300|366247380|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
106159956|NCT02783300|366247381|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
106159957|NCT02783300|366247382|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
106159958|NCT02783300|366247383|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
106159959|NCT02783300|366247384|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
106159960|NCT02783300|366247385|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
106159961|NCT02783300|366247386|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
106159962|NCT02783300|366247387|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
106159963|NCT02783300|366247388|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
106159964|NCT02783300|366247389|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
106159965|NCT02783300|366247390|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
106159966|NCT02783300|366247391|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
106159967|NCT02783300|366247392|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
106159968|NCT02783300|366247393|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
106159969|NCT02783300|366247394|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
106159970|NCT02783300|366247395|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
106159971|NCT02783300|366247396|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
106159972|NCT02783300|366247397|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
106159973|NCT02783300|366247398|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
106159974|NCT02783300|366247399|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
106159975|NCT02783300|366247400|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
106159976|NCT02783300|366247401|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
106159977|NCT02783300|366247402|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
106159978|NCT02783300|366247403|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
106078403|NCT02118428|365949970|FG000|Overall Study|Physician Decision|0|||
106078404|NCT02118428|365949971|FG001|Overall Study|Physician Decision|1|||
106078405|NCT02118428|365949972|FG002|Overall Study|Physician Decision|0|||
106078406|NCT02118428|365949970|FG000|Overall Study|Withdrawal by Subject|2|||
106078407|NCT02118428|365949971|FG001|Overall Study|Withdrawal by Subject|2|||
106078408|NCT02118428|365949972|FG002|Overall Study|Withdrawal by Subject|0|||
106078409|NCT02118428|365949970|FG000|Overall Study|Death|7|||
106078410|NCT02118428|365949971|FG001|Overall Study|Death|5|||
106078411|NCT02118428|365949972|FG002|Overall Study|Death|0|||
106078412|NCT02118428|365949970|FG000|Overall Study|Lost to Follow-up|3|||
106078413|NCT02118428|365949971|FG001|Overall Study|Lost to Follow-up|1|||
106078414|NCT02118428|365949972|FG002|Overall Study|Lost to Follow-up|0|||
106078415|NCT02118428|365949970|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
106159979|NCT02783300|366247404|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
106159980|NCT02783300|366247405|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
106159981|NCT02783300|366247406|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
106159982|NCT02783300|366247380|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159983|NCT02783300|366247381|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159984|NCT02783300|366247382|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159985|NCT02783300|366247383|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159986|NCT02783300|366247384|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159987|NCT02783300|366247385|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159988|NCT02783300|366247386|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
106159989|NCT02783300|366247387|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159990|NCT02783300|366247388|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159991|NCT02783300|366247389|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159992|NCT02783300|366247390|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159993|NCT02783300|366247391|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159994|NCT02783300|366247392|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
106078416|NCT02118428|365949971|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
106078417|NCT02118428|365949972|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
106078418|NCT02884089|365949976|FG000|Period 1|Dosing error|2|||
106078419|NCT02884089|365949977|FG001|Period 1|Dosing error|2|||
106078420|NCT02884089|365949978|FG002|Period 1|Dosing error|0|||
106078421|NCT02884089|365949979|FG003|Period 1|Dosing error|0|||
106078422|NCT02884089|365949976|FG000|Washout Period 1|Lost to Follow-up|0|||
106078423|NCT02884089|365949977|FG001|Washout Period 1|Lost to Follow-up|1|||
106078424|NCT02884089|365949978|FG002|Washout Period 1|Lost to Follow-up|0|||
106078425|NCT02884089|365949979|FG003|Washout Period 1|Lost to Follow-up|1|||
106078426|NCT02884089|365949976|FG000|Washout Period 1|Withdrawal by Subject|0|||
106078427|NCT02884089|365949977|FG001|Washout Period 1|Withdrawal by Subject|1|||
106078428|NCT02884089|365949978|FG002|Washout Period 1|Withdrawal by Subject|0|||
106078429|NCT02884089|365949979|FG003|Washout Period 1|Withdrawal by Subject|0|||
106078430|NCT02884089|365949976|FG000|Period 2|Adverse Event|1|||
106078431|NCT02884089|365949977|FG001|Period 2|Adverse Event|0|||
106078432|NCT02884089|365949978|FG002|Period 2|Adverse Event|0|||
106078433|NCT02884089|365949979|FG003|Period 2|Adverse Event|0|||
106078434|NCT02884089|365949976|FG000|Period 3|Withdrawal by Subject|0|||
106078435|NCT02884089|365949977|FG001|Period 3|Withdrawal by Subject|0|||
106078436|NCT02884089|365949978|FG002|Period 3|Withdrawal by Subject|1|||
106078437|NCT02884089|365949979|FG003|Period 3|Withdrawal by Subject|0|||
106078438|NCT02884089|365949976|FG000|Washout Period 3|Withdrawal by Subject|0|||
106078439|NCT02884089|365949977|FG001|Washout Period 3|Withdrawal by Subject|0|||
106078440|NCT02884089|365949978|FG002|Washout Period 3|Withdrawal by Subject|1|||
106078441|NCT02884089|365949979|FG003|Washout Period 3|Withdrawal by Subject|0|||
106078442|NCT02884089|365949976|FG000|Washout Period 3|Lost to Follow-up|0|||
106078443|NCT02884089|365949977|FG001|Washout Period 3|Lost to Follow-up|0|||
106078444|NCT02884089|365949978|FG002|Washout Period 3|Lost to Follow-up|0|||
106078445|NCT02884089|365949979|FG003|Washout Period 3|Lost to Follow-up|1|||
106078446|NCT02884089|365949976|FG000|Period 4|Withdrawal by Subject|0|||
106078447|NCT02884089|365949977|FG001|Period 4|Withdrawal by Subject|1|||
106078448|NCT02884089|365949978|FG002|Period 4|Withdrawal by Subject|0|||
106078449|NCT02884089|365949979|FG003|Period 4|Withdrawal by Subject|0|||
106078450|NCT02884089|365949976|FG000|Period 4|Lost to Follow-up|1|||
106078451|NCT02884089|365949977|FG001|Period 4|Lost to Follow-up|0|||
106078452|NCT02884089|365949978|FG002|Period 4|Lost to Follow-up|0|||
106078453|NCT02884089|365949979|FG003|Period 4|Lost to Follow-up|0|||
106078454|NCT02884089|365949976|FG000|Follow-up Visit|Withdrawal by Subject|1|||
106078455|NCT02884089|365949977|FG001|Follow-up Visit|Withdrawal by Subject|0|||
106078456|NCT02884089|365949978|FG002|Follow-up Visit|Withdrawal by Subject|0|||
106078457|NCT02884089|365949979|FG003|Follow-up Visit|Withdrawal by Subject|1|||
106078458|NCT02487394|365949980|FG000|Phase 1|Withdrawal by Subject|0|||
106078459|NCT02487394|365949981|FG001|Phase 1|Withdrawal by Subject|1|||
106078460|NCT00594464|365950000|FG000|Overall Study|Withdrawal by Subject|1|||
106078461|NCT00594464|365950000|FG000|Overall Study|Delay in operation|2|||
106078462|NCT03742141|365950001|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
106078463|NCT00291668|365950005|FG000|Overall Study|Lack of Efficacy|1|||
106159995|NCT02783300|366247393|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159996|NCT02783300|366247394|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106159997|NCT02783300|366247395|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106078464|NCT00291668|365950006|FG001|Overall Study|Lack of Efficacy|0|||
106078465|NCT00291668|365950007|FG002|Overall Study|Lack of Efficacy|0|||
106078466|NCT00291668|365950005|FG000|Overall Study|SAE, non-fatal|1|||
106078467|NCT00291668|365950006|FG001|Overall Study|SAE, non-fatal|1|||
106078468|NCT00291668|365950007|FG002|Overall Study|SAE, non-fatal|1|||
106078469|NCT00291668|365950005|FG000|Overall Study|AE, non-serious non-fatal|1|||
106078470|NCT00291668|365950006|FG001|Overall Study|AE, non-serious non-fatal|0|||
106078471|NCT00291668|365950007|FG002|Overall Study|AE, non-serious non-fatal|0|||
106078472|NCT00291668|365950005|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
106078473|NCT00291668|365950006|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
106078474|NCT00291668|365950007|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
106078475|NCT00313612|365950008|FG000|Overall Study|Patient never received treatment|0|||
106078476|NCT00313612|365950009|FG001|Overall Study|Patient never received treatment|1|||
106078477|NCT02281552|365950010|FG000|Overall Study|Medication error|1|||
106078478|NCT02281552|365950011|FG001|Overall Study|Medication error|0|||
106078479|NCT02281552|365950010|FG000|Overall Study|Insufficient clinical response|0|||
106078480|NCT02281552|365950011|FG001|Overall Study|Insufficient clinical response|1|||
106078481|NCT02281552|365950010|FG000|Overall Study|Adverse Event|3|||
106078482|NCT02281552|365950011|FG001|Overall Study|Adverse Event|9|||
106078483|NCT00615056|365950012|FG000|Overall Study|Death|31|||
106078484|NCT00615056|365950013|FG001|Overall Study|Death|31|||
106078485|NCT00615056|365950014|FG002|Overall Study|Death|21|||
106078486|NCT00615056|365950015|FG003|Overall Study|Death|23|||
106078487|NCT00615056|365950012|FG000|Overall Study|Lost to Follow-up|1|||
106078488|NCT00615056|365950013|FG001|Overall Study|Lost to Follow-up|2|||
106078489|NCT00615056|365950014|FG002|Overall Study|Lost to Follow-up|4|||
106078490|NCT00615056|365950015|FG003|Overall Study|Lost to Follow-up|5|||
106078491|NCT00615056|365950012|FG000|Overall Study|Other|13|||
106078492|NCT00615056|365950013|FG001|Overall Study|Other|15|||
106078493|NCT00615056|365950014|FG002|Overall Study|Other|10|||
106078494|NCT00615056|365950015|FG003|Overall Study|Other|7|||
106078495|NCT00615056|365950012|FG000|Overall Study|Objective progression or relapse|0|||
106078496|NCT00615056|365950013|FG001|Overall Study|Objective progression or relapse|2|||
106078497|NCT00615056|365950014|FG002|Overall Study|Objective progression or relapse|0|||
106078498|NCT00615056|365950015|FG003|Overall Study|Objective progression or relapse|0|||
106078499|NCT00615056|365950012|FG000|Overall Study|Withdrawal by Subject|0|||
106078500|NCT00615056|365950013|FG001|Overall Study|Withdrawal by Subject|1|||
106078501|NCT00615056|365950014|FG002|Overall Study|Withdrawal by Subject|1|||
106078502|NCT00615056|365950015|FG003|Overall Study|Withdrawal by Subject|0|||
106078503|NCT00615056|365950012|FG000|Overall Study|Discontinued by Sponsor|1|||
106078504|NCT00615056|365950013|FG001|Overall Study|Discontinued by Sponsor|0|||
106078505|NCT00615056|365950014|FG002|Overall Study|Discontinued by Sponsor|0|||
106078506|NCT00615056|365950015|FG003|Overall Study|Discontinued by Sponsor|0|||
106078507|NCT00615056|365950012|FG000|Overall Study|Randomized but not treated|3|||
106078508|NCT00615056|365950013|FG001|Overall Study|Randomized but not treated|0|||
106078509|NCT00615056|365950014|FG002|Overall Study|Randomized but not treated|0|||
106078510|NCT00615056|365950015|FG003|Overall Study|Randomized but not treated|0|||
106078511|NCT00717769|365950016|FG000|Overall Study|Adverse Event|9|||
106078512|NCT00717769|365950017|FG001|Overall Study|Adverse Event|6|||
106078513|NCT00717769|365950018|FG002|Overall Study|Adverse Event|1|||
106078514|NCT00717769|365950016|FG000|Overall Study|Lack of compliance|0|||
106078515|NCT00717769|365950017|FG001|Overall Study|Lack of compliance|2|||
106078516|NCT00717769|365950018|FG002|Overall Study|Lack of compliance|0|||
106078517|NCT00717769|365950016|FG000|Overall Study|Lost to Follow-up|3|||
106078518|NCT00717769|365950017|FG001|Overall Study|Lost to Follow-up|4|||
106078519|NCT00717769|365950018|FG002|Overall Study|Lost to Follow-up|0|||
106078520|NCT00717769|365950016|FG000|Overall Study|Lack of Efficacy|1|||
106078521|NCT00717769|365950017|FG001|Overall Study|Lack of Efficacy|2|||
106078522|NCT00717769|365950018|FG002|Overall Study|Lack of Efficacy|0|||
106078523|NCT00717769|365950016|FG000|Overall Study|Protocol Violation|0|||
106078524|NCT00717769|365950017|FG001|Overall Study|Protocol Violation|2|||
106078525|NCT00717769|365950018|FG002|Overall Study|Protocol Violation|0|||
106078526|NCT00717769|365950016|FG000|Overall Study|Sponsor decision|1|||
106078527|NCT00717769|365950017|FG001|Overall Study|Sponsor decision|0|||
106078528|NCT00717769|365950018|FG002|Overall Study|Sponsor decision|10|||
106078529|NCT00717769|365950016|FG000|Overall Study|Withdrew consent|2|||
106078530|NCT00717769|365950017|FG001|Overall Study|Withdrew consent|2|||
106078531|NCT00717769|365950018|FG002|Overall Study|Withdrew consent|0|||
106078532|NCT02196324|365950020|FG000|Overall Study|Withdrawal by Subject|8|||
106078533|NCT02196324|365950021|FG001|Overall Study|Withdrawal by Subject|4|||
106078534|NCT02196324|365950020|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
106078535|NCT02196324|365950021|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
106078536|NCT02196324|365950020|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
106078537|NCT02196324|365950021|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
106078538|NCT02196324|365950020|FG000|Overall Study|Other|1|||
106078539|NCT02196324|365950021|FG001|Overall Study|Other|0|||
106078540|NCT00692770|365950024|FG000|Overall Study|Protocol Violation|2|||
106159998|NCT02783300|366247396|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106078541|NCT00692770|365950025|FG001|Overall Study|Protocol Violation|7|||
106078542|NCT00692770|365950024|FG000|Overall Study|Withdrawal by Subject|97|||
106078543|NCT00692770|365950025|FG001|Overall Study|Withdrawal by Subject|36|||
106078544|NCT00692770|365950024|FG000|Overall Study|Adverse Event|136|||
106078545|NCT00692770|365950025|FG001|Overall Study|Adverse Event|41|||
106078546|NCT00692770|365950024|FG000|Overall Study|Death|10|||
106078547|NCT00692770|365950025|FG001|Overall Study|Death|5|||
106078548|NCT00692770|365950024|FG000|Overall Study|Lost to Follow-up|7|||
106078549|NCT00692770|365950025|FG001|Overall Study|Lost to Follow-up|3|||
106078550|NCT00692770|365950024|FG000|Overall Study|Non-compliant with study medication|11|||
106078551|NCT00692770|365950025|FG001|Overall Study|Non-compliant with study medication|5|||
106078552|NCT00692770|365950024|FG000|Overall Study|Progression by clinical judgment|2|||
106078553|NCT00692770|365950025|FG001|Overall Study|Progression by clinical judgment|3|||
106078554|NCT00692770|365950024|FG000|Overall Study|Physician decision not protocol driven|10|||
106078555|NCT00692770|365950025|FG001|Overall Study|Physician decision not protocol driven|14|||
106078556|NCT00692770|365950024|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
106078557|NCT00692770|365950025|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
106078558|NCT00692770|365950024|FG000|Overall Study|Protocol driven decision point|3|||
106078559|NCT00692770|365950025|FG001|Overall Study|Protocol driven decision point|7|||
106078560|NCT00692770|365950024|FG000|Overall Study|Completed all planned assessments|79|||
106078561|NCT00692770|365950025|FG001|Overall Study|Completed all planned assessments|101|||
106078562|NCT00692770|365950024|FG000|Overall Study|Radiological and clinical progression|8|||
106078563|NCT00692770|365950025|FG001|Overall Study|Radiological and clinical progression|8|||
106078564|NCT00692770|365950024|FG000|Overall Study|Clinical endpoint reached|16|||
106078565|NCT00692770|365950025|FG001|Overall Study|Clinical endpoint reached|43|||
106078566|NCT00692770|365950024|FG000|Overall Study|Study terminated by sponsor|2|||
106078567|NCT00692770|365950025|FG001|Overall Study|Study terminated by sponsor|2|||
106078568|NCT00692770|365950024|FG000|Overall Study|Randomized but not treated|3|||
106078569|NCT00692770|365950025|FG001|Overall Study|Randomized but not treated|4|||
106078570|NCT04248816|365950027|FG000|Overall Study|Ineligible post-randomization|7|||
106078571|NCT04248816|365950028|FG001|Overall Study|Ineligible post-randomization|21|||
106078572|NCT04248816|365950029|FG002|Overall Study|Ineligible post-randomization|25|||
106078573|NCT03350503|365950032|FG000|Overall Study|Adverse Event|5|||
106078574|NCT03350503|365950032|FG000|Overall Study|Withdrawal by Subject|5|||
106078575|NCT03350503|365950032|FG000|Overall Study|Continuation impossible due to move|4|||
106078576|NCT03350503|365950032|FG000|Overall Study|Physician Decision|3|||
106078577|NCT00655564|365950038|FG000|Overall Study|Adverse Event|1|||
106078578|NCT00655564|365950038|FG000|Overall Study|Lost to Follow-up|1|||
106078579|NCT00655564|365950038|FG000|Overall Study|Desired Alternate Therapy|1|||
106078580|NCT00344773|365950039|FG000|Overall Study|Adverse Event|2|||
106078581|NCT00344773|365950039|FG000|Overall Study|Objective Disease Progression|16|||
106078582|NCT00344773|365950039|FG000|Overall Study|Withdrawal by Subject|1|||
106078583|NCT00344773|365950039|FG000|Overall Study|Not Eligible for the study|2|||
106078584|NCT04804813|365950040|FG000|Overall Study|Protocol Violation|2|||
106078585|NCT04804813|365950041|FG001|Overall Study|Protocol Violation|0|||
106078586|NCT04804813|365950040|FG000|Overall Study|Withdrawal by Subject|1|||
106078587|NCT04804813|365950041|FG001|Overall Study|Withdrawal by Subject|0|||
106078588|NCT03003520|365951511|FG000|Overall Study|Adverse Event|9|||
106078589|NCT03003520|365951512|FG001|Overall Study|Adverse Event|0|||
106078590|NCT03003520|365951511|FG000|Overall Study|Death|1|||
106078591|NCT03003520|365951512|FG001|Overall Study|Death|0|||
106078592|NCT03003520|365951511|FG000|Overall Study|Other reasons|4|||
106078593|NCT03003520|365951512|FG001|Overall Study|Other reasons|0|||
106078594|NCT03003520|365951511|FG000|Overall Study|Withdrawal by Subject|6|||
106078595|NCT03003520|365951512|FG001|Overall Study|Withdrawal by Subject|0|||
106078596|NCT03003520|365951511|FG000|Overall Study|Progressive disease|9|||
106078597|NCT03003520|365951512|FG001|Overall Study|Progressive disease|1|||
106078598|NCT01332149|365951513|FG000|Overall Study|Adverse Event|11|||
106078599|NCT01332149|365951514|FG001|Overall Study|Adverse Event|9|||
106078600|NCT01332149|365951513|FG000|Overall Study|Other unspecified|5|||
106078601|NCT01332149|365951514|FG001|Overall Study|Other unspecified|7|||
106078602|NCT01332149|365951513|FG000|Overall Study|Protocol Violation|1|||
106078603|NCT01332149|365951514|FG001|Overall Study|Protocol Violation|3|||
106078604|NCT01332149|365951513|FG000|Overall Study|Withdrawal by Subject|4|||
106078605|NCT01332149|365951514|FG001|Overall Study|Withdrawal by Subject|5|||
106078606|NCT01332149|365951513|FG000|Overall Study|Lost to Follow-up|1|||
106078607|NCT01332149|365951514|FG001|Overall Study|Lost to Follow-up|1|||
106078608|NCT01332149|365951513|FG000|Overall Study|Insufficient clinical response|4|||
106078609|NCT01332149|365951514|FG001|Overall Study|Insufficient clinical response|7|||
106078610|NCT01332149|365951513|FG000|Overall Study|Did not meet entrance criteria|3|||
106078611|NCT01332149|365951514|FG001|Overall Study|Did not meet entrance criteria|4|||
106078612|NCT01332149|365951513|FG000|Overall Study|Randomized but not treated|1|||
106078613|NCT01332149|365951514|FG001|Overall Study|Randomized but not treated|2|||
106078614|NCT01802775|365951523|FG000|Overall Study|Death|0|||
106078615|NCT01802775|365951524|FG001|Overall Study|Death|3|||
106078616|NCT01802775|365951523|FG000|Overall Study|Reason not provided|0|||
106078617|NCT01802775|365951524|FG001|Overall Study|Reason not provided|1|||
106078618|NCT01802775|365951523|FG000|Overall Study|Physician Decision|1|||
106078619|NCT01802775|365951524|FG001|Overall Study|Physician Decision|0|||
106078620|NCT01802775|365951523|FG000|Overall Study|Adverse Event|1|||
106078621|NCT01802775|365951524|FG001|Overall Study|Adverse Event|1|||
106078622|NCT01802775|365951523|FG000|Overall Study|Withdrawal by Subject|3|||
106078623|NCT01802775|365951524|FG001|Overall Study|Withdrawal by Subject|5|||
106078624|NCT01802775|365951523|FG000|Overall Study|Lost to Follow-up|1|||
106078625|NCT01802775|365951524|FG001|Overall Study|Lost to Follow-up|2|||
106078626|NCT00782210|365951525|FG000|Overall Study|Adverse Event|21|||
106078627|NCT00782210|365951526|FG001|Overall Study|Adverse Event|17|||
106078628|NCT00782210|365951527|FG002|Overall Study|Adverse Event|16|||
106078629|NCT00782210|365951525|FG000|Overall Study|Lost to Follow-up|2|||
106078630|NCT00782210|365951526|FG001|Overall Study|Lost to Follow-up|1|||
106078631|NCT00782210|365951527|FG002|Overall Study|Lost to Follow-up|2|||
106078632|NCT00782210|365951525|FG000|Overall Study|Withdrawal by Subject|11|||
106078633|NCT00782210|365951526|FG001|Overall Study|Withdrawal by Subject|8|||
106078634|NCT00782210|365951527|FG002|Overall Study|Withdrawal by Subject|11|||
106078635|NCT00782210|365951525|FG000|Overall Study|Non compliance with protocol|0|||
106078636|NCT00782210|365951526|FG001|Overall Study|Non compliance with protocol|3|||
106078637|NCT00782210|365951527|FG002|Overall Study|Non compliance with protocol|2|||
106078638|NCT00782210|365951525|FG000|Overall Study|Lack of Efficacy|13|||
106078639|NCT00782210|365951526|FG001|Overall Study|Lack of Efficacy|4|||
106078640|NCT00782210|365951527|FG002|Overall Study|Lack of Efficacy|1|||
106078641|NCT00782210|365951525|FG000|Overall Study|Other reason not described above|3|||
106078642|NCT00782210|365951526|FG001|Overall Study|Other reason not described above|2|||
106078643|NCT00782210|365951527|FG002|Overall Study|Other reason not described above|3|||
106078644|NCT01067352|365951530|FG000|Overall Study|Withdrawal by Subject|1|||
106078645|NCT01067352|365951531|FG001|Overall Study|Withdrawal by Subject|2|||
106078646|NCT01067352|365951532|FG002|Overall Study|Withdrawal by Subject|1|||
106078647|NCT01067352|365951530|FG000|Overall Study|Physician Decision|0|||
106078648|NCT01067352|365951531|FG001|Overall Study|Physician Decision|1|||
106078649|NCT01067352|365951532|FG002|Overall Study|Physician Decision|0|||
106078650|NCT01604343|365951535|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
106078651|NCT01604343|365951536|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
106078652|NCT01604343|365951537|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
106078653|NCT01604343|365951538|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
106078654|NCT01604343|365951539|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
106078655|NCT01604343|365951535|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
106078656|NCT01604343|365951536|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
106078657|NCT01604343|365951537|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
106078658|NCT01604343|365951538|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
106078659|NCT01604343|365951539|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
106078660|NCT01604343|365951535|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
106078661|NCT01604343|365951536|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
106078662|NCT01604343|365951537|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
106078663|NCT01604343|365951538|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
106078664|NCT01604343|365951539|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
106078665|NCT01604343|365951535|FG000|Prior to W52 Administration(Through W52)|Death|5|||
106078666|NCT01604343|365951536|FG001|Prior to W52 Administration(Through W52)|Death|0|||
106078667|NCT01604343|365951537|FG002|Prior to W52 Administration(Through W52)|Death|2|||
106078668|NCT01604343|365951538|FG003|Prior to W52 Administration(Through W52)|Death|0|||
106078669|NCT01604343|365951539|FG004|Prior to W52 Administration(Through W52)|Death|4|||
106078670|NCT01604343|365951535|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
106078671|NCT01604343|365951536|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
105867008|NCT02422797|365163106|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
105867009|NCT02422797|365163105|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
105867010|NCT02422797|365163106|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
105867011|NCT02422797|365163105|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
105867012|NCT02422797|365163106|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
105867013|NCT02422797|365163105|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
105867014|NCT02422797|365163106|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
105867015|NCT02422797|365163105|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
105867016|NCT02422797|365163106|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
105867017|NCT02422797|365163105|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
105867018|NCT02422797|365163106|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
105867019|NCT02422797|365163105|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
105867020|NCT02422797|365163106|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
105867021|NCT02422797|365163105|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
105867022|NCT02422797|365163106|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
105867023|NCT02422797|365163105|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
105867024|NCT02422797|365163106|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
105867025|NCT02422797|365163105|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
105867026|NCT02422797|365163106|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
105867027|NCT02422797|365163105|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
105867028|NCT02422797|365163106|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
105867029|NCT02422797|365163105|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
105867030|NCT02422797|365163106|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
105867031|NCT02422797|365163105|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
105867032|NCT02422797|365163106|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
105867033|NCT02422797|365163105|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
105867034|NCT02422797|365163106|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
105867035|NCT02422797|365163105|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
105867036|NCT02422797|365163106|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
105867037|NCT02422797|365163105|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
105867038|NCT02422797|365163106|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
106078672|NCT01604343|365951537|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
106078673|NCT01604343|365951538|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
106078674|NCT01604343|365951539|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
106078675|NCT01604343|365951535|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
106078676|NCT01604343|365951536|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
106078677|NCT01604343|365951537|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
106078678|NCT01604343|365951538|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
106078679|NCT01604343|365951539|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
106078680|NCT01604343|365951535|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
106078681|NCT01604343|365951536|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
106078682|NCT01604343|365951537|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
106078683|NCT01604343|365951538|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
106078684|NCT01604343|365951539|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
106078685|NCT01604343|365951535|FG000|Prior to W52 Administration(Through W52)|Other|15|||
106078686|NCT01604343|365951536|FG001|Prior to W52 Administration(Through W52)|Other|0|||
106078687|NCT01604343|365951537|FG002|Prior to W52 Administration(Through W52)|Other|10|||
106078688|NCT01604343|365951538|FG003|Prior to W52 Administration(Through W52)|Other|0|||
106078689|NCT01604343|365951539|FG004|Prior to W52 Administration(Through W52)|Other|6|||
106078690|NCT01604343|365951535|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
106078691|NCT01604343|365951536|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
106078692|NCT01604343|365951537|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
106078693|NCT01604343|365951538|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
106078694|NCT01604343|365951539|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
106078695|NCT01604343|365951535|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
106078696|NCT01604343|365951536|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
106078697|NCT01604343|365951537|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
105867039|NCT02422797|365163105|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
106078698|NCT01604343|365951538|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
106078699|NCT01604343|365951539|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
106078700|NCT01604343|365951535|FG000|Week 52 to Week 104|Adverse Event|0|||
106078701|NCT01604343|365951536|FG001|Week 52 to Week 104|Adverse Event|12|||
106078702|NCT01604343|365951537|FG002|Week 52 to Week 104|Adverse Event|26|||
106078703|NCT01604343|365951538|FG003|Week 52 to Week 104|Adverse Event|21|||
106078704|NCT01604343|365951539|FG004|Week 52 to Week 104|Adverse Event|27|||
106078705|NCT01604343|365951535|FG000|Week 52 to Week 104|Death|0|||
106078706|NCT01604343|365951536|FG001|Week 52 to Week 104|Death|4|||
106078707|NCT01604343|365951537|FG002|Week 52 to Week 104|Death|2|||
106078708|NCT01604343|365951538|FG003|Week 52 to Week 104|Death|5|||
106078709|NCT01604343|365951539|FG004|Week 52 to Week 104|Death|0|||
106078710|NCT01604343|365951535|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
106078711|NCT01604343|365951536|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
106078712|NCT01604343|365951537|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
106078713|NCT01604343|365951538|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
106078714|NCT01604343|365951539|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
106078715|NCT01604343|365951535|FG000|Week 52 to Week 104|Physician Decision|0|||
106078716|NCT01604343|365951536|FG001|Week 52 to Week 104|Physician Decision|1|||
106078717|NCT01604343|365951537|FG002|Week 52 to Week 104|Physician Decision|0|||
106078718|NCT01604343|365951538|FG003|Week 52 to Week 104|Physician Decision|0|||
106078719|NCT01604343|365951539|FG004|Week 52 to Week 104|Physician Decision|2|||
106078720|NCT01604343|365951535|FG000|Week 52 to Week 104|Pregnancy|0|||
106078721|NCT01604343|365951536|FG001|Week 52 to Week 104|Pregnancy|0|||
106078722|NCT01604343|365951537|FG002|Week 52 to Week 104|Pregnancy|1|||
106078723|NCT01604343|365951538|FG003|Week 52 to Week 104|Pregnancy|2|||
106078724|NCT01604343|365951539|FG004|Week 52 to Week 104|Pregnancy|1|||
106078725|NCT01604343|365951535|FG000|Week 52 to Week 104|Other|0|||
106078726|NCT01604343|365951536|FG001|Week 52 to Week 104|Other|11|||
106078727|NCT01604343|365951537|FG002|Week 52 to Week 104|Other|11|||
106078728|NCT01604343|365951538|FG003|Week 52 to Week 104|Other|6|||
106078729|NCT01604343|365951539|FG004|Week 52 to Week 104|Other|3|||
106078730|NCT01604343|365951535|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
106078731|NCT01604343|365951536|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
106078732|NCT01604343|365951537|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
106078733|NCT01604343|365951538|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
106078734|NCT01604343|365951539|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
105867040|NCT02422797|365163106|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
105867041|NCT02422797|365163105|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
105867042|NCT02422797|365163106|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
106078735|NCT01604343|365951535|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
106078736|NCT01604343|365951536|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
106078737|NCT01604343|365951537|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
106078738|NCT01604343|365951538|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
106078739|NCT01604343|365951539|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
106078740|NCT01604343|365951535|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
106078741|NCT01604343|365951536|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
106078742|NCT01604343|365951537|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
106078743|NCT01604343|365951538|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
106078744|NCT01604343|365951539|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
106078745|NCT00436748|365951544|FG000|Overall Study|Ineligibility Determined|1|||
106078746|NCT00436748|365951545|FG001|Overall Study|Ineligibility Determined|1|||
106078747|NCT00436748|365951544|FG000|Overall Study|Adverse Event|0|||
106078748|NCT00436748|365951545|FG001|Overall Study|Adverse Event|2|||
106078749|NCT00436748|365951544|FG000|Overall Study|Consent Withdrawn|1|||
106078750|NCT00436748|365951545|FG001|Overall Study|Consent Withdrawn|4|||
106078751|NCT00436748|365951544|FG000|Overall Study|Administrative Decision|1|||
106078752|NCT00436748|365951545|FG001|Overall Study|Administrative Decision|0|||
106078753|NCT00436748|365951544|FG000|Overall Study|Lost to Follow-up|0|||
106078754|NCT00436748|365951545|FG001|Overall Study|Lost to Follow-up|1|||
106078755|NCT00436748|365951544|FG000|Overall Study|Protocol-specified Criteria|5|||
106078756|NCT00436748|365951545|FG001|Overall Study|Protocol-specified Criteria|4|||
106078757|NCT00436748|365951544|FG000|Overall Study|Other|3|||
106078758|NCT00436748|365951545|FG001|Overall Study|Other|0|||
106078759|NCT00850200|365951547|FG000|Overall Study|Physician Decision|2|||
106078760|NCT00850200|365951547|FG000|Overall Study|Did not recieve treatment|2|||
106078761|NCT00850200|365951547|FG000|Overall Study|Withdrawal by Subject|1|||
106078762|NCT02018458|365951548|FG000|Overall Study|Death|4|||
106078763|NCT00423891|365951549|FG000|Enrolled|Withdrawal by Subject|0|||
106078764|NCT00423891|365951550|FG001|Enrolled|Withdrawal by Subject|0|||
106078765|NCT00423891|365951551|FG002|Enrolled|Withdrawal by Subject|1|||
106078766|NCT00423891|365951549|FG000|Enrolled|Lost to Follow-up|0|||
106078767|NCT00423891|365951550|FG001|Enrolled|Lost to Follow-up|0|||
106078768|NCT00423891|365951551|FG002|Enrolled|Lost to Follow-up|1|||
106078769|NCT00423891|365951549|FG000|Enrolled|No longer met criteria|11|||
106078770|NCT00423891|365951550|FG001|Enrolled|No longer met criteria|2|||
106078771|NCT00423891|365951551|FG002|Enrolled|No longer met criteria|1|||
106078772|NCT00423891|365951549|FG000|Treatment|Withdrawal by Subject|1|||
106159999|NCT02783300|366247397|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160000|NCT02783300|366247398|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160001|NCT02783300|366247399|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160002|NCT02783300|366247400|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160003|NCT02783300|366247401|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160004|NCT02783300|366247402|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160005|NCT02783300|366247403|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160006|NCT02783300|366247404|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160007|NCT02783300|366247405|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160008|NCT02783300|366247406|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
106160009|NCT02783300|366247380|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160010|NCT02783300|366247381|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160011|NCT02783300|366247382|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160012|NCT02783300|366247383|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160013|NCT02783300|366247384|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
106160014|NCT02783300|366247385|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160015|NCT02783300|366247386|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
106160016|NCT02783300|366247387|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160017|NCT02783300|366247388|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160018|NCT02783300|366247389|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
106160019|NCT02783300|366247390|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160020|NCT02783300|366247391|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160021|NCT02783300|366247392|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
106160022|NCT02783300|366247393|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160023|NCT02783300|366247394|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160024|NCT02783300|366247395|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160025|NCT02783300|366247396|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160026|NCT02783300|366247397|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160027|NCT02783300|366247398|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160028|NCT02783300|366247399|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160029|NCT02783300|366247400|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106078773|NCT00423891|365951550|FG001|Treatment|Withdrawal by Subject|0|||
106078774|NCT00423891|365951551|FG002|Treatment|Withdrawal by Subject|0|||
106078775|NCT00423891|365951549|FG000|Treatment|Lost to Follow-up|1|||
106078776|NCT00423891|365951550|FG001|Treatment|Lost to Follow-up|0|||
106078777|NCT00423891|365951551|FG002|Treatment|Lost to Follow-up|0|||
106078778|NCT00423891|365951549|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
106078779|NCT00423891|365951550|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
106078780|NCT00423891|365951551|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
106078781|NCT00423891|365951549|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
106078782|NCT00423891|365951550|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
106078783|NCT00423891|365951551|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
106078784|NCT01988571|365951552|FG000|Overall Study|Death|3|||
106078785|NCT01988571|365951553|FG001|Overall Study|Death|1|||
106078786|NCT01988571|365951552|FG000|Overall Study|Physician Decision|2|||
106078787|NCT01988571|365951553|FG001|Overall Study|Physician Decision|1|||
106078788|NCT01988571|365951552|FG000|Overall Study|Lost to Follow-up|3|||
106078789|NCT01988571|365951553|FG001|Overall Study|Lost to Follow-up|0|||
106078790|NCT01988571|365951552|FG000|Overall Study|Withdrawal by Subject|31|||
106078791|NCT01988571|365951553|FG001|Overall Study|Withdrawal by Subject|33|||
106078792|NCT00486265|365951563|FG000|Overall Study|Adverse Event|1|||
106078793|NCT00486265|365951563|FG000|Overall Study|Lack of Efficacy|8|||
106078794|NCT02308735|365951564|FG000|Overall Study|Physician Decision|2|||
106078795|NCT02308735|365951565|FG001|Overall Study|Physician Decision|0|||
106078796|NCT02308735|365951566|FG002|Overall Study|Physician Decision|0|||
106078797|NCT02308735|365951567|FG003|Overall Study|Physician Decision|2|||
106078798|NCT03013543|365951568|FG000|Overall Study|Withdrawal by Subject|0|||
106078799|NCT03013543|365951569|FG001|Overall Study|Withdrawal by Subject|2|||
106078800|NCT03013543|365951570|FG002|Overall Study|Withdrawal by Subject|0|||
106078801|NCT03013543|365951571|FG003|Overall Study|Withdrawal by Subject|5|||
106078802|NCT03013543|365951572|FG004|Overall Study|Withdrawal by Subject|6|||
106078803|NCT03013543|365951573|FG005|Overall Study|Withdrawal by Subject|2|||
106078804|NCT03013543|365951574|FG006|Overall Study|Withdrawal by Subject|3|||
106078805|NCT03013543|365951575|FG007|Overall Study|Withdrawal by Subject|1|||
106078806|NCT03013543|365951576|FG008|Overall Study|Withdrawal by Subject|0|||
106078807|NCT03013543|365951577|FG009|Overall Study|Withdrawal by Subject|4|||
106078808|NCT03013543|365951568|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
106078809|NCT03013543|365951569|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
106078810|NCT03013543|365951570|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
106078811|NCT03013543|365951571|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
106078812|NCT03013543|365951572|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
106078813|NCT03013543|365951573|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
106078814|NCT03013543|365951574|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
106078815|NCT03013543|365951575|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
106078816|NCT03013543|365951576|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
106078817|NCT03013543|365951577|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
106078818|NCT03013543|365951568|FG000|Overall Study|Other|0|||
106078819|NCT03013543|365951569|FG001|Overall Study|Other|0|||
106078820|NCT03013543|365951570|FG002|Overall Study|Other|2|||
106078821|NCT03013543|365951571|FG003|Overall Study|Other|0|||
106078822|NCT03013543|365951572|FG004|Overall Study|Other|2|||
106078823|NCT03013543|365951573|FG005|Overall Study|Other|0|||
106078824|NCT03013543|365951574|FG006|Overall Study|Other|0|||
106078825|NCT03013543|365951575|FG007|Overall Study|Other|0|||
106078826|NCT03013543|365951576|FG008|Overall Study|Other|1|||
106078827|NCT03013543|365951577|FG009|Overall Study|Other|0|||
106078828|NCT03013543|365951568|FG000|Overall Study|Adverse Event|0|||
106078829|NCT03013543|365951569|FG001|Overall Study|Adverse Event|0|||
106078830|NCT03013543|365951570|FG002|Overall Study|Adverse Event|0|||
106078831|NCT03013543|365951571|FG003|Overall Study|Adverse Event|3|||
105867043|NCT02422797|365163105|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
105867044|NCT02422797|365163106|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
106078832|NCT03013543|365951572|FG004|Overall Study|Adverse Event|2|||
106078833|NCT03013543|365951573|FG005|Overall Study|Adverse Event|1|||
106078834|NCT03013543|365951574|FG006|Overall Study|Adverse Event|3|||
106078835|NCT03013543|365951575|FG007|Overall Study|Adverse Event|8|||
106078836|NCT03013543|365951576|FG008|Overall Study|Adverse Event|0|||
106078837|NCT03013543|365951577|FG009|Overall Study|Adverse Event|2|||
106078838|NCT03013543|365951568|FG000|Overall Study|Death|0|||
106078839|NCT03013543|365951569|FG001|Overall Study|Death|0|||
106078840|NCT03013543|365951570|FG002|Overall Study|Death|0|||
106078841|NCT03013543|365951571|FG003|Overall Study|Death|1|||
106078842|NCT03013543|365951572|FG004|Overall Study|Death|0|||
106078843|NCT03013543|365951573|FG005|Overall Study|Death|0|||
106078844|NCT03013543|365951574|FG006|Overall Study|Death|0|||
106078845|NCT03013543|365951575|FG007|Overall Study|Death|0|||
106078846|NCT03013543|365951576|FG008|Overall Study|Death|0|||
106078847|NCT03013543|365951577|FG009|Overall Study|Death|0|||
106078848|NCT03013543|365951568|FG000|Overall Study|Lack of Efficacy|0|||
106078849|NCT03013543|365951569|FG001|Overall Study|Lack of Efficacy|0|||
106078850|NCT03013543|365951570|FG002|Overall Study|Lack of Efficacy|0|||
106078851|NCT03013543|365951571|FG003|Overall Study|Lack of Efficacy|1|||
106078852|NCT03013543|365951572|FG004|Overall Study|Lack of Efficacy|0|||
106078853|NCT03013543|365951573|FG005|Overall Study|Lack of Efficacy|0|||
106078854|NCT03013543|365951574|FG006|Overall Study|Lack of Efficacy|0|||
106078855|NCT03013543|365951575|FG007|Overall Study|Lack of Efficacy|0|||
106078856|NCT03013543|365951576|FG008|Overall Study|Lack of Efficacy|0|||
106078857|NCT03013543|365951577|FG009|Overall Study|Lack of Efficacy|0|||
106078858|NCT03013543|365951568|FG000|Overall Study|Lost to Follow-up|0|||
106078859|NCT03013543|365951569|FG001|Overall Study|Lost to Follow-up|0|||
106078860|NCT03013543|365951570|FG002|Overall Study|Lost to Follow-up|0|||
106078861|NCT03013543|365951571|FG003|Overall Study|Lost to Follow-up|1|||
106078862|NCT03013543|365951572|FG004|Overall Study|Lost to Follow-up|0|||
106078863|NCT03013543|365951573|FG005|Overall Study|Lost to Follow-up|0|||
106078864|NCT03013543|365951574|FG006|Overall Study|Lost to Follow-up|1|||
106078865|NCT03013543|365951575|FG007|Overall Study|Lost to Follow-up|0|||
106078866|NCT03013543|365951576|FG008|Overall Study|Lost to Follow-up|0|||
106078867|NCT03013543|365951577|FG009|Overall Study|Lost to Follow-up|2|||
106078868|NCT03013543|365951568|FG000|Overall Study|Non-Compliance With Study Drug|0|||
106078869|NCT03013543|365951569|FG001|Overall Study|Non-Compliance With Study Drug|0|||
106078870|NCT03013543|365951570|FG002|Overall Study|Non-Compliance With Study Drug|0|||
106078871|NCT03013543|365951571|FG003|Overall Study|Non-Compliance With Study Drug|0|||
106078872|NCT03013543|365951572|FG004|Overall Study|Non-Compliance With Study Drug|0|||
106078873|NCT03013543|365951573|FG005|Overall Study|Non-Compliance With Study Drug|0|||
106078874|NCT03013543|365951574|FG006|Overall Study|Non-Compliance With Study Drug|0|||
106078875|NCT03013543|365951575|FG007|Overall Study|Non-Compliance With Study Drug|0|||
106078876|NCT03013543|365951576|FG008|Overall Study|Non-Compliance With Study Drug|1|||
106078877|NCT03013543|365951577|FG009|Overall Study|Non-Compliance With Study Drug|0|||
106078878|NCT03013543|365951568|FG000|Overall Study|Physician Decision|0|||
106078879|NCT03013543|365951569|FG001|Overall Study|Physician Decision|0|||
106078880|NCT03013543|365951570|FG002|Overall Study|Physician Decision|0|||
106078881|NCT03013543|365951571|FG003|Overall Study|Physician Decision|0|||
106078882|NCT03013543|365951572|FG004|Overall Study|Physician Decision|1|||
106078883|NCT03013543|365951573|FG005|Overall Study|Physician Decision|0|||
106078884|NCT03013543|365951574|FG006|Overall Study|Physician Decision|0|||
106078885|NCT03013543|365951575|FG007|Overall Study|Physician Decision|0|||
106078886|NCT03013543|365951576|FG008|Overall Study|Physician Decision|0|||
106078887|NCT03013543|365951577|FG009|Overall Study|Physician Decision|0|||
106078888|NCT03013543|365951568|FG000|Overall Study|Protocol Violation|0|||
106078889|NCT03013543|365951569|FG001|Overall Study|Protocol Violation|0|||
106078890|NCT03013543|365951570|FG002|Overall Study|Protocol Violation|0|||
106078891|NCT03013543|365951571|FG003|Overall Study|Protocol Violation|0|||
106078892|NCT03013543|365951572|FG004|Overall Study|Protocol Violation|0|||
106078893|NCT03013543|365951573|FG005|Overall Study|Protocol Violation|0|||
106078894|NCT03013543|365951574|FG006|Overall Study|Protocol Violation|0|||
106078895|NCT03013543|365951575|FG007|Overall Study|Protocol Violation|0|||
106078896|NCT03013543|365951576|FG008|Overall Study|Protocol Violation|0|||
106078897|NCT03013543|365951577|FG009|Overall Study|Protocol Violation|1|||
106078898|NCT00606892|365951578|FG000|First Intervention|Protocol Violation|1|||
106078899|NCT00606892|365951579|FG001|First Intervention|Protocol Violation|4|||
106078900|NCT01417481|365951580|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
106078901|NCT01417481|365951581|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
106078902|NCT01465464|365951591|FG000|Overall Study|Adverse Event|96|||
106078903|NCT01465464|365951592|FG001|Overall Study|Adverse Event|49|||
106078904|NCT01465464|365951591|FG000|Overall Study|Lack of Efficacy|139|||
106078905|NCT01465464|365951592|FG001|Overall Study|Lack of Efficacy|190|||
106078906|NCT01465464|365951591|FG000|Overall Study|Physician Decision|13|||
106078907|NCT01465464|365951592|FG001|Overall Study|Physician Decision|5|||
106078908|NCT01465464|365951591|FG000|Overall Study|Protocol Violation|1|||
106078909|NCT01465464|365951592|FG001|Overall Study|Protocol Violation|1|||
106078910|NCT01465464|365951591|FG000|Overall Study|Withdrawal by Subject|46|||
106078911|NCT01465464|365951592|FG001|Overall Study|Withdrawal by Subject|30|||
106078912|NCT01465464|365951591|FG000|Overall Study|Other|9|||
106078913|NCT01465464|365951592|FG001|Overall Study|Other|3|||
106078914|NCT01465464|365951591|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
106078915|NCT01465464|365951592|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
106078916|NCT00785486|365951593|FG000|Midazolam Alone|Withdrawal by Subject|1|||
106078917|NCT01554618|365951597|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
106078918|NCT01554618|365951598|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
106078919|NCT01554618|365951597|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
106078920|NCT01554618|365951598|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
106078921|NCT01554618|365951597|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
106078922|NCT01554618|365951598|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
106078923|NCT01554618|365951597|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
106078924|NCT01554618|365951598|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
106078925|NCT01554618|365951597|FG000|Open-Label Extension Period|Physician Decision|0|||
106078926|NCT01554618|365951598|FG001|Open-Label Extension Period|Physician Decision|1|||
106078927|NCT01554618|365951597|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
106078928|NCT01554618|365951598|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
106078929|NCT02376166|365951599|FG000|Overall Study|Adverse Event|1|||
106078930|NCT02376166|365951599|FG000|Overall Study|Discontinued metformin early|2|||
106078931|NCT04399161|365951600|FG000|Overall Study|Withdrawal by Subject|1|||
106078932|NCT04399161|365951601|FG001|Overall Study|Withdrawal by Subject|0|||
106078933|NCT04399161|365951602|FG002|Overall Study|Withdrawal by Subject|2|||
106078934|NCT04399161|365951600|FG000|Overall Study|Protocol Violation|1|||
106078935|NCT04399161|365951601|FG001|Overall Study|Protocol Violation|2|||
106078936|NCT04399161|365951602|FG002|Overall Study|Protocol Violation|0|||
106078937|NCT00838565|365951605|FG000|Overall Study|Withdrawal by Subject|0|||
106078938|NCT00838565|365951606|FG001|Overall Study|Withdrawal by Subject|0|||
106078939|NCT00838565|365951607|FG002|Overall Study|Withdrawal by Subject|1|||
106078940|NCT00838565|365951608|FG003|Overall Study|Withdrawal by Subject|0|||
106078941|NCT00838565|365951609|FG004|Overall Study|Withdrawal by Subject|0|||
106078942|NCT00838565|365951610|FG005|Overall Study|Withdrawal by Subject|2|||
106078943|NCT00838565|365951605|FG000|Overall Study|Other|0|||
106078944|NCT00838565|365951606|FG001|Overall Study|Other|2|||
106078945|NCT00838565|365951607|FG002|Overall Study|Other|0|||
106078946|NCT00838565|365951608|FG003|Overall Study|Other|0|||
106078947|NCT00838565|365951609|FG004|Overall Study|Other|0|||
106078948|NCT00838565|365951610|FG005|Overall Study|Other|0|||
106078949|NCT00838565|365951605|FG000|Overall Study|Randomized but not Treated|0|||
106078950|NCT00838565|365951606|FG001|Overall Study|Randomized but not Treated|1|||
106078951|NCT00838565|365951607|FG002|Overall Study|Randomized but not Treated|0|||
106078952|NCT00838565|365951608|FG003|Overall Study|Randomized but not Treated|0|||
106078953|NCT00838565|365951609|FG004|Overall Study|Randomized but not Treated|0|||
106078954|NCT00838565|365951610|FG005|Overall Study|Randomized but not Treated|0|||
106078955|NCT02275481|365951611|FG000|Overall Study|Death|2|||
106078956|NCT02275481|365951612|FG001|Overall Study|Death|1|||
106078957|NCT02275481|365951611|FG000|Overall Study|Lost to Follow-up|2|||
106078958|NCT02275481|365951612|FG001|Overall Study|Lost to Follow-up|0|||
106078959|NCT02275481|365951611|FG000|Overall Study|Withdrawal by Subject|3|||
106078960|NCT02275481|365951612|FG001|Overall Study|Withdrawal by Subject|0|||
106078961|NCT02275481|365951611|FG000|Overall Study|all other reasons combined|2|||
106078962|NCT02275481|365951612|FG001|Overall Study|all other reasons combined|1|||
106078963|NCT02275481|365951611|FG000|Overall Study|Physician Decision|0|||
106078964|NCT02275481|365951612|FG001|Overall Study|Physician Decision|1|||
106078965|NCT01393405|365951613|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
106078966|NCT01393405|365951614|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
106078967|NCT01393405|365951615|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
106078968|NCT01393405|365951613|FG000|Induction Period (week1-16)|Adverse Event|16|||
106078969|NCT01393405|365951614|FG001|Induction Period (week1-16)|Adverse Event|0|||
106078970|NCT01393405|365951615|FG002|Induction Period (week1-16)|Adverse Event|0|||
106078971|NCT01393405|365951613|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
106078972|NCT01393405|365951614|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
106078973|NCT01393405|365951615|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
106078974|NCT01393405|365951613|FG000|Maintenance Period Week|Lack of Efficacy|0|||
106078975|NCT01393405|365951614|FG001|Maintenance Period Week|Lack of Efficacy|22|||
106078976|NCT01393405|365951615|FG002|Maintenance Period Week|Lack of Efficacy|22|||
106078977|NCT01393405|365951613|FG000|Maintenance Period Week|Adverse Event|0|||
106078978|NCT01393405|365951614|FG001|Maintenance Period Week|Adverse Event|5|||
106078979|NCT01393405|365951615|FG002|Maintenance Period Week|Adverse Event|2|||
106078980|NCT01393405|365951613|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
106078981|NCT01393405|365951614|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
106078982|NCT01393405|365951615|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
106078983|NCT01393405|365951613|FG000|Maintenance Period Week|Lost to Follow-up|0|||
106078984|NCT01393405|365951614|FG001|Maintenance Period Week|Lost to Follow-up|1|||
106078985|NCT01393405|365951615|FG002|Maintenance Period Week|Lost to Follow-up|0|||
106078986|NCT00244712|365951624|FG000|Overall Study|Adverse Event|20|||
106078987|NCT00244712|365951625|FG001|Overall Study|Adverse Event|21|||
106078988|NCT00244712|365951624|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
106078989|NCT00244712|365951625|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
106078990|NCT00244712|365951624|FG000|Overall Study|Lack of Compliance|10|||
106078991|NCT00244712|365951625|FG001|Overall Study|Lack of Compliance|11|||
106078992|NCT00244712|365951624|FG000|Overall Study|Lost to Follow-up|45|||
106078993|NCT00244712|365951625|FG001|Overall Study|Lost to Follow-up|52|||
106078994|NCT00244712|365951624|FG000|Overall Study|Withdrawal by Subject|13|||
106078995|NCT00244712|365951625|FG001|Overall Study|Withdrawal by Subject|23|||
106078996|NCT00244712|365951624|FG000|Overall Study|Protocol Violation, disease progression|13|||
106078997|NCT00244712|365951625|FG001|Overall Study|Protocol Violation, disease progression|11|||
106078998|NCT01806896|365951628|FG000|Overall Study|Adverse Event|2|||
106078999|NCT01806896|365951629|FG001|Overall Study|Adverse Event|0|||
106079000|NCT01806896|365951628|FG000|Overall Study|Other|1|||
106079001|NCT01806896|365951629|FG001|Overall Study|Other|0|||
106079002|NCT05627518|365951630|FG000|Treatment Period 1|Adverse Event|0|||
106079003|NCT05627518|365951631|FG001|Treatment Period 1|Adverse Event|0|||
106079004|NCT05627518|365951632|FG002|Treatment Period 1|Adverse Event|1|||
106079005|NCT05627518|365951633|FG003|Treatment Period 1|Adverse Event|0|||
106079006|NCT05627518|365951634|FG004|Treatment Period 1|Adverse Event|0|||
106079007|NCT05627518|365951635|FG005|Treatment Period 1|Adverse Event|0|||
106079008|NCT05627518|365951636|FG006|Treatment Period 1|Adverse Event|0|||
105867045|NCT02422797|365163105|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
105867046|NCT02422797|365163106|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
105867047|NCT02422797|365163105|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
106079009|NCT05627518|365951637|FG007|Treatment Period 1|Adverse Event|1|||
106079010|NCT05627518|365951630|FG000|Treatment Period 1|Withdrawal by Subject|0|||
106079011|NCT05627518|365951631|FG001|Treatment Period 1|Withdrawal by Subject|0|||
106079012|NCT05627518|365951632|FG002|Treatment Period 1|Withdrawal by Subject|1|||
106160030|NCT02783300|366247401|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160031|NCT02783300|366247402|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160032|NCT02783300|366247403|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160033|NCT02783300|366247404|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160034|NCT02783300|366247405|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160035|NCT02783300|366247406|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
106160036|NCT02783300|366247380|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160037|NCT02783300|366247381|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160038|NCT02783300|366247382|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160039|NCT02783300|366247383|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160040|NCT02783300|366247384|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160041|NCT02783300|366247385|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160042|NCT02783300|366247386|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160043|NCT02783300|366247387|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160044|NCT02783300|366247388|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160045|NCT02783300|366247389|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160046|NCT02783300|366247390|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160047|NCT02783300|366247391|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160048|NCT02783300|366247392|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160049|NCT02783300|366247393|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160050|NCT02783300|366247394|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160051|NCT02783300|366247395|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
106160052|NCT02783300|366247396|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160053|NCT02783300|366247397|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
106160054|NCT02783300|366247398|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
106160055|NCT02783300|366247399|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
106160056|NCT02783300|366247400|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160057|NCT02783300|366247401|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160058|NCT02783300|366247402|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160059|NCT02783300|366247403|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160060|NCT02783300|366247404|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
106160061|NCT02783300|366247405|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160062|NCT02783300|366247406|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
106160063|NCT02783300|366247380|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160064|NCT02783300|366247381|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160065|NCT02783300|366247382|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160066|NCT02783300|366247383|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160067|NCT02783300|366247384|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160068|NCT02783300|366247385|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160069|NCT02783300|366247386|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160070|NCT02783300|366247387|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160071|NCT02783300|366247388|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160072|NCT02783300|366247389|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160073|NCT02783300|366247390|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160074|NCT02783300|366247391|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160075|NCT02783300|366247392|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160076|NCT02783300|366247393|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160077|NCT02783300|366247394|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160078|NCT02783300|366247395|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160079|NCT02783300|366247396|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
105867048|NCT02422797|365163106|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
106079013|NCT05627518|365951633|FG003|Treatment Period 1|Withdrawal by Subject|0|||
106079014|NCT05627518|365951634|FG004|Treatment Period 1|Withdrawal by Subject|0|||
106079015|NCT05627518|365951635|FG005|Treatment Period 1|Withdrawal by Subject|1|||
106079016|NCT05627518|365951636|FG006|Treatment Period 1|Withdrawal by Subject|0|||
106079017|NCT05627518|365951637|FG007|Treatment Period 1|Withdrawal by Subject|0|||
106079018|NCT05627518|365951630|FG000|Treatment Period 1|Protocol Violation|0|||
106079019|NCT05627518|365951631|FG001|Treatment Period 1|Protocol Violation|0|||
106079020|NCT05627518|365951632|FG002|Treatment Period 1|Protocol Violation|0|||
106079021|NCT05627518|365951633|FG003|Treatment Period 1|Protocol Violation|0|||
106079022|NCT05627518|365951634|FG004|Treatment Period 1|Protocol Violation|0|||
106079023|NCT05627518|365951635|FG005|Treatment Period 1|Protocol Violation|0|||
106079024|NCT05627518|365951636|FG006|Treatment Period 1|Protocol Violation|6|||
106079025|NCT05627518|365951637|FG007|Treatment Period 1|Protocol Violation|6|||
106079026|NCT05627518|365951630|FG000|Treatment Period 2|Adverse Event|1|||
106079027|NCT05627518|365951631|FG001|Treatment Period 2|Adverse Event|0|||
106079028|NCT05627518|365951632|FG002|Treatment Period 2|Adverse Event|0|||
106079029|NCT05627518|365951633|FG003|Treatment Period 2|Adverse Event|0|||
106079030|NCT05627518|365951634|FG004|Treatment Period 2|Adverse Event|0|||
106079031|NCT05627518|365951635|FG005|Treatment Period 2|Adverse Event|0|||
106079032|NCT05627518|365951636|FG006|Treatment Period 2|Adverse Event|0|||
106079033|NCT05627518|365951637|FG007|Treatment Period 2|Adverse Event|0|||
106079034|NCT05627518|365951630|FG000|Treatment Period 2|Withdrawal by Subject|1|||
106079035|NCT05627518|365951631|FG001|Treatment Period 2|Withdrawal by Subject|0|||
106079036|NCT05627518|365951632|FG002|Treatment Period 2|Withdrawal by Subject|0|||
106079037|NCT05627518|365951633|FG003|Treatment Period 2|Withdrawal by Subject|0|||
106079038|NCT05627518|365951634|FG004|Treatment Period 2|Withdrawal by Subject|0|||
106079039|NCT05627518|365951635|FG005|Treatment Period 2|Withdrawal by Subject|0|||
106079040|NCT05627518|365951636|FG006|Treatment Period 2|Withdrawal by Subject|0|||
106079041|NCT05627518|365951637|FG007|Treatment Period 2|Withdrawal by Subject|0|||
106079042|NCT00316199|365951640|FG000|Overall Study|Adverse Event|2|||
106079043|NCT00316199|365951640|FG000|Overall Study|Death|8|||
106079044|NCT00316199|365951640|FG000|Overall Study|Lost to Follow-up|2|||
106079045|NCT00590954|365951641|FG000|Overall Study|Inevaluable|2|||
106079046|NCT02777125|365951642|FG000|Overall Study|Consent form violation|14|||
106079047|NCT02777125|365951643|FG001|Overall Study|Consent form violation|12|||
106079048|NCT02777125|365951642|FG000|Overall Study|Assent form violation|21|||
106079049|NCT02777125|365951643|FG001|Overall Study|Assent form violation|23|||
106079050|NCT02777125|365951642|FG000|Overall Study|Protocol Violation|8|||
106079051|NCT02777125|365951643|FG001|Overall Study|Protocol Violation|12|||
106079052|NCT02917031|365951644|FG000|Overall Study|Reason not specified|7|||
106079053|NCT02917031|365951645|FG001|Overall Study|Reason not specified|5|||
106079054|NCT02917031|365951646|FG002|Overall Study|Reason not specified|6|||
106079055|NCT02917031|365951644|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
106079056|NCT02917031|365951645|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
106079057|NCT02917031|365951646|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
106079058|NCT02917031|365951644|FG000|Overall Study|Withdrawal by Subject|3|||
106079059|NCT02917031|365951645|FG001|Overall Study|Withdrawal by Subject|3|||
106079060|NCT02917031|365951646|FG002|Overall Study|Withdrawal by Subject|0|||
106079061|NCT02917031|365951644|FG000|Overall Study|Physician Decision|1|||
106079062|NCT02917031|365951645|FG001|Overall Study|Physician Decision|0|||
106079063|NCT02917031|365951646|FG002|Overall Study|Physician Decision|0|||
106079064|NCT02917031|365951644|FG000|Overall Study|Adverse Event|4|||
106079065|NCT02917031|365951645|FG001|Overall Study|Adverse Event|1|||
106079066|NCT02917031|365951646|FG002|Overall Study|Adverse Event|5|||
106079067|NCT02917031|365951644|FG000|Overall Study|Death|2|||
106079068|NCT02917031|365951645|FG001|Overall Study|Death|3|||
106079069|NCT02917031|365951646|FG002|Overall Study|Death|4|||
106079070|NCT03036566|365953285|FG000|Overall Study|Lost to Follow-up|3|||
106079071|NCT01816139|365953288|FG000|Overall Study|Adverse Event|6|||
106079072|NCT01816139|365953289|FG001|Overall Study|Adverse Event|8|||
106079073|NCT01816139|365953288|FG000|Overall Study|Lack of Efficacy|1|||
106079074|NCT01816139|365953289|FG001|Overall Study|Lack of Efficacy|2|||
106079075|NCT01816139|365953288|FG000|Overall Study|Lost to Follow-up|5|||
106079076|NCT01816139|365953289|FG001|Overall Study|Lost to Follow-up|3|||
106079077|NCT01816139|365953288|FG000|Overall Study|Withdrew Consent|6|||
106079078|NCT01816139|365953289|FG001|Overall Study|Withdrew Consent|4|||
106079079|NCT01816139|365953288|FG000|Overall Study|Protocol Violation|6|||
106079080|NCT01816139|365953289|FG001|Overall Study|Protocol Violation|3|||
106079081|NCT01816139|365953288|FG000|Overall Study|Reason not Specified|4|||
106079082|NCT01816139|365953289|FG001|Overall Study|Reason not Specified|2|||
106079083|NCT01940120|365953292|FG000|Overall Study|Death|40|||
106079084|NCT01940120|365953292|FG000|Overall Study|Withdrawal by Subject|8|||
106079085|NCT02554656|365953293|FG000|Overall Study|Protocol Violation|3|||
106079086|NCT01933048|365953294|FG000|Overall Study|Lost to Follow-up|15|||
106079087|NCT01933048|365953295|FG001|Overall Study|Lost to Follow-up|18|||
106079088|NCT01933048|365953294|FG000|Overall Study|personal reasons|1|||
106079089|NCT01933048|365953295|FG001|Overall Study|personal reasons|1|||
106079090|NCT01933048|365953294|FG000|Overall Study|Protocol Violation|7|||
106079091|NCT01933048|365953295|FG001|Overall Study|Protocol Violation|8|||
106079092|NCT01933048|365953294|FG000|Overall Study|Physician Decision|1|||
106079093|NCT01933048|365953295|FG001|Overall Study|Physician Decision|0|||
106079094|NCT01933048|365953294|FG000|Overall Study|unknown reasons|1|||
106079095|NCT01933048|365953295|FG001|Overall Study|unknown reasons|1|||
106079096|NCT01944059|365953300|FG000|Overall Study|Lost to Follow-up|1|||
106079097|NCT01944059|365953300|FG000|Overall Study|Physician Decision|3|||
106079098|NCT01944059|365953300|FG000|Overall Study|Withdrawal by Subject|1|||
106160080|NCT02783300|366247397|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160081|NCT02783300|366247398|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
106160082|NCT02783300|366247399|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
106160083|NCT02783300|366247400|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160084|NCT02783300|366247401|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160085|NCT02783300|366247402|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160086|NCT02783300|366247403|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160087|NCT02783300|366247404|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160088|NCT02783300|366247405|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160089|NCT02783300|366247406|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
106160090|NCT02783300|366247380|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160091|NCT02783300|366247381|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160092|NCT02783300|366247382|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160093|NCT02783300|366247383|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160094|NCT02783300|366247384|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160095|NCT02783300|366247385|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160096|NCT02783300|366247386|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160097|NCT02783300|366247387|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160098|NCT02783300|366247388|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160099|NCT02783300|366247389|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160100|NCT02783300|366247390|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160101|NCT02783300|366247391|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160102|NCT02783300|366247392|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160103|NCT02783300|366247393|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160104|NCT02783300|366247394|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160105|NCT02783300|366247395|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160106|NCT02783300|366247396|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
106160107|NCT02783300|366247397|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160108|NCT02783300|366247398|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
106160109|NCT02783300|366247399|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
106160110|NCT02783300|366247400|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
106160111|NCT02783300|366247401|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160112|NCT02783300|366247402|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160113|NCT02783300|366247403|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160114|NCT02783300|366247404|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160115|NCT02783300|366247405|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106160116|NCT02783300|366247406|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
106079099|NCT01944059|365953300|FG000|Overall Study|Adverse Event|2|||
106079100|NCT03325166|365953301|FG000|Overall Study|Adverse Event|1|||
106079101|NCT01782313|365953302|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
106079102|NCT01782313|365953302|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
106079103|NCT01782313|365953302|FG000|Treated Cycle 3|Progressive Disease|21|||
106079104|NCT01782313|365953302|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
106079105|NCT01782313|365953302|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
106079106|NCT01782313|365953302|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
106079107|NCT01782313|365953302|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
106079108|NCT01782313|365953302|FG000|Survival Follow up|Lost to Follow-up|1|||
106079109|NCT00418691|365953305|FG000|Overall Study|Lost to Follow-up|1|||
106079110|NCT00418691|365953306|FG001|Overall Study|Lost to Follow-up|2|||
106079111|NCT00418691|365953307|FG002|Overall Study|Lost to Follow-up|3|||
106079112|NCT00418691|365953305|FG000|Overall Study|Started new medication voiding entry|0|||
106079113|NCT00418691|365953306|FG001|Overall Study|Started new medication voiding entry|0|||
106079114|NCT00418691|365953307|FG002|Overall Study|Started new medication voiding entry|1|||
106079115|NCT00418691|365953305|FG000|Overall Study|Progressive Disease|1|||
106079116|NCT00418691|365953306|FG001|Overall Study|Progressive Disease|0|||
106079117|NCT00418691|365953307|FG002|Overall Study|Progressive Disease|1|||
106079118|NCT00048542|365953314|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
106079119|NCT00048542|365953315|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
106079120|NCT00048542|365953316|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
106079121|NCT00048542|365953317|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
106079122|NCT00048542|365953318|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
106079123|NCT00048542|365953319|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
106079124|NCT00048542|365953320|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
106079125|NCT00048542|365953321|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
106079126|NCT00048542|365953314|FG000|Double-Blind Phase|Protocol Violation|0|||
106079127|NCT00048542|365953315|FG001|Double-Blind Phase|Protocol Violation|0|||
106079128|NCT00048542|365953316|FG002|Double-Blind Phase|Protocol Violation|1|||
106079129|NCT00048542|365953317|FG003|Double-Blind Phase|Protocol Violation|0|||
106079130|NCT00048542|365953318|FG004|Double-Blind Phase|Protocol Violation|0|||
106079131|NCT00048542|365953319|FG005|Double-Blind Phase|Protocol Violation|0|||
106079132|NCT00048542|365953320|FG006|Double-Blind Phase|Protocol Violation|0|||
106079133|NCT00048542|365953321|FG007|Double-Blind Phase|Protocol Violation|0|||
106079134|NCT00048542|365953314|FG000|Double-Blind Phase|Sponsor request or decision|2|||
106079135|NCT00048542|365953315|FG001|Double-Blind Phase|Sponsor request or decision|0|||
106079136|NCT00048542|365953316|FG002|Double-Blind Phase|Sponsor request or decision|0|||
106079137|NCT00048542|365953317|FG003|Double-Blind Phase|Sponsor request or decision|0|||
106079138|NCT00048542|365953318|FG004|Double-Blind Phase|Sponsor request or decision|0|||
106079139|NCT00048542|365953319|FG005|Double-Blind Phase|Sponsor request or decision|0|||
106079140|NCT00048542|365953320|FG006|Double-Blind Phase|Sponsor request or decision|0|||
106079141|NCT00048542|365953321|FG007|Double-Blind Phase|Sponsor request or decision|0|||
106079142|NCT00048542|365953314|FG000|Double-Blind Phase|Randomized in error|1|||
106079143|NCT00048542|365953315|FG001|Double-Blind Phase|Randomized in error|0|||
106079144|NCT00048542|365953316|FG002|Double-Blind Phase|Randomized in error|0|||
106079145|NCT00048542|365953317|FG003|Double-Blind Phase|Randomized in error|0|||
106079146|NCT00048542|365953318|FG004|Double-Blind Phase|Randomized in error|0|||
106079147|NCT00048542|365953319|FG005|Double-Blind Phase|Randomized in error|0|||
106079148|NCT00048542|365953320|FG006|Double-Blind Phase|Randomized in error|0|||
106079149|NCT00048542|365953321|FG007|Double-Blind Phase|Randomized in error|0|||
106079150|NCT00048542|365953314|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
106079151|NCT00048542|365953315|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
106079152|NCT00048542|365953316|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
106079153|NCT00048542|365953317|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
106079154|NCT00048542|365953318|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
106079155|NCT00048542|365953319|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
106079156|NCT00048542|365953320|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
106079157|NCT00048542|365953321|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
106079158|NCT00048542|365953314|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
106079159|NCT00048542|365953315|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
106079160|NCT00048542|365953316|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
106079161|NCT00048542|365953317|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
106079162|NCT00048542|365953318|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
106160117|NCT02783300|366247380|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106079163|NCT00048542|365953319|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
106079164|NCT00048542|365953320|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
106079165|NCT00048542|365953321|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
106079166|NCT00048542|365953314|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
106079167|NCT00048542|365953315|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
106079168|NCT00048542|365953316|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
106079169|NCT00048542|365953317|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
106079170|NCT00048542|365953318|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
106079171|NCT00048542|365953319|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
106079172|NCT00048542|365953320|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
106079173|NCT00048542|365953321|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
106079174|NCT00048542|365953314|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
106079175|NCT00048542|365953315|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
106079176|NCT00048542|365953316|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
106079177|NCT00048542|365953317|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
106079178|NCT00048542|365953318|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
106079179|NCT00048542|365953319|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
106079180|NCT00048542|365953320|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
106079181|NCT00048542|365953321|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
106079182|NCT00048542|365953314|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
106079183|NCT00048542|365953315|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
106079184|NCT00048542|365953316|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
106079185|NCT00048542|365953317|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
106079186|NCT00048542|365953318|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
106079187|NCT00048542|365953319|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
106079188|NCT00048542|365953320|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
106079189|NCT00048542|365953321|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
106079190|NCT00048542|365953314|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
106079191|NCT00048542|365953315|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
106079192|NCT00048542|365953316|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
106079193|NCT00048542|365953317|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
106079194|NCT00048542|365953318|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
106079195|NCT00048542|365953319|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
106079196|NCT00048542|365953320|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
106079197|NCT00048542|365953321|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
106079198|NCT00048542|365953314|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
106079199|NCT00048542|365953315|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
106079200|NCT00048542|365953316|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
106079201|NCT00048542|365953317|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
106079202|NCT00048542|365953318|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
106079203|NCT00048542|365953319|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
106079204|NCT00048542|365953320|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
106079205|NCT00048542|365953321|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
106079206|NCT00048542|365953314|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
106079207|NCT00048542|365953315|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
106079208|NCT00048542|365953316|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
106079209|NCT00048542|365953317|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
106079210|NCT00048542|365953318|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
106079211|NCT00048542|365953319|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
106079212|NCT00048542|365953320|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
106079213|NCT00048542|365953321|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
106079214|NCT00048542|365953314|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
106079215|NCT00048542|365953315|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
106079216|NCT00048542|365953316|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
106079217|NCT00048542|365953317|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
106079218|NCT00048542|365953318|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
106079219|NCT00048542|365953319|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
106079220|NCT00048542|365953320|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
106079221|NCT00048542|365953321|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
106079222|NCT00048542|365953314|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
106079223|NCT00048542|365953315|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
106079224|NCT00048542|365953316|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
106079225|NCT00048542|365953317|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
106079226|NCT00048542|365953318|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
106079227|NCT00048542|365953319|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
106079228|NCT00048542|365953320|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
106079229|NCT00048542|365953321|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
106079230|NCT00048542|365953314|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
106079231|NCT00048542|365953315|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
106079232|NCT00048542|365953316|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
106079233|NCT00048542|365953317|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
106079234|NCT00048542|365953318|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
106079235|NCT00048542|365953319|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
106079236|NCT00048542|365953320|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
106079237|NCT00048542|365953321|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
106079238|NCT02775344|365953322|FG000|Overall Study|No ovarian cyst identified|3|||
106079239|NCT02775344|365953323|FG001|Overall Study|No ovarian cyst identified|2|||
106079240|NCT04098458|365953348|FG000|Overall Study|Death|1|||
106079241|NCT04098458|365953348|FG000|Overall Study|did not meet study inclusion criteria|3|||
106079242|NCT04033159|365953349|FG000|Washout Period|Physician Decision|0|||
106079243|NCT04033159|365953350|FG001|Washout Period|Physician Decision|1|||
106079244|NCT04033159|365953351|FG002|Washout Period|Physician Decision|0|||
106079245|NCT04033159|365953349|FG000|Washout Period|Study terminated by Sponsor|0|||
106079246|NCT04033159|365953350|FG001|Washout Period|Study terminated by Sponsor|7|||
106079247|NCT04033159|365953351|FG002|Washout Period|Study terminated by Sponsor|0|||
106079248|NCT04033159|365953349|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
106079249|NCT04033159|365953350|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
106079250|NCT04033159|365953351|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
106079251|NCT00314574|365953354|FG000|Overall Study|Death|3|||
106079252|NCT00314574|365953355|FG001|Overall Study|Death|0|||
106079253|NCT00314574|365953354|FG000|Overall Study|Adverse Event|11|||
106079254|NCT00314574|365953355|FG001|Overall Study|Adverse Event|16|||
106079255|NCT00314574|365953354|FG000|Overall Study|Lost to Follow-up|19|||
106079256|NCT00314574|365953355|FG001|Overall Study|Lost to Follow-up|25|||
106079257|NCT00314574|365953354|FG000|Overall Study|Withdrawal by Subject|33|||
106079258|NCT00314574|365953355|FG001|Overall Study|Withdrawal by Subject|22|||
106079259|NCT00314574|365953354|FG000|Overall Study|Physician Decision|22|||
106079260|NCT00314574|365953355|FG001|Overall Study|Physician Decision|15|||
106079261|NCT00314574|365953354|FG000|Overall Study|Pregnancy|6|||
106079262|NCT00314574|365953355|FG001|Overall Study|Pregnancy|4|||
106079263|NCT00314574|365953354|FG000|Overall Study|Data unknown at database lock|0|||
106079264|NCT00314574|365953355|FG001|Overall Study|Data unknown at database lock|1|||
106079265|NCT00006489|365953356|FG000|Overall Study|Adverse Event|3|||
106079266|NCT00006489|365953357|FG001|Overall Study|Adverse Event|2|||
106079267|NCT00006489|365953358|FG002|Overall Study|Adverse Event|4|||
106079268|NCT00006489|365953359|FG003|Overall Study|Adverse Event|3|||
106079269|NCT00006489|365953356|FG000|Overall Study|Withdrawal by Subject|10|||
106079270|NCT00006489|365953357|FG001|Overall Study|Withdrawal by Subject|9|||
106079271|NCT00006489|365953358|FG002|Overall Study|Withdrawal by Subject|9|||
106079272|NCT00006489|365953359|FG003|Overall Study|Withdrawal by Subject|6|||
106079273|NCT00006489|365953356|FG000|Overall Study|Scheduling Conflict|0|||
106079274|NCT00006489|365953357|FG001|Overall Study|Scheduling Conflict|3|||
106079275|NCT00006489|365953358|FG002|Overall Study|Scheduling Conflict|2|||
106079276|NCT00006489|365953359|FG003|Overall Study|Scheduling Conflict|1|||
106079277|NCT00006489|365953356|FG000|Overall Study|Death|0|||
106079278|NCT00006489|365953357|FG001|Overall Study|Death|0|||
106079279|NCT00006489|365953358|FG002|Overall Study|Death|0|||
106079280|NCT00006489|365953359|FG003|Overall Study|Death|1|||
106079281|NCT02086110|365953360|FG000|Overall Study|Withdrawal by Subject|1|||
106079282|NCT02086110|365953361|FG001|Overall Study|Withdrawal by Subject|1|||
106079283|NCT00116558|365953367|FG000|Overall Study|Death|11|||
106079284|NCT00116558|365953368|FG001|Overall Study|Death|5|||
106079285|NCT00116558|365953369|FG002|Overall Study|Death|3|||
106079286|NCT00116558|365953367|FG000|Overall Study|Withdrawal by Subject|17|||
106079287|NCT00116558|365953368|FG001|Overall Study|Withdrawal by Subject|3|||
106079288|NCT00116558|365953369|FG002|Overall Study|Withdrawal by Subject|12|||
106079289|NCT00116558|365953367|FG000|Overall Study|disease progression|3|||
106079290|NCT00116558|365953368|FG001|Overall Study|disease progression|7|||
106079291|NCT00116558|365953369|FG002|Overall Study|disease progression|18|||
106079292|NCT02027844|365953371|FG000|Overall Study|Withdrawal by Subject|3|||
106079293|NCT02027844|365953372|FG001|Overall Study|Withdrawal by Subject|2|||
105867049|NCT02964312|365163107|FG000|Overall Study|Lost to Follow-up|28|||
105867050|NCT02964312|365163107|FG000|Overall Study|Withdrawal by Subject|11|||
106079294|NCT02027844|365953373|FG002|Overall Study|Withdrawal by Subject|1|||
106079295|NCT02027844|365953371|FG000|Overall Study|Lost to Follow-up|0|||
106079296|NCT02027844|365953372|FG001|Overall Study|Lost to Follow-up|2|||
106079297|NCT02027844|365953373|FG002|Overall Study|Lost to Follow-up|1|||
106079298|NCT02027844|365953371|FG000|Overall Study|Protocol Violation|0|||
106079299|NCT02027844|365953372|FG001|Overall Study|Protocol Violation|2|||
106079300|NCT02027844|365953373|FG002|Overall Study|Protocol Violation|0|||
106079301|NCT02027844|365953371|FG000|Overall Study|Incomlete data|2|||
106079302|NCT02027844|365953372|FG001|Overall Study|Incomlete data|0|||
106079303|NCT02027844|365953373|FG002|Overall Study|Incomlete data|0|||
106079304|NCT02272413|365953374|FG000|Randomized Through Treatment Start|Not treated|3|||
106079305|NCT02272413|365953375|FG001|Randomized Through Treatment Start|Not treated|5|||
106079306|NCT02272413|365953374|FG000|Pre-switch Period|Adverse Event|38|||
106079307|NCT02272413|365953375|FG001|Pre-switch Period|Adverse Event|37|||
106079308|NCT02272413|365953374|FG000|Pre-switch Period|Death|26|||
106079309|NCT02272413|365953375|FG001|Pre-switch Period|Death|26|||
106079310|NCT02272413|365953374|FG000|Pre-switch Period|Withdrawal by Subject|27|||
106079311|NCT02272413|365953375|FG001|Pre-switch Period|Withdrawal by Subject|15|||
106079312|NCT02272413|365953374|FG000|Pre-switch Period|Physician Decision|6|||
106079313|NCT02272413|365953375|FG001|Pre-switch Period|Physician Decision|18|||
106079314|NCT02272413|365953374|FG000|Pre-switch Period|Progressive disease|185|||
106079315|NCT02272413|365953375|FG001|Pre-switch Period|Progressive disease|173|||
106079316|NCT02272413|365953374|FG000|Pre-switch Period|Lost to Follow-up|0|||
106079317|NCT02272413|365953375|FG001|Pre-switch Period|Lost to Follow-up|2|||
106079318|NCT02272413|365953374|FG000|Pre-switch Period|Protocol Violation|1|||
106079319|NCT02272413|365953375|FG001|Pre-switch Period|Protocol Violation|0|||
106079320|NCT02272413|365953374|FG000|Pre-switch Period|Other than listed|10|||
106079321|NCT02272413|365953375|FG001|Pre-switch Period|Other than listed|11|||
106079322|NCT02272413|365953374|FG000|Post-switch Period|Adverse Event|4|||
106079323|NCT02272413|365953375|FG001|Post-switch Period|Adverse Event|4|||
106079324|NCT02272413|365953374|FG000|Post-switch Period|Death|3|||
106079325|NCT02272413|365953375|FG001|Post-switch Period|Death|2|||
106079326|NCT02272413|365953374|FG000|Post-switch Period|Withdrawal by Subject|1|||
106079327|NCT02272413|365953375|FG001|Post-switch Period|Withdrawal by Subject|2|||
106079328|NCT02272413|365953374|FG000|Post-switch Period|Physician Decision|1|||
106079329|NCT02272413|365953375|FG001|Post-switch Period|Physician Decision|1|||
106079330|NCT02272413|365953374|FG000|Post-switch Period|Progressive disease|21|||
106079331|NCT02272413|365953375|FG001|Post-switch Period|Progressive disease|21|||
106079332|NCT02272413|365953374|FG000|Post-switch Period|Study terminated by sponsor|8|||
106079333|NCT02272413|365953375|FG001|Post-switch Period|Study terminated by sponsor|11|||
106079334|NCT02272413|365953374|FG000|Post-switch Period|Other than listed|4|||
106079335|NCT02272413|365953375|FG001|Post-switch Period|Other than listed|5|||
106079336|NCT02126969|365953376|FG000|Overall Study|Withdrawal by Subject|1|||
106079337|NCT02126969|365953377|FG001|Overall Study|Withdrawal by Subject|2|||
106079338|NCT01533246|365953378|FG000|Overall Study|Adverse Event|1|||
106079339|NCT01533246|365953378|FG000|Overall Study|Withdrawal by Subject|1|||
106079340|NCT00354172|365953379|FG000|Overall Study|Did not receive transplant|1|||
106079341|NCT00414661|365953380|FG000|Overall Study|Death|2|||
106079342|NCT00414661|365953381|FG001|Overall Study|Death|5|||
106079343|NCT00414661|365953382|FG002|Overall Study|Death|0|||
106079344|NCT00414661|365953383|FG003|Overall Study|Death|0|||
106079345|NCT00414661|365953380|FG000|Overall Study|Lost to Follow-up|1|||
106079346|NCT00414661|365953381|FG001|Overall Study|Lost to Follow-up|4|||
106079347|NCT00414661|365953382|FG002|Overall Study|Lost to Follow-up|0|||
106079348|NCT00414661|365953383|FG003|Overall Study|Lost to Follow-up|1|||
106079349|NCT00414661|365953380|FG000|Overall Study|Withdrawal by Subject|5|||
106079350|NCT00414661|365953381|FG001|Overall Study|Withdrawal by Subject|2|||
106079351|NCT00414661|365953382|FG002|Overall Study|Withdrawal by Subject|2|||
106079352|NCT00414661|365953383|FG003|Overall Study|Withdrawal by Subject|2|||
106079353|NCT00414661|365953380|FG000|Overall Study|Other|6|||
106079354|NCT00414661|365953381|FG001|Overall Study|Other|3|||
106079355|NCT00414661|365953382|FG002|Overall Study|Other|0|||
106079356|NCT00414661|365953383|FG003|Overall Study|Other|0|||
106079357|NCT01143090|365953384|FG000|Overall Study|Lack of Efficacy|2|||
106079358|NCT01143090|365953384|FG000|Overall Study|Adverse Event|17|||
106079359|NCT01143090|365953384|FG000|Overall Study|Lost to Follow-up|9|||
106079360|NCT01143090|365953384|FG000|Overall Study|Protocol Violation|2|||
106079361|NCT01143090|365953384|FG000|Overall Study|Withdrawal by Subject|18|||
106079362|NCT01143090|365953384|FG000|Overall Study|Non-compliance with study drug|1|||
106079363|NCT01143090|365953384|FG000|Overall Study|Failure to meet eligibility criteria|1|||
106079364|NCT01143090|365953384|FG000|Overall Study|Administrative|1|||
106079365|NCT03491150|365953385|FG000|Overall Study|Adverse Event|1|||
106079366|NCT03491150|365953386|FG001|Overall Study|Adverse Event|0|||
106079367|NCT03491150|365953385|FG000|Overall Study|Study Terminated by Sponsor|74|||
106079368|NCT03491150|365953386|FG001|Overall Study|Study Terminated by Sponsor|70|||
105867051|NCT02964312|365163107|FG000|Overall Study|Lack of Efficacy|10|||
106079369|NCT03491150|365953385|FG000|Overall Study|Other|0|||
106079370|NCT03491150|365953386|FG001|Overall Study|Other|1|||
106079371|NCT03491150|365953385|FG000|Overall Study|Withdrawal by Subject|1|||
106079372|NCT03491150|365953386|FG001|Overall Study|Withdrawal by Subject|2|||
106079373|NCT00937547|365953389|FG000|Overall Study|misdiagnosis|1|||
106079374|NCT00937547|365953390|FG001|Overall Study|misdiagnosis|6|||
106079375|NCT00937547|365953391|FG002|Overall Study|misdiagnosis|7|||
106079376|NCT01452412|365953395|FG000|Overall Study|Withdrawal by Subject|15|||
106079377|NCT01452412|365953396|FG001|Overall Study|Withdrawal by Subject|11|||
106079378|NCT01452412|365953395|FG000|Overall Study|Adverse Event|4|||
106079379|NCT01452412|365953396|FG001|Overall Study|Adverse Event|3|||
106079380|NCT01452412|365953395|FG000|Overall Study|Lost to Follow-up|5|||
106079381|NCT01452412|365953396|FG001|Overall Study|Lost to Follow-up|3|||
106079382|NCT01452412|365953395|FG000|Overall Study|Death|1|||
106079383|NCT01452412|365953396|FG001|Overall Study|Death|0|||
106079384|NCT01452412|365953395|FG000|Overall Study|Initiated dialysis|1|||
106079385|NCT01452412|365953396|FG001|Overall Study|Initiated dialysis|0|||
106079386|NCT01452412|365953395|FG000|Overall Study|Other|2|||
106079387|NCT01452412|365953396|FG001|Overall Study|Other|0|||
106079388|NCT02346136|365953397|FG000|Overall Study|Withdrawal by Subject|7|||
106079389|NCT02346136|365953398|FG001|Overall Study|Withdrawal by Subject|5|||
106079390|NCT02346136|365953397|FG000|Overall Study|Death|1|||
106079391|NCT02346136|365953398|FG001|Overall Study|Death|0|||
106079392|NCT02346136|365953397|FG000|Overall Study|Study termination|14|||
106079393|NCT02346136|365953398|FG001|Overall Study|Study termination|18|||
106079394|NCT00855309|365953402|FG000|Overall Study|patient never recieved drug|1|||
106079395|NCT00855309|365953403|FG001|Overall Study|patient never recieved drug|0|||
106079396|NCT00829296|365953404|FG000|Overall Study|Adverse Event|5|||
106079397|NCT00829296|365953405|FG001|Overall Study|Adverse Event|4|||
106079398|NCT03029624|365953406|FG000|Overall Study|Adverse Event|1|||
106079399|NCT03029624|365953406|FG000|Overall Study|Withdrawal by Subject|1|||
106079400|NCT03029624|365953406|FG000|Overall Study|Lack of Efficacy|1|||
106079401|NCT03029624|365953406|FG000|Overall Study|MRI need|2|||
106079402|NCT04116710|365953409|FG000|Overall Study|Death|4|||
106079403|NCT04116710|365953410|FG001|Overall Study|Death|6|||
106079404|NCT04116710|365953411|FG002|Overall Study|Death|3|||
106079405|NCT04116710|365953412|FG003|Overall Study|Death|1|||
106079406|NCT04116710|365953409|FG000|Overall Study|Withdrawal by Subject|0|||
106079407|NCT04116710|365953410|FG001|Overall Study|Withdrawal by Subject|0|||
106079408|NCT04116710|365953411|FG002|Overall Study|Withdrawal by Subject|0|||
106079409|NCT04116710|365953412|FG003|Overall Study|Withdrawal by Subject|1|||
106079410|NCT00582933|365953413|FG000|Overall Study|Physician Decision|3|||
106079411|NCT01077960|365953414|FG000|Overall Study|Adverse Event|6|||
106079412|NCT01077960|365953414|FG000|Overall Study|Protocol Violation|3|||
106079413|NCT01077960|365953414|FG000|Overall Study|Lost to Follow-up|5|||
106160118|NCT02783300|366247381|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160119|NCT02783300|366247382|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160120|NCT02783300|366247383|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160121|NCT02783300|366247384|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160122|NCT02783300|366247385|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160123|NCT02783300|366247386|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160124|NCT02783300|366247387|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160125|NCT02783300|366247388|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160126|NCT02783300|366247389|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160127|NCT02783300|366247390|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160128|NCT02783300|366247391|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160129|NCT02783300|366247392|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160130|NCT02783300|366247393|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160131|NCT02783300|366247394|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160132|NCT02783300|366247395|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
106160133|NCT02783300|366247396|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160134|NCT02783300|366247397|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160135|NCT02783300|366247398|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160136|NCT02783300|366247399|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160137|NCT02783300|366247400|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160138|NCT02783300|366247401|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160139|NCT02783300|366247402|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
106160140|NCT02783300|366247403|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160141|NCT02783300|366247404|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160142|NCT02783300|366247405|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160143|NCT02783300|366247406|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
106160144|NCT02783300|366247380|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160145|NCT02783300|366247381|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160146|NCT02783300|366247382|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160147|NCT02783300|366247383|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160148|NCT02783300|366247384|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160149|NCT02783300|366247385|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160150|NCT02783300|366247386|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160151|NCT02783300|366247387|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160152|NCT02783300|366247388|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160153|NCT02783300|366247389|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106079414|NCT01077960|365953414|FG000|Overall Study|Subject decision|1|||
106079415|NCT01077960|365953414|FG000|Overall Study|Reason unspecified|1|||
106079416|NCT02129803|365953415|FG000|Overall Study|Protocol Violation|4|||
106079417|NCT02129803|365953416|FG001|Overall Study|Protocol Violation|0|||
106079418|NCT02129803|365953415|FG000|Overall Study|Physician Decision|0|||
106079419|NCT02129803|365953416|FG001|Overall Study|Physician Decision|1|||
106079420|NCT02129803|365953415|FG000|Overall Study|Difficulty sleeping|1|||
106079421|NCT02129803|365953416|FG001|Overall Study|Difficulty sleeping|0|||
106079422|NCT02129803|365953415|FG000|Overall Study|Morning headache|0|||
106079423|NCT02129803|365953416|FG001|Overall Study|Morning headache|1|||
106160154|NCT02783300|366247390|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160155|NCT02783300|366247391|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160156|NCT02783300|366247392|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160157|NCT02783300|366247393|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
106160158|NCT02783300|366247394|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
106160159|NCT02783300|366247395|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
106160160|NCT02783300|366247396|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
106160161|NCT02783300|366247397|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160162|NCT02783300|366247398|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
106160163|NCT02783300|366247399|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
106160164|NCT02783300|366247400|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160165|NCT02783300|366247401|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160166|NCT02783300|366247402|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160167|NCT02783300|366247403|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160168|NCT02783300|366247404|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160169|NCT02783300|366247405|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160170|NCT02783300|366247406|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
106160171|NCT02783300|366247380|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160172|NCT02783300|366247381|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160173|NCT02783300|366247382|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160174|NCT02783300|366247383|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160175|NCT02783300|366247384|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160176|NCT02783300|366247385|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160177|NCT02783300|366247386|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160178|NCT02783300|366247387|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160179|NCT02783300|366247388|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160180|NCT02783300|366247389|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160181|NCT02783300|366247390|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160182|NCT02783300|366247391|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160183|NCT02783300|366247392|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160184|NCT02783300|366247393|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
106160185|NCT02783300|366247394|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
106160186|NCT02783300|366247395|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
106160187|NCT02783300|366247396|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
106160188|NCT02783300|366247397|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
106160189|NCT02783300|366247398|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
106160190|NCT02783300|366247399|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
106160191|NCT02783300|366247400|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
106160192|NCT02783300|366247401|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
106160193|NCT02783300|366247402|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
106160194|NCT02783300|366247403|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
106160195|NCT02783300|366247404|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
106160196|NCT02783300|366247405|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
106160197|NCT02783300|366247406|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
106160198|NCT02783300|366247380|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160199|NCT02783300|366247381|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160200|NCT02783300|366247382|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160201|NCT02783300|366247383|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160202|NCT02783300|366247384|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160203|NCT02783300|366247385|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160204|NCT02783300|366247386|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160205|NCT02783300|366247387|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160206|NCT02783300|366247388|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160207|NCT02783300|366247389|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160208|NCT02783300|366247390|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160209|NCT02783300|366247391|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160210|NCT02783300|366247392|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160211|NCT02783300|366247393|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160212|NCT02783300|366247394|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160213|NCT02783300|366247395|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160214|NCT02783300|366247396|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160215|NCT02783300|366247397|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160216|NCT02783300|366247398|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106079424|NCT02129803|365953415|FG000|Overall Study|Withdrawal by Subject|1|||
106079425|NCT02129803|365953416|FG001|Overall Study|Withdrawal by Subject|1|||
106079426|NCT03837899|365953417|FG000|Overall Study|Death|6|||
106079427|NCT03837899|365953418|FG001|Overall Study|Death|8|||
106079428|NCT03837899|365953419|FG002|Overall Study|Death|3|||
106079429|NCT03837899|365953420|FG003|Overall Study|Death|7|||
106079430|NCT03837899|365953421|FG004|Overall Study|Death|8|||
106079431|NCT03837899|365953422|FG005|Overall Study|Death|7|||
106079432|NCT03837899|365953417|FG000|Overall Study|Moved to post-trial access program|0|||
106079433|NCT03837899|365953418|FG001|Overall Study|Moved to post-trial access program|1|||
106079434|NCT03837899|365953419|FG002|Overall Study|Moved to post-trial access program|0|||
106079435|NCT03837899|365953420|FG003|Overall Study|Moved to post-trial access program|0|||
106079436|NCT03837899|365953421|FG004|Overall Study|Moved to post-trial access program|0|||
106079437|NCT03837899|365953422|FG005|Overall Study|Moved to post-trial access program|0|||
106079438|NCT03837899|365953417|FG000|Overall Study|Other|0|||
106079439|NCT03837899|365953418|FG001|Overall Study|Other|0|||
106079440|NCT03837899|365953419|FG002|Overall Study|Other|0|||
106079441|NCT03837899|365953420|FG003|Overall Study|Other|0|||
106079442|NCT03837899|365953421|FG004|Overall Study|Other|0|||
106079443|NCT03837899|365953422|FG005|Overall Study|Other|2|||
106079444|NCT03837899|365953417|FG000|Overall Study|Lost to Follow-up|0|||
106079445|NCT03837899|365953418|FG001|Overall Study|Lost to Follow-up|1|||
106079446|NCT03837899|365953419|FG002|Overall Study|Lost to Follow-up|0|||
106079447|NCT03837899|365953420|FG003|Overall Study|Lost to Follow-up|0|||
106079448|NCT03837899|365953421|FG004|Overall Study|Lost to Follow-up|0|||
106079449|NCT03837899|365953422|FG005|Overall Study|Lost to Follow-up|0|||
106079450|NCT03837899|365953417|FG000|Overall Study|Withdrawal by Subject|0|||
106079451|NCT03837899|365953418|FG001|Overall Study|Withdrawal by Subject|0|||
106079452|NCT03837899|365953419|FG002|Overall Study|Withdrawal by Subject|0|||
106079453|NCT03837899|365953420|FG003|Overall Study|Withdrawal by Subject|1|||
106079454|NCT03837899|365953421|FG004|Overall Study|Withdrawal by Subject|0|||
106079455|NCT03837899|365953422|FG005|Overall Study|Withdrawal by Subject|0|||
106079456|NCT03837899|365953417|FG000|Overall Study|Study specific discontinuation criteria|0|||
106079457|NCT03837899|365953418|FG001|Overall Study|Study specific discontinuation criteria|1|||
106079458|NCT03837899|365953419|FG002|Overall Study|Study specific discontinuation criteria|0|||
106079459|NCT03837899|365953420|FG003|Overall Study|Study specific discontinuation criteria|0|||
106079460|NCT03837899|365953421|FG004|Overall Study|Study specific discontinuation criteria|3|||
106079461|NCT03837899|365953422|FG005|Overall Study|Study specific discontinuation criteria|1|||
106079462|NCT01371656|365953423|FG000|Overall Study|Death|7|||
106079463|NCT01371656|365953424|FG001|Overall Study|Death|4|||
106079464|NCT01371656|365953423|FG000|Overall Study|Physician Decision|46|||
106079465|NCT01371656|365953424|FG001|Overall Study|Physician Decision|7|||
106079466|NCT01371656|365953423|FG000|Overall Study|Withdrawal by Subject|7|||
106079467|NCT01371656|365953424|FG001|Overall Study|Withdrawal by Subject|0|||
106079468|NCT01371656|365953423|FG000|Overall Study|Ineligible|4|||
106079469|NCT01371656|365953424|FG001|Overall Study|Ineligible|3|||
106079470|NCT02703636|365953431|FG000|Overall Study|Adverse Event|14|||
106079471|NCT02703636|365953431|FG000|Overall Study|Study stopped by sponsor|1|||
106079472|NCT02703636|365953431|FG000|Overall Study|Withdrawal by Subject|1|||
106079473|NCT01494610|365953432|FG000|Period 1|Withdrawal by Subject|1|||
106079474|NCT01494610|365953433|FG001|Period 1|Withdrawal by Subject|1|||
106079475|NCT01494610|365953432|FG000|Period 3|Adverse Event|1|||
106079476|NCT01494610|365953433|FG001|Period 3|Adverse Event|0|||
106079477|NCT01494610|365953432|FG000|Period 3|Withdrawal by Subject|1|||
106079478|NCT01494610|365953433|FG001|Period 3|Withdrawal by Subject|0|||
106079479|NCT01494610|365953432|FG000|Period 4|Protocol Violation|1|||
106079480|NCT01494610|365953433|FG001|Period 4|Protocol Violation|0|||
106079481|NCT00547703|365953436|FG000|Overall Study|Lost to Follow-up|1|||
106079482|NCT00547703|365953437|FG001|Overall Study|Lost to Follow-up|0|||
106079483|NCT01537783|365953446|FG000|Overall Study|Lost to Follow-up|11|||
106079484|NCT01537783|365953447|FG001|Overall Study|Lost to Follow-up|2|||
106079485|NCT00477672|365953448|FG000|Overall Study|Adverse Event|3|||
106079486|NCT00477672|365953449|FG001|Overall Study|Adverse Event|5|||
106079487|NCT00477672|365953450|FG002|Overall Study|Adverse Event|6|||
106079488|NCT00477672|365953448|FG000|Overall Study|Death|0|||
106079489|NCT00477672|365953449|FG001|Overall Study|Death|1|||
106079490|NCT00477672|365953450|FG002|Overall Study|Death|0|||
106079491|NCT00477672|365953448|FG000|Overall Study|Disease progression|0|||
106079492|NCT00477672|365953449|FG001|Overall Study|Disease progression|1|||
106079493|NCT00477672|365953450|FG002|Overall Study|Disease progression|0|||
106079494|NCT00477672|365953448|FG000|Overall Study|Physician Decision|1|||
106079495|NCT00477672|365953449|FG001|Overall Study|Physician Decision|0|||
106079496|NCT00477672|365953450|FG002|Overall Study|Physician Decision|0|||
106079497|NCT00477672|365953448|FG000|Overall Study|Protocol noncompliance|0|||
106079498|NCT00477672|365953449|FG001|Overall Study|Protocol noncompliance|2|||
106079499|NCT00477672|365953450|FG002|Overall Study|Protocol noncompliance|0|||
106079500|NCT00477672|365953448|FG000|Overall Study|Consent withdrawn|2|||
105867052|NCT02964312|365163107|FG000|Overall Study|Did not consent to long-term FU|14|||
106079501|NCT00477672|365953449|FG001|Overall Study|Consent withdrawn|5|||
106079502|NCT00477672|365953450|FG002|Overall Study|Consent withdrawn|10|||
106079503|NCT00477672|365953448|FG000|Overall Study|Discretion of Sponsor|1|||
106079504|NCT00477672|365953449|FG001|Overall Study|Discretion of Sponsor|2|||
106079505|NCT00477672|365953450|FG002|Overall Study|Discretion of Sponsor|0|||
106079506|NCT02722928|365953453|FG000|Overall Study|Standard CT was not as required per prot|5|||
106079507|NCT02722928|365953454|FG001|Overall Study|Standard CT was not as required per prot|13|||
106079508|NCT02722928|365953453|FG000|Overall Study|Required Intraoperative MRI|5|||
106079509|NCT02722928|365953454|FG001|Overall Study|Required Intraoperative MRI|7|||
106079510|NCT01116232|365953455|FG000|Overall Study|Progressive diease|4|||
106079511|NCT02442778|365953457|FG000|Overall Study|Adverse Event|2|||
106079512|NCT02442778|365953458|FG001|Overall Study|Adverse Event|6|||
106079513|NCT02442778|365953459|FG002|Overall Study|Adverse Event|6|||
106079514|NCT02442778|365953457|FG000|Overall Study|Death|0|||
106079515|NCT02442778|365953458|FG001|Overall Study|Death|2|||
106079516|NCT02442778|365953459|FG002|Overall Study|Death|0|||
106079517|NCT02442778|365953457|FG000|Overall Study|Lack of Efficacy|1|||
106079518|NCT02442778|365953458|FG001|Overall Study|Lack of Efficacy|0|||
106079519|NCT02442778|365953459|FG002|Overall Study|Lack of Efficacy|0|||
106079520|NCT02442778|365953457|FG000|Overall Study|Lost to Follow-up|1|||
106079521|NCT02442778|365953458|FG001|Overall Study|Lost to Follow-up|1|||
106079522|NCT02442778|365953459|FG002|Overall Study|Lost to Follow-up|1|||
106079523|NCT02442778|365953457|FG000|Overall Study|Non-compliance with study drug|2|||
106079524|NCT02442778|365953458|FG001|Overall Study|Non-compliance with study drug|0|||
106079525|NCT02442778|365953459|FG002|Overall Study|Non-compliance with study drug|1|||
106079526|NCT02442778|365953457|FG000|Overall Study|Physician Decision|1|||
106079527|NCT02442778|365953458|FG001|Overall Study|Physician Decision|1|||
106079528|NCT02442778|365953459|FG002|Overall Study|Physician Decision|1|||
106079529|NCT02442778|365953457|FG000|Overall Study|Protocol Deviation|3|||
106079530|NCT02442778|365953458|FG001|Overall Study|Protocol Deviation|0|||
106079531|NCT02442778|365953459|FG002|Overall Study|Protocol Deviation|1|||
106079532|NCT02442778|365953457|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
106079533|NCT02442778|365953458|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
106079534|NCT02442778|365953459|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
106079535|NCT02442778|365953457|FG000|Overall Study|Withdrawal by Subject|4|||
106079536|NCT02442778|365953458|FG001|Overall Study|Withdrawal by Subject|4|||
106079537|NCT02442778|365953459|FG002|Overall Study|Withdrawal by Subject|3|||
106079538|NCT02442778|365953457|FG000|Overall Study|Reason not specified|1|||
106079539|NCT02442778|365953458|FG001|Overall Study|Reason not specified|4|||
106079540|NCT02442778|365953459|FG002|Overall Study|Reason not specified|0|||
106079541|NCT01557400|365953460|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
106079542|NCT01557400|365953460|FG000|Overall Study|Adverse Event|3|||
106079543|NCT01557400|365953460|FG000|Overall Study|Lost to Follow-up|5|||
106079544|NCT01557400|365953460|FG000|Overall Study|Withdrawal by Subject|9|||
106079545|NCT01434290|365953463|FG000|Overall Study|Protocol Violation|6|||
106079546|NCT01434290|365953464|FG001|Overall Study|Protocol Violation|3|||
106079547|NCT01434290|365953463|FG000|Overall Study|No protocol treatment|2|||
106079548|NCT01434290|365953464|FG001|Overall Study|No protocol treatment|4|||
106079549|NCT00558103|365953467|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
106079550|NCT00558103|365953468|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
106079551|NCT00558103|365953469|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
106079552|NCT00558103|365953470|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
106079553|NCT00558103|365953471|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
106079554|NCT00558103|365953472|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
106079555|NCT00558103|365953467|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
106079556|NCT00558103|365953468|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
106079557|NCT00558103|365953469|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
106079558|NCT00558103|365953470|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
106079559|NCT00558103|365953471|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
106079560|NCT00558103|365953472|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
106079561|NCT00558103|365953467|FG000|Randomized Treatment Phase|Disease Progression|1|||
106079562|NCT00558103|365953468|FG001|Randomized Treatment Phase|Disease Progression|0|||
106079563|NCT00558103|365953469|FG002|Randomized Treatment Phase|Disease Progression|1|||
106079564|NCT00558103|365953470|FG003|Randomized Treatment Phase|Disease Progression|0|||
106079565|NCT00558103|365953471|FG004|Randomized Treatment Phase|Disease Progression|0|||
106079566|NCT00558103|365953472|FG005|Randomized Treatment Phase|Disease Progression|0|||
105867053|NCT02964312|365163107|FG000|Overall Study|Death|1|||
106079567|NCT00558103|365953467|FG000|Randomized Treatment Phase|Adverse Event|0|||
106079568|NCT00558103|365953468|FG001|Randomized Treatment Phase|Adverse Event|0|||
106079569|NCT00558103|365953469|FG002|Randomized Treatment Phase|Adverse Event|0|||
106079570|NCT00558103|365953470|FG003|Randomized Treatment Phase|Adverse Event|1|||
106079571|NCT00558103|365953471|FG004|Randomized Treatment Phase|Adverse Event|1|||
106079572|NCT00558103|365953472|FG005|Randomized Treatment Phase|Adverse Event|0|||
106079573|NCT00558103|365953467|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
106079574|NCT00558103|365953468|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
106079575|NCT00558103|365953469|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
106079576|NCT00558103|365953470|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
106079577|NCT00558103|365953471|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
106079578|NCT00558103|365953472|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
106079579|NCT00558103|365953467|FG000|Monotherapy Extension Phase|Disease Progression|0|||
106079580|NCT00558103|365953468|FG001|Monotherapy Extension Phase|Disease Progression|0|||
106079581|NCT00558103|365953469|FG002|Monotherapy Extension Phase|Disease Progression|0|||
106079582|NCT00558103|365953470|FG003|Monotherapy Extension Phase|Disease Progression|0|||
106079583|NCT00558103|365953471|FG004|Monotherapy Extension Phase|Disease Progression|0|||
106079584|NCT00558103|365953472|FG005|Monotherapy Extension Phase|Disease Progression|8|||
106079585|NCT00262067|365953473|FG000|Overall Study|Death|190|||
106079586|NCT00262067|365953474|FG001|Overall Study|Death|89|||
106079587|NCT00262067|365953475|FG002|Overall Study|Death|186|||
106079588|NCT00262067|365953476|FG003|Overall Study|Death|99|||
106079589|NCT00262067|365953473|FG000|Overall Study|Lost to Follow-up|5|||
106079590|NCT00262067|365953474|FG001|Overall Study|Lost to Follow-up|4|||
106079591|NCT00262067|365953475|FG002|Overall Study|Lost to Follow-up|7|||
106079592|NCT00262067|365953476|FG003|Overall Study|Lost to Follow-up|5|||
106079593|NCT00262067|365953473|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
106079594|NCT00262067|365953474|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
106079595|NCT00262067|365953475|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
106079596|NCT00262067|365953476|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
106079597|NCT00262067|365953473|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
106079598|NCT00262067|365953474|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
106079599|NCT00262067|365953475|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
106079600|NCT00262067|365953476|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
106079601|NCT00989833|365953478|FG000|Overall Study|Lost to Follow-up|0|||
106079602|NCT00989833|365953479|FG001|Overall Study|Lost to Follow-up|1|||
106079603|NCT00989833|365953480|FG002|Overall Study|Lost to Follow-up|0|||
106079604|NCT00989833|365953478|FG000|Overall Study|Protocol Violation|1|||
106079605|NCT00989833|365953479|FG001|Overall Study|Protocol Violation|2|||
106079606|NCT00989833|365953480|FG002|Overall Study|Protocol Violation|1|||
106079607|NCT00989833|365953478|FG000|Overall Study|Withdrawal by Subject|0|||
106079608|NCT00989833|365953479|FG001|Overall Study|Withdrawal by Subject|0|||
106079609|NCT00989833|365953480|FG002|Overall Study|Withdrawal by Subject|1|||
106079610|NCT00989833|365953478|FG000|Overall Study|Incorrectly randomized|1|||
106079611|NCT00989833|365953479|FG001|Overall Study|Incorrectly randomized|0|||
106079612|NCT00989833|365953480|FG002|Overall Study|Incorrectly randomized|0|||
106079613|NCT02970968|365955110|FG000|Overall Study|Withdrawal by Subject|3|||
106079614|NCT02970968|365955111|FG001|Overall Study|Withdrawal by Subject|3|||
106079615|NCT02970968|365955110|FG000|Overall Study|Adverse Event|1|||
106079616|NCT02970968|365955111|FG001|Overall Study|Adverse Event|2|||
106079617|NCT02970968|365955110|FG000|Overall Study|Lost to Follow-up|1|||
106079618|NCT02970968|365955111|FG001|Overall Study|Lost to Follow-up|1|||
106079619|NCT02970968|365955110|FG000|Overall Study|Non-Compliance|0|||
106079620|NCT02970968|365955111|FG001|Overall Study|Non-Compliance|1|||
106079621|NCT03264404|365955112|FG000|Overall Study|Death|2|||
106079622|NCT03264404|365955112|FG000|Overall Study|Physician Decision|1|||
106079623|NCT03264404|365955112|FG000|Overall Study|Disease Progression|28|||
106079624|NCT03264404|365955112|FG000|Overall Study|Adverse Event|1|||
106079625|NCT03264404|365955112|FG000|Overall Study|Off study prior to treatment|2|||
106079626|NCT00333229|365955117|FG000|Overall Study|Lack of Efficacy|0|||
105867054|NCT00606632|365163114|FG000|Overall Study|Withdrawal by Subject|13|||
106079627|NCT00333229|365955118|FG001|Overall Study|Lack of Efficacy|1|||
106079628|NCT01632891|365955119|FG000|Overall Study|Lost to Follow-up|0|||
106079629|NCT01632891|365955120|FG001|Overall Study|Lost to Follow-up|1|||
106079630|NCT01632891|365955119|FG000|Overall Study|Withdrawal by Subject|1|||
106079631|NCT01632891|365955120|FG001|Overall Study|Withdrawal by Subject|0|||
106079632|NCT00348556|365955121|FG000|Overall Study|Adverse Event|1|||
106079633|NCT01466270|365955122|FG000|Overall Study|Withdrawal by Subject|4|||
106079634|NCT01466270|365955123|FG001|Overall Study|Withdrawal by Subject|1|||
106079635|NCT01466270|365955122|FG000|Overall Study|Physician Decision|1|||
106079636|NCT01466270|365955123|FG001|Overall Study|Physician Decision|0|||
106079637|NCT01466270|365955122|FG000|Overall Study|Lost to Follow-up|1|||
106079638|NCT01466270|365955123|FG001|Overall Study|Lost to Follow-up|3|||
106079639|NCT01466270|365955122|FG000|Overall Study|Progression|1|||
106079640|NCT01466270|365955123|FG001|Overall Study|Progression|0|||
106079641|NCT01466270|365955122|FG000|Overall Study|Toxicity|4|||
106079642|NCT01466270|365955123|FG001|Overall Study|Toxicity|1|||
106079643|NCT01466270|365955122|FG000|Overall Study|Multiple|1|||
106079644|NCT01466270|365955123|FG001|Overall Study|Multiple|1|||
106079645|NCT02821962|365955124|FG000|Overall Study|Lost to Follow-up|2|||
106079646|NCT02821962|365955125|FG001|Overall Study|Lost to Follow-up|0|||
106079647|NCT04206293|365955140|FG000|Overall Study|Consent withdrawal|1|||
106079648|NCT00463060|365955144|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
106079649|NCT00463060|365955144|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
106079650|NCT01631474|365955146|FG000|Overall Study|Lost to Follow-up|8|||
106079651|NCT01631474|365955147|FG001|Overall Study|Lost to Follow-up|5|||
106079652|NCT01631474|365955148|FG002|Overall Study|Lost to Follow-up|7|||
106079653|NCT01631474|365955149|FG003|Overall Study|Lost to Follow-up|5|||
106079654|NCT01631474|365955150|FG004|Overall Study|Lost to Follow-up|5|||
106079655|NCT01631474|365955146|FG000|Overall Study|Withdrawal by Subject|4|||
106079656|NCT01631474|365955147|FG001|Overall Study|Withdrawal by Subject|4|||
106079657|NCT01631474|365955148|FG002|Overall Study|Withdrawal by Subject|2|||
106079658|NCT01631474|365955149|FG003|Overall Study|Withdrawal by Subject|6|||
106079659|NCT01631474|365955150|FG004|Overall Study|Withdrawal by Subject|5|||
106079660|NCT01631474|365955146|FG000|Overall Study|Lack of Efficacy|2|||
106079661|NCT01631474|365955147|FG001|Overall Study|Lack of Efficacy|2|||
106079662|NCT01631474|365955148|FG002|Overall Study|Lack of Efficacy|0|||
106079663|NCT01631474|365955149|FG003|Overall Study|Lack of Efficacy|0|||
106079664|NCT01631474|365955150|FG004|Overall Study|Lack of Efficacy|2|||
106079665|NCT01631474|365955146|FG000|Overall Study|Noncompliance with Study Drug|0|||
106079666|NCT01631474|365955147|FG001|Overall Study|Noncompliance with Study Drug|0|||
106079667|NCT01631474|365955148|FG002|Overall Study|Noncompliance with Study Drug|0|||
106079668|NCT01631474|365955149|FG003|Overall Study|Noncompliance with Study Drug|0|||
106079669|NCT01631474|365955150|FG004|Overall Study|Noncompliance with Study Drug|1|||
106079670|NCT01631474|365955146|FG000|Overall Study|Adverse Event|0|||
106079671|NCT01631474|365955147|FG001|Overall Study|Adverse Event|1|||
106079672|NCT01631474|365955148|FG002|Overall Study|Adverse Event|0|||
106079673|NCT01631474|365955149|FG003|Overall Study|Adverse Event|0|||
106079674|NCT01631474|365955150|FG004|Overall Study|Adverse Event|0|||
106079675|NCT02624284|365955151|FG000|Overall Study|Withdrawal by Subject|3|||
106079676|NCT02624284|365955152|FG001|Overall Study|Withdrawal by Subject|6|||
106079677|NCT02624284|365955153|FG002|Overall Study|Withdrawal by Subject|3|||
106079678|NCT02624284|365955151|FG000|Overall Study|Protocol Violation|9|||
106079679|NCT02624284|365955152|FG001|Overall Study|Protocol Violation|10|||
106079680|NCT02624284|365955153|FG002|Overall Study|Protocol Violation|7|||
106079681|NCT02624284|365955151|FG000|Overall Study|Revealed exclusionary condition|2|||
106079682|NCT02624284|365955152|FG001|Overall Study|Revealed exclusionary condition|2|||
106079683|NCT02624284|365955153|FG002|Overall Study|Revealed exclusionary condition|0|||
106079684|NCT02624284|365955151|FG000|Overall Study|Adverse Event|0|||
106079685|NCT02624284|365955152|FG001|Overall Study|Adverse Event|0|||
106079686|NCT02624284|365955153|FG002|Overall Study|Adverse Event|1|||
105867055|NCT00606632|365163114|FG000|Overall Study|Miscellaneous reasons|9|||
105867056|NCT00711880|365163119|FG000|Overall Study|Adverse Event|11|||
106079687|NCT02711800|365955154|FG000|Overall Study|Lost to Follow-up|1|||
106079688|NCT02711800|365955154|FG000|Overall Study|Withdrawal by Subject|1|||
106079689|NCT05923229|365955157|FG000|Overall Study|Withdrawal by Subject|3|||
106079690|NCT05923229|365955158|FG001|Overall Study|Withdrawal by Subject|0|||
106079691|NCT05923229|365955157|FG000|Overall Study|Health related|2|||
106079692|NCT05923229|365955158|FG001|Overall Study|Health related|1|||
106079693|NCT01869192|365955164|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
106079694|NCT01869192|365955165|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
106079695|NCT01869192|365955164|FG000|Postoperative Chemotherapy|Physician Decision|0|||
106079696|NCT01869192|365955165|FG001|Postoperative Chemotherapy|Physician Decision|2|||
106079697|NCT01800916|365955166|FG000|Test Period 1 (1 Week)|Convex product user|0|||
106079698|NCT01800916|365955167|FG001|Test Period 1 (1 Week)|Convex product user|0|||
106079699|NCT01800916|365955168|FG002|Test Period 1 (1 Week)|Convex product user|0|||
106079700|NCT01800916|365955169|FG003|Test Period 1 (1 Week)|Convex product user|1|||
106079701|NCT01800916|365955170|FG004|Test Period 1 (1 Week)|Convex product user|0|||
106079702|NCT01800916|365955171|FG005|Test Period 1 (1 Week)|Convex product user|0|||
106079703|NCT01800916|365955172|FG006|Test Period 1 (1 Week)|Convex product user|0|||
106079704|NCT01800916|365955173|FG007|Test Period 1 (1 Week)|Convex product user|0|||
106079705|NCT01800916|365955174|FG008|Test Period 1 (1 Week)|Convex product user|0|||
106079706|NCT01800916|365955166|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
106079707|NCT01800916|365955167|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
106079708|NCT01800916|365955168|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
106079709|NCT01800916|365955169|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
106079710|NCT01800916|365955170|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
106079711|NCT01800916|365955171|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
106079712|NCT01800916|365955172|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
106079713|NCT01800916|365955173|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
106079714|NCT01800916|365955174|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
106079715|NCT00004412|365955176|FG000|Randomized Period|Moved to Crossover Period|3|||
106079716|NCT00004412|365955177|FG001|Randomized Period|Moved to Crossover Period|0|||
106079717|NCT00004412|365955178|FG002|Randomized Period|Moved to Crossover Period|0|||
106079718|NCT00727714|365955184|FG000|Overall Study|Lost to Follow-up|2|||
106079719|NCT01234467|365955190|FG000|Overall Study|Adverse Event|3|||
106079720|NCT01234467|365955190|FG000|Overall Study|Death|2|||
106079721|NCT01234467|365955190|FG000|Overall Study|Withdrawal by Subject|2|||
106079722|NCT01234467|365955190|FG000|Overall Study|Disease Progression|2|||
106079723|NCT01234467|365955190|FG000|Overall Study|Clinical deterioration|1|||
106079724|NCT01234467|365955190|FG000|Overall Study|Physician Decision|1|||
106079725|NCT01234467|365955190|FG000|Overall Study|Other complicating disease (stroke)|1|||
106079726|NCT01461096|365955194|FG000|Overall Study|Death|3|||
106079727|NCT01461096|365955195|FG001|Overall Study|Death|6|||
106079728|NCT01461096|365955194|FG000|Overall Study|Severe debilitation, unable to continue|1|||
106079729|NCT01461096|365955195|FG001|Overall Study|Severe debilitation, unable to continue|1|||
106079730|NCT01461096|365955194|FG000|Overall Study|Subj not able to get to clinic|15|||
106079731|NCT01461096|365955195|FG001|Overall Study|Subj not able to get to clinic|13|||
106079732|NCT01461096|365955194|FG000|Overall Study|Site is closing|27|||
106079733|NCT01461096|365955195|FG001|Overall Study|Site is closing|30|||
106079734|NCT01461096|365955194|FG000|Overall Study|Withdrawal by Subject|5|||
106079735|NCT01461096|365955195|FG001|Overall Study|Withdrawal by Subject|3|||
106079736|NCT01461096|365955194|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
106079737|NCT01461096|365955195|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
106079738|NCT01461096|365955194|FG000|Overall Study|Lost to Follow-up|8|||
106079739|NCT01461096|365955195|FG001|Overall Study|Lost to Follow-up|4|||
106079740|NCT04889625|365955197|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
106079741|NCT04889625|365955198|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
106079742|NCT04889625|365955197|FG000|Period 1|Subject out of window|0|||
106079743|NCT04889625|365955198|FG001|Period 1|Subject out of window|1|||
106079744|NCT04889625|365955197|FG000|Period 1|Wrong add power dispensed|0|||
106079745|NCT04889625|365955198|FG001|Period 1|Wrong add power dispensed|1|||
106079746|NCT04889625|365955197|FG000|Period 1|Discontinued due to fitting guide error|1|||
106079747|NCT04889625|365955198|FG001|Period 1|Discontinued due to fitting guide error|1|||
106079748|NCT04889625|365955197|FG000|Period 2|Test article no longer available|1|||
106079749|NCT04889625|365955198|FG001|Period 2|Test article no longer available|0|||
106079750|NCT04889625|365955197|FG000|Period 2|Incorrect lens dispensed|1|||
106079751|NCT04889625|365955198|FG001|Period 2|Incorrect lens dispensed|0|||
106079752|NCT04889625|365955197|FG000|Period 2|Wrong add power dispensed|0|||
106079753|NCT04889625|365955198|FG001|Period 2|Wrong add power dispensed|1|||
106079754|NCT03144180|365955199|FG000|Overall Study|STAT Delivery|1|||
106079755|NCT03144180|365955200|FG001|Overall Study|STAT Delivery|1|||
106079756|NCT03144180|365955199|FG000|Overall Study|Provider forgot to fill out forms|1|||
106079757|NCT03144180|365955200|FG001|Overall Study|Provider forgot to fill out forms|3|||
106079758|NCT03144180|365955199|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
106079759|NCT03144180|365955200|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
106079760|NCT03144180|365955199|FG000|Overall Study|Scrub tech removed tube cap|0|||
106079761|NCT03144180|365955200|FG001|Overall Study|Scrub tech removed tube cap|1|||
106079762|NCT01639040|365955203|FG000|Overall Study|Adverse Event|1|||
106079763|NCT01639040|365955204|FG001|Overall Study|Adverse Event|0|||
106079764|NCT00323414|365955212|FG000|Overall Study|Withdrawal by Subject|0|||
106079765|NCT00323414|365955213|FG001|Overall Study|Withdrawal by Subject|1|||
106079766|NCT02659020|365955214|FG000|Overall Study|Adverse Event|0|||
106079767|NCT02659020|365955215|FG001|Overall Study|Adverse Event|0|||
106079768|NCT02659020|365955216|FG002|Overall Study|Adverse Event|0|||
106079769|NCT02659020|365955217|FG003|Overall Study|Adverse Event|2|||
106079770|NCT02659020|365955218|FG004|Overall Study|Adverse Event|0|||
106079771|NCT02659020|365955219|FG005|Overall Study|Adverse Event|0|||
105867057|NCT00711880|365163120|FG001|Overall Study|Adverse Event|2|||
106079772|NCT02659020|365955220|FG006|Overall Study|Adverse Event|2|||
106079773|NCT02659020|365955214|FG000|Overall Study|Lost to Follow-up|1|||
106079774|NCT02659020|365955215|FG001|Overall Study|Lost to Follow-up|2|||
105867058|NCT00711880|365163119|FG000|Overall Study|Patient non-compliance|1|||
106079775|NCT02659020|365955216|FG002|Overall Study|Lost to Follow-up|1|||
106079776|NCT02659020|365955217|FG003|Overall Study|Lost to Follow-up|6|||
106079777|NCT02659020|365955218|FG004|Overall Study|Lost to Follow-up|1|||
106079778|NCT02659020|365955219|FG005|Overall Study|Lost to Follow-up|5|||
106079779|NCT02659020|365955220|FG006|Overall Study|Lost to Follow-up|0|||
106079780|NCT02659020|365955214|FG000|Overall Study|Physician Decision|0|||
106079781|NCT02659020|365955215|FG001|Overall Study|Physician Decision|0|||
106079782|NCT02659020|365955216|FG002|Overall Study|Physician Decision|0|||
106079783|NCT02659020|365955217|FG003|Overall Study|Physician Decision|1|||
106079784|NCT02659020|365955218|FG004|Overall Study|Physician Decision|1|||
106079785|NCT02659020|365955219|FG005|Overall Study|Physician Decision|0|||
106079786|NCT02659020|365955220|FG006|Overall Study|Physician Decision|1|||
106079787|NCT02659020|365955214|FG000|Overall Study|Withdrawal by Subject|2|||
106079788|NCT02659020|365955215|FG001|Overall Study|Withdrawal by Subject|1|||
106079789|NCT02659020|365955216|FG002|Overall Study|Withdrawal by Subject|0|||
106079790|NCT02659020|365955217|FG003|Overall Study|Withdrawal by Subject|3|||
106079791|NCT02659020|365955218|FG004|Overall Study|Withdrawal by Subject|3|||
106079792|NCT02659020|365955219|FG005|Overall Study|Withdrawal by Subject|6|||
106079793|NCT02659020|365955220|FG006|Overall Study|Withdrawal by Subject|3|||
106079794|NCT02659020|365955214|FG000|Overall Study|Progressive Disease|0|||
106079795|NCT02659020|365955215|FG001|Overall Study|Progressive Disease|0|||
106079796|NCT02659020|365955216|FG002|Overall Study|Progressive Disease|0|||
106079797|NCT02659020|365955217|FG003|Overall Study|Progressive Disease|4|||
106079798|NCT02659020|365955218|FG004|Overall Study|Progressive Disease|1|||
106079799|NCT02659020|365955219|FG005|Overall Study|Progressive Disease|0|||
106079800|NCT02659020|365955220|FG006|Overall Study|Progressive Disease|2|||
106079801|NCT04382911|365955221|FG000|Overall Study|unable to be imaged prior to surgery|2|||
106079802|NCT00974571|365955224|FG000|Overall Study|Adverse Event|31|||
106079803|NCT00974571|365955225|FG001|Overall Study|Adverse Event|4|||
106079804|NCT00974571|365955226|FG002|Overall Study|Adverse Event|27|||
106079805|NCT00974571|365955224|FG000|Overall Study|Lack of Efficacy|3|||
106079806|NCT00974571|365955225|FG001|Overall Study|Lack of Efficacy|2|||
106079807|NCT00974571|365955226|FG002|Overall Study|Lack of Efficacy|9|||
106079808|NCT00974571|365955224|FG000|Overall Study|Lost to Follow-up|2|||
106079809|NCT00974571|365955225|FG001|Overall Study|Lost to Follow-up|1|||
106079810|NCT00974571|365955226|FG002|Overall Study|Lost to Follow-up|2|||
105867059|NCT00711880|365163120|FG001|Overall Study|Patient non-compliance|0|||
106079811|NCT00974571|365955224|FG000|Overall Study|Protocol Violation|13|||
106079812|NCT00974571|365955225|FG001|Overall Study|Protocol Violation|4|||
106079813|NCT00974571|365955226|FG002|Overall Study|Protocol Violation|18|||
106079814|NCT00974571|365955224|FG000|Overall Study|Withdrawal by Subject|14|||
106079815|NCT00974571|365955225|FG001|Overall Study|Withdrawal by Subject|5|||
106079816|NCT00974571|365955226|FG002|Overall Study|Withdrawal by Subject|16|||
106079817|NCT00974571|365955224|FG000|Overall Study|Patient Moved|1|||
106079818|NCT00974571|365955225|FG001|Overall Study|Patient Moved|0|||
106079819|NCT00974571|365955226|FG002|Overall Study|Patient Moved|1|||
106079820|NCT00974571|365955224|FG000|Overall Study|Other|4|||
106079821|NCT00974571|365955225|FG001|Overall Study|Other|0|||
106079822|NCT00974571|365955226|FG002|Overall Study|Other|10|||
106079823|NCT04334460|365955229|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
106079824|NCT04334460|365955230|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
106079825|NCT04334460|365955229|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
106079826|NCT04334460|365955230|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
106079827|NCT02385799|365955231|FG000|Overall Study|Lost to Follow-up|1|||
106079828|NCT02385799|365955232|FG001|Overall Study|Lost to Follow-up|2|||
106079829|NCT02385799|365955231|FG000|Overall Study|Adverse Event|4|||
106079830|NCT02385799|365955232|FG001|Overall Study|Adverse Event|2|||
106079831|NCT02385799|365955231|FG000|Overall Study|Withdrawal by Subject|0|||
106079832|NCT02385799|365955232|FG001|Overall Study|Withdrawal by Subject|4|||
106079833|NCT02130765|365955233|FG000|Overall Study|Did not receive treatment|4|||
106160217|NCT02783300|366247399|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160218|NCT02783300|366247400|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160219|NCT02783300|366247401|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160220|NCT02783300|366247402|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160221|NCT02783300|366247403|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160222|NCT02783300|366247404|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160223|NCT02783300|366247405|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
106160224|NCT02783300|366247406|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
106160225|NCT02783300|366247380|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160226|NCT02783300|366247381|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160227|NCT02783300|366247382|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160228|NCT02783300|366247383|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160229|NCT02783300|366247384|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160230|NCT02783300|366247385|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
106079834|NCT02130765|365955234|FG001|Overall Study|Did not receive treatment|0|||
106079835|NCT02130765|365955235|FG002|Overall Study|Did not receive treatment|0|||
106079836|NCT02130765|365955236|FG003|Overall Study|Did not receive treatment|0|||
106079837|NCT00376168|365955238|FG000|Overall Study|Adverse Event|1|||
106079838|NCT00376168|365955239|FG001|Overall Study|Adverse Event|1|||
106079839|NCT00376168|365955238|FG000|Overall Study|Pregnancy|1|||
106079840|NCT00376168|365955239|FG001|Overall Study|Pregnancy|0|||
106079841|NCT03571516|365955240|FG000|Overall Study|Severe diarrhea|1|||
106079842|NCT03571516|365955241|FG001|Overall Study|Severe diarrhea|0|||
106079843|NCT03571516|365955240|FG000|Overall Study|Withdrawal by Subject|0|||
106079844|NCT03571516|365955241|FG001|Overall Study|Withdrawal by Subject|1|||
106079845|NCT04365699|365955242|FG000|Overall Study|Death|2|||
106079846|NCT04365699|365955243|FG001|Overall Study|Death|5|||
106079847|NCT04365699|365955244|FG002|Overall Study|Death|15|||
106079848|NCT04019041|365955245|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
106079849|NCT04019041|365955246|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
106079850|NCT04019041|365955247|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
106079851|NCT04019041|365955248|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
106079852|NCT04019041|365955249|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
106079853|NCT04019041|365955250|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
106079854|NCT04019041|365955245|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
106079855|NCT04019041|365955246|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
106079856|NCT04019041|365955247|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
106079857|NCT04019041|365955248|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
106079858|NCT04019041|365955249|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
106079859|NCT04019041|365955250|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
106079860|NCT04019041|365955245|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
106079861|NCT04019041|365955246|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
106079862|NCT04019041|365955247|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
106079863|NCT04019041|365955248|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
106079864|NCT04019041|365955249|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
106079865|NCT04019041|365955250|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
106079866|NCT04019041|365955245|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
106079867|NCT04019041|365955246|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
106079868|NCT04019041|365955247|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
106079869|NCT04019041|365955248|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
106079870|NCT04019041|365955249|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
106079871|NCT04019041|365955250|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
106079872|NCT04019041|365955245|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
106079873|NCT04019041|365955246|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
106079874|NCT04019041|365955247|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
106079875|NCT04019041|365955248|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
106079876|NCT04019041|365955249|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
106079877|NCT04019041|365955250|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
106079878|NCT04019041|365955245|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
106079879|NCT04019041|365955246|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
106079880|NCT04019041|365955247|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
106079881|NCT04019041|365955248|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
106079882|NCT04019041|365955249|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
106079883|NCT04019041|365955250|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
106079884|NCT04019041|365955245|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
106079885|NCT04019041|365955246|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
106079886|NCT04019041|365955247|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
106079887|NCT04019041|365955248|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
106079888|NCT04019041|365955249|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
106079889|NCT04019041|365955250|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
106079890|NCT04019041|365955245|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
106079891|NCT04019041|365955246|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
106079892|NCT04019041|365955247|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
106079893|NCT04019041|365955248|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
106079894|NCT04019041|365955249|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
106079895|NCT04019041|365955250|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
106079896|NCT04019041|365955245|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
106079897|NCT04019041|365955246|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
106079898|NCT04019041|365955247|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
106079899|NCT04019041|365955248|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
106079900|NCT04019041|365955249|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
106079901|NCT04019041|365955250|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
106079902|NCT02540954|365955251|FG000|Overall Study|Physician Decision|3|||
106079903|NCT02540954|365955252|FG001|Overall Study|Physician Decision|1|||
106079904|NCT02540954|365955251|FG000|Overall Study|Withdrawal by Subject|6|||
106079905|NCT02540954|365955252|FG001|Overall Study|Withdrawal by Subject|5|||
106079906|NCT02540954|365955251|FG000|Overall Study|Lost to Follow-up|1|||
106079907|NCT02540954|365955252|FG001|Overall Study|Lost to Follow-up|1|||
106079908|NCT02540954|365955251|FG000|Overall Study|Adverse Event|4|||
106079909|NCT02540954|365955252|FG001|Overall Study|Adverse Event|2|||
106079910|NCT02540954|365955251|FG000|Overall Study|Death|0|||
105867060|NCT00711880|365163119|FG000|Overall Study|Lack of Efficacy|1|||
106079911|NCT02540954|365955252|FG001|Overall Study|Death|3|||
106079912|NCT02540954|365955251|FG000|Overall Study|Treatment failure|1|||
106079913|NCT02540954|365955252|FG001|Overall Study|Treatment failure|0|||
106079914|NCT02540954|365955251|FG000|Overall Study|Other reason|4|||
106079915|NCT02540954|365955252|FG001|Overall Study|Other reason|2|||
106079916|NCT01393743|365955253|FG000|Core Study|Adverse Event|5|||
106079917|NCT01393743|365955254|FG001|Core Study|Adverse Event|9|||
106079918|NCT01393743|365955255|FG002|Core Study|Adverse Event|0|||
106079919|NCT01393743|365955253|FG000|Core Study|Lost to Follow-up|1|||
106079920|NCT01393743|365955254|FG001|Core Study|Lost to Follow-up|1|||
106079921|NCT01393743|365955255|FG002|Core Study|Lost to Follow-up|0|||
106079922|NCT01393743|365955253|FG000|Core Study|Participant's Choice|2|||
106079923|NCT01393743|365955254|FG001|Core Study|Participant's Choice|3|||
106079924|NCT01393743|365955255|FG002|Core Study|Participant's Choice|0|||
106079925|NCT01393743|365955253|FG000|Core Study|Inadequate therapeutic effect|2|||
106079926|NCT01393743|365955254|FG001|Core Study|Inadequate therapeutic effect|0|||
106079927|NCT01393743|365955255|FG002|Core Study|Inadequate therapeutic effect|0|||
106079928|NCT01393743|365955253|FG000|Extension Phase|Adverse Event|0|||
106079929|NCT01393743|365955254|FG001|Extension Phase|Adverse Event|0|||
106079930|NCT01393743|365955255|FG002|Extension Phase|Adverse Event|12|||
106079931|NCT01393743|365955253|FG000|Extension Phase|Lost to Follow-up|0|||
106079932|NCT01393743|365955254|FG001|Extension Phase|Lost to Follow-up|0|||
106079933|NCT01393743|365955255|FG002|Extension Phase|Lost to Follow-up|2|||
106079934|NCT01393743|365955253|FG000|Extension Phase|Participant choice|0|||
106079935|NCT01393743|365955254|FG001|Extension Phase|Participant choice|0|||
106079936|NCT01393743|365955255|FG002|Extension Phase|Participant choice|16|||
106079937|NCT01393743|365955253|FG000|Extension Phase|Inadequate therapeutic effect|0|||
106079938|NCT01393743|365955254|FG001|Extension Phase|Inadequate therapeutic effect|0|||
106079939|NCT01393743|365955255|FG002|Extension Phase|Inadequate therapeutic effect|7|||
106079940|NCT01393743|365955253|FG000|Extension Phase|Withdrawal by Subject|0|||
106079941|NCT01393743|365955254|FG001|Extension Phase|Withdrawal by Subject|0|||
106079942|NCT01393743|365955255|FG002|Extension Phase|Withdrawal by Subject|8|||
106079943|NCT01393743|365955253|FG000|Extension Phase|Pregnancy|0|||
106079944|NCT01393743|365955254|FG001|Extension Phase|Pregnancy|0|||
106079945|NCT01393743|365955255|FG002|Extension Phase|Pregnancy|1|||
106079946|NCT01393743|365955253|FG000|Extension Phase|Other|0|||
106079947|NCT01393743|365955254|FG001|Extension Phase|Other|0|||
106079948|NCT01393743|365955255|FG002|Extension Phase|Other|14|||
106079949|NCT00213148|365955256|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
106079950|NCT00213148|365955257|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
106079951|NCT00213148|365955258|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
106079952|NCT00213148|365955259|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
106079953|NCT00213148|365955260|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
106079954|NCT00213148|365955256|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
106079955|NCT00213148|365955257|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
106079956|NCT00213148|365955258|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
106079957|NCT00213148|365955259|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
106079958|NCT00213148|365955260|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
106079959|NCT00213148|365955256|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
106079960|NCT00213148|365955257|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
106079961|NCT00213148|365955258|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
106079962|NCT00213148|365955259|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
106079963|NCT00213148|365955260|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
106079964|NCT00213148|365955256|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
106079965|NCT00213148|365955257|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
106079966|NCT00213148|365955258|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
106079967|NCT00213148|365955259|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
106079968|NCT00213148|365955260|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
106079969|NCT00213148|365955256|FG000|Cycle 1 (1 Month)|Other|3|||
106079970|NCT00213148|365955257|FG001|Cycle 1 (1 Month)|Other|0|||
106079971|NCT00213148|365955258|FG002|Cycle 1 (1 Month)|Other|2|||
106079972|NCT00213148|365955259|FG003|Cycle 1 (1 Month)|Other|2|||
106079973|NCT00213148|365955260|FG004|Cycle 1 (1 Month)|Other|7|||
106079974|NCT00213148|365955256|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
105867061|NCT00711880|365163120|FG001|Overall Study|Lack of Efficacy|5|||
106079975|NCT00213148|365955257|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
106079976|NCT00213148|365955258|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
106079977|NCT00213148|365955259|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
106079978|NCT00213148|365955260|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
106160231|NCT02783300|366247386|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
106079979|NCT00213148|365955256|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
106079980|NCT00213148|365955257|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
106079981|NCT00213148|365955258|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
106079982|NCT00213148|365955259|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
106079983|NCT00213148|365955260|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
106079984|NCT00213148|365955256|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
106079985|NCT00213148|365955257|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
106079986|NCT00213148|365955258|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
106079987|NCT00213148|365955259|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
106079988|NCT00213148|365955260|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
106079989|NCT00213148|365955256|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
106079990|NCT00213148|365955257|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
106079991|NCT00213148|365955258|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
106079992|NCT00213148|365955259|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
106079993|NCT00213148|365955260|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
106079994|NCT00213148|365955256|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
106079995|NCT00213148|365955257|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
106079996|NCT00213148|365955258|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
106079997|NCT00213148|365955259|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
106079998|NCT00213148|365955260|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
106079999|NCT00213148|365955256|FG000|Cycle 2 (1 Month)|Other|2|||
106080000|NCT00213148|365955257|FG001|Cycle 2 (1 Month)|Other|1|||
106080001|NCT00213148|365955258|FG002|Cycle 2 (1 Month)|Other|2|||
106080002|NCT00213148|365955259|FG003|Cycle 2 (1 Month)|Other|8|||
106080003|NCT00213148|365955260|FG004|Cycle 2 (1 Month)|Other|7|||
106080004|NCT00213148|365955256|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
106080005|NCT00213148|365955257|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
106080006|NCT00213148|365955258|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
106080007|NCT00213148|365955259|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
106080008|NCT00213148|365955260|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
106080009|NCT00213148|365955256|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
106080010|NCT00213148|365955257|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
106080011|NCT00213148|365955258|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
106080012|NCT00213148|365955259|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
106080013|NCT00213148|365955260|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
106080014|NCT00213148|365955256|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
106080015|NCT00213148|365955257|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
106080016|NCT00213148|365955258|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
106080017|NCT00213148|365955259|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
106080018|NCT00213148|365955260|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
106080019|NCT00213148|365955256|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
106080020|NCT00213148|365955257|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
106080021|NCT00213148|365955258|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
106080022|NCT00213148|365955259|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
106080023|NCT00213148|365955260|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
106080024|NCT00213148|365955256|FG000|Cycle 3 (1 Month)|Other|0|||
106080025|NCT00213148|365955257|FG001|Cycle 3 (1 Month)|Other|0|||
106080026|NCT00213148|365955258|FG002|Cycle 3 (1 Month)|Other|1|||
106080027|NCT00213148|365955259|FG003|Cycle 3 (1 Month)|Other|1|||
106080028|NCT00213148|365955260|FG004|Cycle 3 (1 Month)|Other|0|||
106080029|NCT02321462|365955263|FG000|Overall Study|Withdrawal by Subject|5|||
106080030|NCT02321462|365955264|FG001|Overall Study|Withdrawal by Subject|2|||
106080031|NCT02321462|365955263|FG000|Overall Study|Subject withdrawn before any treatment|1|||
106080032|NCT02321462|365955264|FG001|Overall Study|Subject withdrawn before any treatment|1|||
106080033|NCT00834912|365955266|FG000|Treatment Period 1|Adverse Event|0|||
106080034|NCT00834912|365955267|FG001|Treatment Period 1|Adverse Event|1|||
106080035|NCT00834912|365955268|FG002|Treatment Period 1|Adverse Event|0|||
106080036|NCT00834912|365955269|FG003|Treatment Period 1|Adverse Event|1|||
106080037|NCT00834912|365955270|FG004|Treatment Period 1|Adverse Event|0|||
106080038|NCT00834912|365955271|FG005|Treatment Period 1|Adverse Event|0|||
106080039|NCT00834912|365955266|FG000|Treatment Period 2|Withdrawal by Subject|0|||
106080040|NCT00834912|365955267|FG001|Treatment Period 2|Withdrawal by Subject|0|||
106080041|NCT00834912|365955268|FG002|Treatment Period 2|Withdrawal by Subject|1|||
106080042|NCT00834912|365955269|FG003|Treatment Period 2|Withdrawal by Subject|0|||
106080043|NCT00834912|365955270|FG004|Treatment Period 2|Withdrawal by Subject|1|||
106080044|NCT00834912|365955271|FG005|Treatment Period 2|Withdrawal by Subject|0|||
106080045|NCT01399593|365955272|FG000|Overall Study|Physician Decision|1|||
105867062|NCT03971474|365163123|FG000|Overall Study|Adverse Event|11|||
106080046|NCT01399593|365955273|FG001|Overall Study|Physician Decision|0|||
106080047|NCT01399593|365955272|FG000|Overall Study|Adverse Event|1|||
106080048|NCT01399593|365955273|FG001|Overall Study|Adverse Event|0|||
106080049|NCT01399593|365955272|FG000|Overall Study|Death|1|||
106080050|NCT01399593|365955273|FG001|Overall Study|Death|1|||
106080051|NCT01399593|365955272|FG000|Overall Study|Transplantectomy|0|||
106080052|NCT01399593|365955273|FG001|Overall Study|Transplantectomy|1|||
106080053|NCT00500370|365955286|FG000|Overall Study|Adverse Event|9|||
106080054|NCT00500370|365955287|FG001|Overall Study|Adverse Event|3|||
106080055|NCT00500370|365955286|FG000|Overall Study|Lost to Follow-up|10|||
106080056|NCT00500370|365955287|FG001|Overall Study|Lost to Follow-up|10|||
106080057|NCT00500370|365955286|FG000|Overall Study|Protocol Violation|2|||
106080058|NCT00500370|365955287|FG001|Overall Study|Protocol Violation|4|||
106080059|NCT00500370|365955286|FG000|Overall Study|Sponsor Decision|2|||
106080060|NCT00500370|365955287|FG001|Overall Study|Sponsor Decision|0|||
106080061|NCT00500370|365955286|FG000|Overall Study|Subject Decision|10|||
106080062|NCT00500370|365955287|FG001|Overall Study|Subject Decision|17|||
106080063|NCT02434770|365955289|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
106080064|NCT02434770|365955290|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
106080065|NCT02434770|365955291|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
106080066|NCT02434770|365955289|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
106080067|NCT02434770|365955290|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
106080068|NCT02434770|365955291|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
106080069|NCT02434770|365955289|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
106080070|NCT02434770|365955290|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
106080071|NCT02434770|365955291|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
106080072|NCT02434770|365955289|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
106080073|NCT02434770|365955290|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
106080074|NCT02434770|365955291|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
106080075|NCT02434770|365955289|FG000|Week 1 to Week 18|Death|1|||
106080076|NCT02434770|365955290|FG001|Week 1 to Week 18|Death|0|||
106080077|NCT02434770|365955291|FG002|Week 1 to Week 18|Death|0|||
106080078|NCT02434770|365955289|FG000|Week 18 to Week|Lost to Follow-up|2|||
106080079|NCT02434770|365955290|FG001|Week 18 to Week|Lost to Follow-up|2|||
106080080|NCT02434770|365955291|FG002|Week 18 to Week|Lost to Follow-up|1|||
106080081|NCT02434770|365955289|FG000|Week 18 to Week|Withdrawal by Subject|0|||
106080082|NCT02434770|365955290|FG001|Week 18 to Week|Withdrawal by Subject|0|||
106080083|NCT02434770|365955291|FG002|Week 18 to Week|Withdrawal by Subject|2|||
106080084|NCT02434770|365955289|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
106080085|NCT02434770|365955290|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
106080086|NCT02434770|365955291|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
106080087|NCT00245765|365955297|FG000|Overall Study|Adverse Event|1|||
106080088|NCT00245765|365955298|FG001|Overall Study|Adverse Event|1|||
106080089|NCT00245765|365955299|FG002|Overall Study|Adverse Event|0|||
106080090|NCT00245765|365955297|FG000|Overall Study|Lack of Efficacy|14|||
106080091|NCT00245765|365955298|FG001|Overall Study|Lack of Efficacy|7|||
106080092|NCT00245765|365955299|FG002|Overall Study|Lack of Efficacy|0|||
106080093|NCT00245765|365955297|FG000|Overall Study|Lost to Follow-up|1|||
106080094|NCT00245765|365955298|FG001|Overall Study|Lost to Follow-up|2|||
106080095|NCT00245765|365955299|FG002|Overall Study|Lost to Follow-up|0|||
106080096|NCT00245765|365955297|FG000|Overall Study|Withdrawal by Subject|1|||
106080097|NCT00245765|365955298|FG001|Overall Study|Withdrawal by Subject|0|||
106080098|NCT00245765|365955299|FG002|Overall Study|Withdrawal by Subject|3|||
106080099|NCT00245765|365955297|FG000|Overall Study|Other reason|2|||
106080100|NCT00245765|365955298|FG001|Overall Study|Other reason|0|||
106080101|NCT00245765|365955299|FG002|Overall Study|Other reason|1|||
106080102|NCT00245765|365955297|FG000|Overall Study|Other|13|||
106080103|NCT00245765|365955298|FG001|Overall Study|Other|4|||
106080104|NCT00245765|365955299|FG002|Overall Study|Other|4|||
106080105|NCT01282424|365955300|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
106080106|NCT01282424|365955300|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
106080107|NCT01282424|365955300|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
106080108|NCT01282424|365955300|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
106080109|NCT01282424|365955300|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
106080110|NCT01282424|365955300|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
106080111|NCT01282424|365955300|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
106080112|NCT01282424|365955300|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
106080113|NCT00714259|365955301|FG000|Overall Study|Death|2|||
106080114|NCT00528528|365955302|FG000|Overall Study|Lost to Follow-up|0|||
106080115|NCT00528528|365955303|FG001|Overall Study|Lost to Follow-up|0|||
106080116|NCT00528528|365955304|FG002|Overall Study|Lost to Follow-up|1|||
106080117|NCT00528528|365955305|FG003|Overall Study|Lost to Follow-up|1|||
106080118|NCT00528528|365955302|FG000|Overall Study|Ineligible to continue the trial|0|||
106080119|NCT00528528|365955303|FG001|Overall Study|Ineligible to continue the trial|0|||
106080120|NCT00528528|365955304|FG002|Overall Study|Ineligible to continue the trial|0|||
106080121|NCT00528528|365955305|FG003|Overall Study|Ineligible to continue the trial|1|||
106080122|NCT00528528|365955302|FG000|Overall Study|Other|0|||
106080123|NCT00528528|365955303|FG001|Overall Study|Other|1|||
106080124|NCT00528528|365955304|FG002|Overall Study|Other|0|||
106080125|NCT00528528|365955305|FG003|Overall Study|Other|0|||
106080126|NCT00528528|365955302|FG000|Overall Study|Withdrawal by Subject|3|||
105867063|NCT03971474|365163124|FG001|Overall Study|Adverse Event|7|||
105867064|NCT03971474|365163123|FG000|Overall Study|Refusal unrelated to adverse event|5|||
106080127|NCT00528528|365955303|FG001|Overall Study|Withdrawal by Subject|2|||
105867065|NCT03971474|365163124|FG001|Overall Study|Refusal unrelated to adverse event|1|||
105867066|NCT03971474|365163123|FG000|Overall Study|Progression/relapse|40|||
106080128|NCT00528528|365955304|FG002|Overall Study|Withdrawal by Subject|1|||
106080129|NCT00528528|365955305|FG003|Overall Study|Withdrawal by Subject|1|||
106080130|NCT00528528|365955302|FG000|Overall Study|Ongoing participant|0|||
106080131|NCT00528528|365955303|FG001|Overall Study|Ongoing participant|0|||
106080132|NCT00528528|365955304|FG002|Overall Study|Ongoing participant|1|||
106080133|NCT00528528|365955305|FG003|Overall Study|Ongoing participant|0|||
106080134|NCT00574405|365956869|FG000|Overall Study|Withdrawal by Subject|3|||
106080135|NCT00574405|365956870|FG001|Overall Study|Withdrawal by Subject|2|||
106080136|NCT01920932|365956873|FG000|Overall Study|Death|1|||
106080137|NCT01920932|365956873|FG000|Overall Study|Withdrawal of consent|1|||
106080138|NCT01572038|365956874|FG000|Overall Study|Death|648|||
106080139|NCT01572038|365956874|FG000|Overall Study|Withdrawal by Subject|204|||
106080140|NCT01572038|365956874|FG000|Overall Study|Lost to Follow-up|81|||
106080141|NCT01572038|365956874|FG000|Overall Study|Physician Decision|20|||
106080142|NCT01572038|365956874|FG000|Overall Study|Patient Decision|14|||
106080143|NCT01572038|365956874|FG000|Overall Study|Progressive Disease|8|||
106080144|NCT01572038|365956874|FG000|Overall Study|Site Closed Before Completing Form|6|||
106080145|NCT01572038|365956874|FG000|Overall Study|Enrolled into Another Trial|3|||
106080146|NCT01572038|365956874|FG000|Overall Study|Participated in Another Trial|3|||
106080147|NCT01572038|365956874|FG000|Overall Study|Termination by Sponsor|2|||
106080148|NCT01572038|365956874|FG000|Overall Study|Patient Deterioration|1|||
106080149|NCT01572038|365956874|FG000|Overall Study|Sponsor Decision|1|||
106080150|NCT01904604|365956881|FG000|Overall Study|Withdrew before receiving dosing|0|||
106080151|NCT01904604|365956882|FG001|Overall Study|Withdrew before receiving dosing|1|||
106080152|NCT01904604|365956883|FG002|Overall Study|Withdrew before receiving dosing|0|||
106080153|NCT01904604|365956881|FG000|Overall Study|Non-compliance|1|||
106080154|NCT01904604|365956882|FG001|Overall Study|Non-compliance|0|||
106080155|NCT01904604|365956883|FG002|Overall Study|Non-compliance|0|||
106080156|NCT01904604|365956881|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
106080157|NCT01904604|365956882|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
106080158|NCT01904604|365956883|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
106080159|NCT01904604|365956881|FG000|Overall Study|Patch site reactions|1|||
106080160|NCT01904604|365956882|FG001|Overall Study|Patch site reactions|1|||
106080161|NCT01904604|365956883|FG002|Overall Study|Patch site reactions|0|||
106080162|NCT01904604|365956881|FG000|Overall Study|Increased syncope|0|||
106080163|NCT01904604|365956882|FG001|Overall Study|Increased syncope|1|||
106080164|NCT01904604|365956883|FG002|Overall Study|Increased syncope|0|||
106080165|NCT01904604|365956881|FG000|Overall Study|Unrelated illness|0|||
106080166|NCT01904604|365956882|FG001|Overall Study|Unrelated illness|1|||
106080167|NCT01904604|365956883|FG002|Overall Study|Unrelated illness|0|||
106080168|NCT01904604|365956881|FG000|Overall Study|Passed Week 52 OFC|1|||
106080169|NCT01904604|365956882|FG001|Overall Study|Passed Week 52 OFC|0|||
106080170|NCT01904604|365956883|FG002|Overall Study|Passed Week 52 OFC|0|||
106080171|NCT01904604|365956881|FG000|Overall Study|Withdrawal by Subject|1|||
106080172|NCT01904604|365956882|FG001|Overall Study|Withdrawal by Subject|2|||
106080173|NCT01904604|365956883|FG002|Overall Study|Withdrawal by Subject|0|||
106080174|NCT01904604|365956881|FG000|Overall Study|Participant Relocated|1|||
106080175|NCT01904604|365956882|FG001|Overall Study|Participant Relocated|1|||
106080176|NCT01904604|365956883|FG002|Overall Study|Participant Relocated|1|||
106080177|NCT01904604|365956881|FG000|Overall Study|Lost to Follow-up|0|||
106080178|NCT01904604|365956882|FG001|Overall Study|Lost to Follow-up|0|||
106080179|NCT01904604|365956883|FG002|Overall Study|Lost to Follow-up|1|||
106080180|NCT01945489|365956886|FG000|Cycle 1|Adverse Event|2|||
106080181|NCT01945489|365956887|FG001|Cycle 1|Adverse Event|0|||
106080182|NCT01945489|365956886|FG000|Cycle 1|Lost to Follow-up|4|||
106080183|NCT01945489|365956887|FG001|Cycle 1|Lost to Follow-up|0|||
106080184|NCT01945489|365956886|FG000|Cycle 1|Personal Reasons|4|||
106080185|NCT01945489|365956887|FG001|Cycle 1|Personal Reasons|2|||
106080186|NCT01945489|365956886|FG000|Cycle 1|Protocol Violation|0|||
106080187|NCT01945489|365956887|FG001|Cycle 1|Protocol Violation|1|||
106080188|NCT01945489|365956886|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
106080189|NCT01945489|365956887|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
106080190|NCT01945489|365956886|FG000|Cycle 2|Adverse Event|1|||
106080191|NCT01945489|365956887|FG001|Cycle 2|Adverse Event|0|||
106080192|NCT01945489|365956886|FG000|Cycle 2|Lost to Follow-up|0|||
106080193|NCT01945489|365956887|FG001|Cycle 2|Lost to Follow-up|1|||
106080194|NCT00749463|365956890|FG000|Overall Study|Adverse Event|0|||
106080195|NCT00749463|365956891|FG001|Overall Study|Adverse Event|4|||
106080196|NCT00749463|365956892|FG002|Overall Study|Adverse Event|1|||
106080197|NCT00749463|365956890|FG000|Overall Study|Withdrawal by Subject|1|||
106080198|NCT00749463|365956891|FG001|Overall Study|Withdrawal by Subject|0|||
106080199|NCT00749463|365956892|FG002|Overall Study|Withdrawal by Subject|0|||
106080200|NCT00697346|365956900|FG000|Overall Study|Adverse Event|4|||
106080201|NCT00697346|365956901|FG001|Overall Study|Adverse Event|5|||
106080202|NCT00697346|365956902|FG002|Overall Study|Adverse Event|0|||
106080203|NCT00697346|365956900|FG000|Overall Study|Progressive Disease|19|||
106080204|NCT00697346|365956901|FG001|Overall Study|Progressive Disease|18|||
106080205|NCT00697346|365956902|FG002|Overall Study|Progressive Disease|0|||
106080206|NCT00697346|365956900|FG000|Overall Study|Symptomatic Deterioration|0|||
106080207|NCT00697346|365956901|FG001|Overall Study|Symptomatic Deterioration|1|||
106080208|NCT00697346|365956902|FG002|Overall Study|Symptomatic Deterioration|0|||
106080209|NCT00697346|365956900|FG000|Overall Study|Withdrawal by Subject|2|||
106080210|NCT00697346|365956901|FG001|Overall Study|Withdrawal by Subject|2|||
106080211|NCT00697346|365956902|FG002|Overall Study|Withdrawal by Subject|0|||
105867067|NCT03971474|365163124|FG001|Overall Study|Progression/relapse|47|||
106080212|NCT00697346|365956900|FG000|Overall Study|Reason not Specified|3|||
106080213|NCT00697346|365956901|FG001|Overall Study|Reason not Specified|0|||
106080214|NCT00697346|365956902|FG002|Overall Study|Reason not Specified|1|||
106080215|NCT01921829|365956903|FG000|Overall Study|Withdrawal by Subject|0|||
106080216|NCT01921829|365956904|FG001|Overall Study|Withdrawal by Subject|1|||
106080217|NCT02223767|365956905|FG000|Overall Study|Withdrawal by Subject|4|||
106080218|NCT02223767|365956906|FG001|Overall Study|Withdrawal by Subject|4|||
106080219|NCT00640510|365956907|FG000|Overall Study|Lack of Efficacy|0|||
106080220|NCT00640510|365956908|FG001|Overall Study|Lack of Efficacy|1|||
106080221|NCT00640510|365956907|FG000|Overall Study|Protocol Violation|1|||
106080222|NCT00640510|365956908|FG001|Overall Study|Protocol Violation|0|||
106080223|NCT00640510|365956907|FG000|Overall Study|Physician Decision|0|||
106080224|NCT00640510|365956908|FG001|Overall Study|Physician Decision|1|||
106080225|NCT02643251|365956909|FG000|Overall Study|Adverse Event|3|||
106080226|NCT02643251|365956910|FG001|Overall Study|Adverse Event|1|||
106080227|NCT02643251|365956909|FG000|Overall Study|Withdrawal by Subject|2|||
106080228|NCT02643251|365956910|FG001|Overall Study|Withdrawal by Subject|0|||
106080229|NCT02643251|365956909|FG000|Overall Study|Lost to Follow-up|4|||
106080230|NCT02643251|365956910|FG001|Overall Study|Lost to Follow-up|1|||
106080231|NCT02643251|365956909|FG000|Overall Study|Protocol Violation|1|||
106080232|NCT02643251|365956910|FG001|Overall Study|Protocol Violation|0|||
106080233|NCT02643251|365956909|FG000|Overall Study|PI Decision to terminate patient|1|||
106080234|NCT02643251|365956910|FG001|Overall Study|PI Decision to terminate patient|0|||
106080235|NCT04171414|365956915|FG000|Overall Study|Death|1|||
106080236|NCT04171414|365956915|FG000|Overall Study|Withdrawal by Subject|1|||
106080237|NCT00706966|365956916|FG000|Overall Study|Adverse Event|1|||
106080238|NCT01610791|365956918|FG000|Overall Study|Lost to Follow-up|7|||
106080239|NCT01610791|365956918|FG000|Overall Study|Adverse Event|6|||
106080240|NCT01610791|365956918|FG000|Overall Study|Physician Decision|1|||
106080241|NCT01610791|365956918|FG000|Overall Study|Adverse event and Investigator decision|1|||
106080242|NCT01610791|365956918|FG000|Overall Study|Death|1|||
106080243|NCT01610791|365956918|FG000|Overall Study|Not determined|5|||
106080244|NCT05040152|365956921|FG000|Overall Study|Withdrawal by Subject|5|||
106080245|NCT05040152|365956922|FG001|Overall Study|Withdrawal by Subject|0|||
106080246|NCT05040152|365956921|FG000|Overall Study|Lost to Follow-up|0|||
106080247|NCT05040152|365956922|FG001|Overall Study|Lost to Follow-up|2|||
106080248|NCT00578175|365956925|FG000|Overall Study|Adverse Event|0|||
106080249|NCT00578175|365956926|FG001|Overall Study|Adverse Event|1|||
106080250|NCT00578175|365956927|FG002|Overall Study|Adverse Event|1|||
106080251|NCT00578175|365956925|FG000|Overall Study|Other reasons|70|||
106080252|NCT00578175|365956926|FG001|Overall Study|Other reasons|42|||
106080253|NCT00578175|365956927|FG002|Overall Study|Other reasons|23|||
106080254|NCT00357370|365956931|FG000|Cohort 2|Lack of Efficacy|0|||
106080255|NCT00357370|365956932|FG001|Cohort 2|Lack of Efficacy|2|||
106080256|NCT00357370|365956933|FG002|Cohort 2|Lack of Efficacy|1|||
106080257|NCT00357370|365956931|FG000|Cohort 2|Adverse Event|1|||
106080258|NCT00357370|365956932|FG001|Cohort 2|Adverse Event|1|||
106080259|NCT00357370|365956933|FG002|Cohort 2|Adverse Event|1|||
106080260|NCT00357370|365956931|FG000|Cohort 2|Lost to Follow-up|0|||
106080261|NCT00357370|365956932|FG001|Cohort 2|Lost to Follow-up|1|||
106080262|NCT00357370|365956933|FG002|Cohort 2|Lost to Follow-up|0|||
106080263|NCT00357370|365956931|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
106080264|NCT00357370|365956932|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
106080265|NCT00357370|365956933|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
106080266|NCT00357370|365956931|FG000|Cohort 2|Withdrawal by Subject|0|||
106080267|NCT00357370|365956932|FG001|Cohort 2|Withdrawal by Subject|2|||
106080268|NCT00357370|365956933|FG002|Cohort 2|Withdrawal by Subject|0|||
106080269|NCT01828034|365956934|FG000|Overall Study|Withdrawal by Subject|0|||
106080270|NCT01828034|365956935|FG001|Overall Study|Withdrawal by Subject|0|||
106080271|NCT01828034|365956936|FG002|Overall Study|Withdrawal by Subject|0|||
106080272|NCT01828034|365956937|FG003|Overall Study|Withdrawal by Subject|1|||
106080273|NCT02871375|365956938|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
106080274|NCT02871375|365956939|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
106080275|NCT00499603|365956940|FG000|Overall Study|Adverse Event|0|||
106080276|NCT00499603|365956941|FG001|Overall Study|Adverse Event|1|||
106080277|NCT00325234|365956946|FG000|Overall Study|Adverse Event|10|||
106080278|NCT00325234|365956947|FG001|Overall Study|Adverse Event|7|||
106080279|NCT00325234|365956946|FG000|Overall Study|Death due to Study Disease|1|||
106080280|NCT00325234|365956947|FG001|Overall Study|Death due to Study Disease|0|||
106080281|NCT00325234|365956946|FG000|Overall Study|Entry Criteria Not Met|1|||
106080282|NCT00325234|365956947|FG001|Overall Study|Entry Criteria Not Met|2|||
106080283|NCT00325234|365956946|FG000|Overall Study|Subject Decision|6|||
106080284|NCT00325234|365956947|FG001|Overall Study|Subject Decision|8|||
106080285|NCT00325234|365956946|FG000|Overall Study|Physician Decision|17|||
106080286|NCT00325234|365956947|FG001|Overall Study|Physician Decision|12|||
106080287|NCT00325234|365956946|FG000|Overall Study|Progressive Disease|34|||
106080288|NCT00325234|365956947|FG001|Overall Study|Progressive Disease|37|||
106080289|NCT02287896|365956948|FG000|Second Injection Visit|Withdrawal by Subject|0|||
106080290|NCT02287896|365956949|FG001|Second Injection Visit|Withdrawal by Subject|1|||
106080291|NCT00559962|365956950|FG000|Overall Study|Adverse Event|1|||
106080292|NCT00559962|365956951|FG001|Overall Study|Adverse Event|7|||
106080293|NCT00559962|365956952|FG002|Overall Study|Adverse Event|8|||
106080294|NCT00559962|365956953|FG003|Overall Study|Adverse Event|5|||
106080295|NCT00559962|365956954|FG004|Overall Study|Adverse Event|11|||
106080296|NCT00559962|365956955|FG005|Overall Study|Adverse Event|4|||
106080297|NCT00559962|365956956|FG006|Overall Study|Adverse Event|4|||
106080298|NCT00559962|365956957|FG007|Overall Study|Adverse Event|2|||
106080299|NCT00559962|365956950|FG000|Overall Study|Lost to Follow-up|0|||
106080300|NCT00559962|365956951|FG001|Overall Study|Lost to Follow-up|1|||
106080301|NCT00559962|365956952|FG002|Overall Study|Lost to Follow-up|0|||
106080302|NCT00559962|365956953|FG003|Overall Study|Lost to Follow-up|0|||
106080303|NCT00559962|365956954|FG004|Overall Study|Lost to Follow-up|0|||
106080304|NCT00559962|365956955|FG005|Overall Study|Lost to Follow-up|0|||
106080305|NCT00559962|365956956|FG006|Overall Study|Lost to Follow-up|0|||
106080306|NCT00559962|365956957|FG007|Overall Study|Lost to Follow-up|0|||
106080307|NCT00559962|365956950|FG000|Overall Study|Withdrawal by Subject|1|||
106080308|NCT00559962|365956951|FG001|Overall Study|Withdrawal by Subject|1|||
106080309|NCT00559962|365956952|FG002|Overall Study|Withdrawal by Subject|2|||
106080310|NCT00559962|365956953|FG003|Overall Study|Withdrawal by Subject|0|||
106080311|NCT00559962|365956954|FG004|Overall Study|Withdrawal by Subject|3|||
106080312|NCT00559962|365956955|FG005|Overall Study|Withdrawal by Subject|1|||
106080313|NCT00559962|365956956|FG006|Overall Study|Withdrawal by Subject|0|||
106080314|NCT00559962|365956957|FG007|Overall Study|Withdrawal by Subject|2|||
106080315|NCT00559962|365956950|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
106080316|NCT00559962|365956951|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
106080317|NCT00559962|365956952|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
106080318|NCT00559962|365956953|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
106080319|NCT00559962|365956954|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
106080320|NCT00559962|365956955|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
106080321|NCT00559962|365956956|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
106080322|NCT00559962|365956957|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
106080323|NCT04370691|365956958|FG000|Overall Study|Pending visit|48|||
106080324|NCT04370691|365956958|FG000|Overall Study|Have Not Reached Lower Window|15|||
106080325|NCT04370691|365956958|FG000|Overall Study|Termination|14|||
106080326|NCT04370691|365956958|FG000|Overall Study|Missed or Overdue|10|||
106080327|NCT03690388|365956959|FG000|Overall Study|Adverse Event|8|||
106080328|NCT03690388|365956960|FG001|Overall Study|Adverse Event|1|||
106080329|NCT03690388|365956959|FG000|Overall Study|Radiographic Progression|14|||
106080330|NCT03690388|365956960|FG001|Overall Study|Radiographic Progression|29|||
106080331|NCT03690388|365956959|FG000|Overall Study|Clinical deterioration|10|||
106080332|NCT03690388|365956960|FG001|Overall Study|Clinical deterioration|6|||
106080333|NCT03690388|365956959|FG000|Overall Study|Withdrawal by Subject|2|||
106080334|NCT03690388|365956960|FG001|Overall Study|Withdrawal by Subject|0|||
106080335|NCT03690388|365956959|FG000|Overall Study|Lack of Efficacy|1|||
106080336|NCT03690388|365956960|FG001|Overall Study|Lack of Efficacy|0|||
106080337|NCT03690388|365956959|FG000|Overall Study|Lost to Follow-up|1|||
106080338|NCT03690388|365956960|FG001|Overall Study|Lost to Follow-up|0|||
106080339|NCT04225923|365956961|FG000|Overall Study|Protocol Violation|1|||
106080340|NCT04225923|365956962|FG001|Overall Study|Protocol Violation|0|||
106080341|NCT04225923|365956963|FG002|Overall Study|Protocol Violation|1|||
106080342|NCT04225923|365956961|FG000|Overall Study|Withdrawal by Subject|4|||
106080343|NCT04225923|365956962|FG001|Overall Study|Withdrawal by Subject|1|||
106080344|NCT04225923|365956963|FG002|Overall Study|Withdrawal by Subject|3|||
106080345|NCT04225923|365956961|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
106080346|NCT04225923|365956962|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
106080347|NCT04225923|365956963|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
106080348|NCT01526889|365956964|FG000|Treatment Period|Adverse Event|2|||
106080349|NCT01526889|365956965|FG001|Treatment Period|Adverse Event|0|||
106080350|NCT01526889|365956964|FG000|Treatment Extension Period|Administrative problems|1|||
105867068|NCT03971474|365163123|FG000|Overall Study|Death|6|||
105867069|NCT03971474|365163124|FG001|Overall Study|Death|3|||
106080351|NCT01526889|365956965|FG001|Treatment Extension Period|Administrative problems|0|||
106080352|NCT02098109|365956974|FG000|Overall Study|Protocol Violation|3|||
106080353|NCT02098109|365956975|FG001|Overall Study|Protocol Violation|0|||
106080354|NCT01455012|365956982|FG000|Overall Study|Adverse Event|0|||
106080355|NCT01455012|365956983|FG001|Overall Study|Adverse Event|2|||
106080356|NCT01455012|365956982|FG000|Overall Study|Lack of Efficacy|6|||
106080357|NCT01455012|365956983|FG001|Overall Study|Lack of Efficacy|1|||
106080358|NCT01455012|365956982|FG000|Overall Study|Withdrawal by Subject|3|||
106080359|NCT01455012|365956983|FG001|Overall Study|Withdrawal by Subject|1|||
106080360|NCT01455012|365956982|FG000|Overall Study|Unknown reason|2|||
106080361|NCT01455012|365956983|FG001|Overall Study|Unknown reason|0|||
106080362|NCT00480779|365956985|FG000|Overall Study|Other|2|||
106080363|NCT00480779|365956986|FG001|Overall Study|Other|0|||
106080364|NCT00480779|365956985|FG000|Overall Study|Job and Health-related|0|||
106080365|NCT00480779|365956986|FG001|Overall Study|Job and Health-related|3|||
106080366|NCT01838642|365956987|FG000|Overall Study|Died on study|1|||
106080367|NCT00677807|365956991|FG000|Overall Study|Adverse Event|4|||
106080368|NCT00677807|365956992|FG001|Overall Study|Adverse Event|1|||
106080369|NCT00677807|365956993|FG002|Overall Study|Adverse Event|6|||
106080370|NCT00677807|365956991|FG000|Overall Study|Lack of Efficacy|0|||
106080371|NCT00677807|365956992|FG001|Overall Study|Lack of Efficacy|0|||
106080372|NCT00677807|365956993|FG002|Overall Study|Lack of Efficacy|2|||
106080373|NCT00677807|365956991|FG000|Overall Study|Participant no longer needs study drug|0|||
106080374|NCT00677807|365956992|FG001|Overall Study|Participant no longer needs study drug|0|||
106080375|NCT00677807|365956993|FG002|Overall Study|Participant no longer needs study drug|1|||
106080376|NCT00677807|365956991|FG000|Overall Study|Withdrawal by Subject|10|||
106080377|NCT00677807|365956992|FG001|Overall Study|Withdrawal by Subject|3|||
106080378|NCT00677807|365956993|FG002|Overall Study|Withdrawal by Subject|6|||
106080379|NCT00677807|365956991|FG000|Overall Study|Lost to Follow-up|2|||
106080380|NCT00677807|365956992|FG001|Overall Study|Lost to Follow-up|2|||
106080381|NCT00677807|365956993|FG002|Overall Study|Lost to Follow-up|2|||
106080382|NCT00677807|365956991|FG000|Overall Study|Administrative problems|1|||
106080383|NCT00677807|365956992|FG001|Overall Study|Administrative problems|1|||
106080384|NCT00677807|365956993|FG002|Overall Study|Administrative problems|2|||
106080385|NCT00677807|365956991|FG000|Overall Study|Death|0|||
106080386|NCT00677807|365956992|FG001|Overall Study|Death|1|||
106080387|NCT00677807|365956993|FG002|Overall Study|Death|1|||
106080388|NCT00677807|365956991|FG000|Overall Study|Protocol Deviation|1|||
106080389|NCT00677807|365956992|FG001|Overall Study|Protocol Deviation|3|||
106080390|NCT00677807|365956993|FG002|Overall Study|Protocol Deviation|0|||
106080391|NCT03925727|365956999|FG000|Overall Study|Adverse Event|4|||
106080392|NCT03925727|365957000|FG001|Overall Study|Adverse Event|0|||
106080393|NCT03925727|365957001|FG002|Overall Study|Adverse Event|3|||
106080394|NCT03925727|365956999|FG000|Overall Study|Protocol Violation|1|||
106080395|NCT03925727|365957000|FG001|Overall Study|Protocol Violation|2|||
106080396|NCT03925727|365957001|FG002|Overall Study|Protocol Violation|2|||
106080397|NCT03925727|365956999|FG000|Overall Study|Withdrawal by Subject|3|||
106080398|NCT03925727|365957000|FG001|Overall Study|Withdrawal by Subject|2|||
106080399|NCT03925727|365957001|FG002|Overall Study|Withdrawal by Subject|4|||
106080400|NCT03925727|365956999|FG000|Overall Study|Administrative Reasons|3|||
106080401|NCT03925727|365957000|FG001|Overall Study|Administrative Reasons|1|||
106080402|NCT03925727|365957001|FG002|Overall Study|Administrative Reasons|2|||
106080403|NCT03925727|365956999|FG000|Overall Study|Randomized in error or Disqualified|8|||
106080404|NCT03925727|365957000|FG001|Overall Study|Randomized in error or Disqualified|1|||
106080405|NCT03925727|365957001|FG002|Overall Study|Randomized in error or Disqualified|7|||
106080406|NCT03400033|365957002|FG000|Overall Study|Withdrawal by Subject|1|||
106080407|NCT03400033|365957003|FG001|Overall Study|Withdrawal by Subject|2|||
106080408|NCT01574352|365957007|FG000|Overall Study|Withdrawal by Subject|6|||
106080409|NCT01574352|365957008|FG001|Overall Study|Withdrawal by Subject|13|||
106080410|NCT01574352|365957007|FG000|Overall Study|Injury in non-camp related sport|1|||
106080411|NCT01574352|365957008|FG001|Overall Study|Injury in non-camp related sport|0|||
106080412|NCT02741115|365957012|FG000|Overall Study|Adverse Event|1|||
106080413|NCT02741115|365957013|FG001|Overall Study|Adverse Event|0|||
106080414|NCT02741115|365957012|FG000|Overall Study|Lost to Follow-up|7|||
106080415|NCT02741115|365957013|FG001|Overall Study|Lost to Follow-up|4|||
106080416|NCT02741115|365957012|FG000|Overall Study|Withdrawal by Subject|4|||
106080417|NCT02741115|365957013|FG001|Overall Study|Withdrawal by Subject|2|||
106080418|NCT00445328|365957014|FG000|Overall Study|Death|0|||
106080419|NCT00445328|365957015|FG001|Overall Study|Death|1|||
106080420|NCT00445328|365957014|FG000|Overall Study|Adverse Event|0|||
106080421|NCT00445328|365957015|FG001|Overall Study|Adverse Event|3|||
106080422|NCT00445328|365957014|FG000|Overall Study|Other|0|||
106080423|NCT00445328|365957015|FG001|Overall Study|Other|2|||
106080424|NCT00445328|365957014|FG000|Overall Study|Withdrawal by Subject|2|||
106080425|NCT00445328|365957015|FG001|Overall Study|Withdrawal by Subject|0|||
106080426|NCT00445328|365957014|FG000|Overall Study|Protocol Violation|1|||
106080427|NCT00445328|365957015|FG001|Overall Study|Protocol Violation|0|||
106080428|NCT01336738|365958951|FG000|Overall Study|Adverse Event|0|||
106080429|NCT01336738|365958952|FG001|Overall Study|Adverse Event|3|||
106080430|NCT01336738|365958953|FG002|Overall Study|Adverse Event|2|||
106080431|NCT01336738|365958954|FG003|Overall Study|Adverse Event|1|||
106080432|NCT01336738|365958955|FG004|Overall Study|Adverse Event|3|||
106080433|NCT01336738|365958951|FG000|Overall Study|Lost to Follow-up|2|||
106080434|NCT01336738|365958952|FG001|Overall Study|Lost to Follow-up|1|||
105867070|NCT03971474|365163123|FG000|Overall Study|Other - not protocol specified|5|||
105867071|NCT03971474|365163124|FG001|Overall Study|Other - not protocol specified|4|||
106080435|NCT01336738|365958953|FG002|Overall Study|Lost to Follow-up|2|||
106080436|NCT01336738|365958954|FG003|Overall Study|Lost to Follow-up|2|||
106080437|NCT01336738|365958955|FG004|Overall Study|Lost to Follow-up|2|||
106080438|NCT01336738|365958951|FG000|Overall Study|Did not meet entrance criteria|0|||
106080439|NCT01336738|365958952|FG001|Overall Study|Did not meet entrance criteria|1|||
106080440|NCT01336738|365958953|FG002|Overall Study|Did not meet entrance criteria|0|||
106080441|NCT01336738|365958954|FG003|Overall Study|Did not meet entrance criteria|0|||
106080442|NCT01336738|365958955|FG004|Overall Study|Did not meet entrance criteria|0|||
106080443|NCT01336738|365958951|FG000|Overall Study|Protocol Violation|0|||
106080444|NCT01336738|365958952|FG001|Overall Study|Protocol Violation|1|||
106080445|NCT01336738|365958953|FG002|Overall Study|Protocol Violation|0|||
106080446|NCT01336738|365958954|FG003|Overall Study|Protocol Violation|0|||
106080447|NCT01336738|365958955|FG004|Overall Study|Protocol Violation|0|||
106080448|NCT01336738|365958951|FG000|Overall Study|Withdrawal by Subject|2|||
106080449|NCT01336738|365958952|FG001|Overall Study|Withdrawal by Subject|0|||
106080450|NCT01336738|365958953|FG002|Overall Study|Withdrawal by Subject|2|||
106080451|NCT01336738|365958954|FG003|Overall Study|Withdrawal by Subject|1|||
106080452|NCT01336738|365958955|FG004|Overall Study|Withdrawal by Subject|1|||
106080453|NCT01336738|365958951|FG000|Overall Study|Other|3|||
106080454|NCT01336738|365958952|FG001|Overall Study|Other|3|||
106080455|NCT01336738|365958953|FG002|Overall Study|Other|2|||
106080456|NCT01336738|365958954|FG003|Overall Study|Other|3|||
106080457|NCT01336738|365958955|FG004|Overall Study|Other|4|||
106080458|NCT02565381|365958956|FG000|Overall Study|Lost to Follow-up|1|||
106080459|NCT02565381|365958957|FG001|Overall Study|Lost to Follow-up|0|||
106080460|NCT02565381|365958958|FG002|Overall Study|Lost to Follow-up|1|||
106080461|NCT00978731|365958961|FG000|Overall Study|Death|4|||
106080462|NCT00978731|365958962|FG001|Overall Study|Death|1|||
106080463|NCT00978731|365958963|FG002|Overall Study|Death|1|||
106080464|NCT00978731|365958964|FG003|Overall Study|Death|0|||
106080465|NCT00978731|365958961|FG000|Overall Study|Lost to Follow-up|0|||
106080466|NCT00978731|365958962|FG001|Overall Study|Lost to Follow-up|0|||
106080467|NCT00978731|365958963|FG002|Overall Study|Lost to Follow-up|0|||
106080468|NCT00978731|365958964|FG003|Overall Study|Lost to Follow-up|1|||
106080469|NCT00978731|365958961|FG000|Overall Study|Adverse Event|5|||
106080470|NCT00978731|365958962|FG001|Overall Study|Adverse Event|2|||
106080471|NCT00978731|365958963|FG002|Overall Study|Adverse Event|0|||
106080472|NCT00978731|365958964|FG003|Overall Study|Adverse Event|0|||
106080473|NCT00978731|365958961|FG000|Overall Study|Participant's request|1|||
106080474|NCT00978731|365958962|FG001|Overall Study|Participant's request|0|||
106080475|NCT00978731|365958963|FG002|Overall Study|Participant's request|0|||
106080476|NCT00978731|365958964|FG003|Overall Study|Participant's request|0|||
106080477|NCT00978731|365958961|FG000|Overall Study|Administrative reason|3|||
105867072|NCT03971474|365163123|FG000|Overall Study|On treatment|0|||
106080478|NCT00978731|365958962|FG001|Overall Study|Administrative reason|3|||
106080479|NCT00978731|365958963|FG002|Overall Study|Administrative reason|1|||
106080480|NCT00978731|365958964|FG003|Overall Study|Administrative reason|0|||
106080481|NCT00978731|365958961|FG000|Overall Study|Deterioration without progression|0|||
106080482|NCT00978731|365958962|FG001|Overall Study|Deterioration without progression|1|||
106080483|NCT00978731|365958963|FG002|Overall Study|Deterioration without progression|0|||
106080484|NCT00978731|365958964|FG003|Overall Study|Deterioration without progression|0|||
106080485|NCT00978731|365958961|FG000|Overall Study|Disease progression/relapse|5|||
106080486|NCT00978731|365958962|FG001|Overall Study|Disease progression/relapse|4|||
106080487|NCT00978731|365958963|FG002|Overall Study|Disease progression/relapse|2|||
106080488|NCT00978731|365958964|FG003|Overall Study|Disease progression/relapse|2|||
106080489|NCT00978731|365958961|FG000|Overall Study|Study closure|3|||
106080490|NCT00978731|365958962|FG001|Overall Study|Study closure|4|||
106080491|NCT00978731|365958963|FG002|Overall Study|Study closure|1|||
106080492|NCT00978731|365958964|FG003|Overall Study|Study closure|1|||
106080493|NCT00978731|365958961|FG000|Overall Study|No response|1|||
106080494|NCT00978731|365958962|FG001|Overall Study|No response|0|||
106080495|NCT00978731|365958963|FG002|Overall Study|No response|0|||
106080496|NCT00978731|365958964|FG003|Overall Study|No response|0|||
106080497|NCT00071812|365958965|FG000|24-Week Double-Blind Period|Adverse Event|2|||
106080498|NCT00071812|365958966|FG001|24-Week Double-Blind Period|Adverse Event|3|||
105867073|NCT03971474|365163124|FG001|Overall Study|On treatment|7|||
106080499|NCT00071812|365958967|FG002|24-Week Double-Blind Period|Adverse Event|4|||
106080500|NCT00071812|365958968|FG003|24-Week Double-Blind Period|Adverse Event|4|||
106080501|NCT00071812|365958965|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
106080502|NCT00071812|365958966|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
106080503|NCT00071812|365958967|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
106080504|NCT00071812|365958968|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
106080505|NCT00071812|365958965|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
106080506|NCT00071812|365958966|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
106080507|NCT00071812|365958967|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
106080508|NCT00071812|365958968|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
106080509|NCT00071812|365958965|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
106080510|NCT00071812|365958966|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
105867074|NCT02789137|365163125|FG000|Overall Study|Dropped out/Died|58|||
106080511|NCT00071812|365958967|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
106080512|NCT00071812|365958968|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
106080513|NCT00071812|365958965|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
106080514|NCT00071812|365958966|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
106080515|NCT00071812|365958967|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
106080516|NCT00071812|365958968|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
106080517|NCT00071812|365958965|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
106080518|NCT00071812|365958966|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
106080519|NCT00071812|365958967|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
106080520|NCT00071812|365958968|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
106080521|NCT00071812|365958965|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
106080522|NCT00071812|365958966|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
106080523|NCT00071812|365958967|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
106080524|NCT00071812|365958968|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
106080525|NCT00071812|365958965|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
106080526|NCT00071812|365958966|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
106080527|NCT00071812|365958967|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
106080528|NCT00071812|365958968|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
106080529|NCT00071812|365958965|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
106080530|NCT00071812|365958966|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
106080531|NCT00071812|365958967|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
106080532|NCT00071812|365958968|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
106080533|NCT00071812|365958965|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
106080534|NCT00071812|365958966|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
106080535|NCT00071812|365958967|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
106080536|NCT00071812|365958968|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
106080537|NCT01896895|365958969|FG000|Double-blind MP|Physician Decision|0|||
106080538|NCT01896895|365958970|FG001|Double-blind MP|Physician Decision|0|||
106080539|NCT01896895|365958971|FG002|Double-blind MP|Physician Decision|1|||
106080540|NCT01896895|365958972|FG003|Double-blind MP|Physician Decision|0|||
106080541|NCT01896895|365958969|FG000|Double-blind MP|Withdrawal by Subject|0|||
106080542|NCT01896895|365958970|FG001|Double-blind MP|Withdrawal by Subject|2|||
106080543|NCT01896895|365958971|FG002|Double-blind MP|Withdrawal by Subject|1|||
106080544|NCT01896895|365958972|FG003|Double-blind MP|Withdrawal by Subject|0|||
106080545|NCT01896895|365958969|FG000|Double-blind MP|Lost to Follow-up|1|||
106080546|NCT01896895|365958970|FG001|Double-blind MP|Lost to Follow-up|0|||
106080547|NCT01896895|365958971|FG002|Double-blind MP|Lost to Follow-up|1|||
106080548|NCT01896895|365958972|FG003|Double-blind MP|Lost to Follow-up|0|||
106080549|NCT01433263|365958975|FG000|Overall Study|Adverse Event|3|||
106080550|NCT01433263|365958976|FG001|Overall Study|Adverse Event|1|||
106080551|NCT01433263|365958975|FG000|Overall Study|Death|5|||
106080552|NCT01433263|365958976|FG001|Overall Study|Death|3|||
106080553|NCT01433263|365958975|FG000|Overall Study|Lost to Follow-up|0|||
106080554|NCT01433263|365958976|FG001|Overall Study|Lost to Follow-up|1|||
106080555|NCT01433263|365958975|FG000|Overall Study|Protocol Deviation|1|||
106080556|NCT01433263|365958976|FG001|Overall Study|Protocol Deviation|0|||
106080557|NCT01433263|365958975|FG000|Overall Study|Withdrawal by Subject|10|||
106080558|NCT01433263|365958976|FG001|Overall Study|Withdrawal by Subject|7|||
106080559|NCT01589822|365958977|FG000|Overall Study|Withdrawal by Subject|1|||
106080560|NCT01589822|365958978|FG001|Overall Study|Withdrawal by Subject|2|||
106080561|NCT01589822|365958979|FG002|Overall Study|Withdrawal by Subject|0|||
106080562|NCT01589822|365958977|FG000|Overall Study|Death|1|||
106080563|NCT01589822|365958978|FG001|Overall Study|Death|0|||
106080564|NCT01589822|365958979|FG002|Overall Study|Death|0|||
106080565|NCT01589822|365958977|FG000|Overall Study|Missed 90 day visit|2|||
106080566|NCT01589822|365958978|FG001|Overall Study|Missed 90 day visit|1|||
106080567|NCT01589822|365958979|FG002|Overall Study|Missed 90 day visit|1|||
106080568|NCT05168475|365958980|FG000|Period 1|Protocol Violation|1|||
106080569|NCT05168475|365958980|FG000|Period 1|IMP shortage|2|||
106080570|NCT05168475|365958980|FG000|Period 1|Not randomised|2|||
106080571|NCT05168475|365958980|FG000|Period 2|IMP shortage|1|||
106080572|NCT01302964|365958981|FG000|Overall Study|Adverse Event|1|||
106080573|NCT01302964|365958982|FG001|Overall Study|Adverse Event|0|||
106080574|NCT03568942|365958983|FG000|Overall Study|Family emergency|1|||
106080575|NCT03568942|365958983|FG000|Overall Study|Lost to Follow-up|1|||
106080576|NCT00358527|365958985|FG000|Overall Study|Adverse Event|4|||
106080577|NCT00358527|365958986|FG001|Overall Study|Adverse Event|0|||
106080578|NCT00358527|365958985|FG000|Overall Study|Withdrawal by Subject|1|||
106080579|NCT00358527|365958986|FG001|Overall Study|Withdrawal by Subject|1|||
106080580|NCT00358527|365958985|FG000|Overall Study|Non-compliance with protocol|6|||
106080581|NCT00358527|365958986|FG001|Overall Study|Non-compliance with protocol|1|||
106080582|NCT00358527|365958985|FG000|Overall Study|Administrative|2|||
106080583|NCT00358527|365958986|FG001|Overall Study|Administrative|1|||
106080584|NCT04144166|365958989|FG000|Overall Study|Discharged before study start|1|||
106080585|NCT04144166|365958989|FG000|Overall Study|Pregnancy|1|||
106080586|NCT04144166|365958989|FG000|Overall Study|Nail polish could not be removed from finger|1|||
106080587|NCT03643562|365958993|FG000|Overall Study|Adverse Event|1|||
106080588|NCT03643562|365958994|FG001|Overall Study|Adverse Event|0|||
106080589|NCT03643562|365958993|FG000|Overall Study|Lack of Efficacy|0|||
106080590|NCT03643562|365958994|FG001|Overall Study|Lack of Efficacy|1|||
106080591|NCT03643562|365958993|FG000|Overall Study|Physician Decision|0|||
106080592|NCT03643562|365958994|FG001|Overall Study|Physician Decision|1|||
106080593|NCT03643562|365958993|FG000|Overall Study|Study Terminated by Sponsor|2|||
106080594|NCT03643562|365958994|FG001|Overall Study|Study Terminated by Sponsor|10|||
106080595|NCT03643562|365958993|FG000|Overall Study|Withdrawal by Subject|2|||
106080596|NCT03643562|365958994|FG001|Overall Study|Withdrawal by Subject|2|||
106080597|NCT03643562|365958993|FG000|Overall Study|Other than specified|3|||
106080598|NCT03643562|365958994|FG001|Overall Study|Other than specified|2|||
106080599|NCT01982253|365958995|FG000|Overall Study|Withdrawal by Subject|1|||
106080600|NCT01982253|365958996|FG001|Overall Study|Withdrawal by Subject|0|||
106080601|NCT01982253|365958997|FG002|Overall Study|Withdrawal by Subject|0|||
106080602|NCT01982253|365958995|FG000|Overall Study|Study terminated by sponsor|1|||
106080603|NCT01982253|365958996|FG001|Overall Study|Study terminated by sponsor|4|||
106080604|NCT01982253|365958997|FG002|Overall Study|Study terminated by sponsor|4|||
106080605|NCT04145895|365958998|FG000|Overall Study|Physician Decision|2|||
106080606|NCT04145895|365958999|FG001|Overall Study|Physician Decision|0|||
106080607|NCT04145895|365958998|FG000|Overall Study|Withdrawal by Subject|0|||
106080608|NCT04145895|365958999|FG001|Overall Study|Withdrawal by Subject|2|||
106080609|NCT00326612|365959000|FG000|Overall Study|They did not have a seizure requiring tx|129|||
106080610|NCT00326612|365959001|FG001|Overall Study|They did not have a seizure requiring tx|137|||
106080611|NCT00419562|365959002|FG000|Overall Study|Lost to Follow-up|12|||
106080612|NCT00419562|365959003|FG001|Overall Study|Lost to Follow-up|13|||
106080613|NCT00419562|365959002|FG000|Overall Study|Withdrawal by Subject|20|||
106080614|NCT00419562|365959003|FG001|Overall Study|Withdrawal by Subject|18|||
106080615|NCT00419562|365959002|FG000|Overall Study|Participant Institutionalized|1|||
106080616|NCT00419562|365959003|FG001|Overall Study|Participant Institutionalized|0|||
106080617|NCT00913744|365959006|FG000|Overall Study|Adverse Event|2|||
106080618|NCT00913744|365959007|FG001|Overall Study|Adverse Event|0|||
106080619|NCT00913744|365959006|FG000|Overall Study|Withdrawal by Subject|2|||
106080620|NCT00913744|365959007|FG001|Overall Study|Withdrawal by Subject|1|||
106080621|NCT00913744|365959006|FG000|Overall Study|Death|1|||
106080622|NCT00913744|365959007|FG001|Overall Study|Death|0|||
106080623|NCT00805935|365959008|FG000|Overall Study|Stimulation Failure|1|||
106080624|NCT00805935|365959009|FG001|Overall Study|Stimulation Failure|5|||
106080625|NCT00805935|365959010|FG002|Overall Study|Stimulation Failure|2|||
106080626|NCT00805935|365959011|FG003|Overall Study|Stimulation Failure|2|||
106080627|NCT00805935|365959008|FG000|Overall Study|Cycle cancelled|0|||
106080628|NCT00805935|365959009|FG001|Overall Study|Cycle cancelled|0|||
106080629|NCT00805935|365959010|FG002|Overall Study|Cycle cancelled|2|||
106080630|NCT00805935|365959011|FG003|Overall Study|Cycle cancelled|0|||
106080631|NCT00805935|365959008|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
106080632|NCT00805935|365959009|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
106080633|NCT00805935|365959010|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
106080634|NCT00805935|365959011|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
106080635|NCT00805935|365959008|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
106080636|NCT00805935|365959009|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
106080637|NCT00805935|365959010|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
106080638|NCT00805935|365959011|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
106080639|NCT00805935|365959008|FG000|Overall Study|Lost to Follow-up|1|||
106080640|NCT00805935|365959009|FG001|Overall Study|Lost to Follow-up|0|||
106080641|NCT00805935|365959010|FG002|Overall Study|Lost to Follow-up|0|||
106080642|NCT00805935|365959011|FG003|Overall Study|Lost to Follow-up|0|||
106080643|NCT00805935|365959008|FG000|Overall Study|No positive serum pregnancy|8|||
106080644|NCT00805935|365959009|FG001|Overall Study|No positive serum pregnancy|7|||
106080645|NCT00805935|365959010|FG002|Overall Study|No positive serum pregnancy|6|||
106080646|NCT00805935|365959011|FG003|Overall Study|No positive serum pregnancy|5|||
106080647|NCT00805935|365959008|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
106080648|NCT00805935|365959009|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
106080649|NCT00805935|365959010|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
106080650|NCT00805935|365959011|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
106080651|NCT00805935|365959008|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
106080652|NCT00805935|365959009|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
106080653|NCT00805935|365959010|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
106080654|NCT00805935|365959011|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
106080655|NCT00805935|365959008|FG000|Overall Study|Biochemical pregnancy|0|||
106080656|NCT00805935|365959009|FG001|Overall Study|Biochemical pregnancy|1|||
106080657|NCT00805935|365959010|FG002|Overall Study|Biochemical pregnancy|0|||
106080658|NCT00805935|365959011|FG003|Overall Study|Biochemical pregnancy|0|||
106080659|NCT00805935|365959008|FG000|Overall Study|Chemical pregnancy|0|||
106080660|NCT00805935|365959009|FG001|Overall Study|Chemical pregnancy|5|||
106080661|NCT00805935|365959010|FG002|Overall Study|Chemical pregnancy|3|||
106080662|NCT00805935|365959011|FG003|Overall Study|Chemical pregnancy|2|||
106080663|NCT00805935|365959008|FG000|Overall Study|Ectopic pregnancy|0|||
106080664|NCT00805935|365959009|FG001|Overall Study|Ectopic pregnancy|0|||
106080665|NCT00805935|365959010|FG002|Overall Study|Ectopic pregnancy|1|||
106080666|NCT00805935|365959011|FG003|Overall Study|Ectopic pregnancy|0|||
106080667|NCT00805935|365959008|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
106080668|NCT00805935|365959009|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
106080669|NCT00805935|365959010|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
106080670|NCT00805935|365959011|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
106080671|NCT01886833|365959014|FG000|Overall Study|IgA not available from both periods|204|||
106080672|NCT01467076|365959029|FG000|Overall Study|Lost to Follow-up|1|||
106080673|NCT01467076|365959030|FG001|Overall Study|Lost to Follow-up|0|||
106080674|NCT01467076|365959031|FG002|Overall Study|Lost to Follow-up|0|||
106080675|NCT03064126|365959032|FG000|Overall Study|Death|40|||
106080676|NCT03064126|365959033|FG001|Overall Study|Death|16|||
106080677|NCT03064126|365959034|FG002|Overall Study|Death|4|||
106080678|NCT03064126|365959035|FG003|Overall Study|Death|2|||
106080679|NCT03064126|365959032|FG000|Overall Study|Withdrawal by Subject|17|||
106080680|NCT03064126|365959033|FG001|Overall Study|Withdrawal by Subject|9|||
106080681|NCT03064126|365959034|FG002|Overall Study|Withdrawal by Subject|0|||
106080682|NCT03064126|365959035|FG003|Overall Study|Withdrawal by Subject|2|||
106080683|NCT03064126|365959032|FG000|Overall Study|Lost to Follow-up|7|||
106080684|NCT03064126|365959033|FG001|Overall Study|Lost to Follow-up|3|||
106080685|NCT03064126|365959034|FG002|Overall Study|Lost to Follow-up|0|||
106080686|NCT03064126|365959035|FG003|Overall Study|Lost to Follow-up|0|||
106080687|NCT03064126|365959032|FG000|Overall Study|Adverse Event|2|||
106080688|NCT03064126|365959033|FG001|Overall Study|Adverse Event|0|||
106080689|NCT03064126|365959034|FG002|Overall Study|Adverse Event|0|||
106080690|NCT03064126|365959035|FG003|Overall Study|Adverse Event|0|||
106080691|NCT03064126|365959032|FG000|Overall Study|Physician Decision|3|||
106080692|NCT03064126|365959033|FG001|Overall Study|Physician Decision|0|||
106080693|NCT03064126|365959034|FG002|Overall Study|Physician Decision|0|||
106080694|NCT03064126|365959035|FG003|Overall Study|Physician Decision|0|||
106080695|NCT03064126|365959032|FG000|Overall Study|Other reason for early termination|3|||
106080696|NCT03064126|365959033|FG001|Overall Study|Other reason for early termination|2|||
106080697|NCT03064126|365959034|FG002|Overall Study|Other reason for early termination|0|||
106080698|NCT03064126|365959035|FG003|Overall Study|Other reason for early termination|0|||
106080699|NCT03064126|365959032|FG000|Overall Study|Missed Visit|3|||
106080700|NCT03064126|365959033|FG001|Overall Study|Missed Visit|1|||
106080701|NCT03064126|365959034|FG002|Overall Study|Missed Visit|0|||
106080702|NCT03064126|365959035|FG003|Overall Study|Missed Visit|0|||
106080703|NCT00846742|365959039|FG000|Overall Study|Withdrawal by Subject|1|||
106080704|NCT06034496|365959042|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
106080705|NCT06034496|365959043|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
106080706|NCT06034496|365959042|FG000|Overall Study|Withdrawal by Subject|5|||
106080707|NCT06034496|365959043|FG001|Overall Study|Withdrawal by Subject|4|||
106080708|NCT04960228|365959045|FG000|Overall Study|Withdrawal by Subject|216|||
106080709|NCT04960228|365959046|FG001|Overall Study|Withdrawal by Subject|35|||
106080710|NCT04960228|365959045|FG000|Overall Study|Failed attention check|69|||
106080711|NCT04960228|365959046|FG001|Overall Study|Failed attention check|148|||
106080712|NCT04960228|365959045|FG000|Overall Study|Flagged for response quality by Dynata|3|||
106080713|NCT04960228|365959046|FG001|Overall Study|Flagged for response quality by Dynata|3|||
106080714|NCT01585766|365959047|FG000|Overall Study|Withdrawal by Subject|0|||
106080715|NCT01585766|365959048|FG001|Overall Study|Withdrawal by Subject|1|||
106080716|NCT01585766|365959049|FG002|Overall Study|Withdrawal by Subject|1|||
106080717|NCT01585766|365959050|FG003|Overall Study|Withdrawal by Subject|0|||
106080718|NCT01585766|365959051|FG004|Overall Study|Withdrawal by Subject|0|||
106080719|NCT01585766|365959052|FG005|Overall Study|Withdrawal by Subject|0|||
106080720|NCT01585766|365959047|FG000|Overall Study|Death|0|||
106080721|NCT01585766|365959048|FG001|Overall Study|Death|1|||
106080722|NCT01585766|365959049|FG002|Overall Study|Death|0|||
106080723|NCT01585766|365959050|FG003|Overall Study|Death|0|||
106080724|NCT01585766|365959051|FG004|Overall Study|Death|0|||
106080725|NCT01585766|365959052|FG005|Overall Study|Death|0|||
106080726|NCT01585766|365959047|FG000|Overall Study|Physician Decision|0|||
105867075|NCT01482312|365163136|FG000|Period 1, 90 Minutes of Wear|Other|1|||
106080727|NCT01585766|365959048|FG001|Overall Study|Physician Decision|0|||
106080728|NCT01585766|365959049|FG002|Overall Study|Physician Decision|1|||
106080729|NCT01585766|365959050|FG003|Overall Study|Physician Decision|0|||
106080730|NCT01585766|365959051|FG004|Overall Study|Physician Decision|0|||
106080731|NCT01585766|365959052|FG005|Overall Study|Physician Decision|0|||
106080732|NCT04049760|365959055|FG000|Overall Study|Withdrawal by Subject|1|||
106080733|NCT00393939|365959056|FG000|Overall Study|Protocol Violation|1|||
106080734|NCT00393939|365959057|FG001|Overall Study|Protocol Violation|1|||
106160232|NCT02783300|366247387|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160233|NCT02783300|366247388|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160234|NCT02783300|366247389|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160235|NCT02783300|366247390|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160236|NCT02783300|366247391|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160237|NCT02783300|366247392|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160238|NCT02783300|366247393|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160239|NCT02783300|366247394|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160240|NCT02783300|366247395|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160241|NCT02783300|366247396|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160242|NCT02783300|366247397|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160243|NCT02783300|366247398|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160244|NCT02783300|366247399|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160245|NCT02783300|366247400|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160246|NCT02783300|366247401|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160247|NCT02783300|366247402|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160248|NCT02783300|366247403|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160249|NCT02783300|366247404|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160250|NCT02783300|366247405|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
106160251|NCT02783300|366247406|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
106160252|NCT03535272|366247407|FG000|Overall Study|Lost to Follow-up|71|||
106160253|NCT03535272|366247408|FG001|Overall Study|Lost to Follow-up|73|||
106160254|NCT04177823|366247414|FG000|Overall Study|Physician Decision|1|||
106160255|NCT04177823|366247414|FG000|Overall Study|Withdrawal by Subject|1|||
106160256|NCT05178316|366247415|FG000|Overall Study|Adverse Event|5|||
106160257|NCT05178316|366247416|FG001|Overall Study|Adverse Event|4|||
106160258|NCT05178316|366247417|FG002|Overall Study|Adverse Event|9|||
106160259|NCT05178316|366247415|FG000|Overall Study|Enrolled in Error|1|||
106160260|NCT05178316|366247416|FG001|Overall Study|Enrolled in Error|2|||
106160261|NCT05178316|366247417|FG002|Overall Study|Enrolled in Error|1|||
106160262|NCT05178316|366247415|FG000|Overall Study|Lost to Follow-up|3|||
106160263|NCT05178316|366247416|FG001|Overall Study|Lost to Follow-up|15|||
106160264|NCT05178316|366247417|FG002|Overall Study|Lost to Follow-up|11|||
106160265|NCT05178316|366247415|FG000|Overall Study|Noncompliance|1|||
106160266|NCT05178316|366247416|FG001|Overall Study|Noncompliance|3|||
106160267|NCT05178316|366247417|FG002|Overall Study|Noncompliance|1|||
106160268|NCT05178316|366247415|FG000|Overall Study|Other|0|||
106160269|NCT05178316|366247416|FG001|Overall Study|Other|1|||
106160270|NCT05178316|366247417|FG002|Overall Study|Other|0|||
106160271|NCT05178316|366247415|FG000|Overall Study|Physician Decision|0|||
106160272|NCT05178316|366247416|FG001|Overall Study|Physician Decision|3|||
106160273|NCT05178316|366247417|FG002|Overall Study|Physician Decision|2|||
106160274|NCT05178316|366247415|FG000|Overall Study|Protocol deviation|1|||
106160275|NCT05178316|366247416|FG001|Overall Study|Protocol deviation|0|||
106160276|NCT05178316|366247417|FG002|Overall Study|Protocol deviation|1|||
106160277|NCT05178316|366247415|FG000|Overall Study|Sponsor decision|1|||
106160278|NCT05178316|366247416|FG001|Overall Study|Sponsor decision|0|||
106160279|NCT05178316|366247417|FG002|Overall Study|Sponsor decision|1|||
106160280|NCT05178316|366247415|FG000|Overall Study|Withdrawal by Subject|5|||
106160281|NCT05178316|366247416|FG001|Overall Study|Withdrawal by Subject|11|||
106160282|NCT05178316|366247417|FG002|Overall Study|Withdrawal by Subject|5|||
106160283|NCT04347161|366247418|FG000|Overall Study|Death|0|||
106160284|NCT04347161|366247419|FG001|Overall Study|Death|2|||
106160285|NCT04347161|366247418|FG000|Overall Study|Withdrawal by Subject|1|||
106160286|NCT04347161|366247419|FG001|Overall Study|Withdrawal by Subject|0|||
106160287|NCT04347161|366247418|FG000|Overall Study|Lost to Follow-up|0|||
106160288|NCT04347161|366247419|FG001|Overall Study|Lost to Follow-up|1|||
106160289|NCT04347161|366247418|FG000|Overall Study|No longer on study medication|1|||
106160290|NCT04347161|366247419|FG001|Overall Study|No longer on study medication|1|||
106080735|NCT00393939|365959056|FG000|Overall Study|Lost to Follow-up|2|||
106080736|NCT00393939|365959057|FG001|Overall Study|Lost to Follow-up|4|||
106080737|NCT00393939|365959056|FG000|Overall Study|Death|10|||
106080738|NCT00393939|365959057|FG001|Overall Study|Death|4|||
106080739|NCT00393939|365959056|FG000|Overall Study|Sponsor|5|||
106080740|NCT00393939|365959057|FG001|Overall Study|Sponsor|13|||
106080741|NCT00393939|365959056|FG000|Overall Study|Objective progression or relapse|239|||
106080742|NCT00393939|365959057|FG001|Overall Study|Objective progression or relapse|223|||
106080743|NCT00393939|365959056|FG000|Overall Study|Withdrawal by Subject|2|||
106080744|NCT00393939|365959057|FG001|Overall Study|Withdrawal by Subject|7|||
106080745|NCT00393939|365959056|FG000|Overall Study|Other|37|||
106080746|NCT00393939|365959057|FG001|Overall Study|Other|45|||
106080747|NCT02214121|365959064|FG000|Part A|Patient decision|2|||
106080748|NCT02214121|365959065|FG001|Part A|Patient decision|0|||
106080749|NCT02214121|365959066|FG002|Part A|Patient decision|0|||
106080750|NCT02214121|365959064|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
106080751|NCT02214121|365959065|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
106080752|NCT02214121|365959066|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
106080753|NCT02214121|365959064|FG000|Part A|Other|1|||
106080754|NCT02214121|365959065|FG001|Part A|Other|0|||
106080755|NCT02214121|365959066|FG002|Part A|Other|0|||
106080756|NCT02214121|365959064|FG000|Part B|Patient decision|0|||
106080757|NCT02214121|365959065|FG001|Part B|Patient decision|1|||
106080758|NCT02214121|365959066|FG002|Part B|Patient decision|0|||
106080759|NCT02214121|365959064|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
106080760|NCT02214121|365959065|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
106080761|NCT02214121|365959066|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
106080762|NCT02214121|365959064|FG000|Part B|Lost to Follow-up|0|||
106080763|NCT02214121|365959065|FG001|Part B|Lost to Follow-up|0|||
106080764|NCT02214121|365959066|FG002|Part B|Lost to Follow-up|1|||
106080765|NCT02375672|365959067|FG000|Overall Study|remain on follow up|20|||
106080766|NCT01256710|365959068|FG000|Overall Study|Death|449|||
106080767|NCT01256710|365959068|FG000|Overall Study|System Explant|67|||
106080768|NCT01256710|365959068|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
106080769|NCT01256710|365959068|FG000|Overall Study|Lost to Follow-up|67|||
106080770|NCT01256710|365959068|FG000|Overall Study|Withdrawal by Subject|29|||
106080771|NCT01256710|365959068|FG000|Overall Study|Physician Decision|9|||
106080772|NCT01256710|365959068|FG000|Overall Study|Subject Noncompliance|2|||
106080773|NCT01256710|365959068|FG000|Overall Study|Study Terminated by Sponsor|273|||
106080774|NCT02244580|365959073|FG000|Overall Study|No cancer tissues available|241|||
106080775|NCT01736696|365959074|FG000|Overall Study|Withdrawal by Subject|0|||
106080776|NCT01736696|365959075|FG001|Overall Study|Withdrawal by Subject|0|||
106080777|NCT01736696|365959076|FG002|Overall Study|Withdrawal by Subject|1|||
106080778|NCT01736696|365959077|FG003|Overall Study|Withdrawal by Subject|0|||
106080779|NCT01736696|365959078|FG004|Overall Study|Withdrawal by Subject|0|||
106080780|NCT01736696|365959079|FG005|Overall Study|Withdrawal by Subject|0|||
106080781|NCT01736696|365959080|FG006|Overall Study|Withdrawal by Subject|0|||
106080782|NCT02114879|365959081|FG000|Overall Study|Withdrawal by Subject|9|||
106080783|NCT02114879|365959082|FG001|Overall Study|Withdrawal by Subject|5|||
106080784|NCT02114879|365959081|FG000|Overall Study|Death|6|||
106080785|NCT02114879|365959082|FG001|Overall Study|Death|11|||
106080786|NCT02114879|365959081|FG000|Overall Study|Lost to Follow-up|4|||
106080787|NCT02114879|365959082|FG001|Overall Study|Lost to Follow-up|6|||
106080788|NCT02114879|365959081|FG000|Overall Study|Physician Decision|0|||
106080789|NCT02114879|365959082|FG001|Overall Study|Physician Decision|2|||
106080790|NCT04552587|365959083|FG000|Overall Study|Lost to Follow-up|4|||
106080791|NCT04907032|365959085|FG000|Overall Study|Withdrawal by Subject|7|||
106080792|NCT04907032|365959086|FG001|Overall Study|Withdrawal by Subject|1|||
106080793|NCT02519712|365959089|FG000|Overall Study|Disease Relapse|1|||
106080794|NCT02519712|365959089|FG000|Overall Study|Disease Progression|1|||
106080795|NCT02519712|365959089|FG000|Overall Study|Accruals are donors|2|||
106080796|NCT00613509|365959090|FG000|Cycle 1|Adverse Event|2|||
106080797|NCT00613509|365959091|FG001|Cycle 1|Adverse Event|1|||
106080798|NCT00613509|365959090|FG000|Cycle 1|Disease Progression|2|||
106080799|NCT00613509|365959091|FG001|Cycle 1|Disease Progression|6|||
106080800|NCT00613509|365959090|FG000|Cycle 1|Unacceptable Toxicity|1|||
106080801|NCT00613509|365959091|FG001|Cycle 1|Unacceptable Toxicity|0|||
106080802|NCT00613509|365959090|FG000|Cycle 1|Other administrative reason|0|||
106080803|NCT00613509|365959091|FG001|Cycle 1|Other administrative reason|1|||
106080804|NCT01215227|365959092|FG000|Overall Study|Adverse Event|11|||
106080805|NCT01215227|365959093|FG001|Overall Study|Adverse Event|11|||
106080806|NCT01215227|365959094|FG002|Overall Study|Adverse Event|4|||
106080807|NCT01215227|365959095|FG003|Overall Study|Adverse Event|8|||
106080808|NCT01215227|365959096|FG004|Overall Study|Adverse Event|7|||
106080809|NCT01215227|365959097|FG005|Overall Study|Adverse Event|6|||
106080810|NCT01215227|365959092|FG000|Overall Study|Treatment Failure|8|||
106080811|NCT01215227|365959093|FG001|Overall Study|Treatment Failure|4|||
106080812|NCT01215227|365959094|FG002|Overall Study|Treatment Failure|1|||
106080813|NCT01215227|365959095|FG003|Overall Study|Treatment Failure|5|||
106080814|NCT01215227|365959096|FG004|Overall Study|Treatment Failure|1|||
106080815|NCT01215227|365959097|FG005|Overall Study|Treatment Failure|1|||
106160291|NCT04887129|366247420|FG000|Overall Study|Lost to Follow-up|0|||
106160292|NCT04887129|366247421|FG001|Overall Study|Lost to Follow-up|24|||
106160293|NCT04887129|366247420|FG000|Overall Study|Withdrawal by Subject|9|||
106160294|NCT04887129|366247421|FG001|Overall Study|Withdrawal by Subject|57|||
106160295|NCT04887129|366247420|FG000|Overall Study|Other|2|||
106160296|NCT04887129|366247421|FG001|Overall Study|Other|9|||
106160297|NCT03792256|366247425|FG000|Overall Study|Death|0|||
106160298|NCT03792256|366247426|FG001|Overall Study|Death|1|||
106160299|NCT03792256|366247425|FG000|Overall Study|Lack of Efficacy|0|||
106160300|NCT03792256|366247426|FG001|Overall Study|Lack of Efficacy|1|||
106160301|NCT03792256|366247425|FG000|Overall Study|Withdrawal by Subject|0|||
106160302|NCT03792256|366247426|FG001|Overall Study|Withdrawal by Subject|1|||
106160303|NCT05948670|366247427|FG000|Overall Study|Protocol Violation|6|||
106160304|NCT05948670|366247428|FG001|Overall Study|Protocol Violation|8|||
106160305|NCT05948670|366247427|FG000|Overall Study|Withdrawal by Subject|0|||
106160306|NCT05948670|366247428|FG001|Overall Study|Withdrawal by Subject|1|||
106160307|NCT03699709|366247429|FG000|Overall Study|Death|1|||
106160308|NCT03699709|366247430|FG001|Overall Study|Death|2|||
106160309|NCT03699709|366247429|FG000|Overall Study|Lost to Follow-up|10|||
106160310|NCT03699709|366247430|FG001|Overall Study|Lost to Follow-up|3|||
106160311|NCT03699709|366247429|FG000|Overall Study|Withdrawal by Subject|5|||
106160312|NCT03699709|366247430|FG001|Overall Study|Withdrawal by Subject|0|||
106160313|NCT03699709|366247429|FG000|Overall Study|incarcerated|1|||
106160314|NCT03699709|366247430|FG001|Overall Study|incarcerated|0|||
106160315|NCT03699709|366247429|FG000|Overall Study|scheduled, but no show|0|||
106160316|NCT03699709|366247430|FG001|Overall Study|scheduled, but no show|1|||
106160317|NCT02907099|366247431|FG000|Overall Study|Adverse Event|1|||
106160318|NCT02907099|366247431|FG000|Overall Study|Withdrawal by Subject|2|||
106160319|NCT02907099|366247431|FG000|Overall Study|Screen Fail|2|||
106160320|NCT03988608|366247441|FG000|Overall Study|Adverse Event|1|||
106160321|NCT03988608|366247441|FG000|Overall Study|Lost to Follow-up|1|||
106160322|NCT03988608|366247441|FG000|Overall Study|Withdrawal by Subject|3|||
106160323|NCT03988608|366247441|FG000|Overall Study|Death|1|||
106160324|NCT05048238|366247447|FG000|Overall Study|Withdrawal by Subject|1|||
106160325|NCT00450658|366247448|FG000|Overall Study|Adverse Event|24|||
106160326|NCT00450658|366247449|FG001|Overall Study|Adverse Event|15|||
106160327|NCT00450658|366247448|FG000|Overall Study|Withdrawal by Subject|43|||
106160328|NCT00450658|366247449|FG001|Overall Study|Withdrawal by Subject|26|||
106160329|NCT00450658|366247448|FG000|Overall Study|Lost to Follow-up|22|||
106160330|NCT00450658|366247449|FG001|Overall Study|Lost to Follow-up|5|||
106160331|NCT00450658|366247448|FG000|Overall Study|UGI ulcer|33|||
106160332|NCT00450658|366247449|FG001|Overall Study|UGI ulcer|34|||
106160333|NCT00450658|366247448|FG000|Overall Study|misc|21|||
106160334|NCT00450658|366247449|FG001|Overall Study|misc|10|||
106160335|NCT04764448|366247450|FG000|Overall Study|Study terminated by sponsor|2|||
106160336|NCT04764448|366247451|FG001|Overall Study|Study terminated by sponsor|2|||
106160337|NCT04764448|366247452|FG002|Overall Study|Study terminated by sponsor|5|||
106160338|NCT04764448|366247450|FG000|Overall Study|Withdrawal by Subject|3|||
106160339|NCT04764448|366247451|FG001|Overall Study|Withdrawal by Subject|3|||
106160340|NCT04764448|366247452|FG002|Overall Study|Withdrawal by Subject|1|||
106160341|NCT04727554|366247454|FG000|Overall Study|Lost to Follow-up|0|||
106160342|NCT04727554|366247455|FG001|Overall Study|Lost to Follow-up|1|||
106160343|NCT04727554|366247454|FG000|Overall Study|Death|2|||
106160344|NCT04727554|366247455|FG001|Overall Study|Death|6|||
106160345|NCT04727554|366247454|FG000|Overall Study|Withdrawal by Subject|1|||
106160346|NCT04727554|366247455|FG001|Overall Study|Withdrawal by Subject|0|||
106160347|NCT05256706|366247459|FG000|Overall Study|Lost to Follow-up|9|||
106160348|NCT05256706|366247460|FG001|Overall Study|Lost to Follow-up|3|||
106160349|NCT05256706|366247459|FG000|Overall Study|Withdrawal by Subject|7|||
106160350|NCT05256706|366247460|FG001|Overall Study|Withdrawal by Subject|11|||
106160351|NCT05256706|366247459|FG000|Overall Study|Screen Failures|3|||
106160352|NCT05256706|366247460|FG001|Overall Study|Screen Failures|0|||
106160353|NCT03720795|366247461|FG000|Phase 1|Lost to Follow-up|4|||
106160354|NCT03720795|366247461|FG000|Phase 1|Withdrawal by Subject|6|||
106160355|NCT03720795|366247461|FG000|Phase 1|Protocol Violation|1|||
106160356|NCT03720795|366247461|FG000|Phase 1|Other|1|||
106160357|NCT03720795|366247461|FG000|Phase 2|Lost to Follow-up|5|||
106160358|NCT03720795|366247461|FG000|Phase 2|Withdrawal by Subject|10|||
106080816|NCT01215227|365959092|FG000|Overall Study|Lost to Follow-up|1|||
106080817|NCT01215227|365959093|FG001|Overall Study|Lost to Follow-up|4|||
106080818|NCT01215227|365959094|FG002|Overall Study|Lost to Follow-up|1|||
106080819|NCT01215227|365959095|FG003|Overall Study|Lost to Follow-up|1|||
106080820|NCT01215227|365959096|FG004|Overall Study|Lost to Follow-up|1|||
106080821|NCT01215227|365959097|FG005|Overall Study|Lost to Follow-up|2|||
106080822|NCT01215227|365959092|FG000|Overall Study|Subject Withdrew Consent|16|||
106080823|NCT01215227|365959093|FG001|Overall Study|Subject Withdrew Consent|20|||
106080824|NCT01215227|365959094|FG002|Overall Study|Subject Withdrew Consent|7|||
106080825|NCT01215227|365959095|FG003|Overall Study|Subject Withdrew Consent|10|||
106080826|NCT01215227|365959096|FG004|Overall Study|Subject Withdrew Consent|11|||
106080827|NCT01215227|365959097|FG005|Overall Study|Subject Withdrew Consent|8|||
106080828|NCT01215227|365959092|FG000|Overall Study|Non-Compliance With Protocol|2|||
106080829|NCT01215227|365959093|FG001|Overall Study|Non-Compliance With Protocol|6|||
106080830|NCT01215227|365959094|FG002|Overall Study|Non-Compliance With Protocol|1|||
106080831|NCT01215227|365959095|FG003|Overall Study|Non-Compliance With Protocol|0|||
106080832|NCT01215227|365959096|FG004|Overall Study|Non-Compliance With Protocol|0|||
106080833|NCT01215227|365959097|FG005|Overall Study|Non-Compliance With Protocol|0|||
106080834|NCT01215227|365959092|FG000|Overall Study|Administrative|83|||
106080835|NCT01215227|365959093|FG001|Overall Study|Administrative|73|||
106080836|NCT01215227|365959094|FG002|Overall Study|Administrative|42|||
106080837|NCT01215227|365959095|FG003|Overall Study|Administrative|24|||
106080838|NCT01215227|365959096|FG004|Overall Study|Administrative|28|||
106080839|NCT01215227|365959097|FG005|Overall Study|Administrative|40|||
106080840|NCT01215227|365959092|FG000|Overall Study|Missing Status|0|||
106080841|NCT01215227|365959093|FG001|Overall Study|Missing Status|1|||
106080842|NCT01215227|365959094|FG002|Overall Study|Missing Status|0|||
106080843|NCT01215227|365959095|FG003|Overall Study|Missing Status|0|||
106080844|NCT01215227|365959096|FG004|Overall Study|Missing Status|0|||
106080845|NCT01215227|365959097|FG005|Overall Study|Missing Status|0|||
106080846|NCT01215227|365959092|FG000|Overall Study|Randomized but not treated|0|||
106080847|NCT01215227|365959093|FG001|Overall Study|Randomized but not treated|0|||
106080848|NCT01215227|365959094|FG002|Overall Study|Randomized but not treated|1|||
106080849|NCT01215227|365959095|FG003|Overall Study|Randomized but not treated|1|||
106080850|NCT01215227|365959096|FG004|Overall Study|Randomized but not treated|0|||
106080851|NCT01215227|365959097|FG005|Overall Study|Randomized but not treated|1|||
106080852|NCT01398956|365959107|FG000|Overall Study|Withdrawal by Subject|4|||
106080853|NCT01398956|365959107|FG000|Overall Study|AE, non-serious non-fatal|4|||
106080854|NCT01398956|365959107|FG000|Overall Study|Withdrawal Criteria No.3|1|||
106080855|NCT01398956|365959107|FG000|Overall Study|Subject moved a long distance|1|||
106080856|NCT01339390|365959108|FG000|Overall Study|Death|32|||
106080857|NCT01339390|365959109|FG001|Overall Study|Death|29|||
106080858|NCT01339390|365959108|FG000|Overall Study|Lost to Follow-up|125|||
106080859|NCT01339390|365959109|FG001|Overall Study|Lost to Follow-up|127|||
106080860|NCT01224639|365959116|FG000|Overall Study|Withdrawal by Subject|0|||
106080861|NCT01224639|365959117|FG001|Overall Study|Withdrawal by Subject|0|||
106080862|NCT01224639|365959118|FG002|Overall Study|Withdrawal by Subject|0|||
106080863|NCT01224639|365959119|FG003|Overall Study|Withdrawal by Subject|0|||
106080864|NCT01224639|365959120|FG004|Overall Study|Withdrawal by Subject|2|||
106080865|NCT01224639|365959121|FG005|Overall Study|Withdrawal by Subject|0|||
106080866|NCT01224639|365959122|FG006|Overall Study|Withdrawal by Subject|1|||
106080867|NCT01224639|365959123|FG007|Overall Study|Withdrawal by Subject|1|||
106080868|NCT01224639|365959116|FG000|Overall Study|Adverse Event|0|||
106080869|NCT01224639|365959117|FG001|Overall Study|Adverse Event|0|||
106080870|NCT01224639|365959118|FG002|Overall Study|Adverse Event|0|||
106080871|NCT01224639|365959119|FG003|Overall Study|Adverse Event|0|||
106080872|NCT01224639|365959120|FG004|Overall Study|Adverse Event|0|||
106080873|NCT01224639|365959121|FG005|Overall Study|Adverse Event|0|||
106080874|NCT01224639|365959122|FG006|Overall Study|Adverse Event|0|||
106080875|NCT01224639|365959123|FG007|Overall Study|Adverse Event|1|||
106080876|NCT04656132|365959124|FG000|Overall Study|Lost to Follow-up|4|||
106080877|NCT04656132|365959124|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
106080878|NCT00314366|365959127|FG000|Overall Study|not treated due to patient medical condi|1|||
106080879|NCT00314366|365959128|FG001|Overall Study|not treated due to patient medical condi|0|||
106080880|NCT03945981|365959131|FG000|Overall Study|Lost to Follow-up|12|||
106080881|NCT03945981|365959131|FG000|Overall Study|Physician Decision|4|||
106080882|NCT03945981|365959131|FG000|Overall Study|Withdrawal by Subject|6|||
106080883|NCT03945981|365959131|FG000|Overall Study|Protocol Violation|1|||
106080884|NCT04615949|365960427|FG000|Overall Study|Withdrawal by Subject|2|||
106080885|NCT04615949|365960428|FG001|Overall Study|Withdrawal by Subject|4|||
106080886|NCT04615949|365960427|FG000|Overall Study|Lost to Follow-up|2|||
106080887|NCT04615949|365960428|FG001|Overall Study|Lost to Follow-up|2|||
106080888|NCT04615949|365960427|FG000|Overall Study|Death|0|||
106080889|NCT04615949|365960428|FG001|Overall Study|Death|2|||
106080890|NCT01140477|365960431|FG000|Overall Study|Lost to Follow-up|4|||
106080891|NCT01140477|365960432|FG001|Overall Study|Lost to Follow-up|0|||
106080892|NCT01140477|365960431|FG000|Overall Study|Withdrawal by Subject|1|||
106080893|NCT01140477|365960432|FG001|Overall Study|Withdrawal by Subject|4|||
106080894|NCT01140477|365960431|FG000|Overall Study|Surgical complication preventing implant|2|||
106080895|NCT01140477|365960432|FG001|Overall Study|Surgical complication preventing implant|0|||
106080896|NCT01140477|365960431|FG000|Overall Study|Death|1|||
106080897|NCT01140477|365960432|FG001|Overall Study|Death|1|||
106080898|NCT01140477|365960431|FG000|Overall Study|Subject explanted|0|||
106080899|NCT01140477|365960432|FG001|Overall Study|Subject explanted|1|||
106080900|NCT00145509|365960440|FG000|Overall Study|Adverse Event|10|||
106080901|NCT00145509|365960441|FG001|Overall Study|Adverse Event|3|||
106080902|NCT00145509|365960440|FG000|Overall Study|Lack of Efficacy|3|||
106080903|NCT00145509|365960441|FG001|Overall Study|Lack of Efficacy|1|||
106080904|NCT00145509|365960440|FG000|Overall Study|Lost to Follow-up|5|||
106080905|NCT00145509|365960441|FG001|Overall Study|Lost to Follow-up|9|||
106080906|NCT00145509|365960440|FG000|Overall Study|Withdrew Consent|2|||
106080907|NCT00145509|365960441|FG001|Overall Study|Withdrew Consent|7|||
106080908|NCT00145509|365960440|FG000|Overall Study|Reason not provided|2|||
106080909|NCT00145509|365960441|FG001|Overall Study|Reason not provided|1|||
106080910|NCT01359592|365960442|FG000|Initial Registration|Adverse Event|1|||
106080911|NCT01359592|365960443|FG001|Initial Registration|Adverse Event|0|||
106080912|NCT01359592|365960444|FG002|Initial Registration|Adverse Event|0|||
106080913|NCT01359592|365960445|FG003|Initial Registration|Adverse Event|0|||
106080914|NCT01359592|365960442|FG000|Initial Registration|Death|1|||
106080915|NCT01359592|365960443|FG001|Initial Registration|Death|0|||
106080916|NCT01359592|365960444|FG002|Initial Registration|Death|0|||
106080917|NCT01359592|365960445|FG003|Initial Registration|Death|0|||
106160359|NCT03720795|366247461|FG000|Phase 2|Protocol Violation|2|||
106160360|NCT03720795|366247461|FG000|3 Month Follow Up|Lost to Follow-up|2|||
106160361|NCT03891667|366247466|FG000|Overall Study|Physician Decision|1|||
106160362|NCT03891667|366247467|FG001|Overall Study|Physician Decision|1|||
106160363|NCT03891667|366247466|FG000|Overall Study|COVID related pause|1|||
106160364|NCT03891667|366247467|FG001|Overall Study|COVID related pause|0|||
106160365|NCT03891667|366247466|FG000|Overall Study|Withdrawal by Subject|0|||
106160366|NCT03891667|366247467|FG001|Overall Study|Withdrawal by Subject|1|||
106160367|NCT03891667|366247466|FG000|Overall Study|Adverse Event|0|||
106160368|NCT03891667|366247467|FG001|Overall Study|Adverse Event|1|||
106160369|NCT03018288|366247468|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
106160370|NCT03018288|366247469|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
106160371|NCT03018288|366247470|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
106160372|NCT03018288|366247471|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
106160373|NCT03018288|366247468|FG000|Overall Study|Participant withdrew consent.|0|||
106160374|NCT03018288|366247469|FG001|Overall Study|Participant withdrew consent.|0|||
106160375|NCT03018288|366247470|FG002|Overall Study|Participant withdrew consent.|1|||
106160376|NCT03018288|366247471|FG003|Overall Study|Participant withdrew consent.|0|||
106160377|NCT03018288|366247468|FG000|Overall Study|Switched to alternative treatment.|0|||
106160378|NCT03018288|366247469|FG001|Overall Study|Switched to alternative treatment.|0|||
106160379|NCT03018288|366247470|FG002|Overall Study|Switched to alternative treatment.|1|||
106160380|NCT03018288|366247471|FG003|Overall Study|Switched to alternative treatment.|0|||
106160381|NCT03018288|366247468|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
106160382|NCT03018288|366247469|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
106160383|NCT03018288|366247470|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
106160384|NCT03018288|366247471|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
106160385|NCT03018288|366247468|FG000|Overall Study|Screen failures|0|||
106160386|NCT03018288|366247469|FG001|Overall Study|Screen failures|0|||
106160387|NCT03018288|366247470|FG002|Overall Study|Screen failures|0|||
106160388|NCT03018288|366247471|FG003|Overall Study|Screen failures|51|||
106160389|NCT03018288|366247468|FG000|Overall Study|Chose treatment outside of UNC|0|||
106160390|NCT03018288|366247469|FG001|Overall Study|Chose treatment outside of UNC|0|||
106160391|NCT03018288|366247470|FG002|Overall Study|Chose treatment outside of UNC|0|||
106160392|NCT03018288|366247471|FG003|Overall Study|Chose treatment outside of UNC|1|||
106160393|NCT03018288|366247468|FG000|Overall Study|Unable to comply with protocol requirements|1|||
106160394|NCT03018288|366247469|FG001|Overall Study|Unable to comply with protocol requirements|1|||
106160395|NCT03018288|366247470|FG002|Overall Study|Unable to comply with protocol requirements|0|||
106160396|NCT03018288|366247471|FG003|Overall Study|Unable to comply with protocol requirements|1|||
106160397|NCT03018288|366247468|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
106160398|NCT03018288|366247469|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
106160399|NCT03018288|366247470|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
106160400|NCT03018288|366247471|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
106160401|NCT03018288|366247468|FG000|Overall Study|Physician Decision|0|||
106160402|NCT03018288|366247469|FG001|Overall Study|Physician Decision|0|||
106160403|NCT03018288|366247470|FG002|Overall Study|Physician Decision|0|||
106080918|NCT01359592|365960442|FG000|Initial Registration|Other reason not protocol specified|1|||
106080919|NCT01359592|365960443|FG001|Initial Registration|Other reason not protocol specified|0|||
106080920|NCT01359592|365960444|FG002|Initial Registration|Other reason not protocol specified|0|||
106080921|NCT01359592|365960445|FG003|Initial Registration|Other reason not protocol specified|0|||
106080922|NCT01359592|365960442|FG000|Initial Registration|Ineligible|26|||
106080923|NCT01359592|365960443|FG001|Initial Registration|Ineligible|0|||
106080924|NCT01359592|365960444|FG002|Initial Registration|Ineligible|0|||
106080925|NCT01359592|365960445|FG003|Initial Registration|Ineligible|0|||
106080926|NCT01359592|365960442|FG000|PET-Directed Therapy|Adverse Event|0|||
106080927|NCT01359592|365960443|FG001|PET-Directed Therapy|Adverse Event|0|||
106080928|NCT01359592|365960444|FG002|PET-Directed Therapy|Adverse Event|1|||
106080929|NCT01359592|365960445|FG003|PET-Directed Therapy|Adverse Event|0|||
106080930|NCT01359592|365960442|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
106080931|NCT01359592|365960443|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
106080932|NCT01359592|365960444|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
106080933|NCT01359592|365960445|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
106080934|NCT01359592|365960442|FG000|PET-Directed Therapy|Ineligible|0|||
106080935|NCT01359592|365960443|FG001|PET-Directed Therapy|Ineligible|0|||
106080936|NCT01359592|365960444|FG002|PET-Directed Therapy|Ineligible|24|||
106080937|NCT01359592|365960445|FG003|PET-Directed Therapy|Ineligible|0|||
106080938|NCT02919670|365960447|FG000|Overall Study|Only 17 participants met compliance|43|||
106080939|NCT02919670|365960448|FG001|Overall Study|Only 17 participants met compliance|39|||
106080940|NCT00910715|365960451|FG000|Overall Study|Lost to Follow-up|22|||
106080941|NCT00910715|365960452|FG001|Overall Study|Lost to Follow-up|26|||
106080942|NCT00910715|365960453|FG002|Overall Study|Lost to Follow-up|0|||
106080943|NCT01096784|365960456|FG000|Overall Study|Withdrawal by Subject|2|||
106080944|NCT01096784|365960457|FG001|Overall Study|Withdrawal by Subject|1|||
106080945|NCT01096784|365960456|FG000|Overall Study|Adverse Event|11|||
106080946|NCT01096784|365960457|FG001|Overall Study|Adverse Event|9|||
106080947|NCT01096784|365960456|FG000|Overall Study|Protocol Deviation|2|||
106080948|NCT01096784|365960457|FG001|Overall Study|Protocol Deviation|2|||
106080949|NCT01096784|365960456|FG000|Overall Study|Administrative Decision|0|||
106080950|NCT01096784|365960457|FG001|Overall Study|Administrative Decision|1|||
106080951|NCT01096784|365960456|FG000|Overall Study|Other Unspecified|0|||
106080952|NCT01096784|365960457|FG001|Overall Study|Other Unspecified|1|||
106080953|NCT05288556|365960472|FG000|Overall Study|Protocol Violation|1|||
106080954|NCT05288556|365960472|FG000|Overall Study|Withdrawal by Subject|1|||
106080955|NCT02465528|365960473|FG000|Overall Study|Progressive disease|0|||
106080956|NCT02465528|365960474|FG001|Overall Study|Progressive disease|2|||
106080957|NCT02465528|365960475|FG002|Overall Study|Progressive disease|9|||
106080958|NCT02465528|365960476|FG003|Overall Study|Progressive disease|4|||
106080959|NCT02465528|365960473|FG000|Overall Study|Study terminated by sponsor|1|||
106080960|NCT02465528|365960474|FG001|Overall Study|Study terminated by sponsor|2|||
106080961|NCT02465528|365960475|FG002|Overall Study|Study terminated by sponsor|0|||
106080962|NCT02465528|365960476|FG003|Overall Study|Study terminated by sponsor|0|||
106080963|NCT02465528|365960473|FG000|Overall Study|Withdrawal by Subject|0|||
106080964|NCT02465528|365960474|FG001|Overall Study|Withdrawal by Subject|0|||
106080965|NCT02465528|365960475|FG002|Overall Study|Withdrawal by Subject|2|||
106080966|NCT02465528|365960476|FG003|Overall Study|Withdrawal by Subject|0|||
106080967|NCT02465528|365960473|FG000|Overall Study|Adverse Event|0|||
106080968|NCT02465528|365960474|FG001|Overall Study|Adverse Event|0|||
106080969|NCT02465528|365960475|FG002|Overall Study|Adverse Event|0|||
106080970|NCT02465528|365960476|FG003|Overall Study|Adverse Event|1|||
106080971|NCT02465528|365960473|FG000|Overall Study|Physician Decision|0|||
106080972|NCT02465528|365960474|FG001|Overall Study|Physician Decision|0|||
106080973|NCT02465528|365960475|FG002|Overall Study|Physician Decision|1|||
106080974|NCT02465528|365960476|FG003|Overall Study|Physician Decision|0|||
106080975|NCT03752619|365960477|FG000|Overall Study|Lost to Follow-up|2|||
106080976|NCT03752619|365960478|FG001|Overall Study|Lost to Follow-up|1|||
106080977|NCT03752619|365960477|FG000|Overall Study|Withdrawal by Subject|1|||
106080978|NCT03752619|365960478|FG001|Overall Study|Withdrawal by Subject|1|||
106080979|NCT03752619|365960477|FG000|Overall Study|Adverse Event|0|||
106080980|NCT03752619|365960478|FG001|Overall Study|Adverse Event|1|||
106080981|NCT03907683|365960479|FG000|Overall Study|Pregnancy|1|||
106080982|NCT03907683|365960479|FG000|Overall Study|Withdrawal by Subject|1|||
106080983|NCT03400332|365960480|FG000|Pre-Treatment|Other reasons|0|||
106080984|NCT03400332|365960481|FG001|Pre-Treatment|Other reasons|0|||
106080985|NCT03400332|365960482|FG002|Pre-Treatment|Other reasons|0|||
106080986|NCT03400332|365960483|FG003|Pre-Treatment|Other reasons|0|||
106080987|NCT03400332|365960484|FG004|Pre-Treatment|Other reasons|0|||
106080988|NCT03400332|365960485|FG005|Pre-Treatment|Other reasons|0|||
106080989|NCT03400332|365960486|FG006|Pre-Treatment|Other reasons|0|||
106080990|NCT03400332|365960487|FG007|Pre-Treatment|Other reasons|0|||
106080991|NCT03400332|365960488|FG008|Pre-Treatment|Other reasons|1|||
106080992|NCT03400332|365960480|FG000|Pre-Treatment|No longer met study criteria|0|||
106080993|NCT03400332|365960481|FG001|Pre-Treatment|No longer met study criteria|0|||
106080994|NCT03400332|365960482|FG002|Pre-Treatment|No longer met study criteria|0|||
106080995|NCT03400332|365960483|FG003|Pre-Treatment|No longer met study criteria|0|||
106080996|NCT03400332|365960484|FG004|Pre-Treatment|No longer met study criteria|0|||
106080997|NCT03400332|365960485|FG005|Pre-Treatment|No longer met study criteria|0|||
106080998|NCT03400332|365960486|FG006|Pre-Treatment|No longer met study criteria|0|||
106080999|NCT03400332|365960487|FG007|Pre-Treatment|No longer met study criteria|0|||
106081000|NCT03400332|365960488|FG008|Pre-Treatment|No longer met study criteria|1|||
106081001|NCT03400332|365960480|FG000|Pre-Treatment|Withdrawal by Subject|0|||
106081002|NCT03400332|365960481|FG001|Pre-Treatment|Withdrawal by Subject|0|||
106081003|NCT03400332|365960482|FG002|Pre-Treatment|Withdrawal by Subject|0|||
106081004|NCT03400332|365960483|FG003|Pre-Treatment|Withdrawal by Subject|0|||
106081005|NCT03400332|365960484|FG004|Pre-Treatment|Withdrawal by Subject|0|||
106081006|NCT03400332|365960485|FG005|Pre-Treatment|Withdrawal by Subject|0|||
106081007|NCT03400332|365960486|FG006|Pre-Treatment|Withdrawal by Subject|0|||
106081008|NCT03400332|365960487|FG007|Pre-Treatment|Withdrawal by Subject|0|||
106081009|NCT03400332|365960488|FG008|Pre-Treatment|Withdrawal by Subject|1|||
106081010|NCT03400332|365960480|FG000|Treatment|Participant withdrew consent|2|||
106081011|NCT03400332|365960481|FG001|Treatment|Participant withdrew consent|2|||
106081012|NCT03400332|365960482|FG002|Treatment|Participant withdrew consent|0|||
106081013|NCT03400332|365960483|FG003|Treatment|Participant withdrew consent|0|||
106081014|NCT03400332|365960484|FG004|Treatment|Participant withdrew consent|3|||
106081015|NCT03400332|365960485|FG005|Treatment|Participant withdrew consent|3|||
106081016|NCT03400332|365960486|FG006|Treatment|Participant withdrew consent|1|||
106081017|NCT03400332|365960487|FG007|Treatment|Participant withdrew consent|1|||
106081018|NCT03400332|365960488|FG008|Treatment|Participant withdrew consent|1|||
106081019|NCT03400332|365960480|FG000|Treatment|Other reasons|0|||
106081020|NCT03400332|365960481|FG001|Treatment|Other reasons|1|||
106081021|NCT03400332|365960482|FG002|Treatment|Other reasons|1|||
106081022|NCT03400332|365960483|FG003|Treatment|Other reasons|0|||
106081023|NCT03400332|365960484|FG004|Treatment|Other reasons|3|||
106081024|NCT03400332|365960485|FG005|Treatment|Other reasons|1|||
106081025|NCT03400332|365960486|FG006|Treatment|Other reasons|2|||
106081026|NCT03400332|365960487|FG007|Treatment|Other reasons|0|||
106081027|NCT03400332|365960488|FG008|Treatment|Other reasons|1|||
106081028|NCT03400332|365960480|FG000|Treatment|Lost to Follow-up|0|||
106081029|NCT03400332|365960481|FG001|Treatment|Lost to Follow-up|1|||
106081030|NCT03400332|365960482|FG002|Treatment|Lost to Follow-up|0|||
106081031|NCT03400332|365960483|FG003|Treatment|Lost to Follow-up|0|||
106081032|NCT03400332|365960484|FG004|Treatment|Lost to Follow-up|0|||
106081033|NCT03400332|365960485|FG005|Treatment|Lost to Follow-up|0|||
106081034|NCT03400332|365960486|FG006|Treatment|Lost to Follow-up|0|||
106081035|NCT03400332|365960487|FG007|Treatment|Lost to Follow-up|0|||
106081036|NCT03400332|365960488|FG008|Treatment|Lost to Follow-up|0|||
106081037|NCT03400332|365960480|FG000|Treatment|Death|3|||
106081038|NCT03400332|365960481|FG001|Treatment|Death|1|||
106081039|NCT03400332|365960482|FG002|Treatment|Death|2|||
106081040|NCT03400332|365960483|FG003|Treatment|Death|3|||
106081041|NCT03400332|365960484|FG004|Treatment|Death|6|||
106081042|NCT03400332|365960485|FG005|Treatment|Death|2|||
106081043|NCT03400332|365960486|FG006|Treatment|Death|1|||
106081044|NCT03400332|365960487|FG007|Treatment|Death|3|||
106081045|NCT03400332|365960488|FG008|Treatment|Death|6|||
106081046|NCT02704364|365960489|FG000|Overall Study|Adverse Event|1|||
106081047|NCT02704364|365960490|FG001|Overall Study|Adverse Event|1|||
106081048|NCT02704364|365960491|FG002|Overall Study|Adverse Event|0|||
106081049|NCT02704364|365960489|FG000|Overall Study|Noncompliance with study drug|1|||
106081050|NCT02704364|365960490|FG001|Overall Study|Noncompliance with study drug|1|||
106081051|NCT02704364|365960491|FG002|Overall Study|Noncompliance with study drug|0|||
106081052|NCT02704364|365960489|FG000|Overall Study|Other|0|||
106081053|NCT02704364|365960490|FG001|Overall Study|Other|1|||
106081054|NCT02704364|365960491|FG002|Overall Study|Other|1|||
106081055|NCT02075840|365960492|FG000|Overall Study|Withdrawal by Subject|13|||
106081056|NCT02075840|365960493|FG001|Overall Study|Withdrawal by Subject|22|||
106081057|NCT02075840|365960492|FG000|Overall Study|Reason not specified|1|||
106081058|NCT02075840|365960493|FG001|Overall Study|Reason not specified|0|||
106081059|NCT02075840|365960492|FG000|Overall Study|Adverse Event|0|||
106081060|NCT02075840|365960493|FG001|Overall Study|Adverse Event|2|||
106081061|NCT02075840|365960492|FG000|Overall Study|Death|35|||
106081062|NCT02075840|365960493|FG001|Overall Study|Death|40|||
106081063|NCT02075840|365960492|FG000|Overall Study|Lost to Follow-up|3|||
106081064|NCT02075840|365960493|FG001|Overall Study|Lost to Follow-up|2|||
106081065|NCT02075840|365960492|FG000|Overall Study|Physician Decision|1|||
106081066|NCT02075840|365960493|FG001|Overall Study|Physician Decision|3|||
106081067|NCT02075840|365960492|FG000|Overall Study|Ongoing at CCOD|99|||
106081068|NCT02075840|365960493|FG001|Overall Study|Ongoing at CCOD|82|||
106081069|NCT03795610|365960495|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
106081070|NCT03795610|365960495|FG000|Overall Study|Withdrawal by Subject|1|||
106081071|NCT03795610|365960495|FG000|Overall Study|Screen Failure (Unknown)|1|||
106081072|NCT03909165|365960500|FG000|Overall Study|Physician Decision|0|||
106081073|NCT03909165|365960501|FG001|Overall Study|Physician Decision|1|||
106081074|NCT03909165|365960502|FG002|Overall Study|Physician Decision|0|||
106081075|NCT03909165|365960503|FG003|Overall Study|Physician Decision|0|||
105867076|NCT01482312|365163137|FG001|Period 1, 90 Minutes of Wear|Other|0|||
106081076|NCT03909165|365960504|FG004|Overall Study|Physician Decision|0|||
106081077|NCT03909165|365960500|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106081078|NCT03909165|365960501|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106081079|NCT03909165|365960502|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106081080|NCT03909165|365960503|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
106081081|NCT03909165|365960504|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
106081082|NCT03909165|365960500|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
106081083|NCT03909165|365960501|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
106081084|NCT03909165|365960502|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
106081085|NCT03909165|365960503|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
106081086|NCT03909165|365960504|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
106081087|NCT03909165|365960500|FG000|Overall Study|Previous Drug Exposure|0|||
106081088|NCT03909165|365960501|FG001|Overall Study|Previous Drug Exposure|0|||
106081089|NCT03909165|365960502|FG002|Overall Study|Previous Drug Exposure|1|||
106081090|NCT03909165|365960503|FG003|Overall Study|Previous Drug Exposure|0|||
106081091|NCT03909165|365960504|FG004|Overall Study|Previous Drug Exposure|0|||
106081092|NCT03909165|365960500|FG000|Overall Study|Early Discharge|1|||
106081093|NCT03909165|365960501|FG001|Overall Study|Early Discharge|0|||
106081094|NCT03909165|365960502|FG002|Overall Study|Early Discharge|0|||
106081095|NCT03909165|365960503|FG003|Overall Study|Early Discharge|0|||
106081096|NCT03909165|365960504|FG004|Overall Study|Early Discharge|0|||
106081097|NCT04627064|365960505|FG000|Overall Study|Progressive disease|8|||
106081098|NCT04627064|365960506|FG001|Overall Study|Progressive disease|0|||
106081099|NCT04627064|365960505|FG000|Overall Study|Withdrawal by Subject|2|||
106081100|NCT04627064|365960506|FG001|Overall Study|Withdrawal by Subject|0|||
106081101|NCT04627064|365960505|FG000|Overall Study|Physician Decision|1|||
106081102|NCT04627064|365960506|FG001|Overall Study|Physician Decision|0|||
106081103|NCT03762083|365960507|FG000|Overall Study|Withdrawal by Subject|2|||
106081104|NCT03762083|365960507|FG000|Overall Study|Physician Decision|1|||
106081105|NCT00006916|365960515|FG000|Overall Study|Device not inserted|4|||
106081106|NCT00006916|365960515|FG000|Overall Study|Complication of device insertion|1|||
106081107|NCT03044197|365960518|FG000|Overall Study|Withdrawal by Subject|3|||
106081108|NCT03044197|365960519|FG001|Overall Study|Withdrawal by Subject|1|||
106081109|NCT03829046|365960524|FG000|Overall Study|Withdrawal by Subject|1|||
106081110|NCT03829046|365960525|FG001|Overall Study|Withdrawal by Subject|0|||
106081111|NCT02469610|365960530|FG000|Overall Study|Death|1|||
106081112|NCT02469610|365960531|FG001|Overall Study|Death|0|||
106081113|NCT02469610|365960530|FG000|Overall Study|Lost to Follow-up|1|||
106081114|NCT02469610|365960531|FG001|Overall Study|Lost to Follow-up|0|||
106081115|NCT02469610|365960530|FG000|Overall Study|exclusion criteria|2|||
106081116|NCT02469610|365960531|FG001|Overall Study|exclusion criteria|1|||
106081117|NCT02448875|365960532|FG000|Overall Study|Adverse Event|2|||
106081118|NCT02448875|365960533|FG001|Overall Study|Adverse Event|1|||
106081119|NCT02448875|365960534|FG002|Overall Study|Adverse Event|0|||
106081120|NCT02448875|365960532|FG000|Overall Study|Lost to Follow-up|1|||
106081121|NCT02448875|365960533|FG001|Overall Study|Lost to Follow-up|0|||
106081122|NCT02448875|365960534|FG002|Overall Study|Lost to Follow-up|0|||
106081123|NCT02448875|365960532|FG000|Overall Study|Investigator Decision|3|||
106081124|NCT02448875|365960533|FG001|Overall Study|Investigator Decision|0|||
106081125|NCT02448875|365960534|FG002|Overall Study|Investigator Decision|1|||
106081126|NCT02448875|365960532|FG000|Overall Study|Withdrawal by Subject|1|||
106081127|NCT02448875|365960533|FG001|Overall Study|Withdrawal by Subject|0|||
106081128|NCT02448875|365960534|FG002|Overall Study|Withdrawal by Subject|0|||
106081129|NCT02908529|365960536|FG000|Overall Study|Lost to Follow-up|0|||
106081130|NCT02908529|365960537|FG001|Overall Study|Lost to Follow-up|2|||
106081131|NCT00689481|365960540|FG000|Overall Study|Adverse Event|7|||
106081132|NCT00689481|365960541|FG001|Overall Study|Adverse Event|1|||
106081133|NCT00689481|365960540|FG000|Overall Study|Lost to Follow-up|4|||
106081134|NCT00689481|365960541|FG001|Overall Study|Lost to Follow-up|3|||
106081135|NCT00689481|365960540|FG000|Overall Study|Lack of Efficacy|4|||
106081136|NCT00689481|365960541|FG001|Overall Study|Lack of Efficacy|3|||
106081137|NCT00689481|365960540|FG000|Overall Study|Non-compliance with study treatment|1|||
106081138|NCT00689481|365960541|FG001|Overall Study|Non-compliance with study treatment|1|||
106081139|NCT00689481|365960540|FG000|Overall Study|Withdrawal by Subject|8|||
106081140|NCT00689481|365960541|FG001|Overall Study|Withdrawal by Subject|4|||
106081141|NCT00689481|365960540|FG000|Overall Study|Excluded medication started during study|0|||
106081142|NCT00689481|365960541|FG001|Overall Study|Excluded medication started during study|1|||
106081143|NCT00689481|365960540|FG000|Overall Study|Subject early term, left on vacation|0|||
106081144|NCT00689481|365960541|FG001|Overall Study|Subject early term, left on vacation|1|||
106081145|NCT03551210|365960544|FG000|Overall Study|Adverse Event|5|||
106081146|NCT03551210|365960545|FG001|Overall Study|Adverse Event|6|||
106081147|NCT03551210|365960544|FG000|Overall Study|Withdrawal by Subject|1|||
106081148|NCT03551210|365960545|FG001|Overall Study|Withdrawal by Subject|7|||
106081149|NCT03551210|365960544|FG000|Overall Study|Needed in other antibiotic treatment|2|||
106081150|NCT03551210|365960545|FG001|Overall Study|Needed in other antibiotic treatment|5|||
106081151|NCT03551210|365960544|FG000|Overall Study|Lost to Follow-up|1|||
106081152|NCT03551210|365960545|FG001|Overall Study|Lost to Follow-up|1|||
106081153|NCT03551210|365960544|FG000|Overall Study|Absence of visit 4 and 5|1|||
106081154|NCT03551210|365960545|FG001|Overall Study|Absence of visit 4 and 5|0|||
106081155|NCT03551210|365960544|FG000|Overall Study|No drug for dispensing|0|||
106081156|NCT03551210|365960545|FG001|Overall Study|No drug for dispensing|1|||
106081157|NCT02239536|365960546|FG000|Overall Study|Non-neoplastic polyp|23|||
106081158|NCT02239536|365960547|FG001|Overall Study|Non-neoplastic polyp|17|||
106081159|NCT04074317|365960548|FG000|Third Period|Withdrawal by Subject|0|||
106081160|NCT04074317|365960549|FG001|Third Period|Withdrawal by Subject|0|||
106081161|NCT04074317|365960550|FG002|Third Period|Withdrawal by Subject|0|||
106081162|NCT04074317|365960551|FG003|Third Period|Withdrawal by Subject|1|||
106081163|NCT04074317|365960552|FG004|Third Period|Withdrawal by Subject|0|||
106081164|NCT04074317|365960553|FG005|Third Period|Withdrawal by Subject|0|||
106081165|NCT05458856|365961177|FG000|Overall Study|Withdrawal by Subject|5|||
106081166|NCT05458856|365961177|FG000|Overall Study|Death|4|||
105867077|NCT01482312|365163138|FG002|Period 1, 90 Minutes of Wear|Other|0|||
105867078|NCT01482312|365163136|FG000|Period 2, 90 Minutes of Wear|Other|1|||
105867079|NCT01482312|365163137|FG001|Period 2, 90 Minutes of Wear|Other|0|||
105867080|NCT01482312|365163138|FG002|Period 2, 90 Minutes of Wear|Other|0|||
106081167|NCT05458856|365961177|FG000|Overall Study|Protocol Deviation|3|||
106081168|NCT05458856|365961177|FG000|Overall Study|Physician Decision|1|||
106081169|NCT05308901|365961178|FG000|Overall Study|Death|6|||
106081170|NCT04904185|365961183|FG000|Overall Study|Expansion failure|1|||
106081171|NCT04904185|365961184|FG001|Overall Study|Expansion failure|0|||
106081172|NCT04904185|365961183|FG000|Overall Study|Late response on prior treatment|1|||
106081173|NCT04904185|365961184|FG001|Overall Study|Late response on prior treatment|0|||
106081174|NCT03761628|365961185|FG000|Overall Study|Withdrawal by Subject|3|||
106081175|NCT03761628|365961185|FG000|Overall Study|Physician Decision|1|||
106081176|NCT03761628|365961185|FG000|Overall Study|Pregnancy|1|||
106081177|NCT03761628|365961185|FG000|Overall Study|Lost to Follow-up|1|||
106081178|NCT04656652|365961186|FG000|Overall Study|Lost to Follow-up|2|||
106081179|NCT04656652|365961187|FG001|Overall Study|Lost to Follow-up|2|||
106081180|NCT04656652|365961186|FG000|Overall Study|Death|213|||
106081181|NCT04656652|365961187|FG001|Overall Study|Death|212|||
106081182|NCT04656652|365961186|FG000|Overall Study|Other|1|||
106081183|NCT04656652|365961187|FG001|Overall Study|Other|0|||
106081184|NCT04656652|365961186|FG000|Overall Study|Withdrawal by Subject|15|||
106081185|NCT04656652|365961187|FG001|Overall Study|Withdrawal by Subject|29|||
106081186|NCT02975934|365961188|FG000|Treatment Phase|Never initiated study drug|0|||
106081187|NCT02975934|365961189|FG001|Treatment Phase|Never initiated study drug|5|||
106081188|NCT02975934|365961190|FG002|Treatment Phase|Never initiated study drug|0|||
106081189|NCT01403974|365961191|FG000|Overall Study|Progressive disease according to RECIST|3|||
106081190|NCT01403974|365961192|FG001|Overall Study|Progressive disease according to RECIST|3|||
106081191|NCT01403974|365961193|FG002|Overall Study|Progressive disease according to RECIST|2|||
106081192|NCT01403974|365961194|FG003|Overall Study|Progressive disease according to RECIST|3|||
106081193|NCT01403974|365961195|FG004|Overall Study|Progressive disease according to RECIST|3|||
106081194|NCT01403974|365961196|FG005|Overall Study|Progressive disease according to RECIST|2|||
106081195|NCT01403974|365961197|FG006|Overall Study|Progressive disease according to RECIST|3|||
106081196|NCT01403974|365961198|FG007|Overall Study|Progressive disease according to RECIST|2|||
106160404|NCT03018288|366247471|FG003|Overall Study|Physician Decision|1|||
106160405|NCT05134233|366247476|FG000|Overall Study|Pregnancy|1|||
106160406|NCT05134233|366247476|FG000|Overall Study|MEP value too low|2|||
106160407|NCT05134233|366247476|FG000|Overall Study|Lost to Follow-up|1|||
106160408|NCT01573442|366247477|FG000|Overall Study|Cancels|9|||
106160409|NCT01573442|366247478|FG001|Overall Study|Cancels|10|||
106160410|NCT05710107|366247490|FG000|Overall Study|Withdrawal by Subject|1|||
106160411|NCT05710107|366247491|FG001|Overall Study|Withdrawal by Subject|1|||
106160412|NCT05710107|366247490|FG000|Overall Study|Lost to Follow-up|8|||
106160413|NCT05710107|366247491|FG001|Overall Study|Lost to Follow-up|9|||
106160414|NCT05710107|366247490|FG000|Overall Study|Unable to place assigned block|2|||
106160415|NCT05710107|366247491|FG001|Overall Study|Unable to place assigned block|0|||
106160416|NCT05710107|366247490|FG000|Overall Study|Withdrawn by study team|0|||
106160417|NCT05710107|366247491|FG001|Overall Study|Withdrawn by study team|1|||
106160418|NCT02724631|366247492|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
106160419|NCT04166773|366247493|FG000|Overall Study|Adverse Event|2|||
106160420|NCT04166773|366247494|FG001|Overall Study|Adverse Event|0|||
106160421|NCT04166773|366247495|FG002|Overall Study|Adverse Event|2|||
106160422|NCT04166773|366247496|FG003|Overall Study|Adverse Event|1|||
106160423|NCT04166773|366247493|FG000|Overall Study|Lost to Follow-up|4|||
106160424|NCT04166773|366247494|FG001|Overall Study|Lost to Follow-up|2|||
106160425|NCT04166773|366247495|FG002|Overall Study|Lost to Follow-up|1|||
106160426|NCT04166773|366247496|FG003|Overall Study|Lost to Follow-up|3|||
106160427|NCT04166773|366247493|FG000|Overall Study|Physician Decision|0|||
106160428|NCT04166773|366247494|FG001|Overall Study|Physician Decision|0|||
106160429|NCT04166773|366247495|FG002|Overall Study|Physician Decision|0|||
106160430|NCT04166773|366247496|FG003|Overall Study|Physician Decision|1|||
106081197|NCT01403974|365961199|FG008|Overall Study|Progressive disease according to RECIST|6|||
106081198|NCT01403974|365961200|FG009|Overall Study|Progressive disease according to RECIST|2|||
106081199|NCT01403974|365961201|FG010|Overall Study|Progressive disease according to RECIST|3|||
106081200|NCT01403974|365961202|FG011|Overall Study|Progressive disease according to RECIST|2|||
106081201|NCT01403974|365961203|FG012|Overall Study|Progressive disease according to RECIST|2|||
106081202|NCT01403974|365961204|FG013|Overall Study|Progressive disease according to RECIST|3|||
106081203|NCT01403974|365961205|FG014|Overall Study|Progressive disease according to RECIST|1|||
106081204|NCT01403974|365961206|FG015|Overall Study|Progressive disease according to RECIST|8|||
106081205|NCT01403974|365961191|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
106081206|NCT01403974|365961192|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
106160431|NCT04166773|366247493|FG000|Overall Study|Withdrawal by Subject|1|||
106160432|NCT04166773|366247494|FG001|Overall Study|Withdrawal by Subject|1|||
106160433|NCT04166773|366247495|FG002|Overall Study|Withdrawal by Subject|2|||
106160434|NCT04166773|366247496|FG003|Overall Study|Withdrawal by Subject|5|||
106160435|NCT04072822|366247497|FG000|Treatment|Adverse Event|9|||
106160436|NCT04072822|366247498|FG001|Treatment|Adverse Event|5|||
105867081|NCT00952731|365163139|FG000|Overall Study|Drug supply expired|1|||
105867082|NCT00952731|365163140|FG001|Overall Study|Drug supply expired|0|||
105867083|NCT04895982|365163141|FG000|Overall Study|Withdrawal by Subject|0|||
105867084|NCT04895982|365163142|FG001|Overall Study|Withdrawal by Subject|0|||
105867085|NCT04895982|365163143|FG002|Overall Study|Withdrawal by Subject|0|||
105867086|NCT04895982|365163144|FG003|Overall Study|Withdrawal by Subject|0|||
105867087|NCT04895982|365163145|FG004|Overall Study|Withdrawal by Subject|0|||
105867088|NCT04895982|365163146|FG005|Overall Study|Withdrawal by Subject|1|||
105867089|NCT04895982|365163147|FG006|Overall Study|Withdrawal by Subject|1|||
106081207|NCT01403974|365961193|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
106081208|NCT01403974|365961194|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
106081209|NCT01403974|365961195|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
106081210|NCT01403974|365961196|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
106081211|NCT01403974|365961197|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
106081212|NCT01403974|365961198|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
106081213|NCT01403974|365961199|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
106081214|NCT01403974|365961200|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
106081215|NCT01403974|365961201|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
106081216|NCT01403974|365961202|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
106081217|NCT01403974|365961203|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
106081218|NCT01403974|365961204|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
106081219|NCT01403974|365961205|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
106081220|NCT01403974|365961206|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
106081221|NCT01403974|365961191|FG000|Overall Study|Refused to continue study medication|0|||
106081222|NCT01403974|365961192|FG001|Overall Study|Refused to continue study medication|0|||
106081223|NCT01403974|365961193|FG002|Overall Study|Refused to continue study medication|0|||
106081224|NCT01403974|365961194|FG003|Overall Study|Refused to continue study medication|0|||
106081225|NCT01403974|365961195|FG004|Overall Study|Refused to continue study medication|0|||
106081226|NCT01403974|365961196|FG005|Overall Study|Refused to continue study medication|1|||
106081227|NCT01403974|365961197|FG006|Overall Study|Refused to continue study medication|0|||
106081228|NCT01403974|365961198|FG007|Overall Study|Refused to continue study medication|0|||
106081229|NCT01403974|365961199|FG008|Overall Study|Refused to continue study medication|1|||
106081230|NCT01403974|365961200|FG009|Overall Study|Refused to continue study medication|0|||
106081231|NCT01403974|365961201|FG010|Overall Study|Refused to continue study medication|1|||
106081232|NCT01403974|365961202|FG011|Overall Study|Refused to continue study medication|0|||
106081233|NCT01403974|365961203|FG012|Overall Study|Refused to continue study medication|0|||
106081234|NCT01403974|365961204|FG013|Overall Study|Refused to continue study medication|0|||
106081235|NCT01403974|365961205|FG014|Overall Study|Refused to continue study medication|0|||
106081236|NCT01403974|365961206|FG015|Overall Study|Refused to continue study medication|4|||
106081237|NCT01403974|365961191|FG000|Overall Study|Adverse Event|0|||
106081238|NCT01403974|365961192|FG001|Overall Study|Adverse Event|0|||
106081239|NCT01403974|365961193|FG002|Overall Study|Adverse Event|1|||
106081240|NCT01403974|365961194|FG003|Overall Study|Adverse Event|0|||
106081241|NCT01403974|365961195|FG004|Overall Study|Adverse Event|0|||
106081242|NCT01403974|365961196|FG005|Overall Study|Adverse Event|0|||
106081243|NCT01403974|365961197|FG006|Overall Study|Adverse Event|0|||
106081244|NCT01403974|365961198|FG007|Overall Study|Adverse Event|1|||
106081245|NCT01403974|365961199|FG008|Overall Study|Adverse Event|0|||
106081246|NCT01403974|365961200|FG009|Overall Study|Adverse Event|0|||
106081247|NCT01403974|365961201|FG010|Overall Study|Adverse Event|0|||
106081248|NCT01403974|365961202|FG011|Overall Study|Adverse Event|0|||
106081249|NCT01403974|365961203|FG012|Overall Study|Adverse Event|1|||
106081250|NCT01403974|365961204|FG013|Overall Study|Adverse Event|0|||
106081251|NCT01403974|365961205|FG014|Overall Study|Adverse Event|0|||
106081252|NCT01403974|365961206|FG015|Overall Study|Adverse Event|0|||
106081253|NCT01403974|365961191|FG000|Overall Study|Other than specified|0|||
106081254|NCT01403974|365961192|FG001|Overall Study|Other than specified|0|||
106081255|NCT01403974|365961193|FG002|Overall Study|Other than specified|0|||
106081256|NCT01403974|365961194|FG003|Overall Study|Other than specified|0|||
106081257|NCT01403974|365961195|FG004|Overall Study|Other than specified|0|||
106081258|NCT01403974|365961196|FG005|Overall Study|Other than specified|0|||
106081259|NCT01403974|365961197|FG006|Overall Study|Other than specified|0|||
106081260|NCT01403974|365961198|FG007|Overall Study|Other than specified|0|||
106081261|NCT01403974|365961199|FG008|Overall Study|Other than specified|0|||
106081262|NCT01403974|365961200|FG009|Overall Study|Other than specified|1|||
106081263|NCT01403974|365961201|FG010|Overall Study|Other than specified|0|||
106081264|NCT01403974|365961202|FG011|Overall Study|Other than specified|1|||
105867090|NCT04895982|365163148|FG007|Overall Study|Withdrawal by Subject|0|||
105867091|NCT04895982|365163149|FG008|Overall Study|Withdrawal by Subject|0|||
105867092|NCT04895982|365163150|FG009|Overall Study|Withdrawal by Subject|1|||
105867093|NCT04895982|365163151|FG010|Overall Study|Withdrawal by Subject|0|||
106081265|NCT01403974|365961203|FG012|Overall Study|Other than specified|0|||
106081266|NCT01403974|365961204|FG013|Overall Study|Other than specified|0|||
105867094|NCT04895982|365163152|FG011|Overall Study|Withdrawal by Subject|1|||
105867095|NCT04895982|365163141|FG000|Overall Study|Withdrawal by parent/guardian|2|||
105867096|NCT04895982|365163142|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105867097|NCT04895982|365163143|FG002|Overall Study|Withdrawal by parent/guardian|3|||
105867098|NCT04895982|365163144|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105867099|NCT04895982|365163145|FG004|Overall Study|Withdrawal by parent/guardian|3|||
106081267|NCT01403974|365961205|FG014|Overall Study|Other than specified|0|||
105867100|NCT04895982|365163146|FG005|Overall Study|Withdrawal by parent/guardian|2|||
106081268|NCT01403974|365961206|FG015|Overall Study|Other than specified|0|||
106081269|NCT02681302|365961207|FG000|Overall Study|Withdrawal by Subject|1|||
106081270|NCT02681302|365961208|FG001|Overall Study|Withdrawal by Subject|1|||
106081271|NCT02681302|365961209|FG002|Overall Study|Withdrawal by Subject|0|||
106081272|NCT02681302|365961210|FG003|Overall Study|Withdrawal by Subject|0|||
106081273|NCT02681302|365961211|FG004|Overall Study|Withdrawal by Subject|1|||
106081274|NCT02681302|365961212|FG005|Overall Study|Withdrawal by Subject|0|||
106081275|NCT02681302|365961207|FG000|Overall Study|Screen Failure|2|||
106081276|NCT02681302|365961208|FG001|Overall Study|Screen Failure|4|||
106081277|NCT02681302|365961209|FG002|Overall Study|Screen Failure|2|||
106081278|NCT02681302|365961210|FG003|Overall Study|Screen Failure|0|||
106081279|NCT02681302|365961211|FG004|Overall Study|Screen Failure|1|||
106081280|NCT02681302|365961212|FG005|Overall Study|Screen Failure|1|||
106081281|NCT02681302|365961207|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
106081282|NCT02681302|365961208|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
106081283|NCT02681302|365961209|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
106081284|NCT02681302|365961210|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
106081285|NCT02681302|365961211|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
106081286|NCT02681302|365961212|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
106081287|NCT03706690|365961215|FG000|Overall Study|Withdrawal by Subject|8|||
106081288|NCT03706690|365961216|FG001|Overall Study|Withdrawal by Subject|8|||
106081289|NCT03706690|365961215|FG000|Overall Study|Death|143|||
106081290|NCT03706690|365961216|FG001|Overall Study|Death|75|||
106081291|NCT03706690|365961215|FG000|Overall Study|Ongoing at DCO|121|||
106081292|NCT03706690|365961216|FG001|Overall Study|Ongoing at DCO|52|||
106081293|NCT05569954|365961218|FG000|Overall Study|Lost to Follow-up|3|||
106081294|NCT05569954|365961219|FG001|Overall Study|Lost to Follow-up|4|||
106081295|NCT05569954|365961218|FG000|Overall Study|Protocol Violation|1|||
106081296|NCT05569954|365961219|FG001|Overall Study|Protocol Violation|2|||
106081297|NCT05569954|365961218|FG000|Overall Study|Withdrawal by Subject|4|||
106081298|NCT05569954|365961219|FG001|Overall Study|Withdrawal by Subject|2|||
106081299|NCT02254278|365961220|FG000|Overall Study|Protocol Violation|1|||
106081300|NCT02254278|365961221|FG001|Overall Study|Protocol Violation|1|||
106081301|NCT04579679|365961224|FG000|Overall Study|New Antitumor Therapy|6|||
106081302|NCT04579679|365961225|FG001|Overall Study|New Antitumor Therapy|4|||
106081303|NCT04579679|365961226|FG002|Overall Study|New Antitumor Therapy|7|||
106081304|NCT04579679|365961227|FG003|Overall Study|New Antitumor Therapy|0|||
106081305|NCT04579679|365961224|FG000|Overall Study|Withdrawal of Consent|1|||
106081306|NCT04579679|365961225|FG001|Overall Study|Withdrawal of Consent|1|||
106081307|NCT04579679|365961226|FG002|Overall Study|Withdrawal of Consent|2|||
106081308|NCT04579679|365961227|FG003|Overall Study|Withdrawal of Consent|4|||
106081309|NCT04579679|365961224|FG000|Overall Study|Death|2|||
106081310|NCT04579679|365961225|FG001|Overall Study|Death|2|||
106081311|NCT04579679|365961226|FG002|Overall Study|Death|2|||
106081312|NCT04579679|365961227|FG003|Overall Study|Death|0|||
106081313|NCT04579679|365961224|FG000|Overall Study|Adverse Event|0|||
106081314|NCT04579679|365961225|FG001|Overall Study|Adverse Event|4|||
106081315|NCT04579679|365961226|FG002|Overall Study|Adverse Event|0|||
106081316|NCT04579679|365961227|FG003|Overall Study|Adverse Event|0|||
106081317|NCT04579679|365961224|FG000|Overall Study|Disease Progression|9|||
106081318|NCT04579679|365961225|FG001|Overall Study|Disease Progression|13|||
106081319|NCT04579679|365961226|FG002|Overall Study|Disease Progression|7|||
106081320|NCT04579679|365961227|FG003|Overall Study|Disease Progression|0|||
106081321|NCT04579679|365961224|FG000|Overall Study|Physician Decision|0|||
106081322|NCT04579679|365961225|FG001|Overall Study|Physician Decision|0|||
106081323|NCT04579679|365961226|FG002|Overall Study|Physician Decision|1|||
106081324|NCT04579679|365961227|FG003|Overall Study|Physician Decision|0|||
106081325|NCT04579679|365961224|FG000|Overall Study|Study Terminated by Sponsor|2|||
106081326|NCT04579679|365961225|FG001|Overall Study|Study Terminated by Sponsor|7|||
106081327|NCT04579679|365961226|FG002|Overall Study|Study Terminated by Sponsor|1|||
106081328|NCT04579679|365961227|FG003|Overall Study|Study Terminated by Sponsor|0|||
106081329|NCT03316872|365961228|FG000|Overall Study|Death|1|||
106081330|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
106081331|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
106081332|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
106081333|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Death|1|||
105867101|NCT04895982|365163147|FG006|Overall Study|Withdrawal by parent/guardian|1|||
106081334|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Death|0|||
106081335|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Death|0|||
106081336|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
106081337|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
106081338|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
106081339|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
106081340|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
106081341|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
106081342|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
106081343|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
106081344|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
106081345|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
106081346|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
106081347|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
106081348|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
106081349|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
106081350|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
106081351|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
106081352|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
106081353|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
106081354|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
106081355|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
106081356|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
106081357|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
106081358|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
106081359|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
106081360|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
106081361|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
106081362|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
106081363|NCT03655236|365961229|FG000|Subject Disposition in Part 1 Period|Other|0|||
106081364|NCT03655236|365961230|FG001|Subject Disposition in Part 1 Period|Other|2|||
106081365|NCT03655236|365961231|FG002|Subject Disposition in Part 1 Period|Other|2|||
106081366|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
106081367|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
106081368|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
106081369|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
106081370|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
106081371|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
106081372|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
106081373|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
106081374|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
106081375|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
106081376|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
106081377|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
106081378|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
106081379|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
106081380|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
106081381|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
106081382|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
106081383|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
106081384|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
106081385|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
106081386|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
106081387|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
106081388|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
106081389|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
106081390|NCT03655236|365961229|FG000|Subject Disposition in Part 2 Period|Other|1|||
106081391|NCT03655236|365961230|FG001|Subject Disposition in Part 2 Period|Other|0|||
106081392|NCT03655236|365961231|FG002|Subject Disposition in Part 2 Period|Other|0|||
106081393|NCT03912233|365962139|FG000|Overall Study|Adverse Event|1|||
106081394|NCT03912233|365962140|FG001|Overall Study|Adverse Event|0|||
106081395|NCT03912233|365962141|FG002|Overall Study|Adverse Event|0|||
106081396|NCT03912233|365962142|FG003|Overall Study|Adverse Event|0|||
106081397|NCT03912233|365962143|FG004|Overall Study|Adverse Event|0|||
106081398|NCT03912233|365962144|FG005|Overall Study|Adverse Event|0|||
106081399|NCT03912233|365962139|FG000|Overall Study|Physician Decision|1|||
106081400|NCT03912233|365962140|FG001|Overall Study|Physician Decision|0|||
106081401|NCT03912233|365962141|FG002|Overall Study|Physician Decision|0|||
106081402|NCT03912233|365962142|FG003|Overall Study|Physician Decision|0|||
106081403|NCT03912233|365962143|FG004|Overall Study|Physician Decision|0|||
106081404|NCT03912233|365962144|FG005|Overall Study|Physician Decision|0|||
106081405|NCT03912233|365962139|FG000|Overall Study|Other|0|||
106081406|NCT03912233|365962140|FG001|Overall Study|Other|0|||
106081407|NCT03912233|365962141|FG002|Overall Study|Other|0|||
106081408|NCT03912233|365962142|FG003|Overall Study|Other|0|||
106081409|NCT03912233|365962143|FG004|Overall Study|Other|7|||
106081410|NCT03912233|365962144|FG005|Overall Study|Other|12|||
106081411|NCT00326911|365962145|FG000|Overall Study|Hospitalization prior to treatment|0|||
106081412|NCT00326911|365962146|FG001|Overall Study|Hospitalization prior to treatment|1|||
106081413|NCT00326911|365962145|FG000|Overall Study|Physician decision prior to treatment|1|||
106081414|NCT00326911|365962146|FG001|Overall Study|Physician decision prior to treatment|0|||
106081415|NCT00326911|365962145|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
106081416|NCT00326911|365962146|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
106081417|NCT00519649|365962147|FG000|Overall Study|Withdrawal by Subject|1|||
106081418|NCT02953821|365962148|FG000|Overall Study|Adverse Event|0|||
106081419|NCT02953821|365962149|FG001|Overall Study|Adverse Event|4|||
106081420|NCT02953821|365962148|FG000|Overall Study|Death|1|||
106081421|NCT02953821|365962149|FG001|Overall Study|Death|0|||
106081422|NCT02953821|365962148|FG000|Overall Study|Progressive Disease|5|||
106081423|NCT02953821|365962149|FG001|Overall Study|Progressive Disease|1|||
106081424|NCT02953821|365962148|FG000|Overall Study|Lost to Follow-up|2|||
106081425|NCT02953821|365962149|FG001|Overall Study|Lost to Follow-up|0|||
106081426|NCT02953821|365962148|FG000|Overall Study|Physician Decision|1|||
106081427|NCT02953821|365962149|FG001|Overall Study|Physician Decision|1|||
106081428|NCT02953821|365962148|FG000|Overall Study|Withdrawal by Subject|3|||
106081429|NCT02953821|365962149|FG001|Overall Study|Withdrawal by Subject|3|||
106081430|NCT02953821|365962148|FG000|Overall Study|Change of address|0|||
106081431|NCT02953821|365962149|FG001|Overall Study|Change of address|1|||
106081432|NCT02953821|365962148|FG000|Overall Study|Lack of Efficacy|1|||
106081433|NCT02953821|365962149|FG001|Overall Study|Lack of Efficacy|0|||
106081434|NCT02953821|365962148|FG000|Overall Study|Out of state for indeterminate time|0|||
106081435|NCT02953821|365962149|FG001|Overall Study|Out of state for indeterminate time|1|||
106081436|NCT02953821|365962148|FG000|Overall Study|No improvement|0|||
106081437|NCT02953821|365962149|FG001|Overall Study|No improvement|1|||
106081438|NCT02953821|365962148|FG000|Overall Study|Refused follow-up visit|2|||
106081439|NCT02953821|365962149|FG001|Overall Study|Refused follow-up visit|1|||
106081440|NCT00826267|365962150|FG000|Overall Study|Other Adverse Event|1|||
106081441|NCT00826267|365962151|FG001|Overall Study|Other Adverse Event|0|||
106081442|NCT00826267|365962152|FG002|Overall Study|Other Adverse Event|0|||
106081443|NCT01470469|365962153|FG000|Overall Study|Withdrawal by Subject|4|||
106081444|NCT01470469|365962154|FG001|Overall Study|Withdrawal by Subject|6|||
106081445|NCT01470469|365962153|FG000|Overall Study|Lack of Efficacy|1|||
106081446|NCT01470469|365962154|FG001|Overall Study|Lack of Efficacy|7|||
106081447|NCT01470469|365962153|FG000|Overall Study|Adverse Event|0|||
106081448|NCT01470469|365962154|FG001|Overall Study|Adverse Event|7|||
106081449|NCT01470469|365962153|FG000|Overall Study|Lost to Follow-up|2|||
106081450|NCT01470469|365962154|FG001|Overall Study|Lost to Follow-up|2|||
106081451|NCT01470469|365962153|FG000|Overall Study|Protocol Violation|1|||
106081452|NCT01470469|365962154|FG001|Overall Study|Protocol Violation|1|||
106081453|NCT01470469|365962153|FG000|Overall Study|Other|2|||
106081454|NCT01470469|365962154|FG001|Overall Study|Other|1|||
106081455|NCT02579616|365962155|FG000|Overall Study|Participants did not receive treatment|3|||
106081456|NCT01350128|365962160|FG000|Overall Study|Withdrawal by Subject|3|||
106081457|NCT01350128|365962160|FG000|Overall Study|Protocol discontinuation criteria|8|||
106081458|NCT01350128|365962160|FG000|Overall Study|Physician Decision|1|||
106081459|NCT01350128|365962160|FG000|Overall Study|Lost to Follow-up|2|||
105867102|NCT04895982|365163148|FG007|Overall Study|Withdrawal by parent/guardian|0|||
106081460|NCT01428193|365962161|FG000|Overall Study|Physician Decision|1|||
106081461|NCT01428193|365962161|FG000|Overall Study|Elevated screening liver enzymes|1|||
106081462|NCT00099437|365962164|FG000|Overall Study|Lost to Follow-up|30|||
106081463|NCT00099437|365962165|FG001|Overall Study|Lost to Follow-up|33|||
106081464|NCT00099437|365962164|FG000|Overall Study|Death|293|||
106081465|NCT00099437|365962165|FG001|Overall Study|Death|261|||
106081466|NCT00099437|365962164|FG000|Overall Study|Withdrawal by Subject|6|||
106081467|NCT00099437|365962165|FG001|Overall Study|Withdrawal by Subject|10|||
106081468|NCT00099437|365962164|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
106081469|NCT00099437|365962165|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
106081470|NCT03047135|365962168|FG000|Overall Study|Still being treated|3|||
106081471|NCT02552316|365962171|FG000|Overall Study|Withdrawal by Subject|1|||
106081472|NCT02552316|365962171|FG000|Overall Study|Withdrawal due to non-compliance|1|||
106081473|NCT01120210|365962172|FG000|MAIN INFUSION|Adverse Event|1|||
106081474|NCT01120210|365962173|FG001|MAIN INFUSION|Adverse Event|0|||
106081475|NCT01120210|365962172|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
106081476|NCT01120210|365962173|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
106081477|NCT02043015|365962176|FG000|Overall Study|Lost to Follow-up|4|||
106081478|NCT02043015|365962176|FG000|Overall Study|Withdrawal by Subject|4|||
106081479|NCT02043015|365962176|FG000|Overall Study|Removed once target enrollment reached|15|||
106081480|NCT02043015|365962176|FG000|Overall Study|Participant moved away from study city|4|||
106081481|NCT02043015|365962176|FG000|Overall Study|Incarceration|1|||
106081482|NCT02457598|365962178|FG000|Overall Study|Progressive Disease|2|||
106081483|NCT02457598|365962179|FG001|Overall Study|Progressive Disease|2|||
106081484|NCT02457598|365962180|FG002|Overall Study|Progressive Disease|1|||
106081485|NCT02457598|365962181|FG003|Overall Study|Progressive Disease|11|||
106081486|NCT02457598|365962182|FG004|Overall Study|Progressive Disease|7|||
106081487|NCT02457598|365962183|FG005|Overall Study|Progressive Disease|3|||
106081488|NCT02457598|365962184|FG006|Overall Study|Progressive Disease|2|||
106081489|NCT02457598|365962185|FG007|Overall Study|Progressive Disease|1|||
106081490|NCT02457598|365962186|FG008|Overall Study|Progressive Disease|1|||
106081491|NCT02457598|365962187|FG009|Overall Study|Progressive Disease|2|||
106081492|NCT02457598|365962188|FG010|Overall Study|Progressive Disease|45|||
106081493|NCT02457598|365962189|FG011|Overall Study|Progressive Disease|6|||
106081494|NCT02457598|365962190|FG012|Overall Study|Progressive Disease|2|||
106081495|NCT02457598|365962191|FG013|Overall Study|Progressive Disease|2|||
106081496|NCT02457598|365962192|FG014|Overall Study|Progressive Disease|10|||
106081497|NCT02457598|365962193|FG015|Overall Study|Progressive Disease|1|||
106081498|NCT02457598|365962194|FG016|Overall Study|Progressive Disease|1|||
106081499|NCT02457598|365962178|FG000|Overall Study|Investigator's Discretion|0|||
106081500|NCT02457598|365962179|FG001|Overall Study|Investigator's Discretion|2|||
106081501|NCT02457598|365962180|FG002|Overall Study|Investigator's Discretion|2|||
106081502|NCT02457598|365962181|FG003|Overall Study|Investigator's Discretion|2|||
106081503|NCT02457598|365962182|FG004|Overall Study|Investigator's Discretion|0|||
106081504|NCT02457598|365962183|FG005|Overall Study|Investigator's Discretion|0|||
106081505|NCT02457598|365962184|FG006|Overall Study|Investigator's Discretion|0|||
106081506|NCT02457598|365962185|FG007|Overall Study|Investigator's Discretion|1|||
106081507|NCT02457598|365962186|FG008|Overall Study|Investigator's Discretion|2|||
106081508|NCT02457598|365962187|FG009|Overall Study|Investigator's Discretion|0|||
106081509|NCT02457598|365962188|FG010|Overall Study|Investigator's Discretion|10|||
106081510|NCT02457598|365962189|FG011|Overall Study|Investigator's Discretion|2|||
106081511|NCT02457598|365962190|FG012|Overall Study|Investigator's Discretion|2|||
106081512|NCT02457598|365962191|FG013|Overall Study|Investigator's Discretion|1|||
106081513|NCT02457598|365962192|FG014|Overall Study|Investigator's Discretion|5|||
106081514|NCT02457598|365962193|FG015|Overall Study|Investigator's Discretion|0|||
106081515|NCT02457598|365962194|FG016|Overall Study|Investigator's Discretion|0|||
106081516|NCT02457598|365962178|FG000|Overall Study|Study Terminated by Sponsor|0|||
106081517|NCT02457598|365962179|FG001|Overall Study|Study Terminated by Sponsor|1|||
106081518|NCT02457598|365962180|FG002|Overall Study|Study Terminated by Sponsor|0|||
106081519|NCT02457598|365962181|FG003|Overall Study|Study Terminated by Sponsor|4|||
106081520|NCT02457598|365962182|FG004|Overall Study|Study Terminated by Sponsor|1|||
106081521|NCT02457598|365962183|FG005|Overall Study|Study Terminated by Sponsor|0|||
106081522|NCT02457598|365962184|FG006|Overall Study|Study Terminated by Sponsor|1|||
106081523|NCT02457598|365962185|FG007|Overall Study|Study Terminated by Sponsor|0|||
106081524|NCT02457598|365962186|FG008|Overall Study|Study Terminated by Sponsor|0|||
106081525|NCT02457598|365962187|FG009|Overall Study|Study Terminated by Sponsor|0|||
106081526|NCT02457598|365962188|FG010|Overall Study|Study Terminated by Sponsor|4|||
106081527|NCT02457598|365962189|FG011|Overall Study|Study Terminated by Sponsor|0|||
106081528|NCT02457598|365962190|FG012|Overall Study|Study Terminated by Sponsor|1|||
106081529|NCT02457598|365962191|FG013|Overall Study|Study Terminated by Sponsor|0|||
106081530|NCT02457598|365962192|FG014|Overall Study|Study Terminated by Sponsor|8|||
106081531|NCT02457598|365962193|FG015|Overall Study|Study Terminated by Sponsor|1|||
106081532|NCT02457598|365962194|FG016|Overall Study|Study Terminated by Sponsor|0|||
106081533|NCT02457598|365962178|FG000|Overall Study|Adverse Event|0|||
106081534|NCT02457598|365962179|FG001|Overall Study|Adverse Event|1|||
106081535|NCT02457598|365962180|FG002|Overall Study|Adverse Event|1|||
106081536|NCT02457598|365962181|FG003|Overall Study|Adverse Event|4|||
106081537|NCT02457598|365962182|FG004|Overall Study|Adverse Event|1|||
106081538|NCT02457598|365962183|FG005|Overall Study|Adverse Event|0|||
106081539|NCT02457598|365962184|FG006|Overall Study|Adverse Event|0|||
106081540|NCT02457598|365962185|FG007|Overall Study|Adverse Event|1|||
106081541|NCT02457598|365962186|FG008|Overall Study|Adverse Event|0|||
106081542|NCT02457598|365962187|FG009|Overall Study|Adverse Event|1|||
106081543|NCT02457598|365962188|FG010|Overall Study|Adverse Event|6|||
106081544|NCT02457598|365962189|FG011|Overall Study|Adverse Event|0|||
106081545|NCT02457598|365962190|FG012|Overall Study|Adverse Event|0|||
106081546|NCT02457598|365962191|FG013|Overall Study|Adverse Event|1|||
106081547|NCT02457598|365962192|FG014|Overall Study|Adverse Event|2|||
106081548|NCT02457598|365962193|FG015|Overall Study|Adverse Event|0|||
106081549|NCT02457598|365962194|FG016|Overall Study|Adverse Event|0|||
106081550|NCT02457598|365962178|FG000|Overall Study|Death|0|||
106081551|NCT02457598|365962179|FG001|Overall Study|Death|0|||
106081552|NCT02457598|365962180|FG002|Overall Study|Death|0|||
106081553|NCT02457598|365962181|FG003|Overall Study|Death|3|||
106081554|NCT02457598|365962182|FG004|Overall Study|Death|0|||
106081555|NCT02457598|365962183|FG005|Overall Study|Death|1|||
106081556|NCT02457598|365962184|FG006|Overall Study|Death|0|||
106081557|NCT02457598|365962185|FG007|Overall Study|Death|0|||
106081558|NCT02457598|365962186|FG008|Overall Study|Death|0|||
106081559|NCT02457598|365962187|FG009|Overall Study|Death|0|||
106081560|NCT02457598|365962188|FG010|Overall Study|Death|3|||
106081561|NCT02457598|365962189|FG011|Overall Study|Death|0|||
106081562|NCT02457598|365962190|FG012|Overall Study|Death|0|||
106081563|NCT02457598|365962191|FG013|Overall Study|Death|1|||
106081564|NCT02457598|365962192|FG014|Overall Study|Death|2|||
106081565|NCT02457598|365962193|FG015|Overall Study|Death|0|||
106081566|NCT02457598|365962194|FG016|Overall Study|Death|1|||
106081567|NCT02457598|365962178|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081568|NCT02457598|365962179|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
106081569|NCT02457598|365962180|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081570|NCT02457598|365962181|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
106081571|NCT02457598|365962182|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081572|NCT02457598|365962183|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081573|NCT02457598|365962184|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081574|NCT02457598|365962185|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
106081575|NCT02457598|365962186|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081576|NCT02457598|365962187|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081577|NCT02457598|365962188|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
106081578|NCT02457598|365962189|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081579|NCT02457598|365962190|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081580|NCT02457598|365962191|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
106081581|NCT02457598|365962192|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
106081582|NCT02457598|365962193|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
106081583|NCT02457598|365962194|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
106081584|NCT02457598|365962178|FG000|Overall Study|Withdrew Consent|0|||
106081585|NCT02457598|365962179|FG001|Overall Study|Withdrew Consent|0|||
106081586|NCT02457598|365962180|FG002|Overall Study|Withdrew Consent|0|||
106081587|NCT02457598|365962181|FG003|Overall Study|Withdrew Consent|0|||
106081588|NCT02457598|365962182|FG004|Overall Study|Withdrew Consent|0|||
106081589|NCT02457598|365962183|FG005|Overall Study|Withdrew Consent|0|||
106081590|NCT02457598|365962184|FG006|Overall Study|Withdrew Consent|0|||
106081591|NCT02457598|365962185|FG007|Overall Study|Withdrew Consent|2|||
106081592|NCT02457598|365962186|FG008|Overall Study|Withdrew Consent|0|||
106081593|NCT02457598|365962187|FG009|Overall Study|Withdrew Consent|0|||
106081594|NCT02457598|365962188|FG010|Overall Study|Withdrew Consent|3|||
106081595|NCT02457598|365962189|FG011|Overall Study|Withdrew Consent|0|||
106081596|NCT02457598|365962190|FG012|Overall Study|Withdrew Consent|0|||
106081597|NCT02457598|365962191|FG013|Overall Study|Withdrew Consent|1|||
106081598|NCT02457598|365962192|FG014|Overall Study|Withdrew Consent|0|||
106081599|NCT02457598|365962193|FG015|Overall Study|Withdrew Consent|0|||
106081600|NCT02457598|365962194|FG016|Overall Study|Withdrew Consent|0|||
106081601|NCT02457598|365962178|FG000|Overall Study|Unacceptable Toxicity|0|||
106081602|NCT02457598|365962179|FG001|Overall Study|Unacceptable Toxicity|0|||
106081603|NCT02457598|365962180|FG002|Overall Study|Unacceptable Toxicity|0|||
106081604|NCT02457598|365962181|FG003|Overall Study|Unacceptable Toxicity|0|||
106081605|NCT02457598|365962182|FG004|Overall Study|Unacceptable Toxicity|0|||
106081606|NCT02457598|365962183|FG005|Overall Study|Unacceptable Toxicity|0|||
106081607|NCT02457598|365962184|FG006|Overall Study|Unacceptable Toxicity|0|||
106081608|NCT02457598|365962185|FG007|Overall Study|Unacceptable Toxicity|0|||
106081609|NCT02457598|365962186|FG008|Overall Study|Unacceptable Toxicity|0|||
106081610|NCT02457598|365962187|FG009|Overall Study|Unacceptable Toxicity|0|||
106081611|NCT02457598|365962188|FG010|Overall Study|Unacceptable Toxicity|1|||
106081612|NCT02457598|365962189|FG011|Overall Study|Unacceptable Toxicity|0|||
106081613|NCT02457598|365962190|FG012|Overall Study|Unacceptable Toxicity|1|||
106081614|NCT02457598|365962191|FG013|Overall Study|Unacceptable Toxicity|1|||
106081615|NCT02457598|365962192|FG014|Overall Study|Unacceptable Toxicity|1|||
106081616|NCT02457598|365962193|FG015|Overall Study|Unacceptable Toxicity|0|||
106081617|NCT02457598|365962194|FG016|Overall Study|Unacceptable Toxicity|0|||
106081618|NCT02457598|365962178|FG000|Overall Study|Intercurrent Illness|0|||
106081619|NCT02457598|365962179|FG001|Overall Study|Intercurrent Illness|0|||
106081620|NCT02457598|365962180|FG002|Overall Study|Intercurrent Illness|0|||
106081621|NCT02457598|365962181|FG003|Overall Study|Intercurrent Illness|0|||
106081622|NCT02457598|365962182|FG004|Overall Study|Intercurrent Illness|0|||
106081623|NCT02457598|365962183|FG005|Overall Study|Intercurrent Illness|0|||
106081624|NCT02457598|365962184|FG006|Overall Study|Intercurrent Illness|0|||
106081625|NCT02457598|365962185|FG007|Overall Study|Intercurrent Illness|0|||
106081626|NCT02457598|365962186|FG008|Overall Study|Intercurrent Illness|0|||
106081627|NCT02457598|365962187|FG009|Overall Study|Intercurrent Illness|0|||
106081628|NCT02457598|365962188|FG010|Overall Study|Intercurrent Illness|1|||
106081629|NCT02457598|365962189|FG011|Overall Study|Intercurrent Illness|0|||
105867103|NCT04895982|365163149|FG008|Overall Study|Withdrawal by parent/guardian|3|||
106081630|NCT02457598|365962190|FG012|Overall Study|Intercurrent Illness|0|||
106081631|NCT02457598|365962191|FG013|Overall Study|Intercurrent Illness|0|||
106081632|NCT02457598|365962192|FG014|Overall Study|Intercurrent Illness|0|||
106081633|NCT02457598|365962193|FG015|Overall Study|Intercurrent Illness|0|||
106081634|NCT02457598|365962194|FG016|Overall Study|Intercurrent Illness|0|||
106081635|NCT02457598|365962178|FG000|Overall Study|Protocol Violation|0|||
106081636|NCT02457598|365962179|FG001|Overall Study|Protocol Violation|0|||
106081637|NCT02457598|365962180|FG002|Overall Study|Protocol Violation|0|||
106081638|NCT02457598|365962181|FG003|Overall Study|Protocol Violation|0|||
106081639|NCT02457598|365962182|FG004|Overall Study|Protocol Violation|0|||
106081640|NCT02457598|365962183|FG005|Overall Study|Protocol Violation|0|||
106081641|NCT02457598|365962184|FG006|Overall Study|Protocol Violation|0|||
106081642|NCT02457598|365962185|FG007|Overall Study|Protocol Violation|0|||
106081643|NCT02457598|365962186|FG008|Overall Study|Protocol Violation|0|||
106081644|NCT02457598|365962187|FG009|Overall Study|Protocol Violation|0|||
106081645|NCT02457598|365962188|FG010|Overall Study|Protocol Violation|1|||
106081646|NCT02457598|365962189|FG011|Overall Study|Protocol Violation|0|||
106081647|NCT02457598|365962190|FG012|Overall Study|Protocol Violation|0|||
106081648|NCT02457598|365962191|FG013|Overall Study|Protocol Violation|0|||
106081649|NCT02457598|365962192|FG014|Overall Study|Protocol Violation|0|||
106081650|NCT02457598|365962193|FG015|Overall Study|Protocol Violation|0|||
106081651|NCT02457598|365962194|FG016|Overall Study|Protocol Violation|0|||
106081652|NCT00637195|365962195|FG000|Overall Study|Lost to Follow-up|1|||
106081653|NCT00637195|365962196|FG001|Overall Study|Lost to Follow-up|0|||
106081654|NCT00637195|365962195|FG000|Overall Study|Other|2|||
106081655|NCT00637195|365962196|FG001|Overall Study|Other|0|||
106081656|NCT00637195|365962195|FG000|Overall Study|Withdrawal by Subject|0|||
106081657|NCT00637195|365962196|FG001|Overall Study|Withdrawal by Subject|1|||
106081658|NCT00006184|365962200|FG000|Overall Study|Death|1|||
106081659|NCT00006184|365962201|FG001|Overall Study|Death|0|||
106081660|NCT01110915|365962206|FG000|Overall Study|Death|2|||
106081661|NCT01110915|365962207|FG001|Overall Study|Death|1|||
106081662|NCT01110915|365962206|FG000|Overall Study|Lost to Follow-up|1|||
106081663|NCT01110915|365962207|FG001|Overall Study|Lost to Follow-up|0|||
106081664|NCT01110915|365962206|FG000|Overall Study|Withdrawal by Subject|7|||
106081665|NCT01110915|365962207|FG001|Overall Study|Withdrawal by Subject|1|||
106081666|NCT02948842|365962209|FG000|Overall Study|Withdrawal by Subject|4|||
106081667|NCT03013491|365962216|FG000|Main Study|Death|2|||
106081668|NCT03013491|365962217|FG001|Main Study|Death|2|||
106081669|NCT03013491|365962218|FG002|Main Study|Death|5|||
106081670|NCT03013491|365962219|FG003|Main Study|Death|3|||
106081671|NCT03013491|365962220|FG004|Main Study|Death|9|||
106081672|NCT03013491|365962221|FG005|Main Study|Death|12|||
106081673|NCT03013491|365962222|FG006|Main Study|Death|3|||
106081674|NCT03013491|365962223|FG007|Main Study|Death|5|||
106081675|NCT03013491|365962224|FG008|Main Study|Death|1|||
106081676|NCT03013491|365962225|FG009|Main Study|Death|2|||
106081677|NCT03013491|365962226|FG010|Main Study|Death|4|||
106081678|NCT03013491|365962227|FG011|Main Study|Death|1|||
106081679|NCT03013491|365962228|FG012|Main Study|Death|1|||
106081680|NCT03013491|365962229|FG013|Main Study|Death|4|||
106081681|NCT03013491|365962230|FG014|Main Study|Death|0|||
106081682|NCT03013491|365962231|FG015|Main Study|Death|3|||
106081683|NCT03013491|365962232|FG016|Main Study|Death|5|||
106081684|NCT03013491|365962233|FG017|Main Study|Death|1|||
106081685|NCT03013491|365962234|FG018|Main Study|Death|47|||
106081686|NCT03013491|365962216|FG000|Main Study|Lost to Follow-up|0|||
106081687|NCT03013491|365962217|FG001|Main Study|Lost to Follow-up|0|||
106081688|NCT03013491|365962218|FG002|Main Study|Lost to Follow-up|1|||
106081689|NCT03013491|365962219|FG003|Main Study|Lost to Follow-up|0|||
106081690|NCT03013491|365962220|FG004|Main Study|Lost to Follow-up|1|||
106081691|NCT03013491|365962221|FG005|Main Study|Lost to Follow-up|0|||
106081692|NCT03013491|365962222|FG006|Main Study|Lost to Follow-up|0|||
106081693|NCT03013491|365962223|FG007|Main Study|Lost to Follow-up|0|||
106081694|NCT03013491|365962224|FG008|Main Study|Lost to Follow-up|0|||
106081695|NCT03013491|365962225|FG009|Main Study|Lost to Follow-up|0|||
106081696|NCT03013491|365962226|FG010|Main Study|Lost to Follow-up|0|||
106081697|NCT03013491|365962227|FG011|Main Study|Lost to Follow-up|0|||
106081698|NCT03013491|365962228|FG012|Main Study|Lost to Follow-up|0|||
106081699|NCT03013491|365962229|FG013|Main Study|Lost to Follow-up|0|||
106081700|NCT03013491|365962230|FG014|Main Study|Lost to Follow-up|0|||
105867104|NCT04895982|365163150|FG009|Overall Study|Withdrawal by parent/guardian|0|||
106081701|NCT03013491|365962231|FG015|Main Study|Lost to Follow-up|0|||
106081702|NCT03013491|365962232|FG016|Main Study|Lost to Follow-up|0|||
106081703|NCT03013491|365962233|FG017|Main Study|Lost to Follow-up|0|||
106081704|NCT03013491|365962234|FG018|Main Study|Lost to Follow-up|3|||
106081705|NCT03013491|365962216|FG000|Main Study|Termination of the study by Sponsor|0|||
106081706|NCT03013491|365962217|FG001|Main Study|Termination of the study by Sponsor|0|||
106081707|NCT03013491|365962218|FG002|Main Study|Termination of the study by Sponsor|2|||
106081708|NCT03013491|365962219|FG003|Main Study|Termination of the study by Sponsor|0|||
106081709|NCT03013491|365962220|FG004|Main Study|Termination of the study by Sponsor|1|||
106081710|NCT03013491|365962221|FG005|Main Study|Termination of the study by Sponsor|2|||
106081711|NCT03013491|365962222|FG006|Main Study|Termination of the study by Sponsor|0|||
106081712|NCT03013491|365962223|FG007|Main Study|Termination of the study by Sponsor|0|||
106081713|NCT03013491|365962224|FG008|Main Study|Termination of the study by Sponsor|1|||
106081714|NCT03013491|365962225|FG009|Main Study|Termination of the study by Sponsor|1|||
106081715|NCT03013491|365962226|FG010|Main Study|Termination of the study by Sponsor|1|||
106081716|NCT03013491|365962227|FG011|Main Study|Termination of the study by Sponsor|2|||
106081717|NCT03013491|365962228|FG012|Main Study|Termination of the study by Sponsor|0|||
106081718|NCT03013491|365962229|FG013|Main Study|Termination of the study by Sponsor|0|||
106081719|NCT03013491|365962230|FG014|Main Study|Termination of the study by Sponsor|0|||
106081720|NCT03013491|365962231|FG015|Main Study|Termination of the study by Sponsor|0|||
106081721|NCT03013491|365962232|FG016|Main Study|Termination of the study by Sponsor|0|||
106081722|NCT03013491|365962233|FG017|Main Study|Termination of the study by Sponsor|1|||
106081723|NCT03013491|365962234|FG018|Main Study|Termination of the study by Sponsor|13|||
106081724|NCT03013491|365962216|FG000|Main Study|Withdrawal by Subject|0|||
106081725|NCT03013491|365962217|FG001|Main Study|Withdrawal by Subject|0|||
106081726|NCT03013491|365962218|FG002|Main Study|Withdrawal by Subject|0|||
106081727|NCT03013491|365962219|FG003|Main Study|Withdrawal by Subject|4|||
106081728|NCT03013491|365962220|FG004|Main Study|Withdrawal by Subject|2|||
106081729|NCT03013491|365962221|FG005|Main Study|Withdrawal by Subject|1|||
106081730|NCT03013491|365962222|FG006|Main Study|Withdrawal by Subject|0|||
106081731|NCT03013491|365962223|FG007|Main Study|Withdrawal by Subject|0|||
106081732|NCT03013491|365962224|FG008|Main Study|Withdrawal by Subject|0|||
106081733|NCT03013491|365962225|FG009|Main Study|Withdrawal by Subject|0|||
106081734|NCT03013491|365962226|FG010|Main Study|Withdrawal by Subject|1|||
106081735|NCT03013491|365962227|FG011|Main Study|Withdrawal by Subject|2|||
106081736|NCT03013491|365962228|FG012|Main Study|Withdrawal by Subject|0|||
106081737|NCT03013491|365962229|FG013|Main Study|Withdrawal by Subject|2|||
106081738|NCT03013491|365962230|FG014|Main Study|Withdrawal by Subject|0|||
106081739|NCT03013491|365962231|FG015|Main Study|Withdrawal by Subject|0|||
106081740|NCT03013491|365962232|FG016|Main Study|Withdrawal by Subject|0|||
106081741|NCT03013491|365962233|FG017|Main Study|Withdrawal by Subject|0|||
106081742|NCT03013491|365962234|FG018|Main Study|Withdrawal by Subject|18|||
106081743|NCT03013491|365962216|FG000|Main Study|Disease progression|0|||
106081744|NCT03013491|365962217|FG001|Main Study|Disease progression|0|||
106081745|NCT03013491|365962218|FG002|Main Study|Disease progression|0|||
106081746|NCT03013491|365962219|FG003|Main Study|Disease progression|1|||
106081747|NCT03013491|365962220|FG004|Main Study|Disease progression|0|||
106081748|NCT03013491|365962221|FG005|Main Study|Disease progression|0|||
106081749|NCT03013491|365962222|FG006|Main Study|Disease progression|0|||
106081750|NCT03013491|365962223|FG007|Main Study|Disease progression|0|||
106081751|NCT03013491|365962224|FG008|Main Study|Disease progression|1|||
106081752|NCT03013491|365962225|FG009|Main Study|Disease progression|0|||
106081753|NCT03013491|365962226|FG010|Main Study|Disease progression|1|||
106081754|NCT03013491|365962227|FG011|Main Study|Disease progression|0|||
106081755|NCT03013491|365962228|FG012|Main Study|Disease progression|0|||
106081756|NCT03013491|365962229|FG013|Main Study|Disease progression|0|||
106081757|NCT03013491|365962230|FG014|Main Study|Disease progression|0|||
106081758|NCT03013491|365962231|FG015|Main Study|Disease progression|0|||
106081759|NCT03013491|365962232|FG016|Main Study|Disease progression|0|||
106081760|NCT03013491|365962233|FG017|Main Study|Disease progression|0|||
106081761|NCT03013491|365962234|FG018|Main Study|Disease progression|4|||
106081762|NCT03013491|365962216|FG000|Main Study|Symptomatic deterioration|0|||
106081763|NCT03013491|365962217|FG001|Main Study|Symptomatic deterioration|0|||
106081764|NCT03013491|365962218|FG002|Main Study|Symptomatic deterioration|0|||
106081765|NCT03013491|365962219|FG003|Main Study|Symptomatic deterioration|0|||
106081766|NCT03013491|365962220|FG004|Main Study|Symptomatic deterioration|0|||
106081767|NCT03013491|365962221|FG005|Main Study|Symptomatic deterioration|1|||
106081768|NCT03013491|365962222|FG006|Main Study|Symptomatic deterioration|0|||
106081769|NCT03013491|365962223|FG007|Main Study|Symptomatic deterioration|0|||
106081770|NCT03013491|365962224|FG008|Main Study|Symptomatic deterioration|0|||
106081771|NCT03013491|365962225|FG009|Main Study|Symptomatic deterioration|0|||
106081772|NCT03013491|365962226|FG010|Main Study|Symptomatic deterioration|0|||
106081773|NCT03013491|365962227|FG011|Main Study|Symptomatic deterioration|0|||
106081774|NCT03013491|365962228|FG012|Main Study|Symptomatic deterioration|0|||
106081775|NCT03013491|365962229|FG013|Main Study|Symptomatic deterioration|0|||
106081776|NCT03013491|365962230|FG014|Main Study|Symptomatic deterioration|0|||
106081777|NCT03013491|365962231|FG015|Main Study|Symptomatic deterioration|0|||
106081778|NCT03013491|365962232|FG016|Main Study|Symptomatic deterioration|0|||
106081779|NCT03013491|365962233|FG017|Main Study|Symptomatic deterioration|0|||
106081780|NCT03013491|365962234|FG018|Main Study|Symptomatic deterioration|0|||
106081781|NCT03013491|365962216|FG000|Main Study|Protocol version 8.0 approval|0|||
106081782|NCT03013491|365962217|FG001|Main Study|Protocol version 8.0 approval|0|||
106081783|NCT03013491|365962218|FG002|Main Study|Protocol version 8.0 approval|0|||
106081784|NCT03013491|365962219|FG003|Main Study|Protocol version 8.0 approval|0|||
106081785|NCT03013491|365962220|FG004|Main Study|Protocol version 8.0 approval|0|||
106081786|NCT03013491|365962221|FG005|Main Study|Protocol version 8.0 approval|0|||
106081787|NCT03013491|365962222|FG006|Main Study|Protocol version 8.0 approval|0|||
106081788|NCT03013491|365962223|FG007|Main Study|Protocol version 8.0 approval|0|||
106081789|NCT03013491|365962224|FG008|Main Study|Protocol version 8.0 approval|0|||
106081790|NCT03013491|365962225|FG009|Main Study|Protocol version 8.0 approval|0|||
106081791|NCT03013491|365962226|FG010|Main Study|Protocol version 8.0 approval|1|||
106081792|NCT03013491|365962227|FG011|Main Study|Protocol version 8.0 approval|0|||
106081793|NCT03013491|365962228|FG012|Main Study|Protocol version 8.0 approval|0|||
106081794|NCT03013491|365962229|FG013|Main Study|Protocol version 8.0 approval|0|||
106081795|NCT03013491|365962230|FG014|Main Study|Protocol version 8.0 approval|0|||
106081796|NCT03013491|365962231|FG015|Main Study|Protocol version 8.0 approval|0|||
106081797|NCT03013491|365962232|FG016|Main Study|Protocol version 8.0 approval|0|||
106081798|NCT03013491|365962233|FG017|Main Study|Protocol version 8.0 approval|0|||
106081799|NCT03013491|365962234|FG018|Main Study|Protocol version 8.0 approval|0|||
106081800|NCT03013491|365962216|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
106081801|NCT03013491|365962217|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
106081802|NCT03013491|365962218|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
106081803|NCT03013491|365962219|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
106081804|NCT03013491|365962220|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
106081805|NCT03013491|365962221|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
106081806|NCT03013491|365962222|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
106081807|NCT03013491|365962223|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
106081808|NCT03013491|365962224|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
106081809|NCT03013491|365962225|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
106081810|NCT03013491|365962226|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
106081811|NCT03013491|365962227|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
106081812|NCT03013491|365962228|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
106081813|NCT03013491|365962229|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
106081814|NCT03013491|365962230|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
106081815|NCT03013491|365962231|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
106081816|NCT03013491|365962232|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
106081817|NCT03013491|365962233|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
106081818|NCT03013491|365962234|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
106081819|NCT03013491|365962216|FG000|Main Study|Start of new anticancer therapy|0|||
106081820|NCT03013491|365962217|FG001|Main Study|Start of new anticancer therapy|0|||
106081821|NCT03013491|365962218|FG002|Main Study|Start of new anticancer therapy|0|||
106081822|NCT03013491|365962219|FG003|Main Study|Start of new anticancer therapy|0|||
106081823|NCT03013491|365962220|FG004|Main Study|Start of new anticancer therapy|0|||
106081824|NCT03013491|365962221|FG005|Main Study|Start of new anticancer therapy|0|||
106081825|NCT03013491|365962222|FG006|Main Study|Start of new anticancer therapy|0|||
106081826|NCT03013491|365962223|FG007|Main Study|Start of new anticancer therapy|0|||
106081827|NCT03013491|365962224|FG008|Main Study|Start of new anticancer therapy|0|||
106081828|NCT03013491|365962225|FG009|Main Study|Start of new anticancer therapy|0|||
106081829|NCT03013491|365962226|FG010|Main Study|Start of new anticancer therapy|0|||
106081830|NCT03013491|365962227|FG011|Main Study|Start of new anticancer therapy|0|||
106081831|NCT03013491|365962228|FG012|Main Study|Start of new anticancer therapy|0|||
106081832|NCT03013491|365962229|FG013|Main Study|Start of new anticancer therapy|0|||
106081833|NCT03013491|365962230|FG014|Main Study|Start of new anticancer therapy|0|||
106081834|NCT03013491|365962231|FG015|Main Study|Start of new anticancer therapy|0|||
106081835|NCT03013491|365962232|FG016|Main Study|Start of new anticancer therapy|0|||
106081836|NCT03013491|365962233|FG017|Main Study|Start of new anticancer therapy|0|||
106081837|NCT03013491|365962234|FG018|Main Study|Start of new anticancer therapy|2|||
106081838|NCT03013491|365962216|FG000|Long-term Extension|Disease progression|0|||
106081839|NCT03013491|365962217|FG001|Long-term Extension|Disease progression|0|||
106081840|NCT03013491|365962218|FG002|Long-term Extension|Disease progression|0|||
106081841|NCT03013491|365962219|FG003|Long-term Extension|Disease progression|1|||
106081842|NCT03013491|365962220|FG004|Long-term Extension|Disease progression|0|||
106081843|NCT03013491|365962221|FG005|Long-term Extension|Disease progression|0|||
106081844|NCT03013491|365962222|FG006|Long-term Extension|Disease progression|0|||
106081845|NCT03013491|365962223|FG007|Long-term Extension|Disease progression|0|||
106081846|NCT03013491|365962224|FG008|Long-term Extension|Disease progression|0|||
106081847|NCT03013491|365962225|FG009|Long-term Extension|Disease progression|0|||
106081848|NCT03013491|365962226|FG010|Long-term Extension|Disease progression|0|||
106081849|NCT03013491|365962227|FG011|Long-term Extension|Disease progression|0|||
106081850|NCT03013491|365962228|FG012|Long-term Extension|Disease progression|0|||
106081851|NCT03013491|365962229|FG013|Long-term Extension|Disease progression|0|||
106081852|NCT03013491|365962230|FG014|Long-term Extension|Disease progression|0|||
106081853|NCT03013491|365962231|FG015|Long-term Extension|Disease progression|0|||
106081854|NCT03013491|365962232|FG016|Long-term Extension|Disease progression|0|||
106081855|NCT03013491|365962233|FG017|Long-term Extension|Disease progression|0|||
106081856|NCT03013491|365962234|FG018|Long-term Extension|Disease progression|1|||
106081857|NCT03013491|365962216|FG000|Long-term Extension|Withdrawal by Subject|0|||
106081858|NCT03013491|365962217|FG001|Long-term Extension|Withdrawal by Subject|0|||
106081859|NCT03013491|365962218|FG002|Long-term Extension|Withdrawal by Subject|0|||
105867105|NCT04895982|365163151|FG010|Overall Study|Withdrawal by parent/guardian|0|||
106081860|NCT03013491|365962219|FG003|Long-term Extension|Withdrawal by Subject|0|||
106081861|NCT03013491|365962220|FG004|Long-term Extension|Withdrawal by Subject|0|||
106081862|NCT03013491|365962221|FG005|Long-term Extension|Withdrawal by Subject|0|||
106160437|NCT04072822|366247497|FG000|Treatment|Met Stopping Criteria|13|||
106081863|NCT03013491|365962222|FG006|Long-term Extension|Withdrawal by Subject|0|||
106081864|NCT03013491|365962223|FG007|Long-term Extension|Withdrawal by Subject|1|||
106081865|NCT03013491|365962224|FG008|Long-term Extension|Withdrawal by Subject|0|||
106081866|NCT03013491|365962225|FG009|Long-term Extension|Withdrawal by Subject|0|||
106081867|NCT03013491|365962226|FG010|Long-term Extension|Withdrawal by Subject|0|||
106081868|NCT03013491|365962227|FG011|Long-term Extension|Withdrawal by Subject|0|||
106081869|NCT03013491|365962228|FG012|Long-term Extension|Withdrawal by Subject|0|||
106081870|NCT03013491|365962229|FG013|Long-term Extension|Withdrawal by Subject|0|||
106081871|NCT03013491|365962230|FG014|Long-term Extension|Withdrawal by Subject|0|||
106081872|NCT03013491|365962231|FG015|Long-term Extension|Withdrawal by Subject|0|||
106081873|NCT03013491|365962232|FG016|Long-term Extension|Withdrawal by Subject|0|||
106081874|NCT03013491|365962233|FG017|Long-term Extension|Withdrawal by Subject|0|||
106081875|NCT03013491|365962234|FG018|Long-term Extension|Withdrawal by Subject|0|||
106081876|NCT03013491|365962216|FG000|Long-term Extension|Adverse Event|0|||
106081877|NCT03013491|365962217|FG001|Long-term Extension|Adverse Event|0|||
106081878|NCT03013491|365962218|FG002|Long-term Extension|Adverse Event|0|||
106081879|NCT03013491|365962219|FG003|Long-term Extension|Adverse Event|0|||
106081880|NCT03013491|365962220|FG004|Long-term Extension|Adverse Event|0|||
106081881|NCT03013491|365962221|FG005|Long-term Extension|Adverse Event|0|||
106081882|NCT03013491|365962222|FG006|Long-term Extension|Adverse Event|0|||
106081883|NCT03013491|365962223|FG007|Long-term Extension|Adverse Event|0|||
106081884|NCT03013491|365962224|FG008|Long-term Extension|Adverse Event|0|||
106081885|NCT03013491|365962225|FG009|Long-term Extension|Adverse Event|0|||
106081886|NCT03013491|365962226|FG010|Long-term Extension|Adverse Event|0|||
106081887|NCT03013491|365962227|FG011|Long-term Extension|Adverse Event|0|||
106081888|NCT03013491|365962228|FG012|Long-term Extension|Adverse Event|0|||
106081889|NCT03013491|365962229|FG013|Long-term Extension|Adverse Event|0|||
106081890|NCT03013491|365962230|FG014|Long-term Extension|Adverse Event|0|||
106081891|NCT03013491|365962231|FG015|Long-term Extension|Adverse Event|0|||
106081892|NCT03013491|365962232|FG016|Long-term Extension|Adverse Event|0|||
106081893|NCT03013491|365962233|FG017|Long-term Extension|Adverse Event|0|||
106081894|NCT03013491|365962234|FG018|Long-term Extension|Adverse Event|1|||
106081895|NCT03013491|365962216|FG000|Long-term Extension|Death|0|||
106081896|NCT03013491|365962217|FG001|Long-term Extension|Death|0|||
106081897|NCT03013491|365962218|FG002|Long-term Extension|Death|0|||
106081898|NCT03013491|365962219|FG003|Long-term Extension|Death|0|||
106081899|NCT03013491|365962220|FG004|Long-term Extension|Death|0|||
106081900|NCT03013491|365962221|FG005|Long-term Extension|Death|0|||
106081901|NCT03013491|365962222|FG006|Long-term Extension|Death|0|||
106081902|NCT03013491|365962223|FG007|Long-term Extension|Death|0|||
106081903|NCT03013491|365962224|FG008|Long-term Extension|Death|0|||
106081904|NCT03013491|365962225|FG009|Long-term Extension|Death|0|||
106081905|NCT03013491|365962226|FG010|Long-term Extension|Death|0|||
106081906|NCT03013491|365962227|FG011|Long-term Extension|Death|0|||
106081907|NCT03013491|365962228|FG012|Long-term Extension|Death|0|||
106081908|NCT03013491|365962229|FG013|Long-term Extension|Death|0|||
106081909|NCT03013491|365962230|FG014|Long-term Extension|Death|0|||
106081910|NCT03013491|365962231|FG015|Long-term Extension|Death|0|||
106081911|NCT03013491|365962232|FG016|Long-term Extension|Death|0|||
106081912|NCT03013491|365962233|FG017|Long-term Extension|Death|0|||
106081913|NCT03013491|365962234|FG018|Long-term Extension|Death|1|||
106081914|NCT04745689|365962235|FG000|Overall Study|Death|9|||
106081915|NCT04745689|365962236|FG001|Overall Study|Death|6|||
106081916|NCT04745689|365962235|FG000|Overall Study|Lost to Follow-up|1|||
106081917|NCT04745689|365962236|FG001|Overall Study|Lost to Follow-up|0|||
106081918|NCT04745689|365962235|FG000|Overall Study|Withdrawal by Subject|2|||
106081919|NCT04745689|365962236|FG001|Overall Study|Withdrawal by Subject|0|||
106081920|NCT04745689|365962235|FG000|Overall Study|Study terminated by sponsor|10|||
106081921|NCT04745689|365962236|FG001|Overall Study|Study terminated by sponsor|3|||
106081922|NCT03548584|365963867|FG000|Overall Study|Lost to Follow-up|0|||
106081923|NCT03548584|365963868|FG001|Overall Study|Lost to Follow-up|0|||
106081924|NCT03548584|365963869|FG002|Overall Study|Lost to Follow-up|1|||
106081925|NCT03548584|365963867|FG000|Overall Study|Adverse Event|1|||
106081926|NCT03548584|365963868|FG001|Overall Study|Adverse Event|11|||
106081927|NCT03548584|365963869|FG002|Overall Study|Adverse Event|5|||
106081928|NCT03548584|365963867|FG000|Overall Study|Site Terminated by Sponsor|1|||
106081929|NCT03548584|365963868|FG001|Overall Study|Site Terminated by Sponsor|3|||
106081930|NCT03548584|365963869|FG002|Overall Study|Site Terminated by Sponsor|2|||
106081931|NCT03548584|365963867|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
106081932|NCT03548584|365963868|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
106081933|NCT03548584|365963869|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
106081934|NCT03548584|365963867|FG000|Overall Study|Lack of Efficacy|0|||
106081935|NCT03548584|365963868|FG001|Overall Study|Lack of Efficacy|1|||
106081936|NCT03548584|365963869|FG002|Overall Study|Lack of Efficacy|0|||
106081937|NCT03548584|365963867|FG000|Overall Study|Non-compliance with Study Drug|0|||
106081938|NCT03548584|365963868|FG001|Overall Study|Non-compliance with Study Drug|1|||
106081939|NCT03548584|365963869|FG002|Overall Study|Non-compliance with Study Drug|0|||
106081940|NCT03548584|365963867|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
106081941|NCT03548584|365963868|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
106081942|NCT03548584|365963869|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
106081943|NCT04524403|365963874|FG000|Overall Study|Withdrawal by Subject|10|||
106081944|NCT04524403|365963875|FG001|Overall Study|Withdrawal by Subject|3|||
106081945|NCT04524403|365963876|FG002|Overall Study|Withdrawal by Subject|8|||
106081946|NCT04524403|365963874|FG000|Overall Study|Lost to Follow-up|3|||
106081947|NCT04524403|365963875|FG001|Overall Study|Lost to Follow-up|4|||
106081948|NCT04524403|365963876|FG002|Overall Study|Lost to Follow-up|3|||
106081949|NCT04524403|365963874|FG000|Overall Study|Adverse Event|3|||
106081950|NCT04524403|365963875|FG001|Overall Study|Adverse Event|1|||
106081951|NCT04524403|365963876|FG002|Overall Study|Adverse Event|4|||
106081952|NCT04524403|365963874|FG000|Overall Study|Non-compliant with study drug|1|||
106081953|NCT04524403|365963875|FG001|Overall Study|Non-compliant with study drug|2|||
106081954|NCT04524403|365963876|FG002|Overall Study|Non-compliant with study drug|3|||
106081955|NCT04524403|365963874|FG000|Overall Study|Moved|0|||
106081956|NCT04524403|365963875|FG001|Overall Study|Moved|1|||
106081957|NCT04524403|365963876|FG002|Overall Study|Moved|0|||
106081958|NCT01083433|365963881|FG000|Overall Study|Lost to Follow-up|2|||
106081959|NCT01083433|365963882|FG001|Overall Study|Lost to Follow-up|1|||
106081960|NCT01083433|365963883|FG002|Overall Study|Lost to Follow-up|1|||
106081961|NCT01083433|365963881|FG000|Overall Study|Withdrawal by Subject|0|||
106081962|NCT01083433|365963882|FG001|Overall Study|Withdrawal by Subject|5|||
106081963|NCT01083433|365963883|FG002|Overall Study|Withdrawal by Subject|3|||
106081964|NCT01083433|365963881|FG000|Overall Study|Pregnancy|0|||
106081965|NCT01083433|365963882|FG001|Overall Study|Pregnancy|0|||
106081966|NCT01083433|365963883|FG002|Overall Study|Pregnancy|1|||
106081967|NCT03370341|365963884|FG000|Overall Study|Lost to Follow-up|0|||
106081968|NCT03370341|365963885|FG001|Overall Study|Lost to Follow-up|1|||
106081969|NCT01581593|365963888|FG000|Overall Study|Withdrawal by Subject|1|||
106081970|NCT01101841|365963889|FG000|Overall Study|Adverse Event|15|||
106081971|NCT01101841|365963890|FG001|Overall Study|Adverse Event|15|||
106081972|NCT01101841|365963889|FG000|Overall Study|Lost to Follow-up|9|||
106081973|NCT01101841|365963890|FG001|Overall Study|Lost to Follow-up|3|||
106081974|NCT01101841|365963889|FG000|Overall Study|Withdrawal by Subject|21|||
106081975|NCT01101841|365963890|FG001|Overall Study|Withdrawal by Subject|40|||
106081976|NCT01101841|365963889|FG000|Overall Study|Protocol Violation|1|||
105867106|NCT04895982|365163152|FG011|Overall Study|Withdrawal by parent/guardian|0|||
106081977|NCT01101841|365963890|FG001|Overall Study|Protocol Violation|1|||
106081978|NCT01101841|365963889|FG000|Overall Study|Physician Decision|0|||
105867107|NCT04895982|365163141|FG000|Overall Study|Other|0|||
105867108|NCT04895982|365163142|FG001|Overall Study|Other|0|||
105867109|NCT04895982|365163143|FG002|Overall Study|Other|1|||
105867110|NCT04895982|365163144|FG003|Overall Study|Other|1|||
105867111|NCT04895982|365163145|FG004|Overall Study|Other|0|||
105867112|NCT04895982|365163146|FG005|Overall Study|Other|0|||
105867113|NCT04895982|365163147|FG006|Overall Study|Other|0|||
105867114|NCT04895982|365163148|FG007|Overall Study|Other|0|||
105867115|NCT04895982|365163149|FG008|Overall Study|Other|0|||
106081979|NCT01101841|365963890|FG001|Overall Study|Physician Decision|2|||
105867116|NCT04895982|365163150|FG009|Overall Study|Other|1|||
106081980|NCT01101841|365963889|FG000|Overall Study|Lack of Efficacy|0|||
106081981|NCT01101841|365963890|FG001|Overall Study|Lack of Efficacy|2|||
106081982|NCT01101841|365963889|FG000|Overall Study|Other|0|||
106081983|NCT01101841|365963890|FG001|Overall Study|Other|1|||
106081984|NCT01101841|365963889|FG000|Overall Study|Suicidality Tracking Scale|3|||
106081985|NCT01101841|365963890|FG001|Overall Study|Suicidality Tracking Scale|1|||
106081986|NCT01101841|365963889|FG000|Overall Study|Eligibility Criteria|1|||
106081987|NCT01101841|365963890|FG001|Overall Study|Eligibility Criteria|2|||
106081988|NCT01707004|365963893|FG000|Overall Study|Physician Decision|3|||
106081989|NCT00653224|365963896|FG000|Overall Study|Adverse Event|2|||
106081990|NCT00653224|365963897|FG001|Overall Study|Adverse Event|1|||
106081991|NCT00653224|365963896|FG000|Overall Study|Lack of Efficacy|1|||
106081992|NCT00653224|365963897|FG001|Overall Study|Lack of Efficacy|2|||
106081993|NCT00653224|365963896|FG000|Overall Study|Loss of efficacy|1|||
106081994|NCT00653224|365963897|FG001|Overall Study|Loss of efficacy|0|||
106081995|NCT00653224|365963896|FG000|Overall Study|Lost to Follow-up|1|||
106081996|NCT00653224|365963897|FG001|Overall Study|Lost to Follow-up|0|||
106081997|NCT00653224|365963896|FG000|Overall Study|Other|2|||
106081998|NCT00653224|365963897|FG001|Overall Study|Other|4|||
106081999|NCT04982029|365963898|FG000|Overall Study|Lost to Follow-up|2|||
106082000|NCT04982029|365963899|FG001|Overall Study|Lost to Follow-up|3|||
106082001|NCT05084053|365963900|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
106082002|NCT05084053|365963901|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
106082003|NCT05084053|365963902|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
106082004|NCT05084053|365963903|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
106082005|NCT05084053|365963900|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
106082006|NCT05084053|365963901|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
106082007|NCT05084053|365963902|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
106082008|NCT05084053|365963903|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
106082009|NCT05084053|365963900|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
106082010|NCT05084053|365963901|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
106082011|NCT05084053|365963902|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
106082012|NCT05084053|365963903|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
106082013|NCT00679341|365963904|FG000|Overall Study|Disease progression|42|||
106082014|NCT00679341|365963905|FG001|Overall Study|Disease progression|36|||
106082015|NCT00679341|365963904|FG000|Overall Study|Adverse Event|5|||
106082016|NCT00679341|365963905|FG001|Overall Study|Adverse Event|6|||
106082017|NCT00679341|365963904|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
106082018|NCT00679341|365963905|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
106082019|NCT00679341|365963904|FG000|Overall Study|Death|1|||
106082020|NCT00679341|365963905|FG001|Overall Study|Death|1|||
106082021|NCT00679341|365963904|FG000|Overall Study|Other|1|||
106082022|NCT00679341|365963905|FG001|Overall Study|Other|0|||
106082023|NCT00679341|365963904|FG000|Overall Study|Physician Decision|1|||
106082024|NCT00679341|365963905|FG001|Overall Study|Physician Decision|0|||
106082025|NCT00679341|365963904|FG000|Overall Study|Not treated|0|||
106082026|NCT00679341|365963905|FG001|Overall Study|Not treated|2|||
106082027|NCT00679341|365963904|FG000|Overall Study|Physician/patient decision to withdraw|0|||
106082028|NCT00679341|365963905|FG001|Overall Study|Physician/patient decision to withdraw|6|||
106082029|NCT01207778|365963906|FG000|Overall Study|Lost to Follow-up|0|||
106082030|NCT01207778|365963907|FG001|Overall Study|Lost to Follow-up|3|||
106082031|NCT01207778|365963908|FG002|Overall Study|Lost to Follow-up|3|||
106082032|NCT00646204|365963909|FG000|Overall Study|Adverse Event|3|||
106082033|NCT00646204|365963910|FG001|Overall Study|Adverse Event|0|||
106082034|NCT00646204|365963909|FG000|Overall Study|Withdrawal by Subject|1|||
106082035|NCT00646204|365963910|FG001|Overall Study|Withdrawal by Subject|0|||
106082036|NCT04709237|365963913|FG000|Overall Study|Lost to Follow-up|1|||
106082037|NCT04709237|365963914|FG001|Overall Study|Lost to Follow-up|0|||
106082038|NCT04709237|365963915|FG002|Overall Study|Lost to Follow-up|0|||
106082039|NCT01956110|365963916|FG000|Overall Study|Protocol Violation|25|||
106082040|NCT01956110|365963917|FG001|Overall Study|Protocol Violation|11|||
106082041|NCT01956110|365963916|FG000|Overall Study|Adverse Event|9|||
106082042|NCT01956110|365963917|FG001|Overall Study|Adverse Event|10|||
106082043|NCT01956110|365963916|FG000|Overall Study|Personal reasons|1|||
106082044|NCT01956110|365963917|FG001|Overall Study|Personal reasons|1|||
106082045|NCT02412631|365963919|FG000|Overall Study|Adverse Event|1|||
106082046|NCT02412631|365963920|FG001|Overall Study|Adverse Event|2|||
106082047|NCT02412631|365963919|FG000|Overall Study|Lost to Follow-up|5|||
106082048|NCT02412631|365963920|FG001|Overall Study|Lost to Follow-up|9|||
106082049|NCT02412631|365963919|FG000|Overall Study|Withdrawal by Subject|9|||
106082050|NCT02412631|365963920|FG001|Overall Study|Withdrawal by Subject|3|||
106082051|NCT02412631|365963919|FG000|Overall Study|Early stop by FDA|5|||
106082052|NCT02412631|365963920|FG001|Overall Study|Early stop by FDA|2|||
106082053|NCT02412631|365963919|FG000|Overall Study|Unspecified reason|6|||
106160438|NCT04072822|366247498|FG001|Treatment|Met Stopping Criteria|24|||
106082054|NCT02412631|365963920|FG001|Overall Study|Unspecified reason|8|||
106082055|NCT00770120|365963921|FG000|Overall Study|Progression|31|||
106082056|NCT00770120|365963921|FG000|Overall Study|Adverse Event|11|||
106082057|NCT00770120|365963921|FG000|Overall Study|Not Protocol Specified|11|||
106082058|NCT00770120|365963921|FG000|Overall Study|Death|3|||
106082059|NCT00770120|365963921|FG000|Overall Study|Withdrawal by Subject|2|||
106082060|NCT00770120|365963921|FG000|Overall Study|Ineligible|1|||
106082061|NCT00770120|365963921|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
106082062|NCT00770120|365963921|FG000|Overall Study|Reason under Review|1|||
106082063|NCT02488629|365963922|FG000|Overall Study|Lack of Efficacy|3|||
106082064|NCT02488629|365963923|FG001|Overall Study|Lack of Efficacy|1|||
106082065|NCT02488629|365963924|FG002|Overall Study|Lack of Efficacy|0|||
106082066|NCT02488629|365963925|FG003|Overall Study|Lack of Efficacy|0|||
106082067|NCT02488629|365963922|FG000|Overall Study|Withdrawal by Subject|0|||
106082068|NCT02488629|365963923|FG001|Overall Study|Withdrawal by Subject|1|||
106082069|NCT02488629|365963924|FG002|Overall Study|Withdrawal by Subject|0|||
106082070|NCT02488629|365963925|FG003|Overall Study|Withdrawal by Subject|0|||
106082071|NCT00958776|365963926|FG000|Overall Study|Adverse Event|0|||
106082072|NCT00958776|365963927|FG001|Overall Study|Adverse Event|1|||
106082073|NCT00958776|365963926|FG000|Overall Study|Physician Decision|1|||
106082074|NCT00958776|365963927|FG001|Overall Study|Physician Decision|0|||
106082075|NCT00958776|365963926|FG000|Overall Study|Lost to Follow-up|2|||
106082076|NCT00958776|365963927|FG001|Overall Study|Lost to Follow-up|6|||
106082077|NCT00958776|365963926|FG000|Overall Study|Withdrawal by Subject|7|||
106082078|NCT00958776|365963927|FG001|Overall Study|Withdrawal by Subject|16|||
106082079|NCT00958776|365963926|FG000|Overall Study|Protocol Violation|1|||
106082080|NCT00958776|365963927|FG001|Overall Study|Protocol Violation|1|||
106082081|NCT00958776|365963926|FG000|Overall Study|Death|2|||
106082082|NCT00958776|365963927|FG001|Overall Study|Death|1|||
106082083|NCT00958776|365963926|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
106082084|NCT00958776|365963927|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
106082085|NCT00958776|365963926|FG000|Overall Study|Missing|1|||
106082086|NCT00958776|365963927|FG001|Overall Study|Missing|1|||
106082087|NCT00480636|365963928|FG000|Overall Study|Death|12|||
106082088|NCT00480636|365963928|FG000|Overall Study|Lost to Follow-up|4|||
106082089|NCT00480636|365963928|FG000|Overall Study|Other|2|||
106082090|NCT00480636|365963928|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
106082091|NCT02583256|365963929|FG000|Overall Study|Withdrawal by Subject|0|||
106082092|NCT02583256|365963930|FG001|Overall Study|Withdrawal by Subject|1|||
106082093|NCT02583256|365963931|FG002|Overall Study|Withdrawal by Subject|1|||
106082094|NCT02583256|365963932|FG003|Overall Study|Withdrawal by Subject|0|||
106082095|NCT02583256|365963929|FG000|Overall Study|Lost to Follow-up|1|||
106082096|NCT02583256|365963930|FG001|Overall Study|Lost to Follow-up|1|||
106082097|NCT02583256|365963931|FG002|Overall Study|Lost to Follow-up|0|||
106082098|NCT02583256|365963932|FG003|Overall Study|Lost to Follow-up|1|||
106082099|NCT02583256|365963929|FG000|Overall Study|Administrative/Other|2|||
106082100|NCT02583256|365963930|FG001|Overall Study|Administrative/Other|0|||
106082101|NCT02583256|365963931|FG002|Overall Study|Administrative/Other|1|||
106082102|NCT02583256|365963932|FG003|Overall Study|Administrative/Other|2|||
106082103|NCT00654628|365963942|FG000|6-week Active Treatment Period|Adverse Event|9|||
106082104|NCT00654628|365963942|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
106082105|NCT00654628|365963942|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
106082106|NCT00654628|365963942|FG000|6-week Active Treatment Period|Out of window period|1|||
106082107|NCT00654628|365963942|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
106082108|NCT00654628|365963942|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
106082109|NCT04537806|365963945|FG000|Overall Study|Randomized but not treated|1|||
106082110|NCT04537806|365963946|FG001|Overall Study|Randomized but not treated|0|||
106082111|NCT04537806|365963945|FG000|Overall Study|Adverse Event|1|||
106082112|NCT04537806|365963946|FG001|Overall Study|Adverse Event|1|||
106082113|NCT03019627|365963950|FG000|Overall Study|Adverse Event|8|||
106082114|NCT03019627|365963951|FG001|Overall Study|Adverse Event|0|||
106082115|NCT03019627|365963950|FG000|Overall Study|Unrelated to adverse event|1|||
106082116|NCT03019627|365963951|FG001|Overall Study|Unrelated to adverse event|3|||
106082117|NCT03019627|365963950|FG000|Overall Study|Lost to Follow-up|2|||
106082118|NCT03019627|365963951|FG001|Overall Study|Lost to Follow-up|1|||
106082119|NCT03019627|365963950|FG000|Overall Study|not compliance|2|||
106082120|NCT03019627|365963951|FG001|Overall Study|not compliance|2|||
106082121|NCT03019627|365963950|FG000|Overall Study|Other|2|||
106082122|NCT03019627|365963951|FG001|Overall Study|Other|2|||
106082123|NCT03364049|365963952|FG000|Overall Study|Death|6|||
106082124|NCT03364049|365963953|FG001|Overall Study|Death|4|||
105867117|NCT04895982|365163151|FG010|Overall Study|Other|0|||
106082125|NCT03364049|365963954|FG002|Overall Study|Death|5|||
106082126|NCT03364049|365963955|FG003|Overall Study|Death|14|||
106082127|NCT03364049|365963952|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
106082128|NCT03364049|365963953|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
106082129|NCT03364049|365963954|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
106082130|NCT03364049|365963955|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
106082131|NCT03364049|365963952|FG000|Overall Study|Withdrawal by Subject|0|||
106082132|NCT03364049|365963953|FG001|Overall Study|Withdrawal by Subject|1|||
106082133|NCT03364049|365963954|FG002|Overall Study|Withdrawal by Subject|1|||
106082134|NCT03364049|365963955|FG003|Overall Study|Withdrawal by Subject|1|||
106082135|NCT00953329|365963956|FG000|Overall Study|Lack of Efficacy|1|||
106082136|NCT03277261|365963961|FG000|Overall Study|Adverse Event|17|||
106082137|NCT03277261|365963962|FG001|Overall Study|Adverse Event|1|||
106082138|NCT03277261|365963961|FG000|Overall Study|Participant Withdrawal of Consent|6|||
106082139|NCT03277261|365963962|FG001|Overall Study|Participant Withdrawal of Consent|15|||
106082140|NCT03277261|365963961|FG000|Overall Study|Investigator / Sponsor Decision|4|||
106082141|NCT03277261|365963962|FG001|Overall Study|Investigator / Sponsor Decision|2|||
106082142|NCT03277261|365963961|FG000|Overall Study|Pregnancy|2|||
106082143|NCT03277261|365963962|FG001|Overall Study|Pregnancy|0|||
106082144|NCT03277261|365963961|FG000|Overall Study|Lost to Follow-up|2|||
106082145|NCT03277261|365963962|FG001|Overall Study|Lost to Follow-up|2|||
106082146|NCT03277261|365963961|FG000|Overall Study|Lack of Efficacy|2|||
106082147|NCT03277261|365963962|FG001|Overall Study|Lack of Efficacy|2|||
106082148|NCT03277261|365963961|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
106082149|NCT03277261|365963962|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
106082150|NCT01252290|365963963|FG000|Overall Study|Withdrawal by Subject|1|||
106082151|NCT00378014|365963964|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
106082152|NCT00378014|365963965|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
106082153|NCT00378014|365963964|FG000|Core (Randomization to Month 11)|Graft loss|1|||
106082154|NCT00378014|365963965|FG001|Core (Randomization to Month 11)|Graft loss|2|||
106082155|NCT00378014|365963964|FG000|Core (Randomization to Month 11)|Death|5|||
106082156|NCT00378014|365963965|FG001|Core (Randomization to Month 11)|Death|3|||
106082157|NCT00378014|365963964|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
106082158|NCT00378014|365963965|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
106082159|NCT00378014|365963964|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
106082160|NCT00378014|365963965|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
106082161|NCT00378014|365963964|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
106082162|NCT00378014|365963965|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
106082163|NCT00378014|365963964|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
106082164|NCT00378014|365963965|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
106082165|NCT00378014|365963964|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
106082166|NCT00378014|365963965|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
106082167|NCT00378014|365963964|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
106082168|NCT00378014|365963965|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
106082169|NCT00378014|365963964|FG000|Extension (Month 12 to Month 59)|Death|1|||
106082170|NCT00378014|365963965|FG001|Extension (Month 12 to Month 59)|Death|2|||
106082171|NCT00378014|365963964|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
106082172|NCT00378014|365963965|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
106082173|NCT00378014|365963964|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
106082174|NCT00378014|365963965|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
106082175|NCT00378014|365963964|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
106082176|NCT00378014|365963965|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
106082177|NCT00378014|365963964|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
106082178|NCT00378014|365963965|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
106082179|NCT05179421|365963966|FG000|First Infusion Day|Adverse Event|1|||
106082180|NCT05179421|365963967|FG001|First Infusion Day|Adverse Event|0|||
106082181|NCT01857063|365963968|FG000|Period 1 (7 Days)|Adverse Event|0|||
106082182|NCT01857063|365963969|FG001|Period 1 (7 Days)|Adverse Event|1|||
106082183|NCT01857063|365963968|FG000|Period 1 (7 Days)|Physician Decision|1|||
106082184|NCT01857063|365963969|FG001|Period 1 (7 Days)|Physician Decision|0|||
106082185|NCT01857063|365963968|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
106082186|NCT01857063|365963969|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
106082187|NCT01857063|365963968|FG000|Period 2 (7 Days)|Adverse Event|2|||
106082188|NCT01857063|365963969|FG001|Period 2 (7 Days)|Adverse Event|1|||
106082189|NCT01857063|365963968|FG000|Period 2 (7 Days)|Physician Decision|1|||
106082190|NCT01857063|365963969|FG001|Period 2 (7 Days)|Physician Decision|1|||
106160439|NCT04072822|366247497|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
106082191|NCT01857063|365963968|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
106082192|NCT01857063|365963969|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
106082193|NCT04958109|365963970|FG000|Overall Study|Withdrawal by Subject|0|||
106082194|NCT04958109|365963971|FG001|Overall Study|Withdrawal by Subject|1|||
106082195|NCT04958109|365963970|FG000|Overall Study|Lost to Follow-up|0|||
106082196|NCT04958109|365963971|FG001|Overall Study|Lost to Follow-up|1|||
106082197|NCT01205165|365963973|FG000|Overall Study|Lost to Follow-up|2|||
106082198|NCT02346240|365963976|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082199|NCT02346240|365963977|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
106082200|NCT02346240|365963978|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
106082201|NCT02346240|365963979|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
106082202|NCT02346240|365963980|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082203|NCT02346240|365963981|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082204|NCT02346240|365963982|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082205|NCT02346240|365963983|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082206|NCT02346240|365963984|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082207|NCT02346240|365963985|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082208|NCT02346240|365963986|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082209|NCT02346240|365963987|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082210|NCT02346240|365963988|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082211|NCT02346240|365963989|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082212|NCT02346240|365963990|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082213|NCT02346240|365963991|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082214|NCT02346240|365963992|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082215|NCT02346240|365963993|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082216|NCT02346240|365963994|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082217|NCT02346240|365963995|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082218|NCT02346240|365963996|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082219|NCT02346240|365963997|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082220|NCT02346240|365963998|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082221|NCT02346240|365963999|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
106082222|NCT02346240|365963976|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082223|NCT02346240|365963977|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
106082224|NCT02346240|365963978|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082225|NCT02346240|365963979|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082226|NCT02346240|365963980|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082227|NCT02346240|365963981|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082228|NCT02346240|365963982|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082229|NCT02346240|365963983|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082230|NCT02346240|365963984|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082231|NCT02346240|365963985|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082232|NCT02346240|365963986|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082233|NCT02346240|365963987|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082234|NCT02346240|365963988|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082235|NCT02346240|365963989|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082236|NCT02346240|365963990|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082237|NCT02346240|365963991|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082238|NCT02346240|365963992|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082239|NCT02346240|365963993|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082240|NCT02346240|365963994|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082241|NCT02346240|365963995|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082242|NCT02346240|365963996|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082243|NCT02346240|365963997|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082244|NCT02346240|365963998|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082245|NCT02346240|365963999|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
106082246|NCT02346240|365963976|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082247|NCT02346240|365963977|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
106082248|NCT02346240|365963978|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082249|NCT02346240|365963979|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082250|NCT02346240|365963980|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082251|NCT02346240|365963981|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082252|NCT02346240|365963982|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082253|NCT02346240|365963983|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082254|NCT02346240|365963984|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082255|NCT02346240|365963985|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082256|NCT02346240|365963986|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082257|NCT02346240|365963987|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082258|NCT02346240|365963988|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082259|NCT02346240|365963989|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082260|NCT02346240|365963990|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082261|NCT02346240|365963991|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082262|NCT02346240|365963992|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082263|NCT02346240|365963993|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082264|NCT02346240|365963994|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082265|NCT02346240|365963995|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082266|NCT02346240|365963996|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082267|NCT02346240|365963997|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082268|NCT02346240|365963998|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082269|NCT02346240|365963999|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
106082270|NCT02346240|365963976|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
106082271|NCT02346240|365963977|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
106082272|NCT02346240|365963978|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
105867118|NCT04895982|365163152|FG011|Overall Study|Other|0|||
106082273|NCT02346240|365963979|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
106082274|NCT02346240|365963980|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082275|NCT02346240|365963981|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082276|NCT02346240|365963982|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082277|NCT02346240|365963983|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082278|NCT02346240|365963984|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082279|NCT02346240|365963985|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082280|NCT02346240|365963986|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082281|NCT02346240|365963987|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082282|NCT02346240|365963988|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082283|NCT02346240|365963989|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082284|NCT02346240|365963990|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082285|NCT02346240|365963991|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082286|NCT02346240|365963992|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082287|NCT02346240|365963993|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082288|NCT02346240|365963994|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082289|NCT02346240|365963995|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082290|NCT02346240|365963996|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082291|NCT02346240|365963997|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082292|NCT02346240|365963998|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082293|NCT02346240|365963999|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
106082294|NCT02346240|365963976|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
106082295|NCT02346240|365963977|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
106082296|NCT02346240|365963978|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
106082297|NCT02346240|365963979|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
106082298|NCT02346240|365963980|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082299|NCT02346240|365963981|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082300|NCT02346240|365963982|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082301|NCT02346240|365963983|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082302|NCT02346240|365963984|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082303|NCT02346240|365963985|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082304|NCT02346240|365963986|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082305|NCT02346240|365963987|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082306|NCT02346240|365963988|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082307|NCT02346240|365963989|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082308|NCT02346240|365963990|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082309|NCT02346240|365963991|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082310|NCT02346240|365963992|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082311|NCT02346240|365963993|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082312|NCT02346240|365963994|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082313|NCT02346240|365963995|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082314|NCT02346240|365963996|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082315|NCT02346240|365963997|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082316|NCT02346240|365963998|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082317|NCT02346240|365963999|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
106082318|NCT02346240|365963976|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082319|NCT02346240|365963977|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
106082320|NCT02346240|365963978|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082321|NCT02346240|365963979|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
106082322|NCT02346240|365963980|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082323|NCT02346240|365963981|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082324|NCT02346240|365963982|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082325|NCT02346240|365963983|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082326|NCT02346240|365963984|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082327|NCT02346240|365963985|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082328|NCT02346240|365963986|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082329|NCT02346240|365963987|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082330|NCT02346240|365963988|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082331|NCT02346240|365963989|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082332|NCT02346240|365963990|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082333|NCT02346240|365963991|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082334|NCT02346240|365963992|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082335|NCT02346240|365963993|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082336|NCT02346240|365963994|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082337|NCT02346240|365963995|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082338|NCT02346240|365963996|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082339|NCT02346240|365963997|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082340|NCT02346240|365963998|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082341|NCT02346240|365963999|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
106082342|NCT02346240|365963976|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082343|NCT02346240|365963977|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082344|NCT02346240|365963978|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
106082345|NCT02346240|365963979|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082346|NCT02346240|365963980|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082347|NCT02346240|365963981|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082348|NCT02346240|365963982|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082349|NCT02346240|365963983|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082350|NCT02346240|365963984|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082351|NCT02346240|365963985|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082352|NCT02346240|365963986|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082353|NCT02346240|365963987|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082354|NCT02346240|365963988|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082355|NCT02346240|365963989|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082356|NCT02346240|365963990|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082357|NCT02346240|365963991|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082358|NCT02346240|365963992|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082359|NCT02346240|365963993|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082360|NCT02346240|365963994|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082361|NCT02346240|365963995|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082362|NCT02346240|365963996|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082363|NCT02346240|365963997|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082364|NCT02346240|365963998|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082365|NCT02346240|365963999|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
106082366|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082367|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082368|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082369|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082370|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082371|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082372|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082373|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
106082374|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
106082375|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082376|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082377|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082378|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082379|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
106082380|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
106082381|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
106082382|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
106082383|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082384|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082385|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082386|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082387|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082388|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082389|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
106082390|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082391|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082392|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082393|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082394|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082395|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082396|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082397|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082398|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082399|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082400|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082401|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082402|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082403|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
106082404|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082405|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
106082406|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082407|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082408|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082409|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082410|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082411|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082412|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082413|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
106082414|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082415|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082416|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082417|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082418|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082419|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082420|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082421|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082422|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082423|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082424|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082425|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082426|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082427|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082428|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
106082429|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082430|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082431|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082432|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082433|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082434|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082435|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082436|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082437|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
106082438|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082439|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082440|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082441|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082442|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082443|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
106082444|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
106082445|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
106082446|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
106082447|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082448|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
106082449|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
106082450|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082451|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
106082452|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
106082453|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
106082454|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
105867119|NCT04895982|365163141|FG000|Overall Study|Protocol Violation|0|||
105867120|NCT04895982|365163142|FG001|Overall Study|Protocol Violation|0|||
106082455|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082456|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082457|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082458|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082459|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082460|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082461|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
106082462|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082463|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082464|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082465|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082466|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082467|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082468|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082469|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082470|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082471|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082472|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082473|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082474|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082475|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
106082476|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
106082477|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
106082478|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
106082479|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082480|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082481|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082482|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082483|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082484|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082485|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
106082486|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082487|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082488|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082489|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082490|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082491|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082492|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
106082493|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082494|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082495|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082496|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082497|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082498|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082499|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082500|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082501|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082502|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082503|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082504|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082505|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082506|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082507|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082508|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082509|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
106082510|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082511|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082512|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082513|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082514|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082515|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082516|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082517|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082518|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
106082519|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082520|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082521|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
105867121|NCT04895982|365163143|FG002|Overall Study|Protocol Violation|1|||
106082522|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082523|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
106082524|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
106082525|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106097398|NCT01715805|366014396|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
106082526|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082527|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082528|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082529|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082530|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082531|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082532|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082533|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
106082534|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082535|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082536|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082537|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082538|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082539|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082540|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082541|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082542|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082543|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
106082544|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082545|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082546|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082547|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082548|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082549|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082550|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082551|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082552|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082553|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082554|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082555|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082556|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082557|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
106082558|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082559|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082560|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082561|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082562|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082563|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106160440|NCT04072822|366247498|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
106160441|NCT04072822|366247497|FG000|Treatment|Withdrawal by Subject|0|||
106160442|NCT04072822|366247498|FG001|Treatment|Withdrawal by Subject|2|||
106160443|NCT04072822|366247497|FG000|Treatment|Death|0|||
106160444|NCT04072822|366247498|FG001|Treatment|Death|2|||
106160445|NCT04072822|366247497|FG000|Treatment|Lost to Follow-up|11|||
106160446|NCT04072822|366247498|FG001|Treatment|Lost to Follow-up|3|||
106160447|NCT04072822|366247497|FG000|Treatment|Physician Decision|1|||
106160448|NCT04072822|366247498|FG001|Treatment|Physician Decision|0|||
106160449|NCT04072822|366247497|FG000|Treatment|Other|7|||
106160450|NCT04072822|366247498|FG001|Treatment|Other|9|||
106160451|NCT04072822|366247497|FG000|Follow-up|Withdrawal by Subject|1|||
106160452|NCT04072822|366247498|FG001|Follow-up|Withdrawal by Subject|0|||
106160453|NCT04072822|366247497|FG000|Follow-up|Lost to Follow-up|5|||
106160454|NCT04072822|366247498|FG001|Follow-up|Lost to Follow-up|4|||
106160455|NCT05076708|366247502|FG000|Overall Study|Withdrawal by Subject|4|||
106160456|NCT05076708|366247502|FG000|Overall Study|Lost to study during switch phase|8|||
106160457|NCT04763265|366247503|FG000|Overall Study|Adverse Event|1|||
106160458|NCT04763265|366247504|FG001|Overall Study|Adverse Event|0|||
106160459|NCT04763265|366247503|FG000|Overall Study|Lost to Follow-up|2|||
106160460|NCT04763265|366247504|FG001|Overall Study|Lost to Follow-up|4|||
106160461|NCT04763265|366247503|FG000|Overall Study|Withdrawal by Subject|0|||
106160462|NCT04763265|366247504|FG001|Overall Study|Withdrawal by Subject|1|||
106160463|NCT04221490|366247507|FG000|At 30 Days Follow-up|Death|7|||
106160464|NCT04221490|366247507|FG000|At 30 Days Follow-up|Missed Visit|4|||
106082564|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082565|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082566|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082567|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082568|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
106082569|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082570|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082571|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082572|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082573|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082574|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082575|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082576|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082577|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082578|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082579|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082580|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082581|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
106082582|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082583|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082584|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082585|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082586|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082587|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082588|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082589|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082590|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082591|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082592|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082593|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082594|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082595|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082596|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
106082597|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082598|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082599|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082600|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082601|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082602|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082603|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082604|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082605|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
106082606|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082607|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082608|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082609|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082610|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082611|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082612|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082613|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082614|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082615|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082616|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082617|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082618|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082619|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082620|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
106082621|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082622|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082623|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082624|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082625|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082626|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082627|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082628|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082629|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
106082630|NCT02346240|365963976|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082631|NCT02346240|365963977|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082632|NCT02346240|365963978|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082633|NCT02346240|365963979|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082634|NCT02346240|365963980|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082635|NCT02346240|365963981|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082636|NCT02346240|365963982|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082637|NCT02346240|365963983|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082638|NCT02346240|365963984|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082639|NCT02346240|365963985|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082640|NCT02346240|365963986|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082641|NCT02346240|365963987|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082642|NCT02346240|365963988|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082643|NCT02346240|365963989|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082644|NCT02346240|365963990|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
106082645|NCT02346240|365963991|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082646|NCT02346240|365963992|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082647|NCT02346240|365963993|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082648|NCT02346240|365963994|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082649|NCT02346240|365963995|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082650|NCT02346240|365963996|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082651|NCT02346240|365963997|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082652|NCT02346240|365963998|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082653|NCT02346240|365963999|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
106082654|NCT02346240|365963976|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082655|NCT02346240|365963977|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082656|NCT02346240|365963978|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082657|NCT02346240|365963979|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082658|NCT02346240|365963980|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082659|NCT02346240|365963981|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082660|NCT02346240|365963982|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082661|NCT02346240|365963983|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082662|NCT02346240|365963984|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082663|NCT02346240|365963985|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082664|NCT02346240|365963986|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082665|NCT02346240|365963987|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082666|NCT02346240|365963988|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082667|NCT02346240|365963989|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082668|NCT02346240|365963990|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082669|NCT02346240|365963991|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082670|NCT02346240|365963992|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
106082671|NCT02346240|365963993|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
106082672|NCT02346240|365963994|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
106082673|NCT02346240|365963995|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
106082674|NCT02346240|365963996|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
106082675|NCT02346240|365963997|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
106082676|NCT02346240|365963998|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
106082677|NCT02346240|365963999|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
106082678|NCT02346240|365963976|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082679|NCT02346240|365963977|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082680|NCT02346240|365963978|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082681|NCT02346240|365963979|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
105867122|NCT04895982|365163144|FG003|Overall Study|Protocol Violation|1|||
106082682|NCT02346240|365963980|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082683|NCT02346240|365963981|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082684|NCT02346240|365963982|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082685|NCT02346240|365963983|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082686|NCT02346240|365963984|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082687|NCT02346240|365963985|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082688|NCT02346240|365963986|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082689|NCT02346240|365963987|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082690|NCT02346240|365963988|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082691|NCT02346240|365963989|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082692|NCT02346240|365963990|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082693|NCT02346240|365963991|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082694|NCT02346240|365963992|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082695|NCT02346240|365963993|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082696|NCT02346240|365963994|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
106082697|NCT02346240|365963995|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
106082698|NCT02346240|365963996|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082699|NCT02346240|365963997|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
106082700|NCT02346240|365963998|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082701|NCT02346240|365963999|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
106082702|NCT02346240|365963976|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082703|NCT02346240|365963977|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082704|NCT02346240|365963978|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082705|NCT02346240|365963979|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082706|NCT02346240|365963980|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082707|NCT02346240|365963981|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082708|NCT02346240|365963982|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082709|NCT02346240|365963983|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082710|NCT02346240|365963984|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082711|NCT02346240|365963985|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082712|NCT02346240|365963986|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082713|NCT02346240|365963987|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106160465|NCT04221490|366247507|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
106160466|NCT04221490|366247507|FG000|At 6 Months Follow-up|Death|9|||
106160467|NCT04221490|366247507|FG000|At 6 Months Follow-up|Physician Decision|1|||
106160468|NCT04221490|366247507|FG000|At 6 Months Follow-up|Missed Visit|8|||
106160469|NCT04221490|366247507|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
106160470|NCT04456517|366247510|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
106160471|NCT04456517|366247511|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
106160472|NCT02919683|366247512|FG000|Post-Surgery Follow-Up|Death|2|||
106160473|NCT02919683|366247513|FG001|Post-Surgery Follow-Up|Death|2|||
106160474|NCT02919683|366247512|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
106160475|NCT02919683|366247513|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
106160476|NCT03315754|366248978|FG000|Overall Study|COVID-19 complications leading to death|1|||
106160477|NCT03315754|366248978|FG000|Overall Study|insurance coverage issue|1|||
106160478|NCT03623321|366248979|FG000|Overall Study|Adverse Event|32|||
106160479|NCT03623321|366248979|FG000|Overall Study|Death|9|||
106160480|NCT03623321|366248979|FG000|Overall Study|Lack of Efficacy|9|||
106160481|NCT03623321|366248979|FG000|Overall Study|Lost to Follow-up|6|||
106160482|NCT03623321|366248979|FG000|Overall Study|Noncompliance with study drug|6|||
106160483|NCT03623321|366248979|FG000|Overall Study|Use of prohibited medication|3|||
106160484|NCT03623321|366248979|FG000|Overall Study|Physician Decision|5|||
106160485|NCT03623321|366248979|FG000|Overall Study|Protocol Violation|1|||
106160486|NCT03623321|366248979|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
106160487|NCT03623321|366248979|FG000|Overall Study|Not further specified|43|||
106160488|NCT04492007|366248982|FG000|Overall Study|Lost to Follow-up|1|||
106160489|NCT04492007|366248983|FG001|Overall Study|Lost to Follow-up|1|||
106160490|NCT04492007|366248984|FG002|Overall Study|Lost to Follow-up|2|||
106082714|NCT02346240|365963988|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082715|NCT02346240|365963989|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082716|NCT02346240|365963990|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082717|NCT02346240|365963991|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082718|NCT02346240|365963992|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082719|NCT02346240|365963993|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082720|NCT02346240|365963994|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
106082721|NCT02346240|365963995|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082722|NCT02346240|365963996|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082723|NCT02346240|365963997|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
106082724|NCT02346240|365963998|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082725|NCT02346240|365963999|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
106082726|NCT02346240|365963976|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082727|NCT02346240|365963977|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082728|NCT02346240|365963978|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082729|NCT02346240|365963979|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082730|NCT02346240|365963980|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082731|NCT02346240|365963981|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082732|NCT02346240|365963982|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082733|NCT02346240|365963983|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082734|NCT02346240|365963984|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082735|NCT02346240|365963985|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082736|NCT02346240|365963986|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082737|NCT02346240|365963987|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082738|NCT02346240|365963988|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082739|NCT02346240|365963989|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082740|NCT02346240|365963990|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082741|NCT02346240|365963991|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082742|NCT02346240|365963992|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082743|NCT02346240|365963993|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082744|NCT02346240|365963994|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082745|NCT02346240|365963995|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082746|NCT02346240|365963996|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082747|NCT02346240|365963997|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
106082748|NCT02346240|365963998|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082749|NCT02346240|365963999|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
106082750|NCT02346240|365963976|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082751|NCT02346240|365963977|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082752|NCT02346240|365963978|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082753|NCT02346240|365963979|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082754|NCT02346240|365963980|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082755|NCT02346240|365963981|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082756|NCT02346240|365963982|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082757|NCT02346240|365963983|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082758|NCT02346240|365963984|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082759|NCT02346240|365963985|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082760|NCT02346240|365963986|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082761|NCT02346240|365963987|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082762|NCT02346240|365963988|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082763|NCT02346240|365963989|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082764|NCT02346240|365963990|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082765|NCT02346240|365963991|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082766|NCT02346240|365963992|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082767|NCT02346240|365963993|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
106082768|NCT02346240|365963994|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
106082769|NCT02346240|365963995|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
106082770|NCT02346240|365963996|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
106082771|NCT02346240|365963997|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
106082772|NCT02346240|365963998|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
106082773|NCT02346240|365963999|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
106082774|NCT02346240|365963976|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082775|NCT02346240|365963977|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082776|NCT02346240|365963978|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082777|NCT02346240|365963979|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082778|NCT02346240|365963980|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082779|NCT02346240|365963981|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082780|NCT02346240|365963982|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082781|NCT02346240|365963983|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082782|NCT02346240|365963984|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082783|NCT02346240|365963985|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082784|NCT02346240|365963986|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082785|NCT02346240|365963987|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082786|NCT02346240|365963988|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082787|NCT02346240|365963989|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082788|NCT02346240|365963990|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082789|NCT02346240|365963991|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082790|NCT02346240|365963992|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082791|NCT02346240|365963993|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082792|NCT02346240|365963994|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
106082793|NCT02346240|365963995|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
106082794|NCT02346240|365963996|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
106082795|NCT02346240|365963997|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
106082796|NCT02346240|365963998|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
106082797|NCT02346240|365963999|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
106082798|NCT02346240|365963976|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082799|NCT02346240|365963977|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082800|NCT02346240|365963978|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082801|NCT02346240|365963979|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082802|NCT02346240|365963980|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082803|NCT02346240|365963981|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082804|NCT02346240|365963982|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082805|NCT02346240|365963983|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082806|NCT02346240|365963984|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082807|NCT02346240|365963985|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082808|NCT02346240|365963986|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082809|NCT02346240|365963987|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082810|NCT02346240|365963988|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082811|NCT02346240|365963989|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082812|NCT02346240|365963990|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082813|NCT02346240|365963991|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082814|NCT02346240|365963992|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082815|NCT02346240|365963993|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082816|NCT02346240|365963994|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
106082817|NCT02346240|365963995|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082818|NCT02346240|365963996|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
106082819|NCT02346240|365963997|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
106082820|NCT02346240|365963998|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
106082821|NCT02346240|365963999|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
106082822|NCT02346240|365963976|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082823|NCT02346240|365963977|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082824|NCT02346240|365963978|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082825|NCT02346240|365963979|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082826|NCT02346240|365963980|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082827|NCT02346240|365963981|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082828|NCT02346240|365963982|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082829|NCT02346240|365963983|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082830|NCT02346240|365963984|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082831|NCT02346240|365963985|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082832|NCT02346240|365963986|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082833|NCT02346240|365963987|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082834|NCT02346240|365963988|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082835|NCT02346240|365963989|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082836|NCT02346240|365963990|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082837|NCT02346240|365963991|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106160491|NCT04492007|366248985|FG003|Overall Study|Lost to Follow-up|2|||
106082838|NCT02346240|365963992|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082839|NCT02346240|365963993|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082840|NCT02346240|365963994|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
106082841|NCT02346240|365963995|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082842|NCT02346240|365963996|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082843|NCT02346240|365963997|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082844|NCT02346240|365963998|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082845|NCT02346240|365963999|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
106082846|NCT03306264|365964000|FG000|Overall Study|Death|33|||
106082847|NCT03306264|365964001|FG001|Overall Study|Death|25|||
106082848|NCT03306264|365964002|FG002|Overall Study|Death|34|||
106082849|NCT03306264|365964003|FG003|Overall Study|Death|34|||
106082850|NCT03306264|365964000|FG000|Overall Study|Complete Consent Withdrawal|4|||
106082851|NCT03306264|365964001|FG001|Overall Study|Complete Consent Withdrawal|4|||
106082852|NCT03306264|365964002|FG002|Overall Study|Complete Consent Withdrawal|1|||
106082853|NCT03306264|365964003|FG003|Overall Study|Complete Consent Withdrawal|8|||
106082854|NCT03306264|365964000|FG000|Overall Study|Lost to Follow-up|1|||
106082855|NCT03306264|365964001|FG001|Overall Study|Lost to Follow-up|0|||
106082856|NCT03306264|365964002|FG002|Overall Study|Lost to Follow-up|1|||
106082857|NCT03306264|365964003|FG003|Overall Study|Lost to Follow-up|0|||
106082858|NCT03306264|365964000|FG000|Overall Study|Rollover to ASTX727-06|10|||
106082859|NCT03306264|365964001|FG001|Overall Study|Rollover to ASTX727-06|18|||
106082860|NCT03306264|365964002|FG002|Overall Study|Rollover to ASTX727-06|4|||
106082861|NCT03306264|365964003|FG003|Overall Study|Rollover to ASTX727-06|2|||
106082862|NCT03306264|365964000|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
106082863|NCT03306264|365964001|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
106082864|NCT03306264|365964002|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
106082865|NCT03306264|365964003|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
106082866|NCT01849588|365964004|FG000|Overall Study|Lack of Efficacy|3|||
106082867|NCT02143843|365964005|FG000|Overall Study|Adverse Event|8|||
106082868|NCT02143843|365964005|FG000|Overall Study|Lack of Efficacy|2|||
106082869|NCT02143843|365964005|FG000|Overall Study|Withdrawal by Subject|2|||
106082870|NCT01822132|365964006|FG000|Overall Study|Lost to Follow-up|4|||
106082871|NCT01822132|365964007|FG001|Overall Study|Lost to Follow-up|2|||
106082872|NCT04847674|365964009|FG000|Overall Study|Withdrawal by Subject|0|||
106082873|NCT04847674|365964010|FG001|Overall Study|Withdrawal by Subject|1|||
106082874|NCT04847674|365964011|FG002|Overall Study|Withdrawal by Subject|0|||
106082875|NCT04847674|365964009|FG000|Overall Study|Lost to Follow-up|0|||
106082876|NCT04847674|365964010|FG001|Overall Study|Lost to Follow-up|0|||
106082877|NCT04847674|365964011|FG002|Overall Study|Lost to Follow-up|2|||
106082878|NCT04847674|365964009|FG000|Overall Study|Other than specified|21|||
106082879|NCT04847674|365964010|FG001|Overall Study|Other than specified|20|||
106082880|NCT04847674|365964011|FG002|Overall Study|Other than specified|20|||
106082881|NCT02563028|365964012|FG000|Overall Study|Lack of equipment|1|||
106082882|NCT02563028|365964012|FG000|Overall Study|Unable to elicit VEP post induction|1|||
106082883|NCT00378703|365964013|FG000|Overall Study|Disease progression|59|||
106082884|NCT00378703|365964014|FG001|Overall Study|Disease progression|43|||
106082885|NCT00378703|365964015|FG002|Overall Study|Disease progression|48|||
106082886|NCT00378703|365964016|FG003|Overall Study|Disease progression|49|||
106082887|NCT00378703|365964013|FG000|Overall Study|Adverse Event|11|||
106082888|NCT00378703|365964014|FG001|Overall Study|Adverse Event|17|||
106082889|NCT00378703|365964015|FG002|Overall Study|Adverse Event|20|||
106082890|NCT00378703|365964016|FG003|Overall Study|Adverse Event|18|||
106082891|NCT00378703|365964013|FG000|Overall Study|Death|2|||
106082892|NCT00378703|365964014|FG001|Overall Study|Death|2|||
106082893|NCT00378703|365964015|FG002|Overall Study|Death|4|||
106082894|NCT00378703|365964016|FG003|Overall Study|Death|3|||
106082895|NCT00378703|365964013|FG000|Overall Study|Withdrawal by Subject|4|||
106082896|NCT00378703|365964014|FG001|Overall Study|Withdrawal by Subject|8|||
106082897|NCT00378703|365964015|FG002|Overall Study|Withdrawal by Subject|5|||
106082898|NCT00378703|365964016|FG003|Overall Study|Withdrawal by Subject|7|||
106082899|NCT00378703|365964013|FG000|Overall Study|Physician Decision|1|||
106082900|NCT00378703|365964014|FG001|Overall Study|Physician Decision|4|||
106082901|NCT00378703|365964015|FG002|Overall Study|Physician Decision|1|||
106082902|NCT00378703|365964016|FG003|Overall Study|Physician Decision|0|||
106082903|NCT00378703|365964013|FG000|Overall Study|Alternative therapy|4|||
106082904|NCT00378703|365964014|FG001|Overall Study|Alternative therapy|2|||
106082905|NCT00378703|365964015|FG002|Overall Study|Alternative therapy|0|||
106082906|NCT00378703|365964016|FG003|Overall Study|Alternative therapy|0|||
106082907|NCT00378703|365964013|FG000|Overall Study|Other complicated disease|0|||
106082908|NCT00378703|365964014|FG001|Overall Study|Other complicated disease|2|||
106082909|NCT00378703|365964015|FG002|Overall Study|Other complicated disease|2|||
106082910|NCT00378703|365964016|FG003|Overall Study|Other complicated disease|0|||
106082911|NCT00378703|365964013|FG000|Overall Study|Symptomatic deterioration|0|||
106082912|NCT00378703|365964014|FG001|Overall Study|Symptomatic deterioration|1|||
106082913|NCT00378703|365964015|FG002|Overall Study|Symptomatic deterioration|0|||
106082914|NCT00378703|365964016|FG003|Overall Study|Symptomatic deterioration|2|||
106082915|NCT00378703|365964013|FG000|Overall Study|Surgery|1|||
106082916|NCT00378703|365964014|FG001|Overall Study|Surgery|0|||
106082917|NCT00378703|365964015|FG002|Overall Study|Surgery|0|||
106082918|NCT00378703|365964016|FG003|Overall Study|Surgery|1|||
106082919|NCT00378703|365964013|FG000|Overall Study|Joint decision of physician and patient|1|||
106082920|NCT00378703|365964014|FG001|Overall Study|Joint decision of physician and patient|0|||
106082921|NCT00378703|365964015|FG002|Overall Study|Joint decision of physician and patient|0|||
106082922|NCT00378703|365964016|FG003|Overall Study|Joint decision of physician and patient|0|||
106082923|NCT00378703|365964013|FG000|Overall Study|Adverse events and progressive disease|0|||
106082924|NCT00378703|365964014|FG001|Overall Study|Adverse events and progressive disease|0|||
106082925|NCT00378703|365964015|FG002|Overall Study|Adverse events and progressive disease|0|||
106082926|NCT00378703|365964016|FG003|Overall Study|Adverse events and progressive disease|1|||
106082927|NCT00378703|365964013|FG000|Overall Study|Relocation|0|||
106082928|NCT00378703|365964014|FG001|Overall Study|Relocation|0|||
106082929|NCT00378703|365964015|FG002|Overall Study|Relocation|1|||
106082930|NCT00378703|365964016|FG003|Overall Study|Relocation|0|||
106082931|NCT00378703|365964013|FG000|Overall Study|Ineligible|4|||
106082932|NCT00378703|365964014|FG001|Overall Study|Ineligible|7|||
106082933|NCT00378703|365964015|FG002|Overall Study|Ineligible|7|||
106082934|NCT00378703|365964016|FG003|Overall Study|Ineligible|7|||
106082935|NCT00378703|365964013|FG000|Overall Study|Never started treatment|1|||
106082936|NCT00378703|365964014|FG001|Overall Study|Never started treatment|4|||
106082937|NCT00378703|365964015|FG002|Overall Study|Never started treatment|0|||
106082938|NCT00378703|365964016|FG003|Overall Study|Never started treatment|0|||
106082939|NCT00378703|365964013|FG000|Overall Study|Other|1|||
106082940|NCT00378703|365964014|FG001|Overall Study|Other|1|||
106082941|NCT00378703|365964015|FG002|Overall Study|Other|2|||
106082942|NCT00378703|365964016|FG003|Overall Study|Other|3|||
106082943|NCT05402995|365964017|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
106082944|NCT05402995|365964018|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
106082945|NCT05402995|365964019|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
106082946|NCT05402995|365964020|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
106082947|NCT02705820|365964021|FG000|Overall Study|Death|2|||
106082948|NCT02705820|365964021|FG000|Overall Study|Disease Progression|34|||
106082949|NCT02705820|365964021|FG000|Overall Study|Clinical Deterioration|3|||
106082950|NCT03181542|365964022|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
106082951|NCT03181542|365964023|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
106082952|NCT01009099|365964024|FG000|Overall Study|Lost to Follow-up|1|||
106082953|NCT01009099|365964025|FG001|Overall Study|Lost to Follow-up|0|||
106082954|NCT01009099|365964024|FG000|Overall Study|Physician Decision|3|||
106082955|NCT01009099|365964025|FG001|Overall Study|Physician Decision|2|||
106082956|NCT01009099|365964024|FG000|Overall Study|Withdrawal by Subject|1|||
106082957|NCT01009099|365964025|FG001|Overall Study|Withdrawal by Subject|1|||
106082958|NCT01009099|365964024|FG000|Overall Study|Death|0|||
106082959|NCT01009099|365964025|FG001|Overall Study|Death|1|||
106082960|NCT02702401|365964026|FG000|Overall Study|Death|242|||
106082961|NCT02702401|365964027|FG001|Overall Study|Death|125|||
106082962|NCT02702401|365964026|FG000|Overall Study|Withdrawal by Subject|15|||
106082963|NCT02702401|365964027|FG001|Overall Study|Withdrawal by Subject|5|||
106082964|NCT02702401|365964026|FG000|Overall Study|Sponsor Decision|19|||
106082965|NCT02702401|365964027|FG001|Overall Study|Sponsor Decision|3|||
106082966|NCT02702401|365964026|FG000|Overall Study|Physician Decision|1|||
106082967|NCT02702401|365964027|FG001|Overall Study|Physician Decision|2|||
106082968|NCT02702401|365964026|FG000|Overall Study|Lost to Follow-up|1|||
106082969|NCT02702401|365964027|FG001|Overall Study|Lost to Follow-up|0|||
106082970|NCT01527292|365964030|FG000|Overall Study|Physician Decision|0|||
106082971|NCT01527292|365964031|FG001|Overall Study|Physician Decision|3|||
106082972|NCT01482767|365964032|FG000|Overall Study|Death|1|||
106082973|NCT01482767|365964033|FG001|Overall Study|Death|1|||
106082974|NCT01482767|365964032|FG000|Overall Study|Withdrawal by Subject|7|||
106082975|NCT01482767|365964033|FG001|Overall Study|Withdrawal by Subject|5|||
106082976|NCT01482767|365964032|FG000|Overall Study|Lost to Follow-up|12|||
106082977|NCT01482767|365964033|FG001|Overall Study|Lost to Follow-up|6|||
106082978|NCT01482767|365964032|FG000|Overall Study|Adverse Event|0|||
106082979|NCT01482767|365964033|FG001|Overall Study|Adverse Event|3|||
106082980|NCT01482767|365964032|FG000|Overall Study|Site closure|22|||
106082981|NCT01482767|365964033|FG001|Overall Study|Site closure|14|||
106082982|NCT01482767|365964032|FG000|Overall Study|Non-adherence to study requirements|4|||
106082983|NCT01482767|365964033|FG001|Overall Study|Non-adherence to study requirements|7|||
106082984|NCT01482767|365964032|FG000|Overall Study|Alternate HCV treatment|7|||
106082985|NCT01482767|365964033|FG001|Overall Study|Alternate HCV treatment|8|||
106082986|NCT01482767|365964032|FG000|Overall Study|Ineligible|0|||
106082987|NCT01482767|365964033|FG001|Overall Study|Ineligible|5|||
106082988|NCT01482767|365964032|FG000|Overall Study|Nurse error|1|||
106082989|NCT01482767|365964033|FG001|Overall Study|Nurse error|0|||
106082990|NCT02457325|365964034|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
106082991|NCT02457325|365964035|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
106082992|NCT01541930|365964036|FG000|Overall Study|Withdrawal by Subject|1|||
106082993|NCT01574703|365964037|FG000|Overall Study|Adverse Event|0|||
106082994|NCT01574703|365964038|FG001|Overall Study|Adverse Event|2|||
106082995|NCT01574703|365964039|FG002|Overall Study|Adverse Event|1|||
106082996|NCT01574703|365964040|FG003|Overall Study|Adverse Event|1|||
106082997|NCT01574703|365964037|FG000|Overall Study|Protocol Violation|0|||
106082998|NCT01574703|365964038|FG001|Overall Study|Protocol Violation|0|||
106082999|NCT01574703|365964039|FG002|Overall Study|Protocol Violation|0|||
106083000|NCT01574703|365964040|FG003|Overall Study|Protocol Violation|1|||
106083001|NCT01574703|365964037|FG000|Overall Study|Unspecified Reason|27|||
106083002|NCT01574703|365964038|FG001|Overall Study|Unspecified Reason|15|||
106083003|NCT01574703|365964039|FG002|Overall Study|Unspecified Reason|20|||
106083004|NCT01574703|365964040|FG003|Overall Study|Unspecified Reason|16|||
106083005|NCT01574703|365964037|FG000|Overall Study|Withdrawal by Subject|53|||
106083006|NCT01574703|365964038|FG001|Overall Study|Withdrawal by Subject|52|||
106083007|NCT01574703|365964039|FG002|Overall Study|Withdrawal by Subject|36|||
106083008|NCT01574703|365964040|FG003|Overall Study|Withdrawal by Subject|61|||
106083009|NCT01574703|365964037|FG000|Overall Study|Met Withdrawal Criteria|0|||
106083010|NCT01574703|365964038|FG001|Overall Study|Met Withdrawal Criteria|1|||
106083011|NCT01574703|365964039|FG002|Overall Study|Met Withdrawal Criteria|1|||
106083012|NCT01574703|365964040|FG003|Overall Study|Met Withdrawal Criteria|0|||
106083013|NCT01574703|365964037|FG000|Overall Study|Lost to Follow-up|43|||
106083014|NCT01574703|365964038|FG001|Overall Study|Lost to Follow-up|41|||
106083015|NCT01574703|365964039|FG002|Overall Study|Lost to Follow-up|46|||
106083016|NCT01574703|365964040|FG003|Overall Study|Lost to Follow-up|35|||
106083017|NCT01574703|365964037|FG000|Overall Study|Death|2|||
106083018|NCT01574703|365964038|FG001|Overall Study|Death|1|||
106083019|NCT01574703|365964039|FG002|Overall Study|Death|1|||
106083020|NCT01574703|365964040|FG003|Overall Study|Death|0|||
106083021|NCT01524770|365964041|FG000|First Intervention|Withdrawal by Subject|1|||
106083022|NCT01524770|365964042|FG001|First Intervention|Withdrawal by Subject|0|||
106083023|NCT01524770|365964041|FG000|First Intervention|Adverse Event|1|||
106083024|NCT01524770|365964042|FG001|First Intervention|Adverse Event|1|||
106083025|NCT01524770|365964041|FG000|First Intervention|Protocol Violation|1|||
106083026|NCT01524770|365964042|FG001|First Intervention|Protocol Violation|0|||
106083027|NCT02167256|365964043|FG000|Overall Study|Adverse Event|13|||
106083028|NCT02167256|365964044|FG001|Overall Study|Adverse Event|6|||
106083029|NCT02167256|365964043|FG000|Overall Study|Withdrawal by Subject|4|||
106083030|NCT02167256|365964044|FG001|Overall Study|Withdrawal by Subject|4|||
106083031|NCT02167256|365964043|FG000|Overall Study|non-compliance|3|||
106083032|NCT02167256|365964044|FG001|Overall Study|non-compliance|0|||
106083033|NCT02167256|365964043|FG000|Overall Study|Study partner unable to participate|1|||
106083034|NCT02167256|365964044|FG001|Overall Study|Study partner unable to participate|0|||
106083035|NCT03139916|365964045|FG000|Overall Study|Withdrawal by Subject|2|||
106083036|NCT03139916|365964045|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
106083037|NCT01957475|365964046|FG000|Test Period 1|Withdrawal by Subject|1|||
106083038|NCT01957475|365964047|FG001|Test Period 1|Withdrawal by Subject|0|||
106083039|NCT01957475|365964046|FG000|Test Period 1|Other|1|||
106083040|NCT01957475|365964047|FG001|Test Period 1|Other|0|||
106083041|NCT01957475|365964046|FG000|Test Period 1|Lack of Efficacy|0|||
106083042|NCT01957475|365964047|FG001|Test Period 1|Lack of Efficacy|1|||
106083043|NCT01957475|365964046|FG000|Test Period 2|Adverse Event|1|||
106083044|NCT01957475|365964047|FG001|Test Period 2|Adverse Event|0|||
106083045|NCT04587193|365964048|FG000|Overall Study|Screen failure after consent|3|||
106083046|NCT04587193|365964049|FG001|Overall Study|Screen failure after consent|0|||
106083047|NCT04587193|365964048|FG000|Overall Study|Device broke during study|3|||
106083048|NCT04587193|365964049|FG001|Overall Study|Device broke during study|2|||
106083049|NCT01552772|365964050|FG000|Overall Study|Lost to Follow-up|2|||
106083050|NCT01552772|365964050|FG000|Overall Study|Adverse Event|1|||
106083051|NCT01552772|365964050|FG000|Overall Study|Protocol Deviation|1|||
106083052|NCT00533949|365966159|FG000|Overall Study|Protocol Violation|12|||
106083053|NCT00533949|365966160|FG001|Overall Study|Protocol Violation|12|||
106083054|NCT00533949|365966161|FG002|Overall Study|Protocol Violation|9|||
106083055|NCT00533949|365966162|FG003|Overall Study|Protocol Violation|9|||
106083056|NCT00533949|365966159|FG000|Overall Study|Withdrawal by Subject|3|||
106083057|NCT00533949|365966160|FG001|Overall Study|Withdrawal by Subject|2|||
106083058|NCT00533949|365966161|FG002|Overall Study|Withdrawal by Subject|1|||
106083059|NCT00533949|365966162|FG003|Overall Study|Withdrawal by Subject|1|||
106083060|NCT00727194|365966163|FG000|Screening Period|Low QMG scores|0|||
106083061|NCT00727194|365966164|FG001|Screening Period|Low QMG scores|0|||
106083062|NCT00727194|365966165|FG002|Screening Period|Low QMG scores|6|||
106083063|NCT00727194|365966163|FG000|Screening Period|Lacked AChR antibodies|0|||
106083064|NCT00727194|365966164|FG001|Screening Period|Lacked AChR antibodies|0|||
106083065|NCT00727194|365966165|FG002|Screening Period|Lacked AChR antibodies|5|||
106083066|NCT00727194|365966163|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
106083067|NCT00727194|365966164|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
106083068|NCT00727194|365966165|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
106083069|NCT00727194|365966163|FG000|Screening Period|Severe infections|0|||
106083070|NCT00727194|365966164|FG001|Screening Period|Severe infections|0|||
106083071|NCT00727194|365966165|FG002|Screening Period|Severe infections|2|||
106083072|NCT00727194|365966163|FG000|Screening Period|History of thymoma|0|||
106083073|NCT00727194|365966164|FG001|Screening Period|History of thymoma|0|||
105867123|NCT04895982|365163145|FG004|Overall Study|Protocol Violation|1|||
105867124|NCT04895982|365163146|FG005|Overall Study|Protocol Violation|0|||
105867125|NCT04895982|365163147|FG006|Overall Study|Protocol Violation|0|||
105867126|NCT04895982|365163148|FG007|Overall Study|Protocol Violation|1|||
105867127|NCT04895982|365163149|FG008|Overall Study|Protocol Violation|0|||
105867128|NCT04895982|365163150|FG009|Overall Study|Protocol Violation|0|||
105867129|NCT04895982|365163151|FG010|Overall Study|Protocol Violation|0|||
105867130|NCT04895982|365163152|FG011|Overall Study|Protocol Violation|0|||
105867131|NCT04895982|365163141|FG000|Overall Study|Lost to Follow-up|0|||
105867132|NCT04895982|365163142|FG001|Overall Study|Lost to Follow-up|0|||
105867133|NCT04895982|365163143|FG002|Overall Study|Lost to Follow-up|1|||
106083074|NCT00727194|365966165|FG002|Screening Period|History of thymoma|1|||
106083075|NCT00727194|365966163|FG000|Treatment Period 2|Lack of Efficacy|0|||
106083076|NCT00727194|365966164|FG001|Treatment Period 2|Lack of Efficacy|1|||
106083077|NCT00727194|365966165|FG002|Treatment Period 2|Lack of Efficacy|0|||
106083078|NCT02472756|365966171|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
106083079|NCT02472756|365966171|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
106083080|NCT02472756|365966171|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
106083081|NCT02472756|365966171|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
106083082|NCT02472756|365966171|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
106083083|NCT01700179|365966173|FG000|Overall Study|Physician Decision|2|||
106083084|NCT00667342|365966174|FG000|Overall Study|Protocol Violation|1|||
106083085|NCT00667342|365966175|FG001|Overall Study|Protocol Violation|0|||
106083086|NCT00667342|365966176|FG002|Overall Study|Protocol Violation|0|||
106083087|NCT00667342|365966174|FG000|Overall Study|Withdrawal by Subject|1|||
106083088|NCT00667342|365966175|FG001|Overall Study|Withdrawal by Subject|0|||
106083089|NCT00667342|365966176|FG002|Overall Study|Withdrawal by Subject|0|||
106083090|NCT00667342|365966174|FG000|Overall Study|Physician Decision|3|||
106083091|NCT00667342|365966175|FG001|Overall Study|Physician Decision|0|||
106083092|NCT00667342|365966176|FG002|Overall Study|Physician Decision|0|||
106083093|NCT00667342|365966174|FG000|Overall Study|Relapse or tumor progression|9|||
106083094|NCT00667342|365966175|FG001|Overall Study|Relapse or tumor progression|0|||
106083095|NCT00667342|365966176|FG002|Overall Study|Relapse or tumor progression|7|||
106083096|NCT00667342|365966174|FG000|Overall Study|Adverse Event|0|||
106083097|NCT00667342|365966175|FG001|Overall Study|Adverse Event|0|||
106083098|NCT00667342|365966176|FG002|Overall Study|Adverse Event|1|||
106083099|NCT00667342|365966174|FG000|Overall Study|Ineligible|0|||
106083100|NCT00667342|365966175|FG001|Overall Study|Ineligible|0|||
106083101|NCT00667342|365966176|FG002|Overall Study|Ineligible|1|||
106083102|NCT00293384|365966182|FG000|Overall Study|Non-compliance|2|||
106083103|NCT00293384|365966182|FG000|Overall Study|Missed dosage/study drug|1|||
106083104|NCT00293384|365966182|FG000|Overall Study|Ineligible|2|||
106083105|NCT00773175|365966183|FG000|Overall Study|Adverse Event|2|||
106083106|NCT00773175|365966184|FG001|Overall Study|Adverse Event|0|||
106083107|NCT00773175|365966183|FG000|Overall Study|Consent Withdrawn|0|||
106083108|NCT00773175|365966184|FG001|Overall Study|Consent Withdrawn|2|||
106083109|NCT02789176|365966189|FG000|Overall Study|Death|0|||
106083110|NCT02789176|365966190|FG001|Overall Study|Death|0|||
106083111|NCT02789176|365966191|FG002|Overall Study|Death|3|||
106083112|NCT02789176|365966192|FG003|Overall Study|Death|0|||
106083113|NCT02789176|365966189|FG000|Overall Study|Withdrawal by Subject|0|||
106083114|NCT02789176|365966190|FG001|Overall Study|Withdrawal by Subject|0|||
106083115|NCT02789176|365966191|FG002|Overall Study|Withdrawal by Subject|1|||
106083116|NCT02789176|365966192|FG003|Overall Study|Withdrawal by Subject|0|||
106083117|NCT02789176|365966189|FG000|Overall Study|Lost to Follow-up|8|||
106083118|NCT02789176|365966190|FG001|Overall Study|Lost to Follow-up|2|||
106083119|NCT02789176|365966191|FG002|Overall Study|Lost to Follow-up|6|||
105867134|NCT04895982|365163144|FG003|Overall Study|Lost to Follow-up|0|||
105867135|NCT04895982|365163145|FG004|Overall Study|Lost to Follow-up|0|||
105867136|NCT04895982|365163146|FG005|Overall Study|Lost to Follow-up|1|||
105867137|NCT04895982|365163147|FG006|Overall Study|Lost to Follow-up|0|||
105867138|NCT04895982|365163148|FG007|Overall Study|Lost to Follow-up|0|||
106083120|NCT02789176|365966192|FG003|Overall Study|Lost to Follow-up|1|||
106083121|NCT00192075|365966193|FG000|Overall Study|Disease Progression|23|||
106083122|NCT00192075|365966194|FG001|Overall Study|Disease Progression|6|||
106083123|NCT00192075|365966193|FG000|Overall Study|Adverse Event|1|||
106083124|NCT00192075|365966194|FG001|Overall Study|Adverse Event|3|||
106083125|NCT00192075|365966193|FG000|Overall Study|Death|0|||
106083126|NCT00192075|365966194|FG001|Overall Study|Death|1|||
106083127|NCT00192075|365966193|FG000|Overall Study|Lack of Efficacy|0|||
106083128|NCT00192075|365966194|FG001|Overall Study|Lack of Efficacy|0|||
106083129|NCT00192075|365966193|FG000|Overall Study|Physician Decision|3|||
106083130|NCT00192075|365966194|FG001|Overall Study|Physician Decision|0|||
106083131|NCT00192075|365966193|FG000|Overall Study|Withdrawal by Subject|5|||
106083132|NCT00192075|365966194|FG001|Overall Study|Withdrawal by Subject|5|||
106083133|NCT00192075|365966193|FG000|Overall Study|Patient Non-Compliance|0|||
106083134|NCT00192075|365966194|FG001|Overall Study|Patient Non-Compliance|1|||
106083135|NCT00192075|365966193|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
106083136|NCT00192075|365966194|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
106083137|NCT00192075|365966193|FG000|Overall Study|Other|5|||
106083138|NCT00192075|365966194|FG001|Overall Study|Other|2|||
106083139|NCT00779675|365966195|FG000|Treatment Period|Adverse Event|87|||
106083140|NCT00779675|365966195|FG000|Treatment Period|Treatment Failure|80|||
106083141|NCT00779675|365966195|FG000|Treatment Period|Transferred to Another Study|38|||
106083142|NCT00779675|365966195|FG000|Treatment Period|Lost to Follow-up|23|||
106083143|NCT00779675|365966195|FG000|Treatment Period|Withdrawal by Subject|46|||
106083144|NCT00779675|365966195|FG000|Treatment Period|Protocol Violation|54|||
106083145|NCT00779675|365966195|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
106083146|NCT00779675|365966195|FG000|Treatment Period|Administrative|3|||
106083147|NCT00779675|365966195|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
106083148|NCT00779675|365966195|FG000|Extended Treatment Period|Protocol Violation|13|||
105867139|NCT04895982|365163149|FG008|Overall Study|Lost to Follow-up|1|||
105867140|NCT04895982|365163150|FG009|Overall Study|Lost to Follow-up|0|||
105867141|NCT04895982|365163151|FG010|Overall Study|Lost to Follow-up|0|||
105867142|NCT04895982|365163152|FG011|Overall Study|Lost to Follow-up|0|||
105867143|NCT04895982|365163141|FG000|Overall Study|Refused further study procedures|0|||
105867144|NCT04895982|365163142|FG001|Overall Study|Refused further study procedures|0|||
105867145|NCT04895982|365163143|FG002|Overall Study|Refused further study procedures|1|||
105867146|NCT04895982|365163144|FG003|Overall Study|Refused further study procedures|0|||
105867147|NCT04895982|365163145|FG004|Overall Study|Refused further study procedures|0|||
105867148|NCT04895982|365163146|FG005|Overall Study|Refused further study procedures|0|||
105867149|NCT04895982|365163147|FG006|Overall Study|Refused further study procedures|0|||
105867150|NCT04895982|365163148|FG007|Overall Study|Refused further study procedures|0|||
105867151|NCT04895982|365163149|FG008|Overall Study|Refused further study procedures|0|||
105867152|NCT04895982|365163150|FG009|Overall Study|Refused further study procedures|0|||
105867153|NCT04895982|365163151|FG010|Overall Study|Refused further study procedures|0|||
105867154|NCT04895982|365163152|FG011|Overall Study|Refused further study procedures|0|||
105867155|NCT01866098|365163157|FG000|Overall Study|Lost to Follow-up|11|||
105867156|NCT01866098|365163158|FG001|Overall Study|Lost to Follow-up|18|||
106083149|NCT00779675|365966195|FG000|Extended Treatment Period|Adverse Event|6|||
106083150|NCT00779675|365966195|FG000|Extended Treatment Period|Treatment Failure|11|||
106083151|NCT00779675|365966195|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
106083152|NCT00779675|365966195|FG000|Extended Treatment Period|Lost to Follow-up|6|||
105867157|NCT01866098|365163159|FG002|Overall Study|Lost to Follow-up|13|||
105867158|NCT01866098|365163157|FG000|Overall Study|Physician Decision|0|||
105867159|NCT01866098|365163158|FG001|Overall Study|Physician Decision|1|||
105867160|NCT01866098|365163159|FG002|Overall Study|Physician Decision|2|||
105867161|NCT01866098|365163157|FG000|Overall Study|Adverse Event|1|||
106083153|NCT01440322|365966196|FG000|Overall Study|Discomfort|2|||
106083154|NCT01440322|365966197|FG001|Overall Study|Discomfort|0|||
106083155|NCT01440322|365966196|FG000|Overall Study|Biomicroscopy|1|||
106083156|NCT01440322|365966197|FG001|Overall Study|Biomicroscopy|0|||
106083157|NCT01440322|365966196|FG000|Overall Study|Symptoms and Problems|1|||
106083158|NCT01440322|365966197|FG001|Overall Study|Symptoms and Problems|0|||
106083159|NCT01440322|365966196|FG000|Overall Study|Unacceptable Subjective Vision|1|||
106083160|NCT01440322|365966197|FG001|Overall Study|Unacceptable Subjective Vision|0|||
106083161|NCT01440322|365966196|FG000|Overall Study|Other Product Related|1|||
106083162|NCT01440322|365966197|FG001|Overall Study|Other Product Related|0|||
106083163|NCT01440322|365966196|FG000|Overall Study|Unrelated Medical Problem|0|||
106083164|NCT01440322|365966197|FG001|Overall Study|Unrelated Medical Problem|1|||
106083165|NCT01440322|365966196|FG000|Overall Study|Other Non-Product Related|1|||
106083166|NCT01440322|365966197|FG001|Overall Study|Other Non-Product Related|0|||
106083167|NCT00749775|365966205|FG000|Overall Study|Protocol Violation|24|||
106083168|NCT00749775|365966205|FG000|Overall Study|Lost to Follow-up|36|||
106083169|NCT00749775|365966205|FG000|Overall Study|No visit after first day of treatment|44|||
106083170|NCT00749775|365966205|FG000|Overall Study|No drug administration|3|||
106083171|NCT04300296|365966206|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
106083172|NCT04300296|365966207|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
106083173|NCT04300296|365966208|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
106083174|NCT04300296|365966209|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
106083175|NCT04300296|365966210|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
106083176|NCT04300296|365966211|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
106083177|NCT04300296|365966206|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
106083178|NCT04300296|365966207|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
106083179|NCT04300296|365966208|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
106083180|NCT04300296|365966209|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
106083181|NCT04300296|365966210|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
106083182|NCT04300296|365966211|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
106083183|NCT04300296|365966206|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
106083184|NCT04300296|365966207|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
106083185|NCT04300296|365966208|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
106083186|NCT04300296|365966209|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
106083187|NCT04300296|365966210|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
106083188|NCT04300296|365966211|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
106083189|NCT04300296|365966206|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
106083190|NCT04300296|365966207|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
106083191|NCT04300296|365966208|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
106083192|NCT04300296|365966209|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
106083193|NCT04300296|365966210|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
106083194|NCT04300296|365966211|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
106083195|NCT04300296|365966206|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
106083196|NCT04300296|365966207|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
106083197|NCT04300296|365966208|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
106083198|NCT04300296|365966209|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
106083199|NCT04300296|365966210|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
106083200|NCT04300296|365966211|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
106083201|NCT04300296|365966206|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
106083202|NCT04300296|365966207|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
106083203|NCT04300296|365966208|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
106083204|NCT04300296|365966209|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
106083205|NCT04300296|365966210|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
106083206|NCT04300296|365966211|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
106083207|NCT04300296|365966206|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
106083208|NCT04300296|365966207|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
106083209|NCT04300296|365966208|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
106083210|NCT04300296|365966209|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
106083211|NCT04300296|365966210|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
106083212|NCT04300296|365966211|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
106083213|NCT01633944|365966212|FG000|Open-label Titration Phase|Adverse Event|109|||
106083214|NCT01633944|365966213|FG001|Open-label Titration Phase|Adverse Event|0|||
106083215|NCT01633944|365966214|FG002|Open-label Titration Phase|Adverse Event|0|||
106083216|NCT01633944|365966212|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
106083217|NCT01633944|365966213|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
106083218|NCT01633944|365966214|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
106083219|NCT01633944|365966212|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
106083220|NCT01633944|365966213|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
106083221|NCT01633944|365966214|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
106083222|NCT01633944|365966212|FG000|Open-label Titration Phase|Protocol Violation|24|||
106083223|NCT01633944|365966213|FG001|Open-label Titration Phase|Protocol Violation|0|||
106083224|NCT01633944|365966214|FG002|Open-label Titration Phase|Protocol Violation|0|||
106083225|NCT01633944|365966212|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
106083226|NCT01633944|365966213|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
106083227|NCT01633944|365966214|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
106083228|NCT01633944|365966212|FG000|Open-label Titration Phase|Other|68|||
106083229|NCT01633944|365966213|FG001|Open-label Titration Phase|Other|0|||
106083230|NCT01633944|365966214|FG002|Open-label Titration Phase|Other|0|||
106083231|NCT01633944|365966212|FG000|Double-blind Treatment Phase|Adverse Event|0|||
106083232|NCT01633944|365966213|FG001|Double-blind Treatment Phase|Adverse Event|13|||
106083233|NCT01633944|365966214|FG002|Double-blind Treatment Phase|Adverse Event|7|||
106083234|NCT01633944|365966212|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
106160492|NCT04492007|366248982|FG000|Overall Study|Protocol Violation|1|||
106160493|NCT04492007|366248983|FG001|Overall Study|Protocol Violation|1|||
106160494|NCT04492007|366248984|FG002|Overall Study|Protocol Violation|1|||
106160495|NCT04492007|366248985|FG003|Overall Study|Protocol Violation|1|||
106160496|NCT04492007|366248982|FG000|Overall Study|Withdrawal by Subject|0|||
106160497|NCT04492007|366248983|FG001|Overall Study|Withdrawal by Subject|0|||
106160498|NCT04492007|366248984|FG002|Overall Study|Withdrawal by Subject|1|||
106160499|NCT04492007|366248985|FG003|Overall Study|Withdrawal by Subject|1|||
106160500|NCT05369403|366248988|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
106160501|NCT05369403|366248989|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
106160502|NCT05369403|366248990|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
106160503|NCT05369403|366248988|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
106160504|NCT05369403|366248989|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
106160505|NCT05369403|366248990|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
106160506|NCT05369403|366248988|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
106160507|NCT05369403|366248989|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
106160508|NCT05369403|366248990|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
106160509|NCT05369403|366248988|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
106160510|NCT05369403|366248989|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
106160511|NCT05369403|366248990|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
106160512|NCT05369403|366248988|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
106160513|NCT05369403|366248989|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
106160514|NCT05369403|366248990|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
106160515|NCT05369403|366248988|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
106160516|NCT05369403|366248989|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
106160517|NCT05369403|366248990|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
106160518|NCT05369403|366248988|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
106160519|NCT05369403|366248989|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
106160520|NCT05369403|366248990|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
106160521|NCT05369403|366248988|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
106160522|NCT05369403|366248989|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
106160523|NCT05369403|366248990|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
106160524|NCT05369403|366248988|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
106083235|NCT01633944|365966213|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
106083236|NCT01633944|365966214|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
106083237|NCT01633944|365966212|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
106083238|NCT01633944|365966213|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
106083239|NCT01633944|365966214|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
106083240|NCT01633944|365966212|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
106083241|NCT01633944|365966213|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
106083242|NCT01633944|365966214|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
106083243|NCT01633944|365966212|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
106083244|NCT01633944|365966213|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
106083245|NCT01633944|365966214|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
106083246|NCT01633944|365966212|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
106083247|NCT01633944|365966213|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
106083248|NCT01633944|365966214|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
106083249|NCT01633944|365966212|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
106083250|NCT01633944|365966213|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
106083251|NCT01633944|365966214|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
106083252|NCT01633944|365966212|FG000|Double-blind Treatment Phase|Other|0|||
106083253|NCT01633944|365966213|FG001|Double-blind Treatment Phase|Other|7|||
106083254|NCT01633944|365966214|FG002|Double-blind Treatment Phase|Other|0|||
106083255|NCT00701129|365966215|FG000|Overall Study|Death|2|||
106083256|NCT01400841|365966216|FG000|Initial Study Phase (6 Months)|Death|1|||
106083257|NCT01400841|365966216|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
106083258|NCT00279708|365966217|FG000|Overall Study|Withdrawal by Subject|2|||
106083259|NCT00279708|365966218|FG001|Overall Study|Withdrawal by Subject|3|||
106083260|NCT00279708|365966217|FG000|Overall Study|Adverse Event|1|||
106083261|NCT00279708|365966218|FG001|Overall Study|Adverse Event|1|||
106083262|NCT02177266|365966221|FG000|Overall Study|Adverse Event|0|||
106083263|NCT02177266|365966222|FG001|Overall Study|Adverse Event|1|||
106083264|NCT02177266|365966221|FG000|Overall Study|Withdrawal by Subject|1|||
106083265|NCT02177266|365966222|FG001|Overall Study|Withdrawal by Subject|0|||
106083266|NCT02388997|365966223|FG000|Overall Study|Adverse Event|1|||
106083267|NCT02388997|365966224|FG001|Overall Study|Adverse Event|2|||
106083268|NCT02388997|365966223|FG000|Overall Study|Withdrawal by Subject|2|||
106083269|NCT02388997|365966224|FG001|Overall Study|Withdrawal by Subject|1|||
106083270|NCT02388997|365966223|FG000|Overall Study|Lung function exclusion criteria|0|||
106083271|NCT02388997|365966224|FG001|Overall Study|Lung function exclusion criteria|2|||
106083272|NCT02388997|365966223|FG000|Overall Study|Tested positive for virus during run-in|0|||
106083273|NCT02388997|365966224|FG001|Overall Study|Tested positive for virus during run-in|1|||
106083274|NCT00207142|365966233|FG000|Induction Phase|Adverse Event|9|||
106083275|NCT00207142|365966234|FG001|Induction Phase|Adverse Event|0|||
106083276|NCT00207142|365966235|FG002|Induction Phase|Adverse Event|0|||
106083277|NCT00207142|365966236|FG003|Induction Phase|Adverse Event|0|||
106083278|NCT00207142|365966233|FG000|Induction Phase|Death|1|||
106083279|NCT00207142|365966234|FG001|Induction Phase|Death|0|||
106083280|NCT00207142|365966235|FG002|Induction Phase|Death|0|||
106083281|NCT00207142|365966236|FG003|Induction Phase|Death|0|||
106083282|NCT00207142|365966233|FG000|Induction Phase|Lack of Efficacy|1|||
106083283|NCT00207142|365966234|FG001|Induction Phase|Lack of Efficacy|0|||
106083284|NCT00207142|365966235|FG002|Induction Phase|Lack of Efficacy|0|||
106083285|NCT00207142|365966236|FG003|Induction Phase|Lack of Efficacy|0|||
106083286|NCT00207142|365966233|FG000|Induction Phase|Lost to Follow-up|5|||
106083287|NCT00207142|365966234|FG001|Induction Phase|Lost to Follow-up|0|||
106083288|NCT00207142|365966235|FG002|Induction Phase|Lost to Follow-up|0|||
106083289|NCT00207142|365966236|FG003|Induction Phase|Lost to Follow-up|0|||
106083290|NCT00207142|365966233|FG000|Induction Phase|Physician Decision|2|||
106083291|NCT00207142|365966234|FG001|Induction Phase|Physician Decision|0|||
106083292|NCT00207142|365966235|FG002|Induction Phase|Physician Decision|0|||
106083293|NCT00207142|365966236|FG003|Induction Phase|Physician Decision|0|||
106083294|NCT00207142|365966233|FG000|Induction Phase|Poor/noncompliance|2|||
106083295|NCT00207142|365966234|FG001|Induction Phase|Poor/noncompliance|0|||
106083296|NCT00207142|365966235|FG002|Induction Phase|Poor/noncompliance|0|||
106083297|NCT00207142|365966236|FG003|Induction Phase|Poor/noncompliance|0|||
106083298|NCT00207142|365966233|FG000|Induction Phase|Pregnancy|1|||
106083299|NCT00207142|365966234|FG001|Induction Phase|Pregnancy|0|||
106083300|NCT00207142|365966235|FG002|Induction Phase|Pregnancy|0|||
106083301|NCT00207142|365966236|FG003|Induction Phase|Pregnancy|0|||
106083302|NCT00207142|365966233|FG000|Induction Phase|Subject no longer meets study criteria|3|||
106083303|NCT00207142|365966234|FG001|Induction Phase|Subject no longer meets study criteria|0|||
106083304|NCT00207142|365966235|FG002|Induction Phase|Subject no longer meets study criteria|0|||
106083305|NCT00207142|365966236|FG003|Induction Phase|Subject no longer meets study criteria|0|||
106083306|NCT00207142|365966233|FG000|Induction Phase|Withdrawal by Subject|4|||
106083307|NCT00207142|365966234|FG001|Induction Phase|Withdrawal by Subject|0|||
106083308|NCT00207142|365966235|FG002|Induction Phase|Withdrawal by Subject|0|||
106083309|NCT00207142|365966236|FG003|Induction Phase|Withdrawal by Subject|0|||
106083310|NCT00207142|365966233|FG000|Induction Phase|Incarceration|1|||
106083311|NCT00207142|365966234|FG001|Induction Phase|Incarceration|0|||
106083312|NCT00207142|365966235|FG002|Induction Phase|Incarceration|0|||
106083313|NCT00207142|365966236|FG003|Induction Phase|Incarceration|0|||
106083314|NCT00207142|365966233|FG000|Induction Phase|Missing lab data|1|||
106083315|NCT00207142|365966234|FG001|Induction Phase|Missing lab data|0|||
106083316|NCT00207142|365966235|FG002|Induction Phase|Missing lab data|0|||
106083317|NCT00207142|365966236|FG003|Induction Phase|Missing lab data|0|||
106083318|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
106083319|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
106083320|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
106083321|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
106083322|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
106083323|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
106083324|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
106083325|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
106083326|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
106083327|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
106083328|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
106083329|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
106083330|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
106083331|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
106083332|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
106083333|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
106083334|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
106083335|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
106083336|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
106083337|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
106083338|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
106083339|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
106083340|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
106083341|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
106083342|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
106083343|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
106083344|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
106083345|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
106083346|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|Death|0|||
106083347|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|Death|0|||
106083348|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|Death|0|||
106083349|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|Death|1|||
106083350|NCT00207142|365966233|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
106083351|NCT00207142|365966234|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
106083352|NCT00207142|365966235|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
106083353|NCT00207142|365966236|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
106083354|NCT01020019|365966237|FG000|Overall Study|Lost to Follow-up|21|||
106083355|NCT01020019|365966238|FG001|Overall Study|Lost to Follow-up|18|||
106083356|NCT01020019|365966237|FG000|Overall Study|Adverse Event|1|||
106083357|NCT01020019|365966238|FG001|Overall Study|Adverse Event|5|||
106083358|NCT01020019|365966237|FG000|Overall Study|not interested in treatment|4|||
106083359|NCT01020019|365966238|FG001|Overall Study|not interested in treatment|4|||
106083360|NCT01020019|365966237|FG000|Overall Study|moving|0|||
106083361|NCT01020019|365966238|FG001|Overall Study|moving|2|||
106083362|NCT05091528|365966239|FG000|Overall Study|Study Termination by Sponsor|0|||
106083363|NCT05091528|365966240|FG001|Overall Study|Study Termination by Sponsor|1|||
106083364|NCT05091528|365966241|FG002|Overall Study|Study Termination by Sponsor|0|||
106083365|NCT05091528|365966242|FG003|Overall Study|Study Termination by Sponsor|1|||
106083366|NCT01192152|365966245|FG000|Period 1|left prematurely (while on treatment B)|0|||
106083367|NCT01192152|365966246|FG001|Period 1|left prematurely (while on treatment B)|1|||
106083368|NCT01192152|365966245|FG000|Period 3|family emergency|1|||
106083369|NCT01192152|365966246|FG001|Period 3|family emergency|0|||
106083370|NCT00715793|365966247|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
106083371|NCT00715793|365966248|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
106083372|NCT00715793|365966247|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
106083373|NCT00715793|365966248|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
106083374|NCT04115358|365966249|FG000|Overall Study|exfoliation|0|||
106083375|NCT04115358|365966250|FG001|Overall Study|exfoliation|0|||
106083376|NCT04115358|365966251|FG002|Overall Study|exfoliation|1|||
106083377|NCT00094653|365966254|FG000|Overall Study|Death|306|||
106083378|NCT00094653|365966255|FG001|Overall Study|Death|100|||
106083379|NCT00094653|365966256|FG002|Overall Study|Death|119|||
106083380|NCT00094653|365966254|FG000|Overall Study|Subject Withdrew Consent|10|||
106083381|NCT00094653|365966255|FG001|Overall Study|Subject Withdrew Consent|2|||
106083382|NCT00094653|365966256|FG002|Overall Study|Subject Withdrew Consent|3|||
106083383|NCT00094653|365966254|FG000|Overall Study|Other|2|||
106083384|NCT00094653|365966255|FG001|Overall Study|Other|2|||
106083385|NCT00094653|365966256|FG002|Overall Study|Other|2|||
106083386|NCT00094653|365966254|FG000|Overall Study|Lost to Follow-up|3|||
106083387|NCT00094653|365966255|FG001|Overall Study|Lost to Follow-up|2|||
106083388|NCT00094653|365966256|FG002|Overall Study|Lost to Follow-up|1|||
106083389|NCT00094653|365966254|FG000|Overall Study|Protocol Violation|0|||
106083390|NCT00094653|365966255|FG001|Overall Study|Protocol Violation|0|||
106083391|NCT00094653|365966256|FG002|Overall Study|Protocol Violation|1|||
106083392|NCT03120013|365966259|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
106083393|NCT03120013|365966260|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
106083394|NCT00458484|365966261|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
106083395|NCT00458484|365966262|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
106083396|NCT00458484|365966263|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
106083397|NCT00458484|365966264|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
106083398|NCT00458484|365966265|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
106083399|NCT00458484|365966266|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
106083400|NCT00458484|365966267|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
106083401|NCT01541826|365966269|FG000|Overall Study|Lost to Follow-up|2|||
106083402|NCT01541826|365966270|FG001|Overall Study|Lost to Follow-up|3|||
106083403|NCT01541826|365966271|FG002|Overall Study|Lost to Follow-up|0|||
106083404|NCT01541826|365966269|FG000|Overall Study|Withdrawal by Subject|2|||
106083405|NCT01541826|365966270|FG001|Overall Study|Withdrawal by Subject|0|||
106083406|NCT01541826|365966271|FG002|Overall Study|Withdrawal by Subject|0|||
106083407|NCT02673775|365966272|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
106083408|NCT02673775|365966273|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
106083409|NCT02673775|365966272|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
106083410|NCT02673775|365966273|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
106083411|NCT02673775|365966272|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
106083412|NCT02673775|365966273|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
106083413|NCT02673775|365966272|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
106083414|NCT02673775|365966273|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
106083415|NCT02253810|365966274|FG000|Overall Study|Withdrawal by Subject|2|||
106083416|NCT02253810|365966275|FG001|Overall Study|Withdrawal by Subject|1|||
106083417|NCT02253810|365966274|FG000|Overall Study|Unknown concomitant procedure|3|||
106083418|NCT02253810|365966275|FG001|Overall Study|Unknown concomitant procedure|2|||
106083419|NCT00854581|365966276|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
106083420|NCT00854581|365966276|FG000|Induction (Up to Day 21)|Death|1|||
106083421|NCT00854581|365966276|FG000|Induction (Up to Day 21)|Physician Decision|1|||
106083422|NCT00854581|365966276|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
106083423|NCT03254134|365966277|FG000|Overall Study|Not eligible patients|599|||
106083424|NCT03254134|365966278|FG001|Overall Study|Not eligible patients|3630|||
106083425|NCT01462357|365966285|FG000|Overall Study|Death|0|||
106083426|NCT01462357|365966286|FG001|Overall Study|Death|0|||
106083427|NCT01462357|365966287|FG002|Overall Study|Death|1|||
106083428|NCT01462357|365966285|FG000|Overall Study|Withdrawal by Subject|3|||
106083429|NCT01462357|365966286|FG001|Overall Study|Withdrawal by Subject|11|||
106083430|NCT01462357|365966287|FG002|Overall Study|Withdrawal by Subject|3|||
106083431|NCT01462357|365966285|FG000|Overall Study|Migrated/moved from study area|2|||
106083432|NCT01462357|365966286|FG001|Overall Study|Migrated/moved from study area|3|||
106083433|NCT01462357|365966287|FG002|Overall Study|Migrated/moved from study area|1|||
106083434|NCT01462357|365966285|FG000|Overall Study|Lost to Follow-up|3|||
106083435|NCT01462357|365966286|FG001|Overall Study|Lost to Follow-up|5|||
106083436|NCT01462357|365966287|FG002|Overall Study|Lost to Follow-up|7|||
106083437|NCT04292730|365966294|FG000|Overall Study|Lost to Follow-up|8|||
106083438|NCT04292730|365966295|FG001|Overall Study|Lost to Follow-up|12|||
106083439|NCT04292730|365966296|FG002|Overall Study|Lost to Follow-up|12|||
106083440|NCT04292730|365966297|FG003|Overall Study|Lost to Follow-up|48|||
106083441|NCT04292730|365966294|FG000|Overall Study|Death|2|||
106083442|NCT04292730|365966295|FG001|Overall Study|Death|2|||
106083443|NCT04292730|365966296|FG002|Overall Study|Death|4|||
106083444|NCT04292730|365966297|FG003|Overall Study|Death|12|||
106083445|NCT04292730|365966294|FG000|Overall Study|Withdrew Consent|2|||
106083446|NCT04292730|365966295|FG001|Overall Study|Withdrew Consent|2|||
106083447|NCT04292730|365966296|FG002|Overall Study|Withdrew Consent|5|||
106083448|NCT04292730|365966297|FG003|Overall Study|Withdrew Consent|6|||
106083449|NCT04292730|365966294|FG000|Overall Study|Non-Compliance with Study Drug|0|||
106083450|NCT04292730|365966295|FG001|Overall Study|Non-Compliance with Study Drug|1|||
106083451|NCT04292730|365966296|FG002|Overall Study|Non-Compliance with Study Drug|0|||
106083452|NCT04292730|365966297|FG003|Overall Study|Non-Compliance with Study Drug|0|||
106083453|NCT04292730|365966294|FG000|Overall Study|Protocol Violation|0|||
106083454|NCT04292730|365966295|FG001|Overall Study|Protocol Violation|0|||
106083455|NCT04292730|365966296|FG002|Overall Study|Protocol Violation|1|||
106083456|NCT04292730|365966297|FG003|Overall Study|Protocol Violation|0|||
106083457|NCT04292730|365966294|FG000|Overall Study|Randomized but not Treated|8|||
106083458|NCT04292730|365966295|FG001|Overall Study|Randomized but not Treated|4|||
106083459|NCT04292730|365966296|FG002|Overall Study|Randomized but not Treated|0|||
106083460|NCT04292730|365966297|FG003|Overall Study|Randomized but not Treated|14|||
106083461|NCT00806546|365966298|FG000|Overall Study|Enrolled, not treated|35|||
106083462|NCT00806546|365966298|FG000|Overall Study|Lost to Follow-up|32|||
106083463|NCT00806546|365966298|FG000|Overall Study|Adverse Event|74|||
106083464|NCT00806546|365966298|FG000|Overall Study|Withdrawal by Subject|75|||
106083465|NCT00806546|365966298|FG000|Overall Study|Protocol Violation|49|||
106083466|NCT00806546|365966298|FG000|Overall Study|Various|42|||
106083467|NCT02188485|365966299|FG000|Overall Study|Withdrawal by Subject|2|||
106083468|NCT02188485|365966300|FG001|Overall Study|Withdrawal by Subject|1|||
106083469|NCT02188485|365966299|FG000|Overall Study|PI withdrew, lack of capacity|0|||
106083470|NCT02188485|365966300|FG001|Overall Study|PI withdrew, lack of capacity|2|||
106083471|NCT03385239|365966309|FG000|Overall Study|Voluntary Withdrawal|2|||
106083472|NCT03385239|365966310|FG001|Overall Study|Voluntary Withdrawal|3|||
106083473|NCT03385239|365966311|FG002|Overall Study|Voluntary Withdrawal|2|||
106083474|NCT03385239|365966312|FG003|Overall Study|Voluntary Withdrawal|3|||
106083475|NCT03385239|365966313|FG004|Overall Study|Voluntary Withdrawal|0|||
106083476|NCT03385239|365966309|FG000|Overall Study|Adverse Event|0|||
106083477|NCT03385239|365966310|FG001|Overall Study|Adverse Event|0|||
106083478|NCT03385239|365966311|FG002|Overall Study|Adverse Event|1|||
106083479|NCT03385239|365966312|FG003|Overall Study|Adverse Event|0|||
106083480|NCT03385239|365966313|FG004|Overall Study|Adverse Event|0|||
106083481|NCT03385239|365966309|FG000|Overall Study|Other|0|||
106083482|NCT03385239|365966310|FG001|Overall Study|Other|0|||
106083483|NCT03385239|365966311|FG002|Overall Study|Other|0|||
106083484|NCT03385239|365966312|FG003|Overall Study|Other|1|||
106083485|NCT03385239|365966313|FG004|Overall Study|Other|0|||
106083486|NCT02501096|365966314|FG000|Overall Study|Lost to Follow-up|0|||
106083487|NCT02501096|365966315|FG001|Overall Study|Lost to Follow-up|0|||
106083488|NCT02501096|365966316|FG002|Overall Study|Lost to Follow-up|0|||
106083489|NCT02501096|365966317|FG003|Overall Study|Lost to Follow-up|0|||
106083490|NCT02501096|365966318|FG004|Overall Study|Lost to Follow-up|1|||
106083491|NCT02501096|365966319|FG005|Overall Study|Lost to Follow-up|1|||
106083492|NCT02501096|365966320|FG006|Overall Study|Lost to Follow-up|3|||
106083493|NCT02501096|365966321|FG007|Overall Study|Lost to Follow-up|0|||
106083494|NCT02501096|365966322|FG008|Overall Study|Lost to Follow-up|0|||
106083495|NCT02501096|365966314|FG000|Overall Study|Withdrawal by Subject|1|||
106083496|NCT02501096|365966315|FG001|Overall Study|Withdrawal by Subject|0|||
106083497|NCT02501096|365966316|FG002|Overall Study|Withdrawal by Subject|7|||
106083498|NCT02501096|365966317|FG003|Overall Study|Withdrawal by Subject|13|||
106083499|NCT02501096|365966318|FG004|Overall Study|Withdrawal by Subject|2|||
106083500|NCT02501096|365966319|FG005|Overall Study|Withdrawal by Subject|2|||
106083501|NCT02501096|365966320|FG006|Overall Study|Withdrawal by Subject|2|||
106083502|NCT02501096|365966321|FG007|Overall Study|Withdrawal by Subject|3|||
106083503|NCT02501096|365966322|FG008|Overall Study|Withdrawal by Subject|0|||
106083504|NCT02501096|365966314|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
106083505|NCT02501096|365966315|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
106083506|NCT02501096|365966316|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
106083507|NCT02501096|365966317|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
106083508|NCT02501096|365966318|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
106083509|NCT02501096|365966319|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
106083510|NCT02501096|365966320|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
106083511|NCT02501096|365966321|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
106083512|NCT02501096|365966322|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
106083513|NCT02501096|365966314|FG000|Overall Study|Death|1|||
106083514|NCT02501096|365966315|FG001|Overall Study|Death|1|||
106083515|NCT02501096|365966316|FG002|Overall Study|Death|88|||
106083516|NCT02501096|365966317|FG003|Overall Study|Death|74|||
106083517|NCT02501096|365966318|FG004|Overall Study|Death|15|||
106083518|NCT02501096|365966319|FG005|Overall Study|Death|16|||
106083519|NCT02501096|365966320|FG006|Overall Study|Death|15|||
106083520|NCT02501096|365966321|FG007|Overall Study|Death|16|||
106083521|NCT02501096|365966322|FG008|Overall Study|Death|1|||
106083522|NCT02751983|365966324|FG000|Treatment|Stopped ACT, but Remained in study|2|||
106083523|NCT02751983|365966325|FG001|Treatment|Stopped ACT, but Remained in study|0|||
106083524|NCT02751983|365966324|FG000|Treatment|Discharged prior to beginning ACT|2|||
106083525|NCT02751983|365966325|FG001|Treatment|Discharged prior to beginning ACT|0|||
106083526|NCT02751983|365966324|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
106083527|NCT02751983|365966325|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
106083528|NCT02751983|365966324|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
106083529|NCT02751983|365966325|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
106083530|NCT02751983|365966324|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
106083531|NCT02751983|365966325|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
106083532|NCT00308711|365966326|FG000|Overall Study|Withdrawal by Subject|1|||
106083533|NCT00308711|365966327|FG001|Overall Study|Withdrawal by Subject|0|||
106083534|NCT00308711|365966328|FG002|Overall Study|Withdrawal by Subject|1|||
106083535|NCT00308711|365966326|FG000|Overall Study|Protocol Violation|0|||
106083536|NCT00308711|365966327|FG001|Overall Study|Protocol Violation|1|||
106083537|NCT00308711|365966328|FG002|Overall Study|Protocol Violation|1|||
106083538|NCT00308711|365966326|FG000|Overall Study|Lost to Follow-up|0|||
106083539|NCT00308711|365966327|FG001|Overall Study|Lost to Follow-up|1|||
106083540|NCT00308711|365966328|FG002|Overall Study|Lost to Follow-up|0|||
106083541|NCT00308711|365966326|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
106083542|NCT00308711|365966327|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
106083543|NCT00308711|365966328|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
106083544|NCT00308711|365966326|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
106083545|NCT00308711|365966327|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
106083546|NCT00308711|365966328|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
106083547|NCT00096044|365966329|FG000|Overall Study|Withdrawal by Subject|9|||
106083548|NCT00096044|365966329|FG000|Overall Study|Adverse Event|21|||
106083549|NCT00096044|365966329|FG000|Overall Study|Disease Progression|4|||
106083550|NCT03149237|365966332|FG000|Overall Study|Withdrawal by Subject|4|||
106083551|NCT03149237|365966333|FG001|Overall Study|Withdrawal by Subject|5|||
106083552|NCT01420081|365966334|FG000|Overall Study|Death|1|||
106083553|NCT01420081|365966335|FG001|Overall Study|Death|0|||
106083554|NCT01420081|365966336|FG002|Overall Study|Death|8|||
106083555|NCT01420081|365966337|FG003|Overall Study|Death|0|||
106083556|NCT01420081|365966338|FG004|Overall Study|Death|7|||
106083557|NCT01420081|365966339|FG005|Overall Study|Death|12|||
106083558|NCT01420081|365966340|FG006|Overall Study|Death|0|||
106083559|NCT01420081|365966341|FG007|Overall Study|Death|1|||
106083560|NCT01420081|365966342|FG008|Overall Study|Death|1|||
106083561|NCT01420081|365966334|FG000|Overall Study|Lost to Follow-up|0|||
106083562|NCT01420081|365966335|FG001|Overall Study|Lost to Follow-up|0|||
106083563|NCT01420081|365966336|FG002|Overall Study|Lost to Follow-up|0|||
106083564|NCT01420081|365966337|FG003|Overall Study|Lost to Follow-up|0|||
106083565|NCT01420081|365966338|FG004|Overall Study|Lost to Follow-up|1|||
106083566|NCT01420081|365966339|FG005|Overall Study|Lost to Follow-up|1|||
106083567|NCT01420081|365966340|FG006|Overall Study|Lost to Follow-up|0|||
106083568|NCT01420081|365966341|FG007|Overall Study|Lost to Follow-up|0|||
106083569|NCT01420081|365966342|FG008|Overall Study|Lost to Follow-up|0|||
106083570|NCT01420081|365966334|FG000|Overall Study|Study Terminated by Sponsor|2|||
106083571|NCT01420081|365966335|FG001|Overall Study|Study Terminated by Sponsor|1|||
106083572|NCT01420081|365966336|FG002|Overall Study|Study Terminated by Sponsor|1|||
106083573|NCT01420081|365966337|FG003|Overall Study|Study Terminated by Sponsor|3|||
106083574|NCT01420081|365966338|FG004|Overall Study|Study Terminated by Sponsor|11|||
106083575|NCT01420081|365966339|FG005|Overall Study|Study Terminated by Sponsor|7|||
106083576|NCT01420081|365966340|FG006|Overall Study|Study Terminated by Sponsor|3|||
106083577|NCT01420081|365966341|FG007|Overall Study|Study Terminated by Sponsor|2|||
106083578|NCT01420081|365966342|FG008|Overall Study|Study Terminated by Sponsor|2|||
106083579|NCT01420081|365966334|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
106083580|NCT01420081|365966335|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
106083581|NCT01420081|365966336|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
106083582|NCT01420081|365966337|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
106083583|NCT01420081|365966338|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
106083584|NCT01420081|365966339|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
106083585|NCT01420081|365966340|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
106083586|NCT01420081|365966341|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
106083587|NCT01420081|365966342|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
106083588|NCT01420081|365966334|FG000|Overall Study|Other Reasons|0|||
106083589|NCT01420081|365966335|FG001|Overall Study|Other Reasons|0|||
106083590|NCT01420081|365966336|FG002|Overall Study|Other Reasons|1|||
106083591|NCT01420081|365966337|FG003|Overall Study|Other Reasons|0|||
106083592|NCT01420081|365966338|FG004|Overall Study|Other Reasons|0|||
106083593|NCT01420081|365966339|FG005|Overall Study|Other Reasons|0|||
106083594|NCT01420081|365966340|FG006|Overall Study|Other Reasons|0|||
106083595|NCT01420081|365966341|FG007|Overall Study|Other Reasons|0|||
106083596|NCT01420081|365966342|FG008|Overall Study|Other Reasons|0|||
106083597|NCT00414388|365966343|FG000|Overall Study|Adverse Event|1|||
106083598|NCT00813358|365966344|FG000|Overall Study|Death|32|||
106083599|NCT00813358|365966344|FG000|Overall Study|Lost to Follow-up|12|||
106083600|NCT00813358|365966344|FG000|Overall Study|other endpoints|5|||
106083601|NCT00813358|365966344|FG000|Overall Study|Withdrawal by Subject|20|||
106083602|NCT01723228|365966345|FG000|Overall Study|Adverse Event|2|||
106083603|NCT01723228|365966346|FG001|Overall Study|Adverse Event|6|||
106083604|NCT01723228|365966345|FG000|Overall Study|Withdrawal by Subject|2|||
106083605|NCT01723228|365966346|FG001|Overall Study|Withdrawal by Subject|1|||
106083606|NCT01723228|365966345|FG000|Overall Study|Protocol Violation|0|||
106083607|NCT01723228|365966346|FG001|Overall Study|Protocol Violation|2|||
106083608|NCT01723228|365966345|FG000|Overall Study|Lost to Follow-up|2|||
106083609|NCT01723228|365966346|FG001|Overall Study|Lost to Follow-up|1|||
106083610|NCT01723228|365966345|FG000|Overall Study|Other|2|||
106083611|NCT01723228|365966346|FG001|Overall Study|Other|1|||
106083612|NCT00218543|365966347|FG000|Overall Study|Lost to Follow-up|8|||
106083613|NCT00218543|365966347|FG000|Overall Study|relocated|1|||
106083614|NCT00218543|365966347|FG000|Overall Study|Withdrawal by Subject|1|||
106083615|NCT00218543|365966347|FG000|Overall Study|Physician Decision|3|||
106083616|NCT00218543|365966347|FG000|Overall Study|Adverse Event|2|||
106083617|NCT00004031|365966348|FG000|Overall Study|Adverse Event|5|||
106083618|NCT00004031|365966349|FG001|Overall Study|Adverse Event|0|||
106083619|NCT00004031|365966348|FG000|Overall Study|Refusal unrelated to adverse events|2|||
106083620|NCT00004031|365966349|FG001|Overall Study|Refusal unrelated to adverse events|11|||
106083621|NCT00004031|365966348|FG000|Overall Study|Progression/relapse|9|||
106083622|NCT00004031|365966349|FG001|Overall Study|Progression/relapse|4|||
106083623|NCT00004031|365966348|FG000|Overall Study|Death|3|||
106083624|NCT00004031|365966349|FG001|Overall Study|Death|1|||
106083625|NCT00004031|365966348|FG000|Overall Study|Other- not protocol specified|3|||
106083626|NCT00004031|365966349|FG001|Overall Study|Other- not protocol specified|3|||
106083627|NCT00004031|365966348|FG000|Overall Study|Reason under review|3|||
106083628|NCT00004031|365966349|FG001|Overall Study|Reason under review|2|||
106083629|NCT01864291|365966350|FG000|Overall Study|need for revision surgery|2|||
106083630|NCT01282216|365966351|FG000|Overall Study|Graft failure|0|||
106083631|NCT01282216|365966352|FG001|Overall Study|Graft failure|0|||
106083632|NCT01282216|365966353|FG002|Overall Study|Graft failure|3|||
106083633|NCT01282216|365966354|FG003|Overall Study|Graft failure|2|||
106083634|NCT01282216|365966351|FG000|Overall Study|Physician Decision|0|||
106083635|NCT01282216|365966352|FG001|Overall Study|Physician Decision|0|||
106083636|NCT01282216|365966353|FG002|Overall Study|Physician Decision|11|||
106083637|NCT01282216|365966354|FG003|Overall Study|Physician Decision|0|||
106083638|NCT01282216|365966351|FG000|Overall Study|Relapse|0|||
106083639|NCT01282216|365966352|FG001|Overall Study|Relapse|0|||
106083640|NCT01282216|365966353|FG002|Overall Study|Relapse|17|||
106083641|NCT01282216|365966354|FG003|Overall Study|Relapse|6|||
106083642|NCT01282216|365966351|FG000|Overall Study|Death|0|||
106083643|NCT01282216|365966352|FG001|Overall Study|Death|0|||
106083644|NCT01282216|365966353|FG002|Overall Study|Death|2|||
106160525|NCT05369403|366248989|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
106160526|NCT05369403|366248990|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
106083645|NCT01282216|365966354|FG003|Overall Study|Death|0|||
106083646|NCT04740034|365966355|FG000|Overall Study|Death|0|||
106083647|NCT04740034|365966356|FG001|Overall Study|Death|1|||
106083648|NCT04740034|365966357|FG002|Overall Study|Death|2|||
106083649|NCT04740034|365966358|FG003|Overall Study|Death|3|||
106160527|NCT05369403|366248988|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
106160528|NCT05369403|366248989|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
106160529|NCT05369403|366248990|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
106160530|NCT05369403|366248988|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
106160531|NCT05369403|366248989|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
106160532|NCT05369403|366248990|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
106160533|NCT05875142|366248992|FG000|Overall Study|Lost to Follow-up|0|||
106160534|NCT05875142|366248993|FG001|Overall Study|Lost to Follow-up|1|||
106160535|NCT05875142|366248994|FG002|Overall Study|Lost to Follow-up|1|||
106160536|NCT05784662|366248995|FG000|Overall Study|Lost to Follow-up|21|||
106160537|NCT05784662|366248996|FG001|Overall Study|Lost to Follow-up|17|||
106160538|NCT03425331|366249000|FG000|Overall Study|Withdrawal by Subject|1|||
106160539|NCT03425331|366249000|FG000|Overall Study|Death|1|||
106160540|NCT03425331|366249000|FG000|Overall Study|Adverse Event|1|||
106160541|NCT03425331|366249000|FG000|Overall Study|Disease Progression|2|||
106160542|NCT04274764|366249001|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
106160543|NCT04274764|366249002|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
106160544|NCT02677298|366249007|FG000|Double Blind Phase|Adverse Event|2|||
106160545|NCT02677298|366249008|FG001|Double Blind Phase|Adverse Event|1|||
106160546|NCT02677298|366249009|FG002|Double Blind Phase|Adverse Event|0|||
106160547|NCT02677298|366249007|FG000|Double Blind Phase|Physician Decision|5|||
106160548|NCT02677298|366249008|FG001|Double Blind Phase|Physician Decision|0|||
106160549|NCT02677298|366249009|FG002|Double Blind Phase|Physician Decision|0|||
106160550|NCT02677298|366249007|FG000|Double Blind Phase|Lost to Follow-up|11|||
106160551|NCT02677298|366249008|FG001|Double Blind Phase|Lost to Follow-up|7|||
106160552|NCT02677298|366249009|FG002|Double Blind Phase|Lost to Follow-up|0|||
106160553|NCT02677298|366249007|FG000|Double Blind Phase|Withdrawal by Subject|11|||
106160554|NCT02677298|366249008|FG001|Double Blind Phase|Withdrawal by Subject|8|||
106160555|NCT02677298|366249009|FG002|Double Blind Phase|Withdrawal by Subject|0|||
106160556|NCT02677298|366249007|FG000|Double Blind Phase|No study drug available at site|0|||
106160557|NCT02677298|366249008|FG001|Double Blind Phase|No study drug available at site|1|||
106160558|NCT02677298|366249009|FG002|Double Blind Phase|No study drug available at site|0|||
106160559|NCT02677298|366249007|FG000|Open Label Phase|Adverse Event|0|||
106160560|NCT02677298|366249008|FG001|Open Label Phase|Adverse Event|0|||
106160561|NCT02677298|366249009|FG002|Open Label Phase|Adverse Event|4|||
106160562|NCT02677298|366249007|FG000|Open Label Phase|Physician Decision|0|||
106160563|NCT02677298|366249008|FG001|Open Label Phase|Physician Decision|0|||
106160564|NCT02677298|366249009|FG002|Open Label Phase|Physician Decision|1|||
106160565|NCT02677298|366249007|FG000|Open Label Phase|Lost to Follow-up|0|||
106160566|NCT02677298|366249008|FG001|Open Label Phase|Lost to Follow-up|0|||
106160567|NCT02677298|366249009|FG002|Open Label Phase|Lost to Follow-up|17|||
106160568|NCT02677298|366249007|FG000|Open Label Phase|Withdrawal by Subject|0|||
106160569|NCT02677298|366249008|FG001|Open Label Phase|Withdrawal by Subject|0|||
106160570|NCT02677298|366249009|FG002|Open Label Phase|Withdrawal by Subject|38|||
106160571|NCT03611621|366249010|FG000|Overall Study|Graft loss|3|||
106160572|NCT03611621|366249010|FG000|Overall Study|Death|3|||
106160573|NCT03611621|366249010|FG000|Overall Study|Lost to Follow-up|1|||
106160574|NCT03039023|366249011|FG000|Overall Study|Withdrawal by Subject|1|||
106160575|NCT03039023|366249012|FG001|Overall Study|Withdrawal by Subject|0|||
106160576|NCT03039023|366249013|FG002|Overall Study|Withdrawal by Subject|1|||
106160577|NCT03039023|366249014|FG003|Overall Study|Withdrawal by Subject|1|||
106160578|NCT03039023|366249015|FG004|Overall Study|Withdrawal by Subject|0|||
106160579|NCT03039023|366249011|FG000|Overall Study|Physician Decision|0|||
106160580|NCT03039023|366249012|FG001|Overall Study|Physician Decision|0|||
106160581|NCT03039023|366249013|FG002|Overall Study|Physician Decision|0|||
106160582|NCT03039023|366249014|FG003|Overall Study|Physician Decision|1|||
106083650|NCT04740034|365966359|FG004|Overall Study|Death|4|||
106083651|NCT04740034|365966360|FG005|Overall Study|Death|4|||
106083652|NCT04740034|365966361|FG006|Overall Study|Death|2|||
106083653|NCT04740034|365966362|FG007|Overall Study|Death|2|||
106083654|NCT04740034|365966363|FG008|Overall Study|Death|2|||
106083655|NCT04740034|365966364|FG009|Overall Study|Death|4|||
106083656|NCT04740034|365966365|FG010|Overall Study|Death|0|||
106083657|NCT04740034|365966355|FG000|Overall Study|Lost to Follow-up|0|||
106083658|NCT04740034|365966356|FG001|Overall Study|Lost to Follow-up|0|||
106083659|NCT04740034|365966357|FG002|Overall Study|Lost to Follow-up|0|||
106083660|NCT04740034|365966358|FG003|Overall Study|Lost to Follow-up|1|||
106083661|NCT04740034|365966359|FG004|Overall Study|Lost to Follow-up|2|||
106083662|NCT04740034|365966360|FG005|Overall Study|Lost to Follow-up|2|||
106083663|NCT04740034|365966361|FG006|Overall Study|Lost to Follow-up|0|||
106083664|NCT04740034|365966362|FG007|Overall Study|Lost to Follow-up|0|||
106083665|NCT04740034|365966363|FG008|Overall Study|Lost to Follow-up|0|||
106083666|NCT04740034|365966364|FG009|Overall Study|Lost to Follow-up|1|||
106083667|NCT04740034|365966365|FG010|Overall Study|Lost to Follow-up|0|||
106083668|NCT04740034|365966355|FG000|Overall Study|Withdrawal by Subject|1|||
106083669|NCT04740034|365966356|FG001|Overall Study|Withdrawal by Subject|0|||
106083670|NCT04740034|365966357|FG002|Overall Study|Withdrawal by Subject|0|||
106083671|NCT04740034|365966358|FG003|Overall Study|Withdrawal by Subject|0|||
106083672|NCT04740034|365966359|FG004|Overall Study|Withdrawal by Subject|0|||
106083673|NCT04740034|365966360|FG005|Overall Study|Withdrawal by Subject|0|||
106083674|NCT04740034|365966361|FG006|Overall Study|Withdrawal by Subject|0|||
106083675|NCT04740034|365966362|FG007|Overall Study|Withdrawal by Subject|1|||
106083676|NCT04740034|365966363|FG008|Overall Study|Withdrawal by Subject|0|||
106083677|NCT04740034|365966364|FG009|Overall Study|Withdrawal by Subject|1|||
106083678|NCT04740034|365966365|FG010|Overall Study|Withdrawal by Subject|0|||
106083679|NCT04740034|365966355|FG000|Overall Study|Decision by sponsor|0|||
106083680|NCT04740034|365966356|FG001|Overall Study|Decision by sponsor|0|||
106083681|NCT04740034|365966357|FG002|Overall Study|Decision by sponsor|1|||
106083682|NCT04740034|365966358|FG003|Overall Study|Decision by sponsor|0|||
106083683|NCT04740034|365966359|FG004|Overall Study|Decision by sponsor|0|||
106083684|NCT04740034|365966360|FG005|Overall Study|Decision by sponsor|0|||
106083685|NCT04740034|365966361|FG006|Overall Study|Decision by sponsor|1|||
106083686|NCT04740034|365966362|FG007|Overall Study|Decision by sponsor|2|||
106083687|NCT04740034|365966363|FG008|Overall Study|Decision by sponsor|1|||
106083688|NCT04740034|365966364|FG009|Overall Study|Decision by sponsor|1|||
106083689|NCT04740034|365966365|FG010|Overall Study|Decision by sponsor|2|||
106083690|NCT04346615|365967907|FG000|Overall Study|Lost to Follow-up|0|||
106083691|NCT04346615|365967908|FG001|Overall Study|Lost to Follow-up|2|||
106083692|NCT04346615|365967907|FG000|Overall Study|Withdrawal by Subject|1|||
106083693|NCT04346615|365967908|FG001|Overall Study|Withdrawal by Subject|0|||
106083694|NCT04346615|365967907|FG000|Overall Study|Death|5|||
106083695|NCT04346615|365967908|FG001|Overall Study|Death|1|||
106083696|NCT04346615|365967907|FG000|Overall Study|Other|0|||
106083697|NCT04346615|365967908|FG001|Overall Study|Other|2|||
106083698|NCT04346615|365967907|FG000|Overall Study|Randomized not treated|1|||
106083699|NCT04346615|365967908|FG001|Overall Study|Randomized not treated|0|||
106083700|NCT01513317|365967909|FG000|Overall Study|Withdrawal by Subject|15|||
106083701|NCT01513317|365967910|FG001|Overall Study|Withdrawal by Subject|4|||
106083702|NCT01513317|365967909|FG000|Overall Study|Death|1|||
106083703|NCT01513317|365967910|FG001|Overall Study|Death|1|||
106083704|NCT01513317|365967909|FG000|Overall Study|Study terminated by sponsor|18|||
106083705|NCT01513317|365967910|FG001|Overall Study|Study terminated by sponsor|18|||
106083706|NCT01513317|365967909|FG000|Overall Study|Other|0|||
106083707|NCT01513317|365967910|FG001|Overall Study|Other|1|||
106083708|NCT04108130|365967911|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
106083709|NCT04108130|365967912|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
106083710|NCT04108130|365967911|FG000|Overall Study|Consent Withdrawn|9|||
106083711|NCT04108130|365967912|FG001|Overall Study|Consent Withdrawn|6|||
106083712|NCT04108130|365967911|FG000|Overall Study|Surgery Cancelled|4|||
106083713|NCT04108130|365967912|FG001|Overall Study|Surgery Cancelled|4|||
106083714|NCT04108130|365967911|FG000|Overall Study|Found Ineligible for Study|4|||
106083715|NCT04108130|365967912|FG001|Overall Study|Found Ineligible for Study|3|||
106083716|NCT04108130|365967911|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
106083717|NCT04108130|365967912|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
106083718|NCT04108130|365967911|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
106083719|NCT04108130|365967912|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
106083720|NCT02097134|365967915|FG000|Overall Study|Physician Decision|4|||
106083721|NCT02097134|365967915|FG000|Overall Study|Non-Protocol Therapy|1|||
106083722|NCT02097134|365967915|FG000|Overall Study|Progressive Disease|3|||
106083723|NCT02097134|365967915|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
106083724|NCT00634647|365967916|FG000|Overall Study|death on study|3|||
106083725|NCT00634647|365967916|FG000|Overall Study|refused further treatment|3|||
106083726|NCT00634647|365967916|FG000|Overall Study|declined to participate before treatment|1|||
106083727|NCT00298896|365967917|FG000|Overall Study|Death|3|||
106083728|NCT00298896|365967917|FG000|Overall Study|Physician Decision|2|||
106083729|NCT00298896|365967917|FG000|Overall Study|Intercurrent Illness|1|||
106083730|NCT00298896|365967917|FG000|Overall Study|Disease Progression|41|||
106083731|NCT00298896|365967917|FG000|Overall Study|Withdrawal by Subject|2|||
106083732|NCT00298896|365967917|FG000|Overall Study|Assigned to treatment in error|1|||
106083733|NCT02649972|365967920|FG000|Overall Study|Not treated|1|||
106083734|NCT03285646|365967921|FG000|Overall Study|Adverse Event|1|||
106083735|NCT03285646|365967922|FG001|Overall Study|Adverse Event|0|||
106083736|NCT03285646|365967921|FG000|Overall Study|Withdrawal by Subject|10|||
106083737|NCT03285646|365967922|FG001|Overall Study|Withdrawal by Subject|2|||
106083738|NCT03285646|365967921|FG000|Overall Study|Lost to Follow-up|2|||
106083739|NCT03285646|365967922|FG001|Overall Study|Lost to Follow-up|1|||
106083740|NCT03285646|365967921|FG000|Overall Study|Investigator/Sponsor Decision|0|||
106083741|NCT03285646|365967922|FG001|Overall Study|Investigator/Sponsor Decision|1|||
106083742|NCT00503841|365967923|FG000|Overall Study|All screen failures|44|||
106083743|NCT00306592|365967924|FG000|Overall Study|Adverse Event|8|||
106083744|NCT00306592|365967925|FG001|Overall Study|Adverse Event|15|||
106083745|NCT00306592|365967924|FG000|Overall Study|Lost to Follow-up|1|||
106083746|NCT00306592|365967925|FG001|Overall Study|Lost to Follow-up|0|||
106083747|NCT00306592|365967924|FG000|Overall Study|Noncompliance|0|||
106083748|NCT00306592|365967925|FG001|Overall Study|Noncompliance|2|||
106083749|NCT00306592|365967924|FG000|Overall Study|Persistent Antibodies|6|||
106083750|NCT00306592|365967925|FG001|Overall Study|Persistent Antibodies|3|||
106083751|NCT00306592|365967924|FG000|Overall Study|Voluntary|10|||
106083752|NCT00306592|365967925|FG001|Overall Study|Voluntary|6|||
106083753|NCT00306592|365967924|FG000|Overall Study|Other|5|||
106083754|NCT00306592|365967925|FG001|Overall Study|Other|10|||
106083755|NCT00306592|365967924|FG000|Overall Study|Other|1|||
106083756|NCT00306592|365967925|FG001|Overall Study|Other|2|||
106083757|NCT00306592|365967924|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
106083758|NCT00306592|365967925|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
106083759|NCT01481116|365967926|FG000|Overall Study|Adverse Event|26|||
106083760|NCT01481116|365967927|FG001|Overall Study|Adverse Event|26|||
106083761|NCT01481116|365967928|FG002|Overall Study|Adverse Event|42|||
106083762|NCT01481116|365967926|FG000|Overall Study|Major Protocol Deviation|3|||
106083763|NCT01481116|365967927|FG001|Overall Study|Major Protocol Deviation|7|||
106083764|NCT01481116|365967928|FG002|Overall Study|Major Protocol Deviation|1|||
106083765|NCT01481116|365967926|FG000|Overall Study|Lost to Follow-up|8|||
106083766|NCT01481116|365967927|FG001|Overall Study|Lost to Follow-up|12|||
106083767|NCT01481116|365967928|FG002|Overall Study|Lost to Follow-up|11|||
106083768|NCT01481116|365967926|FG000|Overall Study|Withdrawal by Subject|37|||
106083769|NCT01481116|365967927|FG001|Overall Study|Withdrawal by Subject|33|||
106083770|NCT01481116|365967928|FG002|Overall Study|Withdrawal by Subject|37|||
106083771|NCT01481116|365967926|FG000|Overall Study|Study Termination|730|||
106083772|NCT01481116|365967927|FG001|Overall Study|Study Termination|729|||
106083773|NCT01481116|365967928|FG002|Overall Study|Study Termination|713|||
106083774|NCT01481116|365967926|FG000|Overall Study|Pregnancy|0|||
106083775|NCT01481116|365967927|FG001|Overall Study|Pregnancy|0|||
106083776|NCT01481116|365967928|FG002|Overall Study|Pregnancy|1|||
106083777|NCT01481116|365967926|FG000|Overall Study|Lack of Efficacy|3|||
106083778|NCT01481116|365967927|FG001|Overall Study|Lack of Efficacy|3|||
106083779|NCT01481116|365967928|FG002|Overall Study|Lack of Efficacy|1|||
106083780|NCT01481116|365967926|FG000|Overall Study|Contraindications|1|||
106083781|NCT01481116|365967927|FG001|Overall Study|Contraindications|1|||
106083782|NCT01481116|365967928|FG002|Overall Study|Contraindications|0|||
106083783|NCT01481116|365967926|FG000|Overall Study|Other|1|||
106083784|NCT01481116|365967927|FG001|Overall Study|Other|1|||
106083785|NCT01481116|365967928|FG002|Overall Study|Other|0|||
106083786|NCT01481116|365967926|FG000|Overall Study|Participant Started Taking Glipizide|1|||
106083787|NCT01481116|365967927|FG001|Overall Study|Participant Started Taking Glipizide|0|||
106083788|NCT01481116|365967928|FG002|Overall Study|Participant Started Taking Glipizide|0|||
106083789|NCT01481116|365967926|FG000|Overall Study|Participant Moved Out of Area|2|||
106083790|NCT01481116|365967927|FG001|Overall Study|Participant Moved Out of Area|0|||
106083791|NCT01481116|365967928|FG002|Overall Study|Participant Moved Out of Area|1|||
106083792|NCT01481116|365967926|FG000|Overall Study|Participant Moved Out of Country|1|||
106083793|NCT01481116|365967927|FG001|Overall Study|Participant Moved Out of Country|0|||
106083794|NCT01481116|365967928|FG002|Overall Study|Participant Moved Out of Country|1|||
106083795|NCT01481116|365967926|FG000|Overall Study|Investigator Decision|3|||
106083796|NCT01481116|365967927|FG001|Overall Study|Investigator Decision|2|||
106083797|NCT01481116|365967928|FG002|Overall Study|Investigator Decision|1|||
106083798|NCT01481116|365967926|FG000|Overall Study|Sponsor Decision|0|||
106083799|NCT01481116|365967927|FG001|Overall Study|Sponsor Decision|1|||
106083800|NCT01481116|365967928|FG002|Overall Study|Sponsor Decision|3|||
106083801|NCT01481116|365967926|FG000|Overall Study|Non-Compliant With Study Drug|0|||
106083802|NCT01481116|365967927|FG001|Overall Study|Non-Compliant With Study Drug|1|||
106160583|NCT03039023|366249015|FG004|Overall Study|Physician Decision|0|||
105867162|NCT01866098|365163158|FG001|Overall Study|Adverse Event|5|||
106160584|NCT04739956|366249028|FG000|Overall Study|Withdrawal by Subject|1|||
106160585|NCT04739956|366249029|FG001|Overall Study|Withdrawal by Subject|1|||
106160586|NCT05177848|366249034|FG000|Overall Study|Lost to Follow-up|1|||
106160587|NCT05177848|366249035|FG001|Overall Study|Lost to Follow-up|4|||
106160588|NCT05177848|366249034|FG000|Overall Study|Discontinued|2|||
106160589|NCT05177848|366249035|FG001|Overall Study|Discontinued|1|||
106160590|NCT05516147|366249036|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
106160591|NCT03853746|366249040|FG000|Overall Study|Withdrawal by Subject|1|||
106160592|NCT01084876|366249042|FG000|Main Study Treatment Period|Adverse Event|12|||
106160593|NCT01084876|366249043|FG001|Main Study Treatment Period|Adverse Event|7|||
106160594|NCT01084876|366249042|FG000|Main Study Treatment Period|Disease Progression|41|||
106160595|NCT01084876|366249043|FG001|Main Study Treatment Period|Disease Progression|24|||
106160596|NCT01084876|366249042|FG000|Main Study Treatment Period|Physician Decision|2|||
106160597|NCT01084876|366249043|FG001|Main Study Treatment Period|Physician Decision|0|||
106160598|NCT01084876|366249042|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
106160599|NCT01084876|366249043|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
106160600|NCT01084876|366249042|FG000|Main Study Treatment Period|Other Reason|0|||
106160601|NCT01084876|366249043|FG001|Main Study Treatment Period|Other Reason|1|||
106160602|NCT01084876|366249042|FG000|Main Study Treatment Period|Other|0|||
106160603|NCT01084876|366249043|FG001|Main Study Treatment Period|Other|1|||
106160604|NCT01084876|366249042|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
106160605|NCT01084876|366249043|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
106160606|NCT01084876|366249042|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
106160607|NCT01084876|366249043|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
106160608|NCT01084876|366249042|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
106160609|NCT01084876|366249043|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
106160610|NCT01084876|366249042|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
106083803|NCT01481116|365967928|FG002|Overall Study|Non-Compliant With Study Drug|1|||
106083804|NCT01481116|365967926|FG000|Overall Study|Investigator's Discretion|2|||
106083805|NCT01481116|365967927|FG001|Overall Study|Investigator's Discretion|0|||
106083806|NCT01481116|365967928|FG002|Overall Study|Investigator's Discretion|0|||
106083807|NCT01481116|365967926|FG000|Overall Study|Death|2|||
106083808|NCT01481116|365967927|FG001|Overall Study|Death|1|||
106083809|NCT01481116|365967928|FG002|Overall Study|Death|0|||
106083810|NCT01481116|365967926|FG000|Overall Study|Hypoglycemic Event|4|||
106083811|NCT01481116|365967927|FG001|Overall Study|Hypoglycemic Event|0|||
106083812|NCT01481116|365967928|FG002|Overall Study|Hypoglycemic Event|0|||
106083813|NCT00546715|365967929|FG000|Overall Study|Withdrawal by Subject|0|||
106083814|NCT00546715|365967930|FG001|Overall Study|Withdrawal by Subject|1|||
106083815|NCT00546715|365967931|FG002|Overall Study|Withdrawal by Subject|0|||
106083816|NCT00546715|365967932|FG003|Overall Study|Withdrawal by Subject|0|||
106083817|NCT02148003|365967936|FG000|Overall Study|Failed inclusion criteria|1|||
106083818|NCT02148003|365967937|FG001|Overall Study|Failed inclusion criteria|0|||
106083819|NCT02148003|365967936|FG000|Overall Study|Met exclusion criteria|0|||
106083820|NCT02148003|365967937|FG001|Overall Study|Met exclusion criteria|1|||
106083821|NCT02148003|365967936|FG000|Overall Study|Withdrawal by Subject|0|||
106083822|NCT02148003|365967937|FG001|Overall Study|Withdrawal by Subject|1|||
106083823|NCT01126541|365967942|FG000|Overall Study|Adverse Event|0|||
106083824|NCT01126541|365967943|FG001|Overall Study|Adverse Event|2|||
106083825|NCT01126541|365967944|FG002|Overall Study|Adverse Event|4|||
106083826|NCT01126541|365967942|FG000|Overall Study|Death|0|||
105867163|NCT01866098|365163159|FG002|Overall Study|Adverse Event|4|||
105867164|NCT01866098|365163157|FG000|Overall Study|Protocol Violation|1|||
105867165|NCT01866098|365163158|FG001|Overall Study|Protocol Violation|0|||
105867166|NCT01866098|365163159|FG002|Overall Study|Protocol Violation|0|||
105867167|NCT01866098|365163157|FG000|Overall Study|Withdrawal by Subject|1|||
105867168|NCT01866098|365163158|FG001|Overall Study|Withdrawal by Subject|2|||
105867169|NCT01866098|365163159|FG002|Overall Study|Withdrawal by Subject|0|||
105867170|NCT01866098|365163157|FG000|Overall Study|Unrelated Hospitalization|2|||
106083827|NCT01126541|365967943|FG001|Overall Study|Death|1|||
105867171|NCT01866098|365163158|FG001|Overall Study|Unrelated Hospitalization|0|||
105867172|NCT01866098|365163159|FG002|Overall Study|Unrelated Hospitalization|1|||
106083828|NCT01126541|365967944|FG002|Overall Study|Death|0|||
106083829|NCT01126541|365967942|FG000|Overall Study|Lack of Efficacy|6|||
106083830|NCT01126541|365967943|FG001|Overall Study|Lack of Efficacy|1|||
106083831|NCT01126541|365967944|FG002|Overall Study|Lack of Efficacy|11|||
106083832|NCT01126541|365967942|FG000|Overall Study|Lost to Follow-up|1|||
106083833|NCT01126541|365967943|FG001|Overall Study|Lost to Follow-up|2|||
106083834|NCT01126541|365967944|FG002|Overall Study|Lost to Follow-up|2|||
106083835|NCT01126541|365967942|FG000|Overall Study|Withdrawal by Subject|2|||
106083836|NCT01126541|365967943|FG001|Overall Study|Withdrawal by Subject|5|||
106083837|NCT01126541|365967944|FG002|Overall Study|Withdrawal by Subject|6|||
106083838|NCT01126541|365967942|FG000|Overall Study|Protocol Violation|0|||
106083839|NCT01126541|365967943|FG001|Overall Study|Protocol Violation|0|||
106083840|NCT01126541|365967944|FG002|Overall Study|Protocol Violation|1|||
106083841|NCT01126541|365967942|FG000|Overall Study|Administrative reason or other|1|||
106083842|NCT01126541|365967943|FG001|Overall Study|Administrative reason or other|1|||
106083843|NCT01126541|365967944|FG002|Overall Study|Administrative reason or other|2|||
106083844|NCT00226941|365967945|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
106083845|NCT00226941|365967946|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
106083846|NCT00226941|365967947|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
106083847|NCT00226941|365967948|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
106083848|NCT00226941|365967945|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
106083849|NCT00226941|365967946|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
106083850|NCT00226941|365967947|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
106083851|NCT00226941|365967948|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
106083852|NCT01018264|365967949|FG000|Overall Study|Withdrawal by Subject|1|||
106083853|NCT01018264|365967950|FG001|Overall Study|Withdrawal by Subject|0|||
106083854|NCT01018264|365967949|FG000|Overall Study|Lost to Follow-up|0|||
106083855|NCT01018264|365967950|FG001|Overall Study|Lost to Follow-up|1|||
106083856|NCT03670810|365967953|FG000|Main Study|Adverse Event|37|||
106083857|NCT03670810|365967954|FG001|Main Study|Adverse Event|38|||
106083858|NCT03670810|365967955|FG002|Main Study|Adverse Event|3|||
106083859|NCT03670810|365967956|FG003|Main Study|Adverse Event|4|||
106083860|NCT03670810|365967957|FG004|Main Study|Adverse Event|4|||
106083861|NCT03670810|365967958|FG005|Main Study|Adverse Event|5|||
106083862|NCT03670810|365967959|FG006|Main Study|Adverse Event|0|||
106083863|NCT03670810|365967960|FG007|Main Study|Adverse Event|0|||
106083864|NCT03670810|365967961|FG008|Main Study|Adverse Event|0|||
106083865|NCT03670810|365967953|FG000|Main Study|Lack of Efficacy|8|||
106083866|NCT03670810|365967954|FG001|Main Study|Lack of Efficacy|9|||
106083867|NCT03670810|365967955|FG002|Main Study|Lack of Efficacy|3|||
106083868|NCT03670810|365967956|FG003|Main Study|Lack of Efficacy|4|||
106083869|NCT03670810|365967957|FG004|Main Study|Lack of Efficacy|0|||
106083870|NCT03670810|365967958|FG005|Main Study|Lack of Efficacy|0|||
106083871|NCT03670810|365967959|FG006|Main Study|Lack of Efficacy|0|||
106083872|NCT03670810|365967960|FG007|Main Study|Lack of Efficacy|0|||
106083873|NCT03670810|365967961|FG008|Main Study|Lack of Efficacy|0|||
106083874|NCT03670810|365967953|FG000|Main Study|Lost to Follow-up|9|||
106083875|NCT03670810|365967954|FG001|Main Study|Lost to Follow-up|7|||
106083876|NCT03670810|365967955|FG002|Main Study|Lost to Follow-up|4|||
106083877|NCT03670810|365967956|FG003|Main Study|Lost to Follow-up|6|||
106083878|NCT03670810|365967957|FG004|Main Study|Lost to Follow-up|1|||
106083879|NCT03670810|365967958|FG005|Main Study|Lost to Follow-up|0|||
106083880|NCT03670810|365967959|FG006|Main Study|Lost to Follow-up|0|||
106083881|NCT03670810|365967960|FG007|Main Study|Lost to Follow-up|0|||
106083882|NCT03670810|365967961|FG008|Main Study|Lost to Follow-up|0|||
106083883|NCT03670810|365967953|FG000|Main Study|Non-compliance with Study Drug|0|||
106083884|NCT03670810|365967954|FG001|Main Study|Non-compliance with Study Drug|2|||
106083885|NCT03670810|365967955|FG002|Main Study|Non-compliance with Study Drug|3|||
106083886|NCT03670810|365967956|FG003|Main Study|Non-compliance with Study Drug|0|||
106083887|NCT03670810|365967957|FG004|Main Study|Non-compliance with Study Drug|0|||
106083888|NCT03670810|365967958|FG005|Main Study|Non-compliance with Study Drug|0|||
106083889|NCT03670810|365967959|FG006|Main Study|Non-compliance with Study Drug|0|||
106083890|NCT03670810|365967960|FG007|Main Study|Non-compliance with Study Drug|1|||
106083891|NCT03670810|365967961|FG008|Main Study|Non-compliance with Study Drug|0|||
106083892|NCT03670810|365967953|FG000|Main Study|Physician Decision|3|||
106083893|NCT03670810|365967954|FG001|Main Study|Physician Decision|0|||
106083894|NCT03670810|365967955|FG002|Main Study|Physician Decision|1|||
106083895|NCT03670810|365967956|FG003|Main Study|Physician Decision|0|||
106083896|NCT03670810|365967957|FG004|Main Study|Physician Decision|0|||
106083897|NCT03670810|365967958|FG005|Main Study|Physician Decision|0|||
106083898|NCT03670810|365967959|FG006|Main Study|Physician Decision|1|||
106083899|NCT03670810|365967960|FG007|Main Study|Physician Decision|1|||
106083900|NCT03670810|365967961|FG008|Main Study|Physician Decision|0|||
106083901|NCT03670810|365967953|FG000|Main Study|Pregnancy|1|||
106083902|NCT03670810|365967954|FG001|Main Study|Pregnancy|2|||
106083903|NCT03670810|365967955|FG002|Main Study|Pregnancy|0|||
106083904|NCT03670810|365967956|FG003|Main Study|Pregnancy|0|||
106083905|NCT03670810|365967957|FG004|Main Study|Pregnancy|0|||
106083906|NCT03670810|365967958|FG005|Main Study|Pregnancy|0|||
106083907|NCT03670810|365967959|FG006|Main Study|Pregnancy|0|||
106083908|NCT03670810|365967960|FG007|Main Study|Pregnancy|0|||
106083909|NCT03670810|365967961|FG008|Main Study|Pregnancy|0|||
106083910|NCT03670810|365967953|FG000|Main Study|Protocol Deviation|2|||
106083911|NCT03670810|365967954|FG001|Main Study|Protocol Deviation|12|||
106083912|NCT03670810|365967955|FG002|Main Study|Protocol Deviation|8|||
106083913|NCT03670810|365967956|FG003|Main Study|Protocol Deviation|4|||
106083914|NCT03670810|365967957|FG004|Main Study|Protocol Deviation|0|||
106083915|NCT03670810|365967958|FG005|Main Study|Protocol Deviation|0|||
106083916|NCT03670810|365967959|FG006|Main Study|Protocol Deviation|0|||
106083917|NCT03670810|365967960|FG007|Main Study|Protocol Deviation|0|||
106083918|NCT03670810|365967961|FG008|Main Study|Protocol Deviation|0|||
106083919|NCT03670810|365967953|FG000|Main Study|Withdrawal by Subject|21|||
106083920|NCT03670810|365967954|FG001|Main Study|Withdrawal by Subject|21|||
106083921|NCT03670810|365967955|FG002|Main Study|Withdrawal by Subject|8|||
106083922|NCT03670810|365967956|FG003|Main Study|Withdrawal by Subject|9|||
106083923|NCT03670810|365967957|FG004|Main Study|Withdrawal by Subject|5|||
106083924|NCT03670810|365967958|FG005|Main Study|Withdrawal by Subject|2|||
106083925|NCT03670810|365967959|FG006|Main Study|Withdrawal by Subject|1|||
106083926|NCT03670810|365967960|FG007|Main Study|Withdrawal by Subject|1|||
106083927|NCT03670810|365967961|FG008|Main Study|Withdrawal by Subject|0|||
106083928|NCT03670810|365967953|FG000|Main Study|Participant did not want to take the three other treatments|1|||
106083929|NCT03670810|365967954|FG001|Main Study|Participant did not want to take the three other treatments|0|||
106083930|NCT03670810|365967955|FG002|Main Study|Participant did not want to take the three other treatments|0|||
106083931|NCT03670810|365967956|FG003|Main Study|Participant did not want to take the three other treatments|0|||
106083932|NCT03670810|365967957|FG004|Main Study|Participant did not want to take the three other treatments|0|||
106083933|NCT03670810|365967958|FG005|Main Study|Participant did not want to take the three other treatments|0|||
106083934|NCT03670810|365967959|FG006|Main Study|Participant did not want to take the three other treatments|0|||
106083935|NCT03670810|365967960|FG007|Main Study|Participant did not want to take the three other treatments|0|||
106083936|NCT03670810|365967961|FG008|Main Study|Participant did not want to take the three other treatments|0|||
106083937|NCT03670810|365967953|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
106083938|NCT03670810|365967954|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
106083939|NCT03670810|365967955|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
106083940|NCT03670810|365967956|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
106083941|NCT03670810|365967957|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
106083942|NCT03670810|365967958|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
106083943|NCT03670810|365967959|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
106083944|NCT03670810|365967960|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
106083945|NCT03670810|365967961|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
106083946|NCT03670810|365967953|FG000|Main Study|Travel and Coronavirus issues|0|||
106083947|NCT03670810|365967954|FG001|Main Study|Travel and Coronavirus issues|0|||
106083948|NCT03670810|365967955|FG002|Main Study|Travel and Coronavirus issues|0|||
106083949|NCT03670810|365967956|FG003|Main Study|Travel and Coronavirus issues|1|||
106083950|NCT03670810|365967957|FG004|Main Study|Travel and Coronavirus issues|0|||
106083951|NCT03670810|365967958|FG005|Main Study|Travel and Coronavirus issues|0|||
106083952|NCT03670810|365967959|FG006|Main Study|Travel and Coronavirus issues|0|||
106083953|NCT03670810|365967960|FG007|Main Study|Travel and Coronavirus issues|0|||
106083954|NCT03670810|365967961|FG008|Main Study|Travel and Coronavirus issues|0|||
106083955|NCT03670810|365967953|FG000|Open Label Extension|Protocol Deviation|0|||
106083956|NCT03670810|365967954|FG001|Open Label Extension|Protocol Deviation|0|||
106083957|NCT03670810|365967955|FG002|Open Label Extension|Protocol Deviation|0|||
106083958|NCT03670810|365967956|FG003|Open Label Extension|Protocol Deviation|0|||
106083959|NCT03670810|365967957|FG004|Open Label Extension|Protocol Deviation|0|||
106083960|NCT03670810|365967958|FG005|Open Label Extension|Protocol Deviation|0|||
106083961|NCT03670810|365967959|FG006|Open Label Extension|Protocol Deviation|0|||
106083962|NCT03670810|365967960|FG007|Open Label Extension|Protocol Deviation|0|||
106083963|NCT03670810|365967961|FG008|Open Label Extension|Protocol Deviation|5|||
106083964|NCT03670810|365967953|FG000|Open Label Extension|Death|0|||
106083965|NCT03670810|365967954|FG001|Open Label Extension|Death|0|||
106083966|NCT03670810|365967955|FG002|Open Label Extension|Death|0|||
106083967|NCT03670810|365967956|FG003|Open Label Extension|Death|0|||
106083968|NCT03670810|365967957|FG004|Open Label Extension|Death|0|||
106083969|NCT03670810|365967958|FG005|Open Label Extension|Death|0|||
106083970|NCT03670810|365967959|FG006|Open Label Extension|Death|0|||
106083971|NCT03670810|365967960|FG007|Open Label Extension|Death|0|||
106083972|NCT03670810|365967961|FG008|Open Label Extension|Death|1|||
106083973|NCT03670810|365967953|FG000|Open Label Extension|COVID-19|0|||
106083974|NCT03670810|365967954|FG001|Open Label Extension|COVID-19|0|||
106083975|NCT03670810|365967955|FG002|Open Label Extension|COVID-19|0|||
106083976|NCT03670810|365967956|FG003|Open Label Extension|COVID-19|0|||
106083977|NCT03670810|365967957|FG004|Open Label Extension|COVID-19|0|||
106083978|NCT03670810|365967958|FG005|Open Label Extension|COVID-19|0|||
106083979|NCT03670810|365967959|FG006|Open Label Extension|COVID-19|0|||
106083980|NCT03670810|365967960|FG007|Open Label Extension|COVID-19|0|||
106083981|NCT03670810|365967961|FG008|Open Label Extension|COVID-19|1|||
106083982|NCT03670810|365967953|FG000|Open Label Extension|Lack of Efficacy|0|||
106083983|NCT03670810|365967954|FG001|Open Label Extension|Lack of Efficacy|0|||
106083984|NCT03670810|365967955|FG002|Open Label Extension|Lack of Efficacy|0|||
106083985|NCT03670810|365967956|FG003|Open Label Extension|Lack of Efficacy|0|||
106083986|NCT03670810|365967957|FG004|Open Label Extension|Lack of Efficacy|0|||
106083987|NCT03670810|365967958|FG005|Open Label Extension|Lack of Efficacy|0|||
106083988|NCT03670810|365967959|FG006|Open Label Extension|Lack of Efficacy|0|||
106083989|NCT03670810|365967960|FG007|Open Label Extension|Lack of Efficacy|0|||
106083990|NCT03670810|365967961|FG008|Open Label Extension|Lack of Efficacy|39|||
106083991|NCT03670810|365967953|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
106083992|NCT03670810|365967954|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
106083993|NCT03670810|365967955|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
106083994|NCT03670810|365967956|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
106083995|NCT03670810|365967957|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
106083996|NCT03670810|365967958|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
106083997|NCT03670810|365967959|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
106083998|NCT03670810|365967960|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
106083999|NCT03670810|365967961|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
106084000|NCT03670810|365967953|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
106084001|NCT03670810|365967954|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
106084002|NCT03670810|365967955|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
106084003|NCT03670810|365967956|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
106084004|NCT03670810|365967957|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
106084005|NCT03670810|365967958|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
106084006|NCT03670810|365967959|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
106084007|NCT03670810|365967960|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
106084008|NCT03670810|365967961|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
106084009|NCT03670810|365967953|FG000|Open Label Extension|Withdrawal by Subject|0|||
106084010|NCT03670810|365967954|FG001|Open Label Extension|Withdrawal by Subject|0|||
106084011|NCT03670810|365967955|FG002|Open Label Extension|Withdrawal by Subject|0|||
106084012|NCT03670810|365967956|FG003|Open Label Extension|Withdrawal by Subject|0|||
106084013|NCT03670810|365967957|FG004|Open Label Extension|Withdrawal by Subject|0|||
106084014|NCT03670810|365967958|FG005|Open Label Extension|Withdrawal by Subject|0|||
106084015|NCT03670810|365967959|FG006|Open Label Extension|Withdrawal by Subject|0|||
106084016|NCT03670810|365967960|FG007|Open Label Extension|Withdrawal by Subject|0|||
106084017|NCT03670810|365967961|FG008|Open Label Extension|Withdrawal by Subject|46|||
106084018|NCT03670810|365967953|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
106084019|NCT03670810|365967954|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
106084020|NCT03670810|365967955|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
106084021|NCT03670810|365967956|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
106084022|NCT03670810|365967957|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
106084023|NCT03670810|365967958|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
106084024|NCT03670810|365967959|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
106084025|NCT03670810|365967960|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
106084026|NCT03670810|365967961|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
106084027|NCT03670810|365967953|FG000|Open Label Extension|Physician Decision|0|||
106084028|NCT03670810|365967954|FG001|Open Label Extension|Physician Decision|0|||
106084029|NCT03670810|365967955|FG002|Open Label Extension|Physician Decision|0|||
106084030|NCT03670810|365967956|FG003|Open Label Extension|Physician Decision|0|||
106084031|NCT03670810|365967957|FG004|Open Label Extension|Physician Decision|0|||
106084032|NCT03670810|365967958|FG005|Open Label Extension|Physician Decision|0|||
106084033|NCT03670810|365967959|FG006|Open Label Extension|Physician Decision|0|||
105867173|NCT01866098|365163157|FG000|Overall Study|Non-compliance|1|||
106084034|NCT03670810|365967960|FG007|Open Label Extension|Physician Decision|0|||
106084035|NCT03670810|365967961|FG008|Open Label Extension|Physician Decision|2|||
106084036|NCT03670810|365967953|FG000|Open Label Extension|Non-compliance with study drug|0|||
106084037|NCT03670810|365967954|FG001|Open Label Extension|Non-compliance with study drug|0|||
106084038|NCT03670810|365967955|FG002|Open Label Extension|Non-compliance with study drug|0|||
106084039|NCT03670810|365967956|FG003|Open Label Extension|Non-compliance with study drug|0|||
106160611|NCT01084876|366249043|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
105867174|NCT01866098|365163158|FG001|Overall Study|Non-compliance|0|||
106084040|NCT03670810|365967957|FG004|Open Label Extension|Non-compliance with study drug|0|||
106084041|NCT03670810|365967958|FG005|Open Label Extension|Non-compliance with study drug|0|||
106084042|NCT03670810|365967959|FG006|Open Label Extension|Non-compliance with study drug|0|||
106084043|NCT03670810|365967960|FG007|Open Label Extension|Non-compliance with study drug|0|||
106084044|NCT03670810|365967961|FG008|Open Label Extension|Non-compliance with study drug|5|||
106084045|NCT03670810|365967953|FG000|Open Label Extension|Pregnancy|0|||
106084046|NCT03670810|365967954|FG001|Open Label Extension|Pregnancy|0|||
106084047|NCT03670810|365967955|FG002|Open Label Extension|Pregnancy|0|||
106084048|NCT03670810|365967956|FG003|Open Label Extension|Pregnancy|0|||
106084049|NCT03670810|365967957|FG004|Open Label Extension|Pregnancy|0|||
106084050|NCT03670810|365967958|FG005|Open Label Extension|Pregnancy|0|||
106084051|NCT03670810|365967959|FG006|Open Label Extension|Pregnancy|0|||
106084052|NCT03670810|365967960|FG007|Open Label Extension|Pregnancy|0|||
106084053|NCT03670810|365967961|FG008|Open Label Extension|Pregnancy|3|||
106084054|NCT03670810|365967953|FG000|Open Label Extension|Adverse Event|0|||
106084055|NCT03670810|365967954|FG001|Open Label Extension|Adverse Event|0|||
106084056|NCT03670810|365967955|FG002|Open Label Extension|Adverse Event|0|||
106084057|NCT03670810|365967956|FG003|Open Label Extension|Adverse Event|0|||
106084058|NCT03670810|365967957|FG004|Open Label Extension|Adverse Event|0|||
106084059|NCT03670810|365967958|FG005|Open Label Extension|Adverse Event|0|||
106084060|NCT03670810|365967959|FG006|Open Label Extension|Adverse Event|0|||
106084061|NCT03670810|365967960|FG007|Open Label Extension|Adverse Event|0|||
106084062|NCT03670810|365967961|FG008|Open Label Extension|Adverse Event|24|||
106084063|NCT03670810|365967953|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
106084064|NCT03670810|365967954|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
106084065|NCT03670810|365967955|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
106084066|NCT03670810|365967956|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
106084067|NCT03670810|365967957|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
105867175|NCT01866098|365163159|FG002|Overall Study|Non-compliance|1|||
106084068|NCT03670810|365967958|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
106084069|NCT03670810|365967959|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
106084070|NCT03670810|365967960|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
106084071|NCT03670810|365967961|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
106084072|NCT03670810|365967953|FG000|Open Label Extension|Lost to Follow-up|0|||
106084073|NCT03670810|365967954|FG001|Open Label Extension|Lost to Follow-up|0|||
106084074|NCT03670810|365967955|FG002|Open Label Extension|Lost to Follow-up|0|||
106084075|NCT03670810|365967956|FG003|Open Label Extension|Lost to Follow-up|0|||
106084076|NCT03670810|365967957|FG004|Open Label Extension|Lost to Follow-up|0|||
106084077|NCT03670810|365967958|FG005|Open Label Extension|Lost to Follow-up|0|||
106084078|NCT03670810|365967959|FG006|Open Label Extension|Lost to Follow-up|0|||
106084079|NCT03670810|365967960|FG007|Open Label Extension|Lost to Follow-up|0|||
106084080|NCT03670810|365967961|FG008|Open Label Extension|Lost to Follow-up|23|||
106084081|NCT00482391|365967962|FG000|Overall Study|Withdrawal by Subject|1|||
106084082|NCT00482391|365967962|FG000|Overall Study|Adverse Event|1|||
106084083|NCT00482391|365967962|FG000|Overall Study|Death|1|||
106084084|NCT00086580|365967971|FG000|Treatment Period|Disease progression|9|||
106084085|NCT00086580|365967972|FG001|Treatment Period|Disease progression|8|||
106084086|NCT00086580|365967971|FG000|Treatment Period|Unable to comply with protocol|3|||
106084087|NCT00086580|365967972|FG001|Treatment Period|Unable to comply with protocol|1|||
106084088|NCT00086580|365967971|FG000|Treatment Period|Withdrawal by Subject|7|||
106084089|NCT00086580|365967972|FG001|Treatment Period|Withdrawal by Subject|8|||
106084090|NCT00086580|365967971|FG000|Treatment Period|Physician Decision|13|||
106084091|NCT00086580|365967972|FG001|Treatment Period|Physician Decision|7|||
106084092|NCT00086580|365967971|FG000|Treatment Period|AE - not treatment related|7|||
106084093|NCT00086580|365967972|FG001|Treatment Period|AE - not treatment related|7|||
106084094|NCT00086580|365967971|FG000|Treatment Period|Toxicity - treatment related|15|||
106084095|NCT00086580|365967972|FG001|Treatment Period|Toxicity - treatment related|15|||
106084096|NCT00086580|365967971|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
106084097|NCT00086580|365967972|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
106084098|NCT00086580|365967971|FG000|Treatment Period|Death|5|||
106084099|NCT00086580|365967972|FG001|Treatment Period|Death|7|||
106084100|NCT00086580|365967971|FG000|Treatment Period|Other|5|||
106084101|NCT00086580|365967972|FG001|Treatment Period|Other|3|||
106084102|NCT00086580|365967971|FG000|Follow-up Period|Disease progression|72|||
106084103|NCT00086580|365967972|FG001|Follow-up Period|Disease progression|99|||
106084104|NCT00086580|365967971|FG000|Follow-up Period|Unable to comply with protocol|5|||
106084105|NCT00086580|365967972|FG001|Follow-up Period|Unable to comply with protocol|0|||
106084106|NCT00086580|365967971|FG000|Follow-up Period|Withdrawal by Subject|6|||
106084107|NCT00086580|365967972|FG001|Follow-up Period|Withdrawal by Subject|6|||
106084108|NCT00086580|365967971|FG000|Follow-up Period|Physician Decision|0|||
106084109|NCT00086580|365967972|FG001|Follow-up Period|Physician Decision|1|||
106084110|NCT00086580|365967971|FG000|Follow-up Period|AE - not related|1|||
106084111|NCT00086580|365967972|FG001|Follow-up Period|AE - not related|0|||
106084112|NCT00086580|365967971|FG000|Follow-up Period|Death|13|||
106084113|NCT00086580|365967972|FG001|Follow-up Period|Death|7|||
106084114|NCT00086580|365967971|FG000|Follow-up Period|Other|7|||
106084115|NCT00086580|365967972|FG001|Follow-up Period|Other|6|||
106084116|NCT00086580|365967971|FG000|Observation Period|Unable to comply with protocol|1|||
106084117|NCT00086580|365967972|FG001|Observation Period|Unable to comply with protocol|1|||
106084118|NCT00086580|365967971|FG000|Observation Period|Withdrawal by Subject|4|||
106084119|NCT00086580|365967972|FG001|Observation Period|Withdrawal by Subject|2|||
106084120|NCT00086580|365967971|FG000|Observation Period|Death|33|||
106084121|NCT00086580|365967972|FG001|Observation Period|Death|55|||
106084122|NCT00086580|365967971|FG000|Observation Period|Other|8|||
106084123|NCT00086580|365967972|FG001|Observation Period|Other|7|||
106084124|NCT00261716|365967974|FG000|Overall Study|Withdrawal by Subject|6|||
106084125|NCT00261716|365967975|FG001|Overall Study|Withdrawal by Subject|8|||
106084126|NCT00261716|365967974|FG000|Overall Study|Lost to Follow-up|0|||
106084127|NCT00261716|365967975|FG001|Overall Study|Lost to Follow-up|2|||
106084128|NCT04439240|365967976|FG000|Overall Study|Ineligible|2|||
106084129|NCT04439240|365967976|FG000|Overall Study|Never started treatment|2|||
106084130|NCT04439240|365967976|FG000|Overall Study|Adverse Event|12|||
106084131|NCT04439240|365967976|FG000|Overall Study|Death|2|||
106084132|NCT04439240|365967976|FG000|Overall Study|Disease progression|25|||
106084133|NCT04439240|365967976|FG000|Overall Study|Other diseases|2|||
106084134|NCT04439240|365967976|FG000|Overall Study|Withdrawal by Subject|3|||
106084135|NCT04439240|365967976|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
106084136|NCT04439240|365967976|FG000|Overall Study|Symptomatic decline|1|||
106084137|NCT04439240|365967976|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
106084138|NCT04439240|365967976|FG000|Overall Study|Clinical progression|1|||
106084139|NCT02644967|365967977|FG000|Overall Study|Death|26|||
106084140|NCT02644967|365967977|FG000|Overall Study|Physician Decision|1|||
106084141|NCT02644967|365967977|FG000|Overall Study|Withdrawal by Subject|2|||
106084142|NCT02644967|365967977|FG000|Overall Study|Protocol Violation|1|||
106084143|NCT02644967|365967977|FG000|Overall Study|Progressive Disease|1|||
106084144|NCT02644967|365967977|FG000|Overall Study|Study Terminated by Sponsor|4|||
106084145|NCT02075320|365967983|FG000|Overall Study|Withdrawal by Subject|2|||
106084146|NCT03773757|365967985|FG000|Overall Study|Withdrawal by Subject|2|||
106084147|NCT03773757|365967986|FG001|Overall Study|Withdrawal by Subject|4|||
106084148|NCT01502644|365967987|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
106084149|NCT01502644|365967988|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
106084150|NCT01502644|365967989|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
106084151|NCT01502644|365967990|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
106084152|NCT01502644|365967987|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
106084153|NCT01502644|365967988|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
106084154|NCT01502644|365967989|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
106084155|NCT01502644|365967990|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
106084156|NCT01502644|365967987|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
106084157|NCT01502644|365967988|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
106084158|NCT01502644|365967989|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
106084159|NCT01502644|365967990|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
106084160|NCT01502644|365967987|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
106084161|NCT01502644|365967988|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
106084162|NCT01502644|365967989|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
106084163|NCT01502644|365967990|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
106084164|NCT01502644|365967987|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
106084165|NCT01502644|365967988|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
106084166|NCT01502644|365967989|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
106084167|NCT01502644|365967990|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
106084168|NCT01147653|365967991|FG000|Year 2|Withdrawal by Subject|2|||
106084169|NCT01147653|365967992|FG001|Year 2|Withdrawal by Subject|3|||
106084170|NCT00353366|365967995|FG000|Overall Study|Adverse Event|8|||
106084171|NCT00353366|365967995|FG000|Overall Study|Protocol Violation|12|||
106084172|NCT00353366|365967995|FG000|Overall Study|Withdrawal by Subject|12|||
106084173|NCT00353366|365967995|FG000|Overall Study|Lost to Follow-up|92|||
106084174|NCT00353366|365967995|FG000|Overall Study|Other|19|||
106084175|NCT01109316|365967996|FG000|Study Period 1|Adverse Event|0|||
106084176|NCT01109316|365967997|FG001|Study Period 1|Adverse Event|0|||
106084177|NCT01109316|365967998|FG002|Study Period 1|Adverse Event|1|||
106084178|NCT01109316|365967999|FG003|Study Period 1|Adverse Event|0|||
106084179|NCT01109316|365968000|FG004|Study Period 1|Adverse Event|0|||
106084180|NCT01109316|365968001|FG005|Study Period 1|Adverse Event|0|||
106084181|NCT01109316|365967996|FG000|Study Period 1|Lost to Follow-up|0|||
106084182|NCT01109316|365967997|FG001|Study Period 1|Lost to Follow-up|0|||
106084183|NCT01109316|365967998|FG002|Study Period 1|Lost to Follow-up|1|||
106084184|NCT01109316|365967999|FG003|Study Period 1|Lost to Follow-up|1|||
106084185|NCT01109316|365968000|FG004|Study Period 1|Lost to Follow-up|0|||
106084186|NCT01109316|365968001|FG005|Study Period 1|Lost to Follow-up|0|||
106084187|NCT01109316|365967996|FG000|Study Period 1|Withdrawal by Subject|0|||
106084188|NCT01109316|365967997|FG001|Study Period 1|Withdrawal by Subject|0|||
106084189|NCT01109316|365967998|FG002|Study Period 1|Withdrawal by Subject|1|||
106084190|NCT01109316|365967999|FG003|Study Period 1|Withdrawal by Subject|0|||
106084191|NCT01109316|365968000|FG004|Study Period 1|Withdrawal by Subject|2|||
106084192|NCT01109316|365968001|FG005|Study Period 1|Withdrawal by Subject|0|||
106084193|NCT01109316|365967996|FG000|Study Period 1|Sponsor Decision|0|||
106084194|NCT01109316|365967997|FG001|Study Period 1|Sponsor Decision|0|||
106084195|NCT01109316|365967998|FG002|Study Period 1|Sponsor Decision|0|||
106084196|NCT01109316|365967999|FG003|Study Period 1|Sponsor Decision|0|||
106084197|NCT01109316|365968000|FG004|Study Period 1|Sponsor Decision|0|||
106084198|NCT01109316|365968001|FG005|Study Period 1|Sponsor Decision|2|||
106084199|NCT01109316|365967996|FG000|Study Period 2|Entry Criteria Not Met|0|||
106084200|NCT01109316|365967997|FG001|Study Period 2|Entry Criteria Not Met|1|||
106084201|NCT01109316|365967998|FG002|Study Period 2|Entry Criteria Not Met|0|||
106084202|NCT01109316|365967999|FG003|Study Period 2|Entry Criteria Not Met|0|||
106084203|NCT01109316|365968000|FG004|Study Period 2|Entry Criteria Not Met|0|||
106084204|NCT01109316|365968001|FG005|Study Period 2|Entry Criteria Not Met|0|||
106084205|NCT01109316|365967996|FG000|Study Period 2|Physician Decision|0|||
106084206|NCT01109316|365967997|FG001|Study Period 2|Physician Decision|0|||
106084207|NCT01109316|365967998|FG002|Study Period 2|Physician Decision|0|||
106084208|NCT01109316|365967999|FG003|Study Period 2|Physician Decision|1|||
106084209|NCT01109316|365968000|FG004|Study Period 2|Physician Decision|0|||
106084210|NCT01109316|365968001|FG005|Study Period 2|Physician Decision|0|||
106084211|NCT01109316|365967996|FG000|Study Period 2|Protocol Violation|1|||
106084212|NCT01109316|365967997|FG001|Study Period 2|Protocol Violation|0|||
106084213|NCT01109316|365967998|FG002|Study Period 2|Protocol Violation|0|||
106084214|NCT01109316|365967999|FG003|Study Period 2|Protocol Violation|0|||
106084215|NCT01109316|365968000|FG004|Study Period 2|Protocol Violation|0|||
106084216|NCT01109316|365968001|FG005|Study Period 2|Protocol Violation|0|||
106084217|NCT01109316|365967996|FG000|Study Period 2|Withdrawal by Subject|0|||
106084218|NCT01109316|365967997|FG001|Study Period 2|Withdrawal by Subject|0|||
106084219|NCT01109316|365967998|FG002|Study Period 2|Withdrawal by Subject|1|||
106084220|NCT01109316|365967999|FG003|Study Period 2|Withdrawal by Subject|0|||
106084221|NCT01109316|365968000|FG004|Study Period 2|Withdrawal by Subject|0|||
106084222|NCT01109316|365968001|FG005|Study Period 2|Withdrawal by Subject|1|||
106084223|NCT01109316|365967996|FG000|Study Period 3|Lost to Follow-up|0|||
106084224|NCT01109316|365967997|FG001|Study Period 3|Lost to Follow-up|0|||
106084225|NCT01109316|365967998|FG002|Study Period 3|Lost to Follow-up|0|||
106084226|NCT01109316|365967999|FG003|Study Period 3|Lost to Follow-up|0|||
106084227|NCT01109316|365968000|FG004|Study Period 3|Lost to Follow-up|1|||
106084228|NCT01109316|365968001|FG005|Study Period 3|Lost to Follow-up|0|||
106084229|NCT01109316|365967996|FG000|Study Period 3|Withdrawal by Subject|1|||
106084230|NCT01109316|365967997|FG001|Study Period 3|Withdrawal by Subject|0|||
106084231|NCT01109316|365967998|FG002|Study Period 3|Withdrawal by Subject|0|||
106084232|NCT01109316|365967999|FG003|Study Period 3|Withdrawal by Subject|0|||
106084233|NCT01109316|365968000|FG004|Study Period 3|Withdrawal by Subject|1|||
106084234|NCT01109316|365968001|FG005|Study Period 3|Withdrawal by Subject|0|||
106084235|NCT03075644|365968003|FG000|Overall Study|Withdrawal by Subject|1|||
106084236|NCT03075644|365968004|FG001|Overall Study|Withdrawal by Subject|1|||
106084237|NCT03025828|365968008|FG000|Overall Study|Lost to Follow-up|1|||
106084238|NCT01559311|365968009|FG000|Overall Study|Protocol Violation|0|||
106084239|NCT01559311|365968010|FG001|Overall Study|Protocol Violation|0|||
106084240|NCT01559311|365968011|FG002|Overall Study|Protocol Violation|2|||
106084241|NCT01559311|365968009|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
106084242|NCT01559311|365968010|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
106084243|NCT01559311|365968011|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
106084244|NCT01559311|365968009|FG000|Overall Study|Withdrawal by Subject|2|||
106084245|NCT01559311|365968010|FG001|Overall Study|Withdrawal by Subject|1|||
106084246|NCT01559311|365968011|FG002|Overall Study|Withdrawal by Subject|0|||
106084247|NCT01559311|365968009|FG000|Overall Study|Death|0|||
106084248|NCT01559311|365968010|FG001|Overall Study|Death|2|||
106084249|NCT01559311|365968011|FG002|Overall Study|Death|3|||
106084250|NCT01559311|365968009|FG000|Overall Study|Lost to Follow-up|0|||
106084251|NCT01559311|365968010|FG001|Overall Study|Lost to Follow-up|3|||
106084252|NCT01559311|365968011|FG002|Overall Study|Lost to Follow-up|2|||
106084253|NCT01559311|365968009|FG000|Overall Study|Adverse Event|0|||
105867176|NCT01866098|365163157|FG000|Overall Study|Pregnancy|2|||
106160612|NCT01084876|366249042|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
106160613|NCT01084876|366249043|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
106160614|NCT01084876|366249042|FG000|Treatment Period Beyond Cycle 8|Other|6|||
106160615|NCT01084876|366249043|FG001|Treatment Period Beyond Cycle 8|Other|9|||
106160616|NCT05763823|366249044|FG000|Overall Study|Death|6|||
106160617|NCT05763823|366249044|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
106160618|NCT05763823|366249044|FG000|Overall Study|Withdrawal by Subject|6|||
106160619|NCT00999804|366249047|FG000|Overall Study|Lack of Efficacy|9|||
106160620|NCT00999804|366249048|FG001|Overall Study|Lack of Efficacy|2|||
106160621|NCT00999804|366249047|FG000|Overall Study|Adverse Event|4|||
106160622|NCT00999804|366249048|FG001|Overall Study|Adverse Event|3|||
106160623|NCT00999804|366249047|FG000|Overall Study|Withdrawal by Subject|4|||
106160624|NCT00999804|366249048|FG001|Overall Study|Withdrawal by Subject|0|||
106160625|NCT00999804|366249047|FG000|Overall Study|Death|1|||
106160626|NCT00999804|366249048|FG001|Overall Study|Death|0|||
106160627|NCT00999804|366249047|FG000|Overall Study|Ineligible|3|||
106160628|NCT00999804|366249048|FG001|Overall Study|Ineligible|0|||
106160629|NCT05028634|366249050|FG000|Overall Study|Withdrawal by Subject|0|||
106160630|NCT05028634|366249051|FG001|Overall Study|Withdrawal by Subject|1|||
106160631|NCT01997840|366249054|FG000|Overall Study|Lost to Follow-up|0|||
106160632|NCT01997840|366249055|FG001|Overall Study|Lost to Follow-up|0|||
106160633|NCT01997840|366249056|FG002|Overall Study|Lost to Follow-up|1|||
106160634|NCT01997840|366249057|FG003|Overall Study|Lost to Follow-up|0|||
106160635|NCT01997840|366249054|FG000|Overall Study|Withdrawal by participant|0|||
106160636|NCT01997840|366249055|FG001|Overall Study|Withdrawal by participant|0|||
106160637|NCT01997840|366249056|FG002|Overall Study|Withdrawal by participant|8|||
106160638|NCT01997840|366249057|FG003|Overall Study|Withdrawal by participant|1|||
106160639|NCT01997840|366249054|FG000|Overall Study|Physician Decision|0|||
106160640|NCT01997840|366249055|FG001|Overall Study|Physician Decision|0|||
106160641|NCT01997840|366249056|FG002|Overall Study|Physician Decision|3|||
106160642|NCT01997840|366249057|FG003|Overall Study|Physician Decision|0|||
106160643|NCT01997840|366249054|FG000|Overall Study|Progressive disease|3|||
106160644|NCT01997840|366249055|FG001|Overall Study|Progressive disease|4|||
106160645|NCT01997840|366249056|FG002|Overall Study|Progressive disease|57|||
106160646|NCT01997840|366249057|FG003|Overall Study|Progressive disease|8|||
106160647|NCT01997840|366249054|FG000|Overall Study|Other reasons|0|||
106160648|NCT01997840|366249055|FG001|Overall Study|Other reasons|0|||
106160649|NCT01997840|366249056|FG002|Overall Study|Other reasons|1|||
106160650|NCT01997840|366249057|FG003|Overall Study|Other reasons|0|||
106160651|NCT01997840|366249054|FG000|Overall Study|Adverse Event|0|||
106160652|NCT01997840|366249055|FG001|Overall Study|Adverse Event|0|||
106160653|NCT01997840|366249056|FG002|Overall Study|Adverse Event|15|||
106160654|NCT01997840|366249057|FG003|Overall Study|Adverse Event|2|||
106160655|NCT04410042|366249060|FG000|Overall Study|Not Eligible|1|||
106160656|NCT04410042|366249061|FG001|Overall Study|Not Eligible|1|||
106160657|NCT03850678|366249064|FG000|Overall Study|Withdrawal by Subject|3|||
106160658|NCT03850678|366249065|FG001|Overall Study|Withdrawal by Subject|0|||
106160659|NCT03850678|366249064|FG000|Overall Study|Experimenter Error|1|||
106160660|NCT03850678|366249065|FG001|Overall Study|Experimenter Error|1|||
106160661|NCT03850678|366249064|FG000|Overall Study|Did Not Condition To Experiment|7|||
106160662|NCT03850678|366249065|FG001|Overall Study|Did Not Condition To Experiment|2|||
106160663|NCT03746015|366249067|FG000|Overall Study|Withdrawal of Consent|1|||
106160664|NCT03746015|366249068|FG001|Overall Study|Withdrawal of Consent|0|||
106160665|NCT03746015|366249069|FG002|Overall Study|Withdrawal of Consent|0|||
106160666|NCT04971395|366249085|FG000|Overall Study|Withdrawal by Subject|0|||
106160667|NCT04971395|366249086|FG001|Overall Study|Withdrawal by Subject|1|||
106160668|NCT04971395|366249087|FG002|Overall Study|Withdrawal by Subject|0|||
106160669|NCT04717492|366249088|FG000|Overall Study|Withdrawal by Subject|2|||
106160670|NCT04717492|366249089|FG001|Overall Study|Withdrawal by Subject|13|||
106160671|NCT04717492|366249088|FG000|Overall Study|Lost to Follow-up|2|||
106160672|NCT04717492|366249089|FG001|Overall Study|Lost to Follow-up|9|||
106160673|NCT03771417|366249090|FG000|Overall Study|Withdrawal by Subject|1|||
106160674|NCT03771417|366249091|FG001|Overall Study|Withdrawal by Subject|0|||
106160675|NCT03771417|366249092|FG002|Overall Study|Withdrawal by Subject|0|||
106160676|NCT03771417|366249090|FG000|Overall Study|Covid-19 Shutdown|0|||
106160677|NCT03771417|366249091|FG001|Overall Study|Covid-19 Shutdown|1|||
106160678|NCT03771417|366249092|FG002|Overall Study|Covid-19 Shutdown|0|||
106160679|NCT04055090|366249093|FG000|Overall Study|screen failure|1|||
106160680|NCT04055090|366249094|FG001|Overall Study|screen failure|0|||
106160681|NCT04055090|366249093|FG000|Overall Study|Withdrawal by Subject|1|||
106160682|NCT04055090|366249094|FG001|Overall Study|Withdrawal by Subject|0|||
106160683|NCT03468218|366249097|FG000|Overall Study|Adverse Event|5|||
106160684|NCT03468218|366249097|FG000|Overall Study|Progressive Disease|16|||
106160685|NCT03468218|366249097|FG000|Overall Study|Death|1|||
105867177|NCT01866098|365163158|FG001|Overall Study|Pregnancy|0|||
106160686|NCT03468218|366249097|FG000|Overall Study|Alternate therapy|1|||
106160687|NCT03468218|366249097|FG000|Overall Study|Withdrawal by Subject|2|||
106160688|NCT03033576|366249098|FG000|Overall Study|Ineligible|1|||
106084254|NCT01559311|365968010|FG001|Overall Study|Adverse Event|0|||
106084255|NCT01559311|365968011|FG002|Overall Study|Adverse Event|1|||
106084256|NCT01573624|365968012|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
106084257|NCT01573624|365968013|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
106084258|NCT01573624|365968014|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
106084259|NCT01573624|365968015|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
106084260|NCT01573624|365968016|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
106084261|NCT01573624|365968017|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
106084262|NCT01573624|365968018|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
106084263|NCT01573624|365968012|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
106084264|NCT01573624|365968013|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
106084265|NCT01573624|365968014|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
106084266|NCT01573624|365968015|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
106084267|NCT01573624|365968016|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
106084268|NCT01573624|365968017|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
106084269|NCT01573624|365968018|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
106084270|NCT01573624|365968012|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
106084271|NCT01573624|365968013|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
106084272|NCT01573624|365968014|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
106084273|NCT01573624|365968015|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
106084274|NCT01573624|365968016|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
106084275|NCT01573624|365968017|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
106084276|NCT01573624|365968018|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
106084277|NCT01573624|365968012|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
106084278|NCT01573624|365968013|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
106084279|NCT01573624|365968014|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
106084280|NCT01573624|365968015|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
106084281|NCT01573624|365968016|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
106084282|NCT01573624|365968017|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
106084283|NCT01573624|365968018|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
106084284|NCT01573624|365968012|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
106084285|NCT01573624|365968013|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
106160689|NCT03033576|366249099|FG001|Overall Study|Ineligible|1|||
106160690|NCT03033576|366249098|FG000|Overall Study|Adverse Event|4|||
106160691|NCT03033576|366249099|FG001|Overall Study|Adverse Event|20|||
106160692|NCT03033576|366249098|FG000|Overall Study|Progression/relapse|9|||
106160693|NCT03033576|366249099|FG001|Overall Study|Progression/relapse|36|||
106160694|NCT03033576|366249098|FG000|Overall Study|Death|1|||
106160695|NCT03033576|366249099|FG001|Overall Study|Death|1|||
106160696|NCT03033576|366249098|FG000|Overall Study|Patient refusal|1|||
106160697|NCT03033576|366249099|FG001|Overall Study|Patient refusal|6|||
106160698|NCT03033576|366249098|FG000|Overall Study|Other, unspecified reasons|0|||
106160699|NCT03033576|366249099|FG001|Overall Study|Other, unspecified reasons|4|||
106160700|NCT03033576|366249098|FG000|Overall Study|Currently on protocol therapy|0|||
106160701|NCT03033576|366249099|FG001|Overall Study|Currently on protocol therapy|2|||
106160702|NCT03557697|366249100|FG000|Overall Study|Withdrawal by Subject|2|||
106160703|NCT03557697|366249101|FG001|Overall Study|Withdrawal by Subject|4|||
106160704|NCT06491433|366249102|FG000|Overall Study|Protocol Violation|51|||
106160705|NCT06491433|366249102|FG000|Overall Study|consent withdrawal|2|||
106160706|NCT06491433|366249102|FG000|Overall Study|screen failure|1|||
106160707|NCT02485938|366249114|FG000|Overall Study|Withdrawal of consent|2|||
106160708|NCT02485938|366249115|FG001|Overall Study|Withdrawal of consent|0|||
106160709|NCT04876118|366249117|FG000|Overall Study|Pregnancy|1|||
106160710|NCT04876118|366249117|FG000|Overall Study|Withdrawal by Subject|14|||
106160711|NCT03457142|366250378|FG000|Overall Study|Death|1|||
106160712|NCT03770273|366250379|FG000|Overall Study|Adverse Event|2|||
106160713|NCT03770273|366250380|FG001|Overall Study|Adverse Event|0|||
106160714|NCT03770273|366250379|FG000|Overall Study|Lost to Follow-up|1|||
106160715|NCT03770273|366250380|FG001|Overall Study|Lost to Follow-up|1|||
106160716|NCT01999075|366250381|FG000|Overall Study|Lost to Follow-up|0|||
106160717|NCT01999075|366250382|FG001|Overall Study|Lost to Follow-up|2|||
106160718|NCT01999075|366250381|FG000|Overall Study|Withdrawal by Subject|2|||
106160719|NCT01999075|366250382|FG001|Overall Study|Withdrawal by Subject|7|||
106160720|NCT01999075|366250381|FG000|Overall Study|Enrolled in drug trial|3|||
106160721|NCT01999075|366250382|FG001|Overall Study|Enrolled in drug trial|1|||
106160722|NCT01999075|366250381|FG000|Overall Study|Became ineligible|0|||
106160723|NCT01999075|366250382|FG001|Overall Study|Became ineligible|2|||
106160724|NCT04562649|366250387|FG000|Overall Study|Withdrawal by Subject|11|||
106160725|NCT04562649|366250388|FG001|Overall Study|Withdrawal by Subject|8|||
106160726|NCT04562649|366250387|FG000|Overall Study|Lost to Follow-up|26|||
106160727|NCT04562649|366250388|FG001|Overall Study|Lost to Follow-up|20|||
106160728|NCT05368103|366250389|FG000|Overall Study|Withdrawal by Subject|4|||
106160729|NCT05368103|366250389|FG000|Overall Study|Lost to Follow-up|1|||
106160730|NCT05368103|366250389|FG000|Overall Study|Lack of Efficacy|3|||
106160731|NCT03675282|366250390|FG000|Overall Study|Lost to Follow-up|4|||
106160732|NCT03675282|366250391|FG001|Overall Study|Lost to Follow-up|8|||
106160733|NCT03675282|366250392|FG002|Overall Study|Lost to Follow-up|1|||
106160734|NCT03675282|366250393|FG003|Overall Study|Lost to Follow-up|0|||
106160735|NCT03675282|366250394|FG004|Overall Study|Lost to Follow-up|2|||
106160736|NCT03675282|366250395|FG005|Overall Study|Lost to Follow-up|7|||
106160737|NCT03675282|366250390|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
106160738|NCT03675282|366250391|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
106160739|NCT03675282|366250392|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
106160740|NCT03675282|366250393|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
106160741|NCT03675282|366250394|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
106160742|NCT03675282|366250395|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
106160743|NCT03675282|366250390|FG000|Overall Study|Physician Decision|1|||
106160744|NCT03675282|366250391|FG001|Overall Study|Physician Decision|0|||
106160745|NCT03675282|366250392|FG002|Overall Study|Physician Decision|0|||
106160746|NCT03675282|366250393|FG003|Overall Study|Physician Decision|0|||
106160747|NCT03675282|366250394|FG004|Overall Study|Physician Decision|0|||
106160748|NCT03675282|366250395|FG005|Overall Study|Physician Decision|0|||
106160749|NCT04977947|366250404|FG000|Overall Study|Lost to Follow-up|1|||
106160750|NCT04977947|366250405|FG001|Overall Study|Lost to Follow-up|1|||
106160751|NCT04130438|366250406|FG000|Overall Study|Lost to Follow-up|0|||
106160752|NCT04130438|366250407|FG001|Overall Study|Lost to Follow-up|0|||
106160753|NCT04130438|366250408|FG002|Overall Study|Lost to Follow-up|1|||
106160754|NCT04142788|366250409|FG000|Overall Study|Trial terminated prematurely|2|||
106160755|NCT04142788|366250410|FG001|Overall Study|Trial terminated prematurely|2|||
106160756|NCT01494662|366250411|FG000|Overall Study|Withdrawal by Subject|0|||
106160757|NCT01494662|366250412|FG001|Overall Study|Withdrawal by Subject|0|||
106160758|NCT01494662|366250413|FG002|Overall Study|Withdrawal by Subject|1|||
106160759|NCT01494662|366250414|FG003|Overall Study|Withdrawal by Subject|0|||
106160760|NCT01494662|366250415|FG004|Overall Study|Withdrawal by Subject|0|||
106160761|NCT01494662|366250416|FG005|Overall Study|Withdrawal by Subject|0|||
106160762|NCT01494662|366250417|FG006|Overall Study|Withdrawal by Subject|0|||
106160763|NCT01494662|366250411|FG000|Overall Study|Physician Decision|0|||
106160764|NCT01494662|366250412|FG001|Overall Study|Physician Decision|0|||
106160765|NCT01494662|366250413|FG002|Overall Study|Physician Decision|1|||
106160766|NCT01494662|366250414|FG003|Overall Study|Physician Decision|0|||
106160767|NCT01494662|366250415|FG004|Overall Study|Physician Decision|0|||
106160768|NCT01494662|366250416|FG005|Overall Study|Physician Decision|0|||
106160769|NCT01494662|366250417|FG006|Overall Study|Physician Decision|0|||
106160770|NCT05311384|366250418|FG000|Overall Study|Uncontrolled health conditions|2|||
106160771|NCT05311384|366250418|FG000|Overall Study|Withdrawal by Subject|1|||
106160772|NCT04322643|366250419|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
106160773|NCT04256941|366250427|FG000|Overall Study|Withdrawal by Subject|0|||
106160774|NCT04256941|366250428|FG001|Overall Study|Withdrawal by Subject|1|||
106160775|NCT04256941|366250427|FG000|Overall Study|Death|1|||
106160776|NCT04256941|366250428|FG001|Overall Study|Death|0|||
106160777|NCT04256941|366250427|FG000|Overall Study|Disease Progession|0|||
106160778|NCT04256941|366250428|FG001|Overall Study|Disease Progession|2|||
106160779|NCT05659537|366250429|FG000|Overall Study|Adverse Event|5|||
106160780|NCT05659537|366250429|FG000|Overall Study|Lost to Follow-up|4|||
106160781|NCT05659537|366250429|FG000|Overall Study|Withdrawal by Subject|13|||
106160782|NCT05659537|366250429|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
106160783|NCT05659537|366250429|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
106160784|NCT05659537|366250429|FG000|Overall Study|Participant was suffering from anaemia|1|||
106160785|NCT03953508|366250430|FG000|Baseline|Lost to Follow-up|3|||
106160786|NCT03953508|366250431|FG001|Baseline|Lost to Follow-up|2|||
106160787|NCT03953508|366250430|FG000|6-month Follow-up|Lost to Follow-up|62|||
106160788|NCT03953508|366250431|FG001|6-month Follow-up|Lost to Follow-up|70|||
106160789|NCT03766009|366250432|FG000|Usual Care|Death|0|||
106160790|NCT03766009|366250433|FG001|Usual Care|Death|0|||
106160791|NCT03766009|366250434|FG002|Usual Care|Death|0|||
106160792|NCT03766009|366250435|FG003|Usual Care|Death|1|||
106160793|NCT03766009|366250436|FG004|Usual Care|Death|0|||
106160794|NCT03766009|366250437|FG005|Usual Care|Death|0|||
106160795|NCT03766009|366250432|FG000|Usual Care|Lost to Follow-up|0|||
106160796|NCT03766009|366250433|FG001|Usual Care|Lost to Follow-up|0|||
106160797|NCT03766009|366250434|FG002|Usual Care|Lost to Follow-up|0|||
106160798|NCT03766009|366250435|FG003|Usual Care|Lost to Follow-up|1|||
106160799|NCT03766009|366250436|FG004|Usual Care|Lost to Follow-up|0|||
106160800|NCT03766009|366250437|FG005|Usual Care|Lost to Follow-up|0|||
106160801|NCT03766009|366250432|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
106160802|NCT03766009|366250433|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
106160803|NCT03766009|366250434|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
106160804|NCT03766009|366250435|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
106160805|NCT03766009|366250436|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
106160806|NCT03766009|366250437|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
106160807|NCT03766009|366250432|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
106160808|NCT03766009|366250433|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
106160809|NCT03766009|366250434|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
106160810|NCT03766009|366250435|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
106160811|NCT03766009|366250436|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
106160812|NCT03766009|366250437|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
106160813|NCT03766009|366250432|FG000|Usual Care|No treatment or declined surgery|0|||
106160814|NCT03766009|366250433|FG001|Usual Care|No treatment or declined surgery|0|||
106160815|NCT03766009|366250434|FG002|Usual Care|No treatment or declined surgery|0|||
106160816|NCT03766009|366250435|FG003|Usual Care|No treatment or declined surgery|2|||
106160817|NCT03766009|366250436|FG004|Usual Care|No treatment or declined surgery|0|||
106160818|NCT03766009|366250437|FG005|Usual Care|No treatment or declined surgery|0|||
106160819|NCT03766009|366250432|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
106160820|NCT03766009|366250433|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
106084286|NCT01573624|365968014|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
106084287|NCT01573624|365968015|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
106084288|NCT01573624|365968016|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
106084289|NCT01573624|365968017|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
106084290|NCT01573624|365968018|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
106084291|NCT01573624|365968012|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
106084292|NCT01573624|365968013|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
106084293|NCT01573624|365968014|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
106084294|NCT01573624|365968015|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
106084295|NCT01573624|365968016|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
106084296|NCT01573624|365968017|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
106084297|NCT01573624|365968018|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
106084298|NCT01573624|365968012|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
106084299|NCT01573624|365968013|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
106084300|NCT01573624|365968014|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
106084301|NCT01573624|365968015|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
106084302|NCT01573624|365968016|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
106084303|NCT01573624|365968017|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
106084304|NCT01573624|365968018|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
106084305|NCT01573624|365968012|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
106084306|NCT01573624|365968013|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106084307|NCT01573624|365968014|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
106084308|NCT01573624|365968015|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
106084309|NCT01573624|365968016|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106084310|NCT01573624|365968017|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106084311|NCT01573624|365968018|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
106084312|NCT01573624|365968012|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
106084313|NCT01573624|365968013|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
106084314|NCT01573624|365968014|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
106084315|NCT01573624|365968015|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
106084316|NCT01573624|365968016|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
106084317|NCT01573624|365968017|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
106084318|NCT01573624|365968018|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
106084319|NCT01573624|365968012|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
106084320|NCT01573624|365968013|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
106084321|NCT01573624|365968014|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
106084322|NCT01573624|365968015|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
106084323|NCT01573624|365968016|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
106084324|NCT01573624|365968017|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
106084325|NCT01573624|365968018|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
106084326|NCT01573624|365968012|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
106084327|NCT01573624|365968013|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
106084328|NCT01573624|365968014|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
106084329|NCT01573624|365968015|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
106084330|NCT01573624|365968016|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
106084331|NCT01573624|365968017|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
106084332|NCT01573624|365968018|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
106084333|NCT01573624|365968012|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
106084334|NCT01573624|365968013|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
106084335|NCT01573624|365968014|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
106084336|NCT01573624|365968015|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
106084337|NCT01573624|365968016|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
106084338|NCT01573624|365968017|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
106084339|NCT01573624|365968018|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
106084340|NCT01573624|365968012|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
106084341|NCT01573624|365968013|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
106084342|NCT01573624|365968014|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
106084343|NCT01573624|365968015|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
106084344|NCT01573624|365968016|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
106084345|NCT01573624|365968017|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
106084346|NCT01573624|365968018|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
106084347|NCT01573624|365968012|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
106084348|NCT01573624|365968013|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
106084349|NCT01573624|365968014|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
106084350|NCT01573624|365968015|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
106084351|NCT01573624|365968016|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
106084352|NCT01573624|365968017|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
106084353|NCT01573624|365968018|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
106084354|NCT01573624|365968012|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
106084355|NCT01573624|365968013|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
106084356|NCT01573624|365968014|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
106084357|NCT01573624|365968015|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
105867178|NCT01866098|365163159|FG002|Overall Study|Pregnancy|0|||
105867179|NCT01866098|365163157|FG000|Overall Study|Death|0|||
105867180|NCT01866098|365163158|FG001|Overall Study|Death|1|||
105867181|NCT01866098|365163159|FG002|Overall Study|Death|0|||
105867182|NCT04239027|365163160|FG000|Overall Study|Adverse Event|4|||
105867183|NCT04239027|365163160|FG000|Overall Study|Withdrawal by Subject|9|||
105867184|NCT04239027|365163160|FG000|Overall Study|Death|1|||
105867185|NCT04239027|365163160|FG000|Overall Study|Physician Decision|9|||
105867186|NCT04239027|365163160|FG000|Overall Study|Lost to Follow-up|2|||
105867187|NCT04239027|365163160|FG000|Overall Study|Lack of Efficacy|1|||
105867188|NCT04803305|365163163|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
105867189|NCT04803305|365163164|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
105867190|NCT04803305|365163163|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
105867191|NCT04803305|365163164|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
105867192|NCT04803305|365163163|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
105867193|NCT04803305|365163164|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
105867194|NCT04803305|365163163|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
105867195|NCT04803305|365163164|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
105867196|NCT04803305|365163163|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
105867197|NCT04803305|365163164|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
105867198|NCT04803305|365163163|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
105867199|NCT04803305|365163164|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
105867200|NCT04803305|365163163|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
105867201|NCT04803305|365163164|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
105867202|NCT04803305|365163163|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
105867203|NCT04803305|365163164|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
105867204|NCT00708227|365163165|FG000|Overall Study|Physician Decision|0|||
105867205|NCT00708227|365163166|FG001|Overall Study|Physician Decision|3|||
105867206|NCT00708227|365163167|FG002|Overall Study|Physician Decision|1|||
105867207|NCT00708227|365163168|FG003|Overall Study|Physician Decision|2|||
105867208|NCT00708227|365163165|FG000|Overall Study|Withdrawal by Subject|1|||
105867209|NCT00708227|365163166|FG001|Overall Study|Withdrawal by Subject|2|||
105867210|NCT00708227|365163167|FG002|Overall Study|Withdrawal by Subject|0|||
105867211|NCT00708227|365163168|FG003|Overall Study|Withdrawal by Subject|1|||
105867212|NCT02108912|365163169|FG000|Overall Study|Lost to Follow-up|1|||
105867213|NCT02108912|365163170|FG001|Overall Study|Lost to Follow-up|1|||
105867214|NCT02108912|365163169|FG000|Overall Study|lack of transportation|1|||
105867215|NCT02108912|365163170|FG001|Overall Study|lack of transportation|0|||
105867216|NCT02108912|365163169|FG000|Overall Study|high blood pressure|1|||
105867217|NCT02108912|365163170|FG001|Overall Study|high blood pressure|0|||
105867218|NCT03203850|365164930|FG000|Overall Study|Subject/guardian decision|4|||
105867219|NCT03203850|365164931|FG001|Overall Study|Subject/guardian decision|3|||
105867220|NCT03203850|365164930|FG000|Overall Study|Adverse Event|3|||
105867221|NCT03203850|365164931|FG001|Overall Study|Adverse Event|0|||
105867222|NCT03203850|365164930|FG000|Overall Study|Death|1|||
105867223|NCT03203850|365164931|FG001|Overall Study|Death|0|||
105867224|NCT05048329|365164932|FG000|Overall Study|Withdrawal by Subject|1|||
105867225|NCT05048329|365164932|FG000|Overall Study|Screenfail|1|||
106084358|NCT01573624|365968016|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
106084359|NCT01573624|365968017|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
106084360|NCT01573624|365968018|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
106084361|NCT01573624|365968012|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
106084362|NCT01573624|365968013|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
105867226|NCT01659125|365164933|FG000|Overall Study|Withdrawal by Subject|2|||
105867227|NCT01659125|365164933|FG000|Overall Study|Lost to Follow-up|7|||
105867228|NCT01659125|365164933|FG000|Overall Study|Technical Problem|1|||
105867229|NCT01659125|365164933|FG000|Overall Study|Time Constraints|2|||
106084363|NCT01573624|365968014|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
105867230|NCT01659125|365164933|FG000|Overall Study|Failed to Start Treatment|2|||
105867231|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #1|24|||
105867232|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #1|0|||
105867233|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
105867234|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
105867235|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105867236|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
106084364|NCT01573624|365968015|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
106084365|NCT01573624|365968016|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
106084366|NCT01573624|365968017|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
106084367|NCT01573624|365968018|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
106084368|NCT01573624|365968012|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
106084369|NCT01573624|365968013|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
106160821|NCT03766009|366250434|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
106084370|NCT01573624|365968014|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
106084371|NCT01573624|365968015|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
106084372|NCT01573624|365968016|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
106084373|NCT01573624|365968017|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
106084374|NCT01573624|365968018|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
106084375|NCT01573624|365968012|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
106160822|NCT03766009|366250435|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
106160823|NCT03766009|366250436|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
106160824|NCT03766009|366250437|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
106160825|NCT03766009|366250432|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
106160826|NCT03766009|366250433|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
106160827|NCT03766009|366250434|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
106160828|NCT03766009|366250435|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
106160829|NCT03766009|366250436|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
106160830|NCT03766009|366250437|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
106160831|NCT03766009|366250432|FG000|Usual Care|Ineligible|0|||
106160832|NCT03766009|366250433|FG001|Usual Care|Ineligible|1|||
106160833|NCT03766009|366250434|FG002|Usual Care|Ineligible|0|||
106160834|NCT03766009|366250435|FG003|Usual Care|Ineligible|0|||
106160835|NCT03766009|366250436|FG004|Usual Care|Ineligible|0|||
106160836|NCT03766009|366250437|FG005|Usual Care|Ineligible|0|||
106160837|NCT03766009|366250432|FG000|Usual Care|Other: Staff turnover|0|||
106160838|NCT03766009|366250433|FG001|Usual Care|Other: Staff turnover|0|||
106160839|NCT03766009|366250434|FG002|Usual Care|Other: Staff turnover|0|||
106084376|NCT01573624|365968013|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
106084377|NCT01573624|365968014|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
106084378|NCT01573624|365968015|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
106084379|NCT01573624|365968016|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
106084380|NCT01573624|365968017|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
106084381|NCT01573624|365968018|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
106084382|NCT01573624|365968012|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
106084383|NCT01573624|365968013|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
106084384|NCT01573624|365968014|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
106084385|NCT01573624|365968015|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
106084386|NCT01573624|365968016|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
106084387|NCT01573624|365968017|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
106160840|NCT03766009|366250435|FG003|Usual Care|Other: Staff turnover|0|||
106160841|NCT03766009|366250436|FG004|Usual Care|Other: Staff turnover|0|||
106160842|NCT03766009|366250437|FG005|Usual Care|Other: Staff turnover|2|||
106160843|NCT05071807|366250441|FG000|Overall Study|Withdrawal by Subject|4|||
106084388|NCT01573624|365968018|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
106084389|NCT01573624|365968012|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
106084390|NCT01573624|365968013|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
106084391|NCT01573624|365968014|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
106084392|NCT01573624|365968015|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
106084393|NCT01573624|365968016|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
106160844|NCT05071807|366250442|FG001|Overall Study|Withdrawal by Subject|0|||
106160845|NCT05071807|366250441|FG000|Overall Study|Unrelated medical issues|3|||
106160846|NCT05071807|366250442|FG001|Overall Study|Unrelated medical issues|0|||
106084394|NCT01573624|365968017|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
106084395|NCT01573624|365968018|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
106084396|NCT01573624|365968012|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106084397|NCT01573624|365968013|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106160847|NCT05071807|366250441|FG000|Overall Study|Relocated|0|||
106160848|NCT05071807|366250442|FG001|Overall Study|Relocated|1|||
106160849|NCT05551637|366250451|FG000|Overall Study|Lack of Efficacy|0|||
106160850|NCT05551637|366250452|FG001|Overall Study|Lack of Efficacy|6|||
106160851|NCT05551637|366250451|FG000|Overall Study|Lost to Follow-up|1|||
106160852|NCT05551637|366250452|FG001|Overall Study|Lost to Follow-up|1|||
106160853|NCT04782973|366250455|FG000|Overall Study|Withdrawal by Subject|5|||
106084398|NCT01573624|365968014|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106084399|NCT01573624|365968015|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106084400|NCT01573624|365968016|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
106084401|NCT01573624|365968017|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
106084402|NCT01573624|365968018|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
106084403|NCT01573624|365968012|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
106084404|NCT01573624|365968013|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
106084405|NCT01573624|365968014|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
106084406|NCT01573624|365968015|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
106084407|NCT01573624|365968016|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
106084408|NCT01573624|365968017|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
106084409|NCT01573624|365968018|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
106084410|NCT01573624|365968012|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
106084411|NCT01573624|365968013|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
106084412|NCT01573624|365968014|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
106084413|NCT01573624|365968015|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
106084414|NCT01573624|365968016|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
106084415|NCT01573624|365968017|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
106084416|NCT01573624|365968018|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
106084417|NCT01573624|365968012|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
106084418|NCT01573624|365968013|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
106084419|NCT01573624|365968014|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
106084420|NCT01573624|365968015|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
106084421|NCT01573624|365968016|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
106084422|NCT01573624|365968017|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
106084423|NCT01573624|365968018|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
106084424|NCT01573624|365968012|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
106084425|NCT01573624|365968013|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
106084426|NCT01573624|365968014|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
106084427|NCT01573624|365968015|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
106084428|NCT01573624|365968016|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
106084429|NCT01573624|365968017|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
106084430|NCT01573624|365968018|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
106084431|NCT01573624|365968012|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
106084432|NCT01573624|365968013|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
106084433|NCT01573624|365968014|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
106084434|NCT01573624|365968015|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
106084435|NCT01573624|365968016|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
106084436|NCT01573624|365968017|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
106084437|NCT01573624|365968018|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
106084438|NCT01573624|365968012|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
106084439|NCT01573624|365968013|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
106084440|NCT01573624|365968014|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
106084441|NCT01573624|365968015|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
106084442|NCT01573624|365968016|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
106084443|NCT01573624|365968017|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
106084444|NCT01573624|365968018|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
106084445|NCT04187196|365968019|FG000|Overall Study|Screen Failure|2|||
106084446|NCT04187196|365968020|FG001|Overall Study|Screen Failure|0|||
106084447|NCT03467425|365968023|FG000|Overall Study|Adverse Event|9|||
106084448|NCT03467425|365968024|FG001|Overall Study|Adverse Event|9|||
106084449|NCT03467425|365968023|FG000|Overall Study|Lack of Efficacy|3|||
106084450|NCT03467425|365968024|FG001|Overall Study|Lack of Efficacy|1|||
106084451|NCT03467425|365968023|FG000|Overall Study|Protocol Violation|0|||
106084452|NCT03467425|365968024|FG001|Overall Study|Protocol Violation|1|||
106084453|NCT03467425|365968023|FG000|Overall Study|Lost to Follow-up|18|||
106084454|NCT03467425|365968024|FG001|Overall Study|Lost to Follow-up|25|||
106084455|NCT03467425|365968023|FG000|Overall Study|Physician Decision|2|||
106084456|NCT03467425|365968024|FG001|Overall Study|Physician Decision|1|||
106084457|NCT03467425|365968023|FG000|Overall Study|Withdrawal by Subject|15|||
106084458|NCT03467425|365968024|FG001|Overall Study|Withdrawal by Subject|17|||
106084459|NCT02318693|365968026|FG000|Overall Study|Protocol Violation|0|||
106084460|NCT02318693|365968027|FG001|Overall Study|Protocol Violation|1|||
106084461|NCT03591575|365968030|FG000|Overall Study|Adverse Event|2|||
106084462|NCT03591575|365968031|FG001|Overall Study|Adverse Event|0|||
106084463|NCT03591575|365968030|FG000|Overall Study|Withdrawal by Subject|4|||
106084464|NCT03591575|365968031|FG001|Overall Study|Withdrawal by Subject|1|||
106084465|NCT00025883|365968032|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
106084466|NCT00025883|365968032|FG000|Overall Study|no baseline data|1|||
106084467|NCT00025883|365968032|FG000|Overall Study|Death|1|||
106084468|NCT00025883|365968032|FG000|Overall Study|Adverse Event|1|||
106084469|NCT00025883|365968032|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
106084470|NCT01451424|365968033|FG000|Overall Study|Withdrawal by Subject|1|||
106084471|NCT01451424|365968034|FG001|Overall Study|Withdrawal by Subject|1|||
106084472|NCT01451424|365968035|FG002|Overall Study|Withdrawal by Subject|0|||
106084473|NCT01451424|365968036|FG003|Overall Study|Withdrawal by Subject|2|||
106084474|NCT01451424|365968033|FG000|Overall Study|Lost to Follow-up|0|||
106084475|NCT01451424|365968034|FG001|Overall Study|Lost to Follow-up|1|||
106084476|NCT01451424|365968035|FG002|Overall Study|Lost to Follow-up|0|||
106084477|NCT01451424|365968036|FG003|Overall Study|Lost to Follow-up|1|||
106084478|NCT01451424|365968033|FG000|Overall Study|Physician Decision|0|||
106084479|NCT01451424|365968034|FG001|Overall Study|Physician Decision|0|||
106084480|NCT01451424|365968035|FG002|Overall Study|Physician Decision|1|||
106084481|NCT01451424|365968036|FG003|Overall Study|Physician Decision|1|||
106084482|NCT01451424|365968033|FG000|Overall Study|Adverse Event|0|||
106084483|NCT01451424|365968034|FG001|Overall Study|Adverse Event|0|||
106084484|NCT01451424|365968035|FG002|Overall Study|Adverse Event|0|||
106084485|NCT01451424|365968036|FG003|Overall Study|Adverse Event|1|||
106084486|NCT03851016|365968037|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
106084487|NCT03851016|365968038|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
106084488|NCT03878134|365968039|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
106084489|NCT03080961|365968040|FG000|Overall Study|Withdrawal by Subject|3|||
106084490|NCT00586469|365968041|FG000|Overall Study|Adverse Event|0|||
106084491|NCT00586469|365968042|FG001|Overall Study|Adverse Event|1|||
106084492|NCT04497987|365968043|FG000|Overall Study|Adverse Event|1|||
106084493|NCT04497987|365968044|FG001|Overall Study|Adverse Event|0|||
106084494|NCT04497987|365968043|FG000|Overall Study|Death|21|||
106084495|NCT04497987|365968044|FG001|Overall Study|Death|13|||
106084496|NCT04497987|365968043|FG000|Overall Study|Lost to Follow-up|19|||
106084497|NCT04497987|365968044|FG001|Overall Study|Lost to Follow-up|17|||
106084498|NCT04497987|365968043|FG000|Overall Study|Other - as reported by the investigator|22|||
106084499|NCT04497987|365968044|FG001|Overall Study|Other - as reported by the investigator|16|||
106084500|NCT04497987|365968043|FG000|Overall Study|Physician Decision|1|||
106084501|NCT04497987|365968044|FG001|Overall Study|Physician Decision|0|||
106084502|NCT04497987|365968043|FG000|Overall Study|Withdrawal by Subject|35|||
106084503|NCT04497987|365968044|FG001|Overall Study|Withdrawal by Subject|21|||
106084504|NCT00512096|365968045|FG000|Overall Study|Adverse Event|2|||
106084505|NCT00512096|365968045|FG000|Overall Study|Withdrawal by Subject|2|||
106084506|NCT00512096|365968045|FG000|Overall Study|Lack of Efficacy|3|||
106084507|NCT02696096|365968047|FG000|Overall Study|ruled out at screening|1|||
106084508|NCT02696096|365968047|FG000|Overall Study|did not attend second fMRI|1|||
106084509|NCT03337724|365968052|FG000|Overall Study|Reason not Specified|12|||
106084510|NCT03337724|365968053|FG001|Overall Study|Reason not Specified|21|||
106084511|NCT03337724|365968054|FG002|Overall Study|Reason not Specified|9|||
106084512|NCT03337724|365968055|FG003|Overall Study|Reason not Specified|9|||
106084513|NCT03337724|365968056|FG004|Overall Study|Reason not Specified|29|||
106084514|NCT03337724|365968052|FG000|Overall Study|Withdrawal by Subject|13|||
106084515|NCT03337724|365968053|FG001|Overall Study|Withdrawal by Subject|15|||
106084516|NCT03337724|365968054|FG002|Overall Study|Withdrawal by Subject|4|||
106084517|NCT03337724|365968055|FG003|Overall Study|Withdrawal by Subject|15|||
106084518|NCT03337724|365968056|FG004|Overall Study|Withdrawal by Subject|6|||
106084519|NCT03337724|365968052|FG000|Overall Study|Protocol Deviation|0|||
106084520|NCT03337724|365968053|FG001|Overall Study|Protocol Deviation|1|||
106084521|NCT03337724|365968054|FG002|Overall Study|Protocol Deviation|1|||
106084522|NCT03337724|365968055|FG003|Overall Study|Protocol Deviation|1|||
106084523|NCT03337724|365968056|FG004|Overall Study|Protocol Deviation|0|||
106084524|NCT03337724|365968052|FG000|Overall Study|Adverse Event|1|||
106084525|NCT03337724|365968053|FG001|Overall Study|Adverse Event|1|||
106084526|NCT03337724|365968054|FG002|Overall Study|Adverse Event|0|||
106084527|NCT03337724|365968055|FG003|Overall Study|Adverse Event|1|||
106084528|NCT03337724|365968056|FG004|Overall Study|Adverse Event|0|||
106084529|NCT03337724|365968052|FG000|Overall Study|Death|40|||
106084530|NCT03337724|365968053|FG001|Overall Study|Death|89|||
106084531|NCT03337724|365968054|FG002|Overall Study|Death|43|||
106084532|NCT03337724|365968055|FG003|Overall Study|Death|76|||
106084533|NCT03337724|365968056|FG004|Overall Study|Death|50|||
106084534|NCT03337724|365968052|FG000|Overall Study|Lost to Follow-up|5|||
106084535|NCT03337724|365968053|FG001|Overall Study|Lost to Follow-up|5|||
106084536|NCT03337724|365968054|FG002|Overall Study|Lost to Follow-up|4|||
106084537|NCT03337724|365968055|FG003|Overall Study|Lost to Follow-up|7|||
106084538|NCT03337724|365968056|FG004|Overall Study|Lost to Follow-up|4|||
106084539|NCT03337724|365968052|FG000|Overall Study|Physician Decision|16|||
106084540|NCT03337724|365968053|FG001|Overall Study|Physician Decision|34|||
106084541|NCT03337724|365968054|FG002|Overall Study|Physician Decision|14|||
106084542|NCT03337724|365968055|FG003|Overall Study|Physician Decision|34|||
106084543|NCT03337724|365968056|FG004|Overall Study|Physician Decision|13|||
106084544|NCT03337724|365968052|FG000|Overall Study|Progressive Disease|0|||
106084545|NCT03337724|365968053|FG001|Overall Study|Progressive Disease|2|||
106084546|NCT03337724|365968054|FG002|Overall Study|Progressive Disease|1|||
106084547|NCT03337724|365968055|FG003|Overall Study|Progressive Disease|2|||
106084548|NCT03337724|365968056|FG004|Overall Study|Progressive Disease|0|||
106084549|NCT03337724|365968052|FG000|Overall Study|Symptomatic Deterioration|0|||
106084550|NCT03337724|365968053|FG001|Overall Study|Symptomatic Deterioration|0|||
106084551|NCT03337724|365968054|FG002|Overall Study|Symptomatic Deterioration|0|||
106084552|NCT03337724|365968055|FG003|Overall Study|Symptomatic Deterioration|1|||
106084553|NCT03337724|365968056|FG004|Overall Study|Symptomatic Deterioration|0|||
106084554|NCT06748040|365968057|FG000|Overall Study|Death|3|||
106084555|NCT06748040|365968058|FG001|Overall Study|Death|4|||
106084556|NCT06748040|365968057|FG000|Overall Study|Lost to Follow-up|134|||
106084557|NCT06748040|365968058|FG001|Overall Study|Lost to Follow-up|132|||
106084558|NCT06748040|365968057|FG000|Overall Study|Withdrawal by Subject|3|||
106084559|NCT06748040|365968058|FG001|Overall Study|Withdrawal by Subject|5|||
106084560|NCT00991302|365969533|FG000|Overall Study|Death|0|||
106084561|NCT00991302|365969534|FG001|Overall Study|Death|1|||
106084562|NCT00991302|365969533|FG000|Overall Study|Lost to Follow-up|14|||
106084563|NCT00991302|365969534|FG001|Overall Study|Lost to Follow-up|12|||
106084564|NCT01344057|365969538|FG000|Overall Study|Premature Withdrawal|1|||
106084565|NCT05723770|365969539|FG000|Overall Study|Lost to Follow-up|4|||
106084566|NCT05723770|365969539|FG000|Overall Study|Withdrawal by Subject|2|||
106084567|NCT02433834|365969540|FG000|Overall Study|Protocol-specified criteria|7|||
106084568|NCT02433834|365969540|FG000|Overall Study|Protocol Violation|3|||
106084569|NCT02433834|365969540|FG000|Overall Study|Lost to Follow-up|6|||
106084570|NCT02433834|365969540|FG000|Overall Study|Withdrawal by Subject|14|||
106160854|NCT04782973|366250455|FG000|Overall Study|Protocol Violation|6|||
106160855|NCT04782973|366250455|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
106160856|NCT03611491|366250456|FG000|Overall Study|Lost to Follow-up|1|||
106160857|NCT05478499|366250457|FG000|Overall Study|Adverse Event|4|||
106160858|NCT05478499|366250458|FG001|Overall Study|Adverse Event|2|||
106160859|NCT05478499|366250457|FG000|Overall Study|Withdrawal by Subject|3|||
106160860|NCT05478499|366250458|FG001|Overall Study|Withdrawal by Subject|2|||
106160861|NCT05478499|366250457|FG000|Overall Study|Lack of Efficacy|1|||
106160862|NCT05478499|366250458|FG001|Overall Study|Lack of Efficacy|0|||
106160863|NCT05478499|366250457|FG000|Overall Study|Lost to Follow-up|1|||
106160864|NCT05478499|366250458|FG001|Overall Study|Lost to Follow-up|0|||
106160865|NCT05478499|366250457|FG000|Overall Study|Other reasons|0|||
106160866|NCT05478499|366250458|FG001|Overall Study|Other reasons|1|||
106160867|NCT04509674|366250459|FG000|Overall Study|Not treated|33|||
106160868|NCT04509674|366250460|FG001|Overall Study|Not treated|26|||
106160869|NCT04509674|366250459|FG000|Overall Study|Protocol Violation|9|||
106160870|NCT04509674|366250460|FG001|Overall Study|Protocol Violation|10|||
106160871|NCT04509674|366250459|FG000|Overall Study|Lost to Follow-up|31|||
106160872|NCT04509674|366250460|FG001|Overall Study|Lost to Follow-up|39|||
106160873|NCT04509674|366250459|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
106160874|NCT04509674|366250460|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
106084571|NCT02433834|365969540|FG000|Overall Study|Adverse Event|6|||
106084572|NCT02433834|365969540|FG000|Overall Study|Physician Decision|1|||
106084573|NCT00355238|365969545|FG000|Overall Study|Adverse event unrelated to study drug|2|||
106084574|NCT00355238|365969546|FG001|Overall Study|Adverse event unrelated to study drug|2|||
106084575|NCT00355238|365969547|FG002|Overall Study|Adverse event unrelated to study drug|0|||
106084576|NCT00355238|365969548|FG003|Overall Study|Adverse event unrelated to study drug|1|||
106084577|NCT00355238|365969545|FG000|Overall Study|Death|1|||
106084578|NCT00355238|365969546|FG001|Overall Study|Death|0|||
106084579|NCT00355238|365969547|FG002|Overall Study|Death|0|||
106084580|NCT00355238|365969548|FG003|Overall Study|Death|0|||
106084581|NCT00355238|365969545|FG000|Overall Study|Disease progression|37|||
106084582|NCT00355238|365969546|FG001|Overall Study|Disease progression|36|||
106084583|NCT00355238|365969547|FG002|Overall Study|Disease progression|16|||
106084584|NCT00355238|365969548|FG003|Overall Study|Disease progression|11|||
106084585|NCT00355238|365969545|FG000|Overall Study|Study drug toxicity|11|||
106084586|NCT00355238|365969546|FG001|Overall Study|Study drug toxicity|7|||
106084587|NCT00355238|365969547|FG002|Overall Study|Study drug toxicity|5|||
106084588|NCT00355238|365969548|FG003|Overall Study|Study drug toxicity|2|||
106084589|NCT00355238|365969545|FG000|Overall Study|Participant withdrew consent|3|||
106084590|NCT00355238|365969546|FG001|Overall Study|Participant withdrew consent|1|||
106084591|NCT00355238|365969547|FG002|Overall Study|Participant withdrew consent|0|||
106084592|NCT00355238|365969548|FG003|Overall Study|Participant withdrew consent|0|||
106084593|NCT00355238|365969545|FG000|Overall Study|Participant request to discontinue study treatment|1|||
106084594|NCT00355238|365969546|FG001|Overall Study|Participant request to discontinue study treatment|0|||
106084595|NCT00355238|365969547|FG002|Overall Study|Participant request to discontinue study treatment|1|||
106084596|NCT00355238|365969548|FG003|Overall Study|Participant request to discontinue study treatment|0|||
106084597|NCT00548808|365969549|FG000|Overall Study|Lost to Follow-up|9|||
106084598|NCT00548808|365969550|FG001|Overall Study|Lost to Follow-up|3|||
106084599|NCT00548808|365969549|FG000|Overall Study|Protocol Violation|8|||
106084600|NCT00548808|365969550|FG001|Overall Study|Protocol Violation|8|||
106084601|NCT00548808|365969549|FG000|Overall Study|Withdrawal by Subject|8|||
106084602|NCT00548808|365969550|FG001|Overall Study|Withdrawal by Subject|4|||
106084603|NCT00548808|365969549|FG000|Overall Study|Physician Decision|6|||
106084604|NCT00548808|365969550|FG001|Overall Study|Physician Decision|3|||
106084605|NCT00548808|365969549|FG000|Overall Study|Adverse Event|4|||
106084606|NCT00548808|365969550|FG001|Overall Study|Adverse Event|5|||
106084607|NCT00548808|365969549|FG000|Overall Study|Death|2|||
106084608|NCT00548808|365969550|FG001|Overall Study|Death|0|||
106084609|NCT00548808|365969549|FG000|Overall Study|Entry Criteria Not Met|2|||
106084610|NCT00548808|365969550|FG001|Overall Study|Entry Criteria Not Met|2|||
106084611|NCT00548808|365969549|FG000|Overall Study|Lack of Efficacy|2|||
106084612|NCT00548808|365969550|FG001|Overall Study|Lack of Efficacy|0|||
106084613|NCT00548808|365969549|FG000|Overall Study|Sponsor Decision|1|||
106084614|NCT00548808|365969550|FG001|Overall Study|Sponsor Decision|1|||
106084615|NCT01465802|365969555|FG000|Overall Study|Study terminated by sponsor|1|||
106084616|NCT01465802|365969556|FG001|Overall Study|Study terminated by sponsor|0|||
106084617|NCT01465802|365969557|FG002|Overall Study|Study terminated by sponsor|0|||
106084618|NCT01465802|365969558|FG003|Overall Study|Study terminated by sponsor|1|||
106084619|NCT01465802|365969559|FG004|Overall Study|Study terminated by sponsor|7|||
106084620|NCT01465802|365969555|FG000|Overall Study|Withdrawal by Subject|7|||
106084621|NCT01465802|365969556|FG001|Overall Study|Withdrawal by Subject|7|||
106084622|NCT01465802|365969557|FG002|Overall Study|Withdrawal by Subject|0|||
106084623|NCT01465802|365969558|FG003|Overall Study|Withdrawal by Subject|8|||
106084624|NCT01465802|365969559|FG004|Overall Study|Withdrawal by Subject|1|||
106160875|NCT04509674|366250459|FG000|Overall Study|Adverse event, serious fatal event|11|||
106160876|NCT04509674|366250460|FG001|Overall Study|Adverse event, serious fatal event|4|||
106160877|NCT04509674|366250459|FG000|Overall Study|Adverse event, non-fatal event|107|||
106160878|NCT04509674|366250460|FG001|Overall Study|Adverse event, non-fatal event|118|||
106160879|NCT04509674|366250459|FG000|Overall Study|Other reason than listed|106|||
106160880|NCT04509674|366250460|FG001|Overall Study|Other reason than listed|95|||
106160881|NCT04633122|366250464|FG000|Overall Study|Remained on treatment|19|||
106084625|NCT01465802|365969555|FG000|Overall Study|Lost to Follow-up|1|||
106084626|NCT01465802|365969556|FG001|Overall Study|Lost to Follow-up|1|||
106084627|NCT01465802|365969557|FG002|Overall Study|Lost to Follow-up|0|||
106084628|NCT01465802|365969558|FG003|Overall Study|Lost to Follow-up|0|||
106084629|NCT01465802|365969559|FG004|Overall Study|Lost to Follow-up|0|||
106084630|NCT01465802|365969555|FG000|Overall Study|Reason not specified|9|||
106160882|NCT04633122|366250465|FG001|Overall Study|Remained on treatment|14|||
106084631|NCT01465802|365969556|FG001|Overall Study|Reason not specified|4|||
106084632|NCT01465802|365969557|FG002|Overall Study|Reason not specified|0|||
106084633|NCT01465802|365969558|FG003|Overall Study|Reason not specified|10|||
106084634|NCT01465802|365969559|FG004|Overall Study|Reason not specified|2|||
106084635|NCT01465802|365969555|FG000|Overall Study|Death|15|||
106084636|NCT01465802|365969556|FG001|Overall Study|Death|12|||
106084637|NCT01465802|365969557|FG002|Overall Study|Death|0|||
106084638|NCT01465802|365969558|FG003|Overall Study|Death|10|||
106084639|NCT01465802|365969559|FG004|Overall Study|Death|2|||
106084640|NCT01340976|365969560|FG000|Overall Study|Physician Decision|2|||
106084641|NCT01340976|365969561|FG001|Overall Study|Physician Decision|0|||
106084642|NCT01340976|365969562|FG002|Overall Study|Physician Decision|1|||
106084643|NCT01340976|365969563|FG003|Overall Study|Physician Decision|1|||
106084644|NCT01340976|365969564|FG004|Overall Study|Physician Decision|1|||
106084645|NCT01340976|365969565|FG005|Overall Study|Physician Decision|0|||
106084646|NCT01340976|365969560|FG000|Overall Study|Death|0|||
106084647|NCT01340976|365969561|FG001|Overall Study|Death|1|||
106084648|NCT01340976|365969562|FG002|Overall Study|Death|0|||
106084649|NCT01340976|365969563|FG003|Overall Study|Death|0|||
106084650|NCT01340976|365969564|FG004|Overall Study|Death|0|||
106084651|NCT01340976|365969565|FG005|Overall Study|Death|0|||
106084652|NCT01340976|365969560|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
106084653|NCT01340976|365969561|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
106084654|NCT01340976|365969562|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
106084655|NCT01340976|365969563|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
106084656|NCT01340976|365969564|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
106084657|NCT01340976|365969565|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
106084658|NCT01340976|365969560|FG000|Overall Study|Withdrawal by Subject|0|||
106084659|NCT01340976|365969561|FG001|Overall Study|Withdrawal by Subject|0|||
106084660|NCT01340976|365969562|FG002|Overall Study|Withdrawal by Subject|0|||
106084661|NCT01340976|365969563|FG003|Overall Study|Withdrawal by Subject|1|||
106084662|NCT01340976|365969564|FG004|Overall Study|Withdrawal by Subject|1|||
106084663|NCT01340976|365969565|FG005|Overall Study|Withdrawal by Subject|0|||
106084664|NCT01340976|365969560|FG000|Overall Study|Other anemia treatment|1|||
106084665|NCT01340976|365969561|FG001|Overall Study|Other anemia treatment|0|||
106084666|NCT01340976|365969562|FG002|Overall Study|Other anemia treatment|2|||
106084667|NCT01340976|365969563|FG003|Overall Study|Other anemia treatment|1|||
106084668|NCT01340976|365969564|FG004|Overall Study|Other anemia treatment|0|||
106084669|NCT01340976|365969565|FG005|Overall Study|Other anemia treatment|1|||
106084670|NCT01340976|365969560|FG000|Overall Study|Adverse Event|0|||
106084671|NCT01340976|365969561|FG001|Overall Study|Adverse Event|1|||
106084672|NCT01340976|365969562|FG002|Overall Study|Adverse Event|0|||
106084673|NCT01340976|365969563|FG003|Overall Study|Adverse Event|0|||
106084674|NCT01340976|365969564|FG004|Overall Study|Adverse Event|0|||
106084675|NCT01340976|365969565|FG005|Overall Study|Adverse Event|0|||
106084676|NCT03852316|365969577|FG000|Overall Study|Protocol Violation|1|||
106084677|NCT03852316|365969577|FG000|Overall Study|Withdrawal by Subject|2|||
106084678|NCT03852316|365969577|FG000|Overall Study|Enrolled but Device not Utilized|1|||
106084679|NCT00529386|365969578|FG000|Overall Study|Lost to Follow-up|1|||
106084680|NCT03592641|365969579|FG000|Overall Study|Withdrawal by Subject|1|||
106084681|NCT00436280|365969580|FG000|Period 1: Induction|Adverse Event|8|||
106084682|NCT00436280|365969580|FG000|Period 1: Induction|Progressive Disease|12|||
106084683|NCT00436280|365969580|FG000|Period 1: Induction|Stable Disease|6|||
106084684|NCT00436280|365969580|FG000|Period 1: Induction|Withdrawal by Subject|1|||
106084685|NCT00436280|365969580|FG000|Period 1: Induction|Death|1|||
106084686|NCT00436280|365969580|FG000|Period 2: Consolidation|Adverse Event|1|||
106084687|NCT00436280|365969580|FG000|Period 2: Consolidation|Progressive Disease|10|||
106084688|NCT00436280|365969580|FG000|Period 2: Consolidation|Stable Disease|1|||
106084689|NCT00436280|365969580|FG000|Period 2: Consolidation|Physician Decision|2|||
106084690|NCT00436280|365969580|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
106084691|NCT00436280|365969580|FG000|Period 2: Consolidation|Death|1|||
106084692|NCT00436280|365969580|FG000|Period 3: Maintenance|Adverse Event|6|||
106084693|NCT00436280|365969580|FG000|Period 3: Maintenance|Progressive Disease|12|||
106084694|NCT01049919|365969583|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
106084695|NCT01049919|365969584|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
106084696|NCT01049919|365969583|FG000|Overall Study|Withdrawal by Subject|5|||
106084697|NCT01049919|365969584|FG001|Overall Study|Withdrawal by Subject|0|||
106084698|NCT01049919|365969583|FG000|Overall Study|Lost to Follow-up|6|||
106084699|NCT01049919|365969584|FG001|Overall Study|Lost to Follow-up|1|||
106084700|NCT01049919|365969583|FG000|Overall Study|Physician Decision|2|||
106084701|NCT01049919|365969584|FG001|Overall Study|Physician Decision|0|||
106084702|NCT01049919|365969583|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
106084703|NCT01049919|365969584|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
106084704|NCT01049919|365969583|FG000|Overall Study|Early study termination by sponsor.|2|||
106084705|NCT01049919|365969584|FG001|Overall Study|Early study termination by sponsor.|0|||
106084706|NCT02103478|365969585|FG000|Overall Study|Adverse Event|0|||
106084707|NCT02103478|365969586|FG001|Overall Study|Adverse Event|0|||
106084708|NCT02103478|365969587|FG002|Overall Study|Adverse Event|1|||
106084709|NCT02103478|365969588|FG003|Overall Study|Adverse Event|1|||
106084710|NCT02103478|365969589|FG004|Overall Study|Adverse Event|2|||
106084711|NCT02103478|365969590|FG005|Overall Study|Adverse Event|1|||
106084712|NCT02103478|365969591|FG006|Overall Study|Adverse Event|0|||
106084713|NCT02103478|365969592|FG007|Overall Study|Adverse Event|0|||
106084714|NCT02103478|365969593|FG008|Overall Study|Adverse Event|0|||
106084715|NCT02103478|365969585|FG000|Overall Study|Death|2|||
106084716|NCT02103478|365969586|FG001|Overall Study|Death|2|||
106084717|NCT02103478|365969587|FG002|Overall Study|Death|1|||
106084718|NCT02103478|365969588|FG003|Overall Study|Death|1|||
106084719|NCT02103478|365969589|FG004|Overall Study|Death|5|||
106084720|NCT02103478|365969590|FG005|Overall Study|Death|15|||
106084721|NCT02103478|365969591|FG006|Overall Study|Death|14|||
106084722|NCT02103478|365969592|FG007|Overall Study|Death|10|||
106084723|NCT02103478|365969593|FG008|Overall Study|Death|11|||
106084724|NCT02103478|365969585|FG000|Overall Study|Progressive Disease|2|||
106084725|NCT02103478|365969586|FG001|Overall Study|Progressive Disease|1|||
106084726|NCT02103478|365969587|FG002|Overall Study|Progressive Disease|2|||
106084727|NCT02103478|365969588|FG003|Overall Study|Progressive Disease|0|||
106084728|NCT02103478|365969589|FG004|Overall Study|Progressive Disease|9|||
106084729|NCT02103478|365969590|FG005|Overall Study|Progressive Disease|1|||
106084730|NCT02103478|365969591|FG006|Overall Study|Progressive Disease|2|||
106084731|NCT02103478|365969592|FG007|Overall Study|Progressive Disease|0|||
106084732|NCT02103478|365969593|FG008|Overall Study|Progressive Disease|1|||
106084733|NCT02103478|365969585|FG000|Overall Study|Withdrawal by Subject|2|||
106084734|NCT02103478|365969586|FG001|Overall Study|Withdrawal by Subject|0|||
106084735|NCT02103478|365969587|FG002|Overall Study|Withdrawal by Subject|0|||
106084736|NCT02103478|365969588|FG003|Overall Study|Withdrawal by Subject|4|||
106084737|NCT02103478|365969589|FG004|Overall Study|Withdrawal by Subject|0|||
106084738|NCT02103478|365969590|FG005|Overall Study|Withdrawal by Subject|0|||
106084739|NCT02103478|365969591|FG006|Overall Study|Withdrawal by Subject|1|||
106084740|NCT02103478|365969592|FG007|Overall Study|Withdrawal by Subject|1|||
106084741|NCT02103478|365969593|FG008|Overall Study|Withdrawal by Subject|0|||
106084742|NCT02103478|365969585|FG000|Overall Study|Lost to Follow-up|0|||
106084743|NCT02103478|365969586|FG001|Overall Study|Lost to Follow-up|0|||
106084744|NCT02103478|365969587|FG002|Overall Study|Lost to Follow-up|0|||
106084745|NCT02103478|365969588|FG003|Overall Study|Lost to Follow-up|0|||
106084746|NCT02103478|365969589|FG004|Overall Study|Lost to Follow-up|0|||
106084747|NCT02103478|365969590|FG005|Overall Study|Lost to Follow-up|0|||
106084748|NCT02103478|365969591|FG006|Overall Study|Lost to Follow-up|0|||
106084749|NCT02103478|365969592|FG007|Overall Study|Lost to Follow-up|1|||
106084750|NCT02103478|365969593|FG008|Overall Study|Lost to Follow-up|0|||
106084751|NCT02103478|365969585|FG000|Overall Study|Other|1|||
106084752|NCT02103478|365969586|FG001|Overall Study|Other|3|||
106084753|NCT02103478|365969587|FG002|Overall Study|Other|2|||
106084754|NCT02103478|365969588|FG003|Overall Study|Other|0|||
106084755|NCT02103478|365969589|FG004|Overall Study|Other|3|||
106084756|NCT02103478|365969590|FG005|Overall Study|Other|8|||
106084757|NCT02103478|365969591|FG006|Overall Study|Other|8|||
106084758|NCT02103478|365969592|FG007|Overall Study|Other|4|||
106084759|NCT02103478|365969593|FG008|Overall Study|Other|2|||
106084760|NCT03603964|365969594|FG000|Overall Study|Death|9|||
106084761|NCT03603964|365969594|FG000|Overall Study|Withdrawal by participant|7|||
106084762|NCT03603964|365969594|FG000|Overall Study|Study terminated by Sponsor|19|||
106084763|NCT03219333|365969595|FG000|Overall Study|Withdrawal by Subject|9|||
106084764|NCT03219333|365969596|FG001|Overall Study|Withdrawal by Subject|4|||
106084765|NCT03219333|365969595|FG000|Overall Study|Lost to Follow-up|1|||
106084766|NCT03219333|365969596|FG001|Overall Study|Lost to Follow-up|1|||
106084767|NCT03219333|365969595|FG000|Overall Study|Death|104|||
106084768|NCT03219333|365969596|FG001|Overall Study|Death|72|||
106084769|NCT03219333|365969595|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
106084770|NCT03219333|365969596|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
106084771|NCT03219333|365969595|FG000|Overall Study|Other|2|||
106084772|NCT03219333|365969596|FG001|Overall Study|Other|2|||
106084773|NCT00723606|365969597|FG000|Overall Study|Adverse Event|2|||
106084774|NCT00723606|365969598|FG001|Overall Study|Adverse Event|5|||
106084775|NCT00723606|365969597|FG000|Overall Study|Other|2|||
106084776|NCT00723606|365969598|FG001|Overall Study|Other|0|||
106084777|NCT00723606|365969597|FG000|Overall Study|Withdrawal by Subject|0|||
106084778|NCT00723606|365969598|FG001|Overall Study|Withdrawal by Subject|2|||
106084779|NCT01513291|365969599|FG000|Treatment Period|Adverse Event|8|||
106084780|NCT01513291|365969600|FG001|Treatment Period|Adverse Event|4|||
106084781|NCT01513291|365969601|FG002|Treatment Period|Adverse Event|0|||
106084782|NCT01513291|365969602|FG003|Treatment Period|Adverse Event|0|||
106084783|NCT01513291|365969603|FG004|Treatment Period|Adverse Event|0|||
106084784|NCT01513291|365969599|FG000|Treatment Period|Lack of Efficacy|3|||
106084785|NCT01513291|365969600|FG001|Treatment Period|Lack of Efficacy|0|||
106084786|NCT01513291|365969601|FG002|Treatment Period|Lack of Efficacy|0|||
106084787|NCT01513291|365969602|FG003|Treatment Period|Lack of Efficacy|0|||
106084788|NCT01513291|365969603|FG004|Treatment Period|Lack of Efficacy|0|||
106084789|NCT01513291|365969599|FG000|Treatment Period|Lost to Follow-up|2|||
106084790|NCT01513291|365969600|FG001|Treatment Period|Lost to Follow-up|3|||
106084791|NCT01513291|365969601|FG002|Treatment Period|Lost to Follow-up|0|||
106084792|NCT01513291|365969602|FG003|Treatment Period|Lost to Follow-up|0|||
106084793|NCT01513291|365969603|FG004|Treatment Period|Lost to Follow-up|0|||
106084794|NCT01513291|365969599|FG000|Treatment Period|Physician Decision|1|||
106084795|NCT01513291|365969600|FG001|Treatment Period|Physician Decision|0|||
106084796|NCT01513291|365969601|FG002|Treatment Period|Physician Decision|0|||
106084797|NCT01513291|365969602|FG003|Treatment Period|Physician Decision|0|||
106084798|NCT01513291|365969603|FG004|Treatment Period|Physician Decision|0|||
106084799|NCT01513291|365969599|FG000|Treatment Period|Protocol Violation|1|||
106084800|NCT01513291|365969600|FG001|Treatment Period|Protocol Violation|2|||
106084801|NCT01513291|365969601|FG002|Treatment Period|Protocol Violation|0|||
106084802|NCT01513291|365969602|FG003|Treatment Period|Protocol Violation|0|||
106084803|NCT01513291|365969603|FG004|Treatment Period|Protocol Violation|0|||
106084804|NCT01513291|365969599|FG000|Treatment Period|Withdrawal by Subject|8|||
106084805|NCT01513291|365969600|FG001|Treatment Period|Withdrawal by Subject|5|||
106084806|NCT01513291|365969601|FG002|Treatment Period|Withdrawal by Subject|0|||
106084807|NCT01513291|365969602|FG003|Treatment Period|Withdrawal by Subject|0|||
106084808|NCT01513291|365969603|FG004|Treatment Period|Withdrawal by Subject|0|||
106084809|NCT01513291|365969599|FG000|Treatment Period|Randomized not treated|0|||
106084810|NCT01513291|365969600|FG001|Treatment Period|Randomized not treated|2|||
106084811|NCT01513291|365969601|FG002|Treatment Period|Randomized not treated|0|||
106084812|NCT01513291|365969602|FG003|Treatment Period|Randomized not treated|0|||
106084813|NCT01513291|365969603|FG004|Treatment Period|Randomized not treated|0|||
106084814|NCT01513291|365969599|FG000|Run-out Period|Lost to Follow-up|0|||
106084815|NCT01513291|365969600|FG001|Run-out Period|Lost to Follow-up|0|||
106084816|NCT01513291|365969601|FG002|Run-out Period|Lost to Follow-up|0|||
106084817|NCT01513291|365969602|FG003|Run-out Period|Lost to Follow-up|1|||
106084818|NCT01513291|365969603|FG004|Run-out Period|Lost to Follow-up|0|||
106084819|NCT01513291|365969599|FG000|Run-out Period|Withdrawal by Subject|0|||
106084820|NCT01513291|365969600|FG001|Run-out Period|Withdrawal by Subject|0|||
106084821|NCT01513291|365969601|FG002|Run-out Period|Withdrawal by Subject|0|||
106084822|NCT01513291|365969602|FG003|Run-out Period|Withdrawal by Subject|1|||
106084823|NCT01513291|365969603|FG004|Run-out Period|Withdrawal by Subject|0|||
106084824|NCT01358981|365969604|FG000|Period 1|Withdrawal by Subject|0|||
106084825|NCT01358981|365969605|FG001|Period 1|Withdrawal by Subject|0|||
106084826|NCT01358981|365969606|FG002|Period 1|Withdrawal by Subject|0|||
106084827|NCT01358981|365969607|FG003|Period 1|Withdrawal by Subject|1|||
106084828|NCT01358981|365969608|FG004|Period 1|Withdrawal by Subject|0|||
106084829|NCT01358981|365969609|FG005|Period 1|Withdrawal by Subject|0|||
106084830|NCT01358981|365969610|FG006|Period 1|Withdrawal by Subject|0|||
106084831|NCT02939404|365969611|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
106084832|NCT02939404|365969612|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
106084833|NCT02939404|365969611|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
106084834|NCT02939404|365969612|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
106084835|NCT02247349|365969616|FG000|Overall Study|Disease Progression|7|||
106084836|NCT02247349|365969617|FG001|Overall Study|Disease Progression|4|||
106084837|NCT02247349|365969618|FG002|Overall Study|Disease Progression|26|||
106084838|NCT02247349|365969619|FG003|Overall Study|Disease Progression|31|||
106084839|NCT02247349|365969620|FG004|Overall Study|Disease Progression|16|||
106084840|NCT02247349|365969621|FG005|Overall Study|Disease Progression|6|||
106084841|NCT02247349|365969616|FG000|Overall Study|Study drug toxicity|0|||
106084842|NCT02247349|365969617|FG001|Overall Study|Study drug toxicity|1|||
106084843|NCT02247349|365969618|FG002|Overall Study|Study drug toxicity|1|||
106084844|NCT02247349|365969619|FG003|Overall Study|Study drug toxicity|1|||
106084845|NCT02247349|365969620|FG004|Overall Study|Study drug toxicity|2|||
106084846|NCT02247349|365969621|FG005|Overall Study|Study drug toxicity|2|||
106084847|NCT02247349|365969616|FG000|Overall Study|Death|0|||
106084848|NCT02247349|365969617|FG001|Overall Study|Death|0|||
106084849|NCT02247349|365969618|FG002|Overall Study|Death|0|||
106084850|NCT02247349|365969619|FG003|Overall Study|Death|1|||
106084851|NCT02247349|365969620|FG004|Overall Study|Death|0|||
106084852|NCT02247349|365969621|FG005|Overall Study|Death|0|||
106084853|NCT02247349|365969616|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
106084854|NCT02247349|365969617|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
106084855|NCT02247349|365969618|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
106084856|NCT02247349|365969619|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
106084857|NCT02247349|365969620|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
106084858|NCT02247349|365969621|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
106084859|NCT02247349|365969616|FG000|Overall Study|Participant request to discontinue study treatment|0|||
106084860|NCT02247349|365969617|FG001|Overall Study|Participant request to discontinue study treatment|0|||
106084861|NCT02247349|365969618|FG002|Overall Study|Participant request to discontinue study treatment|1|||
106084862|NCT02247349|365969619|FG003|Overall Study|Participant request to discontinue study treatment|2|||
106084863|NCT02247349|365969620|FG004|Overall Study|Participant request to discontinue study treatment|1|||
106084864|NCT02247349|365969621|FG005|Overall Study|Participant request to discontinue study treatment|0|||
106084865|NCT02247349|365969616|FG000|Overall Study|Withdrawal by Subject|0|||
106084866|NCT02247349|365969617|FG001|Overall Study|Withdrawal by Subject|1|||
106084867|NCT02247349|365969618|FG002|Overall Study|Withdrawal by Subject|0|||
106084868|NCT02247349|365969619|FG003|Overall Study|Withdrawal by Subject|0|||
106084869|NCT02247349|365969620|FG004|Overall Study|Withdrawal by Subject|0|||
106084870|NCT02247349|365969621|FG005|Overall Study|Withdrawal by Subject|0|||
106084871|NCT02247349|365969616|FG000|Overall Study|Administrative reason by sponsor|0|||
106084872|NCT02247349|365969617|FG001|Overall Study|Administrative reason by sponsor|0|||
106084873|NCT02247349|365969618|FG002|Overall Study|Administrative reason by sponsor|0|||
106084874|NCT02247349|365969619|FG003|Overall Study|Administrative reason by sponsor|0|||
106084875|NCT02247349|365969620|FG004|Overall Study|Administrative reason by sponsor|1|||
106084876|NCT02247349|365969621|FG005|Overall Study|Administrative reason by sponsor|0|||
106084877|NCT02247349|365969616|FG000|Overall Study|Other reasons|0|||
106084878|NCT02247349|365969617|FG001|Overall Study|Other reasons|0|||
106084879|NCT02247349|365969618|FG002|Overall Study|Other reasons|1|||
106084880|NCT02247349|365969619|FG003|Overall Study|Other reasons|0|||
106084881|NCT02247349|365969620|FG004|Overall Study|Other reasons|0|||
106084882|NCT02247349|365969621|FG005|Overall Study|Other reasons|0|||
106084883|NCT00259857|365969624|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
106084884|NCT00259857|365969625|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
106084885|NCT00259857|365969624|FG000|24 Months Treatment|Lost to Follow-up|0|||
106084886|NCT00259857|365969625|FG001|24 Months Treatment|Lost to Follow-up|3|||
106084887|NCT02161718|365969626|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
106084888|NCT02161718|365969627|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
106084889|NCT02161718|365969628|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
106084890|NCT02161718|365969626|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
106084891|NCT02161718|365969627|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
106084892|NCT02161718|365969628|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
106084893|NCT02161718|365969626|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
106084894|NCT02161718|365969627|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
106084895|NCT02161718|365969628|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
106084896|NCT02161718|365969626|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
106084897|NCT02161718|365969627|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
106084898|NCT02161718|365969628|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
106084899|NCT02161718|365969626|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
106084900|NCT02161718|365969627|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
106084901|NCT02161718|365969628|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
106084902|NCT02161718|365969626|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
106084903|NCT02161718|365969627|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
106084904|NCT02161718|365969628|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
106084905|NCT02161718|365969626|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
106084906|NCT02161718|365969627|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
106084907|NCT02161718|365969628|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
106084908|NCT02161718|365969626|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
106084909|NCT02161718|365969627|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
106084910|NCT02161718|365969628|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
106084911|NCT02161718|365969626|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
106084912|NCT02161718|365969627|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
106084913|NCT02161718|365969628|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
106084914|NCT02161718|365969626|FG000|Post- Randomization Period|Lost to Follow-up|0|||
106084915|NCT02161718|365969627|FG001|Post- Randomization Period|Lost to Follow-up|9|||
106084916|NCT02161718|365969628|FG002|Post- Randomization Period|Lost to Follow-up|15|||
106084917|NCT02161718|365969626|FG000|Post- Randomization Period|Adverse Event|0|||
106084918|NCT02161718|365969627|FG001|Post- Randomization Period|Adverse Event|9|||
106084919|NCT02161718|365969628|FG002|Post- Randomization Period|Adverse Event|10|||
106084920|NCT02161718|365969626|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
106084921|NCT02161718|365969627|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
106084922|NCT02161718|365969628|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
106084923|NCT02161718|365969626|FG000|Post- Randomization Period|Physician Decision|0|||
106084924|NCT02161718|365969627|FG001|Post- Randomization Period|Physician Decision|2|||
106084925|NCT02161718|365969628|FG002|Post- Randomization Period|Physician Decision|4|||
106084926|NCT02161718|365969626|FG000|Post- Randomization Period|Protocol Violation|0|||
106084927|NCT02161718|365969627|FG001|Post- Randomization Period|Protocol Violation|2|||
106084928|NCT02161718|365969628|FG002|Post- Randomization Period|Protocol Violation|3|||
106084929|NCT02161718|365969626|FG000|Post- Randomization Period|Lack of Efficacy|0|||
106084930|NCT02161718|365969627|FG001|Post- Randomization Period|Lack of Efficacy|0|||
106084931|NCT02161718|365969628|FG002|Post- Randomization Period|Lack of Efficacy|1|||
106084932|NCT02161718|365969626|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
106084933|NCT02161718|365969627|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
106084934|NCT02161718|365969628|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
106084935|NCT02161718|365969626|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
106084936|NCT02161718|365969627|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
106084937|NCT02161718|365969628|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
106084938|NCT02161718|365969626|FG000|Post- Randomization Period|Relocation|0|||
106084939|NCT02161718|365969627|FG001|Post- Randomization Period|Relocation|3|||
106084940|NCT02161718|365969628|FG002|Post- Randomization Period|Relocation|0|||
106084941|NCT03417141|365969629|FG000|Overall Study|Withdrawal by Subject|1|||
106084942|NCT03417141|365969629|FG000|Overall Study|Protocol Violation|3|||
106084943|NCT02550652|365969630|FG000|Overall Study|Death|1|||
106084944|NCT02550652|365969631|FG001|Overall Study|Death|4|||
106084945|NCT02550652|365969630|FG000|Overall Study|Lack of Efficacy|1|||
106084946|NCT02550652|365969631|FG001|Overall Study|Lack of Efficacy|0|||
106084947|NCT02550652|365969630|FG000|Overall Study|Withdrawal by Subject|4|||
106084948|NCT02550652|365969631|FG001|Overall Study|Withdrawal by Subject|7|||
106084949|NCT02550652|365969630|FG000|Overall Study|Post Trial Access|1|||
106084950|NCT02550652|365969631|FG001|Overall Study|Post Trial Access|0|||
106084951|NCT02550652|365969630|FG000|Overall Study|Lost to Follow-up|1|||
106084952|NCT02550652|365969631|FG001|Overall Study|Lost to Follow-up|3|||
106084953|NCT02550652|365969630|FG000|Overall Study|Physician Decision|0|||
106084954|NCT02550652|365969631|FG001|Overall Study|Physician Decision|2|||
106084955|NCT02550652|365969630|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
106084956|NCT02550652|365969631|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
106084957|NCT03921411|365969633|FG000|Overall Study|Withdrawal by Subject|1|||
106084958|NCT03921411|365969633|FG000|Overall Study|Protocol Deviation|2|||
106084959|NCT03921411|365969633|FG000|Overall Study|Enrolled, but never treated|2|||
106084960|NCT03286140|365969634|FG000|Overall Study|Withdrawal by Subject|10|||
106084961|NCT03286140|365969635|FG001|Overall Study|Withdrawal by Subject|5|||
106084962|NCT03286140|365969634|FG000|Overall Study|Lost to Follow-up|5|||
106084963|NCT03286140|365969635|FG001|Overall Study|Lost to Follow-up|10|||
106084964|NCT03286140|365969634|FG000|Overall Study|Failure to comply|0|||
106084965|NCT03286140|365969635|FG001|Overall Study|Failure to comply|1|||
106084966|NCT01565291|365969636|FG000|Overall Study|Withdrawal by Subject|1|||
106084967|NCT01565291|365969637|FG001|Overall Study|Withdrawal by Subject|0|||
106084968|NCT00515827|365969638|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
106084969|NCT00515827|365969639|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
106084970|NCT00515827|365969638|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
106084971|NCT00515827|365969639|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
106084972|NCT01365273|365969642|FG000|Overall Study|Lost to Follow-up|1|||
106084973|NCT01365273|365969643|FG001|Overall Study|Lost to Follow-up|0|||
106084974|NCT01365273|365969642|FG000|Overall Study|Protocol Violation|0|||
106084975|NCT01365273|365969643|FG001|Overall Study|Protocol Violation|1|||
106084976|NCT01365273|365969642|FG000|Overall Study|Physician Decision|1|||
106084977|NCT01365273|365969643|FG001|Overall Study|Physician Decision|0|||
106084978|NCT02920983|365969649|FG000|Dispense 1|Unacceptable Lens Fit|0|||
106084979|NCT02920983|365969650|FG001|Dispense 1|Unacceptable Lens Fit|0|||
106084980|NCT02920983|365969651|FG002|Dispense 1|Unacceptable Lens Fit|0|||
106084981|NCT02920983|365969652|FG003|Dispense 1|Unacceptable Lens Fit|0|||
106084982|NCT02920983|365969653|FG004|Dispense 1|Unacceptable Lens Fit|1|||
106084983|NCT02920983|365969654|FG005|Dispense 1|Unacceptable Lens Fit|0|||
106084984|NCT02920983|365969649|FG000|Dispense 2|Unscceptable lens fit|1|||
106084985|NCT02920983|365969650|FG001|Dispense 2|Unscceptable lens fit|0|||
106084986|NCT02920983|365969651|FG002|Dispense 2|Unscceptable lens fit|0|||
106084987|NCT02920983|365969652|FG003|Dispense 2|Unscceptable lens fit|0|||
106084988|NCT02920983|365969653|FG004|Dispense 2|Unscceptable lens fit|1|||
106084989|NCT02920983|365969654|FG005|Dispense 2|Unscceptable lens fit|0|||
106084990|NCT02920983|365969649|FG000|Dispense 3|Unacceptable Lens Fit|1|||
106084991|NCT02920983|365969650|FG001|Dispense 3|Unacceptable Lens Fit|1|||
106084992|NCT02920983|365969651|FG002|Dispense 3|Unacceptable Lens Fit|0|||
106084993|NCT02920983|365969652|FG003|Dispense 3|Unacceptable Lens Fit|0|||
106084994|NCT02920983|365969653|FG004|Dispense 3|Unacceptable Lens Fit|1|||
106084995|NCT02920983|365969654|FG005|Dispense 3|Unacceptable Lens Fit|0|||
106084996|NCT01387607|365969655|FG000|Overall Study|Adverse Event|23|||
106084997|NCT01387607|365969656|FG001|Overall Study|Adverse Event|11|||
106084998|NCT01387607|365969655|FG000|Overall Study|Lack of Efficacy|8|||
106084999|NCT01387607|365969656|FG001|Overall Study|Lack of Efficacy|6|||
106085000|NCT01387607|365969655|FG000|Overall Study|Lost to Follow-up|2|||
106085001|NCT01387607|365969656|FG001|Overall Study|Lost to Follow-up|1|||
106085002|NCT01387607|365969655|FG000|Overall Study|No longer meets eligibility criteria|0|||
106085003|NCT01387607|365969656|FG001|Overall Study|No longer meets eligibility criteria|1|||
106085004|NCT01387607|365969655|FG000|Overall Study|Protocol Violation|1|||
106085005|NCT01387607|365969656|FG001|Overall Study|Protocol Violation|5|||
106085006|NCT01387607|365969655|FG000|Overall Study|Withdrawal by Subject|13|||
106085007|NCT01387607|365969656|FG001|Overall Study|Withdrawal by Subject|14|||
106085008|NCT01387607|365969655|FG000|Overall Study|Other|1|||
106085009|NCT01387607|365969656|FG001|Overall Study|Other|1|||
106085010|NCT01387607|365969655|FG000|Overall Study|Randomized, not treated|3|||
106085011|NCT01387607|365969656|FG001|Overall Study|Randomized, not treated|6|||
106085012|NCT02774681|365969658|FG000|Treatment on Study|Progressive Disease|7|||
106085013|NCT02774681|365969658|FG000|Follow-Up for 3 Years|Death|11|||
106085014|NCT02774681|365969658|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
106085015|NCT01660412|365969666|FG000|Overall Study|Protocol Violation|0|||
106085016|NCT01660412|365969667|FG001|Overall Study|Protocol Violation|3|||
106085017|NCT01209624|365969669|FG000|Overall Study|Death|2|||
106085018|NCT01209624|365969669|FG000|Overall Study|Adverse Event|13|||
106085019|NCT01209624|365969669|FG000|Overall Study|Lack of Efficacy|17|||
106085020|NCT01209624|365969669|FG000|Overall Study|Lost to Follow-up|290|||
106085021|NCT01209624|365969669|FG000|Overall Study|Other|4|||
106085022|NCT03265119|365969670|FG000|Overall Study|Adverse Event|2|||
106085023|NCT03265119|365969671|FG001|Overall Study|Adverse Event|1|||
106085024|NCT03265119|365969670|FG000|Overall Study|Lack of Efficacy|3|||
106085025|NCT03265119|365969671|FG001|Overall Study|Lack of Efficacy|0|||
106085026|NCT03265119|365969670|FG000|Overall Study|Protocol Violation|1|||
106085027|NCT03265119|365969671|FG001|Overall Study|Protocol Violation|2|||
106085028|NCT03265119|365969670|FG000|Overall Study|Withdrawal by Subject|2|||
106085029|NCT03265119|365969671|FG001|Overall Study|Withdrawal by Subject|4|||
106085030|NCT03265119|365969670|FG000|Overall Study|Lost to Follow-up|1|||
106085031|NCT03265119|365969671|FG001|Overall Study|Lost to Follow-up|0|||
106085032|NCT03265119|365969670|FG000|Overall Study|Lack of Compliance|1|||
106085033|NCT03265119|365969671|FG001|Overall Study|Lack of Compliance|0|||
106085034|NCT03238911|365969673|FG000|Overall Study|Withdrawal by Subject|1|||
106085035|NCT03238911|365969674|FG001|Overall Study|Withdrawal by Subject|2|||
106085036|NCT03238911|365969673|FG000|Overall Study|Lost to Follow-up|2|||
106085037|NCT03238911|365969674|FG001|Overall Study|Lost to Follow-up|1|||
106085038|NCT02383758|365971251|FG000|Overall Study|Withdrawal by Subject|0|||
106085039|NCT02383758|365971252|FG001|Overall Study|Withdrawal by Subject|2|||
106085040|NCT00646958|365971257|FG000|Overall Study|Lack of Efficacy|1|||
106085041|NCT00646958|365971258|FG001|Overall Study|Lack of Efficacy|0|||
106085042|NCT00646958|365971259|FG002|Overall Study|Lack of Efficacy|0|||
106085043|NCT00646958|365971257|FG000|Overall Study|Adverse Event|4|||
106085044|NCT00646958|365971258|FG001|Overall Study|Adverse Event|0|||
106085045|NCT00646958|365971259|FG002|Overall Study|Adverse Event|0|||
106085046|NCT00646958|365971257|FG000|Overall Study|Lost to Follow-up|1|||
106085047|NCT00646958|365971258|FG001|Overall Study|Lost to Follow-up|5|||
106085048|NCT00646958|365971259|FG002|Overall Study|Lost to Follow-up|7|||
106085049|NCT00646958|365971257|FG000|Overall Study|Protocol Violation|1|||
106160883|NCT04633122|366250464|FG000|Overall Study|Survival follow-up stopped|22|||
106085050|NCT00646958|365971258|FG001|Overall Study|Protocol Violation|1|||
106085051|NCT00646958|365971259|FG002|Overall Study|Protocol Violation|0|||
106085052|NCT00646958|365971257|FG000|Overall Study|Abnormal screening lab tests|1|||
106085053|NCT00646958|365971258|FG001|Overall Study|Abnormal screening lab tests|1|||
106085054|NCT00646958|365971259|FG002|Overall Study|Abnormal screening lab tests|0|||
106085055|NCT00646958|365971257|FG000|Overall Study|Withdrawal by Subject|1|||
106085056|NCT00646958|365971258|FG001|Overall Study|Withdrawal by Subject|2|||
106085057|NCT00646958|365971259|FG002|Overall Study|Withdrawal by Subject|0|||
106085058|NCT00646958|365971257|FG000|Overall Study|Did not receive study drug|2|||
106085059|NCT00646958|365971258|FG001|Overall Study|Did not receive study drug|0|||
106085060|NCT00646958|365971259|FG002|Overall Study|Did not receive study drug|2|||
106085061|NCT03085927|365971261|FG000|Overall Study|Withdrawal by Subject|1|||
106085062|NCT03085927|365971262|FG001|Overall Study|Withdrawal by Subject|4|||
106085063|NCT03085927|365971261|FG000|Overall Study|Lost to Follow-up|3|||
106085064|NCT03085927|365971262|FG001|Overall Study|Lost to Follow-up|1|||
106085065|NCT03085927|365971261|FG000|Overall Study|Death|1|||
106085066|NCT03085927|365971262|FG001|Overall Study|Death|0|||
106085067|NCT03085927|365971261|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
106085068|NCT03085927|365971262|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
106085069|NCT03085927|365971261|FG000|Overall Study|Dyad Became Ineligible|0|||
106085070|NCT03085927|365971262|FG001|Overall Study|Dyad Became Ineligible|1|||
106085071|NCT02573324|365971263|FG000|Overall Study|Withdrawal by Subject|26|||
106085072|NCT02573324|365971264|FG001|Overall Study|Withdrawal by Subject|23|||
106085073|NCT02573324|365971265|FG002|Overall Study|Withdrawal by Subject|3|||
106085074|NCT02573324|365971263|FG000|Overall Study|Lost to Follow-up|4|||
106085075|NCT02573324|365971264|FG001|Overall Study|Lost to Follow-up|5|||
106085076|NCT02573324|365971265|FG002|Overall Study|Lost to Follow-up|0|||
106085077|NCT02573324|365971263|FG000|Overall Study|Study Terminated by Sponsor|107|||
106085078|NCT02573324|365971264|FG001|Overall Study|Study Terminated by Sponsor|89|||
106085079|NCT02573324|365971265|FG002|Overall Study|Study Terminated by Sponsor|2|||
106085080|NCT02573324|365971263|FG000|Overall Study|Death|182|||
106085081|NCT02573324|365971264|FG001|Overall Study|Death|200|||
106085082|NCT02573324|365971265|FG002|Overall Study|Death|1|||
106085083|NCT02573324|365971263|FG000|Overall Study|Other, Not Specified|20|||
106085084|NCT02573324|365971264|FG001|Overall Study|Other, Not Specified|27|||
106085085|NCT02573324|365971265|FG002|Overall Study|Other, Not Specified|0|||
106085086|NCT02573324|365971263|FG000|Overall Study|Unknown Reason|2|||
106085087|NCT02573324|365971264|FG001|Overall Study|Unknown Reason|0|||
106085088|NCT02573324|365971265|FG002|Overall Study|Unknown Reason|0|||
106085089|NCT00600821|365971266|FG000|Overall Study|Death|45|||
106085090|NCT00600821|365971267|FG001|Overall Study|Death|46|||
106085091|NCT00600821|365971266|FG000|Overall Study|Lost to Follow-up|2|||
106085092|NCT00600821|365971267|FG001|Overall Study|Lost to Follow-up|2|||
106085093|NCT00600821|365971266|FG000|Overall Study|Withdrawal by Subject|1|||
106085094|NCT00600821|365971267|FG001|Overall Study|Withdrawal by Subject|1|||
106085095|NCT00600821|365971266|FG000|Overall Study|Terminated by sponsor|8|||
106085096|NCT00600821|365971267|FG001|Overall Study|Terminated by sponsor|6|||
106085097|NCT00600821|365971266|FG000|Overall Study|Objective progression or relapse|0|||
106085098|NCT00600821|365971267|FG001|Overall Study|Objective progression or relapse|1|||
106085099|NCT00600821|365971266|FG000|Overall Study|Randomized but not treated|0|||
106085100|NCT00600821|365971267|FG001|Overall Study|Randomized but not treated|1|||
106085101|NCT00600821|365971266|FG000|Overall Study|Other|2|||
106085102|NCT00600821|365971267|FG001|Overall Study|Other|3|||
106085103|NCT04269161|365971268|FG000|Overall Study|Change of modality and no longer eligible|3|||
106085104|NCT04269161|365971269|FG001|Overall Study|Change of modality and no longer eligible|3|||
106085105|NCT04269161|365971268|FG000|Overall Study|Required procedure outside of NICU|1|||
106085106|NCT04269161|365971269|FG001|Overall Study|Required procedure outside of NICU|0|||
106085107|NCT04269161|365971268|FG000|Overall Study|Equipment issue|1|||
106085108|NCT04269161|365971269|FG001|Overall Study|Equipment issue|1|||
106085109|NCT02200042|365971271|FG000|Overall Study|Withdrawal by Subject|0|||
106085110|NCT02200042|365971272|FG001|Overall Study|Withdrawal by Subject|1|||
106085111|NCT00110266|365971273|FG000|Overall Study|Adverse Event|27|||
106085112|NCT00110266|365971273|FG000|Overall Study|Abnormal laboratory value|15|||
106085113|NCT00110266|365971273|FG000|Overall Study|Withdrawal by Subject|16|||
106085114|NCT00110266|365971273|FG000|Overall Study|Death|17|||
106085115|NCT00110266|365971273|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106085116|NCT00110266|365971273|FG000|Overall Study|Participant condition no longer requires study drug|1|||
106085117|NCT02896400|365971274|FG000|1 Month Follow-up|Lost to Follow-up|7|||
106085118|NCT02896400|365971275|FG001|1 Month Follow-up|Lost to Follow-up|7|||
106085119|NCT02896400|365971276|FG002|1 Month Follow-up|Lost to Follow-up|5|||
106085120|NCT02896400|365971277|FG003|1 Month Follow-up|Lost to Follow-up|8|||
106085121|NCT02896400|365971278|FG004|1 Month Follow-up|Lost to Follow-up|9|||
106085122|NCT02896400|365971279|FG005|1 Month Follow-up|Lost to Follow-up|6|||
106085123|NCT02896400|365971280|FG006|1 Month Follow-up|Lost to Follow-up|5|||
106085124|NCT02896400|365971281|FG007|1 Month Follow-up|Lost to Follow-up|6|||
106085125|NCT02896400|365971282|FG008|1 Month Follow-up|Lost to Follow-up|4|||
106085126|NCT02896400|365971283|FG009|1 Month Follow-up|Lost to Follow-up|7|||
106085127|NCT02896400|365971284|FG010|1 Month Follow-up|Lost to Follow-up|5|||
106085128|NCT02896400|365971285|FG011|1 Month Follow-up|Lost to Follow-up|5|||
106085129|NCT02896400|365971286|FG012|1 Month Follow-up|Lost to Follow-up|3|||
106085130|NCT02896400|365971287|FG013|1 Month Follow-up|Lost to Follow-up|4|||
106085131|NCT02896400|365971288|FG014|1 Month Follow-up|Lost to Follow-up|1|||
106085132|NCT02896400|365971289|FG015|1 Month Follow-up|Lost to Follow-up|2|||
106085133|NCT02896400|365971274|FG000|1 Month Follow-up|Death|0|||
106085134|NCT02896400|365971275|FG001|1 Month Follow-up|Death|0|||
106085135|NCT02896400|365971276|FG002|1 Month Follow-up|Death|0|||
106085136|NCT02896400|365971277|FG003|1 Month Follow-up|Death|0|||
106085137|NCT02896400|365971278|FG004|1 Month Follow-up|Death|0|||
106085138|NCT02896400|365971279|FG005|1 Month Follow-up|Death|0|||
106085139|NCT02896400|365971280|FG006|1 Month Follow-up|Death|0|||
106085140|NCT02896400|365971281|FG007|1 Month Follow-up|Death|0|||
106085141|NCT02896400|365971282|FG008|1 Month Follow-up|Death|0|||
106085142|NCT02896400|365971283|FG009|1 Month Follow-up|Death|0|||
106085143|NCT02896400|365971284|FG010|1 Month Follow-up|Death|0|||
106085144|NCT02896400|365971285|FG011|1 Month Follow-up|Death|0|||
106085145|NCT02896400|365971286|FG012|1 Month Follow-up|Death|0|||
106085146|NCT02896400|365971287|FG013|1 Month Follow-up|Death|0|||
106085147|NCT02896400|365971288|FG014|1 Month Follow-up|Death|0|||
106085148|NCT02896400|365971289|FG015|1 Month Follow-up|Death|1|||
106085149|NCT02896400|365971274|FG000|3 Month Follow-up|Lost to Follow-up|6|||
106085150|NCT02896400|365971275|FG001|3 Month Follow-up|Lost to Follow-up|3|||
106085151|NCT02896400|365971276|FG002|3 Month Follow-up|Lost to Follow-up|6|||
106085152|NCT02896400|365971277|FG003|3 Month Follow-up|Lost to Follow-up|11|||
106085153|NCT02896400|365971278|FG004|3 Month Follow-up|Lost to Follow-up|12|||
106085154|NCT02896400|365971279|FG005|3 Month Follow-up|Lost to Follow-up|6|||
106085155|NCT02896400|365971280|FG006|3 Month Follow-up|Lost to Follow-up|4|||
106085156|NCT02896400|365971281|FG007|3 Month Follow-up|Lost to Follow-up|3|||
106085157|NCT02896400|365971282|FG008|3 Month Follow-up|Lost to Follow-up|6|||
106085158|NCT02896400|365971283|FG009|3 Month Follow-up|Lost to Follow-up|5|||
106085159|NCT02896400|365971284|FG010|3 Month Follow-up|Lost to Follow-up|6|||
106085160|NCT02896400|365971285|FG011|3 Month Follow-up|Lost to Follow-up|6|||
106085161|NCT02896400|365971286|FG012|3 Month Follow-up|Lost to Follow-up|3|||
106085162|NCT02896400|365971287|FG013|3 Month Follow-up|Lost to Follow-up|5|||
106085163|NCT02896400|365971288|FG014|3 Month Follow-up|Lost to Follow-up|3|||
106085164|NCT02896400|365971289|FG015|3 Month Follow-up|Lost to Follow-up|2|||
106085165|NCT02896400|365971274|FG000|3 Month Follow-up|Death|0|||
106085166|NCT02896400|365971275|FG001|3 Month Follow-up|Death|0|||
106085167|NCT02896400|365971276|FG002|3 Month Follow-up|Death|0|||
106085168|NCT02896400|365971277|FG003|3 Month Follow-up|Death|0|||
106085169|NCT02896400|365971278|FG004|3 Month Follow-up|Death|0|||
106085170|NCT02896400|365971279|FG005|3 Month Follow-up|Death|0|||
106085171|NCT02896400|365971280|FG006|3 Month Follow-up|Death|0|||
106085172|NCT02896400|365971281|FG007|3 Month Follow-up|Death|0|||
106085173|NCT02896400|365971282|FG008|3 Month Follow-up|Death|0|||
106085174|NCT02896400|365971283|FG009|3 Month Follow-up|Death|0|||
106085175|NCT02896400|365971284|FG010|3 Month Follow-up|Death|0|||
106085176|NCT02896400|365971285|FG011|3 Month Follow-up|Death|0|||
106085177|NCT02896400|365971286|FG012|3 Month Follow-up|Death|0|||
106085178|NCT02896400|365971287|FG013|3 Month Follow-up|Death|1|||
106085179|NCT02896400|365971288|FG014|3 Month Follow-up|Death|1|||
106085180|NCT02896400|365971289|FG015|3 Month Follow-up|Death|0|||
106085181|NCT02896400|365971274|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
106085182|NCT02896400|365971275|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
106085183|NCT02896400|365971276|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
106085184|NCT02896400|365971277|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
106085185|NCT02896400|365971278|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
106085186|NCT02896400|365971279|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
106085187|NCT02896400|365971280|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
106085188|NCT02896400|365971281|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
106085189|NCT02896400|365971282|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
106085190|NCT02896400|365971283|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
106085191|NCT02896400|365971284|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
106085192|NCT02896400|365971285|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
106085193|NCT02896400|365971286|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
106085194|NCT02896400|365971287|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
106085195|NCT02896400|365971288|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
106085196|NCT02896400|365971289|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
106085197|NCT02896400|365971274|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
106085198|NCT02896400|365971275|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
106085199|NCT02896400|365971276|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
106085200|NCT02896400|365971277|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
106085201|NCT02896400|365971278|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
106085202|NCT02896400|365971279|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
106085203|NCT02896400|365971280|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
106085204|NCT02896400|365971281|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
106085205|NCT02896400|365971282|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
106085206|NCT02896400|365971283|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
106085207|NCT02896400|365971284|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
106085208|NCT02896400|365971285|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
106085209|NCT02896400|365971286|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
106085210|NCT02896400|365971287|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
106085211|NCT02896400|365971288|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
106085212|NCT02896400|365971289|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
106085213|NCT02610192|365971292|FG000|Overall Study|Received other treatment|8|||
106085214|NCT02610192|365971292|FG000|Overall Study|Physician Decision|1|||
106085215|NCT04101526|365971296|FG000|Overall Study|Did not complete all sleep diary entries|0|||
106085216|NCT04101526|365971297|FG001|Overall Study|Did not complete all sleep diary entries|1|||
106085217|NCT04127786|365971298|FG000|Primary Series|Adverse Event|1|||
106085218|NCT04127786|365971299|FG001|Primary Series|Adverse Event|0|||
106085219|NCT04127786|365971300|FG002|Primary Series|Adverse Event|0|||
106085220|NCT04127786|365971301|FG003|Primary Series|Adverse Event|1|||
106085221|NCT04127786|365971302|FG004|Primary Series|Adverse Event|0|||
106085222|NCT04127786|365971303|FG005|Primary Series|Adverse Event|1|||
106085223|NCT04127786|365971298|FG000|Primary Series|Protocol Violation|5|||
106085224|NCT04127786|365971299|FG001|Primary Series|Protocol Violation|3|||
106085225|NCT04127786|365971300|FG002|Primary Series|Protocol Violation|4|||
106085226|NCT04127786|365971301|FG003|Primary Series|Protocol Violation|3|||
106085227|NCT04127786|365971302|FG004|Primary Series|Protocol Violation|2|||
106085228|NCT04127786|365971303|FG005|Primary Series|Protocol Violation|0|||
106085229|NCT04127786|365971298|FG000|Primary Series|Withdrawal by Subject|0|||
106085230|NCT04127786|365971299|FG001|Primary Series|Withdrawal by Subject|0|||
106085231|NCT04127786|365971300|FG002|Primary Series|Withdrawal by Subject|0|||
106085232|NCT04127786|365971301|FG003|Primary Series|Withdrawal by Subject|1|||
106085233|NCT04127786|365971302|FG004|Primary Series|Withdrawal by Subject|0|||
106085234|NCT04127786|365971303|FG005|Primary Series|Withdrawal by Subject|0|||
106085235|NCT04127786|365971298|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
106085236|NCT04127786|365971299|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
106085237|NCT04127786|365971300|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
106085238|NCT04127786|365971301|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
106085239|NCT04127786|365971302|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
106085240|NCT04127786|365971303|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
106085241|NCT04127786|365971298|FG000|Booster Phase|Withdrawal by Subject|2|||
106085242|NCT04127786|365971299|FG001|Booster Phase|Withdrawal by Subject|0|||
106085243|NCT04127786|365971300|FG002|Booster Phase|Withdrawal by Subject|0|||
106085244|NCT04127786|365971301|FG003|Booster Phase|Withdrawal by Subject|0|||
106085245|NCT04127786|365971302|FG004|Booster Phase|Withdrawal by Subject|0|||
106085246|NCT04127786|365971303|FG005|Booster Phase|Withdrawal by Subject|0|||
106085247|NCT00596011|365971304|FG000|Overall Study|Withdrawal by Subject|2|||
106085248|NCT00596011|365971305|FG001|Overall Study|Withdrawal by Subject|3|||
106085249|NCT00596011|365971304|FG000|Overall Study|Adverse Event|11|||
106085250|NCT00596011|365971305|FG001|Overall Study|Adverse Event|7|||
106085251|NCT00424372|365971309|FG000|Overall Study|Death|1|||
106085252|NCT00424372|365971309|FG000|Overall Study|Adverse Event|18|||
106085253|NCT00424372|365971309|FG000|Overall Study|Lack of Efficacy|6|||
106085254|NCT00424372|365971309|FG000|Overall Study|Withdrawal by Subject|4|||
106085255|NCT00424372|365971309|FG000|Overall Study|Protocol Violation|1|||
106085256|NCT00424372|365971309|FG000|Overall Study|Health deterioration|1|||
106085257|NCT02940691|365971310|FG000|Overall Study|Lost to Follow-up|5|||
106085258|NCT02940691|365971310|FG000|Overall Study|Incarceration|1|||
106085259|NCT04622254|365971313|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
106085260|NCT04622254|365971314|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
106085261|NCT04622254|365971315|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
106085262|NCT04622254|365971316|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
106085263|NCT04622254|365971317|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
106085264|NCT04622254|365971318|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
106085265|NCT04622254|365971313|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
106085266|NCT04622254|365971314|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
106085267|NCT04622254|365971315|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
106085268|NCT04622254|365971316|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
106085269|NCT04622254|365971317|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
106085270|NCT04622254|365971318|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
106085271|NCT04622254|365971313|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
106085272|NCT04622254|365971314|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
106085273|NCT04622254|365971315|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
106085274|NCT04622254|365971316|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
106085275|NCT04622254|365971317|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
106085276|NCT04622254|365971318|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
106085277|NCT04622254|365971313|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
106085278|NCT04622254|365971314|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
106085279|NCT04622254|365971315|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
106085280|NCT04622254|365971316|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
106085281|NCT04622254|365971317|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
106085282|NCT04622254|365971318|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
106085283|NCT04622254|365971313|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
106085284|NCT04622254|365971314|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
106085285|NCT04622254|365971315|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
106085286|NCT04622254|365971316|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
106085287|NCT04622254|365971317|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
106085288|NCT04622254|365971318|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
106085289|NCT04622254|365971313|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
106085290|NCT04622254|365971314|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
106085291|NCT04622254|365971315|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
106085292|NCT04622254|365971316|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
106085293|NCT04622254|365971317|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
106085294|NCT04622254|365971318|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
106085295|NCT04622254|365971313|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
106085296|NCT04622254|365971314|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
106085297|NCT04622254|365971315|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
106085298|NCT04622254|365971316|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
106085299|NCT04622254|365971317|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
106085300|NCT04622254|365971318|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
106085301|NCT04622254|365971313|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
106085302|NCT04622254|365971314|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
106160884|NCT04633122|366250465|FG001|Overall Study|Survival follow-up stopped|25|||
106160885|NCT04799899|366250470|FG000|Overall Study|Lost to Follow-up|2|||
106160886|NCT04799899|366250471|FG001|Overall Study|Lost to Follow-up|4|||
106160887|NCT04185298|366250473|FG000|Overall Study|Lost to Follow-up|1|||
106160888|NCT04185298|366250474|FG001|Overall Study|Lost to Follow-up|3|||
106160889|NCT04185298|366250473|FG000|Overall Study|Withdrawal by Subject|0|||
106160890|NCT04185298|366250474|FG001|Overall Study|Withdrawal by Subject|3|||
106160891|NCT01798498|366250475|FG000|Overall Study|Lost to Follow-up|1|||
106160892|NCT03896789|366250477|FG000|Baseline|Lost to Follow-up|1|||
106160893|NCT03896789|366250478|FG001|Baseline|Lost to Follow-up|2|||
106160894|NCT03896789|366250477|FG000|Baseline|Death|3|||
106160895|NCT03896789|366250478|FG001|Baseline|Death|6|||
106160896|NCT03896789|366250477|FG000|Post-Randomization|Lost to Follow-up|12|||
106160897|NCT03896789|366250478|FG001|Post-Randomization|Lost to Follow-up|11|||
106160898|NCT03896789|366250477|FG000|Post-Randomization|Death|12|||
106160899|NCT03896789|366250478|FG001|Post-Randomization|Death|13|||
106160900|NCT03447470|366250479|FG000|Overall Study|Death|0|||
106160901|NCT03447470|366250480|FG001|Overall Study|Death|1|||
106160902|NCT03447470|366250481|FG002|Overall Study|Death|3|||
106160903|NCT03447470|366250482|FG003|Overall Study|Death|0|||
106160904|NCT03447470|366250483|FG004|Overall Study|Death|1|||
106160905|NCT03447470|366250484|FG005|Overall Study|Death|0|||
106160906|NCT03447470|366250485|FG006|Overall Study|Death|3|||
106160907|NCT03447470|366250486|FG007|Overall Study|Death|3|||
106160908|NCT03447470|366250487|FG008|Overall Study|Death|1|||
106160909|NCT03447470|366250479|FG000|Overall Study|Withdrawal by Subject|1|||
106160910|NCT03447470|366250480|FG001|Overall Study|Withdrawal by Subject|0|||
106160911|NCT03447470|366250481|FG002|Overall Study|Withdrawal by Subject|0|||
106160912|NCT03447470|366250482|FG003|Overall Study|Withdrawal by Subject|0|||
106160913|NCT03447470|366250483|FG004|Overall Study|Withdrawal by Subject|1|||
106160914|NCT03447470|366250484|FG005|Overall Study|Withdrawal by Subject|0|||
106160915|NCT03447470|366250485|FG006|Overall Study|Withdrawal by Subject|1|||
106160916|NCT03447470|366250486|FG007|Overall Study|Withdrawal by Subject|1|||
106160917|NCT03447470|366250487|FG008|Overall Study|Withdrawal by Subject|3|||
106160918|NCT03447470|366250479|FG000|Overall Study|Treatment discontinued|3|||
106160919|NCT03447470|366250480|FG001|Overall Study|Treatment discontinued|2|||
106160920|NCT03447470|366250481|FG002|Overall Study|Treatment discontinued|4|||
106160921|NCT03447470|366250482|FG003|Overall Study|Treatment discontinued|6|||
106160922|NCT03447470|366250483|FG004|Overall Study|Treatment discontinued|2|||
106160923|NCT03447470|366250484|FG005|Overall Study|Treatment discontinued|1|||
106160924|NCT03447470|366250485|FG006|Overall Study|Treatment discontinued|2|||
106160925|NCT03447470|366250486|FG007|Overall Study|Treatment discontinued|4|||
106160926|NCT03447470|366250487|FG008|Overall Study|Treatment discontinued|3|||
106160927|NCT01606215|366250488|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
106160928|NCT01606215|366250489|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
106160929|NCT05184192|366250491|FG000|Overall Study|Lost to Follow-up|4|||
106160930|NCT05184192|366250492|FG001|Overall Study|Lost to Follow-up|7|||
106160931|NCT05184192|366250491|FG000|Overall Study|Adverse Event|1|||
106160932|NCT05184192|366250492|FG001|Overall Study|Adverse Event|4|||
106160933|NCT05184192|366250491|FG000|Overall Study|PI withdrawal|1|||
106085303|NCT04622254|365971315|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
106085304|NCT04622254|365971316|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
106085305|NCT04622254|365971317|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
106085306|NCT04622254|365971318|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
106085307|NCT04622254|365971313|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
106085308|NCT04622254|365971314|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
106085309|NCT04622254|365971315|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
106085310|NCT04622254|365971316|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
106085311|NCT04622254|365971317|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
106085312|NCT04622254|365971318|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
106085313|NCT04622254|365971313|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
106085314|NCT04622254|365971314|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
106085315|NCT04622254|365971315|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
106085316|NCT04622254|365971316|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
106085317|NCT04622254|365971317|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
106085318|NCT04622254|365971318|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
106085319|NCT04622254|365971313|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
106085320|NCT04622254|365971314|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
106085321|NCT04622254|365971315|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
106085322|NCT04622254|365971316|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
106085323|NCT04622254|365971317|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
106085324|NCT04622254|365971318|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
106085325|NCT00912405|365971319|FG000|Overall Study|Lost to Follow-up|5|||
106085326|NCT01434823|365971320|FG000|Overall Study|Incomplete data in medical record|4|||
106085327|NCT01434823|365971321|FG001|Overall Study|Incomplete data in medical record|7|||
106085328|NCT02477020|365971324|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
106085329|NCT02477020|365971325|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
106085330|NCT02477020|365971324|FG000|Overall Study|Voluntary Withdrawal|7|||
106085331|NCT02477020|365971325|FG001|Overall Study|Voluntary Withdrawal|16|||
106085332|NCT02477020|365971324|FG000|Overall Study|Reason not Specified|3|||
106085333|NCT02477020|365971325|FG001|Overall Study|Reason not Specified|1|||
106085334|NCT02477020|365971324|FG000|Overall Study|Lack of Efficacy|14|||
106085335|NCT02477020|365971325|FG001|Overall Study|Lack of Efficacy|5|||
106085336|NCT02489981|365971327|FG000|Overall Study|Adverse Event|21|||
106085337|NCT02489981|365971327|FG000|Overall Study|Insufficient effectiveness|16|||
106085338|NCT02489981|365971327|FG000|Overall Study|Improved|31|||
106085339|NCT02489981|365971327|FG000|Overall Study|Lost to Follow-up|31|||
106085340|NCT02489981|365971327|FG000|Overall Study|Other than listed|28|||
106085341|NCT00796861|365971333|FG000|Overall Study|Withdrawal by Subject|2|||
106085342|NCT00796861|365971333|FG000|Overall Study|Death|2|||
106085343|NCT04394351|365971336|FG000|Part A (16 Weeks)|Adverse Event|1|||
106085344|NCT04394351|365971337|FG001|Part A (16 Weeks)|Adverse Event|0|||
106085345|NCT04394351|365971338|FG002|Part A (16 Weeks)|Adverse Event|0|||
106085346|NCT04394351|365971339|FG003|Part A (16 Weeks)|Adverse Event|0|||
106085347|NCT04394351|365971340|FG004|Part A (16 Weeks)|Adverse Event|0|||
106085348|NCT04394351|365971341|FG005|Part A (16 Weeks)|Adverse Event|0|||
106085349|NCT04394351|365971342|FG006|Part A (16 Weeks)|Adverse Event|0|||
106085350|NCT04394351|365971343|FG007|Part A (16 Weeks)|Adverse Event|0|||
106085351|NCT04394351|365971336|FG000|Part A (16 Weeks)|Physician Decision|0|||
106085352|NCT04394351|365971337|FG001|Part A (16 Weeks)|Physician Decision|1|||
106085353|NCT04394351|365971338|FG002|Part A (16 Weeks)|Physician Decision|0|||
106085354|NCT04394351|365971339|FG003|Part A (16 Weeks)|Physician Decision|0|||
106085355|NCT04394351|365971340|FG004|Part A (16 Weeks)|Physician Decision|0|||
106085356|NCT04394351|365971341|FG005|Part A (16 Weeks)|Physician Decision|0|||
106085357|NCT04394351|365971342|FG006|Part A (16 Weeks)|Physician Decision|0|||
106085358|NCT04394351|365971343|FG007|Part A (16 Weeks)|Physician Decision|0|||
106085359|NCT04394351|365971336|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
106085360|NCT04394351|365971337|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
106085361|NCT04394351|365971338|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
106085362|NCT04394351|365971339|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
106085363|NCT04394351|365971340|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
106160934|NCT05184192|366250492|FG001|Overall Study|PI withdrawal|2|||
106160935|NCT05184192|366250491|FG000|Overall Study|Withdrew due to adverse effect|1|||
106160936|NCT05184192|366250492|FG001|Overall Study|Withdrew due to adverse effect|0|||
106160937|NCT05184192|366250491|FG000|Overall Study|Medication schedule|1|||
106160938|NCT05184192|366250492|FG001|Overall Study|Medication schedule|0|||
106160939|NCT05184192|366250491|FG000|Overall Study|Concern for adverse effects|0|||
106160940|NCT05184192|366250492|FG001|Overall Study|Concern for adverse effects|4|||
106160941|NCT03945292|366250493|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
106085364|NCT04394351|365971341|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
106085365|NCT04394351|365971342|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
106160942|NCT03945292|366250494|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
106085366|NCT04394351|365971343|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
106085367|NCT04394351|365971336|FG000|Part B (36 Weeks)|Adverse Event|0|||
106085368|NCT04394351|365971337|FG001|Part B (36 Weeks)|Adverse Event|0|||
106085369|NCT04394351|365971338|FG002|Part B (36 Weeks)|Adverse Event|0|||
106085370|NCT04394351|365971339|FG003|Part B (36 Weeks)|Adverse Event|0|||
106085371|NCT04394351|365971340|FG004|Part B (36 Weeks)|Adverse Event|0|||
106085372|NCT04394351|365971341|FG005|Part B (36 Weeks)|Adverse Event|0|||
106085373|NCT04394351|365971342|FG006|Part B (36 Weeks)|Adverse Event|1|||
106085374|NCT04394351|365971343|FG007|Part B (36 Weeks)|Adverse Event|0|||
106085375|NCT03728582|365971344|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
106085376|NCT03728582|365971345|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
106085377|NCT03728582|365971344|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
106085378|NCT03728582|365971345|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
106085379|NCT02738775|365971346|FG000|Overall Study|Withdrawal by Subject|0|||
106085380|NCT02738775|365971347|FG001|Overall Study|Withdrawal by Subject|1|||
106085381|NCT02738775|365971348|FG002|Overall Study|Withdrawal by Subject|0|||
106085382|NCT02738775|365971349|FG003|Overall Study|Withdrawal by Subject|0|||
106085383|NCT02738775|365971350|FG004|Overall Study|Withdrawal by Subject|0|||
106085384|NCT02738775|365971351|FG005|Overall Study|Withdrawal by Subject|0|||
106085385|NCT02738775|365971346|FG000|Overall Study|Adverse Event|0|||
106085386|NCT02738775|365971347|FG001|Overall Study|Adverse Event|0|||
106085387|NCT02738775|365971348|FG002|Overall Study|Adverse Event|0|||
106085388|NCT02738775|365971349|FG003|Overall Study|Adverse Event|1|||
106085389|NCT02738775|365971350|FG004|Overall Study|Adverse Event|0|||
106085390|NCT02738775|365971351|FG005|Overall Study|Adverse Event|0|||
106085391|NCT02738775|365971346|FG000|Overall Study|Pregnancy|0|||
106085392|NCT02738775|365971347|FG001|Overall Study|Pregnancy|1|||
106085393|NCT02738775|365971348|FG002|Overall Study|Pregnancy|0|||
106085394|NCT02738775|365971349|FG003|Overall Study|Pregnancy|0|||
106085395|NCT02738775|365971350|FG004|Overall Study|Pregnancy|0|||
106085396|NCT02738775|365971351|FG005|Overall Study|Pregnancy|0|||
106085397|NCT02738775|365971346|FG000|Overall Study|Missing|0|||
106085398|NCT02738775|365971347|FG001|Overall Study|Missing|0|||
106085399|NCT02738775|365971348|FG002|Overall Study|Missing|0|||
106085400|NCT02738775|365971349|FG003|Overall Study|Missing|0|||
106085401|NCT02738775|365971350|FG004|Overall Study|Missing|0|||
106085402|NCT02738775|365971351|FG005|Overall Study|Missing|1|||
106085403|NCT01034397|365971352|FG000|Overall Study|Lack of compliance|0|||
106085404|NCT01034397|365971353|FG001|Overall Study|Lack of compliance|1|||
106085405|NCT01034397|365971352|FG000|Overall Study|Lack of Efficacy|3|||
106085406|NCT01034397|365971353|FG001|Overall Study|Lack of Efficacy|0|||
106085407|NCT01034397|365971352|FG000|Overall Study|Adverse Event|4|||
106085408|NCT01034397|365971353|FG001|Overall Study|Adverse Event|0|||
106085409|NCT01034397|365971352|FG000|Overall Study|Other|0|||
106085410|NCT01034397|365971353|FG001|Overall Study|Other|1|||
106085411|NCT01785524|365971354|FG000|Overall Study|Withdrawal by Subject|2|||
106085412|NCT01785524|365971355|FG001|Overall Study|Withdrawal by Subject|2|||
106085413|NCT01060384|365971356|FG000|Overall Study|Withdrawal by Subject|0|||
106085414|NCT01060384|365971357|FG001|Overall Study|Withdrawal by Subject|1|||
106085415|NCT01060384|365971358|FG002|Overall Study|Withdrawal by Subject|0|||
106085416|NCT01060384|365971359|FG003|Overall Study|Withdrawal by Subject|0|||
106085417|NCT01060384|365971360|FG004|Overall Study|Withdrawal by Subject|0|||
106085418|NCT01060384|365971356|FG000|Overall Study|Death|0|||
106085419|NCT01060384|365971357|FG001|Overall Study|Death|0|||
106085420|NCT01060384|365971358|FG002|Overall Study|Death|0|||
106085421|NCT01060384|365971359|FG003|Overall Study|Death|0|||
106085422|NCT01060384|365971360|FG004|Overall Study|Death|1|||
106085423|NCT01060384|365971356|FG000|Overall Study|Intercurrent illness|0|||
106085424|NCT01060384|365971357|FG001|Overall Study|Intercurrent illness|0|||
106085425|NCT01060384|365971358|FG002|Overall Study|Intercurrent illness|0|||
106085426|NCT01060384|365971359|FG003|Overall Study|Intercurrent illness|0|||
106085427|NCT01060384|365971360|FG004|Overall Study|Intercurrent illness|1|||
106085428|NCT00812929|365971362|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
106085429|NCT00812929|365971363|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
106085430|NCT00812929|365971364|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
106085431|NCT00812929|365971365|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
106085432|NCT00812929|365971366|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
106085433|NCT00812929|365971367|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
106085434|NCT00812929|365971368|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
106085435|NCT00812929|365971369|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
106085436|NCT00812929|365971370|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
106085437|NCT00812929|365971371|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
106085438|NCT00812929|365971362|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
106085439|NCT00812929|365971363|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
106085440|NCT00812929|365971364|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
106085441|NCT00812929|365971365|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
106085442|NCT00812929|365971366|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
106085443|NCT00812929|365971367|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
106085444|NCT00812929|365971368|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
106085445|NCT00812929|365971369|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
106085446|NCT00812929|365971370|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
106085447|NCT00812929|365971371|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
106085448|NCT00812929|365971362|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
106085449|NCT00812929|365971363|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
106085450|NCT00812929|365971364|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
106085451|NCT00812929|365971365|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
106085452|NCT00812929|365971366|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
106085453|NCT00812929|365971367|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
106085454|NCT00812929|365971368|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
106085455|NCT00812929|365971369|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
106085456|NCT00812929|365971370|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
106085457|NCT00812929|365971371|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
106085458|NCT04027686|365971372|FG000|Overall Study|Lost to Follow-up|2|||
106085459|NCT04027686|365971373|FG001|Overall Study|Lost to Follow-up|0|||
106085460|NCT04027686|365971372|FG000|Overall Study|Withdrawal by Subject|0|||
106085461|NCT04027686|365971373|FG001|Overall Study|Withdrawal by Subject|1|||
106085462|NCT03217136|365971375|FG000|Overall Study|Lost to Follow-up|2|||
106085463|NCT03217136|365971376|FG001|Overall Study|Lost to Follow-up|1|||
106085464|NCT03217136|365971375|FG000|Overall Study|Site Randomized Participant in Error|0|||
106085465|NCT03217136|365971376|FG001|Overall Study|Site Randomized Participant in Error|1|||
106085466|NCT03217136|365971375|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
106085467|NCT03217136|365971376|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
106085468|NCT03217136|365971375|FG000|Overall Study|Dispensing Error|1|||
106085469|NCT03217136|365971376|FG001|Overall Study|Dispensing Error|0|||
106085470|NCT03217136|365971375|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
106085471|NCT03217136|365971376|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
106085472|NCT01401530|365971377|FG000|Overall Study|Disease Progression|1|||
106085473|NCT01401530|365971378|FG001|Overall Study|Disease Progression|2|||
106085474|NCT01401530|365971379|FG002|Overall Study|Disease Progression|1|||
106085475|NCT01401530|365971377|FG000|Overall Study|Adverse Event|1|||
106085476|NCT01401530|365971378|FG001|Overall Study|Adverse Event|1|||
106085477|NCT01401530|365971379|FG002|Overall Study|Adverse Event|1|||
106085478|NCT01401530|365971377|FG000|Overall Study|Participant Choice|1|||
106085479|NCT01401530|365971378|FG001|Overall Study|Participant Choice|2|||
106085480|NCT01401530|365971379|FG002|Overall Study|Participant Choice|1|||
106085481|NCT01401530|365971377|FG000|Overall Study|Physician Decision|0|||
106085482|NCT01401530|365971378|FG001|Overall Study|Physician Decision|1|||
106085483|NCT01401530|365971379|FG002|Overall Study|Physician Decision|0|||
106085484|NCT02104557|365971380|FG000|Overall Study|Adverse Event|24|||
106085485|NCT02104557|365971380|FG000|Overall Study|Lost to Follow-up|34|||
106085486|NCT02104557|365971380|FG000|Overall Study|Violated the usage and dosage|14|||
106085487|NCT02104557|365971380|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
106085488|NCT02104557|365971380|FG000|Overall Study|Administered Sayana prior to the contract|1|||
106085489|NCT02104557|365971380|FG000|Overall Study|Other|17|||
106085490|NCT02104557|365971380|FG000|Overall Study|Change to other contraception methods|5|||
106085491|NCT02104557|365971380|FG000|Overall Study|Discontinuation due to no pain|1|||
106085492|NCT02104557|365971380|FG000|Overall Study|Withdrawal consent|2|||
106085493|NCT02104557|365971380|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
106085494|NCT02104557|365971380|FG000|Overall Study|Discontinuation of contraception|9|||
106085495|NCT03192150|365971386|FG000|Overall Study|Adverse Event|14|||
106085496|NCT03192150|365971387|FG001|Overall Study|Adverse Event|12|||
106085497|NCT03192150|365971386|FG000|Overall Study|Lack of Efficacy|23|||
106085498|NCT03192150|365971387|FG001|Overall Study|Lack of Efficacy|30|||
106085499|NCT03192150|365971386|FG000|Overall Study|Lost to Follow-up|1|||
106085500|NCT03192150|365971387|FG001|Overall Study|Lost to Follow-up|1|||
106085501|NCT03192150|365971386|FG000|Overall Study|Withdrawal by Subject|4|||
106085502|NCT03192150|365971387|FG001|Overall Study|Withdrawal by Subject|2|||
106085503|NCT03192150|365971386|FG000|Overall Study|Protocol Violation|5|||
106085504|NCT03192150|365971387|FG001|Overall Study|Protocol Violation|2|||
106085505|NCT03192150|365971386|FG000|Overall Study|Surgery Canceled|6|||
106085506|NCT03192150|365971387|FG001|Overall Study|Surgery Canceled|2|||
106085507|NCT03192150|365971386|FG000|Overall Study|Other-Various Administrative Reasons|2|||
106085508|NCT03192150|365971387|FG001|Overall Study|Other-Various Administrative Reasons|5|||
106085509|NCT02178475|365971388|FG000|Overall Study|Withdrawal by Subject|7|||
106085510|NCT02178475|365971388|FG000|Overall Study|Lost to Follow-up|10|||
106085511|NCT02178475|365971388|FG000|Overall Study|Death|13|||
106085512|NCT02178475|365971388|FG000|Overall Study|Protocol-specified Criteria|99|||
106085513|NCT01430585|365971389|FG000|Overall Study|Death|1|||
106085514|NCT01430585|365971389|FG000|Overall Study|Objective Progression or Relapse|3|||
106085515|NCT01430585|365971389|FG000|Overall Study|Study Terminated by Sponsor|3|||
106085516|NCT01430585|365971389|FG000|Overall Study|Other|7|||
106085517|NCT01448850|365971390|FG000|Overall Study|Death|3|||
106085518|NCT01448850|365971391|FG001|Overall Study|Death|6|||
106085519|NCT01448850|365971390|FG000|Overall Study|Withdrawal by Subject|13|||
106085520|NCT01448850|365971391|FG001|Overall Study|Withdrawal by Subject|21|||
106085521|NCT01448850|365971390|FG000|Overall Study|Lost to Follow-up|3|||
106085522|NCT01448850|365971391|FG001|Overall Study|Lost to Follow-up|1|||
106085523|NCT01448850|365971390|FG000|Overall Study|Other|15|||
106085524|NCT01448850|365971391|FG001|Overall Study|Other|12|||
106085525|NCT00813124|365971400|FG000|Overall Study|Death|2|||
106085526|NCT00813124|365971400|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
106085527|NCT00813124|365971400|FG000|Overall Study|Withdrawal by Subject|1|||
106085528|NCT00280566|365971404|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
106085529|NCT00280566|365971405|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
106085530|NCT00280566|365971406|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
106085531|NCT00280566|365971404|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
106085532|NCT00280566|365971405|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
106085533|NCT00280566|365971406|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
106085534|NCT00280566|365971404|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
106085535|NCT00280566|365971405|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
106085536|NCT00280566|365971406|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
106085537|NCT00280566|365971404|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
106085538|NCT00280566|365971405|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
106085539|NCT00280566|365971406|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
106085540|NCT00280566|365971404|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
106085541|NCT00280566|365971405|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
106085542|NCT00280566|365971406|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
106085543|NCT00280566|365971404|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
106085544|NCT00280566|365971405|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
106085545|NCT00280566|365971406|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
106085546|NCT00280566|365971404|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
106085547|NCT00280566|365971405|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
106085548|NCT00280566|365971406|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
106085549|NCT00280566|365971404|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
106085550|NCT00280566|365971405|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
106085551|NCT00280566|365971406|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
106085552|NCT00280566|365971404|FG000|Period 2 Double Blind|Adverse Event|0|||
106085553|NCT00280566|365971405|FG001|Period 2 Double Blind|Adverse Event|11|||
106085554|NCT00280566|365971406|FG002|Period 2 Double Blind|Adverse Event|15|||
106085555|NCT00280566|365971404|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
106085556|NCT00280566|365971405|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
106085557|NCT00280566|365971406|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
106085558|NCT00280566|365971404|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
106085559|NCT00280566|365971405|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
106085560|NCT00280566|365971406|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
106085561|NCT00280566|365971404|FG000|Period 2 Double Blind|miscellaneous|0|||
106085562|NCT00280566|365971405|FG001|Period 2 Double Blind|miscellaneous|10|||
106085563|NCT00280566|365971406|FG002|Period 2 Double Blind|miscellaneous|5|||
106085564|NCT02707640|365971412|FG000|Overall Study|Adverse Event|4|||
106085565|NCT02707640|365971413|FG001|Overall Study|Adverse Event|2|||
106085566|NCT02707640|365971412|FG000|Overall Study|Death|1|||
106085567|NCT02707640|365971413|FG001|Overall Study|Death|2|||
106085568|NCT02707640|365971412|FG000|Overall Study|Physician Decision|2|||
106085569|NCT02707640|365971413|FG001|Overall Study|Physician Decision|0|||
106085570|NCT02707640|365971412|FG000|Overall Study|Withdrawal by Subject|0|||
106085571|NCT02707640|365971413|FG001|Overall Study|Withdrawal by Subject|1|||
106085572|NCT02707640|365971412|FG000|Overall Study|Participant's Personal Decision|1|||
106085573|NCT02707640|365971413|FG001|Overall Study|Participant's Personal Decision|2|||
106085574|NCT02707640|365971412|FG000|Overall Study|Sponsor Discretion|1|||
106085575|NCT02707640|365971413|FG001|Overall Study|Sponsor Discretion|0|||
106085576|NCT02517905|365971414|FG000|Overall Study|Lost to Follow-up|4|||
106085577|NCT02517905|365971415|FG001|Overall Study|Lost to Follow-up|0|||
106085578|NCT02517905|365971414|FG000|Overall Study|Withdrawal by Subject|4|||
106085579|NCT02517905|365971415|FG001|Overall Study|Withdrawal by Subject|0|||
106085580|NCT02517905|365971414|FG000|Overall Study|Screen failure|2|||
106085581|NCT02517905|365971415|FG001|Overall Study|Screen failure|2|||
106085582|NCT02564198|365972789|FG000|Overall Study|Withdrawal by Subject|2|||
106085583|NCT02564198|365972790|FG001|Overall Study|Withdrawal by Subject|4|||
106085584|NCT02564198|365972791|FG002|Overall Study|Withdrawal by Subject|0|||
106085585|NCT02564198|365972789|FG000|Overall Study|Adverse Event|0|||
106085586|NCT02564198|365972790|FG001|Overall Study|Adverse Event|1|||
106085587|NCT02564198|365972791|FG002|Overall Study|Adverse Event|0|||
106085588|NCT00938431|365972796|FG000|Overall Study|Adverse Event|5|||
106085589|NCT00938431|365972797|FG001|Overall Study|Adverse Event|8|||
106085590|NCT00938431|365972798|FG002|Overall Study|Adverse Event|6|||
106085591|NCT00938431|365972796|FG000|Overall Study|Lack of Efficacy|0|||
106085592|NCT00938431|365972797|FG001|Overall Study|Lack of Efficacy|1|||
106085593|NCT00938431|365972798|FG002|Overall Study|Lack of Efficacy|0|||
106085594|NCT00938431|365972796|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
106085595|NCT00938431|365972797|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
106085596|NCT00938431|365972798|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
106085597|NCT00938431|365972796|FG000|Overall Study|Dosing compliance issue|0|||
106085598|NCT00938431|365972797|FG001|Overall Study|Dosing compliance issue|0|||
106085599|NCT00938431|365972798|FG002|Overall Study|Dosing compliance issue|1|||
106085600|NCT00938431|365972796|FG000|Overall Study|Reached maximum dose early|0|||
106085601|NCT00938431|365972797|FG001|Overall Study|Reached maximum dose early|0|||
106085602|NCT00938431|365972798|FG002|Overall Study|Reached maximum dose early|1|||
106085603|NCT02984020|365972799|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
106085604|NCT02984020|365972799|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
106085605|NCT02984020|365972799|FG000|Overall Study|Other significant protocol violation|2|||
106085606|NCT05044234|365972808|FG000|Overall Study|Lost to Follow-up|2|||
106085607|NCT05044234|365972809|FG001|Overall Study|Lost to Follow-up|1|||
106085608|NCT05044234|365972810|FG002|Overall Study|Lost to Follow-up|1|||
106085609|NCT05044234|365972811|FG003|Overall Study|Lost to Follow-up|2|||
106085610|NCT05044234|365972808|FG000|Overall Study|Withdrawal by Subject|6|||
106085611|NCT05044234|365972809|FG001|Overall Study|Withdrawal by Subject|4|||
106085612|NCT05044234|365972810|FG002|Overall Study|Withdrawal by Subject|5|||
106085613|NCT05044234|365972811|FG003|Overall Study|Withdrawal by Subject|8|||
106085614|NCT05044234|365972808|FG000|Overall Study|Study terminated by Sponsor|21|||
106085615|NCT05044234|365972809|FG001|Overall Study|Study terminated by Sponsor|21|||
106085616|NCT05044234|365972810|FG002|Overall Study|Study terminated by Sponsor|20|||
106085617|NCT05044234|365972811|FG003|Overall Study|Study terminated by Sponsor|14|||
106085618|NCT05044234|365972808|FG000|Overall Study|Other, not specified|0|||
106085619|NCT05044234|365972809|FG001|Overall Study|Other, not specified|0|||
106085620|NCT05044234|365972810|FG002|Overall Study|Other, not specified|1|||
106085621|NCT05044234|365972811|FG003|Overall Study|Other, not specified|2|||
106085622|NCT05044234|365972808|FG000|Overall Study|Delayed data entry|0|||
106085623|NCT05044234|365972809|FG001|Overall Study|Delayed data entry|0|||
106085624|NCT05044234|365972810|FG002|Overall Study|Delayed data entry|0|||
106085625|NCT05044234|365972811|FG003|Overall Study|Delayed data entry|1|||
106085626|NCT02896127|365972812|FG000|COMPLETED WEEK 52|Adverse Event|9|||
106085627|NCT02896127|365972813|FG001|COMPLETED WEEK 52|Adverse Event|2|||
106085628|NCT02896127|365972812|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
106085629|NCT02896127|365972813|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
106085630|NCT02896127|365972812|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
106085631|NCT02896127|365972813|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
106085632|NCT02896127|365972812|FG000|COMPLETED WEEK 52|Physician Decision|1|||
106085633|NCT02896127|365972813|FG001|COMPLETED WEEK 52|Physician Decision|1|||
106085634|NCT02896127|365972812|FG000|COMPLETED WEEK 52|Pregnancy|2|||
106085635|NCT02896127|365972813|FG001|COMPLETED WEEK 52|Pregnancy|0|||
106085636|NCT02896127|365972812|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
106085637|NCT02896127|365972813|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
106085638|NCT02896127|365972812|FG000|COMPLETED WEEK 52|Technical problems|1|||
106085639|NCT02896127|365972813|FG001|COMPLETED WEEK 52|Technical problems|0|||
106085640|NCT02896127|365972812|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
106085641|NCT02896127|365972813|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
106085642|NCT02896127|365972812|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
106085643|NCT02896127|365972813|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
106085644|NCT02896127|365972812|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
106085645|NCT02896127|365972813|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
106085646|NCT02896127|365972812|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
106085647|NCT02896127|365972813|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
106085648|NCT02896127|365972812|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
106085649|NCT02896127|365972813|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
106085650|NCT03354429|365972814|FG000|Overall Study|Withdrawal by Subject|8|||
106085651|NCT03354429|365972815|FG001|Overall Study|Withdrawal by Subject|7|||
106085652|NCT03354429|365972814|FG000|Overall Study|Lost to Follow-up|1|||
106085653|NCT03354429|365972815|FG001|Overall Study|Lost to Follow-up|0|||
106085654|NCT02932891|365972816|FG000|Overall Study|Lost to Follow-up|2|||
106085655|NCT02932891|365972816|FG000|Overall Study|HPA Suppress|2|||
106085656|NCT02652624|365972817|FG000|Randomized Phase|Pregnancy|3|||
106085657|NCT02652624|365972818|FG001|Randomized Phase|Pregnancy|1|||
106085658|NCT02652624|365972817|FG000|Randomized Phase|Investigator's Discretion|0|||
106085659|NCT02652624|365972818|FG001|Randomized Phase|Investigator's Discretion|2|||
106085660|NCT02652624|365972817|FG000|Randomized Phase|Death|0|||
106085661|NCT02652624|365972818|FG001|Randomized Phase|Death|1|||
106085662|NCT02652624|365972817|FG000|Randomized Phase|Lost to Follow-up|0|||
106085663|NCT02652624|365972818|FG001|Randomized Phase|Lost to Follow-up|1|||
106085664|NCT02652624|365972817|FG000|Extension Phase|Lost to Follow-up|3|||
106085665|NCT02652624|365972818|FG001|Extension Phase|Lost to Follow-up|1|||
106085666|NCT02652624|365972817|FG000|Extension Phase|Pregnancy|1|||
106085667|NCT02652624|365972818|FG001|Extension Phase|Pregnancy|1|||
106085668|NCT02652624|365972817|FG000|Extension Phase|Adverse Event|0|||
106085669|NCT02652624|365972818|FG001|Extension Phase|Adverse Event|1|||
106085670|NCT02652624|365972817|FG000|Extension Phase|Withdrew Consent|0|||
106085671|NCT02652624|365972818|FG001|Extension Phase|Withdrew Consent|1|||
106085672|NCT03228680|365972820|FG000|Overall Study|Adverse Event|13|||
106085673|NCT03228680|365972821|FG001|Overall Study|Adverse Event|18|||
106085674|NCT03228680|365972820|FG000|Overall Study|Randomization failure|0|||
106085675|NCT03228680|365972821|FG001|Overall Study|Randomization failure|1|||
106085676|NCT03228680|365972820|FG000|Overall Study|Withdrawal by Subject|1|||
106085677|NCT03228680|365972821|FG001|Overall Study|Withdrawal by Subject|0|||
106085678|NCT03228680|365972820|FG000|Overall Study|Other|9|||
106085679|NCT03228680|365972821|FG001|Overall Study|Other|16|||
106085680|NCT02331446|365972822|FG000|Overall Study|Lost to Follow-up|2|||
106085681|NCT02331446|365972823|FG001|Overall Study|Lost to Follow-up|1|||
106085682|NCT02331446|365972824|FG002|Overall Study|Lost to Follow-up|0|||
106085683|NCT02331446|365972825|FG003|Overall Study|Lost to Follow-up|1|||
106085684|NCT02331446|365972822|FG000|Overall Study|Personal Problem|2|||
106085685|NCT02331446|365972823|FG001|Overall Study|Personal Problem|0|||
106085686|NCT02331446|365972824|FG002|Overall Study|Personal Problem|0|||
106085687|NCT02331446|365972825|FG003|Overall Study|Personal Problem|0|||
106085688|NCT02331446|365972822|FG000|Overall Study|Disease|0|||
106085689|NCT02331446|365972823|FG001|Overall Study|Disease|2|||
106085690|NCT02331446|365972824|FG002|Overall Study|Disease|2|||
106085691|NCT02331446|365972825|FG003|Overall Study|Disease|1|||
106085692|NCT02331446|365972822|FG000|Overall Study|Physician Decision|0|||
106085693|NCT02331446|365972823|FG001|Overall Study|Physician Decision|1|||
106085694|NCT02331446|365972824|FG002|Overall Study|Physician Decision|0|||
106085695|NCT02331446|365972825|FG003|Overall Study|Physician Decision|1|||
106085696|NCT02331446|365972822|FG000|Overall Study|Lost before baseline analysis|0|||
106085697|NCT02331446|365972823|FG001|Overall Study|Lost before baseline analysis|1|||
106085698|NCT02331446|365972824|FG002|Overall Study|Lost before baseline analysis|1|||
106085699|NCT02331446|365972825|FG003|Overall Study|Lost before baseline analysis|0|||
106085700|NCT02566759|365972827|FG000|All Parts|Withdrawal by Subject|0|||
106085701|NCT02566759|365972828|FG001|All Parts|Withdrawal by Subject|1|||
106085702|NCT02566759|365972829|FG002|All Parts|Withdrawal by Subject|0|||
106085703|NCT02566759|365972830|FG003|All Parts|Withdrawal by Subject|0|||
106085704|NCT02566759|365972831|FG004|All Parts|Withdrawal by Subject|0|||
106085705|NCT02566759|365972832|FG005|All Parts|Withdrawal by Subject|0|||
106085706|NCT02566759|365972833|FG006|All Parts|Withdrawal by Subject|0|||
106085707|NCT02566759|365972834|FG007|All Parts|Withdrawal by Subject|0|||
106085708|NCT02566759|365972835|FG008|All Parts|Withdrawal by Subject|0|||
106085709|NCT02566759|365972836|FG009|All Parts|Withdrawal by Subject|0|||
106085710|NCT02566759|365972837|FG010|All Parts|Withdrawal by Subject|0|||
106085711|NCT02566759|365972838|FG011|All Parts|Withdrawal by Subject|0|||
106085712|NCT02566759|365972839|FG012|All Parts|Withdrawal by Subject|0|||
106085713|NCT02566759|365972840|FG013|All Parts|Withdrawal by Subject|0|||
106085714|NCT02566759|365972841|FG014|All Parts|Withdrawal by Subject|0|||
106085715|NCT02566759|365972842|FG015|All Parts|Withdrawal by Subject|0|||
106085716|NCT02566759|365972843|FG016|All Parts|Withdrawal by Subject|0|||
106085717|NCT02566759|365972827|FG000|All Parts|Adverse Event|0|||
106085718|NCT02566759|365972828|FG001|All Parts|Adverse Event|0|||
106085719|NCT02566759|365972829|FG002|All Parts|Adverse Event|0|||
106085720|NCT02566759|365972830|FG003|All Parts|Adverse Event|0|||
106085721|NCT02566759|365972831|FG004|All Parts|Adverse Event|0|||
106085722|NCT02566759|365972832|FG005|All Parts|Adverse Event|0|||
106085723|NCT02566759|365972833|FG006|All Parts|Adverse Event|0|||
106085724|NCT02566759|365972834|FG007|All Parts|Adverse Event|0|||
106085725|NCT02566759|365972835|FG008|All Parts|Adverse Event|0|||
106085726|NCT02566759|365972836|FG009|All Parts|Adverse Event|0|||
106085727|NCT02566759|365972837|FG010|All Parts|Adverse Event|0|||
106085728|NCT02566759|365972838|FG011|All Parts|Adverse Event|0|||
106085729|NCT02566759|365972839|FG012|All Parts|Adverse Event|1|||
106085730|NCT02566759|365972840|FG013|All Parts|Adverse Event|3|||
106085731|NCT02566759|365972841|FG014|All Parts|Adverse Event|0|||
106085732|NCT02566759|365972842|FG015|All Parts|Adverse Event|0|||
106085733|NCT02566759|365972843|FG016|All Parts|Adverse Event|0|||
106085734|NCT02566759|365972827|FG000|All Parts|Other|0|||
106085735|NCT02566759|365972828|FG001|All Parts|Other|0|||
106085736|NCT02566759|365972829|FG002|All Parts|Other|0|||
106085737|NCT02566759|365972830|FG003|All Parts|Other|0|||
106085738|NCT02566759|365972831|FG004|All Parts|Other|0|||
106085739|NCT02566759|365972832|FG005|All Parts|Other|0|||
106085740|NCT02566759|365972833|FG006|All Parts|Other|0|||
106085741|NCT02566759|365972834|FG007|All Parts|Other|0|||
106085742|NCT02566759|365972835|FG008|All Parts|Other|0|||
106085743|NCT02566759|365972836|FG009|All Parts|Other|0|||
106085744|NCT02566759|365972837|FG010|All Parts|Other|0|||
106085745|NCT02566759|365972838|FG011|All Parts|Other|0|||
106085746|NCT02566759|365972839|FG012|All Parts|Other|0|||
106085747|NCT02566759|365972840|FG013|All Parts|Other|2|||
106085748|NCT02566759|365972841|FG014|All Parts|Other|0|||
106085749|NCT02566759|365972842|FG015|All Parts|Other|0|||
106085750|NCT02566759|365972843|FG016|All Parts|Other|0|||
106085751|NCT02566759|365972827|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085752|NCT02566759|365972828|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085753|NCT02566759|365972829|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085754|NCT02566759|365972830|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085755|NCT02566759|365972831|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085756|NCT02566759|365972832|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085757|NCT02566759|365972833|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085758|NCT02566759|365972834|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085759|NCT02566759|365972835|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085760|NCT02566759|365972836|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085761|NCT02566759|365972837|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085762|NCT02566759|365972838|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085763|NCT02566759|365972839|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085764|NCT02566759|365972840|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085765|NCT02566759|365972841|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085766|NCT02566759|365972842|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
106085767|NCT02566759|365972843|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
106085768|NCT03160703|365972844|FG000|Overall Study|Withdrawal by Subject|0|||
106085769|NCT03160703|365972845|FG001|Overall Study|Withdrawal by Subject|0|||
106085770|NCT03160703|365972846|FG002|Overall Study|Withdrawal by Subject|0|||
106085771|NCT03160703|365972847|FG003|Overall Study|Withdrawal by Subject|1|||
106085772|NCT03732638|365972848|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
106085773|NCT03732638|365972849|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
106085774|NCT03732638|365972848|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
106085775|NCT03732638|365972849|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
106085776|NCT03732638|365972848|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
106085777|NCT03732638|365972849|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
106085778|NCT03732638|365972848|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
106085779|NCT03732638|365972849|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
106085780|NCT03732638|365972848|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
106085781|NCT03732638|365972849|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
106085782|NCT03732638|365972848|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
106085783|NCT03732638|365972849|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
106085784|NCT03732638|365972848|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
106085785|NCT03732638|365972849|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
106085786|NCT03732638|365972848|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
106085787|NCT03732638|365972849|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
106085788|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
106085789|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
106085790|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
106085791|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
106085792|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
106085793|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
106085794|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
106085795|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
106085796|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
106085797|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
106085798|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
106085799|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
106085800|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
106085801|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
106085802|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
106085803|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
106085804|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
106085805|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
106085806|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
106085807|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
106085808|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
106085809|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
106085810|NCT03732638|365972848|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
106085811|NCT03732638|365972849|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
106085812|NCT03732638|365972848|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
106085813|NCT03732638|365972849|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
106085814|NCT03732638|365972848|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
106085815|NCT03732638|365972849|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
106085816|NCT03732638|365972848|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
106085817|NCT03732638|365972849|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
106085818|NCT03732638|365972848|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
106085819|NCT03732638|365972849|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
106085820|NCT01263873|365972850|FG000|Overall Study|One provider unable to complete numbers|1|||
106085821|NCT01263873|365972851|FG001|Overall Study|One provider unable to complete numbers|1|||
106085822|NCT04713748|365972852|FG000|Overall Study|Not enough kits allocated|35|||
106085823|NCT00047463|365972853|FG000|Overall Study|Withdrawal by Subject|0|||
106085824|NCT00047463|365972854|FG001|Overall Study|Withdrawal by Subject|3|||
106085825|NCT00113516|365972855|FG000|Part 1|Adverse Event|6|||
106085826|NCT00113516|365972856|FG001|Part 1|Adverse Event|0|||
106085827|NCT00113516|365972855|FG000|Part 1|Death|3|||
106085828|NCT00113516|365972856|FG001|Part 1|Death|0|||
106085829|NCT00113516|365972855|FG000|Part 1|Other|3|||
106085830|NCT00113516|365972856|FG001|Part 1|Other|0|||
106085831|NCT00113516|365972855|FG000|Part 1|Withdrawal by Subject|2|||
106085832|NCT00113516|365972856|FG001|Part 1|Withdrawal by Subject|0|||
106085833|NCT00113516|365972855|FG000|Part 1|Lack of Efficacy|2|||
106085834|NCT00113516|365972856|FG001|Part 1|Lack of Efficacy|0|||
106085835|NCT00113516|365972855|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
106085836|NCT00113516|365972856|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
106085837|NCT00113516|365972855|FG000|Part 1|Laboratory Abnormality|1|||
106085838|NCT00113516|365972856|FG001|Part 1|Laboratory Abnormality|0|||
106085839|NCT00113516|365972855|FG000|Part 1|Ongoing|1|||
106085840|NCT00113516|365972856|FG001|Part 1|Ongoing|0|||
106085841|NCT00113516|365972855|FG000|Part 1|Missing|65|||
106085842|NCT00113516|365972856|FG001|Part 1|Missing|0|||
106085843|NCT00113516|365972855|FG000|Part 2|Adverse Event|0|||
106085844|NCT00113516|365972856|FG001|Part 2|Adverse Event|16|||
106085845|NCT00113516|365972855|FG000|Part 2|Death|0|||
106085846|NCT00113516|365972856|FG001|Part 2|Death|5|||
106085847|NCT00113516|365972855|FG000|Part 2|Lack of Efficacy|0|||
106085848|NCT00113516|365972856|FG001|Part 2|Lack of Efficacy|37|||
106085849|NCT00113516|365972855|FG000|Part 2|Withdrawal by Subject|0|||
106085850|NCT00113516|365972856|FG001|Part 2|Withdrawal by Subject|3|||
106085851|NCT00113516|365972855|FG000|Part 2|Other|0|||
106085852|NCT00113516|365972856|FG001|Part 2|Other|3|||
106085853|NCT00113516|365972855|FG000|Part 2|Laboratory Abnormality|0|||
106085854|NCT00113516|365972856|FG001|Part 2|Laboratory Abnormality|1|||
106085855|NCT00113516|365972855|FG000|Part 2|Ongoing|0|||
106085856|NCT00113516|365972856|FG001|Part 2|Ongoing|1|||
106085857|NCT01412424|365972857|FG000|Core Treatment Period|Treatment Failure|24|||
106085858|NCT01412424|365972857|FG000|Core Treatment Period|Adverse Event|21|||
106085859|NCT01412424|365972857|FG000|Core Treatment Period|Patient Request|5|||
106085860|NCT01412424|365972857|FG000|Core Treatment Period|Lost to Follow-up|2|||
106085861|NCT01412424|365972857|FG000|Core Treatment Period|Sponsor Request|1|||
106085862|NCT01412424|365972857|FG000|Extension Treatment Period|Adverse Event|2|||
106085863|NCT01412424|365972857|FG000|Extension Treatment Period|Treatment Failure|2|||
106085864|NCT01412424|365972857|FG000|Extension Treatment Period|Patient Request|2|||
106085865|NCT02863354|365972864|FG000|Year 1|Lost to Follow-up|1|||
106085866|NCT02863354|365972865|FG001|Year 1|Lost to Follow-up|1|||
106085867|NCT02863354|365972864|FG000|Year 1|Withdrawal by Subject|3|||
106085868|NCT02863354|365972865|FG001|Year 1|Withdrawal by Subject|0|||
106085869|NCT02863354|365972864|FG000|Year 1|Death|0|||
106085870|NCT02863354|365972865|FG001|Year 1|Death|1|||
106085871|NCT02863354|365972864|FG000|Year 2|Lost to Follow-up|2|||
106085872|NCT02863354|365972865|FG001|Year 2|Lost to Follow-up|2|||
106085873|NCT05218499|365972871|FG000|Overall Study|Not treated|1|||
106085874|NCT05218499|365972872|FG001|Overall Study|Not treated|1|||
106085875|NCT05218499|365972873|FG002|Overall Study|Not treated|8|||
106085876|NCT05218499|365972871|FG000|Overall Study|Death|2|||
106085877|NCT05218499|365972872|FG001|Overall Study|Death|0|||
106085878|NCT05218499|365972873|FG002|Overall Study|Death|0|||
106085879|NCT05218499|365972871|FG000|Overall Study|Other than listed|3|||
106085880|NCT05218499|365972872|FG001|Overall Study|Other than listed|7|||
106085881|NCT05218499|365972873|FG002|Overall Study|Other than listed|10|||
106085882|NCT05218499|365972871|FG000|Overall Study|Protocol deviation|5|||
106085883|NCT05218499|365972872|FG001|Overall Study|Protocol deviation|6|||
106085884|NCT05218499|365972873|FG002|Overall Study|Protocol deviation|4|||
106160943|NCT03945292|366250495|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
106160944|NCT03945292|366250496|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
106085885|NCT05218499|365972871|FG000|Overall Study|Technical problems|0|||
106085886|NCT05218499|365972872|FG001|Overall Study|Technical problems|1|||
106085887|NCT05218499|365972873|FG002|Overall Study|Technical problems|0|||
106085888|NCT05218499|365972871|FG000|Overall Study|Burden of trial procedures|0|||
106085889|NCT05218499|365972872|FG001|Overall Study|Burden of trial procedures|1|||
106085890|NCT05218499|365972873|FG002|Overall Study|Burden of trial procedures|2|||
106085891|NCT05218499|365972871|FG000|Overall Study|Clinical disease progression|6|||
106085892|NCT05218499|365972872|FG001|Overall Study|Clinical disease progression|6|||
106085893|NCT05218499|365972873|FG002|Overall Study|Clinical disease progression|11|||
106085894|NCT05218499|365972871|FG000|Overall Study|Objective disease progression|44|||
106085895|NCT05218499|365972872|FG001|Overall Study|Objective disease progression|61|||
106085896|NCT05218499|365972873|FG002|Overall Study|Objective disease progression|42|||
106085897|NCT05218499|365972871|FG000|Overall Study|Adverse Event|11|||
106085898|NCT05218499|365972872|FG001|Overall Study|Adverse Event|36|||
106085899|NCT05218499|365972873|FG002|Overall Study|Adverse Event|9|||
106085900|NCT05218499|365972871|FG000|Overall Study|On treatment at time of snapshot|18|||
106085901|NCT05218499|365972872|FG001|Overall Study|On treatment at time of snapshot|29|||
106085902|NCT05218499|365972873|FG002|Overall Study|On treatment at time of snapshot|0|||
106085903|NCT03258593|365972874|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
106085904|NCT03258593|365972875|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
106085905|NCT03258593|365972876|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
106085906|NCT03258593|365972877|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
106085907|NCT03258593|365972874|FG000|Run-In Maintenance Phase|Disease progression|3|||
106085908|NCT03258593|365972875|FG001|Run-In Maintenance Phase|Disease progression|0|||
106085909|NCT03258593|365972876|FG002|Run-In Maintenance Phase|Disease progression|0|||
106085910|NCT03258593|365972877|FG003|Run-In Maintenance Phase|Disease progression|0|||
106085911|NCT03258593|365972874|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
106085912|NCT03258593|365972875|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
106085913|NCT03258593|365972876|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
106085914|NCT03258593|365972877|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
106085915|NCT03258593|365972874|FG000|Expansion Maintenance Phase|Physician Decision|0|||
106085916|NCT03258593|365972875|FG001|Expansion Maintenance Phase|Physician Decision|1|||
106085917|NCT03258593|365972876|FG002|Expansion Maintenance Phase|Physician Decision|0|||
106085918|NCT03258593|365972877|FG003|Expansion Maintenance Phase|Physician Decision|0|||
106085919|NCT06640829|365972878|FG000|Overall Study|Withdrawal by Subject|1|||
106085920|NCT06640829|365972878|FG000|Overall Study|Lost to Follow-up|1|||
106085921|NCT04694131|365972886|FG000|Overall Study|Withdrawal by Subject|7|||
106085922|NCT04694131|365972886|FG000|Overall Study|Screen Failure|1|||
106085923|NCT04694131|365972886|FG000|Overall Study|High stimulation threshold|3|||
106085924|NCT04112810|365972887|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
106085925|NCT02075437|365972890|FG000|Overall Study|Withdrawal by Subject|5|||
106085926|NCT02075437|365972890|FG000|Overall Study|Lost to Follow-up|1|||
106085927|NCT00705575|365972891|FG000|Overall Study|Abnormal laboratory value(s)|0|||
106085928|NCT00705575|365972892|FG001|Overall Study|Abnormal laboratory value(s)|3|||
106085929|NCT00705575|365972891|FG000|Overall Study|Abnormal test procedure result(s)|2|||
106085930|NCT00705575|365972892|FG001|Overall Study|Abnormal test procedure result(s)|12|||
106085931|NCT00705575|365972891|FG000|Overall Study|Adverse Event|11|||
106085932|NCT00705575|365972892|FG001|Overall Study|Adverse Event|15|||
106085933|NCT00705575|365972891|FG000|Overall Study|Lost to Follow-up|3|||
106085934|NCT00705575|365972892|FG001|Overall Study|Lost to Follow-up|4|||
106085935|NCT00705575|365972891|FG000|Overall Study|Protocol Violation|2|||
106085936|NCT00705575|365972892|FG001|Overall Study|Protocol Violation|2|||
106085937|NCT00705575|365972891|FG000|Overall Study|Withdrawal by Subject|5|||
106085938|NCT00705575|365972892|FG001|Overall Study|Withdrawal by Subject|10|||
106085939|NCT01000051|365972893|FG000|Overall Study|Withdrawal by Subject|1|||
106085940|NCT01000051|365972894|FG001|Overall Study|Withdrawal by Subject|1|||
106085941|NCT01000051|365972893|FG000|Overall Study|Disease Progression|1|||
106085942|NCT01000051|365972894|FG001|Overall Study|Disease Progression|0|||
106085943|NCT01000051|365972893|FG000|Overall Study|Serious noncompliance|1|||
106085944|NCT01000051|365972894|FG001|Overall Study|Serious noncompliance|0|||
106085945|NCT03323099|365972895|FG000|Overall Study|Withdrawal by Subject|6|||
106085946|NCT03323099|365972896|FG001|Overall Study|Withdrawal by Subject|12|||
106085947|NCT03323099|365972895|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
106085948|NCT03323099|365972896|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
106085949|NCT03495908|365972897|FG000|Overall Study|Withdrawal by Subject|3|||
106085950|NCT03495908|365972898|FG001|Overall Study|Withdrawal by Subject|1|||
106085951|NCT03495908|365972897|FG000|Overall Study|Lost to Follow-up|1|||
106085952|NCT03495908|365972898|FG001|Overall Study|Lost to Follow-up|4|||
106085953|NCT03495908|365972897|FG000|Overall Study|Adverse Event|0|||
106085954|NCT03495908|365972898|FG001|Overall Study|Adverse Event|2|||
106085955|NCT03495908|365972897|FG000|Overall Study|Death|1|||
106085956|NCT03495908|365972898|FG001|Overall Study|Death|0|||
106085957|NCT03495908|365972897|FG000|Overall Study|Physician Decision|5|||
106085958|NCT03495908|365972898|FG001|Overall Study|Physician Decision|4|||
106085959|NCT03495908|365972897|FG000|Overall Study|No documented reason|0|||
106085960|NCT03495908|365972898|FG001|Overall Study|No documented reason|2|||
106085961|NCT00617240|365972899|FG000|Overall Study|Lack of Efficacy|1|||
106085962|NCT00617240|365972900|FG001|Overall Study|Lack of Efficacy|0|||
106085963|NCT04936685|365972901|FG000|Overall Study|Protocol Violation|1|||
106085964|NCT04936685|365972902|FG001|Overall Study|Protocol Violation|0|||
106085965|NCT00670228|365972903|FG000|Overall Study|Adverse Event|1|||
106085966|NCT00670228|365972904|FG001|Overall Study|Adverse Event|0|||
106085967|NCT00670228|365972903|FG000|Overall Study|Death or MACE|0|||
106085968|NCT00670228|365972904|FG001|Overall Study|Death or MACE|1|||
106085969|NCT00670228|365972903|FG000|Overall Study|Not treated|2|||
106085970|NCT00670228|365972904|FG001|Overall Study|Not treated|2|||
106085971|NCT00670228|365972903|FG000|Overall Study|Not meeting the selection criteria|2|||
106085972|NCT00670228|365972904|FG001|Overall Study|Not meeting the selection criteria|0|||
106085973|NCT05013905|365972914|FG000|Overall Study|Adverse Event|1|||
106085974|NCT05013905|365972914|FG000|Overall Study|Lack of Efficacy|1|||
106085975|NCT02047604|365972920|FG000|Overall Study|Withdrawal by Subject|0|||
106085976|NCT02047604|365972921|FG001|Overall Study|Withdrawal by Subject|0|||
106085977|NCT02047604|365972922|FG002|Overall Study|Withdrawal by Subject|0|||
106085978|NCT02047604|365972923|FG003|Overall Study|Withdrawal by Subject|0|||
106085979|NCT02047604|365972924|FG004|Overall Study|Withdrawal by Subject|1|||
106085980|NCT02047604|365972925|FG005|Overall Study|Withdrawal by Subject|1|||
106085981|NCT02553421|365972926|FG000|Overall Study|Lost to Follow-up|21|||
106085982|NCT02553421|365972927|FG001|Overall Study|Lost to Follow-up|1|||
106085983|NCT02553421|365972926|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
106085984|NCT02553421|365972927|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
106085985|NCT02553421|365972926|FG000|Overall Study|Improper Device Placement|3|||
106085986|NCT02553421|365972927|FG001|Overall Study|Improper Device Placement|0|||
106085987|NCT04197713|365972928|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
106085988|NCT04197713|365972929|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
106085989|NCT01755416|365972930|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
106085990|NCT01755416|365972931|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
106085991|NCT01065454|365972932|FG000|Treatment|Adverse Event|7|||
106085992|NCT01065454|365972933|FG001|Treatment|Adverse Event|4|||
106085993|NCT01065454|365972934|FG002|Treatment|Adverse Event|3|||
106085994|NCT01065454|365972935|FG003|Treatment|Adverse Event|6|||
106085995|NCT01065454|365972932|FG000|Treatment|Death|1|||
106085996|NCT01065454|365972933|FG001|Treatment|Death|0|||
106085997|NCT01065454|365972934|FG002|Treatment|Death|0|||
106085998|NCT01065454|365972935|FG003|Treatment|Death|0|||
106085999|NCT01065454|365972932|FG000|Treatment|Non-compliance|1|||
106086000|NCT01065454|365972933|FG001|Treatment|Non-compliance|0|||
106086001|NCT01065454|365972934|FG002|Treatment|Non-compliance|0|||
106086002|NCT01065454|365972935|FG003|Treatment|Non-compliance|1|||
106086003|NCT01065454|365972932|FG000|Treatment|Protocol Decision|0|||
106086004|NCT01065454|365972933|FG001|Treatment|Protocol Decision|0|||
106086005|NCT01065454|365972934|FG002|Treatment|Protocol Decision|3|||
106086006|NCT01065454|365972935|FG003|Treatment|Protocol Decision|2|||
106086007|NCT01065454|365972932|FG000|Treatment|Protocol Violation|1|||
106086008|NCT01065454|365972933|FG001|Treatment|Protocol Violation|0|||
106086009|NCT01065454|365972934|FG002|Treatment|Protocol Violation|1|||
106086010|NCT01065454|365972935|FG003|Treatment|Protocol Violation|0|||
106086011|NCT01065454|365972932|FG000|Treatment|Withdrawal by Subject|3|||
106086012|NCT01065454|365972933|FG001|Treatment|Withdrawal by Subject|1|||
106086013|NCT01065454|365972934|FG002|Treatment|Withdrawal by Subject|2|||
106086014|NCT01065454|365972935|FG003|Treatment|Withdrawal by Subject|3|||
106086015|NCT01065454|365972932|FG000|Follow up|Adverse Event|1|||
106086016|NCT01065454|365972933|FG001|Follow up|Adverse Event|0|||
106086017|NCT01065454|365972934|FG002|Follow up|Adverse Event|0|||
106086018|NCT01065454|365972935|FG003|Follow up|Adverse Event|1|||
106086019|NCT01065454|365972932|FG000|Follow up|Death|0|||
106086020|NCT01065454|365972933|FG001|Follow up|Death|1|||
106086021|NCT01065454|365972934|FG002|Follow up|Death|1|||
106086022|NCT01065454|365972935|FG003|Follow up|Death|0|||
106086023|NCT01065454|365972932|FG000|Follow up|Lost to Follow-up|0|||
106086024|NCT01065454|365972933|FG001|Follow up|Lost to Follow-up|0|||
106086025|NCT01065454|365972934|FG002|Follow up|Lost to Follow-up|0|||
106086026|NCT01065454|365972935|FG003|Follow up|Lost to Follow-up|1|||
106086027|NCT01065454|365972932|FG000|Follow up|Progressive disease|0|||
106086028|NCT01065454|365972933|FG001|Follow up|Progressive disease|0|||
106086029|NCT01065454|365972934|FG002|Follow up|Progressive disease|0|||
106086030|NCT01065454|365972935|FG003|Follow up|Progressive disease|1|||
106086031|NCT01065454|365972932|FG000|Follow up|Withdrawal by Subject|1|||
106086032|NCT01065454|365972933|FG001|Follow up|Withdrawal by Subject|1|||
106086033|NCT01065454|365972934|FG002|Follow up|Withdrawal by Subject|1|||
106086034|NCT01065454|365972935|FG003|Follow up|Withdrawal by Subject|0|||
106086035|NCT01065454|365972932|FG000|Follow up|study ongoing|37|||
106086036|NCT01065454|365972933|FG001|Follow up|study ongoing|22|||
106086037|NCT01065454|365972934|FG002|Follow up|study ongoing|15|||
106086038|NCT01065454|365972935|FG003|Follow up|study ongoing|41|||
106086039|NCT03042312|365975253|FG000|Overall Study|Administrative Reason|1|||
106086040|NCT03042312|365975254|FG001|Overall Study|Administrative Reason|1|||
106086041|NCT03042312|365975253|FG000|Overall Study|Adverse Event|0|||
106086042|NCT03042312|365975254|FG001|Overall Study|Adverse Event|1|||
106086043|NCT03042312|365975253|FG000|Overall Study|Lost to Follow-up|1|||
106086044|NCT03042312|365975254|FG001|Overall Study|Lost to Follow-up|3|||
106086045|NCT03042312|365975253|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
106086046|NCT03042312|365975254|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
106086047|NCT03042312|365975253|FG000|Overall Study|Withdrawal by Subject|4|||
106086048|NCT03042312|365975254|FG001|Overall Study|Withdrawal by Subject|5|||
106086049|NCT02349711|365975255|FG000|Overall Study|Withdrawal by Subject|2|||
106086050|NCT02349711|365975256|FG001|Overall Study|Withdrawal by Subject|1|||
106086051|NCT02349711|365975255|FG000|Overall Study|Lost to Follow-up|1|||
106086052|NCT02349711|365975256|FG001|Overall Study|Lost to Follow-up|1|||
106086053|NCT00194012|365975257|FG000|Randomized Phase|Lack of Efficacy|8|||
106086054|NCT00194012|365975258|FG001|Randomized Phase|Lack of Efficacy|18|||
106086055|NCT00194012|365975257|FG000|Randomized Phase|Study nonadherence|2|||
106086056|NCT00194012|365975258|FG001|Randomized Phase|Study nonadherence|1|||
106086057|NCT00194012|365975257|FG000|Randomized Phase|Withdrawal by Subject|3|||
106086058|NCT00194012|365975258|FG001|Randomized Phase|Withdrawal by Subject|3|||
106086059|NCT00194012|365975257|FG000|Randomized Phase|Adverse Event|2|||
106086060|NCT00194012|365975258|FG001|Randomized Phase|Adverse Event|1|||
106086061|NCT00194012|365975257|FG000|Randomized Phase|Participant reported having a rash|1|||
106086062|NCT00194012|365975258|FG001|Randomized Phase|Participant reported having a rash|0|||
106086063|NCT00194012|365975257|FG000|Randomized Phase|Emesis and enuresis|0|||
106086064|NCT00194012|365975258|FG001|Randomized Phase|Emesis and enuresis|1|||
106086065|NCT00194012|365975257|FG000|Randomized Phase|Oral/nasal twitching|0|||
106086066|NCT00194012|365975258|FG001|Randomized Phase|Oral/nasal twitching|1|||
106086067|NCT00194012|365975257|FG000|Open Label Extension (OLE)|Weight Gain|1|||
106086068|NCT00194012|365975258|FG001|Open Label Extension (OLE)|Weight Gain|0|||
106086069|NCT00194012|365975257|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
106086070|NCT00194012|365975258|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
106086071|NCT00194012|365975257|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
106086072|NCT00194012|365975258|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
106086073|NCT00194012|365975257|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
106086074|NCT00194012|365975258|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
106086075|NCT01105533|365975264|FG000|Overall Study|Death|0|||
106086076|NCT01105533|365975265|FG001|Overall Study|Death|0|||
106086077|NCT01105533|365975266|FG002|Overall Study|Death|0|||
106086078|NCT01105533|365975267|FG003|Overall Study|Death|0|||
106086079|NCT01105533|365975268|FG004|Overall Study|Death|1|||
106086080|NCT01105533|365975269|FG005|Overall Study|Death|0|||
106086081|NCT01105533|365975270|FG006|Overall Study|Death|0|||
106086082|NCT01105533|365975271|FG007|Overall Study|Death|0|||
106086083|NCT01105533|365975272|FG008|Overall Study|Death|0|||
106086084|NCT01105533|365975264|FG000|Overall Study|Lack of Efficacy|1|||
106086085|NCT01105533|365975265|FG001|Overall Study|Lack of Efficacy|1|||
106086086|NCT01105533|365975266|FG002|Overall Study|Lack of Efficacy|3|||
106086087|NCT01105533|365975267|FG003|Overall Study|Lack of Efficacy|3|||
106086088|NCT01105533|365975268|FG004|Overall Study|Lack of Efficacy|4|||
106086089|NCT01105533|365975269|FG005|Overall Study|Lack of Efficacy|5|||
106086090|NCT01105533|365975270|FG006|Overall Study|Lack of Efficacy|3|||
106086091|NCT01105533|365975271|FG007|Overall Study|Lack of Efficacy|2|||
106086092|NCT01105533|365975272|FG008|Overall Study|Lack of Efficacy|9|||
106086093|NCT01105533|365975264|FG000|Overall Study|Adverse Event|0|||
106086094|NCT01105533|365975265|FG001|Overall Study|Adverse Event|0|||
106086095|NCT01105533|365975266|FG002|Overall Study|Adverse Event|0|||
106086096|NCT01105533|365975267|FG003|Overall Study|Adverse Event|0|||
106086097|NCT01105533|365975268|FG004|Overall Study|Adverse Event|1|||
106086098|NCT01105533|365975269|FG005|Overall Study|Adverse Event|2|||
106086099|NCT01105533|365975270|FG006|Overall Study|Adverse Event|2|||
106086100|NCT01105533|365975271|FG007|Overall Study|Adverse Event|0|||
106086101|NCT01105533|365975272|FG008|Overall Study|Adverse Event|1|||
106086102|NCT01105533|365975264|FG000|Overall Study|Other|0|||
106086103|NCT01105533|365975265|FG001|Overall Study|Other|0|||
106086104|NCT01105533|365975266|FG002|Overall Study|Other|0|||
106086105|NCT01105533|365975267|FG003|Overall Study|Other|0|||
106086106|NCT01105533|365975268|FG004|Overall Study|Other|1|||
106086107|NCT01105533|365975269|FG005|Overall Study|Other|0|||
106086108|NCT01105533|365975270|FG006|Overall Study|Other|3|||
106086109|NCT01105533|365975271|FG007|Overall Study|Other|1|||
106086110|NCT01105533|365975272|FG008|Overall Study|Other|2|||
106086111|NCT01105533|365975264|FG000|Overall Study|Physician Decision|0|||
106086112|NCT01105533|365975265|FG001|Overall Study|Physician Decision|0|||
106086113|NCT01105533|365975266|FG002|Overall Study|Physician Decision|0|||
106086114|NCT01105533|365975267|FG003|Overall Study|Physician Decision|0|||
106086115|NCT01105533|365975268|FG004|Overall Study|Physician Decision|0|||
106086116|NCT01105533|365975269|FG005|Overall Study|Physician Decision|0|||
106086117|NCT01105533|365975270|FG006|Overall Study|Physician Decision|0|||
106086118|NCT01105533|365975271|FG007|Overall Study|Physician Decision|1|||
106086119|NCT01105533|365975272|FG008|Overall Study|Physician Decision|0|||
106086120|NCT02096835|365975273|FG000|Overall Study|Withdrawal by Subject|1|||
106086121|NCT02096835|365975274|FG001|Overall Study|Withdrawal by Subject|0|||
106086122|NCT02096835|365975275|FG002|Overall Study|Withdrawal by Subject|0|||
106086123|NCT02096835|365975273|FG000|Overall Study|converted to open procedures|1|||
106086124|NCT02096835|365975274|FG001|Overall Study|converted to open procedures|0|||
106086125|NCT02096835|365975275|FG002|Overall Study|converted to open procedures|0|||
106086126|NCT02096835|365975273|FG000|Overall Study|Lost to Follow-up|1|||
106086127|NCT02096835|365975274|FG001|Overall Study|Lost to Follow-up|0|||
106086128|NCT02096835|365975275|FG002|Overall Study|Lost to Follow-up|1|||
106086129|NCT04260191|365975276|FG000|Overall Study|Decision by Sponsor|0|||
106086130|NCT04260191|365975277|FG001|Overall Study|Decision by Sponsor|1|||
106086131|NCT04260191|365975278|FG002|Overall Study|Decision by Sponsor|0|||
106086132|NCT04260191|365975276|FG000|Overall Study|Withdrawal by Subject|1|||
106086133|NCT04260191|365975277|FG001|Overall Study|Withdrawal by Subject|0|||
106086134|NCT04260191|365975278|FG002|Overall Study|Withdrawal by Subject|3|||
106086135|NCT04260191|365975276|FG000|Overall Study|Death|4|||
106086136|NCT04260191|365975277|FG001|Overall Study|Death|3|||
106086137|NCT04260191|365975278|FG002|Overall Study|Death|2|||
106086138|NCT01677195|365975279|FG000|Overall Study|Lost to Follow-up|14|||
106086139|NCT01677195|365975280|FG001|Overall Study|Lost to Follow-up|22|||
106086140|NCT01677195|365975281|FG002|Overall Study|Lost to Follow-up|22|||
106086141|NCT01677195|365975279|FG000|Overall Study|Withdrawal by Subject|1|||
106086142|NCT01677195|365975280|FG001|Overall Study|Withdrawal by Subject|0|||
106086143|NCT01677195|365975281|FG002|Overall Study|Withdrawal by Subject|1|||
106086144|NCT01677195|365975279|FG000|Overall Study|Adverse Event|6|||
106086145|NCT01677195|365975280|FG001|Overall Study|Adverse Event|4|||
106086146|NCT01677195|365975281|FG002|Overall Study|Adverse Event|1|||
106086147|NCT01677195|365975279|FG000|Overall Study|Physician Decision|1|||
106086148|NCT01677195|365975280|FG001|Overall Study|Physician Decision|2|||
106086149|NCT01677195|365975281|FG002|Overall Study|Physician Decision|2|||
106086150|NCT01677195|365975279|FG000|Overall Study|Pregnancy|0|||
106086151|NCT01677195|365975280|FG001|Overall Study|Pregnancy|1|||
106086152|NCT01677195|365975281|FG002|Overall Study|Pregnancy|0|||
106086153|NCT01677195|365975279|FG000|Overall Study|Protocol Violation|7|||
106086154|NCT01677195|365975280|FG001|Overall Study|Protocol Violation|3|||
106086155|NCT01677195|365975281|FG002|Overall Study|Protocol Violation|4|||
106086156|NCT01643473|365975282|FG000|Overall Study|Lost to Follow-up|1|||
106086157|NCT01643473|365975283|FG001|Overall Study|Lost to Follow-up|0|||
106086158|NCT01312909|365975284|FG000|Overall Study|Randomized but not treated|1|||
106086159|NCT01312909|365975285|FG001|Overall Study|Randomized but not treated|3|||
106086160|NCT01312909|365975286|FG002|Overall Study|Randomized but not treated|1|||
106086161|NCT01312909|365975284|FG000|Overall Study|Adverse Event|1|||
106086162|NCT01312909|365975285|FG001|Overall Study|Adverse Event|0|||
106086163|NCT01312909|365975286|FG002|Overall Study|Adverse Event|3|||
106086164|NCT01312909|365975284|FG000|Overall Study|Protocol Violation|2|||
106086165|NCT01312909|365975285|FG001|Overall Study|Protocol Violation|0|||
106086166|NCT01312909|365975286|FG002|Overall Study|Protocol Violation|2|||
106086167|NCT01312909|365975284|FG000|Overall Study|Other|9|||
106086168|NCT01312909|365975285|FG001|Overall Study|Other|6|||
106086169|NCT01312909|365975286|FG002|Overall Study|Other|11|||
106086170|NCT01312909|365975284|FG000|Overall Study|Withdrawal by Subject|8|||
106086171|NCT01312909|365975285|FG001|Overall Study|Withdrawal by Subject|10|||
106086172|NCT01312909|365975286|FG002|Overall Study|Withdrawal by Subject|7|||
106086173|NCT01312909|365975284|FG000|Overall Study|Lost to Follow-up|21|||
106086174|NCT01312909|365975285|FG001|Overall Study|Lost to Follow-up|17|||
106086175|NCT01312909|365975286|FG002|Overall Study|Lost to Follow-up|20|||
106086176|NCT01312909|365975284|FG000|Overall Study|Insufficient clinical response|0|||
106086177|NCT01312909|365975285|FG001|Overall Study|Insufficient clinical response|0|||
106086178|NCT01312909|365975286|FG002|Overall Study|Insufficient clinical response|1|||
106086179|NCT01312909|365975284|FG000|Overall Study|Entrance criteria not met|0|||
106086180|NCT01312909|365975285|FG001|Overall Study|Entrance criteria not met|0|||
106086181|NCT01312909|365975286|FG002|Overall Study|Entrance criteria not met|2|||
106086182|NCT00659646|365975289|FG000|Overall Study|Protocol Violation|12|||
106086183|NCT00659646|365975290|FG001|Overall Study|Protocol Violation|8|||
106086184|NCT00659646|365975289|FG000|Overall Study|Adverse Event|1|||
106086185|NCT00659646|365975290|FG001|Overall Study|Adverse Event|0|||
106086186|NCT00659646|365975289|FG000|Overall Study|Lost to Follow-up|1|||
106086187|NCT00659646|365975290|FG001|Overall Study|Lost to Follow-up|0|||
106086188|NCT00659646|365975289|FG000|Overall Study|protocol noncompliance after randomized|1|||
106086189|NCT00659646|365975290|FG001|Overall Study|protocol noncompliance after randomized|0|||
106086190|NCT01774903|365975292|FG000|Overall Study|Adverse Event|7|||
106086191|NCT01774903|365975292|FG000|Overall Study|Withdrawal by Subject|2|||
106086192|NCT01774903|365975292|FG000|Overall Study|Lack of Efficacy|1|||
106086193|NCT01774903|365975292|FG000|Overall Study|Ineligible to continue the trial|1|||
106086194|NCT01023659|365975293|FG000|Overall Study|Lost to Follow-up|73|||
106086195|NCT01023659|365975294|FG001|Overall Study|Lost to Follow-up|228|||
106086196|NCT01023659|365975295|FG002|Overall Study|Lost to Follow-up|99|||
106086197|NCT00451282|365975296|FG000|Overall Study|Lost to Follow-up|6|||
106086198|NCT00451282|365975297|FG001|Overall Study|Lost to Follow-up|5|||
106086199|NCT04879745|365975299|FG000|Overall Study|Lost to Follow-up|4|||
106086200|NCT04879745|365975300|FG001|Overall Study|Lost to Follow-up|1|||
106086201|NCT02167035|365975301|FG000|Overall Study|Adverse Event|2|||
106086202|NCT02167035|365975302|FG001|Overall Study|Adverse Event|2|||
106086203|NCT02167035|365975301|FG000|Overall Study|Lost to Follow-up|3|||
106086204|NCT02167035|365975302|FG001|Overall Study|Lost to Follow-up|3|||
106086205|NCT02167035|365975301|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
106086206|NCT02167035|365975302|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
106086207|NCT01565993|365975303|FG000|Overall Study|Physician Decision|0|||
106086208|NCT01565993|365975304|FG001|Overall Study|Physician Decision|3|||
106086209|NCT03348904|365975305|FG000|Overall Study|Administrative reason by the sponsor|0|||
106086210|NCT03348904|365975306|FG001|Overall Study|Administrative reason by the sponsor|1|||
106086211|NCT03348904|365975307|FG002|Overall Study|Administrative reason by the sponsor|0|||
106086212|NCT04354831|365975308|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
106086213|NCT04354831|365975309|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
106086214|NCT00211081|365975312|FG000|Overall Study|Withdrawal by Subject|2|||
106086215|NCT01332305|365975313|FG000|Overall Study|Adverse Event|1|||
106086216|NCT01332305|365975314|FG001|Overall Study|Adverse Event|4|||
106086217|NCT01332305|365975315|FG002|Overall Study|Adverse Event|6|||
106086218|NCT01332305|365975316|FG003|Overall Study|Adverse Event|3|||
106086219|NCT01332305|365975317|FG004|Overall Study|Adverse Event|5|||
106086220|NCT01332305|365975313|FG000|Overall Study|Withdrawal by Subject|6|||
106086221|NCT01332305|365975314|FG001|Overall Study|Withdrawal by Subject|5|||
106086222|NCT01332305|365975315|FG002|Overall Study|Withdrawal by Subject|4|||
106086223|NCT01332305|365975316|FG003|Overall Study|Withdrawal by Subject|1|||
106086224|NCT01332305|365975317|FG004|Overall Study|Withdrawal by Subject|0|||
106086225|NCT01332305|365975313|FG000|Overall Study|Lost to Follow-up|0|||
106086226|NCT01332305|365975314|FG001|Overall Study|Lost to Follow-up|2|||
106086227|NCT01332305|365975315|FG002|Overall Study|Lost to Follow-up|3|||
106086228|NCT01332305|365975316|FG003|Overall Study|Lost to Follow-up|2|||
106086229|NCT01332305|365975317|FG004|Overall Study|Lost to Follow-up|3|||
106086230|NCT01332305|365975313|FG000|Overall Study|Protocol Violation|1|||
106086231|NCT01332305|365975314|FG001|Overall Study|Protocol Violation|2|||
106086232|NCT01332305|365975315|FG002|Overall Study|Protocol Violation|1|||
106086233|NCT01332305|365975316|FG003|Overall Study|Protocol Violation|0|||
106086234|NCT01332305|365975317|FG004|Overall Study|Protocol Violation|3|||
106086235|NCT01332305|365975313|FG000|Overall Study|Withdrawal by Sponsor|1|||
106086236|NCT01332305|365975314|FG001|Overall Study|Withdrawal by Sponsor|0|||
106086237|NCT01332305|365975315|FG002|Overall Study|Withdrawal by Sponsor|0|||
106086238|NCT01332305|365975316|FG003|Overall Study|Withdrawal by Sponsor|1|||
106086239|NCT01332305|365975317|FG004|Overall Study|Withdrawal by Sponsor|1|||
106086240|NCT01332305|365975313|FG000|Overall Study|Treatment Failure|1|||
106086241|NCT01332305|365975314|FG001|Overall Study|Treatment Failure|1|||
106086242|NCT01332305|365975315|FG002|Overall Study|Treatment Failure|0|||
106086243|NCT01332305|365975316|FG003|Overall Study|Treatment Failure|0|||
106086244|NCT01332305|365975317|FG004|Overall Study|Treatment Failure|0|||
106086245|NCT01332305|365975313|FG000|Overall Study|Physician Decision|0|||
106086246|NCT01332305|365975314|FG001|Overall Study|Physician Decision|0|||
106086247|NCT01332305|365975315|FG002|Overall Study|Physician Decision|0|||
106086248|NCT01332305|365975316|FG003|Overall Study|Physician Decision|1|||
106086249|NCT01332305|365975317|FG004|Overall Study|Physician Decision|0|||
106086250|NCT00642304|365975322|FG000|Overall Study|Adverse Event|1|||
106086251|NCT00642304|365975322|FG000|Overall Study|Death|1|||
106086252|NCT00642304|365975322|FG000|Overall Study|Blood transfusion|2|||
106086253|NCT00642304|365975322|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
106086254|NCT00642304|365975322|FG000|Overall Study|Transplantation|1|||
106086255|NCT02047110|365975341|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
106086256|NCT02047110|365975342|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
106086257|NCT02047110|365975343|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
106086258|NCT02047110|365975344|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
106086259|NCT02047110|365975341|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
106086260|NCT02047110|365975342|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
106086261|NCT02047110|365975343|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
106086262|NCT02047110|365975344|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
106086263|NCT02047110|365975341|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
106086264|NCT02047110|365975342|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
106086265|NCT02047110|365975343|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
106086266|NCT02047110|365975344|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
106086267|NCT02047110|365975341|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
106086268|NCT02047110|365975342|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
106086269|NCT02047110|365975343|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
106086270|NCT02047110|365975344|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
106086271|NCT02047110|365975341|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
106086272|NCT02047110|365975342|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
106086273|NCT02047110|365975343|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
106086274|NCT02047110|365975344|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
106086275|NCT02047110|365975341|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
106086276|NCT02047110|365975342|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
106086277|NCT02047110|365975343|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
106086278|NCT02047110|365975344|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
106086279|NCT02047110|365975341|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
106086280|NCT02047110|365975342|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
106086281|NCT02047110|365975343|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
106086282|NCT02047110|365975344|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
106086283|NCT02047110|365975341|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
106086284|NCT02047110|365975342|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
106086285|NCT02047110|365975343|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
106086286|NCT02047110|365975344|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
106086287|NCT02047110|365975341|FG000|Escape Treatment Period|Adverse Event|1|||
106086288|NCT02047110|365975342|FG001|Escape Treatment Period|Adverse Event|2|||
106086289|NCT02047110|365975343|FG002|Escape Treatment Period|Adverse Event|2|||
106086290|NCT02047110|365975344|FG003|Escape Treatment Period|Adverse Event|0|||
106086291|NCT02047110|365975341|FG000|Escape Treatment Period|Other than specified|1|||
106086292|NCT02047110|365975342|FG001|Escape Treatment Period|Other than specified|2|||
106086293|NCT02047110|365975343|FG002|Escape Treatment Period|Other than specified|0|||
106086294|NCT02047110|365975344|FG003|Escape Treatment Period|Other than specified|1|||
106160945|NCT03945292|366250497|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
106160946|NCT03945292|366250498|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
106160947|NCT03945292|366250499|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
106160948|NCT03945292|366250500|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
106160949|NCT03945292|366250493|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
106160950|NCT03945292|366250494|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
106160951|NCT03945292|366250495|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
106160952|NCT03945292|366250496|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
106160953|NCT03945292|366250497|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
106160954|NCT03945292|366250498|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
106086295|NCT02047110|365975341|FG000|OLE Treatment Period|Other than specified|0|||
106086296|NCT02047110|365975342|FG001|OLE Treatment Period|Other than specified|0|||
106086297|NCT02047110|365975343|FG002|OLE Treatment Period|Other than specified|1|||
106086298|NCT02047110|365975344|FG003|OLE Treatment Period|Other than specified|0|||
106086299|NCT00673452|365975347|FG000|Acute Double-Blind Phase|Adverse Event|41|||
106086300|NCT00673452|365975348|FG001|Acute Double-Blind Phase|Adverse Event|24|||
106086301|NCT00673452|365975347|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
106086302|NCT00673452|365975348|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
106086303|NCT00673452|365975347|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
106086304|NCT00673452|365975348|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
106086305|NCT00673452|365975347|FG000|Acute Double-Blind Phase|Physician Decision|0|||
106086306|NCT00673452|365975348|FG001|Acute Double-Blind Phase|Physician Decision|6|||
106086307|NCT00673452|365975347|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
106086308|NCT00673452|365975348|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
106086309|NCT00673452|365975347|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
106086310|NCT00673452|365975348|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
106086311|NCT00673452|365975347|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
106086312|NCT00673452|365975348|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
106086313|NCT00673452|365975347|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
106086314|NCT00673452|365975348|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
106086315|NCT00673452|365975347|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
106086316|NCT00673452|365975348|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
106086317|NCT00673452|365975347|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
106086318|NCT00673452|365975348|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
106086319|NCT00673452|365975347|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
106086320|NCT00673452|365975348|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
106086321|NCT00673452|365975347|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
106086322|NCT00673452|365975348|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
106086323|NCT00673452|365975347|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
106086324|NCT00673452|365975348|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
106086325|NCT00673452|365975347|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
106086326|NCT00673452|365975348|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
106086327|NCT00673452|365975347|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
106086328|NCT00673452|365975348|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
106086329|NCT01959581|365975353|FG000|Overall Study|Lost to Follow-up|5|||
106086330|NCT00414050|365975354|FG000|Overall Study|Adverse Event|1|||
106086331|NCT00414050|365975355|FG001|Overall Study|Adverse Event|1|||
106086332|NCT00414050|365975356|FG002|Overall Study|Adverse Event|1|||
106086333|NCT00414050|365975357|FG003|Overall Study|Adverse Event|1|||
106086334|NCT00414050|365975354|FG000|Overall Study|Lost to Follow-up|2|||
106086335|NCT00414050|365975355|FG001|Overall Study|Lost to Follow-up|2|||
106086336|NCT00414050|365975356|FG002|Overall Study|Lost to Follow-up|1|||
106086337|NCT00414050|365975357|FG003|Overall Study|Lost to Follow-up|1|||
106086338|NCT00414050|365975354|FG000|Overall Study|Withdrawal by Subject|5|||
106086339|NCT00414050|365975355|FG001|Overall Study|Withdrawal by Subject|3|||
106086340|NCT00414050|365975356|FG002|Overall Study|Withdrawal by Subject|2|||
106086341|NCT00414050|365975357|FG003|Overall Study|Withdrawal by Subject|4|||
106086342|NCT00414050|365975354|FG000|Overall Study|Subject discontinued for other reason|1|||
106160955|NCT03945292|366250499|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
106160956|NCT03945292|366250500|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
106160957|NCT03945292|366250493|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
106160958|NCT03945292|366250494|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
106160959|NCT03945292|366250495|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
106160960|NCT03945292|366250496|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
106160961|NCT03945292|366250497|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
106160962|NCT03945292|366250498|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
106160963|NCT03945292|366250499|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
106160964|NCT03945292|366250500|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
106160965|NCT05364671|366250507|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
106160966|NCT05364671|366250508|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
106160967|NCT05364671|366250507|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
106160968|NCT05364671|366250508|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
106160969|NCT05364671|366250507|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
106086343|NCT00414050|365975355|FG001|Overall Study|Subject discontinued for other reason|2|||
106086344|NCT00414050|365975356|FG002|Overall Study|Subject discontinued for other reason|2|||
106086345|NCT00414050|365975357|FG003|Overall Study|Subject discontinued for other reason|1|||
106086346|NCT00414050|365975354|FG000|Overall Study|Subject Moved|0|||
106086347|NCT00414050|365975355|FG001|Overall Study|Subject Moved|0|||
106160970|NCT05364671|366250508|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
106086348|NCT00414050|365975356|FG002|Overall Study|Subject Moved|0|||
106086349|NCT00414050|365975357|FG003|Overall Study|Subject Moved|1|||
106086350|NCT00767676|365975359|FG000|Overall Study|Investigator error|54|||
106086351|NCT03304379|365975360|FG000|Overall Study|Protocol Violation|8|||
106086352|NCT03304379|365975361|FG001|Overall Study|Protocol Violation|10|||
106086353|NCT03304379|365975362|FG002|Overall Study|Protocol Violation|5|||
105867237|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
106086354|NCT03304379|365975363|FG003|Overall Study|Protocol Violation|0|||
106086355|NCT03304379|365975364|FG004|Overall Study|Protocol Violation|2|||
106086356|NCT03304379|365975360|FG000|Overall Study|Adverse Event|4|||
106086357|NCT03304379|365975361|FG001|Overall Study|Adverse Event|20|||
106086358|NCT03304379|365975362|FG002|Overall Study|Adverse Event|17|||
106086359|NCT03304379|365975363|FG003|Overall Study|Adverse Event|1|||
106086360|NCT03304379|365975364|FG004|Overall Study|Adverse Event|0|||
106086361|NCT03304379|365975360|FG000|Overall Study|Lack of Efficacy|17|||
106086362|NCT03304379|365975361|FG001|Overall Study|Lack of Efficacy|16|||
106086363|NCT03304379|365975362|FG002|Overall Study|Lack of Efficacy|20|||
106086364|NCT03304379|365975363|FG003|Overall Study|Lack of Efficacy|0|||
106086365|NCT03304379|365975364|FG004|Overall Study|Lack of Efficacy|0|||
106086366|NCT03304379|365975360|FG000|Overall Study|Physician Decision|6|||
106086367|NCT03304379|365975361|FG001|Overall Study|Physician Decision|10|||
106086368|NCT03304379|365975362|FG002|Overall Study|Physician Decision|6|||
105867238|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
106086369|NCT03304379|365975363|FG003|Overall Study|Physician Decision|9|||
106086370|NCT03304379|365975364|FG004|Overall Study|Physician Decision|10|||
106086371|NCT03304379|365975360|FG000|Overall Study|Withdrawal by Subject|26|||
106086372|NCT03304379|365975361|FG001|Overall Study|Withdrawal by Subject|58|||
106086373|NCT03304379|365975362|FG002|Overall Study|Withdrawal by Subject|66|||
106160971|NCT05364671|366250507|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
106160972|NCT05364671|366250508|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
106160973|NCT05364671|366250507|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
106160974|NCT05364671|366250508|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
106160975|NCT00418886|366252338|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
106160976|NCT00418886|366252339|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
106160977|NCT00418886|366252338|FG000|Randomized Period|Death|122|||
106160978|NCT00418886|366252339|FG001|Randomized Period|Death|147|||
106160979|NCT00418886|366252338|FG000|Randomized Period|Withdrawal by Subject|9|||
106160980|NCT00418886|366252339|FG001|Randomized Period|Withdrawal by Subject|10|||
106160981|NCT00418886|366252338|FG000|Randomized Period|Lost to Follow-up|4|||
106160982|NCT00418886|366252339|FG001|Randomized Period|Lost to Follow-up|6|||
106160983|NCT00418886|366252338|FG000|Randomized Period|withdrawn due to other reason|1|||
106160984|NCT00418886|366252339|FG001|Randomized Period|withdrawn due to other reason|0|||
106160985|NCT00418886|366252338|FG000|Randomized Period|randomised but no treatment received|0|||
106160986|NCT00418886|366252339|FG001|Randomized Period|randomised but no treatment received|1|||
106160987|NCT01413100|366252340|FG000|Overall Study|Withdrawal by Subject|1|||
106160988|NCT02076113|366252343|FG000|Overall Study|Lost to Follow-up|4|||
106160989|NCT02076113|366252344|FG001|Overall Study|Lost to Follow-up|1|||
106160990|NCT02076113|366252343|FG000|Overall Study|Withdrawal by Subject|2|||
106160991|NCT02076113|366252344|FG001|Overall Study|Withdrawal by Subject|3|||
106160992|NCT02076113|366252343|FG000|Overall Study|Death|1|||
106160993|NCT02076113|366252344|FG001|Overall Study|Death|3|||
106086374|NCT03304379|365975363|FG003|Overall Study|Withdrawal by Subject|3|||
106086375|NCT03304379|365975364|FG004|Overall Study|Withdrawal by Subject|5|||
106086376|NCT03304379|365975360|FG000|Overall Study|Lost to Follow-up|8|||
106086377|NCT03304379|365975361|FG001|Overall Study|Lost to Follow-up|24|||
106086378|NCT03304379|365975362|FG002|Overall Study|Lost to Follow-up|35|||
106086379|NCT03304379|365975363|FG003|Overall Study|Lost to Follow-up|4|||
106086380|NCT03304379|365975364|FG004|Overall Study|Lost to Follow-up|0|||
106086381|NCT03304379|365975360|FG000|Overall Study|Death|1|||
106086382|NCT03304379|365975361|FG001|Overall Study|Death|2|||
106160994|NCT04760678|366252345|FG000|Overall Study|Death|13|||
106160995|NCT04760678|366252345|FG000|Overall Study|Lost to Follow-up|48|||
106160996|NCT04760678|366252345|FG000|Overall Study|Withdrawal by Subject|1|||
106160997|NCT02921230|366252348|FG000|Overall Study|Withdrawal by Subject|20|||
106160998|NCT02921230|366252349|FG001|Overall Study|Withdrawal by Subject|8|||
106160999|NCT02921230|366252348|FG000|Overall Study|Death|12|||
106086383|NCT03304379|365975362|FG002|Overall Study|Death|0|||
106086384|NCT03304379|365975363|FG003|Overall Study|Death|0|||
106086385|NCT03304379|365975364|FG004|Overall Study|Death|0|||
106161000|NCT02921230|366252349|FG001|Overall Study|Death|3|||
106161001|NCT02921230|366252348|FG000|Overall Study|Protocol Violation|17|||
106161002|NCT02921230|366252349|FG001|Overall Study|Protocol Violation|6|||
106161003|NCT02921230|366252348|FG000|Overall Study|Early completion|5|||
106161004|NCT02921230|366252349|FG001|Overall Study|Early completion|1|||
106161005|NCT02921230|366252348|FG000|Overall Study|Pending data entry|1|||
106161006|NCT02921230|366252349|FG001|Overall Study|Pending data entry|0|||
106161007|NCT03445988|366252350|FG000|Overall Study|Lost to Follow-up|14|||
106161008|NCT03445988|366252351|FG001|Overall Study|Lost to Follow-up|26|||
106086386|NCT03304379|365975360|FG000|Overall Study|Other|0|||
106086387|NCT03304379|365975361|FG001|Overall Study|Other|1|||
106086388|NCT03304379|365975362|FG002|Overall Study|Other|0|||
106086389|NCT03304379|365975363|FG003|Overall Study|Other|0|||
106086390|NCT03304379|365975364|FG004|Overall Study|Other|0|||
106086391|NCT03969212|365975365|FG000|Overall Study|Adverse Event|1|||
106086392|NCT03969212|365975366|FG001|Overall Study|Adverse Event|0|||
106086393|NCT03969212|365975367|FG002|Overall Study|Adverse Event|0|||
106086394|NCT03969212|365975368|FG003|Overall Study|Adverse Event|0|||
106086395|NCT03969212|365975365|FG000|Overall Study|Lost to Follow-up|2|||
106086396|NCT03969212|365975366|FG001|Overall Study|Lost to Follow-up|2|||
106086397|NCT03969212|365975367|FG002|Overall Study|Lost to Follow-up|2|||
106086398|NCT03969212|365975368|FG003|Overall Study|Lost to Follow-up|2|||
106086399|NCT03969212|365975365|FG000|Overall Study|Protocol Violation|0|||
106086400|NCT03969212|365975366|FG001|Overall Study|Protocol Violation|0|||
106161009|NCT03445988|366252352|FG002|Overall Study|Lost to Follow-up|27|||
106161010|NCT03445988|366252353|FG003|Overall Study|Lost to Follow-up|66|||
106161011|NCT03445988|366252350|FG000|Overall Study|Withdrawal by Subject|7|||
106086401|NCT03969212|365975367|FG002|Overall Study|Protocol Violation|0|||
106086402|NCT03969212|365975368|FG003|Overall Study|Protocol Violation|1|||
106086403|NCT03969212|365975365|FG000|Overall Study|Withdrawal by Subject|7|||
106086404|NCT03969212|365975366|FG001|Overall Study|Withdrawal by Subject|13|||
106161012|NCT03445988|366252351|FG001|Overall Study|Withdrawal by Subject|4|||
106161013|NCT03445988|366252352|FG002|Overall Study|Withdrawal by Subject|3|||
106161014|NCT03445988|366252353|FG003|Overall Study|Withdrawal by Subject|5|||
106086405|NCT03969212|365975367|FG002|Overall Study|Withdrawal by Subject|5|||
106086406|NCT03969212|365975368|FG003|Overall Study|Withdrawal by Subject|11|||
106086407|NCT03969212|365975365|FG000|Overall Study|Physician Decision|0|||
106086408|NCT03969212|365975366|FG001|Overall Study|Physician Decision|0|||
106086409|NCT03969212|365975367|FG002|Overall Study|Physician Decision|1|||
106086410|NCT03969212|365975368|FG003|Overall Study|Physician Decision|0|||
106086411|NCT03969212|365975365|FG000|Overall Study|Reason not Specified|22|||
106086412|NCT03969212|365975366|FG001|Overall Study|Reason not Specified|23|||
106086413|NCT03969212|365975367|FG002|Overall Study|Reason not Specified|28|||
106086414|NCT03969212|365975368|FG003|Overall Study|Reason not Specified|26|||
106086415|NCT00057746|365975369|FG000|Overall Study|Withdrawal by Subject|0|||
106086416|NCT00057746|365975370|FG001|Overall Study|Withdrawal by Subject|0|||
106086417|NCT00057746|365975371|FG002|Overall Study|Withdrawal by Subject|1|||
106086418|NCT01302392|365975374|FG000|Overall Study|Lost to Follow-up|1|||
106086419|NCT01302392|365975375|FG001|Overall Study|Lost to Follow-up|0|||
106086420|NCT01302392|365975374|FG000|Overall Study|Withdrawal by Subject|6|||
106086421|NCT01302392|365975375|FG001|Overall Study|Withdrawal by Subject|1|||
106086422|NCT05857527|365975376|FG000|Overall Study|Withdrawal by Subject|0|||
106086423|NCT05857527|365975377|FG001|Overall Study|Withdrawal by Subject|1|||
106086424|NCT04542070|365975383|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
106086425|NCT04542070|365975384|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
106086426|NCT04542070|365975385|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
106086427|NCT04542070|365975386|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
106086428|NCT04542070|365975383|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
106086429|NCT04542070|365975384|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
106086430|NCT04542070|365975385|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
106086431|NCT04542070|365975386|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
106086432|NCT04542070|365975383|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
106086433|NCT04542070|365975384|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
106086434|NCT04542070|365975385|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
106086435|NCT04542070|365975386|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
106086436|NCT04542070|365975383|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
106086437|NCT04542070|365975384|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
106086438|NCT04542070|365975385|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
106086439|NCT04542070|365975386|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
106086440|NCT04542070|365975383|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
106086441|NCT04542070|365975384|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
106086442|NCT04542070|365975385|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
106086443|NCT04542070|365975386|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
106086444|NCT04542070|365975383|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
106086445|NCT04542070|365975384|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
106086446|NCT04542070|365975385|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
106086447|NCT04542070|365975386|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
106086448|NCT04542070|365975383|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
106086449|NCT04542070|365975384|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
106086450|NCT04542070|365975385|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
106086451|NCT04542070|365975386|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
106086452|NCT04542070|365975383|FG000|Maintenance + Extension Period|Adverse Event|10|||
106086453|NCT04542070|365975384|FG001|Maintenance + Extension Period|Adverse Event|2|||
106086454|NCT04542070|365975385|FG002|Maintenance + Extension Period|Adverse Event|0|||
106086455|NCT04542070|365975386|FG003|Maintenance + Extension Period|Adverse Event|0|||
106086456|NCT04542070|365975383|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
106086457|NCT04542070|365975384|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
106086458|NCT04542070|365975385|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
106086459|NCT04542070|365975386|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
106086460|NCT04542070|365975383|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
106086461|NCT04542070|365975384|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
106086462|NCT04542070|365975385|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
106086463|NCT04542070|365975386|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
106086464|NCT04542070|365975383|FG000|Maintenance + Extension Period|Physician Decision|1|||
106086465|NCT04542070|365975384|FG001|Maintenance + Extension Period|Physician Decision|1|||
106086466|NCT04542070|365975385|FG002|Maintenance + Extension Period|Physician Decision|0|||
106086467|NCT04542070|365975386|FG003|Maintenance + Extension Period|Physician Decision|0|||
106086468|NCT04542070|365975383|FG000|Maintenance + Extension Period|Protocol Violation|2|||
106086469|NCT04542070|365975384|FG001|Maintenance + Extension Period|Protocol Violation|5|||
106086470|NCT04542070|365975385|FG002|Maintenance + Extension Period|Protocol Violation|0|||
106086471|NCT04542070|365975386|FG003|Maintenance + Extension Period|Protocol Violation|0|||
106086472|NCT04542070|365975383|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
106086473|NCT04542070|365975384|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
106161015|NCT03445988|366252350|FG000|Overall Study|Death (unrelated to study)|5|||
106086474|NCT04542070|365975385|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
106086475|NCT04542070|365975386|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
106086476|NCT04542070|365975383|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
106086477|NCT04542070|365975384|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
106086478|NCT04542070|365975385|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
106086479|NCT04542070|365975386|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
106086480|NCT04542070|365975383|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
106086481|NCT04542070|365975384|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
106086482|NCT04542070|365975385|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
106086483|NCT04542070|365975386|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
106086484|NCT04542070|365975383|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
106086485|NCT04542070|365975384|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
106086486|NCT04542070|365975385|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
106086487|NCT04542070|365975386|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
106086488|NCT04542070|365975383|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
106086489|NCT04542070|365975384|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
106086490|NCT04542070|365975385|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
106086491|NCT04542070|365975386|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
106161016|NCT03445988|366252351|FG001|Overall Study|Death (unrelated to study)|1|||
106161017|NCT03445988|366252352|FG002|Overall Study|Death (unrelated to study)|2|||
106161018|NCT03445988|366252353|FG003|Overall Study|Death (unrelated to study)|4|||
106161019|NCT04029688|366252354|FG000|Overall Study|Death|8|||
106161020|NCT04029688|366252355|FG001|Overall Study|Death|3|||
106161021|NCT04029688|366252356|FG002|Overall Study|Death|6|||
106161022|NCT04029688|366252357|FG003|Overall Study|Death|2|||
106161023|NCT04029688|366252358|FG004|Overall Study|Death|5|||
106161024|NCT04029688|366252359|FG005|Overall Study|Death|0|||
106161025|NCT04029688|366252360|FG006|Overall Study|Death|2|||
106161026|NCT04029688|366252361|FG007|Overall Study|Death|3|||
106161027|NCT04029688|366252354|FG000|Overall Study|Study Terminated by Sponsor|0|||
106086492|NCT04542070|365975383|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
106086493|NCT04542070|365975384|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
106086494|NCT04542070|365975385|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
106086495|NCT04542070|365975386|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
106086496|NCT04542070|365975383|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
106086497|NCT04542070|365975384|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
106086498|NCT04542070|365975385|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
106086499|NCT04542070|365975386|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
106086500|NCT01856543|365975396|FG000|Overall Study|Treatment discontinued|6|||
106086501|NCT01856543|365975397|FG001|Overall Study|Treatment discontinued|3|||
106086502|NCT01856543|365975396|FG000|Overall Study|Withdrawn before start|7|||
106086503|NCT01856543|365975397|FG001|Overall Study|Withdrawn before start|3|||
106086504|NCT01247090|365975398|FG000|Overall Study|Physician Decision|1|||
106086505|NCT01247090|365975399|FG001|Overall Study|Physician Decision|0|||
106086506|NCT01247090|365975400|FG002|Overall Study|Physician Decision|0|||
106086507|NCT01247090|365975398|FG000|Overall Study|Withdrawal by Subject|0|||
106086508|NCT01247090|365975399|FG001|Overall Study|Withdrawal by Subject|1|||
106086509|NCT01247090|365975400|FG002|Overall Study|Withdrawal by Subject|0|||
106086510|NCT01466192|365975401|FG000|Overall Study|Physician Decision|1|||
106086511|NCT01466192|365975401|FG000|Overall Study|Withdrawal by Subject|3|||
106086512|NCT04568122|365975402|FG000|Overall Study|Lost to Follow-up|48|||
106086513|NCT04568122|365975403|FG001|Overall Study|Lost to Follow-up|44|||
106086514|NCT04568122|365975404|FG002|Overall Study|Lost to Follow-up|4|||
106086515|NCT04568122|365975405|FG003|Overall Study|Lost to Follow-up|0|||
106086516|NCT04568122|365975406|FG004|Overall Study|Lost to Follow-up|0|||
106086517|NCT00437034|365975407|FG000|Overall Study|Adverse Event|1|||
106086518|NCT00437034|365975407|FG000|Overall Study|Disease progression during treatment|5|||
106086519|NCT02460224|365975410|FG000|Overall Study|Adverse Event|0|||
106086520|NCT02460224|365975411|FG001|Overall Study|Adverse Event|0|||
106086521|NCT02460224|365975412|FG002|Overall Study|Adverse Event|0|||
106086522|NCT02460224|365975413|FG003|Overall Study|Adverse Event|0|||
106086523|NCT02460224|365975414|FG004|Overall Study|Adverse Event|0|||
106086524|NCT02460224|365975415|FG005|Overall Study|Adverse Event|0|||
106086525|NCT02460224|365975416|FG006|Overall Study|Adverse Event|1|||
106086526|NCT02460224|365975417|FG007|Overall Study|Adverse Event|0|||
106161028|NCT04029688|366252355|FG001|Overall Study|Study Terminated by Sponsor|0|||
105867239|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
106086527|NCT02460224|365975418|FG008|Overall Study|Adverse Event|0|||
106086528|NCT02460224|365975419|FG009|Overall Study|Adverse Event|0|||
106086529|NCT02460224|365975420|FG010|Overall Study|Adverse Event|0|||
106086530|NCT02460224|365975421|FG011|Overall Study|Adverse Event|0|||
106161029|NCT04029688|366252356|FG002|Overall Study|Study Terminated by Sponsor|0|||
106161030|NCT04029688|366252357|FG003|Overall Study|Study Terminated by Sponsor|0|||
106086531|NCT02460224|365975422|FG012|Overall Study|Adverse Event|1|||
106086532|NCT02460224|365975423|FG013|Overall Study|Adverse Event|0|||
106086533|NCT02460224|365975424|FG014|Overall Study|Adverse Event|0|||
106086534|NCT02460224|365975425|FG015|Overall Study|Adverse Event|0|||
106086535|NCT02460224|365975426|FG016|Overall Study|Adverse Event|1|||
106086536|NCT02460224|365975427|FG017|Overall Study|Adverse Event|0|||
106086537|NCT02460224|365975428|FG018|Overall Study|Adverse Event|1|||
106086538|NCT02460224|365975429|FG019|Overall Study|Adverse Event|0|||
106086539|NCT02460224|365975430|FG020|Overall Study|Adverse Event|1|||
106086540|NCT02460224|365975431|FG021|Overall Study|Adverse Event|1|||
106086541|NCT02460224|365975432|FG022|Overall Study|Adverse Event|1|||
106086542|NCT02460224|365975433|FG023|Overall Study|Adverse Event|0|||
106086543|NCT02460224|365975434|FG024|Overall Study|Adverse Event|0|||
106086544|NCT02460224|365975435|FG025|Overall Study|Adverse Event|0|||
106086545|NCT02460224|365975436|FG026|Overall Study|Adverse Event|11|||
106086546|NCT02460224|365975437|FG027|Overall Study|Adverse Event|1|||
106086547|NCT02460224|365975438|FG028|Overall Study|Adverse Event|6|||
106086548|NCT02460224|365975410|FG000|Overall Study|Death|0|||
106086549|NCT02460224|365975411|FG001|Overall Study|Death|0|||
106086550|NCT02460224|365975412|FG002|Overall Study|Death|0|||
106086551|NCT02460224|365975413|FG003|Overall Study|Death|0|||
106086552|NCT02460224|365975414|FG004|Overall Study|Death|0|||
106086553|NCT02460224|365975415|FG005|Overall Study|Death|2|||
106086554|NCT02460224|365975416|FG006|Overall Study|Death|1|||
106086555|NCT02460224|365975417|FG007|Overall Study|Death|0|||
106086556|NCT02460224|365975418|FG008|Overall Study|Death|0|||
106086557|NCT02460224|365975419|FG009|Overall Study|Death|1|||
106086558|NCT02460224|365975420|FG010|Overall Study|Death|0|||
106086559|NCT02460224|365975421|FG011|Overall Study|Death|0|||
106086560|NCT02460224|365975422|FG012|Overall Study|Death|0|||
106086561|NCT02460224|365975423|FG013|Overall Study|Death|1|||
106086562|NCT02460224|365975424|FG014|Overall Study|Death|0|||
106086563|NCT02460224|365975425|FG015|Overall Study|Death|0|||
106086564|NCT02460224|365975426|FG016|Overall Study|Death|2|||
106086565|NCT02460224|365975427|FG017|Overall Study|Death|1|||
106086566|NCT02460224|365975428|FG018|Overall Study|Death|0|||
106086567|NCT02460224|365975429|FG019|Overall Study|Death|2|||
106086568|NCT02460224|365975430|FG020|Overall Study|Death|0|||
106086569|NCT02460224|365975431|FG021|Overall Study|Death|0|||
106086570|NCT02460224|365975432|FG022|Overall Study|Death|0|||
106086571|NCT02460224|365975433|FG023|Overall Study|Death|0|||
106086572|NCT02460224|365975434|FG024|Overall Study|Death|1|||
106086573|NCT02460224|365975435|FG025|Overall Study|Death|1|||
106086574|NCT02460224|365975436|FG026|Overall Study|Death|5|||
106086575|NCT02460224|365975437|FG027|Overall Study|Death|0|||
106086576|NCT02460224|365975438|FG028|Overall Study|Death|1|||
106086577|NCT02460224|365975410|FG000|Overall Study|Lost to Follow-up|0|||
106086578|NCT02460224|365975411|FG001|Overall Study|Lost to Follow-up|0|||
106086579|NCT02460224|365975412|FG002|Overall Study|Lost to Follow-up|0|||
106086580|NCT02460224|365975413|FG003|Overall Study|Lost to Follow-up|0|||
106086581|NCT02460224|365975414|FG004|Overall Study|Lost to Follow-up|0|||
106086582|NCT02460224|365975415|FG005|Overall Study|Lost to Follow-up|0|||
106086583|NCT02460224|365975416|FG006|Overall Study|Lost to Follow-up|0|||
106086584|NCT02460224|365975417|FG007|Overall Study|Lost to Follow-up|0|||
106086585|NCT02460224|365975418|FG008|Overall Study|Lost to Follow-up|0|||
106086586|NCT02460224|365975419|FG009|Overall Study|Lost to Follow-up|0|||
106086587|NCT02460224|365975420|FG010|Overall Study|Lost to Follow-up|0|||
106086588|NCT02460224|365975421|FG011|Overall Study|Lost to Follow-up|0|||
106086589|NCT02460224|365975422|FG012|Overall Study|Lost to Follow-up|0|||
106086590|NCT02460224|365975423|FG013|Overall Study|Lost to Follow-up|0|||
106086591|NCT02460224|365975424|FG014|Overall Study|Lost to Follow-up|0|||
106086592|NCT02460224|365975425|FG015|Overall Study|Lost to Follow-up|0|||
106086593|NCT02460224|365975426|FG016|Overall Study|Lost to Follow-up|0|||
106086594|NCT02460224|365975427|FG017|Overall Study|Lost to Follow-up|0|||
106086595|NCT02460224|365975428|FG018|Overall Study|Lost to Follow-up|0|||
106086596|NCT02460224|365975429|FG019|Overall Study|Lost to Follow-up|0|||
106086597|NCT02460224|365975430|FG020|Overall Study|Lost to Follow-up|0|||
106086598|NCT02460224|365975431|FG021|Overall Study|Lost to Follow-up|0|||
106086599|NCT02460224|365975432|FG022|Overall Study|Lost to Follow-up|1|||
106086600|NCT02460224|365975433|FG023|Overall Study|Lost to Follow-up|0|||
106086601|NCT02460224|365975434|FG024|Overall Study|Lost to Follow-up|0|||
106086602|NCT02460224|365975435|FG025|Overall Study|Lost to Follow-up|0|||
106086603|NCT02460224|365975436|FG026|Overall Study|Lost to Follow-up|0|||
106086604|NCT02460224|365975437|FG027|Overall Study|Lost to Follow-up|0|||
106086605|NCT02460224|365975438|FG028|Overall Study|Lost to Follow-up|0|||
106086606|NCT02460224|365975410|FG000|Overall Study|Physician Decision|0|||
106086607|NCT02460224|365975411|FG001|Overall Study|Physician Decision|1|||
106086608|NCT02460224|365975412|FG002|Overall Study|Physician Decision|0|||
106086609|NCT02460224|365975413|FG003|Overall Study|Physician Decision|0|||
106086610|NCT02460224|365975414|FG004|Overall Study|Physician Decision|1|||
106086611|NCT02460224|365975415|FG005|Overall Study|Physician Decision|0|||
106086612|NCT02460224|365975416|FG006|Overall Study|Physician Decision|0|||
106086613|NCT02460224|365975417|FG007|Overall Study|Physician Decision|1|||
106086614|NCT02460224|365975418|FG008|Overall Study|Physician Decision|0|||
106086615|NCT02460224|365975419|FG009|Overall Study|Physician Decision|0|||
106086616|NCT02460224|365975420|FG010|Overall Study|Physician Decision|0|||
106086617|NCT02460224|365975421|FG011|Overall Study|Physician Decision|1|||
106086618|NCT02460224|365975422|FG012|Overall Study|Physician Decision|0|||
106086619|NCT02460224|365975423|FG013|Overall Study|Physician Decision|1|||
106086620|NCT02460224|365975424|FG014|Overall Study|Physician Decision|0|||
106086621|NCT02460224|365975425|FG015|Overall Study|Physician Decision|0|||
106086622|NCT02460224|365975426|FG016|Overall Study|Physician Decision|2|||
106086623|NCT02460224|365975427|FG017|Overall Study|Physician Decision|1|||
106086624|NCT02460224|365975428|FG018|Overall Study|Physician Decision|1|||
106086625|NCT02460224|365975429|FG019|Overall Study|Physician Decision|2|||
106086626|NCT02460224|365975430|FG020|Overall Study|Physician Decision|1|||
106086627|NCT02460224|365975431|FG021|Overall Study|Physician Decision|1|||
106086628|NCT02460224|365975432|FG022|Overall Study|Physician Decision|0|||
106086629|NCT02460224|365975433|FG023|Overall Study|Physician Decision|0|||
106086630|NCT02460224|365975434|FG024|Overall Study|Physician Decision|1|||
106086631|NCT02460224|365975435|FG025|Overall Study|Physician Decision|0|||
106086632|NCT02460224|365975436|FG026|Overall Study|Physician Decision|14|||
106086633|NCT02460224|365975437|FG027|Overall Study|Physician Decision|1|||
106086634|NCT02460224|365975438|FG028|Overall Study|Physician Decision|6|||
106086635|NCT02460224|365975410|FG000|Overall Study|Progressive disease|15|||
106086636|NCT02460224|365975411|FG001|Overall Study|Progressive disease|11|||
106086637|NCT02460224|365975412|FG002|Overall Study|Progressive disease|5|||
106086638|NCT02460224|365975413|FG003|Overall Study|Progressive disease|6|||
106086639|NCT02460224|365975414|FG004|Overall Study|Progressive disease|3|||
106086640|NCT02460224|365975415|FG005|Overall Study|Progressive disease|26|||
106086641|NCT02460224|365975416|FG006|Overall Study|Progressive disease|28|||
106086642|NCT02460224|365975417|FG007|Overall Study|Progressive disease|4|||
106086643|NCT02460224|365975418|FG008|Overall Study|Progressive disease|5|||
106086644|NCT02460224|365975419|FG009|Overall Study|Progressive disease|9|||
106086645|NCT02460224|365975420|FG010|Overall Study|Progressive disease|5|||
106086646|NCT02460224|365975421|FG011|Overall Study|Progressive disease|4|||
106086647|NCT02460224|365975422|FG012|Overall Study|Progressive disease|5|||
106086648|NCT02460224|365975423|FG013|Overall Study|Progressive disease|4|||
106086649|NCT02460224|365975424|FG014|Overall Study|Progressive disease|5|||
106086650|NCT02460224|365975425|FG015|Overall Study|Progressive disease|5|||
106161031|NCT04029688|366252358|FG004|Overall Study|Study Terminated by Sponsor|1|||
106161032|NCT04029688|366252359|FG005|Overall Study|Study Terminated by Sponsor|3|||
106161033|NCT04029688|366252360|FG006|Overall Study|Study Terminated by Sponsor|1|||
106161034|NCT04029688|366252361|FG007|Overall Study|Study Terminated by Sponsor|3|||
106161035|NCT04029688|366252354|FG000|Overall Study|Withdrawal by Subject|0|||
106161036|NCT04029688|366252355|FG001|Overall Study|Withdrawal by Subject|0|||
106161037|NCT04029688|366252356|FG002|Overall Study|Withdrawal by Subject|0|||
106161038|NCT04029688|366252357|FG003|Overall Study|Withdrawal by Subject|1|||
106161039|NCT04029688|366252358|FG004|Overall Study|Withdrawal by Subject|0|||
106161040|NCT04029688|366252359|FG005|Overall Study|Withdrawal by Subject|0|||
106161041|NCT04029688|366252360|FG006|Overall Study|Withdrawal by Subject|0|||
106161042|NCT04029688|366252361|FG007|Overall Study|Withdrawal by Subject|0|||
106161043|NCT03436290|366252362|FG000|Overall Study|Post-randomization Exclusion|1|||
106161044|NCT03436290|366252363|FG001|Overall Study|Post-randomization Exclusion|0|||
106086651|NCT02460224|365975426|FG016|Overall Study|Progressive disease|15|||
106086652|NCT02460224|365975427|FG017|Overall Study|Progressive disease|3|||
106086653|NCT02460224|365975428|FG018|Overall Study|Progressive disease|8|||
106086654|NCT02460224|365975429|FG019|Overall Study|Progressive disease|3|||
106086655|NCT02460224|365975430|FG020|Overall Study|Progressive disease|4|||
106086656|NCT02460224|365975431|FG021|Overall Study|Progressive disease|9|||
106086657|NCT02460224|365975432|FG022|Overall Study|Progressive disease|4|||
106086658|NCT02460224|365975433|FG023|Overall Study|Progressive disease|11|||
106086659|NCT02460224|365975434|FG024|Overall Study|Progressive disease|4|||
106086660|NCT02460224|365975435|FG025|Overall Study|Progressive disease|5|||
106086661|NCT02460224|365975436|FG026|Overall Study|Progressive disease|85|||
106086662|NCT02460224|365975437|FG027|Overall Study|Progressive disease|17|||
106086663|NCT02460224|365975438|FG028|Overall Study|Progressive disease|77|||
106086664|NCT02460224|365975410|FG000|Overall Study|Subject/guardian decision|2|||
106086665|NCT02460224|365975411|FG001|Overall Study|Subject/guardian decision|0|||
106086666|NCT02460224|365975412|FG002|Overall Study|Subject/guardian decision|1|||
106086667|NCT02460224|365975413|FG003|Overall Study|Subject/guardian decision|0|||
106086668|NCT02460224|365975414|FG004|Overall Study|Subject/guardian decision|2|||
106086669|NCT02460224|365975415|FG005|Overall Study|Subject/guardian decision|2|||
106086670|NCT02460224|365975416|FG006|Overall Study|Subject/guardian decision|0|||
106086671|NCT02460224|365975417|FG007|Overall Study|Subject/guardian decision|0|||
106086672|NCT02460224|365975418|FG008|Overall Study|Subject/guardian decision|1|||
106086673|NCT02460224|365975419|FG009|Overall Study|Subject/guardian decision|1|||
106086674|NCT02460224|365975420|FG010|Overall Study|Subject/guardian decision|0|||
106086675|NCT02460224|365975421|FG011|Overall Study|Subject/guardian decision|1|||
106086676|NCT02460224|365975422|FG012|Overall Study|Subject/guardian decision|0|||
106086677|NCT02460224|365975423|FG013|Overall Study|Subject/guardian decision|0|||
106086678|NCT02460224|365975424|FG014|Overall Study|Subject/guardian decision|0|||
106086679|NCT02460224|365975425|FG015|Overall Study|Subject/guardian decision|1|||
106086680|NCT02460224|365975426|FG016|Overall Study|Subject/guardian decision|0|||
106086681|NCT02460224|365975427|FG017|Overall Study|Subject/guardian decision|1|||
106086682|NCT02460224|365975428|FG018|Overall Study|Subject/guardian decision|2|||
106086683|NCT02460224|365975429|FG019|Overall Study|Subject/guardian decision|0|||
106086684|NCT02460224|365975430|FG020|Overall Study|Subject/guardian decision|0|||
106086685|NCT02460224|365975431|FG021|Overall Study|Subject/guardian decision|1|||
106086686|NCT02460224|365975432|FG022|Overall Study|Subject/guardian decision|0|||
106086687|NCT02460224|365975433|FG023|Overall Study|Subject/guardian decision|0|||
106086688|NCT02460224|365975434|FG024|Overall Study|Subject/guardian decision|0|||
106086689|NCT02460224|365975435|FG025|Overall Study|Subject/guardian decision|0|||
106086690|NCT02460224|365975436|FG026|Overall Study|Subject/guardian decision|6|||
106086691|NCT02460224|365975437|FG027|Overall Study|Subject/guardian decision|2|||
106086692|NCT02460224|365975438|FG028|Overall Study|Subject/guardian decision|3|||
106086693|NCT01227512|365975442|FG000|Overall Study|Physician Decision|6|||
106086694|NCT01227512|365975443|FG001|Overall Study|Physician Decision|6|||
106086695|NCT01227512|365975442|FG000|Overall Study|Adverse Event|4|||
106086696|NCT01227512|365975443|FG001|Overall Study|Adverse Event|3|||
106086697|NCT01227512|365975442|FG000|Overall Study|Withdrawal by Subject|3|||
106086698|NCT01227512|365975443|FG001|Overall Study|Withdrawal by Subject|0|||
106086699|NCT01227512|365975442|FG000|Overall Study|Participant met withdrawal criteria|0|||
106086700|NCT01227512|365975443|FG001|Overall Study|Participant met withdrawal criteria|1|||
106086701|NCT04055116|365975444|FG000|First Intervention|Physician Decision|2|||
106086702|NCT04055116|365975445|FG001|First Intervention|Physician Decision|7|||
106086703|NCT03861273|365975456|FG000|Screening Phase (3 Weeks)|Other|1|||
106086704|NCT03861273|365975456|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
106086705|NCT03861273|365975456|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
106086706|NCT03861273|365975456|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
106086707|NCT03861273|365975456|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
106086708|NCT03333486|365975457|FG000|Overall Study|Withdrawal by Subject|1|||
106086709|NCT03333486|365975457|FG000|Overall Study|Lost to Follow-up|1|||
106086710|NCT02742103|365977405|FG000|Overall Study|Protocol Violation|1|||
106086711|NCT02742103|365977406|FG001|Overall Study|Protocol Violation|0|||
106086712|NCT02742103|365977405|FG000|Overall Study|Death|2|||
106086713|NCT02742103|365977406|FG001|Overall Study|Death|2|||
106086714|NCT02742103|365977405|FG000|Overall Study|Adverse Event|1|||
106086715|NCT02742103|365977406|FG001|Overall Study|Adverse Event|0|||
106086716|NCT02742103|365977405|FG000|Overall Study|Moved to another town|0|||
106086717|NCT02742103|365977406|FG001|Overall Study|Moved to another town|1|||
106086718|NCT02742103|365977405|FG000|Overall Study|Withdrawal by Subject|5|||
106086719|NCT02742103|365977406|FG001|Overall Study|Withdrawal by Subject|2|||
106086720|NCT01709318|365977407|FG000|Overall Study|Adverse Event|3|||
106086721|NCT01709318|365977408|FG001|Overall Study|Adverse Event|4|||
106086722|NCT01709318|365977409|FG002|Overall Study|Adverse Event|2|||
106086723|NCT01709318|365977410|FG003|Overall Study|Adverse Event|2|||
106086724|NCT01709318|365977411|FG004|Overall Study|Adverse Event|0|||
106086725|NCT01709318|365977412|FG005|Overall Study|Adverse Event|1|||
106161045|NCT03436290|366252362|FG000|Overall Study|Death|6|||
106161046|NCT03436290|366252363|FG001|Overall Study|Death|0|||
106161047|NCT03436290|366252362|FG000|Overall Study|Withdrawal by Subject|4|||
106161048|NCT03436290|366252363|FG001|Overall Study|Withdrawal by Subject|0|||
106161049|NCT03436290|366252362|FG000|Overall Study|Protocol Violation|30|||
106086726|NCT01709318|365977413|FG006|Overall Study|Adverse Event|2|||
106086727|NCT01709318|365977407|FG000|Overall Study|Lost to Follow-up|2|||
106086728|NCT01709318|365977408|FG001|Overall Study|Lost to Follow-up|0|||
106086729|NCT01709318|365977409|FG002|Overall Study|Lost to Follow-up|0|||
106086730|NCT01709318|365977410|FG003|Overall Study|Lost to Follow-up|0|||
106086731|NCT01709318|365977411|FG004|Overall Study|Lost to Follow-up|1|||
106086732|NCT01709318|365977412|FG005|Overall Study|Lost to Follow-up|1|||
106086733|NCT01709318|365977413|FG006|Overall Study|Lost to Follow-up|1|||
106086734|NCT01709318|365977407|FG000|Overall Study|Non-compliance with Study Drug|0|||
106086735|NCT01709318|365977408|FG001|Overall Study|Non-compliance with Study Drug|2|||
106086736|NCT01709318|365977409|FG002|Overall Study|Non-compliance with Study Drug|1|||
106086737|NCT01709318|365977410|FG003|Overall Study|Non-compliance with Study Drug|1|||
106086738|NCT01709318|365977411|FG004|Overall Study|Non-compliance with Study Drug|0|||
106086739|NCT01709318|365977412|FG005|Overall Study|Non-compliance with Study Drug|0|||
106086740|NCT01709318|365977413|FG006|Overall Study|Non-compliance with Study Drug|2|||
106086741|NCT01709318|365977407|FG000|Overall Study|Physician Decision|0|||
106086742|NCT01709318|365977408|FG001|Overall Study|Physician Decision|0|||
106086743|NCT01709318|365977409|FG002|Overall Study|Physician Decision|0|||
106086744|NCT01709318|365977410|FG003|Overall Study|Physician Decision|0|||
106086745|NCT01709318|365977411|FG004|Overall Study|Physician Decision|0|||
106086746|NCT01709318|365977412|FG005|Overall Study|Physician Decision|0|||
106086747|NCT01709318|365977413|FG006|Overall Study|Physician Decision|1|||
106086748|NCT01709318|365977407|FG000|Overall Study|Pregnancy|0|||
106086749|NCT01709318|365977408|FG001|Overall Study|Pregnancy|0|||
106086750|NCT01709318|365977409|FG002|Overall Study|Pregnancy|0|||
106086751|NCT01709318|365977410|FG003|Overall Study|Pregnancy|0|||
106086752|NCT01709318|365977411|FG004|Overall Study|Pregnancy|1|||
106086753|NCT01709318|365977412|FG005|Overall Study|Pregnancy|0|||
106086754|NCT01709318|365977413|FG006|Overall Study|Pregnancy|0|||
106086755|NCT01709318|365977407|FG000|Overall Study|Protocol Violation|0|||
106086756|NCT01709318|365977408|FG001|Overall Study|Protocol Violation|0|||
106086757|NCT01709318|365977409|FG002|Overall Study|Protocol Violation|0|||
106086758|NCT01709318|365977410|FG003|Overall Study|Protocol Violation|0|||
106086759|NCT01709318|365977411|FG004|Overall Study|Protocol Violation|2|||
106086760|NCT01709318|365977412|FG005|Overall Study|Protocol Violation|0|||
106086761|NCT01709318|365977413|FG006|Overall Study|Protocol Violation|1|||
106086762|NCT01709318|365977407|FG000|Overall Study|Technical Problems|1|||
106086763|NCT01709318|365977408|FG001|Overall Study|Technical Problems|0|||
106086764|NCT01709318|365977409|FG002|Overall Study|Technical Problems|0|||
106086765|NCT01709318|365977410|FG003|Overall Study|Technical Problems|0|||
106086766|NCT01709318|365977411|FG004|Overall Study|Technical Problems|0|||
106086767|NCT01709318|365977412|FG005|Overall Study|Technical Problems|0|||
106086768|NCT01709318|365977413|FG006|Overall Study|Technical Problems|0|||
106086769|NCT01709318|365977407|FG000|Overall Study|Withdrawal by Subject|3|||
106086770|NCT01709318|365977408|FG001|Overall Study|Withdrawal by Subject|0|||
106086771|NCT01709318|365977409|FG002|Overall Study|Withdrawal by Subject|3|||
106086772|NCT01709318|365977410|FG003|Overall Study|Withdrawal by Subject|3|||
106086773|NCT01709318|365977411|FG004|Overall Study|Withdrawal by Subject|0|||
106086774|NCT01709318|365977412|FG005|Overall Study|Withdrawal by Subject|2|||
106086775|NCT01709318|365977413|FG006|Overall Study|Withdrawal by Subject|4|||
106086776|NCT01709318|365977407|FG000|Overall Study|Other Protocol Specified Criteria|0|||
106086777|NCT01709318|365977408|FG001|Overall Study|Other Protocol Specified Criteria|1|||
106086778|NCT01709318|365977409|FG002|Overall Study|Other Protocol Specified Criteria|0|||
106086779|NCT01709318|365977410|FG003|Overall Study|Other Protocol Specified Criteria|0|||
106086780|NCT01709318|365977411|FG004|Overall Study|Other Protocol Specified Criteria|0|||
106086781|NCT01709318|365977412|FG005|Overall Study|Other Protocol Specified Criteria|0|||
106086782|NCT01709318|365977413|FG006|Overall Study|Other Protocol Specified Criteria|0|||
106086783|NCT03143829|365977418|FG000|Overall Study|Withdrawal by Subject|2|||
106086784|NCT03143829|365977419|FG001|Overall Study|Withdrawal by Subject|5|||
106086785|NCT03143829|365977418|FG000|Overall Study|Lost to Follow-up|0|||
106086786|NCT03143829|365977419|FG001|Overall Study|Lost to Follow-up|2|||
106086787|NCT03143829|365977418|FG000|Overall Study|Death|1|||
106086788|NCT03143829|365977419|FG001|Overall Study|Death|1|||
106086789|NCT03143829|365977418|FG000|Overall Study|changed treatment, no longer eligible|2|||
106086790|NCT03143829|365977419|FG001|Overall Study|changed treatment, no longer eligible|2|||
106086791|NCT00672477|365977420|FG000|Overall Study|Adverse Event|10|||
106086792|NCT00672477|365977421|FG001|Overall Study|Adverse Event|7|||
106086793|NCT00672477|365977420|FG000|Overall Study|Death|7|||
106086794|NCT00672477|365977421|FG001|Overall Study|Death|11|||
106086795|NCT00672477|365977420|FG000|Overall Study|Physician Decision|2|||
106086796|NCT00672477|365977421|FG001|Overall Study|Physician Decision|0|||
106086797|NCT00672477|365977420|FG000|Overall Study|Protocol Violation|1|||
106161050|NCT03436290|366252363|FG001|Overall Study|Protocol Violation|0|||
106086798|NCT00672477|365977421|FG001|Overall Study|Protocol Violation|1|||
106086799|NCT00672477|365977420|FG000|Overall Study|Withdrawal by Subject|5|||
106086800|NCT00672477|365977421|FG001|Overall Study|Withdrawal by Subject|3|||
106086801|NCT00672477|365977420|FG000|Overall Study|Lack of Efficacy|1|||
106086802|NCT00672477|365977421|FG001|Overall Study|Lack of Efficacy|1|||
106086803|NCT00672477|365977420|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
106086804|NCT00672477|365977421|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
106086805|NCT02391948|365977422|FG000|6-month Assessment|Death|0|||
106086806|NCT02391948|365977423|FG001|6-month Assessment|Death|0|||
106086807|NCT02391948|365977424|FG002|6-month Assessment|Death|0|||
106086808|NCT02391948|365977425|FG003|6-month Assessment|Death|0|||
106086809|NCT02391948|365977426|FG004|6-month Assessment|Death|1|||
106086810|NCT02391948|365977422|FG000|6-month Assessment|Withdrawal by Subject|0|||
106086811|NCT02391948|365977423|FG001|6-month Assessment|Withdrawal by Subject|0|||
106086812|NCT02391948|365977424|FG002|6-month Assessment|Withdrawal by Subject|1|||
106086813|NCT02391948|365977425|FG003|6-month Assessment|Withdrawal by Subject|2|||
106086814|NCT02391948|365977426|FG004|6-month Assessment|Withdrawal by Subject|0|||
106086815|NCT02391948|365977422|FG000|6-month Assessment|Lost to Follow-up|4|||
106086816|NCT02391948|365977423|FG001|6-month Assessment|Lost to Follow-up|5|||
106086817|NCT02391948|365977424|FG002|6-month Assessment|Lost to Follow-up|2|||
106086818|NCT02391948|365977425|FG003|6-month Assessment|Lost to Follow-up|3|||
106086819|NCT02391948|365977426|FG004|6-month Assessment|Lost to Follow-up|1|||
106086820|NCT02391948|365977422|FG000|6-month Assessment|Medical issue/illness|1|||
106086821|NCT02391948|365977423|FG001|6-month Assessment|Medical issue/illness|1|||
106086822|NCT02391948|365977424|FG002|6-month Assessment|Medical issue/illness|0|||
106086823|NCT02391948|365977425|FG003|6-month Assessment|Medical issue/illness|0|||
106086824|NCT02391948|365977426|FG004|6-month Assessment|Medical issue/illness|0|||
106086825|NCT02391948|365977422|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
106086826|NCT02391948|365977423|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
106086827|NCT02391948|365977424|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
106086828|NCT02391948|365977425|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
106086829|NCT02391948|365977426|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
106086830|NCT02391948|365977422|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
106086831|NCT02391948|365977423|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
106086832|NCT02391948|365977424|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
106086833|NCT02391948|365977425|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
106086834|NCT02391948|365977426|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
106086835|NCT02391948|365977422|FG000|12-month Assessment|Death|0|||
106086836|NCT02391948|365977423|FG001|12-month Assessment|Death|0|||
106086837|NCT02391948|365977424|FG002|12-month Assessment|Death|0|||
106086838|NCT02391948|365977425|FG003|12-month Assessment|Death|1|||
106086839|NCT02391948|365977426|FG004|12-month Assessment|Death|0|||
106086840|NCT02391948|365977422|FG000|12-month Assessment|Withdrawal by Subject|1|||
106086841|NCT02391948|365977423|FG001|12-month Assessment|Withdrawal by Subject|0|||
106086842|NCT02391948|365977424|FG002|12-month Assessment|Withdrawal by Subject|0|||
106086843|NCT02391948|365977425|FG003|12-month Assessment|Withdrawal by Subject|1|||
106086844|NCT02391948|365977426|FG004|12-month Assessment|Withdrawal by Subject|0|||
106086845|NCT02391948|365977422|FG000|12-month Assessment|Lost to Follow-up|5|||
106086846|NCT02391948|365977423|FG001|12-month Assessment|Lost to Follow-up|4|||
106086847|NCT02391948|365977424|FG002|12-month Assessment|Lost to Follow-up|4|||
106086848|NCT02391948|365977425|FG003|12-month Assessment|Lost to Follow-up|4|||
106086849|NCT02391948|365977426|FG004|12-month Assessment|Lost to Follow-up|5|||
106086850|NCT02391948|365977422|FG000|12-month Assessment|Medical issue/illness|0|||
106086851|NCT02391948|365977423|FG001|12-month Assessment|Medical issue/illness|1|||
106086852|NCT02391948|365977424|FG002|12-month Assessment|Medical issue/illness|0|||
106086853|NCT02391948|365977425|FG003|12-month Assessment|Medical issue/illness|1|||
106086854|NCT02391948|365977426|FG004|12-month Assessment|Medical issue/illness|0|||
106086855|NCT02391948|365977422|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
106086856|NCT02391948|365977423|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
106086857|NCT02391948|365977424|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
106086858|NCT02391948|365977425|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
106086859|NCT02391948|365977426|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
106086860|NCT02391948|365977422|FG000|18-month Assessment|Death|0|||
106086861|NCT02391948|365977423|FG001|18-month Assessment|Death|0|||
106086862|NCT02391948|365977424|FG002|18-month Assessment|Death|0|||
106086863|NCT02391948|365977425|FG003|18-month Assessment|Death|1|||
106086864|NCT02391948|365977426|FG004|18-month Assessment|Death|1|||
106086865|NCT02391948|365977422|FG000|18-month Assessment|Withdrawal by Subject|1|||
106086866|NCT02391948|365977423|FG001|18-month Assessment|Withdrawal by Subject|0|||
106086867|NCT02391948|365977424|FG002|18-month Assessment|Withdrawal by Subject|0|||
106086868|NCT02391948|365977425|FG003|18-month Assessment|Withdrawal by Subject|1|||
106086869|NCT02391948|365977426|FG004|18-month Assessment|Withdrawal by Subject|0|||
106086870|NCT02391948|365977422|FG000|18-month Assessment|Lost to Follow-up|2|||
106161051|NCT03519581|366252364|FG000|Overall Study|Lost to Follow-up|3|||
106086871|NCT02391948|365977423|FG001|18-month Assessment|Lost to Follow-up|6|||
106086872|NCT02391948|365977424|FG002|18-month Assessment|Lost to Follow-up|2|||
106086873|NCT02391948|365977425|FG003|18-month Assessment|Lost to Follow-up|2|||
106086874|NCT02391948|365977426|FG004|18-month Assessment|Lost to Follow-up|3|||
106086875|NCT02391948|365977422|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
106086876|NCT02391948|365977423|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
106161052|NCT03519581|366252365|FG001|Overall Study|Lost to Follow-up|2|||
106161053|NCT03519581|366252364|FG000|Overall Study|Adverse Event|5|||
106086877|NCT02391948|365977424|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
106086878|NCT02391948|365977425|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
106086879|NCT02391948|365977426|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
106086880|NCT02391948|365977422|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
106086881|NCT02391948|365977423|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
106086882|NCT02391948|365977424|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
106086883|NCT02391948|365977425|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
106086884|NCT02391948|365977426|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
106086885|NCT02391948|365977422|FG000|24-month Assessment|Death|0|||
106086886|NCT02391948|365977423|FG001|24-month Assessment|Death|0|||
106086887|NCT02391948|365977424|FG002|24-month Assessment|Death|0|||
106086888|NCT02391948|365977425|FG003|24-month Assessment|Death|0|||
106086889|NCT02391948|365977426|FG004|24-month Assessment|Death|1|||
106086890|NCT02391948|365977422|FG000|24-month Assessment|Withdrawal by Subject|1|||
106086891|NCT02391948|365977423|FG001|24-month Assessment|Withdrawal by Subject|1|||
106086892|NCT02391948|365977424|FG002|24-month Assessment|Withdrawal by Subject|0|||
106086893|NCT02391948|365977425|FG003|24-month Assessment|Withdrawal by Subject|0|||
106086894|NCT02391948|365977426|FG004|24-month Assessment|Withdrawal by Subject|1|||
106086895|NCT02391948|365977422|FG000|24-month Assessment|Lost to Follow-up|5|||
106086896|NCT02391948|365977423|FG001|24-month Assessment|Lost to Follow-up|4|||
106086897|NCT02391948|365977424|FG002|24-month Assessment|Lost to Follow-up|0|||
106086898|NCT02391948|365977425|FG003|24-month Assessment|Lost to Follow-up|0|||
106086899|NCT02391948|365977426|FG004|24-month Assessment|Lost to Follow-up|0|||
106086900|NCT02391948|365977422|FG000|24-month Assessment|Medical issue/illness|0|||
106086901|NCT02391948|365977423|FG001|24-month Assessment|Medical issue/illness|0|||
106086902|NCT02391948|365977424|FG002|24-month Assessment|Medical issue/illness|1|||
106086903|NCT02391948|365977425|FG003|24-month Assessment|Medical issue/illness|0|||
106086904|NCT02391948|365977426|FG004|24-month Assessment|Medical issue/illness|0|||
106086905|NCT02391948|365977422|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
106086906|NCT02391948|365977423|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
106086907|NCT02391948|365977424|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
106086908|NCT02391948|365977425|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
106086909|NCT02391948|365977426|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
106086910|NCT00023673|365977427|FG000|Overall Study|Ineligible / no protocol treatment|0|||
106086911|NCT00023673|365977428|FG001|Overall Study|Ineligible / no protocol treatment|0|||
106086912|NCT00023673|365977429|FG002|Overall Study|Ineligible / no protocol treatment|0|||
106086913|NCT00023673|365977430|FG003|Overall Study|Ineligible / no protocol treatment|1|||
106086914|NCT00023673|365977427|FG000|Overall Study|Patient withdrew consent|0|||
106086915|NCT00023673|365977428|FG001|Overall Study|Patient withdrew consent|0|||
106086916|NCT00023673|365977429|FG002|Overall Study|Patient withdrew consent|0|||
106086917|NCT00023673|365977430|FG003|Overall Study|Patient withdrew consent|1|||
106086918|NCT02453594|365977431|FG000|Overall Study|Protocol Violation|0|||
106086919|NCT02453594|365977432|FG001|Overall Study|Protocol Violation|0|||
106086920|NCT02453594|365977433|FG002|Overall Study|Protocol Violation|1|||
106086921|NCT02453594|365977431|FG000|Overall Study|Cohort Was Closed|17|||
106086922|NCT02453594|365977432|FG001|Overall Study|Cohort Was Closed|21|||
106086923|NCT02453594|365977433|FG002|Overall Study|Cohort Was Closed|14|||
106086924|NCT02453594|365977431|FG000|Overall Study|Death|20|||
106086925|NCT02453594|365977432|FG001|Overall Study|Death|24|||
106086926|NCT02453594|365977433|FG002|Overall Study|Death|16|||
106086927|NCT02453594|365977431|FG000|Overall Study|Lost to Follow-up|6|||
106086928|NCT02453594|365977432|FG001|Overall Study|Lost to Follow-up|14|||
106086929|NCT02453594|365977433|FG002|Overall Study|Lost to Follow-up|2|||
106086930|NCT02453594|365977431|FG000|Overall Study|Physician Decision|2|||
106086931|NCT02453594|365977432|FG001|Overall Study|Physician Decision|4|||
106086932|NCT02453594|365977433|FG002|Overall Study|Physician Decision|0|||
106086933|NCT02453594|365977431|FG000|Overall Study|Site Terminated by Sponsor|1|||
106086934|NCT02453594|365977432|FG001|Overall Study|Site Terminated by Sponsor|0|||
106086935|NCT02453594|365977433|FG002|Overall Study|Site Terminated by Sponsor|1|||
106086936|NCT02453594|365977431|FG000|Overall Study|Transitioned to Extension Study|16|||
106086937|NCT02453594|365977432|FG001|Overall Study|Transitioned to Extension Study|9|||
106086938|NCT02453594|365977433|FG002|Overall Study|Transitioned to Extension Study|16|||
106086939|NCT02453594|365977431|FG000|Overall Study|Withdrawal by Subject|7|||
106086940|NCT02453594|365977432|FG001|Overall Study|Withdrawal by Subject|9|||
106086941|NCT02453594|365977433|FG002|Overall Study|Withdrawal by Subject|11|||
106086942|NCT01257204|365977448|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
106086943|NCT01257204|365977449|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
106086944|NCT01257204|365977450|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
106086945|NCT01257204|365977448|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
106086946|NCT01257204|365977449|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
106086947|NCT01257204|365977450|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
106086948|NCT01257204|365977448|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
106086949|NCT01257204|365977449|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
106086950|NCT01257204|365977450|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
106086951|NCT01257204|365977448|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
106086952|NCT01257204|365977449|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
106086953|NCT01257204|365977450|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
106086954|NCT01257204|365977448|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
106086955|NCT01257204|365977449|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
106086956|NCT01257204|365977450|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
106086957|NCT01257204|365977448|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
106086958|NCT01257204|365977449|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
106086959|NCT01257204|365977450|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
106086960|NCT01257204|365977448|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
106086961|NCT01257204|365977449|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
106086962|NCT01257204|365977450|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
106086963|NCT01257204|365977448|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
106086964|NCT01257204|365977449|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
106086965|NCT01257204|365977450|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
106086966|NCT01257204|365977448|FG000|Follow-up Period (up to Week 48)|Other|0|||
106086967|NCT01257204|365977449|FG001|Follow-up Period (up to Week 48)|Other|0|||
106086968|NCT01257204|365977450|FG002|Follow-up Period (up to Week 48)|Other|5|||
106086969|NCT03394391|365977452|FG000|Overall Study|Lost to Follow-up|1|||
106086970|NCT03394391|365977453|FG001|Overall Study|Lost to Follow-up|2|||
106086971|NCT00501540|365977454|FG000|Overall Study|Death|5|||
106086972|NCT01797536|365977455|FG000|Overall Study|Adverse Event|0|||
106086973|NCT01797536|365977456|FG001|Overall Study|Adverse Event|1|||
106086974|NCT01797536|365977457|FG002|Overall Study|Adverse Event|0|||
106086975|NCT01797536|365977458|FG003|Overall Study|Adverse Event|0|||
106086976|NCT00098839|365977459|FG000|Overall Study|Adverse Event|5|||
106086977|NCT00098839|365977460|FG001|Overall Study|Adverse Event|2|||
106086978|NCT00098839|365977459|FG000|Overall Study|Death|1|||
106086979|NCT00098839|365977460|FG001|Overall Study|Death|2|||
106086980|NCT00098839|365977459|FG000|Overall Study|Physician Decision|4|||
106086981|NCT00098839|365977460|FG001|Overall Study|Physician Decision|14|||
106086982|NCT00098839|365977459|FG000|Overall Study|Withdrawal by Subject|1|||
106086983|NCT00098839|365977460|FG001|Overall Study|Withdrawal by Subject|0|||
106086984|NCT00098839|365977459|FG000|Overall Study|Refusal of further protocol therapy|3|||
106086985|NCT00098839|365977460|FG001|Overall Study|Refusal of further protocol therapy|1|||
106086986|NCT00098839|365977459|FG000|Overall Study|Relapse|6|||
106086987|NCT00098839|365977460|FG001|Overall Study|Relapse|3|||
106086988|NCT00098839|365977459|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
106086989|NCT00098839|365977460|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
106086990|NCT00098839|365977459|FG000|Overall Study|Ineligible|2|||
106086991|NCT00098839|365977460|FG001|Overall Study|Ineligible|0|||
106086992|NCT00120042|365977465|FG000|Overall Study|all completed protocl|0|||
106086993|NCT00120042|365977466|FG001|Overall Study|all completed protocl|0|||
106086994|NCT00120042|365977467|FG002|Overall Study|all completed protocl|0|||
106086995|NCT04532112|365977468|FG000|Overall Study|Adverse Event|3|||
106086996|NCT04532112|365977469|FG001|Overall Study|Adverse Event|0|||
106086997|NCT01532687|365977472|FG000|Overall Study|Death|2|||
106086998|NCT01532687|365977473|FG001|Overall Study|Death|0|||
106086999|NCT01532687|365977472|FG000|Overall Study|Adverse Event|6|||
106087000|NCT01532687|365977473|FG001|Overall Study|Adverse Event|1|||
106087001|NCT01532687|365977472|FG000|Overall Study|Withdrawal by Subject|1|||
106087002|NCT01532687|365977473|FG001|Overall Study|Withdrawal by Subject|0|||
106087003|NCT01532687|365977472|FG000|Overall Study|Physician Decision|2|||
106087004|NCT01532687|365977473|FG001|Overall Study|Physician Decision|1|||
106087005|NCT01532687|365977472|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
106087006|NCT01532687|365977473|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
106087007|NCT00807092|365977474|FG000|Overall Study|Adverse Event|0|||
106087008|NCT00807092|365977475|FG001|Overall Study|Adverse Event|1|||
106087009|NCT00807092|365977474|FG000|Overall Study|Protocol Violation|0|||
106087010|NCT00807092|365977475|FG001|Overall Study|Protocol Violation|2|||
106087011|NCT00807092|365977474|FG000|Overall Study|Withdrawal by Subject|1|||
106087012|NCT00807092|365977475|FG001|Overall Study|Withdrawal by Subject|0|||
106161054|NCT03519581|366252365|FG001|Overall Study|Adverse Event|2|||
106161055|NCT03519581|366252364|FG000|Overall Study|Withdrawal by Subject|2|||
106087013|NCT00807092|365977474|FG000|Overall Study|CGMS data collection failed|0|||
106087014|NCT00807092|365977475|FG001|Overall Study|CGMS data collection failed|1|||
106087015|NCT02809976|365977482|FG000|Overall Study|Lost to Follow-up|1|||
106087016|NCT02809976|365977482|FG000|Overall Study|Withdrawal by Subject|1|||
106087017|NCT01859715|365977485|FG000|Overall Study|No 2nd VAS|16|||
106087018|NCT01859715|365977486|FG001|Overall Study|No 2nd VAS|8|||
106087019|NCT01859715|365977487|FG002|Overall Study|No 2nd VAS|23|||
106087020|NCT00720876|365977490|FG000|Overall Study|found to be ineligible after starting tx|2|||
106087021|NCT00079274|365977496|FG000|Overall Study|Withdrawal by Subject|111|||
106087022|NCT00079274|365977497|FG001|Overall Study|Withdrawal by Subject|10|||
106087023|NCT00079274|365977498|FG002|Overall Study|Withdrawal by Subject|12|||
106087024|NCT00079274|365977499|FG003|Overall Study|Withdrawal by Subject|163|||
106087025|NCT00079274|365977500|FG004|Overall Study|Withdrawal by Subject|7|||
106087026|NCT00079274|365977501|FG005|Overall Study|Withdrawal by Subject|8|||
106087027|NCT00079274|365977502|FG006|Overall Study|Withdrawal by Subject|0|||
106087028|NCT00079274|365977496|FG000|Overall Study|Adverse Event|130|||
106087029|NCT00079274|365977497|FG001|Overall Study|Adverse Event|8|||
106087030|NCT00079274|365977498|FG002|Overall Study|Adverse Event|8|||
106087031|NCT00079274|365977499|FG003|Overall Study|Adverse Event|184|||
106087032|NCT00079274|365977500|FG004|Overall Study|Adverse Event|7|||
106087033|NCT00079274|365977501|FG005|Overall Study|Adverse Event|8|||
106087034|NCT00079274|365977502|FG006|Overall Study|Adverse Event|0|||
106087035|NCT00079274|365977496|FG000|Overall Study|Recurrence|21|||
106087036|NCT00079274|365977497|FG001|Overall Study|Recurrence|0|||
106087037|NCT00079274|365977498|FG002|Overall Study|Recurrence|1|||
106087038|NCT00079274|365977499|FG003|Overall Study|Recurrence|15|||
106087039|NCT00079274|365977500|FG004|Overall Study|Recurrence|0|||
106087040|NCT00079274|365977501|FG005|Overall Study|Recurrence|2|||
106087041|NCT00079274|365977502|FG006|Overall Study|Recurrence|0|||
106087042|NCT00079274|365977496|FG000|Overall Study|Alternate Treatment|6|||
106087043|NCT00079274|365977497|FG001|Overall Study|Alternate Treatment|1|||
106087044|NCT00079274|365977498|FG002|Overall Study|Alternate Treatment|0|||
106087045|NCT00079274|365977499|FG003|Overall Study|Alternate Treatment|3|||
106087046|NCT00079274|365977500|FG004|Overall Study|Alternate Treatment|0|||
106087047|NCT00079274|365977501|FG005|Overall Study|Alternate Treatment|0|||
106087048|NCT00079274|365977502|FG006|Overall Study|Alternate Treatment|0|||
106087049|NCT00079274|365977496|FG000|Overall Study|Other Medical Problems|6|||
106087050|NCT00079274|365977497|FG001|Overall Study|Other Medical Problems|1|||
106087051|NCT00079274|365977498|FG002|Overall Study|Other Medical Problems|0|||
106087052|NCT00079274|365977499|FG003|Overall Study|Other Medical Problems|7|||
106087053|NCT00079274|365977500|FG004|Overall Study|Other Medical Problems|0|||
106087054|NCT00079274|365977501|FG005|Overall Study|Other Medical Problems|0|||
106087055|NCT00079274|365977502|FG006|Overall Study|Other Medical Problems|0|||
106087056|NCT00079274|365977496|FG000|Overall Study|Death|4|||
106087057|NCT00079274|365977497|FG001|Overall Study|Death|0|||
106087058|NCT00079274|365977498|FG002|Overall Study|Death|1|||
106087059|NCT00079274|365977499|FG003|Overall Study|Death|15|||
106087060|NCT00079274|365977500|FG004|Overall Study|Death|0|||
106087061|NCT00079274|365977501|FG005|Overall Study|Death|0|||
106087062|NCT00079274|365977502|FG006|Overall Study|Death|0|||
106087063|NCT00079274|365977496|FG000|Overall Study|Cytogenetic resistance|0|||
106087064|NCT00079274|365977497|FG001|Overall Study|Cytogenetic resistance|0|||
106087065|NCT00079274|365977498|FG002|Overall Study|Cytogenetic resistance|0|||
106087066|NCT00079274|365977499|FG003|Overall Study|Cytogenetic resistance|2|||
106087067|NCT00079274|365977500|FG004|Overall Study|Cytogenetic resistance|0|||
106087068|NCT00079274|365977501|FG005|Overall Study|Cytogenetic resistance|0|||
106087069|NCT00079274|365977502|FG006|Overall Study|Cytogenetic resistance|0|||
106087070|NCT00079274|365977496|FG000|Overall Study|Other|43|||
106087071|NCT00079274|365977497|FG001|Overall Study|Other|7|||
106087072|NCT00079274|365977498|FG002|Overall Study|Other|5|||
106087073|NCT00079274|365977499|FG003|Overall Study|Other|55|||
106087074|NCT00079274|365977500|FG004|Overall Study|Other|1|||
106087075|NCT00079274|365977501|FG005|Overall Study|Other|2|||
106087076|NCT00079274|365977502|FG006|Overall Study|Other|0|||
106087077|NCT01611259|365977506|FG000|Overall Study|Physician Decision|1|||
106087078|NCT01611259|365977506|FG000|Overall Study|Lack of Efficacy|2|||
106087079|NCT01611259|365977506|FG000|Overall Study|Adverse Event|4|||
106087080|NCT01611259|365977506|FG000|Overall Study|Withdrawal by Subject|7|||
106087081|NCT00684424|365977511|FG000|Overall Study|Adverse Event|1|||
106087082|NCT00684424|365977511|FG000|Overall Study|Lost to Follow-up|2|||
106087083|NCT00684424|365977511|FG000|Overall Study|Other|2|||
106087084|NCT03056690|365977512|FG000|Overall Study|Adverse Event|3|||
106087085|NCT03056690|365977513|FG001|Overall Study|Adverse Event|2|||
106087086|NCT03056690|365977512|FG000|Overall Study|Lack of Efficacy|1|||
106087087|NCT03056690|365977513|FG001|Overall Study|Lack of Efficacy|2|||
106087088|NCT03056690|365977512|FG000|Overall Study|Lost to Follow-up|3|||
106087089|NCT03056690|365977513|FG001|Overall Study|Lost to Follow-up|2|||
106087090|NCT03056690|365977512|FG000|Overall Study|Protocol Violation|2|||
106087091|NCT03056690|365977513|FG001|Overall Study|Protocol Violation|2|||
106087092|NCT03056690|365977512|FG000|Overall Study|Withdrawal by Subject|3|||
106087093|NCT03056690|365977513|FG001|Overall Study|Withdrawal by Subject|6|||
106087094|NCT03056690|365977512|FG000|Overall Study|Non-compliance with Study Drug|1|||
106087095|NCT03056690|365977513|FG001|Overall Study|Non-compliance with Study Drug|0|||
106087096|NCT03056690|365977512|FG000|Overall Study|Miscellaneous|1|||
106087097|NCT03056690|365977513|FG001|Overall Study|Miscellaneous|2|||
106087098|NCT02052739|365977514|FG000|Overall Study|Withdrew due to Adverse Event|3|||
106087099|NCT02052739|365977515|FG001|Overall Study|Withdrew due to Adverse Event|0|||
106087100|NCT02052739|365977514|FG000|Overall Study|Participant Died|2|||
106087101|NCT02052739|365977515|FG001|Overall Study|Participant Died|1|||
106087102|NCT01469065|365977517|FG000|Overall Study|Lack of Efficacy|0|||
106087103|NCT01469065|365977518|FG001|Overall Study|Lack of Efficacy|0|||
106087104|NCT01469065|365977519|FG002|Overall Study|Lack of Efficacy|0|||
106087105|NCT01469065|365977520|FG003|Overall Study|Lack of Efficacy|0|||
106087106|NCT01469065|365977521|FG004|Overall Study|Lack of Efficacy|1|||
106087107|NCT01469065|365977517|FG000|Overall Study|Other|0|||
106087108|NCT01469065|365977518|FG001|Overall Study|Other|1|||
106087109|NCT01469065|365977519|FG002|Overall Study|Other|0|||
106087110|NCT01469065|365977520|FG003|Overall Study|Other|0|||
106087111|NCT01469065|365977521|FG004|Overall Study|Other|0|||
106087112|NCT03511560|365977524|FG000|Overall Study|Death|0|||
106087113|NCT03511560|365977525|FG001|Overall Study|Death|1|||
106087114|NCT03511560|365977524|FG000|Overall Study|Adverse Event|0|||
106087115|NCT03511560|365977525|FG001|Overall Study|Adverse Event|2|||
106087116|NCT03511560|365977524|FG000|Overall Study|Transplant cancelled|0|||
106087117|NCT03511560|365977525|FG001|Overall Study|Transplant cancelled|1|||
106087118|NCT03511560|365977524|FG000|Overall Study|Patient switched to another drug|1|||
106087119|NCT03511560|365977525|FG001|Overall Study|Patient switched to another drug|0|||
106087120|NCT03049813|365977526|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
106087121|NCT03049813|365977527|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
106087122|NCT03049813|365977528|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
106087123|NCT03049813|365977529|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
106087124|NCT03049813|365977526|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
106087125|NCT03049813|365977527|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
106087126|NCT03049813|365977528|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
106087127|NCT03049813|365977529|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
106087128|NCT03049813|365977526|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
106087129|NCT03049813|365977527|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
106087130|NCT03049813|365977528|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
106087131|NCT03049813|365977529|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
106087132|NCT03049813|365977526|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
106087133|NCT03049813|365977527|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
106087134|NCT03049813|365977528|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
106087135|NCT03049813|365977529|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
106087136|NCT00550836|365977530|FG000|Overall Study|Withdrawal by Subject|3|||
106087137|NCT00550836|365977531|FG001|Overall Study|Withdrawal by Subject|9|||
106087138|NCT01813019|365977534|FG000|Overall Study|Adverse Event|0|||
106087139|NCT01813019|365977535|FG001|Overall Study|Adverse Event|3|||
106087140|NCT01813019|365977534|FG000|Overall Study|Withdrawal by Subject|3|||
106087141|NCT01813019|365977535|FG001|Overall Study|Withdrawal by Subject|2|||
106087142|NCT01813019|365977534|FG000|Overall Study|administrative problems|2|||
106087143|NCT01813019|365977535|FG001|Overall Study|administrative problems|0|||
106087144|NCT01813019|365977534|FG000|Overall Study|Protocol Deviation|2|||
106087145|NCT01813019|365977535|FG001|Overall Study|Protocol Deviation|1|||
106087146|NCT00439140|365977537|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
106087147|NCT00439140|365977538|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
106087148|NCT00439140|365977539|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
106087149|NCT00439140|365977537|FG000|Treatment Cycle 1|Personal reasons|0|||
106087150|NCT00439140|365977538|FG001|Treatment Cycle 1|Personal reasons|2|||
106087151|NCT00439140|365977539|FG002|Treatment Cycle 1|Personal reasons|0|||
106087152|NCT00439140|365977537|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
106087153|NCT00439140|365977538|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
106087154|NCT00439140|365977539|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
106087155|NCT00439140|365977537|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
106087156|NCT00439140|365977538|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
106087157|NCT00439140|365977539|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
106087158|NCT00439140|365977537|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
106087159|NCT00439140|365977538|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
106087160|NCT00439140|365977539|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
106087161|NCT01723904|365977540|FG000|Overall Study|Noncompliant|3|||
106087162|NCT01723904|365977540|FG000|Overall Study|Adverse Event|5|||
106087163|NCT01723904|365977540|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
106087164|NCT01458171|365977541|FG000|Overall Study|Adverse Event|1|||
106087165|NCT01193556|365977544|FG000|Overall Study|Study termination|26|||
106087166|NCT01193556|365977545|FG001|Overall Study|Study termination|25|||
106087167|NCT03169153|365977546|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
106087168|NCT03169153|365977547|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
106087169|NCT03169153|365977546|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
106087170|NCT03169153|365977547|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
106087171|NCT03169153|365977546|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
106087172|NCT03169153|365977547|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
106087173|NCT03169153|365977546|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
106087174|NCT03169153|365977547|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
106087175|NCT02617589|365977548|FG000|Randomization|Request to Discontinue Study Treatment|1|||
106087176|NCT02617589|365977549|FG001|Randomization|Request to Discontinue Study Treatment|3|||
106087177|NCT02617589|365977548|FG000|Randomization|Participant Withdrew Consent|1|||
106087178|NCT02617589|365977549|FG001|Randomization|Participant Withdrew Consent|2|||
106087179|NCT02617589|365977548|FG000|Treatment|Other Reasons|3|||
106087180|NCT02617589|365977549|FG001|Treatment|Other Reasons|3|||
106087181|NCT02617589|365977548|FG000|Treatment|Poor/Non Compliance|1|||
106087182|NCT02617589|365977549|FG001|Treatment|Poor/Non Compliance|1|||
106087183|NCT02617589|365977548|FG000|Treatment|Maximum Clinical Benefit|0|||
106087184|NCT02617589|365977549|FG001|Treatment|Maximum Clinical Benefit|2|||
106087185|NCT02617589|365977548|FG000|Treatment|Participant Withdrew Consent|2|||
106087186|NCT02617589|365977549|FG001|Treatment|Participant Withdrew Consent|6|||
106087187|NCT02617589|365977548|FG000|Treatment|Participant Request to Discontinue|12|||
106087188|NCT02617589|365977549|FG001|Treatment|Participant Request to Discontinue|21|||
106087189|NCT02617589|365977548|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
106087190|NCT02617589|365977549|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
106087191|NCT02617589|365977548|FG000|Treatment|Death|1|||
106087192|NCT02617589|365977549|FG001|Treatment|Death|1|||
106087193|NCT02617589|365977548|FG000|Treatment|Study Drug Toxicity|27|||
106087194|NCT02617589|365977549|FG001|Treatment|Study Drug Toxicity|20|||
106087195|NCT02617589|365977548|FG000|Treatment|Disease Progression|216|||
106087196|NCT02617589|365977549|FG001|Treatment|Disease Progression|136|||
106087197|NCT02138214|365977552|FG000|Overall Study|Withdrawal by Subject|0|||
106087198|NCT02138214|365977553|FG001|Overall Study|Withdrawal by Subject|1|||
106087199|NCT02138214|365977554|FG002|Overall Study|Withdrawal by Subject|0|||
106087200|NCT02138214|365977552|FG000|Overall Study|Lost to Follow-up|0|||
106087201|NCT02138214|365977553|FG001|Overall Study|Lost to Follow-up|2|||
106087202|NCT02138214|365977554|FG002|Overall Study|Lost to Follow-up|4|||
106087203|NCT02138214|365977552|FG000|Overall Study|Screen Failure|0|||
106087204|NCT02138214|365977553|FG001|Overall Study|Screen Failure|1|||
106087205|NCT02138214|365977554|FG002|Overall Study|Screen Failure|0|||
106087206|NCT04666259|365977565|FG000|Treatment Phase|Physician Decision|9|||
106087207|NCT04666259|365977566|FG001|Treatment Phase|Physician Decision|3|||
106087208|NCT04666259|365977567|FG002|Treatment Phase|Physician Decision|3|||
106087209|NCT04666259|365977565|FG000|Treatment Phase|Adverse Event|3|||
106087210|NCT04666259|365977566|FG001|Treatment Phase|Adverse Event|1|||
106087211|NCT04666259|365977567|FG002|Treatment Phase|Adverse Event|0|||
106087212|NCT04666259|365977565|FG000|Treatment Phase|Subject decision|1|||
106087213|NCT04666259|365977566|FG001|Treatment Phase|Subject decision|2|||
106087214|NCT04666259|365977567|FG002|Treatment Phase|Subject decision|0|||
106087215|NCT04666259|365977565|FG000|Treatment Phase|Progressive disease|0|||
106087216|NCT04666259|365977566|FG001|Treatment Phase|Progressive disease|1|||
106087217|NCT04666259|365977567|FG002|Treatment Phase|Progressive disease|0|||
106087218|NCT04666259|365977565|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
106087219|NCT04666259|365977566|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
106087220|NCT04666259|365977567|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
106087221|NCT04666259|365977565|FG000|Safety Follow-up Phase|Physician Decision|2|||
106087222|NCT04666259|365977566|FG001|Safety Follow-up Phase|Physician Decision|0|||
106087223|NCT04666259|365977567|FG002|Safety Follow-up Phase|Physician Decision|0|||
106087224|NCT04666259|365977565|FG000|Safety Follow-up Phase|Subject decision|1|||
106087225|NCT04666259|365977566|FG001|Safety Follow-up Phase|Subject decision|0|||
106087226|NCT04666259|365977567|FG002|Safety Follow-up Phase|Subject decision|0|||
106087227|NCT04666259|365977565|FG000|Safety Follow-up Phase|Death|0|||
106087228|NCT04666259|365977566|FG001|Safety Follow-up Phase|Death|1|||
106087229|NCT04666259|365977567|FG002|Safety Follow-up Phase|Death|0|||
106087230|NCT02127307|365977568|FG000|Overall Study|Protocol Violation|36|||
106087231|NCT02127307|365977568|FG000|Overall Study|Lost to Follow-up|2|||
106087232|NCT02127307|365977568|FG000|Overall Study|Death|101|||
106087233|NCT02127307|365977568|FG000|Overall Study|Other than specified above|169|||
106087234|NCT01079234|365977571|FG000|Main: Week 0 to 26|Adverse Event|5|||
106087235|NCT01079234|365977572|FG001|Main: Week 0 to 26|Adverse Event|4|||
106087236|NCT01079234|365977573|FG002|Main: Week 0 to 26|Adverse Event|1|||
106087237|NCT01079234|365977574|FG003|Main: Week 0 to 26|Adverse Event|0|||
106087238|NCT01079234|365977571|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
106087239|NCT01079234|365977572|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
106087240|NCT01079234|365977573|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
106087241|NCT01079234|365977574|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
106087242|NCT01079234|365977571|FG000|Main: Week 0 to 26|Protocol Violation|6|||
106087243|NCT01079234|365977572|FG001|Main: Week 0 to 26|Protocol Violation|2|||
106087244|NCT01079234|365977573|FG002|Main: Week 0 to 26|Protocol Violation|4|||
106087245|NCT01079234|365977574|FG003|Main: Week 0 to 26|Protocol Violation|0|||
106087246|NCT01079234|365977571|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
106087247|NCT01079234|365977572|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
106087248|NCT01079234|365977573|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
106087249|NCT01079234|365977574|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
106087250|NCT01079234|365977571|FG000|Main: Week 0 to 26|Unclassified|7|||
106087251|NCT01079234|365977572|FG001|Main: Week 0 to 26|Unclassified|13|||
106087252|NCT01079234|365977573|FG002|Main: Week 0 to 26|Unclassified|4|||
106087253|NCT01079234|365977574|FG003|Main: Week 0 to 26|Unclassified|0|||
106087254|NCT01079234|365977571|FG000|Extension: Week 27 to 52|Adverse Event|0|||
106087255|NCT01079234|365977572|FG001|Extension: Week 27 to 52|Adverse Event|0|||
106087256|NCT01079234|365977573|FG002|Extension: Week 27 to 52|Adverse Event|1|||
106087257|NCT01079234|365977574|FG003|Extension: Week 27 to 52|Adverse Event|0|||
106087258|NCT01079234|365977571|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
106087259|NCT01079234|365977572|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
106087260|NCT01079234|365977573|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
106087261|NCT01079234|365977574|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
106087262|NCT01079234|365977571|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
106087263|NCT01079234|365977572|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
106087264|NCT01079234|365977573|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
106087265|NCT01079234|365977574|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
106087266|NCT01079234|365977571|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
106087267|NCT01079234|365977572|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
106087268|NCT01079234|365977573|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
106087269|NCT01079234|365977574|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
106087270|NCT01079234|365977571|FG000|Extension: Week 27 to 52|Unclassified|0|||
106087271|NCT01079234|365977572|FG001|Extension: Week 27 to 52|Unclassified|0|||
106087272|NCT01079234|365977573|FG002|Extension: Week 27 to 52|Unclassified|4|||
106087273|NCT01079234|365977574|FG003|Extension: Week 27 to 52|Unclassified|7|||
106087274|NCT00235989|365977579|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
106087275|NCT00235989|365977580|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
106087276|NCT00235989|365977581|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
106087277|NCT00235989|365977582|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
106087278|NCT00235989|365977583|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
106087279|NCT00235989|365977584|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
106087280|NCT00235989|365977579|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
106087281|NCT00235989|365977580|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
106087282|NCT00235989|365977581|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
106087283|NCT00235989|365977582|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
106087284|NCT00235989|365977583|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
106087285|NCT00235989|365977584|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
106087286|NCT00235989|365977579|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
106087287|NCT00235989|365977580|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
106087288|NCT00235989|365977581|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
106087289|NCT00235989|365977582|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
106087290|NCT00235989|365977583|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
106087291|NCT00235989|365977584|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
106087292|NCT00235989|365977579|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
106087293|NCT00235989|365977580|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
106087294|NCT00235989|365977581|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
106087295|NCT00235989|365977582|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
106087296|NCT00235989|365977583|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
106087297|NCT00235989|365977584|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
106087298|NCT00235989|365977579|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
106087299|NCT00235989|365977580|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
106087300|NCT00235989|365977581|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
106087301|NCT00235989|365977582|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
106087302|NCT00235989|365977583|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
106087303|NCT00235989|365977584|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
106087304|NCT04545515|365977592|FG000|Overall Study|Adverse Event|1|||
106087305|NCT04545515|365977592|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
106087306|NCT04545515|365977592|FG000|Overall Study|Commercial drug is available for participant|7|||
106087307|NCT04035486|365977593|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
106087308|NCT04035486|365977594|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
106087309|NCT04035486|365977595|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
106087310|NCT04035486|365977596|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
106087311|NCT04035486|365977593|FG000|Overall Study|Death|6|||
106087312|NCT04035486|365977594|FG001|Overall Study|Death|3|||
106087313|NCT04035486|365977595|FG002|Overall Study|Death|70|||
106087314|NCT04035486|365977596|FG003|Overall Study|Death|77|||
106087315|NCT04035486|365977593|FG000|Overall Study|Screen Failure|0|||
106087316|NCT04035486|365977594|FG001|Overall Study|Screen Failure|0|||
106087317|NCT04035486|365977595|FG002|Overall Study|Screen Failure|1|||
106087318|NCT04035486|365977596|FG003|Overall Study|Screen Failure|1|||
106087319|NCT04035486|365977593|FG000|Overall Study|Withdrawal by Subject|1|||
106087320|NCT04035486|365977594|FG001|Overall Study|Withdrawal by Subject|1|||
106087321|NCT04035486|365977595|FG002|Overall Study|Withdrawal by Subject|11|||
106087322|NCT04035486|365977596|FG003|Overall Study|Withdrawal by Subject|9|||
106087323|NCT01976845|365977597|FG000|Overall Study|Physician Decision|8|||
106087324|NCT01976845|365977598|FG001|Overall Study|Physician Decision|8|||
106087325|NCT01976845|365977599|FG002|Overall Study|Physician Decision|3|||
106087326|NCT00774995|365977602|FG000|Overall Study|Protocol Violation|0|||
106087327|NCT00774995|365977603|FG001|Overall Study|Protocol Violation|0|||
106087328|NCT00774995|365977604|FG002|Overall Study|Protocol Violation|1|||
106087329|NCT00774995|365977605|FG003|Overall Study|Protocol Violation|0|||
106087330|NCT03568461|365977609|FG000|Overall Study|Death|7|||
106087331|NCT03568461|365977609|FG000|Overall Study|Physician Decision|5|||
106087332|NCT03568461|365977609|FG000|Overall Study|Subject decision|5|||
106087333|NCT03568461|365977609|FG000|Overall Study|Lost to Follow-up|1|||
106087334|NCT01818336|365979317|FG000|Overall Study|Declined retest visit|0|||
106087335|NCT01818336|365979318|FG001|Overall Study|Declined retest visit|11|||
106087336|NCT01818336|365979317|FG000|Overall Study|Lost to Follow-up|0|||
106087337|NCT01818336|365979318|FG001|Overall Study|Lost to Follow-up|1|||
106087338|NCT00612066|365979323|FG000|Overall Study|Adverse Event|1|||
106087339|NCT00844545|365979326|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
106087340|NCT00844545|365979326|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
106087341|NCT00844545|365979326|FG000|Extension Treatment Period|Adverse Event|2|||
106087342|NCT00844545|365979326|FG000|Post Treatment Period|Withdrawal by Subject|1|||
106087343|NCT01743092|365979327|FG000|Overall Study|Lost to Follow-up|14|||
106087344|NCT01743092|365979328|FG001|Overall Study|Lost to Follow-up|15|||
106087345|NCT01794949|365979332|FG000|Overall Study|Lost to Follow-up|1|||
106087346|NCT01794949|365979333|FG001|Overall Study|Lost to Follow-up|0|||
106087347|NCT00087568|365979334|FG000|Overall Study|Adverse Event|4|||
106087348|NCT00087568|365979335|FG001|Overall Study|Adverse Event|0|||
106087349|NCT00087568|365979334|FG000|Overall Study|Withdrawal by Subject|1|||
106087350|NCT00087568|365979335|FG001|Overall Study|Withdrawal by Subject|1|||
106087351|NCT00087568|365979334|FG000|Overall Study|Lost to Follow-up|1|||
106087352|NCT00087568|365979335|FG001|Overall Study|Lost to Follow-up|0|||
106087353|NCT00087568|365979334|FG000|Overall Study|Lack of Efficacy|24|||
106087354|NCT00087568|365979335|FG001|Overall Study|Lack of Efficacy|1|||
106087355|NCT02984995|365979336|FG000|Overall Study|Required stem cell transplant|13|||
106087356|NCT02984995|365979337|FG001|Overall Study|Required stem cell transplant|2|||
106087357|NCT02984995|365979336|FG000|Overall Study|Progressive disease|11|||
106087358|NCT02984995|365979337|FG001|Overall Study|Progressive disease|1|||
106087359|NCT02984995|365979336|FG000|Overall Study|Adverse Event|1|||
106087360|NCT02984995|365979337|FG001|Overall Study|Adverse Event|0|||
106087361|NCT02732847|365979338|FG000|Overall Study|some filled early|42|||
106087362|NCT02732847|365979339|FG001|Overall Study|some filled early|42|||
106087363|NCT02370888|365979340|FG000|Overall Study|disease progression|2|||
106087364|NCT02370888|365979340|FG000|Overall Study|did not meet chimerism criteria|6|||
106087365|NCT04574362|365979341|FG000|Overall Study|Other|0|||
106087366|NCT04574362|365979342|FG001|Overall Study|Other|5|||
106087367|NCT04574362|365979341|FG000|Overall Study|COVID-19|0|||
106087368|NCT04574362|365979342|FG001|Overall Study|COVID-19|1|||
106087369|NCT04574362|365979341|FG000|Overall Study|Adverse Event|1|||
106087370|NCT04574362|365979342|FG001|Overall Study|Adverse Event|1|||
106087371|NCT04574362|365979341|FG000|Overall Study|Withdrawal by Subject|2|||
106087372|NCT04574362|365979342|FG001|Overall Study|Withdrawal by Subject|4|||
106087373|NCT04574362|365979341|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
106087374|NCT04574362|365979342|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
106087375|NCT04574362|365979341|FG000|Overall Study|Participant refused to come to the hospital|1|||
106087376|NCT04574362|365979342|FG001|Overall Study|Participant refused to come to the hospital|0|||
106087377|NCT04574362|365979341|FG000|Overall Study|Participant refused the visit|1|||
106087378|NCT04574362|365979342|FG001|Overall Study|Participant refused the visit|0|||
106087379|NCT04574362|365979341|FG000|Overall Study|Participant quit early because of business trip|1|||
106087380|NCT04574362|365979342|FG001|Overall Study|Participant quit early because of business trip|0|||
106087381|NCT01600040|365979343|FG000|Overall Study|Withdrawal by Subject|1|||
106087382|NCT00812812|365979346|FG000|Overall Study|Adverse Event|2|||
106087383|NCT00812812|365979347|FG001|Overall Study|Adverse Event|1|||
106087384|NCT00812812|365979346|FG000|Overall Study|Lack of Efficacy|1|||
106087385|NCT00812812|365979347|FG001|Overall Study|Lack of Efficacy|0|||
106087386|NCT00812812|365979346|FG000|Overall Study|Lost to Follow-up|0|||
106087387|NCT00812812|365979347|FG001|Overall Study|Lost to Follow-up|1|||
106087388|NCT00812812|365979346|FG000|Overall Study|Withdrawal by Subject|0|||
106087389|NCT00812812|365979347|FG001|Overall Study|Withdrawal by Subject|2|||
106087390|NCT03755765|365979348|FG000|Overall Study|Withdrawal by Subject|2|||
106087391|NCT03755765|365979349|FG001|Overall Study|Withdrawal by Subject|4|||
106087392|NCT03755765|365979350|FG002|Overall Study|Withdrawal by Subject|4|||
106087393|NCT00111228|365979351|FG000|Overall Study|Withdrawal by Subject|5|||
106087394|NCT00111228|365979352|FG001|Overall Study|Withdrawal by Subject|1|||
106087395|NCT00111228|365979353|FG002|Overall Study|Withdrawal by Subject|0|||
106087396|NCT00678691|365979354|FG000|Overall Study|Adverse Event|6|||
106087397|NCT00678691|365979355|FG001|Overall Study|Adverse Event|4|||
106087398|NCT00779766|365979356|FG000|Month 24|Serious Adverse Event|2|||
106087399|NCT00779766|365979357|FG001|Month 24|Serious Adverse Event|3|||
106087400|NCT00779766|365979356|FG000|Month 24|Adverse Event|3|||
106087401|NCT00779766|365979357|FG001|Month 24|Adverse Event|3|||
106087402|NCT00779766|365979356|FG000|Month 24|Protocol Violation|3|||
106087403|NCT00779766|365979357|FG001|Month 24|Protocol Violation|1|||
106087404|NCT00779766|365979356|FG000|Month 24|Withdrawal by Subject|159|||
106087405|NCT00779766|365979357|FG001|Month 24|Withdrawal by Subject|127|||
106087406|NCT00779766|365979356|FG000|Month 24|Migrated/moved from study area|138|||
106087407|NCT00779766|365979357|FG001|Month 24|Migrated/moved from study area|162|||
106087408|NCT00779766|365979356|FG000|Month 24|Lost to Follow-up|9|||
106087409|NCT00779766|365979357|FG001|Month 24|Lost to Follow-up|9|||
106161056|NCT03519581|366252365|FG001|Overall Study|Withdrawal by Subject|0|||
106161057|NCT03519581|366252364|FG000|Overall Study|Change to insurance|2|||
106161058|NCT03519581|366252365|FG001|Overall Study|Change to insurance|1|||
106161059|NCT03519581|366252364|FG000|Overall Study|Other|2|||
106161060|NCT03519581|366252365|FG001|Overall Study|Other|4|||
106161061|NCT05268393|366252366|FG000|Overall Study|Withdrawal by Subject|2|||
106161062|NCT05268393|366252367|FG001|Overall Study|Withdrawal by Subject|1|||
106161063|NCT03396926|366252368|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
106161064|NCT03396926|366252369|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
106161065|NCT06414213|366252370|FG000|Overall Study|Lost to Follow-up|1|||
106161066|NCT06414213|366252371|FG001|Overall Study|Lost to Follow-up|1|||
106161067|NCT06414213|366252372|FG002|Overall Study|Lost to Follow-up|3|||
106161068|NCT04515576|366252373|FG000|Overall Study|Withdrawal by Subject|0|||
106161069|NCT04515576|366252374|FG001|Overall Study|Withdrawal by Subject|0|||
106161070|NCT04515576|366252375|FG002|Overall Study|Withdrawal by Subject|0|||
106161071|NCT04515576|366252376|FG003|Overall Study|Withdrawal by Subject|0|||
106161072|NCT04515576|366252377|FG004|Overall Study|Withdrawal by Subject|0|||
106161073|NCT04515576|366252378|FG005|Overall Study|Withdrawal by Subject|1|||
106161074|NCT01081951|366252379|FG000|Overall Study|Death|54|||
106161075|NCT01081951|366252380|FG001|Overall Study|Death|47|||
106161076|NCT01081951|366252379|FG000|Overall Study|Withdrawal by Subject|2|||
106161077|NCT01081951|366252380|FG001|Overall Study|Withdrawal by Subject|6|||
106161078|NCT01081951|366252379|FG000|Overall Study|Allocated treatment but did not take it|0|||
106161079|NCT01081951|366252380|FG001|Overall Study|Allocated treatment but did not take it|1|||
106161080|NCT01081951|366252379|FG000|Overall Study|Lost to Follow-up|0|||
106161081|NCT01081951|366252380|FG001|Overall Study|Lost to Follow-up|1|||
106161082|NCT04728347|366252381|FG000|Overall Study|Sponsor decision|0|||
106161083|NCT04728347|366252382|FG001|Overall Study|Sponsor decision|0|||
106161084|NCT04728347|366252383|FG002|Overall Study|Sponsor decision|1|||
106161085|NCT04728347|366252384|FG003|Overall Study|Sponsor decision|0|||
106087410|NCT00779766|365979356|FG000|Month 24|Other|18|||
106087411|NCT00779766|365979357|FG001|Month 24|Other|27|||
106087412|NCT00779766|365979356|FG000|Month 48|Withdrawal by Subject|68|||
106161118|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Other|0|||
106161119|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Other|0|||
106161120|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Other|0|||
106161121|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Other|0|||
106161122|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Other|0|||
106087413|NCT00779766|365979357|FG001|Month 48|Withdrawal by Subject|63|||
106087414|NCT00779766|365979356|FG000|Month 48|Migrated/moved from study area|76|||
106087415|NCT00779766|365979357|FG001|Month 48|Migrated/moved from study area|75|||
106087416|NCT00779766|365979356|FG000|Month 48|Lost to Follow-up|29|||
106087417|NCT00779766|365979357|FG001|Month 48|Lost to Follow-up|30|||
106087418|NCT00779766|365979356|FG000|Month 48|Other|1|||
106087419|NCT00779766|365979357|FG001|Month 48|Other|0|||
106087420|NCT00779766|365979356|FG000|Month 72|Withdrawal by Subject|55|||
106087421|NCT00779766|365979357|FG001|Month 72|Withdrawal by Subject|71|||
106087422|NCT00779766|365979356|FG000|Month 72|Migrated/moved from study area|124|||
106087423|NCT00779766|365979357|FG001|Month 72|Migrated/moved from study area|109|||
106087424|NCT00779766|365979356|FG000|Month 72|Lost to Follow-up|6|||
106087425|NCT00779766|365979357|FG001|Month 72|Lost to Follow-up|8|||
106087426|NCT00779766|365979356|FG000|Month 72|Other|0|||
106087427|NCT00779766|365979357|FG001|Month 72|Other|1|||
106087428|NCT04304001|365979358|FG000|Overall Study|Lost to Follow-up|13|||
106087429|NCT04304001|365979359|FG001|Overall Study|Lost to Follow-up|9|||
106087430|NCT02606136|365979367|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
106087431|NCT02606136|365979367|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
106087432|NCT02606136|365979367|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
106087433|NCT02606136|365979367|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
106087434|NCT03296696|365979368|FG000|Overall Study|Started Other Antitumor Therapy|1|||
106087435|NCT03296696|365979369|FG001|Overall Study|Started Other Antitumor Therapy|2|||
106087436|NCT03296696|365979370|FG002|Overall Study|Started Other Antitumor Therapy|1|||
106087437|NCT03296696|365979371|FG003|Overall Study|Started Other Antitumor Therapy|2|||
106087438|NCT03296696|365979372|FG004|Overall Study|Started Other Antitumor Therapy|1|||
106087439|NCT03296696|365979373|FG005|Overall Study|Started Other Antitumor Therapy|1|||
106087440|NCT03296696|365979374|FG006|Overall Study|Started Other Antitumor Therapy|2|||
106087441|NCT03296696|365979375|FG007|Overall Study|Started Other Antitumor Therapy|3|||
106087442|NCT03296696|365979376|FG008|Overall Study|Started Other Antitumor Therapy|1|||
106087443|NCT03296696|365979377|FG009|Overall Study|Started Other Antitumor Therapy|0|||
106087444|NCT03296696|365979368|FG000|Overall Study|Death|0|||
106087445|NCT03296696|365979369|FG001|Overall Study|Death|1|||
106087446|NCT03296696|365979370|FG002|Overall Study|Death|1|||
106087447|NCT03296696|365979371|FG003|Overall Study|Death|2|||
106087448|NCT03296696|365979372|FG004|Overall Study|Death|2|||
106087449|NCT03296696|365979373|FG005|Overall Study|Death|3|||
106087450|NCT03296696|365979374|FG006|Overall Study|Death|1|||
106087451|NCT03296696|365979375|FG007|Overall Study|Death|2|||
106087452|NCT03296696|365979376|FG008|Overall Study|Death|0|||
106087453|NCT03296696|365979377|FG009|Overall Study|Death|0|||
106087454|NCT03296696|365979368|FG000|Overall Study|Withdrawal by Subject|0|||
106087455|NCT03296696|365979369|FG001|Overall Study|Withdrawal by Subject|0|||
106087456|NCT03296696|365979370|FG002|Overall Study|Withdrawal by Subject|1|||
106087457|NCT03296696|365979371|FG003|Overall Study|Withdrawal by Subject|0|||
106087458|NCT03296696|365979372|FG004|Overall Study|Withdrawal by Subject|1|||
106087459|NCT03296696|365979373|FG005|Overall Study|Withdrawal by Subject|0|||
106087460|NCT03296696|365979374|FG006|Overall Study|Withdrawal by Subject|0|||
106087461|NCT03296696|365979375|FG007|Overall Study|Withdrawal by Subject|0|||
106087462|NCT03296696|365979376|FG008|Overall Study|Withdrawal by Subject|0|||
106087463|NCT03296696|365979377|FG009|Overall Study|Withdrawal by Subject|1|||
106087464|NCT04456699|365979381|FG000|Overall Study|Death|48|||
106087465|NCT04456699|365979382|FG001|Overall Study|Death|50|||
106087466|NCT04456699|365979383|FG002|Overall Study|Death|52|||
106087467|NCT04456699|365979381|FG000|Overall Study|Physician Decision|0|||
106087468|NCT04456699|365979382|FG001|Overall Study|Physician Decision|0|||
106087469|NCT04456699|365979383|FG002|Overall Study|Physician Decision|2|||
106087470|NCT04456699|365979381|FG000|Overall Study|Sponsor Decision|55|||
106087471|NCT04456699|365979382|FG001|Overall Study|Sponsor Decision|61|||
106087472|NCT04456699|365979383|FG002|Overall Study|Sponsor Decision|50|||
106087473|NCT04456699|365979381|FG000|Overall Study|Withdrawal by Subject|8|||
106087474|NCT04456699|365979382|FG001|Overall Study|Withdrawal by Subject|4|||
106087475|NCT04456699|365979383|FG002|Overall Study|Withdrawal by Subject|5|||
106087476|NCT03795922|365979384|FG000|Overall Study|Adverse Event|2|||
106087477|NCT03795922|365979385|FG001|Overall Study|Adverse Event|1|||
106087478|NCT03795922|365979384|FG000|Overall Study|Withdrawal by Subject|5|||
106087479|NCT03795922|365979385|FG001|Overall Study|Withdrawal by Subject|13|||
106087480|NCT03795922|365979384|FG000|Overall Study|Lost to Follow-up|2|||
106087481|NCT03795922|365979385|FG001|Overall Study|Lost to Follow-up|3|||
106087482|NCT03795922|365979384|FG000|Overall Study|Pregnancy|0|||
106087483|NCT03795922|365979385|FG001|Overall Study|Pregnancy|1|||
106087484|NCT03795922|365979384|FG000|Overall Study|Physician Decision|1|||
106087485|NCT03795922|365979385|FG001|Overall Study|Physician Decision|2|||
106087486|NCT03795922|365979384|FG000|Overall Study|Protocol Violation|0|||
106087487|NCT03795922|365979385|FG001|Overall Study|Protocol Violation|1|||
106087488|NCT03795922|365979384|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
106087489|NCT03795922|365979385|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
106087490|NCT02985736|365979390|FG000|Overall Study|Lost to Follow-up|3|||
106087491|NCT00382733|365979391|FG000|Overall Study|Withdrawal by Subject|0|||
106087492|NCT00382733|365979392|FG001|Overall Study|Withdrawal by Subject|1|||
106087493|NCT00382733|365979393|FG002|Overall Study|Withdrawal by Subject|0|||
106087494|NCT00382733|365979394|FG003|Overall Study|Withdrawal by Subject|0|||
106087495|NCT00382733|365979395|FG004|Overall Study|Withdrawal by Subject|0|||
106087496|NCT00179413|365979397|FG000|Overall Study|Adverse Event|38|||
106087497|NCT00179413|365979398|FG001|Overall Study|Adverse Event|20|||
106087498|NCT00179413|365979397|FG000|Overall Study|Withdrawal by Subject|87|||
106087499|NCT00179413|365979398|FG001|Overall Study|Withdrawal by Subject|95|||
106087500|NCT01696032|365979399|FG000|Overall Study|Withdrawal by Subject|0|||
106087501|NCT01696032|365979400|FG001|Overall Study|Withdrawal by Subject|0|||
106087502|NCT01696032|365979401|FG002|Overall Study|Withdrawal by Subject|1|||
106087503|NCT01696032|365979402|FG003|Overall Study|Withdrawal by Subject|2|||
106087504|NCT01696032|365979399|FG000|Overall Study|Death|14|||
106087505|NCT01696032|365979400|FG001|Overall Study|Death|4|||
106087506|NCT01696032|365979401|FG002|Overall Study|Death|43|||
106087507|NCT01696032|365979402|FG003|Overall Study|Death|18|||
106087508|NCT01696032|365979399|FG000|Overall Study|Lost to Follow-up|0|||
106087509|NCT01696032|365979400|FG001|Overall Study|Lost to Follow-up|1|||
106087510|NCT01696032|365979401|FG002|Overall Study|Lost to Follow-up|0|||
106087511|NCT01696032|365979402|FG003|Overall Study|Lost to Follow-up|0|||
106087512|NCT01696032|365979399|FG000|Overall Study|Database lock|0|||
106087513|NCT01696032|365979400|FG001|Overall Study|Database lock|1|||
106087514|NCT01696032|365979401|FG002|Overall Study|Database lock|7|||
106087515|NCT01696032|365979402|FG003|Overall Study|Database lock|2|||
106087516|NCT00578565|365979405|FG000|Overall Study|Adverse Event|3|||
106087517|NCT01752933|365979406|FG000|Treatment|Disease Progression|3|||
106087518|NCT01752933|365979407|FG001|Treatment|Disease Progression|29|||
106087519|NCT01752933|365979406|FG000|Treatment|Withdrawal by Subject|0|||
106087520|NCT01752933|365979407|FG001|Treatment|Withdrawal by Subject|5|||
106087521|NCT01752933|365979406|FG000|Treatment|Adverse Event|1|||
106087522|NCT01752933|365979407|FG001|Treatment|Adverse Event|4|||
106087523|NCT01752933|365979406|FG000|Treatment|Physician Decision|0|||
106087524|NCT01752933|365979407|FG001|Treatment|Physician Decision|3|||
106087525|NCT01752933|365979406|FG000|Treatment|Death|0|||
106087526|NCT01752933|365979407|FG001|Treatment|Death|2|||
106087527|NCT01752933|365979406|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
106087528|NCT01752933|365979407|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
106087529|NCT01752933|365979406|FG000|Treatment|Patient noncompliant|0|||
106087530|NCT01752933|365979407|FG001|Treatment|Patient noncompliant|1|||
106087531|NCT01752933|365979406|FG000|Treatment|Patient unable to travel to appointments|0|||
106087532|NCT01752933|365979407|FG001|Treatment|Patient unable to travel to appointments|1|||
106087533|NCT01752933|365979406|FG000|Overall Study and Follow-up|Death|4|||
106087534|NCT01752933|365979407|FG001|Overall Study and Follow-up|Death|34|||
106087535|NCT01752933|365979406|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
106087536|NCT01752933|365979407|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
106087537|NCT01752933|365979406|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
106087538|NCT01752933|365979407|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
106087539|NCT01752933|365979406|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
106087540|NCT01752933|365979407|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
106087541|NCT02203591|365979411|FG000|Overall Study|Did not meet treatment day baseline|147|||
106087542|NCT02203591|365979412|FG001|Overall Study|Did not meet treatment day baseline|141|||
106087543|NCT02203591|365979413|FG002|Overall Study|Did not meet treatment day baseline|150|||
106087544|NCT02203591|365979414|FG003|Overall Study|Did not meet treatment day baseline|45|||
106087545|NCT02203591|365979415|FG004|Overall Study|Did not meet treatment day baseline|33|||
106087546|NCT02203591|365979416|FG005|Overall Study|Did not meet treatment day baseline|35|||
106087547|NCT02203591|365979417|FG006|Overall Study|Did not meet treatment day baseline|29|||
106087548|NCT02203591|365979418|FG007|Overall Study|Did not meet treatment day baseline|12|||
106087549|NCT02203591|365979411|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
106087550|NCT02203591|365979412|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
106087551|NCT02203591|365979413|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
106087552|NCT02203591|365979414|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
106087553|NCT02203591|365979415|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
106087554|NCT02203591|365979416|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
106087555|NCT02203591|365979417|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
106087556|NCT02203591|365979418|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
106087557|NCT04154631|365979419|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
106087558|NCT04154631|365979420|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
106087559|NCT02185768|365979421|FG000|Overall Study|Patients were not treated|2|||
106087560|NCT03027466|365979422|FG000|Overall Study|Opting out of the app|1869|||
106087561|NCT03027466|365979423|FG001|Overall Study|Opting out of the app|1819|||
106087562|NCT03027466|365979424|FG002|Overall Study|Opting out of the app|1743|||
106087563|NCT03027466|365979425|FG003|Overall Study|Opting out of the app|1821|||
106087564|NCT01706250|365979426|FG000|Overall Study|Lost to Follow-up|2|||
106087565|NCT00508742|365979434|FG000|Period 1: Infant Series|Adverse Event|5|||
106087566|NCT00508742|365979435|FG001|Period 1: Infant Series|Adverse Event|4|||
106087567|NCT00508742|365979434|FG000|Period 1: Infant Series|Protocol Violation|1|||
106087568|NCT00508742|365979435|FG001|Period 1: Infant Series|Protocol Violation|0|||
106087569|NCT00508742|365979434|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
106087570|NCT00508742|365979435|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
106087571|NCT00508742|365979434|FG000|Period 1: Infant Series|Physician Decision|1|||
106087572|NCT00508742|365979435|FG001|Period 1: Infant Series|Physician Decision|0|||
106087573|NCT00508742|365979434|FG000|Period 1: Infant Series|Other|4|||
106087574|NCT00508742|365979435|FG001|Period 1: Infant Series|Other|1|||
106087575|NCT00508742|365979434|FG000|Period 2: After Infant Series|Adverse Event|2|||
106087576|NCT00508742|365979435|FG001|Period 2: After Infant Series|Adverse Event|6|||
106087577|NCT00508742|365979434|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
106087578|NCT00508742|365979435|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
106087579|NCT00508742|365979434|FG000|Period 2: After Infant Series|Protocol Violation|1|||
106161123|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Other|0|||
106161124|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Other|0|||
106161125|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Other|0|||
106087580|NCT00508742|365979435|FG001|Period 2: After Infant Series|Protocol Violation|0|||
106087581|NCT00508742|365979434|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
106087582|NCT00508742|365979435|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
106087583|NCT00508742|365979434|FG000|Period 2: After Infant Series|Failed to Return|1|||
106087584|NCT00508742|365979435|FG001|Period 2: After Infant Series|Failed to Return|0|||
106087585|NCT00508742|365979434|FG000|Period 2: After Infant Series|Other|2|||
106087586|NCT00508742|365979435|FG001|Period 2: After Infant Series|Other|1|||
106087587|NCT00508742|365979434|FG000|Period 3: Toddler Dose|Adverse Event|1|||
106087588|NCT00508742|365979435|FG001|Period 3: Toddler Dose|Adverse Event|0|||
106087589|NCT00508742|365979434|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
106087590|NCT00508742|365979435|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
106087591|NCT00508742|365979434|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
106087592|NCT00508742|365979435|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
106087593|NCT00508742|365979434|FG000|Period 3: Toddler Dose|Other|5|||
106087594|NCT00508742|365979435|FG001|Period 3: Toddler Dose|Other|4|||
106087595|NCT00595582|365979438|FG000|Overall Study|Pilot study that PI terminated|2|||
106087596|NCT00595582|365979438|FG000|Overall Study|Lost to Follow-up|1|||
106087597|NCT00595582|365979438|FG000|Overall Study|Adverse Event|2|||
106087598|NCT00595582|365979438|FG000|Overall Study|Physician Decision|5|||
106087599|NCT01069289|365979441|FG000|Overall Study|Withdrawal by Subject|15|||
106087600|NCT01069289|365979442|FG001|Overall Study|Withdrawal by Subject|26|||
106087601|NCT01069289|365979441|FG000|Overall Study|Adverse Event|21|||
106087602|NCT01069289|365979442|FG001|Overall Study|Adverse Event|28|||
106087603|NCT01069289|365979441|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
106087604|NCT01069289|365979442|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
106087605|NCT01069289|365979441|FG000|Overall Study|Severe non-compliance to protocol|3|||
106087606|NCT01069289|365979442|FG001|Overall Study|Severe non-compliance to protocol|2|||
106087607|NCT01069289|365979441|FG000|Overall Study|Due to deteriorating health condition|1|||
106087608|NCT01069289|365979442|FG001|Overall Study|Due to deteriorating health condition|0|||
106087609|NCT00441337|365979456|FG000|Overall Study|Disease Progression|6|||
106087610|NCT00441337|365979457|FG001|Overall Study|Disease Progression|6|||
106087611|NCT00441337|365979458|FG002|Overall Study|Disease Progression|4|||
106087612|NCT00441337|365979459|FG003|Overall Study|Disease Progression|18|||
106087613|NCT00441337|365979456|FG000|Overall Study|Lost to Follow-up|0|||
106087614|NCT00441337|365979457|FG001|Overall Study|Lost to Follow-up|0|||
106087615|NCT00441337|365979458|FG002|Overall Study|Lost to Follow-up|0|||
106087616|NCT00441337|365979459|FG003|Overall Study|Lost to Follow-up|1|||
106087617|NCT00441337|365979456|FG000|Overall Study|Sponsor Decision|0|||
106087618|NCT00441337|365979457|FG001|Overall Study|Sponsor Decision|0|||
106087619|NCT00441337|365979458|FG002|Overall Study|Sponsor Decision|1|||
106087620|NCT00441337|365979459|FG003|Overall Study|Sponsor Decision|2|||
106087621|NCT00441337|365979456|FG000|Overall Study|Did not meet inclusion criteria|0|||
106087622|NCT00441337|365979457|FG001|Overall Study|Did not meet inclusion criteria|0|||
106087623|NCT00441337|365979458|FG002|Overall Study|Did not meet inclusion criteria|1|||
106161126|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Other|0|||
106087624|NCT00441337|365979459|FG003|Overall Study|Did not meet inclusion criteria|0|||
106087625|NCT03570892|365979460|FG000|Overall Study|Death|51|||
106087626|NCT03570892|365979461|FG001|Overall Study|Death|45|||
106087627|NCT03570892|365979460|FG000|Overall Study|Subject decision|5|||
106087628|NCT03570892|365979461|FG001|Overall Study|Subject decision|3|||
106087629|NCT03570892|365979460|FG000|Overall Study|Protocol Violation|1|||
106087630|NCT03570892|365979461|FG001|Overall Study|Protocol Violation|4|||
106087631|NCT03570892|365979460|FG000|Overall Study|Physician Decision|0|||
106161127|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Other|0|||
106087632|NCT03570892|365979461|FG001|Overall Study|Physician Decision|2|||
106087633|NCT03964454|365979462|FG000|Overall Study|Lost to Follow-up|13|||
106087634|NCT03964454|365979463|FG001|Overall Study|Lost to Follow-up|7|||
106087635|NCT03964454|365979462|FG000|Overall Study|Withdrawal by Subject|4|||
106087636|NCT03964454|365979463|FG001|Overall Study|Withdrawal by Subject|11|||
106087637|NCT05350449|365979464|FG000|Overall Study|Withdrawal by Subject|4|||
106087638|NCT05350449|365979465|FG001|Overall Study|Withdrawal by Subject|8|||
106087639|NCT00827372|365980700|FG000|Overall Study|Adverse Event|5|||
106087640|NCT00827372|365980700|FG000|Overall Study|Lack of Efficacy|3|||
106087641|NCT02086591|365980707|FG000|Overall Study|Adverse Event|1|||
106087642|NCT02086591|365980707|FG000|Overall Study|Withdrawal by Subject|1|||
106087643|NCT02086591|365980707|FG000|Overall Study|protocol terminated|3|||
106087644|NCT01602315|365980708|FG000|Overall Study|Protocol Violation|0|||
106087645|NCT01602315|365980709|FG001|Overall Study|Protocol Violation|0|||
106087646|NCT01602315|365980710|FG002|Overall Study|Protocol Violation|0|||
106087647|NCT01602315|365980711|FG003|Overall Study|Protocol Violation|0|||
106087648|NCT01602315|365980712|FG004|Overall Study|Protocol Violation|0|||
106087649|NCT01602315|365980713|FG005|Overall Study|Protocol Violation|1|||
106087650|NCT01602315|365980714|FG006|Overall Study|Protocol Violation|0|||
106087651|NCT01602315|365980708|FG000|Overall Study|Physician Decision|2|||
106087652|NCT01602315|365980709|FG001|Overall Study|Physician Decision|0|||
106087653|NCT01602315|365980710|FG002|Overall Study|Physician Decision|0|||
106087654|NCT01602315|365980711|FG003|Overall Study|Physician Decision|0|||
106087655|NCT01602315|365980712|FG004|Overall Study|Physician Decision|2|||
106087656|NCT01602315|365980713|FG005|Overall Study|Physician Decision|1|||
106087657|NCT01602315|365980714|FG006|Overall Study|Physician Decision|1|||
106087658|NCT01602315|365980708|FG000|Overall Study|Disease progression|6|||
106087659|NCT01602315|365980709|FG001|Overall Study|Disease progression|3|||
106087660|NCT01602315|365980710|FG002|Overall Study|Disease progression|10|||
106087661|NCT01602315|365980711|FG003|Overall Study|Disease progression|1|||
106087662|NCT01602315|365980712|FG004|Overall Study|Disease progression|41|||
106087663|NCT01602315|365980713|FG005|Overall Study|Disease progression|12|||
106087664|NCT01602315|365980714|FG006|Overall Study|Disease progression|15|||
106087665|NCT01602315|365980708|FG000|Overall Study|Death|1|||
106087666|NCT01602315|365980709|FG001|Overall Study|Death|1|||
106087667|NCT01602315|365980710|FG002|Overall Study|Death|1|||
106087668|NCT01602315|365980711|FG003|Overall Study|Death|1|||
106087669|NCT01602315|365980712|FG004|Overall Study|Death|7|||
106087670|NCT01602315|365980713|FG005|Overall Study|Death|2|||
106087671|NCT01602315|365980714|FG006|Overall Study|Death|2|||
106087672|NCT01602315|365980708|FG000|Overall Study|Withdrawal by Subject|2|||
106087673|NCT01602315|365980709|FG001|Overall Study|Withdrawal by Subject|0|||
106087674|NCT01602315|365980710|FG002|Overall Study|Withdrawal by Subject|2|||
106087675|NCT01602315|365980711|FG003|Overall Study|Withdrawal by Subject|0|||
106087676|NCT01602315|365980712|FG004|Overall Study|Withdrawal by Subject|6|||
106087677|NCT01602315|365980713|FG005|Overall Study|Withdrawal by Subject|0|||
106087678|NCT01602315|365980714|FG006|Overall Study|Withdrawal by Subject|1|||
106087679|NCT01602315|365980708|FG000|Overall Study|Adverse Event|5|||
106087680|NCT01602315|365980709|FG001|Overall Study|Adverse Event|1|||
106087681|NCT01602315|365980710|FG002|Overall Study|Adverse Event|5|||
106087682|NCT01602315|365980711|FG003|Overall Study|Adverse Event|4|||
106087683|NCT01602315|365980712|FG004|Overall Study|Adverse Event|15|||
106087684|NCT01602315|365980713|FG005|Overall Study|Adverse Event|3|||
106087685|NCT01602315|365980714|FG006|Overall Study|Adverse Event|9|||
106087686|NCT01602315|365980708|FG000|Overall Study|Subject/guardian decision|0|||
106087687|NCT01602315|365980709|FG001|Overall Study|Subject/guardian decision|0|||
106087688|NCT01602315|365980710|FG002|Overall Study|Subject/guardian decision|0|||
106087689|NCT01602315|365980711|FG003|Overall Study|Subject/guardian decision|0|||
106087690|NCT01602315|365980712|FG004|Overall Study|Subject/guardian decision|0|||
106087691|NCT01602315|365980713|FG005|Overall Study|Subject/guardian decision|0|||
106087692|NCT01602315|365980714|FG006|Overall Study|Subject/guardian decision|1|||
106087693|NCT01602315|365980708|FG000|Overall Study|Cross-over patients to combo treatment|0|||
106087694|NCT01602315|365980709|FG001|Overall Study|Cross-over patients to combo treatment|0|||
106087695|NCT01602315|365980710|FG002|Overall Study|Cross-over patients to combo treatment|0|||
106087696|NCT01602315|365980711|FG003|Overall Study|Cross-over patients to combo treatment|0|||
106087697|NCT01602315|365980712|FG004|Overall Study|Cross-over patients to combo treatment|0|||
106087698|NCT01602315|365980713|FG005|Overall Study|Cross-over patients to combo treatment|16|||
106087699|NCT01602315|365980714|FG006|Overall Study|Cross-over patients to combo treatment|0|||
106087700|NCT02212730|365980717|FG000|Overall Study|Tumor not of the required cell histology|1|||
106087701|NCT02212730|365980718|FG001|Overall Study|Tumor not of the required cell histology|0|||
106087702|NCT02212730|365980717|FG000|Overall Study|Withdrawal by Subject|1|||
106087703|NCT02212730|365980718|FG001|Overall Study|Withdrawal by Subject|0|||
106087704|NCT02212730|365980717|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
106087705|NCT02212730|365980718|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
106087706|NCT01777997|365980721|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
106087707|NCT01777997|365980721|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
106087708|NCT01777997|365980721|FG000|Weeks 48 to 72/96 on ART|Death|1|||
106087709|NCT01777997|365980721|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
106087710|NCT02660359|365980722|FG000|Overall Study|Protocol Deviation|0|||
106087711|NCT02660359|365980723|FG001|Overall Study|Protocol Deviation|0|||
106087712|NCT02660359|365980724|FG002|Overall Study|Protocol Deviation|1|||
106087713|NCT02660359|365980722|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
106087714|NCT02660359|365980723|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
106087715|NCT02660359|365980724|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
106087716|NCT02660359|365980722|FG000|Overall Study|Lack of Efficacy|1|||
106087717|NCT02660359|365980723|FG001|Overall Study|Lack of Efficacy|1|||
106087718|NCT02660359|365980724|FG002|Overall Study|Lack of Efficacy|1|||
106087719|NCT02660359|365980722|FG000|Overall Study|Adverse Event|0|||
106087720|NCT02660359|365980723|FG001|Overall Study|Adverse Event|1|||
106087721|NCT02660359|365980724|FG002|Overall Study|Adverse Event|0|||
106087722|NCT02660359|365980722|FG000|Overall Study|Other|2|||
106087723|NCT02660359|365980723|FG001|Overall Study|Other|1|||
106087724|NCT02660359|365980724|FG002|Overall Study|Other|3|||
106087725|NCT02660359|365980722|FG000|Overall Study|Withdrawal by Subject|7|||
106087726|NCT02660359|365980723|FG001|Overall Study|Withdrawal by Subject|5|||
106087727|NCT02660359|365980724|FG002|Overall Study|Withdrawal by Subject|8|||
106087728|NCT02660359|365980722|FG000|Overall Study|Lost to Follow-up|3|||
106087729|NCT02660359|365980723|FG001|Overall Study|Lost to Follow-up|3|||
106087730|NCT02660359|365980724|FG002|Overall Study|Lost to Follow-up|0|||
106087731|NCT00723801|365980725|FG000|Overall Study|Lost to Follow-up|1|||
106087732|NCT00723801|365980726|FG001|Overall Study|Lost to Follow-up|2|||
106087733|NCT00723801|365980725|FG000|Overall Study|Protocol Violation|2|||
106087734|NCT00723801|365980726|FG001|Overall Study|Protocol Violation|1|||
106087735|NCT01824303|365980727|FG000|Randomized Study|Withdrawal by Subject|1|||
106087736|NCT01824303|365980728|FG001|Randomized Study|Withdrawal by Subject|1|||
106087737|NCT01824303|365980727|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
106087738|NCT01824303|365980728|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
106087739|NCT02039427|365980729|FG000|Overall Study|Duration of surgery > 3h|1|||
106087740|NCT02039427|365980730|FG001|Overall Study|Duration of surgery > 3h|1|||
106087741|NCT02039427|365980731|FG002|Overall Study|Duration of surgery > 3h|0|||
106087742|NCT02039427|365980732|FG003|Overall Study|Duration of surgery > 3h|0|||
106161128|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Other|1|||
106161129|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Other|1|||
106087743|NCT02039427|365980729|FG000|Overall Study|Withdrawal on concent|0|||
106087744|NCT02039427|365980730|FG001|Overall Study|Withdrawal on concent|0|||
106087745|NCT02039427|365980731|FG002|Overall Study|Withdrawal on concent|0|||
106087746|NCT02039427|365980732|FG003|Overall Study|Withdrawal on concent|1|||
106087747|NCT02039427|365980729|FG000|Overall Study|Cancellation of surgery|0|||
106087748|NCT02039427|365980730|FG001|Overall Study|Cancellation of surgery|0|||
106087749|NCT02039427|365980731|FG002|Overall Study|Cancellation of surgery|1|||
106087750|NCT02039427|365980732|FG003|Overall Study|Cancellation of surgery|0|||
106087751|NCT02039427|365980729|FG000|Overall Study|Loss of follow - up|1|||
106087752|NCT02039427|365980730|FG001|Overall Study|Loss of follow - up|0|||
106087753|NCT02039427|365980731|FG002|Overall Study|Loss of follow - up|2|||
106087754|NCT02039427|365980732|FG003|Overall Study|Loss of follow - up|4|||
106087755|NCT02039427|365980729|FG000|Overall Study|Steroid Use|1|||
106087756|NCT02039427|365980730|FG001|Overall Study|Steroid Use|0|||
106161130|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Other|1|||
106161131|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Other|0|||
106161132|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Other|3|||
106161133|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Other|1|||
106161134|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Other|1|||
106161135|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Other|0|||
106161136|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161137|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161138|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
105867240|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
106087757|NCT02039427|365980731|FG002|Overall Study|Steroid Use|0|||
106087758|NCT02039427|365980732|FG003|Overall Study|Steroid Use|0|||
106087759|NCT01274637|365980734|FG000|Overall Study|Withdrawal by Subject|0|||
106087760|NCT01274637|365980735|FG001|Overall Study|Withdrawal by Subject|1|||
106087761|NCT01274637|365980734|FG000|Overall Study|Lost to Follow-up|0|||
106087762|NCT01274637|365980735|FG001|Overall Study|Lost to Follow-up|1|||
106087763|NCT01490060|365980736|FG000|Cycle 1|Change of Treatment|0|||
106087764|NCT01490060|365980737|FG001|Cycle 1|Change of Treatment|1|||
106087765|NCT01490060|365980738|FG002|Cycle 1|Change of Treatment|1|||
106087766|NCT01490060|365980739|FG003|Cycle 1|Change of Treatment|1|||
106087767|NCT01490060|365980736|FG000|Cycle 1|Insurance Denied|0|||
106087768|NCT01490060|365980737|FG001|Cycle 1|Insurance Denied|0|||
106087769|NCT01490060|365980738|FG002|Cycle 1|Insurance Denied|2|||
106087770|NCT01490060|365980739|FG003|Cycle 1|Insurance Denied|0|||
106087771|NCT01490060|365980736|FG000|Cycle 1|Withdrawal by Subject|0|||
106087772|NCT01490060|365980737|FG001|Cycle 1|Withdrawal by Subject|0|||
106087773|NCT01490060|365980738|FG002|Cycle 1|Withdrawal by Subject|0|||
106087774|NCT01490060|365980739|FG003|Cycle 1|Withdrawal by Subject|1|||
106087775|NCT01490060|365980736|FG000|Cycle 1|Treatment at Another Facility|0|||
106087776|NCT01490060|365980737|FG001|Cycle 1|Treatment at Another Facility|0|||
106087777|NCT01490060|365980738|FG002|Cycle 1|Treatment at Another Facility|0|||
106087778|NCT01490060|365980739|FG003|Cycle 1|Treatment at Another Facility|1|||
106087779|NCT01490060|365980736|FG000|Cycle 2|Change of Treatment|1|||
106161139|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161140|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161141|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161142|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
105867241|NCT03888066|365164935|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105867242|NCT03888066|365164936|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105867243|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105867244|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105867245|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
105867246|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
105867247|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105869210|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
106087780|NCT01490060|365980737|FG001|Cycle 2|Change of Treatment|1|||
106087781|NCT01490060|365980738|FG002|Cycle 2|Change of Treatment|0|||
106087782|NCT01490060|365980739|FG003|Cycle 2|Change of Treatment|0|||
106161143|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161144|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
106161145|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161146|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
106087783|NCT01490060|365980736|FG000|Cycle 2|Non-Compliance|0|||
106087784|NCT01490060|365980737|FG001|Cycle 2|Non-Compliance|0|||
106087785|NCT01490060|365980738|FG002|Cycle 2|Non-Compliance|1|||
106161147|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
106087786|NCT01490060|365980739|FG003|Cycle 2|Non-Compliance|0|||
106087787|NCT01490060|365980736|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
106087788|NCT01490060|365980737|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
106087789|NCT01490060|365980738|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
106087790|NCT01490060|365980739|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
106087791|NCT05074433|365980740|FG000|Overall Study|Adverse Event|0|||
106087792|NCT05074433|365980741|FG001|Overall Study|Adverse Event|2|||
106087793|NCT05074433|365980742|FG002|Overall Study|Adverse Event|0|||
106087794|NCT05074433|365980743|FG003|Overall Study|Adverse Event|1|||
106087795|NCT05074433|365980740|FG000|Overall Study|Sponsor Request|0|||
106087796|NCT05074433|365980741|FG001|Overall Study|Sponsor Request|1|||
106087797|NCT05074433|365980742|FG002|Overall Study|Sponsor Request|1|||
106087798|NCT05074433|365980743|FG003|Overall Study|Sponsor Request|0|||
106087799|NCT05074433|365980740|FG000|Overall Study|Death|1|||
106087800|NCT05074433|365980741|FG001|Overall Study|Death|0|||
106087801|NCT05074433|365980742|FG002|Overall Study|Death|0|||
106087802|NCT05074433|365980743|FG003|Overall Study|Death|0|||
106087803|NCT05074433|365980740|FG000|Overall Study|Lost to Follow-up|0|||
106087804|NCT05074433|365980741|FG001|Overall Study|Lost to Follow-up|0|||
106087805|NCT05074433|365980742|FG002|Overall Study|Lost to Follow-up|2|||
106087806|NCT05074433|365980743|FG003|Overall Study|Lost to Follow-up|0|||
106087807|NCT05074433|365980740|FG000|Overall Study|Subject Decision|8|||
106087808|NCT05074433|365980741|FG001|Overall Study|Subject Decision|6|||
106087809|NCT05074433|365980742|FG002|Overall Study|Subject Decision|4|||
106087810|NCT05074433|365980743|FG003|Overall Study|Subject Decision|5|||
106087811|NCT04278417|365980753|FG000|Overall Study|Withdrawal by Subject|20|||
106087812|NCT04278417|365980754|FG001|Overall Study|Withdrawal by Subject|20|||
106087813|NCT04278417|365980753|FG000|Overall Study|Progressive disease|0|||
106087814|NCT04278417|365980754|FG001|Overall Study|Progressive disease|2|||
106087815|NCT04278417|365980753|FG000|Overall Study|Physician Decision|4|||
106087816|NCT04278417|365980754|FG001|Overall Study|Physician Decision|6|||
106087817|NCT04278417|365980753|FG000|Overall Study|Lost to Follow-up|11|||
106087818|NCT04278417|365980754|FG001|Overall Study|Lost to Follow-up|13|||
106087819|NCT04278417|365980753|FG000|Overall Study|Death|8|||
106087820|NCT04278417|365980754|FG001|Overall Study|Death|9|||
106087821|NCT04278417|365980753|FG000|Overall Study|Adverse Event|3|||
106087822|NCT04278417|365980754|FG001|Overall Study|Adverse Event|5|||
106087823|NCT03299192|365980755|FG000|Overall Study|Fell before classes started|1|||
106087824|NCT03299192|365980756|FG001|Overall Study|Fell before classes started|0|||
106087825|NCT03299192|365980757|FG002|Overall Study|Fell before classes started|0|||
106087826|NCT03299192|365980755|FG000|Overall Study|Other|0|||
106087827|NCT03299192|365980756|FG001|Overall Study|Other|2|||
106087828|NCT03299192|365980757|FG002|Overall Study|Other|1|||
106087829|NCT00205712|365980759|FG000|Overall Study|Lost to Follow-up|0|||
106087830|NCT00205712|365980760|FG001|Overall Study|Lost to Follow-up|1|||
106087831|NCT01334866|365980770|FG000|Overall Study|Withdrawal by Subject|10|||
106087832|NCT01334866|365980770|FG000|Overall Study|Lost to Follow-up|3|||
106087833|NCT01334866|365980770|FG000|Overall Study|Physician Decision|3|||
106087834|NCT01334866|365980770|FG000|Overall Study|medically necessary prior to procedure|2|||
106087835|NCT01334866|365980770|FG000|Overall Study|medically necessary post-procedure|1|||
106087836|NCT00983580|365980771|FG000|Overall Study|Cancel Prior to treatment|1|||
106087837|NCT00983580|365980772|FG001|Overall Study|Cancel Prior to treatment|3|||
106087838|NCT00983580|365980771|FG000|Overall Study|Protocol Violation|1|||
106087839|NCT00983580|365980772|FG001|Overall Study|Protocol Violation|1|||
106087840|NCT00983580|365980771|FG000|Overall Study|Ineligible|3|||
106087841|NCT00983580|365980772|FG001|Overall Study|Ineligible|0|||
106087842|NCT01603875|365980773|FG000|Overall Study|Preexisting rabies antibody|3|||
106087843|NCT01603875|365980774|FG001|Overall Study|Preexisting rabies antibody|4|||
106087844|NCT01603875|365980775|FG002|Overall Study|Preexisting rabies antibody|3|||
106087845|NCT01603875|365980773|FG000|Overall Study|Lost to Follow-up|4|||
106087846|NCT01603875|365980774|FG001|Overall Study|Lost to Follow-up|3|||
106087847|NCT01603875|365980775|FG002|Overall Study|Lost to Follow-up|6|||
106087848|NCT01603875|365980773|FG000|Overall Study|Protocol Violation|0|||
106087849|NCT01603875|365980774|FG001|Overall Study|Protocol Violation|1|||
106087850|NCT01603875|365980775|FG002|Overall Study|Protocol Violation|0|||
106087851|NCT01071512|365980776|FG000|Overall Study|Adverse Event|1|||
106087852|NCT01071512|365980776|FG000|Overall Study|Development of antibodies to drug|2|||
106087853|NCT01071512|365980776|FG000|Overall Study|positive anti-JC virus antibody test|2|||
106087854|NCT00799617|365980781|FG000|Main Testosterone Trial|Randomized in error|1|||
106087855|NCT00799617|365980782|FG001|Main Testosterone Trial|Randomized in error|1|||
106087856|NCT00799617|365980781|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
106087857|NCT00799617|365980782|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
106087858|NCT00799617|365980781|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
106087859|NCT00799617|365980782|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
106087860|NCT00799617|365980781|FG000|Sexual Funtion Trial|No Baseline Data|4|||
106087861|NCT00799617|365980782|FG001|Sexual Funtion Trial|No Baseline Data|7|||
106087862|NCT00799617|365980781|FG000|Physical Function Trial|Lost to Follow-up|6|||
106087863|NCT00799617|365980782|FG001|Physical Function Trial|Lost to Follow-up|11|||
106087864|NCT00799617|365980781|FG000|Vitality Trial|Lost to Follow-up|7|||
106087865|NCT00799617|365980782|FG001|Vitality Trial|Lost to Follow-up|22|||
106087866|NCT00799617|365980781|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
106087867|NCT00799617|365980782|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
106087868|NCT00799617|365980781|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
106087869|NCT00799617|365980782|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
106087870|NCT00799617|365980781|FG000|Bone Trial|Month 12 scan not available|6|||
106087871|NCT00799617|365980782|FG001|Bone Trial|Month 12 scan not available|16|||
106087872|NCT00799617|365980781|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
106087873|NCT00799617|365980782|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
106087874|NCT00799617|365980781|FG000|Anemia Trial|Withdrawal by Subject|3|||
106087875|NCT00799617|365980782|FG001|Anemia Trial|Withdrawal by Subject|3|||
106087876|NCT01337297|365980783|FG000|Overall Study|They entered to single anodal tDCS|4|||
106087877|NCT01337297|365980784|FG001|Overall Study|They entered to single anodal tDCS|3|||
106087878|NCT01337297|365980783|FG000|Overall Study|Lost to Follow-up|1|||
106087879|NCT01337297|365980784|FG001|Overall Study|Lost to Follow-up|3|||
106087880|NCT02296112|365980785|FG000|Overall Study|Disease progression|7|||
105867248|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
106087881|NCT02296112|365980785|FG000|Overall Study|Toxicity|1|||
106087882|NCT02296112|365980785|FG000|Overall Study|Began an alternate therapy|1|||
106087883|NCT02442830|365980786|FG000|Overall Study|Technical Failure|0|||
106087884|NCT02442830|365980787|FG001|Overall Study|Technical Failure|1|||
106161148|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
106161149|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161150|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161151|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161152|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161153|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
106161154|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161155|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161156|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161157|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161158|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161159|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161160|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161161|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
106161162|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161163|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161164|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161165|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161166|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161167|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161168|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161169|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161170|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161171|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
106161172|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161173|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161174|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161175|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161176|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161177|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161178|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161179|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161180|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161181|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
106161182|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161183|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161184|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161185|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161186|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161187|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161188|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161189|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
106161190|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Death|0|||
106161191|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Death|0|||
106161192|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Death|0|||
106161193|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Death|0|||
106161194|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Death|0|||
106161195|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Death|0|||
106161196|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Death|0|||
106161197|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Death|0|||
106161198|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Death|0|||
106161199|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Death|1|||
106161200|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Death|0|||
106161201|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Death|1|||
106161202|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Death|0|||
106161203|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Death|1|||
106161204|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Death|0|||
106161205|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Death|0|||
106161206|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Death|2|||
106161207|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Death|0|||
106161208|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
106161209|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
106161210|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
106161211|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
106161212|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
106161213|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
106161214|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
106161215|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
106161216|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
106161217|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
106161218|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
106161219|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
106087885|NCT00183872|365980788|FG000|Overall Study|Death|3|||
106087886|NCT00183872|365980788|FG000|Overall Study|Adverse Event|9|||
106087887|NCT00183872|365980788|FG000|Overall Study|Withdrawal by Subject|2|||
106087888|NCT00183872|365980788|FG000|Overall Study|Drug delayed more than 28 days|2|||
106087889|NCT01720069|365980789|FG000|Overall Study|Could not use e-diary correctly|0|||
106087890|NCT01720069|365980790|FG001|Overall Study|Could not use e-diary correctly|1|||
106087891|NCT01720069|365980791|FG002|Overall Study|Could not use e-diary correctly|1|||
106087892|NCT01720069|365980789|FG000|Overall Study|Randomised without baseline values|0|||
106087893|NCT01720069|365980790|FG001|Overall Study|Randomised without baseline values|0|||
106087894|NCT01720069|365980791|FG002|Overall Study|Randomised without baseline values|1|||
106087895|NCT01720069|365980789|FG000|Overall Study|Adverse Event|0|||
106087896|NCT01720069|365980790|FG001|Overall Study|Adverse Event|0|||
106087897|NCT01720069|365980791|FG002|Overall Study|Adverse Event|1|||
106087898|NCT01720069|365980789|FG000|Overall Study|Lack of Efficacy|0|||
106087899|NCT01720069|365980790|FG001|Overall Study|Lack of Efficacy|4|||
106087900|NCT01720069|365980791|FG002|Overall Study|Lack of Efficacy|0|||
106087901|NCT01720069|365980789|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
106087902|NCT01720069|365980790|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
106087903|NCT01720069|365980791|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
106087904|NCT01720069|365980789|FG000|Overall Study|Withdrawal by Subject|0|||
106087905|NCT01720069|365980790|FG001|Overall Study|Withdrawal by Subject|2|||
106087906|NCT01720069|365980791|FG002|Overall Study|Withdrawal by Subject|1|||
106087907|NCT01720069|365980789|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
106087908|NCT01720069|365980790|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
106087909|NCT01720069|365980791|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
106087910|NCT01720069|365980789|FG000|Overall Study|Non-compliance on using e-diary|0|||
106087911|NCT01720069|365980790|FG001|Overall Study|Non-compliance on using e-diary|0|||
106087912|NCT01720069|365980791|FG002|Overall Study|Non-compliance on using e-diary|1|||
106087913|NCT01720069|365980789|FG000|Overall Study|Lost to Follow-up|0|||
106087914|NCT01720069|365980790|FG001|Overall Study|Lost to Follow-up|0|||
106087915|NCT01720069|365980791|FG002|Overall Study|Lost to Follow-up|1|||
106161220|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
106161221|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
106161222|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
106161223|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
106161224|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
106161225|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
106161226|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Adverse Event|0|||
105867249|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
105869211|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
106087916|NCT00678561|365980795|FG000|Overall Study|Adverse Event|0|||
106161227|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Adverse Event|0|||
106087917|NCT00678561|365980796|FG001|Overall Study|Adverse Event|1|||
106087918|NCT00678561|365980797|FG002|Overall Study|Adverse Event|1|||
106087919|NCT00678561|365980798|FG003|Overall Study|Adverse Event|0|||
106087920|NCT00678561|365980799|FG004|Overall Study|Adverse Event|1|||
106161228|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Adverse Event|0|||
106087921|NCT00678561|365980800|FG005|Overall Study|Adverse Event|0|||
106087922|NCT00678561|365980801|FG006|Overall Study|Adverse Event|0|||
106087923|NCT00678561|365980802|FG007|Overall Study|Adverse Event|0|||
106087924|NCT00678561|365980795|FG000|Overall Study|Protocol Violation|0|||
106087925|NCT00678561|365980796|FG001|Overall Study|Protocol Violation|0|||
106087926|NCT00678561|365980797|FG002|Overall Study|Protocol Violation|0|||
106087927|NCT00678561|365980798|FG003|Overall Study|Protocol Violation|0|||
106087928|NCT00678561|365980799|FG004|Overall Study|Protocol Violation|1|||
106087929|NCT00678561|365980800|FG005|Overall Study|Protocol Violation|1|||
106087930|NCT00678561|365980801|FG006|Overall Study|Protocol Violation|0|||
106087931|NCT00678561|365980802|FG007|Overall Study|Protocol Violation|0|||
106087932|NCT00678561|365980795|FG000|Overall Study|Withdrawal by Subject|0|||
106087933|NCT00678561|365980796|FG001|Overall Study|Withdrawal by Subject|0|||
106087934|NCT00678561|365980797|FG002|Overall Study|Withdrawal by Subject|0|||
106087935|NCT00678561|365980798|FG003|Overall Study|Withdrawal by Subject|0|||
106087936|NCT00678561|365980799|FG004|Overall Study|Withdrawal by Subject|0|||
106087937|NCT00678561|365980800|FG005|Overall Study|Withdrawal by Subject|0|||
106087938|NCT00678561|365980801|FG006|Overall Study|Withdrawal by Subject|0|||
106087939|NCT00678561|365980802|FG007|Overall Study|Withdrawal by Subject|1|||
106087940|NCT00700011|365980803|FG000|Overall Study|Death|0|||
106087941|NCT00700011|365980804|FG001|Overall Study|Death|1|||
106087942|NCT00853658|365980807|FG000|Overall Study|Death|713|||
106087943|NCT00853658|365980808|FG001|Overall Study|Death|768|||
106087944|NCT00853658|365980809|FG002|Overall Study|Death|753|||
106161229|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Adverse Event|0|||
106161230|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Adverse Event|0|||
106161231|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Adverse Event|0|||
106161232|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Adverse Event|2|||
106161233|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Adverse Event|0|||
106161234|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Adverse Event|0|||
106161235|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Adverse Event|0|||
106161236|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Adverse Event|1|||
106161237|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Adverse Event|2|||
106161238|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Adverse Event|0|||
106161239|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Adverse Event|1|||
106161240|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Adverse Event|0|||
106161241|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Adverse Event|0|||
106161242|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Adverse Event|1|||
106161243|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Adverse Event|0|||
106161244|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
106161245|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
106161246|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
106161247|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
106161248|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
106161249|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
106161250|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
106161251|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
106161252|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
106161253|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
106161254|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
106161255|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
106161256|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
106161257|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
106161258|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
106161259|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
106161260|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
106161261|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
106161262|NCT03269136|366252391|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161263|NCT03269136|366252392|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161264|NCT03269136|366252393|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161265|NCT03269136|366252394|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161266|NCT03269136|366252395|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161267|NCT03269136|366252396|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161268|NCT03269136|366252397|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161269|NCT03269136|366252398|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106087945|NCT00853658|365980807|FG000|Overall Study|Lost to Follow-up|11|||
106087946|NCT00853658|365980808|FG001|Overall Study|Lost to Follow-up|6|||
106087947|NCT00853658|365980809|FG002|Overall Study|Lost to Follow-up|11|||
106161270|NCT03269136|366252399|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161271|NCT03269136|366252400|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161272|NCT03269136|366252401|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161273|NCT03269136|366252402|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161274|NCT03269136|366252403|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
106087948|NCT00853658|365980807|FG000|Overall Study|H.A. Request|26|||
106087949|NCT00853658|365980808|FG001|Overall Study|H.A. Request|23|||
106087950|NCT00853658|365980809|FG002|Overall Study|H.A. Request|19|||
106087951|NCT00853658|365980807|FG000|Overall Study|IRB request|0|||
106161275|NCT03269136|366252404|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
106087952|NCT00853658|365980808|FG001|Overall Study|IRB request|0|||
106087953|NCT00853658|365980809|FG002|Overall Study|IRB request|2|||
106087954|NCT00853658|365980807|FG000|Overall Study|Vital Status known (alive) at study end|2|||
106087955|NCT00853658|365980808|FG001|Overall Study|Vital Status known (alive) at study end|3|||
106087956|NCT00853658|365980809|FG002|Overall Study|Vital Status known (alive) at study end|3|||
106087957|NCT00853658|365980807|FG000|Overall Study|Vital Status unknown at study end|1|||
106087958|NCT00853658|365980808|FG001|Overall Study|Vital Status unknown at study end|1|||
106087959|NCT00853658|365980809|FG002|Overall Study|Vital Status unknown at study end|0|||
106087960|NCT00853658|365980807|FG000|Overall Study|Vital Status at study end N/A|8|||
106087961|NCT00853658|365980808|FG001|Overall Study|Vital Status at study end N/A|10|||
106087962|NCT00853658|365980809|FG002|Overall Study|Vital Status at study end N/A|10|||
106087963|NCT00853658|365980807|FG000|Overall Study|Patient's request|21|||
106087964|NCT00853658|365980808|FG001|Overall Study|Patient's request|17|||
106087965|NCT00853658|365980809|FG002|Overall Study|Patient's request|11|||
106087966|NCT00853658|365980807|FG000|Overall Study|Missing study completion information|5|||
106087967|NCT00853658|365980808|FG001|Overall Study|Missing study completion information|4|||
106087968|NCT00853658|365980809|FG002|Overall Study|Missing study completion information|6|||
106087969|NCT02797262|365980810|FG000|Overall Study|Withdrawal by Subject|5|||
106087970|NCT02797262|365980811|FG001|Overall Study|Withdrawal by Subject|1|||
106087971|NCT02797262|365980810|FG000|Overall Study|Lost to Follow-up|10|||
106087972|NCT02797262|365980811|FG001|Overall Study|Lost to Follow-up|7|||
106087973|NCT02797262|365980810|FG000|Overall Study|Death|1|||
106087974|NCT02797262|365980811|FG001|Overall Study|Death|2|||
106087975|NCT02797262|365980810|FG000|Overall Study|Adverse Event|1|||
106087976|NCT02797262|365980811|FG001|Overall Study|Adverse Event|0|||
106087977|NCT02797262|365980810|FG000|Overall Study|COVID-19|2|||
106087978|NCT02797262|365980811|FG001|Overall Study|COVID-19|1|||
106087979|NCT02797262|365980810|FG000|Overall Study|Out-of-country|1|||
106087980|NCT02797262|365980811|FG001|Overall Study|Out-of-country|0|||
106087981|NCT01978184|365980812|FG000|Overall Study|Progressive disease|5|||
106087982|NCT01978184|365980813|FG001|Overall Study|Progressive disease|5|||
106087983|NCT01978184|365980812|FG000|Overall Study|Other than PDA|2|||
106087984|NCT01978184|365980813|FG001|Overall Study|Other than PDA|2|||
106087985|NCT01978184|365980812|FG000|Overall Study|Physician Decision|0|||
106087986|NCT01978184|365980813|FG001|Overall Study|Physician Decision|3|||
106087987|NCT01978184|365980812|FG000|Overall Study|Noncompliance|1|||
106087988|NCT01978184|365980813|FG001|Overall Study|Noncompliance|2|||
106087989|NCT01978184|365980812|FG000|Overall Study|Death|1|||
106087990|NCT01978184|365980813|FG001|Overall Study|Death|0|||
106087991|NCT01978184|365980812|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
106087992|NCT01978184|365980813|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
106087993|NCT01898793|365980815|FG000|Overall Study|Death|2|||
106087994|NCT01898793|365980816|FG001|Overall Study|Death|1|||
106087995|NCT01898793|365980817|FG002|Overall Study|Death|4|||
106087996|NCT01898793|365980818|FG003|Overall Study|Death|0|||
106087997|NCT01898793|365980819|FG004|Overall Study|Death|0|||
106087998|NCT01898793|365980820|FG005|Overall Study|Death|0|||
106087999|NCT01898793|365980821|FG006|Overall Study|Death|0|||
106088000|NCT03146650|365980822|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
106088001|NCT03146650|365980822|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
106088002|NCT03146650|365980822|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
106088003|NCT03146650|365980822|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
106088004|NCT03146650|365980822|FG000|2 Year Follow-up|Death|11|||
106088005|NCT03146650|365980822|FG000|2 Year Follow-up|Still in follow-up|7|||
106088006|NCT03146650|365980822|FG000|2 Year Follow-up|Lost to Follow-up|1|||
106088007|NCT00298038|365980827|FG000|Overall Study|Lost to Follow-up|0|||
106088008|NCT00298038|365980828|FG001|Overall Study|Lost to Follow-up|1|||
106088009|NCT00298038|365980827|FG000|Overall Study|Liver Transplant|0|||
106088010|NCT00298038|365980828|FG001|Overall Study|Liver Transplant|1|||
106088011|NCT00298038|365980827|FG000|Overall Study|Protocol Violation|1|||
106088012|NCT00298038|365980828|FG001|Overall Study|Protocol Violation|3|||
106161276|NCT03269136|366252405|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
106161277|NCT03269136|366252406|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106161278|NCT03269136|366252407|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
106161279|NCT03269136|366252408|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
106088013|NCT00298038|365980827|FG000|Overall Study|Death|6|||
106088014|NCT00298038|365980828|FG001|Overall Study|Death|3|||
106088015|NCT00298038|365980827|FG000|Overall Study|Withdrawal by Subject|6|||
106088016|NCT00298038|365980828|FG001|Overall Study|Withdrawal by Subject|9|||
106088017|NCT00298038|365980827|FG000|Overall Study|Adverse Event|8|||
106088018|NCT00298038|365980828|FG001|Overall Study|Adverse Event|7|||
106088019|NCT00298038|365980827|FG000|Overall Study|Breakthrough overt HE episode|28|||
106088020|NCT00298038|365980828|FG001|Overall Study|Breakthrough overt HE episode|69|||
106088021|NCT00298038|365980827|FG000|Overall Study|Noncompliance|1|||
106088022|NCT00298038|365980828|FG001|Overall Study|Noncompliance|0|||
106088023|NCT00298038|365980827|FG000|Overall Study|Cocaine Abuse|1|||
106088024|NCT00298038|365980828|FG001|Overall Study|Cocaine Abuse|0|||
106088025|NCT00298038|365980827|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
106088026|NCT00298038|365980828|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
106088027|NCT01306617|365980830|FG000|Overall Study|Adverse Event|1|||
106088028|NCT01306617|365980831|FG001|Overall Study|Adverse Event|0|||
106088029|NCT01306617|365980832|FG002|Overall Study|Adverse Event|0|||
106088030|NCT01306617|365980830|FG000|Overall Study|Virologic Failure|0|||
106088031|NCT01306617|365980831|FG001|Overall Study|Virologic Failure|0|||
106088032|NCT01306617|365980832|FG002|Overall Study|Virologic Failure|5|||
106088033|NCT01306617|365980830|FG000|Overall Study|Non-compliance|0|||
106088034|NCT01306617|365980831|FG001|Overall Study|Non-compliance|1|||
106088035|NCT01306617|365980832|FG002|Overall Study|Non-compliance|0|||
106088036|NCT00983814|365980833|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
106088037|NCT00983814|365980834|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
106088038|NCT00983814|365980835|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
106088039|NCT00983814|365980833|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
106088040|NCT00983814|365980834|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
106088041|NCT00983814|365980835|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
106088042|NCT00983814|365980833|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
106088043|NCT00983814|365980834|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
106088044|NCT00983814|365980835|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
106088045|NCT00983814|365980833|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
106088046|NCT00983814|365980834|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
106088047|NCT00983814|365980835|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
106088048|NCT00983814|365980833|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
106088049|NCT00983814|365980834|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
106088050|NCT00983814|365980835|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
106088051|NCT00773097|365980836|FG000|Overall Study|Withdrawal by Subject|1|||
106088052|NCT00773097|365980836|FG000|Overall Study|Physician Decision|6|||
106088053|NCT01114516|365980839|FG000|Overall Study|Lost to Follow-up|2|||
106088054|NCT01114516|365980840|FG001|Overall Study|Lost to Follow-up|1|||
106088055|NCT01994395|365980841|FG000|Overall Study|Withdrawal by Subject|1|||
106088056|NCT01994395|365980842|FG001|Overall Study|Withdrawal by Subject|2|||
106088057|NCT03403634|365980853|FG000|Overall Study|Disease progression|3|||
106088058|NCT03403634|365980853|FG000|Overall Study|Did not meet eligibility criteria|4|||
106088059|NCT02944578|365982772|FG000|Overall Study|Physician Decision|1|||
106088060|NCT02944578|365982773|FG001|Overall Study|Physician Decision|0|||
106088061|NCT02691455|365982774|FG000|Overall Study|Withdrawal by Subject|1|||
106088062|NCT02691455|365982775|FG001|Overall Study|Withdrawal by Subject|2|||
106088063|NCT02691455|365982774|FG000|Overall Study|Lost to Follow-up|15|||
106088064|NCT02691455|365982775|FG001|Overall Study|Lost to Follow-up|15|||
106088065|NCT00048724|365982776|FG000|Overall Study|Adverse Event|53|||
106088066|NCT00048724|365982777|FG001|Overall Study|Adverse Event|12|||
106088067|NCT00048724|365982776|FG000|Overall Study|Withdrawal by Subject|34|||
106088068|NCT00048724|365982777|FG001|Overall Study|Withdrawal by Subject|54|||
106088069|NCT00048724|365982776|FG000|Overall Study|Lost to Follow-up|5|||
106088070|NCT00048724|365982777|FG001|Overall Study|Lost to Follow-up|5|||
106088071|NCT00048724|365982776|FG000|Overall Study|Protocol-defined Clinical Event|17|||
106088072|NCT00048724|365982777|FG001|Overall Study|Protocol-defined Clinical Event|32|||
106088073|NCT00048724|365982776|FG000|Overall Study|Noncompliance With Protocol|4|||
106088074|NCT00048724|365982777|FG001|Overall Study|Noncompliance With Protocol|12|||
106088075|NCT00048724|365982776|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
106088076|NCT00048724|365982777|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
106088077|NCT00048724|365982776|FG000|Overall Study|Administrative|1|||
106088078|NCT00048724|365982777|FG001|Overall Study|Administrative|1|||
106088079|NCT02992899|365982778|FG000|Overall Study|Withdrawal by Subject|1|||
106088080|NCT02992899|365982779|FG001|Overall Study|Withdrawal by Subject|0|||
106088081|NCT02992899|365982778|FG000|Overall Study|Lost to Follow-up|1|||
106088082|NCT02992899|365982779|FG001|Overall Study|Lost to Follow-up|3|||
106088083|NCT02443298|365982780|FG000|Overall Study|Adverse Event|3|||
106088084|NCT02443298|365982781|FG001|Overall Study|Adverse Event|3|||
106088085|NCT02443298|365982780|FG000|Overall Study|Withdrawal by Subject|1|||
106088086|NCT02443298|365982781|FG001|Overall Study|Withdrawal by Subject|2|||
106088087|NCT02664038|365982782|FG000|13 Week|Lost to Follow-up|7|||
106088088|NCT02664038|365982783|FG001|13 Week|Lost to Follow-up|14|||
106088089|NCT02664038|365982782|FG000|13 Week|Withdrawal by Subject|1|||
106088090|NCT02664038|365982783|FG001|13 Week|Withdrawal by Subject|0|||
106088091|NCT02664038|365982782|FG000|26 Week|Lost to Follow-up|5|||
106088092|NCT02664038|365982783|FG001|26 Week|Lost to Follow-up|4|||
106088093|NCT03698773|365982784|FG000|Overall Study|Lost to Follow-up|2|||
106088094|NCT03698773|365982785|FG001|Overall Study|Lost to Follow-up|1|||
106088095|NCT00908960|365982786|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
106088096|NCT00908960|365982787|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
106088097|NCT00908960|365982788|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
106088098|NCT02357576|365982789|FG000|Treatment Period|Withdrawal by Subject|0|||
106088099|NCT02357576|365982790|FG001|Treatment Period|Withdrawal by Subject|1|||
106088100|NCT02357576|365982789|FG000|Treatment Period|Physician Decision|0|||
106088101|NCT02357576|365982790|FG001|Treatment Period|Physician Decision|1|||
106088102|NCT02357576|365982789|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
106088103|NCT02357576|365982790|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
106088104|NCT02357576|365982789|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
106088105|NCT02357576|365982790|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
106088106|NCT02357576|365982789|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
106088107|NCT02357576|365982790|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
106088108|NCT02357576|365982789|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
106088109|NCT02357576|365982790|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
106088110|NCT02822794|365982791|FG000|Overall Study|Withdrew Consent|1|||
106088111|NCT02822794|365982792|FG001|Overall Study|Withdrew Consent|0|||
106088112|NCT01599650|365982793|FG000|Overall Study|Administrative issue|1|||
106088113|NCT01599650|365982794|FG001|Overall Study|Administrative issue|0|||
106088114|NCT01599650|365982795|FG002|Overall Study|Administrative issue|1|||
106088115|NCT01599650|365982793|FG000|Overall Study|Physician Decision|2|||
106088116|NCT01599650|365982794|FG001|Overall Study|Physician Decision|0|||
106088117|NCT01599650|365982795|FG002|Overall Study|Physician Decision|7|||
106088118|NCT01599650|365982793|FG000|Overall Study|Protocol Violation|0|||
106088119|NCT01599650|365982794|FG001|Overall Study|Protocol Violation|3|||
106088120|NCT01599650|365982795|FG002|Overall Study|Protocol Violation|0|||
106088121|NCT01599650|365982793|FG000|Overall Study|Death|2|||
106088122|NCT01599650|365982794|FG001|Overall Study|Death|1|||
106088123|NCT01599650|365982795|FG002|Overall Study|Death|2|||
106088124|NCT01599650|365982793|FG000|Overall Study|Lost to Follow-up|3|||
106088125|NCT01599650|365982794|FG001|Overall Study|Lost to Follow-up|3|||
106088126|NCT01599650|365982795|FG002|Overall Study|Lost to Follow-up|3|||
106088127|NCT01599650|365982793|FG000|Overall Study|Withdrawal by Subject|11|||
106088128|NCT01599650|365982794|FG001|Overall Study|Withdrawal by Subject|11|||
106088129|NCT01599650|365982795|FG002|Overall Study|Withdrawal by Subject|10|||
106088130|NCT01599650|365982793|FG000|Overall Study|Adverse Event|3|||
106088131|NCT01599650|365982794|FG001|Overall Study|Adverse Event|8|||
106088132|NCT01599650|365982795|FG002|Overall Study|Adverse Event|4|||
106088133|NCT01416805|365982800|FG000|Overall Study|Lost to Follow-up|4|||
106088134|NCT01416805|365982801|FG001|Overall Study|Lost to Follow-up|4|||
106088135|NCT01748994|365982802|FG000|Overall Study|Lost to Follow-up|8|||
106088136|NCT01748994|365982803|FG001|Overall Study|Lost to Follow-up|6|||
106088137|NCT01767116|365982804|FG000|Overall Study|Lost to Follow-up|2|||
106088138|NCT01767116|365982805|FG001|Overall Study|Lost to Follow-up|2|||
106088139|NCT02520531|365982810|FG000|Overall Study|Revision of study device components|2|||
106088140|NCT02520531|365982811|FG001|Overall Study|Revision of study device components|2|||
106088141|NCT02520531|365982810|FG000|Overall Study|Death|1|||
106088142|NCT02520531|365982811|FG001|Overall Study|Death|2|||
106088143|NCT02520531|365982810|FG000|Overall Study|Lost to Follow-up|1|||
106088144|NCT02520531|365982811|FG001|Overall Study|Lost to Follow-up|1|||
106088145|NCT02520531|365982810|FG000|Overall Study|Meet exclusion criterion|0|||
106088146|NCT02520531|365982811|FG001|Overall Study|Meet exclusion criterion|1|||
106088147|NCT02520531|365982810|FG000|Overall Study|Withdrawal by Subject|1|||
106088148|NCT02520531|365982811|FG001|Overall Study|Withdrawal by Subject|0|||
106088149|NCT02520531|365982810|FG000|Overall Study|Not study device|1|||
106088150|NCT02520531|365982811|FG001|Overall Study|Not study device|0|||
106088151|NCT02141516|365982812|FG000|Overall Study|Adverse Event|0|||
106088152|NCT02141516|365982813|FG001|Overall Study|Adverse Event|1|||
106088153|NCT02141516|365982814|FG002|Overall Study|Adverse Event|0|||
106088154|NCT02141516|365982812|FG000|Overall Study|Lost to Follow-up|0|||
106088155|NCT02141516|365982813|FG001|Overall Study|Lost to Follow-up|1|||
106088156|NCT02141516|365982814|FG002|Overall Study|Lost to Follow-up|0|||
106088157|NCT02141516|365982812|FG000|Overall Study|Other|0|||
106088158|NCT02141516|365982813|FG001|Overall Study|Other|3|||
106088159|NCT02141516|365982814|FG002|Overall Study|Other|0|||
106088160|NCT02041429|365982817|FG000|Overall Study|Progressive Disease|2|||
106088161|NCT02041429|365982818|FG001|Overall Study|Progressive Disease|2|||
106088162|NCT02041429|365982819|FG002|Overall Study|Progressive Disease|3|||
106088163|NCT02041429|365982820|FG003|Overall Study|Progressive Disease|2|||
106088164|NCT02041429|365982817|FG000|Overall Study|Toxicity|0|||
106088165|NCT02041429|365982818|FG001|Overall Study|Toxicity|1|||
106088166|NCT02041429|365982819|FG002|Overall Study|Toxicity|4|||
106088167|NCT02041429|365982820|FG003|Overall Study|Toxicity|2|||
106088168|NCT02041429|365982817|FG000|Overall Study|Withdrawal by Subject|0|||
106088169|NCT02041429|365982818|FG001|Overall Study|Withdrawal by Subject|1|||
106088170|NCT02041429|365982819|FG002|Overall Study|Withdrawal by Subject|0|||
106088171|NCT02041429|365982820|FG003|Overall Study|Withdrawal by Subject|0|||
106088172|NCT02041429|365982817|FG000|Overall Study|On Maintenance Therapy|1|||
106088173|NCT02041429|365982818|FG001|Overall Study|On Maintenance Therapy|0|||
106088174|NCT02041429|365982819|FG002|Overall Study|On Maintenance Therapy|0|||
106088175|NCT02041429|365982820|FG003|Overall Study|On Maintenance Therapy|2|||
106088176|NCT03251924|365982823|FG000|Overall Study|Disease Progression|6|||
106088177|NCT03251924|365982824|FG001|Overall Study|Disease Progression|6|||
106088178|NCT03251924|365982825|FG002|Overall Study|Disease Progression|7|||
106088179|NCT03251924|365982826|FG003|Overall Study|Disease Progression|8|||
106088180|NCT03251924|365982827|FG004|Overall Study|Disease Progression|8|||
106088181|NCT03251924|365982828|FG005|Overall Study|Disease Progression|7|||
106088182|NCT03251924|365982829|FG006|Overall Study|Disease Progression|6|||
106088183|NCT03251924|365982830|FG007|Overall Study|Disease Progression|10|||
106088184|NCT03251924|365982831|FG008|Overall Study|Disease Progression|6|||
106088185|NCT03251924|365982823|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
106088186|NCT03251924|365982824|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
106088187|NCT03251924|365982825|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
106088188|NCT03251924|365982826|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
106088189|NCT03251924|365982827|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
106088190|NCT03251924|365982828|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
106088191|NCT03251924|365982829|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
106088192|NCT03251924|365982830|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
106088193|NCT03251924|365982831|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
106088194|NCT03251924|365982823|FG000|Overall Study|Death|0|||
106088195|NCT03251924|365982824|FG001|Overall Study|Death|1|||
106088196|NCT03251924|365982825|FG002|Overall Study|Death|0|||
106088197|NCT03251924|365982826|FG003|Overall Study|Death|1|||
106088198|NCT03251924|365982827|FG004|Overall Study|Death|1|||
106088199|NCT03251924|365982828|FG005|Overall Study|Death|1|||
106088200|NCT03251924|365982829|FG006|Overall Study|Death|0|||
106088201|NCT03251924|365982830|FG007|Overall Study|Death|0|||
106088202|NCT03251924|365982831|FG008|Overall Study|Death|0|||
106088203|NCT03251924|365982823|FG000|Overall Study|Study Drug Toxicity|0|||
106088204|NCT03251924|365982824|FG001|Overall Study|Study Drug Toxicity|0|||
106088205|NCT03251924|365982825|FG002|Overall Study|Study Drug Toxicity|0|||
106088206|NCT03251924|365982826|FG003|Overall Study|Study Drug Toxicity|1|||
106088207|NCT03251924|365982827|FG004|Overall Study|Study Drug Toxicity|0|||
106088208|NCT03251924|365982828|FG005|Overall Study|Study Drug Toxicity|0|||
106088209|NCT03251924|365982829|FG006|Overall Study|Study Drug Toxicity|0|||
106088210|NCT03251924|365982830|FG007|Overall Study|Study Drug Toxicity|0|||
106088211|NCT03251924|365982831|FG008|Overall Study|Study Drug Toxicity|1|||
106088212|NCT03251924|365982823|FG000|Overall Study|Other Reasons|0|||
106088213|NCT03251924|365982824|FG001|Overall Study|Other Reasons|0|||
106088214|NCT03251924|365982825|FG002|Overall Study|Other Reasons|0|||
106088215|NCT03251924|365982826|FG003|Overall Study|Other Reasons|0|||
106088216|NCT03251924|365982827|FG004|Overall Study|Other Reasons|0|||
106088217|NCT03251924|365982828|FG005|Overall Study|Other Reasons|0|||
106088218|NCT03251924|365982829|FG006|Overall Study|Other Reasons|0|||
106088219|NCT03251924|365982830|FG007|Overall Study|Other Reasons|0|||
106088220|NCT03251924|365982831|FG008|Overall Study|Other Reasons|1|||
106088221|NCT03251924|365982823|FG000|Overall Study|Participant request to discontinue study treatment|0|||
106088222|NCT03251924|365982824|FG001|Overall Study|Participant request to discontinue study treatment|0|||
106088223|NCT03251924|365982825|FG002|Overall Study|Participant request to discontinue study treatment|0|||
106088224|NCT03251924|365982826|FG003|Overall Study|Participant request to discontinue study treatment|0|||
106088225|NCT03251924|365982827|FG004|Overall Study|Participant request to discontinue study treatment|0|||
106088226|NCT03251924|365982828|FG005|Overall Study|Participant request to discontinue study treatment|0|||
106088227|NCT03251924|365982829|FG006|Overall Study|Participant request to discontinue study treatment|0|||
106088228|NCT03251924|365982830|FG007|Overall Study|Participant request to discontinue study treatment|1|||
106088229|NCT03251924|365982831|FG008|Overall Study|Participant request to discontinue study treatment|0|||
106088230|NCT00153101|365982835|FG000|Overall Study|Lost to Follow-up|14|||
106088231|NCT00153101|365982836|FG001|Overall Study|Lost to Follow-up|14|||
106088232|NCT00153101|365982837|FG002|Overall Study|Lost to Follow-up|12|||
106088233|NCT00153101|365982838|FG003|Overall Study|Lost to Follow-up|5|||
106088234|NCT00153101|365982839|FG004|Overall Study|Lost to Follow-up|5|||
106088235|NCT00153101|365982835|FG000|Overall Study|Withdrawal by Subject|3|||
106088236|NCT00153101|365982836|FG001|Overall Study|Withdrawal by Subject|4|||
106088237|NCT00153101|365982837|FG002|Overall Study|Withdrawal by Subject|3|||
106088238|NCT00153101|365982838|FG003|Overall Study|Withdrawal by Subject|3|||
106088239|NCT00153101|365982839|FG004|Overall Study|Withdrawal by Subject|5|||
106088240|NCT02610140|365982840|FG000|Randomization and Treatment Period|Radiological progression|23|||
106088241|NCT02610140|365982841|FG001|Randomization and Treatment Period|Radiological progression|15|||
106088242|NCT02610140|365982840|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
106088243|NCT02610140|365982841|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
106088244|NCT02610140|365982840|FG000|Randomization and Treatment Period|Protocol Violation|1|||
106088245|NCT02610140|365982841|FG001|Randomization and Treatment Period|Protocol Violation|0|||
106088246|NCT02610140|365982840|FG000|Randomization and Treatment Period|Physician Decision|0|||
106088247|NCT02610140|365982841|FG001|Randomization and Treatment Period|Physician Decision|1|||
106088248|NCT02610140|365982840|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
106088249|NCT02610140|365982841|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
106088250|NCT02610140|365982840|FG000|Randomization and Treatment Period|Death|7|||
106088251|NCT02610140|365982841|FG001|Randomization and Treatment Period|Death|1|||
106088252|NCT02610140|365982840|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
106088253|NCT02610140|365982841|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
106088254|NCT02610140|365982840|FG000|Randomization and Treatment Period|Adverse Event|44|||
106088255|NCT02610140|365982841|FG001|Randomization and Treatment Period|Adverse Event|13|||
106088256|NCT02610140|365982840|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
106088257|NCT02610140|365982841|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
106088258|NCT02610140|365982840|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
106088259|NCT02610140|365982841|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
106088260|NCT02610140|365982840|FG000|Randomization and Treatment Period|Not treated|3|||
106088261|NCT02610140|365982841|FG001|Randomization and Treatment Period|Not treated|10|||
106088262|NCT02610140|365982840|FG000|Safety Follow-up|Other|0|||
106088263|NCT02610140|365982841|FG001|Safety Follow-up|Other|2|||
106088264|NCT02610140|365982840|FG000|Safety Follow-up|Lost to Follow-up|1|||
106088265|NCT02610140|365982841|FG001|Safety Follow-up|Lost to Follow-up|0|||
106088266|NCT02610140|365982840|FG000|Safety Follow-up|No follow-up|5|||
106088267|NCT02610140|365982841|FG001|Safety Follow-up|No follow-up|3|||
106088268|NCT02610140|365982840|FG000|Safety Follow-up|Death|12|||
106088269|NCT02610140|365982841|FG001|Safety Follow-up|Death|2|||
106088270|NCT02610140|365982840|FG000|Safety Follow-up|Deterioration of general conditions|15|||
106088271|NCT02610140|365982841|FG001|Safety Follow-up|Deterioration of general conditions|5|||
106088272|NCT02610140|365982840|FG000|Safety Follow-up|Withdrawal by Subject|12|||
106088273|NCT02610140|365982841|FG001|Safety Follow-up|Withdrawal by Subject|12|||
106088274|NCT02610140|365982840|FG000|Active Follow-up|Progressive disease - radiological|30|||
106088275|NCT02610140|365982841|FG001|Active Follow-up|Progressive disease - radiological|22|||
106088276|NCT02610140|365982840|FG000|Active Follow-up|Death|8|||
106088277|NCT02610140|365982841|FG001|Active Follow-up|Death|1|||
106088278|NCT02610140|365982840|FG000|Active Follow-up|Withdrawal by Subject|4|||
106088279|NCT02610140|365982841|FG001|Active Follow-up|Withdrawal by Subject|0|||
106088280|NCT02610140|365982840|FG000|Active Follow-up|Progressive disease - clinical|1|||
106088281|NCT02610140|365982841|FG001|Active Follow-up|Progressive disease - clinical|2|||
106088282|NCT02610140|365982840|FG000|Active Follow-up|Deterioration of general conditions|1|||
106088283|NCT02610140|365982841|FG001|Active Follow-up|Deterioration of general conditions|0|||
106088284|NCT02610140|365982840|FG000|Active Follow-up|Ongoing but not completed|4|||
106161280|NCT03269136|366252391|FG000|Part 2A: Dose Expansion|Other|0|||
106161281|NCT03269136|366252392|FG001|Part 2A: Dose Expansion|Other|0|||
106161282|NCT03269136|366252393|FG002|Part 2A: Dose Expansion|Other|0|||
106161283|NCT03269136|366252394|FG003|Part 2A: Dose Expansion|Other|0|||
106161284|NCT03269136|366252395|FG004|Part 2A: Dose Expansion|Other|0|||
106161285|NCT03269136|366252396|FG005|Part 2A: Dose Expansion|Other|0|||
106161286|NCT03269136|366252397|FG006|Part 2A: Dose Expansion|Other|0|||
106161287|NCT03269136|366252398|FG007|Part 2A: Dose Expansion|Other|0|||
106161288|NCT03269136|366252399|FG008|Part 2A: Dose Expansion|Other|0|||
106088285|NCT02610140|365982841|FG001|Active Follow-up|Ongoing but not completed|1|||
106088286|NCT02610140|365982840|FG000|Long-term Follow-up|Death|86|||
106088287|NCT02610140|365982841|FG001|Long-term Follow-up|Death|44|||
106161289|NCT03269136|366252400|FG009|Part 2A: Dose Expansion|Other|0|||
106161290|NCT03269136|366252401|FG010|Part 2A: Dose Expansion|Other|0|||
106088288|NCT02610140|365982840|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
106088289|NCT02610140|365982841|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
106088290|NCT02610140|365982840|FG000|Long-term Follow-up|Lost to Follow-up|1|||
106088291|NCT02610140|365982841|FG001|Long-term Follow-up|Lost to Follow-up|2|||
106088292|NCT02610140|365982840|FG000|Long-term Follow-up|Ongoing but not completed|30|||
106088293|NCT02610140|365982841|FG001|Long-term Follow-up|Ongoing but not completed|17|||
106088294|NCT00887341|365982842|FG000|Overall Study|Refused treatment|1|||
106088295|NCT00887341|365982843|FG001|Overall Study|Refused treatment|0|||
106088296|NCT00887341|365982842|FG000|Overall Study|Withdrawal by Subject|1|||
106088297|NCT00887341|365982843|FG001|Overall Study|Withdrawal by Subject|1|||
106088298|NCT00887341|365982842|FG000|Overall Study|Adverse Event|0|||
106088299|NCT00887341|365982843|FG001|Overall Study|Adverse Event|1|||
106088300|NCT00887341|365982842|FG000|Overall Study|Lost to Follow-up|0|||
106088301|NCT00887341|365982843|FG001|Overall Study|Lost to Follow-up|1|||
106088302|NCT01591681|365982846|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
106088303|NCT01591681|365982846|FG000|Overall Study|Failed to use system during run-in|1|||
106088304|NCT01649856|365982847|FG000|Overall Study|Withdrawal by Subject|14|||
106088305|NCT01649856|365982848|FG001|Overall Study|Withdrawal by Subject|14|||
106088306|NCT01649856|365982847|FG000|Overall Study|Protocol Violation|4|||
106088307|NCT01649856|365982848|FG001|Overall Study|Protocol Violation|4|||
106088308|NCT01649856|365982847|FG000|Overall Study|Treatment Failure|1|||
106088309|NCT01649856|365982848|FG001|Overall Study|Treatment Failure|1|||
106088310|NCT01649856|365982847|FG000|Overall Study|Death|69|||
106088311|NCT01649856|365982848|FG001|Overall Study|Death|34|||
106088312|NCT01649856|365982847|FG000|Overall Study|Stable or Progressed Disease|5|||
106088313|NCT01649856|365982848|FG001|Overall Study|Stable or Progressed Disease|3|||
106088314|NCT01649856|365982847|FG000|Overall Study|Lost to Follow-up|20|||
106088315|NCT01649856|365982848|FG001|Overall Study|Lost to Follow-up|16|||
106088316|NCT01649856|365982847|FG000|Overall Study|Lack of Compliance|6|||
106088317|NCT01649856|365982848|FG001|Overall Study|Lack of Compliance|1|||
106088318|NCT01649856|365982847|FG000|Overall Study|Other|20|||
106088319|NCT01649856|365982848|FG001|Overall Study|Other|5|||
106088320|NCT00622635|365982849|FG000|Treatment Period 1|Adverse Event|0|||
106088321|NCT00622635|365982850|FG001|Treatment Period 1|Adverse Event|0|||
106088322|NCT00622635|365982851|FG002|Treatment Period 1|Adverse Event|1|||
106088323|NCT00622635|365982852|FG003|Treatment Period 1|Adverse Event|0|||
106088324|NCT00622635|365982853|FG004|Treatment Period 1|Adverse Event|0|||
106088325|NCT00622635|365982854|FG005|Treatment Period 1|Adverse Event|0|||
106088326|NCT00622635|365982849|FG000|Treatment Period 1|Withdrawal by Subject|0|||
106088327|NCT00622635|365982850|FG001|Treatment Period 1|Withdrawal by Subject|1|||
106088328|NCT00622635|365982851|FG002|Treatment Period 1|Withdrawal by Subject|0|||
106088329|NCT00622635|365982852|FG003|Treatment Period 1|Withdrawal by Subject|0|||
106088330|NCT00622635|365982853|FG004|Treatment Period 1|Withdrawal by Subject|0|||
106088331|NCT00622635|365982854|FG005|Treatment Period 1|Withdrawal by Subject|0|||
106088332|NCT00622635|365982849|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
106088333|NCT00622635|365982850|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
106088334|NCT00622635|365982851|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
106088335|NCT00622635|365982852|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
106088336|NCT00622635|365982853|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
106088337|NCT00622635|365982854|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
106088338|NCT00622635|365982849|FG000|Treatment Period 2|Adverse Event|1|||
106088339|NCT00622635|365982850|FG001|Treatment Period 2|Adverse Event|0|||
106088340|NCT00622635|365982851|FG002|Treatment Period 2|Adverse Event|0|||
106088341|NCT00622635|365982852|FG003|Treatment Period 2|Adverse Event|0|||
106088342|NCT00622635|365982853|FG004|Treatment Period 2|Adverse Event|0|||
106088343|NCT00622635|365982854|FG005|Treatment Period 2|Adverse Event|0|||
106088344|NCT00622635|365982849|FG000|Treatment Period 3|Adverse Event|0|||
106088345|NCT00622635|365982850|FG001|Treatment Period 3|Adverse Event|0|||
106088346|NCT00622635|365982851|FG002|Treatment Period 3|Adverse Event|0|||
106088347|NCT00622635|365982852|FG003|Treatment Period 3|Adverse Event|2|||
106088348|NCT00622635|365982853|FG004|Treatment Period 3|Adverse Event|0|||
106088349|NCT00622635|365982854|FG005|Treatment Period 3|Adverse Event|0|||
106088350|NCT00622635|365982849|FG000|Treatment Period 3|Withdrawal by Subject|0|||
106088351|NCT00622635|365982850|FG001|Treatment Period 3|Withdrawal by Subject|0|||
106088352|NCT00622635|365982851|FG002|Treatment Period 3|Withdrawal by Subject|0|||
106088353|NCT00622635|365982852|FG003|Treatment Period 3|Withdrawal by Subject|1|||
106088354|NCT00622635|365982853|FG004|Treatment Period 3|Withdrawal by Subject|0|||
106161291|NCT03269136|366252402|FG011|Part 2A: Dose Expansion|Other|0|||
106088355|NCT00622635|365982854|FG005|Treatment Period 3|Withdrawal by Subject|0|||
106088356|NCT02486406|365982862|FG000|Overall Study|Withdrew consent|1|||
106088357|NCT02486406|365982863|FG001|Overall Study|Withdrew consent|0|||
106161292|NCT03269136|366252403|FG012|Part 2A: Dose Expansion|Other|0|||
106161293|NCT03269136|366252404|FG013|Part 2A: Dose Expansion|Other|0|||
106161294|NCT03269136|366252405|FG014|Part 2A: Dose Expansion|Other|0|||
106161295|NCT03269136|366252406|FG015|Part 2A: Dose Expansion|Other|0|||
106161296|NCT03269136|366252407|FG016|Part 2A: Dose Expansion|Other|0|||
106161297|NCT03269136|366252408|FG017|Part 2A: Dose Expansion|Other|1|||
106088358|NCT02486406|365982864|FG002|Overall Study|Withdrew consent|0|||
106088359|NCT02486406|365982865|FG003|Overall Study|Withdrew consent|1|||
106088360|NCT02486406|365982862|FG000|Overall Study|Lost to Follow-up|1|||
106088361|NCT02486406|365982863|FG001|Overall Study|Lost to Follow-up|3|||
106088362|NCT02486406|365982864|FG002|Overall Study|Lost to Follow-up|1|||
106088363|NCT02486406|365982865|FG003|Overall Study|Lost to Follow-up|3|||
106088364|NCT02486406|365982862|FG000|Overall Study|Other, not specified|0|||
106088365|NCT02486406|365982863|FG001|Overall Study|Other, not specified|0|||
106088366|NCT02486406|365982864|FG002|Overall Study|Other, not specified|1|||
106088367|NCT02486406|365982865|FG003|Overall Study|Other, not specified|0|||
106088368|NCT01826825|365982866|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
106088369|NCT01826825|365982867|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
106088370|NCT03062891|365982868|FG000|Overall Study|Withdrawal by Subject|2|||
106088371|NCT03062891|365982869|FG001|Overall Study|Withdrawal by Subject|0|||
106088372|NCT03062891|365982868|FG000|Overall Study|Lost to Follow-up|50|||
106088373|NCT03062891|365982869|FG001|Overall Study|Lost to Follow-up|38|||
106088374|NCT01312961|365982873|FG000|Overall Study|Adverse Event|3|||
106088375|NCT01312961|365982874|FG001|Overall Study|Adverse Event|3|||
106088376|NCT01312961|365982873|FG000|Overall Study|Lack of Efficacy|11|||
106088377|NCT01312961|365982874|FG001|Overall Study|Lack of Efficacy|1|||
106088378|NCT01312961|365982873|FG000|Overall Study|Poor compliance to protocol|1|||
106088379|NCT01312961|365982874|FG001|Overall Study|Poor compliance to protocol|0|||
106088380|NCT01312961|365982873|FG000|Overall Study|Other than specified above|2|||
106088381|NCT01312961|365982874|FG001|Overall Study|Other than specified above|3|||
106088382|NCT03509948|365982875|FG000|Overall Study|Protocol Violation|0|||
106088383|NCT03509948|365982876|FG001|Overall Study|Protocol Violation|1|||
106088384|NCT00101101|365982878|FG000|Overall Study|never received vaccine|20|||
106088385|NCT01418209|365982879|FG000|Overall Study|Withdrawal by Subject|1|||
106088386|NCT01418209|365982880|FG001|Overall Study|Withdrawal by Subject|0|||
106088387|NCT01418209|365982881|FG002|Overall Study|Withdrawal by Subject|1|||
106088388|NCT01418209|365982879|FG000|Overall Study|Did not provide hot flash diary data|1|||
106088389|NCT01418209|365982880|FG001|Overall Study|Did not provide hot flash diary data|3|||
106088390|NCT01418209|365982881|FG002|Overall Study|Did not provide hot flash diary data|3|||
106088391|NCT00958880|365982890|FG000|Overall Study|Lost to Follow-up|2|||
106088392|NCT00958880|365982891|FG001|Overall Study|Lost to Follow-up|2|||
106088393|NCT01848990|365982892|FG000|Overall Study|Adverse Event|6|||
106088394|NCT01848990|365982893|FG001|Overall Study|Adverse Event|2|||
106088395|NCT01848990|365982894|FG002|Overall Study|Adverse Event|0|||
106088396|NCT01848990|365982892|FG000|Overall Study|Lost to Follow-up|6|||
106088397|NCT01848990|365982893|FG001|Overall Study|Lost to Follow-up|2|||
106088398|NCT01848990|365982894|FG002|Overall Study|Lost to Follow-up|2|||
106088399|NCT01848990|365982892|FG000|Overall Study|Protocol Violation|1|||
106088400|NCT01848990|365982893|FG001|Overall Study|Protocol Violation|1|||
106088401|NCT01848990|365982894|FG002|Overall Study|Protocol Violation|0|||
106088402|NCT01848990|365982892|FG000|Overall Study|Withdrawal by Subject|29|||
106088403|NCT01848990|365982893|FG001|Overall Study|Withdrawal by Subject|10|||
106088404|NCT01848990|365982894|FG002|Overall Study|Withdrawal by Subject|11|||
106088405|NCT01848990|365982892|FG000|Overall Study|Physician Decision|1|||
106088406|NCT01848990|365982893|FG001|Overall Study|Physician Decision|1|||
106088407|NCT01848990|365982894|FG002|Overall Study|Physician Decision|0|||
106088408|NCT01848990|365982892|FG000|Overall Study|Non Compliance|1|||
106088409|NCT01848990|365982893|FG001|Overall Study|Non Compliance|0|||
106088410|NCT01848990|365982894|FG002|Overall Study|Non Compliance|0|||
106088411|NCT01848990|365982892|FG000|Overall Study|Death|1|||
106088412|NCT01848990|365982893|FG001|Overall Study|Death|0|||
106088413|NCT01848990|365982894|FG002|Overall Study|Death|1|||
106088414|NCT01848990|365982892|FG000|Overall Study|Other|1|||
106088415|NCT01848990|365982893|FG001|Overall Study|Other|4|||
106088416|NCT01848990|365982894|FG002|Overall Study|Other|2|||
106088417|NCT01971346|365982895|FG000|Overall Study|Protocol Violation|3|||
106161298|NCT03269136|366252391|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106088418|NCT01971346|365982895|FG000|Overall Study|Lost to Follow-up|2|||
106088419|NCT01971346|365982895|FG000|Overall Study|Withdrawal by Subject|2|||
106088420|NCT01971346|365982895|FG000|Overall Study|Physician Decision|1|||
106161299|NCT03269136|366252392|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106088421|NCT01712984|365982899|FG000|Overall Study|Adverse Event|0|||
106088422|NCT01712984|365982900|FG001|Overall Study|Adverse Event|0|||
106088423|NCT01712984|365982901|FG002|Overall Study|Adverse Event|1|||
106088424|NCT01712984|365982899|FG000|Overall Study|Protocol Violation|2|||
106088425|NCT01712984|365982900|FG001|Overall Study|Protocol Violation|0|||
106088426|NCT01712984|365982901|FG002|Overall Study|Protocol Violation|1|||
106088427|NCT01712984|365982899|FG000|Overall Study|Lost to Follow-up|8|||
106088428|NCT01712984|365982900|FG001|Overall Study|Lost to Follow-up|10|||
106088429|NCT01712984|365982901|FG002|Overall Study|Lost to Follow-up|1|||
106088430|NCT01712984|365982899|FG000|Overall Study|Withdrawal by Subject|6|||
106161300|NCT03269136|366252393|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161301|NCT03269136|366252394|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106088431|NCT01712984|365982900|FG001|Overall Study|Withdrawal by Subject|6|||
106088432|NCT01712984|365982901|FG002|Overall Study|Withdrawal by Subject|7|||
106088433|NCT01652716|365982902|FG000|Overall Study|Loss of glucose control|1|||
106088434|NCT01652716|365982903|FG001|Overall Study|Loss of glucose control|0|||
106088435|NCT01652716|365982902|FG000|Overall Study|Administrative|0|||
106088436|NCT01652716|365982903|FG001|Overall Study|Administrative|2|||
106088437|NCT01652716|365982902|FG000|Overall Study|Investigator decision|1|||
106088438|NCT01652716|365982903|FG001|Overall Study|Investigator decision|4|||
106088439|NCT01652716|365982902|FG000|Overall Study|Lost to Follow-up|12|||
106088440|NCT01652716|365982903|FG001|Overall Study|Lost to Follow-up|11|||
106088441|NCT01652716|365982902|FG000|Overall Study|Protocol Violation|2|||
106088442|NCT01652716|365982903|FG001|Overall Study|Protocol Violation|1|||
106088443|NCT01652716|365982902|FG000|Overall Study|Adverse Event|7|||
106088444|NCT01652716|365982903|FG001|Overall Study|Adverse Event|10|||
106088445|NCT01652716|365982902|FG000|Overall Study|Withdrawal by Subject|33|||
106088446|NCT01652716|365982903|FG001|Overall Study|Withdrawal by Subject|18|||
106088447|NCT00360334|365982906|FG000|Overall Study|Adverse Event|7|||
106088448|NCT00360334|365982907|FG001|Overall Study|Adverse Event|4|||
106088449|NCT00360334|365982906|FG000|Overall Study|Protocol Violation|1|||
106088450|NCT00360334|365982907|FG001|Overall Study|Protocol Violation|1|||
106088451|NCT00360334|365982906|FG000|Overall Study|Physician Decision|2|||
106088452|NCT00360334|365982907|FG001|Overall Study|Physician Decision|3|||
106088453|NCT00360334|365982906|FG000|Overall Study|Lack of Efficacy|0|||
106088454|NCT00360334|365982907|FG001|Overall Study|Lack of Efficacy|1|||
106088455|NCT00360334|365982906|FG000|Overall Study|Entry criterion not met|1|||
106088456|NCT00360334|365982907|FG001|Overall Study|Entry criterion not met|2|||
106088457|NCT00360334|365982906|FG000|Overall Study|Subject decision|8|||
106088458|NCT00360334|365982907|FG001|Overall Study|Subject decision|2|||
106088459|NCT01600586|365982908|FG000|Overall Study|Physician Decision|3|||
106088460|NCT01600586|365982909|FG001|Overall Study|Physician Decision|3|||
106088461|NCT00162136|365982913|FG000|Overall Study|Adverse Event|1|||
106088462|NCT00162136|365982913|FG000|Overall Study|Death|1|||
106088463|NCT00162136|365982913|FG000|Overall Study|Disease Progression/Relapse|23|||
106088464|NCT00162136|365982913|FG000|Overall Study|Investigator Request|5|||
106088465|NCT00162136|365982913|FG000|Overall Study|Study Drug Toxicity|4|||
106088466|NCT00162136|365982913|FG000|Overall Study|Withdrawal by Subject|1|||
106088467|NCT00818441|365982914|FG000|Overall Study|Death|69|||
106088468|NCT00818441|365982915|FG001|Overall Study|Death|26|||
106088469|NCT00818441|365982914|FG000|Overall Study|Other|5|||
106088470|NCT00818441|365982915|FG001|Overall Study|Other|0|||
106088471|NCT00818441|365982914|FG000|Overall Study|Lost to Follow-up|2|||
106088472|NCT00818441|365982915|FG001|Overall Study|Lost to Follow-up|1|||
106088473|NCT00818441|365982914|FG000|Overall Study|Withdrawal by Subject|2|||
106088474|NCT00818441|365982915|FG001|Overall Study|Withdrawal by Subject|0|||
106088475|NCT00818441|365982914|FG000|Overall Study|Adverse Event|0|||
106088476|NCT00818441|365982915|FG001|Overall Study|Adverse Event|1|||
106088477|NCT00818441|365982914|FG000|Overall Study|Study terminated by sponsor|11|||
106088478|NCT00818441|365982915|FG001|Overall Study|Study terminated by sponsor|2|||
106088479|NCT00560833|365982928|FG000|Overall Study|Adverse Event|16|||
106088480|NCT00560833|365982929|FG001|Overall Study|Adverse Event|10|||
106088481|NCT00560833|365982930|FG002|Overall Study|Adverse Event|25|||
106088482|NCT00560833|365982931|FG003|Overall Study|Adverse Event|23|||
106088483|NCT00560833|365982932|FG004|Overall Study|Adverse Event|35|||
106088484|NCT00560833|365982928|FG000|Overall Study|Lost to Follow-up|0|||
106161302|NCT03269136|366252395|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161303|NCT03269136|366252396|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161304|NCT03269136|366252397|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161305|NCT03269136|366252398|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161306|NCT03269136|366252399|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161307|NCT03269136|366252400|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106088485|NCT00560833|365982929|FG001|Overall Study|Lost to Follow-up|0|||
106088486|NCT00560833|365982930|FG002|Overall Study|Lost to Follow-up|1|||
106088487|NCT00560833|365982931|FG003|Overall Study|Lost to Follow-up|0|||
106088488|NCT00560833|365982932|FG004|Overall Study|Lost to Follow-up|0|||
106088489|NCT00560833|365982928|FG000|Overall Study|Lack of Efficacy|22|||
106088490|NCT00560833|365982929|FG001|Overall Study|Lack of Efficacy|9|||
106088491|NCT00560833|365982930|FG002|Overall Study|Lack of Efficacy|6|||
106088492|NCT00560833|365982931|FG003|Overall Study|Lack of Efficacy|4|||
106088493|NCT00560833|365982932|FG004|Overall Study|Lack of Efficacy|4|||
106088494|NCT00560833|365982928|FG000|Overall Study|Participant uncooperative|5|||
106088495|NCT00560833|365982929|FG001|Overall Study|Participant uncooperative|5|||
106088496|NCT00560833|365982930|FG002|Overall Study|Participant uncooperative|4|||
106088497|NCT00560833|365982931|FG003|Overall Study|Participant uncooperative|4|||
106088498|NCT00560833|365982932|FG004|Overall Study|Participant uncooperative|2|||
106088499|NCT00560833|365982928|FG000|Overall Study|Other|1|||
106088500|NCT00560833|365982929|FG001|Overall Study|Other|1|||
106088501|NCT00560833|365982930|FG002|Overall Study|Other|3|||
106088502|NCT00560833|365982931|FG003|Overall Study|Other|0|||
106088503|NCT00560833|365982932|FG004|Overall Study|Other|0|||
106088504|NCT00560833|365982928|FG000|Overall Study|Never received drug|0|||
106088505|NCT00560833|365982929|FG001|Overall Study|Never received drug|1|||
106088506|NCT00560833|365982930|FG002|Overall Study|Never received drug|0|||
106088507|NCT00560833|365982931|FG003|Overall Study|Never received drug|0|||
106088508|NCT00560833|365982932|FG004|Overall Study|Never received drug|1|||
106088509|NCT00829621|365982933|FG000|Overall Study|Death|1|||
106088510|NCT00829621|365982934|FG001|Overall Study|Death|0|||
106088511|NCT00829621|365982933|FG000|Overall Study|Lost to Follow-up|3|||
106088512|NCT00829621|365982934|FG001|Overall Study|Lost to Follow-up|4|||
106088513|NCT02770391|365982935|FG000|Overall Study|Lost to Follow-up|2|||
106088514|NCT02770391|365982935|FG000|Overall Study|Withdrawal by Subject|1|||
106088515|NCT02770391|365982935|FG000|Overall Study|Surgery delayed unevaluable|2|||
106088516|NCT02770391|365982935|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
106088517|NCT00612313|365982938|FG000|Overall Study|Withdrawal by Subject|6|||
106088518|NCT00612313|365982939|FG001|Overall Study|Withdrawal by Subject|9|||
106088519|NCT00612313|365982938|FG000|Overall Study|Lost to Follow-up|11|||
106088520|NCT00612313|365982939|FG001|Overall Study|Lost to Follow-up|4|||
106088521|NCT04258839|365984898|FG000|Overall Study|Adverse Event|2|||
106088522|NCT04258839|365984899|FG001|Overall Study|Adverse Event|4|||
106088523|NCT04258839|365984898|FG000|Overall Study|Lack of Efficacy|0|||
106088524|NCT04258839|365984899|FG001|Overall Study|Lack of Efficacy|2|||
106088525|NCT04258839|365984898|FG000|Overall Study|Lost to Follow-up|2|||
106088526|NCT04258839|365984899|FG001|Overall Study|Lost to Follow-up|0|||
106088527|NCT04258839|365984898|FG000|Overall Study|Withdrawal by Subject|1|||
106088528|NCT04258839|365984899|FG001|Overall Study|Withdrawal by Subject|2|||
106088529|NCT04258839|365984898|FG000|Overall Study|Withdrawal by Caregiver|5|||
106088530|NCT04258839|365984899|FG001|Overall Study|Withdrawal by Caregiver|6|||
106088531|NCT04258839|365984898|FG000|Overall Study|Reason not Specified|0|||
106088532|NCT04258839|365984899|FG001|Overall Study|Reason not Specified|1|||
106088533|NCT02564471|365984900|FG000|Overall Study|Adverse Event|1|||
106088534|NCT02564471|365984901|FG001|Overall Study|Adverse Event|0|||
106088535|NCT02564471|365984902|FG002|Overall Study|Adverse Event|0|||
106088536|NCT02564471|365984903|FG003|Overall Study|Adverse Event|0|||
106088537|NCT02564471|365984900|FG000|Overall Study|Withdrawal by Subject|2|||
106088538|NCT02564471|365984901|FG001|Overall Study|Withdrawal by Subject|1|||
106088539|NCT02564471|365984902|FG002|Overall Study|Withdrawal by Subject|3|||
106088540|NCT02564471|365984903|FG003|Overall Study|Withdrawal by Subject|0|||
106088541|NCT02564471|365984900|FG000|Overall Study|Lost to Follow-up|0|||
106088542|NCT02564471|365984901|FG001|Overall Study|Lost to Follow-up|2|||
106088543|NCT02564471|365984902|FG002|Overall Study|Lost to Follow-up|0|||
106088544|NCT02564471|365984903|FG003|Overall Study|Lost to Follow-up|0|||
106088545|NCT02880371|365984904|FG000|Phase 1b|Lost to Follow-up|1|||
106088546|NCT02880371|365984905|FG001|Phase 1b|Lost to Follow-up|0|||
106088547|NCT02880371|365984906|FG002|Phase 1b|Lost to Follow-up|0|||
106088548|NCT02880371|365984907|FG003|Phase 1b|Lost to Follow-up|0|||
106088549|NCT02880371|365984908|FG004|Phase 1b|Lost to Follow-up|0|||
106088550|NCT02880371|365984909|FG005|Phase 1b|Lost to Follow-up|0|||
106088551|NCT02880371|365984910|FG006|Phase 1b|Lost to Follow-up|0|||
106088552|NCT02880371|365984911|FG007|Phase 1b|Lost to Follow-up|0|||
106088553|NCT02880371|365984904|FG000|Phase 1b|Participants terminated by Sponsor|1|||
106088554|NCT02880371|365984905|FG001|Phase 1b|Participants terminated by Sponsor|0|||
106088555|NCT02880371|365984906|FG002|Phase 1b|Participants terminated by Sponsor|0|||
106088556|NCT02880371|365984907|FG003|Phase 1b|Participants terminated by Sponsor|0|||
106088557|NCT02880371|365984908|FG004|Phase 1b|Participants terminated by Sponsor|0|||
106088558|NCT02880371|365984909|FG005|Phase 1b|Participants terminated by Sponsor|0|||
106088559|NCT02880371|365984910|FG006|Phase 1b|Participants terminated by Sponsor|0|||
106088560|NCT02880371|365984911|FG007|Phase 1b|Participants terminated by Sponsor|0|||
106088561|NCT02880371|365984904|FG000|Phase 1b|Withdrawal by Subject|0|||
106088562|NCT02880371|365984905|FG001|Phase 1b|Withdrawal by Subject|0|||
106088563|NCT02880371|365984906|FG002|Phase 1b|Withdrawal by Subject|1|||
106088564|NCT02880371|365984907|FG003|Phase 1b|Withdrawal by Subject|0|||
106088565|NCT02880371|365984908|FG004|Phase 1b|Withdrawal by Subject|0|||
106088566|NCT02880371|365984909|FG005|Phase 1b|Withdrawal by Subject|0|||
106088567|NCT02880371|365984910|FG006|Phase 1b|Withdrawal by Subject|0|||
106088568|NCT02880371|365984911|FG007|Phase 1b|Withdrawal by Subject|0|||
106088569|NCT02880371|365984904|FG000|Phase 1b|Death|4|||
106088570|NCT02880371|365984905|FG001|Phase 1b|Death|6|||
106088571|NCT02880371|365984906|FG002|Phase 1b|Death|5|||
106088572|NCT02880371|365984907|FG003|Phase 1b|Death|1|||
106088573|NCT02880371|365984908|FG004|Phase 1b|Death|0|||
106161308|NCT03269136|366252401|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161309|NCT03269136|366252402|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106088574|NCT02880371|365984909|FG005|Phase 1b|Death|0|||
106161310|NCT03269136|366252403|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106088575|NCT02880371|365984910|FG006|Phase 1b|Death|0|||
106088576|NCT02880371|365984911|FG007|Phase 1b|Death|0|||
106088577|NCT02880371|365984904|FG000|Phase 1b|Enrolled but not Treated|0|||
106088578|NCT02880371|365984905|FG001|Phase 1b|Enrolled but not Treated|1|||
106088579|NCT02880371|365984906|FG002|Phase 1b|Enrolled but not Treated|0|||
106088580|NCT02880371|365984907|FG003|Phase 1b|Enrolled but not Treated|0|||
106088581|NCT02880371|365984908|FG004|Phase 1b|Enrolled but not Treated|0|||
106088582|NCT02880371|365984909|FG005|Phase 1b|Enrolled but not Treated|0|||
106088583|NCT02880371|365984910|FG006|Phase 1b|Enrolled but not Treated|0|||
106088584|NCT02880371|365984911|FG007|Phase 1b|Enrolled but not Treated|0|||
106088585|NCT02880371|365984904|FG000|Phase 2|Enrolled but not Treated|0|||
106088586|NCT02880371|365984905|FG001|Phase 2|Enrolled but not Treated|0|||
106088587|NCT02880371|365984906|FG002|Phase 2|Enrolled but not Treated|0|||
106088588|NCT02880371|365984907|FG003|Phase 2|Enrolled but not Treated|0|||
106088589|NCT02880371|365984908|FG004|Phase 2|Enrolled but not Treated|0|||
106088590|NCT02880371|365984909|FG005|Phase 2|Enrolled but not Treated|1|||
106088591|NCT02880371|365984910|FG006|Phase 2|Enrolled but not Treated|1|||
106088592|NCT02880371|365984911|FG007|Phase 2|Enrolled but not Treated|0|||
106088593|NCT02880371|365984904|FG000|Phase 2|Other|0|||
106088594|NCT02880371|365984905|FG001|Phase 2|Other|0|||
106088595|NCT02880371|365984906|FG002|Phase 2|Other|0|||
106088596|NCT02880371|365984907|FG003|Phase 2|Other|0|||
106088597|NCT02880371|365984908|FG004|Phase 2|Other|0|||
106088598|NCT02880371|365984909|FG005|Phase 2|Other|1|||
106088599|NCT02880371|365984910|FG006|Phase 2|Other|2|||
106088600|NCT02880371|365984911|FG007|Phase 2|Other|1|||
106088601|NCT02880371|365984904|FG000|Phase 2|Participants terminated by Sponsor|0|||
106088602|NCT02880371|365984905|FG001|Phase 2|Participants terminated by Sponsor|0|||
106088603|NCT02880371|365984906|FG002|Phase 2|Participants terminated by Sponsor|0|||
106088604|NCT02880371|365984907|FG003|Phase 2|Participants terminated by Sponsor|0|||
106088605|NCT02880371|365984908|FG004|Phase 2|Participants terminated by Sponsor|1|||
106088606|NCT02880371|365984909|FG005|Phase 2|Participants terminated by Sponsor|6|||
106088607|NCT02880371|365984910|FG006|Phase 2|Participants terminated by Sponsor|1|||
106088608|NCT02880371|365984911|FG007|Phase 2|Participants terminated by Sponsor|5|||
106088609|NCT02880371|365984904|FG000|Phase 2|Death|0|||
106088610|NCT02880371|365984905|FG001|Phase 2|Death|0|||
106088611|NCT02880371|365984906|FG002|Phase 2|Death|0|||
106088612|NCT02880371|365984907|FG003|Phase 2|Death|0|||
106088613|NCT02880371|365984908|FG004|Phase 2|Death|1|||
106088614|NCT02880371|365984909|FG005|Phase 2|Death|10|||
106088615|NCT02880371|365984910|FG006|Phase 2|Death|20|||
106088616|NCT02880371|365984911|FG007|Phase 2|Death|5|||
106088617|NCT02880371|365984904|FG000|Phase 2|Lost to Follow-up|0|||
106088618|NCT02880371|365984905|FG001|Phase 2|Lost to Follow-up|0|||
106088619|NCT02880371|365984906|FG002|Phase 2|Lost to Follow-up|0|||
106088620|NCT02880371|365984907|FG003|Phase 2|Lost to Follow-up|0|||
106088621|NCT02880371|365984908|FG004|Phase 2|Lost to Follow-up|0|||
106088622|NCT02880371|365984909|FG005|Phase 2|Lost to Follow-up|0|||
106088623|NCT02880371|365984910|FG006|Phase 2|Lost to Follow-up|3|||
106088624|NCT02880371|365984911|FG007|Phase 2|Lost to Follow-up|0|||
106088625|NCT02880371|365984904|FG000|Phase 2|Withdrawal by Subject|0|||
106088626|NCT02880371|365984905|FG001|Phase 2|Withdrawal by Subject|0|||
106088627|NCT02880371|365984906|FG002|Phase 2|Withdrawal by Subject|0|||
106088628|NCT02880371|365984907|FG003|Phase 2|Withdrawal by Subject|0|||
106088629|NCT02880371|365984908|FG004|Phase 2|Withdrawal by Subject|0|||
106088630|NCT02880371|365984909|FG005|Phase 2|Withdrawal by Subject|1|||
106088631|NCT02880371|365984910|FG006|Phase 2|Withdrawal by Subject|1|||
106088632|NCT02880371|365984911|FG007|Phase 2|Withdrawal by Subject|0|||
106088633|NCT02880371|365984904|FG000|Phase 2|End of Study page not completed by error|0|||
106088634|NCT02880371|365984905|FG001|Phase 2|End of Study page not completed by error|0|||
106088635|NCT02880371|365984906|FG002|Phase 2|End of Study page not completed by error|0|||
106088636|NCT02880371|365984907|FG003|Phase 2|End of Study page not completed by error|0|||
106088637|NCT02880371|365984908|FG004|Phase 2|End of Study page not completed by error|0|||
106088638|NCT02880371|365984909|FG005|Phase 2|End of Study page not completed by error|1|||
106088639|NCT02880371|365984910|FG006|Phase 2|End of Study page not completed by error|0|||
106088640|NCT02880371|365984911|FG007|Phase 2|End of Study page not completed by error|0|||
106088641|NCT00961259|365984912|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
106088642|NCT00961259|365984913|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
106088643|NCT00961259|365984914|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
106088644|NCT01923181|365984915|FG000|Overall Study|Protocol Violation|2|||
106161311|NCT03269136|366252404|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106088645|NCT01923181|365984916|FG001|Overall Study|Protocol Violation|2|||
106161312|NCT03269136|366252405|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106088646|NCT01923181|365984917|FG002|Overall Study|Protocol Violation|0|||
106088647|NCT01923181|365984918|FG003|Overall Study|Protocol Violation|2|||
106088648|NCT01923181|365984919|FG004|Overall Study|Protocol Violation|2|||
106088649|NCT01923181|365984920|FG005|Overall Study|Protocol Violation|1|||
106088650|NCT01923181|365984921|FG006|Overall Study|Protocol Violation|1|||
106088651|NCT01923181|365984922|FG007|Overall Study|Protocol Violation|2|||
106088652|NCT01923181|365984923|FG008|Overall Study|Protocol Violation|1|||
106088653|NCT01923181|365984915|FG000|Overall Study|Withdrawal by Subject|0|||
106088654|NCT01923181|365984916|FG001|Overall Study|Withdrawal by Subject|1|||
106088655|NCT01923181|365984917|FG002|Overall Study|Withdrawal by Subject|0|||
106088656|NCT01923181|365984918|FG003|Overall Study|Withdrawal by Subject|1|||
106088657|NCT01923181|365984919|FG004|Overall Study|Withdrawal by Subject|4|||
106088658|NCT01923181|365984920|FG005|Overall Study|Withdrawal by Subject|2|||
106088659|NCT01923181|365984921|FG006|Overall Study|Withdrawal by Subject|4|||
106088660|NCT01923181|365984922|FG007|Overall Study|Withdrawal by Subject|3|||
106088661|NCT01923181|365984923|FG008|Overall Study|Withdrawal by Subject|1|||
106088662|NCT01923181|365984915|FG000|Overall Study|Other|1|||
106088663|NCT01923181|365984916|FG001|Overall Study|Other|0|||
106088664|NCT01923181|365984917|FG002|Overall Study|Other|0|||
106088665|NCT01923181|365984918|FG003|Overall Study|Other|1|||
106088666|NCT01923181|365984919|FG004|Overall Study|Other|0|||
106088667|NCT01923181|365984920|FG005|Overall Study|Other|0|||
106088668|NCT01923181|365984921|FG006|Overall Study|Other|0|||
106088669|NCT01923181|365984922|FG007|Overall Study|Other|0|||
106088670|NCT01923181|365984923|FG008|Overall Study|Other|0|||
106088671|NCT01923181|365984915|FG000|Overall Study|Lost to Follow-up|0|||
106088672|NCT01923181|365984916|FG001|Overall Study|Lost to Follow-up|3|||
106088673|NCT01923181|365984917|FG002|Overall Study|Lost to Follow-up|2|||
106088674|NCT01923181|365984918|FG003|Overall Study|Lost to Follow-up|1|||
106088675|NCT01923181|365984919|FG004|Overall Study|Lost to Follow-up|2|||
106088676|NCT01923181|365984920|FG005|Overall Study|Lost to Follow-up|1|||
106088677|NCT01923181|365984921|FG006|Overall Study|Lost to Follow-up|3|||
106161313|NCT03269136|366252406|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161314|NCT03269136|366252407|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
106161315|NCT03269136|366252408|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
106161316|NCT03269136|366252391|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
106161317|NCT03269136|366252392|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
106161318|NCT03269136|366252393|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
106161319|NCT03269136|366252394|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
106161320|NCT03269136|366252395|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
106161321|NCT03269136|366252396|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
106161322|NCT03269136|366252397|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
106161323|NCT03269136|366252398|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
106161324|NCT03269136|366252399|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
106161325|NCT03269136|366252400|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
106161326|NCT03269136|366252401|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
106161327|NCT03269136|366252402|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
106161328|NCT03269136|366252403|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
106161329|NCT03269136|366252404|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
106161330|NCT03269136|366252405|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
106161331|NCT03269136|366252406|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
106161332|NCT03269136|366252407|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
106161333|NCT03269136|366252408|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
106161334|NCT03269136|366252391|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
106161335|NCT03269136|366252392|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
106161336|NCT03269136|366252393|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
106161337|NCT03269136|366252394|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
106161338|NCT03269136|366252395|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
106161339|NCT03269136|366252396|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
106161340|NCT03269136|366252397|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
106161341|NCT03269136|366252398|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
106161342|NCT03269136|366252399|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
106161343|NCT03269136|366252400|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
106161344|NCT03269136|366252401|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
106161345|NCT03269136|366252402|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
106161346|NCT03269136|366252403|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
106161347|NCT03269136|366252404|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
106161348|NCT03269136|366252405|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
106161349|NCT03269136|366252406|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
106161350|NCT03269136|366252407|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
106161351|NCT03269136|366252408|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
106161352|NCT03269136|366252391|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
106161353|NCT03269136|366252392|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
106161354|NCT03269136|366252393|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
106161355|NCT03269136|366252394|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
106161356|NCT03269136|366252395|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
106161357|NCT03269136|366252396|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
106161358|NCT03269136|366252397|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
106161359|NCT03269136|366252398|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
106161360|NCT03269136|366252399|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
106088678|NCT01923181|365984922|FG007|Overall Study|Lost to Follow-up|3|||
106088679|NCT01923181|365984923|FG008|Overall Study|Lost to Follow-up|1|||
106088680|NCT00577122|365984924|FG000|Overall Study|Adverse Event|0|||
106088681|NCT00577122|365984925|FG001|Overall Study|Adverse Event|2|||
106088682|NCT00577122|365984924|FG000|Overall Study|Progression, relapse during active trt|6|||
106088683|NCT00577122|365984925|FG001|Overall Study|Progression, relapse during active trt|8|||
106088684|NCT00577122|365984924|FG000|Overall Study|Prog, refract disease during active trt|8|||
106088685|NCT00577122|365984925|FG001|Overall Study|Prog, refract disease during active trt|5|||
106088686|NCT00577122|365984924|FG000|Overall Study|Alternative Therapy|0|||
106088687|NCT00577122|365984925|FG001|Overall Study|Alternative Therapy|1|||
106088688|NCT00633984|365984928|FG000|Overall Study|Lost to Follow-up|0|||
106088689|NCT00633984|365984929|FG001|Overall Study|Lost to Follow-up|6|||
106088690|NCT00633984|365984928|FG000|Overall Study|Withdrawal by Subject|8|||
106088691|NCT00633984|365984929|FG001|Overall Study|Withdrawal by Subject|7|||
106088692|NCT00633984|365984928|FG000|Overall Study|Hospitalized|1|||
106088693|NCT00633984|365984929|FG001|Overall Study|Hospitalized|0|||
106088694|NCT02840877|365984930|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
106088695|NCT02840877|365984930|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
106088696|NCT02840877|365984930|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
106088697|NCT02840877|365984930|FG000|Baseline to 12 Weeks|Death|1|||
106088698|NCT02840877|365984930|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
106088699|NCT02840877|365984930|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
106088700|NCT02840877|365984930|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
106088701|NCT02840877|365984930|FG000|12 Weeks to 6 Months|Treatment failure|1|||
106088702|NCT02840877|365984930|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
106088703|NCT02840877|365984930|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
106088704|NCT02840877|365984930|FG000|12 Weeks to 6 Months|Death|1|||
106088705|NCT02840877|365984930|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
106088706|NCT02840877|365984930|FG000|6 Months to 18 Months|Treatment failure|7|||
106088707|NCT02840877|365984930|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
106088708|NCT02840877|365984930|FG000|6 Months to 18 Months|Moved/transferred out|6|||
106088709|NCT02840877|365984930|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
106088710|NCT02840877|365984930|FG000|6 Months to 18 Months|Death|4|||
106088711|NCT02840877|365984930|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
106088712|NCT02840877|365984930|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
106088713|NCT02840877|365984930|FG000|6 Months to 18 Months|Still in study.|14|||
106088714|NCT04086472|365984933|FG000|Overall Study|Lost to Follow-up|1|||
106088715|NCT04086472|365984934|FG001|Overall Study|Lost to Follow-up|0|||
106088716|NCT04086472|365984935|FG002|Overall Study|Lost to Follow-up|0|||
106088717|NCT04086472|365984936|FG003|Overall Study|Lost to Follow-up|0|||
106088718|NCT04086472|365984937|FG004|Overall Study|Lost to Follow-up|1|||
106088719|NCT04086472|365984933|FG000|Overall Study|Physician Decision|0|||
106088720|NCT04086472|365984934|FG001|Overall Study|Physician Decision|1|||
106088721|NCT04086472|365984935|FG002|Overall Study|Physician Decision|1|||
106088722|NCT04086472|365984936|FG003|Overall Study|Physician Decision|0|||
106088723|NCT04086472|365984937|FG004|Overall Study|Physician Decision|0|||
106088724|NCT04086472|365984933|FG000|Overall Study|Withdrawal by Subject|1|||
106088725|NCT04086472|365984934|FG001|Overall Study|Withdrawal by Subject|1|||
106088726|NCT04086472|365984935|FG002|Overall Study|Withdrawal by Subject|1|||
106088727|NCT04086472|365984936|FG003|Overall Study|Withdrawal by Subject|0|||
106088728|NCT04086472|365984937|FG004|Overall Study|Withdrawal by Subject|0|||
106088729|NCT04086472|365984933|FG000|Overall Study|Various reasons|2|||
106088730|NCT04086472|365984934|FG001|Overall Study|Various reasons|0|||
106088731|NCT04086472|365984935|FG002|Overall Study|Various reasons|0|||
106088732|NCT04086472|365984936|FG003|Overall Study|Various reasons|3|||
106088733|NCT04086472|365984937|FG004|Overall Study|Various reasons|1|||
106088734|NCT04317586|365984943|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
106088735|NCT04317586|365984943|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
106088736|NCT01276327|365984946|FG000|Overall Study|Adverse Event|1|||
106088737|NCT01276327|365984947|FG001|Overall Study|Adverse Event|3|||
106088738|NCT01276327|365984946|FG000|Overall Study|Withdrawal by Subject|1|||
106088739|NCT01276327|365984947|FG001|Overall Study|Withdrawal by Subject|0|||
106088740|NCT03586869|365984948|FG000|Overall Study|Progressive Disease|3|||
106088741|NCT01831089|365984955|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
106088742|NCT01831089|365984956|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
106088743|NCT01831089|365984957|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
106088744|NCT01831089|365984958|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
106088745|NCT01831089|365984959|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
106088746|NCT01831089|365984960|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
106088747|NCT01831089|365984955|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
106088748|NCT01831089|365984956|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
106088749|NCT01831089|365984957|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
106088750|NCT01831089|365984958|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
106088751|NCT01831089|365984959|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
106088752|NCT01831089|365984960|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
106088753|NCT01831089|365984955|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
106088754|NCT01831089|365984956|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
106088755|NCT01831089|365984957|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
106088756|NCT01831089|365984958|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
106088757|NCT01831089|365984959|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
106088758|NCT01831089|365984960|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
106088759|NCT01831089|365984955|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
106088760|NCT01831089|365984956|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
106088761|NCT01831089|365984957|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
106088762|NCT01831089|365984958|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
106088763|NCT01831089|365984959|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
106088764|NCT01831089|365984960|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
106088765|NCT01831089|365984955|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
106088766|NCT01831089|365984956|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
106088767|NCT01831089|365984957|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
106088768|NCT01831089|365984958|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
106088769|NCT01831089|365984959|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
106088770|NCT01831089|365984960|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
106088771|NCT01831089|365984955|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
106088772|NCT01831089|365984956|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
106088773|NCT01831089|365984957|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
106088774|NCT01831089|365984958|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
106088775|NCT01831089|365984959|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
106088776|NCT01831089|365984960|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
106088777|NCT01831089|365984955|FG000|Cohort III: Dose Level 3|Global end of study|0|||
106088778|NCT01831089|365984956|FG001|Cohort III: Dose Level 3|Global end of study|0|||
106088779|NCT01831089|365984957|FG002|Cohort III: Dose Level 3|Global end of study|1|||
106088780|NCT01831089|365984958|FG003|Cohort III: Dose Level 3|Global end of study|0|||
106088781|NCT01831089|365984959|FG004|Cohort III: Dose Level 3|Global end of study|0|||
106088782|NCT01831089|365984960|FG005|Cohort III: Dose Level 3|Global end of study|0|||
106088783|NCT01831089|365984955|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
106088784|NCT01831089|365984956|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
106088785|NCT01831089|365984957|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
106088786|NCT01831089|365984958|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
106088787|NCT01831089|365984959|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
106088788|NCT01831089|365984960|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
106088789|NCT01831089|365984955|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
106088790|NCT01831089|365984956|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
106088791|NCT01831089|365984957|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
106088792|NCT01831089|365984958|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
106088793|NCT01831089|365984959|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
106088794|NCT01831089|365984960|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
106088795|NCT01831089|365984955|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
106088796|NCT01831089|365984956|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
106088797|NCT01831089|365984957|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
106088798|NCT01831089|365984958|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
106088799|NCT01831089|365984959|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
106088800|NCT01831089|365984960|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
106088801|NCT01831089|365984955|FG000|Cohort V: Dose Level 5|Death|0|||
106088802|NCT01831089|365984956|FG001|Cohort V: Dose Level 5|Death|0|||
106088803|NCT01831089|365984957|FG002|Cohort V: Dose Level 5|Death|0|||
106088804|NCT01831089|365984958|FG003|Cohort V: Dose Level 5|Death|0|||
106088805|NCT01831089|365984959|FG004|Cohort V: Dose Level 5|Death|1|||
106088806|NCT01831089|365984960|FG005|Cohort V: Dose Level 5|Death|0|||
106088807|NCT01831089|365984955|FG000|Cohort V: Dose Level 5|Global end of study|0|||
106088808|NCT01831089|365984956|FG001|Cohort V: Dose Level 5|Global end of study|0|||
106088809|NCT01831089|365984957|FG002|Cohort V: Dose Level 5|Global end of study|0|||
106088810|NCT01831089|365984958|FG003|Cohort V: Dose Level 5|Global end of study|0|||
106088811|NCT01831089|365984959|FG004|Cohort V: Dose Level 5|Global end of study|2|||
106088812|NCT01831089|365984960|FG005|Cohort V: Dose Level 5|Global end of study|0|||
106088813|NCT01831089|365984955|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
106088814|NCT01831089|365984956|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
106088815|NCT01831089|365984957|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
106088816|NCT01831089|365984958|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
106088817|NCT01831089|365984959|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
106088818|NCT01831089|365984960|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
106088819|NCT01831089|365984955|FG000|Cohort B: Arm B|Progressive disease|0|||
106088820|NCT01831089|365984956|FG001|Cohort B: Arm B|Progressive disease|0|||
106088821|NCT01831089|365984957|FG002|Cohort B: Arm B|Progressive disease|0|||
106088822|NCT01831089|365984958|FG003|Cohort B: Arm B|Progressive disease|0|||
106088823|NCT01831089|365984959|FG004|Cohort B: Arm B|Progressive disease|0|||
106088824|NCT01831089|365984960|FG005|Cohort B: Arm B|Progressive disease|8|||
106088825|NCT01831089|365984955|FG000|Cohort B: Arm B|Physician Decision|0|||
106088826|NCT01831089|365984956|FG001|Cohort B: Arm B|Physician Decision|0|||
106088827|NCT01831089|365984957|FG002|Cohort B: Arm B|Physician Decision|0|||
106088828|NCT01831089|365984958|FG003|Cohort B: Arm B|Physician Decision|0|||
106088829|NCT01831089|365984959|FG004|Cohort B: Arm B|Physician Decision|0|||
106088830|NCT01831089|365984960|FG005|Cohort B: Arm B|Physician Decision|2|||
106088831|NCT01831089|365984955|FG000|Cohort B: Arm B|Never treated|0|||
106088832|NCT01831089|365984956|FG001|Cohort B: Arm B|Never treated|0|||
106088833|NCT01831089|365984957|FG002|Cohort B: Arm B|Never treated|0|||
106088834|NCT01831089|365984958|FG003|Cohort B: Arm B|Never treated|0|||
106088835|NCT01831089|365984959|FG004|Cohort B: Arm B|Never treated|0|||
106088836|NCT01831089|365984960|FG005|Cohort B: Arm B|Never treated|2|||
106088837|NCT01831089|365984955|FG000|Cohort B: Arm B|Adverse Event|0|||
106088838|NCT01831089|365984956|FG001|Cohort B: Arm B|Adverse Event|0|||
106088839|NCT01831089|365984957|FG002|Cohort B: Arm B|Adverse Event|0|||
106088840|NCT01831089|365984958|FG003|Cohort B: Arm B|Adverse Event|0|||
106088841|NCT01831089|365984959|FG004|Cohort B: Arm B|Adverse Event|0|||
106088842|NCT01831089|365984960|FG005|Cohort B: Arm B|Adverse Event|1|||
106088843|NCT01831089|365984955|FG000|Cohort B: Arm B|Global end of study|0|||
106088844|NCT01831089|365984956|FG001|Cohort B: Arm B|Global end of study|0|||
106088845|NCT01831089|365984957|FG002|Cohort B: Arm B|Global end of study|0|||
106088846|NCT01831089|365984958|FG003|Cohort B: Arm B|Global end of study|0|||
106088847|NCT01831089|365984959|FG004|Cohort B: Arm B|Global end of study|0|||
106088848|NCT01831089|365984960|FG005|Cohort B: Arm B|Global end of study|1|||
106088849|NCT02170727|365984968|FG000|Overall Study|Lost to Follow-up|1|||
106088850|NCT02170727|365984969|FG001|Overall Study|Lost to Follow-up|0|||
106088851|NCT02170727|365984968|FG000|Overall Study|Withdrawal by Subject|2|||
106088852|NCT02170727|365984969|FG001|Overall Study|Withdrawal by Subject|0|||
106088853|NCT01243944|365984970|FG000|Overall Study|Adverse Event|15|||
106088854|NCT01243944|365984971|FG001|Overall Study|Adverse Event|13|||
106088855|NCT01243944|365984970|FG000|Overall Study|Lost to Follow-up|2|||
106088856|NCT01243944|365984971|FG001|Overall Study|Lost to Follow-up|1|||
106088857|NCT01243944|365984970|FG000|Overall Study|Physician Decision|2|||
106088858|NCT01243944|365984971|FG001|Overall Study|Physician Decision|7|||
106161361|NCT03269136|366252400|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
106161362|NCT03269136|366252401|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
106161363|NCT03269136|366252402|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
106161364|NCT03269136|366252403|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
106161365|NCT03269136|366252404|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
106161366|NCT03269136|366252405|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
106161367|NCT03269136|366252406|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
106161368|NCT03269136|366252407|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
106088859|NCT01243944|365984970|FG000|Overall Study|Disease progression|12|||
106088860|NCT01243944|365984971|FG001|Overall Study|Disease progression|11|||
106088861|NCT01243944|365984970|FG000|Overall Study|Protocol deviation|1|||
106088862|NCT01243944|365984971|FG001|Overall Study|Protocol deviation|1|||
106161369|NCT03269136|366252408|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
106161370|NCT02924272|366252412|FG000|Overall Study|Site Terminated by Sponsor|4|||
106088863|NCT01243944|365984970|FG000|Overall Study|Participant decision|10|||
106088864|NCT01243944|365984971|FG001|Overall Study|Participant decision|15|||
106088865|NCT01243944|365984970|FG000|Overall Study|Death|2|||
106088866|NCT01243944|365984971|FG001|Overall Study|Death|3|||
106088867|NCT01243944|365984970|FG000|Overall Study|Non-compliance with study treatment|1|||
106088868|NCT01243944|365984971|FG001|Overall Study|Non-compliance with study treatment|0|||
106088869|NCT01525082|365984980|FG000|Overall Study|Death|1|||
106161371|NCT02924272|366252413|FG001|Overall Study|Site Terminated by Sponsor|1|||
106161372|NCT02924272|366252412|FG000|Overall Study|Withdrawal by Subject|2|||
106088870|NCT02480621|365984981|FG000|Randomization|Withdrawal by Subject|1|||
106088871|NCT02480621|365984982|FG001|Randomization|Withdrawal by Subject|0|||
106088872|NCT02480621|365984981|FG000|Randomization|Surgeon did not give intervention|0|||
106088873|NCT02480621|365984982|FG001|Randomization|Surgeon did not give intervention|1|||
106088874|NCT02480621|365984981|FG000|Follow Up|Lost to Follow-up|4|||
106088875|NCT02480621|365984982|FG001|Follow Up|Lost to Follow-up|2|||
106088876|NCT04632940|365984986|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
106088877|NCT04632940|365984987|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
106088878|NCT04632940|365984986|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
106088879|NCT04632940|365984987|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
106088880|NCT04632940|365984986|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
106088881|NCT04632940|365984987|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
106088882|NCT04632940|365984986|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
106088883|NCT04632940|365984987|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
106088884|NCT04632940|365984986|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
106088885|NCT04632940|365984987|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
106088886|NCT04632940|365984986|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
106088887|NCT04632940|365984987|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
106088888|NCT04632940|365984986|FG000|OLE Period (52 Weeks)|Other than specified|0|||
106088889|NCT04632940|365984987|FG001|OLE Period (52 Weeks)|Other than specified|1|||
106088890|NCT04632940|365984986|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
106088891|NCT04632940|365984987|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
106088892|NCT02410811|365984988|FG000|Overall Study|Withdrawal by Subject|0|||
106088893|NCT02410811|365984989|FG001|Overall Study|Withdrawal by Subject|0|||
106088894|NCT02410811|365984990|FG002|Overall Study|Withdrawal by Subject|1|||
106088895|NCT02410811|365984991|FG003|Overall Study|Withdrawal by Subject|0|||
106088896|NCT02799082|365984998|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
106088897|NCT02799082|365984999|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
106088898|NCT02799082|365984998|FG000|Overall Study|Protocol Violation|0|||
106088899|NCT02799082|365984999|FG001|Overall Study|Protocol Violation|1|||
106088900|NCT03783923|365985000|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
106088901|NCT03783923|365985001|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
106088902|NCT03783923|365985000|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
106088903|NCT03783923|365985001|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
106088904|NCT03783923|365985000|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
106088905|NCT03783923|365985001|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
106088906|NCT03783923|365985000|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
106088907|NCT03783923|365985001|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
106088908|NCT03783923|365985000|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
106088909|NCT03783923|365985001|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
106088910|NCT01592708|365985002|FG000|Overall Study|Protocol Violation|3|||
106088911|NCT01592708|365985003|FG001|Overall Study|Protocol Violation|0|||
106088912|NCT00179647|365985015|FG000|Overall Study|Adverse Event|294|||
106088913|NCT00179647|365985015|FG000|Overall Study|Lack of Efficacy|478|||
106088914|NCT00179647|365985015|FG000|Overall Study|Withdrawal by Subject|83|||
106088915|NCT00179647|365985015|FG000|Overall Study|Lost to Follow-up|4|||
106088916|NCT00179647|365985015|FG000|Overall Study|Death|94|||
106088917|NCT00179647|365985015|FG000|Overall Study|Other|960|||
106088918|NCT00281840|365985016|FG000|Overall Study|Adverse Event|12|||
106088919|NCT00281840|365985016|FG000|Overall Study|Physician Decision|6|||
106088920|NCT00281840|365985016|FG000|Overall Study|Withdrawal by Subject|3|||
106088921|NCT00281840|365985016|FG000|Overall Study|Disease Progression|2|||
106088922|NCT00281840|365985016|FG000|Overall Study|exceed maximum delay in treatment|1|||
106088923|NCT00281840|365985016|FG000|Overall Study|Complicating Disease|1|||
106088924|NCT01440946|365985017|FG000|Overall Study|Lost to Follow-up|1|||
106088925|NCT01440946|365985018|FG001|Overall Study|Lost to Follow-up|1|||
106088926|NCT01440946|365985017|FG000|Overall Study|Physician Decision|1|||
106088927|NCT01440946|365985018|FG001|Overall Study|Physician Decision|0|||
106088928|NCT01858194|365985019|FG000|Overall Study|Total Artificial Heart Implant|0|||
106088929|NCT01858194|365985020|FG001|Overall Study|Total Artificial Heart Implant|1|||
106088930|NCT01858194|365985019|FG000|Overall Study|Lost to Follow-up|0|||
106088931|NCT01858194|365985020|FG001|Overall Study|Lost to Follow-up|1|||
106088932|NCT03221257|365985026|FG000|Overall Study|Lost to Follow-up|0|||
106088933|NCT03221257|365985027|FG001|Overall Study|Lost to Follow-up|1|||
106088934|NCT03221257|365985026|FG000|Overall Study|Withdrawal by Subject|1|||
106088935|NCT03221257|365985027|FG001|Overall Study|Withdrawal by Subject|1|||
106088936|NCT02207829|365985028|FG000|Overall Study|Adverse Event|10|||
106088937|NCT02207829|365985029|FG001|Overall Study|Adverse Event|9|||
106088938|NCT02207829|365985028|FG000|Overall Study|Lack of Efficacy|7|||
106088939|NCT02207829|365985029|FG001|Overall Study|Lack of Efficacy|5|||
106088940|NCT02207829|365985028|FG000|Overall Study|Lost to Follow-up|2|||
106088941|NCT02207829|365985029|FG001|Overall Study|Lost to Follow-up|2|||
106088942|NCT02207829|365985028|FG000|Overall Study|Protocol deviation|5|||
106088943|NCT02207829|365985029|FG001|Overall Study|Protocol deviation|4|||
106088944|NCT02207829|365985028|FG000|Overall Study|Withdrew consent|18|||
106088945|NCT02207829|365985029|FG001|Overall Study|Withdrew consent|14|||
106088946|NCT01687166|365985036|FG000|Overall Study|Attempt subject|2|||
106088947|NCT01687166|365985037|FG001|Overall Study|Attempt subject|3|||
106088948|NCT01687166|365985038|FG002|Overall Study|Attempt subject|2|||
106088949|NCT01687166|365985039|FG003|Overall Study|Attempt subject|0|||
106088950|NCT01687166|365985036|FG000|Overall Study|Did not meet eligibility criteria|4|||
106088951|NCT01687166|365985037|FG001|Overall Study|Did not meet eligibility criteria|6|||
106088952|NCT01687166|365985038|FG002|Overall Study|Did not meet eligibility criteria|1|||
106088953|NCT01687166|365985039|FG003|Overall Study|Did not meet eligibility criteria|1|||
106088954|NCT01687166|365985036|FG000|Overall Study|Adverse Event|2|||
106088955|NCT01687166|365985037|FG001|Overall Study|Adverse Event|1|||
106088956|NCT01687166|365985038|FG002|Overall Study|Adverse Event|0|||
106088957|NCT01687166|365985039|FG003|Overall Study|Adverse Event|0|||
106088958|NCT01687166|365985036|FG000|Overall Study|Physician Decision|3|||
106088959|NCT01687166|365985037|FG001|Overall Study|Physician Decision|2|||
106088960|NCT01687166|365985038|FG002|Overall Study|Physician Decision|1|||
106088961|NCT01687166|365985039|FG003|Overall Study|Physician Decision|0|||
106088962|NCT01687166|365985036|FG000|Overall Study|Withdrawal by Subject|11|||
106088963|NCT01687166|365985037|FG001|Overall Study|Withdrawal by Subject|4|||
106088964|NCT01687166|365985038|FG002|Overall Study|Withdrawal by Subject|3|||
106088965|NCT01687166|365985039|FG003|Overall Study|Withdrawal by Subject|0|||
106088966|NCT01687166|365985036|FG000|Overall Study|Lost to Follow-up|2|||
106088967|NCT01687166|365985037|FG001|Overall Study|Lost to Follow-up|5|||
106088968|NCT01687166|365985038|FG002|Overall Study|Lost to Follow-up|1|||
106088969|NCT01687166|365985039|FG003|Overall Study|Lost to Follow-up|0|||
106088970|NCT01687166|365985036|FG000|Overall Study|Equipment/Device Availability|0|||
106088971|NCT01687166|365985037|FG001|Overall Study|Equipment/Device Availability|1|||
106088972|NCT01687166|365985038|FG002|Overall Study|Equipment/Device Availability|0|||
106088973|NCT01687166|365985039|FG003|Overall Study|Equipment/Device Availability|0|||
106088974|NCT01687166|365985036|FG000|Overall Study|Death|1|||
106088975|NCT01687166|365985037|FG001|Overall Study|Death|1|||
106088976|NCT01687166|365985038|FG002|Overall Study|Death|0|||
106088977|NCT01687166|365985039|FG003|Overall Study|Death|0|||
106088978|NCT01687166|365985036|FG000|Overall Study|Protocol Violation|1|||
106088979|NCT01687166|365985037|FG001|Overall Study|Protocol Violation|1|||
106088980|NCT01687166|365985038|FG002|Overall Study|Protocol Violation|1|||
106088981|NCT01687166|365985039|FG003|Overall Study|Protocol Violation|0|||
106088982|NCT01687166|365985036|FG000|Overall Study|Subject moved out of state|0|||
106088983|NCT01687166|365985037|FG001|Overall Study|Subject moved out of state|1|||
106088984|NCT01687166|365985038|FG002|Overall Study|Subject moved out of state|0|||
106161373|NCT02924272|366252413|FG001|Overall Study|Withdrawal by Subject|0|||
106161374|NCT02924272|366252412|FG000|Overall Study|Adverse Event|3|||
106161375|NCT02924272|366252413|FG001|Overall Study|Adverse Event|0|||
106161376|NCT02924272|366252412|FG000|Overall Study|Progressive Disease|11|||
106161377|NCT02924272|366252413|FG001|Overall Study|Progressive Disease|8|||
106088985|NCT01687166|365985039|FG003|Overall Study|Subject moved out of state|0|||
106088986|NCT01687166|365985036|FG000|Overall Study|Patient unable to be compliant|1|||
106088987|NCT01687166|365985037|FG001|Overall Study|Patient unable to be compliant|0|||
106088988|NCT01687166|365985038|FG002|Overall Study|Patient unable to be compliant|0|||
106088989|NCT01687166|365985039|FG003|Overall Study|Patient unable to be compliant|0|||
106088990|NCT01687166|365985036|FG000|Overall Study|Physician choice to use different device|1|||
106161378|NCT02924272|366252412|FG000|Overall Study|Clinical Deterioration|1|||
106161379|NCT02924272|366252413|FG001|Overall Study|Clinical Deterioration|0|||
106088991|NCT01687166|365985037|FG001|Overall Study|Physician choice to use different device|2|||
106088992|NCT01687166|365985038|FG002|Overall Study|Physician choice to use different device|4|||
106088993|NCT01687166|365985039|FG003|Overall Study|Physician choice to use different device|0|||
106088994|NCT01687166|365985036|FG000|Overall Study|Insurance|0|||
106088995|NCT01687166|365985037|FG001|Overall Study|Insurance|0|||
106088996|NCT01687166|365985038|FG002|Overall Study|Insurance|1|||
106161380|NCT02924272|366252412|FG000|Overall Study|Death|1|||
106161381|NCT02924272|366252413|FG001|Overall Study|Death|0|||
106088997|NCT01687166|365985039|FG003|Overall Study|Insurance|1|||
106088998|NCT01800903|365985040|FG000|Second Test Period|unable to catheterise|1|||
106088999|NCT01800903|365985041|FG001|Second Test Period|unable to catheterise|0|||
106089000|NCT01800903|365985042|FG002|Second Test Period|unable to catheterise|0|||
106089001|NCT01800903|365985043|FG003|Second Test Period|unable to catheterise|0|||
106089002|NCT01800903|365985044|FG004|Second Test Period|unable to catheterise|0|||
106089003|NCT01800903|365985045|FG005|Second Test Period|unable to catheterise|0|||
106089004|NCT02316717|365985046|FG000|Overall Study|Adverse Event|2|||
106089005|NCT02316717|365985047|FG001|Overall Study|Adverse Event|2|||
106089006|NCT02316717|365985048|FG002|Overall Study|Adverse Event|0|||
106089007|NCT02316717|365985046|FG000|Overall Study|Lost to Follow-up|1|||
106089008|NCT02316717|365985047|FG001|Overall Study|Lost to Follow-up|2|||
106089009|NCT02316717|365985048|FG002|Overall Study|Lost to Follow-up|1|||
106089010|NCT02316717|365985046|FG000|Overall Study|Non compliance|3|||
106089011|NCT02316717|365985047|FG001|Overall Study|Non compliance|1|||
106089012|NCT02316717|365985048|FG002|Overall Study|Non compliance|0|||
106089013|NCT02316717|365985046|FG000|Overall Study|Protocol Violation|2|||
106089014|NCT02316717|365985047|FG001|Overall Study|Protocol Violation|0|||
106089015|NCT02316717|365985048|FG002|Overall Study|Protocol Violation|0|||
106089016|NCT02316717|365985046|FG000|Overall Study|Withdrawal by Subject|2|||
106089017|NCT02316717|365985047|FG001|Overall Study|Withdrawal by Subject|1|||
106089018|NCT02316717|365985048|FG002|Overall Study|Withdrawal by Subject|1|||
106089019|NCT02316717|365985046|FG000|Overall Study|Death|0|||
106089020|NCT02316717|365985047|FG001|Overall Study|Death|0|||
106089021|NCT02316717|365985048|FG002|Overall Study|Death|1|||
106089022|NCT02316717|365985046|FG000|Overall Study|Physician Decision|0|||
106089023|NCT02316717|365985047|FG001|Overall Study|Physician Decision|1|||
106089024|NCT02316717|365985048|FG002|Overall Study|Physician Decision|0|||
106089025|NCT02316717|365985046|FG000|Overall Study|TBC|1|||
106089026|NCT02316717|365985047|FG001|Overall Study|TBC|0|||
106089027|NCT02316717|365985048|FG002|Overall Study|TBC|0|||
106089028|NCT04122443|365985049|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
106089029|NCT04122443|365985050|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
106089030|NCT04122443|365985051|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
106089031|NCT04122443|365985049|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
106089032|NCT04122443|365985050|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
106089033|NCT04122443|365985051|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
106089034|NCT01516879|365985052|FG000|Overall Study|Withdrawal by Subject|9|||
106089035|NCT01516879|365985053|FG001|Overall Study|Withdrawal by Subject|11|||
106089036|NCT01516879|365985052|FG000|Overall Study|Death|0|||
106089037|NCT01516879|365985053|FG001|Overall Study|Death|2|||
106089038|NCT01516879|365985052|FG000|Overall Study|Lost to Follow-up|2|||
106089039|NCT01516879|365985053|FG001|Overall Study|Lost to Follow-up|11|||
106089040|NCT01516879|365985052|FG000|Overall Study|Other|5|||
106089041|NCT01516879|365985053|FG001|Overall Study|Other|10|||
106089042|NCT01072201|365985054|FG000|Overall Study|Lost to Follow-up|0|||
106089043|NCT01072201|365985055|FG001|Overall Study|Lost to Follow-up|1|||
106089044|NCT01916304|365985056|FG000|Overall Study|Screening failure|17|||
106089045|NCT00931307|365985058|FG000|Overall Study|Lack of Efficacy|12|||
106089046|NCT00931307|365985058|FG000|Overall Study|Biomicroscopy|1|||
106089047|NCT04666441|365985061|FG000|Overall Study|Lost to Follow-up|1|||
106089048|NCT04666441|365985062|FG001|Overall Study|Lost to Follow-up|4|||
106089049|NCT04666441|365985063|FG002|Overall Study|Lost to Follow-up|1|||
106089050|NCT04666441|365985064|FG003|Overall Study|Lost to Follow-up|3|||
106089051|NCT04666441|365985065|FG004|Overall Study|Lost to Follow-up|0|||
106089052|NCT04666441|365985066|FG005|Overall Study|Lost to Follow-up|2|||
106089053|NCT04666441|365985067|FG006|Overall Study|Lost to Follow-up|2|||
106089054|NCT04666441|365985068|FG007|Overall Study|Lost to Follow-up|2|||
106089055|NCT04666441|365985061|FG000|Overall Study|Subject Decision|1|||
106089056|NCT04666441|365985062|FG001|Overall Study|Subject Decision|1|||
106089057|NCT04666441|365985063|FG002|Overall Study|Subject Decision|3|||
106089058|NCT04666441|365985064|FG003|Overall Study|Subject Decision|1|||
106089059|NCT04666441|365985065|FG004|Overall Study|Subject Decision|0|||
106089060|NCT04666441|365985066|FG005|Overall Study|Subject Decision|1|||
106089061|NCT04666441|365985067|FG006|Overall Study|Subject Decision|3|||
106089062|NCT04666441|365985068|FG007|Overall Study|Subject Decision|2|||
106089063|NCT01328002|365985070|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
106089064|NCT01328002|365985071|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
106161382|NCT02924272|366252412|FG000|Overall Study|Reason Not Specified|1|||
106161383|NCT02924272|366252413|FG001|Overall Study|Reason Not Specified|0|||
106161384|NCT02100813|366252418|FG000|Overall Study|Adverse Event|0|||
106161385|NCT02100813|366252419|FG001|Overall Study|Adverse Event|0|||
106161386|NCT02100813|366252420|FG002|Overall Study|Adverse Event|0|||
106161387|NCT02100813|366252421|FG003|Overall Study|Adverse Event|0|||
106161388|NCT02100813|366252422|FG004|Overall Study|Adverse Event|0|||
106161389|NCT02100813|366252423|FG005|Overall Study|Adverse Event|0|||
106161390|NCT02100813|366252424|FG006|Overall Study|Adverse Event|0|||
106161391|NCT02100813|366252425|FG007|Overall Study|Adverse Event|1|||
106161392|NCT04952909|366252426|FG000|Overall Study|Death|3|||
106161393|NCT05308004|366252428|FG000|Overall Study|Not seen by Palliative Care NP|0|||
106161394|NCT05308004|366252429|FG001|Overall Study|Not seen by Palliative Care NP|1|||
106161395|NCT03575897|366252430|FG000|Overall Study|Lost to Follow-up|12|||
106161396|NCT03575897|366252431|FG001|Overall Study|Lost to Follow-up|13|||
106161397|NCT04552223|366252432|FG000|Overall Study|Withdrawal by Subject|1|||
106161398|NCT04856163|366252433|FG000|Overall Study|Lost to Follow-up|97|||
106161399|NCT04856163|366252434|FG001|Overall Study|Lost to Follow-up|100|||
106161400|NCT03869866|366252437|FG000|Overall Study|Protocol Violation|1|||
106161401|NCT03869866|366252437|FG000|Overall Study|Withdrawal by Subject|3|||
106161402|NCT00506519|366252448|FG000|Overall Study|Death|4|||
106161403|NCT00506519|366252449|FG001|Overall Study|Death|6|||
106161404|NCT00506519|366252450|FG002|Overall Study|Death|0|||
106161405|NCT00506519|366252448|FG000|Overall Study|Adverse Event|1|||
106161406|NCT00506519|366252449|FG001|Overall Study|Adverse Event|0|||
106161407|NCT00506519|366252450|FG002|Overall Study|Adverse Event|0|||
105867250|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105867251|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #2|5|||
105867252|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #2|0|||
106089065|NCT01328002|365985070|FG000|Open-Label Period|Adverse Event|8|||
106089066|NCT01328002|365985071|FG001|Open-Label Period|Adverse Event|0|||
106089067|NCT01328002|365985070|FG000|Open-Label Period|Lack of Efficacy|3|||
106161408|NCT01186367|366252451|FG000|Overall Study|Lost to Follow-up|7|||
106161409|NCT01186367|366252452|FG001|Overall Study|Lost to Follow-up|4|||
106161410|NCT01186367|366252453|FG002|Overall Study|Lost to Follow-up|7|||
106161411|NCT01186367|366252451|FG000|Overall Study|Did not receive study treatment|0|||
106161412|NCT01186367|366252452|FG001|Overall Study|Did not receive study treatment|1|||
106089068|NCT01328002|365985071|FG001|Open-Label Period|Lack of Efficacy|0|||
106089069|NCT01328002|365985070|FG000|Open-Label Period|Protocol Violation|2|||
106089070|NCT01328002|365985071|FG001|Open-Label Period|Protocol Violation|0|||
106089071|NCT01328002|365985070|FG000|Open-Label Period|Withdrawal by Subject|9|||
106089072|NCT01328002|365985071|FG001|Open-Label Period|Withdrawal by Subject|0|||
106089073|NCT01328002|365985070|FG000|Open-Label Period|Lost to Follow-up|6|||
106089074|NCT01328002|365985071|FG001|Open-Label Period|Lost to Follow-up|0|||
106089075|NCT01328002|365985070|FG000|Open-Label Period|Other Reason|2|||
106089076|NCT01328002|365985071|FG001|Open-Label Period|Other Reason|0|||
106089077|NCT01328002|365985070|FG000|Double-Blind Period|Adverse Event|1|||
106089078|NCT01328002|365985071|FG001|Double-Blind Period|Adverse Event|0|||
106089079|NCT01328002|365985070|FG000|Double-Blind Period|Lack of Efficacy|1|||
106089080|NCT01328002|365985071|FG001|Double-Blind Period|Lack of Efficacy|0|||
106089081|NCT01208233|365985074|FG000|Overall Study|Adverse Event|0|||
106089082|NCT01208233|365985075|FG001|Overall Study|Adverse Event|1|||
106089083|NCT01208233|365985076|FG002|Overall Study|Adverse Event|2|||
106089084|NCT01208233|365985077|FG003|Overall Study|Adverse Event|0|||
106089085|NCT01208233|365985078|FG004|Overall Study|Adverse Event|3|||
106089086|NCT01208233|365985079|FG005|Overall Study|Adverse Event|5|||
106089087|NCT01208233|365985074|FG000|Overall Study|Death|0|||
106089088|NCT01208233|365985075|FG001|Overall Study|Death|0|||
106089089|NCT01208233|365985076|FG002|Overall Study|Death|0|||
106089090|NCT01208233|365985077|FG003|Overall Study|Death|0|||
106089091|NCT01208233|365985078|FG004|Overall Study|Death|3|||
106089092|NCT01208233|365985079|FG005|Overall Study|Death|5|||
106089093|NCT01208233|365985074|FG000|Overall Study|Did not meet entrance criteria|2|||
106089094|NCT01208233|365985075|FG001|Overall Study|Did not meet entrance criteria|1|||
106089095|NCT01208233|365985076|FG002|Overall Study|Did not meet entrance criteria|1|||
106089096|NCT01208233|365985077|FG003|Overall Study|Did not meet entrance criteria|0|||
106089097|NCT01208233|365985078|FG004|Overall Study|Did not meet entrance criteria|1|||
106089098|NCT01208233|365985079|FG005|Overall Study|Did not meet entrance criteria|0|||
106089099|NCT01208233|365985074|FG000|Overall Study|Medication error without adverse event|0|||
106089100|NCT01208233|365985075|FG001|Overall Study|Medication error without adverse event|0|||
106089101|NCT01208233|365985076|FG002|Overall Study|Medication error without adverse event|0|||
106089102|NCT01208233|365985077|FG003|Overall Study|Medication error without adverse event|0|||
106089103|NCT01208233|365985078|FG004|Overall Study|Medication error without adverse event|0|||
106089104|NCT01208233|365985079|FG005|Overall Study|Medication error without adverse event|1|||
106089105|NCT01208233|365985074|FG000|Overall Study|Study terminated by sponsor|0|||
106089106|NCT01208233|365985075|FG001|Overall Study|Study terminated by sponsor|0|||
106089107|NCT01208233|365985076|FG002|Overall Study|Study terminated by sponsor|0|||
106089108|NCT01208233|365985077|FG003|Overall Study|Study terminated by sponsor|0|||
106089109|NCT01208233|365985078|FG004|Overall Study|Study terminated by sponsor|10|||
106089110|NCT01208233|365985079|FG005|Overall Study|Study terminated by sponsor|7|||
106089111|NCT01208233|365985074|FG000|Overall Study|Protocol Violation|0|||
106089112|NCT01208233|365985075|FG001|Overall Study|Protocol Violation|0|||
106089113|NCT01208233|365985076|FG002|Overall Study|Protocol Violation|0|||
106089114|NCT01208233|365985077|FG003|Overall Study|Protocol Violation|0|||
106161413|NCT01186367|366252453|FG002|Overall Study|Did not receive study treatment|0|||
106161414|NCT00881621|366252454|FG000|Overall Study|Physician Decision|34|||
106161415|NCT05116787|366252459|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
106161416|NCT05116787|366252460|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
106161417|NCT05116787|366252459|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
106161418|NCT05116787|366252460|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
106161419|NCT05116787|366252459|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
106161420|NCT05116787|366252460|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
106161421|NCT05116787|366252459|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
106161422|NCT05116787|366252460|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
106161423|NCT02737436|366252461|FG000|Washout Period|Lost to Follow-up|5|||
106161424|NCT02737436|366252462|FG001|Washout Period|Lost to Follow-up|11|||
106161425|NCT02737436|366252461|FG000|Data Analysis|Scanning data problems|5|||
106161426|NCT02737436|366252462|FG001|Data Analysis|Scanning data problems|8|||
106161427|NCT06393088|366252464|FG000|Overall Study|Withdrawal by Subject|0|||
106161428|NCT06393088|366252465|FG001|Overall Study|Withdrawal by Subject|2|||
106161429|NCT04072380|366252466|FG000|Overall Study|Adverse Event|4|||
106161430|NCT04072380|366252467|FG001|Overall Study|Adverse Event|6|||
106161431|NCT04072380|366252468|FG002|Overall Study|Adverse Event|0|||
106161432|NCT04072380|366252466|FG000|Overall Study|Withdrawal by Subject|3|||
106161433|NCT04072380|366252467|FG001|Overall Study|Withdrawal by Subject|1|||
106161434|NCT04072380|366252468|FG002|Overall Study|Withdrawal by Subject|1|||
106161435|NCT04072380|366252466|FG000|Overall Study|Physician Decision|2|||
106161436|NCT04072380|366252467|FG001|Overall Study|Physician Decision|0|||
106161437|NCT04072380|366252468|FG002|Overall Study|Physician Decision|0|||
106161438|NCT04072380|366252466|FG000|Overall Study|Protocol Violation|0|||
106161439|NCT04072380|366252467|FG001|Overall Study|Protocol Violation|2|||
106161440|NCT04072380|366252468|FG002|Overall Study|Protocol Violation|3|||
106161441|NCT04072380|366252466|FG000|Overall Study|Intercurrent Illness and Others|3|||
106089115|NCT01208233|365985078|FG004|Overall Study|Protocol Violation|3|||
106089116|NCT01208233|365985079|FG005|Overall Study|Protocol Violation|0|||
106089117|NCT01208233|365985074|FG000|Overall Study|Other|2|||
106089118|NCT01208233|365985075|FG001|Overall Study|Other|1|||
106089119|NCT01208233|365985076|FG002|Overall Study|Other|0|||
106089120|NCT01208233|365985077|FG003|Overall Study|Other|0|||
106089121|NCT01208233|365985078|FG004|Overall Study|Other|0|||
106089122|NCT01208233|365985079|FG005|Overall Study|Other|1|||
106089123|NCT01208233|365985074|FG000|Overall Study|Withdrawal by Subject|1|||
106089124|NCT01208233|365985075|FG001|Overall Study|Withdrawal by Subject|0|||
106089125|NCT01208233|365985076|FG002|Overall Study|Withdrawal by Subject|1|||
106089126|NCT01208233|365985077|FG003|Overall Study|Withdrawal by Subject|1|||
106089127|NCT01208233|365985078|FG004|Overall Study|Withdrawal by Subject|4|||
106089128|NCT01208233|365985079|FG005|Overall Study|Withdrawal by Subject|2|||
106089129|NCT02788175|365985080|FG000|Overall Study|Protocol Violation|3|||
106089130|NCT02788175|365985080|FG000|Overall Study|Withdrawal by Subject|4|||
106089131|NCT02788175|365985080|FG000|Overall Study|Ineligible prior to study agent|6|||
106089132|NCT02447991|365985081|FG000|Overall Study|Withdrawn by subject - no data|0|||
106089133|NCT02447991|365985082|FG001|Overall Study|Withdrawn by subject - no data|2|||
106089134|NCT02447991|365985081|FG000|Overall Study|Withdrawn by Subject - with data|4|||
106089135|NCT02447991|365985082|FG001|Overall Study|Withdrawn by Subject - with data|4|||
106089136|NCT02447991|365985081|FG000|Overall Study|Lost to Follow-up - no data|3|||
106089137|NCT02447991|365985082|FG001|Overall Study|Lost to Follow-up - no data|6|||
106089138|NCT02447991|365985081|FG000|Overall Study|Lost to follow-up - with data|0|||
106089139|NCT02447991|365985082|FG001|Overall Study|Lost to follow-up - with data|3|||
106089140|NCT02447991|365985081|FG000|Overall Study|End of study - no treatment results|3|||
106089141|NCT02447991|365985082|FG001|Overall Study|End of study - no treatment results|6|||
106089142|NCT02447991|365985081|FG000|Overall Study|End of study - partial treatment results|0|||
106089143|NCT02447991|365985082|FG001|Overall Study|End of study - partial treatment results|9|||
106089144|NCT03930745|365985083|FG000|Overall Study|Lost to Follow-up|10|||
106089145|NCT03930745|365985084|FG001|Overall Study|Lost to Follow-up|5|||
106089146|NCT03930745|365985083|FG000|Overall Study|Withdrawal by Subject|1|||
106089147|NCT03930745|365985084|FG001|Overall Study|Withdrawal by Subject|2|||
106089148|NCT03930745|365985083|FG000|Overall Study|Protocol Violation|2|||
106089149|NCT03930745|365985084|FG001|Overall Study|Protocol Violation|2|||
106089150|NCT03930745|365985083|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
106089151|NCT03930745|365985084|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
106089152|NCT03930745|365985083|FG000|Overall Study|Adverse Event|0|||
106089153|NCT03930745|365985084|FG001|Overall Study|Adverse Event|1|||
106089154|NCT03930745|365985083|FG000|Overall Study|Pregnancy|0|||
106089155|NCT03930745|365985084|FG001|Overall Study|Pregnancy|1|||
106089156|NCT02556710|365987312|FG000|Overall Study|Surgical treatment|3|||
106089157|NCT02556710|365987313|FG001|Overall Study|Surgical treatment|0|||
106089158|NCT02556710|365987312|FG000|Overall Study|Required proscribed pain medication|2|||
106089159|NCT02556710|365987313|FG001|Overall Study|Required proscribed pain medication|1|||
106089160|NCT02556710|365987312|FG000|Overall Study|Lack of Efficacy|1|||
106089161|NCT02556710|365987313|FG001|Overall Study|Lack of Efficacy|0|||
106089162|NCT02556710|365987312|FG000|Overall Study|Worsening osteoarthritis|1|||
106089163|NCT02556710|365987313|FG001|Overall Study|Worsening osteoarthritis|0|||
106089164|NCT02556710|365987312|FG000|Overall Study|Moved out of state|1|||
106089165|NCT02556710|365987313|FG001|Overall Study|Moved out of state|0|||
106089166|NCT02556710|365987312|FG000|Overall Study|Missing reason|3|||
106089167|NCT02556710|365987313|FG001|Overall Study|Missing reason|1|||
106089168|NCT02556710|365987312|FG000|Overall Study|Pain as lack of efficacy|0|||
106089169|NCT02556710|365987313|FG001|Overall Study|Pain as lack of efficacy|4|||
106089170|NCT02139644|365987314|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
106089171|NCT02139644|365987315|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
106089172|NCT02139644|365987316|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
106089173|NCT02139644|365987317|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
106089174|NCT02139644|365987318|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
106089175|NCT02139644|365987319|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
106089176|NCT02139644|365987314|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
106089177|NCT02139644|365987315|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
106089178|NCT02139644|365987316|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
106089179|NCT02139644|365987317|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
106089180|NCT02139644|365987318|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
106089181|NCT02139644|365987319|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
106089182|NCT02139644|365987314|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
106089183|NCT02139644|365987315|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
106089184|NCT02139644|365987316|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
106089185|NCT02139644|365987317|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
106089186|NCT02139644|365987318|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
106089187|NCT02139644|365987319|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
106161442|NCT04072380|366252467|FG001|Overall Study|Intercurrent Illness and Others|5|||
106089188|NCT02139644|365987314|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
106089189|NCT02139644|365987315|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
106089190|NCT02139644|365987316|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
106089191|NCT02139644|365987317|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
106089192|NCT02139644|365987318|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
106089193|NCT02139644|365987319|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
106089194|NCT02139644|365987314|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
106089195|NCT02139644|365987315|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
106089196|NCT02139644|365987316|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
106089197|NCT02139644|365987317|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
106089198|NCT02139644|365987318|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
106089199|NCT02139644|365987319|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
106089200|NCT02139644|365987314|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
106089201|NCT02139644|365987315|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
106089202|NCT02139644|365987316|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
106089203|NCT02139644|365987317|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
106089204|NCT02139644|365987318|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
106089205|NCT02139644|365987319|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
106089206|NCT02139644|365987314|FG000|Run-In Period (Pre-assignment)|Other|6|||
106089207|NCT02139644|365987315|FG001|Run-In Period (Pre-assignment)|Other|0|||
106089208|NCT02139644|365987316|FG002|Run-In Period (Pre-assignment)|Other|0|||
106089209|NCT02139644|365987317|FG003|Run-In Period (Pre-assignment)|Other|0|||
106089210|NCT02139644|365987318|FG004|Run-In Period (Pre-assignment)|Other|0|||
106089211|NCT02139644|365987319|FG005|Run-In Period (Pre-assignment)|Other|0|||
106089212|NCT02139644|365987314|FG000|Treatment Period|Adverse Event|0|||
106089213|NCT02139644|365987315|FG001|Treatment Period|Adverse Event|0|||
106089214|NCT02139644|365987316|FG002|Treatment Period|Adverse Event|3|||
106089215|NCT02139644|365987317|FG003|Treatment Period|Adverse Event|2|||
106089216|NCT02139644|365987318|FG004|Treatment Period|Adverse Event|1|||
106161443|NCT04072380|366252468|FG002|Overall Study|Intercurrent Illness and Others|6|||
106161444|NCT03652688|366252469|FG000|Baseline|Withdrawal by Subject|0|||
106161445|NCT03652688|366252470|FG001|Baseline|Withdrawal by Subject|3|||
106161446|NCT03652688|366252469|FG000|Follow-up|Lost to Follow-up|56|||
106161447|NCT03652688|366252470|FG001|Follow-up|Lost to Follow-up|54|||
106161448|NCT03829410|366252471|FG000|Overall Study|Adverse Event|1|||
106161449|NCT03829410|366252472|FG001|Overall Study|Adverse Event|0|||
106161450|NCT03829410|366252473|FG002|Overall Study|Adverse Event|1|||
106161451|NCT03829410|366252474|FG003|Overall Study|Adverse Event|4|||
106161452|NCT03829410|366252471|FG000|Overall Study|Physician Decision|0|||
106161453|NCT03829410|366252472|FG001|Overall Study|Physician Decision|0|||
106161454|NCT03829410|366252473|FG002|Overall Study|Physician Decision|0|||
106161455|NCT03829410|366252474|FG003|Overall Study|Physician Decision|2|||
106161456|NCT03829410|366252471|FG000|Overall Study|Disease Progressing|3|||
106161457|NCT03829410|366252472|FG001|Overall Study|Disease Progressing|4|||
106161458|NCT03829410|366252473|FG002|Overall Study|Disease Progressing|2|||
106161459|NCT03829410|366252474|FG003|Overall Study|Disease Progressing|31|||
106161460|NCT03829410|366252471|FG000|Overall Study|Miscellaneous|2|||
106161461|NCT03829410|366252472|FG001|Overall Study|Miscellaneous|4|||
106161462|NCT03829410|366252473|FG002|Overall Study|Miscellaneous|3|||
106161463|NCT03829410|366252474|FG003|Overall Study|Miscellaneous|10|||
106161464|NCT04342494|366252475|FG000|Overall Study|Questionnaire partially completed|1|||
106161465|NCT04342494|366252476|FG001|Overall Study|Questionnaire partially completed|0|||
106161466|NCT04342494|366252477|FG002|Overall Study|Questionnaire partially completed|2|||
106161467|NCT04342494|366252478|FG003|Overall Study|Questionnaire partially completed|0|||
106161468|NCT04342494|366252479|FG004|Overall Study|Questionnaire partially completed|1|||
106161469|NCT04342494|366252475|FG000|Overall Study|Lost to Follow-up|49|||
106161470|NCT04342494|366252476|FG001|Overall Study|Lost to Follow-up|38|||
106161471|NCT04342494|366252477|FG002|Overall Study|Lost to Follow-up|34|||
106161472|NCT04342494|366252478|FG003|Overall Study|Lost to Follow-up|34|||
106161473|NCT04342494|366252479|FG004|Overall Study|Lost to Follow-up|35|||
106161474|NCT05453773|366252482|FG000|Overall Study|Withdrawal by Subject|3|||
106161475|NCT05453773|366252482|FG000|Overall Study|Lost to Follow-up|3|||
106161476|NCT05453773|366252482|FG000|Overall Study|Difficult Blood Draw|3|||
106161477|NCT02023866|366252485|FG000|Overall Study|Non-compliance|2|||
106161478|NCT02023866|366252485|FG000|Overall Study|Adverse Event|3|||
106161479|NCT02023866|366252485|FG000|Overall Study|Withdrawal by Subject|1|||
106089217|NCT02139644|365987319|FG005|Treatment Period|Adverse Event|6|||
106161480|NCT04987320|366252488|FG000|Overall Study|Withdrawal by Subject|0|||
106161481|NCT04987320|366252489|FG001|Overall Study|Withdrawal by Subject|1|||
106161482|NCT04091750|366252490|FG000|Overall Study|Adverse Event|4|||
106161483|NCT04091750|366252490|FG000|Overall Study|Withdrawal by Subject|1|||
106161484|NCT04473222|366252491|FG000|Overall Study|Lost to Follow-up|13|||
106161485|NCT04473222|366252492|FG001|Overall Study|Lost to Follow-up|13|||
106161486|NCT04473222|366252491|FG000|Overall Study|Withdrawal by Subject|0|||
106089218|NCT02139644|365987314|FG000|Treatment Period|Withdrawal by Subject|0|||
106089219|NCT02139644|365987315|FG001|Treatment Period|Withdrawal by Subject|0|||
106089220|NCT02139644|365987316|FG002|Treatment Period|Withdrawal by Subject|2|||
106089221|NCT02139644|365987317|FG003|Treatment Period|Withdrawal by Subject|2|||
106161487|NCT04473222|366252492|FG001|Overall Study|Withdrawal by Subject|1|||
106089222|NCT02139644|365987318|FG004|Treatment Period|Withdrawal by Subject|3|||
106089223|NCT02139644|365987319|FG005|Treatment Period|Withdrawal by Subject|2|||
106089224|NCT02139644|365987314|FG000|Treatment Period|Non-compliance|0|||
106089225|NCT02139644|365987315|FG001|Treatment Period|Non-compliance|0|||
106089226|NCT02139644|365987316|FG002|Treatment Period|Non-compliance|0|||
106089227|NCT02139644|365987317|FG003|Treatment Period|Non-compliance|1|||
106089228|NCT02139644|365987318|FG004|Treatment Period|Non-compliance|0|||
106089229|NCT02139644|365987319|FG005|Treatment Period|Non-compliance|0|||
106089230|NCT02139644|365987314|FG000|Treatment Period|Protocol Violation|0|||
106089231|NCT02139644|365987315|FG001|Treatment Period|Protocol Violation|0|||
106089232|NCT02139644|365987316|FG002|Treatment Period|Protocol Violation|0|||
106089233|NCT02139644|365987317|FG003|Treatment Period|Protocol Violation|1|||
106089234|NCT02139644|365987318|FG004|Treatment Period|Protocol Violation|1|||
106089235|NCT02139644|365987319|FG005|Treatment Period|Protocol Violation|1|||
106089236|NCT02139644|365987314|FG000|Treatment Period|Disease progression|0|||
106089237|NCT02139644|365987315|FG001|Treatment Period|Disease progression|0|||
106089238|NCT02139644|365987316|FG002|Treatment Period|Disease progression|0|||
106089239|NCT02139644|365987317|FG003|Treatment Period|Disease progression|1|||
106089240|NCT02139644|365987318|FG004|Treatment Period|Disease progression|1|||
106089241|NCT02139644|365987319|FG005|Treatment Period|Disease progression|2|||
106089242|NCT02139644|365987314|FG000|Treatment Period|Lost to Follow-up|0|||
106089243|NCT02139644|365987315|FG001|Treatment Period|Lost to Follow-up|0|||
106089244|NCT02139644|365987316|FG002|Treatment Period|Lost to Follow-up|1|||
106089245|NCT02139644|365987317|FG003|Treatment Period|Lost to Follow-up|1|||
106089246|NCT02139644|365987318|FG004|Treatment Period|Lost to Follow-up|1|||
106089247|NCT02139644|365987319|FG005|Treatment Period|Lost to Follow-up|1|||
106089248|NCT02139644|365987314|FG000|Treatment Period|Lack of Efficacy|0|||
106089249|NCT02139644|365987315|FG001|Treatment Period|Lack of Efficacy|0|||
106089250|NCT02139644|365987316|FG002|Treatment Period|Lack of Efficacy|1|||
106089251|NCT02139644|365987317|FG003|Treatment Period|Lack of Efficacy|0|||
106089252|NCT02139644|365987318|FG004|Treatment Period|Lack of Efficacy|1|||
106089253|NCT02139644|365987319|FG005|Treatment Period|Lack of Efficacy|4|||
106089254|NCT02139644|365987314|FG000|Treatment Period|Other|0|||
106089255|NCT02139644|365987315|FG001|Treatment Period|Other|3|||
106089256|NCT02139644|365987316|FG002|Treatment Period|Other|1|||
106089257|NCT02139644|365987317|FG003|Treatment Period|Other|1|||
106089258|NCT02139644|365987318|FG004|Treatment Period|Other|0|||
106089259|NCT02139644|365987319|FG005|Treatment Period|Other|1|||
106089260|NCT01607905|365987320|FG000|Overall Study|Withdrawal by participant|7|||
106089261|NCT01607905|365987321|FG001|Overall Study|Withdrawal by participant|2|||
106089262|NCT01607905|365987322|FG002|Overall Study|Withdrawal by participant|4|||
106089263|NCT01607905|365987323|FG003|Overall Study|Withdrawal by participant|6|||
106089264|NCT01607905|365987324|FG004|Overall Study|Withdrawal by participant|0|||
106089265|NCT01607905|365987325|FG005|Overall Study|Withdrawal by participant|4|||
106089266|NCT01607905|365987326|FG006|Overall Study|Withdrawal by participant|12|||
106089267|NCT01607905|365987320|FG000|Overall Study|Incidence or severity of AEs|5|||
106089268|NCT01607905|365987321|FG001|Overall Study|Incidence or severity of AEs|1|||
106089269|NCT01607905|365987322|FG002|Overall Study|Incidence or severity of AEs|1|||
106089270|NCT01607905|365987323|FG003|Overall Study|Incidence or severity of AEs|3|||
106089271|NCT01607905|365987324|FG004|Overall Study|Incidence or severity of AEs|0|||
106089272|NCT01607905|365987325|FG005|Overall Study|Incidence or severity of AEs|2|||
106089273|NCT01607905|365987326|FG006|Overall Study|Incidence or severity of AEs|8|||
106089274|NCT01607905|365987320|FG000|Overall Study|Disease progression|44|||
106089275|NCT01607905|365987321|FG001|Overall Study|Disease progression|16|||
106089276|NCT01607905|365987322|FG002|Overall Study|Disease progression|15|||
106089277|NCT01607905|365987323|FG003|Overall Study|Disease progression|11|||
106089278|NCT01607905|365987324|FG004|Overall Study|Disease progression|6|||
106089279|NCT01607905|365987325|FG005|Overall Study|Disease progression|7|||
106089280|NCT01607905|365987326|FG006|Overall Study|Disease progression|21|||
106089281|NCT01607905|365987320|FG000|Overall Study|Non-compliance with study procedures|0|||
106089282|NCT01607905|365987321|FG001|Overall Study|Non-compliance with study procedures|0|||
106089283|NCT01607905|365987322|FG002|Overall Study|Non-compliance with study procedures|0|||
106089284|NCT01607905|365987323|FG003|Overall Study|Non-compliance with study procedures|0|||
106089285|NCT01607905|365987324|FG004|Overall Study|Non-compliance with study procedures|0|||
106089286|NCT01607905|365987325|FG005|Overall Study|Non-compliance with study procedures|0|||
106089287|NCT01607905|365987326|FG006|Overall Study|Non-compliance with study procedures|1|||
106089288|NCT01607905|365987320|FG000|Overall Study|Death|1|||
106089289|NCT01607905|365987321|FG001|Overall Study|Death|1|||
106089290|NCT01607905|365987322|FG002|Overall Study|Death|1|||
106089291|NCT01607905|365987323|FG003|Overall Study|Death|1|||
106089292|NCT01607905|365987324|FG004|Overall Study|Death|0|||
106089293|NCT01607905|365987325|FG005|Overall Study|Death|0|||
106089294|NCT01607905|365987326|FG006|Overall Study|Death|3|||
106089295|NCT01607905|365987320|FG000|Overall Study|Other treatments become available|1|||
106089296|NCT01607905|365987321|FG001|Overall Study|Other treatments become available|0|||
106089297|NCT01607905|365987322|FG002|Overall Study|Other treatments become available|0|||
106089298|NCT01607905|365987323|FG003|Overall Study|Other treatments become available|0|||
106089299|NCT01607905|365987324|FG004|Overall Study|Other treatments become available|0|||
106089300|NCT01607905|365987325|FG005|Overall Study|Other treatments become available|0|||
106089301|NCT01607905|365987326|FG006|Overall Study|Other treatments become available|1|||
106089302|NCT01607905|365987320|FG000|Overall Study|Investigator discretion|0|||
106089303|NCT01607905|365987321|FG001|Overall Study|Investigator discretion|0|||
106089304|NCT01607905|365987322|FG002|Overall Study|Investigator discretion|0|||
106089305|NCT01607905|365987323|FG003|Overall Study|Investigator discretion|0|||
106089306|NCT01607905|365987324|FG004|Overall Study|Investigator discretion|0|||
106089307|NCT01607905|365987325|FG005|Overall Study|Investigator discretion|1|||
106089308|NCT01607905|365987326|FG006|Overall Study|Investigator discretion|0|||
106089309|NCT01607905|365987320|FG000|Overall Study|Other|1|||
106089310|NCT01607905|365987321|FG001|Overall Study|Other|0|||
106089311|NCT01607905|365987322|FG002|Overall Study|Other|0|||
106089312|NCT01607905|365987323|FG003|Overall Study|Other|0|||
106089313|NCT01607905|365987324|FG004|Overall Study|Other|0|||
106089314|NCT01607905|365987325|FG005|Overall Study|Other|0|||
106089315|NCT01607905|365987326|FG006|Overall Study|Other|1|||
106089316|NCT01607905|365987320|FG000|Overall Study|Randomized but not treated|1|||
106089317|NCT01607905|365987321|FG001|Overall Study|Randomized but not treated|0|||
106089318|NCT01607905|365987322|FG002|Overall Study|Randomized but not treated|0|||
106089319|NCT01607905|365987323|FG003|Overall Study|Randomized but not treated|0|||
106089320|NCT01607905|365987324|FG004|Overall Study|Randomized but not treated|1|||
106089321|NCT01607905|365987325|FG005|Overall Study|Randomized but not treated|1|||
106089322|NCT01607905|365987326|FG006|Overall Study|Randomized but not treated|0|||
106089323|NCT01310413|365987327|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
106089324|NCT01310413|365987328|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
106089325|NCT01310413|365987329|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
106089326|NCT01310413|365987330|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
106089327|NCT01310413|365987331|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
106089328|NCT01310413|365987332|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
106089329|NCT01310413|365987333|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
106089330|NCT01310413|365987327|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
106089331|NCT01310413|365987328|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
106089332|NCT01310413|365987329|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
106089333|NCT01310413|365987330|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
106089334|NCT01310413|365987331|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
106089335|NCT01310413|365987332|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
106089336|NCT01310413|365987333|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
106089337|NCT01310413|365987327|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
106089338|NCT01310413|365987328|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
106089339|NCT01310413|365987329|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
106089340|NCT01310413|365987330|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
106089341|NCT01310413|365987331|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
106089342|NCT01310413|365987332|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
106089343|NCT01310413|365987333|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
106089344|NCT01310413|365987327|FG000|Day 0 to Day 385|Other|1|||
106089345|NCT01310413|365987328|FG001|Day 0 to Day 385|Other|0|||
106089346|NCT01310413|365987329|FG002|Day 0 to Day 385|Other|3|||
106089347|NCT01310413|365987330|FG003|Day 0 to Day 385|Other|0|||
106089348|NCT01310413|365987331|FG004|Day 0 to Day 385|Other|0|||
106089349|NCT01310413|365987332|FG005|Day 0 to Day 385|Other|0|||
106089350|NCT01310413|365987333|FG006|Day 0 to Day 385|Other|0|||
106089351|NCT01310413|365987327|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
106089352|NCT01310413|365987328|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
106089353|NCT01310413|365987329|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
106089354|NCT01310413|365987330|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
106089355|NCT01310413|365987331|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
106089356|NCT01310413|365987332|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
106089357|NCT01310413|365987333|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
106089358|NCT01310413|365987327|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
106089359|NCT01310413|365987328|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
106089360|NCT01310413|365987329|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
106089361|NCT01310413|365987330|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
106089362|NCT01310413|365987331|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
106089363|NCT01310413|365987332|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
106089364|NCT01310413|365987333|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
106089365|NCT00941733|365987334|FG000|Overall Study|Death|24|||
106089366|NCT00941733|365987335|FG001|Overall Study|Death|10|||
106089367|NCT00941733|365987334|FG000|Overall Study|Withdrawal by Subject|14|||
106089368|NCT00941733|365987335|FG001|Overall Study|Withdrawal by Subject|6|||
106089369|NCT00941733|365987334|FG000|Overall Study|Adverse Event|20|||
106089370|NCT00941733|365987335|FG001|Overall Study|Adverse Event|4|||
106089371|NCT00941733|365987334|FG000|Overall Study|Lost to Follow-up|1|||
106089372|NCT00941733|365987335|FG001|Overall Study|Lost to Follow-up|2|||
106089373|NCT00941733|365987334|FG000|Overall Study|Protocol Violation|15|||
106089374|NCT00941733|365987335|FG001|Overall Study|Protocol Violation|6|||
106089375|NCT03738865|365987340|FG000|Overall Study|Withdrawal by Subject|3|||
106089376|NCT03738865|365987341|FG001|Overall Study|Withdrawal by Subject|3|||
106089377|NCT03738865|365987340|FG000|Overall Study|Adverse Event|2|||
106089378|NCT03738865|365987341|FG001|Overall Study|Adverse Event|0|||
106089379|NCT03738865|365987340|FG000|Overall Study|Physician Decision|0|||
106089380|NCT03738865|365987341|FG001|Overall Study|Physician Decision|1|||
106089381|NCT01529645|365987342|FG000|Overall Study|Lost to Follow-up|0|||
106089382|NCT01529645|365987343|FG001|Overall Study|Lost to Follow-up|1|||
106089383|NCT01529645|365987344|FG002|Overall Study|Lost to Follow-up|1|||
106089384|NCT01529645|365987345|FG003|Overall Study|Lost to Follow-up|1|||
106089385|NCT01529645|365987346|FG004|Overall Study|Lost to Follow-up|1|||
106089386|NCT01529645|365987347|FG005|Overall Study|Lost to Follow-up|0|||
106089387|NCT01529645|365987348|FG006|Overall Study|Lost to Follow-up|2|||
106089388|NCT01529645|365987349|FG007|Overall Study|Lost to Follow-up|0|||
106089389|NCT01529645|365987350|FG008|Overall Study|Lost to Follow-up|1|||
106089390|NCT01529645|365987351|FG009|Overall Study|Lost to Follow-up|0|||
106089391|NCT01529645|365987342|FG000|Overall Study|SAE - Premature contractions|0|||
106089392|NCT01529645|365987343|FG001|Overall Study|SAE - Premature contractions|0|||
106089393|NCT01529645|365987344|FG002|Overall Study|SAE - Premature contractions|1|||
106089394|NCT01529645|365987345|FG003|Overall Study|SAE - Premature contractions|0|||
106089395|NCT01529645|365987346|FG004|Overall Study|SAE - Premature contractions|0|||
106089396|NCT01529645|365987347|FG005|Overall Study|SAE - Premature contractions|0|||
106089397|NCT01529645|365987348|FG006|Overall Study|SAE - Premature contractions|0|||
106089398|NCT01529645|365987349|FG007|Overall Study|SAE - Premature contractions|0|||
106089399|NCT01529645|365987350|FG008|Overall Study|SAE - Premature contractions|0|||
106089400|NCT01529645|365987351|FG009|Overall Study|SAE - Premature contractions|0|||
106089401|NCT01529645|365987342|FG000|Overall Study|Withdrawal by Subject|2|||
106089402|NCT01529645|365987343|FG001|Overall Study|Withdrawal by Subject|0|||
106089403|NCT01529645|365987344|FG002|Overall Study|Withdrawal by Subject|0|||
106161488|NCT04473222|366252491|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
106161489|NCT04473222|366252492|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
106161490|NCT00227344|366252493|FG000|Overall Study|study terminated early|12|||
106161491|NCT00227344|366252494|FG001|Overall Study|study terminated early|5|||
106161492|NCT05057247|366252500|FG000|Overall Study|Death|4|||
106161493|NCT05057247|366252500|FG000|Overall Study|Physician Decision|3|||
106161494|NCT05057247|366252500|FG000|Overall Study|Progressive Disease|7|||
106161495|NCT05057247|366252500|FG000|Overall Study|Withdrawal by Subject|3|||
106161496|NCT05057247|366252500|FG000|Overall Study|Adverse Event|6|||
106161497|NCT05057247|366252500|FG000|Overall Study|Subject Non-Compliance|1|||
106161498|NCT05057247|366252500|FG000|Overall Study|On treatment|2|||
106161499|NCT03596866|366252501|FG000|Overall Study|Ongoing at Data Cut-off|91|||
106161500|NCT03596866|366252502|FG001|Overall Study|Ongoing at Data Cut-off|101|||
106161501|NCT03596866|366252501|FG000|Overall Study|Randomized but Never Received Drug|0|||
106161502|NCT03596866|366252502|FG001|Overall Study|Randomized but Never Received Drug|1|||
106161503|NCT03596866|366252501|FG000|Overall Study|Death|27|||
106161504|NCT03596866|366252502|FG001|Overall Study|Death|14|||
106161505|NCT03596866|366252501|FG000|Overall Study|Withdrawal by Subject|6|||
106161506|NCT03596866|366252502|FG001|Overall Study|Withdrawal by Subject|5|||
106161507|NCT03596866|366252501|FG000|Overall Study|Lost to Follow-up|1|||
106161508|NCT03596866|366252502|FG001|Overall Study|Lost to Follow-up|1|||
106161509|NCT03596866|366252501|FG000|Overall Study|Reason Not Specified|0|||
106161510|NCT03596866|366252502|FG001|Overall Study|Reason Not Specified|1|||
106161511|NCT02035787|366253756|FG000|Overall Study- 12 Months|Adverse Event|3|||
106161512|NCT02035787|366253757|FG001|Overall Study- 12 Months|Adverse Event|0|||
106161513|NCT02035787|366253756|FG000|Overall Study- 12 Months|Complete response|4|||
106161514|NCT02035787|366253757|FG001|Overall Study- 12 Months|Complete response|1|||
106161515|NCT02035787|366253756|FG000|Overall Study- 12 Months|Protocol Violation|1|||
106161516|NCT02035787|366253757|FG001|Overall Study- 12 Months|Protocol Violation|1|||
106161517|NCT03338933|366253758|FG000|Screening Visit|Lost to Follow-up|1|||
106161518|NCT03338933|366253759|FG001|Screening Visit|Lost to Follow-up|3|||
106161519|NCT03338933|366253760|FG002|Screening Visit|Lost to Follow-up|1|||
106161520|NCT03338933|366253761|FG003|Screening Visit|Lost to Follow-up|4|||
106161521|NCT03338933|366253758|FG000|Screening Visit|Screen fail after consent|2|||
106089404|NCT01529645|365987345|FG003|Overall Study|Withdrawal by Subject|1|||
106089405|NCT01529645|365987346|FG004|Overall Study|Withdrawal by Subject|1|||
106089406|NCT01529645|365987347|FG005|Overall Study|Withdrawal by Subject|1|||
106089407|NCT01529645|365987348|FG006|Overall Study|Withdrawal by Subject|0|||
106089408|NCT01529645|365987349|FG007|Overall Study|Withdrawal by Subject|0|||
106089409|NCT01529645|365987350|FG008|Overall Study|Withdrawal by Subject|0|||
106089410|NCT01529645|365987351|FG009|Overall Study|Withdrawal by Subject|0|||
106089411|NCT03455855|365987352|FG000|Overall Study|Lost to Follow-up|4|||
106089412|NCT03455855|365987353|FG001|Overall Study|Lost to Follow-up|2|||
106089413|NCT00587587|365987354|FG000|Overall Study|Lost to Follow-up|6|||
106089414|NCT00587587|365987355|FG001|Overall Study|Lost to Follow-up|1|||
106089415|NCT01694706|365987362|FG000|Overall Study|Adverse Event|0|||
106089416|NCT01694706|365987363|FG001|Overall Study|Adverse Event|1|||
106089417|NCT01694706|365987364|FG002|Overall Study|Adverse Event|0|||
106089418|NCT01694706|365987362|FG000|Overall Study|other reason not defined above|1|||
106089419|NCT01694706|365987363|FG001|Overall Study|other reason not defined above|0|||
106089420|NCT01694706|365987364|FG002|Overall Study|other reason not defined above|0|||
106089421|NCT00975975|365987365|FG000|Overall Study|Death|6|||
106089422|NCT01324024|365987368|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
106089423|NCT01324024|365987369|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
106089424|NCT03614793|365987377|FG000|Overall Study|Lost to Follow-up|1|||
106089425|NCT03614793|365987378|FG001|Overall Study|Lost to Follow-up|2|||
106089426|NCT03614793|365987377|FG000|Overall Study|Lack of Efficacy|0|||
106089427|NCT03614793|365987378|FG001|Overall Study|Lack of Efficacy|5|||
106089428|NCT03614793|365987377|FG000|Overall Study|Withdrawal by Subject|0|||
106089429|NCT03614793|365987378|FG001|Overall Study|Withdrawal by Subject|1|||
106089430|NCT03614793|365987377|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
106089431|NCT03614793|365987378|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
106089432|NCT02082522|365987379|FG000|Overall Study|Sponsor termination|5|||
106089433|NCT02082522|365987380|FG001|Overall Study|Sponsor termination|3|||
106089434|NCT02082522|365987379|FG000|Overall Study|Withdrawal by Subject|2|||
106089435|NCT02082522|365987380|FG001|Overall Study|Withdrawal by Subject|4|||
106089436|NCT02082522|365987379|FG000|Overall Study|Death|1|||
106089437|NCT02082522|365987380|FG001|Overall Study|Death|0|||
106089438|NCT02082522|365987379|FG000|Overall Study|Lost to Follow-up|1|||
106089439|NCT02082522|365987380|FG001|Overall Study|Lost to Follow-up|0|||
106089440|NCT02082522|365987379|FG000|Overall Study|Physician Decision|3|||
106089441|NCT02082522|365987380|FG001|Overall Study|Physician Decision|1|||
106089442|NCT02082522|365987379|FG000|Overall Study|Disease progression|2|||
106089443|NCT02082522|365987380|FG001|Overall Study|Disease progression|2|||
106089444|NCT02082522|365987379|FG000|Overall Study|Chemotherapy change|1|||
106089445|NCT02082522|365987380|FG001|Overall Study|Chemotherapy change|3|||
106089446|NCT00440271|365987383|FG000|Overall Study|Protocol Violation|1|||
106089447|NCT00440271|365987384|FG001|Overall Study|Protocol Violation|1|||
106089448|NCT00440271|365987383|FG000|Overall Study|Adverse Event|0|||
106089449|NCT00440271|365987384|FG001|Overall Study|Adverse Event|1|||
106089450|NCT00440271|365987383|FG000|Overall Study|Lost to Follow-up|1|||
106089451|NCT00440271|365987384|FG001|Overall Study|Lost to Follow-up|0|||
106089452|NCT00440271|365987383|FG000|Overall Study|Withdrawal by Subject|0|||
106089453|NCT00440271|365987384|FG001|Overall Study|Withdrawal by Subject|2|||
106089454|NCT00440271|365987383|FG000|Overall Study|Lack of Efficacy|0|||
106089455|NCT00440271|365987384|FG001|Overall Study|Lack of Efficacy|1|||
106089456|NCT00440271|365987383|FG000|Overall Study|Due to closure of trial|8|||
106089457|NCT00440271|365987384|FG001|Overall Study|Due to closure of trial|10|||
106089458|NCT00440271|365987383|FG000|Overall Study|Other|2|||
106089459|NCT00440271|365987384|FG001|Overall Study|Other|0|||
106089460|NCT00456092|365987385|FG000|Extension Phase|Grade 2 or Greater AE|2|||
106089461|NCT00456092|365987386|FG001|Extension Phase|Grade 2 or Greater AE|2|||
106089462|NCT00456092|365987387|FG002|Extension Phase|Grade 2 or Greater AE|0|||
106089463|NCT00456092|365987388|FG003|Extension Phase|Grade 2 or Greater AE|0|||
106089464|NCT00456092|365987389|FG004|Extension Phase|Grade 2 or Greater AE|2|||
106089465|NCT00456092|365987385|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
106089466|NCT00456092|365987386|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
106089467|NCT00456092|365987387|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
106089468|NCT00456092|365987388|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
106089469|NCT00456092|365987389|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
106089470|NCT00456092|365987385|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
106089471|NCT00456092|365987386|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
106089472|NCT00456092|365987387|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
106089473|NCT00456092|365987388|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
106089474|NCT00456092|365987389|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
106089475|NCT00456092|365987385|FG000|Extension Phase|Withdrew Consent|2|||
106089476|NCT00456092|365987386|FG001|Extension Phase|Withdrew Consent|0|||
106089477|NCT00456092|365987387|FG002|Extension Phase|Withdrew Consent|0|||
106089478|NCT00456092|365987388|FG003|Extension Phase|Withdrew Consent|0|||
106089479|NCT00456092|365987389|FG004|Extension Phase|Withdrew Consent|0|||
106089480|NCT00456092|365987385|FG000|Extension Phase|Lost to Follow-up|1|||
106089481|NCT00456092|365987386|FG001|Extension Phase|Lost to Follow-up|1|||
106089482|NCT00456092|365987387|FG002|Extension Phase|Lost to Follow-up|0|||
106089483|NCT00456092|365987388|FG003|Extension Phase|Lost to Follow-up|0|||
106089484|NCT00456092|365987389|FG004|Extension Phase|Lost to Follow-up|1|||
106089485|NCT00456092|365987385|FG000|Extension Phase|Other|2|||
106089486|NCT00456092|365987386|FG001|Extension Phase|Other|0|||
106089487|NCT00456092|365987387|FG002|Extension Phase|Other|0|||
106089488|NCT00456092|365987388|FG003|Extension Phase|Other|1|||
106089489|NCT00456092|365987389|FG004|Extension Phase|Other|1|||
106089490|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
106089491|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
106089492|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
106089493|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
106089494|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
106089495|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
106089496|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
106089497|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
106089498|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
106089499|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
106089500|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
106089501|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
106089502|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
106089503|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
106089504|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
106089505|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
106089506|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
106089507|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
106089508|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
106089509|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
106089510|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
106089511|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
106089512|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
106089513|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
106089514|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
106089515|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
106089516|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
106089517|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
106089518|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
106089519|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
106089520|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
106089521|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
106089522|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
106089523|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
106089524|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
106089525|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
106089526|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
106089527|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
106089528|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
106089529|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
106089530|NCT00456092|365987385|FG000|Treatment Phase (12 Weeks)|Other|1|||
106089531|NCT00456092|365987386|FG001|Treatment Phase (12 Weeks)|Other|0|||
106089532|NCT00456092|365987387|FG002|Treatment Phase (12 Weeks)|Other|1|||
106089533|NCT00456092|365987388|FG003|Treatment Phase (12 Weeks)|Other|0|||
106089534|NCT00456092|365987389|FG004|Treatment Phase (12 Weeks)|Other|0|||
106089535|NCT01863446|365987390|FG000|Overall Study|Withdrawal by Subject|1|||
106089536|NCT01863446|365987391|FG001|Overall Study|Withdrawal by Subject|0|||
106089537|NCT01863446|365987392|FG002|Overall Study|Withdrawal by Subject|1|||
106089538|NCT01863446|365987393|FG003|Overall Study|Withdrawal by Subject|2|||
106089539|NCT01863446|365987390|FG000|Overall Study|Physician Decision|0|||
106089540|NCT01863446|365987391|FG001|Overall Study|Physician Decision|0|||
106089541|NCT01863446|365987392|FG002|Overall Study|Physician Decision|1|||
106089542|NCT01863446|365987393|FG003|Overall Study|Physician Decision|0|||
106089543|NCT02252081|365987394|FG000|Overall Study|Withdrawal by Subject|2|||
106089544|NCT02252081|365987395|FG001|Overall Study|Withdrawal by Subject|1|||
106089545|NCT02252081|365987394|FG000|Overall Study|Adverse Event|4|||
106089546|NCT02252081|365987395|FG001|Overall Study|Adverse Event|1|||
106089547|NCT02252081|365987394|FG000|Overall Study|non compliance & others|0|||
106089548|NCT02252081|365987395|FG001|Overall Study|non compliance & others|2|||
106089549|NCT00563797|365987400|FG000|Overall Study|Lost to Follow-up|7|||
106089550|NCT00563797|365987401|FG001|Overall Study|Lost to Follow-up|2|||
106089551|NCT04116229|365987402|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
106089552|NCT04116229|365987403|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
106161522|NCT03338933|366253759|FG001|Screening Visit|Screen fail after consent|7|||
106161523|NCT03338933|366253760|FG002|Screening Visit|Screen fail after consent|1|||
106161524|NCT03338933|366253761|FG003|Screening Visit|Screen fail after consent|4|||
106089553|NCT04116229|365987402|FG000|Overall Study|Scheduling not possible.|0|||
106089554|NCT04116229|365987403|FG001|Overall Study|Scheduling not possible.|1|||
106089555|NCT00403455|365987404|FG000|Overall Study|Withdrawal by Subject|1|||
106089556|NCT02461589|365987405|FG000|Overall Study|Withdrawal by Subject|5|||
106089557|NCT02461589|365987406|FG001|Overall Study|Withdrawal by Subject|1|||
106089558|NCT02461589|365987407|FG002|Overall Study|Withdrawal by Subject|3|||
106089559|NCT02461589|365987408|FG003|Overall Study|Withdrawal by Subject|2|||
106089560|NCT02461589|365987409|FG004|Overall Study|Withdrawal by Subject|1|||
106089561|NCT02461589|365987410|FG005|Overall Study|Withdrawal by Subject|2|||
106089562|NCT02461589|365987411|FG006|Overall Study|Withdrawal by Subject|1|||
106089563|NCT02461589|365987412|FG007|Overall Study|Withdrawal by Subject|3|||
106089564|NCT02461589|365987413|FG008|Overall Study|Withdrawal by Subject|3|||
106089565|NCT02461589|365987414|FG009|Overall Study|Withdrawal by Subject|1|||
106089566|NCT02461589|365987405|FG000|Overall Study|Lost to Follow-up|0|||
106089567|NCT02461589|365987406|FG001|Overall Study|Lost to Follow-up|0|||
106089568|NCT02461589|365987407|FG002|Overall Study|Lost to Follow-up|2|||
106089569|NCT02461589|365987408|FG003|Overall Study|Lost to Follow-up|3|||
106089570|NCT02461589|365987409|FG004|Overall Study|Lost to Follow-up|1|||
106089571|NCT02461589|365987410|FG005|Overall Study|Lost to Follow-up|1|||
106089572|NCT02461589|365987411|FG006|Overall Study|Lost to Follow-up|3|||
106089573|NCT02461589|365987412|FG007|Overall Study|Lost to Follow-up|1|||
106089574|NCT02461589|365987413|FG008|Overall Study|Lost to Follow-up|3|||
106089575|NCT02461589|365987414|FG009|Overall Study|Lost to Follow-up|1|||
106089576|NCT02461589|365987405|FG000|Overall Study|Death|0|||
106089577|NCT02461589|365987406|FG001|Overall Study|Death|0|||
106089578|NCT02461589|365987407|FG002|Overall Study|Death|0|||
106089579|NCT02461589|365987408|FG003|Overall Study|Death|0|||
106089580|NCT02461589|365987409|FG004|Overall Study|Death|0|||
106089581|NCT02461589|365987410|FG005|Overall Study|Death|0|||
106089582|NCT02461589|365987411|FG006|Overall Study|Death|0|||
106089583|NCT02461589|365987412|FG007|Overall Study|Death|1|||
106089584|NCT02461589|365987413|FG008|Overall Study|Death|0|||
106089585|NCT02461589|365987414|FG009|Overall Study|Death|0|||
106089586|NCT02461589|365987405|FG000|Overall Study|Unclassified|0|||
106089587|NCT02461589|365987406|FG001|Overall Study|Unclassified|0|||
106089588|NCT02461589|365987407|FG002|Overall Study|Unclassified|0|||
106089589|NCT02461589|365987408|FG003|Overall Study|Unclassified|0|||
106089590|NCT02461589|365987409|FG004|Overall Study|Unclassified|0|||
106089591|NCT02461589|365987410|FG005|Overall Study|Unclassified|0|||
106089592|NCT02461589|365987411|FG006|Overall Study|Unclassified|1|||
106089593|NCT02461589|365987412|FG007|Overall Study|Unclassified|0|||
106089594|NCT02461589|365987413|FG008|Overall Study|Unclassified|0|||
106089595|NCT02461589|365987414|FG009|Overall Study|Unclassified|2|||
106089596|NCT02461589|365987405|FG000|Overall Study|Missing follow-up information|1|||
106089597|NCT02461589|365987406|FG001|Overall Study|Missing follow-up information|1|||
106089598|NCT02461589|365987407|FG002|Overall Study|Missing follow-up information|0|||
106089599|NCT02461589|365987408|FG003|Overall Study|Missing follow-up information|0|||
106089600|NCT02461589|365987409|FG004|Overall Study|Missing follow-up information|0|||
106089601|NCT02461589|365987410|FG005|Overall Study|Missing follow-up information|0|||
106089602|NCT02461589|365987411|FG006|Overall Study|Missing follow-up information|1|||
106089603|NCT02461589|365987412|FG007|Overall Study|Missing follow-up information|0|||
106089604|NCT02461589|365987413|FG008|Overall Study|Missing follow-up information|0|||
106089605|NCT02461589|365987414|FG009|Overall Study|Missing follow-up information|0|||
106089606|NCT02461589|365987405|FG000|Overall Study|Withdrawal from trial before exposure|0|||
106089607|NCT02461589|365987406|FG001|Overall Study|Withdrawal from trial before exposure|0|||
106089608|NCT02461589|365987407|FG002|Overall Study|Withdrawal from trial before exposure|0|||
106089609|NCT02461589|365987408|FG003|Overall Study|Withdrawal from trial before exposure|0|||
106089610|NCT02461589|365987409|FG004|Overall Study|Withdrawal from trial before exposure|0|||
106089611|NCT02461589|365987410|FG005|Overall Study|Withdrawal from trial before exposure|0|||
106089612|NCT02461589|365987411|FG006|Overall Study|Withdrawal from trial before exposure|0|||
106089613|NCT02461589|365987412|FG007|Overall Study|Withdrawal from trial before exposure|0|||
106089614|NCT02461589|365987413|FG008|Overall Study|Withdrawal from trial before exposure|0|||
106089615|NCT02461589|365987414|FG009|Overall Study|Withdrawal from trial before exposure|1|||
106089616|NCT01557946|365987415|FG000|Overall Study|Adverse Event|3|||
106089617|NCT01557946|365987416|FG001|Overall Study|Adverse Event|0|||
106089618|NCT01047683|365987417|FG000|Overall Study|Adverse Event|3|||
106089619|NCT01047683|365987418|FG001|Overall Study|Adverse Event|1|||
106089620|NCT01047683|365987419|FG002|Overall Study|Adverse Event|0|||
106089621|NCT01047683|365987417|FG000|Overall Study|Withdrew Consent|1|||
106089622|NCT01047683|365987418|FG001|Overall Study|Withdrew Consent|4|||
106089623|NCT01047683|365987419|FG002|Overall Study|Withdrew Consent|2|||
106089624|NCT01047683|365987417|FG000|Overall Study|Lost to Follow-up|0|||
106161525|NCT03338933|366253758|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
106161526|NCT03338933|366253759|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
106161527|NCT03338933|366253760|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
106161528|NCT03338933|366253761|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
106089625|NCT01047683|365987418|FG001|Overall Study|Lost to Follow-up|1|||
106089626|NCT01047683|365987419|FG002|Overall Study|Lost to Follow-up|0|||
106089627|NCT01047683|365987417|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
106089628|NCT01047683|365987418|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
106089629|NCT01047683|365987419|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
106089630|NCT02399085|365987433|FG000|Overall Study|Adverse Event|16|||
106089631|NCT02399085|365987433|FG000|Overall Study|Death|2|||
106089632|NCT02399085|365987433|FG000|Overall Study|Withdrawal by Subject|8|||
106089633|NCT02399085|365987433|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
106089634|NCT02399085|365987433|FG000|Overall Study|Physician Decision|5|||
106089635|NCT00833924|365987434|FG000|Overall Study|Death|21|||
106089636|NCT00833924|365987434|FG000|Overall Study|Conversion|2|||
106089637|NCT00833924|365987434|FG000|Overall Study|Lost to Follow-up|2|||
106089638|NCT00833924|365987434|FG000|Overall Study|Withdrawal by Subject|13|||
106089639|NCT00833924|365987434|FG000|Overall Study|In study follow-up|71|||
106089640|NCT03235024|365987435|FG000|Overall Study|Adverse Event|2|||
106089641|NCT03235024|365987436|FG001|Overall Study|Adverse Event|2|||
106089642|NCT03235024|365987435|FG000|Overall Study|Death|1|||
106089643|NCT03235024|365987436|FG001|Overall Study|Death|0|||
106089644|NCT03235024|365987435|FG000|Overall Study|Lost to Follow-up|2|||
106089645|NCT03235024|365987436|FG001|Overall Study|Lost to Follow-up|5|||
106089646|NCT03235024|365987435|FG000|Overall Study|Protocol Violation|1|||
106089647|NCT03235024|365987436|FG001|Overall Study|Protocol Violation|0|||
106089648|NCT03235024|365987435|FG000|Overall Study|Withdrawal by Subject|0|||
106089649|NCT03235024|365987436|FG001|Overall Study|Withdrawal by Subject|3|||
106089650|NCT01158924|365987437|FG000|Overall Study|Withdrawal by Subject|1|||
106089651|NCT01158924|365987438|FG001|Overall Study|Withdrawal by Subject|2|||
106089652|NCT01158924|365987437|FG000|Overall Study|Lost to Follow-up|0|||
106089653|NCT01158924|365987438|FG001|Overall Study|Lost to Follow-up|1|||
106089654|NCT00699699|365987439|FG000|Overall Study|Adverse Event|36|||
106089655|NCT00699699|365987439|FG000|Overall Study|Individual different reasons|21|||
106089656|NCT03732248|365987441|FG000|Overall Study|Withdrawal by Subject|1|||
106089657|NCT03732248|365987442|FG001|Overall Study|Withdrawal by Subject|0|||
106089658|NCT00733824|365987443|FG000|Phase I|Withdrawal by Subject|1|||
106089659|NCT00733824|365987444|FG001|Phase I|Withdrawal by Subject|0|||
106089660|NCT00733824|365987445|FG002|Phase I|Withdrawal by Subject|0|||
106089661|NCT00733824|365987446|FG003|Phase I|Withdrawal by Subject|0|||
106089662|NCT00733824|365987447|FG004|Phase I|Withdrawal by Subject|0|||
106089663|NCT02802345|365987448|FG000|Overall Study|Not Treated|0|||
106089664|NCT02802345|365987449|FG001|Overall Study|Not Treated|1|||
106089665|NCT02802345|365987448|FG000|Overall Study|Adverse Event|28|||
106089666|NCT02802345|365987449|FG001|Overall Study|Adverse Event|20|||
106089667|NCT02802345|365987448|FG000|Overall Study|Withdrawal by Subject|3|||
106089668|NCT02802345|365987449|FG001|Overall Study|Withdrawal by Subject|3|||
106089669|NCT02802345|365987448|FG000|Overall Study|Protocol Violation|0|||
106089670|NCT02802345|365987449|FG001|Overall Study|Protocol Violation|1|||
106089671|NCT02802345|365987448|FG000|Overall Study|Other than listed|1|||
106089672|NCT02802345|365987449|FG001|Overall Study|Other than listed|5|||
106089673|NCT00835406|365987458|FG000|Period: First Intervention|Adverse Event|0|||
106089674|NCT00835406|365987459|FG001|Period: First Intervention|Adverse Event|1|||
106089675|NCT00835406|365987458|FG000|Period: First Intervention|Withdrawal by Subject|2|||
106089676|NCT00835406|365987459|FG001|Period: First Intervention|Withdrawal by Subject|0|||
106089677|NCT00835406|365987458|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
106089678|NCT00835406|365987459|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
106089679|NCT02158039|365987462|FG000|Overall Study|Withdrawal by Subject|1|||
106089680|NCT02158039|365987462|FG000|Overall Study|Screen Failure|9|||
106089681|NCT02755831|365987468|FG000|Overall Study|Lost to Follow-up|3|||
106089682|NCT02755831|365987469|FG001|Overall Study|Lost to Follow-up|3|||
106089683|NCT00298831|365987470|FG000|Overall Study|Adverse Event|1|||
106089684|NCT00298831|365987470|FG000|Overall Study|Lost to Follow-up|3|||
106089685|NCT00298831|365987470|FG000|Overall Study|Withdrawal by Subject|1|||
106089686|NCT00298831|365987470|FG000|Overall Study|Participants did not receive treatment|27|||
106089687|NCT02052466|365987471|FG000|Overall Study|Withdrawal by Subject|1|||
106089688|NCT02052466|365987471|FG000|Overall Study|Acromial fracture|1|||
106089689|NCT04382612|365987476|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
106089690|NCT03149328|365987477|FG000|Overall Study|Withdrawal by Subject|30|||
106089691|NCT03149328|365987478|FG001|Overall Study|Withdrawal by Subject|26|||
106089692|NCT03149328|365987477|FG000|Overall Study|Changed Dialysis Modality|18|||
106089693|NCT03149328|365987478|FG001|Overall Study|Changed Dialysis Modality|1|||
106089694|NCT03149328|365987477|FG000|Overall Study|Transplant|9|||
106161529|NCT03338933|366253758|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
106089695|NCT03149328|365987478|FG001|Overall Study|Transplant|1|||
106089696|NCT03149328|365987477|FG000|Overall Study|Lost to Follow-up|25|||
106089697|NCT03149328|365987478|FG001|Overall Study|Lost to Follow-up|16|||
106089698|NCT03149328|365987477|FG000|Overall Study|Left Study Site|1|||
106089699|NCT03149328|365987478|FG001|Overall Study|Left Study Site|2|||
106089700|NCT03149328|365987477|FG000|Overall Study|Language Barrier|1|||
106089701|NCT03149328|365987478|FG001|Overall Study|Language Barrier|0|||
106161530|NCT03338933|366253759|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
106161531|NCT03338933|366253760|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
106161532|NCT03338933|366253761|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
106161533|NCT03338933|366253758|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
106089702|NCT00691210|365987479|FG000|Overall Study|Progression of Disease|0|||
106089703|NCT00691210|365987480|FG001|Overall Study|Progression of Disease|0|||
106089704|NCT00691210|365987481|FG002|Overall Study|Progression of Disease|0|||
106089705|NCT00691210|365987482|FG003|Overall Study|Progression of Disease|2|||
106089706|NCT00691210|365987483|FG004|Overall Study|Progression of Disease|0|||
106089707|NCT00691210|365987484|FG005|Overall Study|Progression of Disease|0|||
106089708|NCT00691210|365987485|FG006|Overall Study|Progression of Disease|0|||
106089709|NCT00691210|365987486|FG007|Overall Study|Progression of Disease|0|||
106089710|NCT00691210|365987479|FG000|Overall Study|Lack of Efficacy|0|||
106089711|NCT00691210|365987480|FG001|Overall Study|Lack of Efficacy|0|||
106089712|NCT00691210|365987481|FG002|Overall Study|Lack of Efficacy|0|||
106089713|NCT00691210|365987482|FG003|Overall Study|Lack of Efficacy|1|||
106089714|NCT00691210|365987483|FG004|Overall Study|Lack of Efficacy|0|||
106089715|NCT00691210|365987484|FG005|Overall Study|Lack of Efficacy|1|||
106089716|NCT00691210|365987485|FG006|Overall Study|Lack of Efficacy|0|||
106089717|NCT00691210|365987486|FG007|Overall Study|Lack of Efficacy|0|||
106089718|NCT04028388|365987489|FG000|Overall Study|Evaluations missing|3|||
106089719|NCT04028388|365987490|FG001|Overall Study|Evaluations missing|6|||
106089720|NCT04028388|365987489|FG000|Overall Study|Not started|2|||
106089721|NCT04028388|365987490|FG001|Overall Study|Not started|0|||
106089722|NCT04369469|365987491|FG000|Overall Study|Lost to Follow-up|2|||
106089723|NCT04369469|365987492|FG001|Overall Study|Lost to Follow-up|4|||
106089724|NCT04369469|365987491|FG000|Overall Study|Physician Decision|2|||
106089725|NCT04369469|365987492|FG001|Overall Study|Physician Decision|1|||
106089726|NCT04369469|365987491|FG000|Overall Study|Withdrawal by Subject|2|||
106089727|NCT04369469|365987492|FG001|Overall Study|Withdrawal by Subject|3|||
106089728|NCT04369469|365987491|FG000|Overall Study|Adverse Event|1|||
106089729|NCT04369469|365987492|FG001|Overall Study|Adverse Event|0|||
106089730|NCT04369469|365987491|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
106089731|NCT04369469|365987492|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
106089732|NCT04369469|365987491|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
106089733|NCT04369469|365987492|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
106089734|NCT04369469|365987491|FG000|Overall Study|Unable to Provide Consent|0|||
106089735|NCT04369469|365987492|FG001|Overall Study|Unable to Provide Consent|1|||
106089736|NCT00555438|365987499|FG000|10 Days Post-operative|Death|4|||
106089737|NCT00555438|365987499|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
106089738|NCT00061048|365987500|FG000|Overall Study|Adverse Event|2|||
106089739|NCT00061048|365987500|FG000|Overall Study|disease progression|20|||
106089740|NCT01940705|365987507|FG000|Overall Study|Lost to Follow-up|1|||
106089741|NCT01940705|365987508|FG001|Overall Study|Lost to Follow-up|3|||
106089742|NCT01940705|365987509|FG002|Overall Study|Lost to Follow-up|2|||
106089743|NCT01940705|365987510|FG003|Overall Study|Lost to Follow-up|2|||
106089744|NCT01940705|365987507|FG000|Overall Study|Withdrawal by Subject|2|||
106089745|NCT01940705|365987508|FG001|Overall Study|Withdrawal by Subject|2|||
106089746|NCT01940705|365987509|FG002|Overall Study|Withdrawal by Subject|3|||
106089747|NCT01940705|365987510|FG003|Overall Study|Withdrawal by Subject|2|||
106089748|NCT01940705|365987507|FG000|Overall Study|Intervention not given|0|||
106089749|NCT01940705|365987508|FG001|Overall Study|Intervention not given|3|||
106089750|NCT01940705|365987509|FG002|Overall Study|Intervention not given|3|||
106089751|NCT01940705|365987510|FG003|Overall Study|Intervention not given|0|||
106089752|NCT01940705|365987507|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
106089753|NCT01940705|365987508|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
106089754|NCT01940705|365987509|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
106089755|NCT01940705|365987510|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
106089756|NCT03779841|365987511|FG000|Randomized Population|Did Not Receive Treatment|3|||
106089757|NCT03779841|365987512|FG001|Randomized Population|Did Not Receive Treatment|1|||
106161534|NCT03338933|366253759|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
106161535|NCT03338933|366253760|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
106089758|NCT03779841|365987513|FG002|Randomized Population|Did Not Receive Treatment|0|||
106089759|NCT03779841|365987511|FG000|Treated (Safety) Population|Adverse Event|1|||
106089760|NCT03779841|365987512|FG001|Treated (Safety) Population|Adverse Event|1|||
106089761|NCT03779841|365987513|FG002|Treated (Safety) Population|Adverse Event|0|||
106089762|NCT03779841|365987511|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
106089763|NCT03779841|365987512|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
106089764|NCT03779841|365987513|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
106089765|NCT03779841|365987511|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
106089766|NCT03779841|365987512|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
106089767|NCT03779841|365987513|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
106089768|NCT03779841|365987511|FG000|Treated (Safety) Population|Death|1|||
106089769|NCT03779841|365987512|FG001|Treated (Safety) Population|Death|0|||
106089770|NCT03779841|365987513|FG002|Treated (Safety) Population|Death|2|||
106089771|NCT01632579|365987514|FG000|Washout Period|Adverse Event|1|||
106089772|NCT01632579|365987515|FG001|Washout Period|Adverse Event|0|||
106089773|NCT01632579|365987516|FG002|Washout Period|Adverse Event|0|||
106089774|NCT01632579|365987517|FG003|Washout Period|Adverse Event|0|||
106089775|NCT01632579|365987518|FG004|Washout Period|Adverse Event|0|||
106089776|NCT01632579|365987519|FG005|Washout Period|Adverse Event|0|||
106089777|NCT01632579|365987520|FG006|Washout Period|Adverse Event|0|||
106089778|NCT01632579|365987521|FG007|Washout Period|Adverse Event|0|||
106089779|NCT01632579|365987522|FG008|Washout Period|Adverse Event|0|||
106089780|NCT01632579|365987514|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
106089781|NCT01632579|365987515|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
106089782|NCT01632579|365987516|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
106089783|NCT01632579|365987517|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
106089784|NCT01632579|365987518|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
106089785|NCT01632579|365987519|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
106089786|NCT01632579|365987520|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
106089787|NCT01632579|365987521|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
106089788|NCT01632579|365987522|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
106089789|NCT00459134|365987523|FG000|Overall Study|Physician Decision|1|||
106089790|NCT00459134|365987524|FG001|Overall Study|Physician Decision|1|||
106089791|NCT00459134|365987523|FG000|Overall Study|Withdrawal by Subject|8|||
106089792|NCT00459134|365987524|FG001|Overall Study|Withdrawal by Subject|7|||
106089793|NCT00459134|365987523|FG000|Overall Study|Lost to Follow-up|6|||
106089794|NCT00459134|365987524|FG001|Overall Study|Lost to Follow-up|7|||
106089795|NCT00459134|365987523|FG000|Overall Study|Surgery|1|||
106089796|NCT00459134|365987524|FG001|Overall Study|Surgery|2|||
106089797|NCT00459134|365987523|FG000|Overall Study|Toxicity|4|||
106089798|NCT00459134|365987524|FG001|Overall Study|Toxicity|5|||
106089799|NCT00459134|365987523|FG000|Overall Study|Progression|1|||
106089800|NCT00459134|365987524|FG001|Overall Study|Progression|0|||
106089801|NCT00459134|365987523|FG000|Overall Study|Multiple Reasons|2|||
106089802|NCT00459134|365987524|FG001|Overall Study|Multiple Reasons|3|||
106089803|NCT04095858|365987525|FG000|Overall Study|Death|1|||
106089804|NCT04095858|365987526|FG001|Overall Study|Death|0|||
106089805|NCT04095858|365987525|FG000|Overall Study|Study terminated by Sponsor|2|||
106089806|NCT04095858|365987526|FG001|Overall Study|Study terminated by Sponsor|4|||
106089807|NCT00836875|365987529|FG000|Overall Study|Death|3|||
106089808|NCT00836875|365987530|FG001|Overall Study|Death|2|||
106089809|NCT00836875|365987529|FG000|Overall Study|Withdrawal by Subject|0|||
106089810|NCT00836875|365987530|FG001|Overall Study|Withdrawal by Subject|1|||
106089811|NCT03246529|365987533|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
106089812|NCT03246529|365987534|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
106089813|NCT03246529|365987535|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
106089814|NCT03246529|365987533|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
106089815|NCT03246529|365987534|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
106089816|NCT03246529|365987535|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
106089817|NCT03246529|365987533|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
106089818|NCT03246529|365987534|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
106089819|NCT03246529|365987535|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
106089820|NCT03246529|365987533|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
106089821|NCT03246529|365987534|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
106089822|NCT03246529|365987535|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
106089823|NCT03246529|365987533|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
106089824|NCT03246529|365987534|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
106089825|NCT03246529|365987535|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
106089826|NCT03246529|365987533|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
106089827|NCT03246529|365987534|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
106089828|NCT03246529|365987535|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
106089829|NCT03246529|365987533|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
106089830|NCT03246529|365987534|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
106089831|NCT03246529|365987535|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
106089832|NCT03246529|365987533|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
106089833|NCT03246529|365987534|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
106089834|NCT03246529|365987535|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
106089835|NCT03246529|365987533|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
106089836|NCT03246529|365987534|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
106089837|NCT03246529|365987535|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
106089838|NCT01850004|365987539|FG000|Overall Study|Poor/Non-compliance|1|||
106089839|NCT01850004|365987539|FG000|Overall Study|Participant Withdrew Consent|9|||
106089840|NCT01850004|365987539|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
106089841|NCT01850004|365987539|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
106089842|NCT01850004|365987539|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
106089843|NCT01850004|365987539|FG000|Overall Study|Other Reasons|2|||
106089844|NCT01850004|365987539|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
106089845|NCT01850004|365987539|FG000|Overall Study|Maximum Clinical Benefit|4|||
106089846|NCT00428610|365987540|FG000|Overall Study|Death Due to Adverse Event|3|||
106089847|NCT00428610|365987541|FG001|Overall Study|Death Due to Adverse Event|0|||
106089848|NCT00428610|365987542|FG002|Overall Study|Death Due to Adverse Event|5|||
106089849|NCT00428610|365987540|FG000|Overall Study|Death Due to Progressive Disease|0|||
106089850|NCT00428610|365987541|FG001|Overall Study|Death Due to Progressive Disease|0|||
106089851|NCT00428610|365987542|FG002|Overall Study|Death Due to Progressive Disease|2|||
106089852|NCT00428610|365987540|FG000|Overall Study|Adverse Event|2|||
106089853|NCT00428610|365987541|FG001|Overall Study|Adverse Event|3|||
106089854|NCT00428610|365987542|FG002|Overall Study|Adverse Event|2|||
106089855|NCT00428610|365987540|FG000|Overall Study|Investigator Decision|2|||
106089856|NCT00428610|365987541|FG001|Overall Study|Investigator Decision|1|||
106089857|NCT00428610|365987542|FG002|Overall Study|Investigator Decision|1|||
106089858|NCT00428610|365987540|FG000|Overall Study|Progressive Disease|42|||
106089859|NCT00428610|365987541|FG001|Overall Study|Progressive Disease|14|||
106089860|NCT00428610|365987542|FG002|Overall Study|Progressive Disease|22|||
106089861|NCT00428610|365987540|FG000|Overall Study|Withdrawal by Subject|4|||
106089862|NCT00428610|365987541|FG001|Overall Study|Withdrawal by Subject|0|||
106089863|NCT00428610|365987542|FG002|Overall Study|Withdrawal by Subject|0|||
106089864|NCT03328897|365989580|FG000|Randomized-treatment Epoch|Adverse Event|4|||
106089865|NCT03328897|365989581|FG001|Randomized-treatment Epoch|Adverse Event|1|||
106089866|NCT03328897|365989582|FG002|Randomized-treatment Epoch|Adverse Event|1|||
106089867|NCT03328897|365989580|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
106089868|NCT03328897|365989581|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
106089869|NCT03328897|365989582|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
106089870|NCT03328897|365989580|FG000|Randomized-treatment Epoch|Pregnancy|3|||
106089871|NCT03328897|365989581|FG001|Randomized-treatment Epoch|Pregnancy|0|||
106089872|NCT03328897|365989582|FG002|Randomized-treatment Epoch|Pregnancy|0|||
106089873|NCT03328897|365989580|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
106089874|NCT03328897|365989581|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
106089875|NCT03328897|365989582|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
106089876|NCT03328897|365989580|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
106089877|NCT03328897|365989581|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
106089878|NCT03328897|365989582|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
106089879|NCT03328897|365989580|FG000|Follow-up Epoch|Adverse Event|4|||
106089880|NCT03328897|365989581|FG001|Follow-up Epoch|Adverse Event|0|||
106089881|NCT03328897|365989582|FG002|Follow-up Epoch|Adverse Event|1|||
106089882|NCT03328897|365989580|FG000|Follow-up Epoch|Lack of Efficacy|1|||
106089883|NCT03328897|365989581|FG001|Follow-up Epoch|Lack of Efficacy|1|||
106089884|NCT03328897|365989582|FG002|Follow-up Epoch|Lack of Efficacy|1|||
106089885|NCT03328897|365989580|FG000|Follow-up Epoch|Lost to Follow-up|0|||
106089886|NCT03328897|365989581|FG001|Follow-up Epoch|Lost to Follow-up|1|||
106089887|NCT03328897|365989582|FG002|Follow-up Epoch|Lost to Follow-up|0|||
106089888|NCT03328897|365989580|FG000|Follow-up Epoch|Pregnancy|1|||
106089889|NCT03328897|365989581|FG001|Follow-up Epoch|Pregnancy|0|||
106089890|NCT03328897|365989582|FG002|Follow-up Epoch|Pregnancy|0|||
106089891|NCT03328897|365989580|FG000|Follow-up Epoch|Patient/guardian decision|2|||
106089892|NCT03328897|365989581|FG001|Follow-up Epoch|Patient/guardian decision|1|||
106089893|NCT03328897|365989582|FG002|Follow-up Epoch|Patient/guardian decision|0|||
106089894|NCT02805257|365989583|FG000|Overall Study|Lost to Follow-up|7|||
106089895|NCT02805257|365989584|FG001|Overall Study|Lost to Follow-up|6|||
106089896|NCT02805257|365989583|FG000|Overall Study|Death|0|||
106089897|NCT02805257|365989584|FG001|Overall Study|Death|1|||
106089898|NCT00630877|365989587|FG000|Overall Study|Adverse Event|11|||
106089899|NCT00630877|365989588|FG001|Overall Study|Adverse Event|8|||
106089900|NCT00630877|365989589|FG002|Overall Study|Adverse Event|7|||
106089901|NCT00630877|365989587|FG000|Overall Study|Withdrawal by Subject|3|||
106089902|NCT00630877|365989588|FG001|Overall Study|Withdrawal by Subject|4|||
106089903|NCT00630877|365989589|FG002|Overall Study|Withdrawal by Subject|0|||
106089904|NCT00630877|365989587|FG000|Overall Study|Lost to Follow-up|2|||
106089905|NCT00630877|365989588|FG001|Overall Study|Lost to Follow-up|0|||
106089906|NCT00630877|365989589|FG002|Overall Study|Lost to Follow-up|0|||
106089907|NCT00630877|365989587|FG000|Overall Study|Noncompliance|2|||
106089908|NCT00630877|365989588|FG001|Overall Study|Noncompliance|3|||
106089909|NCT00630877|365989589|FG002|Overall Study|Noncompliance|1|||
106089910|NCT00630877|365989587|FG000|Overall Study|Protocol violation|1|||
106089911|NCT00630877|365989588|FG001|Overall Study|Protocol violation|0|||
106089912|NCT00630877|365989589|FG002|Overall Study|Protocol violation|1|||
106089913|NCT00630877|365989587|FG000|Overall Study|Personal reasons|0|||
106089914|NCT00630877|365989588|FG001|Overall Study|Personal reasons|0|||
106089915|NCT00630877|365989589|FG002|Overall Study|Personal reasons|1|||
106089916|NCT02080091|365989590|FG000|Overall Study|Study Terminated|22|||
106089917|NCT02080091|365989590|FG000|Overall Study|Death|1|||
106089918|NCT02080091|365989590|FG000|Overall Study|Withdrawal by Subject|1|||
106089919|NCT02080091|365989590|FG000|Overall Study|Other|1|||
106089920|NCT01913041|365989591|FG000|Overall Study|Protocol Violation|35|||
106089921|NCT01913041|365989591|FG000|Overall Study|Withdrawal by Subject|3|||
106089922|NCT01913041|365989591|FG000|Overall Study|Physician Decision|1|||
106089923|NCT02866682|365989593|FG000|Overall Study|Death|0|||
106089924|NCT02866682|365989594|FG001|Overall Study|Death|1|||
106089925|NCT02866682|365989593|FG000|Overall Study|Lost to Follow-up|0|||
106089926|NCT02866682|365989594|FG001|Overall Study|Lost to Follow-up|4|||
106089927|NCT02866682|365989593|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
106089928|NCT02866682|365989594|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
106089929|NCT02866682|365989593|FG000|Overall Study|Other|0|||
106089930|NCT02866682|365989594|FG001|Overall Study|Other|1|||
106089931|NCT00201006|365989595|FG000|Overall Study|Withdrawal by Subject|7|||
106089932|NCT00201006|365989596|FG001|Overall Study|Withdrawal by Subject|2|||
106089933|NCT00201006|365989597|FG002|Overall Study|Withdrawal by Subject|3|||
106089934|NCT00201006|365989595|FG000|Overall Study|Adverse Event|1|||
106089935|NCT00201006|365989596|FG001|Overall Study|Adverse Event|0|||
106089936|NCT00201006|365989597|FG002|Overall Study|Adverse Event|1|||
106089937|NCT01750268|365989598|FG000|Overall Study|Lost to Follow-up|0|||
106089938|NCT01750268|365989599|FG001|Overall Study|Lost to Follow-up|2|||
106089939|NCT01750268|365989598|FG000|Overall Study|Physician Decision|0|||
106089940|NCT01750268|365989599|FG001|Overall Study|Physician Decision|3|||
106089941|NCT01750268|365989598|FG000|Overall Study|Withdrawal by Subject|2|||
106089942|NCT01750268|365989599|FG001|Overall Study|Withdrawal by Subject|0|||
106089943|NCT02886572|365989602|FG000|Overall Study|Death|8|||
106089944|NCT02621606|365989606|FG000|Overall Study|Withdrawal by Subject|0|||
106089945|NCT02621606|365989607|FG001|Overall Study|Withdrawal by Subject|1|||
106089946|NCT02621606|365989608|FG002|Overall Study|Withdrawal by Subject|0|||
106089947|NCT01175824|365989609|FG000|Overall Study|Adverse Event|2|||
106089948|NCT01175824|365989610|FG001|Overall Study|Adverse Event|1|||
106089949|NCT01175824|365989609|FG000|Overall Study|Lack of Efficacy|2|||
106089950|NCT01175824|365989610|FG001|Overall Study|Lack of Efficacy|0|||
106089951|NCT01175824|365989609|FG000|Overall Study|Lost to Follow-up|0|||
106089952|NCT01175824|365989610|FG001|Overall Study|Lost to Follow-up|1|||
106089953|NCT01175824|365989609|FG000|Overall Study|Physician Decision|0|||
106089954|NCT01175824|365989610|FG001|Overall Study|Physician Decision|4|||
106089955|NCT01175824|365989609|FG000|Overall Study|Protocol Violation|2|||
106089956|NCT01175824|365989610|FG001|Overall Study|Protocol Violation|5|||
106089957|NCT01175824|365989609|FG000|Overall Study|Withdrawal by Subject|3|||
106089958|NCT01175824|365989610|FG001|Overall Study|Withdrawal by Subject|7|||
106089959|NCT01175824|365989609|FG000|Overall Study|Sponsor Decision|1|||
106089960|NCT01175824|365989610|FG001|Overall Study|Sponsor Decision|0|||
106089961|NCT01175824|365989609|FG000|Overall Study|Entry Criteria Not Met|6|||
106089962|NCT01175824|365989610|FG001|Overall Study|Entry Criteria Not Met|4|||
106089963|NCT00982319|365989616|FG000|Overall Study|Surgery date change|1|||
106089964|NCT00982319|365989617|FG001|Overall Study|Surgery date change|0|||
106089965|NCT00982319|365989616|FG000|Overall Study|Preop values out of acceptable range|1|||
106089966|NCT00982319|365989617|FG001|Overall Study|Preop values out of acceptable range|1|||
106089967|NCT00982319|365989616|FG000|Overall Study|Pregnancy|0|||
106089968|NCT00982319|365989617|FG001|Overall Study|Pregnancy|1|||
106089969|NCT01252251|365989618|FG000|Overall Study|Withdrawal by Subject|1|||
106089970|NCT02057757|365989619|FG000|Overall Study|Withdrawal by Subject|3|||
106089971|NCT02057757|365989620|FG001|Overall Study|Withdrawal by Subject|5|||
106089972|NCT02057757|365989619|FG000|Overall Study|Death|2|||
106089973|NCT02057757|365989620|FG001|Overall Study|Death|0|||
106089974|NCT02057757|365989619|FG000|Overall Study|Lost to Follow-up|8|||
106089975|NCT02057757|365989620|FG001|Overall Study|Lost to Follow-up|3|||
106089976|NCT02057757|365989619|FG000|Overall Study|Non-compliance|1|||
106089977|NCT02057757|365989620|FG001|Overall Study|Non-compliance|0|||
106089978|NCT01168999|365989621|FG000|Overall Study|Lost to Follow-up|2|||
106089979|NCT01168999|365989622|FG001|Overall Study|Lost to Follow-up|1|||
106089980|NCT01168999|365989623|FG002|Overall Study|Lost to Follow-up|0|||
106089981|NCT01168999|365989624|FG003|Overall Study|Lost to Follow-up|0|||
106089982|NCT00009737|365989627|FG000|Overall Study|Adverse Event|112|||
106089983|NCT00009737|365989628|FG001|Overall Study|Adverse Event|75|||
106089984|NCT00009737|365989627|FG000|Overall Study|Death|4|||
106089985|NCT00009737|365989628|FG001|Overall Study|Death|6|||
106089986|NCT00009737|365989627|FG000|Overall Study|Lack of Efficacy|17|||
106089987|NCT00009737|365989628|FG001|Overall Study|Lack of Efficacy|15|||
106089988|NCT00009737|365989627|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
106089989|NCT00009737|365989628|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
106089990|NCT00009737|365989627|FG000|Overall Study|Other Protocol Violation|1|||
106089991|NCT00009737|365989628|FG001|Overall Study|Other Protocol Violation|0|||
106089992|NCT00009737|365989627|FG000|Overall Study|Refused Treatment|15|||
106089993|NCT00009737|365989628|FG001|Overall Study|Refused Treatment|16|||
106089994|NCT00009737|365989627|FG000|Overall Study|Lost to Follow-up|1|||
106089995|NCT00009737|365989628|FG001|Overall Study|Lost to Follow-up|1|||
106089996|NCT00009737|365989627|FG000|Overall Study|Administrative/Other Reasons|7|||
106089997|NCT00009737|365989628|FG001|Overall Study|Administrative/Other Reasons|1|||
106089998|NCT02956629|365989630|FG000|Overall Study|Adverse Event|0|||
106089999|NCT02956629|365989631|FG001|Overall Study|Adverse Event|0|||
106090000|NCT02956629|365989632|FG002|Overall Study|Adverse Event|1|||
106090001|NCT02956629|365989633|FG003|Overall Study|Adverse Event|0|||
106090002|NCT02956629|365989634|FG004|Overall Study|Adverse Event|0|||
106090003|NCT02956629|365989635|FG005|Overall Study|Adverse Event|0|||
106090004|NCT02956629|365989630|FG000|Overall Study|Lost to Follow-up|2|||
106090005|NCT02956629|365989631|FG001|Overall Study|Lost to Follow-up|5|||
106090006|NCT02956629|365989632|FG002|Overall Study|Lost to Follow-up|3|||
106090007|NCT02956629|365989633|FG003|Overall Study|Lost to Follow-up|1|||
106090008|NCT02956629|365989634|FG004|Overall Study|Lost to Follow-up|0|||
106090009|NCT02956629|365989635|FG005|Overall Study|Lost to Follow-up|1|||
106090010|NCT02956629|365989630|FG000|Overall Study|Withdrawal by Subject|3|||
106090011|NCT02956629|365989631|FG001|Overall Study|Withdrawal by Subject|1|||
106090012|NCT02956629|365989632|FG002|Overall Study|Withdrawal by Subject|0|||
106090013|NCT02956629|365989633|FG003|Overall Study|Withdrawal by Subject|0|||
106090014|NCT02956629|365989634|FG004|Overall Study|Withdrawal by Subject|0|||
106090015|NCT02956629|365989635|FG005|Overall Study|Withdrawal by Subject|0|||
106090016|NCT04808609|365989636|FG000|Overall Study|Lost to Follow-up|0|||
106161536|NCT03338933|366253761|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
106161537|NCT05371652|366253762|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
106161538|NCT05371652|366253762|FG000|Overall Study|Withdrawal by Subject|12|||
106161539|NCT05371652|366253762|FG000|Overall Study|Adverse Event|1|||
106161540|NCT05371652|366253762|FG000|Overall Study|Other|11|||
106161541|NCT03302494|366253763|FG000|Overall Study|Other|7|||
106161542|NCT03302494|366253764|FG001|Overall Study|Other|4|||
106161543|NCT03302494|366253765|FG002|Overall Study|Other|6|||
106161544|NCT03302494|366253763|FG000|Overall Study|Withdrawal by Subject|10|||
106161545|NCT03302494|366253764|FG001|Overall Study|Withdrawal by Subject|2|||
106161546|NCT03302494|366253765|FG002|Overall Study|Withdrawal by Subject|9|||
106161547|NCT03302494|366253763|FG000|Overall Study|Study Terminated by Sponsor|32|||
106161548|NCT03302494|366253764|FG001|Overall Study|Study Terminated by Sponsor|29|||
106161549|NCT03302494|366253765|FG002|Overall Study|Study Terminated by Sponsor|30|||
106161550|NCT03302494|366253763|FG000|Overall Study|Physician Decision|1|||
106161551|NCT03302494|366253764|FG001|Overall Study|Physician Decision|0|||
106161552|NCT03302494|366253765|FG002|Overall Study|Physician Decision|1|||
106161553|NCT03302494|366253763|FG000|Overall Study|Lost to Follow-up|1|||
106161554|NCT03302494|366253764|FG001|Overall Study|Lost to Follow-up|3|||
106161555|NCT03302494|366253765|FG002|Overall Study|Lost to Follow-up|3|||
106161556|NCT03302494|366253763|FG000|Overall Study|Death|13|||
106161557|NCT03302494|366253764|FG001|Overall Study|Death|11|||
106161558|NCT03302494|366253765|FG002|Overall Study|Death|4|||
106161559|NCT03302494|366253763|FG000|Overall Study|Adverse Event|1|||
106161560|NCT03302494|366253764|FG001|Overall Study|Adverse Event|2|||
106161561|NCT03302494|366253765|FG002|Overall Study|Adverse Event|0|||
106161562|NCT03302494|366253763|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
106161563|NCT03302494|366253764|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
106161564|NCT03302494|366253765|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
106161565|NCT04359108|366253766|FG000|Overall Study|Withdrawal by Subject|1|||
106161566|NCT04359108|366253767|FG001|Overall Study|Withdrawal by Subject|0|||
106161567|NCT04359108|366253766|FG000|Overall Study|Unable or too feeble to walk independently|0|||
106161568|NCT04359108|366253767|FG001|Overall Study|Unable or too feeble to walk independently|2|||
106161569|NCT04359108|366253766|FG000|Overall Study|Argus II system stopped functioning|0|||
106161570|NCT04359108|366253767|FG001|Overall Study|Argus II system stopped functioning|1|||
106090017|NCT04808609|365989637|FG001|Overall Study|Lost to Follow-up|2|||
106161571|NCT04359108|366253766|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
106161572|NCT04359108|366253767|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
106161573|NCT03936322|366253768|FG000|Overall Study|Lost to Follow-up|1|||
106161574|NCT03936322|366253768|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
106161575|NCT02515773|366253769|FG000|Overall Study|Withdrawal by Subject|12|||
106161576|NCT02515773|366253770|FG001|Overall Study|Withdrawal by Subject|2|||
106161577|NCT02515773|366253769|FG000|Overall Study|Lost to Follow-up|119|||
106161578|NCT02515773|366253770|FG001|Overall Study|Lost to Follow-up|126|||
106090018|NCT04808609|365989636|FG000|Overall Study|Administrative Withdrawal|0|||
106090019|NCT04808609|365989637|FG001|Overall Study|Administrative Withdrawal|1|||
106090020|NCT01993719|365989638|FG000|First Drug Administration|Not treated|1|||
106161579|NCT02515773|366253769|FG000|Overall Study|Discharged from Clinic Services|53|||
106090021|NCT01993719|365989639|FG001|First Drug Administration|Not treated|0|||
106090022|NCT01993719|365989640|FG002|First Drug Administration|Not treated|0|||
106090023|NCT01993719|365989641|FG003|First Drug Administration|Not treated|0|||
106090024|NCT01993719|365989642|FG004|First Drug Administration|Not treated|0|||
106090025|NCT04382326|365989646|FG000|Overall Study|Adverse Event, not serious|1|||
106090026|NCT04382326|365989647|FG001|Overall Study|Adverse Event, not serious|2|||
106090027|NCT04382326|365989646|FG000|Overall Study|Other|1|||
106090028|NCT04382326|365989647|FG001|Overall Study|Other|0|||
106090029|NCT04382326|365989646|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
106090030|NCT04382326|365989647|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
106090031|NCT04382326|365989646|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
106090032|NCT04382326|365989647|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
106090033|NCT04382326|365989646|FG000|Overall Study|Protocol Violation|29|||
106090034|NCT04382326|365989647|FG001|Overall Study|Protocol Violation|23|||
106090035|NCT04382326|365989646|FG000|Overall Study|Physician Decision|0|||
106090036|NCT04382326|365989647|FG001|Overall Study|Physician Decision|1|||
106090037|NCT04382326|365989646|FG000|Overall Study|Lost to Follow-up|48|||
106090038|NCT04382326|365989647|FG001|Overall Study|Lost to Follow-up|63|||
106090039|NCT04382326|365989646|FG000|Overall Study|Adverse Event, non-fatal|1|||
106090040|NCT04382326|365989647|FG001|Overall Study|Adverse Event, non-fatal|1|||
106090041|NCT04067141|365989657|FG000|First Intervention|Withdrawal by Subject|0|||
106090042|NCT04067141|365989658|FG001|First Intervention|Withdrawal by Subject|1|||
106090043|NCT04067141|365989657|FG000|Second Intervention|Adverse Event|0|||
106090044|NCT04067141|365989658|FG001|Second Intervention|Adverse Event|2|||
106090045|NCT01038921|365989659|FG000|Overall Study|Withdrawal by Subject|1|||
106090046|NCT01038921|365989660|FG001|Overall Study|Withdrawal by Subject|0|||
106161580|NCT02515773|366253770|FG001|Overall Study|Discharged from Clinic Services|84|||
106161581|NCT02515773|366253769|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
106161582|NCT02515773|366253770|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
106161583|NCT02515773|366253769|FG000|Overall Study|Follow-up at non-study site|8|||
106161584|NCT02515773|366253770|FG001|Overall Study|Follow-up at non-study site|16|||
106161585|NCT02515773|366253769|FG000|Overall Study|Moved from area|9|||
106161586|NCT02515773|366253770|FG001|Overall Study|Moved from area|14|||
106161587|NCT01160211|366253771|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
106161588|NCT01160211|366253772|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
106161589|NCT01160211|366253773|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
106161590|NCT01160211|366253771|FG000|Overall Study|Lost to Follow-up|4|||
106161591|NCT01160211|366253772|FG001|Overall Study|Lost to Follow-up|8|||
106161592|NCT01160211|366253773|FG002|Overall Study|Lost to Follow-up|4|||
106161593|NCT01160211|366253771|FG000|Overall Study|Physician Decision|1|||
106161594|NCT01160211|366253772|FG001|Overall Study|Physician Decision|0|||
106161595|NCT01160211|366253773|FG002|Overall Study|Physician Decision|0|||
106161596|NCT01160211|366253771|FG000|Overall Study|Withdrawal by Subject|4|||
106161597|NCT01160211|366253772|FG001|Overall Study|Withdrawal by Subject|2|||
106161598|NCT01160211|366253773|FG002|Overall Study|Withdrawal by Subject|2|||
106161599|NCT01160211|366253771|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
106161600|NCT01160211|366253772|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
106161601|NCT01160211|366253773|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
106161602|NCT03719443|366253777|FG000|Overall Study|Lost to Follow-up|0|||
106161603|NCT03719443|366253778|FG001|Overall Study|Lost to Follow-up|0|||
106161604|NCT03719443|366253779|FG002|Overall Study|Lost to Follow-up|1|||
106161605|NCT03719443|366253780|FG003|Overall Study|Lost to Follow-up|0|||
106161606|NCT03719443|366253781|FG004|Overall Study|Lost to Follow-up|1|||
106161607|NCT03719443|366253782|FG005|Overall Study|Lost to Follow-up|0|||
106161608|NCT03719443|366253783|FG006|Overall Study|Lost to Follow-up|1|||
106161609|NCT03719443|366253777|FG000|Overall Study|Withdrawal by Subject|0|||
106161610|NCT03719443|366253778|FG001|Overall Study|Withdrawal by Subject|0|||
106090047|NCT01038921|365989659|FG000|Overall Study|Physician Decision|1|||
106090048|NCT01038921|365989660|FG001|Overall Study|Physician Decision|0|||
106090049|NCT01709227|365989661|FG000|Overall Study|Physician Decision|1|||
106090050|NCT01709227|365989662|FG001|Overall Study|Physician Decision|0|||
106161611|NCT03719443|366253779|FG002|Overall Study|Withdrawal by Subject|1|||
106161612|NCT03719443|366253780|FG003|Overall Study|Withdrawal by Subject|0|||
106161613|NCT03719443|366253781|FG004|Overall Study|Withdrawal by Subject|0|||
106090051|NCT01709227|365989661|FG000|Overall Study|Pleural Peritoneal communication|0|||
106090052|NCT01709227|365989662|FG001|Overall Study|Pleural Peritoneal communication|9|||
106090053|NCT01978119|365989663|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
106090054|NCT01978119|365989664|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
106161614|NCT03719443|366253782|FG005|Overall Study|Withdrawal by Subject|0|||
106161615|NCT03719443|366253783|FG006|Overall Study|Withdrawal by Subject|0|||
106090055|NCT01978119|365989663|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
106090056|NCT01978119|365989664|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
106090057|NCT01978119|365989663|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
106090058|NCT01978119|365989664|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
106090059|NCT03669081|365989665|FG000|Overall Study|Data could not be validated|1|||
106090060|NCT03669081|365989666|FG001|Overall Study|Data could not be validated|1|||
106090061|NCT02352493|365989667|FG000|Overall Study|Pregnancy|0|||
106090062|NCT02352493|365989668|FG001|Overall Study|Pregnancy|0|||
106090063|NCT02352493|365989669|FG002|Overall Study|Pregnancy|0|||
106090064|NCT02352493|365989670|FG003|Overall Study|Pregnancy|0|||
106090065|NCT02352493|365989671|FG004|Overall Study|Pregnancy|0|||
106090066|NCT02352493|365989672|FG005|Overall Study|Pregnancy|0|||
106090067|NCT02352493|365989673|FG006|Overall Study|Pregnancy|1|||
106090068|NCT02352493|365989674|FG007|Overall Study|Pregnancy|0|||
106090069|NCT02352493|365989675|FG008|Overall Study|Pregnancy|1|||
106090070|NCT02352493|365989676|FG009|Overall Study|Pregnancy|0|||
106090071|NCT02352493|365989677|FG010|Overall Study|Pregnancy|0|||
106090072|NCT02352493|365989678|FG011|Overall Study|Pregnancy|0|||
106090073|NCT02352493|365989679|FG012|Overall Study|Pregnancy|0|||
106090074|NCT02352493|365989680|FG013|Overall Study|Pregnancy|0|||
106090075|NCT02352493|365989681|FG014|Overall Study|Pregnancy|0|||
106090076|NCT02352493|365989682|FG015|Overall Study|Pregnancy|0|||
106090077|NCT02352493|365989683|FG016|Overall Study|Pregnancy|0|||
106090078|NCT02352493|365989684|FG017|Overall Study|Pregnancy|0|||
106090079|NCT02352493|365989667|FG000|Overall Study|Withdrawal by Subject|0|||
106090080|NCT02352493|365989668|FG001|Overall Study|Withdrawal by Subject|0|||
106090081|NCT02352493|365989669|FG002|Overall Study|Withdrawal by Subject|0|||
106090082|NCT02352493|365989670|FG003|Overall Study|Withdrawal by Subject|0|||
106090083|NCT02352493|365989671|FG004|Overall Study|Withdrawal by Subject|0|||
106090084|NCT02352493|365989672|FG005|Overall Study|Withdrawal by Subject|0|||
106090085|NCT02352493|365989673|FG006|Overall Study|Withdrawal by Subject|0|||
106090086|NCT02352493|365989674|FG007|Overall Study|Withdrawal by Subject|0|||
106090087|NCT02352493|365989675|FG008|Overall Study|Withdrawal by Subject|1|||
106090088|NCT02352493|365989676|FG009|Overall Study|Withdrawal by Subject|0|||
106090089|NCT02352493|365989677|FG010|Overall Study|Withdrawal by Subject|0|||
106090090|NCT02352493|365989678|FG011|Overall Study|Withdrawal by Subject|0|||
106090091|NCT02352493|365989679|FG012|Overall Study|Withdrawal by Subject|0|||
106090092|NCT02352493|365989680|FG013|Overall Study|Withdrawal by Subject|0|||
106090093|NCT02352493|365989681|FG014|Overall Study|Withdrawal by Subject|1|||
106090094|NCT02352493|365989682|FG015|Overall Study|Withdrawal by Subject|0|||
106090095|NCT02352493|365989683|FG016|Overall Study|Withdrawal by Subject|0|||
106090096|NCT02352493|365989684|FG017|Overall Study|Withdrawal by Subject|0|||
106090097|NCT02352493|365989667|FG000|Overall Study|Lost to Follow-up|0|||
106090098|NCT02352493|365989668|FG001|Overall Study|Lost to Follow-up|0|||
106090099|NCT02352493|365989669|FG002|Overall Study|Lost to Follow-up|0|||
106090100|NCT02352493|365989670|FG003|Overall Study|Lost to Follow-up|0|||
106090101|NCT02352493|365989671|FG004|Overall Study|Lost to Follow-up|0|||
106090102|NCT02352493|365989672|FG005|Overall Study|Lost to Follow-up|0|||
106090103|NCT02352493|365989673|FG006|Overall Study|Lost to Follow-up|0|||
106090104|NCT02352493|365989674|FG007|Overall Study|Lost to Follow-up|0|||
106090105|NCT02352493|365989675|FG008|Overall Study|Lost to Follow-up|0|||
106090106|NCT02352493|365989676|FG009|Overall Study|Lost to Follow-up|1|||
106090107|NCT02352493|365989677|FG010|Overall Study|Lost to Follow-up|0|||
106090108|NCT02352493|365989678|FG011|Overall Study|Lost to Follow-up|0|||
106090109|NCT02352493|365989679|FG012|Overall Study|Lost to Follow-up|1|||
106090110|NCT02352493|365989680|FG013|Overall Study|Lost to Follow-up|2|||
106090111|NCT02352493|365989681|FG014|Overall Study|Lost to Follow-up|0|||
106090112|NCT02352493|365989682|FG015|Overall Study|Lost to Follow-up|0|||
106090113|NCT02352493|365989683|FG016|Overall Study|Lost to Follow-up|0|||
106090114|NCT02352493|365989684|FG017|Overall Study|Lost to Follow-up|0|||
106090115|NCT03295201|365989685|FG000|Overall Study|Lost to Follow-up|1|||
106090116|NCT03295201|365989686|FG001|Overall Study|Lost to Follow-up|1|||
106090117|NCT03295201|365989685|FG000|Overall Study|Hospital admission|0|||
106090118|NCT03295201|365989686|FG001|Overall Study|Hospital admission|1|||
106090119|NCT00389324|365989687|FG000|Run-In Phase|Adverse Event|1|||
106090120|NCT00389324|365989687|FG000|Run-In Phase|Lost to Follow-up|1|||
106090121|NCT00389324|365989687|FG000|Run-In Phase|Withdrawal by Subject|1|||
106090122|NCT00389324|365989687|FG000|Subcutaneous Phase|Adverse Event|2|||
106090123|NCT00389324|365989687|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
106090124|NCT00389324|365989687|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
106090125|NCT00389324|365989687|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
106090126|NCT04327934|365989688|FG000|Overall Study|Did not qualify|7|||
106090127|NCT04327934|365989689|FG001|Overall Study|Did not qualify|4|||
106090128|NCT04327934|365989688|FG000|Overall Study|Physician Decision|0|||
106090129|NCT04327934|365989689|FG001|Overall Study|Physician Decision|1|||
106090130|NCT00840970|365989690|FG000|Overall Study|Adverse Event|0|||
106090131|NCT00840970|365989691|FG001|Overall Study|Adverse Event|0|||
106090132|NCT00840970|365989692|FG002|Overall Study|Adverse Event|1|||
106090133|NCT01877421|365989693|FG000|Phase 2|Lost to Follow-up|0|||
106090134|NCT01877421|365989694|FG001|Phase 2|Lost to Follow-up|0|||
106090135|NCT01877421|365989695|FG002|Phase 2|Lost to Follow-up|0|||
106090136|NCT01877421|365989696|FG003|Phase 2|Lost to Follow-up|0|||
106090137|NCT01877421|365989697|FG004|Phase 2|Lost to Follow-up|0|||
106090138|NCT01877421|365989698|FG005|Phase 2|Lost to Follow-up|0|||
106090139|NCT01877421|365989699|FG006|Phase 2|Lost to Follow-up|1|||
106090140|NCT01877421|365989700|FG007|Phase 2|Lost to Follow-up|0|||
106090141|NCT01877421|365989701|FG008|Phase 2|Lost to Follow-up|0|||
106090142|NCT01877421|365989702|FG009|Phase 2|Lost to Follow-up|0|||
106090143|NCT01877421|365989703|FG010|Phase 2|Lost to Follow-up|0|||
106090144|NCT01877421|365989704|FG011|Phase 2|Lost to Follow-up|0|||
106090145|NCT01877421|365989705|FG012|Phase 2|Lost to Follow-up|0|||
106090146|NCT01877421|365989706|FG013|Phase 2|Lost to Follow-up|0|||
106090147|NCT01877421|365989707|FG014|Phase 2|Lost to Follow-up|0|||
106090148|NCT01877421|365989708|FG015|Phase 2|Lost to Follow-up|0|||
106090149|NCT01877421|365989709|FG016|Phase 2|Lost to Follow-up|0|||
106090150|NCT01877421|365989710|FG017|Phase 2|Lost to Follow-up|0|||
106090151|NCT01877421|365989693|FG000|Phase 2|Withdrawal by Subject|0|||
106090152|NCT01877421|365989694|FG001|Phase 2|Withdrawal by Subject|0|||
106090153|NCT01877421|365989695|FG002|Phase 2|Withdrawal by Subject|0|||
106090154|NCT01877421|365989696|FG003|Phase 2|Withdrawal by Subject|0|||
106090155|NCT01877421|365989697|FG004|Phase 2|Withdrawal by Subject|0|||
106090156|NCT01877421|365989698|FG005|Phase 2|Withdrawal by Subject|0|||
106090157|NCT01877421|365989699|FG006|Phase 2|Withdrawal by Subject|0|||
106090158|NCT01877421|365989700|FG007|Phase 2|Withdrawal by Subject|0|||
106090159|NCT01877421|365989701|FG008|Phase 2|Withdrawal by Subject|1|||
106090160|NCT01877421|365989702|FG009|Phase 2|Withdrawal by Subject|0|||
106090161|NCT01877421|365989703|FG010|Phase 2|Withdrawal by Subject|1|||
106090162|NCT01877421|365989704|FG011|Phase 2|Withdrawal by Subject|0|||
106090163|NCT01877421|365989705|FG012|Phase 2|Withdrawal by Subject|1|||
106090164|NCT01877421|365989706|FG013|Phase 2|Withdrawal by Subject|0|||
106090165|NCT01877421|365989707|FG014|Phase 2|Withdrawal by Subject|0|||
106090166|NCT01877421|365989708|FG015|Phase 2|Withdrawal by Subject|1|||
106090167|NCT01877421|365989709|FG016|Phase 2|Withdrawal by Subject|0|||
106090168|NCT01877421|365989710|FG017|Phase 2|Withdrawal by Subject|0|||
106090169|NCT01877421|365989693|FG000|Phase 2|Protocol Violation|0|||
106090170|NCT01877421|365989694|FG001|Phase 2|Protocol Violation|0|||
106090171|NCT01877421|365989695|FG002|Phase 2|Protocol Violation|0|||
106090172|NCT01877421|365989696|FG003|Phase 2|Protocol Violation|0|||
106090173|NCT01877421|365989697|FG004|Phase 2|Protocol Violation|0|||
106090174|NCT01877421|365989698|FG005|Phase 2|Protocol Violation|0|||
106090175|NCT01877421|365989699|FG006|Phase 2|Protocol Violation|0|||
106090176|NCT01877421|365989700|FG007|Phase 2|Protocol Violation|0|||
106090177|NCT01877421|365989701|FG008|Phase 2|Protocol Violation|0|||
106090178|NCT01877421|365989702|FG009|Phase 2|Protocol Violation|0|||
106090179|NCT01877421|365989703|FG010|Phase 2|Protocol Violation|1|||
106090180|NCT01877421|365989704|FG011|Phase 2|Protocol Violation|0|||
106090181|NCT01877421|365989705|FG012|Phase 2|Protocol Violation|0|||
106090182|NCT01877421|365989706|FG013|Phase 2|Protocol Violation|0|||
106090183|NCT01877421|365989707|FG014|Phase 2|Protocol Violation|0|||
106090184|NCT01877421|365989708|FG015|Phase 2|Protocol Violation|0|||
106090185|NCT01877421|365989709|FG016|Phase 2|Protocol Violation|0|||
106090186|NCT01877421|365989710|FG017|Phase 2|Protocol Violation|0|||
106090187|NCT01485861|365989711|FG000|Phase Ib|Death|1|||
106090188|NCT01485861|365989712|FG001|Phase Ib|Death|0|||
106090189|NCT01485861|365989713|FG002|Phase Ib|Death|0|||
106090190|NCT01485861|365989714|FG003|Phase Ib|Death|0|||
106090191|NCT01485861|365989715|FG004|Phase Ib|Death|0|||
106090192|NCT01485861|365989716|FG005|Phase Ib|Death|0|||
106090193|NCT01485861|365989711|FG000|Phase Ib|Physician Decision|1|||
106090194|NCT01485861|365989712|FG001|Phase Ib|Physician Decision|1|||
106090195|NCT01485861|365989713|FG002|Phase Ib|Physician Decision|0|||
106090196|NCT01485861|365989714|FG003|Phase Ib|Physician Decision|0|||
106090197|NCT01485861|365989715|FG004|Phase Ib|Physician Decision|0|||
106090198|NCT01485861|365989716|FG005|Phase Ib|Physician Decision|0|||
106090199|NCT01485861|365989711|FG000|Phase Ib|Adverse Event|0|||
106090200|NCT01485861|365989712|FG001|Phase Ib|Adverse Event|4|||
106090201|NCT01485861|365989713|FG002|Phase Ib|Adverse Event|0|||
106090202|NCT01485861|365989714|FG003|Phase Ib|Adverse Event|0|||
106090203|NCT01485861|365989715|FG004|Phase Ib|Adverse Event|0|||
106090204|NCT01485861|365989716|FG005|Phase Ib|Adverse Event|0|||
106161616|NCT06205407|366253784|FG000|Period 2|Withdrawal by Subject|0|||
106161617|NCT06205407|366253785|FG001|Period 2|Withdrawal by Subject|1|||
106161618|NCT06205407|366253784|FG000|Period 2|Adverse Event|2|||
106161619|NCT06205407|366253785|FG001|Period 2|Adverse Event|1|||
106161620|NCT04516967|366253786|FG000|Core Phase|Adverse Event|2|||
106161621|NCT04516967|366253787|FG001|Core Phase|Adverse Event|1|||
106161622|NCT04516967|366253788|FG002|Core Phase|Adverse Event|0|||
106161623|NCT04516967|366253786|FG000|Core Phase|Physician Decision|1|||
106161624|NCT04516967|366253787|FG001|Core Phase|Physician Decision|1|||
106090205|NCT01485861|365989711|FG000|Phase Ib|Progression of disease|5|||
106090206|NCT01485861|365989712|FG001|Phase Ib|Progression of disease|0|||
106090207|NCT01485861|365989713|FG002|Phase Ib|Progression of disease|0|||
106090208|NCT01485861|365989714|FG003|Phase Ib|Progression of disease|0|||
106090209|NCT01485861|365989715|FG004|Phase Ib|Progression of disease|0|||
106090210|NCT01485861|365989716|FG005|Phase Ib|Progression of disease|0|||
106090211|NCT01485861|365989711|FG000|Phase Ib|Other|3|||
106090212|NCT01485861|365989712|FG001|Phase Ib|Other|0|||
106090213|NCT01485861|365989713|FG002|Phase Ib|Other|0|||
106090214|NCT01485861|365989714|FG003|Phase Ib|Other|0|||
106090215|NCT01485861|365989715|FG004|Phase Ib|Other|0|||
106161625|NCT04516967|366253788|FG002|Core Phase|Physician Decision|0|||
106161626|NCT04516967|366253786|FG000|Core Phase|Lack of Efficacy|7|||
106161627|NCT04516967|366253787|FG001|Core Phase|Lack of Efficacy|18|||
106161628|NCT04516967|366253788|FG002|Core Phase|Lack of Efficacy|0|||
106161629|NCT04676022|366253789|FG000|Overall Study|Screen Failure/|1|||
106161630|NCT04676022|366253790|FG001|Overall Study|Screen Failure/|1|||
106161631|NCT04676022|366253791|FG002|Overall Study|Screen Failure/|85|||
106161632|NCT04676022|366253789|FG000|Overall Study|Lost to Follow-up|1|||
106161633|NCT04676022|366253790|FG001|Overall Study|Lost to Follow-up|1|||
106161634|NCT04676022|366253791|FG002|Overall Study|Lost to Follow-up|0|||
106161635|NCT04676022|366253789|FG000|Overall Study|Adverse Event|2|||
106161636|NCT04676022|366253790|FG001|Overall Study|Adverse Event|0|||
106161637|NCT04676022|366253791|FG002|Overall Study|Adverse Event|1|||
106161638|NCT04676022|366253789|FG000|Overall Study|Physician Decision|2|||
106161639|NCT04676022|366253790|FG001|Overall Study|Physician Decision|0|||
106161640|NCT04676022|366253791|FG002|Overall Study|Physician Decision|1|||
106161641|NCT04676022|366253789|FG000|Overall Study|Withdrawal by Subject|3|||
106161642|NCT04676022|366253790|FG001|Overall Study|Withdrawal by Subject|1|||
106161643|NCT04676022|366253791|FG002|Overall Study|Withdrawal by Subject|6|||
106161644|NCT04676022|366253789|FG000|Overall Study|Will not move forward with permanent implant|6|||
106161645|NCT04676022|366253790|FG001|Overall Study|Will not move forward with permanent implant|0|||
106161646|NCT04676022|366253791|FG002|Overall Study|Will not move forward with permanent implant|0|||
106161647|NCT04676022|366253789|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
106161648|NCT04676022|366253790|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
106161649|NCT04676022|366253791|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
106161650|NCT05409183|366253792|FG000|Complete Study|Adverse Event|1|||
106161651|NCT05409183|366253793|FG001|Complete Study|Adverse Event|2|||
106161652|NCT05409183|366253792|FG000|Complete Study|Withdrawal by Subject|3|||
106161653|NCT05409183|366253793|FG001|Complete Study|Withdrawal by Subject|0|||
106161654|NCT02936752|366253794|FG000|Overall Study|Death|2|||
106161655|NCT02936752|366253795|FG001|Overall Study|Death|1|||
106161656|NCT02936752|366253794|FG000|Overall Study|Physician Decision|4|||
106161657|NCT02936752|366253795|FG001|Overall Study|Physician Decision|0|||
106161658|NCT02936752|366253794|FG000|Overall Study|Withdrawal by Subject|0|||
106161659|NCT02936752|366253795|FG001|Overall Study|Withdrawal by Subject|2|||
106161660|NCT05292365|366253802|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
106161661|NCT05292365|366253803|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
106161662|NCT05292365|366253804|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
106161663|NCT05292365|366253805|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
106161664|NCT06516705|366253817|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
106161665|NCT06516705|366253818|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
106161666|NCT06516705|366253817|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
106161667|NCT06516705|366253818|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
106161668|NCT06516705|366253817|FG000|T3 ( 3 Month After Education)|covid-19|1|||
106161669|NCT06516705|366253818|FG001|T3 ( 3 Month After Education)|covid-19|2|||
106161670|NCT06516705|366253817|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
106161671|NCT06516705|366253818|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
106161672|NCT06516705|366253817|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
106161673|NCT06516705|366253818|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
106161674|NCT06516705|366253817|FG000|T4 ( 6 Month After Education)|covid-19|3|||
106161675|NCT06516705|366253818|FG001|T4 ( 6 Month After Education)|covid-19|2|||
106161676|NCT06516705|366253817|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
106161677|NCT06516705|366253818|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
106161678|NCT05579899|366253820|FG000|Overall Study|Lost to Follow-up|3|||
106161679|NCT05579899|366253821|FG001|Overall Study|Lost to Follow-up|1|||
106161680|NCT05579899|366253820|FG000|Overall Study|Adverse Event|0|||
106161681|NCT05579899|366253821|FG001|Overall Study|Adverse Event|3|||
106161682|NCT05579899|366253820|FG000|Overall Study|Pregnancy|0|||
106161683|NCT05579899|366253821|FG001|Overall Study|Pregnancy|1|||
106161684|NCT05579899|366253820|FG000|Overall Study|Withdrawal by Subject|0|||
106161685|NCT05579899|366253821|FG001|Overall Study|Withdrawal by Subject|3|||
106161686|NCT03199469|366253826|FG000|Overall Study|Randomized, not treated|0|||
106161687|NCT03199469|366253827|FG001|Overall Study|Randomized, not treated|3|||
106161688|NCT03199469|366253826|FG000|Overall Study|Withdrawal by Subject|1|||
106161689|NCT03199469|366253827|FG001|Overall Study|Withdrawal by Subject|0|||
106161690|NCT03199469|366253826|FG000|Overall Study|Death|1|||
106161691|NCT03199469|366253827|FG001|Overall Study|Death|3|||
106161692|NCT03199469|366253826|FG000|Overall Study|Ongoing|5|||
106161693|NCT03199469|366253827|FG001|Overall Study|Ongoing|14|||
106161694|NCT03307343|366253828|FG000|Overall Study|Withdrawal by Subject|1|||
106161695|NCT03307343|366253829|FG001|Overall Study|Withdrawal by Subject|2|||
106161696|NCT03307343|366253828|FG000|Overall Study|Pregnancy|0|||
106161697|NCT03307343|366253829|FG001|Overall Study|Pregnancy|2|||
106161698|NCT03307343|366253828|FG000|Overall Study|Physician Decision|1|||
106090216|NCT01485861|365989716|FG005|Phase Ib|Other|0|||
106090217|NCT01485861|365989711|FG000|Phase Ib|Withdrawal by Subject|4|||
106090218|NCT01485861|365989712|FG001|Phase Ib|Withdrawal by Subject|1|||
106090219|NCT01485861|365989713|FG002|Phase Ib|Withdrawal by Subject|0|||
106090220|NCT01485861|365989714|FG003|Phase Ib|Withdrawal by Subject|0|||
106090221|NCT01485861|365989715|FG004|Phase Ib|Withdrawal by Subject|0|||
106090222|NCT01485861|365989716|FG005|Phase Ib|Withdrawal by Subject|0|||
106090223|NCT01485861|365989711|FG000|Phase II|Death|0|||
106090224|NCT01485861|365989712|FG001|Phase II|Death|0|||
106090225|NCT01485861|365989713|FG002|Phase II|Death|67|||
106090226|NCT01485861|365989714|FG003|Phase II|Death|71|||
106090227|NCT01485861|365989715|FG004|Phase II|Death|68|||
106090228|NCT01485861|365989716|FG005|Phase II|Death|0|||
106090229|NCT01485861|365989711|FG000|Phase II|Progression of Disease|0|||
106090230|NCT01485861|365989712|FG001|Phase II|Progression of Disease|0|||
106090231|NCT01485861|365989713|FG002|Phase II|Progression of Disease|1|||
106090232|NCT01485861|365989714|FG003|Phase II|Progression of Disease|0|||
106090233|NCT01485861|365989715|FG004|Phase II|Progression of Disease|0|||
106090234|NCT01485861|365989716|FG005|Phase II|Progression of Disease|0|||
106090235|NCT01485861|365989711|FG000|Phase II|Other|0|||
106090236|NCT01485861|365989712|FG001|Phase II|Other|0|||
106090237|NCT01485861|365989713|FG002|Phase II|Other|0|||
106090238|NCT01485861|365989714|FG003|Phase II|Other|1|||
106090239|NCT01485861|365989715|FG004|Phase II|Other|0|||
106090240|NCT01485861|365989716|FG005|Phase II|Other|0|||
106090241|NCT01485861|365989711|FG000|Phase II|Withdrawal by Subject|0|||
106090242|NCT01485861|365989712|FG001|Phase II|Withdrawal by Subject|0|||
106090243|NCT01485861|365989713|FG002|Phase II|Withdrawal by Subject|6|||
106090244|NCT01485861|365989714|FG003|Phase II|Withdrawal by Subject|3|||
106090245|NCT01485861|365989715|FG004|Phase II|Withdrawal by Subject|4|||
106090246|NCT01485861|365989716|FG005|Phase II|Withdrawal by Subject|0|||
106090247|NCT01485861|365989711|FG000|Phase II|Lost to Follow-up|0|||
106090248|NCT01485861|365989712|FG001|Phase II|Lost to Follow-up|0|||
106090249|NCT01485861|365989713|FG002|Phase II|Lost to Follow-up|2|||
106090250|NCT01485861|365989714|FG003|Phase II|Lost to Follow-up|3|||
106090251|NCT01485861|365989715|FG004|Phase II|Lost to Follow-up|5|||
106090252|NCT01485861|365989716|FG005|Phase II|Lost to Follow-up|0|||
106090253|NCT01485861|365989711|FG000|Phase II|Study Ended|0|||
106090254|NCT01485861|365989712|FG001|Phase II|Study Ended|0|||
106090255|NCT01485861|365989713|FG002|Phase II|Study Ended|7|||
106090256|NCT01485861|365989714|FG003|Phase II|Study Ended|8|||
106090257|NCT01485861|365989715|FG004|Phase II|Study Ended|6|||
106090258|NCT01485861|365989716|FG005|Phase II|Study Ended|0|||
106090259|NCT01485861|365989711|FG000|Safety Phase|Death|0|||
106090260|NCT01485861|365989712|FG001|Safety Phase|Death|0|||
106090261|NCT01485861|365989713|FG002|Safety Phase|Death|0|||
106090262|NCT01485861|365989714|FG003|Safety Phase|Death|0|||
106090263|NCT01485861|365989715|FG004|Safety Phase|Death|0|||
106090264|NCT01485861|365989716|FG005|Safety Phase|Death|2|||
106090265|NCT01485861|365989711|FG000|Safety Phase|Adverse Event|0|||
106090266|NCT01485861|365989712|FG001|Safety Phase|Adverse Event|0|||
106090267|NCT01485861|365989713|FG002|Safety Phase|Adverse Event|0|||
106090268|NCT01485861|365989714|FG003|Safety Phase|Adverse Event|0|||
106090269|NCT01485861|365989715|FG004|Safety Phase|Adverse Event|0|||
106090270|NCT01485861|365989716|FG005|Safety Phase|Adverse Event|1|||
106090271|NCT01485861|365989711|FG000|Safety Phase|Other|0|||
106090272|NCT01485861|365989712|FG001|Safety Phase|Other|0|||
106090273|NCT01485861|365989713|FG002|Safety Phase|Other|0|||
106090274|NCT01485861|365989714|FG003|Safety Phase|Other|0|||
106090275|NCT01485861|365989715|FG004|Safety Phase|Other|0|||
106090276|NCT01485861|365989716|FG005|Safety Phase|Other|5|||
106090277|NCT01485861|365989711|FG000|Safety Phase|Progression of Disease|0|||
106090278|NCT01485861|365989712|FG001|Safety Phase|Progression of Disease|0|||
106090279|NCT01485861|365989713|FG002|Safety Phase|Progression of Disease|0|||
106090280|NCT01485861|365989714|FG003|Safety Phase|Progression of Disease|0|||
106090281|NCT01485861|365989715|FG004|Safety Phase|Progression of Disease|0|||
106090282|NCT01485861|365989716|FG005|Safety Phase|Progression of Disease|9|||
106090283|NCT01485861|365989711|FG000|Safety Phase|Withdrawal by Subject|0|||
106090284|NCT01485861|365989712|FG001|Safety Phase|Withdrawal by Subject|0|||
106090285|NCT01485861|365989713|FG002|Safety Phase|Withdrawal by Subject|0|||
106090286|NCT01485861|365989714|FG003|Safety Phase|Withdrawal by Subject|0|||
106090287|NCT01485861|365989715|FG004|Safety Phase|Withdrawal by Subject|0|||
106090288|NCT01485861|365989716|FG005|Safety Phase|Withdrawal by Subject|6|||
106090289|NCT01485861|365989711|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
106090290|NCT01485861|365989712|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
106090291|NCT01485861|365989713|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
106090292|NCT01485861|365989714|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
106090293|NCT01485861|365989715|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
106161699|NCT03307343|366253829|FG001|Overall Study|Physician Decision|0|||
106161700|NCT03307343|366253828|FG000|Overall Study|Lost to Follow-up|0|||
106161701|NCT03307343|366253829|FG001|Overall Study|Lost to Follow-up|2|||
106161702|NCT03241745|366253830|FG000|Overall Study|Adverse Event|7|||
106161703|NCT03241745|366253830|FG000|Overall Study|Death|1|||
106161704|NCT03241745|366253830|FG000|Overall Study|Withdrawal by Subject|5|||
106161705|NCT03241745|366253830|FG000|Overall Study|Treatment delay >28 days|2|||
106161706|NCT03241745|366253830|FG000|Overall Study|Lack of Efficacy|14|||
106161707|NCT03524118|366253831|FG000|Overall Study|Lost to Follow-up|0|||
106161708|NCT03524118|366253832|FG001|Overall Study|Lost to Follow-up|0|||
106161709|NCT03524118|366253833|FG002|Overall Study|Lost to Follow-up|0|||
106161710|NCT03524118|366253834|FG003|Overall Study|Lost to Follow-up|0|||
106161711|NCT03524118|366253835|FG004|Overall Study|Lost to Follow-up|1|||
106161712|NCT03524118|366253836|FG005|Overall Study|Lost to Follow-up|0|||
106161713|NCT03524118|366253831|FG000|Overall Study|Other|0|||
106161714|NCT03524118|366253832|FG001|Overall Study|Other|1|||
106161715|NCT03524118|366253833|FG002|Overall Study|Other|0|||
106161716|NCT03524118|366253834|FG003|Overall Study|Other|0|||
106161717|NCT03524118|366253835|FG004|Overall Study|Other|1|||
106161718|NCT03524118|366253836|FG005|Overall Study|Other|1|||
106161719|NCT03524118|366253831|FG000|Overall Study|Physician Decision|0|||
106161720|NCT03524118|366253832|FG001|Overall Study|Physician Decision|0|||
106161721|NCT03524118|366253833|FG002|Overall Study|Physician Decision|0|||
106161722|NCT03524118|366253834|FG003|Overall Study|Physician Decision|0|||
106161723|NCT03524118|366253835|FG004|Overall Study|Physician Decision|1|||
106161724|NCT03524118|366253836|FG005|Overall Study|Physician Decision|0|||
106161725|NCT03524118|366253831|FG000|Overall Study|Protocol Violation|0|||
106161726|NCT03524118|366253832|FG001|Overall Study|Protocol Violation|0|||
106161727|NCT03524118|366253833|FG002|Overall Study|Protocol Violation|1|||
106161728|NCT03524118|366253834|FG003|Overall Study|Protocol Violation|0|||
106161729|NCT03524118|366253835|FG004|Overall Study|Protocol Violation|1|||
106161730|NCT03524118|366253836|FG005|Overall Study|Protocol Violation|0|||
106161731|NCT03524118|366253831|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
106161732|NCT03524118|366253832|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
106161733|NCT03524118|366253833|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
106161734|NCT03524118|366253834|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
106161735|NCT03524118|366253835|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
106161736|NCT03524118|366253836|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
106161737|NCT04624633|366253842|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
106161738|NCT04624633|366253843|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
106161739|NCT04624633|366253842|FG000|Overall Study|Death|1|||
106161740|NCT04624633|366253843|FG001|Overall Study|Death|0|||
106161741|NCT04316871|366253844|FG000|Overall Study|Protocol Violation|2|||
106161742|NCT04316871|366253845|FG001|Overall Study|Protocol Violation|2|||
106161743|NCT04316871|366253846|FG002|Overall Study|Protocol Violation|2|||
106161744|NCT04316871|366253847|FG003|Overall Study|Protocol Violation|2|||
105867253|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
106161745|NCT04650269|366253848|FG000|Overall Study|Death|3|||
106161746|NCT04650269|366253848|FG000|Overall Study|Lost to Follow-up|6|||
106161747|NCT01437709|366253849|FG000|Overall Study|Adverse Event|0|||
106161748|NCT01437709|366253850|FG001|Overall Study|Adverse Event|1|||
106161749|NCT01437709|366253851|FG002|Overall Study|Adverse Event|0|||
106161750|NCT01437709|366253849|FG000|Overall Study|Pt trasnferred care|0|||
106161751|NCT01437709|366253850|FG001|Overall Study|Pt trasnferred care|1|||
106161752|NCT01437709|366253851|FG002|Overall Study|Pt trasnferred care|0|||
106161753|NCT01824394|366253852|FG000|Overall Study|Early Termination|1|||
106161754|NCT01824394|366253853|FG001|Overall Study|Early Termination|1|||
106161755|NCT01824394|366253854|FG002|Overall Study|Early Termination|3|||
106090294|NCT01485861|365989716|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
106090295|NCT00724451|365989720|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
106090296|NCT00724451|365989720|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
106090297|NCT00724451|365989720|FG000|Overall Study|Not Eligible for Treatment|431|||
106090298|NCT00724451|365989720|FG000|Overall Study|Participant Refused Treatment|89|||
106090299|NCT00724451|365989720|FG000|Overall Study|Never Started Treatment|89|||
106090300|NCT00724451|365989720|FG000|Overall Study|Unknown; No Data Sources Available|9|||
106090301|NCT00724451|365989720|FG000|Overall Study|Physician Decision|116|||
106090302|NCT00724451|365989720|FG000|Overall Study|Withdrawal by Subject|45|||
106090303|NCT00724451|365989720|FG000|Overall Study|Investigator + Participant Decision|13|||
106090304|NCT01632800|365989721|FG000|Overall Study|Subject did not fit in apparatus|1|||
106090305|NCT01260922|365989722|FG000|First Intervention|Withdrawal by Subject|0|||
106090306|NCT01260922|365989723|FG001|First Intervention|Withdrawal by Subject|1|||
106090307|NCT01260922|365989722|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
106090308|NCT01260922|365989723|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
106090309|NCT01260922|365989722|FG000|Second Intervention|Emesis|0|||
106090310|NCT01260922|365989723|FG001|Second Intervention|Emesis|2|||
106090311|NCT02266381|365989724|FG000|Overall Study|Physician Decision|3|||
106090312|NCT02266381|365989725|FG001|Overall Study|Physician Decision|5|||
106090313|NCT02266381|365989726|FG002|Overall Study|Physician Decision|4|||
106090314|NCT01459796|365989727|FG000|Overall Study|Non compliance with protocol|2|||
106090315|NCT01459796|365989728|FG001|Overall Study|Non compliance with protocol|4|||
106090316|NCT01459796|365989727|FG000|Overall Study|Adverse Event|5|||
106090317|NCT01459796|365989728|FG001|Overall Study|Adverse Event|5|||
106090318|NCT01459796|365989727|FG000|Overall Study|Withdrawal by Subject|6|||
106090319|NCT01459796|365989728|FG001|Overall Study|Withdrawal by Subject|3|||
106090320|NCT01459796|365989727|FG000|Overall Study|Lost to Follow-up|5|||
106090321|NCT01459796|365989728|FG001|Overall Study|Lost to Follow-up|4|||
106090322|NCT01459796|365989727|FG000|Overall Study|Reason unspecified|1|||
106090323|NCT01459796|365989728|FG001|Overall Study|Reason unspecified|2|||
106090324|NCT01459796|365989727|FG000|Overall Study|Decision by the sponsor|75|||
106090325|NCT01459796|365989728|FG001|Overall Study|Decision by the sponsor|108|||
106090326|NCT03433456|365989729|FG000|Overall Study|Death|1|||
106090327|NCT03433456|365989730|FG001|Overall Study|Death|1|||
106090328|NCT03433456|365989729|FG000|Overall Study|Lost to Follow-up|14|||
106090329|NCT03433456|365989730|FG001|Overall Study|Lost to Follow-up|11|||
106090330|NCT03433456|365989729|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
106090331|NCT03433456|365989730|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
106090332|NCT01669343|365989735|FG000|Part A: All Patients|Withdrawal by Subject|7|||
106090333|NCT01669343|365989735|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
106090334|NCT01669343|365989735|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
106090335|NCT01669343|365989735|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
106090336|NCT01669343|365989735|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
106090337|NCT03791398|365989742|FG000|Overall Study|Progression of Disease Under Study|2|||
106090338|NCT03791398|365989743|FG001|Overall Study|Progression of Disease Under Study|0|||
106090339|NCT03791398|365989744|FG002|Overall Study|Progression of Disease Under Study|0|||
106090340|NCT03135522|365989749|FG000|Overall Study|Adverse Event|1|||
106090341|NCT03135522|365989750|FG001|Overall Study|Adverse Event|0|||
106090342|NCT02752048|365989751|FG000|Overall Study|Withdrawal by Subject|0|||
106090343|NCT02752048|365989752|FG001|Overall Study|Withdrawal by Subject|0|||
106090344|NCT02752048|365989753|FG002|Overall Study|Withdrawal by Subject|3|||
106090345|NCT01431508|365989756|FG000|Overall Study|Lack of Efficacy|1|||
106090346|NCT01431508|365989756|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
106090347|NCT02758236|365989759|FG000|Overall Study|Investigator discretion|43|||
106090348|NCT03099382|365989760|FG000|Overall Study|Protocol Violation|2|||
106090349|NCT03099382|365989761|FG001|Overall Study|Protocol Violation|3|||
106090350|NCT00499369|365989762|FG000|Overall Study|Adverse Event|2|||
106090351|NCT00499369|365989763|FG001|Overall Study|Adverse Event|2|||
106090352|NCT00499369|365989764|FG002|Overall Study|Adverse Event|3|||
106090353|NCT00499369|365989765|FG003|Overall Study|Adverse Event|1|||
106090354|NCT00499369|365989766|FG004|Overall Study|Adverse Event|2|||
106090355|NCT00499369|365989762|FG000|Overall Study|Withdrawal by Subject|0|||
106090356|NCT00499369|365989763|FG001|Overall Study|Withdrawal by Subject|1|||
106090357|NCT00499369|365989764|FG002|Overall Study|Withdrawal by Subject|1|||
106090358|NCT00499369|365989765|FG003|Overall Study|Withdrawal by Subject|0|||
106090359|NCT00499369|365989766|FG004|Overall Study|Withdrawal by Subject|0|||
106090360|NCT00499369|365989762|FG000|Overall Study|Progression|10|||
106090361|NCT00499369|365989763|FG001|Overall Study|Progression|12|||
106090362|NCT00499369|365989764|FG002|Overall Study|Progression|9|||
106090363|NCT00499369|365989765|FG003|Overall Study|Progression|6|||
106090364|NCT00499369|365989766|FG004|Overall Study|Progression|10|||
106090365|NCT00499369|365989762|FG000|Overall Study|Death|0|||
106090366|NCT00499369|365989763|FG001|Overall Study|Death|1|||
106090367|NCT00499369|365989764|FG002|Overall Study|Death|0|||
106090368|NCT00499369|365989765|FG003|Overall Study|Death|0|||
106090369|NCT00499369|365989766|FG004|Overall Study|Death|0|||
106161756|NCT01824394|366253852|FG000|Overall Study|Withdrawn due to Study Termination|91|||
106161757|NCT01824394|366253853|FG001|Overall Study|Withdrawn due to Study Termination|83|||
106161758|NCT01824394|366253854|FG002|Overall Study|Withdrawn due to Study Termination|41|||
106161759|NCT01824394|366253852|FG000|Overall Study|Lost to Follow-up|0|||
106161760|NCT01824394|366253853|FG001|Overall Study|Lost to Follow-up|9|||
106161761|NCT01824394|366253854|FG002|Overall Study|Lost to Follow-up|3|||
106161762|NCT01824394|366253852|FG000|Overall Study|Death|3|||
106161763|NCT01824394|366253853|FG001|Overall Study|Death|2|||
106161764|NCT01824394|366253854|FG002|Overall Study|Death|4|||
106161765|NCT01824394|366253852|FG000|Overall Study|Discontinued Subjects|1|||
106161766|NCT01824394|366253853|FG001|Overall Study|Discontinued Subjects|1|||
106161767|NCT01824394|366253854|FG002|Overall Study|Discontinued Subjects|2|||
106161768|NCT01824394|366253852|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
106161769|NCT01824394|366253853|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
106161770|NCT01824394|366253854|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
106161771|NCT01987895|366253858|FG000|Overall Study|Withdrawal by Subject|12|||
106161772|NCT01987895|366253859|FG001|Overall Study|Withdrawal by Subject|7|||
106161773|NCT01987895|366253858|FG000|Overall Study|Physician Decision|8|||
106161774|NCT01987895|366253859|FG001|Overall Study|Physician Decision|10|||
106161775|NCT01987895|366253858|FG000|Overall Study|Death|7|||
106161776|NCT01987895|366253859|FG001|Overall Study|Death|7|||
106161777|NCT01987895|366253858|FG000|Overall Study|Lost to Follow-up|3|||
106161778|NCT01987895|366253859|FG001|Overall Study|Lost to Follow-up|5|||
106161779|NCT01987895|366253858|FG000|Overall Study|randomized before giving IC|0|||
106161780|NCT01987895|366253859|FG001|Overall Study|randomized before giving IC|1|||
106161781|NCT02359890|366253860|FG000|Overall Study|Not meeting eligibility|4|||
106161782|NCT02359890|366253860|FG000|Overall Study|Never treated with study catheter|6|||
106090370|NCT00499369|365989762|FG000|Overall Study|Not protocol specified|2|||
106090371|NCT00499369|365989763|FG001|Overall Study|Not protocol specified|0|||
106090372|NCT00499369|365989764|FG002|Overall Study|Not protocol specified|3|||
106090373|NCT00499369|365989765|FG003|Overall Study|Not protocol specified|1|||
106090374|NCT00499369|365989766|FG004|Overall Study|Not protocol specified|0|||
106090375|NCT00499369|365989762|FG000|Overall Study|Ineligible|2|||
106090376|NCT00499369|365989763|FG001|Overall Study|Ineligible|2|||
106090377|NCT00499369|365989764|FG002|Overall Study|Ineligible|1|||
106090378|NCT00499369|365989765|FG003|Overall Study|Ineligible|1|||
106090379|NCT00499369|365989766|FG004|Overall Study|Ineligible|0|||
106090380|NCT03285477|365989772|FG000|Treatment and Response Assessment Period|Death|1|||
106090381|NCT03285477|365989773|FG001|Treatment and Response Assessment Period|Death|0|||
106090382|NCT03285477|365989772|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
106090383|NCT03285477|365989773|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
106090384|NCT03285477|365989772|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
106090385|NCT03285477|365989773|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
106090386|NCT03285477|365989772|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
106090387|NCT03285477|365989773|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
106090388|NCT03285477|365989772|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
106090389|NCT03285477|365989773|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
106090390|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
106090391|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
106090392|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
106090393|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
106090394|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
106090395|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
106090396|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
106090397|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
106090398|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
106090399|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
106090400|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
106090401|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
106090402|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
106161783|NCT04015167|366253863|FG000|Overall Study|Lost to Follow-up|40|||
106161784|NCT04015167|366253863|FG000|Overall Study|Adverse Event|5|||
106161785|NCT04015167|366253863|FG000|Overall Study|Withdrawal by Subject|2|||
106090403|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
106090404|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
106090405|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
106090406|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
106161786|NCT04015167|366253863|FG000|Overall Study|Subject went to jail|1|||
106161787|NCT04788511|366253864|FG000|Overall Study|Withdrawal by Subject|2|||
106161788|NCT04788511|366253865|FG001|Overall Study|Withdrawal by Subject|1|||
106161789|NCT04788511|366253864|FG000|Overall Study|Lost to Follow-up|2|||
106161790|NCT04788511|366253865|FG001|Overall Study|Lost to Follow-up|7|||
106090407|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
106090408|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
106090409|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
106090410|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
106090411|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
106090412|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
106090413|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
106090414|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
106090415|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
106090416|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
106090417|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
106090418|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
106090419|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
106090420|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
106090421|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
106090422|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
106090423|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
106090424|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
106090425|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
106090426|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
106090427|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
106090428|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
106090429|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
106090430|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
106090431|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
106090432|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
106090433|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
106090434|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
106090435|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
106090436|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
106090437|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
106090438|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
106090439|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
106090440|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
106090441|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
106090442|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
106090443|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
106090444|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
106161791|NCT04788511|366253864|FG000|Overall Study|Death|3|||
106161792|NCT04788511|366253865|FG001|Overall Study|Death|4|||
106161793|NCT04277442|366253866|FG000|Overall Study|Death|1|||
106161794|NCT02734290|366255316|FG000|Overall Study|Adverse Event|1|||
106161795|NCT02734290|366255317|FG001|Overall Study|Adverse Event|0|||
106161796|NCT02734290|366255316|FG000|Overall Study|Death|1|||
106161797|NCT02734290|366255317|FG001|Overall Study|Death|0|||
106161798|NCT03867500|366255318|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
106161799|NCT03897465|366255319|FG000|Overall Study|Lost to Follow-up|2|||
106161800|NCT03897465|366255320|FG001|Overall Study|Lost to Follow-up|1|||
106161801|NCT03897465|366255319|FG000|Overall Study|Adverse Event|2|||
106161802|NCT03897465|366255320|FG001|Overall Study|Adverse Event|0|||
106161803|NCT03897465|366255319|FG000|Overall Study|complete healing by V2|1|||
106161804|NCT03897465|366255320|FG001|Overall Study|complete healing by V2|0|||
106161805|NCT03897465|366255319|FG000|Overall Study|occurence of exclusion criterion|1|||
106090445|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
106090446|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
106090447|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
106090448|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
106161806|NCT03897465|366255320|FG001|Overall Study|occurence of exclusion criterion|1|||
106161807|NCT03897465|366255319|FG000|Overall Study|Other|1|||
106090449|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
106090450|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
106161808|NCT03897465|366255320|FG001|Overall Study|Other|0|||
106161809|NCT04225039|366255322|FG000|Overall Study|Withdrawal by Subject|1|||
106161810|NCT04225039|366255323|FG001|Overall Study|Withdrawal by Subject|0|||
106090451|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
106090452|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
106090453|NCT01884350|365989774|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
106090454|NCT01884350|365989775|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
106090455|NCT01884350|365989776|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
106090456|NCT01438541|365989777|FG000|Overall Study|Physician Decision|1|||
106090457|NCT01438541|365989777|FG000|Overall Study|Withdrawal by Subject|1|||
106090458|NCT01438541|365989777|FG000|Overall Study|discharge from the hospital|5|||
106090459|NCT01968434|365989778|FG000|Overall Study|Lost to Follow-up|3|||
106090460|NCT01968434|365989779|FG001|Overall Study|Lost to Follow-up|6|||
106090461|NCT02091167|365989780|FG000|Overall Study|Lost to Follow-up|0|||
106090462|NCT02091167|365989781|FG001|Overall Study|Lost to Follow-up|2|||
106090463|NCT02199691|365989784|FG000|Overall Study|Protocol Violation|3|||
106090464|NCT02199691|365989785|FG001|Overall Study|Protocol Violation|3|||
106090465|NCT02199691|365989786|FG002|Overall Study|Protocol Violation|6|||
106090466|NCT02199691|365989787|FG003|Overall Study|Protocol Violation|7|||
106090467|NCT02199691|365989784|FG000|Overall Study|Withdrawal by Subject|5|||
106090468|NCT02199691|365989785|FG001|Overall Study|Withdrawal by Subject|3|||
106090469|NCT02199691|365989786|FG002|Overall Study|Withdrawal by Subject|12|||
106090470|NCT02199691|365989787|FG003|Overall Study|Withdrawal by Subject|13|||
106090471|NCT02199691|365989784|FG000|Overall Study|Lost to Follow-up|2|||
106090472|NCT02199691|365989785|FG001|Overall Study|Lost to Follow-up|1|||
106090473|NCT02199691|365989786|FG002|Overall Study|Lost to Follow-up|9|||
106090474|NCT02199691|365989787|FG003|Overall Study|Lost to Follow-up|10|||
106090475|NCT02293005|365991219|FG000|Overall Study|Adverse Event|2|||
106090476|NCT02293005|365991219|FG000|Overall Study|Death|4|||
106090477|NCT02293005|365991219|FG000|Overall Study|Lost to Follow-up|1|||
106090478|NCT02293005|365991219|FG000|Overall Study|Withdrawal by Subject|2|||
106090479|NCT02293005|365991219|FG000|Overall Study|Progression|17|||
106090480|NCT03892889|365991225|FG000|Overall Study|Adverse Event|17|||
106090481|NCT03892889|365991225|FG000|Overall Study|Lack of Efficacy|1|||
106090482|NCT03892889|365991225|FG000|Overall Study|Lost to Follow-up|46|||
106090483|NCT03892889|365991225|FG000|Overall Study|Non-compliance with study drug|22|||
106090484|NCT03892889|365991225|FG000|Overall Study|Pregnancy|1|||
106090485|NCT03892889|365991225|FG000|Overall Study|Protocol Deviation|3|||
106090486|NCT03892889|365991225|FG000|Overall Study|Withdrawal by Subject|50|||
106090487|NCT03892889|365991225|FG000|Overall Study|Withdrawal by Caregiver|1|||
106090488|NCT03892889|365991225|FG000|Overall Study|Study Terminated by Sponsor|50|||
106090489|NCT03892889|365991225|FG000|Overall Study|Physician Decision|8|||
106090490|NCT03892889|365991225|FG000|Overall Study|Reason not Specified|5|||
106090491|NCT01519518|365991226|FG000|Overall Study|Consent not available|7|||
106090492|NCT01519518|365991227|FG001|Overall Study|Consent not available|10|||
106090493|NCT01265953|365991228|FG000|Overall Study|Non compliance|5|||
106090494|NCT01265953|365991229|FG001|Overall Study|Non compliance|3|||
106090495|NCT01610700|365991230|FG000|Overall Study|Adverse Event|3|||
106090496|NCT01610700|365991231|FG001|Overall Study|Adverse Event|1|||
106090497|NCT01610700|365991230|FG000|Overall Study|Withdrawal by Subject|0|||
106090498|NCT01610700|365991231|FG001|Overall Study|Withdrawal by Subject|1|||
106090499|NCT01610700|365991230|FG000|Overall Study|subject took one dose of street cannabis|0|||
106090500|NCT01610700|365991231|FG001|Overall Study|subject took one dose of street cannabis|1|||
106090501|NCT01640301|365991234|FG000|Overall Study|Death|0|||
106090502|NCT01640301|365991235|FG001|Overall Study|Death|8|||
106090503|NCT02348489|365991238|FG000|Overall Study|Death|336|||
106090504|NCT02348489|365991239|FG001|Overall Study|Death|335|||
106090505|NCT02348489|365991238|FG000|Overall Study|Withdrawal by Subject|14|||
106090506|NCT02348489|365991239|FG001|Overall Study|Withdrawal by Subject|27|||
106090507|NCT02348489|365991238|FG000|Overall Study|Lost to Follow-up|3|||
106090508|NCT02348489|365991239|FG001|Overall Study|Lost to Follow-up|5|||
106090509|NCT01639001|365991240|FG000|Overall Study|Refused further follow-up|9|||
106090510|NCT01639001|365991241|FG001|Overall Study|Refused further follow-up|12|||
106090511|NCT01639001|365991240|FG000|Overall Study|Lost to Follow-up|3|||
106090512|NCT01639001|365991241|FG001|Overall Study|Lost to Follow-up|0|||
106090513|NCT01639001|365991240|FG000|Overall Study|Death|62|||
106090514|NCT01639001|365991241|FG001|Overall Study|Death|61|||
106090515|NCT01639001|365991240|FG000|Overall Study|Randomized but not treated|0|||
106090516|NCT01639001|365991241|FG001|Overall Study|Randomized but not treated|2|||
106090517|NCT01639001|365991240|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
106090518|NCT01639001|365991241|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
106090519|NCT01040871|365991243|FG000|Overall Study|Adverse Event|6|||
106090520|NCT01040871|365991244|FG001|Overall Study|Adverse Event|2|||
106090521|NCT01040871|365991243|FG000|Overall Study|Withdrawal by Subject|2|||
106090522|NCT01040871|365991244|FG001|Overall Study|Withdrawal by Subject|0|||
106090523|NCT01040871|365991243|FG000|Overall Study|Death|1|||
106090524|NCT01040871|365991244|FG001|Overall Study|Death|3|||
106090525|NCT01040871|365991243|FG000|Overall Study|Lack of Efficacy|1|||
106090526|NCT01040871|365991244|FG001|Overall Study|Lack of Efficacy|1|||
106090527|NCT01040871|365991243|FG000|Overall Study|drug supply issue|1|||
106090528|NCT01040871|365991244|FG001|Overall Study|drug supply issue|0|||
106090529|NCT01040871|365991243|FG000|Overall Study|Randomized and Not Treated|2|||
106090530|NCT01040871|365991244|FG001|Overall Study|Randomized and Not Treated|1|||
106090531|NCT01969838|365991245|FG000|Double-blind Phase|Adverse Event|10|||
106090532|NCT01969838|365991246|FG001|Double-blind Phase|Adverse Event|4|||
106090533|NCT01969838|365991247|FG002|Double-blind Phase|Adverse Event|0|||
106090534|NCT01969838|365991248|FG003|Double-blind Phase|Adverse Event|0|||
106090535|NCT01969838|365991245|FG000|Double-blind Phase|Death|5|||
106090536|NCT01969838|365991246|FG001|Double-blind Phase|Death|2|||
106090537|NCT01969838|365991247|FG002|Double-blind Phase|Death|0|||
106090538|NCT01969838|365991248|FG003|Double-blind Phase|Death|0|||
106090539|NCT01969838|365991245|FG000|Double-blind Phase|Physician Decision|5|||
106090540|NCT01969838|365991246|FG001|Double-blind Phase|Physician Decision|1|||
106090541|NCT01969838|365991247|FG002|Double-blind Phase|Physician Decision|0|||
106090542|NCT01969838|365991248|FG003|Double-blind Phase|Physician Decision|0|||
106090543|NCT01969838|365991245|FG000|Double-blind Phase|Subject Decision|4|||
106090544|NCT01969838|365991246|FG001|Double-blind Phase|Subject Decision|2|||
106090545|NCT01969838|365991247|FG002|Double-blind Phase|Subject Decision|0|||
106090546|NCT01969838|365991248|FG003|Double-blind Phase|Subject Decision|0|||
106090547|NCT01969838|365991245|FG000|Double-blind Phase|Disease Progression|2|||
106090548|NCT01969838|365991246|FG001|Double-blind Phase|Disease Progression|0|||
106090549|NCT01969838|365991247|FG002|Double-blind Phase|Disease Progression|0|||
106090550|NCT01969838|365991248|FG003|Double-blind Phase|Disease Progression|0|||
106090551|NCT01969838|365991245|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
106090552|NCT01969838|365991246|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
106090553|NCT01969838|365991247|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
106090554|NCT01969838|365991248|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
106090555|NCT01969838|365991245|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
106090556|NCT01969838|365991246|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
106090557|NCT01969838|365991247|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
106090558|NCT01969838|365991248|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
106090559|NCT01969838|365991245|FG000|Open-label Phase|Adverse Event|0|||
106090560|NCT01969838|365991246|FG001|Open-label Phase|Adverse Event|0|||
106090561|NCT01969838|365991247|FG002|Open-label Phase|Adverse Event|37|||
106090562|NCT01969838|365991248|FG003|Open-label Phase|Adverse Event|49|||
106090563|NCT01969838|365991245|FG000|Open-label Phase|Disease Progression|0|||
106090564|NCT01969838|365991246|FG001|Open-label Phase|Disease Progression|0|||
106090565|NCT01969838|365991247|FG002|Open-label Phase|Disease Progression|26|||
106090566|NCT01969838|365991248|FG003|Open-label Phase|Disease Progression|27|||
106090567|NCT01969838|365991245|FG000|Open-label Phase|Lack of Efficacy|0|||
106090568|NCT01969838|365991246|FG001|Open-label Phase|Lack of Efficacy|0|||
106090569|NCT01969838|365991247|FG002|Open-label Phase|Lack of Efficacy|17|||
106090570|NCT01969838|365991248|FG003|Open-label Phase|Lack of Efficacy|19|||
106090571|NCT01969838|365991245|FG000|Open-label Phase|Subject Decision|0|||
106090572|NCT01969838|365991246|FG001|Open-label Phase|Subject Decision|0|||
106090573|NCT01969838|365991247|FG002|Open-label Phase|Subject Decision|14|||
106090574|NCT01969838|365991248|FG003|Open-label Phase|Subject Decision|15|||
106090575|NCT01969838|365991245|FG000|Open-label Phase|Death|0|||
106090576|NCT01969838|365991246|FG001|Open-label Phase|Death|0|||
106090577|NCT01969838|365991247|FG002|Open-label Phase|Death|13|||
106090578|NCT01969838|365991248|FG003|Open-label Phase|Death|11|||
106090579|NCT01969838|365991245|FG000|Open-label Phase|Physician Decision|0|||
106090580|NCT01969838|365991246|FG001|Open-label Phase|Physician Decision|0|||
106090581|NCT01969838|365991247|FG002|Open-label Phase|Physician Decision|9|||
106090582|NCT01969838|365991248|FG003|Open-label Phase|Physician Decision|14|||
106090583|NCT01969838|365991245|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
106090584|NCT01969838|365991246|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
106090585|NCT01969838|365991247|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
106090586|NCT01969838|365991248|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
106090587|NCT00408993|365991249|FG000|Overall Study|Adverse Event|15|||
106090588|NCT00408993|365991250|FG001|Overall Study|Adverse Event|4|||
106090589|NCT00408993|365991249|FG000|Overall Study|Protocol Violation|1|||
106090590|NCT00408993|365991250|FG001|Overall Study|Protocol Violation|6|||
106090591|NCT00408993|365991249|FG000|Overall Study|Lack of Efficacy|1|||
106090592|NCT00408993|365991250|FG001|Overall Study|Lack of Efficacy|4|||
106090593|NCT00408993|365991249|FG000|Overall Study|Withdrawal by Subject|2|||
106090594|NCT00408993|365991250|FG001|Overall Study|Withdrawal by Subject|3|||
106090595|NCT04820673|365991253|FG000|Overall Study|Adverse Event|6|||
106090596|NCT04820673|365991253|FG000|Overall Study|Due to Lack of Effectiveness|1|||
106090597|NCT04820673|365991253|FG000|Overall Study|Pregnancy|1|||
106090598|NCT04820673|365991253|FG000|Overall Study|Voluntary Withdrawal|20|||
106090599|NCT04820673|365991253|FG000|Overall Study|Lost to Follow-up|10|||
106090600|NCT01933334|365991257|FG000|Overall Study|Adverse Event|5|||
106090601|NCT01933334|365991258|FG001|Overall Study|Adverse Event|1|||
106090602|NCT01933334|365991257|FG000|Overall Study|Withdrawal by Subject|0|||
106090603|NCT01933334|365991258|FG001|Overall Study|Withdrawal by Subject|1|||
106090604|NCT00767000|365991259|FG000|54-week Study|Adverse Event|4|||
106090605|NCT00767000|365991260|FG001|54-week Study|Adverse Event|6|||
106090606|NCT00767000|365991261|FG002|54-week Study|Adverse Event|6|||
106090607|NCT00767000|365991262|FG003|54-week Study|Adverse Event|8|||
106090608|NCT00767000|365991263|FG004|54-week Study|Adverse Event|4|||
106090609|NCT00767000|365991259|FG000|54-week Study|Creaninine/creatinine clearance|2|||
106090610|NCT00767000|365991260|FG001|54-week Study|Creaninine/creatinine clearance|1|||
106090611|NCT00767000|365991261|FG002|54-week Study|Creaninine/creatinine clearance|2|||
106090612|NCT00767000|365991262|FG003|54-week Study|Creaninine/creatinine clearance|2|||
106090613|NCT00767000|365991263|FG004|54-week Study|Creaninine/creatinine clearance|4|||
106090614|NCT00767000|365991259|FG000|54-week Study|Hyperglycemia|0|||
106090615|NCT00767000|365991260|FG001|54-week Study|Hyperglycemia|0|||
106090616|NCT00767000|365991261|FG002|54-week Study|Hyperglycemia|1|||
106090617|NCT00767000|365991262|FG003|54-week Study|Hyperglycemia|0|||
106090618|NCT00767000|365991263|FG004|54-week Study|Hyperglycemia|1|||
106090619|NCT00767000|365991259|FG000|54-week Study|Hypoglycemia|0|||
106090620|NCT00767000|365991260|FG001|54-week Study|Hypoglycemia|1|||
106090621|NCT00767000|365991261|FG002|54-week Study|Hypoglycemia|0|||
106090622|NCT00767000|365991262|FG003|54-week Study|Hypoglycemia|0|||
106090623|NCT00767000|365991263|FG004|54-week Study|Hypoglycemia|0|||
106090624|NCT00767000|365991259|FG000|54-week Study|Interruption of study medication|0|||
106090625|NCT00767000|365991260|FG001|54-week Study|Interruption of study medication|0|||
106090626|NCT00767000|365991261|FG002|54-week Study|Interruption of study medication|1|||
106090627|NCT00767000|365991262|FG003|54-week Study|Interruption of study medication|0|||
106090628|NCT00767000|365991263|FG004|54-week Study|Interruption of study medication|0|||
106090629|NCT00767000|365991259|FG000|54-week Study|Lack of Efficacy|2|||
106090630|NCT00767000|365991260|FG001|54-week Study|Lack of Efficacy|0|||
106161811|NCT04225039|366255324|FG002|Overall Study|Withdrawal by Subject|0|||
106161812|NCT04225039|366255325|FG003|Overall Study|Withdrawal by Subject|1|||
106161813|NCT04225039|366255322|FG000|Overall Study|Currently active on study treatment|0|||
106161814|NCT04225039|366255323|FG001|Overall Study|Currently active on study treatment|1|||
106161815|NCT04225039|366255324|FG002|Overall Study|Currently active on study treatment|0|||
106161816|NCT04225039|366255325|FG003|Overall Study|Currently active on study treatment|0|||
106161817|NCT04225039|366255322|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
106161818|NCT04225039|366255323|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
106161819|NCT04225039|366255324|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
106161820|NCT04225039|366255325|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
106161821|NCT04225039|366255322|FG000|Overall Study|Ineligible for treatment|0|||
106161822|NCT04225039|366255323|FG001|Overall Study|Ineligible for treatment|0|||
106161823|NCT04225039|366255324|FG002|Overall Study|Ineligible for treatment|0|||
106161824|NCT04225039|366255325|FG003|Overall Study|Ineligible for treatment|4|||
106161825|NCT02577835|366255326|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
106161826|NCT04749615|366255327|FG000|Overall Study|Lost to Follow-up|6|||
106161827|NCT04749615|366255328|FG001|Overall Study|Lost to Follow-up|10|||
106161828|NCT05119023|366255334|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
106161829|NCT05119023|366255334|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
106161830|NCT05119023|366255334|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
106161831|NCT02274662|366255339|FG000|Overall Study|Death|1|||
106161832|NCT02274662|366255339|FG000|Overall Study|Lost to Follow-up|3|||
106161833|NCT03194217|366255340|FG000|Overall Study|Adverse Event|0|||
106161834|NCT03194217|366255341|FG001|Overall Study|Adverse Event|2|||
106161835|NCT03194217|366255342|FG002|Overall Study|Adverse Event|3|||
106161836|NCT03194217|366255343|FG003|Overall Study|Adverse Event|3|||
106161837|NCT03194217|366255340|FG000|Overall Study|Failure to meet randomisation criteria|0|||
106161838|NCT03194217|366255341|FG001|Overall Study|Failure to meet randomisation criteria|0|||
106161839|NCT03194217|366255342|FG002|Overall Study|Failure to meet randomisation criteria|0|||
106161840|NCT03194217|366255343|FG003|Overall Study|Failure to meet randomisation criteria|1|||
106161841|NCT03194217|366255340|FG000|Overall Study|Other|0|||
106161842|NCT03194217|366255341|FG001|Overall Study|Other|1|||
106161843|NCT03194217|366255342|FG002|Overall Study|Other|1|||
106161844|NCT03194217|366255343|FG003|Overall Study|Other|0|||
106161845|NCT04806451|366255344|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
106161846|NCT04806451|366255345|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
106161847|NCT04806451|366255344|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
106090631|NCT00767000|365991261|FG002|54-week Study|Lack of Efficacy|1|||
106090632|NCT00767000|365991262|FG003|54-week Study|Lack of Efficacy|0|||
106090633|NCT00767000|365991263|FG004|54-week Study|Lack of Efficacy|5|||
106090634|NCT00767000|365991259|FG000|54-week Study|Lost to Follow-up|4|||
106090635|NCT00767000|365991260|FG001|54-week Study|Lost to Follow-up|0|||
106090636|NCT00767000|365991261|FG002|54-week Study|Lost to Follow-up|1|||
106090637|NCT00767000|365991262|FG003|54-week Study|Lost to Follow-up|4|||
106161848|NCT04806451|366255345|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
106161849|NCT04806451|366255344|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
106161850|NCT04806451|366255345|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
106161851|NCT05835336|366255346|FG000|Overall Study|Withdrawal by Subject|5|||
106161852|NCT05835336|366255346|FG000|Overall Study|Did not complete the personalization process|3|||
106161853|NCT04489771|366255349|FG000|Overall Study|Death|27|||
106161854|NCT04489771|366255350|FG001|Overall Study|Death|25|||
106161855|NCT04489771|366255349|FG000|Overall Study|Withdrawal by Subject|1|||
106161856|NCT04489771|366255350|FG001|Overall Study|Withdrawal by Subject|0|||
106161857|NCT04489771|366255349|FG000|Overall Study|Participants Ongoing in Study|50|||
106161858|NCT04489771|366255350|FG001|Overall Study|Participants Ongoing in Study|51|||
106161859|NCT05894577|366255351|FG000|Overall Study|No receipt of study drug|14|||
106161860|NCT05894577|366255352|FG001|Overall Study|No receipt of study drug|13|||
106161861|NCT05894577|366255351|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
106161862|NCT05894577|366255352|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
106161863|NCT05894577|366255351|FG000|Overall Study|Screen Fail|2|||
106161864|NCT05894577|366255352|FG001|Overall Study|Screen Fail|0|||
106161865|NCT05894577|366255351|FG000|Overall Study|Study drug recall|86|||
106161866|NCT05894577|366255352|FG001|Overall Study|Study drug recall|63|||
106161867|NCT03197662|366255355|FG000|Overall Study|Withdrawn by family|0|||
106161868|NCT03197662|366255356|FG001|Overall Study|Withdrawn by family|2|||
106161869|NCT01214616|366255357|FG000|Overall Study|Progressive disease|2|||
106161870|NCT01214616|366255358|FG001|Overall Study|Progressive disease|2|||
106161871|NCT01214616|366255359|FG002|Overall Study|Progressive disease|2|||
106161872|NCT01214616|366255360|FG003|Overall Study|Progressive disease|4|||
106161873|NCT01214616|366255357|FG000|Overall Study|Dose limiting toxicity|0|||
106161874|NCT01214616|366255358|FG001|Overall Study|Dose limiting toxicity|2|||
106161875|NCT01214616|366255359|FG002|Overall Study|Dose limiting toxicity|0|||
106161876|NCT01214616|366255360|FG003|Overall Study|Dose limiting toxicity|0|||
106161877|NCT01214616|366255357|FG000|Overall Study|Other adverse events|0|||
106161878|NCT01214616|366255358|FG001|Overall Study|Other adverse events|1|||
106161879|NCT01214616|366255359|FG002|Overall Study|Other adverse events|1|||
106161880|NCT01214616|366255360|FG003|Overall Study|Other adverse events|1|||
106161881|NCT01214616|366255357|FG000|Overall Study|Withdrawal by Subject|1|||
106161882|NCT01214616|366255358|FG001|Overall Study|Withdrawal by Subject|0|||
106161883|NCT01214616|366255359|FG002|Overall Study|Withdrawal by Subject|0|||
106161884|NCT01214616|366255360|FG003|Overall Study|Withdrawal by Subject|1|||
106161885|NCT04064164|366255372|FG000|Overall Study|Withdrawal by Subject|8|||
106161886|NCT04064164|366255373|FG001|Overall Study|Withdrawal by Subject|8|||
106161887|NCT01000961|366255374|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
106161888|NCT01000961|366255375|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
106161889|NCT01000961|366255374|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
106161890|NCT01000961|366255375|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
106161891|NCT02949362|366255376|FG000|Retrospective Period|Inform consent not signed by participant|4|||
106161892|NCT02949362|366255377|FG001|Retrospective Period|Inform consent not signed by participant|1|||
106161893|NCT02949362|366255378|FG002|Retrospective Period|Inform consent not signed by participant|0|||
106161894|NCT02949362|366255379|FG003|Retrospective Period|Inform consent not signed by participant|0|||
106161895|NCT02949362|366255376|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
105867254|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
106090638|NCT00767000|365991263|FG004|54-week Study|Lost to Follow-up|2|||
106090639|NCT00767000|365991259|FG000|54-week Study|Physician Decision|4|||
106090640|NCT00767000|365991260|FG001|54-week Study|Physician Decision|0|||
106090641|NCT00767000|365991261|FG002|54-week Study|Physician Decision|1|||
106090642|NCT00767000|365991262|FG003|54-week Study|Physician Decision|1|||
106090643|NCT00767000|365991263|FG004|54-week Study|Physician Decision|1|||
106090644|NCT00767000|365991259|FG000|54-week Study|Progressive disease|0|||
106090645|NCT00767000|365991260|FG001|54-week Study|Progressive disease|0|||
106090646|NCT00767000|365991261|FG002|54-week Study|Progressive disease|1|||
106090647|NCT00767000|365991262|FG003|54-week Study|Progressive disease|0|||
106161896|NCT02949362|366255377|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
106161897|NCT02949362|366255378|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
106161898|NCT02949362|366255379|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
106161899|NCT02949362|366255376|FG000|Prospective Period|Other|0|||
106161900|NCT02949362|366255377|FG001|Prospective Period|Other|0|||
106161901|NCT02949362|366255378|FG002|Prospective Period|Other|0|||
106161902|NCT02949362|366255379|FG003|Prospective Period|Other|4|||
106161903|NCT04719390|366255383|FG000|Overall Study|Withdrawal by Subject|1|||
106161904|NCT04292223|366255384|FG000|Overall Study|Adverse Event|1|||
106090648|NCT00767000|365991263|FG004|54-week Study|Progressive disease|0|||
106161905|NCT04292223|366255384|FG000|Overall Study|Lost to Follow-up|1|||
106161906|NCT04292223|366255384|FG000|Overall Study|Noncompliance with study drug|2|||
106090649|NCT00767000|365991259|FG000|54-week Study|Protocol Violation|0|||
106090650|NCT00767000|365991260|FG001|54-week Study|Protocol Violation|0|||
106090651|NCT00767000|365991261|FG002|54-week Study|Protocol Violation|1|||
106090652|NCT00767000|365991262|FG003|54-week Study|Protocol Violation|2|||
106090653|NCT00767000|365991263|FG004|54-week Study|Protocol Violation|0|||
106090654|NCT00767000|365991259|FG000|54-week Study|Withdrawal by Subject|2|||
106090655|NCT00767000|365991260|FG001|54-week Study|Withdrawal by Subject|3|||
106090656|NCT00767000|365991261|FG002|54-week Study|Withdrawal by Subject|5|||
106090657|NCT00767000|365991262|FG003|54-week Study|Withdrawal by Subject|11|||
106090658|NCT00767000|365991263|FG004|54-week Study|Withdrawal by Subject|13|||
106161907|NCT04292223|366255384|FG000|Overall Study|Patient moved out of the state|1|||
106161908|NCT04683744|366255386|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
106090659|NCT00767000|365991259|FG000|54-week Study|Study terminated by sponsor|90|||
106090660|NCT00767000|365991260|FG001|54-week Study|Study terminated by sponsor|102|||
106090661|NCT00767000|365991261|FG002|54-week Study|Study terminated by sponsor|89|||
106090662|NCT00767000|365991262|FG003|54-week Study|Study terminated by sponsor|196|||
106090663|NCT00767000|365991263|FG004|54-week Study|Study terminated by sponsor|194|||
106090664|NCT00767000|365991259|FG000|54-week Study|Reason not reported|0|||
106090665|NCT00767000|365991260|FG001|54-week Study|Reason not reported|0|||
106090666|NCT00767000|365991261|FG002|54-week Study|Reason not reported|0|||
106090667|NCT00767000|365991262|FG003|54-week Study|Reason not reported|1|||
106090668|NCT00767000|365991263|FG004|54-week Study|Reason not reported|0|||
106090669|NCT00767000|365991259|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
106090670|NCT00767000|365991260|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
106090671|NCT00767000|365991261|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
106090672|NCT00767000|365991262|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
106090673|NCT00767000|365991263|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
106090674|NCT00466193|365991264|FG000|Overall Study|Adverse Event|0|||
106090675|NCT00466193|365991265|FG001|Overall Study|Adverse Event|1|||
106090676|NCT00466193|365991264|FG000|Overall Study|Lost to Follow-up|2|||
106090677|NCT00466193|365991265|FG001|Overall Study|Lost to Follow-up|4|||
106090678|NCT00466193|365991264|FG000|Overall Study|Physician Decision|1|||
106090679|NCT00466193|365991265|FG001|Overall Study|Physician Decision|0|||
106090680|NCT00466193|365991264|FG000|Overall Study|Protocol Violation|1|||
106090681|NCT00466193|365991265|FG001|Overall Study|Protocol Violation|1|||
106090682|NCT00466193|365991264|FG000|Overall Study|Withdrawal by Subject|7|||
106090683|NCT00466193|365991265|FG001|Overall Study|Withdrawal by Subject|2|||
106090684|NCT00466193|365991264|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
106090685|NCT00466193|365991265|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
106090686|NCT01375049|365991266|FG000|Overall Study|Adverse Event|2|||
106090687|NCT01375049|365991266|FG000|Overall Study|Lost to Follow-up|1|||
106090688|NCT01375049|365991266|FG000|Overall Study|Withdrawal by Subject|2|||
106090689|NCT01375049|365991266|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
106090690|NCT01175382|365991267|FG000|Overall Study|Lost to Follow-up|4|||
106090691|NCT01175382|365991268|FG001|Overall Study|Lost to Follow-up|3|||
106090692|NCT01175382|365991269|FG002|Overall Study|Lost to Follow-up|1|||
106090693|NCT01175382|365991267|FG000|Overall Study|Physician Decision|0|||
106090694|NCT01175382|365991268|FG001|Overall Study|Physician Decision|1|||
106090695|NCT01175382|365991269|FG002|Overall Study|Physician Decision|0|||
106090696|NCT01175382|365991267|FG000|Overall Study|Withdrawal by Subject|0|||
106090697|NCT01175382|365991268|FG001|Overall Study|Withdrawal by Subject|0|||
106090698|NCT01175382|365991269|FG002|Overall Study|Withdrawal by Subject|1|||
106090699|NCT01175382|365991267|FG000|Overall Study|No longer having problem|1|||
106090700|NCT01175382|365991268|FG001|Overall Study|No longer having problem|0|||
106090701|NCT01175382|365991269|FG002|Overall Study|No longer having problem|1|||
106090702|NCT01175382|365991267|FG000|Overall Study|Unable/unwilling to attend visits|3|||
106161909|NCT04683744|366255387|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
106090703|NCT01175382|365991268|FG001|Overall Study|Unable/unwilling to attend visits|1|||
106090704|NCT01175382|365991269|FG002|Overall Study|Unable/unwilling to attend visits|2|||
106090705|NCT01175382|365991267|FG000|Overall Study|Unwilling to follow protocol|0|||
106090706|NCT01175382|365991268|FG001|Overall Study|Unwilling to follow protocol|1|||
106090707|NCT01175382|365991269|FG002|Overall Study|Unwilling to follow protocol|0|||
106090708|NCT01175382|365991267|FG000|Overall Study|Unable to tolerate study meds|0|||
106090709|NCT01175382|365991268|FG001|Overall Study|Unable to tolerate study meds|1|||
106090710|NCT01175382|365991269|FG002|Overall Study|Unable to tolerate study meds|1|||
106090711|NCT03766646|365991271|FG000|Overall Study|Withdrawal by Subject|1|||
106090712|NCT03766646|365991272|FG001|Overall Study|Withdrawal by Subject|0|||
106090713|NCT03766646|365991271|FG000|Overall Study|Protocol Violation|0|||
106090714|NCT03766646|365991272|FG001|Overall Study|Protocol Violation|3|||
106090715|NCT02530619|365991280|FG000|Registered for Study|Withdrawal by Subject|2|||
106090716|NCT02530619|365991280|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
106090717|NCT02530619|365991280|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
106090718|NCT02530619|365991280|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
106090719|NCT02530619|365991280|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
106090720|NCT02530619|365991280|FG000|Follow-up Period (6 Months)|Death|4|||
106090721|NCT02530619|365991280|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
106090722|NCT02530619|365991280|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
106090723|NCT02317575|365991288|FG000|Period 1|Difficulty with venous cannulation|0|||
106090724|NCT02317575|365991289|FG001|Period 1|Difficulty with venous cannulation|1|||
106090725|NCT02317575|365991290|FG002|Period 1|Difficulty with venous cannulation|0|||
106090726|NCT02317575|365991291|FG003|Period 1|Difficulty with venous cannulation|0|||
106090727|NCT02317575|365991292|FG004|Period 1|Difficulty with venous cannulation|0|||
106090728|NCT02317575|365991288|FG000|Period 1|Withdrawal by Subject|1|||
106090729|NCT02317575|365991289|FG001|Period 1|Withdrawal by Subject|0|||
106090730|NCT02317575|365991290|FG002|Period 1|Withdrawal by Subject|0|||
106090731|NCT02317575|365991291|FG003|Period 1|Withdrawal by Subject|0|||
106090732|NCT02317575|365991292|FG004|Period 1|Withdrawal by Subject|0|||
106090733|NCT02223390|365991293|FG000|Overall Study|Lost to Follow-up|9|||
106090734|NCT02223390|365991294|FG001|Overall Study|Lost to Follow-up|4|||
106090735|NCT00572572|365991295|FG000|Overall Study|Withdrawal by Subject|3|||
106090736|NCT00572572|365991296|FG001|Overall Study|Withdrawal by Subject|6|||
106090737|NCT01958918|365991300|FG000|Overall Study|Death|1|||
106090738|NCT01958918|365991301|FG001|Overall Study|Death|3|||
106090739|NCT01958918|365991300|FG000|Overall Study|Lost to Follow-up|4|||
106090740|NCT01958918|365991301|FG001|Overall Study|Lost to Follow-up|7|||
106090741|NCT01958918|365991300|FG000|Overall Study|Withdrawal by Subject|13|||
106090742|NCT01958918|365991301|FG001|Overall Study|Withdrawal by Subject|8|||
106090743|NCT01958918|365991300|FG000|Overall Study|Lack of Efficacy|13|||
106090744|NCT01958918|365991301|FG001|Overall Study|Lack of Efficacy|10|||
106090745|NCT01958918|365991300|FG000|Overall Study|Adverse Event|12|||
106090746|NCT01958918|365991301|FG001|Overall Study|Adverse Event|12|||
106090747|NCT01958918|365991300|FG000|Overall Study|administrative problems|0|||
106090748|NCT01958918|365991301|FG001|Overall Study|administrative problems|2|||
106090749|NCT01925183|365991304|FG000|Overall Study|Adverse Event|1|||
106090750|NCT01925183|365991305|FG001|Overall Study|Adverse Event|0|||
106090751|NCT02114892|365991306|FG000|Overall Study|Lost to Follow-up|1|||
106090752|NCT02114892|365991307|FG001|Overall Study|Lost to Follow-up|2|||
106090753|NCT02013765|365991310|FG000|Overall Study|Trial was terminated by sponsor|1|||
106090754|NCT00659269|365991313|FG000|Overall Study|Physician Decision|1|||
106090755|NCT00659269|365991314|FG001|Overall Study|Physician Decision|1|||
106090756|NCT01158222|365991315|FG000|Overall Study|Not eligible for intermediate phase|17|||
106090757|NCT00718042|365991316|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
106090758|NCT00718042|365991317|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
106090759|NCT00718042|365991318|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
106090760|NCT00718042|365991319|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
106090761|NCT00718042|365991320|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
106090762|NCT00718042|365991321|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
106090763|NCT00718042|365991316|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
106090764|NCT00718042|365991317|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
106090765|NCT00718042|365991318|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
106090766|NCT00718042|365991319|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
106090767|NCT00718042|365991320|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
106090768|NCT00718042|365991321|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
106090769|NCT00718042|365991316|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
106090770|NCT00718042|365991317|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
106090771|NCT00718042|365991318|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
106090772|NCT00718042|365991319|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
106090773|NCT00718042|365991320|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
106090774|NCT00718042|365991321|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
106090775|NCT00718042|365991316|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
106090776|NCT00718042|365991317|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
106090777|NCT00718042|365991318|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
106090778|NCT00718042|365991319|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
106090779|NCT00718042|365991320|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
106090780|NCT00718042|365991321|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
106090781|NCT00718042|365991316|FG000|Donor Follow-up|Lost to Follow-up|13|||
106090782|NCT00718042|365991317|FG001|Donor Follow-up|Lost to Follow-up|0|||
106090783|NCT00718042|365991318|FG002|Donor Follow-up|Lost to Follow-up|0|||
106090784|NCT00718042|365991319|FG003|Donor Follow-up|Lost to Follow-up|0|||
106090785|NCT00718042|365991320|FG004|Donor Follow-up|Lost to Follow-up|19|||
106090786|NCT00718042|365991321|FG005|Donor Follow-up|Lost to Follow-up|0|||
106090787|NCT01430130|365991322|FG000|Overall Study|Lost to Follow-up|1|||
106090788|NCT01430130|365991322|FG000|Overall Study|Infection on Control Side of Incision|1|||
106090789|NCT03525834|365991323|FG000|Overall Study|Progressive disease|1|||
106090790|NCT03095417|365991326|FG000|Overall Study|missed|1|||
106090791|NCT03095417|365991327|FG001|Overall Study|missed|2|||
106090792|NCT03095417|365991328|FG002|Overall Study|missed|0|||
106090793|NCT03095417|365991329|FG003|Overall Study|missed|1|||
106090794|NCT03095417|365991326|FG000|Overall Study|Lost to Follow-up|2|||
106090795|NCT03095417|365991327|FG001|Overall Study|Lost to Follow-up|2|||
106090796|NCT03095417|365991328|FG002|Overall Study|Lost to Follow-up|1|||
106090797|NCT03095417|365991329|FG003|Overall Study|Lost to Follow-up|0|||
106090798|NCT03095417|365991326|FG000|Overall Study|refusal|0|||
106090799|NCT03095417|365991327|FG001|Overall Study|refusal|1|||
106090800|NCT03095417|365991328|FG002|Overall Study|refusal|0|||
106090801|NCT03095417|365991329|FG003|Overall Study|refusal|1|||
106090802|NCT03095417|365991326|FG000|Overall Study|Withdrawal by Subject|8|||
106090803|NCT03095417|365991327|FG001|Overall Study|Withdrawal by Subject|2|||
106090804|NCT03095417|365991328|FG002|Overall Study|Withdrawal by Subject|5|||
106090805|NCT03095417|365991329|FG003|Overall Study|Withdrawal by Subject|4|||
106090806|NCT03095417|365991326|FG000|Overall Study|Physician Decision|1|||
106090807|NCT03095417|365991327|FG001|Overall Study|Physician Decision|2|||
106090808|NCT03095417|365991328|FG002|Overall Study|Physician Decision|2|||
106090809|NCT03095417|365991329|FG003|Overall Study|Physician Decision|2|||
106090810|NCT03095417|365991326|FG000|Overall Study|Death|1|||
106090811|NCT03095417|365991327|FG001|Overall Study|Death|2|||
106090812|NCT03095417|365991328|FG002|Overall Study|Death|1|||
106090813|NCT03095417|365991329|FG003|Overall Study|Death|3|||
106090814|NCT04096560|365991330|FG000|Overall Study|Reason not Specified|1|||
106090815|NCT04096560|365991331|FG001|Overall Study|Reason not Specified|0|||
106090816|NCT04096560|365991332|FG002|Overall Study|Reason not Specified|0|||
106090817|NCT04096560|365991333|FG003|Overall Study|Reason not Specified|0|||
106090818|NCT04096560|365991334|FG004|Overall Study|Reason not Specified|1|||
106090819|NCT04096560|365991335|FG005|Overall Study|Reason not Specified|1|||
106090820|NCT04096560|365991336|FG006|Overall Study|Reason not Specified|1|||
106090821|NCT04096560|365991337|FG007|Overall Study|Reason not Specified|0|||
106090822|NCT04096560|365991330|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
106090823|NCT04096560|365991331|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
106090824|NCT04096560|365991332|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
106090825|NCT04096560|365991333|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
106090826|NCT04096560|365991334|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
106090827|NCT04096560|365991335|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
106161910|NCT04683744|366255388|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
106161911|NCT04927364|366255395|FG000|Overall Study|Withdrawal by Subject|3|||
106161912|NCT04927364|366255395|FG000|Overall Study|Unable to complete preassessment MRI|1|||
106161913|NCT05087992|366255396|FG000|Overall Study|Adverse Event|0|||
106161914|NCT05087992|366255397|FG001|Overall Study|Adverse Event|1|||
106161915|NCT05087992|366255398|FG002|Overall Study|Adverse Event|0|||
106161916|NCT05087992|366255396|FG000|Overall Study|Withdrawal by Subject|2|||
106161917|NCT05087992|366255397|FG001|Overall Study|Withdrawal by Subject|0|||
106161918|NCT05087992|366255398|FG002|Overall Study|Withdrawal by Subject|0|||
106161919|NCT05087992|366255396|FG000|Overall Study|clinical disease progression|3|||
106161920|NCT05087992|366255397|FG001|Overall Study|clinical disease progression|1|||
106161921|NCT05087992|366255398|FG002|Overall Study|clinical disease progression|0|||
106161922|NCT05087992|366255396|FG000|Overall Study|objective disease progression|4|||
106161923|NCT05087992|366255397|FG001|Overall Study|objective disease progression|1|||
106161924|NCT05087992|366255398|FG002|Overall Study|objective disease progression|0|||
106161925|NCT04293055|366255399|FG000|Overall Study|Lost to Follow-up|1|||
106161926|NCT04293055|366255400|FG001|Overall Study|Lost to Follow-up|1|||
106161927|NCT04293055|366255399|FG000|Overall Study|Did not trigger randomization|6|||
106161928|NCT04293055|366255400|FG001|Overall Study|Did not trigger randomization|5|||
106161929|NCT03560609|366255401|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
106161930|NCT03560609|366255402|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
106161931|NCT04195698|366255413|FG000|Overall Study|Adverse Event|4|||
106161932|NCT04195698|366255414|FG001|Overall Study|Adverse Event|11|||
106161933|NCT04195698|366255413|FG000|Overall Study|Withdrawal by Subject|9|||
106161934|NCT04195698|366255414|FG001|Overall Study|Withdrawal by Subject|10|||
106161935|NCT04195698|366255413|FG000|Overall Study|Lost to Follow-up|5|||
106161936|NCT04195698|366255414|FG001|Overall Study|Lost to Follow-up|4|||
106161937|NCT04195698|366255413|FG000|Overall Study|Lack of Efficacy|2|||
106161938|NCT04195698|366255414|FG001|Overall Study|Lack of Efficacy|10|||
106161939|NCT04195698|366255413|FG000|Overall Study|Other|5|||
106090828|NCT04096560|365991336|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
106161940|NCT04195698|366255414|FG001|Overall Study|Other|4|||
106161941|NCT00433329|366255415|FG000|Overall Study|Adverse Event|9|||
106090829|NCT04096560|365991337|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
106090830|NCT04096560|365991330|FG000|Overall Study|Study Terminated by Sponsor|0|||
106090831|NCT04096560|365991331|FG001|Overall Study|Study Terminated by Sponsor|0|||
106161942|NCT00433329|366255415|FG000|Overall Study|Death|4|||
106090832|NCT04096560|365991332|FG002|Overall Study|Study Terminated by Sponsor|0|||
106090833|NCT04096560|365991333|FG003|Overall Study|Study Terminated by Sponsor|5|||
106090834|NCT04096560|365991334|FG004|Overall Study|Study Terminated by Sponsor|6|||
106090835|NCT04096560|365991335|FG005|Overall Study|Study Terminated by Sponsor|4|||
106090836|NCT04096560|365991336|FG006|Overall Study|Study Terminated by Sponsor|6|||
106090837|NCT04096560|365991337|FG007|Overall Study|Study Terminated by Sponsor|1|||
106090838|NCT04096560|365991330|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
106090839|NCT04096560|365991331|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
106090840|NCT04096560|365991332|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
106090841|NCT04096560|365991333|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
106090842|NCT04096560|365991334|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
106090843|NCT04096560|365991335|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
106161943|NCT00433329|366255415|FG000|Overall Study|Withdrew consent|3|||
106161944|NCT00433329|366255415|FG000|Overall Study|Discontinued sildenafil|2|||
106161945|NCT00433329|366255415|FG000|Overall Study|Moved out of state|1|||
106161946|NCT00433329|366255415|FG000|Overall Study|Lost to Follow-up|1|||
106161947|NCT00433329|366255415|FG000|Overall Study|Physician Decision|1|||
106161948|NCT05459688|366255416|FG000|Overall Study|Lost to Follow-up|6|||
106161949|NCT05459688|366255416|FG000|Overall Study|Physician Decision|1|||
106161950|NCT05459688|366255416|FG000|Overall Study|Withdrawal by Subject|19|||
106161951|NCT05459688|366255416|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
106161952|NCT06424236|366255417|FG000|Overall Study|Adverse Event|0|||
106161953|NCT06424236|366255418|FG001|Overall Study|Adverse Event|1|||
106161954|NCT06424236|366255419|FG002|Overall Study|Adverse Event|0|||
106161955|NCT06424236|366255417|FG000|Overall Study|Withdrawal by Subject|3|||
106161956|NCT06424236|366255418|FG001|Overall Study|Withdrawal by Subject|1|||
106161957|NCT06424236|366255419|FG002|Overall Study|Withdrawal by Subject|2|||
106161958|NCT06424236|366255417|FG000|Overall Study|Physician Decision|0|||
106161959|NCT06424236|366255418|FG001|Overall Study|Physician Decision|1|||
106161960|NCT06424236|366255419|FG002|Overall Study|Physician Decision|0|||
106161961|NCT06424236|366255417|FG000|Overall Study|Study Terminated by Sponsor|11|||
106161962|NCT06424236|366255418|FG001|Overall Study|Study Terminated by Sponsor|20|||
106161963|NCT06424236|366255419|FG002|Overall Study|Study Terminated by Sponsor|16|||
106161964|NCT06424236|366255417|FG000|Overall Study|Lost to Follow-up|0|||
106161965|NCT06424236|366255418|FG001|Overall Study|Lost to Follow-up|1|||
106161966|NCT06424236|366255419|FG002|Overall Study|Lost to Follow-up|0|||
106161967|NCT06424236|366255417|FG000|Overall Study|Disease Progression|0|||
106161968|NCT06424236|366255418|FG001|Overall Study|Disease Progression|1|||
106161969|NCT06424236|366255419|FG002|Overall Study|Disease Progression|2|||
106161970|NCT06424236|366255417|FG000|Overall Study|Other|0|||
106161971|NCT06424236|366255418|FG001|Overall Study|Other|0|||
106161972|NCT06424236|366255419|FG002|Overall Study|Other|1|||
106161973|NCT01902173|366255423|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
106161974|NCT01902173|366255424|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
106090844|NCT04096560|365991336|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
106090845|NCT04096560|365991337|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
106090846|NCT00096941|365991340|FG000|Overall Study|disease progression|3|||
106090847|NCT04796610|365991341|FG000|Overall Study|Withdrawal by Subject|1|||
106090848|NCT04796610|365991342|FG001|Overall Study|Withdrawal by Subject|0|||
106090849|NCT04796610|365991343|FG002|Overall Study|Withdrawal by Subject|0|||
106090850|NCT04796610|365991344|FG003|Overall Study|Withdrawal by Subject|0|||
106090851|NCT04796610|365991341|FG000|Overall Study|Lost to Follow-up|2|||
106090852|NCT04796610|365991342|FG001|Overall Study|Lost to Follow-up|0|||
106090853|NCT04796610|365991343|FG002|Overall Study|Lost to Follow-up|1|||
106090854|NCT04796610|365991344|FG003|Overall Study|Lost to Follow-up|1|||
106090855|NCT02059148|365991345|FG000|Treatment 1|Protocol Violation|0|||
106090856|NCT02059148|365991346|FG001|Treatment 1|Protocol Violation|0|||
106090857|NCT02059148|365991347|FG002|Treatment 1|Protocol Violation|0|||
106090858|NCT02059148|365991348|FG003|Treatment 1|Protocol Violation|0|||
106090859|NCT02059148|365991349|FG004|Treatment 1|Protocol Violation|0|||
106090860|NCT02059148|365991350|FG005|Treatment 1|Protocol Violation|1|||
106090861|NCT00022516|365991354|FG000|Overall Study|Adverse Event|0|||
106090862|NCT00022516|365991355|FG001|Overall Study|Adverse Event|59|||
106090863|NCT00022516|365991354|FG000|Overall Study|Lack of Efficacy|0|||
106090864|NCT00022516|365991355|FG001|Overall Study|Lack of Efficacy|27|||
106090865|NCT00022516|365991354|FG000|Overall Study|Physician Decision|0|||
106090866|NCT00022516|365991355|FG001|Overall Study|Physician Decision|1|||
106090867|NCT00022516|365991354|FG000|Overall Study|Protocol Violation|1|||
106090868|NCT00022516|365991355|FG001|Overall Study|Protocol Violation|3|||
106090869|NCT00022516|365991354|FG000|Overall Study|Withdrawal by Subject|2|||
106090870|NCT00022516|365991355|FG001|Overall Study|Withdrawal by Subject|113|||
106090871|NCT00022516|365991354|FG000|Overall Study|Incomplete documentation|0|||
106090872|NCT00022516|365991355|FG001|Overall Study|Incomplete documentation|27|||
106090873|NCT01785602|365991356|FG000|Overall Study|Withdrawal by Subject|2|||
106090874|NCT01785602|365991357|FG001|Overall Study|Withdrawal by Subject|0|||
106090875|NCT01785602|365991356|FG000|Overall Study|Lost to Follow-up|1|||
106090876|NCT01785602|365991357|FG001|Overall Study|Lost to Follow-up|1|||
106090877|NCT01785602|365991356|FG000|Overall Study|Adverse Event|3|||
106090878|NCT01785602|365991357|FG001|Overall Study|Adverse Event|5|||
106090879|NCT01785602|365991356|FG000|Overall Study|Administrative problems|7|||
106090880|NCT01785602|365991357|FG001|Overall Study|Administrative problems|3|||
106090881|NCT02778204|365991360|FG000|Overall Study|Adverse Event|1|||
106090882|NCT02778204|365991361|FG001|Overall Study|Adverse Event|0|||
106090883|NCT02778204|365991362|FG002|Overall Study|Adverse Event|0|||
106090884|NCT02778204|365991363|FG003|Overall Study|Adverse Event|0|||
106090885|NCT02778204|365991360|FG000|Overall Study|Withdrawal by Subject|0|||
106090886|NCT02778204|365991361|FG001|Overall Study|Withdrawal by Subject|0|||
106090887|NCT02778204|365991362|FG002|Overall Study|Withdrawal by Subject|1|||
106090888|NCT02778204|365991363|FG003|Overall Study|Withdrawal by Subject|2|||
106090889|NCT02778204|365991360|FG000|Overall Study|Lost to Follow-up|1|||
106090890|NCT02778204|365991361|FG001|Overall Study|Lost to Follow-up|0|||
106090891|NCT02778204|365991362|FG002|Overall Study|Lost to Follow-up|2|||
106090892|NCT02778204|365991363|FG003|Overall Study|Lost to Follow-up|1|||
106090893|NCT02778204|365991360|FG000|Overall Study|Protocol Violation|0|||
106090894|NCT02778204|365991361|FG001|Overall Study|Protocol Violation|0|||
106090895|NCT02778204|365991362|FG002|Overall Study|Protocol Violation|1|||
106090896|NCT02778204|365991363|FG003|Overall Study|Protocol Violation|0|||
106090897|NCT02778204|365991360|FG000|Overall Study|Eligibility Violation|0|||
106090898|NCT02778204|365991361|FG001|Overall Study|Eligibility Violation|0|||
106090899|NCT02778204|365991362|FG002|Overall Study|Eligibility Violation|0|||
106090900|NCT02778204|365991363|FG003|Overall Study|Eligibility Violation|1|||
106090901|NCT05204134|365991366|FG000|Overall Study|Withdrawal by Subject|3|||
106090902|NCT05204134|365991366|FG000|Overall Study|Physician Decision|1|||
106090903|NCT00129259|365991368|FG000|Overall Study|Lost to Follow-up|1|||
106090904|NCT00129259|365991369|FG001|Overall Study|Lost to Follow-up|1|||
106090905|NCT00129259|365991368|FG000|Overall Study|Withdrawal by Subject|2|||
106090906|NCT00129259|365991369|FG001|Overall Study|Withdrawal by Subject|1|||
105867255|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
106090907|NCT00129259|365991368|FG000|Overall Study|Only available minimal phone assessments|0|||
106090908|NCT00129259|365991369|FG001|Overall Study|Only available minimal phone assessments|1|||
106090909|NCT05789875|365991370|FG000|Overall Study|Lost to Follow-up|6|||
106090910|NCT01663636|365991371|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
106090911|NCT01663636|365991372|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
106090912|NCT02120924|365991373|FG000|Overall Study|Lack of Efficacy|1|||
106090913|NCT02120924|365991374|FG001|Overall Study|Lack of Efficacy|2|||
106090914|NCT02120924|365991375|FG002|Overall Study|Lack of Efficacy|3|||
106090915|NCT02120924|365991373|FG000|Overall Study|Adverse Event|0|||
106090916|NCT02120924|365991374|FG001|Overall Study|Adverse Event|1|||
106090917|NCT02120924|365991375|FG002|Overall Study|Adverse Event|3|||
106090918|NCT02120924|365991373|FG000|Overall Study|Withdrawal by Subject|16|||
106090919|NCT02120924|365991374|FG001|Overall Study|Withdrawal by Subject|20|||
106090920|NCT02120924|365991375|FG002|Overall Study|Withdrawal by Subject|8|||
106090921|NCT02120924|365991373|FG000|Overall Study|Lost to Follow-up|14|||
106090922|NCT02120924|365991374|FG001|Overall Study|Lost to Follow-up|14|||
106090923|NCT02120924|365991375|FG002|Overall Study|Lost to Follow-up|11|||
106090924|NCT02120924|365991373|FG000|Overall Study|Pregnancy|2|||
106090925|NCT02120924|365991374|FG001|Overall Study|Pregnancy|0|||
106090926|NCT02120924|365991375|FG002|Overall Study|Pregnancy|0|||
106090927|NCT02120924|365991373|FG000|Overall Study|Protocol Violation|3|||
106090928|NCT02120924|365991374|FG001|Overall Study|Protocol Violation|7|||
106090929|NCT02120924|365991375|FG002|Overall Study|Protocol Violation|2|||
106090930|NCT02120924|365991373|FG000|Overall Study|Physician Decision|0|||
106090931|NCT02120924|365991374|FG001|Overall Study|Physician Decision|1|||
106090932|NCT02120924|365991375|FG002|Overall Study|Physician Decision|1|||
106090933|NCT02120924|365991373|FG000|Overall Study|Death|1|||
106090934|NCT02120924|365991374|FG001|Overall Study|Death|0|||
106090935|NCT02120924|365991375|FG002|Overall Study|Death|0|||
106090936|NCT02120924|365991373|FG000|Overall Study|Compliance with IP|5|||
106090937|NCT02120924|365991374|FG001|Overall Study|Compliance with IP|1|||
106090938|NCT02120924|365991375|FG002|Overall Study|Compliance with IP|1|||
106090939|NCT02766608|365993309|FG000|Overall Study|Adverse Event|27|||
106090940|NCT02766608|365993310|FG001|Overall Study|Adverse Event|22|||
106090941|NCT02766608|365993311|FG002|Overall Study|Adverse Event|17|||
106090942|NCT02766608|365993312|FG003|Overall Study|Adverse Event|13|||
106090943|NCT02766608|365993313|FG004|Overall Study|Adverse Event|12|||
106090944|NCT02766608|365993309|FG000|Overall Study|Withdrawal by Subject|21|||
106090945|NCT02766608|365993310|FG001|Overall Study|Withdrawal by Subject|20|||
106090946|NCT02766608|365993311|FG002|Overall Study|Withdrawal by Subject|24|||
106090947|NCT02766608|365993312|FG003|Overall Study|Withdrawal by Subject|13|||
106090948|NCT02766608|365993313|FG004|Overall Study|Withdrawal by Subject|10|||
106090949|NCT02766608|365993309|FG000|Overall Study|Lack of Efficacy|16|||
106090950|NCT02766608|365993310|FG001|Overall Study|Lack of Efficacy|15|||
106090951|NCT02766608|365993311|FG002|Overall Study|Lack of Efficacy|32|||
106090952|NCT02766608|365993312|FG003|Overall Study|Lack of Efficacy|8|||
106090953|NCT02766608|365993313|FG004|Overall Study|Lack of Efficacy|2|||
106090954|NCT02766608|365993309|FG000|Overall Study|Lost to Follow-up|6|||
106090955|NCT02766608|365993310|FG001|Overall Study|Lost to Follow-up|3|||
106090956|NCT02766608|365993311|FG002|Overall Study|Lost to Follow-up|5|||
106090957|NCT02766608|365993312|FG003|Overall Study|Lost to Follow-up|2|||
106090958|NCT02766608|365993313|FG004|Overall Study|Lost to Follow-up|2|||
106090959|NCT02766608|365993309|FG000|Overall Study|Physician Decision|3|||
106090960|NCT02766608|365993310|FG001|Overall Study|Physician Decision|2|||
106090961|NCT02766608|365993311|FG002|Overall Study|Physician Decision|3|||
106090962|NCT02766608|365993312|FG003|Overall Study|Physician Decision|1|||
106090963|NCT02766608|365993313|FG004|Overall Study|Physician Decision|2|||
106090964|NCT02766608|365993309|FG000|Overall Study|Protocol disc criteria|3|||
106090965|NCT02766608|365993310|FG001|Overall Study|Protocol disc criteria|3|||
106090966|NCT02766608|365993311|FG002|Overall Study|Protocol disc criteria|4|||
106090967|NCT02766608|365993312|FG003|Overall Study|Protocol disc criteria|0|||
106090968|NCT02766608|365993313|FG004|Overall Study|Protocol disc criteria|0|||
106090969|NCT02766608|365993309|FG000|Overall Study|Protocol Violation|0|||
106090970|NCT02766608|365993310|FG001|Overall Study|Protocol Violation|4|||
106090971|NCT02766608|365993311|FG002|Overall Study|Protocol Violation|4|||
106090972|NCT02766608|365993312|FG003|Overall Study|Protocol Violation|0|||
106090973|NCT02766608|365993313|FG004|Overall Study|Protocol Violation|1|||
106090974|NCT02766608|365993309|FG000|Overall Study|Administrative Reasons|3|||
106090975|NCT02766608|365993310|FG001|Overall Study|Administrative Reasons|1|||
106090976|NCT02766608|365993311|FG002|Overall Study|Administrative Reasons|1|||
106090977|NCT02766608|365993312|FG003|Overall Study|Administrative Reasons|0|||
106090978|NCT02766608|365993313|FG004|Overall Study|Administrative Reasons|0|||
106090979|NCT02066298|365993314|FG000|Overall Study|Lost to Follow-up|3|||
106090980|NCT02066298|365993315|FG001|Overall Study|Lost to Follow-up|2|||
106090981|NCT02066298|365993316|FG002|Overall Study|Lost to Follow-up|3|||
106090982|NCT02066298|365993317|FG003|Overall Study|Lost to Follow-up|2|||
106090983|NCT02066298|365993318|FG004|Overall Study|Lost to Follow-up|3|||
106090984|NCT02066298|365993319|FG005|Overall Study|Lost to Follow-up|4|||
106090985|NCT02066298|365993314|FG000|Overall Study|Withdrawal by Subject|6|||
106090986|NCT02066298|365993315|FG001|Overall Study|Withdrawal by Subject|6|||
106090987|NCT02066298|365993316|FG002|Overall Study|Withdrawal by Subject|6|||
106090988|NCT02066298|365993317|FG003|Overall Study|Withdrawal by Subject|4|||
106090989|NCT02066298|365993318|FG004|Overall Study|Withdrawal by Subject|5|||
106090990|NCT02066298|365993319|FG005|Overall Study|Withdrawal by Subject|8|||
106090991|NCT02066298|365993314|FG000|Overall Study|Physician Decision|0|||
106090992|NCT02066298|365993315|FG001|Overall Study|Physician Decision|0|||
106090993|NCT02066298|365993316|FG002|Overall Study|Physician Decision|1|||
106090994|NCT02066298|365993317|FG003|Overall Study|Physician Decision|0|||
106090995|NCT02066298|365993318|FG004|Overall Study|Physician Decision|1|||
106090996|NCT02066298|365993319|FG005|Overall Study|Physician Decision|0|||
106090997|NCT02033889|365993322|FG000|Overall Study|Adverse Event|3|||
106090998|NCT02033889|365993323|FG001|Overall Study|Adverse Event|1|||
106090999|NCT02033889|365993324|FG002|Overall Study|Adverse Event|3|||
106091000|NCT02033889|365993322|FG000|Overall Study|Death|3|||
106091001|NCT02033889|365993323|FG001|Overall Study|Death|1|||
106091002|NCT02033889|365993324|FG002|Overall Study|Death|2|||
106091003|NCT02033889|365993322|FG000|Overall Study|Excluded Medication|1|||
106091004|NCT02033889|365993323|FG001|Overall Study|Excluded Medication|1|||
106091005|NCT02033889|365993324|FG002|Overall Study|Excluded Medication|0|||
106091006|NCT02033889|365993322|FG000|Overall Study|Lost to Follow-up|8|||
106091007|NCT02033889|365993323|FG001|Overall Study|Lost to Follow-up|5|||
106091008|NCT02033889|365993324|FG002|Overall Study|Lost to Follow-up|6|||
106091009|NCT02033889|365993322|FG000|Overall Study|Non-Compliance With Study Drug|1|||
106091010|NCT02033889|365993323|FG001|Overall Study|Non-Compliance With Study Drug|0|||
106091011|NCT02033889|365993324|FG002|Overall Study|Non-Compliance With Study Drug|0|||
106091012|NCT02033889|365993322|FG000|Overall Study|Physician Decision|0|||
106091013|NCT02033889|365993323|FG001|Overall Study|Physician Decision|1|||
106091014|NCT02033889|365993324|FG002|Overall Study|Physician Decision|1|||
106091015|NCT02033889|365993322|FG000|Overall Study|Participant moved|0|||
106091016|NCT02033889|365993323|FG001|Overall Study|Participant moved|1|||
106091017|NCT02033889|365993324|FG002|Overall Study|Participant moved|0|||
106091018|NCT02033889|365993322|FG000|Overall Study|Withdrawal by Subject|18|||
106091019|NCT02033889|365993323|FG001|Overall Study|Withdrawal by Subject|10|||
106091020|NCT02033889|365993324|FG002|Overall Study|Withdrawal by Subject|13|||
106091021|NCT01043874|365993329|FG000|Overall Study|Adverse Event|3|||
106091022|NCT01043874|365993329|FG000|Overall Study|Withdrawal by Subject|1|||
106091023|NCT01043874|365993329|FG000|Overall Study|Lack of Efficacy|1|||
106091024|NCT01043874|365993329|FG000|Overall Study|Administrative Problems|1|||
106091025|NCT00182689|365993335|FG000|Overall Study|Adverse Event|8|||
106091026|NCT00182689|365993336|FG001|Overall Study|Adverse Event|11|||
106091027|NCT00182689|365993335|FG000|Overall Study|Withdrawal by Subject|2|||
106091028|NCT00182689|365993336|FG001|Overall Study|Withdrawal by Subject|2|||
106091029|NCT00182689|365993335|FG000|Overall Study|Progression|27|||
106091030|NCT00182689|365993336|FG001|Overall Study|Progression|29|||
106091031|NCT00182689|365993335|FG000|Overall Study|Death|1|||
106091032|NCT00182689|365993336|FG001|Overall Study|Death|0|||
106091033|NCT00182689|365993335|FG000|Overall Study|not protocol specified|0|||
106091034|NCT00182689|365993336|FG001|Overall Study|not protocol specified|3|||
106091035|NCT00182689|365993335|FG000|Overall Study|Ineligible|1|||
106091036|NCT00182689|365993336|FG001|Overall Study|Ineligible|4|||
106091037|NCT00182689|365993335|FG000|Overall Study|Never received treatment|1|||
106091038|NCT00182689|365993336|FG001|Overall Study|Never received treatment|0|||
106091039|NCT03422003|365993337|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
106091040|NCT03422003|365993338|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
106091041|NCT03422003|365993337|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
106091042|NCT03422003|365993338|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
106091043|NCT01337089|365993339|FG000|Overall Study|Adverse Event|237|||
106091044|NCT01337089|365993339|FG000|Overall Study|Withdrawal by Subject|129|||
106091045|NCT01337089|365993339|FG000|Overall Study|Withdrawal by Investigator|33|||
106091046|NCT01337089|365993339|FG000|Overall Study|Met Withdrawal Criteria|3|||
106091047|NCT01337089|365993339|FG000|Overall Study|Lost to Follow-up|2|||
106091048|NCT03087591|365993340|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
106091049|NCT03087591|365993340|FG000|Overall Study|Withdrawal by Subject|1|||
106091050|NCT02032901|365993341|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
106091051|NCT02032901|365993342|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
106091052|NCT02032901|365993341|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
106091053|NCT02032901|365993342|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
106091054|NCT03003676|365993343|FG000|Overall Study|Lack of Efficacy|5|||
106091055|NCT03003676|365993344|FG001|Overall Study|Lack of Efficacy|7|||
106091056|NCT03003676|365993343|FG000|Overall Study|Withdrawal by Subject|0|||
106091057|NCT03003676|365993344|FG001|Overall Study|Withdrawal by Subject|1|||
106091058|NCT03003676|365993343|FG000|Overall Study|Hepatitis B infection|1|||
106091059|NCT03003676|365993344|FG001|Overall Study|Hepatitis B infection|0|||
106091060|NCT01762761|365993356|FG000|Overall Study|Adverse Event|15|||
106091061|NCT01762761|365993357|FG001|Overall Study|Adverse Event|17|||
106091062|NCT01762761|365993356|FG000|Overall Study|Lack of Efficacy|9|||
106091063|NCT01762761|365993357|FG001|Overall Study|Lack of Efficacy|25|||
106091064|NCT01762761|365993356|FG000|Overall Study|Protocol Violation|1|||
106091065|NCT01762761|365993357|FG001|Overall Study|Protocol Violation|1|||
106091066|NCT01762761|365993356|FG000|Overall Study|Study closed/terminated|0|||
106091067|NCT01762761|365993357|FG001|Overall Study|Study closed/terminated|2|||
106091068|NCT01762761|365993356|FG000|Overall Study|Lost to Follow-up|3|||
106091069|NCT01762761|365993357|FG001|Overall Study|Lost to Follow-up|6|||
106091070|NCT01762761|365993356|FG000|Overall Study|Physician Decision|4|||
106091071|NCT01762761|365993357|FG001|Overall Study|Physician Decision|6|||
106091072|NCT01762761|365993356|FG000|Overall Study|Withdrawal by Subject|7|||
106091073|NCT01762761|365993357|FG001|Overall Study|Withdrawal by Subject|8|||
106091074|NCT00575588|365993361|FG000|Overall Study|Adverse Event|11|||
106091075|NCT00575588|365993362|FG001|Overall Study|Adverse Event|13|||
106091076|NCT00575588|365993361|FG000|Overall Study|Withdrawal by Subject|27|||
106091077|NCT00575588|365993362|FG001|Overall Study|Withdrawal by Subject|31|||
106091078|NCT00575588|365993361|FG000|Overall Study|Lost to Follow-up|1|||
106091079|NCT00575588|365993362|FG001|Overall Study|Lost to Follow-up|3|||
106091080|NCT00575588|365993361|FG000|Overall Study|Death|4|||
106091081|NCT00575588|365993362|FG001|Overall Study|Death|2|||
106091082|NCT00575588|365993361|FG000|Overall Study|Incorrect enrollment|8|||
106091083|NCT00575588|365993362|FG001|Overall Study|Incorrect enrollment|4|||
106091084|NCT00575588|365993361|FG000|Overall Study|Study specific discontinuation criteria|203|||
106091085|NCT00575588|365993362|FG001|Overall Study|Study specific discontinuation criteria|218|||
106091086|NCT00575588|365993361|FG000|Overall Study|Severe non-compliance to protocol|5|||
106091087|NCT00575588|365993362|FG001|Overall Study|Severe non-compliance to protocol|7|||
106091088|NCT00575588|365993361|FG000|Overall Study|Safety reasons|2|||
106091089|NCT00575588|365993362|FG001|Overall Study|Safety reasons|1|||
106091090|NCT00575588|365993361|FG000|Overall Study|Elevated triglyceride|1|||
106091091|NCT00575588|365993362|FG001|Overall Study|Elevated triglyceride|0|||
106091092|NCT00575588|365993361|FG000|Overall Study|Patient moved|1|||
106091093|NCT00575588|365993362|FG001|Overall Study|Patient moved|3|||
106091094|NCT00575588|365993361|FG000|Overall Study|Impossible to determine HbA1c|0|||
106091095|NCT00575588|365993362|FG001|Overall Study|Impossible to determine HbA1c|1|||
106091096|NCT00377676|365993363|FG000|Overall Study|Adverse Event|498|||
106091097|NCT00377676|365993364|FG001|Overall Study|Adverse Event|107|||
106091098|NCT00377676|365993363|FG000|Overall Study|Protocol Violation|33|||
106091099|NCT00377676|365993364|FG001|Overall Study|Protocol Violation|27|||
106091100|NCT00377676|365993363|FG000|Overall Study|Death|5|||
106091101|NCT00377676|365993364|FG001|Overall Study|Death|2|||
106091102|NCT00377676|365993363|FG000|Overall Study|Withdrawal by Subject|187|||
106091103|NCT00377676|365993364|FG001|Overall Study|Withdrawal by Subject|72|||
106091104|NCT00377676|365993363|FG000|Overall Study|Lost to Follow-up|120|||
106091105|NCT00377676|365993364|FG001|Overall Study|Lost to Follow-up|56|||
106091106|NCT00377676|365993363|FG000|Overall Study|Other|118|||
106091107|NCT00377676|365993364|FG001|Overall Study|Other|58|||
106091108|NCT00614939|365993366|FG000|Overall Study|Withdrawal by Subject|10|||
106091109|NCT00614939|365993367|FG001|Overall Study|Withdrawal by Subject|17|||
106091110|NCT00614939|365993366|FG000|Overall Study|Study specific discontinuation criteris|13|||
106091111|NCT00614939|365993367|FG001|Overall Study|Study specific discontinuation criteris|16|||
106091112|NCT00614939|365993366|FG000|Overall Study|Adverse Event|2|||
106091113|NCT00614939|365993367|FG001|Overall Study|Adverse Event|5|||
106091114|NCT00614939|365993366|FG000|Overall Study|Incorrect enrollment|1|||
106091115|NCT00614939|365993367|FG001|Overall Study|Incorrect enrollment|2|||
106091116|NCT00614939|365993366|FG000|Overall Study|Death|4|||
106091117|NCT00614939|365993367|FG001|Overall Study|Death|3|||
106091118|NCT00614939|365993366|FG000|Overall Study|Poor/non-compliance|4|||
106091119|NCT00614939|365993367|FG001|Overall Study|Poor/non-compliance|0|||
106091120|NCT00614939|365993366|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
106091121|NCT00614939|365993367|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
106091122|NCT00504829|365993368|FG000|Overall Study|Protocol Violation|6|||
106091123|NCT00504829|365993369|FG001|Overall Study|Protocol Violation|4|||
106091124|NCT00504829|365993370|FG002|Overall Study|Protocol Violation|10|||
106091125|NCT00462384|365993371|FG000|Overall Study|Adverse Event|2|||
106091126|NCT00462384|365993371|FG000|Overall Study|Death|2|||
106091127|NCT00462384|365993371|FG000|Overall Study|Withdrawal by Subject|1|||
106091128|NCT00462384|365993371|FG000|Overall Study|Other|4|||
106091129|NCT02571452|365993372|FG000|Overall Study Treatment|Protocol Violation|0|||
106091130|NCT02571452|365993373|FG001|Overall Study Treatment|Protocol Violation|1|||
106091131|NCT02571452|365993372|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
106091132|NCT02571452|365993373|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
106091133|NCT02571452|365993372|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
106091134|NCT02571452|365993373|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
106091135|NCT01751568|365993374|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
106091136|NCT01751568|365993375|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
106091137|NCT01751568|365993376|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
106091138|NCT02660944|365993377|FG000|Overall Study|Adverse Event|3|||
106091139|NCT02660944|365993378|FG001|Overall Study|Adverse Event|4|||
106091140|NCT02660944|365993377|FG000|Overall Study|Physician Decision|3|||
106091141|NCT02660944|365993378|FG001|Overall Study|Physician Decision|1|||
106091142|NCT02660944|365993377|FG000|Overall Study|Withdrawal by Subject|5|||
106091143|NCT02660944|365993378|FG001|Overall Study|Withdrawal by Subject|3|||
106091144|NCT02660944|365993377|FG000|Overall Study|Lost to Follow-up|4|||
106091145|NCT02660944|365993378|FG001|Overall Study|Lost to Follow-up|1|||
106091146|NCT02660944|365993377|FG000|Overall Study|Subject schedule|0|||
106091147|NCT02660944|365993378|FG001|Overall Study|Subject schedule|1|||
106091148|NCT02660944|365993377|FG000|Overall Study|Exclusion criteria met|2|||
106091149|NCT02660944|365993378|FG001|Overall Study|Exclusion criteria met|0|||
106091150|NCT04776148|365993379|FG000|Overall Study|Death|172|||
106091151|NCT04776148|365993380|FG001|Overall Study|Death|188|||
106091152|NCT04776148|365993379|FG000|Overall Study|Lost to Follow-up|0|||
106091153|NCT04776148|365993380|FG001|Overall Study|Lost to Follow-up|1|||
106091154|NCT04776148|365993379|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
106091155|NCT04776148|365993380|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
106091156|NCT04776148|365993379|FG000|Overall Study|Withdrawal by Subject|2|||
106091157|NCT04776148|365993380|FG001|Overall Study|Withdrawal by Subject|4|||
106091158|NCT04776148|365993379|FG000|Overall Study|Ongoing in Study|67|||
106091159|NCT04776148|365993380|FG001|Overall Study|Ongoing in Study|45|||
106091160|NCT03586999|365993381|FG000|Overall Study|Lack of Efficacy|2|||
106091161|NCT02464969|365993382|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
106091162|NCT02464969|365993383|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
106091163|NCT02464969|365993382|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
106091164|NCT02464969|365993383|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
106091165|NCT02464969|365993382|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
106091166|NCT02464969|365993383|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
106091167|NCT02464969|365993382|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
106091168|NCT02464969|365993383|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
106091169|NCT02464969|365993382|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
106091170|NCT02464969|365993383|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
106091171|NCT02464969|365993382|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
106091172|NCT02464969|365993383|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
106091173|NCT02464969|365993382|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
106091174|NCT02464969|365993383|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
106091175|NCT02464969|365993382|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
106091176|NCT02464969|365993383|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
106091177|NCT02464969|365993382|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
106091178|NCT02464969|365993383|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
106091179|NCT02464969|365993382|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
106091180|NCT02464969|365993383|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
106091181|NCT02464969|365993382|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
106091182|NCT02464969|365993383|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
106091183|NCT00534352|365993384|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
106091184|NCT00534352|365993384|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
106091185|NCT00534352|365993384|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
106091186|NCT00534352|365993384|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
106091187|NCT00534352|365993384|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
106091188|NCT00534352|365993384|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
106091189|NCT01986829|365993401|FG000|Overall Study|Death|1|||
106091190|NCT02504866|365993402|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
106091191|NCT02504866|365993403|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
106091192|NCT02504866|365993404|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
106091193|NCT05101252|365993407|FG000|Overall Study|Unsatisfactory Test Article|1|||
106091194|NCT05101252|365993408|FG001|Overall Study|Unsatisfactory Test Article|0|||
106091195|NCT05101252|365993407|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
106091196|NCT05101252|365993408|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
106091197|NCT05101252|365993407|FG000|Overall Study|Withdrew Consent during study|0|||
106091198|NCT05101252|365993408|FG001|Overall Study|Withdrew Consent during study|1|||
106091199|NCT05101252|365993407|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
106091200|NCT05101252|365993408|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
106091201|NCT02401672|365993411|FG000|Overall Study|Withdrawal by Subject|1|||
106091202|NCT02401672|365993412|FG001|Overall Study|Withdrawal by Subject|3|||
106091203|NCT00701051|365993413|FG000|Screening|Failed Screening|40|||
106091204|NCT00701051|365993414|FG001|Screening|Failed Screening|0|||
106091205|NCT00701051|365993415|FG002|Screening|Failed Screening|0|||
106091206|NCT00701051|365993413|FG000|Screening|Time conflicts|19|||
106091207|NCT00701051|365993414|FG001|Screening|Time conflicts|0|||
106091208|NCT00701051|365993415|FG002|Screening|Time conflicts|0|||
106091209|NCT00701051|365993413|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
106091210|NCT00701051|365993414|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
106091211|NCT00701051|365993415|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
106091212|NCT01731171|365993422|FG000|Overall Study|Withdrawal by Subject|4|||
106091213|NCT01731171|365993423|FG001|Overall Study|Withdrawal by Subject|1|||
106091214|NCT01731171|365993422|FG000|Overall Study|Lost to Follow-up|3|||
106091215|NCT01731171|365993423|FG001|Overall Study|Lost to Follow-up|2|||
106091216|NCT01731171|365993422|FG000|Overall Study|Moved out of Area|0|||
106091217|NCT01731171|365993423|FG001|Overall Study|Moved out of Area|2|||
106091218|NCT01731171|365993422|FG000|Overall Study|Terminated for Lack of Adherence|0|||
106091219|NCT01731171|365993423|FG001|Overall Study|Terminated for Lack of Adherence|1|||
106091220|NCT01731171|365993422|FG000|Overall Study|Terminated for Safety Reasons|0|||
106091221|NCT01731171|365993423|FG001|Overall Study|Terminated for Safety Reasons|1|||
106091222|NCT01410110|365993424|FG000|Overall Study|Withdrawal by Subject|4|||
106091223|NCT01410110|365993425|FG001|Overall Study|Withdrawal by Subject|2|||
106091224|NCT03653429|365993428|FG000|Overall Study|Physician Decision|4|||
106091225|NCT03653429|365993429|FG001|Overall Study|Physician Decision|10|||
106091226|NCT00403546|365993436|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
106091227|NCT00403546|365993437|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
106091228|NCT00403546|365993438|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
106091229|NCT00403546|365993436|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
106091230|NCT00403546|365993437|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
106091231|NCT00403546|365993438|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
106091232|NCT00403546|365993436|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
106091233|NCT00403546|365993437|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
106091234|NCT00403546|365993438|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
106091235|NCT00403546|365993436|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
106091236|NCT00403546|365993437|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
106091237|NCT00403546|365993438|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
106091238|NCT00403546|365993436|FG000|Screening Phase|Screening Failure|22|||
106091239|NCT00403546|365993437|FG001|Screening Phase|Screening Failure|0|||
106091240|NCT00403546|365993438|FG002|Screening Phase|Screening Failure|0|||
106091241|NCT00403546|365993436|FG000|Screening Phase|Adverse Event|1|||
106091242|NCT00403546|365993437|FG001|Screening Phase|Adverse Event|0|||
106091243|NCT00403546|365993438|FG002|Screening Phase|Adverse Event|0|||
106091244|NCT00403546|365993436|FG000|Screening Phase|Terminated Prior to Randomization|5|||
106091245|NCT00403546|365993437|FG001|Screening Phase|Terminated Prior to Randomization|0|||
106091246|NCT00403546|365993438|FG002|Screening Phase|Terminated Prior to Randomization|0|||
106091247|NCT00403546|365993436|FG000|Randomized Trial|Early Terminations|0|||
106091248|NCT00403546|365993437|FG001|Randomized Trial|Early Terminations|17|||
106091249|NCT00403546|365993438|FG002|Randomized Trial|Early Terminations|16|||
106091250|NCT00437489|365993439|FG000|Overall Study|Study terminated by sponsor|23|||
106091251|NCT00437489|365993440|FG001|Overall Study|Study terminated by sponsor|21|||
106091252|NCT00437489|365993439|FG000|Overall Study|Lost to Follow-up|0|||
106091253|NCT00437489|365993440|FG001|Overall Study|Lost to Follow-up|1|||
106091254|NCT03893448|365993448|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
106091255|NCT03893448|365993449|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
106091256|NCT03893448|365993448|FG000|Overall Study|Physician Decision|8|||
106091257|NCT03893448|365993449|FG001|Overall Study|Physician Decision|14|||
106091258|NCT03893448|365993448|FG000|Overall Study|Lost to Follow-up|34|||
106091259|NCT03893448|365993449|FG001|Overall Study|Lost to Follow-up|27|||
106091260|NCT03893448|365993448|FG000|Overall Study|Death|1|||
106091261|NCT03893448|365993449|FG001|Overall Study|Death|0|||
106091262|NCT04177108|365993456|FG000|Overall Study|Withdrawal by Subject|4|||
106091263|NCT04177108|365993457|FG001|Overall Study|Withdrawal by Subject|8|||
106091264|NCT04177108|365993458|FG002|Overall Study|Withdrawal by Subject|9|||
106091265|NCT04177108|365993459|FG003|Overall Study|Withdrawal by Subject|11|||
106091266|NCT04177108|365993460|FG004|Overall Study|Withdrawal by Subject|13|||
106091267|NCT04177108|365993456|FG000|Overall Study|Physician Decision|23|||
106091268|NCT04177108|365993457|FG001|Overall Study|Physician Decision|15|||
106091269|NCT04177108|365993458|FG002|Overall Study|Physician Decision|18|||
106091270|NCT04177108|365993459|FG003|Overall Study|Physician Decision|29|||
106091271|NCT04177108|365993460|FG004|Overall Study|Physician Decision|23|||
106091272|NCT04177108|365993456|FG000|Overall Study|Reason Not Specified|0|||
106091273|NCT04177108|365993457|FG001|Overall Study|Reason Not Specified|1|||
106091274|NCT04177108|365993458|FG002|Overall Study|Reason Not Specified|0|||
106091275|NCT04177108|365993459|FG003|Overall Study|Reason Not Specified|0|||
106091276|NCT04177108|365993460|FG004|Overall Study|Reason Not Specified|2|||
106091277|NCT04177108|365993456|FG000|Overall Study|Lost to Follow-up|0|||
106091278|NCT04177108|365993457|FG001|Overall Study|Lost to Follow-up|0|||
106091279|NCT04177108|365993458|FG002|Overall Study|Lost to Follow-up|1|||
106091280|NCT04177108|365993459|FG003|Overall Study|Lost to Follow-up|1|||
106091281|NCT04177108|365993460|FG004|Overall Study|Lost to Follow-up|1|||
106091282|NCT04177108|365993456|FG000|Overall Study|Death|16|||
106091283|NCT04177108|365993457|FG001|Overall Study|Death|19|||
106091284|NCT04177108|365993458|FG002|Overall Study|Death|13|||
106091285|NCT04177108|365993459|FG003|Overall Study|Death|17|||
106091286|NCT04177108|365993460|FG004|Overall Study|Death|18|||
106091287|NCT03855189|365993461|FG000|Overall Study|Adverse Event|5|||
106091288|NCT03855189|365993462|FG001|Overall Study|Adverse Event|2|||
106091289|NCT03855189|365993463|FG002|Overall Study|Adverse Event|4|||
106091290|NCT03855189|365993461|FG000|Overall Study|Treatment Failure|1|||
106091291|NCT03855189|365993462|FG001|Overall Study|Treatment Failure|1|||
106091292|NCT03855189|365993463|FG002|Overall Study|Treatment Failure|2|||
106091293|NCT03855189|365993461|FG000|Overall Study|Noncompliance with Protocol|0|||
106091294|NCT03855189|365993462|FG001|Overall Study|Noncompliance with Protocol|1|||
105867256|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
106091295|NCT03855189|365993463|FG002|Overall Study|Noncompliance with Protocol|0|||
106091296|NCT03855189|365993461|FG000|Overall Study|Did Not Return|4|||
106091297|NCT03855189|365993462|FG001|Overall Study|Did Not Return|3|||
106091298|NCT03855189|365993463|FG002|Overall Study|Did Not Return|0|||
106091299|NCT03864900|365993464|FG000|Overall Study|Withdrawal by Subject|1|||
106091300|NCT03864900|365993465|FG001|Overall Study|Withdrawal by Subject|1|||
106091301|NCT03864900|365993464|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
106091302|NCT03864900|365993465|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
106091303|NCT01827904|365993466|FG000|Main Study|Withdrawal by Subject|1|||
106091304|NCT01827904|365993467|FG001|Main Study|Withdrawal by Subject|0|||
106091305|NCT01827904|365993468|FG002|Main Study|Withdrawal by Subject|0|||
106091306|NCT01827904|365993466|FG000|Main Study|Adverse Event|1|||
106091307|NCT01827904|365993467|FG001|Main Study|Adverse Event|0|||
106091308|NCT01827904|365993468|FG002|Main Study|Adverse Event|0|||
106091309|NCT01827904|365993466|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
106091310|NCT01827904|365993467|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
106091311|NCT01827904|365993468|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
106091312|NCT01827904|365993466|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
106091313|NCT01827904|365993467|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
106091314|NCT01827904|365993468|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
106091315|NCT01827904|365993466|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
106091316|NCT01827904|365993467|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
106091317|NCT01827904|365993468|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
106091318|NCT01827904|365993466|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
106091319|NCT01827904|365993467|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
106091320|NCT01827904|365993468|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
106091321|NCT01827904|365993466|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
106091322|NCT01827904|365993467|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
106091323|NCT01827904|365993468|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
106091324|NCT01827904|365993466|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
106091325|NCT01827904|365993467|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
106091326|NCT01827904|365993468|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
106091327|NCT01827904|365993466|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
106091328|NCT01827904|365993467|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
106161975|NCT01902173|366255425|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
106161976|NCT01902173|366255426|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
106161977|NCT01902173|366255427|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
106161978|NCT01902173|366255428|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
106161979|NCT01902173|366255423|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
106161980|NCT01902173|366255424|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
106161981|NCT01902173|366255425|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
106161982|NCT01902173|366255426|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
106161983|NCT01902173|366255427|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
106161984|NCT01902173|366255428|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
106161985|NCT01902173|366255423|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
106161986|NCT01902173|366255424|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
106161987|NCT01902173|366255425|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
106161988|NCT01902173|366255426|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
106161989|NCT01902173|366255427|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
106161990|NCT01902173|366255428|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
106161991|NCT01902173|366255423|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
106161992|NCT01902173|366255424|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
106161993|NCT01902173|366255425|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
106161994|NCT01902173|366255426|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
106161995|NCT01902173|366255427|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
106161996|NCT01902173|366255428|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
106161997|NCT01902173|366255423|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
106161998|NCT01902173|366255424|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
106161999|NCT01902173|366255425|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
106162000|NCT01902173|366255426|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
106162001|NCT01902173|366255427|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
106162002|NCT01902173|366255428|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
106162003|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
106162004|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
106162005|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
105867257|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
105867258|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
106091329|NCT01827904|365993468|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
106162006|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
106162007|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
106162008|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
106162009|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
106162010|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
106162011|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
106162012|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
106162013|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
106162014|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
106162015|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
106162016|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
106162017|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
106162018|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
106162019|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
106162020|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
106162021|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
106162022|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
106162023|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
106162024|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
106162025|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
106162026|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
106162027|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
106162028|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
106162029|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
106162030|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
106162031|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
106162032|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
106162033|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
106162034|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
106162035|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
106162036|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
106162037|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
106162038|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
106162039|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
106162040|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
106162041|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
106162042|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
106162043|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
106162044|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
106162045|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
106162046|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
106162047|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
106162048|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
106162049|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
106162050|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
106162051|NCT01902173|366255423|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
106162052|NCT01902173|366255424|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
106162053|NCT01902173|366255425|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
106162054|NCT01902173|366255426|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
106162055|NCT01902173|366255427|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
106162056|NCT01902173|366255428|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
106162057|NCT02817776|366255432|FG000|Overall Study|Excluded|33|||
106162058|NCT02817776|366255432|FG000|Overall Study|Lost to Follow-up|20|||
106162059|NCT02817776|366255432|FG000|Overall Study|Withdrawal by Subject|33|||
106162060|NCT02817776|366255432|FG000|Overall Study|Death|2|||
106162061|NCT04066244|366255433|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
106162062|NCT04066244|366255434|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
106162063|NCT04066244|366255435|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
106162064|NCT04066244|366255436|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
106162065|NCT04066244|366255437|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
106162066|NCT04066244|366255438|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
106162067|NCT04066244|366255433|FG000|Part 2 (Cohort 5)|Death|0|||
106162068|NCT04066244|366255434|FG001|Part 2 (Cohort 5)|Death|0|||
106162069|NCT04066244|366255435|FG002|Part 2 (Cohort 5)|Death|0|||
106162070|NCT04066244|366255436|FG003|Part 2 (Cohort 5)|Death|0|||
106162071|NCT04066244|366255437|FG004|Part 2 (Cohort 5)|Death|0|||
106162072|NCT04066244|366255438|FG005|Part 2 (Cohort 5)|Death|2|||
106162073|NCT04066244|366255433|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
106162074|NCT04066244|366255434|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
106162075|NCT04066244|366255435|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
106162076|NCT04066244|366255436|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
106162077|NCT04066244|366255437|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
106162078|NCT04066244|366255438|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
106162079|NCT04066244|366255433|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
106162080|NCT04066244|366255434|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
106162081|NCT04066244|366255435|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
106162082|NCT04066244|366255436|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
106162083|NCT04066244|366255437|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
106162084|NCT04066244|366255438|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
106162085|NCT03382652|366255440|FG000|Overall Study|Lost to Follow-up|6|||
106162086|NCT03382652|366255440|FG000|Overall Study|Death|4|||
106162087|NCT03382652|366255440|FG000|Overall Study|Revision|5|||
106162088|NCT03382652|366255440|FG000|Overall Study|Patient withdrew|3|||
106162089|NCT03382652|366255440|FG000|Overall Study|Other reasons|21|||
106162090|NCT04810650|366255441|FG000|Overall Study|Disenrolled in error|0|||
106162091|NCT04810650|366255442|FG001|Overall Study|Disenrolled in error|0|||
106162092|NCT04810650|366255443|FG002|Overall Study|Disenrolled in error|0|||
106162093|NCT04810650|366255444|FG003|Overall Study|Disenrolled in error|0|||
106162094|NCT04810650|366255445|FG004|Overall Study|Disenrolled in error|0|||
106162095|NCT04810650|366255446|FG005|Overall Study|Disenrolled in error|0|||
106162096|NCT04810650|366255447|FG006|Overall Study|Disenrolled in error|0|||
106162097|NCT04810650|366255448|FG007|Overall Study|Disenrolled in error|0|||
106162098|NCT04810650|366255449|FG008|Overall Study|Disenrolled in error|1|||
106162099|NCT04810650|366255450|FG009|Overall Study|Disenrolled in error|0|||
106162100|NCT04810650|366255451|FG010|Overall Study|Disenrolled in error|0|||
106162101|NCT04810650|366255452|FG011|Overall Study|Disenrolled in error|0|||
106162102|NCT04810650|366255453|FG012|Overall Study|Disenrolled in error|0|||
106162103|NCT04810650|366255454|FG013|Overall Study|Disenrolled in error|0|||
106162104|NCT04810650|366255441|FG000|Overall Study|Death|0|||
106162105|NCT04810650|366255442|FG001|Overall Study|Death|0|||
106162106|NCT04810650|366255443|FG002|Overall Study|Death|0|||
106162107|NCT04810650|366255444|FG003|Overall Study|Death|0|||
106162108|NCT04810650|366255445|FG004|Overall Study|Death|0|||
106162109|NCT04810650|366255446|FG005|Overall Study|Death|0|||
106162110|NCT04810650|366255447|FG006|Overall Study|Death|2|||
106162111|NCT04810650|366255448|FG007|Overall Study|Death|2|||
106162112|NCT04810650|366255449|FG008|Overall Study|Death|0|||
106162113|NCT04810650|366255450|FG009|Overall Study|Death|1|||
106162114|NCT04810650|366255451|FG010|Overall Study|Death|0|||
106162115|NCT04810650|366255452|FG011|Overall Study|Death|0|||
106162116|NCT04810650|366255453|FG012|Overall Study|Death|2|||
106162117|NCT04810650|366255454|FG013|Overall Study|Death|1|||
106162118|NCT04810650|366255441|FG000|Overall Study|Moved/transferred care|0|||
106162119|NCT04810650|366255442|FG001|Overall Study|Moved/transferred care|0|||
106091330|NCT01827904|365993466|FG000|Long-term Annual Follow-up|Physician Decision|1|||
106091331|NCT01827904|365993467|FG001|Long-term Annual Follow-up|Physician Decision|0|||
106091332|NCT01827904|365993468|FG002|Long-term Annual Follow-up|Physician Decision|0|||
106091333|NCT01827904|365993466|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
106091334|NCT01827904|365993467|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
106091335|NCT01827904|365993468|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
106091336|NCT01827904|365993466|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
106091337|NCT01827904|365993467|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
106091338|NCT01827904|365993468|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
106091339|NCT01866709|365993469|FG000|Overall Study|Adverse Event|1|||
106091340|NCT01866709|365993470|FG001|Overall Study|Adverse Event|0|||
106091341|NCT01975389|365993471|FG000|Overall Study|Adverse Event|10|||
106091342|NCT01975389|365993472|FG001|Overall Study|Adverse Event|6|||
106091343|NCT01975389|365993471|FG000|Overall Study|Death|61|||
106091344|NCT01975389|365993472|FG001|Overall Study|Death|54|||
106091345|NCT01975389|365993471|FG000|Overall Study|Lost to Follow-up|81|||
106162120|NCT04810650|366255443|FG002|Overall Study|Moved/transferred care|0|||
106162121|NCT04810650|366255444|FG003|Overall Study|Moved/transferred care|0|||
106162122|NCT04810650|366255445|FG004|Overall Study|Moved/transferred care|0|||
106162123|NCT04810650|366255446|FG005|Overall Study|Moved/transferred care|0|||
106091346|NCT01975389|365993472|FG001|Overall Study|Lost to Follow-up|86|||
106091347|NCT01975389|365993471|FG000|Overall Study|Withdrawal by Subject|90|||
106162124|NCT04810650|366255447|FG006|Overall Study|Moved/transferred care|0|||
106162125|NCT04810650|366255448|FG007|Overall Study|Moved/transferred care|1|||
106162126|NCT04810650|366255449|FG008|Overall Study|Moved/transferred care|12|||
106162127|NCT04810650|366255450|FG009|Overall Study|Moved/transferred care|10|||
106162128|NCT04810650|366255451|FG010|Overall Study|Moved/transferred care|0|||
106091348|NCT01975389|365993472|FG001|Overall Study|Withdrawal by Subject|76|||
106162129|NCT04810650|366255452|FG011|Overall Study|Moved/transferred care|0|||
106162130|NCT04810650|366255453|FG012|Overall Study|Moved/transferred care|0|||
106091349|NCT01975389|365993471|FG000|Overall Study|Other|6|||
106091350|NCT01975389|365993472|FG001|Overall Study|Other|9|||
106091351|NCT01975389|365993471|FG000|Overall Study|Randomized, not treated|4|||
106091352|NCT01975389|365993472|FG001|Overall Study|Randomized, not treated|5|||
106091353|NCT02460198|365993473|FG000|Overall Study|Adverse Event|1|||
106091354|NCT02460198|365993474|FG001|Overall Study|Adverse Event|3|||
106091355|NCT02460198|365993473|FG000|Overall Study|Death|36|||
106091356|NCT02460198|365993474|FG001|Overall Study|Death|28|||
106091357|NCT02460198|365993473|FG000|Overall Study|Lost to Follow-up|1|||
106091358|NCT02460198|365993474|FG001|Overall Study|Lost to Follow-up|1|||
106091359|NCT02460198|365993473|FG000|Overall Study|Transferred to Extension Study|15|||
106091360|NCT02460198|365993474|FG001|Overall Study|Transferred to Extension Study|15|||
106091361|NCT02460198|365993473|FG000|Overall Study|Withdrawal by Subject|2|||
106091362|NCT02460198|365993474|FG001|Overall Study|Withdrawal by Subject|4|||
106091363|NCT02460198|365993473|FG000|Overall Study|Site Terminated By Sponsor|0|||
106091364|NCT02460198|365993474|FG001|Overall Study|Site Terminated By Sponsor|1|||
106091365|NCT02460198|365993473|FG000|Overall Study|Did Not Continue on Extension Study|6|||
106091366|NCT02460198|365993474|FG001|Overall Study|Did Not Continue on Extension Study|11|||
106091367|NCT00965848|365993475|FG000|Overall Study|Protocol Violation|3|||
106091368|NCT00965848|365993476|FG001|Overall Study|Protocol Violation|0|||
106091369|NCT00965848|365993477|FG002|Overall Study|Protocol Violation|1|||
106091370|NCT00965848|365993475|FG000|Overall Study|Death|11|||
106091371|NCT00965848|365993476|FG001|Overall Study|Death|1|||
106091372|NCT00965848|365993477|FG002|Overall Study|Death|5|||
106091373|NCT00965848|365993475|FG000|Overall Study|Lost to Follow-up|0|||
106091374|NCT00965848|365993476|FG001|Overall Study|Lost to Follow-up|0|||
106091375|NCT00965848|365993477|FG002|Overall Study|Lost to Follow-up|1|||
106091376|NCT00965848|365993475|FG000|Overall Study|Withdrawal by Subject|1|||
106091377|NCT00965848|365993476|FG001|Overall Study|Withdrawal by Subject|0|||
106091378|NCT00965848|365993477|FG002|Overall Study|Withdrawal by Subject|0|||
106091379|NCT00965848|365993475|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
106091380|NCT00965848|365993476|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
106091381|NCT00965848|365993477|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
106091382|NCT00965848|365993475|FG000|Overall Study|Not Clinically Evaluable|7|||
106091383|NCT00965848|365993476|FG001|Overall Study|Not Clinically Evaluable|1|||
106091384|NCT00965848|365993477|FG002|Overall Study|Not Clinically Evaluable|1|||
106091385|NCT00965848|365993475|FG000|Overall Study|Other|5|||
106091386|NCT00965848|365993476|FG001|Overall Study|Other|0|||
106091387|NCT00965848|365993477|FG002|Overall Study|Other|1|||
106091388|NCT03191903|365993478|FG000|Overall Study|Withdrawal by Subject|6|||
106091389|NCT03191903|365993479|FG001|Overall Study|Withdrawal by Subject|5|||
106091390|NCT03191903|365993480|FG002|Overall Study|Withdrawal by Subject|4|||
106091391|NCT03191903|365993478|FG000|Overall Study|Adverse Event|1|||
106091392|NCT03191903|365993479|FG001|Overall Study|Adverse Event|0|||
106091393|NCT03191903|365993480|FG002|Overall Study|Adverse Event|0|||
106091394|NCT00813761|365993481|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
106091395|NCT00813761|365993482|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
106091396|NCT00813761|365993483|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
106091397|NCT00813761|365993484|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
106091398|NCT00813761|365993481|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
106091399|NCT00813761|365993482|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
106091400|NCT00813761|365993483|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
106091401|NCT00813761|365993484|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
106091402|NCT00813761|365993481|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
106091403|NCT00813761|365993482|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
106091404|NCT00813761|365993483|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
106091405|NCT00813761|365993484|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
106091406|NCT00813761|365993481|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
106091407|NCT00813761|365993482|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
106162131|NCT04810650|366255454|FG013|Overall Study|Moved/transferred care|0|||
106162132|NCT04810650|366255441|FG000|Overall Study|Lost to Follow-up|15|||
106091408|NCT00813761|365993483|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
106091409|NCT00813761|365993484|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
106091410|NCT00813761|365993481|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
106091411|NCT00813761|365993482|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
106091412|NCT00813761|365993483|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
106091413|NCT00813761|365993484|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
106091414|NCT00813761|365993481|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
106091415|NCT00813761|365993482|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
106091416|NCT00813761|365993483|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
106091417|NCT00813761|365993484|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
106091418|NCT00813761|365993481|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
106091419|NCT00813761|365993482|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
106091420|NCT00813761|365993483|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
106091421|NCT00813761|365993484|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
106091422|NCT00813761|365993481|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
106091423|NCT00813761|365993482|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
106091424|NCT00813761|365993483|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
106091425|NCT00813761|365993484|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
106091426|NCT00813761|365993481|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
106091427|NCT00813761|365993482|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
106091428|NCT00813761|365993483|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
106091429|NCT00813761|365993484|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
106091430|NCT00813761|365993481|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
106091431|NCT00813761|365993482|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
106091432|NCT00813761|365993483|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
106091433|NCT00813761|365993484|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
106091434|NCT00813761|365993481|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
106091435|NCT00813761|365993482|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
106091436|NCT00813761|365993483|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
106091437|NCT00813761|365993484|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
106091438|NCT00813761|365993481|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
106091439|NCT00813761|365993482|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
106091440|NCT00813761|365993483|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
106091441|NCT00813761|365993484|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
106091442|NCT00927927|365993490|FG000|Overall Study|Withdrawal by Subject|0|||
106091443|NCT00927927|365993491|FG001|Overall Study|Withdrawal by Subject|0|||
106091444|NCT00927927|365993492|FG002|Overall Study|Withdrawal by Subject|0|||
106091445|NCT00927927|365993493|FG003|Overall Study|Withdrawal by Subject|0|||
106091446|NCT00927927|365993494|FG004|Overall Study|Withdrawal by Subject|0|||
106091447|NCT00927927|365993495|FG005|Overall Study|Withdrawal by Subject|0|||
106091448|NCT00927927|365993496|FG006|Overall Study|Withdrawal by Subject|0|||
106091449|NCT00927927|365993497|FG007|Overall Study|Withdrawal by Subject|2|||
106091450|NCT00927927|365993498|FG008|Overall Study|Withdrawal by Subject|0|||
106091451|NCT00927927|365993499|FG009|Overall Study|Withdrawal by Subject|0|||
106091452|NCT00927927|365993500|FG010|Overall Study|Withdrawal by Subject|0|||
106091453|NCT00927927|365993501|FG011|Overall Study|Withdrawal by Subject|2|||
106091454|NCT00927927|365993502|FG012|Overall Study|Withdrawal by Subject|0|||
106091455|NCT00927927|365993503|FG013|Overall Study|Withdrawal by Subject|0|||
106091456|NCT00927927|365993504|FG014|Overall Study|Withdrawal by Subject|0|||
106091457|NCT00766415|365993506|FG000|Overall Study|Withdrawal by Subject|0|||
106091458|NCT00766415|365993507|FG001|Overall Study|Withdrawal by Subject|1|||
106091459|NCT01312467|365993508|FG000|Overall Study|Adverse Event|4|||
106091460|NCT01312467|365993508|FG000|Overall Study|Lost to Follow-up|1|||
106091461|NCT01312467|365993508|FG000|Overall Study|Withdrawal by Subject|2|||
106091462|NCT01312467|365993508|FG000|Overall Study|Deported to country of origin|1|||
106091463|NCT01312467|365993508|FG000|Overall Study|Another medical condition|1|||
106091464|NCT01312467|365993508|FG000|Overall Study|Ineligible|4|||
106091465|NCT04452344|365993509|FG000|Overall Study|Withdrawal by Subject|3|||
106091466|NCT04452344|365993510|FG001|Overall Study|Withdrawal by Subject|6|||
106091467|NCT04452344|365993509|FG000|Overall Study|Adverse Event|1|||
106091468|NCT04452344|365993510|FG001|Overall Study|Adverse Event|2|||
106091469|NCT04452344|365993509|FG000|Overall Study|Lost to Follow-up|2|||
106091470|NCT04452344|365993510|FG001|Overall Study|Lost to Follow-up|2|||
106091471|NCT04452344|365993509|FG000|Overall Study|No Post-Op Visit|6|||
106091472|NCT04452344|365993510|FG001|Overall Study|No Post-Op Visit|7|||
106091473|NCT03823651|365993514|FG000|Overall Study|Death|5|||
106091474|NCT03823651|365993515|FG001|Overall Study|Death|0|||
106091475|NCT03823651|365993514|FG000|Overall Study|Physician Decision|1|||
106091476|NCT03823651|365993515|FG001|Overall Study|Physician Decision|0|||
106091477|NCT03823651|365993514|FG000|Overall Study|Caregiver to patient who died|0|||
106091478|NCT03823651|365993515|FG001|Overall Study|Caregiver to patient who died|5|||
106091479|NCT03823651|365993514|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
106091480|NCT03823651|365993515|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
106091481|NCT00608829|365995375|FG000|Overall Study|Death|6|||
106091482|NCT00608829|365995375|FG000|Overall Study|Withdrawal by Subject|4|||
106091483|NCT00608829|365995375|FG000|Overall Study|Subject refuses to follow up or return.|5|||
106091484|NCT02602288|365995376|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
106091485|NCT02602288|365995377|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
106091486|NCT02602288|365995376|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
106091487|NCT02602288|365995377|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
106091488|NCT02602288|365995376|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
106162133|NCT04810650|366255442|FG001|Overall Study|Lost to Follow-up|12|||
106091489|NCT02602288|365995377|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
106091490|NCT02602288|365995376|FG000|12 Month Follow-up|Lost to Follow-up|0|||
106091491|NCT02602288|365995377|FG001|12 Month Follow-up|Lost to Follow-up|4|||
106162134|NCT04810650|366255443|FG002|Overall Study|Lost to Follow-up|7|||
106162135|NCT04810650|366255444|FG003|Overall Study|Lost to Follow-up|9|||
106091492|NCT02602288|365995376|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
106091493|NCT02602288|365995377|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
106091494|NCT02343458|365995378|FG000|Overall Study|Adverse Event|15|||
106091495|NCT02343458|365995379|FG001|Overall Study|Adverse Event|14|||
106091496|NCT02343458|365995380|FG002|Overall Study|Adverse Event|15|||
106091497|NCT02343458|365995381|FG003|Overall Study|Adverse Event|3|||
106091498|NCT02343458|365995378|FG000|Overall Study|Lack of Efficacy|3|||
106091499|NCT02343458|365995379|FG001|Overall Study|Lack of Efficacy|8|||
106091500|NCT02343458|365995380|FG002|Overall Study|Lack of Efficacy|4|||
106091501|NCT02343458|365995381|FG003|Overall Study|Lack of Efficacy|8|||
106091502|NCT02343458|365995378|FG000|Overall Study|Withdrawal by Subject|18|||
106091503|NCT02343458|365995379|FG001|Overall Study|Withdrawal by Subject|17|||
106091504|NCT02343458|365995380|FG002|Overall Study|Withdrawal by Subject|23|||
106091505|NCT02343458|365995381|FG003|Overall Study|Withdrawal by Subject|14|||
106091506|NCT02343458|365995378|FG000|Overall Study|Physician Decision|1|||
106091507|NCT02343458|365995379|FG001|Overall Study|Physician Decision|4|||
106091508|NCT02343458|365995380|FG002|Overall Study|Physician Decision|2|||
106091509|NCT02343458|365995381|FG003|Overall Study|Physician Decision|2|||
106091510|NCT02343458|365995378|FG000|Overall Study|Lost to Follow-up|5|||
106091511|NCT02343458|365995379|FG001|Overall Study|Lost to Follow-up|5|||
106091512|NCT02343458|365995380|FG002|Overall Study|Lost to Follow-up|3|||
106091513|NCT02343458|365995381|FG003|Overall Study|Lost to Follow-up|1|||
106091514|NCT02343458|365995378|FG000|Overall Study|Protocol Violation|2|||
106091515|NCT02343458|365995379|FG001|Overall Study|Protocol Violation|5|||
106091516|NCT02343458|365995380|FG002|Overall Study|Protocol Violation|2|||
106091517|NCT02343458|365995381|FG003|Overall Study|Protocol Violation|2|||
106091518|NCT02343458|365995378|FG000|Overall Study|Protocol Specified Criteria|17|||
106091519|NCT02343458|365995379|FG001|Overall Study|Protocol Specified Criteria|13|||
106091520|NCT02343458|365995380|FG002|Overall Study|Protocol Specified Criteria|14|||
106091521|NCT02343458|365995381|FG003|Overall Study|Protocol Specified Criteria|8|||
106091522|NCT03019536|365995382|FG000|Overall Study|Withdrawal by Subject|1|||
106091523|NCT03019536|365995383|FG001|Overall Study|Withdrawal by Subject|1|||
106091524|NCT03019536|365995384|FG002|Overall Study|Withdrawal by Subject|0|||
106091525|NCT03019536|365995382|FG000|Overall Study|Adverse Event|0|||
106091526|NCT03019536|365995383|FG001|Overall Study|Adverse Event|0|||
106091527|NCT03019536|365995384|FG002|Overall Study|Adverse Event|2|||
106091528|NCT03859323|365995385|FG000|Overall Study|Lost to Follow-up|0|||
106091529|NCT03859323|365995386|FG001|Overall Study|Lost to Follow-up|0|||
106091530|NCT03859323|365995387|FG002|Overall Study|Lost to Follow-up|0|||
106091531|NCT03859323|365995388|FG003|Overall Study|Lost to Follow-up|0|||
106091532|NCT03859323|365995389|FG004|Overall Study|Lost to Follow-up|0|||
106091533|NCT03859323|365995390|FG005|Overall Study|Lost to Follow-up|0|||
106091534|NCT03859323|365995391|FG006|Overall Study|Lost to Follow-up|1|||
106091535|NCT03859323|365995392|FG007|Overall Study|Lost to Follow-up|0|||
106091536|NCT03859323|365995393|FG008|Overall Study|Lost to Follow-up|0|||
106091537|NCT03859323|365995394|FG009|Overall Study|Lost to Follow-up|0|||
106091538|NCT03859323|365995395|FG010|Overall Study|Lost to Follow-up|0|||
106091539|NCT03859323|365995396|FG011|Overall Study|Lost to Follow-up|0|||
106091540|NCT03859323|365995397|FG012|Overall Study|Lost to Follow-up|0|||
106091541|NCT03859323|365995385|FG000|Overall Study|Withdrawal by Subject|0|||
106091542|NCT03859323|365995386|FG001|Overall Study|Withdrawal by Subject|0|||
106091543|NCT03859323|365995387|FG002|Overall Study|Withdrawal by Subject|1|||
106091544|NCT03859323|365995388|FG003|Overall Study|Withdrawal by Subject|0|||
106091545|NCT03859323|365995389|FG004|Overall Study|Withdrawal by Subject|0|||
106091546|NCT03859323|365995390|FG005|Overall Study|Withdrawal by Subject|1|||
106091547|NCT03859323|365995391|FG006|Overall Study|Withdrawal by Subject|0|||
106091548|NCT03859323|365995392|FG007|Overall Study|Withdrawal by Subject|0|||
106091549|NCT03859323|365995393|FG008|Overall Study|Withdrawal by Subject|0|||
106091550|NCT03859323|365995394|FG009|Overall Study|Withdrawal by Subject|1|||
106091551|NCT03859323|365995395|FG010|Overall Study|Withdrawal by Subject|1|||
106091552|NCT03859323|365995396|FG011|Overall Study|Withdrawal by Subject|2|||
106091553|NCT03859323|365995397|FG012|Overall Study|Withdrawal by Subject|1|||
106091554|NCT03859323|365995385|FG000|Overall Study|Pregnancy|0|||
106091555|NCT03859323|365995386|FG001|Overall Study|Pregnancy|0|||
106091556|NCT03859323|365995387|FG002|Overall Study|Pregnancy|0|||
106091557|NCT03859323|365995388|FG003|Overall Study|Pregnancy|0|||
106091558|NCT03859323|365995389|FG004|Overall Study|Pregnancy|0|||
106091559|NCT03859323|365995390|FG005|Overall Study|Pregnancy|0|||
106091560|NCT03859323|365995391|FG006|Overall Study|Pregnancy|0|||
106162136|NCT04810650|366255445|FG004|Overall Study|Lost to Follow-up|10|||
106162137|NCT04810650|366255446|FG005|Overall Study|Lost to Follow-up|6|||
106162138|NCT04810650|366255447|FG006|Overall Study|Lost to Follow-up|0|||
106162139|NCT04810650|366255448|FG007|Overall Study|Lost to Follow-up|0|||
106162140|NCT04810650|366255449|FG008|Overall Study|Lost to Follow-up|0|||
106162141|NCT04810650|366255450|FG009|Overall Study|Lost to Follow-up|0|||
106162142|NCT04810650|366255451|FG010|Overall Study|Lost to Follow-up|1|||
106162143|NCT04810650|366255452|FG011|Overall Study|Lost to Follow-up|0|||
106162144|NCT04810650|366255453|FG012|Overall Study|Lost to Follow-up|3|||
106162145|NCT04810650|366255454|FG013|Overall Study|Lost to Follow-up|9|||
106162146|NCT04810650|366255441|FG000|Overall Study|Participant declined|0|||
106162147|NCT04810650|366255442|FG001|Overall Study|Participant declined|0|||
106162148|NCT04810650|366255443|FG002|Overall Study|Participant declined|0|||
106162149|NCT04810650|366255444|FG003|Overall Study|Participant declined|0|||
106162150|NCT04810650|366255445|FG004|Overall Study|Participant declined|0|||
106162151|NCT04810650|366255446|FG005|Overall Study|Participant declined|0|||
106162152|NCT04810650|366255447|FG006|Overall Study|Participant declined|0|||
106162153|NCT04810650|366255448|FG007|Overall Study|Participant declined|0|||
106162154|NCT04810650|366255449|FG008|Overall Study|Participant declined|0|||
106162155|NCT04810650|366255450|FG009|Overall Study|Participant declined|0|||
106162156|NCT04810650|366255451|FG010|Overall Study|Participant declined|2|||
106162157|NCT04810650|366255452|FG011|Overall Study|Participant declined|0|||
106162158|NCT04810650|366255453|FG012|Overall Study|Participant declined|0|||
106162159|NCT04810650|366255454|FG013|Overall Study|Participant declined|0|||
106162160|NCT04025554|366255464|FG000|Overall Study|Adverse Event|3|||
106162161|NCT02489903|366255465|FG000|Screening|Screen Failure|24|||
106162162|NCT02489903|366255466|FG001|Screening|Screen Failure|0|||
106162163|NCT02489903|366255467|FG002|Screening|Screen Failure|0|||
106162164|NCT02489903|366255468|FG003|Screening|Screen Failure|8|||
106162165|NCT02489903|366255465|FG000|Randomized and Received Treatment|Protocol Violation|0|||
106162166|NCT02489903|366255466|FG001|Randomized and Received Treatment|Protocol Violation|1|||
106162167|NCT02489903|366255467|FG002|Randomized and Received Treatment|Protocol Violation|0|||
106162168|NCT02489903|366255468|FG003|Randomized and Received Treatment|Protocol Violation|0|||
106091561|NCT03859323|365995392|FG007|Overall Study|Pregnancy|0|||
106091562|NCT03859323|365995393|FG008|Overall Study|Pregnancy|0|||
106091563|NCT03859323|365995394|FG009|Overall Study|Pregnancy|1|||
106091564|NCT03859323|365995395|FG010|Overall Study|Pregnancy|0|||
106091565|NCT03859323|365995396|FG011|Overall Study|Pregnancy|0|||
106091566|NCT03859323|365995397|FG012|Overall Study|Pregnancy|0|||
106091567|NCT02648698|365995400|FG000|Overall Study|Protocol Violation|1|||
106091568|NCT02648698|365995401|FG001|Overall Study|Protocol Violation|5|||
106091569|NCT00274716|365995407|FG000|Phase A|Other non-reported reason|4|||
106091570|NCT00274716|365995408|FG001|Phase A|Other non-reported reason|2|||
106091571|NCT00274716|365995409|FG002|Phase A|Other non-reported reason|1|||
106091572|NCT00274716|365995410|FG003|Phase A|Other non-reported reason|2|||
106091573|NCT00274716|365995411|FG004|Phase A|Other non-reported reason|0|||
106091574|NCT00274716|365995412|FG005|Phase A|Other non-reported reason|1|||
106091575|NCT00274716|365995407|FG000|Phase A|Participant moved|0|||
106091576|NCT00274716|365995408|FG001|Phase A|Participant moved|0|||
106091577|NCT00274716|365995409|FG002|Phase A|Participant moved|1|||
106091578|NCT00274716|365995410|FG003|Phase A|Participant moved|0|||
106091579|NCT00274716|365995411|FG004|Phase A|Participant moved|0|||
106091580|NCT00274716|365995412|FG005|Phase A|Participant moved|1|||
106091581|NCT00274716|365995407|FG000|Phase A|Site Terminated|0|||
106091582|NCT00274716|365995408|FG001|Phase A|Site Terminated|0|||
106091583|NCT00274716|365995409|FG002|Phase A|Site Terminated|0|||
106091584|NCT00274716|365995410|FG003|Phase A|Site Terminated|1|||
106091585|NCT00274716|365995411|FG004|Phase A|Site Terminated|0|||
106091586|NCT00274716|365995412|FG005|Phase A|Site Terminated|0|||
106091587|NCT00274716|365995407|FG000|Phase A|Protocol Violation|1|||
106091588|NCT00274716|365995408|FG001|Phase A|Protocol Violation|0|||
106091589|NCT00274716|365995409|FG002|Phase A|Protocol Violation|0|||
106091590|NCT00274716|365995410|FG003|Phase A|Protocol Violation|1|||
106091591|NCT00274716|365995411|FG004|Phase A|Protocol Violation|0|||
106091592|NCT00274716|365995412|FG005|Phase A|Protocol Violation|0|||
106091593|NCT00274716|365995407|FG000|Phase A|Met criteria for discontinuation|1|||
106091594|NCT00274716|365995408|FG001|Phase A|Met criteria for discontinuation|1|||
106091595|NCT00274716|365995409|FG002|Phase A|Met criteria for discontinuation|0|||
106091596|NCT00274716|365995410|FG003|Phase A|Met criteria for discontinuation|0|||
106091597|NCT00274716|365995411|FG004|Phase A|Met criteria for discontinuation|0|||
106091598|NCT00274716|365995412|FG005|Phase A|Met criteria for discontinuation|0|||
106091599|NCT00274716|365995407|FG000|Phase A|Withdrawal by Subject|2|||
106091600|NCT00274716|365995408|FG001|Phase A|Withdrawal by Subject|2|||
106091601|NCT00274716|365995409|FG002|Phase A|Withdrawal by Subject|1|||
106091602|NCT00274716|365995410|FG003|Phase A|Withdrawal by Subject|3|||
106091603|NCT00274716|365995411|FG004|Phase A|Withdrawal by Subject|0|||
106091604|NCT00274716|365995412|FG005|Phase A|Withdrawal by Subject|1|||
106091605|NCT00274716|365995407|FG000|Phase A|Adverse Event|2|||
106091606|NCT00274716|365995408|FG001|Phase A|Adverse Event|3|||
106091607|NCT00274716|365995409|FG002|Phase A|Adverse Event|3|||
106091608|NCT00274716|365995410|FG003|Phase A|Adverse Event|0|||
106091609|NCT00274716|365995411|FG004|Phase A|Adverse Event|2|||
106091610|NCT00274716|365995412|FG005|Phase A|Adverse Event|0|||
106091611|NCT00274716|365995407|FG000|Phase A|Completed but did not enter Phase B|1|||
106091612|NCT00274716|365995408|FG001|Phase A|Completed but did not enter Phase B|2|||
106091613|NCT00274716|365995409|FG002|Phase A|Completed but did not enter Phase B|2|||
106091614|NCT00274716|365995410|FG003|Phase A|Completed but did not enter Phase B|2|||
106091615|NCT00274716|365995411|FG004|Phase A|Completed but did not enter Phase B|1|||
106091616|NCT00274716|365995412|FG005|Phase A|Completed but did not enter Phase B|1|||
106091617|NCT00274716|365995407|FG000|Phase B|Adverse Event|0|||
106091618|NCT00274716|365995408|FG001|Phase B|Adverse Event|0|||
106091619|NCT00274716|365995409|FG002|Phase B|Adverse Event|2|||
106091620|NCT00274716|365995410|FG003|Phase B|Adverse Event|0|||
106091621|NCT00274716|365995411|FG004|Phase B|Adverse Event|0|||
106091622|NCT00274716|365995412|FG005|Phase B|Adverse Event|1|||
106091623|NCT00274716|365995407|FG000|Phase B|Protocol Violation|0|||
106091624|NCT00274716|365995408|FG001|Phase B|Protocol Violation|2|||
106091625|NCT00274716|365995409|FG002|Phase B|Protocol Violation|0|||
106091626|NCT00274716|365995410|FG003|Phase B|Protocol Violation|0|||
106091627|NCT00274716|365995411|FG004|Phase B|Protocol Violation|0|||
106091628|NCT00274716|365995412|FG005|Phase B|Protocol Violation|0|||
106091629|NCT00274716|365995407|FG000|Phase B|Withdrawal by Subject|0|||
106091630|NCT00274716|365995408|FG001|Phase B|Withdrawal by Subject|1|||
106091631|NCT00274716|365995409|FG002|Phase B|Withdrawal by Subject|0|||
106091632|NCT00274716|365995410|FG003|Phase B|Withdrawal by Subject|0|||
106091633|NCT00274716|365995411|FG004|Phase B|Withdrawal by Subject|0|||
106091634|NCT00274716|365995412|FG005|Phase B|Withdrawal by Subject|0|||
106091635|NCT00274716|365995407|FG000|Phase B|Participant moved|1|||
106091636|NCT00274716|365995408|FG001|Phase B|Participant moved|0|||
106091637|NCT00274716|365995409|FG002|Phase B|Participant moved|0|||
106091638|NCT00274716|365995410|FG003|Phase B|Participant moved|0|||
106091639|NCT00274716|365995411|FG004|Phase B|Participant moved|0|||
106091640|NCT00274716|365995412|FG005|Phase B|Participant moved|0|||
106091641|NCT00274716|365995407|FG000|Phase B|Other non-reported reason|0|||
106091642|NCT00274716|365995408|FG001|Phase B|Other non-reported reason|0|||
106091643|NCT00274716|365995409|FG002|Phase B|Other non-reported reason|1|||
106091644|NCT00274716|365995410|FG003|Phase B|Other non-reported reason|1|||
106091645|NCT00274716|365995411|FG004|Phase B|Other non-reported reason|0|||
106091646|NCT00274716|365995412|FG005|Phase B|Other non-reported reason|0|||
106091647|NCT00274716|365995407|FG000|Phase B|Lost to Follow-up|0|||
106091648|NCT00274716|365995408|FG001|Phase B|Lost to Follow-up|1|||
106091649|NCT00274716|365995409|FG002|Phase B|Lost to Follow-up|0|||
106091650|NCT00274716|365995410|FG003|Phase B|Lost to Follow-up|0|||
106091651|NCT00274716|365995411|FG004|Phase B|Lost to Follow-up|0|||
106091652|NCT00274716|365995412|FG005|Phase B|Lost to Follow-up|0|||
106091653|NCT00982020|365995413|FG000|Overall Study|Adverse Event|19|||
106091654|NCT00982020|365995414|FG001|Overall Study|Adverse Event|15|||
106091655|NCT00982020|365995413|FG000|Overall Study|Withdrawal by Subject|11|||
106091656|NCT00982020|365995414|FG001|Overall Study|Withdrawal by Subject|14|||
106091657|NCT00982020|365995413|FG000|Overall Study|Lost to Follow-up|5|||
106091658|NCT00982020|365995414|FG001|Overall Study|Lost to Follow-up|11|||
106091659|NCT00982020|365995413|FG000|Overall Study|Lack of Efficacy|10|||
106091660|NCT00982020|365995414|FG001|Overall Study|Lack of Efficacy|4|||
106091661|NCT00982020|365995413|FG000|Overall Study|Parent/Caregiver Decision|5|||
106091662|NCT00982020|365995414|FG001|Overall Study|Parent/Caregiver Decision|5|||
106091663|NCT00982020|365995413|FG000|Overall Study|Treatment Non-compliance|3|||
106091664|NCT00982020|365995414|FG001|Overall Study|Treatment Non-compliance|6|||
106091665|NCT00982020|365995413|FG000|Overall Study|Physician Decision|2|||
106091666|NCT00982020|365995414|FG001|Overall Study|Physician Decision|5|||
106091667|NCT00982020|365995413|FG000|Overall Study|Entry Criteria Not Met|2|||
106091668|NCT00982020|365995414|FG001|Overall Study|Entry Criteria Not Met|1|||
106091669|NCT00982020|365995413|FG000|Overall Study|Protocol Violation|0|||
106091670|NCT00982020|365995414|FG001|Overall Study|Protocol Violation|2|||
106091671|NCT00982020|365995413|FG000|Overall Study|Clinical Relapse|0|||
106091672|NCT00982020|365995414|FG001|Overall Study|Clinical Relapse|1|||
106091673|NCT00086346|365995417|FG000|Randomization|Did not receive test article|4|||
106091674|NCT00086346|365995418|FG001|Randomization|Did not receive test article|4|||
106091675|NCT00086346|365995417|FG000|Patients Dosed With Test Article|Adverse Event|94|||
106091676|NCT00086346|365995418|FG001|Patients Dosed With Test Article|Adverse Event|11|||
106091677|NCT00086346|365995417|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
106091678|NCT00086346|365995418|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
106091679|NCT00086346|365995417|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
106091680|NCT00086346|365995418|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
106091681|NCT00086346|365995417|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
106091682|NCT00086346|365995418|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
106091683|NCT00086346|365995417|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
106091684|NCT00086346|365995418|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
106091685|NCT00086346|365995417|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
106091686|NCT00086346|365995418|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
106091687|NCT00353704|365995419|FG000|Overall Study|Protocol Violation|3|||
106091688|NCT00353704|365995420|FG001|Overall Study|Protocol Violation|1|||
106091689|NCT02019719|365995421|FG000|Overall Study|Adverse Event|1|||
106091690|NCT02019719|365995422|FG001|Overall Study|Adverse Event|0|||
106091691|NCT02019719|365995423|FG002|Overall Study|Adverse Event|0|||
106091692|NCT02019719|365995424|FG003|Overall Study|Adverse Event|1|||
106091693|NCT02019719|365995425|FG004|Overall Study|Adverse Event|1|||
106091694|NCT02019719|365995421|FG000|Overall Study|Protocol Violation|1|||
106091695|NCT02019719|365995422|FG001|Overall Study|Protocol Violation|1|||
106162169|NCT02489903|366255465|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
106162170|NCT02489903|366255466|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
106162171|NCT02489903|366255467|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
106162172|NCT02489903|366255468|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
106162173|NCT02489903|366255465|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
106162174|NCT02489903|366255466|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
106162175|NCT02489903|366255467|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
106162176|NCT02489903|366255468|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
106162177|NCT02489903|366255465|FG000|Randomized and Received Treatment|Death|10|||
106162178|NCT02489903|366255466|FG001|Randomized and Received Treatment|Death|1|||
106162179|NCT02489903|366255467|FG002|Randomized and Received Treatment|Death|0|||
106162180|NCT02489903|366255468|FG003|Randomized and Received Treatment|Death|0|||
106162181|NCT01396278|366257247|FG000|Overall Study|Adverse Event|0|||
106162182|NCT01396278|366257248|FG001|Overall Study|Adverse Event|0|||
106162183|NCT01396278|366257249|FG002|Overall Study|Adverse Event|0|||
106162184|NCT01396278|366257250|FG003|Overall Study|Adverse Event|2|||
106162185|NCT01396278|366257251|FG004|Overall Study|Adverse Event|0|||
106162186|NCT01396278|366257247|FG000|Overall Study|Withdraw due to trial termination|2|||
106162187|NCT01396278|366257248|FG001|Overall Study|Withdraw due to trial termination|1|||
106091696|NCT02019719|365995423|FG002|Overall Study|Protocol Violation|0|||
106091697|NCT02019719|365995424|FG003|Overall Study|Protocol Violation|0|||
106091698|NCT02019719|365995425|FG004|Overall Study|Protocol Violation|0|||
106091699|NCT02019719|365995421|FG000|Overall Study|Protocol defined stopping criteria|2|||
106091700|NCT02019719|365995422|FG001|Overall Study|Protocol defined stopping criteria|0|||
106091701|NCT02019719|365995423|FG002|Overall Study|Protocol defined stopping criteria|0|||
106091702|NCT02019719|365995424|FG003|Overall Study|Protocol defined stopping criteria|1|||
106091703|NCT02019719|365995425|FG004|Overall Study|Protocol defined stopping criteria|1|||
106091704|NCT02019719|365995421|FG000|Overall Study|Physician Decision|2|||
106091705|NCT02019719|365995422|FG001|Overall Study|Physician Decision|0|||
106091706|NCT02019719|365995423|FG002|Overall Study|Physician Decision|0|||
106091707|NCT02019719|365995424|FG003|Overall Study|Physician Decision|0|||
106091708|NCT02019719|365995425|FG004|Overall Study|Physician Decision|0|||
106091709|NCT01931839|365995430|FG000|Overall Study|Death|0|||
106091710|NCT01931839|365995431|FG001|Overall Study|Death|1|||
106091711|NCT01931839|365995432|FG002|Overall Study|Death|2|||
106091712|NCT01931839|365995433|FG003|Overall Study|Death|0|||
106091713|NCT01931839|365995434|FG004|Overall Study|Death|0|||
106091714|NCT01931839|365995435|FG005|Overall Study|Death|0|||
106091715|NCT01931839|365995436|FG006|Overall Study|Death|0|||
106091716|NCT01931839|365995430|FG000|Overall Study|Physician Decision|1|||
106091717|NCT01931839|365995431|FG001|Overall Study|Physician Decision|0|||
106091718|NCT01931839|365995432|FG002|Overall Study|Physician Decision|1|||
106091719|NCT01931839|365995433|FG003|Overall Study|Physician Decision|0|||
106091720|NCT01931839|365995434|FG004|Overall Study|Physician Decision|0|||
106091721|NCT01931839|365995435|FG005|Overall Study|Physician Decision|0|||
106091722|NCT01931839|365995436|FG006|Overall Study|Physician Decision|1|||
106091723|NCT01931839|365995430|FG000|Overall Study|Withdrawal of consent|0|||
106091724|NCT01931839|365995431|FG001|Overall Study|Withdrawal of consent|0|||
106091725|NCT01931839|365995432|FG002|Overall Study|Withdrawal of consent|0|||
106091726|NCT01931839|365995433|FG003|Overall Study|Withdrawal of consent|0|||
106091727|NCT01931839|365995434|FG004|Overall Study|Withdrawal of consent|1|||
106091728|NCT01931839|365995435|FG005|Overall Study|Withdrawal of consent|0|||
106091729|NCT01931839|365995436|FG006|Overall Study|Withdrawal of consent|0|||
106091730|NCT01931839|365995430|FG000|Overall Study|Adverse Event|9|||
106091731|NCT01931839|365995431|FG001|Overall Study|Adverse Event|4|||
106091732|NCT01931839|365995432|FG002|Overall Study|Adverse Event|1|||
106091733|NCT01931839|365995433|FG003|Overall Study|Adverse Event|3|||
106162188|NCT01396278|366257249|FG002|Overall Study|Withdraw due to trial termination|1|||
106162189|NCT01396278|366257250|FG003|Overall Study|Withdraw due to trial termination|0|||
106162190|NCT01396278|366257251|FG004|Overall Study|Withdraw due to trial termination|2|||
106162191|NCT05653427|366257253|FG000|Overall Study|Study Terminated by Sponsor|13|||
106162192|NCT01415882|366257254|FG000|Overall Study|Ineligible|1|||
106162193|NCT01415882|366257255|FG001|Overall Study|Ineligible|0|||
106162194|NCT01415882|366257256|FG002|Overall Study|Ineligible|0|||
106162195|NCT01415882|366257257|FG003|Overall Study|Ineligible|3|||
106162196|NCT01415882|366257258|FG004|Overall Study|Ineligible|0|||
106162197|NCT01415882|366257254|FG000|Overall Study|Withdrawal by Subject|0|||
106162198|NCT01415882|366257255|FG001|Overall Study|Withdrawal by Subject|1|||
106162199|NCT01415882|366257256|FG002|Overall Study|Withdrawal by Subject|0|||
106162200|NCT01415882|366257257|FG003|Overall Study|Withdrawal by Subject|1|||
106162201|NCT01415882|366257258|FG004|Overall Study|Withdrawal by Subject|0|||
106162202|NCT02908477|366257269|FG000|Overall Study|Withdrawal by Subject|8|||
106162203|NCT02908477|366257270|FG001|Overall Study|Withdrawal by Subject|28|||
106162204|NCT02140554|366257271|FG000|Overall Study|Withdrawal of consent|1|||
106162205|NCT02140554|366257272|FG001|Overall Study|Withdrawal of consent|0|||
106162206|NCT02140554|366257273|FG002|Overall Study|Withdrawal of consent|4|||
106162207|NCT02140554|366257271|FG000|Overall Study|Physician Decision|1|||
106162208|NCT02140554|366257272|FG001|Overall Study|Physician Decision|0|||
106162209|NCT02140554|366257273|FG002|Overall Study|Physician Decision|2|||
106162210|NCT02140554|366257271|FG000|Overall Study|Death|0|||
106162211|NCT02140554|366257272|FG001|Overall Study|Death|0|||
106162212|NCT02140554|366257273|FG002|Overall Study|Death|1|||
106162213|NCT02140554|366257271|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
106162214|NCT02140554|366257272|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
106162215|NCT02140554|366257273|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
106162216|NCT05590403|366257274|FG000|Overall Study|Lost to Follow-up|13|||
106162217|NCT05590403|366257275|FG001|Overall Study|Lost to Follow-up|1|||
106162218|NCT05590403|366257276|FG002|Overall Study|Lost to Follow-up|7|||
106162219|NCT05590403|366257277|FG003|Overall Study|Lost to Follow-up|3|||
106162220|NCT05590403|366257278|FG004|Overall Study|Lost to Follow-up|4|||
106091734|NCT01931839|365995434|FG004|Overall Study|Adverse Event|0|||
106091735|NCT01931839|365995435|FG005|Overall Study|Adverse Event|0|||
106162221|NCT05590403|366257274|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
106162222|NCT05590403|366257275|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
106162223|NCT05590403|366257276|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
106162224|NCT05590403|366257277|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
106162225|NCT05590403|366257278|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
106162226|NCT05590403|366257274|FG000|Overall Study|Other|2|||
106162227|NCT05590403|366257275|FG001|Overall Study|Other|0|||
106091736|NCT01931839|365995436|FG006|Overall Study|Adverse Event|1|||
106091737|NCT01931839|365995430|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
106091738|NCT01931839|365995431|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
106091739|NCT01931839|365995432|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
106162228|NCT05590403|366257276|FG002|Overall Study|Other|2|||
106091740|NCT01931839|365995433|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
106091741|NCT01931839|365995434|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
106091742|NCT01931839|365995435|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
106091743|NCT01931839|365995436|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
106091744|NCT01931839|365995430|FG000|Overall Study|Other non-compliance|15|||
106091745|NCT01931839|365995431|FG001|Overall Study|Other non-compliance|9|||
106091746|NCT01931839|365995432|FG002|Overall Study|Other non-compliance|12|||
106091747|NCT01931839|365995433|FG003|Overall Study|Other non-compliance|3|||
106091748|NCT01931839|365995434|FG004|Overall Study|Other non-compliance|0|||
106091749|NCT01931839|365995435|FG005|Overall Study|Other non-compliance|3|||
106091750|NCT01931839|365995436|FG006|Overall Study|Other non-compliance|0|||
106091751|NCT01931839|365995430|FG000|Overall Study|Lost to Follow-up|1|||
106162229|NCT05590403|366257277|FG003|Overall Study|Other|2|||
106162230|NCT05590403|366257278|FG004|Overall Study|Other|0|||
106162231|NCT05590403|366257274|FG000|Overall Study|Migrated / moved from the study area|1|||
106162232|NCT05590403|366257275|FG001|Overall Study|Migrated / moved from the study area|1|||
106162233|NCT05590403|366257276|FG002|Overall Study|Migrated / moved from the study area|0|||
106162234|NCT05590403|366257277|FG003|Overall Study|Migrated / moved from the study area|3|||
106162235|NCT05590403|366257278|FG004|Overall Study|Migrated / moved from the study area|1|||
106162236|NCT05590403|366257274|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
106162237|NCT05590403|366257275|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
106162238|NCT05590403|366257276|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
106162239|NCT05590403|366257277|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
106162240|NCT05590403|366257278|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
106162241|NCT04526704|366257279|FG000|Overall Study|Adverse Event|1|||
106162242|NCT04526704|366257280|FG001|Overall Study|Adverse Event|0|||
106162243|NCT04526704|366257279|FG000|Overall Study|Physician Decision|1|||
106162244|NCT04526704|366257280|FG001|Overall Study|Physician Decision|0|||
106162245|NCT04526704|366257279|FG000|Overall Study|Withdrawal by Subject|2|||
106162246|NCT04526704|366257280|FG001|Overall Study|Withdrawal by Subject|0|||
106162247|NCT02975882|366257281|FG000|Overall Study|Adverse Event|1|||
106162248|NCT02975882|366257282|FG001|Overall Study|Adverse Event|2|||
106162249|NCT02975882|366257283|FG002|Overall Study|Adverse Event|1|||
106162250|NCT02975882|366257284|FG003|Overall Study|Adverse Event|1|||
106162251|NCT02975882|366257281|FG000|Overall Study|Death|0|||
106162252|NCT02975882|366257282|FG001|Overall Study|Death|1|||
106162253|NCT02975882|366257283|FG002|Overall Study|Death|0|||
106162254|NCT02975882|366257284|FG003|Overall Study|Death|0|||
106162255|NCT02975882|366257281|FG000|Overall Study|Lack of Efficacy|3|||
106162256|NCT02975882|366257282|FG001|Overall Study|Lack of Efficacy|7|||
106162257|NCT02975882|366257283|FG002|Overall Study|Lack of Efficacy|4|||
106162258|NCT02975882|366257284|FG003|Overall Study|Lack of Efficacy|3|||
106162259|NCT02975882|366257281|FG000|Overall Study|Physician Decision|0|||
106162260|NCT02975882|366257282|FG001|Overall Study|Physician Decision|2|||
106162261|NCT02975882|366257283|FG002|Overall Study|Physician Decision|4|||
106162262|NCT02975882|366257284|FG003|Overall Study|Physician Decision|2|||
106162263|NCT02975882|366257281|FG000|Overall Study|Ineligible|0|||
106162264|NCT02975882|366257282|FG001|Overall Study|Ineligible|1|||
106162265|NCT02975882|366257283|FG002|Overall Study|Ineligible|0|||
106162266|NCT02975882|366257284|FG003|Overall Study|Ineligible|0|||
106162267|NCT03903146|366257285|FG000|Overall Study|Lost to Follow-up|6|||
106162268|NCT03903146|366257286|FG001|Overall Study|Lost to Follow-up|4|||
106162269|NCT03903146|366257285|FG000|Overall Study|Withdrawal by Subject|0|||
106162270|NCT03903146|366257286|FG001|Overall Study|Withdrawal by Subject|1|||
106162271|NCT05434078|366257288|FG000|Overall Study|Lost to Follow-up|2|||
106162272|NCT05434078|366257289|FG001|Overall Study|Lost to Follow-up|1|||
106162273|NCT05434078|366257288|FG000|Overall Study|Withdrawal by Subject|1|||
106162274|NCT05434078|366257289|FG001|Overall Study|Withdrawal by Subject|0|||
106162275|NCT05179837|366257291|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
106162276|NCT05179837|366257291|FG000|Overall Study|Device malfunctioned|1|||
106091752|NCT01931839|365995431|FG001|Overall Study|Lost to Follow-up|2|||
106091753|NCT01931839|365995432|FG002|Overall Study|Lost to Follow-up|4|||
106162277|NCT05179837|366257291|FG000|Overall Study|Image quality too low|2|||
106162278|NCT03158129|366257292|FG000|Overall Study|Adverse Event|0|||
106162279|NCT03158129|366257293|FG001|Overall Study|Adverse Event|1|||
106162280|NCT03158129|366257294|FG002|Overall Study|Adverse Event|0|||
106162281|NCT03158129|366257295|FG003|Overall Study|Adverse Event|0|||
106162282|NCT03158129|366257292|FG000|Overall Study|Death|0|||
106162283|NCT03158129|366257293|FG001|Overall Study|Death|0|||
106091754|NCT01931839|365995433|FG003|Overall Study|Lost to Follow-up|5|||
106091755|NCT01931839|365995434|FG004|Overall Study|Lost to Follow-up|0|||
106091756|NCT01931839|365995435|FG005|Overall Study|Lost to Follow-up|0|||
106162284|NCT03158129|366257294|FG002|Overall Study|Death|0|||
106162285|NCT03158129|366257295|FG003|Overall Study|Death|1|||
106162286|NCT03158129|366257292|FG000|Overall Study|High surgical risk|1|||
106162287|NCT03158129|366257293|FG001|Overall Study|High surgical risk|1|||
106162288|NCT03158129|366257294|FG002|Overall Study|High surgical risk|0|||
106091757|NCT01931839|365995436|FG006|Overall Study|Lost to Follow-up|0|||
106091758|NCT01931839|365995430|FG000|Overall Study|Other|4|||
106091759|NCT01931839|365995431|FG001|Overall Study|Other|2|||
106091760|NCT01931839|365995432|FG002|Overall Study|Other|6|||
106091761|NCT01931839|365995433|FG003|Overall Study|Other|0|||
106091762|NCT01931839|365995434|FG004|Overall Study|Other|0|||
106091763|NCT01931839|365995435|FG005|Overall Study|Other|0|||
106091764|NCT01931839|365995436|FG006|Overall Study|Other|0|||
106091765|NCT01465334|365995446|FG000|Overall Study|Disease Progression|1|||
106091766|NCT01465334|365995447|FG001|Overall Study|Disease Progression|0|||
106091767|NCT01465334|365995446|FG000|Overall Study|Adverse Event|1|||
106091768|NCT01465334|365995447|FG001|Overall Study|Adverse Event|0|||
106091769|NCT01465334|365995446|FG000|Overall Study|Richter's transformation|0|||
106091770|NCT01465334|365995447|FG001|Overall Study|Richter's transformation|3|||
106091771|NCT01465334|365995446|FG000|Overall Study|Refractory Disease|0|||
106091772|NCT01465334|365995447|FG001|Overall Study|Refractory Disease|3|||
106091773|NCT04443218|365995453|FG000|Overall Study|Exited study for other reasons|9|||
106091774|NCT04443218|365995453|FG000|Overall Study|Withdrawal by Subject|1|||
106091775|NCT04443218|365995453|FG000|Overall Study|Lost to Follow-up|4|||
106091776|NCT04443218|365995453|FG000|Overall Study|Death|19|||
106091777|NCT01255358|365995458|FG000|Overall Study|Adverse Event|2|||
106091778|NCT01255358|365995458|FG000|Overall Study|Protocol Violation|2|||
106091779|NCT04079933|365995459|FG000|Overall Study|Withdrawal by Subject|3|||
106091780|NCT04079933|365995460|FG001|Overall Study|Withdrawal by Subject|4|||
106091781|NCT04079933|365995459|FG000|Overall Study|Lost to Follow-up|0|||
106091782|NCT04079933|365995460|FG001|Overall Study|Lost to Follow-up|1|||
106091783|NCT04788147|365995461|FG000|Overall Study|Screen Failure|3|||
106091784|NCT04788147|365995462|FG001|Overall Study|Screen Failure|10|||
106091785|NCT04788147|365995461|FG000|Overall Study|Incomplete RMRS image session|2|||
106091786|NCT04788147|365995462|FG001|Overall Study|Incomplete RMRS image session|0|||
106091787|NCT03231371|365995464|FG000|Overall Study|Withdrawal by Subject|1|||
106162289|NCT03158129|366257295|FG003|Overall Study|High surgical risk|0|||
106162290|NCT03158129|366257292|FG000|Overall Study|Progression|1|||
106162291|NCT03158129|366257293|FG001|Overall Study|Progression|1|||
106162292|NCT03158129|366257294|FG002|Overall Study|Progression|0|||
106162293|NCT03158129|366257295|FG003|Overall Study|Progression|0|||
106162294|NCT03158129|366257292|FG000|Overall Study|Lack of resectability|0|||
106162295|NCT03158129|366257293|FG001|Overall Study|Lack of resectability|1|||
106162296|NCT03158129|366257294|FG002|Overall Study|Lack of resectability|0|||
106162297|NCT03158129|366257295|FG003|Overall Study|Lack of resectability|0|||
106162298|NCT03158129|366257292|FG000|Overall Study|Declined surgery|0|||
106162299|NCT03158129|366257293|FG001|Overall Study|Declined surgery|1|||
106162300|NCT03158129|366257294|FG002|Overall Study|Declined surgery|0|||
106162301|NCT03158129|366257295|FG003|Overall Study|Declined surgery|0|||
106162302|NCT03158129|366257292|FG000|Overall Study|No longer surgical candidate|0|||
106162303|NCT03158129|366257293|FG001|Overall Study|No longer surgical candidate|0|||
106162304|NCT03158129|366257294|FG002|Overall Study|No longer surgical candidate|0|||
106162305|NCT03158129|366257295|FG003|Overall Study|No longer surgical candidate|1|||
106162306|NCT02105766|366257300|FG000|Overall Study|Physician Decision|1|||
106162307|NCT02105766|366257301|FG001|Overall Study|Physician Decision|1|||
106162308|NCT02105766|366257302|FG002|Overall Study|Physician Decision|0|||
106162309|NCT02105766|366257300|FG000|Overall Study|Lost to Follow-up|2|||
106091788|NCT03231371|365995464|FG000|Overall Study|chose or were ineligible to have MRI|12|||
106091789|NCT00345579|365995465|FG000|Overall Study|Adverse Event|9|||
106091790|NCT00345579|365995466|FG001|Overall Study|Adverse Event|6|||
106091791|NCT00345579|365995465|FG000|Overall Study|Protocol Violation|14|||
106162310|NCT02105766|366257301|FG001|Overall Study|Lost to Follow-up|0|||
106162311|NCT02105766|366257302|FG002|Overall Study|Lost to Follow-up|0|||
106162312|NCT02105766|366257300|FG000|Overall Study|Death|1|||
106162313|NCT02105766|366257301|FG001|Overall Study|Death|1|||
106162314|NCT02105766|366257302|FG002|Overall Study|Death|0|||
106162315|NCT03701399|366257303|FG000|Overall Study|Adverse Event|3|||
106162316|NCT03701399|366257304|FG001|Overall Study|Adverse Event|5|||
106162317|NCT03701399|366257303|FG000|Overall Study|Withdrawal by Subject|6|||
106162318|NCT03701399|366257304|FG001|Overall Study|Withdrawal by Subject|3|||
106162319|NCT03701399|366257303|FG000|Overall Study|Investigators decision|1|||
106162320|NCT03701399|366257304|FG001|Overall Study|Investigators decision|2|||
106091792|NCT00345579|365995466|FG001|Overall Study|Protocol Violation|5|||
106091793|NCT00345579|365995465|FG000|Overall Study|Withdrawal by Subject|50|||
106162321|NCT03701399|366257303|FG000|Overall Study|Lost to Follow-up|1|||
106162322|NCT03701399|366257304|FG001|Overall Study|Lost to Follow-up|2|||
106091794|NCT00345579|365995466|FG001|Overall Study|Withdrawal by Subject|17|||
106091795|NCT00345579|365995465|FG000|Overall Study|Lost to Follow-up|82|||
106091796|NCT00345579|365995466|FG001|Overall Study|Lost to Follow-up|36|||
106091797|NCT00345579|365995465|FG000|Overall Study|Other|9|||
106162323|NCT03701399|366257303|FG000|Overall Study|Death|1|||
106162324|NCT03701399|366257304|FG001|Overall Study|Death|1|||
106162325|NCT03701399|366257303|FG000|Overall Study|Randomized but not treated|1|||
106091798|NCT00345579|365995466|FG001|Overall Study|Other|1|||
106091799|NCT00413413|365995467|FG000|Single-Blind|Adverse Event|0|||
106091800|NCT00413413|365995468|FG001|Single-Blind|Adverse Event|9|||
106091801|NCT00413413|365995469|FG002|Single-Blind|Adverse Event|0|||
106091802|NCT00413413|365995467|FG000|Single-Blind|Lack of Efficacy|0|||
106091803|NCT00413413|365995468|FG001|Single-Blind|Lack of Efficacy|5|||
106091804|NCT00413413|365995469|FG002|Single-Blind|Lack of Efficacy|0|||
106091805|NCT00413413|365995467|FG000|Single-Blind|Subject no longer requires study drug|0|||
106091806|NCT00413413|365995468|FG001|Single-Blind|Subject no longer requires study drug|151|||
106091807|NCT00413413|365995469|FG002|Single-Blind|Subject no longer requires study drug|0|||
106091808|NCT00413413|365995467|FG000|Single-Blind|Protocol Violation|0|||
106091809|NCT00413413|365995468|FG001|Single-Blind|Protocol Violation|16|||
106091810|NCT00413413|365995469|FG002|Single-Blind|Protocol Violation|0|||
106091811|NCT00413413|365995467|FG000|Single-Blind|Withdrawal by Subject|0|||
106091812|NCT00413413|365995468|FG001|Single-Blind|Withdrawal by Subject|27|||
106091813|NCT00413413|365995469|FG002|Single-Blind|Withdrawal by Subject|0|||
106091814|NCT00413413|365995467|FG000|Single-Blind|Lost to Follow-up|0|||
106162326|NCT03701399|366257304|FG001|Overall Study|Randomized but not treated|0|||
106162327|NCT02985957|366257306|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
106162328|NCT02985957|366257307|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
106162329|NCT02985957|366257308|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
106162330|NCT02985957|366257309|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
106162331|NCT02985957|366257310|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
106162332|NCT02985957|366257311|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
106162333|NCT02985957|366257312|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
106162334|NCT02985957|366257306|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
106162335|NCT02985957|366257307|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
106162336|NCT02985957|366257308|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
106162337|NCT02985957|366257309|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
106162338|NCT02985957|366257310|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
106162339|NCT02985957|366257311|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
106162340|NCT02985957|366257312|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
106162341|NCT02985957|366257306|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
106162342|NCT02985957|366257307|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
106162343|NCT02985957|366257308|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
106162344|NCT02985957|366257309|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
106162345|NCT02985957|366257310|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
106162346|NCT02985957|366257311|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
106162347|NCT02985957|366257312|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
106162348|NCT02985957|366257306|FG000|Treatment Period|Death|0|||
106162349|NCT02985957|366257307|FG001|Treatment Period|Death|0|||
106162350|NCT02985957|366257308|FG002|Treatment Period|Death|0|||
106162351|NCT02985957|366257309|FG003|Treatment Period|Death|0|||
106162352|NCT02985957|366257310|FG004|Treatment Period|Death|1|||
106162353|NCT02985957|366257311|FG005|Treatment Period|Death|0|||
106162354|NCT02985957|366257312|FG006|Treatment Period|Death|0|||
106162355|NCT02985957|366257306|FG000|Treatment Period|Participant withdrew consent|0|||
106162356|NCT02985957|366257307|FG001|Treatment Period|Participant withdrew consent|0|||
106162357|NCT02985957|366257308|FG002|Treatment Period|Participant withdrew consent|0|||
106162358|NCT02985957|366257309|FG003|Treatment Period|Participant withdrew consent|1|||
106162359|NCT02985957|366257310|FG004|Treatment Period|Participant withdrew consent|3|||
106162360|NCT02985957|366257311|FG005|Treatment Period|Participant withdrew consent|0|||
106162361|NCT02985957|366257312|FG006|Treatment Period|Participant withdrew consent|1|||
106162362|NCT02985957|366257306|FG000|Treatment Period|Lost to Follow-up|0|||
106162363|NCT02985957|366257307|FG001|Treatment Period|Lost to Follow-up|0|||
106162364|NCT02985957|366257308|FG002|Treatment Period|Lost to Follow-up|0|||
106162365|NCT02985957|366257309|FG003|Treatment Period|Lost to Follow-up|0|||
106162366|NCT02985957|366257310|FG004|Treatment Period|Lost to Follow-up|1|||
106162367|NCT02985957|366257311|FG005|Treatment Period|Lost to Follow-up|0|||
106162368|NCT02985957|366257312|FG006|Treatment Period|Lost to Follow-up|0|||
106162369|NCT02985957|366257306|FG000|Treatment Period|Other reasons|0|||
106162370|NCT02985957|366257307|FG001|Treatment Period|Other reasons|0|||
106162371|NCT02985957|366257308|FG002|Treatment Period|Other reasons|1|||
106162372|NCT02985957|366257309|FG003|Treatment Period|Other reasons|3|||
106162373|NCT02985957|366257310|FG004|Treatment Period|Other reasons|6|||
106162374|NCT02985957|366257311|FG005|Treatment Period|Other reasons|0|||
106162375|NCT02985957|366257312|FG006|Treatment Period|Other reasons|1|||
106162376|NCT02985957|366257306|FG000|Treatment Period|Not reported|0|||
106091815|NCT00413413|365995468|FG001|Single-Blind|Lost to Follow-up|8|||
106091816|NCT00413413|365995469|FG002|Single-Blind|Lost to Follow-up|0|||
106162377|NCT02985957|366257307|FG001|Treatment Period|Not reported|1|||
106162378|NCT02985957|366257308|FG002|Treatment Period|Not reported|2|||
106162379|NCT02985957|366257309|FG003|Treatment Period|Not reported|5|||
106091817|NCT00413413|365995467|FG000|Double-Blind|Adverse Event|6|||
106091818|NCT00413413|365995468|FG001|Double-Blind|Adverse Event|0|||
106091819|NCT00413413|365995469|FG002|Double-Blind|Adverse Event|5|||
106091820|NCT00413413|365995467|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
106091821|NCT00413413|365995468|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
106091822|NCT00413413|365995469|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
106091823|NCT00413413|365995467|FG000|Double-Blind|Protocol deviation|1|||
106091824|NCT00413413|365995468|FG001|Double-Blind|Protocol deviation|2|||
106091825|NCT00413413|365995469|FG002|Double-Blind|Protocol deviation|1|||
106091826|NCT00413413|365995467|FG000|Double-Blind|Subject withdrew consent|4|||
106091827|NCT00413413|365995468|FG001|Double-Blind|Subject withdrew consent|6|||
106091828|NCT00413413|365995469|FG002|Double-Blind|Subject withdrew consent|9|||
106091829|NCT00413413|365995467|FG000|Double-Blind|Lost to Follow-up|3|||
106091830|NCT00413413|365995468|FG001|Double-Blind|Lost to Follow-up|4|||
106091831|NCT00413413|365995469|FG002|Double-Blind|Lost to Follow-up|2|||
106091832|NCT02673697|365995470|FG000|Overall Study|Adverse Event|2|||
106091833|NCT02673697|365995471|FG001|Overall Study|Adverse Event|0|||
106091834|NCT02673697|365995470|FG000|Overall Study|Death|32|||
106091835|NCT02673697|365995471|FG001|Overall Study|Death|24|||
106091836|NCT02673697|365995470|FG000|Overall Study|Lost to Follow-up|5|||
106091837|NCT02673697|365995471|FG001|Overall Study|Lost to Follow-up|2|||
106091838|NCT02673697|365995470|FG000|Overall Study|Physician Decision|2|||
106091839|NCT02673697|365995471|FG001|Overall Study|Physician Decision|1|||
106091840|NCT02673697|365995470|FG000|Overall Study|Withdrawal by Subject|10|||
106091841|NCT02673697|365995471|FG001|Overall Study|Withdrawal by Subject|7|||
106091842|NCT02673697|365995470|FG000|Overall Study|Change subj medical status|1|||
106091843|NCT02673697|365995471|FG001|Overall Study|Change subj medical status|2|||
106091844|NCT02673697|365995470|FG000|Overall Study|Explant|10|||
106091845|NCT02673697|365995471|FG001|Overall Study|Explant|5|||
106091846|NCT02673697|365995470|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
106091847|NCT02673697|365995471|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
106091848|NCT02604589|365995472|FG000|Overall Study|catheter dislodgement|0|||
106091849|NCT02604589|365995473|FG001|Overall Study|catheter dislodgement|0|||
106091850|NCT02604589|365995474|FG002|Overall Study|catheter dislodgement|1|||
106091851|NCT03880578|365995479|FG000|Overall Study|Withdrawal by Subject|0|||
106091852|NCT03880578|365995480|FG001|Overall Study|Withdrawal by Subject|3|||
106091853|NCT03880578|365995481|FG002|Overall Study|Withdrawal by Subject|1|||
106091854|NCT03880578|365995479|FG000|Overall Study|Death|0|||
106091855|NCT03880578|365995480|FG001|Overall Study|Death|1|||
106091856|NCT03880578|365995481|FG002|Overall Study|Death|0|||
106091857|NCT02056301|365995482|FG000|Overall Study|Protocol Violation|1|||
106091858|NCT02056301|365995483|FG001|Overall Study|Protocol Violation|2|||
106091859|NCT02056301|365995482|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
106091860|NCT02056301|365995483|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
106091861|NCT02056301|365995482|FG000|Overall Study|Withdrawal by Subject|0|||
106091862|NCT02056301|365995483|FG001|Overall Study|Withdrawal by Subject|1|||
106091863|NCT02056301|365995482|FG000|Overall Study|Issues with epidural|0|||
106091864|NCT02056301|365995483|FG001|Overall Study|Issues with epidural|3|||
106091865|NCT04496258|365995484|FG000|Overall Study|Withdrawal by Subject|2|||
106091866|NCT04496258|365995485|FG001|Overall Study|Withdrawal by Subject|1|||
106091867|NCT00439777|365995486|FG000|Treatment Period|Death|29|||
106091868|NCT00439777|365995487|FG001|Treatment Period|Death|21|||
106091869|NCT00439777|365995486|FG000|Treatment Period|Study terminated by sponsor|125|||
106091870|NCT00439777|365995487|FG001|Treatment Period|Study terminated by sponsor|132|||
106091871|NCT00439777|365995486|FG000|Treatment Period|Site closed by investigator|0|||
106091872|NCT00439777|365995487|FG001|Treatment Period|Site closed by investigator|1|||
106091873|NCT00439777|365995486|FG000|Treatment Period|Did not take study treatment|7|||
106091874|NCT00439777|365995487|FG001|Treatment Period|Did not take study treatment|8|||
106091875|NCT00439777|365995486|FG000|Treatment Period|Adverse Event|111|||
106091876|NCT00439777|365995487|FG001|Treatment Period|Adverse Event|92|||
106091877|NCT00439777|365995486|FG000|Treatment Period|Protocol Violation|23|||
106091878|NCT00439777|365995487|FG001|Treatment Period|Protocol Violation|30|||
106091879|NCT00439777|365995486|FG000|Treatment Period|Withdrawal by Subject|66|||
106091880|NCT00439777|365995487|FG001|Treatment Period|Withdrawal by Subject|118|||
106091881|NCT00439777|365995486|FG000|Treatment Period|Lack of Efficacy|1|||
106091882|NCT00439777|365995487|FG001|Treatment Period|Lack of Efficacy|4|||
106091883|NCT00439777|365995486|FG000|Treatment Period|Lost to Follow-up|8|||
106091884|NCT00439777|365995487|FG001|Treatment Period|Lost to Follow-up|10|||
106091885|NCT00439777|365995486|FG000|Treatment Period|Protocol driven decision point|1|||
106091886|NCT00439777|365995487|FG001|Treatment Period|Protocol driven decision point|3|||
106091887|NCT00439777|365995486|FG000|Treatment Period|Physician Decision|7|||
106091888|NCT00439777|365995487|FG001|Treatment Period|Physician Decision|18|||
106091889|NCT00439777|365995486|FG000|Treatment Period|Clinical endpoint reached|26|||
106091890|NCT00439777|365995487|FG001|Treatment Period|Clinical endpoint reached|13|||
106091891|NCT00439777|365995486|FG000|Treatment Period|Technical problems|3|||
106091892|NCT00439777|365995487|FG001|Treatment Period|Technical problems|1|||
106091893|NCT00439777|365995486|FG000|Treatment Period|Participant convenience|12|||
106091894|NCT00439777|365995487|FG001|Treatment Period|Participant convenience|8|||
106162380|NCT02985957|366257310|FG004|Treatment Period|Not reported|0|||
106091895|NCT00439777|365995486|FG000|Observational Period|Protocol Violation|0|||
106091896|NCT00439777|365995487|FG001|Observational Period|Protocol Violation|2|||
106091897|NCT00439777|365995486|FG000|Observational Period|Withdrawal by Subject|9|||
106091898|NCT00439777|365995487|FG001|Observational Period|Withdrawal by Subject|5|||
106091899|NCT00439777|365995486|FG000|Observational Period|Lost to Follow-up|1|||
106091900|NCT00439777|365995487|FG001|Observational Period|Lost to Follow-up|11|||
106091901|NCT00439777|365995486|FG000|Observational Period|Death|27|||
106091902|NCT00439777|365995487|FG001|Observational Period|Death|20|||
106091903|NCT00439777|365995486|FG000|Observational Period|Study terminated by sponsor|3|||
106091904|NCT00439777|365995487|FG001|Observational Period|Study terminated by sponsor|1|||
106091905|NCT00439777|365995486|FG000|Observational Period|Protocol driven decision point|0|||
106091906|NCT00439777|365995487|FG001|Observational Period|Protocol driven decision point|1|||
106091907|NCT00439777|365995486|FG000|Observational Period|Lack of Efficacy|1|||
106091908|NCT00439777|365995487|FG001|Observational Period|Lack of Efficacy|0|||
106091909|NCT00439777|365995486|FG000|Observational Period|Technical problems|0|||
106091910|NCT00439777|365995487|FG001|Observational Period|Technical problems|1|||
106091911|NCT00861341|365995490|FG000|Overall Study|Withdrawal by Subject|2|||
106091912|NCT00503685|365995491|FG000|Overall Study|Adverse Event|0|||
106091913|NCT00503685|365995492|FG001|Overall Study|Adverse Event|0|||
106091914|NCT00503685|365995493|FG002|Overall Study|Adverse Event|2|||
106091915|NCT00503685|365995491|FG000|Overall Study|Withdrawal by Subject|0|||
106091916|NCT00503685|365995492|FG001|Overall Study|Withdrawal by Subject|1|||
106091917|NCT00503685|365995493|FG002|Overall Study|Withdrawal by Subject|0|||
106091918|NCT00503685|365995491|FG000|Overall Study|Protocol Violation|0|||
106091919|NCT00503685|365995492|FG001|Overall Study|Protocol Violation|1|||
106091920|NCT00503685|365995493|FG002|Overall Study|Protocol Violation|0|||
106091921|NCT00503685|365995491|FG000|Overall Study|Eligibility Criteria Not Met|0|||
106091922|NCT00503685|365995492|FG001|Overall Study|Eligibility Criteria Not Met|1|||
106091923|NCT00503685|365995493|FG002|Overall Study|Eligibility Criteria Not Met|0|||
106091924|NCT01578551|365995500|FG000|Overall Study|Adverse Event|1|||
106091925|NCT01578551|365995501|FG001|Overall Study|Adverse Event|0|||
106091926|NCT01181895|365995505|FG000|Overall Study|Adverse Event|3|||
106091927|NCT01181895|365995506|FG001|Overall Study|Adverse Event|1|||
106091928|NCT01181895|365995507|FG002|Overall Study|Adverse Event|1|||
106091929|NCT01181895|365995505|FG000|Overall Study|Lack of Efficacy|8|||
106091930|NCT01181895|365995506|FG001|Overall Study|Lack of Efficacy|9|||
106091931|NCT01181895|365995507|FG002|Overall Study|Lack of Efficacy|9|||
106091932|NCT01181895|365995505|FG000|Overall Study|Protocol Violation|2|||
106091933|NCT01181895|365995506|FG001|Overall Study|Protocol Violation|1|||
106091934|NCT01181895|365995507|FG002|Overall Study|Protocol Violation|0|||
106091935|NCT01181895|365995505|FG000|Overall Study|Lost to Follow-up|0|||
106091936|NCT01181895|365995506|FG001|Overall Study|Lost to Follow-up|1|||
106091937|NCT01181895|365995507|FG002|Overall Study|Lost to Follow-up|2|||
106091938|NCT01181895|365995505|FG000|Overall Study|Investigator Discretion|1|||
106091939|NCT01181895|365995506|FG001|Overall Study|Investigator Discretion|2|||
106091940|NCT01181895|365995507|FG002|Overall Study|Investigator Discretion|1|||
106091941|NCT01181895|365995505|FG000|Overall Study|Withdrawal by Subject|3|||
106091942|NCT01181895|365995506|FG001|Overall Study|Withdrawal by Subject|0|||
106091943|NCT01181895|365995507|FG002|Overall Study|Withdrawal by Subject|5|||
106091944|NCT00080223|365995510|FG000|Overall Study|Adverse Event|23|||
106091945|NCT00080223|365995510|FG000|Overall Study|Death|21|||
106091946|NCT00080223|365995510|FG000|Overall Study|Withdrawal by Subject|13|||
106091947|NCT00080223|365995510|FG000|Overall Study|Lung Transplantation|9|||
106091948|NCT00080223|365995510|FG000|Overall Study|Non-compliance With Study Treatment|7|||
106091949|NCT00080223|365995510|FG000|Overall Study|Participant unwilling to continue|2|||
106091950|NCT00080223|365995510|FG000|Overall Study|Physician Decision|1|||
106091951|NCT01609556|365995511|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091952|NCT01609556|365995512|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091953|NCT01609556|365995513|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091954|NCT01609556|365995514|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091955|NCT01609556|365995515|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
106091956|NCT01609556|365995516|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091957|NCT01609556|365995517|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091958|NCT01609556|365995518|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
106091959|NCT01609556|365995519|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
106091960|NCT01609556|365995520|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091961|NCT01609556|365995521|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
106091962|NCT01609556|365995522|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
106091963|NCT01609556|365995523|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091964|NCT01609556|365995524|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091965|NCT01609556|365995525|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091966|NCT01609556|365995526|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
106091967|NCT01609556|365995511|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
106162381|NCT02985957|366257311|FG005|Treatment Period|Not reported|0|||
106091968|NCT01609556|365995512|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
106091969|NCT01609556|365995513|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
106091970|NCT01609556|365995514|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
106091971|NCT01609556|365995515|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
106091972|NCT01609556|365995516|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
106091973|NCT01609556|365995517|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
106091974|NCT01609556|365995518|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
106091975|NCT01609556|365995519|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
106091976|NCT01609556|365995520|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
106091977|NCT01609556|365995521|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
106091978|NCT01609556|365995522|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
106091979|NCT01609556|365995523|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
106091980|NCT01609556|365995524|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
106091981|NCT01609556|365995525|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
106091982|NCT01609556|365995526|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
106091983|NCT01609556|365995511|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091984|NCT01609556|365995512|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091985|NCT01609556|365995513|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091986|NCT01609556|365995514|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091987|NCT01609556|365995515|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091988|NCT01609556|365995516|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
106091989|NCT01609556|365995517|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
106091990|NCT01609556|365995518|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091991|NCT01609556|365995519|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091992|NCT01609556|365995520|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
106091993|NCT01609556|365995521|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
106091994|NCT01609556|365995522|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
106091995|NCT01609556|365995523|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091996|NCT01609556|365995524|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091997|NCT01609556|365995525|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091998|NCT01609556|365995526|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
106091999|NCT01609556|365995511|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092000|NCT01609556|365995512|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092001|NCT01609556|365995513|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092002|NCT01609556|365995514|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092003|NCT01609556|365995515|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092004|NCT01609556|365995516|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
106092005|NCT01609556|365995517|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092006|NCT01609556|365995518|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092007|NCT01609556|365995519|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092008|NCT01609556|365995520|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092009|NCT01609556|365995521|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092010|NCT01609556|365995522|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
106092011|NCT01609556|365995523|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092012|NCT01609556|365995524|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092013|NCT01609556|365995525|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092014|NCT01609556|365995526|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
106092015|NCT01609556|365995511|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092016|NCT01609556|365995512|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092017|NCT01609556|365995513|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092018|NCT01609556|365995514|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092019|NCT01609556|365995515|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092020|NCT01609556|365995516|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
106092021|NCT01609556|365995517|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092022|NCT01609556|365995518|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092023|NCT01609556|365995519|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092024|NCT01609556|365995520|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092025|NCT01609556|365995521|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106162382|NCT02985957|366257312|FG006|Treatment Period|Not reported|0|||
106092026|NCT01609556|365995522|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092027|NCT01609556|365995523|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092028|NCT01609556|365995524|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092029|NCT01609556|365995525|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106162383|NCT02985957|366257306|FG000|Treatment Period|Maximum clinical benefit|0|||
106162384|NCT02985957|366257307|FG001|Treatment Period|Maximum clinical benefit|0|||
106162385|NCT02985957|366257308|FG002|Treatment Period|Maximum clinical benefit|1|||
106162386|NCT02985957|366257309|FG003|Treatment Period|Maximum clinical benefit|1|||
106162387|NCT02985957|366257310|FG004|Treatment Period|Maximum clinical benefit|0|||
106162388|NCT02985957|366257311|FG005|Treatment Period|Maximum clinical benefit|0|||
106162389|NCT02985957|366257312|FG006|Treatment Period|Maximum clinical benefit|2|||
106162390|NCT02985957|366257306|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
106162391|NCT02985957|366257307|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
106162392|NCT02985957|366257308|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
106162393|NCT02985957|366257309|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
106162394|NCT02985957|366257310|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
106092030|NCT01609556|365995526|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
106092031|NCT01609556|365995511|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092032|NCT01609556|365995512|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092033|NCT01609556|365995513|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092034|NCT01609556|365995514|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092035|NCT01609556|365995515|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092036|NCT01609556|365995516|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092037|NCT01609556|365995517|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092038|NCT01609556|365995518|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092039|NCT01609556|365995519|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
106092040|NCT01609556|365995520|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092041|NCT01609556|365995521|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092042|NCT01609556|365995522|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092043|NCT01609556|365995523|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092044|NCT01609556|365995524|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092045|NCT01609556|365995525|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092046|NCT01609556|365995526|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
106092047|NCT01609556|365995511|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
106092048|NCT01609556|365995512|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092049|NCT01609556|365995513|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092050|NCT01609556|365995514|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092051|NCT01609556|365995515|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092052|NCT01609556|365995516|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
106092053|NCT01609556|365995517|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092054|NCT01609556|365995518|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092055|NCT01609556|365995519|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092056|NCT01609556|365995520|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092057|NCT01609556|365995521|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
106092058|NCT01609556|365995522|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092059|NCT01609556|365995523|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092060|NCT01609556|365995524|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092061|NCT01609556|365995525|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092062|NCT01609556|365995526|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
106092063|NCT01609556|365995511|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092064|NCT01609556|365995512|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092065|NCT01609556|365995513|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092066|NCT01609556|365995514|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092067|NCT01609556|365995515|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092068|NCT01609556|365995516|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092069|NCT01609556|365995517|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106162395|NCT02985957|366257311|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
106162396|NCT02985957|366257312|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
106162397|NCT02985957|366257306|FG000|Treatment Period|Study drug toxicity|1|||
106162398|NCT02985957|366257307|FG001|Treatment Period|Study drug toxicity|23|||
106162399|NCT02985957|366257308|FG002|Treatment Period|Study drug toxicity|20|||
106162400|NCT02985957|366257309|FG003|Treatment Period|Study drug toxicity|11|||
106162401|NCT02985957|366257310|FG004|Treatment Period|Study drug toxicity|19|||
106162402|NCT02985957|366257311|FG005|Treatment Period|Study drug toxicity|3|||
106092070|NCT01609556|365995518|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092071|NCT01609556|365995519|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092072|NCT01609556|365995520|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092073|NCT01609556|365995521|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092074|NCT01609556|365995522|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
106092075|NCT01609556|365995523|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
106092076|NCT01609556|365995524|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
106092077|NCT01609556|365995525|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
106092078|NCT01609556|365995526|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
106092079|NCT01609556|365995511|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092080|NCT01609556|365995512|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092081|NCT01609556|365995513|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092082|NCT01609556|365995514|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092083|NCT01609556|365995515|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092084|NCT01609556|365995516|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092085|NCT01609556|365995517|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092086|NCT01609556|365995518|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092087|NCT01609556|365995519|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092088|NCT01609556|365995520|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092089|NCT01609556|365995521|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092090|NCT01609556|365995522|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
106092091|NCT01609556|365995523|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
106092092|NCT01609556|365995524|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
106092093|NCT01609556|365995525|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
106092094|NCT01609556|365995526|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
106092095|NCT01609556|365995511|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092096|NCT01609556|365995512|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092097|NCT01609556|365995513|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092098|NCT01609556|365995514|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092099|NCT01609556|365995515|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092100|NCT01609556|365995516|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092101|NCT01609556|365995517|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092102|NCT01609556|365995518|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092103|NCT01609556|365995519|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092104|NCT01609556|365995520|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092105|NCT01609556|365995521|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092106|NCT01609556|365995522|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
106092107|NCT01609556|365995523|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
106092108|NCT01609556|365995524|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
106092109|NCT01609556|365995525|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
106092110|NCT01609556|365995526|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
106092111|NCT01609556|365995511|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092112|NCT01609556|365995512|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092113|NCT01609556|365995513|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092114|NCT01609556|365995514|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092115|NCT01609556|365995515|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092116|NCT01609556|365995516|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092117|NCT01609556|365995517|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092118|NCT01609556|365995518|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092119|NCT01609556|365995519|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092120|NCT01609556|365995520|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092121|NCT01609556|365995521|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092122|NCT01609556|365995522|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092123|NCT01609556|365995523|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
106092124|NCT01609556|365995524|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092125|NCT01609556|365995525|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092126|NCT01609556|365995526|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
106092127|NCT01609556|365995511|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092128|NCT01609556|365995512|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092129|NCT01609556|365995513|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092130|NCT01609556|365995514|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092131|NCT01609556|365995515|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092132|NCT01609556|365995516|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092133|NCT01609556|365995517|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092134|NCT01609556|365995518|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092135|NCT01609556|365995519|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092136|NCT01609556|365995520|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092137|NCT01609556|365995521|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092138|NCT01609556|365995522|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
106092139|NCT01609556|365995523|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
106092140|NCT01609556|365995524|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
106092141|NCT01609556|365995525|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
106092142|NCT01609556|365995526|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
106092143|NCT01609556|365995511|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092144|NCT01609556|365995512|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092145|NCT01609556|365995513|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092146|NCT01609556|365995514|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092147|NCT01609556|365995515|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092148|NCT01609556|365995516|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092149|NCT01609556|365995517|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092150|NCT01609556|365995518|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092151|NCT01609556|365995519|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092152|NCT01609556|365995520|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092153|NCT01609556|365995521|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092154|NCT01609556|365995522|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092155|NCT01609556|365995523|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092156|NCT01609556|365995524|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092157|NCT01609556|365995525|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
106092158|NCT01609556|365995526|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
106092159|NCT01609556|365995511|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092160|NCT01609556|365995512|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092161|NCT01609556|365995513|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092162|NCT01609556|365995514|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092163|NCT01609556|365995515|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092164|NCT01609556|365995516|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092165|NCT01609556|365995517|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092166|NCT01609556|365995518|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092167|NCT01609556|365995519|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092168|NCT01609556|365995520|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092169|NCT01609556|365995521|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092170|NCT01609556|365995522|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092171|NCT01609556|365995523|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
106092172|NCT01609556|365995524|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
106092173|NCT01609556|365995525|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
106092174|NCT01609556|365995526|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
106092175|NCT01609556|365995511|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092176|NCT01609556|365995512|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092177|NCT01609556|365995513|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092178|NCT01609556|365995514|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092179|NCT01609556|365995515|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092180|NCT01609556|365995516|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092181|NCT01609556|365995517|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092182|NCT01609556|365995518|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092183|NCT01609556|365995519|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092184|NCT01609556|365995520|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092185|NCT01609556|365995521|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092186|NCT01609556|365995522|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092187|NCT01609556|365995523|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
106092188|NCT01609556|365995524|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092189|NCT01609556|365995525|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092190|NCT01609556|365995526|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
106092191|NCT00898677|365995530|FG000|Overall Study|Adverse Event|0|||
106092192|NCT00898677|365995531|FG001|Overall Study|Adverse Event|0|||
106092193|NCT00898677|365995532|FG002|Overall Study|Adverse Event|1|||
106092194|NCT00898677|365995533|FG003|Overall Study|Adverse Event|0|||
106092195|NCT00898677|365995530|FG000|Overall Study|Lost to Follow-up|0|||
106092196|NCT00898677|365995531|FG001|Overall Study|Lost to Follow-up|0|||
106092197|NCT00898677|365995532|FG002|Overall Study|Lost to Follow-up|2|||
106162403|NCT02985957|366257312|FG006|Treatment Period|Study drug toxicity|5|||
106162404|NCT02985957|366257306|FG000|Treatment Period|Disease progression|0|||
106162405|NCT02985957|366257307|FG001|Treatment Period|Disease progression|16|||
106162406|NCT02985957|366257308|FG002|Treatment Period|Disease progression|20|||
106162407|NCT02985957|366257309|FG003|Treatment Period|Disease progression|39|||
106162408|NCT02985957|366257310|FG004|Treatment Period|Disease progression|29|||
106162409|NCT02985957|366257311|FG005|Treatment Period|Disease progression|11|||
106162410|NCT02985957|366257312|FG006|Treatment Period|Disease progression|28|||
106162411|NCT02985957|366257306|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
106162412|NCT02985957|366257307|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
106162413|NCT02985957|366257308|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
106162414|NCT02985957|366257309|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
106162415|NCT02985957|366257310|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
106162416|NCT02985957|366257311|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
106092198|NCT00898677|365995533|FG003|Overall Study|Lost to Follow-up|0|||
106092199|NCT00898677|365995530|FG000|Overall Study|Protocol Violation|1|||
106092200|NCT00898677|365995531|FG001|Overall Study|Protocol Violation|1|||
106092201|NCT00898677|365995532|FG002|Overall Study|Protocol Violation|2|||
106092202|NCT00898677|365995533|FG003|Overall Study|Protocol Violation|0|||
106092203|NCT00898677|365995530|FG000|Overall Study|Withdrawal by Subject|0|||
106092204|NCT00898677|365995531|FG001|Overall Study|Withdrawal by Subject|0|||
106092205|NCT00898677|365995532|FG002|Overall Study|Withdrawal by Subject|0|||
106092206|NCT00898677|365995533|FG003|Overall Study|Withdrawal by Subject|1|||
106092207|NCT00898677|365995530|FG000|Overall Study|Not Treated: Adverse Event|0|||
106092208|NCT00898677|365995531|FG001|Overall Study|Not Treated: Adverse Event|2|||
106092209|NCT00898677|365995532|FG002|Overall Study|Not Treated: Adverse Event|1|||
106092210|NCT00898677|365995533|FG003|Overall Study|Not Treated: Adverse Event|0|||
106092211|NCT00898677|365995530|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
106092212|NCT00898677|365995531|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
106092213|NCT00898677|365995532|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
106092214|NCT00898677|365995533|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
106092215|NCT00898677|365995530|FG000|Overall Study|Not Treated: Pregnancy|0|||
106092216|NCT00898677|365995531|FG001|Overall Study|Not Treated: Pregnancy|0|||
106092217|NCT00898677|365995532|FG002|Overall Study|Not Treated: Pregnancy|1|||
106092218|NCT00898677|365995533|FG003|Overall Study|Not Treated: Pregnancy|0|||
106092219|NCT00898677|365995530|FG000|Overall Study|Not Treated: Protocol Violation|2|||
106092220|NCT00898677|365995531|FG001|Overall Study|Not Treated: Protocol Violation|0|||
106092221|NCT00898677|365995532|FG002|Overall Study|Not Treated: Protocol Violation|2|||
106092222|NCT00898677|365995533|FG003|Overall Study|Not Treated: Protocol Violation|0|||
106092223|NCT00898677|365995530|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
106092224|NCT00898677|365995531|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
106092225|NCT00898677|365995532|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
106092226|NCT00898677|365995533|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
106092227|NCT00898677|365995530|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
106092228|NCT00898677|365995531|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
106092229|NCT00898677|365995532|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
106092230|NCT00898677|365995533|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
106092231|NCT00898677|365995530|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
106092232|NCT00898677|365995531|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
106092233|NCT00898677|365995532|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
106092234|NCT00898677|365995533|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
106092235|NCT00898677|365995530|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
106092236|NCT00898677|365995531|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
106092237|NCT00898677|365995532|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
106092238|NCT00898677|365995533|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
106092239|NCT00898677|365995530|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
106092240|NCT00898677|365995531|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
106092241|NCT00898677|365995532|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
106092242|NCT00898677|365995533|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
106092243|NCT00898677|365995530|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
106092244|NCT00898677|365995531|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
106092245|NCT00898677|365995532|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
106092246|NCT00898677|365995533|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
106092247|NCT00898677|365995530|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
106092248|NCT00898677|365995531|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
106092249|NCT00898677|365995532|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
106092250|NCT00898677|365995533|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
106092251|NCT03864614|365995536|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
106092252|NCT03864614|365995537|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
106092253|NCT03864614|365995538|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
106092254|NCT03864614|365995539|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
106092255|NCT03864614|365995536|FG000|Overall Study|Withdrawal by Subject|72|||
106092256|NCT03864614|365995537|FG001|Overall Study|Withdrawal by Subject|100|||
106092257|NCT03864614|365995538|FG002|Overall Study|Withdrawal by Subject|1|||
106092258|NCT03864614|365995539|FG003|Overall Study|Withdrawal by Subject|21|||
106092259|NCT03864614|365995536|FG000|Overall Study|Lost to Follow-up|45|||
106092260|NCT03864614|365995537|FG001|Overall Study|Lost to Follow-up|54|||
106092261|NCT03864614|365995538|FG002|Overall Study|Lost to Follow-up|0|||
106092262|NCT03864614|365995539|FG003|Overall Study|Lost to Follow-up|9|||
106092263|NCT03864614|365995536|FG000|Overall Study|Adverse Event|42|||
106092264|NCT03864614|365995537|FG001|Overall Study|Adverse Event|30|||
106092265|NCT03864614|365995538|FG002|Overall Study|Adverse Event|1|||
106092266|NCT03864614|365995539|FG003|Overall Study|Adverse Event|9|||
106092267|NCT03864614|365995536|FG000|Overall Study|Protocol Deviation|6|||
106092268|NCT03864614|365995537|FG001|Overall Study|Protocol Deviation|26|||
106092269|NCT03864614|365995538|FG002|Overall Study|Protocol Deviation|0|||
106092270|NCT03864614|365995539|FG003|Overall Study|Protocol Deviation|1|||
106092271|NCT03864614|365995536|FG000|Overall Study|Physician Decision|7|||
106092272|NCT03864614|365995537|FG001|Overall Study|Physician Decision|10|||
106092273|NCT03864614|365995538|FG002|Overall Study|Physician Decision|1|||
106092274|NCT03864614|365995539|FG003|Overall Study|Physician Decision|5|||
106092275|NCT03864614|365995536|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
106092276|NCT03864614|365995537|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
106092277|NCT03864614|365995538|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
106092278|NCT03864614|365995539|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
106092279|NCT03864614|365995536|FG000|Overall Study|Sponsor Decision|1|||
106092280|NCT03864614|365995537|FG001|Overall Study|Sponsor Decision|2|||
106092281|NCT03864614|365995538|FG002|Overall Study|Sponsor Decision|0|||
106092282|NCT03864614|365995539|FG003|Overall Study|Sponsor Decision|0|||
106092283|NCT03864614|365995536|FG000|Overall Study|Pregnancy|0|||
106092284|NCT03864614|365995537|FG001|Overall Study|Pregnancy|1|||
106092285|NCT03864614|365995538|FG002|Overall Study|Pregnancy|0|||
106092286|NCT03864614|365995539|FG003|Overall Study|Pregnancy|0|||
106092287|NCT03864614|365995536|FG000|Overall Study|Other|7|||
106092288|NCT03864614|365995537|FG001|Overall Study|Other|9|||
106092289|NCT03864614|365995538|FG002|Overall Study|Other|1|||
106092290|NCT03864614|365995539|FG003|Overall Study|Other|4|||
106092291|NCT03864614|365995536|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
106092292|NCT03864614|365995537|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
106092293|NCT03864614|365995538|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
106092294|NCT03864614|365995539|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
106092295|NCT00966940|365997799|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
106092296|NCT00966940|365997800|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
106092297|NCT00966940|365997799|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
106092298|NCT00966940|365997800|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
106092299|NCT00924950|365997805|FG000|Overall Study|Lost to Follow-up|2|||
106092300|NCT04193202|365997806|FG000|Overall Study|Adverse Event|2|||
106092301|NCT04193202|365997807|FG001|Overall Study|Adverse Event|1|||
106092302|NCT04193202|365997806|FG000|Overall Study|Death|0|||
106092303|NCT04193202|365997807|FG001|Overall Study|Death|1|||
106092304|NCT04193202|365997806|FG000|Overall Study|Physician Decision|1|||
106092305|NCT04193202|365997807|FG001|Overall Study|Physician Decision|1|||
106092306|NCT04193202|365997806|FG000|Overall Study|Protocol Violation|2|||
106092307|NCT04193202|365997807|FG001|Overall Study|Protocol Violation|2|||
106092308|NCT04193202|365997806|FG000|Overall Study|Withdrawal by Subject|11|||
106092309|NCT04193202|365997807|FG001|Overall Study|Withdrawal by Subject|5|||
106092310|NCT01075321|365997811|FG000|Overall Study|Withdrawal by Subject|0|||
106092311|NCT01075321|365997812|FG001|Overall Study|Withdrawal by Subject|0|||
106092312|NCT01075321|365997813|FG002|Overall Study|Withdrawal by Subject|1|||
106092313|NCT01075321|365997814|FG003|Overall Study|Withdrawal by Subject|1|||
106092314|NCT01075321|365997811|FG000|Overall Study|Protocol Violation|0|||
106092315|NCT01075321|365997812|FG001|Overall Study|Protocol Violation|0|||
106092316|NCT01075321|365997813|FG002|Overall Study|Protocol Violation|1|||
106092317|NCT01075321|365997814|FG003|Overall Study|Protocol Violation|0|||
106092318|NCT01075321|365997811|FG000|Overall Study|Treatment Incomplete due to progression|1|||
106092319|NCT01075321|365997812|FG001|Overall Study|Treatment Incomplete due to progression|0|||
106092320|NCT01075321|365997813|FG002|Overall Study|Treatment Incomplete due to progression|0|||
106092321|NCT01075321|365997814|FG003|Overall Study|Treatment Incomplete due to progression|0|||
106092322|NCT01075321|365997811|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
106092323|NCT01075321|365997812|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
106092324|NCT01075321|365997813|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
106092325|NCT01075321|365997814|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
106092326|NCT02039505|365997816|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
106092327|NCT02039505|365997817|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
106092328|NCT02039505|365997818|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
106092329|NCT02039505|365997819|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
106092330|NCT02039505|365997820|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
106162417|NCT02985957|366257312|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
105867259|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #3|11|||
105867260|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #3|0|||
106092331|NCT02039505|365997821|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
106092332|NCT02039505|365997822|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
106092333|NCT02039505|365997816|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
106092334|NCT02039505|365997817|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
106092335|NCT02039505|365997818|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
106092336|NCT02039505|365997819|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
106092337|NCT02039505|365997820|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
105867261|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
106092338|NCT02039505|365997821|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
106092339|NCT02039505|365997822|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
106092340|NCT02039505|365997816|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
106092341|NCT02039505|365997817|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
106092342|NCT02039505|365997818|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
106092343|NCT02039505|365997819|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
106092344|NCT02039505|365997820|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
106092345|NCT02039505|365997821|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
106092346|NCT02039505|365997822|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
106092347|NCT02039505|365997816|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
106092348|NCT02039505|365997817|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
106092349|NCT02039505|365997818|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
106092350|NCT02039505|365997819|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
106092351|NCT02039505|365997820|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
106092352|NCT02039505|365997821|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
106092353|NCT02039505|365997822|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
106092354|NCT02039505|365997816|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
106092355|NCT02039505|365997817|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
106092356|NCT02039505|365997818|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
106092357|NCT02039505|365997819|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
106092358|NCT02039505|365997820|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
106092359|NCT02039505|365997821|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
106092360|NCT02039505|365997822|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
106092361|NCT02039505|365997816|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
106092362|NCT02039505|365997817|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
106092363|NCT02039505|365997818|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
106092364|NCT02039505|365997819|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
106092365|NCT02039505|365997820|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
106092366|NCT02039505|365997821|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
106092367|NCT02039505|365997822|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
106092368|NCT02039505|365997816|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
106092369|NCT02039505|365997817|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
106092370|NCT02039505|365997818|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
106092371|NCT02039505|365997819|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
106092372|NCT02039505|365997820|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
106092373|NCT02039505|365997821|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
106092374|NCT02039505|365997822|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
106092375|NCT02039505|365997816|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
106092376|NCT02039505|365997817|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
106092377|NCT02039505|365997818|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
106092378|NCT02039505|365997819|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
106092379|NCT02039505|365997820|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
106092380|NCT02039505|365997821|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
106092381|NCT02039505|365997822|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
106092382|NCT02039505|365997816|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
106162418|NCT02985957|366257306|FG000|Treatment Period|Poor/Non-Compliance|0|||
106162419|NCT02985957|366257307|FG001|Treatment Period|Poor/Non-Compliance|0|||
106162420|NCT02985957|366257308|FG002|Treatment Period|Poor/Non-Compliance|0|||
106162421|NCT02985957|366257309|FG003|Treatment Period|Poor/Non-Compliance|0|||
106162422|NCT02985957|366257310|FG004|Treatment Period|Poor/Non-Compliance|1|||
106162423|NCT02985957|366257311|FG005|Treatment Period|Poor/Non-Compliance|1|||
106162424|NCT02985957|366257312|FG006|Treatment Period|Poor/Non-Compliance|0|||
106162425|NCT02985957|366257306|FG000|Treatment Period|Continuing in Treatment Period|0|||
106162426|NCT02985957|366257307|FG001|Treatment Period|Continuing in Treatment Period|1|||
106162427|NCT02985957|366257308|FG002|Treatment Period|Continuing in Treatment Period|0|||
106162428|NCT02985957|366257309|FG003|Treatment Period|Continuing in Treatment Period|4|||
106162429|NCT02985957|366257310|FG004|Treatment Period|Continuing in Treatment Period|4|||
106162430|NCT02985957|366257311|FG005|Treatment Period|Continuing in Treatment Period|0|||
106162431|NCT02985957|366257312|FG006|Treatment Period|Continuing in Treatment Period|0|||
106162432|NCT05481320|366257315|FG000|Overall Study|Withdrawal by Subject|1|||
106162433|NCT05481320|366257316|FG001|Overall Study|Withdrawal by Subject|1|||
106162434|NCT05481320|366257315|FG000|Overall Study|Care recipent passed away|0|||
106162435|NCT05481320|366257316|FG001|Overall Study|Care recipent passed away|1|||
106162436|NCT05481320|366257315|FG000|Overall Study|Out-of-window assessment|0|||
106162437|NCT05481320|366257316|FG001|Overall Study|Out-of-window assessment|1|||
106162438|NCT05481320|366257315|FG000|Overall Study|No longer a primary caregiver|3|||
106162439|NCT05481320|366257316|FG001|Overall Study|No longer a primary caregiver|0|||
106092383|NCT02039505|365997817|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
106092384|NCT02039505|365997818|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
106092385|NCT02039505|365997819|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
106092386|NCT02039505|365997820|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
106092387|NCT02039505|365997821|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
106092388|NCT02039505|365997822|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
106092389|NCT02039505|365997816|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
106092390|NCT02039505|365997817|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
106092391|NCT02039505|365997818|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
106092392|NCT02039505|365997819|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
106092393|NCT02039505|365997820|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
106092394|NCT02039505|365997821|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
106092395|NCT02039505|365997822|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
106092396|NCT02039505|365997816|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
106092397|NCT02039505|365997817|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
106092398|NCT02039505|365997818|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
106092399|NCT02039505|365997819|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
106092400|NCT02039505|365997820|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
106092401|NCT02039505|365997821|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
106092402|NCT02039505|365997822|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
106092403|NCT00262834|365997823|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
106092404|NCT00262834|365997824|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
106092405|NCT02246998|365997825|FG000|Overall Study|Adverse Event|0|||
106092406|NCT02246998|365997826|FG001|Overall Study|Adverse Event|1|||
106092407|NCT02246998|365997827|FG002|Overall Study|Adverse Event|1|||
106092408|NCT02246998|365997828|FG003|Overall Study|Adverse Event|0|||
106092409|NCT02246998|365997825|FG000|Overall Study|Lost to Follow-up|1|||
106092410|NCT02246998|365997826|FG001|Overall Study|Lost to Follow-up|0|||
106092411|NCT02246998|365997827|FG002|Overall Study|Lost to Follow-up|0|||
106092412|NCT02246998|365997828|FG003|Overall Study|Lost to Follow-up|1|||
106092413|NCT02246998|365997825|FG000|Overall Study|Randomized but Never Dosed|1|||
106092414|NCT02246998|365997826|FG001|Overall Study|Randomized but Never Dosed|2|||
106092415|NCT02246998|365997827|FG002|Overall Study|Randomized but Never Dosed|2|||
106092416|NCT02246998|365997828|FG003|Overall Study|Randomized but Never Dosed|1|||
106092417|NCT02473614|365997829|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
106092418|NCT02473614|365997830|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
106092419|NCT02525133|365997831|FG000|Overall Study|Adverse Event|0|||
106092420|NCT02525133|365997832|FG001|Overall Study|Adverse Event|1|||
106092421|NCT02525133|365997831|FG000|Overall Study|Death|0|||
106092422|NCT02525133|365997832|FG001|Overall Study|Death|1|||
106092423|NCT02525133|365997831|FG000|Overall Study|did not meet randomization criteria|1|||
106092424|NCT02525133|365997832|FG001|Overall Study|did not meet randomization criteria|0|||
106092425|NCT02525133|365997831|FG000|Overall Study|Lost to Follow-up|5|||
106092426|NCT02525133|365997832|FG001|Overall Study|Lost to Follow-up|1|||
106092427|NCT02525133|365997831|FG000|Overall Study|randomized not enrolled|3|||
106092428|NCT02525133|365997832|FG001|Overall Study|randomized not enrolled|0|||
106092429|NCT02525133|365997831|FG000|Overall Study|Withdrawal by Subject|1|||
106092430|NCT02525133|365997832|FG001|Overall Study|Withdrawal by Subject|0|||
106092431|NCT01075074|365997833|FG000|Overall Study|Surgeon changed to open incisional case|1|||
106092432|NCT01075074|365997834|FG001|Overall Study|Surgeon changed to open incisional case|2|||
106092433|NCT01075074|365997835|FG002|Overall Study|Surgeon changed to open incisional case|2|||
106092434|NCT01054729|365997837|FG000|Overall Study|Randomized but Not Treated|0|||
106092435|NCT01054729|365997838|FG001|Overall Study|Randomized but Not Treated|1|||
106092436|NCT01054729|365997839|FG002|Overall Study|Randomized but Not Treated|0|||
106092437|NCT01054729|365997840|FG003|Overall Study|Randomized but Not Treated|0|||
106092438|NCT01054729|365997837|FG000|Overall Study|Adverse Event|1|||
106092439|NCT01054729|365997838|FG001|Overall Study|Adverse Event|1|||
106092440|NCT01054729|365997839|FG002|Overall Study|Adverse Event|2|||
106092441|NCT01054729|365997840|FG003|Overall Study|Adverse Event|1|||
106092442|NCT01054729|365997837|FG000|Overall Study|Withdrawal by Subject|1|||
106092443|NCT01054729|365997838|FG001|Overall Study|Withdrawal by Subject|0|||
106092444|NCT01054729|365997839|FG002|Overall Study|Withdrawal by Subject|1|||
106092445|NCT01054729|365997840|FG003|Overall Study|Withdrawal by Subject|0|||
106092446|NCT01054729|365997837|FG000|Overall Study|Lost to Follow-up|0|||
106092447|NCT01054729|365997838|FG001|Overall Study|Lost to Follow-up|1|||
106092448|NCT01054729|365997839|FG002|Overall Study|Lost to Follow-up|0|||
106092449|NCT01054729|365997840|FG003|Overall Study|Lost to Follow-up|0|||
106092450|NCT01054729|365997837|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
106092451|NCT01054729|365997838|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
106092452|NCT01054729|365997839|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
106092453|NCT01054729|365997840|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
106092454|NCT01054729|365997837|FG000|Overall Study|Non-responder|1|||
106092455|NCT01054729|365997838|FG001|Overall Study|Non-responder|0|||
106092456|NCT01054729|365997839|FG002|Overall Study|Non-responder|1|||
106092457|NCT01054729|365997840|FG003|Overall Study|Non-responder|1|||
106092458|NCT01054729|365997837|FG000|Overall Study|PEG/RBV Non-responder|1|||
106092459|NCT01054729|365997838|FG001|Overall Study|PEG/RBV Non-responder|0|||
106092460|NCT01054729|365997839|FG002|Overall Study|PEG/RBV Non-responder|1|||
106092461|NCT01054729|365997840|FG003|Overall Study|PEG/RBV Non-responder|0|||
106092462|NCT01054729|365997837|FG000|Overall Study|Personal/Obligations|0|||
106092463|NCT01054729|365997838|FG001|Overall Study|Personal/Obligations|1|||
106092464|NCT01054729|365997839|FG002|Overall Study|Personal/Obligations|0|||
106092465|NCT01054729|365997840|FG003|Overall Study|Personal/Obligations|0|||
106092466|NCT01054729|365997837|FG000|Overall Study|Subject moved|0|||
106092467|NCT01054729|365997838|FG001|Overall Study|Subject moved|0|||
106092468|NCT01054729|365997839|FG002|Overall Study|Subject moved|1|||
106092469|NCT01054729|365997840|FG003|Overall Study|Subject moved|0|||
106092470|NCT01054729|365997837|FG000|Overall Study|Lack of Efficacy|0|||
106092471|NCT01054729|365997838|FG001|Overall Study|Lack of Efficacy|0|||
106092472|NCT01054729|365997839|FG002|Overall Study|Lack of Efficacy|0|||
106092473|NCT01054729|365997840|FG003|Overall Study|Lack of Efficacy|1|||
106092474|NCT04265755|365997841|FG000|Overall Study|Withdrawal by Subject|39|||
106092475|NCT04265755|365997841|FG000|Overall Study|Decision by sponsor|2|||
106092476|NCT04265755|365997841|FG000|Overall Study|Lost to Follow-up|11|||
106092477|NCT04265755|365997841|FG000|Overall Study|Death|1|||
106092478|NCT04535037|365997842|FG000|Overall Study|Protocol Violation|1|||
106092479|NCT04535037|365997843|FG001|Overall Study|Protocol Violation|0|||
106092480|NCT04535037|365997842|FG000|Overall Study|Withdrawal by Subject|8|||
106092481|NCT04535037|365997843|FG001|Overall Study|Withdrawal by Subject|9|||
106092482|NCT04535037|365997842|FG000|Overall Study|Migrated / moved from the study area|1|||
106092483|NCT04535037|365997843|FG001|Overall Study|Migrated / moved from the study area|4|||
106092484|NCT04535037|365997842|FG000|Overall Study|Other|2|||
106092485|NCT04535037|365997843|FG001|Overall Study|Other|5|||
106092486|NCT01172938|365997844|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
106092487|NCT01172938|365997845|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
106092488|NCT01172938|365997846|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
106092489|NCT01172938|365997847|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
106092490|NCT01172938|365997848|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
106092491|NCT01172938|365997849|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
106092492|NCT01172938|365997850|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
106092493|NCT01172938|365997851|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
106092494|NCT01172938|365997852|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
106092495|NCT01172938|365997844|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
106092496|NCT01172938|365997845|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
106092497|NCT01172938|365997846|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
106092498|NCT01172938|365997847|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
106092499|NCT01172938|365997848|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
106092500|NCT01172938|365997849|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
106092501|NCT01172938|365997850|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
106092502|NCT01172938|365997851|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
106092503|NCT01172938|365997852|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
106092504|NCT01172938|365997844|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
106092505|NCT01172938|365997845|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
106092506|NCT01172938|365997846|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
106092507|NCT01172938|365997847|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
106092508|NCT01172938|365997848|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
106092509|NCT01172938|365997849|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
106092510|NCT01172938|365997850|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
106092511|NCT01172938|365997851|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
106092512|NCT01172938|365997852|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
106092513|NCT01172938|365997844|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
106092514|NCT01172938|365997845|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
106092515|NCT01172938|365997846|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
106092516|NCT01172938|365997847|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
106092517|NCT01172938|365997848|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
106092518|NCT01172938|365997849|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
106092519|NCT01172938|365997850|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
106092520|NCT01172938|365997851|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
106092521|NCT01172938|365997852|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
106092522|NCT01172938|365997844|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
106092523|NCT01172938|365997845|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
106092524|NCT01172938|365997846|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
106092525|NCT01172938|365997847|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
106092526|NCT01172938|365997848|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
106092527|NCT01172938|365997849|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
106092528|NCT01172938|365997850|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
106092529|NCT01172938|365997851|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
106092530|NCT01172938|365997852|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
106092531|NCT01172938|365997844|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
106092532|NCT01172938|365997845|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
106092533|NCT01172938|365997846|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
106092534|NCT01172938|365997847|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
106092535|NCT01172938|365997848|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
106092536|NCT01172938|365997849|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
106092537|NCT01172938|365997850|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
106092538|NCT01172938|365997851|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
106092539|NCT01172938|365997852|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
106092540|NCT01172938|365997844|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
106092541|NCT01172938|365997845|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
106092542|NCT01172938|365997846|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
106092543|NCT01172938|365997847|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
106092544|NCT01172938|365997848|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
106092545|NCT01172938|365997849|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
106092546|NCT01172938|365997850|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
106092547|NCT01172938|365997851|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
106092548|NCT01172938|365997852|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
106092549|NCT01172938|365997844|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
106092550|NCT01172938|365997845|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
106092551|NCT01172938|365997846|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
106092552|NCT01172938|365997847|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
106092553|NCT01172938|365997848|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
106092554|NCT01172938|365997849|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
106092555|NCT01172938|365997850|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
106092556|NCT01172938|365997851|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
106092557|NCT01172938|365997852|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
106092558|NCT01172938|365997844|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
106092559|NCT01172938|365997845|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
106092560|NCT01172938|365997846|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
106092561|NCT01172938|365997847|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
106092562|NCT01172938|365997848|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
106092563|NCT01172938|365997849|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
106092564|NCT01172938|365997850|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
106092565|NCT01172938|365997851|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
106092566|NCT01172938|365997852|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
106092567|NCT01172938|365997844|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
106092568|NCT01172938|365997845|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
106092569|NCT01172938|365997846|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
106092570|NCT01172938|365997847|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
106092571|NCT01172938|365997848|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
106092572|NCT01172938|365997849|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
106092573|NCT01172938|365997850|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
106092574|NCT01172938|365997851|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
106092575|NCT01172938|365997852|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
106092576|NCT01172938|365997844|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
106092577|NCT01172938|365997845|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
106092578|NCT01172938|365997846|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
106092579|NCT01172938|365997847|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
106092580|NCT01172938|365997848|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
106092581|NCT01172938|365997849|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
106092582|NCT01172938|365997850|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
106092583|NCT01172938|365997851|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
106092584|NCT01172938|365997852|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
106092585|NCT01172938|365997844|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
106092586|NCT01172938|365997845|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
106092587|NCT01172938|365997846|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
106092588|NCT01172938|365997847|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
106092589|NCT01172938|365997848|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
106092590|NCT01172938|365997849|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
106092591|NCT01172938|365997850|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
106092592|NCT01172938|365997851|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
106092593|NCT01172938|365997852|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
106092594|NCT01172938|365997844|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
106092595|NCT01172938|365997845|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
106092596|NCT01172938|365997846|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
106092597|NCT01172938|365997847|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
106092598|NCT01172938|365997848|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
106092599|NCT01172938|365997849|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
106092600|NCT01172938|365997850|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
106092601|NCT01172938|365997851|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
106092602|NCT01172938|365997852|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
106092603|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
106092604|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
106092605|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
106092606|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
106092607|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
106092608|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
106092609|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
106092610|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
106092611|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
106092612|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
106092613|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
106092614|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
106092615|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
106092616|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
106092617|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
106092618|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
106092619|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
106092620|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
106092621|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
106092622|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
106092623|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
106092624|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
106092625|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
106092626|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
106092627|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
106092628|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
106092629|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
106092630|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
106092631|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
106092632|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
106092633|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
106092634|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
106092635|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
106092636|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
106092637|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
106092638|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
106092639|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
106092640|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
106092641|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
106092642|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
106092643|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
106092644|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
106092645|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
106162440|NCT05481320|366257315|FG000|Overall Study|Unable to contact|1|||
106162441|NCT05481320|366257316|FG001|Overall Study|Unable to contact|0|||
106162442|NCT03721952|366257318|FG000|Overall Study|Lost to Follow-up|0|||
106162443|NCT03721952|366257319|FG001|Overall Study|Lost to Follow-up|0|||
106162444|NCT03721952|366257320|FG002|Overall Study|Lost to Follow-up|2|||
106162445|NCT03721952|366257321|FG003|Overall Study|Lost to Follow-up|0|||
106092646|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
106092647|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
106092648|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
106092649|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
106092650|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
106092651|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
106092652|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
106092653|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
106092654|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
106092655|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
106092656|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
106092657|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
106092658|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
106092659|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
106092660|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
106092661|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
106092662|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
106092663|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
106092664|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
106092665|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
106092666|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
106092667|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
106092668|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
106092669|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
106092670|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
106092671|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
106092672|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
106092673|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
106092674|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
106092675|NCT01172938|365997844|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
106092676|NCT01172938|365997845|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
106092677|NCT01172938|365997846|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
106092678|NCT01172938|365997847|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
106092679|NCT01172938|365997848|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
106092680|NCT01172938|365997849|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
106092681|NCT01172938|365997850|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
106092682|NCT01172938|365997851|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
106092683|NCT01172938|365997852|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
106092684|NCT01172938|365997844|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
106092685|NCT01172938|365997845|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
106092686|NCT01172938|365997846|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
106092687|NCT01172938|365997847|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
106092688|NCT01172938|365997848|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
106092689|NCT01172938|365997849|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
106092690|NCT01172938|365997850|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
106092691|NCT01172938|365997851|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
106092692|NCT01172938|365997852|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
106092693|NCT01172938|365997844|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
106092694|NCT01172938|365997845|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
106092695|NCT01172938|365997846|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
106092696|NCT01172938|365997847|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
106092697|NCT01172938|365997848|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
106092698|NCT01172938|365997849|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
106092699|NCT01172938|365997850|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
106092700|NCT01172938|365997851|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
106092701|NCT01172938|365997852|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
106092702|NCT01172938|365997844|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
106092703|NCT01172938|365997845|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
106092704|NCT01172938|365997846|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
106092705|NCT01172938|365997847|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
106092706|NCT01172938|365997848|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
106092707|NCT01172938|365997849|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
106162446|NCT03721952|366257322|FG004|Overall Study|Lost to Follow-up|0|||
106162447|NCT03721952|366257318|FG000|Overall Study|Protocol Violation|0|||
105867262|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
105867263|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
106092708|NCT01172938|365997850|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
106092709|NCT01172938|365997851|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
106092710|NCT01172938|365997852|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
106092711|NCT01172938|365997844|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
106092712|NCT01172938|365997845|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
106092713|NCT01172938|365997846|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
106092714|NCT01172938|365997847|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
106092715|NCT01172938|365997848|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
106092716|NCT01172938|365997849|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
106092717|NCT01172938|365997850|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
106092718|NCT01172938|365997851|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
106092719|NCT01172938|365997852|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
106092720|NCT01172938|365997844|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
106092721|NCT01172938|365997845|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
106092722|NCT01172938|365997846|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
106092723|NCT01172938|365997847|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
106092724|NCT01172938|365997848|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
106092725|NCT01172938|365997849|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
106092726|NCT01172938|365997850|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
106092727|NCT01172938|365997851|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
106092728|NCT01172938|365997852|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
106092729|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
106092730|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
106092731|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
106092732|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
106092733|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
106092734|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
106092735|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
106092736|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
106092737|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
106092738|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
106092739|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
106092740|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
106092741|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
106092742|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
106092743|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
106092744|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
106092745|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
106092746|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
106092747|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
106092748|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
106092749|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
106092750|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
106092751|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
106092752|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
106092753|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
106092754|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
106092755|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
106092756|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
106092757|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
106092758|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
106092759|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
106092760|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
106092761|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
106092762|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
106092763|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
106092764|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
106092765|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
106092766|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
106092767|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
106092768|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
106092769|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
106092770|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
106162448|NCT03721952|366257319|FG001|Overall Study|Protocol Violation|1|||
105869212|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
106092771|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
106092772|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
106092773|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
106092774|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
106092775|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
106092776|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
106092777|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
106092778|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
106092779|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
106092780|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
106092781|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
106092782|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
106092783|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
106092784|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
106092785|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
106092786|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
106092787|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
106092788|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
106092789|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
106092790|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
106092791|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
106092792|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
106092793|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
106092794|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
106092795|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
106092796|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
106092797|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
106092798|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
106092799|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
106092800|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
106092801|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
106092802|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
106092803|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
106092804|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
106092805|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
106092806|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
106092807|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
106092808|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
106092809|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
106092810|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
106092811|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
106092812|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
106092813|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
106092814|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
106092815|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
106092816|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
106092817|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
106092818|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
106092819|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
106092820|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
106092821|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
106092822|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
106092823|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
106092824|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
106162449|NCT03721952|366257320|FG002|Overall Study|Protocol Violation|0|||
105867264|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105867265|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
105867266|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105867267|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #4|3|||
105867268|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #4|0|||
105867269|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
105867270|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
105867271|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
105867272|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
106092825|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
106092826|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
106092827|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
106092828|NCT01172938|365997844|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
106092829|NCT01172938|365997845|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
106092830|NCT01172938|365997846|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
106092831|NCT01172938|365997847|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
106092832|NCT01172938|365997848|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
106092833|NCT01172938|365997849|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
106092834|NCT01172938|365997850|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
106092835|NCT01172938|365997851|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
106092836|NCT01172938|365997852|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
106092837|NCT05282004|365997853|FG000|Overall Study|Adverse Event|2|||
106092838|NCT01992536|365997856|FG000|Overall Study|Administrative Reason|0|||
106092839|NCT01992536|365997857|FG001|Overall Study|Administrative Reason|0|||
106092840|NCT01992536|365997858|FG002|Overall Study|Administrative Reason|0|||
106092841|NCT01992536|365997859|FG003|Overall Study|Administrative Reason|0|||
106092842|NCT01992536|365997860|FG004|Overall Study|Administrative Reason|0|||
106092843|NCT01992536|365997861|FG005|Overall Study|Administrative Reason|0|||
106092844|NCT01992536|365997862|FG006|Overall Study|Administrative Reason|7|||
106092845|NCT01992536|365997863|FG007|Overall Study|Administrative Reason|0|||
106092846|NCT01992536|365997864|FG008|Overall Study|Administrative Reason|0|||
106092847|NCT01992536|365997865|FG009|Overall Study|Administrative Reason|0|||
106092848|NCT01992536|365997856|FG000|Overall Study|Lost to Follow-up|4|||
106092849|NCT01992536|365997857|FG001|Overall Study|Lost to Follow-up|2|||
106092850|NCT01992536|365997858|FG002|Overall Study|Lost to Follow-up|1|||
106092851|NCT01992536|365997859|FG003|Overall Study|Lost to Follow-up|0|||
106092852|NCT01992536|365997860|FG004|Overall Study|Lost to Follow-up|0|||
106092853|NCT01992536|365997861|FG005|Overall Study|Lost to Follow-up|1|||
106092854|NCT01992536|365997862|FG006|Overall Study|Lost to Follow-up|0|||
106092855|NCT01992536|365997863|FG007|Overall Study|Lost to Follow-up|0|||
106092856|NCT01992536|365997864|FG008|Overall Study|Lost to Follow-up|1|||
106092857|NCT01992536|365997865|FG009|Overall Study|Lost to Follow-up|1|||
106092858|NCT01992536|365997856|FG000|Overall Study|Withdrawal by Subject|0|||
106092859|NCT01992536|365997857|FG001|Overall Study|Withdrawal by Subject|1|||
106092860|NCT01992536|365997858|FG002|Overall Study|Withdrawal by Subject|0|||
106092861|NCT01992536|365997859|FG003|Overall Study|Withdrawal by Subject|2|||
106092862|NCT01992536|365997860|FG004|Overall Study|Withdrawal by Subject|0|||
106092863|NCT01992536|365997861|FG005|Overall Study|Withdrawal by Subject|0|||
106092864|NCT01992536|365997862|FG006|Overall Study|Withdrawal by Subject|0|||
106092865|NCT01992536|365997863|FG007|Overall Study|Withdrawal by Subject|0|||
106092866|NCT01992536|365997864|FG008|Overall Study|Withdrawal by Subject|0|||
106092867|NCT01992536|365997865|FG009|Overall Study|Withdrawal by Subject|0|||
106092868|NCT03224468|365997866|FG000|Overall Study|Did not obtain MM card|53|||
106092869|NCT03224468|365997867|FG001|Overall Study|Did not obtain MM card|0|||
106092870|NCT03224468|365997866|FG000|Overall Study|Lost to Follow-up|4|||
106092871|NCT03224468|365997867|FG001|Overall Study|Lost to Follow-up|11|||
106092872|NCT03224468|365997866|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
106092873|NCT03224468|365997867|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
106092874|NCT00889421|365997868|FG000|Overall Study|Lack of Efficacy|3|||
106092875|NCT00795600|365997869|FG000|Overall Study|Adverse Event|1|||
106092876|NCT00795600|365997870|FG001|Overall Study|Adverse Event|1|||
106092877|NCT00795600|365997869|FG000|Overall Study|Protocol Violation|1|||
106092878|NCT00795600|365997870|FG001|Overall Study|Protocol Violation|2|||
106092879|NCT00795600|365997869|FG000|Overall Study|Withdrawal by Subject|1|||
106092880|NCT00795600|365997870|FG001|Overall Study|Withdrawal by Subject|0|||
106092881|NCT00795600|365997869|FG000|Overall Study|Unclassified|1|||
106092882|NCT00795600|365997870|FG001|Overall Study|Unclassified|1|||
105867273|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
105867274|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105867275|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
105867276|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
106092883|NCT02806986|365997882|FG000|Treatment Stage 1|Adverse Event|1|||
106092884|NCT02806986|365997882|FG000|Treatment Stage 2|Adverse Event|3|||
106092885|NCT02806986|365997882|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
106092886|NCT02667912|365997883|FG000|Overall Study|Death|3|||
106092887|NCT02667912|365997884|FG001|Overall Study|Death|1|||
106092888|NCT02667912|365997883|FG000|Overall Study|Withdrawal by Subject|1|||
106092889|NCT02667912|365997884|FG001|Overall Study|Withdrawal by Subject|2|||
106092890|NCT02667912|365997883|FG000|Overall Study|Withdrawal by Subject|1|||
106092891|NCT02667912|365997884|FG001|Overall Study|Withdrawal by Subject|0|||
105867277|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
105867278|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
105867279|NCT03888066|365164935|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
105867280|NCT03888066|365164936|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105867281|NCT03888066|365164935|FG000|Run-in Phase|AE (Adverse Event)|17|||
106092892|NCT00383435|365997885|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
106092893|NCT00383435|365997886|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
106092894|NCT00383435|365997887|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
106092895|NCT00383435|365997888|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
106092896|NCT00383435|365997889|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
106092897|NCT00383435|365997885|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
106092898|NCT00383435|365997886|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
106092899|NCT00383435|365997887|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
106092900|NCT00383435|365997888|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
106092901|NCT00383435|365997889|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
106092902|NCT00383435|365997885|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
106092903|NCT00383435|365997886|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
106092904|NCT00383435|365997887|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
106092905|NCT00383435|365997888|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
106092906|NCT00383435|365997889|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
106092907|NCT00383435|365997885|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
106092908|NCT00383435|365997886|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
106092909|NCT00383435|365997887|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
106092910|NCT00383435|365997888|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
106092911|NCT00383435|365997889|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
106092912|NCT00383435|365997885|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
106092913|NCT00383435|365997886|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
106092914|NCT00383435|365997887|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
106092915|NCT00383435|365997888|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
106092916|NCT00383435|365997889|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
106092917|NCT00383435|365997885|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
106092918|NCT00383435|365997886|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
106092919|NCT00383435|365997887|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
106092920|NCT00383435|365997888|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
106092921|NCT00383435|365997889|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
106092922|NCT00383435|365997885|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
106092923|NCT00383435|365997886|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
106092924|NCT00383435|365997887|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
106092925|NCT00383435|365997888|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
106092926|NCT00383435|365997889|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
106092927|NCT00383435|365997885|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
106092928|NCT00383435|365997886|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
106092929|NCT00383435|365997887|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
106092930|NCT00383435|365997888|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
106092931|NCT00383435|365997889|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
106092932|NCT00383435|365997885|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
106092933|NCT00383435|365997886|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
106092934|NCT00383435|365997887|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
106092935|NCT00383435|365997888|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
106092936|NCT00383435|365997889|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
106092937|NCT00383435|365997885|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
106092938|NCT00383435|365997886|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
106092939|NCT00383435|365997887|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
106092940|NCT00383435|365997888|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
106092941|NCT00383435|365997889|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
106092942|NCT00383435|365997885|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
106092943|NCT00383435|365997886|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
106092944|NCT00383435|365997887|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
106092945|NCT00383435|365997888|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
106092946|NCT00383435|365997889|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
106092947|NCT00383435|365997885|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
106092948|NCT00383435|365997886|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
106092949|NCT00383435|365997887|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
106092950|NCT00383435|365997888|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
106092951|NCT00383435|365997889|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
106092952|NCT00383435|365997885|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
106092953|NCT00383435|365997886|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
106092954|NCT00383435|365997887|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
106092955|NCT00383435|365997888|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
106092956|NCT00383435|365997889|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
106092957|NCT00383435|365997885|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
106092958|NCT00383435|365997886|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
106092959|NCT00383435|365997887|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
106092960|NCT00383435|365997888|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
106092961|NCT00383435|365997889|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
106092962|NCT00383435|365997885|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
106092963|NCT00383435|365997886|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
106092964|NCT00383435|365997887|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
106092965|NCT00383435|365997888|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
106092966|NCT00383435|365997889|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
106092967|NCT00383435|365997885|FG000|26-Week Treatment Safety Extension|Administrative|1|||
106092968|NCT00383435|365997886|FG001|26-Week Treatment Safety Extension|Administrative|1|||
106092969|NCT00383435|365997887|FG002|26-Week Treatment Safety Extension|Administrative|0|||
106092970|NCT00383435|365997888|FG003|26-Week Treatment Safety Extension|Administrative|1|||
106092971|NCT00383435|365997889|FG004|26-Week Treatment Safety Extension|Administrative|0|||
106092972|NCT05061446|365997892|FG000|Overall Study|Adverse Event|2|||
106092973|NCT05061446|365997893|FG001|Overall Study|Adverse Event|0|||
106092974|NCT05061446|365997894|FG002|Overall Study|Adverse Event|0|||
106092975|NCT05061446|365997892|FG000|Overall Study|Participant no longer available due to personal reason|0|||
106092976|NCT05061446|365997893|FG001|Overall Study|Participant no longer available due to personal reason|1|||
106092977|NCT05061446|365997894|FG002|Overall Study|Participant no longer available due to personal reason|0|||
106092978|NCT04111497|365997895|FG000|Overall Study|relapse of primary disease|1|||
106092979|NCT04111497|365997895|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
106092980|NCT03321019|365997896|FG000|Overall Study|Withdrawal by Subject|0|||
106092981|NCT03321019|365997897|FG001|Overall Study|Withdrawal by Subject|6|||
106092982|NCT03321019|365997896|FG000|Overall Study|Lost to Follow-up|0|||
106092983|NCT03321019|365997897|FG001|Overall Study|Lost to Follow-up|22|||
106092984|NCT03067441|365997898|FG000|Overall Study|Withdrawal by Subject|16|||
106092985|NCT03067441|365997899|FG001|Overall Study|Withdrawal by Subject|34|||
106092986|NCT03067441|365997898|FG000|Overall Study|Lost to Follow-up|7|||
106092987|NCT03067441|365997899|FG001|Overall Study|Lost to Follow-up|5|||
106092988|NCT03067441|365997898|FG000|Overall Study|Adverse Event|7|||
106092989|NCT03067441|365997899|FG001|Overall Study|Adverse Event|14|||
106092990|NCT03067441|365997898|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
106092991|NCT03067441|365997899|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
106092992|NCT03067441|365997898|FG000|Overall Study|Physician Decision|1|||
106092993|NCT03067441|365997899|FG001|Overall Study|Physician Decision|3|||
106092994|NCT03067441|365997898|FG000|Overall Study|Other|1|||
106092995|NCT03067441|365997899|FG001|Overall Study|Other|1|||
106092996|NCT02209324|365997909|FG000|Overall Study|Adverse Event|2|||
106092997|NCT02209324|365997909|FG000|Overall Study|Lack of Efficacy|1|||
106092998|NCT02209324|365997909|FG000|Overall Study|Lost to Follow-up|1|||
106092999|NCT02209324|365997909|FG000|Overall Study|Physician Decision|3|||
106093000|NCT02209324|365997909|FG000|Overall Study|Protocol Violation|14|||
106093001|NCT02209324|365997909|FG000|Overall Study|Withdrawal by Subject|8|||
106093002|NCT02209324|365997909|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
106093003|NCT02209324|365997909|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
106093004|NCT02209324|365997909|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
106093005|NCT05799495|365997910|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
106162450|NCT03721952|366257321|FG003|Overall Study|Protocol Violation|0|||
106162451|NCT03721952|366257322|FG004|Overall Study|Protocol Violation|0|||
106093006|NCT05799495|365997911|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
106093007|NCT05799495|365997912|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
106093008|NCT05799495|365997913|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
106093009|NCT05799495|365997910|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
106093010|NCT05799495|365997911|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
106093011|NCT05799495|365997912|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
106093012|NCT05799495|365997913|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
106093013|NCT05799495|365997910|FG000|Treatment (Up to 5 Days)|Other|0|||
106093014|NCT05799495|365997911|FG001|Treatment (Up to 5 Days)|Other|1|||
106162452|NCT03721952|366257318|FG000|Overall Study|Withdrawal by Subject|1|||
106162453|NCT03721952|366257319|FG001|Overall Study|Withdrawal by Subject|0|||
106093015|NCT05799495|365997912|FG002|Treatment (Up to 5 Days)|Other|0|||
106093016|NCT05799495|365997913|FG003|Treatment (Up to 5 Days)|Other|0|||
106093017|NCT05799495|365997910|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
106093018|NCT05799495|365997911|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
106093019|NCT05799495|365997912|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
106093020|NCT05799495|365997913|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
106093021|NCT05799495|365997910|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
106093022|NCT05799495|365997911|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
106093023|NCT05799495|365997912|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
106093024|NCT05799495|365997913|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
106093025|NCT05799495|365997910|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
106093026|NCT05799495|365997911|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
106093027|NCT05799495|365997912|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
106093028|NCT05799495|365997913|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
106093029|NCT01198600|365997914|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
106093030|NCT01198600|365997915|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
106093031|NCT01198600|365997916|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
106093032|NCT01198600|365997917|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
106093033|NCT01198600|365997914|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
106093034|NCT01198600|365997915|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
106093035|NCT01198600|365997916|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
106093036|NCT01198600|365997917|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
106093037|NCT01198600|365997914|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
106093038|NCT01198600|365997915|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
106093039|NCT01198600|365997916|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
106093040|NCT01198600|365997917|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
106093041|NCT01198600|365997914|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
106093042|NCT01198600|365997915|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
106093043|NCT01198600|365997916|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
106093044|NCT01198600|365997917|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
106093045|NCT01198600|365997914|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
106093046|NCT01198600|365997915|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
106093047|NCT01198600|365997916|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
106093048|NCT01198600|365997917|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
106093049|NCT01198600|365997914|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
106093050|NCT01198600|365997915|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
106093051|NCT01198600|365997916|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
106093052|NCT01198600|365997917|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
106093053|NCT01198600|365997914|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
106093054|NCT01198600|365997915|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
106093055|NCT01198600|365997916|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
106093056|NCT01198600|365997917|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
106093057|NCT03694548|365997918|FG000|Part A Survey|Protocol Violation|3|||
106093058|NCT03694548|365997919|FG001|Part A Survey|Protocol Violation|3|||
106093059|NCT03694548|365997920|FG002|Part A Survey|Protocol Violation|0|||
106093060|NCT03694548|365997918|FG000|Part B Yoga Program|Protocol Violation|0|||
106093061|NCT03694548|365997919|FG001|Part B Yoga Program|Protocol Violation|0|||
106093062|NCT03694548|365997920|FG002|Part B Yoga Program|Protocol Violation|3|||
106093063|NCT03694548|365997918|FG000|Part B Yoga Program|Did not attend intervention|0|||
106093064|NCT03694548|365997919|FG001|Part B Yoga Program|Did not attend intervention|0|||
106093065|NCT03694548|365997920|FG002|Part B Yoga Program|Did not attend intervention|8|||
106093066|NCT04102501|365997922|FG000|Overall Study|Withdrawal by Subject|7|||
106093067|NCT04102501|365997923|FG001|Overall Study|Withdrawal by Subject|9|||
106093068|NCT04102501|365997922|FG000|Overall Study|Adverse Event|1|||
106093069|NCT04102501|365997923|FG001|Overall Study|Adverse Event|3|||
106093070|NCT01427712|365997924|FG000|Overall Study|Transfer to a different hospital|2|||
106093071|NCT01427712|365997924|FG000|Overall Study|Lost to Follow-up|1|||
106093072|NCT01427712|365997924|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
106093073|NCT01427712|365997924|FG000|Overall Study|Failure to visit|1|||
106093074|NCT00968617|365997926|FG000|Overall Study|Study terminated by sponsor|6|||
106093075|NCT04433767|365997927|FG000|Overall Study|Adverse Event|1|||
106093076|NCT00661492|365997928|FG000|Overall Study|Adverse Event|16|||
106093077|NCT00661492|365997929|FG001|Overall Study|Adverse Event|13|||
106093078|NCT00661492|365997928|FG000|Overall Study|Disease Progression|44|||
106093079|NCT00661492|365997929|FG001|Overall Study|Disease Progression|14|||
106093080|NCT00661492|365997928|FG000|Overall Study|Patient Request|6|||
106093081|NCT00661492|365997929|FG001|Overall Study|Patient Request|1|||
106093082|NCT00661492|365997928|FG000|Overall Study|Investigator Request|1|||
106093083|NCT00661492|365997929|FG001|Overall Study|Investigator Request|0|||
106093084|NCT00661492|365997928|FG000|Overall Study|Lost to Follow-up|0|||
106162454|NCT03721952|366257320|FG002|Overall Study|Withdrawal by Subject|40|||
106093085|NCT00661492|365997929|FG001|Overall Study|Lost to Follow-up|1|||
106093086|NCT00661492|365997928|FG000|Overall Study|Other|1|||
106093087|NCT00661492|365997929|FG001|Overall Study|Other|0|||
106093088|NCT01024387|365997930|FG000|Overall Study|Radiographic Progression|29|||
106093089|NCT01024387|365997930|FG000|Overall Study|Symptomatic Progression|10|||
106093090|NCT01024387|365997930|FG000|Overall Study|Physician Decision|5|||
106093091|NCT01024387|365997930|FG000|Overall Study|Withdrawal by Subject|5|||
106093092|NCT01024387|365997930|FG000|Overall Study|Death|2|||
106093093|NCT01024387|365997930|FG000|Overall Study|Prolonged Treatment Delay|1|||
106093094|NCT01024387|365997930|FG000|Overall Study|Adverse Event|3|||
106093095|NCT01024387|365997930|FG000|Overall Study|Other|5|||
106093096|NCT03965052|365997932|FG000|Overall Study|Protocol Violation|1|||
106093097|NCT03965052|365997933|FG001|Overall Study|Protocol Violation|0|||
106093098|NCT03238001|365997940|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
106093099|NCT03238001|365997940|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
106093100|NCT03238001|365997940|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
106093101|NCT03238001|365997940|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
106093102|NCT03238001|365997940|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
106093103|NCT03238001|365997940|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
106093104|NCT03238001|365997940|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
106093105|NCT03238001|365997940|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
106093106|NCT00766376|365997954|FG000|Overall Study|Withdrawal by Subject|27|||
106093107|NCT01110239|365997955|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
106093108|NCT01110239|365997956|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
106093109|NCT01110239|365997957|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
106093110|NCT01110239|365997958|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
106093111|NCT01110239|365997955|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
106093112|NCT01110239|365997956|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
106093113|NCT01110239|365997957|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
106093114|NCT01110239|365997958|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
106093115|NCT00132769|365997959|FG000|Overall Study|Withdrawal by Subject|1|||
106093116|NCT00132769|365997960|FG001|Overall Study|Withdrawal by Subject|3|||
106093117|NCT00132769|365997959|FG000|Overall Study|Lack of Efficacy|7|||
106093118|NCT00132769|365997960|FG001|Overall Study|Lack of Efficacy|6|||
106093119|NCT00132769|365997959|FG000|Overall Study|Adverse Event|2|||
106093120|NCT00132769|365997960|FG001|Overall Study|Adverse Event|1|||
106093121|NCT00132769|365997959|FG000|Overall Study|Protocol Violation|1|||
106093122|NCT00132769|365997960|FG001|Overall Study|Protocol Violation|1|||
106093123|NCT00023452|365997964|FG000|Overall Study|Ineligible for Study|163|||
106093124|NCT00023452|365997965|FG001|Overall Study|Ineligible for Study|159|||
106093125|NCT00023452|365997964|FG000|Overall Study|Out of Window|129|||
106093126|NCT00023452|365997965|FG001|Overall Study|Out of Window|69|||
106093127|NCT00023452|365997964|FG000|Overall Study|Death|2|||
106093128|NCT00023452|365997965|FG001|Overall Study|Death|0|||
106093129|NCT00023452|365997964|FG000|Overall Study|Withdrawal by Subject|66|||
106093130|NCT00023452|365997965|FG001|Overall Study|Withdrawal by Subject|54|||
106093131|NCT00023452|365997964|FG000|Overall Study|Adverse Event|139|||
106093132|NCT00023452|365997965|FG001|Overall Study|Adverse Event|196|||
106093133|NCT00023452|365997964|FG000|Overall Study|Lost to Follow-up|293|||
106093134|NCT00023452|365997965|FG001|Overall Study|Lost to Follow-up|60|||
106093135|NCT00023452|365997964|FG000|Overall Study|Physician Decision|49|||
106093136|NCT00023452|365997965|FG001|Overall Study|Physician Decision|21|||
106093137|NCT00023452|365997964|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
106093138|NCT00023452|365997965|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
106093139|NCT00023452|365997964|FG000|Overall Study|Pregnant|53|||
106093140|NCT00023452|365997965|FG001|Overall Study|Pregnant|20|||
106093141|NCT00023452|365997964|FG000|Overall Study|Other|204|||
106093142|NCT00023452|365997965|FG001|Overall Study|Other|69|||
106093143|NCT01337245|365997968|FG000|Overall Study|Lost to Follow-up|1|||
106093144|NCT03483623|365997971|FG000|Overall Study|43 complete sets achieved|1|||
106093145|NCT00852397|365997974|FG000|Overall Study|Adverse Event|4|||
106093146|NCT00852397|365997975|FG001|Overall Study|Adverse Event|6|||
106093147|NCT00852397|365997976|FG002|Overall Study|Adverse Event|4|||
106093148|NCT00852397|365997974|FG000|Overall Study|Death|0|||
106093149|NCT00852397|365997975|FG001|Overall Study|Death|0|||
106093150|NCT00852397|365997976|FG002|Overall Study|Death|1|||
106093151|NCT00852397|365997974|FG000|Overall Study|Withdrawal by Subject|4|||
106093152|NCT00852397|365997975|FG001|Overall Study|Withdrawal by Subject|1|||
106093153|NCT00852397|365997976|FG002|Overall Study|Withdrawal by Subject|2|||
106093154|NCT00852397|365997974|FG000|Overall Study|Study terminated by sponsor|2|||
106093155|NCT00852397|365997975|FG001|Overall Study|Study terminated by sponsor|1|||
106093156|NCT00852397|365997976|FG002|Overall Study|Study terminated by sponsor|6|||
106093157|NCT00852397|365997974|FG000|Overall Study|Difficulty in study site visit|1|||
106093158|NCT00852397|365997975|FG001|Overall Study|Difficulty in study site visit|0|||
106093159|NCT00852397|365997976|FG002|Overall Study|Difficulty in study site visit|0|||
106093160|NCT00852397|365997974|FG000|Overall Study|Protocol Violation|0|||
105867282|NCT03888066|365164936|FG001|Run-in Phase|AE (Adverse Event)|0|||
105867283|NCT03888066|365164935|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
105867284|NCT03888066|365164936|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
105867285|NCT03888066|365164935|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
106093161|NCT00852397|365997975|FG001|Overall Study|Protocol Violation|0|||
106093162|NCT00852397|365997976|FG002|Overall Study|Protocol Violation|1|||
106093163|NCT02345512|365997977|FG000|Overall Study|Adverse Event|1|||
106093164|NCT02345512|365997977|FG000|Overall Study|Withdrawal by Subject|1|||
106093165|NCT02663817|365997978|FG000|Overall Study|Screen failure|2|||
106093166|NCT00659334|365997980|FG000|Overall Study|Screen Failure|8|||
106093167|NCT00659334|365997981|FG001|Overall Study|Screen Failure|5|||
106093168|NCT00659334|365997982|FG002|Overall Study|Screen Failure|0|||
106093169|NCT00659334|365997983|FG003|Overall Study|Screen Failure|0|||
106093170|NCT00659334|365997984|FG004|Overall Study|Screen Failure|0|||
106093171|NCT00659334|365997985|FG005|Overall Study|Screen Failure|0|||
106093172|NCT00659334|365997986|FG006|Overall Study|Screen Failure|1|||
106093173|NCT03096782|365997987|FG000|Overall Study|Death|1|||
106093174|NCT03096782|365997987|FG000|Overall Study|Participant Relapsed|1|||
106093175|NCT00932893|365997988|FG000|Overall Study|Death|115|||
106093176|NCT00932893|365997989|FG001|Overall Study|Death|24|||
106093177|NCT00932893|365997988|FG000|Overall Study|Lost to Follow-up|8|||
106093178|NCT00932893|365997989|FG001|Overall Study|Lost to Follow-up|0|||
106093179|NCT00932893|365997988|FG000|Overall Study|Withdrawal by Subject|5|||
106093180|NCT00932893|365997989|FG001|Overall Study|Withdrawal by Subject|2|||
106093181|NCT00932893|365997988|FG000|Overall Study|Other|5|||
106093182|NCT00932893|365997989|FG001|Overall Study|Other|144|||
106093183|NCT03136068|365999410|FG000|Overall Study|Lost to Follow-up|1|||
106093184|NCT03136068|365999411|FG001|Overall Study|Lost to Follow-up|1|||
106093185|NCT03136068|365999410|FG000|Overall Study|Protocol Violation|1|||
106093186|NCT03136068|365999411|FG001|Overall Study|Protocol Violation|0|||
106093187|NCT00432380|365999417|FG000|Overall Study|Migrated/moved from study area|3|||
106093188|NCT00432380|365999418|FG001|Overall Study|Migrated/moved from study area|4|||
106093189|NCT00432380|365999419|FG002|Overall Study|Migrated/moved from study area|1|||
106093190|NCT00432380|365999417|FG000|Overall Study|Adverse Event|1|||
106093191|NCT00432380|365999418|FG001|Overall Study|Adverse Event|0|||
106093192|NCT00432380|365999419|FG002|Overall Study|Adverse Event|0|||
106093193|NCT01071395|365999420|FG000|Overall Study|Withdrawal by Subject|2|||
106093194|NCT01071395|365999421|FG001|Overall Study|Withdrawal by Subject|1|||
106093195|NCT01071395|365999420|FG000|Overall Study|Adverse Event|3|||
106093196|NCT01071395|365999421|FG001|Overall Study|Adverse Event|1|||
106093197|NCT01539291|365999422|FG000|Study GS-US-312-0116|Adverse Event|9|||
106093198|NCT01539291|365999423|FG001|Study GS-US-312-0116|Adverse Event|0|||
106093199|NCT01539291|365999424|FG002|Study GS-US-312-0116|Adverse Event|0|||
106093200|NCT01539291|365999425|FG003|Study GS-US-312-0116|Adverse Event|0|||
106093201|NCT01539291|365999422|FG000|Study GS-US-312-0116|Physician Decision|1|||
106093202|NCT01539291|365999423|FG001|Study GS-US-312-0116|Physician Decision|0|||
106093203|NCT01539291|365999424|FG002|Study GS-US-312-0116|Physician Decision|0|||
106093204|NCT01539291|365999425|FG003|Study GS-US-312-0116|Physician Decision|0|||
106093205|NCT01539291|365999422|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
106093206|NCT01539291|365999423|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
106093207|NCT01539291|365999424|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
106093208|NCT01539291|365999425|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
106093209|NCT01539291|365999422|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
106093210|NCT01539291|365999423|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
106093211|NCT01539291|365999424|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
106093212|NCT01539291|365999425|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
106093213|NCT01539291|365999422|FG000|Study GS-US-312-0116|Other|1|||
106093214|NCT01539291|365999423|FG001|Study GS-US-312-0116|Other|0|||
106093215|NCT01539291|365999424|FG002|Study GS-US-312-0116|Other|0|||
106093216|NCT01539291|365999425|FG003|Study GS-US-312-0116|Other|0|||
106093217|NCT01539291|365999422|FG000|Study GS-US-312-0117|Adverse Event|22|||
106093218|NCT01539291|365999423|FG001|Study GS-US-312-0117|Adverse Event|1|||
106093219|NCT01539291|365999424|FG002|Study GS-US-312-0117|Adverse Event|9|||
106093220|NCT01539291|365999425|FG003|Study GS-US-312-0117|Adverse Event|12|||
106093221|NCT01539291|365999422|FG000|Study GS-US-312-0117|Physician Decision|9|||
106093222|NCT01539291|365999423|FG001|Study GS-US-312-0117|Physician Decision|0|||
106093223|NCT01539291|365999424|FG002|Study GS-US-312-0117|Physician Decision|6|||
106093224|NCT01539291|365999425|FG003|Study GS-US-312-0117|Physician Decision|4|||
106093225|NCT01539291|365999422|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
106093226|NCT01539291|365999423|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
106093227|NCT01539291|365999424|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
106093228|NCT01539291|365999425|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
106093229|NCT01539291|365999422|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
106093230|NCT01539291|365999423|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
106093231|NCT01539291|365999424|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
106093232|NCT01539291|365999425|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
106093233|NCT01539291|365999422|FG000|Study GS-US-312-0117|Other|2|||
106093234|NCT01539291|365999423|FG001|Study GS-US-312-0117|Other|1|||
106093235|NCT01539291|365999424|FG002|Study GS-US-312-0117|Other|1|||
106093236|NCT01539291|365999425|FG003|Study GS-US-312-0117|Other|1|||
106093237|NCT02239510|365999426|FG000|Overall Study|Lost to Follow-up|2|||
106093238|NCT02239510|365999427|FG001|Overall Study|Lost to Follow-up|1|||
106093239|NCT01782131|365999430|FG000|Overall Study|Death|93|||
106093240|NCT01782131|365999431|FG001|Overall Study|Death|96|||
106093241|NCT01782131|365999430|FG000|Overall Study|Lost to Follow-up|1|||
106093242|NCT01782131|365999431|FG001|Overall Study|Lost to Follow-up|3|||
106093243|NCT01782131|365999430|FG000|Overall Study|Withdrawal by Subject|10|||
106093244|NCT01782131|365999431|FG001|Overall Study|Withdrawal by Subject|10|||
106093245|NCT01782131|365999430|FG000|Overall Study|Randomized but not treated|5|||
106093246|NCT01782131|365999431|FG001|Overall Study|Randomized but not treated|5|||
106093247|NCT01782131|365999430|FG000|Overall Study|Reason not provided|0|||
106093248|NCT01782131|365999431|FG001|Overall Study|Reason not provided|1|||
106093249|NCT01627249|365999432|FG000|Overall Study|Death|3|||
106093250|NCT01627249|365999433|FG001|Overall Study|Death|5|||
106093251|NCT01627249|365999434|FG002|Overall Study|Death|3|||
106093252|NCT01627249|365999432|FG000|Overall Study|Withdrawal by Subject|12|||
106093253|NCT01627249|365999433|FG001|Overall Study|Withdrawal by Subject|6|||
106093254|NCT01627249|365999434|FG002|Overall Study|Withdrawal by Subject|9|||
106093255|NCT01627249|365999432|FG000|Overall Study|Missed Visit|1|||
106093256|NCT01627249|365999433|FG001|Overall Study|Missed Visit|1|||
106093257|NCT01627249|365999434|FG002|Overall Study|Missed Visit|0|||
106093258|NCT03564496|365999435|FG000|Overall Study|Withdrawal by Subject|1|||
106093259|NCT03564496|365999436|FG001|Overall Study|Withdrawal by Subject|1|||
106093260|NCT03564496|365999437|FG002|Overall Study|Withdrawal by Subject|0|||
106093261|NCT03564496|365999435|FG000|Overall Study|Screen failure|0|||
106093262|NCT03564496|365999436|FG001|Overall Study|Screen failure|3|||
106093263|NCT03564496|365999437|FG002|Overall Study|Screen failure|0|||
106093264|NCT02044510|365999440|FG000|Overall Study|Adverse Event|1|||
106093265|NCT02044510|365999441|FG001|Overall Study|Adverse Event|2|||
106093266|NCT00581945|365999442|FG000|Overall Study|Adverse Event|4|||
106093267|NCT00581945|365999443|FG001|Overall Study|Adverse Event|4|||
106093268|NCT00581945|365999442|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106093269|NCT00581945|365999443|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
106093270|NCT00581945|365999442|FG000|Overall Study|Withdrawal by Subject|2|||
106093271|NCT00581945|365999443|FG001|Overall Study|Withdrawal by Subject|6|||
106093272|NCT00581945|365999442|FG000|Overall Study|Death|1|||
106093273|NCT00581945|365999443|FG001|Overall Study|Death|0|||
106093274|NCT02496884|365999444|FG000|Overall Study|Counted twice as enrolled|2|||
106162455|NCT03721952|366257321|FG003|Overall Study|Withdrawal by Subject|28|||
106093275|NCT02496884|365999445|FG001|Overall Study|Counted twice as enrolled|0|||
106093276|NCT02496884|365999446|FG002|Overall Study|Counted twice as enrolled|0|||
106093277|NCT02496884|365999447|FG003|Overall Study|Counted twice as enrolled|0|||
106093278|NCT02496884|365999444|FG000|Overall Study|Withdrawal by Subject|0|||
106093279|NCT02496884|365999445|FG001|Overall Study|Withdrawal by Subject|3|||
106093280|NCT02496884|365999446|FG002|Overall Study|Withdrawal by Subject|0|||
106093281|NCT02496884|365999447|FG003|Overall Study|Withdrawal by Subject|0|||
106093282|NCT00530023|365999453|FG000|Overall Study|Withdrawal by Subject|0|||
106093283|NCT00530023|365999454|FG001|Overall Study|Withdrawal by Subject|1|||
106093284|NCT00359762|365999455|FG000|Period II|Adverse Event|17|||
106093285|NCT00359762|365999456|FG001|Period II|Adverse Event|0|||
106093286|NCT00359762|365999457|FG002|Period II|Adverse Event|0|||
106093287|NCT00359762|365999458|FG003|Period II|Adverse Event|0|||
106093288|NCT00359762|365999459|FG004|Period II|Adverse Event|49|||
106093289|NCT00359762|365999455|FG000|Period II|Protocol Violation|18|||
106093290|NCT00359762|365999456|FG001|Period II|Protocol Violation|0|||
106093291|NCT00359762|365999457|FG002|Period II|Protocol Violation|0|||
106093292|NCT00359762|365999458|FG003|Period II|Protocol Violation|0|||
106093293|NCT00359762|365999459|FG004|Period II|Protocol Violation|11|||
106093294|NCT00359762|365999455|FG000|Period II|Physician Decision|17|||
106093295|NCT00359762|365999456|FG001|Period II|Physician Decision|0|||
106093296|NCT00359762|365999457|FG002|Period II|Physician Decision|0|||
106093297|NCT00359762|365999458|FG003|Period II|Physician Decision|0|||
106093298|NCT00359762|365999459|FG004|Period II|Physician Decision|23|||
106093299|NCT00359762|365999455|FG000|Period II|Death|2|||
106093300|NCT00359762|365999456|FG001|Period II|Death|0|||
106093301|NCT00359762|365999457|FG002|Period II|Death|0|||
106093302|NCT00359762|365999458|FG003|Period II|Death|0|||
106093303|NCT00359762|365999459|FG004|Period II|Death|4|||
106093304|NCT00359762|365999455|FG000|Period II|Lack of Efficacy|11|||
106093305|NCT00359762|365999456|FG001|Period II|Lack of Efficacy|0|||
106093306|NCT00359762|365999457|FG002|Period II|Lack of Efficacy|0|||
106093307|NCT00359762|365999458|FG003|Period II|Lack of Efficacy|0|||
106093308|NCT00359762|365999459|FG004|Period II|Lack of Efficacy|8|||
106093309|NCT00359762|365999455|FG000|Period II|Lost to follow up|5|||
106093310|NCT00359762|365999456|FG001|Period II|Lost to follow up|0|||
106093311|NCT00359762|365999457|FG002|Period II|Lost to follow up|0|||
106093312|NCT00359762|365999458|FG003|Period II|Lost to follow up|0|||
106093313|NCT00359762|365999459|FG004|Period II|Lost to follow up|5|||
106093314|NCT00359762|365999455|FG000|Period II|Entry Criteria Not Met|8|||
106093315|NCT00359762|365999456|FG001|Period II|Entry Criteria Not Met|0|||
106093316|NCT00359762|365999457|FG002|Period II|Entry Criteria Not Met|0|||
106093317|NCT00359762|365999458|FG003|Period II|Entry Criteria Not Met|0|||
106093318|NCT00359762|365999459|FG004|Period II|Entry Criteria Not Met|4|||
106093319|NCT00359762|365999455|FG000|Period II|Subject Decision|50|||
106093320|NCT00359762|365999456|FG001|Period II|Subject Decision|0|||
106093321|NCT00359762|365999457|FG002|Period II|Subject Decision|0|||
106093322|NCT00359762|365999458|FG003|Period II|Subject Decision|0|||
106093323|NCT00359762|365999459|FG004|Period II|Subject Decision|70|||
106093324|NCT00359762|365999455|FG000|Period III|Protocol Violation|0|||
106093325|NCT00359762|365999456|FG001|Period III|Protocol Violation|5|||
106093326|NCT00359762|365999457|FG002|Period III|Protocol Violation|3|||
106093327|NCT00359762|365999458|FG003|Period III|Protocol Violation|8|||
106093328|NCT00359762|365999459|FG004|Period III|Protocol Violation|0|||
106093329|NCT00359762|365999455|FG000|Period III|Adverse Event|0|||
106093330|NCT00359762|365999456|FG001|Period III|Adverse Event|3|||
106093331|NCT00359762|365999457|FG002|Period III|Adverse Event|4|||
106093332|NCT00359762|365999458|FG003|Period III|Adverse Event|10|||
106093333|NCT00359762|365999459|FG004|Period III|Adverse Event|0|||
106093334|NCT00359762|365999455|FG000|Period III|Physician Decision|0|||
106093335|NCT00359762|365999456|FG001|Period III|Physician Decision|5|||
106093336|NCT00359762|365999457|FG002|Period III|Physician Decision|9|||
106093337|NCT00359762|365999458|FG003|Period III|Physician Decision|15|||
106093338|NCT00359762|365999459|FG004|Period III|Physician Decision|0|||
106093339|NCT00359762|365999455|FG000|Period III|Lack of Efficacy|0|||
106093340|NCT00359762|365999456|FG001|Period III|Lack of Efficacy|7|||
106093341|NCT00359762|365999457|FG002|Period III|Lack of Efficacy|5|||
106093342|NCT00359762|365999458|FG003|Period III|Lack of Efficacy|9|||
106093343|NCT00359762|365999459|FG004|Period III|Lack of Efficacy|0|||
106093344|NCT00359762|365999455|FG000|Period III|Lost to follow up|0|||
106093345|NCT00359762|365999456|FG001|Period III|Lost to follow up|1|||
106093346|NCT00359762|365999457|FG002|Period III|Lost to follow up|1|||
106093347|NCT00359762|365999458|FG003|Period III|Lost to follow up|2|||
106093348|NCT00359762|365999459|FG004|Period III|Lost to follow up|0|||
106093349|NCT00359762|365999455|FG000|Period III|Entry Criteria Not Met|0|||
106093350|NCT00359762|365999456|FG001|Period III|Entry Criteria Not Met|1|||
106093351|NCT00359762|365999457|FG002|Period III|Entry Criteria Not Met|0|||
106093352|NCT00359762|365999458|FG003|Period III|Entry Criteria Not Met|1|||
106093353|NCT00359762|365999459|FG004|Period III|Entry Criteria Not Met|0|||
106093354|NCT00359762|365999455|FG000|Period III|Subject Decision|0|||
106093355|NCT00359762|365999456|FG001|Period III|Subject Decision|7|||
106093356|NCT00359762|365999457|FG002|Period III|Subject Decision|8|||
106093357|NCT00359762|365999458|FG003|Period III|Subject Decision|20|||
106093358|NCT00359762|365999459|FG004|Period III|Subject Decision|0|||
106093359|NCT00003498|365999462|FG000|Overall Study|Not evaluable.|4|||
106093360|NCT00346034|365999463|FG000|Overall Study|Adverse Event|34|||
106093361|NCT00346034|365999463|FG000|Overall Study|Lack of Efficacy|8|||
106093362|NCT00346034|365999463|FG000|Overall Study|Withdrawal by Subject|13|||
106093363|NCT00346034|365999463|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
106093364|NCT00346034|365999463|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
106093365|NCT02843568|365999464|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
106093366|NCT02843568|365999465|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
106093367|NCT02843568|365999464|FG000|Overall Study|Death|3|||
106093368|NCT02843568|365999465|FG001|Overall Study|Death|3|||
106093369|NCT02843568|365999464|FG000|Overall Study|Withdrawal by Subject|1|||
106093370|NCT02843568|365999465|FG001|Overall Study|Withdrawal by Subject|1|||
106093371|NCT02843568|365999464|FG000|Overall Study|Lost to Follow-up|2|||
106093372|NCT02843568|365999465|FG001|Overall Study|Lost to Follow-up|0|||
106093373|NCT00797667|365999466|FG000|Overall Study|Lack of Efficacy|0|||
106093374|NCT00797667|365999467|FG001|Overall Study|Lack of Efficacy|1|||
106093375|NCT00797667|365999468|FG002|Overall Study|Lack of Efficacy|0|||
106093376|NCT00797667|365999466|FG000|Overall Study|Lost to Follow-up|8|||
106093377|NCT00797667|365999467|FG001|Overall Study|Lost to Follow-up|12|||
106093378|NCT00797667|365999468|FG002|Overall Study|Lost to Follow-up|2|||
106093379|NCT00797667|365999466|FG000|Overall Study|Physician Decision|3|||
106093380|NCT00797667|365999467|FG001|Overall Study|Physician Decision|1|||
106093381|NCT00797667|365999468|FG002|Overall Study|Physician Decision|0|||
106093382|NCT00797667|365999466|FG000|Overall Study|Pregnancy|2|||
106093383|NCT00797667|365999467|FG001|Overall Study|Pregnancy|0|||
106093384|NCT00797667|365999468|FG002|Overall Study|Pregnancy|0|||
106093385|NCT00797667|365999466|FG000|Overall Study|Protocol Violation|2|||
106093386|NCT00797667|365999467|FG001|Overall Study|Protocol Violation|7|||
106093387|NCT00797667|365999468|FG002|Overall Study|Protocol Violation|0|||
106093388|NCT00797667|365999466|FG000|Overall Study|Study Terminated by Sponsor|217|||
106093389|NCT00797667|365999467|FG001|Overall Study|Study Terminated by Sponsor|216|||
106093390|NCT00797667|365999468|FG002|Overall Study|Study Terminated by Sponsor|115|||
106093391|NCT00797667|365999466|FG000|Overall Study|Withdrawal by Subject|9|||
106093392|NCT00797667|365999467|FG001|Overall Study|Withdrawal by Subject|14|||
106093393|NCT00797667|365999468|FG002|Overall Study|Withdrawal by Subject|2|||
106093394|NCT00797667|365999466|FG000|Overall Study|Adverse Event|19|||
106093395|NCT00797667|365999467|FG001|Overall Study|Adverse Event|8|||
106093396|NCT00797667|365999468|FG002|Overall Study|Adverse Event|8|||
106093397|NCT01229436|365999469|FG000|Overall Study|Withdrawal by Subject|2|||
106093398|NCT01229436|365999469|FG000|Overall Study|Lost to Follow-up|3|||
106093399|NCT00781326|365999470|FG000|Phase I|Adverse Event|1|||
106093400|NCT00781326|365999470|FG000|Phase I|Withdrawal by Subject|1|||
106093401|NCT00781326|365999470|FG000|Phase I|Physician Decision|2|||
106093402|NCT01775137|365999471|FG000|Overall Study|Death|1|||
106093403|NCT01775137|365999471|FG000|Overall Study|Protocol deviation|2|||
106093404|NCT01775137|365999471|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106093405|NCT01775137|365999471|FG000|Overall Study|Adverse Event|1|||
106093406|NCT01775137|365999471|FG000|Overall Study|Withdrawal by participants|5|||
106093407|NCT01732835|365999484|FG000|6-month Primary Endpoint|Did not receive device|19|||
106093408|NCT01732835|365999484|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
106093409|NCT01732835|365999484|FG000|6-month Primary Endpoint|Adverse Event|3|||
106093410|NCT01732835|365999484|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
106093411|NCT01732835|365999484|FG000|2-year Extended Follow-up|Adverse Event|3|||
106093412|NCT01732835|365999484|FG000|2-year Extended Follow-up|Death|1|||
106093413|NCT00793910|365999485|FG000|Overall Study|discarded study pills|0|||
106093414|NCT00793910|365999486|FG001|Overall Study|discarded study pills|1|||
106093415|NCT00793910|365999485|FG000|Overall Study|did not pick up medications|1|||
106093416|NCT00793910|365999486|FG001|Overall Study|did not pick up medications|1|||
106093417|NCT00793910|365999485|FG000|Overall Study|ineligible based on entry criteria|2|||
106093418|NCT00793910|365999486|FG001|Overall Study|ineligible based on entry criteria|3|||
106093419|NCT00793910|365999485|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
106093420|NCT00793910|365999486|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
106093421|NCT00793910|365999485|FG000|Overall Study|Withdrawal by Subject|0|||
106093422|NCT00793910|365999486|FG001|Overall Study|Withdrawal by Subject|1|||
106093423|NCT01700946|365999487|FG000|Overall Study|Lost to Follow-up|1|||
106093424|NCT01700946|365999488|FG001|Overall Study|Lost to Follow-up|0|||
106093425|NCT01700946|365999487|FG000|Overall Study|Physician Decision|7|||
106093426|NCT01700946|365999488|FG001|Overall Study|Physician Decision|12|||
106093427|NCT01700946|365999487|FG000|Overall Study|Withdrawal by Subject|0|||
106093428|NCT01700946|365999488|FG001|Overall Study|Withdrawal by Subject|2|||
106093429|NCT01700946|365999487|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
106093430|NCT01700946|365999488|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
106093431|NCT01700946|365999487|FG000|Overall Study|Relapse|2|||
106093432|NCT01700946|365999488|FG001|Overall Study|Relapse|1|||
106093433|NCT01700946|365999487|FG000|Overall Study|Unacceptable toxicity|1|||
106093434|NCT01700946|365999488|FG001|Overall Study|Unacceptable toxicity|0|||
106093435|NCT03321981|365999493|FG000|Overall Study|Progressive Disease (PD)|15|||
106093436|NCT03321981|365999494|FG001|Overall Study|Progressive Disease (PD)|30|||
106093437|NCT03321981|365999495|FG002|Overall Study|Progressive Disease (PD)|47|||
106093438|NCT03321981|365999493|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
106093439|NCT03321981|365999494|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
106093440|NCT03321981|365999495|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
106093441|NCT03321981|365999493|FG000|Overall Study|Adverse Event|0|||
106093442|NCT03321981|365999494|FG001|Overall Study|Adverse Event|0|||
106093443|NCT03321981|365999495|FG002|Overall Study|Adverse Event|2|||
106093444|NCT03321981|365999493|FG000|Overall Study|symptomatic deterioration|0|||
106093445|NCT03321981|365999494|FG001|Overall Study|symptomatic deterioration|1|||
106093446|NCT03321981|365999495|FG002|Overall Study|symptomatic deterioration|1|||
106093447|NCT03321981|365999493|FG000|Overall Study|Lack of compliance|0|||
106093448|NCT03321981|365999494|FG001|Overall Study|Lack of compliance|1|||
106093449|NCT03321981|365999495|FG002|Overall Study|Lack of compliance|0|||
106093450|NCT03321981|365999493|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
106093451|NCT03321981|365999494|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
106093452|NCT03321981|365999495|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
106093453|NCT03321981|365999493|FG000|Overall Study|Death|0|||
106093454|NCT03321981|365999494|FG001|Overall Study|Death|1|||
106093455|NCT03321981|365999495|FG002|Overall Study|Death|0|||
106093456|NCT03321981|365999493|FG000|Overall Study|Subject withdrawal of investigational product|0|||
106093457|NCT03321981|365999494|FG001|Overall Study|Subject withdrawal of investigational product|1|||
106093458|NCT03321981|365999495|FG002|Overall Study|Subject withdrawal of investigational product|0|||
106093459|NCT03321981|365999493|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
106093460|NCT03321981|365999494|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
106093461|NCT03321981|365999495|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
106093462|NCT03321981|365999493|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
106093463|NCT03321981|365999494|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
106093464|NCT03321981|365999495|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
106093465|NCT04934670|365999496|FG000|Overall Study|Death|4|||
106093466|NCT04934670|365999497|FG001|Overall Study|Death|0|||
106093467|NCT04934670|365999496|FG000|Overall Study|Lost to Follow-up|1|||
106093468|NCT04934670|365999497|FG001|Overall Study|Lost to Follow-up|4|||
106093469|NCT00817089|365999498|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
106093470|NCT00817089|365999499|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
106093471|NCT00817089|365999500|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
106093472|NCT00817089|365999501|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
106093473|NCT00817089|365999498|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
106093474|NCT00817089|365999499|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
106093475|NCT00817089|365999500|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
106093476|NCT00817089|365999501|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
106093477|NCT02543346|365999508|FG000|Second Priming Visit|Withdrawal by Subject|0|||
106093478|NCT02543346|365999509|FG001|Second Priming Visit|Withdrawal by Subject|2|||
106093479|NCT02543346|365999510|FG002|Second Priming Visit|Withdrawal by Subject|2|||
106093480|NCT02543346|365999511|FG003|Second Priming Visit|Withdrawal by Subject|2|||
106093481|NCT02543346|365999508|FG000|Second Priming Visit|Adverse Event|1|||
106093482|NCT02543346|365999509|FG001|Second Priming Visit|Adverse Event|0|||
106093483|NCT02543346|365999510|FG002|Second Priming Visit|Adverse Event|0|||
106093484|NCT02543346|365999511|FG003|Second Priming Visit|Adverse Event|0|||
106093485|NCT04798586|365999512|FG000|Overall Study|Death|2|||
106093486|NCT02371369|365999517|FG000|Part 1|Physician Decision|0|||
106093487|NCT02371369|365999518|FG001|Part 1|Physician Decision|3|||
106093488|NCT02371369|365999517|FG000|Part 1|Adverse Event|8|||
106093489|NCT02371369|365999518|FG001|Part 1|Adverse Event|0|||
106093490|NCT02371369|365999517|FG000|Part 1|Withdrawal by Subject|1|||
106093491|NCT02371369|365999518|FG001|Part 1|Withdrawal by Subject|6|||
106093492|NCT02371369|365999517|FG000|Part 1|Disease progression|0|||
106093493|NCT02371369|365999518|FG001|Part 1|Disease progression|1|||
106093494|NCT02371369|365999517|FG000|Part 1|Protocol Violation|0|||
106093495|NCT02371369|365999518|FG001|Part 1|Protocol Violation|1|||
106093496|NCT02371369|365999517|FG000|Part 2|Adverse Event|6|||
106093497|NCT02371369|365999518|FG001|Part 2|Adverse Event|5|||
106093498|NCT02371369|365999517|FG000|Part 2|Withdrawal by Subject|16|||
106093499|NCT02371369|365999518|FG001|Part 2|Withdrawal by Subject|6|||
106093500|NCT02371369|365999517|FG000|Part 2|Investigator decision|1|||
106093501|NCT02371369|365999518|FG001|Part 2|Investigator decision|2|||
106093502|NCT02371369|365999517|FG000|Part 2|Death|0|||
106093503|NCT02371369|365999518|FG001|Part 2|Death|1|||
106093504|NCT02371369|365999517|FG000|Part 2|Disease progression|1|||
106093505|NCT02371369|365999518|FG001|Part 2|Disease progression|0|||
106093506|NCT02371369|365999517|FG000|Part 2|Subject Noncompliance|1|||
106093507|NCT02371369|365999518|FG001|Part 2|Subject Noncompliance|0|||
106093508|NCT02371369|365999517|FG000|Part 2|Lost to Follow-up|1|||
106093509|NCT02371369|365999518|FG001|Part 2|Lost to Follow-up|1|||
106093510|NCT02371369|365999517|FG000|Part 2|Subject transitioned to commercial supply|6|||
106093511|NCT02371369|365999518|FG001|Part 2|Subject transitioned to commercial supply|4|||
106093512|NCT02371369|365999517|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
106093513|NCT02371369|365999518|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
106093514|NCT02371369|365999517|FG000|Part 2|Surgical resection of tumor|1|||
106093515|NCT02371369|365999518|FG001|Part 2|Surgical resection of tumor|1|||
106162456|NCT03721952|366257322|FG004|Overall Study|Withdrawal by Subject|0|||
106093516|NCT02371369|365999517|FG000|Part 2|Other|0|||
106093517|NCT02371369|365999518|FG001|Part 2|Other|1|||
106093518|NCT01143259|365999524|FG000|Overall Study|Withdrawal by Subject|3|||
106093519|NCT01143259|365999525|FG001|Overall Study|Withdrawal by Subject|2|||
106093520|NCT01143259|365999524|FG000|Overall Study|Protocol Violation|13|||
106093521|NCT01143259|365999525|FG001|Overall Study|Protocol Violation|9|||
106093522|NCT01143259|365999524|FG000|Overall Study|Screen Failure|7|||
106093523|NCT01143259|365999525|FG001|Overall Study|Screen Failure|9|||
106093524|NCT00142909|365999526|FG000|Randomization|Various Reasons|7|||
106093525|NCT00142909|365999527|FG001|Randomization|Various Reasons|10|||
106093526|NCT00142909|365999526|FG000|Medications Begin|Protocol Violation|2|||
106093527|NCT00142909|365999527|FG001|Medications Begin|Protocol Violation|0|||
106093528|NCT00142909|365999526|FG000|Medications Begin|Withdrawal by Subject|5|||
106093529|NCT00142909|365999527|FG001|Medications Begin|Withdrawal by Subject|3|||
106093530|NCT00142909|365999526|FG000|Medications Begin|Withdrawal by Subject|2|||
106093531|NCT00142909|365999527|FG001|Medications Begin|Withdrawal by Subject|0|||
106093532|NCT03832192|365999530|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
106093533|NCT03832192|365999531|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
106093534|NCT01802411|365999537|FG000|Overall Study|Death|2|||
106093535|NCT01802411|365999538|FG001|Overall Study|Death|1|||
106093536|NCT01802411|365999537|FG000|Overall Study|Adverse Event|2|||
106093537|NCT01802411|365999538|FG001|Overall Study|Adverse Event|7|||
106093538|NCT01802411|365999537|FG000|Overall Study|Lack of Efficacy|8|||
106093539|NCT01802411|365999538|FG001|Overall Study|Lack of Efficacy|10|||
106093540|NCT01802411|365999537|FG000|Overall Study|Withdrawal by Subject|0|||
106093541|NCT01802411|365999538|FG001|Overall Study|Withdrawal by Subject|2|||
106093542|NCT01802411|365999537|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
106093543|NCT01802411|365999538|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
106093544|NCT01802411|365999537|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
106093545|NCT01802411|365999538|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
106093546|NCT01802411|365999537|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
106093547|NCT01802411|365999538|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
106093548|NCT02720484|365999539|FG000|Treatment on Study|Adverse Event|1|||
106093549|NCT02720484|365999539|FG000|Treatment on Study|Withdrawal by Subject|1|||
106093550|NCT02720484|365999539|FG000|Treatment on Study|Progressive Disease|4|||
106093551|NCT02720484|365999539|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
106093552|NCT02720484|365999539|FG000|Follow Up for 2 Years|Death|3|||
106093553|NCT02720484|365999539|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
106093554|NCT05070897|365999543|FG000|Overall Study|Protocol Violation|123|||
106093555|NCT05070897|365999544|FG001|Overall Study|Protocol Violation|68|||
106093556|NCT03588572|365999545|FG000|Visitation 1|Lack of Efficacy|1|||
106093557|NCT03588572|365999546|FG001|Visitation 1|Lack of Efficacy|1|||
106093558|NCT03588572|365999545|FG000|Visitation 2|Lost to Follow-up|1|||
106093559|NCT03588572|365999546|FG001|Visitation 2|Lost to Follow-up|1|||
106093560|NCT03588572|365999545|FG000|Visitation 2|Lack of Efficacy|0|||
106093561|NCT03588572|365999546|FG001|Visitation 2|Lack of Efficacy|1|||
106093562|NCT03588572|365999545|FG000|Visitation 2|Withdrawal by Subject|1|||
106093563|NCT03588572|365999546|FG001|Visitation 2|Withdrawal by Subject|0|||
106093564|NCT03588572|365999545|FG000|Visitation 3|Lost to Follow-up|1|||
106093565|NCT03588572|365999546|FG001|Visitation 3|Lost to Follow-up|1|||
106093566|NCT03588572|365999545|FG000|Visitation 3|Physician Decision|1|||
106093567|NCT03588572|365999546|FG001|Visitation 3|Physician Decision|1|||
106093568|NCT03588572|365999545|FG000|Visitation 3|Withdrawal by Subject|1|||
106093569|NCT03588572|365999546|FG001|Visitation 3|Withdrawal by Subject|0|||
106093570|NCT01059617|365999549|FG000|Overall Study|Other|7|||
106093571|NCT01059617|365999550|FG001|Overall Study|Other|1|||
106093572|NCT01059617|365999551|FG002|Overall Study|Other|8|||
106093573|NCT01059617|365999552|FG003|Overall Study|Other|6|||
106093574|NCT01076400|366001295|FG000|Overall Study|Adverse Event|2|||
106093575|NCT01076400|366001296|FG001|Overall Study|Adverse Event|0|||
106093576|NCT01076400|366001297|FG002|Overall Study|Adverse Event|0|||
106093577|NCT01076400|366001295|FG000|Overall Study|Progressive Disease|5|||
106093578|NCT01076400|366001296|FG001|Overall Study|Progressive Disease|0|||
106093579|NCT01076400|366001297|FG002|Overall Study|Progressive Disease|0|||
106093580|NCT01773226|366001300|FG000|Overall Study|Withdrawal by Subject|1|||
106093581|NCT00116805|366001306|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
106093582|NCT00116805|366001307|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
106093583|NCT00116805|366001306|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
106093584|NCT00116805|366001307|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
106093585|NCT00116805|366001306|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
106093586|NCT00116805|366001307|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
106093587|NCT00116805|366001306|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
106093588|NCT00116805|366001307|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
106093589|NCT00116805|366001306|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
106093590|NCT00116805|366001307|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
106093591|NCT00116805|366001306|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
106093592|NCT00116805|366001307|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
106093593|NCT00116805|366001306|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
106093594|NCT00116805|366001307|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
106093595|NCT00116805|366001306|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
106093596|NCT00116805|366001307|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
106093597|NCT00116805|366001306|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
106093598|NCT00116805|366001307|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
106093599|NCT00116805|366001306|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
106093600|NCT00116805|366001307|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
106093601|NCT00116805|366001306|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
106093602|NCT00116805|366001307|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
106093603|NCT00116805|366001306|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
106093604|NCT00116805|366001307|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
106093605|NCT00116805|366001306|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
106093606|NCT00116805|366001307|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
106093607|NCT00116805|366001306|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
106093608|NCT00116805|366001307|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
106093609|NCT00116805|366001306|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
106093610|NCT00116805|366001307|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
106093611|NCT00116805|366001306|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
106093612|NCT00116805|366001307|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
106093613|NCT00116805|366001306|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
106093614|NCT00116805|366001307|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
106093615|NCT00116805|366001306|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
106093616|NCT00116805|366001307|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
106093617|NCT00116805|366001306|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
106093618|NCT00116805|366001307|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
106093619|NCT00116805|366001306|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
106093620|NCT00116805|366001307|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
106093621|NCT00116805|366001306|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
106093622|NCT00116805|366001307|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
106093623|NCT00116805|366001306|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
106093624|NCT00116805|366001307|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
106093625|NCT00116805|366001306|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
106093626|NCT00116805|366001307|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
106093627|NCT00116805|366001306|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
106093628|NCT00116805|366001307|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
106093629|NCT00116805|366001306|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
106093630|NCT00116805|366001307|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
106093631|NCT00116805|366001306|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
106093632|NCT00116805|366001307|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
106093633|NCT00116805|366001306|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
106093634|NCT00116805|366001307|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
106093635|NCT00116805|366001306|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
106093636|NCT00116805|366001307|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
106093637|NCT00116805|366001306|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
106093638|NCT00116805|366001307|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
106093639|NCT00116805|366001306|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
106093640|NCT00116805|366001307|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
106093641|NCT00116805|366001306|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
106093642|NCT00116805|366001307|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
106093643|NCT00116805|366001306|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
106093644|NCT00116805|366001307|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
106093645|NCT00116805|366001306|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
106093646|NCT00116805|366001307|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
106093647|NCT00116805|366001306|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
106093648|NCT00116805|366001307|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
106093649|NCT00116805|366001306|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
106093650|NCT00116805|366001307|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
106093651|NCT00116805|366001306|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
106093652|NCT00116805|366001307|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
106093653|NCT00116805|366001306|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
106093654|NCT00116805|366001307|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
106093655|NCT00116805|366001306|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
106093656|NCT00116805|366001307|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
106093657|NCT00116805|366001306|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
105984892|NCT02678923|365605974|FG001|Overall Study|Did Not Return for Study Visits|0|||
106093658|NCT00116805|366001307|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
106093659|NCT00116805|366001306|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
106093660|NCT00116805|366001307|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
106093661|NCT00116805|366001306|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
106093662|NCT00116805|366001307|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
106093663|NCT00116805|366001306|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
106093664|NCT00116805|366001307|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
106093665|NCT00116805|366001306|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
106093666|NCT00116805|366001307|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
106093667|NCT00116805|366001306|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
106093668|NCT00116805|366001307|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
106093669|NCT00116805|366001306|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
106093670|NCT00116805|366001307|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
106093671|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
106093672|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
106093673|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
106093674|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
106093675|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Adverse Event|5|||
106093676|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Adverse Event|3|||
106093677|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Adverse Event|4|||
106093678|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Adverse Event|10|||
106093679|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
106093680|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
106093681|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
106093682|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
106093683|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
106093684|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
106093685|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
106093686|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
106093687|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Pregnancy|5|||
106093688|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Pregnancy|0|||
106093689|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Pregnancy|3|||
106093690|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Pregnancy|2|||
106093691|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Non-compliance|1|||
106093692|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Non-compliance|4|||
106093693|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Non-compliance|0|||
106093694|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Non-compliance|3|||
106093695|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Other|0|||
106093696|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Other|3|||
106093697|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Other|3|||
106093698|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Other|1|||
106093699|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
106093700|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
106093701|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
106093702|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
106093703|NCT01760954|366001308|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
106093704|NCT01760954|366001309|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
106093705|NCT01760954|366001310|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
106093706|NCT01760954|366001311|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
106093707|NCT01760954|366001308|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
106093708|NCT01760954|366001309|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
106093709|NCT01760954|366001310|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
106093710|NCT01760954|366001311|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
106093711|NCT01760954|366001308|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
106093712|NCT01760954|366001309|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
106093713|NCT01760954|366001310|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
106093714|NCT01760954|366001311|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
106093715|NCT01760954|366001308|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
106093716|NCT01760954|366001309|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
106093717|NCT01760954|366001310|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
106093718|NCT01760954|366001311|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
106093719|NCT01760954|366001308|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
106093720|NCT01760954|366001309|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
106093721|NCT01760954|366001310|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
106097399|NCT01715805|366014397|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
106162457|NCT04495894|366257324|FG000|Overall Study|Withdrawal by Subject|2|||
106162458|NCT04495894|366257325|FG001|Overall Study|Withdrawal by Subject|0|||
106162459|NCT04495894|366257326|FG002|Overall Study|Withdrawal by Subject|2|||
106162460|NCT04495894|366257327|FG003|Overall Study|Withdrawal by Subject|3|||
106162461|NCT04495894|366257324|FG000|Overall Study|Early termination|0|||
106162462|NCT04495894|366257325|FG001|Overall Study|Early termination|0|||
106162463|NCT04495894|366257326|FG002|Overall Study|Early termination|3|||
106162464|NCT04495894|366257327|FG003|Overall Study|Early termination|0|||
106162465|NCT03364647|366257328|FG000|Overall Study|Withdrawal by Subject|3|||
106162466|NCT03364647|366257329|FG001|Overall Study|Withdrawal by Subject|1|||
106162467|NCT04059484|366257331|FG000|Overall Study|Adverse Event|2|||
106162468|NCT04059484|366257332|FG001|Overall Study|Adverse Event|5|||
106162469|NCT04059484|366257331|FG000|Overall Study|Withdrawal by Subject|5|||
106162470|NCT04059484|366257332|FG001|Overall Study|Withdrawal by Subject|3|||
106162471|NCT04059484|366257331|FG000|Overall Study|Progressive disease|112|||
106162472|NCT04059484|366257332|FG001|Overall Study|Progressive disease|112|||
106162473|NCT04059484|366257331|FG000|Overall Study|Other|8|||
106162474|NCT04059484|366257332|FG001|Overall Study|Other|3|||
106093722|NCT01760954|366001311|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
106093723|NCT01760954|366001308|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
106093724|NCT01760954|366001309|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
106093725|NCT01760954|366001310|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
106093726|NCT01760954|366001311|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
106093727|NCT01760954|366001308|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
106093728|NCT01760954|366001309|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
106093729|NCT01760954|366001310|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
106093730|NCT01760954|366001311|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
106093731|NCT02707055|366001312|FG000|Phase 1|Withdrawal by Subject|1|||
106093732|NCT02707055|366001313|FG001|Phase 1|Withdrawal by Subject|2|||
106093733|NCT02707055|366001312|FG000|Phase 1|Physician Decision|0|||
106093734|NCT02707055|366001313|FG001|Phase 1|Physician Decision|1|||
106093735|NCT02707055|366001312|FG000|Phase 2|Adverse Event|1|||
106093736|NCT02707055|366001313|FG001|Phase 2|Adverse Event|2|||
106093737|NCT00796718|366001314|FG000|Overall Study|Adverse Event|2|||
106093738|NCT00796718|366001314|FG000|Overall Study|Exclusion Criteria|1|||
106093739|NCT00796718|366001314|FG000|Overall Study|Lost to Follow-up|5|||
106093740|NCT00796718|366001314|FG000|Overall Study|Withdrawal by Informed Consent|1|||
106093741|NCT03266588|366001315|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
106093742|NCT03266588|366001316|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
106093743|NCT03266588|366001317|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
106093744|NCT03266588|366001315|FG000|Observational Period|Withdrawal by Subject|44|||
106093745|NCT03266588|366001316|FG001|Observational Period|Withdrawal by Subject|22|||
106093746|NCT03266588|366001317|FG002|Observational Period|Withdrawal by Subject|13|||
106093747|NCT03266588|366001315|FG000|Observational Period|Non-compliance|18|||
106093748|NCT03266588|366001316|FG001|Observational Period|Non-compliance|12|||
106093749|NCT03266588|366001317|FG002|Observational Period|Non-compliance|10|||
106093750|NCT03266588|366001315|FG000|Observational Period|Lost to Follow-up|8|||
106093751|NCT03266588|366001316|FG001|Observational Period|Lost to Follow-up|12|||
106093752|NCT03266588|366001317|FG002|Observational Period|Lost to Follow-up|4|||
106093753|NCT03266588|366001315|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
106093754|NCT03266588|366001316|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
106093755|NCT03266588|366001317|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
106093756|NCT03266588|366001315|FG000|Observational Period|Protocol Deviation|1|||
106093757|NCT03266588|366001316|FG001|Observational Period|Protocol Deviation|0|||
106093758|NCT03266588|366001317|FG002|Observational Period|Protocol Deviation|0|||
106093759|NCT03266588|366001315|FG000|Observational Period|Other Reasons|3|||
106093760|NCT03266588|366001316|FG001|Observational Period|Other Reasons|0|||
106093761|NCT03266588|366001317|FG002|Observational Period|Other Reasons|1|||
106093762|NCT03266588|366001315|FG000|Long-term Treatment Period|Adverse Event|33|||
106162475|NCT04059484|366257331|FG000|Overall Study|Ongoing|20|||
106162476|NCT04059484|366257332|FG001|Overall Study|Ongoing|20|||
106162477|NCT03476460|366257333|FG000|Overall Study|Withdrawal by Subject|3|||
106162478|NCT03476460|366257334|FG001|Overall Study|Withdrawal by Subject|2|||
106162479|NCT03476460|366257333|FG000|Overall Study|Non-compliance with treatment|3|||
106093763|NCT03266588|366001316|FG001|Long-term Treatment Period|Adverse Event|17|||
106093764|NCT03266588|366001317|FG002|Long-term Treatment Period|Adverse Event|8|||
106093765|NCT03266588|366001315|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
106093766|NCT03266588|366001316|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
106093767|NCT03266588|366001317|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
106162480|NCT03476460|366257334|FG001|Overall Study|Non-compliance with treatment|0|||
106162481|NCT03476460|366257333|FG000|Overall Study|Missing laboratory tests|5|||
106162482|NCT03476460|366257334|FG001|Overall Study|Missing laboratory tests|5|||
106162483|NCT03476460|366257333|FG000|Overall Study|Adverse Event|0|||
106093768|NCT03266588|366001315|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
106093769|NCT03266588|366001316|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
106093770|NCT03266588|366001317|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
106093771|NCT03266588|366001315|FG000|Long-term Treatment Period|Non-Compliance|126|||
106093772|NCT03266588|366001316|FG001|Long-term Treatment Period|Non-Compliance|57|||
106093773|NCT03266588|366001317|FG002|Long-term Treatment Period|Non-Compliance|7|||
106093774|NCT03266588|366001315|FG000|Long-term Treatment Period|Pregnancy|11|||
106093775|NCT03266588|366001316|FG001|Long-term Treatment Period|Pregnancy|5|||
106093776|NCT03266588|366001317|FG002|Long-term Treatment Period|Pregnancy|0|||
106093777|NCT03266588|366001315|FG000|Long-term Treatment Period|Protocol Deviation|17|||
106093778|NCT03266588|366001316|FG001|Long-term Treatment Period|Protocol Deviation|10|||
106093779|NCT03266588|366001317|FG002|Long-term Treatment Period|Protocol Deviation|4|||
106093780|NCT03266588|366001315|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
106093781|NCT03266588|366001316|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
106093782|NCT03266588|366001317|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
106093783|NCT03266588|366001315|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
106093784|NCT03266588|366001316|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
106093785|NCT03266588|366001317|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
106093786|NCT03266588|366001315|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
106093787|NCT03266588|366001316|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
106093788|NCT03266588|366001317|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
106093789|NCT03266588|366001315|FG000|Long-term Treatment Period|Other Reasons|5|||
106093790|NCT03266588|366001316|FG001|Long-term Treatment Period|Other Reasons|0|||
106093791|NCT03266588|366001317|FG002|Long-term Treatment Period|Other Reasons|0|||
106093792|NCT03266588|366001315|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
106093793|NCT03266588|366001316|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
106093794|NCT03266588|366001317|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
106093795|NCT02627677|366001318|FG000|Overall Study|Adverse event (not progressive disease)|1|||
106093796|NCT02627677|366001319|FG001|Overall Study|Adverse event (not progressive disease)|4|||
106093797|NCT02627677|366001320|FG002|Overall Study|Adverse event (not progressive disease)|1|||
106093798|NCT02627677|366001318|FG000|Overall Study|Progressive disease|1|||
106093799|NCT02627677|366001319|FG001|Overall Study|Progressive disease|3|||
106093800|NCT02627677|366001320|FG002|Overall Study|Progressive disease|0|||
106093801|NCT02627677|366001318|FG000|Overall Study|Lack of Efficacy|1|||
106093802|NCT02627677|366001319|FG001|Overall Study|Lack of Efficacy|2|||
106093803|NCT02627677|366001320|FG002|Overall Study|Lack of Efficacy|0|||
106093804|NCT02627677|366001318|FG000|Overall Study|Lost to Follow-up|0|||
106093805|NCT02627677|366001319|FG001|Overall Study|Lost to Follow-up|0|||
106093806|NCT02627677|366001320|FG002|Overall Study|Lost to Follow-up|1|||
106093807|NCT02627677|366001318|FG000|Overall Study|Pregnancy|0|||
106093808|NCT02627677|366001319|FG001|Overall Study|Pregnancy|1|||
106093809|NCT02627677|366001320|FG002|Overall Study|Pregnancy|0|||
106093810|NCT02627677|366001318|FG000|Overall Study|Study Terminated by Sponsor|5|||
106093811|NCT02627677|366001319|FG001|Overall Study|Study Terminated by Sponsor|10|||
106093812|NCT02627677|366001320|FG002|Overall Study|Study Terminated by Sponsor|6|||
106093813|NCT02627677|366001318|FG000|Overall Study|Physician Decision|0|||
106093814|NCT02627677|366001319|FG001|Overall Study|Physician Decision|0|||
106093815|NCT02627677|366001320|FG002|Overall Study|Physician Decision|2|||
106093816|NCT02627677|366001318|FG000|Overall Study|Withdrawal by Subject|2|||
106093817|NCT02627677|366001319|FG001|Overall Study|Withdrawal by Subject|1|||
106093818|NCT02627677|366001320|FG002|Overall Study|Withdrawal by Subject|1|||
106093819|NCT02627677|366001318|FG000|Overall Study|Reason not Specified|0|||
106093820|NCT02627677|366001319|FG001|Overall Study|Reason not Specified|0|||
106093821|NCT02627677|366001320|FG002|Overall Study|Reason not Specified|1|||
106093822|NCT02627677|366001318|FG000|Overall Study|Randomized but not Treated|1|||
106093823|NCT02627677|366001319|FG001|Overall Study|Randomized but not Treated|0|||
106093824|NCT02627677|366001320|FG002|Overall Study|Randomized but not Treated|0|||
106093825|NCT02244944|366001321|FG000|Overall Study|Withdrawal by Subject|1|||
106093826|NCT02244944|366001321|FG000|Overall Study|Study Terminated|1|||
106093827|NCT01153633|366001322|FG000|Overall Study|Protocol Violation|1|||
106093828|NCT01153633|366001323|FG001|Overall Study|Protocol Violation|1|||
106093829|NCT01153633|366001322|FG000|Overall Study|Therapeutic failure|3|||
106093830|NCT01153633|366001323|FG001|Overall Study|Therapeutic failure|3|||
106093831|NCT02979535|366001324|FG000|Overall Study|Non compliance with the protocol|78|||
106093832|NCT02979535|366001325|FG001|Overall Study|Non compliance with the protocol|82|||
106093833|NCT02979535|366001324|FG000|Overall Study|Consent withdrawn by participant|11|||
106093834|NCT02979535|366001325|FG001|Overall Study|Consent withdrawn by participant|18|||
106093835|NCT02979535|366001324|FG000|Overall Study|Lost to Follow-up|6|||
106093836|NCT02979535|366001325|FG001|Overall Study|Lost to Follow-up|1|||
106093837|NCT01722331|366001326|FG000|Part 1|Adverse Event|5|||
106093838|NCT01722331|366001327|FG001|Part 1|Adverse Event|0|||
106093839|NCT01722331|366001328|FG002|Part 1|Adverse Event|0|||
106093840|NCT01722331|366001329|FG003|Part 1|Adverse Event|0|||
106093841|NCT01722331|366001330|FG004|Part 1|Adverse Event|0|||
106093842|NCT01722331|366001331|FG005|Part 1|Adverse Event|0|||
106093843|NCT01722331|366001332|FG006|Part 1|Adverse Event|0|||
106093844|NCT01722331|366001326|FG000|Part 1|Lack of Efficacy|0|||
106093845|NCT01722331|366001327|FG001|Part 1|Lack of Efficacy|0|||
106093846|NCT01722331|366001328|FG002|Part 1|Lack of Efficacy|1|||
106093847|NCT01722331|366001329|FG003|Part 1|Lack of Efficacy|0|||
106093848|NCT01722331|366001330|FG004|Part 1|Lack of Efficacy|2|||
106093849|NCT01722331|366001331|FG005|Part 1|Lack of Efficacy|0|||
106093850|NCT01722331|366001332|FG006|Part 1|Lack of Efficacy|0|||
106093851|NCT01722331|366001326|FG000|Part 1|Lost to Follow-up|1|||
106093852|NCT01722331|366001327|FG001|Part 1|Lost to Follow-up|0|||
106093853|NCT01722331|366001328|FG002|Part 1|Lost to Follow-up|2|||
106093854|NCT01722331|366001329|FG003|Part 1|Lost to Follow-up|0|||
106093855|NCT01722331|366001330|FG004|Part 1|Lost to Follow-up|1|||
106093856|NCT01722331|366001331|FG005|Part 1|Lost to Follow-up|0|||
106093857|NCT01722331|366001332|FG006|Part 1|Lost to Follow-up|0|||
106093858|NCT01722331|366001326|FG000|Part 1|Physician Decision|0|||
106093859|NCT01722331|366001327|FG001|Part 1|Physician Decision|0|||
106093860|NCT01722331|366001328|FG002|Part 1|Physician Decision|3|||
106093861|NCT01722331|366001329|FG003|Part 1|Physician Decision|0|||
106093862|NCT01722331|366001330|FG004|Part 1|Physician Decision|1|||
106093863|NCT01722331|366001331|FG005|Part 1|Physician Decision|0|||
106093864|NCT01722331|366001332|FG006|Part 1|Physician Decision|0|||
106093865|NCT01722331|366001326|FG000|Part 1|Pregnancy|1|||
106093866|NCT01722331|366001327|FG001|Part 1|Pregnancy|0|||
106093867|NCT01722331|366001328|FG002|Part 1|Pregnancy|0|||
106093868|NCT01722331|366001329|FG003|Part 1|Pregnancy|0|||
106093869|NCT01722331|366001330|FG004|Part 1|Pregnancy|0|||
106093870|NCT01722331|366001331|FG005|Part 1|Pregnancy|0|||
106093871|NCT01722331|366001332|FG006|Part 1|Pregnancy|0|||
106093872|NCT01722331|366001326|FG000|Part 1|Progressive Disease|0|||
106093873|NCT01722331|366001327|FG001|Part 1|Progressive Disease|0|||
106093874|NCT01722331|366001328|FG002|Part 1|Progressive Disease|0|||
106093875|NCT01722331|366001329|FG003|Part 1|Progressive Disease|0|||
106093876|NCT01722331|366001330|FG004|Part 1|Progressive Disease|1|||
106093877|NCT01722331|366001331|FG005|Part 1|Progressive Disease|0|||
106093878|NCT01722331|366001332|FG006|Part 1|Progressive Disease|0|||
106093879|NCT01722331|366001326|FG000|Part 1|Protocol Violation|1|||
106093880|NCT01722331|366001327|FG001|Part 1|Protocol Violation|0|||
106093881|NCT01722331|366001328|FG002|Part 1|Protocol Violation|0|||
106093882|NCT01722331|366001329|FG003|Part 1|Protocol Violation|0|||
106093883|NCT01722331|366001330|FG004|Part 1|Protocol Violation|1|||
106093884|NCT01722331|366001331|FG005|Part 1|Protocol Violation|0|||
106093885|NCT01722331|366001332|FG006|Part 1|Protocol Violation|0|||
106093886|NCT01722331|366001326|FG000|Part 1|Withdrawal by Subject|2|||
106093887|NCT01722331|366001327|FG001|Part 1|Withdrawal by Subject|0|||
106093888|NCT01722331|366001328|FG002|Part 1|Withdrawal by Subject|3|||
106093889|NCT01722331|366001329|FG003|Part 1|Withdrawal by Subject|0|||
106093890|NCT01722331|366001330|FG004|Part 1|Withdrawal by Subject|3|||
106093891|NCT01722331|366001331|FG005|Part 1|Withdrawal by Subject|0|||
106093892|NCT01722331|366001332|FG006|Part 1|Withdrawal by Subject|0|||
106093893|NCT01722331|366001326|FG000|Part 2|Adverse Event|3|||
106093894|NCT01722331|366001327|FG001|Part 2|Adverse Event|0|||
106093895|NCT01722331|366001328|FG002|Part 2|Adverse Event|0|||
106093896|NCT01722331|366001329|FG003|Part 2|Adverse Event|0|||
106093897|NCT01722331|366001330|FG004|Part 2|Adverse Event|0|||
106093898|NCT01722331|366001331|FG005|Part 2|Adverse Event|1|||
106093899|NCT01722331|366001332|FG006|Part 2|Adverse Event|0|||
106093900|NCT01722331|366001326|FG000|Part 2|Lack of Efficacy|3|||
106093901|NCT01722331|366001327|FG001|Part 2|Lack of Efficacy|0|||
106093902|NCT01722331|366001328|FG002|Part 2|Lack of Efficacy|11|||
106093903|NCT01722331|366001329|FG003|Part 2|Lack of Efficacy|0|||
106093904|NCT01722331|366001330|FG004|Part 2|Lack of Efficacy|0|||
106093905|NCT01722331|366001331|FG005|Part 2|Lack of Efficacy|3|||
106093906|NCT01722331|366001332|FG006|Part 2|Lack of Efficacy|3|||
106093907|NCT01722331|366001326|FG000|Part 2|Lost to Follow-up|0|||
106093908|NCT01722331|366001327|FG001|Part 2|Lost to Follow-up|0|||
106093909|NCT01722331|366001328|FG002|Part 2|Lost to Follow-up|3|||
106093910|NCT01722331|366001329|FG003|Part 2|Lost to Follow-up|0|||
106093911|NCT01722331|366001330|FG004|Part 2|Lost to Follow-up|0|||
106162484|NCT03476460|366257334|FG001|Overall Study|Adverse Event|1|||
106093912|NCT01722331|366001331|FG005|Part 2|Lost to Follow-up|1|||
106093913|NCT01722331|366001332|FG006|Part 2|Lost to Follow-up|1|||
106093914|NCT01722331|366001326|FG000|Part 2|Non-Compliance with Study Drug|1|||
106093915|NCT01722331|366001327|FG001|Part 2|Non-Compliance with Study Drug|0|||
106093916|NCT01722331|366001328|FG002|Part 2|Non-Compliance with Study Drug|1|||
106093917|NCT01722331|366001329|FG003|Part 2|Non-Compliance with Study Drug|0|||
106093918|NCT01722331|366001330|FG004|Part 2|Non-Compliance with Study Drug|0|||
106093919|NCT01722331|366001331|FG005|Part 2|Non-Compliance with Study Drug|0|||
106093920|NCT01722331|366001332|FG006|Part 2|Non-Compliance with Study Drug|0|||
106093921|NCT01722331|366001326|FG000|Part 2|Physician Decision|0|||
106093922|NCT01722331|366001327|FG001|Part 2|Physician Decision|0|||
106093923|NCT01722331|366001328|FG002|Part 2|Physician Decision|2|||
106093924|NCT01722331|366001329|FG003|Part 2|Physician Decision|0|||
106093925|NCT01722331|366001330|FG004|Part 2|Physician Decision|0|||
106093926|NCT01722331|366001331|FG005|Part 2|Physician Decision|0|||
106093927|NCT01722331|366001332|FG006|Part 2|Physician Decision|0|||
106093928|NCT01722331|366001326|FG000|Part 2|Pregnancy|0|||
106093929|NCT01722331|366001327|FG001|Part 2|Pregnancy|0|||
106093930|NCT01722331|366001328|FG002|Part 2|Pregnancy|0|||
106093931|NCT01722331|366001329|FG003|Part 2|Pregnancy|0|||
106093932|NCT01722331|366001330|FG004|Part 2|Pregnancy|0|||
106093933|NCT01722331|366001331|FG005|Part 2|Pregnancy|1|||
106162485|NCT03023410|366257341|FG000|Overall Study|study termination|0|||
106162486|NCT03023410|366257342|FG001|Overall Study|study termination|1|||
106162487|NCT00470704|366257343|FG000|Overall Study|Withdrawal by Subject|4|||
106162488|NCT00470704|366257344|FG001|Overall Study|Withdrawal by Subject|3|||
106162489|NCT00470704|366257343|FG000|Overall Study|Relapse/Progression|37|||
106162490|NCT00470704|366257344|FG001|Overall Study|Relapse/Progression|42|||
106162491|NCT00470704|366257343|FG000|Overall Study|toxicity|0|||
106162492|NCT00470704|366257344|FG001|Overall Study|toxicity|1|||
106162493|NCT04019873|366257345|FG000|Overall Study|Discontinued from the treatment|1|||
106162494|NCT04019873|366257346|FG001|Overall Study|Discontinued from the treatment|39|||
106162495|NCT04019873|366257347|FG002|Overall Study|Discontinued from the treatment|2|||
106162496|NCT03694418|366257354|FG000|Overall Study|Lost to Follow-up|115|||
106162497|NCT03694418|366257355|FG001|Overall Study|Lost to Follow-up|23|||
106162498|NCT03694418|366257356|FG002|Overall Study|Lost to Follow-up|12|||
106162499|NCT03694418|366257357|FG003|Overall Study|Lost to Follow-up|12|||
106162500|NCT03694418|366257358|FG004|Overall Study|Lost to Follow-up|13|||
106162501|NCT04332926|366257360|FG000|Overall Study|Withdrawal by Subject|6|||
106162502|NCT04332926|366257360|FG000|Overall Study|Physician Decision|6|||
106162503|NCT04111536|366257363|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
106162504|NCT04111536|366257364|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
106162505|NCT04111536|366257363|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
106162506|NCT04111536|366257364|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
106162507|NCT04111536|366257363|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
106162508|NCT04111536|366257364|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
106162509|NCT04111536|366257363|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
106162510|NCT04111536|366257364|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
106162511|NCT05783102|366257365|FG000|Overall Study|Lost to Follow-up|1|||
106162512|NCT05783102|366257365|FG000|Overall Study|Withdrawal by Subject|2|||
106162513|NCT05949788|366257366|FG000|Overall Study|severe birth deformity|2|||
106162514|NCT05949788|366257367|FG001|Overall Study|severe birth deformity|7|||
106162515|NCT05949788|366257366|FG000|Overall Study|twin-twin transfusion syndrome|2|||
106162516|NCT05949788|366257367|FG001|Overall Study|twin-twin transfusion syndrome|7|||
106162517|NCT05949788|366257366|FG000|Overall Study|neonatal hemolytic disease|3|||
106162518|NCT05949788|366257367|FG001|Overall Study|neonatal hemolytic disease|8|||
106162519|NCT05949788|366257366|FG000|Overall Study|death within 14 days after birth|2|||
106162520|NCT05949788|366257367|FG001|Overall Study|death within 14 days after birth|6|||
106162521|NCT05949788|366257366|FG000|Overall Study|transfer to another hospital|2|||
106162522|NCT05949788|366257367|FG001|Overall Study|transfer to another hospital|6|||
106162523|NCT05213390|366257373|FG000|Overall Study|Withdrawal by Subject|2|||
106162524|NCT05213390|366257373|FG000|Overall Study|Lost to Follow-up|12|||
106162525|NCT05213390|366257373|FG000|Overall Study|Protocol Violation|9|||
106162526|NCT03524612|366257382|FG000|Overall Study|Lack of Efficacy|10|||
106093934|NCT01722331|366001332|FG006|Part 2|Pregnancy|0|||
106093935|NCT01722331|366001326|FG000|Part 2|Progressive Disease|0|||
106093936|NCT01722331|366001327|FG001|Part 2|Progressive Disease|0|||
106093937|NCT01722331|366001328|FG002|Part 2|Progressive Disease|1|||
106093938|NCT01722331|366001329|FG003|Part 2|Progressive Disease|0|||
106093939|NCT01722331|366001330|FG004|Part 2|Progressive Disease|0|||
106093940|NCT01722331|366001331|FG005|Part 2|Progressive Disease|0|||
106093941|NCT01722331|366001332|FG006|Part 2|Progressive Disease|0|||
106093942|NCT01722331|366001326|FG000|Part 2|Protocol Violation|1|||
106093943|NCT01722331|366001327|FG001|Part 2|Protocol Violation|0|||
106093944|NCT01722331|366001328|FG002|Part 2|Protocol Violation|0|||
106093945|NCT01722331|366001329|FG003|Part 2|Protocol Violation|0|||
106093946|NCT01722331|366001330|FG004|Part 2|Protocol Violation|0|||
106093947|NCT01722331|366001331|FG005|Part 2|Protocol Violation|0|||
106093948|NCT01722331|366001332|FG006|Part 2|Protocol Violation|0|||
106093949|NCT01722331|366001326|FG000|Part 2|Withdrawal by Subject|5|||
106162527|NCT03524612|366257382|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
106162528|NCT03524612|366257382|FG000|Overall Study|Adverse Event|10|||
106162529|NCT03524612|366257382|FG000|Overall Study|Withdrawal by Subject|7|||
106093950|NCT01722331|366001327|FG001|Part 2|Withdrawal by Subject|0|||
106162530|NCT03524612|366257382|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
106162531|NCT03524612|366257382|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
106093951|NCT01722331|366001328|FG002|Part 2|Withdrawal by Subject|3|||
106093952|NCT01722331|366001329|FG003|Part 2|Withdrawal by Subject|0|||
106093953|NCT01722331|366001330|FG004|Part 2|Withdrawal by Subject|0|||
106093954|NCT01722331|366001331|FG005|Part 2|Withdrawal by Subject|2|||
106093955|NCT01722331|366001332|FG006|Part 2|Withdrawal by Subject|2|||
106093956|NCT01722331|366001326|FG000|Part 2|Other Protocol Specified Criteria|6|||
106093957|NCT01722331|366001327|FG001|Part 2|Other Protocol Specified Criteria|0|||
106093958|NCT01722331|366001328|FG002|Part 2|Other Protocol Specified Criteria|10|||
105867286|NCT03888066|365164936|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
106093959|NCT01722331|366001329|FG003|Part 2|Other Protocol Specified Criteria|0|||
106093960|NCT01722331|366001330|FG004|Part 2|Other Protocol Specified Criteria|0|||
106093961|NCT01722331|366001331|FG005|Part 2|Other Protocol Specified Criteria|2|||
106093962|NCT01722331|366001332|FG006|Part 2|Other Protocol Specified Criteria|1|||
106093963|NCT01722331|366001326|FG000|Part 3|Adverse Event|2|||
106093964|NCT01722331|366001327|FG001|Part 3|Adverse Event|2|||
106093965|NCT01722331|366001328|FG002|Part 3|Adverse Event|0|||
106093966|NCT01722331|366001329|FG003|Part 3|Adverse Event|1|||
106093967|NCT01722331|366001330|FG004|Part 3|Adverse Event|0|||
106093968|NCT01722331|366001331|FG005|Part 3|Adverse Event|0|||
106093969|NCT01722331|366001332|FG006|Part 3|Adverse Event|0|||
106093970|NCT01722331|366001326|FG000|Part 3|Death|1|||
106093971|NCT01722331|366001327|FG001|Part 3|Death|0|||
106093972|NCT01722331|366001328|FG002|Part 3|Death|0|||
106093973|NCT01722331|366001329|FG003|Part 3|Death|0|||
106093974|NCT01722331|366001330|FG004|Part 3|Death|0|||
106093975|NCT01722331|366001331|FG005|Part 3|Death|0|||
106093976|NCT01722331|366001332|FG006|Part 3|Death|0|||
106093977|NCT01722331|366001326|FG000|Part 3|Lack of Efficacy|1|||
106093978|NCT01722331|366001327|FG001|Part 3|Lack of Efficacy|0|||
106093979|NCT01722331|366001328|FG002|Part 3|Lack of Efficacy|0|||
106093980|NCT01722331|366001329|FG003|Part 3|Lack of Efficacy|0|||
106093981|NCT01722331|366001330|FG004|Part 3|Lack of Efficacy|0|||
106093982|NCT01722331|366001331|FG005|Part 3|Lack of Efficacy|0|||
106093983|NCT01722331|366001332|FG006|Part 3|Lack of Efficacy|0|||
106093984|NCT01722331|366001326|FG000|Part 3|Lost to Follow-up|3|||
106093985|NCT01722331|366001327|FG001|Part 3|Lost to Follow-up|4|||
106093986|NCT01722331|366001328|FG002|Part 3|Lost to Follow-up|0|||
106093987|NCT01722331|366001329|FG003|Part 3|Lost to Follow-up|0|||
106093988|NCT01722331|366001330|FG004|Part 3|Lost to Follow-up|0|||
106093989|NCT01722331|366001331|FG005|Part 3|Lost to Follow-up|1|||
106093990|NCT01722331|366001332|FG006|Part 3|Lost to Follow-up|0|||
106093991|NCT01722331|366001326|FG000|Part 3|Non-Compliance with Study Drug|0|||
106093992|NCT01722331|366001327|FG001|Part 3|Non-Compliance with Study Drug|1|||
106093993|NCT01722331|366001328|FG002|Part 3|Non-Compliance with Study Drug|0|||
106093994|NCT01722331|366001329|FG003|Part 3|Non-Compliance with Study Drug|0|||
106093995|NCT01722331|366001330|FG004|Part 3|Non-Compliance with Study Drug|0|||
106093996|NCT01722331|366001331|FG005|Part 3|Non-Compliance with Study Drug|0|||
106093997|NCT01722331|366001332|FG006|Part 3|Non-Compliance with Study Drug|0|||
106093998|NCT01722331|366001326|FG000|Part 3|Physician Decision|1|||
106093999|NCT01722331|366001327|FG001|Part 3|Physician Decision|1|||
106094000|NCT01722331|366001328|FG002|Part 3|Physician Decision|0|||
106094001|NCT01722331|366001329|FG003|Part 3|Physician Decision|0|||
106094002|NCT01722331|366001330|FG004|Part 3|Physician Decision|0|||
106094003|NCT01722331|366001331|FG005|Part 3|Physician Decision|0|||
106094004|NCT01722331|366001332|FG006|Part 3|Physician Decision|1|||
106094005|NCT01722331|366001326|FG000|Part 3|Protocol Violation|2|||
106094006|NCT01722331|366001327|FG001|Part 3|Protocol Violation|1|||
106094007|NCT01722331|366001328|FG002|Part 3|Protocol Violation|0|||
106094008|NCT01722331|366001329|FG003|Part 3|Protocol Violation|0|||
106094009|NCT01722331|366001330|FG004|Part 3|Protocol Violation|0|||
106094010|NCT01722331|366001331|FG005|Part 3|Protocol Violation|0|||
106094011|NCT01722331|366001332|FG006|Part 3|Protocol Violation|0|||
106094012|NCT01722331|366001326|FG000|Part 3|Withdrawal by Subject|4|||
106094013|NCT01722331|366001327|FG001|Part 3|Withdrawal by Subject|7|||
106094014|NCT01722331|366001328|FG002|Part 3|Withdrawal by Subject|0|||
106094015|NCT01722331|366001329|FG003|Part 3|Withdrawal by Subject|0|||
106094016|NCT01722331|366001330|FG004|Part 3|Withdrawal by Subject|0|||
106094017|NCT01722331|366001331|FG005|Part 3|Withdrawal by Subject|2|||
106094018|NCT01722331|366001332|FG006|Part 3|Withdrawal by Subject|1|||
106094019|NCT01722331|366001326|FG000|Part 3|Other Protocol Specified Criteria|1|||
106094020|NCT01722331|366001327|FG001|Part 3|Other Protocol Specified Criteria|1|||
106094021|NCT01722331|366001328|FG002|Part 3|Other Protocol Specified Criteria|0|||
106094022|NCT01722331|366001329|FG003|Part 3|Other Protocol Specified Criteria|0|||
106094023|NCT01722331|366001330|FG004|Part 3|Other Protocol Specified Criteria|0|||
106094024|NCT01722331|366001331|FG005|Part 3|Other Protocol Specified Criteria|0|||
106094025|NCT01722331|366001332|FG006|Part 3|Other Protocol Specified Criteria|0|||
106094026|NCT00512135|366001333|FG000|Overall Study|Not Treated|5|||
106094027|NCT00512135|366001333|FG000|Overall Study|Lack of Efficacy|2|||
106094028|NCT00512135|366001333|FG000|Overall Study|Adverse Event|6|||
106094029|NCT00512135|366001333|FG000|Overall Study|Withdrawal by Subject|22|||
106094030|NCT00512135|366001333|FG000|Overall Study|Lost to Follow-up|27|||
106094031|NCT00512135|366001333|FG000|Overall Study|Other|22|||
106094032|NCT00003457|366001336|FG000|Overall Study|Not evaluable|9|||
106094033|NCT04121962|366001349|FG000|Overall Study|Lost to Follow-up|42|||
106094034|NCT04121962|366001350|FG001|Overall Study|Lost to Follow-up|39|||
106094035|NCT01575561|366001351|FG000|Overall Study|Adverse Event|9|||
106094036|NCT01575561|366001351|FG000|Overall Study|Lack of Efficacy|8|||
106094037|NCT01575561|366001351|FG000|Overall Study|Lost to Follow-up|6|||
106094038|NCT01575561|366001351|FG000|Overall Study|Protocol Violation|4|||
106094039|NCT01575561|366001351|FG000|Overall Study|Withdrawal by Subject|11|||
106094040|NCT01575561|366001351|FG000|Overall Study|administration|1|||
106162532|NCT03524612|366257382|FG000|Overall Study|New therapy for study indication|6|||
106162533|NCT03524612|366257382|FG000|Overall Study|Death|3|||
106162534|NCT03524612|366257382|FG000|Overall Study|Lost to Follow-up|2|||
106162535|NCT03524612|366257382|FG000|Overall Study|Protocol Violation|1|||
106162536|NCT03448107|366257384|FG000|Overall Study|Lost to Follow-up|229|||
106162537|NCT03448107|366257385|FG001|Overall Study|Lost to Follow-up|258|||
106162538|NCT03115476|366257386|FG000|LP0084-1369|Death|1|||
106162539|NCT03115476|366257387|FG001|LP0084-1369|Death|0|||
106162540|NCT03115476|366257388|FG002|LP0084-1369|Death|2|||
106162541|NCT03115476|366257386|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
106162542|NCT03115476|366257387|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
106162543|NCT03115476|366257388|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
106162544|NCT05533632|366257391|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
106162545|NCT05533632|366257391|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
106162546|NCT05533632|366257391|FG000|Overall Study|Lost to Follow-up|1|||
106162547|NCT05533632|366257391|FG000|Overall Study|Withdrawal by Subject|4|||
106162548|NCT05533632|366257391|FG000|Overall Study|Adverse Event|4|||
106162549|NCT05144009|366257392|FG000|Overall Study|Lost to Follow-up|0|||
106162550|NCT05144009|366257393|FG001|Overall Study|Lost to Follow-up|1|||
106162551|NCT05144009|366257392|FG000|Overall Study|Study Termination by the Sponsor|11|||
106162552|NCT05144009|366257393|FG001|Overall Study|Study Termination by the Sponsor|11|||
106162553|NCT05144009|366257392|FG000|Overall Study|Disease Progression|1|||
106162554|NCT05144009|366257393|FG001|Overall Study|Disease Progression|0|||
106162555|NCT05144009|366257392|FG000|Overall Study|Participant Decision|0|||
106162556|NCT05144009|366257393|FG001|Overall Study|Participant Decision|2|||
106162557|NCT05144009|366257392|FG000|Overall Study|Death|5|||
106162558|NCT05144009|366257393|FG001|Overall Study|Death|10|||
106162559|NCT05084508|366257398|FG000|Overall Study|Lost to Follow-up|6|||
106162560|NCT05084508|366257399|FG001|Overall Study|Lost to Follow-up|3|||
106162561|NCT05084508|366257400|FG002|Overall Study|Lost to Follow-up|7|||
106162562|NCT05084508|366257401|FG003|Overall Study|Lost to Follow-up|3|||
106162563|NCT05084508|366257398|FG000|Overall Study|Withdrawal by Subject|0|||
106162564|NCT05084508|366257399|FG001|Overall Study|Withdrawal by Subject|2|||
106162565|NCT05084508|366257400|FG002|Overall Study|Withdrawal by Subject|3|||
106094041|NCT02554773|366001352|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
106094042|NCT02554773|366001353|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
106094043|NCT02554773|366001352|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
106094044|NCT02554773|366001353|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
106094045|NCT02554773|366001352|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
106094046|NCT02554773|366001353|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
106094047|NCT02554773|366001352|FG000|Original Dose Regimen (SAS 1)|Death|1|||
106094048|NCT02554773|366001353|FG001|Original Dose Regimen (SAS 1)|Death|0|||
106094049|NCT02554773|366001352|FG000|Original Dose Regimen (SAS 1)|Other|4|||
106094050|NCT02554773|366001353|FG001|Original Dose Regimen (SAS 1)|Other|0|||
106094051|NCT02554773|366001352|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
106094052|NCT02554773|366001353|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
106094053|NCT02554773|366001352|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
106094054|NCT02554773|366001353|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
106094055|NCT02554773|366001352|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
106094056|NCT02554773|366001353|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
106094057|NCT02554773|366001352|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
106094058|NCT02554773|366001353|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
106094059|NCT00097591|366001354|FG000|Overall Study|Withdrawal of consent|342|||
106094060|NCT00097591|366001355|FG001|Overall Study|Withdrawal of consent|323|||
106094061|NCT00097591|366001354|FG000|Overall Study|Less than 6 months on study drug|9|||
106094062|NCT00097591|366001355|FG001|Overall Study|Less than 6 months on study drug|7|||
106094063|NCT00097591|366001354|FG000|Overall Study|Unable to attend termination visit|53|||
106094064|NCT00097591|366001355|FG001|Overall Study|Unable to attend termination visit|51|||
106094065|NCT00097591|366001354|FG000|Overall Study|Lost to follow up|6|||
106094066|NCT00097591|366001355|FG001|Overall Study|Lost to follow up|10|||
106094067|NCT00097591|366001354|FG000|Overall Study|Other|0|||
106162566|NCT05084508|366257401|FG003|Overall Study|Withdrawal by Subject|1|||
106162567|NCT05084508|366257398|FG000|Overall Study|Other|0|||
106162568|NCT05084508|366257399|FG001|Overall Study|Other|0|||
106162569|NCT05084508|366257400|FG002|Overall Study|Other|0|||
106162570|NCT05084508|366257401|FG003|Overall Study|Other|1|||
106162571|NCT05296525|366257402|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
106162572|NCT05296525|366257403|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
106162573|NCT05296525|366257404|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
106162574|NCT05296525|366257405|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
106162575|NCT01420237|366257408|FG000|Overall Study|Death|13|||
106162576|NCT01420237|366257408|FG000|Overall Study|Withdrawal by Subject|41|||
106094068|NCT00097591|366001355|FG001|Overall Study|Other|3|||
106094069|NCT02031276|366001358|FG000|Period 1 Double-blind IV|Adverse Event|6|||
106162577|NCT01420237|366257408|FG000|Overall Study|Lost to Follow-up|32|||
106094070|NCT02031276|366001359|FG001|Period 1 Double-blind IV|Adverse Event|5|||
106094071|NCT02031276|366001360|FG002|Period 1 Double-blind IV|Adverse Event|1|||
106094072|NCT02031276|366001358|FG000|Period 1 Double-blind IV|Other|0|||
106094073|NCT02031276|366001359|FG001|Period 1 Double-blind IV|Other|1|||
106094074|NCT02031276|366001360|FG002|Period 1 Double-blind IV|Other|0|||
106094075|NCT02031276|366001358|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
106094076|NCT02031276|366001359|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
106094077|NCT02031276|366001360|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
106094078|NCT02031276|366001358|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
106094079|NCT02031276|366001359|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
106094080|NCT02031276|366001360|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
106094081|NCT02031276|366001358|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
106094082|NCT02031276|366001359|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
106094083|NCT02031276|366001360|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
106094084|NCT02031276|366001358|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
106094085|NCT02031276|366001359|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
106094086|NCT02031276|366001360|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
106094087|NCT02031276|366001358|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
106094088|NCT02031276|366001359|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
106094089|NCT02031276|366001360|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
106094090|NCT02031276|366001358|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
106094091|NCT02031276|366001359|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
106094092|NCT02031276|366001360|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
106094093|NCT02031276|366001358|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
106094094|NCT02031276|366001359|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
106094095|NCT02031276|366001360|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
106094096|NCT01148810|366001361|FG000|Overall Study|Adverse Event|0|||
106094097|NCT01148810|366001362|FG001|Overall Study|Adverse Event|2|||
106094098|NCT01148810|366001361|FG000|Overall Study|Lack of Efficacy|0|||
106094099|NCT01148810|366001362|FG001|Overall Study|Lack of Efficacy|1|||
106094100|NCT01148810|366001361|FG000|Overall Study|Withdrawal by Subject|0|||
106094101|NCT01148810|366001362|FG001|Overall Study|Withdrawal by Subject|2|||
106094102|NCT01148810|366001361|FG000|Overall Study|Protocol Violation|1|||
106094103|NCT01148810|366001362|FG001|Overall Study|Protocol Violation|0|||
106094104|NCT01163682|366001366|FG000|Overall Study|Lost to Follow-up|6|||
106094105|NCT01163682|366001367|FG001|Overall Study|Lost to Follow-up|9|||
106094106|NCT00844194|366001371|FG000|Overall Study|Adverse Event|17|||
106094107|NCT00844194|366001372|FG001|Overall Study|Adverse Event|5|||
106094108|NCT00844194|366001371|FG000|Overall Study|Protocol Violation|1|||
106094109|NCT00844194|366001372|FG001|Overall Study|Protocol Violation|1|||
106094110|NCT00844194|366001371|FG000|Overall Study|Lost to Follow-up|1|||
106094111|NCT00844194|366001372|FG001|Overall Study|Lost to Follow-up|1|||
106094112|NCT00844194|366001371|FG000|Overall Study|Withdrawal by Subject|2|||
106094113|NCT00844194|366001372|FG001|Overall Study|Withdrawal by Subject|1|||
106094114|NCT00844194|366001371|FG000|Overall Study|Lack of Efficacy|3|||
106094115|NCT00844194|366001372|FG001|Overall Study|Lack of Efficacy|0|||
106094116|NCT00844194|366001371|FG000|Overall Study|Other reason (not specified)|1|||
106094117|NCT00844194|366001372|FG001|Overall Study|Other reason (not specified)|0|||
106094118|NCT00803023|366001373|FG000|Overall Study|Adverse Event|5|||
106094119|NCT00803023|366001374|FG001|Overall Study|Adverse Event|4|||
106094120|NCT00803023|366001375|FG002|Overall Study|Adverse Event|8|||
106094121|NCT00803023|366001376|FG003|Overall Study|Adverse Event|6|||
106094122|NCT00803023|366001373|FG000|Overall Study|Withdrawal by Subject|0|||
106094123|NCT00803023|366001374|FG001|Overall Study|Withdrawal by Subject|2|||
106094124|NCT00803023|366001375|FG002|Overall Study|Withdrawal by Subject|0|||
106094125|NCT00803023|366001376|FG003|Overall Study|Withdrawal by Subject|0|||
106094126|NCT00803023|366001373|FG000|Overall Study|Lost to Follow-up|0|||
106094127|NCT00803023|366001374|FG001|Overall Study|Lost to Follow-up|1|||
106094128|NCT00803023|366001375|FG002|Overall Study|Lost to Follow-up|2|||
106094129|NCT00803023|366001376|FG003|Overall Study|Lost to Follow-up|1|||
106094130|NCT00803023|366001373|FG000|Overall Study|Lack of Efficacy|0|||
106094131|NCT00803023|366001374|FG001|Overall Study|Lack of Efficacy|1|||
106094132|NCT00803023|366001375|FG002|Overall Study|Lack of Efficacy|1|||
105984893|NCT00231413|365605975|FG000|Overall Study|Non-serious AE|0|||
106094133|NCT00803023|366001376|FG003|Overall Study|Lack of Efficacy|1|||
106094134|NCT01542528|366001377|FG000|Overall Study|Lost to Follow-up|2|||
106094135|NCT01542528|366001378|FG001|Overall Study|Lost to Follow-up|1|||
106094136|NCT01542528|366001377|FG000|Overall Study|Physician Decision|1|||
106094137|NCT01542528|366001378|FG001|Overall Study|Physician Decision|0|||
106094138|NCT01542528|366001377|FG000|Overall Study|Withdrawal by Subject|9|||
106094139|NCT01542528|366001378|FG001|Overall Study|Withdrawal by Subject|6|||
106094140|NCT00765245|366001381|FG000|Overall Study|disease progression|3|||
106094141|NCT00765245|366001382|FG001|Overall Study|disease progression|2|||
106094142|NCT00765245|366001381|FG000|Overall Study|Withdrawal by Subject|3|||
106094143|NCT00765245|366001382|FG001|Overall Study|Withdrawal by Subject|0|||
106094144|NCT00765245|366001381|FG000|Overall Study|Adverse Event|5|||
106162578|NCT01420237|366257408|FG000|Overall Study|Adverse Event|10|||
106094145|NCT00765245|366001382|FG001|Overall Study|Adverse Event|0|||
106094146|NCT00765245|366001381|FG000|Overall Study|Physician Decision|1|||
106094147|NCT00765245|366001382|FG001|Overall Study|Physician Decision|0|||
106094148|NCT00765245|366001381|FG000|Overall Study|Death|1|||
106094149|NCT00765245|366001382|FG001|Overall Study|Death|0|||
106094150|NCT02417246|366001385|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
106094151|NCT02417246|366001386|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
106094152|NCT02417246|366001385|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
106094153|NCT02417246|366001386|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
106094154|NCT02417246|366001385|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
106094155|NCT02417246|366001386|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
106094156|NCT02417246|366001385|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
106094157|NCT02417246|366001386|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
106094158|NCT04321460|366001387|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
106094159|NCT04321460|366001388|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
106094160|NCT02162810|366001389|FG000|Overall Study|Protocol Violation|1|||
106094161|NCT02162810|366001390|FG001|Overall Study|Protocol Violation|0|||
106094162|NCT02162810|366001389|FG000|Overall Study|patients did not report compliance|4|||
106094163|NCT02162810|366001390|FG001|Overall Study|patients did not report compliance|1|||
106094164|NCT01308749|366001391|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
106094165|NCT01308749|366001392|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
106094166|NCT01308749|366001391|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
106094167|NCT01308749|366001392|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
106094168|NCT01308749|366001391|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
106094169|NCT01308749|366001392|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
106094170|NCT04726709|366001393|FG000|Overall Study|Withdrawal by Subject|2|||
106094171|NCT04726709|366001394|FG001|Overall Study|Withdrawal by Subject|2|||
106094172|NCT01921348|366001395|FG000|Overall Study|Withdrawal by Subject|1|||
106094173|NCT01921348|366001396|FG001|Overall Study|Withdrawal by Subject|0|||
106094174|NCT01921348|366001395|FG000|Overall Study|Lost to Follow-up|0|||
106094175|NCT01921348|366001396|FG001|Overall Study|Lost to Follow-up|2|||
106094176|NCT03936244|366001397|FG000|Overall Study|Lost to Follow-up|5|||
106094177|NCT03936244|366001398|FG001|Overall Study|Lost to Follow-up|1|||
106094178|NCT03936244|366001397|FG000|Overall Study|Physician Decision|7|||
106094179|NCT03936244|366001398|FG001|Overall Study|Physician Decision|3|||
106094180|NCT01046110|366001402|FG000|Overall Study|Adverse Event|9|||
106094181|NCT01046110|366001403|FG001|Overall Study|Adverse Event|2|||
106094182|NCT01046110|366001402|FG000|Overall Study|Lack of Efficacy|0|||
106094183|NCT01046110|366001403|FG001|Overall Study|Lack of Efficacy|1|||
106094184|NCT01046110|366001402|FG000|Overall Study|Protocol Violation|7|||
106094185|NCT01046110|366001403|FG001|Overall Study|Protocol Violation|12|||
106094186|NCT01046110|366001402|FG000|Overall Study|Withdrawal Criteria|3|||
106094187|NCT01046110|366001403|FG001|Overall Study|Withdrawal Criteria|5|||
106094188|NCT01046110|366001402|FG000|Overall Study|Unclassified|36|||
106094189|NCT01046110|366001403|FG001|Overall Study|Unclassified|35|||
106094190|NCT01114646|366001404|FG000|Overall Study|Withdrawal by Subject|3|||
106094191|NCT01114646|366001405|FG001|Overall Study|Withdrawal by Subject|2|||
106094192|NCT04479618|366001408|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
106094193|NCT04479618|366001409|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
106094194|NCT04479618|366001410|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
106094195|NCT04479618|366001408|FG000|Overall Study|Lack of Efficacy|1|||
106094196|NCT04479618|366001409|FG001|Overall Study|Lack of Efficacy|0|||
106094197|NCT04479618|366001410|FG002|Overall Study|Lack of Efficacy|0|||
106094198|NCT04479618|366001408|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
106094199|NCT04479618|366001409|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
106094200|NCT04479618|366001410|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
106162579|NCT01420237|366257408|FG000|Overall Study|Investigative Site Termination|43|||
106162580|NCT01420237|366257408|FG000|Overall Study|Censored because study device not implanted|21|||
106162581|NCT01420237|366257408|FG000|Overall Study|Censored because surgery not performed|2|||
106162582|NCT01420237|366257408|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
106094201|NCT04479618|366001408|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
106094202|NCT04479618|366001409|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
106094203|NCT04479618|366001410|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
106094204|NCT04479618|366001408|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
106094205|NCT04479618|366001409|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
106094206|NCT04479618|366001410|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
106094207|NCT04479618|366001408|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
106094208|NCT04479618|366001409|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
106094209|NCT04479618|366001410|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
106094210|NCT04360824|366001411|FG000|Overall Study|Withdrawal by Subject|2|||
106094211|NCT04360824|366001412|FG001|Overall Study|Withdrawal by Subject|1|||
106094212|NCT04360824|366001411|FG000|Overall Study|Did not receive assigned treatment|1|||
106094213|NCT04360824|366001412|FG001|Overall Study|Did not receive assigned treatment|3|||
106094214|NCT02265705|366001413|FG000|Treatment Period Week 0-24|Adverse Event|3|||
106162583|NCT01420237|366257408|FG000|Overall Study|Sponsor terminated study early|127|||
106162584|NCT05269667|366257409|FG000|Overall Study|Study Terminated by Sponsor|4|||
106162585|NCT04948697|366257410|FG000|Overall Study|Progressive disease|27|||
106162586|NCT04948697|366257411|FG001|Overall Study|Progressive disease|18|||
106162587|NCT04948697|366257410|FG000|Overall Study|Adverse Event|14|||
106162588|NCT04948697|366257411|FG001|Overall Study|Adverse Event|4|||
106162589|NCT04948697|366257410|FG000|Overall Study|Participant moved to long term extension study|7|||
106162590|NCT04948697|366257411|FG001|Overall Study|Participant moved to long term extension study|4|||
106162591|NCT04948697|366257410|FG000|Overall Study|Withdrawal by Subject|10|||
106162592|NCT04948697|366257411|FG001|Overall Study|Withdrawal by Subject|0|||
106162593|NCT04948697|366257410|FG000|Overall Study|Closed by Sponsor|3|||
106162594|NCT04948697|366257411|FG001|Overall Study|Closed by Sponsor|2|||
106162595|NCT04948697|366257410|FG000|Overall Study|Physician Decision|0|||
106162596|NCT04948697|366257411|FG001|Overall Study|Physician Decision|2|||
106162597|NCT04948697|366257410|FG000|Overall Study|Lost to Follow-up|0|||
106162598|NCT04948697|366257411|FG001|Overall Study|Lost to Follow-up|1|||
106162599|NCT04948697|366257410|FG000|Overall Study|Other-Miscellaneous|1|||
106162600|NCT04948697|366257411|FG001|Overall Study|Other-Miscellaneous|0|||
106162601|NCT04948697|366257410|FG000|Overall Study|Randomized but not treated|0|||
106162602|NCT04948697|366257411|FG001|Overall Study|Randomized but not treated|1|||
106162603|NCT04338061|366257412|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
106162604|NCT04338061|366257413|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
106162605|NCT04338061|366257412|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
106162606|NCT04338061|366257413|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
106162607|NCT04338061|366257412|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
106162608|NCT04338061|366257413|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
106162609|NCT04338061|366257412|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
106162610|NCT04338061|366257413|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
106162611|NCT04338061|366257412|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
106162612|NCT04338061|366257413|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
106162613|NCT04338061|366257412|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
106162614|NCT04338061|366257413|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
106162615|NCT04338061|366257412|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
106162616|NCT04338061|366257413|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
106162617|NCT04338061|366257412|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
106162618|NCT04338061|366257413|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
106162619|NCT04338061|366257412|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
106162620|NCT04338061|366257413|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
106162621|NCT04338061|366257412|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
106162622|NCT04338061|366257413|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
106162623|NCT04338061|366257412|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
106162624|NCT04338061|366257413|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
106162625|NCT04338061|366257412|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
106162626|NCT04338061|366257413|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
106162627|NCT04599062|366257414|FG000|Overall Study|Physician Decision|1|||
106162628|NCT04599062|366257415|FG001|Overall Study|Physician Decision|0|||
106162629|NCT03631784|366257417|FG000|Overall Study|Participants Ongoing|1|||
106162630|NCT03631784|366257418|FG001|Overall Study|Participants Ongoing|0|||
106162631|NCT03631784|366257417|FG000|Overall Study|Withdrawal by Subject|3|||
106162632|NCT03631784|366257418|FG001|Overall Study|Withdrawal by Subject|3|||
106162633|NCT03631784|366257417|FG000|Overall Study|Sponsor's Decision|36|||
106162634|NCT03631784|366257418|FG001|Overall Study|Sponsor's Decision|52|||
106094215|NCT02265705|366001414|FG001|Treatment Period Week 0-24|Adverse Event|2|||
106094216|NCT02265705|366001415|FG002|Treatment Period Week 0-24|Adverse Event|0|||
106094217|NCT02265705|366001416|FG003|Treatment Period Week 0-24|Adverse Event|0|||
106162635|NCT03631784|366257417|FG000|Overall Study|Lost to Follow-up|1|||
106162636|NCT03631784|366257418|FG001|Overall Study|Lost to Follow-up|0|||
106162637|NCT03631784|366257417|FG000|Overall Study|Death|71|||
106162638|NCT03631784|366257418|FG001|Overall Study|Death|49|||
106162639|NCT03020199|366257421|FG000|Treatment Period|Adverse Event|0|||
105867287|NCT03888066|365164935|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
106094218|NCT02265705|366001417|FG004|Treatment Period Week 0-24|Adverse Event|0|||
106094219|NCT02265705|366001418|FG005|Treatment Period Week 0-24|Adverse Event|0|||
106094220|NCT02265705|366001419|FG006|Treatment Period Week 0-24|Adverse Event|0|||
106094221|NCT02265705|366001413|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
106094222|NCT02265705|366001414|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
106094223|NCT02265705|366001415|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
106094224|NCT02265705|366001416|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
106094225|NCT02265705|366001417|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
106094226|NCT02265705|366001418|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
106094227|NCT02265705|366001419|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
106094228|NCT02265705|366001413|FG000|Treatment Period Week 0-24|Physician Decision|1|||
106094229|NCT02265705|366001414|FG001|Treatment Period Week 0-24|Physician Decision|0|||
106094230|NCT02265705|366001415|FG002|Treatment Period Week 0-24|Physician Decision|0|||
106094231|NCT02265705|366001416|FG003|Treatment Period Week 0-24|Physician Decision|0|||
106094232|NCT02265705|366001417|FG004|Treatment Period Week 0-24|Physician Decision|0|||
106094233|NCT02265705|366001418|FG005|Treatment Period Week 0-24|Physician Decision|0|||
106094234|NCT02265705|366001419|FG006|Treatment Period Week 0-24|Physician Decision|0|||
106094235|NCT02265705|366001413|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
106094236|NCT02265705|366001414|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
106094237|NCT02265705|366001415|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
106094238|NCT02265705|366001416|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
106094239|NCT02265705|366001417|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
106094240|NCT02265705|366001418|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
106094241|NCT02265705|366001419|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
106094242|NCT02265705|366001413|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
106094243|NCT02265705|366001414|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
106094244|NCT02265705|366001415|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
106094245|NCT02265705|366001416|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
106094246|NCT02265705|366001417|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
106094247|NCT02265705|366001418|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
106094248|NCT02265705|366001419|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
106094249|NCT02265705|366001413|FG000|Rescue Period|Withdrawal by Subject|0|||
106094250|NCT02265705|366001414|FG001|Rescue Period|Withdrawal by Subject|0|||
106094251|NCT02265705|366001415|FG002|Rescue Period|Withdrawal by Subject|1|||
106094252|NCT02265705|366001416|FG003|Rescue Period|Withdrawal by Subject|0|||
106094253|NCT02265705|366001417|FG004|Rescue Period|Withdrawal by Subject|0|||
106094254|NCT02265705|366001418|FG005|Rescue Period|Withdrawal by Subject|0|||
106094255|NCT02265705|366001419|FG006|Rescue Period|Withdrawal by Subject|0|||
106094256|NCT02265705|366001413|FG000|Rescue Period|Death|0|||
106094257|NCT02265705|366001414|FG001|Rescue Period|Death|0|||
106094258|NCT02265705|366001415|FG002|Rescue Period|Death|1|||
106094259|NCT02265705|366001416|FG003|Rescue Period|Death|0|||
106094260|NCT02265705|366001417|FG004|Rescue Period|Death|0|||
106094261|NCT02265705|366001418|FG005|Rescue Period|Death|0|||
106094262|NCT02265705|366001419|FG006|Rescue Period|Death|0|||
106094263|NCT02265705|366001413|FG000|Rescue Period|Lack of Efficacy|0|||
106094264|NCT02265705|366001414|FG001|Rescue Period|Lack of Efficacy|0|||
106094265|NCT02265705|366001415|FG002|Rescue Period|Lack of Efficacy|1|||
106094266|NCT02265705|366001416|FG003|Rescue Period|Lack of Efficacy|0|||
106094267|NCT02265705|366001417|FG004|Rescue Period|Lack of Efficacy|0|||
106094268|NCT02265705|366001418|FG005|Rescue Period|Lack of Efficacy|0|||
106094269|NCT02265705|366001419|FG006|Rescue Period|Lack of Efficacy|0|||
106094270|NCT02265705|366001413|FG000|Open Label Period|Adverse Event|0|||
106094271|NCT02265705|366001414|FG001|Open Label Period|Adverse Event|0|||
106094272|NCT02265705|366001415|FG002|Open Label Period|Adverse Event|0|||
106094273|NCT02265705|366001416|FG003|Open Label Period|Adverse Event|2|||
106094274|NCT02265705|366001417|FG004|Open Label Period|Adverse Event|2|||
106094275|NCT02265705|366001418|FG005|Open Label Period|Adverse Event|0|||
106094276|NCT02265705|366001419|FG006|Open Label Period|Adverse Event|0|||
106094277|NCT02265705|366001413|FG000|Open Label Period|Physician Decision|0|||
106094278|NCT02265705|366001414|FG001|Open Label Period|Physician Decision|0|||
106094279|NCT02265705|366001415|FG002|Open Label Period|Physician Decision|0|||
106094280|NCT02265705|366001416|FG003|Open Label Period|Physician Decision|0|||
106094281|NCT02265705|366001417|FG004|Open Label Period|Physician Decision|1|||
106094282|NCT02265705|366001418|FG005|Open Label Period|Physician Decision|0|||
106094283|NCT02265705|366001419|FG006|Open Label Period|Physician Decision|0|||
106094284|NCT02265705|366001413|FG000|Open Label Period|Withdrawal by Subject|0|||
106094285|NCT02265705|366001414|FG001|Open Label Period|Withdrawal by Subject|0|||
106094286|NCT02265705|366001415|FG002|Open Label Period|Withdrawal by Subject|0|||
106094287|NCT02265705|366001416|FG003|Open Label Period|Withdrawal by Subject|0|||
106094288|NCT02265705|366001417|FG004|Open Label Period|Withdrawal by Subject|2|||
106094289|NCT02265705|366001418|FG005|Open Label Period|Withdrawal by Subject|0|||
106094290|NCT02265705|366001419|FG006|Open Label Period|Withdrawal by Subject|0|||
106094291|NCT02265705|366001413|FG000|Follow-up Period|Sponsor Decision|0|||
106094292|NCT02265705|366001414|FG001|Follow-up Period|Sponsor Decision|0|||
106094293|NCT02265705|366001415|FG002|Follow-up Period|Sponsor Decision|0|||
106162640|NCT03020199|366257422|FG001|Treatment Period|Adverse Event|2|||
106162641|NCT03020199|366257421|FG000|Treatment Period|Lack of Efficacy|1|||
106162642|NCT03020199|366257422|FG001|Treatment Period|Lack of Efficacy|6|||
106162643|NCT03020199|366257421|FG000|Treatment Period|Lost to Follow-up|1|||
106162644|NCT03020199|366257422|FG001|Treatment Period|Lost to Follow-up|6|||
106162645|NCT03020199|366257421|FG000|Treatment Period|Physician Decision|0|||
106162646|NCT03020199|366257422|FG001|Treatment Period|Physician Decision|1|||
106094294|NCT02265705|366001416|FG003|Follow-up Period|Sponsor Decision|0|||
106094295|NCT02265705|366001417|FG004|Follow-up Period|Sponsor Decision|0|||
106094296|NCT02265705|366001418|FG005|Follow-up Period|Sponsor Decision|1|||
106094297|NCT02265705|366001419|FG006|Follow-up Period|Sponsor Decision|6|||
106094298|NCT02265705|366001413|FG000|Follow-up Period|Adverse Event|0|||
106094299|NCT02265705|366001414|FG001|Follow-up Period|Adverse Event|0|||
106094300|NCT02265705|366001415|FG002|Follow-up Period|Adverse Event|0|||
106094301|NCT02265705|366001416|FG003|Follow-up Period|Adverse Event|0|||
106094302|NCT02265705|366001417|FG004|Follow-up Period|Adverse Event|0|||
106094303|NCT02265705|366001418|FG005|Follow-up Period|Adverse Event|0|||
106094304|NCT02265705|366001419|FG006|Follow-up Period|Adverse Event|3|||
106094305|NCT02265705|366001413|FG000|Follow-up Period|Physician Decision|0|||
106094306|NCT02265705|366001414|FG001|Follow-up Period|Physician Decision|0|||
106094307|NCT02265705|366001415|FG002|Follow-up Period|Physician Decision|0|||
106094308|NCT02265705|366001416|FG003|Follow-up Period|Physician Decision|0|||
106094309|NCT02265705|366001417|FG004|Follow-up Period|Physician Decision|0|||
106094310|NCT02265705|366001418|FG005|Follow-up Period|Physician Decision|0|||
106094311|NCT02265705|366001419|FG006|Follow-up Period|Physician Decision|1|||
106094312|NCT02265705|366001413|FG000|Follow-up Period|Withdrawal by Subject|0|||
106094313|NCT02265705|366001414|FG001|Follow-up Period|Withdrawal by Subject|0|||
106094314|NCT02265705|366001415|FG002|Follow-up Period|Withdrawal by Subject|0|||
106094315|NCT02265705|366001416|FG003|Follow-up Period|Withdrawal by Subject|0|||
106094316|NCT02265705|366001417|FG004|Follow-up Period|Withdrawal by Subject|0|||
106094317|NCT02265705|366001418|FG005|Follow-up Period|Withdrawal by Subject|0|||
106094318|NCT02265705|366001419|FG006|Follow-up Period|Withdrawal by Subject|1|||
106094319|NCT00583557|366001422|FG000|Overall Study|Withdrawal by Subject|18|||
106094320|NCT00583557|366001422|FG000|Overall Study|Adverse Event|9|||
106094321|NCT00583557|366001422|FG000|Overall Study|Lack of Efficacy|31|||
106094322|NCT00583557|366001422|FG000|Overall Study|Lack of Compliance|5|||
106094323|NCT00583557|366001422|FG000|Overall Study|Other|5|||
106094324|NCT00583557|366001422|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
106094325|NCT03207750|366001425|FG000|Overall Study|Adverse Event|3|||
106094326|NCT03207750|366001426|FG001|Overall Study|Adverse Event|2|||
106094327|NCT03207750|366001425|FG000|Overall Study|Lost to Follow-up|21|||
106094328|NCT03207750|366001426|FG001|Overall Study|Lost to Follow-up|29|||
106094329|NCT03207750|366001425|FG000|Overall Study|Protocol Violation|0|||
106094330|NCT03207750|366001426|FG001|Overall Study|Protocol Violation|1|||
106094331|NCT03207750|366001425|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
106094332|NCT03207750|366001426|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
106094333|NCT03207750|366001425|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
106094334|NCT03207750|366001426|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
106094335|NCT03207750|366001425|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
106094336|NCT03207750|366001426|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
106094337|NCT03207750|366001425|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
106094338|NCT03207750|366001426|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
106094339|NCT03207750|366001425|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
106094340|NCT03207750|366001426|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
106094341|NCT03634579|366001435|FG000|Overall Study|study termination|9|||
106094342|NCT00096135|366001436|FG000|Overall Study|Physician Decision|20|||
106162647|NCT03020199|366257421|FG000|Treatment Period|Subject/guardian decision|8|||
106094343|NCT00096135|366001437|FG001|Overall Study|Physician Decision|4|||
106094344|NCT00096135|366001436|FG000|Overall Study|Refusal of further protocol therapy|4|||
106094345|NCT00096135|366001437|FG001|Overall Study|Refusal of further protocol therapy|1|||
106094346|NCT00096135|366001436|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
106094347|NCT00096135|366001437|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
106094348|NCT00096135|366001436|FG000|Overall Study|Other, specify|15|||
106094349|NCT00096135|366001437|FG001|Overall Study|Other, specify|3|||
106094350|NCT00096135|366001436|FG000|Overall Study|Ineligible|2|||
106094351|NCT00096135|366001437|FG001|Overall Study|Ineligible|0|||
106094352|NCT00803634|366001443|FG000|Overall Study|Withdrew Consent|1|||
106094353|NCT00803634|366001444|FG001|Overall Study|Withdrew Consent|0|||
106094354|NCT00803634|366001443|FG000|Overall Study|Lost to Follow-up|2|||
106094355|NCT00803634|366001444|FG001|Overall Study|Lost to Follow-up|3|||
106094356|NCT00803634|366001443|FG000|Overall Study|Death|3|||
106094357|NCT00803634|366001444|FG001|Overall Study|Death|2|||
106094358|NCT01307501|366001448|FG000|Overall Study|Treatment Failure|1|||
106094359|NCT01307501|366001448|FG000|Overall Study|Death|20|||
106094360|NCT01307501|366001448|FG000|Overall Study|Lost to Follow-up|1|||
106094361|NCT01307501|366001448|FG000|Overall Study|Starting Hospice|1|||
106094362|NCT03712917|366001451|FG000|Overall Study|Pregnancy|0|||
106094363|NCT03712917|366001452|FG001|Overall Study|Pregnancy|0|||
106094364|NCT03712917|366001453|FG002|Overall Study|Pregnancy|1|||
106094365|NCT03712917|366001451|FG000|Overall Study|Adverse Event|0|||
106094366|NCT03712917|366001452|FG001|Overall Study|Adverse Event|4|||
106094367|NCT03712917|366001453|FG002|Overall Study|Adverse Event|3|||
106094368|NCT03712917|366001451|FG000|Overall Study|Lost to Follow-up|9|||
106094369|NCT03712917|366001452|FG001|Overall Study|Lost to Follow-up|4|||
106094370|NCT03712917|366001453|FG002|Overall Study|Lost to Follow-up|5|||
106094371|NCT03662750|366001457|FG000|Overall Study|Withdrawal by Subject|1|||
106094372|NCT00464542|366002740|FG000|Pre-treatment|Withdrawal by Subject|2|||
106094373|NCT03794089|366002745|FG000|Overall Study|Lost to Follow-up|4|||
106094374|NCT03794089|366002746|FG001|Overall Study|Lost to Follow-up|1|||
106094375|NCT03794089|366002745|FG000|Overall Study|Withdrawal by Subject|2|||
106094376|NCT03794089|366002746|FG001|Overall Study|Withdrawal by Subject|0|||
106094377|NCT00993447|366002755|FG000|Overall Study|Withdrawal by Subject|23|||
106094378|NCT00993447|366002756|FG001|Overall Study|Withdrawal by Subject|8|||
106094379|NCT00993447|366002755|FG000|Overall Study|Protocol Violation|12|||
106094380|NCT00993447|366002756|FG001|Overall Study|Protocol Violation|8|||
106094381|NCT00993447|366002755|FG000|Overall Study|Lost to Follow-up|1|||
106094382|NCT00993447|366002756|FG001|Overall Study|Lost to Follow-up|3|||
106094383|NCT00993447|366002755|FG000|Overall Study|Adverse Event|1|||
106094384|NCT00993447|366002756|FG001|Overall Study|Adverse Event|0|||
106094385|NCT01159938|366002757|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
106094386|NCT01159938|366002758|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
106094387|NCT01159938|366002759|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
106094388|NCT01159938|366002760|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
106094389|NCT01159938|366002761|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
106094390|NCT01073618|366002764|FG000|Overall Study|Death|208|||
106094391|NCT01073618|366002764|FG000|Overall Study|Adverse Event|19|||
106094392|NCT01073618|366002764|FG000|Overall Study|Other|80|||
106094393|NCT02696850|366002765|FG000|Overall Study|Withdrawal by Subject|3|||
106094394|NCT02696850|366002766|FG001|Overall Study|Withdrawal by Subject|3|||
106094395|NCT02696850|366002765|FG000|Overall Study|Lost to Follow-up|8|||
106094396|NCT02696850|366002766|FG001|Overall Study|Lost to Follow-up|5|||
106094397|NCT00673049|366002767|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
106094398|NCT00673049|366002768|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
106094399|NCT00673049|366002769|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
106094400|NCT00673049|366002770|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
106094401|NCT00673049|366002767|FG000|Before Progression on Erlotinib|Death|235|||
106094402|NCT00673049|366002768|FG001|Before Progression on Erlotinib|Death|167|||
106094403|NCT00673049|366002769|FG002|Before Progression on Erlotinib|Death|1|||
106094404|NCT00673049|366002770|FG003|Before Progression on Erlotinib|Death|0|||
106094405|NCT00673049|366002767|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
106094406|NCT00673049|366002768|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
106094407|NCT00673049|366002769|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
106094408|NCT00673049|366002770|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
106094409|NCT00673049|366002767|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
106094410|NCT00673049|366002768|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
106094411|NCT00673049|366002769|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
106094412|NCT00673049|366002770|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
106094413|NCT00673049|366002767|FG000|Before Progression on Erlotinib|Other|1|||
106094414|NCT00673049|366002768|FG001|Before Progression on Erlotinib|Other|2|||
106094415|NCT00673049|366002769|FG002|Before Progression on Erlotinib|Other|0|||
106094416|NCT00673049|366002770|FG003|Before Progression on Erlotinib|Other|0|||
106094417|NCT00673049|366002767|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
106094418|NCT00673049|366002768|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
106094419|NCT00673049|366002769|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
106094420|NCT00673049|366002770|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
106094421|NCT00673049|366002767|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
106094422|NCT00673049|366002768|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
106094423|NCT00673049|366002769|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
106094424|NCT00673049|366002770|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
106094425|NCT00673049|366002767|FG000|After Progression on Erlotinib|Death|0|||
106094426|NCT00673049|366002768|FG001|After Progression on Erlotinib|Death|0|||
106094427|NCT00673049|366002769|FG002|After Progression on Erlotinib|Death|0|||
106094428|NCT00673049|366002770|FG003|After Progression on Erlotinib|Death|71|||
106094429|NCT00673049|366002767|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
106094430|NCT00673049|366002768|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
106094431|NCT00673049|366002769|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
106094432|NCT00673049|366002770|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
106094433|NCT00673049|366002767|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
106094434|NCT00673049|366002768|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
106094435|NCT00673049|366002769|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
106094436|NCT00673049|366002770|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
106094437|NCT00673049|366002767|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
106094438|NCT00673049|366002768|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
106094439|NCT00673049|366002769|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
106094440|NCT00673049|366002770|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
106094441|NCT04837482|366002772|FG000|Period 2|Withdrawal by Subject|0|||
106094442|NCT04837482|366002773|FG001|Period 2|Withdrawal by Subject|1|||
106094443|NCT04495374|366002777|FG000|Overall Study|Protocol Violation|2|||
106094444|NCT04495374|366002778|FG001|Overall Study|Protocol Violation|1|||
106094445|NCT02807948|366002779|FG000|Overall Study|Physician Decision|1|||
106094446|NCT02807948|366002780|FG001|Overall Study|Physician Decision|0|||
106094447|NCT01303627|366002782|FG000|Overall Study|the failure while performing URS|0|||
106094448|NCT01303627|366002783|FG001|Overall Study|the failure while performing URS|1|||
106094449|NCT01343082|366002784|FG000|The run-in Period|Not meeting criteria|3|||
106094450|NCT01343082|366002785|FG001|The run-in Period|Not meeting criteria|4|||
106094451|NCT01343082|366002786|FG002|The run-in Period|Not meeting criteria|5|||
106094452|NCT01343082|366002784|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
106094453|NCT01343082|366002785|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
106094454|NCT01343082|366002786|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
106094455|NCT01343082|366002784|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
106094456|NCT01343082|366002785|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
106094457|NCT01343082|366002786|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
106094458|NCT01343082|366002784|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
106094459|NCT01343082|366002785|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
106094460|NCT01343082|366002786|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
106094461|NCT01343082|366002784|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
106094462|NCT01343082|366002785|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
106094463|NCT01343082|366002786|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
106094464|NCT02416791|366002787|FG000|6 Months|Lost to Follow-up|0|||
106094465|NCT02416791|366002788|FG001|6 Months|Lost to Follow-up|0|||
106094466|NCT02416791|366002789|FG002|6 Months|Lost to Follow-up|1|||
106094467|NCT01054820|366002790|FG000|Overall Study|Withdrawal by Subject|2|||
106094468|NCT01154166|366002792|FG000|Overall Study|Adverse Event|14|||
106094469|NCT01154166|366002793|FG001|Overall Study|Adverse Event|9|||
106094470|NCT01154166|366002792|FG000|Overall Study|Lost to Follow-up|1|||
106094471|NCT01154166|366002793|FG001|Overall Study|Lost to Follow-up|1|||
106094472|NCT01154166|366002792|FG000|Overall Study|Protocol Violation|4|||
106094473|NCT01154166|366002793|FG001|Overall Study|Protocol Violation|1|||
106094474|NCT01154166|366002792|FG000|Overall Study|Withdrawal by Subject|10|||
106094475|NCT01154166|366002793|FG001|Overall Study|Withdrawal by Subject|1|||
106094476|NCT01154166|366002792|FG000|Overall Study|Lack of Efficacy|3|||
106094477|NCT01154166|366002793|FG001|Overall Study|Lack of Efficacy|0|||
106094478|NCT01154166|366002792|FG000|Overall Study|Disease Progression|1|||
106094479|NCT01154166|366002793|FG001|Overall Study|Disease Progression|0|||
106094480|NCT01154166|366002792|FG000|Overall Study|Poor Compliance|1|||
106094481|NCT01154166|366002793|FG001|Overall Study|Poor Compliance|0|||
106094482|NCT02099838|366002794|FG000|Overall Study|Death|1|||
106094483|NCT02099838|366002795|FG001|Overall Study|Death|0|||
106094484|NCT02099838|366002794|FG000|Overall Study|Lost to Follow-up|3|||
106094485|NCT02099838|366002795|FG001|Overall Study|Lost to Follow-up|1|||
106094486|NCT02099838|366002794|FG000|Overall Study|Withdrawal by Subject|0|||
106094487|NCT02099838|366002795|FG001|Overall Study|Withdrawal by Subject|1|||
106094488|NCT02301143|366002796|FG000|Induction Period|Enrolled But Not Treated|1|||
106094489|NCT02301143|366002797|FG001|Induction Period|Enrolled But Not Treated|0|||
106094490|NCT02301143|366002796|FG000|Induction Period|Death|1|||
106094491|NCT02301143|366002797|FG001|Induction Period|Death|0|||
106094492|NCT02301143|366002796|FG000|Induction Period|Adverse Event|22|||
106094493|NCT02301143|366002797|FG001|Induction Period|Adverse Event|0|||
106094494|NCT02301143|366002796|FG000|Induction Period|Progressive Disease|8|||
106094495|NCT02301143|366002797|FG001|Induction Period|Progressive Disease|0|||
106094496|NCT02301143|366002796|FG000|Induction Period|Withdrawal by Subject|3|||
106094497|NCT02301143|366002797|FG001|Induction Period|Withdrawal by Subject|0|||
106094498|NCT02301143|366002796|FG000|Induction Period|Noncompliance with Study Drug|1|||
106094499|NCT02301143|366002797|FG001|Induction Period|Noncompliance with Study Drug|0|||
106094500|NCT02301143|366002796|FG000|Induction Period|Physician Decision|4|||
106094501|NCT02301143|366002797|FG001|Induction Period|Physician Decision|0|||
106094502|NCT02301143|366002796|FG000|Induction Period|Symptomatic Deterioration|2|||
106094503|NCT02301143|366002797|FG001|Induction Period|Symptomatic Deterioration|0|||
106094504|NCT02301143|366002796|FG000|Induction Period|Protocol Violation|2|||
106094505|NCT02301143|366002797|FG001|Induction Period|Protocol Violation|0|||
106094506|NCT02301143|366002796|FG000|Induction Period|Other|1|||
106094507|NCT02301143|366002797|FG001|Induction Period|Other|0|||
106094508|NCT02301143|366002796|FG000|Investigator's Choice|Adverse Event|0|||
106094509|NCT02301143|366002797|FG001|Investigator's Choice|Adverse Event|3|||
106094510|NCT02301143|366002796|FG000|Investigator's Choice|Progressive Disease|0|||
106094511|NCT02301143|366002797|FG001|Investigator's Choice|Progressive Disease|3|||
106094512|NCT02301143|366002796|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
106094513|NCT02301143|366002797|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
106094514|NCT02301143|366002796|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
106094515|NCT02301143|366002797|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
106094516|NCT02301143|366002796|FG000|Investigator's Choice|Other|0|||
106094517|NCT02301143|366002797|FG001|Investigator's Choice|Other|1|||
106094518|NCT02301143|366002796|FG000|Investigator's Choice|Unresectable Surgery|0|||
106094519|NCT02301143|366002797|FG001|Investigator's Choice|Unresectable Surgery|1|||
106094520|NCT01227889|366002798|FG000|Randomized Phase (RP)|Adverse Event|13|||
106094521|NCT01227889|366002799|FG001|Randomized Phase (RP)|Adverse Event|0|||
106094522|NCT01227889|366002798|FG000|Randomized Phase (RP)|Physician Decision|13|||
106094523|NCT01227889|366002799|FG001|Randomized Phase (RP)|Physician Decision|5|||
106094524|NCT01227889|366002798|FG000|Randomized Phase (RP)|Progressive Disease|135|||
106094525|NCT01227889|366002799|FG001|Randomized Phase (RP)|Progressive Disease|52|||
106094526|NCT01227889|366002798|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
106094527|NCT01227889|366002799|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
106094528|NCT01227889|366002798|FG000|Randomized Phase (RP)|Missing|1|||
106094529|NCT01227889|366002799|FG001|Randomized Phase (RP)|Missing|3|||
106094530|NCT01227889|366002798|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
106094531|NCT01227889|366002799|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
106094532|NCT01227889|366002798|FG000|Crossover Phase|Adverse Event|0|||
106094533|NCT01227889|366002799|FG001|Crossover Phase|Adverse Event|1|||
106094534|NCT01227889|366002798|FG000|Crossover Phase|Physician Decision|0|||
106094535|NCT01227889|366002799|FG001|Crossover Phase|Physician Decision|3|||
106094536|NCT01227889|366002798|FG000|Crossover Phase|Progressive Disease|0|||
106094537|NCT01227889|366002799|FG001|Crossover Phase|Progressive Disease|31|||
106094538|NCT01227889|366002798|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
106094539|NCT01227889|366002799|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
106094540|NCT01227889|366002798|FG000|Crossover Phase|Withdrawal by Subject|0|||
106094541|NCT01227889|366002799|FG001|Crossover Phase|Withdrawal by Subject|1|||
106094542|NCT00774787|366002800|FG000|Overall Study|Lost to Follow-up|1|||
106094543|NCT01854554|366002802|FG000|Overall Study|Denial of Insurance Coverage|12|||
106094544|NCT01854554|366002803|FG001|Overall Study|Denial of Insurance Coverage|0|||
106094545|NCT01854554|366002802|FG000|Overall Study|Decided to get treatment locally|1|||
106094546|NCT01854554|366002803|FG001|Overall Study|Decided to get treatment locally|5|||
106094547|NCT01854554|366002802|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
106094548|NCT01854554|366002803|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
106094549|NCT01854554|366002802|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
106094550|NCT01854554|366002803|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
106094551|NCT01854554|366002802|FG000|Overall Study|Progression|0|||
106094552|NCT01854554|366002803|FG001|Overall Study|Progression|1|||
106094553|NCT01854554|366002802|FG000|Overall Study|Lost to Follow-up|0|||
106094554|NCT01854554|366002803|FG001|Overall Study|Lost to Follow-up|1|||
106094555|NCT02819726|366002804|FG000|Part A (All Participants)|Lost to Follow-up|0|||
106094556|NCT02819726|366002805|FG001|Part A (All Participants)|Lost to Follow-up|1|||
106094557|NCT02819726|366002806|FG002|Part A (All Participants)|Lost to Follow-up|0|||
106094558|NCT02819726|366002807|FG003|Part A (All Participants)|Lost to Follow-up|0|||
106094559|NCT02819726|366002804|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
106094560|NCT02819726|366002805|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
106094561|NCT02819726|366002806|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
106094562|NCT02819726|366002807|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
106094563|NCT02819726|366002804|FG000|Part A (All Participants)|Protocol non-compliance|3|||
106094564|NCT02819726|366002805|FG001|Part A (All Participants)|Protocol non-compliance|4|||
106094565|NCT02819726|366002806|FG002|Part A (All Participants)|Protocol non-compliance|5|||
106094566|NCT02819726|366002807|FG003|Part A (All Participants)|Protocol non-compliance|0|||
106094567|NCT02819726|366002804|FG000|Part B (All Participants)|Lost to Follow-up|1|||
106094568|NCT02819726|366002805|FG001|Part B (All Participants)|Lost to Follow-up|1|||
106094569|NCT02819726|366002806|FG002|Part B (All Participants)|Lost to Follow-up|2|||
106094570|NCT02819726|366002807|FG003|Part B (All Participants)|Lost to Follow-up|2|||
106094571|NCT02819726|366002804|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
106094572|NCT02819726|366002805|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
106094573|NCT02819726|366002806|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
106094574|NCT02819726|366002807|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
106094575|NCT02819726|366002804|FG000|Part B (All Participants)|Protocol non-compliance|0|||
106094576|NCT02819726|366002805|FG001|Part B (All Participants)|Protocol non-compliance|0|||
106094577|NCT02819726|366002806|FG002|Part B (All Participants)|Protocol non-compliance|1|||
106094578|NCT02819726|366002807|FG003|Part B (All Participants)|Protocol non-compliance|0|||
106094579|NCT02536508|366002808|FG000|Overall Study|Withdrawal by Subject|18|||
106094580|NCT02536508|366002809|FG001|Overall Study|Withdrawal by Subject|13|||
106094581|NCT02536508|366002810|FG002|Overall Study|Withdrawal by Subject|7|||
106094582|NCT02536508|366002808|FG000|Overall Study|Adverse Event|14|||
106094583|NCT02536508|366002809|FG001|Overall Study|Adverse Event|13|||
106094584|NCT02536508|366002810|FG002|Overall Study|Adverse Event|6|||
106094585|NCT02536508|366002808|FG000|Overall Study|Lost to Follow-up|12|||
106094586|NCT02536508|366002809|FG001|Overall Study|Lost to Follow-up|4|||
106094587|NCT02536508|366002810|FG002|Overall Study|Lost to Follow-up|0|||
106094588|NCT02536508|366002808|FG000|Overall Study|Lack of Efficacy|3|||
106094589|NCT02536508|366002809|FG001|Overall Study|Lack of Efficacy|5|||
106094590|NCT02536508|366002810|FG002|Overall Study|Lack of Efficacy|4|||
106094591|NCT02536508|366002808|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
106094592|NCT02536508|366002809|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
106094593|NCT02536508|366002810|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
106094594|NCT02536508|366002808|FG000|Overall Study|Physician Decision|0|||
106094595|NCT02536508|366002809|FG001|Overall Study|Physician Decision|4|||
106094596|NCT02536508|366002810|FG002|Overall Study|Physician Decision|2|||
106094597|NCT02536508|366002808|FG000|Overall Study|Major Protocol Deviation|2|||
106094598|NCT02536508|366002809|FG001|Overall Study|Major Protocol Deviation|2|||
106094599|NCT02536508|366002810|FG002|Overall Study|Major Protocol Deviation|2|||
106094600|NCT02536508|366002808|FG000|Overall Study|Administrative Reasons|0|||
106094601|NCT02536508|366002809|FG001|Overall Study|Administrative Reasons|1|||
106094602|NCT02536508|366002810|FG002|Overall Study|Administrative Reasons|0|||
106094603|NCT02613481|366002811|FG000|Overall Study|Lost to Follow-up|7|||
106094604|NCT02613481|366002811|FG000|Overall Study|Withdrawal by Subject|2|||
106094605|NCT01033747|366002812|FG000|Overall Study|Adverse Event|9|||
106094606|NCT01033747|366002813|FG001|Overall Study|Adverse Event|4|||
106094607|NCT01033747|366002812|FG000|Overall Study|Abnormal Laboratory Value|1|||
106094608|NCT01033747|366002813|FG001|Overall Study|Abnormal Laboratory Value|0|||
106094609|NCT01033747|366002812|FG000|Overall Study|Abnormal test procedure|0|||
106094610|NCT01033747|366002813|FG001|Overall Study|Abnormal test procedure|1|||
106094611|NCT01033747|366002812|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
106094612|NCT01033747|366002813|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
106094613|NCT01033747|366002812|FG000|Overall Study|Protocol Violation|1|||
106094614|NCT01033747|366002813|FG001|Overall Study|Protocol Violation|0|||
106094615|NCT01033747|366002812|FG000|Overall Study|Withdrawal by Subject|9|||
106094616|NCT01033747|366002813|FG001|Overall Study|Withdrawal by Subject|6|||
106094617|NCT01033747|366002812|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
106094618|NCT01033747|366002813|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
106094619|NCT01033747|366002812|FG000|Overall Study|Stopped at end of Extension 1|2|||
106094620|NCT01033747|366002813|FG001|Overall Study|Stopped at end of Extension 1|0|||
106094621|NCT02647658|366002818|FG000|Overall Study|Consent refusal|15|||
106094622|NCT02647658|366002819|FG001|Overall Study|Consent refusal|24|||
106094623|NCT01181921|366002823|FG000|Overall Study|Lost to Follow-up|1|||
106094624|NCT00304070|366002831|FG000|Overall Study|Death|0|||
106094625|NCT00304070|366002832|FG001|Overall Study|Death|0|||
106094626|NCT00304070|366002833|FG002|Overall Study|Death|3|||
106094627|NCT00304070|366002831|FG000|Overall Study|Lost to Follow-up|0|||
106094628|NCT00304070|366002832|FG001|Overall Study|Lost to Follow-up|0|||
106094629|NCT00304070|366002833|FG002|Overall Study|Lost to Follow-up|1|||
106094630|NCT00304070|366002831|FG000|Overall Study|Physician Decision|0|||
106094631|NCT00304070|366002832|FG001|Overall Study|Physician Decision|0|||
106094632|NCT00304070|366002833|FG002|Overall Study|Physician Decision|3|||
106094633|NCT00304070|366002831|FG000|Overall Study|Withdrawal by Subject|0|||
106094634|NCT00304070|366002832|FG001|Overall Study|Withdrawal by Subject|0|||
106094635|NCT00304070|366002833|FG002|Overall Study|Withdrawal by Subject|1|||
106094636|NCT00304070|366002831|FG000|Overall Study|Progressive Disease|3|||
106094637|NCT00304070|366002832|FG001|Overall Study|Progressive Disease|7|||
106094638|NCT00304070|366002833|FG002|Overall Study|Progressive Disease|4|||
106094639|NCT00941603|366002837|FG000|Overall Study|Adverse Event|10|||
106094640|NCT00941603|366002838|FG001|Overall Study|Adverse Event|15|||
106094641|NCT00941603|366002839|FG002|Overall Study|Adverse Event|5|||
106094642|NCT00941603|366002840|FG003|Overall Study|Adverse Event|1|||
106094643|NCT00941603|366002841|FG004|Overall Study|Adverse Event|4|||
106094644|NCT00941603|366002842|FG005|Overall Study|Adverse Event|0|||
106094645|NCT00941603|366002837|FG000|Overall Study|Lost to Follow-up|0|||
106094646|NCT00941603|366002838|FG001|Overall Study|Lost to Follow-up|0|||
106094647|NCT00941603|366002839|FG002|Overall Study|Lost to Follow-up|0|||
106094648|NCT00941603|366002840|FG003|Overall Study|Lost to Follow-up|1|||
106094649|NCT00941603|366002841|FG004|Overall Study|Lost to Follow-up|0|||
106094650|NCT00941603|366002842|FG005|Overall Study|Lost to Follow-up|2|||
106094651|NCT00941603|366002837|FG000|Overall Study|Withdrawal by Subject|0|||
106094652|NCT00941603|366002838|FG001|Overall Study|Withdrawal by Subject|0|||
106094653|NCT00941603|366002839|FG002|Overall Study|Withdrawal by Subject|0|||
106094654|NCT00941603|366002840|FG003|Overall Study|Withdrawal by Subject|2|||
106094655|NCT00941603|366002841|FG004|Overall Study|Withdrawal by Subject|0|||
106094656|NCT00941603|366002842|FG005|Overall Study|Withdrawal by Subject|1|||
106094657|NCT00941603|366002837|FG000|Overall Study|Protocol Violation|0|||
106094658|NCT00941603|366002838|FG001|Overall Study|Protocol Violation|1|||
106094659|NCT00941603|366002839|FG002|Overall Study|Protocol Violation|0|||
106094660|NCT00941603|366002840|FG003|Overall Study|Protocol Violation|0|||
106094661|NCT00941603|366002841|FG004|Overall Study|Protocol Violation|0|||
106094662|NCT00941603|366002842|FG005|Overall Study|Protocol Violation|0|||
106094663|NCT00941603|366002837|FG000|Overall Study|Did not meet protocol eligibility|1|||
106094664|NCT00941603|366002838|FG001|Overall Study|Did not meet protocol eligibility|0|||
106094665|NCT00941603|366002839|FG002|Overall Study|Did not meet protocol eligibility|0|||
106094666|NCT00941603|366002840|FG003|Overall Study|Did not meet protocol eligibility|0|||
106094667|NCT00941603|366002841|FG004|Overall Study|Did not meet protocol eligibility|0|||
106094668|NCT00941603|366002842|FG005|Overall Study|Did not meet protocol eligibility|0|||
106094669|NCT02014116|366002843|FG000|Overall Study|Progressive Disease|3|||
106094670|NCT02014116|366002844|FG001|Overall Study|Progressive Disease|4|||
106094671|NCT02014116|366002845|FG002|Overall Study|Progressive Disease|2|||
106094672|NCT02014116|366002846|FG003|Overall Study|Progressive Disease|6|||
106094673|NCT02014116|366002847|FG004|Overall Study|Progressive Disease|1|||
106094674|NCT02014116|366002848|FG005|Overall Study|Progressive Disease|13|||
106094675|NCT02014116|366002849|FG006|Overall Study|Progressive Disease|1|||
106094676|NCT02014116|366002850|FG007|Overall Study|Progressive Disease|3|||
106094677|NCT02014116|366002851|FG008|Overall Study|Progressive Disease|7|||
106094678|NCT02014116|366002843|FG000|Overall Study|Adverse Event|0|||
106094679|NCT02014116|366002844|FG001|Overall Study|Adverse Event|0|||
106094680|NCT02014116|366002845|FG002|Overall Study|Adverse Event|0|||
106094681|NCT02014116|366002846|FG003|Overall Study|Adverse Event|0|||
106094682|NCT02014116|366002847|FG004|Overall Study|Adverse Event|1|||
106094683|NCT02014116|366002848|FG005|Overall Study|Adverse Event|0|||
106094684|NCT02014116|366002849|FG006|Overall Study|Adverse Event|0|||
106094685|NCT02014116|366002850|FG007|Overall Study|Adverse Event|1|||
106094686|NCT02014116|366002851|FG008|Overall Study|Adverse Event|0|||
106094687|NCT02014116|366002843|FG000|Overall Study|Lost to Follow-up|0|||
106094688|NCT02014116|366002844|FG001|Overall Study|Lost to Follow-up|0|||
106094689|NCT02014116|366002845|FG002|Overall Study|Lost to Follow-up|0|||
106094690|NCT02014116|366002846|FG003|Overall Study|Lost to Follow-up|0|||
106094691|NCT02014116|366002847|FG004|Overall Study|Lost to Follow-up|0|||
106094692|NCT02014116|366002848|FG005|Overall Study|Lost to Follow-up|1|||
106094693|NCT02014116|366002849|FG006|Overall Study|Lost to Follow-up|0|||
106094694|NCT02014116|366002850|FG007|Overall Study|Lost to Follow-up|0|||
106094695|NCT02014116|366002851|FG008|Overall Study|Lost to Follow-up|1|||
106094696|NCT02014116|366002843|FG000|Overall Study|Death|0|||
106094697|NCT02014116|366002844|FG001|Overall Study|Death|0|||
106094698|NCT02014116|366002845|FG002|Overall Study|Death|0|||
106094699|NCT02014116|366002846|FG003|Overall Study|Death|0|||
106094700|NCT02014116|366002847|FG004|Overall Study|Death|0|||
106094701|NCT02014116|366002848|FG005|Overall Study|Death|0|||
106094702|NCT02014116|366002849|FG006|Overall Study|Death|0|||
106094703|NCT02014116|366002850|FG007|Overall Study|Death|1|||
106094704|NCT02014116|366002851|FG008|Overall Study|Death|1|||
106094705|NCT02014116|366002843|FG000|Overall Study|Withdrawal by Subject|0|||
106094706|NCT02014116|366002844|FG001|Overall Study|Withdrawal by Subject|0|||
106094707|NCT02014116|366002845|FG002|Overall Study|Withdrawal by Subject|1|||
106094708|NCT02014116|366002846|FG003|Overall Study|Withdrawal by Subject|1|||
106094709|NCT02014116|366002847|FG004|Overall Study|Withdrawal by Subject|0|||
106094710|NCT02014116|366002848|FG005|Overall Study|Withdrawal by Subject|1|||
106094711|NCT02014116|366002849|FG006|Overall Study|Withdrawal by Subject|0|||
106094712|NCT02014116|366002850|FG007|Overall Study|Withdrawal by Subject|0|||
106094713|NCT02014116|366002851|FG008|Overall Study|Withdrawal by Subject|0|||
106094714|NCT02014116|366002843|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
106094715|NCT02014116|366002844|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
106094716|NCT02014116|366002845|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
106094717|NCT02014116|366002846|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
106094718|NCT02014116|366002847|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
106094719|NCT02014116|366002848|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
106094720|NCT02014116|366002849|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
106094721|NCT02014116|366002850|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
106094722|NCT02014116|366002851|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
106094723|NCT02014116|366002843|FG000|Overall Study|Physician Decision|0|||
106094724|NCT02014116|366002844|FG001|Overall Study|Physician Decision|0|||
106094725|NCT02014116|366002845|FG002|Overall Study|Physician Decision|0|||
106094726|NCT02014116|366002846|FG003|Overall Study|Physician Decision|0|||
106094727|NCT02014116|366002847|FG004|Overall Study|Physician Decision|0|||
106094728|NCT02014116|366002848|FG005|Overall Study|Physician Decision|0|||
106094729|NCT02014116|366002849|FG006|Overall Study|Physician Decision|0|||
106094730|NCT02014116|366002850|FG007|Overall Study|Physician Decision|0|||
106094731|NCT02014116|366002851|FG008|Overall Study|Physician Decision|1|||
106094732|NCT02682264|366002852|FG000|Overall Study|Withdrawal by Subject|56|||
106094733|NCT02682264|366002853|FG001|Overall Study|Withdrawal by Subject|45|||
106094734|NCT02682264|366002852|FG000|Overall Study|Lost to Follow-up|49|||
106094735|NCT02682264|366002853|FG001|Overall Study|Lost to Follow-up|41|||
106094736|NCT02682264|366002852|FG000|Overall Study|Lack of Efficacy|14|||
106094737|NCT02682264|366002853|FG001|Overall Study|Lack of Efficacy|16|||
106094738|NCT02682264|366002852|FG000|Overall Study|Withdrawal by Parent|6|||
106094739|NCT02682264|366002853|FG001|Overall Study|Withdrawal by Parent|7|||
106094740|NCT02682264|366002852|FG000|Overall Study|Adverse Event|9|||
106094741|NCT02682264|366002853|FG001|Overall Study|Adverse Event|0|||
106094742|NCT02682264|366002852|FG000|Overall Study|Noncompliance with study drug|1|||
106094743|NCT02682264|366002853|FG001|Overall Study|Noncompliance with study drug|4|||
106094744|NCT02682264|366002852|FG000|Overall Study|Pregnancy|1|||
106094745|NCT02682264|366002853|FG001|Overall Study|Pregnancy|2|||
106094746|NCT02682264|366002852|FG000|Overall Study|Recovery|1|||
106094747|NCT02682264|366002853|FG001|Overall Study|Recovery|2|||
106094748|NCT02682264|366002852|FG000|Overall Study|Progressive Disease|1|||
106094749|NCT02682264|366002853|FG001|Overall Study|Progressive Disease|0|||
106094750|NCT02682264|366002852|FG000|Overall Study|Technical Problems|0|||
106094751|NCT02682264|366002853|FG001|Overall Study|Technical Problems|1|||
106094752|NCT02682264|366002852|FG000|Overall Study|Moved abroad and unable to continue|0|||
106094753|NCT02682264|366002853|FG001|Overall Study|Moved abroad and unable to continue|3|||
106094754|NCT02682264|366002852|FG000|Overall Study|Stopped test article application|0|||
106094755|NCT02682264|366002853|FG001|Overall Study|Stopped test article application|1|||
106094756|NCT03713593|366002855|FG000|Overall Study|Participants Ongoing|140|||
106094757|NCT03713593|366002856|FG001|Overall Study|Participants Ongoing|114|||
106094758|NCT03713593|366002855|FG000|Overall Study|Withdrawal by Subject|3|||
106094759|NCT03713593|366002856|FG001|Overall Study|Withdrawal by Subject|6|||
106094760|NCT03713593|366002855|FG000|Overall Study|Death|252|||
106094761|NCT03713593|366002856|FG001|Overall Study|Death|279|||
106094762|NCT05348681|366002858|FG000|Overall Study|Study terminated by Sponsor|8|||
106094763|NCT05348681|366002859|FG001|Overall Study|Study terminated by Sponsor|3|||
106094764|NCT05348681|366002858|FG000|Overall Study|Withdrawal by Subject|1|||
106094765|NCT05348681|366002859|FG001|Overall Study|Withdrawal by Subject|1|||
106094766|NCT05348681|366002858|FG000|Overall Study|Lost to Follow-up|1|||
106094767|NCT05348681|366002859|FG001|Overall Study|Lost to Follow-up|1|||
106094768|NCT05348681|366002858|FG000|Overall Study|Adverse Event|1|||
106094769|NCT05348681|366002859|FG001|Overall Study|Adverse Event|0|||
106094770|NCT05348681|366002858|FG000|Overall Study|Other|2|||
106094771|NCT05348681|366002859|FG001|Overall Study|Other|1|||
106094772|NCT03646513|366002863|FG000|Overall Study|Premature study termination|4|||
106094773|NCT04389840|366002864|FG000|Overall Study|Adverse Event|0|||
106094774|NCT04389840|366002865|FG001|Overall Study|Adverse Event|0|||
106094775|NCT04389840|366002866|FG002|Overall Study|Adverse Event|0|||
106094776|NCT04389840|366002867|FG003|Overall Study|Adverse Event|1|||
106094777|NCT04389840|366002868|FG004|Overall Study|Adverse Event|0|||
106094778|NCT04389840|366002869|FG005|Overall Study|Adverse Event|0|||
106094779|NCT04389840|366002864|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
106094780|NCT04389840|366002865|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
106094781|NCT04389840|366002866|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
106094782|NCT04389840|366002867|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
106094783|NCT04389840|366002868|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
106094784|NCT04389840|366002869|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
106094785|NCT04389840|366002864|FG000|Overall Study|Death|0|||
106094786|NCT04389840|366002865|FG001|Overall Study|Death|1|||
106094787|NCT04389840|366002866|FG002|Overall Study|Death|0|||
106094788|NCT04389840|366002867|FG003|Overall Study|Death|0|||
106094789|NCT04389840|366002868|FG004|Overall Study|Death|0|||
106094790|NCT04389840|366002869|FG005|Overall Study|Death|0|||
106094791|NCT00856583|366002871|FG000|Overall Study|Lack of Efficacy|389|||
106094792|NCT00856583|366002872|FG001|Overall Study|Lack of Efficacy|377|||
106094793|NCT00856583|366002871|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
106094794|NCT00856583|366002872|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
106094795|NCT00856583|366002871|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
106094796|NCT00856583|366002872|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
106094797|NCT00856583|366002871|FG000|Overall Study|Non-compliance|305|||
106094798|NCT00856583|366002872|FG001|Overall Study|Non-compliance|262|||
106094799|NCT00856583|366002871|FG000|Overall Study|Withdrawal by Subject|1092|||
106094800|NCT00856583|366002872|FG001|Overall Study|Withdrawal by Subject|919|||
106094801|NCT00856583|366002871|FG000|Overall Study|Physician Decision|59|||
106094802|NCT00856583|366002872|FG001|Overall Study|Physician Decision|82|||
106094803|NCT00856583|366002871|FG000|Overall Study|Pregnancy|14|||
106094804|NCT00856583|366002872|FG001|Overall Study|Pregnancy|5|||
106094805|NCT00856583|366002871|FG000|Overall Study|Other|92|||
106094806|NCT00856583|366002872|FG001|Overall Study|Other|104|||
106094807|NCT00856583|366002871|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
106094808|NCT00856583|366002872|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
106094809|NCT02641080|366002876|FG000|Overall Study|Physician Decision|2|||
106094810|NCT02641080|366002877|FG001|Overall Study|Physician Decision|0|||
106094811|NCT02641080|366002876|FG000|Overall Study|Withdrawal by Subject|0|||
106094812|NCT02641080|366002877|FG001|Overall Study|Withdrawal by Subject|1|||
106094813|NCT02641080|366002876|FG000|Overall Study|Rehab Center denied use of pumps|0|||
106094814|NCT02641080|366002877|FG001|Overall Study|Rehab Center denied use of pumps|3|||
106094815|NCT02641080|366002876|FG000|Overall Study|Lost to Follow-up|0|||
106094816|NCT02641080|366002877|FG001|Overall Study|Lost to Follow-up|3|||
106094817|NCT01404312|366005062|FG000|Overall Study|Death|21|||
106094818|NCT01404312|366005063|FG001|Overall Study|Death|27|||
106094819|NCT01404312|366005062|FG000|Overall Study|Withdrawal by Subject|15|||
106094820|NCT01404312|366005063|FG001|Overall Study|Withdrawal by Subject|18|||
106094821|NCT01404312|366005062|FG000|Overall Study|Participant Unable to get to clinic|93|||
106094822|NCT01404312|366005063|FG001|Overall Study|Participant Unable to get to clinic|103|||
106094823|NCT01404312|366005062|FG000|Overall Study|Lost to Follow-up|115|||
106094824|NCT01404312|366005063|FG001|Overall Study|Lost to Follow-up|111|||
106094825|NCT01404312|366005062|FG000|Overall Study|Site closed|22|||
106094826|NCT01404312|366005063|FG001|Overall Study|Site closed|21|||
106094827|NCT01404312|366005062|FG000|Overall Study|Participant not willing to adhere to req|31|||
106094828|NCT01404312|366005063|FG001|Overall Study|Participant not willing to adhere to req|29|||
106094829|NCT01404312|366005062|FG000|Overall Study|Severe debilitation, unable to continue|1|||
106094830|NCT01404312|366005063|FG001|Overall Study|Severe debilitation, unable to continue|2|||
106094831|NCT02055352|366005064|FG000|Overall Study|Adverse Event|0|||
106094832|NCT02055352|366005065|FG001|Overall Study|Adverse Event|1|||
106094833|NCT02055352|366005064|FG000|Overall Study|Non-eligible|0|||
106094834|NCT02055352|366005065|FG001|Overall Study|Non-eligible|1|||
106094835|NCT02055352|366005064|FG000|Overall Study|Poor compliance|1|||
106094836|NCT02055352|366005065|FG001|Overall Study|Poor compliance|1|||
106094837|NCT02055352|366005064|FG000|Overall Study|Death|1|||
106094838|NCT02055352|366005065|FG001|Overall Study|Death|2|||
106094839|NCT02055352|366005064|FG000|Overall Study|Patient decision|1|||
106094840|NCT02055352|366005065|FG001|Overall Study|Patient decision|1|||
106094841|NCT02055352|366005064|FG000|Overall Study|Use of prohibited treatment|0|||
106094842|NCT02055352|366005065|FG001|Overall Study|Use of prohibited treatment|3|||
106094843|NCT02055352|366005064|FG000|Overall Study|AE, study drug would be detrimental|1|||
106094844|NCT02055352|366005065|FG001|Overall Study|AE, study drug would be detrimental|3|||
106094845|NCT02055352|366005064|FG000|Overall Study|Withdrawal of informed consent|1|||
106094846|NCT02055352|366005065|FG001|Overall Study|Withdrawal of informed consent|0|||
106094847|NCT02055352|366005064|FG000|Overall Study|Reason unknown|1|||
106094848|NCT02055352|366005065|FG001|Overall Study|Reason unknown|5|||
106094849|NCT04419493|366005066|FG000|Wash-out After Period 1|Adverse Event|1|||
106094850|NCT04419493|366005067|FG001|Wash-out After Period 1|Adverse Event|2|||
106094851|NCT04419493|366005068|FG002|Wash-out After Period 1|Adverse Event|1|||
106094852|NCT04419493|366005069|FG003|Wash-out After Period 1|Adverse Event|0|||
106094853|NCT00524134|366005070|FG000|Overall Study|Withdrawal by Subject|1|||
106094854|NCT00524134|366005070|FG000|Overall Study|Physician Decision|1|||
106094855|NCT03985423|366005071|FG000|Overall Study|Adverse Event|1|||
106094856|NCT03985423|366005071|FG000|Overall Study|Death|2|||
106094857|NCT03985423|366005071|FG000|Overall Study|Physician Decision|1|||
106094858|NCT03985423|366005071|FG000|Overall Study|Withdrawal by Subject|2|||
106094859|NCT03985423|366005071|FG000|Overall Study|Lack of insurance and citizenship|1|||
106094860|NCT01045447|366005075|FG000|Overall Study|Adverse Event|0|||
106094861|NCT01045447|366005076|FG001|Overall Study|Adverse Event|1|||
106094862|NCT01045447|366005075|FG000|Overall Study|Lack of Efficacy|3|||
106094863|NCT01045447|366005076|FG001|Overall Study|Lack of Efficacy|1|||
106094864|NCT01045447|366005075|FG000|Overall Study|Protocol Violation|6|||
106094865|NCT01045447|366005076|FG001|Overall Study|Protocol Violation|3|||
106162648|NCT03020199|366257422|FG001|Treatment Period|Subject/guardian decision|15|||
106162649|NCT03020199|366257421|FG000|Treatment Period|Subjects not treated|3|||
106162650|NCT03020199|366257422|FG001|Treatment Period|Subjects not treated|4|||
106162651|NCT03020199|366257421|FG000|Follow-up Period|Disease relapse|32|||
106162652|NCT03020199|366257422|FG001|Follow-up Period|Disease relapse|7|||
106162653|NCT03020199|366257421|FG000|Follow-up Period|Lack of Efficacy|1|||
106162654|NCT03020199|366257422|FG001|Follow-up Period|Lack of Efficacy|2|||
106162655|NCT03020199|366257421|FG000|Follow-up Period|Lost to Follow-up|4|||
106162656|NCT03020199|366257422|FG001|Follow-up Period|Lost to Follow-up|6|||
106162657|NCT03020199|366257421|FG000|Follow-up Period|Physician Decision|2|||
106094866|NCT01045447|366005075|FG000|Overall Study|Withdrawal Criteria|10|||
106094867|NCT01045447|366005076|FG001|Overall Study|Withdrawal Criteria|10|||
106094868|NCT01045447|366005075|FG000|Overall Study|Unclassified|17|||
106094869|NCT01045447|366005076|FG001|Overall Study|Unclassified|13|||
106094870|NCT00129987|366005079|FG000|1st Educational Session|Withdrawal by Subject|141|||
106094871|NCT00129987|366005080|FG001|1st Educational Session|Withdrawal by Subject|109|||
106094872|NCT00129987|366005079|FG000|1 Year|Withdrawal by Subject|32|||
106094873|NCT00129987|366005080|FG001|1 Year|Withdrawal by Subject|21|||
106094874|NCT00970502|366005081|FG000|Overall Study|Withdrawal by Subject|1|||
106094875|NCT03811912|366005082|FG000|Overall Study|Withdrew Consent|4|||
106094876|NCT03811912|366005083|FG001|Overall Study|Withdrew Consent|2|||
106094877|NCT04401579|366005084|FG000|Overall Study|Death|23|||
106094878|NCT04401579|366005085|FG001|Overall Study|Death|36|||
106094879|NCT04401579|366005084|FG000|Overall Study|Lost to Follow-up|40|||
106094880|NCT04401579|366005085|FG001|Overall Study|Lost to Follow-up|41|||
106094881|NCT04401579|366005084|FG000|Overall Study|Withdrawal by Subject|8|||
106094882|NCT04401579|366005085|FG001|Overall Study|Withdrawal by Subject|16|||
106094883|NCT04401579|366005084|FG000|Overall Study|Physician Decision|1|||
106094884|NCT04401579|366005085|FG001|Overall Study|Physician Decision|2|||
106094885|NCT04401579|366005084|FG000|Overall Study|Became ineligible after enrollment|1|||
106094886|NCT04401579|366005085|FG001|Overall Study|Became ineligible after enrollment|1|||
106094887|NCT04401579|366005084|FG000|Overall Study|Enrolled but treatment not administered|7|||
106094888|NCT04401579|366005085|FG001|Overall Study|Enrolled but treatment not administered|9|||
106094889|NCT04401579|366005084|FG000|Overall Study|Adverse Event|2|||
106094890|NCT04401579|366005085|FG001|Overall Study|Adverse Event|1|||
106094891|NCT04401579|366005084|FG000|Overall Study|Scheduling error|1|||
106094892|NCT04401579|366005085|FG001|Overall Study|Scheduling error|2|||
106094893|NCT04401579|366005084|FG000|Overall Study|Transferred to another hospital|1|||
106094894|NCT04401579|366005085|FG001|Overall Study|Transferred to another hospital|2|||
106094895|NCT01438411|366005086|FG000|Overall Study|Adverse Event|8|||
106094896|NCT01438411|366005086|FG000|Overall Study|Lost to Follow-up|1|||
106094897|NCT01438411|366005086|FG000|Overall Study|Lack of Efficacy|1|||
106094898|NCT01438411|366005086|FG000|Overall Study|Withdrawal by Subject|3|||
106094899|NCT01863680|366005087|FG000|Overall Study|Adverse Event|17|||
106094900|NCT01863680|366005087|FG000|Overall Study|Risk of OHSS|17|||
106094901|NCT01863680|366005087|FG000|Overall Study|Spontaneous pregnancy|2|||
106094902|NCT01863680|366005087|FG000|Overall Study|Withdrawal by Subject|1|||
106094903|NCT01863680|366005087|FG000|Overall Study|Did not undergo IVF/ET|14|||
106094904|NCT01863680|366005087|FG000|Overall Study|Other|6|||
106094905|NCT00566228|366005092|FG000|Overall Study|Withdrawal by Subject|1|||
106094906|NCT00566228|366005093|FG001|Overall Study|Withdrawal by Subject|0|||
106094907|NCT00566228|366005092|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
106094908|NCT00566228|366005093|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
106094909|NCT00566228|366005092|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
106094910|NCT00566228|366005093|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
106094911|NCT00566228|366005092|FG000|Overall Study|progressed before infusion could occur|0|||
106094912|NCT00566228|366005093|FG001|Overall Study|progressed before infusion could occur|1|||
106094913|NCT00317772|366005094|FG000|Overall Study|Adverse Event|0|||
106094914|NCT00317772|366005095|FG001|Overall Study|Adverse Event|0|||
106094915|NCT00317772|366005096|FG002|Overall Study|Adverse Event|0|||
106094916|NCT00317772|366005097|FG003|Overall Study|Adverse Event|2|||
106094917|NCT00317772|366005094|FG000|Overall Study|Disease Progression|2|||
106094918|NCT00317772|366005095|FG001|Overall Study|Disease Progression|2|||
106094919|NCT00317772|366005096|FG002|Overall Study|Disease Progression|1|||
106094920|NCT00317772|366005097|FG003|Overall Study|Disease Progression|7|||
106094921|NCT02731131|366005100|FG000|Overall Study|Psychiatric Disorder|0|||
106094922|NCT02731131|366005101|FG001|Overall Study|Psychiatric Disorder|1|||
106094923|NCT02731131|366005100|FG000|Overall Study|Refused Therapy|0|||
106094924|NCT02731131|366005101|FG001|Overall Study|Refused Therapy|1|||
106162658|NCT03020199|366257422|FG001|Follow-up Period|Physician Decision|2|||
106094925|NCT04408469|366005104|FG000|Overall Study|Lost to Follow-up|6|||
106094926|NCT04408469|366005105|FG001|Overall Study|Lost to Follow-up|9|||
106094927|NCT04408469|366005104|FG000|Overall Study|Withdrawal by Subject|6|||
106094928|NCT04408469|366005105|FG001|Overall Study|Withdrawal by Subject|1|||
106094929|NCT04408469|366005104|FG000|Overall Study|Dismissal due to ineligibility|0|||
106094930|NCT04408469|366005105|FG001|Overall Study|Dismissal due to ineligibility|1|||
106094931|NCT02519504|366005106|FG000|Overall Study|Protocol Violation|6|||
106094932|NCT02519504|366005107|FG001|Overall Study|Protocol Violation|5|||
106094933|NCT02519504|366005106|FG000|Overall Study|Ineligible for direct testing|12|||
106094934|NCT02519504|366005107|FG001|Overall Study|Ineligible for direct testing|12|||
106162659|NCT03020199|366257421|FG000|Follow-up Period|Protocol Violation|1|||
106162660|NCT03020199|366257422|FG001|Follow-up Period|Protocol Violation|2|||
106162661|NCT03020199|366257421|FG000|Follow-up Period|Study terminated by Sponsor|6|||
106162662|NCT03020199|366257422|FG001|Follow-up Period|Study terminated by Sponsor|3|||
106162663|NCT03020199|366257421|FG000|Follow-up Period|Subject/guardian decision|14|||
106162664|NCT03020199|366257422|FG001|Follow-up Period|Subject/guardian decision|9|||
106162665|NCT04042233|366257423|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
106162666|NCT04042233|366257424|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
106162667|NCT04042233|366257423|FG000|Overall Study|Protocol Violation|0|||
106162668|NCT04042233|366257424|FG001|Overall Study|Protocol Violation|2|||
106162669|NCT04907851|366257425|FG000|Overall Study|Consent withdrawn|1|||
106162670|NCT04907851|366257426|FG001|Overall Study|Consent withdrawn|2|||
106162671|NCT04907851|366257427|FG002|Overall Study|Consent withdrawn|0|||
106162672|NCT04907851|366257425|FG000|Overall Study|Death|5|||
106162673|NCT04907851|366257426|FG001|Overall Study|Death|15|||
106162674|NCT04907851|366257427|FG002|Overall Study|Death|10|||
106162675|NCT00753545|366260133|FG000|Overall Study|Death|98|||
106162676|NCT00753545|366260134|FG001|Overall Study|Death|112|||
106162677|NCT00753545|366260133|FG000|Overall Study|Lost to Follow-up|2|||
106162678|NCT00753545|366260134|FG001|Overall Study|Lost to Follow-up|3|||
106162679|NCT00753545|366260133|FG000|Overall Study|Protocol Violation|1|||
106162680|NCT00753545|366260134|FG001|Overall Study|Protocol Violation|0|||
106162681|NCT00753545|366260133|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
106162682|NCT00753545|366260134|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
106162683|NCT06190691|366260135|FG000|Overall Study|Adverse Event|2|||
106162684|NCT06190691|366260136|FG001|Overall Study|Adverse Event|0|||
106162685|NCT06190691|366260137|FG002|Overall Study|Adverse Event|0|||
106162686|NCT06190691|366260138|FG003|Overall Study|Adverse Event|0|||
106162687|NCT05746455|366260139|FG000|Overall Study|Discharged from Clinical Service|1|||
106162688|NCT05746455|366260139|FG000|Overall Study|Lost to Follow-up|1|||
106162689|NCT03016754|366260140|FG000|Overall Study|Death|5|||
106162690|NCT03016754|366260141|FG001|Overall Study|Death|4|||
106162691|NCT03016754|366260142|FG002|Overall Study|Death|5|||
106162692|NCT03016754|366260143|FG003|Overall Study|Death|1|||
106094935|NCT02519504|366005106|FG000|Overall Study|Did not participate in direct testing|95|||
106094936|NCT02519504|366005107|FG001|Overall Study|Did not participate in direct testing|86|||
106094937|NCT02546544|366005108|FG000|Overall Study|Disease Progression|14|||
106094938|NCT02546544|366005108|FG000|Overall Study|Adverse Event|1|||
106094939|NCT02546544|366005108|FG000|Overall Study|Withdrawal by Subject|1|||
106094940|NCT03465540|366005118|FG000|Overall Study|Withdrawal by Subject|0|||
106094941|NCT03465540|366005119|FG001|Overall Study|Withdrawal by Subject|0|||
106094942|NCT03465540|366005120|FG002|Overall Study|Withdrawal by Subject|1|||
106094943|NCT03465540|366005121|FG003|Overall Study|Withdrawal by Subject|1|||
106094944|NCT03465540|366005122|FG004|Overall Study|Withdrawal by Subject|1|||
106094945|NCT03465540|366005123|FG005|Overall Study|Withdrawal by Subject|0|||
106094946|NCT03465540|366005118|FG000|Overall Study|Lost to Follow-up|0|||
106094947|NCT03465540|366005119|FG001|Overall Study|Lost to Follow-up|1|||
106094948|NCT03465540|366005120|FG002|Overall Study|Lost to Follow-up|0|||
106094949|NCT03465540|366005121|FG003|Overall Study|Lost to Follow-up|0|||
106094950|NCT03465540|366005122|FG004|Overall Study|Lost to Follow-up|1|||
106094951|NCT03465540|366005123|FG005|Overall Study|Lost to Follow-up|0|||
106094952|NCT03465540|366005118|FG000|Overall Study|Death|1|||
106094953|NCT03465540|366005119|FG001|Overall Study|Death|1|||
106094954|NCT03465540|366005120|FG002|Overall Study|Death|0|||
106094955|NCT03465540|366005121|FG003|Overall Study|Death|2|||
106094956|NCT03465540|366005122|FG004|Overall Study|Death|0|||
106162693|NCT03016754|366260140|FG000|Overall Study|Lost to Follow-up|23|||
106162694|NCT03016754|366260141|FG001|Overall Study|Lost to Follow-up|17|||
106094957|NCT03465540|366005123|FG005|Overall Study|Death|2|||
106094958|NCT03465540|366005118|FG000|Overall Study|Protocol specified criteria|0|||
106094959|NCT03465540|366005119|FG001|Overall Study|Protocol specified criteria|2|||
105867288|NCT03888066|365164936|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
106094960|NCT03465540|366005120|FG002|Overall Study|Protocol specified criteria|2|||
106094961|NCT03465540|366005121|FG003|Overall Study|Protocol specified criteria|0|||
106094962|NCT03465540|366005122|FG004|Overall Study|Protocol specified criteria|2|||
106094963|NCT03465540|366005123|FG005|Overall Study|Protocol specified criteria|0|||
106094964|NCT01854827|366005124|FG000|Overall Study|Death|1|||
106162695|NCT03016754|366260142|FG002|Overall Study|Lost to Follow-up|4|||
106162696|NCT03016754|366260143|FG003|Overall Study|Lost to Follow-up|2|||
106162697|NCT03016754|366260140|FG000|Overall Study|Withdrawal by Subject|6|||
105984894|NCT00231413|365605976|FG001|Overall Study|Non-serious AE|0|||
106162698|NCT03016754|366260141|FG001|Overall Study|Withdrawal by Subject|6|||
106162699|NCT03016754|366260142|FG002|Overall Study|Withdrawal by Subject|2|||
106162700|NCT03016754|366260143|FG003|Overall Study|Withdrawal by Subject|2|||
106162701|NCT03016754|366260140|FG000|Overall Study|Other/Unknown|2|||
106162702|NCT03016754|366260141|FG001|Overall Study|Other/Unknown|4|||
106162703|NCT03016754|366260142|FG002|Overall Study|Other/Unknown|2|||
106162704|NCT03016754|366260143|FG003|Overall Study|Other/Unknown|1|||
106162705|NCT03016754|366260140|FG000|Overall Study|Protocol Violation|0|||
106162706|NCT03016754|366260141|FG001|Overall Study|Protocol Violation|0|||
106162707|NCT03016754|366260142|FG002|Overall Study|Protocol Violation|0|||
106162708|NCT03016754|366260143|FG003|Overall Study|Protocol Violation|4|||
106162709|NCT03839940|366260144|FG000|Overall Study|Withdrawal by Subject|3|||
106162710|NCT03839940|366260145|FG001|Overall Study|Withdrawal by Subject|0|||
106162711|NCT03839940|366260144|FG000|Overall Study|Protocol Violation|0|||
106162712|NCT03839940|366260145|FG001|Overall Study|Protocol Violation|1|||
106162713|NCT03839940|366260144|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
106162714|NCT03839940|366260145|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
106162715|NCT04592549|366260153|FG000|Overall Study|Withdrawal by Subject|0|||
106162716|NCT04592549|366260154|FG001|Overall Study|Withdrawal by Subject|1|||
106162717|NCT04592549|366260155|FG002|Overall Study|Withdrawal by Subject|0|||
106162718|NCT04592549|366260156|FG003|Overall Study|Withdrawal by Subject|1|||
106162719|NCT04592549|366260157|FG004|Overall Study|Withdrawal by Subject|1|||
106162720|NCT04592549|366260158|FG005|Overall Study|Withdrawal by Subject|0|||
106162721|NCT04592549|366260153|FG000|Overall Study|Lost to Follow-up|2|||
106162722|NCT04592549|366260154|FG001|Overall Study|Lost to Follow-up|0|||
106162723|NCT04592549|366260155|FG002|Overall Study|Lost to Follow-up|0|||
106094965|NCT00736996|366005125|FG000|Overall Study|Lost to Follow-up|1|||
106094966|NCT00736996|366005126|FG001|Overall Study|Lost to Follow-up|9|||
106094967|NCT00736996|366005127|FG002|Overall Study|Lost to Follow-up|2|||
106094968|NCT03264989|366005128|FG000|Overall Study|Lost to Follow-up|1|||
106094969|NCT03264989|366005129|FG001|Overall Study|Lost to Follow-up|0|||
106094970|NCT03264989|366005128|FG000|Overall Study|New Therapy for study Indication|1|||
106094971|NCT03264989|366005129|FG001|Overall Study|New Therapy for study Indication|0|||
106094972|NCT03264989|366005128|FG000|Overall Study|Protocol Violation|0|||
106094973|NCT03264989|366005129|FG001|Overall Study|Protocol Violation|1|||
106094974|NCT03264989|366005128|FG000|Overall Study|Patient decision|13|||
106094975|NCT03264989|366005129|FG001|Overall Study|Patient decision|0|||
106094976|NCT03264989|366005128|FG000|Overall Study|Physician Decision|6|||
106094977|NCT03264989|366005129|FG001|Overall Study|Physician Decision|4|||
106094978|NCT03264989|366005128|FG000|Overall Study|Adverse Event|2|||
106094979|NCT03264989|366005129|FG001|Overall Study|Adverse Event|1|||
106094980|NCT03264989|366005128|FG000|Overall Study|Death|1|||
106094981|NCT03264989|366005129|FG001|Overall Study|Death|1|||
106094982|NCT03264989|366005128|FG000|Overall Study|Pregnancy|2|||
106094983|NCT03264989|366005129|FG001|Overall Study|Pregnancy|0|||
106094984|NCT03264989|366005128|FG000|Overall Study|End of Study|19|||
106094985|NCT03264989|366005129|FG001|Overall Study|End of Study|5|||
106094986|NCT01040130|366005130|FG000|Overall Study|Adverse Event|1|||
106094987|NCT01040130|366005131|FG001|Overall Study|Adverse Event|1|||
106094988|NCT01040130|366005132|FG002|Overall Study|Adverse Event|0|||
106094989|NCT01040130|366005133|FG003|Overall Study|Adverse Event|5|||
106094990|NCT01040130|366005134|FG004|Overall Study|Adverse Event|0|||
106094991|NCT01040130|366005135|FG005|Overall Study|Adverse Event|3|||
106094992|NCT01040130|366005130|FG000|Overall Study|Protocol Violation|0|||
106094993|NCT01040130|366005131|FG001|Overall Study|Protocol Violation|0|||
106094994|NCT01040130|366005132|FG002|Overall Study|Protocol Violation|2|||
106094995|NCT01040130|366005133|FG003|Overall Study|Protocol Violation|0|||
106094996|NCT01040130|366005134|FG004|Overall Study|Protocol Violation|0|||
106094997|NCT01040130|366005135|FG005|Overall Study|Protocol Violation|0|||
106094998|NCT01040130|366005130|FG000|Overall Study|Withdrawal by Subject|0|||
106094999|NCT01040130|366005131|FG001|Overall Study|Withdrawal by Subject|2|||
106095000|NCT01040130|366005132|FG002|Overall Study|Withdrawal by Subject|0|||
106095001|NCT01040130|366005133|FG003|Overall Study|Withdrawal by Subject|0|||
106095002|NCT01040130|366005134|FG004|Overall Study|Withdrawal by Subject|0|||
106095003|NCT01040130|366005135|FG005|Overall Study|Withdrawal by Subject|1|||
106095004|NCT01040130|366005130|FG000|Overall Study|Other reasons not listed above|2|||
106095005|NCT01040130|366005131|FG001|Overall Study|Other reasons not listed above|0|||
106095006|NCT01040130|366005132|FG002|Overall Study|Other reasons not listed above|0|||
106162724|NCT04592549|366260156|FG003|Overall Study|Lost to Follow-up|1|||
106162725|NCT04592549|366260157|FG004|Overall Study|Lost to Follow-up|1|||
106095007|NCT01040130|366005133|FG003|Overall Study|Other reasons not listed above|0|||
106095008|NCT01040130|366005134|FG004|Overall Study|Other reasons not listed above|0|||
106095009|NCT01040130|366005135|FG005|Overall Study|Other reasons not listed above|0|||
106095010|NCT03029208|366005136|FG000|Overall Study|Withdrawal by Subject|2|||
106095011|NCT03029208|366005137|FG001|Overall Study|Withdrawal by Subject|3|||
106095012|NCT03029208|366005136|FG000|Overall Study|Lost to Follow-up|0|||
106095013|NCT03029208|366005137|FG001|Overall Study|Lost to Follow-up|1|||
106162726|NCT04592549|366260158|FG005|Overall Study|Lost to Follow-up|1|||
106162727|NCT04295798|366260159|FG000|Overall Study|Lost to Follow-up|1|||
106162728|NCT02362503|366260161|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
106095014|NCT02334748|366005138|FG000|Overall Study|Adverse Event|1|||
106095015|NCT02334748|366005138|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
106095016|NCT02334748|366005138|FG000|Overall Study|Patient no longer required study drug|2|||
106095017|NCT02334748|366005138|FG000|Overall Study|Lack of Efficacy|4|||
106095018|NCT01046643|366005139|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
106095019|NCT01046643|366005140|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
106095020|NCT01046643|366005141|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
106095021|NCT01046643|366005142|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
106095022|NCT00553267|366005152|FG000|Overall Study|Adverse Event|8|||
106095023|NCT00553267|366005153|FG001|Overall Study|Adverse Event|10|||
106095024|NCT00553267|366005154|FG002|Overall Study|Adverse Event|5|||
106095025|NCT00553267|366005152|FG000|Overall Study|Non compliant with protocol|3|||
106095026|NCT00553267|366005153|FG001|Overall Study|Non compliant with protocol|3|||
106095027|NCT00553267|366005154|FG002|Overall Study|Non compliant with protocol|2|||
106095028|NCT00553267|366005152|FG000|Overall Study|Lost to Follow-up|0|||
106095029|NCT00553267|366005153|FG001|Overall Study|Lost to Follow-up|0|||
106095030|NCT00553267|366005154|FG002|Overall Study|Lost to Follow-up|1|||
106095031|NCT00553267|366005152|FG000|Overall Study|Consent withdrawn|2|||
106095032|NCT00553267|366005153|FG001|Overall Study|Consent withdrawn|3|||
106095033|NCT00553267|366005154|FG002|Overall Study|Consent withdrawn|1|||
106095034|NCT00553267|366005152|FG000|Overall Study|Specified category|1|||
106095035|NCT00553267|366005153|FG001|Overall Study|Specified category|2|||
106095036|NCT00553267|366005154|FG002|Overall Study|Specified category|1|||
106095037|NCT01944046|366005162|FG000|Randomized to DB|Adverse Event|5|||
106095038|NCT01944046|366005163|FG001|Randomized to DB|Adverse Event|2|||
106095039|NCT01944046|366005162|FG000|Randomized to DB|Clinical Worsening|3|||
106095040|NCT01944046|366005163|FG001|Randomized to DB|Clinical Worsening|2|||
106095041|NCT01944046|366005162|FG000|Randomized to DB|Lost to Follow-up|3|||
106095042|NCT01944046|366005163|FG001|Randomized to DB|Lost to Follow-up|3|||
106095043|NCT01944046|366005162|FG000|Randomized to DB|Withdrawal by Subject|2|||
106095044|NCT01944046|366005163|FG001|Randomized to DB|Withdrawal by Subject|4|||
106095045|NCT01944046|366005162|FG000|Randomized to DB|Physician Decision|1|||
106095046|NCT01944046|366005163|FG001|Randomized to DB|Physician Decision|2|||
106095047|NCT01944046|366005162|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
106095048|NCT01944046|366005163|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
106095049|NCT01944046|366005162|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
106095050|NCT01944046|366005163|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
106095051|NCT01944046|366005162|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
106095052|NCT01944046|366005163|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
106095053|NCT01944046|366005162|FG000|Open Label Eligible and Consented|Adverse Event|6|||
106095054|NCT01944046|366005163|FG001|Open Label Eligible and Consented|Adverse Event|1|||
106095055|NCT01944046|366005162|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
106095056|NCT01944046|366005163|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
106095057|NCT01944046|366005162|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
106095058|NCT01944046|366005163|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
106095059|NCT02252211|366005164|FG000|Overall Study|Adverse Event|0|||
106095060|NCT02252211|366005165|FG001|Overall Study|Adverse Event|1|||
106095061|NCT02252211|366005166|FG002|Overall Study|Adverse Event|0|||
106095062|NCT02252211|366005164|FG000|Overall Study|Progressive disease|3|||
106095063|NCT02252211|366005165|FG001|Overall Study|Progressive disease|2|||
106095064|NCT02252211|366005166|FG002|Overall Study|Progressive disease|0|||
106095065|NCT02252211|366005164|FG000|Overall Study|Withdrawal by Subject|1|||
106162729|NCT02362503|366260162|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
106162730|NCT02362503|366260163|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
106095066|NCT02252211|366005165|FG001|Overall Study|Withdrawal by Subject|0|||
106095067|NCT02252211|366005166|FG002|Overall Study|Withdrawal by Subject|0|||
106095068|NCT02252211|366005164|FG000|Overall Study|Serious Adverse Event During Screening|1|||
106095069|NCT02252211|366005165|FG001|Overall Study|Serious Adverse Event During Screening|0|||
106095070|NCT02252211|366005166|FG002|Overall Study|Serious Adverse Event During Screening|1|||
106095071|NCT00968669|366005167|FG000|Overall Study|Lost to Follow-up|5|||
106095072|NCT00968669|366005168|FG001|Overall Study|Lost to Follow-up|2|||
106095073|NCT00968669|366005169|FG002|Overall Study|Lost to Follow-up|1|||
106095074|NCT00968669|366005170|FG003|Overall Study|Lost to Follow-up|4|||
106095075|NCT00968669|366005167|FG000|Overall Study|Withdrawal by Subject|9|||
106095076|NCT00968669|366005168|FG001|Overall Study|Withdrawal by Subject|7|||
106095077|NCT00968669|366005169|FG002|Overall Study|Withdrawal by Subject|5|||
106095078|NCT00968669|366005170|FG003|Overall Study|Withdrawal by Subject|3|||
106095079|NCT00968669|366005167|FG000|Overall Study|Pregnancy|0|||
106095080|NCT00968669|366005168|FG001|Overall Study|Pregnancy|0|||
106162731|NCT02362503|366260161|FG000|Double-blind Period-Up to 8 Days|Death|1|||
106095081|NCT00968669|366005169|FG002|Overall Study|Pregnancy|2|||
106095082|NCT00968669|366005170|FG003|Overall Study|Pregnancy|0|||
106095083|NCT00968669|366005167|FG000|Overall Study|AE|1|||
106095084|NCT00968669|366005168|FG001|Overall Study|AE|0|||
106095085|NCT00968669|366005169|FG002|Overall Study|AE|0|||
106095086|NCT00968669|366005170|FG003|Overall Study|AE|0|||
106095087|NCT00968669|366005167|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
106095088|NCT00968669|366005168|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
106095089|NCT00968669|366005169|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
106095090|NCT00968669|366005170|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
106095091|NCT00968669|366005167|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
106095092|NCT00968669|366005168|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
106095093|NCT00968669|366005169|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
106095094|NCT00968669|366005170|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
106095095|NCT00968669|366005167|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
106095096|NCT00968669|366005168|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
106095097|NCT00968669|366005169|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
106095098|NCT00968669|366005170|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
106095099|NCT00968669|366005167|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
106095100|NCT00968669|366005168|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
106095101|NCT00968669|366005169|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
106095102|NCT00968669|366005170|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
106095103|NCT00968669|366005167|FG000|Overall Study|EARLY WITHDRAWAL|0|||
106095104|NCT00968669|366005168|FG001|Overall Study|EARLY WITHDRAWAL|1|||
106095105|NCT00968669|366005169|FG002|Overall Study|EARLY WITHDRAWAL|0|||
106095106|NCT00968669|366005170|FG003|Overall Study|EARLY WITHDRAWAL|0|||
106095107|NCT00968669|366005167|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
106095108|NCT00968669|366005168|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
106095109|NCT00968669|366005169|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
106095110|NCT00968669|366005170|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
106095111|NCT00968669|366005167|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
106095112|NCT00968669|366005168|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
106095113|NCT00968669|366005169|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
106095114|NCT00968669|366005170|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
106095115|NCT00968669|366005167|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
106095116|NCT00968669|366005168|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
106095117|NCT00968669|366005169|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
106095118|NCT00968669|366005170|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
106095119|NCT00968669|366005167|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
106095120|NCT00968669|366005168|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
106095121|NCT00968669|366005169|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
106095122|NCT00968669|366005170|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
106095123|NCT00968669|366005167|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
106095124|NCT00968669|366005168|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
106095125|NCT00968669|366005169|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
106095126|NCT00968669|366005170|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
106095127|NCT00968669|366005167|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
106095128|NCT00968669|366005168|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
106095129|NCT00968669|366005169|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
106095130|NCT00968669|366005170|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
106095131|NCT00968669|366005167|FG000|Overall Study|SPONSOR DECISION|0|||
106095132|NCT00968669|366005168|FG001|Overall Study|SPONSOR DECISION|1|||
106095133|NCT00968669|366005169|FG002|Overall Study|SPONSOR DECISION|0|||
106095134|NCT00968669|366005170|FG003|Overall Study|SPONSOR DECISION|0|||
106095135|NCT00968669|366005167|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
106095136|NCT00968669|366005168|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
106095137|NCT00968669|366005169|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
106095138|NCT00968669|366005170|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
106095139|NCT00968669|366005167|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
106095140|NCT00968669|366005168|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
106095141|NCT00968669|366005169|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
106095142|NCT00968669|366005170|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
106095143|NCT00968669|366005167|FG000|Overall Study|SUBJECT INCARCERATED|0|||
106095144|NCT00968669|366005168|FG001|Overall Study|SUBJECT INCARCERATED|1|||
106095145|NCT00968669|366005169|FG002|Overall Study|SUBJECT INCARCERATED|0|||
106095146|NCT00968669|366005170|FG003|Overall Study|SUBJECT INCARCERATED|0|||
106095147|NCT00968669|366005167|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
106095148|NCT00968669|366005168|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
106095149|NCT00968669|366005169|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
106095150|NCT00968669|366005170|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
106095151|NCT00968669|366005167|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
106095152|NCT00968669|366005168|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
106095153|NCT00968669|366005169|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
106095154|NCT00968669|366005170|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
106095155|NCT03105362|366005171|FG000|Overall Study|Withdrawal by Subject|1|||
106095156|NCT03105362|366005171|FG000|Overall Study|Lost to Follow-up|1|||
106095157|NCT00144339|366005172|FG000|Overall Study|Adverse Event|746|||
106095158|NCT00144339|366005173|FG001|Overall Study|Adverse Event|627|||
106095159|NCT00144339|366005172|FG000|Overall Study|Protocol Violation|75|||
106095160|NCT00144339|366005173|FG001|Overall Study|Protocol Violation|48|||
106095161|NCT00144339|366005172|FG000|Overall Study|Withdrawal by Subject|403|||
106095162|NCT00144339|366005173|FG001|Overall Study|Withdrawal by Subject|300|||
106095163|NCT00144339|366005172|FG000|Overall Study|Lost to Follow-up|76|||
106095164|NCT00144339|366005173|FG001|Overall Study|Lost to Follow-up|64|||
106095165|NCT00144339|366005172|FG000|Overall Study|Other|58|||
106095166|NCT00144339|366005173|FG001|Overall Study|Other|60|||
106095167|NCT00305058|366005174|FG000|Overall Study|Participant too young|1|||
106095168|NCT00305058|366005175|FG001|Overall Study|Participant too young|0|||
106095169|NCT00305058|366005174|FG000|Overall Study|Missing data collection instrument|3|||
106095170|NCT00305058|366005175|FG001|Overall Study|Missing data collection instrument|2|||
106095171|NCT00305058|366005174|FG000|Overall Study|Missing outcome data|3|||
106095172|NCT00305058|366005175|FG001|Overall Study|Missing outcome data|2|||
106095173|NCT01109992|366005176|FG000|Overall Study|Withdrawal by Subject|0|||
106095174|NCT01109992|366005177|FG001|Overall Study|Withdrawal by Subject|1|||
106095175|NCT01109992|366005176|FG000|Overall Study|Movement during rest scan.|0|||
106095176|NCT01109992|366005177|FG001|Overall Study|Movement during rest scan.|1|||
106095177|NCT02338362|366005178|FG000|Overall Study|Withdrawal by Subject|1|||
106095178|NCT02338362|366005179|FG001|Overall Study|Withdrawal by Subject|1|||
106095179|NCT00690755|366005184|FG000|Overall Study|Physician Decision|2|||
106095180|NCT00690755|366005185|FG001|Overall Study|Physician Decision|0|||
106095181|NCT00690755|366005186|FG002|Overall Study|Physician Decision|46|||
106095182|NCT00690755|366005187|FG003|Overall Study|Physician Decision|5|||
106095183|NCT00690755|366005188|FG004|Overall Study|Physician Decision|0|||
106095184|NCT00690755|366005189|FG005|Overall Study|Physician Decision|4|||
106095185|NCT00690755|366005190|FG006|Overall Study|Physician Decision|0|||
106095186|NCT00784043|366005191|FG000|Overall Study|Withdrawal by Subject|8|||
106095187|NCT00784043|366005192|FG001|Overall Study|Withdrawal by Subject|5|||
106095188|NCT00784043|366005191|FG000|Overall Study|Protocol Terminated|23|||
106095189|NCT00784043|366005192|FG001|Overall Study|Protocol Terminated|1|||
106095190|NCT01272934|366005193|FG000|Overall Study|Adverse Event|0|||
106095191|NCT01272934|366005194|FG001|Overall Study|Adverse Event|1|||
106095192|NCT01272934|366005193|FG000|Overall Study|Abnormal Laboratory Value|0|||
106095193|NCT01272934|366005194|FG001|Overall Study|Abnormal Laboratory Value|1|||
106095194|NCT04287920|366005195|FG000|Overall Study|Lost to Follow-up|1|||
106095195|NCT04287920|366005196|FG001|Overall Study|Lost to Follow-up|1|||
106095196|NCT04287920|366005195|FG000|Overall Study|Withdrawal by Subject|0|||
106095197|NCT04287920|366005196|FG001|Overall Study|Withdrawal by Subject|3|||
106095198|NCT04313634|366005197|FG000|Overall Study|Adverse Event|2|||
106095199|NCT04313634|366005198|FG001|Overall Study|Adverse Event|2|||
106095200|NCT04313634|366005199|FG002|Overall Study|Adverse Event|0|||
106095201|NCT04313634|366005197|FG000|Overall Study|Withdrawal by Subject|1|||
106095202|NCT04313634|366005198|FG001|Overall Study|Withdrawal by Subject|0|||
106095203|NCT04313634|366005199|FG002|Overall Study|Withdrawal by Subject|1|||
106095204|NCT04313634|366005197|FG000|Overall Study|Protocol Violation|0|||
106095205|NCT04313634|366005198|FG001|Overall Study|Protocol Violation|0|||
106095206|NCT04313634|366005199|FG002|Overall Study|Protocol Violation|1|||
106095207|NCT00099983|366005204|FG000|Overall Study|Lost to Follow-up|2|||
106095208|NCT00099983|366005205|FG001|Overall Study|Lost to Follow-up|3|||
106095209|NCT00099983|366005204|FG000|Overall Study|Missing Source Documents|14|||
106095210|NCT00099983|366005205|FG001|Overall Study|Missing Source Documents|15|||
106095211|NCT00099983|366005204|FG000|Overall Study|Withdrawal by Subject|3|||
106095212|NCT00099983|366005205|FG001|Overall Study|Withdrawal by Subject|2|||
106095213|NCT00099983|366005204|FG000|Overall Study|Adverse Event|1|||
106095214|NCT00099983|366005205|FG001|Overall Study|Adverse Event|1|||
106095215|NCT00099983|366005204|FG000|Overall Study|Lack of Efficacy|0|||
106095216|NCT00099983|366005205|FG001|Overall Study|Lack of Efficacy|1|||
106095217|NCT00099983|366005204|FG000|Overall Study|Unable to return for appointments|1|||
106095218|NCT00099983|366005205|FG001|Overall Study|Unable to return for appointments|1|||
106095219|NCT00099983|366005204|FG000|Overall Study|Moved|1|||
106095220|NCT00099983|366005205|FG001|Overall Study|Moved|0|||
106095221|NCT00099983|366005204|FG000|Overall Study|Other psychiatric problem|1|||
106095222|NCT00099983|366005205|FG001|Overall Study|Other psychiatric problem|0|||
106095223|NCT00099983|366005204|FG000|Overall Study|Incarcerated|0|||
106095224|NCT00099983|366005205|FG001|Overall Study|Incarcerated|1|||
106095225|NCT00099983|366005204|FG000|Overall Study|Intolerant of burden of visits|0|||
106095226|NCT00099983|366005205|FG001|Overall Study|Intolerant of burden of visits|1|||
106095227|NCT00099983|366005204|FG000|Overall Study|Other issue|1|||
106095228|NCT00099983|366005205|FG001|Overall Study|Other issue|0|||
106095229|NCT03585244|366005210|FG000|Overall Study|Withdrawal by Subject|15|||
106095230|NCT04307186|366005211|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
106095231|NCT04307186|366005211|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
106095232|NCT04307186|366005211|FG000|Washout 3-14 Days|Progressive disease|1|||
106095233|NCT04307186|366005211|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
106095234|NCT04307186|366005211|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
106095235|NCT03538626|366005213|FG000|Overall Study|Withdrawal by Subject|0|||
106095236|NCT03538626|366005214|FG001|Overall Study|Withdrawal by Subject|1|||
106095237|NCT03538626|366005215|FG002|Overall Study|Withdrawal by Subject|0|||
106095238|NCT03538626|366005216|FG003|Overall Study|Withdrawal by Subject|0|||
106095239|NCT03538626|366005217|FG004|Overall Study|Withdrawal by Subject|0|||
106095240|NCT03538626|366005218|FG005|Overall Study|Withdrawal by Subject|0|||
106095241|NCT03538626|366005219|FG006|Overall Study|Withdrawal by Subject|0|||
106095242|NCT03538626|366005220|FG007|Overall Study|Withdrawal by Subject|0|||
106095243|NCT03538626|366005213|FG000|Overall Study|Lost to Follow-up|0|||
106095244|NCT03538626|366005214|FG001|Overall Study|Lost to Follow-up|0|||
106095245|NCT03538626|366005215|FG002|Overall Study|Lost to Follow-up|0|||
106095246|NCT03538626|366005216|FG003|Overall Study|Lost to Follow-up|0|||
106095247|NCT03538626|366005217|FG004|Overall Study|Lost to Follow-up|0|||
106095248|NCT03538626|366005218|FG005|Overall Study|Lost to Follow-up|0|||
106095249|NCT03538626|366005219|FG006|Overall Study|Lost to Follow-up|1|||
106095250|NCT03538626|366005220|FG007|Overall Study|Lost to Follow-up|0|||
106095251|NCT00288587|366005221|FG000|Overall Study|Death|4|||
106095252|NCT00288587|366005222|FG001|Overall Study|Death|4|||
106095253|NCT00288587|366005221|FG000|Overall Study|Transplant|0|||
106095254|NCT00288587|366005222|FG001|Overall Study|Transplant|3|||
106095255|NCT00288587|366005221|FG000|Overall Study|Adverse Event|0|||
106095256|NCT00288587|366005222|FG001|Overall Study|Adverse Event|1|||
106095257|NCT00288587|366005221|FG000|Overall Study|Physician Decision|0|||
106095258|NCT00288587|366005222|FG001|Overall Study|Physician Decision|2|||
106095259|NCT00288587|366005221|FG000|Overall Study|Severe Aortic Stenosis|1|||
106095260|NCT00288587|366005222|FG001|Overall Study|Severe Aortic Stenosis|0|||
106095261|NCT01434602|366005228|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
106095262|NCT01434602|366005229|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
106095263|NCT01434602|366005230|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
106095264|NCT01434602|366005231|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
106095265|NCT01434602|366005232|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
106095266|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
106095267|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
106095268|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
106095269|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
106095270|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
106095271|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
106095272|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
106095273|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
106095274|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
106095275|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
106095276|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
106095277|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
106095278|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
106095279|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
106095280|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
106095281|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
106095282|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
106095283|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
106095284|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
106095285|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
106095286|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
106162732|NCT02362503|366260162|FG001|Double-blind Period-Up to 8 Days|Death|0|||
106162733|NCT02362503|366260163|FG002|Double-blind Period-Up to 8 Days|Death|0|||
106095287|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
106095288|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
106095289|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
106095290|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
106095291|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
106095292|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
106095293|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
106162734|NCT02362503|366260161|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
106162735|NCT02362503|366260162|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
106162736|NCT02362503|366260163|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
106095294|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
106095295|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
106095296|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
106095297|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
106095298|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
106095299|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
106095300|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
106095301|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
106095302|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
106095303|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
106095304|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
106095305|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
106095306|NCT01434602|366005228|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
106095307|NCT01434602|366005229|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
106095308|NCT01434602|366005230|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
106095309|NCT01434602|366005231|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
106095310|NCT01434602|366005232|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
106095311|NCT05077267|366005233|FG000|Treatment Period|Lost to Follow-up|0|||
106095312|NCT05077267|366005234|FG001|Treatment Period|Lost to Follow-up|1|||
106095313|NCT05077267|366005235|FG002|Treatment Period|Lost to Follow-up|0|||
106095314|NCT05077267|366005233|FG000|Treatment Period|Withdrawal by Subject|0|||
106095315|NCT05077267|366005234|FG001|Treatment Period|Withdrawal by Subject|1|||
106095316|NCT05077267|366005235|FG002|Treatment Period|Withdrawal by Subject|0|||
106095317|NCT05077267|366005233|FG000|Follow-up Period|Lost to Follow-up|0|||
106095318|NCT05077267|366005234|FG001|Follow-up Period|Lost to Follow-up|5|||
106095319|NCT05077267|366005235|FG002|Follow-up Period|Lost to Follow-up|7|||
106095320|NCT05077267|366005233|FG000|Follow-up Period|Withdrawal by Subject|0|||
106095321|NCT05077267|366005234|FG001|Follow-up Period|Withdrawal by Subject|2|||
106095322|NCT05077267|366005235|FG002|Follow-up Period|Withdrawal by Subject|5|||
106095323|NCT05077267|366005233|FG000|Follow-up Period|Study terminated by sponsor|0|||
106095324|NCT05077267|366005234|FG001|Follow-up Period|Study terminated by sponsor|27|||
106095325|NCT05077267|366005235|FG002|Follow-up Period|Study terminated by sponsor|23|||
106095326|NCT05077267|366005233|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
106095327|NCT05077267|366005234|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
106095328|NCT05077267|366005235|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
106095329|NCT05077267|366005233|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
106095330|NCT05077267|366005234|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
106095331|NCT05077267|366005235|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
106095332|NCT01136291|366005236|FG000|Overall Study|Lost to Follow-up|1|||
106095333|NCT01136291|366005237|FG001|Overall Study|Lost to Follow-up|1|||
106095334|NCT00759109|366005240|FG000|Overall Study|Adverse Event|17|||
106095335|NCT00759109|366005241|FG001|Overall Study|Adverse Event|12|||
106095336|NCT00759109|366005240|FG000|Overall Study|Inability to comply|1|||
106095337|NCT00759109|366005241|FG001|Overall Study|Inability to comply|1|||
106095338|NCT00759109|366005240|FG000|Overall Study|Withdrawal by Subject|9|||
106095339|NCT00759109|366005241|FG001|Overall Study|Withdrawal by Subject|5|||
106095340|NCT00759109|366005240|FG000|Overall Study|Death|4|||
106095341|NCT00759109|366005241|FG001|Overall Study|Death|3|||
106095342|NCT00759109|366005240|FG000|Overall Study|Lost to Follow-up|4|||
106095343|NCT00759109|366005241|FG001|Overall Study|Lost to Follow-up|6|||
106095344|NCT00759109|366005240|FG000|Overall Study|Started new therapy|2|||
106095345|NCT00759109|366005241|FG001|Overall Study|Started new therapy|6|||
106095346|NCT00759109|366005240|FG000|Overall Study|HCV RNA negative|1|||
106095347|NCT00759109|366005241|FG001|Overall Study|HCV RNA negative|0|||
106095348|NCT00759109|366005240|FG000|Overall Study|Participant moved to a different city|0|||
106095349|NCT00759109|366005241|FG001|Overall Study|Participant moved to a different city|1|||
106095350|NCT00759109|366005240|FG000|Overall Study|Participant had a liver transplant|0|||
106095351|NCT00759109|366005241|FG001|Overall Study|Participant had a liver transplant|1|||
106095352|NCT00759109|366005240|FG000|Overall Study|Lost during study|1|||
106095353|NCT00759109|366005241|FG001|Overall Study|Lost during study|0|||
106095354|NCT03165045|366005242|FG000|Visit 1|No registration after visit 1|9|||
106095355|NCT03165045|366005242|FG000|Visit 1|No treatment documented|10|||
106095356|NCT03165045|366005242|FG000|Visit 1|No visit 1|10|||
106095357|NCT03165045|366005242|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
106095358|NCT03165045|366005242|FG000|Visit 2|No available total CCQ score at all|29|||
106095359|NCT03165045|366005242|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
106095360|NCT02308033|366005243|FG000|Overall Study|Normal Gram stain at Baseline|13|||
106095361|NCT02308033|366005244|FG001|Overall Study|Normal Gram stain at Baseline|10|||
106095362|NCT02308033|366005243|FG000|Overall Study|Positive for STD at Baseline|7|||
106095363|NCT02308033|366005244|FG001|Overall Study|Positive for STD at Baseline|4|||
106095364|NCT02308033|366005243|FG000|Overall Study|Lost to Follow-up|6|||
106095365|NCT02308033|366005244|FG001|Overall Study|Lost to Follow-up|5|||
106095366|NCT00718718|366005245|FG000|Prior to Week 12|Adverse Event|0|||
106095367|NCT00718718|366005246|FG001|Prior to Week 12|Adverse Event|0|||
106095368|NCT00718718|366005247|FG002|Prior to Week 12|Adverse Event|0|||
106095369|NCT00718718|366005248|FG003|Prior to Week 12|Adverse Event|0|||
106095370|NCT00718718|366005249|FG004|Prior to Week 12|Adverse Event|0|||
106095371|NCT00718718|366005250|FG005|Prior to Week 12|Adverse Event|0|||
106095372|NCT00718718|366005251|FG006|Prior to Week 12|Adverse Event|0|||
106095373|NCT00718718|366005252|FG007|Prior to Week 12|Adverse Event|1|||
106095374|NCT00718718|366005253|FG008|Prior to Week 12|Adverse Event|1|||
106095375|NCT00718718|366005254|FG009|Prior to Week 12|Adverse Event|0|||
106095376|NCT00718718|366005245|FG000|Prior to Week 12|Withdrawal by Subject|0|||
106095377|NCT00718718|366005246|FG001|Prior to Week 12|Withdrawal by Subject|0|||
106095378|NCT00718718|366005247|FG002|Prior to Week 12|Withdrawal by Subject|0|||
106095379|NCT00718718|366005248|FG003|Prior to Week 12|Withdrawal by Subject|0|||
106095380|NCT00718718|366005249|FG004|Prior to Week 12|Withdrawal by Subject|3|||
106095381|NCT00718718|366005250|FG005|Prior to Week 12|Withdrawal by Subject|0|||
106095382|NCT00718718|366005251|FG006|Prior to Week 12|Withdrawal by Subject|1|||
106095383|NCT00718718|366005252|FG007|Prior to Week 12|Withdrawal by Subject|1|||
106095384|NCT00718718|366005253|FG008|Prior to Week 12|Withdrawal by Subject|1|||
106095385|NCT00718718|366005254|FG009|Prior to Week 12|Withdrawal by Subject|0|||
106095386|NCT00718718|366005245|FG000|Prior to Week 12|Other|1|||
106095387|NCT00718718|366005246|FG001|Prior to Week 12|Other|0|||
106095388|NCT00718718|366005247|FG002|Prior to Week 12|Other|1|||
106095389|NCT00718718|366005248|FG003|Prior to Week 12|Other|0|||
106095390|NCT00718718|366005249|FG004|Prior to Week 12|Other|0|||
106095391|NCT00718718|366005250|FG005|Prior to Week 12|Other|0|||
106095392|NCT00718718|366005251|FG006|Prior to Week 12|Other|0|||
106095393|NCT00718718|366005252|FG007|Prior to Week 12|Other|0|||
106095394|NCT00718718|366005253|FG008|Prior to Week 12|Other|0|||
106095395|NCT00718718|366005254|FG009|Prior to Week 12|Other|0|||
106095396|NCT00718718|366005245|FG000|Week 12 to End of Study|Adverse Event|0|||
106095397|NCT00718718|366005246|FG001|Week 12 to End of Study|Adverse Event|0|||
106095398|NCT00718718|366005247|FG002|Week 12 to End of Study|Adverse Event|0|||
106095399|NCT00718718|366005248|FG003|Week 12 to End of Study|Adverse Event|0|||
106095400|NCT00718718|366005249|FG004|Week 12 to End of Study|Adverse Event|0|||
106095401|NCT00718718|366005250|FG005|Week 12 to End of Study|Adverse Event|0|||
106095402|NCT00718718|366005251|FG006|Week 12 to End of Study|Adverse Event|0|||
106095403|NCT00718718|366005252|FG007|Week 12 to End of Study|Adverse Event|1|||
106095404|NCT00718718|366005253|FG008|Week 12 to End of Study|Adverse Event|0|||
106095405|NCT00718718|366005254|FG009|Week 12 to End of Study|Adverse Event|0|||
106095406|NCT00718718|366005245|FG000|Week 12 to End of Study|Death|0|||
106095407|NCT00718718|366005246|FG001|Week 12 to End of Study|Death|0|||
106095408|NCT00718718|366005247|FG002|Week 12 to End of Study|Death|0|||
106095409|NCT00718718|366005248|FG003|Week 12 to End of Study|Death|0|||
106095410|NCT00718718|366005249|FG004|Week 12 to End of Study|Death|0|||
106095411|NCT00718718|366005250|FG005|Week 12 to End of Study|Death|1|||
106095412|NCT00718718|366005251|FG006|Week 12 to End of Study|Death|0|||
106095413|NCT00718718|366005252|FG007|Week 12 to End of Study|Death|0|||
106095414|NCT00718718|366005253|FG008|Week 12 to End of Study|Death|0|||
106095415|NCT00718718|366005254|FG009|Week 12 to End of Study|Death|0|||
106095416|NCT00718718|366005245|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
106095417|NCT00718718|366005246|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
106095418|NCT00718718|366005247|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
106095419|NCT00718718|366005248|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
106095420|NCT00718718|366005249|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
106095421|NCT00718718|366005250|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
106095422|NCT00718718|366005251|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
106095423|NCT00718718|366005252|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
106095424|NCT00718718|366005253|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
106095425|NCT00718718|366005254|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
106095426|NCT00718718|366005245|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
106095427|NCT00718718|366005246|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
106095428|NCT00718718|366005247|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
106095429|NCT00718718|366005248|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
106095430|NCT00718718|366005249|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
106095431|NCT00718718|366005250|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
106095432|NCT00718718|366005251|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
106095433|NCT00718718|366005252|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
106095434|NCT00718718|366005253|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
106095435|NCT00718718|366005254|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
106095436|NCT00718718|366005245|FG000|Week 12 to End of Study|Other|0|||
106095437|NCT00718718|366005246|FG001|Week 12 to End of Study|Other|1|||
106095438|NCT00718718|366005247|FG002|Week 12 to End of Study|Other|0|||
106095439|NCT00718718|366005248|FG003|Week 12 to End of Study|Other|1|||
106162737|NCT02362503|366260161|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
106162738|NCT02362503|366260162|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
106095440|NCT00718718|366005249|FG004|Week 12 to End of Study|Other|0|||
106095441|NCT00718718|366005250|FG005|Week 12 to End of Study|Other|0|||
106095442|NCT00718718|366005251|FG006|Week 12 to End of Study|Other|1|||
106095443|NCT00718718|366005252|FG007|Week 12 to End of Study|Other|0|||
106095444|NCT00718718|366005253|FG008|Week 12 to End of Study|Other|0|||
106095445|NCT00718718|366005254|FG009|Week 12 to End of Study|Other|0|||
106095446|NCT04558346|366005263|FG000|Overall Study|Withdrawal by Subject|2|||
106095447|NCT04558346|366005264|FG001|Overall Study|Withdrawal by Subject|0|||
106095448|NCT04558346|366005263|FG000|Overall Study|Lost to Follow-up|0|||
106095449|NCT04558346|366005264|FG001|Overall Study|Lost to Follow-up|1|||
106095450|NCT04558346|366005263|FG000|Overall Study|Adverse Event|0|||
106095451|NCT04558346|366005264|FG001|Overall Study|Adverse Event|1|||
106095452|NCT01660906|366005272|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
106095453|NCT03478891|366005275|FG000|Overall Study|Enrolled, but product never administered|0|||
106095454|NCT03478891|366005276|FG001|Overall Study|Enrolled, but product never administered|0|||
106095455|NCT03478891|366005277|FG002|Overall Study|Enrolled, but product never administered|1|||
106095456|NCT03478891|366005275|FG000|Overall Study|Moved from area|0|||
106095457|NCT03478891|366005276|FG001|Overall Study|Moved from area|0|||
106095458|NCT03478891|366005277|FG002|Overall Study|Moved from area|1|||
106095459|NCT03478891|366005275|FG000|Overall Study|Lost to Follow-up|1|||
106095460|NCT03478891|366005276|FG001|Overall Study|Lost to Follow-up|0|||
106095461|NCT03478891|366005277|FG002|Overall Study|Lost to Follow-up|1|||
106095462|NCT00809757|366005280|FG000|Overall Study|Adverse Event|2|||
106095463|NCT00809757|366005281|FG001|Overall Study|Adverse Event|3|||
106095464|NCT00809757|366005282|FG002|Overall Study|Adverse Event|3|||
106095465|NCT00809757|366005280|FG000|Overall Study|Lost to Follow-up|0|||
106095466|NCT00809757|366005281|FG001|Overall Study|Lost to Follow-up|0|||
106095467|NCT00809757|366005282|FG002|Overall Study|Lost to Follow-up|1|||
106095468|NCT00809757|366005280|FG000|Overall Study|Protocol Violation|1|||
106095469|NCT00809757|366005281|FG001|Overall Study|Protocol Violation|1|||
106095470|NCT00809757|366005282|FG002|Overall Study|Protocol Violation|1|||
106095471|NCT00809757|366005280|FG000|Overall Study|Withdrawal by Subject|2|||
106095472|NCT00809757|366005281|FG001|Overall Study|Withdrawal by Subject|1|||
106095473|NCT00809757|366005282|FG002|Overall Study|Withdrawal by Subject|3|||
106095474|NCT00809757|366005280|FG000|Overall Study|Subject Uncooperative|1|||
106095475|NCT00809757|366005281|FG001|Overall Study|Subject Uncooperative|0|||
106095476|NCT00809757|366005282|FG002|Overall Study|Subject Uncooperative|2|||
106095477|NCT00809757|366005280|FG000|Overall Study|Noncompliance with Medication|0|||
106095478|NCT00809757|366005281|FG001|Overall Study|Noncompliance with Medication|0|||
106095479|NCT00809757|366005282|FG002|Overall Study|Noncompliance with Medication|1|||
106095480|NCT00253864|366005283|FG000|Overall Study|Lost to Follow-up|5|||
106095481|NCT00253864|366005284|FG001|Overall Study|Lost to Follow-up|8|||
106095482|NCT04368429|366007210|FG000|Overall Study|Adverse Event|1|||
106095483|NCT04368429|366007211|FG001|Overall Study|Adverse Event|0|||
106095484|NCT00618514|366007214|FG000|Overall Study|Lost to Follow-up|11|||
106095485|NCT00618514|366007215|FG001|Overall Study|Lost to Follow-up|12|||
106095486|NCT00618514|366007216|FG002|Overall Study|Lost to Follow-up|4|||
106095487|NCT03320070|366007219|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
106095488|NCT03320070|366007220|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
106095489|NCT03320070|366007219|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
106095490|NCT03320070|366007220|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
106095491|NCT03320070|366007219|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
106095492|NCT03320070|366007220|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
106095493|NCT03320070|366007219|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
106095494|NCT03320070|366007220|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
106095495|NCT03320070|366007219|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
106095496|NCT03320070|366007220|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
106095497|NCT03320070|366007219|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
106095498|NCT03320070|366007220|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
106162739|NCT02362503|366260163|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
106095499|NCT03521635|366007221|FG000|Overall Study|Adverse Event|1|||
106095500|NCT03521635|366007222|FG001|Overall Study|Adverse Event|1|||
105984895|NCT00231413|365605977|FG002|Overall Study|Non-serious AE|1|||
106095501|NCT03521635|366007221|FG000|Overall Study|Refused to complete study visit|1|||
106095502|NCT03521635|366007222|FG001|Overall Study|Refused to complete study visit|0|||
106095503|NCT03521635|366007221|FG000|Overall Study|Refused to continue trial medication|2|||
106095504|NCT03521635|366007222|FG001|Overall Study|Refused to continue trial medication|2|||
106095505|NCT03521635|366007221|FG000|Overall Study|Lost to Follow-up|0|||
106095506|NCT03521635|366007222|FG001|Overall Study|Lost to Follow-up|1|||
106095507|NCT03521635|366007221|FG000|Overall Study|Meet exclusion criteria|0|||
106095508|NCT03521635|366007222|FG001|Overall Study|Meet exclusion criteria|1|||
106095509|NCT03521635|366007221|FG000|Overall Study|Patient not taken study medicine|0|||
106095510|NCT03521635|366007222|FG001|Overall Study|Patient not taken study medicine|1|||
106095511|NCT04579757|366007228|FG000|Overall Study|Adverse Event|0|||
106095512|NCT04579757|366007229|FG001|Overall Study|Adverse Event|0|||
106095513|NCT04579757|366007230|FG002|Overall Study|Adverse Event|0|||
106095514|NCT04579757|366007231|FG003|Overall Study|Adverse Event|2|||
106095515|NCT04579757|366007232|FG004|Overall Study|Adverse Event|1|||
106095516|NCT04579757|366007233|FG005|Overall Study|Adverse Event|1|||
106095517|NCT04579757|366007234|FG006|Overall Study|Adverse Event|0|||
106095518|NCT04579757|366007235|FG007|Overall Study|Adverse Event|0|||
106095519|NCT04579757|366007236|FG008|Overall Study|Adverse Event|0|||
106095520|NCT04579757|366007228|FG000|Overall Study|Death|4|||
106095521|NCT04579757|366007229|FG001|Overall Study|Death|1|||
106095522|NCT04579757|366007230|FG002|Overall Study|Death|14|||
106095523|NCT04579757|366007231|FG003|Overall Study|Death|3|||
106095524|NCT04579757|366007232|FG004|Overall Study|Death|2|||
106095525|NCT04579757|366007233|FG005|Overall Study|Death|7|||
106095526|NCT04579757|366007234|FG006|Overall Study|Death|0|||
106095527|NCT04579757|366007235|FG007|Overall Study|Death|1|||
106095528|NCT04579757|366007236|FG008|Overall Study|Death|3|||
106095529|NCT04579757|366007228|FG000|Overall Study|Physician Decision|0|||
106095530|NCT04579757|366007229|FG001|Overall Study|Physician Decision|0|||
106095531|NCT04579757|366007230|FG002|Overall Study|Physician Decision|0|||
106095532|NCT04579757|366007231|FG003|Overall Study|Physician Decision|2|||
106095533|NCT04579757|366007232|FG004|Overall Study|Physician Decision|1|||
106095534|NCT04579757|366007233|FG005|Overall Study|Physician Decision|1|||
106095535|NCT04579757|366007234|FG006|Overall Study|Physician Decision|1|||
106095536|NCT04579757|366007235|FG007|Overall Study|Physician Decision|0|||
106095537|NCT04579757|366007236|FG008|Overall Study|Physician Decision|0|||
106095538|NCT04579757|366007228|FG000|Overall Study|Study Terminated By Sponsor|0|||
106095539|NCT04579757|366007229|FG001|Overall Study|Study Terminated By Sponsor|0|||
106095540|NCT04579757|366007230|FG002|Overall Study|Study Terminated By Sponsor|0|||
106095541|NCT04579757|366007231|FG003|Overall Study|Study Terminated By Sponsor|0|||
106095542|NCT04579757|366007232|FG004|Overall Study|Study Terminated By Sponsor|2|||
106095543|NCT04579757|366007233|FG005|Overall Study|Study Terminated By Sponsor|0|||
106095544|NCT04579757|366007234|FG006|Overall Study|Study Terminated By Sponsor|0|||
106095545|NCT04579757|366007235|FG007|Overall Study|Study Terminated By Sponsor|2|||
106095546|NCT04579757|366007236|FG008|Overall Study|Study Terminated By Sponsor|0|||
106095547|NCT04579757|366007228|FG000|Overall Study|Withdrawal by Subject|1|||
106095548|NCT04579757|366007229|FG001|Overall Study|Withdrawal by Subject|1|||
106095549|NCT04579757|366007230|FG002|Overall Study|Withdrawal by Subject|0|||
106095550|NCT04579757|366007231|FG003|Overall Study|Withdrawal by Subject|0|||
106095551|NCT04579757|366007232|FG004|Overall Study|Withdrawal by Subject|2|||
106095552|NCT04579757|366007233|FG005|Overall Study|Withdrawal by Subject|1|||
106095553|NCT04579757|366007234|FG006|Overall Study|Withdrawal by Subject|0|||
106095554|NCT04579757|366007235|FG007|Overall Study|Withdrawal by Subject|3|||
106095555|NCT04579757|366007236|FG008|Overall Study|Withdrawal by Subject|0|||
106095556|NCT04579757|366007228|FG000|Overall Study|Radiological or Clinical PD|1|||
106095557|NCT04579757|366007229|FG001|Overall Study|Radiological or Clinical PD|4|||
106095558|NCT04579757|366007230|FG002|Overall Study|Radiological or Clinical PD|1|||
106095559|NCT04579757|366007231|FG003|Overall Study|Radiological or Clinical PD|3|||
106095560|NCT04579757|366007232|FG004|Overall Study|Radiological or Clinical PD|9|||
106095561|NCT04579757|366007233|FG005|Overall Study|Radiological or Clinical PD|4|||
106095562|NCT04579757|366007234|FG006|Overall Study|Radiological or Clinical PD|2|||
106095563|NCT04579757|366007235|FG007|Overall Study|Radiological or Clinical PD|2|||
106095564|NCT04579757|366007236|FG008|Overall Study|Radiological or Clinical PD|0|||
106095565|NCT04579757|366007228|FG000|Overall Study|Start of New Therapy|0|||
106095566|NCT04579757|366007229|FG001|Overall Study|Start of New Therapy|0|||
106095567|NCT04579757|366007230|FG002|Overall Study|Start of New Therapy|0|||
106095568|NCT04579757|366007231|FG003|Overall Study|Start of New Therapy|0|||
106095569|NCT04579757|366007232|FG004|Overall Study|Start of New Therapy|2|||
106095570|NCT04579757|366007233|FG005|Overall Study|Start of New Therapy|1|||
106095571|NCT04579757|366007234|FG006|Overall Study|Start of New Therapy|0|||
106095572|NCT04579757|366007235|FG007|Overall Study|Start of New Therapy|0|||
106095573|NCT04579757|366007236|FG008|Overall Study|Start of New Therapy|0|||
106095574|NCT00384085|366007238|FG000|Overall Study|Adverse Event|5|||
106095575|NCT00384085|366007239|FG001|Overall Study|Adverse Event|5|||
106095576|NCT00384085|366007240|FG002|Overall Study|Adverse Event|4|||
106095577|NCT00384085|366007238|FG000|Overall Study|Lack of Efficacy|0|||
106095578|NCT00384085|366007239|FG001|Overall Study|Lack of Efficacy|3|||
106095579|NCT00384085|366007240|FG002|Overall Study|Lack of Efficacy|2|||
106095580|NCT00384085|366007238|FG000|Overall Study|No longer Requires Study Treatment|1|||
106095581|NCT00384085|366007239|FG001|Overall Study|No longer Requires Study Treatment|0|||
106095582|NCT00384085|366007240|FG002|Overall Study|No longer Requires Study Treatment|1|||
106095583|NCT00384085|366007238|FG000|Overall Study|Protocol Violation|2|||
106095584|NCT00384085|366007239|FG001|Overall Study|Protocol Violation|2|||
106095585|NCT00384085|366007240|FG002|Overall Study|Protocol Violation|2|||
106095586|NCT00384085|366007238|FG000|Overall Study|Lost to Follow-up|9|||
106095587|NCT00384085|366007239|FG001|Overall Study|Lost to Follow-up|9|||
106095588|NCT00384085|366007240|FG002|Overall Study|Lost to Follow-up|10|||
106095589|NCT00384085|366007238|FG000|Overall Study|Progressive Disease|0|||
106095590|NCT00384085|366007239|FG001|Overall Study|Progressive Disease|1|||
106095591|NCT00384085|366007240|FG002|Overall Study|Progressive Disease|0|||
106095592|NCT00384085|366007238|FG000|Overall Study|Withdrawal by Subject|14|||
106095593|NCT00384085|366007239|FG001|Overall Study|Withdrawal by Subject|19|||
106095594|NCT00384085|366007240|FG002|Overall Study|Withdrawal by Subject|29|||
106095595|NCT00384085|366007238|FG000|Overall Study|Patient non-compliant|4|||
106095596|NCT00384085|366007239|FG001|Overall Study|Patient non-compliant|4|||
106095597|NCT00384085|366007240|FG002|Overall Study|Patient non-compliant|5|||
106095598|NCT00384085|366007238|FG000|Overall Study|Physician Decision|1|||
106095599|NCT00384085|366007239|FG001|Overall Study|Physician Decision|0|||
106095600|NCT00384085|366007240|FG002|Overall Study|Physician Decision|0|||
106095601|NCT00384085|366007238|FG000|Overall Study|Loss of site personnel|1|||
106095602|NCT00384085|366007239|FG001|Overall Study|Loss of site personnel|0|||
106095603|NCT00384085|366007240|FG002|Overall Study|Loss of site personnel|1|||
106095604|NCT00384085|366007238|FG000|Overall Study|Sponsor decision|1|||
106095605|NCT00384085|366007239|FG001|Overall Study|Sponsor decision|2|||
106095606|NCT00384085|366007240|FG002|Overall Study|Sponsor decision|1|||
106095607|NCT00384085|366007238|FG000|Overall Study|Patient moved|1|||
106095608|NCT00384085|366007239|FG001|Overall Study|Patient moved|0|||
106095609|NCT00384085|366007240|FG002|Overall Study|Patient moved|1|||
106095610|NCT00384085|366007238|FG000|Overall Study|Patient required surgery|0|||
106095611|NCT00384085|366007239|FG001|Overall Study|Patient required surgery|1|||
106095612|NCT00384085|366007240|FG002|Overall Study|Patient required surgery|0|||
106095613|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Adverse Event|5|||
106095614|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Adverse Event|8|||
106095615|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Adverse Event|4|||
106095616|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Adverse Event|8|||
106095617|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
106095618|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
106095619|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
106095620|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
106095621|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
106095622|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
106095623|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
106095624|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
106095625|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Physician Decision|1|||
106095626|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Physician Decision|0|||
106095627|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Physician Decision|0|||
106095628|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Physician Decision|0|||
106095629|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
106095630|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
106095631|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
106095632|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
106095633|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Pregnancy|0|||
106095634|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Pregnancy|1|||
106095635|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Pregnancy|0|||
106095636|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Pregnancy|0|||
106095637|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
106095638|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
106095639|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
106095640|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
106095641|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Death|0|||
106095642|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Death|1|||
106095643|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Death|0|||
106095644|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Death|0|||
106095645|NCT00071487|366007241|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
106095646|NCT00071487|366007242|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
106095647|NCT00071487|366007243|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
106095648|NCT00071487|366007244|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
106095649|NCT00071487|366007241|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
106095650|NCT00071487|366007242|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
106095651|NCT00071487|366007243|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
106095652|NCT00071487|366007244|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
106095653|NCT00071487|366007241|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
106095654|NCT00071487|366007242|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
105867289|NCT03888066|365164935|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
106095655|NCT00071487|366007243|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
106095656|NCT00071487|366007244|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
106095657|NCT00071487|366007241|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
106095658|NCT00071487|366007242|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
106095659|NCT00071487|366007243|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
106095660|NCT00071487|366007244|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
106095661|NCT00071487|366007241|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
106095662|NCT00071487|366007242|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
106095663|NCT00071487|366007243|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
106095664|NCT00071487|366007244|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
106095665|NCT00071487|366007241|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
106095666|NCT00071487|366007242|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
106095667|NCT00071487|366007243|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
106095668|NCT00071487|366007244|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
106095669|NCT00071487|366007241|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
106095670|NCT00071487|366007242|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
106095671|NCT00071487|366007243|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
106095672|NCT00071487|366007244|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
106095673|NCT02318329|366007247|FG000|Overall Study|Progressive Disease|2|||
106095674|NCT02318329|366007248|FG001|Overall Study|Progressive Disease|3|||
106095675|NCT02318329|366007249|FG002|Overall Study|Progressive Disease|2|||
106095676|NCT02318329|366007250|FG003|Overall Study|Progressive Disease|3|||
106095677|NCT02318329|366007251|FG004|Overall Study|Progressive Disease|3|||
106095678|NCT02318329|366007252|FG005|Overall Study|Progressive Disease|3|||
106095679|NCT02318329|366007253|FG006|Overall Study|Progressive Disease|1|||
106095680|NCT02318329|366007254|FG007|Overall Study|Progressive Disease|1|||
106095681|NCT02318329|366007255|FG008|Overall Study|Progressive Disease|5|||
106095682|NCT02318329|366007256|FG009|Overall Study|Progressive Disease|39|||
106095683|NCT02318329|366007247|FG000|Overall Study|Death|0|||
106095684|NCT02318329|366007248|FG001|Overall Study|Death|0|||
106095685|NCT02318329|366007249|FG002|Overall Study|Death|0|||
106095686|NCT02318329|366007250|FG003|Overall Study|Death|0|||
106095687|NCT02318329|366007251|FG004|Overall Study|Death|0|||
106095688|NCT02318329|366007252|FG005|Overall Study|Death|0|||
106095689|NCT02318329|366007253|FG006|Overall Study|Death|0|||
106095690|NCT02318329|366007254|FG007|Overall Study|Death|0|||
106095691|NCT02318329|366007255|FG008|Overall Study|Death|0|||
106095692|NCT02318329|366007256|FG009|Overall Study|Death|5|||
106095693|NCT02318329|366007247|FG000|Overall Study|Lost to Follow-up|0|||
106095694|NCT02318329|366007248|FG001|Overall Study|Lost to Follow-up|0|||
106095695|NCT02318329|366007249|FG002|Overall Study|Lost to Follow-up|0|||
106095696|NCT02318329|366007250|FG003|Overall Study|Lost to Follow-up|0|||
106095697|NCT02318329|366007251|FG004|Overall Study|Lost to Follow-up|0|||
106095698|NCT02318329|366007252|FG005|Overall Study|Lost to Follow-up|0|||
106095699|NCT02318329|366007253|FG006|Overall Study|Lost to Follow-up|0|||
106095700|NCT02318329|366007254|FG007|Overall Study|Lost to Follow-up|0|||
106095701|NCT02318329|366007255|FG008|Overall Study|Lost to Follow-up|0|||
106095702|NCT02318329|366007256|FG009|Overall Study|Lost to Follow-up|1|||
106095703|NCT02318329|366007247|FG000|Overall Study|Withdrawal by Subject|0|||
106095704|NCT02318329|366007248|FG001|Overall Study|Withdrawal by Subject|0|||
106095705|NCT02318329|366007249|FG002|Overall Study|Withdrawal by Subject|0|||
106095706|NCT02318329|366007250|FG003|Overall Study|Withdrawal by Subject|0|||
106095707|NCT02318329|366007251|FG004|Overall Study|Withdrawal by Subject|0|||
106095708|NCT02318329|366007252|FG005|Overall Study|Withdrawal by Subject|0|||
106095709|NCT02318329|366007253|FG006|Overall Study|Withdrawal by Subject|0|||
106095710|NCT02318329|366007254|FG007|Overall Study|Withdrawal by Subject|0|||
106095711|NCT02318329|366007255|FG008|Overall Study|Withdrawal by Subject|0|||
106095712|NCT02318329|366007256|FG009|Overall Study|Withdrawal by Subject|6|||
106095713|NCT02318329|366007247|FG000|Overall Study|Other|1|||
106095714|NCT02318329|366007248|FG001|Overall Study|Other|1|||
106095715|NCT02318329|366007249|FG002|Overall Study|Other|1|||
106095716|NCT02318329|366007250|FG003|Overall Study|Other|0|||
106095717|NCT02318329|366007251|FG004|Overall Study|Other|0|||
106095718|NCT02318329|366007252|FG005|Overall Study|Other|0|||
106095719|NCT02318329|366007253|FG006|Overall Study|Other|0|||
106095720|NCT02318329|366007254|FG007|Overall Study|Other|0|||
106095721|NCT02318329|366007255|FG008|Overall Study|Other|1|||
106095722|NCT02318329|366007256|FG009|Overall Study|Other|1|||
106095723|NCT03725982|366007257|FG000|First Intervention|Withdrawal by Subject|0|||
106095724|NCT03725982|366007258|FG001|First Intervention|Withdrawal by Subject|1|||
105984896|NCT00231413|365605978|FG003|Overall Study|Non-serious AE|0|||
106095725|NCT03725982|366007257|FG000|First Intervention|Physician Decision|1|||
106095726|NCT03725982|366007258|FG001|First Intervention|Physician Decision|1|||
106095727|NCT00987467|366007262|FG000|Overall Study|Lost to Follow-up|2|||
106095728|NCT00406029|366007265|FG000|Overall Study|Adverse Event|12|||
106095729|NCT00406029|366007266|FG001|Overall Study|Adverse Event|2|||
106095730|NCT00406029|366007267|FG002|Overall Study|Adverse Event|5|||
106095731|NCT00406029|366007268|FG003|Overall Study|Adverse Event|10|||
106095732|NCT00406029|366007269|FG004|Overall Study|Adverse Event|7|||
106095733|NCT00406029|366007265|FG000|Overall Study|Withdrawal by Subject|3|||
106095734|NCT00406029|366007266|FG001|Overall Study|Withdrawal by Subject|4|||
106095735|NCT00406029|366007267|FG002|Overall Study|Withdrawal by Subject|2|||
106095736|NCT00406029|366007268|FG003|Overall Study|Withdrawal by Subject|2|||
106095737|NCT00406029|366007269|FG004|Overall Study|Withdrawal by Subject|0|||
106095738|NCT00406029|366007265|FG000|Overall Study|Protocol Violation|1|||
106095739|NCT00406029|366007266|FG001|Overall Study|Protocol Violation|2|||
106095740|NCT00406029|366007267|FG002|Overall Study|Protocol Violation|0|||
106095741|NCT00406029|366007268|FG003|Overall Study|Protocol Violation|2|||
106095742|NCT00406029|366007269|FG004|Overall Study|Protocol Violation|0|||
106095743|NCT00406029|366007265|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
106095744|NCT00406029|366007266|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
106095745|NCT00406029|366007267|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
106095746|NCT00406029|366007268|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
106095747|NCT00406029|366007269|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
106095748|NCT00406029|366007265|FG000|Overall Study|Randomized in Error|0|||
106095749|NCT00406029|366007266|FG001|Overall Study|Randomized in Error|0|||
106095750|NCT00406029|366007267|FG002|Overall Study|Randomized in Error|2|||
106095751|NCT00406029|366007268|FG003|Overall Study|Randomized in Error|3|||
106095752|NCT00406029|366007269|FG004|Overall Study|Randomized in Error|1|||
106095753|NCT02548962|366007271|FG000|Overall Study|Withdrawal by Subject|1|||
106095754|NCT02548962|366007272|FG001|Overall Study|Withdrawal by Subject|0|||
106095755|NCT01197950|366007273|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
106095756|NCT01197950|366007274|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
106095757|NCT01197950|366007275|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
106095758|NCT04831736|366007278|FG000|Overall Study|Withdrawal by Subject|0|||
106095759|NCT04831736|366007279|FG001|Overall Study|Withdrawal by Subject|1|||
106095760|NCT02553330|366007280|FG000|Overall Study|Study Terminated by Sponsor|2|||
106095761|NCT02553330|366007281|FG001|Overall Study|Study Terminated by Sponsor|13|||
106095762|NCT02553330|366007282|FG002|Overall Study|Study Terminated by Sponsor|12|||
106095763|NCT02553330|366007280|FG000|Overall Study|Withdrawal by Subject|3|||
106095764|NCT02553330|366007281|FG001|Overall Study|Withdrawal by Subject|19|||
106095765|NCT02553330|366007282|FG002|Overall Study|Withdrawal by Subject|21|||
106095766|NCT02553330|366007280|FG000|Overall Study|Other|0|||
106095767|NCT02553330|366007281|FG001|Overall Study|Other|1|||
106095768|NCT02553330|366007282|FG002|Overall Study|Other|0|||
106095769|NCT02553330|366007280|FG000|Overall Study|Non compliance to study treatment|0|||
106095770|NCT02553330|366007281|FG001|Overall Study|Non compliance to study treatment|1|||
106095771|NCT02553330|366007282|FG002|Overall Study|Non compliance to study treatment|0|||
106095772|NCT02553330|366007280|FG000|Overall Study|Adverse Event|0|||
106095773|NCT02553330|366007281|FG001|Overall Study|Adverse Event|1|||
106095774|NCT02553330|366007282|FG002|Overall Study|Adverse Event|0|||
106095775|NCT02553330|366007280|FG000|Overall Study|Lost to Follow-up|0|||
106095776|NCT02553330|366007281|FG001|Overall Study|Lost to Follow-up|4|||
106095777|NCT02553330|366007282|FG002|Overall Study|Lost to Follow-up|4|||
106095778|NCT01666002|366007288|FG000|Overall Study|Lost to Follow-up|5|||
106095779|NCT01666002|366007289|FG001|Overall Study|Lost to Follow-up|0|||
106095780|NCT02159482|366007290|FG000|Overall Study|Withdrawal by Subject|2|||
106095781|NCT02159482|366007290|FG000|Overall Study|Physician Decision|3|||
106095782|NCT01233817|366007291|FG000|Overall Study|Lost to Follow-up|1|||
106095783|NCT01233817|366007291|FG000|Overall Study|Withdrawal by Subject|2|||
106095784|NCT00726752|366007292|FG000|Overall Study|Lack of Efficacy|6|||
106095785|NCT01248884|366007293|FG000|Overall Study|Withdrawal by Subject|1|||
106095786|NCT01248884|366007294|FG001|Overall Study|Withdrawal by Subject|3|||
106095787|NCT01248884|366007295|FG002|Overall Study|Withdrawal by Subject|1|||
106095788|NCT01248884|366007293|FG000|Overall Study|Adverse Event|1|||
106095789|NCT01248884|366007294|FG001|Overall Study|Adverse Event|0|||
106095790|NCT01248884|366007295|FG002|Overall Study|Adverse Event|0|||
106095791|NCT02511431|366007296|FG000|Treatment|Lost to Follow-up|0|||
106095792|NCT02511431|366007297|FG001|Treatment|Lost to Follow-up|0|||
106095793|NCT02511431|366007298|FG002|Treatment|Lost to Follow-up|1|||
106095794|NCT02511431|366007299|FG003|Treatment|Lost to Follow-up|0|||
106095795|NCT02511431|366007300|FG004|Treatment|Lost to Follow-up|0|||
106095796|NCT02511431|366007301|FG005|Treatment|Lost to Follow-up|1|||
106095797|NCT01202773|366007304|FG000|Overall Study|Adverse Event|4|||
106095798|NCT01202773|366007305|FG001|Overall Study|Adverse Event|5|||
106095799|NCT01202773|366007306|FG002|Overall Study|Adverse Event|5|||
106095800|NCT01202773|366007304|FG000|Overall Study|Lack of Efficacy|5|||
106095801|NCT01202773|366007305|FG001|Overall Study|Lack of Efficacy|4|||
106095802|NCT01202773|366007306|FG002|Overall Study|Lack of Efficacy|9|||
106095803|NCT01202773|366007304|FG000|Overall Study|Entry Criteria Not Met|2|||
106095804|NCT01202773|366007305|FG001|Overall Study|Entry Criteria Not Met|0|||
106095805|NCT01202773|366007306|FG002|Overall Study|Entry Criteria Not Met|1|||
106095806|NCT01202773|366007304|FG000|Overall Study|Lost to Follow-up|1|||
106095807|NCT01202773|366007305|FG001|Overall Study|Lost to Follow-up|2|||
106095808|NCT01202773|366007306|FG002|Overall Study|Lost to Follow-up|2|||
106095809|NCT01202773|366007304|FG000|Overall Study|Withdrawal by Subject|13|||
106095810|NCT01202773|366007305|FG001|Overall Study|Withdrawal by Subject|6|||
106095811|NCT01202773|366007306|FG002|Overall Study|Withdrawal by Subject|5|||
106095812|NCT01202773|366007304|FG000|Overall Study|Physician Decision|2|||
106095813|NCT01202773|366007305|FG001|Overall Study|Physician Decision|0|||
106095814|NCT01202773|366007306|FG002|Overall Study|Physician Decision|0|||
106095815|NCT01202773|366007304|FG000|Overall Study|Protocol Violation|11|||
106095816|NCT01202773|366007305|FG001|Overall Study|Protocol Violation|6|||
106095817|NCT01202773|366007306|FG002|Overall Study|Protocol Violation|10|||
106095818|NCT01202773|366007304|FG000|Overall Study|Sponsor Decision|19|||
106095819|NCT01202773|366007305|FG001|Overall Study|Sponsor Decision|20|||
106095820|NCT01202773|366007306|FG002|Overall Study|Sponsor Decision|23|||
106095821|NCT04827212|366007313|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
106095822|NCT04827212|366007314|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
106095823|NCT04827212|366007313|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
106095824|NCT04827212|366007314|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
106095825|NCT03058679|366007315|FG000|Baseline to Week 6|Lost to Follow-up|3|||
106095826|NCT03058679|366007316|FG001|Baseline to Week 6|Lost to Follow-up|2|||
106095827|NCT03058679|366007315|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
106095828|NCT03058679|366007316|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
106095829|NCT03058679|366007315|FG000|Baseline to Week 6|Adverse Event|6|||
106095830|NCT03058679|366007316|FG001|Baseline to Week 6|Adverse Event|6|||
106095831|NCT03058679|366007315|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
106095832|NCT03058679|366007316|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
106095833|NCT03058679|366007315|FG000|Baseline to Week 6|Difficulty following the diet|0|||
106095834|NCT03058679|366007316|FG001|Baseline to Week 6|Difficulty following the diet|2|||
106095835|NCT03058679|366007315|FG000|Baseline to Week 6|Physician Decision|1|||
106095836|NCT03058679|366007316|FG001|Baseline to Week 6|Physician Decision|0|||
106095837|NCT03058679|366007315|FG000|Week 6 to Week 12|Change in medication|5|||
106095838|NCT03058679|366007316|FG001|Week 6 to Week 12|Change in medication|7|||
106095839|NCT03058679|366007315|FG000|Week 6 to Week 12|Adverse Event|4|||
106095840|NCT03058679|366007316|FG001|Week 6 to Week 12|Adverse Event|3|||
106095841|NCT03058679|366007315|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
106095842|NCT03058679|366007316|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
106095843|NCT03058679|366007315|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
106095844|NCT03058679|366007316|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
106095845|NCT00599326|366007317|FG000|Overall Study|Lost to Follow-up|1|||
106095846|NCT00599326|366007317|FG000|Overall Study|Noncompliant|1|||
106095847|NCT02862106|366007318|FG000|Overall Study|Adverse Event|4|||
106095848|NCT02862106|366007319|FG001|Overall Study|Adverse Event|0|||
106095849|NCT02862106|366007318|FG000|Overall Study|Protocol Violation|16|||
106095850|NCT02862106|366007319|FG001|Overall Study|Protocol Violation|1|||
106095851|NCT02862106|366007318|FG000|Overall Study|Lost to Follow-up|15|||
106095852|NCT02862106|366007319|FG001|Overall Study|Lost to Follow-up|5|||
106095853|NCT02862106|366007318|FG000|Overall Study|Withdrawal by Subject|2|||
106095854|NCT02862106|366007319|FG001|Overall Study|Withdrawal by Subject|0|||
106095855|NCT02862106|366007318|FG000|Overall Study|Subjects moved to other city|1|||
106095856|NCT02862106|366007319|FG001|Overall Study|Subjects moved to other city|0|||
106095857|NCT03434119|366007324|FG000|Overall Study|Randomized but not treated|1|||
106095858|NCT03434119|366007325|FG001|Overall Study|Randomized but not treated|0|||
106095859|NCT03434119|366007324|FG000|Overall Study|Adverse Event|1|||
106095860|NCT03434119|366007325|FG001|Overall Study|Adverse Event|0|||
106095861|NCT03434119|366007324|FG000|Overall Study|Poor Compliance to Protocol|0|||
106095862|NCT03434119|366007325|FG001|Overall Study|Poor Compliance to Protocol|1|||
106095863|NCT03434119|366007324|FG000|Overall Study|Study Terminated by Sponsor|91|||
106095864|NCT03434119|366007325|FG001|Overall Study|Study Terminated by Sponsor|102|||
106095865|NCT03434119|366007324|FG000|Overall Study|Withdrawal by Subject|7|||
106095866|NCT03434119|366007325|FG001|Overall Study|Withdrawal by Subject|5|||
106095867|NCT03434119|366007324|FG000|Overall Study|Other than specified|7|||
106095868|NCT03434119|366007325|FG001|Overall Study|Other than specified|5|||
106095869|NCT00320216|366007326|FG000|Overall Study|Adverse Event|0|||
106095870|NCT00320216|366007327|FG001|Overall Study|Adverse Event|6|||
106095871|NCT00320216|366007328|FG002|Overall Study|Adverse Event|0|||
106095872|NCT00320216|366007329|FG003|Overall Study|Adverse Event|2|||
106095873|NCT00320216|366007330|FG004|Overall Study|Adverse Event|2|||
106095874|NCT00320216|366007326|FG000|Overall Study|Lack of Efficacy|6|||
106095875|NCT00320216|366007327|FG001|Overall Study|Lack of Efficacy|2|||
106095876|NCT00320216|366007328|FG002|Overall Study|Lack of Efficacy|1|||
106095877|NCT00320216|366007329|FG003|Overall Study|Lack of Efficacy|0|||
106095878|NCT00320216|366007330|FG004|Overall Study|Lack of Efficacy|1|||
106095879|NCT00320216|366007326|FG000|Overall Study|Lost to Follow-up|3|||
106095880|NCT00320216|366007327|FG001|Overall Study|Lost to Follow-up|0|||
106095881|NCT00320216|366007328|FG002|Overall Study|Lost to Follow-up|0|||
106095882|NCT00320216|366007329|FG003|Overall Study|Lost to Follow-up|0|||
106095883|NCT00320216|366007330|FG004|Overall Study|Lost to Follow-up|0|||
106095884|NCT00320216|366007326|FG000|Overall Study|Other|7|||
106095885|NCT00320216|366007327|FG001|Overall Study|Other|2|||
106162740|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
106162741|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
106162742|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
106162743|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
106162744|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
106162745|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
106162746|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
106162747|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
106162748|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
106162749|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
106162750|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
106162751|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
106162752|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
106162753|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
106162754|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
106162755|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
106162756|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
106162757|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
106162758|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
106162759|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
106162760|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
106162761|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
106162762|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
106162763|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
106162764|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
106162765|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
106162766|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
106162767|NCT02362503|366260161|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
106162768|NCT02362503|366260162|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
106162769|NCT02362503|366260163|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
106162770|NCT00085735|366260164|FG000|Overall Study|Adverse Event|1|||
106162771|NCT00085735|366260165|FG001|Overall Study|Adverse Event|0|||
106162772|NCT00085735|366260166|FG002|Overall Study|Adverse Event|0|||
106162773|NCT00085735|366260167|FG003|Overall Study|Adverse Event|0|||
106162774|NCT00085735|366260168|FG004|Overall Study|Adverse Event|0|||
106162775|NCT00085735|366260169|FG005|Overall Study|Adverse Event|0|||
106162776|NCT00085735|366260164|FG000|Overall Study|Lack of Efficacy|2|||
106162777|NCT00085735|366260165|FG001|Overall Study|Lack of Efficacy|4|||
106162778|NCT00085735|366260166|FG002|Overall Study|Lack of Efficacy|6|||
106162779|NCT00085735|366260167|FG003|Overall Study|Lack of Efficacy|3|||
106162780|NCT00085735|366260168|FG004|Overall Study|Lack of Efficacy|4|||
106162781|NCT00085735|366260169|FG005|Overall Study|Lack of Efficacy|3|||
106162782|NCT00085735|366260164|FG000|Overall Study|Lost to Follow-up|0|||
106162783|NCT00085735|366260165|FG001|Overall Study|Lost to Follow-up|1|||
106162784|NCT00085735|366260166|FG002|Overall Study|Lost to Follow-up|0|||
106162785|NCT00085735|366260167|FG003|Overall Study|Lost to Follow-up|0|||
106162786|NCT00085735|366260168|FG004|Overall Study|Lost to Follow-up|1|||
106162787|NCT00085735|366260169|FG005|Overall Study|Lost to Follow-up|0|||
106162788|NCT00085735|366260164|FG000|Overall Study|Physician Decision|2|||
106162789|NCT00085735|366260165|FG001|Overall Study|Physician Decision|3|||
106162790|NCT00085735|366260166|FG002|Overall Study|Physician Decision|2|||
106162791|NCT00085735|366260167|FG003|Overall Study|Physician Decision|3|||
106162792|NCT00085735|366260168|FG004|Overall Study|Physician Decision|11|||
106162793|NCT00085735|366260169|FG005|Overall Study|Physician Decision|8|||
106162794|NCT00085735|366260164|FG000|Overall Study|Protocol Violation|1|||
106162795|NCT00085735|366260165|FG001|Overall Study|Protocol Violation|0|||
106162796|NCT00085735|366260166|FG002|Overall Study|Protocol Violation|0|||
106162797|NCT00085735|366260167|FG003|Overall Study|Protocol Violation|0|||
106162798|NCT00085735|366260168|FG004|Overall Study|Protocol Violation|0|||
106162799|NCT00085735|366260169|FG005|Overall Study|Protocol Violation|0|||
106162800|NCT00085735|366260164|FG000|Overall Study|Withdrawal by Subject|1|||
106162801|NCT00085735|366260165|FG001|Overall Study|Withdrawal by Subject|0|||
106162802|NCT00085735|366260166|FG002|Overall Study|Withdrawal by Subject|4|||
106162803|NCT00085735|366260167|FG003|Overall Study|Withdrawal by Subject|5|||
106162804|NCT00085735|366260168|FG004|Overall Study|Withdrawal by Subject|7|||
106162805|NCT00085735|366260169|FG005|Overall Study|Withdrawal by Subject|8|||
106162806|NCT00085735|366260164|FG000|Overall Study|Patient ineligible|1|||
106162807|NCT00085735|366260165|FG001|Overall Study|Patient ineligible|0|||
106162808|NCT00085735|366260166|FG002|Overall Study|Patient ineligible|3|||
106162809|NCT00085735|366260167|FG003|Overall Study|Patient ineligible|7|||
106162810|NCT00085735|366260168|FG004|Overall Study|Patient ineligible|17|||
106162811|NCT00085735|366260169|FG005|Overall Study|Patient ineligible|8|||
106162812|NCT00085735|366260164|FG000|Overall Study|Excess residual disease|2|||
106162813|NCT00085735|366260165|FG001|Overall Study|Excess residual disease|2|||
106162814|NCT00085735|366260166|FG002|Overall Study|Excess residual disease|1|||
106162815|NCT00085735|366260167|FG003|Overall Study|Excess residual disease|1|||
106162816|NCT00085735|366260168|FG004|Overall Study|Excess residual disease|1|||
106162817|NCT00085735|366260169|FG005|Overall Study|Excess residual disease|4|||
106162818|NCT00085735|366260164|FG000|Overall Study|Reason not documented|1|||
106162819|NCT00085735|366260165|FG001|Overall Study|Reason not documented|0|||
106162820|NCT00085735|366260166|FG002|Overall Study|Reason not documented|1|||
106162821|NCT00085735|366260167|FG003|Overall Study|Reason not documented|0|||
106162822|NCT00085735|366260168|FG004|Overall Study|Reason not documented|1|||
106162823|NCT00085735|366260169|FG005|Overall Study|Reason not documented|0|||
106162824|NCT00085735|366260164|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
106162825|NCT00085735|366260165|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
106162826|NCT00085735|366260166|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
106162827|NCT00085735|366260167|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
106162828|NCT00085735|366260168|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
106162829|NCT00085735|366260169|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
106162830|NCT02919306|366260172|FG000|Overall Study|Withdrawal by Subject|1|||
106162831|NCT02919306|366260173|FG001|Overall Study|Withdrawal by Subject|0|||
106162832|NCT02919306|366260172|FG000|Overall Study|Protocol Violation|1|||
106162833|NCT02919306|366260173|FG001|Overall Study|Protocol Violation|0|||
106162834|NCT01959425|366260178|FG000|Overall Study|Withdrawal by Subject|5|||
106162835|NCT01959425|366260179|FG001|Overall Study|Withdrawal by Subject|4|||
106162836|NCT01959425|366260178|FG000|Overall Study|Lost to Follow-up|1|||
106162837|NCT01959425|366260179|FG001|Overall Study|Lost to Follow-up|0|||
106162838|NCT01959425|366260178|FG000|Overall Study|Discontinued Subjects|6|||
106162839|NCT01959425|366260179|FG001|Overall Study|Discontinued Subjects|4|||
106162840|NCT02262728|366260188|FG000|Follow-up Phase (3 Years)|Death|0|||
106162841|NCT02262728|366260189|FG001|Follow-up Phase (3 Years)|Death|1|||
106162842|NCT02262728|366260188|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
106162843|NCT02262728|366260189|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
106162844|NCT02262728|366260188|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
106162845|NCT02262728|366260189|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
106162846|NCT04625283|366260190|FG000|Overall Study|post randomization exclusion|28|||
106162847|NCT04625283|366260191|FG001|Overall Study|post randomization exclusion|20|||
106162848|NCT05256017|366260194|FG000|Treatment Period|Withdrawal by Subject|1|||
106162849|NCT05256017|366260195|FG001|Treatment Period|Withdrawal by Subject|1|||
106162850|NCT05256017|366260194|FG000|Follow-up|Lost to Follow-up|7|||
106162851|NCT05256017|366260195|FG001|Follow-up|Lost to Follow-up|1|||
106162852|NCT05256017|366260194|FG000|Follow-up|Withdrawal by Subject|1|||
106162853|NCT05256017|366260195|FG001|Follow-up|Withdrawal by Subject|0|||
106162854|NCT05256017|366260194|FG000|Follow-up|Death|0|||
106162855|NCT05256017|366260195|FG001|Follow-up|Death|1|||
106162856|NCT05780437|366260200|FG000|Overall Study|Withdrawal by Subject|22|||
106162857|NCT05780437|366260201|FG001|Overall Study|Withdrawal by Subject|16|||
106162858|NCT03640312|366260202|FG000|Overall Study|Lost to Follow-up|3|||
106162859|NCT03640312|366260203|FG001|Overall Study|Lost to Follow-up|6|||
106162860|NCT03452579|366260208|FG000|Overall Study|Death|0|||
106162861|NCT03452579|366260209|FG001|Overall Study|Death|1|||
106162862|NCT03452579|366260208|FG000|Overall Study|Withdrawal by Subject|2|||
106162863|NCT03452579|366260209|FG001|Overall Study|Withdrawal by Subject|0|||
106162864|NCT03452579|366260208|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
106162865|NCT03452579|366260209|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
106162866|NCT03452579|366260208|FG000|Overall Study|Physician Decision|1|||
106162867|NCT03452579|366260209|FG001|Overall Study|Physician Decision|1|||
106162868|NCT03452579|366260208|FG000|Overall Study|Adverse Event|1|||
106162869|NCT03452579|366260209|FG001|Overall Study|Adverse Event|4|||
106162870|NCT04858321|366260210|FG000|Overall Study|Withdrawal by Subject|3|||
106162871|NCT01539083|366260211|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
106162872|NCT01539083|366260212|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
106162873|NCT01539083|366260213|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
106162874|NCT01539083|366260211|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
106162875|NCT01539083|366260212|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
106162876|NCT01539083|366260213|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
106162877|NCT01539083|366260211|FG000|Before Randomization (VCD Induction)|Death|6|||
106162878|NCT01539083|366260212|FG001|Before Randomization (VCD Induction)|Death|0|||
106162879|NCT01539083|366260213|FG002|Before Randomization (VCD Induction)|Death|0|||
106162880|NCT01539083|366260211|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
106162881|NCT01539083|366260212|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
106162882|NCT01539083|366260213|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
106162883|NCT01539083|366260211|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
106162884|NCT01539083|366260212|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
106162885|NCT01539083|366260213|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
106162886|NCT01539083|366260211|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
106162887|NCT01539083|366260212|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
106162888|NCT01539083|366260213|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
106162889|NCT01539083|366260211|FG000|Before Randomization (VCD Induction)|Other|5|||
106162890|NCT01539083|366260212|FG001|Before Randomization (VCD Induction)|Other|0|||
106162891|NCT01539083|366260213|FG002|Before Randomization (VCD Induction)|Other|0|||
106162892|NCT01539083|366260211|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
106162893|NCT01539083|366260212|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
106162894|NCT01539083|366260213|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
106162895|NCT01539083|366260211|FG000|After Randomization (TP and VTP)|Other|0|||
106162896|NCT01539083|366260212|FG001|After Randomization (TP and VTP)|Other|1|||
106162897|NCT01539083|366260213|FG002|After Randomization (TP and VTP)|Other|1|||
106162898|NCT01539083|366260211|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
106162899|NCT01539083|366260212|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
106162900|NCT01539083|366260213|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
106162901|NCT01539083|366260211|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
106162902|NCT01539083|366260212|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
106162903|NCT01539083|366260213|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
106162904|NCT01539083|366260211|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
106162905|NCT01539083|366260212|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
106162906|NCT01539083|366260213|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
106162907|NCT01539083|366260211|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
106162908|NCT01539083|366260212|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
106162909|NCT01539083|366260213|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
106162910|NCT01539083|366260211|FG000|After Randomization (TP and VTP)|Death|0|||
106162911|NCT01539083|366260212|FG001|After Randomization (TP and VTP)|Death|6|||
106162912|NCT01539083|366260213|FG002|After Randomization (TP and VTP)|Death|11|||
106162913|NCT05071053|366260220|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|2|||
106162914|NCT05071053|366260220|FG000|Overall Study|Progressive disease|28|||
106162915|NCT05071053|366260220|FG000|Overall Study|Adverse Event|5|||
106162916|NCT04350463|366260227|FG000|Overall Study|Other reason|0|||
106162917|NCT04350463|366260228|FG001|Overall Study|Other reason|0|||
106162918|NCT04350463|366260229|FG002|Overall Study|Other reason|0|||
106162919|NCT04350463|366260230|FG003|Overall Study|Other reason|1|||
106162920|NCT04350463|366260227|FG000|Overall Study|Lost to Follow-up|0|||
106095886|NCT00320216|366007328|FG002|Overall Study|Other|5|||
106095887|NCT00320216|366007329|FG003|Overall Study|Other|1|||
106095888|NCT00320216|366007330|FG004|Overall Study|Other|3|||
106095889|NCT00779246|366007331|FG000|Overall Study|Missing sufficient data for analysis|33|||
106095890|NCT00779246|366007332|FG001|Overall Study|Missing sufficient data for analysis|53|||
106095891|NCT03579459|366007335|FG000|Overall Study|Adverse Event|7|||
106095892|NCT03579459|366007336|FG001|Overall Study|Adverse Event|6|||
106095893|NCT03579459|366007337|FG002|Overall Study|Adverse Event|2|||
106095894|NCT03579459|366007338|FG003|Overall Study|Adverse Event|6|||
106095895|NCT03579459|366007335|FG000|Overall Study|Death|1|||
106095896|NCT03579459|366007336|FG001|Overall Study|Death|0|||
106095897|NCT03579459|366007337|FG002|Overall Study|Death|1|||
106095898|NCT03579459|366007338|FG003|Overall Study|Death|2|||
106095899|NCT03579459|366007335|FG000|Overall Study|Lost to Follow-up|6|||
106095900|NCT03579459|366007336|FG001|Overall Study|Lost to Follow-up|2|||
106095901|NCT03579459|366007337|FG002|Overall Study|Lost to Follow-up|4|||
106095902|NCT03579459|366007338|FG003|Overall Study|Lost to Follow-up|1|||
106095903|NCT03579459|366007335|FG000|Overall Study|Physician Decision|0|||
106095904|NCT03579459|366007336|FG001|Overall Study|Physician Decision|1|||
106095905|NCT03579459|366007337|FG002|Overall Study|Physician Decision|0|||
106095906|NCT03579459|366007338|FG003|Overall Study|Physician Decision|1|||
106095907|NCT03579459|366007335|FG000|Overall Study|Protocol Violation|1|||
106095908|NCT03579459|366007336|FG001|Overall Study|Protocol Violation|2|||
106095909|NCT03579459|366007337|FG002|Overall Study|Protocol Violation|3|||
106162921|NCT04350463|366260228|FG001|Overall Study|Lost to Follow-up|0|||
106162922|NCT04350463|366260229|FG002|Overall Study|Lost to Follow-up|0|||
106162923|NCT04350463|366260230|FG003|Overall Study|Lost to Follow-up|2|||
106162924|NCT04350463|366260227|FG000|Overall Study|Withdrawal by Subject|4|||
106162925|NCT04350463|366260228|FG001|Overall Study|Withdrawal by Subject|0|||
106162926|NCT04350463|366260229|FG002|Overall Study|Withdrawal by Subject|1|||
106095910|NCT03579459|366007338|FG003|Overall Study|Protocol Violation|5|||
106095911|NCT03579459|366007335|FG000|Overall Study|Withdrawal by Subject|12|||
106095912|NCT03579459|366007336|FG001|Overall Study|Withdrawal by Subject|8|||
106095913|NCT03579459|366007337|FG002|Overall Study|Withdrawal by Subject|11|||
106095914|NCT03579459|366007338|FG003|Overall Study|Withdrawal by Subject|8|||
106095915|NCT03579459|366007335|FG000|Overall Study|Medication error without associated adverse event|2|||
106095916|NCT03579459|366007336|FG001|Overall Study|Medication error without associated adverse event|1|||
106095917|NCT03579459|366007337|FG002|Overall Study|Medication error without associated adverse event|1|||
106095918|NCT03579459|366007338|FG003|Overall Study|Medication error without associated adverse event|0|||
106095919|NCT03579459|366007335|FG000|Overall Study|Other|0|||
106095920|NCT03579459|366007336|FG001|Overall Study|Other|1|||
106095921|NCT03579459|366007337|FG002|Overall Study|Other|1|||
106095922|NCT03579459|366007338|FG003|Overall Study|Other|0|||
106095923|NCT03579459|366007335|FG000|Overall Study|Randomized not vaccinated|0|||
106095924|NCT03579459|366007336|FG001|Overall Study|Randomized not vaccinated|2|||
106095925|NCT03579459|366007337|FG002|Overall Study|Randomized not vaccinated|0|||
106095926|NCT03579459|366007338|FG003|Overall Study|Randomized not vaccinated|1|||
106095927|NCT04000165|366007339|FG000|Overall Study|Physician Decision|1|||
106095928|NCT04000165|366007339|FG000|Overall Study|Withdrawal by Subject|1|||
106095929|NCT00499889|366007344|FG000|Overall Study|Infection prior to treatment|1|||
106095930|NCT01660763|366007348|FG000|Overall Study|Lack of Efficacy|45|||
106095931|NCT01660763|366007349|FG001|Overall Study|Lack of Efficacy|50|||
106095932|NCT01660763|366007348|FG000|Overall Study|Adverse Event|22|||
106095933|NCT01660763|366007349|FG001|Overall Study|Adverse Event|7|||
106095934|NCT01660763|366007348|FG000|Overall Study|Protocol Violation|1|||
106095935|NCT01660763|366007349|FG001|Overall Study|Protocol Violation|0|||
106095936|NCT01660763|366007348|FG000|Overall Study|Withdrawal by Subject|4|||
106095937|NCT01660763|366007349|FG001|Overall Study|Withdrawal by Subject|0|||
106095938|NCT01660763|366007348|FG000|Overall Study|Patient ready for early discharge|28|||
106095939|NCT01660763|366007349|FG001|Overall Study|Patient ready for early discharge|4|||
106095940|NCT00345397|366007350|FG000|Overall Study|Death|1|||
106095941|NCT01870843|366007351|FG000|Overall Study|Adverse Event|10|||
106095942|NCT01870843|366007351|FG000|Overall Study|Lost to Follow-up|24|||
106095943|NCT01870843|366007351|FG000|Overall Study|Death|1|||
106095944|NCT01870843|366007351|FG000|Overall Study|Withdrawal by Subject|18|||
106095945|NCT01910519|366007354|FG000|Overall Study|Withdrawal by Subject|2|||
106095946|NCT01910519|366007355|FG001|Overall Study|Withdrawal by Subject|0|||
106095947|NCT01910519|366007354|FG000|Overall Study|Adverse Event|2|||
106095948|NCT01910519|366007355|FG001|Overall Study|Adverse Event|0|||
106095949|NCT04266028|366007356|FG000|Overall Study|Adverse Event|0|||
106095950|NCT04266028|366007357|FG001|Overall Study|Adverse Event|0|||
106095951|NCT04266028|366007358|FG002|Overall Study|Adverse Event|1|||
106095952|NCT04266028|366007359|FG003|Overall Study|Adverse Event|0|||
106095953|NCT04266028|366007360|FG004|Overall Study|Adverse Event|1|||
106095954|NCT04266028|366007361|FG005|Overall Study|Adverse Event|0|||
106095955|NCT04266028|366007362|FG006|Overall Study|Adverse Event|2|||
106095956|NCT04266028|366007363|FG007|Overall Study|Adverse Event|0|||
106095957|NCT04266028|366007356|FG000|Overall Study|temporary halt of the study|0|||
106095958|NCT04266028|366007357|FG001|Overall Study|temporary halt of the study|0|||
106095959|NCT04266028|366007358|FG002|Overall Study|temporary halt of the study|0|||
106095960|NCT04266028|366007359|FG003|Overall Study|temporary halt of the study|0|||
106095961|NCT04266028|366007360|FG004|Overall Study|temporary halt of the study|0|||
106095962|NCT04266028|366007361|FG005|Overall Study|temporary halt of the study|0|||
106095963|NCT04266028|366007362|FG006|Overall Study|temporary halt of the study|2|||
106095964|NCT04266028|366007363|FG007|Overall Study|temporary halt of the study|1|||
106095965|NCT04266028|366007356|FG000|Overall Study|Onset of birch pollen season|0|||
106095966|NCT04266028|366007357|FG001|Overall Study|Onset of birch pollen season|0|||
106095967|NCT04266028|366007358|FG002|Overall Study|Onset of birch pollen season|0|||
106095968|NCT04266028|366007359|FG003|Overall Study|Onset of birch pollen season|0|||
106095969|NCT04266028|366007360|FG004|Overall Study|Onset of birch pollen season|1|||
106095970|NCT04266028|366007361|FG005|Overall Study|Onset of birch pollen season|0|||
106095971|NCT04266028|366007362|FG006|Overall Study|Onset of birch pollen season|0|||
106095972|NCT04266028|366007363|FG007|Overall Study|Onset of birch pollen season|0|||
106095973|NCT04964089|366007364|FG000|Overall Study|Adverse Event|8|||
106095974|NCT04964089|366007365|FG001|Overall Study|Adverse Event|6|||
106095975|NCT04964089|366007364|FG000|Overall Study|Non-compliance with study schedule|1|||
106095976|NCT04964089|366007365|FG001|Overall Study|Non-compliance with study schedule|0|||
106095977|NCT04964089|366007364|FG000|Overall Study|Withdrawal by Subject|6|||
106095978|NCT04964089|366007365|FG001|Overall Study|Withdrawal by Subject|5|||
106095979|NCT04964089|366007364|FG000|Overall Study|Lost to Follow-up|1|||
106095980|NCT04964089|366007365|FG001|Overall Study|Lost to Follow-up|1|||
106095981|NCT04964089|366007364|FG000|Overall Study|Progressive disease|4|||
106095982|NCT04964089|366007365|FG001|Overall Study|Progressive disease|0|||
106095983|NCT04964089|366007364|FG000|Overall Study|Physician Decision|1|||
106095984|NCT04964089|366007365|FG001|Overall Study|Physician Decision|0|||
106095985|NCT04964089|366007364|FG000|Overall Study|Participant did not want to continue study treatment|1|||
106095986|NCT04964089|366007365|FG001|Overall Study|Participant did not want to continue study treatment|0|||
106095987|NCT04964089|366007364|FG000|Overall Study|Participant moved to different state|1|||
106095988|NCT04964089|366007365|FG001|Overall Study|Participant moved to different state|0|||
106095989|NCT04964089|366007364|FG000|Overall Study|Participant decided to discontinue|0|||
106095990|NCT04964089|366007365|FG001|Overall Study|Participant decided to discontinue|1|||
106095991|NCT03021187|366007366|FG000|Overall Study|Death|0|||
106095992|NCT03021187|366007367|FG001|Overall Study|Death|0|||
106095993|NCT03021187|366007368|FG002|Overall Study|Death|3|||
106095994|NCT03021187|366007369|FG003|Overall Study|Death|0|||
106095995|NCT03021187|366007366|FG000|Overall Study|Withdrawal by Subject|0|||
106095996|NCT03021187|366007367|FG001|Overall Study|Withdrawal by Subject|6|||
106095997|NCT03021187|366007368|FG002|Overall Study|Withdrawal by Subject|2|||
106095998|NCT03021187|366007369|FG003|Overall Study|Withdrawal by Subject|5|||
106095999|NCT03021187|366007366|FG000|Overall Study|Lost to Follow-up|10|||
106096000|NCT03021187|366007367|FG001|Overall Study|Lost to Follow-up|3|||
106096001|NCT03021187|366007368|FG002|Overall Study|Lost to Follow-up|1|||
106096002|NCT03021187|366007369|FG003|Overall Study|Lost to Follow-up|4|||
106096003|NCT03351049|366007370|FG000|Overall Study|Withdrawal|26|||
106096004|NCT03351049|366007371|FG001|Overall Study|Withdrawal|22|||
106096005|NCT01617629|366007372|FG000|Overall Study|Death|2|||
106096006|NCT01617629|366007372|FG000|Overall Study|Investigator's Clinical Judgement|1|||
106096007|NCT01617629|366007372|FG000|Overall Study|Reason Not Specified|1|||
106096008|NCT01617629|366007372|FG000|Overall Study|Participant Withdrew Consent|2|||
106096009|NCT01462344|366007373|FG000|Overall Study|Withdrawal by Subject|245|||
106096010|NCT01462344|366007374|FG001|Overall Study|Withdrawal by Subject|226|||
106096011|NCT01462344|366007373|FG000|Overall Study|Adverse Event|24|||
106096012|NCT01462344|366007374|FG001|Overall Study|Adverse Event|23|||
106096013|NCT01462344|366007373|FG000|Overall Study|Asthma Exacerbation|34|||
106096014|NCT01462344|366007374|FG001|Overall Study|Asthma Exacerbation|35|||
106096015|NCT01462344|366007373|FG000|Overall Study|Lack of Efficacy|5|||
106096016|NCT01462344|366007374|FG001|Overall Study|Lack of Efficacy|6|||
106096017|NCT01462344|366007373|FG000|Overall Study|Protocol Violation|68|||
106096018|NCT01462344|366007374|FG001|Overall Study|Protocol Violation|53|||
106096019|NCT01462344|366007373|FG000|Overall Study|Lost to Follow-up|7|||
106096020|NCT01462344|366007374|FG001|Overall Study|Lost to Follow-up|7|||
106096021|NCT00724971|366007375|FG000|Overall Study|Adverse Event|5|||
106096022|NCT00724971|366007375|FG000|Overall Study|Withdrawal by Subject|1|||
106096023|NCT01003249|366007376|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
106096024|NCT01003249|366007377|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
106096025|NCT01003249|366007376|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
106096026|NCT01003249|366007377|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
106096027|NCT01003249|366007376|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
106096028|NCT01003249|366007377|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
106096029|NCT01003249|366007376|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
106096030|NCT01003249|366007377|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
106096031|NCT01962974|366007380|FG000|Overall Study|Study termination|7|||
106096032|NCT02838017|366007381|FG000|Overall Study|Lost to Follow-up|14|||
106096033|NCT02838017|366007382|FG001|Overall Study|Lost to Follow-up|11|||
106096034|NCT01692197|366007383|FG000|Overall Study|Failed Screening|3|||
106096035|NCT03283670|366007393|FG000|Placebo Gas|Withdrawal by Subject|2|||
106096036|NCT03283670|366007393|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
106096037|NCT03283670|366007393|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
106096038|NCT02276482|366007396|FG000|Overall Study|Adverse Event|1|||
106096039|NCT02276482|366007397|FG001|Overall Study|Adverse Event|0|||
106096040|NCT02276482|366007396|FG000|Overall Study|Withdrawal by Subject|1|||
106096041|NCT02276482|366007397|FG001|Overall Study|Withdrawal by Subject|0|||
106096042|NCT02276482|366007396|FG000|Overall Study|Gram-negative infection|1|||
106096043|NCT02276482|366007397|FG001|Overall Study|Gram-negative infection|0|||
106096044|NCT02276482|366007396|FG000|Overall Study|Reason not specified|0|||
106096045|NCT02276482|366007397|FG001|Overall Study|Reason not specified|1|||
106096046|NCT02863991|366007398|FG000|Overall Study|Death|0|||
106096047|NCT02863991|366007399|FG001|Overall Study|Death|3|||
106096048|NCT02863991|366007398|FG000|Overall Study|Lack of Efficacy|0|||
106096049|NCT02863991|366007399|FG001|Overall Study|Lack of Efficacy|1|||
106096050|NCT02863991|366007398|FG000|Overall Study|Study Terminated|2|||
106096051|NCT02863991|366007399|FG001|Overall Study|Study Terminated|8|||
106096052|NCT01055639|366009079|FG000|Overall Study|Adverse Event|0|||
106096053|NCT01055639|366009080|FG001|Overall Study|Adverse Event|1|||
106096054|NCT01055639|366009079|FG000|Overall Study|Lack of Efficacy|0|||
106096055|NCT01055639|366009080|FG001|Overall Study|Lack of Efficacy|1|||
106096056|NCT01055639|366009079|FG000|Overall Study|Lost to Follow-up|8|||
106096057|NCT01055639|366009080|FG001|Overall Study|Lost to Follow-up|11|||
106096058|NCT01055639|366009079|FG000|Overall Study|Protocol Violation|5|||
106096059|NCT01055639|366009080|FG001|Overall Study|Protocol Violation|5|||
106096060|NCT01055639|366009079|FG000|Overall Study|Withdrawal by Subject|8|||
106096061|NCT01055639|366009080|FG001|Overall Study|Withdrawal by Subject|11|||
106096062|NCT00562159|366009081|FG000|Overall Study|Adverse Event|11|||
106096063|NCT00562159|366009082|FG001|Overall Study|Adverse Event|8|||
106096064|NCT00562159|366009081|FG000|Overall Study|Lost to Follow-up|5|||
106096065|NCT00562159|366009082|FG001|Overall Study|Lost to Follow-up|4|||
106096066|NCT00562159|366009081|FG000|Overall Study|Withdrawal by Subject|9|||
106096067|NCT00562159|366009082|FG001|Overall Study|Withdrawal by Subject|8|||
106096068|NCT00562159|366009081|FG000|Overall Study|Protocol Violation|12|||
106096069|NCT00562159|366009082|FG001|Overall Study|Protocol Violation|12|||
106096070|NCT00562159|366009081|FG000|Overall Study|Did not meet protocol eligibility|1|||
106096071|NCT00562159|366009082|FG001|Overall Study|Did not meet protocol eligibility|1|||
106096072|NCT02473952|366009083|FG000|Overall Study|Adverse Event|2|||
106096073|NCT02473952|366009084|FG001|Overall Study|Adverse Event|2|||
106096074|NCT02473952|366009083|FG000|Overall Study|Withdrawal by Subject|0|||
106096075|NCT02473952|366009084|FG001|Overall Study|Withdrawal by Subject|6|||
106096076|NCT00823719|366009085|FG000|Overall Study|Adverse Event|1|||
106096077|NCT00823719|366009086|FG001|Overall Study|Adverse Event|2|||
106096078|NCT00823719|366009085|FG000|Overall Study|Physician Decision|1|||
106096079|NCT00823719|366009086|FG001|Overall Study|Physician Decision|4|||
106096080|NCT00823719|366009085|FG000|Overall Study|Withdrawal by Subject|0|||
106096081|NCT00823719|366009086|FG001|Overall Study|Withdrawal by Subject|1|||
106096082|NCT00823719|366009085|FG000|Overall Study|Disease Progression|4|||
106096083|NCT00823719|366009086|FG001|Overall Study|Disease Progression|4|||
106096084|NCT01286779|366009089|FG000|Overall Study|Withdrawal by Subject|9|||
106096085|NCT01286779|366009089|FG000|Overall Study|Protocol Violation|5|||
106096086|NCT01286779|366009089|FG000|Overall Study|Physician Decision|2|||
106096087|NCT01286779|366009089|FG000|Overall Study|Participant had scheduled surgery|1|||
106096088|NCT01286779|366009089|FG000|Overall Study|Participant moved to another country|1|||
106096089|NCT01286779|366009089|FG000|Overall Study|Discontinued by sponsor|1|||
106096090|NCT01205685|366009090|FG000|Overall Study|Disease Progression|10|||
106096091|NCT01205685|366009090|FG000|Overall Study|Withdrawal by Subject|1|||
106096092|NCT03349710|366009091|FG000|Treatment Period|Death|0|||
106096093|NCT03349710|366009092|FG001|Treatment Period|Death|0|||
106096094|NCT03349710|366009093|FG002|Treatment Period|Death|1|||
106096095|NCT03349710|366009094|FG003|Treatment Period|Death|0|||
106096096|NCT03349710|366009091|FG000|Treatment Period|Disease Progression|0|||
106096097|NCT03349710|366009092|FG001|Treatment Period|Disease Progression|2|||
106096098|NCT03349710|366009093|FG002|Treatment Period|Disease Progression|0|||
106096099|NCT03349710|366009094|FG003|Treatment Period|Disease Progression|1|||
106096100|NCT03349710|366009091|FG000|Treatment Period|Study Drug Toxicity|1|||
106096101|NCT03349710|366009092|FG001|Treatment Period|Study Drug Toxicity|0|||
106096102|NCT03349710|366009093|FG002|Treatment Period|Study Drug Toxicity|1|||
106096103|NCT03349710|366009094|FG003|Treatment Period|Study Drug Toxicity|1|||
106096104|NCT03349710|366009091|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
106096105|NCT03349710|366009092|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
106096106|NCT03349710|366009093|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
106096107|NCT03349710|366009094|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
106096108|NCT03349710|366009091|FG000|Treatment Period|admin reason by sponsor|0|||
106096109|NCT03349710|366009092|FG001|Treatment Period|admin reason by sponsor|7|||
106096110|NCT03349710|366009093|FG002|Treatment Period|admin reason by sponsor|0|||
106096111|NCT03349710|366009094|FG003|Treatment Period|admin reason by sponsor|19|||
106096112|NCT03349710|366009091|FG000|Treatment Period|Other Reason|2|||
106096113|NCT03349710|366009092|FG001|Treatment Period|Other Reason|0|||
106096114|NCT03349710|366009093|FG002|Treatment Period|Other Reason|2|||
106096115|NCT03349710|366009094|FG003|Treatment Period|Other Reason|1|||
106096116|NCT03349710|366009091|FG000|Treatment Period|completed|6|||
106096117|NCT03349710|366009092|FG001|Treatment Period|completed|0|||
106096118|NCT03349710|366009093|FG002|Treatment Period|completed|18|||
106096119|NCT03349710|366009094|FG003|Treatment Period|completed|1|||
106096120|NCT03349710|366009091|FG000|Treatment Period|participant request to discontinue|0|||
106096121|NCT03349710|366009092|FG001|Treatment Period|participant request to discontinue|0|||
106096122|NCT03349710|366009093|FG002|Treatment Period|participant request to discontinue|4|||
106096123|NCT03349710|366009094|FG003|Treatment Period|participant request to discontinue|0|||
106096124|NCT03349710|366009091|FG000|Treatment Period|participant withdrew consent|1|||
106096125|NCT03349710|366009092|FG001|Treatment Period|participant withdrew consent|0|||
106096126|NCT03349710|366009093|FG002|Treatment Period|participant withdrew consent|0|||
106096127|NCT03349710|366009094|FG003|Treatment Period|participant withdrew consent|0|||
106096128|NCT01343368|366009095|FG000|Overall Study|Death|1|||
106096129|NCT01343368|366009096|FG001|Overall Study|Death|0|||
106096130|NCT01343368|366009095|FG000|Overall Study|Lost to Follow-up|1|||
106096131|NCT01343368|366009096|FG001|Overall Study|Lost to Follow-up|0|||
106096132|NCT00563784|366009097|FG000|Overall Study|Withdrawal by Subject|2|||
106096133|NCT00563784|366009097|FG000|Overall Study|Screen Failures|20|||
106096134|NCT02528214|366009098|FG000|Overall Study|Protocol Violation|0|||
106096135|NCT02528214|366009099|FG001|Overall Study|Protocol Violation|1|||
106096136|NCT02528214|366009098|FG000|Overall Study|Adverse Event|0|||
106096137|NCT02528214|366009099|FG001|Overall Study|Adverse Event|1|||
106096138|NCT02528214|366009098|FG000|Overall Study|Other than specified above|0|||
106096139|NCT02528214|366009099|FG001|Overall Study|Other than specified above|1|||
106096140|NCT02079805|366009103|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
106096141|NCT02079805|366009104|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
106096142|NCT02079805|366009103|FG000|Overall Study|Voluntary Withdrawal|0|||
106096143|NCT02079805|366009104|FG001|Overall Study|Voluntary Withdrawal|1|||
106096144|NCT01519206|366009105|FG000|Overall Study|Lost to Follow-up|3|||
106096145|NCT01519206|366009105|FG000|Overall Study|Missed Visit|2|||
106162927|NCT04350463|366260230|FG003|Overall Study|Withdrawal by Subject|4|||
106162928|NCT04350463|366260227|FG000|Overall Study|Adverse Event|0|||
106162929|NCT04350463|366260228|FG001|Overall Study|Adverse Event|0|||
106162930|NCT04350463|366260229|FG002|Overall Study|Adverse Event|0|||
106162931|NCT04350463|366260230|FG003|Overall Study|Adverse Event|2|||
106162932|NCT04350463|366260227|FG000|Overall Study|Death|27|||
106162933|NCT04350463|366260228|FG001|Overall Study|Death|2|||
106162934|NCT04350463|366260229|FG002|Overall Study|Death|13|||
106162935|NCT04350463|366260230|FG003|Overall Study|Death|26|||
106162936|NCT04187833|366260231|FG000|Overall Study|Withdrawal by Subject|1|||
106162937|NCT02268253|366260232|FG000|Stage 1|Withdrawal by Subject|1|||
106162938|NCT02268253|366260233|FG001|Stage 1|Withdrawal by Subject|0|||
106162939|NCT02268253|366260234|FG002|Stage 1|Withdrawal by Subject|0|||
106162940|NCT02268253|366260235|FG003|Stage 1|Withdrawal by Subject|0|||
106162941|NCT02268253|366260236|FG004|Stage 1|Withdrawal by Subject|0|||
106162942|NCT02268253|366260237|FG005|Stage 1|Withdrawal by Subject|0|||
106162943|NCT02268253|366260238|FG006|Stage 1|Withdrawal by Subject|0|||
106162944|NCT02268253|366260232|FG000|Stage 1|Death|0|||
106162945|NCT02268253|366260233|FG001|Stage 1|Death|2|||
106162946|NCT02268253|366260234|FG002|Stage 1|Death|2|||
106162947|NCT02268253|366260235|FG003|Stage 1|Death|2|||
106162948|NCT02268253|366260236|FG004|Stage 1|Death|1|||
106162949|NCT02268253|366260237|FG005|Stage 1|Death|1|||
106162950|NCT02268253|366260238|FG006|Stage 1|Death|0|||
106162951|NCT02268253|366260232|FG000|Stage 2|Disease Recurrence/ Progression|0|||
106162952|NCT02268253|366260233|FG001|Stage 2|Disease Recurrence/ Progression|0|||
106162953|NCT02268253|366260234|FG002|Stage 2|Disease Recurrence/ Progression|1|||
106162954|NCT02268253|366260235|FG003|Stage 2|Disease Recurrence/ Progression|0|||
106162955|NCT02268253|366260236|FG004|Stage 2|Disease Recurrence/ Progression|0|||
106162956|NCT02268253|366260237|FG005|Stage 2|Disease Recurrence/ Progression|0|||
106162957|NCT02268253|366260238|FG006|Stage 2|Disease Recurrence/ Progression|0|||
106162958|NCT02268253|366260232|FG000|Stage 2|Withdrawal by Subject|0|||
106162959|NCT02268253|366260233|FG001|Stage 2|Withdrawal by Subject|0|||
106162960|NCT02268253|366260234|FG002|Stage 2|Withdrawal by Subject|2|||
106162961|NCT02268253|366260235|FG003|Stage 2|Withdrawal by Subject|0|||
106162962|NCT02268253|366260236|FG004|Stage 2|Withdrawal by Subject|0|||
106162963|NCT02268253|366260237|FG005|Stage 2|Withdrawal by Subject|2|||
106162964|NCT02268253|366260238|FG006|Stage 2|Withdrawal by Subject|0|||
106162965|NCT02268253|366260232|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
106162966|NCT02268253|366260233|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
106162967|NCT02268253|366260234|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
106162968|NCT02268253|366260235|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
106162969|NCT02268253|366260236|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
106162970|NCT02268253|366260237|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
106162971|NCT02268253|366260238|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
106162972|NCT02268253|366260232|FG000|Stage 2|Death|0|||
106162973|NCT02268253|366260233|FG001|Stage 2|Death|0|||
106162974|NCT02268253|366260234|FG002|Stage 2|Death|19|||
106162975|NCT02268253|366260235|FG003|Stage 2|Death|0|||
106162976|NCT02268253|366260236|FG004|Stage 2|Death|0|||
106162977|NCT02268253|366260237|FG005|Stage 2|Death|20|||
106162978|NCT02268253|366260238|FG006|Stage 2|Death|1|||
106162979|NCT02268253|366260232|FG000|Stage 2|Lost to Follow-up|0|||
106162980|NCT02268253|366260233|FG001|Stage 2|Lost to Follow-up|0|||
106162981|NCT02268253|366260234|FG002|Stage 2|Lost to Follow-up|0|||
106162982|NCT02268253|366260235|FG003|Stage 2|Lost to Follow-up|0|||
106162983|NCT02268253|366260236|FG004|Stage 2|Lost to Follow-up|0|||
106162984|NCT02268253|366260237|FG005|Stage 2|Lost to Follow-up|4|||
106162985|NCT02268253|366260238|FG006|Stage 2|Lost to Follow-up|0|||
106162986|NCT02268253|366260232|FG000|Stage 2|Transferred to Hospice|0|||
106162987|NCT02268253|366260233|FG001|Stage 2|Transferred to Hospice|0|||
106162988|NCT02268253|366260234|FG002|Stage 2|Transferred to Hospice|0|||
106162989|NCT02268253|366260235|FG003|Stage 2|Transferred to Hospice|0|||
106162990|NCT02268253|366260236|FG004|Stage 2|Transferred to Hospice|0|||
106162991|NCT02268253|366260237|FG005|Stage 2|Transferred to Hospice|2|||
106162992|NCT02268253|366260238|FG006|Stage 2|Transferred to Hospice|0|||
106162993|NCT02268253|366260232|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
106162994|NCT02268253|366260233|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
106162995|NCT02268253|366260234|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
106162996|NCT02268253|366260235|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
106162997|NCT02268253|366260236|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
106162998|NCT02268253|366260237|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
106162999|NCT02268253|366260238|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
106163000|NCT02268253|366260232|FG000|Stage 3A|Withdrawal by Subject|0|||
106163001|NCT02268253|366260233|FG001|Stage 3A|Withdrawal by Subject|0|||
106163002|NCT02268253|366260234|FG002|Stage 3A|Withdrawal by Subject|2|||
106163003|NCT02268253|366260235|FG003|Stage 3A|Withdrawal by Subject|0|||
106163004|NCT02268253|366260236|FG004|Stage 3A|Withdrawal by Subject|0|||
106163005|NCT02268253|366260237|FG005|Stage 3A|Withdrawal by Subject|0|||
106163006|NCT02268253|366260238|FG006|Stage 3A|Withdrawal by Subject|0|||
106163007|NCT02268253|366260232|FG000|Stage 3A|Physician Decision|0|||
106163008|NCT02268253|366260233|FG001|Stage 3A|Physician Decision|0|||
106163009|NCT02268253|366260234|FG002|Stage 3A|Physician Decision|2|||
106163010|NCT02268253|366260235|FG003|Stage 3A|Physician Decision|0|||
106163011|NCT02268253|366260236|FG004|Stage 3A|Physician Decision|0|||
106163012|NCT02268253|366260237|FG005|Stage 3A|Physician Decision|0|||
106163013|NCT02268253|366260238|FG006|Stage 3A|Physician Decision|0|||
106163014|NCT02268253|366260232|FG000|Stage 3A|Study Terminated by Sponsor|0|||
106163015|NCT02268253|366260233|FG001|Stage 3A|Study Terminated by Sponsor|0|||
106163016|NCT02268253|366260234|FG002|Stage 3A|Study Terminated by Sponsor|2|||
106163017|NCT02268253|366260235|FG003|Stage 3A|Study Terminated by Sponsor|0|||
106163018|NCT02268253|366260236|FG004|Stage 3A|Study Terminated by Sponsor|0|||
106163019|NCT02268253|366260237|FG005|Stage 3A|Study Terminated by Sponsor|0|||
106163020|NCT02268253|366260238|FG006|Stage 3A|Study Terminated by Sponsor|0|||
106163021|NCT02268253|366260232|FG000|Stage 3A|Lost to Follow-up|0|||
106163022|NCT02268253|366260233|FG001|Stage 3A|Lost to Follow-up|0|||
106163023|NCT02268253|366260234|FG002|Stage 3A|Lost to Follow-up|1|||
106163024|NCT02268253|366260235|FG003|Stage 3A|Lost to Follow-up|0|||
106163025|NCT02268253|366260236|FG004|Stage 3A|Lost to Follow-up|0|||
106163026|NCT02268253|366260237|FG005|Stage 3A|Lost to Follow-up|0|||
106163027|NCT02268253|366260238|FG006|Stage 3A|Lost to Follow-up|0|||
106163028|NCT02268253|366260232|FG000|Stage 3A|Death|0|||
106163029|NCT02268253|366260233|FG001|Stage 3A|Death|0|||
106163030|NCT02268253|366260234|FG002|Stage 3A|Death|5|||
106163031|NCT02268253|366260235|FG003|Stage 3A|Death|0|||
106163032|NCT02268253|366260236|FG004|Stage 3A|Death|0|||
106163033|NCT02268253|366260237|FG005|Stage 3A|Death|0|||
106163034|NCT02268253|366260238|FG006|Stage 3A|Death|0|||
106163035|NCT06037369|366260239|FG000|Overall Study|Lost to Follow-up|0|||
106163036|NCT06037369|366260240|FG001|Overall Study|Lost to Follow-up|1|||
106096146|NCT01753193|366009107|FG000|Overall Study|Withdrawal by Subject|23|||
106096147|NCT01753193|366009107|FG000|Overall Study|Lost to Follow-up|6|||
106096148|NCT01753193|366009107|FG000|Overall Study|Death|1|||
106096149|NCT01753193|366009107|FG000|Overall Study|Other|16|||
106096150|NCT01131312|366009108|FG000|Overall Study|Lost to Follow-up|425|||
106096151|NCT01131312|366009109|FG001|Overall Study|Lost to Follow-up|229|||
106096152|NCT01131312|366009110|FG002|Overall Study|Lost to Follow-up|351|||
106096153|NCT02347761|366009111|FG000|All Collected|Death|1|||
106096154|NCT02347761|366009112|FG001|All Collected|Death|0|||
106096155|NCT02347761|366009113|FG002|All Collected|Death|0|||
106096156|NCT02347761|366009111|FG000|All Collected|Lost to Follow-up|3|||
106096157|NCT02347761|366009112|FG001|All Collected|Lost to Follow-up|2|||
106096158|NCT02347761|366009113|FG002|All Collected|Lost to Follow-up|3|||
106096159|NCT02347761|366009111|FG000|All Collected|Withdrawal by Subject|11|||
106096160|NCT02347761|366009112|FG001|All Collected|Withdrawal by Subject|11|||
106096161|NCT02347761|366009113|FG002|All Collected|Withdrawal by Subject|22|||
106096162|NCT02347761|366009111|FG000|All Collected|invetigator disretion|2|||
106096163|NCT02347761|366009112|FG001|All Collected|invetigator disretion|0|||
106096164|NCT02347761|366009113|FG002|All Collected|invetigator disretion|0|||
106096165|NCT02347761|366009111|FG000|All Collected|instillation site pain|0|||
106096166|NCT02347761|366009112|FG001|All Collected|instillation site pain|0|||
106096167|NCT02347761|366009113|FG002|All Collected|instillation site pain|1|||
106096168|NCT02347761|366009111|FG000|All Collected|exacerbation of COPD|0|||
106096169|NCT02347761|366009112|FG001|All Collected|exacerbation of COPD|0|||
106096170|NCT02347761|366009113|FG002|All Collected|exacerbation of COPD|1|||
106096171|NCT02347761|366009111|FG000|All Collected|moved/travel|0|||
106096172|NCT02347761|366009112|FG001|All Collected|moved/travel|1|||
106096173|NCT02347761|366009113|FG002|All Collected|moved/travel|0|||
106096174|NCT02347761|366009111|FG000|On Study Treatment|Lack of Efficacy|2|||
106096175|NCT02347761|366009112|FG001|On Study Treatment|Lack of Efficacy|3|||
106096176|NCT02347761|366009113|FG002|On Study Treatment|Lack of Efficacy|4|||
106096177|NCT02347761|366009111|FG000|On Study Treatment|non-compliance with study medication|0|||
106096178|NCT02347761|366009112|FG001|On Study Treatment|non-compliance with study medication|0|||
106096179|NCT02347761|366009113|FG002|On Study Treatment|non-compliance with study medication|2|||
106096180|NCT02347761|366009111|FG000|On Study Treatment|Withdrawal by Subject|7|||
106163037|NCT05603143|366260241|FG000|Overall Study|Withdrew consent|6|||
106096181|NCT02347761|366009112|FG001|On Study Treatment|Withdrawal by Subject|3|||
106096182|NCT02347761|366009113|FG002|On Study Treatment|Withdrawal by Subject|5|||
106096183|NCT02347761|366009111|FG000|On Study Treatment|move/travel|2|||
106096184|NCT02347761|366009112|FG001|On Study Treatment|move/travel|6|||
106096185|NCT02347761|366009113|FG002|On Study Treatment|move/travel|5|||
106163038|NCT05603143|366260242|FG001|Overall Study|Withdrew consent|2|||
106163039|NCT05603143|366260241|FG000|Overall Study|Randomized but never treated|0|||
106163040|NCT05603143|366260242|FG001|Overall Study|Randomized but never treated|3|||
106163041|NCT05603143|366260241|FG000|Overall Study|Adverse Event|2|||
106163042|NCT05603143|366260242|FG001|Overall Study|Adverse Event|0|||
106163043|NCT05603143|366260241|FG000|Overall Study|Death|0|||
106163044|NCT05603143|366260242|FG001|Overall Study|Death|1|||
106096186|NCT02347761|366009111|FG000|On Study Treatment|dissastisfaction with device|2|||
106163045|NCT05603143|366260241|FG000|Overall Study|Investigator's discretion|1|||
106096187|NCT02347761|366009112|FG001|On Study Treatment|dissastisfaction with device|1|||
106096188|NCT02347761|366009113|FG002|On Study Treatment|dissastisfaction with device|4|||
106096189|NCT02347761|366009111|FG000|On Study Treatment|Lost to Follow-up|2|||
106096190|NCT02347761|366009112|FG001|On Study Treatment|Lost to Follow-up|1|||
106096191|NCT02347761|366009113|FG002|On Study Treatment|Lost to Follow-up|1|||
106096192|NCT02347761|366009111|FG000|On Study Treatment|investigator discretion|2|||
106096193|NCT02347761|366009112|FG001|On Study Treatment|investigator discretion|0|||
106096194|NCT02347761|366009113|FG002|On Study Treatment|investigator discretion|0|||
106096195|NCT02347761|366009111|FG000|On Study Treatment|durg not working|0|||
106096196|NCT02347761|366009112|FG001|On Study Treatment|durg not working|1|||
106096197|NCT02347761|366009113|FG002|On Study Treatment|durg not working|1|||
106096198|NCT02347761|366009111|FG000|On Study Treatment|Adverse Event|10|||
106096199|NCT02347761|366009112|FG001|On Study Treatment|Adverse Event|8|||
106096200|NCT02347761|366009113|FG002|On Study Treatment|Adverse Event|20|||
106096201|NCT01380327|366009114|FG000|Overall Study|Lost to Follow-up|0|||
106096202|NCT01380327|366009115|FG001|Overall Study|Lost to Follow-up|1|||
106096203|NCT01380327|366009116|FG002|Overall Study|Lost to Follow-up|1|||
106096204|NCT01380327|366009114|FG000|Overall Study|Protocol Violation|3|||
106096205|NCT01380327|366009115|FG001|Overall Study|Protocol Violation|2|||
106096206|NCT01380327|366009116|FG002|Overall Study|Protocol Violation|3|||
106096207|NCT01380327|366009114|FG000|Overall Study|Withdrawal by Subject|0|||
106096208|NCT01380327|366009115|FG001|Overall Study|Withdrawal by Subject|0|||
106096209|NCT01380327|366009116|FG002|Overall Study|Withdrawal by Subject|1|||
106096210|NCT01380327|366009114|FG000|Overall Study|Housing situation precluded ability to k|0|||
106096211|NCT01380327|366009115|FG001|Overall Study|Housing situation precluded ability to k|0|||
106096212|NCT01380327|366009116|FG002|Overall Study|Housing situation precluded ability to k|1|||
106096213|NCT01380327|366009114|FG000|Overall Study|Questionable onset of epilepsy|0|||
106096214|NCT01380327|366009115|FG001|Overall Study|Questionable onset of epilepsy|0|||
106096215|NCT01380327|366009116|FG002|Overall Study|Questionable onset of epilepsy|1|||
106096216|NCT03447769|366009117|FG000|Overall Study|Progressive disease|138|||
106096217|NCT03447769|366009118|FG001|Overall Study|Progressive disease|148|||
106096218|NCT03447769|366009117|FG000|Overall Study|Study terminated by Sponsor|60|||
106096219|NCT03447769|366009118|FG001|Overall Study|Study terminated by Sponsor|44|||
106096220|NCT03447769|366009117|FG000|Overall Study|Adverse Event|34|||
106096221|NCT03447769|366009118|FG001|Overall Study|Adverse Event|31|||
106096222|NCT03447769|366009117|FG000|Overall Study|Patient decision|27|||
106096223|NCT03447769|366009118|FG001|Overall Study|Patient decision|27|||
106096224|NCT03447769|366009117|FG000|Overall Study|Protocol deviation|4|||
106096225|NCT03447769|366009118|FG001|Overall Study|Protocol deviation|6|||
106096226|NCT03447769|366009117|FG000|Overall Study|Death|2|||
106096227|NCT03447769|366009118|FG001|Overall Study|Death|7|||
106096228|NCT03447769|366009117|FG000|Overall Study|Technical problems|1|||
106096229|NCT03447769|366009118|FG001|Overall Study|Technical problems|0|||
106096230|NCT03447769|366009117|FG000|Overall Study|Lost to Follow-up|0|||
106096231|NCT03447769|366009118|FG001|Overall Study|Lost to Follow-up|1|||
106096232|NCT03447769|366009117|FG000|Overall Study|Physician Decision|13|||
106096233|NCT03447769|366009118|FG001|Overall Study|Physician Decision|5|||
106096234|NCT03625570|366009119|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
106096235|NCT03625570|366009120|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
106096236|NCT03625570|366009119|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
106096237|NCT03625570|366009120|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
106096238|NCT03625570|366009119|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
106096239|NCT03625570|366009120|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
106096240|NCT01343056|366009121|FG000|Overall Study|Lost to Follow-up|7|||
106096241|NCT01343056|366009122|FG001|Overall Study|Lost to Follow-up|5|||
106096242|NCT01343056|366009123|FG002|Overall Study|Lost to Follow-up|3|||
106096243|NCT01343056|366009124|FG003|Overall Study|Lost to Follow-up|9|||
106096244|NCT01568047|366009125|FG000|Overall Study|Ineligibility|1|||
106096245|NCT01568047|366009126|FG001|Overall Study|Ineligibility|0|||
106096246|NCT01568047|366009127|FG002|Overall Study|Ineligibility|0|||
106096247|NCT01568047|366009128|FG003|Overall Study|Ineligibility|0|||
106096248|NCT01568047|366009125|FG000|Overall Study|Withdrawal by Subject|0|||
106096249|NCT01568047|366009126|FG001|Overall Study|Withdrawal by Subject|1|||
106096250|NCT01568047|366009127|FG002|Overall Study|Withdrawal by Subject|0|||
106096251|NCT01568047|366009128|FG003|Overall Study|Withdrawal by Subject|0|||
106096252|NCT01568047|366009125|FG000|Overall Study|Adverse Event|0|||
106096253|NCT01568047|366009126|FG001|Overall Study|Adverse Event|0|||
106096254|NCT01568047|366009127|FG002|Overall Study|Adverse Event|1|||
106096255|NCT01568047|366009128|FG003|Overall Study|Adverse Event|1|||
106096256|NCT01985126|366009129|FG000|Overall Study|Death|15|||
106096257|NCT01985126|366009130|FG001|Overall Study|Death|69|||
106163046|NCT05603143|366260242|FG001|Overall Study|Investigator's discretion|0|||
106163047|NCT05603143|366260241|FG000|Overall Study|Lost to Follow-up|0|||
106096258|NCT01985126|366009129|FG000|Overall Study|Lost to Follow-up|0|||
106096259|NCT01985126|366009130|FG001|Overall Study|Lost to Follow-up|8|||
106096260|NCT01985126|366009129|FG000|Overall Study|Study Terminated By Sponsor|1|||
106096261|NCT01985126|366009130|FG001|Overall Study|Study Terminated By Sponsor|22|||
106096262|NCT01985126|366009129|FG000|Overall Study|Withdrawal by Subject|2|||
106096263|NCT01985126|366009130|FG001|Overall Study|Withdrawal by Subject|7|||
106096264|NCT06281548|366009133|FG000|Overall Study|Lost to Follow-up|3|||
106096265|NCT01618838|366009134|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
106096266|NCT01764945|366009136|FG000|Overall Study|Adverse Event|0|||
106096267|NCT01764945|366009137|FG001|Overall Study|Adverse Event|1|||
106096268|NCT01764945|366009138|FG002|Overall Study|Adverse Event|0|||
106096269|NCT01764945|366009139|FG003|Overall Study|Adverse Event|0|||
106096270|NCT01764945|366009140|FG004|Overall Study|Adverse Event|0|||
106096271|NCT01764945|366009141|FG005|Overall Study|Adverse Event|0|||
106096272|NCT01764945|366009142|FG006|Overall Study|Adverse Event|1|||
106096273|NCT01764945|366009143|FG007|Overall Study|Adverse Event|0|||
106096274|NCT02911948|366009145|FG000|Overall Study|Protocol Violation|0|||
106096275|NCT02911948|366009146|FG001|Overall Study|Protocol Violation|1|||
106096276|NCT02911948|366009145|FG000|Overall Study|Withdrawal by Subject|0|||
106096277|NCT02911948|366009146|FG001|Overall Study|Withdrawal by Subject|2|||
106096278|NCT02911948|366009145|FG000|Overall Study|Lack of Efficacy|0|||
106096279|NCT02911948|366009146|FG001|Overall Study|Lack of Efficacy|1|||
106096280|NCT02911948|366009145|FG000|Overall Study|Unclassified|0|||
106096281|NCT02911948|366009146|FG001|Overall Study|Unclassified|3|||
106096282|NCT00586105|366009149|FG000|Overall Study|Adverse Event|4|||
106096283|NCT00586105|366009149|FG000|Overall Study|Death|2|||
106096284|NCT00586105|366009149|FG000|Overall Study|Protocol Violation|1|||
106096285|NCT00586105|366009149|FG000|Overall Study|Withdrawal by Subject|3|||
106096286|NCT00586105|366009149|FG000|Overall Study|Disease progression|19|||
106096287|NCT00586105|366009149|FG000|Overall Study|Switched to commercial drug|9|||
106096288|NCT00586105|366009149|FG000|Overall Study|Reason not reported|1|||
106096289|NCT03835533|366009152|FG000|Overall Study|Death|5|||
106096290|NCT03835533|366009153|FG001|Overall Study|Death|10|||
106096291|NCT03835533|366009154|FG002|Overall Study|Death|9|||
106096292|NCT03835533|366009152|FG000|Overall Study|Withdrawal by Subject|2|||
106096293|NCT03835533|366009153|FG001|Overall Study|Withdrawal by Subject|2|||
106096294|NCT03835533|366009154|FG002|Overall Study|Withdrawal by Subject|2|||
106096295|NCT03835533|366009152|FG000|Overall Study|Lost to Follow-up|1|||
106096296|NCT03835533|366009153|FG001|Overall Study|Lost to Follow-up|0|||
106096297|NCT03835533|366009154|FG002|Overall Study|Lost to Follow-up|0|||
106096298|NCT03867734|366009157|FG000|Overall Study|Lost to Follow-up|2|||
106096299|NCT00380068|366009164|FG000|Overall Study|Adverse Event|40|||
106096300|NCT00380068|366009164|FG000|Overall Study|Withdrawal by Subject|10|||
106096301|NCT00380068|366009164|FG000|Overall Study|Not compliant|6|||
106096302|NCT00380068|366009164|FG000|Overall Study|Lost to Follow-up|1|||
106096303|NCT00380068|366009164|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
106096304|NCT00380068|366009164|FG000|Overall Study|Lung transplant|3|||
106096305|NCT00380068|366009164|FG000|Overall Study|Physician Decision|2|||
106096306|NCT00380068|366009164|FG000|Overall Study|Partipant moved away|1|||
106096307|NCT00380068|366009164|FG000|Overall Study|Lack of Efficacy|5|||
106096308|NCT01682837|366009165|FG000|Baseline|Withdrawal by Subject|5|||
106096309|NCT03738150|366009166|FG000|Base Study|Withdrawal by Subject|1|||
106096310|NCT03738150|366009166|FG000|Extension Study|Withdrawal by Subject|1|||
106096311|NCT01898195|366009167|FG000|Smoking Abstinence|Did not have good measurements|35|||
106096312|NCT01898195|366009168|FG001|Smoking Abstinence|Did not have good measurements|38|||
106096313|NCT01898195|366009169|FG002|Smoking Abstinence|Did not have good measurements|36|||
106096314|NCT02663128|366009170|FG000|Period 2|Physician Decision|0|||
106096315|NCT02663128|366009171|FG001|Period 2|Physician Decision|0|||
106096316|NCT02663128|366009172|FG002|Period 2|Physician Decision|0|||
106096317|NCT02663128|366009173|FG003|Period 2|Physician Decision|0|||
106096318|NCT02663128|366009174|FG004|Period 2|Physician Decision|1|||
106096319|NCT02663128|366009175|FG005|Period 2|Physician Decision|0|||
106096320|NCT01358526|366009176|FG000|Open-label Titration Period|Adverse Event|95|||
106096321|NCT01358526|366009177|FG001|Open-label Titration Period|Adverse Event|0|||
106096322|NCT01358526|366009178|FG002|Open-label Titration Period|Adverse Event|0|||
106096323|NCT01358526|366009176|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
106096324|NCT01358526|366009177|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
106096325|NCT01358526|366009178|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
106096326|NCT01358526|366009176|FG000|Open-label Titration Period|Lost to Follow-up|25|||
106096327|NCT01358526|366009177|FG001|Open-label Titration Period|Lost to Follow-up|0|||
106096328|NCT01358526|366009178|FG002|Open-label Titration Period|Lost to Follow-up|0|||
106096329|NCT01358526|366009176|FG000|Open-label Titration Period|Lack of Efficacy|107|||
106096330|NCT01358526|366009177|FG001|Open-label Titration Period|Lack of Efficacy|0|||
106096331|NCT01358526|366009178|FG002|Open-label Titration Period|Lack of Efficacy|0|||
106096332|NCT01358526|366009176|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
106096333|NCT01358526|366009177|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
106096334|NCT01358526|366009178|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
106096335|NCT01358526|366009176|FG000|Open-label Titration Period|Administrative|8|||
106096336|NCT01358526|366009177|FG001|Open-label Titration Period|Administrative|0|||
106163048|NCT05603143|366260242|FG001|Overall Study|Lost to Follow-up|1|||
106163049|NCT05603143|366260241|FG000|Overall Study|Protocol Violation|0|||
106163050|NCT05603143|366260242|FG001|Overall Study|Protocol Violation|1|||
106163051|NCT03097549|366260243|FG000|Overall Study|Withdrawal by Subject|1|||
106163052|NCT03097549|366260244|FG001|Overall Study|Withdrawal by Subject|0|||
106163053|NCT03097549|366260243|FG000|Overall Study|Lost to Follow-up|1|||
106163054|NCT03097549|366260244|FG001|Overall Study|Lost to Follow-up|0|||
106163055|NCT05647304|366260245|FG000|Overall Study|Withdrawal by Subject|1|||
106163056|NCT05647304|366260246|FG001|Overall Study|Withdrawal by Subject|0|||
106163057|NCT04505904|366260247|FG000|Overall Study|Withdrawal by Subject|1|||
106163058|NCT04505904|366260248|FG001|Overall Study|Withdrawal by Subject|2|||
106163059|NCT04505904|366260249|FG002|Overall Study|Withdrawal by Subject|0|||
106163060|NCT04505904|366260250|FG003|Overall Study|Withdrawal by Subject|0|||
106163061|NCT04505904|366260247|FG000|Overall Study|Physician Decision|1|||
106163062|NCT04505904|366260248|FG001|Overall Study|Physician Decision|0|||
106163063|NCT04505904|366260249|FG002|Overall Study|Physician Decision|0|||
106163064|NCT04505904|366260250|FG003|Overall Study|Physician Decision|0|||
106163065|NCT04505904|366260247|FG000|Overall Study|Adverse Event|0|||
106163066|NCT04505904|366260248|FG001|Overall Study|Adverse Event|1|||
106163067|NCT04505904|366260249|FG002|Overall Study|Adverse Event|0|||
106163068|NCT04505904|366260250|FG003|Overall Study|Adverse Event|0|||
106163069|NCT03544281|366260253|FG000|Main Study Phase|Death|3|||
106163070|NCT03544281|366260254|FG001|Main Study Phase|Death|2|||
106163071|NCT03544281|366260255|FG002|Main Study Phase|Death|6|||
106163072|NCT03544281|366260256|FG003|Main Study Phase|Death|8|||
106163073|NCT03544281|366260257|FG004|Main Study Phase|Death|4|||
106163074|NCT03544281|366260258|FG005|Main Study Phase|Death|2|||
106163075|NCT03544281|366260259|FG006|Main Study Phase|Death|4|||
106163076|NCT03544281|366260260|FG007|Main Study Phase|Death|5|||
106163077|NCT03544281|366260261|FG008|Main Study Phase|Death|5|||
106163078|NCT03544281|366260262|FG009|Main Study Phase|Death|8|||
106163079|NCT03544281|366260263|FG010|Main Study Phase|Death|6|||
106163080|NCT03544281|366260264|FG011|Main Study Phase|Death|4|||
106163081|NCT03544281|366260265|FG012|Main Study Phase|Death|0|||
106163082|NCT03544281|366260266|FG013|Main Study Phase|Death|0|||
106163083|NCT03544281|366260267|FG014|Main Study Phase|Death|0|||
106163084|NCT03544281|366260268|FG015|Main Study Phase|Death|0|||
106163085|NCT03544281|366260269|FG016|Main Study Phase|Death|0|||
106163086|NCT03544281|366260270|FG017|Main Study Phase|Death|0|||
106163087|NCT03544281|366260271|FG018|Main Study Phase|Death|0|||
106163088|NCT03544281|366260272|FG019|Main Study Phase|Death|0|||
106163089|NCT03544281|366260273|FG020|Main Study Phase|Death|0|||
106096337|NCT01358526|366009178|FG002|Open-label Titration Period|Administrative|0|||
106096338|NCT01358526|366009176|FG000|Open-label Titration Period|Did not qualify|178|||
106096339|NCT01358526|366009177|FG001|Open-label Titration Period|Did not qualify|0|||
106096340|NCT01358526|366009178|FG002|Open-label Titration Period|Did not qualify|0|||
106096341|NCT01358526|366009176|FG000|Double-blind Phase|Adverse Event|0|||
106096342|NCT01358526|366009177|FG001|Double-blind Phase|Adverse Event|24|||
106096343|NCT01358526|366009178|FG002|Double-blind Phase|Adverse Event|23|||
106096344|NCT01358526|366009176|FG000|Double-blind Phase|Withdrawal by Subject|0|||
106096345|NCT01358526|366009177|FG001|Double-blind Phase|Withdrawal by Subject|10|||
106096346|NCT01358526|366009178|FG002|Double-blind Phase|Withdrawal by Subject|8|||
106096347|NCT01358526|366009176|FG000|Double-blind Phase|Lost to Follow-up|0|||
106096348|NCT01358526|366009177|FG001|Double-blind Phase|Lost to Follow-up|4|||
106096349|NCT01358526|366009178|FG002|Double-blind Phase|Lost to Follow-up|1|||
106096350|NCT01358526|366009176|FG000|Double-blind Phase|Lack of Efficacy|0|||
106096351|NCT01358526|366009177|FG001|Double-blind Phase|Lack of Efficacy|31|||
106096352|NCT01358526|366009178|FG002|Double-blind Phase|Lack of Efficacy|73|||
106096353|NCT01358526|366009176|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
106096354|NCT01358526|366009177|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
106096355|NCT01358526|366009178|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
106163090|NCT03544281|366260274|FG021|Main Study Phase|Death|0|||
106163091|NCT03544281|366260253|FG000|Main Study Phase|Lost to Follow-up|0|||
106163092|NCT03544281|366260254|FG001|Main Study Phase|Lost to Follow-up|0|||
106163093|NCT03544281|366260255|FG002|Main Study Phase|Lost to Follow-up|0|||
106096356|NCT01358526|366009176|FG000|Double-blind Phase|Administrative|0|||
106096357|NCT01358526|366009177|FG001|Double-blind Phase|Administrative|6|||
106163094|NCT03544281|366260256|FG003|Main Study Phase|Lost to Follow-up|0|||
106163095|NCT03544281|366260257|FG004|Main Study Phase|Lost to Follow-up|0|||
106163096|NCT03544281|366260258|FG005|Main Study Phase|Lost to Follow-up|0|||
106163097|NCT03544281|366260259|FG006|Main Study Phase|Lost to Follow-up|0|||
106163098|NCT03544281|366260260|FG007|Main Study Phase|Lost to Follow-up|0|||
106163099|NCT03544281|366260261|FG008|Main Study Phase|Lost to Follow-up|0|||
106163100|NCT03544281|366260262|FG009|Main Study Phase|Lost to Follow-up|0|||
106163101|NCT03544281|366260263|FG010|Main Study Phase|Lost to Follow-up|1|||
106163102|NCT03544281|366260264|FG011|Main Study Phase|Lost to Follow-up|0|||
106163103|NCT03544281|366260265|FG012|Main Study Phase|Lost to Follow-up|0|||
106163104|NCT03544281|366260266|FG013|Main Study Phase|Lost to Follow-up|0|||
106163105|NCT03544281|366260267|FG014|Main Study Phase|Lost to Follow-up|0|||
106163106|NCT03544281|366260268|FG015|Main Study Phase|Lost to Follow-up|0|||
106163107|NCT03544281|366260269|FG016|Main Study Phase|Lost to Follow-up|0|||
106163108|NCT03544281|366260270|FG017|Main Study Phase|Lost to Follow-up|0|||
106163109|NCT03544281|366260271|FG018|Main Study Phase|Lost to Follow-up|0|||
106163110|NCT03544281|366260272|FG019|Main Study Phase|Lost to Follow-up|0|||
106163111|NCT03544281|366260273|FG020|Main Study Phase|Lost to Follow-up|0|||
106163112|NCT03544281|366260274|FG021|Main Study Phase|Lost to Follow-up|0|||
106163113|NCT03544281|366260253|FG000|Main Study Phase|Physician Decision|0|||
106163114|NCT03544281|366260254|FG001|Main Study Phase|Physician Decision|0|||
106163115|NCT03544281|366260255|FG002|Main Study Phase|Physician Decision|0|||
106163116|NCT03544281|366260256|FG003|Main Study Phase|Physician Decision|0|||
106163117|NCT03544281|366260257|FG004|Main Study Phase|Physician Decision|0|||
106096358|NCT01358526|366009178|FG002|Double-blind Phase|Administrative|10|||
106096359|NCT01344460|366009179|FG000|Overall Study|Withdrawal by Subject|1|||
106096360|NCT01344460|366009179|FG000|Overall Study|Lost to Follow-up|2|||
106163118|NCT03544281|366260258|FG005|Main Study Phase|Physician Decision|0|||
106163119|NCT03544281|366260259|FG006|Main Study Phase|Physician Decision|0|||
106163120|NCT03544281|366260260|FG007|Main Study Phase|Physician Decision|1|||
106163121|NCT03544281|366260261|FG008|Main Study Phase|Physician Decision|0|||
106163122|NCT03544281|366260262|FG009|Main Study Phase|Physician Decision|0|||
106096361|NCT03086447|366009180|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
106096362|NCT03086447|366009181|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
106096363|NCT03086447|366009180|FG000|Overall Study|Lost Lens|2|||
106096364|NCT03086447|366009181|FG001|Overall Study|Lost Lens|5|||
106096365|NCT03086447|366009180|FG000|Overall Study|Product quality complaint|0|||
106096366|NCT03086447|366009181|FG001|Overall Study|Product quality complaint|1|||
106096367|NCT03086447|366009180|FG000|Overall Study|Lens Damage|1|||
106096368|NCT03086447|366009181|FG001|Overall Study|Lens Damage|6|||
106096369|NCT03086447|366009180|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
106096370|NCT03086447|366009181|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
106096371|NCT03086447|366009180|FG000|Overall Study|Test Article No Longer Available|1|||
106096372|NCT03086447|366009181|FG001|Overall Study|Test Article No Longer Available|0|||
106096373|NCT03086447|366009180|FG000|Overall Study|Protocol Violation|2|||
106096374|NCT03086447|366009181|FG001|Overall Study|Protocol Violation|4|||
106096375|NCT03086447|366009180|FG000|Overall Study|Lost to Follow-up|0|||
106096376|NCT03086447|366009181|FG001|Overall Study|Lost to Follow-up|1|||
106096377|NCT03086447|366009180|FG000|Overall Study|Adverse Event|3|||
106096378|NCT03086447|366009181|FG001|Overall Study|Adverse Event|0|||
106096379|NCT03086447|366009180|FG000|Overall Study|Lens Discomfort|2|||
106096380|NCT03086447|366009181|FG001|Overall Study|Lens Discomfort|1|||
106096381|NCT00364858|366009188|FG000|Overall Study|Adverse Event|1|||
106096382|NCT00364858|366009189|FG001|Overall Study|Adverse Event|5|||
106096383|NCT00364858|366009188|FG000|Overall Study|Withdrawal by Subject|1|||
106096384|NCT00364858|366009189|FG001|Overall Study|Withdrawal by Subject|1|||
106096385|NCT00364858|366009188|FG000|Overall Study|Pregnancy|1|||
106096386|NCT00364858|366009189|FG001|Overall Study|Pregnancy|1|||
106096387|NCT00364858|366009188|FG000|Overall Study|Clinical failure|2|||
106096388|NCT00364858|366009189|FG001|Overall Study|Clinical failure|13|||
106096389|NCT00364858|366009188|FG000|Overall Study|Discontinuation at baseline|1|||
106096390|NCT00364858|366009189|FG001|Overall Study|Discontinuation at baseline|0|||
106096391|NCT00364858|366009188|FG000|Overall Study|Non-compliant|1|||
106096392|NCT00364858|366009189|FG001|Overall Study|Non-compliant|0|||
106096393|NCT00364858|366009188|FG000|Overall Study|Return to Q2 regimen|0|||
106096394|NCT00364858|366009189|FG001|Overall Study|Return to Q2 regimen|1|||
106163123|NCT03544281|366260263|FG010|Main Study Phase|Physician Decision|0|||
106163124|NCT03544281|366260264|FG011|Main Study Phase|Physician Decision|0|||
106163125|NCT03544281|366260265|FG012|Main Study Phase|Physician Decision|0|||
106163126|NCT03544281|366260266|FG013|Main Study Phase|Physician Decision|0|||
106163127|NCT03544281|366260267|FG014|Main Study Phase|Physician Decision|0|||
106163128|NCT03544281|366260268|FG015|Main Study Phase|Physician Decision|0|||
106163129|NCT03544281|366260269|FG016|Main Study Phase|Physician Decision|0|||
106163130|NCT03544281|366260270|FG017|Main Study Phase|Physician Decision|0|||
106163131|NCT03544281|366260271|FG018|Main Study Phase|Physician Decision|0|||
106163132|NCT03544281|366260272|FG019|Main Study Phase|Physician Decision|0|||
106163133|NCT03544281|366260273|FG020|Main Study Phase|Physician Decision|0|||
106096395|NCT00364858|366009188|FG000|Overall Study|Clinical baseline issue|0|||
106096396|NCT00364858|366009189|FG001|Overall Study|Clinical baseline issue|1|||
106096397|NCT00627705|366009190|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
106096398|NCT00627705|366009191|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
106096399|NCT00627705|366009190|FG000|Overall Study|Adverse Event|1|||
106096400|NCT00627705|366009191|FG001|Overall Study|Adverse Event|0|||
106096401|NCT00627705|366009190|FG000|Overall Study|Withdrawal by Subject|0|||
106096402|NCT00627705|366009191|FG001|Overall Study|Withdrawal by Subject|2|||
106163134|NCT03544281|366260274|FG021|Main Study Phase|Physician Decision|0|||
106096403|NCT00627705|366009190|FG000|Overall Study|Lost to Follow-up|0|||
106163135|NCT03544281|366260253|FG000|Main Study Phase|Withdrawal by Subject|2|||
106096404|NCT00627705|366009191|FG001|Overall Study|Lost to Follow-up|1|||
106096405|NCT02730819|366009192|FG000|Overall Study|Lost to Follow-up|9|||
106096406|NCT00110617|366009193|FG000|Overall Study|Adverse Event|2|||
106096407|NCT00110617|366009194|FG001|Overall Study|Adverse Event|4|||
106096408|NCT00110617|366009193|FG000|Overall Study|Abnormal Laboratory Value|4|||
106096409|NCT00110617|366009194|FG001|Overall Study|Abnormal Laboratory Value|2|||
106096410|NCT00110617|366009193|FG000|Overall Study|Lack of Efficacy|1|||
106096411|NCT00110617|366009194|FG001|Overall Study|Lack of Efficacy|0|||
106096412|NCT00110617|366009193|FG000|Overall Study|Patient no longer requires study drug|1|||
106096413|NCT00110617|366009194|FG001|Overall Study|Patient no longer requires study drug|0|||
106163136|NCT03544281|366260254|FG001|Main Study Phase|Withdrawal by Subject|0|||
106163137|NCT03544281|366260255|FG002|Main Study Phase|Withdrawal by Subject|1|||
106163138|NCT03544281|366260256|FG003|Main Study Phase|Withdrawal by Subject|2|||
106163139|NCT03544281|366260257|FG004|Main Study Phase|Withdrawal by Subject|0|||
106163140|NCT03544281|366260258|FG005|Main Study Phase|Withdrawal by Subject|0|||
106163141|NCT03544281|366260259|FG006|Main Study Phase|Withdrawal by Subject|0|||
106163142|NCT03544281|366260260|FG007|Main Study Phase|Withdrawal by Subject|0|||
106163143|NCT03544281|366260261|FG008|Main Study Phase|Withdrawal by Subject|2|||
106163144|NCT03544281|366260262|FG009|Main Study Phase|Withdrawal by Subject|3|||
106163145|NCT03544281|366260263|FG010|Main Study Phase|Withdrawal by Subject|0|||
106163146|NCT03544281|366260264|FG011|Main Study Phase|Withdrawal by Subject|4|||
106163147|NCT03544281|366260265|FG012|Main Study Phase|Withdrawal by Subject|0|||
106163148|NCT03544281|366260266|FG013|Main Study Phase|Withdrawal by Subject|0|||
106163149|NCT03544281|366260267|FG014|Main Study Phase|Withdrawal by Subject|0|||
106163150|NCT03544281|366260268|FG015|Main Study Phase|Withdrawal by Subject|0|||
106163151|NCT03544281|366260269|FG016|Main Study Phase|Withdrawal by Subject|0|||
106163152|NCT03544281|366260270|FG017|Main Study Phase|Withdrawal by Subject|0|||
106163153|NCT03544281|366260271|FG018|Main Study Phase|Withdrawal by Subject|0|||
106163154|NCT03544281|366260272|FG019|Main Study Phase|Withdrawal by Subject|0|||
106163155|NCT03544281|366260273|FG020|Main Study Phase|Withdrawal by Subject|0|||
106163156|NCT03544281|366260274|FG021|Main Study Phase|Withdrawal by Subject|0|||
106163157|NCT03544281|366260253|FG000|Main Study Phase|Ongoing|3|||
106163158|NCT03544281|366260254|FG001|Main Study Phase|Ongoing|1|||
106163159|NCT03544281|366260255|FG002|Main Study Phase|Ongoing|2|||
106163160|NCT03544281|366260256|FG003|Main Study Phase|Ongoing|4|||
106163161|NCT03544281|366260257|FG004|Main Study Phase|Ongoing|2|||
106163162|NCT03544281|366260258|FG005|Main Study Phase|Ongoing|4|||
106163163|NCT03544281|366260259|FG006|Main Study Phase|Ongoing|4|||
106163164|NCT03544281|366260260|FG007|Main Study Phase|Ongoing|0|||
106163165|NCT03544281|366260261|FG008|Main Study Phase|Ongoing|2|||
106163166|NCT03544281|366260262|FG009|Main Study Phase|Ongoing|2|||
106163167|NCT03544281|366260263|FG010|Main Study Phase|Ongoing|1|||
106163168|NCT03544281|366260264|FG011|Main Study Phase|Ongoing|0|||
106163169|NCT03544281|366260265|FG012|Main Study Phase|Ongoing|0|||
106163170|NCT03544281|366260266|FG013|Main Study Phase|Ongoing|0|||
106163171|NCT03544281|366260267|FG014|Main Study Phase|Ongoing|0|||
106163172|NCT03544281|366260268|FG015|Main Study Phase|Ongoing|0|||
106163173|NCT03544281|366260269|FG016|Main Study Phase|Ongoing|0|||
106163174|NCT03544281|366260270|FG017|Main Study Phase|Ongoing|0|||
106163175|NCT03544281|366260271|FG018|Main Study Phase|Ongoing|0|||
106096414|NCT00110617|366009193|FG000|Overall Study|Protocol Violation|5|||
106163176|NCT03544281|366260272|FG019|Main Study Phase|Ongoing|0|||
106163177|NCT03544281|366260273|FG020|Main Study Phase|Ongoing|0|||
106163178|NCT03544281|366260274|FG021|Main Study Phase|Ongoing|0|||
106163179|NCT03544281|366260253|FG000|Main Study Phase|Investigator Site Closed|0|||
106163180|NCT03544281|366260254|FG001|Main Study Phase|Investigator Site Closed|0|||
106163181|NCT03544281|366260255|FG002|Main Study Phase|Investigator Site Closed|0|||
106163182|NCT03544281|366260256|FG003|Main Study Phase|Investigator Site Closed|0|||
106163183|NCT03544281|366260257|FG004|Main Study Phase|Investigator Site Closed|0|||
106163184|NCT03544281|366260258|FG005|Main Study Phase|Investigator Site Closed|0|||
106163185|NCT03544281|366260259|FG006|Main Study Phase|Investigator Site Closed|0|||
106163186|NCT03544281|366260260|FG007|Main Study Phase|Investigator Site Closed|0|||
106163187|NCT03544281|366260261|FG008|Main Study Phase|Investigator Site Closed|0|||
106163188|NCT03544281|366260262|FG009|Main Study Phase|Investigator Site Closed|1|||
106163189|NCT03544281|366260263|FG010|Main Study Phase|Investigator Site Closed|0|||
106163190|NCT03544281|366260264|FG011|Main Study Phase|Investigator Site Closed|0|||
106163191|NCT03544281|366260265|FG012|Main Study Phase|Investigator Site Closed|0|||
106163192|NCT03544281|366260266|FG013|Main Study Phase|Investigator Site Closed|0|||
106163193|NCT03544281|366260267|FG014|Main Study Phase|Investigator Site Closed|0|||
106163194|NCT03544281|366260268|FG015|Main Study Phase|Investigator Site Closed|0|||
106163195|NCT03544281|366260269|FG016|Main Study Phase|Investigator Site Closed|0|||
106163196|NCT03544281|366260270|FG017|Main Study Phase|Investigator Site Closed|0|||
106096415|NCT00110617|366009194|FG001|Overall Study|Protocol Violation|0|||
106096416|NCT00110617|366009193|FG000|Overall Study|Withdrawal by Subject|10|||
106096417|NCT00110617|366009194|FG001|Overall Study|Withdrawal by Subject|4|||
106163197|NCT03544281|366260271|FG018|Main Study Phase|Investigator Site Closed|0|||
106163198|NCT03544281|366260272|FG019|Main Study Phase|Investigator Site Closed|0|||
106163199|NCT03544281|366260273|FG020|Main Study Phase|Investigator Site Closed|0|||
106163200|NCT03544281|366260274|FG021|Main Study Phase|Investigator Site Closed|0|||
106096418|NCT00110617|366009193|FG000|Overall Study|Lost to Follow-up|9|||
106096419|NCT00110617|366009194|FG001|Overall Study|Lost to Follow-up|1|||
106096420|NCT00110617|366009193|FG000|Overall Study|Administrative problems|6|||
106096421|NCT00110617|366009194|FG001|Overall Study|Administrative problems|5|||
106096422|NCT00110617|366009193|FG000|Overall Study|Death|1|||
106096423|NCT00110617|366009194|FG001|Overall Study|Death|1|||
106096424|NCT00110617|366009193|FG000|Overall Study|Did not receive study drug|0|||
106096425|NCT00110617|366009194|FG001|Overall Study|Did not receive study drug|12|||
106096426|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
106096427|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
106096428|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
106096429|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
106096430|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
106096431|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
106096432|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
106096433|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
106096434|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
106096435|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
106096436|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
106096437|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
106096438|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
106096439|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
106096440|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
106096441|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
106096442|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
106096443|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
106096444|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
106096445|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
106096446|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
106096447|NCT01781572|366009195|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
106096448|NCT01781572|366009196|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
106096449|NCT01781572|366009197|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
106096450|NCT01781572|366009195|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
106096451|NCT01781572|366009196|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
106096452|NCT01781572|366009197|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
106096453|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
106096454|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
106096455|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
106096456|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
106096457|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
106096458|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
106096459|NCT01781572|366009195|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
106096460|NCT01781572|366009196|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
106096461|NCT01781572|366009197|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
106096462|NCT01781572|366009195|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
106096463|NCT01781572|366009196|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
106096464|NCT01781572|366009197|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
106096465|NCT01781572|366009195|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
106096466|NCT01781572|366009196|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
106096467|NCT01781572|366009197|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
106096468|NCT01781572|366009195|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
106096469|NCT01781572|366009196|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
106096470|NCT01781572|366009197|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
106096471|NCT01781572|366009195|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
106096472|NCT01781572|366009196|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
106096473|NCT01781572|366009197|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
106096474|NCT01781572|366009195|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
106096475|NCT01781572|366009196|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
106096476|NCT01781572|366009197|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
106096477|NCT01781572|366009195|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
106096478|NCT01781572|366009196|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
106096479|NCT01781572|366009197|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
106096480|NCT02010060|366009201|FG000|Overall Study|Lost to Follow-up|1|||
106096481|NCT02010060|366009202|FG001|Overall Study|Lost to Follow-up|2|||
106096482|NCT02010060|366009203|FG002|Overall Study|Lost to Follow-up|2|||
106096483|NCT02010060|366009201|FG000|Overall Study|Injury|0|||
106096484|NCT02010060|366009202|FG001|Overall Study|Injury|1|||
106096485|NCT02010060|366009203|FG002|Overall Study|Injury|0|||
106096486|NCT00660010|366009204|FG000|Overall Study|Withdrawal by Subject|2|||
106096487|NCT00660010|366009204|FG000|Overall Study|Lost to Follow-up|3|||
106096488|NCT00660010|366009204|FG000|Overall Study|Adverse Event|1|||
106096489|NCT00660010|366009204|FG000|Overall Study|Noncompliance with visit schedule|3|||
106096490|NCT00902304|366011504|FG000|Overall Study|Adverse Event|4|||
106096491|NCT00902304|366011505|FG001|Overall Study|Adverse Event|10|||
106096492|NCT00902304|366011506|FG002|Overall Study|Adverse Event|25|||
106096493|NCT00902304|366011504|FG000|Overall Study|Investigator discretion|3|||
106096494|NCT00902304|366011505|FG001|Overall Study|Investigator discretion|5|||
106096495|NCT00902304|366011506|FG002|Overall Study|Investigator discretion|13|||
106096496|NCT00902304|366011504|FG000|Overall Study|Lost to Follow-up|7|||
106096497|NCT00902304|366011505|FG001|Overall Study|Lost to Follow-up|7|||
106096498|NCT00902304|366011506|FG002|Overall Study|Lost to Follow-up|7|||
106096499|NCT00902304|366011504|FG000|Overall Study|Protocol Violation|9|||
106096500|NCT00902304|366011505|FG001|Overall Study|Protocol Violation|18|||
106096501|NCT00902304|366011506|FG002|Overall Study|Protocol Violation|20|||
106096502|NCT00902304|366011504|FG000|Overall Study|Withdrawal by Subject|32|||
106096503|NCT00902304|366011505|FG001|Overall Study|Withdrawal by Subject|22|||
106096504|NCT00902304|366011506|FG002|Overall Study|Withdrawal by Subject|43|||
106096505|NCT00902304|366011504|FG000|Overall Study|includes pregnancy|3|||
106096506|NCT00902304|366011505|FG001|Overall Study|includes pregnancy|9|||
106096507|NCT00902304|366011506|FG002|Overall Study|includes pregnancy|2|||
106096508|NCT02624804|366011507|FG000|Overall Study|Screen Failure|5|||
106096509|NCT00996996|366011511|FG000|Overall Study|Progressive Disease|10|||
106096510|NCT00996996|366011511|FG000|Overall Study|Non-compliance|8|||
106096511|NCT00996996|366011511|FG000|Overall Study|Lost to Follow-up|9|||
106096512|NCT00996996|366011511|FG000|Overall Study|Death|5|||
106163201|NCT03544281|366260253|FG000|Main Study Phase|Did not receive study treatment|0|||
106163202|NCT03544281|366260254|FG001|Main Study Phase|Did not receive study treatment|0|||
106096513|NCT00996996|366011511|FG000|Overall Study|Did Not Receive Study Medications|1|||
106096514|NCT00760929|366011512|FG000|Overall Study|Adverse Event|2|||
106096515|NCT00760929|366011513|FG001|Overall Study|Adverse Event|0|||
106096516|NCT00760929|366011514|FG002|Overall Study|Adverse Event|6|||
106096517|NCT00760929|366011515|FG003|Overall Study|Adverse Event|10|||
106163203|NCT03544281|366260255|FG002|Main Study Phase|Did not receive study treatment|0|||
106096518|NCT00760929|366011512|FG000|Overall Study|Lack of Efficacy|0|||
106096519|NCT00760929|366011513|FG001|Overall Study|Lack of Efficacy|2|||
106096520|NCT00760929|366011514|FG002|Overall Study|Lack of Efficacy|1|||
106096521|NCT00760929|366011515|FG003|Overall Study|Lack of Efficacy|0|||
106096522|NCT00760929|366011512|FG000|Overall Study|Withdrawal by Subject|1|||
106096523|NCT00760929|366011513|FG001|Overall Study|Withdrawal by Subject|0|||
106096524|NCT00760929|366011514|FG002|Overall Study|Withdrawal by Subject|9|||
106096525|NCT00760929|366011515|FG003|Overall Study|Withdrawal by Subject|1|||
106096526|NCT00760929|366011512|FG000|Overall Study|Lost to Follow-up|0|||
106096527|NCT00760929|366011513|FG001|Overall Study|Lost to Follow-up|0|||
106096528|NCT00760929|366011514|FG002|Overall Study|Lost to Follow-up|1|||
106096529|NCT00760929|366011515|FG003|Overall Study|Lost to Follow-up|0|||
106096530|NCT00760929|366011512|FG000|Overall Study|Progression of Disease|21|||
106096531|NCT00760929|366011513|FG001|Overall Study|Progression of Disease|26|||
106096532|NCT00760929|366011514|FG002|Overall Study|Progression of Disease|38|||
106096533|NCT00760929|366011515|FG003|Overall Study|Progression of Disease|42|||
106096534|NCT00760929|366011512|FG000|Overall Study|Other|2|||
106096535|NCT00760929|366011513|FG001|Overall Study|Other|0|||
106096536|NCT00760929|366011514|FG002|Overall Study|Other|2|||
106096537|NCT00760929|366011515|FG003|Overall Study|Other|1|||
106096538|NCT00760929|366011512|FG000|Overall Study|Death|0|||
106096539|NCT00760929|366011513|FG001|Overall Study|Death|0|||
106096540|NCT00760929|366011514|FG002|Overall Study|Death|1|||
106096541|NCT00760929|366011515|FG003|Overall Study|Death|0|||
106096542|NCT00760929|366011512|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
106096543|NCT00760929|366011513|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
106096544|NCT00760929|366011514|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
106096545|NCT00760929|366011515|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
106096546|NCT03268811|366011518|FG000|Overall Study|Adverse Event|0|||
106096547|NCT03268811|366011519|FG001|Overall Study|Adverse Event|1|||
106096548|NCT02348216|366011521|FG000|Overall Study|Death|5|||
106096549|NCT02348216|366011522|FG001|Overall Study|Death|53|||
106096550|NCT02348216|366011523|FG002|Overall Study|Death|11|||
106096551|NCT02348216|366011524|FG003|Overall Study|Death|20|||
106096552|NCT02348216|366011525|FG004|Overall Study|Death|16|||
106096553|NCT02348216|366011526|FG005|Overall Study|Death|32|||
106096554|NCT02348216|366011527|FG006|Overall Study|Death|17|||
106096555|NCT02348216|366011521|FG000|Overall Study|Full consent withdrawal|0|||
106096556|NCT02348216|366011522|FG001|Overall Study|Full consent withdrawal|0|||
106096557|NCT02348216|366011523|FG002|Overall Study|Full consent withdrawal|0|||
106096558|NCT02348216|366011524|FG003|Overall Study|Full consent withdrawal|1|||
106096559|NCT02348216|366011525|FG004|Overall Study|Full consent withdrawal|3|||
106096560|NCT02348216|366011526|FG005|Overall Study|Full consent withdrawal|0|||
106096561|NCT02348216|366011527|FG006|Overall Study|Full consent withdrawal|3|||
106096562|NCT02348216|366011521|FG000|Overall Study|Lost to Follow-up|0|||
106096563|NCT02348216|366011522|FG001|Overall Study|Lost to Follow-up|5|||
106096564|NCT02348216|366011523|FG002|Overall Study|Lost to Follow-up|2|||
106096565|NCT02348216|366011524|FG003|Overall Study|Lost to Follow-up|0|||
106096566|NCT02348216|366011525|FG004|Overall Study|Lost to Follow-up|1|||
106096567|NCT02348216|366011526|FG005|Overall Study|Lost to Follow-up|1|||
106096568|NCT02348216|366011527|FG006|Overall Study|Lost to Follow-up|1|||
106096569|NCT02348216|366011521|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
106096570|NCT02348216|366011522|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
106096571|NCT02348216|366011523|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
106096572|NCT02348216|366011524|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
106096573|NCT02348216|366011525|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
106096574|NCT02348216|366011526|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
106096575|NCT02348216|366011527|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
106096576|NCT02348216|366011521|FG000|Overall Study|Reason not specified|2|||
106096577|NCT02348216|366011522|FG001|Overall Study|Reason not specified|19|||
106096578|NCT02348216|366011523|FG002|Overall Study|Reason not specified|11|||
106096579|NCT02348216|366011524|FG003|Overall Study|Reason not specified|17|||
106096580|NCT02348216|366011525|FG004|Overall Study|Reason not specified|21|||
106096581|NCT02348216|366011526|FG005|Overall Study|Reason not specified|17|||
106163204|NCT03544281|366260256|FG003|Main Study Phase|Did not receive study treatment|0|||
106163205|NCT03544281|366260257|FG004|Main Study Phase|Did not receive study treatment|0|||
106163206|NCT03544281|366260258|FG005|Main Study Phase|Did not receive study treatment|0|||
106163207|NCT03544281|366260259|FG006|Main Study Phase|Did not receive study treatment|1|||
106163208|NCT03544281|366260260|FG007|Main Study Phase|Did not receive study treatment|0|||
106163209|NCT03544281|366260261|FG008|Main Study Phase|Did not receive study treatment|0|||
106163210|NCT03544281|366260262|FG009|Main Study Phase|Did not receive study treatment|0|||
106163211|NCT03544281|366260263|FG010|Main Study Phase|Did not receive study treatment|0|||
106163212|NCT03544281|366260264|FG011|Main Study Phase|Did not receive study treatment|0|||
106163213|NCT03544281|366260265|FG012|Main Study Phase|Did not receive study treatment|0|||
106163214|NCT03544281|366260266|FG013|Main Study Phase|Did not receive study treatment|0|||
106096582|NCT02348216|366011527|FG006|Overall Study|Reason not specified|19|||
106096583|NCT00434057|366011537|FG000|Overall Study|Withdrawal by Subject|1|||
106096584|NCT03073603|366011538|FG000|Overall Study|Noncompliance|3|||
106096585|NCT03073603|366011539|FG001|Overall Study|Noncompliance|1|||
106096586|NCT03073603|366011538|FG000|Overall Study|Adverse Event|5|||
106096587|NCT03073603|366011539|FG001|Overall Study|Adverse Event|3|||
106163215|NCT03544281|366260267|FG014|Main Study Phase|Did not receive study treatment|0|||
106096588|NCT03073603|366011538|FG000|Overall Study|Physician Decision|1|||
106096589|NCT03073603|366011539|FG001|Overall Study|Physician Decision|2|||
106096590|NCT03073603|366011538|FG000|Overall Study|Required treatment not allowed by protocol|1|||
106096591|NCT03073603|366011539|FG001|Overall Study|Required treatment not allowed by protocol|0|||
106096592|NCT03073603|366011538|FG000|Overall Study|Financial or insurance-related|8|||
106096593|NCT03073603|366011539|FG001|Overall Study|Financial or insurance-related|0|||
106096594|NCT03073603|366011538|FG000|Overall Study|Withdrawal by Subject|0|||
106096595|NCT03073603|366011539|FG001|Overall Study|Withdrawal by Subject|1|||
106096596|NCT03073603|366011538|FG000|Overall Study|Discontinued DMT|4|||
106096597|NCT03073603|366011539|FG001|Overall Study|Discontinued DMT|0|||
106096598|NCT03073603|366011538|FG000|Overall Study|Restarted DMT|0|||
106096599|NCT03073603|366011539|FG001|Overall Study|Restarted DMT|1|||
106096600|NCT02117570|366011542|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
106096601|NCT02117570|366011543|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
106096602|NCT02117570|366011544|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
106096603|NCT02117570|366011542|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
106096604|NCT02117570|366011543|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
106096605|NCT02117570|366011544|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
106096606|NCT02117570|366011542|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
106096607|NCT02117570|366011543|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
106096608|NCT02117570|366011544|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
106096609|NCT02117570|366011542|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
106096610|NCT02117570|366011543|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
106096611|NCT02117570|366011544|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
106096612|NCT02117570|366011542|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
106096613|NCT02117570|366011543|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
106096614|NCT02117570|366011544|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
106096615|NCT02117570|366011542|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
106096616|NCT02117570|366011543|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
106096617|NCT02117570|366011544|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
106096618|NCT02117570|366011542|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
106096619|NCT02117570|366011543|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
106096620|NCT02117570|366011544|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
106096621|NCT02370602|366011545|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
106096622|NCT02370602|366011546|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
106096623|NCT02370602|366011547|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
106096624|NCT02370602|366011548|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
106096625|NCT02370602|366011549|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
106096626|NCT02370602|366011550|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
106096627|NCT00237744|366011551|FG000|Overall Study|Withdrawal by Subject|3|||
106096628|NCT00237744|366011552|FG001|Overall Study|Withdrawal by Subject|1|||
106096629|NCT00237744|366011553|FG002|Overall Study|Withdrawal by Subject|0|||
106096630|NCT00574080|366011556|FG000|Overall Study|Death|10|||
106096631|NCT00574080|366011557|FG001|Overall Study|Death|10|||
106096632|NCT02097472|366011566|FG000|Received Vaccination 2|Adverse Event|0|||
106096633|NCT02097472|366011567|FG001|Received Vaccination 2|Adverse Event|0|||
106096634|NCT02097472|366011568|FG002|Received Vaccination 2|Adverse Event|0|||
106096635|NCT02097472|366011569|FG003|Received Vaccination 2|Adverse Event|0|||
106096636|NCT02097472|366011570|FG004|Received Vaccination 2|Adverse Event|0|||
106096637|NCT02097472|366011571|FG005|Received Vaccination 2|Adverse Event|0|||
106096638|NCT02097472|366011572|FG006|Received Vaccination 2|Adverse Event|1|||
106096639|NCT02097472|366011573|FG007|Received Vaccination 2|Adverse Event|0|||
106096640|NCT00784810|366011574|FG000|Overall Study|Adverse Event|32|||
106096641|NCT00784810|366011575|FG001|Overall Study|Adverse Event|20|||
106096642|NCT00784810|366011574|FG000|Overall Study|Lack of Efficacy|14|||
106096643|NCT00784810|366011575|FG001|Overall Study|Lack of Efficacy|11|||
106096644|NCT00784810|366011574|FG000|Overall Study|Withdrawal by Subject|11|||
106096645|NCT00784810|366011575|FG001|Overall Study|Withdrawal by Subject|9|||
106096646|NCT00784810|366011574|FG000|Overall Study|Administrative|5|||
106096647|NCT00784810|366011575|FG001|Overall Study|Administrative|8|||
106096648|NCT00784810|366011574|FG000|Overall Study|Lost to Follow-up|1|||
106096649|NCT00784810|366011575|FG001|Overall Study|Lost to Follow-up|1|||
106096650|NCT03305016|366011576|FG000|Overall Study|Withdrawal by Subject|2|||
106096651|NCT02828111|366011581|FG000|Overall Study|Withdrawal by Subject|0|||
106096652|NCT02828111|366011582|FG001|Overall Study|Withdrawal by Subject|0|||
106096653|NCT02828111|366011583|FG002|Overall Study|Withdrawal by Subject|2|||
106096654|NCT02828111|366011584|FG003|Overall Study|Withdrawal by Subject|0|||
106163216|NCT03544281|366260268|FG015|Main Study Phase|Did not receive study treatment|0|||
106163217|NCT03544281|366260269|FG016|Main Study Phase|Did not receive study treatment|0|||
106163218|NCT03544281|366260270|FG017|Main Study Phase|Did not receive study treatment|0|||
106163219|NCT03544281|366260271|FG018|Main Study Phase|Did not receive study treatment|0|||
106163220|NCT03544281|366260272|FG019|Main Study Phase|Did not receive study treatment|0|||
106163221|NCT03544281|366260273|FG020|Main Study Phase|Did not receive study treatment|0|||
106163222|NCT03544281|366260274|FG021|Main Study Phase|Did not receive study treatment|0|||
106163223|NCT03544281|366260253|FG000|PACT Phase|Adverse Event|0|||
106163224|NCT03544281|366260254|FG001|PACT Phase|Adverse Event|0|||
106163225|NCT03544281|366260255|FG002|PACT Phase|Adverse Event|0|||
106163226|NCT03544281|366260256|FG003|PACT Phase|Adverse Event|0|||
106163227|NCT03544281|366260257|FG004|PACT Phase|Adverse Event|0|||
106163228|NCT03544281|366260258|FG005|PACT Phase|Adverse Event|0|||
106163229|NCT03544281|366260259|FG006|PACT Phase|Adverse Event|0|||
106163230|NCT03544281|366260260|FG007|PACT Phase|Adverse Event|0|||
106163231|NCT03544281|366260261|FG008|PACT Phase|Adverse Event|0|||
106163232|NCT03544281|366260262|FG009|PACT Phase|Adverse Event|0|||
106163233|NCT03544281|366260263|FG010|PACT Phase|Adverse Event|0|||
106163234|NCT03544281|366260264|FG011|PACT Phase|Adverse Event|0|||
106163235|NCT03544281|366260265|FG012|PACT Phase|Adverse Event|1|||
106163236|NCT03544281|366260266|FG013|PACT Phase|Adverse Event|0|||
106163237|NCT03544281|366260267|FG014|PACT Phase|Adverse Event|0|||
106163238|NCT03544281|366260268|FG015|PACT Phase|Adverse Event|0|||
106163239|NCT03544281|366260269|FG016|PACT Phase|Adverse Event|0|||
106163240|NCT03544281|366260270|FG017|PACT Phase|Adverse Event|1|||
106163241|NCT03544281|366260271|FG018|PACT Phase|Adverse Event|1|||
106163242|NCT03544281|366260272|FG019|PACT Phase|Adverse Event|0|||
106163243|NCT03544281|366260273|FG020|PACT Phase|Adverse Event|0|||
106163244|NCT03544281|366260274|FG021|PACT Phase|Adverse Event|0|||
106163245|NCT02547233|366260275|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
106163246|NCT02547233|366260276|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
106163247|NCT02547233|366260275|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
106163248|NCT02547233|366260276|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
106163249|NCT02547233|366260275|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
106163250|NCT02547233|366260276|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
106163251|NCT02547233|366260275|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
106163252|NCT02547233|366260276|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
105984897|NCT00231413|365605979|FG004|Overall Study|Non-serious AE|0|||
106096655|NCT02828111|366011585|FG004|Overall Study|Withdrawal by Subject|0|||
106096656|NCT02828111|366011581|FG000|Overall Study|Lost to Follow-up|0|||
106096657|NCT02828111|366011582|FG001|Overall Study|Lost to Follow-up|0|||
106096658|NCT02828111|366011583|FG002|Overall Study|Lost to Follow-up|0|||
106096659|NCT02828111|366011584|FG003|Overall Study|Lost to Follow-up|1|||
106096660|NCT02828111|366011585|FG004|Overall Study|Lost to Follow-up|1|||
106096661|NCT00148343|366011586|FG000|Overall Study|Withdrawal by Subject|12|||
106096662|NCT00148343|366011587|FG001|Overall Study|Withdrawal by Subject|7|||
106096663|NCT00148343|366011586|FG000|Overall Study|Physician Decision|3|||
106096664|NCT00148343|366011587|FG001|Overall Study|Physician Decision|4|||
106096665|NCT02844946|366011588|FG000|Overall Study|Lost to Follow-up|7|||
106096666|NCT02844946|366011589|FG001|Overall Study|Lost to Follow-up|0|||
106096667|NCT00407537|366011595|FG000|Overall Study|Death|5|||
106096668|NCT00407537|366011596|FG001|Overall Study|Death|2|||
106096669|NCT00407537|366011595|FG000|Overall Study|Adverse Event|36|||
106096670|NCT00407537|366011596|FG001|Overall Study|Adverse Event|0|||
106096671|NCT00407537|366011595|FG000|Overall Study|Lost to Follow-up|12|||
106096672|NCT00407537|366011596|FG001|Overall Study|Lost to Follow-up|19|||
106096673|NCT00407537|366011595|FG000|Overall Study|Other|6|||
106096674|NCT00407537|366011596|FG001|Overall Study|Other|7|||
106096675|NCT00407537|366011595|FG000|Overall Study|Withdrawal by Subject|34|||
106096676|NCT00407537|366011596|FG001|Overall Study|Withdrawal by Subject|16|||
106096677|NCT02864082|366011597|FG000|Overall Study|Adverse Event|1|||
106096678|NCT02864082|366011598|FG001|Overall Study|Adverse Event|1|||
106096679|NCT02864082|366011597|FG000|Overall Study|Lost to Follow-up|0|||
106096680|NCT02864082|366011598|FG001|Overall Study|Lost to Follow-up|1|||
106096681|NCT02864082|366011597|FG000|Overall Study|Withdrawal by Subject|2|||
106163253|NCT02547233|366260275|FG000|12-month Follow-up|Withdrawal by Subject|10|||
106163254|NCT02547233|366260276|FG001|12-month Follow-up|Withdrawal by Subject|10|||
106163255|NCT02547233|366260275|FG000|12-month Follow-up|Lost to Follow-up|3|||
106163256|NCT02547233|366260276|FG001|12-month Follow-up|Lost to Follow-up|3|||
106163257|NCT02547233|366260275|FG000|12-month Follow-up|Lack of Efficacy|1|||
106163258|NCT02547233|366260276|FG001|12-month Follow-up|Lack of Efficacy|2|||
106163259|NCT02547233|366260275|FG000|12-month Follow-up|Protocol Violation|0|||
106163260|NCT02547233|366260276|FG001|12-month Follow-up|Protocol Violation|1|||
106163261|NCT02547233|366260275|FG000|12-month Follow-up|Other|0|||
106163262|NCT02547233|366260276|FG001|12-month Follow-up|Other|1|||
106096682|NCT02864082|366011598|FG001|Overall Study|Withdrawal by Subject|2|||
106096683|NCT03879798|366011599|FG000|Overall Study|Adverse Event|0|||
106096684|NCT03879798|366011600|FG001|Overall Study|Adverse Event|0|||
106096685|NCT03879798|366011601|FG002|Overall Study|Adverse Event|0|||
106096686|NCT03879798|366011602|FG003|Overall Study|Adverse Event|0|||
106096687|NCT03879798|366011603|FG004|Overall Study|Adverse Event|0|||
106096688|NCT03879798|366011604|FG005|Overall Study|Adverse Event|1|||
106096689|NCT03879798|366011599|FG000|Overall Study|Lack of Efficacy|0|||
106096690|NCT03879798|366011600|FG001|Overall Study|Lack of Efficacy|0|||
106096691|NCT03879798|366011601|FG002|Overall Study|Lack of Efficacy|0|||
106096692|NCT03879798|366011602|FG003|Overall Study|Lack of Efficacy|0|||
106096693|NCT03879798|366011603|FG004|Overall Study|Lack of Efficacy|0|||
106096694|NCT03879798|366011604|FG005|Overall Study|Lack of Efficacy|1|||
106096695|NCT03879798|366011599|FG000|Overall Study|Withdrawal by Subject|0|||
106096696|NCT03879798|366011600|FG001|Overall Study|Withdrawal by Subject|0|||
106096697|NCT03879798|366011601|FG002|Overall Study|Withdrawal by Subject|0|||
106096698|NCT03879798|366011602|FG003|Overall Study|Withdrawal by Subject|0|||
106096699|NCT03879798|366011603|FG004|Overall Study|Withdrawal by Subject|0|||
106096700|NCT03879798|366011604|FG005|Overall Study|Withdrawal by Subject|1|||
106096701|NCT03759873|366011605|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
106096702|NCT03759873|366011606|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
106096703|NCT03759873|366011607|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
106096704|NCT03759873|366011608|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
106096705|NCT03759873|366011605|FG000|Overall Study|Moved outside eligible area|0|||
106096706|NCT03759873|366011606|FG001|Overall Study|Moved outside eligible area|2|||
106096707|NCT03759873|366011607|FG002|Overall Study|Moved outside eligible area|0|||
106096708|NCT03759873|366011608|FG003|Overall Study|Moved outside eligible area|0|||
106096709|NCT03759873|366011605|FG000|Overall Study|Withdrawal by Subject|0|||
106096710|NCT03759873|366011606|FG001|Overall Study|Withdrawal by Subject|0|||
106096711|NCT03759873|366011607|FG002|Overall Study|Withdrawal by Subject|1|||
106096712|NCT03759873|366011608|FG003|Overall Study|Withdrawal by Subject|0|||
106096713|NCT00782340|366011614|FG000|Open Label Titration|Adverse Event|12|||
106096714|NCT00782340|366011615|FG001|Open Label Titration|Adverse Event|0|||
106096715|NCT00782340|366011616|FG002|Open Label Titration|Adverse Event|0|||
106096716|NCT00782340|366011614|FG000|Open Label Titration|Treatment failure|50|||
106096717|NCT00782340|366011615|FG001|Open Label Titration|Treatment failure|0|||
106096718|NCT00782340|366011616|FG002|Open Label Titration|Treatment failure|0|||
106096719|NCT00782340|366011614|FG000|Open Label Titration|Protocol Violation|5|||
106096720|NCT00782340|366011615|FG001|Open Label Titration|Protocol Violation|0|||
106096721|NCT00782340|366011616|FG002|Open Label Titration|Protocol Violation|0|||
106096722|NCT00782340|366011614|FG000|Open Label Titration|Withdrawal by Subject|5|||
106096723|NCT00782340|366011615|FG001|Open Label Titration|Withdrawal by Subject|0|||
106096724|NCT00782340|366011616|FG002|Open Label Titration|Withdrawal by Subject|0|||
106096725|NCT00782340|366011614|FG000|Open Label Titration|Enrollment capped|16|||
106096726|NCT00782340|366011615|FG001|Open Label Titration|Enrollment capped|0|||
106096727|NCT00782340|366011616|FG002|Open Label Titration|Enrollment capped|0|||
106096728|NCT00782340|366011614|FG000|Open Label Titration|Did not meet responder criteria|2|||
106096729|NCT00782340|366011615|FG001|Open Label Titration|Did not meet responder criteria|0|||
106096730|NCT00782340|366011616|FG002|Open Label Titration|Did not meet responder criteria|0|||
106096731|NCT00782340|366011614|FG000|Open Label Titration|Lost to Follow-up|5|||
106096732|NCT00782340|366011615|FG001|Open Label Titration|Lost to Follow-up|0|||
106096733|NCT00782340|366011616|FG002|Open Label Titration|Lost to Follow-up|0|||
106096734|NCT00782340|366011614|FG000|Open Label Titration|Randomized in error|6|||
106096735|NCT00782340|366011615|FG001|Open Label Titration|Randomized in error|0|||
106096736|NCT00782340|366011616|FG002|Open Label Titration|Randomized in error|0|||
106096737|NCT02493361|366011617|FG000|Overall Study|Withdrawal by Subject|3|||
106096738|NCT02219932|366011619|FG000|Overall Study|Other|5|||
106096739|NCT02219932|366011620|FG001|Overall Study|Other|11|||
106096740|NCT02219932|366011619|FG000|Overall Study|Death|1|||
106096741|NCT02219932|366011620|FG001|Overall Study|Death|1|||
106096742|NCT02219932|366011619|FG000|Overall Study|Investigator Decision|0|||
106096743|NCT02219932|366011620|FG001|Overall Study|Investigator Decision|1|||
106096744|NCT02219932|366011619|FG000|Overall Study|Consent Withdrawn|11|||
106096745|NCT02219932|366011620|FG001|Overall Study|Consent Withdrawn|7|||
106096746|NCT02219932|366011619|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
106096747|NCT02219932|366011620|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
106096748|NCT02219932|366011619|FG000|Overall Study|Protocol Violation|10|||
106096749|NCT02219932|366011620|FG001|Overall Study|Protocol Violation|6|||
106096750|NCT02219932|366011619|FG000|Overall Study|Pregnancy|1|||
106096751|NCT02219932|366011620|FG001|Overall Study|Pregnancy|0|||
106096752|NCT02219932|366011619|FG000|Overall Study|Lost to Follow-up|4|||
106096753|NCT02219932|366011620|FG001|Overall Study|Lost to Follow-up|2|||
106096754|NCT02219932|366011619|FG000|Overall Study|Adverse Event|23|||
106096755|NCT02219932|366011620|FG001|Overall Study|Adverse Event|21|||
106096756|NCT00093145|366011621|FG000|Overall Study|Unacceptable Toxicity Only|2|||
106096757|NCT00093145|366011621|FG000|Overall Study|Physician Decision|5|||
106096758|NCT00093145|366011621|FG000|Overall Study|Withdrawal by Subject|9|||
106096759|NCT00093145|366011621|FG000|Overall Study|Other|1|||
106096760|NCT01175668|366011622|FG000|Overall Study|Withdrawal by Subject|2|||
106096761|NCT01175668|366011623|FG001|Overall Study|Withdrawal by Subject|0|||
106096762|NCT04667117|366011629|FG000|Investigational Period|Lost to Follow-up|0|||
106096763|NCT04667117|366011630|FG001|Investigational Period|Lost to Follow-up|0|||
106096764|NCT04667117|366011631|FG002|Investigational Period|Lost to Follow-up|1|||
106096765|NCT04667117|366011629|FG000|Investigational Period|Protocol Deviation|0|||
106096766|NCT04667117|366011630|FG001|Investigational Period|Protocol Deviation|1|||
106096767|NCT04667117|366011631|FG002|Investigational Period|Protocol Deviation|0|||
106096768|NCT04667117|366011629|FG000|Extension Period|Lost to Follow-up|1|||
106096769|NCT04667117|366011630|FG001|Extension Period|Lost to Follow-up|0|||
106096770|NCT04667117|366011631|FG002|Extension Period|Lost to Follow-up|0|||
106096771|NCT02328326|366011634|FG000|Overall Study|Withdrawal by Subject|10|||
106096772|NCT02328326|366011635|FG001|Overall Study|Withdrawal by Subject|3|||
106096773|NCT02328326|366011634|FG000|Overall Study|Death|2|||
106096774|NCT02328326|366011635|FG001|Overall Study|Death|1|||
106096775|NCT02328326|366011634|FG000|Overall Study|Lost to Follow-up|10|||
106096776|NCT02328326|366011635|FG001|Overall Study|Lost to Follow-up|4|||
106096777|NCT02937545|366011641|FG000|Overall Study|Withdrawal by Subject|1|||
106096778|NCT02937545|366011642|FG001|Overall Study|Withdrawal by Subject|2|||
106096779|NCT02937545|366011643|FG002|Overall Study|Withdrawal by Subject|6|||
106096780|NCT02937545|366011644|FG003|Overall Study|Withdrawal by Subject|7|||
106096781|NCT02937545|366011641|FG000|Overall Study|Lost to Follow-up|1|||
106096782|NCT02937545|366011642|FG001|Overall Study|Lost to Follow-up|0|||
106096783|NCT02937545|366011643|FG002|Overall Study|Lost to Follow-up|0|||
106096784|NCT02937545|366011644|FG003|Overall Study|Lost to Follow-up|0|||
106096785|NCT02007577|366011645|FG000|Overall Study|Adverse Event|1|||
106096786|NCT02007577|366011646|FG001|Overall Study|Adverse Event|0|||
106096787|NCT02007577|366011645|FG000|Overall Study|Withdrawal by Subject|0|||
106096788|NCT02007577|366011646|FG001|Overall Study|Withdrawal by Subject|1|||
106096789|NCT02504294|366011647|FG000|Overall Study|Adverse Event|15|||
106096790|NCT02504294|366011648|FG001|Overall Study|Adverse Event|12|||
106096791|NCT02504294|366011647|FG000|Overall Study|Withdrawal by Subject|7|||
106096792|NCT02504294|366011648|FG001|Overall Study|Withdrawal by Subject|1|||
106096793|NCT02504294|366011647|FG000|Overall Study|Protocol Violation|27|||
106096794|NCT02504294|366011648|FG001|Overall Study|Protocol Violation|26|||
106096795|NCT02504294|366011647|FG000|Overall Study|Physician Decision|1|||
106096796|NCT02504294|366011648|FG001|Overall Study|Physician Decision|2|||
106096797|NCT02504294|366011647|FG000|Overall Study|Lost to Follow-up|6|||
106096798|NCT02504294|366011648|FG001|Overall Study|Lost to Follow-up|7|||
106096799|NCT00214136|366011655|FG000|Overall Study|Death|5|||
106096800|NCT01435577|366011656|FG000|Overall Study|Adverse Event|10|||
106096801|NCT01435577|366011657|FG001|Overall Study|Adverse Event|0|||
106096802|NCT01435577|366011656|FG000|Overall Study|Lack of Efficacy|7|||
106096803|NCT01435577|366011657|FG001|Overall Study|Lack of Efficacy|51|||
106096804|NCT01435577|366011656|FG000|Overall Study|Alternative treatment started|0|||
106096805|NCT01435577|366011657|FG001|Overall Study|Alternative treatment started|1|||
106096806|NCT01220557|366011663|FG000|Overall Study|Lost to Follow-up|5|||
106096807|NCT01220557|366011664|FG001|Overall Study|Lost to Follow-up|3|||
106096808|NCT01220557|366011663|FG000|Overall Study|attended less than 6 lessons|1|||
106096809|NCT01220557|366011664|FG001|Overall Study|attended less than 6 lessons|2|||
106096810|NCT00355082|366011667|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
106096811|NCT00355082|366011668|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
106096812|NCT00355082|366011669|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
106096813|NCT00355082|366011667|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
106096814|NCT00355082|366011668|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
106096815|NCT00355082|366011669|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
106096816|NCT00355082|366011667|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
106163263|NCT06019559|366260277|FG000|Overall Study|Withdrawal by Subject|7|||
106163264|NCT06019559|366260278|FG001|Overall Study|Withdrawal by Subject|6|||
106163265|NCT06019559|366260279|FG002|Overall Study|Withdrawal by Subject|5|||
106163266|NCT06019559|366260277|FG000|Overall Study|Lost to Follow-up|2|||
106163267|NCT06019559|366260278|FG001|Overall Study|Lost to Follow-up|0|||
106096817|NCT00355082|366011668|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
106096818|NCT00355082|366011669|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
106096819|NCT00355082|366011667|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
106096820|NCT00355082|366011668|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
106096821|NCT00355082|366011669|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
106096822|NCT00355082|366011667|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
106096823|NCT00355082|366011668|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
106096824|NCT00355082|366011669|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
106096825|NCT00355082|366011667|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
106096826|NCT00355082|366011668|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
106163268|NCT06019559|366260279|FG002|Overall Study|Lost to Follow-up|3|||
106163269|NCT03092518|366260280|FG000|Overall Study|Ineligible|2|||
106163270|NCT01824537|366260281|FG000|Overall Study|Lost to Follow-up|78|||
106163271|NCT01824537|366260282|FG001|Overall Study|Lost to Follow-up|87|||
106163272|NCT02547987|366260283|FG000|Overall Study|Withdrawal by Subject|1|||
106163273|NCT02547987|366260283|FG000|Overall Study|Adverse Event|2|||
106163274|NCT04282148|366260284|FG000|Overall Study|Death|7|||
106163275|NCT04282148|366260284|FG000|Overall Study|Withdrawal by Subject|1|||
106163276|NCT04282148|366260284|FG000|Overall Study|Physician Decision|1|||
106163277|NCT02146378|366260285|FG000|Overall Study|No information of administration|2|||
106163278|NCT06181760|366260286|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
106163279|NCT06181760|366260287|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
106163280|NCT06181760|366260288|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
106163281|NCT06181760|366260289|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
106163282|NCT04770532|366260290|FG000|Overall Study|Withdrawal by Subject|0|||
106163283|NCT04770532|366260291|FG001|Overall Study|Withdrawal by Subject|3|||
106163284|NCT04770532|366260290|FG000|Overall Study|Physician Decision|1|||
106163285|NCT04770532|366260291|FG001|Overall Study|Physician Decision|0|||
106163286|NCT04770532|366260290|FG000|Overall Study|Death|2|||
106163287|NCT04770532|366260291|FG001|Overall Study|Death|2|||
106163288|NCT04623671|366260293|FG000|Overall Study|Adverse Event|0|||
106163289|NCT04623671|366260294|FG001|Overall Study|Adverse Event|1|||
106163290|NCT04623671|366260293|FG000|Overall Study|Lost to Follow-up|2|||
106163291|NCT04623671|366260294|FG001|Overall Study|Lost to Follow-up|1|||
106163292|NCT04623671|366260293|FG000|Overall Study|Death|5|||
106163293|NCT04623671|366260294|FG001|Overall Study|Death|5|||
106163294|NCT04663737|366260295|FG000|Overall Study|Withdrawal by Subject|2|||
106163295|NCT04663737|366260296|FG001|Overall Study|Withdrawal by Subject|0|||
106163296|NCT04016662|366260297|FG000|Run-In Phase|Death|1|||
106163297|NCT04016662|366260297|FG000|Run-In Phase|Withdrawal by Subject|11|||
106163298|NCT04016662|366260297|FG000|Run-In Phase|Not meeting screening eligibility|9|||
106163299|NCT04016662|366260297|FG000|Run-In Phase|Physician Decision|3|||
106163300|NCT04016662|366260297|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
106163301|NCT04016662|366260297|FG000|PLGS (12 Weeks)|Death|1|||
106163302|NCT04016662|366260297|FG000|SAP (12 Weeks)|Death|1|||
106163303|NCT04542317|366260301|FG000|Overall Study|Care recipients passed away|18|||
106163304|NCT04542317|366260302|FG001|Overall Study|Care recipients passed away|13|||
106163305|NCT04542317|366260301|FG000|Overall Study|No longer a primary caregiver|5|||
106163306|NCT04542317|366260302|FG001|Overall Study|No longer a primary caregiver|1|||
106163307|NCT04542317|366260301|FG000|Overall Study|Withdrawal by Subject|4|||
106163308|NCT04542317|366260302|FG001|Overall Study|Withdrawal by Subject|2|||
106163309|NCT04542317|366260301|FG000|Overall Study|Caregivers passed away|0|||
106163310|NCT04542317|366260302|FG001|Overall Study|Caregivers passed away|2|||
106163311|NCT03976362|366260305|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
106163312|NCT03976362|366260306|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
106163313|NCT03976362|366260307|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
106163314|NCT03976362|366260305|FG000|Induction Phase|Death|62|||
106163315|NCT03976362|366260306|FG001|Induction Phase|Death|0|||
106163316|NCT03976362|366260307|FG002|Induction Phase|Death|0|||
106163317|NCT03976362|366260305|FG000|Maintenance Phase|Participants Ongoing|0|||
106163318|NCT03976362|366260306|FG001|Maintenance Phase|Participants Ongoing|106|||
106163319|NCT03976362|366260307|FG002|Maintenance Phase|Participants Ongoing|103|||
106163320|NCT03976362|366260305|FG000|Maintenance Phase|Withdrawal by Subject|0|||
106163321|NCT03976362|366260306|FG001|Maintenance Phase|Withdrawal by Subject|4|||
106163322|NCT03976362|366260307|FG002|Maintenance Phase|Withdrawal by Subject|4|||
106163323|NCT03976362|366260305|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
106163324|NCT03976362|366260306|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
106163325|NCT03976362|366260307|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
106163326|NCT03976362|366260305|FG000|Maintenance Phase|Death|0|||
106163327|NCT03976362|366260306|FG001|Maintenance Phase|Death|186|||
106163328|NCT03976362|366260307|FG002|Maintenance Phase|Death|187|||
106163329|NCT00613106|366260308|FG000|Overall Study|Adverse Event|3|||
106163330|NCT00613106|366260309|FG001|Overall Study|Adverse Event|1|||
106163331|NCT00613106|366260308|FG000|Overall Study|Withdrawal by Subject|6|||
106163332|NCT00613106|366260309|FG001|Overall Study|Withdrawal by Subject|3|||
105984898|NCT00231413|365605980|FG005|Overall Study|Non-serious AE|0|||
106163333|NCT00613106|366260308|FG000|Overall Study|Lost to Follow-up|7|||
106163334|NCT00613106|366260309|FG001|Overall Study|Lost to Follow-up|2|||
106163335|NCT00613106|366260308|FG000|Overall Study|misc|4|||
106163336|NCT00613106|366260309|FG001|Overall Study|misc|3|||
106163337|NCT05126433|366260316|FG000|Overall Study|Withdrawal by Subject|3|||
106163338|NCT05126433|366260317|FG001|Overall Study|Withdrawal by Subject|0|||
106163339|NCT05126433|366260318|FG002|Overall Study|Withdrawal by Subject|4|||
106163340|NCT05126433|366260316|FG000|Overall Study|Death|9|||
106163341|NCT05126433|366260317|FG001|Overall Study|Death|3|||
106163342|NCT05126433|366260318|FG002|Overall Study|Death|5|||
106163343|NCT05126433|366260316|FG000|Overall Study|Study Terminated by sponsor|0|||
106163344|NCT05126433|366260317|FG001|Overall Study|Study Terminated by sponsor|1|||
106163345|NCT05126433|366260318|FG002|Overall Study|Study Terminated by sponsor|2|||
106163346|NCT05126433|366260316|FG000|Overall Study|Progressive Disease|1|||
106163347|NCT05126433|366260317|FG001|Overall Study|Progressive Disease|4|||
106163348|NCT05126433|366260318|FG002|Overall Study|Progressive Disease|3|||
106163349|NCT05126433|366260316|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
106163350|NCT05126433|366260317|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
106163351|NCT05126433|366260318|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
106163352|NCT03907878|366260319|FG000|Treatment Period|Withdrawal by Subject|5|||
106163353|NCT03907878|366260319|FG000|Treatment Period|Adverse Event|4|||
106163354|NCT03907878|366260319|FG000|Treatment Period|Lack of Efficacy|1|||
106163355|NCT03907878|366260319|FG000|Treatment Period|Protocol Violation|1|||
106163356|NCT03907878|366260319|FG000|Follow-up Period|Adverse Event|3|||
106163357|NCT03907878|366260319|FG000|Follow-up Period|Withdrawal by Subject|3|||
106163358|NCT00777036|366260321|FG000|On Treatment|Reason Not Specified|4|||
106163359|NCT00777036|366260322|FG001|On Treatment|Reason Not Specified|7|||
106163360|NCT00777036|366260323|FG002|On Treatment|Reason Not Specified|12|||
106163361|NCT00777036|366260321|FG000|On Treatment|Failure to Meet Study Criteria|0|||
106163362|NCT00777036|366260322|FG001|On Treatment|Failure to Meet Study Criteria|1|||
106163363|NCT00777036|366260323|FG002|On Treatment|Failure to Meet Study Criteria|0|||
106163364|NCT00777036|366260321|FG000|On Treatment|Non-compliance with Study Drug|1|||
106163365|NCT00777036|366260322|FG001|On Treatment|Non-compliance with Study Drug|0|||
106163366|NCT00777036|366260323|FG002|On Treatment|Non-compliance with Study Drug|0|||
106163367|NCT00777036|366260321|FG000|On Treatment|Maximum Clinical Benefit|2|||
106163368|NCT00777036|366260322|FG001|On Treatment|Maximum Clinical Benefit|0|||
106163369|NCT00777036|366260323|FG002|On Treatment|Maximum Clinical Benefit|1|||
106163370|NCT00777036|366260321|FG000|On Treatment|Withdrawal by Subject|3|||
106163371|NCT00777036|366260322|FG001|On Treatment|Withdrawal by Subject|2|||
106163372|NCT00777036|366260323|FG002|On Treatment|Withdrawal by Subject|3|||
106163373|NCT00777036|366260321|FG000|On Treatment|Death|0|||
106163374|NCT00777036|366260322|FG001|On Treatment|Death|2|||
106163375|NCT00777036|366260323|FG002|On Treatment|Death|0|||
106163376|NCT00777036|366260321|FG000|On Treatment|Study Drug Toxicity|0|||
106163377|NCT00777036|366260322|FG001|On Treatment|Study Drug Toxicity|0|||
106163378|NCT00777036|366260323|FG002|On Treatment|Study Drug Toxicity|1|||
106163379|NCT00777036|366260321|FG000|On Treatment|Progressive Disease|5|||
106163380|NCT00777036|366260322|FG001|On Treatment|Progressive Disease|4|||
106163381|NCT00777036|366260323|FG002|On Treatment|Progressive Disease|6|||
106163382|NCT00777036|366260321|FG000|Follow-Up|Lost to Follow-up|1|||
106163383|NCT00777036|366260322|FG001|Follow-Up|Lost to Follow-up|0|||
106163384|NCT00777036|366260323|FG002|Follow-Up|Lost to Follow-up|0|||
106163385|NCT00777036|366260321|FG000|Follow-Up|Reason Not Specified|2|||
106163386|NCT00777036|366260322|FG001|Follow-Up|Reason Not Specified|0|||
106163387|NCT00777036|366260323|FG002|Follow-Up|Reason Not Specified|0|||
106163388|NCT00777036|366260321|FG000|Follow-Up|Withdrawal by Subject|1|||
106163389|NCT00777036|366260322|FG001|Follow-Up|Withdrawal by Subject|0|||
106163390|NCT00777036|366260323|FG002|Follow-Up|Withdrawal by Subject|4|||
106163391|NCT00777036|366260321|FG000|Follow-Up|Death|1|||
106163392|NCT00777036|366260322|FG001|Follow-Up|Death|8|||
106163393|NCT00777036|366260323|FG002|Follow-Up|Death|0|||
106163394|NCT00324805|366260324|FG000|Overall Study|Adverse Event|62|||
106163395|NCT00324805|366260325|FG001|Overall Study|Adverse Event|203|||
106163396|NCT00324805|366260324|FG000|Overall Study|Progression|7|||
106163397|NCT00324805|366260325|FG001|Overall Study|Progression|35|||
106163398|NCT00324805|366260324|FG000|Overall Study|Withdrawal by Subject|51|||
106163399|NCT00324805|366260325|FG001|Overall Study|Withdrawal by Subject|174|||
106163400|NCT00324805|366260324|FG000|Overall Study|Death|6|||
106163401|NCT00324805|366260325|FG001|Overall Study|Death|9|||
106163402|NCT00324805|366260324|FG000|Overall Study|Alternative therapy|4|||
106163403|NCT00324805|366260325|FG001|Overall Study|Alternative therapy|8|||
106163404|NCT00324805|366260324|FG000|Overall Study|Other complicating disease|1|||
106163405|NCT00324805|366260325|FG001|Overall Study|Other complicating disease|9|||
106163406|NCT00324805|366260324|FG000|Overall Study|Other reasons|7|||
106163407|NCT00324805|366260325|FG001|Overall Study|Other reasons|26|||
106163408|NCT00324805|366260324|FG000|Overall Study|Other|0|||
106163409|NCT00324805|366260325|FG001|Overall Study|Other|2|||
106163410|NCT00324805|366260324|FG000|Overall Study|Did not start therapy|12|||
106163411|NCT00324805|366260325|FG001|Overall Study|Did not start therapy|17|||
106163412|NCT03852472|366260326|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
106163413|NCT03852472|366260327|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
106163414|NCT03852472|366260328|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
106163415|NCT03852472|366260329|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
106163416|NCT03852472|366260330|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
106163417|NCT03852472|366260326|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
106163418|NCT03852472|366260327|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
106163419|NCT03852472|366260328|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
106163420|NCT03852472|366260329|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
106163421|NCT03852472|366260330|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
106163422|NCT03852472|366260326|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
106163423|NCT03852472|366260327|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
106163424|NCT03852472|366260328|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
106163425|NCT03852472|366260329|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
106163426|NCT03852472|366260330|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
106163427|NCT03852472|366260326|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
106163428|NCT03852472|366260327|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
106163429|NCT03852472|366260328|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
106163430|NCT03852472|366260329|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
106163431|NCT03852472|366260330|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
106163432|NCT03852472|366260326|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
106163433|NCT03852472|366260327|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
106163434|NCT03852472|366260328|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
106163435|NCT03852472|366260329|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
106163436|NCT03852472|366260330|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
106163437|NCT03852472|366260326|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
106163438|NCT03852472|366260327|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
106163439|NCT03852472|366260328|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
106163440|NCT03852472|366260329|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
106163441|NCT03852472|366260330|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
106163442|NCT03852472|366260326|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
106163443|NCT03852472|366260327|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
106163444|NCT03852472|366260328|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
106163445|NCT03852472|366260329|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
106163446|NCT03852472|366260330|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
106163447|NCT03852472|366260326|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
106163448|NCT03852472|366260327|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
106163449|NCT03852472|366260328|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
106163450|NCT03852472|366260329|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
106163451|NCT03852472|366260330|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
106163452|NCT03852472|366260326|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
106163453|NCT03852472|366260327|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
106163454|NCT03852472|366260328|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
106163455|NCT03852472|366260329|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
106163456|NCT03852472|366260330|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
106163457|NCT03852472|366260326|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
106163458|NCT03852472|366260327|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
106163459|NCT03852472|366260328|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
106163460|NCT03852472|366260329|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
106163461|NCT03852472|366260330|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
106163462|NCT03852472|366260326|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
106163463|NCT03852472|366260327|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
106163464|NCT03852472|366260328|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
106163465|NCT03852472|366260329|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
106163466|NCT03852472|366260330|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
106163467|NCT03852472|366260326|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
106163468|NCT03852472|366260327|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
106163469|NCT03852472|366260328|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
106163470|NCT03852472|366260329|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
106163471|NCT03852472|366260330|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
106163472|NCT03852472|366260326|FG000|Period 2 - Week 44|Adverse Event|0|||
106163473|NCT03852472|366260327|FG001|Period 2 - Week 44|Adverse Event|3|||
106163474|NCT03852472|366260328|FG002|Period 2 - Week 44|Adverse Event|1|||
106163475|NCT03852472|366260329|FG003|Period 2 - Week 44|Adverse Event|2|||
106163476|NCT03852472|366260330|FG004|Period 2 - Week 44|Adverse Event|2|||
106163477|NCT03852472|366260326|FG000|Period 2 - Week 44|COVID-19 Related|0|||
106163478|NCT03852472|366260327|FG001|Period 2 - Week 44|COVID-19 Related|0|||
106163479|NCT03852472|366260328|FG002|Period 2 - Week 44|COVID-19 Related|0|||
106163480|NCT03852472|366260329|FG003|Period 2 - Week 44|COVID-19 Related|1|||
106163481|NCT03852472|366260330|FG004|Period 2 - Week 44|COVID-19 Related|0|||
106163482|NCT03852472|366260326|FG000|Period 2 - Week 44|Reason not stated|0|||
106163483|NCT03852472|366260327|FG001|Period 2 - Week 44|Reason not stated|0|||
106163484|NCT03852472|366260328|FG002|Period 2 - Week 44|Reason not stated|0|||
106163485|NCT03852472|366260329|FG003|Period 2 - Week 44|Reason not stated|0|||
106163486|NCT03852472|366260330|FG004|Period 2 - Week 44|Reason not stated|1|||
106163487|NCT04880863|366260331|FG000|Overall Study|Adverse Event|1|||
106163488|NCT04880863|366260331|FG000|Overall Study|Patient decision|2|||
106163489|NCT04880863|366260331|FG000|Overall Study|Confirmed Disease Progression|15|||
106163490|NCT04880863|366260331|FG000|Overall Study|Death|3|||
106163491|NCT04880863|366260331|FG000|Overall Study|Physician Decision|4|||
106163492|NCT04880863|366260331|FG000|Overall Study|Unconfirmed Disease Progression|4|||
106163493|NCT04880863|366260331|FG000|Overall Study|Withdrawal by Subject|2|||
106163494|NCT04880863|366260331|FG000|Overall Study|Study discontinuation by the sponsor|4|||
106163495|NCT04880863|366260331|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
106163496|NCT04880863|366260331|FG000|Overall Study|Not received study drug NAP|2|||
106163497|NCT00554788|366262216|FG000|Overall Study|Adverse Event|0|||
106163498|NCT00554788|366262217|FG001|Overall Study|Adverse Event|1|||
106163499|NCT00554788|366262218|FG002|Overall Study|Adverse Event|2|||
106163500|NCT00554788|366262216|FG000|Overall Study|Lost to Follow-up|4|||
106163501|NCT00554788|366262217|FG001|Overall Study|Lost to Follow-up|3|||
106163502|NCT00554788|366262218|FG002|Overall Study|Lost to Follow-up|3|||
106163503|NCT00554788|366262216|FG000|Overall Study|Physician Decision|1|||
106163504|NCT00554788|366262217|FG001|Overall Study|Physician Decision|1|||
106163505|NCT00554788|366262218|FG002|Overall Study|Physician Decision|3|||
106163506|NCT00554788|366262216|FG000|Overall Study|Withdrawal by Subject|0|||
106163507|NCT00554788|366262217|FG001|Overall Study|Withdrawal by Subject|0|||
106163508|NCT00554788|366262218|FG002|Overall Study|Withdrawal by Subject|1|||
106163509|NCT00554788|366262216|FG000|Overall Study|Refusal of further protocol therapy|0|||
106163510|NCT00554788|366262217|FG001|Overall Study|Refusal of further protocol therapy|1|||
106163511|NCT00554788|366262218|FG002|Overall Study|Refusal of further protocol therapy|1|||
106163512|NCT00554788|366262216|FG000|Overall Study|Progressive disease|0|||
106163513|NCT00554788|366262217|FG001|Overall Study|Progressive disease|0|||
106163514|NCT00554788|366262218|FG002|Overall Study|Progressive disease|3|||
106163515|NCT00554788|366262216|FG000|Overall Study|Ineligible|2|||
106163516|NCT00554788|366262217|FG001|Overall Study|Ineligible|0|||
106163517|NCT00554788|366262218|FG002|Overall Study|Ineligible|1|||
106163518|NCT04963270|366262220|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
106163519|NCT04963270|366262221|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
106163520|NCT04963270|366262222|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
106163521|NCT04963270|366262223|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
106163522|NCT04963270|366262220|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
106163523|NCT04963270|366262221|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
106163524|NCT04963270|366262222|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
106163525|NCT04963270|366262223|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
106163526|NCT04963270|366262220|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
106163527|NCT04963270|366262221|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
106163528|NCT04963270|366262222|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
106163529|NCT04963270|366262223|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
106163530|NCT04963270|366262220|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
106163531|NCT04963270|366262221|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
106163532|NCT04963270|366262222|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
106163533|NCT04963270|366262223|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
106163534|NCT04963270|366262220|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
106163535|NCT04963270|366262221|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
106163536|NCT04963270|366262222|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
106163537|NCT04963270|366262223|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
106163538|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
106163539|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
106163540|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
106163541|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
106163542|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
106163543|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
106163544|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
106163545|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
106163546|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
106163547|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
106163548|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
106163549|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
106163550|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
106163551|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
106163552|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
106163553|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
106163554|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
106163555|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
106163556|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
106163557|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
106163558|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
106163559|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
106163560|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
106163561|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
106163562|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
106163563|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
106163564|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
106163565|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
106163566|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
106163567|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
106163568|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
106163569|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
106163570|NCT04963270|366262220|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
106163571|NCT04963270|366262221|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
106163572|NCT04963270|366262222|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
106163573|NCT04963270|366262223|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
106163574|NCT01842542|366262224|FG000|Overall Study|Withdrawal by Subject|2|||
106163575|NCT01842542|366262224|FG000|Overall Study|Lack of Efficacy|1|||
106163576|NCT01842542|366262224|FG000|Overall Study|Protocol Non-compliance|2|||
106163577|NCT01842542|366262224|FG000|Overall Study|Lost to Follow-up|1|||
106163578|NCT04908722|366262225|FG000|Overall Study|Protocol deviation|1|||
106163579|NCT04908722|366262226|FG001|Overall Study|Protocol deviation|0|||
106163580|NCT04908722|366262227|FG002|Overall Study|Protocol deviation|0|||
106163581|NCT04908722|366262228|FG003|Overall Study|Protocol deviation|0|||
106163582|NCT04908722|366262229|FG004|Overall Study|Protocol deviation|0|||
106163583|NCT04908722|366262230|FG005|Overall Study|Protocol deviation|1|||
106163584|NCT04908722|366262225|FG000|Overall Study|Lost to Follow-up|33|||
106163585|NCT04908722|366262226|FG001|Overall Study|Lost to Follow-up|33|||
106163586|NCT04908722|366262227|FG002|Overall Study|Lost to Follow-up|36|||
106163587|NCT04908722|366262228|FG003|Overall Study|Lost to Follow-up|30|||
106163588|NCT04908722|366262229|FG004|Overall Study|Lost to Follow-up|32|||
106163589|NCT04908722|366262230|FG005|Overall Study|Lost to Follow-up|34|||
106163590|NCT04908722|366262225|FG000|Overall Study|Physician Decision|1|||
106163591|NCT04908722|366262226|FG001|Overall Study|Physician Decision|1|||
106163592|NCT04908722|366262227|FG002|Overall Study|Physician Decision|1|||
106163593|NCT04908722|366262228|FG003|Overall Study|Physician Decision|2|||
106163594|NCT04908722|366262229|FG004|Overall Study|Physician Decision|0|||
106163595|NCT04908722|366262230|FG005|Overall Study|Physician Decision|0|||
106163596|NCT04908722|366262225|FG000|Overall Study|Death|1|||
106163597|NCT04908722|366262226|FG001|Overall Study|Death|0|||
106163598|NCT04908722|366262227|FG002|Overall Study|Death|0|||
106163599|NCT04908722|366262228|FG003|Overall Study|Death|0|||
106163600|NCT04908722|366262229|FG004|Overall Study|Death|0|||
106163601|NCT04908722|366262230|FG005|Overall Study|Death|1|||
106163602|NCT04908722|366262225|FG000|Overall Study|Withdrawal by Subject|12|||
106163603|NCT04908722|366262226|FG001|Overall Study|Withdrawal by Subject|8|||
106163604|NCT04908722|366262227|FG002|Overall Study|Withdrawal by Subject|7|||
106163605|NCT04908722|366262228|FG003|Overall Study|Withdrawal by Subject|6|||
106163606|NCT04908722|366262229|FG004|Overall Study|Withdrawal by Subject|12|||
106163607|NCT04908722|366262230|FG005|Overall Study|Withdrawal by Subject|14|||
106163608|NCT04908722|366262225|FG000|Overall Study|Other|3|||
106163609|NCT04908722|366262226|FG001|Overall Study|Other|1|||
106163610|NCT04908722|366262227|FG002|Overall Study|Other|3|||
106163611|NCT04908722|366262228|FG003|Overall Study|Other|2|||
106163612|NCT04908722|366262229|FG004|Overall Study|Other|4|||
106163613|NCT04908722|366262230|FG005|Overall Study|Other|1|||
106163614|NCT04908722|366262225|FG000|Overall Study|Initiated prohibited medication|0|||
106163615|NCT04908722|366262226|FG001|Overall Study|Initiated prohibited medication|0|||
106163616|NCT04908722|366262227|FG002|Overall Study|Initiated prohibited medication|0|||
106163617|NCT04908722|366262228|FG003|Overall Study|Initiated prohibited medication|1|||
106163618|NCT04908722|366262229|FG004|Overall Study|Initiated prohibited medication|0|||
106163619|NCT04908722|366262230|FG005|Overall Study|Initiated prohibited medication|1|||
106163620|NCT04908722|366262225|FG000|Overall Study|Randomized but not vaccinated|3|||
106163621|NCT04908722|366262226|FG001|Overall Study|Randomized but not vaccinated|1|||
106163622|NCT04908722|366262227|FG002|Overall Study|Randomized but not vaccinated|2|||
106163623|NCT04908722|366262228|FG003|Overall Study|Randomized but not vaccinated|2|||
106163624|NCT04908722|366262229|FG004|Overall Study|Randomized but not vaccinated|3|||
106163625|NCT04908722|366262230|FG005|Overall Study|Randomized but not vaccinated|4|||
106163626|NCT03339713|366262233|FG000|Overall Study|Lost to Follow-up|2|||
106163627|NCT03339713|366262234|FG001|Overall Study|Lost to Follow-up|1|||
106163628|NCT03339713|366262233|FG000|Overall Study|Protocol Violation|1|||
106163629|NCT03339713|366262234|FG001|Overall Study|Protocol Violation|0|||
106163630|NCT03339713|366262233|FG000|Overall Study|Withdrawal by Subject|1|||
106163631|NCT03339713|366262234|FG001|Overall Study|Withdrawal by Subject|1|||
106163632|NCT02619838|366262237|FG000|Overall Study|Lost to Follow-up|9|||
106163633|NCT02619838|366262237|FG000|Overall Study|Withdrawal by Subject|15|||
106163634|NCT03371381|366262238|FG000|Overall Study|Death|5|||
106163635|NCT03371381|366262238|FG000|Overall Study|Study terminated by sponsor|3|||
106163636|NCT03371381|366262238|FG000|Overall Study|Other|4|||
106163637|NCT02979327|366262239|FG000|First Intervention|Protocol Violation|1|||
106163638|NCT02979327|366262240|FG001|First Intervention|Protocol Violation|0|||
106163639|NCT05020249|366262241|FG000|Overall Study|Protocol Violation|1|||
106163640|NCT05020249|366262242|FG001|Overall Study|Protocol Violation|0|||
106163641|NCT01073566|366262244|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
106163642|NCT01073566|366262245|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
106163643|NCT03474679|366262252|FG000|Overall Study|Death|7|||
106163644|NCT03474679|366262252|FG000|Overall Study|Withdrawal by Subject|1|||
106163645|NCT03536754|366262253|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
106163646|NCT03536754|366262254|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
106163647|NCT03536754|366262255|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
106163648|NCT03536754|366262256|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
106163649|NCT03536754|366262257|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
106163650|NCT03536754|366262253|FG000|Open Label Extension|Other|0|||
106163651|NCT03536754|366262254|FG001|Open Label Extension|Other|0|||
106163652|NCT03536754|366262255|FG002|Open Label Extension|Other|0|||
106163653|NCT03536754|366262256|FG003|Open Label Extension|Other|0|||
106163654|NCT03536754|366262257|FG004|Open Label Extension|Other|1|||
106163655|NCT05794243|366262263|FG000|Overall Study|Withdrawal by Subject|1|||
106163656|NCT05794243|366262264|FG001|Overall Study|Withdrawal by Subject|0|||
106163657|NCT05794243|366262265|FG002|Overall Study|Withdrawal by Subject|1|||
106163658|NCT05794243|366262263|FG000|Overall Study|Physician Decision|0|||
106163659|NCT05794243|366262264|FG001|Overall Study|Physician Decision|3|||
106163660|NCT05794243|366262265|FG002|Overall Study|Physician Decision|1|||
106163661|NCT05714761|366262271|FG000|Overall Study|Lost to Follow-up|3|||
106163662|NCT05714761|366262271|FG000|Overall Study|Withdrawal by Subject|3|||
106163663|NCT05714761|366262271|FG000|Overall Study|unblinding of sensor data|1|||
106163664|NCT05714761|366262271|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
106163665|NCT05714761|366262271|FG000|Overall Study|did not return second CGM sensor|4|||
106163666|NCT05008835|366262275|FG000|Overall Study|Adverse Event|5|||
106163667|NCT05008835|366262276|FG001|Overall Study|Adverse Event|2|||
106163668|NCT05008835|366262277|FG002|Overall Study|Adverse Event|1|||
106163669|NCT05008835|366262275|FG000|Overall Study|Lack of Efficacy|0|||
106163670|NCT05008835|366262276|FG001|Overall Study|Lack of Efficacy|0|||
106163671|NCT05008835|366262277|FG002|Overall Study|Lack of Efficacy|1|||
106163672|NCT05008835|366262275|FG000|Overall Study|Study terminated by sponsor|0|||
106163673|NCT05008835|366262276|FG001|Overall Study|Study terminated by sponsor|0|||
106163674|NCT05008835|366262277|FG002|Overall Study|Study terminated by sponsor|1|||
106163675|NCT05008835|366262275|FG000|Overall Study|Not further specified|3|||
106163676|NCT05008835|366262276|FG001|Overall Study|Not further specified|2|||
106163677|NCT05008835|366262277|FG002|Overall Study|Not further specified|1|||
106163678|NCT04171999|366262278|FG000|Overall Study|deemed ineligible after randomization|2|||
106163679|NCT04171999|366262279|FG001|Overall Study|deemed ineligible after randomization|1|||
106163680|NCT03858634|366262288|FG000|Overall Study|Withdrawal by Subject|1|||
106163681|NCT03858634|366262289|FG001|Overall Study|Withdrawal by Subject|0|||
106163682|NCT03858634|366262288|FG000|Overall Study|Adverse Event|1|||
106163683|NCT03858634|366262289|FG001|Overall Study|Adverse Event|0|||
106163684|NCT03858634|366262288|FG000|Overall Study|Lost to Follow-up|0|||
106163685|NCT03858634|366262289|FG001|Overall Study|Lost to Follow-up|1|||
106163686|NCT03858634|366262288|FG000|Overall Study|Other, Not Specified|1|||
106163687|NCT03858634|366262289|FG001|Overall Study|Other, Not Specified|1|||
106163688|NCT04629716|366262291|FG000|Overall Study|Lost to Follow-up|7|||
106163689|NCT04629716|366262292|FG001|Overall Study|Lost to Follow-up|3|||
106163690|NCT04537715|366262293|FG000|Overall Study|Death|3|||
106163691|NCT04537715|366262294|FG001|Overall Study|Death|1|||
106163692|NCT04537715|366262293|FG000|Overall Study|Withdrawal by Subject|3|||
106163693|NCT04537715|366262294|FG001|Overall Study|Withdrawal by Subject|1|||
106163694|NCT04537715|366262293|FG000|Overall Study|Other|4|||
106163695|NCT04537715|366262294|FG001|Overall Study|Other|3|||
106163696|NCT04537715|366262293|FG000|Overall Study|Progressive disease|1|||
106163697|NCT04537715|366262294|FG001|Overall Study|Progressive disease|0|||
106163698|NCT02683447|366262296|FG000|Overall Study|Lost to Follow-up|2|||
106163699|NCT04568603|366262305|FG000|Overall Study|Physician Decision|1|||
106163700|NCT04137367|366262306|FG000|Overall Study|Lost to Follow-up|8|||
106163701|NCT04137367|366262307|FG001|Overall Study|Lost to Follow-up|6|||
106163702|NCT04137367|366262308|FG002|Overall Study|Lost to Follow-up|4|||
106163703|NCT04065841|366262327|FG000|Overall Study|Adverse Event|4|||
106163704|NCT04065841|366262328|FG001|Overall Study|Adverse Event|2|||
106163705|NCT04065841|366262329|FG002|Overall Study|Adverse Event|10|||
106163706|NCT04065841|366262330|FG003|Overall Study|Adverse Event|1|||
106163707|NCT04065841|366262327|FG000|Overall Study|Lost to Follow-up|1|||
106163708|NCT04065841|366262328|FG001|Overall Study|Lost to Follow-up|2|||
106163709|NCT04065841|366262329|FG002|Overall Study|Lost to Follow-up|2|||
106163710|NCT04065841|366262330|FG003|Overall Study|Lost to Follow-up|2|||
106163711|NCT04065841|366262327|FG000|Overall Study|Physician Decision|1|||
106163712|NCT04065841|366262328|FG001|Overall Study|Physician Decision|0|||
106163713|NCT04065841|366262329|FG002|Overall Study|Physician Decision|0|||
106163714|NCT04065841|366262330|FG003|Overall Study|Physician Decision|0|||
106163715|NCT04065841|366262327|FG000|Overall Study|Protocol Violation|0|||
106163716|NCT04065841|366262328|FG001|Overall Study|Protocol Violation|1|||
106163717|NCT04065841|366262329|FG002|Overall Study|Protocol Violation|0|||
106163718|NCT04065841|366262330|FG003|Overall Study|Protocol Violation|0|||
106163719|NCT04065841|366262327|FG000|Overall Study|Study terminated by Sponsor|22|||
106163720|NCT04065841|366262328|FG001|Overall Study|Study terminated by Sponsor|16|||
106163721|NCT04065841|366262329|FG002|Overall Study|Study terminated by Sponsor|28|||
106163722|NCT04065841|366262330|FG003|Overall Study|Study terminated by Sponsor|17|||
106163723|NCT04065841|366262327|FG000|Overall Study|Withdrawal by Subject|1|||
106163724|NCT04065841|366262328|FG001|Overall Study|Withdrawal by Subject|1|||
106163725|NCT04065841|366262329|FG002|Overall Study|Withdrawal by Subject|2|||
106163726|NCT04065841|366262330|FG003|Overall Study|Withdrawal by Subject|0|||
106163727|NCT02998268|366262333|FG000|Overall Study|Adverse Event|0|||
106163728|NCT02998268|366262334|FG001|Overall Study|Adverse Event|2|||
106163729|NCT02998268|366262333|FG000|Overall Study|Withdrawal by Subject|0|||
106163730|NCT02998268|366262334|FG001|Overall Study|Withdrawal by Subject|1|||
106163731|NCT03652389|366262338|FG000|Overall Study|Lost to Follow-up|1|||
106163732|NCT03652389|366262339|FG001|Overall Study|Lost to Follow-up|5|||
106163733|NCT03652389|366262338|FG000|Overall Study|Withdrawal by Subject|5|||
106163734|NCT03652389|366262339|FG001|Overall Study|Withdrawal by Subject|1|||
106163735|NCT03652389|366262338|FG000|Overall Study|New diagnosis|2|||
106163736|NCT03652389|366262339|FG001|Overall Study|New diagnosis|0|||
106163737|NCT04568486|366262354|FG000|Overall Study|Withdrawal by Subject|26|||
106163738|NCT04568486|366262354|FG000|Overall Study|Lost to Follow-up|7|||
106163739|NCT03931174|366262361|FG000|Providers|Staff left organization|26|||
106163740|NCT03931174|366262362|FG001|Providers|Staff left organization|25|||
106163741|NCT03931174|366262361|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
106163742|NCT03931174|366262362|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
106163743|NCT03931174|366262361|FG000|Providers|Lost to Follow-up|4|||
106163744|NCT03931174|366262362|FG001|Providers|Lost to Follow-up|4|||
106163745|NCT03931174|366262361|FG000|Patients|Post-consent screening failure|1|||
106163746|NCT03931174|366262362|FG001|Patients|Post-consent screening failure|1|||
106163747|NCT03931174|366262361|FG000|Patients|Death|1|||
106163748|NCT03931174|366262362|FG001|Patients|Death|1|||
106163749|NCT03931174|366262361|FG000|Patients|Lost to Follow-up|60|||
106163750|NCT03931174|366262362|FG001|Patients|Lost to Follow-up|89|||
106163751|NCT01824875|366264334|FG000|Overall Study|Disease progression|22|||
106163752|NCT01824875|366264335|FG001|Overall Study|Disease progression|15|||
106163753|NCT01824875|366264334|FG000|Overall Study|Withdrawal by Subject|5|||
106163754|NCT01824875|366264335|FG001|Overall Study|Withdrawal by Subject|4|||
106163755|NCT01824875|366264334|FG000|Overall Study|Adverse Event|4|||
106163756|NCT01824875|366264335|FG001|Overall Study|Adverse Event|10|||
106163757|NCT01824875|366264334|FG000|Overall Study|Alternative therapy|3|||
106163758|NCT01824875|366264335|FG001|Overall Study|Alternative therapy|0|||
106163759|NCT01824875|366264334|FG000|Overall Study|Complicating disease|1|||
106163760|NCT01824875|366264335|FG001|Overall Study|Complicating disease|0|||
106163761|NCT01824875|366264334|FG000|Overall Study|Physician Decision|0|||
106163762|NCT01824875|366264335|FG001|Overall Study|Physician Decision|1|||
106163763|NCT01824875|366264334|FG000|Overall Study|Non-compliance|1|||
106163764|NCT01824875|366264335|FG001|Overall Study|Non-compliance|1|||
106163765|NCT01824875|366264334|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
106163766|NCT01824875|366264335|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
106163767|NCT01824875|366264334|FG000|Overall Study|Administrative issues|0|||
106163768|NCT01824875|366264335|FG001|Overall Study|Administrative issues|2|||
106163769|NCT01824875|366264334|FG000|Overall Study|Ineligible or never started treatment|9|||
106163770|NCT01824875|366264335|FG001|Overall Study|Ineligible or never started treatment|5|||
106163771|NCT01824875|366264334|FG000|Overall Study|Other|0|||
106163772|NCT01824875|366264335|FG001|Overall Study|Other|2|||
106163773|NCT01098812|366264336|FG000|Overall Study|Death|2|||
106163774|NCT01098812|366264337|FG001|Overall Study|Death|0|||
106163775|NCT01098812|366264338|FG002|Overall Study|Death|1|||
106163776|NCT01098812|366264336|FG000|Overall Study|Lost to Follow-up|0|||
106163777|NCT01098812|366264337|FG001|Overall Study|Lost to Follow-up|1|||
106163778|NCT01098812|366264338|FG002|Overall Study|Lost to Follow-up|0|||
106163779|NCT01369355|366264339|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
106163780|NCT01369355|366264340|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
106163781|NCT01369355|366264341|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
106163782|NCT01369355|366264342|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
106163783|NCT01369355|366264343|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
106163784|NCT01369355|366264344|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
106163785|NCT01369355|366264345|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
106163786|NCT01369355|366264346|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
106163787|NCT01369355|366264347|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
106163788|NCT01369355|366264339|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
106163789|NCT01369355|366264340|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
106163790|NCT01369355|366264341|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
106163791|NCT01369355|366264342|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
106163792|NCT01369355|366264343|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
106163793|NCT01369355|366264344|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
106163794|NCT01369355|366264345|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
106163795|NCT01369355|366264346|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
106163796|NCT01369355|366264347|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
106163797|NCT01369355|366264339|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
106163798|NCT01369355|366264340|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
106163799|NCT01369355|366264341|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
106163800|NCT01369355|366264342|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
106163801|NCT01369355|366264343|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
106163802|NCT01369355|366264344|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
106163803|NCT01369355|366264345|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
106163804|NCT01369355|366264346|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
106163805|NCT01369355|366264347|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
106163806|NCT01369355|366264339|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
106163807|NCT01369355|366264340|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
106163808|NCT01369355|366264341|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
106163809|NCT01369355|366264342|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
106163810|NCT01369355|366264343|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
106163811|NCT01369355|366264344|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
106163812|NCT01369355|366264345|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
106163813|NCT01369355|366264346|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
106163814|NCT01369355|366264347|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
106163815|NCT01369355|366264339|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
106163816|NCT01369355|366264340|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
106163817|NCT01369355|366264341|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
106163818|NCT01369355|366264342|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
106163819|NCT01369355|366264343|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
106163820|NCT01369355|366264344|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
106163821|NCT01369355|366264345|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
106163822|NCT01369355|366264346|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
106163823|NCT01369355|366264347|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
106163824|NCT01369355|366264339|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
106163825|NCT01369355|366264340|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
106163826|NCT01369355|366264341|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
106163827|NCT01369355|366264342|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
106163828|NCT01369355|366264343|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
106163829|NCT01369355|366264344|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
106163830|NCT01369355|366264345|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
106163831|NCT01369355|366264346|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
106163832|NCT01369355|366264347|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
106163833|NCT01369355|366264339|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
106163834|NCT01369355|366264340|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
106163835|NCT01369355|366264341|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
106163836|NCT01369355|366264342|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
106163837|NCT01369355|366264343|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
106163838|NCT01369355|366264344|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
106163839|NCT01369355|366264345|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
106163840|NCT01369355|366264346|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
106163841|NCT01369355|366264347|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
106163842|NCT01369355|366264339|FG000|Long-term Extension (Week 44-272)|Death|0|||
106163843|NCT01369355|366264340|FG001|Long-term Extension (Week 44-272)|Death|0|||
106163844|NCT01369355|366264341|FG002|Long-term Extension (Week 44-272)|Death|0|||
106163845|NCT01369355|366264342|FG003|Long-term Extension (Week 44-272)|Death|0|||
106163846|NCT01369355|366264343|FG004|Long-term Extension (Week 44-272)|Death|0|||
106163847|NCT01369355|366264344|FG005|Long-term Extension (Week 44-272)|Death|0|||
106163848|NCT01369355|366264345|FG006|Long-term Extension (Week 44-272)|Death|0|||
106163849|NCT01369355|366264346|FG007|Long-term Extension (Week 44-272)|Death|1|||
106163850|NCT01369355|366264347|FG008|Long-term Extension (Week 44-272)|Death|3|||
106163851|NCT01369355|366264339|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
106163852|NCT01369355|366264340|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
106163853|NCT01369355|366264341|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
106163854|NCT01369355|366264342|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
106163855|NCT01369355|366264343|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
106163856|NCT01369355|366264344|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
106163857|NCT01369355|366264345|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
106163858|NCT01369355|366264346|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
106163859|NCT01369355|366264347|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
106163860|NCT01369355|366264339|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
106163861|NCT01369355|366264340|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
106163862|NCT01369355|366264341|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
106163863|NCT01369355|366264342|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
106163864|NCT01369355|366264343|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
106163865|NCT01369355|366264344|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
106163866|NCT01369355|366264345|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
106163867|NCT01369355|366264346|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
106163868|NCT01369355|366264347|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
106163869|NCT01369355|366264339|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
106163870|NCT01369355|366264340|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
106163871|NCT01369355|366264341|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
106163872|NCT01369355|366264342|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
106163873|NCT01369355|366264343|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
106163874|NCT01369355|366264344|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
106163875|NCT01369355|366264345|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
106163876|NCT01369355|366264346|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
106163877|NCT01369355|366264347|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
106163878|NCT01369355|366264339|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
106163879|NCT01369355|366264340|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
106163880|NCT01369355|366264341|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
106163881|NCT01369355|366264342|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
106163882|NCT01369355|366264343|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
106163883|NCT01369355|366264344|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
106163884|NCT01369355|366264345|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
106163885|NCT01369355|366264346|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
106163886|NCT01369355|366264347|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
106163887|NCT01369355|366264339|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
106163888|NCT01369355|366264340|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
106163889|NCT01369355|366264341|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
106163890|NCT01369355|366264342|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
106163891|NCT01369355|366264343|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
106163892|NCT01369355|366264344|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
106163893|NCT01369355|366264345|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
106163894|NCT01369355|366264346|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
106163895|NCT01369355|366264347|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
106163896|NCT01369355|366264339|FG000|Long-term Extension (Week 44-272)|Other|0|||
106163897|NCT01369355|366264340|FG001|Long-term Extension (Week 44-272)|Other|0|||
106163898|NCT01369355|366264341|FG002|Long-term Extension (Week 44-272)|Other|0|||
106163899|NCT01369355|366264342|FG003|Long-term Extension (Week 44-272)|Other|0|||
106163900|NCT01369355|366264343|FG004|Long-term Extension (Week 44-272)|Other|0|||
106163901|NCT01369355|366264344|FG005|Long-term Extension (Week 44-272)|Other|0|||
106163902|NCT01369355|366264345|FG006|Long-term Extension (Week 44-272)|Other|110|||
106163903|NCT01369355|366264346|FG007|Long-term Extension (Week 44-272)|Other|9|||
106163904|NCT01369355|366264347|FG008|Long-term Extension (Week 44-272)|Other|17|||
106163905|NCT02319759|366264350|FG000|Week 0 - 16|Lack of Efficacy|1|||
106163906|NCT02319759|366264351|FG001|Week 0 - 16|Lack of Efficacy|0|||
106163907|NCT02319759|366264352|FG002|Week 0 - 16|Lack of Efficacy|0|||
106163908|NCT02319759|366264353|FG003|Week 0 - 16|Lack of Efficacy|0|||
106163909|NCT02319759|366264354|FG004|Week 0 - 16|Lack of Efficacy|0|||
106163910|NCT02319759|366264350|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
106163911|NCT02319759|366264351|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
106163912|NCT02319759|366264352|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
106163913|NCT02319759|366264353|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
106163914|NCT02319759|366264354|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
106163915|NCT02319759|366264350|FG000|Week 16 - 24|Lack of Efficacy|1|||
106163916|NCT02319759|366264351|FG001|Week 16 - 24|Lack of Efficacy|0|||
106163917|NCT02319759|366264352|FG002|Week 16 - 24|Lack of Efficacy|1|||
106163918|NCT02319759|366264353|FG003|Week 16 - 24|Lack of Efficacy|0|||
106163919|NCT02319759|366264354|FG004|Week 16 - 24|Lack of Efficacy|0|||
106163920|NCT02319759|366264350|FG000|Week 16 - 24|Lost to Follow-up|1|||
106163921|NCT02319759|366264351|FG001|Week 16 - 24|Lost to Follow-up|0|||
106163922|NCT02319759|366264352|FG002|Week 16 - 24|Lost to Follow-up|0|||
106163923|NCT02319759|366264353|FG003|Week 16 - 24|Lost to Follow-up|0|||
106163924|NCT02319759|366264354|FG004|Week 16 - 24|Lost to Follow-up|0|||
106163925|NCT02319759|366264350|FG000|Week 16 - 24|Withdrawal by Subject|0|||
106163926|NCT02319759|366264351|FG001|Week 16 - 24|Withdrawal by Subject|0|||
106163927|NCT02319759|366264352|FG002|Week 16 - 24|Withdrawal by Subject|2|||
106163928|NCT02319759|366264353|FG003|Week 16 - 24|Withdrawal by Subject|0|||
106163929|NCT02319759|366264354|FG004|Week 16 - 24|Withdrawal by Subject|0|||
106163930|NCT02319759|366264350|FG000|Week 24 - 56|Adverse Event|0|||
106163931|NCT02319759|366264351|FG001|Week 24 - 56|Adverse Event|0|||
106163932|NCT02319759|366264352|FG002|Week 24 - 56|Adverse Event|2|||
106163933|NCT02319759|366264353|FG003|Week 24 - 56|Adverse Event|0|||
106163934|NCT02319759|366264354|FG004|Week 24 - 56|Adverse Event|0|||
106163935|NCT02319759|366264350|FG000|Week 24 - 56|Lack of Efficacy|0|||
106163936|NCT02319759|366264351|FG001|Week 24 - 56|Lack of Efficacy|0|||
106163937|NCT02319759|366264352|FG002|Week 24 - 56|Lack of Efficacy|0|||
106163938|NCT02319759|366264353|FG003|Week 24 - 56|Lack of Efficacy|2|||
106163939|NCT02319759|366264354|FG004|Week 24 - 56|Lack of Efficacy|1|||
106163940|NCT02319759|366264350|FG000|Week 24 - 56|Withdrawal by Subject|0|||
106163941|NCT02319759|366264351|FG001|Week 24 - 56|Withdrawal by Subject|1|||
106163942|NCT02319759|366264352|FG002|Week 24 - 56|Withdrawal by Subject|0|||
106163943|NCT02319759|366264353|FG003|Week 24 - 56|Withdrawal by Subject|0|||
106163944|NCT02319759|366264354|FG004|Week 24 - 56|Withdrawal by Subject|0|||
106163945|NCT02319759|366264350|FG000|Week 24 - 56|Lost to Follow-up|0|||
106163946|NCT02319759|366264351|FG001|Week 24 - 56|Lost to Follow-up|0|||
106163947|NCT02319759|366264352|FG002|Week 24 - 56|Lost to Follow-up|0|||
106163948|NCT02319759|366264353|FG003|Week 24 - 56|Lost to Follow-up|0|||
106163949|NCT02319759|366264354|FG004|Week 24 - 56|Lost to Follow-up|1|||
106163950|NCT05540665|366264356|FG000|Overall Study|Study terminated by sponsor|6|||
106163951|NCT05540665|366264357|FG001|Overall Study|Study terminated by sponsor|6|||
106163952|NCT05540665|366264358|FG002|Overall Study|Study terminated by sponsor|7|||
106163953|NCT03462030|366264359|FG000|Overall Study|Withdrawal by Subject|1|||
106163954|NCT03462030|366264360|FG001|Overall Study|Withdrawal by Subject|1|||
106163955|NCT02879695|366264361|FG000|Overall Study|Did not start study treatment|2|||
106163956|NCT02879695|366264362|FG001|Overall Study|Did not start study treatment|0|||
106163957|NCT02879695|366264363|FG002|Overall Study|Did not start study treatment|3|||
106163958|NCT02879695|366264364|FG003|Overall Study|Did not start study treatment|0|||
106163959|NCT02675751|366264365|FG000|Overall Study|Lost to Follow-up|16|||
106163960|NCT02598388|366264366|FG000|Overall Study|Lost to Follow-up|1|||
106163961|NCT02598388|366264367|FG001|Overall Study|Lost to Follow-up|0|||
106163962|NCT02598388|366264368|FG002|Overall Study|Lost to Follow-up|1|||
106163963|NCT02598388|366264369|FG003|Overall Study|Lost to Follow-up|0|||
106163964|NCT02598388|366264370|FG004|Overall Study|Lost to Follow-up|5|||
106163965|NCT02598388|366264371|FG005|Overall Study|Lost to Follow-up|1|||
106163966|NCT02598388|366264372|FG006|Overall Study|Lost to Follow-up|2|||
106163967|NCT02598388|366264373|FG007|Overall Study|Lost to Follow-up|1|||
106163968|NCT02598388|366264374|FG008|Overall Study|Lost to Follow-up|0|||
106163969|NCT02598388|366264375|FG009|Overall Study|Lost to Follow-up|0|||
106163970|NCT02598388|366264376|FG010|Overall Study|Lost to Follow-up|1|||
106163971|NCT02598388|366264377|FG011|Overall Study|Lost to Follow-up|0|||
106163972|NCT02598388|366264366|FG000|Overall Study|Withdrawal by Subject|0|||
106163973|NCT02598388|366264367|FG001|Overall Study|Withdrawal by Subject|0|||
106163974|NCT02598388|366264368|FG002|Overall Study|Withdrawal by Subject|0|||
106163975|NCT02598388|366264369|FG003|Overall Study|Withdrawal by Subject|0|||
106163976|NCT02598388|366264370|FG004|Overall Study|Withdrawal by Subject|2|||
106163977|NCT02598388|366264371|FG005|Overall Study|Withdrawal by Subject|0|||
106163978|NCT02598388|366264372|FG006|Overall Study|Withdrawal by Subject|2|||
106163979|NCT02598388|366264373|FG007|Overall Study|Withdrawal by Subject|0|||
106163980|NCT02598388|366264374|FG008|Overall Study|Withdrawal by Subject|0|||
106163981|NCT02598388|366264375|FG009|Overall Study|Withdrawal by Subject|1|||
106163982|NCT02598388|366264376|FG010|Overall Study|Withdrawal by Subject|0|||
106163983|NCT02598388|366264377|FG011|Overall Study|Withdrawal by Subject|0|||
106163984|NCT02598388|366264366|FG000|Overall Study|Other|0|||
106163985|NCT02598388|366264367|FG001|Overall Study|Other|0|||
106163986|NCT02598388|366264368|FG002|Overall Study|Other|1|||
106163987|NCT02598388|366264369|FG003|Overall Study|Other|0|||
106163988|NCT02598388|366264370|FG004|Overall Study|Other|3|||
106163989|NCT02598388|366264371|FG005|Overall Study|Other|0|||
106163990|NCT02598388|366264372|FG006|Overall Study|Other|1|||
106163991|NCT02598388|366264373|FG007|Overall Study|Other|0|||
106163992|NCT02598388|366264374|FG008|Overall Study|Other|0|||
106163993|NCT02598388|366264375|FG009|Overall Study|Other|0|||
106163994|NCT02598388|366264376|FG010|Overall Study|Other|0|||
106163995|NCT02598388|366264377|FG011|Overall Study|Other|0|||
106163996|NCT02438722|366264380|FG000|Overall Study|Adverse Event|12|||
106163997|NCT02438722|366264381|FG001|Overall Study|Adverse Event|9|||
106163998|NCT02438722|366264380|FG000|Overall Study|Refusal unrelated to AE|2|||
106163999|NCT02438722|366264381|FG001|Overall Study|Refusal unrelated to AE|5|||
106164000|NCT02438722|366264380|FG000|Overall Study|Disease progression/relapse|46|||
106164001|NCT02438722|366264381|FG001|Overall Study|Disease progression/relapse|51|||
106164002|NCT02438722|366264380|FG000|Overall Study|Death|0|||
106164003|NCT02438722|366264381|FG001|Overall Study|Death|3|||
106164004|NCT02438722|366264380|FG000|Overall Study|Physician Decision|2|||
106164005|NCT02438722|366264381|FG001|Overall Study|Physician Decision|2|||
106164006|NCT02438722|366264380|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
106164007|NCT02438722|366264381|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
106164008|NCT02438722|366264380|FG000|Overall Study|Withdrawal by Subject|0|||
106164009|NCT02438722|366264381|FG001|Overall Study|Withdrawal by Subject|1|||
106164010|NCT02438722|366264380|FG000|Overall Study|On protocol treatment|15|||
106164011|NCT02438722|366264381|FG001|Overall Study|On protocol treatment|14|||
106164012|NCT02438722|366264380|FG000|Overall Study|Did not receive protocol treatment|5|||
106164013|NCT02438722|366264381|FG001|Overall Study|Did not receive protocol treatment|0|||
106164014|NCT05006872|366264385|FG000|Overall Study|Lost to Follow-up|37|||
106164015|NCT05006872|366264386|FG001|Overall Study|Lost to Follow-up|31|||
106164016|NCT02761057|366264392|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
106164017|NCT02761057|366264393|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
106164018|NCT02761057|366264394|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
106164019|NCT02761057|366264395|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
106164020|NCT02761057|366264392|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
106164021|NCT02761057|366264393|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
106164022|NCT02761057|366264394|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
106164023|NCT02761057|366264395|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
106164024|NCT02761057|366264392|FG000|Overall Study|Currently On Study Treatment|0|||
106164025|NCT02761057|366264393|FG001|Overall Study|Currently On Study Treatment|3|||
106164026|NCT02761057|366264394|FG002|Overall Study|Currently On Study Treatment|0|||
106164027|NCT02761057|366264395|FG003|Overall Study|Currently On Study Treatment|0|||
106164028|NCT02761057|366264392|FG000|Overall Study|Adverse Event|11|||
106164029|NCT02761057|366264393|FG001|Overall Study|Adverse Event|9|||
106164030|NCT02761057|366264394|FG002|Overall Study|Adverse Event|5|||
106164031|NCT02761057|366264395|FG003|Overall Study|Adverse Event|3|||
106164032|NCT02761057|366264392|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
106164033|NCT02761057|366264393|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
106164034|NCT02761057|366264394|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
106164035|NCT02761057|366264395|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
106164036|NCT02761057|366264392|FG000|Overall Study|Progression/Relapse|29|||
106164037|NCT02761057|366264393|FG001|Overall Study|Progression/Relapse|27|||
106164038|NCT02761057|366264394|FG002|Overall Study|Progression/Relapse|20|||
106164039|NCT02761057|366264395|FG003|Overall Study|Progression/Relapse|23|||
106164040|NCT02761057|366264392|FG000|Overall Study|Death|2|||
106164041|NCT02761057|366264393|FG001|Overall Study|Death|2|||
106164042|NCT02761057|366264394|FG002|Overall Study|Death|1|||
106164043|NCT02761057|366264395|FG003|Overall Study|Death|1|||
106164044|NCT02761057|366264392|FG000|Overall Study|Other - Not Protocol Specified|2|||
106164045|NCT02761057|366264393|FG001|Overall Study|Other - Not Protocol Specified|1|||
106164046|NCT02761057|366264394|FG002|Overall Study|Other - Not Protocol Specified|2|||
106164047|NCT02761057|366264395|FG003|Overall Study|Other - Not Protocol Specified|0|||
106164048|NCT04149704|366264399|FG000|Three Month Follow-up|Death|2|||
106164049|NCT04149704|366264400|FG001|Three Month Follow-up|Death|0|||
106164050|NCT04149704|366264401|FG002|Three Month Follow-up|Death|0|||
106164051|NCT04149704|366264402|FG003|Three Month Follow-up|Death|0|||
106164052|NCT04149704|366264399|FG000|Three Month Follow-up|Lost to Follow-up|1|||
106164053|NCT04149704|366264400|FG001|Three Month Follow-up|Lost to Follow-up|4|||
106164054|NCT04149704|366264401|FG002|Three Month Follow-up|Lost to Follow-up|5|||
106164055|NCT04149704|366264402|FG003|Three Month Follow-up|Lost to Follow-up|5|||
106164056|NCT04149704|366264399|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
106164057|NCT04149704|366264400|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
106164058|NCT04149704|366264401|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
106164059|NCT04149704|366264402|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
106164060|NCT04149704|366264399|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
106164061|NCT04149704|366264400|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
106164062|NCT04149704|366264401|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
106164063|NCT04149704|366264402|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
106164064|NCT06132282|366264403|FG000|Overall Study|Lost to Follow-up|31|||
106164065|NCT04376502|366264410|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
106164066|NCT04632992|366264411|FG000|Overall Study|Adverse Event|0|||
106164067|NCT04632992|366264412|FG001|Overall Study|Adverse Event|0|||
106164068|NCT04632992|366264413|FG002|Overall Study|Adverse Event|0|||
106164069|NCT04632992|366264414|FG003|Overall Study|Adverse Event|0|||
106164070|NCT04632992|366264415|FG004|Overall Study|Adverse Event|0|||
106164071|NCT04632992|366264416|FG005|Overall Study|Adverse Event|0|||
106164072|NCT04632992|366264417|FG006|Overall Study|Adverse Event|0|||
106164073|NCT04632992|366264418|FG007|Overall Study|Adverse Event|0|||
106164074|NCT04632992|366264419|FG008|Overall Study|Adverse Event|0|||
106164075|NCT04632992|366264420|FG009|Overall Study|Adverse Event|0|||
106164076|NCT04632992|366264421|FG010|Overall Study|Adverse Event|0|||
106164077|NCT04632992|366264422|FG011|Overall Study|Adverse Event|0|||
106164078|NCT04632992|366264423|FG012|Overall Study|Adverse Event|1|||
106164079|NCT04632992|366264424|FG013|Overall Study|Adverse Event|0|||
106164080|NCT04632992|366264411|FG000|Overall Study|Death|17|||
106164081|NCT04632992|366264412|FG001|Overall Study|Death|1|||
106164082|NCT04632992|366264413|FG002|Overall Study|Death|14|||
106164083|NCT04632992|366264414|FG003|Overall Study|Death|14|||
106164084|NCT04632992|366264415|FG004|Overall Study|Death|13|||
106164085|NCT04632992|366264416|FG005|Overall Study|Death|6|||
106164086|NCT04632992|366264417|FG006|Overall Study|Death|7|||
106164087|NCT04632992|366264418|FG007|Overall Study|Death|12|||
106164088|NCT04632992|366264419|FG008|Overall Study|Death|15|||
106164089|NCT04632992|366264420|FG009|Overall Study|Death|20|||
106164090|NCT04632992|366264421|FG010|Overall Study|Death|8|||
106164091|NCT04632992|366264422|FG011|Overall Study|Death|2|||
106164092|NCT04632992|366264423|FG012|Overall Study|Death|10|||
106164093|NCT04632992|366264424|FG013|Overall Study|Death|1|||
106164094|NCT04632992|366264411|FG000|Overall Study|Lost to Follow-up|1|||
106164095|NCT04632992|366264412|FG001|Overall Study|Lost to Follow-up|0|||
106164096|NCT04632992|366264413|FG002|Overall Study|Lost to Follow-up|1|||
106164097|NCT04632992|366264414|FG003|Overall Study|Lost to Follow-up|0|||
106164098|NCT04632992|366264415|FG004|Overall Study|Lost to Follow-up|2|||
106164099|NCT04632992|366264416|FG005|Overall Study|Lost to Follow-up|0|||
106164100|NCT04632992|366264417|FG006|Overall Study|Lost to Follow-up|1|||
106164101|NCT04632992|366264418|FG007|Overall Study|Lost to Follow-up|1|||
106164102|NCT04632992|366264419|FG008|Overall Study|Lost to Follow-up|1|||
106164103|NCT04632992|366264420|FG009|Overall Study|Lost to Follow-up|1|||
106164104|NCT04632992|366264421|FG010|Overall Study|Lost to Follow-up|2|||
106164105|NCT04632992|366264422|FG011|Overall Study|Lost to Follow-up|0|||
106164106|NCT04632992|366264423|FG012|Overall Study|Lost to Follow-up|0|||
106164107|NCT04632992|366264424|FG013|Overall Study|Lost to Follow-up|0|||
106164108|NCT04632992|366264411|FG000|Overall Study|Reason not Specified|2|||
106164109|NCT04632992|366264412|FG001|Overall Study|Reason not Specified|0|||
106164110|NCT04632992|366264413|FG002|Overall Study|Reason not Specified|1|||
106164111|NCT04632992|366264414|FG003|Overall Study|Reason not Specified|1|||
106164112|NCT04632992|366264415|FG004|Overall Study|Reason not Specified|0|||
106164113|NCT04632992|366264416|FG005|Overall Study|Reason not Specified|0|||
106164114|NCT04632992|366264417|FG006|Overall Study|Reason not Specified|0|||
106164115|NCT04632992|366264418|FG007|Overall Study|Reason not Specified|0|||
106164116|NCT04632992|366264419|FG008|Overall Study|Reason not Specified|0|||
106164117|NCT04632992|366264420|FG009|Overall Study|Reason not Specified|0|||
106164118|NCT04632992|366264421|FG010|Overall Study|Reason not Specified|1|||
106164119|NCT04632992|366264422|FG011|Overall Study|Reason not Specified|0|||
106164120|NCT04632992|366264423|FG012|Overall Study|Reason not Specified|0|||
106164121|NCT04632992|366264424|FG013|Overall Study|Reason not Specified|0|||
106164122|NCT04632992|366264411|FG000|Overall Study|Physician Decision|0|||
106164123|NCT04632992|366264412|FG001|Overall Study|Physician Decision|0|||
106164124|NCT04632992|366264413|FG002|Overall Study|Physician Decision|0|||
106164125|NCT04632992|366264414|FG003|Overall Study|Physician Decision|2|||
106164126|NCT04632992|366264415|FG004|Overall Study|Physician Decision|1|||
106164127|NCT04632992|366264416|FG005|Overall Study|Physician Decision|0|||
106164128|NCT04632992|366264417|FG006|Overall Study|Physician Decision|0|||
106164129|NCT04632992|366264418|FG007|Overall Study|Physician Decision|0|||
106164130|NCT04632992|366264419|FG008|Overall Study|Physician Decision|0|||
106164131|NCT04632992|366264420|FG009|Overall Study|Physician Decision|0|||
106164132|NCT04632992|366264421|FG010|Overall Study|Physician Decision|0|||
106164133|NCT04632992|366264422|FG011|Overall Study|Physician Decision|0|||
106164134|NCT04632992|366264423|FG012|Overall Study|Physician Decision|3|||
106164135|NCT04632992|366264424|FG013|Overall Study|Physician Decision|0|||
106164136|NCT04632992|366264411|FG000|Overall Study|Progressive Disease|0|||
106164137|NCT04632992|366264412|FG001|Overall Study|Progressive Disease|0|||
106164138|NCT04632992|366264413|FG002|Overall Study|Progressive Disease|0|||
106164139|NCT04632992|366264414|FG003|Overall Study|Progressive Disease|0|||
106164140|NCT04632992|366264415|FG004|Overall Study|Progressive Disease|1|||
106164141|NCT04632992|366264416|FG005|Overall Study|Progressive Disease|0|||
106164142|NCT04632992|366264417|FG006|Overall Study|Progressive Disease|0|||
106164143|NCT04632992|366264418|FG007|Overall Study|Progressive Disease|0|||
106164144|NCT04632992|366264419|FG008|Overall Study|Progressive Disease|0|||
106164145|NCT04632992|366264420|FG009|Overall Study|Progressive Disease|1|||
106164146|NCT04632992|366264421|FG010|Overall Study|Progressive Disease|1|||
106164147|NCT04632992|366264422|FG011|Overall Study|Progressive Disease|0|||
106164148|NCT04632992|366264423|FG012|Overall Study|Progressive Disease|2|||
106164149|NCT04632992|366264424|FG013|Overall Study|Progressive Disease|0|||
106164150|NCT04632992|366264411|FG000|Overall Study|Withdrawal by Subject|4|||
106164151|NCT04632992|366264412|FG001|Overall Study|Withdrawal by Subject|1|||
106164152|NCT04632992|366264413|FG002|Overall Study|Withdrawal by Subject|5|||
106164153|NCT04632992|366264414|FG003|Overall Study|Withdrawal by Subject|4|||
106164154|NCT04632992|366264415|FG004|Overall Study|Withdrawal by Subject|3|||
106164155|NCT04632992|366264416|FG005|Overall Study|Withdrawal by Subject|3|||
106164156|NCT04632992|366264417|FG006|Overall Study|Withdrawal by Subject|0|||
106164157|NCT04632992|366264418|FG007|Overall Study|Withdrawal by Subject|5|||
106164158|NCT04632992|366264419|FG008|Overall Study|Withdrawal by Subject|0|||
106164159|NCT04632992|366264420|FG009|Overall Study|Withdrawal by Subject|2|||
106164160|NCT04632992|366264421|FG010|Overall Study|Withdrawal by Subject|8|||
106164161|NCT04632992|366264422|FG011|Overall Study|Withdrawal by Subject|0|||
106164162|NCT04632992|366264423|FG012|Overall Study|Withdrawal by Subject|1|||
106164163|NCT04632992|366264424|FG013|Overall Study|Withdrawal by Subject|1|||
106164164|NCT02677805|366264425|FG000|Double Blind Phase|Lost to Follow-up|8|||
106164165|NCT02677805|366264426|FG001|Double Blind Phase|Lost to Follow-up|3|||
106164166|NCT02677805|366264427|FG002|Double Blind Phase|Lost to Follow-up|0|||
106164167|NCT02677805|366264425|FG000|Double Blind Phase|Withdrawal by Subject|5|||
106164168|NCT02677805|366264426|FG001|Double Blind Phase|Withdrawal by Subject|2|||
106164169|NCT02677805|366264427|FG002|Double Blind Phase|Withdrawal by Subject|0|||
106164170|NCT02677805|366264425|FG000|Open Label Phase|Lost to Follow-up|0|||
106164171|NCT02677805|366264426|FG001|Open Label Phase|Lost to Follow-up|0|||
106164172|NCT02677805|366264427|FG002|Open Label Phase|Lost to Follow-up|10|||
106164173|NCT02677805|366264425|FG000|Open Label Phase|Withdrawal by Subject|0|||
106164174|NCT02677805|366264426|FG001|Open Label Phase|Withdrawal by Subject|0|||
106164175|NCT02677805|366264427|FG002|Open Label Phase|Withdrawal by Subject|6|||
106164176|NCT04652700|366264428|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
106164177|NCT04652700|366264429|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
106164178|NCT04652700|366264428|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
106164179|NCT04652700|366264429|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
106164180|NCT04652700|366264428|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
106164181|NCT04652700|366264429|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
106164182|NCT04652700|366264428|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
106164183|NCT04652700|366264429|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
106164184|NCT04652700|366264428|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
106164185|NCT04652700|366264429|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
106164186|NCT04652700|366264428|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
106164187|NCT04652700|366264429|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
106164188|NCT04652700|366264428|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
106164189|NCT04652700|366264429|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
106164190|NCT04652700|366264428|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
106164191|NCT04652700|366264429|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
106164192|NCT04652700|366264428|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
106164193|NCT04652700|366264429|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
106164194|NCT05362487|366264430|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
106164195|NCT04096040|366264431|FG000|Overall Study|Protocol Violation|12|||
106164196|NCT04096040|366264431|FG000|Overall Study|Non-compliant site|4|||
106164197|NCT04439357|366264432|FG000|Overall Study|Disease Progression|4|||
106164198|NCT03808818|366264440|FG000|Overall Study|Death|6|||
106164199|NCT03808818|366264441|FG001|Overall Study|Death|6|||
106164200|NCT03808818|366264440|FG000|Overall Study|Withdrawal by Subject|7|||
106164201|NCT03808818|366264441|FG001|Overall Study|Withdrawal by Subject|18|||
106164202|NCT03808818|366264440|FG000|Overall Study|Lost to Follow-up|31|||
106164203|NCT03808818|366264441|FG001|Overall Study|Lost to Follow-up|33|||
106164204|NCT04676763|366264442|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
106164205|NCT04676763|366264443|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
106164206|NCT04676763|366264444|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
106164207|NCT04676763|366264442|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
106164208|NCT04676763|366264443|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
106164209|NCT04676763|366264444|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
106164210|NCT04676763|366264442|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
106164211|NCT04676763|366264443|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
106164212|NCT04676763|366264444|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
106164213|NCT03150173|366264445|FG000|Overall Study|Lost to Follow-up|13|||
106164214|NCT03150173|366264446|FG001|Overall Study|Lost to Follow-up|5|||
106164215|NCT05415722|366264447|FG000|Overall Study|Lost to Follow-up|0|||
106164216|NCT05415722|366264448|FG001|Overall Study|Lost to Follow-up|2|||
106164217|NCT05415722|366264449|FG002|Overall Study|Lost to Follow-up|0|||
106164218|NCT05415722|366264450|FG003|Overall Study|Lost to Follow-up|1|||
106164219|NCT05415722|366264451|FG004|Overall Study|Lost to Follow-up|0|||
106164220|NCT05415722|366264452|FG005|Overall Study|Lost to Follow-up|0|||
106164221|NCT05415722|366264453|FG006|Overall Study|Lost to Follow-up|1|||
106164222|NCT05415722|366264447|FG000|Overall Study|Physician Decision|0|||
106164223|NCT05415722|366264448|FG001|Overall Study|Physician Decision|0|||
106164224|NCT05415722|366264449|FG002|Overall Study|Physician Decision|0|||
106164225|NCT05415722|366264450|FG003|Overall Study|Physician Decision|1|||
106164226|NCT05415722|366264451|FG004|Overall Study|Physician Decision|0|||
106164227|NCT05415722|366264452|FG005|Overall Study|Physician Decision|0|||
106164228|NCT05415722|366264453|FG006|Overall Study|Physician Decision|1|||
106164229|NCT05415722|366264447|FG000|Overall Study|Protocol Violation|0|||
106164230|NCT05415722|366264448|FG001|Overall Study|Protocol Violation|0|||
106164231|NCT05415722|366264449|FG002|Overall Study|Protocol Violation|0|||
106164232|NCT05415722|366264450|FG003|Overall Study|Protocol Violation|1|||
106164233|NCT05415722|366264451|FG004|Overall Study|Protocol Violation|0|||
106164234|NCT05415722|366264452|FG005|Overall Study|Protocol Violation|0|||
106164235|NCT05415722|366264453|FG006|Overall Study|Protocol Violation|0|||
106164236|NCT05415722|366264447|FG000|Overall Study|Sponsor Discretion|0|||
106164237|NCT05415722|366264448|FG001|Overall Study|Sponsor Discretion|0|||
106164238|NCT05415722|366264449|FG002|Overall Study|Sponsor Discretion|0|||
106164239|NCT05415722|366264450|FG003|Overall Study|Sponsor Discretion|0|||
106164240|NCT05415722|366264451|FG004|Overall Study|Sponsor Discretion|1|||
106164241|NCT05415722|366264452|FG005|Overall Study|Sponsor Discretion|1|||
106164242|NCT05415722|366264453|FG006|Overall Study|Sponsor Discretion|0|||
106164243|NCT05415722|366264447|FG000|Overall Study|Withdrawal by Subject|0|||
106164244|NCT05415722|366264448|FG001|Overall Study|Withdrawal by Subject|1|||
106164245|NCT05415722|366264449|FG002|Overall Study|Withdrawal by Subject|0|||
106164246|NCT05415722|366264450|FG003|Overall Study|Withdrawal by Subject|1|||
106164247|NCT05415722|366264451|FG004|Overall Study|Withdrawal by Subject|1|||
106164248|NCT05415722|366264452|FG005|Overall Study|Withdrawal by Subject|0|||
106164249|NCT05415722|366264453|FG006|Overall Study|Withdrawal by Subject|1|||
106164250|NCT03031470|366264467|FG000|Overall Study|Adverse Event|3|||
106164251|NCT03031470|366264468|FG001|Overall Study|Adverse Event|0|||
106164252|NCT03031470|366264467|FG000|Overall Study|Death|3|||
106164253|NCT03031470|366264468|FG001|Overall Study|Death|1|||
106164254|NCT03031470|366264467|FG000|Overall Study|Lost to Follow-up|1|||
106164255|NCT03031470|366264468|FG001|Overall Study|Lost to Follow-up|1|||
106164256|NCT03031470|366264467|FG000|Overall Study|Withdrawal by Subject|1|||
106164257|NCT03031470|366264468|FG001|Overall Study|Withdrawal by Subject|0|||
106164258|NCT03031470|366264467|FG000|Overall Study|Protocol entry criteria not met|0|||
106164259|NCT03031470|366264468|FG001|Overall Study|Protocol entry criteria not met|1|||
106164260|NCT03031470|366264467|FG000|Overall Study|Cancel the operation|0|||
106164261|NCT03031470|366264468|FG001|Overall Study|Cancel the operation|1|||
106164262|NCT03461276|366264469|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
106164263|NCT03461276|366264470|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
106164264|NCT03461276|366264469|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
106164265|NCT03461276|366264470|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
106164266|NCT03461276|366264469|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
106164267|NCT03461276|366264470|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
106164268|NCT03461276|366264469|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
106164269|NCT03461276|366264470|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
106164270|NCT03461276|366264469|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
106164271|NCT03461276|366264470|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
106164272|NCT03461276|366264469|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
106164273|NCT03461276|366264470|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
106164274|NCT03461276|366264469|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
106164275|NCT03461276|366264470|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
106164276|NCT03461276|366264469|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
106164277|NCT03461276|366264470|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
106164278|NCT03461276|366264469|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
106164279|NCT03461276|366264470|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
106164280|NCT03461276|366264469|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
106164281|NCT03461276|366264470|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
106164282|NCT01802788|366264472|FG000|Overall Study|Withdrawal by Subject|102|||
106164283|NCT01802788|366264473|FG001|Overall Study|Withdrawal by Subject|5|||
106164284|NCT01802788|366264472|FG000|Overall Study|Death|382|||
106164285|NCT01802788|366264473|FG001|Overall Study|Death|18|||
106164286|NCT01802788|366264472|FG000|Overall Study|Lost to Follow-up|31|||
106164287|NCT01802788|366264473|FG001|Overall Study|Lost to Follow-up|2|||
106164288|NCT01802788|366264472|FG000|Overall Study|Physician Decision|3|||
106164289|NCT01802788|366264473|FG001|Overall Study|Physician Decision|0|||
106164290|NCT01802788|366264472|FG000|Overall Study|Patient Non-Compliance|1|||
106164291|NCT01802788|366264473|FG001|Overall Study|Patient Non-Compliance|0|||
106164292|NCT01802788|366264472|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
106164293|NCT01802788|366264473|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
106164294|NCT01802788|366264472|FG000|Overall Study|Other Reasons|19|||
106164295|NCT01802788|366264473|FG001|Overall Study|Other Reasons|0|||
106164296|NCT02310646|366264474|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
106164297|NCT02310646|366264475|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
106164298|NCT02310646|366264474|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
106164299|NCT02310646|366264475|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
106164300|NCT04700163|366264476|FG000|Overall Study|Lost to Follow-up|0|||
106164301|NCT04700163|366264477|FG001|Overall Study|Lost to Follow-up|0|||
106164302|NCT04700163|366264478|FG002|Overall Study|Lost to Follow-up|0|||
106164303|NCT04700163|366264479|FG003|Overall Study|Lost to Follow-up|0|||
106164304|NCT04700163|366264480|FG004|Overall Study|Lost to Follow-up|0|||
106164305|NCT04700163|366264481|FG005|Overall Study|Lost to Follow-up|1|||
106164306|NCT03848065|366264482|FG000|Overall Study|Death|0|||
106164307|NCT03848065|366264483|FG001|Overall Study|Death|1|||
106164308|NCT03848065|366264484|FG002|Overall Study|Death|0|||
106164309|NCT03848065|366264482|FG000|Overall Study|Lost to Follow-up|0|||
106164310|NCT03848065|366264483|FG001|Overall Study|Lost to Follow-up|0|||
106164311|NCT03848065|366264484|FG002|Overall Study|Lost to Follow-up|1|||
106164312|NCT03848065|366264482|FG000|Overall Study|Physician Decision|0|||
106164313|NCT03848065|366264483|FG001|Overall Study|Physician Decision|0|||
106164314|NCT03848065|366264484|FG002|Overall Study|Physician Decision|1|||
106164315|NCT03496168|366264485|FG000|Overall Study|Other Reasons|1|||
106164316|NCT03496168|366264485|FG000|Overall Study|Adverse Event|1|||
106164317|NCT03865498|366264486|FG000|Overall Study|Lack of Efficacy|12|||
106164318|NCT03865498|366264487|FG001|Overall Study|Lack of Efficacy|11|||
106164319|NCT03865498|366264486|FG000|Overall Study|Lost to Follow-up|125|||
106164320|NCT03865498|366264487|FG001|Overall Study|Lost to Follow-up|133|||
106164321|NCT03865498|366264486|FG000|Overall Study|Withdrawal by Subject|2|||
106164322|NCT03865498|366264487|FG001|Overall Study|Withdrawal by Subject|4|||
106164323|NCT02043678|366264492|FG000|Overall Study|Never treated|11|||
106164324|NCT02043678|366264493|FG001|Overall Study|Never treated|9|||
106164325|NCT02043678|366264492|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
106164326|NCT02043678|366264493|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
106164327|NCT02043678|366264492|FG000|Overall Study|AE without clinical PD|54|||
106164328|NCT02043678|366264493|FG001|Overall Study|AE without clinical PD|36|||
106164329|NCT02043678|366264492|FG000|Overall Study|Lost to Follow-up|1|||
106164330|NCT02043678|366264493|FG001|Overall Study|Lost to Follow-up|1|||
106164331|NCT02043678|366264492|FG000|Overall Study|Other|10|||
106164332|NCT02043678|366264493|FG001|Overall Study|Other|14|||
106164333|NCT02043678|366264492|FG000|Overall Study|Clinical PD|114|||
106164334|NCT02043678|366264493|FG001|Overall Study|Clinical PD|148|||
106164335|NCT02043678|366264492|FG000|Overall Study|Radiological PD|100|||
106164336|NCT02043678|366264493|FG001|Overall Study|Radiological PD|90|||
106164337|NCT02043678|366264492|FG000|Overall Study|Protocol-driven decision point|59|||
106164338|NCT02043678|366264493|FG001|Overall Study|Protocol-driven decision point|58|||
106164339|NCT02043678|366264492|FG000|Overall Study|Withdrawal by Subject|16|||
106164340|NCT02043678|366264493|FG001|Overall Study|Withdrawal by Subject|20|||
106164341|NCT02043678|366264492|FG000|Overall Study|Protocol Violation|1|||
106164342|NCT02043678|366264493|FG001|Overall Study|Protocol Violation|0|||
106164343|NCT02043678|366264492|FG000|Overall Study|Deterioration of general conditions|1|||
106164344|NCT02043678|366264493|FG001|Overall Study|Deterioration of general conditions|1|||
106164345|NCT02043678|366264492|FG000|Overall Study|Logistical difficulties|2|||
106164346|NCT02043678|366264493|FG001|Overall Study|Logistical difficulties|0|||
106164347|NCT02043678|366264492|FG000|Overall Study|Non-compliance with study drug|3|||
106164348|NCT02043678|366264493|FG001|Overall Study|Non-compliance with study drug|1|||
106164349|NCT02043678|366264492|FG000|Overall Study|Physician Decision|4|||
106164350|NCT02043678|366264493|FG001|Overall Study|Physician Decision|3|||
106164351|NCT02043678|366264492|FG000|Overall Study|Subject decision|0|||
106164352|NCT02043678|366264493|FG001|Overall Study|Subject decision|1|||
106164353|NCT02043678|366264492|FG000|Overall Study|Switching to other therapy|3|||
106164354|NCT02043678|366264493|FG001|Overall Study|Switching to other therapy|2|||
106164355|NCT02043678|366264492|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
106164356|NCT02043678|366264493|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
106164357|NCT02043678|366264492|FG000|Overall Study|Missing|1|||
106164358|NCT02043678|366264493|FG001|Overall Study|Missing|0|||
106164359|NCT02043678|366264492|FG000|Overall Study|Adverse Event|0|||
106164360|NCT02043678|366264493|FG001|Overall Study|Adverse Event|1|||
106164361|NCT03314454|366264494|FG000|Overall Study|Protocol Violation|1|||
106164362|NCT05543629|366264495|FG000|Overall Study|Death|1|||
106164363|NCT05543629|366264496|FG001|Overall Study|Death|0|||
106164364|NCT05543629|366264497|FG002|Overall Study|Death|1|||
106164365|NCT05543629|366264498|FG003|Overall Study|Death|0|||
106164366|NCT05543629|366264499|FG004|Overall Study|Death|0|||
106164367|NCT05543629|366264500|FG005|Overall Study|Death|1|||
106164368|NCT05543629|366264501|FG006|Overall Study|Death|2|||
106164369|NCT05543629|366264502|FG007|Overall Study|Death|2|||
106164370|NCT05543629|366264495|FG000|Overall Study|Other Reasons|0|||
106164371|NCT05543629|366264496|FG001|Overall Study|Other Reasons|0|||
106164372|NCT05543629|366264497|FG002|Overall Study|Other Reasons|0|||
106164373|NCT05543629|366264498|FG003|Overall Study|Other Reasons|0|||
106164374|NCT05543629|366264499|FG004|Overall Study|Other Reasons|1|||
106164375|NCT05543629|366264500|FG005|Overall Study|Other Reasons|0|||
106164376|NCT05543629|366264501|FG006|Overall Study|Other Reasons|0|||
106164377|NCT05543629|366264502|FG007|Overall Study|Other Reasons|0|||
106164378|NCT05543629|366264495|FG000|Overall Study|Physician Decision|0|||
106164379|NCT05543629|366264496|FG001|Overall Study|Physician Decision|0|||
106164380|NCT05543629|366264497|FG002|Overall Study|Physician Decision|3|||
106164381|NCT05543629|366264498|FG003|Overall Study|Physician Decision|0|||
106164382|NCT05543629|366264499|FG004|Overall Study|Physician Decision|0|||
106164383|NCT05543629|366264500|FG005|Overall Study|Physician Decision|0|||
106164384|NCT05543629|366264501|FG006|Overall Study|Physician Decision|1|||
106164385|NCT05543629|366264502|FG007|Overall Study|Physician Decision|0|||
106164386|NCT05543629|366264495|FG000|Overall Study|Study terminated by Sponsor|1|||
106164387|NCT05543629|366264496|FG001|Overall Study|Study terminated by Sponsor|0|||
106164388|NCT05543629|366264497|FG002|Overall Study|Study terminated by Sponsor|0|||
106164389|NCT05543629|366264498|FG003|Overall Study|Study terminated by Sponsor|1|||
106164390|NCT05543629|366264499|FG004|Overall Study|Study terminated by Sponsor|0|||
106164391|NCT05543629|366264500|FG005|Overall Study|Study terminated by Sponsor|4|||
106164392|NCT05543629|366264501|FG006|Overall Study|Study terminated by Sponsor|1|||
106164393|NCT05543629|366264502|FG007|Overall Study|Study terminated by Sponsor|0|||
106164394|NCT05543629|366264495|FG000|Overall Study|Withdrawal by Subject|1|||
106164395|NCT05543629|366264496|FG001|Overall Study|Withdrawal by Subject|1|||
106164396|NCT05543629|366264497|FG002|Overall Study|Withdrawal by Subject|0|||
106164397|NCT05543629|366264498|FG003|Overall Study|Withdrawal by Subject|2|||
106164398|NCT05543629|366264499|FG004|Overall Study|Withdrawal by Subject|1|||
106164399|NCT05543629|366264500|FG005|Overall Study|Withdrawal by Subject|1|||
106164400|NCT05543629|366264501|FG006|Overall Study|Withdrawal by Subject|1|||
106164401|NCT05543629|366264502|FG007|Overall Study|Withdrawal by Subject|1|||
106164402|NCT05543629|366264495|FG000|Overall Study|Not Reported|2|||
106164403|NCT05543629|366264496|FG001|Overall Study|Not Reported|2|||
106164404|NCT05543629|366264497|FG002|Overall Study|Not Reported|0|||
106164405|NCT05543629|366264498|FG003|Overall Study|Not Reported|0|||
106164406|NCT05543629|366264499|FG004|Overall Study|Not Reported|1|||
106164407|NCT05543629|366264500|FG005|Overall Study|Not Reported|1|||
106164408|NCT05543629|366264501|FG006|Overall Study|Not Reported|3|||
106164409|NCT05543629|366264502|FG007|Overall Study|Not Reported|0|||
106164410|NCT04499924|366264503|FG000|Overall Study|Study termination by sponsor|4|||
106164411|NCT04499924|366264504|FG001|Overall Study|Study termination by sponsor|6|||
106164412|NCT04499924|366264503|FG000|Overall Study|Withdrawal by Subject|1|||
106164413|NCT04499924|366264504|FG001|Overall Study|Withdrawal by Subject|3|||
106164414|NCT03322267|366264507|FG000|Overall Study|Lack of Efficacy|11|||
106164415|NCT03322267|366264507|FG000|Overall Study|Adverse Event|1|||
106164416|NCT03322267|366264507|FG000|Overall Study|Withdrawal by Subject|2|||
106164417|NCT01919554|366264508|FG000|Overall Study|Withdrawal by Subject|0|||
106164418|NCT01919554|366264509|FG001|Overall Study|Withdrawal by Subject|0|||
106164419|NCT01919554|366264510|FG002|Overall Study|Withdrawal by Subject|1|||
106164420|NCT01919554|366264511|FG003|Overall Study|Withdrawal by Subject|1|||
106164421|NCT04719832|366264514|FG000|Overall Study|Adverse Event|2|||
106164422|NCT04719832|366264515|FG001|Overall Study|Adverse Event|0|||
106164423|NCT04719832|366264514|FG000|Overall Study|Lack of Efficacy|2|||
106164424|NCT04719832|366264515|FG001|Overall Study|Lack of Efficacy|4|||
106164425|NCT04719832|366264514|FG000|Overall Study|Lost to Follow-up|0|||
106164426|NCT04719832|366264515|FG001|Overall Study|Lost to Follow-up|2|||
106164427|NCT04719832|366264514|FG000|Overall Study|Physician Decision|0|||
106164428|NCT04719832|366264515|FG001|Overall Study|Physician Decision|1|||
106164429|NCT04719832|366264514|FG000|Overall Study|Pregnancy|1|||
106164430|NCT04719832|366264515|FG001|Overall Study|Pregnancy|1|||
106164431|NCT04719832|366264514|FG000|Overall Study|Withdrawal by Subject|5|||
106164432|NCT04719832|366264515|FG001|Overall Study|Withdrawal by Subject|5|||
106164433|NCT04719832|366264514|FG000|Overall Study|Randomized, not treated|0|||
106164434|NCT04719832|366264515|FG001|Overall Study|Randomized, not treated|2|||
106164435|NCT04719832|366264514|FG000|Overall Study|GCP violations|4|||
106164436|NCT04719832|366264515|FG001|Overall Study|GCP violations|7|||
106164437|NCT04898673|366264516|FG000|Overall Study|Screenfail|1|||
106164438|NCT04898673|366264517|FG001|Overall Study|Screenfail|0|||
106164439|NCT04797897|366264518|FG000|Overall Study|Study Termination by Sponsor|1|||
106164440|NCT04797897|366264519|FG001|Overall Study|Study Termination by Sponsor|1|||
106164441|NCT03134196|366265758|FG000|Overall Study|Death|2|||
106164442|NCT03134196|366265759|FG001|Overall Study|Death|1|||
106164443|NCT03134196|366265758|FG000|Overall Study|Lost to Follow-up|13|||
106164444|NCT03134196|366265759|FG001|Overall Study|Lost to Follow-up|15|||
106164445|NCT03134196|366265758|FG000|Overall Study|Physician Decision|0|||
106164446|NCT03134196|366265759|FG001|Overall Study|Physician Decision|1|||
106164447|NCT03134196|366265758|FG000|Overall Study|Withdrawal by Subject|19|||
106164448|NCT03134196|366265759|FG001|Overall Study|Withdrawal by Subject|12|||
106164449|NCT03134196|366265758|FG000|Overall Study|Site Unable to Contact Participant|2|||
106164450|NCT03134196|366265759|FG001|Overall Study|Site Unable to Contact Participant|0|||
106164451|NCT03134196|366265758|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
106164452|NCT03134196|366265759|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
106164453|NCT03134196|366265758|FG000|Overall Study|Scheduling Conflict|1|||
106164454|NCT03134196|366265759|FG001|Overall Study|Scheduling Conflict|0|||
106164455|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
106164456|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
106164457|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
106164458|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
106164459|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
106164460|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
106164461|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
106164462|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
106164463|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
106164464|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
106164465|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
106164466|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
106164467|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
106164468|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
106164469|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
106164470|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
106164471|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
106164472|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
106164473|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
106164474|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
106164475|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
106164476|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
106164477|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
106164478|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
106164479|NCT01715285|366265760|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
106164480|NCT01715285|366265761|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
106164481|NCT01715285|366265762|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
106164482|NCT01715285|366265760|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
106164483|NCT01715285|366265761|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
106164484|NCT01715285|366265762|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
106164485|NCT01715285|366265760|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
106164486|NCT01715285|366265761|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
106164487|NCT01715285|366265762|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
106164488|NCT01715285|366265760|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
106164489|NCT01715285|366265761|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
106164490|NCT01715285|366265762|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
106164491|NCT01715285|366265760|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
106164492|NCT01715285|366265761|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
106164493|NCT01715285|366265762|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
106164494|NCT01715285|366265760|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
106164495|NCT01715285|366265761|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
106164496|NCT01715285|366265762|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
106164497|NCT03628924|366265770|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
106164498|NCT03628924|366265771|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
106164499|NCT03628924|366265772|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
106164500|NCT03628924|366265773|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
106164501|NCT03628924|366265774|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
106164502|NCT03628924|366265775|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
106164503|NCT03628924|366265776|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
106164504|NCT03628924|366265770|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
106164505|NCT03628924|366265771|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
106164506|NCT03628924|366265772|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
106164507|NCT03628924|366265773|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
106164508|NCT03628924|366265774|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
106164509|NCT03628924|366265775|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
106164510|NCT03628924|366265776|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
106164511|NCT03628924|366265770|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
106164512|NCT03628924|366265771|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
106164513|NCT03628924|366265772|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
106164514|NCT03628924|366265773|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
106164515|NCT03628924|366265774|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
106164516|NCT03628924|366265775|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
106164517|NCT03628924|366265776|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
106164518|NCT03628924|366265770|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
106164519|NCT03628924|366265771|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
106164520|NCT03628924|366265772|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
106164521|NCT03628924|366265773|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
106164522|NCT03628924|366265774|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
106164523|NCT03628924|366265775|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
106164524|NCT03628924|366265776|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
106164525|NCT03628924|366265770|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
106164526|NCT03628924|366265771|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
106164527|NCT03628924|366265772|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
106164528|NCT03628924|366265773|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
106164529|NCT03628924|366265774|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
106164530|NCT03628924|366265775|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
106164531|NCT03628924|366265776|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
106164532|NCT03628924|366265770|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
106164533|NCT03628924|366265771|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
106164534|NCT03628924|366265772|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
106164535|NCT03628924|366265773|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
106164536|NCT03628924|366265774|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
106164537|NCT03628924|366265775|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
106164538|NCT03628924|366265776|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
106164539|NCT03628924|366265770|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
106164540|NCT03628924|366265771|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
106164541|NCT03628924|366265772|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
106164542|NCT03628924|366265773|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
106164543|NCT03628924|366265774|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
106164544|NCT03628924|366265775|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
106164545|NCT03628924|366265776|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
106164546|NCT03628924|366265770|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
106164547|NCT03628924|366265771|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
106164548|NCT03628924|366265772|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
106164549|NCT03628924|366265773|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
106164550|NCT03628924|366265774|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
106164551|NCT03628924|366265775|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
106164552|NCT03628924|366265776|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
106164553|NCT03628924|366265770|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
106164554|NCT03628924|366265771|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
106164555|NCT03628924|366265772|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
106164556|NCT03628924|366265773|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
106164557|NCT03628924|366265774|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
106164558|NCT03628924|366265775|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
106164559|NCT03628924|366265776|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
106164560|NCT03628924|366265770|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
106164561|NCT03628924|366265771|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
106164562|NCT03628924|366265772|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
106164563|NCT03628924|366265773|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
106164564|NCT03628924|366265774|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
106164565|NCT03628924|366265775|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
106164566|NCT03628924|366265776|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
106164567|NCT04971681|366265780|FG000|Followup|Lost to Follow-up|1|||
106164568|NCT04971681|366265781|FG001|Followup|Lost to Follow-up|0|||
106164569|NCT06215521|366265785|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
106164570|NCT06215521|366265786|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
106164571|NCT06215521|366265787|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
106164572|NCT06215521|366265788|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
106164573|NCT06215521|366265789|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
106164574|NCT06215521|366265790|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
106164575|NCT03603600|366265791|FG000|Overall Study|Withdrawal by Subject|5|||
106164576|NCT03603600|366265792|FG001|Overall Study|Withdrawal by Subject|7|||
106164577|NCT03603600|366265791|FG000|Overall Study|Lost to Follow-up|2|||
106164578|NCT03603600|366265792|FG001|Overall Study|Lost to Follow-up|3|||
106164579|NCT03603600|366265791|FG000|Overall Study|Death|3|||
106164580|NCT03603600|366265792|FG001|Overall Study|Death|1|||
106164581|NCT03603600|366265791|FG000|Overall Study|Physician Decision|2|||
106164582|NCT03603600|366265792|FG001|Overall Study|Physician Decision|1|||
106164583|NCT03603600|366265791|FG000|Overall Study|Other reason|1|||
106164584|NCT03603600|366265792|FG001|Overall Study|Other reason|0|||
106164585|NCT04973254|366265793|FG000|Overall Study|Not adherent|0|||
106164586|NCT04973254|366265794|FG001|Overall Study|Not adherent|1|||
106164587|NCT04973254|366265795|FG002|Overall Study|Not adherent|0|||
106164588|NCT05457647|366265796|FG000|Overall Study|Lost to Follow-up|3|||
106164589|NCT04938492|366265797|FG000|Overall Study|Lost to Follow-up|17|||
106164590|NCT04938492|366265798|FG001|Overall Study|Lost to Follow-up|18|||
106164591|NCT05257486|366265804|FG000|Overall Study|Protocol Violation|3|||
106164592|NCT03021096|366265805|FG000|Overall Study|Lost to Follow-up|4|||
106164593|NCT03021096|366265805|FG000|Overall Study|Protocol Violation|2|||
106164594|NCT04564742|366265808|FG000|Overall Study|Lost to Follow-up|1|||
106164595|NCT04564742|366265809|FG001|Overall Study|Lost to Follow-up|0|||
106164596|NCT04564742|366265808|FG000|Overall Study|Consent Withdrawal|4|||
106164597|NCT04564742|366265809|FG001|Overall Study|Consent Withdrawal|4|||
106164598|NCT03313076|366265813|FG000|Overall Study|Withdrawal by Subject|2|||
106164599|NCT03313076|366265814|FG001|Overall Study|Withdrawal by Subject|0|||
106164600|NCT03313076|366265815|FG002|Overall Study|Withdrawal by Subject|0|||
106164601|NCT03313076|366265816|FG003|Overall Study|Withdrawal by Subject|0|||
106164602|NCT03313076|366265813|FG000|Overall Study|Lost to Follow-up|0|||
106164603|NCT03313076|366265814|FG001|Overall Study|Lost to Follow-up|2|||
106164604|NCT03313076|366265815|FG002|Overall Study|Lost to Follow-up|2|||
106164605|NCT03313076|366265816|FG003|Overall Study|Lost to Follow-up|2|||
106164606|NCT04119843|366265817|FG000|Overall Study|Adverse Event|3|||
106164607|NCT04119843|366265817|FG000|Overall Study|Death|1|||
106164608|NCT05869383|366265818|FG000|Overall Study|Withdrawal by Subject|2|||
106164609|NCT05869383|366265819|FG001|Overall Study|Withdrawal by Subject|0|||
106164610|NCT03270501|366265824|FG000|Overall Study|Screen failure|6|||
106164611|NCT03270501|366265824|FG000|Overall Study|Lost to Follow-up|2|||
106164612|NCT03270501|366265824|FG000|Overall Study|Adverse Event|1|||
106164613|NCT01648023|366265825|FG000|Overall Study|Screen Fail Post Randomization|1|||
106164614|NCT01648023|366265826|FG001|Overall Study|Screen Fail Post Randomization|2|||
106164615|NCT00764751|366265827|FG000|Overall Study|Adverse Event|1|||
106164616|NCT00764751|366265828|FG001|Overall Study|Adverse Event|1|||
106164617|NCT00764751|366265827|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
106164618|NCT00764751|366265828|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
106164619|NCT03011333|366265837|FG000|Overall Study|Lost to Follow-up|0|||
106164620|NCT03011333|366265838|FG001|Overall Study|Lost to Follow-up|1|||
106164621|NCT03011333|366265839|FG002|Overall Study|Lost to Follow-up|0|||
106164622|NCT03011333|366265840|FG003|Overall Study|Lost to Follow-up|1|||
106164623|NCT03011333|366265841|FG004|Overall Study|Lost to Follow-up|4|||
106164624|NCT03011333|366265842|FG005|Overall Study|Lost to Follow-up|4|||
106164625|NCT03011333|366265843|FG006|Overall Study|Lost to Follow-up|5|||
106164626|NCT04492722|366265847|FG000|Overall Study|Adverse Event|7|||
106164627|NCT04492722|366265848|FG001|Overall Study|Adverse Event|2|||
106164628|NCT04492722|366265849|FG002|Overall Study|Adverse Event|3|||
106164629|NCT04492722|366265850|FG003|Overall Study|Adverse Event|0|||
106164630|NCT04492722|366265847|FG000|Overall Study|Death|0|||
106164631|NCT04492722|366265848|FG001|Overall Study|Death|0|||
106164632|NCT04492722|366265849|FG002|Overall Study|Death|0|||
106164633|NCT04492722|366265850|FG003|Overall Study|Death|1|||
106164634|NCT04492722|366265847|FG000|Overall Study|Lost to Follow-up|0|||
106164635|NCT04492722|366265848|FG001|Overall Study|Lost to Follow-up|1|||
106164636|NCT04492722|366265849|FG002|Overall Study|Lost to Follow-up|0|||
106164637|NCT04492722|366265850|FG003|Overall Study|Lost to Follow-up|1|||
106164638|NCT04492722|366265847|FG000|Overall Study|Physician Decision|0|||
106164639|NCT04492722|366265848|FG001|Overall Study|Physician Decision|3|||
106164640|NCT04492722|366265849|FG002|Overall Study|Physician Decision|1|||
106164641|NCT04492722|366265850|FG003|Overall Study|Physician Decision|1|||
106164642|NCT04492722|366265847|FG000|Overall Study|Withdrawal by Subject|6|||
106164643|NCT04492722|366265848|FG001|Overall Study|Withdrawal by Subject|6|||
106164644|NCT04492722|366265849|FG002|Overall Study|Withdrawal by Subject|0|||
106164645|NCT04492722|366265850|FG003|Overall Study|Withdrawal by Subject|3|||
106164646|NCT04492722|366265847|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
106164647|NCT04492722|366265848|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
106164648|NCT04492722|366265849|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
106164649|NCT04492722|366265850|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
106164650|NCT04492722|366265847|FG000|Overall Study|Due to Covid-19 pandemic|7|||
106164651|NCT04492722|366265848|FG001|Overall Study|Due to Covid-19 pandemic|3|||
106164652|NCT04492722|366265849|FG002|Overall Study|Due to Covid-19 pandemic|7|||
106164653|NCT04492722|366265850|FG003|Overall Study|Due to Covid-19 pandemic|6|||
106164654|NCT04492722|366265847|FG000|Overall Study|Failure to meet randomisation criteria|2|||
106164655|NCT04492722|366265848|FG001|Overall Study|Failure to meet randomisation criteria|3|||
106164656|NCT04492722|366265849|FG002|Overall Study|Failure to meet randomisation criteria|4|||
106164657|NCT04492722|366265850|FG003|Overall Study|Failure to meet randomisation criteria|2|||
106164658|NCT04492722|366265847|FG000|Overall Study|Early termination from the study|54|||
106164659|NCT04492722|366265848|FG001|Overall Study|Early termination from the study|51|||
106164660|NCT04492722|366265849|FG002|Overall Study|Early termination from the study|50|||
106164661|NCT04492722|366265850|FG003|Overall Study|Early termination from the study|50|||
106164662|NCT04492722|366265847|FG000|Overall Study|Missing|3|||
106164663|NCT04492722|366265848|FG001|Overall Study|Missing|0|||
106164664|NCT04492722|366265849|FG002|Overall Study|Missing|0|||
106164665|NCT04492722|366265850|FG003|Overall Study|Missing|5|||
106164666|NCT04492722|366265847|FG000|Overall Study|Participants who did not receive treatment|0|||
106164667|NCT04492722|366265848|FG001|Overall Study|Participants who did not receive treatment|1|||
106164668|NCT04492722|366265849|FG002|Overall Study|Participants who did not receive treatment|4|||
106164669|NCT04492722|366265850|FG003|Overall Study|Participants who did not receive treatment|0|||
106164670|NCT05329220|366265853|FG000|Active Trial Period|Adverse Event|0|||
106164671|NCT05329220|366265854|FG001|Active Trial Period|Adverse Event|0|||
106164672|NCT05329220|366265855|FG002|Active Trial Period|Adverse Event|0|||
106164673|NCT05329220|366265856|FG003|Active Trial Period|Adverse Event|0|||
106164674|NCT05329220|366265857|FG004|Active Trial Period|Adverse Event|1|||
106164675|NCT05329220|366265858|FG005|Active Trial Period|Adverse Event|0|||
106164676|NCT05329220|366265853|FG000|Active Trial Period|Lost to Follow-up|0|||
106164677|NCT05329220|366265854|FG001|Active Trial Period|Lost to Follow-up|0|||
106164678|NCT05329220|366265855|FG002|Active Trial Period|Lost to Follow-up|0|||
106164679|NCT05329220|366265856|FG003|Active Trial Period|Lost to Follow-up|0|||
106164680|NCT05329220|366265857|FG004|Active Trial Period|Lost to Follow-up|32|||
106164681|NCT05329220|366265858|FG005|Active Trial Period|Lost to Follow-up|28|||
106164682|NCT05329220|366265853|FG000|Active Trial Period|Physician Decision|0|||
106164683|NCT05329220|366265854|FG001|Active Trial Period|Physician Decision|0|||
106164684|NCT05329220|366265855|FG002|Active Trial Period|Physician Decision|0|||
106164685|NCT05329220|366265856|FG003|Active Trial Period|Physician Decision|0|||
106164686|NCT05329220|366265857|FG004|Active Trial Period|Physician Decision|2|||
106164687|NCT05329220|366265858|FG005|Active Trial Period|Physician Decision|0|||
106164688|NCT05329220|366265853|FG000|Active Trial Period|Protocol Violation|0|||
106164689|NCT05329220|366265854|FG001|Active Trial Period|Protocol Violation|0|||
106164690|NCT05329220|366265855|FG002|Active Trial Period|Protocol Violation|0|||
106164691|NCT05329220|366265856|FG003|Active Trial Period|Protocol Violation|0|||
106164692|NCT05329220|366265857|FG004|Active Trial Period|Protocol Violation|1|||
106164693|NCT05329220|366265858|FG005|Active Trial Period|Protocol Violation|3|||
106164694|NCT05329220|366265853|FG000|Active Trial Period|Withdrawal by Subject|0|||
106164695|NCT05329220|366265854|FG001|Active Trial Period|Withdrawal by Subject|0|||
106164696|NCT05329220|366265855|FG002|Active Trial Period|Withdrawal by Subject|0|||
106164697|NCT05329220|366265856|FG003|Active Trial Period|Withdrawal by Subject|1|||
106164698|NCT05329220|366265857|FG004|Active Trial Period|Withdrawal by Subject|12|||
106164699|NCT05329220|366265858|FG005|Active Trial Period|Withdrawal by Subject|13|||
106164700|NCT05329220|366265853|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
106164701|NCT05329220|366265854|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
106164702|NCT05329220|366265855|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
106164703|NCT05329220|366265856|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
106164704|NCT05329220|366265857|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
106164705|NCT05329220|366265858|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
106164706|NCT05329220|366265853|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
106164707|NCT05329220|366265854|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
106164708|NCT05329220|366265855|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
106164709|NCT05329220|366265856|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
106164710|NCT05329220|366265857|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
106164711|NCT05329220|366265858|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
106164712|NCT05329220|366265853|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
106164713|NCT05329220|366265854|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
106164714|NCT05329220|366265855|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
106164715|NCT05329220|366265856|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
106164716|NCT05329220|366265857|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
106164717|NCT05329220|366265858|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
106164718|NCT05329220|366265853|FG000|Follow-up Period|Adverse Event|0|||
106164719|NCT05329220|366265854|FG001|Follow-up Period|Adverse Event|0|||
106164720|NCT05329220|366265855|FG002|Follow-up Period|Adverse Event|0|||
106164721|NCT05329220|366265856|FG003|Follow-up Period|Adverse Event|0|||
106164722|NCT05329220|366265857|FG004|Follow-up Period|Adverse Event|2|||
106164723|NCT05329220|366265858|FG005|Follow-up Period|Adverse Event|1|||
106164724|NCT05329220|366265853|FG000|Follow-up Period|Death|0|||
106164725|NCT05329220|366265854|FG001|Follow-up Period|Death|0|||
106164726|NCT05329220|366265855|FG002|Follow-up Period|Death|1|||
106164727|NCT05329220|366265856|FG003|Follow-up Period|Death|1|||
106164728|NCT05329220|366265857|FG004|Follow-up Period|Death|0|||
106164729|NCT05329220|366265858|FG005|Follow-up Period|Death|1|||
106164730|NCT05329220|366265853|FG000|Follow-up Period|Lost to Follow-up|0|||
106164731|NCT05329220|366265854|FG001|Follow-up Period|Lost to Follow-up|1|||
106164732|NCT05329220|366265855|FG002|Follow-up Period|Lost to Follow-up|2|||
106164733|NCT05329220|366265856|FG003|Follow-up Period|Lost to Follow-up|2|||
106164734|NCT05329220|366265857|FG004|Follow-up Period|Lost to Follow-up|113|||
106164735|NCT05329220|366265858|FG005|Follow-up Period|Lost to Follow-up|89|||
106164736|NCT05329220|366265853|FG000|Follow-up Period|Physician Decision|0|||
106164737|NCT05329220|366265854|FG001|Follow-up Period|Physician Decision|0|||
106164738|NCT05329220|366265855|FG002|Follow-up Period|Physician Decision|0|||
106164739|NCT05329220|366265856|FG003|Follow-up Period|Physician Decision|0|||
106164740|NCT05329220|366265857|FG004|Follow-up Period|Physician Decision|2|||
106164741|NCT05329220|366265858|FG005|Follow-up Period|Physician Decision|2|||
106164742|NCT05329220|366265853|FG000|Follow-up Period|Protocol Violation|0|||
106164743|NCT05329220|366265854|FG001|Follow-up Period|Protocol Violation|0|||
106164744|NCT05329220|366265855|FG002|Follow-up Period|Protocol Violation|0|||
106164745|NCT05329220|366265856|FG003|Follow-up Period|Protocol Violation|0|||
106164746|NCT05329220|366265857|FG004|Follow-up Period|Protocol Violation|0|||
106164747|NCT05329220|366265858|FG005|Follow-up Period|Protocol Violation|1|||
106164748|NCT05329220|366265853|FG000|Follow-up Period|Withdrawal by Subject|0|||
106164749|NCT05329220|366265854|FG001|Follow-up Period|Withdrawal by Subject|0|||
106164750|NCT05329220|366265855|FG002|Follow-up Period|Withdrawal by Subject|1|||
106164751|NCT05329220|366265856|FG003|Follow-up Period|Withdrawal by Subject|1|||
106164752|NCT05329220|366265857|FG004|Follow-up Period|Withdrawal by Subject|34|||
106164753|NCT05329220|366265858|FG005|Follow-up Period|Withdrawal by Subject|35|||
106164754|NCT05329220|366265853|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
106164755|NCT05329220|366265854|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
106164756|NCT05329220|366265855|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
106164757|NCT05329220|366265856|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
106164758|NCT05329220|366265857|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
106164759|NCT05329220|366265858|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
106164760|NCT05329220|366265853|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
106164761|NCT05329220|366265854|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
106164762|NCT05329220|366265855|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
106164763|NCT05329220|366265856|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
106164764|NCT05329220|366265857|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
106164765|NCT05329220|366265858|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
106164766|NCT05329220|366265853|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
106164767|NCT05329220|366265854|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
106164768|NCT05329220|366265855|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
106164769|NCT05329220|366265856|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
106164770|NCT05329220|366265857|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
106164771|NCT05329220|366265858|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
106164772|NCT05329220|366265853|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
106164773|NCT05329220|366265854|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
106164774|NCT05329220|366265855|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
106164775|NCT05329220|366265856|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
106164776|NCT05329220|366265857|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
106164777|NCT05329220|366265858|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
106164778|NCT05329220|366265853|FG000|Follow-up Period|EARLY TERMINATION|0|||
106164779|NCT05329220|366265854|FG001|Follow-up Period|EARLY TERMINATION|0|||
106164780|NCT05329220|366265855|FG002|Follow-up Period|EARLY TERMINATION|0|||
106164781|NCT05329220|366265856|FG003|Follow-up Period|EARLY TERMINATION|0|||
106164782|NCT05329220|366265857|FG004|Follow-up Period|EARLY TERMINATION|0|||
106164783|NCT05329220|366265858|FG005|Follow-up Period|EARLY TERMINATION|1|||
106164784|NCT05329220|366265853|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
106164785|NCT05329220|366265854|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
106164786|NCT05329220|366265855|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
106164787|NCT05329220|366265856|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
106164788|NCT05329220|366265857|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
106164789|NCT05329220|366265858|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
106164790|NCT05329220|366265853|FG000|Follow-up Period|DROPPED|0|||
106164791|NCT05329220|366265854|FG001|Follow-up Period|DROPPED|0|||
106164792|NCT05329220|366265855|FG002|Follow-up Period|DROPPED|0|||
106164793|NCT05329220|366265856|FG003|Follow-up Period|DROPPED|0|||
106164794|NCT05329220|366265857|FG004|Follow-up Period|DROPPED|0|||
106164795|NCT05329220|366265858|FG005|Follow-up Period|DROPPED|1|||
106164796|NCT05329220|366265853|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
106164797|NCT05329220|366265854|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
106164798|NCT05329220|366265855|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
106164799|NCT05329220|366265856|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
106164800|NCT05329220|366265857|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
106164801|NCT05329220|366265858|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
106164802|NCT05808257|366265861|FG000|Overall Study|Lost to Follow-up|8|||
106164803|NCT05808257|366265862|FG001|Overall Study|Lost to Follow-up|8|||
106164804|NCT05792085|366265863|FG000|Overall Study|Death|0|||
106164805|NCT05792085|366265864|FG001|Overall Study|Death|0|||
106164806|NCT05792085|366265865|FG002|Overall Study|Death|0|||
106164807|NCT05792085|366265866|FG003|Overall Study|Death|0|||
106164808|NCT05792085|366265867|FG004|Overall Study|Death|1|||
106164809|NCT05977530|366265870|FG000|Overall Study|Withdrawal by Subject|1|||
106164810|NCT05977530|366265870|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
106164811|NCT01467427|366265880|FG000|Overall Study|Withdrawal by Subject|1|||
106164812|NCT01467427|366265881|FG001|Overall Study|Withdrawal by Subject|0|||
106164813|NCT01467427|366265880|FG000|Overall Study|Not continuing in extension phase|0|||
106164814|NCT01467427|366265881|FG001|Overall Study|Not continuing in extension phase|2|||
106164815|NCT01467427|366265880|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
106164816|NCT01467427|366265881|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
106164817|NCT01467427|366265880|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
106164818|NCT01467427|366265881|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
106164819|NCT01467427|366265880|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
106164820|NCT01467427|366265881|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
106164821|NCT01467427|366265880|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
106164822|NCT01467427|366265881|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
106164823|NCT03161028|366265882|FG000|Overall Study|Withdrawal by Subject|6|||
106164824|NCT03161028|366265883|FG001|Overall Study|Withdrawal by Subject|4|||
106164825|NCT03161028|366265882|FG000|Overall Study|Adverse Event|5|||
106164826|NCT03161028|366265883|FG001|Overall Study|Adverse Event|1|||
106164827|NCT03161028|366265882|FG000|Overall Study|Study drug side effects|2|||
106164828|NCT03161028|366265883|FG001|Overall Study|Study drug side effects|2|||
106164829|NCT03161028|366265882|FG000|Overall Study|Administrative PD/UP|4|||
106164830|NCT03161028|366265883|FG001|Overall Study|Administrative PD/UP|2|||
106164831|NCT03161028|366265882|FG000|Overall Study|Lost to Follow-up|2|||
106164832|NCT03161028|366265883|FG001|Overall Study|Lost to Follow-up|0|||
106164833|NCT03161028|366265882|FG000|Overall Study|Unable to comply with procedures|1|||
106164834|NCT03161028|366265883|FG001|Overall Study|Unable to comply with procedures|1|||
106164835|NCT05670587|366265884|FG000|Overall Study|Withdrawal by Subject|3|||
106164836|NCT01197378|366265886|FG000|Overall Study|Adverse Event|3|||
106164837|NCT01197378|366265886|FG000|Overall Study|Withdrawal by Subject|1|||
106164838|NCT01197378|366265886|FG000|Overall Study|Physician Decision|1|||
106164839|NCT01197378|366265886|FG000|Overall Study|Other|2|||
106164840|NCT06232590|366265889|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
106164841|NCT06232590|366265890|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
106164842|NCT04802967|366267955|FG000|Part B|Withdrawal by Subject|0|||
106164843|NCT04802967|366267956|FG001|Part B|Withdrawal by Subject|0|||
106164844|NCT04802967|366267957|FG002|Part B|Withdrawal by Subject|0|||
106164845|NCT04802967|366267958|FG003|Part B|Withdrawal by Subject|0|||
106164846|NCT04802967|366267959|FG004|Part B|Withdrawal by Subject|0|||
106164847|NCT04802967|366267960|FG005|Part B|Withdrawal by Subject|1|||
106164848|NCT04802967|366267961|FG006|Part B|Withdrawal by Subject|0|||
106164849|NCT04802967|366267962|FG007|Part B|Withdrawal by Subject|0|||
106164850|NCT04802967|366267963|FG008|Part B|Withdrawal by Subject|0|||
106164851|NCT04802967|366267964|FG009|Part B|Withdrawal by Subject|0|||
106164852|NCT01129102|366267965|FG000|Overall Study|No study drug treatment|2|||
106164853|NCT01129102|366267966|FG001|Overall Study|No study drug treatment|3|||
106164854|NCT01129102|366267967|FG002|Overall Study|No study drug treatment|1|||
106164855|NCT01129102|366267965|FG000|Overall Study|Withdrawal by Subject|2|||
106164856|NCT01129102|366267966|FG001|Overall Study|Withdrawal by Subject|0|||
106164857|NCT01129102|366267967|FG002|Overall Study|Withdrawal by Subject|3|||
106164858|NCT01129102|366267965|FG000|Overall Study|Protocol Violation|0|||
106164859|NCT01129102|366267966|FG001|Overall Study|Protocol Violation|1|||
106164860|NCT01129102|366267967|FG002|Overall Study|Protocol Violation|1|||
106164861|NCT01129102|366267965|FG000|Overall Study|Pregnancy|0|||
106164862|NCT01129102|366267966|FG001|Overall Study|Pregnancy|0|||
106164863|NCT01129102|366267967|FG002|Overall Study|Pregnancy|1|||
106164864|NCT01129102|366267965|FG000|Overall Study|Adverse Event|2|||
106164865|NCT01129102|366267966|FG001|Overall Study|Adverse Event|2|||
106164866|NCT01129102|366267967|FG002|Overall Study|Adverse Event|1|||
106164867|NCT01129102|366267965|FG000|Overall Study|Lost to Follow-up|2|||
106164868|NCT01129102|366267966|FG001|Overall Study|Lost to Follow-up|0|||
106164869|NCT01129102|366267967|FG002|Overall Study|Lost to Follow-up|0|||
106164870|NCT03379675|366267970|FG000|Overall Study|Lost to Follow-up|0|||
106164871|NCT03379675|366267971|FG001|Overall Study|Lost to Follow-up|1|||
106164872|NCT03379675|366267972|FG002|Overall Study|Lost to Follow-up|0|||
106164873|NCT03379675|366267970|FG000|Overall Study|Adverse Event|2|||
106164874|NCT03379675|366267971|FG001|Overall Study|Adverse Event|0|||
106164875|NCT03379675|366267972|FG002|Overall Study|Adverse Event|0|||
106164876|NCT03379675|366267970|FG000|Overall Study|Withdrawal by Subject|2|||
106164877|NCT03379675|366267971|FG001|Overall Study|Withdrawal by Subject|1|||
106164878|NCT03379675|366267972|FG002|Overall Study|Withdrawal by Subject|2|||
106164879|NCT03381196|366267973|FG000|Overall Study|Withdrawal by Subject|7|||
106164880|NCT03381196|366267974|FG001|Overall Study|Withdrawal by Subject|7|||
106164881|NCT03381196|366267973|FG000|Overall Study|Other|0|||
106164882|NCT03381196|366267974|FG001|Overall Study|Other|1|||
106164883|NCT03381196|366267973|FG000|Overall Study|Lost to Follow-up|5|||
106164884|NCT03381196|366267974|FG001|Overall Study|Lost to Follow-up|4|||
106164885|NCT03381196|366267973|FG000|Overall Study|Death|0|||
106164886|NCT03381196|366267974|FG001|Overall Study|Death|1|||
106164887|NCT03381196|366267973|FG000|Overall Study|Adverse Event|1|||
106164888|NCT03381196|366267974|FG001|Overall Study|Adverse Event|0|||
106164889|NCT03381196|366267973|FG000|Overall Study|Randomized, not treated|3|||
106164890|NCT03381196|366267974|FG001|Overall Study|Randomized, not treated|6|||
106164891|NCT05499377|366267985|FG000|Overall Study|Withdrawal by Subject|2|||
106164892|NCT05499377|366267986|FG001|Overall Study|Withdrawal by Subject|0|||
106164893|NCT05499377|366267985|FG000|Overall Study|Physician Decision|1|||
106164894|NCT05499377|366267986|FG001|Overall Study|Physician Decision|0|||
106164895|NCT02573493|366267987|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
106164896|NCT02573493|366267988|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
106164897|NCT02573493|366267989|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
106164898|NCT02573493|366267990|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
106164899|NCT03854227|366267991|FG000|Overall Study|Adverse Event|0|||
106164900|NCT03854227|366267992|FG001|Overall Study|Adverse Event|0|||
106164901|NCT03854227|366267993|FG002|Overall Study|Adverse Event|0|||
106164902|NCT03854227|366267994|FG003|Overall Study|Adverse Event|1|||
106164903|NCT03854227|366267995|FG004|Overall Study|Adverse Event|0|||
106164904|NCT03854227|366267996|FG005|Overall Study|Adverse Event|0|||
106164905|NCT03854227|366267997|FG006|Overall Study|Adverse Event|1|||
106164906|NCT03854227|366267998|FG007|Overall Study|Adverse Event|0|||
106164907|NCT03854227|366267999|FG008|Overall Study|Adverse Event|0|||
106164908|NCT03854227|366268000|FG009|Overall Study|Adverse Event|3|||
106164909|NCT03854227|366268001|FG010|Overall Study|Adverse Event|0|||
106164910|NCT03854227|366268002|FG011|Overall Study|Adverse Event|1|||
106164911|NCT03854227|366267991|FG000|Overall Study|Death|0|||
106164912|NCT03854227|366267992|FG001|Overall Study|Death|0|||
106164913|NCT03854227|366267993|FG002|Overall Study|Death|0|||
106164914|NCT03854227|366267994|FG003|Overall Study|Death|0|||
106164915|NCT03854227|366267995|FG004|Overall Study|Death|0|||
106164916|NCT03854227|366267996|FG005|Overall Study|Death|1|||
106164917|NCT03854227|366267997|FG006|Overall Study|Death|0|||
106164918|NCT03854227|366267998|FG007|Overall Study|Death|0|||
106164919|NCT03854227|366267999|FG008|Overall Study|Death|0|||
106164920|NCT03854227|366268000|FG009|Overall Study|Death|1|||
106164921|NCT03854227|366268001|FG010|Overall Study|Death|0|||
106164922|NCT03854227|366268002|FG011|Overall Study|Death|1|||
106164923|NCT03854227|366267991|FG000|Overall Study|Physician Decision|0|||
106164924|NCT03854227|366267992|FG001|Overall Study|Physician Decision|0|||
106164925|NCT03854227|366267993|FG002|Overall Study|Physician Decision|0|||
106164926|NCT03854227|366267994|FG003|Overall Study|Physician Decision|0|||
106164927|NCT03854227|366267995|FG004|Overall Study|Physician Decision|0|||
106164928|NCT03854227|366267996|FG005|Overall Study|Physician Decision|1|||
106164929|NCT03854227|366267997|FG006|Overall Study|Physician Decision|0|||
106164930|NCT03854227|366267998|FG007|Overall Study|Physician Decision|0|||
106164931|NCT03854227|366267999|FG008|Overall Study|Physician Decision|1|||
106164932|NCT03854227|366268000|FG009|Overall Study|Physician Decision|1|||
106164933|NCT03854227|366268001|FG010|Overall Study|Physician Decision|0|||
106164934|NCT03854227|366268002|FG011|Overall Study|Physician Decision|1|||
106164935|NCT03854227|366267991|FG000|Overall Study|Progressive disease|1|||
106164936|NCT03854227|366267992|FG001|Overall Study|Progressive disease|1|||
106164937|NCT03854227|366267993|FG002|Overall Study|Progressive disease|1|||
106164938|NCT03854227|366267994|FG003|Overall Study|Progressive disease|2|||
106164939|NCT03854227|366267995|FG004|Overall Study|Progressive disease|3|||
106164940|NCT03854227|366267996|FG005|Overall Study|Progressive disease|1|||
106164941|NCT03854227|366267997|FG006|Overall Study|Progressive disease|2|||
106164942|NCT03854227|366267998|FG007|Overall Study|Progressive disease|5|||
106164943|NCT03854227|366267999|FG008|Overall Study|Progressive disease|2|||
106164944|NCT03854227|366268000|FG009|Overall Study|Progressive disease|5|||
106164945|NCT03854227|366268001|FG010|Overall Study|Progressive disease|1|||
106164946|NCT03854227|366268002|FG011|Overall Study|Progressive disease|6|||
106164947|NCT03854227|366267991|FG000|Overall Study|Study terminated by sponsor|0|||
106164948|NCT03854227|366267992|FG001|Overall Study|Study terminated by sponsor|0|||
106164949|NCT03854227|366267993|FG002|Overall Study|Study terminated by sponsor|0|||
106164950|NCT03854227|366267994|FG003|Overall Study|Study terminated by sponsor|0|||
106164951|NCT03854227|366267995|FG004|Overall Study|Study terminated by sponsor|0|||
106164952|NCT03854227|366267996|FG005|Overall Study|Study terminated by sponsor|0|||
106164953|NCT03854227|366267997|FG006|Overall Study|Study terminated by sponsor|0|||
106164954|NCT03854227|366267998|FG007|Overall Study|Study terminated by sponsor|0|||
106164955|NCT03854227|366267999|FG008|Overall Study|Study terminated by sponsor|0|||
106164956|NCT03854227|366268000|FG009|Overall Study|Study terminated by sponsor|1|||
106164957|NCT03854227|366268001|FG010|Overall Study|Study terminated by sponsor|0|||
106164958|NCT03854227|366268002|FG011|Overall Study|Study terminated by sponsor|0|||
106164959|NCT03854227|366267991|FG000|Overall Study|Withdrawal by Subject|0|||
106164960|NCT03854227|366267992|FG001|Overall Study|Withdrawal by Subject|0|||
106164961|NCT03854227|366267993|FG002|Overall Study|Withdrawal by Subject|1|||
106164962|NCT03854227|366267994|FG003|Overall Study|Withdrawal by Subject|0|||
106164963|NCT03854227|366267995|FG004|Overall Study|Withdrawal by Subject|0|||
106164964|NCT03854227|366267996|FG005|Overall Study|Withdrawal by Subject|0|||
106164965|NCT03854227|366267997|FG006|Overall Study|Withdrawal by Subject|0|||
106164966|NCT03854227|366267998|FG007|Overall Study|Withdrawal by Subject|0|||
106164967|NCT03854227|366267999|FG008|Overall Study|Withdrawal by Subject|0|||
106164968|NCT03854227|366268000|FG009|Overall Study|Withdrawal by Subject|1|||
106164969|NCT03854227|366268001|FG010|Overall Study|Withdrawal by Subject|1|||
106164970|NCT03854227|366268002|FG011|Overall Study|Withdrawal by Subject|0|||
106164971|NCT03854227|366267991|FG000|Overall Study|Disease relapse|0|||
106164972|NCT03854227|366267992|FG001|Overall Study|Disease relapse|0|||
106164973|NCT03854227|366267993|FG002|Overall Study|Disease relapse|0|||
106164974|NCT03854227|366267994|FG003|Overall Study|Disease relapse|0|||
106164975|NCT03854227|366267995|FG004|Overall Study|Disease relapse|0|||
106164976|NCT03854227|366267996|FG005|Overall Study|Disease relapse|0|||
106164977|NCT03854227|366267997|FG006|Overall Study|Disease relapse|0|||
106164978|NCT03854227|366267998|FG007|Overall Study|Disease relapse|0|||
106164979|NCT03854227|366267999|FG008|Overall Study|Disease relapse|1|||
106164980|NCT03854227|366268000|FG009|Overall Study|Disease relapse|0|||
106164981|NCT03854227|366268001|FG010|Overall Study|Disease relapse|0|||
106164982|NCT03854227|366268002|FG011|Overall Study|Disease relapse|0|||
106164983|NCT03854227|366267991|FG000|Overall Study|Global deterioration of health status|0|||
106164984|NCT03854227|366267992|FG001|Overall Study|Global deterioration of health status|0|||
106164985|NCT03854227|366267993|FG002|Overall Study|Global deterioration of health status|0|||
106164986|NCT03854227|366267994|FG003|Overall Study|Global deterioration of health status|0|||
106164987|NCT03854227|366267995|FG004|Overall Study|Global deterioration of health status|0|||
106164988|NCT03854227|366267996|FG005|Overall Study|Global deterioration of health status|1|||
106164989|NCT03854227|366267997|FG006|Overall Study|Global deterioration of health status|0|||
106164990|NCT03854227|366267998|FG007|Overall Study|Global deterioration of health status|1|||
106164991|NCT03854227|366267999|FG008|Overall Study|Global deterioration of health status|0|||
106164992|NCT03854227|366268000|FG009|Overall Study|Global deterioration of health status|0|||
106164993|NCT03854227|366268001|FG010|Overall Study|Global deterioration of health status|0|||
106164994|NCT03854227|366268002|FG011|Overall Study|Global deterioration of health status|0|||
106164995|NCT03854227|366267991|FG000|Overall Study|Refused further treatment|0|||
106164996|NCT03854227|366267992|FG001|Overall Study|Refused further treatment|0|||
106164997|NCT03854227|366267993|FG002|Overall Study|Refused further treatment|0|||
106164998|NCT03854227|366267994|FG003|Overall Study|Refused further treatment|0|||
106164999|NCT03854227|366267995|FG004|Overall Study|Refused further treatment|0|||
106165000|NCT03854227|366267996|FG005|Overall Study|Refused further treatment|0|||
106165001|NCT03854227|366267997|FG006|Overall Study|Refused further treatment|0|||
106165002|NCT03854227|366267998|FG007|Overall Study|Refused further treatment|0|||
106165003|NCT03854227|366267999|FG008|Overall Study|Refused further treatment|0|||
106165004|NCT03854227|366268000|FG009|Overall Study|Refused further treatment|1|||
106165005|NCT03854227|366268001|FG010|Overall Study|Refused further treatment|0|||
106165006|NCT03854227|366268002|FG011|Overall Study|Refused further treatment|1|||
106165007|NCT03854227|366267991|FG000|Overall Study|Other|0|||
106165008|NCT03854227|366267992|FG001|Overall Study|Other|0|||
106165009|NCT03854227|366267993|FG002|Overall Study|Other|0|||
106165010|NCT03854227|366267994|FG003|Overall Study|Other|0|||
106165011|NCT03854227|366267995|FG004|Overall Study|Other|0|||
106165012|NCT03854227|366267996|FG005|Overall Study|Other|0|||
106165013|NCT03854227|366267997|FG006|Overall Study|Other|0|||
106165014|NCT03854227|366267998|FG007|Overall Study|Other|0|||
106165015|NCT03854227|366267999|FG008|Overall Study|Other|1|||
106165016|NCT03854227|366268000|FG009|Overall Study|Other|1|||
106165017|NCT03854227|366268001|FG010|Overall Study|Other|0|||
106165018|NCT03854227|366268002|FG011|Overall Study|Other|0|||
106165019|NCT04044768|366268007|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
106165020|NCT04044768|366268008|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
106165021|NCT05089019|366268010|FG000|Period 1|Withdrawal by Subject|0|||
106165022|NCT05089019|366268011|FG001|Period 1|Withdrawal by Subject|1|||
106165023|NCT05089019|366268010|FG000|Washout Period|Adverse Event|3|||
106165024|NCT05089019|366268011|FG001|Washout Period|Adverse Event|4|||
106165025|NCT05089019|366268010|FG000|Washout Period|Lost to Follow-up|1|||
106165026|NCT05089019|366268011|FG001|Washout Period|Lost to Follow-up|0|||
106165027|NCT05089019|366268010|FG000|Washout Period|Physician Decision|2|||
106165028|NCT05089019|366268011|FG001|Washout Period|Physician Decision|0|||
106165029|NCT05089019|366268010|FG000|Washout Period|Withdrawal by Subject|6|||
106165030|NCT05089019|366268011|FG001|Washout Period|Withdrawal by Subject|3|||
106165031|NCT05089019|366268010|FG000|Period 2|Adverse Event|4|||
106165032|NCT05089019|366268011|FG001|Period 2|Adverse Event|2|||
106165033|NCT05089019|366268010|FG000|Period 2|Lost to Follow-up|1|||
106165034|NCT05089019|366268011|FG001|Period 2|Lost to Follow-up|0|||
106165035|NCT05089019|366268010|FG000|Period 2|Withdrawal by Subject|0|||
106165036|NCT05089019|366268011|FG001|Period 2|Withdrawal by Subject|1|||
106165037|NCT05170009|366268012|FG000|Overall Study|Physician Decision|0|||
106165038|NCT05170009|366268013|FG001|Overall Study|Physician Decision|1|||
106165039|NCT03904147|366268015|FG000|Overall Study|Death|15|||
106165040|NCT03904147|366268016|FG001|Overall Study|Death|13|||
106165041|NCT03904147|366268017|FG002|Overall Study|Death|15|||
106165042|NCT03904147|366268015|FG000|Overall Study|Withdrawal by Subject|7|||
106165043|NCT03904147|366268016|FG001|Overall Study|Withdrawal by Subject|12|||
106165044|NCT03904147|366268017|FG002|Overall Study|Withdrawal by Subject|1|||
106165045|NCT03904147|366268015|FG000|Overall Study|1Y visit completed after 365 days|1|||
106165046|NCT03904147|366268016|FG001|Overall Study|1Y visit completed after 365 days|1|||
106165047|NCT03904147|366268017|FG002|Overall Study|1Y visit completed after 365 days|0|||
106165048|NCT02841579|366268018|FG000|Overall Study|Death|1|||
106165049|NCT02841579|366268018|FG000|Overall Study|Adverse Event|1|||
106165050|NCT02841579|366268018|FG000|Overall Study|Lack of Efficacy|9|||
106165051|NCT04233216|366268021|FG000|Overall Study|Lost to Follow-up|1|||
106165052|NCT04233216|366268022|FG001|Overall Study|Lost to Follow-up|0|||
106165053|NCT04233216|366268023|FG002|Overall Study|Lost to Follow-up|2|||
106165054|NCT04233216|366268024|FG003|Overall Study|Lost to Follow-up|0|||
106165055|NCT04233216|366268021|FG000|Overall Study|Physician Decision|0|||
106165056|NCT04233216|366268022|FG001|Overall Study|Physician Decision|3|||
106165057|NCT04233216|366268023|FG002|Overall Study|Physician Decision|0|||
106165058|NCT04233216|366268024|FG003|Overall Study|Physician Decision|2|||
106165059|NCT04233216|366268021|FG000|Overall Study|Withdrawal by Subject|0|||
106165060|NCT04233216|366268022|FG001|Overall Study|Withdrawal by Subject|2|||
106165061|NCT04233216|366268023|FG002|Overall Study|Withdrawal by Subject|1|||
106165062|NCT04233216|366268024|FG003|Overall Study|Withdrawal by Subject|0|||
106165063|NCT04137289|366268025|FG000|Overall Study|Death|0|||
106165064|NCT04137289|366268026|FG001|Overall Study|Death|0|||
106165065|NCT04137289|366268027|FG002|Overall Study|Death|0|||
106165066|NCT04137289|366268028|FG003|Overall Study|Death|0|||
106165067|NCT04137289|366268029|FG004|Overall Study|Death|0|||
106165068|NCT04137289|366268030|FG005|Overall Study|Death|0|||
106165069|NCT04137289|366268031|FG006|Overall Study|Death|1|||
106165070|NCT04137289|366268032|FG007|Overall Study|Death|0|||
106165071|NCT04137289|366268033|FG008|Overall Study|Death|0|||
106165072|NCT04137289|366268025|FG000|Overall Study|Clinical disease progression|0|||
106165073|NCT04137289|366268026|FG001|Overall Study|Clinical disease progression|0|||
106165074|NCT04137289|366268027|FG002|Overall Study|Clinical disease progression|0|||
106165075|NCT04137289|366268028|FG003|Overall Study|Clinical disease progression|4|||
106165076|NCT04137289|366268029|FG004|Overall Study|Clinical disease progression|4|||
106165077|NCT04137289|366268030|FG005|Overall Study|Clinical disease progression|2|||
106165078|NCT04137289|366268031|FG006|Overall Study|Clinical disease progression|5|||
106165079|NCT04137289|366268032|FG007|Overall Study|Clinical disease progression|1|||
106165080|NCT04137289|366268033|FG008|Overall Study|Clinical disease progression|0|||
106165081|NCT04137289|366268025|FG000|Overall Study|Lost to Follow-up|0|||
106165082|NCT04137289|366268026|FG001|Overall Study|Lost to Follow-up|0|||
106165083|NCT04137289|366268027|FG002|Overall Study|Lost to Follow-up|0|||
106165084|NCT04137289|366268028|FG003|Overall Study|Lost to Follow-up|1|||
106165085|NCT04137289|366268029|FG004|Overall Study|Lost to Follow-up|0|||
106165086|NCT04137289|366268030|FG005|Overall Study|Lost to Follow-up|0|||
106165087|NCT04137289|366268031|FG006|Overall Study|Lost to Follow-up|0|||
106165088|NCT04137289|366268032|FG007|Overall Study|Lost to Follow-up|0|||
106165089|NCT04137289|366268033|FG008|Overall Study|Lost to Follow-up|0|||
106165090|NCT04137289|366268025|FG000|Overall Study|Adverse Event|0|||
106165091|NCT04137289|366268026|FG001|Overall Study|Adverse Event|0|||
106165092|NCT04137289|366268027|FG002|Overall Study|Adverse Event|1|||
106165093|NCT04137289|366268028|FG003|Overall Study|Adverse Event|0|||
106165094|NCT04137289|366268029|FG004|Overall Study|Adverse Event|0|||
106165095|NCT04137289|366268030|FG005|Overall Study|Adverse Event|1|||
106165096|NCT04137289|366268031|FG006|Overall Study|Adverse Event|0|||
106165097|NCT04137289|366268032|FG007|Overall Study|Adverse Event|0|||
106165098|NCT04137289|366268033|FG008|Overall Study|Adverse Event|0|||
106165099|NCT04137289|366268025|FG000|Overall Study|Lack of clinical benefit|0|||
106165100|NCT04137289|366268026|FG001|Overall Study|Lack of clinical benefit|0|||
106165101|NCT04137289|366268027|FG002|Overall Study|Lack of clinical benefit|0|||
106165102|NCT04137289|366268028|FG003|Overall Study|Lack of clinical benefit|0|||
106165103|NCT04137289|366268029|FG004|Overall Study|Lack of clinical benefit|0|||
106165104|NCT04137289|366268030|FG005|Overall Study|Lack of clinical benefit|0|||
106165105|NCT04137289|366268031|FG006|Overall Study|Lack of clinical benefit|0|||
106165106|NCT04137289|366268032|FG007|Overall Study|Lack of clinical benefit|0|||
106165107|NCT04137289|366268033|FG008|Overall Study|Lack of clinical benefit|1|||
106165108|NCT04137289|366268025|FG000|Overall Study|Objective disease progression|1|||
106165109|NCT04137289|366268026|FG001|Overall Study|Objective disease progression|1|||
106165110|NCT04137289|366268027|FG002|Overall Study|Objective disease progression|6|||
106165111|NCT04137289|366268028|FG003|Overall Study|Objective disease progression|18|||
106165112|NCT04137289|366268029|FG004|Overall Study|Objective disease progression|12|||
106165113|NCT04137289|366268030|FG005|Overall Study|Objective disease progression|20|||
106165114|NCT04137289|366268031|FG006|Overall Study|Objective disease progression|18|||
106165115|NCT04137289|366268032|FG007|Overall Study|Objective disease progression|7|||
106165116|NCT04137289|366268033|FG008|Overall Study|Objective disease progression|6|||
106165117|NCT04307355|366268034|FG000|Overall Study|Non-Compliance|3|||
106165118|NCT04307355|366268035|FG001|Overall Study|Non-Compliance|3|||
106165119|NCT04307355|366268036|FG002|Overall Study|Non-Compliance|0|||
106165120|NCT04225273|366268040|FG000|Overall Study|Lost to Follow-up|3|||
106165121|NCT04074759|366268045|FG000|Overall Study|Withdrawal by Subject|0|||
106165122|NCT04074759|366268046|FG001|Overall Study|Withdrawal by Subject|0|||
106165123|NCT04074759|366268047|FG002|Overall Study|Withdrawal by Subject|0|||
106165124|NCT04074759|366268048|FG003|Overall Study|Withdrawal by Subject|0|||
106165125|NCT04074759|366268049|FG004|Overall Study|Withdrawal by Subject|0|||
106165126|NCT04074759|366268050|FG005|Overall Study|Withdrawal by Subject|2|||
106165127|NCT04074759|366268051|FG006|Overall Study|Withdrawal by Subject|0|||
106165128|NCT04074759|366268052|FG007|Overall Study|Withdrawal by Subject|2|||
106165129|NCT04074759|366268053|FG008|Overall Study|Withdrawal by Subject|1|||
106165130|NCT04074759|366268054|FG009|Overall Study|Withdrawal by Subject|2|||
106165131|NCT04074759|366268055|FG010|Overall Study|Withdrawal by Subject|9|||
106165132|NCT04074759|366268056|FG011|Overall Study|Withdrawal by Subject|2|||
106165133|NCT04074759|366268057|FG012|Overall Study|Withdrawal by Subject|1|||
106165134|NCT04074759|366268058|FG013|Overall Study|Withdrawal by Subject|3|||
106165135|NCT04074759|366268059|FG014|Overall Study|Withdrawal by Subject|2|||
106165136|NCT04074759|366268060|FG015|Overall Study|Withdrawal by Subject|0|||
106165137|NCT04074759|366268061|FG016|Overall Study|Withdrawal by Subject|0|||
106165138|NCT04074759|366268062|FG017|Overall Study|Withdrawal by Subject|3|||
106165139|NCT04074759|366268063|FG018|Overall Study|Withdrawal by Subject|1|||
106165140|NCT04074759|366268045|FG000|Overall Study|Death|1|||
106165141|NCT04074759|366268046|FG001|Overall Study|Death|0|||
106165142|NCT04074759|366268047|FG002|Overall Study|Death|1|||
106165143|NCT04074759|366268048|FG003|Overall Study|Death|1|||
106165144|NCT04074759|366268049|FG004|Overall Study|Death|2|||
106165145|NCT04074759|366268050|FG005|Overall Study|Death|0|||
106165146|NCT04074759|366268051|FG006|Overall Study|Death|1|||
106165147|NCT04074759|366268052|FG007|Overall Study|Death|0|||
106165148|NCT04074759|366268053|FG008|Overall Study|Death|3|||
106165149|NCT04074759|366268054|FG009|Overall Study|Death|2|||
106165150|NCT04074759|366268055|FG010|Overall Study|Death|4|||
106165151|NCT04074759|366268056|FG011|Overall Study|Death|1|||
106165152|NCT04074759|366268057|FG012|Overall Study|Death|0|||
106165153|NCT04074759|366268058|FG013|Overall Study|Death|2|||
106165154|NCT04074759|366268059|FG014|Overall Study|Death|1|||
106165155|NCT04074759|366268060|FG015|Overall Study|Death|0|||
106165156|NCT04074759|366268061|FG016|Overall Study|Death|1|||
106165157|NCT04074759|366268062|FG017|Overall Study|Death|0|||
106165158|NCT04074759|366268063|FG018|Overall Study|Death|1|||
106165159|NCT04074759|366268045|FG000|Overall Study|Lost to Follow-up|0|||
106165160|NCT04074759|366268046|FG001|Overall Study|Lost to Follow-up|0|||
106165161|NCT04074759|366268047|FG002|Overall Study|Lost to Follow-up|0|||
106165162|NCT04074759|366268048|FG003|Overall Study|Lost to Follow-up|0|||
106165163|NCT04074759|366268049|FG004|Overall Study|Lost to Follow-up|0|||
106165164|NCT04074759|366268050|FG005|Overall Study|Lost to Follow-up|0|||
106165165|NCT04074759|366268051|FG006|Overall Study|Lost to Follow-up|0|||
106165166|NCT04074759|366268052|FG007|Overall Study|Lost to Follow-up|0|||
106165167|NCT04074759|366268053|FG008|Overall Study|Lost to Follow-up|0|||
106165168|NCT04074759|366268054|FG009|Overall Study|Lost to Follow-up|0|||
106165169|NCT04074759|366268055|FG010|Overall Study|Lost to Follow-up|1|||
106165170|NCT04074759|366268056|FG011|Overall Study|Lost to Follow-up|0|||
106165171|NCT04074759|366268057|FG012|Overall Study|Lost to Follow-up|0|||
106165172|NCT04074759|366268058|FG013|Overall Study|Lost to Follow-up|0|||
106165173|NCT04074759|366268059|FG014|Overall Study|Lost to Follow-up|0|||
106165174|NCT04074759|366268060|FG015|Overall Study|Lost to Follow-up|0|||
106165175|NCT04074759|366268061|FG016|Overall Study|Lost to Follow-up|1|||
106165176|NCT04074759|366268062|FG017|Overall Study|Lost to Follow-up|0|||
106165177|NCT04074759|366268063|FG018|Overall Study|Lost to Follow-up|1|||
106165178|NCT04074759|366268045|FG000|Overall Study|Other|0|||
106165179|NCT04074759|366268046|FG001|Overall Study|Other|1|||
106165180|NCT04074759|366268047|FG002|Overall Study|Other|1|||
106165181|NCT04074759|366268048|FG003|Overall Study|Other|0|||
106165182|NCT04074759|366268049|FG004|Overall Study|Other|2|||
106165183|NCT04074759|366268050|FG005|Overall Study|Other|1|||
106165184|NCT04074759|366268051|FG006|Overall Study|Other|2|||
106165185|NCT04074759|366268052|FG007|Overall Study|Other|1|||
106165186|NCT04074759|366268053|FG008|Overall Study|Other|1|||
106165187|NCT04074759|366268054|FG009|Overall Study|Other|4|||
106165188|NCT04074759|366268055|FG010|Overall Study|Other|4|||
106165189|NCT04074759|366268056|FG011|Overall Study|Other|2|||
106165190|NCT04074759|366268057|FG012|Overall Study|Other|0|||
106165191|NCT04074759|366268058|FG013|Overall Study|Other|0|||
106165192|NCT04074759|366268059|FG014|Overall Study|Other|0|||
106165193|NCT04074759|366268060|FG015|Overall Study|Other|1|||
106165194|NCT04074759|366268061|FG016|Overall Study|Other|0|||
106165195|NCT04074759|366268062|FG017|Overall Study|Other|0|||
106165196|NCT04074759|366268063|FG018|Overall Study|Other|0|||
106165197|NCT04074759|366268045|FG000|Overall Study|Missing end of study status|0|||
106165198|NCT04074759|366268046|FG001|Overall Study|Missing end of study status|0|||
106165199|NCT04074759|366268047|FG002|Overall Study|Missing end of study status|0|||
106165200|NCT04074759|366268048|FG003|Overall Study|Missing end of study status|0|||
106165201|NCT04074759|366268049|FG004|Overall Study|Missing end of study status|0|||
106165202|NCT04074759|366268050|FG005|Overall Study|Missing end of study status|0|||
106165203|NCT04074759|366268051|FG006|Overall Study|Missing end of study status|0|||
106165204|NCT04074759|366268052|FG007|Overall Study|Missing end of study status|0|||
106165205|NCT04074759|366268053|FG008|Overall Study|Missing end of study status|0|||
106165206|NCT04074759|366268054|FG009|Overall Study|Missing end of study status|0|||
106165207|NCT04074759|366268055|FG010|Overall Study|Missing end of study status|2|||
106165208|NCT04074759|366268056|FG011|Overall Study|Missing end of study status|0|||
106165209|NCT04074759|366268057|FG012|Overall Study|Missing end of study status|0|||
106165210|NCT04074759|366268058|FG013|Overall Study|Missing end of study status|0|||
106165211|NCT04074759|366268059|FG014|Overall Study|Missing end of study status|0|||
106165212|NCT04074759|366268060|FG015|Overall Study|Missing end of study status|0|||
106165213|NCT04074759|366268061|FG016|Overall Study|Missing end of study status|1|||
106165214|NCT04074759|366268062|FG017|Overall Study|Missing end of study status|0|||
106165215|NCT04074759|366268063|FG018|Overall Study|Missing end of study status|0|||
106165216|NCT04032704|366268064|FG000|Part A|Withdrawal by Subject|0|||
106165217|NCT04032704|366268065|FG001|Part A|Withdrawal by Subject|0|||
106165218|NCT04032704|366268066|FG002|Part A|Withdrawal by Subject|3|||
106165219|NCT04032704|366268067|FG003|Part A|Withdrawal by Subject|0|||
106165220|NCT04032704|366268068|FG004|Part A|Withdrawal by Subject|1|||
106165221|NCT04032704|366268069|FG005|Part A|Withdrawal by Subject|7|||
106165222|NCT04032704|366268070|FG006|Part A|Withdrawal by Subject|0|||
106165223|NCT04032704|366268071|FG007|Part A|Withdrawal by Subject|0|||
106165224|NCT04032704|366268072|FG008|Part A|Withdrawal by Subject|0|||
106165225|NCT04032704|366268073|FG009|Part A|Withdrawal by Subject|0|||
106165226|NCT04032704|366268074|FG010|Part A|Withdrawal by Subject|0|||
106165227|NCT04032704|366268075|FG011|Part A|Withdrawal by Subject|0|||
106165228|NCT04032704|366268076|FG012|Part A|Withdrawal by Subject|0|||
106165229|NCT04032704|366268077|FG013|Part A|Withdrawal by Subject|0|||
106165230|NCT04032704|366268078|FG014|Part A|Withdrawal by Subject|0|||
106165231|NCT04032704|366268079|FG015|Part A|Withdrawal by Subject|0|||
106165232|NCT04032704|366268080|FG016|Part A|Withdrawal by Subject|0|||
106165233|NCT04032704|366268081|FG017|Part A|Withdrawal by Subject|0|||
106165234|NCT04032704|366268064|FG000|Part A|Lost to Follow-up|1|||
106165235|NCT04032704|366268065|FG001|Part A|Lost to Follow-up|0|||
106165236|NCT04032704|366268066|FG002|Part A|Lost to Follow-up|0|||
106165237|NCT04032704|366268067|FG003|Part A|Lost to Follow-up|0|||
106165238|NCT04032704|366268068|FG004|Part A|Lost to Follow-up|0|||
106165239|NCT04032704|366268069|FG005|Part A|Lost to Follow-up|0|||
106165240|NCT04032704|366268070|FG006|Part A|Lost to Follow-up|0|||
106165241|NCT04032704|366268071|FG007|Part A|Lost to Follow-up|0|||
106165242|NCT04032704|366268072|FG008|Part A|Lost to Follow-up|0|||
106165243|NCT04032704|366268073|FG009|Part A|Lost to Follow-up|0|||
106165244|NCT04032704|366268074|FG010|Part A|Lost to Follow-up|0|||
106165245|NCT04032704|366268075|FG011|Part A|Lost to Follow-up|0|||
106165246|NCT04032704|366268076|FG012|Part A|Lost to Follow-up|0|||
106165247|NCT04032704|366268077|FG013|Part A|Lost to Follow-up|0|||
106165248|NCT04032704|366268078|FG014|Part A|Lost to Follow-up|0|||
106165249|NCT04032704|366268079|FG015|Part A|Lost to Follow-up|0|||
106165250|NCT04032704|366268080|FG016|Part A|Lost to Follow-up|0|||
106165251|NCT04032704|366268081|FG017|Part A|Lost to Follow-up|0|||
106165252|NCT04032704|366268064|FG000|Part A|Death|9|||
106165253|NCT04032704|366268065|FG001|Part A|Death|2|||
106165254|NCT04032704|366268066|FG002|Part A|Death|10|||
106165255|NCT04032704|366268067|FG003|Part A|Death|7|||
106165256|NCT04032704|366268068|FG004|Part A|Death|4|||
106165257|NCT04032704|366268069|FG005|Part A|Death|5|||
106165258|NCT04032704|366268070|FG006|Part A|Death|0|||
106165259|NCT04032704|366268071|FG007|Part A|Death|0|||
106165260|NCT04032704|366268072|FG008|Part A|Death|0|||
106165261|NCT04032704|366268073|FG009|Part A|Death|0|||
106165262|NCT04032704|366268074|FG010|Part A|Death|0|||
106165263|NCT04032704|366268075|FG011|Part A|Death|0|||
106165264|NCT04032704|366268076|FG012|Part A|Death|0|||
106165265|NCT04032704|366268077|FG013|Part A|Death|0|||
106165266|NCT04032704|366268078|FG014|Part A|Death|0|||
106165267|NCT04032704|366268079|FG015|Part A|Death|0|||
106165268|NCT04032704|366268080|FG016|Part A|Death|0|||
106165269|NCT04032704|366268081|FG017|Part A|Death|0|||
106165270|NCT04032704|366268064|FG000|Part B|Other|0|||
106165271|NCT04032704|366268065|FG001|Part B|Other|0|||
106165272|NCT04032704|366268066|FG002|Part B|Other|0|||
106165273|NCT04032704|366268067|FG003|Part B|Other|0|||
106165274|NCT04032704|366268068|FG004|Part B|Other|0|||
106165275|NCT04032704|366268069|FG005|Part B|Other|0|||
106165276|NCT04032704|366268070|FG006|Part B|Other|0|||
106165277|NCT04032704|366268071|FG007|Part B|Other|1|||
106165278|NCT04032704|366268072|FG008|Part B|Other|2|||
106165279|NCT04032704|366268073|FG009|Part B|Other|1|||
106165280|NCT04032704|366268074|FG010|Part B|Other|1|||
106165281|NCT04032704|366268075|FG011|Part B|Other|1|||
106165282|NCT04032704|366268076|FG012|Part B|Other|5|||
106165283|NCT04032704|366268077|FG013|Part B|Other|13|||
106165284|NCT04032704|366268078|FG014|Part B|Other|0|||
106165285|NCT04032704|366268079|FG015|Part B|Other|0|||
106165286|NCT04032704|366268080|FG016|Part B|Other|0|||
106165287|NCT04032704|366268081|FG017|Part B|Other|0|||
106165288|NCT04032704|366268064|FG000|Part B|Study termination by Sponsor|0|||
106165289|NCT04032704|366268065|FG001|Part B|Study termination by Sponsor|0|||
106165290|NCT04032704|366268066|FG002|Part B|Study termination by Sponsor|0|||
106165291|NCT04032704|366268067|FG003|Part B|Study termination by Sponsor|0|||
106165292|NCT04032704|366268068|FG004|Part B|Study termination by Sponsor|0|||
106165293|NCT04032704|366268069|FG005|Part B|Study termination by Sponsor|0|||
106165294|NCT04032704|366268070|FG006|Part B|Study termination by Sponsor|0|||
106165295|NCT04032704|366268071|FG007|Part B|Study termination by Sponsor|0|||
106165296|NCT04032704|366268072|FG008|Part B|Study termination by Sponsor|1|||
106165297|NCT04032704|366268073|FG009|Part B|Study termination by Sponsor|0|||
106165298|NCT04032704|366268074|FG010|Part B|Study termination by Sponsor|0|||
106165299|NCT04032704|366268075|FG011|Part B|Study termination by Sponsor|0|||
106165300|NCT04032704|366268076|FG012|Part B|Study termination by Sponsor|0|||
106165301|NCT04032704|366268077|FG013|Part B|Study termination by Sponsor|0|||
106165302|NCT04032704|366268078|FG014|Part B|Study termination by Sponsor|0|||
106165303|NCT04032704|366268079|FG015|Part B|Study termination by Sponsor|0|||
106165304|NCT04032704|366268080|FG016|Part B|Study termination by Sponsor|0|||
106165305|NCT04032704|366268081|FG017|Part B|Study termination by Sponsor|0|||
106165306|NCT04032704|366268064|FG000|Part B|Withdrawal by Subject|0|||
106165307|NCT04032704|366268065|FG001|Part B|Withdrawal by Subject|0|||
106165308|NCT04032704|366268066|FG002|Part B|Withdrawal by Subject|0|||
106165309|NCT04032704|366268067|FG003|Part B|Withdrawal by Subject|0|||
106165310|NCT04032704|366268068|FG004|Part B|Withdrawal by Subject|0|||
106165311|NCT04032704|366268069|FG005|Part B|Withdrawal by Subject|0|||
106165312|NCT04032704|366268070|FG006|Part B|Withdrawal by Subject|3|||
106165313|NCT04032704|366268071|FG007|Part B|Withdrawal by Subject|2|||
106165314|NCT04032704|366268072|FG008|Part B|Withdrawal by Subject|2|||
106165315|NCT04032704|366268073|FG009|Part B|Withdrawal by Subject|1|||
106165316|NCT04032704|366268074|FG010|Part B|Withdrawal by Subject|4|||
106165317|NCT04032704|366268075|FG011|Part B|Withdrawal by Subject|6|||
106165318|NCT04032704|366268076|FG012|Part B|Withdrawal by Subject|2|||
106165319|NCT04032704|366268077|FG013|Part B|Withdrawal by Subject|1|||
106165320|NCT04032704|366268078|FG014|Part B|Withdrawal by Subject|0|||
106165321|NCT04032704|366268079|FG015|Part B|Withdrawal by Subject|1|||
106165322|NCT04032704|366268080|FG016|Part B|Withdrawal by Subject|0|||
106165323|NCT04032704|366268081|FG017|Part B|Withdrawal by Subject|0|||
106165324|NCT04032704|366268064|FG000|Part B|Lost to Follow-up|0|||
106165325|NCT04032704|366268065|FG001|Part B|Lost to Follow-up|0|||
106165326|NCT04032704|366268066|FG002|Part B|Lost to Follow-up|0|||
106165327|NCT04032704|366268067|FG003|Part B|Lost to Follow-up|0|||
106165328|NCT04032704|366268068|FG004|Part B|Lost to Follow-up|0|||
106165329|NCT04032704|366268069|FG005|Part B|Lost to Follow-up|0|||
106165330|NCT04032704|366268070|FG006|Part B|Lost to Follow-up|0|||
106165331|NCT04032704|366268071|FG007|Part B|Lost to Follow-up|0|||
106165332|NCT04032704|366268072|FG008|Part B|Lost to Follow-up|0|||
106165333|NCT04032704|366268073|FG009|Part B|Lost to Follow-up|0|||
106165334|NCT04032704|366268074|FG010|Part B|Lost to Follow-up|0|||
106165335|NCT04032704|366268075|FG011|Part B|Lost to Follow-up|1|||
106165336|NCT04032704|366268076|FG012|Part B|Lost to Follow-up|0|||
106165337|NCT04032704|366268077|FG013|Part B|Lost to Follow-up|0|||
106165338|NCT04032704|366268078|FG014|Part B|Lost to Follow-up|0|||
106165339|NCT04032704|366268079|FG015|Part B|Lost to Follow-up|0|||
106165340|NCT04032704|366268080|FG016|Part B|Lost to Follow-up|0|||
106165341|NCT04032704|366268081|FG017|Part B|Lost to Follow-up|0|||
106165342|NCT04032704|366268064|FG000|Part B|Death|0|||
106165343|NCT04032704|366268065|FG001|Part B|Death|0|||
106165344|NCT04032704|366268066|FG002|Part B|Death|0|||
106165345|NCT04032704|366268067|FG003|Part B|Death|0|||
106165346|NCT04032704|366268068|FG004|Part B|Death|0|||
106165347|NCT04032704|366268069|FG005|Part B|Death|0|||
106165348|NCT04032704|366268070|FG006|Part B|Death|13|||
106165349|NCT04032704|366268071|FG007|Part B|Death|13|||
106165350|NCT04032704|366268072|FG008|Part B|Death|14|||
106165351|NCT04032704|366268073|FG009|Part B|Death|12|||
106165352|NCT04032704|366268074|FG010|Part B|Death|12|||
106165353|NCT04032704|366268075|FG011|Part B|Death|13|||
106165354|NCT04032704|366268076|FG012|Part B|Death|7|||
106165355|NCT04032704|366268077|FG013|Part B|Death|17|||
106165356|NCT04032704|366268078|FG014|Part B|Death|2|||
106165357|NCT04032704|366268079|FG015|Part B|Death|1|||
106165358|NCT04032704|366268080|FG016|Part B|Death|2|||
106165359|NCT04032704|366268081|FG017|Part B|Death|2|||
106165360|NCT02861300|366268085|FG000|Overall Study|Death|0|||
106165361|NCT02861300|366268086|FG001|Overall Study|Death|0|||
106165362|NCT02861300|366268087|FG002|Overall Study|Death|0|||
106165363|NCT02861300|366268088|FG003|Overall Study|Death|0|||
106165364|NCT02861300|366268089|FG004|Overall Study|Death|0|||
106165365|NCT02861300|366268090|FG005|Overall Study|Death|0|||
106165366|NCT02861300|366268091|FG006|Overall Study|Death|24|||
106165367|NCT02861300|366268085|FG000|Overall Study|Delay in treatment|0|||
106165368|NCT02861300|366268086|FG001|Overall Study|Delay in treatment|0|||
106165369|NCT02861300|366268087|FG002|Overall Study|Delay in treatment|0|||
106165370|NCT02861300|366268088|FG003|Overall Study|Delay in treatment|0|||
106165371|NCT02861300|366268089|FG004|Overall Study|Delay in treatment|0|||
106165372|NCT02861300|366268090|FG005|Overall Study|Delay in treatment|1|||
106165373|NCT02861300|366268091|FG006|Overall Study|Delay in treatment|0|||
106165374|NCT02861300|366268085|FG000|Overall Study|Disease Progression|0|||
106165375|NCT02861300|366268086|FG001|Overall Study|Disease Progression|1|||
106165376|NCT02861300|366268087|FG002|Overall Study|Disease Progression|0|||
106165377|NCT02861300|366268088|FG003|Overall Study|Disease Progression|0|||
106165378|NCT02861300|366268089|FG004|Overall Study|Disease Progression|0|||
106165379|NCT02861300|366268090|FG005|Overall Study|Disease Progression|0|||
106165380|NCT02861300|366268091|FG006|Overall Study|Disease Progression|2|||
106165381|NCT02861300|366268085|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
106165382|NCT02861300|366268086|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
106165383|NCT02861300|366268087|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
106165384|NCT02861300|366268088|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
106165385|NCT02861300|366268089|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
106165386|NCT02861300|366268090|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
106165387|NCT02861300|366268091|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
106165388|NCT02861300|366268085|FG000|Overall Study|Clinical Complications|0|||
106165389|NCT02861300|366268086|FG001|Overall Study|Clinical Complications|0|||
106165390|NCT02861300|366268087|FG002|Overall Study|Clinical Complications|0|||
106165391|NCT02861300|366268088|FG003|Overall Study|Clinical Complications|0|||
106165392|NCT02861300|366268089|FG004|Overall Study|Clinical Complications|0|||
106165393|NCT02861300|366268090|FG005|Overall Study|Clinical Complications|0|||
106165394|NCT02861300|366268091|FG006|Overall Study|Clinical Complications|1|||
106165395|NCT02465268|366268092|FG000|Overall Study|Withdrawal by Subject|4|||
106165396|NCT02465268|366268093|FG001|Overall Study|Withdrawal by Subject|3|||
106165397|NCT02465268|366268094|FG002|Overall Study|Withdrawal by Subject|1|||
106165398|NCT02465268|366268092|FG000|Overall Study|Not evaluable per protocol criteria|3|||
106165399|NCT02465268|366268093|FG001|Overall Study|Not evaluable per protocol criteria|2|||
106165400|NCT02465268|366268094|FG002|Overall Study|Not evaluable per protocol criteria|1|||
106165401|NCT02465268|366268092|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
106165402|NCT02465268|366268093|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
106165403|NCT02465268|366268094|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
106165404|NCT02465268|366268092|FG000|Overall Study|Study drug did not pass QA/QC|1|||
106165405|NCT02465268|366268093|FG001|Overall Study|Study drug did not pass QA/QC|0|||
106165406|NCT02465268|366268094|FG002|Overall Study|Study drug did not pass QA/QC|0|||
106165407|NCT02465268|366268092|FG000|Overall Study|Adverse Event|0|||
106165408|NCT02465268|366268093|FG001|Overall Study|Adverse Event|1|||
106165409|NCT02465268|366268094|FG002|Overall Study|Adverse Event|0|||
106165410|NCT02465268|366268092|FG000|Overall Study|Physician Decision|0|||
106165411|NCT02465268|366268093|FG001|Overall Study|Physician Decision|1|||
106165412|NCT02465268|366268094|FG002|Overall Study|Physician Decision|0|||
106165413|NCT02365467|366268095|FG000|Overall Study|Death|3|||
106165414|NCT03252847|366268096|FG000|Overall Study|Withdrawal by Subject|0|||
106165415|NCT03252847|366268097|FG001|Overall Study|Withdrawal by Subject|0|||
106165416|NCT03252847|366268098|FG002|Overall Study|Withdrawal by Subject|1|||
106165417|NCT03252847|366268099|FG003|Overall Study|Withdrawal by Subject|0|||
106165418|NCT03252847|366268100|FG004|Overall Study|Withdrawal by Subject|0|||
106165419|NCT03252847|366268101|FG005|Overall Study|Withdrawal by Subject|0|||
106165420|NCT03252847|366268102|FG006|Overall Study|Withdrawal by Subject|0|||
106165421|NCT03252847|366268096|FG000|Overall Study|Other: Patient decision|0|||
106165422|NCT03252847|366268097|FG001|Overall Study|Other: Patient decision|0|||
106165423|NCT03252847|366268098|FG002|Overall Study|Other: Patient decision|0|||
106165424|NCT03252847|366268099|FG003|Overall Study|Other: Patient decision|0|||
106165425|NCT03252847|366268100|FG004|Overall Study|Other: Patient decision|1|||
106165426|NCT03252847|366268101|FG005|Overall Study|Other: Patient decision|0|||
106165427|NCT03252847|366268102|FG006|Overall Study|Other: Patient decision|0|||
106165428|NCT03133546|366268107|FG000|Overall Study|Death|46|||
106165429|NCT03133546|366268108|FG001|Overall Study|Death|43|||
106165430|NCT03133546|366268107|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
106165431|NCT03133546|366268108|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
106165432|NCT00736723|366268112|FG000|Overall Study|Withdrawal by Subject|4|||
106165433|NCT00736723|366268113|FG001|Overall Study|Withdrawal by Subject|3|||
106165434|NCT03492216|366268114|FG000|Overall Study|Death|1|||
106165435|NCT03492216|366268115|FG001|Overall Study|Death|0|||
106165436|NCT03492216|366268116|FG002|Overall Study|Death|4|||
106165437|NCT03492216|366268117|FG003|Overall Study|Death|0|||
106165438|NCT03492216|366268114|FG000|Overall Study|Withdrawal by Subject|5|||
106165439|NCT03492216|366268115|FG001|Overall Study|Withdrawal by Subject|3|||
106165440|NCT03492216|366268116|FG002|Overall Study|Withdrawal by Subject|1|||
106165441|NCT03492216|366268117|FG003|Overall Study|Withdrawal by Subject|1|||
106165442|NCT03492216|366268114|FG000|Overall Study|Lost to Follow-up|9|||
106165443|NCT03492216|366268115|FG001|Overall Study|Lost to Follow-up|2|||
106165444|NCT03492216|366268116|FG002|Overall Study|Lost to Follow-up|7|||
106165445|NCT03492216|366268117|FG003|Overall Study|Lost to Follow-up|8|||
106165446|NCT03492216|366268114|FG000|Overall Study|Moved|5|||
106165447|NCT03492216|366268115|FG001|Overall Study|Moved|3|||
106165448|NCT03492216|366268116|FG002|Overall Study|Moved|3|||
106165449|NCT03492216|366268117|FG003|Overall Study|Moved|5|||
106165450|NCT03492216|366268114|FG000|Overall Study|Too ill|0|||
106165451|NCT03492216|366268115|FG001|Overall Study|Too ill|1|||
106165452|NCT03492216|366268116|FG002|Overall Study|Too ill|0|||
106165453|NCT03492216|366268117|FG003|Overall Study|Too ill|0|||
106165454|NCT03492216|366268114|FG000|Overall Study|Incarcerated|0|||
106165455|NCT03492216|366268115|FG001|Overall Study|Incarcerated|0|||
106165456|NCT03492216|366268116|FG002|Overall Study|Incarcerated|2|||
106165457|NCT03492216|366268117|FG003|Overall Study|Incarcerated|0|||
106165458|NCT05566639|366268124|FG000|Overall Study|Adverse Event|1|||
106165459|NCT05566639|366268125|FG001|Overall Study|Adverse Event|1|||
106165460|NCT05566639|366268124|FG000|Overall Study|Serious Adverse Event|1|||
106165461|NCT05566639|366268125|FG001|Overall Study|Serious Adverse Event|3|||
106165462|NCT05566639|366268124|FG000|Overall Study|Death|44|||
106165463|NCT05566639|366268125|FG001|Overall Study|Death|45|||
106165464|NCT05566639|366268124|FG000|Overall Study|Lost to Follow-up|467|||
106165465|NCT05566639|366268125|FG001|Overall Study|Lost to Follow-up|461|||
106165466|NCT05566639|366268124|FG000|Overall Study|Physician Decision|45|||
106165467|NCT05566639|366268125|FG001|Overall Study|Physician Decision|44|||
106165468|NCT05566639|366268124|FG000|Overall Study|Protocol Deviation|4|||
106165469|NCT05566639|366268125|FG001|Overall Study|Protocol Deviation|4|||
106165470|NCT05566639|366268124|FG000|Overall Study|Withdrawal by Subject|277|||
106165471|NCT05566639|366268125|FG001|Overall Study|Withdrawal by Subject|271|||
106165472|NCT05566639|366268124|FG000|Overall Study|Other Than Specified|52|||
106165473|NCT05566639|366268125|FG001|Overall Study|Other Than Specified|64|||
106165474|NCT02364557|366268127|FG000|Overall Study|Protocol Violation|3|||
106165475|NCT02364557|366268128|FG001|Overall Study|Protocol Violation|1|||
106165476|NCT03785964|366268130|FG000|Overall Study|Adverse Event|14|||
106165477|NCT03785964|366268131|FG001|Overall Study|Adverse Event|1|||
106165478|NCT03785964|366268130|FG000|Overall Study|Unqualified Clinical Progression|1|||
106165479|NCT03785964|366268131|FG001|Overall Study|Unqualified Clinical Progression|1|||
106165480|NCT03785964|366268130|FG000|Overall Study|Participant non-compliance|1|||
106165481|NCT03785964|366268131|FG001|Overall Study|Participant non-compliance|1|||
106165482|NCT03785964|366268130|FG000|Overall Study|Not treated|1|||
106165483|NCT03785964|366268131|FG001|Overall Study|Not treated|0|||
106165484|NCT03785964|366268130|FG000|Overall Study|Other reason|5|||
106165485|NCT03785964|366268131|FG001|Overall Study|Other reason|11|||
106165486|NCT03785964|366268130|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
106165487|NCT03785964|366268131|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
106165488|NCT04550221|366268132|FG000|Overall Study|Lost to Follow-up|0|||
106165489|NCT04550221|366268133|FG001|Overall Study|Lost to Follow-up|4|||
106165490|NCT04550221|366268132|FG000|Overall Study|Withdrawn|3|||
106165491|NCT04550221|366268133|FG001|Overall Study|Withdrawn|0|||
106165492|NCT04550221|366268132|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
106165493|NCT04550221|366268133|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
106165494|NCT00686335|366269628|FG000|Run-in Period|Adverse Event|1|||
106165495|NCT00686335|366269628|FG000|Run-in Period|asthma exacerbation|1|||
106165496|NCT00686335|366269628|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
106165497|NCT03668236|366269629|FG000|90-day Follow-up|Withdrawal by Subject|3|||
106165498|NCT03668236|366269630|FG001|90-day Follow-up|Withdrawal by Subject|2|||
106165499|NCT03668236|366269629|FG000|90-day Follow-up|Lost to Follow-up|3|||
106165500|NCT03668236|366269630|FG001|90-day Follow-up|Lost to Follow-up|1|||
106165501|NCT03668236|366269629|FG000|Baseline Characteristics|Lost to Follow-up|9|||
106165502|NCT03668236|366269630|FG001|Baseline Characteristics|Lost to Follow-up|5|||
106165503|NCT03668236|366269629|FG000|1-year Follow-up|Withdrawal by Subject|17|||
106165504|NCT03668236|366269630|FG001|1-year Follow-up|Withdrawal by Subject|15|||
106165505|NCT03748953|366269631|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
106165506|NCT03748953|366269632|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
106165507|NCT03748953|366269631|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
106165508|NCT03748953|366269632|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
106165509|NCT03748953|366269631|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
106165510|NCT03748953|366269632|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
106165511|NCT03748953|366269631|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
106165512|NCT03748953|366269632|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
106165513|NCT03748953|366269631|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
106165514|NCT03748953|366269632|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
106165515|NCT02276885|366269633|FG000|Overall Study|Withdrawal by Subject|2|||
106165516|NCT02276885|366269634|FG001|Overall Study|Withdrawal by Subject|0|||
106165517|NCT02276885|366269633|FG000|Overall Study|Lost to Follow-up|5|||
106165518|NCT02276885|366269634|FG001|Overall Study|Lost to Follow-up|2|||
106165519|NCT05672069|366269635|FG000|Overall Study|Implant removal|1|||
106165520|NCT05672069|366269635|FG000|Overall Study|Lost to Follow-up|2|||
106165521|NCT02191618|366269640|FG000|Overall Study|Withdrawal by Subject|3|||
106165522|NCT02191618|366269640|FG000|Overall Study|Missed Visit|4|||
106165523|NCT01593917|366269641|FG000|Overall Study|Death|67|||
106165524|NCT01593917|366269641|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
106165525|NCT01593917|366269641|FG000|Overall Study|Withdrawal by Subject|23|||
106165526|NCT01593917|366269641|FG000|Overall Study|Lost to Follow-up|12|||
106165527|NCT01593917|366269641|FG000|Overall Study|Protocol Violation|5|||
106165528|NCT01593917|366269641|FG000|Overall Study|Physician Decision|3|||
106165529|NCT04171141|366269642|FG000|Overall Study|Adverse Event|0|||
106165530|NCT04171141|366269643|FG001|Overall Study|Adverse Event|0|||
106165531|NCT04171141|366269644|FG002|Overall Study|Adverse Event|2|||
106165532|NCT04171141|366269645|FG003|Overall Study|Adverse Event|0|||
106165533|NCT04171141|366269646|FG004|Overall Study|Adverse Event|0|||
106165534|NCT04171141|366269647|FG005|Overall Study|Adverse Event|0|||
106165535|NCT04171141|366269648|FG006|Overall Study|Adverse Event|0|||
106165536|NCT04171141|366269649|FG007|Overall Study|Adverse Event|0|||
106165537|NCT04171141|366269650|FG008|Overall Study|Adverse Event|0|||
106165538|NCT04171141|366269651|FG009|Overall Study|Adverse Event|0|||
106165539|NCT04171141|366269652|FG010|Overall Study|Adverse Event|0|||
106165540|NCT04171141|366269653|FG011|Overall Study|Adverse Event|0|||
106165541|NCT04171141|366269654|FG012|Overall Study|Adverse Event|0|||
106165542|NCT04171141|366269655|FG013|Overall Study|Adverse Event|2|||
106165543|NCT04171141|366269656|FG014|Overall Study|Adverse Event|0|||
106165544|NCT04171141|366269657|FG015|Overall Study|Adverse Event|0|||
106165545|NCT04171141|366269642|FG000|Overall Study|Physician Decision|0|||
106165546|NCT04171141|366269643|FG001|Overall Study|Physician Decision|0|||
106165547|NCT04171141|366269644|FG002|Overall Study|Physician Decision|0|||
106165548|NCT04171141|366269645|FG003|Overall Study|Physician Decision|0|||
106165549|NCT04171141|366269646|FG004|Overall Study|Physician Decision|1|||
106165550|NCT04171141|366269647|FG005|Overall Study|Physician Decision|0|||
106165551|NCT04171141|366269648|FG006|Overall Study|Physician Decision|0|||
106165552|NCT04171141|366269649|FG007|Overall Study|Physician Decision|0|||
106165553|NCT04171141|366269650|FG008|Overall Study|Physician Decision|0|||
106165554|NCT04171141|366269651|FG009|Overall Study|Physician Decision|0|||
106165555|NCT04171141|366269652|FG010|Overall Study|Physician Decision|0|||
106165556|NCT04171141|366269653|FG011|Overall Study|Physician Decision|0|||
106165557|NCT04171141|366269654|FG012|Overall Study|Physician Decision|0|||
106165558|NCT04171141|366269655|FG013|Overall Study|Physician Decision|0|||
106165559|NCT04171141|366269656|FG014|Overall Study|Physician Decision|0|||
106165560|NCT04171141|366269657|FG015|Overall Study|Physician Decision|1|||
106165561|NCT04171141|366269642|FG000|Overall Study|Progressive disease|2|||
106165562|NCT04171141|366269643|FG001|Overall Study|Progressive disease|3|||
106165563|NCT04171141|366269644|FG002|Overall Study|Progressive disease|4|||
106165564|NCT04171141|366269645|FG003|Overall Study|Progressive disease|7|||
106165565|NCT04171141|366269646|FG004|Overall Study|Progressive disease|1|||
106165566|NCT04171141|366269647|FG005|Overall Study|Progressive disease|8|||
106165567|NCT04171141|366269648|FG006|Overall Study|Progressive disease|4|||
106165568|NCT04171141|366269649|FG007|Overall Study|Progressive disease|6|||
106165569|NCT04171141|366269650|FG008|Overall Study|Progressive disease|7|||
106165570|NCT04171141|366269651|FG009|Overall Study|Progressive disease|3|||
106165571|NCT04171141|366269652|FG010|Overall Study|Progressive disease|4|||
106165572|NCT04171141|366269653|FG011|Overall Study|Progressive disease|3|||
106165573|NCT04171141|366269654|FG012|Overall Study|Progressive disease|4|||
106165574|NCT04171141|366269655|FG013|Overall Study|Progressive disease|2|||
106165575|NCT04171141|366269656|FG014|Overall Study|Progressive disease|4|||
106165576|NCT04171141|366269657|FG015|Overall Study|Progressive disease|1|||
106165577|NCT04171141|366269642|FG000|Overall Study|Withdrawal by Subject|0|||
106165578|NCT04171141|366269643|FG001|Overall Study|Withdrawal by Subject|0|||
106165579|NCT04171141|366269644|FG002|Overall Study|Withdrawal by Subject|0|||
106165580|NCT04171141|366269645|FG003|Overall Study|Withdrawal by Subject|1|||
106165581|NCT04171141|366269646|FG004|Overall Study|Withdrawal by Subject|0|||
106165582|NCT04171141|366269647|FG005|Overall Study|Withdrawal by Subject|0|||
106165583|NCT04171141|366269648|FG006|Overall Study|Withdrawal by Subject|1|||
106165584|NCT04171141|366269649|FG007|Overall Study|Withdrawal by Subject|0|||
106165585|NCT04171141|366269650|FG008|Overall Study|Withdrawal by Subject|0|||
106165586|NCT04171141|366269651|FG009|Overall Study|Withdrawal by Subject|1|||
106165587|NCT04171141|366269652|FG010|Overall Study|Withdrawal by Subject|0|||
106165588|NCT04171141|366269653|FG011|Overall Study|Withdrawal by Subject|0|||
106165589|NCT04171141|366269654|FG012|Overall Study|Withdrawal by Subject|0|||
106165590|NCT04171141|366269655|FG013|Overall Study|Withdrawal by Subject|0|||
106165591|NCT04171141|366269656|FG014|Overall Study|Withdrawal by Subject|0|||
106165592|NCT04171141|366269657|FG015|Overall Study|Withdrawal by Subject|0|||
106165593|NCT04171141|366269642|FG000|Overall Study|Global deterioration of health status|0|||
106165594|NCT04171141|366269643|FG001|Overall Study|Global deterioration of health status|0|||
106165595|NCT04171141|366269644|FG002|Overall Study|Global deterioration of health status|0|||
106165596|NCT04171141|366269645|FG003|Overall Study|Global deterioration of health status|1|||
106165597|NCT04171141|366269646|FG004|Overall Study|Global deterioration of health status|0|||
106165598|NCT04171141|366269647|FG005|Overall Study|Global deterioration of health status|2|||
106165599|NCT04171141|366269648|FG006|Overall Study|Global deterioration of health status|1|||
106165600|NCT04171141|366269649|FG007|Overall Study|Global deterioration of health status|0|||
106165601|NCT04171141|366269650|FG008|Overall Study|Global deterioration of health status|1|||
106165602|NCT04171141|366269651|FG009|Overall Study|Global deterioration of health status|0|||
106165603|NCT04171141|366269652|FG010|Overall Study|Global deterioration of health status|0|||
106165604|NCT04171141|366269653|FG011|Overall Study|Global deterioration of health status|0|||
106165605|NCT04171141|366269654|FG012|Overall Study|Global deterioration of health status|0|||
106165606|NCT04171141|366269655|FG013|Overall Study|Global deterioration of health status|0|||
106165607|NCT04171141|366269656|FG014|Overall Study|Global deterioration of health status|1|||
106165608|NCT04171141|366269657|FG015|Overall Study|Global deterioration of health status|1|||
106165609|NCT04908397|366269658|FG000|Overall Study|Withdrawal by Subject|2|||
106165610|NCT01943409|366269659|FG000|Overall Study|resumed oral/entral|24|||
106165611|NCT01943409|366269660|FG001|Overall Study|resumed oral/entral|20|||
106165612|NCT01943409|366269659|FG000|Overall Study|Protocol Violation|14|||
106165613|NCT01943409|366269660|FG001|Overall Study|Protocol Violation|24|||
106165614|NCT01943409|366269659|FG000|Overall Study|Death|3|||
106165615|NCT01943409|366269660|FG001|Overall Study|Death|1|||
106165616|NCT01943409|366269659|FG000|Overall Study|Withdrawal by Subject|4|||
106165617|NCT01943409|366269660|FG001|Overall Study|Withdrawal by Subject|3|||
106165618|NCT04413708|366269664|FG000|Overall Study|Lost to Follow-up|1|||
106165619|NCT04413708|366269665|FG001|Overall Study|Lost to Follow-up|2|||
106165620|NCT05270408|366269666|FG000|Started Treatment|Withdrawal by Subject|0|||
106165621|NCT05270408|366269667|FG001|Started Treatment|Withdrawal by Subject|0|||
106165622|NCT05270408|366269668|FG002|Started Treatment|Withdrawal by Subject|3|||
106165623|NCT05270408|366269666|FG000|Started Treatment|Adverse Event|0|||
106165624|NCT05270408|366269667|FG001|Started Treatment|Adverse Event|0|||
106165625|NCT05270408|366269668|FG002|Started Treatment|Adverse Event|1|||
106165626|NCT05270408|366269666|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
106165627|NCT05270408|366269667|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
106165628|NCT05270408|366269668|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
106165629|NCT01501955|366269670|FG000|Overall Study|Withdrawal by Subject|1|||
106165630|NCT01501955|366269671|FG001|Overall Study|Withdrawal by Subject|0|||
106165631|NCT01501955|366269670|FG000|Overall Study|Adverse Event|1|||
106165632|NCT01501955|366269671|FG001|Overall Study|Adverse Event|3|||
106165633|NCT04298983|366269679|FG000|Overall Study|Adverse Event|4|||
106165634|NCT04298983|366269679|FG000|Overall Study|Lack of Efficacy|3|||
106165635|NCT04005794|366269682|FG000|Overall Study|Lost to Follow-up|0|||
106165636|NCT04005794|366269683|FG001|Overall Study|Lost to Follow-up|4|||
106165637|NCT04005794|366269684|FG002|Overall Study|Lost to Follow-up|0|||
106165638|NCT04313972|366269687|FG000|Overall Study|Withdrawal by Subject|0|||
106165639|NCT04313972|366269688|FG001|Overall Study|Withdrawal by Subject|1|||
106165640|NCT05877976|366269689|FG000|Overall Study|Lost to Follow-up|31|||
106165641|NCT02547363|366269690|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
106165642|NCT02547363|366269691|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
106165643|NCT02547363|366269690|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
106165644|NCT02547363|366269691|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
106165645|NCT02547363|366269690|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
106165646|NCT02547363|366269691|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
106165647|NCT02547363|366269690|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
106165648|NCT02547363|366269691|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
106165649|NCT02547363|366269690|FG000|12-month Follow-up|Withdrawal by Subject|4|||
106165650|NCT02547363|366269691|FG001|12-month Follow-up|Withdrawal by Subject|3|||
106165651|NCT02547363|366269690|FG000|12-month Follow-up|Lost to Follow-up|4|||
106165652|NCT02547363|366269691|FG001|12-month Follow-up|Lost to Follow-up|1|||
106165653|NCT02547363|366269690|FG000|12-month Follow-up|Lack of Efficacy|1|||
106165654|NCT02547363|366269691|FG001|12-month Follow-up|Lack of Efficacy|1|||
106165655|NCT02547363|366269690|FG000|12-month Follow-up|Other|1|||
106165656|NCT02547363|366269691|FG001|12-month Follow-up|Other|0|||
106165657|NCT00248287|366269693|FG000|Overall Study|Adverse Event|11|||
106165658|NCT00248287|366269694|FG001|Overall Study|Adverse Event|10|||
106165659|NCT00248287|366269693|FG000|Overall Study|Death|1|||
106165660|NCT00248287|366269694|FG001|Overall Study|Death|0|||
106165661|NCT00248287|366269693|FG000|Overall Study|Lost to Follow-up|0|||
106165662|NCT00248287|366269694|FG001|Overall Study|Lost to Follow-up|1|||
106165663|NCT00248287|366269693|FG000|Overall Study|Investigator Request|4|||
106165664|NCT00248287|366269694|FG001|Overall Study|Investigator Request|3|||
106165665|NCT00248287|366269693|FG000|Overall Study|Patient Request|5|||
106165666|NCT00248287|366269694|FG001|Overall Study|Patient Request|3|||
106165667|NCT00248287|366269693|FG000|Overall Study|Other|3|||
106165668|NCT00248287|366269694|FG001|Overall Study|Other|2|||
106165669|NCT02714257|366269695|FG000|Overall Study|Withdrawal by Subject|6|||
106165670|NCT02714257|366269696|FG001|Overall Study|Withdrawal by Subject|11|||
106165671|NCT02714257|366269695|FG000|Overall Study|Death|3|||
106165672|NCT02714257|366269696|FG001|Overall Study|Death|4|||
106165673|NCT02714257|366269695|FG000|Overall Study|Lost to Follow-up|1|||
106165674|NCT02714257|366269696|FG001|Overall Study|Lost to Follow-up|6|||
106165675|NCT05201079|366269697|FG000|Overall Study|Adverse Event|7|||
106165676|NCT05201079|366269698|FG001|Overall Study|Adverse Event|11|||
106165677|NCT05201079|366269697|FG000|Overall Study|Death|1|||
106165678|NCT05201079|366269698|FG001|Overall Study|Death|1|||
106165679|NCT05201079|366269697|FG000|Overall Study|Lack of Efficacy|0|||
106165680|NCT05201079|366269698|FG001|Overall Study|Lack of Efficacy|2|||
106165681|NCT05201079|366269697|FG000|Overall Study|Lost to Follow-up|0|||
106165682|NCT05201079|366269698|FG001|Overall Study|Lost to Follow-up|1|||
106165683|NCT05201079|366269697|FG000|Overall Study|Physician Decision|1|||
106165684|NCT05201079|366269698|FG001|Overall Study|Physician Decision|1|||
106165685|NCT05201079|366269697|FG000|Overall Study|Protocol Violation|1|||
106165686|NCT05201079|366269698|FG001|Overall Study|Protocol Violation|0|||
106165687|NCT05201079|366269697|FG000|Overall Study|Withdrawal by Subject|1|||
106165688|NCT05201079|366269698|FG001|Overall Study|Withdrawal by Subject|0|||
106165689|NCT05201079|366269697|FG000|Overall Study|Forbidden medication|9|||
106165690|NCT05201079|366269698|FG001|Overall Study|Forbidden medication|5|||
106165691|NCT05201079|366269697|FG000|Overall Study|Transfer to another hospital|0|||
106165692|NCT05201079|366269698|FG001|Overall Study|Transfer to another hospital|1|||
106165693|NCT05201079|366269697|FG000|Overall Study|Clinical condition|1|||
106165694|NCT05201079|366269698|FG001|Overall Study|Clinical condition|0|||
106165695|NCT05201079|366269697|FG000|Overall Study|SAE and sepsis|1|||
106165696|NCT05201079|366269698|FG001|Overall Study|SAE and sepsis|0|||
106165697|NCT01210807|366269707|FG000|Overall Study|Lost to Follow-up|1|||
106165698|NCT01210807|366269708|FG001|Overall Study|Lost to Follow-up|2|||
106165699|NCT01210807|366269707|FG000|Overall Study|Not implanted bilaterally|2|||
106165700|NCT01210807|366269708|FG001|Overall Study|Not implanted bilaterally|1|||
106165701|NCT05281562|366269710|FG000|Overall Study|Ineligible patient|1|||
106165702|NCT05281562|366269711|FG001|Overall Study|Ineligible patient|0|||
106165703|NCT06457802|366269713|FG000|Overall Study|Early termination of study prior to participant completion|2|||
106165704|NCT06457802|366269714|FG001|Overall Study|Early termination of study prior to participant completion|2|||
106165705|NCT05386030|366269716|FG000|Overall Study|Death|1|||
106165706|NCT05386030|366269717|FG001|Overall Study|Death|0|||
106165707|NCT05386030|366269716|FG000|Overall Study|Physician Decision|2|||
106165708|NCT05386030|366269717|FG001|Overall Study|Physician Decision|1|||
106165709|NCT05386030|366269716|FG000|Overall Study|Lost to Follow-up|19|||
106165710|NCT05386030|366269717|FG001|Overall Study|Lost to Follow-up|7|||
106165711|NCT05386030|366269716|FG000|Overall Study|Withdrawal by Subject|20|||
106165712|NCT05386030|366269717|FG001|Overall Study|Withdrawal by Subject|10|||
106165713|NCT05386030|366269716|FG000|Overall Study|Eligibility criteria violation|1|||
106165714|NCT05386030|366269717|FG001|Overall Study|Eligibility criteria violation|1|||
106165715|NCT05386030|366269716|FG000|Overall Study|Personal Reasons|1|||
106165716|NCT05386030|366269717|FG001|Overall Study|Personal Reasons|0|||
106165717|NCT05940194|366269724|FG000|Overall Study|Adverse Event|0|||
106165718|NCT05940194|366269725|FG001|Overall Study|Adverse Event|1|||
106165719|NCT05940194|366269726|FG002|Overall Study|Adverse Event|0|||
106165720|NCT05940194|366269724|FG000|Overall Study|Migrated/Moved from the study area|2|||
106165721|NCT05940194|366269725|FG001|Overall Study|Migrated/Moved from the study area|2|||
106165722|NCT05940194|366269726|FG002|Overall Study|Migrated/Moved from the study area|4|||
106165723|NCT03024437|366269727|FG000|Overall Study|Adverse Event|0|||
106165724|NCT03024437|366269728|FG001|Overall Study|Adverse Event|1|||
106165725|NCT03024437|366269729|FG002|Overall Study|Adverse Event|3|||
106165726|NCT03024437|366269730|FG003|Overall Study|Adverse Event|5|||
106165727|NCT03024437|366269731|FG004|Overall Study|Adverse Event|0|||
106165728|NCT03024437|366269727|FG000|Overall Study|Physician Decision|1|||
106165729|NCT03024437|366269728|FG001|Overall Study|Physician Decision|0|||
106165730|NCT03024437|366269729|FG002|Overall Study|Physician Decision|0|||
106165731|NCT03024437|366269730|FG003|Overall Study|Physician Decision|1|||
106165732|NCT03024437|366269731|FG004|Overall Study|Physician Decision|0|||
106165733|NCT03024437|366269727|FG000|Overall Study|Disease progression, relapse|1|||
106165734|NCT03024437|366269728|FG001|Overall Study|Disease progression, relapse|0|||
106165735|NCT03024437|366269729|FG002|Overall Study|Disease progression, relapse|0|||
106165736|NCT03024437|366269730|FG003|Overall Study|Disease progression, relapse|3|||
106165737|NCT03024437|366269731|FG004|Overall Study|Disease progression, relapse|0|||
106165738|NCT03024437|366269727|FG000|Overall Study|Disease progression, refractory disease|4|||
106165739|NCT03024437|366269728|FG001|Overall Study|Disease progression, refractory disease|4|||
106165740|NCT03024437|366269729|FG002|Overall Study|Disease progression, refractory disease|2|||
106165741|NCT03024437|366269730|FG003|Overall Study|Disease progression, refractory disease|2|||
106165742|NCT03024437|366269731|FG004|Overall Study|Disease progression, refractory disease|1|||
106165743|NCT03024437|366269727|FG000|Overall Study|Newly diagnosed cancer|0|||
106165744|NCT03024437|366269728|FG001|Overall Study|Newly diagnosed cancer|0|||
106165745|NCT03024437|366269729|FG002|Overall Study|Newly diagnosed cancer|0|||
106165746|NCT03024437|366269730|FG003|Overall Study|Newly diagnosed cancer|1|||
106165747|NCT03024437|366269731|FG004|Overall Study|Newly diagnosed cancer|0|||
106165748|NCT03024437|366269727|FG000|Overall Study|Moved out of state|0|||
106165749|NCT03024437|366269728|FG001|Overall Study|Moved out of state|1|||
106165750|NCT03024437|366269729|FG002|Overall Study|Moved out of state|0|||
106165751|NCT03024437|366269730|FG003|Overall Study|Moved out of state|0|||
106165752|NCT03024437|366269731|FG004|Overall Study|Moved out of state|0|||
106165753|NCT03024437|366269727|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
106165754|NCT03024437|366269728|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
106165755|NCT03024437|366269729|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
106165756|NCT03024437|366269730|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
106165757|NCT03024437|366269731|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
106165758|NCT02606422|366269732|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
106165759|NCT02606422|366269733|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
106165760|NCT02606422|366269732|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
106165761|NCT02606422|366269733|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
106165762|NCT02606422|366269732|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
106165763|NCT02606422|366269733|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
106165764|NCT02606422|366269732|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
106165765|NCT02606422|366269733|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
106165766|NCT02601313|366269734|FG000|Overall Study|Death|2|||
106165767|NCT02601313|366269735|FG001|Overall Study|Death|41|||
106165768|NCT02601313|366269736|FG002|Overall Study|Death|6|||
106165769|NCT02601313|366269734|FG000|Overall Study|Enrolled but never treated|0|||
106165770|NCT02601313|366269735|FG001|Overall Study|Enrolled but never treated|6|||
106165771|NCT02601313|366269736|FG002|Overall Study|Enrolled but never treated|3|||
106165772|NCT02601313|366269734|FG000|Overall Study|Enrolled, did not initiate AC|4|||
106165773|NCT02601313|366269735|FG001|Overall Study|Enrolled, did not initiate AC|0|||
106165774|NCT02601313|366269736|FG002|Overall Study|Enrolled, did not initiate AC|0|||
106165775|NCT02601313|366269734|FG000|Overall Study|Full consent withdrawal|0|||
106165776|NCT02601313|366269735|FG001|Overall Study|Full consent withdrawal|3|||
106165777|NCT02601313|366269736|FG002|Overall Study|Full consent withdrawal|2|||
106165778|NCT02601313|366269734|FG000|Overall Study|Lost to Follow-up|0|||
106165779|NCT02601313|366269735|FG001|Overall Study|Lost to Follow-up|1|||
106165780|NCT02601313|366269736|FG002|Overall Study|Lost to Follow-up|1|||
106165781|NCT04501614|366269737|FG000|Overall Study|Study Terminated by Sponsor|6|||
106165782|NCT04501614|366269738|FG001|Overall Study|Study Terminated by Sponsor|3|||
106165783|NCT04501614|366269737|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
106165784|NCT04501614|366269738|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
106165785|NCT05239455|366269740|FG000|Overall Study|Adverse Event|1|||
106165786|NCT05239455|366269740|FG000|Overall Study|Sponsor Decision|5|||
106165787|NCT05239455|366269740|FG000|Overall Study|Incomplete Blood Collection|1|||
106165788|NCT01799265|366269741|FG000|Overall Study|Lost to Follow-up|1|||
106165789|NCT01799265|366269742|FG001|Overall Study|Lost to Follow-up|0|||
106165790|NCT01799265|366269741|FG000|Overall Study|Protocol Violation|2|||
106165791|NCT01799265|366269742|FG001|Overall Study|Protocol Violation|1|||
106165792|NCT01799265|366269741|FG000|Overall Study|inadequate sleep study|0|||
106165793|NCT01799265|366269742|FG001|Overall Study|inadequate sleep study|2|||
106165794|NCT05704543|366269743|FG000|Overall Study|Withdrawal by Subject|1|||
106165795|NCT05704543|366269744|FG001|Overall Study|Withdrawal by Subject|1|||
106165796|NCT05704543|366269745|FG002|Overall Study|Withdrawal by Subject|0|||
106165797|NCT05704543|366269746|FG003|Overall Study|Withdrawal by Subject|2|||
106165798|NCT05704543|366269743|FG000|Overall Study|Lost to Follow-up|1|||
106165799|NCT05704543|366269744|FG001|Overall Study|Lost to Follow-up|2|||
106165800|NCT05704543|366269745|FG002|Overall Study|Lost to Follow-up|0|||
106165801|NCT05704543|366269746|FG003|Overall Study|Lost to Follow-up|0|||
106165802|NCT04830800|366269749|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
106165803|NCT04830800|366269750|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
106165804|NCT04830800|366269751|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
106165805|NCT04830800|366269752|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
106165806|NCT04830800|366269753|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
106165807|NCT04909801|366269754|FG000|Overall Study|Lack of Efficacy|2|||
106165808|NCT04909801|366269755|FG001|Overall Study|Lack of Efficacy|1|||
106165809|NCT04909801|366269754|FG000|Overall Study|Adverse Event|1|||
106165810|NCT04909801|366269755|FG001|Overall Study|Adverse Event|2|||
106165811|NCT04909801|366269754|FG000|Overall Study|Participant request to discontinue study treatment|1|||
106165812|NCT04909801|366269755|FG001|Overall Study|Participant request to discontinue study treatment|2|||
106165813|NCT04909801|366269754|FG000|Overall Study|Withdrawal by Subject|2|||
106165814|NCT04909801|366269755|FG001|Overall Study|Withdrawal by Subject|1|||
106165815|NCT04909801|366269754|FG000|Overall Study|other reasons|1|||
106165816|NCT04909801|366269755|FG001|Overall Study|other reasons|1|||
106165817|NCT01946789|366269756|FG000|Overall Study|Death|0|||
106165818|NCT01946789|366269757|FG001|Overall Study|Death|2|||
106165819|NCT01946789|366269758|FG002|Overall Study|Death|1|||
106165820|NCT01946789|366269759|FG003|Overall Study|Death|1|||
106165821|NCT01946789|366269760|FG004|Overall Study|Death|1|||
106165822|NCT01946789|366269761|FG005|Overall Study|Death|1|||
106165823|NCT01946789|366269762|FG006|Overall Study|Death|3|||
106165824|NCT01946789|366269763|FG007|Overall Study|Death|1|||
106165825|NCT01946789|366269764|FG008|Overall Study|Death|2|||
106165826|NCT01946789|366269756|FG000|Overall Study|Progressive Disease|0|||
106165827|NCT01946789|366269757|FG001|Overall Study|Progressive Disease|0|||
106165828|NCT01946789|366269758|FG002|Overall Study|Progressive Disease|1|||
106165829|NCT01946789|366269759|FG003|Overall Study|Progressive Disease|0|||
106165830|NCT01946789|366269760|FG004|Overall Study|Progressive Disease|0|||
106165831|NCT01946789|366269761|FG005|Overall Study|Progressive Disease|2|||
106165832|NCT01946789|366269762|FG006|Overall Study|Progressive Disease|0|||
106165833|NCT01946789|366269763|FG007|Overall Study|Progressive Disease|0|||
106165834|NCT01946789|366269764|FG008|Overall Study|Progressive Disease|0|||
106165835|NCT01946789|366269756|FG000|Overall Study|Withdrawal by Subject|0|||
106165836|NCT01946789|366269757|FG001|Overall Study|Withdrawal by Subject|0|||
106165837|NCT01946789|366269758|FG002|Overall Study|Withdrawal by Subject|0|||
106165838|NCT01946789|366269759|FG003|Overall Study|Withdrawal by Subject|2|||
106165839|NCT01946789|366269760|FG004|Overall Study|Withdrawal by Subject|1|||
106165840|NCT01946789|366269761|FG005|Overall Study|Withdrawal by Subject|0|||
106165841|NCT01946789|366269762|FG006|Overall Study|Withdrawal by Subject|1|||
106165842|NCT01946789|366269763|FG007|Overall Study|Withdrawal by Subject|0|||
106165843|NCT01946789|366269764|FG008|Overall Study|Withdrawal by Subject|0|||
106165844|NCT05399485|366271565|FG000|DBT Phase|Other|6|||
106165845|NCT05399485|366271566|FG001|DBT Phase|Other|5|||
106165846|NCT05399485|366271565|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
106165847|NCT05399485|366271566|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
106165848|NCT05399485|366271565|FG000|DBT Phase|Withdrawal by Subject|3|||
106165849|NCT05399485|366271566|FG001|DBT Phase|Withdrawal by Subject|2|||
106165850|NCT05399485|366271565|FG000|DBT Phase|Protocol Violation|2|||
106165851|NCT05399485|366271566|FG001|DBT Phase|Protocol Violation|1|||
106165852|NCT05399485|366271565|FG000|DBT Phase|Physician Decision|0|||
106165853|NCT05399485|366271566|FG001|DBT Phase|Physician Decision|1|||
106165854|NCT05399485|366271565|FG000|DBT Phase|Adverse Event|2|||
106165855|NCT05399485|366271566|FG001|DBT Phase|Adverse Event|1|||
106165856|NCT05399485|366271565|FG000|OLE Phase|Not reported|0|||
106165857|NCT05399485|366271566|FG001|OLE Phase|Not reported|1|||
106165858|NCT05399485|366271565|FG000|OLE Phase|Other|3|||
106165859|NCT05399485|366271566|FG001|OLE Phase|Other|3|||
106165860|NCT05399485|366271565|FG000|OLE Phase|Withdrawal by Subject|8|||
106165861|NCT05399485|366271566|FG001|OLE Phase|Withdrawal by Subject|5|||
106165862|NCT05399485|366271565|FG000|OLE Phase|Pregnancy|0|||
106165863|NCT05399485|366271566|FG001|OLE Phase|Pregnancy|1|||
106165864|NCT05399485|366271565|FG000|OLE Phase|Physician Decision|2|||
106165865|NCT05399485|366271566|FG001|OLE Phase|Physician Decision|0|||
106165866|NCT05399485|366271565|FG000|OLE Phase|Adverse Event|0|||
106165867|NCT05399485|366271566|FG001|OLE Phase|Adverse Event|1|||
106165868|NCT05399485|366271565|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
106165869|NCT05399485|366271566|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
106165870|NCT03287817|366271577|FG000|Overall Study|Progressive disease|4|||
106165871|NCT03287817|366271578|FG001|Overall Study|Progressive disease|2|||
106165872|NCT03287817|366271579|FG002|Overall Study|Progressive disease|3|||
106165873|NCT03287817|366271580|FG003|Overall Study|Progressive disease|10|||
106165874|NCT03287817|366271581|FG004|Overall Study|Progressive disease|8|||
106165875|NCT03287817|366271577|FG000|Overall Study|Death|0|||
106165876|NCT03287817|366271578|FG001|Overall Study|Death|0|||
106165877|NCT03287817|366271579|FG002|Overall Study|Death|2|||
106165878|NCT03287817|366271580|FG003|Overall Study|Death|3|||
106165879|NCT03287817|366271581|FG004|Overall Study|Death|4|||
106165880|NCT03287817|366271577|FG000|Overall Study|Physician Decision|0|||
106165881|NCT03287817|366271578|FG001|Overall Study|Physician Decision|0|||
106165882|NCT03287817|366271579|FG002|Overall Study|Physician Decision|0|||
106165883|NCT03287817|366271580|FG003|Overall Study|Physician Decision|1|||
106165884|NCT03287817|366271581|FG004|Overall Study|Physician Decision|0|||
106165885|NCT03287817|366271577|FG000|Overall Study|Withdrawal by Subject|0|||
106165886|NCT03287817|366271578|FG001|Overall Study|Withdrawal by Subject|0|||
106165887|NCT03287817|366271579|FG002|Overall Study|Withdrawal by Subject|0|||
106165888|NCT03287817|366271580|FG003|Overall Study|Withdrawal by Subject|0|||
106165889|NCT03287817|366271581|FG004|Overall Study|Withdrawal by Subject|4|||
106165890|NCT02696707|366271582|FG000|Per Protocol Population|Physician Decision|2|||
106165891|NCT02696707|366271583|FG001|Per Protocol Population|Physician Decision|1|||
106165892|NCT02696707|366271582|FG000|Per Protocol Population|Participant Decision|0|||
106165893|NCT02696707|366271583|FG001|Per Protocol Population|Participant Decision|2|||
106165894|NCT02696707|366271582|FG000|Completed Study as Planned|Reason = LVEF|2|||
106165895|NCT02696707|366271583|FG001|Completed Study as Planned|Reason = LVEF|2|||
106165896|NCT02696707|366271582|FG000|Completed Study as Planned|Protocol Violation|2|||
106165897|NCT02696707|366271583|FG001|Completed Study as Planned|Protocol Violation|6|||
106165898|NCT02696707|366271582|FG000|Completed Study as Planned|Metastatic disease|3|||
106165899|NCT02696707|366271583|FG001|Completed Study as Planned|Metastatic disease|0|||
106165900|NCT02696707|366271582|FG000|Completed Study as Planned|Location|1|||
106165901|NCT02696707|366271583|FG001|Completed Study as Planned|Location|1|||
106165902|NCT03812679|366271586|FG000|Overall Study|Adverse Event|2|||
106165903|NCT03812679|366271586|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
106165904|NCT03812679|366271586|FG000|Overall Study|Renal transplant|1|||
106165905|NCT03812679|366271586|FG000|Overall Study|Withdrawal by Subject|1|||
106165906|NCT03812679|366271586|FG000|Overall Study|Termination of study|2|||
106165907|NCT03812679|366271586|FG000|Overall Study|Water device replacement|1|||
106165908|NCT05486078|366271587|FG000|Overall Study|4 drop out and one withdrawn|5|||
106165909|NCT01574274|366271588|FG000|Overall Study|Ineligible|0|||
106165910|NCT01574274|366271589|FG001|Overall Study|Ineligible|1|||
106165911|NCT01574274|366271588|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
106165912|NCT01574274|366271589|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
106165913|NCT01574274|366271588|FG000|Overall Study|Ph+ B-ALL|3|||
106165914|NCT01574274|366271589|FG001|Overall Study|Ph+ B-ALL|4|||
106165915|NCT01574274|366271588|FG000|Overall Study|Induction Death|2|||
106165916|NCT01574274|366271589|FG001|Overall Study|Induction Death|0|||
106165917|NCT01574274|366271588|FG000|Overall Study|Induction Failure|4|||
106165918|NCT01574274|366271589|FG001|Overall Study|Induction Failure|1|||
106165919|NCT01574274|366271588|FG000|Overall Study|Adverse Event|16|||
106165920|NCT01574274|366271589|FG001|Overall Study|Adverse Event|13|||
106165921|NCT01574274|366271588|FG000|Overall Study|Remission Death|1|||
106165922|NCT01574274|366271589|FG001|Overall Study|Remission Death|0|||
106165923|NCT01574274|366271588|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
106165924|NCT01574274|366271589|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
106165925|NCT01574274|366271588|FG000|Overall Study|Other, unknown|3|||
106165926|NCT01574274|366271589|FG001|Overall Study|Other, unknown|2|||
106165927|NCT04858451|366271592|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
106165928|NCT04858451|366271593|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
106165929|NCT04858451|366271594|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
106165930|NCT04858451|366271595|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
106165931|NCT04858451|366271596|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
106165932|NCT04858451|366271597|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
106165933|NCT04858451|366271598|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
106165934|NCT04858451|366271599|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
106165935|NCT04858451|366271600|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
106165936|NCT04858451|366271592|FG000|Part 2|Discontinued|0|||
106165937|NCT04858451|366271593|FG001|Part 2|Discontinued|0|||
106165938|NCT04858451|366271594|FG002|Part 2|Discontinued|0|||
106165939|NCT04858451|366271595|FG003|Part 2|Discontinued|0|||
106165940|NCT04858451|366271596|FG004|Part 2|Discontinued|0|||
106165941|NCT04858451|366271597|FG005|Part 2|Discontinued|0|||
106165942|NCT04858451|366271598|FG006|Part 2|Discontinued|0|||
106165943|NCT04858451|366271599|FG007|Part 2|Discontinued|0|||
106165944|NCT04858451|366271600|FG008|Part 2|Discontinued|63|||
106165945|NCT03216057|366271601|FG000|Overall Study|Lost to Follow-up|2|||
106165946|NCT03216057|366271602|FG001|Overall Study|Lost to Follow-up|2|||
106165947|NCT04662931|366271603|FG000|Overall Study|Withdrawal by Subject|17|||
106165948|NCT04662931|366271603|FG000|Overall Study|Death|3|||
106165949|NCT04662931|366271603|FG000|Overall Study|Lost to Follow-up|3|||
106165950|NCT04662931|366271603|FG000|Overall Study|Guardian Decision|1|||
106165951|NCT03768505|366271604|FG000|Overall Study|sponsor decision|76|||
106165952|NCT03768505|366271604|FG000|Overall Study|Death|35|||
106165953|NCT03768505|366271604|FG000|Overall Study|Other -Various|30|||
106165954|NCT03768505|366271604|FG000|Overall Study|Withdrawal by Subject|22|||
105984899|NCT00231413|365605981|FG006|Overall Study|Non-serious AE|1|||
106165955|NCT03768505|366271604|FG000|Overall Study|Lost to Follow-up|6|||
106165956|NCT02815566|366271607|FG000|Overall Study|Adverse Event|1|||
106165957|NCT02815566|366271608|FG001|Overall Study|Adverse Event|1|||
106165958|NCT02815566|366271607|FG000|Overall Study|Withdrawal by Subject|1|||
106165959|NCT02815566|366271608|FG001|Overall Study|Withdrawal by Subject|0|||
106165960|NCT02815566|366271607|FG000|Overall Study|Lost to Follow-up|0|||
106165961|NCT02815566|366271608|FG001|Overall Study|Lost to Follow-up|1|||
106165962|NCT04231149|366271609|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
106165963|NCT04231149|366271610|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
106165964|NCT04231149|366271611|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
106165965|NCT04231149|366271612|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
106165966|NCT04231149|366271613|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
106165967|NCT05034328|366271614|FG000|Overall Study|Protocol Violation|1|||
106165968|NCT05034328|366271615|FG001|Overall Study|Protocol Violation|0|||
106165969|NCT05034328|366271614|FG000|Overall Study|Lost to Follow-up|0|||
106165970|NCT05034328|366271615|FG001|Overall Study|Lost to Follow-up|10|||
106165971|NCT05399459|366271616|FG000|Overall Study|Randomized but not treated|29|||
106165972|NCT05399459|366271617|FG001|Overall Study|Randomized but not treated|30|||
106165973|NCT05399459|366271618|FG002|Overall Study|Randomized but not treated|38|||
106165974|NCT05399459|366271616|FG000|Overall Study|Lost to Follow-up|1|||
106165975|NCT05399459|366271617|FG001|Overall Study|Lost to Follow-up|0|||
106165976|NCT05399459|366271618|FG002|Overall Study|Lost to Follow-up|0|||
106165977|NCT04992520|366271619|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
106165978|NCT04992520|366271620|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
106165979|NCT04992520|366271621|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
106165980|NCT04992520|366271622|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
106165981|NCT04992520|366271623|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
106165982|NCT04992520|366271624|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
106165983|NCT04992520|366271619|FG000|Part A: First Challenge|Non-compliance|0|||
106165984|NCT04992520|366271620|FG001|Part A: First Challenge|Non-compliance|0|||
106165985|NCT04992520|366271621|FG002|Part A: First Challenge|Non-compliance|0|||
106165986|NCT04992520|366271622|FG003|Part A: First Challenge|Non-compliance|1|||
106165987|NCT04992520|366271623|FG004|Part A: First Challenge|Non-compliance|0|||
106165988|NCT04992520|366271624|FG005|Part A: First Challenge|Non-compliance|0|||
106165989|NCT04992520|366271619|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
106165990|NCT04992520|366271620|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
106165991|NCT04992520|366271621|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
106165992|NCT04992520|366271622|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
106165993|NCT04992520|366271623|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
106165994|NCT04992520|366271624|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
106165995|NCT04992520|366271619|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
106165996|NCT04992520|366271620|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
106165997|NCT04992520|366271621|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
106165998|NCT04992520|366271622|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
106165999|NCT04992520|366271623|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
106166000|NCT04992520|366271624|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
106166001|NCT02231164|366271628|FG000|Overall Study|Adverse Event|1|||
106166002|NCT02231164|366271629|FG001|Overall Study|Adverse Event|1|||
106166003|NCT02231164|366271628|FG000|Overall Study|Lack of Efficacy|4|||
106166004|NCT02231164|366271629|FG001|Overall Study|Lack of Efficacy|3|||
106166005|NCT02231164|366271628|FG000|Overall Study|Withdrawal by Subject|1|||
106166006|NCT02231164|366271629|FG001|Overall Study|Withdrawal by Subject|2|||
106166007|NCT02969707|366271631|FG000|Overall Study|Withdrawal by Subject|6|||
106166008|NCT02969707|366271632|FG001|Overall Study|Withdrawal by Subject|5|||
106166009|NCT02969707|366271631|FG000|Overall Study|Severe anxiety|0|||
106166010|NCT02969707|366271632|FG001|Overall Study|Severe anxiety|1|||
106166011|NCT02969707|366271631|FG000|Overall Study|Positive toxicology screen|0|||
106166012|NCT02969707|366271632|FG001|Overall Study|Positive toxicology screen|2|||
106166013|NCT02969707|366271631|FG000|Overall Study|Claustrophobia|2|||
106166014|NCT02969707|366271632|FG001|Overall Study|Claustrophobia|2|||
106166015|NCT02969707|366271631|FG000|Overall Study|Non-compliance|1|||
106166016|NCT02969707|366271632|FG001|Overall Study|Non-compliance|2|||
106166017|NCT01175356|366271633|FG000|Overall Study|Death|1|||
106166018|NCT01175356|366271633|FG000|Overall Study|Lack of Efficacy|12|||
106166019|NCT01175356|366271633|FG000|Overall Study|Lost to Follow-up|1|||
106166020|NCT01175356|366271633|FG000|Overall Study|Physician Decision|23|||
106166021|NCT01175356|366271633|FG000|Overall Study|Ineligible|1|||
106166022|NCT01175356|366271633|FG000|Overall Study|Treatment Slot Not Available|18|||
106166023|NCT01175356|366271633|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
106166024|NCT01175356|366271633|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
106166025|NCT01175356|366271633|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
106166026|NCT01175356|366271633|FG000|Overall Study|Inadequate stem cell for transplant|1|||
106166027|NCT01175356|366271633|FG000|Overall Study|Initiation other tx prior to completion|9|||
106166028|NCT05583578|366271636|FG000|Overall Study|Withdrawal by Subject|2|||
106166029|NCT05583578|366271637|FG001|Overall Study|Withdrawal by Subject|0|||
106166030|NCT04314713|366271638|FG000|Overall Study|Lost to Follow-up|0|||
106166031|NCT04314713|366271639|FG001|Overall Study|Lost to Follow-up|0|||
106166032|NCT04314713|366271640|FG002|Overall Study|Lost to Follow-up|0|||
106166033|NCT04314713|366271641|FG003|Overall Study|Lost to Follow-up|1|||
106166034|NCT04314713|366271642|FG004|Overall Study|Lost to Follow-up|0|||
106166035|NCT04314713|366271643|FG005|Overall Study|Lost to Follow-up|0|||
106166036|NCT02427464|366271645|FG000|Overall Study|Adverse Event|6|||
106166037|NCT02427464|366271646|FG001|Overall Study|Adverse Event|1|||
106166038|NCT02427464|366271645|FG000|Overall Study|Lost to Follow-up|16|||
106166039|NCT02427464|366271646|FG001|Overall Study|Lost to Follow-up|5|||
106166040|NCT02427464|366271645|FG000|Overall Study|Physician Decision|2|||
106166041|NCT02427464|366271646|FG001|Overall Study|Physician Decision|0|||
106166042|NCT02427464|366271645|FG000|Overall Study|Withdrawal by Subject|10|||
106166043|NCT02427464|366271646|FG001|Overall Study|Withdrawal by Subject|8|||
106166044|NCT02427464|366271645|FG000|Overall Study|Noncompliance|16|||
106166045|NCT02427464|366271646|FG001|Overall Study|Noncompliance|10|||
106166046|NCT04145440|366271647|FG000|Overall Study|Physician Decision|3|||
106166047|NCT04145440|366271648|FG001|Overall Study|Physician Decision|0|||
106166048|NCT04145440|366271647|FG000|Overall Study|Use of prohibited therapy|2|||
106166049|NCT04145440|366271648|FG001|Overall Study|Use of prohibited therapy|3|||
106166050|NCT04436276|366271669|FG000|Overall Study|Adverse Event|0|||
106166051|NCT04436276|366271670|FG001|Overall Study|Adverse Event|0|||
106166052|NCT04436276|366271671|FG002|Overall Study|Adverse Event|0|||
106166053|NCT04436276|366271672|FG003|Overall Study|Adverse Event|0|||
106166054|NCT04436276|366271673|FG004|Overall Study|Adverse Event|0|||
106166055|NCT04436276|366271674|FG005|Overall Study|Adverse Event|0|||
106166056|NCT04436276|366271675|FG006|Overall Study|Adverse Event|0|||
106166057|NCT04436276|366271676|FG007|Overall Study|Adverse Event|0|||
106166058|NCT04436276|366271677|FG008|Overall Study|Adverse Event|0|||
106166059|NCT04436276|366271678|FG009|Overall Study|Adverse Event|0|||
106166060|NCT04436276|366271679|FG010|Overall Study|Adverse Event|0|||
106166061|NCT04436276|366271680|FG011|Overall Study|Adverse Event|0|||
106166062|NCT04436276|366271681|FG012|Overall Study|Adverse Event|0|||
106166063|NCT04436276|366271682|FG013|Overall Study|Adverse Event|0|||
106166064|NCT04436276|366271683|FG014|Overall Study|Adverse Event|0|||
106166065|NCT04436276|366271684|FG015|Overall Study|Adverse Event|0|||
106166066|NCT04436276|366271685|FG016|Overall Study|Adverse Event|1|||
106166067|NCT04436276|366271686|FG017|Overall Study|Adverse Event|0|||
106166068|NCT04436276|366271687|FG018|Overall Study|Adverse Event|0|||
106166069|NCT04436276|366271688|FG019|Overall Study|Adverse Event|0|||
106166070|NCT04436276|366271689|FG020|Overall Study|Adverse Event|0|||
106166071|NCT04436276|366271690|FG021|Overall Study|Adverse Event|0|||
106166072|NCT04436276|366271691|FG022|Overall Study|Adverse Event|0|||
106166073|NCT04436276|366271669|FG000|Overall Study|Death|0|||
106166074|NCT04436276|366271670|FG001|Overall Study|Death|0|||
106166075|NCT04436276|366271671|FG002|Overall Study|Death|0|||
106166076|NCT04436276|366271672|FG003|Overall Study|Death|0|||
106166077|NCT04436276|366271673|FG004|Overall Study|Death|0|||
106166078|NCT04436276|366271674|FG005|Overall Study|Death|0|||
106166079|NCT04436276|366271675|FG006|Overall Study|Death|0|||
106166080|NCT04436276|366271676|FG007|Overall Study|Death|0|||
106166081|NCT04436276|366271677|FG008|Overall Study|Death|0|||
106166082|NCT04436276|366271678|FG009|Overall Study|Death|0|||
106166083|NCT04436276|366271679|FG010|Overall Study|Death|0|||
106166084|NCT04436276|366271680|FG011|Overall Study|Death|0|||
106166085|NCT04436276|366271681|FG012|Overall Study|Death|1|||
106166086|NCT04436276|366271682|FG013|Overall Study|Death|0|||
106166087|NCT04436276|366271683|FG014|Overall Study|Death|1|||
106166088|NCT04436276|366271684|FG015|Overall Study|Death|0|||
106166089|NCT04436276|366271685|FG016|Overall Study|Death|0|||
106166090|NCT04436276|366271686|FG017|Overall Study|Death|0|||
106166091|NCT04436276|366271687|FG018|Overall Study|Death|0|||
106166092|NCT04436276|366271688|FG019|Overall Study|Death|2|||
106166093|NCT04436276|366271689|FG020|Overall Study|Death|0|||
106166094|NCT04436276|366271690|FG021|Overall Study|Death|1|||
106166095|NCT04436276|366271691|FG022|Overall Study|Death|0|||
106166096|NCT04436276|366271669|FG000|Overall Study|Lost to Follow-up|0|||
106166097|NCT04436276|366271670|FG001|Overall Study|Lost to Follow-up|2|||
106166098|NCT04436276|366271671|FG002|Overall Study|Lost to Follow-up|2|||
106166099|NCT04436276|366271672|FG003|Overall Study|Lost to Follow-up|1|||
106166100|NCT04436276|366271673|FG004|Overall Study|Lost to Follow-up|4|||
106166101|NCT04436276|366271674|FG005|Overall Study|Lost to Follow-up|1|||
106166102|NCT04436276|366271675|FG006|Overall Study|Lost to Follow-up|0|||
106166103|NCT04436276|366271676|FG007|Overall Study|Lost to Follow-up|0|||
106166104|NCT04436276|366271677|FG008|Overall Study|Lost to Follow-up|1|||
106166105|NCT04436276|366271678|FG009|Overall Study|Lost to Follow-up|0|||
106166106|NCT04436276|366271679|FG010|Overall Study|Lost to Follow-up|5|||
106166107|NCT04436276|366271680|FG011|Overall Study|Lost to Follow-up|5|||
106166108|NCT04436276|366271681|FG012|Overall Study|Lost to Follow-up|4|||
106166109|NCT04436276|366271682|FG013|Overall Study|Lost to Follow-up|1|||
106166110|NCT04436276|366271683|FG014|Overall Study|Lost to Follow-up|7|||
106166111|NCT04436276|366271684|FG015|Overall Study|Lost to Follow-up|7|||
106166112|NCT04436276|366271685|FG016|Overall Study|Lost to Follow-up|1|||
106166113|NCT04436276|366271686|FG017|Overall Study|Lost to Follow-up|0|||
106166114|NCT04436276|366271687|FG018|Overall Study|Lost to Follow-up|1|||
106166115|NCT04436276|366271688|FG019|Overall Study|Lost to Follow-up|1|||
106166116|NCT04436276|366271689|FG020|Overall Study|Lost to Follow-up|2|||
106166117|NCT04436276|366271690|FG021|Overall Study|Lost to Follow-up|1|||
106166118|NCT04436276|366271691|FG022|Overall Study|Lost to Follow-up|1|||
106166119|NCT04436276|366271669|FG000|Overall Study|Physician Decision|1|||
106166120|NCT04436276|366271670|FG001|Overall Study|Physician Decision|0|||
106166121|NCT04436276|366271671|FG002|Overall Study|Physician Decision|2|||
106166122|NCT04436276|366271672|FG003|Overall Study|Physician Decision|1|||
106166123|NCT04436276|366271673|FG004|Overall Study|Physician Decision|0|||
106166124|NCT04436276|366271674|FG005|Overall Study|Physician Decision|0|||
106166125|NCT04436276|366271675|FG006|Overall Study|Physician Decision|0|||
106166126|NCT04436276|366271676|FG007|Overall Study|Physician Decision|0|||
106166127|NCT04436276|366271677|FG008|Overall Study|Physician Decision|0|||
106166128|NCT04436276|366271678|FG009|Overall Study|Physician Decision|0|||
106166129|NCT04436276|366271679|FG010|Overall Study|Physician Decision|0|||
106166130|NCT04436276|366271680|FG011|Overall Study|Physician Decision|1|||
106166131|NCT04436276|366271681|FG012|Overall Study|Physician Decision|2|||
106166132|NCT04436276|366271682|FG013|Overall Study|Physician Decision|0|||
106166133|NCT04436276|366271683|FG014|Overall Study|Physician Decision|0|||
106166134|NCT04436276|366271684|FG015|Overall Study|Physician Decision|0|||
106166135|NCT04436276|366271685|FG016|Overall Study|Physician Decision|0|||
106166136|NCT04436276|366271686|FG017|Overall Study|Physician Decision|0|||
106166137|NCT04436276|366271687|FG018|Overall Study|Physician Decision|0|||
106166138|NCT04436276|366271688|FG019|Overall Study|Physician Decision|0|||
106166139|NCT04436276|366271689|FG020|Overall Study|Physician Decision|1|||
106166140|NCT04436276|366271690|FG021|Overall Study|Physician Decision|2|||
106166141|NCT04436276|366271691|FG022|Overall Study|Physician Decision|0|||
106166142|NCT04436276|366271669|FG000|Overall Study|Protocol Violation|0|||
106166143|NCT04436276|366271670|FG001|Overall Study|Protocol Violation|0|||
106166144|NCT04436276|366271671|FG002|Overall Study|Protocol Violation|0|||
106166145|NCT04436276|366271672|FG003|Overall Study|Protocol Violation|0|||
106166146|NCT04436276|366271673|FG004|Overall Study|Protocol Violation|0|||
106166147|NCT04436276|366271674|FG005|Overall Study|Protocol Violation|0|||
106166148|NCT04436276|366271675|FG006|Overall Study|Protocol Violation|0|||
106166149|NCT04436276|366271676|FG007|Overall Study|Protocol Violation|0|||
106166150|NCT04436276|366271677|FG008|Overall Study|Protocol Violation|0|||
106166151|NCT04436276|366271678|FG009|Overall Study|Protocol Violation|0|||
106166152|NCT04436276|366271679|FG010|Overall Study|Protocol Violation|0|||
106166153|NCT04436276|366271680|FG011|Overall Study|Protocol Violation|0|||
106166154|NCT04436276|366271681|FG012|Overall Study|Protocol Violation|0|||
106166155|NCT04436276|366271682|FG013|Overall Study|Protocol Violation|1|||
106166156|NCT04436276|366271683|FG014|Overall Study|Protocol Violation|0|||
106166157|NCT04436276|366271684|FG015|Overall Study|Protocol Violation|1|||
106166158|NCT04436276|366271685|FG016|Overall Study|Protocol Violation|0|||
106166159|NCT04436276|366271686|FG017|Overall Study|Protocol Violation|0|||
106166160|NCT04436276|366271687|FG018|Overall Study|Protocol Violation|0|||
106166161|NCT04436276|366271688|FG019|Overall Study|Protocol Violation|0|||
106166162|NCT04436276|366271689|FG020|Overall Study|Protocol Violation|0|||
106166163|NCT04436276|366271690|FG021|Overall Study|Protocol Violation|0|||
106166164|NCT04436276|366271691|FG022|Overall Study|Protocol Violation|0|||
106166165|NCT04436276|366271669|FG000|Overall Study|Withdrawal by Subject|25|||
106166166|NCT04436276|366271670|FG001|Overall Study|Withdrawal by Subject|22|||
106166167|NCT04436276|366271671|FG002|Overall Study|Withdrawal by Subject|24|||
106166168|NCT04436276|366271672|FG003|Overall Study|Withdrawal by Subject|23|||
106166169|NCT04436276|366271673|FG004|Overall Study|Withdrawal by Subject|14|||
106166170|NCT04436276|366271674|FG005|Overall Study|Withdrawal by Subject|0|||
106166171|NCT04436276|366271675|FG006|Overall Study|Withdrawal by Subject|0|||
106166172|NCT04436276|366271676|FG007|Overall Study|Withdrawal by Subject|1|||
106166173|NCT04436276|366271677|FG008|Overall Study|Withdrawal by Subject|0|||
106166174|NCT04436276|366271678|FG009|Overall Study|Withdrawal by Subject|1|||
106166175|NCT04436276|366271679|FG010|Overall Study|Withdrawal by Subject|17|||
106166176|NCT04436276|366271680|FG011|Overall Study|Withdrawal by Subject|7|||
106166177|NCT04436276|366271681|FG012|Overall Study|Withdrawal by Subject|10|||
106166178|NCT04436276|366271682|FG013|Overall Study|Withdrawal by Subject|6|||
106166179|NCT04436276|366271683|FG014|Overall Study|Withdrawal by Subject|20|||
106166180|NCT04436276|366271684|FG015|Overall Study|Withdrawal by Subject|6|||
106166181|NCT04436276|366271685|FG016|Overall Study|Withdrawal by Subject|11|||
106166182|NCT04436276|366271686|FG017|Overall Study|Withdrawal by Subject|4|||
106166183|NCT04436276|366271687|FG018|Overall Study|Withdrawal by Subject|14|||
106166184|NCT04436276|366271688|FG019|Overall Study|Withdrawal by Subject|24|||
106166185|NCT04436276|366271689|FG020|Overall Study|Withdrawal by Subject|24|||
106166186|NCT04436276|366271690|FG021|Overall Study|Withdrawal by Subject|16|||
106166187|NCT04436276|366271691|FG022|Overall Study|Withdrawal by Subject|14|||
106166188|NCT04436276|366271669|FG000|Overall Study|Other|3|||
106166189|NCT04436276|366271670|FG001|Overall Study|Other|2|||
106166190|NCT04436276|366271671|FG002|Overall Study|Other|5|||
106166191|NCT04436276|366271672|FG003|Overall Study|Other|9|||
106166192|NCT04436276|366271673|FG004|Overall Study|Other|23|||
106166193|NCT04436276|366271674|FG005|Overall Study|Other|1|||
106166194|NCT04436276|366271675|FG006|Overall Study|Other|0|||
106166195|NCT04436276|366271676|FG007|Overall Study|Other|0|||
106166196|NCT04436276|366271677|FG008|Overall Study|Other|0|||
106166197|NCT04436276|366271678|FG009|Overall Study|Other|0|||
106166198|NCT04436276|366271679|FG010|Overall Study|Other|3|||
106166199|NCT04436276|366271680|FG011|Overall Study|Other|1|||
106166200|NCT04436276|366271681|FG012|Overall Study|Other|1|||
106166201|NCT04436276|366271682|FG013|Overall Study|Other|2|||
106166202|NCT04436276|366271683|FG014|Overall Study|Other|3|||
106166203|NCT04436276|366271684|FG015|Overall Study|Other|0|||
106166204|NCT04436276|366271685|FG016|Overall Study|Other|0|||
106166205|NCT04436276|366271686|FG017|Overall Study|Other|6|||
106166206|NCT04436276|366271687|FG018|Overall Study|Other|1|||
106166207|NCT04436276|366271688|FG019|Overall Study|Other|0|||
106166208|NCT04436276|366271689|FG020|Overall Study|Other|2|||
106166209|NCT04436276|366271690|FG021|Overall Study|Other|2|||
106166210|NCT04436276|366271691|FG022|Overall Study|Other|60|||
106166211|NCT05477186|366271692|FG000|Overall Study|Vaccine not administered|0|||
106166212|NCT05477186|366271693|FG001|Overall Study|Vaccine not administered|2|||
106166213|NCT05477186|366271694|FG002|Overall Study|Vaccine not administered|1|||
106166214|NCT05477186|366271695|FG003|Overall Study|Vaccine not administered|0|||
106166215|NCT05477186|366271696|FG004|Overall Study|Vaccine not administered|1|||
106166216|NCT05477186|366271697|FG005|Overall Study|Vaccine not administered|0|||
106166217|NCT05477186|366271698|FG006|Overall Study|Vaccine not administered|0|||
106166218|NCT05477186|366271692|FG000|Overall Study|Withdrawal by Subject|1|||
106166219|NCT05477186|366271693|FG001|Overall Study|Withdrawal by Subject|0|||
106166220|NCT05477186|366271694|FG002|Overall Study|Withdrawal by Subject|0|||
106166221|NCT05477186|366271695|FG003|Overall Study|Withdrawal by Subject|0|||
106166222|NCT05477186|366271696|FG004|Overall Study|Withdrawal by Subject|0|||
106166223|NCT05477186|366271697|FG005|Overall Study|Withdrawal by Subject|1|||
106166224|NCT05477186|366271698|FG006|Overall Study|Withdrawal by Subject|0|||
106166225|NCT05477186|366271692|FG000|Overall Study|Lost to Follow-up|1|||
106166226|NCT05477186|366271693|FG001|Overall Study|Lost to Follow-up|0|||
106166227|NCT05477186|366271694|FG002|Overall Study|Lost to Follow-up|2|||
106166228|NCT05477186|366271695|FG003|Overall Study|Lost to Follow-up|1|||
106166229|NCT05477186|366271696|FG004|Overall Study|Lost to Follow-up|1|||
106166230|NCT05477186|366271697|FG005|Overall Study|Lost to Follow-up|0|||
106166231|NCT05477186|366271698|FG006|Overall Study|Lost to Follow-up|2|||
106166232|NCT05297565|366271707|FG000|Overall Study|Other Reasons|0|||
106166233|NCT05297565|366271708|FG001|Overall Study|Other Reasons|1|||
106166234|NCT05297565|366271707|FG000|Overall Study|Physician Decision|0|||
106166235|NCT05297565|366271708|FG001|Overall Study|Physician Decision|1|||
106166236|NCT05297565|366271707|FG000|Overall Study|Disease recurrence|1|||
106166237|NCT05297565|366271708|FG001|Overall Study|Disease recurrence|0|||
106166238|NCT05496231|366271709|FG000|Overall Study|Adverse Event|1|||
106166239|NCT05496231|366271710|FG001|Overall Study|Adverse Event|1|||
106166240|NCT05496231|366271711|FG002|Overall Study|Adverse Event|0|||
106166241|NCT05496231|366271712|FG003|Overall Study|Adverse Event|4|||
106166242|NCT05496231|366271709|FG000|Overall Study|Withdrawal by Subject|5|||
106166243|NCT05496231|366271710|FG001|Overall Study|Withdrawal by Subject|5|||
106166244|NCT05496231|366271711|FG002|Overall Study|Withdrawal by Subject|4|||
106166245|NCT05496231|366271712|FG003|Overall Study|Withdrawal by Subject|11|||
106166246|NCT05496231|366271709|FG000|Overall Study|Migrated/moved from the study area|3|||
106166247|NCT05496231|366271710|FG001|Overall Study|Migrated/moved from the study area|5|||
106166248|NCT05496231|366271711|FG002|Overall Study|Migrated/moved from the study area|3|||
106166249|NCT05496231|366271712|FG003|Overall Study|Migrated/moved from the study area|3|||
106166250|NCT05496231|366271709|FG000|Overall Study|Lost to Follow-up|13|||
106166251|NCT05496231|366271710|FG001|Overall Study|Lost to Follow-up|6|||
106166252|NCT05496231|366271711|FG002|Overall Study|Lost to Follow-up|11|||
106166253|NCT05496231|366271712|FG003|Overall Study|Lost to Follow-up|6|||
106166254|NCT05496231|366271709|FG000|Overall Study|Other|9|||
106166255|NCT05496231|366271710|FG001|Overall Study|Other|7|||
106166256|NCT05496231|366271711|FG002|Overall Study|Other|7|||
106166257|NCT05496231|366271712|FG003|Overall Study|Other|8|||
106166258|NCT01267955|366271713|FG000|Stage 1 (6 Months)|Death|3|||
106166259|NCT01267955|366271713|FG000|Stage 2 (6 Months)|Death|5|||
106166260|NCT01267955|366271713|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
106166261|NCT02589522|366271717|FG000|Overall Study|Physician Decision|1|||
106166262|NCT02589522|366271718|FG001|Overall Study|Physician Decision|2|||
106166263|NCT02589522|366271719|FG002|Overall Study|Physician Decision|0|||
106166264|NCT02589522|366271717|FG000|Overall Study|Did not start treatment|1|||
106166265|NCT02589522|366271718|FG001|Overall Study|Did not start treatment|0|||
106166266|NCT02589522|366271719|FG002|Overall Study|Did not start treatment|0|||
106166267|NCT03800654|366271720|FG000|Overall Study|Time constraints|3|||
106166268|NCT03800654|366271721|FG001|Overall Study|Time constraints|3|||
106166269|NCT03800654|366271722|FG002|Overall Study|Time constraints|3|||
106166270|NCT03800654|366271720|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
106166271|NCT03800654|366271721|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
106166272|NCT03800654|366271722|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
106166273|NCT03800654|366271720|FG000|Overall Study|Lost to Follow-up|2|||
106166274|NCT03800654|366271721|FG001|Overall Study|Lost to Follow-up|1|||
106166275|NCT03800654|366271722|FG002|Overall Study|Lost to Follow-up|6|||
106166276|NCT03800654|366271720|FG000|Overall Study|Medical Health Issue|0|||
106166277|NCT03800654|366271721|FG001|Overall Study|Medical Health Issue|0|||
106166278|NCT03800654|366271722|FG002|Overall Study|Medical Health Issue|1|||
106166279|NCT03800654|366271720|FG000|Overall Study|Personal Issues|0|||
106166280|NCT03800654|366271721|FG001|Overall Study|Personal Issues|2|||
106166281|NCT03800654|366271722|FG002|Overall Study|Personal Issues|0|||
106166282|NCT03800654|366271720|FG000|Overall Study|Protocol Violation|0|||
106166283|NCT03800654|366271721|FG001|Overall Study|Protocol Violation|1|||
106166284|NCT03800654|366271722|FG002|Overall Study|Protocol Violation|0|||
106166285|NCT04159415|366271723|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
106166286|NCT04159415|366271724|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
106166287|NCT04159415|366271725|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
106166288|NCT04159415|366271726|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
106166289|NCT04159415|366271727|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
106166290|NCT04159415|366271728|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
106166291|NCT04159415|366271729|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
106166292|NCT04159415|366271730|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
106166293|NCT03459729|366271731|FG000|Overall Study|Physician Decision|2|||
106166294|NCT06182033|366271732|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
106166295|NCT06182033|366271733|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
106166296|NCT06182033|366271732|FG000|Overall Study|Target child relocation|1|||
106166297|NCT06182033|366271733|FG001|Overall Study|Target child relocation|1|||
106166298|NCT06182033|366271732|FG000|Overall Study|Withdrawal by Subject|1|||
106166299|NCT06182033|366271733|FG001|Overall Study|Withdrawal by Subject|0|||
106166300|NCT05374798|366271739|FG000|Overall Study|Lost to Follow-up|2|||
106166301|NCT05374798|366271739|FG000|Overall Study|Withdrawal by Subject|2|||
106166302|NCT05374798|366271739|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
106166303|NCT01275677|366271740|FG000|Overall Study|Not at risk for recurrence.|1|||
106166304|NCT01275677|366271741|FG001|Overall Study|Not at risk for recurrence.|1|||
106166305|NCT01275677|366271740|FG000|Overall Study|No follow-up|26|||
106166306|NCT01275677|366271741|FG001|Overall Study|No follow-up|37|||
106166307|NCT01275677|366271740|FG000|Overall Study|No clinical follow up.|1|||
106166308|NCT01275677|366271741|FG001|Overall Study|No clinical follow up.|4|||
106166309|NCT04857723|366271742|FG000|Overall Study|Withdrawal by Subject|2|||
106166310|NCT05809453|366272906|FG000|Overall Study|Withdrawal by Subject|1|||
106166311|NCT05809453|366272907|FG001|Overall Study|Withdrawal by Subject|0|||
106166312|NCT05809453|366272908|FG002|Overall Study|Withdrawal by Subject|0|||
106166313|NCT05809453|366272909|FG003|Overall Study|Withdrawal by Subject|0|||
106166314|NCT05251909|366272914|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
106166315|NCT05251909|366272915|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
106166316|NCT06181227|366272916|FG000|Overall Study|Study terminated by sponsor|7|||
106166317|NCT06181227|366272917|FG001|Overall Study|Study terminated by sponsor|9|||
106166318|NCT05543915|366272918|FG000|Overall Study|Lost to Follow-up|0|||
106166319|NCT05543915|366272919|FG001|Overall Study|Lost to Follow-up|1|||
106166320|NCT04250194|366272920|FG000|Overall Study|Declined to schedule biopsy|6|||
106166321|NCT04250194|366272921|FG001|Overall Study|Declined to schedule biopsy|10|||
106166322|NCT04250194|366272920|FG000|Overall Study|Medically Unfit for Biopsy|2|||
106166323|NCT04250194|366272921|FG001|Overall Study|Medically Unfit for Biopsy|1|||
106166324|NCT04250194|366272920|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
106166325|NCT04250194|366272921|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
106166326|NCT04250194|366272920|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
106166327|NCT04250194|366272921|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
106166328|NCT04250194|366272920|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
106166329|NCT04250194|366272921|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
106166330|NCT03257410|366272922|FG000|Overall Study|Adverse Event|2|||
106166331|NCT03257410|366272923|FG001|Overall Study|Adverse Event|3|||
106166332|NCT03257410|366272922|FG000|Overall Study|Protocol Violation|1|||
106166333|NCT03257410|366272923|FG001|Overall Study|Protocol Violation|2|||
106166334|NCT03257410|366272922|FG000|Overall Study|Lost to Follow-up|1|||
106166335|NCT03257410|366272923|FG001|Overall Study|Lost to Follow-up|0|||
106166336|NCT03257410|366272922|FG000|Overall Study|Withdrawal by Subject|1|||
106166337|NCT03257410|366272923|FG001|Overall Study|Withdrawal by Subject|2|||
106166338|NCT03257410|366272922|FG000|Overall Study|Physician Decision|1|||
106166339|NCT03257410|366272923|FG001|Overall Study|Physician Decision|1|||
106166340|NCT03257410|366272922|FG000|Overall Study|Renal transplantation|2|||
106166341|NCT03257410|366272923|FG001|Overall Study|Renal transplantation|0|||
106166342|NCT03257410|366272922|FG000|Overall Study|Switch to peritoneal dialysis|1|||
106166343|NCT03257410|366272923|FG001|Overall Study|Switch to peritoneal dialysis|0|||
106166344|NCT03257410|366272922|FG000|Overall Study|Death|3|||
106166345|NCT03257410|366272923|FG001|Overall Study|Death|2|||
106166346|NCT03257410|366272922|FG000|Overall Study|Change to another dialysis center|2|||
106166347|NCT03257410|366272923|FG001|Overall Study|Change to another dialysis center|2|||
106166348|NCT03257410|366272922|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
106166349|NCT03257410|366272923|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
106166350|NCT03257410|366272922|FG000|Overall Study|Miscellaneous|2|||
106166351|NCT03257410|366272923|FG001|Overall Study|Miscellaneous|2|||
106166352|NCT03257410|366272922|FG000|Overall Study|Other|0|||
106166353|NCT03257410|366272923|FG001|Overall Study|Other|1|||
106166354|NCT02561247|366272924|FG000|Overall Study|Protocol Violation|1|||
106166355|NCT02561247|366272924|FG000|Overall Study|Withdrawal by Subject|1|||
106166356|NCT02561247|366272924|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
106166357|NCT02993159|366272928|FG000|Overall Study|Withdrawal by Subject|1|||
106166358|NCT02993159|366272929|FG001|Overall Study|Withdrawal by Subject|3|||
106166359|NCT02993159|366272928|FG000|Overall Study|Protocol Violation|1|||
106166360|NCT02993159|366272929|FG001|Overall Study|Protocol Violation|0|||
106166361|NCT02993159|366272928|FG000|Overall Study|Opted out of surgery|2|||
106166362|NCT02993159|366272929|FG001|Overall Study|Opted out of surgery|0|||
106166363|NCT02993159|366272928|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
106166364|NCT02993159|366272929|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
106166365|NCT02993159|366272928|FG000|Overall Study|Physician Decision|0|||
106166366|NCT02993159|366272929|FG001|Overall Study|Physician Decision|1|||
106166367|NCT03625167|366272931|FG000|Overall Study|Protocol Violation|5|||
106166368|NCT06103188|366272932|FG000|Overall Study|Lost to Follow-up|1|||
106166369|NCT06103188|366272933|FG001|Overall Study|Lost to Follow-up|6|||
106166370|NCT06103188|366272934|FG002|Overall Study|Lost to Follow-up|4|||
106166371|NCT04248725|366272942|FG000|Post-Treatment|Lost to Follow-up|6|||
106166372|NCT04248725|366272943|FG001|Post-Treatment|Lost to Follow-up|5|||
106166373|NCT04248725|366272942|FG000|6-Month Follow Up|Lost to Follow-up|9|||
106166374|NCT04248725|366272943|FG001|6-Month Follow Up|Lost to Follow-up|8|||
106166375|NCT03766685|366272946|FG000|Overall Study|Lost to Follow-up|1|||
106166376|NCT03766685|366272947|FG001|Overall Study|Lost to Follow-up|1|||
106166377|NCT03766685|366272948|FG002|Overall Study|Lost to Follow-up|0|||
106166378|NCT03766685|366272949|FG003|Overall Study|Lost to Follow-up|0|||
106166379|NCT03766685|366272946|FG000|Overall Study|Adverse Event, not fatal|0|||
106166380|NCT03766685|366272947|FG001|Overall Study|Adverse Event, not fatal|1|||
106166381|NCT03766685|366272948|FG002|Overall Study|Adverse Event, not fatal|0|||
106166382|NCT03766685|366272949|FG003|Overall Study|Adverse Event, not fatal|1|||
106166383|NCT03766685|366272946|FG000|Overall Study|Withdrawal by Subject|0|||
106166384|NCT03766685|366272947|FG001|Overall Study|Withdrawal by Subject|2|||
106166385|NCT03766685|366272948|FG002|Overall Study|Withdrawal by Subject|0|||
106166386|NCT03766685|366272949|FG003|Overall Study|Withdrawal by Subject|0|||
106166387|NCT03766685|366272946|FG000|Overall Study|Protocol Violation|0|||
106166388|NCT03766685|366272947|FG001|Overall Study|Protocol Violation|1|||
106166389|NCT03766685|366272948|FG002|Overall Study|Protocol Violation|0|||
106166390|NCT03766685|366272949|FG003|Overall Study|Protocol Violation|0|||
106166391|NCT03766685|366272946|FG000|Overall Study|Non-compliance|0|||
106166392|NCT03766685|366272947|FG001|Overall Study|Non-compliance|2|||
106166393|NCT03766685|366272948|FG002|Overall Study|Non-compliance|0|||
106166394|NCT03766685|366272949|FG003|Overall Study|Non-compliance|0|||
106166395|NCT05228457|366272952|FG000|Overall Study|Withdrawal by Subject|1|||
106166396|NCT05228457|366272953|FG001|Overall Study|Withdrawal by Subject|1|||
106166397|NCT01152450|366272959|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
106166398|NCT01152450|366272960|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
106166399|NCT01152450|366272961|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
106166400|NCT01152450|366272962|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
106166401|NCT01152450|366272963|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
106166402|NCT01152450|366272964|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
106166403|NCT01152450|366272959|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
106166404|NCT01152450|366272960|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
106166405|NCT01152450|366272961|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
106166406|NCT01152450|366272962|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
106166407|NCT01152450|366272963|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
106166408|NCT01152450|366272964|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
106166409|NCT01152450|366272959|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
106166410|NCT01152450|366272960|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
106166411|NCT01152450|366272961|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
106166412|NCT01152450|366272962|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
106166413|NCT01152450|366272963|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
106166414|NCT01152450|366272964|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
106166415|NCT01544114|366272967|FG000|Overall Study|Withdrawal by Subject|0|||
106166416|NCT01544114|366272968|FG001|Overall Study|Withdrawal by Subject|0|||
106166417|NCT01544114|366272969|FG002|Overall Study|Withdrawal by Subject|3|||
106166418|NCT01544114|366272967|FG000|Overall Study|Lost to Follow-up|0|||
106166419|NCT01544114|366272968|FG001|Overall Study|Lost to Follow-up|2|||
106166420|NCT01544114|366272969|FG002|Overall Study|Lost to Follow-up|0|||
106166421|NCT01544114|366272967|FG000|Overall Study|Adverse Event|1|||
106166422|NCT01544114|366272968|FG001|Overall Study|Adverse Event|1|||
106166423|NCT01544114|366272969|FG002|Overall Study|Adverse Event|2|||
106166424|NCT01544114|366272967|FG000|Overall Study|Protocol Violation|0|||
106166425|NCT01544114|366272968|FG001|Overall Study|Protocol Violation|1|||
106166426|NCT01544114|366272969|FG002|Overall Study|Protocol Violation|0|||
106166427|NCT04625465|366272972|FG000|Overall Study|Lost to Follow-up|2|||
106166428|NCT04625465|366272973|FG001|Overall Study|Lost to Follow-up|2|||
106166429|NCT04625465|366272974|FG002|Overall Study|Lost to Follow-up|1|||
106166430|NCT04625465|366272975|FG003|Overall Study|Lost to Follow-up|0|||
106166431|NCT04625465|366272976|FG004|Overall Study|Lost to Follow-up|0|||
106166432|NCT04625465|366272977|FG005|Overall Study|Lost to Follow-up|2|||
106166433|NCT04625465|366272978|FG006|Overall Study|Lost to Follow-up|0|||
106166434|NCT04625465|366272979|FG007|Overall Study|Lost to Follow-up|0|||
106166435|NCT04625465|366272972|FG000|Overall Study|Death|1|||
106166436|NCT04625465|366272973|FG001|Overall Study|Death|0|||
106166437|NCT04625465|366272974|FG002|Overall Study|Death|0|||
106166438|NCT04625465|366272975|FG003|Overall Study|Death|0|||
106166439|NCT04625465|366272976|FG004|Overall Study|Death|0|||
106166440|NCT04625465|366272977|FG005|Overall Study|Death|0|||
106166441|NCT04625465|366272978|FG006|Overall Study|Death|0|||
106166442|NCT04625465|366272979|FG007|Overall Study|Death|0|||
106166443|NCT04625465|366272972|FG000|Overall Study|Withdrawal by Subject|1|||
106166444|NCT04625465|366272973|FG001|Overall Study|Withdrawal by Subject|0|||
106166445|NCT04625465|366272974|FG002|Overall Study|Withdrawal by Subject|4|||
106166446|NCT04625465|366272975|FG003|Overall Study|Withdrawal by Subject|4|||
106166447|NCT04625465|366272976|FG004|Overall Study|Withdrawal by Subject|4|||
106166448|NCT04625465|366272977|FG005|Overall Study|Withdrawal by Subject|0|||
106166449|NCT04625465|366272978|FG006|Overall Study|Withdrawal by Subject|0|||
106166450|NCT04625465|366272979|FG007|Overall Study|Withdrawal by Subject|0|||
106166451|NCT03084536|366272983|FG000|Overall Study|Determined to be ineligible|0|||
106166452|NCT03084536|366272984|FG001|Overall Study|Determined to be ineligible|0|||
106166453|NCT03084536|366272985|FG002|Overall Study|Determined to be ineligible|16|||
106166454|NCT03084536|366272983|FG000|Overall Study|Withdrawal by Subject|0|||
106166455|NCT03084536|366272984|FG001|Overall Study|Withdrawal by Subject|0|||
106166456|NCT03084536|366272985|FG002|Overall Study|Withdrawal by Subject|4|||
106166457|NCT03084536|366272983|FG000|Overall Study|Physician Decision|0|||
106166458|NCT03084536|366272984|FG001|Overall Study|Physician Decision|0|||
106166459|NCT03084536|366272985|FG002|Overall Study|Physician Decision|3|||
106166460|NCT03084536|366272983|FG000|Overall Study|Death|0|||
106166461|NCT03084536|366272984|FG001|Overall Study|Death|0|||
106166462|NCT03084536|366272985|FG002|Overall Study|Death|1|||
106166463|NCT03084536|366272983|FG000|Overall Study|Lost to Follow-up|0|||
106166464|NCT03084536|366272984|FG001|Overall Study|Lost to Follow-up|0|||
106166465|NCT03084536|366272985|FG002|Overall Study|Lost to Follow-up|1|||
106166466|NCT03084536|366272983|FG000|Overall Study|Protocol Violation|0|||
106166467|NCT03084536|366272984|FG001|Overall Study|Protocol Violation|0|||
106166468|NCT03084536|366272985|FG002|Overall Study|Protocol Violation|1|||
106166469|NCT03084536|366272983|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
106166470|NCT03084536|366272984|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
106166471|NCT03084536|366272985|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
106166472|NCT03571581|366272989|FG000|Overall Study|Death|2|||
106166473|NCT03571581|366272989|FG000|Overall Study|Withdrawal by Subject|2|||
105867290|NCT03888066|365164936|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
106166474|NCT02823145|366272990|FG000|Enrollment|Other|1|||
106166475|NCT02823145|366272991|FG001|Enrollment|Other|0|||
106166476|NCT02823145|366272990|FG000|Treatment|Adverse Event|0|||
106166477|NCT02823145|366272991|FG001|Treatment|Adverse Event|11|||
106166478|NCT02823145|366272990|FG000|Treatment|Death|0|||
106166479|NCT02823145|366272991|FG001|Treatment|Death|3|||
106166480|NCT02823145|366272990|FG000|Treatment|Family Decision|0|||
106166481|NCT02823145|366272991|FG001|Treatment|Family Decision|1|||
106166482|NCT02823145|366272990|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
106166483|NCT02823145|366272991|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
106166484|NCT02823145|366272990|FG000|Treatment|Lack of Efficacy|0|||
106166485|NCT02823145|366272991|FG001|Treatment|Lack of Efficacy|48|||
106166486|NCT02823145|366272990|FG000|Treatment|Non-Compliance With E-Diary|0|||
106166487|NCT02823145|366272991|FG001|Treatment|Non-Compliance With E-Diary|1|||
106166488|NCT02823145|366272990|FG000|Treatment|Physician Decision|0|||
106166489|NCT02823145|366272991|FG001|Treatment|Physician Decision|2|||
106166490|NCT02823145|366272990|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
106166491|NCT02823145|366272991|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
106166492|NCT02823145|366272990|FG000|Treatment|Subject needed to take prohibited medication|0|||
106166493|NCT02823145|366272991|FG001|Treatment|Subject needed to take prohibited medication|1|||
106166494|NCT02823145|366272990|FG000|Treatment|Subject transferred to direct access programme|0|||
106166495|NCT02823145|366272991|FG001|Treatment|Subject transferred to direct access programme|1|||
106166496|NCT02823145|366272990|FG000|Treatment|Switching to commercially available drug|0|||
106166497|NCT02823145|366272991|FG001|Treatment|Switching to commercially available drug|11|||
106166498|NCT02823145|366272990|FG000|Treatment|Transitioned to commercial supply of medication|0|||
106166499|NCT02823145|366272991|FG001|Treatment|Transitioned to commercial supply of medication|1|||
106166500|NCT02823145|366272990|FG000|Treatment|Withdrawal By Caregiver|0|||
106166501|NCT02823145|366272991|FG001|Treatment|Withdrawal By Caregiver|1|||
106166502|NCT02823145|366272990|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
106166503|NCT02823145|366272991|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
106166504|NCT02823145|366272990|FG000|Treatment|Withdrawal by Subject|0|||
106166505|NCT02823145|366272991|FG001|Treatment|Withdrawal by Subject|16|||
106166506|NCT02823145|366272990|FG000|Treatment|Reason unknown|0|||
106166507|NCT02823145|366272991|FG001|Treatment|Reason unknown|1|||
106166508|NCT03221426|366272992|FG000|Overall Study|Ongoing in study|212|||
106166509|NCT03221426|366272993|FG001|Overall Study|Ongoing in study|193|||
106166510|NCT03221426|366272994|FG002|Overall Study|Ongoing in study|61|||
106166511|NCT03221426|366272995|FG003|Overall Study|Ongoing in study|55|||
106166512|NCT03221426|366272992|FG000|Overall Study|Withdrawal by Subject|12|||
106166513|NCT03221426|366272993|FG001|Overall Study|Withdrawal by Subject|4|||
106166514|NCT03221426|366272994|FG002|Overall Study|Withdrawal by Subject|2|||
106166515|NCT03221426|366272995|FG003|Overall Study|Withdrawal by Subject|3|||
106166516|NCT03221426|366272992|FG000|Overall Study|Lost to Follow-up|4|||
106166517|NCT03221426|366272993|FG001|Overall Study|Lost to Follow-up|1|||
106166518|NCT03221426|366272994|FG002|Overall Study|Lost to Follow-up|1|||
106166519|NCT03221426|366272995|FG003|Overall Study|Lost to Follow-up|0|||
106166520|NCT03221426|366272992|FG000|Overall Study|Death|174|||
106166521|NCT03221426|366272993|FG001|Overall Study|Death|204|||
106166522|NCT03221426|366272994|FG002|Overall Study|Death|36|||
106166523|NCT03221426|366272995|FG003|Overall Study|Death|45|||
106166524|NCT04828005|366272996|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
106166525|NCT04828005|366272997|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
106166526|NCT04828005|366272998|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
106166527|NCT04828005|366272999|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
106166528|NCT04828005|366272996|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
106166529|NCT04828005|366272997|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
106166530|NCT04828005|366272998|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
106166531|NCT04828005|366272999|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
106166532|NCT04828005|366272996|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
106166533|NCT04828005|366272997|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
106166534|NCT04828005|366272998|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
106166535|NCT04828005|366272999|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
106166536|NCT04828005|366272996|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
106166537|NCT04828005|366272997|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
106166538|NCT04828005|366272998|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
106166539|NCT04828005|366272999|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
106166540|NCT04828005|366272996|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
106166541|NCT04828005|366272997|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
106166542|NCT04828005|366272998|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
106166543|NCT04828005|366272999|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
106166544|NCT04828005|366272996|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
106166545|NCT04828005|366272997|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
106166546|NCT04828005|366272998|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
106166547|NCT04828005|366272999|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
106166548|NCT04828005|366272996|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
106166549|NCT04828005|366272997|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
106166550|NCT04828005|366272998|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
106166551|NCT04828005|366272999|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
106166552|NCT04828005|366272996|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
106166553|NCT04828005|366272997|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
106166554|NCT04828005|366272998|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
106166555|NCT04828005|366272999|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
106166556|NCT04828005|366272996|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
106166557|NCT04828005|366272997|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
106166558|NCT04828005|366272998|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
106166559|NCT04828005|366272999|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
106166560|NCT04979442|366274582|FG000|Overall Study|Death|43|||
106166561|NCT04979442|366274583|FG001|Overall Study|Death|30|||
106166562|NCT04979442|366274582|FG000|Overall Study|Withdrawal by Subject|8|||
106166563|NCT04979442|366274583|FG001|Overall Study|Withdrawal by Subject|13|||
106166564|NCT04979442|366274582|FG000|Overall Study|Physician Decision|1|||
106166565|NCT04979442|366274583|FG001|Overall Study|Physician Decision|1|||
106166566|NCT04979442|366274582|FG000|Overall Study|Lost to Follow-up|0|||
106166567|NCT04979442|366274583|FG001|Overall Study|Lost to Follow-up|2|||
106166568|NCT04979442|366274582|FG000|Overall Study|do not want to continue|0|||
106166569|NCT04979442|366274583|FG001|Overall Study|do not want to continue|1|||
106166570|NCT04103580|366274586|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
106166571|NCT04103580|366274587|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
106166572|NCT04103580|366274586|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
106166573|NCT04103580|366274587|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
106166574|NCT04103580|366274586|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
106166575|NCT04103580|366274587|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
106166576|NCT04103580|366274586|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
106166577|NCT04103580|366274587|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
106166578|NCT04103580|366274586|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
106166579|NCT04103580|366274587|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
106166580|NCT04103580|366274586|FG000|Phase 1 Active Caregiving|Other|3|||
106166581|NCT04103580|366274587|FG001|Phase 1 Active Caregiving|Other|3|||
106166582|NCT04103580|366274586|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
106166583|NCT04103580|366274587|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
106166584|NCT04103580|366274586|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
106166585|NCT04103580|366274587|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
106166586|NCT04103580|366274586|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
106166587|NCT04103580|366274587|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
106166588|NCT04103580|366274586|FG000|Phase 2 Bereavement|Other|8|||
106166589|NCT04103580|366274587|FG001|Phase 2 Bereavement|Other|6|||
106166590|NCT02425904|366274588|FG000|Overall Study|Lost to Follow-up|1|||
106166591|NCT02425904|366274589|FG001|Overall Study|Lost to Follow-up|0|||
106166592|NCT02425904|366274588|FG000|Overall Study|Withdrawal by Subject|2|||
106166593|NCT02425904|366274589|FG001|Overall Study|Withdrawal by Subject|0|||
106166594|NCT02425904|366274588|FG000|Overall Study|Death|0|||
106166595|NCT02425904|366274589|FG001|Overall Study|Death|3|||
106166596|NCT03916185|366274590|FG000|Overall Study|Lost to Follow-up|0|||
106166597|NCT03916185|366274591|FG001|Overall Study|Lost to Follow-up|1|||
106166598|NCT03916185|366274592|FG002|Overall Study|Lost to Follow-up|0|||
106166599|NCT03916185|366274593|FG003|Overall Study|Lost to Follow-up|0|||
106166600|NCT03916185|366274590|FG000|Overall Study|Moved|1|||
106166601|NCT03916185|366274591|FG001|Overall Study|Moved|0|||
106166602|NCT03916185|366274592|FG002|Overall Study|Moved|0|||
106166603|NCT03916185|366274593|FG003|Overall Study|Moved|1|||
106166604|NCT03916185|366274590|FG000|Overall Study|Not Able to Get to Clinic|1|||
106166605|NCT03916185|366274591|FG001|Overall Study|Not Able to Get to Clinic|0|||
106166606|NCT03916185|366274592|FG002|Overall Study|Not Able to Get to Clinic|0|||
106166607|NCT03916185|366274593|FG003|Overall Study|Not Able to Get to Clinic|0|||
106166608|NCT04564027|366274594|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
106166609|NCT04564027|366274595|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
106166610|NCT04564027|366274596|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
106166611|NCT04564027|366274597|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
106166612|NCT02116530|366274598|FG000|Overall Study|Withdrawal by Subject|1|||
106166613|NCT02116530|366274599|FG001|Overall Study|Withdrawal by Subject|2|||
106166614|NCT02116530|366274598|FG000|Overall Study|Adverse Event|4|||
106166615|NCT02116530|366274599|FG001|Overall Study|Adverse Event|0|||
106166616|NCT02116530|366274598|FG000|Overall Study|Physician Decision|1|||
106166617|NCT02116530|366274599|FG001|Overall Study|Physician Decision|0|||
106166618|NCT02116530|366274598|FG000|Overall Study|Lost to Follow-up|1|||
106166619|NCT02116530|366274599|FG001|Overall Study|Lost to Follow-up|0|||
106166620|NCT02116530|366274598|FG000|Overall Study|Other Medical Problems|2|||
106166621|NCT02116530|366274599|FG001|Overall Study|Other Medical Problems|2|||
106166622|NCT02927236|366274600|FG000|Characterization Phase|Physician Decision|0|||
106166623|NCT02927236|366274601|FG001|Characterization Phase|Physician Decision|3|||
106166624|NCT02927236|366274602|FG002|Characterization Phase|Physician Decision|0|||
106166625|NCT02927236|366274603|FG003|Characterization Phase|Physician Decision|2|||
106166626|NCT02927236|366274600|FG000|Characterization Phase|Lost to Follow-up|0|||
106166627|NCT02927236|366274601|FG001|Characterization Phase|Lost to Follow-up|0|||
106166628|NCT02927236|366274602|FG002|Characterization Phase|Lost to Follow-up|0|||
106166629|NCT02927236|366274603|FG003|Characterization Phase|Lost to Follow-up|3|||
106166630|NCT02927236|366274600|FG000|Characterization Phase|Withdrawal by Subject|1|||
106166631|NCT02927236|366274601|FG001|Characterization Phase|Withdrawal by Subject|0|||
106166632|NCT02927236|366274602|FG002|Characterization Phase|Withdrawal by Subject|0|||
106166633|NCT02927236|366274603|FG003|Characterization Phase|Withdrawal by Subject|1|||
106166634|NCT02927236|366274600|FG000|Treatment Phase|Adverse Event|1|||
106166635|NCT02927236|366274601|FG001|Treatment Phase|Adverse Event|0|||
106166636|NCT02927236|366274602|FG002|Treatment Phase|Adverse Event|1|||
106166637|NCT02927236|366274603|FG003|Treatment Phase|Adverse Event|1|||
106166638|NCT02927236|366274600|FG000|Treatment Phase|Protocol Violation|3|||
106166639|NCT02927236|366274601|FG001|Treatment Phase|Protocol Violation|0|||
106166640|NCT02927236|366274602|FG002|Treatment Phase|Protocol Violation|0|||
106166641|NCT02927236|366274603|FG003|Treatment Phase|Protocol Violation|1|||
106166642|NCT02927236|366274600|FG000|Treatment Phase|Lost to Follow-up|1|||
106166643|NCT02927236|366274601|FG001|Treatment Phase|Lost to Follow-up|0|||
106166644|NCT02927236|366274602|FG002|Treatment Phase|Lost to Follow-up|0|||
106166645|NCT02927236|366274603|FG003|Treatment Phase|Lost to Follow-up|0|||
106166646|NCT02927236|366274600|FG000|Follow-up Phase|Lost to Follow-up|1|||
106166647|NCT02927236|366274601|FG001|Follow-up Phase|Lost to Follow-up|0|||
106166648|NCT02927236|366274602|FG002|Follow-up Phase|Lost to Follow-up|1|||
106166649|NCT02927236|366274603|FG003|Follow-up Phase|Lost to Follow-up|0|||
106166650|NCT03656510|366274606|FG000|Overall Study|Lost to Follow-up|1|||
106166651|NCT03656510|366274607|FG001|Overall Study|Lost to Follow-up|0|||
106166652|NCT03656510|366274608|FG002|Overall Study|Lost to Follow-up|0|||
106166653|NCT03656510|366274609|FG003|Overall Study|Lost to Follow-up|0|||
106166654|NCT03656510|366274610|FG004|Overall Study|Lost to Follow-up|0|||
106166655|NCT03656510|366274611|FG005|Overall Study|Lost to Follow-up|0|||
106166656|NCT03656510|366274606|FG000|Overall Study|Withdrawal by Subject|1|||
106166657|NCT03656510|366274607|FG001|Overall Study|Withdrawal by Subject|1|||
106166658|NCT03656510|366274608|FG002|Overall Study|Withdrawal by Subject|0|||
106166659|NCT03656510|366274609|FG003|Overall Study|Withdrawal by Subject|1|||
106166660|NCT03656510|366274610|FG004|Overall Study|Withdrawal by Subject|0|||
106166661|NCT03656510|366274611|FG005|Overall Study|Withdrawal by Subject|0|||
106166662|NCT04524442|366274615|FG000|Overall Study|Subject Decision|1|||
106166663|NCT01733316|366274621|FG000|RP103 Phase|Non-compliance|1|||
106166664|NCT01733316|366274621|FG000|Long Term Extension Phase|Adverse Event|1|||
106166665|NCT01733316|366274621|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
106166666|NCT01733316|366274621|FG000|Long Term Extension Phase|Sponsor Decision|2|||
106166667|NCT04508309|366274622|FG000|Overall Study|Death|0|||
106166668|NCT04508309|366274623|FG001|Overall Study|Death|0|||
106166669|NCT04508309|366274624|FG002|Overall Study|Death|0|||
106166670|NCT04508309|366274625|FG003|Overall Study|Death|0|||
106166671|NCT04508309|366274626|FG004|Overall Study|Death|1|||
106166672|NCT04508309|366274622|FG000|Overall Study|Lost to Follow-up|0|||
106166673|NCT04508309|366274623|FG001|Overall Study|Lost to Follow-up|0|||
106166674|NCT04508309|366274624|FG002|Overall Study|Lost to Follow-up|1|||
106166675|NCT04508309|366274625|FG003|Overall Study|Lost to Follow-up|1|||
106166676|NCT04508309|366274626|FG004|Overall Study|Lost to Follow-up|0|||
106166677|NCT04508309|366274622|FG000|Overall Study|Withdrawal by Subject|0|||
106166678|NCT04508309|366274623|FG001|Overall Study|Withdrawal by Subject|0|||
106166679|NCT04508309|366274624|FG002|Overall Study|Withdrawal by Subject|0|||
106166680|NCT04508309|366274625|FG003|Overall Study|Withdrawal by Subject|0|||
106166681|NCT04508309|366274626|FG004|Overall Study|Withdrawal by Subject|1|||
106166682|NCT05139810|366274629|FG000|Overall Study|Voluntary Withdrawal|2|||
106166683|NCT05139810|366274630|FG001|Overall Study|Voluntary Withdrawal|1|||
106166684|NCT05139810|366274631|FG002|Overall Study|Voluntary Withdrawal|0|||
106166685|NCT05139810|366274629|FG000|Overall Study|Pregnancy|1|||
106166686|NCT05139810|366274630|FG001|Overall Study|Pregnancy|0|||
106166687|NCT05139810|366274631|FG002|Overall Study|Pregnancy|0|||
106166688|NCT05139810|366274629|FG000|Overall Study|Roll Over to CS7|19|||
106166689|NCT05139810|366274630|FG001|Overall Study|Roll Over to CS7|44|||
106166690|NCT05139810|366274631|FG002|Overall Study|Roll Over to CS7|20|||
106166691|NCT04914676|366274632|FG000|Overall Study|Study termination|3|||
106166692|NCT04914676|366274633|FG001|Overall Study|Study termination|0|||
106166693|NCT03085810|366274634|FG000|Main Study|Withdrawal by Subject|77|||
106166694|NCT03085810|366274635|FG001|Main Study|Withdrawal by Subject|0|||
106166695|NCT03085810|366274636|FG002|Main Study|Withdrawal by Subject|0|||
106166696|NCT03085810|366274634|FG000|Main Study|Terminated By Sponsor|14|||
106166697|NCT03085810|366274635|FG001|Main Study|Terminated By Sponsor|0|||
106166698|NCT03085810|366274636|FG002|Main Study|Terminated By Sponsor|0|||
106166699|NCT03085810|366274634|FG000|Main Study|Protocol Violation|15|||
106166700|NCT03085810|366274635|FG001|Main Study|Protocol Violation|0|||
106166701|NCT03085810|366274636|FG002|Main Study|Protocol Violation|0|||
106166702|NCT03085810|366274634|FG000|Main Study|Physician Decision|13|||
106166703|NCT03085810|366274635|FG001|Main Study|Physician Decision|0|||
106166704|NCT03085810|366274636|FG002|Main Study|Physician Decision|0|||
106166705|NCT03085810|366274634|FG000|Main Study|Lost to Follow-up|17|||
106166706|NCT03085810|366274635|FG001|Main Study|Lost to Follow-up|0|||
106166707|NCT03085810|366274636|FG002|Main Study|Lost to Follow-up|0|||
106166708|NCT03085810|366274634|FG000|Main Study|Adverse Event|25|||
106166709|NCT03085810|366274635|FG001|Main Study|Adverse Event|0|||
106166710|NCT03085810|366274636|FG002|Main Study|Adverse Event|0|||
106166711|NCT03085810|366274634|FG000|Main Study|Pregnancy|7|||
106166712|NCT03085810|366274635|FG001|Main Study|Pregnancy|0|||
106166713|NCT03085810|366274636|FG002|Main Study|Pregnancy|0|||
106166714|NCT03085810|366274634|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
106166715|NCT03085810|366274635|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
106166716|NCT03085810|366274636|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
106166717|NCT03085810|366274634|FG000|Main Study|Lack of Efficacy|10|||
106166718|NCT03085810|366274635|FG001|Main Study|Lack of Efficacy|0|||
106166719|NCT03085810|366274636|FG002|Main Study|Lack of Efficacy|0|||
106166720|NCT03085810|366274634|FG000|Main Study|Death|12|||
106166721|NCT03085810|366274635|FG001|Main Study|Death|0|||
106166722|NCT03085810|366274636|FG002|Main Study|Death|0|||
106166723|NCT03085810|366274634|FG000|Main Study|Disease progression|1|||
106166724|NCT03085810|366274635|FG001|Main Study|Disease progression|0|||
106166725|NCT03085810|366274636|FG002|Main Study|Disease progression|0|||
106166726|NCT03085810|366274634|FG000|Main Study|Site Closure|3|||
106166727|NCT03085810|366274635|FG001|Main Study|Site Closure|0|||
106166728|NCT03085810|366274636|FG002|Main Study|Site Closure|0|||
106166729|NCT03085810|366274634|FG000|Main Study|Planned pregnancy|17|||
106166730|NCT03085810|366274635|FG001|Main Study|Planned pregnancy|0|||
106166731|NCT03085810|366274636|FG002|Main Study|Planned pregnancy|0|||
106166732|NCT03085810|366274634|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
106166733|NCT03085810|366274635|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
106166734|NCT03085810|366274636|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
106166735|NCT03085810|366274634|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
106166736|NCT03085810|366274635|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
106166737|NCT03085810|366274636|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
106166738|NCT03085810|366274634|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
106166739|NCT03085810|366274635|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
106166740|NCT03085810|366274636|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
106166741|NCT03085810|366274634|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
106166742|NCT03085810|366274635|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
106166743|NCT03085810|366274636|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
106166744|NCT05546411|366274637|FG000|Overall Study|Progressive Disease|1|||
106166745|NCT05546411|366274638|FG001|Overall Study|Progressive Disease|0|||
106166746|NCT05546411|366274637|FG000|Overall Study|Adverse Event|0|||
106166747|NCT05546411|366274638|FG001|Overall Study|Adverse Event|1|||
106166748|NCT05546411|366274637|FG000|Overall Study|Metastatic disease|1|||
106166749|NCT05546411|366274638|FG001|Overall Study|Metastatic disease|0|||
106166750|NCT02966873|366274643|FG000|Overall Study|Lost to Follow-up|16|||
106166751|NCT02966873|366274644|FG001|Overall Study|Lost to Follow-up|15|||
106166752|NCT02460458|366274651|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
106166753|NCT02460458|366274651|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
106166754|NCT02460458|366274651|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
106166755|NCT02460458|366274651|FG000|First Prospective Phase|Lost to Follow-up|84|||
106166756|NCT02460458|366274651|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
106166757|NCT04447755|366274653|FG000|Overall Study|Death|8|||
106166758|NCT04447755|366274654|FG001|Overall Study|Death|14|||
106166759|NCT04447755|366274655|FG002|Overall Study|Death|8|||
106166760|NCT04447755|366274656|FG003|Overall Study|Death|9|||
106166761|NCT04447755|366274657|FG004|Overall Study|Death|7|||
106166762|NCT04447755|366274658|FG005|Overall Study|Death|7|||
106166763|NCT04447755|366274659|FG006|Overall Study|Death|40|||
106166764|NCT04447755|366274653|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
106166765|NCT04447755|366274654|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
106166766|NCT04447755|366274655|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
106166767|NCT04447755|366274656|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
106166768|NCT04447755|366274657|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
106166769|NCT04447755|366274658|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
106166770|NCT04447755|366274659|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
106166771|NCT04447755|366274653|FG000|Overall Study|Ongoing in Study|1|||
106166772|NCT04447755|366274654|FG001|Overall Study|Ongoing in Study|2|||
106166773|NCT04447755|366274655|FG002|Overall Study|Ongoing in Study|0|||
106166774|NCT04447755|366274656|FG003|Overall Study|Ongoing in Study|0|||
106166775|NCT04447755|366274657|FG004|Overall Study|Ongoing in Study|2|||
106166776|NCT04447755|366274658|FG005|Overall Study|Ongoing in Study|2|||
106166777|NCT04447755|366274659|FG006|Overall Study|Ongoing in Study|26|||
106166778|NCT04200456|366274660|FG000|Overall Study|Physician Decision|0|||
106166779|NCT04200456|366274661|FG001|Overall Study|Physician Decision|1|||
106166780|NCT04200456|366274660|FG000|Overall Study|Withdrawal by Subject|2|||
106166781|NCT04200456|366274661|FG001|Overall Study|Withdrawal by Subject|2|||
106166782|NCT04200456|366274660|FG000|Overall Study|Lack of Efficacy|1|||
106166783|NCT04200456|366274661|FG001|Overall Study|Lack of Efficacy|1|||
106166784|NCT04200456|366274660|FG000|Overall Study|Adverse event, non-fatal|0|||
106166785|NCT04200456|366274661|FG001|Overall Study|Adverse event, non-fatal|1|||
106166786|NCT04200456|366274660|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
106166787|NCT04200456|366274661|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
106166788|NCT02723591|366274663|FG000|Overall Study|Adverse Event|48|||
106166789|NCT02723591|366274664|FG001|Overall Study|Adverse Event|40|||
106166790|NCT02723591|366274663|FG000|Overall Study|Death|2|||
106166791|NCT02723591|366274664|FG001|Overall Study|Death|2|||
106166792|NCT02723591|366274663|FG000|Overall Study|Lack of Efficacy|4|||
106166793|NCT02723591|366274664|FG001|Overall Study|Lack of Efficacy|3|||
106166794|NCT02723591|366274663|FG000|Overall Study|Lost to Follow-up|1|||
106166795|NCT02723591|366274664|FG001|Overall Study|Lost to Follow-up|7|||
106166796|NCT02723591|366274663|FG000|Overall Study|Protocol Violation|20|||
106166797|NCT02723591|366274664|FG001|Overall Study|Protocol Violation|23|||
106166798|NCT02723591|366274663|FG000|Overall Study|Withdrawal by Subject|4|||
106166799|NCT02723591|366274664|FG001|Overall Study|Withdrawal by Subject|8|||
106166800|NCT02723591|366274663|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
106166801|NCT02723591|366274664|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
106166802|NCT02723591|366274663|FG000|Overall Study|Miscellaneous|5|||
106166803|NCT02723591|366274664|FG001|Overall Study|Miscellaneous|6|||
106166804|NCT05070728|366274665|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
106166805|NCT05070728|366274666|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
106166806|NCT03852719|366274673|FG000|Overall Study|Still on study after Week 192|37|||
106166807|NCT03852719|366274674|FG001|Overall Study|Still on study after Week 192|35|||
106166808|NCT03852719|366274675|FG002|Overall Study|Still on study after Week 192|35|||
106166809|NCT03852719|366274673|FG000|Overall Study|Withdrawal of consent|5|||
106166810|NCT03852719|366274674|FG001|Overall Study|Withdrawal of consent|8|||
106166811|NCT03852719|366274675|FG002|Overall Study|Withdrawal of consent|7|||
106166812|NCT03852719|366274673|FG000|Overall Study|Physician Decision|0|||
106166813|NCT03852719|366274674|FG001|Overall Study|Physician Decision|1|||
106166814|NCT03852719|366274675|FG002|Overall Study|Physician Decision|1|||
106166815|NCT03852719|366274673|FG000|Overall Study|Pregnancy|2|||
106166816|NCT03852719|366274674|FG001|Overall Study|Pregnancy|1|||
106166817|NCT03852719|366274675|FG002|Overall Study|Pregnancy|0|||
106166818|NCT03852719|366274673|FG000|Overall Study|Death|1|||
106166819|NCT03852719|366274674|FG001|Overall Study|Death|0|||
106166820|NCT03852719|366274675|FG002|Overall Study|Death|0|||
106166821|NCT03852719|366274673|FG000|Overall Study|Reason not Specified|3|||
106166822|NCT03852719|366274674|FG001|Overall Study|Reason not Specified|2|||
106166823|NCT03852719|366274675|FG002|Overall Study|Reason not Specified|2|||
106166824|NCT03852719|366274673|FG000|Overall Study|Adverse Event|1|||
106166825|NCT03852719|366274674|FG001|Overall Study|Adverse Event|0|||
106166826|NCT03852719|366274675|FG002|Overall Study|Adverse Event|4|||
106166827|NCT03852719|366274673|FG000|Overall Study|Progressive disease|1|||
106166828|NCT03852719|366274674|FG001|Overall Study|Progressive disease|2|||
106166829|NCT03852719|366274675|FG002|Overall Study|Progressive disease|1|||
106166830|NCT03852719|366274673|FG000|Overall Study|Lost to Follow-up|1|||
106166831|NCT03852719|366274674|FG001|Overall Study|Lost to Follow-up|0|||
106166832|NCT03852719|366274675|FG002|Overall Study|Lost to Follow-up|0|||
106166833|NCT03599661|366274677|FG000|Overall Study|Lost to Follow-up|9|||
106166834|NCT04811040|366274682|FG000|Overall Study|Lost to Follow-up|2|||
106166835|NCT04811040|366274683|FG001|Overall Study|Lost to Follow-up|0|||
106166836|NCT04811040|366274684|FG002|Overall Study|Lost to Follow-up|0|||
106166837|NCT04811040|366274685|FG003|Overall Study|Lost to Follow-up|0|||
106166838|NCT04811040|366274682|FG000|Overall Study|Withdrew consent|1|||
106166839|NCT04811040|366274683|FG001|Overall Study|Withdrew consent|1|||
106166840|NCT04811040|366274684|FG002|Overall Study|Withdrew consent|0|||
106166841|NCT04811040|366274685|FG003|Overall Study|Withdrew consent|0|||
106166842|NCT04117347|366274686|FG000|Overall Study|Adverse Event|0|||
106166843|NCT04117347|366274687|FG001|Overall Study|Adverse Event|0|||
106166844|NCT04117347|366274688|FG002|Overall Study|Adverse Event|1|||
106166845|NCT04117347|366274686|FG000|Overall Study|No time for study|0|||
106166846|NCT04117347|366274687|FG001|Overall Study|No time for study|2|||
106166847|NCT04117347|366274688|FG002|Overall Study|No time for study|0|||
106166848|NCT04117347|366274686|FG000|Overall Study|Family emergency|1|||
106166849|NCT04117347|366274687|FG001|Overall Study|Family emergency|0|||
106166850|NCT04117347|366274688|FG002|Overall Study|Family emergency|0|||
106166851|NCT03691935|366274689|FG000|Overall Study|Physician Decision|2|||
106166852|NCT03691935|366274690|FG001|Overall Study|Physician Decision|1|||
106166853|NCT03691935|366274689|FG000|Overall Study|Adverse Event|3|||
106166854|NCT03691935|366274690|FG001|Overall Study|Adverse Event|0|||
106166855|NCT04577963|366274697|FG000|Part 2|Death|0|||
106166856|NCT04577963|366274698|FG001|Part 2|Death|1|||
106166857|NCT04577963|366274699|FG002|Part 2|Death|8|||
106166858|NCT04577963|366274700|FG003|Part 2|Death|0|||
106166859|NCT04577963|366274701|FG004|Part 2|Death|20|||
106166860|NCT04577963|366274697|FG000|Part 2|Lost to Follow-up|0|||
106166861|NCT04577963|366274698|FG001|Part 2|Lost to Follow-up|0|||
106166862|NCT04577963|366274699|FG002|Part 2|Lost to Follow-up|0|||
106166863|NCT04577963|366274700|FG003|Part 2|Lost to Follow-up|0|||
106166864|NCT04577963|366274701|FG004|Part 2|Lost to Follow-up|2|||
106166865|NCT04577963|366274697|FG000|Part 2|Withdrawal by Subject|0|||
106166866|NCT04577963|366274698|FG001|Part 2|Withdrawal by Subject|0|||
106166867|NCT04577963|366274699|FG002|Part 2|Withdrawal by Subject|0|||
106166868|NCT04577963|366274700|FG003|Part 2|Withdrawal by Subject|0|||
106166869|NCT04577963|366274701|FG004|Part 2|Withdrawal by Subject|10|||
106166870|NCT04577963|366274697|FG000|Part 2|Progressive disease|0|||
106166871|NCT04577963|366274698|FG001|Part 2|Progressive disease|0|||
106166872|NCT04577963|366274699|FG002|Part 2|Progressive disease|0|||
106166873|NCT04577963|366274700|FG003|Part 2|Progressive disease|0|||
106166874|NCT04577963|366274701|FG004|Part 2|Progressive disease|2|||
106166875|NCT04577963|366274697|FG000|Part 2|Investigator decision|0|||
106166876|NCT04577963|366274698|FG001|Part 2|Investigator decision|0|||
106166877|NCT04577963|366274699|FG002|Part 2|Investigator decision|0|||
106166878|NCT04577963|366274700|FG003|Part 2|Investigator decision|0|||
106166879|NCT04577963|366274701|FG004|Part 2|Investigator decision|1|||
106166880|NCT04577963|366274697|FG000|Part 2|Sponsor terminated study|0|||
106166881|NCT04577963|366274698|FG001|Part 2|Sponsor terminated study|0|||
106166882|NCT04577963|366274699|FG002|Part 2|Sponsor terminated study|3|||
106166883|NCT04577963|366274700|FG003|Part 2|Sponsor terminated study|1|||
106166884|NCT04577963|366274701|FG004|Part 2|Sponsor terminated study|4|||
106166885|NCT04081103|366274702|FG000|Overall Study|Adverse Event|1|||
106166886|NCT04081103|366274703|FG001|Overall Study|Adverse Event|1|||
106166887|NCT04081103|366274704|FG002|Overall Study|Adverse Event|1|||
106166888|NCT04081103|366274702|FG000|Overall Study|Physician Decision|0|||
106166889|NCT04081103|366274703|FG001|Overall Study|Physician Decision|0|||
106166890|NCT04081103|366274704|FG002|Overall Study|Physician Decision|1|||
106166891|NCT02521493|366274705|FG000|Overall Study|Death|3|||
106166892|NCT02521493|366274706|FG001|Overall Study|Death|4|||
106166893|NCT02521493|366274707|FG002|Overall Study|Death|1|||
106166894|NCT02521493|366274705|FG000|Overall Study|Physician Decision|19|||
106166895|NCT02521493|366274706|FG001|Overall Study|Physician Decision|1|||
106166896|NCT02521493|366274707|FG002|Overall Study|Physician Decision|2|||
106166897|NCT02521493|366274705|FG000|Overall Study|Withdrawal by Subject|3|||
106166898|NCT02521493|366274706|FG001|Overall Study|Withdrawal by Subject|0|||
106166899|NCT02521493|366274707|FG002|Overall Study|Withdrawal by Subject|0|||
106166900|NCT02521493|366274705|FG000|Overall Study|Ineligible|0|||
106166901|NCT02521493|366274706|FG001|Overall Study|Ineligible|1|||
106166902|NCT02521493|366274707|FG002|Overall Study|Ineligible|0|||
106166903|NCT02521493|366274705|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
106166904|NCT02521493|366274706|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
106166905|NCT02521493|366274707|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
106166906|NCT02521493|366274705|FG000|Overall Study|No MRD result|0|||
106166907|NCT02521493|366274706|FG001|Overall Study|No MRD result|0|||
106166908|NCT02521493|366274707|FG002|Overall Study|No MRD result|4|||
106166909|NCT03034356|366274708|FG000|Baseline|Lost to Follow-up|2|||
106166910|NCT03034356|366274709|FG001|Baseline|Lost to Follow-up|4|||
106166911|NCT03034356|366274708|FG000|Baseline|Withdrawal by Subject|2|||
106166912|NCT03034356|366274709|FG001|Baseline|Withdrawal by Subject|0|||
106166913|NCT03034356|366274708|FG000|Baseline|Physician Decision|0|||
106166914|NCT03034356|366274709|FG001|Baseline|Physician Decision|1|||
106166915|NCT03034356|366274708|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
106166916|NCT03034356|366274709|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
106166917|NCT03034356|366274708|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
106166918|NCT03034356|366274709|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
106166919|NCT03034356|366274708|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
106166920|NCT03034356|366274709|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
106166921|NCT03034356|366274708|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
106166922|NCT03034356|366274709|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
106166923|NCT05309291|366274710|FG000|Overall Study|Adverse Event|0|||
106166924|NCT05309291|366274711|FG001|Overall Study|Adverse Event|1|||
106166925|NCT05209152|366274716|FG000|Overall Study|Sponsor decision|1|||
106166926|NCT05209152|366274717|FG001|Overall Study|Sponsor decision|2|||
106166927|NCT05209152|366274716|FG000|Overall Study|Death|3|||
106166928|NCT05209152|366274717|FG001|Overall Study|Death|1|||
106166929|NCT05292391|366274720|FG000|Overall Study|Lost to Follow-up|0|||
106166930|NCT05292391|366274721|FG001|Overall Study|Lost to Follow-up|0|||
106166931|NCT05292391|366274722|FG002|Overall Study|Lost to Follow-up|0|||
106166932|NCT05292391|366274723|FG003|Overall Study|Lost to Follow-up|1|||
106166933|NCT05292391|366274724|FG004|Overall Study|Lost to Follow-up|0|||
106166934|NCT03058289|366276319|FG000|Overall Study|Radiographic Deterioration|0|||
106166935|NCT03058289|366276320|FG001|Overall Study|Radiographic Deterioration|3|||
106166936|NCT03058289|366276321|FG002|Overall Study|Radiographic Deterioration|1|||
106166937|NCT03058289|366276322|FG003|Overall Study|Radiographic Deterioration|2|||
106166938|NCT03058289|366276323|FG004|Overall Study|Radiographic Deterioration|6|||
106166939|NCT03058289|366276324|FG005|Overall Study|Radiographic Deterioration|3|||
106166940|NCT03058289|366276325|FG006|Overall Study|Radiographic Deterioration|0|||
106166941|NCT03058289|366276326|FG007|Overall Study|Radiographic Deterioration|4|||
106166942|NCT03058289|366276327|FG008|Overall Study|Radiographic Deterioration|2|||
106166943|NCT03058289|366276319|FG000|Overall Study|Adverse Event|2|||
106166944|NCT03058289|366276320|FG001|Overall Study|Adverse Event|0|||
106166945|NCT03058289|366276321|FG002|Overall Study|Adverse Event|1|||
106166946|NCT03058289|366276322|FG003|Overall Study|Adverse Event|3|||
106166947|NCT03058289|366276323|FG004|Overall Study|Adverse Event|1|||
106166948|NCT03058289|366276324|FG005|Overall Study|Adverse Event|0|||
106166949|NCT03058289|366276325|FG006|Overall Study|Adverse Event|1|||
106166950|NCT03058289|366276326|FG007|Overall Study|Adverse Event|3|||
106166951|NCT03058289|366276327|FG008|Overall Study|Adverse Event|0|||
106166952|NCT03058289|366276319|FG000|Overall Study|Withdrawal by Subject|0|||
106166953|NCT03058289|366276320|FG001|Overall Study|Withdrawal by Subject|0|||
106166954|NCT03058289|366276321|FG002|Overall Study|Withdrawal by Subject|0|||
106166955|NCT03058289|366276322|FG003|Overall Study|Withdrawal by Subject|2|||
106166956|NCT03058289|366276323|FG004|Overall Study|Withdrawal by Subject|0|||
106166957|NCT03058289|366276324|FG005|Overall Study|Withdrawal by Subject|2|||
106166958|NCT03058289|366276325|FG006|Overall Study|Withdrawal by Subject|0|||
106166959|NCT03058289|366276326|FG007|Overall Study|Withdrawal by Subject|4|||
106166960|NCT03058289|366276327|FG008|Overall Study|Withdrawal by Subject|1|||
106166961|NCT03058289|366276319|FG000|Overall Study|Physician Decision|1|||
106166962|NCT03058289|366276320|FG001|Overall Study|Physician Decision|0|||
106166963|NCT03058289|366276321|FG002|Overall Study|Physician Decision|0|||
106166964|NCT03058289|366276322|FG003|Overall Study|Physician Decision|2|||
106166965|NCT03058289|366276323|FG004|Overall Study|Physician Decision|1|||
106166966|NCT03058289|366276324|FG005|Overall Study|Physician Decision|0|||
106166967|NCT03058289|366276325|FG006|Overall Study|Physician Decision|2|||
106166968|NCT03058289|366276326|FG007|Overall Study|Physician Decision|3|||
106166969|NCT03058289|366276327|FG008|Overall Study|Physician Decision|0|||
106166970|NCT03058289|366276319|FG000|Overall Study|Clinical Deterioration|2|||
106166971|NCT03058289|366276320|FG001|Overall Study|Clinical Deterioration|0|||
106166972|NCT03058289|366276321|FG002|Overall Study|Clinical Deterioration|0|||
106166973|NCT03058289|366276322|FG003|Overall Study|Clinical Deterioration|2|||
106166974|NCT03058289|366276323|FG004|Overall Study|Clinical Deterioration|1|||
106166975|NCT03058289|366276324|FG005|Overall Study|Clinical Deterioration|1|||
106166976|NCT03058289|366276325|FG006|Overall Study|Clinical Deterioration|0|||
106166977|NCT03058289|366276326|FG007|Overall Study|Clinical Deterioration|3|||
106166978|NCT03058289|366276327|FG008|Overall Study|Clinical Deterioration|2|||
106166979|NCT03058289|366276319|FG000|Overall Study|Lost to Follow-up|0|||
106166980|NCT03058289|366276320|FG001|Overall Study|Lost to Follow-up|0|||
106166981|NCT03058289|366276321|FG002|Overall Study|Lost to Follow-up|0|||
106166982|NCT03058289|366276322|FG003|Overall Study|Lost to Follow-up|0|||
106166983|NCT03058289|366276323|FG004|Overall Study|Lost to Follow-up|1|||
106166984|NCT03058289|366276324|FG005|Overall Study|Lost to Follow-up|0|||
106166985|NCT03058289|366276325|FG006|Overall Study|Lost to Follow-up|0|||
106166986|NCT03058289|366276326|FG007|Overall Study|Lost to Follow-up|0|||
106166987|NCT03058289|366276327|FG008|Overall Study|Lost to Follow-up|0|||
106166988|NCT03058289|366276319|FG000|Overall Study|Refused Further Treatment|0|||
106166989|NCT03058289|366276320|FG001|Overall Study|Refused Further Treatment|0|||
106166990|NCT03058289|366276321|FG002|Overall Study|Refused Further Treatment|1|||
106166991|NCT03058289|366276322|FG003|Overall Study|Refused Further Treatment|0|||
106166992|NCT03058289|366276323|FG004|Overall Study|Refused Further Treatment|1|||
106166993|NCT03058289|366276324|FG005|Overall Study|Refused Further Treatment|0|||
106166994|NCT03058289|366276325|FG006|Overall Study|Refused Further Treatment|0|||
106166995|NCT03058289|366276326|FG007|Overall Study|Refused Further Treatment|0|||
106166996|NCT03058289|366276327|FG008|Overall Study|Refused Further Treatment|0|||
106166997|NCT03058289|366276319|FG000|Overall Study|Rapid Progression of Disease|0|||
106166998|NCT03058289|366276320|FG001|Overall Study|Rapid Progression of Disease|0|||
106166999|NCT03058289|366276321|FG002|Overall Study|Rapid Progression of Disease|0|||
106167000|NCT03058289|366276322|FG003|Overall Study|Rapid Progression of Disease|1|||
106167001|NCT03058289|366276323|FG004|Overall Study|Rapid Progression of Disease|0|||
106167002|NCT03058289|366276324|FG005|Overall Study|Rapid Progression of Disease|0|||
106167003|NCT03058289|366276325|FG006|Overall Study|Rapid Progression of Disease|0|||
106167004|NCT03058289|366276326|FG007|Overall Study|Rapid Progression of Disease|0|||
106167005|NCT03058289|366276327|FG008|Overall Study|Rapid Progression of Disease|0|||
106167006|NCT05436262|366276331|FG000|Pre-Randomization|Withdrawal by Subject|1|||
106167007|NCT05436262|366276332|FG001|Pre-Randomization|Withdrawal by Subject|0|||
106167008|NCT05436262|366276333|FG002|Pre-Randomization|Withdrawal by Subject|0|||
106167009|NCT05436262|366276331|FG000|Randomization|Withdrawal by Subject|0|||
106167010|NCT05436262|366276332|FG001|Randomization|Withdrawal by Subject|1|||
106167011|NCT05436262|366276333|FG002|Randomization|Withdrawal by Subject|0|||
106167012|NCT03952338|366276334|FG000|Overall Study|Lost to Follow-up|11|||
106167013|NCT03952338|366276335|FG001|Overall Study|Lost to Follow-up|17|||
106167014|NCT03952338|366276334|FG000|Overall Study|Withdrawal by Subject|1|||
106167015|NCT03952338|366276335|FG001|Overall Study|Withdrawal by Subject|1|||
106167016|NCT03952338|366276334|FG000|Overall Study|Protocol Violation|1|||
106167017|NCT03952338|366276335|FG001|Overall Study|Protocol Violation|0|||
106167018|NCT03816332|366276338|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
106167019|NCT03816332|366276338|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
106167020|NCT01456949|366276339|FG000|Enrollment|PI death- incomplete data|6|||
106167021|NCT01456949|366276339|FG000|Enrollment|Death|1|||
106167022|NCT01456949|366276339|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
106167023|NCT01456949|366276339|FG000|Enrollment|Physician Decision|10|||
106167024|NCT01456949|366276339|FG000|Enrollment|Withdrawal by Subject|7|||
106167025|NCT01456949|366276339|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
106167026|NCT01456949|366276339|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
106167027|NCT01456949|366276339|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
106167028|NCT01456949|366276339|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
106167029|NCT01456949|366276339|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
106167030|NCT01456949|366276339|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
106167031|NCT01456949|366276339|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
106167032|NCT01456949|366276339|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
106167033|NCT03710603|366276340|FG000|Overall Study|Adverse Event|1|||
106167034|NCT03710603|366276341|FG001|Overall Study|Adverse Event|0|||
106167035|NCT03710603|366276340|FG000|Overall Study|Death|44|||
106167036|NCT03710603|366276341|FG001|Overall Study|Death|34|||
106167037|NCT03710603|366276340|FG000|Overall Study|Lost to Follow-up|3|||
106167038|NCT03710603|366276341|FG001|Overall Study|Lost to Follow-up|5|||
106167039|NCT03710603|366276340|FG000|Overall Study|Withdrawal by Subject|11|||
106167040|NCT03710603|366276341|FG001|Overall Study|Withdrawal by Subject|10|||
106167041|NCT02626533|366276342|FG000|Overall Study|Protocol Violation|14|||
106167042|NCT02626533|366276342|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
106167043|NCT02626533|366276342|FG000|Overall Study|Withdrawal by Subject|1|||
106167044|NCT04753697|366276343|FG000|Induction Phase|Withdrawal by Subject|12|||
106167045|NCT04753697|366276344|FG001|Induction Phase|Withdrawal by Subject|5|||
106167046|NCT04753697|366276345|FG002|Induction Phase|Withdrawal by Subject|6|||
106167047|NCT04753697|366276343|FG000|Induction Phase|Physician Decision|1|||
106167048|NCT04753697|366276344|FG001|Induction Phase|Physician Decision|0|||
106167049|NCT04753697|366276345|FG002|Induction Phase|Physician Decision|0|||
106167050|NCT04753697|366276343|FG000|Induction Phase|Lost to Follow-up|2|||
106167051|NCT04753697|366276344|FG001|Induction Phase|Lost to Follow-up|2|||
106167052|NCT04753697|366276345|FG002|Induction Phase|Lost to Follow-up|1|||
106167053|NCT04753697|366276343|FG000|Induction Phase|Lack of Efficacy|1|||
106167054|NCT04753697|366276344|FG001|Induction Phase|Lack of Efficacy|0|||
106167055|NCT04753697|366276345|FG002|Induction Phase|Lack of Efficacy|0|||
106167056|NCT04753697|366276343|FG000|Maintenance Phase|Physician Decision|0|||
106167057|NCT04753697|366276344|FG001|Maintenance Phase|Physician Decision|0|||
106167058|NCT04753697|366276345|FG002|Maintenance Phase|Physician Decision|1|||
106167059|NCT04753697|366276343|FG000|Maintenance Phase|Withdrawal by Subject|3|||
106167060|NCT04753697|366276344|FG001|Maintenance Phase|Withdrawal by Subject|4|||
106167061|NCT04753697|366276345|FG002|Maintenance Phase|Withdrawal by Subject|6|||
106167062|NCT04753697|366276343|FG000|Maintenance Phase|Lost to Follow-up|2|||
106167063|NCT04753697|366276344|FG001|Maintenance Phase|Lost to Follow-up|2|||
106167064|NCT04753697|366276345|FG002|Maintenance Phase|Lost to Follow-up|0|||
106167065|NCT04753697|366276343|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
106167066|NCT04753697|366276344|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
106167067|NCT04753697|366276345|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
106167068|NCT04753697|366276343|FG000|Maintenance Phase|Adverse Event|0|||
106167069|NCT04753697|366276344|FG001|Maintenance Phase|Adverse Event|1|||
106167070|NCT04753697|366276345|FG002|Maintenance Phase|Adverse Event|1|||
106167071|NCT04753697|366276343|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
106167072|NCT04753697|366276344|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
106167073|NCT04753697|366276345|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
106167074|NCT04850898|366276348|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
106167075|NCT04850898|366276349|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
106167076|NCT03701763|366276350|FG000|Placebo-controlled Phase|Adverse Event|1|||
106167077|NCT03701763|366276351|FG001|Placebo-controlled Phase|Adverse Event|5|||
106167078|NCT03701763|366276352|FG002|Placebo-controlled Phase|Adverse Event|0|||
106167079|NCT03701763|366276353|FG003|Placebo-controlled Phase|Adverse Event|0|||
106167080|NCT03701763|366276350|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
106167081|NCT03701763|366276351|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
106167082|NCT03701763|366276352|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
106167083|NCT03701763|366276353|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
106167084|NCT03701763|366276350|FG000|Placebo-controlled Phase|Miscellaneous|2|||
106167085|NCT03701763|366276351|FG001|Placebo-controlled Phase|Miscellaneous|0|||
106167086|NCT03701763|366276352|FG002|Placebo-controlled Phase|Miscellaneous|0|||
106167087|NCT03701763|366276353|FG003|Placebo-controlled Phase|Miscellaneous|0|||
106167088|NCT03701763|366276350|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
106167089|NCT03701763|366276351|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
106167090|NCT03701763|366276352|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
106167091|NCT03701763|366276353|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
106167092|NCT03701763|366276350|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
106167093|NCT03701763|366276351|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
106167094|NCT03701763|366276352|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
106167095|NCT03701763|366276353|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
106167096|NCT03701763|366276350|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
106167097|NCT03701763|366276351|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
106167098|NCT03701763|366276352|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
106167099|NCT03701763|366276353|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
106167100|NCT03701763|366276350|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
106167101|NCT03701763|366276351|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
106167102|NCT03701763|366276352|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
106167103|NCT03701763|366276353|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
106167104|NCT03701763|366276350|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
106167105|NCT03701763|366276351|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
106167106|NCT03701763|366276352|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
106167107|NCT03701763|366276353|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
106167108|NCT03701763|366276350|FG000|Apremilast Extension Phase|Adverse Event|0|||
106167109|NCT03701763|366276351|FG001|Apremilast Extension Phase|Adverse Event|0|||
106167110|NCT03701763|366276352|FG002|Apremilast Extension Phase|Adverse Event|3|||
106167111|NCT03701763|366276353|FG003|Apremilast Extension Phase|Adverse Event|1|||
106167112|NCT03701763|366276350|FG000|Apremilast Extension Phase|Miscellaneous|0|||
106167113|NCT03701763|366276351|FG001|Apremilast Extension Phase|Miscellaneous|0|||
106167114|NCT03701763|366276352|FG002|Apremilast Extension Phase|Miscellaneous|2|||
106167115|NCT03701763|366276353|FG003|Apremilast Extension Phase|Miscellaneous|1|||
106167116|NCT03701763|366276350|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
106167117|NCT03701763|366276351|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
106167118|NCT03701763|366276352|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
106167119|NCT03701763|366276353|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
106167120|NCT03701763|366276350|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
106167121|NCT03701763|366276351|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
106167122|NCT03701763|366276352|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
106167123|NCT03701763|366276353|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
106167124|NCT03701763|366276350|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
106167125|NCT03701763|366276351|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
106167126|NCT03701763|366276352|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
106167127|NCT03701763|366276353|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
106167128|NCT03701763|366276350|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
106167129|NCT03701763|366276351|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
106167130|NCT03701763|366276352|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
106167131|NCT03701763|366276353|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
106167132|NCT03701763|366276350|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
106167133|NCT03701763|366276351|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
106167134|NCT03701763|366276352|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
106167135|NCT03701763|366276353|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
106167136|NCT03701763|366276350|FG000|14-Week Observational Follow-up Phase|Other|0|||
106167137|NCT03701763|366276351|FG001|14-Week Observational Follow-up Phase|Other|0|||
106167138|NCT03701763|366276352|FG002|14-Week Observational Follow-up Phase|Other|1|||
106167139|NCT03701763|366276353|FG003|14-Week Observational Follow-up Phase|Other|0|||
106167140|NCT03701763|366276350|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
106167141|NCT03701763|366276351|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
106167142|NCT03701763|366276352|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
106167143|NCT03701763|366276353|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
106167144|NCT03701763|366276350|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
106167145|NCT03701763|366276351|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
106167146|NCT03701763|366276352|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
106167147|NCT03701763|366276353|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
106167148|NCT00592852|366276354|FG000|Overall Study|Non-compliance|1|||
106167149|NCT00592852|366276354|FG000|Overall Study|Adverse Event|3|||
106167150|NCT00592852|366276354|FG000|Overall Study|Found ineligible|1|||
106167151|NCT00592852|366276354|FG000|Overall Study|Withdrawal by Subject|1|||
106167152|NCT02589795|366276355|FG000|Overall Study|Lost to Follow-up|1|||
106167153|NCT02589795|366276356|FG001|Overall Study|Lost to Follow-up|0|||
106167154|NCT02589795|366276357|FG002|Overall Study|Lost to Follow-up|0|||
106167155|NCT02589795|366276355|FG000|Overall Study|Withdrawal by Subject|0|||
106167156|NCT02589795|366276356|FG001|Overall Study|Withdrawal by Subject|0|||
106167157|NCT02589795|366276357|FG002|Overall Study|Withdrawal by Subject|2|||
106167158|NCT02589795|366276355|FG000|Overall Study|Protocol Violation|0|||
106167159|NCT02589795|366276356|FG001|Overall Study|Protocol Violation|0|||
106167160|NCT02589795|366276357|FG002|Overall Study|Protocol Violation|1|||
106167161|NCT05194956|366276359|FG000|Washout Period|Withdrawal by Subject|0|||
106167162|NCT05194956|366276360|FG001|Washout Period|Withdrawal by Subject|2|||
106167163|NCT05446870|366276383|FG000|Overall Study|Death|6|||
106167164|NCT05446870|366276384|FG001|Overall Study|Death|2|||
106167165|NCT05446870|366276383|FG000|Overall Study|Lost to Follow-up|0|||
106167166|NCT05446870|366276384|FG001|Overall Study|Lost to Follow-up|1|||
106167167|NCT05446870|366276383|FG000|Overall Study|Physician Decision|27|||
106167168|NCT05446870|366276384|FG001|Overall Study|Physician Decision|25|||
106167169|NCT05446870|366276383|FG000|Overall Study|Withdrawal by Subject|3|||
106167170|NCT05446870|366276384|FG001|Overall Study|Withdrawal by Subject|2|||
106167171|NCT05446870|366276383|FG000|Overall Study|Study Ongoing|37|||
106167172|NCT05446870|366276384|FG001|Overall Study|Study Ongoing|43|||
106167173|NCT04299464|366276391|FG000|Overall Study|Adverse Event|1|||
106167174|NCT04299464|366276392|FG001|Overall Study|Adverse Event|0|||
106167175|NCT04299464|366276393|FG002|Overall Study|Adverse Event|2|||
106167176|NCT04299464|366276391|FG000|Overall Study|Non-compliance with Study Drug|1|||
106167177|NCT04299464|366276392|FG001|Overall Study|Non-compliance with Study Drug|0|||
106167178|NCT04299464|366276393|FG002|Overall Study|Non-compliance with Study Drug|0|||
106167179|NCT04299464|366276391|FG000|Overall Study|Reason not Specified|0|||
106167180|NCT04299464|366276392|FG001|Overall Study|Reason not Specified|1|||
106167181|NCT04299464|366276393|FG002|Overall Study|Reason not Specified|3|||
106167182|NCT04299464|366276391|FG000|Overall Study|Physician Decision|0|||
106167183|NCT04299464|366276392|FG001|Overall Study|Physician Decision|1|||
106167184|NCT04299464|366276393|FG002|Overall Study|Physician Decision|1|||
106167185|NCT04299464|366276391|FG000|Overall Study|Withdrawal by Subject|0|||
106167186|NCT04299464|366276392|FG001|Overall Study|Withdrawal by Subject|2|||
106167187|NCT04299464|366276393|FG002|Overall Study|Withdrawal by Subject|1|||
106167188|NCT05192109|366276401|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
106167189|NCT05192109|366276402|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
106167190|NCT05192109|366276403|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
106167191|NCT05192109|366276404|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
106167192|NCT05192109|366276401|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
106167193|NCT05192109|366276402|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
106167194|NCT05192109|366276403|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
106167195|NCT05192109|366276404|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
106167196|NCT04498390|366276405|FG000|Overall Study|Adverse Event|0|||
106167197|NCT04498390|366276406|FG001|Overall Study|Adverse Event|0|||
106167198|NCT04498390|366276407|FG002|Overall Study|Adverse Event|1|||
106167199|NCT04498390|366276408|FG003|Overall Study|Adverse Event|0|||
106167200|NCT04498390|366276409|FG004|Overall Study|Adverse Event|0|||
106167201|NCT04498390|366276405|FG000|Overall Study|Withdrawal by Subject|0|||
106167202|NCT04498390|366276406|FG001|Overall Study|Withdrawal by Subject|0|||
106167203|NCT04498390|366276407|FG002|Overall Study|Withdrawal by Subject|0|||
106167204|NCT04498390|366276408|FG003|Overall Study|Withdrawal by Subject|1|||
106167205|NCT04498390|366276409|FG004|Overall Study|Withdrawal by Subject|0|||
106167206|NCT05318937|366276410|FG000|Overall Study|Non-Compliance with Study Drug|1|||
106167207|NCT05318937|366276411|FG001|Overall Study|Non-Compliance with Study Drug|0|||
106167208|NCT05318937|366276410|FG000|Overall Study|Lost to Follow-up|0|||
106167209|NCT05318937|366276411|FG001|Overall Study|Lost to Follow-up|1|||
106167210|NCT05318937|366276410|FG000|Overall Study|Withdrawal by Subject|0|||
106167211|NCT05318937|366276411|FG001|Overall Study|Withdrawal by Subject|2|||
106167212|NCT05318937|366276410|FG000|Overall Study|Protocol Violation|0|||
106167213|NCT05318937|366276411|FG001|Overall Study|Protocol Violation|1|||
106167214|NCT04515849|366276412|FG000|Overall Study|Adverse Event|0|||
106167215|NCT04515849|366276413|FG001|Overall Study|Adverse Event|0|||
106167216|NCT04515849|366276414|FG002|Overall Study|Adverse Event|0|||
106167217|NCT04515849|366276415|FG003|Overall Study|Adverse Event|1|||
106167218|NCT04515849|366276416|FG004|Overall Study|Adverse Event|2|||
106167219|NCT04515849|366276412|FG000|Overall Study|Death|2|||
106167220|NCT04515849|366276413|FG001|Overall Study|Death|0|||
106167221|NCT04515849|366276414|FG002|Overall Study|Death|0|||
106167222|NCT04515849|366276415|FG003|Overall Study|Death|0|||
106167223|NCT04515849|366276416|FG004|Overall Study|Death|0|||
106167224|NCT04515849|366276412|FG000|Overall Study|Other:family emergency|0|||
106167225|NCT04515849|366276413|FG001|Overall Study|Other:family emergency|0|||
106167226|NCT04515849|366276414|FG002|Overall Study|Other:family emergency|0|||
106167227|NCT04515849|366276415|FG003|Overall Study|Other:family emergency|1|||
106167228|NCT04515849|366276416|FG004|Overall Study|Other:family emergency|0|||
106167229|NCT04515849|366276412|FG000|Overall Study|Other:randomised by error|0|||
106167230|NCT04515849|366276413|FG001|Overall Study|Other:randomised by error|1|||
106167231|NCT04515849|366276414|FG002|Overall Study|Other:randomised by error|0|||
106167232|NCT04515849|366276415|FG003|Overall Study|Other:randomised by error|0|||
106167233|NCT04515849|366276416|FG004|Overall Study|Other:randomised by error|0|||
106167234|NCT04515849|366276412|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
106167235|NCT04515849|366276413|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
106167236|NCT04515849|366276414|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
106167237|NCT04515849|366276415|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
106167238|NCT04515849|366276416|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
106167239|NCT04515849|366276412|FG000|Overall Study|Physician Decision|0|||
106167240|NCT04515849|366276413|FG001|Overall Study|Physician Decision|1|||
106167241|NCT04515849|366276414|FG002|Overall Study|Physician Decision|0|||
106167242|NCT04515849|366276415|FG003|Overall Study|Physician Decision|0|||
106167243|NCT04515849|366276416|FG004|Overall Study|Physician Decision|0|||
106167244|NCT04515849|366276412|FG000|Overall Study|Withdrawal by Subject|1|||
106167245|NCT04515849|366276413|FG001|Overall Study|Withdrawal by Subject|2|||
106167246|NCT04515849|366276414|FG002|Overall Study|Withdrawal by Subject|1|||
106167247|NCT04515849|366276415|FG003|Overall Study|Withdrawal by Subject|0|||
106167248|NCT04515849|366276416|FG004|Overall Study|Withdrawal by Subject|0|||
106167249|NCT01868997|366276417|FG000|Overall Study|Adverse Event|2|||
106167250|NCT01868997|366276418|FG001|Overall Study|Adverse Event|5|||
106167251|NCT01868997|366276417|FG000|Overall Study|Lack of Efficacy|2|||
106167252|NCT01868997|366276418|FG001|Overall Study|Lack of Efficacy|0|||
106167253|NCT01868997|366276417|FG000|Overall Study|Other|3|||
106167254|NCT01868997|366276418|FG001|Overall Study|Other|1|||
106167255|NCT05370040|366276419|FG000|Overall Study|Lost to Follow-up|0|||
106167256|NCT05370040|366276420|FG001|Overall Study|Lost to Follow-up|0|||
106167257|NCT05370040|366276421|FG002|Overall Study|Lost to Follow-up|1|||
106167258|NCT05370040|366276422|FG003|Overall Study|Lost to Follow-up|0|||
106167259|NCT05370040|366276423|FG004|Overall Study|Lost to Follow-up|1|||
106167260|NCT05370040|366276424|FG005|Overall Study|Lost to Follow-up|0|||
106167261|NCT04766892|366276426|FG000|Overall Study|Withdrawal by Subject|1|||
106167262|NCT04766892|366276426|FG000|Overall Study|Lost to Follow-up|1|||
106167263|NCT04766892|366276426|FG000|Overall Study|Adverse Event|3|||
106167264|NCT04766892|366276426|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
106167265|NCT06122194|366276430|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
106167266|NCT06122194|366276431|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
106167267|NCT06122194|366276432|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
106167268|NCT06122194|366276433|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
106167269|NCT04409353|366276434|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
106167270|NCT04409353|366276435|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
106167271|NCT04409353|366276436|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
106167272|NCT04409353|366276434|FG000|Overall Study|Lost to Follow-up|6|||
106167273|NCT04409353|366276435|FG001|Overall Study|Lost to Follow-up|8|||
106167274|NCT04409353|366276436|FG002|Overall Study|Lost to Follow-up|7|||
106167275|NCT04409353|366276434|FG000|Overall Study|Major surgery during participation window|4|||
106167276|NCT04409353|366276435|FG001|Overall Study|Major surgery during participation window|3|||
106167277|NCT04409353|366276436|FG002|Overall Study|Major surgery during participation window|3|||
106167278|NCT04409353|366276434|FG000|Overall Study|Life event occurred during participation window|3|||
106167279|NCT04409353|366276435|FG001|Overall Study|Life event occurred during participation window|2|||
106167280|NCT04409353|366276436|FG002|Overall Study|Life event occurred during participation window|4|||
106167281|NCT04409353|366276434|FG000|Overall Study|Lack of Efficacy|4|||
106167282|NCT04409353|366276435|FG001|Overall Study|Lack of Efficacy|1|||
106167283|NCT04409353|366276436|FG002|Overall Study|Lack of Efficacy|3|||
106167284|NCT04409353|366276434|FG000|Overall Study|Adverse Event|2|||
106167285|NCT04409353|366276435|FG001|Overall Study|Adverse Event|1|||
106167286|NCT04409353|366276436|FG002|Overall Study|Adverse Event|1|||
106167287|NCT04409353|366276434|FG000|Overall Study|Disease burden - unable to participate|0|||
106167288|NCT04409353|366276435|FG001|Overall Study|Disease burden - unable to participate|1|||
106167289|NCT04409353|366276436|FG002|Overall Study|Disease burden - unable to participate|1|||
106167290|NCT04409353|366276434|FG000|Overall Study|Intervention too complicated|1|||
106167291|NCT04409353|366276435|FG001|Overall Study|Intervention too complicated|0|||
106167292|NCT04409353|366276436|FG002|Overall Study|Intervention too complicated|1|||
106167293|NCT03519178|366276439|FG000|PF-06873600 Treatment|Adverse Event|0|||
106167294|NCT03519178|366276440|FG001|PF-06873600 Treatment|Adverse Event|0|||
106167295|NCT03519178|366276441|FG002|PF-06873600 Treatment|Adverse Event|0|||
106167296|NCT03519178|366276442|FG003|PF-06873600 Treatment|Adverse Event|0|||
106167297|NCT03519178|366276443|FG004|PF-06873600 Treatment|Adverse Event|0|||
106167298|NCT03519178|366276444|FG005|PF-06873600 Treatment|Adverse Event|0|||
106167299|NCT03519178|366276445|FG006|PF-06873600 Treatment|Adverse Event|0|||
106167300|NCT03519178|366276446|FG007|PF-06873600 Treatment|Adverse Event|2|||
106167301|NCT03519178|366276447|FG008|PF-06873600 Treatment|Adverse Event|1|||
106167302|NCT03519178|366276448|FG009|PF-06873600 Treatment|Adverse Event|0|||
106167303|NCT03519178|366276449|FG010|PF-06873600 Treatment|Adverse Event|0|||
106167304|NCT03519178|366276450|FG011|PF-06873600 Treatment|Adverse Event|0|||
106167305|NCT03519178|366276451|FG012|PF-06873600 Treatment|Adverse Event|1|||
106167306|NCT03519178|366276452|FG013|PF-06873600 Treatment|Adverse Event|3|||
106167307|NCT03519178|366276453|FG014|PF-06873600 Treatment|Adverse Event|2|||
106167308|NCT03519178|366276439|FG000|PF-06873600 Treatment|Death|0|||
106167309|NCT03519178|366276440|FG001|PF-06873600 Treatment|Death|0|||
106167310|NCT03519178|366276441|FG002|PF-06873600 Treatment|Death|0|||
106167311|NCT03519178|366276442|FG003|PF-06873600 Treatment|Death|0|||
106167312|NCT03519178|366276443|FG004|PF-06873600 Treatment|Death|0|||
106167313|NCT03519178|366276444|FG005|PF-06873600 Treatment|Death|0|||
106167314|NCT03519178|366276445|FG006|PF-06873600 Treatment|Death|0|||
106167315|NCT03519178|366276446|FG007|PF-06873600 Treatment|Death|0|||
106167316|NCT03519178|366276447|FG008|PF-06873600 Treatment|Death|1|||
106167317|NCT03519178|366276448|FG009|PF-06873600 Treatment|Death|1|||
106167318|NCT03519178|366276449|FG010|PF-06873600 Treatment|Death|0|||
106167319|NCT03519178|366276450|FG011|PF-06873600 Treatment|Death|0|||
106167320|NCT03519178|366276451|FG012|PF-06873600 Treatment|Death|0|||
106167321|NCT03519178|366276452|FG013|PF-06873600 Treatment|Death|0|||
106167322|NCT03519178|366276453|FG014|PF-06873600 Treatment|Death|1|||
106167323|NCT03519178|366276439|FG000|PF-06873600 Treatment|Physician Decision|0|||
106167324|NCT03519178|366276440|FG001|PF-06873600 Treatment|Physician Decision|0|||
106167325|NCT03519178|366276441|FG002|PF-06873600 Treatment|Physician Decision|0|||
106167326|NCT03519178|366276442|FG003|PF-06873600 Treatment|Physician Decision|0|||
106167327|NCT03519178|366276443|FG004|PF-06873600 Treatment|Physician Decision|0|||
106167328|NCT03519178|366276444|FG005|PF-06873600 Treatment|Physician Decision|0|||
106167329|NCT03519178|366276445|FG006|PF-06873600 Treatment|Physician Decision|0|||
106167330|NCT03519178|366276446|FG007|PF-06873600 Treatment|Physician Decision|1|||
106167331|NCT03519178|366276447|FG008|PF-06873600 Treatment|Physician Decision|0|||
106167332|NCT03519178|366276448|FG009|PF-06873600 Treatment|Physician Decision|0|||
106167333|NCT03519178|366276449|FG010|PF-06873600 Treatment|Physician Decision|1|||
106167334|NCT03519178|366276450|FG011|PF-06873600 Treatment|Physician Decision|0|||
106167335|NCT03519178|366276451|FG012|PF-06873600 Treatment|Physician Decision|0|||
106167336|NCT03519178|366276452|FG013|PF-06873600 Treatment|Physician Decision|4|||
106167337|NCT03519178|366276453|FG014|PF-06873600 Treatment|Physician Decision|1|||
106167338|NCT03519178|366276439|FG000|PF-06873600 Treatment|Progressive disease|1|||
106167339|NCT03519178|366276440|FG001|PF-06873600 Treatment|Progressive disease|1|||
106167340|NCT03519178|366276441|FG002|PF-06873600 Treatment|Progressive disease|1|||
106167341|NCT03519178|366276442|FG003|PF-06873600 Treatment|Progressive disease|1|||
106167342|NCT03519178|366276443|FG004|PF-06873600 Treatment|Progressive disease|6|||
106167343|NCT03519178|366276444|FG005|PF-06873600 Treatment|Progressive disease|7|||
106167344|NCT03519178|366276445|FG006|PF-06873600 Treatment|Progressive disease|3|||
106167345|NCT03519178|366276446|FG007|PF-06873600 Treatment|Progressive disease|7|||
106167346|NCT03519178|366276447|FG008|PF-06873600 Treatment|Progressive disease|3|||
106167347|NCT03519178|366276448|FG009|PF-06873600 Treatment|Progressive disease|5|||
106167348|NCT03519178|366276449|FG010|PF-06873600 Treatment|Progressive disease|4|||
106167349|NCT03519178|366276450|FG011|PF-06873600 Treatment|Progressive disease|3|||
106167350|NCT03519178|366276451|FG012|PF-06873600 Treatment|Progressive disease|4|||
106167351|NCT03519178|366276452|FG013|PF-06873600 Treatment|Progressive disease|28|||
106167352|NCT03519178|366276453|FG014|PF-06873600 Treatment|Progressive disease|7|||
106167353|NCT03519178|366276439|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
106167354|NCT03519178|366276440|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
106167355|NCT03519178|366276441|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
106167356|NCT03519178|366276442|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
106167357|NCT03519178|366276443|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
106167358|NCT03519178|366276444|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
106167359|NCT03519178|366276445|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
106167360|NCT03519178|366276446|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
106167361|NCT03519178|366276447|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
106167362|NCT03519178|366276448|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
106167363|NCT03519178|366276449|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
106167364|NCT03519178|366276450|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
106167365|NCT03519178|366276451|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
106167366|NCT03519178|366276452|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
106167367|NCT03519178|366276453|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
106167368|NCT03519178|366276439|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
106167369|NCT03519178|366276440|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
106167370|NCT03519178|366276441|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
106167371|NCT03519178|366276442|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
106167372|NCT03519178|366276443|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
106167373|NCT03519178|366276444|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
106167374|NCT03519178|366276445|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
106167375|NCT03519178|366276446|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
106167376|NCT03519178|366276447|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
106167377|NCT03519178|366276448|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
106167378|NCT03519178|366276449|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
106167379|NCT03519178|366276450|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
106167380|NCT03519178|366276451|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
106167381|NCT03519178|366276452|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
106167382|NCT03519178|366276453|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
106167383|NCT03519178|366276439|FG000|PF-06873600 Treatment|Refused further treatment|0|||
106167384|NCT03519178|366276440|FG001|PF-06873600 Treatment|Refused further treatment|1|||
106167385|NCT03519178|366276441|FG002|PF-06873600 Treatment|Refused further treatment|0|||
106167386|NCT03519178|366276442|FG003|PF-06873600 Treatment|Refused further treatment|0|||
106167387|NCT03519178|366276443|FG004|PF-06873600 Treatment|Refused further treatment|1|||
106167388|NCT03519178|366276444|FG005|PF-06873600 Treatment|Refused further treatment|0|||
106167389|NCT03519178|366276445|FG006|PF-06873600 Treatment|Refused further treatment|0|||
106167390|NCT03519178|366276446|FG007|PF-06873600 Treatment|Refused further treatment|0|||
106167391|NCT03519178|366276447|FG008|PF-06873600 Treatment|Refused further treatment|0|||
106167392|NCT03519178|366276448|FG009|PF-06873600 Treatment|Refused further treatment|0|||
106167393|NCT03519178|366276449|FG010|PF-06873600 Treatment|Refused further treatment|0|||
106167394|NCT03519178|366276450|FG011|PF-06873600 Treatment|Refused further treatment|0|||
106167395|NCT03519178|366276451|FG012|PF-06873600 Treatment|Refused further treatment|0|||
106167396|NCT03519178|366276452|FG013|PF-06873600 Treatment|Refused further treatment|0|||
106167397|NCT03519178|366276453|FG014|PF-06873600 Treatment|Refused further treatment|1|||
106167398|NCT03519178|366276439|FG000|PF-06873600 Treatment|Other|0|||
106167399|NCT03519178|366276440|FG001|PF-06873600 Treatment|Other|0|||
106167400|NCT03519178|366276441|FG002|PF-06873600 Treatment|Other|0|||
106167401|NCT03519178|366276442|FG003|PF-06873600 Treatment|Other|0|||
106167402|NCT03519178|366276443|FG004|PF-06873600 Treatment|Other|0|||
106167403|NCT03519178|366276444|FG005|PF-06873600 Treatment|Other|0|||
106167404|NCT03519178|366276445|FG006|PF-06873600 Treatment|Other|0|||
106167405|NCT03519178|366276446|FG007|PF-06873600 Treatment|Other|0|||
106167406|NCT03519178|366276447|FG008|PF-06873600 Treatment|Other|1|||
106167407|NCT03519178|366276448|FG009|PF-06873600 Treatment|Other|0|||
106167408|NCT03519178|366276449|FG010|PF-06873600 Treatment|Other|0|||
106167409|NCT03519178|366276450|FG011|PF-06873600 Treatment|Other|0|||
106167410|NCT03519178|366276451|FG012|PF-06873600 Treatment|Other|0|||
106167411|NCT03519178|366276452|FG013|PF-06873600 Treatment|Other|1|||
106167412|NCT03519178|366276453|FG014|PF-06873600 Treatment|Other|3|||
106167413|NCT03519178|366276439|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
106167414|NCT03519178|366276440|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
106167415|NCT03519178|366276441|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
106167416|NCT03519178|366276442|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
106167417|NCT03519178|366276443|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
106167418|NCT03519178|366276444|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
106167419|NCT03519178|366276445|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
106167420|NCT03519178|366276446|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
106167421|NCT03519178|366276447|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
106167422|NCT03519178|366276448|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
106167423|NCT03519178|366276449|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
106167424|NCT03519178|366276450|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
106167425|NCT03519178|366276451|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
106167426|NCT03519178|366276452|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
106167427|NCT03519178|366276453|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
106167428|NCT03519178|366276439|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167429|NCT03519178|366276440|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167430|NCT03519178|366276441|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167431|NCT03519178|366276442|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167432|NCT03519178|366276443|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167433|NCT03519178|366276444|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167434|NCT03519178|366276445|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167435|NCT03519178|366276446|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167436|NCT03519178|366276447|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167437|NCT03519178|366276448|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167438|NCT03519178|366276449|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167439|NCT03519178|366276450|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167440|NCT03519178|366276451|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
106167441|NCT03519178|366276452|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
106167442|NCT03519178|366276453|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
106167443|NCT03519178|366276439|FG000|PF-06873600 Treatment|Ongoing|0|||
106167444|NCT03519178|366276440|FG001|PF-06873600 Treatment|Ongoing|0|||
106167445|NCT03519178|366276441|FG002|PF-06873600 Treatment|Ongoing|0|||
106167446|NCT03519178|366276442|FG003|PF-06873600 Treatment|Ongoing|0|||
106167447|NCT03519178|366276443|FG004|PF-06873600 Treatment|Ongoing|0|||
106167448|NCT03519178|366276444|FG005|PF-06873600 Treatment|Ongoing|0|||
106167449|NCT03519178|366276445|FG006|PF-06873600 Treatment|Ongoing|0|||
106167450|NCT03519178|366276446|FG007|PF-06873600 Treatment|Ongoing|0|||
106167451|NCT03519178|366276447|FG008|PF-06873600 Treatment|Ongoing|0|||
106167452|NCT03519178|366276448|FG009|PF-06873600 Treatment|Ongoing|0|||
106167453|NCT03519178|366276449|FG010|PF-06873600 Treatment|Ongoing|0|||
106167454|NCT03519178|366276450|FG011|PF-06873600 Treatment|Ongoing|0|||
106167455|NCT03519178|366276451|FG012|PF-06873600 Treatment|Ongoing|0|||
106167456|NCT03519178|366276452|FG013|PF-06873600 Treatment|Ongoing|1|||
106167457|NCT03519178|366276453|FG014|PF-06873600 Treatment|Ongoing|6|||
106167458|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167459|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167460|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167461|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167462|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167463|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167464|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167465|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167466|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167467|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167468|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167469|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167470|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167471|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
106167472|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
106167473|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Death|0|||
106167474|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Death|0|||
106167475|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Death|0|||
106167476|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Death|0|||
106167477|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Death|0|||
106167478|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Death|0|||
106167479|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Death|0|||
106167480|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Death|0|||
106167481|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Death|0|||
106167482|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Death|1|||
106167483|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Death|0|||
106167484|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Death|0|||
106167485|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Death|0|||
106167486|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Death|0|||
106167487|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Death|1|||
106167488|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167489|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167490|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167491|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167492|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167493|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167494|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167495|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167496|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167497|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167498|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167499|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167500|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167501|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
106167502|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
106167503|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167504|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167505|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167506|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167507|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167508|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167509|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167510|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167511|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167512|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167513|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167514|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167515|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
106167516|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
106167517|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
106167518|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167519|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167520|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167521|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167522|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167523|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167524|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167525|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167526|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167527|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
106167528|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167529|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167530|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
106167531|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
106167532|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
106167533|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167534|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167535|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167536|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167537|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167538|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167539|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167540|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167541|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167542|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167543|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167544|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167545|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
106167546|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
106167547|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
106167548|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167549|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167550|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167551|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167552|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167553|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167554|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167555|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167556|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167557|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
106167558|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167559|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167560|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
106167561|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
106167562|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
106167563|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167564|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167565|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167566|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167567|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167568|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167569|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167570|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167571|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167572|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
106167573|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167574|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167575|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167576|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
106167577|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
106167578|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167579|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167580|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167581|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167582|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167583|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167584|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167585|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167586|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167587|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167588|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167589|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167590|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167591|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
106167592|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
106167593|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Other|0|||
106167594|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Other|0|||
106167595|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Other|0|||
106167596|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Other|0|||
106167597|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Other|0|||
106167598|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Other|0|||
106167599|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Other|0|||
106167600|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Other|0|||
106167601|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Other|0|||
106167602|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Other|0|||
106167603|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Other|0|||
106167604|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Other|0|||
106167605|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Other|0|||
106167606|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Other|1|||
106167607|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Other|3|||
106167608|NCT03519178|366276439|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167609|NCT03519178|366276440|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167610|NCT03519178|366276441|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167611|NCT03519178|366276442|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167612|NCT03519178|366276443|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167613|NCT03519178|366276444|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167614|NCT03519178|366276445|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167615|NCT03519178|366276446|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167616|NCT03519178|366276447|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167617|NCT03519178|366276448|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167618|NCT03519178|366276449|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167619|NCT03519178|366276450|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167620|NCT03519178|366276451|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
106167621|NCT03519178|366276452|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
106167622|NCT03519178|366276453|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
106167623|NCT03519178|366276439|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
106167624|NCT03519178|366276440|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
106167625|NCT03519178|366276441|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
106167626|NCT03519178|366276442|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
106167627|NCT03519178|366276443|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
106167628|NCT03519178|366276444|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
106167629|NCT03519178|366276445|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
106167630|NCT03519178|366276446|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
106167631|NCT03519178|366276447|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
106167632|NCT03519178|366276448|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
106167633|NCT03519178|366276449|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
106167634|NCT03519178|366276450|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
106167635|NCT03519178|366276451|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
106167636|NCT03519178|366276452|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
106167637|NCT03519178|366276453|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
106167638|NCT03519178|366276439|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
106167639|NCT03519178|366276440|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
106167640|NCT03519178|366276441|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
106167641|NCT03519178|366276442|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
106167642|NCT03519178|366276443|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
106167643|NCT03519178|366276444|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
106167644|NCT03519178|366276445|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
106167645|NCT03519178|366276446|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
106167646|NCT03519178|366276447|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
106167647|NCT03519178|366276448|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
106167648|NCT03519178|366276449|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
106167649|NCT03519178|366276450|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
106167650|NCT03519178|366276451|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
106167651|NCT03519178|366276452|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
106167652|NCT03519178|366276453|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
106167653|NCT03519178|366276439|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167654|NCT03519178|366276440|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167655|NCT03519178|366276441|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167656|NCT03519178|366276442|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167657|NCT03519178|366276443|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167658|NCT03519178|366276444|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167659|NCT03519178|366276445|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167660|NCT03519178|366276446|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167661|NCT03519178|366276447|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167662|NCT03519178|366276448|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167663|NCT03519178|366276449|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
106167664|NCT03519178|366276450|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167665|NCT03519178|366276451|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167666|NCT03519178|366276452|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167667|NCT03519178|366276453|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
106167668|NCT03519178|366276439|FG000|Follow-Up|Death|0|||
106167669|NCT03519178|366276440|FG001|Follow-Up|Death|0|||
106167670|NCT03519178|366276441|FG002|Follow-Up|Death|1|||
106167671|NCT03519178|366276442|FG003|Follow-Up|Death|0|||
106167672|NCT03519178|366276443|FG004|Follow-Up|Death|0|||
106167673|NCT03519178|366276444|FG005|Follow-Up|Death|0|||
106167674|NCT03519178|366276445|FG006|Follow-Up|Death|0|||
106167675|NCT03519178|366276446|FG007|Follow-Up|Death|0|||
106167676|NCT03519178|366276447|FG008|Follow-Up|Death|3|||
106167677|NCT03519178|366276448|FG009|Follow-Up|Death|1|||
106167678|NCT03519178|366276449|FG010|Follow-Up|Death|0|||
106167679|NCT03519178|366276450|FG011|Follow-Up|Death|0|||
106167680|NCT03519178|366276451|FG012|Follow-Up|Death|2|||
106167681|NCT03519178|366276452|FG013|Follow-Up|Death|0|||
106167682|NCT03519178|366276453|FG014|Follow-Up|Death|0|||
106167683|NCT03519178|366276439|FG000|Follow-Up|Lost to Follow-up|0|||
106167684|NCT03519178|366276440|FG001|Follow-Up|Lost to Follow-up|0|||
106167685|NCT03519178|366276441|FG002|Follow-Up|Lost to Follow-up|0|||
106167686|NCT03519178|366276442|FG003|Follow-Up|Lost to Follow-up|0|||
106167687|NCT03519178|366276443|FG004|Follow-Up|Lost to Follow-up|0|||
106167688|NCT03519178|366276444|FG005|Follow-Up|Lost to Follow-up|3|||
106167689|NCT03519178|366276445|FG006|Follow-Up|Lost to Follow-up|1|||
106167690|NCT03519178|366276446|FG007|Follow-Up|Lost to Follow-up|4|||
106167691|NCT03519178|366276447|FG008|Follow-Up|Lost to Follow-up|1|||
106167692|NCT03519178|366276448|FG009|Follow-Up|Lost to Follow-up|0|||
106167693|NCT03519178|366276449|FG010|Follow-Up|Lost to Follow-up|0|||
106167694|NCT03519178|366276450|FG011|Follow-Up|Lost to Follow-up|0|||
106167695|NCT03519178|366276451|FG012|Follow-Up|Lost to Follow-up|0|||
106167696|NCT03519178|366276452|FG013|Follow-Up|Lost to Follow-up|0|||
106167697|NCT03519178|366276453|FG014|Follow-Up|Lost to Follow-up|0|||
106167698|NCT03519178|366276439|FG000|Follow-Up|Withdrawal by Subject|1|||
106167699|NCT03519178|366276440|FG001|Follow-Up|Withdrawal by Subject|2|||
106167700|NCT03519178|366276441|FG002|Follow-Up|Withdrawal by Subject|2|||
106167701|NCT03519178|366276442|FG003|Follow-Up|Withdrawal by Subject|3|||
106167702|NCT03519178|366276443|FG004|Follow-Up|Withdrawal by Subject|5|||
106167703|NCT03519178|366276444|FG005|Follow-Up|Withdrawal by Subject|1|||
106167704|NCT03519178|366276445|FG006|Follow-Up|Withdrawal by Subject|2|||
106167705|NCT03519178|366276446|FG007|Follow-Up|Withdrawal by Subject|6|||
106167706|NCT03519178|366276447|FG008|Follow-Up|Withdrawal by Subject|5|||
106167707|NCT03519178|366276448|FG009|Follow-Up|Withdrawal by Subject|2|||
106167708|NCT03519178|366276449|FG010|Follow-Up|Withdrawal by Subject|3|||
106167709|NCT03519178|366276450|FG011|Follow-Up|Withdrawal by Subject|5|||
106167710|NCT03519178|366276451|FG012|Follow-Up|Withdrawal by Subject|2|||
106167711|NCT03519178|366276452|FG013|Follow-Up|Withdrawal by Subject|0|||
106167712|NCT03519178|366276453|FG014|Follow-Up|Withdrawal by Subject|0|||
106167713|NCT03519178|366276439|FG000|Follow-Up|Other|0|||
106167714|NCT03519178|366276440|FG001|Follow-Up|Other|0|||
106167715|NCT03519178|366276441|FG002|Follow-Up|Other|0|||
106167716|NCT03519178|366276442|FG003|Follow-Up|Other|0|||
106167717|NCT03519178|366276443|FG004|Follow-Up|Other|0|||
106167718|NCT03519178|366276444|FG005|Follow-Up|Other|0|||
106167719|NCT03519178|366276445|FG006|Follow-Up|Other|0|||
106167720|NCT03519178|366276446|FG007|Follow-Up|Other|1|||
106167721|NCT03519178|366276447|FG008|Follow-Up|Other|0|||
106167722|NCT03519178|366276448|FG009|Follow-Up|Other|0|||
106167723|NCT03519178|366276449|FG010|Follow-Up|Other|0|||
106167724|NCT03519178|366276450|FG011|Follow-Up|Other|0|||
106167725|NCT03519178|366276451|FG012|Follow-Up|Other|0|||
106167726|NCT03519178|366276452|FG013|Follow-Up|Other|0|||
106167727|NCT03519178|366276453|FG014|Follow-Up|Other|0|||
106167728|NCT03519178|366276439|FG000|Long-term Follow-up|Death|0|||
106167729|NCT03519178|366276440|FG001|Long-term Follow-up|Death|0|||
106167730|NCT03519178|366276441|FG002|Long-term Follow-up|Death|0|||
106167731|NCT03519178|366276442|FG003|Long-term Follow-up|Death|0|||
106167732|NCT03519178|366276443|FG004|Long-term Follow-up|Death|0|||
106167733|NCT03519178|366276444|FG005|Long-term Follow-up|Death|0|||
106167734|NCT03519178|366276445|FG006|Long-term Follow-up|Death|0|||
106167735|NCT03519178|366276446|FG007|Long-term Follow-up|Death|0|||
106167736|NCT03519178|366276447|FG008|Long-term Follow-up|Death|0|||
106167737|NCT03519178|366276448|FG009|Long-term Follow-up|Death|0|||
106167738|NCT03519178|366276449|FG010|Long-term Follow-up|Death|0|||
106167739|NCT03519178|366276450|FG011|Long-term Follow-up|Death|0|||
106167740|NCT03519178|366276451|FG012|Long-term Follow-up|Death|0|||
106167741|NCT03519178|366276452|FG013|Long-term Follow-up|Death|4|||
106167742|NCT03519178|366276453|FG014|Long-term Follow-up|Death|4|||
106167743|NCT03519178|366276439|FG000|Long-term Follow-up|Lost to Follow-up|0|||
106167744|NCT03519178|366276440|FG001|Long-term Follow-up|Lost to Follow-up|0|||
106167745|NCT03519178|366276441|FG002|Long-term Follow-up|Lost to Follow-up|0|||
106167746|NCT03519178|366276442|FG003|Long-term Follow-up|Lost to Follow-up|0|||
106167747|NCT03519178|366276443|FG004|Long-term Follow-up|Lost to Follow-up|0|||
106167748|NCT03519178|366276444|FG005|Long-term Follow-up|Lost to Follow-up|0|||
106167749|NCT03519178|366276445|FG006|Long-term Follow-up|Lost to Follow-up|0|||
106167750|NCT03519178|366276446|FG007|Long-term Follow-up|Lost to Follow-up|0|||
106167751|NCT03519178|366276447|FG008|Long-term Follow-up|Lost to Follow-up|0|||
106167752|NCT03519178|366276448|FG009|Long-term Follow-up|Lost to Follow-up|0|||
106167753|NCT03519178|366276449|FG010|Long-term Follow-up|Lost to Follow-up|0|||
106167754|NCT03519178|366276450|FG011|Long-term Follow-up|Lost to Follow-up|0|||
106167755|NCT03519178|366276451|FG012|Long-term Follow-up|Lost to Follow-up|0|||
106167756|NCT03519178|366276452|FG013|Long-term Follow-up|Lost to Follow-up|1|||
106167757|NCT03519178|366276453|FG014|Long-term Follow-up|Lost to Follow-up|1|||
106167758|NCT03519178|366276439|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
106167759|NCT03519178|366276440|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
106167760|NCT03519178|366276441|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
106167761|NCT03519178|366276442|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
106167762|NCT03519178|366276443|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
106167763|NCT03519178|366276444|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
106167764|NCT03519178|366276445|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
106167765|NCT03519178|366276446|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
106167766|NCT03519178|366276447|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
106167767|NCT03519178|366276448|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
106167768|NCT03519178|366276449|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
106167769|NCT03519178|366276450|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
106167770|NCT03519178|366276451|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
106167771|NCT03519178|366276452|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
106167772|NCT03519178|366276453|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
106167773|NCT03519178|366276439|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
106167774|NCT03519178|366276440|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
106167775|NCT03519178|366276441|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
106167776|NCT03519178|366276442|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
106167777|NCT03519178|366276443|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
106167778|NCT03519178|366276444|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
106167779|NCT03519178|366276445|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
106167780|NCT03519178|366276446|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
106167781|NCT03519178|366276447|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
106167782|NCT03519178|366276448|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
106167783|NCT03519178|366276449|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
106167784|NCT03519178|366276450|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
106167785|NCT03519178|366276451|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
106167786|NCT03519178|366276452|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
106167787|NCT03519178|366276453|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
106167788|NCT03519178|366276439|FG000|Long-term Follow-up|Other|0|||
106167789|NCT03519178|366276440|FG001|Long-term Follow-up|Other|0|||
106167790|NCT03519178|366276441|FG002|Long-term Follow-up|Other|0|||
106167791|NCT03519178|366276442|FG003|Long-term Follow-up|Other|0|||
106167792|NCT03519178|366276443|FG004|Long-term Follow-up|Other|0|||
106167793|NCT03519178|366276444|FG005|Long-term Follow-up|Other|0|||
106167794|NCT03519178|366276445|FG006|Long-term Follow-up|Other|0|||
106167795|NCT03519178|366276446|FG007|Long-term Follow-up|Other|0|||
106167796|NCT03519178|366276447|FG008|Long-term Follow-up|Other|0|||
106167797|NCT03519178|366276448|FG009|Long-term Follow-up|Other|0|||
106167798|NCT03519178|366276449|FG010|Long-term Follow-up|Other|0|||
106167799|NCT03519178|366276450|FG011|Long-term Follow-up|Other|0|||
106167800|NCT03519178|366276451|FG012|Long-term Follow-up|Other|0|||
106167801|NCT03519178|366276452|FG013|Long-term Follow-up|Other|0|||
106167802|NCT03519178|366276453|FG014|Long-term Follow-up|Other|1|||
106167803|NCT03519178|366276439|FG000|Long-term Follow-up|Ongoing|0|||
106167804|NCT03519178|366276440|FG001|Long-term Follow-up|Ongoing|0|||
106167805|NCT03519178|366276441|FG002|Long-term Follow-up|Ongoing|0|||
106167806|NCT03519178|366276442|FG003|Long-term Follow-up|Ongoing|0|||
106167807|NCT03519178|366276443|FG004|Long-term Follow-up|Ongoing|0|||
106167808|NCT03519178|366276444|FG005|Long-term Follow-up|Ongoing|0|||
106167809|NCT03519178|366276445|FG006|Long-term Follow-up|Ongoing|0|||
106167810|NCT03519178|366276446|FG007|Long-term Follow-up|Ongoing|0|||
106167811|NCT03519178|366276447|FG008|Long-term Follow-up|Ongoing|0|||
106167812|NCT03519178|366276448|FG009|Long-term Follow-up|Ongoing|0|||
106167813|NCT03519178|366276449|FG010|Long-term Follow-up|Ongoing|0|||
106167814|NCT03519178|366276450|FG011|Long-term Follow-up|Ongoing|0|||
106167815|NCT03519178|366276451|FG012|Long-term Follow-up|Ongoing|0|||
106167816|NCT03519178|366276452|FG013|Long-term Follow-up|Ongoing|1|||
106167817|NCT03519178|366276453|FG014|Long-term Follow-up|Ongoing|0|||
106167818|NCT03663569|366278033|FG000|Overall Study|Discontinuation of study|11|||
106167819|NCT03663569|366278033|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
106167820|NCT03663569|366278033|FG000|Overall Study|Deceased patient|6|||
106167821|NCT03663569|366278033|FG000|Overall Study|Lost to Follow-up|18|||
106167822|NCT03663569|366278033|FG000|Overall Study|Withdrawal of consent|5|||
106167823|NCT03663569|366278033|FG000|Overall Study|Patient's request|11|||
106167824|NCT03663569|366278033|FG000|Overall Study|Adverse Event|4|||
106167825|NCT03663569|366278033|FG000|Overall Study|Not come to second visit|3|||
106167826|NCT03663569|366278033|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
106167827|NCT03663569|366278033|FG000|Overall Study|Serious adverse event|1|||
106167828|NCT00104676|366278034|FG000|Overall Study|Death|3|||
106167829|NCT00104676|366278035|FG001|Overall Study|Death|2|||
106167830|NCT00104676|366278034|FG000|Overall Study|Withdrawal by Subject|0|||
106167831|NCT00104676|366278035|FG001|Overall Study|Withdrawal by Subject|2|||
106167832|NCT00104676|366278034|FG000|Overall Study|treatment interruption|4|||
106167833|NCT00104676|366278035|FG001|Overall Study|treatment interruption|10|||
106167834|NCT05622812|366278036|FG000|Overall Study|Withdrawal by Subject|1|||
106167835|NCT05622812|366278037|FG001|Overall Study|Withdrawal by Subject|4|||
106167836|NCT05622812|366278036|FG000|Overall Study|Lost to Follow-up|2|||
106167837|NCT05622812|366278037|FG001|Overall Study|Lost to Follow-up|1|||
106167838|NCT02844465|366278044|FG000|Overall Study|Screen Failure|36|||
106167839|NCT02844465|366278044|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
106167840|NCT02844465|366278044|FG000|Overall Study|Withdrawal by Subject|5|||
106167841|NCT02844465|366278044|FG000|Overall Study|Lost to Follow-up|1|||
106167842|NCT02844465|366278044|FG000|Overall Study|Retreatment|1|||
106167843|NCT03819153|366278048|FG000|Overall Study|Withdrawal by Subject|20|||
106167844|NCT03819153|366278049|FG001|Overall Study|Withdrawal by Subject|28|||
106167845|NCT03819153|366278048|FG000|Overall Study|Lost to Follow-up|23|||
106167846|NCT03819153|366278049|FG001|Overall Study|Lost to Follow-up|30|||
106167847|NCT05029622|366278050|FG000|Overall Study|Lost to Follow-up|1|||
106167848|NCT05671653|366278051|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
106167849|NCT05671653|366278052|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
106167850|NCT05671653|366278053|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
106167851|NCT05671653|366278054|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
106167852|NCT05671653|366278055|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
106167853|NCT05671653|366278056|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
106167854|NCT05671653|366278057|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
106167855|NCT05671653|366278058|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
106167856|NCT05671653|366278059|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
106167857|NCT05671653|366278060|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
106167858|NCT05671653|366278061|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
106167859|NCT05671653|366278062|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
106167860|NCT05671653|366278063|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
106167861|NCT05671653|366278051|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167862|NCT05671653|366278052|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167863|NCT05671653|366278053|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167864|NCT05671653|366278054|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167865|NCT05671653|366278055|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167866|NCT05671653|366278056|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
106167867|NCT05671653|366278057|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167868|NCT05671653|366278058|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167869|NCT05671653|366278059|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167870|NCT05671653|366278060|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167871|NCT05671653|366278061|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167872|NCT05671653|366278062|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167873|NCT05671653|366278063|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
106167874|NCT05671653|366278051|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167875|NCT05671653|366278052|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167876|NCT05671653|366278053|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167877|NCT05671653|366278054|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167878|NCT05671653|366278055|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167879|NCT05671653|366278056|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
106167880|NCT05671653|366278057|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167881|NCT05671653|366278058|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167882|NCT05671653|366278059|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167883|NCT05671653|366278060|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167884|NCT05671653|366278061|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167885|NCT05671653|366278062|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167886|NCT05671653|366278063|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
106167887|NCT05671653|366278051|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167888|NCT05671653|366278052|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167889|NCT05671653|366278053|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167890|NCT05671653|366278054|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167891|NCT05671653|366278055|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167892|NCT05671653|366278056|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167893|NCT05671653|366278057|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167894|NCT05671653|366278058|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167895|NCT05671653|366278059|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
106167896|NCT05671653|366278060|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167897|NCT05671653|366278061|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167898|NCT05671653|366278062|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167899|NCT05671653|366278063|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
106167900|NCT05671653|366278051|FG000|Cohort 2 Period 2|Adverse Event|0|||
106167901|NCT05671653|366278052|FG001|Cohort 2 Period 2|Adverse Event|0|||
106167902|NCT05671653|366278053|FG002|Cohort 2 Period 2|Adverse Event|0|||
106167903|NCT05671653|366278054|FG003|Cohort 2 Period 2|Adverse Event|0|||
106167904|NCT05671653|366278055|FG004|Cohort 2 Period 2|Adverse Event|0|||
106167905|NCT05671653|366278056|FG005|Cohort 2 Period 2|Adverse Event|0|||
106167906|NCT05671653|366278057|FG006|Cohort 2 Period 2|Adverse Event|0|||
106167907|NCT05671653|366278058|FG007|Cohort 2 Period 2|Adverse Event|0|||
106167908|NCT05671653|366278059|FG008|Cohort 2 Period 2|Adverse Event|0|||
106167909|NCT05671653|366278060|FG009|Cohort 2 Period 2|Adverse Event|0|||
106167910|NCT05671653|366278061|FG010|Cohort 2 Period 2|Adverse Event|1|||
106167911|NCT05671653|366278062|FG011|Cohort 2 Period 2|Adverse Event|0|||
106167912|NCT05671653|366278063|FG012|Cohort 2 Period 2|Adverse Event|0|||
106167913|NCT05671653|366278051|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
106167914|NCT05671653|366278052|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
106167915|NCT05671653|366278053|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
106167916|NCT05671653|366278054|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
106167917|NCT05671653|366278055|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
106167918|NCT05671653|366278056|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
106167919|NCT05671653|366278057|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
106167920|NCT05671653|366278058|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
106167921|NCT05671653|366278059|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
106167922|NCT05671653|366278060|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
106167923|NCT05671653|366278061|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
106167924|NCT05671653|366278062|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
106167925|NCT05671653|366278063|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
106167926|NCT05671653|366278051|FG000|Cohort 2 Period 2|Pregnancy|0|||
106167927|NCT05671653|366278052|FG001|Cohort 2 Period 2|Pregnancy|0|||
106167928|NCT05671653|366278053|FG002|Cohort 2 Period 2|Pregnancy|0|||
106167929|NCT05671653|366278054|FG003|Cohort 2 Period 2|Pregnancy|0|||
106167930|NCT05671653|366278055|FG004|Cohort 2 Period 2|Pregnancy|0|||
106167931|NCT05671653|366278056|FG005|Cohort 2 Period 2|Pregnancy|0|||
106167932|NCT05671653|366278057|FG006|Cohort 2 Period 2|Pregnancy|0|||
106167933|NCT05671653|366278058|FG007|Cohort 2 Period 2|Pregnancy|0|||
106167934|NCT05671653|366278059|FG008|Cohort 2 Period 2|Pregnancy|0|||
106167935|NCT05671653|366278060|FG009|Cohort 2 Period 2|Pregnancy|0|||
106167936|NCT05671653|366278061|FG010|Cohort 2 Period 2|Pregnancy|1|||
106167937|NCT05671653|366278062|FG011|Cohort 2 Period 2|Pregnancy|0|||
106167938|NCT05671653|366278063|FG012|Cohort 2 Period 2|Pregnancy|0|||
106167939|NCT05671653|366278051|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167940|NCT05671653|366278052|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167941|NCT05671653|366278053|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167942|NCT05671653|366278054|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167943|NCT05671653|366278055|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167944|NCT05671653|366278056|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167945|NCT05671653|366278057|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167946|NCT05671653|366278058|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167947|NCT05671653|366278059|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167948|NCT05671653|366278060|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167949|NCT05671653|366278061|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
106167950|NCT05671653|366278062|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167951|NCT05671653|366278063|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
106167952|NCT05671653|366278051|FG000|Cohort 2 Period 2|Other|0|||
106167953|NCT05671653|366278052|FG001|Cohort 2 Period 2|Other|0|||
106167954|NCT05671653|366278053|FG002|Cohort 2 Period 2|Other|0|||
106167955|NCT05671653|366278054|FG003|Cohort 2 Period 2|Other|0|||
106167956|NCT05671653|366278055|FG004|Cohort 2 Period 2|Other|0|||
106167957|NCT05671653|366278056|FG005|Cohort 2 Period 2|Other|0|||
106167958|NCT05671653|366278057|FG006|Cohort 2 Period 2|Other|0|||
106167959|NCT05671653|366278058|FG007|Cohort 2 Period 2|Other|0|||
106167960|NCT05671653|366278059|FG008|Cohort 2 Period 2|Other|0|||
106167961|NCT05671653|366278060|FG009|Cohort 2 Period 2|Other|0|||
106167962|NCT05671653|366278061|FG010|Cohort 2 Period 2|Other|1|||
106167963|NCT05671653|366278062|FG011|Cohort 2 Period 2|Other|0|||
106167964|NCT05671653|366278063|FG012|Cohort 2 Period 2|Other|0|||
106167965|NCT05671653|366278051|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167966|NCT05671653|366278052|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167967|NCT05671653|366278053|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167968|NCT05671653|366278054|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167969|NCT05671653|366278055|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167970|NCT05671653|366278056|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167971|NCT05671653|366278057|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167972|NCT05671653|366278058|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167973|NCT05671653|366278059|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167974|NCT05671653|366278060|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167975|NCT05671653|366278061|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167976|NCT05671653|366278062|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
106167977|NCT05671653|366278063|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
106167978|NCT03213691|366278072|FG000|Overall Study|Adverse Event|2|||
106167979|NCT03213691|366278072|FG000|Overall Study|Death|3|||
106167980|NCT03213691|366278072|FG000|Overall Study|Physician Decision|1|||
106167981|NCT03213691|366278072|FG000|Overall Study|Progressive Disease|14|||
106167982|NCT03213691|366278072|FG000|Overall Study|Ineligible|1|||
106167983|NCT03604692|366278073|FG000|Overall Study|Investigator's Decision|0|||
106167984|NCT03604692|366278074|FG001|Overall Study|Investigator's Decision|0|||
106167985|NCT03604692|366278075|FG002|Overall Study|Investigator's Decision|0|||
106167986|NCT03604692|366278076|FG003|Overall Study|Investigator's Decision|1|||
106167987|NCT03604692|366278077|FG004|Overall Study|Investigator's Decision|0|||
106167988|NCT03604692|366278078|FG005|Overall Study|Investigator's Decision|7|||
106167989|NCT03604692|366278073|FG000|Overall Study|Withdrawal by Subject|0|||
106167990|NCT03604692|366278074|FG001|Overall Study|Withdrawal by Subject|0|||
106167991|NCT03604692|366278075|FG002|Overall Study|Withdrawal by Subject|0|||
106167992|NCT03604692|366278076|FG003|Overall Study|Withdrawal by Subject|0|||
106167993|NCT03604692|366278077|FG004|Overall Study|Withdrawal by Subject|0|||
106167994|NCT03604692|366278078|FG005|Overall Study|Withdrawal by Subject|2|||
106167995|NCT03604692|366278073|FG000|Overall Study|Progressive Disease|1|||
106167996|NCT03604692|366278074|FG001|Overall Study|Progressive Disease|0|||
106167997|NCT03604692|366278075|FG002|Overall Study|Progressive Disease|1|||
106167998|NCT03604692|366278076|FG003|Overall Study|Progressive Disease|0|||
106167999|NCT03604692|366278077|FG004|Overall Study|Progressive Disease|3|||
106168000|NCT03604692|366278078|FG005|Overall Study|Progressive Disease|4|||
106168001|NCT03604692|366278073|FG000|Overall Study|Difficulty Coming into Site.|0|||
106168002|NCT03604692|366278074|FG001|Overall Study|Difficulty Coming into Site.|0|||
106168003|NCT03604692|366278075|FG002|Overall Study|Difficulty Coming into Site.|0|||
106168004|NCT03604692|366278076|FG003|Overall Study|Difficulty Coming into Site.|0|||
106168005|NCT03604692|366278077|FG004|Overall Study|Difficulty Coming into Site.|0|||
106168006|NCT03604692|366278078|FG005|Overall Study|Difficulty Coming into Site.|1|||
106168007|NCT03604692|366278073|FG000|Overall Study|Death|0|||
106168008|NCT03604692|366278074|FG001|Overall Study|Death|0|||
106168009|NCT03604692|366278075|FG002|Overall Study|Death|1|||
106168010|NCT03604692|366278076|FG003|Overall Study|Death|0|||
106168011|NCT03604692|366278077|FG004|Overall Study|Death|0|||
106168012|NCT03604692|366278078|FG005|Overall Study|Death|0|||
106168013|NCT03604692|366278073|FG000|Overall Study|Drug Intolerance|0|||
106168014|NCT03604692|366278074|FG001|Overall Study|Drug Intolerance|0|||
106168015|NCT03604692|366278075|FG002|Overall Study|Drug Intolerance|0|||
106168016|NCT03604692|366278076|FG003|Overall Study|Drug Intolerance|1|||
106168017|NCT03604692|366278077|FG004|Overall Study|Drug Intolerance|0|||
106168018|NCT03604692|366278078|FG005|Overall Study|Drug Intolerance|0|||
106168019|NCT03604692|366278073|FG000|Overall Study|Noncompliance with follow-up visit|0|||
106168020|NCT03604692|366278074|FG001|Overall Study|Noncompliance with follow-up visit|0|||
106168021|NCT03604692|366278075|FG002|Overall Study|Noncompliance with follow-up visit|0|||
106168022|NCT03604692|366278076|FG003|Overall Study|Noncompliance with follow-up visit|1|||
106168023|NCT03604692|366278077|FG004|Overall Study|Noncompliance with follow-up visit|0|||
106168024|NCT03604692|366278078|FG005|Overall Study|Noncompliance with follow-up visit|0|||
106168025|NCT03604692|366278073|FG000|Overall Study|Continuing Treatment/In Follow-Up|0|||
106168026|NCT03604692|366278074|FG001|Overall Study|Continuing Treatment/In Follow-Up|0|||
106168027|NCT03604692|366278075|FG002|Overall Study|Continuing Treatment/In Follow-Up|1|||
106168028|NCT03604692|366278076|FG003|Overall Study|Continuing Treatment/In Follow-Up|1|||
106168029|NCT03604692|366278077|FG004|Overall Study|Continuing Treatment/In Follow-Up|0|||
106168030|NCT03604692|366278078|FG005|Overall Study|Continuing Treatment/In Follow-Up|0|||
106168031|NCT03604692|366278073|FG000|Overall Study|Not Treated|0|||
106168032|NCT03604692|366278074|FG001|Overall Study|Not Treated|0|||
106168033|NCT03604692|366278075|FG002|Overall Study|Not Treated|0|||
106168034|NCT03604692|366278076|FG003|Overall Study|Not Treated|0|||
106168035|NCT03604692|366278077|FG004|Overall Study|Not Treated|1|||
106168036|NCT03604692|366278078|FG005|Overall Study|Not Treated|0|||
106168037|NCT03899259|366278079|FG000|Overall Study|Adverse Event|5|||
106168038|NCT03899259|366278080|FG001|Overall Study|Adverse Event|4|||
106168039|NCT03899259|366278081|FG002|Overall Study|Adverse Event|6|||
106168040|NCT03899259|366278079|FG000|Overall Study|Lack of Efficacy|5|||
106168041|NCT03899259|366278080|FG001|Overall Study|Lack of Efficacy|0|||
106168042|NCT03899259|366278081|FG002|Overall Study|Lack of Efficacy|2|||
106168043|NCT03899259|366278079|FG000|Overall Study|Pregnancy|3|||
106168044|NCT03899259|366278080|FG001|Overall Study|Pregnancy|0|||
106168045|NCT03899259|366278081|FG002|Overall Study|Pregnancy|1|||
106168046|NCT03899259|366278079|FG000|Overall Study|Physician Decision|0|||
106168047|NCT03899259|366278080|FG001|Overall Study|Physician Decision|1|||
106168048|NCT03899259|366278081|FG002|Overall Study|Physician Decision|0|||
106168049|NCT03899259|366278079|FG000|Overall Study|Protocol Deviation|1|||
106168050|NCT03899259|366278080|FG001|Overall Study|Protocol Deviation|1|||
106168051|NCT03899259|366278081|FG002|Overall Study|Protocol Deviation|1|||
106168052|NCT03899259|366278079|FG000|Overall Study|Withdrawal by Subject|8|||
106168053|NCT03899259|366278080|FG001|Overall Study|Withdrawal by Subject|10|||
106168054|NCT03899259|366278081|FG002|Overall Study|Withdrawal by Subject|12|||
106168055|NCT03899259|366278079|FG000|Overall Study|Lost to Follow-up|5|||
106168056|NCT03899259|366278080|FG001|Overall Study|Lost to Follow-up|6|||
106168057|NCT03899259|366278081|FG002|Overall Study|Lost to Follow-up|2|||
106168058|NCT03899259|366278079|FG000|Overall Study|Lack of Adherence|1|||
106168059|NCT03899259|366278080|FG001|Overall Study|Lack of Adherence|0|||
106168060|NCT03899259|366278081|FG002|Overall Study|Lack of Adherence|0|||
106168061|NCT03899259|366278079|FG000|Overall Study|Screen Failure|1|||
106168062|NCT03899259|366278080|FG001|Overall Study|Screen Failure|0|||
106168063|NCT03899259|366278081|FG002|Overall Study|Screen Failure|0|||
106168064|NCT03899259|366278079|FG000|Overall Study|Ongoing Study Participation|127|||
106168065|NCT03899259|366278080|FG001|Overall Study|Ongoing Study Participation|134|||
106168066|NCT03899259|366278081|FG002|Overall Study|Ongoing Study Participation|210|||
106168067|NCT02305888|366278089|FG000|Overall Study|Lost to Follow-up|0|||
106168068|NCT02305888|366278090|FG001|Overall Study|Lost to Follow-up|0|||
106168069|NCT02305888|366278091|FG002|Overall Study|Lost to Follow-up|1|||
106168070|NCT02305888|366278089|FG000|Overall Study|Adverse Event|0|||
106168071|NCT02305888|366278090|FG001|Overall Study|Adverse Event|1|||
106168072|NCT02305888|366278091|FG002|Overall Study|Adverse Event|0|||
106168073|NCT01959607|366278094|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
106168074|NCT01959607|366278095|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
106168075|NCT01959607|366278096|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
106168076|NCT01959607|366278097|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
106168077|NCT03913442|366278098|FG000|Overall Study|Adverse Event|0|||
106168078|NCT03913442|366278099|FG001|Overall Study|Adverse Event|3|||
106168079|NCT03913442|366278098|FG000|Overall Study|Withdrawal by Subject|5|||
106168080|NCT03913442|366278099|FG001|Overall Study|Withdrawal by Subject|5|||
106168081|NCT03913442|366278098|FG000|Overall Study|Terminations|2|||
106168082|NCT03913442|366278099|FG001|Overall Study|Terminations|1|||
106168083|NCT03913442|366278098|FG000|Overall Study|Lost to Follow-up|2|||
106168084|NCT03913442|366278099|FG001|Overall Study|Lost to Follow-up|2|||
106168085|NCT04054193|366278108|FG000|Cycle 1|Physician Decision|1|||
106168086|NCT04054193|366278108|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
106168087|NCT04054193|366278108|FG000|Cycle 1|Allocated but not treated|3|||
106168088|NCT04054193|366278108|FG000|Cycles 2-3|Physician Decision|2|||
106168089|NCT04054193|366278108|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
106168090|NCT04054193|366278108|FG000|Cycles 2-3|Various reasons|17|||
106168091|NCT05073458|366278109|FG000|24-week Double-blind Period|Adverse Event|1|||
106168092|NCT05073458|366278110|FG001|24-week Double-blind Period|Adverse Event|0|||
106168093|NCT05073458|366278109|FG000|24-week Double-blind Period|Physician Decision|1|||
106168094|NCT05073458|366278110|FG001|24-week Double-blind Period|Physician Decision|0|||
106168095|NCT05073458|366278109|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
106168096|NCT05073458|366278110|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
106168097|NCT05073458|366278109|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
106168098|NCT05073458|366278110|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
106168099|NCT05073458|366278109|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
106168100|NCT05073458|366278110|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
106168101|NCT05073458|366278109|FG000|24-week Open-label Period|Adverse Event|1|||
106168102|NCT05073458|366278110|FG001|24-week Open-label Period|Adverse Event|2|||
106168103|NCT03235544|366278111|FG000|Overall Study|Death|11|||
106168104|NCT03235544|366278112|FG001|Overall Study|Death|31|||
106168105|NCT03235544|366278113|FG002|Overall Study|Death|19|||
106168106|NCT03235544|366278114|FG003|Overall Study|Death|34|||
106168107|NCT03235544|366278111|FG000|Overall Study|Lost to Follow-up|0|||
106168108|NCT03235544|366278112|FG001|Overall Study|Lost to Follow-up|1|||
106168109|NCT03235544|366278113|FG002|Overall Study|Lost to Follow-up|1|||
106168110|NCT03235544|366278114|FG003|Overall Study|Lost to Follow-up|1|||
106168111|NCT03235544|366278111|FG000|Overall Study|Withdrawal by Subject|0|||
106168112|NCT03235544|366278112|FG001|Overall Study|Withdrawal by Subject|3|||
106168113|NCT03235544|366278113|FG002|Overall Study|Withdrawal by Subject|1|||
106168114|NCT03235544|366278114|FG003|Overall Study|Withdrawal by Subject|5|||
106168115|NCT03235544|366278111|FG000|Overall Study|Disease Progression|0|||
106168116|NCT03235544|366278112|FG001|Overall Study|Disease Progression|1|||
106168117|NCT03235544|366278113|FG002|Overall Study|Disease Progression|0|||
106168118|NCT03235544|366278114|FG003|Overall Study|Disease Progression|2|||
106168119|NCT03235544|366278111|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
106168120|NCT03235544|366278112|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
106168121|NCT03235544|366278113|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
106168122|NCT03235544|366278114|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
106168123|NCT03235544|366278111|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
106168124|NCT03235544|366278112|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
106168125|NCT03235544|366278113|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
106168126|NCT03235544|366278114|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
106168127|NCT00950742|366278115|FG000|Overall Study|Other Adverse Event|1|||
106168128|NCT00950742|366278116|FG001|Overall Study|Other Adverse Event|0|||
106168129|NCT00950742|366278115|FG000|Overall Study|Withdrawal by Subject|3|||
106168130|NCT00950742|366278116|FG001|Overall Study|Withdrawal by Subject|0|||
106168131|NCT00950742|366278115|FG000|Overall Study|Progressive Disease|6|||
106168132|NCT00950742|366278116|FG001|Overall Study|Progressive Disease|2|||
106168133|NCT00950742|366278115|FG000|Overall Study|Dose limiting toxicity|6|||
106168134|NCT00950742|366278116|FG001|Overall Study|Dose limiting toxicity|0|||
106168135|NCT05299073|366278117|FG000|Overall Study|Withdrawal by Subject|0|||
106168136|NCT05299073|366278118|FG001|Overall Study|Withdrawal by Subject|0|||
106168137|NCT05299073|366278119|FG002|Overall Study|Withdrawal by Subject|1|||
106168138|NCT05299073|366278117|FG000|Overall Study|Adverse Event|0|||
106168139|NCT05299073|366278118|FG001|Overall Study|Adverse Event|1|||
106168140|NCT05299073|366278119|FG002|Overall Study|Adverse Event|0|||
106168141|NCT05299073|366278117|FG000|Overall Study|Lost to Follow-up|0|||
106168142|NCT05299073|366278118|FG001|Overall Study|Lost to Follow-up|1|||
106168143|NCT05299073|366278119|FG002|Overall Study|Lost to Follow-up|0|||
106168144|NCT05446168|366278122|FG000|Overall Study|Physician Decision|0|||
106168145|NCT05446168|366278123|FG001|Overall Study|Physician Decision|1|||
106168146|NCT05452460|366278125|FG000|Overall Study|Lost to Follow-up|3|||
106168147|NCT05452460|366278126|FG001|Overall Study|Lost to Follow-up|3|||
106168148|NCT05452460|366278125|FG000|Overall Study|Did not receive intervention|1|||
106168149|NCT05452460|366278126|FG001|Overall Study|Did not receive intervention|0|||
106168150|NCT03511664|366278132|FG000|Overall Study|Death|457|||
106168151|NCT03511664|366278133|FG001|Overall Study|Death|201|||
106168152|NCT03511664|366278134|FG002|Overall Study|Death|21|||
106168153|NCT03511664|366278132|FG000|Overall Study|Withdrew consent|40|||
106168154|NCT03511664|366278133|FG001|Overall Study|Withdrew consent|63|||
106168155|NCT03511664|366278134|FG002|Overall Study|Withdrew consent|3|||
106168156|NCT03511664|366278132|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
106168157|NCT03511664|366278133|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
106168158|NCT03511664|366278134|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
106168159|NCT03511664|366278132|FG000|Overall Study|Lost to Follow-up|8|||
106168160|NCT03511664|366278133|FG001|Overall Study|Lost to Follow-up|5|||
106168161|NCT03511664|366278134|FG002|Overall Study|Lost to Follow-up|0|||
106168162|NCT03511664|366278132|FG000|Overall Study|Physician Decision|2|||
106168163|NCT03511664|366278133|FG001|Overall Study|Physician Decision|1|||
106168164|NCT03511664|366278134|FG002|Overall Study|Physician Decision|0|||
106168165|NCT03511664|366278132|FG000|Overall Study|Patient non-compliance|1|||
106168166|NCT03511664|366278133|FG001|Overall Study|Patient non-compliance|0|||
106168167|NCT03511664|366278134|FG002|Overall Study|Patient non-compliance|0|||
106168168|NCT01828099|366278136|FG000|Treatment Period|Adverse Event|24|||
106168169|NCT01828099|366278137|FG001|Treatment Period|Adverse Event|23|||
106168170|NCT01828099|366278136|FG000|Treatment Period|Death|10|||
106168171|NCT01828099|366278137|FG001|Treatment Period|Death|12|||
106168172|NCT01828099|366278136|FG000|Treatment Period|Lost to Follow-up|2|||
106168173|NCT01828099|366278137|FG001|Treatment Period|Lost to Follow-up|1|||
106168174|NCT01828099|366278136|FG000|Treatment Period|Non-compliance with study treatment|1|||
106168175|NCT01828099|366278137|FG001|Treatment Period|Non-compliance with study treatment|0|||
106168176|NCT01828099|366278136|FG000|Treatment Period|Physician Decision|17|||
106168177|NCT01828099|366278137|FG001|Treatment Period|Physician Decision|16|||
106168178|NCT01828099|366278136|FG000|Treatment Period|Progressive disease|99|||
106168179|NCT01828099|366278137|FG001|Treatment Period|Progressive disease|107|||
106168180|NCT01828099|366278136|FG000|Treatment Period|Subject/guardian decision|22|||
106168181|NCT01828099|366278137|FG001|Treatment Period|Subject/guardian decision|26|||
106168182|NCT01828099|366278136|FG000|Treatment Period|Study terminated by Sponsor|13|||
106168183|NCT01828099|366278137|FG001|Treatment Period|Study terminated by Sponsor|1|||
106168184|NCT01828099|366278136|FG000|Treatment Period|Protocol deviation|1|||
106168185|NCT01828099|366278137|FG001|Treatment Period|Protocol deviation|0|||
106168186|NCT01828099|366278136|FG000|Treatment Period|No longer requires treatment|0|||
106168187|NCT01828099|366278137|FG001|Treatment Period|No longer requires treatment|1|||
106168188|NCT01828099|366278136|FG000|Extension-treatment Phase|Adverse Event|0|||
106168189|NCT01828099|366278137|FG001|Extension-treatment Phase|Adverse Event|17|||
106168190|NCT01828099|366278136|FG000|Extension-treatment Phase|Death|0|||
106168191|NCT01828099|366278137|FG001|Extension-treatment Phase|Death|11|||
106168192|NCT01828099|366278136|FG000|Extension-treatment Phase|Physician Decision|0|||
106168193|NCT01828099|366278137|FG001|Extension-treatment Phase|Physician Decision|5|||
106168194|NCT01828099|366278136|FG000|Extension-treatment Phase|Progressive disease|0|||
106168195|NCT01828099|366278137|FG001|Extension-treatment Phase|Progressive disease|54|||
106168196|NCT01828099|366278136|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
106168197|NCT01828099|366278137|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
106168198|NCT01828099|366278136|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
106168199|NCT01828099|366278137|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
106168200|NCT05246670|366278138|FG000|Overall Study|Withdrawal by Subject|2|||
106168201|NCT05246670|366278139|FG001|Overall Study|Withdrawal by Subject|3|||
106168202|NCT05246670|366278140|FG002|Overall Study|Withdrawal by Subject|0|||
106168203|NCT05246670|366278141|FG003|Overall Study|Withdrawal by Subject|1|||
106168204|NCT05246670|366278138|FG000|Overall Study|Adverse Event|0|||
106168205|NCT05246670|366278139|FG001|Overall Study|Adverse Event|0|||
106168206|NCT05246670|366278140|FG002|Overall Study|Adverse Event|1|||
106168207|NCT05246670|366278141|FG003|Overall Study|Adverse Event|0|||
106168208|NCT05246670|366278138|FG000|Overall Study|Physician Decision|1|||
106168209|NCT05246670|366278139|FG001|Overall Study|Physician Decision|0|||
106168210|NCT05246670|366278140|FG002|Overall Study|Physician Decision|0|||
106168211|NCT05246670|366278141|FG003|Overall Study|Physician Decision|0|||
106168212|NCT05246670|366278138|FG000|Overall Study|Protocol Violation|1|||
106168213|NCT05246670|366278139|FG001|Overall Study|Protocol Violation|0|||
106168214|NCT05246670|366278140|FG002|Overall Study|Protocol Violation|0|||
106168215|NCT05246670|366278141|FG003|Overall Study|Protocol Violation|0|||
106168216|NCT05485779|366278142|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168217|NCT05485779|366278143|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168218|NCT05485779|366278144|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168219|NCT05485779|366278145|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168220|NCT05485779|366278146|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168221|NCT05485779|366278147|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168222|NCT05485779|366278148|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168223|NCT05485779|366278149|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
106168224|NCT05485779|366278150|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
106168225|NCT05485779|366278151|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168226|NCT05485779|366278152|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
106168227|NCT05485779|366278142|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168228|NCT05485779|366278143|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168229|NCT05485779|366278144|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168230|NCT05485779|366278145|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168231|NCT05485779|366278146|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168232|NCT05485779|366278147|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168233|NCT05485779|366278148|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168234|NCT05485779|366278149|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168235|NCT05485779|366278150|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168236|NCT05485779|366278151|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
106168237|NCT05485779|366278152|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
106168238|NCT05485779|366278142|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168239|NCT05485779|366278143|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168240|NCT05485779|366278144|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168241|NCT05485779|366278145|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
106168242|NCT05485779|366278146|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168243|NCT05485779|366278147|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168244|NCT05485779|366278148|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168245|NCT05485779|366278149|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168246|NCT05485779|366278150|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168247|NCT05485779|366278151|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168248|NCT05485779|366278152|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
106168249|NCT03463044|366278153|FG000|Overall Study|Lost to Follow-up|0|||
106168250|NCT03463044|366278154|FG001|Overall Study|Lost to Follow-up|0|||
106168251|NCT03463044|366278155|FG002|Overall Study|Lost to Follow-up|0|||
106168252|NCT03463044|366278156|FG003|Overall Study|Lost to Follow-up|0|||
106168253|NCT03463044|366278157|FG004|Overall Study|Lost to Follow-up|0|||
106168254|NCT03463044|366278158|FG005|Overall Study|Lost to Follow-up|0|||
106168255|NCT03463044|366278159|FG006|Overall Study|Lost to Follow-up|0|||
106168256|NCT03463044|366278160|FG007|Overall Study|Lost to Follow-up|1|||
106168257|NCT03463044|366278161|FG008|Overall Study|Lost to Follow-up|0|||
106168258|NCT05764525|366278162|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
106168259|NCT05764525|366278163|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
106168260|NCT05764525|366278162|FG000|Overall Study|Withdrawal by Subject|4|||
106168261|NCT05764525|366278163|FG001|Overall Study|Withdrawal by Subject|8|||
106168262|NCT05764525|366278162|FG000|Overall Study|Physician Decision|1|||
106168263|NCT05764525|366278163|FG001|Overall Study|Physician Decision|0|||
106168264|NCT05576155|366278164|FG000|Overall Study|Withdrawal by Subject|1|||
106168265|NCT05576155|366278165|FG001|Overall Study|Withdrawal by Subject|1|||
106168266|NCT05907174|366278166|FG000|3-Month Assessment|Withdrawal by Subject|0|||
106168267|NCT05907174|366278167|FG001|3-Month Assessment|Withdrawal by Subject|0|||
106168268|NCT05907174|366278168|FG002|3-Month Assessment|Withdrawal by Subject|0|||
106168269|NCT05907174|366278169|FG003|3-Month Assessment|Withdrawal by Subject|1|||
106168270|NCT05907174|366278166|FG000|3-Month Assessment|Lost to Follow-up|1|||
106168271|NCT05907174|366278167|FG001|3-Month Assessment|Lost to Follow-up|1|||
106168272|NCT05907174|366278168|FG002|3-Month Assessment|Lost to Follow-up|1|||
106168273|NCT05907174|366278169|FG003|3-Month Assessment|Lost to Follow-up|1|||
106168274|NCT05907174|366278166|FG000|6-Month Assessment|Death|0|||
106168275|NCT05907174|366278167|FG001|6-Month Assessment|Death|0|||
106168276|NCT05907174|366278168|FG002|6-Month Assessment|Death|3|||
106168277|NCT05907174|366278169|FG003|6-Month Assessment|Death|0|||
106168278|NCT05907174|366278166|FG000|6-Month Assessment|Withdrawal by Subject|0|||
106168279|NCT05907174|366278167|FG001|6-Month Assessment|Withdrawal by Subject|0|||
106168280|NCT05907174|366278168|FG002|6-Month Assessment|Withdrawal by Subject|1|||
106168281|NCT05907174|366278169|FG003|6-Month Assessment|Withdrawal by Subject|1|||
106168282|NCT05907174|366278166|FG000|6-Month Assessment|Lost to Follow-up|0|||
106168283|NCT05907174|366278167|FG001|6-Month Assessment|Lost to Follow-up|1|||
106168284|NCT05907174|366278168|FG002|6-Month Assessment|Lost to Follow-up|1|||
106168285|NCT05907174|366278169|FG003|6-Month Assessment|Lost to Follow-up|1|||
106168286|NCT02694822|366278174|FG000|Phase 1|Death|2|||
106168287|NCT02694822|366278175|FG001|Phase 1|Death|1|||
106168288|NCT02694822|366278176|FG002|Phase 1|Death|6|||
106168289|NCT02694822|366278177|FG003|Phase 1|Death|6|||
106168290|NCT02694822|366278178|FG004|Phase 1|Death|3|||
106168291|NCT02694822|366278179|FG005|Phase 1|Death|0|||
106168292|NCT02694822|366278174|FG000|Phase 1|Withdrawal by Subject|2|||
106168293|NCT02694822|366278175|FG001|Phase 1|Withdrawal by Subject|2|||
106168294|NCT02694822|366278176|FG002|Phase 1|Withdrawal by Subject|4|||
106168295|NCT02694822|366278177|FG003|Phase 1|Withdrawal by Subject|8|||
106168296|NCT02694822|366278178|FG004|Phase 1|Withdrawal by Subject|1|||
106168297|NCT02694822|366278179|FG005|Phase 1|Withdrawal by Subject|0|||
106168298|NCT02694822|366278174|FG000|Phase 2|Death|0|||
106168299|NCT02694822|366278175|FG001|Phase 2|Death|0|||
106168300|NCT02694822|366278176|FG002|Phase 2|Death|0|||
106168301|NCT02694822|366278177|FG003|Phase 2|Death|0|||
106168302|NCT02694822|366278178|FG004|Phase 2|Death|0|||
106168303|NCT02694822|366278179|FG005|Phase 2|Death|26|||
106168304|NCT02694822|366278174|FG000|Phase 2|Withdrawal by Subject|0|||
106168305|NCT02694822|366278175|FG001|Phase 2|Withdrawal by Subject|0|||
106168306|NCT02694822|366278176|FG002|Phase 2|Withdrawal by Subject|0|||
106168307|NCT02694822|366278177|FG003|Phase 2|Withdrawal by Subject|0|||
106168308|NCT02694822|366278178|FG004|Phase 2|Withdrawal by Subject|0|||
106168309|NCT02694822|366278179|FG005|Phase 2|Withdrawal by Subject|13|||
106168310|NCT02694822|366278174|FG000|Phase 2|Administrative Study Closure|0|||
106168311|NCT02694822|366278175|FG001|Phase 2|Administrative Study Closure|0|||
106168312|NCT02694822|366278176|FG002|Phase 2|Administrative Study Closure|0|||
106168313|NCT02694822|366278177|FG003|Phase 2|Administrative Study Closure|0|||
106168314|NCT02694822|366278178|FG004|Phase 2|Administrative Study Closure|0|||
106168315|NCT02694822|366278179|FG005|Phase 2|Administrative Study Closure|2|||
106168316|NCT02694822|366278174|FG000|Phase 2|Lost to Follow-up|0|||
106168317|NCT02694822|366278175|FG001|Phase 2|Lost to Follow-up|0|||
106168318|NCT02694822|366278176|FG002|Phase 2|Lost to Follow-up|0|||
106168319|NCT02694822|366278177|FG003|Phase 2|Lost to Follow-up|0|||
106168320|NCT02694822|366278178|FG004|Phase 2|Lost to Follow-up|0|||
106168321|NCT02694822|366278179|FG005|Phase 2|Lost to Follow-up|1|||
106168322|NCT02694822|366278174|FG000|Phase 2|Participant Transferred to Another Site|0|||
106168323|NCT02694822|366278175|FG001|Phase 2|Participant Transferred to Another Site|0|||
106168324|NCT02694822|366278176|FG002|Phase 2|Participant Transferred to Another Site|0|||
106168325|NCT02694822|366278177|FG003|Phase 2|Participant Transferred to Another Site|0|||
106168326|NCT02694822|366278178|FG004|Phase 2|Participant Transferred to Another Site|0|||
106168327|NCT02694822|366278179|FG005|Phase 2|Participant Transferred to Another Site|1|||
106168328|NCT02424617|366278180|FG000|Overall Study|Adverse Event|0|||
106168329|NCT02424617|366278181|FG001|Overall Study|Adverse Event|1|||
106168330|NCT02424617|366278182|FG002|Overall Study|Adverse Event|0|||
106168331|NCT02424617|366278183|FG003|Overall Study|Adverse Event|0|||
106168332|NCT02424617|366278180|FG000|Overall Study|Investigator Decision|0|||
106168333|NCT02424617|366278181|FG001|Overall Study|Investigator Decision|0|||
106168334|NCT02424617|366278182|FG002|Overall Study|Investigator Decision|0|||
106168335|NCT02424617|366278183|FG003|Overall Study|Investigator Decision|1|||
106168336|NCT02424617|366278180|FG000|Overall Study|Withdrawal by Subject|1|||
106168337|NCT02424617|366278181|FG001|Overall Study|Withdrawal by Subject|1|||
106168338|NCT02424617|366278182|FG002|Overall Study|Withdrawal by Subject|0|||
106168339|NCT02424617|366278183|FG003|Overall Study|Withdrawal by Subject|1|||
106168340|NCT02424617|366278180|FG000|Overall Study|Progressive Disease|7|||
106168341|NCT02424617|366278181|FG001|Overall Study|Progressive Disease|6|||
106168342|NCT02424617|366278182|FG002|Overall Study|Progressive Disease|11|||
106168343|NCT02424617|366278183|FG003|Overall Study|Progressive Disease|10|||
106168344|NCT02424617|366278180|FG000|Overall Study|Other|0|||
106168345|NCT02424617|366278181|FG001|Overall Study|Other|0|||
106168346|NCT02424617|366278182|FG002|Overall Study|Other|0|||
106168347|NCT02424617|366278183|FG003|Overall Study|Other|1|||
106168348|NCT04875195|366278198|FG000|Overall Study|Death|9|||
106168349|NCT04875195|366278199|FG001|Overall Study|Death|3|||
106168350|NCT04875195|366278198|FG000|Overall Study|Withdrawal by Subject|2|||
106168351|NCT04875195|366278199|FG001|Overall Study|Withdrawal by Subject|1|||
106168352|NCT04875195|366278198|FG000|Overall Study|Ongoing in study|49|||
106168353|NCT04875195|366278199|FG001|Overall Study|Ongoing in study|2|||
106168354|NCT03240016|366279997|FG000|Overall Study|Adverse Event|9|||
106168355|NCT03240016|366279997|FG000|Overall Study|Withdrawal by Subject|7|||
106168356|NCT03240016|366279997|FG000|Overall Study|Death|1|||
106168357|NCT03240016|366279997|FG000|Overall Study|Physician Decision|2|||
106168358|NCT05200403|366279998|FG000|Overall Study|Withdrawal by Subject|4|||
106168359|NCT05200403|366279999|FG001|Overall Study|Withdrawal by Subject|2|||
106168360|NCT05200403|366280000|FG002|Overall Study|Withdrawal by Subject|6|||
106168361|NCT05299723|366280001|FG000|Overall Study|Withdrawal by Subject|0|||
106168362|NCT05299723|366280002|FG001|Overall Study|Withdrawal by Subject|2|||
106168363|NCT05299723|366280003|FG002|Overall Study|Withdrawal by Subject|0|||
106168364|NCT03220035|366280005|FG000|Overall Study|Adverse Event|1|||
106168365|NCT03220035|366280005|FG000|Overall Study|Protocol Violation|1|||
106168366|NCT03220035|366280005|FG000|Overall Study|Progressive Disease|2|||
106168367|NCT00696111|366280006|FG000|Overall Study|Withdrawal by Subject|17|||
106168368|NCT02593773|366280007|FG000|Overall Study|Voluntary Withdrawal|3|||
106168369|NCT02593773|366280007|FG000|Overall Study|Study Terminated by Sponsor|31|||
106168370|NCT02593773|366280007|FG000|Overall Study|Death|1|||
106168371|NCT02151981|366280008|FG000|Overall Study|Death|184|||
106168372|NCT02151981|366280009|FG001|Overall Study|Death|88|||
106168373|NCT02151981|366280008|FG000|Overall Study|Lost to Follow-up|7|||
106168374|NCT02151981|366280009|FG001|Overall Study|Lost to Follow-up|1|||
106168375|NCT02151981|366280008|FG000|Overall Study|Withdrawal by Subject|27|||
106168376|NCT02151981|366280009|FG001|Overall Study|Withdrawal by Subject|21|||
106168377|NCT02151981|366280008|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
106168378|NCT02151981|366280009|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
106168379|NCT02151981|366280008|FG000|Overall Study|Other reasons|1|||
106168380|NCT02151981|366280009|FG001|Overall Study|Other reasons|2|||
106168381|NCT04201262|366280012|FG000|Overall Study|Adverse Event|1|||
106168382|NCT04201262|366280013|FG001|Overall Study|Adverse Event|2|||
106168383|NCT04201262|366280012|FG000|Overall Study|Continuing in the study|57|||
106168384|NCT04201262|366280013|FG001|Overall Study|Continuing in the study|0|||
106168385|NCT04201262|366280012|FG000|Overall Study|Withdrawal by Subject|0|||
106168386|NCT04201262|366280013|FG001|Overall Study|Withdrawal by Subject|1|||
106168387|NCT05645757|366280017|FG000|Overall Study|Enrolled but treatment not administered|0|||
106168388|NCT05645757|366280018|FG001|Overall Study|Enrolled but treatment not administered|0|||
106168389|NCT05645757|366280019|FG002|Overall Study|Enrolled but treatment not administered|0|||
106168390|NCT05645757|366280020|FG003|Overall Study|Enrolled but treatment not administered|0|||
106168391|NCT05645757|366280021|FG004|Overall Study|Enrolled but treatment not administered|1|||
106168392|NCT05645757|366280022|FG005|Overall Study|Enrolled but treatment not administered|1|||
106168393|NCT05645757|366280023|FG006|Overall Study|Enrolled but treatment not administered|0|||
106168394|NCT05645757|366280024|FG007|Overall Study|Enrolled but treatment not administered|0|||
106168395|NCT03905798|366280027|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
106168396|NCT01928394|366280028|FG000|Treatment Period|Disease progression|17|||
106168397|NCT01928394|366280029|FG001|Treatment Period|Disease progression|2|||
106168398|NCT01928394|366280030|FG002|Treatment Period|Disease progression|12|||
106168399|NCT01928394|366280031|FG003|Treatment Period|Disease progression|48|||
106168400|NCT01928394|366280032|FG004|Treatment Period|Disease progression|3|||
106168401|NCT01928394|366280033|FG005|Treatment Period|Disease progression|25|||
106168402|NCT01928394|366280034|FG006|Treatment Period|Disease progression|38|||
106168403|NCT01928394|366280035|FG007|Treatment Period|Disease progression|16|||
106168404|NCT01928394|366280036|FG008|Treatment Period|Disease progression|3|||
106168405|NCT01928394|366280037|FG009|Treatment Period|Disease progression|11|||
106168406|NCT01928394|366280038|FG010|Treatment Period|Disease progression|22|||
106168407|NCT01928394|366280039|FG011|Treatment Period|Disease progression|73|||
106168408|NCT01928394|366280040|FG012|Treatment Period|Disease progression|38|||
106168409|NCT01928394|366280041|FG013|Treatment Period|Disease progression|118|||
106168410|NCT01928394|366280042|FG014|Treatment Period|Disease progression|59|||
106168411|NCT01928394|366280043|FG015|Treatment Period|Disease progression|1|||
106168412|NCT01928394|366280044|FG016|Treatment Period|Disease progression|43|||
106168413|NCT01928394|366280045|FG017|Treatment Period|Disease progression|56|||
106168414|NCT01928394|366280046|FG018|Treatment Period|Disease progression|50|||
106168415|NCT01928394|366280047|FG019|Treatment Period|Disease progression|71|||
106168416|NCT01928394|366280048|FG020|Treatment Period|Disease progression|30|||
106168417|NCT01928394|366280049|FG021|Treatment Period|Disease progression|31|||
106168418|NCT01928394|366280050|FG022|Treatment Period|Disease progression|31|||
106168419|NCT01928394|366280028|FG000|Treatment Period|Study drug toxicity|1|||
106168420|NCT01928394|366280029|FG001|Treatment Period|Study drug toxicity|1|||
106168421|NCT01928394|366280030|FG002|Treatment Period|Study drug toxicity|3|||
106168422|NCT01928394|366280031|FG003|Treatment Period|Study drug toxicity|3|||
106168423|NCT01928394|366280032|FG004|Treatment Period|Study drug toxicity|0|||
106168424|NCT01928394|366280033|FG005|Treatment Period|Study drug toxicity|9|||
106168425|NCT01928394|366280034|FG006|Treatment Period|Study drug toxicity|7|||
106168426|NCT01928394|366280035|FG007|Treatment Period|Study drug toxicity|1|||
106168427|NCT01928394|366280036|FG008|Treatment Period|Study drug toxicity|0|||
106168428|NCT01928394|366280037|FG009|Treatment Period|Study drug toxicity|5|||
106168429|NCT01928394|366280038|FG010|Treatment Period|Study drug toxicity|2|||
106168430|NCT01928394|366280039|FG011|Treatment Period|Study drug toxicity|3|||
106168431|NCT01928394|366280040|FG012|Treatment Period|Study drug toxicity|7|||
106168432|NCT01928394|366280041|FG013|Treatment Period|Study drug toxicity|5|||
106168433|NCT01928394|366280042|FG014|Treatment Period|Study drug toxicity|12|||
106168434|NCT01928394|366280043|FG015|Treatment Period|Study drug toxicity|0|||
106168435|NCT01928394|366280044|FG016|Treatment Period|Study drug toxicity|3|||
106168436|NCT01928394|366280045|FG017|Treatment Period|Study drug toxicity|3|||
106168437|NCT01928394|366280046|FG018|Treatment Period|Study drug toxicity|12|||
106168438|NCT01928394|366280047|FG019|Treatment Period|Study drug toxicity|15|||
106168439|NCT01928394|366280048|FG020|Treatment Period|Study drug toxicity|4|||
106168440|NCT01928394|366280049|FG021|Treatment Period|Study drug toxicity|7|||
106168441|NCT01928394|366280050|FG022|Treatment Period|Study drug toxicity|4|||
106168442|NCT01928394|366280028|FG000|Treatment Period|AE unrelated to study drug|0|||
106168443|NCT01928394|366280029|FG001|Treatment Period|AE unrelated to study drug|0|||
106168444|NCT01928394|366280030|FG002|Treatment Period|AE unrelated to study drug|2|||
106168445|NCT01928394|366280031|FG003|Treatment Period|AE unrelated to study drug|3|||
106168446|NCT01928394|366280032|FG004|Treatment Period|AE unrelated to study drug|0|||
106168447|NCT01928394|366280033|FG005|Treatment Period|AE unrelated to study drug|5|||
106168448|NCT01928394|366280034|FG006|Treatment Period|AE unrelated to study drug|1|||
106168449|NCT01928394|366280035|FG007|Treatment Period|AE unrelated to study drug|0|||
106168450|NCT01928394|366280036|FG008|Treatment Period|AE unrelated to study drug|0|||
106168451|NCT01928394|366280037|FG009|Treatment Period|AE unrelated to study drug|2|||
106168452|NCT01928394|366280038|FG010|Treatment Period|AE unrelated to study drug|0|||
106168453|NCT01928394|366280039|FG011|Treatment Period|AE unrelated to study drug|12|||
106168454|NCT01928394|366280040|FG012|Treatment Period|AE unrelated to study drug|6|||
106168455|NCT01928394|366280041|FG013|Treatment Period|AE unrelated to study drug|13|||
106168456|NCT01928394|366280042|FG014|Treatment Period|AE unrelated to study drug|6|||
106168457|NCT01928394|366280043|FG015|Treatment Period|AE unrelated to study drug|1|||
106168458|NCT01928394|366280044|FG016|Treatment Period|AE unrelated to study drug|1|||
106168459|NCT01928394|366280045|FG017|Treatment Period|AE unrelated to study drug|6|||
106168460|NCT01928394|366280046|FG018|Treatment Period|AE unrelated to study drug|3|||
106168461|NCT01928394|366280047|FG019|Treatment Period|AE unrelated to study drug|5|||
106168462|NCT01928394|366280048|FG020|Treatment Period|AE unrelated to study drug|1|||
106168463|NCT01928394|366280049|FG021|Treatment Period|AE unrelated to study drug|1|||
106168464|NCT01928394|366280050|FG022|Treatment Period|AE unrelated to study drug|0|||
106168465|NCT01928394|366280028|FG000|Treatment Period|Participant request to stop therapy|0|||
106168466|NCT01928394|366280029|FG001|Treatment Period|Participant request to stop therapy|0|||
106168467|NCT01928394|366280030|FG002|Treatment Period|Participant request to stop therapy|0|||
106168468|NCT01928394|366280031|FG003|Treatment Period|Participant request to stop therapy|0|||
106168469|NCT01928394|366280032|FG004|Treatment Period|Participant request to stop therapy|0|||
106168470|NCT01928394|366280033|FG005|Treatment Period|Participant request to stop therapy|3|||
106168471|NCT01928394|366280034|FG006|Treatment Period|Participant request to stop therapy|3|||
106168472|NCT01928394|366280035|FG007|Treatment Period|Participant request to stop therapy|0|||
106168473|NCT01928394|366280036|FG008|Treatment Period|Participant request to stop therapy|0|||
106168474|NCT01928394|366280037|FG009|Treatment Period|Participant request to stop therapy|0|||
106168475|NCT01928394|366280038|FG010|Treatment Period|Participant request to stop therapy|3|||
106168476|NCT01928394|366280039|FG011|Treatment Period|Participant request to stop therapy|2|||
106168477|NCT01928394|366280040|FG012|Treatment Period|Participant request to stop therapy|1|||
106168478|NCT01928394|366280041|FG013|Treatment Period|Participant request to stop therapy|2|||
106168479|NCT01928394|366280042|FG014|Treatment Period|Participant request to stop therapy|4|||
106168480|NCT01928394|366280043|FG015|Treatment Period|Participant request to stop therapy|0|||
106168481|NCT01928394|366280044|FG016|Treatment Period|Participant request to stop therapy|1|||
106168482|NCT01928394|366280045|FG017|Treatment Period|Participant request to stop therapy|3|||
106168483|NCT01928394|366280046|FG018|Treatment Period|Participant request to stop therapy|1|||
106168484|NCT01928394|366280047|FG019|Treatment Period|Participant request to stop therapy|1|||
106168485|NCT01928394|366280048|FG020|Treatment Period|Participant request to stop therapy|3|||
106168486|NCT01928394|366280049|FG021|Treatment Period|Participant request to stop therapy|1|||
106168487|NCT01928394|366280050|FG022|Treatment Period|Participant request to stop therapy|3|||
106168488|NCT01928394|366280028|FG000|Treatment Period|Participant withdrew consent|0|||
106168489|NCT01928394|366280029|FG001|Treatment Period|Participant withdrew consent|0|||
106168490|NCT01928394|366280030|FG002|Treatment Period|Participant withdrew consent|1|||
106168491|NCT01928394|366280031|FG003|Treatment Period|Participant withdrew consent|1|||
106168492|NCT01928394|366280032|FG004|Treatment Period|Participant withdrew consent|0|||
106168493|NCT01928394|366280033|FG005|Treatment Period|Participant withdrew consent|1|||
106168494|NCT01928394|366280034|FG006|Treatment Period|Participant withdrew consent|0|||
106168495|NCT01928394|366280035|FG007|Treatment Period|Participant withdrew consent|1|||
106168496|NCT01928394|366280036|FG008|Treatment Period|Participant withdrew consent|0|||
106168497|NCT01928394|366280037|FG009|Treatment Period|Participant withdrew consent|0|||
106168498|NCT01928394|366280038|FG010|Treatment Period|Participant withdrew consent|1|||
106168499|NCT01928394|366280039|FG011|Treatment Period|Participant withdrew consent|1|||
106168500|NCT01928394|366280040|FG012|Treatment Period|Participant withdrew consent|1|||
106168501|NCT01928394|366280041|FG013|Treatment Period|Participant withdrew consent|0|||
106168502|NCT01928394|366280042|FG014|Treatment Period|Participant withdrew consent|2|||
106168503|NCT01928394|366280043|FG015|Treatment Period|Participant withdrew consent|0|||
106168504|NCT01928394|366280044|FG016|Treatment Period|Participant withdrew consent|2|||
106168505|NCT01928394|366280045|FG017|Treatment Period|Participant withdrew consent|1|||
106168506|NCT01928394|366280046|FG018|Treatment Period|Participant withdrew consent|1|||
106168507|NCT01928394|366280047|FG019|Treatment Period|Participant withdrew consent|1|||
106168508|NCT01928394|366280048|FG020|Treatment Period|Participant withdrew consent|0|||
106168509|NCT01928394|366280049|FG021|Treatment Period|Participant withdrew consent|2|||
106168510|NCT01928394|366280050|FG022|Treatment Period|Participant withdrew consent|0|||
106168511|NCT01928394|366280028|FG000|Treatment Period|Poor/non-compliance|0|||
106168512|NCT01928394|366280029|FG001|Treatment Period|Poor/non-compliance|0|||
106168513|NCT01928394|366280030|FG002|Treatment Period|Poor/non-compliance|0|||
106168514|NCT01928394|366280031|FG003|Treatment Period|Poor/non-compliance|1|||
106168515|NCT01928394|366280032|FG004|Treatment Period|Poor/non-compliance|0|||
106168516|NCT01928394|366280033|FG005|Treatment Period|Poor/non-compliance|0|||
106168517|NCT01928394|366280034|FG006|Treatment Period|Poor/non-compliance|0|||
106168518|NCT01928394|366280035|FG007|Treatment Period|Poor/non-compliance|0|||
106168519|NCT01928394|366280036|FG008|Treatment Period|Poor/non-compliance|0|||
106168520|NCT01928394|366280037|FG009|Treatment Period|Poor/non-compliance|0|||
106168521|NCT01928394|366280038|FG010|Treatment Period|Poor/non-compliance|0|||
106168522|NCT01928394|366280039|FG011|Treatment Period|Poor/non-compliance|0|||
106168523|NCT01928394|366280040|FG012|Treatment Period|Poor/non-compliance|1|||
106168524|NCT01928394|366280041|FG013|Treatment Period|Poor/non-compliance|0|||
106168525|NCT01928394|366280042|FG014|Treatment Period|Poor/non-compliance|1|||
106168526|NCT01928394|366280043|FG015|Treatment Period|Poor/non-compliance|0|||
106168527|NCT01928394|366280044|FG016|Treatment Period|Poor/non-compliance|0|||
106168528|NCT01928394|366280045|FG017|Treatment Period|Poor/non-compliance|1|||
106168529|NCT01928394|366280046|FG018|Treatment Period|Poor/non-compliance|0|||
106168530|NCT01928394|366280047|FG019|Treatment Period|Poor/non-compliance|1|||
106168531|NCT01928394|366280048|FG020|Treatment Period|Poor/non-compliance|0|||
106168532|NCT01928394|366280049|FG021|Treatment Period|Poor/non-compliance|0|||
106168533|NCT01928394|366280050|FG022|Treatment Period|Poor/non-compliance|0|||
106168534|NCT01928394|366280028|FG000|Treatment Period|other reason|0|||
106168535|NCT01928394|366280029|FG001|Treatment Period|other reason|0|||
106168536|NCT01928394|366280030|FG002|Treatment Period|other reason|0|||
106168537|NCT01928394|366280031|FG003|Treatment Period|other reason|0|||
106168538|NCT01928394|366280032|FG004|Treatment Period|other reason|0|||
106168539|NCT01928394|366280033|FG005|Treatment Period|other reason|0|||
106168540|NCT01928394|366280034|FG006|Treatment Period|other reason|0|||
106168541|NCT01928394|366280035|FG007|Treatment Period|other reason|0|||
106168542|NCT01928394|366280036|FG008|Treatment Period|other reason|0|||
106168543|NCT01928394|366280037|FG009|Treatment Period|other reason|0|||
106168544|NCT01928394|366280038|FG010|Treatment Period|other reason|1|||
106168545|NCT01928394|366280039|FG011|Treatment Period|other reason|1|||
106168546|NCT01928394|366280040|FG012|Treatment Period|other reason|1|||
106168547|NCT01928394|366280041|FG013|Treatment Period|other reason|0|||
106168548|NCT01928394|366280042|FG014|Treatment Period|other reason|1|||
106168549|NCT01928394|366280043|FG015|Treatment Period|other reason|0|||
106168550|NCT01928394|366280044|FG016|Treatment Period|other reason|0|||
106168551|NCT01928394|366280045|FG017|Treatment Period|other reason|0|||
106168552|NCT01928394|366280046|FG018|Treatment Period|other reason|2|||
106168553|NCT01928394|366280047|FG019|Treatment Period|other reason|2|||
106168554|NCT01928394|366280048|FG020|Treatment Period|other reason|0|||
106168555|NCT01928394|366280049|FG021|Treatment Period|other reason|0|||
106168556|NCT01928394|366280050|FG022|Treatment Period|other reason|0|||
106168557|NCT01928394|366280028|FG000|Treatment Period|Maximum clinical benefit|0|||
106168558|NCT01928394|366280029|FG001|Treatment Period|Maximum clinical benefit|0|||
106168559|NCT01928394|366280030|FG002|Treatment Period|Maximum clinical benefit|0|||
106168560|NCT01928394|366280031|FG003|Treatment Period|Maximum clinical benefit|0|||
106168561|NCT01928394|366280032|FG004|Treatment Period|Maximum clinical benefit|0|||
106168562|NCT01928394|366280033|FG005|Treatment Period|Maximum clinical benefit|0|||
106168563|NCT01928394|366280034|FG006|Treatment Period|Maximum clinical benefit|0|||
106168564|NCT01928394|366280035|FG007|Treatment Period|Maximum clinical benefit|0|||
106168565|NCT01928394|366280036|FG008|Treatment Period|Maximum clinical benefit|0|||
106168566|NCT01928394|366280037|FG009|Treatment Period|Maximum clinical benefit|0|||
106168567|NCT01928394|366280038|FG010|Treatment Period|Maximum clinical benefit|1|||
106168568|NCT01928394|366280039|FG011|Treatment Period|Maximum clinical benefit|1|||
106168569|NCT01928394|366280040|FG012|Treatment Period|Maximum clinical benefit|0|||
106168570|NCT01928394|366280041|FG013|Treatment Period|Maximum clinical benefit|0|||
106168571|NCT01928394|366280042|FG014|Treatment Period|Maximum clinical benefit|1|||
106168572|NCT01928394|366280043|FG015|Treatment Period|Maximum clinical benefit|0|||
106168573|NCT01928394|366280044|FG016|Treatment Period|Maximum clinical benefit|0|||
106168574|NCT01928394|366280045|FG017|Treatment Period|Maximum clinical benefit|1|||
106168575|NCT01928394|366280046|FG018|Treatment Period|Maximum clinical benefit|1|||
106168576|NCT01928394|366280047|FG019|Treatment Period|Maximum clinical benefit|0|||
106168577|NCT01928394|366280048|FG020|Treatment Period|Maximum clinical benefit|2|||
106168578|NCT01928394|366280049|FG021|Treatment Period|Maximum clinical benefit|0|||
106168579|NCT01928394|366280050|FG022|Treatment Period|Maximum clinical benefit|0|||
106168580|NCT01928394|366280028|FG000|Treatment Period|Lost to Follow-up|0|||
106168581|NCT01928394|366280029|FG001|Treatment Period|Lost to Follow-up|0|||
106168582|NCT01928394|366280030|FG002|Treatment Period|Lost to Follow-up|0|||
106168583|NCT01928394|366280031|FG003|Treatment Period|Lost to Follow-up|0|||
106168584|NCT01928394|366280032|FG004|Treatment Period|Lost to Follow-up|0|||
106168585|NCT01928394|366280033|FG005|Treatment Period|Lost to Follow-up|0|||
106168586|NCT01928394|366280034|FG006|Treatment Period|Lost to Follow-up|0|||
106168587|NCT01928394|366280035|FG007|Treatment Period|Lost to Follow-up|0|||
106168588|NCT01928394|366280036|FG008|Treatment Period|Lost to Follow-up|0|||
106168589|NCT01928394|366280037|FG009|Treatment Period|Lost to Follow-up|0|||
106168590|NCT01928394|366280038|FG010|Treatment Period|Lost to Follow-up|0|||
106168591|NCT01928394|366280039|FG011|Treatment Period|Lost to Follow-up|0|||
106168592|NCT01928394|366280040|FG012|Treatment Period|Lost to Follow-up|0|||
106168593|NCT01928394|366280041|FG013|Treatment Period|Lost to Follow-up|0|||
106168594|NCT01928394|366280042|FG014|Treatment Period|Lost to Follow-up|0|||
106168595|NCT01928394|366280043|FG015|Treatment Period|Lost to Follow-up|0|||
106168596|NCT01928394|366280044|FG016|Treatment Period|Lost to Follow-up|0|||
106168597|NCT01928394|366280045|FG017|Treatment Period|Lost to Follow-up|0|||
106168598|NCT01928394|366280046|FG018|Treatment Period|Lost to Follow-up|0|||
106168599|NCT01928394|366280047|FG019|Treatment Period|Lost to Follow-up|0|||
106168600|NCT01928394|366280048|FG020|Treatment Period|Lost to Follow-up|0|||
106168601|NCT01928394|366280049|FG021|Treatment Period|Lost to Follow-up|0|||
106168602|NCT01928394|366280050|FG022|Treatment Period|Lost to Follow-up|1|||
106168603|NCT01928394|366280028|FG000|Treatment Period|Death|0|||
106168604|NCT01928394|366280029|FG001|Treatment Period|Death|0|||
106168605|NCT01928394|366280030|FG002|Treatment Period|Death|0|||
106168606|NCT01928394|366280031|FG003|Treatment Period|Death|0|||
106168607|NCT01928394|366280032|FG004|Treatment Period|Death|0|||
106168608|NCT01928394|366280033|FG005|Treatment Period|Death|0|||
106168609|NCT01928394|366280034|FG006|Treatment Period|Death|0|||
106168610|NCT01928394|366280035|FG007|Treatment Period|Death|0|||
106168611|NCT01928394|366280036|FG008|Treatment Period|Death|0|||
106168612|NCT01928394|366280037|FG009|Treatment Period|Death|0|||
106168613|NCT01928394|366280038|FG010|Treatment Period|Death|0|||
106168614|NCT01928394|366280039|FG011|Treatment Period|Death|0|||
106168615|NCT01928394|366280040|FG012|Treatment Period|Death|0|||
106168616|NCT01928394|366280041|FG013|Treatment Period|Death|1|||
106168617|NCT01928394|366280042|FG014|Treatment Period|Death|2|||
106168618|NCT01928394|366280043|FG015|Treatment Period|Death|0|||
106168619|NCT01928394|366280044|FG016|Treatment Period|Death|0|||
106168620|NCT01928394|366280045|FG017|Treatment Period|Death|0|||
106168621|NCT01928394|366280046|FG018|Treatment Period|Death|0|||
106168622|NCT01928394|366280047|FG019|Treatment Period|Death|0|||
106168623|NCT01928394|366280048|FG020|Treatment Period|Death|0|||
106168624|NCT01928394|366280049|FG021|Treatment Period|Death|0|||
106168625|NCT01928394|366280050|FG022|Treatment Period|Death|0|||
106168626|NCT01928394|366280028|FG000|Follow-up Period|Participant withdrew consent|3|||
106168627|NCT01928394|366280029|FG001|Follow-up Period|Participant withdrew consent|0|||
106168628|NCT01928394|366280030|FG002|Follow-up Period|Participant withdrew consent|1|||
106168629|NCT01928394|366280031|FG003|Follow-up Period|Participant withdrew consent|4|||
106168630|NCT01928394|366280032|FG004|Follow-up Period|Participant withdrew consent|0|||
106168631|NCT01928394|366280033|FG005|Follow-up Period|Participant withdrew consent|2|||
106168632|NCT01928394|366280034|FG006|Follow-up Period|Participant withdrew consent|5|||
106168633|NCT01928394|366280035|FG007|Follow-up Period|Participant withdrew consent|1|||
106168634|NCT01928394|366280036|FG008|Follow-up Period|Participant withdrew consent|0|||
106168635|NCT01928394|366280037|FG009|Follow-up Period|Participant withdrew consent|0|||
106168636|NCT01928394|366280038|FG010|Follow-up Period|Participant withdrew consent|5|||
106168637|NCT01928394|366280039|FG011|Follow-up Period|Participant withdrew consent|8|||
106168638|NCT01928394|366280040|FG012|Follow-up Period|Participant withdrew consent|2|||
106168639|NCT01928394|366280041|FG013|Follow-up Period|Participant withdrew consent|12|||
106168640|NCT01928394|366280042|FG014|Follow-up Period|Participant withdrew consent|7|||
106168641|NCT01928394|366280043|FG015|Follow-up Period|Participant withdrew consent|0|||
106168642|NCT01928394|366280044|FG016|Follow-up Period|Participant withdrew consent|5|||
106168643|NCT01928394|366280045|FG017|Follow-up Period|Participant withdrew consent|3|||
106168644|NCT01928394|366280046|FG018|Follow-up Period|Participant withdrew consent|2|||
106168645|NCT01928394|366280047|FG019|Follow-up Period|Participant withdrew consent|7|||
106168646|NCT01928394|366280048|FG020|Follow-up Period|Participant withdrew consent|4|||
106168647|NCT01928394|366280049|FG021|Follow-up Period|Participant withdrew consent|6|||
106168648|NCT01928394|366280050|FG022|Follow-up Period|Participant withdrew consent|2|||
106168649|NCT01928394|366280028|FG000|Follow-up Period|Death|0|||
106168650|NCT01928394|366280029|FG001|Follow-up Period|Death|0|||
106168651|NCT01928394|366280030|FG002|Follow-up Period|Death|2|||
106168652|NCT01928394|366280031|FG003|Follow-up Period|Death|6|||
106168653|NCT01928394|366280032|FG004|Follow-up Period|Death|0|||
106168654|NCT01928394|366280033|FG005|Follow-up Period|Death|6|||
106168655|NCT01928394|366280034|FG006|Follow-up Period|Death|6|||
106168656|NCT01928394|366280035|FG007|Follow-up Period|Death|2|||
106168657|NCT01928394|366280036|FG008|Follow-up Period|Death|1|||
106168658|NCT01928394|366280037|FG009|Follow-up Period|Death|2|||
106168659|NCT01928394|366280038|FG010|Follow-up Period|Death|4|||
106168660|NCT01928394|366280039|FG011|Follow-up Period|Death|12|||
106168661|NCT01928394|366280040|FG012|Follow-up Period|Death|11|||
106168662|NCT01928394|366280041|FG013|Follow-up Period|Death|25|||
106168663|NCT01928394|366280042|FG014|Follow-up Period|Death|18|||
106168664|NCT01928394|366280043|FG015|Follow-up Period|Death|0|||
106168665|NCT01928394|366280044|FG016|Follow-up Period|Death|6|||
106168666|NCT01928394|366280045|FG017|Follow-up Period|Death|5|||
106168667|NCT01928394|366280046|FG018|Follow-up Period|Death|13|||
106168668|NCT01928394|366280047|FG019|Follow-up Period|Death|13|||
106168669|NCT01928394|366280048|FG020|Follow-up Period|Death|5|||
106168670|NCT01928394|366280049|FG021|Follow-up Period|Death|3|||
106168671|NCT01928394|366280050|FG022|Follow-up Period|Death|2|||
106168672|NCT01928394|366280028|FG000|Follow-up Period|other reason|0|||
106168673|NCT01928394|366280029|FG001|Follow-up Period|other reason|0|||
106168674|NCT01928394|366280030|FG002|Follow-up Period|other reason|0|||
106168675|NCT01928394|366280031|FG003|Follow-up Period|other reason|0|||
106168676|NCT01928394|366280032|FG004|Follow-up Period|other reason|0|||
106168677|NCT01928394|366280033|FG005|Follow-up Period|other reason|0|||
106168678|NCT01928394|366280034|FG006|Follow-up Period|other reason|1|||
106168679|NCT01928394|366280035|FG007|Follow-up Period|other reason|3|||
106168680|NCT01928394|366280036|FG008|Follow-up Period|other reason|0|||
106168681|NCT01928394|366280037|FG009|Follow-up Period|other reason|0|||
106168682|NCT01928394|366280038|FG010|Follow-up Period|other reason|2|||
106168683|NCT01928394|366280039|FG011|Follow-up Period|other reason|1|||
106168684|NCT01928394|366280040|FG012|Follow-up Period|other reason|0|||
106168685|NCT01928394|366280041|FG013|Follow-up Period|other reason|1|||
106168686|NCT01928394|366280042|FG014|Follow-up Period|other reason|4|||
106168687|NCT01928394|366280043|FG015|Follow-up Period|other reason|0|||
106168688|NCT01928394|366280044|FG016|Follow-up Period|other reason|2|||
106168689|NCT01928394|366280045|FG017|Follow-up Period|other reason|0|||
106168690|NCT01928394|366280046|FG018|Follow-up Period|other reason|1|||
106168691|NCT01928394|366280047|FG019|Follow-up Period|other reason|1|||
106168692|NCT01928394|366280048|FG020|Follow-up Period|other reason|0|||
106168693|NCT01928394|366280049|FG021|Follow-up Period|other reason|0|||
106168694|NCT01928394|366280050|FG022|Follow-up Period|other reason|1|||
106168695|NCT01928394|366280028|FG000|Follow-up Period|Lost to Follow-up|0|||
106168696|NCT01928394|366280029|FG001|Follow-up Period|Lost to Follow-up|0|||
106168697|NCT01928394|366280030|FG002|Follow-up Period|Lost to Follow-up|0|||
106168698|NCT01928394|366280031|FG003|Follow-up Period|Lost to Follow-up|0|||
106168699|NCT01928394|366280032|FG004|Follow-up Period|Lost to Follow-up|0|||
106168700|NCT01928394|366280033|FG005|Follow-up Period|Lost to Follow-up|0|||
106168701|NCT01928394|366280034|FG006|Follow-up Period|Lost to Follow-up|0|||
106168702|NCT01928394|366280035|FG007|Follow-up Period|Lost to Follow-up|0|||
106168703|NCT01928394|366280036|FG008|Follow-up Period|Lost to Follow-up|0|||
106168704|NCT01928394|366280037|FG009|Follow-up Period|Lost to Follow-up|0|||
106168705|NCT01928394|366280038|FG010|Follow-up Period|Lost to Follow-up|0|||
106168706|NCT01928394|366280039|FG011|Follow-up Period|Lost to Follow-up|1|||
106168707|NCT01928394|366280040|FG012|Follow-up Period|Lost to Follow-up|1|||
106168708|NCT01928394|366280041|FG013|Follow-up Period|Lost to Follow-up|0|||
106168709|NCT01928394|366280042|FG014|Follow-up Period|Lost to Follow-up|1|||
106168710|NCT01928394|366280043|FG015|Follow-up Period|Lost to Follow-up|0|||
106168711|NCT01928394|366280044|FG016|Follow-up Period|Lost to Follow-up|1|||
106168712|NCT01928394|366280045|FG017|Follow-up Period|Lost to Follow-up|0|||
106168713|NCT01928394|366280046|FG018|Follow-up Period|Lost to Follow-up|0|||
106168714|NCT01928394|366280047|FG019|Follow-up Period|Lost to Follow-up|0|||
106168715|NCT01928394|366280048|FG020|Follow-up Period|Lost to Follow-up|0|||
106168716|NCT01928394|366280049|FG021|Follow-up Period|Lost to Follow-up|0|||
106168717|NCT01928394|366280050|FG022|Follow-up Period|Lost to Follow-up|1|||
106168718|NCT03676192|366280051|FG000|Induction Study Period|Adverse Event|21|||
106168719|NCT03676192|366280052|FG001|Induction Study Period|Adverse Event|20|||
106168720|NCT03676192|366280051|FG000|Induction Study Period|Death|23|||
106168721|NCT03676192|366280052|FG001|Induction Study Period|Death|20|||
106168722|NCT03676192|366280051|FG000|Induction Study Period|Lost to Follow-up|3|||
106168723|NCT03676192|366280052|FG001|Induction Study Period|Lost to Follow-up|3|||
106168724|NCT03676192|366280051|FG000|Induction Study Period|Physician Decision|6|||
106168725|NCT03676192|366280052|FG001|Induction Study Period|Physician Decision|3|||
106168726|NCT03676192|366280051|FG000|Induction Study Period|Progressive Disease|32|||
106168727|NCT03676192|366280052|FG001|Induction Study Period|Progressive Disease|21|||
106168728|NCT03676192|366280051|FG000|Induction Study Period|Protocol Violation|1|||
106168729|NCT03676192|366280052|FG001|Induction Study Period|Protocol Violation|2|||
106168730|NCT03676192|366280051|FG000|Induction Study Period|Withdrawal by Subject|20|||
106168731|NCT03676192|366280052|FG001|Induction Study Period|Withdrawal by Subject|15|||
106168732|NCT03334630|366280053|FG000|Overall Study|Withdrawal by Subject|7|||
106168733|NCT03334630|366280054|FG001|Overall Study|Withdrawal by Subject|7|||
106168734|NCT03334630|366280053|FG000|Overall Study|Lost to Follow-up|3|||
106168735|NCT03334630|366280054|FG001|Overall Study|Lost to Follow-up|1|||
106168736|NCT03334630|366280053|FG000|Overall Study|Adverse Event|0|||
106168737|NCT03334630|366280054|FG001|Overall Study|Adverse Event|1|||
106168738|NCT03334630|366280053|FG000|Overall Study|Physician Decision|1|||
106168739|NCT03334630|366280054|FG001|Overall Study|Physician Decision|1|||
106168740|NCT03334630|366280053|FG000|Overall Study|Enrollment closed|2|||
106168741|NCT03334630|366280054|FG001|Overall Study|Enrollment closed|1|||
106168742|NCT03334630|366280053|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
106168743|NCT03334630|366280054|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
106168744|NCT03334630|366280053|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
106168745|NCT03334630|366280054|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
106168746|NCT04079218|366280059|FG000|Overall Study|Death|1|||
106168747|NCT04079218|366280060|FG001|Overall Study|Death|0|||
106168748|NCT04079218|366280059|FG000|Overall Study|Withdrawal by Subject|3|||
106168749|NCT04079218|366280060|FG001|Overall Study|Withdrawal by Subject|0|||
106168750|NCT04079218|366280059|FG000|Overall Study|Physician Decision|4|||
106168751|NCT04079218|366280060|FG001|Overall Study|Physician Decision|0|||
106168752|NCT04079218|366280059|FG000|Overall Study|Lost to Follow-up|0|||
106168753|NCT04079218|366280060|FG001|Overall Study|Lost to Follow-up|1|||
106168754|NCT03030261|366280061|FG000|Overall Study|Still receiving continuation therapy|5|||
106168755|NCT05093842|366280065|FG000|Overall Study|Pregnancy loss|1|||
106168756|NCT05093842|366280066|FG001|Overall Study|Pregnancy loss|1|||
106168757|NCT05093842|366280065|FG000|Overall Study|Lost to Follow-up|6|||
106168758|NCT05093842|366280066|FG001|Overall Study|Lost to Follow-up|0|||
106168759|NCT05093842|366280065|FG000|Overall Study|Physician Decision|0|||
106168760|NCT05093842|366280066|FG001|Overall Study|Physician Decision|1|||
106168761|NCT04971109|366280067|FG000|Overall Study|Adverse Event|4|||
106168762|NCT04971109|366280068|FG001|Overall Study|Adverse Event|3|||
106168763|NCT04971109|366280067|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
106168764|NCT04971109|366280068|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
106168765|NCT04971109|366280067|FG000|Overall Study|Lost to Follow-up|8|||
106168766|NCT04971109|366280068|FG001|Overall Study|Lost to Follow-up|2|||
106168767|NCT04971109|366280067|FG000|Overall Study|Physician Decision|5|||
106168768|NCT04971109|366280068|FG001|Overall Study|Physician Decision|0|||
106168769|NCT04971109|366280067|FG000|Overall Study|Protocol Violation|0|||
106168770|NCT04971109|366280068|FG001|Overall Study|Protocol Violation|1|||
106168771|NCT04971109|366280067|FG000|Overall Study|Withdrawal by Subject|18|||
106168772|NCT04971109|366280068|FG001|Overall Study|Withdrawal by Subject|3|||
106168773|NCT04971109|366280067|FG000|Overall Study|Subject was randomized in error|1|||
106168774|NCT04971109|366280068|FG001|Overall Study|Subject was randomized in error|0|||
106168775|NCT03910478|366280069|FG000|Overall Study|Death|13|||
106168776|NCT03910478|366280070|FG001|Overall Study|Death|6|||
106168777|NCT03910478|366280069|FG000|Overall Study|Withdrawal by Subject|23|||
106168778|NCT03910478|366280070|FG001|Overall Study|Withdrawal by Subject|2|||
106168779|NCT03910478|366280069|FG000|Overall Study|Physician Decision|5|||
106168780|NCT03910478|366280070|FG001|Overall Study|Physician Decision|0|||
106168781|NCT03910478|366280069|FG000|Overall Study|Protocol Violation|1|||
106168782|NCT03910478|366280070|FG001|Overall Study|Protocol Violation|0|||
106168783|NCT03910478|366280069|FG000|Overall Study|Failure to meet continuation criteria|2|||
106168784|NCT03910478|366280070|FG001|Overall Study|Failure to meet continuation criteria|0|||
106168785|NCT03910478|366280069|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
106168786|NCT03910478|366280070|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
106168787|NCT05293171|366280071|FG000|Washout 5 to 7 Days|Adverse Event|1|||
106168788|NCT05293171|366280072|FG001|Washout 5 to 7 Days|Adverse Event|1|||
106168789|NCT05293171|366280073|FG002|Washout 5 to 7 Days|Adverse Event|0|||
106168790|NCT05293171|366280074|FG003|Washout 5 to 7 Days|Adverse Event|0|||
106168791|NCT05293171|366280075|FG004|Washout 5 to 7 Days|Adverse Event|0|||
106168792|NCT05293171|366280076|FG005|Washout 5 to 7 Days|Adverse Event|0|||
106168793|NCT05293171|366280077|FG006|Washout 5 to 7 Days|Adverse Event|0|||
106168794|NCT05293171|366280078|FG007|Washout 5 to 7 Days|Adverse Event|0|||
106168795|NCT05293171|366280079|FG008|Washout 5 to 7 Days|Adverse Event|0|||
106168796|NCT05293171|366280080|FG009|Washout 5 to 7 Days|Adverse Event|0|||
106168797|NCT05293171|366280081|FG010|Washout 5 to 7 Days|Adverse Event|0|||
106168798|NCT05293171|366280082|FG011|Washout 5 to 7 Days|Adverse Event|0|||
106168799|NCT05293171|366280071|FG000|Washout 5 to 7 Days|Adverse Event|0|||
106168800|NCT05293171|366280072|FG001|Washout 5 to 7 Days|Adverse Event|0|||
106168801|NCT05293171|366280073|FG002|Washout 5 to 7 Days|Adverse Event|0|||
106168802|NCT05293171|366280074|FG003|Washout 5 to 7 Days|Adverse Event|0|||
106168803|NCT05293171|366280075|FG004|Washout 5 to 7 Days|Adverse Event|0|||
106168804|NCT05293171|366280076|FG005|Washout 5 to 7 Days|Adverse Event|1|||
106168805|NCT05293171|366280077|FG006|Washout 5 to 7 Days|Adverse Event|0|||
106168806|NCT05293171|366280078|FG007|Washout 5 to 7 Days|Adverse Event|0|||
106168807|NCT05293171|366280079|FG008|Washout 5 to 7 Days|Adverse Event|0|||
106168808|NCT05293171|366280080|FG009|Washout 5 to 7 Days|Adverse Event|0|||
106168809|NCT05293171|366280081|FG010|Washout 5 to 7 Days|Adverse Event|0|||
106168810|NCT05293171|366280082|FG011|Washout 5 to 7 Days|Adverse Event|0|||
106168811|NCT01712490|366280084|FG000|Overall Study|Ongoing|601|||
106168812|NCT01712490|366280085|FG001|Overall Study|Ongoing|586|||
106168813|NCT01712490|366280084|FG000|Overall Study|Other|11|||
106168814|NCT01712490|366280085|FG001|Overall Study|Other|11|||
106168815|NCT01712490|366280084|FG000|Overall Study|Withdrawal by Subject|36|||
106168816|NCT01712490|366280085|FG001|Overall Study|Withdrawal by Subject|44|||
106168817|NCT01712490|366280084|FG000|Overall Study|Lost to Follow-up|16|||
106168818|NCT01712490|366280085|FG001|Overall Study|Lost to Follow-up|29|||
106168819|NCT03987022|366280086|FG000|Overall Study|Lost to Follow-up|2|||
106168820|NCT03987022|366280087|FG001|Overall Study|Lost to Follow-up|2|||
106168821|NCT03987022|366280086|FG000|Overall Study|Withdrawal by Subject|1|||
106168822|NCT03987022|366280087|FG001|Overall Study|Withdrawal by Subject|0|||
106168823|NCT03478956|366280089|FG000|Randomized Treatment Period|Adverse Event|1|||
106168824|NCT03478956|366280090|FG001|Randomized Treatment Period|Adverse Event|0|||
106168825|NCT03478956|366280091|FG002|Randomized Treatment Period|Adverse Event|0|||
106168826|NCT03478956|366280092|FG003|Randomized Treatment Period|Adverse Event|0|||
106168827|NCT03478956|366280089|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
106168828|NCT03478956|366280090|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
106168829|NCT03478956|366280091|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
106168830|NCT03478956|366280092|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
106168831|NCT03478956|366280089|FG000|Open Label Extension Period|Adverse Event|0|||
106168832|NCT03478956|366280090|FG001|Open Label Extension Period|Adverse Event|0|||
106168833|NCT03478956|366280091|FG002|Open Label Extension Period|Adverse Event|4|||
106168834|NCT03478956|366280092|FG003|Open Label Extension Period|Adverse Event|0|||
106168835|NCT03478956|366280089|FG000|Open Label Extension Period|Lack of Efficacy|0|||
106168836|NCT03478956|366280090|FG001|Open Label Extension Period|Lack of Efficacy|0|||
106168837|NCT03478956|366280091|FG002|Open Label Extension Period|Lack of Efficacy|8|||
106168838|NCT03478956|366280092|FG003|Open Label Extension Period|Lack of Efficacy|0|||
106168839|NCT03478956|366280089|FG000|Open Label Extension Period|Reason Not Provided|0|||
106168840|NCT03478956|366280090|FG001|Open Label Extension Period|Reason Not Provided|0|||
106168841|NCT03478956|366280091|FG002|Open Label Extension Period|Reason Not Provided|1|||
106168842|NCT03478956|366280092|FG003|Open Label Extension Period|Reason Not Provided|0|||
106168843|NCT03478956|366280089|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
106168844|NCT03478956|366280090|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
106168845|NCT03478956|366280091|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
106168846|NCT03478956|366280092|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
106168847|NCT03478956|366280089|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
106168848|NCT03478956|366280090|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
106168849|NCT03478956|366280091|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
106168850|NCT03478956|366280092|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
106168851|NCT03478956|366280089|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
106168852|NCT03478956|366280090|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
106168853|NCT03478956|366280091|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
106168854|NCT03478956|366280092|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
106168855|NCT04800211|366280093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
106168856|NCT04800211|366280094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
106168857|NCT04800211|366280095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
106168858|NCT04800211|366280093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
106168859|NCT04800211|366280094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
106168860|NCT04800211|366280095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
106168861|NCT04800211|366280093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
106168862|NCT04800211|366280094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
106168863|NCT04800211|366280095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
106168864|NCT04800211|366280093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
106168865|NCT04800211|366280094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
106168866|NCT04800211|366280095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
106168867|NCT04800211|366280093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
106168868|NCT04800211|366280094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
106168869|NCT04800211|366280095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
106168870|NCT04800211|366280093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
106168871|NCT04800211|366280094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
106168872|NCT04800211|366280095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
106168873|NCT04800211|366280093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
106168874|NCT04800211|366280094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
106168875|NCT04800211|366280095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
106168876|NCT04800211|366280093|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
106168877|NCT04800211|366280094|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
106168878|NCT04800211|366280095|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
106168879|NCT04800211|366280093|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
106168880|NCT04800211|366280094|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
106168881|NCT04800211|366280095|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
106168882|NCT04800211|366280093|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
106168883|NCT04800211|366280094|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
106168884|NCT04800211|366280095|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
106168885|NCT04800211|366280093|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
106168886|NCT04800211|366280094|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
106168887|NCT04800211|366280095|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
106168888|NCT05975840|366280096|FG000|Overall Study|Other|1|||
106168889|NCT05975840|366280097|FG001|Overall Study|Other|0|||
106168890|NCT05975840|366280098|FG002|Overall Study|Other|0|||
106168891|NCT05975840|366280099|FG003|Overall Study|Other|0|||
106168892|NCT05975840|366280100|FG004|Overall Study|Other|1|||
106168893|NCT05975840|366280101|FG005|Overall Study|Other|0|||
106168894|NCT05975840|366280102|FG006|Overall Study|Other|0|||
106168895|NCT05975840|366280103|FG007|Overall Study|Other|0|||
106168896|NCT05975840|366280096|FG000|Overall Study|Lost to Follow-up|3|||
106168897|NCT05975840|366280097|FG001|Overall Study|Lost to Follow-up|6|||
106168898|NCT05975840|366280098|FG002|Overall Study|Lost to Follow-up|3|||
106168899|NCT05975840|366280099|FG003|Overall Study|Lost to Follow-up|1|||
106168900|NCT05975840|366280100|FG004|Overall Study|Lost to Follow-up|4|||
106168901|NCT05975840|366280101|FG005|Overall Study|Lost to Follow-up|1|||
106168902|NCT05975840|366280102|FG006|Overall Study|Lost to Follow-up|2|||
106168903|NCT05975840|366280103|FG007|Overall Study|Lost to Follow-up|4|||
106168904|NCT05975840|366280096|FG000|Overall Study|Migrated/moved from the study area|1|||
106168905|NCT05975840|366280097|FG001|Overall Study|Migrated/moved from the study area|0|||
106168906|NCT05975840|366280098|FG002|Overall Study|Migrated/moved from the study area|0|||
106168907|NCT05975840|366280099|FG003|Overall Study|Migrated/moved from the study area|0|||
106168908|NCT05975840|366280100|FG004|Overall Study|Migrated/moved from the study area|0|||
106168909|NCT05975840|366280101|FG005|Overall Study|Migrated/moved from the study area|0|||
106168910|NCT05975840|366280102|FG006|Overall Study|Migrated/moved from the study area|0|||
106168911|NCT05975840|366280103|FG007|Overall Study|Migrated/moved from the study area|0|||
106168912|NCT05975840|366280096|FG000|Overall Study|Withdrawal by Subject|0|||
106168913|NCT05975840|366280097|FG001|Overall Study|Withdrawal by Subject|5|||
106168914|NCT05975840|366280098|FG002|Overall Study|Withdrawal by Subject|2|||
106168915|NCT05975840|366280099|FG003|Overall Study|Withdrawal by Subject|2|||
106168916|NCT05975840|366280100|FG004|Overall Study|Withdrawal by Subject|0|||
106168917|NCT05975840|366280101|FG005|Overall Study|Withdrawal by Subject|2|||
106168918|NCT05975840|366280102|FG006|Overall Study|Withdrawal by Subject|2|||
106168919|NCT05975840|366280103|FG007|Overall Study|Withdrawal by Subject|1|||
106168920|NCT05975840|366280096|FG000|Overall Study|Protocol Violation|0|||
106168921|NCT05975840|366280097|FG001|Overall Study|Protocol Violation|1|||
106168922|NCT05975840|366280098|FG002|Overall Study|Protocol Violation|0|||
106168923|NCT05975840|366280099|FG003|Overall Study|Protocol Violation|0|||
106168924|NCT05975840|366280100|FG004|Overall Study|Protocol Violation|0|||
106168925|NCT05975840|366280101|FG005|Overall Study|Protocol Violation|0|||
106168926|NCT05975840|366280102|FG006|Overall Study|Protocol Violation|0|||
106168927|NCT05975840|366280103|FG007|Overall Study|Protocol Violation|0|||
106168928|NCT05975840|366280096|FG000|Overall Study|Adverse Event|0|||
106168929|NCT05975840|366280097|FG001|Overall Study|Adverse Event|0|||
106168930|NCT05975840|366280098|FG002|Overall Study|Adverse Event|0|||
106168931|NCT05975840|366280099|FG003|Overall Study|Adverse Event|1|||
106168932|NCT05975840|366280100|FG004|Overall Study|Adverse Event|0|||
106168933|NCT05975840|366280101|FG005|Overall Study|Adverse Event|0|||
106168934|NCT05975840|366280102|FG006|Overall Study|Adverse Event|0|||
106168935|NCT05975840|366280103|FG007|Overall Study|Adverse Event|0|||
106168936|NCT05975840|366280096|FG000|Overall Study|Death|0|||
106168937|NCT05975840|366280097|FG001|Overall Study|Death|1|||
106168938|NCT05975840|366280098|FG002|Overall Study|Death|0|||
106168939|NCT05975840|366280099|FG003|Overall Study|Death|0|||
106168940|NCT05975840|366280100|FG004|Overall Study|Death|0|||
106168941|NCT05975840|366280101|FG005|Overall Study|Death|0|||
106168942|NCT05975840|366280102|FG006|Overall Study|Death|0|||
106168943|NCT05975840|366280103|FG007|Overall Study|Death|1|||
106168944|NCT05646355|366280114|FG000|Overall Study|Lost to Follow-up|1|||
106168945|NCT05646355|366280115|FG001|Overall Study|Lost to Follow-up|0|||
106168946|NCT05646355|366280114|FG000|Overall Study|translated materials not available for pilot|2|||
106168947|NCT05646355|366280115|FG001|Overall Study|translated materials not available for pilot|0|||
106168948|NCT05646355|366280114|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
106168949|NCT05646355|366280115|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
106168950|NCT02315703|366280116|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
106168951|NCT02315703|366280117|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
106168952|NCT02315703|366280118|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
106168953|NCT02315703|366280119|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
106168954|NCT02315703|366280120|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
106168955|NCT02315703|366280121|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
106168956|NCT02315703|366280122|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
106168957|NCT02315703|366280123|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
106168958|NCT02315703|366280116|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
106168959|NCT02315703|366280117|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
106168960|NCT02315703|366280118|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
106168961|NCT02315703|366280119|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
106168962|NCT02315703|366280120|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
106168963|NCT02315703|366280121|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
106168964|NCT02315703|366280122|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
106168965|NCT02315703|366280123|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
106168966|NCT02315703|366280116|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
106168967|NCT02315703|366280117|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
106168968|NCT02315703|366280118|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
106168969|NCT02315703|366280119|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
106168970|NCT02315703|366280120|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
106168971|NCT02315703|366280121|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
106168972|NCT02315703|366280122|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
106168973|NCT02315703|366280123|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
106168974|NCT02315703|366280116|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
106168975|NCT02315703|366280117|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
106168976|NCT02315703|366280118|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
106168977|NCT02315703|366280119|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
106168978|NCT02315703|366280120|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
106168979|NCT02315703|366280121|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
106168980|NCT02315703|366280122|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
106168981|NCT02315703|366280123|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
106168982|NCT02315703|366280116|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
106168983|NCT02315703|366280117|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
106168984|NCT02315703|366280118|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
106168985|NCT02315703|366280119|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
106168986|NCT02315703|366280120|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
106168987|NCT02315703|366280121|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
106168988|NCT02315703|366280122|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
106168989|NCT02315703|366280123|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
106168990|NCT02315703|366280116|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
106168991|NCT02315703|366280117|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
106168992|NCT02315703|366280118|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
106168993|NCT02315703|366280119|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
106168994|NCT02315703|366280120|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
106168995|NCT02315703|366280121|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
106168996|NCT02315703|366280122|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
106168997|NCT02315703|366280123|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
106168998|NCT02315703|366280116|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
106168999|NCT02315703|366280117|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
106169000|NCT02315703|366280118|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
106169001|NCT02315703|366280119|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
106169002|NCT02315703|366280120|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
106169003|NCT02315703|366280121|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
106169004|NCT02315703|366280122|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
106169005|NCT02315703|366280123|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
106169006|NCT02315703|366280116|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
106169007|NCT02315703|366280117|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
106169008|NCT02315703|366280118|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
106169009|NCT02315703|366280119|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
106169010|NCT02315703|366280120|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
106169011|NCT02315703|366280121|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
106169012|NCT02315703|366280122|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
106169013|NCT02315703|366280123|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
106169014|NCT02315703|366280116|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
106169015|NCT02315703|366280117|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
106169016|NCT02315703|366280118|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
106169017|NCT02315703|366280119|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
106169018|NCT02315703|366280120|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
106169019|NCT02315703|366280121|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
106169020|NCT02315703|366280122|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
106169021|NCT02315703|366280123|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
106169022|NCT02152995|366280124|FG000|Overall Study|Withdrawal by Subject|1|||
106169023|NCT02152995|366280125|FG001|Overall Study|Withdrawal by Subject|0|||
106169024|NCT03476343|366280127|FG000|Overall Study|Clinical exam moved to another scanner|7|||
106169025|NCT03476343|366280127|FG000|Overall Study|Clinical order cancelled|4|||
106169026|NCT03476343|366280127|FG000|Overall Study|Neonate did not settle down for the scan|1|||
106169027|NCT03088878|366280128|FG000|Overall Study|Adverse Event|0|||
106169028|NCT03088878|366280129|FG001|Overall Study|Adverse Event|0|||
106169029|NCT03088878|366280130|FG002|Overall Study|Adverse Event|0|||
106169030|NCT03088878|366280131|FG003|Overall Study|Adverse Event|0|||
106169031|NCT03088878|366280132|FG004|Overall Study|Adverse Event|4|||
106169032|NCT03088878|366280133|FG005|Overall Study|Adverse Event|2|||
106169033|NCT03088878|366280134|FG006|Overall Study|Adverse Event|1|||
106169034|NCT03088878|366280135|FG007|Overall Study|Adverse Event|0|||
106169035|NCT03088878|366280136|FG008|Overall Study|Adverse Event|0|||
106169036|NCT03088878|366280137|FG009|Overall Study|Adverse Event|0|||
106169037|NCT03088878|366280138|FG010|Overall Study|Adverse Event|0|||
106169038|NCT03088878|366280139|FG011|Overall Study|Adverse Event|0|||
106169039|NCT03088878|366280140|FG012|Overall Study|Adverse Event|5|||
106169040|NCT03088878|366280141|FG013|Overall Study|Adverse Event|3|||
106169041|NCT03088878|366280128|FG000|Overall Study|Clinical Progression|0|||
106169042|NCT03088878|366280129|FG001|Overall Study|Clinical Progression|0|||
106169043|NCT03088878|366280130|FG002|Overall Study|Clinical Progression|0|||
106169044|NCT03088878|366280131|FG003|Overall Study|Clinical Progression|0|||
106169045|NCT03088878|366280132|FG004|Overall Study|Clinical Progression|2|||
106169046|NCT03088878|366280133|FG005|Overall Study|Clinical Progression|0|||
106169047|NCT03088878|366280134|FG006|Overall Study|Clinical Progression|0|||
106169048|NCT03088878|366280135|FG007|Overall Study|Clinical Progression|0|||
106169049|NCT03088878|366280136|FG008|Overall Study|Clinical Progression|0|||
106169050|NCT03088878|366280137|FG009|Overall Study|Clinical Progression|0|||
106169051|NCT03088878|366280138|FG010|Overall Study|Clinical Progression|0|||
106169052|NCT03088878|366280139|FG011|Overall Study|Clinical Progression|0|||
106169053|NCT03088878|366280140|FG012|Overall Study|Clinical Progression|0|||
106169054|NCT03088878|366280141|FG013|Overall Study|Clinical Progression|0|||
106169055|NCT03088878|366280128|FG000|Overall Study|Death|0|||
106169056|NCT03088878|366280129|FG001|Overall Study|Death|0|||
106169057|NCT03088878|366280130|FG002|Overall Study|Death|0|||
106169058|NCT03088878|366280131|FG003|Overall Study|Death|0|||
106169059|NCT03088878|366280132|FG004|Overall Study|Death|2|||
106169060|NCT03088878|366280133|FG005|Overall Study|Death|0|||
106169061|NCT03088878|366280134|FG006|Overall Study|Death|0|||
106169062|NCT03088878|366280135|FG007|Overall Study|Death|0|||
106169063|NCT03088878|366280136|FG008|Overall Study|Death|0|||
106169064|NCT03088878|366280137|FG009|Overall Study|Death|0|||
106169065|NCT03088878|366280138|FG010|Overall Study|Death|0|||
106169066|NCT03088878|366280139|FG011|Overall Study|Death|1|||
106169067|NCT03088878|366280140|FG012|Overall Study|Death|0|||
106169068|NCT03088878|366280141|FG013|Overall Study|Death|0|||
106169069|NCT03088878|366280128|FG000|Overall Study|Disease Progression|1|||
106169070|NCT03088878|366280129|FG001|Overall Study|Disease Progression|2|||
106169071|NCT03088878|366280130|FG002|Overall Study|Disease Progression|3|||
106169072|NCT03088878|366280131|FG003|Overall Study|Disease Progression|0|||
106169073|NCT03088878|366280132|FG004|Overall Study|Disease Progression|3|||
106169074|NCT03088878|366280133|FG005|Overall Study|Disease Progression|0|||
106169075|NCT03088878|366280134|FG006|Overall Study|Disease Progression|0|||
106169076|NCT03088878|366280135|FG007|Overall Study|Disease Progression|0|||
106169077|NCT03088878|366280136|FG008|Overall Study|Disease Progression|0|||
106169078|NCT03088878|366280137|FG009|Overall Study|Disease Progression|0|||
106169079|NCT03088878|366280138|FG010|Overall Study|Disease Progression|0|||
106169080|NCT03088878|366280139|FG011|Overall Study|Disease Progression|0|||
106169081|NCT03088878|366280140|FG012|Overall Study|Disease Progression|1|||
106169082|NCT03088878|366280141|FG013|Overall Study|Disease Progression|1|||
106169083|NCT03088878|366280128|FG000|Overall Study|Initiation of Alternative Treatment|0|||
106169084|NCT03088878|366280129|FG001|Overall Study|Initiation of Alternative Treatment|0|||
106169085|NCT03088878|366280130|FG002|Overall Study|Initiation of Alternative Treatment|0|||
106169086|NCT03088878|366280131|FG003|Overall Study|Initiation of Alternative Treatment|1|||
106169087|NCT03088878|366280132|FG004|Overall Study|Initiation of Alternative Treatment|0|||
106169088|NCT03088878|366280133|FG005|Overall Study|Initiation of Alternative Treatment|0|||
106169089|NCT03088878|366280134|FG006|Overall Study|Initiation of Alternative Treatment|0|||
106169090|NCT03088878|366280135|FG007|Overall Study|Initiation of Alternative Treatment|1|||
106169091|NCT03088878|366280136|FG008|Overall Study|Initiation of Alternative Treatment|1|||
106169092|NCT03088878|366280137|FG009|Overall Study|Initiation of Alternative Treatment|0|||
106169093|NCT03088878|366280138|FG010|Overall Study|Initiation of Alternative Treatment|0|||
106169094|NCT03088878|366280139|FG011|Overall Study|Initiation of Alternative Treatment|0|||
106169095|NCT03088878|366280140|FG012|Overall Study|Initiation of Alternative Treatment|0|||
106169096|NCT03088878|366280141|FG013|Overall Study|Initiation of Alternative Treatment|0|||
106169097|NCT03088878|366280128|FG000|Overall Study|Withdrawal by Subject|0|||
106169098|NCT03088878|366280129|FG001|Overall Study|Withdrawal by Subject|0|||
106169099|NCT03088878|366280130|FG002|Overall Study|Withdrawal by Subject|0|||
106169100|NCT03088878|366280131|FG003|Overall Study|Withdrawal by Subject|1|||
106169101|NCT03088878|366280132|FG004|Overall Study|Withdrawal by Subject|4|||
106169102|NCT03088878|366280133|FG005|Overall Study|Withdrawal by Subject|1|||
106169103|NCT03088878|366280134|FG006|Overall Study|Withdrawal by Subject|1|||
106169104|NCT03088878|366280135|FG007|Overall Study|Withdrawal by Subject|0|||
106169105|NCT03088878|366280136|FG008|Overall Study|Withdrawal by Subject|1|||
106169106|NCT03088878|366280137|FG009|Overall Study|Withdrawal by Subject|2|||
106169107|NCT03088878|366280138|FG010|Overall Study|Withdrawal by Subject|0|||
106169108|NCT03088878|366280139|FG011|Overall Study|Withdrawal by Subject|2|||
106169109|NCT03088878|366280140|FG012|Overall Study|Withdrawal by Subject|1|||
106169110|NCT03088878|366280141|FG013|Overall Study|Withdrawal by Subject|0|||
106169111|NCT03088878|366280128|FG000|Overall Study|Terminated by Sponsor|2|||
106169112|NCT03088878|366280129|FG001|Overall Study|Terminated by Sponsor|1|||
106169113|NCT03088878|366280130|FG002|Overall Study|Terminated by Sponsor|0|||
106169114|NCT03088878|366280131|FG003|Overall Study|Terminated by Sponsor|1|||
106169115|NCT03088878|366280132|FG004|Overall Study|Terminated by Sponsor|6|||
106169116|NCT03088878|366280133|FG005|Overall Study|Terminated by Sponsor|0|||
106169117|NCT03088878|366280134|FG006|Overall Study|Terminated by Sponsor|0|||
106169118|NCT03088878|366280135|FG007|Overall Study|Terminated by Sponsor|0|||
106169119|NCT03088878|366280136|FG008|Overall Study|Terminated by Sponsor|0|||
106169120|NCT03088878|366280137|FG009|Overall Study|Terminated by Sponsor|0|||
106169121|NCT03088878|366280138|FG010|Overall Study|Terminated by Sponsor|3|||
106169122|NCT03088878|366280139|FG011|Overall Study|Terminated by Sponsor|13|||
106169123|NCT03088878|366280140|FG012|Overall Study|Terminated by Sponsor|2|||
106169124|NCT03088878|366280141|FG013|Overall Study|Terminated by Sponsor|1|||
106169125|NCT03088878|366280128|FG000|Overall Study|Completed 2 years of Treatment|0|||
106169126|NCT03088878|366280129|FG001|Overall Study|Completed 2 years of Treatment|0|||
106169127|NCT03088878|366280130|FG002|Overall Study|Completed 2 years of Treatment|0|||
106169128|NCT03088878|366280131|FG003|Overall Study|Completed 2 years of Treatment|0|||
106169129|NCT03088878|366280132|FG004|Overall Study|Completed 2 years of Treatment|0|||
106169130|NCT03088878|366280133|FG005|Overall Study|Completed 2 years of Treatment|0|||
106169131|NCT03088878|366280134|FG006|Overall Study|Completed 2 years of Treatment|1|||
106169132|NCT03088878|366280135|FG007|Overall Study|Completed 2 years of Treatment|0|||
106169133|NCT03088878|366280136|FG008|Overall Study|Completed 2 years of Treatment|0|||
106169134|NCT03088878|366280137|FG009|Overall Study|Completed 2 years of Treatment|1|||
106169135|NCT03088878|366280138|FG010|Overall Study|Completed 2 years of Treatment|0|||
106169136|NCT03088878|366280139|FG011|Overall Study|Completed 2 years of Treatment|0|||
106169137|NCT03088878|366280140|FG012|Overall Study|Completed 2 years of Treatment|8|||
106169138|NCT03088878|366280141|FG013|Overall Study|Completed 2 years of Treatment|3|||
106169139|NCT03088878|366280128|FG000|Overall Study|Physician Decision|0|||
106169140|NCT03088878|366280129|FG001|Overall Study|Physician Decision|0|||
106169141|NCT03088878|366280130|FG002|Overall Study|Physician Decision|0|||
106169142|NCT03088878|366280131|FG003|Overall Study|Physician Decision|0|||
106169143|NCT03088878|366280132|FG004|Overall Study|Physician Decision|0|||
106169144|NCT03088878|366280133|FG005|Overall Study|Physician Decision|0|||
106169145|NCT03088878|366280134|FG006|Overall Study|Physician Decision|0|||
106169146|NCT03088878|366280135|FG007|Overall Study|Physician Decision|2|||
106169147|NCT03088878|366280136|FG008|Overall Study|Physician Decision|1|||
106169148|NCT03088878|366280137|FG009|Overall Study|Physician Decision|0|||
106169149|NCT03088878|366280138|FG010|Overall Study|Physician Decision|0|||
106169150|NCT03088878|366280139|FG011|Overall Study|Physician Decision|0|||
106169151|NCT03088878|366280140|FG012|Overall Study|Physician Decision|0|||
106169152|NCT03088878|366280141|FG013|Overall Study|Physician Decision|1|||
106169153|NCT03088878|366280128|FG000|Overall Study|COVID Related noncompliance|0|||
106169154|NCT03088878|366280129|FG001|Overall Study|COVID Related noncompliance|0|||
106169155|NCT03088878|366280130|FG002|Overall Study|COVID Related noncompliance|0|||
106169156|NCT03088878|366280131|FG003|Overall Study|COVID Related noncompliance|0|||
106169157|NCT03088878|366280132|FG004|Overall Study|COVID Related noncompliance|0|||
106169158|NCT03088878|366280133|FG005|Overall Study|COVID Related noncompliance|0|||
106169159|NCT03088878|366280134|FG006|Overall Study|COVID Related noncompliance|0|||
106169160|NCT03088878|366280135|FG007|Overall Study|COVID Related noncompliance|0|||
106169161|NCT03088878|366280136|FG008|Overall Study|COVID Related noncompliance|0|||
106169162|NCT03088878|366280137|FG009|Overall Study|COVID Related noncompliance|0|||
106169163|NCT03088878|366280138|FG010|Overall Study|COVID Related noncompliance|0|||
106169164|NCT03088878|366280139|FG011|Overall Study|COVID Related noncompliance|0|||
106169165|NCT03088878|366280140|FG012|Overall Study|COVID Related noncompliance|0|||
106169166|NCT03088878|366280141|FG013|Overall Study|COVID Related noncompliance|1|||
106169167|NCT03088878|366280128|FG000|Overall Study|Drug or Study Noncompliance|0|||
106169168|NCT03088878|366280129|FG001|Overall Study|Drug or Study Noncompliance|0|||
106169169|NCT03088878|366280130|FG002|Overall Study|Drug or Study Noncompliance|0|||
106169170|NCT03088878|366280131|FG003|Overall Study|Drug or Study Noncompliance|0|||
106169171|NCT03088878|366280132|FG004|Overall Study|Drug or Study Noncompliance|0|||
106169172|NCT03088878|366280133|FG005|Overall Study|Drug or Study Noncompliance|0|||
106169173|NCT03088878|366280134|FG006|Overall Study|Drug or Study Noncompliance|0|||
106169174|NCT03088878|366280135|FG007|Overall Study|Drug or Study Noncompliance|0|||
106169175|NCT03088878|366280136|FG008|Overall Study|Drug or Study Noncompliance|0|||
106169176|NCT03088878|366280137|FG009|Overall Study|Drug or Study Noncompliance|0|||
106169177|NCT03088878|366280138|FG010|Overall Study|Drug or Study Noncompliance|0|||
106169178|NCT03088878|366280139|FG011|Overall Study|Drug or Study Noncompliance|0|||
106169179|NCT03088878|366280140|FG012|Overall Study|Drug or Study Noncompliance|1|||
106169180|NCT03088878|366280141|FG013|Overall Study|Drug or Study Noncompliance|0|||
106169181|NCT02724969|366280142|FG000|Overall Study|Lost to Follow-up|12|||
106169182|NCT02724969|366280143|FG001|Overall Study|Lost to Follow-up|6|||
106169183|NCT02724969|366280142|FG000|Overall Study|Withdrawal by Subject|3|||
106169184|NCT02724969|366280143|FG001|Overall Study|Withdrawal by Subject|3|||
106169185|NCT02724969|366280142|FG000|Overall Study|Infant demise|0|||
106169186|NCT02724969|366280143|FG001|Overall Study|Infant demise|2|||
106169187|NCT03362476|366280145|FG000|Overall Study|Withdrawal by Subject|0|||
106169188|NCT03362476|366280146|FG001|Overall Study|Withdrawal by Subject|1|||
106169189|NCT04230681|366280147|FG000|Overall Study|Physician Decision|2|||
106169190|NCT04230681|366280148|FG001|Overall Study|Physician Decision|3|||
106169191|NCT04230681|366280147|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
106169192|NCT04230681|366280148|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
106169193|NCT04230681|366280147|FG000|Overall Study|IV inadvertently removed|0|||
106169194|NCT04230681|366280148|FG001|Overall Study|IV inadvertently removed|1|||
106169195|NCT03527043|366281816|FG000|Overall Study|Withdrawal by Subject|1|||
106169196|NCT03527043|366281817|FG001|Overall Study|Withdrawal by Subject|0|||
106169197|NCT03974178|366281818|FG000|Overall Study|Death|0|||
106169198|NCT03974178|366281819|FG001|Overall Study|Death|1|||
106169199|NCT02433379|366281824|FG000|Overall Study|Screen Failures|55|||
106169200|NCT02433379|366281824|FG000|Overall Study|Death|57|||
106169201|NCT02433379|366281824|FG000|Overall Study|Total Withdrawals|209|||
106169202|NCT03483038|366281825|FG000|Overall Study|Subjects still in follow-up|18|||
106169203|NCT02505984|366281826|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
106169204|NCT02505984|366281827|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
106169205|NCT02505984|366281826|FG000|Overall Study|Unreliable self-report data|1|||
106169206|NCT02505984|366281827|FG001|Overall Study|Unreliable self-report data|0|||
106169207|NCT02505984|366281826|FG000|Overall Study|Study blind opened during assessment|0|||
106169208|NCT02505984|366281827|FG001|Overall Study|Study blind opened during assessment|1|||
106169209|NCT02505984|366281826|FG000|Overall Study|Noncompliance with study protocol|0|||
106169210|NCT02505984|366281827|FG001|Overall Study|Noncompliance with study protocol|1|||
106169211|NCT04447040|366281831|FG000|Overall Study|Lost to Follow-up|2|||
106169212|NCT04447040|366281832|FG001|Overall Study|Lost to Follow-up|1|||
106169213|NCT04447040|366281833|FG002|Overall Study|Lost to Follow-up|3|||
106169214|NCT04447040|366281834|FG003|Overall Study|Lost to Follow-up|3|||
106169215|NCT04447040|366281835|FG004|Overall Study|Lost to Follow-up|1|||
106169216|NCT04447040|366281836|FG005|Overall Study|Lost to Follow-up|3|||
106169217|NCT04447040|366281831|FG000|Overall Study|Withdrawal by Subject|0|||
106169218|NCT04447040|366281832|FG001|Overall Study|Withdrawal by Subject|1|||
106169219|NCT04447040|366281833|FG002|Overall Study|Withdrawal by Subject|1|||
106169220|NCT04447040|366281834|FG003|Overall Study|Withdrawal by Subject|1|||
106169221|NCT04447040|366281835|FG004|Overall Study|Withdrawal by Subject|0|||
106169222|NCT04447040|366281836|FG005|Overall Study|Withdrawal by Subject|0|||
106169223|NCT04568434|366281837|FG000|Overall Study|Voluntary Withdrawal|0|||
106169224|NCT04568434|366281838|FG001|Overall Study|Voluntary Withdrawal|1|||
106169225|NCT04568434|366281839|FG002|Overall Study|Voluntary Withdrawal|1|||
106169226|NCT04568434|366281837|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
106169227|NCT04568434|366281838|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
106169228|NCT04568434|366281839|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
106169229|NCT04568434|366281837|FG000|Overall Study|Investigator Judgement|1|||
106169230|NCT04568434|366281838|FG001|Overall Study|Investigator Judgement|0|||
106169231|NCT04568434|366281839|FG002|Overall Study|Investigator Judgement|0|||
106169232|NCT05469464|366281840|FG000|Overall Study|Withdrawal by Subject|8|||
106169233|NCT05469464|366281841|FG001|Overall Study|Withdrawal by Subject|7|||
106169234|NCT05469464|366281842|FG002|Overall Study|Withdrawal by Subject|4|||
106169235|NCT05469464|366281843|FG003|Overall Study|Withdrawal by Subject|5|||
106169236|NCT05469464|366281840|FG000|Overall Study|Adverse Event|8|||
106169237|NCT05469464|366281841|FG001|Overall Study|Adverse Event|14|||
106169238|NCT05469464|366281842|FG002|Overall Study|Adverse Event|13|||
106169239|NCT05469464|366281843|FG003|Overall Study|Adverse Event|2|||
106169240|NCT05469464|366281840|FG000|Overall Study|Lost to Follow-up|2|||
106169241|NCT05469464|366281841|FG001|Overall Study|Lost to Follow-up|5|||
106169242|NCT05469464|366281842|FG002|Overall Study|Lost to Follow-up|3|||
106169243|NCT05469464|366281843|FG003|Overall Study|Lost to Follow-up|3|||
106169244|NCT05469464|366281840|FG000|Overall Study|Lack of Efficacy|4|||
106169245|NCT05469464|366281841|FG001|Overall Study|Lack of Efficacy|1|||
106169246|NCT05469464|366281842|FG002|Overall Study|Lack of Efficacy|2|||
106169247|NCT05469464|366281843|FG003|Overall Study|Lack of Efficacy|2|||
106169248|NCT05469464|366281840|FG000|Overall Study|Physician Decision|0|||
106169249|NCT05469464|366281841|FG001|Overall Study|Physician Decision|0|||
106169250|NCT05469464|366281842|FG002|Overall Study|Physician Decision|0|||
106169251|NCT05469464|366281843|FG003|Overall Study|Physician Decision|1|||
106169252|NCT04730739|366281849|FG000|Overall Study|Death|1|||
106169253|NCT05170841|366281851|FG000|Single Dose Phase|Adverse Event|1|||
106169254|NCT05170841|366281852|FG001|Single Dose Phase|Adverse Event|2|||
106169255|NCT05170841|366281853|FG002|Single Dose Phase|Adverse Event|0|||
106169256|NCT05170841|366281854|FG003|Single Dose Phase|Adverse Event|2|||
106169257|NCT05170841|366281851|FG000|Multiple Dose Phase|Adverse Event|1|||
106169258|NCT05170841|366281852|FG001|Multiple Dose Phase|Adverse Event|2|||
106169259|NCT05170841|366281853|FG002|Multiple Dose Phase|Adverse Event|1|||
106169260|NCT05170841|366281854|FG003|Multiple Dose Phase|Adverse Event|4|||
106169261|NCT05170841|366281851|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
106169262|NCT05170841|366281852|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
106169263|NCT05170841|366281853|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
106169264|NCT05170841|366281854|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
106169265|NCT03308877|366281857|FG000|Overall Study|Lost to Follow-up|32|||
106169266|NCT03308877|366281858|FG001|Overall Study|Lost to Follow-up|28|||
106169267|NCT05123586|366281859|FG000|Overall Study|Physician Decision|1|||
106169268|NCT05123586|366281860|FG001|Overall Study|Physician Decision|1|||
106169269|NCT05123586|366281859|FG000|Overall Study|Withdrawal by Subject|0|||
106169270|NCT05123586|366281860|FG001|Overall Study|Withdrawal by Subject|3|||
106169271|NCT04865289|366281865|FG000|Overall Study|Participant ongoing in study|47|||
106169272|NCT04865289|366281866|FG001|Overall Study|Participant ongoing in study|35|||
106169273|NCT04865289|366281865|FG000|Overall Study|Death|27|||
106169274|NCT04865289|366281866|FG001|Overall Study|Death|21|||
106169275|NCT04707469|366281876|FG000|Overall Study|Site closure|0|||
106169276|NCT04707469|366281877|FG001|Overall Study|Site closure|2|||
106169277|NCT04707469|366281878|FG002|Overall Study|Site closure|0|||
106169278|NCT04707469|366281876|FG000|Overall Study|Physician Decision|2|||
106169279|NCT04707469|366281877|FG001|Overall Study|Physician Decision|2|||
106169280|NCT04707469|366281878|FG002|Overall Study|Physician Decision|2|||
106169281|NCT04707469|366281876|FG000|Overall Study|Death|1|||
106169282|NCT04707469|366281877|FG001|Overall Study|Death|6|||
106169283|NCT04707469|366281878|FG002|Overall Study|Death|2|||
106169284|NCT04707469|366281876|FG000|Overall Study|Lost to Follow-up|9|||
106169285|NCT04707469|366281877|FG001|Overall Study|Lost to Follow-up|19|||
106169286|NCT04707469|366281878|FG002|Overall Study|Lost to Follow-up|14|||
106169287|NCT04707469|366281876|FG000|Overall Study|Withdrawal by Subject|17|||
106169288|NCT04707469|366281877|FG001|Overall Study|Withdrawal by Subject|16|||
106169289|NCT04707469|366281878|FG002|Overall Study|Withdrawal by Subject|12|||
106169290|NCT04677738|366281879|FG000|Overall Study|Withdrawal by Subject|4|||
106169291|NCT04677738|366281880|FG001|Overall Study|Withdrawal by Subject|2|||
106169292|NCT03734679|366281893|FG000|Overall Study|Missed Visit|1|||
106169293|NCT03249090|366281899|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
106169294|NCT03249090|366281900|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
106169295|NCT03249090|366281899|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
106169296|NCT03249090|366281900|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
106169297|NCT03249090|366281899|FG000|3 Month Time Point|Voluntary withdrawal|6|||
106169298|NCT03249090|366281900|FG001|3 Month Time Point|Voluntary withdrawal|3|||
106169299|NCT03249090|366281899|FG000|3 Month Time Point|Changed oncology practice|4|||
106169300|NCT03249090|366281900|FG001|3 Month Time Point|Changed oncology practice|2|||
106169301|NCT03249090|366281899|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
106169302|NCT03249090|366281900|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
106169303|NCT03249090|366281899|FG000|12 Month Time Point|Voluntary withdrawal|35|||
106169304|NCT03249090|366281900|FG001|12 Month Time Point|Voluntary withdrawal|4|||
106169305|NCT03249090|366281899|FG000|12 Month Time Point|Changed oncology practice|20|||
106169306|NCT03249090|366281900|FG001|12 Month Time Point|Changed oncology practice|9|||
106169307|NCT04635423|366281904|FG000|Overall Study|Ongoing|493|||
106169308|NCT04635423|366281905|FG001|Overall Study|Ongoing|501|||
106169309|NCT04635423|366281904|FG000|Overall Study|Withdrawal by Subject|36|||
106169310|NCT04635423|366281905|FG001|Overall Study|Withdrawal by Subject|29|||
106169311|NCT02733159|366281906|FG000|Overall Study|Adverse Event|1|||
106169312|NCT02733159|366281906|FG000|Overall Study|Lack of disease progression|1|||
106169313|NCT01346540|366281909|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
106169314|NCT01346540|366281910|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
106169315|NCT01346540|366281909|FG000|Overall Study|Adverse Event|0|||
106169316|NCT01346540|366281910|FG001|Overall Study|Adverse Event|4|||
106169317|NCT05216406|366281911|FG000|Overall Study|Lost to Follow-up|8|||
106169318|NCT05216406|366281912|FG001|Overall Study|Lost to Follow-up|9|||
106169319|NCT05974501|366281915|FG000|Overall Study|Physician Decision|0|||
106169320|NCT05974501|366281916|FG001|Overall Study|Physician Decision|1|||
106169321|NCT01236781|366281923|FG000|Overall Study|Ineligible|2|||
106169322|NCT01236781|366281924|FG001|Overall Study|Ineligible|1|||
106169323|NCT01236781|366281923|FG000|Overall Study|Did not complete study imaging|5|||
106169324|NCT01236781|366281924|FG001|Overall Study|Did not complete study imaging|0|||
106169325|NCT04587453|366281925|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
106169326|NCT04587453|366281926|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
106169327|NCT03213665|366281927|FG000|Overall Study|Adverse Event|1|||
106169328|NCT03213665|366281927|FG000|Overall Study|Physician Decision|2|||
106169329|NCT03213665|366281927|FG000|Overall Study|Withdrawal by Subject|3|||
106169330|NCT03213665|366281927|FG000|Overall Study|Progressive Disease|13|||
106169331|NCT03325985|366281928|FG000|Overall Study|Lost to Follow-up|122|||
106169332|NCT03325985|366281929|FG001|Overall Study|Lost to Follow-up|26|||
106169333|NCT03325985|366281930|FG002|Overall Study|Lost to Follow-up|141|||
106169334|NCT03325985|366281931|FG003|Overall Study|Lost to Follow-up|28|||
106169335|NCT03325985|366281928|FG000|Overall Study|Death|99|||
106169336|NCT03325985|366281929|FG001|Overall Study|Death|36|||
106169337|NCT03325985|366281930|FG002|Overall Study|Death|94|||
106169338|NCT03325985|366281931|FG003|Overall Study|Death|32|||
106169339|NCT03056573|366281932|FG000|Overall Study|Death|2|||
106169340|NCT03056573|366281933|FG001|Overall Study|Death|4|||
106169341|NCT03056573|366281932|FG000|Overall Study|Withdrawal by Subject|2|||
106169342|NCT03056573|366281933|FG001|Overall Study|Withdrawal by Subject|0|||
106169343|NCT03056573|366281932|FG000|Overall Study|Lost to Follow-up|1|||
106169344|NCT03056573|366281933|FG001|Overall Study|Lost to Follow-up|1|||
106169345|NCT03556293|366281934|FG000|Overall Study|Ineligible for analysis|1904|||
106169346|NCT03556293|366281935|FG001|Overall Study|Ineligible for analysis|1471|||
106169347|NCT03556293|366281936|FG002|Overall Study|Ineligible for analysis|1091|||
106169348|NCT03556293|366281937|FG003|Overall Study|Ineligible for analysis|1269|||
106169349|NCT05104463|366281938|FG000|Overall Study|Adverse Event|1|||
106169350|NCT05104463|366281939|FG001|Overall Study|Adverse Event|1|||
106169351|NCT05104463|366281938|FG000|Overall Study|Lost to Follow-up|1|||
106169352|NCT05104463|366281939|FG001|Overall Study|Lost to Follow-up|1|||
106169353|NCT05104463|366281938|FG000|Overall Study|Physician Decision|1|||
106169354|NCT05104463|366281939|FG001|Overall Study|Physician Decision|0|||
106169355|NCT05104463|366281938|FG000|Overall Study|Protocol Violation|0|||
106169356|NCT05104463|366281939|FG001|Overall Study|Protocol Violation|2|||
106169357|NCT05104463|366281938|FG000|Overall Study|Withdrawal by Subject|1|||
106169358|NCT05104463|366281939|FG001|Overall Study|Withdrawal by Subject|1|||
106169359|NCT05002088|366283435|FG000|Overall Study|Withdrawal by Subject|9|||
106169360|NCT05002088|366283436|FG001|Overall Study|Withdrawal by Subject|0|||
106169361|NCT05002088|366283435|FG000|Overall Study|Lost to Follow-up|0|||
106169362|NCT05002088|366283436|FG001|Overall Study|Lost to Follow-up|1|||
106169363|NCT05002088|366283435|FG000|Overall Study|Death|16|||
106169364|NCT05002088|366283436|FG001|Overall Study|Death|2|||
106169365|NCT05002088|366283435|FG000|Overall Study|Protocol Violation|25|||
106169366|NCT05002088|366283436|FG001|Overall Study|Protocol Violation|7|||
106169367|NCT04068181|366283437|FG000|Overall Study|Death|17|||
106169368|NCT04068181|366283438|FG001|Overall Study|Death|12|||
106169369|NCT04068181|366283439|FG002|Overall Study|Death|4|||
106169370|NCT04068181|366283440|FG003|Overall Study|Death|7|||
106169371|NCT04068181|366283437|FG000|Overall Study|Lost to Follow-up|1|||
106169372|NCT04068181|366283438|FG001|Overall Study|Lost to Follow-up|0|||
106169373|NCT04068181|366283439|FG002|Overall Study|Lost to Follow-up|0|||
106169374|NCT04068181|366283440|FG003|Overall Study|Lost to Follow-up|0|||
106169375|NCT04068181|366283437|FG000|Overall Study|Withdrawal of consent from study|3|||
106169376|NCT04068181|366283438|FG001|Overall Study|Withdrawal of consent from study|0|||
106169377|NCT04068181|366283439|FG002|Overall Study|Withdrawal of consent from study|0|||
106169378|NCT04068181|366283440|FG003|Overall Study|Withdrawal of consent from study|0|||
106169379|NCT02134925|366283443|FG000|Overall Study|Withdrawal by Subject|1|||
106169380|NCT02134925|366283444|FG001|Overall Study|Withdrawal by Subject|0|||
106169381|NCT02134925|366283443|FG000|Overall Study|Cancel|1|||
106169382|NCT02134925|366283444|FG001|Overall Study|Cancel|6|||
106169383|NCT04770402|366283451|FG000|Overall Study|Lost to Follow-up|1|||
106169384|NCT04770402|366283452|FG001|Overall Study|Lost to Follow-up|2|||
106169385|NCT04770402|366283451|FG000|Overall Study|Non-compliance|1|||
106169386|NCT04770402|366283452|FG001|Overall Study|Non-compliance|0|||
106169387|NCT04770402|366283451|FG000|Overall Study|Withdrawal by Subject|0|||
106169388|NCT04770402|366283452|FG001|Overall Study|Withdrawal by Subject|1|||
106169389|NCT05274074|366283453|FG000|Overall Study|Lost to Follow-up|2|||
106169390|NCT05274074|366283454|FG001|Overall Study|Lost to Follow-up|3|||
106169391|NCT05274074|366283453|FG000|Overall Study|Withdrawal by Subject|1|||
106169392|NCT05274074|366283454|FG001|Overall Study|Withdrawal by Subject|2|||
106169393|NCT04362254|366283462|FG000|Overall Study|Adverse Event|1|||
106169394|NCT04362254|366283462|FG000|Overall Study|Protocol Violation|1|||
106169395|NCT04362254|366283462|FG000|Overall Study|Due to early termination of the trial|10|||
106169396|NCT01208662|366283463|FG000|Induction and Consolidation|Disease Progression|23|||
106169397|NCT01208662|366283464|FG001|Induction and Consolidation|Disease Progression|13|||
106169398|NCT01208662|366283465|FG002|Induction and Consolidation|Disease Progression|0|||
106169399|NCT01208662|366283463|FG000|Induction and Consolidation|Adverse Event|16|||
106169400|NCT01208662|366283464|FG001|Induction and Consolidation|Adverse Event|18|||
106169401|NCT01208662|366283465|FG002|Induction and Consolidation|Adverse Event|2|||
106169402|NCT01208662|366283463|FG000|Induction and Consolidation|MD or Participant Decision|16|||
106169403|NCT01208662|366283464|FG001|Induction and Consolidation|MD or Participant Decision|34|||
106169404|NCT01208662|366283465|FG002|Induction and Consolidation|MD or Participant Decision|4|||
106169405|NCT01208662|366283463|FG000|Induction and Consolidation|Death|1|||
106169406|NCT01208662|366283464|FG001|Induction and Consolidation|Death|3|||
106169407|NCT01208662|366283465|FG002|Induction and Consolidation|Death|1|||
106169408|NCT01208662|366283463|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
106169409|NCT01208662|366283464|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
106169410|NCT01208662|366283465|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
106169411|NCT01208662|366283463|FG000|Maintenance|Disease Progression|156|||
106169412|NCT01208662|366283464|FG001|Maintenance|Disease Progression|102|||
106169413|NCT01208662|366283465|FG002|Maintenance|Disease Progression|0|||
106169414|NCT01208662|366283463|FG000|Maintenance|Adverse Event|12|||
106169415|NCT01208662|366283464|FG001|Maintenance|Adverse Event|28|||
106169416|NCT01208662|366283465|FG002|Maintenance|Adverse Event|0|||
106169417|NCT01208662|366283463|FG000|Maintenance|MD or Participant Decision|24|||
106169418|NCT01208662|366283464|FG001|Maintenance|MD or Participant Decision|36|||
106169419|NCT01208662|366283465|FG002|Maintenance|MD or Participant Decision|0|||
106169420|NCT01208662|366283463|FG000|Maintenance|Death|0|||
106169421|NCT01208662|366283464|FG001|Maintenance|Death|3|||
106169422|NCT01208662|366283465|FG002|Maintenance|Death|0|||
106169423|NCT01208662|366283463|FG000|Maintenance|Discontinued for other reasons|21|||
106169424|NCT01208662|366283464|FG001|Maintenance|Discontinued for other reasons|31|||
106169425|NCT01208662|366283465|FG002|Maintenance|Discontinued for other reasons|0|||
106169426|NCT01208662|366283463|FG000|Maintenance|Still on Treatment|78|||
106169427|NCT01208662|366283464|FG001|Maintenance|Still on Treatment|89|||
106169428|NCT01208662|366283465|FG002|Maintenance|Still on Treatment|0|||
106169429|NCT04076618|366283466|FG000|Overall Study|Lost to Follow-up|2|||
106169430|NCT04076618|366283467|FG001|Overall Study|Lost to Follow-up|1|||
106169431|NCT04076618|366283468|FG002|Overall Study|Lost to Follow-up|3|||
106169432|NCT04076618|366283466|FG000|Overall Study|Withdrawal by Subject|3|||
106169433|NCT04076618|366283467|FG001|Overall Study|Withdrawal by Subject|1|||
106169434|NCT04076618|366283468|FG002|Overall Study|Withdrawal by Subject|2|||
106169435|NCT04076618|366283466|FG000|Overall Study|Relocated out of state|0|||
106169436|NCT04076618|366283467|FG001|Overall Study|Relocated out of state|2|||
106169437|NCT04076618|366283468|FG002|Overall Study|Relocated out of state|0|||
106169438|NCT04076618|366283466|FG000|Overall Study|COVID concerns|0|||
106169439|NCT04076618|366283467|FG001|Overall Study|COVID concerns|1|||
106169440|NCT04076618|366283468|FG002|Overall Study|COVID concerns|0|||
106169441|NCT04076618|366283466|FG000|Overall Study|Adverse Event|0|||
106169442|NCT04076618|366283467|FG001|Overall Study|Adverse Event|0|||
106169443|NCT04076618|366283468|FG002|Overall Study|Adverse Event|2|||
106169444|NCT04707625|366283469|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
106169445|NCT00321048|366283470|FG000|Overall Study|Withdrawal by Subject|6|||
106169446|NCT00321048|366283471|FG001|Overall Study|Withdrawal by Subject|8|||
106169447|NCT04433208|366283472|FG000|Overall Study|Withdrawal by Subject|0|||
106169448|NCT04433208|366283473|FG001|Overall Study|Withdrawal by Subject|1|||
106169449|NCT04433208|366283474|FG002|Overall Study|Withdrawal by Subject|1|||
106169450|NCT04433208|366283475|FG003|Overall Study|Withdrawal by Subject|0|||
106169451|NCT04433208|366283476|FG004|Overall Study|Withdrawal by Subject|2|||
106169452|NCT04433208|366283477|FG005|Overall Study|Withdrawal by Subject|1|||
106169453|NCT04433208|366283472|FG000|Overall Study|Lost to Follow-up|0|||
106169454|NCT04433208|366283473|FG001|Overall Study|Lost to Follow-up|0|||
106169455|NCT04433208|366283474|FG002|Overall Study|Lost to Follow-up|0|||
106169456|NCT04433208|366283475|FG003|Overall Study|Lost to Follow-up|0|||
106169457|NCT04433208|366283476|FG004|Overall Study|Lost to Follow-up|0|||
106169458|NCT04433208|366283477|FG005|Overall Study|Lost to Follow-up|1|||
106169459|NCT06473662|366283478|FG000|Overall Study|Withdrawal by Subject|1|||
106169460|NCT06473662|366283479|FG001|Overall Study|Withdrawal by Subject|6|||
106169461|NCT06473662|366283480|FG002|Overall Study|Withdrawal by Subject|5|||
106169462|NCT06473662|366283478|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
106169463|NCT06473662|366283479|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
106169464|NCT06473662|366283480|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
106169465|NCT06473662|366283478|FG000|Overall Study|Starting HbA1c below 7%|0|||
106169466|NCT06473662|366283479|FG001|Overall Study|Starting HbA1c below 7%|1|||
106169467|NCT06473662|366283480|FG002|Overall Study|Starting HbA1c below 7%|1|||
106169468|NCT06473662|366283478|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
106169469|NCT06473662|366283479|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
106169470|NCT06473662|366283480|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
106169471|NCT06473662|366283478|FG000|Overall Study|Did not take medication|2|||
106169472|NCT06473662|366283479|FG001|Overall Study|Did not take medication|3|||
106169473|NCT06473662|366283480|FG002|Overall Study|Did not take medication|2|||
106169474|NCT03209973|366283481|FG000|Overall Study|Withdrawal by Subject|7|||
106169475|NCT03209973|366283481|FG000|Overall Study|Lost to Follow-up|2|||
106169476|NCT03209973|366283481|FG000|Overall Study|Death|8|||
106169477|NCT03209973|366283481|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
106169478|NCT03209973|366283481|FG000|Overall Study|Sponsor Decision|18|||
106169479|NCT03209973|366283481|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
106169480|NCT03209973|366283481|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
106169481|NCT04066205|366283482|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
106169482|NCT04066205|366283483|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
106169483|NCT04066205|366283482|FG000|T2 Immediate Post-Intervention|did not respond|5|||
106169484|NCT04066205|366283483|FG001|T2 Immediate Post-Intervention|did not respond|3|||
106169485|NCT04778397|366283486|FG000|Overall Study|Death|59|||
106169486|NCT04778397|366283487|FG001|Overall Study|Death|54|||
106169487|NCT04778397|366283488|FG002|Overall Study|Death|11|||
106169488|NCT04778397|366283489|FG003|Overall Study|Death|9|||
106169489|NCT04778397|366283486|FG000|Overall Study|Study Terminated by Sponsor|34|||
106169490|NCT04778397|366283487|FG001|Overall Study|Study Terminated by Sponsor|42|||
106169491|NCT04778397|366283488|FG002|Overall Study|Study Terminated by Sponsor|15|||
106169492|NCT04778397|366283489|FG003|Overall Study|Study Terminated by Sponsor|12|||
106169493|NCT04778397|366283486|FG000|Overall Study|Withdrew Consent|5|||
106169494|NCT04778397|366283487|FG001|Overall Study|Withdrew Consent|4|||
106169495|NCT04778397|366283488|FG002|Overall Study|Withdrew Consent|1|||
106169496|NCT04778397|366283489|FG003|Overall Study|Withdrew Consent|1|||
106169497|NCT04778397|366283486|FG000|Overall Study|Reason Not Specified|1|||
106169498|NCT04778397|366283487|FG001|Overall Study|Reason Not Specified|3|||
106169499|NCT04778397|366283488|FG002|Overall Study|Reason Not Specified|0|||
106169500|NCT04778397|366283489|FG003|Overall Study|Reason Not Specified|2|||
106169501|NCT04778397|366283486|FG000|Overall Study|Lost to Follow-up|2|||
106169502|NCT04778397|366283487|FG001|Overall Study|Lost to Follow-up|1|||
106169503|NCT04778397|366283488|FG002|Overall Study|Lost to Follow-up|0|||
106169504|NCT04778397|366283489|FG003|Overall Study|Lost to Follow-up|1|||
106169505|NCT04294641|366283490|FG000|Overall Study|Screen failure|4|||
106169506|NCT05906784|366283491|FG000|Overall Study|Lost to Follow-up|2|||
106169507|NCT05906784|366283492|FG001|Overall Study|Lost to Follow-up|1|||
106169508|NCT05906784|366283493|FG002|Overall Study|Lost to Follow-up|1|||
106169509|NCT05906784|366283494|FG003|Overall Study|Lost to Follow-up|1|||
106169510|NCT00792948|366283497|FG000|Overall Study|Adverse Event|6|||
106169511|NCT00792948|366283497|FG000|Overall Study|Death|4|||
106169512|NCT00792948|366283497|FG000|Overall Study|Withdrawal by Subject|3|||
106169513|NCT00792948|366283497|FG000|Overall Study|Ineligible|2|||
106169514|NCT00792948|366283497|FG000|Overall Study|Insurance denial - not treated|1|||
106169515|NCT00792948|366283497|FG000|Overall Study|Physician Decision|11|||
106169516|NCT00792948|366283497|FG000|Overall Study|Protocol Violation|1|||
106169517|NCT04359654|366283505|FG000|Overall Study|Withdrawal by Subject|1|||
106169518|NCT04359654|366283506|FG001|Overall Study|Withdrawal by Subject|0|||
106169519|NCT04359654|366283505|FG000|Overall Study|Adverse Event|0|||
106169520|NCT04359654|366283506|FG001|Overall Study|Adverse Event|1|||
106169521|NCT03523572|366283513|FG000|Dose Escalation|Progressive disease|1|||
106169522|NCT03523572|366283514|FG001|Dose Escalation|Progressive disease|0|||
105867291|NCT03888066|365164935|FG000|Run-in Phase|Withdrawal by Subject|43|||
105867292|NCT03888066|365164936|FG001|Run-in Phase|Withdrawal by Subject|0|||
105867293|NCT03888066|365164935|FG000|Run-in Phase|AE; Physician Decision|1|||
105867294|NCT03888066|365164936|FG001|Run-in Phase|AE; Physician Decision|0|||
106169523|NCT03523572|366283515|FG002|Dose Escalation|Progressive disease|0|||
106169524|NCT03523572|366283516|FG003|Dose Escalation|Progressive disease|0|||
106169525|NCT03523572|366283517|FG004|Dose Escalation|Progressive disease|0|||
106169526|NCT03523572|366283518|FG005|Dose Escalation|Progressive disease|0|||
106169527|NCT03523572|366283513|FG000|Dose Escalation|Clinical Progression|0|||
106169528|NCT03523572|366283514|FG001|Dose Escalation|Clinical Progression|1|||
106169529|NCT03523572|366283515|FG002|Dose Escalation|Clinical Progression|0|||
106169530|NCT03523572|366283516|FG003|Dose Escalation|Clinical Progression|0|||
106169531|NCT03523572|366283517|FG004|Dose Escalation|Clinical Progression|0|||
106169532|NCT03523572|366283518|FG005|Dose Escalation|Clinical Progression|0|||
106169533|NCT03523572|366283513|FG000|Dose Escalation|Adverse Event|2|||
106169534|NCT03523572|366283514|FG001|Dose Escalation|Adverse Event|0|||
106169535|NCT03523572|366283515|FG002|Dose Escalation|Adverse Event|0|||
106169536|NCT03523572|366283516|FG003|Dose Escalation|Adverse Event|0|||
106169537|NCT03523572|366283517|FG004|Dose Escalation|Adverse Event|0|||
106169538|NCT03523572|366283518|FG005|Dose Escalation|Adverse Event|0|||
106169539|NCT03523572|366283513|FG000|Dose Escalation|Physician Decision|1|||
106169540|NCT03523572|366283514|FG001|Dose Escalation|Physician Decision|1|||
106169541|NCT03523572|366283515|FG002|Dose Escalation|Physician Decision|0|||
106169542|NCT03523572|366283516|FG003|Dose Escalation|Physician Decision|0|||
106169543|NCT03523572|366283517|FG004|Dose Escalation|Physician Decision|0|||
106169544|NCT03523572|366283518|FG005|Dose Escalation|Physician Decision|0|||
106169545|NCT03523572|366283513|FG000|Dose Expansion|Progressive Disease|0|||
106169546|NCT03523572|366283514|FG001|Dose Expansion|Progressive Disease|0|||
106169547|NCT03523572|366283515|FG002|Dose Expansion|Progressive Disease|9|||
106169548|NCT03523572|366283516|FG003|Dose Expansion|Progressive Disease|11|||
106169549|NCT03523572|366283517|FG004|Dose Expansion|Progressive Disease|15|||
106169550|NCT03523572|366283518|FG005|Dose Expansion|Progressive Disease|2|||
106169551|NCT03523572|366283513|FG000|Dose Expansion|Clinical Progression|0|||
106169552|NCT03523572|366283514|FG001|Dose Expansion|Clinical Progression|0|||
106169553|NCT03523572|366283515|FG002|Dose Expansion|Clinical Progression|2|||
106169554|NCT03523572|366283516|FG003|Dose Expansion|Clinical Progression|2|||
106169555|NCT03523572|366283517|FG004|Dose Expansion|Clinical Progression|2|||
106169556|NCT03523572|366283518|FG005|Dose Expansion|Clinical Progression|0|||
106169557|NCT03523572|366283513|FG000|Dose Expansion|Adverse Event|0|||
106169558|NCT03523572|366283514|FG001|Dose Expansion|Adverse Event|0|||
106169559|NCT03523572|366283515|FG002|Dose Expansion|Adverse Event|10|||
106169560|NCT03523572|366283516|FG003|Dose Expansion|Adverse Event|1|||
106169561|NCT03523572|366283517|FG004|Dose Expansion|Adverse Event|5|||
106169562|NCT03523572|366283518|FG005|Dose Expansion|Adverse Event|2|||
106169563|NCT03523572|366283513|FG000|Dose Expansion|Withdrawal by Subject|0|||
106169564|NCT03523572|366283514|FG001|Dose Expansion|Withdrawal by Subject|0|||
106169565|NCT03523572|366283515|FG002|Dose Expansion|Withdrawal by Subject|1|||
106169566|NCT03523572|366283516|FG003|Dose Expansion|Withdrawal by Subject|1|||
106169567|NCT03523572|366283517|FG004|Dose Expansion|Withdrawal by Subject|0|||
106169568|NCT03523572|366283518|FG005|Dose Expansion|Withdrawal by Subject|0|||
106169569|NCT03523572|366283513|FG000|Dose Expansion|Physician Decision|0|||
106169570|NCT03523572|366283514|FG001|Dose Expansion|Physician Decision|0|||
106169571|NCT03523572|366283515|FG002|Dose Expansion|Physician Decision|1|||
106169572|NCT03523572|366283516|FG003|Dose Expansion|Physician Decision|0|||
106169573|NCT03523572|366283517|FG004|Dose Expansion|Physician Decision|1|||
106169574|NCT03523572|366283518|FG005|Dose Expansion|Physician Decision|0|||
106169575|NCT03523572|366283513|FG000|Dose Expansion|Miscellaneous|0|||
106169576|NCT03523572|366283514|FG001|Dose Expansion|Miscellaneous|0|||
106169577|NCT03523572|366283515|FG002|Dose Expansion|Miscellaneous|0|||
106169578|NCT03523572|366283516|FG003|Dose Expansion|Miscellaneous|0|||
106169579|NCT03523572|366283517|FG004|Dose Expansion|Miscellaneous|3|||
106169580|NCT03523572|366283518|FG005|Dose Expansion|Miscellaneous|0|||
106169581|NCT05269966|366283519|FG000|Overall Study|Adverse Event|4|||
106169582|NCT05269966|366283519|FG000|Overall Study|Withdrawal by Subject|1|||
106169583|NCT05269966|366283519|FG000|Overall Study|Lost to Follow-up|4|||
106169584|NCT05269966|366283519|FG000|Overall Study|Physician Decision|1|||
106169585|NCT04685135|366283520|FG000|Overall Study|Death|126|||
106169586|NCT04685135|366283521|FG001|Overall Study|Death|53|||
106169587|NCT04685135|366283520|FG000|Overall Study|Withdrawal by Subject|12|||
105867295|NCT03888066|365164935|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
106169588|NCT04685135|366283521|FG001|Overall Study|Withdrawal by Subject|16|||
106169592|NCT03711474|366283534|FG000|Overall Study|Physician Decision|2|||
106169593|NCT03711474|366283535|FG001|Overall Study|Physician Decision|0|||
106169594|NCT04270942|366283536|FG000|Overall Study|Death|1|||
106169595|NCT03069352|366283537|FG000|Overall Study|Ongoing|12|||
106169596|NCT03069352|366283538|FG001|Overall Study|Ongoing|40|||
106169597|NCT05147116|366283543|FG000|Overall Study|Withdrawal by Subject|0|||
106169598|NCT05147116|366283544|FG001|Overall Study|Withdrawal by Subject|1|||
106169599|NCT04197336|366283545|FG000|Overall Study|Withdrawal by Subject|1|||
106169600|NCT04101357|366283546|FG000|Overall Study|Death|1|||
106169601|NCT04101357|366283547|FG001|Overall Study|Death|1|||
106169602|NCT04101357|366283548|FG002|Overall Study|Death|1|||
106169603|NCT04101357|366283549|FG003|Overall Study|Death|2|||
106169604|NCT04101357|366283550|FG004|Overall Study|Death|4|||
106169605|NCT04101357|366283551|FG005|Overall Study|Death|11|||
106169606|NCT04101357|366283552|FG006|Overall Study|Death|4|||
106169607|NCT04101357|366283553|FG007|Overall Study|Death|4|||
106169608|NCT04101357|366283554|FG008|Overall Study|Death|5|||
106169609|NCT04101357|366283555|FG009|Overall Study|Death|2|||
106169610|NCT04101357|366283556|FG010|Overall Study|Death|3|||
106169611|NCT04101357|366283546|FG000|Overall Study|Trial closure|0|||
106169612|NCT04101357|366283547|FG001|Overall Study|Trial closure|0|||
106169613|NCT04101357|366283548|FG002|Overall Study|Trial closure|0|||
106169614|NCT04101357|366283549|FG003|Overall Study|Trial closure|0|||
106169615|NCT04101357|366283550|FG004|Overall Study|Trial closure|0|||
106169616|NCT04101357|366283551|FG005|Overall Study|Trial closure|2|||
106169617|NCT04101357|366283552|FG006|Overall Study|Trial closure|2|||
106169618|NCT04101357|366283553|FG007|Overall Study|Trial closure|0|||
106169619|NCT04101357|366283554|FG008|Overall Study|Trial closure|0|||
106169620|NCT04101357|366283555|FG009|Overall Study|Trial closure|0|||
106169621|NCT04101357|366283556|FG010|Overall Study|Trial closure|1|||
106169622|NCT04101357|366283546|FG000|Overall Study|Lost to Follow-up|0|||
106169623|NCT04101357|366283547|FG001|Overall Study|Lost to Follow-up|0|||
106169624|NCT04101357|366283548|FG002|Overall Study|Lost to Follow-up|0|||
106169625|NCT04101357|366283549|FG003|Overall Study|Lost to Follow-up|1|||
106169626|NCT04101357|366283550|FG004|Overall Study|Lost to Follow-up|0|||
106169627|NCT04101357|366283551|FG005|Overall Study|Lost to Follow-up|0|||
106169628|NCT04101357|366283552|FG006|Overall Study|Lost to Follow-up|0|||
106169629|NCT04101357|366283553|FG007|Overall Study|Lost to Follow-up|1|||
106169630|NCT04101357|366283554|FG008|Overall Study|Lost to Follow-up|0|||
106169631|NCT04101357|366283555|FG009|Overall Study|Lost to Follow-up|0|||
106169632|NCT04101357|366283556|FG010|Overall Study|Lost to Follow-up|0|||
106169633|NCT04101357|366283546|FG000|Overall Study|Withdrawal by Subject|1|||
106169634|NCT04101357|366283547|FG001|Overall Study|Withdrawal by Subject|0|||
106169635|NCT04101357|366283548|FG002|Overall Study|Withdrawal by Subject|0|||
106169636|NCT04101357|366283549|FG003|Overall Study|Withdrawal by Subject|0|||
106169637|NCT04101357|366283550|FG004|Overall Study|Withdrawal by Subject|0|||
106169638|NCT04101357|366283551|FG005|Overall Study|Withdrawal by Subject|0|||
106169639|NCT04101357|366283552|FG006|Overall Study|Withdrawal by Subject|0|||
106169640|NCT04101357|366283553|FG007|Overall Study|Withdrawal by Subject|0|||
106169641|NCT04101357|366283554|FG008|Overall Study|Withdrawal by Subject|1|||
106169642|NCT04101357|366283555|FG009|Overall Study|Withdrawal by Subject|1|||
106169643|NCT04101357|366283556|FG010|Overall Study|Withdrawal by Subject|0|||
106169644|NCT04101357|366283546|FG000|Overall Study|Other|0|||
106169645|NCT04101357|366283547|FG001|Overall Study|Other|0|||
106169646|NCT04101357|366283548|FG002|Overall Study|Other|0|||
106169647|NCT04101357|366283549|FG003|Overall Study|Other|0|||
106169648|NCT04101357|366283550|FG004|Overall Study|Other|0|||
106169649|NCT04101357|366283551|FG005|Overall Study|Other|1|||
106169650|NCT04101357|366283552|FG006|Overall Study|Other|2|||
106169651|NCT04101357|366283553|FG007|Overall Study|Other|1|||
106169652|NCT04101357|366283554|FG008|Overall Study|Other|0|||
106169653|NCT04101357|366283555|FG009|Overall Study|Other|0|||
106169654|NCT04101357|366283556|FG010|Overall Study|Other|0|||
106169655|NCT04101357|366283546|FG000|Overall Study|Enrolled but not treated|0|||
106169656|NCT04101357|366283547|FG001|Overall Study|Enrolled but not treated|0|||
106169657|NCT04101357|366283548|FG002|Overall Study|Enrolled but not treated|0|||
106169658|NCT04101357|366283549|FG003|Overall Study|Enrolled but not treated|0|||
106169659|NCT04101357|366283550|FG004|Overall Study|Enrolled but not treated|0|||
106169660|NCT04101357|366283551|FG005|Overall Study|Enrolled but not treated|1|||
106169661|NCT04101357|366283552|FG006|Overall Study|Enrolled but not treated|1|||
106169662|NCT04101357|366283553|FG007|Overall Study|Enrolled but not treated|0|||
106169663|NCT04101357|366283554|FG008|Overall Study|Enrolled but not treated|0|||
106169664|NCT04101357|366283555|FG009|Overall Study|Enrolled but not treated|0|||
106169665|NCT04101357|366283556|FG010|Overall Study|Enrolled but not treated|0|||
106169666|NCT02497950|366283561|FG000|Overall Study|Death|209|||
106169667|NCT02497950|366283561|FG000|Overall Study|Transplanted|85|||
106169668|NCT02497950|366283561|FG000|Overall Study|Explanted|8|||
106169669|NCT02497950|366283561|FG000|Overall Study|Device Permanently Deactivated|4|||
106169670|NCT02497950|366283561|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
106169671|NCT02497950|366283561|FG000|Overall Study|Lost to Follow-up|6|||
106169672|NCT02497950|366283561|FG000|Overall Study|Withdrawal by Subject|2|||
106169673|NCT02497950|366283561|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
106169674|NCT02497950|366283561|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
106169675|NCT02887521|366283562|FG000|Overall Study|Withdrawal by Subject|0|||
106169676|NCT02887521|366283563|FG001|Overall Study|Withdrawal by Subject|3|||
106169677|NCT02709161|366283568|FG000|Overall Study|Withdrawal by Subject|1|||
106169678|NCT02709161|366283569|FG001|Overall Study|Withdrawal by Subject|0|||
106169679|NCT03852550|366283575|FG000|Overall Study|Lost to Follow-up|4|||
106169680|NCT03852550|366283576|FG001|Overall Study|Lost to Follow-up|3|||
106169681|NCT03852550|366283575|FG000|Overall Study|Only parent outcomes completed|0|||
106169682|NCT03852550|366283576|FG001|Overall Study|Only parent outcomes completed|1|||
106169683|NCT03852550|366283575|FG000|Overall Study|Withdrawal by Subject|1|||
106169684|NCT03852550|366283576|FG001|Overall Study|Withdrawal by Subject|0|||
106169685|NCT03756662|366283577|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
106169686|NCT04295512|366283580|FG000|Overall Study|Lack of family response to schedule assessment|0|||
106169687|NCT04295512|366283581|FG001|Overall Study|Lack of family response to schedule assessment|0|||
106169688|NCT04295512|366283582|FG002|Overall Study|Lack of family response to schedule assessment|0|||
106169689|NCT04295512|366283583|FG003|Overall Study|Lack of family response to schedule assessment|2|||
106169690|NCT04295512|366283580|FG000|Overall Study|Therapist did not refer eligible family|7|||
106169691|NCT04295512|366283581|FG001|Overall Study|Therapist did not refer eligible family|7|||
106169692|NCT04295512|366283582|FG002|Overall Study|Therapist did not refer eligible family|0|||
106169693|NCT04295512|366283583|FG003|Overall Study|Therapist did not refer eligible family|0|||
106169694|NCT05623228|366283592|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
106169695|NCT05623228|366283593|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
106169696|NCT05623228|366283594|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
106169697|NCT05623228|366283595|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
106169698|NCT05623228|366283596|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
106169699|NCT05623228|366283597|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
106169700|NCT05623228|366283598|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
106169701|NCT05623228|366283599|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
106169702|NCT05623228|366283592|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
106169703|NCT05623228|366283593|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
106169704|NCT05623228|366283594|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
106169705|NCT05623228|366283595|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
106169706|NCT05623228|366283596|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
106169707|NCT05623228|366283597|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
106169708|NCT05623228|366283598|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
106169709|NCT05623228|366283599|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
106169710|NCT04871529|366283602|FG000|Overall Study|Withdrawal by Subject|0|||
106169711|NCT04871529|366283603|FG001|Overall Study|Withdrawal by Subject|1|||
106169712|NCT04871529|366283602|FG000|Overall Study|Death|0|||
106169713|NCT04871529|366283603|FG001|Overall Study|Death|1|||
106169714|NCT04871529|366283602|FG000|Overall Study|Not protocol specified|0|||
106169715|NCT04871529|366283603|FG001|Overall Study|Not protocol specified|1|||
106169716|NCT05526430|366285272|FG000|Overall Study|Withdrawal by Subject|0|||
106169717|NCT05526430|366285273|FG001|Overall Study|Withdrawal by Subject|2|||
106169718|NCT05526430|366285274|FG002|Overall Study|Withdrawal by Subject|0|||
106169719|NCT05526430|366285275|FG003|Overall Study|Withdrawal by Subject|0|||
106169720|NCT03687086|366285276|FG000|Overall Study|Withdrawal by Subject|3|||
106169721|NCT03687086|366285277|FG001|Overall Study|Withdrawal by Subject|4|||
106169722|NCT03687086|366285276|FG000|Overall Study|Lost to Follow-up|1|||
106169723|NCT03687086|366285277|FG001|Overall Study|Lost to Follow-up|1|||
106169724|NCT03687086|366285276|FG000|Overall Study|Death|1|||
106169725|NCT03687086|366285277|FG001|Overall Study|Death|0|||
106169726|NCT03687086|366285276|FG000|Overall Study|Incomplete assessment|0|||
106169727|NCT03687086|366285277|FG001|Overall Study|Incomplete assessment|2|||
106169728|NCT05934942|366285278|FG000|Run-in Period|Not treated|1|||
106169729|NCT05934942|366285278|FG000|Run-in Period|Withdrawal by Subject|1|||
106169730|NCT00539591|366285279|FG000|Overall Study|Toxicity|3|||
106169731|NCT00539591|366285280|FG001|Overall Study|Toxicity|0|||
106169732|NCT00539591|366285281|FG002|Overall Study|Toxicity|0|||
106169733|NCT00539591|366285279|FG000|Overall Study|Disease progression|2|||
106169734|NCT00539591|366285280|FG001|Overall Study|Disease progression|2|||
106169735|NCT00539591|366285281|FG002|Overall Study|Disease progression|3|||
106169736|NCT03924635|366285282|FG000|Overall Study|Withdrawal by Subject|2|||
106169737|NCT03924635|366285283|FG001|Overall Study|Withdrawal by Subject|4|||
106169738|NCT02038777|366285284|FG000|Overall Study|Death|0|||
106169739|NCT02038777|366285285|FG001|Overall Study|Death|2|||
106169740|NCT02038777|366285286|FG002|Overall Study|Death|0|||
106169741|NCT02038777|366285287|FG003|Overall Study|Death|1|||
106169742|NCT02038777|366285288|FG004|Overall Study|Death|2|||
106169743|NCT02038777|366285289|FG005|Overall Study|Death|4|||
106169744|NCT02038777|366285290|FG006|Overall Study|Death|0|||
106169745|NCT02038777|366285291|FG007|Overall Study|Death|11|||
106169746|NCT02038777|366285284|FG000|Overall Study|Lost to Follow-up|0|||
106169747|NCT02038777|366285285|FG001|Overall Study|Lost to Follow-up|0|||
106169748|NCT02038777|366285286|FG002|Overall Study|Lost to Follow-up|0|||
106169749|NCT02038777|366285287|FG003|Overall Study|Lost to Follow-up|1|||
106169750|NCT02038777|366285288|FG004|Overall Study|Lost to Follow-up|0|||
106169751|NCT02038777|366285289|FG005|Overall Study|Lost to Follow-up|0|||
106169752|NCT02038777|366285290|FG006|Overall Study|Lost to Follow-up|0|||
106169753|NCT02038777|366285291|FG007|Overall Study|Lost to Follow-up|0|||
106169754|NCT02038777|366285284|FG000|Overall Study|Other|0|||
106169755|NCT02038777|366285285|FG001|Overall Study|Other|1|||
106169756|NCT02038777|366285286|FG002|Overall Study|Other|0|||
106169757|NCT02038777|366285287|FG003|Overall Study|Other|2|||
106169758|NCT02038777|366285288|FG004|Overall Study|Other|1|||
106169759|NCT02038777|366285289|FG005|Overall Study|Other|0|||
106169760|NCT02038777|366285290|FG006|Overall Study|Other|0|||
106169761|NCT02038777|366285291|FG007|Overall Study|Other|0|||
106169762|NCT02038777|366285284|FG000|Overall Study|Randomized but not treated|0|||
106169763|NCT02038777|366285285|FG001|Overall Study|Randomized but not treated|1|||
106169764|NCT02038777|366285286|FG002|Overall Study|Randomized but not treated|0|||
106169765|NCT02038777|366285287|FG003|Overall Study|Randomized but not treated|0|||
106169766|NCT02038777|366285288|FG004|Overall Study|Randomized but not treated|0|||
106169767|NCT02038777|366285289|FG005|Overall Study|Randomized but not treated|0|||
106169768|NCT02038777|366285290|FG006|Overall Study|Randomized but not treated|0|||
106169769|NCT02038777|366285291|FG007|Overall Study|Randomized but not treated|0|||
106169770|NCT02038777|366285284|FG000|Overall Study|Started Chemotherapy|1|||
106169771|NCT02038777|366285285|FG001|Overall Study|Started Chemotherapy|0|||
106169772|NCT02038777|366285286|FG002|Overall Study|Started Chemotherapy|3|||
106169773|NCT02038777|366285287|FG003|Overall Study|Started Chemotherapy|0|||
106169774|NCT02038777|366285288|FG004|Overall Study|Started Chemotherapy|0|||
106169775|NCT02038777|366285289|FG005|Overall Study|Started Chemotherapy|0|||
106169776|NCT02038777|366285290|FG006|Overall Study|Started Chemotherapy|0|||
106169777|NCT02038777|366285291|FG007|Overall Study|Started Chemotherapy|0|||
106169778|NCT02038777|366285284|FG000|Overall Study|participation terminated by sponsor|0|||
106169779|NCT02038777|366285285|FG001|Overall Study|participation terminated by sponsor|0|||
106169780|NCT02038777|366285286|FG002|Overall Study|participation terminated by sponsor|0|||
106169781|NCT02038777|366285287|FG003|Overall Study|participation terminated by sponsor|0|||
106169782|NCT02038777|366285288|FG004|Overall Study|participation terminated by sponsor|0|||
106169783|NCT02038777|366285289|FG005|Overall Study|participation terminated by sponsor|0|||
106169784|NCT02038777|366285290|FG006|Overall Study|participation terminated by sponsor|1|||
106169785|NCT02038777|366285291|FG007|Overall Study|participation terminated by sponsor|1|||
106169786|NCT04471246|366285292|FG000|Overall Study|Lost to Follow-up|2|||
106169787|NCT04471246|366285293|FG001|Overall Study|Lost to Follow-up|2|||
106169788|NCT04826471|366285294|FG000|Overall Study|Lost to Follow-up|2|||
106169789|NCT04826471|366285294|FG000|Overall Study|Protocol Violation|3|||
106169790|NCT04826471|366285294|FG000|Overall Study|Withdrawal by Subject|1|||
106169791|NCT03386578|366285295|FG000|PK Component|Lost to Follow-up|0|||
106169792|NCT03386578|366285296|FG001|PK Component|Lost to Follow-up|1|||
106169793|NCT03386578|366285297|FG002|PK Component|Lost to Follow-up|0|||
106169794|NCT03386578|366285298|FG003|PK Component|Lost to Follow-up|0|||
106169795|NCT03386578|366285299|FG004|PK Component|Lost to Follow-up|0|||
106169796|NCT03386578|366285300|FG005|PK Component|Lost to Follow-up|0|||
106169797|NCT03386578|366285301|FG006|PK Component|Lost to Follow-up|1|||
106169798|NCT03386578|366285302|FG007|PK Component|Lost to Follow-up|0|||
106169799|NCT03386578|366285303|FG008|PK Component|Lost to Follow-up|0|||
106169800|NCT03386578|366285304|FG009|PK Component|Lost to Follow-up|0|||
106169801|NCT03386578|366285295|FG000|PK Component|Stillbirth/Abortion|0|||
106169802|NCT03386578|366285296|FG001|PK Component|Stillbirth/Abortion|0|||
106169803|NCT03386578|366285297|FG002|PK Component|Stillbirth/Abortion|0|||
106169804|NCT03386578|366285298|FG003|PK Component|Stillbirth/Abortion|0|||
106169805|NCT03386578|366285299|FG004|PK Component|Stillbirth/Abortion|0|||
106169806|NCT03386578|366285300|FG005|PK Component|Stillbirth/Abortion|2|||
106169807|NCT03386578|366285301|FG006|PK Component|Stillbirth/Abortion|0|||
106169808|NCT03386578|366285302|FG007|PK Component|Stillbirth/Abortion|0|||
106169809|NCT03386578|366285303|FG008|PK Component|Stillbirth/Abortion|0|||
106169810|NCT03386578|366285304|FG009|PK Component|Stillbirth/Abortion|0|||
106169811|NCT03386578|366285295|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
106169812|NCT03386578|366285296|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
106169813|NCT03386578|366285297|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
106169814|NCT03386578|366285298|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
106169815|NCT03386578|366285299|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
106169816|NCT03386578|366285300|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
106169817|NCT03386578|366285301|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
106169818|NCT03386578|366285302|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
106169819|NCT03386578|366285303|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
106169820|NCT03386578|366285304|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
106169821|NCT03386578|366285295|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
106169822|NCT03386578|366285296|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
106169823|NCT03386578|366285297|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
106169824|NCT03386578|366285298|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
106169825|NCT03386578|366285299|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
106169826|NCT03386578|366285300|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
106169827|NCT03386578|366285301|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
106169828|NCT03386578|366285302|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
106169829|NCT03386578|366285303|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
106169830|NCT03386578|366285304|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
106169831|NCT03386578|366285295|FG000|PrEP Comparison Component Step 1|Death|0|||
106169832|NCT03386578|366285296|FG001|PrEP Comparison Component Step 1|Death|0|||
106169833|NCT03386578|366285297|FG002|PrEP Comparison Component Step 1|Death|1|||
106169834|NCT03386578|366285298|FG003|PrEP Comparison Component Step 1|Death|0|||
106169835|NCT03386578|366285299|FG004|PrEP Comparison Component Step 1|Death|0|||
106169836|NCT03386578|366285300|FG005|PrEP Comparison Component Step 1|Death|0|||
106169837|NCT03386578|366285301|FG006|PrEP Comparison Component Step 1|Death|0|||
106169838|NCT03386578|366285302|FG007|PrEP Comparison Component Step 1|Death|9|||
106169839|NCT03386578|366285303|FG008|PrEP Comparison Component Step 1|Death|5|||
106169840|NCT03386578|366285304|FG009|PrEP Comparison Component Step 1|Death|0|||
106169841|NCT03386578|366285295|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
106169842|NCT03386578|366285296|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
106169843|NCT03386578|366285297|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
106169844|NCT03386578|366285298|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
106169845|NCT03386578|366285299|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
106169846|NCT03386578|366285300|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
106169847|NCT03386578|366285301|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
106169848|NCT03386578|366285302|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
106169849|NCT03386578|366285303|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
106169850|NCT03386578|366285304|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
106169851|NCT03386578|366285295|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
106169852|NCT03386578|366285296|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
106169853|NCT03386578|366285297|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
106169854|NCT03386578|366285298|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
106169855|NCT03386578|366285299|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
106169856|NCT03386578|366285300|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
106169857|NCT03386578|366285301|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
106169858|NCT03386578|366285302|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
106169859|NCT03386578|366285303|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
106169860|NCT03386578|366285304|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
106169861|NCT03386578|366285295|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
106169862|NCT03386578|366285296|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
106169863|NCT03386578|366285297|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
106169864|NCT03386578|366285298|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
106169865|NCT03386578|366285299|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
106169866|NCT03386578|366285300|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
106169867|NCT03386578|366285301|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
106169868|NCT03386578|366285302|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
106169869|NCT03386578|366285303|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
106169870|NCT03386578|366285304|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
106169871|NCT01960452|366285305|FG000|Overall Study|Withdrawal by Subject|2|||
106169872|NCT01960452|366285306|FG001|Overall Study|Withdrawal by Subject|1|||
106169873|NCT01960452|366285305|FG000|Overall Study|Sleep apnea in Night 1|1|||
106169874|NCT01960452|366285306|FG001|Overall Study|Sleep apnea in Night 1|0|||
106169875|NCT01960452|366285305|FG000|Overall Study|Poor Sleep in Night 1|0|||
106169876|NCT01960452|366285306|FG001|Overall Study|Poor Sleep in Night 1|2|||
106169877|NCT01960452|366285305|FG000|Overall Study|No Sex/Age Match Night 1|1|||
106169878|NCT01960452|366285306|FG001|Overall Study|No Sex/Age Match Night 1|0|||
106169879|NCT01960452|366285305|FG000|Overall Study|No Sex/Age Match Night 2|0|||
106169880|NCT01960452|366285306|FG001|Overall Study|No Sex/Age Match Night 2|2|||
106169881|NCT01960452|366285305|FG000|Overall Study|Technical Difficulties Night 2|2|||
106169882|NCT01960452|366285306|FG001|Overall Study|Technical Difficulties Night 2|0|||
106169883|NCT04414722|366285309|FG000|Overall Study|Lost to Follow-up|3|||
106169884|NCT04414722|366285310|FG001|Overall Study|Lost to Follow-up|4|||
106169885|NCT04414722|366285311|FG002|Overall Study|Lost to Follow-up|3|||
106169886|NCT04414722|366285312|FG003|Overall Study|Lost to Follow-up|2|||
106169887|NCT04414722|366285313|FG004|Overall Study|Lost to Follow-up|3|||
106169888|NCT04414722|366285309|FG000|Overall Study|Withdrawal by Subject|6|||
106169889|NCT04414722|366285310|FG001|Overall Study|Withdrawal by Subject|3|||
106169890|NCT04414722|366285311|FG002|Overall Study|Withdrawal by Subject|1|||
106169891|NCT04414722|366285312|FG003|Overall Study|Withdrawal by Subject|5|||
106169892|NCT04414722|366285313|FG004|Overall Study|Withdrawal by Subject|1|||
106169893|NCT04414722|366285309|FG000|Overall Study|Physician Decision|0|||
106169894|NCT04414722|366285310|FG001|Overall Study|Physician Decision|1|||
106169895|NCT04414722|366285311|FG002|Overall Study|Physician Decision|2|||
106169896|NCT04414722|366285312|FG003|Overall Study|Physician Decision|0|||
106169897|NCT04414722|366285313|FG004|Overall Study|Physician Decision|0|||
106169898|NCT04414722|366285309|FG000|Overall Study|Non-participatory|0|||
106169899|NCT04414722|366285310|FG001|Overall Study|Non-participatory|1|||
106169900|NCT04414722|366285311|FG002|Overall Study|Non-participatory|1|||
106169901|NCT04414722|366285312|FG003|Overall Study|Non-participatory|0|||
106169902|NCT04414722|366285313|FG004|Overall Study|Non-participatory|0|||
106169903|NCT04690582|366285323|FG000|Overall Study|Withdrawal by Subject|6|||
106169904|NCT04690582|366285324|FG001|Overall Study|Withdrawal by Subject|4|||
106169905|NCT03625115|366285327|FG000|Overall Study|Withdrawal by Subject|4|||
106169906|NCT03625115|366285328|FG001|Overall Study|Withdrawal by Subject|7|||
106169907|NCT03625115|366285327|FG000|Overall Study|Lost to Follow-up|17|||
106169908|NCT03625115|366285328|FG001|Overall Study|Lost to Follow-up|24|||
106169909|NCT05868382|366285329|FG000|Overall Study|Lost to Follow-up|5|||
106169910|NCT05868382|366285330|FG001|Overall Study|Lost to Follow-up|0|||
106169911|NCT05868382|366285331|FG002|Overall Study|Lost to Follow-up|6|||
106169912|NCT05868382|366285332|FG003|Overall Study|Lost to Follow-up|4|||
106169913|NCT05868382|366285333|FG004|Overall Study|Lost to Follow-up|2|||
106169914|NCT05868382|366285334|FG005|Overall Study|Lost to Follow-up|6|||
106169915|NCT05868382|366285329|FG000|Overall Study|Withdrawal by Subject|1|||
106169916|NCT05868382|366285330|FG001|Overall Study|Withdrawal by Subject|0|||
106169917|NCT05868382|366285331|FG002|Overall Study|Withdrawal by Subject|0|||
106169918|NCT05868382|366285332|FG003|Overall Study|Withdrawal by Subject|0|||
106169919|NCT05868382|366285333|FG004|Overall Study|Withdrawal by Subject|1|||
106169920|NCT05868382|366285334|FG005|Overall Study|Withdrawal by Subject|0|||
106169921|NCT04585815|366285335|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
106169922|NCT04585815|366285336|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
106169923|NCT04585815|366285337|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
106169924|NCT04585815|366285338|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
106169925|NCT04585815|366285339|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
106169926|NCT04585815|366285340|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
106169927|NCT04585815|366285341|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
106169928|NCT04585815|366285335|FG000|Sub-study A- Treatment Phase|Death|0|||
106169929|NCT04585815|366285336|FG001|Sub-study A- Treatment Phase|Death|1|||
106169930|NCT04585815|366285337|FG002|Sub-study A- Treatment Phase|Death|0|||
106169931|NCT04585815|366285338|FG003|Sub-study A- Treatment Phase|Death|0|||
106169932|NCT04585815|366285339|FG004|Sub-study A- Treatment Phase|Death|0|||
106169933|NCT04585815|366285340|FG005|Sub-study A- Treatment Phase|Death|0|||
106169934|NCT04585815|366285341|FG006|Sub-study A- Treatment Phase|Death|0|||
106169935|NCT04585815|366285335|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
106169936|NCT04585815|366285336|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
106169937|NCT04585815|366285337|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
106169938|NCT04585815|366285338|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
106169939|NCT04585815|366285339|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
106169940|NCT04585815|366285340|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
106169941|NCT04585815|366285341|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
106169942|NCT04585815|366285335|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
106169943|NCT04585815|366285336|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
106169944|NCT04585815|366285337|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
106169945|NCT04585815|366285338|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
106169946|NCT04585815|366285339|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
106169947|NCT04585815|366285340|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
106169948|NCT04585815|366285341|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
106169949|NCT04585815|366285335|FG000|Sub-study A- Treatment Phase|Other|1|||
106169950|NCT04585815|366285336|FG001|Sub-study A- Treatment Phase|Other|0|||
106169951|NCT04585815|366285337|FG002|Sub-study A- Treatment Phase|Other|0|||
106169952|NCT04585815|366285338|FG003|Sub-study A- Treatment Phase|Other|0|||
106169953|NCT04585815|366285339|FG004|Sub-study A- Treatment Phase|Other|0|||
106169954|NCT04585815|366285340|FG005|Sub-study A- Treatment Phase|Other|0|||
106169955|NCT04585815|366285341|FG006|Sub-study A- Treatment Phase|Other|0|||
106169956|NCT04585815|366285335|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
106169957|NCT04585815|366285336|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
106169958|NCT04585815|366285337|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
106169959|NCT04585815|366285338|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
106169960|NCT04585815|366285339|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
106169961|NCT04585815|366285340|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
106169962|NCT04585815|366285341|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
106169963|NCT04585815|366285335|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
106169964|NCT04585815|366285336|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
106169965|NCT04585815|366285337|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
106169966|NCT04585815|366285338|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
106169967|NCT04585815|366285339|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
106169968|NCT04585815|366285340|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
106169969|NCT04585815|366285341|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
106169970|NCT04585815|366285335|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
106169971|NCT04585815|366285336|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
106169972|NCT04585815|366285337|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
106169973|NCT04585815|366285338|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
106169974|NCT04585815|366285339|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
106169975|NCT04585815|366285340|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
106169976|NCT04585815|366285341|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
106169977|NCT04585815|366285335|FG000|Sub-study B- Treatment Phase|Death|0|||
106169978|NCT04585815|366285336|FG001|Sub-study B- Treatment Phase|Death|0|||
106169979|NCT04585815|366285337|FG002|Sub-study B- Treatment Phase|Death|0|||
106169980|NCT04585815|366285338|FG003|Sub-study B- Treatment Phase|Death|1|||
106169981|NCT04585815|366285339|FG004|Sub-study B- Treatment Phase|Death|0|||
106169982|NCT04585815|366285340|FG005|Sub-study B- Treatment Phase|Death|0|||
106169983|NCT04585815|366285341|FG006|Sub-study B- Treatment Phase|Death|0|||
106169984|NCT04585815|366285335|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
106169985|NCT04585815|366285336|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
106169986|NCT04585815|366285337|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
106169987|NCT04585815|366285338|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
106169988|NCT04585815|366285339|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
106169989|NCT04585815|366285340|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
106169990|NCT04585815|366285341|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
106169991|NCT04585815|366285335|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
106169992|NCT04585815|366285336|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
106169993|NCT04585815|366285337|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
106169994|NCT04585815|366285338|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
106169995|NCT04585815|366285339|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
106169996|NCT04585815|366285340|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
106169997|NCT04585815|366285341|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
106169998|NCT04585815|366285335|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
106169999|NCT04585815|366285336|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
106170000|NCT04585815|366285337|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
106170001|NCT04585815|366285338|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
106170002|NCT04585815|366285339|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
106170003|NCT04585815|366285340|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
106170004|NCT04585815|366285341|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
106170005|NCT04585815|366285335|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
106170006|NCT04585815|366285336|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
106170007|NCT04585815|366285337|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
106170008|NCT04585815|366285338|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
106170009|NCT04585815|366285339|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
106170010|NCT04585815|366285340|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
106170011|NCT04585815|366285341|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
106170012|NCT04585815|366285335|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
106170013|NCT04585815|366285336|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
106170014|NCT04585815|366285337|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
106170015|NCT04585815|366285338|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
106170016|NCT04585815|366285339|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
106170017|NCT04585815|366285340|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
106170018|NCT04585815|366285341|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
106170019|NCT04585815|366285335|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
106170020|NCT04585815|366285336|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
106170021|NCT04585815|366285337|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
106170022|NCT04585815|366285338|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
106170023|NCT04585815|366285339|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
106170024|NCT04585815|366285340|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
106170025|NCT04585815|366285341|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
106170026|NCT04585815|366285335|FG000|Sub-study B- Follow-up Phase|Death|0|||
106170027|NCT04585815|366285336|FG001|Sub-study B- Follow-up Phase|Death|0|||
106170028|NCT04585815|366285337|FG002|Sub-study B- Follow-up Phase|Death|1|||
106170029|NCT04585815|366285338|FG003|Sub-study B- Follow-up Phase|Death|3|||
106170030|NCT04585815|366285339|FG004|Sub-study B- Follow-up Phase|Death|0|||
106170031|NCT04585815|366285340|FG005|Sub-study B- Follow-up Phase|Death|0|||
106170032|NCT04585815|366285341|FG006|Sub-study B- Follow-up Phase|Death|1|||
106170033|NCT05167864|366285344|FG000|Overall Study|Lost to Follow-up|7|||
106170034|NCT05167864|366285345|FG001|Overall Study|Lost to Follow-up|6|||
106170035|NCT05167864|366285346|FG002|Overall Study|Lost to Follow-up|7|||
106170036|NCT05167864|366285347|FG003|Overall Study|Lost to Follow-up|9|||
106170037|NCT04059185|366285348|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
106170038|NCT04059185|366285349|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
106170039|NCT04059185|366285350|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
106170040|NCT04059185|366285348|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
106170041|NCT04059185|366285349|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
106170042|NCT04059185|366285350|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
106170043|NCT04059185|366285348|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
106170044|NCT04059185|366285349|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
106170045|NCT04059185|366285350|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
106170046|NCT04059185|366285348|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
106170047|NCT04059185|366285349|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
106170048|NCT04059185|366285350|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
106170049|NCT04059185|366285348|FG000|Longitudinal Assessment-Adults Only|Death|4|||
106170050|NCT04059185|366285349|FG001|Longitudinal Assessment-Adults Only|Death|4|||
106170051|NCT04059185|366285350|FG002|Longitudinal Assessment-Adults Only|Death|3|||
106170052|NCT03295721|366285355|FG000|Overall Study|Adverse Event|1|||
106170053|NCT03295721|366285356|FG001|Overall Study|Adverse Event|0|||
106170054|NCT03295721|366285357|FG002|Overall Study|Adverse Event|0|||
106170055|NCT03295721|366285355|FG000|Overall Study|Lost to Follow-up|1|||
106170056|NCT03295721|366285356|FG001|Overall Study|Lost to Follow-up|1|||
106170057|NCT03295721|366285357|FG002|Overall Study|Lost to Follow-up|1|||
106170058|NCT03295721|366285355|FG000|Overall Study|Withdrawal by Subject|1|||
106170059|NCT03295721|366285356|FG001|Overall Study|Withdrawal by Subject|0|||
106170060|NCT03295721|366285357|FG002|Overall Study|Withdrawal by Subject|1|||
106170061|NCT03295721|366285355|FG000|Overall Study|Death|0|||
106170062|NCT03295721|366285356|FG001|Overall Study|Death|0|||
106170063|NCT03295721|366285357|FG002|Overall Study|Death|1|||
106170064|NCT01651403|366285365|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
106170065|NCT01651403|366285366|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
106170066|NCT01651403|366285365|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
106170067|NCT01651403|366285366|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
106170068|NCT01651403|366285365|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
106170069|NCT01651403|366285366|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
106170070|NCT01651403|366285365|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
106170071|NCT01651403|366285366|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
106170072|NCT01651403|366285365|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
106170073|NCT01651403|366285366|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
106170074|NCT01651403|366285365|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
106170075|NCT01651403|366285366|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
106170076|NCT00429364|366285370|FG000|Overall Study|Withdrawal by Subject|11|||
106170077|NCT00429364|366285371|FG001|Overall Study|Withdrawal by Subject|5|||
106170078|NCT00429364|366285370|FG000|Overall Study|Physician Decision|4|||
106170079|NCT00429364|366285371|FG001|Overall Study|Physician Decision|2|||
106170080|NCT00429364|366285370|FG000|Overall Study|Lost to Follow-up|7|||
106170081|NCT00429364|366285371|FG001|Overall Study|Lost to Follow-up|6|||
106170082|NCT00429364|366285370|FG000|Overall Study|Death|0|||
106170083|NCT00429364|366285371|FG001|Overall Study|Death|1|||
106170084|NCT00429364|366285370|FG000|Overall Study|Underwent aortic root surgery|10|||
106170085|NCT00429364|366285371|FG001|Overall Study|Underwent aortic root surgery|18|||
106170086|NCT00429364|366285370|FG000|Overall Study|Pregnancy|0|||
106170087|NCT00429364|366285371|FG001|Overall Study|Pregnancy|1|||
106170088|NCT04032847|366285372|FG000|Overall Study|Study termination by sponsor|8|||
106170089|NCT04032847|366285373|FG001|Overall Study|Study termination by sponsor|0|||
106170090|NCT04032847|366285374|FG002|Overall Study|Study termination by sponsor|4|||
106170091|NCT04032847|366285372|FG000|Overall Study|Death|12|||
106170092|NCT04032847|366285373|FG001|Overall Study|Death|0|||
106170093|NCT04032847|366285374|FG002|Overall Study|Death|0|||
106170094|NCT04032847|366285372|FG000|Overall Study|Progressive disease|2|||
106170095|NCT04032847|366285373|FG001|Overall Study|Progressive disease|0|||
106170096|NCT04032847|366285374|FG002|Overall Study|Progressive disease|1|||
106170097|NCT01796197|366285375|FG000|Overall Study|Lost to Follow-up|1|||
106170098|NCT01796197|366285375|FG000|Overall Study|Lack of Efficacy|1|||
106170099|NCT02684227|366285376|FG000|Overall Study|Adverse Event|1|||
106170100|NCT02684227|366285377|FG001|Overall Study|Adverse Event|7|||
106170101|NCT02684227|366285376|FG000|Overall Study|Death|0|||
106170102|NCT02684227|366285377|FG001|Overall Study|Death|2|||
106170103|NCT02684227|366285376|FG000|Overall Study|Withdrawal by Subject|0|||
106170104|NCT02684227|366285377|FG001|Overall Study|Withdrawal by Subject|1|||
106170105|NCT02684227|366285376|FG000|Overall Study|Progressive Disease|0|||
106170106|NCT02684227|366285377|FG001|Overall Study|Progressive Disease|2|||
106170107|NCT03606408|366285379|FG000|Overall Study|Adverse Event|13|||
106170108|NCT03606408|366285379|FG000|Overall Study|Withdrawal by Subject|7|||
106170109|NCT03606408|366285379|FG000|Overall Study|Physician Decision|4|||
106170110|NCT03606408|366285379|FG000|Overall Study|Lack of Efficacy|2|||
106170111|NCT03606408|366285379|FG000|Overall Study|Death|1|||
106170112|NCT03606408|366285379|FG000|Overall Study|new therapy for study indication|1|||
106170113|NCT04689256|366285380|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
106170114|NCT04689256|366285381|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
106170115|NCT04862234|366285384|FG000|Overall Study|Surgery cancellation|1|||
106170116|NCT04862234|366285385|FG001|Overall Study|Surgery cancellation|2|||
106170117|NCT04862234|366285384|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
106170118|NCT04862234|366285385|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
106170119|NCT04862234|366285384|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
106170120|NCT04862234|366285385|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
106170121|NCT03292484|366285386|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
106170122|NCT03292484|366285386|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
106170123|NCT03292484|366285386|FG000|Overall Study|Protocol Violation|2|||
106170124|NCT03292484|366285386|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
106170125|NCT03292484|366285386|FG000|Overall Study|Sponsor decision|349|||
106170126|NCT03292484|366285386|FG000|Overall Study|Lost to Follow-up|7|||
106170127|NCT03292484|366285386|FG000|Overall Study|Coronavirus Disease 2019|1|||
106170128|NCT03292484|366285386|FG000|Overall Study|Other|20|||
106170129|NCT03381586|366285396|FG000|Overall Study|Adverse Event|1|||
106170130|NCT03381586|366285397|FG001|Overall Study|Adverse Event|1|||
106170131|NCT03381586|366285396|FG000|Overall Study|Protocol Violation|1|||
106170132|NCT03381586|366285397|FG001|Overall Study|Protocol Violation|0|||
106170133|NCT03381586|366285396|FG000|Overall Study|Withdrawal by Subject|1|||
106170134|NCT03381586|366285397|FG001|Overall Study|Withdrawal by Subject|2|||
106170135|NCT04086121|366285402|FG000|Overall Study|Other than listed|8|||
106170136|NCT04086121|366285402|FG000|Overall Study|Withdrawal by Subject|3|||
106170137|NCT04086121|366285402|FG000|Overall Study|Lost to Follow-up|2|||
106170138|NCT04086121|366285402|FG000|Overall Study|Adverse Event|1|||
106170139|NCT02668692|366287054|FG000|Overall Study|Adverse Event|1|||
106170140|NCT02668692|366287055|FG001|Overall Study|Adverse Event|0|||
106170141|NCT04314778|366287056|FG000|Overall Study|Lost to Follow-up|5|||
106170142|NCT04314778|366287057|FG001|Overall Study|Lost to Follow-up|3|||
106170143|NCT04024020|366287058|FG000|Overall Study|Withdrawal by Subject|2|||
106170144|NCT04024020|366287059|FG001|Overall Study|Withdrawal by Subject|2|||
106170145|NCT05863156|366287096|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
106170146|NCT05863156|366287097|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
106170147|NCT05863156|366287098|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
106170148|NCT04141891|366287111|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
106170149|NCT04141891|366287112|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
106170150|NCT04141891|366287111|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
106170151|NCT04141891|366287112|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
106170152|NCT04141891|366287111|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
106170153|NCT04141891|366287112|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
106170154|NCT04141891|366287111|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
106170155|NCT04141891|366287112|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
106170156|NCT04141891|366287111|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
106170157|NCT04141891|366287112|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
106170158|NCT04141891|366287111|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
106170159|NCT04141891|366287112|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
106170160|NCT04141891|366287111|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
106170161|NCT04141891|366287112|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
106170162|NCT04141891|366287111|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
106170163|NCT04141891|366287112|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
106170164|NCT04141891|366287111|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
106170165|NCT04141891|366287112|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
106170166|NCT04141891|366287111|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
106170167|NCT04141891|366287112|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
106170168|NCT04141891|366287111|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
106170169|NCT04141891|366287112|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
106170170|NCT04141891|366287111|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
106170171|NCT04141891|366287112|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
106170172|NCT04141891|366287111|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
106170173|NCT04141891|366287112|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
106170174|NCT04141891|366287111|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
106170175|NCT04141891|366287112|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
106170176|NCT03626220|366287113|FG000|Overall Study|Withdrawal by Subject|2|||
106170177|NCT03626220|366287114|FG001|Overall Study|Withdrawal by Subject|0|||
106170178|NCT04625725|366287115|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
106170179|NCT04625725|366287116|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
106170180|NCT04625725|366287117|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
106170181|NCT04625725|366287118|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
106170182|NCT04625725|366287119|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
106170183|NCT04625725|366287120|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
106170184|NCT04625725|366287115|FG000|Provent Main Study|Withdrawal by Subject|242|||
106170185|NCT04625725|366287116|FG001|Provent Main Study|Withdrawal by Subject|144|||
106170186|NCT04625725|366287117|FG002|Provent Main Study|Withdrawal by Subject|0|||
106170187|NCT04625725|366287118|FG003|Provent Main Study|Withdrawal by Subject|0|||
106170188|NCT04625725|366287119|FG004|Provent Main Study|Withdrawal by Subject|0|||
106170189|NCT04625725|366287120|FG005|Provent Main Study|Withdrawal by Subject|0|||
106170190|NCT04625725|366287115|FG000|Provent Main Study|Physician Decision|5|||
106170191|NCT04625725|366287116|FG001|Provent Main Study|Physician Decision|0|||
106170192|NCT04625725|366287117|FG002|Provent Main Study|Physician Decision|0|||
106170193|NCT04625725|366287118|FG003|Provent Main Study|Physician Decision|0|||
106170194|NCT04625725|366287119|FG004|Provent Main Study|Physician Decision|0|||
106170195|NCT04625725|366287120|FG005|Provent Main Study|Physician Decision|0|||
106170196|NCT04625725|366287115|FG000|Provent Main Study|Protocol Violation|1|||
106170197|NCT04625725|366287116|FG001|Provent Main Study|Protocol Violation|0|||
106170198|NCT04625725|366287117|FG002|Provent Main Study|Protocol Violation|0|||
106170199|NCT04625725|366287118|FG003|Provent Main Study|Protocol Violation|0|||
106170200|NCT04625725|366287119|FG004|Provent Main Study|Protocol Violation|0|||
106170201|NCT04625725|366287120|FG005|Provent Main Study|Protocol Violation|0|||
106170202|NCT04625725|366287115|FG000|Provent Main Study|Lost to Follow-up|357|||
106170203|NCT04625725|366287116|FG001|Provent Main Study|Lost to Follow-up|200|||
106170204|NCT04625725|366287117|FG002|Provent Main Study|Lost to Follow-up|0|||
106170205|NCT04625725|366287118|FG003|Provent Main Study|Lost to Follow-up|0|||
106170206|NCT04625725|366287119|FG004|Provent Main Study|Lost to Follow-up|0|||
106170207|NCT04625725|366287120|FG005|Provent Main Study|Lost to Follow-up|0|||
106170208|NCT04625725|366287115|FG000|Provent Main Study|Death|22|||
106170209|NCT04625725|366287116|FG001|Provent Main Study|Death|10|||
106170210|NCT04625725|366287117|FG002|Provent Main Study|Death|0|||
106170211|NCT04625725|366287118|FG003|Provent Main Study|Death|0|||
106170212|NCT04625725|366287119|FG004|Provent Main Study|Death|0|||
106170213|NCT04625725|366287120|FG005|Provent Main Study|Death|0|||
106170214|NCT04625725|366287115|FG000|Provent Main Study|Adverse Event|2|||
106170215|NCT04625725|366287116|FG001|Provent Main Study|Adverse Event|1|||
106170216|NCT04625725|366287117|FG002|Provent Main Study|Adverse Event|0|||
106170217|NCT04625725|366287118|FG003|Provent Main Study|Adverse Event|0|||
106170218|NCT04625725|366287119|FG004|Provent Main Study|Adverse Event|0|||
106170219|NCT04625725|366287120|FG005|Provent Main Study|Adverse Event|0|||
106170220|NCT04625725|366287115|FG000|Provent Main Study|Participants dosed in sub-study|310|||
106170221|NCT04625725|366287116|FG001|Provent Main Study|Participants dosed in sub-study|193|||
106170222|NCT04625725|366287117|FG002|Provent Main Study|Participants dosed in sub-study|0|||
106170223|NCT04625725|366287118|FG003|Provent Main Study|Participants dosed in sub-study|0|||
106170224|NCT04625725|366287119|FG004|Provent Main Study|Participants dosed in sub-study|0|||
106170225|NCT04625725|366287120|FG005|Provent Main Study|Participants dosed in sub-study|0|||
106170226|NCT04625725|366287115|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
106170227|NCT04625725|366287116|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
106170228|NCT04625725|366287117|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
106170229|NCT04625725|366287118|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
106170230|NCT04625725|366287119|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
106170231|NCT04625725|366287120|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
106170232|NCT04625725|366287115|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
106170233|NCT04625725|366287116|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
106170234|NCT04625725|366287117|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
106170235|NCT04625725|366287118|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
106170236|NCT04625725|366287119|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
106170237|NCT04625725|366287120|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
106170238|NCT04625725|366287115|FG000|Provent Main Study|INCARCERATION|3|||
106170239|NCT04625725|366287116|FG001|Provent Main Study|INCARCERATION|0|||
106170240|NCT04625725|366287117|FG002|Provent Main Study|INCARCERATION|0|||
106170241|NCT04625725|366287118|FG003|Provent Main Study|INCARCERATION|0|||
106170242|NCT04625725|366287119|FG004|Provent Main Study|INCARCERATION|0|||
106170243|NCT04625725|366287120|FG005|Provent Main Study|INCARCERATION|0|||
106170244|NCT04625725|366287115|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
106170245|NCT04625725|366287116|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
106170246|NCT04625725|366287117|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
106170247|NCT04625725|366287118|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
106170248|NCT04625725|366287119|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
106170249|NCT04625725|366287120|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
106170250|NCT04625725|366287115|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
106170251|NCT04625725|366287116|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
106170252|NCT04625725|366287117|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
106170253|NCT04625725|366287118|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
106170254|NCT04625725|366287119|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
106170255|NCT04625725|366287120|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
106170256|NCT04625725|366287115|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
106170257|NCT04625725|366287116|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
106170258|NCT04625725|366287117|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
106170259|NCT04625725|366287118|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
106170260|NCT04625725|366287119|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
106170261|NCT04625725|366287120|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
106170262|NCT04625725|366287115|FG000|Provent Main Study|MISSING REASON|0|||
106170263|NCT04625725|366287116|FG001|Provent Main Study|MISSING REASON|1|||
106170264|NCT04625725|366287117|FG002|Provent Main Study|MISSING REASON|0|||
106170265|NCT04625725|366287118|FG003|Provent Main Study|MISSING REASON|0|||
106170266|NCT04625725|366287119|FG004|Provent Main Study|MISSING REASON|0|||
106170267|NCT04625725|366287120|FG005|Provent Main Study|MISSING REASON|0|||
106170268|NCT04625725|366287115|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
106170269|NCT04625725|366287116|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
106170270|NCT04625725|366287117|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
106170271|NCT04625725|366287118|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
106170272|NCT04625725|366287119|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
106170273|NCT04625725|366287120|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
106170274|NCT04625725|366287115|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
106170275|NCT04625725|366287116|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
106170276|NCT04625725|366287117|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
106170277|NCT04625725|366287118|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
106170278|NCT04625725|366287119|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
106170279|NCT04625725|366287120|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
106170280|NCT04625725|366287115|FG000|Provent Sub Study|Lost to Follow-up|0|||
106170281|NCT04625725|366287116|FG001|Provent Sub Study|Lost to Follow-up|0|||
106170282|NCT04625725|366287117|FG002|Provent Sub Study|Lost to Follow-up|20|||
106170283|NCT04625725|366287118|FG003|Provent Sub Study|Lost to Follow-up|10|||
106170284|NCT04625725|366287119|FG004|Provent Sub Study|Lost to Follow-up|6|||
106170285|NCT04625725|366287120|FG005|Provent Sub Study|Lost to Follow-up|4|||
106170286|NCT04625725|366287115|FG000|Provent Sub Study|Death|0|||
106170287|NCT04625725|366287116|FG001|Provent Sub Study|Death|0|||
106170288|NCT04625725|366287117|FG002|Provent Sub Study|Death|8|||
106170289|NCT04625725|366287118|FG003|Provent Sub Study|Death|5|||
106170290|NCT04625725|366287119|FG004|Provent Sub Study|Death|0|||
106170291|NCT04625725|366287120|FG005|Provent Sub Study|Death|1|||
106170292|NCT04625725|366287115|FG000|Provent Sub Study|Adverse Event|0|||
106170293|NCT04625725|366287116|FG001|Provent Sub Study|Adverse Event|0|||
106170294|NCT04625725|366287117|FG002|Provent Sub Study|Adverse Event|0|||
106170295|NCT04625725|366287118|FG003|Provent Sub Study|Adverse Event|0|||
106170296|NCT04625725|366287119|FG004|Provent Sub Study|Adverse Event|0|||
106170297|NCT04625725|366287120|FG005|Provent Sub Study|Adverse Event|1|||
106170298|NCT04625725|366287115|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
106170299|NCT04625725|366287116|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
106170300|NCT04625725|366287117|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
106170301|NCT04625725|366287118|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
106170302|NCT04625725|366287119|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
106170303|NCT04625725|366287120|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
106170304|NCT04625725|366287115|FG000|Provent Sub Study|Withdrawal by Subject|0|||
106170305|NCT04625725|366287116|FG001|Provent Sub Study|Withdrawal by Subject|0|||
106170306|NCT04625725|366287117|FG002|Provent Sub Study|Withdrawal by Subject|11|||
106170307|NCT04625725|366287118|FG003|Provent Sub Study|Withdrawal by Subject|13|||
106170308|NCT04625725|366287119|FG004|Provent Sub Study|Withdrawal by Subject|5|||
106170309|NCT04625725|366287120|FG005|Provent Sub Study|Withdrawal by Subject|6|||
106170310|NCT04625725|366287115|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
106170311|NCT04625725|366287116|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
106170312|NCT04625725|366287117|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
106170313|NCT04625725|366287118|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
106170314|NCT04625725|366287119|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
106170315|NCT04625725|366287120|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
106170316|NCT04737330|366287121|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
106170317|NCT04737330|366287122|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
106170318|NCT04737330|366287121|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
106170319|NCT04737330|366287122|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
106170320|NCT04737330|366287121|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
106170321|NCT04737330|366287122|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
106170322|NCT04737330|366287121|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
106170323|NCT04737330|366287122|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
106170324|NCT04737330|366287121|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
106170325|NCT04737330|366287122|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
106170326|NCT04737330|366287121|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
106170327|NCT04737330|366287122|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
106170328|NCT03298451|366287134|FG000|Overall Study|Death|275|||
106170329|NCT03298451|366287135|FG001|Overall Study|Death|260|||
106170330|NCT03298451|366287136|FG002|Overall Study|Death|122|||
106170331|NCT03298451|366287137|FG003|Overall Study|Death|280|||
106170332|NCT03298451|366287134|FG000|Overall Study|Lost to Follow-up|1|||
106170333|NCT03298451|366287135|FG001|Overall Study|Lost to Follow-up|1|||
106170334|NCT03298451|366287136|FG002|Overall Study|Lost to Follow-up|0|||
106170335|NCT03298451|366287137|FG003|Overall Study|Lost to Follow-up|7|||
106170336|NCT03298451|366287134|FG000|Overall Study|Withdrawal by Subject|9|||
106170337|NCT03298451|366287135|FG001|Overall Study|Withdrawal by Subject|7|||
106170338|NCT03298451|366287136|FG002|Overall Study|Withdrawal by Subject|1|||
106170339|NCT03298451|366287137|FG003|Overall Study|Withdrawal by Subject|20|||
106170340|NCT04308681|366287142|FG000|Pre-Treatment|Not reported|1|||
106170341|NCT04308681|366287143|FG001|Pre-Treatment|Not reported|1|||
106170342|NCT04308681|366287144|FG002|Pre-Treatment|Not reported|0|||
106170343|NCT04308681|366287145|FG003|Pre-Treatment|Not reported|0|||
106170344|NCT04308681|366287146|FG004|Pre-Treatment|Not reported|0|||
106170345|NCT04308681|366287147|FG005|Pre-Treatment|Not reported|2|||
106170346|NCT04308681|366287148|FG006|Pre-Treatment|Not reported|0|||
106170347|NCT04308681|366287149|FG007|Pre-Treatment|Not reported|0|||
106170348|NCT04308681|366287142|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
106170349|NCT04308681|366287143|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
106170350|NCT04308681|366287144|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
106170351|NCT04308681|366287145|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
106170352|NCT04308681|366287146|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
106170353|NCT04308681|366287147|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
106170354|NCT04308681|366287148|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
106170355|NCT04308681|366287149|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
106170356|NCT04308681|366287142|FG000|Treatment up to Week 26|Other reasons|2|||
106170357|NCT04308681|366287143|FG001|Treatment up to Week 26|Other reasons|0|||
106170358|NCT04308681|366287144|FG002|Treatment up to Week 26|Other reasons|0|||
106170359|NCT04308681|366287145|FG003|Treatment up to Week 26|Other reasons|0|||
106170360|NCT04308681|366287146|FG004|Treatment up to Week 26|Other reasons|1|||
106170361|NCT04308681|366287147|FG005|Treatment up to Week 26|Other reasons|1|||
106170362|NCT04308681|366287148|FG006|Treatment up to Week 26|Other reasons|0|||
106170363|NCT04308681|366287149|FG007|Treatment up to Week 26|Other reasons|0|||
106170364|NCT04308681|366287142|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
106170365|NCT04308681|366287143|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
106170366|NCT04308681|366287144|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
106170367|NCT04308681|366287145|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
106170368|NCT04308681|366287146|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
106170369|NCT04308681|366287147|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
106170370|NCT04308681|366287148|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
106170371|NCT04308681|366287149|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
106170372|NCT04308681|366287142|FG000|Treatment up to Week 26|Adverse Event|6|||
106170373|NCT04308681|366287143|FG001|Treatment up to Week 26|Adverse Event|5|||
106170374|NCT04308681|366287144|FG002|Treatment up to Week 26|Adverse Event|5|||
106170375|NCT04308681|366287145|FG003|Treatment up to Week 26|Adverse Event|0|||
106170376|NCT04308681|366287146|FG004|Treatment up to Week 26|Adverse Event|6|||
106170377|NCT04308681|366287147|FG005|Treatment up to Week 26|Adverse Event|1|||
106170378|NCT04308681|366287148|FG006|Treatment up to Week 26|Adverse Event|0|||
106170379|NCT04308681|366287149|FG007|Treatment up to Week 26|Adverse Event|0|||
106170380|NCT04308681|366287142|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
106170381|NCT04308681|366287143|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
106170382|NCT04308681|366287144|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
106170383|NCT04308681|366287145|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
106170384|NCT04308681|366287146|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
106170385|NCT04308681|366287147|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
106170386|NCT04308681|366287148|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
106170387|NCT04308681|366287149|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
106170388|NCT04308681|366287142|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
106170389|NCT04308681|366287143|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
106170390|NCT04308681|366287144|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
106170391|NCT04308681|366287145|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
106170392|NCT04308681|366287146|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
106170393|NCT04308681|366287147|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
106170394|NCT04308681|366287148|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
106170395|NCT04308681|366287149|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
106170396|NCT04308681|366287142|FG000|OTE - 26 Weeks|Death|0|||
106170397|NCT04308681|366287143|FG001|OTE - 26 Weeks|Death|1|||
106170398|NCT04308681|366287144|FG002|OTE - 26 Weeks|Death|0|||
106170399|NCT04308681|366287145|FG003|OTE - 26 Weeks|Death|0|||
106170400|NCT04308681|366287146|FG004|OTE - 26 Weeks|Death|0|||
106170401|NCT04308681|366287147|FG005|OTE - 26 Weeks|Death|0|||
106170402|NCT04308681|366287148|FG006|OTE - 26 Weeks|Death|1|||
106170403|NCT04308681|366287149|FG007|OTE - 26 Weeks|Death|0|||
106170404|NCT04308681|366287142|FG000|OTE - 26 Weeks|Adverse Event|0|||
106170405|NCT04308681|366287143|FG001|OTE - 26 Weeks|Adverse Event|2|||
106170406|NCT04308681|366287144|FG002|OTE - 26 Weeks|Adverse Event|8|||
106170407|NCT04308681|366287145|FG003|OTE - 26 Weeks|Adverse Event|3|||
106170408|NCT04308681|366287146|FG004|OTE - 26 Weeks|Adverse Event|0|||
106170409|NCT04308681|366287147|FG005|OTE - 26 Weeks|Adverse Event|1|||
106170410|NCT04308681|366287148|FG006|OTE - 26 Weeks|Adverse Event|2|||
106170411|NCT04308681|366287149|FG007|OTE - 26 Weeks|Adverse Event|0|||
106170412|NCT04308681|366287142|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
106170413|NCT04308681|366287143|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
106170414|NCT04308681|366287144|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
106170415|NCT04308681|366287145|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
106170416|NCT04308681|366287146|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
106170417|NCT04308681|366287147|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
106170418|NCT04308681|366287148|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
106170419|NCT04308681|366287149|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
106170420|NCT05565820|366287150|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
106170421|NCT05565820|366287151|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
106170422|NCT05565820|366287150|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
106170423|NCT05565820|366287151|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
106170424|NCT02446236|366287152|FG000|Overall Study|Screen Failure|1|||
106170425|NCT02446236|366287153|FG001|Overall Study|Screen Failure|0|||
106170426|NCT02446236|366287154|FG002|Overall Study|Screen Failure|1|||
106170427|NCT02446236|366287152|FG000|Overall Study|Actively Receiving Therapy|0|||
106170428|NCT02446236|366287153|FG001|Overall Study|Actively Receiving Therapy|0|||
106170429|NCT02446236|366287154|FG002|Overall Study|Actively Receiving Therapy|1|||
106170430|NCT05090683|366287157|FG000|Overall Study|Lost to Follow-up|10|||
106170431|NCT05090683|366287158|FG001|Overall Study|Lost to Follow-up|2|||
106170432|NCT05090683|366287157|FG000|Overall Study|Withdrawal by Subject|15|||
106170433|NCT05090683|366287158|FG001|Overall Study|Withdrawal by Subject|0|||
106170434|NCT05184452|366287159|FG000|Overall Study|Lost to Follow-up|0|||
106170435|NCT05184452|366287160|FG001|Overall Study|Lost to Follow-up|0|||
106170436|NCT05184452|366287161|FG002|Overall Study|Lost to Follow-up|0|||
106170437|NCT05184452|366287162|FG003|Overall Study|Lost to Follow-up|0|||
106170438|NCT05184452|366287163|FG004|Overall Study|Lost to Follow-up|0|||
106170439|NCT05184452|366287164|FG005|Overall Study|Lost to Follow-up|2|||
106170440|NCT05184452|366287165|FG006|Overall Study|Lost to Follow-up|0|||
106170441|NCT05184452|366287166|FG007|Overall Study|Lost to Follow-up|0|||
106170442|NCT05184452|366287167|FG008|Overall Study|Lost to Follow-up|0|||
106170443|NCT05184452|366287168|FG009|Overall Study|Lost to Follow-up|1|||
106170444|NCT05184452|366287159|FG000|Overall Study|Withdrawal by Subject|0|||
106170445|NCT05184452|366287160|FG001|Overall Study|Withdrawal by Subject|0|||
106170446|NCT05184452|366287161|FG002|Overall Study|Withdrawal by Subject|0|||
106170447|NCT05184452|366287162|FG003|Overall Study|Withdrawal by Subject|0|||
106170448|NCT05184452|366287163|FG004|Overall Study|Withdrawal by Subject|0|||
106170449|NCT05184452|366287164|FG005|Overall Study|Withdrawal by Subject|1|||
106170450|NCT05184452|366287165|FG006|Overall Study|Withdrawal by Subject|0|||
106170451|NCT05184452|366287166|FG007|Overall Study|Withdrawal by Subject|0|||
106170452|NCT05184452|366287167|FG008|Overall Study|Withdrawal by Subject|0|||
106170453|NCT05184452|366287168|FG009|Overall Study|Withdrawal by Subject|1|||
106170454|NCT05586490|366287169|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
106170455|NCT05586490|366287170|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
106170456|NCT05586490|366287171|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
106170457|NCT05586490|366287172|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
106170458|NCT05586490|366287173|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
106170459|NCT05586490|366287169|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
106170460|NCT05586490|366287170|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
106170461|NCT05586490|366287171|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
106170462|NCT05586490|366287172|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
106170463|NCT05586490|366287173|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
106170464|NCT05586490|366287169|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
106170465|NCT05586490|366287170|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
106170466|NCT05586490|366287171|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
106170467|NCT05586490|366287172|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
106170468|NCT05586490|366287173|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
106170469|NCT04786119|366287176|FG000|Overall Study|Withdrawal by Subject|2|||
106170470|NCT05873556|366287177|FG000|Overall Study|Lost to Follow-up|4|||
106170471|NCT05873556|366287178|FG001|Overall Study|Lost to Follow-up|1|||
106170472|NCT05828017|366287179|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
106170473|NCT05012163|366287180|FG000|Overall Study|Protocol Violation|0|||
106170474|NCT05012163|366287181|FG001|Overall Study|Protocol Violation|0|||
106170475|NCT05012163|366287182|FG002|Overall Study|Protocol Violation|1|||
106170476|NCT05012163|366287183|FG003|Overall Study|Protocol Violation|1|||
106170477|NCT04615273|366287184|FG000|Overall Study|Withdrawal by Subject|3|||
106170478|NCT04615273|366287185|FG001|Overall Study|Withdrawal by Subject|1|||
106170479|NCT04615273|366287186|FG002|Overall Study|Withdrawal by Subject|2|||
106170480|NCT04615273|366287184|FG000|Overall Study|Adverse Event|1|||
106170481|NCT04615273|366287185|FG001|Overall Study|Adverse Event|0|||
106170482|NCT04615273|366287186|FG002|Overall Study|Adverse Event|1|||
106170483|NCT04615273|366287184|FG000|Overall Study|Lost to Follow-up|0|||
106170484|NCT04615273|366287185|FG001|Overall Study|Lost to Follow-up|1|||
106170485|NCT04615273|366287186|FG002|Overall Study|Lost to Follow-up|0|||
106170486|NCT04615273|366287184|FG000|Overall Study|Physician Decision|0|||
106170487|NCT04615273|366287185|FG001|Overall Study|Physician Decision|0|||
106170488|NCT04615273|366287186|FG002|Overall Study|Physician Decision|1|||
106170489|NCT04615273|366287184|FG000|Overall Study|Other|0|||
106170490|NCT04615273|366287185|FG001|Overall Study|Other|1|||
106170491|NCT04615273|366287186|FG002|Overall Study|Other|0|||
106170492|NCT04615273|366287184|FG000|Overall Study|Randomized but not treated|1|||
106170493|NCT04615273|366287185|FG001|Overall Study|Randomized but not treated|3|||
106170494|NCT04615273|366287186|FG002|Overall Study|Randomized but not treated|1|||
106170495|NCT05076266|366287187|FG000|Overall Study|Survey not complete - Participant refusal|2|||
106170496|NCT05076266|366287188|FG001|Overall Study|Survey not complete - Participant refusal|0|||
106170497|NCT04003246|366287189|FG000|Overall Study|Death|9|||
106170498|NCT02142803|366287190|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
106170499|NCT02142803|366287191|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
106170500|NCT02142803|366287192|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
106170501|NCT02142803|366287193|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
106170502|NCT05524402|366287194|FG000|Overall Study|Withdrawal by Subject|3|||
106170503|NCT05524402|366287195|FG001|Overall Study|Withdrawal by Subject|1|||
106170504|NCT05524402|366287194|FG000|Overall Study|Lost to Follow-up|2|||
106170505|NCT05524402|366287195|FG001|Overall Study|Lost to Follow-up|1|||
106170506|NCT04428203|366287197|FG000|Overall Study|Adverse Event|1|||
106170507|NCT04428203|366287198|FG001|Overall Study|Adverse Event|0|||
106170508|NCT04428203|366287199|FG002|Overall Study|Adverse Event|0|||
106170509|NCT04428203|366287197|FG000|Overall Study|Withdrawal by Subject|1|||
106170510|NCT04428203|366287198|FG001|Overall Study|Withdrawal by Subject|0|||
106170511|NCT04428203|366287199|FG002|Overall Study|Withdrawal by Subject|1|||
106170512|NCT05237284|366287200|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
105867296|NCT03888066|365164936|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
106170513|NCT05237284|366287201|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
106170514|NCT05237284|366287202|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
106170515|NCT05237284|366287203|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
106170516|NCT05237284|366287200|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
106170517|NCT05237284|366287201|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
106170518|NCT05237284|366287202|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
106170519|NCT05237284|366287203|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
106170520|NCT05237284|366287200|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
106170521|NCT05237284|366287201|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
106170522|NCT05237284|366287202|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
106170523|NCT05237284|366287203|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
106170524|NCT05237284|366287200|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
106170525|NCT05237284|366287201|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
106170526|NCT05237284|366287202|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
106170527|NCT05237284|366287203|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
106170528|NCT05237284|366287200|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
106170529|NCT05237284|366287201|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
106170530|NCT05237284|366287202|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
106170531|NCT05237284|366287203|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
106170532|NCT05237284|366287200|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
106170533|NCT05237284|366287201|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
106170534|NCT05237284|366287202|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
106170535|NCT05237284|366287203|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
106170536|NCT05237284|366287200|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
106170537|NCT05237284|366287201|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
106170538|NCT05237284|366287202|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
106170539|NCT05237284|366287203|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
106170540|NCT05237284|366287200|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
106170541|NCT05237284|366287201|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
106170542|NCT05237284|366287202|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
106170543|NCT05237284|366287203|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
106170544|NCT05237284|366287200|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
106170545|NCT05237284|366287201|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
106170546|NCT05237284|366287202|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
106170547|NCT05237284|366287203|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
106170548|NCT04999111|366287206|FG000|Overall Study|Lost to Follow-up|21|||
106170549|NCT04999111|366287207|FG001|Overall Study|Lost to Follow-up|16|||
106170550|NCT04999111|366287208|FG002|Overall Study|Lost to Follow-up|2|||
106170551|NCT04999111|366287209|FG003|Overall Study|Lost to Follow-up|26|||
106170552|NCT04999111|366287210|FG004|Overall Study|Lost to Follow-up|30|||
106170553|NCT04999111|366287211|FG005|Overall Study|Lost to Follow-up|6|||
106170554|NCT04999111|366287206|FG000|Overall Study|Physician Decision|1|||
106170555|NCT04999111|366287207|FG001|Overall Study|Physician Decision|3|||
106170556|NCT04999111|366287208|FG002|Overall Study|Physician Decision|0|||
106170557|NCT04999111|366287209|FG003|Overall Study|Physician Decision|1|||
106170558|NCT04999111|366287210|FG004|Overall Study|Physician Decision|2|||
106170559|NCT04999111|366287211|FG005|Overall Study|Physician Decision|0|||
106170560|NCT04999111|366287206|FG000|Overall Study|Withdrawal by Subject|23|||
106170561|NCT04999111|366287207|FG001|Overall Study|Withdrawal by Subject|29|||
106170562|NCT04999111|366287208|FG002|Overall Study|Withdrawal by Subject|15|||
106170563|NCT04999111|366287209|FG003|Overall Study|Withdrawal by Subject|30|||
106170564|NCT04999111|366287210|FG004|Overall Study|Withdrawal by Subject|35|||
106170565|NCT04999111|366287211|FG005|Overall Study|Withdrawal by Subject|10|||
106170566|NCT04999111|366287206|FG000|Overall Study|Other|6|||
106170567|NCT04999111|366287207|FG001|Overall Study|Other|6|||
106170568|NCT04999111|366287208|FG002|Overall Study|Other|3|||
106170569|NCT04999111|366287209|FG003|Overall Study|Other|8|||
106170570|NCT04999111|366287210|FG004|Overall Study|Other|8|||
106170571|NCT04999111|366287211|FG005|Overall Study|Other|5|||
106170572|NCT04999111|366287206|FG000|Overall Study|Non-compliance with study schedule|1|||
106170573|NCT04999111|366287207|FG001|Overall Study|Non-compliance with study schedule|0|||
106170574|NCT04999111|366287208|FG002|Overall Study|Non-compliance with study schedule|0|||
106170575|NCT04999111|366287209|FG003|Overall Study|Non-compliance with study schedule|1|||
106170576|NCT04999111|366287210|FG004|Overall Study|Non-compliance with study schedule|1|||
106170577|NCT04999111|366287211|FG005|Overall Study|Non-compliance with study schedule|1|||
106170578|NCT04999111|366287206|FG000|Overall Study|Randomized but not vaccinated|1|||
106170579|NCT04999111|366287207|FG001|Overall Study|Randomized but not vaccinated|2|||
106170580|NCT04999111|366287208|FG002|Overall Study|Randomized but not vaccinated|0|||
106170581|NCT04999111|366287209|FG003|Overall Study|Randomized but not vaccinated|3|||
106170582|NCT04999111|366287210|FG004|Overall Study|Randomized but not vaccinated|3|||
106170583|NCT04999111|366287211|FG005|Overall Study|Randomized but not vaccinated|0|||
106170584|NCT04999111|366287206|FG000|Overall Study|Adverse Event|1|||
105867297|NCT03888066|365164935|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
105867298|NCT03888066|365164936|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
105867299|NCT03888066|365164935|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
105867300|NCT03888066|365164936|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
105867301|NCT03888066|365164935|FG000|Run-in Phase|Death|1|||
105867302|NCT03888066|365164936|FG001|Run-in Phase|Death|0|||
105867303|NCT03888066|365164935|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
105867304|NCT03888066|365164936|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
105867305|NCT03888066|365164935|FG000|Run-in Phase|Physician Decision|1|||
105867306|NCT03888066|365164936|FG001|Run-in Phase|Physician Decision|0|||
105867307|NCT03888066|365164935|FG000|Run-in Phase|Protocol Violation|13|||
105867308|NCT03888066|365164936|FG001|Run-in Phase|Protocol Violation|0|||
105867309|NCT03888066|365164935|FG000|Run-in Phase|Sponsor Request|34|||
105867310|NCT03888066|365164936|FG001|Run-in Phase|Sponsor Request|0|||
106170585|NCT04999111|366287207|FG001|Overall Study|Adverse Event|1|||
106170586|NCT04999111|366287208|FG002|Overall Study|Adverse Event|0|||
106170587|NCT04999111|366287209|FG003|Overall Study|Adverse Event|0|||
106170588|NCT04999111|366287210|FG004|Overall Study|Adverse Event|0|||
106170589|NCT04999111|366287211|FG005|Overall Study|Adverse Event|0|||
106170590|NCT04999111|366287206|FG000|Overall Study|Initiated prohibited medication|0|||
106170591|NCT04999111|366287207|FG001|Overall Study|Initiated prohibited medication|0|||
106170592|NCT04999111|366287208|FG002|Overall Study|Initiated prohibited medication|0|||
106170593|NCT04999111|366287209|FG003|Overall Study|Initiated prohibited medication|0|||
106170594|NCT04999111|366287210|FG004|Overall Study|Initiated prohibited medication|1|||
106170595|NCT04999111|366287211|FG005|Overall Study|Initiated prohibited medication|0|||
106170596|NCT04056611|366287213|FG000|Overall Study|Physician Decision|1|||
106170597|NCT03824366|366287223|FG000|Overall Study|Death|1|||
106170598|NCT03824366|366287223|FG000|Overall Study|Previously unidentified metal artifact|1|||
106170599|NCT03824366|366287223|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
106170600|NCT03824366|366287223|FG000|Overall Study|Withdrawal by Subject|1|||
106170601|NCT05962814|366287226|FG000|Overall Study|failed eligibility|1|||
106170602|NCT01627574|366288706|FG000|Overall Study|Withdrawal by Subject|8|||
106170603|NCT01627574|366288707|FG001|Overall Study|Withdrawal by Subject|5|||
106170604|NCT01627574|366288706|FG000|Overall Study|Lost to Follow-up|13|||
106170605|NCT01627574|366288707|FG001|Overall Study|Lost to Follow-up|13|||
106170606|NCT05218096|366288708|FG000|Primary Evaluation|Withdrawal by Subject|0|||
106170607|NCT05218096|366288709|FG001|Primary Evaluation|Withdrawal by Subject|0|||
106170608|NCT05218096|366288710|FG002|Primary Evaluation|Withdrawal by Subject|2|||
106170609|NCT05218096|366288711|FG003|Primary Evaluation|Withdrawal by Subject|0|||
106170610|NCT05218096|366288712|FG004|Primary Evaluation|Withdrawal by Subject|0|||
106170611|NCT05218096|366288708|FG000|Primary Evaluation|Physician Decision|1|||
106170612|NCT05218096|366288709|FG001|Primary Evaluation|Physician Decision|0|||
106170613|NCT05218096|366288710|FG002|Primary Evaluation|Physician Decision|0|||
106170614|NCT05218096|366288711|FG003|Primary Evaluation|Physician Decision|0|||
106170615|NCT05218096|366288712|FG004|Primary Evaluation|Physician Decision|0|||
106170616|NCT05218096|366288708|FG000|Extended Treatment|Clinical Deterioration|1|||
106170617|NCT05218096|366288709|FG001|Extended Treatment|Clinical Deterioration|1|||
106170618|NCT05218096|366288710|FG002|Extended Treatment|Clinical Deterioration|0|||
106170619|NCT05218096|366288711|FG003|Extended Treatment|Clinical Deterioration|0|||
106170620|NCT05218096|366288712|FG004|Extended Treatment|Clinical Deterioration|0|||
106170621|NCT05218096|366288708|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
106170622|NCT05218096|366288709|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
106170623|NCT05218096|366288710|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
106170624|NCT05218096|366288711|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
106170625|NCT05218096|366288712|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
106170626|NCT05218096|366288708|FG000|Extended Treatment|Withdrawal by Subject|1|||
106170627|NCT05218096|366288709|FG001|Extended Treatment|Withdrawal by Subject|3|||
106170628|NCT05218096|366288710|FG002|Extended Treatment|Withdrawal by Subject|0|||
106170629|NCT05218096|366288711|FG003|Extended Treatment|Withdrawal by Subject|2|||
106170630|NCT05218096|366288712|FG004|Extended Treatment|Withdrawal by Subject|2|||
106170631|NCT05218096|366288708|FG000|Extended Treatment|Lack of Efficacy|3|||
106170632|NCT05218096|366288709|FG001|Extended Treatment|Lack of Efficacy|0|||
106170633|NCT05218096|366288710|FG002|Extended Treatment|Lack of Efficacy|0|||
106170634|NCT05218096|366288711|FG003|Extended Treatment|Lack of Efficacy|0|||
106170635|NCT05218096|366288712|FG004|Extended Treatment|Lack of Efficacy|0|||
106170636|NCT05218096|366288708|FG000|Extended Treatment|Physician Decision|0|||
106170637|NCT05218096|366288709|FG001|Extended Treatment|Physician Decision|1|||
106170638|NCT05218096|366288710|FG002|Extended Treatment|Physician Decision|0|||
106170639|NCT05218096|366288711|FG003|Extended Treatment|Physician Decision|0|||
106170640|NCT05218096|366288712|FG004|Extended Treatment|Physician Decision|0|||
106170641|NCT05218096|366288708|FG000|Open-label Extension|Adverse Event|1|||
106170642|NCT05218096|366288709|FG001|Open-label Extension|Adverse Event|0|||
106170643|NCT05218096|366288710|FG002|Open-label Extension|Adverse Event|0|||
105867311|NCT03888066|365164935|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
106170644|NCT05218096|366288711|FG003|Open-label Extension|Adverse Event|0|||
106170645|NCT05218096|366288712|FG004|Open-label Extension|Adverse Event|1|||
106170646|NCT05218096|366288708|FG000|Open-label Extension|Pregnancy|0|||
106170647|NCT05218096|366288709|FG001|Open-label Extension|Pregnancy|0|||
106170648|NCT05218096|366288710|FG002|Open-label Extension|Pregnancy|0|||
106170649|NCT05218096|366288711|FG003|Open-label Extension|Pregnancy|0|||
106170650|NCT05218096|366288712|FG004|Open-label Extension|Pregnancy|1|||
106170651|NCT05218096|366288708|FG000|Open-label Extension|Lack of Efficacy|1|||
106170652|NCT05218096|366288709|FG001|Open-label Extension|Lack of Efficacy|2|||
106170653|NCT05218096|366288710|FG002|Open-label Extension|Lack of Efficacy|0|||
106170654|NCT05218096|366288711|FG003|Open-label Extension|Lack of Efficacy|0|||
106170655|NCT05218096|366288712|FG004|Open-label Extension|Lack of Efficacy|0|||
106170656|NCT05218096|366288708|FG000|Open-label Extension|Lost to Follow-up|1|||
106170657|NCT05218096|366288709|FG001|Open-label Extension|Lost to Follow-up|0|||
106170658|NCT05218096|366288710|FG002|Open-label Extension|Lost to Follow-up|0|||
106170659|NCT05218096|366288711|FG003|Open-label Extension|Lost to Follow-up|0|||
106170660|NCT05218096|366288712|FG004|Open-label Extension|Lost to Follow-up|0|||
106170661|NCT05218096|366288708|FG000|Open-label Extension|Death|0|||
106170662|NCT05218096|366288709|FG001|Open-label Extension|Death|0|||
106170663|NCT05218096|366288710|FG002|Open-label Extension|Death|0|||
106170664|NCT05218096|366288711|FG003|Open-label Extension|Death|1|||
106170665|NCT05218096|366288712|FG004|Open-label Extension|Death|0|||
106170666|NCT05218096|366288708|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
106170667|NCT05218096|366288709|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
106170668|NCT05218096|366288710|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
106170669|NCT05218096|366288711|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
106170670|NCT05218096|366288712|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
106170671|NCT01009788|366288718|FG000|Overall Study|Withdrawal by Subject|1|||
106170672|NCT01009788|366288719|FG001|Overall Study|Withdrawal by Subject|0|||
106170673|NCT02974621|366288724|FG000|Overall Study|Didn't receive study treatment|1|||
106170674|NCT02974621|366288725|FG001|Overall Study|Didn't receive study treatment|10|||
106170675|NCT01309672|366288726|FG000|Overall Study|Lack of Efficacy|20|||
106170676|NCT01309672|366288726|FG000|Overall Study|Other|9|||
106170677|NCT01309672|366288726|FG000|Overall Study|Adverse Event|5|||
106170678|NCT01309672|366288726|FG000|Overall Study|Withdrawal by Subject|3|||
106170679|NCT01254864|366288727|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
106170680|NCT01254864|366288728|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
106170681|NCT01254864|366288729|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
106170682|NCT01254864|366288727|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
106170683|NCT01254864|366288728|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
106170684|NCT01254864|366288729|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
106170685|NCT01254864|366288727|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
106170686|NCT01254864|366288728|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
106170687|NCT01254864|366288729|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
106170688|NCT01254864|366288727|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
106170689|NCT01254864|366288728|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
106170690|NCT01254864|366288729|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
106170691|NCT01254864|366288727|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
106170692|NCT01254864|366288728|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
106170693|NCT01254864|366288729|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
106170694|NCT01254864|366288727|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
106170695|NCT01254864|366288728|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
106170696|NCT01254864|366288729|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
106170697|NCT01254864|366288727|FG000|Randomization Phase|Adverse Event|0|||
106170698|NCT01254864|366288728|FG001|Randomization Phase|Adverse Event|5|||
106170699|NCT01254864|366288729|FG002|Randomization Phase|Adverse Event|17|||
106170700|NCT01254864|366288727|FG000|Randomization Phase|Death|0|||
106170701|NCT01254864|366288728|FG001|Randomization Phase|Death|1|||
106170702|NCT01254864|366288729|FG002|Randomization Phase|Death|0|||
106170703|NCT01254864|366288727|FG000|Randomization Phase|Lost to Follow-up|0|||
106170704|NCT01254864|366288728|FG001|Randomization Phase|Lost to Follow-up|0|||
106170705|NCT01254864|366288729|FG002|Randomization Phase|Lost to Follow-up|1|||
106170706|NCT01254864|366288727|FG000|Randomization Phase|Physician Decision|0|||
106170707|NCT01254864|366288728|FG001|Randomization Phase|Physician Decision|20|||
106170708|NCT01254864|366288729|FG002|Randomization Phase|Physician Decision|25|||
106170709|NCT01254864|366288727|FG000|Randomization Phase|Withdrawal by Subject|0|||
106170710|NCT01254864|366288728|FG001|Randomization Phase|Withdrawal by Subject|4|||
106170711|NCT01254864|366288729|FG002|Randomization Phase|Withdrawal by Subject|2|||
106170712|NCT01254864|366288727|FG000|Randomization Phase|Non-Compliance|0|||
106170713|NCT01254864|366288728|FG001|Randomization Phase|Non-Compliance|1|||
106170714|NCT01254864|366288729|FG002|Randomization Phase|Non-Compliance|0|||
106170715|NCT01254864|366288727|FG000|Randomization Phase|Comorbidities|0|||
106170716|NCT01254864|366288728|FG001|Randomization Phase|Comorbidities|2|||
106170717|NCT01254864|366288729|FG002|Randomization Phase|Comorbidities|1|||
106170718|NCT01828112|366288730|FG000|Treatment Phase|Adverse Event|7|||
106170719|NCT01828112|366288731|FG001|Treatment Phase|Adverse Event|8|||
106170720|NCT01828112|366288732|FG002|Treatment Phase|Adverse Event|0|||
106170721|NCT01828112|366288730|FG000|Treatment Phase|Death|9|||
106170722|NCT01828112|366288731|FG001|Treatment Phase|Death|5|||
106170723|NCT01828112|366288732|FG002|Treatment Phase|Death|0|||
106170724|NCT01828112|366288730|FG000|Treatment Phase|No longer required treatment|0|||
106170725|NCT01828112|366288731|FG001|Treatment Phase|No longer required treatment|1|||
106170726|NCT01828112|366288732|FG002|Treatment Phase|No longer required treatment|0|||
106170727|NCT01828112|366288730|FG000|Treatment Phase|Physician Decision|6|||
106170728|NCT01828112|366288731|FG001|Treatment Phase|Physician Decision|7|||
106170729|NCT01828112|366288732|FG002|Treatment Phase|Physician Decision|0|||
106170730|NCT01828112|366288730|FG000|Treatment Phase|Pregnancy|1|||
106170731|NCT01828112|366288731|FG001|Treatment Phase|Pregnancy|0|||
106170732|NCT01828112|366288732|FG002|Treatment Phase|Pregnancy|0|||
106170733|NCT01828112|366288730|FG000|Treatment Phase|Progressive disease|79|||
106170734|NCT01828112|366288731|FG001|Treatment Phase|Progressive disease|87|||
106170735|NCT01828112|366288732|FG002|Treatment Phase|Progressive disease|0|||
106170736|NCT01828112|366288730|FG000|Treatment Phase|Study terminated by sponsor|1|||
106170737|NCT01828112|366288731|FG001|Treatment Phase|Study terminated by sponsor|0|||
106170738|NCT01828112|366288732|FG002|Treatment Phase|Study terminated by sponsor|0|||
106170739|NCT01828112|366288730|FG000|Treatment Phase|Subject/guardian decision|12|||
106170740|NCT01828112|366288731|FG001|Treatment Phase|Subject/guardian decision|8|||
106170741|NCT01828112|366288732|FG002|Treatment Phase|Subject/guardian decision|0|||
106170742|NCT01828112|366288730|FG000|Extension Treatment Phase|Adverse Event|0|||
106170743|NCT01828112|366288731|FG001|Extension Treatment Phase|Adverse Event|0|||
106170744|NCT01828112|366288732|FG002|Extension Treatment Phase|Adverse Event|6|||
106170745|NCT01828112|366288730|FG000|Extension Treatment Phase|Death|0|||
106170746|NCT01828112|366288731|FG001|Extension Treatment Phase|Death|0|||
106170747|NCT01828112|366288732|FG002|Extension Treatment Phase|Death|17|||
106170748|NCT01828112|366288730|FG000|Extension Treatment Phase|Physician Decision|0|||
106170749|NCT01828112|366288731|FG001|Extension Treatment Phase|Physician Decision|0|||
106170750|NCT01828112|366288732|FG002|Extension Treatment Phase|Physician Decision|5|||
106170751|NCT01828112|366288730|FG000|Extension Treatment Phase|Progressive disease|0|||
106170752|NCT01828112|366288731|FG001|Extension Treatment Phase|Progressive disease|0|||
106170753|NCT01828112|366288732|FG002|Extension Treatment Phase|Progressive disease|46|||
106170754|NCT01828112|366288730|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
106170755|NCT01828112|366288731|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
106170756|NCT01828112|366288732|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
106170757|NCT01828112|366288730|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
106170758|NCT01828112|366288731|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
106170759|NCT01828112|366288732|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
106170760|NCT05267470|366288738|FG000|Overall Study|Decision by sponsor|0|||
106170761|NCT05267470|366288739|FG001|Overall Study|Decision by sponsor|3|||
106170762|NCT05267470|366288740|FG002|Overall Study|Decision by sponsor|19|||
106170763|NCT05267470|366288741|FG003|Overall Study|Decision by sponsor|7|||
106170764|NCT05267470|366288742|FG004|Overall Study|Decision by sponsor|3|||
106170765|NCT05267470|366288738|FG000|Overall Study|Withdrawal by Subject|1|||
106170766|NCT05267470|366288739|FG001|Overall Study|Withdrawal by Subject|1|||
106170767|NCT05267470|366288740|FG002|Overall Study|Withdrawal by Subject|2|||
106170768|NCT05267470|366288741|FG003|Overall Study|Withdrawal by Subject|2|||
106170769|NCT05267470|366288742|FG004|Overall Study|Withdrawal by Subject|0|||
106170770|NCT05267470|366288738|FG000|Overall Study|Death|3|||
106170771|NCT05267470|366288739|FG001|Overall Study|Death|5|||
106170772|NCT05267470|366288740|FG002|Overall Study|Death|8|||
106170773|NCT05267470|366288741|FG003|Overall Study|Death|18|||
106170774|NCT05267470|366288742|FG004|Overall Study|Death|1|||
106170775|NCT05267470|366288738|FG000|Overall Study|Lost to Follow-up|0|||
106170776|NCT05267470|366288739|FG001|Overall Study|Lost to Follow-up|0|||
106170777|NCT05267470|366288740|FG002|Overall Study|Lost to Follow-up|0|||
106170778|NCT05267470|366288741|FG003|Overall Study|Lost to Follow-up|1|||
106170779|NCT05267470|366288742|FG004|Overall Study|Lost to Follow-up|0|||
106170780|NCT05290493|366288743|FG000|Overall Study|Withdrawal by Subject|2|||
106170781|NCT05290493|366288744|FG001|Overall Study|Withdrawal by Subject|2|||
106170782|NCT05290493|366288743|FG000|Overall Study|Adverse Event|1|||
106170783|NCT05290493|366288744|FG001|Overall Study|Adverse Event|0|||
106170784|NCT03677141|366288753|FG000|Overall Study|Death|2|||
106170785|NCT03677141|366288754|FG001|Overall Study|Death|1|||
106170786|NCT03677141|366288755|FG002|Overall Study|Death|6|||
106170787|NCT03677141|366288756|FG003|Overall Study|Death|9|||
106170788|NCT03677141|366288757|FG004|Overall Study|Death|5|||
106170789|NCT03677141|366288758|FG005|Overall Study|Death|3|||
106170790|NCT03677141|366288753|FG000|Overall Study|Lost to Follow-up|0|||
106170791|NCT03677141|366288754|FG001|Overall Study|Lost to Follow-up|0|||
106170792|NCT03677141|366288755|FG002|Overall Study|Lost to Follow-up|0|||
106170793|NCT03677141|366288756|FG003|Overall Study|Lost to Follow-up|2|||
106170794|NCT03677141|366288757|FG004|Overall Study|Lost to Follow-up|0|||
106170795|NCT03677141|366288758|FG005|Overall Study|Lost to Follow-up|0|||
106170796|NCT03677141|366288753|FG000|Overall Study|Screen failure or enrolled in error|0|||
106170797|NCT03677141|366288754|FG001|Overall Study|Screen failure or enrolled in error|0|||
106170798|NCT03677141|366288755|FG002|Overall Study|Screen failure or enrolled in error|0|||
106170799|NCT03677141|366288756|FG003|Overall Study|Screen failure or enrolled in error|0|||
106170800|NCT03677141|366288757|FG004|Overall Study|Screen failure or enrolled in error|2|||
106170801|NCT03677141|366288758|FG005|Overall Study|Screen failure or enrolled in error|0|||
106170802|NCT03677141|366288753|FG000|Overall Study|Physician Decision|0|||
106170803|NCT03677141|366288754|FG001|Overall Study|Physician Decision|0|||
106170804|NCT03677141|366288755|FG002|Overall Study|Physician Decision|0|||
106170805|NCT03677141|366288756|FG003|Overall Study|Physician Decision|0|||
106170806|NCT03677141|366288757|FG004|Overall Study|Physician Decision|1|||
106170807|NCT03677141|366288758|FG005|Overall Study|Physician Decision|0|||
106170808|NCT03677141|366288753|FG000|Overall Study|Withdrawal by Subject|0|||
106170809|NCT03677141|366288754|FG001|Overall Study|Withdrawal by Subject|0|||
106170810|NCT03677141|366288755|FG002|Overall Study|Withdrawal by Subject|1|||
106170811|NCT03677141|366288756|FG003|Overall Study|Withdrawal by Subject|1|||
106170812|NCT03677141|366288757|FG004|Overall Study|Withdrawal by Subject|1|||
106170813|NCT03677141|366288758|FG005|Overall Study|Withdrawal by Subject|0|||
106170814|NCT04132518|366288769|FG000|Overall Study|Prematurely withdrawn from the study|0|||
106170815|NCT04132518|366288770|FG001|Overall Study|Prematurely withdrawn from the study|9|||
106170816|NCT04132518|366288771|FG002|Overall Study|Prematurely withdrawn from the study|1|||
106170817|NCT02361216|366288772|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
106170818|NCT02361216|366288773|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
106170819|NCT02361216|366288772|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
106170820|NCT02361216|366288773|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
106170821|NCT02361216|366288772|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
106170822|NCT02361216|366288773|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
106170823|NCT02361216|366288772|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
106170824|NCT02361216|366288773|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
106170825|NCT02361216|366288772|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
106170826|NCT02361216|366288773|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
106170827|NCT02361216|366288772|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
106170828|NCT02361216|366288773|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
106170829|NCT04709419|366288774|FG000|Overall Study|Physician Decision|1|||
106170830|NCT04709419|366288775|FG001|Overall Study|Physician Decision|0|||
106170831|NCT05683340|366288776|FG000|Overall Study|Adverse Event|1|||
106170832|NCT05683340|366288777|FG001|Overall Study|Adverse Event|1|||
106170833|NCT05683340|366288776|FG000|Overall Study|Protocol Violation|1|||
106170834|NCT05683340|366288777|FG001|Overall Study|Protocol Violation|0|||
106170835|NCT05683340|366288776|FG000|Overall Study|Withdrawal by Subject|0|||
106170836|NCT05683340|366288777|FG001|Overall Study|Withdrawal by Subject|2|||
106170837|NCT02224144|366288781|FG000|Overall Study|Lost to Follow-up|3|||
106170838|NCT02224144|366288782|FG001|Overall Study|Lost to Follow-up|1|||
106170839|NCT02224144|366288781|FG000|Overall Study|Death|2|||
106170840|NCT02224144|366288782|FG001|Overall Study|Death|0|||
106170841|NCT02224144|366288781|FG000|Overall Study|Withdrawal by Subject|0|||
106170842|NCT02224144|366288782|FG001|Overall Study|Withdrawal by Subject|1|||
106170843|NCT03505008|366288783|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
106170844|NCT03505008|366288784|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
106170845|NCT03505008|366288785|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
106170846|NCT03505008|366288786|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
106170847|NCT03505008|366288783|FG000|Before Week 24 Randomization|Adverse Event|10|||
106170848|NCT03505008|366288784|FG001|Before Week 24 Randomization|Adverse Event|0|||
106170849|NCT03505008|366288785|FG002|Before Week 24 Randomization|Adverse Event|0|||
106170850|NCT03505008|366288786|FG003|Before Week 24 Randomization|Adverse Event|0|||
106170851|NCT03505008|366288783|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
105867312|NCT03888066|365164936|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
105867313|NCT03888066|365164935|FG000|Run-in Phase|Withdrawal Of Consent|1|||
105867314|NCT03888066|365164936|FG001|Run-in Phase|Withdrawal Of Consent|0|||
105867315|NCT03888066|365164935|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
106170852|NCT03505008|366288784|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
106170853|NCT03505008|366288785|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
106170854|NCT03505008|366288786|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
106170855|NCT03505008|366288783|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
106170856|NCT03505008|366288784|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
106170857|NCT03505008|366288785|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
106170858|NCT03505008|366288786|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
106170859|NCT03505008|366288783|FG000|Before Week 24 Randomization|Physician Decision|2|||
106170860|NCT03505008|366288784|FG001|Before Week 24 Randomization|Physician Decision|0|||
106170861|NCT03505008|366288785|FG002|Before Week 24 Randomization|Physician Decision|0|||
106170862|NCT03505008|366288786|FG003|Before Week 24 Randomization|Physician Decision|0|||
106170863|NCT03505008|366288783|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
106170864|NCT03505008|366288784|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
106170865|NCT03505008|366288785|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
106170866|NCT03505008|366288786|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
106170867|NCT03505008|366288783|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
106170868|NCT03505008|366288784|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
106170869|NCT03505008|366288785|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
106170870|NCT03505008|366288786|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
106170871|NCT03505008|366288783|FG000|Before Week 24 Randomization|Complication|1|||
106170872|NCT03505008|366288784|FG001|Before Week 24 Randomization|Complication|0|||
106170873|NCT03505008|366288785|FG002|Before Week 24 Randomization|Complication|0|||
106170874|NCT03505008|366288786|FG003|Before Week 24 Randomization|Complication|0|||
106170875|NCT03505008|366288783|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
106170876|NCT03505008|366288784|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
106170877|NCT03505008|366288785|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
106170878|NCT03505008|366288786|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
106170879|NCT03505008|366288783|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
106170880|NCT03505008|366288784|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
106170881|NCT03505008|366288785|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
106170882|NCT03505008|366288786|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
106170883|NCT03505008|366288783|FG000|After Week 24 Randomization|Adverse Event|0|||
106170884|NCT03505008|366288784|FG001|After Week 24 Randomization|Adverse Event|1|||
106170885|NCT03505008|366288785|FG002|After Week 24 Randomization|Adverse Event|2|||
106170886|NCT03505008|366288786|FG003|After Week 24 Randomization|Adverse Event|2|||
106170887|NCT03505008|366288783|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
106170888|NCT03505008|366288784|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
106170889|NCT03505008|366288785|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
106170890|NCT03505008|366288786|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
106170891|NCT03505008|366288783|FG000|After Week 24 Randomization|Protocol Violation|0|||
106170892|NCT03505008|366288784|FG001|After Week 24 Randomization|Protocol Violation|0|||
106170893|NCT03505008|366288785|FG002|After Week 24 Randomization|Protocol Violation|1|||
106170894|NCT03505008|366288786|FG003|After Week 24 Randomization|Protocol Violation|0|||
106170895|NCT02437136|366288787|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
106170896|NCT02437136|366288788|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
106170897|NCT02437136|366288789|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
106170898|NCT02437136|366288790|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
106170899|NCT02437136|366288791|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
106170900|NCT02437136|366288792|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
106170901|NCT02437136|366288793|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
106170902|NCT02437136|366288787|FG000|Expansion (Phase 2)|Death|0|||
106170903|NCT02437136|366288788|FG001|Expansion (Phase 2)|Death|0|||
106170904|NCT02437136|366288789|FG002|Expansion (Phase 2)|Death|0|||
106170905|NCT02437136|366288790|FG003|Expansion (Phase 2)|Death|6|||
106170906|NCT02437136|366288791|FG004|Expansion (Phase 2)|Death|37|||
106170907|NCT02437136|366288792|FG005|Expansion (Phase 2)|Death|29|||
106170908|NCT02437136|366288793|FG006|Expansion (Phase 2)|Death|24|||
106170909|NCT02437136|366288787|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
106170910|NCT02437136|366288788|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
106170911|NCT02437136|366288789|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
106170912|NCT02437136|366288790|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
106170913|NCT02437136|366288791|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
106170914|NCT02437136|366288792|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
106170915|NCT02437136|366288793|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
106170916|NCT02437136|366288787|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
106170917|NCT02437136|366288788|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
106170918|NCT02437136|366288789|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
106170919|NCT02437136|366288790|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
106170920|NCT02437136|366288791|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
106170921|NCT02437136|366288792|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
106170922|NCT02437136|366288793|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
106170923|NCT02056834|366288794|FG000|Overall Study|Lost to Follow-up|7|||
106170924|NCT03156465|366288804|FG000|Overall Study|Withdrawal by Subject|2|||
106170925|NCT05524116|366288805|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
106170926|NCT05524116|366288806|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
106170927|NCT05524116|366288805|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
106170928|NCT05524116|366288806|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
106170929|NCT05524116|366288805|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
106170930|NCT05524116|366288806|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
106170931|NCT05524116|366288805|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
106170932|NCT05524116|366288806|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
106170933|NCT05524116|366288805|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
106170934|NCT05524116|366288806|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
106170935|NCT03580356|366288817|FG000|Treatment Period|Withdrawal by Subject|13|||
106170936|NCT03580356|366288818|FG001|Treatment Period|Withdrawal by Subject|0|||
106170937|NCT03580356|366288819|FG002|Treatment Period|Withdrawal by Subject|13|||
106170938|NCT03580356|366288820|FG003|Treatment Period|Withdrawal by Subject|1|||
106170939|NCT03580356|366288821|FG004|Treatment Period|Withdrawal by Subject|17|||
106170940|NCT03580356|366288822|FG005|Treatment Period|Withdrawal by Subject|0|||
106170941|NCT03580356|366288823|FG006|Treatment Period|Withdrawal by Subject|5|||
106170942|NCT03580356|366288824|FG007|Treatment Period|Withdrawal by Subject|0|||
106170943|NCT03580356|366288817|FG000|Treatment Period|Adverse Event|10|||
106170944|NCT03580356|366288818|FG001|Treatment Period|Adverse Event|0|||
106170945|NCT03580356|366288819|FG002|Treatment Period|Adverse Event|13|||
106170946|NCT03580356|366288820|FG003|Treatment Period|Adverse Event|0|||
106170947|NCT03580356|366288821|FG004|Treatment Period|Adverse Event|5|||
106170948|NCT03580356|366288822|FG005|Treatment Period|Adverse Event|0|||
106170949|NCT03580356|366288823|FG006|Treatment Period|Adverse Event|8|||
106170950|NCT03580356|366288824|FG007|Treatment Period|Adverse Event|0|||
106170951|NCT03580356|366288817|FG000|Treatment Period|Protocol Violation|5|||
106170952|NCT03580356|366288818|FG001|Treatment Period|Protocol Violation|0|||
106170953|NCT03580356|366288819|FG002|Treatment Period|Protocol Violation|6|||
106170954|NCT03580356|366288820|FG003|Treatment Period|Protocol Violation|1|||
106170955|NCT03580356|366288821|FG004|Treatment Period|Protocol Violation|9|||
106170956|NCT03580356|366288822|FG005|Treatment Period|Protocol Violation|1|||
106170957|NCT03580356|366288823|FG006|Treatment Period|Protocol Violation|1|||
106170958|NCT03580356|366288824|FG007|Treatment Period|Protocol Violation|0|||
106170959|NCT03580356|366288817|FG000|Treatment Period|Lack of Efficacy|6|||
106170960|NCT03580356|366288818|FG001|Treatment Period|Lack of Efficacy|0|||
106170961|NCT03580356|366288819|FG002|Treatment Period|Lack of Efficacy|2|||
106170962|NCT03580356|366288820|FG003|Treatment Period|Lack of Efficacy|0|||
106170963|NCT03580356|366288821|FG004|Treatment Period|Lack of Efficacy|3|||
106170964|NCT03580356|366288822|FG005|Treatment Period|Lack of Efficacy|0|||
106170965|NCT03580356|366288823|FG006|Treatment Period|Lack of Efficacy|3|||
106170966|NCT03580356|366288824|FG007|Treatment Period|Lack of Efficacy|0|||
106170967|NCT03580356|366288817|FG000|Treatment Period|Pregnancy|1|||
106170968|NCT03580356|366288818|FG001|Treatment Period|Pregnancy|0|||
106170969|NCT03580356|366288819|FG002|Treatment Period|Pregnancy|7|||
106170970|NCT03580356|366288820|FG003|Treatment Period|Pregnancy|0|||
106170971|NCT03580356|366288821|FG004|Treatment Period|Pregnancy|2|||
106170972|NCT03580356|366288822|FG005|Treatment Period|Pregnancy|0|||
106170973|NCT03580356|366288823|FG006|Treatment Period|Pregnancy|1|||
106170974|NCT03580356|366288824|FG007|Treatment Period|Pregnancy|0|||
106170975|NCT03580356|366288817|FG000|Treatment Period|Physician Decision|2|||
106170976|NCT03580356|366288818|FG001|Treatment Period|Physician Decision|0|||
106170977|NCT03580356|366288819|FG002|Treatment Period|Physician Decision|1|||
106170978|NCT03580356|366288820|FG003|Treatment Period|Physician Decision|0|||
106170979|NCT03580356|366288821|FG004|Treatment Period|Physician Decision|4|||
106170980|NCT03580356|366288822|FG005|Treatment Period|Physician Decision|0|||
106170981|NCT03580356|366288823|FG006|Treatment Period|Physician Decision|2|||
106170982|NCT03580356|366288824|FG007|Treatment Period|Physician Decision|0|||
106170983|NCT03580356|366288817|FG000|Treatment Period|Lost to Follow-up|1|||
106170984|NCT03580356|366288818|FG001|Treatment Period|Lost to Follow-up|1|||
106170985|NCT03580356|366288819|FG002|Treatment Period|Lost to Follow-up|1|||
106170986|NCT03580356|366288820|FG003|Treatment Period|Lost to Follow-up|0|||
106170987|NCT03580356|366288821|FG004|Treatment Period|Lost to Follow-up|3|||
106170988|NCT03580356|366288822|FG005|Treatment Period|Lost to Follow-up|0|||
106170989|NCT03580356|366288823|FG006|Treatment Period|Lost to Follow-up|1|||
106170990|NCT03580356|366288824|FG007|Treatment Period|Lost to Follow-up|0|||
106170991|NCT03580356|366288817|FG000|Treatment Period|Death|0|||
106170992|NCT03580356|366288818|FG001|Treatment Period|Death|0|||
106170993|NCT03580356|366288819|FG002|Treatment Period|Death|1|||
106170994|NCT03580356|366288820|FG003|Treatment Period|Death|0|||
106170995|NCT03580356|366288821|FG004|Treatment Period|Death|0|||
106170996|NCT03580356|366288822|FG005|Treatment Period|Death|0|||
106170997|NCT03580356|366288823|FG006|Treatment Period|Death|0|||
106170998|NCT03580356|366288824|FG007|Treatment Period|Death|0|||
106170999|NCT03580356|366288817|FG000|Treatment Period|Technical problems|0|||
106171000|NCT03580356|366288818|FG001|Treatment Period|Technical problems|0|||
106171001|NCT03580356|366288819|FG002|Treatment Period|Technical problems|0|||
106171002|NCT03580356|366288820|FG003|Treatment Period|Technical problems|0|||
106171003|NCT03580356|366288821|FG004|Treatment Period|Technical problems|1|||
106171004|NCT03580356|366288822|FG005|Treatment Period|Technical problems|0|||
106171005|NCT03580356|366288823|FG006|Treatment Period|Technical problems|0|||
106171006|NCT03580356|366288824|FG007|Treatment Period|Technical problems|0|||
106171007|NCT03580356|366288817|FG000|Treatment Period|Misrandomized, no treatment|0|||
106171008|NCT03580356|366288818|FG001|Treatment Period|Misrandomized, no treatment|0|||
106171009|NCT03580356|366288819|FG002|Treatment Period|Misrandomized, no treatment|1|||
106171010|NCT03580356|366288820|FG003|Treatment Period|Misrandomized, no treatment|0|||
106171011|NCT03580356|366288821|FG004|Treatment Period|Misrandomized, no treatment|2|||
106171012|NCT03580356|366288822|FG005|Treatment Period|Misrandomized, no treatment|0|||
106171013|NCT03580356|366288823|FG006|Treatment Period|Misrandomized, no treatment|0|||
106171014|NCT03580356|366288824|FG007|Treatment Period|Misrandomized, no treatment|0|||
106171015|NCT03580356|366288817|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
106171016|NCT03580356|366288818|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
106171017|NCT03580356|366288819|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
106171018|NCT03580356|366288820|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
106171019|NCT03580356|366288821|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
106171020|NCT03580356|366288822|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
106171021|NCT03580356|366288823|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
106171022|NCT03580356|366288824|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
106171023|NCT03580356|366288817|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
106171024|NCT03580356|366288818|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
106171025|NCT03580356|366288819|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
106171026|NCT03580356|366288820|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
106171027|NCT03580356|366288821|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
106171028|NCT03580356|366288822|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
106171029|NCT03580356|366288823|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
106171030|NCT03580356|366288824|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
106171031|NCT03580356|366288817|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
106171032|NCT03580356|366288818|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
106171033|NCT03580356|366288819|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
106171034|NCT03580356|366288820|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
106171035|NCT03580356|366288821|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
106171036|NCT03580356|366288822|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
106171037|NCT03580356|366288823|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
106171038|NCT03580356|366288824|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
106171039|NCT03580356|366288817|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
106171040|NCT03580356|366288818|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
106171041|NCT03580356|366288819|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
106171042|NCT03580356|366288820|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
106171043|NCT03580356|366288821|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
106171044|NCT03580356|366288822|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
106171045|NCT03580356|366288823|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
106171046|NCT03580356|366288824|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
106171047|NCT03580356|366288817|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
106171048|NCT03580356|366288818|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
106171049|NCT03580356|366288819|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
106171050|NCT03580356|366288820|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
106171051|NCT03580356|366288821|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
106171052|NCT03580356|366288822|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
106171053|NCT03580356|366288823|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
106171054|NCT03580356|366288824|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
106171055|NCT03580356|366288817|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
106171056|NCT03580356|366288818|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
106171057|NCT03580356|366288819|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
106171058|NCT03580356|366288820|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
106171059|NCT03580356|366288821|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
106171060|NCT03580356|366288822|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
105867316|NCT03888066|365164936|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
106171061|NCT03580356|366288823|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
106171062|NCT03580356|366288824|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
106171063|NCT03580356|366288817|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
106171064|NCT03580356|366288818|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
106171065|NCT03580356|366288819|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
106171066|NCT03580356|366288820|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
106171067|NCT03580356|366288821|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
106171068|NCT03580356|366288822|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
106171069|NCT03580356|366288823|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
106171070|NCT03580356|366288824|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
106171071|NCT05715528|366288826|FG000|Overall Study|Randomized but never treated|11|||
106171072|NCT05715528|366288827|FG001|Overall Study|Randomized but never treated|13|||
106171073|NCT05715528|366288826|FG000|Overall Study|Withdrew consent|7|||
106171074|NCT05715528|366288827|FG001|Overall Study|Withdrew consent|15|||
106171075|NCT05715528|366288826|FG000|Overall Study|Lost to Follow-up|5|||
106171076|NCT05715528|366288827|FG001|Overall Study|Lost to Follow-up|13|||
106171077|NCT05715528|366288826|FG000|Overall Study|Investigator's discretion|3|||
106171078|NCT05715528|366288827|FG001|Overall Study|Investigator's discretion|1|||
106171079|NCT05715528|366288826|FG000|Overall Study|Protocol Violation|2|||
106171080|NCT05715528|366288827|FG001|Overall Study|Protocol Violation|0|||
106171081|NCT05715528|366288826|FG000|Overall Study|Non-compliance with study drug|0|||
106171082|NCT05715528|366288827|FG001|Overall Study|Non-compliance with study drug|1|||
106171083|NCT03118518|366288828|FG000|Overall Study|Early Exit after treatment|2|||
106171084|NCT03118518|366288829|FG001|Overall Study|Early Exit after treatment|8|||
106171085|NCT03118518|366288828|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
106171086|NCT03118518|366288829|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
106171087|NCT04544007|366288833|FG000|Overall Study|Withdrawal by Subject|1|||
106171088|NCT04544007|366288833|FG000|Overall Study|Confirmed Progressive Disease|1|||
106171089|NCT04456296|366288841|FG000|Overall Study|Withdrawal by Subject|14|||
106171090|NCT04456296|366288842|FG001|Overall Study|Withdrawal by Subject|21|||
106171091|NCT04456296|366288843|FG002|Overall Study|Withdrawal by Subject|21|||
106171092|NCT04456296|366288841|FG000|Overall Study|Adverse Event|2|||
106171093|NCT04456296|366288842|FG001|Overall Study|Adverse Event|2|||
106171094|NCT04456296|366288843|FG002|Overall Study|Adverse Event|2|||
106171095|NCT04456296|366288841|FG000|Overall Study|Death|1|||
106171096|NCT04456296|366288842|FG001|Overall Study|Death|0|||
106171097|NCT04456296|366288843|FG002|Overall Study|Death|0|||
106171098|NCT04456296|366288841|FG000|Overall Study|Lost to Follow-up|3|||
106171099|NCT04456296|366288842|FG001|Overall Study|Lost to Follow-up|5|||
106171100|NCT04456296|366288843|FG002|Overall Study|Lost to Follow-up|6|||
106171101|NCT04456296|366288841|FG000|Overall Study|Other than specified|0|||
106171102|NCT04456296|366288842|FG001|Overall Study|Other than specified|1|||
106171103|NCT04456296|366288843|FG002|Overall Study|Other than specified|4|||
106171104|NCT04456296|366288841|FG000|Overall Study|Randomized, not treated|2|||
106171105|NCT04456296|366288842|FG001|Overall Study|Randomized, not treated|1|||
106171106|NCT04456296|366288843|FG002|Overall Study|Randomized, not treated|0|||
106171107|NCT05736458|366288844|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
106171108|NCT05736458|366288845|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
106171109|NCT05736458|366288846|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
106171110|NCT05736458|366288844|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
106171111|NCT05736458|366288845|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
106171112|NCT05736458|366288846|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
106171113|NCT05736458|366288844|FG000|TMS/fMRI #1|Physician Decision|0|||
106171114|NCT05736458|366288845|FG001|TMS/fMRI #1|Physician Decision|0|||
106171115|NCT05736458|366288846|FG002|TMS/fMRI #1|Physician Decision|2|||
106171116|NCT05736458|366288844|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
106171117|NCT05736458|366288845|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
106171118|NCT05736458|366288846|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
106171119|NCT04247802|366288851|FG000|Overall Study|Withdrawal by Subject|1|||
106171120|NCT04247802|366288852|FG001|Overall Study|Withdrawal by Subject|3|||
106171121|NCT04247802|366288851|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
106171122|NCT04247802|366288852|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
106171123|NCT04629339|366288853|FG000|Overall Study|Death|1|||
106171124|NCT04629339|366288854|FG001|Overall Study|Death|0|||
106171125|NCT04629339|366288855|FG002|Overall Study|Death|2|||
106171126|NCT04629339|366288856|FG003|Overall Study|Death|2|||
106171127|NCT04629339|366288857|FG004|Overall Study|Death|0|||
106171128|NCT04629339|366288853|FG000|Overall Study|Disease Progression|0|||
106171129|NCT04629339|366288854|FG001|Overall Study|Disease Progression|0|||
106171130|NCT04629339|366288855|FG002|Overall Study|Disease Progression|1|||
106171131|NCT04629339|366288856|FG003|Overall Study|Disease Progression|1|||
106171132|NCT04629339|366288857|FG004|Overall Study|Disease Progression|0|||
106171133|NCT04629339|366288853|FG000|Overall Study|Lost to Follow-up|0|||
106171134|NCT04629339|366288854|FG001|Overall Study|Lost to Follow-up|0|||
106171135|NCT04629339|366288855|FG002|Overall Study|Lost to Follow-up|0|||
106171136|NCT04629339|366288856|FG003|Overall Study|Lost to Follow-up|1|||
106171137|NCT04629339|366288857|FG004|Overall Study|Lost to Follow-up|0|||
106171138|NCT04629339|366288853|FG000|Overall Study|Physician Decision|0|||
106171139|NCT04629339|366288854|FG001|Overall Study|Physician Decision|1|||
106171140|NCT04629339|366288855|FG002|Overall Study|Physician Decision|0|||
106171141|NCT04629339|366288856|FG003|Overall Study|Physician Decision|0|||
106171142|NCT04629339|366288857|FG004|Overall Study|Physician Decision|0|||
106171143|NCT04629339|366288853|FG000|Overall Study|Study Terminated by Sponsor|0|||
106171144|NCT04629339|366288854|FG001|Overall Study|Study Terminated by Sponsor|0|||
106171145|NCT04629339|366288855|FG002|Overall Study|Study Terminated by Sponsor|0|||
106171146|NCT04629339|366288856|FG003|Overall Study|Study Terminated by Sponsor|1|||
106171147|NCT04629339|366288857|FG004|Overall Study|Study Terminated by Sponsor|0|||
106171148|NCT04629339|366288853|FG000|Overall Study|Withdrawal by Subject|0|||
106171149|NCT04629339|366288854|FG001|Overall Study|Withdrawal by Subject|0|||
106171150|NCT04629339|366288855|FG002|Overall Study|Withdrawal by Subject|2|||
106171151|NCT04629339|366288856|FG003|Overall Study|Withdrawal by Subject|2|||
106171152|NCT04629339|366288857|FG004|Overall Study|Withdrawal by Subject|0|||
106171153|NCT02052882|366290616|FG000|Overall Study|Not treated|11|||
106171154|NCT02052882|366290616|FG000|Overall Study|Protocol Violation|1|||
106171155|NCT02052882|366290616|FG000|Overall Study|Inadequate testing|1|||
106171156|NCT03389802|366290620|FG000|Overall Study|Lack of Efficacy|3|||
106171157|NCT03389802|366290621|FG001|Overall Study|Lack of Efficacy|3|||
106171158|NCT03389802|366290622|FG002|Overall Study|Lack of Efficacy|13|||
106171159|NCT03389802|366290623|FG003|Overall Study|Lack of Efficacy|6|||
106171160|NCT03389802|366290624|FG004|Overall Study|Lack of Efficacy|1|||
106171161|NCT03389802|366290620|FG000|Overall Study|Adverse Event|0|||
106171162|NCT03389802|366290621|FG001|Overall Study|Adverse Event|0|||
106171163|NCT03389802|366290622|FG002|Overall Study|Adverse Event|1|||
106171164|NCT03389802|366290623|FG003|Overall Study|Adverse Event|0|||
106171165|NCT03389802|366290624|FG004|Overall Study|Adverse Event|4|||
106171166|NCT03389802|366290620|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
106171167|NCT03389802|366290621|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
106171168|NCT03389802|366290622|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
106171169|NCT03389802|366290623|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
106171170|NCT03389802|366290624|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
106171171|NCT02240238|366290627|FG000|Phase 1|Adverse Event|0|||
106171172|NCT02240238|366290628|FG001|Phase 1|Adverse Event|0|||
106171173|NCT02240238|366290629|FG002|Phase 1|Adverse Event|0|||
106171174|NCT02240238|366290630|FG003|Phase 1|Adverse Event|0|||
106171175|NCT02240238|366290631|FG004|Phase 1|Adverse Event|0|||
106171176|NCT02240238|366290632|FG005|Phase 1|Adverse Event|0|||
106171177|NCT02240238|366290633|FG006|Phase 1|Adverse Event|3|||
106171178|NCT02240238|366290634|FG007|Phase 1|Adverse Event|1|||
106171179|NCT02240238|366290635|FG008|Phase 1|Adverse Event|0|||
106171180|NCT02240238|366290636|FG009|Phase 1|Adverse Event|0|||
106171181|NCT02240238|366290637|FG010|Phase 1|Adverse Event|0|||
106171182|NCT02240238|366290638|FG011|Phase 1|Adverse Event|0|||
106171183|NCT02240238|366290627|FG000|Phase 1|Death|0|||
106171184|NCT02240238|366290628|FG001|Phase 1|Death|0|||
106171185|NCT02240238|366290629|FG002|Phase 1|Death|0|||
106171186|NCT02240238|366290630|FG003|Phase 1|Death|0|||
106171187|NCT02240238|366290631|FG004|Phase 1|Death|0|||
106171188|NCT02240238|366290632|FG005|Phase 1|Death|1|||
106171189|NCT02240238|366290633|FG006|Phase 1|Death|0|||
106171190|NCT02240238|366290634|FG007|Phase 1|Death|0|||
106171191|NCT02240238|366290635|FG008|Phase 1|Death|0|||
106171192|NCT02240238|366290636|FG009|Phase 1|Death|0|||
106171193|NCT02240238|366290637|FG010|Phase 1|Death|0|||
106171194|NCT02240238|366290638|FG011|Phase 1|Death|0|||
106171195|NCT02240238|366290627|FG000|Phase 1|Sponsor termination|0|||
106171196|NCT02240238|366290628|FG001|Phase 1|Sponsor termination|0|||
106171197|NCT02240238|366290629|FG002|Phase 1|Sponsor termination|0|||
106171198|NCT02240238|366290630|FG003|Phase 1|Sponsor termination|0|||
106171199|NCT02240238|366290631|FG004|Phase 1|Sponsor termination|0|||
106171200|NCT02240238|366290632|FG005|Phase 1|Sponsor termination|1|||
106171201|NCT02240238|366290633|FG006|Phase 1|Sponsor termination|0|||
106171202|NCT02240238|366290634|FG007|Phase 1|Sponsor termination|0|||
106171203|NCT02240238|366290635|FG008|Phase 1|Sponsor termination|0|||
106171204|NCT02240238|366290636|FG009|Phase 1|Sponsor termination|0|||
106171205|NCT02240238|366290637|FG010|Phase 1|Sponsor termination|0|||
106171206|NCT02240238|366290638|FG011|Phase 1|Sponsor termination|0|||
106171207|NCT02240238|366290627|FG000|Phase 1|Withdrawal by Subject|0|||
106171208|NCT02240238|366290628|FG001|Phase 1|Withdrawal by Subject|0|||
105867317|NCT03888066|365164935|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
106171209|NCT02240238|366290629|FG002|Phase 1|Withdrawal by Subject|0|||
106171210|NCT02240238|366290630|FG003|Phase 1|Withdrawal by Subject|0|||
106171211|NCT02240238|366290631|FG004|Phase 1|Withdrawal by Subject|0|||
106171212|NCT02240238|366290632|FG005|Phase 1|Withdrawal by Subject|2|||
106171213|NCT02240238|366290633|FG006|Phase 1|Withdrawal by Subject|0|||
106171214|NCT02240238|366290634|FG007|Phase 1|Withdrawal by Subject|0|||
106171215|NCT02240238|366290635|FG008|Phase 1|Withdrawal by Subject|0|||
106171216|NCT02240238|366290636|FG009|Phase 1|Withdrawal by Subject|0|||
106171217|NCT02240238|366290637|FG010|Phase 1|Withdrawal by Subject|0|||
106171218|NCT02240238|366290638|FG011|Phase 1|Withdrawal by Subject|0|||
106171219|NCT02240238|366290627|FG000|Phase 1|Physician Decision|0|||
106171220|NCT02240238|366290628|FG001|Phase 1|Physician Decision|0|||
106171221|NCT02240238|366290629|FG002|Phase 1|Physician Decision|0|||
106171222|NCT02240238|366290630|FG003|Phase 1|Physician Decision|0|||
106171223|NCT02240238|366290631|FG004|Phase 1|Physician Decision|0|||
106171224|NCT02240238|366290632|FG005|Phase 1|Physician Decision|2|||
106171225|NCT02240238|366290633|FG006|Phase 1|Physician Decision|0|||
106171226|NCT02240238|366290634|FG007|Phase 1|Physician Decision|0|||
106171227|NCT02240238|366290635|FG008|Phase 1|Physician Decision|0|||
106171228|NCT02240238|366290636|FG009|Phase 1|Physician Decision|0|||
106171229|NCT02240238|366290637|FG010|Phase 1|Physician Decision|0|||
106171230|NCT02240238|366290638|FG011|Phase 1|Physician Decision|0|||
106171231|NCT02240238|366290627|FG000|Phase 2|Adverse Event|0|||
106171232|NCT02240238|366290628|FG001|Phase 2|Adverse Event|0|||
106171233|NCT02240238|366290629|FG002|Phase 2|Adverse Event|0|||
106171234|NCT02240238|366290630|FG003|Phase 2|Adverse Event|0|||
106171235|NCT02240238|366290631|FG004|Phase 2|Adverse Event|0|||
106171236|NCT02240238|366290632|FG005|Phase 2|Adverse Event|0|||
106171237|NCT02240238|366290633|FG006|Phase 2|Adverse Event|0|||
106171238|NCT02240238|366290634|FG007|Phase 2|Adverse Event|0|||
106171239|NCT02240238|366290635|FG008|Phase 2|Adverse Event|0|||
106171240|NCT02240238|366290636|FG009|Phase 2|Adverse Event|7|||
106171241|NCT02240238|366290637|FG010|Phase 2|Adverse Event|14|||
106171242|NCT02240238|366290638|FG011|Phase 2|Adverse Event|2|||
106171243|NCT02240238|366290627|FG000|Phase 2|Death|0|||
106171244|NCT02240238|366290628|FG001|Phase 2|Death|0|||
106171245|NCT02240238|366290629|FG002|Phase 2|Death|0|||
106171246|NCT02240238|366290630|FG003|Phase 2|Death|0|||
106171247|NCT02240238|366290631|FG004|Phase 2|Death|0|||
106171248|NCT02240238|366290632|FG005|Phase 2|Death|0|||
106171249|NCT02240238|366290633|FG006|Phase 2|Death|0|||
106171250|NCT02240238|366290634|FG007|Phase 2|Death|0|||
106171251|NCT02240238|366290635|FG008|Phase 2|Death|0|||
106171252|NCT02240238|366290636|FG009|Phase 2|Death|3|||
106171253|NCT02240238|366290637|FG010|Phase 2|Death|2|||
106171254|NCT02240238|366290638|FG011|Phase 2|Death|1|||
106171255|NCT02240238|366290627|FG000|Phase 2|Disease progression|0|||
106171256|NCT02240238|366290628|FG001|Phase 2|Disease progression|0|||
106171257|NCT02240238|366290629|FG002|Phase 2|Disease progression|0|||
106171258|NCT02240238|366290630|FG003|Phase 2|Disease progression|0|||
106171259|NCT02240238|366290631|FG004|Phase 2|Disease progression|0|||
106171260|NCT02240238|366290632|FG005|Phase 2|Disease progression|0|||
106171261|NCT02240238|366290633|FG006|Phase 2|Disease progression|0|||
106171262|NCT02240238|366290634|FG007|Phase 2|Disease progression|0|||
106171263|NCT02240238|366290635|FG008|Phase 2|Disease progression|0|||
106171264|NCT02240238|366290636|FG009|Phase 2|Disease progression|5|||
106171265|NCT02240238|366290637|FG010|Phase 2|Disease progression|11|||
106171266|NCT02240238|366290638|FG011|Phase 2|Disease progression|1|||
106171267|NCT02240238|366290627|FG000|Phase 2|Withdrawal by Subject|0|||
106171268|NCT02240238|366290628|FG001|Phase 2|Withdrawal by Subject|0|||
106171269|NCT02240238|366290629|FG002|Phase 2|Withdrawal by Subject|0|||
106171270|NCT02240238|366290630|FG003|Phase 2|Withdrawal by Subject|0|||
106171271|NCT02240238|366290631|FG004|Phase 2|Withdrawal by Subject|0|||
106171272|NCT02240238|366290632|FG005|Phase 2|Withdrawal by Subject|0|||
106171273|NCT02240238|366290633|FG006|Phase 2|Withdrawal by Subject|0|||
106171274|NCT02240238|366290634|FG007|Phase 2|Withdrawal by Subject|0|||
106171275|NCT02240238|366290635|FG008|Phase 2|Withdrawal by Subject|0|||
106171276|NCT02240238|366290636|FG009|Phase 2|Withdrawal by Subject|1|||
106171277|NCT02240238|366290637|FG010|Phase 2|Withdrawal by Subject|1|||
106171278|NCT02240238|366290638|FG011|Phase 2|Withdrawal by Subject|0|||
106171279|NCT02240238|366290627|FG000|Phase 2|Physician Decision|0|||
106171280|NCT02240238|366290628|FG001|Phase 2|Physician Decision|0|||
106171281|NCT02240238|366290629|FG002|Phase 2|Physician Decision|0|||
106171282|NCT02240238|366290630|FG003|Phase 2|Physician Decision|0|||
106171283|NCT02240238|366290631|FG004|Phase 2|Physician Decision|0|||
106171284|NCT02240238|366290632|FG005|Phase 2|Physician Decision|0|||
106171285|NCT02240238|366290633|FG006|Phase 2|Physician Decision|0|||
106171286|NCT02240238|366290634|FG007|Phase 2|Physician Decision|0|||
106171287|NCT02240238|366290635|FG008|Phase 2|Physician Decision|0|||
106171288|NCT02240238|366290636|FG009|Phase 2|Physician Decision|1|||
106171289|NCT02240238|366290637|FG010|Phase 2|Physician Decision|3|||
106171290|NCT02240238|366290638|FG011|Phase 2|Physician Decision|0|||
106171291|NCT02240238|366290627|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171292|NCT02240238|366290628|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171293|NCT02240238|366290629|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171294|NCT02240238|366290630|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171295|NCT02240238|366290631|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171296|NCT02240238|366290632|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171297|NCT02240238|366290633|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171298|NCT02240238|366290634|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171299|NCT02240238|366290635|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171300|NCT02240238|366290636|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
106171301|NCT02240238|366290637|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171302|NCT02240238|366290638|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
106171303|NCT02240238|366290627|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171304|NCT02240238|366290628|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171305|NCT02240238|366290629|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171306|NCT02240238|366290630|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171307|NCT02240238|366290631|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171308|NCT02240238|366290632|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171309|NCT02240238|366290633|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171310|NCT02240238|366290634|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171311|NCT02240238|366290635|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171312|NCT02240238|366290636|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
106171313|NCT02240238|366290637|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171314|NCT02240238|366290638|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
106171315|NCT02240238|366290627|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171316|NCT02240238|366290628|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171317|NCT02240238|366290629|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171318|NCT02240238|366290630|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171319|NCT02240238|366290631|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171320|NCT02240238|366290632|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171321|NCT02240238|366290633|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171322|NCT02240238|366290634|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171323|NCT02240238|366290635|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171324|NCT02240238|366290636|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171325|NCT02240238|366290637|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
106171326|NCT02240238|366290638|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
106171327|NCT02240238|366290627|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171328|NCT02240238|366290628|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171329|NCT02240238|366290629|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171330|NCT02240238|366290630|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171331|NCT02240238|366290631|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171332|NCT02240238|366290632|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171333|NCT02240238|366290633|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171334|NCT02240238|366290634|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171335|NCT02240238|366290635|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171336|NCT02240238|366290636|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171337|NCT02240238|366290637|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
106171338|NCT02240238|366290638|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
106171339|NCT02240238|366290627|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171340|NCT02240238|366290628|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171341|NCT02240238|366290629|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171342|NCT02240238|366290630|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171343|NCT02240238|366290631|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171344|NCT02240238|366290632|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171345|NCT02240238|366290633|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171346|NCT02240238|366290634|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171347|NCT02240238|366290635|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171348|NCT02240238|366290636|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171349|NCT02240238|366290637|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
106171350|NCT02240238|366290638|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
106171351|NCT02240238|366290627|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171352|NCT02240238|366290628|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171353|NCT02240238|366290629|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171354|NCT02240238|366290630|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171355|NCT02240238|366290631|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171356|NCT02240238|366290632|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171357|NCT02240238|366290633|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171358|NCT02240238|366290634|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171359|NCT02240238|366290635|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171360|NCT02240238|366290636|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171361|NCT02240238|366290637|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
106171362|NCT02240238|366290638|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
106171363|NCT02240238|366290627|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171364|NCT02240238|366290628|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171365|NCT02240238|366290629|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171366|NCT02240238|366290630|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171367|NCT02240238|366290631|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171368|NCT02240238|366290632|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171369|NCT02240238|366290633|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171370|NCT02240238|366290634|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171371|NCT02240238|366290635|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171372|NCT02240238|366290636|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171373|NCT02240238|366290637|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
106171374|NCT02240238|366290638|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
106171375|NCT02240238|366290627|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171376|NCT02240238|366290628|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171377|NCT02240238|366290629|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171378|NCT02240238|366290630|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171379|NCT02240238|366290631|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171380|NCT02240238|366290632|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171381|NCT02240238|366290633|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171382|NCT02240238|366290634|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171383|NCT02240238|366290635|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171384|NCT02240238|366290636|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171385|NCT02240238|366290637|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
106171386|NCT02240238|366290638|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
106171387|NCT04797195|366290639|FG000|Overall Study|Death|8|||
106171388|NCT04797195|366290640|FG001|Overall Study|Death|15|||
106171389|NCT04797195|366290639|FG000|Overall Study|Change from PD|15|||
106171390|NCT04797195|366290640|FG001|Overall Study|Change from PD|15|||
106171391|NCT04797195|366290639|FG000|Overall Study|Withdrawal by Subject|3|||
106171392|NCT04797195|366290640|FG001|Overall Study|Withdrawal by Subject|2|||
106171393|NCT04304144|366290641|FG000|DLT Observation Period|Physician Decision|0|||
106171394|NCT04304144|366290642|FG001|DLT Observation Period|Physician Decision|1|||
106171395|NCT04304144|366290643|FG002|DLT Observation Period|Physician Decision|0|||
106171396|NCT04304144|366290644|FG003|DLT Observation Period|Physician Decision|0|||
106171397|NCT04304144|366290641|FG000|Continued Treatment Period|Adverse Event|0|||
106171398|NCT04304144|366290642|FG001|Continued Treatment Period|Adverse Event|1|||
106171399|NCT04304144|366290643|FG002|Continued Treatment Period|Adverse Event|0|||
106171400|NCT04304144|366290644|FG003|Continued Treatment Period|Adverse Event|0|||
106171401|NCT04304144|366290641|FG000|Continued Treatment Period|Death|0|||
106171402|NCT04304144|366290642|FG001|Continued Treatment Period|Death|0|||
106171403|NCT04304144|366290643|FG002|Continued Treatment Period|Death|1|||
106171404|NCT04304144|366290644|FG003|Continued Treatment Period|Death|2|||
106171405|NCT04304144|366290641|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
106171406|NCT04304144|366290642|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
106171407|NCT04304144|366290643|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
106171408|NCT04304144|366290644|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
106171409|NCT04304144|366290641|FG000|Continued Treatment Period|Other than specified|2|||
106171410|NCT04304144|366290642|FG001|Continued Treatment Period|Other than specified|0|||
106171411|NCT04304144|366290643|FG002|Continued Treatment Period|Other than specified|1|||
106171412|NCT04304144|366290644|FG003|Continued Treatment Period|Other than specified|1|||
106171413|NCT04660539|366290645|FG000|Overall Study|Adverse Event|10|||
106171414|NCT04660539|366290645|FG000|Overall Study|Lack of Efficacy|4|||
106171415|NCT04660539|366290645|FG000|Overall Study|Lost to Follow-up|5|||
106171416|NCT04660539|366290645|FG000|Overall Study|Non-Compliance With Study Drug|3|||
106171417|NCT04660539|366290645|FG000|Overall Study|Reason not Specified|12|||
106171418|NCT04660539|366290645|FG000|Overall Study|Pregnancy|2|||
106171419|NCT04660539|366290645|FG000|Overall Study|Protocol Violation|2|||
106171420|NCT04660539|366290645|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
106171421|NCT04660539|366290645|FG000|Overall Study|Withdrawal by Subject|21|||
106171422|NCT03655028|366290648|FG000|12-weeks Follow up|Death|1|||
106171423|NCT03655028|366290649|FG001|12-weeks Follow up|Death|0|||
106171424|NCT03655028|366290648|FG000|12-weeks Follow up|Physician Decision|3|||
106171425|NCT03655028|366290649|FG001|12-weeks Follow up|Physician Decision|3|||
106171426|NCT03655028|366290648|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
106171427|NCT03655028|366290649|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
106171428|NCT03655028|366290648|FG000|12-weeks Follow up|Lost to Follow-up|4|||
106171429|NCT03655028|366290649|FG001|12-weeks Follow up|Lost to Follow-up|4|||
106171430|NCT03655028|366290648|FG000|24-weeks|Lost to Follow-up|1|||
106171431|NCT03655028|366290649|FG001|24-weeks|Lost to Follow-up|1|||
106171432|NCT03655028|366290648|FG000|24-weeks|Death|0|||
106171433|NCT03655028|366290649|FG001|24-weeks|Death|1|||
106171434|NCT03513302|366290650|FG000|First Intervention (14 Days)|Screen failure|15|||
106171435|NCT03513302|366290651|FG001|First Intervention (14 Days)|Screen failure|16|||
106171436|NCT00746096|366290652|FG000|Overall Study|Adverse Event|1|||
106171437|NCT00746096|366290653|FG001|Overall Study|Adverse Event|0|||
106171438|NCT00746096|366290652|FG000|Overall Study|Withdrawal by Subject|5|||
106171439|NCT00746096|366290653|FG001|Overall Study|Withdrawal by Subject|1|||
106171440|NCT00746096|366290652|FG000|Overall Study|Lost to Follow-up|2|||
106171441|NCT00746096|366290653|FG001|Overall Study|Lost to Follow-up|1|||
106171442|NCT00746096|366290652|FG000|Overall Study|Protocol Violation|1|||
106171443|NCT00746096|366290653|FG001|Overall Study|Protocol Violation|0|||
106171444|NCT00746096|366290652|FG000|Overall Study|No study drug treatment|1|||
106171445|NCT00746096|366290653|FG001|Overall Study|No study drug treatment|1|||
106171446|NCT04599634|366290677|FG000|Overall Study|Dose limiting toxicity|0|||
106171447|NCT04599634|366290678|FG001|Overall Study|Dose limiting toxicity|0|||
106171448|NCT04599634|366290679|FG002|Overall Study|Dose limiting toxicity|2|||
106171449|NCT04599634|366290680|FG003|Overall Study|Dose limiting toxicity|0|||
106171450|NCT03733925|366290681|FG000|Overall Study|Lost to Follow-up|1|||
106171451|NCT03733925|366290681|FG000|Overall Study|Withdrawal by Subject|2|||
106171452|NCT03733925|366290681|FG000|Overall Study|Adverse Event|2|||
106171453|NCT03733925|366290681|FG000|Overall Study|Non-Compliance with Study Drug|1|||
106171454|NCT05245071|366290682|FG000|Overall Study|Progressive disease|16|||
106171455|NCT05245071|366290682|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
106171456|NCT05245071|366290682|FG000|Overall Study|Ongoing study intervention|4|||
106171457|NCT02676973|366290683|FG000|Overall Study|Withdrawal by Subject|9|||
106171458|NCT02676973|366290684|FG001|Overall Study|Withdrawal by Subject|8|||
106171459|NCT02676973|366290685|FG002|Overall Study|Withdrawal by Subject|11|||
106171460|NCT02676973|366290683|FG000|Overall Study|Lost to Follow-up|8|||
106171461|NCT02676973|366290684|FG001|Overall Study|Lost to Follow-up|12|||
106171462|NCT02676973|366290685|FG002|Overall Study|Lost to Follow-up|8|||
106171463|NCT02676973|366290683|FG000|Overall Study|Death|2|||
106171464|NCT02676973|366290684|FG001|Overall Study|Death|1|||
106171465|NCT02676973|366290685|FG002|Overall Study|Death|5|||
106171466|NCT02631746|366290691|FG000|Overall Study|Lack of Efficacy|3|||
106171467|NCT04571619|366290692|FG000|Phase 1|Death|22|||
106171468|NCT04571619|366290693|FG001|Phase 1|Death|18|||
106171469|NCT04571619|366290692|FG000|Phase 1|Withdrawal by Subject|7|||
106171470|NCT04571619|366290693|FG001|Phase 1|Withdrawal by Subject|2|||
106171471|NCT04571619|366290692|FG000|Phase 2|Death|13|||
106171472|NCT04571619|366290693|FG001|Phase 2|Death|16|||
106171473|NCT04571619|366290692|FG000|Phase 2|Withdrawal by Subject|6|||
106171474|NCT04571619|366290693|FG001|Phase 2|Withdrawal by Subject|4|||
106171475|NCT04469270|366290710|FG000|Overall Study|Adverse Event|2|||
106171476|NCT04469270|366290711|FG001|Overall Study|Adverse Event|0|||
106171477|NCT04469270|366290710|FG000|Overall Study|Lost to Follow-up|4|||
106171478|NCT04469270|366290711|FG001|Overall Study|Lost to Follow-up|3|||
106171479|NCT04469270|366290710|FG000|Overall Study|Withdrawal by Subject|7|||
106171480|NCT04469270|366290711|FG001|Overall Study|Withdrawal by Subject|3|||
106171481|NCT04469270|366290710|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
106171482|NCT04469270|366290711|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
106171483|NCT04469270|366290710|FG000|Overall Study|missing|1|||
106171484|NCT04469270|366290711|FG001|Overall Study|missing|0|||
106171485|NCT04209855|366290712|FG000|Overall Study|Adverse Event|20|||
106171486|NCT04209855|366290713|FG001|Overall Study|Adverse Event|28|||
106171487|NCT04209855|366290712|FG000|Overall Study|Death|3|||
106171488|NCT04209855|366290713|FG001|Overall Study|Death|1|||
106171489|NCT04209855|366290712|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
106171490|NCT04209855|366290713|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
106171491|NCT04209855|366290712|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
106171492|NCT04209855|366290713|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
106171493|NCT04209855|366290712|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
106171494|NCT04209855|366290713|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
106171495|NCT04209855|366290712|FG000|Overall Study|Progressive Disease|154|||
106171496|NCT04209855|366290713|FG001|Overall Study|Progressive Disease|145|||
106171497|NCT04209855|366290712|FG000|Overall Study|Protocol Deviation|1|||
106171498|NCT04209855|366290713|FG001|Overall Study|Protocol Deviation|1|||
106171499|NCT04209855|366290712|FG000|Overall Study|Other Than Specified|5|||
106171500|NCT04209855|366290713|FG001|Overall Study|Other Than Specified|10|||
106171501|NCT02003924|366290716|FG000|Double-blind Phase|Lost to Follow-up|2|||
106171502|NCT02003924|366290717|FG001|Double-blind Phase|Lost to Follow-up|1|||
106171503|NCT02003924|366290718|FG002|Double-blind Phase|Lost to Follow-up|0|||
106171504|NCT02003924|366290716|FG000|Double-blind Phase|Protocol Violation|1|||
106171505|NCT02003924|366290717|FG001|Double-blind Phase|Protocol Violation|2|||
106171506|NCT02003924|366290718|FG002|Double-blind Phase|Protocol Violation|0|||
106171507|NCT02003924|366290716|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
106171508|NCT02003924|366290717|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
106171509|NCT02003924|366290718|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
106171510|NCT02003924|366290716|FG000|Double-blind Phase|Disease Progression|229|||
106171511|NCT02003924|366290717|FG001|Double-blind Phase|Disease Progression|247|||
106171512|NCT02003924|366290718|FG002|Double-blind Phase|Disease Progression|0|||
106171513|NCT02003924|366290716|FG000|Double-blind Phase|Adverse Event|120|||
106171514|NCT02003924|366290717|FG001|Double-blind Phase|Adverse Event|31|||
106171515|NCT02003924|366290718|FG002|Double-blind Phase|Adverse Event|0|||
106171516|NCT02003924|366290716|FG000|Double-blind Phase|Randomized But not Treated|3|||
106171517|NCT02003924|366290717|FG001|Double-blind Phase|Randomized But not Treated|3|||
106171518|NCT02003924|366290718|FG002|Double-blind Phase|Randomized But not Treated|0|||
106171519|NCT02003924|366290716|FG000|Double-blind Phase|Other|29|||
106171520|NCT02003924|366290717|FG001|Double-blind Phase|Other|50|||
106171521|NCT02003924|366290718|FG002|Double-blind Phase|Other|0|||
106171522|NCT02003924|366290716|FG000|Open-label Phase|Lost to Follow-up|0|||
106171523|NCT02003924|366290717|FG001|Open-label Phase|Lost to Follow-up|0|||
106171524|NCT02003924|366290718|FG002|Open-label Phase|Lost to Follow-up|1|||
106171525|NCT02003924|366290716|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
106171526|NCT02003924|366290717|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
106171527|NCT02003924|366290718|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
106171528|NCT02003924|366290716|FG000|Open-label Phase|Disease Progression|59|||
106171529|NCT02003924|366290717|FG001|Open-label Phase|Disease Progression|0|||
106171530|NCT02003924|366290718|FG002|Open-label Phase|Disease Progression|5|||
106171531|NCT02003924|366290716|FG000|Open-label Phase|Adverse Event|25|||
106171532|NCT02003924|366290717|FG001|Open-label Phase|Adverse Event|0|||
106171533|NCT02003924|366290718|FG002|Open-label Phase|Adverse Event|10|||
106171534|NCT02003924|366290716|FG000|Open-label Phase|Other|7|||
106171535|NCT02003924|366290717|FG001|Open-label Phase|Other|0|||
106171536|NCT02003924|366290718|FG002|Open-label Phase|Other|0|||
106171537|NCT02003924|366290716|FG000|Long-term Follow-up Phase|Death|288|||
106171538|NCT02003924|366290717|FG001|Long-term Follow-up Phase|Death|174|||
106171539|NCT02003924|366290718|FG002|Long-term Follow-up Phase|Death|4|||
106171540|NCT02003924|366290716|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
106171541|NCT02003924|366290717|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
106171542|NCT02003924|366290718|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
106171543|NCT02003924|366290716|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
106171544|NCT02003924|366290717|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
106171545|NCT02003924|366290718|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
106171546|NCT02003924|366290716|FG000|Long-term Follow-up Phase|Other|5|||
106171547|NCT02003924|366290717|FG001|Long-term Follow-up Phase|Other|2|||
106171548|NCT02003924|366290718|FG002|Long-term Follow-up Phase|Other|1|||
106171549|NCT02998528|366290719|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
106171550|NCT02998528|366290720|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
106171551|NCT02998528|366290721|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
106171552|NCT02998528|366290719|FG000|Randomization Period|Participant withdrew consent|0|||
106171553|NCT02998528|366290720|FG001|Randomization Period|Participant withdrew consent|3|||
106171554|NCT02998528|366290721|FG002|Randomization Period|Participant withdrew consent|0|||
106171555|NCT02998528|366290719|FG000|Randomization Period|Participant no longer meets study criteria|1|||
106171556|NCT02998528|366290720|FG001|Randomization Period|Participant no longer meets study criteria|3|||
106171557|NCT02998528|366290721|FG002|Randomization Period|Participant no longer meets study criteria|2|||
106171558|NCT02998528|366290719|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
106171559|NCT02998528|366290720|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
106171560|NCT02998528|366290721|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
106171561|NCT02998528|366290719|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
106171562|NCT02998528|366290720|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
106171563|NCT02998528|366290721|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
106171564|NCT02998528|366290719|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
106171565|NCT02998528|366290720|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
106171566|NCT02998528|366290721|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
106171567|NCT02998528|366290719|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
106171568|NCT02998528|366290720|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
106171569|NCT02998528|366290721|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
106171570|NCT02998528|366290719|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
106171571|NCT02998528|366290720|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
106171572|NCT02998528|366290721|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
106171573|NCT02998528|366290719|FG000|Neoadjuvant Treatment Period|Death|1|||
106171574|NCT02998528|366290720|FG001|Neoadjuvant Treatment Period|Death|0|||
106171575|NCT02998528|366290721|FG002|Neoadjuvant Treatment Period|Death|0|||
106171576|NCT02998528|366290719|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
106171577|NCT02998528|366290720|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
106171578|NCT02998528|366290721|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
106171579|NCT02998528|366290719|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
106171580|NCT02998528|366290720|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
106171581|NCT02998528|366290721|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
106171582|NCT02998528|366290719|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
106171583|NCT02998528|366290720|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
106171584|NCT02998528|366290721|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
106171585|NCT02998528|366290719|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
106171586|NCT02998528|366290720|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
106171587|NCT02998528|366290721|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
106171588|NCT02998528|366290719|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
106171589|NCT02998528|366290720|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
106171590|NCT02998528|366290721|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
106171591|NCT02998528|366290719|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
106171592|NCT02998528|366290720|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
106171593|NCT02998528|366290721|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
106171594|NCT03485729|366290725|FG000|Overall Study|Withdrawal by Subject|0|||
106171595|NCT03485729|366290726|FG001|Overall Study|Withdrawal by Subject|0|||
106171596|NCT03485729|366290727|FG002|Overall Study|Withdrawal by Subject|1|||
106171597|NCT03485729|366290725|FG000|Overall Study|Disease progression|8|||
106171598|NCT03485729|366290726|FG001|Overall Study|Disease progression|13|||
106171599|NCT03485729|366290727|FG002|Overall Study|Disease progression|1|||
106171600|NCT03485729|366290725|FG000|Overall Study|Hospice care|1|||
106171601|NCT03485729|366290726|FG001|Overall Study|Hospice care|0|||
106171602|NCT03485729|366290727|FG002|Overall Study|Hospice care|0|||
106171603|NCT03485729|366290725|FG000|Overall Study|Poor performance status|1|||
106171604|NCT03485729|366290726|FG001|Overall Study|Poor performance status|0|||
106171605|NCT03485729|366290727|FG002|Overall Study|Poor performance status|0|||
106171606|NCT03485729|366290725|FG000|Overall Study|Illness|0|||
106171607|NCT03485729|366290726|FG001|Overall Study|Illness|1|||
106171608|NCT03485729|366290727|FG002|Overall Study|Illness|0|||
106171609|NCT04880733|366290728|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
106171610|NCT04880733|366290729|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
106171611|NCT04880733|366290730|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
106171612|NCT04880733|366290728|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
106171613|NCT04880733|366290729|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
106171614|NCT04880733|366290730|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
106171615|NCT04880733|366290728|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
106171616|NCT04880733|366290729|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
106171617|NCT04880733|366290730|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
106171618|NCT04880733|366290728|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
106171619|NCT04880733|366290729|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
106171620|NCT04880733|366290730|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
106171621|NCT04880733|366290728|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
106171622|NCT04880733|366290729|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
106171623|NCT04880733|366290730|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
106171624|NCT02990338|366290733|FG000|Overall Study|Randomized and not treated|4|||
106171625|NCT02990338|366290734|FG001|Overall Study|Randomized and not treated|2|||
106171626|NCT02990338|366290733|FG000|Overall Study|Adverse Event|23|||
106171627|NCT02990338|366290734|FG001|Overall Study|Adverse Event|22|||
106171628|NCT02990338|366290733|FG000|Overall Study|Progressive disease|118|||
106171629|NCT02990338|366290734|FG001|Overall Study|Progressive disease|107|||
106171630|NCT02990338|366290733|FG000|Overall Study|Poor compliance to protocol|0|||
106171631|NCT02990338|366290734|FG001|Overall Study|Poor compliance to protocol|1|||
106171632|NCT02990338|366290733|FG000|Overall Study|Withdrawal by Subject|6|||
106171633|NCT02990338|366290734|FG001|Overall Study|Withdrawal by Subject|8|||
106171634|NCT02990338|366290733|FG000|Overall Study|Physician's decision|2|||
106171635|NCT02990338|366290734|FG001|Overall Study|Physician's decision|6|||
106171636|NCT02990338|366290733|FG000|Overall Study|Treatment extension study|0|||
106171637|NCT02990338|366290734|FG001|Overall Study|Treatment extension study|6|||
106171638|NCT02990338|366290733|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
106171639|NCT02990338|366290734|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
106171640|NCT02990338|366290733|FG000|Overall Study|Continue with therapy available commercially|0|||
106171641|NCT02990338|366290734|FG001|Overall Study|Continue with therapy available commercially|1|||
106171642|NCT04158739|366290738|FG000|Overall Study|Adverse Event|1|||
106171643|NCT04158739|366290739|FG001|Overall Study|Adverse Event|0|||
106171644|NCT04158739|366290738|FG000|Overall Study|Death|0|||
106171645|NCT04158739|366290739|FG001|Overall Study|Death|1|||
106171646|NCT04158739|366290738|FG000|Overall Study|Lack of Efficacy|3|||
106171647|NCT04158739|366290739|FG001|Overall Study|Lack of Efficacy|7|||
106171648|NCT04158739|366290738|FG000|Overall Study|Physician Decision|0|||
106171649|NCT04158739|366290739|FG001|Overall Study|Physician Decision|1|||
106171650|NCT04158739|366290738|FG000|Overall Study|Withdrawal by Subject|3|||
106171651|NCT04158739|366290739|FG001|Overall Study|Withdrawal by Subject|0|||
106171652|NCT02865538|366290741|FG000|Overall Study|Withdrawal by Subject|0|||
106171653|NCT02865538|366290742|FG001|Overall Study|Withdrawal by Subject|0|||
106171654|NCT02865538|366290743|FG002|Overall Study|Withdrawal by Subject|1|||
106171655|NCT02865538|366290744|FG003|Overall Study|Withdrawal by Subject|0|||
106171656|NCT02865538|366290745|FG004|Overall Study|Withdrawal by Subject|0|||
106171657|NCT02865538|366290741|FG000|Overall Study|Lost to Follow-up|1|||
106171658|NCT02865538|366290742|FG001|Overall Study|Lost to Follow-up|0|||
106171659|NCT02865538|366290743|FG002|Overall Study|Lost to Follow-up|0|||
106171660|NCT02865538|366290744|FG003|Overall Study|Lost to Follow-up|0|||
106171661|NCT02865538|366290745|FG004|Overall Study|Lost to Follow-up|0|||
106171662|NCT04678856|366290746|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
106171663|NCT04678856|366290747|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
106171664|NCT04678856|366290746|FG000|Overall Study|Withdrawal by Subject|5|||
106171665|NCT04678856|366290747|FG001|Overall Study|Withdrawal by Subject|1|||
106171666|NCT05618587|366291981|FG000|Overall Study|Lost to Follow-up|2|||
106171667|NCT05618587|366291982|FG001|Overall Study|Lost to Follow-up|0|||
106171668|NCT05256654|366291983|FG000|Overall Study|Adverse Event|0|||
106171669|NCT05256654|366291984|FG001|Overall Study|Adverse Event|0|||
106171670|NCT05256654|366291985|FG002|Overall Study|Adverse Event|1|||
106171671|NCT05256654|366291986|FG003|Overall Study|Adverse Event|0|||
106171672|NCT05256654|366291983|FG000|Overall Study|Lost to Follow-up|0|||
106171673|NCT05256654|366291984|FG001|Overall Study|Lost to Follow-up|0|||
106171674|NCT05256654|366291985|FG002|Overall Study|Lost to Follow-up|0|||
106171675|NCT05256654|366291986|FG003|Overall Study|Lost to Follow-up|1|||
106171676|NCT05256654|366291983|FG000|Overall Study|Withdrawal by Subject|1|||
106171677|NCT05256654|366291984|FG001|Overall Study|Withdrawal by Subject|2|||
106171678|NCT05256654|366291985|FG002|Overall Study|Withdrawal by Subject|1|||
106171679|NCT05256654|366291986|FG003|Overall Study|Withdrawal by Subject|3|||
106171680|NCT05256654|366291983|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
106171681|NCT05256654|366291984|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
106171682|NCT05256654|366291985|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
106171683|NCT05256654|366291986|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
106171684|NCT05256654|366291983|FG000|Overall Study|Other|0|||
106171685|NCT05256654|366291984|FG001|Overall Study|Other|0|||
106171686|NCT05256654|366291985|FG002|Overall Study|Other|0|||
106171687|NCT05256654|366291986|FG003|Overall Study|Other|1|||
106171688|NCT04862416|366291991|FG000|Overall Study|Withdrawal by Subject|0|||
106171689|NCT04862416|366291992|FG001|Overall Study|Withdrawal by Subject|1|||
106171690|NCT04862416|366291993|FG002|Overall Study|Withdrawal by Subject|0|||
106171691|NCT04862416|366291994|FG003|Overall Study|Withdrawal by Subject|1|||
106171692|NCT04862416|366291995|FG004|Overall Study|Withdrawal by Subject|0|||
106171693|NCT04862416|366291996|FG005|Overall Study|Withdrawal by Subject|0|||
106171694|NCT04862416|366291997|FG006|Overall Study|Withdrawal by Subject|0|||
106171695|NCT04862416|366291998|FG007|Overall Study|Withdrawal by Subject|0|||
106171696|NCT03442309|366291999|FG000|Overall Study|Lost to Follow-up|1676|||
106171697|NCT03442309|366292000|FG001|Overall Study|Lost to Follow-up|1642|||
106171698|NCT02970318|366292001|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
106171699|NCT02970318|366292002|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
106171700|NCT02970318|366292003|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
106171701|NCT02970318|366292004|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
106171702|NCT02970318|366292001|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
106171703|NCT02970318|366292002|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
106171704|NCT02970318|366292003|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
106171705|NCT02970318|366292004|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
106171706|NCT02970318|366292001|FG000|Overall for Arm A & Main for Arm B|Death|41|||
106171707|NCT02970318|366292002|FG001|Overall for Arm A & Main for Arm B|Death|33|||
106171708|NCT02970318|366292003|FG002|Overall for Arm A & Main for Arm B|Death|0|||
106171709|NCT02970318|366292004|FG003|Overall for Arm A & Main for Arm B|Death|0|||
106171710|NCT02970318|366292001|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
106171711|NCT02970318|366292002|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
106171712|NCT02970318|366292003|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
106171713|NCT02970318|366292004|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
106171714|NCT02970318|366292001|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
106171715|NCT02970318|366292002|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
106171716|NCT02970318|366292003|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
106171717|NCT02970318|366292004|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
106171718|NCT02970318|366292001|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
106171719|NCT02970318|366292002|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
106171720|NCT02970318|366292003|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
106171721|NCT02970318|366292004|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
106171722|NCT02970318|366292001|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
106171723|NCT02970318|366292002|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
106171724|NCT02970318|366292003|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
106171725|NCT02970318|366292004|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
106171726|NCT05204654|366292005|FG000|Overall Study|Study terminated due to time restraint|2|||
106171727|NCT05204654|366292006|FG001|Overall Study|Study terminated due to time restraint|2|||
106171728|NCT01221948|366292007|FG000|Overall Study|Physician Decision|5|||
106171729|NCT01221948|366292007|FG000|Overall Study|Withdrawal by Subject|2|||
106171730|NCT01221948|366292007|FG000|Overall Study|not disclosed|2|||
106171731|NCT01221948|366292007|FG000|Overall Study|Death|1|||
106171732|NCT01221948|366292007|FG000|Overall Study|Protocol Violation|4|||
106171733|NCT05207956|366292010|FG000|Overall Study|Lost to follow up|1|||
106171734|NCT05207956|366292011|FG001|Overall Study|Lost to follow up|2|||
106171735|NCT02296684|366292012|FG000|Overall Study|Withdrawal by Subject|0|||
106171736|NCT02296684|366292013|FG001|Overall Study|Withdrawal by Subject|1|||
106171737|NCT02296684|366292014|FG002|Overall Study|Withdrawal by Subject|1|||
106171738|NCT02296684|366292012|FG000|Overall Study|Death|2|||
106171739|NCT02296684|366292013|FG001|Overall Study|Death|0|||
106171740|NCT02296684|366292014|FG002|Overall Study|Death|0|||
106171741|NCT05425420|366292020|FG000|Overall Study|Physician Decision|1|||
106171742|NCT05425420|366292020|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
106171743|NCT05280574|366292021|FG000|Overall Study|Withdrawal by Subject|0|||
106171744|NCT05280574|366292022|FG001|Overall Study|Withdrawal by Subject|2|||
106171745|NCT05280574|366292023|FG002|Overall Study|Withdrawal by Subject|0|||
106171746|NCT05838027|366292024|FG000|Overall Study|Lost to Follow-up|5|||
106171747|NCT05838027|366292025|FG001|Overall Study|Lost to Follow-up|1|||
106171748|NCT05838027|366292024|FG000|Overall Study|Withdrawal by Subject|1|||
106171749|NCT05838027|366292025|FG001|Overall Study|Withdrawal by Subject|0|||
106171750|NCT03213873|366292035|FG000|Overall Study|Withdrawal by Subject|8|||
106171751|NCT03213873|366292036|FG001|Overall Study|Withdrawal by Subject|9|||
106171752|NCT03213873|366292035|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
106171753|NCT03213873|366292036|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
106171754|NCT03213873|366292035|FG000|Overall Study|Lost to Follow-up|0|||
106171755|NCT03213873|366292036|FG001|Overall Study|Lost to Follow-up|2|||
106171756|NCT02962076|366292040|FG000|Overall Study|MHED tracer not available|5|||
106171757|NCT02962076|366292040|FG000|Overall Study|Protocol Violation|1|||
106171758|NCT02962076|366292040|FG000|Overall Study|Physician Decision|1|||
106171759|NCT02780700|366292041|FG000|Overall Study|Progressive disease|1|||
106171760|NCT02852655|366292051|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
106171761|NCT02852655|366292052|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
106171762|NCT02852655|366292053|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
106171763|NCT02852655|366292051|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
106171764|NCT02852655|366292052|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
106171765|NCT02852655|366292053|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
106171766|NCT02852655|366292051|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
106171767|NCT02852655|366292052|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
106171768|NCT02852655|366292053|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
106171769|NCT02852655|366292051|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
106171770|NCT02852655|366292052|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
106171771|NCT02852655|366292053|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
106171772|NCT02852655|366292051|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
106171773|NCT02852655|366292052|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
106171774|NCT02852655|366292053|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
106171775|NCT02852655|366292051|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
106171776|NCT02852655|366292052|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
106171777|NCT02852655|366292053|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
106171778|NCT02852655|366292051|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
106171779|NCT02852655|366292052|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
106171780|NCT02852655|366292053|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
106171781|NCT02852655|366292051|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
106171782|NCT02852655|366292052|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
106171783|NCT02852655|366292053|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
106171784|NCT02852655|366292051|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
106171785|NCT02852655|366292052|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
106171786|NCT02852655|366292053|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
106171787|NCT04186845|366292062|FG000|Overall Study|Death|2|||
106171788|NCT04186845|366292062|FG000|Overall Study|Lost to Follow-up|1|||
106171789|NCT04186845|366292062|FG000|Overall Study|Physician Decision|1|||
106171790|NCT04186845|366292062|FG000|Overall Study|Protocol Violation|1|||
106171791|NCT04186845|366292062|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
106171792|NCT04186845|366292062|FG000|Overall Study|Biopsy ordered but not done|1|||
106171793|NCT04186845|366292062|FG000|Overall Study|It was previously confirmed|1|||
106171794|NCT04186845|366292062|FG000|Overall Study|Patient cancelled scheduled scans|2|||
106171795|NCT04186845|366292062|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
106171796|NCT04186845|366292062|FG000|Overall Study|Subject refused confirmatory imaging|1|||
106171797|NCT04186845|366292062|FG000|Overall Study|Too small to biopsy|1|||
106171798|NCT05069896|366292063|FG000|Overall Study|Adverse Event|0|||
106171799|NCT05069896|366292064|FG001|Overall Study|Adverse Event|1|||
106171800|NCT05069896|366292065|FG002|Overall Study|Adverse Event|1|||
106171801|NCT05069896|366292066|FG003|Overall Study|Adverse Event|0|||
106171802|NCT05069896|366292067|FG004|Overall Study|Adverse Event|0|||
106171803|NCT05069896|366292068|FG005|Overall Study|Adverse Event|0|||
106171804|NCT05069896|366292063|FG000|Overall Study|Lost to Follow-up|0|||
106171805|NCT05069896|366292064|FG001|Overall Study|Lost to Follow-up|0|||
106171806|NCT05069896|366292065|FG002|Overall Study|Lost to Follow-up|1|||
106171807|NCT05069896|366292066|FG003|Overall Study|Lost to Follow-up|0|||
106171808|NCT05069896|366292067|FG004|Overall Study|Lost to Follow-up|1|||
106171809|NCT05069896|366292068|FG005|Overall Study|Lost to Follow-up|2|||
106171810|NCT04068831|366292069|FG000|Overall Study|Disease Progression|10|||
106171811|NCT04068831|366292070|FG001|Overall Study|Disease Progression|8|||
106171812|NCT04820322|366292071|FG000|Overall Study|Adverse Event|1|||
106171813|NCT04820322|366292072|FG001|Overall Study|Adverse Event|0|||
106171814|NCT03640286|366292078|FG000|Overall Study|Adverse Event|6|||
106171815|NCT03640286|366292079|FG001|Overall Study|Adverse Event|6|||
106171816|NCT03640286|366292078|FG000|Overall Study|Lost to Follow-up|3|||
106171817|NCT03640286|366292079|FG001|Overall Study|Lost to Follow-up|6|||
106171818|NCT03640286|366292078|FG000|Overall Study|Pregnancy|1|||
106171819|NCT03640286|366292079|FG001|Overall Study|Pregnancy|0|||
106171820|NCT03640286|366292078|FG000|Overall Study|Withdrawal by Subject|10|||
106171821|NCT03640286|366292079|FG001|Overall Study|Withdrawal by Subject|10|||
106171822|NCT03640286|366292078|FG000|Overall Study|Non-compliance|4|||
106171823|NCT03640286|366292079|FG001|Overall Study|Non-compliance|10|||
106171824|NCT03640286|366292078|FG000|Overall Study|Medication change|1|||
106171825|NCT03640286|366292079|FG001|Overall Study|Medication change|0|||
106171826|NCT03640286|366292078|FG000|Overall Study|Other|1|||
106171827|NCT03640286|366292079|FG001|Overall Study|Other|2|||
106171828|NCT03640286|366292078|FG000|Overall Study|Joined another lifestyle program|0|||
106171829|NCT03640286|366292079|FG001|Overall Study|Joined another lifestyle program|1|||
106171830|NCT03181516|366292080|FG000|Overall Study|Withdrawal by Subject|14|||
106171831|NCT03181516|366292081|FG001|Overall Study|Withdrawal by Subject|7|||
106171832|NCT03181516|366292080|FG000|Overall Study|Lost to Follow-up|2|||
106171833|NCT03181516|366292081|FG001|Overall Study|Lost to Follow-up|2|||
106171834|NCT02834390|366292082|FG000|Induction Phase|Progressive disease|0|||
106171835|NCT02834390|366292083|FG001|Induction Phase|Progressive disease|1|||
106171836|NCT02834390|366292082|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
106171837|NCT02834390|366292083|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
106171838|NCT02834390|366292082|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
106171839|NCT02834390|366292083|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
106171840|NCT02834390|366292082|FG000|Consolidation Phase|Physician Decision|1|||
106171841|NCT02834390|366292083|FG001|Consolidation Phase|Physician Decision|1|||
106171842|NCT03536884|366292084|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
106171843|NCT03536884|366292085|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
106171844|NCT03536884|366292086|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171845|NCT03536884|366292087|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171846|NCT03536884|366292088|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171847|NCT03536884|366292089|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171848|NCT03536884|366292090|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171849|NCT03536884|366292091|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171850|NCT03536884|366292092|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171851|NCT03536884|366292093|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171852|NCT03536884|366292094|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171853|NCT03536884|366292095|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
106171854|NCT03536884|366292084|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171855|NCT03536884|366292085|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
106171856|NCT03536884|366292086|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171857|NCT03536884|366292087|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171858|NCT03536884|366292088|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171859|NCT03536884|366292089|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171860|NCT03536884|366292090|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171861|NCT03536884|366292091|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171862|NCT03536884|366292092|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171863|NCT03536884|366292093|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171864|NCT03536884|366292094|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171865|NCT03536884|366292095|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
106171866|NCT03536884|366292084|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
106171867|NCT03536884|366292085|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
106171868|NCT03536884|366292086|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171869|NCT03536884|366292087|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171870|NCT03536884|366292088|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171871|NCT03536884|366292089|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171872|NCT03536884|366292090|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171873|NCT03536884|366292091|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171874|NCT03536884|366292092|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171875|NCT03536884|366292093|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171876|NCT03536884|366292094|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171877|NCT03536884|366292095|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
106171878|NCT03536884|366292084|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171879|NCT03536884|366292085|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
106171880|NCT03536884|366292086|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171881|NCT03536884|366292087|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171882|NCT03536884|366292088|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171883|NCT03536884|366292089|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171884|NCT03536884|366292090|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171885|NCT03536884|366292091|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171886|NCT03536884|366292092|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171887|NCT03536884|366292093|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171888|NCT03536884|366292094|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171889|NCT03536884|366292095|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
106171890|NCT03536884|366292084|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171891|NCT03536884|366292085|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
106171892|NCT03536884|366292086|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171893|NCT03536884|366292087|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171894|NCT03536884|366292088|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171895|NCT03536884|366292089|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171896|NCT03536884|366292090|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171897|NCT03536884|366292091|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171898|NCT03536884|366292092|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171899|NCT03536884|366292093|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171900|NCT03536884|366292094|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171901|NCT03536884|366292095|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
106171902|NCT03536884|366292084|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171903|NCT03536884|366292085|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
106171904|NCT03536884|366292086|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171905|NCT03536884|366292087|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171906|NCT03536884|366292088|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171907|NCT03536884|366292089|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171908|NCT03536884|366292090|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171909|NCT03536884|366292091|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171910|NCT03536884|366292092|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171911|NCT03536884|366292093|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171912|NCT03536884|366292094|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171913|NCT03536884|366292095|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
106171914|NCT03536884|366292084|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171915|NCT03536884|366292085|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171916|NCT03536884|366292086|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
106171917|NCT03536884|366292087|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171918|NCT03536884|366292088|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
106171919|NCT03536884|366292089|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171920|NCT03536884|366292090|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171921|NCT03536884|366292091|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171922|NCT03536884|366292092|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171923|NCT03536884|366292093|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171924|NCT03536884|366292094|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171925|NCT03536884|366292095|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
106171926|NCT03536884|366292084|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171927|NCT03536884|366292085|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171928|NCT03536884|366292086|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
106171929|NCT03536884|366292087|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
106171930|NCT03536884|366292088|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
106171931|NCT03536884|366292089|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171932|NCT03536884|366292090|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171933|NCT03536884|366292091|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171934|NCT03536884|366292092|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171935|NCT03536884|366292093|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171936|NCT03536884|366292094|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171937|NCT03536884|366292095|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
106171938|NCT03536884|366292084|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171939|NCT03536884|366292085|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171940|NCT03536884|366292086|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171941|NCT03536884|366292087|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
106171942|NCT03536884|366292088|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
106171943|NCT03536884|366292089|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171944|NCT03536884|366292090|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171945|NCT03536884|366292091|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171946|NCT03536884|366292092|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171947|NCT03536884|366292093|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171948|NCT03536884|366292094|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171949|NCT03536884|366292095|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
106171950|NCT03536884|366292084|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171951|NCT03536884|366292085|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171952|NCT03536884|366292086|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
106171953|NCT03536884|366292087|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
106171954|NCT03536884|366292088|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
106171955|NCT03536884|366292089|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171956|NCT03536884|366292090|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171957|NCT03536884|366292091|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171958|NCT03536884|366292092|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171959|NCT03536884|366292093|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171960|NCT03536884|366292094|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171961|NCT03536884|366292095|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
106171962|NCT03536884|366292084|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171963|NCT03536884|366292085|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171964|NCT03536884|366292086|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
106171965|NCT03536884|366292087|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
106171966|NCT03536884|366292088|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
106171967|NCT03536884|366292089|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171968|NCT03536884|366292090|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171969|NCT03536884|366292091|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171970|NCT03536884|366292092|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171971|NCT03536884|366292093|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171972|NCT03536884|366292094|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171973|NCT03536884|366292095|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
106171974|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
106171975|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
106171976|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
106171977|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
106171978|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
106171979|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
106171980|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
106171981|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
106171982|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
106171983|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
106171984|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
106171985|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
106171986|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
106171987|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
106171988|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
106171989|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
106171990|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
106171991|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
106171992|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
106171993|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
106171994|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
106171995|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
106171996|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
106171997|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
106171998|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106171999|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172000|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172001|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172002|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172003|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
106172004|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172005|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
106172006|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172007|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172008|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172009|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
106172010|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172011|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172012|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172013|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172014|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172015|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
106172016|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172017|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
106172018|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
106172019|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172020|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172021|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
106172022|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
106172023|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
106172024|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
106172025|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
106172026|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
106172027|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
106172028|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
106172029|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
106172030|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
106172031|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
106172032|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
106172033|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
106172034|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172035|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172036|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172037|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172038|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172039|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
106172040|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172041|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172042|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172043|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172044|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172045|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
106172046|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172047|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172048|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172049|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172050|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172051|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172052|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
106172053|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172054|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172055|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172056|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172057|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
106172058|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172059|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172060|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172061|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172062|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172063|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172064|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
106172065|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172066|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172067|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172068|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172069|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
106172070|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172071|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172072|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172073|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172074|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172075|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
106172076|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172077|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172078|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172079|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172080|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172081|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
106172082|NCT03536884|366292084|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172083|NCT03536884|366292085|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172084|NCT03536884|366292086|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172085|NCT03536884|366292087|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172086|NCT03536884|366292088|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172087|NCT03536884|366292089|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172088|NCT03536884|366292090|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172089|NCT03536884|366292091|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172090|NCT03536884|366292092|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
106172091|NCT03536884|366292093|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172092|NCT03536884|366292094|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172093|NCT03536884|366292095|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
106172094|NCT03536884|366292084|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172095|NCT03536884|366292085|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172096|NCT03536884|366292086|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172097|NCT03536884|366292087|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172098|NCT03536884|366292088|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172099|NCT03536884|366292089|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172100|NCT03536884|366292090|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172101|NCT03536884|366292091|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172102|NCT03536884|366292092|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
106172103|NCT03536884|366292093|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
106172104|NCT03536884|366292094|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
106172105|NCT03536884|366292095|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
106172106|NCT03536884|366292084|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172107|NCT03536884|366292085|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172108|NCT03536884|366292086|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172109|NCT03536884|366292087|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172110|NCT03536884|366292088|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172111|NCT03536884|366292089|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172112|NCT03536884|366292090|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172113|NCT03536884|366292091|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172114|NCT03536884|366292092|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
106172115|NCT03536884|366292093|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
106172116|NCT03536884|366292094|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
106172117|NCT03536884|366292095|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
106172118|NCT03536884|366292084|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172119|NCT03536884|366292085|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172120|NCT03536884|366292086|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172121|NCT03536884|366292087|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172122|NCT03536884|366292088|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172123|NCT03536884|366292089|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172124|NCT03536884|366292090|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172125|NCT03536884|366292091|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172126|NCT03536884|366292092|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172127|NCT03536884|366292093|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172128|NCT03536884|366292094|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
106172129|NCT03536884|366292095|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
106172130|NCT03536884|366292084|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172131|NCT03536884|366292085|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172132|NCT03536884|366292086|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172133|NCT03536884|366292087|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172134|NCT03536884|366292088|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172135|NCT03536884|366292089|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172136|NCT03536884|366292090|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172137|NCT03536884|366292091|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172138|NCT03536884|366292092|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172139|NCT03536884|366292093|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172140|NCT03536884|366292094|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
106172141|NCT03536884|366292095|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
106172142|NCT03536884|366292084|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172143|NCT03536884|366292085|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172144|NCT03536884|366292086|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172145|NCT03536884|366292087|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172146|NCT03536884|366292088|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172147|NCT03536884|366292089|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172148|NCT03536884|366292090|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172149|NCT03536884|366292091|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172150|NCT03536884|366292092|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172151|NCT03536884|366292093|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
105867318|NCT03888066|365164936|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
105867319|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
106172152|NCT03536884|366292094|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
106172153|NCT03536884|366292095|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
106172154|NCT04804540|366292100|FG000|Overall Study|Adverse Event|26|||
106172155|NCT04804540|366292101|FG001|Overall Study|Adverse Event|13|||
106172156|NCT01828021|366292102|FG000|Overall Study|Adverse Event|5|||
106172157|NCT01828021|366292102|FG000|Overall Study|Lack of Efficacy|17|||
106172158|NCT01828021|366292102|FG000|Overall Study|Withdrawal by Subject|2|||
106172159|NCT01828021|366292102|FG000|Overall Study|Ileal obstruction, unrelated|1|||
106172160|NCT02413489|366292103|FG000|Overall Study|Death|11|||
106172161|NCT02413489|366292104|FG001|Overall Study|Death|3|||
106172162|NCT02413489|366292105|FG002|Overall Study|Death|4|||
106172163|NCT02413489|366292103|FG000|Overall Study|Withdrawal by Subject|2|||
106172164|NCT02413489|366292104|FG001|Overall Study|Withdrawal by Subject|0|||
106172165|NCT02413489|366292105|FG002|Overall Study|Withdrawal by Subject|0|||
106172166|NCT02413489|366292103|FG000|Overall Study|Study Terminated By Sponsor|2|||
106172167|NCT02413489|366292104|FG001|Overall Study|Study Terminated By Sponsor|13|||
106172168|NCT02413489|366292105|FG002|Overall Study|Study Terminated By Sponsor|1|||
106172169|NCT04479761|366292106|FG000|Overall Study|could not perform the balance tasks|1|||
106172170|NCT04479761|366292107|FG001|Overall Study|could not perform the balance tasks|0|||
106172171|NCT04479761|366292108|FG002|Overall Study|could not perform the balance tasks|0|||
106172172|NCT04479761|366292106|FG000|Overall Study|Adverse Event|1|||
106172173|NCT04479761|366292107|FG001|Overall Study|Adverse Event|0|||
106172174|NCT04479761|366292108|FG002|Overall Study|Adverse Event|0|||
106172175|NCT04479761|366292106|FG000|Overall Study|one control did not meet screening criteria|0|||
106172176|NCT04479761|366292107|FG001|Overall Study|one control did not meet screening criteria|0|||
106172177|NCT04479761|366292108|FG002|Overall Study|one control did not meet screening criteria|1|||
106172178|NCT04479761|366292106|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
106172179|NCT04479761|366292107|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
106172180|NCT04479761|366292108|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
106172181|NCT04063878|366292109|FG000|Overall Study|Withdrawal by Subject|2|||
106172182|NCT04063878|366292109|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
106172183|NCT01199133|366292110|FG000|Year 1|Adverse Event|16|||
106172184|NCT01199133|366292111|FG001|Year 1|Adverse Event|4|||
106172185|NCT01199133|366292110|FG000|Year 1|Withdrawal by Subject|8|||
106172186|NCT01199133|366292111|FG001|Year 1|Withdrawal by Subject|4|||
106172187|NCT01199133|366292110|FG000|Year 1|Any other reason not above-mentioned|6|||
106172188|NCT01199133|366292111|FG001|Year 1|Any other reason not above-mentioned|7|||
106172189|NCT01199133|366292110|FG000|Year 2|Adverse Event|1|||
106172190|NCT01199133|366292111|FG001|Year 2|Adverse Event|0|||
106172191|NCT01199133|366292110|FG000|Year 2|Withdrawal by Subject|1|||
106172192|NCT01199133|366292111|FG001|Year 2|Withdrawal by Subject|1|||
106172193|NCT01199133|366292110|FG000|Year 2|Any other reason not above-mentioned|1|||
106172194|NCT01199133|366292111|FG001|Year 2|Any other reason not above-mentioned|2|||
106172195|NCT04778410|366292113|FG000|Safety Run-in Period|Death|5|||
106172196|NCT04778410|366292114|FG001|Safety Run-in Period|Death|6|||
106172197|NCT04778410|366292115|FG002|Safety Run-in Period|Death|0|||
106172198|NCT04778410|366292116|FG003|Safety Run-in Period|Death|0|||
106172199|NCT04778410|366292117|FG004|Safety Run-in Period|Death|0|||
106172200|NCT04778410|366292118|FG005|Safety Run-in Period|Death|0|||
106172201|NCT04778410|366292113|FG000|Phase 2 Period|Death|0|||
106172202|NCT04778410|366292114|FG001|Phase 2 Period|Death|0|||
106172203|NCT04778410|366292115|FG002|Phase 2 Period|Death|0|||
106172204|NCT04778410|366292116|FG003|Phase 2 Period|Death|5|||
106172205|NCT04778410|366292117|FG004|Phase 2 Period|Death|18|||
106172206|NCT04778410|366292118|FG005|Phase 2 Period|Death|0|||
106172207|NCT04778410|366292113|FG000|Phase 2 Period|Lost to Follow-up|0|||
106172208|NCT04778410|366292114|FG001|Phase 2 Period|Lost to Follow-up|0|||
106172209|NCT04778410|366292115|FG002|Phase 2 Period|Lost to Follow-up|0|||
106172210|NCT04778410|366292116|FG003|Phase 2 Period|Lost to Follow-up|1|||
106172211|NCT04778410|366292117|FG004|Phase 2 Period|Lost to Follow-up|1|||
106172212|NCT04778410|366292118|FG005|Phase 2 Period|Lost to Follow-up|0|||
106172213|NCT04778410|366292113|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
106172214|NCT04778410|366292114|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
106172215|NCT04778410|366292115|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
106172216|NCT04778410|366292116|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
106172217|NCT04778410|366292117|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
106172218|NCT04778410|366292118|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
105867320|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
106172219|NCT04778410|366292113|FG000|Phase 2 Period|Withdrew Consent|0|||
106172220|NCT04778410|366292114|FG001|Phase 2 Period|Withdrew Consent|0|||
106172221|NCT04778410|366292115|FG002|Phase 2 Period|Withdrew Consent|0|||
106172222|NCT04778410|366292116|FG003|Phase 2 Period|Withdrew Consent|0|||
106172223|NCT04778410|366292117|FG004|Phase 2 Period|Withdrew Consent|2|||
106172224|NCT04778410|366292118|FG005|Phase 2 Period|Withdrew Consent|0|||
106172225|NCT00964392|366292121|FG000|Overall Study|Withdrawal by Subject|4|||
106172226|NCT00964392|366292122|FG001|Overall Study|Withdrawal by Subject|6|||
106172227|NCT00964392|366292121|FG000|Overall Study|Lost to Follow-up|4|||
106172228|NCT00964392|366292122|FG001|Overall Study|Lost to Follow-up|10|||
106172229|NCT00964392|366292121|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
106172230|NCT00964392|366292122|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
106172231|NCT00964392|366292121|FG000|Overall Study|Not completed|44|||
106172232|NCT00964392|366292122|FG001|Overall Study|Not completed|168|||
106172233|NCT04271046|366292123|FG000|Overall Study|Death|0|||
106172234|NCT04271046|366292124|FG001|Overall Study|Death|2|||
106172235|NCT04271046|366292125|FG002|Overall Study|Death|0|||
106172236|NCT04271046|366292126|FG003|Overall Study|Death|2|||
106172237|NCT04271046|366292123|FG000|Overall Study|Lost to Follow-up|12|||
106172238|NCT04271046|366292124|FG001|Overall Study|Lost to Follow-up|12|||
106172239|NCT04271046|366292125|FG002|Overall Study|Lost to Follow-up|11|||
106172240|NCT04271046|366292126|FG003|Overall Study|Lost to Follow-up|11|||
106172241|NCT04271046|366292123|FG000|Overall Study|Patient with Dementia Died|2|||
106172242|NCT04271046|366292124|FG001|Overall Study|Patient with Dementia Died|0|||
106172243|NCT04271046|366292125|FG002|Overall Study|Patient with Dementia Died|2|||
106172244|NCT04271046|366292126|FG003|Overall Study|Patient with Dementia Died|0|||
106172245|NCT04271046|366292123|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
106172246|NCT04271046|366292124|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
106172247|NCT04271046|366292125|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
106172248|NCT04271046|366292126|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
106172249|NCT00303459|366292127|FG000|Overall Study|Death|33|||
106172250|NCT00303459|366292128|FG001|Overall Study|Death|44|||
106172251|NCT00303459|366292127|FG000|Overall Study|Withdrawal of consent|32|||
106172252|NCT00303459|366292128|FG001|Overall Study|Withdrawal of consent|26|||
106172253|NCT00303459|366292127|FG000|Overall Study|Lost to Follow-up|5|||
106172254|NCT00303459|366292128|FG001|Overall Study|Lost to Follow-up|4|||
106172255|NCT00303459|366292127|FG000|Overall Study|Administrative reason|7|||
106172256|NCT00303459|366292128|FG001|Overall Study|Administrative reason|7|||
106172257|NCT00303459|366292127|FG000|Overall Study|Decision by the investigator|5|||
106172258|NCT00303459|366292128|FG001|Overall Study|Decision by the investigator|7|||
106172259|NCT00303459|366292127|FG000|Overall Study|Lung transplantation|1|||
106172260|NCT00303459|366292128|FG001|Overall Study|Lung transplantation|1|||
106172261|NCT01570361|366292129|FG000|Overall Study|Subject discontinued|1|||
106172262|NCT01570361|366292130|FG001|Overall Study|Subject discontinued|2|||
106172263|NCT01570361|366292129|FG000|Overall Study|Sponsor closing the study|51|||
106172264|NCT01570361|366292130|FG001|Overall Study|Sponsor closing the study|50|||
106172265|NCT01570361|366292129|FG000|Overall Study|Subject excluded|5|||
106172266|NCT01570361|366292130|FG001|Overall Study|Subject excluded|3|||
106172267|NCT01570361|366292129|FG000|Overall Study|Subject withdrew consent|14|||
106172268|NCT01570361|366292130|FG001|Overall Study|Subject withdrew consent|9|||
106172269|NCT01570361|366292129|FG000|Overall Study|Adverse Event|2|||
106172270|NCT01570361|366292130|FG001|Overall Study|Adverse Event|1|||
106172271|NCT01570361|366292129|FG000|Overall Study|Lost to Follow-up|4|||
106172272|NCT01570361|366292130|FG001|Overall Study|Lost to Follow-up|4|||
106172273|NCT01570361|366292129|FG000|Overall Study|Death|5|||
106172274|NCT01570361|366292130|FG001|Overall Study|Death|4|||
106172275|NCT01570361|366292129|FG000|Overall Study|Other|0|||
106172276|NCT01570361|366292130|FG001|Overall Study|Other|2|||
106172277|NCT03673501|366293337|FG000|Overall Study|Participants ongoing.|36|||
106172278|NCT03673501|366293338|FG001|Overall Study|Participants ongoing.|24|||
106172279|NCT03714815|366293339|FG000|Overall Study|Physician Decision|2|||
106172280|NCT03714815|366293339|FG000|Overall Study|Withdrawal by Subject|2|||
106172281|NCT03714815|366293339|FG000|Overall Study|Death|11|||
106172282|NCT01909934|366293344|FG000|Overall Study|Ongoing|23|||
106172283|NCT01909934|366293344|FG000|Overall Study|Withdrawal by Subject|3|||
106172284|NCT01909934|366293344|FG000|Overall Study|Lost to Follow-up|1|||
106172285|NCT01909934|366293344|FG000|Overall Study|Withdrawal of Informed Consent|1|||
106172286|NCT01909934|366293344|FG000|Overall Study|Death|22|||
106172287|NCT04741776|366293346|FG000|Overall Study|Withdrawal by Subject|7|||
106172288|NCT04741776|366293347|FG001|Overall Study|Withdrawal by Subject|10|||
106172289|NCT04741776|366293348|FG002|Overall Study|Withdrawal by Subject|10|||
106172290|NCT04741776|366293349|FG003|Overall Study|Withdrawal by Subject|17|||
106172291|NCT04741776|366293346|FG000|Overall Study|Death|0|||
106172292|NCT04741776|366293347|FG001|Overall Study|Death|0|||
106172293|NCT04741776|366293348|FG002|Overall Study|Death|1|||
106172294|NCT04741776|366293349|FG003|Overall Study|Death|0|||
106172295|NCT03926130|366293350|FG000|Overall Study|Adverse Event|9|||
106172296|NCT03926130|366293351|FG001|Overall Study|Adverse Event|11|||
106172297|NCT03926130|366293352|FG002|Overall Study|Adverse Event|2|||
106172298|NCT03926130|366293353|FG003|Overall Study|Adverse Event|0|||
106172299|NCT03926130|366293350|FG000|Overall Study|Death|2|||
106172300|NCT03926130|366293351|FG001|Overall Study|Death|0|||
106172301|NCT03926130|366293352|FG002|Overall Study|Death|1|||
106172302|NCT03926130|366293353|FG003|Overall Study|Death|0|||
106172303|NCT03926130|366293350|FG000|Overall Study|Lack of Efficacy|14|||
106172304|NCT03926130|366293351|FG001|Overall Study|Lack of Efficacy|11|||
106172305|NCT03926130|366293352|FG002|Overall Study|Lack of Efficacy|7|||
106172306|NCT03926130|366293353|FG003|Overall Study|Lack of Efficacy|1|||
106172307|NCT03926130|366293350|FG000|Overall Study|Lost to Follow-up|0|||
106172308|NCT03926130|366293351|FG001|Overall Study|Lost to Follow-up|7|||
106172309|NCT03926130|366293352|FG002|Overall Study|Lost to Follow-up|1|||
106172310|NCT03926130|366293353|FG003|Overall Study|Lost to Follow-up|0|||
106172311|NCT03926130|366293350|FG000|Overall Study|As Reported by Investigator|2|||
106172312|NCT03926130|366293351|FG001|Overall Study|As Reported by Investigator|6|||
106172313|NCT03926130|366293352|FG002|Overall Study|As Reported by Investigator|6|||
106172314|NCT03926130|366293353|FG003|Overall Study|As Reported by Investigator|0|||
106172315|NCT03926130|366293350|FG000|Overall Study|Physician Decision|3|||
106172316|NCT03926130|366293351|FG001|Overall Study|Physician Decision|2|||
106172317|NCT03926130|366293352|FG002|Overall Study|Physician Decision|1|||
106172318|NCT03926130|366293353|FG003|Overall Study|Physician Decision|0|||
106172319|NCT03926130|366293350|FG000|Overall Study|Pregnancy|2|||
106172320|NCT03926130|366293351|FG001|Overall Study|Pregnancy|2|||
106172321|NCT03926130|366293352|FG002|Overall Study|Pregnancy|1|||
106172322|NCT03926130|366293353|FG003|Overall Study|Pregnancy|0|||
106172323|NCT03926130|366293350|FG000|Overall Study|Withdrawal by Subject|20|||
106172324|NCT03926130|366293351|FG001|Overall Study|Withdrawal by Subject|28|||
106172325|NCT03926130|366293352|FG002|Overall Study|Withdrawal by Subject|18|||
106172326|NCT03926130|366293353|FG003|Overall Study|Withdrawal by Subject|1|||
106172327|NCT03926130|366293350|FG000|Overall Study|Non-Compliance|1|||
106172328|NCT03926130|366293351|FG001|Overall Study|Non-Compliance|1|||
106172329|NCT03926130|366293352|FG002|Overall Study|Non-Compliance|0|||
106172330|NCT03926130|366293353|FG003|Overall Study|Non-Compliance|0|||
106172331|NCT03926130|366293350|FG000|Overall Study|Disposition Not Captured|0|||
106172332|NCT03926130|366293351|FG001|Overall Study|Disposition Not Captured|2|||
106172333|NCT03926130|366293352|FG002|Overall Study|Disposition Not Captured|1|||
106172334|NCT03926130|366293353|FG003|Overall Study|Disposition Not Captured|0|||
106172335|NCT01730937|366293354|FG000|Overall Study|Protocol Violation|5|||
106172336|NCT01730937|366293355|FG001|Overall Study|Protocol Violation|11|||
106172337|NCT04659603|366293360|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|0|||
106172338|NCT04659603|366293361|FG001|Overall Study|Ongoing study treatment at the time of primary analysis completion|0|||
106172339|NCT04659603|366293362|FG002|Overall Study|Ongoing study treatment at the time of primary analysis completion|6|||
106172340|NCT04659603|366293360|FG000|Overall Study|Withdrawal by Subject|0|||
106172341|NCT04659603|366293361|FG001|Overall Study|Withdrawal by Subject|5|||
106172342|NCT04659603|366293362|FG002|Overall Study|Withdrawal by Subject|0|||
106172343|NCT04659603|366293360|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
106172344|NCT04659603|366293361|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
106172345|NCT04659603|366293362|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
106172346|NCT05405985|366293363|FG000|Overall Study|Withdrawal by Subject|1|||
106172347|NCT05405985|366293364|FG001|Overall Study|Withdrawal by Subject|0|||
106172348|NCT04282980|366293365|FG000|Overall Study|Remained on treatment|6|||
106172349|NCT04282980|366293365|FG000|Overall Study|Survival follow-up|11|||
106172350|NCT04282980|366293365|FG000|Overall Study|Withdrawal of informed consent|1|||
106172351|NCT04282980|366293365|FG000|Overall Study|Lost to Follow-up|1|||
106172352|NCT05035654|366293367|FG000|Overall Study|Physician Decision|0|||
106172353|NCT05035654|366293368|FG001|Overall Study|Physician Decision|1|||
106172354|NCT05035654|366293369|FG002|Overall Study|Physician Decision|0|||
106172355|NCT05035654|366293367|FG000|Overall Study|Adverse Event|0|||
106172356|NCT05035654|366293368|FG001|Overall Study|Adverse Event|1|||
106172357|NCT05035654|366293369|FG002|Overall Study|Adverse Event|0|||
106172358|NCT05035654|366293367|FG000|Overall Study|Withdrawal by Subject|0|||
106172359|NCT05035654|366293368|FG001|Overall Study|Withdrawal by Subject|0|||
106172360|NCT05035654|366293369|FG002|Overall Study|Withdrawal by Subject|4|||
106172361|NCT05035654|366293367|FG000|Overall Study|Bilateral Dislodgement|1|||
106172362|NCT05035654|366293368|FG001|Overall Study|Bilateral Dislodgement|0|||
106172363|NCT05035654|366293369|FG002|Overall Study|Bilateral Dislodgement|0|||
106172364|NCT04679935|366293371|FG000|Overall Study|Death|0|||
105867321|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
106172365|NCT04679935|366293372|FG001|Overall Study|Death|1|||
106172366|NCT02988661|366293373|FG000|Overall Study|Death|2|||
106172367|NCT02988661|366293374|FG001|Overall Study|Death|18|||
106172368|NCT02988661|366293373|FG000|Overall Study|Lost to Follow-up|0|||
106172369|NCT02988661|366293374|FG001|Overall Study|Lost to Follow-up|33|||
106172370|NCT02988661|366293373|FG000|Overall Study|Withdrawal by Subject|0|||
106172371|NCT02988661|366293374|FG001|Overall Study|Withdrawal by Subject|6|||
106172372|NCT02988661|366293373|FG000|Overall Study|Unable to complete the 18-month survey|1|||
106172373|NCT02988661|366293374|FG001|Overall Study|Unable to complete the 18-month survey|27|||
106172374|NCT02839265|366293375|FG000|Overall Study|Screen Failure|2|||
106172375|NCT02839265|366293375|FG000|Overall Study|Death|1|||
106172376|NCT02839265|366293375|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
106172393|NCT04451772|366293391|FG000|Overall Study|Adverse Event|1|||
106172394|NCT04451772|366293392|FG001|Overall Study|Adverse Event|0|||
106172395|NCT04451772|366293393|FG002|Overall Study|Adverse Event|1|||
106172396|NCT04451772|366293394|FG003|Overall Study|Adverse Event|1|||
106172397|NCT04451772|366293395|FG004|Overall Study|Adverse Event|0|||
106172398|NCT04451772|366293396|FG005|Overall Study|Adverse Event|3|||
106172399|NCT04451772|366293391|FG000|Overall Study|Withdrawal by Subject|2|||
106172400|NCT04451772|366293392|FG001|Overall Study|Withdrawal by Subject|7|||
106172401|NCT04451772|366293393|FG002|Overall Study|Withdrawal by Subject|2|||
106172402|NCT04451772|366293394|FG003|Overall Study|Withdrawal by Subject|1|||
106172403|NCT04451772|366293395|FG004|Overall Study|Withdrawal by Subject|1|||
106172404|NCT04451772|366293396|FG005|Overall Study|Withdrawal by Subject|0|||
106172405|NCT04451772|366293391|FG000|Overall Study|Other, not specified|1|||
106172406|NCT04451772|366293392|FG001|Overall Study|Other, not specified|2|||
106172407|NCT04451772|366293393|FG002|Overall Study|Other, not specified|1|||
106172408|NCT04451772|366293394|FG003|Overall Study|Other, not specified|0|||
106172409|NCT04451772|366293395|FG004|Overall Study|Other, not specified|0|||
106172410|NCT04451772|366293396|FG005|Overall Study|Other, not specified|1|||
106172411|NCT04451772|366293391|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
106172412|NCT04451772|366293392|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
106172413|NCT04451772|366293393|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
106172414|NCT04451772|366293394|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
106172415|NCT04451772|366293395|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
106172416|NCT04451772|366293396|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
106172417|NCT04311632|366293397|FG000|Overall Study|Withdrawal by Subject|0|||
106172418|NCT04311632|366293398|FG001|Overall Study|Withdrawal by Subject|0|||
106172419|NCT04311632|366293399|FG002|Overall Study|Withdrawal by Subject|1|||
106172420|NCT04934072|366293400|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
106172421|NCT04934072|366293401|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
106172422|NCT04934072|366293402|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
106172423|NCT04934072|366293403|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
106172424|NCT04934072|366293404|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
106172425|NCT04934072|366293400|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
106172426|NCT04934072|366293401|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
106172427|NCT04934072|366293402|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
106172428|NCT04934072|366293403|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
106172429|NCT04934072|366293404|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
106172430|NCT04934072|366293400|FG000|Day 0 to Week 52|Other|3|||
106172431|NCT04934072|366293401|FG001|Day 0 to Week 52|Other|1|||
106172432|NCT04934072|366293402|FG002|Day 0 to Week 52|Other|0|||
106172433|NCT04934072|366293403|FG003|Day 0 to Week 52|Other|0|||
106172434|NCT04934072|366293404|FG004|Day 0 to Week 52|Other|0|||
106172435|NCT04934072|366293400|FG000|Day 0 to Week 52|Adverse Event|1|||
106172436|NCT04934072|366293401|FG001|Day 0 to Week 52|Adverse Event|3|||
106172437|NCT04934072|366293402|FG002|Day 0 to Week 52|Adverse Event|0|||
106172438|NCT04934072|366293403|FG003|Day 0 to Week 52|Adverse Event|0|||
106172439|NCT04934072|366293404|FG004|Day 0 to Week 52|Adverse Event|0|||
106172440|NCT04934072|366293400|FG000|Week 52 to Week 78|Adverse Event|0|||
106172441|NCT04934072|366293401|FG001|Week 52 to Week 78|Adverse Event|0|||
106172442|NCT04934072|366293402|FG002|Week 52 to Week 78|Adverse Event|0|||
106172443|NCT04934072|366293403|FG003|Week 52 to Week 78|Adverse Event|1|||
106172444|NCT04934072|366293404|FG004|Week 52 to Week 78|Adverse Event|1|||
106172445|NCT04934072|366293400|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
106172446|NCT04934072|366293401|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
106172447|NCT04934072|366293402|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
106172448|NCT04934072|366293403|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
106172449|NCT04934072|366293404|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
106172450|NCT04934072|366293400|FG000|Week 52 to Week 78|Other|0|||
106172451|NCT04934072|366293401|FG001|Week 52 to Week 78|Other|0|||
106172452|NCT04934072|366293402|FG002|Week 52 to Week 78|Other|1|||
106172453|NCT04934072|366293403|FG003|Week 52 to Week 78|Other|0|||
106172454|NCT04934072|366293404|FG004|Week 52 to Week 78|Other|0|||
106172455|NCT05424380|366293412|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
106172456|NCT05424380|366293413|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
106172457|NCT05424380|366293414|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
106172458|NCT05424380|366293415|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
106172459|NCT05424380|366293416|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
106172460|NCT05424380|366293417|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
106172461|NCT05424380|366293412|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
106172462|NCT05424380|366293413|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
106172463|NCT05424380|366293414|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
106172464|NCT05424380|366293415|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
106172465|NCT05424380|366293416|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
106172466|NCT05424380|366293417|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
106172467|NCT05424380|366293412|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
106172468|NCT05424380|366293413|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
106172469|NCT05424380|366293414|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
106172470|NCT05424380|366293415|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
106172471|NCT05424380|366293416|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
106172472|NCT05424380|366293417|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
106172473|NCT05424380|366293412|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
106172474|NCT05424380|366293413|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
106172475|NCT05424380|366293414|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
106172476|NCT05424380|366293415|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
106172477|NCT05424380|366293416|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
106172478|NCT05424380|366293417|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
106172479|NCT05424380|366293412|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
106172480|NCT05424380|366293413|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
106172481|NCT05424380|366293414|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
106172482|NCT05424380|366293415|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
106172483|NCT05424380|366293416|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
106172484|NCT05424380|366293417|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
106172485|NCT05424380|366293412|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
106172486|NCT05424380|366293413|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
106172487|NCT05424380|366293414|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
106172488|NCT05424380|366293415|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
106172489|NCT05424380|366293416|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
106172490|NCT05424380|366293417|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
106172491|NCT05424380|366293412|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
106172492|NCT05424380|366293413|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
106172493|NCT05424380|366293414|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
106172494|NCT05424380|366293415|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
106172495|NCT05424380|366293416|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
106172496|NCT05424380|366293417|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
106172497|NCT05424380|366293412|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
106172498|NCT05424380|366293413|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
106172499|NCT05424380|366293414|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
106172500|NCT05424380|366293415|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
106172501|NCT05424380|366293416|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
106172502|NCT05424380|366293417|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
106172503|NCT05424380|366293412|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172504|NCT05424380|366293413|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172505|NCT05424380|366293414|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172506|NCT05424380|366293415|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
106172507|NCT05424380|366293416|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172508|NCT05424380|366293417|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172509|NCT05424380|366293412|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
106172510|NCT05424380|366293413|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
106172511|NCT05424380|366293414|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
106172512|NCT05424380|366293415|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
106172513|NCT05424380|366293416|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
106172514|NCT05424380|366293417|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
106172515|NCT05424380|366293412|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
106172516|NCT05424380|366293413|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
106172517|NCT05424380|366293414|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
106172518|NCT05424380|366293415|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
106172519|NCT05424380|366293416|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
106172520|NCT05424380|366293417|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
106172521|NCT05424380|366293412|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
106172522|NCT05424380|366293413|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
106172523|NCT05424380|366293414|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
106172524|NCT05424380|366293415|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
106172525|NCT05424380|366293416|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
106172526|NCT05424380|366293417|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
106172527|NCT05424380|366293412|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172528|NCT05424380|366293413|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172529|NCT05424380|366293414|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172530|NCT05424380|366293415|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172531|NCT05424380|366293416|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
106172532|NCT05424380|366293417|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
106172533|NCT05424380|366293412|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
106172534|NCT05424380|366293413|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
106172535|NCT05424380|366293414|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
106172536|NCT05424380|366293415|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
106172537|NCT05424380|366293416|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
106172538|NCT05424380|366293417|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
106172539|NCT02909686|366293418|FG000|Overall Study|Physician Decision|3|||
106172540|NCT02909686|366293418|FG000|Overall Study|Withdrawal by Subject|2|||
106172541|NCT02828358|366293423|FG000|Overall Study|Physician Decision|7|||
106172542|NCT02828358|366293424|FG001|Overall Study|Physician Decision|1|||
106172543|NCT02828358|366293423|FG000|Overall Study|Treatment Failure|6|||
106172544|NCT02828358|366293424|FG001|Overall Study|Treatment Failure|0|||
106172545|NCT02828358|366293423|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
106172546|NCT02828358|366293424|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
106172547|NCT02828358|366293423|FG000|Overall Study|Refusal of further protocol therapy|2|||
106172548|NCT02828358|366293424|FG001|Overall Study|Refusal of further protocol therapy|0|||
106172549|NCT02828358|366293423|FG000|Overall Study|Relapse|25|||
106172550|NCT02828358|366293424|FG001|Overall Study|Relapse|0|||
106172551|NCT02828358|366293423|FG000|Overall Study|Still on therapy|5|||
106172552|NCT02828358|366293424|FG001|Overall Study|Still on therapy|0|||
106172553|NCT05172232|366293425|FG000|Overall Study|Lost to Follow-up|3|||
106172554|NCT02575950|366293426|FG000|Overall Study|Withdrawal by Subject|0|||
106172555|NCT02575950|366293427|FG001|Overall Study|Withdrawal by Subject|0|||
106172556|NCT02575950|366293428|FG002|Overall Study|Withdrawal by Subject|0|||
106172557|NCT02575950|366293429|FG003|Overall Study|Withdrawal by Subject|2|||
106172558|NCT02575950|366293426|FG000|Overall Study|Lost to Follow-up|0|||
106172559|NCT02575950|366293427|FG001|Overall Study|Lost to Follow-up|1|||
106172560|NCT02575950|366293428|FG002|Overall Study|Lost to Follow-up|0|||
106172561|NCT02575950|366293429|FG003|Overall Study|Lost to Follow-up|3|||
106172562|NCT04129554|366293430|FG000|Overall Study|Withdrawal by Subject|4|||
106172563|NCT04129554|366293431|FG001|Overall Study|Withdrawal by Subject|3|||
106172564|NCT04129554|366293430|FG000|Overall Study|Other|0|||
106172565|NCT04129554|366293431|FG001|Overall Study|Other|2|||
106172566|NCT02492711|366293434|FG000|Overall Study|Adverse Event|9|||
106172567|NCT02492711|366293435|FG001|Overall Study|Adverse Event|9|||
106172568|NCT02492711|366293436|FG002|Overall Study|Adverse Event|2|||
106172569|NCT02492711|366293434|FG000|Overall Study|Death|3|||
106172570|NCT02492711|366293435|FG001|Overall Study|Death|3|||
106172571|NCT02492711|366293436|FG002|Overall Study|Death|0|||
106172572|NCT02492711|366293434|FG000|Overall Study|Withdrawal by Subject|10|||
106172573|NCT02492711|366293435|FG001|Overall Study|Withdrawal by Subject|16|||
106172574|NCT02492711|366293436|FG002|Overall Study|Withdrawal by Subject|5|||
106172575|NCT02492711|366293434|FG000|Overall Study|Physician Decision|10|||
106172576|NCT02492711|366293435|FG001|Overall Study|Physician Decision|6|||
106172577|NCT02492711|366293436|FG002|Overall Study|Physician Decision|4|||
106172578|NCT02492711|366293434|FG000|Overall Study|Lost to Follow-up|0|||
106172579|NCT02492711|366293435|FG001|Overall Study|Lost to Follow-up|0|||
106172580|NCT02492711|366293436|FG002|Overall Study|Lost to Follow-up|1|||
106172581|NCT02492711|366293434|FG000|Overall Study|study treatment delay|2|||
106172582|NCT02492711|366293435|FG001|Overall Study|study treatment delay|1|||
106172583|NCT02492711|366293436|FG002|Overall Study|study treatment delay|0|||
106172584|NCT02492711|366293434|FG000|Overall Study|change in chemotherapy|0|||
106172585|NCT02492711|366293435|FG001|Overall Study|change in chemotherapy|1|||
106172586|NCT02492711|366293436|FG002|Overall Study|change in chemotherapy|0|||
106172587|NCT02492711|366293434|FG000|Overall Study|never treated|2|||
106172588|NCT02492711|366293435|FG001|Overall Study|never treated|4|||
106172589|NCT02492711|366293436|FG002|Overall Study|never treated|0|||
106172590|NCT02492711|366293434|FG000|Overall Study|Other|0|||
106172591|NCT02492711|366293435|FG001|Overall Study|Other|0|||
106172592|NCT02492711|366293436|FG002|Overall Study|Other|1|||
106172593|NCT03672916|366294907|FG000|Overall Study|Death|6|||
106172594|NCT03672916|366294907|FG000|Overall Study|Lost to Follow-up|29|||
106172595|NCT03672916|366294907|FG000|Overall Study|Adverse Event|6|||
106172596|NCT03672916|366294907|FG000|Overall Study|Withdrawal by Subject|11|||
106172597|NCT05363163|366294915|FG000|Overall Study|Withdrawal by Subject|13|||
106172598|NCT02906007|366294916|FG000|Overall Study|Physician Decision|0|||
106172599|NCT02906007|366294917|FG001|Overall Study|Physician Decision|0|||
106172600|NCT02906007|366294918|FG002|Overall Study|Physician Decision|1|||
106172601|NCT02906007|366294916|FG000|Overall Study|Died|1|||
106172602|NCT02906007|366294917|FG001|Overall Study|Died|0|||
106172603|NCT02906007|366294918|FG002|Overall Study|Died|0|||
106172604|NCT01314105|366294919|FG000|Overall Study|Progressive Disease|6|||
106172605|NCT01314105|366294920|FG001|Overall Study|Progressive Disease|10|||
106172606|NCT01314105|366294919|FG000|Overall Study|Refused to continue taking medication|0|||
106172607|NCT01314105|366294920|FG001|Overall Study|Refused to continue taking medication|1|||
106172608|NCT01314105|366294919|FG000|Overall Study|Other Adverse Event|1|||
106172609|NCT01314105|366294920|FG001|Overall Study|Other Adverse Event|1|||
106172610|NCT06106022|366294921|FG000|Overall Study|Lost to Follow-up|1|||
106172611|NCT06106022|366294922|FG001|Overall Study|Lost to Follow-up|0|||
106172612|NCT06106022|366294921|FG000|Overall Study|Voluntary Withdrawal|0|||
106172613|NCT06106022|366294922|FG001|Overall Study|Voluntary Withdrawal|2|||
106172614|NCT03276676|366294923|FG000|Overall Study|Withdrawal by Subject|2|||
106172615|NCT03276676|366294924|FG001|Overall Study|Withdrawal by Subject|1|||
106172616|NCT04089865|366294925|FG000|Overall Study|Withdrawal by Subject|2|||
106172617|NCT04089865|366294926|FG001|Overall Study|Withdrawal by Subject|2|||
106172618|NCT04089865|366294927|FG002|Overall Study|Withdrawal by Subject|7|||
106172619|NCT04089865|366294928|FG003|Overall Study|Withdrawal by Subject|2|||
106172620|NCT03583333|366294929|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
106172621|NCT03583333|366294930|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
106172622|NCT03583333|366294929|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
106172623|NCT03583333|366294930|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
106172624|NCT03583333|366294929|FG000|Overall Study|Withdrawal by Subject|9|||
106172625|NCT03583333|366294930|FG001|Overall Study|Withdrawal by Subject|5|||
106172626|NCT03583333|366294929|FG000|Overall Study|Physician Decision|3|||
106172627|NCT03583333|366294930|FG001|Overall Study|Physician Decision|2|||
106172628|NCT03583333|366294929|FG000|Overall Study|Death|12|||
106172629|NCT03583333|366294930|FG001|Overall Study|Death|7|||
106172630|NCT00323856|366294935|FG000|Overall Study|Withdrawal by Subject|1|||
106172631|NCT00323856|366294935|FG000|Overall Study|Was uncooperative and noncompliant|1|||
106172632|NCT00323856|366294935|FG000|Overall Study|Reason not specified|1|||
106172633|NCT00323856|366294935|FG000|Overall Study|Missing|2|||
106172634|NCT05660434|366294941|FG000|Overall Study|Never obtained study materials|2|||
106172635|NCT05660434|366294942|FG001|Overall Study|Never obtained study materials|1|||
106172636|NCT03858517|366294943|FG000|Overall Study|Adverse Event|1|||
106172637|NCT03858517|366294943|FG000|Overall Study|Lost to Follow-up|1|||
106172638|NCT03858517|366294943|FG000|Overall Study|removed for being incarcerated|1|||
106172639|NCT03858517|366294943|FG000|Overall Study|Sponsor Closure|48|||
106172640|NCT06037668|366294947|FG000|Overall Study|Lost to Follow-up|1|||
106172641|NCT06037668|366294948|FG001|Overall Study|Lost to Follow-up|1|||
106172642|NCT06037668|366294947|FG000|Overall Study|Protocol Violation|1|||
106172643|NCT06037668|366294948|FG001|Overall Study|Protocol Violation|0|||
106172644|NCT06037668|366294947|FG000|Overall Study|Withdrawal by Subject|1|||
106172645|NCT06037668|366294948|FG001|Overall Study|Withdrawal by Subject|0|||
106172646|NCT06037668|366294947|FG000|Overall Study|Other Study Discontinuation Reason|1|||
106172647|NCT06037668|366294948|FG001|Overall Study|Other Study Discontinuation Reason|0|||
106172648|NCT05224544|366294949|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
106172649|NCT05224544|366294950|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
106172650|NCT03213678|366294952|FG000|Overall Study|Death|1|||
106172651|NCT03213678|366294952|FG000|Overall Study|Physician Decision|1|||
106172652|NCT03213678|366294952|FG000|Overall Study|Progressive disease|16|||
106172653|NCT04218851|366294953|FG000|Overall Study|Death|1|||
106172654|NCT04218851|366294954|FG001|Overall Study|Death|3|||
106172655|NCT00844415|366294955|FG000|Overall Study|Withdrawal by Subject|1|||
106172656|NCT05285137|366294958|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
106172657|NCT05285137|366294959|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
106172658|NCT05285137|366294960|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
106172659|NCT05285137|366294961|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
106172660|NCT05285137|366294962|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
106172661|NCT05285137|366294963|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
106172662|NCT05285137|366294964|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
106172663|NCT05285137|366294965|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
106172664|NCT05285137|366294966|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
106172665|NCT05285137|366294958|FG000|Overall Study|Lost to Follow-up|0|||
106172666|NCT05285137|366294959|FG001|Overall Study|Lost to Follow-up|0|||
106172667|NCT05285137|366294960|FG002|Overall Study|Lost to Follow-up|1|||
106172668|NCT05285137|366294961|FG003|Overall Study|Lost to Follow-up|3|||
106172669|NCT05285137|366294962|FG004|Overall Study|Lost to Follow-up|0|||
106172670|NCT05285137|366294963|FG005|Overall Study|Lost to Follow-up|0|||
106172671|NCT05285137|366294964|FG006|Overall Study|Lost to Follow-up|1|||
106172672|NCT05285137|366294965|FG007|Overall Study|Lost to Follow-up|0|||
106172673|NCT05285137|366294966|FG008|Overall Study|Lost to Follow-up|0|||
106172674|NCT05285137|366294958|FG000|Overall Study|Physician Decision|0|||
106172675|NCT05285137|366294959|FG001|Overall Study|Physician Decision|1|||
106172676|NCT05285137|366294960|FG002|Overall Study|Physician Decision|0|||
106172677|NCT05285137|366294961|FG003|Overall Study|Physician Decision|0|||
106172678|NCT05285137|366294962|FG004|Overall Study|Physician Decision|0|||
106172679|NCT05285137|366294963|FG005|Overall Study|Physician Decision|0|||
106172680|NCT05285137|366294964|FG006|Overall Study|Physician Decision|0|||
106172681|NCT05285137|366294965|FG007|Overall Study|Physician Decision|0|||
106172682|NCT05285137|366294966|FG008|Overall Study|Physician Decision|0|||
106172683|NCT05285137|366294958|FG000|Overall Study|Pregnancy|0|||
106172684|NCT05285137|366294959|FG001|Overall Study|Pregnancy|0|||
106172685|NCT05285137|366294960|FG002|Overall Study|Pregnancy|0|||
106172686|NCT05285137|366294961|FG003|Overall Study|Pregnancy|0|||
106172687|NCT05285137|366294962|FG004|Overall Study|Pregnancy|0|||
106172688|NCT05285137|366294963|FG005|Overall Study|Pregnancy|0|||
106172689|NCT05285137|366294964|FG006|Overall Study|Pregnancy|1|||
106172690|NCT05285137|366294965|FG007|Overall Study|Pregnancy|0|||
106172691|NCT05285137|366294966|FG008|Overall Study|Pregnancy|0|||
106172692|NCT05285137|366294958|FG000|Overall Study|Withdrawal by Subject|0|||
106172693|NCT05285137|366294959|FG001|Overall Study|Withdrawal by Subject|1|||
106172694|NCT05285137|366294960|FG002|Overall Study|Withdrawal by Subject|2|||
106172695|NCT05285137|366294961|FG003|Overall Study|Withdrawal by Subject|1|||
106172696|NCT05285137|366294962|FG004|Overall Study|Withdrawal by Subject|0|||
106172697|NCT05285137|366294963|FG005|Overall Study|Withdrawal by Subject|0|||
106172698|NCT05285137|366294964|FG006|Overall Study|Withdrawal by Subject|0|||
106172699|NCT05285137|366294965|FG007|Overall Study|Withdrawal by Subject|0|||
106172700|NCT05285137|366294966|FG008|Overall Study|Withdrawal by Subject|1|||
106172701|NCT03717935|366294967|FG000|Overall Study|Withdrawal by Subject|0|||
106172702|NCT03717935|366294968|FG001|Overall Study|Withdrawal by Subject|2|||
106172703|NCT01820611|366294969|FG000|Overall Study|Death|8|||
106172704|NCT01820611|366294969|FG000|Overall Study|Adverse Event|1|||
106172705|NCT01820611|366294969|FG000|Overall Study|Withdrawal by Subject|9|||
106172706|NCT02473445|366294970|FG000|Overall Study|Withdrawal by Subject|2|||
106172707|NCT02473445|366294970|FG000|Overall Study|Sponsor Decision|20|||
106172708|NCT04881461|366294971|FG000|Overall Study|Adverse Event|2|||
106172709|NCT04881461|366294972|FG001|Overall Study|Adverse Event|4|||
106172710|NCT04881461|366294971|FG000|Overall Study|Withdrawal by Subject|19|||
106172711|NCT04881461|366294972|FG001|Overall Study|Withdrawal by Subject|19|||
106172712|NCT04881461|366294971|FG000|Overall Study|Lost to Follow-up|4|||
106172713|NCT04881461|366294972|FG001|Overall Study|Lost to Follow-up|4|||
106172714|NCT04881461|366294971|FG000|Overall Study|Lack of Efficacy|1|||
105867322|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
106172715|NCT04881461|366294972|FG001|Overall Study|Lack of Efficacy|0|||
106172716|NCT04881461|366294971|FG000|Overall Study|"Reason stated as other in CRF"|1|||
106172717|NCT04881461|366294972|FG001|Overall Study|"Reason stated as other in CRF"|2|||
106172718|NCT03484819|366294973|FG000|Overall Study|Death|2|||
106172719|NCT03484819|366294973|FG000|Overall Study|Adverse Event|2|||
106172720|NCT03484819|366294973|FG000|Overall Study|Physician Decision|1|||
106172721|NCT03484819|366294973|FG000|Overall Study|Withdrawal by Subject|2|||
106172722|NCT03484819|366294973|FG000|Overall Study|Disease Progression|4|||
106172723|NCT03484819|366294973|FG000|Overall Study|Complicating Condition|1|||
106172724|NCT03015532|366294974|FG000|Overall Study|Adverse Event|0|||
106172725|NCT03015532|366294975|FG001|Overall Study|Adverse Event|0|||
106172726|NCT03015532|366294976|FG002|Overall Study|Adverse Event|0|||
106172727|NCT03015532|366294977|FG003|Overall Study|Adverse Event|0|||
106172728|NCT03015532|366294978|FG004|Overall Study|Adverse Event|0|||
106172729|NCT03015532|366294979|FG005|Overall Study|Adverse Event|2|||
106172730|NCT03015532|366294980|FG006|Overall Study|Adverse Event|1|||
106172731|NCT03015532|366294981|FG007|Overall Study|Adverse Event|0|||
106172732|NCT03015532|366294974|FG000|Overall Study|Withdrawal by Subject|0|||
106172733|NCT03015532|366294975|FG001|Overall Study|Withdrawal by Subject|0|||
106172734|NCT03015532|366294976|FG002|Overall Study|Withdrawal by Subject|0|||
106172735|NCT03015532|366294977|FG003|Overall Study|Withdrawal by Subject|0|||
106172736|NCT03015532|366294978|FG004|Overall Study|Withdrawal by Subject|0|||
106172737|NCT03015532|366294979|FG005|Overall Study|Withdrawal by Subject|0|||
106172738|NCT03015532|366294980|FG006|Overall Study|Withdrawal by Subject|1|||
106172739|NCT03015532|366294981|FG007|Overall Study|Withdrawal by Subject|0|||
106172740|NCT05970861|366294982|FG000|Overall Study|Physician Decision|4|||
106172741|NCT05970861|366294983|FG001|Overall Study|Physician Decision|4|||
106172742|NCT05970861|366294982|FG000|Overall Study|Lost to Follow-up|4|||
106172743|NCT05970861|366294983|FG001|Overall Study|Lost to Follow-up|3|||
106172744|NCT02997202|366294987|FG000|Overall Study|Miscellaneous|2|||
106172745|NCT02997202|366294988|FG001|Overall Study|Miscellaneous|2|||
106172746|NCT02997202|366294987|FG000|Overall Study|Withdrawal by Subject|8|||
106172747|NCT02997202|366294988|FG001|Overall Study|Withdrawal by Subject|12|||
106172748|NCT02997202|366294987|FG000|Overall Study|Lost to Follow-up|5|||
106172749|NCT02997202|366294988|FG001|Overall Study|Lost to Follow-up|3|||
106172750|NCT02997202|366294987|FG000|Overall Study|Death|41|||
106172751|NCT02997202|366294988|FG001|Overall Study|Death|45|||
106172752|NCT05100628|366294992|FG000|Overall Study|Progressive Disease|1|||
106172753|NCT05100628|366294993|FG001|Overall Study|Progressive Disease|0|||
106172754|NCT05100628|366294994|FG002|Overall Study|Progressive Disease|0|||
106172755|NCT05100628|366294995|FG003|Overall Study|Progressive Disease|0|||
106172756|NCT05100628|366294992|FG000|Overall Study|Study Terminated by Sponsor|0|||
106172757|NCT05100628|366294993|FG001|Overall Study|Study Terminated by Sponsor|0|||
106172758|NCT05100628|366294994|FG002|Overall Study|Study Terminated by Sponsor|3|||
106172759|NCT05100628|366294995|FG003|Overall Study|Study Terminated by Sponsor|0|||
106172760|NCT05100628|366294992|FG000|Overall Study|unkown|0|||
106172761|NCT05100628|366294993|FG001|Overall Study|unkown|1|||
106172762|NCT05100628|366294994|FG002|Overall Study|unkown|0|||
106172763|NCT05100628|366294995|FG003|Overall Study|unkown|0|||
106172764|NCT05422885|366295005|FG000|Overall Study|Lost to Follow-up|1|||
106172765|NCT05422885|366295005|FG000|Overall Study|Withdrawal by Subject|2|||
106172766|NCT01121588|366295006|FG000|Overall Study|Death|5|||
106172767|NCT01121588|366295007|FG001|Overall Study|Death|3|||
106172768|NCT01121588|366295008|FG002|Overall Study|Death|13|||
106172769|NCT01121588|366295006|FG000|Overall Study|Study Terminated by Sponsor|1|||
106172770|NCT01121588|366295007|FG001|Overall Study|Study Terminated by Sponsor|1|||
106172771|NCT01121588|366295008|FG002|Overall Study|Study Terminated by Sponsor|0|||
106172772|NCT01121588|366295006|FG000|Overall Study|Participant Refused Further Followup|2|||
106172773|NCT01121588|366295007|FG001|Overall Study|Participant Refused Further Followup|0|||
106172774|NCT01121588|366295008|FG002|Overall Study|Participant Refused Further Followup|2|||
106172775|NCT01121588|366295006|FG000|Overall Study|Lost to Follow-up|0|||
106172776|NCT01121588|366295007|FG001|Overall Study|Lost to Follow-up|1|||
106172777|NCT01121588|366295008|FG002|Overall Study|Lost to Follow-up|1|||
106172778|NCT01121588|366295006|FG000|Overall Study|Non-Specified Reasons|9|||
106172779|NCT01121588|366295007|FG001|Overall Study|Non-Specified Reasons|4|||
106172780|NCT01121588|366295008|FG002|Overall Study|Non-Specified Reasons|2|||
106172781|NCT02782676|366295009|FG000|Overall Study|Lost to Follow-up|0|||
106172782|NCT02782676|366295010|FG001|Overall Study|Lost to Follow-up|1|||
106172783|NCT05513937|366295014|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
106172784|NCT05513937|366295015|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
106172785|NCT05513937|366295016|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
106172786|NCT05513937|366295017|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
106172787|NCT05513937|366295014|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
106172788|NCT05513937|366295015|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
106172789|NCT05513937|366295016|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
106172790|NCT05513937|366295017|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
106172791|NCT05513937|366295014|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
106172792|NCT05513937|366295015|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
106172793|NCT05513937|366295016|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
106172794|NCT05513937|366295017|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
106172795|NCT05513937|366295014|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
106172796|NCT05513937|366295015|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
106172797|NCT05513937|366295016|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
106172798|NCT05513937|366295017|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
106172799|NCT05513937|366295014|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
106172800|NCT05513937|366295015|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
106172801|NCT05513937|366295016|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
106172802|NCT05513937|366295017|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
106172803|NCT05513937|366295014|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
106172804|NCT05513937|366295015|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
106172805|NCT05513937|366295016|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
106172806|NCT05513937|366295017|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
106172807|NCT04924400|366295018|FG000|Overall Study|Lost to Follow-up|3|||
106172808|NCT04924400|366295019|FG001|Overall Study|Lost to Follow-up|0|||
106172809|NCT04424316|366295022|FG000|Overall Study|Adverse Event|0|||
106172810|NCT04424316|366295023|FG001|Overall Study|Adverse Event|1|||
106172811|NCT04424316|366295024|FG002|Overall Study|Adverse Event|0|||
106172812|NCT04424316|366295025|FG003|Overall Study|Adverse Event|0|||
106172813|NCT04424316|366295022|FG000|Overall Study|Death|1|||
106172814|NCT04424316|366295023|FG001|Overall Study|Death|0|||
106172815|NCT04424316|366295024|FG002|Overall Study|Death|8|||
106172816|NCT04424316|366295025|FG003|Overall Study|Death|14|||
106172817|NCT04424316|366295022|FG000|Overall Study|Lost to Follow-up|93|||
106172818|NCT04424316|366295023|FG001|Overall Study|Lost to Follow-up|88|||
106172819|NCT04424316|366295024|FG002|Overall Study|Lost to Follow-up|224|||
106172820|NCT04424316|366295025|FG003|Overall Study|Lost to Follow-up|211|||
106172821|NCT04424316|366295022|FG000|Overall Study|No longer met eligibility criteria|1|||
106172822|NCT04424316|366295023|FG001|Overall Study|No longer met eligibility criteria|0|||
106172823|NCT04424316|366295024|FG002|Overall Study|No longer met eligibility criteria|0|||
106172824|NCT04424316|366295025|FG003|Overall Study|No longer met eligibility criteria|0|||
106172825|NCT04424316|366295022|FG000|Overall Study|Other|15|||
106172826|NCT04424316|366295023|FG001|Overall Study|Other|11|||
106172827|NCT04424316|366295024|FG002|Overall Study|Other|34|||
106172828|NCT04424316|366295025|FG003|Overall Study|Other|45|||
106172829|NCT04424316|366295022|FG000|Overall Study|Physician Decision|1|||
106172830|NCT04424316|366295023|FG001|Overall Study|Physician Decision|0|||
106172831|NCT04424316|366295024|FG002|Overall Study|Physician Decision|1|||
106172832|NCT04424316|366295025|FG003|Overall Study|Physician Decision|1|||
106172833|NCT04424316|366295022|FG000|Overall Study|Protocol Violation|0|||
106172834|NCT04424316|366295023|FG001|Overall Study|Protocol Violation|1|||
106172835|NCT04424316|366295024|FG002|Overall Study|Protocol Violation|0|||
106172836|NCT04424316|366295025|FG003|Overall Study|Protocol Violation|0|||
106172837|NCT04424316|366295022|FG000|Overall Study|Withdrawal by Subject|71|||
106172838|NCT04424316|366295023|FG001|Overall Study|Withdrawal by Subject|77|||
106172839|NCT04424316|366295024|FG002|Overall Study|Withdrawal by Subject|0|||
106172840|NCT04424316|366295025|FG003|Overall Study|Withdrawal by Subject|0|||
106172841|NCT04424316|366295022|FG000|Overall Study|Withdrawal by parent/guardian|0|||
106172842|NCT04424316|366295023|FG001|Overall Study|Withdrawal by parent/guardian|0|||
106172843|NCT04424316|366295024|FG002|Overall Study|Withdrawal by parent/guardian|74|||
106172844|NCT04424316|366295025|FG003|Overall Study|Withdrawal by parent/guardian|81|||
106172845|NCT04424316|366295022|FG000|Overall Study|Randomized but not vaccinated|13|||
106172846|NCT04424316|366295023|FG001|Overall Study|Randomized but not vaccinated|21|||
106172847|NCT04424316|366295024|FG002|Overall Study|Randomized but not vaccinated|0|||
106172848|NCT04424316|366295025|FG003|Overall Study|Randomized but not vaccinated|0|||
106172849|NCT04424316|366295022|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
106172850|NCT04424316|366295023|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
106172851|NCT04424316|366295024|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
106172852|NCT04424316|366295025|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
106172853|NCT03993392|366295026|FG000|Overall Study|Withdrawal by Subject|3|||
106172854|NCT03993392|366295026|FG000|Overall Study|Lost to Follow-up|2|||
106172855|NCT03993392|366295026|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
106172856|NCT02510235|366295027|FG000|Overall Study|Withdrawal by Subject|1|||
106172857|NCT02510235|366295028|FG001|Overall Study|Withdrawal by Subject|0|||
106172858|NCT04505410|366295029|FG000|Overall Study|Adverse Event|2|||
106172859|NCT04505410|366295030|FG001|Overall Study|Adverse Event|0|||
106172860|NCT04505410|366295029|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
106172861|NCT04505410|366295030|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
106172862|NCT04505410|366295029|FG000|Overall Study|did not want to follow diet|1|||
106172863|NCT04505410|366295030|FG001|Overall Study|did not want to follow diet|0|||
106172864|NCT04505410|366295029|FG000|Overall Study|flare up of ulcerative colitis|0|||
106172865|NCT04505410|366295030|FG001|Overall Study|flare up of ulcerative colitis|1|||
106172866|NCT04505410|366295029|FG000|Overall Study|Lost to Follow-up|0|||
106172867|NCT04505410|366295030|FG001|Overall Study|Lost to Follow-up|2|||
106172868|NCT04505410|366295029|FG000|Overall Study|Lost to Follow-up|1|||
106172869|NCT04505410|366295030|FG001|Overall Study|Lost to Follow-up|0|||
106172870|NCT04505410|366295029|FG000|Overall Study|initiated another diet on their own|0|||
106172871|NCT04505410|366295030|FG001|Overall Study|initiated another diet on their own|2|||
106172872|NCT05525104|366295031|FG000|Overall Study|Failed caudal analgesia|1|||
106172873|NCT05525104|366295032|FG001|Overall Study|Failed caudal analgesia|3|||
106172874|NCT05525104|366295031|FG000|Overall Study|Premedication needed|0|||
106172875|NCT05525104|366295032|FG001|Overall Study|Premedication needed|1|||
106172876|NCT05525104|366295031|FG000|Overall Study|Protocol Violation|10|||
106172877|NCT05525104|366295032|FG001|Overall Study|Protocol Violation|0|||
106172878|NCT05525104|366295031|FG000|Overall Study|Cancelled operation|1|||
106172879|NCT05525104|366295032|FG001|Overall Study|Cancelled operation|0|||
106172880|NCT03990883|366295033|FG000|Blinded Treatment Phase|Adverse Event|1|||
106172881|NCT03990883|366295034|FG001|Blinded Treatment Phase|Adverse Event|1|||
106172882|NCT03990883|366295035|FG002|Blinded Treatment Phase|Adverse Event|0|||
106172883|NCT03990883|366295033|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
106172884|NCT03990883|366295034|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
106172885|NCT03990883|366295035|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
106172886|NCT03990883|366295033|FG000|Blinded Treatment Phase|Physician Decision|1|||
106172887|NCT03990883|366295034|FG001|Blinded Treatment Phase|Physician Decision|0|||
106172888|NCT03990883|366295035|FG002|Blinded Treatment Phase|Physician Decision|0|||
106172889|NCT03990883|366295033|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
106172890|NCT03990883|366295034|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
106172891|NCT03990883|366295035|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
106172892|NCT03990883|366295033|FG000|Blinded Treatment Phase|COVID-19|3|||
106172893|NCT03990883|366295034|FG001|Blinded Treatment Phase|COVID-19|2|||
106172894|NCT03990883|366295035|FG002|Blinded Treatment Phase|COVID-19|0|||
106172895|NCT03990883|366295033|FG000|Blinded Treatment Phase|Personal Reasons|6|||
106172896|NCT03990883|366295034|FG001|Blinded Treatment Phase|Personal Reasons|3|||
106172897|NCT03990883|366295035|FG002|Blinded Treatment Phase|Personal Reasons|0|||
106172898|NCT03990883|366295033|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
106172899|NCT03990883|366295034|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
106172900|NCT03990883|366295035|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
106172901|NCT03990883|366295033|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
106172902|NCT03990883|366295034|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
106172903|NCT03990883|366295035|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
106172904|NCT03990883|366295033|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
106172905|NCT03990883|366295034|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
106172906|NCT03990883|366295035|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
106172907|NCT04580914|366296208|FG000|Overall Study|Withdrawal by Subject|6|||
106172908|NCT04580914|366296208|FG000|Overall Study|Lost to Follow-up|2|||
106172909|NCT05533190|366296209|FG000|Overall Study|Lost to Follow-up|19|||
106172910|NCT05533190|366296210|FG001|Overall Study|Lost to Follow-up|7|||
106172911|NCT05533190|366296209|FG000|Overall Study|Failed to download app|1|||
106172912|NCT05533190|366296210|FG001|Overall Study|Failed to download app|0|||
106172913|NCT05533190|366296209|FG000|Overall Study|Thought app was a scam|1|||
106172914|NCT05533190|366296210|FG001|Overall Study|Thought app was a scam|0|||
106172915|NCT05533190|366296209|FG000|Overall Study|Withdrawal by Subject|2|||
106172916|NCT05533190|366296210|FG001|Overall Study|Withdrawal by Subject|0|||
106172917|NCT05552508|366296211|FG000|Overall Study|Adverse Event|3|||
105867323|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
105867324|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
106172918|NCT02367040|366296215|FG000|Overall Study|Lost to Follow-up|1|||
106172919|NCT02367040|366296216|FG001|Overall Study|Lost to Follow-up|1|||
106172920|NCT02367040|366296215|FG000|Overall Study|Lack of Efficacy|1|||
106172921|NCT02367040|366296216|FG001|Overall Study|Lack of Efficacy|0|||
106172922|NCT02367040|366296215|FG000|Overall Study|Additional primary malignancy|0|||
106172923|NCT02367040|366296216|FG001|Overall Study|Additional primary malignancy|1|||
106172924|NCT02367040|366296215|FG000|Overall Study|AE not associated with clinical disease progression|114|||
106172925|NCT02367040|366296216|FG001|Overall Study|AE not associated with clinical disease progression|11|||
106172926|NCT02367040|366296215|FG000|Overall Study|AE associated with clinical disease progression|1|||
106172927|NCT02367040|366296216|FG001|Overall Study|AE associated with clinical disease progression|3|||
106172928|NCT02367040|366296215|FG000|Overall Study|Physician Decision|2|||
106172929|NCT02367040|366296216|FG001|Overall Study|Physician Decision|8|||
106172930|NCT02367040|366296215|FG000|Overall Study|Non-compliance with study drug|1|||
106172931|NCT02367040|366296216|FG001|Overall Study|Non-compliance with study drug|0|||
106172932|NCT02367040|366296215|FG000|Overall Study|Failure to meet continuation criteria|1|||
106172933|NCT02367040|366296216|FG001|Overall Study|Failure to meet continuation criteria|0|||
106172934|NCT02367040|366296215|FG000|Overall Study|Switching to other therapy|2|||
106172935|NCT02367040|366296216|FG001|Overall Study|Switching to other therapy|0|||
106172936|NCT02367040|366296215|FG000|Overall Study|Withdrawal by Subject|46|||
106172937|NCT02367040|366296216|FG001|Overall Study|Withdrawal by Subject|16|||
106172938|NCT02367040|366296215|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
106172939|NCT02367040|366296216|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
106172940|NCT02367040|366296215|FG000|Overall Study|Patient decision|39|||
106172941|NCT02367040|366296216|FG001|Overall Study|Patient decision|14|||
106172942|NCT02367040|366296215|FG000|Overall Study|Required procedure failed|1|||
106172943|NCT02367040|366296216|FG001|Overall Study|Required procedure failed|0|||
106172944|NCT02367040|366296215|FG000|Overall Study|Randomized by mistake with study treatment|1|||
106172945|NCT02367040|366296216|FG001|Overall Study|Randomized by mistake with study treatment|0|||
106172946|NCT02367040|366296215|FG000|Overall Study|Protocol Violation|1|||
106172947|NCT02367040|366296216|FG001|Overall Study|Protocol Violation|0|||
106172948|NCT02367040|366296215|FG000|Overall Study|Progressive disease - radiological progression|51|||
106172949|NCT02367040|366296216|FG001|Overall Study|Progressive disease - radiological progression|78|||
106172950|NCT02367040|366296215|FG000|Overall Study|Progressive disease - clinical progression|6|||
106172951|NCT02367040|366296216|FG001|Overall Study|Progressive disease - clinical progression|6|||
106172952|NCT02367040|366296215|FG000|Overall Study|Drug not administered|3|||
106172953|NCT02367040|366296216|FG001|Overall Study|Drug not administered|2|||
106172954|NCT02367040|366296215|FG000|Overall Study|Progressive disease|0|||
106172955|NCT02367040|366296216|FG001|Overall Study|Progressive disease|1|||
106172956|NCT02367040|366296215|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
106172957|NCT02367040|366296216|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
106172958|NCT02367040|366296215|FG000|Overall Study|Death|2|||
106172959|NCT02367040|366296216|FG001|Overall Study|Death|0|||
106172960|NCT01917084|366296219|FG000|Overall Study|Withdrawal by Subject|1|||
106172961|NCT03571386|366296221|FG000|Overall Study|scheduling conflict|4|||
106172962|NCT03571386|366296222|FG001|Overall Study|scheduling conflict|0|||
106172963|NCT03571386|366296221|FG000|Overall Study|Withdrawal by Subject|15|||
106172964|NCT03571386|366296222|FG001|Overall Study|Withdrawal by Subject|5|||
106172965|NCT05856435|366296229|FG000|Overall Study|Lost to Follow-up|6|||
106172966|NCT04605159|366296230|FG000|Overall Study|Adverse Event|6|||
106172967|NCT04605159|366296231|FG001|Overall Study|Adverse Event|3|||
106172968|NCT04605159|366296232|FG002|Overall Study|Adverse Event|21|||
106172969|NCT04605159|366296233|FG003|Overall Study|Adverse Event|4|||
106172970|NCT04605159|366296230|FG000|Overall Study|Lost to Follow-up|74|||
106172971|NCT04605159|366296231|FG001|Overall Study|Lost to Follow-up|45|||
106172972|NCT04605159|366296232|FG002|Overall Study|Lost to Follow-up|119|||
106172973|NCT04605159|366296233|FG003|Overall Study|Lost to Follow-up|80|||
105867325|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
105867326|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
106172974|NCT04605159|366296230|FG000|Overall Study|Protocol Violation|4|||
106172975|NCT04605159|366296231|FG001|Overall Study|Protocol Violation|5|||
106172976|NCT04605159|366296232|FG002|Overall Study|Protocol Violation|2|||
106172977|NCT04605159|366296233|FG003|Overall Study|Protocol Violation|0|||
106172978|NCT04605159|366296230|FG000|Overall Study|Withdrawal by Subject|66|||
106172979|NCT04605159|366296231|FG001|Overall Study|Withdrawal by Subject|37|||
106172980|NCT04605159|366296232|FG002|Overall Study|Withdrawal by Subject|68|||
106172981|NCT04605159|366296233|FG003|Overall Study|Withdrawal by Subject|50|||
106172982|NCT04605159|366296230|FG000|Overall Study|Migrated / moved from the study area|32|||
106172983|NCT04605159|366296231|FG001|Overall Study|Migrated / moved from the study area|22|||
106172984|NCT04605159|366296232|FG002|Overall Study|Migrated / moved from the study area|41|||
106172985|NCT04605159|366296233|FG003|Overall Study|Migrated / moved from the study area|21|||
106172986|NCT04605159|366296230|FG000|Overall Study|Other|1|||
106172987|NCT04605159|366296231|FG001|Overall Study|Other|2|||
106172988|NCT04605159|366296232|FG002|Overall Study|Other|7|||
106172989|NCT04605159|366296233|FG003|Overall Study|Other|3|||
106172990|NCT02323880|366296234|FG000|Overall Study|Adverse Event|2|||
106172991|NCT02323880|366296235|FG001|Overall Study|Adverse Event|0|||
106172992|NCT02323880|366296236|FG002|Overall Study|Adverse Event|1|||
106172993|NCT02323880|366296237|FG003|Overall Study|Adverse Event|1|||
106172994|NCT02323880|366296238|FG004|Overall Study|Adverse Event|1|||
106172995|NCT02323880|366296239|FG005|Overall Study|Adverse Event|0|||
106172996|NCT02323880|366296240|FG006|Overall Study|Adverse Event|1|||
106172997|NCT02323880|366296241|FG007|Overall Study|Adverse Event|0|||
106172998|NCT02323880|366296234|FG000|Overall Study|Death|0|||
106172999|NCT02323880|366296235|FG001|Overall Study|Death|0|||
106173000|NCT02323880|366296236|FG002|Overall Study|Death|0|||
106173001|NCT02323880|366296237|FG003|Overall Study|Death|0|||
106173002|NCT02323880|366296238|FG004|Overall Study|Death|0|||
106173003|NCT02323880|366296239|FG005|Overall Study|Death|1|||
106173004|NCT02323880|366296240|FG006|Overall Study|Death|0|||
106173005|NCT02323880|366296241|FG007|Overall Study|Death|0|||
106173006|NCT02323880|366296234|FG000|Overall Study|Lack of Efficacy|4|||
106173007|NCT02323880|366296235|FG001|Overall Study|Lack of Efficacy|11|||
106173008|NCT02323880|366296236|FG002|Overall Study|Lack of Efficacy|5|||
106173009|NCT02323880|366296237|FG003|Overall Study|Lack of Efficacy|5|||
106173010|NCT02323880|366296238|FG004|Overall Study|Lack of Efficacy|4|||
106173011|NCT02323880|366296239|FG005|Overall Study|Lack of Efficacy|8|||
106173012|NCT02323880|366296240|FG006|Overall Study|Lack of Efficacy|4|||
106173013|NCT02323880|366296241|FG007|Overall Study|Lack of Efficacy|6|||
106173014|NCT02323880|366296234|FG000|Overall Study|Physician Decision|0|||
106173015|NCT02323880|366296235|FG001|Overall Study|Physician Decision|0|||
106173016|NCT02323880|366296236|FG002|Overall Study|Physician Decision|0|||
106173017|NCT02323880|366296237|FG003|Overall Study|Physician Decision|0|||
106173018|NCT02323880|366296238|FG004|Overall Study|Physician Decision|1|||
106173019|NCT02323880|366296239|FG005|Overall Study|Physician Decision|1|||
106173020|NCT02323880|366296240|FG006|Overall Study|Physician Decision|1|||
106173021|NCT02323880|366296241|FG007|Overall Study|Physician Decision|0|||
106173022|NCT02323880|366296234|FG000|Overall Study|Withdrawal by Subject|0|||
106173023|NCT02323880|366296235|FG001|Overall Study|Withdrawal by Subject|2|||
106173024|NCT02323880|366296236|FG002|Overall Study|Withdrawal by Subject|0|||
106173025|NCT02323880|366296237|FG003|Overall Study|Withdrawal by Subject|0|||
106173026|NCT02323880|366296238|FG004|Overall Study|Withdrawal by Subject|0|||
106173027|NCT02323880|366296239|FG005|Overall Study|Withdrawal by Subject|0|||
106173028|NCT02323880|366296240|FG006|Overall Study|Withdrawal by Subject|0|||
106173029|NCT02323880|366296241|FG007|Overall Study|Withdrawal by Subject|0|||
106173030|NCT02278211|366296242|FG000|Overall Study|Unable to analyse PET scan|2|||
106173031|NCT04167553|366296243|FG000|Overall Study|Withdrawal by Subject|1|||
106173032|NCT04167553|366296244|FG001|Overall Study|Withdrawal by Subject|0|||
106173033|NCT04167553|366296245|FG002|Overall Study|Withdrawal by Subject|1|||
106173034|NCT04167553|366296246|FG003|Overall Study|Withdrawal by Subject|2|||
106173035|NCT04167553|366296247|FG004|Overall Study|Withdrawal by Subject|1|||
106173036|NCT04167553|366296248|FG005|Overall Study|Withdrawal by Subject|0|||
106173037|NCT04167553|366296249|FG006|Overall Study|Withdrawal by Subject|0|||
106173038|NCT04167553|366296243|FG000|Overall Study|Physician Decision|0|||
106173039|NCT04167553|366296244|FG001|Overall Study|Physician Decision|0|||
106173040|NCT04167553|366296245|FG002|Overall Study|Physician Decision|0|||
106173041|NCT04167553|366296246|FG003|Overall Study|Physician Decision|0|||
106173042|NCT04167553|366296247|FG004|Overall Study|Physician Decision|2|||
106173043|NCT04167553|366296248|FG005|Overall Study|Physician Decision|2|||
106173044|NCT04167553|366296249|FG006|Overall Study|Physician Decision|0|||
106173045|NCT04167553|366296243|FG000|Overall Study|Lost to Follow-up|0|||
106173046|NCT04167553|366296244|FG001|Overall Study|Lost to Follow-up|0|||
106173047|NCT04167553|366296245|FG002|Overall Study|Lost to Follow-up|2|||
106173048|NCT04167553|366296246|FG003|Overall Study|Lost to Follow-up|0|||
106173049|NCT04167553|366296247|FG004|Overall Study|Lost to Follow-up|0|||
106173050|NCT04167553|366296248|FG005|Overall Study|Lost to Follow-up|0|||
106173051|NCT04167553|366296249|FG006|Overall Study|Lost to Follow-up|0|||
106173052|NCT03174275|366296253|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
106173053|NCT03174275|366296253|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
106173054|NCT03174275|366296253|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
106173055|NCT03174275|366296253|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
106173056|NCT03174275|366296253|FG000|Adjuvant Chemotherapy|Progression|1|||
106173057|NCT03174275|366296253|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
106173058|NCT03174275|366296253|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
106173059|NCT03174275|366296253|FG000|Adjuvant Durvalumab|Progression|1|||
106173060|NCT03174275|366296253|FG000|Adjuvant Durvalumab|Adverse Event|3|||
106173061|NCT03174275|366296253|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
106173062|NCT03174275|366296253|FG000|Adjuvant Radiotherapy|Progression|1|||
106173063|NCT03174275|366296253|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
106173064|NCT04186819|366296271|FG000|Overall Study|Adverse Event|1|||
106173065|NCT04186819|366296271|FG000|Overall Study|Lost to Follow-up|1|||
106173066|NCT04186819|366296271|FG000|Overall Study|Opted for EBRT|1|||
106173067|NCT04186819|366296271|FG000|Overall Study|Opted SBRT|1|||
106173068|NCT04186819|366296271|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
106173069|NCT04186819|366296271|FG000|Overall Study|Physician Decision|1|||
106173070|NCT04186819|366296271|FG000|Overall Study|RP Delayed|1|||
106173071|NCT04186819|366296271|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
106173072|NCT04186819|366296271|FG000|Overall Study|Subject declined for financial reasons|1|||
106173073|NCT04186819|366296271|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
106173074|NCT04186819|366296271|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
106173075|NCT04186819|366296271|FG000|Overall Study|The subject opted for other treatment option|2|||
106173076|NCT04186819|366296271|FG000|Overall Study|The subject opted for other treatment options|1|||
106173077|NCT04186819|366296271|FG000|Overall Study|Withdrawal by Subject|3|||
106173078|NCT04186819|366296271|FG000|Overall Study|Reason not specified|1|||
106173079|NCT03988621|366296272|FG000|Overall Study|Lost to Follow-up|16|||
106173080|NCT03988621|366296273|FG001|Overall Study|Lost to Follow-up|17|||
106173081|NCT03988621|366296272|FG000|Overall Study|Withdrawal by Subject|14|||
106173082|NCT03988621|366296273|FG001|Overall Study|Withdrawal by Subject|7|||
106173083|NCT03988621|366296272|FG000|Overall Study|Patient Lost to Follow Up|15|||
106173084|NCT03988621|366296273|FG001|Overall Study|Patient Lost to Follow Up|15|||
106173085|NCT03988621|366296272|FG000|Overall Study|Patient death|1|||
106173086|NCT03988621|366296273|FG001|Overall Study|Patient death|5|||
106173087|NCT05013385|366296274|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
106173088|NCT03914469|366296279|FG000|Overall Study|Lost to Follow-up|1|||
106173089|NCT03914469|366296280|FG001|Overall Study|Lost to Follow-up|4|||
106173090|NCT03252288|366296283|FG000|Overall Study|Death|1|||
106173091|NCT03252288|366296284|FG001|Overall Study|Death|0|||
106173092|NCT03252288|366296285|FG002|Overall Study|Death|0|||
106173093|NCT03252288|366296283|FG000|Overall Study|Death|11|||
106173094|NCT03252288|366296284|FG001|Overall Study|Death|0|||
106173095|NCT03252288|366296285|FG002|Overall Study|Death|0|||
106173096|NCT03252288|366296283|FG000|Overall Study|Withdrawal by Subject|2|||
106173097|NCT03252288|366296284|FG001|Overall Study|Withdrawal by Subject|0|||
106173098|NCT03252288|366296285|FG002|Overall Study|Withdrawal by Subject|0|||
106173099|NCT03252288|366296283|FG000|Overall Study|Lost to Follow-up|79|||
106173100|NCT03252288|366296284|FG001|Overall Study|Lost to Follow-up|0|||
106173101|NCT03252288|366296285|FG002|Overall Study|Lost to Follow-up|0|||
106173102|NCT03252288|366296283|FG000|Overall Study|Loss of baseline data on tablets|6|||
106173103|NCT03252288|366296284|FG001|Overall Study|Loss of baseline data on tablets|0|||
106173104|NCT03252288|366296285|FG002|Overall Study|Loss of baseline data on tablets|0|||
106173105|NCT00677365|366296286|FG000|Overall Study|Adverse Event|2|||
106173106|NCT00677365|366296287|FG001|Overall Study|Adverse Event|1|||
106173107|NCT00677365|366296288|FG002|Overall Study|Adverse Event|1|||
106173108|NCT00677365|366296289|FG003|Overall Study|Adverse Event|2|||
106173109|NCT00677365|366296286|FG000|Overall Study|Withdrawal by Subject|0|||
106173110|NCT00677365|366296287|FG001|Overall Study|Withdrawal by Subject|0|||
106173111|NCT00677365|366296288|FG002|Overall Study|Withdrawal by Subject|1|||
106173112|NCT00677365|366296289|FG003|Overall Study|Withdrawal by Subject|0|||
106173113|NCT00677365|366296286|FG000|Overall Study|Other reason|0|||
106173114|NCT00677365|366296287|FG001|Overall Study|Other reason|0|||
106173115|NCT00677365|366296288|FG002|Overall Study|Other reason|0|||
106173116|NCT00677365|366296289|FG003|Overall Study|Other reason|1|||
106173117|NCT05900154|366296290|FG000|Follow-Up Period|Lost to Follow-up|1|||
106173118|NCT05900154|366296291|FG001|Follow-Up Period|Lost to Follow-up|2|||
106173119|NCT05900154|366296292|FG002|Follow-Up Period|Lost to Follow-up|1|||
106173120|NCT05900154|366296293|FG003|Follow-Up Period|Lost to Follow-up|0|||
106173121|NCT05900154|366296294|FG004|Follow-Up Period|Lost to Follow-up|1|||
106173122|NCT05900154|366296295|FG005|Follow-Up Period|Lost to Follow-up|1|||
106173123|NCT02874742|366296296|FG000|Overall Study|Death|0|||
106173124|NCT02874742|366296297|FG001|Overall Study|Death|1|||
106173125|NCT02874742|366296298|FG002|Overall Study|Death|0|||
106173126|NCT02874742|366296296|FG000|Overall Study|Lost to Follow-up|5|||
106173127|NCT02874742|366296297|FG001|Overall Study|Lost to Follow-up|4|||
106173128|NCT02874742|366296298|FG002|Overall Study|Lost to Follow-up|1|||
106173129|NCT02874742|366296296|FG000|Overall Study|Withdrawal by Subject|17|||
106173130|NCT02874742|366296297|FG001|Overall Study|Withdrawal by Subject|8|||
106173131|NCT02874742|366296298|FG002|Overall Study|Withdrawal by Subject|0|||
106173132|NCT02874742|366296296|FG000|Overall Study|Other|4|||
106173133|NCT02874742|366296297|FG001|Overall Study|Other|1|||
106173134|NCT02874742|366296298|FG002|Overall Study|Other|0|||
106173135|NCT02874742|366296296|FG000|Overall Study|Progressive Disease|1|||
106173136|NCT02874742|366296297|FG001|Overall Study|Progressive Disease|0|||
106173137|NCT02874742|366296298|FG002|Overall Study|Progressive Disease|0|||
106173138|NCT02874742|366296296|FG000|Overall Study|Screen Failure|0|||
106173139|NCT02874742|366296297|FG001|Overall Study|Screen Failure|2|||
106173140|NCT02874742|366296298|FG002|Overall Study|Screen Failure|0|||
106173141|NCT04623775|366296299|FG000|Randomization|No Longer Meets Study Criteria|2|||
106173142|NCT04623775|366296300|FG001|Randomization|No Longer Meets Study Criteria|1|||
106173143|NCT04623775|366296301|FG002|Randomization|No Longer Meets Study Criteria|0|||
106173144|NCT04623775|366296302|FG003|Randomization|No Longer Meets Study Criteria|0|||
106173145|NCT04623775|366296299|FG000|Randomization|Withdrew Consent|0|||
106173146|NCT04623775|366296300|FG001|Randomization|Withdrew Consent|0|||
106173147|NCT04623775|366296301|FG002|Randomization|Withdrew Consent|0|||
106173148|NCT04623775|366296302|FG003|Randomization|Withdrew Consent|1|||
106173149|NCT04623775|366296299|FG000|Randomization|Other Reasons|0|||
106173150|NCT04623775|366296300|FG001|Randomization|Other Reasons|0|||
106173151|NCT04623775|366296301|FG002|Randomization|Other Reasons|0|||
106173152|NCT04623775|366296302|FG003|Randomization|Other Reasons|1|||
106173153|NCT04623775|366296299|FG000|Treatment Period|participant withdrew consent|4|||
106173154|NCT04623775|366296300|FG001|Treatment Period|participant withdrew consent|0|||
106173155|NCT04623775|366296301|FG002|Treatment Period|participant withdrew consent|1|||
106173156|NCT04623775|366296302|FG003|Treatment Period|participant withdrew consent|2|||
106173157|NCT04623775|366296299|FG000|Treatment Period|Death|3|||
106173158|NCT04623775|366296300|FG001|Treatment Period|Death|1|||
106173159|NCT04623775|366296301|FG002|Treatment Period|Death|4|||
106173160|NCT04623775|366296302|FG003|Treatment Period|Death|2|||
106173161|NCT04623775|366296299|FG000|Treatment Period|Lost to Follow-up|0|||
106173162|NCT04623775|366296300|FG001|Treatment Period|Lost to Follow-up|2|||
106173163|NCT04623775|366296301|FG002|Treatment Period|Lost to Follow-up|0|||
106173164|NCT04623775|366296302|FG003|Treatment Period|Lost to Follow-up|0|||
106173165|NCT04623775|366296299|FG000|Treatment Period|poor/non compliance|0|||
106173166|NCT04623775|366296300|FG001|Treatment Period|poor/non compliance|0|||
106173167|NCT04623775|366296301|FG002|Treatment Period|poor/non compliance|1|||
106173168|NCT04623775|366296302|FG003|Treatment Period|poor/non compliance|0|||
106173169|NCT04623775|366296299|FG000|Treatment Period|participant no longer meets study criteria|0|||
106173170|NCT04623775|366296300|FG001|Treatment Period|participant no longer meets study criteria|1|||
106173171|NCT04623775|366296301|FG002|Treatment Period|participant no longer meets study criteria|0|||
106173172|NCT04623775|366296302|FG003|Treatment Period|participant no longer meets study criteria|0|||
106173173|NCT04623775|366296299|FG000|Treatment Period|administrative reasons by sponsor|3|||
106173174|NCT04623775|366296300|FG001|Treatment Period|administrative reasons by sponsor|2|||
106173175|NCT04623775|366296301|FG002|Treatment Period|administrative reasons by sponsor|0|||
106173176|NCT04623775|366296302|FG003|Treatment Period|administrative reasons by sponsor|0|||
106173177|NCT04623775|366296299|FG000|Treatment Period|other reasons|2|||
106173178|NCT04623775|366296300|FG001|Treatment Period|other reasons|0|||
106173179|NCT04623775|366296301|FG002|Treatment Period|other reasons|1|||
106173180|NCT04623775|366296302|FG003|Treatment Period|other reasons|1|||
106173181|NCT04623775|366296299|FG000|Treatment Period|disease progression|40|||
106173182|NCT04623775|366296300|FG001|Treatment Period|disease progression|35|||
106173183|NCT04623775|366296301|FG002|Treatment Period|disease progression|63|||
106173184|NCT04623775|366296302|FG003|Treatment Period|disease progression|63|||
106173185|NCT04623775|366296299|FG000|Treatment Period|study drug toxicity|12|||
106173186|NCT04623775|366296300|FG001|Treatment Period|study drug toxicity|15|||
106173187|NCT04623775|366296301|FG002|Treatment Period|study drug toxicity|13|||
106173188|NCT04623775|366296302|FG003|Treatment Period|study drug toxicity|12|||
106173189|NCT04623775|366296299|FG000|Treatment Period|AE unrelated to study drug|4|||
106173190|NCT04623775|366296300|FG001|Treatment Period|AE unrelated to study drug|9|||
106173191|NCT04623775|366296301|FG002|Treatment Period|AE unrelated to study drug|12|||
106173192|NCT04623775|366296302|FG003|Treatment Period|AE unrelated to study drug|9|||
106173193|NCT04623775|366296299|FG000|Treatment Period|participant request to discontinue treatment|0|||
106173194|NCT04623775|366296300|FG001|Treatment Period|participant request to discontinue treatment|2|||
106173195|NCT04623775|366296301|FG002|Treatment Period|participant request to discontinue treatment|2|||
106173196|NCT04623775|366296302|FG003|Treatment Period|participant request to discontinue treatment|0|||
106173197|NCT04583280|366296305|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
106173198|NCT04583280|366296306|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
106173199|NCT03498521|366296307|FG000|Overall Study|Death|191|||
106173200|NCT03498521|366296308|FG001|Overall Study|Death|64|||
106173201|NCT03498521|366296309|FG002|Overall Study|Death|72|||
106173202|NCT03498521|366296307|FG000|Overall Study|Exclusion criteria|1|||
106173203|NCT03498521|366296308|FG001|Overall Study|Exclusion criteria|0|||
106173204|NCT03498521|366296309|FG002|Overall Study|Exclusion criteria|0|||
106173205|NCT03498521|366296307|FG000|Overall Study|Lost to Follow-up|3|||
106173206|NCT03498521|366296308|FG001|Overall Study|Lost to Follow-up|3|||
106173207|NCT03498521|366296309|FG002|Overall Study|Lost to Follow-up|3|||
106173208|NCT03498521|366296307|FG000|Overall Study|No profile due to technical failure|1|||
106173209|NCT03498521|366296308|FG001|Overall Study|No profile due to technical failure|0|||
106173210|NCT03498521|366296309|FG002|Overall Study|No profile due to technical failure|0|||
106173211|NCT03498521|366296307|FG000|Overall Study|Physician Decision|0|||
106173212|NCT03498521|366296308|FG001|Overall Study|Physician Decision|1|||
106173213|NCT03498521|366296309|FG002|Overall Study|Physician Decision|0|||
106173214|NCT03498521|366296307|FG000|Overall Study|Withdrawal by Subject|9|||
106173215|NCT03498521|366296308|FG001|Overall Study|Withdrawal by Subject|6|||
106173216|NCT03498521|366296309|FG002|Overall Study|Withdrawal by Subject|2|||
106173217|NCT03498521|366296307|FG000|Overall Study|Study ongoing|121|||
106173218|NCT03498521|366296308|FG001|Overall Study|Study ongoing|36|||
106173219|NCT03498521|366296309|FG002|Overall Study|Study ongoing|15|||
106173220|NCT02326974|366296312|FG000|Overall Study|Withdrawal by Subject|2|||
106173221|NCT02326974|366296312|FG000|Overall Study|failed heterogenity evaluation|5|||
106173222|NCT02938520|366296316|FG000|Overall Study|On-going at the time of analysis|258|||
106173223|NCT02938520|366296317|FG001|Overall Study|On-going at the time of analysis|261|||
106173224|NCT02938520|366296316|FG000|Overall Study|Physician Decision|2|||
106173225|NCT02938520|366296317|FG001|Overall Study|Physician Decision|5|||
105867327|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
106173226|NCT02938520|366296316|FG000|Overall Study|Lost to Follow-up|2|||
106173227|NCT02938520|366296317|FG001|Overall Study|Lost to Follow-up|2|||
106173228|NCT02938520|366296316|FG000|Overall Study|Withdrawal by Subject|7|||
106173229|NCT02938520|366296317|FG001|Overall Study|Withdrawal by Subject|7|||
106173230|NCT02938520|366296316|FG000|Overall Study|Protocol Violation|0|||
106173231|NCT02938520|366296317|FG001|Overall Study|Protocol Violation|1|||
106173232|NCT02938520|366296316|FG000|Overall Study|Lack of Efficacy|5|||
106173233|NCT02938520|366296317|FG001|Overall Study|Lack of Efficacy|3|||
106173234|NCT02938520|366296316|FG000|Overall Study|Adverse Event|9|||
106173235|NCT02938520|366296317|FG001|Overall Study|Adverse Event|4|||
106173236|NCT02518048|366296318|FG000|Overall Study|Withdrawal by Subject|1|||
106173237|NCT04679389|366296319|FG000|Overall Study|Adverse Event|1|||
106173238|NCT04679389|366296320|FG001|Overall Study|Adverse Event|0|||
106173239|NCT04679389|366296319|FG000|Overall Study|Protocol Violation|2|||
106173240|NCT04679389|366296320|FG001|Overall Study|Protocol Violation|0|||
106173241|NCT04679389|366296319|FG000|Overall Study|Physician Decision|3|||
106173242|NCT04679389|366296320|FG001|Overall Study|Physician Decision|5|||
106173243|NCT04679389|366296319|FG000|Overall Study|Withdrawal by Subject|5|||
106173244|NCT04679389|366296320|FG001|Overall Study|Withdrawal by Subject|7|||
106173245|NCT05123027|366296325|FG000|Overall Study|Lost to Follow-up|17|||
106173246|NCT05123027|366296326|FG001|Overall Study|Lost to Follow-up|22|||
106173247|NCT05123027|366296325|FG000|Overall Study|Incarceration|3|||
106173248|NCT05123027|366296326|FG001|Overall Study|Incarceration|4|||
106173249|NCT05123027|366296325|FG000|Overall Study|Death|2|||
106173250|NCT05123027|366296326|FG001|Overall Study|Death|2|||
106173251|NCT05123027|366296325|FG000|Overall Study|Other|2|||
106173252|NCT05123027|366296326|FG001|Overall Study|Other|0|||
106173253|NCT01447719|366297596|FG000|Overall Study|Image acquisition failure|2|||
106173254|NCT01447719|366297596|FG000|Overall Study|Invalid image or not imaged|3|||
106173255|NCT01447719|366297596|FG000|Overall Study|Subject still living at end of study|79|||
106173256|NCT01447719|366297596|FG000|Overall Study|Withdrawal by Subject|2|||
106173257|NCT01447719|366297596|FG000|Overall Study|Family withdrew autopsy consent|7|||
106173258|NCT02944968|366297603|FG000|Overall Study|Subject excluded before study procedure|1|||
106173259|NCT02944968|366297603|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
106173260|NCT02905331|366297604|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
106173261|NCT02905331|366297605|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
106173262|NCT02905331|366297606|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
106173263|NCT02905331|366297604|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
106173264|NCT02905331|366297605|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
106173265|NCT02905331|366297606|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
106173266|NCT02905331|366297604|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
106173267|NCT02905331|366297605|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
106173268|NCT02905331|366297606|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
106173269|NCT02905331|366297604|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
106173270|NCT02905331|366297605|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
106173271|NCT02905331|366297606|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
106173272|NCT02905331|366297604|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
106173273|NCT02905331|366297605|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
106173274|NCT02905331|366297606|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
106173275|NCT02095691|366297607|FG000|Overall Study|Physician Decision|1|||
106173276|NCT03681262|366297608|FG000|Overall Study|Continuing on study|3|||
106173277|NCT03681262|366297609|FG001|Overall Study|Continuing on study|3|||
106173278|NCT03681262|366297608|FG000|Overall Study|Lost to Follow-up|1|||
106173279|NCT03681262|366297609|FG001|Overall Study|Lost to Follow-up|0|||
106173280|NCT02890329|366297610|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
106173281|NCT02890329|366297611|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
106173282|NCT02890329|366297612|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
106173283|NCT02890329|366297613|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
106173284|NCT02890329|366297614|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
106173285|NCT02890329|366297615|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
106173286|NCT02890329|366297610|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
106173287|NCT02890329|366297611|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
106173288|NCT02890329|366297612|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
106173289|NCT02890329|366297613|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
106173290|NCT02890329|366297614|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
106173291|NCT02890329|366297615|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
106173292|NCT02890329|366297610|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
106173293|NCT02890329|366297611|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
106173294|NCT02890329|366297612|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
106173295|NCT02890329|366297613|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
106173296|NCT02890329|366297614|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
106173297|NCT02890329|366297615|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
106173298|NCT02890329|366297610|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
106173299|NCT02890329|366297611|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
106173300|NCT02890329|366297612|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
106173301|NCT02890329|366297613|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
106173302|NCT02890329|366297614|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
106173303|NCT02890329|366297615|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
106173304|NCT04102111|366297624|FG000|Overall Study|Withdrawal by Subject|2|||
106173305|NCT04102111|366297625|FG001|Overall Study|Withdrawal by Subject|3|||
106173306|NCT04102111|366297624|FG000|Overall Study|Adverse Event|1|||
106173307|NCT04102111|366297625|FG001|Overall Study|Adverse Event|1|||
106173308|NCT04102111|366297624|FG000|Overall Study|Study terminated by sponsor|1|||
106173309|NCT04102111|366297625|FG001|Overall Study|Study terminated by sponsor|3|||
106173310|NCT00887198|366297626|FG000|Randomized Period|Ongoing|42|||
106173311|NCT00887198|366297627|FG001|Randomized Period|Ongoing|0|||
106173312|NCT00887198|366297628|FG002|Randomized Period|Ongoing|0|||
106173313|NCT00887198|366297626|FG000|Randomized Period|Adverse Event|50|||
106173314|NCT00887198|366297627|FG001|Randomized Period|Adverse Event|33|||
106173315|NCT00887198|366297628|FG002|Randomized Period|Adverse Event|0|||
106173316|NCT00887198|366297626|FG000|Randomized Period|Lost to Follow-up|1|||
106173317|NCT00887198|366297627|FG001|Randomized Period|Lost to Follow-up|0|||
106173318|NCT00887198|366297628|FG002|Randomized Period|Lost to Follow-up|0|||
106173319|NCT00887198|366297626|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
106173320|NCT00887198|366297627|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
106173321|NCT00887198|366297628|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
106173322|NCT00887198|366297626|FG000|Randomized Period|Withdrawal by Subject|41|||
106173323|NCT00887198|366297627|FG001|Randomized Period|Withdrawal by Subject|56|||
106173324|NCT00887198|366297628|FG002|Randomized Period|Withdrawal by Subject|0|||
106173325|NCT00887198|366297626|FG000|Randomized Period|Progressive disease|366|||
106173326|NCT00887198|366297627|FG001|Randomized Period|Progressive disease|370|||
106173327|NCT00887198|366297628|FG002|Randomized Period|Progressive disease|0|||
106173328|NCT00887198|366297626|FG000|Randomized Period|Other|42|||
106173329|NCT00887198|366297627|FG001|Randomized Period|Other|30|||
106173330|NCT00887198|366297628|FG002|Randomized Period|Other|0|||
106173331|NCT00887198|366297626|FG000|Randomized Period|Randomized, Not treated|4|||
106173332|NCT00887198|366297627|FG001|Randomized Period|Randomized, Not treated|2|||
106173333|NCT00887198|366297628|FG002|Randomized Period|Randomized, Not treated|0|||
106173334|NCT00887198|366297626|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
106173335|NCT00887198|366297627|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
106173336|NCT00887198|366297628|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
106173337|NCT00887198|366297626|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
106173338|NCT00887198|366297627|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
106173339|NCT00887198|366297628|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
106173340|NCT00887198|366297626|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
106173341|NCT00887198|366297627|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
106173342|NCT00887198|366297628|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
106173343|NCT00887198|366297626|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
106173344|NCT00887198|366297627|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
106173345|NCT00887198|366297628|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
106173346|NCT00887198|366297626|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
106173347|NCT00887198|366297627|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
106173348|NCT00887198|366297628|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
106173349|NCT00887198|366297626|FG000|Cross Over (Placebo to AA)|Other|0|||
106173350|NCT00887198|366297627|FG001|Cross Over (Placebo to AA)|Other|0|||
106173351|NCT00887198|366297628|FG002|Cross Over (Placebo to AA)|Other|19|||
106173352|NCT03334695|366297629|FG000|Overall Study|Lost to Follow-up|3|||
106173353|NCT03334695|366297630|FG001|Overall Study|Lost to Follow-up|3|||
106173354|NCT03334695|366297629|FG000|Overall Study|Physician Decision|1|||
106173355|NCT03334695|366297630|FG001|Overall Study|Physician Decision|2|||
106173356|NCT03334695|366297629|FG000|Overall Study|Protocol Violation|0|||
106173357|NCT03334695|366297630|FG001|Overall Study|Protocol Violation|1|||
106173358|NCT02542631|366297631|FG000|Overall Study|Adverse Event|1|||
106173359|NCT02542631|366297632|FG001|Overall Study|Adverse Event|1|||
106173360|NCT02542631|366297631|FG000|Overall Study|Sponsor Termination|1|||
106173361|NCT02542631|366297632|FG001|Overall Study|Sponsor Termination|0|||
106173362|NCT02542631|366297631|FG000|Overall Study|Withdrawal by Subject|11|||
106173363|NCT02542631|366297632|FG001|Overall Study|Withdrawal by Subject|16|||
106173364|NCT02542631|366297631|FG000|Overall Study|Protocol Violation|1|||
106173365|NCT02542631|366297632|FG001|Overall Study|Protocol Violation|1|||
106173366|NCT02542631|366297631|FG000|Overall Study|Physician Decision|6|||
106173367|NCT02542631|366297632|FG001|Overall Study|Physician Decision|4|||
106173368|NCT02542631|366297631|FG000|Overall Study|Lost to Follow-up|6|||
106173369|NCT02542631|366297632|FG001|Overall Study|Lost to Follow-up|5|||
106173370|NCT02542631|366297631|FG000|Overall Study|Death|1|||
106173371|NCT02542631|366297632|FG001|Overall Study|Death|2|||
106173372|NCT02542631|366297631|FG000|Overall Study|Other|2|||
106173373|NCT02542631|366297632|FG001|Overall Study|Other|1|||
106173374|NCT02542631|366297631|FG000|Overall Study|Used Prohibited Medication|2|||
106173375|NCT02542631|366297632|FG001|Overall Study|Used Prohibited Medication|1|||
106173376|NCT05007080|366297633|FG000|Overall Study|Lost to Follow-up|0|||
106173377|NCT05007080|366297634|FG001|Overall Study|Lost to Follow-up|1|||
106173378|NCT05007080|366297635|FG002|Overall Study|Lost to Follow-up|0|||
106173379|NCT05007080|366297636|FG003|Overall Study|Lost to Follow-up|1|||
106173380|NCT05007080|366297637|FG004|Overall Study|Lost to Follow-up|1|||
106173381|NCT05007080|366297638|FG005|Overall Study|Lost to Follow-up|1|||
106173382|NCT05007080|366297633|FG000|Overall Study|Death|0|||
106173383|NCT05007080|366297634|FG001|Overall Study|Death|1|||
106173384|NCT05007080|366297635|FG002|Overall Study|Death|0|||
106173385|NCT05007080|366297636|FG003|Overall Study|Death|0|||
106173386|NCT05007080|366297637|FG004|Overall Study|Death|0|||
106173387|NCT05007080|366297638|FG005|Overall Study|Death|0|||
106173388|NCT05007080|366297633|FG000|Overall Study|Withdrawal by Subject|1|||
106173389|NCT05007080|366297634|FG001|Overall Study|Withdrawal by Subject|2|||
106173390|NCT05007080|366297635|FG002|Overall Study|Withdrawal by Subject|0|||
106173391|NCT05007080|366297636|FG003|Overall Study|Withdrawal by Subject|2|||
106173392|NCT05007080|366297637|FG004|Overall Study|Withdrawal by Subject|1|||
106173393|NCT05007080|366297638|FG005|Overall Study|Withdrawal by Subject|1|||
106173394|NCT05007080|366297633|FG000|Overall Study|Other|1|||
106173395|NCT05007080|366297634|FG001|Overall Study|Other|0|||
106173396|NCT05007080|366297635|FG002|Overall Study|Other|1|||
106173397|NCT05007080|366297636|FG003|Overall Study|Other|1|||
106173398|NCT05007080|366297637|FG004|Overall Study|Other|0|||
106173399|NCT05007080|366297638|FG005|Overall Study|Other|2|||
106173400|NCT05007080|366297633|FG000|Overall Study|Randomized not vaccinated|0|||
106173401|NCT05007080|366297634|FG001|Overall Study|Randomized not vaccinated|0|||
106173402|NCT05007080|366297635|FG002|Overall Study|Randomized not vaccinated|0|||
106173403|NCT05007080|366297636|FG003|Overall Study|Randomized not vaccinated|0|||
106173404|NCT05007080|366297637|FG004|Overall Study|Randomized not vaccinated|0|||
106173405|NCT05007080|366297638|FG005|Overall Study|Randomized not vaccinated|1|||
106173406|NCT02641730|366297639|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
106173407|NCT02641730|366297640|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
106173408|NCT02641730|366297641|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
106173409|NCT02641730|366297642|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
106173410|NCT02641730|366297643|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
106173411|NCT02641730|366297639|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
106173412|NCT02641730|366297640|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
106173413|NCT02641730|366297641|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
106173414|NCT02641730|366297642|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
106173415|NCT02641730|366297643|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
106173416|NCT02641730|366297639|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
106173417|NCT02641730|366297640|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
106173418|NCT02641730|366297641|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
106173419|NCT02641730|366297642|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
106173420|NCT02641730|366297643|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
106173421|NCT02641730|366297639|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
106173422|NCT02641730|366297640|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
106173423|NCT02641730|366297641|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
106173424|NCT02641730|366297642|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
106173425|NCT02641730|366297643|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
106173426|NCT02641730|366297639|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
106173427|NCT02641730|366297640|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
106173428|NCT02641730|366297641|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
106173429|NCT02641730|366297642|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
106173430|NCT02641730|366297643|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
106173431|NCT02641730|366297639|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
106173432|NCT02641730|366297640|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
106173433|NCT02641730|366297641|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
106173434|NCT02641730|366297642|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
106173435|NCT02641730|366297643|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
106173436|NCT00319046|366297644|FG000|Overall Study|withdrawal of subject's consent|7|||
106173437|NCT00319046|366297644|FG000|Overall Study|administrative reason|1|||
106173438|NCT05147584|366297645|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
106173439|NCT05460871|366297646|FG000|Overall Study|Withdrawal by Subject|1|||
106173440|NCT05460871|366297647|FG001|Overall Study|Withdrawal by Subject|2|||
106173441|NCT02938923|366297648|FG000|Overall Study|Death|1|||
106173442|NCT02938923|366297649|FG001|Overall Study|Death|0|||
106173443|NCT02938923|366297650|FG002|Overall Study|Death|0|||
106173444|NCT02938923|366297648|FG000|Overall Study|Physician Decision|0|||
106173445|NCT02938923|366297649|FG001|Overall Study|Physician Decision|2|||
106173446|NCT02938923|366297650|FG002|Overall Study|Physician Decision|0|||
106173447|NCT02938923|366297648|FG000|Overall Study|Withdrawal by Subject|0|||
106173448|NCT02938923|366297649|FG001|Overall Study|Withdrawal by Subject|1|||
106173449|NCT02938923|366297650|FG002|Overall Study|Withdrawal by Subject|1|||
106173450|NCT00721149|366297651|FG000|Overall Study|Physician Decision|1|||
106173451|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
106173452|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
106173453|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
106173454|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
106173455|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
106173456|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
106173457|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
106173458|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
106173459|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
106173460|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
106173461|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
106173462|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
106173463|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
106173464|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
106173465|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
106173466|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
106173467|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
106173468|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
106173469|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
106173470|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
106173471|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
106173472|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
106173473|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
106173474|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
106173475|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
106173476|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
106173477|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
106173478|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
106173479|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
106173480|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
106173481|NCT04614948|366297665|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
106173482|NCT04614948|366297666|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
106173483|NCT04614948|366297667|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
106173484|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
106173485|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
106173486|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
106173487|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
106173488|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
106173489|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
106173490|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
106173491|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
106173492|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
106173493|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
106173494|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
106173495|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
106173496|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
106173497|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
106173498|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
106173499|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
106173500|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
106173501|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
106173502|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
106173503|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
106173504|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
106173505|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
106173506|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
106173507|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
106173508|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
106173509|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
106173510|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
106173511|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
106173512|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
106173513|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
106173514|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
106173515|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
106173516|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
106173517|NCT04614948|366297665|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
106173518|NCT04614948|366297666|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
106173519|NCT04614948|366297667|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
106173520|NCT00631475|366297668|FG000|Overall Study|Death|18|||
106173521|NCT00631475|366297668|FG000|Overall Study|Adverse Event|14|||
106173522|NCT00631475|366297668|FG000|Overall Study|Withdrew consent|5|||
106173523|NCT00631475|366297668|FG000|Overall Study|Preparation for lung transplant|8|||
106173524|NCT04055012|366297669|FG000|Overall Study|Withdrawal by Subject|1|||
106173525|NCT04055012|366297670|FG001|Overall Study|Withdrawal by Subject|3|||
106173526|NCT04055012|366297671|FG002|Overall Study|Withdrawal by Subject|1|||
106173527|NCT04055012|366297672|FG003|Overall Study|Withdrawal by Subject|0|||
106173528|NCT04055012|366297669|FG000|Overall Study|Metformin Recall|1|||
106173529|NCT04055012|366297670|FG001|Overall Study|Metformin Recall|1|||
106173530|NCT04055012|366297671|FG002|Overall Study|Metformin Recall|1|||
106173531|NCT04055012|366297672|FG003|Overall Study|Metformin Recall|0|||
106173532|NCT03218826|366297673|FG000|Overall Study|Non-compliance with protocol|1|||
106173533|NCT03218826|366297674|FG001|Overall Study|Non-compliance with protocol|0|||
106173534|NCT03218826|366297675|FG002|Overall Study|Non-compliance with protocol|2|||
106173535|NCT03218826|366297676|FG003|Overall Study|Non-compliance with protocol|1|||
106173536|NCT03218826|366297677|FG004|Overall Study|Non-compliance with protocol|1|||
106173537|NCT05158504|366297678|FG000|Overall Study|Lost to Follow-up|2|||
106173538|NCT05158504|366297679|FG001|Overall Study|Lost to Follow-up|3|||
106173539|NCT03606512|366297682|FG000|Overall Study|Lost to Follow-up|0|||
106173540|NCT03606512|366297683|FG001|Overall Study|Lost to Follow-up|1|||
106173541|NCT03606512|366297682|FG000|Overall Study|'moved from study area|0|||
106173542|NCT03606512|366297683|FG001|Overall Study|'moved from study area|1|||
106173543|NCT02846545|366297686|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
106173544|NCT02846545|366297687|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
106173545|NCT02846545|366297686|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
105867328|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
105867329|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
105867330|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
105867331|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
105867332|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
105867333|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
105867334|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
105867335|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
105867336|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
105867337|NCT03888066|365164935|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
105867338|NCT03888066|365164936|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
105867339|NCT03278626|365164937|FG000|Overall Study|Death|2|||
105867340|NCT03278626|365164937|FG000|Overall Study|Toxicity|1|||
105867341|NCT03278626|365164937|FG000|Overall Study|Disease Progression|2|||
105867342|NCT00618371|365164938|FG000|Overall Study|Withdrawal by Subject|2|||
105867343|NCT01207583|365164945|FG000|Overall Study|Withdrawal by Subject|0|||
105867344|NCT01207583|365164946|FG001|Overall Study|Withdrawal by Subject|3|||
105867345|NCT01207583|365164947|FG002|Overall Study|Withdrawal by Subject|1|||
105867346|NCT01207583|365164945|FG000|Overall Study|Participant failed to return|1|||
105867347|NCT01207583|365164946|FG001|Overall Study|Participant failed to return|0|||
105867348|NCT01207583|365164947|FG002|Overall Study|Participant failed to return|0|||
105867349|NCT01207583|365164945|FG000|Overall Study|Lost to Follow-up|0|||
105867350|NCT01207583|365164946|FG001|Overall Study|Lost to Follow-up|2|||
105867351|NCT01207583|365164947|FG002|Overall Study|Lost to Follow-up|0|||
105867352|NCT03055624|365164948|FG000|Overall Study|Study closed|9|||
105867353|NCT02437903|365164951|FG000|Overall Study|Adverse Event|1|||
105867354|NCT02437903|365164951|FG000|Overall Study|Withdrawal by Subject|1|||
105867355|NCT02437903|365164951|FG000|Overall Study|Lost to Follow-up|3|||
105867356|NCT00595309|365164952|FG000|Overall Study|Lost to Follow-up|1|||
105867357|NCT00595309|365164952|FG000|Overall Study|planned vaccination against yellow fever|1|||
105867358|NCT00595309|365164952|FG000|Overall Study|acute infection after V0|1|||
105867359|NCT00595309|365164952|FG000|Overall Study|personal reason|1|||
105867360|NCT00101283|365164953|FG000|Overall Study|Withdrawal by Subject|0|||
105867361|NCT00101283|365164954|FG001|Overall Study|Withdrawal by Subject|1|||
105867362|NCT00101283|365164953|FG000|Overall Study|Insurance Refusal|0|||
105867363|NCT00101283|365164954|FG001|Overall Study|Insurance Refusal|1|||
105867364|NCT00101283|365164953|FG000|Overall Study|Prostate Cancer Recurrence|0|||
106173546|NCT02846545|366297687|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
106173547|NCT02846545|366297686|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
106173548|NCT02846545|366297687|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
105867365|NCT00101283|365164954|FG001|Overall Study|Prostate Cancer Recurrence|1|||
106173549|NCT02846545|366297686|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
106173550|NCT02846545|366297687|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
106173551|NCT02846545|366297686|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
106173552|NCT02846545|366297687|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
106173553|NCT03691298|366297690|FG000|Overall Study|Lost to Follow-up|8|||
106173554|NCT03691298|366297690|FG000|Overall Study|Sponsor terminated study|2|||
106173555|NCT03663205|366297697|FG000|Overall Study|Death|144|||
106173556|NCT03663205|366297698|FG001|Overall Study|Death|69|||
106173557|NCT03663205|366297697|FG000|Overall Study|Sponsor decision|53|||
106173558|NCT03663205|366297698|FG001|Overall Study|Sponsor decision|19|||
106173559|NCT03663205|366297697|FG000|Overall Study|Withdrawal by Subject|8|||
106173560|NCT03663205|366297698|FG001|Overall Study|Withdrawal by Subject|11|||
106173561|NCT03663205|366297697|FG000|Overall Study|Lost to Follow-up|7|||
106173562|NCT03663205|366297698|FG001|Overall Study|Lost to Follow-up|9|||
106173563|NCT03663205|366297697|FG000|Overall Study|Transferred to long term extension study|11|||
106173564|NCT03663205|366297698|FG001|Overall Study|Transferred to long term extension study|3|||
106173565|NCT03652272|366297699|FG000|3 Month|Withdrawal by Subject|1|||
106173566|NCT03652272|366297700|FG001|3 Month|Withdrawal by Subject|1|||
106173567|NCT03652272|366297699|FG000|3 Month|Lost to Follow-up|16|||
106173568|NCT03652272|366297700|FG001|3 Month|Lost to Follow-up|14|||
106173569|NCT02577354|366297701|FG000|Overall Study|Lack of Efficacy|4|||
106173570|NCT02577354|366297702|FG001|Overall Study|Lack of Efficacy|4|||
106173571|NCT02577354|366297701|FG000|Overall Study|Lost to Follow-up|3|||
106173572|NCT02577354|366297702|FG001|Overall Study|Lost to Follow-up|1|||
106173573|NCT02577354|366297701|FG000|Overall Study|Missed Visit|4|||
106173574|NCT02577354|366297702|FG001|Overall Study|Missed Visit|3|||
106173575|NCT02577354|366297701|FG000|Overall Study|Adverse Event|4|||
106173576|NCT02577354|366297702|FG001|Overall Study|Adverse Event|5|||
106173577|NCT04173247|366297705|FG000|Overall Study|Withdrawal by Subject|0|||
106173578|NCT04173247|366297706|FG001|Overall Study|Withdrawal by Subject|2|||
106173579|NCT04173247|366297705|FG000|Overall Study|Death|1|||
106173580|NCT04173247|366297706|FG001|Overall Study|Death|0|||
106173581|NCT04173247|366297705|FG000|Overall Study|Physician Decision|1|||
106173582|NCT04173247|366297706|FG001|Overall Study|Physician Decision|0|||
106173583|NCT04084574|366298249|FG000|Overall Study|Lost to Follow-up|1|||
106173584|NCT04084574|366298250|FG001|Overall Study|Lost to Follow-up|0|||
106173585|NCT04084574|366298249|FG000|Overall Study|Physician Decision|1|||
106173586|NCT04084574|366298250|FG001|Overall Study|Physician Decision|0|||
106173587|NCT04084574|366298249|FG000|Overall Study|Relocated out of state|1|||
106173588|NCT04084574|366298250|FG001|Overall Study|Relocated out of state|0|||
106173589|NCT06655818|366298251|FG000|Overall Study|Withdrawal by Subject|1|||
106173590|NCT04214834|366298252|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
106173591|NCT04214834|366298253|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
106173592|NCT02163694|366298256|FG000|Overall Study|Adverse event- related to progression|4|||
106173593|NCT02163694|366298257|FG001|Overall Study|Adverse event- related to progression|10|||
106173594|NCT02163694|366298256|FG000|Overall Study|Adverse event- not related to progression|7|||
106173595|NCT02163694|366298257|FG001|Overall Study|Adverse event- not related to progression|22|||
106173596|NCT02163694|366298256|FG000|Overall Study|Withdrew consent|13|||
106173597|NCT02163694|366298257|FG001|Overall Study|Withdrew consent|28|||
106173598|NCT02163694|366298256|FG000|Overall Study|Lost to Follow-up|2|||
106173599|NCT02163694|366298257|FG001|Overall Study|Lost to Follow-up|2|||
106173600|NCT02163694|366298256|FG000|Overall Study|Sponsor discontinued study|3|||
106173601|NCT02163694|366298257|FG001|Overall Study|Sponsor discontinued study|29|||
106173602|NCT02163694|366298256|FG000|Overall Study|Progressive disease per protocol|125|||
106173603|NCT02163694|366298257|FG001|Overall Study|Progressive disease per protocol|224|||
106173604|NCT02163694|366298256|FG000|Overall Study|Other, not specified|17|||
106173605|NCT02163694|366298257|FG001|Overall Study|Other, not specified|22|||
106173606|NCT02163694|366298256|FG000|Overall Study|Randomized but Not Treated|1|||
106173607|NCT02163694|366298257|FG001|Overall Study|Randomized but Not Treated|0|||
106173608|NCT02163694|366298256|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
106173609|NCT02163694|366298257|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
106173610|NCT03884101|366298262|FG000|Overall Study|Participant Ongoing in Study|202|||
106173611|NCT03884101|366298263|FG001|Overall Study|Participant Ongoing in Study|186|||
106173612|NCT03884101|366298262|FG000|Overall Study|Death|212|||
106173613|NCT03884101|366298263|FG001|Overall Study|Death|224|||
106173614|NCT03884101|366298262|FG000|Overall Study|Lost to Follow-up|0|||
106173615|NCT03884101|366298263|FG001|Overall Study|Lost to Follow-up|1|||
106173616|NCT03884101|366298262|FG000|Overall Study|Withdrawal by Subject|6|||
106173617|NCT03884101|366298263|FG001|Overall Study|Withdrawal by Subject|11|||
106173618|NCT00412607|366298269|FG000|Overall Study|Withdrawal by Subject|9|||
106173619|NCT00412607|366298269|FG000|Overall Study|Lost to Follow-up|19|||
106173620|NCT00412607|366298269|FG000|Overall Study|Death|61|||
106173621|NCT00412607|366298269|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
106173622|NCT03245840|366298272|FG000|Overall Study|Adverse Event|6|||
106173623|NCT03245840|366298273|FG001|Overall Study|Adverse Event|0|||
106173624|NCT03245840|366298272|FG000|Overall Study|Death|2|||
106173625|NCT03245840|366298273|FG001|Overall Study|Death|0|||
106173626|NCT03245840|366298272|FG000|Overall Study|Withdrawal by Subject|31|||
106173627|NCT03245840|366298273|FG001|Overall Study|Withdrawal by Subject|1|||
106173628|NCT03245840|366298272|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
106173629|NCT03245840|366298273|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
106173630|NCT03245840|366298272|FG000|Overall Study|Physician Decision|4|||
106173631|NCT03245840|366298273|FG001|Overall Study|Physician Decision|1|||
106173632|NCT03245840|366298272|FG000|Overall Study|Study Terminated by Sponsor|56|||
106173633|NCT03245840|366298273|FG001|Overall Study|Study Terminated by Sponsor|6|||
106173634|NCT03245840|366298272|FG000|Overall Study|Site Terminated by Sponsor|4|||
106173635|NCT03245840|366298273|FG001|Overall Study|Site Terminated by Sponsor|0|||
106173636|NCT03245840|366298272|FG000|Overall Study|Lost to Follow-up|12|||
106173637|NCT03245840|366298273|FG001|Overall Study|Lost to Follow-up|2|||
106173638|NCT03245840|366298272|FG000|Overall Study|Pregnancy|2|||
106173639|NCT03245840|366298273|FG001|Overall Study|Pregnancy|0|||
106173640|NCT03245840|366298272|FG000|Overall Study|Non-Compliance with Study Drug|2|||
106173641|NCT03245840|366298273|FG001|Overall Study|Non-Compliance with Study Drug|0|||
106173642|NCT03245840|366298272|FG000|Overall Study|Not treated|1|||
106173643|NCT03245840|366298273|FG001|Overall Study|Not treated|1|||
106173644|NCT05836012|366298281|FG000|Overall Study|Lost to Follow-up|1|||
106173645|NCT05836012|366298282|FG001|Overall Study|Lost to Follow-up|0|||
106173646|NCT05836012|366298281|FG000|Overall Study|Withdrawal by Subject|1|||
106173647|NCT05836012|366298282|FG001|Overall Study|Withdrawal by Subject|3|||
106173648|NCT05836012|366298281|FG000|Overall Study|Reason not included in pre-specified categories|2|||
106173649|NCT05836012|366298282|FG001|Overall Study|Reason not included in pre-specified categories|1|||
106173650|NCT05112900|366298284|FG000|Overall Study|Withdrawal by Subject|960|||
106173651|NCT05112900|366298285|FG001|Overall Study|Withdrawal by Subject|921|||
106173652|NCT05112900|366298286|FG002|Overall Study|Withdrawal by Subject|968|||
106173653|NCT00319111|366298287|FG000|Overall Study|Adverse Event|20|||
106173654|NCT00319111|366298287|FG000|Overall Study|Withdrawal of consent|11|||
106173655|NCT00319111|366298287|FG000|Overall Study|Death|9|||
106173656|NCT00319111|366298287|FG000|Overall Study|Lack of clinical improvement|4|||
106173657|NCT00319111|366298287|FG000|Overall Study|Administrative|2|||
106173658|NCT00319111|366298287|FG000|Overall Study|Treatment failure|1|||
106173659|NCT05541484|366298293|FG000|Overall Study|Withdrawal by Subject|1|||
106173660|NCT05541484|366298294|FG001|Overall Study|Withdrawal by Subject|0|||
106173661|NCT03370913|366299067|FG000|Overall Study|Death|1|||
106173662|NCT03370913|366299067|FG000|Overall Study|Lost to Follow-up|1|||
106173663|NCT04633538|366299068|FG000|Overall Study|Death|1|||
106173664|NCT04633538|366299068|FG000|Overall Study|Lost to Follow-up|3|||
106173665|NCT04633538|366299068|FG000|Overall Study|Withdrawal by Subject|1|||
106173666|NCT05070741|366299070|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
106173667|NCT03582033|366299074|FG000|Part A|Other|0|||
106173668|NCT03582033|366299075|FG001|Part A|Other|0|||
106173669|NCT03582033|366299076|FG002|Part A|Other|0|||
106173670|NCT03582033|366299077|FG003|Part A|Other|0|||
106173671|NCT03582033|366299078|FG004|Part A|Other|2|||
106173672|NCT03582033|366299079|FG005|Part A|Other|0|||
106173673|NCT03582033|366299080|FG006|Part A|Other|0|||
106173674|NCT03582033|366299081|FG007|Part A|Other|0|||
106173675|NCT03582033|366299082|FG008|Part A|Other|0|||
106173676|NCT03582033|366299083|FG009|Part A|Other|0|||
106173677|NCT03582033|366299074|FG000|Part A|Death|1|||
106173678|NCT03582033|366299075|FG001|Part A|Death|1|||
106173679|NCT03582033|366299076|FG002|Part A|Death|2|||
106173680|NCT03582033|366299077|FG003|Part A|Death|4|||
106173681|NCT03582033|366299078|FG004|Part A|Death|11|||
106173682|NCT03582033|366299079|FG005|Part A|Death|0|||
106173683|NCT03582033|366299080|FG006|Part A|Death|0|||
106173684|NCT03582033|366299081|FG007|Part A|Death|0|||
106173685|NCT03582033|366299082|FG008|Part A|Death|0|||
106173686|NCT03582033|366299083|FG009|Part A|Death|0|||
106173687|NCT03582033|366299074|FG000|Part A|Lost to Follow-up|0|||
106173688|NCT03582033|366299075|FG001|Part A|Lost to Follow-up|0|||
106173689|NCT03582033|366299076|FG002|Part A|Lost to Follow-up|0|||
106173690|NCT03582033|366299077|FG003|Part A|Lost to Follow-up|0|||
106173691|NCT03582033|366299078|FG004|Part A|Lost to Follow-up|1|||
106173692|NCT03582033|366299079|FG005|Part A|Lost to Follow-up|0|||
106173693|NCT03582033|366299080|FG006|Part A|Lost to Follow-up|0|||
106173694|NCT03582033|366299081|FG007|Part A|Lost to Follow-up|0|||
106173695|NCT03582033|366299082|FG008|Part A|Lost to Follow-up|0|||
106173696|NCT03582033|366299083|FG009|Part A|Lost to Follow-up|0|||
106173697|NCT03582033|366299074|FG000|Part A|Study terminated by sponsor|0|||
106173698|NCT03582033|366299075|FG001|Part A|Study terminated by sponsor|0|||
106173699|NCT03582033|366299076|FG002|Part A|Study terminated by sponsor|0|||
106173700|NCT03582033|366299077|FG003|Part A|Study terminated by sponsor|2|||
106173701|NCT03582033|366299078|FG004|Part A|Study terminated by sponsor|1|||
106173702|NCT03582033|366299079|FG005|Part A|Study terminated by sponsor|0|||
106173703|NCT03582033|366299080|FG006|Part A|Study terminated by sponsor|0|||
106173704|NCT03582033|366299081|FG007|Part A|Study terminated by sponsor|0|||
106173705|NCT03582033|366299082|FG008|Part A|Study terminated by sponsor|0|||
106173706|NCT03582033|366299083|FG009|Part A|Study terminated by sponsor|0|||
106173707|NCT03582033|366299074|FG000|Part A|Withdrawal by Subject|1|||
106173708|NCT03582033|366299075|FG001|Part A|Withdrawal by Subject|1|||
106173709|NCT03582033|366299076|FG002|Part A|Withdrawal by Subject|0|||
106173710|NCT03582033|366299077|FG003|Part A|Withdrawal by Subject|1|||
106173711|NCT03582033|366299078|FG004|Part A|Withdrawal by Subject|7|||
106173712|NCT03582033|366299079|FG005|Part A|Withdrawal by Subject|0|||
106173713|NCT03582033|366299080|FG006|Part A|Withdrawal by Subject|0|||
106173714|NCT03582033|366299081|FG007|Part A|Withdrawal by Subject|0|||
106173715|NCT03582033|366299082|FG008|Part A|Withdrawal by Subject|0|||
106173716|NCT03582033|366299083|FG009|Part A|Withdrawal by Subject|0|||
106173717|NCT03582033|366299074|FG000|Part B|Death|0|||
106173718|NCT03582033|366299075|FG001|Part B|Death|0|||
106173719|NCT03582033|366299076|FG002|Part B|Death|0|||
106173720|NCT03582033|366299077|FG003|Part B|Death|0|||
106173721|NCT03582033|366299078|FG004|Part B|Death|0|||
106173722|NCT03582033|366299079|FG005|Part B|Death|2|||
106173723|NCT03582033|366299080|FG006|Part B|Death|0|||
106173724|NCT03582033|366299081|FG007|Part B|Death|0|||
106173725|NCT03582033|366299082|FG008|Part B|Death|0|||
106173726|NCT03582033|366299083|FG009|Part B|Death|0|||
106173727|NCT03582033|366299074|FG000|Part B|Study terminated by sponsor|0|||
106173728|NCT03582033|366299075|FG001|Part B|Study terminated by sponsor|0|||
106173729|NCT03582033|366299076|FG002|Part B|Study terminated by sponsor|0|||
106173730|NCT03582033|366299077|FG003|Part B|Study terminated by sponsor|0|||
106173731|NCT03582033|366299078|FG004|Part B|Study terminated by sponsor|0|||
106173732|NCT03582033|366299079|FG005|Part B|Study terminated by sponsor|12|||
106173733|NCT03582033|366299080|FG006|Part B|Study terminated by sponsor|0|||
106173734|NCT03582033|366299081|FG007|Part B|Study terminated by sponsor|0|||
106173735|NCT03582033|366299082|FG008|Part B|Study terminated by sponsor|0|||
106173736|NCT03582033|366299083|FG009|Part B|Study terminated by sponsor|0|||
106173737|NCT03582033|366299074|FG000|Part B|Withdrawal by Subject|0|||
106173738|NCT03582033|366299075|FG001|Part B|Withdrawal by Subject|0|||
106173739|NCT03582033|366299076|FG002|Part B|Withdrawal by Subject|0|||
106173740|NCT03582033|366299077|FG003|Part B|Withdrawal by Subject|0|||
106173741|NCT03582033|366299078|FG004|Part B|Withdrawal by Subject|0|||
106173742|NCT03582033|366299079|FG005|Part B|Withdrawal by Subject|6|||
106173743|NCT03582033|366299080|FG006|Part B|Withdrawal by Subject|0|||
106173744|NCT03582033|366299081|FG007|Part B|Withdrawal by Subject|0|||
106173745|NCT03582033|366299082|FG008|Part B|Withdrawal by Subject|0|||
106173746|NCT03582033|366299083|FG009|Part B|Withdrawal by Subject|0|||
106173747|NCT03582033|366299074|FG000|Part C|Other|0|||
106173748|NCT03582033|366299075|FG001|Part C|Other|0|||
106173749|NCT03582033|366299076|FG002|Part C|Other|0|||
106173750|NCT03582033|366299077|FG003|Part C|Other|0|||
106173751|NCT03582033|366299078|FG004|Part C|Other|0|||
106173752|NCT03582033|366299079|FG005|Part C|Other|0|||
106173753|NCT03582033|366299080|FG006|Part C|Other|2|||
106173754|NCT03582033|366299081|FG007|Part C|Other|0|||
106173755|NCT03582033|366299082|FG008|Part C|Other|0|||
106173756|NCT03582033|366299083|FG009|Part C|Other|0|||
106173757|NCT03582033|366299074|FG000|Part C|Death|0|||
106173758|NCT03582033|366299075|FG001|Part C|Death|0|||
106173759|NCT03582033|366299076|FG002|Part C|Death|0|||
106173760|NCT03582033|366299077|FG003|Part C|Death|0|||
106173761|NCT03582033|366299078|FG004|Part C|Death|0|||
106173762|NCT03582033|366299079|FG005|Part C|Death|0|||
106173763|NCT03582033|366299080|FG006|Part C|Death|6|||
106173764|NCT03582033|366299081|FG007|Part C|Death|1|||
106173765|NCT03582033|366299082|FG008|Part C|Death|2|||
106173766|NCT03582033|366299083|FG009|Part C|Death|0|||
106173767|NCT03582033|366299074|FG000|Part C|Study terminated by sponsor|0|||
106173768|NCT03582033|366299075|FG001|Part C|Study terminated by sponsor|0|||
106173769|NCT03582033|366299076|FG002|Part C|Study terminated by sponsor|0|||
106173770|NCT03582033|366299077|FG003|Part C|Study terminated by sponsor|0|||
106173771|NCT03582033|366299078|FG004|Part C|Study terminated by sponsor|0|||
106173772|NCT03582033|366299079|FG005|Part C|Study terminated by sponsor|0|||
106173773|NCT03582033|366299080|FG006|Part C|Study terminated by sponsor|3|||
106173774|NCT03582033|366299081|FG007|Part C|Study terminated by sponsor|3|||
106173775|NCT03582033|366299082|FG008|Part C|Study terminated by sponsor|2|||
106173776|NCT03582033|366299083|FG009|Part C|Study terminated by sponsor|0|||
106173777|NCT03582033|366299074|FG000|Part C|Withdrawal by Subject|0|||
106173778|NCT03582033|366299075|FG001|Part C|Withdrawal by Subject|0|||
106173779|NCT03582033|366299076|FG002|Part C|Withdrawal by Subject|0|||
106173780|NCT03582033|366299077|FG003|Part C|Withdrawal by Subject|0|||
106173781|NCT03582033|366299078|FG004|Part C|Withdrawal by Subject|0|||
106173782|NCT03582033|366299079|FG005|Part C|Withdrawal by Subject|0|||
106173783|NCT03582033|366299080|FG006|Part C|Withdrawal by Subject|1|||
106173784|NCT03582033|366299081|FG007|Part C|Withdrawal by Subject|2|||
106173785|NCT03582033|366299082|FG008|Part C|Withdrawal by Subject|1|||
106173786|NCT03582033|366299083|FG009|Part C|Withdrawal by Subject|0|||
106173787|NCT03582033|366299074|FG000|Part D|Death|0|||
106173788|NCT03582033|366299075|FG001|Part D|Death|0|||
106173789|NCT03582033|366299076|FG002|Part D|Death|0|||
106173790|NCT03582033|366299077|FG003|Part D|Death|0|||
106173791|NCT03582033|366299078|FG004|Part D|Death|0|||
106173792|NCT03582033|366299079|FG005|Part D|Death|0|||
106173793|NCT03582033|366299080|FG006|Part D|Death|0|||
106173794|NCT03582033|366299081|FG007|Part D|Death|0|||
106173795|NCT03582033|366299082|FG008|Part D|Death|0|||
106173796|NCT03582033|366299083|FG009|Part D|Death|1|||
106173797|NCT03582033|366299074|FG000|Part D|Study terminated by sponsor|0|||
106173798|NCT03582033|366299075|FG001|Part D|Study terminated by sponsor|0|||
106173799|NCT03582033|366299076|FG002|Part D|Study terminated by sponsor|0|||
106173800|NCT03582033|366299077|FG003|Part D|Study terminated by sponsor|0|||
106173801|NCT03582033|366299078|FG004|Part D|Study terminated by sponsor|0|||
106173802|NCT03582033|366299079|FG005|Part D|Study terminated by sponsor|0|||
106173803|NCT03582033|366299080|FG006|Part D|Study terminated by sponsor|0|||
106173804|NCT03582033|366299081|FG007|Part D|Study terminated by sponsor|0|||
106173805|NCT03582033|366299082|FG008|Part D|Study terminated by sponsor|0|||
106173806|NCT03582033|366299083|FG009|Part D|Study terminated by sponsor|4|||
106173807|NCT04631016|366299084|FG000|Overall Study|Adverse Event|3|||
106173808|NCT04631016|366299085|FG001|Overall Study|Adverse Event|0|||
106173809|NCT04631016|366299084|FG000|Overall Study|Withdrawal by Subject|5|||
106173810|NCT04631016|366299085|FG001|Overall Study|Withdrawal by Subject|4|||
106173811|NCT04631016|366299084|FG000|Overall Study|Reason unspecified|1|||
106173812|NCT04631016|366299085|FG001|Overall Study|Reason unspecified|0|||
106173813|NCT04631016|366299084|FG000|Overall Study|Failure to meet randomization criteria|2|||
106173814|NCT04631016|366299085|FG001|Overall Study|Failure to meet randomization criteria|1|||
106173815|NCT04109066|366299086|FG000|Pre-treatment|Participant withdrew consent|2|||
106173816|NCT04109066|366299087|FG001|Pre-treatment|Participant withdrew consent|0|||
106173817|NCT04109066|366299086|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
106173818|NCT04109066|366299087|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
106173819|NCT04109066|366299086|FG000|Treatment|Lack of Efficacy|2|||
106173820|NCT04109066|366299087|FG001|Treatment|Lack of Efficacy|4|||
106173821|NCT04109066|366299086|FG000|Treatment|Adverse Event|23|||
106173822|NCT04109066|366299087|FG001|Treatment|Adverse Event|7|||
106173823|NCT04109066|366299086|FG000|Treatment|Participant request to discontinue Study treatment|15|||
106173824|NCT04109066|366299087|FG001|Treatment|Participant request to discontinue Study treatment|14|||
106173825|NCT04109066|366299086|FG000|Treatment|Withdrawal by Subject|8|||
106173826|NCT04109066|366299087|FG001|Treatment|Withdrawal by Subject|8|||
106173827|NCT04109066|366299086|FG000|Treatment|Death|3|||
106173828|NCT04109066|366299087|FG001|Treatment|Death|0|||
106173829|NCT04109066|366299086|FG000|Treatment|Participant no longer meets study criteria|2|||
106173830|NCT04109066|366299087|FG001|Treatment|Participant no longer meets study criteria|2|||
106173831|NCT04109066|366299086|FG000|Treatment|Administrative reasons by sponsor|2|||
106173832|NCT04109066|366299087|FG001|Treatment|Administrative reasons by sponsor|3|||
106173833|NCT04109066|366299086|FG000|Treatment|Other reasons|17|||
106173834|NCT04109066|366299087|FG001|Treatment|Other reasons|23|||
106173835|NCT04109066|366299086|FG000|Treatment|Disease Progression|4|||
106173836|NCT04109066|366299087|FG001|Treatment|Disease Progression|7|||
106173837|NCT04109066|366299086|FG000|Treatment|Study drug toxicity|12|||
106173838|NCT04109066|366299087|FG001|Treatment|Study drug toxicity|5|||
106173839|NCT04109066|366299086|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
106173840|NCT04109066|366299087|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
106173841|NCT04109066|366299086|FG000|Treatment|Disease Recurrence|0|||
106173842|NCT04109066|366299087|FG001|Treatment|Disease Recurrence|2|||
106173843|NCT04109066|366299086|FG000|Treatment|Not reported|4|||
106173844|NCT04109066|366299087|FG001|Treatment|Not reported|8|||
106173845|NCT05652010|366299088|FG000|First Intervention|Withdrawal by Subject|0|||
106173846|NCT05652010|366299089|FG001|First Intervention|Withdrawal by Subject|1|||
106173847|NCT05652010|366299088|FG000|Second Intervention|Withdrawal by Subject|1|||
106173848|NCT05652010|366299089|FG001|Second Intervention|Withdrawal by Subject|0|||
106173849|NCT04163991|366299101|FG000|Overall Study|Adverse Event|0|||
106173850|NCT04163991|366299102|FG001|Overall Study|Adverse Event|0|||
106173851|NCT04163991|366299103|FG002|Overall Study|Adverse Event|0|||
106173852|NCT04163991|366299104|FG003|Overall Study|Adverse Event|1|||
106173853|NCT04163991|366299105|FG004|Overall Study|Adverse Event|0|||
106173854|NCT04163991|366299101|FG000|Overall Study|Death|0|||
106173855|NCT04163991|366299102|FG001|Overall Study|Death|0|||
106173856|NCT04163991|366299103|FG002|Overall Study|Death|1|||
106173857|NCT04163991|366299104|FG003|Overall Study|Death|0|||
106173858|NCT04163991|366299105|FG004|Overall Study|Death|0|||
106173859|NCT04163991|366299101|FG000|Overall Study|Lost to Follow-up|0|||
106173860|NCT04163991|366299102|FG001|Overall Study|Lost to Follow-up|1|||
106173861|NCT04163991|366299103|FG002|Overall Study|Lost to Follow-up|0|||
106173862|NCT04163991|366299104|FG003|Overall Study|Lost to Follow-up|0|||
106173863|NCT04163991|366299105|FG004|Overall Study|Lost to Follow-up|0|||
106173864|NCT04163991|366299101|FG000|Overall Study|Withdrawal by Subject|1|||
106173865|NCT04163991|366299102|FG001|Overall Study|Withdrawal by Subject|1|||
106173866|NCT04163991|366299103|FG002|Overall Study|Withdrawal by Subject|3|||
106173867|NCT04163991|366299104|FG003|Overall Study|Withdrawal by Subject|1|||
106173868|NCT04163991|366299105|FG004|Overall Study|Withdrawal by Subject|1|||
106173869|NCT04163991|366299101|FG000|Overall Study|Other, Not Specified|0|||
106173870|NCT04163991|366299102|FG001|Overall Study|Other, Not Specified|1|||
106173871|NCT04163991|366299103|FG002|Overall Study|Other, Not Specified|1|||
106173872|NCT04163991|366299104|FG003|Overall Study|Other, Not Specified|1|||
106173873|NCT04163991|366299105|FG004|Overall Study|Other, Not Specified|0|||
106173874|NCT04206787|366299108|FG000|Overall Study|Other than listed|2|||
106173875|NCT04206787|366299108|FG000|Overall Study|Investigator decision|1|||
106173876|NCT04206787|366299108|FG000|Overall Study|Death|25|||
106173877|NCT04206787|366299108|FG000|Overall Study|Lost to Follow-up|9|||
106173878|NCT04206787|366299108|FG000|Overall Study|Withdrawal of consent|9|||
106173879|NCT05008055|366299109|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
106173880|NCT05008055|366299110|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
106173881|NCT05008055|366299111|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
106173882|NCT04635059|366299112|FG000|Overall Study|Study terminated early.|4|||
106173883|NCT03011034|366299117|FG000|Overall Study|Adverse Event|1|||
106173884|NCT03011034|366299118|FG001|Overall Study|Adverse Event|0|||
106173885|NCT02777593|366299119|FG000|Overall Study|Still in study|1|||
106173886|NCT02777593|366299120|FG001|Overall Study|Still in study|32|||
106173887|NCT02777593|366299121|FG002|Overall Study|Still in study|3|||
106173888|NCT02777593|366299122|FG003|Overall Study|Still in study|6|||
106173889|NCT02777593|366299123|FG004|Overall Study|Still in study|5|||
106173890|NCT02777593|366299119|FG000|Overall Study|Death|21|||
106173891|NCT02777593|366299120|FG001|Overall Study|Death|28|||
106173892|NCT02777593|366299121|FG002|Overall Study|Death|0|||
106173893|NCT02777593|366299122|FG003|Overall Study|Death|5|||
106173894|NCT02777593|366299123|FG004|Overall Study|Death|0|||
106173895|NCT02777593|366299119|FG000|Overall Study|Withdrawal by Subject|8|||
106173896|NCT02777593|366299120|FG001|Overall Study|Withdrawal by Subject|4|||
106173897|NCT02777593|366299121|FG002|Overall Study|Withdrawal by Subject|1|||
106173898|NCT02777593|366299122|FG003|Overall Study|Withdrawal by Subject|1|||
106173899|NCT02777593|366299123|FG004|Overall Study|Withdrawal by Subject|0|||
106173900|NCT02777593|366299119|FG000|Overall Study|Lost to Follow-up|8|||
106173901|NCT02777593|366299120|FG001|Overall Study|Lost to Follow-up|16|||
106173902|NCT02777593|366299121|FG002|Overall Study|Lost to Follow-up|5|||
106173903|NCT02777593|366299122|FG003|Overall Study|Lost to Follow-up|0|||
106173904|NCT02777593|366299123|FG004|Overall Study|Lost to Follow-up|1|||
106173905|NCT02777593|366299119|FG000|Overall Study|Physician Decision|2|||
106173906|NCT02777593|366299120|FG001|Overall Study|Physician Decision|2|||
106173907|NCT02777593|366299121|FG002|Overall Study|Physician Decision|0|||
106173908|NCT02777593|366299122|FG003|Overall Study|Physician Decision|0|||
106173909|NCT02777593|366299123|FG004|Overall Study|Physician Decision|0|||
106173910|NCT02777593|366299119|FG000|Overall Study|Discontinued due to Other|1|||
106173911|NCT02777593|366299120|FG001|Overall Study|Discontinued due to Other|0|||
106173912|NCT02777593|366299121|FG002|Overall Study|Discontinued due to Other|0|||
106173913|NCT02777593|366299122|FG003|Overall Study|Discontinued due to Other|0|||
106173914|NCT02777593|366299123|FG004|Overall Study|Discontinued due to Other|0|||
106173915|NCT04743973|366299124|FG000|Overall Study|Withdrawal by Subject|5|||
106173916|NCT05654662|366299125|FG000|Overall Study|Withdrawal by Subject|1|||
106173917|NCT05654662|366299126|FG001|Overall Study|Withdrawal by Subject|0|||
106173918|NCT05654662|366299125|FG000|Overall Study|A death in the family|1|||
106173919|NCT05654662|366299126|FG001|Overall Study|A death in the family|0|||
106173920|NCT04157517|366299127|FG000|Overall Study|Death|1|||
106173921|NCT04157517|366299128|FG001|Overall Study|Death|2|||
106173922|NCT04157517|366299129|FG002|Overall Study|Death|2|||
106173923|NCT04157517|366299130|FG003|Overall Study|Death|3|||
106173924|NCT04157517|366299131|FG004|Overall Study|Death|3|||
106173925|NCT04157517|366299132|FG005|Overall Study|Death|4|||
106173926|NCT04157517|366299133|FG006|Overall Study|Death|1|||
106173927|NCT04157517|366299134|FG007|Overall Study|Death|2|||
106173928|NCT04157517|366299135|FG008|Overall Study|Death|4|||
106173929|NCT04157517|366299136|FG009|Overall Study|Death|0|||
106173930|NCT04157517|366299127|FG000|Overall Study|Withdrawal by Subject|1|||
106173931|NCT04157517|366299128|FG001|Overall Study|Withdrawal by Subject|1|||
106173932|NCT04157517|366299129|FG002|Overall Study|Withdrawal by Subject|1|||
106173933|NCT04157517|366299130|FG003|Overall Study|Withdrawal by Subject|0|||
106173934|NCT04157517|366299131|FG004|Overall Study|Withdrawal by Subject|0|||
106173935|NCT04157517|366299132|FG005|Overall Study|Withdrawal by Subject|1|||
106173936|NCT04157517|366299133|FG006|Overall Study|Withdrawal by Subject|0|||
106173937|NCT04157517|366299134|FG007|Overall Study|Withdrawal by Subject|0|||
106173938|NCT04157517|366299135|FG008|Overall Study|Withdrawal by Subject|1|||
106173939|NCT04157517|366299136|FG009|Overall Study|Withdrawal by Subject|0|||
106173940|NCT04157517|366299127|FG000|Overall Study|Other|1|||
106173941|NCT04157517|366299128|FG001|Overall Study|Other|0|||
106173942|NCT04157517|366299129|FG002|Overall Study|Other|0|||
106173943|NCT04157517|366299130|FG003|Overall Study|Other|0|||
106173944|NCT04157517|366299131|FG004|Overall Study|Other|0|||
106173945|NCT04157517|366299132|FG005|Overall Study|Other|1|||
106173946|NCT04157517|366299133|FG006|Overall Study|Other|2|||
106173947|NCT04157517|366299134|FG007|Overall Study|Other|7|||
106173948|NCT04157517|366299135|FG008|Overall Study|Other|7|||
106173949|NCT04157517|366299136|FG009|Overall Study|Other|0|||
106173950|NCT04565990|366299917|FG000|Overall Study|Death|5|||
106173951|NCT04565990|366299917|FG000|Overall Study|Lost to Follow-up|1|||
106173952|NCT04565990|366299917|FG000|Overall Study|Withdrawal by Subject|1|||
106173953|NCT04797858|366299918|FG000|Overall Study|Withdrawal by Subject|0|||
106173954|NCT04797858|366299919|FG001|Overall Study|Withdrawal by Subject|1|||
106173955|NCT04797858|366299918|FG000|Overall Study|Excluded due to administrative error|7|||
106173956|NCT04797858|366299919|FG001|Overall Study|Excluded due to administrative error|8|||
106173957|NCT00942877|366299920|FG000|Overall Study|Refused further treatment|1|||
106173958|NCT00942877|366299921|FG001|Overall Study|Refused further treatment|1|||
106173959|NCT00942877|366299920|FG000|Overall Study|Patient was not treated|1|||
106173960|NCT00942877|366299921|FG001|Overall Study|Patient was not treated|0|||
106173961|NCT00942877|366299920|FG000|Overall Study|Adverse Event|1|||
106173962|NCT00942877|366299921|FG001|Overall Study|Adverse Event|0|||
106173963|NCT00942877|366299920|FG000|Overall Study|Progressive disease|42|||
106173964|NCT00942877|366299921|FG001|Overall Study|Progressive disease|3|||
106173965|NCT01385202|366299922|FG000|Overall Study|Lost to Follow-up|6|||
106173966|NCT01385202|366299922|FG000|Overall Study|Not Eligible|11|||
106173967|NCT01385202|366299922|FG000|Overall Study|Withdrawn|1|||
106173968|NCT05830799|366299926|FG000|Overall Study|Withdrawal by Subject|1|||
106173969|NCT04560179|366299936|FG000|Overall Study|Physician Decision|1|||
106173970|NCT04560179|366299937|FG001|Overall Study|Physician Decision|0|||
106173971|NCT04560179|366299938|FG002|Overall Study|Physician Decision|0|||
106173972|NCT04560179|366299939|FG003|Overall Study|Physician Decision|0|||
106173973|NCT04560179|366299940|FG004|Overall Study|Physician Decision|0|||
106173974|NCT04560179|366299936|FG000|Overall Study|Adverse Event|0|||
106173975|NCT04560179|366299937|FG001|Overall Study|Adverse Event|0|||
106173976|NCT04560179|366299938|FG002|Overall Study|Adverse Event|0|||
106173977|NCT04560179|366299939|FG003|Overall Study|Adverse Event|1|||
106173978|NCT04560179|366299940|FG004|Overall Study|Adverse Event|0|||
106173979|NCT05205161|366299941|FG000|Overall Study|Study terminated by sponsor|3|||
106173980|NCT05205161|366299942|FG001|Overall Study|Study terminated by sponsor|3|||
106173981|NCT05205161|366299943|FG002|Overall Study|Study terminated by sponsor|1|||
106173982|NCT04524689|366299950|FG000|Overall Study|Withdrawal by Subject|1|||
106173983|NCT04524689|366299951|FG001|Overall Study|Withdrawal by Subject|1|||
106173984|NCT04524689|366299952|FG002|Overall Study|Withdrawal by Subject|0|||
106173985|NCT04524689|366299953|FG003|Overall Study|Withdrawal by Subject|0|||
106173986|NCT04524689|366299954|FG004|Overall Study|Withdrawal by Subject|1|||
106173987|NCT04524689|366299955|FG005|Overall Study|Withdrawal by Subject|0|||
106173988|NCT04524689|366299950|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
106173989|NCT04524689|366299951|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
106173990|NCT04524689|366299952|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
106173991|NCT04524689|366299953|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
106173992|NCT04524689|366299954|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
106173993|NCT04524689|366299955|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
106173994|NCT04524689|366299950|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
106173995|NCT04524689|366299951|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
106173996|NCT04524689|366299952|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
106173997|NCT04524689|366299953|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
106173998|NCT04524689|366299954|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
106173999|NCT04524689|366299955|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
106174000|NCT04369911|366299957|FG000|Overall Study|Lost to Follow-up|3|||
106174001|NCT04369911|366299958|FG001|Overall Study|Lost to Follow-up|3|||
106174002|NCT04369911|366299957|FG000|Overall Study|Withdrawal by Subject|1|||
106174003|NCT04369911|366299958|FG001|Overall Study|Withdrawal by Subject|2|||
106174004|NCT05741294|366299961|FG000|Overall Study|Lost to Follow-up|3|||
106174005|NCT05741294|366299961|FG000|Overall Study|Protocol deviation|3|||
106174006|NCT05741294|366299961|FG000|Overall Study|Withdrawal by Subject|1|||
106174007|NCT05451693|366299962|FG000|Overall Study|Withdrawal by Subject|1|||
106174008|NCT05451693|366299963|FG001|Overall Study|Withdrawal by Subject|1|||
106174009|NCT04707768|366299970|FG000|Overall Study|Adverse Event|9|||
106174010|NCT04707768|366299971|FG001|Overall Study|Adverse Event|18|||
106174011|NCT04707768|366299972|FG002|Overall Study|Adverse Event|3|||
106174012|NCT04707768|366299970|FG000|Overall Study|Investigator's Discretion|8|||
106174013|NCT04707768|366299971|FG001|Overall Study|Investigator's Discretion|4|||
106174014|NCT04707768|366299972|FG002|Overall Study|Investigator's Discretion|3|||
106174015|NCT04707768|366299970|FG000|Overall Study|Withdrawal by Subject|6|||
106174016|NCT04707768|366299971|FG001|Overall Study|Withdrawal by Subject|8|||
106174017|NCT04707768|366299972|FG002|Overall Study|Withdrawal by Subject|2|||
106174018|NCT04707768|366299970|FG000|Overall Study|Lack of Efficacy|1|||
106174019|NCT04707768|366299971|FG001|Overall Study|Lack of Efficacy|3|||
106174020|NCT04707768|366299972|FG002|Overall Study|Lack of Efficacy|0|||
106174021|NCT04707768|366299970|FG000|Overall Study|Lost to Follow-up|0|||
106174022|NCT04707768|366299971|FG001|Overall Study|Lost to Follow-up|0|||
106174023|NCT04707768|366299972|FG002|Overall Study|Lost to Follow-up|3|||
106174024|NCT04707768|366299970|FG000|Overall Study|Death|13|||
106174025|NCT04707768|366299971|FG001|Overall Study|Death|11|||
106174026|NCT04707768|366299972|FG002|Overall Study|Death|13|||
106174027|NCT04707768|366299970|FG000|Overall Study|Protocol Violation|2|||
106174028|NCT04707768|366299971|FG001|Overall Study|Protocol Violation|1|||
106174029|NCT04707768|366299972|FG002|Overall Study|Protocol Violation|0|||
106174030|NCT04707768|366299970|FG000|Overall Study|Non Compliance with Study Drug|1|||
106174031|NCT04707768|366299971|FG001|Overall Study|Non Compliance with Study Drug|0|||
106174032|NCT04707768|366299972|FG002|Overall Study|Non Compliance with Study Drug|0|||
106174033|NCT04707768|366299970|FG000|Overall Study|Transplant|4|||
106174034|NCT04707768|366299971|FG001|Overall Study|Transplant|4|||
106174035|NCT04707768|366299972|FG002|Overall Study|Transplant|8|||
106174036|NCT04707768|366299970|FG000|Overall Study|Other|9|||
106174037|NCT04707768|366299971|FG001|Overall Study|Other|5|||
106174038|NCT04707768|366299972|FG002|Overall Study|Other|2|||
106174039|NCT03372057|366299973|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
106174040|NCT03372057|366299974|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
106174041|NCT03372057|366299975|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
106174042|NCT03372057|366299973|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
106174043|NCT03372057|366299974|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
106174044|NCT03372057|366299975|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
106174045|NCT03372057|366299973|FG000|Dose Optimization Phase|Death|16|||
106174046|NCT03372057|366299974|FG001|Dose Optimization Phase|Death|11|||
106174047|NCT03372057|366299975|FG002|Dose Optimization Phase|Death|0|||
106174048|NCT03372057|366299973|FG000|Expansion Phase|Withdrawal by Subject|0|||
106174049|NCT03372057|366299974|FG001|Expansion Phase|Withdrawal by Subject|0|||
106174050|NCT03372057|366299975|FG002|Expansion Phase|Withdrawal by Subject|4|||
106174051|NCT03372057|366299973|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
106174052|NCT03372057|366299974|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
106174053|NCT03372057|366299975|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
106174054|NCT03372057|366299973|FG000|Expansion Phase|Death|0|||
106174055|NCT03372057|366299974|FG001|Expansion Phase|Death|0|||
106174056|NCT03372057|366299975|FG002|Expansion Phase|Death|78|||
106174057|NCT03372057|366299973|FG000|Expansion Phase|Progressive Disease|0|||
106174058|NCT03372057|366299974|FG001|Expansion Phase|Progressive Disease|0|||
106174059|NCT03372057|366299975|FG002|Expansion Phase|Progressive Disease|1|||
106174060|NCT03372057|366299973|FG000|Expansion Phase|Adverse Event|0|||
106174061|NCT03372057|366299974|FG001|Expansion Phase|Adverse Event|0|||
106174062|NCT03372057|366299975|FG002|Expansion Phase|Adverse Event|1|||
106174063|NCT04214418|366299976|FG000|Overall Study|Withdrawal by Subject|1|||
106174064|NCT04214418|366299977|FG001|Overall Study|Withdrawal by Subject|0|||
106174065|NCT04214418|366299978|FG002|Overall Study|Withdrawal by Subject|0|||
106174066|NCT04214418|366299979|FG003|Overall Study|Withdrawal by Subject|0|||
106174067|NCT04214418|366299980|FG004|Overall Study|Withdrawal by Subject|0|||
106174068|NCT04214418|366299981|FG005|Overall Study|Withdrawal by Subject|0|||
106174069|NCT04214418|366299976|FG000|Overall Study|Adverse Event|0|||
106174070|NCT04214418|366299977|FG001|Overall Study|Adverse Event|2|||
106174071|NCT04214418|366299978|FG002|Overall Study|Adverse Event|0|||
106174072|NCT04214418|366299979|FG003|Overall Study|Adverse Event|0|||
106174073|NCT04214418|366299980|FG004|Overall Study|Adverse Event|0|||
106174074|NCT04214418|366299981|FG005|Overall Study|Adverse Event|0|||
106174075|NCT04214418|366299976|FG000|Overall Study|Death|1|||
106174076|NCT04214418|366299977|FG001|Overall Study|Death|0|||
106174077|NCT04214418|366299978|FG002|Overall Study|Death|0|||
106174078|NCT04214418|366299979|FG003|Overall Study|Death|0|||
106174079|NCT04214418|366299980|FG004|Overall Study|Death|0|||
106174080|NCT04214418|366299981|FG005|Overall Study|Death|0|||
106174081|NCT04477304|366299982|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
106174082|NCT04477304|366299983|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
106174083|NCT03333915|366299984|FG000|Overall Study|Lost to Follow-up|0|||
106174084|NCT03333915|366299985|FG001|Overall Study|Lost to Follow-up|0|||
106174085|NCT03333915|366299986|FG002|Overall Study|Lost to Follow-up|1|||
106174086|NCT03333915|366299987|FG003|Overall Study|Lost to Follow-up|0|||
106174087|NCT03333915|366299988|FG004|Overall Study|Lost to Follow-up|0|||
106174088|NCT03333915|366299984|FG000|Overall Study|Disease Progression|0|||
106174089|NCT03333915|366299985|FG001|Overall Study|Disease Progression|1|||
106174090|NCT03333915|366299986|FG002|Overall Study|Disease Progression|0|||
106174091|NCT03333915|366299987|FG003|Overall Study|Disease Progression|0|||
106174092|NCT03333915|366299988|FG004|Overall Study|Disease Progression|0|||
106174093|NCT03333915|366299984|FG000|Overall Study|Death|0|||
106174094|NCT03333915|366299985|FG001|Overall Study|Death|0|||
106174095|NCT03333915|366299986|FG002|Overall Study|Death|0|||
106174096|NCT03333915|366299987|FG003|Overall Study|Death|37|||
106174097|NCT03333915|366299988|FG004|Overall Study|Death|18|||
106174098|NCT03333915|366299984|FG000|Overall Study|Sponsor's Decision|0|||
106174099|NCT03333915|366299985|FG001|Overall Study|Sponsor's Decision|0|||
106174100|NCT03333915|366299986|FG002|Overall Study|Sponsor's Decision|0|||
106174101|NCT03333915|366299987|FG003|Overall Study|Sponsor's Decision|48|||
106174102|NCT03333915|366299988|FG004|Overall Study|Sponsor's Decision|4|||
106174103|NCT03333915|366299984|FG000|Overall Study|Withdrawal by Subject|0|||
106174104|NCT03333915|366299985|FG001|Overall Study|Withdrawal by Subject|0|||
106174105|NCT03333915|366299986|FG002|Overall Study|Withdrawal by Subject|0|||
106174106|NCT03333915|366299987|FG003|Overall Study|Withdrawal by Subject|5|||
106174107|NCT03333915|366299988|FG004|Overall Study|Withdrawal by Subject|1|||
106174108|NCT04078152|366299989|FG000|Overall Study|Other|83|||
106174109|NCT04078152|366299990|FG001|Overall Study|Other|22|||
106174110|NCT04078152|366299991|FG002|Overall Study|Other|25|||
106174111|NCT04078152|366299989|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
106174112|NCT04078152|366299990|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
106174113|NCT04078152|366299991|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
106174114|NCT04078152|366299989|FG000|Overall Study|Withdrawal by Subject|5|||
106174115|NCT04078152|366299990|FG001|Overall Study|Withdrawal by Subject|0|||
106174116|NCT04078152|366299991|FG002|Overall Study|Withdrawal by Subject|1|||
106174117|NCT04078152|366299989|FG000|Overall Study|Death|10|||
106174118|NCT04078152|366299990|FG001|Overall Study|Death|2|||
106174119|NCT04078152|366299991|FG002|Overall Study|Death|12|||
106174120|NCT04078152|366299989|FG000|Overall Study|Adverse Event|1|||
106174121|NCT04078152|366299990|FG001|Overall Study|Adverse Event|0|||
106174122|NCT04078152|366299991|FG002|Overall Study|Adverse Event|0|||
106174123|NCT03279978|366299996|FG000|Overall Study|Withdrawal by Subject|0|||
106174124|NCT03279978|366299997|FG001|Overall Study|Withdrawal by Subject|1|||
106174125|NCT03279978|366299998|FG002|Overall Study|Withdrawal by Subject|0|||
106174126|NCT03279978|366299999|FG003|Overall Study|Withdrawal by Subject|0|||
106174127|NCT03279978|366300000|FG004|Overall Study|Withdrawal by Subject|0|||
106174128|NCT03279978|366300001|FG005|Overall Study|Withdrawal by Subject|0|||
106174129|NCT03279978|366300002|FG006|Overall Study|Withdrawal by Subject|0|||
106174130|NCT03279978|366300003|FG007|Overall Study|Withdrawal by Subject|0|||
106174131|NCT03279978|366300004|FG008|Overall Study|Withdrawal by Subject|0|||
106174132|NCT03279978|366300005|FG009|Overall Study|Withdrawal by Subject|1|||
106174133|NCT03279978|366299996|FG000|Overall Study|Lost to Follow-up|1|||
106174134|NCT03279978|366299997|FG001|Overall Study|Lost to Follow-up|0|||
106174135|NCT03279978|366299998|FG002|Overall Study|Lost to Follow-up|1|||
106174136|NCT03279978|366299999|FG003|Overall Study|Lost to Follow-up|0|||
106174137|NCT03279978|366300000|FG004|Overall Study|Lost to Follow-up|0|||
106174138|NCT03279978|366300001|FG005|Overall Study|Lost to Follow-up|0|||
106174139|NCT03279978|366300002|FG006|Overall Study|Lost to Follow-up|0|||
106174140|NCT03279978|366300003|FG007|Overall Study|Lost to Follow-up|0|||
106174141|NCT03279978|366300004|FG008|Overall Study|Lost to Follow-up|0|||
106174142|NCT03279978|366300005|FG009|Overall Study|Lost to Follow-up|0|||
106174143|NCT03279978|366299996|FG000|Overall Study|Other than stated above|0|||
106174144|NCT03279978|366299997|FG001|Overall Study|Other than stated above|0|||
106174145|NCT03279978|366299998|FG002|Overall Study|Other than stated above|0|||
106174146|NCT03279978|366299999|FG003|Overall Study|Other than stated above|0|||
106174147|NCT03279978|366300000|FG004|Overall Study|Other than stated above|0|||
106174148|NCT03279978|366300001|FG005|Overall Study|Other than stated above|0|||
106174149|NCT03279978|366300002|FG006|Overall Study|Other than stated above|1|||
106174150|NCT03279978|366300003|FG007|Overall Study|Other than stated above|0|||
106174151|NCT03279978|366300004|FG008|Overall Study|Other than stated above|0|||
106174152|NCT03279978|366300005|FG009|Overall Study|Other than stated above|0|||
106174153|NCT04675034|366301198|FG000|Overall Study|Lost to Follow-up|1|||
106174154|NCT04675034|366301199|FG001|Overall Study|Lost to Follow-up|1|||
106174155|NCT04675034|366301200|FG002|Overall Study|Lost to Follow-up|0|||
106174156|NCT04675034|366301201|FG003|Overall Study|Lost to Follow-up|2|||
106174157|NCT04675034|366301202|FG004|Overall Study|Lost to Follow-up|0|||
106174158|NCT04675034|366301198|FG000|Overall Study|Protocol Violation|1|||
106174159|NCT04675034|366301199|FG001|Overall Study|Protocol Violation|0|||
106174160|NCT04675034|366301200|FG002|Overall Study|Protocol Violation|0|||
106174161|NCT04675034|366301201|FG003|Overall Study|Protocol Violation|1|||
106174162|NCT04675034|366301202|FG004|Overall Study|Protocol Violation|3|||
106174163|NCT04675034|366301198|FG000|Overall Study|Withdrawal by Subject|9|||
106174164|NCT04675034|366301199|FG001|Overall Study|Withdrawal by Subject|3|||
106174165|NCT04675034|366301200|FG002|Overall Study|Withdrawal by Subject|4|||
106174166|NCT04675034|366301201|FG003|Overall Study|Withdrawal by Subject|8|||
106174167|NCT04675034|366301202|FG004|Overall Study|Withdrawal by Subject|6|||
106174168|NCT05953740|366301205|FG000|Period 1|Physician Decision|0|||
106174169|NCT05953740|366301206|FG001|Period 1|Physician Decision|1|||
106174170|NCT05953740|366301207|FG002|Period 1|Physician Decision|0|||
106174171|NCT05953740|366301208|FG003|Period 1|Physician Decision|0|||
106174172|NCT05953740|366301209|FG004|Period 1|Physician Decision|0|||
106174173|NCT05953740|366301210|FG005|Period 1|Physician Decision|0|||
106174174|NCT05953740|366301211|FG006|Period 1|Physician Decision|0|||
106174175|NCT05953740|366301212|FG007|Period 1|Physician Decision|0|||
106174176|NCT05953740|366301205|FG000|Period 2|Withdrawal by Subject|0|||
106174177|NCT05953740|366301206|FG001|Period 2|Withdrawal by Subject|1|||
106174178|NCT05953740|366301207|FG002|Period 2|Withdrawal by Subject|1|||
106174179|NCT05953740|366301208|FG003|Period 2|Withdrawal by Subject|0|||
106174180|NCT05953740|366301209|FG004|Period 2|Withdrawal by Subject|0|||
106174181|NCT05953740|366301210|FG005|Period 2|Withdrawal by Subject|0|||
106174182|NCT05953740|366301211|FG006|Period 2|Withdrawal by Subject|0|||
106174183|NCT05953740|366301212|FG007|Period 2|Withdrawal by Subject|0|||
106174184|NCT03880955|366301213|FG000|Overall Study|Adverse Event|1|||
106174185|NCT03880955|366301213|FG000|Overall Study|Death|1|||
106174186|NCT03880955|366301213|FG000|Overall Study|Lost to Follow-up|12|||
106174187|NCT03880955|366301213|FG000|Overall Study|Withdrawal by Subject|4|||
106174188|NCT03880955|366301213|FG000|Overall Study|Missing- Study Site Closed|27|||
106174189|NCT05985395|366301218|FG000|Overall Study|Physician Decision|2|||
106174190|NCT05985395|366301219|FG001|Overall Study|Physician Decision|1|||
106174191|NCT05985395|366301218|FG000|Overall Study|Withdrawal by Subject|1|||
106174192|NCT05985395|366301219|FG001|Overall Study|Withdrawal by Subject|0|||
106174193|NCT05890105|366301220|FG000|Overall Study|Adverse Event|1|||
106174194|NCT05890105|366301221|FG001|Overall Study|Adverse Event|0|||
106174195|NCT05890105|366301222|FG002|Overall Study|Adverse Event|0|||
106174196|NCT05890105|366301220|FG000|Overall Study|Other|1|||
106174197|NCT05890105|366301221|FG001|Overall Study|Other|2|||
106174198|NCT05890105|366301222|FG002|Overall Study|Other|0|||
106174199|NCT00450216|366301223|FG000|Overall Study|Adverse Event|38|||
106174200|NCT00450216|366301224|FG001|Overall Study|Adverse Event|23|||
106174201|NCT00450216|366301223|FG000|Overall Study|Withdrawal by Subject|48|||
106174202|NCT00450216|366301224|FG001|Overall Study|Withdrawal by Subject|26|||
106174203|NCT00450216|366301223|FG000|Overall Study|Lost to Follow-up|16|||
106174204|NCT00450216|366301224|FG001|Overall Study|Lost to Follow-up|9|||
106174205|NCT00450216|366301223|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
106174206|NCT00450216|366301224|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
106174207|NCT00450216|366301223|FG000|Overall Study|misc|21|||
106174208|NCT00450216|366301224|FG001|Overall Study|misc|20|||
106174209|NCT03248479|366301230|FG000|Overall Study|Death|12|||
106174210|NCT03248479|366301231|FG001|Overall Study|Death|44|||
106174211|NCT03248479|366301232|FG002|Overall Study|Death|1|||
106174212|NCT03248479|366301233|FG003|Overall Study|Death|72|||
106174213|NCT03248479|366301234|FG004|Overall Study|Death|17|||
106174214|NCT03248479|366301235|FG005|Overall Study|Death|6|||
106174215|NCT03248479|366301236|FG006|Overall Study|Death|1|||
106174216|NCT03248479|366301237|FG007|Overall Study|Death|14|||
106174217|NCT03248479|366301238|FG008|Overall Study|Death|3|||
106174218|NCT03248479|366301239|FG009|Overall Study|Death|7|||
106174219|NCT03248479|366301240|FG010|Overall Study|Death|3|||
106174220|NCT03248479|366301241|FG011|Overall Study|Death|1|||
106174221|NCT03248479|366301242|FG012|Overall Study|Death|1|||
106174222|NCT03248479|366301230|FG000|Overall Study|Study terminated by sponsor|12|||
106174223|NCT03248479|366301231|FG001|Overall Study|Study terminated by sponsor|15|||
106174224|NCT03248479|366301232|FG002|Overall Study|Study terminated by sponsor|0|||
106174225|NCT03248479|366301233|FG003|Overall Study|Study terminated by sponsor|5|||
106174226|NCT03248479|366301234|FG004|Overall Study|Study terminated by sponsor|0|||
106174227|NCT03248479|366301235|FG005|Overall Study|Study terminated by sponsor|0|||
106174228|NCT03248479|366301236|FG006|Overall Study|Study terminated by sponsor|0|||
106174229|NCT03248479|366301237|FG007|Overall Study|Study terminated by sponsor|1|||
106174230|NCT03248479|366301238|FG008|Overall Study|Study terminated by sponsor|1|||
106174231|NCT03248479|366301239|FG009|Overall Study|Study terminated by sponsor|0|||
106174232|NCT03248479|366301240|FG010|Overall Study|Study terminated by sponsor|5|||
106174233|NCT03248479|366301241|FG011|Overall Study|Study terminated by sponsor|4|||
106174234|NCT03248479|366301242|FG012|Overall Study|Study terminated by sponsor|0|||
106174235|NCT03248479|366301230|FG000|Overall Study|Consent withdrawn|6|||
106174236|NCT03248479|366301231|FG001|Overall Study|Consent withdrawn|3|||
106174237|NCT03248479|366301232|FG002|Overall Study|Consent withdrawn|0|||
106174238|NCT03248479|366301233|FG003|Overall Study|Consent withdrawn|9|||
106174239|NCT03248479|366301234|FG004|Overall Study|Consent withdrawn|1|||
106174240|NCT03248479|366301235|FG005|Overall Study|Consent withdrawn|0|||
106174241|NCT03248479|366301236|FG006|Overall Study|Consent withdrawn|0|||
106174242|NCT03248479|366301237|FG007|Overall Study|Consent withdrawn|1|||
106174243|NCT03248479|366301238|FG008|Overall Study|Consent withdrawn|0|||
106174244|NCT03248479|366301239|FG009|Overall Study|Consent withdrawn|3|||
106174245|NCT03248479|366301240|FG010|Overall Study|Consent withdrawn|1|||
106174246|NCT03248479|366301241|FG011|Overall Study|Consent withdrawn|0|||
106174247|NCT03248479|366301242|FG012|Overall Study|Consent withdrawn|1|||
106174248|NCT03248479|366301230|FG000|Overall Study|Lost to Follow-up|2|||
106174249|NCT03248479|366301231|FG001|Overall Study|Lost to Follow-up|1|||
106174250|NCT03248479|366301232|FG002|Overall Study|Lost to Follow-up|0|||
106174251|NCT03248479|366301233|FG003|Overall Study|Lost to Follow-up|0|||
106174252|NCT03248479|366301234|FG004|Overall Study|Lost to Follow-up|0|||
106174253|NCT03248479|366301235|FG005|Overall Study|Lost to Follow-up|0|||
106174254|NCT03248479|366301236|FG006|Overall Study|Lost to Follow-up|0|||
106174255|NCT03248479|366301237|FG007|Overall Study|Lost to Follow-up|0|||
106174256|NCT03248479|366301238|FG008|Overall Study|Lost to Follow-up|0|||
106174257|NCT03248479|366301239|FG009|Overall Study|Lost to Follow-up|0|||
106174258|NCT03248479|366301240|FG010|Overall Study|Lost to Follow-up|0|||
106174259|NCT03248479|366301241|FG011|Overall Study|Lost to Follow-up|0|||
106174260|NCT03248479|366301242|FG012|Overall Study|Lost to Follow-up|1|||
106174261|NCT03248479|366301230|FG000|Overall Study|Not reported|0|||
106174262|NCT03248479|366301231|FG001|Overall Study|Not reported|0|||
106174263|NCT03248479|366301232|FG002|Overall Study|Not reported|0|||
106174264|NCT03248479|366301233|FG003|Overall Study|Not reported|1|||
106174265|NCT03248479|366301234|FG004|Overall Study|Not reported|1|||
106174266|NCT03248479|366301235|FG005|Overall Study|Not reported|0|||
106174267|NCT03248479|366301236|FG006|Overall Study|Not reported|0|||
106174268|NCT03248479|366301237|FG007|Overall Study|Not reported|1|||
106174269|NCT03248479|366301238|FG008|Overall Study|Not reported|1|||
106174270|NCT03248479|366301239|FG009|Overall Study|Not reported|0|||
106174271|NCT03248479|366301240|FG010|Overall Study|Not reported|0|||
106174272|NCT03248479|366301241|FG011|Overall Study|Not reported|0|||
106174273|NCT03248479|366301242|FG012|Overall Study|Not reported|0|||
106174274|NCT03735979|366301245|FG000|Overall Study|Lost to Follow-up|1|||
106174275|NCT03735979|366301246|FG001|Overall Study|Lost to Follow-up|12|||
106174276|NCT03735979|366301247|FG002|Overall Study|Lost to Follow-up|14|||
106174277|NCT03735979|366301245|FG000|Overall Study|Withdrawal by Subject|1|||
106174278|NCT03735979|366301246|FG001|Overall Study|Withdrawal by Subject|5|||
106174279|NCT03735979|366301247|FG002|Overall Study|Withdrawal by Subject|2|||
106174280|NCT03735979|366301245|FG000|Overall Study|Not due to the above reasons|1|||
106174281|NCT03735979|366301246|FG001|Overall Study|Not due to the above reasons|0|||
106174282|NCT03735979|366301247|FG002|Overall Study|Not due to the above reasons|0|||
106174283|NCT05454514|366301248|FG000|Overall Study|Withdrawal by Subject|4|||
106174284|NCT01438853|366301253|FG000|Overall Study|Death|0|||
106174285|NCT01438853|366301254|FG001|Overall Study|Death|0|||
106174286|NCT01438853|366301255|FG002|Overall Study|Death|0|||
106174287|NCT01438853|366301256|FG003|Overall Study|Death|1|||
106174288|NCT01438853|366301253|FG000|Overall Study|Withdrawal by Subject|0|||
106174289|NCT01438853|366301254|FG001|Overall Study|Withdrawal by Subject|0|||
106174290|NCT01438853|366301255|FG002|Overall Study|Withdrawal by Subject|1|||
106174291|NCT01438853|366301256|FG003|Overall Study|Withdrawal by Subject|0|||
106174300|NCT03547271|366301259|FG000|Overall Study|Adverse Event|1|||
106174301|NCT03547271|366301260|FG001|Overall Study|Adverse Event|1|||
106174302|NCT03547271|366301261|FG002|Overall Study|Adverse Event|0|||
106174303|NCT03547271|366301262|FG003|Overall Study|Adverse Event|0|||
106174304|NCT03547271|366301259|FG000|Overall Study|Protocol deviation|5|||
106174305|NCT03547271|366301260|FG001|Overall Study|Protocol deviation|7|||
106174306|NCT03547271|366301261|FG002|Overall Study|Protocol deviation|3|||
106174307|NCT03547271|366301262|FG003|Overall Study|Protocol deviation|0|||
106174308|NCT03547271|366301259|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
106174309|NCT03547271|366301260|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
106174310|NCT03547271|366301261|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
106174311|NCT03547271|366301262|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
106174312|NCT03547271|366301259|FG000|Overall Study|Lost to Follow-up|3|||
106174313|NCT03547271|366301260|FG001|Overall Study|Lost to Follow-up|3|||
106174314|NCT03547271|366301261|FG002|Overall Study|Lost to Follow-up|1|||
106174315|NCT03547271|366301262|FG003|Overall Study|Lost to Follow-up|0|||
106174316|NCT04622046|366301263|FG000|Intervention Period|Adverse Event|1|||
106174317|NCT04622046|366301263|FG000|Intervention Period|Withdrawal by Subject|2|||
106174318|NCT04622046|366301263|FG000|Extension Period|Ongoing in the Extension Period|21|||
106174319|NCT03165955|366301264|FG000|Treatment|Withdrawal by Subject|3|||
106174320|NCT03165955|366301264|FG000|Treatment|Death|1|||
106174321|NCT03165955|366301264|FG000|Treatment|Adverse Event|1|||
106174322|NCT03165955|366301264|FG000|Treatment|Progressive disease|3|||
106174323|NCT02994927|366301265|FG000|Overall Study|Withdrawal by parent/guardian|0|||
106174324|NCT02994927|366301266|FG001|Overall Study|Withdrawal by parent/guardian|1|||
106174325|NCT02994927|366301265|FG000|Overall Study|Did not meet eligibility criteria|0|||
106174326|NCT02994927|366301266|FG001|Overall Study|Did not meet eligibility criteria|1|||
106174327|NCT02994927|366301265|FG000|Overall Study|Physician Decision|4|||
106174328|NCT02994927|366301266|FG001|Overall Study|Physician Decision|3|||
106174329|NCT02994927|366301265|FG000|Overall Study|Death|4|||
106174330|NCT02994927|366301266|FG001|Overall Study|Death|2|||
106174331|NCT02994927|366301265|FG000|Overall Study|Adverse Event|2|||
106174332|NCT02994927|366301266|FG001|Overall Study|Adverse Event|1|||
106174333|NCT02994927|366301265|FG000|Overall Study|Withdrawal by Subject|3|||
106174334|NCT02994927|366301266|FG001|Overall Study|Withdrawal by Subject|6|||
106174335|NCT02994927|366301265|FG000|Overall Study|Lost to Follow-up|2|||
106174336|NCT02994927|366301266|FG001|Overall Study|Lost to Follow-up|1|||
106174337|NCT04499521|366301270|FG000|Overall Study|Disease Progression|1|||
106174338|NCT04499521|366301271|FG001|Overall Study|Disease Progression|0|||
106174339|NCT04626427|366301273|FG000|Overall Study|Death|1|||
106174340|NCT04626427|366301273|FG000|Overall Study|Withdrawal by Subject|1|||
106174341|NCT04626427|366301273|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
106174342|NCT04626427|366301273|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
106174343|NCT03781089|366302137|FG000|Overall Study|Constipation|1|||
106174344|NCT03781089|366302138|FG001|Overall Study|Constipation|0|||
106174345|NCT03781089|366302137|FG000|Overall Study|Positive pregnancy test|0|||
106174346|NCT03781089|366302138|FG001|Overall Study|Positive pregnancy test|1|||
106174347|NCT05020353|366302139|FG000|Overall Study|Protocol Violation|7|||
106174348|NCT05020353|366302139|FG000|Overall Study|Withdrawal by Subject|33|||
106174349|NCT04427007|366302142|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
106174350|NCT04427007|366302143|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
106174351|NCT04633278|366302144|FG000|Overall Study|Adverse Event|1|||
106174352|NCT04633278|366302145|FG001|Overall Study|Adverse Event|0|||
106174353|NCT04633278|366302144|FG000|Overall Study|Withdrawal by Subject|1|||
106174354|NCT04633278|366302145|FG001|Overall Study|Withdrawal by Subject|0|||
106174355|NCT04633278|366302144|FG000|Overall Study|Death|11|||
106174356|NCT04633278|366302145|FG001|Overall Study|Death|7|||
106174357|NCT04633278|366302144|FG000|Overall Study|Sponsor Decision|3|||
106174358|NCT04633278|366302145|FG001|Overall Study|Sponsor Decision|0|||
106174359|NCT04633278|366302144|FG000|Overall Study|Not Listed|1|||
106174360|NCT04633278|366302145|FG001|Overall Study|Not Listed|0|||
106174361|NCT03505710|366302146|FG000|Overall Study|Progressive Disease|24|||
106174362|NCT03505710|366302147|FG001|Overall Study|Progressive Disease|17|||
106174363|NCT03505710|366302148|FG002|Overall Study|Progressive Disease|43|||
106174364|NCT03505710|366302146|FG000|Overall Study|Clinical Progression|6|||
106174365|NCT03505710|366302147|FG001|Overall Study|Clinical Progression|8|||
106174366|NCT03505710|366302148|FG002|Overall Study|Clinical Progression|3|||
106174367|NCT03505710|366302146|FG000|Overall Study|Adverse Event|12|||
106174368|NCT03505710|366302147|FG001|Overall Study|Adverse Event|6|||
106174369|NCT03505710|366302148|FG002|Overall Study|Adverse Event|28|||
106174370|NCT03505710|366302146|FG000|Overall Study|Withdrawal by Subject|1|||
106174371|NCT03505710|366302147|FG001|Overall Study|Withdrawal by Subject|3|||
106174372|NCT03505710|366302148|FG002|Overall Study|Withdrawal by Subject|7|||
106174373|NCT03505710|366302146|FG000|Overall Study|Physician Decision|1|||
106174374|NCT03505710|366302147|FG001|Overall Study|Physician Decision|1|||
106174375|NCT03505710|366302148|FG002|Overall Study|Physician Decision|2|||
106174376|NCT03505710|366302146|FG000|Overall Study|Death|4|||
106174377|NCT03505710|366302147|FG001|Overall Study|Death|5|||
106174378|NCT03505710|366302148|FG002|Overall Study|Death|6|||
106174379|NCT03505710|366302146|FG000|Overall Study|Other Reasons|1|||
106174380|NCT03505710|366302147|FG001|Overall Study|Other Reasons|1|||
106174381|NCT03505710|366302148|FG002|Overall Study|Other Reasons|1|||
106174382|NCT03505710|366302146|FG000|Overall Study|Study Terminated by Sponsor|0|||
106174383|NCT03505710|366302147|FG001|Overall Study|Study Terminated by Sponsor|0|||
106174384|NCT03505710|366302148|FG002|Overall Study|Study Terminated by Sponsor|1|||
106174385|NCT00942734|366302149|FG000|Overall Study|Adverse Event|2|||
106174386|NCT00942734|366302149|FG000|Overall Study|Protocol Violation|3|||
106174387|NCT00942734|366302149|FG000|Overall Study|Disease Progression|2|||
106174388|NCT00942734|366302149|FG000|Overall Study|Physician Decision|1|||
106174389|NCT06010836|366302152|FG000|Overall Study|Lost to Follow-up|2|||
106174390|NCT06010836|366302153|FG001|Overall Study|Lost to Follow-up|2|||
106174391|NCT06010836|366302152|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
106174392|NCT06010836|366302153|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
106174393|NCT06010836|366302152|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
106174394|NCT06010836|366302153|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
106174395|NCT06010836|366302152|FG000|Overall Study|Did not receive intervention discussion|0|||
106174396|NCT06010836|366302153|FG001|Overall Study|Did not receive intervention discussion|4|||
106174397|NCT04496752|366302154|FG000|Second Assessment|Lost to Follow-up|3|||
106174398|NCT04496752|366302155|FG001|Second Assessment|Lost to Follow-up|3|||
106174399|NCT04496752|366302154|FG000|Second Assessment|Adverse Event|2|||
106174400|NCT04496752|366302155|FG001|Second Assessment|Adverse Event|0|||
106174401|NCT03884439|366302177|FG000|Overall Study|No informed consent for publication of study results|38|||
106174402|NCT03884439|366302177|FG000|Overall Study|Contract violation/deficiency|7|||
106174403|NCT02624050|366302180|FG000|Overall Study|Physician Decision|4|||
106174404|NCT02624050|366302181|FG001|Overall Study|Physician Decision|0|||
106174405|NCT02624050|366302180|FG000|Overall Study|Protocol Violation|2|||
106174406|NCT02624050|366302181|FG001|Overall Study|Protocol Violation|0|||
106174407|NCT02933489|366302187|FG000|Overall Study|Ineligible|3|||
106174408|NCT02933489|366302188|FG001|Overall Study|Ineligible|3|||
106174409|NCT02933489|366302187|FG000|Overall Study|Withdrawal by Subject|27|||
106174410|NCT02933489|366302188|FG001|Overall Study|Withdrawal by Subject|18|||
106174411|NCT02933489|366302187|FG000|Overall Study|Unable to complete exams (other)|14|||
106174412|NCT02933489|366302188|FG001|Overall Study|Unable to complete exams (other)|7|||
106174413|NCT04330040|366302189|FG000|Overall Study|Other: Adverse event|5|||
106174414|NCT04330040|366302190|FG001|Overall Study|Other: Adverse event|0|||
106174415|NCT04330040|366302191|FG002|Overall Study|Other: Adverse event|0|||
106174416|NCT04330040|366302189|FG000|Overall Study|Disease progression|38|||
106174417|NCT04330040|366302190|FG001|Overall Study|Disease progression|10|||
106174418|NCT04330040|366302191|FG002|Overall Study|Disease progression|0|||
106174419|NCT04330040|366302189|FG000|Overall Study|Physician Decision|5|||
106174420|NCT04330040|366302190|FG001|Overall Study|Physician Decision|3|||
106174421|NCT04330040|366302191|FG002|Overall Study|Physician Decision|0|||
106174422|NCT04330040|366302189|FG000|Overall Study|Lost to Follow-up|1|||
106174423|NCT04330040|366302190|FG001|Overall Study|Lost to Follow-up|1|||
106174424|NCT04330040|366302191|FG002|Overall Study|Lost to Follow-up|0|||
106174425|NCT04330040|366302189|FG000|Overall Study|Death|2|||
106174426|NCT04330040|366302190|FG001|Overall Study|Death|1|||
106174427|NCT04330040|366302191|FG002|Overall Study|Death|0|||
106174428|NCT04330040|366302189|FG000|Overall Study|Withdrawal by Subject|3|||
106174429|NCT04330040|366302190|FG001|Overall Study|Withdrawal by Subject|3|||
106174430|NCT04330040|366302191|FG002|Overall Study|Withdrawal by Subject|0|||
106174431|NCT04330040|366302189|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
106174432|NCT04330040|366302190|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
106174433|NCT04330040|366302191|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
106174434|NCT04330040|366302189|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
106174435|NCT04330040|366302190|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
106174436|NCT04330040|366302191|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
106174437|NCT04330040|366302189|FG000|Overall Study|Other: Disease progression|1|||
106174438|NCT04330040|366302190|FG001|Overall Study|Other: Disease progression|0|||
106174439|NCT04330040|366302191|FG002|Overall Study|Other: Disease progression|0|||
106174440|NCT04330040|366302189|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
106174441|NCT04330040|366302190|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
106174442|NCT04330040|366302191|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
106174443|NCT04330040|366302189|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
106174444|NCT04330040|366302190|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
106174445|NCT04330040|366302191|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
106174446|NCT04330040|366302189|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
106174447|NCT04330040|366302190|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
106174448|NCT04330040|366302191|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
106174449|NCT00626795|366302192|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
106174450|NCT00626795|366302193|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
106174451|NCT00626795|366302194|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
106174452|NCT00626795|366302192|FG000|Blinded Treatment|Lack of Efficacy|2|||
106174453|NCT00626795|366302193|FG001|Blinded Treatment|Lack of Efficacy|0|||
106174454|NCT00626795|366302194|FG002|Blinded Treatment|Lack of Efficacy|0|||
106174455|NCT00626795|366302192|FG000|Blinded Treatment|Unacceptable adverse event|0|||
106174456|NCT00626795|366302193|FG001|Blinded Treatment|Unacceptable adverse event|0|||
106174457|NCT00626795|366302194|FG002|Blinded Treatment|Unacceptable adverse event|1|||
106174458|NCT00626795|366302192|FG000|Blinded Treatment|Protocol Violation|0|||
106174459|NCT00626795|366302193|FG001|Blinded Treatment|Protocol Violation|1|||
106174460|NCT00626795|366302194|FG002|Blinded Treatment|Protocol Violation|1|||
106174461|NCT00626795|366302192|FG000|Blinded Treatment|Withdrawal by Subject|1|||
106174462|NCT00626795|366302193|FG001|Blinded Treatment|Withdrawal by Subject|1|||
106174463|NCT00626795|366302194|FG002|Blinded Treatment|Withdrawal by Subject|0|||
106174464|NCT00626795|366302192|FG000|Blinded Treatment|Other reasons|2|||
106174465|NCT00626795|366302193|FG001|Blinded Treatment|Other reasons|0|||
106174466|NCT00626795|366302194|FG002|Blinded Treatment|Other reasons|2|||
106174467|NCT00626795|366302192|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
106174468|NCT00626795|366302193|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
106174469|NCT00626795|366302194|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
106174470|NCT03092674|366302197|FG000|Overall Study|Adverse Event or Side Effects|1|||
106174471|NCT03092674|366302198|FG001|Overall Study|Adverse Event or Side Effects|4|||
106174472|NCT03092674|366302199|FG002|Overall Study|Adverse Event or Side Effects|4|||
106174473|NCT03092674|366302197|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
106174474|NCT03092674|366302198|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
106174475|NCT03092674|366302199|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
106174476|NCT03092674|366302197|FG000|Overall Study|Progression/Relapse|5|||
106174477|NCT03092674|366302198|FG001|Overall Study|Progression/Relapse|4|||
106174478|NCT03092674|366302199|FG002|Overall Study|Progression/Relapse|8|||
106174479|NCT03092674|366302197|FG000|Overall Study|Death|4|||
106174480|NCT03092674|366302198|FG001|Overall Study|Death|8|||
106174481|NCT03092674|366302199|FG002|Overall Study|Death|2|||
106174482|NCT03092674|366302197|FG000|Overall Study|Other - Not Protocol Specified|11|||
106174483|NCT03092674|366302198|FG001|Overall Study|Other - Not Protocol Specified|8|||
106174484|NCT03092674|366302199|FG002|Overall Study|Other - Not Protocol Specified|8|||
106174485|NCT03587805|366302200|FG000|Overall Study|Adverse Event|72|||
106174486|NCT03587805|366302200|FG000|Overall Study|Death|1|||
106174487|NCT03587805|366302200|FG000|Overall Study|Lost to Follow-up|78|||
106174488|NCT03587805|366302200|FG000|Overall Study|Withdrawal by Subject|105|||
106174489|NCT03587805|366302200|FG000|Overall Study|Lack of Efficacy|119|||
106174490|NCT03587805|366302200|FG000|Overall Study|Reason unknown|26|||
106174491|NCT03587805|366302200|FG000|Overall Study|COVID_19 pandemic|4|||
106174492|NCT03587805|366302200|FG000|Overall Study|Various reasons|121|||
106174493|NCT03587805|366302200|FG000|Overall Study|Withdrawal by parent/guardian|3|||
106174494|NCT03982186|366302201|FG000|Overall Study|Lost to Follow-up|0|||
106174495|NCT03982186|366302202|FG001|Overall Study|Lost to Follow-up|1|||
106174496|NCT03982186|366302203|FG002|Overall Study|Lost to Follow-up|2|||
106174497|NCT03982186|366302204|FG003|Overall Study|Lost to Follow-up|1|||
106174498|NCT03982186|366302205|FG004|Overall Study|Lost to Follow-up|1|||
106174499|NCT03982186|366302206|FG005|Overall Study|Lost to Follow-up|0|||
106174500|NCT03982186|366302201|FG000|Overall Study|Physician Decision|0|||
106174501|NCT03982186|366302202|FG001|Overall Study|Physician Decision|1|||
106174502|NCT03982186|366302203|FG002|Overall Study|Physician Decision|0|||
106174503|NCT03982186|366302204|FG003|Overall Study|Physician Decision|0|||
106174504|NCT03982186|366302205|FG004|Overall Study|Physician Decision|0|||
106174505|NCT03982186|366302206|FG005|Overall Study|Physician Decision|0|||
106174506|NCT03982186|366302201|FG000|Overall Study|Withdrawal by Subject|3|||
106174507|NCT03982186|366302202|FG001|Overall Study|Withdrawal by Subject|4|||
106174508|NCT03982186|366302203|FG002|Overall Study|Withdrawal by Subject|1|||
106174509|NCT03982186|366302204|FG003|Overall Study|Withdrawal by Subject|7|||
106174510|NCT03982186|366302205|FG004|Overall Study|Withdrawal by Subject|2|||
106174511|NCT03982186|366302206|FG005|Overall Study|Withdrawal by Subject|0|||
106174512|NCT03982186|366302201|FG000|Overall Study|Randomized and not treated|0|||
106174513|NCT03982186|366302202|FG001|Overall Study|Randomized and not treated|0|||
106174514|NCT03982186|366302203|FG002|Overall Study|Randomized and not treated|0|||
106174515|NCT03982186|366302204|FG003|Overall Study|Randomized and not treated|1|||
106174516|NCT03982186|366302205|FG004|Overall Study|Randomized and not treated|0|||
106174517|NCT03982186|366302206|FG005|Overall Study|Randomized and not treated|0|||
106174518|NCT03367156|366303036|FG000|Overall Study|Lack of interest|3|||
106174519|NCT03367156|366303037|FG001|Overall Study|Lack of interest|1|||
106174520|NCT03367156|366303036|FG000|Overall Study|Death|2|||
106174521|NCT03367156|366303037|FG001|Overall Study|Death|0|||
106174522|NCT03367156|366303036|FG000|Overall Study|Lost to Follow-up|2|||
106174523|NCT03367156|366303037|FG001|Overall Study|Lost to Follow-up|1|||
106174524|NCT03367156|366303036|FG000|Overall Study|Became ineligible|1|||
106174525|NCT03367156|366303037|FG001|Overall Study|Became ineligible|2|||
106174526|NCT03367156|366303036|FG000|Overall Study|Hospitalization|1|||
106174527|NCT03367156|366303037|FG001|Overall Study|Hospitalization|0|||
106174528|NCT03367156|366303036|FG000|Overall Study|Concerned about Treatment|11|||
106174529|NCT03367156|366303037|FG001|Overall Study|Concerned about Treatment|3|||
106174530|NCT03367156|366303036|FG000|Overall Study|Started new treatment|4|||
106174531|NCT03367156|366303037|FG001|Overall Study|Started new treatment|1|||
106174532|NCT03106740|366303038|FG000|Overall Study|Lost to Follow-up|2|||
106174533|NCT03106740|366303039|FG001|Overall Study|Lost to Follow-up|2|||
106174534|NCT03106740|366303038|FG000|Overall Study|Withdrawal by Subject|2|||
106174535|NCT03106740|366303039|FG001|Overall Study|Withdrawal by Subject|4|||
106174536|NCT03106740|366303038|FG000|Overall Study|Physician Decision|0|||
106174537|NCT03106740|366303039|FG001|Overall Study|Physician Decision|1|||
106174538|NCT03106740|366303038|FG000|Overall Study|Partial data|1|||
106174539|NCT03106740|366303039|FG001|Overall Study|Partial data|0|||
106174540|NCT01586910|366303041|FG000|Overall Study|Death|4|||
106174541|NCT01586910|366303042|FG001|Overall Study|Death|4|||
106174542|NCT01586910|366303041|FG000|Overall Study|Withdrawal by Subject|6|||
106174543|NCT01586910|366303042|FG001|Overall Study|Withdrawal by Subject|43|||
106174544|NCT01586910|366303041|FG000|Overall Study|Physician withdrew Subject|5|||
106174545|NCT01586910|366303042|FG001|Overall Study|Physician withdrew Subject|24|||
106174546|NCT05507437|366303043|FG000|Overall Study|Withdrawal by Subject|1|||
106174547|NCT05507437|366303044|FG001|Overall Study|Withdrawal by Subject|1|||
106174548|NCT05507437|366303043|FG000|Overall Study|Death|3|||
106174549|NCT05507437|366303044|FG001|Overall Study|Death|0|||
106174550|NCT03636490|366303045|FG000|Overall Study|Dropped out or incomplete data|141|||
105867366|NCT01473407|365164955|FG000|Overall Study|Physician Decision|1|||
105867367|NCT01473407|365164956|FG001|Overall Study|Physician Decision|4|||
106174551|NCT02246127|366303046|FG000|First Course Treatment|Adverse Event|9|||
106174552|NCT02246127|366303047|FG001|First Course Treatment|Adverse Event|7|||
106174553|NCT02246127|366303046|FG000|First Course Treatment|Withdrawal by Subject|6|||
106174554|NCT02246127|366303047|FG001|First Course Treatment|Withdrawal by Subject|7|||
106174555|NCT02246127|366303046|FG000|First Course Treatment|Physician Decision|9|||
106174556|NCT02246127|366303047|FG001|First Course Treatment|Physician Decision|9|||
106174557|NCT02246127|366303046|FG000|First Course Treatment|Death|3|||
106174558|NCT02246127|366303047|FG001|First Course Treatment|Death|3|||
106174559|NCT02246127|366303046|FG000|First Course Treatment|Not reported reasons|6|||
106174560|NCT02246127|366303047|FG001|First Course Treatment|Not reported reasons|7|||
106174561|NCT02246127|366303046|FG000|First Course Treatment|Not treated|3|||
106174562|NCT02246127|366303047|FG001|First Course Treatment|Not treated|3|||
106174563|NCT05311176|366303048|FG000|Overall Study|Death|6|||
106174564|NCT05311176|366303048|FG000|Overall Study|Sponsor discontinued the study|1|||
106174565|NCT04967599|366303054|FG000|Overall Study|Lost to Follow-up|35|||
106174566|NCT04967599|366303055|FG001|Overall Study|Lost to Follow-up|19|||
106174567|NCT04967599|366303056|FG002|Overall Study|Lost to Follow-up|23|||
106174568|NCT03662022|366303063|FG000|Year 1 2019|prevalent case|83|||
106174569|NCT03662022|366303064|FG001|Year 1 2019|prevalent case|116|||
106174570|NCT03662022|366303065|FG002|Year 1 2019|prevalent case|158|||
106174571|NCT03662022|366303066|FG003|Year 1 2019|prevalent case|99|||
106174572|NCT03662022|366303063|FG000|Year 2 2020|incident case|18|||
106174573|NCT03662022|366303064|FG001|Year 2 2020|incident case|18|||
106174574|NCT03662022|366303065|FG002|Year 2 2020|incident case|16|||
106174575|NCT03662022|366303066|FG003|Year 2 2020|incident case|26|||
106174576|NCT03662022|366303063|FG000|Year 2 2020|other case|18|||
106174577|NCT03662022|366303064|FG001|Year 2 2020|other case|16|||
106174578|NCT03662022|366303065|FG002|Year 2 2020|other case|16|||
106174579|NCT03662022|366303066|FG003|Year 2 2020|other case|24|||
106174580|NCT03662022|366303063|FG000|Year 2 2020|Lost to Follow-up|1633|||
106174581|NCT03662022|366303064|FG001|Year 2 2020|Lost to Follow-up|1183|||
106174582|NCT03662022|366303065|FG002|Year 2 2020|Lost to Follow-up|1381|||
106174583|NCT03662022|366303066|FG003|Year 2 2020|Lost to Follow-up|2858|||
106174584|NCT03662022|366303063|FG000|Year 3 2021|incident case|24|||
106174585|NCT03662022|366303064|FG001|Year 3 2021|incident case|27|||
106174586|NCT03662022|366303065|FG002|Year 3 2021|incident case|24|||
106174587|NCT03662022|366303066|FG003|Year 3 2021|incident case|11|||
106174588|NCT03662022|366303063|FG000|Year 3 2021|other case|4|||
106174589|NCT03662022|366303064|FG001|Year 3 2021|other case|15|||
106174590|NCT03662022|366303065|FG002|Year 3 2021|other case|10|||
106174591|NCT03662022|366303066|FG003|Year 3 2021|other case|14|||
106174592|NCT03662022|366303063|FG000|Year 3 2021|Lost to Follow-up|179|||
106174593|NCT03662022|366303064|FG001|Year 3 2021|Lost to Follow-up|244|||
106174594|NCT03662022|366303065|FG002|Year 3 2021|Lost to Follow-up|480|||
106174595|NCT03662022|366303066|FG003|Year 3 2021|Lost to Follow-up|477|||
106174596|NCT03662022|366303063|FG000|Year 4 2022|incident case|25|||
106174597|NCT03662022|366303064|FG001|Year 4 2022|incident case|41|||
106174598|NCT03662022|366303065|FG002|Year 4 2022|incident case|28|||
106174599|NCT03662022|366303066|FG003|Year 4 2022|incident case|7|||
106174600|NCT03662022|366303063|FG000|Year 4 2022|other case|8|||
106174601|NCT03662022|366303064|FG001|Year 4 2022|other case|19|||
106174602|NCT03662022|366303065|FG002|Year 4 2022|other case|13|||
106174603|NCT03662022|366303066|FG003|Year 4 2022|other case|7|||
106174604|NCT03662022|366303063|FG000|Year 4 2022|Lost to Follow-up|986|||
106174605|NCT03662022|366303064|FG001|Year 4 2022|Lost to Follow-up|1079|||
106174606|NCT03662022|366303065|FG002|Year 4 2022|Lost to Follow-up|1236|||
106174607|NCT03662022|366303066|FG003|Year 4 2022|Lost to Follow-up|1826|||
106174608|NCT04490109|366303067|FG000|Overall Study|Lost to Follow-up|3|||
106174609|NCT04490109|366303068|FG001|Overall Study|Lost to Follow-up|10|||
106174610|NCT04490109|366303069|FG002|Overall Study|Lost to Follow-up|4|||
106174611|NCT04490109|366303067|FG000|Overall Study|Withdrawal by Subject|8|||
106174612|NCT04490109|366303068|FG001|Overall Study|Withdrawal by Subject|6|||
106174613|NCT04490109|366303069|FG002|Overall Study|Withdrawal by Subject|9|||
106174614|NCT04490109|366303067|FG000|Overall Study|Physician Decision|0|||
106174615|NCT04490109|366303068|FG001|Overall Study|Physician Decision|2|||
106174616|NCT04490109|366303069|FG002|Overall Study|Physician Decision|3|||
106174617|NCT04490109|366303067|FG000|Overall Study|Adverse Event|2|||
106174618|NCT04490109|366303068|FG001|Overall Study|Adverse Event|1|||
106174619|NCT04490109|366303069|FG002|Overall Study|Adverse Event|0|||
106174620|NCT04490109|366303067|FG000|Overall Study|Significant Non-Compliance|2|||
106174621|NCT04490109|366303068|FG001|Overall Study|Significant Non-Compliance|4|||
106174622|NCT04490109|366303069|FG002|Overall Study|Significant Non-Compliance|4|||
106174623|NCT04490109|366303067|FG000|Overall Study|Significant Clinical Event|0|||
106174624|NCT04490109|366303068|FG001|Overall Study|Significant Clinical Event|1|||
106174625|NCT04490109|366303069|FG002|Overall Study|Significant Clinical Event|0|||
106174626|NCT04490109|366303067|FG000|Overall Study|Other Reason|4|||
106174627|NCT04490109|366303068|FG001|Overall Study|Other Reason|1|||
106174628|NCT04490109|366303069|FG002|Overall Study|Other Reason|1|||
106174629|NCT03817983|366303070|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
106174630|NCT03817983|366303071|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
106174631|NCT03817983|366303072|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
106174632|NCT04908930|366303073|FG000|Overall Study|Lost to Follow-up|1|||
106174633|NCT04908930|366303074|FG001|Overall Study|Lost to Follow-up|1|||
106174634|NCT04908930|366303075|FG002|Overall Study|Lost to Follow-up|0|||
106174635|NCT04908930|366303076|FG003|Overall Study|Lost to Follow-up|0|||
106174636|NCT04908930|366303077|FG004|Overall Study|Lost to Follow-up|0|||
106174637|NCT04908930|366303073|FG000|Overall Study|hardware in mouth|1|||
106174638|NCT04908930|366303074|FG001|Overall Study|hardware in mouth|1|||
106174639|NCT04908930|366303075|FG002|Overall Study|hardware in mouth|0|||
106174640|NCT04908930|366303076|FG003|Overall Study|hardware in mouth|0|||
106174641|NCT04908930|366303077|FG004|Overall Study|hardware in mouth|0|||
106174642|NCT04908930|366303073|FG000|Overall Study|wrong team|1|||
106174643|NCT04908930|366303074|FG001|Overall Study|wrong team|0|||
106174644|NCT04908930|366303075|FG002|Overall Study|wrong team|0|||
106174645|NCT04908930|366303076|FG003|Overall Study|wrong team|0|||
106174646|NCT04908930|366303077|FG004|Overall Study|wrong team|0|||
106174647|NCT04908930|366303073|FG000|Overall Study|quit team|2|||
106174648|NCT04908930|366303074|FG001|Overall Study|quit team|4|||
106174649|NCT04908930|366303075|FG002|Overall Study|quit team|0|||
106174650|NCT04908930|366303076|FG003|Overall Study|quit team|0|||
106174651|NCT04908930|366303077|FG004|Overall Study|quit team|0|||
106174652|NCT04908930|366303073|FG000|Overall Study|Withdrawal by Subject|1|||
106174653|NCT04908930|366303074|FG001|Overall Study|Withdrawal by Subject|2|||
106174654|NCT04908930|366303075|FG002|Overall Study|Withdrawal by Subject|0|||
106174655|NCT04908930|366303076|FG003|Overall Study|Withdrawal by Subject|0|||
106174656|NCT04908930|366303077|FG004|Overall Study|Withdrawal by Subject|0|||
106174657|NCT04908930|366303073|FG000|Overall Study|parent not liking program|0|||
106174658|NCT04908930|366303074|FG001|Overall Study|parent not liking program|1|||
106174659|NCT04908930|366303075|FG002|Overall Study|parent not liking program|0|||
106174660|NCT04908930|366303076|FG003|Overall Study|parent not liking program|0|||
106174661|NCT04908930|366303077|FG004|Overall Study|parent not liking program|0|||
106174662|NCT05785130|366303080|FG000|Overall Study|Withdrawal by Subject|1|||
106174663|NCT05785130|366303081|FG001|Overall Study|Withdrawal by Subject|0|||
106174664|NCT05785130|366303080|FG000|Overall Study|Lack of Efficacy|0|||
106174665|NCT05785130|366303081|FG001|Overall Study|Lack of Efficacy|1|||
106174666|NCT02532621|366303086|FG000|Overall Study|Death|3|||
106174667|NCT02532621|366303086|FG000|Overall Study|Lost to Follow-up|3|||
106174668|NCT02532621|366303086|FG000|Overall Study|Withdrawal by Subject|6|||
106174669|NCT02532621|366303086|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
106174670|NCT02532621|366303086|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
106174671|NCT03522298|366303087|FG000|Overall Study|Adverse Event|1|||
106174672|NCT03522298|366303088|FG001|Overall Study|Adverse Event|0|||
106174673|NCT03522298|366303089|FG002|Overall Study|Adverse Event|0|||
106174674|NCT03522298|366303090|FG003|Overall Study|Adverse Event|1|||
106174675|NCT03522298|366303087|FG000|Overall Study|Death|2|||
106174676|NCT03522298|366303088|FG001|Overall Study|Death|4|||
106174677|NCT03522298|366303089|FG002|Overall Study|Death|8|||
106174678|NCT03522298|366303090|FG003|Overall Study|Death|8|||
106174679|NCT03522298|366303087|FG000|Overall Study|Patient decision|0|||
106174680|NCT03522298|366303088|FG001|Overall Study|Patient decision|2|||
106174681|NCT03522298|366303089|FG002|Overall Study|Patient decision|2|||
106174682|NCT03522298|366303090|FG003|Overall Study|Patient decision|2|||
106174683|NCT04761198|366303100|FG000|Overall Study|Progressive Disease|1|||
106174684|NCT04761198|366303101|FG001|Overall Study|Progressive Disease|0|||
106174685|NCT04761198|366303102|FG002|Overall Study|Progressive Disease|0|||
106174686|NCT04761198|366303103|FG003|Overall Study|Progressive Disease|1|||
106174687|NCT04761198|366303104|FG004|Overall Study|Progressive Disease|4|||
106174688|NCT04761198|366303105|FG005|Overall Study|Progressive Disease|1|||
106174689|NCT04761198|366303106|FG006|Overall Study|Progressive Disease|2|||
106174690|NCT04761198|366303100|FG000|Overall Study|Protocol Violation|0|||
106174691|NCT04761198|366303101|FG001|Overall Study|Protocol Violation|0|||
106174692|NCT04761198|366303102|FG002|Overall Study|Protocol Violation|0|||
106174693|NCT04761198|366303103|FG003|Overall Study|Protocol Violation|0|||
106174694|NCT04761198|366303104|FG004|Overall Study|Protocol Violation|1|||
106174695|NCT04761198|366303105|FG005|Overall Study|Protocol Violation|0|||
106174696|NCT04761198|366303106|FG006|Overall Study|Protocol Violation|0|||
106174697|NCT04761198|366303100|FG000|Overall Study|Death|2|||
106174698|NCT04761198|366303101|FG001|Overall Study|Death|1|||
106174699|NCT04761198|366303102|FG002|Overall Study|Death|2|||
106174700|NCT04761198|366303103|FG003|Overall Study|Death|5|||
106174701|NCT04761198|366303104|FG004|Overall Study|Death|14|||
106174702|NCT04761198|366303105|FG005|Overall Study|Death|2|||
106174703|NCT04761198|366303106|FG006|Overall Study|Death|5|||
106174704|NCT04761198|366303100|FG000|Overall Study|Lost to Follow-up|0|||
106174705|NCT04761198|366303101|FG001|Overall Study|Lost to Follow-up|0|||
106174706|NCT04761198|366303102|FG002|Overall Study|Lost to Follow-up|0|||
106174707|NCT04761198|366303103|FG003|Overall Study|Lost to Follow-up|0|||
106174708|NCT04761198|366303104|FG004|Overall Study|Lost to Follow-up|1|||
106174709|NCT04761198|366303105|FG005|Overall Study|Lost to Follow-up|0|||
106174710|NCT04761198|366303106|FG006|Overall Study|Lost to Follow-up|0|||
106174711|NCT04761198|366303100|FG000|Overall Study|Withdrawal by Subject|2|||
106174712|NCT04761198|366303101|FG001|Overall Study|Withdrawal by Subject|0|||
106174713|NCT04761198|366303102|FG002|Overall Study|Withdrawal by Subject|1|||
106174714|NCT04761198|366303103|FG003|Overall Study|Withdrawal by Subject|0|||
106174715|NCT04761198|366303104|FG004|Overall Study|Withdrawal by Subject|2|||
106174716|NCT04761198|366303105|FG005|Overall Study|Withdrawal by Subject|0|||
106174717|NCT04761198|366303106|FG006|Overall Study|Withdrawal by Subject|1|||
106174718|NCT04761198|366303100|FG000|Overall Study|Study Terminated by Sponsor|6|||
106174719|NCT04761198|366303101|FG001|Overall Study|Study Terminated by Sponsor|0|||
106174720|NCT04761198|366303102|FG002|Overall Study|Study Terminated by Sponsor|5|||
106174721|NCT04761198|366303103|FG003|Overall Study|Study Terminated by Sponsor|3|||
106174722|NCT04761198|366303104|FG004|Overall Study|Study Terminated by Sponsor|10|||
106174723|NCT04761198|366303105|FG005|Overall Study|Study Terminated by Sponsor|1|||
106174724|NCT04761198|366303106|FG006|Overall Study|Study Terminated by Sponsor|2|||
106174725|NCT03493542|366303114|FG000|Base Study|Withdrawal by Subject|0|||
106174726|NCT03493542|366303115|FG001|Base Study|Withdrawal by Subject|4|||
106174727|NCT03493542|366303116|FG002|Base Study|Withdrawal by Subject|0|||
106174728|NCT03493542|366303114|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
106174729|NCT03493542|366303115|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
106174730|NCT03493542|366303116|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
106174731|NCT03493542|366303114|FG000|Extension Study|Withdrawal by Subject|0|||
106174732|NCT03493542|366303115|FG001|Extension Study|Withdrawal by Subject|0|||
106174733|NCT03493542|366303116|FG002|Extension Study|Withdrawal by Subject|25|||
106174734|NCT05485935|366303117|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
106174735|NCT05485935|366303118|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
106174736|NCT05485935|366303117|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
106174737|NCT05485935|366303118|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
106174738|NCT05485935|366303117|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
106174739|NCT05485935|366303118|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
106174740|NCT05485935|366303117|FG000|Period 2 (T2 and V3)|loss of contact|0|||
106174741|NCT05485935|366303118|FG001|Period 2 (T2 and V3)|loss of contact|1|||
106174742|NCT04093869|366303120|FG000|Overall Study|Death|0|||
106174743|NCT04093869|366303121|FG001|Overall Study|Death|1|||
106174744|NCT04093869|366303120|FG000|Overall Study|Withdrawal by Subject|1|||
106174745|NCT04093869|366303121|FG001|Overall Study|Withdrawal by Subject|0|||
106174746|NCT04780581|366303122|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
106174747|NCT04780581|366303123|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
106174748|NCT04780581|366303122|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
106174749|NCT04780581|366303123|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
106174750|NCT01756300|366303124|FG000|Overall Study|Death|1|||
106174751|NCT01756300|366303124|FG000|Overall Study|Withdrawal by Subject|1|||
106174752|NCT05866926|366303125|FG000|Overall Study|Death|16|||
106174753|NCT05866926|366303126|FG001|Overall Study|Death|9|||
106174754|NCT05866926|366303125|FG000|Overall Study|Lost to Follow-up|0|||
106174755|NCT05866926|366303126|FG001|Overall Study|Lost to Follow-up|1|||
106174756|NCT05866926|366303125|FG000|Overall Study|Adverse Event|1|||
106174757|NCT05866926|366303126|FG001|Overall Study|Adverse Event|0|||
106174758|NCT05866926|366303125|FG000|Overall Study|Withdrawal by Subject|5|||
106174759|NCT05866926|366303126|FG001|Overall Study|Withdrawal by Subject|1|||
106174760|NCT05866926|366303125|FG000|Overall Study|Disease progression|1|||
106174761|NCT05866926|366303126|FG001|Overall Study|Disease progression|0|||
106174762|NCT05866926|366303125|FG000|Overall Study|other causes|2|||
106174763|NCT05866926|366303126|FG001|Overall Study|other causes|1|||
106174764|NCT06065735|366303787|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
106174765|NCT06065735|366303788|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
106174766|NCT06065735|366303789|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
106174767|NCT06065735|366303787|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
106174768|NCT06065735|366303788|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
106174769|NCT06065735|366303789|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
106174770|NCT06065735|366303787|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
106174771|NCT06065735|366303788|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
106174772|NCT06065735|366303789|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
106174773|NCT06065735|366303787|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
106174774|NCT06065735|366303788|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
106174775|NCT06065735|366303789|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
106174776|NCT06065735|366303787|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
106174777|NCT06065735|366303788|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
106174778|NCT06065735|366303789|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
106174779|NCT05718687|366303790|FG000|Overall Study|Withdrawal by Subject|3|||
106174780|NCT03418740|366303791|FG000|Overall Study|Lost to Follow-up|13|||
106174781|NCT03418740|366303791|FG000|Overall Study|Scheduling Issues|7|||
106174782|NCT03418740|366303791|FG000|Overall Study|Withdrawal by Subject|2|||
106174783|NCT03418740|366303791|FG000|Overall Study|Unable to Continue Consent|1|||
106174784|NCT05215054|366303796|FG000|Overall Study|Lost to Follow-up|1|||
106174785|NCT05215054|366303797|FG001|Overall Study|Lost to Follow-up|1|||
106174786|NCT05215054|366303796|FG000|Overall Study|Protocol Violation|1|||
106174787|NCT05215054|366303797|FG001|Overall Study|Protocol Violation|1|||
106174788|NCT05215054|366303796|FG000|Overall Study|Withdrawal by Subject|4|||
106174789|NCT05215054|366303797|FG001|Overall Study|Withdrawal by Subject|4|||
106174790|NCT01897441|366303799|FG000|Overall Study|Lost to Follow-up|0|||
106174791|NCT01897441|366303800|FG001|Overall Study|Lost to Follow-up|0|||
106174792|NCT01897441|366303801|FG002|Overall Study|Lost to Follow-up|1|||
106174793|NCT01897441|366303802|FG003|Overall Study|Lost to Follow-up|0|||
106174794|NCT01897441|366303803|FG004|Overall Study|Lost to Follow-up|0|||
106174795|NCT01897441|366303804|FG005|Overall Study|Lost to Follow-up|0|||
106174796|NCT01897441|366303799|FG000|Overall Study|Withdrawal by Subject|0|||
106174797|NCT01897441|366303800|FG001|Overall Study|Withdrawal by Subject|0|||
106174798|NCT01897441|366303801|FG002|Overall Study|Withdrawal by Subject|0|||
106174799|NCT01897441|366303802|FG003|Overall Study|Withdrawal by Subject|0|||
106174800|NCT01897441|366303803|FG004|Overall Study|Withdrawal by Subject|1|||
106174801|NCT01897441|366303804|FG005|Overall Study|Withdrawal by Subject|0|||
106174802|NCT01897441|366303799|FG000|Overall Study|Withdrawn by Provider|0|||
106174803|NCT01897441|366303800|FG001|Overall Study|Withdrawn by Provider|2|||
106174804|NCT01897441|366303801|FG002|Overall Study|Withdrawn by Provider|0|||
106174805|NCT01897441|366303802|FG003|Overall Study|Withdrawn by Provider|0|||
106174806|NCT01897441|366303803|FG004|Overall Study|Withdrawn by Provider|0|||
106174807|NCT01897441|366303804|FG005|Overall Study|Withdrawn by Provider|0|||
106174808|NCT05424718|366303808|FG000|Overall Study|Lost to Follow-up|5|||
106174809|NCT05424718|366303809|FG001|Overall Study|Lost to Follow-up|4|||
106174810|NCT02461134|366303810|FG000|Overall Study|Adverse Event|1|||
106174811|NCT03533257|366303811|FG000|Overall Study|Adverse Event|4|||
106174812|NCT03533257|366303812|FG001|Overall Study|Adverse Event|2|||
106174813|NCT03533257|366303811|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
106174814|NCT03533257|366303812|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
106174815|NCT04159519|366303813|FG000|Overall Study|Adverse Event|1|||
106174816|NCT04159519|366303814|FG001|Overall Study|Adverse Event|1|||
106174817|NCT04159519|366303813|FG000|Overall Study|Lack of Efficacy|1|||
106174818|NCT04159519|366303814|FG001|Overall Study|Lack of Efficacy|0|||
106174819|NCT04159519|366303813|FG000|Overall Study|Discontinued from study|1|||
106174820|NCT04159519|366303814|FG001|Overall Study|Discontinued from study|0|||
106174821|NCT04159519|366303813|FG000|Overall Study|Protocol Violation|1|||
106174822|NCT04159519|366303814|FG001|Overall Study|Protocol Violation|1|||
106174823|NCT04159519|366303813|FG000|Overall Study|Withdrawal by Subject|4|||
106174824|NCT04159519|366303814|FG001|Overall Study|Withdrawal by Subject|4|||
106174825|NCT02325154|366303822|FG000|Overall Study|Physician Decision|1|||
106174826|NCT00709956|366303823|FG000|Overall Study|Withdrawal by Subject|1|||
106174827|NCT00709956|366303824|FG001|Overall Study|Withdrawal by Subject|1|||
106174828|NCT00709956|366303823|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
106174829|NCT00709956|366303824|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
106174830|NCT01105091|366303825|FG000|Overall Study|Death|2|||
106174831|NCT01105091|366303826|FG001|Overall Study|Death|0|||
106174832|NCT02765412|366303827|FG000|Overall Study|Death|482|||
106174833|NCT02765412|366303828|FG001|Overall Study|Death|855|||
106174834|NCT04464564|366304291|FG000|Period A (Placebo lead-in)|Other|5|||
106174835|NCT04464564|366304292|FG001|Period A (Placebo lead-in)|Other|0|||
106174836|NCT04464564|366304293|FG002|Period A (Placebo lead-in)|Other|0|||
106174837|NCT04464564|366304294|FG003|Period A (Placebo lead-in)|Other|0|||
106174838|NCT04464564|366304291|FG000|Period B (Randomization Period)|Adverse Event|0|||
106174839|NCT04464564|366304292|FG001|Period B (Randomization Period)|Adverse Event|1|||
106174840|NCT04464564|366304293|FG002|Period B (Randomization Period)|Adverse Event|2|||
106174841|NCT04464564|366304294|FG003|Period B (Randomization Period)|Adverse Event|8|||
106174842|NCT04464564|366304291|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
106174843|NCT04464564|366304292|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
106174844|NCT04464564|366304293|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
106174845|NCT04464564|366304294|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
106174846|NCT04464564|366304291|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
106174847|NCT04464564|366304292|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
106174848|NCT04464564|366304293|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
106174849|NCT04464564|366304294|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
106174850|NCT04464564|366304291|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
106174851|NCT04464564|366304292|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
106174852|NCT04464564|366304293|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
106174853|NCT04464564|366304294|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
106174854|NCT04464564|366304291|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
106174855|NCT04464564|366304292|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
106174856|NCT04464564|366304293|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
106174857|NCT04464564|366304294|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
106174858|NCT04464564|366304291|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
106174859|NCT04464564|366304292|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
106174860|NCT04464564|366304293|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
106174861|NCT04464564|366304294|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
106174862|NCT04464564|366304291|FG000|Period B (Randomization Period)|Reason not Specified|0|||
106174863|NCT04464564|366304292|FG001|Period B (Randomization Period)|Reason not Specified|3|||
106174864|NCT04464564|366304293|FG002|Period B (Randomization Period)|Reason not Specified|3|||
106174865|NCT04464564|366304294|FG003|Period B (Randomization Period)|Reason not Specified|3|||
106174866|NCT04389957|366304300|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
106174867|NCT04389957|366304301|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
106174868|NCT04389957|366304302|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
106174869|NCT04389957|366304303|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
106174870|NCT04389957|366304304|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
106174871|NCT03635424|366304305|FG000|Overall Study|Adverse Event|1|||
106174872|NCT03635424|366304305|FG000|Overall Study|Death|1|||
106174873|NCT03635424|366304305|FG000|Overall Study|Device not implanted|1|||
106174874|NCT03812614|366304306|FG000|Intervention|Withdrawal by Subject|7|||
106174875|NCT03812614|366304307|FG001|Intervention|Withdrawal by Subject|2|||
106174876|NCT03812614|366304308|FG002|Intervention|Withdrawal by Subject|7|||
106174877|NCT03812614|366304309|FG003|Intervention|Withdrawal by Subject|2|||
106174878|NCT03812614|366304306|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
106174879|NCT03812614|366304307|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
106174880|NCT03812614|366304308|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
106174881|NCT03812614|366304309|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
106174882|NCT03812614|366304306|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
106174883|NCT03812614|366304307|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
106174884|NCT03812614|366304308|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
106174885|NCT03812614|366304309|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
106174886|NCT03812614|366304306|FG000|6-month Follow-up|Lost to Follow-up|0|||
106174887|NCT03812614|366304307|FG001|6-month Follow-up|Lost to Follow-up|0|||
106174888|NCT03812614|366304308|FG002|6-month Follow-up|Lost to Follow-up|12|||
106174889|NCT03812614|366304309|FG003|6-month Follow-up|Lost to Follow-up|8|||
106174890|NCT03812614|366304306|FG000|12-month Follow-up|Lost to Follow-up|18|||
106174891|NCT03812614|366304307|FG001|12-month Follow-up|Lost to Follow-up|17|||
106174892|NCT03812614|366304308|FG002|12-month Follow-up|Lost to Follow-up|5|||
106174893|NCT03812614|366304309|FG003|12-month Follow-up|Lost to Follow-up|2|||
106174894|NCT03744676|366304310|FG000|Pre-Treatment Phase|Disease related complications|2|||
106174895|NCT03744676|366304310|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
106174896|NCT03744676|366304310|FG000|Pre-Treatment Phase|Death|7|||
106174897|NCT03744676|366304310|FG000|Pre-Treatment Phase|Other Reasons|7|||
106174898|NCT03744676|366304310|FG000|Treatment Phase|Participant withdrew consent|8|||
106174899|NCT03744676|366304310|FG000|Treatment Phase|Death|33|||
106174900|NCT03744676|366304310|FG000|Treatment Phase|other reasons|6|||
106174901|NCT04586244|366304311|FG000|Overall Study|Lost to Follow-up|1|||
106174902|NCT04586244|366304312|FG001|Overall Study|Lost to Follow-up|0|||
106174903|NCT04586244|366304313|FG002|Overall Study|Lost to Follow-up|0|||
106174904|NCT04586244|366304314|FG003|Overall Study|Lost to Follow-up|1|||
106174905|NCT04586244|366304315|FG004|Overall Study|Lost to Follow-up|0|||
106174906|NCT04586244|366304311|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
106174907|NCT04586244|366304312|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
106174908|NCT04586244|366304313|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
106174909|NCT04586244|366304314|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
106174910|NCT04586244|366304315|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
106174911|NCT04795245|366304317|FG000|Overall Study|Unkown reason|7|||
106174912|NCT04795245|366304317|FG000|Overall Study|Death|17|||
106174913|NCT04795245|366304317|FG000|Overall Study|Other than listed|19|||
106174914|NCT04795245|366304317|FG000|Overall Study|Adverse Event|143|||
106174915|NCT04795245|366304317|FG000|Overall Study|Progressive disease|512|||
106174916|NCT04795245|366304317|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
106174917|NCT03904576|366304318|FG000|Washout Period|Protocol Violation|1|||
106174918|NCT03904576|366304319|FG001|Washout Period|Protocol Violation|1|||
106174919|NCT02919917|366304320|FG000|Overall Study|Withdrawal by Subject|4|||
106174920|NCT02919917|366304321|FG001|Overall Study|Withdrawal by Subject|8|||
106174921|NCT04174560|366304322|FG000|Overall Study|Lost to Follow-up|1|||
106174922|NCT04174560|366304323|FG001|Overall Study|Lost to Follow-up|0|||
106174923|NCT04174560|366304324|FG002|Overall Study|Lost to Follow-up|0|||
106174924|NCT04174560|366304325|FG003|Overall Study|Lost to Follow-up|0|||
106174925|NCT04174560|366304322|FG000|Overall Study|Withdrawal by Subject|0|||
106174926|NCT04174560|366304323|FG001|Overall Study|Withdrawal by Subject|0|||
106174927|NCT04174560|366304324|FG002|Overall Study|Withdrawal by Subject|2|||
106174928|NCT04174560|366304325|FG003|Overall Study|Withdrawal by Subject|0|||
106174929|NCT03250676|366304330|FG000|Overall Study|Adverse Event|0|||
106174930|NCT03250676|366304331|FG001|Overall Study|Adverse Event|0|||
106174931|NCT03250676|366304332|FG002|Overall Study|Adverse Event|0|||
106174932|NCT03250676|366304333|FG003|Overall Study|Adverse Event|1|||
106174933|NCT03250676|366304334|FG004|Overall Study|Adverse Event|2|||
106174934|NCT03250676|366304335|FG005|Overall Study|Adverse Event|9|||
106174935|NCT03250676|366304330|FG000|Overall Study|Withdrawal by Subject|1|||
106174936|NCT03250676|366304331|FG001|Overall Study|Withdrawal by Subject|0|||
106174937|NCT03250676|366304332|FG002|Overall Study|Withdrawal by Subject|0|||
106174938|NCT03250676|366304333|FG003|Overall Study|Withdrawal by Subject|1|||
106174939|NCT03250676|366304334|FG004|Overall Study|Withdrawal by Subject|1|||
106174940|NCT03250676|366304335|FG005|Overall Study|Withdrawal by Subject|2|||
106174941|NCT03250676|366304330|FG000|Overall Study|Physician Decision|0|||
106174942|NCT03250676|366304331|FG001|Overall Study|Physician Decision|0|||
106174943|NCT03250676|366304332|FG002|Overall Study|Physician Decision|0|||
106174944|NCT03250676|366304333|FG003|Overall Study|Physician Decision|2|||
106174945|NCT03250676|366304334|FG004|Overall Study|Physician Decision|0|||
106174946|NCT03250676|366304335|FG005|Overall Study|Physician Decision|3|||
106174947|NCT03250676|366304330|FG000|Overall Study|Withdrawal of consent|0|||
106174948|NCT03250676|366304331|FG001|Overall Study|Withdrawal of consent|0|||
106174949|NCT03250676|366304332|FG002|Overall Study|Withdrawal of consent|2|||
106174950|NCT03250676|366304333|FG003|Overall Study|Withdrawal of consent|0|||
106174951|NCT03250676|366304334|FG004|Overall Study|Withdrawal of consent|0|||
106174952|NCT03250676|366304335|FG005|Overall Study|Withdrawal of consent|2|||
106174953|NCT03250676|366304330|FG000|Overall Study|Other|1|||
106174954|NCT03250676|366304331|FG001|Overall Study|Other|0|||
106174955|NCT03250676|366304332|FG002|Overall Study|Other|0|||
106174956|NCT03250676|366304333|FG003|Overall Study|Other|0|||
106174957|NCT03250676|366304334|FG004|Overall Study|Other|0|||
106174958|NCT03250676|366304335|FG005|Overall Study|Other|0|||
106174959|NCT03250676|366304330|FG000|Overall Study|Disease progression|4|||
106174960|NCT03250676|366304331|FG001|Overall Study|Disease progression|12|||
106174961|NCT03250676|366304332|FG002|Overall Study|Disease progression|9|||
106174962|NCT03250676|366304333|FG003|Overall Study|Disease progression|7|||
106174963|NCT03250676|366304334|FG004|Overall Study|Disease progression|4|||
106174964|NCT03250676|366304335|FG005|Overall Study|Disease progression|88|||
106174965|NCT04166513|366304336|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
106174966|NCT04166513|366304337|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
106174967|NCT04166513|366304338|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
106174968|NCT04166513|366304339|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
106174969|NCT04166513|366304336|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
106174970|NCT04166513|366304337|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
106174971|NCT04166513|366304338|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
106174972|NCT04166513|366304339|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
106174973|NCT04166513|366304336|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
106174974|NCT04166513|366304337|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
106174975|NCT04166513|366304338|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
106174976|NCT04166513|366304339|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
106174977|NCT04166513|366304336|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
106174978|NCT04166513|366304337|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
106174979|NCT04166513|366304338|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
106174980|NCT04166513|366304339|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
106174981|NCT04166513|366304336|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
106174982|NCT04166513|366304337|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
106174983|NCT04166513|366304338|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
106174984|NCT04166513|366304339|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
106174985|NCT01651000|366304342|FG000|Overall Study|Adverse Event|2|||
106174986|NCT01651000|366304343|FG001|Overall Study|Adverse Event|8|||
106174987|NCT01651000|366304342|FG000|Overall Study|Lost to Follow-up|3|||
106174988|NCT01651000|366304343|FG001|Overall Study|Lost to Follow-up|2|||
106174989|NCT01651000|366304342|FG000|Overall Study|Protocol Violation|0|||
106174990|NCT01651000|366304343|FG001|Overall Study|Protocol Violation|3|||
106174991|NCT01651000|366304342|FG000|Overall Study|Withdrawal by Subject|2|||
106174992|NCT01651000|366304343|FG001|Overall Study|Withdrawal by Subject|10|||
106174993|NCT01651000|366304342|FG000|Overall Study|Subject noncompliance|0|||
106174994|NCT01651000|366304343|FG001|Overall Study|Subject noncompliance|3|||
106174995|NCT01651000|366304342|FG000|Overall Study|Lack of Efficacy|1|||
106174996|NCT01651000|366304343|FG001|Overall Study|Lack of Efficacy|1|||
106174997|NCT01651000|366304342|FG000|Overall Study|Physician Decision|1|||
106174998|NCT01651000|366304343|FG001|Overall Study|Physician Decision|0|||
106174999|NCT01651000|366304342|FG000|Overall Study|Administrative reason|1|||
106175000|NCT01651000|366304343|FG001|Overall Study|Administrative reason|0|||
106175001|NCT01651000|366304342|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
106175002|NCT01651000|366304343|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
106175003|NCT00447980|366304640|FG000|Overall Study|Withdrawal by Subject|1|||
106175004|NCT00447980|366304641|FG001|Overall Study|Withdrawal by Subject|1|||
106175005|NCT00447980|366304642|FG002|Overall Study|Withdrawal by Subject|4|||
106175006|NCT00447980|366304643|FG003|Overall Study|Withdrawal by Subject|4|||
106175007|NCT00447980|366304640|FG000|Overall Study|Lost to Follow-up|1|||
106175008|NCT00447980|366304641|FG001|Overall Study|Lost to Follow-up|1|||
106175009|NCT00447980|366304642|FG002|Overall Study|Lost to Follow-up|0|||
106175010|NCT00447980|366304643|FG003|Overall Study|Lost to Follow-up|0|||
106175011|NCT00447980|366304640|FG000|Overall Study|Did not proceed with surgery|3|||
106175012|NCT00447980|366304641|FG001|Overall Study|Did not proceed with surgery|3|||
106175013|NCT00447980|366304642|FG002|Overall Study|Did not proceed with surgery|2|||
106175014|NCT00447980|366304643|FG003|Overall Study|Did not proceed with surgery|2|||
106175015|NCT01880515|366304647|FG000|Overall Study|Lost to Follow-up|3|||
106175016|NCT01880515|366304648|FG001|Overall Study|Lost to Follow-up|2|||
106175017|NCT01880515|366304647|FG000|Overall Study|Disease Progression|5|||
106175018|NCT01880515|366304648|FG001|Overall Study|Disease Progression|7|||
106175019|NCT03286114|366304656|FG000|Overall Study|Adverse Event|6|||
106175020|NCT03286114|366304656|FG000|Overall Study|Death|3|||
106175021|NCT05247034|366304657|FG000|Overall Study|Lost to Follow-up|3|||
106175022|NCT05247034|366304658|FG001|Overall Study|Lost to Follow-up|2|||
106175023|NCT05247034|366304657|FG000|Overall Study|Organizational problems when attending appointments|1|||
106175024|NCT05247034|366304658|FG001|Overall Study|Organizational problems when attending appointments|0|||
106175025|NCT02076009|366304659|FG000|Overall Study|Death|172|||
106175026|NCT02076009|366304660|FG001|Overall Study|Death|153|||
106175027|NCT02076009|366304659|FG000|Overall Study|Withdrawal by Subject|16|||
106175028|NCT02076009|366304660|FG001|Overall Study|Withdrawal by Subject|12|||
106175029|NCT02076009|366304659|FG000|Overall Study|Lost to Follow-up|4|||
106175030|NCT02076009|366304660|FG001|Overall Study|Lost to Follow-up|2|||
106175031|NCT02076009|366304659|FG000|Overall Study|Progressive Disease|1|||
106175032|NCT02076009|366304660|FG001|Overall Study|Progressive Disease|0|||
106175033|NCT02076009|366304659|FG000|Overall Study|Physician Decision|0|||
106175034|NCT02076009|366304660|FG001|Overall Study|Physician Decision|1|||
106175035|NCT02076009|366304659|FG000|Overall Study|End of data collection|90|||
106175036|NCT02076009|366304660|FG001|Overall Study|End of data collection|118|||
106175037|NCT03983382|366304661|FG000|Overall Study|Death|1|||
106175038|NCT03983382|366304661|FG000|Overall Study|Lost to Follow-up|3|||
106175039|NCT03983382|366304661|FG000|Overall Study|Physician Decision|2|||
106175040|NCT03983382|366304661|FG000|Overall Study|Withdrawal by Subject|10|||
106175041|NCT03983382|366304661|FG000|Overall Study|Change in cancer treatment|2|||
106175042|NCT04174170|366304664|FG000|Placebo Run-in Period|Not Randomized|38|||
106175043|NCT04174170|366304665|FG001|Placebo Run-in Period|Not Randomized|0|||
106175044|NCT04174170|366304666|FG002|Placebo Run-in Period|Not Randomized|0|||
106175045|NCT04174170|366304667|FG003|Placebo Run-in Period|Not Randomized|0|||
106175046|NCT04174170|366304664|FG000|Double Blind Treatment Period|Adverse Event|0|||
106175047|NCT04174170|366304665|FG001|Double Blind Treatment Period|Adverse Event|9|||
106175048|NCT04174170|366304666|FG002|Double Blind Treatment Period|Adverse Event|9|||
106175049|NCT04174170|366304667|FG003|Double Blind Treatment Period|Adverse Event|8|||
106175050|NCT04174170|366304664|FG000|Double Blind Treatment Period|Death|0|||
106175051|NCT04174170|366304665|FG001|Double Blind Treatment Period|Death|1|||
106175052|NCT04174170|366304666|FG002|Double Blind Treatment Period|Death|0|||
106175053|NCT04174170|366304667|FG003|Double Blind Treatment Period|Death|0|||
106175054|NCT04174170|366304664|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
106175055|NCT04174170|366304665|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
106175056|NCT04174170|366304666|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
106175057|NCT04174170|366304667|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
106175058|NCT04174170|366304664|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
106175059|NCT04174170|366304665|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
106175060|NCT04174170|366304666|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
106175061|NCT04174170|366304667|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
106175062|NCT04174170|366304664|FG000|Double Blind Treatment Period|Physician Decision|0|||
106175063|NCT04174170|366304665|FG001|Double Blind Treatment Period|Physician Decision|1|||
106175064|NCT04174170|366304666|FG002|Double Blind Treatment Period|Physician Decision|0|||
106175065|NCT04174170|366304667|FG003|Double Blind Treatment Period|Physician Decision|1|||
106175066|NCT04174170|366304664|FG000|Double Blind Treatment Period|Pregnancy|0|||
106175067|NCT04174170|366304665|FG001|Double Blind Treatment Period|Pregnancy|1|||
106175068|NCT04174170|366304666|FG002|Double Blind Treatment Period|Pregnancy|0|||
106175069|NCT04174170|366304667|FG003|Double Blind Treatment Period|Pregnancy|1|||
106175070|NCT04174170|366304664|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
106175071|NCT04174170|366304665|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
106175072|NCT04174170|366304666|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
106175073|NCT04174170|366304667|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
106175074|NCT04174170|366304664|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
106175075|NCT04174170|366304665|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
106175076|NCT04174170|366304666|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
106175077|NCT04174170|366304667|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
106175078|NCT04174170|366304664|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
106175079|NCT04174170|366304665|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
106175080|NCT04174170|366304666|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
106175081|NCT04174170|366304667|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
106175082|NCT03008382|366304676|FG000|Overall Study|Withdrawal by Subject|2|||
106175083|NCT03008382|366304677|FG001|Overall Study|Withdrawal by Subject|5|||
106175084|NCT03008382|366304678|FG002|Overall Study|Withdrawal by Subject|2|||
106175085|NCT03008382|366304679|FG003|Overall Study|Withdrawal by Subject|0|||
106175086|NCT03008382|366304676|FG000|Overall Study|Protocol Violation|1|||
106175087|NCT03008382|366304677|FG001|Overall Study|Protocol Violation|0|||
106175088|NCT03008382|366304678|FG002|Overall Study|Protocol Violation|0|||
106175089|NCT03008382|366304679|FG003|Overall Study|Protocol Violation|0|||
106175090|NCT03008382|366304676|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
106175091|NCT03008382|366304677|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
106175092|NCT03008382|366304678|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
106175093|NCT03008382|366304679|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
106175094|NCT03008382|366304676|FG000|Overall Study|Lost to Follow-up|0|||
106175095|NCT03008382|366304677|FG001|Overall Study|Lost to Follow-up|0|||
106175096|NCT03008382|366304678|FG002|Overall Study|Lost to Follow-up|1|||
106175097|NCT03008382|366304679|FG003|Overall Study|Lost to Follow-up|0|||
106175098|NCT03008382|366304676|FG000|Overall Study|Screenfail|0|||
106175099|NCT03008382|366304677|FG001|Overall Study|Screenfail|0|||
106175100|NCT03008382|366304678|FG002|Overall Study|Screenfail|2|||
106175101|NCT03008382|366304679|FG003|Overall Study|Screenfail|0|||
106175102|NCT04244175|366304903|FG000|Overall Study|Adverse Event|3|||
106175103|NCT04244175|366304904|FG001|Overall Study|Adverse Event|2|||
106175104|NCT04244175|366304905|FG002|Overall Study|Adverse Event|5|||
106175105|NCT04244175|366304903|FG000|Overall Study|Lack of Efficacy|1|||
106175106|NCT04244175|366304904|FG001|Overall Study|Lack of Efficacy|0|||
106175107|NCT04244175|366304905|FG002|Overall Study|Lack of Efficacy|1|||
106175108|NCT04244175|366304903|FG000|Overall Study|Lost to Follow-up|1|||
106175109|NCT04244175|366304904|FG001|Overall Study|Lost to Follow-up|0|||
106175110|NCT04244175|366304905|FG002|Overall Study|Lost to Follow-up|0|||
106175111|NCT04244175|366304903|FG000|Overall Study|Non-compliance with study drug|1|||
106175112|NCT04244175|366304904|FG001|Overall Study|Non-compliance with study drug|0|||
106175113|NCT04244175|366304905|FG002|Overall Study|Non-compliance with study drug|1|||
106175114|NCT04244175|366304903|FG000|Overall Study|Protocol deviation|0|||
106175115|NCT04244175|366304904|FG001|Overall Study|Protocol deviation|1|||
106175116|NCT04244175|366304905|FG002|Overall Study|Protocol deviation|0|||
106175117|NCT04244175|366304903|FG000|Overall Study|Withdrawal by Subject|1|||
106175118|NCT04244175|366304904|FG001|Overall Study|Withdrawal by Subject|3|||
106175119|NCT04244175|366304905|FG002|Overall Study|Withdrawal by Subject|1|||
106175120|NCT04244175|366304903|FG000|Overall Study|Other, not specified|0|||
106175121|NCT04244175|366304904|FG001|Overall Study|Other, not specified|1|||
106175122|NCT04244175|366304905|FG002|Overall Study|Other, not specified|2|||
106175123|NCT04046549|366304913|FG000|Overall Study|Adverse Event|1|||
106175124|NCT04046549|366304913|FG000|Overall Study|Physician Decision|1|||
106175125|NCT04046549|366304913|FG000|Overall Study|Withdrawal by Subject|3|||
106175126|NCT04046549|366304913|FG000|Overall Study|Other, Not Specified|5|||
106175127|NCT02806726|366304914|FG000|Overall Study|Lost to Follow-up|1|||
105867368|NCT01473407|365164955|FG000|Overall Study|Lost to Follow-up|10|||
106175128|NCT05129501|366304915|FG000|Overall Study|Lost to Follow-up|54|||
106175129|NCT05129501|366304916|FG001|Overall Study|Lost to Follow-up|41|||
106175130|NCT04281498|366304917|FG000|Overall Study|Progression of disease|1|||
106175131|NCT04281498|366304917|FG000|Overall Study|Planned SCT|1|||
106175132|NCT04281498|366304917|FG000|Overall Study|Alternative Treatment|1|||
106175133|NCT01527188|366304918|FG000|Overall Study|Adverse Event|5|||
106175134|NCT01527188|366304919|FG001|Overall Study|Adverse Event|5|||
106175135|NCT01527188|366304920|FG002|Overall Study|Adverse Event|11|||
106175136|NCT01527188|366304921|FG003|Overall Study|Adverse Event|0|||
106175137|NCT01527188|366304918|FG000|Overall Study|Withdrawal by Subject|3|||
106175138|NCT01527188|366304919|FG001|Overall Study|Withdrawal by Subject|6|||
106175139|NCT01527188|366304920|FG002|Overall Study|Withdrawal by Subject|4|||
106175140|NCT01527188|366304921|FG003|Overall Study|Withdrawal by Subject|4|||
106175141|NCT01527188|366304918|FG000|Overall Study|Any other reason not above-mentioned|6|||
106175142|NCT01527188|366304919|FG001|Overall Study|Any other reason not above-mentioned|7|||
106175143|NCT01527188|366304920|FG002|Overall Study|Any other reason not above-mentioned|8|||
106175144|NCT01527188|366304921|FG003|Overall Study|Any other reason not above-mentioned|8|||
106175145|NCT01553149|366304922|FG000|Overall Study|Adverse Event|0|||
106175146|NCT01553149|366304923|FG001|Overall Study|Adverse Event|9|||
106175147|NCT01553149|366304922|FG000|Overall Study|Physician Decision|5|||
106175148|NCT01553149|366304923|FG001|Overall Study|Physician Decision|10|||
106175149|NCT01553149|366304922|FG000|Overall Study|Ineligible|0|||
106175150|NCT01553149|366304923|FG001|Overall Study|Ineligible|1|||
106175151|NCT04644029|366305151|FG000|Overall Study|Death|1|||
106175152|NCT04644029|366305152|FG001|Overall Study|Death|0|||
106175153|NCT04644029|366305151|FG000|Overall Study|Physician Decision|1|||
106175154|NCT04644029|366305152|FG001|Overall Study|Physician Decision|2|||
106175155|NCT04644029|366305151|FG000|Overall Study|Withdrawal by Subject|21|||
106175156|NCT04644029|366305152|FG001|Overall Study|Withdrawal by Subject|19|||
106175157|NCT04644029|366305151|FG000|Overall Study|Lost to Follow-up|31|||
106175158|NCT04644029|366305152|FG001|Overall Study|Lost to Follow-up|34|||
106175159|NCT04644029|366305151|FG000|Overall Study|Study Terminated by Sponsor|308|||
106175160|NCT04644029|366305152|FG001|Overall Study|Study Terminated by Sponsor|309|||
106175161|NCT04644029|366305151|FG000|Overall Study|Randomized in Error|2|||
106175162|NCT04644029|366305152|FG001|Overall Study|Randomized in Error|1|||
106175163|NCT04644029|366305151|FG000|Overall Study|Other|0|||
106175164|NCT04644029|366305152|FG001|Overall Study|Other|1|||
106175165|NCT04227899|366305153|FG000|Overall Study|Withdrawal by Subject|6|||
106175166|NCT04227899|366305154|FG001|Overall Study|Withdrawal by Subject|3|||
106175167|NCT04227899|366305153|FG000|Overall Study|Death|12|||
106175168|NCT04227899|366305154|FG001|Overall Study|Death|6|||
106175169|NCT04227899|366305153|FG000|Overall Study|Lost to Follow-up|2|||
106175170|NCT04227899|366305154|FG001|Overall Study|Lost to Follow-up|1|||
106175171|NCT02989662|366305159|FG000|Overall Study|Lost to Follow-up|0|||
106175172|NCT02989662|366305160|FG001|Overall Study|Lost to Follow-up|0|||
106175173|NCT02989662|366305161|FG002|Overall Study|Lost to Follow-up|0|||
106175174|NCT02989662|366305162|FG003|Overall Study|Lost to Follow-up|2|||
106175175|NCT02989662|366305159|FG000|Overall Study|Physician Decision|3|||
106175176|NCT02989662|366305160|FG001|Overall Study|Physician Decision|0|||
106175177|NCT02989662|366305161|FG002|Overall Study|Physician Decision|0|||
106175178|NCT02989662|366305162|FG003|Overall Study|Physician Decision|0|||
106175179|NCT02989662|366305159|FG000|Overall Study|Withdrawal by Subject|1|||
106175180|NCT02989662|366305160|FG001|Overall Study|Withdrawal by Subject|0|||
106175181|NCT02989662|366305161|FG002|Overall Study|Withdrawal by Subject|0|||
106175182|NCT02989662|366305162|FG003|Overall Study|Withdrawal by Subject|0|||
106175183|NCT03552965|366305165|FG000|Overall Study|Death|1|||
106175184|NCT03552965|366305166|FG001|Overall Study|Death|1|||
106175185|NCT03552965|366305165|FG000|Overall Study|Lost to Follow-up|1|||
106175186|NCT03552965|366305166|FG001|Overall Study|Lost to Follow-up|1|||
106175187|NCT03552965|366305165|FG000|Overall Study|Physician Decision|1|||
106175188|NCT03552965|366305166|FG001|Overall Study|Physician Decision|1|||
106175189|NCT03552965|366305165|FG000|Overall Study|Withdrawal by Subject|0|||
106175190|NCT03552965|366305166|FG001|Overall Study|Withdrawal by Subject|2|||
106175191|NCT03552965|366305165|FG000|Overall Study|Continuation not in patient best interest|1|||
106175192|NCT03552965|366305166|FG001|Overall Study|Continuation not in patient best interest|0|||
106175193|NCT03552965|366305165|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
106175194|NCT03552965|366305166|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
106175195|NCT01220531|366305168|FG000|Overall Study|Death|7|||
106175196|NCT01220531|366305168|FG000|Overall Study|Lost to Follow-up|1|||
106175197|NCT04873232|366305171|FG000|Overall Study|Lost to Follow-up|1|||
106175198|NCT04873232|366305172|FG001|Overall Study|Lost to Follow-up|4|||
106175199|NCT04873232|366305171|FG000|Overall Study|Withdrawal by Subject|1|||
106175200|NCT04873232|366305172|FG001|Overall Study|Withdrawal by Subject|0|||
106175201|NCT05267639|366305733|FG000|Overall Study|Withdrawal by Subject|1|||
106175202|NCT05267639|366305734|FG001|Overall Study|Withdrawal by Subject|0|||
106175203|NCT03417284|366305738|FG000|Overall Study|Inadequate supply on study drug|1|||
106175204|NCT03417284|366305739|FG001|Overall Study|Inadequate supply on study drug|0|||
106175205|NCT03417284|366305740|FG002|Overall Study|Inadequate supply on study drug|0|||
106175206|NCT03417284|366305741|FG003|Overall Study|Inadequate supply on study drug|0|||
106175207|NCT03417284|366305738|FG000|Overall Study|Disease Progression|0|||
106175208|NCT03417284|366305739|FG001|Overall Study|Disease Progression|0|||
106175209|NCT03417284|366305740|FG002|Overall Study|Disease Progression|1|||
106175210|NCT03417284|366305741|FG003|Overall Study|Disease Progression|0|||
106175211|NCT05132400|366305742|FG000|Overall Study|Withdrawal by Subject|14|||
106175212|NCT05132400|366305743|FG001|Overall Study|Withdrawal by Subject|8|||
106175213|NCT05132400|366305742|FG000|Overall Study|Lost to Follow-up|132|||
106175214|NCT05132400|366305743|FG001|Overall Study|Lost to Follow-up|121|||
105867369|NCT01473407|365164956|FG001|Overall Study|Lost to Follow-up|4|||
106175215|NCT03934931|366305746|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
106175216|NCT03934931|366305747|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
106175217|NCT03934931|366305748|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
106175218|NCT02720068|366305749|FG000|Overall Study|Adverse Event|0|||
106175219|NCT02720068|366305750|FG001|Overall Study|Adverse Event|0|||
106175220|NCT02720068|366305751|FG002|Overall Study|Adverse Event|0|||
106175221|NCT02720068|366305752|FG003|Overall Study|Adverse Event|0|||
106175222|NCT02720068|366305753|FG004|Overall Study|Adverse Event|0|||
106175223|NCT02720068|366305754|FG005|Overall Study|Adverse Event|0|||
106175224|NCT02720068|366305755|FG006|Overall Study|Adverse Event|0|||
106175225|NCT02720068|366305756|FG007|Overall Study|Adverse Event|0|||
106175226|NCT02720068|366305757|FG008|Overall Study|Adverse Event|0|||
106175227|NCT02720068|366305758|FG009|Overall Study|Adverse Event|0|||
106175228|NCT02720068|366305759|FG010|Overall Study|Adverse Event|0|||
106175229|NCT02720068|366305760|FG011|Overall Study|Adverse Event|1|||
106175230|NCT02720068|366305761|FG012|Overall Study|Adverse Event|0|||
106175231|NCT02720068|366305762|FG013|Overall Study|Adverse Event|0|||
106175232|NCT02720068|366305763|FG014|Overall Study|Adverse Event|0|||
106175233|NCT02720068|366305764|FG015|Overall Study|Adverse Event|0|||
106175234|NCT02720068|366305765|FG016|Overall Study|Adverse Event|0|||
106175235|NCT02720068|366305766|FG017|Overall Study|Adverse Event|0|||
106175236|NCT02720068|366305749|FG000|Overall Study|Death|1|||
106175237|NCT02720068|366305750|FG001|Overall Study|Death|3|||
106175238|NCT02720068|366305751|FG002|Overall Study|Death|2|||
106175239|NCT02720068|366305752|FG003|Overall Study|Death|1|||
106175240|NCT02720068|366305753|FG004|Overall Study|Death|2|||
106175241|NCT02720068|366305754|FG005|Overall Study|Death|1|||
106175242|NCT02720068|366305755|FG006|Overall Study|Death|2|||
106175243|NCT02720068|366305756|FG007|Overall Study|Death|2|||
106175244|NCT02720068|366305757|FG008|Overall Study|Death|3|||
106175245|NCT02720068|366305758|FG009|Overall Study|Death|1|||
106175246|NCT02720068|366305759|FG010|Overall Study|Death|20|||
106175247|NCT02720068|366305760|FG011|Overall Study|Death|166|||
106175248|NCT02720068|366305761|FG012|Overall Study|Death|34|||
106175249|NCT02720068|366305762|FG013|Overall Study|Death|30|||
106175250|NCT02720068|366305763|FG014|Overall Study|Death|45|||
106175251|NCT02720068|366305764|FG015|Overall Study|Death|16|||
106175252|NCT02720068|366305765|FG016|Overall Study|Death|20|||
106175253|NCT02720068|366305766|FG017|Overall Study|Death|28|||
106175254|NCT02720068|366305749|FG000|Overall Study|Lost to Follow-up|0|||
106175255|NCT02720068|366305750|FG001|Overall Study|Lost to Follow-up|0|||
106175256|NCT02720068|366305751|FG002|Overall Study|Lost to Follow-up|0|||
106175257|NCT02720068|366305752|FG003|Overall Study|Lost to Follow-up|0|||
106175258|NCT02720068|366305753|FG004|Overall Study|Lost to Follow-up|0|||
106175259|NCT02720068|366305754|FG005|Overall Study|Lost to Follow-up|0|||
106175260|NCT02720068|366305755|FG006|Overall Study|Lost to Follow-up|0|||
106175261|NCT02720068|366305756|FG007|Overall Study|Lost to Follow-up|0|||
106175262|NCT02720068|366305757|FG008|Overall Study|Lost to Follow-up|0|||
106175263|NCT02720068|366305758|FG009|Overall Study|Lost to Follow-up|0|||
106175264|NCT02720068|366305759|FG010|Overall Study|Lost to Follow-up|0|||
106175265|NCT02720068|366305760|FG011|Overall Study|Lost to Follow-up|1|||
106175266|NCT02720068|366305761|FG012|Overall Study|Lost to Follow-up|0|||
106175267|NCT02720068|366305762|FG013|Overall Study|Lost to Follow-up|1|||
106175268|NCT02720068|366305763|FG014|Overall Study|Lost to Follow-up|2|||
106175269|NCT02720068|366305764|FG015|Overall Study|Lost to Follow-up|0|||
106175270|NCT02720068|366305765|FG016|Overall Study|Lost to Follow-up|0|||
106175271|NCT02720068|366305766|FG017|Overall Study|Lost to Follow-up|1|||
106175272|NCT02720068|366305749|FG000|Overall Study|Physician Decision|0|||
106175273|NCT02720068|366305750|FG001|Overall Study|Physician Decision|0|||
106175274|NCT02720068|366305751|FG002|Overall Study|Physician Decision|0|||
106175275|NCT02720068|366305752|FG003|Overall Study|Physician Decision|1|||
106175276|NCT02720068|366305753|FG004|Overall Study|Physician Decision|0|||
106175277|NCT02720068|366305754|FG005|Overall Study|Physician Decision|0|||
106175278|NCT02720068|366305755|FG006|Overall Study|Physician Decision|0|||
106175279|NCT02720068|366305756|FG007|Overall Study|Physician Decision|0|||
106175280|NCT02720068|366305757|FG008|Overall Study|Physician Decision|0|||
106175281|NCT02720068|366305758|FG009|Overall Study|Physician Decision|0|||
106175282|NCT02720068|366305759|FG010|Overall Study|Physician Decision|0|||
106175283|NCT02720068|366305760|FG011|Overall Study|Physician Decision|1|||
106175284|NCT02720068|366305761|FG012|Overall Study|Physician Decision|0|||
106175285|NCT02720068|366305762|FG013|Overall Study|Physician Decision|0|||
106175286|NCT02720068|366305763|FG014|Overall Study|Physician Decision|0|||
106175287|NCT02720068|366305764|FG015|Overall Study|Physician Decision|0|||
106175288|NCT02720068|366305765|FG016|Overall Study|Physician Decision|0|||
106175289|NCT02720068|366305766|FG017|Overall Study|Physician Decision|1|||
106175290|NCT02720068|366305749|FG000|Overall Study|Progressive Disease|2|||
106175291|NCT02720068|366305750|FG001|Overall Study|Progressive Disease|3|||
106175292|NCT02720068|366305751|FG002|Overall Study|Progressive Disease|1|||
106175293|NCT02720068|366305752|FG003|Overall Study|Progressive Disease|1|||
106175294|NCT02720068|366305753|FG004|Overall Study|Progressive Disease|1|||
106175295|NCT02720068|366305754|FG005|Overall Study|Progressive Disease|2|||
106175296|NCT02720068|366305755|FG006|Overall Study|Progressive Disease|1|||
106175297|NCT02720068|366305756|FG007|Overall Study|Progressive Disease|1|||
106175298|NCT02720068|366305757|FG008|Overall Study|Progressive Disease|0|||
106175299|NCT02720068|366305758|FG009|Overall Study|Progressive Disease|1|||
106175300|NCT02720068|366305759|FG010|Overall Study|Progressive Disease|0|||
106175301|NCT02720068|366305760|FG011|Overall Study|Progressive Disease|4|||
106175302|NCT02720068|366305761|FG012|Overall Study|Progressive Disease|1|||
106175303|NCT02720068|366305762|FG013|Overall Study|Progressive Disease|0|||
106175304|NCT02720068|366305763|FG014|Overall Study|Progressive Disease|0|||
106175305|NCT02720068|366305764|FG015|Overall Study|Progressive Disease|0|||
106175306|NCT02720068|366305765|FG016|Overall Study|Progressive Disease|0|||
106175307|NCT02720068|366305766|FG017|Overall Study|Progressive Disease|0|||
106175308|NCT02720068|366305749|FG000|Overall Study|Sponsor Decision|0|||
106175309|NCT02720068|366305750|FG001|Overall Study|Sponsor Decision|0|||
106175310|NCT02720068|366305751|FG002|Overall Study|Sponsor Decision|0|||
106175311|NCT02720068|366305752|FG003|Overall Study|Sponsor Decision|0|||
106175312|NCT02720068|366305753|FG004|Overall Study|Sponsor Decision|0|||
106175313|NCT02720068|366305754|FG005|Overall Study|Sponsor Decision|0|||
106175314|NCT02720068|366305755|FG006|Overall Study|Sponsor Decision|0|||
106175315|NCT02720068|366305756|FG007|Overall Study|Sponsor Decision|0|||
106175316|NCT02720068|366305757|FG008|Overall Study|Sponsor Decision|0|||
106175317|NCT02720068|366305758|FG009|Overall Study|Sponsor Decision|0|||
106175318|NCT02720068|366305759|FG010|Overall Study|Sponsor Decision|0|||
106175319|NCT02720068|366305760|FG011|Overall Study|Sponsor Decision|6|||
106175320|NCT02720068|366305761|FG012|Overall Study|Sponsor Decision|3|||
106175321|NCT02720068|366305762|FG013|Overall Study|Sponsor Decision|2|||
106175322|NCT02720068|366305763|FG014|Overall Study|Sponsor Decision|4|||
106175323|NCT02720068|366305764|FG015|Overall Study|Sponsor Decision|4|||
106175324|NCT02720068|366305765|FG016|Overall Study|Sponsor Decision|0|||
106175325|NCT02720068|366305766|FG017|Overall Study|Sponsor Decision|8|||
106175326|NCT02720068|366305749|FG000|Overall Study|Withdrawal by Subject|0|||
106175327|NCT02720068|366305750|FG001|Overall Study|Withdrawal by Subject|0|||
106175328|NCT02720068|366305751|FG002|Overall Study|Withdrawal by Subject|0|||
106175329|NCT02720068|366305752|FG003|Overall Study|Withdrawal by Subject|0|||
106175330|NCT02720068|366305753|FG004|Overall Study|Withdrawal by Subject|0|||
106175331|NCT02720068|366305754|FG005|Overall Study|Withdrawal by Subject|0|||
106175332|NCT02720068|366305755|FG006|Overall Study|Withdrawal by Subject|0|||
106175333|NCT02720068|366305756|FG007|Overall Study|Withdrawal by Subject|0|||
106175334|NCT02720068|366305757|FG008|Overall Study|Withdrawal by Subject|0|||
106175335|NCT02720068|366305758|FG009|Overall Study|Withdrawal by Subject|1|||
106175336|NCT02720068|366305759|FG010|Overall Study|Withdrawal by Subject|0|||
106175337|NCT02720068|366305760|FG011|Overall Study|Withdrawal by Subject|27|||
106175338|NCT02720068|366305761|FG012|Overall Study|Withdrawal by Subject|2|||
106175339|NCT02720068|366305762|FG013|Overall Study|Withdrawal by Subject|8|||
106175340|NCT02720068|366305763|FG014|Overall Study|Withdrawal by Subject|7|||
106175341|NCT02720068|366305764|FG015|Overall Study|Withdrawal by Subject|0|||
106175342|NCT02720068|366305765|FG016|Overall Study|Withdrawal by Subject|0|||
106175343|NCT02720068|366305766|FG017|Overall Study|Withdrawal by Subject|2|||
106175344|NCT02720068|366305749|FG000|Overall Study|Protocol Violation|0|||
106175345|NCT02720068|366305750|FG001|Overall Study|Protocol Violation|0|||
106175346|NCT02720068|366305751|FG002|Overall Study|Protocol Violation|0|||
106175347|NCT02720068|366305752|FG003|Overall Study|Protocol Violation|0|||
106175348|NCT02720068|366305753|FG004|Overall Study|Protocol Violation|0|||
106175349|NCT02720068|366305754|FG005|Overall Study|Protocol Violation|0|||
106175350|NCT02720068|366305755|FG006|Overall Study|Protocol Violation|0|||
106175351|NCT02720068|366305756|FG007|Overall Study|Protocol Violation|0|||
106175352|NCT02720068|366305757|FG008|Overall Study|Protocol Violation|0|||
106175353|NCT02720068|366305758|FG009|Overall Study|Protocol Violation|0|||
106175354|NCT02720068|366305759|FG010|Overall Study|Protocol Violation|1|||
106175355|NCT02720068|366305760|FG011|Overall Study|Protocol Violation|0|||
106175356|NCT02720068|366305761|FG012|Overall Study|Protocol Violation|0|||
106175357|NCT02720068|366305762|FG013|Overall Study|Protocol Violation|0|||
106175358|NCT02720068|366305763|FG014|Overall Study|Protocol Violation|1|||
106175359|NCT02720068|366305764|FG015|Overall Study|Protocol Violation|0|||
106175360|NCT02720068|366305765|FG016|Overall Study|Protocol Violation|1|||
106175361|NCT02720068|366305766|FG017|Overall Study|Protocol Violation|0|||
106175362|NCT02467270|366305769|FG000|Overall Study|Participants Never Treated|0|||
106175363|NCT02467270|366305770|FG001|Overall Study|Participants Never Treated|1|||
106175364|NCT02467270|366305771|FG002|Overall Study|Participants Never Treated|0|||
106175365|NCT02467270|366305769|FG000|Overall Study|Ongoing|50|||
106175366|NCT02467270|366305770|FG001|Overall Study|Ongoing|41|||
106175367|NCT02467270|366305771|FG002|Overall Study|Ongoing|43|||
106175368|NCT02467270|366305769|FG000|Overall Study|Adverse Event|16|||
105867370|NCT01473407|365164955|FG000|Overall Study|Adverse Event|8|||
106175369|NCT02467270|366305770|FG001|Overall Study|Adverse Event|15|||
106175370|NCT02467270|366305771|FG002|Overall Study|Adverse Event|14|||
106175371|NCT02467270|366305769|FG000|Overall Study|Progressive Disease|7|||
106175372|NCT02467270|366305770|FG001|Overall Study|Progressive Disease|7|||
106175373|NCT02467270|366305771|FG002|Overall Study|Progressive Disease|4|||
106175374|NCT02467270|366305769|FG000|Overall Study|Death|2|||
106175375|NCT02467270|366305770|FG001|Overall Study|Death|0|||
106175376|NCT02467270|366305771|FG002|Overall Study|Death|2|||
106175377|NCT02467270|366305769|FG000|Overall Study|Lack of Efficacy|12|||
106175378|NCT02467270|366305770|FG001|Overall Study|Lack of Efficacy|18|||
106175379|NCT02467270|366305771|FG002|Overall Study|Lack of Efficacy|23|||
106175380|NCT02467270|366305769|FG000|Overall Study|Non-compliance With Study Drug|0|||
106175381|NCT02467270|366305770|FG001|Overall Study|Non-compliance With Study Drug|2|||
106175382|NCT02467270|366305771|FG002|Overall Study|Non-compliance With Study Drug|1|||
106175383|NCT02467270|366305769|FG000|Overall Study|Lost to Follow-up|2|||
106175384|NCT02467270|366305770|FG001|Overall Study|Lost to Follow-up|1|||
106175385|NCT02467270|366305771|FG002|Overall Study|Lost to Follow-up|0|||
106175386|NCT02467270|366305769|FG000|Overall Study|Pregnancy|0|||
106175387|NCT02467270|366305770|FG001|Overall Study|Pregnancy|1|||
106175388|NCT02467270|366305771|FG002|Overall Study|Pregnancy|0|||
106175389|NCT02467270|366305769|FG000|Overall Study|Physician Decision|0|||
106175390|NCT02467270|366305770|FG001|Overall Study|Physician Decision|4|||
106175391|NCT02467270|366305771|FG002|Overall Study|Physician Decision|1|||
106175392|NCT02467270|366305769|FG000|Overall Study|Withdrawal by Subject|4|||
106175393|NCT02467270|366305770|FG001|Overall Study|Withdrawal by Subject|3|||
106175394|NCT02467270|366305771|FG002|Overall Study|Withdrawal by Subject|5|||
106175395|NCT02467270|366305769|FG000|Overall Study|Reason not Specified|1|||
106175396|NCT02467270|366305770|FG001|Overall Study|Reason not Specified|2|||
106175397|NCT02467270|366305771|FG002|Overall Study|Reason not Specified|1|||
106175398|NCT05157841|366305772|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
106175399|NCT05157841|366305773|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
106175400|NCT05157841|366305774|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
106175401|NCT05157841|366305772|FG000|Part A (14 Days)|Adverse Event|1|||
106175402|NCT05157841|366305773|FG001|Part A (14 Days)|Adverse Event|0|||
106175403|NCT05157841|366305774|FG002|Part A (14 Days)|Adverse Event|0|||
106175404|NCT05157841|366305772|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
106175405|NCT05157841|366305773|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
106175406|NCT05157841|366305774|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
106175407|NCT06262347|366305783|FG000|Overall Study|Lost to Follow-up|4|||
106175408|NCT06262347|366305784|FG001|Overall Study|Lost to Follow-up|3|||
106175409|NCT06262347|366305783|FG000|Overall Study|Withdrawal by Subject|0|||
106175410|NCT06262347|366305784|FG001|Overall Study|Withdrawal by Subject|1|||
106175411|NCT03803774|366305785|FG000|Dose Escalation|Withdrawal by Subject|0|||
106175412|NCT03803774|366305786|FG001|Dose Escalation|Withdrawal by Subject|0|||
106175413|NCT03803774|366305787|FG002|Dose Escalation|Withdrawal by Subject|0|||
106175414|NCT03803774|366305788|FG003|Dose Escalation|Withdrawal by Subject|1|||
106175415|NCT03803774|366305789|FG004|Dose Escalation|Withdrawal by Subject|0|||
106175416|NCT04408755|366305790|FG000|Period A (Placebo lead-in)|Other|11|||
106175417|NCT04408755|366305791|FG001|Period A (Placebo lead-in)|Other|0|||
106175418|NCT04408755|366305792|FG002|Period A (Placebo lead-in)|Other|0|||
106175419|NCT04408755|366305793|FG003|Period A (Placebo lead-in)|Other|0|||
106175420|NCT04408755|366305790|FG000|Period B (Randomization Period)|Adverse Event|0|||
106175421|NCT04408755|366305791|FG001|Period B (Randomization Period)|Adverse Event|3|||
106175422|NCT04408755|366305792|FG002|Period B (Randomization Period)|Adverse Event|0|||
106175423|NCT04408755|366305793|FG003|Period B (Randomization Period)|Adverse Event|1|||
106175424|NCT04408755|366305790|FG000|Period B (Randomization Period)|Death|0|||
106175425|NCT04408755|366305791|FG001|Period B (Randomization Period)|Death|0|||
106175426|NCT04408755|366305792|FG002|Period B (Randomization Period)|Death|1|||
106175427|NCT04408755|366305793|FG003|Period B (Randomization Period)|Death|0|||
106175428|NCT04408755|366305790|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
106175429|NCT04408755|366305791|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
106175430|NCT04408755|366305792|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
106175431|NCT04408755|366305793|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
106175432|NCT04408755|366305790|FG000|Period B (Randomization Period)|Physician Decision|0|||
106175433|NCT04408755|366305791|FG001|Period B (Randomization Period)|Physician Decision|0|||
106175434|NCT04408755|366305792|FG002|Period B (Randomization Period)|Physician Decision|1|||
106175435|NCT04408755|366305793|FG003|Period B (Randomization Period)|Physician Decision|0|||
106175436|NCT04408755|366305790|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
106175437|NCT04408755|366305791|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
106175438|NCT04408755|366305792|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
106175439|NCT04408755|366305793|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
106175440|NCT04408755|366305790|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
106175441|NCT04408755|366305791|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
106175442|NCT04408755|366305792|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
106175443|NCT04408755|366305793|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
106175444|NCT04408755|366305790|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
106175445|NCT04408755|366305791|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
106175446|NCT04408755|366305792|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
106175447|NCT04408755|366305793|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
106175448|NCT04408755|366305790|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
106175449|NCT04408755|366305791|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
106175450|NCT04408755|366305792|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
106175451|NCT04408755|366305793|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
106175452|NCT04408755|366305790|FG000|Period B (Randomization Period)|Reason not Specified|0|||
106175453|NCT04408755|366305791|FG001|Period B (Randomization Period)|Reason not Specified|1|||
106175454|NCT04408755|366305792|FG002|Period B (Randomization Period)|Reason not Specified|0|||
106175455|NCT04408755|366305793|FG003|Period B (Randomization Period)|Reason not Specified|2|||
106175456|NCT03872466|366305794|FG000|Overall Study|Withdrawal by Subject|1|||
106175457|NCT03872466|366305795|FG001|Overall Study|Withdrawal by Subject|0|||
106175458|NCT03872466|366305794|FG000|Overall Study|Physician Decision|2|||
106175459|NCT03872466|366305795|FG001|Overall Study|Physician Decision|0|||
106175460|NCT01778686|366305796|FG000|Overall Study|Adverse Event|0|||
106175461|NCT01778686|366305797|FG001|Overall Study|Adverse Event|0|||
106175462|NCT01778686|366305798|FG002|Overall Study|Adverse Event|1|||
106175463|NCT04012567|366305799|FG000|Overall Study|Lost to Follow-up|0|||
106175464|NCT04012567|366305800|FG001|Overall Study|Lost to Follow-up|1|||
106175465|NCT04012567|366305799|FG000|Overall Study|Withdrawal by Subject|1|||
106175466|NCT04012567|366305800|FG001|Overall Study|Withdrawal by Subject|0|||
106175467|NCT06059443|366305801|FG000|Overall Study|Withdrawal by Subject|2|||
106175468|NCT06059443|366305802|FG001|Overall Study|Withdrawal by Subject|0|||
106175469|NCT06059443|366305801|FG000|Overall Study|Lost to Follow-up|2|||
106175470|NCT06059443|366305802|FG001|Overall Study|Lost to Follow-up|2|||
106175471|NCT03512301|366306377|FG000|Overall Study|Protocol Violation|2|||
106175472|NCT03512301|366306377|FG000|Overall Study|Did Not Qualify|3|||
106175473|NCT03512301|366306377|FG000|Overall Study|Age-ineligible|1|||
106175474|NCT03512301|366306377|FG000|Overall Study|Inadequate fluency with the English language|3|||
106175475|NCT02701283|366306384|FG000|Overall Study|Death|25|||
106175476|NCT02701283|366306385|FG001|Overall Study|Death|29|||
106175477|NCT02701283|366306386|FG002|Overall Study|Death|19|||
106175478|NCT02701283|366306384|FG000|Overall Study|Lost to Follow-up|3|||
106175479|NCT02701283|366306385|FG001|Overall Study|Lost to Follow-up|8|||
106175480|NCT02701283|366306386|FG002|Overall Study|Lost to Follow-up|1|||
106175481|NCT02701283|366306384|FG000|Overall Study|Withdrawal by Subject|12|||
106175482|NCT02701283|366306385|FG001|Overall Study|Withdrawal by Subject|41|||
106175483|NCT02701283|366306386|FG002|Overall Study|Withdrawal by Subject|1|||
106175484|NCT02701283|366306384|FG000|Overall Study|Missed 2-year visit|22|||
106175485|NCT02701283|366306385|FG001|Overall Study|Missed 2-year visit|27|||
106175486|NCT02701283|366306386|FG002|Overall Study|Missed 2-year visit|0|||
106175487|NCT02701283|366306384|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
106175488|NCT02701283|366306385|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
106175489|NCT02701283|366306386|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
106175490|NCT05707351|366306387|FG000|Overall Study|Withdrawal by Subject|2|||
106175491|NCT05707351|366306387|FG000|Overall Study|Reason Not Specified|1|||
106175492|NCT01366092|366306388|FG000|Overall Study|Progressive cGVHD|2|||
106175493|NCT01366092|366306388|FG000|Overall Study|Physician Decision|1|||
106175494|NCT01366092|366306388|FG000|Overall Study|Withdrawal by Subject|1|||
106175495|NCT03142009|366306389|FG000|Overall Study|Lost to Follow-up|45|||
106175496|NCT03142009|366306390|FG001|Overall Study|Lost to Follow-up|30|||
106175497|NCT01499368|366306391|FG000|Overall Study|Did not meet I/E criteria|8|||
106175498|NCT01499368|366306392|FG001|Overall Study|Did not meet I/E criteria|4|||
106175499|NCT01499368|366306393|FG002|Overall Study|Did not meet I/E criteria|4|||
106175500|NCT01499368|366306391|FG000|Overall Study|Prohibited Concomitant medication|1|||
106175501|NCT01499368|366306392|FG001|Overall Study|Prohibited Concomitant medication|1|||
106175502|NCT01499368|366306393|FG002|Overall Study|Prohibited Concomitant medication|0|||
106175503|NCT01499368|366306391|FG000|Overall Study|Withdrawal by Subject|11|||
106175504|NCT01499368|366306392|FG001|Overall Study|Withdrawal by Subject|10|||
106175505|NCT01499368|366306393|FG002|Overall Study|Withdrawal by Subject|8|||
106175506|NCT01499368|366306391|FG000|Overall Study|Lost to Follow-up|3|||
106175507|NCT01499368|366306392|FG001|Overall Study|Lost to Follow-up|2|||
106175508|NCT01499368|366306393|FG002|Overall Study|Lost to Follow-up|5|||
106175509|NCT01499368|366306391|FG000|Overall Study|Adverse Event|4|||
106175510|NCT01499368|366306392|FG001|Overall Study|Adverse Event|0|||
106175511|NCT01499368|366306393|FG002|Overall Study|Adverse Event|2|||
106175512|NCT01499368|366306391|FG000|Overall Study|Physician Decision|0|||
106175513|NCT01499368|366306392|FG001|Overall Study|Physician Decision|1|||
106175514|NCT01499368|366306393|FG002|Overall Study|Physician Decision|0|||
106175515|NCT01499368|366306391|FG000|Overall Study|Deviation from visit window|0|||
105867371|NCT01473407|365164956|FG001|Overall Study|Adverse Event|8|||
106175516|NCT01499368|366306392|FG001|Overall Study|Deviation from visit window|0|||
106175517|NCT01499368|366306393|FG002|Overall Study|Deviation from visit window|1|||
106175518|NCT01499368|366306391|FG000|Overall Study|Error of Prescriptions|0|||
106175519|NCT01499368|366306392|FG001|Overall Study|Error of Prescriptions|0|||
106175520|NCT01499368|366306393|FG002|Overall Study|Error of Prescriptions|1|||
106175521|NCT05771467|366306395|FG000|Overall Study|Lost to Follow-up|6|||
106175522|NCT05771467|366306396|FG001|Overall Study|Lost to Follow-up|3|||
106175523|NCT02951052|366306397|FG000|Overall Study|Adverse Event|13|||
106175524|NCT02951052|366306398|FG001|Overall Study|Adverse Event|5|||
106175525|NCT02951052|366306397|FG000|Overall Study|Withdrawal by Subject|1|||
105867372|NCT01473407|365164955|FG000|Overall Study|Randomization Error|3|||
106175526|NCT02951052|366306398|FG001|Overall Study|Withdrawal by Subject|5|||
106175527|NCT02951052|366306397|FG000|Overall Study|Physician Decision|2|||
106175528|NCT02951052|366306398|FG001|Overall Study|Physician Decision|0|||
106175529|NCT02951052|366306397|FG000|Overall Study|Lost to Follow-up|1|||
106175530|NCT02951052|366306398|FG001|Overall Study|Lost to Follow-up|1|||
106175531|NCT02951052|366306397|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
106175532|NCT02951052|366306398|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
106175533|NCT02951052|366306397|FG000|Overall Study|Protocol Violation|5|||
106175534|NCT02951052|366306398|FG001|Overall Study|Protocol Violation|3|||
106175535|NCT02951052|366306397|FG000|Overall Study|Lack of Efficacy|3|||
106175536|NCT02951052|366306398|FG001|Overall Study|Lack of Efficacy|4|||
106175537|NCT02951052|366306397|FG000|Overall Study|Ongoing|1|||
106175538|NCT02951052|366306398|FG001|Overall Study|Ongoing|0|||
106175539|NCT01265537|366306403|FG000|Overall Study|Adverse Event|2|||
106175540|NCT01265537|366306404|FG001|Overall Study|Adverse Event|1|||
106175541|NCT01265537|366306403|FG000|Overall Study|Physician Decision|0|||
106175542|NCT01265537|366306404|FG001|Overall Study|Physician Decision|1|||
106175543|NCT00994643|366307419|FG000|Overall Study|Withdrawal by Subject|1|||
106175544|NCT04595331|366307420|FG000|Overall Study|Withdrawal by Subject|0|||
106175545|NCT04595331|366307421|FG001|Overall Study|Withdrawal by Subject|1|||
106175546|NCT04595331|366307420|FG000|Overall Study|Lost to Follow-up|0|||
106175547|NCT04595331|366307421|FG001|Overall Study|Lost to Follow-up|5|||
106175548|NCT04595331|366307420|FG000|Overall Study|Medical reason|0|||
106175549|NCT04595331|366307421|FG001|Overall Study|Medical reason|1|||
106175550|NCT02611687|366307424|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
106175551|NCT02611687|366307425|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
106175552|NCT03705793|366307429|FG000|Overall Study|Lost to Follow-up|3|||
106175553|NCT03705793|366307430|FG001|Overall Study|Lost to Follow-up|4|||
106175554|NCT03705793|366307429|FG000|Overall Study|Withdrawal by Subject|2|||
106175555|NCT03705793|366307430|FG001|Overall Study|Withdrawal by Subject|1|||
106175556|NCT02719574|366307431|FG000|Phase 1 (Dose Escalation)|Other|0|||
106175557|NCT02719574|366307432|FG001|Phase 1 (Dose Escalation)|Other|2|||
106175558|NCT02719574|366307433|FG002|Phase 1 (Dose Escalation)|Other|1|||
106175559|NCT02719574|366307434|FG003|Phase 1 (Dose Escalation)|Other|2|||
106175560|NCT02719574|366307435|FG004|Phase 1 (Dose Escalation)|Other|2|||
106175561|NCT02719574|366307436|FG005|Phase 1 (Dose Escalation)|Other|0|||
106175562|NCT02719574|366307437|FG006|Phase 1 (Dose Escalation)|Other|0|||
106175563|NCT02719574|366307438|FG007|Phase 1 (Dose Escalation)|Other|0|||
106175564|NCT02719574|366307439|FG008|Phase 1 (Dose Escalation)|Other|0|||
106175565|NCT02719574|366307440|FG009|Phase 1 (Dose Escalation)|Other|0|||
106175566|NCT02719574|366307441|FG010|Phase 1 (Dose Escalation)|Other|0|||
106175567|NCT02719574|366307442|FG011|Phase 1 (Dose Escalation)|Other|0|||
106175568|NCT02719574|366307443|FG012|Phase 1 (Dose Escalation)|Other|0|||
106175569|NCT02719574|366307444|FG013|Phase 1 (Dose Escalation)|Other|0|||
106175570|NCT02719574|366307445|FG014|Phase 1 (Dose Escalation)|Other|0|||
106175571|NCT02719574|366307446|FG015|Phase 1 (Dose Escalation)|Other|0|||
106175572|NCT02719574|366307447|FG016|Phase 1 (Dose Escalation)|Other|0|||
106175573|NCT02719574|366307431|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
106175574|NCT02719574|366307432|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
106175575|NCT02719574|366307433|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
106175576|NCT02719574|366307434|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
106175577|NCT02719574|366307435|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
106175578|NCT02719574|366307436|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
106175579|NCT02719574|366307437|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175580|NCT02719574|366307438|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175581|NCT02719574|366307439|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175582|NCT02719574|366307440|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175583|NCT02719574|366307441|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175584|NCT02719574|366307442|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175585|NCT02719574|366307443|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175586|NCT02719574|366307444|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175587|NCT02719574|366307445|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175588|NCT02719574|366307446|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175589|NCT02719574|366307447|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
106175590|NCT02719574|366307431|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175591|NCT02719574|366307432|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
106175592|NCT02719574|366307433|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
106175593|NCT02719574|366307434|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175594|NCT02719574|366307435|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
106175595|NCT02719574|366307436|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
106175596|NCT02719574|366307437|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175597|NCT02719574|366307438|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175598|NCT02719574|366307439|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175599|NCT02719574|366307440|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175600|NCT02719574|366307441|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175601|NCT02719574|366307442|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175602|NCT02719574|366307443|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175603|NCT02719574|366307444|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175604|NCT02719574|366307445|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175605|NCT02719574|366307446|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175606|NCT02719574|366307447|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
106175607|NCT02719574|366307431|FG000|Phase 1 (Dose Escalation)|Death|2|||
106175608|NCT02719574|366307432|FG001|Phase 1 (Dose Escalation)|Death|1|||
106175609|NCT02719574|366307433|FG002|Phase 1 (Dose Escalation)|Death|1|||
106175610|NCT02719574|366307434|FG003|Phase 1 (Dose Escalation)|Death|0|||
106175611|NCT02719574|366307435|FG004|Phase 1 (Dose Escalation)|Death|0|||
106175612|NCT02719574|366307436|FG005|Phase 1 (Dose Escalation)|Death|0|||
106175613|NCT02719574|366307437|FG006|Phase 1 (Dose Escalation)|Death|0|||
106175614|NCT02719574|366307438|FG007|Phase 1 (Dose Escalation)|Death|0|||
106175615|NCT02719574|366307439|FG008|Phase 1 (Dose Escalation)|Death|0|||
106175616|NCT02719574|366307440|FG009|Phase 1 (Dose Escalation)|Death|0|||
106175617|NCT02719574|366307441|FG010|Phase 1 (Dose Escalation)|Death|0|||
106175618|NCT02719574|366307442|FG011|Phase 1 (Dose Escalation)|Death|0|||
106175619|NCT02719574|366307443|FG012|Phase 1 (Dose Escalation)|Death|0|||
106175620|NCT02719574|366307444|FG013|Phase 1 (Dose Escalation)|Death|0|||
106175621|NCT02719574|366307445|FG014|Phase 1 (Dose Escalation)|Death|0|||
106175622|NCT02719574|366307446|FG015|Phase 1 (Dose Escalation)|Death|0|||
106175623|NCT02719574|366307447|FG016|Phase 1 (Dose Escalation)|Death|0|||
106175624|NCT02719574|366307431|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175625|NCT02719574|366307432|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
106175626|NCT02719574|366307433|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175627|NCT02719574|366307434|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175628|NCT02719574|366307435|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
106175629|NCT02719574|366307436|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
106175630|NCT02719574|366307437|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175631|NCT02719574|366307438|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175632|NCT02719574|366307439|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175633|NCT02719574|366307440|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175634|NCT02719574|366307441|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175635|NCT02719574|366307442|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175636|NCT02719574|366307443|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175637|NCT02719574|366307444|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175638|NCT02719574|366307445|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175639|NCT02719574|366307446|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175640|NCT02719574|366307447|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
106175641|NCT02719574|366307431|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175642|NCT02719574|366307432|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175643|NCT02719574|366307433|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175644|NCT02719574|366307434|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175645|NCT02719574|366307435|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
106175646|NCT02719574|366307436|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
106175647|NCT02719574|366307437|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175648|NCT02719574|366307438|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175649|NCT02719574|366307439|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175650|NCT02719574|366307440|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175651|NCT02719574|366307441|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175652|NCT02719574|366307442|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175653|NCT02719574|366307443|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175654|NCT02719574|366307444|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175655|NCT02719574|366307445|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175656|NCT02719574|366307446|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175657|NCT02719574|366307447|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
106175658|NCT02719574|366307431|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175659|NCT02719574|366307432|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175660|NCT02719574|366307433|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
106175661|NCT02719574|366307434|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175662|NCT02719574|366307435|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175663|NCT02719574|366307436|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175664|NCT02719574|366307437|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175665|NCT02719574|366307438|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175666|NCT02719574|366307439|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175667|NCT02719574|366307440|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175668|NCT02719574|366307441|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175669|NCT02719574|366307442|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175670|NCT02719574|366307443|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175671|NCT02719574|366307444|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175672|NCT02719574|366307445|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175673|NCT02719574|366307446|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175674|NCT02719574|366307447|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
106175675|NCT02719574|366307431|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175676|NCT02719574|366307432|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175677|NCT02719574|366307433|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175678|NCT02719574|366307434|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175679|NCT02719574|366307435|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175680|NCT02719574|366307436|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175681|NCT02719574|366307437|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
106175682|NCT02719574|366307438|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
106175683|NCT02719574|366307439|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
106175684|NCT02719574|366307440|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175685|NCT02719574|366307441|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175686|NCT02719574|366307442|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175687|NCT02719574|366307443|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175688|NCT02719574|366307444|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175689|NCT02719574|366307445|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175690|NCT02719574|366307446|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175691|NCT02719574|366307447|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
106175692|NCT02719574|366307431|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175693|NCT02719574|366307432|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175694|NCT02719574|366307433|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175695|NCT02719574|366307434|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175696|NCT02719574|366307435|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175697|NCT02719574|366307436|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175698|NCT02719574|366307437|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
106175699|NCT02719574|366307438|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
106175700|NCT02719574|366307439|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175701|NCT02719574|366307440|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175702|NCT02719574|366307441|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175703|NCT02719574|366307442|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175704|NCT02719574|366307443|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175705|NCT02719574|366307444|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175706|NCT02719574|366307445|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175707|NCT02719574|366307446|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175708|NCT02719574|366307447|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
106175709|NCT02719574|366307431|FG000|Phase 1 (Dose Expansion)|Death|0|||
106175710|NCT02719574|366307432|FG001|Phase 1 (Dose Expansion)|Death|0|||
106175711|NCT02719574|366307433|FG002|Phase 1 (Dose Expansion)|Death|0|||
106175712|NCT02719574|366307434|FG003|Phase 1 (Dose Expansion)|Death|0|||
106175713|NCT02719574|366307435|FG004|Phase 1 (Dose Expansion)|Death|0|||
106175714|NCT02719574|366307436|FG005|Phase 1 (Dose Expansion)|Death|0|||
106175715|NCT02719574|366307437|FG006|Phase 1 (Dose Expansion)|Death|1|||
106175716|NCT02719574|366307438|FG007|Phase 1 (Dose Expansion)|Death|6|||
106175717|NCT02719574|366307439|FG008|Phase 1 (Dose Expansion)|Death|0|||
106175718|NCT02719574|366307440|FG009|Phase 1 (Dose Expansion)|Death|0|||
106175719|NCT02719574|366307441|FG010|Phase 1 (Dose Expansion)|Death|0|||
106175720|NCT02719574|366307442|FG011|Phase 1 (Dose Expansion)|Death|0|||
106175721|NCT02719574|366307443|FG012|Phase 1 (Dose Expansion)|Death|0|||
106175722|NCT02719574|366307444|FG013|Phase 1 (Dose Expansion)|Death|0|||
106175723|NCT02719574|366307445|FG014|Phase 1 (Dose Expansion)|Death|0|||
106175724|NCT02719574|366307446|FG015|Phase 1 (Dose Expansion)|Death|0|||
106175725|NCT02719574|366307447|FG016|Phase 1 (Dose Expansion)|Death|0|||
106175726|NCT02719574|366307431|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175727|NCT02719574|366307432|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175728|NCT02719574|366307433|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175729|NCT02719574|366307434|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175730|NCT02719574|366307435|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175731|NCT02719574|366307436|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175732|NCT02719574|366307437|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
106175733|NCT02719574|366307438|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
106175734|NCT02719574|366307439|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175735|NCT02719574|366307440|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175736|NCT02719574|366307441|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175737|NCT02719574|366307442|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175738|NCT02719574|366307443|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175739|NCT02719574|366307444|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175740|NCT02719574|366307445|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175741|NCT02719574|366307446|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175742|NCT02719574|366307447|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
106175743|NCT02719574|366307431|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175744|NCT02719574|366307432|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175745|NCT02719574|366307433|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175746|NCT02719574|366307434|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175747|NCT02719574|366307435|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175748|NCT02719574|366307436|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175749|NCT02719574|366307437|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
106175750|NCT02719574|366307438|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
106175751|NCT02719574|366307439|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175752|NCT02719574|366307440|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175753|NCT02719574|366307441|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175754|NCT02719574|366307442|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175755|NCT02719574|366307443|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175756|NCT02719574|366307444|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175757|NCT02719574|366307445|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175758|NCT02719574|366307446|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175759|NCT02719574|366307447|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
106175760|NCT02719574|366307431|FG000|Phase 1 (Dose Expansion)|Other|0|||
106175761|NCT02719574|366307432|FG001|Phase 1 (Dose Expansion)|Other|0|||
106175762|NCT02719574|366307433|FG002|Phase 1 (Dose Expansion)|Other|0|||
106175763|NCT02719574|366307434|FG003|Phase 1 (Dose Expansion)|Other|0|||
106175764|NCT02719574|366307435|FG004|Phase 1 (Dose Expansion)|Other|0|||
106175765|NCT02719574|366307436|FG005|Phase 1 (Dose Expansion)|Other|0|||
106175766|NCT02719574|366307437|FG006|Phase 1 (Dose Expansion)|Other|1|||
106175767|NCT02719574|366307438|FG007|Phase 1 (Dose Expansion)|Other|7|||
106175768|NCT02719574|366307439|FG008|Phase 1 (Dose Expansion)|Other|0|||
106175769|NCT02719574|366307440|FG009|Phase 1 (Dose Expansion)|Other|0|||
106175770|NCT02719574|366307441|FG010|Phase 1 (Dose Expansion)|Other|0|||
106175771|NCT02719574|366307442|FG011|Phase 1 (Dose Expansion)|Other|0|||
106175772|NCT02719574|366307443|FG012|Phase 1 (Dose Expansion)|Other|0|||
106175773|NCT02719574|366307444|FG013|Phase 1 (Dose Expansion)|Other|0|||
106175774|NCT02719574|366307445|FG014|Phase 1 (Dose Expansion)|Other|0|||
106175775|NCT02719574|366307446|FG015|Phase 1 (Dose Expansion)|Other|0|||
106175776|NCT02719574|366307447|FG016|Phase 1 (Dose Expansion)|Other|0|||
106175777|NCT02719574|366307431|FG000|Phase 2|Protocol Defined Disease Progression|0|||
106175778|NCT02719574|366307432|FG001|Phase 2|Protocol Defined Disease Progression|0|||
106175779|NCT02719574|366307433|FG002|Phase 2|Protocol Defined Disease Progression|0|||
106175780|NCT02719574|366307434|FG003|Phase 2|Protocol Defined Disease Progression|0|||
106175781|NCT02719574|366307435|FG004|Phase 2|Protocol Defined Disease Progression|0|||
106175782|NCT02719574|366307436|FG005|Phase 2|Protocol Defined Disease Progression|0|||
106175783|NCT02719574|366307437|FG006|Phase 2|Protocol Defined Disease Progression|0|||
106175784|NCT02719574|366307438|FG007|Phase 2|Protocol Defined Disease Progression|0|||
106175785|NCT02719574|366307439|FG008|Phase 2|Protocol Defined Disease Progression|0|||
106175786|NCT02719574|366307440|FG009|Phase 2|Protocol Defined Disease Progression|65|||
106175787|NCT02719574|366307441|FG010|Phase 2|Protocol Defined Disease Progression|8|||
106175788|NCT02719574|366307442|FG011|Phase 2|Protocol Defined Disease Progression|2|||
106175789|NCT02719574|366307443|FG012|Phase 2|Protocol Defined Disease Progression|4|||
106175790|NCT02719574|366307444|FG013|Phase 2|Protocol Defined Disease Progression|9|||
106175791|NCT02719574|366307445|FG014|Phase 2|Protocol Defined Disease Progression|11|||
106175792|NCT02719574|366307446|FG015|Phase 2|Protocol Defined Disease Progression|3|||
106175793|NCT02719574|366307447|FG016|Phase 2|Protocol Defined Disease Progression|4|||
106175794|NCT02719574|366307431|FG000|Phase 2|Adverse Event|0|||
106175795|NCT02719574|366307432|FG001|Phase 2|Adverse Event|0|||
106175796|NCT02719574|366307433|FG002|Phase 2|Adverse Event|0|||
106175797|NCT02719574|366307434|FG003|Phase 2|Adverse Event|0|||
106175798|NCT02719574|366307435|FG004|Phase 2|Adverse Event|0|||
106175799|NCT02719574|366307436|FG005|Phase 2|Adverse Event|0|||
106175800|NCT02719574|366307437|FG006|Phase 2|Adverse Event|0|||
106175801|NCT02719574|366307438|FG007|Phase 2|Adverse Event|0|||
106175802|NCT02719574|366307439|FG008|Phase 2|Adverse Event|0|||
106175803|NCT02719574|366307440|FG009|Phase 2|Adverse Event|27|||
106175804|NCT02719574|366307441|FG010|Phase 2|Adverse Event|0|||
106175805|NCT02719574|366307442|FG011|Phase 2|Adverse Event|1|||
106175806|NCT02719574|366307443|FG012|Phase 2|Adverse Event|1|||
106175807|NCT02719574|366307444|FG013|Phase 2|Adverse Event|1|||
106175808|NCT02719574|366307445|FG014|Phase 2|Adverse Event|2|||
106175809|NCT02719574|366307446|FG015|Phase 2|Adverse Event|2|||
106175810|NCT02719574|366307447|FG016|Phase 2|Adverse Event|3|||
106175811|NCT02719574|366307431|FG000|Phase 2|Other|0|||
106175812|NCT02719574|366307432|FG001|Phase 2|Other|0|||
106175813|NCT02719574|366307433|FG002|Phase 2|Other|0|||
106175814|NCT02719574|366307434|FG003|Phase 2|Other|0|||
106175815|NCT02719574|366307435|FG004|Phase 2|Other|0|||
106175816|NCT02719574|366307436|FG005|Phase 2|Other|0|||
106175817|NCT02719574|366307437|FG006|Phase 2|Other|0|||
106175818|NCT02719574|366307438|FG007|Phase 2|Other|0|||
106175819|NCT02719574|366307439|FG008|Phase 2|Other|0|||
106175820|NCT02719574|366307440|FG009|Phase 2|Other|20|||
106175821|NCT02719574|366307441|FG010|Phase 2|Other|7|||
106175822|NCT02719574|366307442|FG011|Phase 2|Other|0|||
106175823|NCT02719574|366307443|FG012|Phase 2|Other|5|||
106175824|NCT02719574|366307444|FG013|Phase 2|Other|7|||
106175825|NCT02719574|366307445|FG014|Phase 2|Other|0|||
106175826|NCT02719574|366307446|FG015|Phase 2|Other|1|||
106175827|NCT02719574|366307447|FG016|Phase 2|Other|4|||
106175828|NCT02719574|366307431|FG000|Phase 2|Transplant|0|||
106175829|NCT02719574|366307432|FG001|Phase 2|Transplant|0|||
106175830|NCT02719574|366307433|FG002|Phase 2|Transplant|0|||
106175831|NCT02719574|366307434|FG003|Phase 2|Transplant|0|||
106175832|NCT02719574|366307435|FG004|Phase 2|Transplant|0|||
106175833|NCT02719574|366307436|FG005|Phase 2|Transplant|0|||
106175834|NCT02719574|366307437|FG006|Phase 2|Transplant|0|||
106175835|NCT02719574|366307438|FG007|Phase 2|Transplant|0|||
106175836|NCT02719574|366307439|FG008|Phase 2|Transplant|0|||
106175837|NCT02719574|366307440|FG009|Phase 2|Transplant|15|||
106175838|NCT02719574|366307441|FG010|Phase 2|Transplant|2|||
106175839|NCT02719574|366307442|FG011|Phase 2|Transplant|0|||
106175840|NCT02719574|366307443|FG012|Phase 2|Transplant|6|||
106175841|NCT02719574|366307444|FG013|Phase 2|Transplant|1|||
106175842|NCT02719574|366307445|FG014|Phase 2|Transplant|1|||
106175843|NCT02719574|366307446|FG015|Phase 2|Transplant|0|||
106175844|NCT02719574|366307447|FG016|Phase 2|Transplant|0|||
106175845|NCT02719574|366307431|FG000|Phase 2|Death|0|||
106175846|NCT02719574|366307432|FG001|Phase 2|Death|0|||
106175847|NCT02719574|366307433|FG002|Phase 2|Death|0|||
106175848|NCT02719574|366307434|FG003|Phase 2|Death|0|||
106175849|NCT02719574|366307435|FG004|Phase 2|Death|0|||
106175850|NCT02719574|366307436|FG005|Phase 2|Death|0|||
106175851|NCT02719574|366307437|FG006|Phase 2|Death|0|||
106175852|NCT02719574|366307438|FG007|Phase 2|Death|0|||
106175853|NCT02719574|366307439|FG008|Phase 2|Death|0|||
106175854|NCT02719574|366307440|FG009|Phase 2|Death|14|||
106175855|NCT02719574|366307441|FG010|Phase 2|Death|0|||
106175856|NCT02719574|366307442|FG011|Phase 2|Death|0|||
106175857|NCT02719574|366307443|FG012|Phase 2|Death|1|||
106175858|NCT02719574|366307444|FG013|Phase 2|Death|1|||
106175859|NCT02719574|366307445|FG014|Phase 2|Death|2|||
106175860|NCT02719574|366307446|FG015|Phase 2|Death|0|||
106175861|NCT02719574|366307447|FG016|Phase 2|Death|0|||
106175862|NCT02719574|366307431|FG000|Phase 2|Investigator Decision|0|||
106175863|NCT02719574|366307432|FG001|Phase 2|Investigator Decision|0|||
106175864|NCT02719574|366307433|FG002|Phase 2|Investigator Decision|0|||
106175865|NCT02719574|366307434|FG003|Phase 2|Investigator Decision|0|||
106175866|NCT02719574|366307435|FG004|Phase 2|Investigator Decision|0|||
106175867|NCT02719574|366307436|FG005|Phase 2|Investigator Decision|0|||
106175868|NCT02719574|366307437|FG006|Phase 2|Investigator Decision|0|||
106175869|NCT02719574|366307438|FG007|Phase 2|Investigator Decision|0|||
106175870|NCT02719574|366307439|FG008|Phase 2|Investigator Decision|0|||
106175871|NCT02719574|366307440|FG009|Phase 2|Investigator Decision|6|||
106175872|NCT02719574|366307441|FG010|Phase 2|Investigator Decision|1|||
106175873|NCT02719574|366307442|FG011|Phase 2|Investigator Decision|2|||
106175874|NCT02719574|366307443|FG012|Phase 2|Investigator Decision|3|||
106175875|NCT02719574|366307444|FG013|Phase 2|Investigator Decision|1|||
106175876|NCT02719574|366307445|FG014|Phase 2|Investigator Decision|3|||
106175877|NCT02719574|366307446|FG015|Phase 2|Investigator Decision|2|||
106175878|NCT02719574|366307447|FG016|Phase 2|Investigator Decision|0|||
106175879|NCT02719574|366307431|FG000|Phase 2|Withdrawal by Subject|0|||
106175880|NCT02719574|366307432|FG001|Phase 2|Withdrawal by Subject|0|||
106175881|NCT02719574|366307433|FG002|Phase 2|Withdrawal by Subject|0|||
106175882|NCT02719574|366307434|FG003|Phase 2|Withdrawal by Subject|0|||
106175883|NCT02719574|366307435|FG004|Phase 2|Withdrawal by Subject|0|||
106175884|NCT02719574|366307436|FG005|Phase 2|Withdrawal by Subject|0|||
106175885|NCT02719574|366307437|FG006|Phase 2|Withdrawal by Subject|0|||
106175886|NCT02719574|366307438|FG007|Phase 2|Withdrawal by Subject|0|||
106175887|NCT02719574|366307439|FG008|Phase 2|Withdrawal by Subject|0|||
106175888|NCT02719574|366307440|FG009|Phase 2|Withdrawal by Subject|5|||
106175889|NCT02719574|366307441|FG010|Phase 2|Withdrawal by Subject|0|||
106175890|NCT02719574|366307442|FG011|Phase 2|Withdrawal by Subject|0|||
106175891|NCT02719574|366307443|FG012|Phase 2|Withdrawal by Subject|0|||
106175892|NCT02719574|366307444|FG013|Phase 2|Withdrawal by Subject|1|||
106175893|NCT02719574|366307445|FG014|Phase 2|Withdrawal by Subject|1|||
106175894|NCT02719574|366307446|FG015|Phase 2|Withdrawal by Subject|2|||
106175895|NCT02719574|366307447|FG016|Phase 2|Withdrawal by Subject|0|||
106175896|NCT02719574|366307431|FG000|Phase 2|Protocol Violation|0|||
106175897|NCT02719574|366307432|FG001|Phase 2|Protocol Violation|0|||
106175898|NCT02719574|366307433|FG002|Phase 2|Protocol Violation|0|||
106175899|NCT02719574|366307434|FG003|Phase 2|Protocol Violation|0|||
106175900|NCT02719574|366307435|FG004|Phase 2|Protocol Violation|0|||
106175901|NCT02719574|366307436|FG005|Phase 2|Protocol Violation|0|||
106175902|NCT02719574|366307437|FG006|Phase 2|Protocol Violation|0|||
106175903|NCT02719574|366307438|FG007|Phase 2|Protocol Violation|0|||
106175904|NCT02719574|366307439|FG008|Phase 2|Protocol Violation|0|||
106175905|NCT02719574|366307440|FG009|Phase 2|Protocol Violation|1|||
106175906|NCT02719574|366307441|FG010|Phase 2|Protocol Violation|0|||
106175907|NCT02719574|366307442|FG011|Phase 2|Protocol Violation|0|||
106175908|NCT02719574|366307443|FG012|Phase 2|Protocol Violation|0|||
106175909|NCT02719574|366307444|FG013|Phase 2|Protocol Violation|0|||
106175910|NCT02719574|366307445|FG014|Phase 2|Protocol Violation|0|||
106175911|NCT02719574|366307446|FG015|Phase 2|Protocol Violation|0|||
106175912|NCT02719574|366307447|FG016|Phase 2|Protocol Violation|0|||
106175913|NCT00113360|366307451|FG000|Overall Study|Adverse Event|3|||
106175914|NCT00113360|366307451|FG000|Overall Study|Subject required surgery|1|||
106175915|NCT00113360|366307451|FG000|Overall Study|Did not meet eligibility criteria|3|||
106175916|NCT03635567|366307452|FG000|Overall Study|Lost to Follow-up|4|||
106175917|NCT03635567|366307453|FG001|Overall Study|Lost to Follow-up|1|||
106175918|NCT03635567|366307452|FG000|Overall Study|Withdrawal by Subject|11|||
106175919|NCT03635567|366307453|FG001|Overall Study|Withdrawal by Subject|16|||
106175920|NCT03635567|366307452|FG000|Overall Study|Sponsor Decision|99|||
106175921|NCT03635567|366307453|FG001|Overall Study|Sponsor Decision|57|||
106175922|NCT03635567|366307452|FG000|Overall Study|Death|194|||
106175923|NCT03635567|366307453|FG001|Overall Study|Death|235|||
106175924|NCT00495677|366307454|FG000|Stage 1 (25 Days)|Adverse Event|0|||
106175925|NCT00495677|366307455|FG001|Stage 1 (25 Days)|Adverse Event|0|||
106175926|NCT00495677|366307456|FG002|Stage 1 (25 Days)|Adverse Event|1|||
106175927|NCT00495677|366307457|FG003|Stage 1 (25 Days)|Adverse Event|0|||
106175928|NCT00495677|366307458|FG004|Stage 1 (25 Days)|Adverse Event|0|||
106175929|NCT00495677|366307459|FG005|Stage 1 (25 Days)|Adverse Event|0|||
106175930|NCT00495677|366307460|FG006|Stage 1 (25 Days)|Adverse Event|0|||
106175931|NCT03875313|366307461|FG000|Overall Study|Withdrawal by Subject|1|||
106175932|NCT03875313|366307462|FG001|Overall Study|Withdrawal by Subject|3|||
106175933|NCT03875313|366307463|FG002|Overall Study|Withdrawal by Subject|0|||
106175934|NCT03875313|366307464|FG003|Overall Study|Withdrawal by Subject|0|||
106175935|NCT03875313|366307465|FG004|Overall Study|Withdrawal by Subject|0|||
106175936|NCT03875313|366307461|FG000|Overall Study|Death|0|||
106175937|NCT03875313|366307462|FG001|Overall Study|Death|0|||
106175938|NCT03875313|366307463|FG002|Overall Study|Death|0|||
106175939|NCT03875313|366307464|FG003|Overall Study|Death|0|||
106175940|NCT03875313|366307465|FG004|Overall Study|Death|1|||
106175941|NCT03875313|366307461|FG000|Overall Study|Lost to Follow-up|0|||
106175942|NCT03875313|366307462|FG001|Overall Study|Lost to Follow-up|0|||
106175943|NCT03875313|366307463|FG002|Overall Study|Lost to Follow-up|0|||
106175944|NCT03875313|366307464|FG003|Overall Study|Lost to Follow-up|0|||
106175945|NCT03875313|366307465|FG004|Overall Study|Lost to Follow-up|1|||
106175946|NCT03875313|366307461|FG000|Overall Study|Study Termination by Sponsor|0|||
106175947|NCT03875313|366307462|FG001|Overall Study|Study Termination by Sponsor|1|||
106175948|NCT03875313|366307463|FG002|Overall Study|Study Termination by Sponsor|1|||
106175949|NCT03875313|366307464|FG003|Overall Study|Study Termination by Sponsor|0|||
106175950|NCT03875313|366307465|FG004|Overall Study|Study Termination by Sponsor|1|||
106175951|NCT03875313|366307461|FG000|Overall Study|New Anticancer Treatment|0|||
106175952|NCT03875313|366307462|FG001|Overall Study|New Anticancer Treatment|1|||
106175953|NCT03875313|366307463|FG002|Overall Study|New Anticancer Treatment|2|||
106175954|NCT03875313|366307464|FG003|Overall Study|New Anticancer Treatment|1|||
106175955|NCT03875313|366307465|FG004|Overall Study|New Anticancer Treatment|0|||
106175956|NCT03875313|366307461|FG000|Overall Study|Other, Not Specified|2|||
106175957|NCT03875313|366307462|FG001|Overall Study|Other, Not Specified|11|||
106175958|NCT03875313|366307463|FG002|Overall Study|Other, Not Specified|3|||
106175959|NCT03875313|366307464|FG003|Overall Study|Other, Not Specified|3|||
106175960|NCT03875313|366307465|FG004|Overall Study|Other, Not Specified|1|||
106175961|NCT03868930|366307466|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
106175962|NCT03868930|366307467|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
106175963|NCT03868930|366307466|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
106175964|NCT03868930|366307467|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
106175965|NCT03868930|366307466|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
106175966|NCT03868930|366307467|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
106175967|NCT03868930|366307466|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
106175968|NCT03868930|366307467|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
106175969|NCT03868930|366307466|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
106175970|NCT03868930|366307467|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
106175971|NCT01046825|366307469|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
106175972|NCT01046825|366307470|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
106175973|NCT01046825|366307471|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
106175974|NCT01046825|366307472|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
106175975|NCT01046825|366307473|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
106175976|NCT01046825|366307469|FG000|Overall Study|Physician Decision|0|||
106175977|NCT01046825|366307470|FG001|Overall Study|Physician Decision|1|||
106175978|NCT01046825|366307471|FG002|Overall Study|Physician Decision|2|||
106175979|NCT01046825|366307472|FG003|Overall Study|Physician Decision|0|||
106175980|NCT01046825|366307473|FG004|Overall Study|Physician Decision|0|||
106175981|NCT01046825|366307469|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
106175982|NCT01046825|366307470|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
106175983|NCT01046825|366307471|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
106175984|NCT01046825|366307472|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
106175985|NCT01046825|366307473|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
106175986|NCT01046825|366307469|FG000|Overall Study|Found to be ineligible|0|||
106175987|NCT01046825|366307470|FG001|Overall Study|Found to be ineligible|1|||
106175988|NCT01046825|366307471|FG002|Overall Study|Found to be ineligible|0|||
106175989|NCT01046825|366307472|FG003|Overall Study|Found to be ineligible|0|||
106175990|NCT01046825|366307473|FG004|Overall Study|Found to be ineligible|0|||
106175991|NCT01046825|366307469|FG000|Overall Study|Death|0|||
106175992|NCT01046825|366307470|FG001|Overall Study|Death|0|||
106175993|NCT01046825|366307471|FG002|Overall Study|Death|0|||
106175994|NCT01046825|366307472|FG003|Overall Study|Death|1|||
106175995|NCT01046825|366307473|FG004|Overall Study|Death|0|||
106175996|NCT01046825|366307469|FG000|Overall Study|Did not submit biology samples|0|||
106175997|NCT01046825|366307470|FG001|Overall Study|Did not submit biology samples|0|||
106175998|NCT01046825|366307471|FG002|Overall Study|Did not submit biology samples|0|||
106175999|NCT01046825|366307472|FG003|Overall Study|Did not submit biology samples|0|||
106176000|NCT01046825|366307473|FG004|Overall Study|Did not submit biology samples|13|||
106176001|NCT04933474|366307475|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
106176002|NCT04933474|366307476|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
106176003|NCT04933474|366307475|FG000|Overall Study|Lost to Follow-up|19|||
106176004|NCT04933474|366307476|FG001|Overall Study|Lost to Follow-up|9|||
106176005|NCT04933474|366307475|FG000|Overall Study|Life Burden - unable to participate|6|||
106176006|NCT04933474|366307476|FG001|Overall Study|Life Burden - unable to participate|2|||
106176007|NCT04933474|366307475|FG000|Overall Study|Disease Burden - unable to participate|4|||
106176008|NCT04933474|366307476|FG001|Overall Study|Disease Burden - unable to participate|1|||
106176009|NCT04933474|366307475|FG000|Overall Study|Surgery/Hospitalization|1|||
106176010|NCT04933474|366307476|FG001|Overall Study|Surgery/Hospitalization|2|||
106176011|NCT04933474|366307475|FG000|Overall Study|Dissatisfied with Intervention|1|||
106176012|NCT04933474|366307476|FG001|Overall Study|Dissatisfied with Intervention|1|||
106176013|NCT04933474|366307475|FG000|Overall Study|Withdrew interest in participation|1|||
106176014|NCT04933474|366307476|FG001|Overall Study|Withdrew interest in participation|0|||
106176015|NCT04933474|366307475|FG000|Overall Study|Had previously enrolled in the study|0|||
106176016|NCT04933474|366307476|FG001|Overall Study|Had previously enrolled in the study|1|||
106176017|NCT04993677|366307477|FG000|Overall Study|Lost to Follow-up|1|||
106176018|NCT04993677|366307478|FG001|Overall Study|Lost to Follow-up|0|||
106176019|NCT04993677|366307479|FG002|Overall Study|Lost to Follow-up|0|||
106176020|NCT04993677|366307480|FG003|Overall Study|Lost to Follow-up|0|||
106176021|NCT04993677|366307477|FG000|Overall Study|Death|11|||
106176022|NCT04993677|366307478|FG001|Overall Study|Death|8|||
106176023|NCT04993677|366307479|FG002|Overall Study|Death|3|||
106176024|NCT04993677|366307480|FG003|Overall Study|Death|1|||
106176025|NCT04993677|366307477|FG000|Overall Study|Subject withdrawal of consent|4|||
106176026|NCT04993677|366307478|FG001|Overall Study|Subject withdrawal of consent|3|||
106176027|NCT04993677|366307479|FG002|Overall Study|Subject withdrawal of consent|0|||
106176028|NCT04993677|366307480|FG003|Overall Study|Subject withdrawal of consent|2|||
106176029|NCT04993677|366307477|FG000|Overall Study|Study termination by sponsor|3|||
106176030|NCT04993677|366307478|FG001|Overall Study|Study termination by sponsor|25|||
106176031|NCT04993677|366307479|FG002|Overall Study|Study termination by sponsor|3|||
106176032|NCT04993677|366307480|FG003|Overall Study|Study termination by sponsor|3|||
106176033|NCT04993677|366307477|FG000|Overall Study|Other|2|||
106176034|NCT04993677|366307478|FG001|Overall Study|Other|3|||
106176035|NCT04993677|366307479|FG002|Overall Study|Other|3|||
106176036|NCT04993677|366307480|FG003|Overall Study|Other|2|||
106176037|NCT04664881|366307481|FG000|Overall Study|Withdrawal by Subject|1|||
106176038|NCT04664881|366307482|FG001|Overall Study|Withdrawal by Subject|8|||
106176039|NCT04664881|366307481|FG000|Overall Study|Physician Decision|0|||
106176040|NCT04664881|366307482|FG001|Overall Study|Physician Decision|5|||
106176041|NCT04664881|366307481|FG000|Overall Study|Lost to Follow-up|1|||
106176042|NCT04664881|366307482|FG001|Overall Study|Lost to Follow-up|0|||
106176043|NCT03767335|366307498|FG000|Overall Study|Physician Decision|1|||
106176044|NCT03767335|366307499|FG001|Overall Study|Physician Decision|1|||
106176045|NCT03767335|366307500|FG002|Overall Study|Physician Decision|0|||
106176046|NCT03767335|366307498|FG000|Overall Study|Withdrawal by Subject|0|||
106176047|NCT03767335|366307499|FG001|Overall Study|Withdrawal by Subject|0|||
106176048|NCT03767335|366307500|FG002|Overall Study|Withdrawal by Subject|6|||
106176049|NCT03767335|366307498|FG000|Overall Study|Participant excluded from efficacy population|0|||
106176050|NCT03767335|366307499|FG001|Overall Study|Participant excluded from efficacy population|0|||
106176051|NCT03767335|366307500|FG002|Overall Study|Participant excluded from efficacy population|1|||
106176052|NCT03767335|366307498|FG000|Overall Study|Death|0|||
106176053|NCT03767335|366307499|FG001|Overall Study|Death|0|||
106176054|NCT03767335|366307500|FG002|Overall Study|Death|2|||
106176055|NCT03767335|366307498|FG000|Overall Study|Progressive Disease|2|||
106176056|NCT03767335|366307499|FG001|Overall Study|Progressive Disease|2|||
106176057|NCT03767335|366307500|FG002|Overall Study|Progressive Disease|2|||
106176058|NCT03767335|366307498|FG000|Overall Study|Disease progression needing additional medication|0|||
106176059|NCT03767335|366307499|FG001|Overall Study|Disease progression needing additional medication|0|||
106176060|NCT03767335|366307500|FG002|Overall Study|Disease progression needing additional medication|17|||
106176061|NCT03767335|366307498|FG000|Overall Study|Sponsor decision|0|||
106176062|NCT03767335|366307499|FG001|Overall Study|Sponsor decision|0|||
106176063|NCT03767335|366307500|FG002|Overall Study|Sponsor decision|2|||
106176064|NCT03767335|366307498|FG000|Overall Study|Other Medical Reasons|0|||
106176065|NCT03767335|366307499|FG001|Overall Study|Other Medical Reasons|0|||
106176066|NCT03767335|366307500|FG002|Overall Study|Other Medical Reasons|3|||
106176067|NCT03242915|366307503|FG000|Overall Study|Adverse Event|5|||
106176068|NCT03242915|366307504|FG001|Overall Study|Adverse Event|1|||
106176069|NCT03242915|366307503|FG000|Overall Study|Withdrawal by Subject|0|||
106176070|NCT03242915|366307504|FG001|Overall Study|Withdrawal by Subject|2|||
106176071|NCT03242915|366307503|FG000|Overall Study|Physician Decision|4|||
106176072|NCT03242915|366307504|FG001|Overall Study|Physician Decision|1|||
106176073|NCT03733626|366307505|FG000|Overall Study|Physician Decision|4|||
106176074|NCT03733626|366307506|FG001|Overall Study|Physician Decision|4|||
106176075|NCT03881696|366307512|FG000|Overall Study|Adverse Event|2|||
106176076|NCT03881696|366307513|FG001|Overall Study|Adverse Event|0|||
106176077|NCT03881696|366307512|FG000|Overall Study|Withdrawal by Subject|2|||
106176078|NCT03881696|366307513|FG001|Overall Study|Withdrawal by Subject|0|||
106176079|NCT03881696|366307512|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
106176080|NCT03881696|366307513|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
106176081|NCT03881696|366307512|FG000|Overall Study|Failure to meet continuation criteria|1|||
106176082|NCT03881696|366307513|FG001|Overall Study|Failure to meet continuation criteria|0|||
106176083|NCT02206828|366307516|FG000|Overall Study|Lost to Follow-up|7|||
106176084|NCT00945724|366307520|FG000|Overall Study|Withdrawal by Subject|2|||
106176085|NCT00945724|366307520|FG000|Overall Study|Physician Decision|1|||
106176086|NCT00945724|366307520|FG000|Overall Study|Adverse Event|5|||
106176087|NCT00945724|366307520|FG000|Overall Study|Second malignancy|1|||
106176088|NCT04772534|366308348|FG000|Overall Study|Physician Decision|1|||
106176089|NCT04772534|366308349|FG001|Overall Study|Physician Decision|0|||
106176090|NCT04772534|366308350|FG002|Overall Study|Physician Decision|0|||
106176091|NCT04772534|366308348|FG000|Overall Study|Withdrawal by Subject|3|||
106176092|NCT04772534|366308349|FG001|Overall Study|Withdrawal by Subject|0|||
106176093|NCT04772534|366308350|FG002|Overall Study|Withdrawal by Subject|1|||
106176094|NCT03786926|366308356|FG000|Overall Study|Adverse Event|0|||
106176095|NCT03786926|366308357|FG001|Overall Study|Adverse Event|0|||
106176096|NCT03786926|366308358|FG002|Overall Study|Adverse Event|0|||
106176097|NCT03786926|366308359|FG003|Overall Study|Adverse Event|0|||
106176098|NCT03786926|366308360|FG004|Overall Study|Adverse Event|0|||
106176099|NCT03786926|366308361|FG005|Overall Study|Adverse Event|0|||
106176100|NCT03786926|366308362|FG006|Overall Study|Adverse Event|0|||
106176101|NCT03786926|366308363|FG007|Overall Study|Adverse Event|1|||
106176102|NCT03786926|366308364|FG008|Overall Study|Adverse Event|1|||
106176103|NCT03786926|366308365|FG009|Overall Study|Adverse Event|0|||
106176104|NCT03786926|366308366|FG010|Overall Study|Adverse Event|1|||
106176105|NCT03786926|366308356|FG000|Overall Study|Progressive disease|3|||
106176106|NCT03786926|366308357|FG001|Overall Study|Progressive disease|0|||
106176107|NCT03786926|366308358|FG002|Overall Study|Progressive disease|3|||
106176108|NCT03786926|366308359|FG003|Overall Study|Progressive disease|1|||
106176109|NCT03786926|366308360|FG004|Overall Study|Progressive disease|2|||
106176110|NCT03786926|366308361|FG005|Overall Study|Progressive disease|2|||
106176111|NCT03786926|366308362|FG006|Overall Study|Progressive disease|1|||
106176112|NCT03786926|366308363|FG007|Overall Study|Progressive disease|6|||
106176113|NCT03786926|366308364|FG008|Overall Study|Progressive disease|1|||
106176114|NCT03786926|366308365|FG009|Overall Study|Progressive disease|1|||
106176115|NCT03786926|366308366|FG010|Overall Study|Progressive disease|1|||
106176116|NCT03786926|366308356|FG000|Overall Study|Death|0|||
106176117|NCT03786926|366308357|FG001|Overall Study|Death|1|||
106176118|NCT03786926|366308358|FG002|Overall Study|Death|1|||
106176119|NCT03786926|366308359|FG003|Overall Study|Death|0|||
106176120|NCT03786926|366308360|FG004|Overall Study|Death|0|||
106176121|NCT03786926|366308361|FG005|Overall Study|Death|0|||
106176122|NCT03786926|366308362|FG006|Overall Study|Death|0|||
106176123|NCT03786926|366308363|FG007|Overall Study|Death|0|||
106176124|NCT03786926|366308364|FG008|Overall Study|Death|0|||
106176125|NCT03786926|366308365|FG009|Overall Study|Death|1|||
106176126|NCT03786926|366308366|FG010|Overall Study|Death|2|||
106176127|NCT03786926|366308356|FG000|Overall Study|Physician Decision|0|||
106176128|NCT03786926|366308357|FG001|Overall Study|Physician Decision|1|||
106176129|NCT03786926|366308358|FG002|Overall Study|Physician Decision|0|||
106176130|NCT03786926|366308359|FG003|Overall Study|Physician Decision|1|||
106176131|NCT03786926|366308360|FG004|Overall Study|Physician Decision|2|||
106176132|NCT03786926|366308361|FG005|Overall Study|Physician Decision|0|||
106176133|NCT03786926|366308362|FG006|Overall Study|Physician Decision|0|||
106176134|NCT03786926|366308363|FG007|Overall Study|Physician Decision|2|||
106176135|NCT03786926|366308364|FG008|Overall Study|Physician Decision|1|||
106176136|NCT03786926|366308365|FG009|Overall Study|Physician Decision|1|||
106176137|NCT03786926|366308366|FG010|Overall Study|Physician Decision|0|||
106176138|NCT03786926|366308356|FG000|Overall Study|Withdrawal by Subject|0|||
106176139|NCT03786926|366308357|FG001|Overall Study|Withdrawal by Subject|1|||
106176140|NCT03786926|366308358|FG002|Overall Study|Withdrawal by Subject|1|||
106176141|NCT03786926|366308359|FG003|Overall Study|Withdrawal by Subject|0|||
106176142|NCT03786926|366308360|FG004|Overall Study|Withdrawal by Subject|0|||
106176143|NCT03786926|366308361|FG005|Overall Study|Withdrawal by Subject|0|||
106176144|NCT03786926|366308362|FG006|Overall Study|Withdrawal by Subject|1|||
106176145|NCT03786926|366308363|FG007|Overall Study|Withdrawal by Subject|0|||
106176146|NCT03786926|366308364|FG008|Overall Study|Withdrawal by Subject|1|||
106176147|NCT03786926|366308365|FG009|Overall Study|Withdrawal by Subject|0|||
106176148|NCT03786926|366308366|FG010|Overall Study|Withdrawal by Subject|1|||
106176149|NCT03786926|366308356|FG000|Overall Study|Study terminated by Sponsor|0|||
106176150|NCT03786926|366308357|FG001|Overall Study|Study terminated by Sponsor|0|||
106176151|NCT03786926|366308358|FG002|Overall Study|Study terminated by Sponsor|0|||
106176152|NCT03786926|366308359|FG003|Overall Study|Study terminated by Sponsor|0|||
106176153|NCT03786926|366308360|FG004|Overall Study|Study terminated by Sponsor|1|||
106176154|NCT03786926|366308361|FG005|Overall Study|Study terminated by Sponsor|0|||
106176155|NCT03786926|366308362|FG006|Overall Study|Study terminated by Sponsor|0|||
106176156|NCT03786926|366308363|FG007|Overall Study|Study terminated by Sponsor|4|||
106176157|NCT03786926|366308364|FG008|Overall Study|Study terminated by Sponsor|0|||
106176158|NCT03786926|366308365|FG009|Overall Study|Study terminated by Sponsor|0|||
106176159|NCT03786926|366308366|FG010|Overall Study|Study terminated by Sponsor|0|||
106176160|NCT03786926|366308356|FG000|Overall Study|Anti-neoplasm treatment|0|||
106176161|NCT03786926|366308357|FG001|Overall Study|Anti-neoplasm treatment|0|||
106176162|NCT03786926|366308358|FG002|Overall Study|Anti-neoplasm treatment|0|||
106176163|NCT03786926|366308359|FG003|Overall Study|Anti-neoplasm treatment|0|||
106176164|NCT03786926|366308360|FG004|Overall Study|Anti-neoplasm treatment|1|||
106176165|NCT03786926|366308361|FG005|Overall Study|Anti-neoplasm treatment|0|||
106176166|NCT03786926|366308362|FG006|Overall Study|Anti-neoplasm treatment|1|||
106176167|NCT03786926|366308363|FG007|Overall Study|Anti-neoplasm treatment|0|||
106176168|NCT03786926|366308364|FG008|Overall Study|Anti-neoplasm treatment|0|||
106176169|NCT03786926|366308365|FG009|Overall Study|Anti-neoplasm treatment|0|||
106176170|NCT03786926|366308366|FG010|Overall Study|Anti-neoplasm treatment|0|||
106176171|NCT03786926|366308356|FG000|Overall Study|Other|0|||
106176172|NCT03786926|366308357|FG001|Overall Study|Other|0|||
106176173|NCT03786926|366308358|FG002|Overall Study|Other|0|||
106176174|NCT03786926|366308359|FG003|Overall Study|Other|1|||
106176175|NCT03786926|366308360|FG004|Overall Study|Other|0|||
106176176|NCT03786926|366308361|FG005|Overall Study|Other|1|||
106176177|NCT03786926|366308362|FG006|Overall Study|Other|0|||
106176178|NCT03786926|366308363|FG007|Overall Study|Other|0|||
106176179|NCT03786926|366308364|FG008|Overall Study|Other|2|||
106176180|NCT03786926|366308365|FG009|Overall Study|Other|0|||
106176181|NCT03786926|366308366|FG010|Overall Study|Other|0|||
106176182|NCT06152224|366308367|FG000|Overall Study|Withdrawal by Subject|1|||
106176183|NCT06152224|366308368|FG001|Overall Study|Withdrawal by Subject|0|||
106176184|NCT06152224|366308367|FG000|Overall Study|Lost to Follow-up|0|||
106176185|NCT06152224|366308368|FG001|Overall Study|Lost to Follow-up|1|||
106176186|NCT06152224|366308367|FG000|Overall Study|On Follow Up|18|||
106176187|NCT06152224|366308368|FG001|Overall Study|On Follow Up|18|||
106176188|NCT04495621|366308369|FG000|Overall Study|Withdrawal by Subject|0|||
106176189|NCT04495621|366308370|FG001|Overall Study|Withdrawal by Subject|3|||
106176190|NCT04495621|366308369|FG000|Overall Study|Death|7|||
106176191|NCT04495621|366308370|FG001|Overall Study|Death|11|||
106176192|NCT04495621|366308369|FG000|Overall Study|Investigator Decision|0|||
106176193|NCT04495621|366308370|FG001|Overall Study|Investigator Decision|7|||
106176194|NCT04495621|366308369|FG000|Overall Study|Lost to Follow-up|0|||
106176195|NCT04495621|366308370|FG001|Overall Study|Lost to Follow-up|1|||
106176196|NCT05875701|366308378|FG000|Overall Study|Lost to Follow-up|2|||
106176197|NCT05875701|366308379|FG001|Overall Study|Lost to Follow-up|0|||
106176198|NCT05875701|366308378|FG000|Overall Study|Withdrawal by Subject|1|||
106176199|NCT05875701|366308379|FG001|Overall Study|Withdrawal by Subject|1|||
106176200|NCT05988398|366308384|FG000|Overall Study|Lack of time|21|||
106176201|NCT05988398|366308385|FG001|Overall Study|Lack of time|0|||
106176202|NCT05988398|366308384|FG000|Overall Study|Absent from school|0|||
106176203|NCT05988398|366308385|FG001|Overall Study|Absent from school|38|||
106176204|NCT05988398|366308384|FG000|Overall Study|Chose not to participate|0|||
106176205|NCT05988398|366308385|FG001|Overall Study|Chose not to participate|42|||
106176206|NCT05988398|366308384|FG000|Overall Study|Other commitments (e.g., sports)|0|||
106176207|NCT05988398|366308385|FG001|Overall Study|Other commitments (e.g., sports)|25|||
106176208|NCT02726386|366308393|FG000|Overall Study|Adverse Event|17|||
106176209|NCT02726386|366308394|FG001|Overall Study|Adverse Event|20|||
106176210|NCT02726386|366308393|FG000|Overall Study|Withdrawal by Subject|14|||
106176211|NCT02726386|366308394|FG001|Overall Study|Withdrawal by Subject|28|||
106176212|NCT02726386|366308393|FG000|Overall Study|Other reasons|7|||
106176213|NCT02726386|366308394|FG001|Overall Study|Other reasons|8|||
106176214|NCT04490356|366308397|FG000|Overall Study|Lost to Follow-up|1|||
106176215|NCT03816397|366308398|FG000|Overall Study|Censored at interim analysis date.|13|||
106176216|NCT03816397|366308399|FG001|Overall Study|Censored at interim analysis date.|6|||
106176217|NCT03816397|366308398|FG000|Overall Study|Withdrawal by Subject|1|||
106176218|NCT03816397|366308399|FG001|Overall Study|Withdrawal by Subject|1|||
106176219|NCT03213457|366308408|FG000|Screening Period|Withdrawal by Subject|0|||
106176220|NCT03213457|366308409|FG001|Screening Period|Withdrawal by Subject|1|||
106176221|NCT03213457|366308410|FG002|Screening Period|Withdrawal by Subject|0|||
106176222|NCT03213457|366308408|FG000|Screening Period|Other|1|||
106176223|NCT03213457|366308409|FG001|Screening Period|Other|0|||
106176224|NCT03213457|366308410|FG002|Screening Period|Other|0|||
106176225|NCT03213457|366308408|FG000|Double-Blind Period|Adverse Event|3|||
106176226|NCT03213457|366308409|FG001|Double-Blind Period|Adverse Event|2|||
106176227|NCT03213457|366308410|FG002|Double-Blind Period|Adverse Event|7|||
106176228|NCT03213457|366308408|FG000|Double-Blind Period|Withdrawal by Subject|14|||
106176229|NCT03213457|366308409|FG001|Double-Blind Period|Withdrawal by Subject|2|||
106176230|NCT03213457|366308410|FG002|Double-Blind Period|Withdrawal by Subject|14|||
106176231|NCT03213457|366308408|FG000|Double-Blind Period|Lost to Follow-up|2|||
106176232|NCT03213457|366308409|FG001|Double-Blind Period|Lost to Follow-up|3|||
106176233|NCT03213457|366308410|FG002|Double-Blind Period|Lost to Follow-up|9|||
106176234|NCT03213457|366308408|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
106176235|NCT03213457|366308409|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
106176236|NCT03213457|366308410|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
106176237|NCT03213457|366308408|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
106176238|NCT03213457|366308409|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
106176239|NCT03213457|366308410|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
106176240|NCT03213457|366308408|FG000|Double-Blind Period|Pregnancy|5|||
106176241|NCT03213457|366308409|FG001|Double-Blind Period|Pregnancy|0|||
106176242|NCT03213457|366308410|FG002|Double-Blind Period|Pregnancy|0|||
106176243|NCT03213457|366308408|FG000|Double-Blind Period|Other|10|||
106176244|NCT03213457|366308409|FG001|Double-Blind Period|Other|3|||
106176245|NCT03213457|366308410|FG002|Double-Blind Period|Other|17|||
106176246|NCT03213457|366308408|FG000|Open-Label Period|Adverse Event|1|||
106176247|NCT03213457|366308409|FG001|Open-Label Period|Adverse Event|2|||
106176248|NCT03213457|366308410|FG002|Open-Label Period|Adverse Event|2|||
106176249|NCT03213457|366308408|FG000|Open-Label Period|Withdrawal by Subject|12|||
106176250|NCT03213457|366308409|FG001|Open-Label Period|Withdrawal by Subject|5|||
106176251|NCT03213457|366308410|FG002|Open-Label Period|Withdrawal by Subject|24|||
106176252|NCT03213457|366308408|FG000|Open-Label Period|Lost to Follow-up|1|||
106176253|NCT03213457|366308409|FG001|Open-Label Period|Lost to Follow-up|2|||
106176254|NCT03213457|366308410|FG002|Open-Label Period|Lost to Follow-up|8|||
106176255|NCT03213457|366308408|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
106176256|NCT03213457|366308409|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
106176257|NCT03213457|366308410|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
106176258|NCT03213457|366308408|FG000|Open-Label Period|Non-compliance with study procedures|1|||
106176259|NCT03213457|366308409|FG001|Open-Label Period|Non-compliance with study procedures|1|||
106176260|NCT03213457|366308410|FG002|Open-Label Period|Non-compliance with study procedures|2|||
106176261|NCT03213457|366308408|FG000|Open-Label Period|Exclusionary medications|0|||
106176262|NCT03213457|366308409|FG001|Open-Label Period|Exclusionary medications|0|||
106176263|NCT03213457|366308410|FG002|Open-Label Period|Exclusionary medications|1|||
106176264|NCT03213457|366308408|FG000|Open-Label Period|Other|1|||
106176265|NCT03213457|366308409|FG001|Open-Label Period|Other|1|||
106176266|NCT03213457|366308410|FG002|Open-Label Period|Other|6|||
106176267|NCT03213457|366308408|FG000|Follow-Up Period|Adverse Event|16|||
106176268|NCT03213457|366308409|FG001|Follow-Up Period|Adverse Event|8|||
106176269|NCT03213457|366308410|FG002|Follow-Up Period|Adverse Event|37|||
106176270|NCT03213457|366308408|FG000|Follow-Up Period|Withdrawal by Subject|18|||
106176271|NCT03213457|366308409|FG001|Follow-Up Period|Withdrawal by Subject|11|||
106176272|NCT03213457|366308410|FG002|Follow-Up Period|Withdrawal by Subject|55|||
106176273|NCT03213457|366308408|FG000|Follow-Up Period|Lost to Follow-up|28|||
106176274|NCT03213457|366308409|FG001|Follow-Up Period|Lost to Follow-up|15|||
106176275|NCT03213457|366308410|FG002|Follow-Up Period|Lost to Follow-up|50|||
106176276|NCT03213457|366308408|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
106176277|NCT03213457|366308409|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
106176278|NCT03213457|366308410|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
106176279|NCT03213457|366308408|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
106176280|NCT03213457|366308409|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
106176281|NCT03213457|366308410|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
106176282|NCT03213457|366308408|FG000|Follow-Up Period|Pregnancy|7|||
106176283|NCT03213457|366308409|FG001|Follow-Up Period|Pregnancy|0|||
106176284|NCT03213457|366308410|FG002|Follow-Up Period|Pregnancy|18|||
106176285|NCT03213457|366308408|FG000|Follow-Up Period|Exclusionary medications|1|||
106176286|NCT03213457|366308409|FG001|Follow-Up Period|Exclusionary medications|1|||
106176287|NCT03213457|366308410|FG002|Follow-Up Period|Exclusionary medications|5|||
106176288|NCT03213457|366308408|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
106176289|NCT03213457|366308409|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
106176290|NCT03213457|366308410|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
106176291|NCT03213457|366308408|FG000|Follow-Up Period|Other|14|||
106176292|NCT03213457|366308409|FG001|Follow-Up Period|Other|10|||
106176293|NCT03213457|366308410|FG002|Follow-Up Period|Other|31|||
106176294|NCT04940624|366308411|FG000|Overall Study|Adverse Event|4|||
106176295|NCT04940624|366308412|FG001|Overall Study|Adverse Event|11|||
106176296|NCT04940624|366308411|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
106176297|NCT04940624|366308412|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
106176298|NCT04940624|366308411|FG000|Overall Study|Physician Decision|1|||
106176299|NCT04940624|366308412|FG001|Overall Study|Physician Decision|0|||
106176300|NCT04940624|366308411|FG000|Overall Study|Lost to Follow-up|1|||
106176301|NCT04940624|366308412|FG001|Overall Study|Lost to Follow-up|0|||
106176302|NCT04940624|366308411|FG000|Overall Study|Reason Not Specified|1|||
106176303|NCT04940624|366308412|FG001|Overall Study|Reason Not Specified|0|||
106176304|NCT05934292|366308414|FG000|Overall Study|Lost to Follow-up|0|||
106176305|NCT05934292|366308415|FG001|Overall Study|Lost to Follow-up|0|||
106176306|NCT05934292|366308416|FG002|Overall Study|Lost to Follow-up|1|||
106176307|NCT05934292|366308417|FG003|Overall Study|Lost to Follow-up|0|||
106176308|NCT04479787|366308418|FG000|Through 6 Months|Withdrawal by Subject|16|||
106176309|NCT04479787|366308419|FG001|Through 6 Months|Withdrawal by Subject|14|||
106176310|NCT04479787|366308418|FG000|Through 6 Months|Unsuccessful Trial|17|||
106176311|NCT04479787|366308419|FG001|Through 6 Months|Unsuccessful Trial|0|||
106176312|NCT04479787|366308418|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
106176313|NCT04479787|366308419|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
106176314|NCT04479787|366308418|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
106176315|NCT04479787|366308419|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
106176316|NCT04479787|366308418|FG000|Through 6 Months|Lost to Follow-up|3|||
106176317|NCT04479787|366308419|FG001|Through 6 Months|Lost to Follow-up|2|||
106176318|NCT04479787|366308418|FG000|Through 6 Months|Death|3|||
106176319|NCT04479787|366308419|FG001|Through 6 Months|Death|0|||
106176320|NCT04479787|366308418|FG000|Through 6 Months|Inclusion/Exclusion|2|||
106176321|NCT04479787|366308419|FG001|Through 6 Months|Inclusion/Exclusion|1|||
106176322|NCT04479787|366308418|FG000|Through 6 Months|Subject Became Pregnant|1|||
106176323|NCT04479787|366308419|FG001|Through 6 Months|Subject Became Pregnant|1|||
106176324|NCT04479787|366308418|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
106176325|NCT04479787|366308419|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
106176326|NCT04479787|366308418|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
106176327|NCT04479787|366308419|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
106176328|NCT04479787|366308418|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
106176329|NCT04479787|366308419|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
106176330|NCT04479787|366308418|FG000|After 6 Months|Withdrawal by Subject|3|||
106176331|NCT04479787|366308419|FG001|After 6 Months|Withdrawal by Subject|13|||
106176332|NCT04479787|366308418|FG000|After 6 Months|Unsuccessful Trial|0|||
106176333|NCT04479787|366308419|FG001|After 6 Months|Unsuccessful Trial|7|||
106176334|NCT04479787|366308418|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
106176335|NCT04479787|366308419|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
106176336|NCT04479787|366308418|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
106176337|NCT04479787|366308419|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
106176338|NCT04479787|366308418|FG000|After 6 Months|Death|2|||
106176339|NCT04479787|366308419|FG001|After 6 Months|Death|0|||
106176340|NCT04479787|366308418|FG000|After 6 Months|Lost to Follow-up|1|||
106176341|NCT04479787|366308419|FG001|After 6 Months|Lost to Follow-up|1|||
106176342|NCT04479787|366308418|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
106176343|NCT04479787|366308419|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
106176344|NCT04479787|366308418|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
106176345|NCT04479787|366308419|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
106176346|NCT04479787|366308418|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
106176347|NCT04479787|366308419|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
106176348|NCT04479787|366308418|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
106176349|NCT04479787|366308419|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
106176350|NCT04165213|366308993|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
106176351|NCT04165213|366308994|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
106176352|NCT04165213|366308993|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
106176353|NCT04165213|366308994|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
106176354|NCT04165213|366308993|FG000|Clinician Enrollment|Termination from site|0|||
106176355|NCT04165213|366308994|FG001|Clinician Enrollment|Termination from site|1|||
106176356|NCT04165213|366308993|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
106176357|NCT04165213|366308994|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
106176358|NCT04165213|366308993|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
106176359|NCT04165213|366308994|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
106176360|NCT04165213|366308993|FG000|Caregiver Enrollment|Physician Decision|1|||
106176361|NCT04165213|366308994|FG001|Caregiver Enrollment|Physician Decision|0|||
106176362|NCT04165213|366308993|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
106176363|NCT04165213|366308994|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
106176364|NCT04165213|366308993|FG000|Caregiver Enrollment|PLWD death|2|||
106176365|NCT04165213|366308994|FG001|Caregiver Enrollment|PLWD death|0|||
106176366|NCT04165213|366308993|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
106176367|NCT04165213|366308994|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
106176368|NCT04165213|366308993|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
106176369|NCT04165213|366308994|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
106176370|NCT04165213|366308993|FG000|PLWD Enrollment|Lost to Follow-up|1|||
106176371|NCT04165213|366308994|FG001|PLWD Enrollment|Lost to Follow-up|1|||
106176372|NCT04165213|366308993|FG000|PLWD Enrollment|Physician Decision|1|||
106176373|NCT04165213|366308994|FG001|PLWD Enrollment|Physician Decision|0|||
106176374|NCT04165213|366308993|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
106176375|NCT04165213|366308994|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
106176376|NCT04165213|366308993|FG000|PLWD Enrollment|Death|2|||
106176377|NCT04165213|366308994|FG001|PLWD Enrollment|Death|0|||
106176378|NCT04165213|366308993|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
106176379|NCT04165213|366308994|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
106176380|NCT02231749|366308995|FG000|Overall Study|Disease progression|229|||
106176381|NCT02231749|366308996|FG001|Overall Study|Disease progression|297|||
106176382|NCT02231749|366308995|FG000|Overall Study|Study Drug Toxicity|134|||
106176383|NCT02231749|366308996|FG001|Overall Study|Study Drug Toxicity|63|||
106176384|NCT02231749|366308995|FG000|Overall Study|Death|1|||
106176385|NCT02231749|366308996|FG001|Overall Study|Death|1|||
106176386|NCT02231749|366308995|FG000|Overall Study|AE unrelated to Study drug|32|||
106176387|NCT02231749|366308996|FG001|Overall Study|AE unrelated to Study drug|31|||
106176388|NCT02231749|366308995|FG000|Overall Study|Participant's request to discontinue|10|||
106176389|NCT02231749|366308996|FG001|Overall Study|Participant's request to discontinue|21|||
106176390|NCT02231749|366308995|FG000|Overall Study|Participant withdrew Consent|8|||
106176391|NCT02231749|366308996|FG001|Overall Study|Participant withdrew Consent|15|||
106176392|NCT02231749|366308995|FG000|Overall Study|Lost to Follow-up|1|||
106176393|NCT02231749|366308996|FG001|Overall Study|Lost to Follow-up|2|||
106176394|NCT02231749|366308995|FG000|Overall Study|Maximum Clinical Benefit|5|||
106176395|NCT02231749|366308996|FG001|Overall Study|Maximum Clinical Benefit|8|||
106176396|NCT02231749|366308995|FG000|Overall Study|Poor/Non-Compliance|0|||
106176397|NCT02231749|366308996|FG001|Overall Study|Poor/Non-Compliance|3|||
106176398|NCT02231749|366308995|FG000|Overall Study|Pregnancy|1|||
106176399|NCT02231749|366308996|FG001|Overall Study|Pregnancy|0|||
106176400|NCT02231749|366308995|FG000|Overall Study|other|0|||
106176401|NCT02231749|366308996|FG001|Overall Study|other|8|||
106176402|NCT02231749|366308995|FG000|Overall Study|No longer meets Study Criteria|1|||
106176403|NCT02231749|366308996|FG001|Overall Study|No longer meets Study Criteria|0|||
106176404|NCT04194450|366308999|FG000|Overall Study|not eligible|1|||
106176405|NCT04194450|366309000|FG001|Overall Study|not eligible|0|||
106176406|NCT00357682|366309002|FG000|Overall Study|Did not receive allocated Treatment|10|||
106176407|NCT00357682|366309003|FG001|Overall Study|Did not receive allocated Treatment|9|||
106176408|NCT00357682|366309004|FG002|Overall Study|Did not receive allocated Treatment|9|||
106176409|NCT00357682|366309005|FG003|Overall Study|Did not receive allocated Treatment|10|||
106176410|NCT00357682|366309002|FG000|Overall Study|Withdrew consent|6|||
106176411|NCT00357682|366309003|FG001|Overall Study|Withdrew consent|6|||
106176412|NCT00357682|366309004|FG002|Overall Study|Withdrew consent|5|||
106176413|NCT00357682|366309005|FG003|Overall Study|Withdrew consent|5|||
106176414|NCT00357682|366309002|FG000|Overall Study|Lost to Follow-up|39|||
106176415|NCT00357682|366309003|FG001|Overall Study|Lost to Follow-up|33|||
106176416|NCT00357682|366309004|FG002|Overall Study|Lost to Follow-up|26|||
106176417|NCT00357682|366309005|FG003|Overall Study|Lost to Follow-up|35|||
106176418|NCT00357682|366309002|FG000|Overall Study|Adverse Event|24|||
106176419|NCT00357682|366309003|FG001|Overall Study|Adverse Event|32|||
106176420|NCT00357682|366309004|FG002|Overall Study|Adverse Event|22|||
106176421|NCT00357682|366309005|FG003|Overall Study|Adverse Event|27|||
106176422|NCT00357682|366309002|FG000|Overall Study|Physician Decision|32|||
106176423|NCT00357682|366309003|FG001|Overall Study|Physician Decision|20|||
106176424|NCT00357682|366309004|FG002|Overall Study|Physician Decision|24|||
106176425|NCT00357682|366309005|FG003|Overall Study|Physician Decision|30|||
106176426|NCT00357682|366309002|FG000|Overall Study|Patient decision|73|||
106176427|NCT00357682|366309003|FG001|Overall Study|Patient decision|80|||
106176428|NCT00357682|366309004|FG002|Overall Study|Patient decision|51|||
106176429|NCT00357682|366309005|FG003|Overall Study|Patient decision|59|||
106176430|NCT00357682|366309002|FG000|Overall Study|Other reason|157|||
106176431|NCT00357682|366309003|FG001|Overall Study|Other reason|130|||
106176432|NCT00357682|366309004|FG002|Overall Study|Other reason|114|||
106176433|NCT00357682|366309005|FG003|Overall Study|Other reason|99|||
106176434|NCT03782116|366309015|FG000|Completed Intervetion|Lost to Follow-up|11|||
106176435|NCT03782116|366309016|FG001|Completed Intervetion|Lost to Follow-up|7|||
106176436|NCT03782116|366309015|FG000|Completed Intervetion|Withdrawal by Subject|6|||
106176437|NCT03782116|366309016|FG001|Completed Intervetion|Withdrawal by Subject|5|||
106176438|NCT03782116|366309015|FG000|Included in Analysis|Protocol Violation|5|||
106176439|NCT03782116|366309016|FG001|Included in Analysis|Protocol Violation|5|||
106176440|NCT03774472|366309023|FG000|Overall Study|Physician Decision|1|||
106176441|NCT03774472|366309024|FG001|Overall Study|Physician Decision|0|||
106176442|NCT03774472|366309025|FG002|Overall Study|Physician Decision|0|||
106176443|NCT03774472|366309023|FG000|Overall Study|Progression prior to 4 weeks|0|||
106176444|NCT03774472|366309024|FG001|Overall Study|Progression prior to 4 weeks|1|||
106176445|NCT03774472|366309025|FG002|Overall Study|Progression prior to 4 weeks|0|||
106176446|NCT03774472|366309023|FG000|Overall Study|Withdrawal by Subject|0|||
106176447|NCT03774472|366309024|FG001|Overall Study|Withdrawal by Subject|1|||
106176448|NCT03774472|366309025|FG002|Overall Study|Withdrawal by Subject|0|||
106176449|NCT05601882|366309030|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
106176450|NCT05601882|366309031|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
106176451|NCT05601882|366309032|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
106176452|NCT05601882|366309033|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
106176453|NCT05601882|366309030|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
106176454|NCT05601882|366309031|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
106176455|NCT05601882|366309032|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
106176456|NCT05601882|366309033|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
106176457|NCT05601882|366309030|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
106176458|NCT05601882|366309031|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
106176459|NCT05601882|366309032|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
106176460|NCT05601882|366309033|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
106176461|NCT05601882|366309030|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
106176462|NCT05601882|366309031|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
106176463|NCT05601882|366309032|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
106176464|NCT05601882|366309033|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
106176465|NCT05601882|366309030|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
106176466|NCT05601882|366309031|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
106176467|NCT05601882|366309032|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
106176468|NCT05601882|366309033|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
106176469|NCT05601882|366309030|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
106176470|NCT05601882|366309031|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
106176471|NCT05601882|366309032|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
106176472|NCT05601882|366309033|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
106176473|NCT03834740|366309038|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
106176474|NCT03834740|366309039|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
106176475|NCT03834740|366309040|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
106176476|NCT04305327|366309041|FG000|Overall Study|Study early termination|2|||
106176477|NCT04305327|366309042|FG001|Overall Study|Study early termination|5|||
106176478|NCT04305327|366309043|FG002|Overall Study|Study early termination|2|||
106176479|NCT04305327|366309044|FG003|Overall Study|Study early termination|2|||
106176480|NCT04305327|366309041|FG000|Overall Study|Withdrawal by Subject|0|||
106176481|NCT04305327|366309042|FG001|Overall Study|Withdrawal by Subject|1|||
106176482|NCT04305327|366309043|FG002|Overall Study|Withdrawal by Subject|0|||
106176483|NCT04305327|366309044|FG003|Overall Study|Withdrawal by Subject|0|||
106176484|NCT00115934|366309045|FG000|Overall Study|Lost to Follow-up|1|||
106176485|NCT00115934|366309046|FG001|Overall Study|Lost to Follow-up|0|||
106176486|NCT00115934|366309045|FG000|Overall Study|Did not receive intervention|3|||
106176487|NCT00115934|366309046|FG001|Overall Study|Did not receive intervention|2|||
106176488|NCT03891758|366309047|FG000|Overall Study|Adverse Event|2|||
106176489|NCT03891758|366309048|FG001|Overall Study|Adverse Event|0|||
106176490|NCT03891758|366309047|FG000|Overall Study|Withdrawal by parent/guardian|0|||
106176491|NCT03891758|366309048|FG001|Overall Study|Withdrawal by parent/guardian|2|||
106176492|NCT01773993|366309388|FG000|Overall Study|No Visit After Treatment|35|||
106176493|NCT00328783|366309389|FG000|Overall Study|Could not tolerate ABC|21|||
106176494|NCT00328783|366309389|FG000|Overall Study|No heart in RT field|4|||
106176495|NCT00328783|366309389|FG000|Overall Study|Withdrawal by Subject|1|||
106176496|NCT03725332|366309391|FG000|Overall Study|Adverse Event|5|||
106176497|NCT03725332|366309392|FG001|Overall Study|Adverse Event|10|||
106176498|NCT03725332|366309391|FG000|Overall Study|Death|1|||
106176499|NCT03725332|366309392|FG001|Overall Study|Death|3|||
106176500|NCT03725332|366309391|FG000|Overall Study|Lost to Follow-up|43|||
106176501|NCT03725332|366309392|FG001|Overall Study|Lost to Follow-up|122|||
106176502|NCT03725332|366309391|FG000|Overall Study|Withdrawal by Subject|0|||
106176503|NCT03725332|366309392|FG001|Overall Study|Withdrawal by Subject|1|||
106176504|NCT03725332|366309391|FG000|Overall Study|Duplicate enrollment|0|||
106176505|NCT03725332|366309392|FG001|Overall Study|Duplicate enrollment|1|||
106176506|NCT03725332|366309391|FG000|Overall Study|Did not consent|0|||
106176507|NCT03725332|366309392|FG001|Overall Study|Did not consent|1|||
106176508|NCT01830595|366309393|FG000|First Period|Withdrawal by Subject|1|||
106176509|NCT01830595|366309394|FG001|First Period|Withdrawal by Subject|3|||
106176510|NCT01830595|366309393|FG000|Washout|Withdrawal by Subject|2|||
106176511|NCT01830595|366309394|FG001|Washout|Withdrawal by Subject|2|||
106176512|NCT03414684|366309399|FG000|First-course Treatment|Complete response|0|||
106176513|NCT03414684|366309400|FG001|First-course Treatment|Complete response|1|||
106176514|NCT03414684|366309399|FG000|First-course Treatment|Intercurrent illness|1|||
106176515|NCT03414684|366309400|FG001|First-course Treatment|Intercurrent illness|0|||
106176516|NCT03414684|366309399|FG000|First-course Treatment|Progressive Disease|31|||
106176517|NCT03414684|366309400|FG001|First-course Treatment|Progressive Disease|32|||
106176518|NCT03414684|366309399|FG000|First-course Treatment|Adverse Event|1|||
106176519|NCT03414684|366309400|FG001|First-course Treatment|Adverse Event|2|||
106176520|NCT03414684|366309399|FG000|First-course Treatment|Physician Decision|0|||
106176521|NCT03414684|366309400|FG001|First-course Treatment|Physician Decision|1|||
106176522|NCT03414684|366309399|FG000|First-course Treatment|Withdrawal by Subject|0|||
106176523|NCT03414684|366309400|FG001|First-course Treatment|Withdrawal by Subject|1|||
106176524|NCT03414684|366309399|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
106176525|NCT03414684|366309400|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
106176526|NCT03414684|366309399|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
106176527|NCT03414684|366309400|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
106176528|NCT03414684|366309399|FG000|First-course Treatment|Still on treatment|3|||
106176529|NCT03414684|366309400|FG001|First-course Treatment|Still on treatment|0|||
106176530|NCT03414684|366309399|FG000|First-course Treatment|Never started protocol therapy|2|||
106176531|NCT03414684|366309400|FG001|First-course Treatment|Never started protocol therapy|1|||
106176532|NCT03414684|366309399|FG000|Crossover Treatment|Progressive disease|0|||
106176533|NCT03414684|366309400|FG001|Crossover Treatment|Progressive disease|12|||
106176534|NCT03414684|366309399|FG000|Crossover Treatment|Adverse Event|0|||
106176535|NCT03414684|366309400|FG001|Crossover Treatment|Adverse Event|3|||
106176536|NCT03414684|366309399|FG000|Crossover Treatment|Physician Decision|0|||
106176537|NCT03414684|366309400|FG001|Crossover Treatment|Physician Decision|1|||
106176538|NCT03414684|366309399|FG000|Crossover Treatment|Still on treatment|0|||
106176539|NCT03414684|366309400|FG001|Crossover Treatment|Still on treatment|2|||
106176540|NCT03215706|366309410|FG000|Randomization|Adverse Event unrelated to study drug|1|||
106176541|NCT03215706|366309411|FG001|Randomization|Adverse Event unrelated to study drug|0|||
106176542|NCT03215706|366309410|FG000|Randomization|participant withdrew consent|1|||
106176543|NCT03215706|366309411|FG001|Randomization|participant withdrew consent|3|||
106176544|NCT03215706|366309410|FG000|Randomization|no longer meets study criteria|1|||
106176545|NCT03215706|366309411|FG001|Randomization|no longer meets study criteria|4|||
106176546|NCT03215706|366309410|FG000|Randomization|other reasons|0|||
106176547|NCT03215706|366309411|FG001|Randomization|other reasons|2|||
106176548|NCT03215706|366309410|FG000|Treatment Period|Disease Progression|150|||
106176549|NCT03215706|366309411|FG001|Treatment Period|Disease Progression|142|||
106176550|NCT03215706|366309410|FG000|Treatment Period|Study Drug Toxicity|53|||
106176551|NCT03215706|366309411|FG001|Treatment Period|Study Drug Toxicity|21|||
106176552|NCT03215706|366309410|FG000|Treatment Period|Death|2|||
106176553|NCT03215706|366309411|FG001|Treatment Period|Death|1|||
106176554|NCT03215706|366309410|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
106176555|NCT03215706|366309411|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
106176556|NCT03215706|366309410|FG000|Treatment Period|Request to D/C treatment|1|||
106176557|NCT03215706|366309411|FG001|Treatment Period|Request to D/C treatment|6|||
106176558|NCT03215706|366309410|FG000|Treatment Period|Participant withdrew consent|3|||
106176559|NCT03215706|366309411|FG001|Treatment Period|Participant withdrew consent|4|||
106176560|NCT03215706|366309410|FG000|Treatment Period|Lost to Follow-up|0|||
106176561|NCT03215706|366309411|FG001|Treatment Period|Lost to Follow-up|1|||
106176562|NCT03215706|366309410|FG000|Treatment Period|Other Reasons|4|||
106176563|NCT03215706|366309411|FG001|Treatment Period|Other Reasons|5|||
106176564|NCT03215706|366309410|FG000|Treatment Period|Ongoing in the treatment period|105|||
106176565|NCT03215706|366309411|FG001|Treatment Period|Ongoing in the treatment period|43|||
106176566|NCT00593840|366309412|FG000|Overall Study|Withdrawal by Subject|1|||
106176567|NCT02566889|366310283|FG000|Overall Study|Withdrawal by Subject|3|||
106176568|NCT02566889|366310284|FG001|Overall Study|Withdrawal by Subject|1|||
106176569|NCT02566889|366310283|FG000|Overall Study|Adverse Event|4|||
106176570|NCT02566889|366310284|FG001|Overall Study|Adverse Event|2|||
106176571|NCT02566889|366310283|FG000|Overall Study|Other|6|||
106176572|NCT02566889|366310284|FG001|Overall Study|Other|2|||
106176573|NCT00739908|366310285|FG000|Overall Study|Adverse Event|5|||
106176574|NCT00739908|366310286|FG001|Overall Study|Adverse Event|6|||
106176575|NCT00739908|366310285|FG000|Overall Study|Withdrawal by Subject|4|||
106176576|NCT00739908|366310286|FG001|Overall Study|Withdrawal by Subject|2|||
106176577|NCT00739908|366310285|FG000|Overall Study|Lost to Follow-up|14|||
106176578|NCT00739908|366310286|FG001|Overall Study|Lost to Follow-up|9|||
106176579|NCT00739908|366310285|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
106176580|NCT00739908|366310286|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
106176581|NCT00739908|366310285|FG000|Overall Study|Non-Compliance With Study Medication|0|||
106176582|NCT00739908|366310286|FG001|Overall Study|Non-Compliance With Study Medication|3|||
106176583|NCT00739908|366310285|FG000|Overall Study|Lack of Efficacy|0|||
106176584|NCT00739908|366310286|FG001|Overall Study|Lack of Efficacy|1|||
106176585|NCT00739908|366310285|FG000|Overall Study|Relocation|0|||
106176586|NCT00739908|366310286|FG001|Overall Study|Relocation|1|||
106176587|NCT02075554|366310288|FG000|Overall Study|Lost to Follow-up|7|||
106176588|NCT02075554|366310288|FG000|Overall Study|Withdrawal by Subject|5|||
106176589|NCT02075554|366310288|FG000|Overall Study|Physician Decision|3|||
106176590|NCT03248492|366310289|FG000|Overall Study|Progressive Disease|24|||
106176591|NCT03248492|366310290|FG001|Overall Study|Progressive Disease|23|||
106176592|NCT03248492|366310291|FG002|Overall Study|Progressive Disease|11|||
106176593|NCT03248492|366310292|FG003|Overall Study|Progressive Disease|66|||
106176594|NCT03248492|366310293|FG004|Overall Study|Progressive Disease|1|||
106176595|NCT03248492|366310289|FG000|Overall Study|Adverse Event|14|||
106176596|NCT03248492|366310290|FG001|Overall Study|Adverse Event|13|||
106176597|NCT03248492|366310291|FG002|Overall Study|Adverse Event|9|||
106176598|NCT03248492|366310292|FG003|Overall Study|Adverse Event|22|||
106176599|NCT03248492|366310293|FG004|Overall Study|Adverse Event|2|||
106176600|NCT03248492|366310289|FG000|Overall Study|Withdrawal by Subject|5|||
106176601|NCT03248492|366310290|FG001|Overall Study|Withdrawal by Subject|4|||
106176602|NCT03248492|366310291|FG002|Overall Study|Withdrawal by Subject|0|||
106176603|NCT03248492|366310292|FG003|Overall Study|Withdrawal by Subject|8|||
106176604|NCT03248492|366310293|FG004|Overall Study|Withdrawal by Subject|1|||
106176605|NCT03248492|366310289|FG000|Overall Study|Physician Decision|1|||
106176606|NCT03248492|366310290|FG001|Overall Study|Physician Decision|1|||
106176607|NCT03248492|366310291|FG002|Overall Study|Physician Decision|1|||
106176608|NCT03248492|366310292|FG003|Overall Study|Physician Decision|7|||
106176609|NCT03248492|366310293|FG004|Overall Study|Physician Decision|0|||
106176610|NCT03248492|366310289|FG000|Overall Study|Death|1|||
106176611|NCT03248492|366310290|FG001|Overall Study|Death|1|||
106176612|NCT03248492|366310291|FG002|Overall Study|Death|0|||
106176613|NCT03248492|366310292|FG003|Overall Study|Death|6|||
106176614|NCT03248492|366310293|FG004|Overall Study|Death|0|||
106176615|NCT03248492|366310289|FG000|Overall Study|Study Terminated by Sponsor|3|||
106176616|NCT03248492|366310290|FG001|Overall Study|Study Terminated by Sponsor|1|||
106176617|NCT03248492|366310291|FG002|Overall Study|Study Terminated by Sponsor|0|||
106176618|NCT03248492|366310292|FG003|Overall Study|Study Terminated by Sponsor|7|||
106176619|NCT03248492|366310293|FG004|Overall Study|Study Terminated by Sponsor|0|||
106176620|NCT03248492|366310289|FG000|Overall Study|Other|2|||
106176621|NCT03248492|366310290|FG001|Overall Study|Other|5|||
106176622|NCT03248492|366310291|FG002|Overall Study|Other|0|||
106176623|NCT03248492|366310292|FG003|Overall Study|Other|14|||
106176624|NCT03248492|366310293|FG004|Overall Study|Other|0|||
106176625|NCT04757753|366310298|FG000|Overall Study|Lost to Follow-up|7|||
106176626|NCT04757753|366310299|FG001|Overall Study|Lost to Follow-up|7|||
106176627|NCT04757753|366310298|FG000|Overall Study|Withdrawal by Subject|0|||
106176628|NCT04757753|366310299|FG001|Overall Study|Withdrawal by Subject|3|||
106176629|NCT04757753|366310298|FG000|Overall Study|Endodontic treatment failure|1|||
106176630|NCT04757753|366310299|FG001|Overall Study|Endodontic treatment failure|2|||
106176631|NCT04757753|366310298|FG000|Overall Study|Tooth fracture/extraction|3|||
106176632|NCT04757753|366310299|FG001|Overall Study|Tooth fracture/extraction|0|||
106176633|NCT00308997|366310300|FG000|Overall Study|Subject feigned clinical data|0|||
106176634|NCT00308997|366310301|FG001|Overall Study|Subject feigned clinical data|1|||
106176635|NCT00308997|366310300|FG000|Overall Study|Unable to tolerate intervention|1|||
106176636|NCT00308997|366310301|FG001|Overall Study|Unable to tolerate intervention|0|||
106176637|NCT03201939|366310303|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
106176638|NCT03201939|366310304|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
106176639|NCT06688357|366310310|FG000|Overall Study|Adverse Event|0|||
106176640|NCT06688357|366310311|FG001|Overall Study|Adverse Event|1|||
106176641|NCT05116774|366310312|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
106176642|NCT05116774|366310313|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
106176643|NCT05116774|366310312|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
106176644|NCT05116774|366310313|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
106176645|NCT05116774|366310312|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
106176646|NCT05116774|366310313|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
106176647|NCT05116774|366310312|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
106176648|NCT05116774|366310313|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
106176649|NCT05289037|366310314|FG000|Overall Study|Withdrawal by Subject|7|||
106176650|NCT05289037|366310315|FG001|Overall Study|Withdrawal by Subject|0|||
106176651|NCT05289037|366310316|FG002|Overall Study|Withdrawal by Subject|3|||
106176652|NCT05289037|366310317|FG003|Overall Study|Withdrawal by Subject|3|||
106176653|NCT05289037|366310318|FG004|Overall Study|Withdrawal by Subject|1|||
106176654|NCT05289037|366310319|FG005|Overall Study|Withdrawal by Subject|5|||
106176655|NCT05289037|366310320|FG006|Overall Study|Withdrawal by Subject|2|||
106176656|NCT05289037|366310321|FG007|Overall Study|Withdrawal by Subject|1|||
106176657|NCT05289037|366310322|FG008|Overall Study|Withdrawal by Subject|2|||
106176658|NCT05289037|366310323|FG009|Overall Study|Withdrawal by Subject|2|||
106176659|NCT05289037|366310324|FG010|Overall Study|Withdrawal by Subject|1|||
106176660|NCT05289037|366310325|FG011|Overall Study|Withdrawal by Subject|0|||
106176661|NCT05289037|366310326|FG012|Overall Study|Withdrawal by Subject|1|||
106176662|NCT05289037|366310327|FG013|Overall Study|Withdrawal by Subject|2|||
106176663|NCT05289037|366310328|FG014|Overall Study|Withdrawal by Subject|0|||
106176664|NCT05289037|366310329|FG015|Overall Study|Withdrawal by Subject|3|||
106176665|NCT05289037|366310330|FG016|Overall Study|Withdrawal by Subject|3|||
106176666|NCT05289037|366310314|FG000|Overall Study|Lost to Follow-up|1|||
106176667|NCT05289037|366310315|FG001|Overall Study|Lost to Follow-up|4|||
106176668|NCT05289037|366310316|FG002|Overall Study|Lost to Follow-up|3|||
106176669|NCT05289037|366310317|FG003|Overall Study|Lost to Follow-up|3|||
106176670|NCT05289037|366310318|FG004|Overall Study|Lost to Follow-up|3|||
106176671|NCT05289037|366310319|FG005|Overall Study|Lost to Follow-up|2|||
106176672|NCT05289037|366310320|FG006|Overall Study|Lost to Follow-up|3|||
106176673|NCT05289037|366310321|FG007|Overall Study|Lost to Follow-up|2|||
106176674|NCT05289037|366310322|FG008|Overall Study|Lost to Follow-up|2|||
106176675|NCT05289037|366310323|FG009|Overall Study|Lost to Follow-up|1|||
106176676|NCT05289037|366310324|FG010|Overall Study|Lost to Follow-up|3|||
106176677|NCT05289037|366310325|FG011|Overall Study|Lost to Follow-up|4|||
106176678|NCT05289037|366310326|FG012|Overall Study|Lost to Follow-up|2|||
106176679|NCT05289037|366310327|FG013|Overall Study|Lost to Follow-up|7|||
106176680|NCT05289037|366310328|FG014|Overall Study|Lost to Follow-up|4|||
106176681|NCT05289037|366310329|FG015|Overall Study|Lost to Follow-up|6|||
106176682|NCT05289037|366310330|FG016|Overall Study|Lost to Follow-up|4|||
106176683|NCT05289037|366310314|FG000|Overall Study|Death|0|||
106176684|NCT05289037|366310315|FG001|Overall Study|Death|0|||
106176685|NCT05289037|366310316|FG002|Overall Study|Death|0|||
106176686|NCT05289037|366310317|FG003|Overall Study|Death|0|||
106176687|NCT05289037|366310318|FG004|Overall Study|Death|0|||
106176688|NCT05289037|366310319|FG005|Overall Study|Death|1|||
106176689|NCT05289037|366310320|FG006|Overall Study|Death|0|||
106176690|NCT05289037|366310321|FG007|Overall Study|Death|0|||
106176691|NCT05289037|366310322|FG008|Overall Study|Death|0|||
106176692|NCT05289037|366310323|FG009|Overall Study|Death|0|||
106176693|NCT05289037|366310324|FG010|Overall Study|Death|0|||
106176694|NCT05289037|366310325|FG011|Overall Study|Death|0|||
106176695|NCT05289037|366310326|FG012|Overall Study|Death|0|||
106176696|NCT05289037|366310327|FG013|Overall Study|Death|0|||
106176697|NCT05289037|366310328|FG014|Overall Study|Death|1|||
106176698|NCT05289037|366310329|FG015|Overall Study|Death|0|||
106176699|NCT05289037|366310330|FG016|Overall Study|Death|0|||
106176700|NCT05289037|366310314|FG000|Overall Study|Did not receive vaccine|0|||
106176701|NCT05289037|366310315|FG001|Overall Study|Did not receive vaccine|3|||
106176702|NCT05289037|366310316|FG002|Overall Study|Did not receive vaccine|0|||
106176703|NCT05289037|366310317|FG003|Overall Study|Did not receive vaccine|0|||
106176704|NCT05289037|366310318|FG004|Overall Study|Did not receive vaccine|1|||
106176705|NCT05289037|366310319|FG005|Overall Study|Did not receive vaccine|1|||
106176706|NCT05289037|366310320|FG006|Overall Study|Did not receive vaccine|1|||
106176707|NCT05289037|366310321|FG007|Overall Study|Did not receive vaccine|0|||
106176708|NCT05289037|366310322|FG008|Overall Study|Did not receive vaccine|0|||
106176709|NCT05289037|366310323|FG009|Overall Study|Did not receive vaccine|0|||
106176710|NCT05289037|366310324|FG010|Overall Study|Did not receive vaccine|0|||
106176711|NCT05289037|366310325|FG011|Overall Study|Did not receive vaccine|0|||
106176712|NCT05289037|366310326|FG012|Overall Study|Did not receive vaccine|0|||
106176713|NCT05289037|366310327|FG013|Overall Study|Did not receive vaccine|0|||
106176714|NCT05289037|366310328|FG014|Overall Study|Did not receive vaccine|1|||
106176715|NCT05289037|366310329|FG015|Overall Study|Did not receive vaccine|0|||
106176716|NCT05289037|366310330|FG016|Overall Study|Did not receive vaccine|0|||
106176717|NCT05289037|366310314|FG000|Overall Study|Unable to make last visit|0|||
106176718|NCT05289037|366310315|FG001|Overall Study|Unable to make last visit|0|||
106176719|NCT05289037|366310316|FG002|Overall Study|Unable to make last visit|1|||
106176720|NCT05289037|366310317|FG003|Overall Study|Unable to make last visit|0|||
106176721|NCT05289037|366310318|FG004|Overall Study|Unable to make last visit|0|||
106176722|NCT05289037|366310319|FG005|Overall Study|Unable to make last visit|0|||
106176723|NCT05289037|366310320|FG006|Overall Study|Unable to make last visit|0|||
106176724|NCT05289037|366310321|FG007|Overall Study|Unable to make last visit|0|||
106176725|NCT05289037|366310322|FG008|Overall Study|Unable to make last visit|0|||
106176726|NCT05289037|366310323|FG009|Overall Study|Unable to make last visit|0|||
106176727|NCT05289037|366310324|FG010|Overall Study|Unable to make last visit|0|||
106176728|NCT05289037|366310325|FG011|Overall Study|Unable to make last visit|0|||
106176729|NCT05289037|366310326|FG012|Overall Study|Unable to make last visit|0|||
106176730|NCT05289037|366310327|FG013|Overall Study|Unable to make last visit|0|||
106176731|NCT05289037|366310328|FG014|Overall Study|Unable to make last visit|0|||
106176732|NCT05289037|366310329|FG015|Overall Study|Unable to make last visit|0|||
106176733|NCT05289037|366310330|FG016|Overall Study|Unable to make last visit|0|||
106176734|NCT05289037|366310314|FG000|Overall Study|Protocol deviation|0|||
106176735|NCT05289037|366310315|FG001|Overall Study|Protocol deviation|0|||
106176736|NCT05289037|366310316|FG002|Overall Study|Protocol deviation|0|||
106176737|NCT05289037|366310317|FG003|Overall Study|Protocol deviation|0|||
106176738|NCT05289037|366310318|FG004|Overall Study|Protocol deviation|0|||
106176739|NCT05289037|366310319|FG005|Overall Study|Protocol deviation|0|||
106176740|NCT05289037|366310320|FG006|Overall Study|Protocol deviation|0|||
106176741|NCT05289037|366310321|FG007|Overall Study|Protocol deviation|0|||
106176742|NCT05289037|366310322|FG008|Overall Study|Protocol deviation|0|||
106176743|NCT05289037|366310323|FG009|Overall Study|Protocol deviation|0|||
106176744|NCT05289037|366310324|FG010|Overall Study|Protocol deviation|0|||
106176745|NCT05289037|366310325|FG011|Overall Study|Protocol deviation|0|||
106176746|NCT05289037|366310326|FG012|Overall Study|Protocol deviation|0|||
106176747|NCT05289037|366310327|FG013|Overall Study|Protocol deviation|0|||
106176748|NCT05289037|366310328|FG014|Overall Study|Protocol deviation|0|||
106176749|NCT05289037|366310329|FG015|Overall Study|Protocol deviation|1|||
106176750|NCT05289037|366310330|FG016|Overall Study|Protocol deviation|0|||
106176751|NCT04505722|366310332|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
106176752|NCT04505722|366310333|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
106176753|NCT04505722|366310334|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
106176754|NCT04505722|366310332|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
106176755|NCT04505722|366310333|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
106176756|NCT04505722|366310334|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
106176757|NCT04505722|366310332|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
106176758|NCT04505722|366310333|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
106176759|NCT04505722|366310334|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
106176760|NCT04505722|366310332|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
106176761|NCT04505722|366310333|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
106176762|NCT04505722|366310334|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
106176763|NCT04505722|366310332|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
106176764|NCT04505722|366310333|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
106176765|NCT04505722|366310334|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
106176766|NCT04505722|366310332|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
106176767|NCT04505722|366310333|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
106176768|NCT04505722|366310334|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
106176769|NCT04505722|366310332|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
106176770|NCT04505722|366310333|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
106176771|NCT04505722|366310334|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
106176772|NCT04505722|366310332|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
106176773|NCT04505722|366310333|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
106176774|NCT04505722|366310334|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
106176775|NCT04505722|366310332|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
106176776|NCT04505722|366310333|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
106176777|NCT04505722|366310334|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
106176778|NCT04505722|366310332|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
106176779|NCT04505722|366310333|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
106176780|NCT04505722|366310334|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
106176781|NCT04505722|366310332|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
106176782|NCT04505722|366310333|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
106176783|NCT04505722|366310334|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
106176784|NCT04505722|366310332|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
106176785|NCT04505722|366310333|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
106176786|NCT04505722|366310334|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
106176787|NCT04505722|366310332|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
106176788|NCT04505722|366310333|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
106176789|NCT04505722|366310334|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
106176790|NCT04505722|366310332|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
106176791|NCT04505722|366310333|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
106176792|NCT04505722|366310334|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
106176793|NCT04505722|366310332|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
106176794|NCT04505722|366310333|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
106176795|NCT04505722|366310334|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
106176796|NCT01639131|366310894|FG000|Overall Study|Disease Progression|6|||
106176797|NCT04121546|366310905|FG000|Overall Study|Lost to Follow-up|1|||
106176798|NCT04121546|366310906|FG001|Overall Study|Lost to Follow-up|3|||
106176799|NCT04129164|366310907|FG000|Overall Study|Non-compliance with procedures|0|||
106176800|NCT04129164|366310908|FG001|Overall Study|Non-compliance with procedures|0|||
106176801|NCT04129164|366310909|FG002|Overall Study|Non-compliance with procedures|2|||
106176802|NCT04129164|366310910|FG003|Overall Study|Non-compliance with procedures|0|||
106176803|NCT04129164|366310907|FG000|Overall Study|Adverse Event|0|||
106176804|NCT04129164|366310908|FG001|Overall Study|Adverse Event|0|||
106176805|NCT04129164|366310909|FG002|Overall Study|Adverse Event|2|||
106176806|NCT04129164|366310910|FG003|Overall Study|Adverse Event|0|||
106176807|NCT04129164|366310907|FG000|Overall Study|Pregnancy|0|||
106176808|NCT04129164|366310908|FG001|Overall Study|Pregnancy|0|||
106176809|NCT04129164|366310909|FG002|Overall Study|Pregnancy|0|||
106176810|NCT04129164|366310910|FG003|Overall Study|Pregnancy|1|||
106176811|NCT04129164|366310907|FG000|Overall Study|Withdrawal by Subject|3|||
106176812|NCT04129164|366310908|FG001|Overall Study|Withdrawal by Subject|2|||
106176813|NCT04129164|366310909|FG002|Overall Study|Withdrawal by Subject|4|||
106176814|NCT04129164|366310910|FG003|Overall Study|Withdrawal by Subject|6|||
106176815|NCT04129164|366310907|FG000|Overall Study|Death|0|||
106176816|NCT04129164|366310908|FG001|Overall Study|Death|1|||
106176817|NCT04129164|366310909|FG002|Overall Study|Death|0|||
106176818|NCT04129164|366310910|FG003|Overall Study|Death|0|||
106176819|NCT04129164|366310907|FG000|Overall Study|Lost to Follow-up|0|||
106176820|NCT04129164|366310908|FG001|Overall Study|Lost to Follow-up|1|||
106176821|NCT04129164|366310909|FG002|Overall Study|Lost to Follow-up|0|||
106176822|NCT04129164|366310910|FG003|Overall Study|Lost to Follow-up|0|||
106176823|NCT03705390|366310916|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
106176824|NCT03705390|366310916|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
106176825|NCT00087685|366310917|FG000|Overall Study|Adverse Event|5|||
106176826|NCT00087685|366310917|FG000|Overall Study|Non-Compliance|1|||
106176827|NCT00087685|366310917|FG000|Overall Study|Progressive Disease|5|||
106176828|NCT00087685|366310917|FG000|Overall Study|Withdrawal by Subject|3|||
106176829|NCT04908514|366310920|FG000|Overall Study|Lost to Follow-up|2|||
106176830|NCT04908514|366310920|FG000|Overall Study|Withdrawal by Subject|1|||
106176831|NCT05714059|366310921|FG000|Overall Study|Withdrawal by Subject|2|||
106176832|NCT05714059|366310922|FG001|Overall Study|Withdrawal by Subject|2|||
106176833|NCT05714059|366310921|FG000|Overall Study|Adverse Event|0|||
106176834|NCT05714059|366310922|FG001|Overall Study|Adverse Event|1|||
106176835|NCT05714059|366310921|FG000|Overall Study|Lost to Follow-up|0|||
106176836|NCT05714059|366310922|FG001|Overall Study|Lost to Follow-up|1|||
106176837|NCT05714059|366310921|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
106176838|NCT05714059|366310922|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
106176839|NCT05714059|366310921|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
106176840|NCT05714059|366310922|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
106176841|NCT04899674|366310923|FG000|Test|Adverse Event|1|||
106176842|NCT04059406|366310924|FG000|Overall Study|Early Treatment Termination|5|||
106176843|NCT04059406|366310925|FG001|Overall Study|Early Treatment Termination|5|||
106176844|NCT04059406|366310926|FG002|Overall Study|Early Treatment Termination|15|||
106176845|NCT03150862|366310931|FG000|Overall Study|Death|2|||
106176846|NCT03150862|366310932|FG001|Overall Study|Death|7|||
106176847|NCT03150862|366310933|FG002|Overall Study|Death|8|||
106176848|NCT03150862|366310934|FG003|Overall Study|Death|27|||
106176849|NCT03150862|366310935|FG004|Overall Study|Death|4|||
106176850|NCT03150862|366310936|FG005|Overall Study|Death|8|||
106176851|NCT03150862|366310937|FG006|Overall Study|Death|6|||
106176852|NCT03150862|366310938|FG007|Overall Study|Death|21|||
106176853|NCT03150862|366310931|FG000|Overall Study|Withdrawal by Subject|1|||
106176854|NCT03150862|366310932|FG001|Overall Study|Withdrawal by Subject|1|||
106176855|NCT03150862|366310933|FG002|Overall Study|Withdrawal by Subject|0|||
106176856|NCT03150862|366310934|FG003|Overall Study|Withdrawal by Subject|3|||
106176857|NCT03150862|366310935|FG004|Overall Study|Withdrawal by Subject|1|||
106176858|NCT03150862|366310936|FG005|Overall Study|Withdrawal by Subject|1|||
106176859|NCT03150862|366310937|FG006|Overall Study|Withdrawal by Subject|1|||
106176860|NCT03150862|366310938|FG007|Overall Study|Withdrawal by Subject|3|||
106176861|NCT03150862|366310931|FG000|Overall Study|Lost to Follow-up|0|||
106176862|NCT03150862|366310932|FG001|Overall Study|Lost to Follow-up|0|||
106176863|NCT03150862|366310933|FG002|Overall Study|Lost to Follow-up|1|||
106176864|NCT03150862|366310934|FG003|Overall Study|Lost to Follow-up|0|||
106176865|NCT03150862|366310935|FG004|Overall Study|Lost to Follow-up|0|||
106176866|NCT03150862|366310936|FG005|Overall Study|Lost to Follow-up|0|||
106176867|NCT03150862|366310937|FG006|Overall Study|Lost to Follow-up|0|||
106176868|NCT03150862|366310938|FG007|Overall Study|Lost to Follow-up|2|||
106176869|NCT03150862|366310931|FG000|Overall Study|Sponsor's decision|0|||
106176870|NCT03150862|366310932|FG001|Overall Study|Sponsor's decision|0|||
106176871|NCT03150862|366310933|FG002|Overall Study|Sponsor's decision|0|||
106176872|NCT03150862|366310934|FG003|Overall Study|Sponsor's decision|10|||
106176873|NCT03150862|366310935|FG004|Overall Study|Sponsor's decision|3|||
106176874|NCT03150862|366310936|FG005|Overall Study|Sponsor's decision|0|||
106176875|NCT03150862|366310937|FG006|Overall Study|Sponsor's decision|1|||
106176876|NCT03150862|366310938|FG007|Overall Study|Sponsor's decision|1|||
106176877|NCT03150862|366310931|FG000|Overall Study|Change in Methylation status|0|||
106176878|NCT03150862|366310932|FG001|Overall Study|Change in Methylation status|0|||
106176879|NCT03150862|366310933|FG002|Overall Study|Change in Methylation status|0|||
106176880|NCT03150862|366310934|FG003|Overall Study|Change in Methylation status|0|||
106176881|NCT03150862|366310935|FG004|Overall Study|Change in Methylation status|1|||
106176882|NCT03150862|366310936|FG005|Overall Study|Change in Methylation status|0|||
106176883|NCT03150862|366310937|FG006|Overall Study|Change in Methylation status|0|||
106176884|NCT03150862|366310938|FG007|Overall Study|Change in Methylation status|0|||
106176885|NCT03150862|366310931|FG000|Overall Study|Roll over in to Long Term Extension|0|||
106176886|NCT03150862|366310932|FG001|Overall Study|Roll over in to Long Term Extension|0|||
106176887|NCT03150862|366310933|FG002|Overall Study|Roll over in to Long Term Extension|0|||
106176888|NCT03150862|366310934|FG003|Overall Study|Roll over in to Long Term Extension|0|||
106176889|NCT03150862|366310935|FG004|Overall Study|Roll over in to Long Term Extension|0|||
106176890|NCT03150862|366310936|FG005|Overall Study|Roll over in to Long Term Extension|0|||
106176891|NCT03150862|366310937|FG006|Overall Study|Roll over in to Long Term Extension|0|||
106176892|NCT03150862|366310938|FG007|Overall Study|Roll over in to Long Term Extension|1|||
106176893|NCT03150862|366310931|FG000|Overall Study|Progressive Disease|0|||
106176894|NCT03150862|366310932|FG001|Overall Study|Progressive Disease|0|||
106176895|NCT03150862|366310933|FG002|Overall Study|Progressive Disease|0|||
106176896|NCT03150862|366310934|FG003|Overall Study|Progressive Disease|0|||
106176897|NCT03150862|366310935|FG004|Overall Study|Progressive Disease|0|||
106176898|NCT03150862|366310936|FG005|Overall Study|Progressive Disease|0|||
106176899|NCT03150862|366310937|FG006|Overall Study|Progressive Disease|0|||
106176900|NCT03150862|366310938|FG007|Overall Study|Progressive Disease|2|||
106176901|NCT03280030|366310941|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
106176902|NCT03280030|366310942|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
106176903|NCT03280030|366310943|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
106176904|NCT03280030|366310941|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
106176905|NCT03280030|366310942|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
106176906|NCT03280030|366310943|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
106176907|NCT03280030|366310941|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
106176908|NCT03280030|366310942|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
106176909|NCT03280030|366310943|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
106176910|NCT03280030|366310941|FG000|Part 2 - Efficacy|Adverse Event|0|||
106176911|NCT03280030|366310942|FG001|Part 2 - Efficacy|Adverse Event|4|||
106176912|NCT03280030|366310943|FG002|Part 2 - Efficacy|Adverse Event|6|||
106176913|NCT03280030|366310941|FG000|Part 2 - Efficacy|Death|0|||
106176914|NCT03280030|366310942|FG001|Part 2 - Efficacy|Death|3|||
106176915|NCT03280030|366310943|FG002|Part 2 - Efficacy|Death|0|||
106176916|NCT03280030|366310941|FG000|Part 2 - Efficacy|Physician Decision|0|||
106176917|NCT03280030|366310942|FG001|Part 2 - Efficacy|Physician Decision|10|||
106176918|NCT03280030|366310943|FG002|Part 2 - Efficacy|Physician Decision|16|||
106176919|NCT03280030|366310941|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
106176920|NCT03280030|366310942|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
106176921|NCT03280030|366310943|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
106176922|NCT03280030|366310941|FG000|Part 2 - Efficacy|Progressive disease|0|||
106176923|NCT03280030|366310942|FG001|Part 2 - Efficacy|Progressive disease|7|||
106176924|NCT03280030|366310943|FG002|Part 2 - Efficacy|Progressive disease|5|||
106176925|NCT02039401|366310944|FG000|Overall Study|Adverse Event|0|||
106176926|NCT02039401|366310945|FG001|Overall Study|Adverse Event|1|||
106176927|NCT03867201|366310946|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
106176928|NCT03867201|366310947|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
106176929|NCT03867201|366310946|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
106176930|NCT03867201|366310947|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
106176931|NCT03867201|366310946|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
106176932|NCT03867201|366310947|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
106176933|NCT03867201|366310946|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
106176934|NCT03867201|366310947|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
106176935|NCT03867201|366310946|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
106176936|NCT03867201|366310947|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
106176937|NCT03867201|366310946|FG000|Open-Label Period From Week 12|Adverse Event|5|||
106176938|NCT03867201|366310947|FG001|Open-Label Period From Week 12|Adverse Event|11|||
106176939|NCT03867201|366310946|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
106176940|NCT03867201|366310947|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
106176941|NCT03867201|366310946|FG000|Open-Label Period From Week 12|Physician Decision|6|||
106176942|NCT03867201|366310947|FG001|Open-Label Period From Week 12|Physician Decision|3|||
106176943|NCT03867201|366310946|FG000|Open-Label Period From Week 12|Pregnancy|2|||
106176944|NCT03867201|366310947|FG001|Open-Label Period From Week 12|Pregnancy|2|||
106176945|NCT03867201|366310946|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
106176946|NCT03867201|366310947|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
106176947|NCT03867201|366310946|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
106176948|NCT03867201|366310947|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
106176949|NCT03867201|366310946|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
106176950|NCT03867201|366310947|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
106176951|NCT03867201|366310946|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
106176952|NCT03867201|366310947|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
106176953|NCT05795153|366311536|FG000|Overall Study|Adverse Event|2|||
106176954|NCT05795153|366311536|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106176955|NCT05795153|366311536|FG000|Overall Study|Lost to Follow-up|1|||
106176956|NCT05795153|366311536|FG000|Overall Study|Subject decision|2|||
106176957|NCT05180539|366311539|FG000|Overall Study|Lost to Follow-up|27|||
106176958|NCT05180539|366311540|FG001|Overall Study|Lost to Follow-up|30|||
106176959|NCT02866942|366311547|FG000|Overall Study|Invalid consent|1|||
106176960|NCT00439270|366311548|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
106176961|NCT00439270|366311549|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
106176962|NCT00439270|366311550|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
106176963|NCT00439270|366311551|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
106176964|NCT00439270|366311552|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
106176965|NCT00439270|366311548|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
106176966|NCT00439270|366311549|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
106176967|NCT00439270|366311550|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
106176968|NCT00439270|366311551|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
106176969|NCT00439270|366311552|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
106176970|NCT00439270|366311548|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
106176971|NCT00439270|366311549|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
106176972|NCT00439270|366311550|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
106176973|NCT00439270|366311551|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
106176974|NCT00439270|366311552|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
106176975|NCT00439270|366311548|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
106176976|NCT00439270|366311549|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
106176977|NCT00439270|366311550|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
106176978|NCT00439270|366311551|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
106176979|NCT00439270|366311552|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
106176980|NCT00439270|366311548|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
106176981|NCT00439270|366311549|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
106176982|NCT00439270|366311550|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
106176983|NCT00439270|366311551|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
106176984|NCT00439270|366311552|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
106176985|NCT00439270|366311548|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
106176986|NCT00439270|366311549|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
106176987|NCT00439270|366311550|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
106176988|NCT00439270|366311551|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
106176989|NCT00439270|366311552|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
106176990|NCT00439270|366311548|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
106176991|NCT00439270|366311549|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
106176992|NCT00439270|366311550|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
106176993|NCT00439270|366311551|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
106176994|NCT00439270|366311552|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
106176995|NCT00439270|366311548|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
106176996|NCT00439270|366311549|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
106176997|NCT00439270|366311550|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
106176998|NCT00439270|366311551|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
106176999|NCT00439270|366311552|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
106177000|NCT00439270|366311548|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
106177001|NCT00439270|366311549|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
106177002|NCT00439270|366311550|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
106177003|NCT00439270|366311551|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
106177004|NCT00439270|366311552|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
106177005|NCT00439270|366311548|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
106177006|NCT00439270|366311549|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
106177007|NCT00439270|366311550|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
106177008|NCT00439270|366311551|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
106177009|NCT00439270|366311552|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
106177010|NCT00312208|366311553|FG000|Overall Study|Adverse Event|97|||
106177011|NCT00312208|366311554|FG001|Overall Study|Adverse Event|61|||
106177012|NCT00312208|366311553|FG000|Overall Study|Protocol Violation|5|||
106177013|NCT00312208|366311554|FG001|Overall Study|Protocol Violation|3|||
106177014|NCT00312208|366311553|FG000|Overall Study|Death|2|||
106177015|NCT00312208|366311554|FG001|Overall Study|Death|1|||
106177016|NCT00312208|366311553|FG000|Overall Study|Lack of Efficacy|7|||
106177017|NCT00312208|366311554|FG001|Overall Study|Lack of Efficacy|4|||
106177018|NCT00312208|366311553|FG000|Overall Study|Lost to Follow-up|3|||
106177019|NCT00312208|366311554|FG001|Overall Study|Lost to Follow-up|5|||
106177020|NCT00312208|366311553|FG000|Overall Study|Withdrawal by Subject|53|||
106177021|NCT00312208|366311554|FG001|Overall Study|Withdrawal by Subject|42|||
106177022|NCT00312208|366311553|FG000|Overall Study|Other|5|||
106177023|NCT00312208|366311554|FG001|Overall Study|Other|7|||
106177024|NCT01313559|366311561|FG000|Overall Study|Withdrawal by Subject|1|||
106177025|NCT01313559|366311562|FG001|Overall Study|Withdrawal by Subject|2|||
106177026|NCT01313559|366311561|FG000|Overall Study|Disease progression|1|||
106177027|NCT01313559|366311562|FG001|Overall Study|Disease progression|0|||
106177028|NCT01313559|366311561|FG000|Overall Study|Rising PSA|2|||
106177029|NCT01313559|366311562|FG001|Overall Study|Rising PSA|0|||
106177030|NCT02656706|366311563|FG000|Overall Study|Insurance Denial|1|||
106177031|NCT03222609|366311565|FG000|Overall Study|Withdrew consent|2|||
106177032|NCT03222609|366311566|FG001|Overall Study|Withdrew consent|3|||
106177033|NCT03222609|366311567|FG002|Overall Study|Withdrew consent|4|||
106177034|NCT03222609|366311568|FG003|Overall Study|Withdrew consent|2|||
106177035|NCT03222609|366311565|FG000|Overall Study|Lost to Follow-up|1|||
106177036|NCT03222609|366311566|FG001|Overall Study|Lost to Follow-up|0|||
106177037|NCT03222609|366311567|FG002|Overall Study|Lost to Follow-up|0|||
106177038|NCT03222609|366311568|FG003|Overall Study|Lost to Follow-up|0|||
106177039|NCT03222609|366311565|FG000|Overall Study|Death|16|||
106177040|NCT03222609|366311566|FG001|Overall Study|Death|13|||
106177041|NCT03222609|366311567|FG002|Overall Study|Death|9|||
106177042|NCT03222609|366311568|FG003|Overall Study|Death|6|||
106177043|NCT03222609|366311565|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
106177044|NCT03222609|366311566|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
106177045|NCT03222609|366311567|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
106177046|NCT03222609|366311568|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
106177047|NCT04158141|366311569|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
106177048|NCT04158141|366311570|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
106177049|NCT04158141|366311571|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
106177050|NCT04158141|366311569|FG000|Step 1: Registration|Adverse Event|1|||
106177051|NCT04158141|366311570|FG001|Step 1: Registration|Adverse Event|0|||
106177052|NCT04158141|366311571|FG002|Step 1: Registration|Adverse Event|0|||
106177053|NCT04158141|366311569|FG000|Step 1: Registration|Withdrawal by Subject|1|||
106177054|NCT04158141|366311570|FG001|Step 1: Registration|Withdrawal by Subject|0|||
106177055|NCT04158141|366311571|FG002|Step 1: Registration|Withdrawal by Subject|0|||
106177056|NCT04158141|366311569|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
106177057|NCT04158141|366311570|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
106177058|NCT04158141|366311571|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
106177059|NCT01084863|366311572|FG000|Main Study Treatment Period|Disease progression|11|||
106177060|NCT01084863|366311573|FG001|Main Study Treatment Period|Disease progression|7|||
106177061|NCT01084863|366311572|FG000|Main Study Treatment Period|Adverse Event|5|||
106177062|NCT01084863|366311573|FG001|Main Study Treatment Period|Adverse Event|3|||
106177063|NCT01084863|366311572|FG000|Main Study Treatment Period|Other Reason|0|||
106177064|NCT01084863|366311573|FG001|Main Study Treatment Period|Other Reason|1|||
106177065|NCT01084863|366311572|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
106177066|NCT01084863|366311573|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
106177067|NCT01084863|366311572|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
106177068|NCT01084863|366311573|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
106177069|NCT01084863|366311572|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
106177070|NCT01084863|366311573|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
106177071|NCT01084863|366311572|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
106177072|NCT01084863|366311573|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
106177073|NCT01084863|366311572|FG000|Treatment Period Beyond Cycle 8|Other|0|||
106177074|NCT01084863|366311573|FG001|Treatment Period Beyond Cycle 8|Other|1|||
106177075|NCT01084863|366311572|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
106177076|NCT01084863|366311573|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
106177077|NCT00319696|366311574|FG000|Overall Study|Adverse Event|36|||
106177078|NCT00319696|366311574|FG000|Overall Study|withdrawal of consent|14|||
106177079|NCT00319696|366311574|FG000|Overall Study|administrative|7|||
106177080|NCT00319696|366311574|FG000|Overall Study|Lost to Follow-up|3|||
106177081|NCT03275285|366311579|FG000|Overall Study|Ongoing|45|||
106177082|NCT03275285|366311580|FG001|Overall Study|Ongoing|69|||
106177083|NCT06191679|366311581|FG000|Baseline|Lost to Follow-up|1|||
106177084|NCT06191679|366311582|FG001|Baseline|Lost to Follow-up|0|||
106177085|NCT06191679|366311583|FG002|Baseline|Lost to Follow-up|1|||
106177086|NCT06191679|366311584|FG003|Baseline|Lost to Follow-up|0|||
106177087|NCT06191679|366311581|FG000|Allocation to Group|Withdrawal by Subject|0|||
106177088|NCT06191679|366311582|FG001|Allocation to Group|Withdrawal by Subject|1|||
106177089|NCT06191679|366311583|FG002|Allocation to Group|Withdrawal by Subject|2|||
106177090|NCT06191679|366311584|FG003|Allocation to Group|Withdrawal by Subject|0|||
106177091|NCT06191679|366311581|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
106177092|NCT06191679|366311582|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
106177093|NCT06191679|366311583|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
106177094|NCT06191679|366311584|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
106177095|NCT06191679|366311581|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
106177096|NCT06191679|366311582|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
106177097|NCT06191679|366311583|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
106177098|NCT06191679|366311584|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
106177099|NCT06191679|366311581|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
106177100|NCT06191679|366311582|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
106177101|NCT06191679|366311583|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
106177102|NCT06191679|366311584|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
106177103|NCT03997474|366311588|FG000|Overall Study|Death|6|||
106177104|NCT03997474|366311589|FG001|Overall Study|Death|2|||
106177105|NCT03997474|366311590|FG002|Overall Study|Death|1|||
106177106|NCT03997474|366311588|FG000|Overall Study|Physician Decision|2|||
106177107|NCT03997474|366311589|FG001|Overall Study|Physician Decision|0|||
106177108|NCT03997474|366311590|FG002|Overall Study|Physician Decision|0|||
106177109|NCT03997474|366311588|FG000|Overall Study|study terminated by sponsor|1|||
106177110|NCT03997474|366311589|FG001|Overall Study|study terminated by sponsor|0|||
106177111|NCT03997474|366311590|FG002|Overall Study|study terminated by sponsor|1|||
106177112|NCT04980300|366311591|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
106177113|NCT04980300|366311592|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
106177114|NCT04980300|366311591|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
106177115|NCT04980300|366311592|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
106177116|NCT04980300|366311591|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
106177117|NCT04980300|366311592|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
106177118|NCT04980300|366311591|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
106177119|NCT04980300|366311592|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
106177120|NCT05529992|366311594|FG000|Overall Study|Withdrawal by Subject|1|||
106177121|NCT01142388|366314638|FG000|Overall Study|Lack of Efficacy|21|||
106177122|NCT01142388|366314639|FG001|Overall Study|Lack of Efficacy|31|||
106177123|NCT01142388|366314638|FG000|Overall Study|Adverse Event|9|||
106177124|NCT01142388|366314639|FG001|Overall Study|Adverse Event|5|||
106177125|NCT01142388|366314638|FG000|Overall Study|Death|3|||
106177126|NCT01142388|366314639|FG001|Overall Study|Death|2|||
106177127|NCT01142388|366314638|FG000|Overall Study|Withdrawal by Subject|5|||
106177128|NCT01142388|366314639|FG001|Overall Study|Withdrawal by Subject|3|||
106177129|NCT01142388|366314638|FG000|Overall Study|Alternative therapy|1|||
106177130|NCT01142388|366314639|FG001|Overall Study|Alternative therapy|0|||
106177131|NCT01142388|366314638|FG000|Overall Study|Other complications|0|||
106177132|NCT01142388|366314639|FG001|Overall Study|Other complications|2|||
106177133|NCT01142388|366314638|FG000|Overall Study|Other|1|||
106177134|NCT01142388|366314639|FG001|Overall Study|Other|1|||
106177135|NCT01142388|366314638|FG000|Overall Study|Never started therapy|7|||
106177136|NCT01142388|366314639|FG001|Overall Study|Never started therapy|3|||
106177137|NCT01274338|366314640|FG000|Overall Study|Lack of Efficacy|72|||
106177138|NCT01274338|366314641|FG001|Overall Study|Lack of Efficacy|108|||
106177139|NCT01274338|366314642|FG002|Overall Study|Lack of Efficacy|116|||
106177140|NCT01274338|366314643|FG003|Overall Study|Lack of Efficacy|0|||
106177141|NCT01274338|366314644|FG004|Overall Study|Lack of Efficacy|0|||
106177142|NCT01274338|366314645|FG005|Overall Study|Lack of Efficacy|0|||
106177143|NCT01274338|366314640|FG000|Overall Study|Adverse Event|272|||
106177144|NCT01274338|366314641|FG001|Overall Study|Adverse Event|105|||
106177145|NCT01274338|366314642|FG002|Overall Study|Adverse Event|180|||
106177146|NCT01274338|366314643|FG003|Overall Study|Adverse Event|1|||
106177147|NCT01274338|366314644|FG004|Overall Study|Adverse Event|0|||
106177148|NCT01274338|366314645|FG005|Overall Study|Adverse Event|0|||
106177149|NCT01274338|366314640|FG000|Overall Study|Death|8|||
106177150|NCT01274338|366314641|FG001|Overall Study|Death|1|||
106177151|NCT01274338|366314642|FG002|Overall Study|Death|0|||
106177152|NCT01274338|366314643|FG003|Overall Study|Death|0|||
106177153|NCT01274338|366314644|FG004|Overall Study|Death|0|||
106177154|NCT01274338|366314645|FG005|Overall Study|Death|0|||
106177155|NCT01274338|366314640|FG000|Overall Study|Withdrawal by Subject|27|||
106177156|NCT01274338|366314641|FG001|Overall Study|Withdrawal by Subject|99|||
106177157|NCT01274338|366314642|FG002|Overall Study|Withdrawal by Subject|17|||
106177158|NCT01274338|366314643|FG003|Overall Study|Withdrawal by Subject|0|||
106177159|NCT01274338|366314644|FG004|Overall Study|Withdrawal by Subject|0|||
106177160|NCT01274338|366314645|FG005|Overall Study|Withdrawal by Subject|0|||
106177161|NCT01274338|366314640|FG000|Overall Study|Did not start treatment|8|||
106177162|NCT01274338|366314641|FG001|Overall Study|Did not start treatment|116|||
106177163|NCT01274338|366314642|FG002|Overall Study|Did not start treatment|7|||
106177164|NCT01274338|366314643|FG003|Overall Study|Did not start treatment|0|||
106177165|NCT01274338|366314644|FG004|Overall Study|Did not start treatment|0|||
106177166|NCT01274338|366314645|FG005|Overall Study|Did not start treatment|0|||
106177167|NCT01274338|366314640|FG000|Overall Study|Alternative therapy|0|||
106177168|NCT01274338|366314641|FG001|Overall Study|Alternative therapy|1|||
106177169|NCT01274338|366314642|FG002|Overall Study|Alternative therapy|0|||
106177170|NCT01274338|366314643|FG003|Overall Study|Alternative therapy|0|||
106177171|NCT01274338|366314644|FG004|Overall Study|Alternative therapy|0|||
106177172|NCT01274338|366314645|FG005|Overall Study|Alternative therapy|0|||
106177173|NCT01274338|366314640|FG000|Overall Study|Other complicating diseases|0|||
106177174|NCT01274338|366314641|FG001|Overall Study|Other complicating diseases|3|||
106177175|NCT01274338|366314642|FG002|Overall Study|Other complicating diseases|1|||
106177176|NCT01274338|366314643|FG003|Overall Study|Other complicating diseases|0|||
106177177|NCT01274338|366314644|FG004|Overall Study|Other complicating diseases|0|||
106177178|NCT01274338|366314645|FG005|Overall Study|Other complicating diseases|0|||
106177179|NCT01274338|366314640|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
106177180|NCT01274338|366314641|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
106177181|NCT01274338|366314642|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
106177182|NCT01274338|366314643|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
106177183|NCT01274338|366314644|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
106177184|NCT01274338|366314645|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
106177185|NCT01274338|366314640|FG000|Overall Study|Pregnancy|0|||
106177186|NCT01274338|366314641|FG001|Overall Study|Pregnancy|0|||
106177187|NCT01274338|366314642|FG002|Overall Study|Pregnancy|1|||
106177188|NCT01274338|366314643|FG003|Overall Study|Pregnancy|0|||
106177189|NCT01274338|366314644|FG004|Overall Study|Pregnancy|0|||
106177190|NCT01274338|366314645|FG005|Overall Study|Pregnancy|0|||
106177191|NCT01274338|366314640|FG000|Overall Study|Reason not reported|12|||
106177192|NCT01274338|366314641|FG001|Overall Study|Reason not reported|21|||
106177193|NCT01274338|366314642|FG002|Overall Study|Reason not reported|3|||
106177194|NCT01274338|366314643|FG003|Overall Study|Reason not reported|0|||
106177195|NCT01274338|366314644|FG004|Overall Study|Reason not reported|1|||
106177196|NCT01274338|366314645|FG005|Overall Study|Reason not reported|0|||
106177197|NCT01386385|366314646|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
106177198|NCT01386385|366314647|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
106177199|NCT01386385|366314648|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
106177200|NCT01386385|366314649|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
106177201|NCT01386385|366314650|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
106177202|NCT01386385|366314651|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
106177203|NCT01386385|366314652|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
106177204|NCT01386385|366314653|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
106177205|NCT01386385|366314646|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
106177206|NCT01386385|366314647|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
106177207|NCT01386385|366314648|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
106177208|NCT01386385|366314649|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
106177209|NCT01386385|366314650|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
106177210|NCT01386385|366314651|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
106177211|NCT01386385|366314652|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
106177212|NCT01386385|366314653|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
106177213|NCT01386385|366314646|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
106177214|NCT01386385|366314647|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
106177215|NCT01386385|366314648|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
106177216|NCT01386385|366314649|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
106177217|NCT01386385|366314650|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
106177218|NCT01386385|366314651|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
106177219|NCT01386385|366314652|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
106177220|NCT01386385|366314653|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
106177221|NCT01386385|366314646|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
106177222|NCT01386385|366314647|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
106177223|NCT01386385|366314648|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
106177224|NCT01386385|366314649|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
106177225|NCT01386385|366314650|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
106177226|NCT01386385|366314651|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
106177227|NCT01386385|366314652|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
106177228|NCT01386385|366314653|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
106177229|NCT01386385|366314646|FG000|Phase II Concurrent CRT|Adverse Event|0|||
106177230|NCT01386385|366314647|FG001|Phase II Concurrent CRT|Adverse Event|0|||
106177231|NCT01386385|366314648|FG002|Phase II Concurrent CRT|Adverse Event|0|||
106177232|NCT01386385|366314649|FG003|Phase II Concurrent CRT|Adverse Event|0|||
106177233|NCT01386385|366314650|FG004|Phase II Concurrent CRT|Adverse Event|0|||
106177234|NCT01386385|366314651|FG005|Phase II Concurrent CRT|Adverse Event|0|||
106177235|NCT01386385|366314652|FG006|Phase II Concurrent CRT|Adverse Event|3|||
106177236|NCT01386385|366314653|FG007|Phase II Concurrent CRT|Adverse Event|3|||
106177237|NCT01386385|366314646|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
106177238|NCT01386385|366314647|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
106177239|NCT01386385|366314648|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
106177240|NCT01386385|366314649|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
106177241|NCT01386385|366314650|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
106177242|NCT01386385|366314651|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
106177243|NCT01386385|366314652|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
106177244|NCT01386385|366314653|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
106177245|NCT01386385|366314646|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
106177246|NCT01386385|366314647|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
106177247|NCT01386385|366314648|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
106177248|NCT01386385|366314649|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
106177249|NCT01386385|366314650|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
106177250|NCT01386385|366314651|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
106177251|NCT01386385|366314652|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
106177252|NCT01386385|366314653|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
106177253|NCT01386385|366314646|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
106177254|NCT01386385|366314647|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
106177255|NCT01386385|366314648|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
106177256|NCT01386385|366314649|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
106177257|NCT01386385|366314650|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
106177258|NCT01386385|366314651|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
106177259|NCT01386385|366314652|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
106177260|NCT01386385|366314653|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
106177261|NCT01386385|366314646|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
106177262|NCT01386385|366314647|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
106177263|NCT01386385|366314648|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
106177264|NCT01386385|366314649|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
106177265|NCT01386385|366314650|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
106177266|NCT01386385|366314651|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
106177267|NCT01386385|366314652|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
106177268|NCT01386385|366314653|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
106177269|NCT04179175|366314655|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
106177270|NCT04179175|366314656|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
106177271|NCT04179175|366314657|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
106177272|NCT04179175|366314658|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
106177273|NCT04179175|366314659|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
106177274|NCT04179175|366314660|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
106177275|NCT04179175|366314655|FG000|Overall Study|Adverse Event|5|||
106177276|NCT04179175|366314656|FG001|Overall Study|Adverse Event|3|||
106177277|NCT04179175|366314657|FG002|Overall Study|Adverse Event|3|||
106177278|NCT04179175|366314658|FG003|Overall Study|Adverse Event|4|||
106177279|NCT04179175|366314659|FG004|Overall Study|Adverse Event|6|||
106177280|NCT04179175|366314660|FG005|Overall Study|Adverse Event|6|||
106177281|NCT04179175|366314655|FG000|Overall Study|Lack of Efficacy|5|||
106177282|NCT04179175|366314656|FG001|Overall Study|Lack of Efficacy|1|||
106177283|NCT04179175|366314657|FG002|Overall Study|Lack of Efficacy|3|||
106177284|NCT04179175|366314658|FG003|Overall Study|Lack of Efficacy|2|||
106177285|NCT04179175|366314659|FG004|Overall Study|Lack of Efficacy|18|||
106177286|NCT04179175|366314660|FG005|Overall Study|Lack of Efficacy|7|||
106177287|NCT04179175|366314655|FG000|Overall Study|Lost to Follow-up|5|||
106177288|NCT04179175|366314656|FG001|Overall Study|Lost to Follow-up|3|||
106177289|NCT04179175|366314657|FG002|Overall Study|Lost to Follow-up|2|||
106177290|NCT04179175|366314658|FG003|Overall Study|Lost to Follow-up|2|||
106177291|NCT04179175|366314659|FG004|Overall Study|Lost to Follow-up|4|||
106177292|NCT04179175|366314660|FG005|Overall Study|Lost to Follow-up|5|||
106177293|NCT04179175|366314655|FG000|Overall Study|Physician Decision|2|||
106177294|NCT04179175|366314656|FG001|Overall Study|Physician Decision|0|||
106177295|NCT04179175|366314657|FG002|Overall Study|Physician Decision|2|||
106177296|NCT04179175|366314658|FG003|Overall Study|Physician Decision|3|||
106177297|NCT04179175|366314659|FG004|Overall Study|Physician Decision|1|||
106177298|NCT04179175|366314660|FG005|Overall Study|Physician Decision|1|||
106177299|NCT04179175|366314655|FG000|Overall Study|Pregnancy|3|||
106177300|NCT04179175|366314656|FG001|Overall Study|Pregnancy|0|||
106177301|NCT04179175|366314657|FG002|Overall Study|Pregnancy|3|||
106177302|NCT04179175|366314658|FG003|Overall Study|Pregnancy|0|||
106177303|NCT04179175|366314659|FG004|Overall Study|Pregnancy|1|||
106177304|NCT04179175|366314660|FG005|Overall Study|Pregnancy|2|||
106177305|NCT04179175|366314655|FG000|Overall Study|Withdrawal by Subject|22|||
106177306|NCT04179175|366314656|FG001|Overall Study|Withdrawal by Subject|10|||
106177307|NCT04179175|366314657|FG002|Overall Study|Withdrawal by Subject|12|||
106177308|NCT04179175|366314658|FG003|Overall Study|Withdrawal by Subject|8|||
106177309|NCT04179175|366314659|FG004|Overall Study|Withdrawal by Subject|23|||
106177310|NCT04179175|366314660|FG005|Overall Study|Withdrawal by Subject|31|||
106177311|NCT04179175|366314655|FG000|Overall Study|Technical problems|0|||
106177312|NCT04179175|366314656|FG001|Overall Study|Technical problems|0|||
106177313|NCT04179175|366314657|FG002|Overall Study|Technical problems|1|||
106177314|NCT04179175|366314658|FG003|Overall Study|Technical problems|1|||
106177315|NCT04179175|366314659|FG004|Overall Study|Technical problems|0|||
106177316|NCT04179175|366314660|FG005|Overall Study|Technical problems|0|||
106177317|NCT06025396|366314668|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
106177318|NCT06025396|366314669|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
106177319|NCT06025396|366314670|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
106177320|NCT06025396|366314671|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
106177321|NCT06025396|366314672|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
106177322|NCT06025396|366314668|FG000|Overall Study|Withdrawal by Subject|0|||
106177323|NCT06025396|366314669|FG001|Overall Study|Withdrawal by Subject|1|||
106177324|NCT06025396|366314670|FG002|Overall Study|Withdrawal by Subject|1|||
106177325|NCT06025396|366314671|FG003|Overall Study|Withdrawal by Subject|0|||
106177326|NCT06025396|366314672|FG004|Overall Study|Withdrawal by Subject|0|||
106177327|NCT02775851|366314673|FG000|Overall Study|Adverse Event|1|||
106177328|NCT02775851|366314674|FG001|Overall Study|Adverse Event|10|||
106177329|NCT02775851|366314673|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
106177330|NCT02775851|366314674|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
106177331|NCT02775851|366314673|FG000|Overall Study|Progression/Relapse|0|||
106177332|NCT02775851|366314674|FG001|Overall Study|Progression/Relapse|4|||
106177333|NCT02775851|366314673|FG000|Overall Study|Other - Not Protocol Specified|0|||
106177334|NCT02775851|366314674|FG001|Overall Study|Other - Not Protocol Specified|7|||
106177335|NCT02775851|366314673|FG000|Overall Study|Withdrawal by Subject|1|||
106177336|NCT02775851|366314674|FG001|Overall Study|Withdrawal by Subject|0|||
106177337|NCT03938324|366314676|FG000|Overall Study|Lost to Follow-up|42|||
106177338|NCT03938324|366314677|FG001|Overall Study|Lost to Follow-up|21|||
106177339|NCT03938324|366314676|FG000|Overall Study|Withdrawal by Subject|6|||
106177340|NCT03938324|366314677|FG001|Overall Study|Withdrawal by Subject|1|||
106177341|NCT05691829|366314678|FG000|Overall Study|Physician Decision|2|||
106177342|NCT05691829|366314678|FG000|Overall Study|Eligibility criteria not met|3|||
106177343|NCT02769962|366314679|FG000|Overall Study|Physician Decision|0|||
106177344|NCT02769962|366314680|FG001|Overall Study|Physician Decision|0|||
106177345|NCT02769962|366314681|FG002|Overall Study|Physician Decision|0|||
106177346|NCT02769962|366314682|FG003|Overall Study|Physician Decision|0|||
106177347|NCT02769962|366314683|FG004|Overall Study|Physician Decision|0|||
106177348|NCT02769962|366314684|FG005|Overall Study|Physician Decision|1|||
106177349|NCT02769962|366314685|FG006|Overall Study|Physician Decision|0|||
106177350|NCT02769962|366314686|FG007|Overall Study|Physician Decision|1|||
106177351|NCT02769962|366314679|FG000|Overall Study|Refused further treatment|0|||
106177352|NCT02769962|366314680|FG001|Overall Study|Refused further treatment|0|||
106177353|NCT02769962|366314681|FG002|Overall Study|Refused further treatment|0|||
106177354|NCT02769962|366314682|FG003|Overall Study|Refused further treatment|0|||
106177355|NCT02769962|366314683|FG004|Overall Study|Refused further treatment|0|||
106177356|NCT02769962|366314684|FG005|Overall Study|Refused further treatment|1|||
106177357|NCT02769962|366314685|FG006|Overall Study|Refused further treatment|1|||
106177358|NCT02769962|366314686|FG007|Overall Study|Refused further treatment|0|||
106177359|NCT03737994|366314687|FG000|Overall Study|Withdrawal by Subject|0|||
106177360|NCT03737994|366314688|FG001|Overall Study|Withdrawal by Subject|0|||
106177361|NCT03737994|366314689|FG002|Overall Study|Withdrawal by Subject|0|||
106177362|NCT03737994|366314690|FG003|Overall Study|Withdrawal by Subject|0|||
106177363|NCT03737994|366314691|FG004|Overall Study|Withdrawal by Subject|0|||
106177364|NCT03737994|366314692|FG005|Overall Study|Withdrawal by Subject|0|||
106177365|NCT03737994|366314693|FG006|Overall Study|Withdrawal by Subject|1|||
106177366|NCT03548207|366314694|FG000|Overall Study|Death|10|||
106177367|NCT03548207|366314695|FG001|Overall Study|Death|23|||
106177368|NCT03548207|366314696|FG002|Overall Study|Death|3|||
106177369|NCT03548207|366314694|FG000|Overall Study|Lost to Follow-up|0|||
106177370|NCT03548207|366314695|FG001|Overall Study|Lost to Follow-up|2|||
106177371|NCT03548207|366314696|FG002|Overall Study|Lost to Follow-up|0|||
106177372|NCT03548207|366314694|FG000|Overall Study|Withdrawal by Subject|0|||
106177373|NCT03548207|366314695|FG001|Overall Study|Withdrawal by Subject|3|||
106177374|NCT03548207|366314696|FG002|Overall Study|Withdrawal by Subject|0|||
106177375|NCT03548207|366314694|FG000|Overall Study|Sponsor decision|19|||
106177376|NCT03548207|366314695|FG001|Overall Study|Sponsor decision|40|||
106177377|NCT03548207|366314696|FG002|Overall Study|Sponsor decision|6|||
106177378|NCT03548207|366314694|FG000|Overall Study|Randomized but not treated|6|||
106177379|NCT03548207|366314695|FG001|Overall Study|Randomized but not treated|10|||
106177380|NCT03548207|366314696|FG002|Overall Study|Randomized but not treated|4|||
106177381|NCT01286272|366314701|FG000|Overall Study|Ineligible after beginning treatment|1|||
106177382|NCT01286272|366314702|FG001|Overall Study|Ineligible after beginning treatment|3|||
106177383|NCT00937937|366314705|FG000|Overall Study|Adverse Event|6|||
106177384|NCT00937937|366314705|FG000|Overall Study|Withdrawal by Subject|2|||
106177385|NCT00937937|366314705|FG000|Overall Study|Progression/relapse|61|||
106177386|NCT00937937|366314705|FG000|Overall Study|Death|1|||
106177387|NCT00937937|366314705|FG000|Overall Study|Other|2|||
106177388|NCT03563716|366314706|FG000|Overall Study|Death|20|||
106177389|NCT03563716|366314707|FG001|Overall Study|Death|14|||
106177390|NCT03563716|366314706|FG000|Overall Study|Withdrawal by Subject|3|||
106177391|NCT03563716|366314707|FG001|Overall Study|Withdrawal by Subject|3|||
106177392|NCT03563716|366314706|FG000|Overall Study|Still on Study|45|||
106177393|NCT03563716|366314707|FG001|Overall Study|Still on Study|50|||
106177394|NCT04075487|366314708|FG000|Overall Study|Withdrawal by Subject|1|||
106177395|NCT02783170|366314709|FG000|Overall Study|Randomized but not Vaccinated|1|||
106177396|NCT02783170|366314710|FG001|Overall Study|Randomized but not Vaccinated|0|||
106177397|NCT06422377|366314711|FG000|Overall Study|Study Terminated by Sponsor|1|||
106177398|NCT00070564|366314714|FG000|Overall Study|Progression|2|||
106177399|NCT00070564|366314715|FG001|Overall Study|Progression|4|||
106177400|NCT00070564|366314716|FG002|Overall Study|Progression|7|||
106177401|NCT00070564|366314717|FG003|Overall Study|Progression|7|||
106177402|NCT00070564|366314718|FG004|Overall Study|Progression|1|||
106177403|NCT00070564|366314719|FG005|Overall Study|Progression|0|||
106177404|NCT00070564|366314714|FG000|Overall Study|Delinquent|1|||
106177405|NCT00070564|366314715|FG001|Overall Study|Delinquent|4|||
106177406|NCT00070564|366314716|FG002|Overall Study|Delinquent|2|||
106177407|NCT00070564|366314717|FG003|Overall Study|Delinquent|0|||
106177408|NCT00070564|366314718|FG004|Overall Study|Delinquent|0|||
106177409|NCT00070564|366314719|FG005|Overall Study|Delinquent|0|||
106177410|NCT00070564|366314714|FG000|Overall Study|Adverse Event|150|||
106177411|NCT00070564|366314715|FG001|Overall Study|Adverse Event|142|||
106177412|NCT00070564|366314716|FG002|Overall Study|Adverse Event|120|||
106177413|NCT00070564|366314717|FG003|Overall Study|Adverse Event|108|||
106177414|NCT00070564|366314718|FG004|Overall Study|Adverse Event|63|||
106177415|NCT00070564|366314719|FG005|Overall Study|Adverse Event|36|||
106177416|NCT00070564|366314714|FG000|Overall Study|Death|4|||
106177417|NCT00070564|366314715|FG001|Overall Study|Death|1|||
106177418|NCT00070564|366314716|FG002|Overall Study|Death|5|||
106177419|NCT00070564|366314717|FG003|Overall Study|Death|3|||
106177420|NCT00070564|366314718|FG004|Overall Study|Death|0|||
106177421|NCT00070564|366314719|FG005|Overall Study|Death|1|||
106177422|NCT00070564|366314714|FG000|Overall Study|Other, not protocol specified|17|||
106177423|NCT00070564|366314715|FG001|Overall Study|Other, not protocol specified|15|||
106177424|NCT00070564|366314716|FG002|Overall Study|Other, not protocol specified|14|||
106177425|NCT00070564|366314717|FG003|Overall Study|Other, not protocol specified|19|||
106177426|NCT00070564|366314718|FG004|Overall Study|Other, not protocol specified|6|||
106177427|NCT00070564|366314719|FG005|Overall Study|Other, not protocol specified|7|||
106177428|NCT00070564|366314714|FG000|Overall Study|Withdrawal by Subject|26|||
106177429|NCT00070564|366314715|FG001|Overall Study|Withdrawal by Subject|37|||
106177430|NCT00070564|366314716|FG002|Overall Study|Withdrawal by Subject|23|||
106177431|NCT00070564|366314717|FG003|Overall Study|Withdrawal by Subject|30|||
106177432|NCT00070564|366314718|FG004|Overall Study|Withdrawal by Subject|8|||
106177433|NCT00070564|366314719|FG005|Overall Study|Withdrawal by Subject|8|||
106177434|NCT00070564|366314714|FG000|Overall Study|Not reported|0|||
106177435|NCT00070564|366314715|FG001|Overall Study|Not reported|0|||
106177436|NCT00070564|366314716|FG002|Overall Study|Not reported|0|||
106177437|NCT00070564|366314717|FG003|Overall Study|Not reported|0|||
106177438|NCT00070564|366314718|FG004|Overall Study|Not reported|1|||
106177439|NCT00070564|366314719|FG005|Overall Study|Not reported|0|||
106177440|NCT03104699|366314720|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
106177441|NCT03104699|366314721|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
106177442|NCT03104699|366314722|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
106177443|NCT03104699|366314723|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
106177444|NCT03104699|366314724|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
106177445|NCT03104699|366314725|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
106177446|NCT03104699|366314720|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
106177447|NCT03104699|366314721|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
106177448|NCT03104699|366314722|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
106177449|NCT03104699|366314723|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
106177450|NCT03104699|366314724|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
106177451|NCT03104699|366314725|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
106177452|NCT03104699|366314720|FG000|Phase 1: Dose Escalation|Death|6|||
106177453|NCT03104699|366314721|FG001|Phase 1: Dose Escalation|Death|3|||
106177454|NCT03104699|366314722|FG002|Phase 1: Dose Escalation|Death|0|||
106177455|NCT03104699|366314723|FG003|Phase 1: Dose Escalation|Death|1|||
106177456|NCT03104699|366314724|FG004|Phase 1: Dose Escalation|Death|1|||
106177457|NCT03104699|366314725|FG005|Phase 1: Dose Escalation|Death|0|||
106177458|NCT03104699|366314720|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
106177459|NCT03104699|366314721|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
106177460|NCT03104699|366314722|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
106177461|NCT03104699|366314723|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
106177462|NCT03104699|366314724|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
106177463|NCT03104699|366314725|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
106177464|NCT03104699|366314720|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
106177465|NCT03104699|366314721|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
106177466|NCT03104699|366314722|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
106177467|NCT03104699|366314723|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
106177468|NCT03104699|366314724|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
106177469|NCT03104699|366314725|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
106177470|NCT03104699|366314720|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
106177471|NCT03104699|366314721|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
106177472|NCT03104699|366314722|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
106177473|NCT03104699|366314723|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
106177474|NCT03104699|366314724|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
106177475|NCT03104699|366314725|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
106177476|NCT03104699|366314720|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
106177477|NCT03104699|366314721|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
106177478|NCT03104699|366314722|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
106177479|NCT03104699|366314723|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
106177480|NCT03104699|366314724|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
106177481|NCT03104699|366314725|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
106177482|NCT03104699|366314720|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
106177483|NCT03104699|366314721|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
106177484|NCT03104699|366314722|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
106177485|NCT03104699|366314723|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
106177486|NCT03104699|366314724|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
106177487|NCT03104699|366314725|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
106177488|NCT03104699|366314720|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106177489|NCT03104699|366314721|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106177490|NCT03104699|366314722|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106177491|NCT03104699|366314723|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106177492|NCT03104699|366314724|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
106177493|NCT03104699|366314725|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
106177494|NCT03104699|366314720|FG000|Phase 2: Dose Expansion|Death|0|||
106177495|NCT03104699|366314721|FG001|Phase 2: Dose Expansion|Death|0|||
106177496|NCT03104699|366314722|FG002|Phase 2: Dose Expansion|Death|0|||
106177497|NCT03104699|366314723|FG003|Phase 2: Dose Expansion|Death|0|||
106177498|NCT03104699|366314724|FG004|Phase 2: Dose Expansion|Death|0|||
106177499|NCT03104699|366314725|FG005|Phase 2: Dose Expansion|Death|107|||
106177500|NCT03104699|366314720|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
106177501|NCT03104699|366314721|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
106177502|NCT03104699|366314722|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
106177503|NCT03104699|366314723|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
106177504|NCT03104699|366314724|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
106177505|NCT03104699|366314725|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
106177506|NCT03104699|366314720|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
106177507|NCT03104699|366314721|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
106177508|NCT03104699|366314722|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
106177509|NCT03104699|366314723|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
106177510|NCT03104699|366314724|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
106177511|NCT03104699|366314725|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
106177512|NCT03104699|366314720|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106177513|NCT03104699|366314721|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106177514|NCT03104699|366314722|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106177515|NCT03104699|366314723|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106177516|NCT03104699|366314724|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
106177517|NCT03104699|366314725|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
106177518|NCT03104699|366314720|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
106177519|NCT03104699|366314721|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
106177520|NCT03104699|366314722|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
106177521|NCT03104699|366314723|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
106177522|NCT03104699|366314724|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
106177523|NCT03104699|366314725|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
106177524|NCT01171898|366314728|FG000|Overall Study|Death|0|||
106177525|NCT01171898|366314729|FG001|Overall Study|Death|0|||
106177526|NCT01171898|366314730|FG002|Overall Study|Death|2|||
106177527|NCT01171898|366314731|FG003|Overall Study|Death|0|||
106177528|NCT01171898|366314728|FG000|Overall Study|Lost to Follow-up|0|||
106177529|NCT01171898|366314729|FG001|Overall Study|Lost to Follow-up|1|||
106177530|NCT01171898|366314730|FG002|Overall Study|Lost to Follow-up|1|||
106177531|NCT01171898|366314731|FG003|Overall Study|Lost to Follow-up|1|||
106177532|NCT01171898|366314728|FG000|Overall Study|Withdrawal by Subject|1|||
106177533|NCT01171898|366314729|FG001|Overall Study|Withdrawal by Subject|4|||
106177534|NCT01171898|366314730|FG002|Overall Study|Withdrawal by Subject|6|||
106177535|NCT01171898|366314731|FG003|Overall Study|Withdrawal by Subject|3|||
106177536|NCT01171898|366314728|FG000|Overall Study|Terminated by Sponsor|1|||
106177537|NCT01171898|366314729|FG001|Overall Study|Terminated by Sponsor|0|||
106177538|NCT01171898|366314730|FG002|Overall Study|Terminated by Sponsor|0|||
106177539|NCT01171898|366314731|FG003|Overall Study|Terminated by Sponsor|0|||
106177540|NCT01171898|366314728|FG000|Overall Study|Ongoing|1|||
106177541|NCT01171898|366314729|FG001|Overall Study|Ongoing|9|||
106177542|NCT01171898|366314730|FG002|Overall Study|Ongoing|3|||
106177543|NCT01171898|366314731|FG003|Overall Study|Ongoing|0|||
106177544|NCT01171898|366314728|FG000|Overall Study|Other|1|||
106177545|NCT01171898|366314729|FG001|Overall Study|Other|5|||
106177546|NCT01171898|366314730|FG002|Overall Study|Other|0|||
106177547|NCT01171898|366314731|FG003|Overall Study|Other|2|||
106177548|NCT03055013|366314733|FG000|Overall Study|Adverse Event|78|||
106177549|NCT03055013|366314734|FG001|Overall Study|Adverse Event|0|||
106177550|NCT03055013|366314733|FG000|Overall Study|Death|6|||
106177551|NCT03055013|366314734|FG001|Overall Study|Death|0|||
106177552|NCT03055013|366314733|FG000|Overall Study|Disease relapse|33|||
106177553|NCT03055013|366314734|FG001|Overall Study|Disease relapse|0|||
106177554|NCT03055013|366314733|FG000|Overall Study|Withdrawal by Subject|28|||
106177555|NCT03055013|366314734|FG001|Overall Study|Withdrawal by Subject|0|||
106177556|NCT03055013|366314733|FG000|Overall Study|Other complicating disease|5|||
106177557|NCT03055013|366314734|FG001|Overall Study|Other complicating disease|0|||
106177558|NCT03055013|366314733|FG000|Overall Study|Physician Decision|1|||
106177559|NCT03055013|366314734|FG001|Overall Study|Physician Decision|0|||
106177560|NCT03055013|366314733|FG000|Overall Study|Benign mass/non-RCC|4|||
106177561|NCT03055013|366314734|FG001|Overall Study|Benign mass/non-RCC|0|||
106177562|NCT03055013|366314733|FG000|Overall Study|Enrolled in another trial|1|||
106177563|NCT03055013|366314734|FG001|Overall Study|Enrolled in another trial|0|||
106177564|NCT03055013|366314733|FG000|Overall Study|Non-protocol therapy|1|||
106177565|NCT03055013|366314734|FG001|Overall Study|Non-protocol therapy|0|||
106177566|NCT03055013|366314733|FG000|Overall Study|Incompliance|1|||
106177567|NCT03055013|366314734|FG001|Overall Study|Incompliance|0|||
106177568|NCT03055013|366314733|FG000|Overall Study|Insurance issues|1|||
106177569|NCT03055013|366314734|FG001|Overall Study|Insurance issues|0|||
106177570|NCT03055013|366314733|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
106177571|NCT03055013|366314734|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
106177572|NCT03055013|366314733|FG000|Overall Study|Did not receive nivolumab|10|||
106177573|NCT03055013|366314734|FG001|Overall Study|Did not receive nivolumab|0|||
106177574|NCT03055013|366314733|FG000|Overall Study|Did not receive surgery|0|||
106177575|NCT03055013|366314734|FG001|Overall Study|Did not receive surgery|28|||
106177576|NCT02506153|366314742|FG000|Overall Study|Adverse Event|359|||
106177577|NCT02506153|366314743|FG001|Overall Study|Adverse Event|114|||
106177578|NCT02506153|366314742|FG000|Overall Study|Refused unrelated to adverse event|127|||
106177579|NCT02506153|366314743|FG001|Overall Study|Refused unrelated to adverse event|18|||
106177580|NCT02506153|366314742|FG000|Overall Study|Progression/relapse|91|||
106177581|NCT02506153|366314743|FG001|Overall Study|Progression/relapse|136|||
106177582|NCT02506153|366314742|FG000|Overall Study|Death|2|||
106177583|NCT02506153|366314743|FG001|Overall Study|Death|1|||
106177584|NCT02506153|366314742|FG000|Overall Study|Other - not protocol specified|23|||
106177585|NCT02506153|366314743|FG001|Overall Study|Other - not protocol specified|12|||
106177586|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
106177587|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
106177588|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
106177589|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
106177590|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
106177591|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
106177592|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
106177593|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
106177594|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
106177595|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
106177596|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
106177597|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
106177598|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
106177599|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
106177600|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
106177601|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
106177602|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
106177603|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
106177604|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
106177605|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
106177606|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
106177607|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
106177608|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
106177609|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
106177610|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
106177611|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
106177612|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
106177613|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
106177614|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
106177615|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
106177616|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
106177617|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
106177618|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
106177619|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
106177620|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
106177621|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
106177622|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
106177623|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
106177624|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
106177625|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
106177626|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
106177627|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
106177628|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
106177629|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
106177630|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
106177631|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
106177632|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
106177633|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
106177634|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
106177635|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
106177636|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
106177637|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
106177638|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
106177639|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
106177640|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
106177641|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
106177642|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
106177643|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
106177644|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
106177645|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
106177646|NCT03395197|366314744|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
106177647|NCT03395197|366314745|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
106177648|NCT03395197|366314746|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
106177649|NCT03395197|366314747|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
106177650|NCT03395197|366314748|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
106177651|NCT03395197|366314749|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
106177652|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|Death|0|||
106177653|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|Death|0|||
106177654|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|Death|0|||
106177655|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|Death|0|||
106177656|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|Death|1|||
106177657|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|Death|4|||
106177658|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
106177659|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
106177660|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
106177661|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
106177662|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
106177663|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
106177664|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
106177665|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
106177666|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
106177667|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
106177668|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
106177669|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
106177670|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
106177671|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
106177672|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
106177673|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
106177674|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
106177675|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
106177676|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
106177677|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
106177678|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
106177679|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
106177680|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
106177681|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
106177682|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
106177683|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
106177684|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
106177685|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
106177686|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
106177687|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
106177688|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
106177689|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
106177690|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
106177691|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
106177692|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
106177693|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
106177694|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|Other|0|||
106177695|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|Other|0|||
106177696|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|Other|0|||
106177697|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|Other|0|||
106177698|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|Other|3|||
106177699|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|Other|3|||
106177700|NCT03395197|366314744|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
106177701|NCT03395197|366314745|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
106177702|NCT03395197|366314746|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
106177703|NCT03395197|366314747|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
106177704|NCT03395197|366314748|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
106177705|NCT03395197|366314749|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
106177706|NCT00861705|366314750|FG000|Overall Study|Never Began Treatment|7|||
106177707|NCT00861705|366314751|FG001|Overall Study|Never Began Treatment|3|||
106177708|NCT00861705|366314752|FG002|Overall Study|Never Began Treatment|0|||
106177709|NCT00861705|366314753|FG003|Overall Study|Never Began Treatment|1|||
106177710|NCT00433511|366314765|FG000|Step 1|Adverse Event|50|||
106177711|NCT00433511|366314766|FG001|Step 1|Adverse Event|157|||
106177712|NCT00433511|366314767|FG002|Step 1|Adverse Event|153|||
106177713|NCT00433511|366314765|FG000|Step 1|Withdrawal by Subject|45|||
106177714|NCT00433511|366314766|FG001|Step 1|Withdrawal by Subject|143|||
106177715|NCT00433511|366314767|FG002|Step 1|Withdrawal by Subject|154|||
106177716|NCT00433511|366314765|FG000|Step 1|Death|3|||
106177717|NCT00433511|366314766|FG001|Step 1|Death|1|||
106177718|NCT00433511|366314767|FG002|Step 1|Death|1|||
106177719|NCT00433511|366314765|FG000|Step 1|Physician Decision|1|||
106177720|NCT00433511|366314766|FG001|Step 1|Physician Decision|4|||
106177721|NCT00433511|366314767|FG002|Step 1|Physician Decision|3|||
106177722|NCT00433511|366314765|FG000|Step 1|Never started protocol therapy|28|||
106177723|NCT00433511|366314766|FG001|Step 1|Never started protocol therapy|64|||
106177724|NCT00433511|366314767|FG002|Step 1|Never started protocol therapy|66|||
106177725|NCT00433511|366314765|FG000|Step 1|Alternative therapy|2|||
106177726|NCT00433511|366314766|FG001|Step 1|Alternative therapy|1|||
106177727|NCT00433511|366314767|FG002|Step 1|Alternative therapy|3|||
106177728|NCT00433511|366314765|FG000|Step 1|Disease progression, relapse|5|||
106177729|NCT00433511|366314766|FG001|Step 1|Disease progression, relapse|3|||
106177730|NCT00433511|366314767|FG002|Step 1|Disease progression, relapse|3|||
106177731|NCT00433511|366314765|FG000|Step 1|Other complicating disease|2|||
106177732|NCT00433511|366314766|FG001|Step 1|Other complicating disease|6|||
106177733|NCT00433511|366314767|FG002|Step 1|Other complicating disease|3|||
106177734|NCT00433511|366314765|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
106177735|NCT00433511|366314766|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
106177736|NCT00433511|366314767|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
106177737|NCT00433511|366314765|FG000|Step 1|Suspected recurrence|0|||
106177738|NCT00433511|366314766|FG001|Step 1|Suspected recurrence|1|||
106177739|NCT00433511|366314767|FG002|Step 1|Suspected recurrence|0|||
106177740|NCT00433511|366314765|FG000|Step 1|Insurance/drug distribution issues|0|||
106177741|NCT00433511|366314766|FG001|Step 1|Insurance/drug distribution issues|1|||
106177742|NCT00433511|366314767|FG002|Step 1|Insurance/drug distribution issues|2|||
106177743|NCT00433511|366314765|FG000|Step 1|Patient moved|0|||
106177744|NCT00433511|366314766|FG001|Step 1|Patient moved|0|||
106177745|NCT00433511|366314767|FG002|Step 1|Patient moved|1|||
106177746|NCT00433511|366314765|FG000|Step 2 (Arm D)|Adverse Event|0|||
106177747|NCT00433511|366314766|FG001|Step 2 (Arm D)|Adverse Event|0|||
106177748|NCT00433511|366314767|FG002|Step 2 (Arm D)|Adverse Event|135|||
106177749|NCT00433511|366314765|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
106177750|NCT00433511|366314766|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
106177751|NCT00433511|366314767|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
106177752|NCT00433511|366314765|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
106177753|NCT00433511|366314766|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
106177754|NCT00433511|366314767|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
106177755|NCT00433511|366314765|FG000|Step 2 (Arm D)|Physician Decision|0|||
106177756|NCT00433511|366314766|FG001|Step 2 (Arm D)|Physician Decision|0|||
106177757|NCT00433511|366314767|FG002|Step 2 (Arm D)|Physician Decision|9|||
106177758|NCT00433511|366314765|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
106177759|NCT00433511|366314766|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
106177760|NCT00433511|366314767|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
106177761|NCT00433511|366314765|FG000|Step 2 (Arm D)|Other complicating disease|0|||
106177762|NCT00433511|366314766|FG001|Step 2 (Arm D)|Other complicating disease|0|||
106177763|NCT00433511|366314767|FG002|Step 2 (Arm D)|Other complicating disease|3|||
106177764|NCT00433511|366314765|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
106177765|NCT00433511|366314766|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
106177766|NCT00433511|366314767|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
106177767|NCT00433511|366314765|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
106177768|NCT00433511|366314766|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
106177769|NCT00433511|366314767|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
106177770|NCT00433511|366314765|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
106177771|NCT00433511|366314766|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
106177772|NCT00433511|366314767|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
106177773|NCT00433511|366314765|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
106177774|NCT00433511|366314766|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
106177775|NCT00433511|366314767|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
106177776|NCT02595879|366314768|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
106177777|NCT02595879|366314769|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
106177778|NCT05383209|366314770|FG000|Overall Study|Adverse Event: Non-ocular|0|||
106177779|NCT05383209|366314771|FG001|Overall Study|Adverse Event: Non-ocular|1|||
106177780|NCT05383209|366314772|FG002|Overall Study|Adverse Event: Non-ocular|0|||
106177781|NCT05383209|366314770|FG000|Overall Study|Lost to Follow-up|2|||
106177782|NCT05383209|366314771|FG001|Overall Study|Lost to Follow-up|1|||
106177783|NCT05383209|366314772|FG002|Overall Study|Lost to Follow-up|4|||
106177784|NCT05383209|366314770|FG000|Overall Study|Withdrawal by Subject|2|||
106177785|NCT05383209|366314771|FG001|Overall Study|Withdrawal by Subject|0|||
106177786|NCT05383209|366314772|FG002|Overall Study|Withdrawal by Subject|1|||
106177787|NCT05383209|366314770|FG000|Overall Study|Death|1|||
106177788|NCT05383209|366314771|FG001|Overall Study|Death|0|||
106177789|NCT05383209|366314772|FG002|Overall Study|Death|0|||
106177790|NCT05383209|366314770|FG000|Overall Study|Other|0|||
106177791|NCT05383209|366314771|FG001|Overall Study|Other|1|||
106177792|NCT05383209|366314772|FG002|Overall Study|Other|0|||
106177793|NCT00602641|366314773|FG000|Overall Study|Never started protocol therapy|6|||
106177794|NCT00602641|366314774|FG001|Overall Study|Never started protocol therapy|2|||
106177795|NCT00602641|366314773|FG000|Overall Study|Still on treatment at time of analysis|8|||
106177796|NCT00602641|366314774|FG001|Overall Study|Still on treatment at time of analysis|15|||
106177797|NCT00602641|366314773|FG000|Overall Study|Adverse Event|62|||
106177798|NCT00602641|366314774|FG001|Overall Study|Adverse Event|53|||
106177799|NCT00602641|366314773|FG000|Overall Study|Disease progression|38|||
106177800|NCT00602641|366314774|FG001|Overall Study|Disease progression|55|||
106177801|NCT00602641|366314773|FG000|Overall Study|Death|6|||
106177802|NCT00602641|366314774|FG001|Overall Study|Death|5|||
106177803|NCT00602641|366314773|FG000|Overall Study|Withdrawal by Subject|15|||
106177804|NCT00602641|366314774|FG001|Overall Study|Withdrawal by Subject|12|||
106177805|NCT00602641|366314773|FG000|Overall Study|Alternative therapy|5|||
106177806|NCT00602641|366314774|FG001|Overall Study|Alternative therapy|2|||
106177807|NCT00602641|366314773|FG000|Overall Study|Other Complicating Disease|5|||
106177808|NCT00602641|366314774|FG001|Overall Study|Other Complicating Disease|2|||
106177809|NCT00602641|366314773|FG000|Overall Study|Physician Decision|5|||
106177810|NCT00602641|366314774|FG001|Overall Study|Physician Decision|4|||
106177811|NCT00602641|366314773|FG000|Overall Study|Administrative Closure|1|||
106177812|NCT00602641|366314774|FG001|Overall Study|Administrative Closure|1|||
106177813|NCT00602641|366314773|FG000|Overall Study|Other|3|||
106177814|NCT00602641|366314774|FG001|Overall Study|Other|1|||
106177815|NCT04452669|366314775|FG000|Overall Study|Death|1|||
106177816|NCT04452669|366314776|FG001|Overall Study|Death|4|||
106177817|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
106177818|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
106177819|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
106177820|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
106177821|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
106177822|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
106177823|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
106177824|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
106177825|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
106177826|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
106177827|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
106177828|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
106177829|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
106177830|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
106177831|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
106177832|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
106177833|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
106177834|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
106177835|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
106177836|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
106177837|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
106177838|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
106177839|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
106177840|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
106177841|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
106177842|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
106177843|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
106177844|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
106177845|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
106177846|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
106177847|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
106177848|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
106177849|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177850|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177851|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
106177852|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177853|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177854|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177855|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
106177856|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177857|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
106177858|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
106177859|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
106177860|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
106177861|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
106177862|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
106177863|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
106177864|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
106177865|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
106177866|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
106177867|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
106177868|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
106177869|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
106177870|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
106177871|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
106177872|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
106177873|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
106177874|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
106177875|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
106177876|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
106177877|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
106177878|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
106177879|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
106177880|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
106177881|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
106177882|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
106177883|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
106177884|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
106177885|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
106177886|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
106177887|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
106177888|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
106177889|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177890|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177891|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177892|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177893|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177894|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
106177895|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177896|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
106177897|NCT03896503|366314779|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
106177898|NCT03896503|366314780|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
106177899|NCT03896503|366314781|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
106177900|NCT03896503|366314782|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
106177901|NCT03896503|366314783|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
106177902|NCT03896503|366314784|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
106177903|NCT03896503|366314785|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
106177904|NCT03896503|366314786|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
106177905|NCT03056755|366314787|FG000|Treatment- Core Phase|Progressive disease|89|||
106177906|NCT03056755|366314788|FG001|Treatment- Core Phase|Progressive disease|88|||
106177907|NCT03056755|366314789|FG002|Treatment- Core Phase|Progressive disease|90|||
106177908|NCT03056755|366314787|FG000|Treatment- Core Phase|Adverse Event|20|||
106177909|NCT03056755|366314788|FG001|Treatment- Core Phase|Adverse Event|14|||
106177910|NCT03056755|366314789|FG002|Treatment- Core Phase|Adverse Event|13|||
106177911|NCT03056755|366314787|FG000|Treatment- Core Phase|Physician Decision|7|||
106177912|NCT03056755|366314788|FG001|Treatment- Core Phase|Physician Decision|13|||
106177913|NCT03056755|366314789|FG002|Treatment- Core Phase|Physician Decision|5|||
106177914|NCT03056755|366314787|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
106177915|NCT03056755|366314788|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
106177916|NCT03056755|366314789|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
106177917|NCT03056755|366314787|FG000|Treatment- Core Phase|Death|3|||
106177918|NCT03056755|366314788|FG001|Treatment- Core Phase|Death|2|||
106177919|NCT03056755|366314789|FG002|Treatment- Core Phase|Death|4|||
106177920|NCT03056755|366314787|FG000|Treatment- Core Phase|Protocol deviation|1|||
106177921|NCT03056755|366314788|FG001|Treatment- Core Phase|Protocol deviation|1|||
106177922|NCT03056755|366314789|FG002|Treatment- Core Phase|Protocol deviation|0|||
106177923|NCT03056755|366314787|FG000|Treatment- Core Phase|Technical problems|1|||
106177924|NCT03056755|366314788|FG001|Treatment- Core Phase|Technical problems|0|||
106177925|NCT03056755|366314789|FG002|Treatment- Core Phase|Technical problems|0|||
106177926|NCT03056755|366314787|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
106177927|NCT03056755|366314788|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
106177928|NCT03056755|366314789|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
106177929|NCT03056755|366314787|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
106177930|NCT03056755|366314788|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
106177931|NCT03056755|366314789|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
106177932|NCT03056755|366314787|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
106177933|NCT03056755|366314788|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
106177934|NCT03056755|366314789|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
106177935|NCT03056755|366314787|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
106177936|NCT03056755|366314788|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
106177937|NCT03056755|366314789|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
106177938|NCT03729596|366314791|FG000|Overall Study|Death|3|||
106177939|NCT03729596|366314792|FG001|Overall Study|Death|5|||
106177940|NCT03729596|366314793|FG002|Overall Study|Death|4|||
106177941|NCT03729596|366314794|FG003|Overall Study|Death|1|||
106177942|NCT03729596|366314795|FG004|Overall Study|Death|0|||
106177943|NCT03729596|366314796|FG005|Overall Study|Death|34|||
106177944|NCT03729596|366314797|FG006|Overall Study|Death|18|||
106177945|NCT03729596|366314798|FG007|Overall Study|Death|14|||
106177946|NCT03729596|366314799|FG008|Overall Study|Death|19|||
106177947|NCT03729596|366314800|FG009|Overall Study|Death|9|||
106177948|NCT03729596|366314791|FG000|Overall Study|Lost to Follow-up|0|||
106177949|NCT03729596|366314792|FG001|Overall Study|Lost to Follow-up|0|||
106177950|NCT03729596|366314793|FG002|Overall Study|Lost to Follow-up|0|||
106177951|NCT03729596|366314794|FG003|Overall Study|Lost to Follow-up|0|||
106177952|NCT03729596|366314795|FG004|Overall Study|Lost to Follow-up|0|||
106177953|NCT03729596|366314796|FG005|Overall Study|Lost to Follow-up|0|||
106177954|NCT03729596|366314797|FG006|Overall Study|Lost to Follow-up|1|||
106177955|NCT03729596|366314798|FG007|Overall Study|Lost to Follow-up|0|||
106177956|NCT03729596|366314799|FG008|Overall Study|Lost to Follow-up|0|||
106177957|NCT03729596|366314800|FG009|Overall Study|Lost to Follow-up|1|||
106177958|NCT03729596|366314791|FG000|Overall Study|protocol amendment|0|||
106177959|NCT03729596|366314792|FG001|Overall Study|protocol amendment|1|||
106177960|NCT03729596|366314793|FG002|Overall Study|protocol amendment|3|||
106177961|NCT03729596|366314794|FG003|Overall Study|protocol amendment|6|||
106177962|NCT03729596|366314795|FG004|Overall Study|protocol amendment|5|||
106177963|NCT03729596|366314796|FG005|Overall Study|protocol amendment|0|||
106177964|NCT03729596|366314797|FG006|Overall Study|protocol amendment|0|||
106177965|NCT03729596|366314798|FG007|Overall Study|protocol amendment|0|||
106177966|NCT03729596|366314799|FG008|Overall Study|protocol amendment|0|||
106177967|NCT03729596|366314800|FG009|Overall Study|protocol amendment|0|||
106177968|NCT03729596|366314791|FG000|Overall Study|Withdrawal by Subject|0|||
106177969|NCT03729596|366314792|FG001|Overall Study|Withdrawal by Subject|0|||
106177970|NCT03729596|366314793|FG002|Overall Study|Withdrawal by Subject|0|||
106177971|NCT03729596|366314794|FG003|Overall Study|Withdrawal by Subject|0|||
106177972|NCT03729596|366314795|FG004|Overall Study|Withdrawal by Subject|0|||
106177973|NCT03729596|366314796|FG005|Overall Study|Withdrawal by Subject|4|||
106177974|NCT03729596|366314797|FG006|Overall Study|Withdrawal by Subject|2|||
106177975|NCT03729596|366314798|FG007|Overall Study|Withdrawal by Subject|3|||
106177976|NCT03729596|366314799|FG008|Overall Study|Withdrawal by Subject|2|||
106177977|NCT03729596|366314800|FG009|Overall Study|Withdrawal by Subject|3|||
106177978|NCT03729596|366314791|FG000|Overall Study|study terminated by sponsor|0|||
106177979|NCT03729596|366314792|FG001|Overall Study|study terminated by sponsor|0|||
106177980|NCT03729596|366314793|FG002|Overall Study|study terminated by sponsor|0|||
106177981|NCT03729596|366314794|FG003|Overall Study|study terminated by sponsor|0|||
106177982|NCT03729596|366314795|FG004|Overall Study|study terminated by sponsor|1|||
106177983|NCT03729596|366314796|FG005|Overall Study|study terminated by sponsor|3|||
106177984|NCT03729596|366314797|FG006|Overall Study|study terminated by sponsor|0|||
106177985|NCT03729596|366314798|FG007|Overall Study|study terminated by sponsor|1|||
106177986|NCT03729596|366314799|FG008|Overall Study|study terminated by sponsor|0|||
106177987|NCT03729596|366314800|FG009|Overall Study|study terminated by sponsor|0|||
106177988|NCT04467840|366314801|FG000|Overall Study|Death|35|||
106177989|NCT04467840|366314802|FG001|Overall Study|Death|39|||
106177990|NCT04467840|366314801|FG000|Overall Study|Withdrawal by Subject|8|||
106177991|NCT04467840|366314802|FG001|Overall Study|Withdrawal by Subject|4|||
106177992|NCT04467840|366314801|FG000|Overall Study|Adverse Event|2|||
106177993|NCT04467840|366314802|FG001|Overall Study|Adverse Event|0|||
106177994|NCT04467840|366314801|FG000|Overall Study|Lost to Follow-up|1|||
106177995|NCT04467840|366314802|FG001|Overall Study|Lost to Follow-up|3|||
106177996|NCT04467840|366314801|FG000|Overall Study|Physician Decision|1|||
106177997|NCT04467840|366314802|FG001|Overall Study|Physician Decision|0|||
106177998|NCT04467840|366314801|FG000|Overall Study|Other|1|||
106177999|NCT04467840|366314802|FG001|Overall Study|Other|5|||
106178000|NCT04467840|366314801|FG000|Overall Study|Missing study completion status|3|||
106178001|NCT04467840|366314802|FG001|Overall Study|Missing study completion status|1|||
106178002|NCT04037254|366314803|FG000|Overall Study|Protocol Violation|1|||
106178003|NCT04037254|366314804|FG001|Overall Study|Protocol Violation|0|||
106178004|NCT04037254|366314805|FG002|Overall Study|Protocol Violation|0|||
106178005|NCT04037254|366314806|FG003|Overall Study|Protocol Violation|0|||
106178006|NCT04037254|366314807|FG004|Overall Study|Protocol Violation|0|||
106178007|NCT04037254|366314803|FG000|Overall Study|Withdrawal by Subject|0|||
106178008|NCT04037254|366314804|FG001|Overall Study|Withdrawal by Subject|0|||
106178009|NCT04037254|366314805|FG002|Overall Study|Withdrawal by Subject|1|||
106178010|NCT04037254|366314806|FG003|Overall Study|Withdrawal by Subject|0|||
106178011|NCT04037254|366314807|FG004|Overall Study|Withdrawal by Subject|0|||
106178012|NCT04037254|366314803|FG000|Overall Study|Delayed or incomplete treatment|0|||
106178013|NCT04037254|366314804|FG001|Overall Study|Delayed or incomplete treatment|2|||
106178014|NCT04037254|366314805|FG002|Overall Study|Delayed or incomplete treatment|1|||
106178015|NCT04037254|366314806|FG003|Overall Study|Delayed or incomplete treatment|0|||
106178016|NCT04037254|366314807|FG004|Overall Study|Delayed or incomplete treatment|0|||
106178017|NCT04918147|366314810|FG000|Overall Study|Disease flare as defined in protocol|0|||
106178018|NCT04918147|366314811|FG001|Overall Study|Disease flare as defined in protocol|2|||
106178019|NCT05201794|366314814|FG000|Overall Study|Withdrawal by Subject|13|||
106178020|NCT05201794|366314815|FG001|Overall Study|Withdrawal by Subject|12|||
106178021|NCT05201794|366314816|FG002|Overall Study|Withdrawal by Subject|14|||
106178022|NCT05201794|366314817|FG003|Overall Study|Withdrawal by Subject|0|||
106178023|NCT05201794|366314814|FG000|Overall Study|Adverse Event|5|||
106178024|NCT05201794|366314815|FG001|Overall Study|Adverse Event|5|||
106178025|NCT05201794|366314816|FG002|Overall Study|Adverse Event|4|||
106178026|NCT05201794|366314817|FG003|Overall Study|Adverse Event|0|||
106178027|NCT05201794|366314814|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
106178028|NCT05201794|366314815|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
106178029|NCT05201794|366314816|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
106178030|NCT05201794|366314817|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
106178031|NCT05201794|366314814|FG000|Overall Study|Non-Compliance With Study Drug|2|||
106178032|NCT05201794|366314815|FG001|Overall Study|Non-Compliance With Study Drug|3|||
106178033|NCT05201794|366314816|FG002|Overall Study|Non-Compliance With Study Drug|3|||
106178034|NCT05201794|366314817|FG003|Overall Study|Non-Compliance With Study Drug|0|||
106178035|NCT05201794|366314814|FG000|Overall Study|Physician Decision|1|||
106178036|NCT05201794|366314815|FG001|Overall Study|Physician Decision|3|||
106178037|NCT05201794|366314816|FG002|Overall Study|Physician Decision|2|||
106178038|NCT05201794|366314817|FG003|Overall Study|Physician Decision|0|||
106178039|NCT05201794|366314814|FG000|Overall Study|Lost to Follow-up|2|||
106178040|NCT05201794|366314815|FG001|Overall Study|Lost to Follow-up|2|||
106178041|NCT05201794|366314816|FG002|Overall Study|Lost to Follow-up|0|||
106178042|NCT05201794|366314817|FG003|Overall Study|Lost to Follow-up|0|||
106178043|NCT05201794|366314814|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
106178044|NCT05201794|366314815|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
106178045|NCT05201794|366314816|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
106178046|NCT05201794|366314817|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
106178047|NCT05201794|366314814|FG000|Overall Study|Protocol Violation|2|||
106178048|NCT05201794|366314815|FG001|Overall Study|Protocol Violation|0|||
106178049|NCT05201794|366314816|FG002|Overall Study|Protocol Violation|1|||
106178050|NCT05201794|366314817|FG003|Overall Study|Protocol Violation|0|||
106178051|NCT05201794|366314814|FG000|Overall Study|Death|1|||
106178052|NCT05201794|366314815|FG001|Overall Study|Death|0|||
106178053|NCT05201794|366314816|FG002|Overall Study|Death|0|||
106178054|NCT05201794|366314817|FG003|Overall Study|Death|0|||
106178055|NCT05201794|366314814|FG000|Overall Study|Site Terminated By Sponsor|0|||
106178056|NCT05201794|366314815|FG001|Overall Study|Site Terminated By Sponsor|1|||
106178057|NCT05201794|366314816|FG002|Overall Study|Site Terminated By Sponsor|0|||
106178058|NCT05201794|366314817|FG003|Overall Study|Site Terminated By Sponsor|0|||
106178059|NCT05201794|366314814|FG000|Overall Study|Other|3|||
106178060|NCT05201794|366314815|FG001|Overall Study|Other|3|||
106178061|NCT05201794|366314816|FG002|Overall Study|Other|3|||
106178062|NCT05201794|366314817|FG003|Overall Study|Other|0|||
106178063|NCT05201794|366314814|FG000|Overall Study|Randomized But Not Treated|1|||
106178064|NCT05201794|366314815|FG001|Overall Study|Randomized But Not Treated|2|||
106178065|NCT05201794|366314816|FG002|Overall Study|Randomized But Not Treated|1|||
106178066|NCT05201794|366314817|FG003|Overall Study|Randomized But Not Treated|0|||
106178067|NCT05355818|366314822|FG000|Overall Study|Adverse Event|1|||
106178068|NCT05355818|366314823|FG001|Overall Study|Adverse Event|1|||
106178069|NCT05355818|366314822|FG000|Overall Study|Lack of Efficacy|2|||
106178070|NCT05355818|366314823|FG001|Overall Study|Lack of Efficacy|1|||
106178071|NCT05355818|366314822|FG000|Overall Study|Lost to Follow-up|0|||
106178072|NCT05355818|366314823|FG001|Overall Study|Lost to Follow-up|1|||
106178073|NCT01375114|366314831|FG000|Overall Study|Lost to Follow-up|1|||
106178074|NCT01375114|366314832|FG001|Overall Study|Lost to Follow-up|0|||
106178075|NCT01375114|366314833|FG002|Overall Study|Lost to Follow-up|1|||
106178076|NCT01375114|366314831|FG000|Overall Study|Disease Progression|3|||
106178077|NCT01375114|366314832|FG001|Overall Study|Disease Progression|2|||
106178078|NCT01375114|366314833|FG002|Overall Study|Disease Progression|2|||
106178079|NCT01375114|366314831|FG000|Overall Study|Patient Changed Mind|0|||
106178080|NCT01375114|366314832|FG001|Overall Study|Patient Changed Mind|0|||
106178081|NCT01375114|366314833|FG002|Overall Study|Patient Changed Mind|2|||
106178082|NCT01375114|366314831|FG000|Overall Study|Pruritus|0|||
106178083|NCT01375114|366314832|FG001|Overall Study|Pruritus|0|||
105867373|NCT01473407|365164956|FG001|Overall Study|Randomization Error|1|||
106178084|NCT01375114|366314833|FG002|Overall Study|Pruritus|1|||
106178085|NCT01375114|366314831|FG000|Overall Study|Restlessness|0|||
106178086|NCT01375114|366314832|FG001|Overall Study|Restlessness|0|||
106178087|NCT01375114|366314833|FG002|Overall Study|Restlessness|1|||
106178088|NCT01375114|366314831|FG000|Overall Study|Diarrhea|0|||
106178089|NCT01375114|366314832|FG001|Overall Study|Diarrhea|0|||
106178090|NCT01375114|366314833|FG002|Overall Study|Diarrhea|1|||
106178091|NCT01375114|366314831|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
106178092|NCT01375114|366314832|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
106178093|NCT01375114|366314833|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
106178094|NCT01375114|366314831|FG000|Overall Study|Nausea|0|||
106178095|NCT01375114|366314832|FG001|Overall Study|Nausea|1|||
106178096|NCT01375114|366314833|FG002|Overall Study|Nausea|0|||
106178097|NCT01375114|366314831|FG000|Overall Study|Increased AST/ALT|0|||
106178098|NCT01375114|366314832|FG001|Overall Study|Increased AST/ALT|1|||
106178099|NCT01375114|366314833|FG002|Overall Study|Increased AST/ALT|0|||
106178100|NCT01375114|366314831|FG000|Overall Study|Vaginal Hemorrhage|0|||
106178101|NCT01375114|366314832|FG001|Overall Study|Vaginal Hemorrhage|1|||
106178102|NCT01375114|366314833|FG002|Overall Study|Vaginal Hemorrhage|0|||
106178103|NCT01375114|366314831|FG000|Overall Study|Family problem|0|||
106178104|NCT01375114|366314832|FG001|Overall Study|Family problem|1|||
106178105|NCT01375114|366314833|FG002|Overall Study|Family problem|0|||
106178106|NCT01375114|366314831|FG000|Overall Study|Protocol Violation|2|||
106178107|NCT01375114|366314832|FG001|Overall Study|Protocol Violation|0|||
106178108|NCT01375114|366314833|FG002|Overall Study|Protocol Violation|0|||
106178109|NCT02769832|366314834|FG000|Overall Study|Death|30|||
106178110|NCT00070499|366314837|FG000|Overall Study|Adverse Event|6|||
106178111|NCT00070499|366314838|FG001|Overall Study|Adverse Event|6|||
106178112|NCT00070499|366314839|FG002|Overall Study|Adverse Event|19|||
106178113|NCT00070499|366314840|FG003|Overall Study|Adverse Event|15|||
106178114|NCT00070499|366314837|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
106178115|NCT00070499|366314838|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
106178116|NCT00070499|366314839|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
106178117|NCT00070499|366314840|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
106178118|NCT00070499|366314837|FG000|Overall Study|Progression/relapse|4|||
106178119|NCT00070499|366314838|FG001|Overall Study|Progression/relapse|2|||
106178120|NCT00070499|366314839|FG002|Overall Study|Progression/relapse|1|||
106178121|NCT00070499|366314840|FG003|Overall Study|Progression/relapse|4|||
106178122|NCT00070499|366314837|FG000|Overall Study|Death|1|||
106178123|NCT00070499|366314838|FG001|Overall Study|Death|1|||
106178124|NCT00070499|366314839|FG002|Overall Study|Death|1|||
106178125|NCT00070499|366314840|FG003|Overall Study|Death|2|||
106178126|NCT00070499|366314837|FG000|Overall Study|Other - not protocol specified|7|||
106178127|NCT00070499|366314838|FG001|Overall Study|Other - not protocol specified|3|||
106178128|NCT00070499|366314839|FG002|Overall Study|Other - not protocol specified|12|||
106178129|NCT00070499|366314840|FG003|Overall Study|Other - not protocol specified|20|||
106178130|NCT00070499|366314837|FG000|Overall Study|Still on protocol treatment|10|||
106178131|NCT00070499|366314838|FG001|Overall Study|Still on protocol treatment|4|||
106178132|NCT00070499|366314839|FG002|Overall Study|Still on protocol treatment|79|||
106178133|NCT00070499|366314840|FG003|Overall Study|Still on protocol treatment|57|||
106178134|NCT00070499|366314837|FG000|Overall Study|Did not start treatment|1|||
106178135|NCT00070499|366314838|FG001|Overall Study|Did not start treatment|0|||
106178136|NCT00070499|366314839|FG002|Overall Study|Did not start treatment|0|||
106178137|NCT00070499|366314840|FG003|Overall Study|Did not start treatment|2|||
106178138|NCT00070499|366314837|FG000|Overall Study|Not eligible|2|||
106178139|NCT00070499|366314838|FG001|Overall Study|Not eligible|5|||
106178140|NCT00070499|366314839|FG002|Overall Study|Not eligible|3|||
106178141|NCT00070499|366314840|FG003|Overall Study|Not eligible|2|||
106178142|NCT06134180|366314841|FG000|Overall Study|Lost to Follow-up|4|||
106178143|NCT04512976|366314842|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
106178144|NCT04512976|366314843|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
106178145|NCT04512976|366314844|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
106178146|NCT04512976|366314845|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
106178147|NCT04512976|366314846|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
106178148|NCT04512976|366314847|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
106178149|NCT04653454|366314848|FG000|Overall Study|Withdrawal by Subject|1|||
106178150|NCT04653454|366314848|FG000|Overall Study|Physician Decision|40|||
106178151|NCT02152982|366314849|FG000|Overall Study|Ineligible|4|||
106178152|NCT02152982|366314850|FG001|Overall Study|Ineligible|4|||
106178153|NCT02152982|366314849|FG000|Overall Study|Did not start treatment|12|||
106178154|NCT02152982|366314850|FG001|Overall Study|Did not start treatment|6|||
106178155|NCT01169337|366314851|FG000|Overall Study|Lack of Efficacy|5|||
106178156|NCT01169337|366314852|FG001|Overall Study|Lack of Efficacy|7|||
106178157|NCT01169337|366314853|FG002|Overall Study|Lack of Efficacy|0|||
106178158|NCT01169337|366314851|FG000|Overall Study|Adverse Event|12|||
106178159|NCT01169337|366314852|FG001|Overall Study|Adverse Event|18|||
106178160|NCT01169337|366314853|FG002|Overall Study|Adverse Event|0|||
106178161|NCT01169337|366314851|FG000|Overall Study|Death|2|||
106178162|NCT01169337|366314852|FG001|Overall Study|Death|0|||
106178163|NCT01169337|366314853|FG002|Overall Study|Death|0|||
106178164|NCT01169337|366314851|FG000|Overall Study|Withdrawal by Subject|11|||
106178165|NCT01169337|366314852|FG001|Overall Study|Withdrawal by Subject|11|||
106178166|NCT01169337|366314853|FG002|Overall Study|Withdrawal by Subject|6|||
106178167|NCT01169337|366314851|FG000|Overall Study|Noncompliance|2|||
106178168|NCT01169337|366314852|FG001|Overall Study|Noncompliance|0|||
106178169|NCT01169337|366314853|FG002|Overall Study|Noncompliance|0|||
106178170|NCT01169337|366314851|FG000|Overall Study|Other complicating disease|1|||
106178171|NCT01169337|366314852|FG001|Overall Study|Other complicating disease|1|||
106178172|NCT01169337|366314853|FG002|Overall Study|Other complicating disease|0|||
106178173|NCT01169337|366314851|FG000|Overall Study|Physician Decision|1|||
106178174|NCT01169337|366314852|FG001|Overall Study|Physician Decision|5|||
106178175|NCT01169337|366314853|FG002|Overall Study|Physician Decision|0|||
106178176|NCT01169337|366314851|FG000|Overall Study|Alternative therapy|0|||
106178177|NCT01169337|366314852|FG001|Overall Study|Alternative therapy|2|||
106178178|NCT01169337|366314853|FG002|Overall Study|Alternative therapy|0|||
106178179|NCT01169337|366314851|FG000|Overall Study|Changed hospital|0|||
106178180|NCT01169337|366314852|FG001|Overall Study|Changed hospital|1|||
106178181|NCT01169337|366314853|FG002|Overall Study|Changed hospital|0|||
106178182|NCT01169337|366314851|FG000|Overall Study|Never started treatment|0|||
106178183|NCT01169337|366314852|FG001|Overall Study|Never started treatment|2|||
106178184|NCT01169337|366314853|FG002|Overall Study|Never started treatment|0|||
106178185|NCT01169337|366314851|FG000|Overall Study|Reason not reported|1|||
106178186|NCT01169337|366314852|FG001|Overall Study|Reason not reported|0|||
106178187|NCT01169337|366314853|FG002|Overall Study|Reason not reported|0|||
106178188|NCT01169337|366314851|FG000|Overall Study|Continuing lenalidomide|9|||
106178189|NCT01169337|366314852|FG001|Overall Study|Continuing lenalidomide|43|||
106178190|NCT01169337|366314853|FG002|Overall Study|Continuing lenalidomide|0|||
106178191|NCT01134614|366314854|FG000|Overall Study|Still on treatment as of March 2013|21|||
106178192|NCT01134614|366314855|FG001|Overall Study|Still on treatment as of March 2013|13|||
106178193|NCT01134614|366314854|FG000|Overall Study|Progressive disease|60|||
106178194|NCT01134614|366314855|FG001|Overall Study|Progressive disease|54|||
106178195|NCT01134614|366314854|FG000|Overall Study|Adverse Event|26|||
106178196|NCT01134614|366314855|FG001|Overall Study|Adverse Event|39|||
106178197|NCT01134614|366314854|FG000|Overall Study|Death|5|||
106178198|NCT01134614|366314855|FG001|Overall Study|Death|8|||
106178199|NCT01134614|366314854|FG000|Overall Study|Withdrawal by Subject|3|||
106178200|NCT01134614|366314855|FG001|Overall Study|Withdrawal by Subject|2|||
106178201|NCT01134614|366314854|FG000|Overall Study|Alternative therapy|2|||
105867374|NCT01473407|365164955|FG000|Overall Study|Withdrawal by Subject|4|||
106178202|NCT01134614|366314855|FG001|Overall Study|Alternative therapy|0|||
106178203|NCT01134614|366314854|FG000|Overall Study|Complicating disease|2|||
106178204|NCT01134614|366314855|FG001|Overall Study|Complicating disease|1|||
106178205|NCT01134614|366314854|FG000|Overall Study|Physician's decision|0|||
106178206|NCT01134614|366314855|FG001|Overall Study|Physician's decision|1|||
106178207|NCT01134614|366314854|FG000|Overall Study|Never started treatment|4|||
106178208|NCT01134614|366314855|FG001|Overall Study|Never started treatment|1|||
106178209|NCT01134614|366314854|FG000|Overall Study|Pt received tx not allowed on study|0|||
106178210|NCT01134614|366314855|FG001|Overall Study|Pt received tx not allowed on study|1|||
106178211|NCT01134614|366314854|FG000|Overall Study|Symptomatic deterioration|0|||
106178212|NCT01134614|366314855|FG001|Overall Study|Symptomatic deterioration|1|||
106178213|NCT01134614|366314854|FG000|Overall Study|Patient in hospice care|0|||
106178214|NCT01134614|366314855|FG001|Overall Study|Patient in hospice care|1|||
106178215|NCT04034927|366314858|FG000|Overall Study|Adverse Event|4|||
106178216|NCT04034927|366314859|FG001|Overall Study|Adverse Event|9|||
106178217|NCT04034927|366314858|FG000|Overall Study|Death|0|||
106178218|NCT04034927|366314859|FG001|Overall Study|Death|1|||
106178219|NCT04034927|366314858|FG000|Overall Study|Withdrawal by Subject|0|||
106178220|NCT04034927|366314859|FG001|Overall Study|Withdrawal by Subject|3|||
106178221|NCT04034927|366314858|FG000|Overall Study|Still on Treatment|2|||
106178222|NCT04034927|366314859|FG001|Overall Study|Still on Treatment|1|||
106178223|NCT04034927|366314858|FG000|Overall Study|Other|1|||
106178224|NCT04034927|366314859|FG001|Overall Study|Other|1|||
106178225|NCT03997383|366314862|FG000|Double-blind Treatment Period|Adverse Event|4|||
106178226|NCT03997383|366314863|FG001|Double-blind Treatment Period|Adverse Event|3|||
106178227|NCT03997383|366314862|FG000|Double-blind Treatment Period|Death|4|||
106178228|NCT03997383|366314863|FG001|Double-blind Treatment Period|Death|4|||
106178229|NCT03997383|366314862|FG000|Double-blind Treatment Period|Physician Decision|2|||
106178230|NCT03997383|366314863|FG001|Double-blind Treatment Period|Physician Decision|0|||
106178231|NCT03997383|366314862|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
106178232|NCT03997383|366314863|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
106178233|NCT03997383|366314862|FG000|Open-label Extension Period|Ongoing|148|||
106178234|NCT03997383|366314863|FG001|Open-label Extension Period|Ongoing|151|||
106178235|NCT03997383|366314862|FG000|Open-label Extension Period|Adverse Event|4|||
106178236|NCT03997383|366314863|FG001|Open-label Extension Period|Adverse Event|1|||
106178237|NCT03997383|366314862|FG000|Open-label Extension Period|Death|8|||
106178238|NCT03997383|366314863|FG001|Open-label Extension Period|Death|9|||
106178239|NCT03997383|366314862|FG000|Open-label Extension Period|Physician Decision|1|||
106178240|NCT03997383|366314863|FG001|Open-label Extension Period|Physician Decision|1|||
106178241|NCT03997383|366314862|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
106178242|NCT03997383|366314863|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
106178243|NCT03997383|366314862|FG000|Open-label Extension Period|Reason Not Specified|2|||
106178244|NCT03997383|366314863|FG001|Open-label Extension Period|Reason Not Specified|0|||
106178245|NCT02306161|366314864|FG000|Overall Study|Death|1|||
106178246|NCT02306161|366314865|FG001|Overall Study|Death|3|||
106178247|NCT02306161|366314864|FG000|Overall Study|Lack of Efficacy|20|||
106178248|NCT02306161|366314865|FG001|Overall Study|Lack of Efficacy|43|||
106178249|NCT02306161|366314864|FG000|Overall Study|Physician Decision|30|||
106178250|NCT02306161|366314865|FG001|Overall Study|Physician Decision|18|||
106178251|NCT02306161|366314864|FG000|Overall Study|Withdrawal by Subject|4|||
106178252|NCT02306161|366314865|FG001|Overall Study|Withdrawal by Subject|0|||
106178253|NCT02306161|366314864|FG000|Overall Study|Ineligible|9|||
106178254|NCT02306161|366314865|FG001|Overall Study|Ineligible|5|||
106178255|NCT03909152|366314866|FG000|Overall Study|Adverse Event|14|||
106178256|NCT03909152|366314867|FG001|Overall Study|Adverse Event|5|||
106178257|NCT03909152|366314868|FG002|Overall Study|Adverse Event|1|||
106178258|NCT03909152|366314869|FG003|Overall Study|Adverse Event|14|||
106178259|NCT03880019|366314870|FG000|Overall Study|Competing disease|1|||
106178260|NCT05905601|366314871|FG000|Overall Study|Lost to Follow-up|1|||
106178261|NCT05905601|366314872|FG001|Overall Study|Lost to Follow-up|3|||
106178262|NCT03583606|366314873|FG000|Overall Study|Lost to Follow-up|0|||
106178263|NCT03583606|366314874|FG001|Overall Study|Lost to Follow-up|1|||
106178264|NCT03583606|366314875|FG002|Overall Study|Lost to Follow-up|0|||
106178265|NCT03583606|366314873|FG000|Overall Study|Ineligible at baseline|1|||
106178266|NCT03583606|366314874|FG001|Overall Study|Ineligible at baseline|0|||
106178267|NCT03583606|366314875|FG002|Overall Study|Ineligible at baseline|0|||
106178268|NCT03362502|366314880|FG000|Overall Study|Death|0|||
106178269|NCT03362502|366314881|FG001|Overall Study|Death|0|||
106178270|NCT03362502|366314882|FG002|Overall Study|Death|1|||
106178271|NCT03338829|366314883|FG000|Overall Study|Lost to Follow-up|4|||
106178272|NCT03338829|366314884|FG001|Overall Study|Lost to Follow-up|2|||
106178273|NCT03338829|366314885|FG002|Overall Study|Lost to Follow-up|4|||
106178274|NCT03338829|366314883|FG000|Overall Study|Pregnancy loss|1|||
106178275|NCT03338829|366314884|FG001|Overall Study|Pregnancy loss|1|||
106178276|NCT03338829|366314885|FG002|Overall Study|Pregnancy loss|0|||
106178277|NCT03338829|366314883|FG000|Overall Study|Protocol Violation|0|||
106178278|NCT03338829|366314884|FG001|Overall Study|Protocol Violation|1|||
106178279|NCT03338829|366314885|FG002|Overall Study|Protocol Violation|0|||
106178280|NCT02498613|366314886|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
105867375|NCT01473407|365164956|FG001|Overall Study|Withdrawal by Subject|7|||
106178281|NCT02498613|366314887|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
106178282|NCT02498613|366314888|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
106178283|NCT02498613|366314889|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
106178284|NCT02498613|366314886|FG000|Overall Study|Withdrawal by Subject|3|||
106178285|NCT02498613|366314887|FG001|Overall Study|Withdrawal by Subject|1|||
106178286|NCT02498613|366314888|FG002|Overall Study|Withdrawal by Subject|0|||
106178287|NCT02498613|366314889|FG003|Overall Study|Withdrawal by Subject|0|||
106178288|NCT05063539|366314890|FG000|Overall Study|Adverse Event|1|||
106178289|NCT05063539|366314891|FG001|Overall Study|Adverse Event|2|||
106178290|NCT05063539|366314892|FG002|Overall Study|Adverse Event|1|||
106178291|NCT05063539|366314890|FG000|Overall Study|Death|0|||
106178292|NCT05063539|366314891|FG001|Overall Study|Death|1|||
106178293|NCT05063539|366314892|FG002|Overall Study|Death|1|||
106178294|NCT05063539|366314890|FG000|Overall Study|Lost to Follow-up|0|||
106178295|NCT05063539|366314891|FG001|Overall Study|Lost to Follow-up|1|||
106178296|NCT05063539|366314892|FG002|Overall Study|Lost to Follow-up|0|||
106178297|NCT05063539|366314890|FG000|Overall Study|Physician Decision|4|||
106178298|NCT05063539|366314891|FG001|Overall Study|Physician Decision|3|||
106178299|NCT05063539|366314892|FG002|Overall Study|Physician Decision|1|||
106178300|NCT05063539|366314890|FG000|Overall Study|Progressive Disease|0|||
106178301|NCT05063539|366314891|FG001|Overall Study|Progressive Disease|2|||
106178302|NCT05063539|366314892|FG002|Overall Study|Progressive Disease|0|||
106178303|NCT05063539|366314890|FG000|Overall Study|Withdrawal by Subject|17|||
106178304|NCT05063539|366314891|FG001|Overall Study|Withdrawal by Subject|26|||
106178305|NCT05063539|366314892|FG002|Overall Study|Withdrawal by Subject|14|||
106178306|NCT05063539|366314890|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
106178307|NCT05063539|366314891|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
106178308|NCT05063539|366314892|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
106178309|NCT05063539|366314890|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
106178310|NCT05063539|366314891|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
106178311|NCT05063539|366314892|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
106178312|NCT05063539|366314890|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
106178313|NCT05063539|366314891|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
106178314|NCT05063539|366314892|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
106178315|NCT05063539|366314890|FG000|Overall Study|Discontinued due to Common Close Design|0|||
106178316|NCT05063539|366314891|FG001|Overall Study|Discontinued due to Common Close Design|1|||
106178317|NCT05063539|366314892|FG002|Overall Study|Discontinued due to Common Close Design|0|||
106178318|NCT05063539|366314890|FG000|Overall Study|Participant not co-operative|0|||
106178319|NCT05063539|366314891|FG001|Overall Study|Participant not co-operative|1|||
106178320|NCT05063539|366314892|FG002|Overall Study|Participant not co-operative|0|||
106178321|NCT05063539|366314890|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
106178322|NCT05063539|366314891|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
106178323|NCT05063539|366314892|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
106178324|NCT05063539|366314890|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
106178325|NCT05063539|366314891|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
106178326|NCT05063539|366314892|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
106178327|NCT05126693|366314893|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
106178328|NCT05126693|366314894|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
106178329|NCT05126693|366314893|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
106178330|NCT05126693|366314894|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
106178331|NCT05126693|366314893|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
106178332|NCT05126693|366314894|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
106178333|NCT03250377|366314895|FG000|Overall Study|Adverse Event|2|||
106178334|NCT03250377|366314896|FG001|Overall Study|Adverse Event|4|||
106178335|NCT03250377|366314897|FG002|Overall Study|Adverse Event|0|||
106178336|NCT03250377|366314898|FG003|Overall Study|Adverse Event|4|||
106178337|NCT03250377|366314895|FG000|Overall Study|Lack of Efficacy|5|||
106178338|NCT03250377|366314896|FG001|Overall Study|Lack of Efficacy|14|||
106178339|NCT03250377|366314897|FG002|Overall Study|Lack of Efficacy|1|||
106178340|NCT03250377|366314898|FG003|Overall Study|Lack of Efficacy|3|||
106178341|NCT03250377|366314895|FG000|Overall Study|Protocol Violation|0|||
106178342|NCT03250377|366314896|FG001|Overall Study|Protocol Violation|2|||
106178343|NCT03250377|366314897|FG002|Overall Study|Protocol Violation|0|||
106178344|NCT03250377|366314898|FG003|Overall Study|Protocol Violation|1|||
106178345|NCT03250377|366314895|FG000|Overall Study|Lost to Follow-up|0|||
106178346|NCT03250377|366314896|FG001|Overall Study|Lost to Follow-up|1|||
106178347|NCT03250377|366314897|FG002|Overall Study|Lost to Follow-up|0|||
106178348|NCT03250377|366314898|FG003|Overall Study|Lost to Follow-up|0|||
106178349|NCT03250377|366314895|FG000|Overall Study|Withdrawal by Subject|7|||
106178350|NCT03250377|366314896|FG001|Overall Study|Withdrawal by Subject|7|||
106178351|NCT03250377|366314897|FG002|Overall Study|Withdrawal by Subject|0|||
106178352|NCT03250377|366314898|FG003|Overall Study|Withdrawal by Subject|4|||
106178353|NCT03250377|366314895|FG000|Overall Study|Investigator's Judgment|1|||
106178354|NCT03250377|366314896|FG001|Overall Study|Investigator's Judgment|0|||
106178355|NCT03250377|366314897|FG002|Overall Study|Investigator's Judgment|0|||
106178356|NCT03250377|366314898|FG003|Overall Study|Investigator's Judgment|0|||
106178357|NCT03250377|366314895|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
106178358|NCT03250377|366314896|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
106178359|NCT03250377|366314897|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
106178360|NCT03250377|366314898|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
106178361|NCT03250377|366314895|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
106178362|NCT03250377|366314896|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
106178363|NCT03250377|366314897|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
106178364|NCT03250377|366314898|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
106178365|NCT03250377|366314895|FG000|Overall Study|Epilepsy Surgery|0|||
106178366|NCT03250377|366314896|FG001|Overall Study|Epilepsy Surgery|1|||
106178367|NCT03250377|366314897|FG002|Overall Study|Epilepsy Surgery|2|||
106178368|NCT03250377|366314898|FG003|Overall Study|Epilepsy Surgery|0|||
106178369|NCT03250377|366314895|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
106178370|NCT03250377|366314896|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
106178371|NCT03250377|366314897|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
106178372|NCT03250377|366314898|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
106178373|NCT03250377|366314895|FG000|Overall Study|Request From The Sponsor|0|||
106178374|NCT03250377|366314896|FG001|Overall Study|Request From The Sponsor|1|||
106178375|NCT03250377|366314897|FG002|Overall Study|Request From The Sponsor|0|||
106178376|NCT03250377|366314898|FG003|Overall Study|Request From The Sponsor|0|||
106178377|NCT03250377|366314895|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
106178378|NCT03250377|366314896|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
106178379|NCT03250377|366314897|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
106178380|NCT03250377|366314898|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
106178381|NCT03250377|366314895|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
106178382|NCT03250377|366314896|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
106178383|NCT03250377|366314897|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
106178384|NCT03250377|366314898|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
106178385|NCT03250377|366314895|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
106178386|NCT03250377|366314896|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
106178387|NCT03250377|366314897|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
106178388|NCT03250377|366314898|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
106178389|NCT03250377|366314895|FG000|Overall Study|Pregnancy Event|0|||
106178390|NCT03250377|366314896|FG001|Overall Study|Pregnancy Event|1|||
106178391|NCT03250377|366314897|FG002|Overall Study|Pregnancy Event|0|||
106178392|NCT03250377|366314898|FG003|Overall Study|Pregnancy Event|0|||
106178393|NCT03250377|366314895|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
106178394|NCT03250377|366314896|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
106178395|NCT03250377|366314897|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
106178396|NCT03250377|366314898|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
106178397|NCT03250377|366314895|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
106178398|NCT03250377|366314896|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
106178399|NCT03250377|366314897|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
106178400|NCT03250377|366314898|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
106178401|NCT03250377|366314895|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
106178402|NCT03250377|366314896|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
106178403|NCT03250377|366314897|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
106178404|NCT03250377|366314898|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
106178405|NCT03250377|366314895|FG000|Overall Study|Patient requested to change hospital|0|||
106178406|NCT03250377|366314896|FG001|Overall Study|Patient requested to change hospital|0|||
106178407|NCT03250377|366314897|FG002|Overall Study|Patient requested to change hospital|0|||
106178408|NCT03250377|366314898|FG003|Overall Study|Patient requested to change hospital|1|||
106178409|NCT03250377|366314895|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
106178410|NCT03250377|366314896|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
106178411|NCT03250377|366314897|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
106178412|NCT03250377|366314898|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
106178413|NCT04011722|366314903|FG000|30 Days|Death|5|||
106178414|NCT04011722|366314904|FG001|30 Days|Death|1|||
106178415|NCT04011722|366314903|FG000|1 Year|Death|13|||
106178416|NCT04011722|366314904|FG001|1 Year|Death|5|||
106178417|NCT04011722|366314903|FG000|1 Year|Withdrawal by Subject|8|||
106178418|NCT04011722|366314904|FG001|1 Year|Withdrawal by Subject|2|||
106178419|NCT04011722|366314903|FG000|1 Year|Missed Visit|6|||
106178420|NCT04011722|366314904|FG001|1 Year|Missed Visit|1|||
106178421|NCT04011722|366314903|FG000|1 Year|Pending Visit|0|||
106178422|NCT04011722|366314904|FG001|1 Year|Pending Visit|11|||
106178423|NCT04011722|366314903|FG000|1 Year|Not Yet Due|0|||
106178424|NCT04011722|366314904|FG001|1 Year|Not Yet Due|9|||
106178425|NCT04011722|366314903|FG000|2 Year|Death|16|||
106178426|NCT04011722|366314904|FG001|2 Year|Death|1|||
106178427|NCT04011722|366314903|FG000|2 Year|Withdrawal by Subject|10|||
106178428|NCT04011722|366314904|FG001|2 Year|Withdrawal by Subject|1|||
106178429|NCT04011722|366314903|FG000|2 Year|Missed Visit|9|||
106178430|NCT04011722|366314904|FG001|2 Year|Missed Visit|0|||
106178431|NCT04011722|366314903|FG000|2 Year|Visit Pending|1|||
106178432|NCT04011722|366314904|FG001|2 Year|Visit Pending|3|||
106178433|NCT04011722|366314903|FG000|2 Year|Not Yet Due|43|||
106178434|NCT04011722|366314904|FG001|2 Year|Not Yet Due|54|||
106178435|NCT04011722|366314903|FG000|3 Year|Death|10|||
106178436|NCT04011722|366314904|FG001|3 Year|Death|0|||
106178437|NCT04011722|366314903|FG000|3 Year|Withdrawal by Subject|2|||
106178438|NCT04011722|366314904|FG001|3 Year|Withdrawal by Subject|0|||
106178439|NCT04011722|366314903|FG000|3 Year|Missed Visit|2|||
106178440|NCT04011722|366314904|FG001|3 Year|Missed Visit|0|||
106178441|NCT04011722|366314903|FG000|3 Year|Pending Visit|34|||
106178442|NCT04011722|366314904|FG001|3 Year|Pending Visit|0|||
106178443|NCT04011722|366314903|FG000|3 Year|Not Yet Due|99|||
106178444|NCT04011722|366314904|FG001|3 Year|Not Yet Due|0|||
106178445|NCT01708941|366314914|FG000|Overall Study|Adverse Event|4|||
106178446|NCT01708941|366314915|FG001|Overall Study|Adverse Event|6|||
106178447|NCT01708941|366314916|FG002|Overall Study|Adverse Event|1|||
106178448|NCT01708941|366314917|FG003|Overall Study|Adverse Event|0|||
106178449|NCT01708941|366314914|FG000|Overall Study|Death|1|||
106178450|NCT01708941|366314915|FG001|Overall Study|Death|1|||
106178451|NCT01708941|366314916|FG002|Overall Study|Death|2|||
106178452|NCT01708941|366314917|FG003|Overall Study|Death|14|||
106178453|NCT01708941|366314914|FG000|Overall Study|Withdrawal by Subject|1|||
106178454|NCT01708941|366314915|FG001|Overall Study|Withdrawal by Subject|0|||
106178455|NCT01708941|366314916|FG002|Overall Study|Withdrawal by Subject|3|||
106178456|NCT01708941|366314917|FG003|Overall Study|Withdrawal by Subject|4|||
106178457|NCT01708941|366314914|FG000|Overall Study|Disease progression|9|||
106178458|NCT01708941|366314915|FG001|Overall Study|Disease progression|10|||
106178459|NCT01708941|366314916|FG002|Overall Study|Disease progression|8|||
106178460|NCT01708941|366314917|FG003|Overall Study|Disease progression|0|||
106178461|NCT01708941|366314914|FG000|Overall Study|Alternative therapy|0|||
106178462|NCT01708941|366314915|FG001|Overall Study|Alternative therapy|0|||
106178463|NCT01708941|366314916|FG002|Overall Study|Alternative therapy|2|||
106178464|NCT01708941|366314917|FG003|Overall Study|Alternative therapy|0|||
106178465|NCT01708941|366314914|FG000|Overall Study|Ineligible and never started treatment|1|||
106178466|NCT01708941|366314915|FG001|Overall Study|Ineligible and never started treatment|0|||
106178467|NCT01708941|366314916|FG002|Overall Study|Ineligible and never started treatment|1|||
106178468|NCT01708941|366314917|FG003|Overall Study|Ineligible and never started treatment|0|||
106178469|NCT01708941|366314914|FG000|Overall Study|Never started treatment|2|||
106178470|NCT01708941|366314915|FG001|Overall Study|Never started treatment|1|||
106178471|NCT01708941|366314916|FG002|Overall Study|Never started treatment|0|||
106178472|NCT01708941|366314917|FG003|Overall Study|Never started treatment|0|||
106178473|NCT01708941|366314914|FG000|Overall Study|Ineligible|0|||
106178474|NCT01708941|366314915|FG001|Overall Study|Ineligible|0|||
106178475|NCT01708941|366314916|FG002|Overall Study|Ineligible|2|||
106178476|NCT01708941|366314917|FG003|Overall Study|Ineligible|0|||
106178477|NCT01575548|366314918|FG000|Overall Study|Adverse Event|15|||
106178478|NCT01575548|366314919|FG001|Overall Study|Adverse Event|2|||
106178479|NCT01575548|366314918|FG000|Overall Study|Disease progression|12|||
106178480|NCT01575548|366314919|FG001|Overall Study|Disease progression|25|||
106178481|NCT01575548|366314918|FG000|Overall Study|Death|1|||
106178482|NCT01575548|366314919|FG001|Overall Study|Death|0|||
106178483|NCT01575548|366314918|FG000|Overall Study|Other complicating disease|1|||
106178484|NCT01575548|366314919|FG001|Overall Study|Other complicating disease|0|||
106178485|NCT01575548|366314918|FG000|Overall Study|Withdrawal by Subject|7|||
106178486|NCT01575548|366314919|FG001|Overall Study|Withdrawal by Subject|3|||
106178487|NCT01575548|366314918|FG000|Overall Study|Noncompliance|1|||
106178488|NCT01575548|366314919|FG001|Overall Study|Noncompliance|0|||
106178489|NCT01575548|366314918|FG000|Overall Study|Anticipated surgery|0|||
106178490|NCT01575548|366314919|FG001|Overall Study|Anticipated surgery|1|||
106178491|NCT01575548|366314918|FG000|Overall Study|Never started protocol therapy|3|||
106178492|NCT01575548|366314919|FG001|Overall Study|Never started protocol therapy|2|||
106178493|NCT04116073|366314920|FG000|Overall Study|Withdrawal by Subject|2|||
106178494|NCT04116073|366314920|FG000|Overall Study|failed to maintained eligibility|1|||
106178495|NCT04971226|366314921|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
106178496|NCT04971226|366314922|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
106178497|NCT04971226|366314923|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
106178498|NCT04971226|366314924|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
106178499|NCT04971226|366314921|FG000|Overall Study|Adverse Event|6|||
106178500|NCT04971226|366314922|FG001|Overall Study|Adverse Event|5|||
106178501|NCT04971226|366314923|FG002|Overall Study|Adverse Event|11|||
106178502|NCT04971226|366314924|FG003|Overall Study|Adverse Event|10|||
106178503|NCT04971226|366314921|FG000|Overall Study|Progressive disease|2|||
106178504|NCT04971226|366314922|FG001|Overall Study|Progressive disease|0|||
106178505|NCT04971226|366314923|FG002|Overall Study|Progressive disease|3|||
106178506|NCT04971226|366314924|FG003|Overall Study|Progressive disease|1|||
106178507|NCT04971226|366314921|FG000|Overall Study|Protocol Deviation|1|||
106178508|NCT04971226|366314922|FG001|Overall Study|Protocol Deviation|0|||
106178509|NCT04971226|366314923|FG002|Overall Study|Protocol Deviation|1|||
106178510|NCT04971226|366314924|FG003|Overall Study|Protocol Deviation|1|||
106178511|NCT04971226|366314921|FG000|Overall Study|Subject Decision|0|||
106178512|NCT04971226|366314922|FG001|Overall Study|Subject Decision|1|||
106178513|NCT04971226|366314923|FG002|Overall Study|Subject Decision|1|||
106178514|NCT04971226|366314924|FG003|Overall Study|Subject Decision|1|||
106178515|NCT04971226|366314921|FG000|Overall Study|Pregnancy|0|||
106178516|NCT04971226|366314922|FG001|Overall Study|Pregnancy|0|||
106178517|NCT04971226|366314923|FG002|Overall Study|Pregnancy|0|||
106178518|NCT04971226|366314924|FG003|Overall Study|Pregnancy|1|||
106178519|NCT04971226|366314921|FG000|Overall Study|Participants not treated|1|||
106178520|NCT04971226|366314922|FG001|Overall Study|Participants not treated|0|||
106178521|NCT04971226|366314923|FG002|Overall Study|Participants not treated|2|||
106178522|NCT04971226|366314924|FG003|Overall Study|Participants not treated|1|||
106178523|NCT02615691|366314925|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
106178524|NCT02615691|366314925|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
106178525|NCT02615691|366314925|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
106178526|NCT02615691|366314925|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
106178527|NCT02048813|366314929|FG000|Overall Study|Still on treatment|279|||
106178528|NCT02048813|366314930|FG001|Overall Study|Still on treatment|0|||
106178529|NCT02048813|366314929|FG000|Overall Study|Adverse Event|40|||
106178530|NCT02048813|366314930|FG001|Overall Study|Adverse Event|38|||
106178531|NCT02048813|366314929|FG000|Overall Study|Disease progression|13|||
106178532|NCT02048813|366314930|FG001|Overall Study|Disease progression|3|||
106178533|NCT02048813|366314929|FG000|Overall Study|Withdrawal by Subject|7|||
106178534|NCT02048813|366314930|FG001|Overall Study|Withdrawal by Subject|8|||
106178535|NCT02048813|366314929|FG000|Overall Study|Death|2|||
106178536|NCT02048813|366314930|FG001|Overall Study|Death|1|||
106178537|NCT02048813|366314929|FG000|Overall Study|Complication|2|||
106178538|NCT02048813|366314930|FG001|Overall Study|Complication|2|||
106178539|NCT02048813|366314929|FG000|Overall Study|Non-protocol therapy|0|||
106178540|NCT02048813|366314930|FG001|Overall Study|Non-protocol therapy|1|||
106178541|NCT02048813|366314929|FG000|Overall Study|Second primary cancer|2|||
106178542|NCT02048813|366314930|FG001|Overall Study|Second primary cancer|0|||
106178543|NCT02048813|366314929|FG000|Overall Study|Insurance|2|||
106178544|NCT02048813|366314930|FG001|Overall Study|Insurance|0|||
106178545|NCT02048813|366314929|FG000|Overall Study|Wound infection/healing|2|||
106178546|NCT02048813|366314930|FG001|Overall Study|Wound infection/healing|0|||
106178547|NCT02048813|366314929|FG000|Overall Study|Missed appointment|3|||
106178548|NCT02048813|366314930|FG001|Overall Study|Missed appointment|0|||
106178549|NCT02048813|366314929|FG000|Overall Study|Never started treatment|2|||
106178550|NCT02048813|366314930|FG001|Overall Study|Never started treatment|17|||
106178551|NCT00972478|366314931|FG000|Overall Study|Adverse Event|3|||
106178552|NCT00972478|366314932|FG001|Overall Study|Adverse Event|16|||
106178553|NCT00972478|366314931|FG000|Overall Study|Withdrawal by Subject|1|||
106178554|NCT00972478|366314932|FG001|Overall Study|Withdrawal by Subject|8|||
106178555|NCT00972478|366314931|FG000|Overall Study|Progression/Relapse|0|||
106178556|NCT00972478|366314932|FG001|Overall Study|Progression/Relapse|2|||
106178557|NCT00972478|366314931|FG000|Overall Study|Death|0|||
106178558|NCT00972478|366314932|FG001|Overall Study|Death|2|||
106178559|NCT00972478|366314931|FG000|Overall Study|Not protocol specified|1|||
106178560|NCT00972478|366314932|FG001|Overall Study|Not protocol specified|1|||
106178561|NCT00972478|366314931|FG000|Overall Study|Ineligible|1|||
106178562|NCT00972478|366314932|FG001|Overall Study|Ineligible|7|||
106178563|NCT00972478|366314931|FG000|Overall Study|Not start protocol treatment|1|||
106178564|NCT00972478|366314932|FG001|Overall Study|Not start protocol treatment|2|||
106178565|NCT05061134|366314933|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
106178566|NCT05061134|366314934|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
106178567|NCT05061134|366314935|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
106178568|NCT05061134|366314933|FG000|Overall Study|Subject not treated|0|||
106178569|NCT05061134|366314934|FG001|Overall Study|Subject not treated|0|||
106178570|NCT05061134|366314935|FG002|Overall Study|Subject not treated|2|||
106178571|NCT05061134|366314933|FG000|Overall Study|Other|0|||
106178572|NCT05061134|366314934|FG001|Overall Study|Other|0|||
106178573|NCT05061134|366314935|FG002|Overall Study|Other|9|||
106178574|NCT05061134|366314933|FG000|Overall Study|Withdrawal by Subject|9|||
106178575|NCT05061134|366314934|FG001|Overall Study|Withdrawal by Subject|8|||
106178576|NCT05061134|366314935|FG002|Overall Study|Withdrawal by Subject|5|||
106178577|NCT05061134|366314933|FG000|Overall Study|Study Terminated by Sponsor|22|||
106178578|NCT05061134|366314934|FG001|Overall Study|Study Terminated by Sponsor|14|||
106178579|NCT05061134|366314935|FG002|Overall Study|Study Terminated by Sponsor|7|||
106178580|NCT05061134|366314933|FG000|Overall Study|Progressive Disease|1|||
106178581|NCT05061134|366314934|FG001|Overall Study|Progressive Disease|2|||
106178582|NCT05061134|366314935|FG002|Overall Study|Progressive Disease|0|||
106178583|NCT05061134|366314933|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
106178584|NCT05061134|366314934|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
106178585|NCT05061134|366314935|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
106178586|NCT05061134|366314933|FG000|Overall Study|Lost to Follow-up|1|||
106178587|NCT05061134|366314934|FG001|Overall Study|Lost to Follow-up|0|||
106178588|NCT05061134|366314935|FG002|Overall Study|Lost to Follow-up|0|||
106178589|NCT05061134|366314933|FG000|Overall Study|Physician Decision|1|||
106178590|NCT05061134|366314934|FG001|Overall Study|Physician Decision|1|||
106178591|NCT05061134|366314935|FG002|Overall Study|Physician Decision|0|||
106178592|NCT05061134|366314933|FG000|Overall Study|Disease progression|1|||
106178593|NCT05061134|366314934|FG001|Overall Study|Disease progression|0|||
106178594|NCT05061134|366314935|FG002|Overall Study|Disease progression|0|||
106178595|NCT05061134|366314933|FG000|Overall Study|Death|43|||
106178596|NCT05061134|366314934|FG001|Overall Study|Death|23|||
106178597|NCT05061134|366314935|FG002|Overall Study|Death|14|||
106178598|NCT05061134|366314933|FG000|Overall Study|Database lock|2|||
106178599|NCT05061134|366314934|FG001|Overall Study|Database lock|0|||
106178600|NCT05061134|366314935|FG002|Overall Study|Database lock|0|||
106178601|NCT01708954|366314936|FG000|Step 1|Disease progression|26|||
106178602|NCT01708954|366314937|FG001|Step 1|Disease progression|17|||
106178603|NCT01708954|366314938|FG002|Step 1|Disease progression|14|||
106178604|NCT01708954|366314936|FG000|Step 1|Adverse Event|3|||
106178605|NCT01708954|366314937|FG001|Step 1|Adverse Event|11|||
106178606|NCT01708954|366314938|FG002|Step 1|Adverse Event|13|||
106178607|NCT01708954|366314936|FG000|Step 1|Death|3|||
106178608|NCT01708954|366314937|FG001|Step 1|Death|2|||
106178609|NCT01708954|366314938|FG002|Step 1|Death|3|||
106178610|NCT01708954|366314936|FG000|Step 1|Withdrawal by Subject|2|||
106178611|NCT01708954|366314937|FG001|Step 1|Withdrawal by Subject|5|||
106178612|NCT01708954|366314938|FG002|Step 1|Withdrawal by Subject|3|||
106178613|NCT01708954|366314936|FG000|Step 1|Other complicating disease|0|||
106178614|NCT01708954|366314937|FG001|Step 1|Other complicating disease|2|||
106178615|NCT01708954|366314938|FG002|Step 1|Other complicating disease|0|||
106178616|NCT01708954|366314936|FG000|Step 1|Crossed over to Step 2|2|||
106178617|NCT01708954|366314937|FG001|Step 1|Crossed over to Step 2|0|||
106178618|NCT01708954|366314938|FG002|Step 1|Crossed over to Step 2|0|||
106178619|NCT01708954|366314936|FG000|Step 1|Symptomatic deterioration|1|||
106178620|NCT01708954|366314937|FG001|Step 1|Symptomatic deterioration|0|||
106178621|NCT01708954|366314938|FG002|Step 1|Symptomatic deterioration|1|||
106178622|NCT01708954|366314936|FG000|Step 1|Off-treatment reason not submitted|1|||
106178623|NCT01708954|366314937|FG001|Step 1|Off-treatment reason not submitted|1|||
106178624|NCT01708954|366314938|FG002|Step 1|Off-treatment reason not submitted|1|||
106178625|NCT01708954|366314936|FG000|Step 1|Ineligible or never received treatment|4|||
106178626|NCT01708954|366314937|FG001|Step 1|Ineligible or never received treatment|2|||
106178627|NCT01708954|366314938|FG002|Step 1|Ineligible or never received treatment|8|||
106178628|NCT01708954|366314936|FG000|Step 2|Disease progression|9|||
106178629|NCT01708954|366314937|FG001|Step 2|Disease progression|4|||
106178630|NCT01708954|366314938|FG002|Step 2|Disease progression|0|||
106178631|NCT01708954|366314936|FG000|Step 2|Adverse Event|3|||
106178632|NCT01708954|366314937|FG001|Step 2|Adverse Event|2|||
106178633|NCT01708954|366314938|FG002|Step 2|Adverse Event|0|||
106178634|NCT01708954|366314936|FG000|Step 2|Withdrawal by Subject|1|||
106178635|NCT01708954|366314937|FG001|Step 2|Withdrawal by Subject|1|||
106178636|NCT01708954|366314938|FG002|Step 2|Withdrawal by Subject|0|||
106178637|NCT04201093|366314939|FG000|Overall Study|Adverse Event|6|||
106178638|NCT04201093|366314940|FG001|Overall Study|Adverse Event|29|||
106178639|NCT04201093|366314941|FG002|Overall Study|Adverse Event|35|||
106178640|NCT04201093|366314939|FG000|Overall Study|Death|2|||
106178641|NCT04201093|366314940|FG001|Overall Study|Death|1|||
106178642|NCT04201093|366314941|FG002|Overall Study|Death|0|||
106178643|NCT04201093|366314939|FG000|Overall Study|Lack of Efficacy|5|||
106178644|NCT04201093|366314940|FG001|Overall Study|Lack of Efficacy|1|||
106178645|NCT04201093|366314941|FG002|Overall Study|Lack of Efficacy|2|||
106178646|NCT04201093|366314939|FG000|Overall Study|Lost to Follow-up|0|||
106178647|NCT04201093|366314940|FG001|Overall Study|Lost to Follow-up|0|||
106178648|NCT04201093|366314941|FG002|Overall Study|Lost to Follow-up|1|||
106178649|NCT04201093|366314939|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
106178650|NCT04201093|366314940|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
106178651|NCT04201093|366314941|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
106178652|NCT04201093|366314939|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
106178653|NCT04201093|366314940|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
106178654|NCT04201093|366314941|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
106178655|NCT04201093|366314939|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
106178656|NCT04201093|366314940|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
106178657|NCT04201093|366314941|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
106178658|NCT04201093|366314939|FG000|Overall Study|Physician Decision|1|||
106178659|NCT04201093|366314940|FG001|Overall Study|Physician Decision|0|||
106178660|NCT04201093|366314941|FG002|Overall Study|Physician Decision|0|||
106178661|NCT04201093|366314939|FG000|Overall Study|Protocol Deviation|1|||
106178662|NCT04201093|366314940|FG001|Overall Study|Protocol Deviation|0|||
106178663|NCT04201093|366314941|FG002|Overall Study|Protocol Deviation|0|||
106178664|NCT04201093|366314939|FG000|Overall Study|Site Terminated by Sponsor|5|||
106178665|NCT04201093|366314940|FG001|Overall Study|Site Terminated by Sponsor|3|||
106178666|NCT04201093|366314941|FG002|Overall Study|Site Terminated by Sponsor|1|||
106178667|NCT04201093|366314939|FG000|Overall Study|Withdrawal by Subject|7|||
106178668|NCT04201093|366314940|FG001|Overall Study|Withdrawal by Subject|8|||
106178669|NCT04201093|366314941|FG002|Overall Study|Withdrawal by Subject|15|||
106178670|NCT04201093|366314939|FG000|Overall Study|Other|0|||
106178671|NCT04201093|366314940|FG001|Overall Study|Other|1|||
106178672|NCT04201093|366314941|FG002|Overall Study|Other|2|||
106178673|NCT04256512|366314942|FG000|Overall Study|Withdrawal by Subject|1|||
106178674|NCT01522976|366314949|FG000|Overall Study|Ineligible|4|||
106178675|NCT01522976|366314950|FG001|Overall Study|Ineligible|0|||
106178676|NCT01522976|366314951|FG002|Overall Study|Ineligible|1|||
106178677|NCT01522976|366314949|FG000|Overall Study|Death|7|||
106178678|NCT01522976|366314950|FG001|Overall Study|Death|6|||
106178679|NCT01522976|366314951|FG002|Overall Study|Death|2|||
106178680|NCT01522976|366314949|FG000|Overall Study|Still on treatment|9|||
106178681|NCT01522976|366314950|FG001|Overall Study|Still on treatment|9|||
106178682|NCT01522976|366314951|FG002|Overall Study|Still on treatment|6|||
106178683|NCT01522976|366314949|FG000|Overall Study|Disease progression|28|||
106178684|NCT01522976|366314950|FG001|Overall Study|Disease progression|30|||
106178685|NCT01522976|366314951|FG002|Overall Study|Disease progression|25|||
106178686|NCT01522976|366314949|FG000|Overall Study|Adverse Event|17|||
106178687|NCT01522976|366314950|FG001|Overall Study|Adverse Event|7|||
106178688|NCT01522976|366314951|FG002|Overall Study|Adverse Event|18|||
106178689|NCT01522976|366314949|FG000|Overall Study|Refusal unrelated to adverse event|10|||
106178690|NCT01522976|366314950|FG001|Overall Study|Refusal unrelated to adverse event|13|||
106178691|NCT01522976|366314951|FG002|Overall Study|Refusal unrelated to adverse event|14|||
106178692|NCT01522976|366314949|FG000|Overall Study|Not protocol specified|22|||
106178693|NCT01522976|366314950|FG001|Overall Study|Not protocol specified|27|||
106178694|NCT01522976|366314951|FG002|Overall Study|Not protocol specified|27|||
106178695|NCT01013649|366314952|FG000|First Step|Withdrawal by Subject|36|||
106178696|NCT01013649|366314953|FG001|First Step|Withdrawal by Subject|19|||
106178697|NCT01013649|366314954|FG002|First Step|Withdrawal by Subject|0|||
106178698|NCT01013649|366314955|FG003|First Step|Withdrawal by Subject|0|||
106178699|NCT01013649|366314952|FG000|First Step|Progression|58|||
106178700|NCT01013649|366314953|FG001|First Step|Progression|23|||
106178701|NCT01013649|366314954|FG002|First Step|Progression|0|||
106178702|NCT01013649|366314955|FG003|First Step|Progression|0|||
106178703|NCT01013649|366314952|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
106178704|NCT01013649|366314953|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
106178705|NCT01013649|366314954|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
106178706|NCT01013649|366314955|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
106178707|NCT01013649|366314952|FG000|First Step|Death|3|||
106178708|NCT01013649|366314953|FG001|First Step|Death|4|||
106178709|NCT01013649|366314954|FG002|First Step|Death|0|||
106178710|NCT01013649|366314955|FG003|First Step|Death|0|||
106178711|NCT01013649|366314952|FG000|First Step|Adverse Event|9|||
106178712|NCT01013649|366314953|FG001|First Step|Adverse Event|5|||
106178713|NCT01013649|366314954|FG002|First Step|Adverse Event|0|||
106178714|NCT01013649|366314955|FG003|First Step|Adverse Event|0|||
106178715|NCT01013649|366314952|FG000|First Step|Other|4|||
106178716|NCT01013649|366314953|FG001|First Step|Other|6|||
106178717|NCT01013649|366314954|FG002|First Step|Other|0|||
106178718|NCT01013649|366314955|FG003|First Step|Other|0|||
106178719|NCT02684006|366314960|FG000|Overall Study|Other|18|||
106178720|NCT02684006|366314961|FG001|Overall Study|Other|6|||
106178721|NCT02684006|366314960|FG000|Overall Study|Protocol Violation|2|||
106178722|NCT02684006|366314961|FG001|Overall Study|Protocol Violation|1|||
106178723|NCT02684006|366314960|FG000|Overall Study|Non-compliance with study drug|1|||
106178724|NCT02684006|366314961|FG001|Overall Study|Non-compliance with study drug|1|||
106178725|NCT02684006|366314960|FG000|Overall Study|No longer met eligibility criteria|6|||
106178726|NCT02684006|366314961|FG001|Overall Study|No longer met eligibility criteria|2|||
106178727|NCT02684006|366314960|FG000|Overall Study|Lost to Follow-up|0|||
106178728|NCT02684006|366314961|FG001|Overall Study|Lost to Follow-up|1|||
106178729|NCT02684006|366314960|FG000|Overall Study|Death|25|||
106178730|NCT02684006|366314961|FG001|Overall Study|Death|22|||
106178731|NCT02684006|366314960|FG000|Overall Study|Global deterioration of health status|18|||
106178732|NCT02684006|366314961|FG001|Overall Study|Global deterioration of health status|20|||
105867376|NCT01473407|365164955|FG000|Overall Study|Kidney Transplant|7|||
105867377|NCT01473407|365164956|FG001|Overall Study|Kidney Transplant|6|||
106178733|NCT02684006|366314960|FG000|Overall Study|Physician Decision|15|||
106178734|NCT02684006|366314961|FG001|Overall Study|Physician Decision|8|||
106178735|NCT02684006|366314960|FG000|Overall Study|Adverse Event|86|||
106178736|NCT02684006|366314961|FG001|Overall Study|Adverse Event|65|||
105867378|NCT01473407|365164955|FG000|Overall Study|Vacation/Travel|1|||
105867379|NCT01473407|365164956|FG001|Overall Study|Vacation/Travel|1|||
105867380|NCT01473407|365164955|FG000|Overall Study|Elevated Hemoglobin|1|||
105867381|NCT01473407|365164956|FG001|Overall Study|Elevated Hemoglobin|0|||
105867382|NCT01473407|365164955|FG000|Overall Study|Patient Received Aranesp|1|||
106178737|NCT02684006|366314960|FG000|Overall Study|Withdrawal by Subject|29|||
106178738|NCT02684006|366314961|FG001|Overall Study|Withdrawal by Subject|43|||
106178739|NCT02684006|366314960|FG000|Overall Study|Progressive disease|236|||
106178740|NCT02684006|366314961|FG001|Overall Study|Progressive disease|266|||
106178741|NCT02684006|366314960|FG000|Overall Study|Participation terminated by sponsor|6|||
106178742|NCT02684006|366314961|FG001|Overall Study|Participation terminated by sponsor|9|||
106178743|NCT04397263|366314962|FG000|Overall Study|Withdrawal by Subject|2|||
106178744|NCT02883049|366314963|FG000|Induction|Adverse Event|52|||
106178745|NCT02883049|366314964|FG001|Induction|Adverse Event|2|||
106178746|NCT02883049|366314965|FG002|Induction|Adverse Event|0|||
106178747|NCT02883049|366314966|FG003|Induction|Adverse Event|0|||
106178748|NCT02883049|366314967|FG004|Induction|Adverse Event|0|||
106178749|NCT02883049|366314968|FG005|Induction|Adverse Event|0|||
106178750|NCT02883049|366314969|FG006|Induction|Adverse Event|0|||
106178751|NCT02883049|366314970|FG007|Induction|Adverse Event|0|||
106178752|NCT02883049|366314971|FG008|Induction|Adverse Event|0|||
106178753|NCT02883049|366314972|FG009|Induction|Adverse Event|0|||
106178754|NCT02883049|366314973|FG010|Induction|Adverse Event|0|||
106178755|NCT02883049|366314974|FG011|Induction|Adverse Event|0|||
105867383|NCT01473407|365164956|FG001|Overall Study|Patient Received Aranesp|0|||
105867384|NCT01473407|365164955|FG000|Overall Study|Patient Lost Green Card Status|1|||
105867385|NCT01473407|365164956|FG001|Overall Study|Patient Lost Green Card Status|0|||
105867386|NCT01473407|365164955|FG000|Overall Study|Temperature Excursion|2|||
106178756|NCT02883049|366314975|FG012|Induction|Adverse Event|0|||
106178757|NCT02883049|366314976|FG013|Induction|Adverse Event|0|||
106178758|NCT02883049|366314977|FG014|Induction|Adverse Event|0|||
106178759|NCT02883049|366314978|FG015|Induction|Adverse Event|0|||
106178760|NCT02883049|366314963|FG000|Induction|Death|76|||
106178761|NCT02883049|366314964|FG001|Induction|Death|8|||
106178762|NCT02883049|366314965|FG002|Induction|Death|0|||
106178763|NCT02883049|366314966|FG003|Induction|Death|0|||
106178764|NCT02883049|366314967|FG004|Induction|Death|0|||
106178765|NCT02883049|366314968|FG005|Induction|Death|0|||
106178766|NCT02883049|366314969|FG006|Induction|Death|0|||
106178767|NCT02883049|366314970|FG007|Induction|Death|0|||
106178768|NCT02883049|366314971|FG008|Induction|Death|0|||
106178769|NCT02883049|366314972|FG009|Induction|Death|0|||
106178770|NCT02883049|366314973|FG010|Induction|Death|0|||
106178771|NCT02883049|366314974|FG011|Induction|Death|0|||
106178772|NCT02883049|366314975|FG012|Induction|Death|0|||
106178773|NCT02883049|366314976|FG013|Induction|Death|0|||
106178774|NCT02883049|366314977|FG014|Induction|Death|0|||
106178775|NCT02883049|366314978|FG015|Induction|Death|0|||
106178776|NCT02883049|366314963|FG000|Induction|Lost to Follow-up|2|||
106178777|NCT02883049|366314964|FG001|Induction|Lost to Follow-up|0|||
106178778|NCT02883049|366314965|FG002|Induction|Lost to Follow-up|0|||
106178779|NCT02883049|366314966|FG003|Induction|Lost to Follow-up|0|||
106178780|NCT02883049|366314967|FG004|Induction|Lost to Follow-up|0|||
106178781|NCT02883049|366314968|FG005|Induction|Lost to Follow-up|0|||
106178782|NCT02883049|366314969|FG006|Induction|Lost to Follow-up|0|||
106178783|NCT02883049|366314970|FG007|Induction|Lost to Follow-up|0|||
106178784|NCT02883049|366314971|FG008|Induction|Lost to Follow-up|0|||
106178785|NCT02883049|366314972|FG009|Induction|Lost to Follow-up|0|||
106178786|NCT02883049|366314973|FG010|Induction|Lost to Follow-up|0|||
106178787|NCT02883049|366314974|FG011|Induction|Lost to Follow-up|0|||
106178788|NCT02883049|366314975|FG012|Induction|Lost to Follow-up|0|||
106178789|NCT02883049|366314976|FG013|Induction|Lost to Follow-up|0|||
106178790|NCT02883049|366314977|FG014|Induction|Lost to Follow-up|0|||
106178791|NCT02883049|366314978|FG015|Induction|Lost to Follow-up|0|||
106178792|NCT02883049|366314963|FG000|Induction|Physician Decision|1407|||
106178793|NCT02883049|366314964|FG001|Induction|Physician Decision|8|||
106178794|NCT02883049|366314965|FG002|Induction|Physician Decision|0|||
106178795|NCT02883049|366314966|FG003|Induction|Physician Decision|0|||
106178796|NCT02883049|366314967|FG004|Induction|Physician Decision|0|||
106178797|NCT02883049|366314968|FG005|Induction|Physician Decision|0|||
106178798|NCT02883049|366314969|FG006|Induction|Physician Decision|0|||
106178799|NCT02883049|366314970|FG007|Induction|Physician Decision|0|||
106178800|NCT02883049|366314971|FG008|Induction|Physician Decision|0|||
106178801|NCT02883049|366314972|FG009|Induction|Physician Decision|0|||
106178802|NCT02883049|366314973|FG010|Induction|Physician Decision|0|||
106178803|NCT02883049|366314974|FG011|Induction|Physician Decision|0|||
106178804|NCT02883049|366314975|FG012|Induction|Physician Decision|0|||
106178805|NCT02883049|366314976|FG013|Induction|Physician Decision|0|||
106178806|NCT02883049|366314977|FG014|Induction|Physician Decision|0|||
106178807|NCT02883049|366314978|FG015|Induction|Physician Decision|0|||
106178808|NCT02883049|366314963|FG000|Induction|Protocol Violation|6|||
106178809|NCT02883049|366314964|FG001|Induction|Protocol Violation|0|||
106178810|NCT02883049|366314965|FG002|Induction|Protocol Violation|0|||
106178811|NCT02883049|366314966|FG003|Induction|Protocol Violation|0|||
106178812|NCT02883049|366314967|FG004|Induction|Protocol Violation|0|||
106178813|NCT02883049|366314968|FG005|Induction|Protocol Violation|0|||
106178814|NCT02883049|366314969|FG006|Induction|Protocol Violation|0|||
106178815|NCT02883049|366314970|FG007|Induction|Protocol Violation|0|||
106178816|NCT02883049|366314971|FG008|Induction|Protocol Violation|0|||
106178817|NCT02883049|366314972|FG009|Induction|Protocol Violation|0|||
106178818|NCT02883049|366314973|FG010|Induction|Protocol Violation|0|||
106178819|NCT02883049|366314974|FG011|Induction|Protocol Violation|0|||
106178820|NCT02883049|366314975|FG012|Induction|Protocol Violation|0|||
106178821|NCT02883049|366314976|FG013|Induction|Protocol Violation|0|||
106178822|NCT02883049|366314977|FG014|Induction|Protocol Violation|0|||
106178823|NCT02883049|366314978|FG015|Induction|Protocol Violation|0|||
106178824|NCT02883049|366314963|FG000|Induction|Withdrawal by Subject|6|||
106178825|NCT02883049|366314964|FG001|Induction|Withdrawal by Subject|0|||
106178826|NCT02883049|366314965|FG002|Induction|Withdrawal by Subject|0|||
106178827|NCT02883049|366314966|FG003|Induction|Withdrawal by Subject|0|||
106178828|NCT02883049|366314967|FG004|Induction|Withdrawal by Subject|0|||
106178829|NCT02883049|366314968|FG005|Induction|Withdrawal by Subject|0|||
106178830|NCT02883049|366314969|FG006|Induction|Withdrawal by Subject|0|||
106178831|NCT02883049|366314970|FG007|Induction|Withdrawal by Subject|0|||
106178832|NCT02883049|366314971|FG008|Induction|Withdrawal by Subject|0|||
106178833|NCT02883049|366314972|FG009|Induction|Withdrawal by Subject|0|||
106178834|NCT02883049|366314973|FG010|Induction|Withdrawal by Subject|0|||
106178835|NCT02883049|366314974|FG011|Induction|Withdrawal by Subject|0|||
106178836|NCT02883049|366314975|FG012|Induction|Withdrawal by Subject|0|||
106178837|NCT02883049|366314976|FG013|Induction|Withdrawal by Subject|0|||
106178838|NCT02883049|366314977|FG014|Induction|Withdrawal by Subject|0|||
106178839|NCT02883049|366314978|FG015|Induction|Withdrawal by Subject|0|||
106178840|NCT02883049|366314963|FG000|Induction|Ineligible|35|||
106178841|NCT02883049|366314964|FG001|Induction|Ineligible|1|||
106178842|NCT02883049|366314965|FG002|Induction|Ineligible|0|||
106178843|NCT02883049|366314966|FG003|Induction|Ineligible|0|||
106178844|NCT02883049|366314967|FG004|Induction|Ineligible|0|||
106178845|NCT02883049|366314968|FG005|Induction|Ineligible|0|||
106178846|NCT02883049|366314969|FG006|Induction|Ineligible|0|||
106178847|NCT02883049|366314970|FG007|Induction|Ineligible|0|||
106178848|NCT02883049|366314971|FG008|Induction|Ineligible|0|||
106178849|NCT02883049|366314972|FG009|Induction|Ineligible|0|||
106178850|NCT02883049|366314973|FG010|Induction|Ineligible|0|||
106178851|NCT02883049|366314974|FG011|Induction|Ineligible|0|||
106178852|NCT02883049|366314975|FG012|Induction|Ineligible|0|||
106178853|NCT02883049|366314976|FG013|Induction|Ineligible|0|||
106178854|NCT02883049|366314977|FG014|Induction|Ineligible|0|||
106178855|NCT02883049|366314978|FG015|Induction|Ineligible|0|||
106178856|NCT02883049|366314963|FG000|Induction|Refusal of further protocol therapy|466|||
106178857|NCT02883049|366314964|FG001|Induction|Refusal of further protocol therapy|2|||
106178858|NCT02883049|366314965|FG002|Induction|Refusal of further protocol therapy|0|||
106178859|NCT02883049|366314966|FG003|Induction|Refusal of further protocol therapy|0|||
106178860|NCT02883049|366314967|FG004|Induction|Refusal of further protocol therapy|0|||
106178861|NCT02883049|366314968|FG005|Induction|Refusal of further protocol therapy|0|||
106178862|NCT02883049|366314969|FG006|Induction|Refusal of further protocol therapy|0|||
106178863|NCT02883049|366314970|FG007|Induction|Refusal of further protocol therapy|0|||
106178864|NCT02883049|366314971|FG008|Induction|Refusal of further protocol therapy|0|||
106178865|NCT02883049|366314972|FG009|Induction|Refusal of further protocol therapy|0|||
106178866|NCT02883049|366314973|FG010|Induction|Refusal of further protocol therapy|0|||
106178867|NCT02883049|366314974|FG011|Induction|Refusal of further protocol therapy|0|||
106178868|NCT02883049|366314975|FG012|Induction|Refusal of further protocol therapy|0|||
106178869|NCT02883049|366314976|FG013|Induction|Refusal of further protocol therapy|0|||
106178870|NCT02883049|366314977|FG014|Induction|Refusal of further protocol therapy|0|||
106178871|NCT02883049|366314978|FG015|Induction|Refusal of further protocol therapy|0|||
106178872|NCT02883049|366314963|FG000|Induction|Identified as Ph+ patients|279|||
106178873|NCT02883049|366314964|FG001|Induction|Identified as Ph+ patients|1|||
106178874|NCT02883049|366314965|FG002|Induction|Identified as Ph+ patients|0|||
106178875|NCT02883049|366314966|FG003|Induction|Identified as Ph+ patients|0|||
106178876|NCT02883049|366314967|FG004|Induction|Identified as Ph+ patients|0|||
106178877|NCT02883049|366314968|FG005|Induction|Identified as Ph+ patients|0|||
106178878|NCT02883049|366314969|FG006|Induction|Identified as Ph+ patients|0|||
106178879|NCT02883049|366314970|FG007|Induction|Identified as Ph+ patients|0|||
106178880|NCT02883049|366314971|FG008|Induction|Identified as Ph+ patients|0|||
106178881|NCT02883049|366314972|FG009|Induction|Identified as Ph+ patients|0|||
106178882|NCT02883049|366314973|FG010|Induction|Identified as Ph+ patients|0|||
106178883|NCT02883049|366314974|FG011|Induction|Identified as Ph+ patients|0|||
106178884|NCT02883049|366314975|FG012|Induction|Identified as Ph+ patients|0|||
106178885|NCT02883049|366314976|FG013|Induction|Identified as Ph+ patients|0|||
106178886|NCT02883049|366314977|FG014|Induction|Identified as Ph+ patients|0|||
106178887|NCT02883049|366314978|FG015|Induction|Identified as Ph+ patients|0|||
106178888|NCT02883049|366314963|FG000|Induction|M3 Marrow at Day29|8|||
106178889|NCT02883049|366314964|FG001|Induction|M3 Marrow at Day29|1|||
106178890|NCT02883049|366314965|FG002|Induction|M3 Marrow at Day29|0|||
106178891|NCT02883049|366314966|FG003|Induction|M3 Marrow at Day29|0|||
106178892|NCT02883049|366314967|FG004|Induction|M3 Marrow at Day29|0|||
106178893|NCT02883049|366314968|FG005|Induction|M3 Marrow at Day29|0|||
106178894|NCT02883049|366314969|FG006|Induction|M3 Marrow at Day29|0|||
106178895|NCT02883049|366314970|FG007|Induction|M3 Marrow at Day29|0|||
106178896|NCT02883049|366314971|FG008|Induction|M3 Marrow at Day29|0|||
106178897|NCT02883049|366314972|FG009|Induction|M3 Marrow at Day29|0|||
106178898|NCT02883049|366314973|FG010|Induction|M3 Marrow at Day29|0|||
106178899|NCT02883049|366314974|FG011|Induction|M3 Marrow at Day29|0|||
106178900|NCT02883049|366314975|FG012|Induction|M3 Marrow at Day29|0|||
106178901|NCT02883049|366314976|FG013|Induction|M3 Marrow at Day29|0|||
106178902|NCT02883049|366314977|FG014|Induction|M3 Marrow at Day29|0|||
106178903|NCT02883049|366314978|FG015|Induction|M3 Marrow at Day29|0|||
106178904|NCT02883049|366314963|FG000|Induction|Inevaluable|33|||
106178905|NCT02883049|366314964|FG001|Induction|Inevaluable|1|||
106178906|NCT02883049|366314965|FG002|Induction|Inevaluable|0|||
106178907|NCT02883049|366314966|FG003|Induction|Inevaluable|0|||
105867387|NCT01473407|365164956|FG001|Overall Study|Temperature Excursion|3|||
105867388|NCT01473407|365164955|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
105867389|NCT01473407|365164956|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
106178908|NCT02883049|366314967|FG004|Induction|Inevaluable|0|||
106178909|NCT02883049|366314968|FG005|Induction|Inevaluable|0|||
106178910|NCT02883049|366314969|FG006|Induction|Inevaluable|0|||
106178911|NCT02883049|366314970|FG007|Induction|Inevaluable|0|||
106178912|NCT02883049|366314971|FG008|Induction|Inevaluable|0|||
106178913|NCT02883049|366314972|FG009|Induction|Inevaluable|0|||
106178914|NCT02883049|366314973|FG010|Induction|Inevaluable|0|||
106178915|NCT02883049|366314974|FG011|Induction|Inevaluable|0|||
106178916|NCT02883049|366314975|FG012|Induction|Inevaluable|0|||
106178917|NCT02883049|366314976|FG013|Induction|Inevaluable|0|||
106178918|NCT02883049|366314977|FG014|Induction|Inevaluable|0|||
106178919|NCT02883049|366314978|FG015|Induction|Inevaluable|0|||
106178920|NCT02883049|366314963|FG000|Induction|Identified as VHR at end of Induction|244|||
106178921|NCT02883049|366314964|FG001|Induction|Identified as VHR at end of Induction|0|||
106178922|NCT02883049|366314965|FG002|Induction|Identified as VHR at end of Induction|0|||
106178923|NCT02883049|366314966|FG003|Induction|Identified as VHR at end of Induction|0|||
106178924|NCT02883049|366314967|FG004|Induction|Identified as VHR at end of Induction|0|||
106178925|NCT02883049|366314968|FG005|Induction|Identified as VHR at end of Induction|0|||
106178926|NCT02883049|366314969|FG006|Induction|Identified as VHR at end of Induction|0|||
106178927|NCT02883049|366314970|FG007|Induction|Identified as VHR at end of Induction|0|||
106178928|NCT02883049|366314971|FG008|Induction|Identified as VHR at end of Induction|0|||
106178929|NCT02883049|366314972|FG009|Induction|Identified as VHR at end of Induction|0|||
106178930|NCT02883049|366314973|FG010|Induction|Identified as VHR at end of Induction|0|||
106178931|NCT02883049|366314974|FG011|Induction|Identified as VHR at end of Induction|0|||
106178932|NCT02883049|366314975|FG012|Induction|Identified as VHR at end of Induction|0|||
106178933|NCT02883049|366314976|FG013|Induction|Identified as VHR at end of Induction|0|||
106178934|NCT02883049|366314977|FG014|Induction|Identified as VHR at end of Induction|0|||
106178935|NCT02883049|366314978|FG015|Induction|Identified as VHR at end of Induction|0|||
106178936|NCT02883049|366314963|FG000|Induction|Moved to another non-COG institution|3|||
106178937|NCT02883049|366314964|FG001|Induction|Moved to another non-COG institution|0|||
106178938|NCT02883049|366314965|FG002|Induction|Moved to another non-COG institution|0|||
106178939|NCT02883049|366314966|FG003|Induction|Moved to another non-COG institution|0|||
106178940|NCT02883049|366314967|FG004|Induction|Moved to another non-COG institution|0|||
106178941|NCT02883049|366314968|FG005|Induction|Moved to another non-COG institution|0|||
106178942|NCT02883049|366314969|FG006|Induction|Moved to another non-COG institution|0|||
106178943|NCT02883049|366314970|FG007|Induction|Moved to another non-COG institution|0|||
106178944|NCT02883049|366314971|FG008|Induction|Moved to another non-COG institution|0|||
106178945|NCT02883049|366314972|FG009|Induction|Moved to another non-COG institution|0|||
106178946|NCT02883049|366314973|FG010|Induction|Moved to another non-COG institution|0|||
106178947|NCT02883049|366314974|FG011|Induction|Moved to another non-COG institution|0|||
106178948|NCT02883049|366314975|FG012|Induction|Moved to another non-COG institution|0|||
106178949|NCT02883049|366314976|FG013|Induction|Moved to another non-COG institution|0|||
106178950|NCT02883049|366314977|FG014|Induction|Moved to another non-COG institution|0|||
106178951|NCT02883049|366314978|FG015|Induction|Moved to another non-COG institution|0|||
106178952|NCT02883049|366314963|FG000|Induction|Randomization closed|41|||
106178953|NCT02883049|366314964|FG001|Induction|Randomization closed|0|||
106178954|NCT02883049|366314965|FG002|Induction|Randomization closed|0|||
106178955|NCT02883049|366314966|FG003|Induction|Randomization closed|0|||
106178956|NCT02883049|366314967|FG004|Induction|Randomization closed|0|||
106178957|NCT02883049|366314968|FG005|Induction|Randomization closed|0|||
106178958|NCT02883049|366314969|FG006|Induction|Randomization closed|0|||
106178959|NCT02883049|366314970|FG007|Induction|Randomization closed|0|||
106178960|NCT02883049|366314971|FG008|Induction|Randomization closed|0|||
106178961|NCT02883049|366314972|FG009|Induction|Randomization closed|0|||
106178962|NCT02883049|366314973|FG010|Induction|Randomization closed|0|||
106178963|NCT02883049|366314974|FG011|Induction|Randomization closed|0|||
106178964|NCT02883049|366314975|FG012|Induction|Randomization closed|0|||
106178965|NCT02883049|366314976|FG013|Induction|Randomization closed|0|||
106178966|NCT02883049|366314977|FG014|Induction|Randomization closed|0|||
106178967|NCT02883049|366314978|FG015|Induction|Randomization closed|0|||
106178968|NCT02883049|366314963|FG000|Induction|MRD negative|36|||
106178969|NCT02883049|366314964|FG001|Induction|MRD negative|0|||
106178970|NCT02883049|366314965|FG002|Induction|MRD negative|0|||
106178971|NCT02883049|366314966|FG003|Induction|MRD negative|0|||
106178972|NCT02883049|366314967|FG004|Induction|MRD negative|0|||
106178973|NCT02883049|366314968|FG005|Induction|MRD negative|0|||
106178974|NCT02883049|366314969|FG006|Induction|MRD negative|0|||
106178975|NCT02883049|366314970|FG007|Induction|MRD negative|0|||
106178976|NCT02883049|366314971|FG008|Induction|MRD negative|0|||
106178977|NCT02883049|366314972|FG009|Induction|MRD negative|0|||
106178978|NCT02883049|366314973|FG010|Induction|MRD negative|0|||
106178979|NCT02883049|366314974|FG011|Induction|MRD negative|0|||
106178980|NCT02883049|366314975|FG012|Induction|MRD negative|0|||
106178981|NCT02883049|366314976|FG013|Induction|MRD negative|0|||
106178982|NCT02883049|366314977|FG014|Induction|MRD negative|0|||
106178983|NCT02883049|366314978|FG015|Induction|MRD negative|0|||
106178984|NCT02883049|366314963|FG000|Induction|Identified as HR patients|165|||
106178985|NCT02883049|366314964|FG001|Induction|Identified as HR patients|0|||
106178986|NCT02883049|366314965|FG002|Induction|Identified as HR patients|0|||
106178987|NCT02883049|366314966|FG003|Induction|Identified as HR patients|0|||
106178988|NCT02883049|366314967|FG004|Induction|Identified as HR patients|0|||
106178989|NCT02883049|366314968|FG005|Induction|Identified as HR patients|0|||
106178990|NCT02883049|366314969|FG006|Induction|Identified as HR patients|0|||
106178991|NCT02883049|366314970|FG007|Induction|Identified as HR patients|0|||
106178992|NCT02883049|366314971|FG008|Induction|Identified as HR patients|0|||
106178993|NCT02883049|366314972|FG009|Induction|Identified as HR patients|0|||
106178994|NCT02883049|366314973|FG010|Induction|Identified as HR patients|0|||
106178995|NCT02883049|366314974|FG011|Induction|Identified as HR patients|0|||
106178996|NCT02883049|366314975|FG012|Induction|Identified as HR patients|0|||
106178997|NCT02883049|366314976|FG013|Induction|Identified as HR patients|0|||
106178998|NCT02883049|366314977|FG014|Induction|Identified as HR patients|0|||
106178999|NCT02883049|366314978|FG015|Induction|Identified as HR patients|0|||
106179000|NCT02883049|366314963|FG000|Induction|Developed SMN|0|||
106179001|NCT02883049|366314964|FG001|Induction|Developed SMN|1|||
106179002|NCT02883049|366314965|FG002|Induction|Developed SMN|0|||
106179003|NCT02883049|366314966|FG003|Induction|Developed SMN|0|||
106179004|NCT02883049|366314967|FG004|Induction|Developed SMN|0|||
106179005|NCT02883049|366314968|FG005|Induction|Developed SMN|0|||
106179006|NCT02883049|366314969|FG006|Induction|Developed SMN|0|||
106179007|NCT02883049|366314970|FG007|Induction|Developed SMN|0|||
106179008|NCT02883049|366314971|FG008|Induction|Developed SMN|0|||
106179009|NCT02883049|366314972|FG009|Induction|Developed SMN|0|||
106179010|NCT02883049|366314973|FG010|Induction|Developed SMN|0|||
106179011|NCT02883049|366314974|FG011|Induction|Developed SMN|0|||
106179012|NCT02883049|366314975|FG012|Induction|Developed SMN|0|||
106179013|NCT02883049|366314976|FG013|Induction|Developed SMN|0|||
106179014|NCT02883049|366314977|FG014|Induction|Developed SMN|0|||
106179015|NCT02883049|366314978|FG015|Induction|Developed SMN|0|||
106179016|NCT02883049|366314963|FG000|Induction|Enrolled onto another COG study|72|||
106179017|NCT02883049|366314964|FG001|Induction|Enrolled onto another COG study|0|||
106179018|NCT02883049|366314965|FG002|Induction|Enrolled onto another COG study|0|||
106179019|NCT02883049|366314966|FG003|Induction|Enrolled onto another COG study|0|||
106179020|NCT02883049|366314967|FG004|Induction|Enrolled onto another COG study|0|||
106179021|NCT02883049|366314968|FG005|Induction|Enrolled onto another COG study|0|||
106179022|NCT02883049|366314969|FG006|Induction|Enrolled onto another COG study|0|||
106179023|NCT02883049|366314970|FG007|Induction|Enrolled onto another COG study|0|||
106179024|NCT02883049|366314971|FG008|Induction|Enrolled onto another COG study|0|||
106179025|NCT02883049|366314972|FG009|Induction|Enrolled onto another COG study|0|||
106179026|NCT02883049|366314973|FG010|Induction|Enrolled onto another COG study|0|||
106179027|NCT02883049|366314974|FG011|Induction|Enrolled onto another COG study|0|||
106179028|NCT02883049|366314975|FG012|Induction|Enrolled onto another COG study|0|||
106179029|NCT02883049|366314976|FG013|Induction|Enrolled onto another COG study|0|||
106179030|NCT02883049|366314977|FG014|Induction|Enrolled onto another COG study|0|||
106179031|NCT02883049|366314978|FG015|Induction|Enrolled onto another COG study|0|||
106179032|NCT02883049|366314963|FG000|Induction|Incomplete induction data|17|||
106179033|NCT02883049|366314964|FG001|Induction|Incomplete induction data|0|||
106179034|NCT02883049|366314965|FG002|Induction|Incomplete induction data|0|||
106179035|NCT02883049|366314966|FG003|Induction|Incomplete induction data|0|||
106179036|NCT02883049|366314967|FG004|Induction|Incomplete induction data|0|||
106179037|NCT02883049|366314968|FG005|Induction|Incomplete induction data|0|||
106179038|NCT02883049|366314969|FG006|Induction|Incomplete induction data|0|||
106179039|NCT02883049|366314970|FG007|Induction|Incomplete induction data|0|||
106179040|NCT02883049|366314971|FG008|Induction|Incomplete induction data|0|||
106179041|NCT02883049|366314972|FG009|Induction|Incomplete induction data|0|||
106179042|NCT02883049|366314973|FG010|Induction|Incomplete induction data|0|||
106179043|NCT02883049|366314974|FG011|Induction|Incomplete induction data|0|||
106179044|NCT02883049|366314975|FG012|Induction|Incomplete induction data|0|||
106179045|NCT02883049|366314976|FG013|Induction|Incomplete induction data|0|||
106179046|NCT02883049|366314977|FG014|Induction|Incomplete induction data|0|||
106179047|NCT02883049|366314978|FG015|Induction|Incomplete induction data|0|||
106179048|NCT02883049|366314963|FG000|Post Induction|Adverse Event|0|||
106179049|NCT02883049|366314964|FG001|Post Induction|Adverse Event|0|||
106179050|NCT02883049|366314965|FG002|Post Induction|Adverse Event|0|||
106179051|NCT02883049|366314966|FG003|Post Induction|Adverse Event|7|||
106179052|NCT02883049|366314967|FG004|Post Induction|Adverse Event|8|||
106179053|NCT02883049|366314968|FG005|Post Induction|Adverse Event|3|||
106179054|NCT02883049|366314969|FG006|Post Induction|Adverse Event|4|||
106179055|NCT02883049|366314970|FG007|Post Induction|Adverse Event|5|||
106179056|NCT02883049|366314971|FG008|Post Induction|Adverse Event|6|||
106179057|NCT02883049|366314972|FG009|Post Induction|Adverse Event|7|||
106179058|NCT02883049|366314973|FG010|Post Induction|Adverse Event|2|||
106179059|NCT02883049|366314974|FG011|Post Induction|Adverse Event|2|||
106179060|NCT02883049|366314975|FG012|Post Induction|Adverse Event|0|||
106179061|NCT02883049|366314976|FG013|Post Induction|Adverse Event|0|||
106179062|NCT02883049|366314977|FG014|Post Induction|Adverse Event|5|||
106179063|NCT02883049|366314978|FG015|Post Induction|Adverse Event|2|||
106179064|NCT02883049|366314963|FG000|Post Induction|Death|0|||
106179065|NCT02883049|366314964|FG001|Post Induction|Death|0|||
106179066|NCT02883049|366314965|FG002|Post Induction|Death|0|||
106179067|NCT02883049|366314966|FG003|Post Induction|Death|9|||
106179068|NCT02883049|366314967|FG004|Post Induction|Death|9|||
106179069|NCT02883049|366314968|FG005|Post Induction|Death|0|||
106179070|NCT02883049|366314969|FG006|Post Induction|Death|1|||
106179071|NCT02883049|366314970|FG007|Post Induction|Death|6|||
106179072|NCT02883049|366314971|FG008|Post Induction|Death|5|||
106179073|NCT02883049|366314972|FG009|Post Induction|Death|3|||
106179074|NCT02883049|366314973|FG010|Post Induction|Death|1|||
106179075|NCT02883049|366314974|FG011|Post Induction|Death|0|||
106179076|NCT02883049|366314975|FG012|Post Induction|Death|1|||
106179077|NCT02883049|366314976|FG013|Post Induction|Death|1|||
106179078|NCT02883049|366314977|FG014|Post Induction|Death|10|||
106179079|NCT02883049|366314978|FG015|Post Induction|Death|2|||
106179080|NCT02883049|366314963|FG000|Post Induction|Lost to Follow-up|0|||
106179081|NCT02883049|366314964|FG001|Post Induction|Lost to Follow-up|0|||
106179082|NCT02883049|366314965|FG002|Post Induction|Lost to Follow-up|0|||
106179083|NCT02883049|366314966|FG003|Post Induction|Lost to Follow-up|0|||
106179084|NCT02883049|366314967|FG004|Post Induction|Lost to Follow-up|1|||
106179085|NCT02883049|366314968|FG005|Post Induction|Lost to Follow-up|1|||
106179086|NCT02883049|366314969|FG006|Post Induction|Lost to Follow-up|0|||
106179087|NCT02883049|366314970|FG007|Post Induction|Lost to Follow-up|0|||
106179088|NCT02883049|366314971|FG008|Post Induction|Lost to Follow-up|3|||
106179089|NCT02883049|366314972|FG009|Post Induction|Lost to Follow-up|0|||
106179090|NCT02883049|366314973|FG010|Post Induction|Lost to Follow-up|1|||
106179091|NCT02883049|366314974|FG011|Post Induction|Lost to Follow-up|0|||
106179092|NCT02883049|366314975|FG012|Post Induction|Lost to Follow-up|0|||
106179093|NCT02883049|366314976|FG013|Post Induction|Lost to Follow-up|0|||
106179094|NCT02883049|366314977|FG014|Post Induction|Lost to Follow-up|0|||
106179095|NCT02883049|366314978|FG015|Post Induction|Lost to Follow-up|0|||
106179096|NCT02883049|366314963|FG000|Post Induction|Physician Decision|0|||
106179097|NCT02883049|366314964|FG001|Post Induction|Physician Decision|0|||
106179098|NCT02883049|366314965|FG002|Post Induction|Physician Decision|0|||
106179099|NCT02883049|366314966|FG003|Post Induction|Physician Decision|27|||
106179100|NCT02883049|366314967|FG004|Post Induction|Physician Decision|27|||
106179101|NCT02883049|366314968|FG005|Post Induction|Physician Decision|23|||
106179102|NCT02883049|366314969|FG006|Post Induction|Physician Decision|30|||
106179103|NCT02883049|366314970|FG007|Post Induction|Physician Decision|56|||
106179104|NCT02883049|366314971|FG008|Post Induction|Physician Decision|85|||
106179105|NCT02883049|366314972|FG009|Post Induction|Physician Decision|12|||
106179106|NCT02883049|366314973|FG010|Post Induction|Physician Decision|5|||
106179107|NCT02883049|366314974|FG011|Post Induction|Physician Decision|14|||
106179108|NCT02883049|366314975|FG012|Post Induction|Physician Decision|1|||
106179109|NCT02883049|366314976|FG013|Post Induction|Physician Decision|11|||
106179110|NCT02883049|366314977|FG014|Post Induction|Physician Decision|19|||
106179111|NCT02883049|366314978|FG015|Post Induction|Physician Decision|5|||
106179112|NCT02883049|366314963|FG000|Post Induction|Protocol Violation|0|||
106179113|NCT02883049|366314964|FG001|Post Induction|Protocol Violation|0|||
106179114|NCT02883049|366314965|FG002|Post Induction|Protocol Violation|0|||
106179115|NCT02883049|366314966|FG003|Post Induction|Protocol Violation|0|||
106179116|NCT02883049|366314967|FG004|Post Induction|Protocol Violation|0|||
106179117|NCT02883049|366314968|FG005|Post Induction|Protocol Violation|0|||
106179118|NCT02883049|366314969|FG006|Post Induction|Protocol Violation|0|||
106179119|NCT02883049|366314970|FG007|Post Induction|Protocol Violation|1|||
106179120|NCT02883049|366314971|FG008|Post Induction|Protocol Violation|0|||
106179121|NCT02883049|366314972|FG009|Post Induction|Protocol Violation|0|||
106179122|NCT02883049|366314973|FG010|Post Induction|Protocol Violation|0|||
106179123|NCT02883049|366314974|FG011|Post Induction|Protocol Violation|0|||
106179124|NCT02883049|366314975|FG012|Post Induction|Protocol Violation|0|||
106179125|NCT02883049|366314976|FG013|Post Induction|Protocol Violation|0|||
106179126|NCT02883049|366314977|FG014|Post Induction|Protocol Violation|0|||
106179127|NCT02883049|366314978|FG015|Post Induction|Protocol Violation|0|||
106179128|NCT02883049|366314963|FG000|Post Induction|Withdrawal by Subject|0|||
106179129|NCT02883049|366314964|FG001|Post Induction|Withdrawal by Subject|0|||
106179130|NCT02883049|366314965|FG002|Post Induction|Withdrawal by Subject|0|||
106179131|NCT02883049|366314966|FG003|Post Induction|Withdrawal by Subject|5|||
106179132|NCT02883049|366314967|FG004|Post Induction|Withdrawal by Subject|2|||
106179133|NCT02883049|366314968|FG005|Post Induction|Withdrawal by Subject|1|||
106179134|NCT02883049|366314969|FG006|Post Induction|Withdrawal by Subject|0|||
106179135|NCT02883049|366314970|FG007|Post Induction|Withdrawal by Subject|0|||
106179136|NCT02883049|366314971|FG008|Post Induction|Withdrawal by Subject|2|||
106179137|NCT02883049|366314972|FG009|Post Induction|Withdrawal by Subject|0|||
106179138|NCT02883049|366314973|FG010|Post Induction|Withdrawal by Subject|1|||
106179139|NCT02883049|366314974|FG011|Post Induction|Withdrawal by Subject|1|||
106179140|NCT02883049|366314975|FG012|Post Induction|Withdrawal by Subject|0|||
106179141|NCT02883049|366314976|FG013|Post Induction|Withdrawal by Subject|0|||
106179142|NCT02883049|366314977|FG014|Post Induction|Withdrawal by Subject|1|||
106179143|NCT02883049|366314978|FG015|Post Induction|Withdrawal by Subject|0|||
106179144|NCT02883049|366314963|FG000|Post Induction|Ineligible|0|||
106179145|NCT02883049|366314964|FG001|Post Induction|Ineligible|0|||
106179146|NCT02883049|366314965|FG002|Post Induction|Ineligible|2|||
106179147|NCT02883049|366314966|FG003|Post Induction|Ineligible|0|||
106179148|NCT02883049|366314967|FG004|Post Induction|Ineligible|0|||
106179149|NCT02883049|366314968|FG005|Post Induction|Ineligible|0|||
106179150|NCT02883049|366314969|FG006|Post Induction|Ineligible|1|||
106179151|NCT02883049|366314970|FG007|Post Induction|Ineligible|0|||
106179152|NCT02883049|366314971|FG008|Post Induction|Ineligible|0|||
106179153|NCT02883049|366314972|FG009|Post Induction|Ineligible|0|||
106179154|NCT02883049|366314973|FG010|Post Induction|Ineligible|1|||
106179155|NCT02883049|366314974|FG011|Post Induction|Ineligible|0|||
106179156|NCT02883049|366314975|FG012|Post Induction|Ineligible|0|||
106179157|NCT02883049|366314976|FG013|Post Induction|Ineligible|0|||
106179158|NCT02883049|366314977|FG014|Post Induction|Ineligible|0|||
106179159|NCT02883049|366314978|FG015|Post Induction|Ineligible|1|||
106179160|NCT02883049|366314963|FG000|Post Induction|Refusal of further protocol therapy|0|||
106179161|NCT02883049|366314964|FG001|Post Induction|Refusal of further protocol therapy|0|||
106179162|NCT02883049|366314965|FG002|Post Induction|Refusal of further protocol therapy|0|||
106179163|NCT02883049|366314966|FG003|Post Induction|Refusal of further protocol therapy|11|||
106179164|NCT02883049|366314967|FG004|Post Induction|Refusal of further protocol therapy|15|||
106179165|NCT02883049|366314968|FG005|Post Induction|Refusal of further protocol therapy|9|||
106179166|NCT02883049|366314969|FG006|Post Induction|Refusal of further protocol therapy|13|||
106179167|NCT02883049|366314970|FG007|Post Induction|Refusal of further protocol therapy|5|||
106179168|NCT02883049|366314971|FG008|Post Induction|Refusal of further protocol therapy|21|||
106179169|NCT02883049|366314972|FG009|Post Induction|Refusal of further protocol therapy|7|||
106179170|NCT02883049|366314973|FG010|Post Induction|Refusal of further protocol therapy|0|||
106179171|NCT02883049|366314974|FG011|Post Induction|Refusal of further protocol therapy|7|||
106179172|NCT02883049|366314975|FG012|Post Induction|Refusal of further protocol therapy|3|||
106179173|NCT02883049|366314976|FG013|Post Induction|Refusal of further protocol therapy|0|||
106179174|NCT02883049|366314977|FG014|Post Induction|Refusal of further protocol therapy|4|||
106179175|NCT02883049|366314978|FG015|Post Induction|Refusal of further protocol therapy|1|||
106179176|NCT02883049|366314963|FG000|Post Induction|Inevaluable|0|||
106179177|NCT02883049|366314964|FG001|Post Induction|Inevaluable|0|||
106179178|NCT02883049|366314965|FG002|Post Induction|Inevaluable|0|||
106179179|NCT02883049|366314966|FG003|Post Induction|Inevaluable|1|||
106179180|NCT02883049|366314967|FG004|Post Induction|Inevaluable|1|||
106179181|NCT02883049|366314968|FG005|Post Induction|Inevaluable|2|||
106179182|NCT02883049|366314969|FG006|Post Induction|Inevaluable|7|||
106179183|NCT02883049|366314970|FG007|Post Induction|Inevaluable|6|||
106179184|NCT02883049|366314971|FG008|Post Induction|Inevaluable|4|||
106179185|NCT02883049|366314972|FG009|Post Induction|Inevaluable|4|||
106179186|NCT02883049|366314973|FG010|Post Induction|Inevaluable|1|||
106179187|NCT02883049|366314974|FG011|Post Induction|Inevaluable|1|||
106179188|NCT02883049|366314975|FG012|Post Induction|Inevaluable|2|||
106179189|NCT02883049|366314976|FG013|Post Induction|Inevaluable|0|||
106179190|NCT02883049|366314977|FG014|Post Induction|Inevaluable|0|||
106179191|NCT02883049|366314978|FG015|Post Induction|Inevaluable|1|||
106179192|NCT02883049|366314963|FG000|Post Induction|Moved to another non-COG institution|0|||
106179193|NCT02883049|366314964|FG001|Post Induction|Moved to another non-COG institution|0|||
106179194|NCT02883049|366314965|FG002|Post Induction|Moved to another non-COG institution|0|||
106179195|NCT02883049|366314966|FG003|Post Induction|Moved to another non-COG institution|0|||
106179196|NCT02883049|366314967|FG004|Post Induction|Moved to another non-COG institution|0|||
106179197|NCT02883049|366314968|FG005|Post Induction|Moved to another non-COG institution|0|||
106179198|NCT02883049|366314969|FG006|Post Induction|Moved to another non-COG institution|0|||
106179199|NCT02883049|366314970|FG007|Post Induction|Moved to another non-COG institution|2|||
106179200|NCT02883049|366314971|FG008|Post Induction|Moved to another non-COG institution|2|||
106179201|NCT02883049|366314972|FG009|Post Induction|Moved to another non-COG institution|0|||
106179202|NCT02883049|366314973|FG010|Post Induction|Moved to another non-COG institution|0|||
106179203|NCT02883049|366314974|FG011|Post Induction|Moved to another non-COG institution|1|||
106179204|NCT02883049|366314975|FG012|Post Induction|Moved to another non-COG institution|0|||
106179205|NCT02883049|366314976|FG013|Post Induction|Moved to another non-COG institution|0|||
106179206|NCT02883049|366314977|FG014|Post Induction|Moved to another non-COG institution|0|||
106179207|NCT02883049|366314978|FG015|Post Induction|Moved to another non-COG institution|0|||
106179208|NCT02883049|366314963|FG000|Post Induction|Randomization closed|0|||
106179209|NCT02883049|366314964|FG001|Post Induction|Randomization closed|0|||
106179210|NCT02883049|366314965|FG002|Post Induction|Randomization closed|0|||
106179211|NCT02883049|366314966|FG003|Post Induction|Randomization closed|0|||
106179212|NCT02883049|366314967|FG004|Post Induction|Randomization closed|0|||
106179213|NCT02883049|366314968|FG005|Post Induction|Randomization closed|0|||
106179214|NCT02883049|366314969|FG006|Post Induction|Randomization closed|0|||
106179215|NCT02883049|366314970|FG007|Post Induction|Randomization closed|20|||
106179216|NCT02883049|366314971|FG008|Post Induction|Randomization closed|0|||
106179217|NCT02883049|366314972|FG009|Post Induction|Randomization closed|0|||
106179218|NCT02883049|366314973|FG010|Post Induction|Randomization closed|0|||
106179219|NCT02883049|366314974|FG011|Post Induction|Randomization closed|0|||
106179220|NCT02883049|366314975|FG012|Post Induction|Randomization closed|0|||
106179221|NCT02883049|366314976|FG013|Post Induction|Randomization closed|0|||
106179222|NCT02883049|366314977|FG014|Post Induction|Randomization closed|0|||
106179223|NCT02883049|366314978|FG015|Post Induction|Randomization closed|0|||
106179224|NCT02883049|366314963|FG000|Post Induction|MRD negative|0|||
106179225|NCT02883049|366314964|FG001|Post Induction|MRD negative|0|||
106179226|NCT02883049|366314965|FG002|Post Induction|MRD negative|0|||
106179227|NCT02883049|366314966|FG003|Post Induction|MRD negative|0|||
106179228|NCT02883049|366314967|FG004|Post Induction|MRD negative|0|||
106179229|NCT02883049|366314968|FG005|Post Induction|MRD negative|0|||
106179230|NCT02883049|366314969|FG006|Post Induction|MRD negative|0|||
106179231|NCT02883049|366314970|FG007|Post Induction|MRD negative|11|||
106179232|NCT02883049|366314971|FG008|Post Induction|MRD negative|0|||
106179233|NCT02883049|366314972|FG009|Post Induction|MRD negative|0|||
106179234|NCT02883049|366314973|FG010|Post Induction|MRD negative|0|||
106179235|NCT02883049|366314974|FG011|Post Induction|MRD negative|0|||
106179236|NCT02883049|366314975|FG012|Post Induction|MRD negative|0|||
106179237|NCT02883049|366314976|FG013|Post Induction|MRD negative|0|||
106179238|NCT02883049|366314977|FG014|Post Induction|MRD negative|0|||
106179239|NCT02883049|366314978|FG015|Post Induction|MRD negative|0|||
106179240|NCT02883049|366314963|FG000|Post Induction|Developed SMN|0|||
106179241|NCT02883049|366314964|FG001|Post Induction|Developed SMN|0|||
106179242|NCT02883049|366314965|FG002|Post Induction|Developed SMN|0|||
106179243|NCT02883049|366314966|FG003|Post Induction|Developed SMN|0|||
106179244|NCT02883049|366314967|FG004|Post Induction|Developed SMN|1|||
106179245|NCT02883049|366314968|FG005|Post Induction|Developed SMN|0|||
106179246|NCT02883049|366314969|FG006|Post Induction|Developed SMN|1|||
106179247|NCT02883049|366314970|FG007|Post Induction|Developed SMN|0|||
106179248|NCT02883049|366314971|FG008|Post Induction|Developed SMN|0|||
106179249|NCT02883049|366314972|FG009|Post Induction|Developed SMN|0|||
106179250|NCT02883049|366314973|FG010|Post Induction|Developed SMN|1|||
106179251|NCT02883049|366314974|FG011|Post Induction|Developed SMN|1|||
106179252|NCT02883049|366314975|FG012|Post Induction|Developed SMN|0|||
106179253|NCT02883049|366314976|FG013|Post Induction|Developed SMN|0|||
106179254|NCT02883049|366314977|FG014|Post Induction|Developed SMN|1|||
106179255|NCT02883049|366314978|FG015|Post Induction|Developed SMN|0|||
106179256|NCT02883049|366314963|FG000|Post Induction|Enrolled onto another COG study|0|||
106179257|NCT02883049|366314964|FG001|Post Induction|Enrolled onto another COG study|0|||
106179258|NCT02883049|366314965|FG002|Post Induction|Enrolled onto another COG study|0|||
106179259|NCT02883049|366314966|FG003|Post Induction|Enrolled onto another COG study|1|||
106179260|NCT02883049|366314967|FG004|Post Induction|Enrolled onto another COG study|1|||
106179261|NCT02883049|366314968|FG005|Post Induction|Enrolled onto another COG study|0|||
106179262|NCT02883049|366314969|FG006|Post Induction|Enrolled onto another COG study|0|||
106179263|NCT02883049|366314970|FG007|Post Induction|Enrolled onto another COG study|4|||
106179264|NCT02883049|366314971|FG008|Post Induction|Enrolled onto another COG study|0|||
106179265|NCT02883049|366314972|FG009|Post Induction|Enrolled onto another COG study|0|||
106179266|NCT02883049|366314973|FG010|Post Induction|Enrolled onto another COG study|0|||
106179267|NCT02883049|366314974|FG011|Post Induction|Enrolled onto another COG study|2|||
106179268|NCT02883049|366314975|FG012|Post Induction|Enrolled onto another COG study|0|||
106179269|NCT02883049|366314976|FG013|Post Induction|Enrolled onto another COG study|1|||
106179270|NCT02883049|366314977|FG014|Post Induction|Enrolled onto another COG study|0|||
106179271|NCT02883049|366314978|FG015|Post Induction|Enrolled onto another COG study|0|||
106179272|NCT02883049|366314963|FG000|Post Induction|Recurrent leukemia|0|||
106179273|NCT02883049|366314964|FG001|Post Induction|Recurrent leukemia|0|||
106179274|NCT02883049|366314965|FG002|Post Induction|Recurrent leukemia|0|||
106179275|NCT02883049|366314966|FG003|Post Induction|Recurrent leukemia|17|||
106179276|NCT02883049|366314967|FG004|Post Induction|Recurrent leukemia|12|||
106179277|NCT02883049|366314968|FG005|Post Induction|Recurrent leukemia|4|||
106179278|NCT02883049|366314969|FG006|Post Induction|Recurrent leukemia|1|||
106179279|NCT02883049|366314970|FG007|Post Induction|Recurrent leukemia|13|||
106179280|NCT02883049|366314971|FG008|Post Induction|Recurrent leukemia|27|||
106179281|NCT02883049|366314972|FG009|Post Induction|Recurrent leukemia|5|||
106179282|NCT02883049|366314973|FG010|Post Induction|Recurrent leukemia|3|||
106179283|NCT02883049|366314974|FG011|Post Induction|Recurrent leukemia|12|||
106179284|NCT02883049|366314975|FG012|Post Induction|Recurrent leukemia|1|||
106179285|NCT02883049|366314976|FG013|Post Induction|Recurrent leukemia|1|||
106179286|NCT02883049|366314977|FG014|Post Induction|Recurrent leukemia|9|||
106179287|NCT02883049|366314978|FG015|Post Induction|Recurrent leukemia|3|||
106179288|NCT02883049|366314963|FG000|Post Induction|Induction Failure|0|||
106179289|NCT02883049|366314964|FG001|Post Induction|Induction Failure|0|||
106179290|NCT02883049|366314965|FG002|Post Induction|Induction Failure|0|||
106179291|NCT02883049|366314966|FG003|Post Induction|Induction Failure|0|||
106179292|NCT02883049|366314967|FG004|Post Induction|Induction Failure|0|||
106179293|NCT02883049|366314968|FG005|Post Induction|Induction Failure|0|||
106179294|NCT02883049|366314969|FG006|Post Induction|Induction Failure|0|||
106179295|NCT02883049|366314970|FG007|Post Induction|Induction Failure|2|||
106179296|NCT02883049|366314971|FG008|Post Induction|Induction Failure|2|||
106179297|NCT02883049|366314972|FG009|Post Induction|Induction Failure|0|||
106179298|NCT02883049|366314973|FG010|Post Induction|Induction Failure|0|||
106179299|NCT02883049|366314974|FG011|Post Induction|Induction Failure|0|||
106179300|NCT02883049|366314975|FG012|Post Induction|Induction Failure|0|||
106179301|NCT02883049|366314976|FG013|Post Induction|Induction Failure|2|||
106179302|NCT02883049|366314977|FG014|Post Induction|Induction Failure|0|||
106179303|NCT02883049|366314978|FG015|Post Induction|Induction Failure|0|||
106179304|NCT05525520|366314979|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
106179305|NCT05525520|366314980|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
106179306|NCT05525520|366314979|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
106179307|NCT05525520|366314980|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
106179308|NCT03698994|366314981|FG000|Overall Study|Adverse Event|2|||
106179309|NCT03698994|366314981|FG000|Overall Study|Death|1|||
106179310|NCT03698994|366314981|FG000|Overall Study|Physician Decision|1|||
106179311|NCT03698994|366314981|FG000|Overall Study|Withdrawal by Subject|3|||
106179312|NCT03698994|366314981|FG000|Overall Study|Progressive Disease|12|||
106179313|NCT02567435|366314985|FG000|Overall Study|Death|1|||
106179314|NCT02567435|366314986|FG001|Overall Study|Death|1|||
106179315|NCT02567435|366314987|FG002|Overall Study|Death|0|||
106179316|NCT02567435|366314988|FG003|Overall Study|Death|0|||
106179317|NCT02567435|366314985|FG000|Overall Study|Ineligible|1|||
106179318|NCT02567435|366314986|FG001|Overall Study|Ineligible|3|||
106179319|NCT02567435|366314987|FG002|Overall Study|Ineligible|0|||
106179320|NCT02567435|366314988|FG003|Overall Study|Ineligible|0|||
106179321|NCT02567435|366314985|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
106179322|NCT02567435|366314986|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
106179323|NCT02567435|366314987|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
106179324|NCT02567435|366314988|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
106179325|NCT02166463|366314989|FG000|Overall Study|Lost to Follow-up|0|||
106179326|NCT02166463|366314990|FG001|Overall Study|Lost to Follow-up|1|||
106179327|NCT02166463|366314989|FG000|Overall Study|Physician Decision|10|||
106179328|NCT02166463|366314990|FG001|Overall Study|Physician Decision|10|||
106179329|NCT02166463|366314989|FG000|Overall Study|Ineligible|11|||
106179330|NCT02166463|366314990|FG001|Overall Study|Ineligible|2|||
106179331|NCT02166463|366314989|FG000|Overall Study|Progressive Disease|9|||
106179332|NCT02166463|366314990|FG001|Overall Study|Progressive Disease|6|||
106179333|NCT02166463|366314989|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
106179334|NCT02166463|366314990|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
106179335|NCT02166463|366314989|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
106179336|NCT02166463|366314990|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
106179337|NCT02166463|366314989|FG000|Overall Study|Refusal of further protocol therapy|5|||
106179338|NCT02166463|366314990|FG001|Overall Study|Refusal of further protocol therapy|6|||
106179339|NCT03641313|366314991|FG000|Overall Study|Death|1|||
106179340|NCT03641313|366314991|FG000|Overall Study|Withdrawal by Subject|2|||
106179341|NCT03641313|366314991|FG000|Overall Study|Declining health|1|||
106179342|NCT03641313|366314991|FG000|Overall Study|Adverse Event|1|||
106179343|NCT04642898|366314992|FG000|Overall Study|Withdrawal by Subject|2|||
106179344|NCT04642898|366314993|FG001|Overall Study|Withdrawal by Subject|4|||
106179345|NCT04642898|366314994|FG002|Overall Study|Withdrawal by Subject|4|||
106179346|NCT04642898|366314995|FG003|Overall Study|Withdrawal by Subject|6|||
106179347|NCT04642898|366314996|FG004|Overall Study|Withdrawal by Subject|2|||
106179348|NCT04642898|366314997|FG005|Overall Study|Withdrawal by Subject|6|||
106179349|NCT04642898|366314992|FG000|Overall Study|Lost to Follow-up|0|||
106179350|NCT04642898|366314993|FG001|Overall Study|Lost to Follow-up|0|||
106179351|NCT04642898|366314994|FG002|Overall Study|Lost to Follow-up|0|||
106179352|NCT04642898|366314995|FG003|Overall Study|Lost to Follow-up|2|||
106179353|NCT04642898|366314996|FG004|Overall Study|Lost to Follow-up|0|||
106179354|NCT04642898|366314997|FG005|Overall Study|Lost to Follow-up|1|||
106179355|NCT04642898|366314992|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
106179356|NCT04642898|366314993|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
106179357|NCT04642898|366314994|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
106179358|NCT04642898|366314995|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
106179359|NCT04642898|366314996|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
106179360|NCT04642898|366314997|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
106179361|NCT04642898|366314992|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
106179362|NCT04642898|366314993|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
106179363|NCT04642898|366314994|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
106179364|NCT04642898|366314995|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
106179365|NCT04642898|366314996|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
106179366|NCT04642898|366314997|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
106179367|NCT03033225|366314998|FG000|Overall Study|Withdrawal by Subject|5|||
106179368|NCT05856227|366314999|FG000|Overall Study|Adverse Event|0|||
106179369|NCT05856227|366315000|FG001|Overall Study|Adverse Event|1|||
106179370|NCT05856227|366314999|FG000|Overall Study|Due to Investigator absence|1|||
106179371|NCT05856227|366315000|FG001|Overall Study|Due to Investigator absence|0|||
106179372|NCT05856227|366314999|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
106179373|NCT05856227|366315000|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
106179374|NCT03434678|366315002|FG000|Overall Study|Withdrawal by Subject|13|||
106179375|NCT03434678|366315003|FG001|Overall Study|Withdrawal by Subject|13|||
106179376|NCT03434678|366315002|FG000|Overall Study|Found to be ineligible post randomization|2|||
106179377|NCT03434678|366315003|FG001|Overall Study|Found to be ineligible post randomization|1|||
106179378|NCT05011058|366315004|FG000|Overall Study|Sponsor Decision|2|||
106179379|NCT05011058|366315005|FG001|Overall Study|Sponsor Decision|0|||
106179380|NCT05011058|366315006|FG002|Overall Study|Sponsor Decision|14|||
106179381|NCT05011058|366315007|FG003|Overall Study|Sponsor Decision|0|||
106179382|NCT05011058|366315008|FG004|Overall Study|Sponsor Decision|0|||
106179383|NCT05011058|366315009|FG005|Overall Study|Sponsor Decision|1|||
106179384|NCT05011058|366315010|FG006|Overall Study|Sponsor Decision|0|||
106179385|NCT05011058|366315011|FG007|Overall Study|Sponsor Decision|5|||
106179386|NCT06060457|366315016|FG000|Overall Study|Adverse Event|1|||
106179387|NCT06060457|366315017|FG001|Overall Study|Adverse Event|1|||
106179388|NCT06060457|366315016|FG000|Overall Study|Death|2|||
106179389|NCT06060457|366315017|FG001|Overall Study|Death|2|||
106179390|NCT06060457|366315016|FG000|Overall Study|Lost to Follow-up|17|||
106179391|NCT06060457|366315017|FG001|Overall Study|Lost to Follow-up|19|||
106179392|NCT06060457|366315016|FG000|Overall Study|Physician Decision|0|||
106179393|NCT06060457|366315017|FG001|Overall Study|Physician Decision|1|||
106179394|NCT06060457|366315016|FG000|Overall Study|Protocol Violation|1|||
106179395|NCT06060457|366315017|FG001|Overall Study|Protocol Violation|1|||
106179396|NCT06060457|366315016|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
106179397|NCT06060457|366315017|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
106179398|NCT06060457|366315016|FG000|Overall Study|Withdrawal by Subject|12|||
106179399|NCT06060457|366315017|FG001|Overall Study|Withdrawal by Subject|15|||
106179400|NCT06060457|366315016|FG000|Overall Study|Other Than Specified|2|||
106179401|NCT06060457|366315017|FG001|Overall Study|Other Than Specified|1|||
106179402|NCT02003222|366315018|FG000|Induction|Never started treatment|0|||
106179403|NCT02003222|366315019|FG001|Induction|Never started treatment|0|||
106179404|NCT02003222|366315020|FG002|Induction|Never started treatment|0|||
106179405|NCT02003222|366315021|FG003|Induction|Never started treatment|0|||
106179406|NCT02003222|366315022|FG004|Induction|Never started treatment|8|||
106179407|NCT02003222|366315018|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
106179408|NCT02003222|366315019|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
106179409|NCT02003222|366315020|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
106179410|NCT02003222|366315021|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
106179411|NCT02003222|366315022|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
106179412|NCT02003222|366315018|FG000|Induction|Adverse Event|0|||
106179413|NCT02003222|366315019|FG001|Induction|Adverse Event|0|||
106179414|NCT02003222|366315020|FG002|Induction|Adverse Event|0|||
106179415|NCT02003222|366315021|FG003|Induction|Adverse Event|0|||
106179416|NCT02003222|366315022|FG004|Induction|Adverse Event|13|||
106179417|NCT02003222|366315018|FG000|Induction|Alternative therapy|0|||
106179418|NCT02003222|366315019|FG001|Induction|Alternative therapy|0|||
106179419|NCT02003222|366315020|FG002|Induction|Alternative therapy|0|||
106179420|NCT02003222|366315021|FG003|Induction|Alternative therapy|0|||
106179421|NCT02003222|366315022|FG004|Induction|Alternative therapy|12|||
106179422|NCT02003222|366315018|FG000|Induction|Disease progression|0|||
106179423|NCT02003222|366315019|FG001|Induction|Disease progression|0|||
106179424|NCT02003222|366315020|FG002|Induction|Disease progression|0|||
106179425|NCT02003222|366315021|FG003|Induction|Disease progression|0|||
106179426|NCT02003222|366315022|FG004|Induction|Disease progression|22|||
106179427|NCT02003222|366315018|FG000|Induction|Death|0|||
106179428|NCT02003222|366315019|FG001|Induction|Death|0|||
106179429|NCT02003222|366315020|FG002|Induction|Death|0|||
106179430|NCT02003222|366315021|FG003|Induction|Death|0|||
106179431|NCT02003222|366315022|FG004|Induction|Death|3|||
106179432|NCT02003222|366315018|FG000|Induction|Withdrawal by Subject|0|||
106179433|NCT02003222|366315019|FG001|Induction|Withdrawal by Subject|0|||
106179434|NCT02003222|366315020|FG002|Induction|Withdrawal by Subject|0|||
106179435|NCT02003222|366315021|FG003|Induction|Withdrawal by Subject|0|||
106179436|NCT02003222|366315022|FG004|Induction|Withdrawal by Subject|8|||
106179437|NCT02003222|366315018|FG000|Induction|Other reasons|0|||
106179438|NCT02003222|366315019|FG001|Induction|Other reasons|0|||
106179439|NCT02003222|366315020|FG002|Induction|Other reasons|0|||
106179440|NCT02003222|366315021|FG003|Induction|Other reasons|0|||
106179441|NCT02003222|366315022|FG004|Induction|Other reasons|22|||
106179442|NCT02003222|366315018|FG000|Intensification|Never started treatment|0|||
106179443|NCT02003222|366315019|FG001|Intensification|Never started treatment|0|||
106179444|NCT02003222|366315020|FG002|Intensification|Never started treatment|0|||
106179445|NCT02003222|366315021|FG003|Intensification|Never started treatment|0|||
106179446|NCT02003222|366315022|FG004|Intensification|Never started treatment|2|||
106179447|NCT02003222|366315018|FG000|Intensification|Adverse Event|0|||
106179448|NCT02003222|366315019|FG001|Intensification|Adverse Event|0|||
106179449|NCT02003222|366315020|FG002|Intensification|Adverse Event|0|||
106179450|NCT02003222|366315021|FG003|Intensification|Adverse Event|0|||
106179451|NCT02003222|366315022|FG004|Intensification|Adverse Event|6|||
106179452|NCT02003222|366315018|FG000|Intensification|Alternative therapy|0|||
106179453|NCT02003222|366315019|FG001|Intensification|Alternative therapy|0|||
106179454|NCT02003222|366315020|FG002|Intensification|Alternative therapy|0|||
106179455|NCT02003222|366315021|FG003|Intensification|Alternative therapy|0|||
106179456|NCT02003222|366315022|FG004|Intensification|Alternative therapy|8|||
106179457|NCT02003222|366315018|FG000|Intensification|Disease progression|0|||
106179458|NCT02003222|366315019|FG001|Intensification|Disease progression|0|||
106179459|NCT02003222|366315020|FG002|Intensification|Disease progression|0|||
106179460|NCT02003222|366315021|FG003|Intensification|Disease progression|0|||
106179461|NCT02003222|366315022|FG004|Intensification|Disease progression|18|||
106179462|NCT02003222|366315018|FG000|Intensification|Withdrawal by Subject|0|||
106179463|NCT02003222|366315019|FG001|Intensification|Withdrawal by Subject|0|||
106179464|NCT02003222|366315020|FG002|Intensification|Withdrawal by Subject|0|||
106179465|NCT02003222|366315021|FG003|Intensification|Withdrawal by Subject|0|||
106179466|NCT02003222|366315022|FG004|Intensification|Withdrawal by Subject|5|||
106179467|NCT02003222|366315018|FG000|Intensification|Other reasons|0|||
106179468|NCT02003222|366315019|FG001|Intensification|Other reasons|0|||
106179469|NCT02003222|366315020|FG002|Intensification|Other reasons|0|||
106179470|NCT02003222|366315021|FG003|Intensification|Other reasons|0|||
106179471|NCT02003222|366315022|FG004|Intensification|Other reasons|8|||
106179472|NCT02721732|366318183|FG000|Overall Study|Adverse Event|2|||
106179473|NCT02721732|366318184|FG001|Overall Study|Adverse Event|0|||
106179474|NCT02721732|366318185|FG002|Overall Study|Adverse Event|2|||
106179475|NCT02721732|366318186|FG003|Overall Study|Adverse Event|0|||
106179476|NCT02721732|366318187|FG004|Overall Study|Adverse Event|1|||
106179477|NCT02721732|366318188|FG005|Overall Study|Adverse Event|0|||
106179478|NCT02721732|366318189|FG006|Overall Study|Adverse Event|1|||
106179479|NCT02721732|366318190|FG007|Overall Study|Adverse Event|0|||
106179480|NCT02721732|366318191|FG008|Overall Study|Adverse Event|1|||
106179481|NCT02721732|366318192|FG009|Overall Study|Adverse Event|1|||
106179482|NCT02721732|366318183|FG000|Overall Study|Death|0|||
106179483|NCT02721732|366318184|FG001|Overall Study|Death|0|||
106179484|NCT02721732|366318185|FG002|Overall Study|Death|0|||
106179485|NCT02721732|366318186|FG003|Overall Study|Death|0|||
106179486|NCT02721732|366318187|FG004|Overall Study|Death|1|||
106179487|NCT02721732|366318188|FG005|Overall Study|Death|0|||
106179488|NCT02721732|366318189|FG006|Overall Study|Death|1|||
106179489|NCT02721732|366318190|FG007|Overall Study|Death|0|||
106179490|NCT02721732|366318191|FG008|Overall Study|Death|0|||
106179491|NCT02721732|366318192|FG009|Overall Study|Death|1|||
106179492|NCT02721732|366318183|FG000|Overall Study|Lack of Efficacy|12|||
106179493|NCT02721732|366318184|FG001|Overall Study|Lack of Efficacy|11|||
106179494|NCT02721732|366318185|FG002|Overall Study|Lack of Efficacy|18|||
106179495|NCT02721732|366318186|FG003|Overall Study|Lack of Efficacy|5|||
106179496|NCT02721732|366318187|FG004|Overall Study|Lack of Efficacy|21|||
106179497|NCT02721732|366318188|FG005|Overall Study|Lack of Efficacy|2|||
105867390|NCT01473407|365164955|FG000|Overall Study|Sponsor's Decision|10|||
106179498|NCT02721732|366318189|FG006|Overall Study|Lack of Efficacy|8|||
106179499|NCT02721732|366318190|FG007|Overall Study|Lack of Efficacy|11|||
106179500|NCT02721732|366318191|FG008|Overall Study|Lack of Efficacy|10|||
106179501|NCT02721732|366318192|FG009|Overall Study|Lack of Efficacy|20|||
106179502|NCT02721732|366318183|FG000|Overall Study|Physician Decision|0|||
106179503|NCT02721732|366318184|FG001|Overall Study|Physician Decision|0|||
106179504|NCT02721732|366318185|FG002|Overall Study|Physician Decision|1|||
106179505|NCT02721732|366318186|FG003|Overall Study|Physician Decision|0|||
106179506|NCT02721732|366318187|FG004|Overall Study|Physician Decision|0|||
106179507|NCT02721732|366318188|FG005|Overall Study|Physician Decision|0|||
106179508|NCT02721732|366318189|FG006|Overall Study|Physician Decision|0|||
106179509|NCT02721732|366318190|FG007|Overall Study|Physician Decision|0|||
106179510|NCT02721732|366318191|FG008|Overall Study|Physician Decision|0|||
106179511|NCT02721732|366318192|FG009|Overall Study|Physician Decision|0|||
106179512|NCT02721732|366318183|FG000|Overall Study|Withdrawal by Subject|1|||
106179513|NCT02721732|366318184|FG001|Overall Study|Withdrawal by Subject|0|||
106179514|NCT02721732|366318185|FG002|Overall Study|Withdrawal by Subject|0|||
106179515|NCT02721732|366318186|FG003|Overall Study|Withdrawal by Subject|0|||
106179516|NCT02721732|366318187|FG004|Overall Study|Withdrawal by Subject|3|||
106179517|NCT02721732|366318188|FG005|Overall Study|Withdrawal by Subject|0|||
106179518|NCT02721732|366318189|FG006|Overall Study|Withdrawal by Subject|1|||
106179519|NCT02721732|366318190|FG007|Overall Study|Withdrawal by Subject|1|||
106179520|NCT02721732|366318191|FG008|Overall Study|Withdrawal by Subject|0|||
106179521|NCT02721732|366318192|FG009|Overall Study|Withdrawal by Subject|1|||
106179522|NCT02721732|366318183|FG000|Overall Study|Participant Choice|1|||
106179523|NCT02721732|366318184|FG001|Overall Study|Participant Choice|0|||
106179524|NCT02721732|366318185|FG002|Overall Study|Participant Choice|0|||
106179525|NCT02721732|366318186|FG003|Overall Study|Participant Choice|0|||
106179526|NCT02721732|366318187|FG004|Overall Study|Participant Choice|0|||
106179527|NCT02721732|366318188|FG005|Overall Study|Participant Choice|0|||
106179528|NCT02721732|366318189|FG006|Overall Study|Participant Choice|0|||
106179529|NCT02721732|366318190|FG007|Overall Study|Participant Choice|0|||
106179530|NCT02721732|366318191|FG008|Overall Study|Participant Choice|0|||
106179531|NCT02721732|366318192|FG009|Overall Study|Participant Choice|1|||
106179532|NCT02721732|366318183|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179533|NCT02721732|366318184|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179534|NCT02721732|366318185|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
106179535|NCT02721732|366318186|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179536|NCT02721732|366318187|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179537|NCT02721732|366318188|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179538|NCT02721732|366318189|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179539|NCT02721732|366318190|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179540|NCT02721732|366318191|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179541|NCT02721732|366318192|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
106179542|NCT02721732|366318183|FG000|Overall Study|Progression and withdrew consent|1|||
106179543|NCT02721732|366318184|FG001|Overall Study|Progression and withdrew consent|1|||
106179544|NCT02721732|366318185|FG002|Overall Study|Progression and withdrew consent|0|||
106179545|NCT02721732|366318186|FG003|Overall Study|Progression and withdrew consent|0|||
106179546|NCT02721732|366318187|FG004|Overall Study|Progression and withdrew consent|0|||
106179547|NCT02721732|366318188|FG005|Overall Study|Progression and withdrew consent|0|||
106179548|NCT02721732|366318189|FG006|Overall Study|Progression and withdrew consent|0|||
106179549|NCT02721732|366318190|FG007|Overall Study|Progression and withdrew consent|0|||
106179550|NCT02721732|366318191|FG008|Overall Study|Progression and withdrew consent|0|||
106179551|NCT02721732|366318192|FG009|Overall Study|Progression and withdrew consent|1|||
106179552|NCT02721732|366318183|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
106179553|NCT02721732|366318184|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
106179554|NCT02721732|366318185|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
106179555|NCT02721732|366318186|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
106179556|NCT02721732|366318187|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
106179557|NCT02721732|366318188|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
106179558|NCT02721732|366318189|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
106179559|NCT02721732|366318190|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
106179560|NCT02721732|366318191|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
106179561|NCT02721732|366318192|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
106179562|NCT01886872|366318194|FG000|Overall Study|Ineligible|7|||
106179563|NCT01886872|366318195|FG001|Overall Study|Ineligible|4|||
106179564|NCT01886872|366318196|FG002|Overall Study|Ineligible|12|||
106179565|NCT05163522|366318197|FG000|Overall Study|Withdrawal by Subject|0|||
106179566|NCT05163522|366318198|FG001|Overall Study|Withdrawal by Subject|0|||
106179567|NCT05163522|366318199|FG002|Overall Study|Withdrawal by Subject|1|||
106179568|NCT05163522|366318200|FG003|Overall Study|Withdrawal by Subject|0|||
106179569|NCT05163522|366318201|FG004|Overall Study|Withdrawal by Subject|0|||
106179570|NCT05163522|366318202|FG005|Overall Study|Withdrawal by Subject|0|||
106179571|NCT05163522|366318203|FG006|Overall Study|Withdrawal by Subject|0|||
106179572|NCT05163522|366318204|FG007|Overall Study|Withdrawal by Subject|0|||
106179573|NCT05163522|366318205|FG008|Overall Study|Withdrawal by Subject|0|||
106179574|NCT05163522|366318206|FG009|Overall Study|Withdrawal by Subject|0|||
106179575|NCT05163522|366318207|FG010|Overall Study|Withdrawal by Subject|0|||
106179576|NCT03176134|366318221|FG000|Overall Study|Lost to Follow-up|0|||
106179577|NCT03176134|366318222|FG001|Overall Study|Lost to Follow-up|2|||
106179578|NCT03176134|366318223|FG002|Overall Study|Lost to Follow-up|0|||
106179579|NCT03176134|366318224|FG003|Overall Study|Lost to Follow-up|0|||
106179580|NCT03176134|366318225|FG004|Overall Study|Lost to Follow-up|0|||
106179581|NCT03176134|366318226|FG005|Overall Study|Lost to Follow-up|0|||
106179582|NCT03176134|366318227|FG006|Overall Study|Lost to Follow-up|0|||
106179583|NCT03176134|366318228|FG007|Overall Study|Lost to Follow-up|0|||
106179584|NCT03176134|366318221|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
106179585|NCT03176134|366318222|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
106179586|NCT03176134|366318223|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
106179587|NCT03176134|366318224|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
106179588|NCT03176134|366318225|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
106179589|NCT03176134|366318226|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
106179590|NCT03176134|366318227|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
106179591|NCT03176134|366318228|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
106179592|NCT03939637|366318229|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
106179593|NCT03939637|366318230|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
106179594|NCT03939637|366318229|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
106179595|NCT03939637|366318230|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
106179596|NCT03412396|366318231|FG000|Overall Study|Withdrawal by Subject|2|||
106179597|NCT03412396|366318231|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
106179598|NCT03412396|366318231|FG000|Overall Study|Did not undergo RP|2|||
106179599|NCT05224076|366318237|FG000|Overall Study|Lost to Follow-up|24|||
106179600|NCT03698019|366318238|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
106179601|NCT03698019|366318239|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
106179602|NCT03698019|366318238|FG000|Step 1: Registration|Withdrawal by Subject|7|||
106179603|NCT03698019|366318239|FG001|Step 1: Registration|Withdrawal by Subject|2|||
106179604|NCT03698019|366318238|FG000|Step 1: Registration|Toxicity|0|||
106179605|NCT03698019|366318239|FG001|Step 1: Registration|Toxicity|1|||
106179606|NCT03698019|366318238|FG000|Step 1: Registration|Disease Progression|0|||
106179607|NCT03698019|366318239|FG001|Step 1: Registration|Disease Progression|12|||
106179608|NCT03698019|366318238|FG000|Step 1: Registration|Co-morbidities|0|||
106179609|NCT03698019|366318239|FG001|Step 1: Registration|Co-morbidities|1|||
106179610|NCT03698019|366318238|FG000|Step 1: Registration|Scheduling Issues|1|||
106179611|NCT03698019|366318239|FG001|Step 1: Registration|Scheduling Issues|0|||
106179612|NCT03698019|366318238|FG000|Step 1: Registration|Participant Refusal|0|||
106179613|NCT03698019|366318239|FG001|Step 1: Registration|Participant Refusal|1|||
106179614|NCT03698019|366318238|FG000|Step 2: Surgery|Participant Refusal|2|||
106179615|NCT03698019|366318239|FG001|Step 2: Surgery|Participant Refusal|1|||
106179616|NCT03698019|366318238|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
106179617|NCT03698019|366318239|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
106179618|NCT03698019|366318238|FG000|Step 2: Surgery|Metastatic Disease|16|||
106179619|NCT03698019|366318239|FG001|Step 2: Surgery|Metastatic Disease|9|||
106179620|NCT03698019|366318238|FG000|Step 2: Surgery|Residual Disease|2|||
106179621|NCT03698019|366318239|FG001|Step 2: Surgery|Residual Disease|1|||
106179622|NCT03698019|366318238|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
106179623|NCT03698019|366318239|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
106179624|NCT03698019|366318238|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
106179625|NCT03698019|366318239|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
106179626|NCT03698019|366318238|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
106179627|NCT03698019|366318239|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
106179628|NCT03698019|366318238|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
106179629|NCT03698019|366318239|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
106179630|NCT03698019|366318238|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
106179631|NCT03698019|366318239|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
106179632|NCT03698019|366318238|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
106179633|NCT03698019|366318239|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
106179634|NCT03698019|366318238|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
106179635|NCT03698019|366318239|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
106179636|NCT03698019|366318238|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
106179637|NCT03698019|366318239|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
106179638|NCT00588770|366318240|FG000|Overall Study|Disease progression|85|||
106179639|NCT00588770|366318241|FG001|Overall Study|Disease progression|68|||
106179640|NCT00588770|366318240|FG000|Overall Study|Adverse Event|29|||
106179641|NCT00588770|366318241|FG001|Overall Study|Adverse Event|58|||
106179642|NCT00588770|366318240|FG000|Overall Study|Death|13|||
106179643|NCT00588770|366318241|FG001|Overall Study|Death|22|||
106179644|NCT00588770|366318240|FG000|Overall Study|Withdrawal by Subject|15|||
106179645|NCT00588770|366318241|FG001|Overall Study|Withdrawal by Subject|25|||
106179646|NCT00588770|366318240|FG000|Overall Study|Alternative therapy|2|||
106179647|NCT00588770|366318241|FG001|Overall Study|Alternative therapy|4|||
106179648|NCT00588770|366318240|FG000|Overall Study|Other complicating disease|3|||
106179649|NCT00588770|366318241|FG001|Overall Study|Other complicating disease|2|||
106179650|NCT00588770|366318240|FG000|Overall Study|Not start protocol therapy|0|||
106179651|NCT00588770|366318241|FG001|Overall Study|Not start protocol therapy|9|||
106179652|NCT00588770|366318240|FG000|Overall Study|Lack of Efficacy|8|||
106179653|NCT00588770|366318241|FG001|Overall Study|Lack of Efficacy|10|||
106179654|NCT00588770|366318240|FG000|Overall Study|Physician discretion|2|||
106179655|NCT00588770|366318241|FG001|Overall Study|Physician discretion|0|||
106179656|NCT00588770|366318240|FG000|Overall Study|Patient non-compliance|2|||
106179657|NCT00588770|366318241|FG001|Overall Study|Patient non-compliance|2|||
106179658|NCT00569127|366318242|FG000|Overall Study|Adverse Event|57|||
106179659|NCT00569127|366318243|FG001|Overall Study|Adverse Event|47|||
106179660|NCT00569127|366318242|FG000|Overall Study|Withdrawal by Subject|13|||
106179661|NCT00569127|366318243|FG001|Overall Study|Withdrawal by Subject|27|||
106179662|NCT00569127|366318242|FG000|Overall Study|Progression|99|||
106179663|NCT00569127|366318243|FG001|Overall Study|Progression|100|||
106179664|NCT00569127|366318242|FG000|Overall Study|Death|4|||
106179665|NCT00569127|366318243|FG001|Overall Study|Death|3|||
106179666|NCT00569127|366318242|FG000|Overall Study|Other|20|||
106179667|NCT00569127|366318243|FG001|Overall Study|Other|19|||
106179668|NCT00569127|366318242|FG000|Overall Study|Lost to Follow-up|0|||
106179669|NCT00569127|366318243|FG001|Overall Study|Lost to Follow-up|3|||
106179670|NCT00569127|366318242|FG000|Overall Study|Not Eligible|14|||
106179671|NCT00569127|366318243|FG001|Overall Study|Not Eligible|11|||
106179672|NCT00569127|366318242|FG000|Overall Study|Still on Treatment|7|||
106179673|NCT00569127|366318243|FG001|Overall Study|Still on Treatment|3|||
106179674|NCT03517969|366318244|FG000|Overall Study|Never started protocol treatment|3|||
106179675|NCT03517969|366318245|FG001|Overall Study|Never started protocol treatment|5|||
106179676|NCT03517969|366318244|FG000|Overall Study|Disease progression|11|||
106179677|NCT03517969|366318245|FG001|Overall Study|Disease progression|16|||
106179678|NCT03517969|366318244|FG000|Overall Study|PSA progression|8|||
106179679|NCT03517969|366318245|FG001|Overall Study|PSA progression|1|||
106179680|NCT03517969|366318244|FG000|Overall Study|Clinical progression|4|||
106179681|NCT03517969|366318245|FG001|Overall Study|Clinical progression|2|||
106179682|NCT03517969|366318244|FG000|Overall Study|Adverse Event|5|||
106179683|NCT03517969|366318245|FG001|Overall Study|Adverse Event|4|||
106179684|NCT03517969|366318244|FG000|Overall Study|Intercurrent illness|1|||
106179685|NCT03517969|366318245|FG001|Overall Study|Intercurrent illness|2|||
106179686|NCT03517969|366318244|FG000|Overall Study|Death|1|||
106179687|NCT03517969|366318245|FG001|Overall Study|Death|1|||
106179688|NCT03517969|366318244|FG000|Overall Study|Withdrawal by Subject|1|||
106179689|NCT03517969|366318245|FG001|Overall Study|Withdrawal by Subject|2|||
106179690|NCT03517969|366318244|FG000|Overall Study|Physician Decision|1|||
106179691|NCT03517969|366318245|FG001|Overall Study|Physician Decision|1|||
106179692|NCT03517969|366318244|FG000|Overall Study|No clinical benefit|1|||
106179693|NCT03517969|366318245|FG001|Overall Study|No clinical benefit|0|||
106179694|NCT03517969|366318244|FG000|Overall Study|Delayed treatment for dental treatment|1|||
106179695|NCT03517969|366318245|FG001|Overall Study|Delayed treatment for dental treatment|0|||
106179696|NCT03517969|366318244|FG000|Overall Study|Difficult to maintain appointment|0|||
106179697|NCT03517969|366318245|FG001|Overall Study|Difficult to maintain appointment|1|||
106179698|NCT03517969|366318244|FG000|Overall Study|Protocol Violation|0|||
106179699|NCT03517969|366318245|FG001|Overall Study|Protocol Violation|1|||
106179700|NCT01856192|366318246|FG000|Overall Study|Adverse Event|12|||
106179701|NCT01856192|366318247|FG001|Overall Study|Adverse Event|4|||
106179702|NCT01856192|366318246|FG000|Overall Study|Alternative therapy|0|||
106179703|NCT01856192|366318247|FG001|Overall Study|Alternative therapy|3|||
106179704|NCT01856192|366318246|FG000|Overall Study|Death|3|||
106179705|NCT01856192|366318247|FG001|Overall Study|Death|5|||
106179706|NCT01856192|366318246|FG000|Overall Study|Lack of Efficacy|0|||
106179707|NCT01856192|366318247|FG001|Overall Study|Lack of Efficacy|5|||
106179708|NCT01856192|366318246|FG000|Overall Study|Withdrawal by Subject|1|||
106179709|NCT01856192|366318247|FG001|Overall Study|Withdrawal by Subject|1|||
106179710|NCT01856192|366318246|FG000|Overall Study|Other diseases|1|||
106179711|NCT01856192|366318247|FG001|Overall Study|Other diseases|0|||
106179712|NCT01856192|366318246|FG000|Overall Study|Never started treatment|7|||
106179713|NCT01856192|366318247|FG001|Overall Study|Never started treatment|5|||
106179714|NCT01856192|366318246|FG000|Overall Study|Path ineligible|20|||
106179715|NCT01856192|366318247|FG001|Overall Study|Path ineligible|34|||
106179716|NCT01856192|366318246|FG000|Overall Study|Non-path ineligible|2|||
106179717|NCT01856192|366318247|FG001|Overall Study|Non-path ineligible|2|||
106179718|NCT01856192|366318246|FG000|Overall Study|Physician Decision|1|||
106179719|NCT01856192|366318247|FG001|Overall Study|Physician Decision|1|||
106179720|NCT01856192|366318246|FG000|Overall Study|Suspicion of progressive disease|1|||
106179721|NCT01856192|366318247|FG001|Overall Study|Suspicion of progressive disease|0|||
106179722|NCT01856192|366318246|FG000|Overall Study|Non-compliance|1|||
106179723|NCT01856192|366318247|FG001|Overall Study|Non-compliance|0|||
106179724|NCT04428151|366318248|FG000|Overall Study|Death|100|||
106179725|NCT04428151|366318249|FG001|Overall Study|Death|86|||
106179726|NCT04428151|366318250|FG002|Overall Study|Death|57|||
106179727|NCT04428151|366318248|FG000|Overall Study|Lost to Follow-up|1|||
106179728|NCT04428151|366318249|FG001|Overall Study|Lost to Follow-up|1|||
106179729|NCT04428151|366318250|FG002|Overall Study|Lost to Follow-up|0|||
106179730|NCT04428151|366318248|FG000|Overall Study|Withdrawal by Subject|2|||
106179731|NCT04428151|366318249|FG001|Overall Study|Withdrawal by Subject|2|||
106179732|NCT04428151|366318250|FG002|Overall Study|Withdrawal by Subject|3|||
106179733|NCT04428151|366318248|FG000|Overall Study|Participant Ongoing in Study|41|||
106179734|NCT04428151|366318249|FG001|Overall Study|Participant Ongoing in Study|53|||
106179735|NCT04428151|366318250|FG002|Overall Study|Participant Ongoing in Study|28|||
106179736|NCT02642042|366318254|FG000|Overall Study|Adverse Event|22|||
106179737|NCT02642042|366318254|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
106179738|NCT02642042|366318254|FG000|Overall Study|Progression/Relapse|28|||
106179739|NCT02642042|366318254|FG000|Overall Study|Death|1|||
106179740|NCT02642042|366318254|FG000|Overall Study|Not Protocol Specified|2|||
106179741|NCT03375320|366318255|FG000|Overall Study|Adverse Event|34|||
106179742|NCT03375320|366318256|FG001|Overall Study|Adverse Event|9|||
106179743|NCT03375320|366318257|FG002|Overall Study|Adverse Event|10|||
106179744|NCT03375320|366318258|FG003|Overall Study|Adverse Event|0|||
106179745|NCT03375320|366318255|FG000|Overall Study|Death|6|||
106179746|NCT03375320|366318256|FG001|Overall Study|Death|3|||
106179747|NCT03375320|366318257|FG002|Overall Study|Death|0|||
106179748|NCT03375320|366318258|FG003|Overall Study|Death|0|||
106179749|NCT03375320|366318255|FG000|Overall Study|Withdrawal by Subject|7|||
106179750|NCT03375320|366318256|FG001|Overall Study|Withdrawal by Subject|4|||
106179751|NCT03375320|366318257|FG002|Overall Study|Withdrawal by Subject|5|||
106179752|NCT03375320|366318258|FG003|Overall Study|Withdrawal by Subject|4|||
106179753|NCT03375320|366318255|FG000|Overall Study|Progressive disease|55|||
106179754|NCT03375320|366318256|FG001|Overall Study|Progressive disease|41|||
106179755|NCT03375320|366318257|FG002|Overall Study|Progressive disease|29|||
106179756|NCT03375320|366318258|FG003|Overall Study|Progressive disease|24|||
106179757|NCT03375320|366318255|FG000|Overall Study|Alternative treatment|6|||
106179758|NCT03375320|366318256|FG001|Overall Study|Alternative treatment|1|||
106179759|NCT03375320|366318257|FG002|Overall Study|Alternative treatment|1|||
106179760|NCT03375320|366318258|FG003|Overall Study|Alternative treatment|0|||
106179761|NCT03375320|366318255|FG000|Overall Study|Other disease|1|||
106179762|NCT03375320|366318256|FG001|Overall Study|Other disease|1|||
106179763|NCT03375320|366318257|FG002|Overall Study|Other disease|3|||
106179764|NCT03375320|366318258|FG003|Overall Study|Other disease|0|||
106179765|NCT03375320|366318255|FG000|Overall Study|Withdrawal prior to initiation|2|||
106179766|NCT03375320|366318256|FG001|Overall Study|Withdrawal prior to initiation|2|||
106179767|NCT03375320|366318257|FG002|Overall Study|Withdrawal prior to initiation|1|||
106179768|NCT03375320|366318258|FG003|Overall Study|Withdrawal prior to initiation|0|||
106179769|NCT03375320|366318255|FG000|Overall Study|Physician Decision|1|||
106179770|NCT03375320|366318256|FG001|Overall Study|Physician Decision|1|||
106179771|NCT03375320|366318257|FG002|Overall Study|Physician Decision|1|||
106179772|NCT03375320|366318258|FG003|Overall Study|Physician Decision|1|||
106179773|NCT03375320|366318255|FG000|Overall Study|Non-compliance|1|||
106179774|NCT03375320|366318256|FG001|Overall Study|Non-compliance|0|||
106179775|NCT03375320|366318257|FG002|Overall Study|Non-compliance|0|||
106179776|NCT03375320|366318258|FG003|Overall Study|Non-compliance|0|||
106179777|NCT03829319|366318259|FG000|Overall Study|Ongoing|4|||
106179778|NCT03829319|366318260|FG001|Overall Study|Ongoing|125|||
106179779|NCT03829319|366318261|FG002|Overall Study|Ongoing|130|||
106179780|NCT03829319|366318259|FG000|Overall Study|Withdrawal by Subject|1|||
106179781|NCT03829319|366318260|FG001|Overall Study|Withdrawal by Subject|6|||
106179782|NCT03829319|366318261|FG002|Overall Study|Withdrawal by Subject|8|||
106179783|NCT03829319|366318259|FG000|Overall Study|Physician Decision|0|||
106179784|NCT03829319|366318260|FG001|Overall Study|Physician Decision|1|||
106179785|NCT03829319|366318261|FG002|Overall Study|Physician Decision|0|||
106179786|NCT03829319|366318259|FG000|Overall Study|Lost to Follow-up|0|||
106179787|NCT03829319|366318260|FG001|Overall Study|Lost to Follow-up|0|||
106179788|NCT03829319|366318261|FG002|Overall Study|Lost to Follow-up|1|||
106179789|NCT03829319|366318259|FG000|Overall Study|Death|8|||
106179790|NCT03829319|366318260|FG001|Overall Study|Death|243|||
106179791|NCT03829319|366318261|FG002|Overall Study|Death|234|||
106179792|NCT04268004|366318268|FG000|Overall Study|Excluded from analyses|0|||
106179793|NCT04268004|366318269|FG001|Overall Study|Excluded from analyses|1|||
106179794|NCT03348631|366318270|FG000|Overall Study|Not Eligible, No treatment|0|||
106179795|NCT03348631|366318271|FG001|Overall Study|Not Eligible, No treatment|1|||
106179796|NCT03348631|366318270|FG000|Overall Study|Not Eligible, Treated|2|||
106179797|NCT03348631|366318271|FG001|Overall Study|Not Eligible, Treated|0|||
106179798|NCT03348631|366318270|FG000|Overall Study|Eligible, No Treatment|1|||
106179799|NCT03348631|366318271|FG001|Overall Study|Eligible, No Treatment|0|||
106179800|NCT04099511|366318272|FG000|Overall Study|Lost to Follow-up|2|||
106179801|NCT04099511|366318273|FG001|Overall Study|Lost to Follow-up|2|||
106179802|NCT04099511|366318272|FG000|Overall Study|Withdrawal by Subject|8|||
106179803|NCT04099511|366318273|FG001|Overall Study|Withdrawal by Subject|4|||
106179804|NCT02302833|366318274|FG000|Overall Study|Lost to Follow-up|3|||
106179805|NCT03783442|366318275|FG000|Overall Study|Death|252|||
106179806|NCT03783442|366318276|FG001|Overall Study|Death|268|||
106179807|NCT03783442|366318275|FG000|Overall Study|Withdrawal by Subject|19|||
106179808|NCT03783442|366318276|FG001|Overall Study|Withdrawal by Subject|21|||
106179809|NCT03783442|366318275|FG000|Overall Study|Lost to Follow-up|7|||
106179810|NCT03783442|366318276|FG001|Overall Study|Lost to Follow-up|6|||
106179811|NCT03783442|366318275|FG000|Overall Study|Sponsor Ended Study|48|||
106179812|NCT03783442|366318276|FG001|Overall Study|Sponsor Ended Study|28|||
106179813|NCT01570868|366318277|FG000|Overall Study|Adverse Event|8|||
106179814|NCT01570868|366318278|FG001|Overall Study|Adverse Event|1|||
106179815|NCT01570868|366318277|FG000|Overall Study|FDA Recommendation|23|||
106179816|NCT01570868|366318278|FG001|Overall Study|FDA Recommendation|3|||
106179817|NCT01570868|366318277|FG000|Overall Study|Physician Decision|10|||
106179818|NCT01570868|366318278|FG001|Overall Study|Physician Decision|4|||
106179819|NCT01570868|366318277|FG000|Overall Study|Lost to Follow-up|1|||
106179820|NCT01570868|366318278|FG001|Overall Study|Lost to Follow-up|0|||
106179821|NCT01570868|366318277|FG000|Overall Study|Withdrawal by Subject|1|||
106179822|NCT01570868|366318278|FG001|Overall Study|Withdrawal by Subject|0|||
106179823|NCT04878432|366318279|FG000|Overall Study|Adverse Event|1|||
106179824|NCT04878432|366318279|FG000|Overall Study|Death|2|||
106179825|NCT04878432|366318279|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
106179826|NCT04878432|366318279|FG000|Overall Study|Withdrawal by Subject|6|||
106179827|NCT04878432|366318279|FG000|Overall Study|Progressive Disease|7|||
106179828|NCT04878432|366318279|FG000|Overall Study|New Therapy for Study Indication|7|||
106179829|NCT04878432|366318279|FG000|Overall Study|Physician Decision|11|||
106179830|NCT05194267|366318280|FG000|Overall Study|Withdrawal by Subject|2|||
106179831|NCT00098475|366318286|FG000|Step 1|Progressive disease|33|||
106179832|NCT00098475|366318287|FG001|Step 1|Progressive disease|35|||
106179833|NCT00098475|366318288|FG002|Step 1|Progressive disease|2|||
106179834|NCT00098475|366318289|FG003|Step 1|Progressive disease|1|||
106179835|NCT00098475|366318286|FG000|Step 1|Adverse Event|56|||
106179836|NCT00098475|366318287|FG001|Step 1|Adverse Event|37|||
106179837|NCT00098475|366318288|FG002|Step 1|Adverse Event|0|||
106179838|NCT00098475|366318289|FG003|Step 1|Adverse Event|1|||
106179839|NCT00098475|366318286|FG000|Step 1|Death|8|||
106179840|NCT00098475|366318287|FG001|Step 1|Death|5|||
106179841|NCT00098475|366318288|FG002|Step 1|Death|0|||
106179842|NCT00098475|366318289|FG003|Step 1|Death|1|||
106179843|NCT00098475|366318286|FG000|Step 1|Withdrawal by Subject|14|||
106179844|NCT00098475|366318287|FG001|Step 1|Withdrawal by Subject|11|||
106179845|NCT00098475|366318288|FG002|Step 1|Withdrawal by Subject|0|||
106179846|NCT00098475|366318289|FG003|Step 1|Withdrawal by Subject|0|||
106179847|NCT00098475|366318286|FG000|Step 1|Physician Decision|5|||
106179848|NCT00098475|366318287|FG001|Step 1|Physician Decision|2|||
106179849|NCT00098475|366318288|FG002|Step 1|Physician Decision|0|||
106179850|NCT00098475|366318289|FG003|Step 1|Physician Decision|0|||
106179851|NCT00098475|366318286|FG000|Step 1|Alternative therapy|31|||
106179852|NCT00098475|366318287|FG001|Step 1|Alternative therapy|43|||
106179853|NCT00098475|366318288|FG002|Step 1|Alternative therapy|1|||
106179854|NCT00098475|366318289|FG003|Step 1|Alternative therapy|0|||
106179855|NCT00098475|366318286|FG000|Step 1|Other disease|2|||
106179856|NCT00098475|366318287|FG001|Step 1|Other disease|1|||
106179857|NCT00098475|366318288|FG002|Step 1|Other disease|1|||
106179858|NCT00098475|366318289|FG003|Step 1|Other disease|0|||
106179859|NCT00098475|366318286|FG000|Step 1|Never started treatment|0|||
106179860|NCT00098475|366318287|FG001|Step 1|Never started treatment|2|||
106179861|NCT00098475|366318288|FG002|Step 1|Never started treatment|0|||
106179862|NCT00098475|366318289|FG003|Step 1|Never started treatment|0|||
106179863|NCT00098475|366318286|FG000|Step 1|Still on treatment as of this analysis|14|||
106179864|NCT00098475|366318287|FG001|Step 1|Still on treatment as of this analysis|27|||
106179865|NCT00098475|366318288|FG002|Step 1|Still on treatment as of this analysis|0|||
106179866|NCT00098475|366318289|FG003|Step 1|Still on treatment as of this analysis|0|||
106179867|NCT00098475|366318286|FG000|Step 1|Knee surgery|1|||
106179868|NCT00098475|366318287|FG001|Step 1|Knee surgery|0|||
106179869|NCT00098475|366318288|FG002|Step 1|Knee surgery|0|||
106179870|NCT00098475|366318289|FG003|Step 1|Knee surgery|0|||
106179871|NCT00098475|366318286|FG000|Step 1|Complications|1|||
106179872|NCT00098475|366318287|FG001|Step 1|Complications|0|||
106179873|NCT00098475|366318288|FG002|Step 1|Complications|0|||
106179874|NCT00098475|366318289|FG003|Step 1|Complications|0|||
106179875|NCT00098475|366318286|FG000|Step 1|Cannot comply due to other tx|0|||
106179876|NCT00098475|366318287|FG001|Step 1|Cannot comply due to other tx|1|||
106179877|NCT00098475|366318288|FG002|Step 1|Cannot comply due to other tx|0|||
106179878|NCT00098475|366318289|FG003|Step 1|Cannot comply due to other tx|0|||
106179879|NCT00098475|366318286|FG000|Step 1|Both patient and physician's decision|2|||
106179880|NCT00098475|366318287|FG001|Step 1|Both patient and physician's decision|1|||
106179881|NCT00098475|366318288|FG002|Step 1|Both patient and physician's decision|0|||
106179882|NCT00098475|366318289|FG003|Step 1|Both patient and physician's decision|0|||
106179883|NCT00098475|366318286|FG000|Step 1|Incorrect disease assessment|2|||
106179884|NCT00098475|366318287|FG001|Step 1|Incorrect disease assessment|0|||
106179885|NCT00098475|366318288|FG002|Step 1|Incorrect disease assessment|0|||
106179886|NCT00098475|366318289|FG003|Step 1|Incorrect disease assessment|0|||
106179887|NCT00098475|366318286|FG000|Step 1|Off treatment for > specified timeframe|1|||
106179888|NCT00098475|366318287|FG001|Step 1|Off treatment for > specified timeframe|1|||
106179889|NCT00098475|366318288|FG002|Step 1|Off treatment for > specified timeframe|0|||
106179890|NCT00098475|366318289|FG003|Step 1|Off treatment for > specified timeframe|0|||
106179891|NCT00098475|366318286|FG000|Step 1|Declining performance status|0|||
106179892|NCT00098475|366318287|FG001|Step 1|Declining performance status|1|||
106179893|NCT00098475|366318288|FG002|Step 1|Declining performance status|0|||
106179894|NCT00098475|366318289|FG003|Step 1|Declining performance status|0|||
106179895|NCT00098475|366318286|FG000|Step 1|Insurance issue|0|||
106179896|NCT00098475|366318287|FG001|Step 1|Insurance issue|1|||
106179897|NCT00098475|366318288|FG002|Step 1|Insurance issue|0|||
106179898|NCT00098475|366318289|FG003|Step 1|Insurance issue|0|||
106179899|NCT00098475|366318286|FG000|Step 1|Rising paraprotein|0|||
106179900|NCT00098475|366318287|FG001|Step 1|Rising paraprotein|1|||
106179901|NCT00098475|366318288|FG002|Step 1|Rising paraprotein|0|||
106179902|NCT00098475|366318289|FG003|Step 1|Rising paraprotein|0|||
106179903|NCT00098475|366318286|FG000|Step 1|Referred to other physicians|0|||
106179904|NCT00098475|366318287|FG001|Step 1|Referred to other physicians|1|||
106179905|NCT00098475|366318288|FG002|Step 1|Referred to other physicians|0|||
106179906|NCT00098475|366318289|FG003|Step 1|Referred to other physicians|0|||
106179907|NCT00098475|366318286|FG000|Step 1|Criteria to continue treatment not met|0|||
106179908|NCT00098475|366318287|FG001|Step 1|Criteria to continue treatment not met|1|||
106179909|NCT00098475|366318288|FG002|Step 1|Criteria to continue treatment not met|0|||
106179910|NCT00098475|366318289|FG003|Step 1|Criteria to continue treatment not met|0|||
106179911|NCT00098475|366318286|FG000|Step 1|Misinterpretation of lab data|0|||
106179912|NCT00098475|366318287|FG001|Step 1|Misinterpretation of lab data|1|||
106179913|NCT00098475|366318288|FG002|Step 1|Misinterpretation of lab data|0|||
106179914|NCT00098475|366318289|FG003|Step 1|Misinterpretation of lab data|0|||
106179915|NCT00098475|366318286|FG000|Step 1|Patient fell with fracture|1|||
106179916|NCT00098475|366318287|FG001|Step 1|Patient fell with fracture|0|||
106179917|NCT00098475|366318288|FG002|Step 1|Patient fell with fracture|0|||
106179918|NCT00098475|366318289|FG003|Step 1|Patient fell with fracture|0|||
106179919|NCT00098475|366318286|FG000|Step 1|Not documented|0|||
106179920|NCT00098475|366318287|FG001|Step 1|Not documented|1|||
106179921|NCT00098475|366318288|FG002|Step 1|Not documented|0|||
106179922|NCT00098475|366318289|FG003|Step 1|Not documented|0|||
106179923|NCT00098475|366318286|FG000|Step 2|Disease progression|1|||
106179924|NCT00098475|366318287|FG001|Step 2|Disease progression|4|||
106179925|NCT00098475|366318288|FG002|Step 2|Disease progression|0|||
106179926|NCT00098475|366318289|FG003|Step 2|Disease progression|0|||
106179927|NCT00098475|366318286|FG000|Step 2|Adverse Event|2|||
106179928|NCT00098475|366318287|FG001|Step 2|Adverse Event|0|||
106179929|NCT00098475|366318288|FG002|Step 2|Adverse Event|0|||
106179930|NCT00098475|366318289|FG003|Step 2|Adverse Event|0|||
106179931|NCT00098475|366318286|FG000|Step 2|Withdrawal by Subject|0|||
106179932|NCT00098475|366318287|FG001|Step 2|Withdrawal by Subject|2|||
106179933|NCT00098475|366318288|FG002|Step 2|Withdrawal by Subject|0|||
106179934|NCT00098475|366318289|FG003|Step 2|Withdrawal by Subject|0|||
106179935|NCT00098475|366318286|FG000|Step 2|Physician Decision|0|||
106179936|NCT00098475|366318287|FG001|Step 2|Physician Decision|1|||
106179937|NCT00098475|366318288|FG002|Step 2|Physician Decision|0|||
106179938|NCT00098475|366318289|FG003|Step 2|Physician Decision|0|||
106179939|NCT00098475|366318286|FG000|Step 2|Alternative therapy|1|||
106179940|NCT00098475|366318287|FG001|Step 2|Alternative therapy|2|||
106179941|NCT00098475|366318288|FG002|Step 2|Alternative therapy|0|||
106179942|NCT00098475|366318289|FG003|Step 2|Alternative therapy|0|||
106179943|NCT00098475|366318286|FG000|Step 2|Never started treatment|1|||
106179944|NCT00098475|366318287|FG001|Step 2|Never started treatment|1|||
106179945|NCT00098475|366318288|FG002|Step 2|Never started treatment|0|||
106179946|NCT00098475|366318289|FG003|Step 2|Never started treatment|0|||
106179947|NCT06151288|366318290|FG000|Overall Study|Lost to Follow-up|4|||
106179948|NCT06151288|366318291|FG001|Overall Study|Lost to Follow-up|2|||
106179949|NCT06151288|366318292|FG002|Overall Study|Lost to Follow-up|4|||
106179950|NCT06151288|366318293|FG003|Overall Study|Lost to Follow-up|3|||
106179951|NCT06151288|366318290|FG000|Overall Study|Withdrawal by Subject|4|||
106179952|NCT06151288|366318291|FG001|Overall Study|Withdrawal by Subject|5|||
106179953|NCT06151288|366318292|FG002|Overall Study|Withdrawal by Subject|1|||
106179954|NCT06151288|366318293|FG003|Overall Study|Withdrawal by Subject|1|||
106179955|NCT05722015|366318294|FG000|Overall Study|Death|57|||
106179956|NCT05722015|366318295|FG001|Overall Study|Death|37|||
106179957|NCT05722015|366318294|FG000|Overall Study|Lost to Follow-up|1|||
106179958|NCT05722015|366318295|FG001|Overall Study|Lost to Follow-up|0|||
106179959|NCT05722015|366318294|FG000|Overall Study|Withdrawal by Subject|5|||
106179960|NCT05722015|366318295|FG001|Overall Study|Withdrawal by Subject|1|||
106179961|NCT05722015|366318294|FG000|Overall Study|Participants Ongoing|188|||
106179962|NCT05722015|366318295|FG001|Overall Study|Participants Ongoing|88|||
106179963|NCT04542018|366318300|FG000|Overall Study|Withdrawal by Subject|0|||
106179964|NCT04542018|366318301|FG001|Overall Study|Withdrawal by Subject|0|||
106179965|NCT04542018|366318302|FG002|Overall Study|Withdrawal by Subject|4|||
106179966|NCT04542018|366318300|FG000|Overall Study|Protocol Violation|0|||
106179967|NCT04542018|366318301|FG001|Overall Study|Protocol Violation|0|||
106179968|NCT04542018|366318302|FG002|Overall Study|Protocol Violation|2|||
106179969|NCT04181827|366318307|FG000|Overall Study|Ongoing|124|||
106179970|NCT04181827|366318308|FG001|Overall Study|Ongoing|157|||
106179971|NCT04181827|366318307|FG000|Overall Study|Death|82|||
106179972|NCT04181827|366318308|FG001|Overall Study|Death|50|||
106179973|NCT04181827|366318307|FG000|Overall Study|Lost to Follow-up|0|||
106179974|NCT04181827|366318308|FG001|Overall Study|Lost to Follow-up|1|||
106179975|NCT04181827|366318307|FG000|Overall Study|Withdrawal by Subject|5|||
106179976|NCT04181827|366318308|FG001|Overall Study|Withdrawal by Subject|0|||
106179977|NCT04588389|366318309|FG000|Overall Study|Issues with anesthesia during surgery|2|||
106179978|NCT04588389|366318310|FG001|Overall Study|Issues with anesthesia during surgery|0|||
106179979|NCT04588389|366318311|FG002|Overall Study|Issues with anesthesia during surgery|0|||
106179980|NCT04190186|366318312|FG000|Overall Study|ILR is no longer functioning|0|||
106179981|NCT04190186|366318313|FG001|Overall Study|ILR is no longer functioning|1|||
106179982|NCT04190186|366318312|FG000|Overall Study|Lost to Follow-up|0|||
106179983|NCT04190186|366318313|FG001|Overall Study|Lost to Follow-up|1|||
106179984|NCT04190186|366318312|FG000|Overall Study|Withdrawal by Subject|2|||
106179985|NCT04190186|366318313|FG001|Overall Study|Withdrawal by Subject|0|||
106179986|NCT04190186|366318312|FG000|Overall Study|Subject choice to explant|1|||
106179987|NCT04190186|366318313|FG001|Overall Study|Subject choice to explant|0|||
106179988|NCT04190186|366318312|FG000|Overall Study|Physician Decision|0|||
106179989|NCT04190186|366318313|FG001|Overall Study|Physician Decision|1|||
106179990|NCT04190186|366318312|FG000|Overall Study|Study was stopped|4|||
106179991|NCT04190186|366318313|FG001|Overall Study|Study was stopped|5|||
106179992|NCT05017246|366318316|FG000|Overall Study|Withdrawal by Subject|5|||
106179993|NCT05017246|366318317|FG001|Overall Study|Withdrawal by Subject|3|||
106179994|NCT05017246|366318316|FG000|Overall Study|Determined to be ineligible|0|||
106179995|NCT05017246|366318317|FG001|Overall Study|Determined to be ineligible|1|||
106179996|NCT05017246|366318316|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
106179997|NCT05017246|366318317|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
106179998|NCT05017246|366318316|FG000|Overall Study|Technical failure|1|||
106179999|NCT05017246|366318317|FG001|Overall Study|Technical failure|3|||
106180000|NCT04068610|366318319|FG000|Overall Study|Death|4|||
106180001|NCT04068610|366318320|FG001|Overall Study|Death|8|||
106180002|NCT04068610|366318321|FG002|Overall Study|Death|13|||
106180003|NCT04068610|366318319|FG000|Overall Study|Lost to Follow-up|0|||
106180004|NCT04068610|366318320|FG001|Overall Study|Lost to Follow-up|2|||
106180005|NCT04068610|366318321|FG002|Overall Study|Lost to Follow-up|0|||
106180006|NCT04068610|366318319|FG000|Overall Study|Withdrawal by Subject|0|||
106180007|NCT04068610|366318320|FG001|Overall Study|Withdrawal by Subject|4|||
106180008|NCT04068610|366318321|FG002|Overall Study|Withdrawal by Subject|2|||
106180009|NCT04068610|366318319|FG000|Overall Study|Other|3|||
106180010|NCT04068610|366318320|FG001|Overall Study|Other|12|||
106180011|NCT04068610|366318321|FG002|Overall Study|Other|11|||
106180012|NCT03194646|366318322|FG000|Overall Study|Adverse Event|24|||
106180013|NCT03194646|366318323|FG001|Overall Study|Adverse Event|25|||
106180014|NCT03194646|366318324|FG002|Overall Study|Adverse Event|14|||
106180015|NCT03194646|366318325|FG003|Overall Study|Adverse Event|17|||
106180016|NCT03194646|366318322|FG000|Overall Study|Lack of Efficacy|4|||
106180017|NCT03194646|366318323|FG001|Overall Study|Lack of Efficacy|2|||
106180018|NCT03194646|366318324|FG002|Overall Study|Lack of Efficacy|2|||
106180019|NCT03194646|366318325|FG003|Overall Study|Lack of Efficacy|12|||
106180020|NCT03194646|366318322|FG000|Overall Study|Lost to Follow-up|30|||
106180021|NCT03194646|366318323|FG001|Overall Study|Lost to Follow-up|22|||
106180022|NCT03194646|366318324|FG002|Overall Study|Lost to Follow-up|12|||
106180023|NCT03194646|366318325|FG003|Overall Study|Lost to Follow-up|35|||
106180024|NCT03194646|366318322|FG000|Overall Study|Non-compliance with study drug|4|||
106180025|NCT03194646|366318323|FG001|Overall Study|Non-compliance with study drug|0|||
106180026|NCT03194646|366318324|FG002|Overall Study|Non-compliance with study drug|1|||
106180027|NCT03194646|366318325|FG003|Overall Study|Non-compliance with study drug|1|||
106180028|NCT03194646|366318322|FG000|Overall Study|Other|89|||
106180029|NCT03194646|366318323|FG001|Overall Study|Other|68|||
106180030|NCT03194646|366318324|FG002|Overall Study|Other|34|||
106180031|NCT03194646|366318325|FG003|Overall Study|Other|31|||
106180032|NCT03194646|366318322|FG000|Overall Study|Physician Decision|7|||
106180033|NCT03194646|366318323|FG001|Overall Study|Physician Decision|9|||
106180034|NCT03194646|366318324|FG002|Overall Study|Physician Decision|5|||
106180035|NCT03194646|366318325|FG003|Overall Study|Physician Decision|4|||
106180036|NCT03194646|366318322|FG000|Overall Study|Pregnancy|4|||
106180037|NCT03194646|366318323|FG001|Overall Study|Pregnancy|5|||
106180038|NCT03194646|366318324|FG002|Overall Study|Pregnancy|1|||
106180039|NCT03194646|366318325|FG003|Overall Study|Pregnancy|2|||
106180040|NCT03194646|366318322|FG000|Overall Study|Protocol Violation|4|||
106180041|NCT03194646|366318323|FG001|Overall Study|Protocol Violation|2|||
106180042|NCT03194646|366318324|FG002|Overall Study|Protocol Violation|1|||
106180043|NCT03194646|366318325|FG003|Overall Study|Protocol Violation|1|||
106180044|NCT03194646|366318322|FG000|Overall Study|Site terminated by sponsor|0|||
106180045|NCT03194646|366318323|FG001|Overall Study|Site terminated by sponsor|0|||
106180046|NCT03194646|366318324|FG002|Overall Study|Site terminated by sponsor|2|||
106180047|NCT03194646|366318325|FG003|Overall Study|Site terminated by sponsor|0|||
106180048|NCT03194646|366318322|FG000|Overall Study|Study terminated by sponsor|62|||
106180049|NCT03194646|366318323|FG001|Overall Study|Study terminated by sponsor|61|||
106180050|NCT03194646|366318324|FG002|Overall Study|Study terminated by sponsor|30|||
106180051|NCT03194646|366318325|FG003|Overall Study|Study terminated by sponsor|34|||
106180052|NCT03194646|366318322|FG000|Overall Study|Withdrawal by Subject|75|||
106180053|NCT03194646|366318323|FG001|Overall Study|Withdrawal by Subject|74|||
106180054|NCT03194646|366318324|FG002|Overall Study|Withdrawal by Subject|36|||
106180055|NCT03194646|366318325|FG003|Overall Study|Withdrawal by Subject|131|||
106180056|NCT03194646|366318322|FG000|Overall Study|Missing|1|||
106180057|NCT03194646|366318323|FG001|Overall Study|Missing|0|||
106180058|NCT03194646|366318324|FG002|Overall Study|Missing|1|||
106180059|NCT03194646|366318325|FG003|Overall Study|Missing|12|||
106180060|NCT00843882|366318326|FG000|Step 1|Lack of Efficacy|14|||
106180061|NCT00843882|366318327|FG001|Step 1|Lack of Efficacy|10|||
106180062|NCT00843882|366318328|FG002|Step 1|Lack of Efficacy|21|||
106180063|NCT00843882|366318326|FG000|Step 1|Adverse Event|8|||
106180064|NCT00843882|366318327|FG001|Step 1|Adverse Event|17|||
106180065|NCT00843882|366318328|FG002|Step 1|Adverse Event|20|||
106180066|NCT00843882|366318326|FG000|Step 1|Death|1|||
106180067|NCT00843882|366318327|FG001|Step 1|Death|2|||
106180068|NCT00843882|366318328|FG002|Step 1|Death|4|||
106180069|NCT00843882|366318326|FG000|Step 1|Withdrawal by Subject|6|||
106180070|NCT00843882|366318327|FG001|Step 1|Withdrawal by Subject|12|||
106180071|NCT00843882|366318328|FG002|Step 1|Withdrawal by Subject|9|||
106180072|NCT00843882|366318326|FG000|Step 1|Physician Decision|0|||
106180073|NCT00843882|366318327|FG001|Step 1|Physician Decision|5|||
106180074|NCT00843882|366318328|FG002|Step 1|Physician Decision|1|||
106180075|NCT00843882|366318326|FG000|Step 1|Patient and physician's decision|0|||
106180076|NCT00843882|366318327|FG001|Step 1|Patient and physician's decision|0|||
106180077|NCT00843882|366318328|FG002|Step 1|Patient and physician's decision|1|||
106180078|NCT00843882|366318326|FG000|Step 1|Other complicating disease|1|||
106180079|NCT00843882|366318327|FG001|Step 1|Other complicating disease|3|||
106180080|NCT00843882|366318328|FG002|Step 1|Other complicating disease|4|||
106180081|NCT00843882|366318326|FG000|Step 1|Alternative therapy|0|||
106180082|NCT00843882|366318327|FG001|Step 1|Alternative therapy|1|||
106180083|NCT00843882|366318328|FG002|Step 1|Alternative therapy|1|||
106180084|NCT00843882|366318326|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
106180085|NCT00843882|366318327|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
106180086|NCT00843882|366318328|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
106180087|NCT00843882|366318326|FG000|Step 1|Off treatment reason unknown|0|||
106180088|NCT00843882|366318327|FG001|Step 1|Off treatment reason unknown|1|||
106180089|NCT00843882|366318328|FG002|Step 1|Off treatment reason unknown|4|||
106180090|NCT00843882|366318326|FG000|Step 1|Never started treatment|2|||
106180091|NCT00843882|366318327|FG001|Step 1|Never started treatment|0|||
106180092|NCT00843882|366318328|FG002|Step 1|Never started treatment|0|||
106180093|NCT00843882|366318326|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
106180094|NCT00843882|366318327|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
106180095|NCT00843882|366318328|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
106180096|NCT00843882|366318326|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
106180097|NCT00843882|366318327|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
106180098|NCT00843882|366318328|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
106180099|NCT00843882|366318326|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
106180100|NCT00843882|366318327|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
106180101|NCT00843882|366318328|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
106180102|NCT00843882|366318326|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
106180103|NCT00843882|366318327|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
106180104|NCT00843882|366318328|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
106180105|NCT00843882|366318326|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
106180106|NCT00843882|366318327|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
106180107|NCT00843882|366318328|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
106180108|NCT00843882|366318326|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
106180109|NCT00843882|366318327|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
106180110|NCT00843882|366318328|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
106180111|NCT00843882|366318326|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
106180112|NCT00843882|366318327|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
106180113|NCT00843882|366318328|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
106180114|NCT02115282|366318329|FG000|Overall Study|Disease progression during treatment|216|||
106180115|NCT02115282|366318330|FG001|Overall Study|Disease progression during treatment|229|||
106180116|NCT02115282|366318329|FG000|Overall Study|Adverse Event|49|||
106180117|NCT02115282|366318330|FG001|Overall Study|Adverse Event|23|||
106180118|NCT02115282|366318329|FG000|Overall Study|Death|1|||
106180119|NCT02115282|366318330|FG001|Overall Study|Death|3|||
106180120|NCT02115282|366318329|FG000|Overall Study|Alternative therapy|1|||
106180121|NCT02115282|366318330|FG001|Overall Study|Alternative therapy|1|||
106180122|NCT02115282|366318329|FG000|Overall Study|Complicating disease|0|||
106180123|NCT02115282|366318330|FG001|Overall Study|Complicating disease|3|||
106180124|NCT02115282|366318329|FG000|Overall Study|Withdrawal by Subject|12|||
106180125|NCT02115282|366318330|FG001|Overall Study|Withdrawal by Subject|10|||
106180126|NCT02115282|366318329|FG000|Overall Study|Symptomatic progression/deterioration|7|||
106180127|NCT02115282|366318330|FG001|Overall Study|Symptomatic progression/deterioration|18|||
106180128|NCT02115282|366318329|FG000|Overall Study|Non-compliance|5|||
106180129|NCT02115282|366318330|FG001|Overall Study|Non-compliance|1|||
106180130|NCT02115282|366318329|FG000|Overall Study|Protocol Violation|2|||
106180131|NCT02115282|366318330|FG001|Overall Study|Protocol Violation|2|||
106180132|NCT02115282|366318329|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
106180133|NCT02115282|366318330|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
106180134|NCT02115282|366318329|FG000|Overall Study|Not start protocol therapy|9|||
106180135|NCT02115282|366318330|FG001|Overall Study|Not start protocol therapy|10|||
106180136|NCT00644228|366318331|FG000|Randomization & Eligibility|Ineligible|31|||
106180137|NCT00644228|366318332|FG001|Randomization & Eligibility|Ineligible|21|||
106180138|NCT00644228|366318331|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
106180139|NCT00644228|366318332|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
106180140|NCT00644228|366318331|FG000|Randomization & Eligibility|Invalid Consent|0|||
106180141|NCT00644228|366318332|FG001|Randomization & Eligibility|Invalid Consent|1|||
106180142|NCT00644228|366318331|FG000|Induction Therapy|Adverse Event|22|||
106180143|NCT00644228|366318332|FG001|Induction Therapy|Adverse Event|55|||
106180144|NCT00644228|366318331|FG000|Induction Therapy|Withdrawal by Subject|10|||
106180145|NCT00644228|366318332|FG001|Induction Therapy|Withdrawal by Subject|3|||
106180146|NCT00644228|366318331|FG000|Induction Therapy|Progression/Relapse|24|||
106180147|NCT00644228|366318332|FG001|Induction Therapy|Progression/Relapse|12|||
106180148|NCT00644228|366318331|FG000|Induction Therapy|Death|3|||
106180149|NCT00644228|366318332|FG001|Induction Therapy|Death|7|||
106180150|NCT00644228|366318331|FG000|Induction Therapy|Not Protocol-Specified|24|||
106180151|NCT00644228|366318332|FG001|Induction Therapy|Not Protocol-Specified|28|||
106180152|NCT00644228|366318331|FG000|Maintenance|Adverse Event|27|||
106180153|NCT00644228|366318332|FG001|Maintenance|Adverse Event|31|||
106180154|NCT00644228|366318331|FG000|Maintenance|Withdrawal by Subject|6|||
106180155|NCT00644228|366318332|FG001|Maintenance|Withdrawal by Subject|4|||
106180156|NCT00644228|366318331|FG000|Maintenance|Progression/Relapse|67|||
106180157|NCT00644228|366318332|FG001|Maintenance|Progression/Relapse|42|||
106180158|NCT00644228|366318331|FG000|Maintenance|Death|3|||
106180159|NCT00644228|366318332|FG001|Maintenance|Death|3|||
106180160|NCT00644228|366318331|FG000|Maintenance|Not Protocol-Specified|14|||
106180161|NCT00644228|366318332|FG001|Maintenance|Not Protocol-Specified|15|||
106180162|NCT00644228|366318331|FG000|Maintenance|On Treatment|26|||
106180163|NCT00644228|366318332|FG001|Maintenance|On Treatment|40|||
106180164|NCT00658814|366318333|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
106180165|NCT00658814|366318334|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
106180166|NCT00658814|366318333|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
106180167|NCT00658814|366318334|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
106180168|NCT00658814|366318333|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
106180169|NCT00658814|366318334|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
106180170|NCT00658814|366318333|FG000|Remission Induction Chemotherapy|Death|1|||
106180171|NCT00658814|366318334|FG001|Remission Induction Chemotherapy|Death|4|||
106180172|NCT00658814|366318333|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
106180173|NCT00658814|366318334|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
106180174|NCT00658814|366318333|FG000|Remission Induction Chemotherapy|Not eligible|1|||
106180175|NCT00658814|366318334|FG001|Remission Induction Chemotherapy|Not eligible|2|||
106180176|NCT00658814|366318333|FG000|Consolidation Therapy|Not protocol specified|0|||
106180177|NCT00658814|366318334|FG001|Consolidation Therapy|Not protocol specified|1|||
106180178|NCT00658814|366318333|FG000|Consolidation Therapy|Not eligible|2|||
106180179|NCT00658814|366318334|FG001|Consolidation Therapy|Not eligible|2|||
106180180|NCT00658814|366318333|FG000|Maintenance Therapy|Adverse Event|1|||
106180181|NCT00658814|366318334|FG001|Maintenance Therapy|Adverse Event|1|||
106180182|NCT00658814|366318333|FG000|Maintenance Therapy|Not protocol specified|1|||
106180183|NCT00658814|366318334|FG001|Maintenance Therapy|Not protocol specified|0|||
106180184|NCT00658814|366318333|FG000|Maintenance Therapy|Not eligible|1|||
106180185|NCT00658814|366318334|FG001|Maintenance Therapy|Not eligible|0|||
106180186|NCT02911142|366318335|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
105867391|NCT01473407|365164956|FG001|Overall Study|Sponsor's Decision|10|||
106180187|NCT02911142|366318335|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
106180188|NCT02911142|366318335|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
106180189|NCT02911142|366318335|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
106180190|NCT03260894|366318336|FG000|Overall Study|Death|6|||
106180191|NCT03260894|366318337|FG001|Overall Study|Death|8|||
106180192|NCT03260894|366318336|FG000|Overall Study|Withdrawal by Subject|4|||
106180193|NCT03260894|366318337|FG001|Overall Study|Withdrawal by Subject|11|||
106180194|NCT03260894|366318336|FG000|Overall Study|On-going at clinical cut off date|36|||
106180195|NCT03260894|366318337|FG001|Overall Study|On-going at clinical cut off date|31|||
106180196|NCT04755283|366318338|FG000|Overall Study|Withdrawal by Subject|14|||
106180197|NCT04755283|366318339|FG001|Overall Study|Withdrawal by Subject|3|||
106180198|NCT04755283|366318340|FG002|Overall Study|Withdrawal by Subject|6|||
106180199|NCT04755283|366318338|FG000|Overall Study|Lost to Follow-up|0|||
106180200|NCT04755283|366318339|FG001|Overall Study|Lost to Follow-up|0|||
106180201|NCT04755283|366318340|FG002|Overall Study|Lost to Follow-up|1|||
106180202|NCT04755283|366318338|FG000|Overall Study|Death|31|||
106180203|NCT04755283|366318339|FG001|Overall Study|Death|36|||
106180204|NCT04755283|366318340|FG002|Overall Study|Death|34|||
106180205|NCT04886596|366318341|FG000|Overall Study|Adverse Event|442|||
106180206|NCT04886596|366318342|FG001|Overall Study|Adverse Event|441|||
106180207|NCT04886596|366318341|FG000|Overall Study|Lost to Follow-up|448|||
106180208|NCT04886596|366318342|FG001|Overall Study|Lost to Follow-up|465|||
106180209|NCT04886596|366318341|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
106180210|NCT04886596|366318342|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
106180211|NCT04886596|366318341|FG000|Overall Study|Migrated/moved from the study area|201|||
106180212|NCT04886596|366318342|FG001|Overall Study|Migrated/moved from the study area|184|||
106180213|NCT04886596|366318341|FG000|Overall Study|Other|298|||
106180214|NCT04886596|366318342|FG001|Overall Study|Other|326|||
106180215|NCT02411656|366318343|FG000|Overall Study|Adverse Event|4|||
106180216|NCT02411656|366318343|FG000|Overall Study|Clinical Progression|33|||
106180217|NCT02446600|366318344|FG000|Overall Study|Never treated|20|||
106180218|NCT02446600|366318345|FG001|Overall Study|Never treated|2|||
106180219|NCT02446600|366318346|FG002|Overall Study|Never treated|6|||
106180220|NCT02446600|366318347|FG003|Overall Study|Never treated|0|||
106180221|NCT02446600|366318344|FG000|Overall Study|Withdrawal by Subject|19|||
106180222|NCT02446600|366318345|FG001|Overall Study|Withdrawal by Subject|5|||
106180223|NCT02446600|366318346|FG002|Overall Study|Withdrawal by Subject|17|||
106180224|NCT02446600|366318347|FG003|Overall Study|Withdrawal by Subject|0|||
106180225|NCT02446600|366318344|FG000|Overall Study|Ineligible|1|||
106180226|NCT02446600|366318345|FG001|Overall Study|Ineligible|4|||
106180227|NCT02446600|366318346|FG002|Overall Study|Ineligible|4|||
106180228|NCT02446600|366318347|FG003|Overall Study|Ineligible|1|||
106180229|NCT02446600|366318344|FG000|Overall Study|Duplicate Enrollment|0|||
106180230|NCT02446600|366318345|FG001|Overall Study|Duplicate Enrollment|1|||
106180231|NCT02446600|366318346|FG002|Overall Study|Duplicate Enrollment|0|||
106180232|NCT02446600|366318347|FG003|Overall Study|Duplicate Enrollment|0|||
106180233|NCT05007392|366318348|FG000|Overall Study|Randomized but not treated|1|||
106180234|NCT05007392|366318349|FG001|Overall Study|Randomized but not treated|2|||
106180235|NCT05007392|366318348|FG000|Overall Study|Other|5|||
106180236|NCT05007392|366318349|FG001|Overall Study|Other|4|||
106180237|NCT05007392|366318348|FG000|Overall Study|Lost to Follow-up|1|||
106180238|NCT05007392|366318349|FG001|Overall Study|Lost to Follow-up|2|||
106180239|NCT05007392|366318348|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
106180240|NCT05007392|366318349|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
106180241|NCT05007392|366318348|FG000|Overall Study|Use of prohibited concomitant drug|1|||
106180242|NCT05007392|366318349|FG001|Overall Study|Use of prohibited concomitant drug|1|||
106180243|NCT05007392|366318348|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
106180244|NCT05007392|366318349|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
106180245|NCT05007392|366318348|FG000|Overall Study|Adverse Event|10|||
106180246|NCT05007392|366318349|FG001|Overall Study|Adverse Event|6|||
106180247|NCT05007392|366318348|FG000|Overall Study|Participant choice|5|||
106180248|NCT05007392|366318349|FG001|Overall Study|Participant choice|10|||
106180249|NCT05007392|366318348|FG000|Overall Study|Withdrawal of consent|5|||
106180250|NCT05007392|366318349|FG001|Overall Study|Withdrawal of consent|4|||
106180251|NCT03228537|366318350|FG000|Neoadjuvant|Adverse Event|2|||
106180252|NCT03228537|366318350|FG000|Neoadjuvant|Progression/Relapse|4|||
106180253|NCT03228537|366318350|FG000|Neoadjuvant|Death|1|||
106180254|NCT03228537|366318350|FG000|Surgery|Death|1|||
106180255|NCT03228537|366318350|FG000|Surgery|Other - Not Protocol Specified|2|||
106180256|NCT03228537|366318350|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
106180257|NCT03228537|366318350|FG000|Maintenance|Progression/Relapse|10|||
106180258|NCT02603887|366318351|FG000|Stage 1|Adverse Event|4|||
106180259|NCT02603887|366318351|FG000|Stage 1|Disease progression|1|||
106180260|NCT02603887|366318351|FG000|Stage 2|FDA guidance|1|||
106180261|NCT02466971|366318352|FG000|Overall Study|eligible and never treated|14|||
106180262|NCT02466971|366318353|FG001|Overall Study|eligible and never treated|20|||
106180263|NCT02466971|366318352|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
106180264|NCT02466971|366318353|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
106180265|NCT02466971|366318352|FG000|Overall Study|ineligible and treated|1|||
106180266|NCT02466971|366318353|FG001|Overall Study|ineligible and treated|0|||
106180267|NCT02466971|366318352|FG000|Overall Study|ineligible and never treated|0|||
106180268|NCT02466971|366318353|FG001|Overall Study|ineligible and never treated|1|||
106180269|NCT06213701|366318354|FG000|Overall Study|Withdrawal by Subject|2|||
106180270|NCT06213701|366318355|FG001|Overall Study|Withdrawal by Subject|1|||
106180271|NCT06213701|366318356|FG002|Overall Study|Withdrawal by Subject|0|||
106180272|NCT05014542|366318357|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
106180273|NCT05014542|366318358|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
106180274|NCT05014542|366318357|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
106180275|NCT05014542|366318358|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
106180276|NCT05014542|366318357|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
106180277|NCT05014542|366318358|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
106180278|NCT05014542|366318357|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
106180279|NCT05014542|366318358|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
106180280|NCT05507580|366318361|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
106180281|NCT05507580|366318362|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
106180282|NCT05507580|366318363|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
106180283|NCT05507580|366318364|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
106180284|NCT05507580|366318365|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
106180285|NCT05507580|366318366|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
106180286|NCT05507580|366318361|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
106180287|NCT05507580|366318362|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
106180288|NCT05507580|366318363|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106180289|NCT05507580|366318364|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106180290|NCT05507580|366318365|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106180291|NCT05507580|366318366|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
106180292|NCT05507580|366318361|FG000|Double-Blind Treatment Period|Other, not specified|5|||
106180293|NCT05507580|366318362|FG001|Double-Blind Treatment Period|Other, not specified|4|||
106180294|NCT05507580|366318363|FG002|Double-Blind Treatment Period|Other, not specified|0|||
106180295|NCT05507580|366318364|FG003|Double-Blind Treatment Period|Other, not specified|0|||
106180296|NCT05507580|366318365|FG004|Double-Blind Treatment Period|Other, not specified|0|||
106180297|NCT05507580|366318366|FG005|Double-Blind Treatment Period|Other, not specified|0|||
106180298|NCT05507580|366318361|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
106180299|NCT05507580|366318362|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
106180300|NCT05507580|366318363|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
106180301|NCT05507580|366318364|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
106180302|NCT05507580|366318365|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
106180303|NCT05507580|366318366|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
106180304|NCT05507580|366318361|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
106180305|NCT05507580|366318362|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
106180306|NCT05507580|366318363|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
106180307|NCT05507580|366318364|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
106180308|NCT05507580|366318365|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
106180309|NCT05507580|366318366|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
106180310|NCT05507580|366318361|FG000|Single-Blind Treatment Period|Other, not specified|0|||
106180311|NCT05507580|366318362|FG001|Single-Blind Treatment Period|Other, not specified|0|||
106180312|NCT05507580|366318363|FG002|Single-Blind Treatment Period|Other, not specified|2|||
106180313|NCT05507580|366318364|FG003|Single-Blind Treatment Period|Other, not specified|7|||
106180314|NCT05507580|366318365|FG004|Single-Blind Treatment Period|Other, not specified|3|||
106180315|NCT05507580|366318366|FG005|Single-Blind Treatment Period|Other, not specified|5|||
106180316|NCT04661150|366318368|FG000|Overall Study|Ongoing in study|19|||
106180317|NCT04661150|366318369|FG001|Overall Study|Ongoing in study|20|||
106180318|NCT04661150|366318368|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
106180319|NCT04661150|366318369|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
106180320|NCT04661150|366318368|FG000|Overall Study|Death|2|||
106180321|NCT04661150|366318369|FG001|Overall Study|Death|0|||
106180322|NCT03535740|366318374|FG000|Overall Study|Death|44|||
106180323|NCT03535740|366318374|FG000|Overall Study|Lost to Follow-up|1|||
106180324|NCT03535740|366318374|FG000|Overall Study|Withdrawal by Subject|13|||
106180325|NCT03535740|366318374|FG000|Overall Study|Site terminated by Sponsor|45|||
106180326|NCT06000501|366318375|FG000|Overall Study|Screen failure|3|||
106180327|NCT06000501|366318375|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
106180328|NCT06000501|366318375|FG000|Overall Study|Physician Decision|4|||
106180329|NCT06000501|366318375|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
106180330|NCT06000501|366318375|FG000|Overall Study|Scheduling issues|2|||
106180331|NCT03496662|366318377|FG000|Overall Study|Adverse Event|0|||
106180332|NCT03496662|366318378|FG001|Overall Study|Adverse Event|0|||
106180333|NCT03496662|366318379|FG002|Overall Study|Adverse Event|4|||
106180334|NCT03496662|366318377|FG000|Overall Study|Withdrawal by Subject|1|||
106180335|NCT03496662|366318378|FG001|Overall Study|Withdrawal by Subject|0|||
105867392|NCT01473407|365164955|FG000|Overall Study|Site Closure|1|||
106180336|NCT03496662|366318379|FG002|Overall Study|Withdrawal by Subject|2|||
106180337|NCT03496662|366318377|FG000|Overall Study|Death|0|||
106180338|NCT03496662|366318378|FG001|Overall Study|Death|0|||
106180339|NCT03496662|366318379|FG002|Overall Study|Death|2|||
106180340|NCT03496662|366318377|FG000|Overall Study|Noncompliance|0|||
106180341|NCT03496662|366318378|FG001|Overall Study|Noncompliance|0|||
106180342|NCT03496662|366318379|FG002|Overall Study|Noncompliance|1|||
106180343|NCT03210714|366318386|FG000|Overall Study|Adverse Event|6|||
106180344|NCT03210714|366318386|FG000|Overall Study|Physician Decision|1|||
106180345|NCT03210714|366318386|FG000|Overall Study|Progressive disease|11|||
106180346|NCT03210714|366318386|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
106180347|NCT02883062|366318387|FG000|Overall Study|Withdrawal by Subject|6|||
106180348|NCT02883062|366318388|FG001|Overall Study|Withdrawal by Subject|0|||
106180349|NCT05366010|366318389|FG000|Overall Study|Withdrawal by Subject|1|||
106180350|NCT05366010|366318389|FG000|Overall Study|Protocol Violation|1|||
106180351|NCT05366010|366318389|FG000|Overall Study|Lost to Follow-up|2|||
106180352|NCT05366010|366318389|FG000|Overall Study|Screen Failure|2|||
106180353|NCT04051827|366318390|FG000|Overall Study|Death|1|||
106180354|NCT04051827|366318390|FG000|Overall Study|Withdrawal by Subject|4|||
106180355|NCT04051827|366318390|FG000|Overall Study|Progressive disease|16|||
106180356|NCT04051827|366318390|FG000|Overall Study|Physician Decision|1|||
106180357|NCT04051827|366318390|FG000|Overall Study|Other|4|||
106180358|NCT02888743|366318391|FG000|Overall Study|Withdrawal by Subject|1|||
106180359|NCT02888743|366318392|FG001|Overall Study|Withdrawal by Subject|2|||
106180360|NCT02888743|366318393|FG002|Overall Study|Withdrawal by Subject|2|||
106180361|NCT02888743|366318394|FG003|Overall Study|Withdrawal by Subject|0|||
106180362|NCT02888743|366318395|FG004|Overall Study|Withdrawal by Subject|1|||
106180363|NCT02888743|366318391|FG000|Overall Study|Disease progression before treatment|2|||
106180364|NCT02888743|366318392|FG001|Overall Study|Disease progression before treatment|0|||
106180365|NCT02888743|366318393|FG002|Overall Study|Disease progression before treatment|2|||
106180366|NCT02888743|366318394|FG003|Overall Study|Disease progression before treatment|0|||
106180367|NCT02888743|366318395|FG004|Overall Study|Disease progression before treatment|0|||
106180368|NCT02888743|366318391|FG000|Overall Study|Patient ineligible|1|||
106180369|NCT02888743|366318392|FG001|Overall Study|Patient ineligible|2|||
106180370|NCT02888743|366318393|FG002|Overall Study|Patient ineligible|0|||
106180371|NCT02888743|366318394|FG003|Overall Study|Patient ineligible|0|||
106180372|NCT02888743|366318395|FG004|Overall Study|Patient ineligible|0|||
106180373|NCT05779007|366318399|FG000|Overall Study|not meeting eligibility criteria|3517|||
106180374|NCT05779007|366318400|FG001|Overall Study|not meeting eligibility criteria|2009|||
106180375|NCT04589650|366318401|FG000|Overall Study|Subject decision|6|||
106180376|NCT04589650|366318402|FG001|Overall Study|Subject decision|2|||
106180377|NCT04589650|366318403|FG002|Overall Study|Subject decision|2|||
106180378|NCT04589650|366318404|FG003|Overall Study|Subject decision|0|||
106180379|NCT04589650|366318405|FG004|Overall Study|Subject decision|0|||
106180380|NCT04589650|366318406|FG005|Overall Study|Subject decision|0|||
106180381|NCT04589650|366318401|FG000|Overall Study|Adverse Event|3|||
106180382|NCT04589650|366318402|FG001|Overall Study|Adverse Event|1|||
106180383|NCT04589650|366318403|FG002|Overall Study|Adverse Event|1|||
106180384|NCT04589650|366318404|FG003|Overall Study|Adverse Event|1|||
106180385|NCT04589650|366318405|FG004|Overall Study|Adverse Event|0|||
106180386|NCT04589650|366318406|FG005|Overall Study|Adverse Event|1|||
106180387|NCT04589650|366318401|FG000|Overall Study|Physician Decision|1|||
106180388|NCT04589650|366318402|FG001|Overall Study|Physician Decision|1|||
106180389|NCT04589650|366318403|FG002|Overall Study|Physician Decision|0|||
106180390|NCT04589650|366318404|FG003|Overall Study|Physician Decision|0|||
106180391|NCT04589650|366318405|FG004|Overall Study|Physician Decision|0|||
106180392|NCT04589650|366318406|FG005|Overall Study|Physician Decision|0|||
106180393|NCT04589650|366318401|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
106180394|NCT04589650|366318402|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
106180395|NCT04589650|366318403|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
106180396|NCT04589650|366318404|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
106180397|NCT04589650|366318405|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
106180398|NCT04589650|366318406|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
106180399|NCT04589650|366318401|FG000|Overall Study|Death|0|||
106180400|NCT04589650|366318402|FG001|Overall Study|Death|0|||
106180401|NCT04589650|366318403|FG002|Overall Study|Death|0|||
106180402|NCT04589650|366318404|FG003|Overall Study|Death|1|||
106180403|NCT04589650|366318405|FG004|Overall Study|Death|0|||
106180404|NCT04589650|366318406|FG005|Overall Study|Death|0|||
106180405|NCT04589650|366318401|FG000|Overall Study|Guardian Decision|0|||
106180406|NCT04589650|366318402|FG001|Overall Study|Guardian Decision|0|||
106180407|NCT04589650|366318403|FG002|Overall Study|Guardian Decision|0|||
106180408|NCT04589650|366318404|FG003|Overall Study|Guardian Decision|1|||
106180409|NCT04589650|366318405|FG004|Overall Study|Guardian Decision|0|||
106180410|NCT04589650|366318406|FG005|Overall Study|Guardian Decision|0|||
106180411|NCT05906628|366318409|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
106180412|NCT05906628|366318410|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
106180413|NCT05906628|366318409|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
106180414|NCT05906628|366318410|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
106180415|NCT05906628|366318409|FG000|16-Week DBVC Period|Protocol Violation|4|||
106180416|NCT05906628|366318410|FG001|16-Week DBVC Period|Protocol Violation|2|||
106180417|NCT05906628|366318409|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
106180418|NCT05906628|366318410|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
106180419|NCT05906628|366318409|FG000|16-Week OLE Period|Death|1|||
106180420|NCT05906628|366318410|FG001|16-Week OLE Period|Death|0|||
106180421|NCT05906628|366318409|FG000|16-Week OLE Period|Lost to Follow-up|1|||
106180422|NCT05906628|366318410|FG001|16-Week OLE Period|Lost to Follow-up|1|||
106180423|NCT05906628|366318409|FG000|16-Week OLE Period|Protocol Violation|0|||
106180424|NCT05906628|366318410|FG001|16-Week OLE Period|Protocol Violation|1|||
106180425|NCT05906628|366318409|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
106180426|NCT05906628|366318410|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
106180427|NCT00902694|366318411|FG000|Overall Study|Death|1|||
106180428|NCT00902694|366318412|FG001|Overall Study|Death|3|||
106180429|NCT00902694|366318411|FG000|Overall Study|Lost to Follow-up|1|||
106180430|NCT00902694|366318412|FG001|Overall Study|Lost to Follow-up|0|||
106180431|NCT00902694|366318411|FG000|Overall Study|Censored per protocol|3|||
106180432|NCT00902694|366318412|FG001|Overall Study|Censored per protocol|1|||
106180433|NCT00902694|366318411|FG000|Overall Study|Pregnancy|1|||
106180434|NCT00902694|366318412|FG001|Overall Study|Pregnancy|1|||
106180435|NCT00902694|366318411|FG000|Overall Study|Incarceration|1|||
106180436|NCT00902694|366318412|FG001|Overall Study|Incarceration|0|||
106180437|NCT04017962|366318413|FG000|Overall Study|Death|2|||
106180438|NCT04017962|366318414|FG001|Overall Study|Death|0|||
106180439|NCT04017962|366318413|FG000|Overall Study|Lost to Follow-up|2|||
106180440|NCT04017962|366318414|FG001|Overall Study|Lost to Follow-up|0|||
106180441|NCT04017962|366318413|FG000|Overall Study|Physician Decision|1|||
106180442|NCT04017962|366318414|FG001|Overall Study|Physician Decision|0|||
106180443|NCT04017962|366318413|FG000|Overall Study|Discontinued LTV|5|||
106180444|NCT04017962|366318414|FG001|Overall Study|Discontinued LTV|0|||
106180445|NCT04969263|366318415|FG000|Overall Study|Death|1|||
106180446|NCT04969263|366318415|FG000|Overall Study|Lost to Follow-up|2|||
106180447|NCT04969263|366318415|FG000|Overall Study|Withdrawal by Subject|5|||
106180448|NCT04969263|366318415|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
106180449|NCT05489081|366318417|FG000|Overall Study|student left classroom|0|||
106180450|NCT05489081|366318418|FG001|Overall Study|student left classroom|1|||
106180451|NCT05489081|366318417|FG000|Overall Study|teacher left school|0|||
106180452|NCT05489081|366318418|FG001|Overall Study|teacher left school|2|||
106180453|NCT04539938|366318423|FG000|Overall Study|Death|30|||
106180454|NCT04539938|366318423|FG000|Overall Study|Withdrawal by Subject|4|||
106180455|NCT04816721|366318427|FG000|Overall Study|Withdrawal by Subject|0|||
106180456|NCT04816721|366318428|FG001|Overall Study|Withdrawal by Subject|2|||
106180457|NCT04816721|366318429|FG002|Overall Study|Withdrawal by Subject|0|||
106180458|NCT04816721|366318430|FG003|Overall Study|Withdrawal by Subject|1|||
106180459|NCT04816721|366318431|FG004|Overall Study|Withdrawal by Subject|1|||
106180460|NCT04816721|366318432|FG005|Overall Study|Withdrawal by Subject|0|||
106180461|NCT04816721|366318433|FG006|Overall Study|Withdrawal by Subject|0|||
106180462|NCT04816721|366318434|FG007|Overall Study|Withdrawal by Subject|0|||
106180463|NCT04816721|366318427|FG000|Overall Study|Miscellaneous|0|||
106180464|NCT04816721|366318428|FG001|Overall Study|Miscellaneous|0|||
106180465|NCT04816721|366318429|FG002|Overall Study|Miscellaneous|0|||
106180466|NCT04816721|366318430|FG003|Overall Study|Miscellaneous|0|||
106180467|NCT04816721|366318431|FG004|Overall Study|Miscellaneous|0|||
106180468|NCT04816721|366318432|FG005|Overall Study|Miscellaneous|1|||
106180469|NCT04816721|366318433|FG006|Overall Study|Miscellaneous|0|||
106180470|NCT04816721|366318434|FG007|Overall Study|Miscellaneous|0|||
106180471|NCT04816721|366318427|FG000|Overall Study|Lost to Follow-up|0|||
106180472|NCT04816721|366318428|FG001|Overall Study|Lost to Follow-up|0|||
106180473|NCT04816721|366318429|FG002|Overall Study|Lost to Follow-up|0|||
106180474|NCT04816721|366318430|FG003|Overall Study|Lost to Follow-up|1|||
106180475|NCT04816721|366318431|FG004|Overall Study|Lost to Follow-up|0|||
106180476|NCT04816721|366318432|FG005|Overall Study|Lost to Follow-up|0|||
106180477|NCT04816721|366318433|FG006|Overall Study|Lost to Follow-up|0|||
106180478|NCT04816721|366318434|FG007|Overall Study|Lost to Follow-up|0|||
106180479|NCT02257528|366318435|FG000|Overall Study|Never received study treatment|1|||
106180480|NCT01371981|366318436|FG000|Overall Study|Adverse Event|12|||
106180481|NCT01371981|366318437|FG001|Overall Study|Adverse Event|17|||
106180482|NCT01371981|366318438|FG002|Overall Study|Adverse Event|0|||
106180483|NCT01371981|366318439|FG003|Overall Study|Adverse Event|4|||
106180484|NCT01371981|366318440|FG004|Overall Study|Adverse Event|1|||
106180485|NCT01371981|366318441|FG005|Overall Study|Adverse Event|0|||
106180486|NCT01371981|366318436|FG000|Overall Study|Death|22|||
106180487|NCT01371981|366318437|FG001|Overall Study|Death|16|||
106180488|NCT01371981|366318438|FG002|Overall Study|Death|0|||
106180489|NCT01371981|366318439|FG003|Overall Study|Death|0|||
106180490|NCT01371981|366318440|FG004|Overall Study|Death|2|||
106180491|NCT01371981|366318441|FG005|Overall Study|Death|2|||
106180492|NCT01371981|366318436|FG000|Overall Study|Lack of Efficacy|69|||
106180493|NCT01371981|366318437|FG001|Overall Study|Lack of Efficacy|61|||
106180494|NCT01371981|366318438|FG002|Overall Study|Lack of Efficacy|4|||
106180495|NCT01371981|366318439|FG003|Overall Study|Lack of Efficacy|8|||
106180496|NCT01371981|366318440|FG004|Overall Study|Lack of Efficacy|5|||
106180497|NCT01371981|366318441|FG005|Overall Study|Lack of Efficacy|0|||
106180498|NCT01371981|366318436|FG000|Overall Study|Physician Decision|48|||
106180499|NCT01371981|366318437|FG001|Overall Study|Physician Decision|63|||
106180500|NCT01371981|366318438|FG002|Overall Study|Physician Decision|1|||
106180501|NCT01371981|366318439|FG003|Overall Study|Physician Decision|7|||
106180502|NCT01371981|366318440|FG004|Overall Study|Physician Decision|14|||
106180503|NCT01371981|366318441|FG005|Overall Study|Physician Decision|3|||
106180504|NCT01371981|366318436|FG000|Overall Study|Withdrawal by Subject|12|||
106180505|NCT01371981|366318437|FG001|Overall Study|Withdrawal by Subject|19|||
106180506|NCT01371981|366318438|FG002|Overall Study|Withdrawal by Subject|1|||
106180507|NCT01371981|366318439|FG003|Overall Study|Withdrawal by Subject|2|||
106180508|NCT01371981|366318440|FG004|Overall Study|Withdrawal by Subject|10|||
106180509|NCT01371981|366318441|FG005|Overall Study|Withdrawal by Subject|3|||
106180510|NCT01371981|366318436|FG000|Overall Study|Ineligible|19|||
106180511|NCT01371981|366318437|FG001|Overall Study|Ineligible|13|||
106180512|NCT01371981|366318438|FG002|Overall Study|Ineligible|0|||
106180513|NCT01371981|366318439|FG003|Overall Study|Ineligible|0|||
106180514|NCT01371981|366318440|FG004|Overall Study|Ineligible|0|||
106180515|NCT01371981|366318441|FG005|Overall Study|Ineligible|4|||
106180516|NCT01371981|366318436|FG000|Overall Study|Did not start treatment|2|||
106180517|NCT01371981|366318437|FG001|Overall Study|Did not start treatment|3|||
106180518|NCT01371981|366318438|FG002|Overall Study|Did not start treatment|0|||
106180519|NCT01371981|366318439|FG003|Overall Study|Did not start treatment|0|||
106180520|NCT01371981|366318440|FG004|Overall Study|Did not start treatment|0|||
106180521|NCT01371981|366318441|FG005|Overall Study|Did not start treatment|2|||
106180522|NCT00026312|366318442|FG000|Overall Study|Adverse Event|0|||
106180523|NCT00026312|366318443|FG001|Overall Study|Adverse Event|32|||
106180524|NCT00026312|366318442|FG000|Overall Study|Death|1|||
106180525|NCT00026312|366318443|FG001|Overall Study|Death|7|||
106180526|NCT00026312|366318442|FG000|Overall Study|Lack of Efficacy|19|||
106180527|NCT00026312|366318443|FG001|Overall Study|Lack of Efficacy|114|||
106180528|NCT00026312|366318442|FG000|Overall Study|Lost to Follow-up|0|||
106180529|NCT00026312|366318443|FG001|Overall Study|Lost to Follow-up|5|||
106180530|NCT00026312|366318442|FG000|Overall Study|Physician Decision|1|||
106180531|NCT00026312|366318443|FG001|Overall Study|Physician Decision|37|||
106180532|NCT00026312|366318442|FG000|Overall Study|Protocol Violation|0|||
106180533|NCT00026312|366318443|FG001|Overall Study|Protocol Violation|3|||
106180534|NCT00026312|366318442|FG000|Overall Study|Withdrawal by Subject|1|||
106180535|NCT00026312|366318443|FG001|Overall Study|Withdrawal by Subject|6|||
106180536|NCT00026312|366318442|FG000|Overall Study|Ineligible|4|||
106180537|NCT00026312|366318443|FG001|Overall Study|Ineligible|5|||
106180538|NCT00026312|366318442|FG000|Overall Study|Entry onto another COG study|0|||
106180539|NCT00026312|366318443|FG001|Overall Study|Entry onto another COG study|1|||
106180540|NCT00026312|366318442|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
106180541|NCT00026312|366318443|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
106180542|NCT02101853|366318444|FG000|Block 1 Induction|Adverse Event|11|||
106180543|NCT02101853|366318445|FG001|Block 1 Induction|Adverse Event|0|||
106180544|NCT02101853|366318446|FG002|Block 1 Induction|Adverse Event|0|||
106180545|NCT02101853|366318447|FG003|Block 1 Induction|Adverse Event|0|||
106180546|NCT02101853|366318448|FG004|Block 1 Induction|Adverse Event|0|||
106180547|NCT02101853|366318449|FG005|Block 1 Induction|Adverse Event|0|||
106180548|NCT02101853|366318444|FG000|Block 1 Induction|Death|20|||
106180549|NCT02101853|366318445|FG001|Block 1 Induction|Death|0|||
106180550|NCT02101853|366318446|FG002|Block 1 Induction|Death|0|||
106180551|NCT02101853|366318447|FG003|Block 1 Induction|Death|0|||
106180552|NCT02101853|366318448|FG004|Block 1 Induction|Death|0|||
106180553|NCT02101853|366318449|FG005|Block 1 Induction|Death|0|||
106180554|NCT02101853|366318444|FG000|Block 1 Induction|Lack of Efficacy|6|||
105867393|NCT01473407|365164956|FG001|Overall Study|Site Closure|0|||
106180555|NCT02101853|366318445|FG001|Block 1 Induction|Lack of Efficacy|0|||
106180556|NCT02101853|366318446|FG002|Block 1 Induction|Lack of Efficacy|0|||
106180557|NCT02101853|366318447|FG003|Block 1 Induction|Lack of Efficacy|0|||
106180558|NCT02101853|366318448|FG004|Block 1 Induction|Lack of Efficacy|0|||
106180559|NCT02101853|366318449|FG005|Block 1 Induction|Lack of Efficacy|0|||
106180560|NCT02101853|366318444|FG000|Block 1 Induction|Physician Decision|61|||
106180561|NCT02101853|366318445|FG001|Block 1 Induction|Physician Decision|0|||
105867394|NCT04071405|365164957|FG000|Overall Study|Protocol Violation|3|||
106180562|NCT02101853|366318446|FG002|Block 1 Induction|Physician Decision|0|||
106180563|NCT02101853|366318447|FG003|Block 1 Induction|Physician Decision|0|||
106180564|NCT02101853|366318448|FG004|Block 1 Induction|Physician Decision|0|||
106180565|NCT02101853|366318449|FG005|Block 1 Induction|Physician Decision|0|||
106180566|NCT02101853|366318444|FG000|Block 1 Induction|Protocol Violation|2|||
106180567|NCT02101853|366318445|FG001|Block 1 Induction|Protocol Violation|0|||
106180568|NCT02101853|366318446|FG002|Block 1 Induction|Protocol Violation|0|||
106180569|NCT02101853|366318447|FG003|Block 1 Induction|Protocol Violation|0|||
105867395|NCT00134901|365164958|FG000|Overall Study|Lost to Follow-up|5|||
106180570|NCT02101853|366318448|FG004|Block 1 Induction|Protocol Violation|0|||
106180571|NCT02101853|366318449|FG005|Block 1 Induction|Protocol Violation|0|||
106180572|NCT02101853|366318444|FG000|Block 1 Induction|Withdrawal by Subject|65|||
106180573|NCT02101853|366318445|FG001|Block 1 Induction|Withdrawal by Subject|0|||
106180574|NCT02101853|366318446|FG002|Block 1 Induction|Withdrawal by Subject|0|||
106180575|NCT02101853|366318447|FG003|Block 1 Induction|Withdrawal by Subject|0|||
106180576|NCT02101853|366318448|FG004|Block 1 Induction|Withdrawal by Subject|0|||
106180577|NCT02101853|366318449|FG005|Block 1 Induction|Withdrawal by Subject|0|||
106180578|NCT02101853|366318444|FG000|Block 1 Induction|Ineligible|8|||
106180579|NCT02101853|366318445|FG001|Block 1 Induction|Ineligible|0|||
106180580|NCT02101853|366318446|FG002|Block 1 Induction|Ineligible|0|||
106180581|NCT02101853|366318447|FG003|Block 1 Induction|Ineligible|0|||
106180582|NCT02101853|366318448|FG004|Block 1 Induction|Ineligible|0|||
106180583|NCT02101853|366318449|FG005|Block 1 Induction|Ineligible|0|||
106180584|NCT02101853|366318444|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
106180585|NCT02101853|366318445|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
106180586|NCT02101853|366318446|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
106180587|NCT02101853|366318447|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
106180588|NCT02101853|366318448|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
106180589|NCT02101853|366318449|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
106180590|NCT02101853|366318444|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
106180591|NCT02101853|366318445|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180592|NCT02101853|366318446|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180593|NCT02101853|366318447|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180594|NCT02101853|366318448|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180595|NCT02101853|366318449|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180596|NCT02101853|366318444|FG000|Post Induction Randomization|Adverse Event|0|||
106180597|NCT02101853|366318445|FG001|Post Induction Randomization|Adverse Event|3|||
106180598|NCT02101853|366318446|FG002|Post Induction Randomization|Adverse Event|8|||
106180599|NCT02101853|366318447|FG003|Post Induction Randomization|Adverse Event|4|||
106180600|NCT02101853|366318448|FG004|Post Induction Randomization|Adverse Event|4|||
106180601|NCT02101853|366318449|FG005|Post Induction Randomization|Adverse Event|0|||
106180602|NCT02101853|366318444|FG000|Post Induction Randomization|Death|0|||
106180603|NCT02101853|366318445|FG001|Post Induction Randomization|Death|9|||
106180604|NCT02101853|366318446|FG002|Post Induction Randomization|Death|2|||
106180605|NCT02101853|366318447|FG003|Post Induction Randomization|Death|2|||
106180606|NCT02101853|366318448|FG004|Post Induction Randomization|Death|0|||
106180607|NCT02101853|366318449|FG005|Post Induction Randomization|Death|0|||
106180608|NCT02101853|366318444|FG000|Post Induction Randomization|Lack of Efficacy|0|||
106180609|NCT02101853|366318445|FG001|Post Induction Randomization|Lack of Efficacy|14|||
106180610|NCT02101853|366318446|FG002|Post Induction Randomization|Lack of Efficacy|23|||
106180611|NCT02101853|366318447|FG003|Post Induction Randomization|Lack of Efficacy|18|||
106180612|NCT02101853|366318448|FG004|Post Induction Randomization|Lack of Efficacy|21|||
106180613|NCT02101853|366318449|FG005|Post Induction Randomization|Lack of Efficacy|0|||
106180614|NCT02101853|366318444|FG000|Post Induction Randomization|Physician Decision|0|||
106180615|NCT02101853|366318445|FG001|Post Induction Randomization|Physician Decision|43|||
106180616|NCT02101853|366318446|FG002|Post Induction Randomization|Physician Decision|23|||
106180617|NCT02101853|366318447|FG003|Post Induction Randomization|Physician Decision|14|||
106180618|NCT02101853|366318448|FG004|Post Induction Randomization|Physician Decision|14|||
106180619|NCT02101853|366318449|FG005|Post Induction Randomization|Physician Decision|0|||
106180620|NCT02101853|366318444|FG000|Post Induction Randomization|Protocol Violation|0|||
106180621|NCT02101853|366318445|FG001|Post Induction Randomization|Protocol Violation|3|||
106180622|NCT02101853|366318446|FG002|Post Induction Randomization|Protocol Violation|0|||
106180623|NCT02101853|366318447|FG003|Post Induction Randomization|Protocol Violation|0|||
106180624|NCT02101853|366318448|FG004|Post Induction Randomization|Protocol Violation|0|||
106180625|NCT02101853|366318449|FG005|Post Induction Randomization|Protocol Violation|0|||
106180626|NCT02101853|366318444|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
106180627|NCT02101853|366318445|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
106180628|NCT02101853|366318446|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
106180629|NCT02101853|366318447|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
106180630|NCT02101853|366318448|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
106180631|NCT02101853|366318449|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
106180632|NCT02101853|366318444|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180633|NCT02101853|366318445|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180634|NCT02101853|366318446|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180635|NCT02101853|366318447|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
106180636|NCT02101853|366318448|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180637|NCT02101853|366318449|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
106180638|NCT02101853|366318444|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
106180639|NCT02101853|366318445|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
106180640|NCT02101853|366318446|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
106180641|NCT02101853|366318447|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
106180642|NCT02101853|366318448|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
106180643|NCT02101853|366318449|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
106180644|NCT02101853|366318444|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
106180645|NCT02101853|366318445|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
106180646|NCT02101853|366318446|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
106180647|NCT02101853|366318447|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
106180648|NCT02101853|366318448|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
106180649|NCT02101853|366318449|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
106180650|NCT02101853|366318444|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
106180651|NCT02101853|366318445|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
106180652|NCT02101853|366318446|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
106180653|NCT02101853|366318447|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
106180654|NCT02101853|366318448|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
106180655|NCT02101853|366318449|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
106180656|NCT02101853|366318444|FG000|Blinatumomab Salvage Therapy|Death|0|||
106180657|NCT02101853|366318445|FG001|Blinatumomab Salvage Therapy|Death|0|||
106180658|NCT02101853|366318446|FG002|Blinatumomab Salvage Therapy|Death|0|||
106180659|NCT02101853|366318447|FG003|Blinatumomab Salvage Therapy|Death|0|||
106180660|NCT02101853|366318448|FG004|Blinatumomab Salvage Therapy|Death|0|||
106180661|NCT02101853|366318449|FG005|Blinatumomab Salvage Therapy|Death|2|||
106180662|NCT02101853|366318444|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
106180663|NCT02101853|366318445|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
106180664|NCT02101853|366318446|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
106180665|NCT02101853|366318447|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
106180666|NCT02101853|366318448|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
106180667|NCT02101853|366318449|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
106180668|NCT02101853|366318444|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
106180669|NCT02101853|366318445|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
106180670|NCT02101853|366318446|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
106180671|NCT02101853|366318447|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
106180672|NCT02101853|366318448|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
106180673|NCT02101853|366318449|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
106180674|NCT02101853|366318444|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
106180675|NCT02101853|366318445|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
106180676|NCT02101853|366318446|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
106180677|NCT02101853|366318447|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
106180678|NCT02101853|366318448|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
106180679|NCT02101853|366318449|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
106180680|NCT02112916|366318450|FG000|Overall Study|Adverse Event|6|||
106180681|NCT02112916|366318451|FG001|Overall Study|Adverse Event|9|||
106180682|NCT02112916|366318452|FG002|Overall Study|Adverse Event|3|||
106180683|NCT02112916|366318453|FG003|Overall Study|Adverse Event|2|||
106180684|NCT02112916|366318450|FG000|Overall Study|Death|9|||
106180685|NCT02112916|366318451|FG001|Overall Study|Death|9|||
106180686|NCT02112916|366318452|FG002|Overall Study|Death|3|||
106180687|NCT02112916|366318453|FG003|Overall Study|Death|4|||
106180688|NCT02112916|366318450|FG000|Overall Study|Lost to Follow-up|1|||
106180689|NCT02112916|366318451|FG001|Overall Study|Lost to Follow-up|0|||
106180690|NCT02112916|366318452|FG002|Overall Study|Lost to Follow-up|0|||
106180691|NCT02112916|366318453|FG003|Overall Study|Lost to Follow-up|0|||
106180692|NCT02112916|366318450|FG000|Overall Study|Physician Decision|94|||
106180693|NCT02112916|366318451|FG001|Overall Study|Physician Decision|72|||
106180694|NCT02112916|366318452|FG002|Overall Study|Physician Decision|24|||
106180695|NCT02112916|366318453|FG003|Overall Study|Physician Decision|15|||
106180696|NCT02112916|366318450|FG000|Overall Study|Withdrawal by Subject|5|||
106180697|NCT02112916|366318451|FG001|Overall Study|Withdrawal by Subject|3|||
106180698|NCT02112916|366318452|FG002|Overall Study|Withdrawal by Subject|1|||
106180699|NCT02112916|366318453|FG003|Overall Study|Withdrawal by Subject|1|||
106180700|NCT02112916|366318450|FG000|Overall Study|Ineligible|4|||
106180701|NCT02112916|366318451|FG001|Overall Study|Ineligible|8|||
106180702|NCT02112916|366318452|FG002|Overall Study|Ineligible|3|||
106180703|NCT02112916|366318453|FG003|Overall Study|Ineligible|8|||
106180704|NCT02112916|366318450|FG000|Overall Study|Inevaluable|6|||
106180705|NCT02112916|366318451|FG001|Overall Study|Inevaluable|4|||
106180706|NCT02112916|366318452|FG002|Overall Study|Inevaluable|5|||
106180707|NCT02112916|366318453|FG003|Overall Study|Inevaluable|5|||
106180708|NCT02112916|366318450|FG000|Overall Study|Refusal of further protocol therapy|19|||
106180709|NCT02112916|366318451|FG001|Overall Study|Refusal of further protocol therapy|16|||
106180710|NCT02112916|366318452|FG002|Overall Study|Refusal of further protocol therapy|1|||
106180711|NCT02112916|366318453|FG003|Overall Study|Refusal of further protocol therapy|7|||
106180712|NCT02112916|366318450|FG000|Overall Study|Development of SMN|1|||
106180713|NCT02112916|366318451|FG001|Overall Study|Development of SMN|0|||
106180714|NCT02112916|366318452|FG002|Overall Study|Development of SMN|0|||
106180715|NCT02112916|366318453|FG003|Overall Study|Development of SMN|1|||
106180716|NCT02112916|366318450|FG000|Overall Study|Relapse/Progression|10|||
106180717|NCT02112916|366318451|FG001|Overall Study|Relapse/Progression|18|||
106180718|NCT02112916|366318452|FG002|Overall Study|Relapse/Progression|15|||
106180719|NCT02112916|366318453|FG003|Overall Study|Relapse/Progression|2|||
106180720|NCT02112916|366318450|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
106180721|NCT02112916|366318451|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
106180722|NCT02112916|366318452|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
106180723|NCT02112916|366318453|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
106180724|NCT02112916|366318450|FG000|Overall Study|Still on Therapy|44|||
106180725|NCT02112916|366318451|FG001|Overall Study|Still on Therapy|47|||
106180726|NCT02112916|366318452|FG002|Overall Study|Still on Therapy|3|||
106180727|NCT02112916|366318453|FG003|Overall Study|Still on Therapy|2|||
106180728|NCT02112916|366318450|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
106180729|NCT02112916|366318451|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
106180730|NCT02112916|366318452|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
106180731|NCT02112916|366318453|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
106180732|NCT02112916|366318450|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
106180733|NCT02112916|366318451|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
106180734|NCT02112916|366318452|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
106180735|NCT02112916|366318453|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
106180736|NCT05067452|366318454|FG000|Overall Study|Lost to Follow-up|0|||
106180737|NCT05067452|366318455|FG001|Overall Study|Lost to Follow-up|4|||
106180738|NCT01638546|366318466|FG000|Overall Study|Adverse Event|1|||
106180739|NCT01638546|366318467|FG001|Overall Study|Adverse Event|3|||
106180740|NCT05724589|366319328|FG000|Overall Study|Lost to Follow-up|1|||
106180741|NCT01949662|366319333|FG000|Overall Study|Death|9|||
106180742|NCT01949662|366319334|FG001|Overall Study|Death|7|||
106180743|NCT01949662|366319333|FG000|Overall Study|Discharged before an agitation event|8|||
106180744|NCT01949662|366319334|FG001|Overall Study|Discharged before an agitation event|3|||
106180745|NCT01949662|366319333|FG000|Overall Study|Dropped out|1|||
106180746|NCT01949662|366319334|FG001|Overall Study|Dropped out|3|||
106180747|NCT01949662|366319333|FG000|Overall Study|Ineligible|0|||
106180748|NCT01949662|366319334|FG001|Overall Study|Ineligible|1|||
106180749|NCT05147662|366319339|FG000|Overall Study|Withdrawal by parent/guardian|3|||
106180750|NCT05147662|366319339|FG000|Overall Study|Assigned to treatment but never treated|1|||
106180751|NCT03779906|366319346|FG000|Overall Study|Lost to Follow-up|7|||
106180752|NCT03779906|366319346|FG000|Overall Study|COVID pandemic|1|||
106180753|NCT03907488|366319347|FG000|Overall Study|Adverse Event|20|||
106180754|NCT03907488|366319348|FG001|Overall Study|Adverse Event|20|||
106180755|NCT03907488|366319347|FG000|Overall Study|Withdrawal by Subject|9|||
106180756|NCT03907488|366319348|FG001|Overall Study|Withdrawal by Subject|13|||
106180757|NCT03907488|366319347|FG000|Overall Study|Lack of Efficacy|0|||
106180758|NCT03907488|366319348|FG001|Overall Study|Lack of Efficacy|9|||
106180759|NCT03907488|366319347|FG000|Overall Study|Death|3|||
106180760|NCT03907488|366319348|FG001|Overall Study|Death|8|||
106180761|NCT03907488|366319347|FG000|Overall Study|not protocol specified|5|||
106180762|NCT03907488|366319348|FG001|Overall Study|not protocol specified|8|||
106180763|NCT03907488|366319347|FG000|Overall Study|Ineligible|9|||
106180764|NCT03907488|366319348|FG001|Overall Study|Ineligible|15|||
106180765|NCT03307629|366319349|FG000|Overall Study|Withdrawal by Subject|0|||
106180766|NCT03307629|366319350|FG001|Overall Study|Withdrawal by Subject|0|||
106180767|NCT03307629|366319351|FG002|Overall Study|Withdrawal by Subject|0|||
106180768|NCT03307629|366319352|FG003|Overall Study|Withdrawal by Subject|2|||
106180769|NCT03307629|366319349|FG000|Overall Study|Disease Progression|0|||
106180770|NCT03307629|366319350|FG001|Overall Study|Disease Progression|0|||
106180771|NCT03307629|366319351|FG002|Overall Study|Disease Progression|0|||
106180772|NCT03307629|366319352|FG003|Overall Study|Disease Progression|3|||
106180773|NCT03307629|366319349|FG000|Overall Study|Death|0|||
106180774|NCT03307629|366319350|FG001|Overall Study|Death|3|||
106180775|NCT03307629|366319351|FG002|Overall Study|Death|0|||
106180776|NCT03307629|366319352|FG003|Overall Study|Death|1|||
106180777|NCT03444376|366319353|FG000|Part A|Disease relapse or Progression|1|||
106180778|NCT03444376|366319353|FG000|Part A|Withdrawal by Subject|2|||
106180779|NCT03444376|366319353|FG000|Part A|Adverse Event|1|||
106180780|NCT03444376|366319353|FG000|Part B|Disease relapse or Progression|18|||
106180781|NCT03444376|366319353|FG000|Part B|Withdrawal by Subject|2|||
106180782|NCT03444376|366319353|FG000|Part B|Adverse Event|2|||
106180783|NCT03444376|366319353|FG000|Part B|Physician Decision|1|||
106180784|NCT03444376|366319353|FG000|Part C|Disease relapse or Progression|43|||
106180785|NCT03444376|366319353|FG000|Part C|Withdrawal by Subject|5|||
106180786|NCT03444376|366319353|FG000|Part C|Adverse Event|2|||
106180787|NCT03444376|366319353|FG000|Part C|Physician Decision|2|||
106180788|NCT03444376|366319353|FG000|Part C|Death|1|||
106180789|NCT00977574|366319354|FG000|Overall Study|Never Treated|4|||
106180790|NCT00977574|366319355|FG001|Overall Study|Never Treated|2|||
106180791|NCT00977574|366319356|FG002|Overall Study|Never Treated|4|||
106180792|NCT03326193|366319357|FG000|Overall Study|Sponsor decision|35|||
106180793|NCT02553460|366319358|FG000|Overall Study|Death|3|||
106180794|NCT02553460|366319358|FG000|Overall Study|Withdrawal by Subject|1|||
106180795|NCT02553460|366319358|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
106180796|NCT02553460|366319358|FG000|Overall Study|Relapse or Transplant|14|||
106180797|NCT02553460|366319358|FG000|Overall Study|No response to treatment|2|||
106180798|NCT02553460|366319358|FG000|Overall Study|CAR T cells|2|||
106180799|NCT02839707|366319359|FG000|Phase I|Not eligible for analysis|9|||
106180800|NCT02839707|366319360|FG001|Phase I|Not eligible for analysis|0|||
106180801|NCT02839707|366319361|FG002|Phase I|Not eligible for analysis|0|||
106180802|NCT02839707|366319359|FG000|Phase II|Not treated according to protocol|4|||
106180803|NCT02839707|366319360|FG001|Phase II|Not treated according to protocol|0|||
106180804|NCT02839707|366319361|FG002|Phase II|Not treated according to protocol|2|||
106180805|NCT02839707|366319359|FG000|Phase III|Not treated according to protocol|0|||
106180806|NCT02839707|366319360|FG001|Phase III|Not treated according to protocol|0|||
106180807|NCT02839707|366319361|FG002|Phase III|Not treated according to protocol|4|||
106180808|NCT02890355|366319362|FG000|Overall Study|Adverse Event|5|||
106180809|NCT02890355|366319363|FG001|Overall Study|Adverse Event|5|||
106180810|NCT02890355|366319362|FG000|Overall Study|Refusal unrelated to adverse event|5|||
106180811|NCT02890355|366319363|FG001|Overall Study|Refusal unrelated to adverse event|10|||
106180812|NCT02890355|366319362|FG000|Overall Study|Progression/relapse|46|||
106180813|NCT02890355|366319363|FG001|Overall Study|Progression/relapse|39|||
106180814|NCT02890355|366319362|FG000|Overall Study|Not protocol specified|3|||
106180815|NCT02890355|366319363|FG001|Overall Study|Not protocol specified|4|||
106180816|NCT03862131|366319368|FG000|Overall Study|Lost to Follow-up|1|||
106180817|NCT03862131|366319369|FG001|Overall Study|Lost to Follow-up|0|||
106180818|NCT03862131|366319370|FG002|Overall Study|Lost to Follow-up|1|||
106180819|NCT03862131|366319368|FG000|Overall Study|Determined to be ineligible|0|||
106180820|NCT03862131|366319369|FG001|Overall Study|Determined to be ineligible|0|||
106180821|NCT03862131|366319370|FG002|Overall Study|Determined to be ineligible|5|||
106180822|NCT03862131|366319368|FG000|Overall Study|Death|4|||
106180823|NCT03862131|366319369|FG001|Overall Study|Death|4|||
106180824|NCT03862131|366319370|FG002|Overall Study|Death|0|||
106180825|NCT03862131|366319368|FG000|Overall Study|Withdrawal by Subject|5|||
106180826|NCT03862131|366319369|FG001|Overall Study|Withdrawal by Subject|3|||
106180827|NCT03862131|366319370|FG002|Overall Study|Withdrawal by Subject|0|||
106180828|NCT03862131|366319368|FG000|Overall Study|Physician Decision|0|||
106180829|NCT03862131|366319369|FG001|Overall Study|Physician Decision|1|||
106180830|NCT03862131|366319370|FG002|Overall Study|Physician Decision|0|||
106180831|NCT04814368|366319371|FG000|Overall Study|Study Terminated by Sponsor|0|||
106180832|NCT04814368|366319372|FG001|Overall Study|Study Terminated by Sponsor|3|||
106180833|NCT04814368|366319373|FG002|Overall Study|Study Terminated by Sponsor|0|||
106180834|NCT04814368|366319374|FG003|Overall Study|Study Terminated by Sponsor|2|||
106180835|NCT04814368|366319371|FG000|Overall Study|Subject Decision|1|||
106180836|NCT04814368|366319372|FG001|Overall Study|Subject Decision|2|||
106180837|NCT04814368|366319373|FG002|Overall Study|Subject Decision|0|||
106180838|NCT04814368|366319374|FG003|Overall Study|Subject Decision|0|||
106180839|NCT00980460|366319673|FG000|Overall Study|Death|0|||
106180840|NCT00980460|366319674|FG001|Overall Study|Death|0|||
106180841|NCT00980460|366319675|FG002|Overall Study|Death|1|||
106180842|NCT00980460|366319676|FG003|Overall Study|Death|2|||
106180843|NCT00980460|366319677|FG004|Overall Study|Death|1|||
106180844|NCT00980460|366319673|FG000|Overall Study|Lack of Efficacy|0|||
106180845|NCT00980460|366319674|FG001|Overall Study|Lack of Efficacy|0|||
106180846|NCT00980460|366319675|FG002|Overall Study|Lack of Efficacy|10|||
106180847|NCT00980460|366319676|FG003|Overall Study|Lack of Efficacy|6|||
106180848|NCT00980460|366319677|FG004|Overall Study|Lack of Efficacy|8|||
106180849|NCT00980460|366319673|FG000|Overall Study|Lost to Follow-up|0|||
106180850|NCT00980460|366319674|FG001|Overall Study|Lost to Follow-up|0|||
106180851|NCT00980460|366319675|FG002|Overall Study|Lost to Follow-up|0|||
106180852|NCT00980460|366319676|FG003|Overall Study|Lost to Follow-up|1|||
106180853|NCT00980460|366319677|FG004|Overall Study|Lost to Follow-up|0|||
106180854|NCT00980460|366319673|FG000|Overall Study|Physician Decision|0|||
106180855|NCT00980460|366319674|FG001|Overall Study|Physician Decision|0|||
106180856|NCT00980460|366319675|FG002|Overall Study|Physician Decision|11|||
106180857|NCT00980460|366319676|FG003|Overall Study|Physician Decision|5|||
106180858|NCT00980460|366319677|FG004|Overall Study|Physician Decision|3|||
106180859|NCT00980460|366319673|FG000|Overall Study|Withdrawal by Subject|0|||
106180860|NCT00980460|366319674|FG001|Overall Study|Withdrawal by Subject|0|||
106180861|NCT00980460|366319675|FG002|Overall Study|Withdrawal by Subject|1|||
106180862|NCT00980460|366319676|FG003|Overall Study|Withdrawal by Subject|0|||
106180863|NCT00980460|366319677|FG004|Overall Study|Withdrawal by Subject|0|||
106180864|NCT00980460|366319673|FG000|Overall Study|Ineligible|0|||
106180865|NCT00980460|366319674|FG001|Overall Study|Ineligible|2|||
106180866|NCT00980460|366319675|FG002|Overall Study|Ineligible|3|||
106180867|NCT00980460|366319676|FG003|Overall Study|Ineligible|1|||
106180868|NCT00980460|366319677|FG004|Overall Study|Ineligible|4|||
106180869|NCT00980460|366319673|FG000|Overall Study|Refusal of further therapy|0|||
106180870|NCT00980460|366319674|FG001|Overall Study|Refusal of further therapy|2|||
106180871|NCT00980460|366319675|FG002|Overall Study|Refusal of further therapy|3|||
106180872|NCT00980460|366319676|FG003|Overall Study|Refusal of further therapy|2|||
106180873|NCT00980460|366319677|FG004|Overall Study|Refusal of further therapy|0|||
106180874|NCT00980460|366319673|FG000|Overall Study|No therapy within 42 days of resection|0|||
106180875|NCT00980460|366319674|FG001|Overall Study|No therapy within 42 days of resection|0|||
106180876|NCT00980460|366319675|FG002|Overall Study|No therapy within 42 days of resection|3|||
106180877|NCT00980460|366319676|FG003|Overall Study|No therapy within 42 days of resection|1|||
106180878|NCT00980460|366319677|FG004|Overall Study|No therapy within 42 days of resection|0|||
106180879|NCT00980460|366319673|FG000|Overall Study|No transplant by protocol timepoints|0|||
106180880|NCT00980460|366319674|FG001|Overall Study|No transplant by protocol timepoints|0|||
106180881|NCT00980460|366319675|FG002|Overall Study|No transplant by protocol timepoints|3|||
106180882|NCT00980460|366319676|FG003|Overall Study|No transplant by protocol timepoints|0|||
106180883|NCT00980460|366319677|FG004|Overall Study|No transplant by protocol timepoints|0|||
106180884|NCT01950390|366319682|FG000|Overall Study|Never started treatment|3|||
106180885|NCT01950390|366319683|FG001|Overall Study|Never started treatment|2|||
106180886|NCT01950390|366319682|FG000|Overall Study|Disease progression|45|||
106180887|NCT01950390|366319683|FG001|Overall Study|Disease progression|52|||
106180888|NCT01950390|366319682|FG000|Overall Study|Adverse Event|22|||
106180889|NCT01950390|366319683|FG001|Overall Study|Adverse Event|16|||
106180890|NCT01950390|366319682|FG000|Overall Study|Death|5|||
106180891|NCT01950390|366319683|FG001|Overall Study|Death|3|||
106180892|NCT01950390|366319682|FG000|Overall Study|Withdrawal by Subject|5|||
106180893|NCT01950390|366319683|FG001|Overall Study|Withdrawal by Subject|1|||
106180894|NCT01950390|366319682|FG000|Overall Study|Alternative therapy|0|||
106180895|NCT01950390|366319683|FG001|Overall Study|Alternative therapy|3|||
106180896|NCT01950390|366319682|FG000|Overall Study|Complicating disease|1|||
106180897|NCT01950390|366319683|FG001|Overall Study|Complicating disease|0|||
106180898|NCT01950390|366319682|FG000|Overall Study|On treatment|1|||
106180899|NCT01950390|366319683|FG001|Overall Study|On treatment|0|||
106180900|NCT01950390|366319682|FG000|Overall Study|Symptomatic deterioration|2|||
106180901|NCT01950390|366319683|FG001|Overall Study|Symptomatic deterioration|1|||
106180902|NCT01950390|366319682|FG000|Overall Study|Physician Decision|0|||
106180903|NCT01950390|366319683|FG001|Overall Study|Physician Decision|4|||
106180904|NCT01950390|366319682|FG000|Overall Study|Lack of clinical benefit|0|||
106180905|NCT01950390|366319683|FG001|Overall Study|Lack of clinical benefit|1|||
106180906|NCT01950390|366319682|FG000|Overall Study|Maintained PR and moved to observation only|0|||
106180907|NCT01950390|366319683|FG001|Overall Study|Maintained PR and moved to observation only|1|||
106180908|NCT02180867|366319686|FG000|Overall Study|Adverse Event|3|||
106180909|NCT02180867|366319687|FG001|Overall Study|Adverse Event|4|||
106180910|NCT02180867|366319688|FG002|Overall Study|Adverse Event|1|||
106180911|NCT02180867|366319689|FG003|Overall Study|Adverse Event|5|||
106180912|NCT02180867|366319690|FG004|Overall Study|Adverse Event|0|||
106180913|NCT02180867|366319691|FG005|Overall Study|Adverse Event|0|||
106180914|NCT02180867|366319692|FG006|Overall Study|Adverse Event|0|||
106180915|NCT02180867|366319686|FG000|Overall Study|Death|0|||
106180916|NCT02180867|366319687|FG001|Overall Study|Death|0|||
106180917|NCT02180867|366319688|FG002|Overall Study|Death|0|||
106180918|NCT02180867|366319689|FG003|Overall Study|Death|0|||
106180919|NCT02180867|366319690|FG004|Overall Study|Death|1|||
106180920|NCT02180867|366319691|FG005|Overall Study|Death|0|||
106180921|NCT02180867|366319692|FG006|Overall Study|Death|0|||
106180922|NCT02180867|366319686|FG000|Overall Study|Lack of Efficacy|0|||
106180923|NCT02180867|366319687|FG001|Overall Study|Lack of Efficacy|2|||
106180924|NCT02180867|366319688|FG002|Overall Study|Lack of Efficacy|0|||
106180925|NCT02180867|366319689|FG003|Overall Study|Lack of Efficacy|1|||
106180926|NCT02180867|366319690|FG004|Overall Study|Lack of Efficacy|6|||
106180927|NCT02180867|366319691|FG005|Overall Study|Lack of Efficacy|0|||
106180928|NCT02180867|366319692|FG006|Overall Study|Lack of Efficacy|1|||
106180929|NCT02180867|366319686|FG000|Overall Study|Physician Decision|1|||
106180930|NCT02180867|366319687|FG001|Overall Study|Physician Decision|3|||
106180931|NCT02180867|366319688|FG002|Overall Study|Physician Decision|1|||
106180932|NCT02180867|366319689|FG003|Overall Study|Physician Decision|10|||
106180933|NCT02180867|366319690|FG004|Overall Study|Physician Decision|9|||
106180934|NCT02180867|366319691|FG005|Overall Study|Physician Decision|3|||
106180935|NCT02180867|366319692|FG006|Overall Study|Physician Decision|4|||
106180936|NCT02180867|366319686|FG000|Overall Study|Withdrawal by Subject|0|||
106180937|NCT02180867|366319687|FG001|Overall Study|Withdrawal by Subject|0|||
106180938|NCT02180867|366319688|FG002|Overall Study|Withdrawal by Subject|0|||
106180939|NCT02180867|366319689|FG003|Overall Study|Withdrawal by Subject|1|||
106180940|NCT02180867|366319690|FG004|Overall Study|Withdrawal by Subject|1|||
106180941|NCT02180867|366319691|FG005|Overall Study|Withdrawal by Subject|0|||
106180942|NCT02180867|366319692|FG006|Overall Study|Withdrawal by Subject|0|||
106180943|NCT02180867|366319686|FG000|Overall Study|Ineligible|1|||
106180944|NCT02180867|366319687|FG001|Overall Study|Ineligible|2|||
106180945|NCT02180867|366319688|FG002|Overall Study|Ineligible|0|||
106180946|NCT02180867|366319689|FG003|Overall Study|Ineligible|3|||
106180947|NCT02180867|366319690|FG004|Overall Study|Ineligible|5|||
106180948|NCT02180867|366319691|FG005|Overall Study|Ineligible|0|||
106180949|NCT02180867|366319692|FG006|Overall Study|Ineligible|0|||
106180950|NCT02180867|366319686|FG000|Overall Study|Repeat Eligibility Studies|0|||
106180951|NCT02180867|366319687|FG001|Overall Study|Repeat Eligibility Studies|0|||
106180952|NCT02180867|366319688|FG002|Overall Study|Repeat Eligibility Studies|0|||
106180953|NCT02180867|366319689|FG003|Overall Study|Repeat Eligibility Studies|0|||
106180954|NCT02180867|366319690|FG004|Overall Study|Repeat Eligibility Studies|1|||
106180955|NCT02180867|366319691|FG005|Overall Study|Repeat Eligibility Studies|0|||
106180956|NCT02180867|366319692|FG006|Overall Study|Repeat Eligibility Studies|0|||
106180957|NCT02180867|366319686|FG000|Overall Study|Refusal of further protocol therapy|1|||
106180958|NCT02180867|366319687|FG001|Overall Study|Refusal of further protocol therapy|0|||
106180959|NCT02180867|366319688|FG002|Overall Study|Refusal of further protocol therapy|2|||
106180960|NCT02180867|366319689|FG003|Overall Study|Refusal of further protocol therapy|6|||
106180961|NCT02180867|366319690|FG004|Overall Study|Refusal of further protocol therapy|4|||
106180962|NCT02180867|366319691|FG005|Overall Study|Refusal of further protocol therapy|0|||
106180963|NCT02180867|366319692|FG006|Overall Study|Refusal of further protocol therapy|0|||
106180964|NCT01251861|366319693|FG000|Overall Study|Disease progression|6|||
106180965|NCT01251861|366319694|FG001|Overall Study|Disease progression|6|||
106180966|NCT01251861|366319693|FG000|Overall Study|Adverse Event|2|||
106180967|NCT01251861|366319694|FG001|Overall Study|Adverse Event|17|||
106180968|NCT01251861|366319693|FG000|Overall Study|Withdrawal by Subject|2|||
106180969|NCT01251861|366319694|FG001|Overall Study|Withdrawal by Subject|2|||
106180970|NCT01251861|366319693|FG000|Overall Study|Alternative therapy|1|||
106180971|NCT01251861|366319694|FG001|Overall Study|Alternative therapy|0|||
106180972|NCT01251861|366319693|FG000|Overall Study|Other complicating disease|0|||
106180973|NCT01251861|366319694|FG001|Overall Study|Other complicating disease|1|||
106180974|NCT01251861|366319693|FG000|Overall Study|Physician Decision|1|||
106180975|NCT01251861|366319694|FG001|Overall Study|Physician Decision|0|||
106180976|NCT01251861|366319693|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
106180977|NCT01251861|366319694|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
106180978|NCT01251861|366319693|FG000|Overall Study|Other|1|||
106180979|NCT01251861|366319694|FG001|Overall Study|Other|0|||
106180980|NCT01251861|366319693|FG000|Overall Study|Never started therapy|4|||
106180981|NCT01251861|366319694|FG001|Overall Study|Never started therapy|1|||
106180982|NCT01251861|366319693|FG000|Overall Study|Potential interaction of drugs|0|||
106180983|NCT01251861|366319694|FG001|Overall Study|Potential interaction of drugs|1|||
106180984|NCT05222555|366319695|FG000|Overall Study|Ongoing|2|||
106180985|NCT05222555|366319696|FG001|Overall Study|Ongoing|18|||
106180986|NCT05222555|366319695|FG000|Overall Study|Adverse Event|1|||
106180987|NCT05222555|366319696|FG001|Overall Study|Adverse Event|1|||
106180988|NCT05222555|366319695|FG000|Overall Study|Death|0|||
106180989|NCT05222555|366319696|FG001|Overall Study|Death|6|||
106180990|NCT05222555|366319695|FG000|Overall Study|Withdrawal by Subject|0|||
106180991|NCT05222555|366319696|FG001|Overall Study|Withdrawal by Subject|11|||
106180992|NCT03581292|366319697|FG000|Overall Study|Physician Decision|9|||
106180993|NCT03581292|366319698|FG001|Overall Study|Physician Decision|5|||
106180994|NCT03581292|366319697|FG000|Overall Study|Withdrawal by Subject|3|||
106180995|NCT03581292|366319698|FG001|Overall Study|Withdrawal by Subject|0|||
106180996|NCT03581292|366319697|FG000|Overall Study|Withdrawal before Therapy Start|1|||
106180997|NCT03581292|366319698|FG001|Overall Study|Withdrawal before Therapy Start|0|||
106180998|NCT04284774|366319699|FG000|Overall Study|Progressive disease|5|||
106180999|NCT03578887|366319700|FG000|Overall Study|Withdrawal by Subject|7|||
106181000|NCT03578887|366319701|FG001|Overall Study|Withdrawal by Subject|2|||
106181001|NCT03578887|366319702|FG002|Overall Study|Withdrawal by Subject|1|||
106181002|NCT03578887|366319700|FG000|Overall Study|Lost to Follow-up|13|||
106181003|NCT03578887|366319701|FG001|Overall Study|Lost to Follow-up|1|||
106181004|NCT03578887|366319702|FG002|Overall Study|Lost to Follow-up|4|||
106181005|NCT03578887|366319700|FG000|Overall Study|Physician Decision|0|||
106181006|NCT03578887|366319701|FG001|Overall Study|Physician Decision|1|||
106181007|NCT03578887|366319702|FG002|Overall Study|Physician Decision|1|||
106181008|NCT04922554|366319704|FG000|Overall Study|Adverse Event|4|||
106181009|NCT04922554|366319705|FG001|Overall Study|Adverse Event|0|||
106181010|NCT04922554|366319704|FG000|Overall Study|Withdrawal by Subject|1|||
106181011|NCT04922554|366319705|FG001|Overall Study|Withdrawal by Subject|0|||
105867396|NCT00134901|365164959|FG001|Overall Study|Lost to Follow-up|5|||
105867397|NCT00134901|365164958|FG000|Overall Study|discontinued intervention|12|||
105867398|NCT00134901|365164959|FG001|Overall Study|discontinued intervention|10|||
105867399|NCT00369941|365164962|FG000|Overall Study|Never Treated|1|||
105867400|NCT00369941|365164963|FG001|Overall Study|Never Treated|2|||
105867401|NCT00369941|365164962|FG000|Overall Study|Adverse Event|14|||
105867402|NCT00369941|365164963|FG001|Overall Study|Adverse Event|28|||
105867403|NCT00369941|365164962|FG000|Overall Study|Lack of Efficacy|6|||
105867404|NCT00369941|365164963|FG001|Overall Study|Lack of Efficacy|10|||
105867405|NCT00369941|365164962|FG000|Overall Study|Lost to Follow-up|12|||
105867406|NCT00369941|365164963|FG001|Overall Study|Lost to Follow-up|22|||
105867407|NCT00369941|365164962|FG000|Overall Study|Protocol Violation|5|||
105867408|NCT00369941|365164963|FG001|Overall Study|Protocol Violation|3|||
105867409|NCT00369941|365164962|FG000|Overall Study|Withdrawal by Subject|5|||
105867410|NCT00369941|365164963|FG001|Overall Study|Withdrawal by Subject|18|||
105867411|NCT00369941|365164962|FG000|Overall Study|Pregnancy|4|||
105867412|NCT00369941|365164963|FG001|Overall Study|Pregnancy|2|||
105867413|NCT00369941|365164962|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
105867414|NCT00369941|365164963|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
105867415|NCT00369941|365164962|FG000|Overall Study|Moved|11|||
105867416|NCT00369941|365164963|FG001|Overall Study|Moved|5|||
105867417|NCT00369941|365164962|FG000|Overall Study|Treatment with Prohibited Medication|3|||
105867418|NCT00369941|365164963|FG001|Overall Study|Treatment with Prohibited Medication|1|||
105867419|NCT00369941|365164962|FG000|Overall Study|Employment Interfered with Study Visits|1|||
105867420|NCT00369941|365164963|FG001|Overall Study|Employment Interfered with Study Visits|0|||
105867421|NCT00369941|365164962|FG000|Overall Study|Study Site Terminated|2|||
105867422|NCT00369941|365164963|FG001|Overall Study|Study Site Terminated|0|||
105867423|NCT00369941|365164962|FG000|Overall Study|Miscellaneous|3|||
105867424|NCT00369941|365164963|FG001|Overall Study|Miscellaneous|3|||
105867425|NCT01027702|365164964|FG000|Overall Study|Received subsequent therapy|1|||
105867426|NCT01027702|365164965|FG001|Overall Study|Received subsequent therapy|2|||
105867427|NCT01027702|365164966|FG002|Overall Study|Received subsequent therapy|0|||
105867428|NCT01027702|365164967|FG003|Overall Study|Received subsequent therapy|4|||
105867429|NCT01027702|365164968|FG004|Overall Study|Received subsequent therapy|1|||
105867430|NCT01027702|365164969|FG005|Overall Study|Received subsequent therapy|0|||
106096827|NCT00355082|366011669|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
106096828|NCT00355082|366011667|FG000|Continuation Phase|Adverse Event|2|||
106096829|NCT00355082|366011668|FG001|Continuation Phase|Adverse Event|0|||
106096830|NCT00355082|366011669|FG002|Continuation Phase|Adverse Event|1|||
106096831|NCT00355082|366011667|FG000|Continuation Phase|Lost to Follow-up|2|||
106096832|NCT00355082|366011668|FG001|Continuation Phase|Lost to Follow-up|0|||
106096833|NCT00355082|366011669|FG002|Continuation Phase|Lost to Follow-up|1|||
106096834|NCT00355082|366011667|FG000|Continuation Phase|Protocol Violation|1|||
106096835|NCT00355082|366011668|FG001|Continuation Phase|Protocol Violation|0|||
106096836|NCT00355082|366011669|FG002|Continuation Phase|Protocol Violation|1|||
106096837|NCT00355082|366011667|FG000|Continuation Phase|Withdrawal by Subject|4|||
106096838|NCT00355082|366011668|FG001|Continuation Phase|Withdrawal by Subject|0|||
106096839|NCT00355082|366011669|FG002|Continuation Phase|Withdrawal by Subject|0|||
106096840|NCT00355082|366011667|FG000|Continuation Phase|Lack of Efficacy|5|||
106096841|NCT00355082|366011668|FG001|Continuation Phase|Lack of Efficacy|0|||
106096842|NCT00355082|366011669|FG002|Continuation Phase|Lack of Efficacy|0|||
106096843|NCT00355082|366011667|FG000|Continuation Phase|Site Closed by Sponsor|8|||
106096844|NCT00355082|366011668|FG001|Continuation Phase|Site Closed by Sponsor|0|||
106096845|NCT00355082|366011669|FG002|Continuation Phase|Site Closed by Sponsor|0|||
106096846|NCT00355082|366011667|FG000|Continuation Phase|Scheduling Error|1|||
106096847|NCT00355082|366011668|FG001|Continuation Phase|Scheduling Error|0|||
106096848|NCT00355082|366011669|FG002|Continuation Phase|Scheduling Error|0|||
106096849|NCT00355082|366011667|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
106096850|NCT00355082|366011668|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
106096851|NCT00355082|366011669|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
106096852|NCT02132611|366011670|FG000|Overall Study|Death|2|||
106096853|NCT00363766|366011671|FG000|Overall Study|Progressive Disease|15|||
106096854|NCT00363766|366011672|FG001|Overall Study|Progressive Disease|9|||
106096855|NCT00363766|366011671|FG000|Overall Study|Adverse Event|10|||
106096856|NCT00363766|366011672|FG001|Overall Study|Adverse Event|2|||
106096857|NCT00363766|366011671|FG000|Overall Study|Disease Related Death|1|||
106096858|NCT00363766|366011672|FG001|Overall Study|Disease Related Death|3|||
106096859|NCT00363766|366011671|FG000|Overall Study|Not Disease Related Death|3|||
106096860|NCT00363766|366011672|FG001|Overall Study|Not Disease Related Death|4|||
106096861|NCT00363766|366011671|FG000|Overall Study|Withdrawal by Subject|2|||
106096862|NCT00363766|366011672|FG001|Overall Study|Withdrawal by Subject|0|||
106096863|NCT00363766|366011671|FG000|Overall Study|Physician Decision|1|||
106096864|NCT00363766|366011672|FG001|Overall Study|Physician Decision|2|||
106096865|NCT00558285|366011674|FG000|Overall Study|Adverse Event|1|||
106096866|NCT00558285|366011675|FG001|Overall Study|Adverse Event|1|||
106096867|NCT00558285|366011676|FG002|Overall Study|Adverse Event|4|||
106096868|NCT00558285|366011677|FG003|Overall Study|Adverse Event|1|||
106096869|NCT00558285|366011678|FG004|Overall Study|Adverse Event|2|||
106096870|NCT00558285|366011674|FG000|Overall Study|Abnormal test procedure result(s)|1|||
106096871|NCT00558285|366011675|FG001|Overall Study|Abnormal test procedure result(s)|0|||
106096872|NCT00558285|366011676|FG002|Overall Study|Abnormal test procedure result(s)|0|||
106096873|NCT00558285|366011677|FG003|Overall Study|Abnormal test procedure result(s)|0|||
106096874|NCT00558285|366011678|FG004|Overall Study|Abnormal test procedure result(s)|0|||
106096875|NCT00558285|366011674|FG000|Overall Study|Subject withdrew consent|2|||
106096876|NCT00558285|366011675|FG001|Overall Study|Subject withdrew consent|0|||
106096877|NCT00558285|366011676|FG002|Overall Study|Subject withdrew consent|1|||
106096878|NCT00558285|366011677|FG003|Overall Study|Subject withdrew consent|1|||
106096879|NCT00558285|366011678|FG004|Overall Study|Subject withdrew consent|1|||
106096880|NCT00558285|366011674|FG000|Overall Study|Lost to Follow-up|1|||
106096881|NCT00558285|366011675|FG001|Overall Study|Lost to Follow-up|1|||
106096882|NCT00558285|366011676|FG002|Overall Study|Lost to Follow-up|0|||
106096883|NCT00558285|366011677|FG003|Overall Study|Lost to Follow-up|0|||
106096884|NCT00558285|366011678|FG004|Overall Study|Lost to Follow-up|0|||
106096885|NCT00558285|366011674|FG000|Overall Study|Administrative problems|0|||
106096886|NCT00558285|366011675|FG001|Overall Study|Administrative problems|0|||
106096887|NCT00558285|366011676|FG002|Overall Study|Administrative problems|0|||
106096888|NCT00558285|366011677|FG003|Overall Study|Administrative problems|1|||
106096889|NCT00558285|366011678|FG004|Overall Study|Administrative problems|1|||
106096890|NCT00558285|366011674|FG000|Overall Study|Protocol deviation|1|||
106096891|NCT00558285|366011675|FG001|Overall Study|Protocol deviation|1|||
106096892|NCT00558285|366011676|FG002|Overall Study|Protocol deviation|0|||
106096893|NCT00558285|366011677|FG003|Overall Study|Protocol deviation|1|||
106096894|NCT00558285|366011678|FG004|Overall Study|Protocol deviation|0|||
106096895|NCT00074282|366014268|FG000|Step 1|Adverse Event|32|||
106096896|NCT00074282|366014269|FG001|Step 1|Adverse Event|0|||
106096897|NCT00074282|366014270|FG002|Step 1|Adverse Event|0|||
106096898|NCT00074282|366014268|FG000|Step 1|Death|6|||
106096899|NCT00074282|366014269|FG001|Step 1|Death|0|||
106096900|NCT00074282|366014270|FG002|Step 1|Death|0|||
106096901|NCT00074282|366014268|FG000|Step 1|Withdrawal by Subject|7|||
106096902|NCT00074282|366014269|FG001|Step 1|Withdrawal by Subject|0|||
106096903|NCT00074282|366014270|FG002|Step 1|Withdrawal by Subject|0|||
106096904|NCT00074282|366014268|FG000|Step 1|Disease progression|2|||
106096905|NCT00074282|366014269|FG001|Step 1|Disease progression|0|||
106096906|NCT00074282|366014270|FG002|Step 1|Disease progression|0|||
106096907|NCT00074282|366014268|FG000|Step 1|Alternative therapy|2|||
106096908|NCT00074282|366014269|FG001|Step 1|Alternative therapy|0|||
106096909|NCT00074282|366014270|FG002|Step 1|Alternative therapy|0|||
106096910|NCT00074282|366014268|FG000|Step 1|Other complicating disease|2|||
106096911|NCT00074282|366014269|FG001|Step 1|Other complicating disease|0|||
106096912|NCT00074282|366014270|FG002|Step 1|Other complicating disease|0|||
106096913|NCT00074282|366014268|FG000|Step 1|Physician Decision|1|||
105867431|NCT01027702|365164970|FG006|Overall Study|Received subsequent therapy|1|||
105867432|NCT01027702|365164964|FG000|Overall Study|Death|0|||
105867433|NCT01027702|365164965|FG001|Overall Study|Death|0|||
105867434|NCT01027702|365164966|FG002|Overall Study|Death|1|||
105867435|NCT01027702|365164967|FG003|Overall Study|Death|0|||
105867436|NCT01027702|365164968|FG004|Overall Study|Death|0|||
105867437|NCT01027702|365164969|FG005|Overall Study|Death|0|||
106096914|NCT00074282|366014269|FG001|Step 1|Physician Decision|0|||
106096915|NCT00074282|366014270|FG002|Step 1|Physician Decision|0|||
106096916|NCT00074282|366014268|FG000|Step 1|Ineligible|4|||
106096917|NCT00074282|366014269|FG001|Step 1|Ineligible|0|||
106096918|NCT00074282|366014270|FG002|Step 1|Ineligible|0|||
106096919|NCT00074282|366014268|FG000|Step 1|Never started treatment|2|||
106096920|NCT00074282|366014269|FG001|Step 1|Never started treatment|0|||
106096921|NCT00074282|366014270|FG002|Step 1|Never started treatment|0|||
106096922|NCT00074282|366014268|FG000|Step 2|Adverse Event|0|||
106096923|NCT00074282|366014269|FG001|Step 2|Adverse Event|2|||
106096924|NCT00074282|366014270|FG002|Step 2|Adverse Event|12|||
106096925|NCT00074282|366014268|FG000|Step 2|Disease progression|0|||
106096926|NCT00074282|366014269|FG001|Step 2|Disease progression|0|||
106096927|NCT00074282|366014270|FG002|Step 2|Disease progression|5|||
106096928|NCT00074282|366014268|FG000|Step 2|Death|0|||
106096929|NCT00074282|366014269|FG001|Step 2|Death|0|||
106096930|NCT00074282|366014270|FG002|Step 2|Death|3|||
106096931|NCT00074282|366014268|FG000|Step 2|Withdrawal by Subject|0|||
106096932|NCT00074282|366014269|FG001|Step 2|Withdrawal by Subject|0|||
106096933|NCT00074282|366014270|FG002|Step 2|Withdrawal by Subject|2|||
106096934|NCT00074282|366014268|FG000|Step 2|Physician Decision|0|||
106096935|NCT00074282|366014269|FG001|Step 2|Physician Decision|0|||
106096936|NCT00074282|366014270|FG002|Step 2|Physician Decision|1|||
106096937|NCT00074282|366014268|FG000|Step 2|Ineligible|0|||
106096938|NCT00074282|366014269|FG001|Step 2|Ineligible|0|||
106096939|NCT00074282|366014270|FG002|Step 2|Ineligible|1|||
106096940|NCT00724282|366014276|FG000|Overall Study|Withdrawal by Subject|3|||
106096941|NCT00724282|366014276|FG000|Overall Study|Physician Decision|1|||
106096942|NCT00489970|366014278|FG000|Persistence Year 9|Lost to Follow-up|2|||
106096943|NCT00489970|366014279|FG001|Persistence Year 9|Lost to Follow-up|2|||
106096944|NCT00489970|366014280|FG002|Persistence Year 9|Lost to Follow-up|3|||
106096945|NCT00489970|366014278|FG000|Persistence Year 9|Other|1|||
106096946|NCT00489970|366014279|FG001|Persistence Year 9|Other|0|||
106096947|NCT00489970|366014280|FG002|Persistence Year 9|Other|2|||
106096948|NCT02395120|366014281|FG000|Overall Study|Missed follow-up dental exam|57|||
106096949|NCT02395120|366014282|FG001|Overall Study|Missed follow-up dental exam|62|||
106096950|NCT02395120|366014283|FG002|Overall Study|Missed follow-up dental exam|6|||
106096951|NCT02395120|366014284|FG003|Overall Study|Missed follow-up dental exam|6|||
106096952|NCT02395120|366014285|FG004|Overall Study|Missed follow-up dental exam|51|||
106096953|NCT02053350|366014286|FG000|Overall Study|Withdrawal by Subject|1|||
106096954|NCT02053350|366014286|FG000|Overall Study|Adverse Event|4|||
106096955|NCT01159691|366014289|FG000|Overall Study|Lost to Follow-up|2|||
106096956|NCT01159691|366014289|FG000|Overall Study|Unknown reasons|1|||
106096957|NCT01159691|366014289|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
106096958|NCT01159691|366014289|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
106096959|NCT01159691|366014289|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
106096960|NCT01159691|366014289|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
106096961|NCT01159691|366014289|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
106096962|NCT01159691|366014289|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
106096963|NCT00352365|366014290|FG000|Induction Therapy|Adverse Event|7|||
106096964|NCT00352365|366014290|FG000|Induction Therapy|Progression/Relapse|8|||
106096965|NCT00352365|366014290|FG000|Induction Therapy|Death|7|||
106096966|NCT00352365|366014290|FG000|Induction Therapy|Not protocol specified|1|||
106096967|NCT00352365|366014290|FG000|Induction Therapy|Not eligible|3|||
106096968|NCT00352365|366014290|FG000|Induction Therapy|Death before starting protocol therapy|1|||
106096969|NCT00352365|366014290|FG000|Maintenance Therapy|Progression/Relapse|3|||
106096970|NCT00352365|366014290|FG000|Maintenance Therapy|Death|2|||
106096971|NCT00352365|366014290|FG000|Maintenance Therapy|Not protocol specified|3|||
106096972|NCT00352365|366014290|FG000|Maintenance Therapy|Not eligible|4|||
106096973|NCT04743908|366014291|FG000|Overall Study|Death|1|||
106096974|NCT04743908|366014292|FG001|Overall Study|Death|0|||
106096975|NCT04743908|366014291|FG000|Overall Study|Lost to Follow-up|181|||
106096976|NCT04743908|366014292|FG001|Overall Study|Lost to Follow-up|180|||
106096977|NCT04743908|366014291|FG000|Overall Study|Withdrawal by Subject|1|||
106096978|NCT04743908|366014292|FG001|Overall Study|Withdrawal by Subject|2|||
106096979|NCT02646423|366014293|FG000|Overall Study|Adverse Event|5|||
106096980|NCT02646423|366014294|FG001|Overall Study|Adverse Event|7|||
106096981|NCT02646423|366014293|FG000|Overall Study|Ineligible|2|||
106096982|NCT02646423|366014294|FG001|Overall Study|Ineligible|1|||
106096983|NCT00377819|366014295|FG000|Overall Study|Adverse Event|2|||
106096984|NCT00377819|366014296|FG001|Overall Study|Adverse Event|3|||
106096985|NCT00377819|366014295|FG000|Overall Study|Withdrawal by Subject|10|||
106096986|NCT00377819|366014296|FG001|Overall Study|Withdrawal by Subject|4|||
106096987|NCT00377819|366014295|FG000|Overall Study|Death|0|||
106096988|NCT00377819|366014296|FG001|Overall Study|Death|1|||
106096989|NCT00377819|366014295|FG000|Overall Study|Lost to Follow-up|0|||
106096990|NCT00377819|366014296|FG001|Overall Study|Lost to Follow-up|1|||
106096991|NCT00377819|366014295|FG000|Overall Study|Protocol Violation|1|||
106096992|NCT00377819|366014296|FG001|Overall Study|Protocol Violation|1|||
106096993|NCT03727750|366014297|FG000|Overall Study|Death|45|||
106096994|NCT03727750|366014297|FG000|Overall Study|Withdrawal by Subject|2|||
106096995|NCT03727750|366014297|FG000|Overall Study|Lost to Follow-up|1|||
106096996|NCT03727750|366014297|FG000|Overall Study|Other|1|||
106096997|NCT00467870|366014298|FG000|Overall Study|Adverse Event|13|||
106096998|NCT00467870|366014299|FG001|Overall Study|Adverse Event|9|||
106096999|NCT00467870|366014300|FG002|Overall Study|Adverse Event|1|||
106097000|NCT00467870|366014301|FG003|Overall Study|Adverse Event|15|||
106097001|NCT00467870|366014302|FG004|Overall Study|Adverse Event|15|||
106097002|NCT00467870|366014303|FG005|Overall Study|Adverse Event|1|||
106097003|NCT00467870|366014298|FG000|Overall Study|Protocol Violation|2|||
106097004|NCT00467870|366014299|FG001|Overall Study|Protocol Violation|1|||
106097005|NCT00467870|366014300|FG002|Overall Study|Protocol Violation|1|||
106097006|NCT00467870|366014301|FG003|Overall Study|Protocol Violation|2|||
106097007|NCT00467870|366014302|FG004|Overall Study|Protocol Violation|0|||
106097008|NCT00467870|366014303|FG005|Overall Study|Protocol Violation|0|||
106097009|NCT00467870|366014298|FG000|Overall Study|Withdrawal by Subject|14|||
106097010|NCT00467870|366014299|FG001|Overall Study|Withdrawal by Subject|21|||
106097011|NCT00467870|366014300|FG002|Overall Study|Withdrawal by Subject|0|||
106097012|NCT00467870|366014301|FG003|Overall Study|Withdrawal by Subject|9|||
106097013|NCT00467870|366014302|FG004|Overall Study|Withdrawal by Subject|10|||
106097014|NCT00467870|366014303|FG005|Overall Study|Withdrawal by Subject|1|||
106097015|NCT00467870|366014298|FG000|Overall Study|Lost to Follow-up|5|||
106097016|NCT00467870|366014299|FG001|Overall Study|Lost to Follow-up|3|||
106097017|NCT00467870|366014300|FG002|Overall Study|Lost to Follow-up|1|||
106097018|NCT00467870|366014301|FG003|Overall Study|Lost to Follow-up|1|||
106097019|NCT00467870|366014302|FG004|Overall Study|Lost to Follow-up|3|||
106097020|NCT00467870|366014303|FG005|Overall Study|Lost to Follow-up|0|||
106097021|NCT00467870|366014298|FG000|Overall Study|Subject Non-compliance|3|||
106097022|NCT00467870|366014299|FG001|Overall Study|Subject Non-compliance|4|||
106097023|NCT00467870|366014300|FG002|Overall Study|Subject Non-compliance|0|||
106097024|NCT00467870|366014301|FG003|Overall Study|Subject Non-compliance|1|||
106097025|NCT00467870|366014302|FG004|Overall Study|Subject Non-compliance|5|||
106097026|NCT00467870|366014303|FG005|Overall Study|Subject Non-compliance|0|||
106097027|NCT00467870|366014298|FG000|Overall Study|Other/Unknown|8|||
106097028|NCT00467870|366014299|FG001|Overall Study|Other/Unknown|5|||
106097029|NCT00467870|366014300|FG002|Overall Study|Other/Unknown|1|||
106097030|NCT00467870|366014301|FG003|Overall Study|Other/Unknown|5|||
106097031|NCT00467870|366014302|FG004|Overall Study|Other/Unknown|4|||
106097032|NCT00467870|366014303|FG005|Overall Study|Other/Unknown|0|||
106097033|NCT00321919|366014304|FG000|Overall Study|Adverse Event|17|||
106097034|NCT00321919|366014305|FG001|Overall Study|Adverse Event|10|||
106097035|NCT00321919|366014304|FG000|Overall Study|Death|21|||
106097036|NCT00321919|366014305|FG001|Overall Study|Death|17|||
106097037|NCT00321919|366014304|FG000|Overall Study|Insufficient Therapeutic Response|1|||
106097038|NCT00321919|366014305|FG001|Overall Study|Insufficient Therapeutic Response|0|||
106097039|NCT00321919|366014304|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
106097040|NCT00321919|366014305|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
106097041|NCT00321919|366014304|FG000|Overall Study|Refused Treatment|23|||
106097042|NCT00321919|366014305|FG001|Overall Study|Refused Treatment|14|||
106097043|NCT00321919|366014304|FG000|Overall Study|Other Protocol Violation|2|||
106097044|NCT00321919|366014305|FG001|Overall Study|Other Protocol Violation|3|||
106097045|NCT00321919|366014304|FG000|Overall Study|Failure to Return|3|||
106097046|NCT00321919|366014305|FG001|Overall Study|Failure to Return|1|||
106097047|NCT00321919|366014304|FG000|Overall Study|Other withdrawal reason|7|||
106097048|NCT00321919|366014305|FG001|Overall Study|Other withdrawal reason|6|||
106097049|NCT01917526|366014306|FG000|Overall Study|Protocol Violation|1|||
105867438|NCT01027702|365164970|FG006|Overall Study|Death|0|||
105867439|NCT02301390|365164971|FG000|Overall Study|Withdrawal by Subject|3|||
105867440|NCT02301390|365164972|FG001|Overall Study|Withdrawal by Subject|5|||
105867441|NCT02301390|365164971|FG000|Overall Study|Protocol Violation|1|||
105867442|NCT02301390|365164972|FG001|Overall Study|Protocol Violation|0|||
105867443|NCT02301390|365164971|FG000|Overall Study|Physician Decision|1|||
105867444|NCT02301390|365164972|FG001|Overall Study|Physician Decision|0|||
105867445|NCT02301390|365164971|FG000|Overall Study|Lost to Follow-up|0|||
105867446|NCT02301390|365164972|FG001|Overall Study|Lost to Follow-up|1|||
105867447|NCT02301390|365164971|FG000|Overall Study|Death|2|||
105867448|NCT02301390|365164972|FG001|Overall Study|Death|2|||
105867449|NCT02301390|365164971|FG000|Overall Study|Procedure not completed|0|||
105867450|NCT02301390|365164972|FG001|Overall Study|Procedure not completed|4|||
105867451|NCT02301390|365164971|FG000|Overall Study|Missed multiple visits|1|||
105867452|NCT02301390|365164972|FG001|Overall Study|Missed multiple visits|1|||
105867453|NCT02301390|365164971|FG000|Overall Study|study terminated|2|||
105867454|NCT02301390|365164972|FG001|Overall Study|study terminated|0|||
105867455|NCT00403585|365164973|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
105867456|NCT00403585|365164973|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
105867457|NCT00403585|365164973|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
105867458|NCT02604407|365164974|FG000|Overall Study|Adverse Event|0|||
105867459|NCT02604407|365164975|FG001|Overall Study|Adverse Event|7|||
105867460|NCT02604407|365164976|FG002|Overall Study|Adverse Event|5|||
105867461|NCT02604407|365164974|FG000|Overall Study|Protocol Violation|2|||
105867462|NCT02604407|365164975|FG001|Overall Study|Protocol Violation|0|||
105867463|NCT02604407|365164976|FG002|Overall Study|Protocol Violation|0|||
105867464|NCT02604407|365164974|FG000|Overall Study|Withdrawal by Subject|3|||
105867465|NCT02604407|365164975|FG001|Overall Study|Withdrawal by Subject|3|||
105867466|NCT02604407|365164976|FG002|Overall Study|Withdrawal by Subject|5|||
105867467|NCT02604407|365164974|FG000|Overall Study|Lost to Follow-up|2|||
105867468|NCT02604407|365164975|FG001|Overall Study|Lost to Follow-up|1|||
105867469|NCT02604407|365164976|FG002|Overall Study|Lost to Follow-up|2|||
105867470|NCT02604407|365164974|FG000|Overall Study|Lack of Efficacy|1|||
105867471|NCT02604407|365164975|FG001|Overall Study|Lack of Efficacy|0|||
105867472|NCT02604407|365164976|FG002|Overall Study|Lack of Efficacy|0|||
105867473|NCT02604407|365164974|FG000|Overall Study|Other|3|||
105867474|NCT02604407|365164975|FG001|Overall Study|Other|1|||
105867475|NCT02604407|365164976|FG002|Overall Study|Other|4|||
105867476|NCT00185588|365164977|FG000|Overall Study|Adverse Event|3|||
105867477|NCT00185588|365164978|FG001|Overall Study|Adverse Event|1|||
105867478|NCT00185588|365164979|FG002|Overall Study|Adverse Event|4|||
105867479|NCT00185588|365164980|FG003|Overall Study|Adverse Event|2|||
105867480|NCT00185588|365164977|FG000|Overall Study|Lost to Follow-up|0|||
105867481|NCT00185588|365164978|FG001|Overall Study|Lost to Follow-up|0|||
105867482|NCT00185588|365164979|FG002|Overall Study|Lost to Follow-up|1|||
105867483|NCT00185588|365164980|FG003|Overall Study|Lost to Follow-up|2|||
105867484|NCT00185588|365164977|FG000|Overall Study|Withdrawal by Subject|0|||
105867485|NCT00185588|365164978|FG001|Overall Study|Withdrawal by Subject|1|||
105867486|NCT00185588|365164979|FG002|Overall Study|Withdrawal by Subject|0|||
105867487|NCT00185588|365164980|FG003|Overall Study|Withdrawal by Subject|0|||
105867488|NCT00185588|365164977|FG000|Overall Study|Physician Decision|0|||
105867489|NCT00185588|365164978|FG001|Overall Study|Physician Decision|0|||
105867490|NCT00185588|365164979|FG002|Overall Study|Physician Decision|1|||
105867491|NCT00185588|365164980|FG003|Overall Study|Physician Decision|0|||
105867492|NCT01699815|365164981|FG000|Overall Study|Protocol Violation|4|||
105867493|NCT01699815|365164982|FG001|Overall Study|Protocol Violation|7|||
105867494|NCT01699815|365164981|FG000|Overall Study|record could not be located|1|||
105867495|NCT01699815|365164982|FG001|Overall Study|record could not be located|0|||
105867496|NCT01699815|365164981|FG000|Overall Study|Adverse Event|0|||
105867497|NCT01699815|365164982|FG001|Overall Study|Adverse Event|1|||
105867498|NCT00356525|365164988|FG000|Overall Study|Progressive Disease|8|||
105867499|NCT00356525|365164989|FG001|Overall Study|Progressive Disease|5|||
105867500|NCT00356525|365164990|FG002|Overall Study|Progressive Disease|4|||
105867501|NCT00356525|365164991|FG003|Overall Study|Progressive Disease|2|||
106097050|NCT01917526|366014307|FG001|Overall Study|Protocol Violation|1|||
106097051|NCT02261363|366014308|FG000|Overall Study|Lost to Follow-up|21|||
106097052|NCT01517802|366014309|FG000|Overall Study|Death|1|||
106097053|NCT02590354|366014310|FG000|Phase 1|Active hepatitis B or C infection|1|||
106097054|NCT02590354|366014310|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
106097055|NCT02590354|366014310|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
106097056|NCT02590354|366014310|FG000|Phase 1|Subject does not want to participate|20|||
106097057|NCT02590354|366014310|FG000|Phase 1|Lost to Follow-up|1|||
106097058|NCT02590354|366014310|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
106097059|NCT00455195|366014312|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
106097060|NCT00455195|366014313|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
106097061|NCT00455195|366014312|FG000|Double-blind Study AGLU02704|Death|1|||
106097062|NCT00455195|366014313|FG001|Double-blind Study AGLU02704|Death|0|||
106097063|NCT00455195|366014312|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
106097064|NCT00455195|366014313|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
106097065|NCT00455195|366014312|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
106097066|NCT00455195|366014313|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
106097067|NCT02148250|366014316|FG000|Screening|Withdrawal by Subject|5|||
106097068|NCT02148250|366014317|FG001|Screening|Withdrawal by Subject|0|||
106097069|NCT00922428|366014320|FG000|Overall Study|retrospective/extremely implausible data|2|||
106097070|NCT00922428|366014320|FG000|Overall Study|no medication use or questionable use|13|||
106097071|NCT03701555|366014322|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
106097072|NCT03701555|366014323|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
106097073|NCT03701555|366014324|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
106097074|NCT03701555|366014325|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
106097075|NCT03701555|366014326|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
106097076|NCT03701555|366014327|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
106097077|NCT03701555|366014328|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
106097078|NCT03701555|366014329|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
106097079|NCT03701555|366014330|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
106097080|NCT03701555|366014331|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
106097081|NCT03701555|366014332|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
106097082|NCT03701555|366014333|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
106097083|NCT03701555|366014334|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
106097084|NCT03701555|366014335|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
106097085|NCT03701555|366014336|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
106097086|NCT03701555|366014337|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
106097087|NCT03701555|366014338|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
106097088|NCT03701555|366014339|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
106097089|NCT03701555|366014340|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
106097090|NCT03701555|366014341|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
106097091|NCT03701555|366014342|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
106097092|NCT03701555|366014343|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
106097093|NCT03701555|366014344|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
106097094|NCT03701555|366014345|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
106097095|NCT03701555|366014346|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
106097096|NCT03701555|366014347|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
106097097|NCT03701555|366014348|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
106097098|NCT03701555|366014349|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
106097099|NCT03701555|366014350|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
106097100|NCT03701555|366014351|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
106097101|NCT03701555|366014352|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
106097102|NCT03701555|366014353|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
106097103|NCT03701555|366014354|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
106097104|NCT03701555|366014355|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
106097105|NCT03701555|366014356|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
106097106|NCT03701555|366014357|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
106097107|NCT03701555|366014322|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
106097108|NCT03701555|366014323|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
106097109|NCT03701555|366014324|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
106097110|NCT03701555|366014325|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
106097111|NCT03701555|366014326|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
106097112|NCT03701555|366014327|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
106097113|NCT03701555|366014328|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
106097114|NCT03701555|366014329|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
106097115|NCT03701555|366014330|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
106097116|NCT03701555|366014331|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
106097117|NCT03701555|366014332|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
106097118|NCT03701555|366014333|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
106097119|NCT03701555|366014334|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
106097120|NCT03701555|366014335|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
106097121|NCT03701555|366014336|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
106097122|NCT03701555|366014337|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
106097123|NCT03701555|366014338|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
106097124|NCT03701555|366014339|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
106097125|NCT03701555|366014340|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
106097126|NCT03701555|366014341|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
106097127|NCT03701555|366014342|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
106097128|NCT03701555|366014343|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
106097129|NCT03701555|366014344|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
106097130|NCT03701555|366014345|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
106097131|NCT03701555|366014346|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
106097132|NCT03701555|366014347|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
106097133|NCT03701555|366014348|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
106097134|NCT03701555|366014349|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
106097135|NCT03701555|366014350|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
106097136|NCT03701555|366014351|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
106097137|NCT03701555|366014352|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
106097138|NCT03701555|366014353|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
106097139|NCT03701555|366014354|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
106097140|NCT03701555|366014355|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
106097141|NCT03701555|366014356|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
106097142|NCT03701555|366014357|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
106097143|NCT03701555|366014322|FG000|Part 2 (Day 1)|Other|0|||
106097144|NCT03701555|366014323|FG001|Part 2 (Day 1)|Other|0|||
106097145|NCT03701555|366014324|FG002|Part 2 (Day 1)|Other|0|||
106097146|NCT03701555|366014325|FG003|Part 2 (Day 1)|Other|0|||
106097147|NCT03701555|366014326|FG004|Part 2 (Day 1)|Other|0|||
106097148|NCT03701555|366014327|FG005|Part 2 (Day 1)|Other|0|||
106097149|NCT03701555|366014328|FG006|Part 2 (Day 1)|Other|0|||
106097150|NCT03701555|366014329|FG007|Part 2 (Day 1)|Other|0|||
106097151|NCT03701555|366014330|FG008|Part 2 (Day 1)|Other|0|||
106097152|NCT03701555|366014331|FG009|Part 2 (Day 1)|Other|0|||
106097153|NCT03701555|366014332|FG010|Part 2 (Day 1)|Other|3|||
106097154|NCT03701555|366014333|FG011|Part 2 (Day 1)|Other|1|||
106097155|NCT03701555|366014334|FG012|Part 2 (Day 1)|Other|0|||
106097156|NCT03701555|366014335|FG013|Part 2 (Day 1)|Other|1|||
106097157|NCT03701555|366014336|FG014|Part 2 (Day 1)|Other|0|||
106097158|NCT03701555|366014337|FG015|Part 2 (Day 1)|Other|2|||
106097159|NCT03701555|366014338|FG016|Part 2 (Day 1)|Other|2|||
106097160|NCT03701555|366014339|FG017|Part 2 (Day 1)|Other|0|||
106097161|NCT03701555|366014340|FG018|Part 2 (Day 1)|Other|0|||
106097162|NCT03701555|366014341|FG019|Part 2 (Day 1)|Other|0|||
106097163|NCT03701555|366014342|FG020|Part 2 (Day 1)|Other|0|||
106097164|NCT03701555|366014343|FG021|Part 2 (Day 1)|Other|0|||
106097165|NCT03701555|366014344|FG022|Part 2 (Day 1)|Other|0|||
106097166|NCT03701555|366014345|FG023|Part 2 (Day 1)|Other|0|||
106097167|NCT03701555|366014346|FG024|Part 2 (Day 1)|Other|0|||
106097168|NCT03701555|366014347|FG025|Part 2 (Day 1)|Other|0|||
106097169|NCT03701555|366014348|FG026|Part 2 (Day 1)|Other|0|||
106097170|NCT03701555|366014349|FG027|Part 2 (Day 1)|Other|0|||
106097171|NCT03701555|366014350|FG028|Part 2 (Day 1)|Other|0|||
106097172|NCT03701555|366014351|FG029|Part 2 (Day 1)|Other|0|||
106097173|NCT03701555|366014352|FG030|Part 2 (Day 1)|Other|0|||
106097174|NCT03701555|366014353|FG031|Part 2 (Day 1)|Other|0|||
106097175|NCT03701555|366014354|FG032|Part 2 (Day 1)|Other|0|||
106097176|NCT03701555|366014355|FG033|Part 2 (Day 1)|Other|0|||
106097177|NCT03701555|366014356|FG034|Part 2 (Day 1)|Other|0|||
106097178|NCT03701555|366014357|FG035|Part 2 (Day 1)|Other|0|||
105867502|NCT00356525|365164988|FG000|Overall Study|Adverse Event|1|||
105867503|NCT00356525|365164989|FG001|Overall Study|Adverse Event|3|||
105867504|NCT00356525|365164990|FG002|Overall Study|Adverse Event|1|||
105867505|NCT00356525|365164991|FG003|Overall Study|Adverse Event|1|||
105867506|NCT00356525|365164988|FG000|Overall Study|Lost to Follow-up|1|||
105867507|NCT00356525|365164989|FG001|Overall Study|Lost to Follow-up|0|||
105867508|NCT00356525|365164990|FG002|Overall Study|Lost to Follow-up|0|||
105867509|NCT00356525|365164991|FG003|Overall Study|Lost to Follow-up|0|||
105867510|NCT00356525|365164988|FG000|Overall Study|Physician Decision|2|||
105867511|NCT00356525|365164989|FG001|Overall Study|Physician Decision|2|||
105867512|NCT00356525|365164990|FG002|Overall Study|Physician Decision|2|||
105867513|NCT00356525|365164991|FG003|Overall Study|Physician Decision|1|||
105867514|NCT00356525|365164988|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
105867515|NCT00356525|365164989|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
105867516|NCT00356525|365164990|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
105867517|NCT00356525|365164991|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
105867518|NCT00356525|365164988|FG000|Overall Study|Withdrawal by Subject|1|||
105867519|NCT00356525|365164989|FG001|Overall Study|Withdrawal by Subject|1|||
105867520|NCT00356525|365164990|FG002|Overall Study|Withdrawal by Subject|0|||
105867521|NCT00356525|365164991|FG003|Overall Study|Withdrawal by Subject|3|||
105867522|NCT00356525|365164988|FG000|Overall Study|Death|0|||
105867523|NCT00356525|365164989|FG001|Overall Study|Death|0|||
105867524|NCT00356525|365164990|FG002|Overall Study|Death|0|||
105867525|NCT00356525|365164991|FG003|Overall Study|Death|1|||
105867526|NCT00356525|365164988|FG000|Overall Study|Sponsor Decision|0|||
105867527|NCT00356525|365164989|FG001|Overall Study|Sponsor Decision|0|||
105867528|NCT00356525|365164990|FG002|Overall Study|Sponsor Decision|0|||
105867529|NCT00356525|365164991|FG003|Overall Study|Sponsor Decision|1|||
105867530|NCT02932462|365164992|FG000|Overall Study|Adverse Event|1|||
105867531|NCT02932462|365164993|FG001|Overall Study|Adverse Event|2|||
105867532|NCT02932462|365164992|FG000|Overall Study|Lost to Follow-up|4|||
105867533|NCT02932462|365164993|FG001|Overall Study|Lost to Follow-up|1|||
105867534|NCT02932462|365164992|FG000|Overall Study|Protocol Violation|0|||
105867535|NCT02932462|365164993|FG001|Overall Study|Protocol Violation|5|||
105867536|NCT02932462|365164992|FG000|Overall Study|Withdrawal by Subject|1|||
105867537|NCT02932462|365164993|FG001|Overall Study|Withdrawal by Subject|4|||
105867538|NCT02932462|365164992|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105867539|NCT02932462|365164993|FG001|Overall Study|Non-Compliance With Study Drug|1|||
106097179|NCT03701555|366014322|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
106097180|NCT03701555|366014323|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
106097181|NCT03701555|366014324|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
106097182|NCT03701555|366014325|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
106097183|NCT03701555|366014326|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
106097184|NCT03701555|366014327|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
106097185|NCT03701555|366014328|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
106097186|NCT03701555|366014329|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
106097187|NCT03701555|366014330|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
106097188|NCT03701555|366014331|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
106097189|NCT03701555|366014332|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
106097190|NCT03701555|366014333|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
106097191|NCT03701555|366014334|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
106097192|NCT03701555|366014335|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
106097193|NCT03701555|366014336|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
106097194|NCT03701555|366014337|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
106097195|NCT03701555|366014338|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
106097196|NCT03701555|366014339|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
106097197|NCT03701555|366014340|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
106097198|NCT03701555|366014341|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
106097199|NCT03701555|366014342|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
106097200|NCT03701555|366014343|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
106097201|NCT03701555|366014344|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
106097202|NCT03701555|366014345|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
106097203|NCT03701555|366014346|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
106097204|NCT03701555|366014347|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
106097205|NCT03701555|366014348|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
106097206|NCT03701555|366014349|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
106097207|NCT03701555|366014350|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
106097208|NCT03701555|366014351|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
106097209|NCT03701555|366014352|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
106097210|NCT03701555|366014353|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
106097211|NCT03701555|366014354|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
106097212|NCT03701555|366014355|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
106097213|NCT03701555|366014356|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
106097214|NCT03701555|366014357|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
106097215|NCT03701555|366014322|FG000|Part 3 (Day 1)|Subject Decision|0|||
106097216|NCT03701555|366014323|FG001|Part 3 (Day 1)|Subject Decision|0|||
106097217|NCT03701555|366014324|FG002|Part 3 (Day 1)|Subject Decision|0|||
106097218|NCT03701555|366014325|FG003|Part 3 (Day 1)|Subject Decision|0|||
106097219|NCT03701555|366014326|FG004|Part 3 (Day 1)|Subject Decision|0|||
106097220|NCT03701555|366014327|FG005|Part 3 (Day 1)|Subject Decision|0|||
106097221|NCT03701555|366014328|FG006|Part 3 (Day 1)|Subject Decision|0|||
106097222|NCT03701555|366014329|FG007|Part 3 (Day 1)|Subject Decision|0|||
106097223|NCT03701555|366014330|FG008|Part 3 (Day 1)|Subject Decision|0|||
106097224|NCT03701555|366014331|FG009|Part 3 (Day 1)|Subject Decision|0|||
106097225|NCT03701555|366014332|FG010|Part 3 (Day 1)|Subject Decision|0|||
106097226|NCT03701555|366014333|FG011|Part 3 (Day 1)|Subject Decision|0|||
106097227|NCT03701555|366014334|FG012|Part 3 (Day 1)|Subject Decision|0|||
106097228|NCT03701555|366014335|FG013|Part 3 (Day 1)|Subject Decision|0|||
106097229|NCT03701555|366014336|FG014|Part 3 (Day 1)|Subject Decision|0|||
106097230|NCT03701555|366014337|FG015|Part 3 (Day 1)|Subject Decision|0|||
106097231|NCT03701555|366014338|FG016|Part 3 (Day 1)|Subject Decision|0|||
106097232|NCT03701555|366014339|FG017|Part 3 (Day 1)|Subject Decision|0|||
106097233|NCT03701555|366014340|FG018|Part 3 (Day 1)|Subject Decision|0|||
106097234|NCT03701555|366014341|FG019|Part 3 (Day 1)|Subject Decision|0|||
106097235|NCT03701555|366014342|FG020|Part 3 (Day 1)|Subject Decision|0|||
106097236|NCT03701555|366014343|FG021|Part 3 (Day 1)|Subject Decision|0|||
106097237|NCT03701555|366014344|FG022|Part 3 (Day 1)|Subject Decision|0|||
106097238|NCT03701555|366014345|FG023|Part 3 (Day 1)|Subject Decision|0|||
106097239|NCT03701555|366014346|FG024|Part 3 (Day 1)|Subject Decision|0|||
106097240|NCT03701555|366014347|FG025|Part 3 (Day 1)|Subject Decision|0|||
106097241|NCT03701555|366014348|FG026|Part 3 (Day 1)|Subject Decision|1|||
106097242|NCT03701555|366014349|FG027|Part 3 (Day 1)|Subject Decision|0|||
106097243|NCT03701555|366014350|FG028|Part 3 (Day 1)|Subject Decision|0|||
106097244|NCT03701555|366014351|FG029|Part 3 (Day 1)|Subject Decision|0|||
106097245|NCT03701555|366014352|FG030|Part 3 (Day 1)|Subject Decision|0|||
106097246|NCT03701555|366014353|FG031|Part 3 (Day 1)|Subject Decision|2|||
106097247|NCT03701555|366014354|FG032|Part 3 (Day 1)|Subject Decision|1|||
106097248|NCT03701555|366014355|FG033|Part 3 (Day 1)|Subject Decision|1|||
106097249|NCT03701555|366014356|FG034|Part 3 (Day 1)|Subject Decision|0|||
106097250|NCT03701555|366014357|FG035|Part 3 (Day 1)|Subject Decision|0|||
106097251|NCT03701555|366014322|FG000|Part 3 (Day 1)|Other|0|||
106097252|NCT03701555|366014323|FG001|Part 3 (Day 1)|Other|0|||
106097253|NCT03701555|366014324|FG002|Part 3 (Day 1)|Other|0|||
106097254|NCT03701555|366014325|FG003|Part 3 (Day 1)|Other|0|||
106097255|NCT03701555|366014326|FG004|Part 3 (Day 1)|Other|0|||
106097256|NCT03701555|366014327|FG005|Part 3 (Day 1)|Other|0|||
106097257|NCT03701555|366014328|FG006|Part 3 (Day 1)|Other|0|||
106097258|NCT03701555|366014329|FG007|Part 3 (Day 1)|Other|0|||
106097259|NCT03701555|366014330|FG008|Part 3 (Day 1)|Other|0|||
106097260|NCT03701555|366014331|FG009|Part 3 (Day 1)|Other|0|||
106097261|NCT03701555|366014332|FG010|Part 3 (Day 1)|Other|0|||
106097262|NCT03701555|366014333|FG011|Part 3 (Day 1)|Other|0|||
106097263|NCT03701555|366014334|FG012|Part 3 (Day 1)|Other|0|||
106097264|NCT03701555|366014335|FG013|Part 3 (Day 1)|Other|0|||
106097265|NCT03701555|366014336|FG014|Part 3 (Day 1)|Other|0|||
106097266|NCT03701555|366014337|FG015|Part 3 (Day 1)|Other|0|||
106097267|NCT03701555|366014338|FG016|Part 3 (Day 1)|Other|0|||
106097268|NCT03701555|366014339|FG017|Part 3 (Day 1)|Other|0|||
106097269|NCT03701555|366014340|FG018|Part 3 (Day 1)|Other|0|||
106097270|NCT03701555|366014341|FG019|Part 3 (Day 1)|Other|0|||
106097271|NCT03701555|366014342|FG020|Part 3 (Day 1)|Other|0|||
106097272|NCT03701555|366014343|FG021|Part 3 (Day 1)|Other|0|||
106097273|NCT03701555|366014344|FG022|Part 3 (Day 1)|Other|0|||
106097274|NCT03701555|366014345|FG023|Part 3 (Day 1)|Other|0|||
106097275|NCT03701555|366014346|FG024|Part 3 (Day 1)|Other|1|||
106097276|NCT03701555|366014347|FG025|Part 3 (Day 1)|Other|1|||
106097277|NCT03701555|366014348|FG026|Part 3 (Day 1)|Other|0|||
106097278|NCT03701555|366014349|FG027|Part 3 (Day 1)|Other|0|||
106097279|NCT03701555|366014350|FG028|Part 3 (Day 1)|Other|0|||
106097280|NCT03701555|366014351|FG029|Part 3 (Day 1)|Other|1|||
106097281|NCT03701555|366014352|FG030|Part 3 (Day 1)|Other|1|||
106097282|NCT03701555|366014353|FG031|Part 3 (Day 1)|Other|0|||
106097283|NCT03701555|366014354|FG032|Part 3 (Day 1)|Other|1|||
106097284|NCT03701555|366014355|FG033|Part 3 (Day 1)|Other|1|||
106097285|NCT03701555|366014356|FG034|Part 3 (Day 1)|Other|0|||
106097286|NCT03701555|366014357|FG035|Part 3 (Day 1)|Other|0|||
106097287|NCT04757649|366014358|FG000|Overall Study|Withdrawal by Subject|1|||
106097288|NCT04757649|366014358|FG000|Overall Study|Adverse Event|1|||
106097289|NCT01659021|366014359|FG000|Main Study|Adverse Event|2|||
106097290|NCT01659021|366014360|FG001|Main Study|Adverse Event|3|||
106097291|NCT01659021|366014359|FG000|Main Study|Lost to Follow-up|1|||
106097292|NCT01659021|366014360|FG001|Main Study|Lost to Follow-up|0|||
106097293|NCT01659021|366014359|FG000|Main Study|Unknown Reasons|2|||
106097294|NCT01659021|366014360|FG001|Main Study|Unknown Reasons|1|||
106097295|NCT01659021|366014359|FG000|Main Study|Physician Decision|34|||
106097296|NCT01659021|366014360|FG001|Main Study|Physician Decision|16|||
106097297|NCT01659021|366014359|FG000|Main Study|Withdrawal by Subject|19|||
106097298|NCT01659021|366014360|FG001|Main Study|Withdrawal by Subject|16|||
106097299|NCT01659021|366014359|FG000|Main Study|Study Terminated by Sponsor|16|||
106097300|NCT01659021|366014360|FG001|Main Study|Study Terminated by Sponsor|1|||
106097301|NCT01659021|366014359|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
106097302|NCT01659021|366014360|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
106097303|NCT01659021|366014359|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
106097304|NCT01659021|366014360|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
106097305|NCT02508311|366014363|FG000|Overall Study|Withdrawal by Subject|1|||
106097306|NCT02508311|366014364|FG001|Overall Study|Withdrawal by Subject|0|||
106097307|NCT03551938|366014365|FG000|3-Month Follow Up|Lost to Follow-up|39|||
106097308|NCT03551938|366014366|FG001|3-Month Follow Up|Lost to Follow-up|38|||
106097309|NCT03551938|366014365|FG000|6-Month Follow Up|Lost to Follow-up|46|||
106097310|NCT03551938|366014366|FG001|6-Month Follow Up|Lost to Follow-up|42|||
106097311|NCT03551938|366014365|FG000|9-Month Follow Up|Lost to Follow-up|44|||
106097312|NCT03551938|366014366|FG001|9-Month Follow Up|Lost to Follow-up|43|||
106097313|NCT02169674|366014367|FG000|Overall Study|Withdrawal by Subject|2|||
106097314|NCT02169674|366014368|FG001|Overall Study|Withdrawal by Subject|1|||
106097315|NCT02169674|366014367|FG000|Overall Study|Seroprotected|30|||
106097316|NCT02169674|366014368|FG001|Overall Study|Seroprotected|76|||
106097317|NCT02169674|366014367|FG000|Overall Study|Lost to Follow-up|0|||
106097318|NCT02169674|366014368|FG001|Overall Study|Lost to Follow-up|1|||
106097319|NCT00695903|366014369|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
106097320|NCT00695903|366014370|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
106097321|NCT00695903|366014369|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
106097322|NCT00695903|366014370|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
106097323|NCT00695903|366014369|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
106097324|NCT00695903|366014370|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
106097325|NCT00695903|366014369|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
106097326|NCT00695903|366014370|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
106097327|NCT00695903|366014369|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
106097328|NCT00695903|366014370|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
106097329|NCT00695903|366014369|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
106097330|NCT00695903|366014370|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
106097331|NCT00695903|366014369|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
106097332|NCT00695903|366014370|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
106097333|NCT00695903|366014369|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
106097334|NCT00695903|366014370|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
106097335|NCT00695903|366014369|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
106097336|NCT00695903|366014370|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
106097337|NCT01296568|366014371|FG000|Continued Access Phase|Lost to Follow-up|1|||
106097338|NCT01296568|366014371|FG000|Continued Access Phase|Withdrawal by Subject|1|||
106097339|NCT01296568|366014371|FG000|Continued Access Phase|Disease Progression|1|||
106097340|NCT04258020|366014372|FG000|Overall Study|Withdrawal by Subject|1|||
106097341|NCT04258020|366014373|FG001|Overall Study|Withdrawal by Subject|0|||
106097342|NCT04137380|366014378|FG000|Overall Study|Physician Decision|0|||
106097343|NCT04137380|366014379|FG001|Overall Study|Physician Decision|0|||
106097344|NCT04137380|366014380|FG002|Overall Study|Physician Decision|0|||
106097345|NCT04137380|366014381|FG003|Overall Study|Physician Decision|1|||
105867540|NCT02932462|365164992|FG000|Overall Study|Progressive Disease|1|||
105867541|NCT02932462|365164993|FG001|Overall Study|Progressive Disease|0|||
105867542|NCT03682107|365164994|FG000|Overall Study|Withdrawal by Subject|0|||
105867543|NCT03682107|365164995|FG001|Overall Study|Withdrawal by Subject|1|||
105867544|NCT03682107|365164996|FG002|Overall Study|Withdrawal by Subject|0|||
105867545|NCT03682107|365164997|FG003|Overall Study|Withdrawal by Subject|0|||
105867546|NCT03682107|365164998|FG004|Overall Study|Withdrawal by Subject|0|||
105867547|NCT04123405|365164999|FG000|Overall Study|Adverse Event|1|||
105867548|NCT04123405|365165000|FG001|Overall Study|Adverse Event|2|||
105867549|NCT04123405|365165001|FG002|Overall Study|Adverse Event|3|||
105867550|NCT04123405|365165002|FG003|Overall Study|Adverse Event|3|||
105867551|NCT04123405|365164999|FG000|Overall Study|Exclusion criteria met|1|||
105867552|NCT04123405|365165000|FG001|Overall Study|Exclusion criteria met|2|||
105867553|NCT04123405|365165001|FG002|Overall Study|Exclusion criteria met|0|||
105867554|NCT04123405|365165002|FG003|Overall Study|Exclusion criteria met|2|||
105867555|NCT04123405|365164999|FG000|Overall Study|Withdrawal by Subject|1|||
105867556|NCT04123405|365165000|FG001|Overall Study|Withdrawal by Subject|3|||
105867557|NCT04123405|365165001|FG002|Overall Study|Withdrawal by Subject|0|||
105867558|NCT04123405|365165002|FG003|Overall Study|Withdrawal by Subject|2|||
105867559|NCT04123405|365164999|FG000|Overall Study|Contact to subject lost|0|||
105867560|NCT04123405|365165000|FG001|Overall Study|Contact to subject lost|0|||
105867561|NCT04123405|365165001|FG002|Overall Study|Contact to subject lost|0|||
105867562|NCT04123405|365165002|FG003|Overall Study|Contact to subject lost|1|||
105867563|NCT04123405|365164999|FG000|Overall Study|screening failure|1|||
105867564|NCT04123405|365165000|FG001|Overall Study|screening failure|0|||
105867565|NCT04123405|365165001|FG002|Overall Study|screening failure|0|||
105867566|NCT04123405|365165002|FG003|Overall Study|screening failure|0|||
105867567|NCT04036110|365165005|FG000|Overall Study|Lost to Follow-up|3|||
105867568|NCT04036110|365165006|FG001|Overall Study|Lost to Follow-up|2|||
105867569|NCT04036110|365165007|FG002|Overall Study|Lost to Follow-up|1|||
105867570|NCT04036110|365165005|FG000|Overall Study|Study Suspended|4|||
105867571|NCT04036110|365165006|FG001|Overall Study|Study Suspended|5|||
105867572|NCT04036110|365165007|FG002|Overall Study|Study Suspended|1|||
105867573|NCT02859142|365165010|FG000|Overall Study|Adverse Event|1|||
105867574|NCT02859142|365165011|FG001|Overall Study|Adverse Event|2|||
105867575|NCT02859142|365165010|FG000|Overall Study|Lost to Follow-up|1|||
105867576|NCT02859142|365165011|FG001|Overall Study|Lost to Follow-up|4|||
105867577|NCT02859142|365165010|FG000|Overall Study|Withdrawal by Subject|2|||
105867578|NCT02859142|365165011|FG001|Overall Study|Withdrawal by Subject|0|||
105867579|NCT02859142|365165010|FG000|Overall Study|Scheduling difficulties|0|||
105867580|NCT02859142|365165011|FG001|Overall Study|Scheduling difficulties|3|||
105867581|NCT03340974|365165012|FG000|Completion of Study -Long Term Follow up|Death|8|||
105867582|NCT03340974|365165013|FG001|Completion of Study -Long Term Follow up|Death|5|||
105867583|NCT03340974|365165014|FG002|Completion of Study -Long Term Follow up|Death|5|||
105867584|NCT03340974|365165015|FG003|Completion of Study -Long Term Follow up|Death|7|||
105867585|NCT03340974|365165012|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
105867586|NCT03340974|365165013|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
105867587|NCT03340974|365165014|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
105867588|NCT03340974|365165015|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
105867589|NCT03340974|365165012|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
105867590|NCT03340974|365165013|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
105867591|NCT03340974|365165014|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
105867592|NCT03340974|365165015|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
105867593|NCT03340974|365165012|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
105867594|NCT03340974|365165013|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
105867595|NCT03340974|365165014|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
105867596|NCT03340974|365165015|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
105867597|NCT00098774|365165025|FG000|Overall Study|Adverse Event|2|||
105867598|NCT00098774|365165025|FG000|Overall Study|Disease Progression|9|||
105867599|NCT00098774|365165025|FG000|Overall Study|Withdrawal by Subject|1|||
105867600|NCT00098774|365165025|FG000|Overall Study|Failed (to respond) during induction|4|||
105867601|NCT00098774|365165025|FG000|Overall Study|Physician Decision|2|||
105867602|NCT04877457|365165026|FG000|Overall Study|Early termination of study due to low enrollment|2|||
105867603|NCT04877457|365165027|FG001|Overall Study|Early termination of study due to low enrollment|1|||
105867604|NCT00246324|365165028|FG000|Overall Study|Withdrawal by Subject|1|||
105867605|NCT02006732|365165029|FG000|Overall Study|Adverse Event|10|||
105867606|NCT02006732|365165030|FG001|Overall Study|Adverse Event|7|||
105867607|NCT02006732|365165031|FG002|Overall Study|Adverse Event|4|||
105867608|NCT02006732|365165032|FG003|Overall Study|Adverse Event|2|||
105867609|NCT02006732|365165029|FG000|Overall Study|Lack of Efficacy|6|||
105867610|NCT02006732|365165030|FG001|Overall Study|Lack of Efficacy|3|||
105867611|NCT02006732|365165031|FG002|Overall Study|Lack of Efficacy|1|||
105867612|NCT02006732|365165032|FG003|Overall Study|Lack of Efficacy|1|||
105867613|NCT02006732|365165029|FG000|Overall Study|Protocol Violation|1|||
106097346|NCT04137380|366014382|FG004|Overall Study|Physician Decision|0|||
106097347|NCT04137380|366014383|FG005|Overall Study|Physician Decision|0|||
106097348|NCT04137380|366014384|FG006|Overall Study|Physician Decision|0|||
106097349|NCT01343407|366014385|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
106097350|NCT01343407|366014386|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
106097351|NCT01343407|366014387|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
106097352|NCT01343407|366014388|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
105867614|NCT02006732|365165030|FG001|Overall Study|Protocol Violation|1|||
105867615|NCT02006732|365165031|FG002|Overall Study|Protocol Violation|0|||
105867616|NCT02006732|365165032|FG003|Overall Study|Protocol Violation|0|||
105867617|NCT02006732|365165029|FG000|Overall Study|Lost to Follow-up|0|||
105867618|NCT02006732|365165030|FG001|Overall Study|Lost to Follow-up|1|||
105867619|NCT02006732|365165031|FG002|Overall Study|Lost to Follow-up|0|||
105867620|NCT02006732|365165032|FG003|Overall Study|Lost to Follow-up|0|||
105867621|NCT02006732|365165029|FG000|Overall Study|Withdrawal by Subject|3|||
105867622|NCT02006732|365165030|FG001|Overall Study|Withdrawal by Subject|0|||
105867623|NCT02006732|365165031|FG002|Overall Study|Withdrawal by Subject|4|||
105867624|NCT02006732|365165032|FG003|Overall Study|Withdrawal by Subject|1|||
105867625|NCT00299130|365165033|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
105867626|NCT00299130|365165034|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
105867627|NCT00299130|365165035|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
105867628|NCT00299130|365165033|FG000|Treatment Period (up to 5 Years)|Death|1|||
105867629|NCT00299130|365165034|FG001|Treatment Period (up to 5 Years)|Death|3|||
105867630|NCT00299130|365165035|FG002|Treatment Period (up to 5 Years)|Death|1|||
105867631|NCT00299130|365165033|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
105867632|NCT00299130|365165034|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
105867633|NCT00299130|365165035|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
105867634|NCT00299130|365165033|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
105867635|NCT00299130|365165034|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
105867636|NCT00299130|365165035|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
105867637|NCT00299130|365165033|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
105867638|NCT00299130|365165034|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
105867639|NCT00299130|365165035|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
105867640|NCT00299130|365165033|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
105867641|NCT00299130|365165034|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
105867642|NCT00299130|365165035|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
105867643|NCT00299130|365165033|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
105867644|NCT00299130|365165034|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
105867645|NCT00299130|365165035|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
105867646|NCT00299130|365165033|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
105867647|NCT00299130|365165034|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
105867648|NCT00299130|365165035|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
105867649|NCT00299130|365165033|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
105867650|NCT00299130|365165034|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
105867651|NCT00299130|365165035|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
105867652|NCT00299130|365165033|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
105867653|NCT00299130|365165034|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
105867654|NCT00299130|365165035|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
105867655|NCT00299130|365165033|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
105867656|NCT00299130|365165034|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
105867657|NCT00299130|365165035|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
105867658|NCT00299130|365165033|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
105867659|NCT00299130|365165034|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
105867660|NCT00299130|365165035|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
105867661|NCT00299130|365165033|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
105867662|NCT00299130|365165034|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
105867663|NCT00299130|365165035|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
105867664|NCT00299130|365165033|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
105867665|NCT00299130|365165034|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
105867666|NCT00299130|365165035|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
105867667|NCT00299130|365165033|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
105867668|NCT00299130|365165034|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
105867669|NCT00299130|365165035|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
105867670|NCT00299130|365165033|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
105867671|NCT00299130|365165034|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
105867672|NCT00299130|365165035|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
105867673|NCT00299130|365165033|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
105867674|NCT00299130|365165034|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
105867675|NCT00299130|365165035|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
105867676|NCT02211417|365165036|FG000|Overall Study|Withdrawal by Subject|11|||
105867677|NCT02211417|365165037|FG001|Overall Study|Withdrawal by Subject|8|||
105867678|NCT02211417|365165036|FG000|Overall Study|Protocol Violation|1|||
105867679|NCT02211417|365165037|FG001|Overall Study|Protocol Violation|0|||
105867680|NCT02211417|365165036|FG000|Overall Study|Pregnancy|0|||
105867681|NCT02211417|365165037|FG001|Overall Study|Pregnancy|1|||
105867682|NCT02211417|365165036|FG000|Overall Study|Lost to Follow-up|2|||
105867683|NCT02211417|365165037|FG001|Overall Study|Lost to Follow-up|3|||
105867684|NCT02211417|365165036|FG000|Overall Study|Adverse Event|1|||
105867685|NCT02211417|365165037|FG001|Overall Study|Adverse Event|4|||
105867686|NCT01198132|365165038|FG000|Overall Study|Withdrawal by Subject|4|||
105867687|NCT01198132|365165039|FG001|Overall Study|Withdrawal by Subject|5|||
105867688|NCT01198132|365165038|FG000|Overall Study|Physician Decision|5|||
105867689|NCT01198132|365165039|FG001|Overall Study|Physician Decision|4|||
105867690|NCT01198132|365165038|FG000|Overall Study|Other Unspecified|3|||
105867691|NCT01198132|365165039|FG001|Overall Study|Other Unspecified|6|||
105867692|NCT01198132|365165038|FG000|Overall Study|Lack of Efficacy|2|||
105867693|NCT01198132|365165039|FG001|Overall Study|Lack of Efficacy|3|||
105867694|NCT01198132|365165038|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
105867695|NCT01198132|365165039|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
105867696|NCT01198132|365165038|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
105867697|NCT01198132|365165039|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
105867698|NCT01198132|365165038|FG000|Overall Study|Adverse Event|0|||
105867699|NCT01198132|365165039|FG001|Overall Study|Adverse Event|1|||
105867700|NCT01198132|365165038|FG000|Overall Study|Protocol Violation|1|||
105867701|NCT01198132|365165039|FG001|Overall Study|Protocol Violation|0|||
105867702|NCT01487525|365165041|FG000|Overall Study|Withdrawal by Subject|0|||
105867703|NCT01487525|365165042|FG001|Overall Study|Withdrawal by Subject|1|||
105867704|NCT00879086|365165043|FG000|Overall Study|Adverse Event|3|||
105867705|NCT00879086|365165044|FG001|Overall Study|Adverse Event|15|||
105867706|NCT00879086|365165043|FG000|Overall Study|Participant choice|2|||
105867707|NCT00879086|365165044|FG001|Overall Study|Participant choice|2|||
105867708|NCT00879086|365165043|FG000|Overall Study|Progression of disease|40|||
105867709|NCT00879086|365165044|FG001|Overall Study|Progression of disease|26|||
105867710|NCT00879086|365165043|FG000|Overall Study|Withdrawal of consent|2|||
105867711|NCT00879086|365165044|FG001|Overall Study|Withdrawal of consent|1|||
105867712|NCT00879086|365165043|FG000|Overall Study|Other|4|||
105867713|NCT00879086|365165044|FG001|Overall Study|Other|6|||
105867714|NCT00879086|365165043|FG000|Overall Study|Death|1|||
105867715|NCT00879086|365165044|FG001|Overall Study|Death|2|||
105867716|NCT01107197|365165046|FG000|Overall Study|Death|12|||
105867717|NCT01107197|365165047|FG001|Overall Study|Death|10|||
105867718|NCT01107197|365165046|FG000|Overall Study|Lost to Follow-up|5|||
105867719|NCT01107197|365165047|FG001|Overall Study|Lost to Follow-up|8|||
105867720|NCT01107197|365165046|FG000|Overall Study|Withdrawal by Subject|3|||
105867721|NCT01107197|365165047|FG001|Overall Study|Withdrawal by Subject|5|||
105867722|NCT03548337|365165048|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
105867723|NCT03548337|365165049|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
105867724|NCT03548337|365165048|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
105867725|NCT03548337|365165049|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
105867726|NCT03548337|365165048|FG000|Infant Series|Lost to Follow-up|2|||
105867727|NCT03548337|365165049|FG001|Infant Series|Lost to Follow-up|1|||
105867728|NCT03548337|365165048|FG000|Infant Series|Adverse Event|0|||
105867729|NCT03548337|365165049|FG001|Infant Series|Adverse Event|2|||
105867730|NCT03548337|365165048|FG000|Infant Series|Randomized but Not Vaccinated|1|||
105867731|NCT03548337|365165049|FG001|Infant Series|Randomized but Not Vaccinated|0|||
105867732|NCT03548337|365165048|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
105867733|NCT03548337|365165049|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
105984900|NCT00231413|365605975|FG000|Overall Study|Withdrawal by Subject|3|||
105984901|NCT00231413|365605976|FG001|Overall Study|Withdrawal by Subject|1|||
105984902|NCT00231413|365605977|FG002|Overall Study|Withdrawal by Subject|4|||
105984903|NCT00231413|365605978|FG003|Overall Study|Withdrawal by Subject|2|||
105984904|NCT00231413|365605979|FG004|Overall Study|Withdrawal by Subject|2|||
105984905|NCT00231413|365605980|FG005|Overall Study|Withdrawal by Subject|0|||
105984906|NCT00231413|365605981|FG006|Overall Study|Withdrawal by Subject|3|||
105984907|NCT00231413|365605975|FG000|Overall Study|Migrated/moved from study area|0|||
105984908|NCT00231413|365605976|FG001|Overall Study|Migrated/moved from study area|0|||
105984909|NCT00231413|365605977|FG002|Overall Study|Migrated/moved from study area|1|||
105984910|NCT00231413|365605978|FG003|Overall Study|Migrated/moved from study area|0|||
105984911|NCT00231413|365605979|FG004|Overall Study|Migrated/moved from study area|0|||
105984912|NCT00231413|365605980|FG005|Overall Study|Migrated/moved from study area|1|||
105984913|NCT00231413|365605981|FG006|Overall Study|Migrated/moved from study area|0|||
105984914|NCT00231413|365605975|FG000|Overall Study|Lost to Follow-up|4|||
105984915|NCT00231413|365605976|FG001|Overall Study|Lost to Follow-up|4|||
105984916|NCT00231413|365605977|FG002|Overall Study|Lost to Follow-up|1|||
105984917|NCT00231413|365605978|FG003|Overall Study|Lost to Follow-up|1|||
105984918|NCT00231413|365605979|FG004|Overall Study|Lost to Follow-up|1|||
105984919|NCT00231413|365605980|FG005|Overall Study|Lost to Follow-up|4|||
105984920|NCT00231413|365605981|FG006|Overall Study|Lost to Follow-up|0|||
105984921|NCT00231413|365605975|FG000|Overall Study|Pregnancy|1|||
105984922|NCT00231413|365605976|FG001|Overall Study|Pregnancy|0|||
105984923|NCT00231413|365605977|FG002|Overall Study|Pregnancy|0|||
105984924|NCT00231413|365605978|FG003|Overall Study|Pregnancy|0|||
105984925|NCT00231413|365605979|FG004|Overall Study|Pregnancy|0|||
105984926|NCT00231413|365605980|FG005|Overall Study|Pregnancy|0|||
105984927|NCT00231413|365605981|FG006|Overall Study|Pregnancy|0|||
105984928|NCT00902174|365605984|FG000|Overall Study|Adverse Event|27|||
105984929|NCT00902174|365605985|FG001|Overall Study|Adverse Event|7|||
105984930|NCT00902174|365605984|FG000|Overall Study|Lack of Efficacy|1|||
105984931|NCT00902174|365605985|FG001|Overall Study|Lack of Efficacy|5|||
105984932|NCT00902174|365605984|FG000|Overall Study|Death|2|||
105984933|NCT00902174|365605985|FG001|Overall Study|Death|2|||
105984934|NCT00902174|365605984|FG000|Overall Study|Withdrawal by Subject|2|||
105984935|NCT00902174|365605985|FG001|Overall Study|Withdrawal by Subject|1|||
105984936|NCT00902174|365605984|FG000|Overall Study|Abnormal labs|1|||
105984937|NCT00902174|365605985|FG001|Overall Study|Abnormal labs|1|||
105984938|NCT00902174|365605984|FG000|Overall Study|Protocol Violation|1|||
105984939|NCT00902174|365605985|FG001|Overall Study|Protocol Violation|1|||
105984940|NCT00902174|365605984|FG000|Overall Study|Administration problem|0|||
105984941|NCT00902174|365605985|FG001|Overall Study|Administration problem|1|||
105984942|NCT01641822|365605986|FG000|Run-in Phase|Noncompliance with study drug|1|||
105984943|NCT01641822|365605987|FG001|Run-in Phase|Noncompliance with study drug|0|||
105984944|NCT01641822|365605988|FG002|Run-in Phase|Noncompliance with study drug|0|||
105984945|NCT01641822|365605986|FG000|Run-in Phase|Adverse Event|3|||
105984946|NCT01641822|365605987|FG001|Run-in Phase|Adverse Event|0|||
105984947|NCT01641822|365605988|FG002|Run-in Phase|Adverse Event|0|||
105984948|NCT01641822|365605986|FG000|Run-in Phase|Withdrew consent|1|||
105984949|NCT01641822|365605987|FG001|Run-in Phase|Withdrew consent|0|||
105984950|NCT01641822|365605988|FG002|Run-in Phase|Withdrew consent|0|||
105984951|NCT01641822|365605986|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
105984952|NCT01641822|365605987|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
105984953|NCT01641822|365605988|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
105984954|NCT01641822|365605986|FG000|Comparative Phase|Noncompliance with study drug|0|||
105984955|NCT01641822|365605987|FG001|Comparative Phase|Noncompliance with study drug|1|||
105984956|NCT01641822|365605988|FG002|Comparative Phase|Noncompliance with study drug|0|||
105984957|NCT01641822|365605986|FG000|Comparative Phase|Investigator's discretion|0|||
105984958|NCT01641822|365605987|FG001|Comparative Phase|Investigator's discretion|0|||
105984959|NCT01641822|365605988|FG002|Comparative Phase|Investigator's discretion|1|||
105984960|NCT01641822|365605986|FG000|Comparative Phase|Pregnancy|0|||
105984961|NCT01641822|365605987|FG001|Comparative Phase|Pregnancy|0|||
105984962|NCT01641822|365605988|FG002|Comparative Phase|Pregnancy|1|||
105984963|NCT01641822|365605986|FG000|Comparative Phase|Adverse event, serious fatal|0|||
105984964|NCT01641822|365605987|FG001|Comparative Phase|Adverse event, serious fatal|1|||
105984965|NCT01641822|365605988|FG002|Comparative Phase|Adverse event, serious fatal|0|||
105984966|NCT01641822|365605986|FG000|Comparative Phase|Withdrew consent|0|||
105984967|NCT01641822|365605987|FG001|Comparative Phase|Withdrew consent|3|||
105984968|NCT01641822|365605988|FG002|Comparative Phase|Withdrew consent|7|||
105984969|NCT01641822|365605986|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
105984970|NCT01641822|365605987|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
105984971|NCT01641822|365605988|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
105984972|NCT03129360|365605989|FG000|Overall Study|Did not meet entry criteria|0|||
105984973|NCT03129360|365605990|FG001|Overall Study|Did not meet entry criteria|2|||
105984974|NCT03129360|365605991|FG002|Overall Study|Did not meet entry criteria|1|||
105984975|NCT03129360|365605989|FG000|Overall Study|Excluded due to motion in scanner|1|||
105984976|NCT03129360|365605990|FG001|Overall Study|Excluded due to motion in scanner|0|||
105984977|NCT03129360|365605991|FG002|Overall Study|Excluded due to motion in scanner|0|||
105984978|NCT00494507|365605992|FG000|Double-Blind Phase|Adverse Event|2|||
105984979|NCT00494507|365605993|FG001|Double-Blind Phase|Adverse Event|0|||
105984980|NCT00494507|365605994|FG002|Double-Blind Phase|Adverse Event|1|||
105984981|NCT00494507|365605995|FG003|Double-Blind Phase|Adverse Event|0|||
105984982|NCT00494507|365605992|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
105984983|NCT00494507|365605993|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
105984984|NCT00494507|365605994|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
105984985|NCT00494507|365605995|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
105984986|NCT00494507|365605992|FG000|Double-Blind Phase|Subject Non-compliance|0|||
105984987|NCT00494507|365605993|FG001|Double-Blind Phase|Subject Non-compliance|0|||
105984988|NCT00494507|365605994|FG002|Double-Blind Phase|Subject Non-compliance|1|||
105984989|NCT00494507|365605995|FG003|Double-Blind Phase|Subject Non-compliance|0|||
105984990|NCT00494507|365605992|FG000|Double-Blind Phase|Negative DNA test|0|||
105984991|NCT00494507|365605993|FG001|Double-Blind Phase|Negative DNA test|0|||
105984992|NCT00494507|365605994|FG002|Double-Blind Phase|Negative DNA test|0|||
105984993|NCT00494507|365605995|FG003|Double-Blind Phase|Negative DNA test|1|||
105984994|NCT00494507|365605992|FG000|Open-Label Phase|Adverse Event|0|||
105984995|NCT00494507|365605993|FG001|Open-Label Phase|Adverse Event|1|||
105984996|NCT00494507|365605994|FG002|Open-Label Phase|Adverse Event|5|||
105984997|NCT00494507|365605995|FG003|Open-Label Phase|Adverse Event|3|||
105984998|NCT00494507|365605992|FG000|Open-Label Phase|Worsening Disease|0|||
105984999|NCT00494507|365605993|FG001|Open-Label Phase|Worsening Disease|0|||
105985000|NCT00494507|365605994|FG002|Open-Label Phase|Worsening Disease|0|||
105985001|NCT00494507|365605995|FG003|Open-Label Phase|Worsening Disease|2|||
105985002|NCT00764673|365605996|FG000|Overall Study|Death|1|||
105985003|NCT00764673|365605996|FG000|Overall Study|Lost to Follow-up|3|||
105985004|NCT00764673|365605996|FG000|Overall Study|Withdrawal by Subject|6|||
105985005|NCT00764673|365605996|FG000|Overall Study|Revision of Device|2|||
105985006|NCT01438177|365605998|FG000|Overall Study|Withdrawal by Subject|1|||
105985007|NCT01438177|365605998|FG000|Overall Study|Initiation of new therapy|1|||
105985008|NCT00084487|365606002|FG000|Overall Study|Death|1|||
105985009|NCT00565136|365606003|FG000|Overall Study|Lost to Follow-up|1|||
105985010|NCT00565136|365606003|FG000|Overall Study|Withdrawal by Subject|1|||
105985011|NCT00565136|365606003|FG000|Overall Study|Protocol Violation|1|||
105985012|NCT00619099|365606004|FG000|Overall Study|Progressive Disease|7|||
105985013|NCT00619099|365606005|FG001|Overall Study|Progressive Disease|5|||
105985014|NCT00619099|365606004|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
105985015|NCT00619099|365606005|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
105985016|NCT00619099|365606004|FG000|Overall Study|Adverse Event|4|||
105985017|NCT00619099|365606005|FG001|Overall Study|Adverse Event|3|||
105985018|NCT00619099|365606004|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
105985019|NCT00619099|365606005|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
105985020|NCT00619099|365606004|FG000|Overall Study|Withdrawal by Subject|10|||
105985021|NCT00619099|365606005|FG001|Overall Study|Withdrawal by Subject|2|||
105985022|NCT00619099|365606004|FG000|Overall Study|Physician Decision|9|||
105985023|NCT00619099|365606005|FG001|Overall Study|Physician Decision|6|||
105985024|NCT00084656|365606006|FG000|Overall Study|Other reasons|0|||
105985025|NCT00084656|365606007|FG001|Overall Study|Other reasons|12|||
105985026|NCT00084656|365606008|FG002|Overall Study|Other reasons|11|||
105985027|NCT00084656|365606006|FG000|Overall Study|Withdrawal by Subject|15|||
105985028|NCT00084656|365606007|FG001|Overall Study|Withdrawal by Subject|4|||
105985029|NCT00084656|365606008|FG002|Overall Study|Withdrawal by Subject|4|||
105985030|NCT00084656|365606006|FG000|Overall Study|Disease relapse|0|||
105985031|NCT00084656|365606007|FG001|Overall Study|Disease relapse|9|||
105985032|NCT00084656|365606008|FG002|Overall Study|Disease relapse|10|||
105985033|NCT00084656|365606006|FG000|Overall Study|Disease progression|9|||
105985034|NCT00084656|365606007|FG001|Overall Study|Disease progression|0|||
105985035|NCT00084656|365606008|FG002|Overall Study|Disease progression|0|||
105985036|NCT00084656|365606006|FG000|Overall Study|Lost to Follow-up|1|||
105985037|NCT00084656|365606007|FG001|Overall Study|Lost to Follow-up|0|||
105985038|NCT00084656|365606008|FG002|Overall Study|Lost to Follow-up|1|||
105985039|NCT02772978|365606009|FG000|Overall Study|Withdrawal by Subject|1|||
105985040|NCT02772978|365606010|FG001|Overall Study|Withdrawal by Subject|1|||
105985041|NCT00694304|365606011|FG000|Overall Study|Adverse Event|42|||
105985042|NCT00694304|365606011|FG000|Overall Study|Lack of Efficacy|35|||
105985043|NCT00694304|365606011|FG000|Overall Study|Non-compliance With Study Product|16|||
105985044|NCT00694304|365606011|FG000|Overall Study|Protocol Violation|6|||
105985045|NCT00694304|365606011|FG000|Overall Study|Withdrawal of Consent|61|||
105985046|NCT00694304|365606011|FG000|Overall Study|Lost to Follow-up|15|||
105985047|NCT00694304|365606011|FG000|Overall Study|Administrative or Other Reasons|32|||
105985048|NCT03550404|365606013|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
105985049|NCT03550404|365606014|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
105985050|NCT03550404|365606015|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
105985051|NCT03550404|365606013|FG000|Phase 2|Vacated position|1|||
105985052|NCT03550404|365606014|FG001|Phase 2|Vacated position|0|||
105985053|NCT03550404|365606015|FG002|Phase 2|Vacated position|0|||
105985054|NCT00576576|365606017|FG000|Overall Study|Lost to Follow-up|6|||
105985055|NCT00576576|365606017|FG000|Overall Study|Protocol Violation|1|||
105985056|NCT03517566|365606022|FG000|Overall Study|Adverse Event|5|||
105985057|NCT03517566|365606023|FG001|Overall Study|Adverse Event|2|||
105985058|NCT03517566|365606024|FG002|Overall Study|Adverse Event|2|||
105985059|NCT03517566|365606025|FG003|Overall Study|Adverse Event|8|||
105985060|NCT03517566|365606026|FG004|Overall Study|Adverse Event|7|||
105985061|NCT03517566|365606022|FG000|Overall Study|Lack of Efficacy|3|||
105985062|NCT03517566|365606023|FG001|Overall Study|Lack of Efficacy|2|||
105985063|NCT03517566|365606024|FG002|Overall Study|Lack of Efficacy|1|||
105985064|NCT03517566|365606025|FG003|Overall Study|Lack of Efficacy|1|||
105985065|NCT03517566|365606026|FG004|Overall Study|Lack of Efficacy|4|||
105985066|NCT03517566|365606022|FG000|Overall Study|Lost to Follow-up|3|||
105985067|NCT03517566|365606023|FG001|Overall Study|Lost to Follow-up|1|||
105985068|NCT03517566|365606024|FG002|Overall Study|Lost to Follow-up|1|||
105985069|NCT03517566|365606025|FG003|Overall Study|Lost to Follow-up|1|||
105985070|NCT03517566|365606026|FG004|Overall Study|Lost to Follow-up|0|||
105985071|NCT03517566|365606022|FG000|Overall Study|Physician Decision|1|||
105985072|NCT03517566|365606023|FG001|Overall Study|Physician Decision|1|||
105985073|NCT03517566|365606024|FG002|Overall Study|Physician Decision|0|||
105985074|NCT03517566|365606025|FG003|Overall Study|Physician Decision|1|||
105985075|NCT03517566|365606026|FG004|Overall Study|Physician Decision|0|||
105985076|NCT03517566|365606022|FG000|Overall Study|Pregnancy|0|||
105985077|NCT03517566|365606023|FG001|Overall Study|Pregnancy|1|||
105985078|NCT03517566|365606024|FG002|Overall Study|Pregnancy|0|||
105985079|NCT03517566|365606025|FG003|Overall Study|Pregnancy|0|||
105985080|NCT03517566|365606026|FG004|Overall Study|Pregnancy|0|||
105985081|NCT03517566|365606022|FG000|Overall Study|Protocol Deviation|0|||
105985082|NCT03517566|365606023|FG001|Overall Study|Protocol Deviation|1|||
105985083|NCT03517566|365606024|FG002|Overall Study|Protocol Deviation|0|||
105985084|NCT03517566|365606025|FG003|Overall Study|Protocol Deviation|1|||
105985085|NCT03517566|365606026|FG004|Overall Study|Protocol Deviation|1|||
105985086|NCT03517566|365606022|FG000|Overall Study|Study terminated by Sponsor|11|||
105985087|NCT03517566|365606023|FG001|Overall Study|Study terminated by Sponsor|5|||
105985088|NCT03517566|365606024|FG002|Overall Study|Study terminated by Sponsor|6|||
105985089|NCT03517566|365606025|FG003|Overall Study|Study terminated by Sponsor|14|||
105985090|NCT03517566|365606026|FG004|Overall Study|Study terminated by Sponsor|12|||
105985091|NCT03517566|365606022|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
105985092|NCT03517566|365606023|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
105985093|NCT03517566|365606024|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
105985094|NCT03517566|365606025|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
105985095|NCT03517566|365606026|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
105985096|NCT00671437|365606027|FG000|Overall Study|Progressive disease before C1 week 8|8|||
105985097|NCT00671437|365606027|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
105985098|NCT00671437|365606027|FG000|Overall Study|Adverse Event|3|||
105985099|NCT00671437|365606027|FG000|Overall Study|Ineligible post-hoc|1|||
105985100|NCT00590577|365606028|FG000|Overall Study|Lack of Efficacy|31|||
105985101|NCT00590577|365606029|FG001|Overall Study|Lack of Efficacy|28|||
105985102|NCT00590577|365606030|FG002|Overall Study|Lack of Efficacy|23|||
105985103|NCT00590577|365606031|FG003|Overall Study|Lack of Efficacy|45|||
105985104|NCT00590577|365606028|FG000|Overall Study|Withdrawal by Subject|23|||
105985105|NCT00590577|365606029|FG001|Overall Study|Withdrawal by Subject|28|||
105985106|NCT00590577|365606030|FG002|Overall Study|Withdrawal by Subject|30|||
105985107|NCT00590577|365606031|FG003|Overall Study|Withdrawal by Subject|26|||
105985108|NCT00590577|365606028|FG000|Overall Study|Adverse Event|10|||
105985109|NCT00590577|365606029|FG001|Overall Study|Adverse Event|10|||
105985110|NCT00590577|365606030|FG002|Overall Study|Adverse Event|13|||
105985111|NCT00590577|365606031|FG003|Overall Study|Adverse Event|11|||
105985112|NCT00590577|365606028|FG000|Overall Study|Lost to Follow-up|12|||
105985113|NCT00590577|365606029|FG001|Overall Study|Lost to Follow-up|6|||
105985114|NCT00590577|365606030|FG002|Overall Study|Lost to Follow-up|6|||
105985115|NCT00590577|365606031|FG003|Overall Study|Lost to Follow-up|9|||
105985116|NCT00590577|365606028|FG000|Overall Study|Pregnancy|0|||
105985117|NCT00590577|365606029|FG001|Overall Study|Pregnancy|1|||
105985118|NCT00590577|365606030|FG002|Overall Study|Pregnancy|0|||
105985119|NCT00590577|365606031|FG003|Overall Study|Pregnancy|0|||
105985120|NCT00590577|365606028|FG000|Overall Study|Various reasons|1|||
105985121|NCT00590577|365606029|FG001|Overall Study|Various reasons|3|||
105985122|NCT00590577|365606030|FG002|Overall Study|Various reasons|1|||
105985123|NCT00590577|365606031|FG003|Overall Study|Various reasons|2|||
105985124|NCT00932165|365606032|FG000|Overall Study|Lost to Follow-up|1|||
105985125|NCT03927404|365606033|FG000|Overall Study|Withdrawal by Subject|1|||
105985126|NCT00737633|365606035|FG000|Overall Study|Study terminated by sponsor|44|||
105985127|NCT00737633|365606036|FG001|Overall Study|Study terminated by sponsor|55|||
105985128|NCT00737633|365606035|FG000|Overall Study|Lost to Follow-up|0|||
105985129|NCT00737633|365606036|FG001|Overall Study|Lost to Follow-up|1|||
105985130|NCT00737633|365606035|FG000|Overall Study|protocol non-compliance|0|||
105985131|NCT00737633|365606036|FG001|Overall Study|protocol non-compliance|1|||
105985132|NCT01300260|365606041|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
105985133|NCT01300260|365606042|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
105985134|NCT01300260|365606041|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
105985135|NCT01300260|365606042|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
105985136|NCT01300260|365606041|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
105985137|NCT01300260|365606042|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
105985138|NCT01147848|365606047|FG000|Run-in Period|Screen Failure|623|||
105985139|NCT01147848|365606048|FG001|Run-in Period|Screen Failure|0|||
105985140|NCT01147848|365606049|FG002|Run-in Period|Screen Failure|0|||
105985141|NCT01147848|365606047|FG000|Run-in Period|Run-in Failure|135|||
105985142|NCT01147848|365606048|FG001|Run-in Period|Run-in Failure|0|||
105985143|NCT01147848|365606049|FG002|Run-in Period|Run-in Failure|0|||
105985144|NCT01147848|365606047|FG000|Randomized Phase|Adverse Event|0|||
105985145|NCT01147848|365606048|FG001|Randomized Phase|Adverse Event|6|||
105985146|NCT01147848|365606049|FG002|Randomized Phase|Adverse Event|8|||
105985147|NCT01147848|365606047|FG000|Randomized Phase|Lack of Efficacy|0|||
105985148|NCT01147848|365606048|FG001|Randomized Phase|Lack of Efficacy|20|||
105985149|NCT01147848|365606049|FG002|Randomized Phase|Lack of Efficacy|11|||
105985150|NCT01147848|365606047|FG000|Randomized Phase|Protocol Violation|0|||
105985151|NCT01147848|365606048|FG001|Randomized Phase|Protocol Violation|7|||
105985152|NCT01147848|365606049|FG002|Randomized Phase|Protocol Violation|10|||
105985153|NCT01147848|365606047|FG000|Randomized Phase|Lost to Follow-up|0|||
105985154|NCT01147848|365606048|FG001|Randomized Phase|Lost to Follow-up|5|||
105985155|NCT01147848|365606049|FG002|Randomized Phase|Lost to Follow-up|7|||
105985156|NCT01147848|365606047|FG000|Randomized Phase|Physician Decision|0|||
105985157|NCT01147848|365606048|FG001|Randomized Phase|Physician Decision|0|||
105985158|NCT01147848|365606049|FG002|Randomized Phase|Physician Decision|1|||
105985159|NCT01147848|365606047|FG000|Randomized Phase|Withdrawal by Subject|0|||
105985160|NCT01147848|365606048|FG001|Randomized Phase|Withdrawal by Subject|7|||
105985161|NCT01147848|365606049|FG002|Randomized Phase|Withdrawal by Subject|9|||
105985162|NCT03180307|365606050|FG000|Overall Study|Lost to Follow-up|2|||
105985163|NCT03180307|365606051|FG001|Overall Study|Lost to Follow-up|0|||
105985164|NCT03180307|365606050|FG000|Overall Study|Death|1|||
105985165|NCT03180307|365606051|FG001|Overall Study|Death|0|||
105985166|NCT03180307|365606050|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
105985167|NCT03180307|365606051|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
105985168|NCT04583956|365606065|FG000|Overall Study|Death|9|||
105985169|NCT04583956|365606066|FG001|Overall Study|Death|11|||
105985170|NCT04583956|365606065|FG000|Overall Study|Lost to Follow-up|7|||
105985171|NCT04583956|365606066|FG001|Overall Study|Lost to Follow-up|9|||
105985172|NCT04583956|365606065|FG000|Overall Study|Protocol Violation|2|||
105985173|NCT04583956|365606066|FG001|Overall Study|Protocol Violation|0|||
105985174|NCT04583956|365606065|FG000|Overall Study|Withdrawal by Subject|0|||
105985175|NCT04583956|365606066|FG001|Overall Study|Withdrawal by Subject|2|||
105985176|NCT04583956|365606065|FG000|Overall Study|Randomized but not dosed|2|||
105985177|NCT04583956|365606066|FG001|Overall Study|Randomized but not dosed|3|||
105985178|NCT04583956|365606065|FG000|Overall Study|Withdrawal of consent before product administration|1|||
105985179|NCT04583956|365606066|FG001|Overall Study|Withdrawal of consent before product administration|0|||
105985180|NCT02332291|365606067|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
105985181|NCT02332291|365606068|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
105985182|NCT02332291|365606067|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
105985183|NCT02332291|365606068|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
105985184|NCT02332291|365606067|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
105985185|NCT02332291|365606068|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
105985186|NCT02332291|365606067|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
105985187|NCT02332291|365606068|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
105985188|NCT02332291|365606067|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
105985189|NCT02332291|365606068|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
105985190|NCT02332291|365606067|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
105985191|NCT02332291|365606068|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
105985192|NCT00727558|365606073|FG000|Overall Study|Lens issue|0|||
105985193|NCT00727558|365606074|FG001|Overall Study|Lens issue|1|||
105985194|NCT00727558|365606073|FG000|Overall Study|Adverse Event|0|||
105985195|NCT00727558|365606074|FG001|Overall Study|Adverse Event|1|||
105985196|NCT00727558|365606073|FG000|Overall Study|Subject unable to return for follow-up|1|||
105985197|NCT00727558|365606074|FG001|Overall Study|Subject unable to return for follow-up|1|||
105985198|NCT00727558|365606073|FG000|Overall Study|Lost to Follow-up|1|||
105985199|NCT00727558|365606074|FG001|Overall Study|Lost to Follow-up|0|||
105985200|NCT02456857|365606075|FG000|Overall Study|Disease Progression|4|||
105985201|NCT00781859|365606076|FG000|Overall Study|Adverse Event|2|||
105985202|NCT00781859|365606077|FG001|Overall Study|Adverse Event|2|||
105985203|NCT00781859|365606076|FG000|Overall Study|Withdrawal by Subject|8|||
105985204|NCT00781859|365606077|FG001|Overall Study|Withdrawal by Subject|4|||
105985205|NCT00781859|365606076|FG000|Overall Study|Lost to Follow-up|6|||
105985206|NCT00781859|365606077|FG001|Overall Study|Lost to Follow-up|3|||
105985207|NCT00781859|365606076|FG000|Overall Study|Death|3|||
105985208|NCT00781859|365606077|FG001|Overall Study|Death|0|||
105985209|NCT01220180|365606078|FG000|Overall Study|Lost to Follow-up|76|||
105985210|NCT01220180|365606078|FG000|Overall Study|Other|72|||
105985211|NCT01220180|365606078|FG000|Overall Study|Adverse Event|35|||
105985212|NCT01220180|365606078|FG000|Overall Study|Lack of Efficacy|22|||
105985213|NCT01220180|365606078|FG000|Overall Study|Death|1|||
105985214|NCT01220180|365606078|FG000|Overall Study|Randomized but not treated|1|||
105985215|NCT00348309|365606081|FG000|Overall Study|Adverse Event|56|||
105985216|NCT00348309|365606082|FG001|Overall Study|Adverse Event|28|||
105985217|NCT00348309|365606083|FG002|Overall Study|Adverse Event|63|||
105985218|NCT00348309|365606081|FG000|Overall Study|Lost to Follow-up|6|||
105985219|NCT00348309|365606082|FG001|Overall Study|Lost to Follow-up|7|||
105985220|NCT00348309|365606083|FG002|Overall Study|Lost to Follow-up|4|||
105985221|NCT00348309|365606081|FG000|Overall Study|Protocol Violation|7|||
105985222|NCT00348309|365606082|FG001|Overall Study|Protocol Violation|12|||
105985223|NCT00348309|365606083|FG002|Overall Study|Protocol Violation|7|||
105985224|NCT00348309|365606081|FG000|Overall Study|Withdrawal by Subject|33|||
105985225|NCT00348309|365606082|FG001|Overall Study|Withdrawal by Subject|37|||
105985226|NCT00348309|365606083|FG002|Overall Study|Withdrawal by Subject|40|||
105985227|NCT00348309|365606081|FG000|Overall Study|Non-compliance|8|||
105985228|NCT00348309|365606082|FG001|Overall Study|Non-compliance|6|||
105985229|NCT00348309|365606083|FG002|Overall Study|Non-compliance|8|||
105867734|NCT04700137|365165052|FG000|Overall Study|Lost to Follow-up|1|||
105867735|NCT04700137|365165053|FG001|Overall Study|Lost to Follow-up|6|||
105867736|NCT04700137|365165054|FG002|Overall Study|Lost to Follow-up|1|||
105867737|NCT04700137|365165055|FG003|Overall Study|Lost to Follow-up|1|||
105867738|NCT04700137|365165052|FG000|Overall Study|Withdrawal by Subject|0|||
105867739|NCT04700137|365165053|FG001|Overall Study|Withdrawal by Subject|0|||
105867740|NCT04700137|365165054|FG002|Overall Study|Withdrawal by Subject|1|||
105867741|NCT04700137|365165055|FG003|Overall Study|Withdrawal by Subject|0|||
105867742|NCT04700137|365165052|FG000|Overall Study|Death|0|||
105867743|NCT04700137|365165053|FG001|Overall Study|Death|0|||
105867744|NCT04700137|365165054|FG002|Overall Study|Death|1|||
105867745|NCT04700137|365165055|FG003|Overall Study|Death|0|||
105867746|NCT02503787|365165056|FG000|Enrollment|Withdrawal by Subject|6|||
105867747|NCT02503787|365165056|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
105867748|NCT02503787|365165056|FG000|Enrollment|Physician Decision|2|||
105867749|NCT02503787|365165056|FG000|Enrollment|Insurance issue|2|||
105867750|NCT02503787|365165056|FG000|Enrollment|Lost to Follow-up|1|||
105867751|NCT02503787|365165056|FG000|Enrollment|Study closure|1|||
105867752|NCT02503787|365165056|FG000|Enrollment|Adverse Event|1|||
105867753|NCT02503787|365165056|FG000|Enrollment|Protocol Violation|1|||
105867754|NCT02503787|365165056|FG000|Enrollment|Inability to implant system|1|||
105867755|NCT02503787|365165056|FG000|Enrollment|Unable to be programmed|1|||
105867756|NCT02503787|365165056|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
105867757|NCT02503787|365165056|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
105867758|NCT02503787|365165056|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
105867759|NCT02503787|365165056|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
105867760|NCT02503787|365165056|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
105867761|NCT02503787|365165056|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
105867762|NCT01449812|365165057|FG000|Overall Study|Migrated/moved from study area|1|||
105867763|NCT01449812|365165058|FG001|Overall Study|Migrated/moved from study area|0|||
105867764|NCT01449812|365165059|FG002|Overall Study|Migrated/moved from study area|0|||
105867765|NCT01449812|365165057|FG000|Overall Study|Withdrawal by Subject|0|||
105867766|NCT01449812|365165058|FG001|Overall Study|Withdrawal by Subject|0|||
105867767|NCT01449812|365165059|FG002|Overall Study|Withdrawal by Subject|1|||
105867768|NCT01449812|365165057|FG000|Overall Study|Lost to Follow-up|1|||
105867769|NCT01449812|365165058|FG001|Overall Study|Lost to Follow-up|0|||
105867770|NCT01449812|365165059|FG002|Overall Study|Lost to Follow-up|0|||
105867771|NCT02296931|365165067|FG000|Overall Study|Protocol Violation|0|||
105867772|NCT02296931|365165068|FG001|Overall Study|Protocol Violation|2|||
105867773|NCT05513391|365165071|FG000|Overall Study|Adverse Event|1|||
105867774|NCT05513391|365165072|FG001|Overall Study|Adverse Event|0|||
105867775|NCT05513391|365165071|FG000|Overall Study|Protocol Deviation|0|||
105867776|NCT05513391|365165072|FG001|Overall Study|Protocol Deviation|1|||
105867777|NCT05513391|365165071|FG000|Overall Study|Withdrawal by Subject|3|||
105867778|NCT05513391|365165072|FG001|Overall Study|Withdrawal by Subject|1|||
105867779|NCT05513391|365165071|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
105867780|NCT05513391|365165072|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
105867781|NCT05513391|365165071|FG000|Overall Study|Lost to Follow-up|0|||
105867782|NCT05513391|365165072|FG001|Overall Study|Lost to Follow-up|2|||
105867783|NCT01632280|365165086|FG000|Overall Study|Withdrawal by Subject|1|||
105867784|NCT01632280|365165087|FG001|Overall Study|Withdrawal by Subject|0|||
105867785|NCT04208750|365165088|FG000|Overall Study|Lost to Follow-up|16|||
105867786|NCT04208750|365165089|FG001|Overall Study|Lost to Follow-up|15|||
105867787|NCT05022212|365165096|FG000|Overall Study|Lost to Follow-up|0|||
105867788|NCT05022212|365165097|FG001|Overall Study|Lost to Follow-up|2|||
105867789|NCT02291510|365167004|FG000|Overall Study|Adverse Event|0|||
105867790|NCT02291510|365167005|FG001|Overall Study|Adverse Event|0|||
105867791|NCT02291510|365167006|FG002|Overall Study|Adverse Event|0|||
105867792|NCT02291510|365167007|FG003|Overall Study|Adverse Event|1|||
105867793|NCT02454608|365167008|FG000|Double-Blind Period|Lack of Efficacy|0|||
105867794|NCT02454608|365167009|FG001|Double-Blind Period|Lack of Efficacy|2|||
105867795|NCT02454608|365167010|FG002|Double-Blind Period|Lack of Efficacy|0|||
105867796|NCT02454608|365167008|FG000|Open Label Period|Lost to Follow-up|0|||
105867797|NCT02454608|365167009|FG001|Open Label Period|Lost to Follow-up|0|||
105867798|NCT02454608|365167010|FG002|Open Label Period|Lost to Follow-up|11|||
105867799|NCT02454608|365167008|FG000|Open Label Period|Withdrawal by Subject|0|||
105867800|NCT02454608|365167009|FG001|Open Label Period|Withdrawal by Subject|0|||
105867801|NCT02454608|365167010|FG002|Open Label Period|Withdrawal by Subject|8|||
105867802|NCT01433055|365167011|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
105867803|NCT01433055|365167012|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
105867804|NCT01433055|365167011|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
105867805|NCT01433055|365167012|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
105867806|NCT00233948|365167015|FG000|Overall Study|Adverse Event|1|||
105867807|NCT00233948|365167016|FG001|Overall Study|Adverse Event|0|||
105985230|NCT00348309|365606081|FG000|Overall Study|Death of caregiver|1|||
105985231|NCT00348309|365606082|FG001|Overall Study|Death of caregiver|0|||
105985232|NCT00348309|365606083|FG002|Overall Study|Death of caregiver|1|||
105985233|NCT00348309|365606081|FG000|Overall Study|Lack of insight, dementia|1|||
105985234|NCT00348309|365606082|FG001|Overall Study|Lack of insight, dementia|0|||
105985235|NCT00348309|365606083|FG002|Overall Study|Lack of insight, dementia|0|||
105985236|NCT00348309|365606081|FG000|Overall Study|Wrong bottle allocated|1|||
105985237|NCT00348309|365606082|FG001|Overall Study|Wrong bottle allocated|0|||
105985238|NCT00348309|365606083|FG002|Overall Study|Wrong bottle allocated|0|||
105985239|NCT00348309|365606081|FG000|Overall Study|Caregiver sick|1|||
105985240|NCT00348309|365606082|FG001|Overall Study|Caregiver sick|0|||
105985241|NCT00348309|365606083|FG002|Overall Study|Caregiver sick|0|||
105985242|NCT00348309|365606081|FG000|Overall Study|Use of prohibited medication|5|||
105985243|NCT00348309|365606082|FG001|Overall Study|Use of prohibited medication|2|||
105985244|NCT00348309|365606083|FG002|Overall Study|Use of prohibited medication|2|||
105985245|NCT00348309|365606081|FG000|Overall Study|Caregiver withdrawal|3|||
105985246|NCT00348309|365606082|FG001|Overall Study|Caregiver withdrawal|0|||
105985247|NCT00348309|365606083|FG002|Overall Study|Caregiver withdrawal|7|||
105985248|NCT00348309|365606081|FG000|Overall Study|Unable to complete ET visit|1|||
105985249|NCT00348309|365606082|FG001|Overall Study|Unable to complete ET visit|0|||
105985250|NCT00348309|365606083|FG002|Overall Study|Unable to complete ET visit|0|||
105985251|NCT00348309|365606081|FG000|Overall Study|PI closing medical practice|1|||
105985252|NCT00348309|365606082|FG001|Overall Study|PI closing medical practice|0|||
105985253|NCT00348309|365606083|FG002|Overall Study|PI closing medical practice|0|||
105985254|NCT00348309|365606081|FG000|Overall Study|Principal investigator's decision|1|||
105985255|NCT00348309|365606082|FG001|Overall Study|Principal investigator's decision|0|||
105985256|NCT00348309|365606083|FG002|Overall Study|Principal investigator's decision|0|||
105985257|NCT00348309|365606081|FG000|Overall Study|No disponibility of medication|1|||
105985258|NCT00348309|365606082|FG001|Overall Study|No disponibility of medication|0|||
105985259|NCT00348309|365606083|FG002|Overall Study|No disponibility of medication|0|||
105985260|NCT00348309|365606081|FG000|Overall Study|Worsened neurodegenerative disease|1|||
105985261|NCT00348309|365606082|FG001|Overall Study|Worsened neurodegenerative disease|0|||
105985262|NCT00348309|365606083|FG002|Overall Study|Worsened neurodegenerative disease|0|||
105985263|NCT00348309|365606081|FG000|Overall Study|Cognitive and behaviour worsening|2|||
105985264|NCT00348309|365606082|FG001|Overall Study|Cognitive and behaviour worsening|0|||
105985265|NCT00348309|365606083|FG002|Overall Study|Cognitive and behaviour worsening|0|||
105985266|NCT00348309|365606081|FG000|Overall Study|Worsening of alzheimer|1|||
105985267|NCT00348309|365606082|FG001|Overall Study|Worsening of alzheimer|0|||
105985268|NCT00348309|365606083|FG002|Overall Study|Worsening of alzheimer|1|||
105985269|NCT00348309|365606081|FG000|Overall Study|Did not appear in time for Visit 3|1|||
105985270|NCT00348309|365606082|FG001|Overall Study|Did not appear in time for Visit 3|0|||
105985271|NCT00348309|365606083|FG002|Overall Study|Did not appear in time for Visit 3|0|||
105985272|NCT00348309|365606081|FG000|Overall Study|Participant died|2|||
105985273|NCT00348309|365606082|FG001|Overall Study|Participant died|1|||
105985274|NCT00348309|365606083|FG002|Overall Study|Participant died|1|||
105985275|NCT00348309|365606081|FG000|Overall Study|Decision of sponsor|1|||
105985276|NCT00348309|365606082|FG001|Overall Study|Decision of sponsor|0|||
105985277|NCT00348309|365606083|FG002|Overall Study|Decision of sponsor|0|||
105985278|NCT00348309|365606081|FG000|Overall Study|Ineffectiveness of treatment|0|||
105985279|NCT00348309|365606082|FG001|Overall Study|Ineffectiveness of treatment|1|||
105985280|NCT00348309|365606083|FG002|Overall Study|Ineffectiveness of treatment|0|||
105985281|NCT00348309|365606081|FG000|Overall Study|A foul of exclusion criteria|0|||
105985282|NCT00348309|365606082|FG001|Overall Study|A foul of exclusion criteria|1|||
105985283|NCT00348309|365606083|FG002|Overall Study|A foul of exclusion criteria|0|||
105985284|NCT00348309|365606081|FG000|Overall Study|Participant was hospitalized|0|||
105985285|NCT00348309|365606082|FG001|Overall Study|Participant was hospitalized|1|||
105985286|NCT00348309|365606083|FG002|Overall Study|Participant was hospitalized|0|||
105985287|NCT00348309|365606081|FG000|Overall Study|Sponsor refuseal|0|||
105985288|NCT00348309|365606082|FG001|Overall Study|Sponsor refuseal|1|||
105985289|NCT00348309|365606083|FG002|Overall Study|Sponsor refuseal|1|||
105985290|NCT00348309|365606081|FG000|Overall Study|Forgot often medication|0|||
105985291|NCT00348309|365606082|FG001|Overall Study|Forgot often medication|1|||
105985292|NCT00348309|365606083|FG002|Overall Study|Forgot often medication|0|||
105985293|NCT00348309|365606081|FG000|Overall Study|Medical Monitor decision|0|||
105985294|NCT00348309|365606082|FG001|Overall Study|Medical Monitor decision|0|||
105985295|NCT00348309|365606083|FG002|Overall Study|Medical Monitor decision|1|||
105985296|NCT00348309|365606081|FG000|Overall Study|Increased dose of Aricept|0|||
105985297|NCT00348309|365606082|FG001|Overall Study|Increased dose of Aricept|0|||
105985298|NCT00348309|365606083|FG002|Overall Study|Increased dose of Aricept|1|||
105985299|NCT00348309|365606081|FG000|Overall Study|Site closure|0|||
105985300|NCT00348309|365606082|FG001|Overall Study|Site closure|0|||
105985301|NCT00348309|365606083|FG002|Overall Study|Site closure|1|||
105985302|NCT00348309|365606081|FG000|Overall Study|Adverse event not attended|0|||
105985303|NCT00348309|365606082|FG001|Overall Study|Adverse event not attended|0|||
105985304|NCT00348309|365606083|FG002|Overall Study|Adverse event not attended|1|||
105985305|NCT00348309|365606081|FG000|Overall Study|ECG abnormal|0|||
105985306|NCT00348309|365606082|FG001|Overall Study|ECG abnormal|0|||
105985307|NCT00348309|365606083|FG002|Overall Study|ECG abnormal|2|||
105985308|NCT00348309|365606081|FG000|Overall Study|Cardiologist recommendations|0|||
105985309|NCT00348309|365606082|FG001|Overall Study|Cardiologist recommendations|0|||
105985310|NCT00348309|365606083|FG002|Overall Study|Cardiologist recommendations|1|||
105985311|NCT00348309|365606081|FG000|Overall Study|HCV career|0|||
105985312|NCT00348309|365606082|FG001|Overall Study|HCV career|0|||
105985313|NCT00348309|365606083|FG002|Overall Study|HCV career|1|||
105985314|NCT01717326|365606084|FG000|Overall Study|Death|0|||
105985315|NCT01717326|365606085|FG001|Overall Study|Death|0|||
105985316|NCT01717326|365606086|FG002|Overall Study|Death|0|||
105985317|NCT01717326|365606087|FG003|Overall Study|Death|0|||
105985318|NCT01717326|365606088|FG004|Overall Study|Death|0|||
105985319|NCT01717326|365606089|FG005|Overall Study|Death|0|||
105985320|NCT01717326|365606090|FG006|Overall Study|Death|0|||
105985321|NCT01717326|365606091|FG007|Overall Study|Death|0|||
105985322|NCT01717326|365606092|FG008|Overall Study|Death|0|||
105985323|NCT01717326|365606093|FG009|Overall Study|Death|0|||
105985324|NCT01717326|365606094|FG010|Overall Study|Death|1|||
105985325|NCT01717326|365606095|FG011|Overall Study|Death|0|||
105985326|NCT01717326|365606096|FG012|Overall Study|Death|0|||
105985327|NCT01717326|365606097|FG013|Overall Study|Death|0|||
105985328|NCT01717326|365606098|FG014|Overall Study|Death|0|||
105985329|NCT01717326|365606099|FG015|Overall Study|Death|0|||
105985330|NCT01717326|365606100|FG016|Overall Study|Death|0|||
105985331|NCT01717326|365606101|FG017|Overall Study|Death|0|||
105985332|NCT01717326|365606102|FG018|Overall Study|Death|0|||
105985333|NCT01717326|365606103|FG019|Overall Study|Death|0|||
105985334|NCT01717326|365606084|FG000|Overall Study|Lost to Follow-up|3|||
105985335|NCT01717326|365606085|FG001|Overall Study|Lost to Follow-up|0|||
105985336|NCT01717326|365606086|FG002|Overall Study|Lost to Follow-up|0|||
105985337|NCT01717326|365606087|FG003|Overall Study|Lost to Follow-up|2|||
105985338|NCT01717326|365606088|FG004|Overall Study|Lost to Follow-up|1|||
105985339|NCT01717326|365606089|FG005|Overall Study|Lost to Follow-up|0|||
105985340|NCT01717326|365606090|FG006|Overall Study|Lost to Follow-up|1|||
105985341|NCT01717326|365606091|FG007|Overall Study|Lost to Follow-up|0|||
105985342|NCT01717326|365606092|FG008|Overall Study|Lost to Follow-up|0|||
105985343|NCT01717326|365606093|FG009|Overall Study|Lost to Follow-up|0|||
105985344|NCT01717326|365606094|FG010|Overall Study|Lost to Follow-up|1|||
105985345|NCT01717326|365606095|FG011|Overall Study|Lost to Follow-up|0|||
105985346|NCT01717326|365606096|FG012|Overall Study|Lost to Follow-up|0|||
105985347|NCT01717326|365606097|FG013|Overall Study|Lost to Follow-up|0|||
105985348|NCT01717326|365606098|FG014|Overall Study|Lost to Follow-up|0|||
105985349|NCT01717326|365606099|FG015|Overall Study|Lost to Follow-up|2|||
105985350|NCT01717326|365606100|FG016|Overall Study|Lost to Follow-up|1|||
105985351|NCT01717326|365606101|FG017|Overall Study|Lost to Follow-up|0|||
105985352|NCT01717326|365606102|FG018|Overall Study|Lost to Follow-up|2|||
105985353|NCT01717326|365606103|FG019|Overall Study|Lost to Follow-up|3|||
105985354|NCT01717326|365606084|FG000|Overall Study|Physician Decision|0|||
105985355|NCT01717326|365606085|FG001|Overall Study|Physician Decision|0|||
105985356|NCT01717326|365606086|FG002|Overall Study|Physician Decision|0|||
105985357|NCT01717326|365606087|FG003|Overall Study|Physician Decision|0|||
105985358|NCT01717326|365606088|FG004|Overall Study|Physician Decision|0|||
105985359|NCT01717326|365606089|FG005|Overall Study|Physician Decision|0|||
105985360|NCT01717326|365606090|FG006|Overall Study|Physician Decision|0|||
105985361|NCT01717326|365606091|FG007|Overall Study|Physician Decision|0|||
105985362|NCT01717326|365606092|FG008|Overall Study|Physician Decision|0|||
105985363|NCT01717326|365606093|FG009|Overall Study|Physician Decision|1|||
105985364|NCT01717326|365606094|FG010|Overall Study|Physician Decision|0|||
105985365|NCT01717326|365606095|FG011|Overall Study|Physician Decision|0|||
105985366|NCT01717326|365606096|FG012|Overall Study|Physician Decision|0|||
105985367|NCT01717326|365606097|FG013|Overall Study|Physician Decision|0|||
105985368|NCT01717326|365606098|FG014|Overall Study|Physician Decision|0|||
105985369|NCT01717326|365606099|FG015|Overall Study|Physician Decision|0|||
105985370|NCT01717326|365606100|FG016|Overall Study|Physician Decision|0|||
105985371|NCT01717326|365606101|FG017|Overall Study|Physician Decision|0|||
105985372|NCT01717326|365606102|FG018|Overall Study|Physician Decision|0|||
105985373|NCT01717326|365606103|FG019|Overall Study|Physician Decision|0|||
105985374|NCT01717326|365606084|FG000|Overall Study|Protocol Violation|0|||
105985375|NCT01717326|365606085|FG001|Overall Study|Protocol Violation|0|||
105985376|NCT01717326|365606086|FG002|Overall Study|Protocol Violation|0|||
105985377|NCT01717326|365606087|FG003|Overall Study|Protocol Violation|0|||
105985378|NCT01717326|365606088|FG004|Overall Study|Protocol Violation|1|||
105985379|NCT01717326|365606089|FG005|Overall Study|Protocol Violation|0|||
105985380|NCT01717326|365606090|FG006|Overall Study|Protocol Violation|0|||
105985381|NCT01717326|365606091|FG007|Overall Study|Protocol Violation|0|||
105985382|NCT01717326|365606092|FG008|Overall Study|Protocol Violation|0|||
105985383|NCT01717326|365606093|FG009|Overall Study|Protocol Violation|0|||
105985384|NCT01717326|365606094|FG010|Overall Study|Protocol Violation|0|||
105985385|NCT01717326|365606095|FG011|Overall Study|Protocol Violation|0|||
105985386|NCT01717326|365606096|FG012|Overall Study|Protocol Violation|0|||
105985387|NCT01717326|365606097|FG013|Overall Study|Protocol Violation|0|||
105985388|NCT01717326|365606098|FG014|Overall Study|Protocol Violation|0|||
105985389|NCT01717326|365606099|FG015|Overall Study|Protocol Violation|0|||
105985390|NCT01717326|365606100|FG016|Overall Study|Protocol Violation|0|||
105985391|NCT01717326|365606101|FG017|Overall Study|Protocol Violation|0|||
105985392|NCT01717326|365606102|FG018|Overall Study|Protocol Violation|0|||
105985393|NCT01717326|365606103|FG019|Overall Study|Protocol Violation|0|||
105985394|NCT01717326|365606084|FG000|Overall Study|Withdrawal by Subject|0|||
105985395|NCT01717326|365606085|FG001|Overall Study|Withdrawal by Subject|1|||
105985396|NCT01717326|365606086|FG002|Overall Study|Withdrawal by Subject|0|||
105985397|NCT01717326|365606087|FG003|Overall Study|Withdrawal by Subject|0|||
105985398|NCT01717326|365606088|FG004|Overall Study|Withdrawal by Subject|0|||
105985399|NCT01717326|365606089|FG005|Overall Study|Withdrawal by Subject|0|||
105985400|NCT01717326|365606090|FG006|Overall Study|Withdrawal by Subject|0|||
105985401|NCT01717326|365606091|FG007|Overall Study|Withdrawal by Subject|0|||
105985402|NCT01717326|365606092|FG008|Overall Study|Withdrawal by Subject|0|||
105985403|NCT01717326|365606093|FG009|Overall Study|Withdrawal by Subject|1|||
105985404|NCT01717326|365606094|FG010|Overall Study|Withdrawal by Subject|0|||
105985405|NCT01717326|365606095|FG011|Overall Study|Withdrawal by Subject|0|||
105985406|NCT01717326|365606096|FG012|Overall Study|Withdrawal by Subject|1|||
105985407|NCT01717326|365606097|FG013|Overall Study|Withdrawal by Subject|0|||
105985408|NCT01717326|365606098|FG014|Overall Study|Withdrawal by Subject|0|||
105985409|NCT01717326|365606099|FG015|Overall Study|Withdrawal by Subject|1|||
105985410|NCT01717326|365606100|FG016|Overall Study|Withdrawal by Subject|0|||
105985411|NCT01717326|365606101|FG017|Overall Study|Withdrawal by Subject|0|||
105985412|NCT01717326|365606102|FG018|Overall Study|Withdrawal by Subject|2|||
105985413|NCT01717326|365606103|FG019|Overall Study|Withdrawal by Subject|3|||
105985414|NCT01067469|365606104|FG000|Overall Study|Withdrawal by Subject|0|||
105985415|NCT01067469|365606105|FG001|Overall Study|Withdrawal by Subject|1|||
105985416|NCT01067469|365606104|FG000|Overall Study|Disease Progression|0|||
105985417|NCT01067469|365606105|FG001|Overall Study|Disease Progression|1|||
105985418|NCT00629798|365606108|FG000|Overall Study|Not Treated|4|||
105985419|NCT02126839|365606110|FG000|Overall Study|Adverse Event|0|||
105985420|NCT02126839|365606111|FG001|Overall Study|Adverse Event|1|||
105985421|NCT02126839|365606110|FG000|Overall Study|Withdrawal by Subject|1|||
105985422|NCT02126839|365606111|FG001|Overall Study|Withdrawal by Subject|0|||
105985423|NCT02126839|365606110|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105985424|NCT02126839|365606111|FG001|Overall Study|Withdrawal by parent/guardian|0|||
105985425|NCT02126839|365606110|FG000|Overall Study|Protocol Violation|2|||
105985426|NCT02126839|365606111|FG001|Overall Study|Protocol Violation|3|||
105985427|NCT02126839|365606110|FG000|Overall Study|Sponsor request|0|||
105985428|NCT02126839|365606111|FG001|Overall Study|Sponsor request|1|||
105985429|NCT02126839|365606110|FG000|Overall Study|Lost to Follow-up|1|||
105985430|NCT02126839|365606111|FG001|Overall Study|Lost to Follow-up|4|||
105985431|NCT02126839|365606110|FG000|Overall Study|Other|5|||
105985432|NCT02126839|365606111|FG001|Overall Study|Other|5|||
105985433|NCT02160145|365606114|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
105985434|NCT02160145|365606115|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
105985435|NCT02160145|365606116|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
105985436|NCT02160145|365606114|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
105985437|NCT02160145|365606115|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
105985438|NCT02160145|365606116|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
105985439|NCT02160145|365606114|FG000|Randomized Double-blind Period|Subject decision|0|||
105985440|NCT02160145|365606115|FG001|Randomized Double-blind Period|Subject decision|21|||
105985441|NCT02160145|365606116|FG002|Randomized Double-blind Period|Subject decision|20|||
105985442|NCT02160145|365606114|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
105985443|NCT02160145|365606115|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
105985444|NCT02160145|365606116|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
105985445|NCT02160145|365606114|FG000|Randomized Double-blind Period|Physician Decision|0|||
105985446|NCT02160145|365606115|FG001|Randomized Double-blind Period|Physician Decision|7|||
105985447|NCT02160145|365606116|FG002|Randomized Double-blind Period|Physician Decision|5|||
105985448|NCT02100475|365607658|FG000|Overall Study|Unclassified|1|||
105985449|NCT02100475|365607659|FG001|Overall Study|Unclassified|2|||
105985450|NCT02100475|365607658|FG000|Overall Study|Withdrawal criteria|1|||
105985451|NCT02100475|365607659|FG001|Overall Study|Withdrawal criteria|0|||
105985452|NCT03268941|365607660|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105985453|NCT03268941|365607661|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105985454|NCT03268941|365607662|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105985455|NCT03268941|365607663|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
105985456|NCT03268941|365607664|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105985457|NCT03268941|365607665|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105985458|NCT03268941|365607666|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
105985459|NCT03268941|365607660|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
105985460|NCT03268941|365607661|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
105985461|NCT03268941|365607662|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
105985462|NCT03268941|365607663|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
105985463|NCT03268941|365607664|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
105985464|NCT03268941|365607665|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
105985465|NCT03268941|365607666|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
105985466|NCT03268941|365607660|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
105985467|NCT03268941|365607661|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105985468|NCT03268941|365607662|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105985469|NCT03268941|365607663|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105985470|NCT03268941|365607664|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105985471|NCT03268941|365607665|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105985472|NCT03268941|365607666|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
105985473|NCT03268941|365607660|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
105985474|NCT03268941|365607661|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
105985475|NCT03268941|365607662|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
105985476|NCT03268941|365607663|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
105985477|NCT03268941|365607664|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
105985478|NCT03268941|365607665|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
105985479|NCT03268941|365607666|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
105985480|NCT03268941|365607660|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105985481|NCT03268941|365607661|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105985482|NCT03268941|365607662|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105985483|NCT03268941|365607663|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105985484|NCT03268941|365607664|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105985485|NCT03268941|365607665|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
105985486|NCT03268941|365607666|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
105985487|NCT01949090|365607675|FG000|Overall Study|Serious Adverse Event|0|||
105985488|NCT01949090|365607676|FG001|Overall Study|Serious Adverse Event|1|||
105985489|NCT01949090|365607677|FG002|Overall Study|Serious Adverse Event|2|||
105985490|NCT01949090|365607678|FG003|Overall Study|Serious Adverse Event|0|||
105985491|NCT01949090|365607679|FG004|Overall Study|Serious Adverse Event|1|||
105985492|NCT01949090|365607675|FG000|Overall Study|Withdrawal by Subject|2|||
105985493|NCT01949090|365607676|FG001|Overall Study|Withdrawal by Subject|0|||
105985494|NCT01949090|365607677|FG002|Overall Study|Withdrawal by Subject|0|||
105985495|NCT01949090|365607678|FG003|Overall Study|Withdrawal by Subject|0|||
105985496|NCT01949090|365607679|FG004|Overall Study|Withdrawal by Subject|1|||
105985497|NCT01949090|365607675|FG000|Overall Study|Protocol non-compliance|0|||
105985498|NCT01949090|365607676|FG001|Overall Study|Protocol non-compliance|0|||
105985499|NCT01949090|365607677|FG002|Overall Study|Protocol non-compliance|0|||
105985500|NCT01949090|365607678|FG003|Overall Study|Protocol non-compliance|0|||
105985501|NCT01949090|365607679|FG004|Overall Study|Protocol non-compliance|1|||
105985502|NCT01949090|365607675|FG000|Overall Study|Lost to Follow-up|2|||
105985503|NCT01949090|365607676|FG001|Overall Study|Lost to Follow-up|1|||
105985504|NCT01949090|365607677|FG002|Overall Study|Lost to Follow-up|0|||
105985505|NCT01949090|365607678|FG003|Overall Study|Lost to Follow-up|1|||
105985506|NCT01949090|365607679|FG004|Overall Study|Lost to Follow-up|1|||
105985507|NCT00567359|365607680|FG000|Overall Study|Withdrawal by Subject|1|||
105985508|NCT00785980|365607681|FG000|7 Day Washout Period|Protocol Violation|3|||
105985509|NCT02241343|365607682|FG000|Overall Study|Adverse Event|1|||
105985510|NCT03927144|365607683|FG000|Core Phase|Adverse Event|9|||
105985511|NCT03927144|365607684|FG001|Core Phase|Adverse Event|5|||
105985512|NCT03927144|365607683|FG000|Core Phase|Lost to Follow-up|3|||
105985513|NCT03927144|365607684|FG001|Core Phase|Lost to Follow-up|2|||
105985514|NCT03927144|365607683|FG000|Core Phase|New Therapy for Study Indication|0|||
105985515|NCT03927144|365607684|FG001|Core Phase|New Therapy for Study Indication|1|||
105985516|NCT03927144|365607683|FG000|Core Phase|No Longer Clinically Benefiting|4|||
105985517|NCT03927144|365607684|FG001|Core Phase|No Longer Clinically Benefiting|4|||
105985518|NCT03927144|365607683|FG000|Core Phase|Physician Decision|2|||
105985519|NCT03927144|365607684|FG001|Core Phase|Physician Decision|8|||
105985520|NCT03927144|365607683|FG000|Core Phase|Protocol Violation|2|||
105985521|NCT03927144|365607684|FG001|Core Phase|Protocol Violation|2|||
105985522|NCT03927144|365607683|FG000|Core Phase|Withdrawal by Subject|16|||
105985523|NCT03927144|365607684|FG001|Core Phase|Withdrawal by Subject|40|||
105985524|NCT03927144|365607683|FG000|Extension Phase|Adverse Event|2|||
105985525|NCT03927144|365607684|FG001|Extension Phase|Adverse Event|1|||
105985526|NCT03927144|365607683|FG000|Extension Phase|No longer clinically benefiting|4|||
105985527|NCT03927144|365607684|FG001|Extension Phase|No longer clinically benefiting|5|||
105985528|NCT03927144|365607683|FG000|Extension Phase|Pregnancy|1|||
105985529|NCT03927144|365607684|FG001|Extension Phase|Pregnancy|0|||
105985530|NCT03927144|365607683|FG000|Extension Phase|Protocol Violation|0|||
105985531|NCT03927144|365607684|FG001|Extension Phase|Protocol Violation|1|||
105985532|NCT03927144|365607683|FG000|Extension Phase|Withdrawal by Subject|8|||
105985533|NCT03927144|365607684|FG001|Extension Phase|Withdrawal by Subject|3|||
105985534|NCT02702414|365607687|FG000|Overall Study|Death|96|||
105985535|NCT02702414|365607688|FG001|Overall Study|Death|42|||
105985536|NCT02702414|365607687|FG000|Overall Study|Lost to Follow-up|0|||
105985537|NCT02702414|365607688|FG001|Overall Study|Lost to Follow-up|1|||
105985538|NCT02702414|365607687|FG000|Overall Study|Withdrawal by Subject|0|||
105985539|NCT02702414|365607688|FG001|Overall Study|Withdrawal by Subject|1|||
105985540|NCT02702414|365607687|FG000|Overall Study|Protocol Violation|1|||
105985541|NCT02702414|365607688|FG001|Overall Study|Protocol Violation|0|||
105985542|NCT02702414|365607687|FG000|Overall Study|Sponsor Decision|8|||
105985543|NCT02702414|365607688|FG001|Overall Study|Sponsor Decision|7|||
105985544|NCT02596230|365607689|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
105985545|NCT02596230|365607690|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
105985546|NCT02596230|365607691|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
105985547|NCT02596230|365607692|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
105985548|NCT02596230|365607693|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
105985549|NCT02596230|365607689|FG000|Objective 2, One Year|Lost to Follow-up|0|||
105985550|NCT02596230|365607690|FG001|Objective 2, One Year|Lost to Follow-up|41|||
105985551|NCT02596230|365607691|FG002|Objective 2, One Year|Lost to Follow-up|41|||
105985552|NCT02596230|365607692|FG003|Objective 2, One Year|Lost to Follow-up|32|||
105985553|NCT02596230|365607693|FG004|Objective 2, One Year|Lost to Follow-up|46|||
105985554|NCT02596230|365607689|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
105985555|NCT02596230|365607690|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
105985556|NCT02596230|365607691|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
105985557|NCT02596230|365607692|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
105985558|NCT02596230|365607693|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
105985559|NCT02596230|365607689|FG000|Objective 2, One Year|Adverse drug reaction|0|||
105985560|NCT02596230|365607690|FG001|Objective 2, One Year|Adverse drug reaction|1|||
105985561|NCT02596230|365607691|FG002|Objective 2, One Year|Adverse drug reaction|0|||
105985562|NCT02596230|365607692|FG003|Objective 2, One Year|Adverse drug reaction|0|||
105985563|NCT02596230|365607693|FG004|Objective 2, One Year|Adverse drug reaction|0|||
105985564|NCT02596230|365607689|FG000|Objective 2, One Year|Death|0|||
105985565|NCT02596230|365607690|FG001|Objective 2, One Year|Death|12|||
105985566|NCT02596230|365607691|FG002|Objective 2, One Year|Death|41|||
105985567|NCT02596230|365607692|FG003|Objective 2, One Year|Death|21|||
105985568|NCT02596230|365607693|FG004|Objective 2, One Year|Death|30|||
105985569|NCT02596230|365607689|FG000|Objective 2, One Year|Other|0|||
105985570|NCT02596230|365607690|FG001|Objective 2, One Year|Other|3|||
105985571|NCT02596230|365607691|FG002|Objective 2, One Year|Other|2|||
105985572|NCT02596230|365607692|FG003|Objective 2, One Year|Other|0|||
105985573|NCT02596230|365607693|FG004|Objective 2, One Year|Other|0|||
105985574|NCT02421588|365607695|FG000|Overall Study|Non-treatment-related AE|8|||
105985575|NCT02421588|365607696|FG001|Overall Study|Non-treatment-related AE|8|||
105985576|NCT02421588|365607695|FG000|Overall Study|Progressive disease|152|||
105985577|NCT02421588|365607696|FG001|Overall Study|Progressive disease|135|||
105985578|NCT02421588|365607695|FG000|Overall Study|Death|11|||
105985579|NCT02421588|365607696|FG001|Overall Study|Death|3|||
105985580|NCT02421588|365607695|FG000|Overall Study|Physician Decision|8|||
105985581|NCT02421588|365607696|FG001|Overall Study|Physician Decision|17|||
105985582|NCT02421588|365607695|FG000|Overall Study|Other reason not specified|3|||
105985583|NCT02421588|365607696|FG001|Overall Study|Other reason not specified|1|||
105985584|NCT02421588|365607695|FG000|Overall Study|Symptomatic deterioration|13|||
105985585|NCT02421588|365607696|FG001|Overall Study|Symptomatic deterioration|19|||
105985586|NCT02421588|365607695|FG000|Overall Study|Treatment-related AE|10|||
105985587|NCT02421588|365607696|FG001|Overall Study|Treatment-related AE|14|||
105985588|NCT02421588|365607695|FG000|Overall Study|Withdrawal by Subject|14|||
105985589|NCT02421588|365607696|FG001|Overall Study|Withdrawal by Subject|16|||
105985590|NCT02421588|365607695|FG000|Overall Study|Not treated|2|||
105985591|NCT02421588|365607696|FG001|Overall Study|Not treated|8|||
105985592|NCT00615030|365607697|FG000|Period I|Administrative problem|0|||
105985593|NCT00615030|365607698|FG001|Period I|Administrative problem|0|||
105985594|NCT00615030|365607699|FG002|Period I|Administrative problem|0|||
105985595|NCT00615030|365607700|FG003|Period I|Administrative problem|0|||
105985596|NCT00615030|365607701|FG004|Period I|Administrative problem|1|||
105985597|NCT00615030|365607702|FG005|Period I|Administrative problem|0|||
105985598|NCT00615030|365607703|FG006|Period I|Administrative problem|0|||
105985599|NCT00615030|365607704|FG007|Period I|Administrative problem|0|||
105985600|NCT00615030|365607705|FG008|Period I|Administrative problem|0|||
105985601|NCT00615030|365607706|FG009|Period I|Administrative problem|0|||
105985602|NCT00615030|365607707|FG010|Period I|Administrative problem|0|||
105985603|NCT00615030|365607708|FG011|Period I|Administrative problem|0|||
105985604|NCT00615030|365607697|FG000|Period I|Protocol deviation|1|||
105985605|NCT00615030|365607698|FG001|Period I|Protocol deviation|0|||
105985606|NCT00615030|365607699|FG002|Period I|Protocol deviation|0|||
105985607|NCT00615030|365607700|FG003|Period I|Protocol deviation|0|||
105985608|NCT00615030|365607701|FG004|Period I|Protocol deviation|0|||
105985609|NCT00615030|365607702|FG005|Period I|Protocol deviation|0|||
105985610|NCT00615030|365607703|FG006|Period I|Protocol deviation|0|||
105985611|NCT00615030|365607704|FG007|Period I|Protocol deviation|0|||
105985612|NCT00615030|365607705|FG008|Period I|Protocol deviation|0|||
105985613|NCT00615030|365607706|FG009|Period I|Protocol deviation|0|||
105985614|NCT00615030|365607707|FG010|Period I|Protocol deviation|0|||
105985615|NCT00615030|365607708|FG011|Period I|Protocol deviation|0|||
105985616|NCT00615030|365607697|FG000|Period I|Subject withdrew consent|0|||
105985617|NCT00615030|365607698|FG001|Period I|Subject withdrew consent|0|||
105985618|NCT00615030|365607699|FG002|Period I|Subject withdrew consent|0|||
105985619|NCT00615030|365607700|FG003|Period I|Subject withdrew consent|0|||
105985620|NCT00615030|365607701|FG004|Period I|Subject withdrew consent|0|||
105985621|NCT00615030|365607702|FG005|Period I|Subject withdrew consent|0|||
105985622|NCT00615030|365607703|FG006|Period I|Subject withdrew consent|0|||
105985623|NCT00615030|365607704|FG007|Period I|Subject withdrew consent|0|||
105985624|NCT00615030|365607705|FG008|Period I|Subject withdrew consent|1|||
105985625|NCT00615030|365607706|FG009|Period I|Subject withdrew consent|0|||
105985626|NCT00615030|365607707|FG010|Period I|Subject withdrew consent|1|||
105985627|NCT00615030|365607708|FG011|Period I|Subject withdrew consent|1|||
105985628|NCT00615030|365607697|FG000|Period I|Abnormal laboratory value(s)|0|||
105985629|NCT00615030|365607698|FG001|Period I|Abnormal laboratory value(s)|0|||
105985630|NCT00615030|365607699|FG002|Period I|Abnormal laboratory value(s)|0|||
105985631|NCT00615030|365607700|FG003|Period I|Abnormal laboratory value(s)|0|||
105985632|NCT00615030|365607701|FG004|Period I|Abnormal laboratory value(s)|0|||
105985633|NCT00615030|365607702|FG005|Period I|Abnormal laboratory value(s)|1|||
105985634|NCT00615030|365607703|FG006|Period I|Abnormal laboratory value(s)|0|||
105985635|NCT00615030|365607704|FG007|Period I|Abnormal laboratory value(s)|0|||
105985636|NCT00615030|365607705|FG008|Period I|Abnormal laboratory value(s)|0|||
105985637|NCT00615030|365607706|FG009|Period I|Abnormal laboratory value(s)|0|||
105985638|NCT00615030|365607707|FG010|Period I|Abnormal laboratory value(s)|0|||
105985639|NCT00615030|365607708|FG011|Period I|Abnormal laboratory value(s)|0|||
105985640|NCT00615030|365607697|FG000|Period II|Adverse Event|0|||
105985641|NCT00615030|365607698|FG001|Period II|Adverse Event|0|||
105985642|NCT00615030|365607699|FG002|Period II|Adverse Event|1|||
105985643|NCT00615030|365607700|FG003|Period II|Adverse Event|0|||
105985644|NCT00615030|365607701|FG004|Period II|Adverse Event|0|||
105985645|NCT00615030|365607702|FG005|Period II|Adverse Event|0|||
105985646|NCT00615030|365607703|FG006|Period II|Adverse Event|0|||
105985647|NCT00615030|365607704|FG007|Period II|Adverse Event|0|||
105985648|NCT00615030|365607705|FG008|Period II|Adverse Event|1|||
105985649|NCT00615030|365607706|FG009|Period II|Adverse Event|0|||
105985650|NCT00615030|365607707|FG010|Period II|Adverse Event|0|||
105985651|NCT00615030|365607708|FG011|Period II|Adverse Event|0|||
105985652|NCT00615030|365607697|FG000|Period II|Subject withdrew consent|0|||
105985653|NCT00615030|365607698|FG001|Period II|Subject withdrew consent|0|||
105985654|NCT00615030|365607699|FG002|Period II|Subject withdrew consent|0|||
105985655|NCT00615030|365607700|FG003|Period II|Subject withdrew consent|1|||
105985656|NCT00615030|365607701|FG004|Period II|Subject withdrew consent|0|||
105985657|NCT00615030|365607702|FG005|Period II|Subject withdrew consent|0|||
105985658|NCT00615030|365607703|FG006|Period II|Subject withdrew consent|1|||
105985659|NCT00615030|365607704|FG007|Period II|Subject withdrew consent|0|||
105985660|NCT00615030|365607705|FG008|Period II|Subject withdrew consent|0|||
105985661|NCT00615030|365607706|FG009|Period II|Subject withdrew consent|0|||
105985662|NCT00615030|365607707|FG010|Period II|Subject withdrew consent|0|||
105985663|NCT00615030|365607708|FG011|Period II|Subject withdrew consent|0|||
105985664|NCT00615030|365607697|FG000|Period III|Administrative problems|1|||
105985665|NCT00615030|365607698|FG001|Period III|Administrative problems|0|||
105985666|NCT00615030|365607699|FG002|Period III|Administrative problems|0|||
105985667|NCT00615030|365607700|FG003|Period III|Administrative problems|1|||
105985668|NCT00615030|365607701|FG004|Period III|Administrative problems|0|||
105985669|NCT00615030|365607702|FG005|Period III|Administrative problems|0|||
105985670|NCT00615030|365607703|FG006|Period III|Administrative problems|0|||
105985671|NCT00615030|365607704|FG007|Period III|Administrative problems|0|||
105985672|NCT00615030|365607705|FG008|Period III|Administrative problems|0|||
105985673|NCT00615030|365607706|FG009|Period III|Administrative problems|0|||
105985674|NCT00615030|365607707|FG010|Period III|Administrative problems|0|||
105985675|NCT00615030|365607708|FG011|Period III|Administrative problems|0|||
105985676|NCT03722524|365607712|FG000|Overall Study|Protocol Violation|86|||
105985677|NCT03722524|365607712|FG000|Overall Study|Adverse Event|7|||
105985678|NCT03722524|365607712|FG000|Overall Study|Lost to Follow-up|1|||
105985679|NCT03722524|365607712|FG000|Overall Study|Reason is not stated|1|||
105985680|NCT03722524|365607712|FG000|Overall Study|Physician Decision|1|||
105985681|NCT03722524|365607712|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
105985682|NCT01753401|365607713|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
105985683|NCT01753401|365607714|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
105985684|NCT01753401|365607715|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
105985685|NCT01753401|365607716|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
105985686|NCT01753401|365607713|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
105985687|NCT01753401|365607714|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
105985688|NCT01753401|365607715|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
105985689|NCT01753401|365607716|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
105985690|NCT01753401|365607713|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
105985691|NCT01753401|365607714|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
105985692|NCT01753401|365607715|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
105985693|NCT01753401|365607716|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
105985694|NCT01753401|365607713|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
105985695|NCT01753401|365607714|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
105985696|NCT01753401|365607715|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
105985697|NCT01753401|365607716|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
105985698|NCT01753401|365607713|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
105985699|NCT01753401|365607714|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
105985700|NCT01753401|365607715|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
105985701|NCT01753401|365607716|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
105985702|NCT01753401|365607713|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
105985703|NCT01753401|365607714|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
105985704|NCT01753401|365607715|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
105985705|NCT01753401|365607716|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
105985706|NCT01753401|365607713|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
105985707|NCT01753401|365607714|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
105985708|NCT01753401|365607715|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
105985709|NCT01753401|365607716|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
105985710|NCT00470418|365607717|FG000|Overall Study|Withdrawal by Subject|1|||
105985711|NCT00470418|365607718|FG001|Overall Study|Withdrawal by Subject|0|||
105985712|NCT00462748|365607721|FG000|Overall Study|Adverse Event|7|||
105985713|NCT00462748|365607722|FG001|Overall Study|Adverse Event|5|||
105985714|NCT00462748|365607723|FG002|Overall Study|Adverse Event|9|||
105985715|NCT00462748|365607721|FG000|Overall Study|Protocol Violation|0|||
105985716|NCT00462748|365607722|FG001|Overall Study|Protocol Violation|2|||
105985717|NCT00462748|365607723|FG002|Overall Study|Protocol Violation|1|||
105985718|NCT00462748|365607721|FG000|Overall Study|Withdrew consent|3|||
105985719|NCT00462748|365607722|FG001|Overall Study|Withdrew consent|3|||
105985720|NCT00462748|365607723|FG002|Overall Study|Withdrew consent|0|||
105985721|NCT00462748|365607721|FG000|Overall Study|Lost to Follow-up|1|||
105985722|NCT00462748|365607722|FG001|Overall Study|Lost to Follow-up|1|||
105985723|NCT00462748|365607723|FG002|Overall Study|Lost to Follow-up|1|||
105985724|NCT00462748|365607721|FG000|Overall Study|Discontinued after 41 days Rx|1|||
105985725|NCT00462748|365607722|FG001|Overall Study|Discontinued after 41 days Rx|0|||
105985726|NCT00462748|365607723|FG002|Overall Study|Discontinued after 41 days Rx|0|||
105985727|NCT02345330|365607725|FG000|Overall Study|Death|1|||
105985728|NCT02345330|365607725|FG000|Overall Study|Progressive Disease|2|||
105985729|NCT03615066|365607726|FG000|Main Study|Withdrew Consent|0|||
105985730|NCT03615066|365607727|FG001|Main Study|Withdrew Consent|1|||
105985731|NCT03615066|365607728|FG002|Main Study|Withdrew Consent|1|||
105985732|NCT03615066|365607726|FG000|Main Study|Lost to Follow-up|0|||
105985733|NCT03615066|365607727|FG001|Main Study|Lost to Follow-up|0|||
105985734|NCT03615066|365607728|FG002|Main Study|Lost to Follow-up|1|||
105985735|NCT03615066|365607726|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
105985736|NCT03615066|365607727|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
105985737|NCT03615066|365607728|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
105985738|NCT03615066|365607726|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
105985739|NCT03615066|365607727|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
105985740|NCT03615066|365607728|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
105985741|NCT03615066|365607726|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
105985742|NCT03615066|365607727|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
105985743|NCT03615066|365607728|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
105985744|NCT02437084|365607730|FG000|Overall Study|Withdrawal by Subject|2|||
105985745|NCT02437084|365607730|FG000|Overall Study|Physician Decision|1|||
105985746|NCT00454181|365607731|FG000|Overall Study|Adverse Event|1|||
105985747|NCT00454181|365607732|FG001|Overall Study|Adverse Event|1|||
105985748|NCT00454181|365607731|FG000|Overall Study|Lost to Follow-up|11|||
105985749|NCT00454181|365607732|FG001|Overall Study|Lost to Follow-up|1|||
105985750|NCT00454181|365607731|FG000|Overall Study|Protocol Violation|1|||
105985751|NCT00454181|365607732|FG001|Overall Study|Protocol Violation|1|||
105985752|NCT00454181|365607731|FG000|Overall Study|Withdrawal by Subject|2|||
105985753|NCT00454181|365607732|FG001|Overall Study|Withdrawal by Subject|0|||
105985754|NCT00109577|365607733|FG000|Overall Study|Withdrawal by Subject|3|||
105985755|NCT00109577|365607734|FG001|Overall Study|Withdrawal by Subject|3|||
105985756|NCT03729245|365607735|FG000|Overall Study|Lost to Follow-up|5|||
105985757|NCT03729245|365607736|FG001|Overall Study|Lost to Follow-up|6|||
105985758|NCT03729245|365607735|FG000|Overall Study|Withdrawal by Subject|16|||
105985759|NCT03729245|365607736|FG001|Overall Study|Withdrawal by Subject|19|||
105985760|NCT03729245|365607735|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
105985761|NCT03729245|365607736|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
105985762|NCT00885482|365607737|FG000|Overall Study|Pregnancy|1|||
105985763|NCT00885482|365607737|FG000|Overall Study|Lack of Efficacy|1|||
105985764|NCT00885482|365607737|FG000|Overall Study|Death|1|||
105985765|NCT00885482|365607737|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
105985766|NCT00129467|365607740|FG000|Received Intervention|Death|1|||
105985767|NCT00129467|365607741|FG001|Received Intervention|Death|1|||
105985768|NCT00129467|365607740|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
105985769|NCT00129467|365607741|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
105985770|NCT00129467|365607740|FG000|Received Intervention|Delirium|2|||
105985771|NCT00129467|365607741|FG001|Received Intervention|Delirium|0|||
105985772|NCT00129467|365607740|FG000|Received Intervention|Withdrawal by Subject|1|||
105985773|NCT00129467|365607741|FG001|Received Intervention|Withdrawal by Subject|0|||
105985774|NCT00129467|365607740|FG000|Received Intervention|Nausea|1|||
105985775|NCT00129467|365607741|FG001|Received Intervention|Nausea|0|||
105985776|NCT00129467|365607740|FG000|Received Intervention|Intolerance to citalopram|0|||
105985777|NCT00129467|365607741|FG001|Received Intervention|Intolerance to citalopram|1|||
105985778|NCT00129467|365607740|FG000|Received Intervention|Dizzyness, fatigue|0|||
105985779|NCT00129467|365607741|FG001|Received Intervention|Dizzyness, fatigue|1|||
105985780|NCT00129467|365607740|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
105985781|NCT00129467|365607741|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
105985782|NCT00129467|365607740|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
105985783|NCT00129467|365607741|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
105985784|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
105985785|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
105985786|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
105985787|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
105985788|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
105985789|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
105985790|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
105985791|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
105985792|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
105985793|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
105985794|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
105985795|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
105985796|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
105985797|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
105985798|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
105985799|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
105985800|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
105985801|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
105985802|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
105985803|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
105985804|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
105985805|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
105985806|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
105985807|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
105985808|NCT01532869|365607742|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
105985809|NCT01532869|365607743|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
105985810|NCT01532869|365607742|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
105985811|NCT01532869|365607743|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
105985812|NCT01532869|365607742|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
105985813|NCT01532869|365607743|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
105985814|NCT01532869|365607742|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
105985815|NCT01532869|365607743|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
105985816|NCT01532869|365607742|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
105985817|NCT01532869|365607743|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
105985818|NCT01026220|365607744|FG000|Induction|Death|1|||
105985819|NCT01026220|365607745|FG001|Induction|Death|0|||
105985820|NCT01026220|365607746|FG002|Induction|Death|0|||
105985821|NCT01026220|365607744|FG000|Induction|Lack of Efficacy|2|||
105985822|NCT01026220|365607745|FG001|Induction|Lack of Efficacy|0|||
105985823|NCT01026220|365607746|FG002|Induction|Lack of Efficacy|0|||
105985824|NCT01026220|365607744|FG000|Induction|Physician Decision|12|||
105985825|NCT01026220|365607745|FG001|Induction|Physician Decision|0|||
105985826|NCT01026220|365607746|FG002|Induction|Physician Decision|0|||
105985827|NCT01026220|365607744|FG000|Induction|Withdrawal by Subject|9|||
105985828|NCT01026220|365607745|FG001|Induction|Withdrawal by Subject|0|||
105985829|NCT01026220|365607746|FG002|Induction|Withdrawal by Subject|0|||
105985830|NCT01026220|365607744|FG000|Induction|Ineligible|1|||
105985831|NCT01026220|365607745|FG001|Induction|Ineligible|0|||
105985832|NCT01026220|365607746|FG002|Induction|Ineligible|0|||
105985833|NCT01026220|365607744|FG000|Consolidation Maintenance|Death|0|||
105985834|NCT01026220|365607745|FG001|Consolidation Maintenance|Death|1|||
105985835|NCT01026220|365607746|FG002|Consolidation Maintenance|Death|0|||
105985836|NCT01026220|365607744|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
105985837|NCT01026220|365607745|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
105985838|NCT01026220|365607746|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
105985839|NCT01026220|365607744|FG000|Consolidation Maintenance|Physician Decision|0|||
105985840|NCT01026220|365607745|FG001|Consolidation Maintenance|Physician Decision|2|||
105985841|NCT01026220|365607746|FG002|Consolidation Maintenance|Physician Decision|7|||
105985842|NCT01026220|365607744|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
105985843|NCT01026220|365607745|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
105985844|NCT01026220|365607746|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
105985845|NCT00409344|365607747|FG000|Overall Study|no enrollment|0|||
105985846|NCT00409344|365607748|FG001|Overall Study|no enrollment|0|||
105985847|NCT02683668|365607754|FG000|Period 2|Withdrawal by Subject|0|||
105985848|NCT02683668|365607755|FG001|Period 2|Withdrawal by Subject|1|||
105985849|NCT02683668|365607756|FG002|Period 2|Withdrawal by Subject|0|||
105985850|NCT01805037|365607757|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
105985851|NCT01805037|365607758|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
105985852|NCT01805037|365607757|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
105985853|NCT01805037|365607758|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
105985854|NCT01805037|365607757|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
105985855|NCT01805037|365607758|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
105985856|NCT01805037|365607757|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
105985857|NCT01805037|365607758|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
105985858|NCT01805037|365607757|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
105985859|NCT01805037|365607758|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
105985860|NCT01805037|365607757|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
105985861|NCT01805037|365607758|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
105985862|NCT01805037|365607757|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
105985863|NCT01805037|365607758|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
105985864|NCT01805037|365607757|FG000|Follow Up (up to 3 Years)|Death|0|||
105985865|NCT01805037|365607758|FG001|Follow Up (up to 3 Years)|Death|2|||
105985866|NCT01805037|365607757|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
105985867|NCT01805037|365607758|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
105985868|NCT01805037|365607757|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
105985869|NCT01805037|365607758|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
105985870|NCT00844558|365607759|FG000|Overall Study|Withdrawal by Subject|9|||
105985871|NCT00844558|365607760|FG001|Overall Study|Withdrawal by Subject|2|||
105985872|NCT00844558|365607759|FG000|Overall Study|Death|1|||
105985873|NCT00844558|365607760|FG001|Overall Study|Death|0|||
105985874|NCT00844558|365607759|FG000|Overall Study|Protocol Violation|1|||
105985875|NCT00844558|365607760|FG001|Overall Study|Protocol Violation|1|||
105985876|NCT00844558|365607759|FG000|Overall Study|Lost to Follow-up|0|||
105985877|NCT00844558|365607760|FG001|Overall Study|Lost to Follow-up|1|||
105985878|NCT00844558|365607759|FG000|Overall Study|Physician Decision|1|||
105985879|NCT00844558|365607760|FG001|Overall Study|Physician Decision|0|||
105985880|NCT01229449|365607761|FG000|Overall Study|Withdrawal by Subject|0|||
105985881|NCT01229449|365607762|FG001|Overall Study|Withdrawal by Subject|3|||
105985882|NCT01229449|365607763|FG002|Overall Study|Withdrawal by Subject|0|||
105985883|NCT01229449|365607764|FG003|Overall Study|Withdrawal by Subject|1|||
105985884|NCT01229449|365607765|FG004|Overall Study|Withdrawal by Subject|1|||
105985885|NCT01229449|365607761|FG000|Overall Study|Lost to Follow-up|1|||
105985886|NCT01229449|365607762|FG001|Overall Study|Lost to Follow-up|1|||
105985887|NCT01229449|365607763|FG002|Overall Study|Lost to Follow-up|1|||
105985888|NCT01229449|365607764|FG003|Overall Study|Lost to Follow-up|0|||
105985889|NCT01229449|365607765|FG004|Overall Study|Lost to Follow-up|0|||
105985890|NCT01229449|365607761|FG000|Overall Study|Physician Decision|0|||
105985891|NCT01229449|365607762|FG001|Overall Study|Physician Decision|0|||
105985892|NCT01229449|365607763|FG002|Overall Study|Physician Decision|1|||
105985893|NCT01229449|365607764|FG003|Overall Study|Physician Decision|0|||
105985894|NCT01229449|365607765|FG004|Overall Study|Physician Decision|0|||
105985895|NCT00410605|365607766|FG000|Overall Study|Adverse Event|12|||
105985896|NCT00410605|365607766|FG000|Overall Study|Physician Decision|3|||
105985897|NCT00410605|365607766|FG000|Overall Study|Withdrawal by Subject|5|||
105985898|NCT00410605|365607766|FG000|Overall Study|Started Non-Protocol Therapy|3|||
105985899|NCT00410605|365607766|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
105985900|NCT00410605|365607766|FG000|Overall Study|Transferred to another Institution|1|||
105985901|NCT02726022|365607772|FG000|Overall Study|Adverse Event|14|||
105985902|NCT02726022|365607772|FG000|Overall Study|Treatment Failure|8|||
105985903|NCT02726022|365607772|FG000|Overall Study|Poor Compliance|13|||
105985904|NCT02726022|365607772|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
105985905|NCT02220712|365607773|FG000|Overall Study|Adverse Event|1|||
105985906|NCT02220712|365607773|FG000|Overall Study|Withdrawal by Subject|2|||
105985907|NCT02220712|365607773|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
105985908|NCT00760838|365607775|FG000|Overall Study|Adverse Event|1|||
105985909|NCT00760838|365607776|FG001|Overall Study|Adverse Event|1|||
105985910|NCT00760838|365607775|FG000|Overall Study|Lack of Efficacy|1|||
105985911|NCT00760838|365607776|FG001|Overall Study|Lack of Efficacy|0|||
105985912|NCT00760838|365607775|FG000|Overall Study|Lost to Follow-up|2|||
105985913|NCT00760838|365607776|FG001|Overall Study|Lost to Follow-up|0|||
105985914|NCT00760838|365607775|FG000|Overall Study|Withdrawal by Subject|1|||
105985915|NCT00760838|365607776|FG001|Overall Study|Withdrawal by Subject|1|||
105985916|NCT01545050|365607779|FG000|Overall Study|Lack of Efficacy|0|||
105985917|NCT01545050|365607780|FG001|Overall Study|Lack of Efficacy|0|||
105985918|NCT01545050|365607781|FG002|Overall Study|Lack of Efficacy|0|||
105985919|NCT01545050|365607782|FG003|Overall Study|Lack of Efficacy|3|||
105985920|NCT01545050|365607783|FG004|Overall Study|Lack of Efficacy|2|||
105985921|NCT01545050|365607779|FG000|Overall Study|Adverse Event|1|||
105985922|NCT01545050|365607780|FG001|Overall Study|Adverse Event|1|||
105985923|NCT01545050|365607781|FG002|Overall Study|Adverse Event|2|||
105985924|NCT01545050|365607782|FG003|Overall Study|Adverse Event|2|||
105985925|NCT01545050|365607783|FG004|Overall Study|Adverse Event|0|||
105985926|NCT01545050|365607779|FG000|Overall Study|Discontinued study treatment|1|||
105985927|NCT01545050|365607780|FG001|Overall Study|Discontinued study treatment|0|||
105985928|NCT01545050|365607781|FG002|Overall Study|Discontinued study treatment|0|||
105985929|NCT01545050|365607782|FG003|Overall Study|Discontinued study treatment|0|||
105985930|NCT01545050|365607783|FG004|Overall Study|Discontinued study treatment|0|||
105985931|NCT01545050|365607779|FG000|Overall Study|Withdrawal by Subject|1|||
105985932|NCT01545050|365607780|FG001|Overall Study|Withdrawal by Subject|0|||
105985933|NCT01545050|365607781|FG002|Overall Study|Withdrawal by Subject|0|||
105985934|NCT01545050|365607782|FG003|Overall Study|Withdrawal by Subject|2|||
105985935|NCT01545050|365607783|FG004|Overall Study|Withdrawal by Subject|1|||
105867808|NCT00233948|365167017|FG002|Overall Study|Adverse Event|0|||
105867809|NCT00233948|365167018|FG003|Overall Study|Adverse Event|0|||
105867810|NCT00233948|365167019|FG004|Overall Study|Adverse Event|0|||
105867811|NCT00233948|365167020|FG005|Overall Study|Adverse Event|0|||
105867812|NCT04981717|365167023|FG000|Overall Study|Protocol Violation|0|||
105867813|NCT04981717|365167024|FG001|Overall Study|Protocol Violation|3|||
105867814|NCT04981717|365167023|FG000|Overall Study|Adverse Event|1|||
105867815|NCT04981717|365167024|FG001|Overall Study|Adverse Event|3|||
105867816|NCT04981717|365167023|FG000|Overall Study|Pregnancy|1|||
105867817|NCT04981717|365167024|FG001|Overall Study|Pregnancy|0|||
105867818|NCT04981717|365167023|FG000|Overall Study|Physician Decision|1|||
105867819|NCT04981717|365167024|FG001|Overall Study|Physician Decision|0|||
105867820|NCT04981717|365167023|FG000|Overall Study|Sponsor Request|157|||
105867821|NCT04981717|365167024|FG001|Overall Study|Sponsor Request|172|||
105867822|NCT04981717|365167023|FG000|Overall Study|Lost to Follow-up|4|||
105867823|NCT04981717|365167024|FG001|Overall Study|Lost to Follow-up|5|||
105867824|NCT04981717|365167023|FG000|Overall Study|Withdrawal by Subject|50|||
105867825|NCT04981717|365167024|FG001|Overall Study|Withdrawal by Subject|37|||
105867826|NCT00615199|365167032|FG000|Overall Study|Adverse Event|3|||
105867827|NCT00615199|365167033|FG001|Overall Study|Adverse Event|1|||
105867828|NCT00615199|365167034|FG002|Overall Study|Adverse Event|1|||
105867829|NCT00615199|365167035|FG003|Overall Study|Adverse Event|0|||
105867830|NCT00615199|365167032|FG000|Overall Study|Lack of Efficacy|2|||
105867831|NCT00615199|365167033|FG001|Overall Study|Lack of Efficacy|0|||
105867832|NCT00615199|365167034|FG002|Overall Study|Lack of Efficacy|0|||
105867833|NCT00615199|365167035|FG003|Overall Study|Lack of Efficacy|1|||
105867834|NCT00615199|365167032|FG000|Overall Study|Lost to Follow-up|1|||
105867835|NCT00615199|365167033|FG001|Overall Study|Lost to Follow-up|0|||
105867836|NCT00615199|365167034|FG002|Overall Study|Lost to Follow-up|0|||
105867837|NCT00615199|365167035|FG003|Overall Study|Lost to Follow-up|0|||
105867838|NCT00615199|365167032|FG000|Overall Study|Other|0|||
105867839|NCT00615199|365167033|FG001|Overall Study|Other|0|||
105867840|NCT00615199|365167034|FG002|Overall Study|Other|0|||
105867841|NCT00615199|365167035|FG003|Overall Study|Other|1|||
105867842|NCT00615199|365167032|FG000|Overall Study|Withdrawal by Subject|2|||
105867843|NCT00615199|365167033|FG001|Overall Study|Withdrawal by Subject|1|||
105867844|NCT00615199|365167034|FG002|Overall Study|Withdrawal by Subject|0|||
105867845|NCT00615199|365167035|FG003|Overall Study|Withdrawal by Subject|0|||
105867846|NCT04825912|365167036|FG000|Overall Study|Death|3|||
105867847|NCT04825912|365167036|FG000|Overall Study|Withdrawal by Subject|1|||
105867848|NCT02640482|365167041|FG000|Overall Study|Lost to Follow-up|3|||
105867849|NCT02640482|365167042|FG001|Overall Study|Lost to Follow-up|0|||
105867850|NCT01173120|365167043|FG000|Overall Study|Lack of Efficacy|2|||
105867851|NCT01173120|365167043|FG000|Overall Study|Lost to Follow-up|1|||
105867852|NCT01173120|365167043|FG000|Overall Study|Participant Decision|2|||
105867853|NCT01173120|365167043|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
105867854|NCT01173120|365167043|FG000|Overall Study|Switch-Participant Decision|12|||
105867855|NCT01173120|365167043|FG000|Overall Study|Switch-Difficulty With Device|12|||
105867856|NCT03066258|365167044|FG000|Overall Study|Death|1|||
105867857|NCT03066258|365167045|FG001|Overall Study|Death|0|||
105867858|NCT03066258|365167046|FG002|Overall Study|Death|0|||
105867859|NCT03066258|365167047|FG003|Overall Study|Death|0|||
105867860|NCT03066258|365167048|FG004|Overall Study|Death|1|||
105867861|NCT02797171|365167049|FG000|Overall Study|Lost to Follow-up|2|||
105867862|NCT02797171|365167050|FG001|Overall Study|Lost to Follow-up|0|||
105867863|NCT02797171|365167051|FG002|Overall Study|Lost to Follow-up|2|||
105867864|NCT02797171|365167052|FG003|Overall Study|Lost to Follow-up|1|||
105867865|NCT02797171|365167053|FG004|Overall Study|Lost to Follow-up|2|||
105867866|NCT02797171|365167054|FG005|Overall Study|Lost to Follow-up|0|||
105867867|NCT02797171|365167049|FG000|Overall Study|Withdrawal by Subject|1|||
105867868|NCT02797171|365167050|FG001|Overall Study|Withdrawal by Subject|1|||
105867869|NCT02797171|365167051|FG002|Overall Study|Withdrawal by Subject|0|||
105867870|NCT02797171|365167052|FG003|Overall Study|Withdrawal by Subject|0|||
105867871|NCT02797171|365167053|FG004|Overall Study|Withdrawal by Subject|0|||
105867872|NCT02797171|365167054|FG005|Overall Study|Withdrawal by Subject|0|||
105867873|NCT02797171|365167049|FG000|Overall Study|Protocol Violation|1|||
105867874|NCT02797171|365167050|FG001|Overall Study|Protocol Violation|0|||
105867875|NCT02797171|365167051|FG002|Overall Study|Protocol Violation|0|||
105867876|NCT02797171|365167052|FG003|Overall Study|Protocol Violation|0|||
105867877|NCT02797171|365167053|FG004|Overall Study|Protocol Violation|0|||
105867878|NCT02797171|365167054|FG005|Overall Study|Protocol Violation|0|||
105867879|NCT02797171|365167049|FG000|Overall Study|Participant unable to adhere|0|||
105867880|NCT02797171|365167050|FG001|Overall Study|Participant unable to adhere|1|||
105867881|NCT02797171|365167051|FG002|Overall Study|Participant unable to adhere|0|||
105867882|NCT02797171|365167052|FG003|Overall Study|Participant unable to adhere|0|||
105867883|NCT02797171|365167053|FG004|Overall Study|Participant unable to adhere|0|||
105867884|NCT02797171|365167054|FG005|Overall Study|Participant unable to adhere|0|||
105985936|NCT01545050|365607779|FG000|Overall Study|Participant no longer meets study criteria|0|||
105985937|NCT01545050|365607780|FG001|Overall Study|Participant no longer meets study criteria|2|||
105985938|NCT01545050|365607781|FG002|Overall Study|Participant no longer meets study criteria|0|||
105985939|NCT01545050|365607782|FG003|Overall Study|Participant no longer meets study criteria|0|||
105985940|NCT01545050|365607783|FG004|Overall Study|Participant no longer meets study criteria|1|||
105985941|NCT01545050|365607779|FG000|Overall Study|Administrative reason by sponsor|4|||
105985942|NCT01545050|365607780|FG001|Overall Study|Administrative reason by sponsor|2|||
105985943|NCT01545050|365607781|FG002|Overall Study|Administrative reason by sponsor|3|||
105985944|NCT01545050|365607782|FG003|Overall Study|Administrative reason by sponsor|5|||
105985945|NCT01545050|365607783|FG004|Overall Study|Administrative reason by sponsor|5|||
105985946|NCT02607228|365607784|FG000|Overall Study|Progressive Disease|4|||
105985947|NCT02607228|365607785|FG001|Overall Study|Progressive Disease|3|||
105985948|NCT02607228|365607786|FG002|Overall Study|Progressive Disease|1|||
105985949|NCT02607228|365607787|FG003|Overall Study|Progressive Disease|5|||
105985950|NCT02607228|365607788|FG004|Overall Study|Progressive Disease|4|||
105985951|NCT02607228|365607789|FG005|Overall Study|Progressive Disease|3|||
105985952|NCT02607228|365607790|FG006|Overall Study|Progressive Disease|1|||
105985953|NCT02607228|365607784|FG000|Overall Study|Adverse Event|1|||
105985954|NCT02607228|365607785|FG001|Overall Study|Adverse Event|0|||
105985955|NCT02607228|365607786|FG002|Overall Study|Adverse Event|1|||
105985956|NCT02607228|365607787|FG003|Overall Study|Adverse Event|0|||
105985957|NCT02607228|365607788|FG004|Overall Study|Adverse Event|1|||
105985958|NCT02607228|365607789|FG005|Overall Study|Adverse Event|1|||
105985959|NCT02607228|365607790|FG006|Overall Study|Adverse Event|1|||
105985960|NCT02607228|365607784|FG000|Overall Study|Investigator's Discretion|0|||
105985961|NCT02607228|365607785|FG001|Overall Study|Investigator's Discretion|0|||
105985962|NCT02607228|365607786|FG002|Overall Study|Investigator's Discretion|1|||
105985963|NCT02607228|365607787|FG003|Overall Study|Investigator's Discretion|0|||
105985964|NCT02607228|365607788|FG004|Overall Study|Investigator's Discretion|0|||
105985965|NCT02607228|365607789|FG005|Overall Study|Investigator's Discretion|1|||
105985966|NCT02607228|365607790|FG006|Overall Study|Investigator's Discretion|0|||
105985967|NCT02607228|365607784|FG000|Overall Study|Withdrew Consent|0|||
105985968|NCT02607228|365607785|FG001|Overall Study|Withdrew Consent|1|||
105985969|NCT02607228|365607786|FG002|Overall Study|Withdrew Consent|0|||
105985970|NCT02607228|365607787|FG003|Overall Study|Withdrew Consent|0|||
105985971|NCT02607228|365607788|FG004|Overall Study|Withdrew Consent|0|||
105985972|NCT02607228|365607789|FG005|Overall Study|Withdrew Consent|1|||
105985973|NCT02607228|365607790|FG006|Overall Study|Withdrew Consent|0|||
105985974|NCT02607228|365607784|FG000|Overall Study|Study Terminated by Sponsor|0|||
105985975|NCT02607228|365607785|FG001|Overall Study|Study Terminated by Sponsor|0|||
105985976|NCT02607228|365607786|FG002|Overall Study|Study Terminated by Sponsor|0|||
105985977|NCT02607228|365607787|FG003|Overall Study|Study Terminated by Sponsor|1|||
105985978|NCT02607228|365607788|FG004|Overall Study|Study Terminated by Sponsor|0|||
105985979|NCT02607228|365607789|FG005|Overall Study|Study Terminated by Sponsor|0|||
105985980|NCT02607228|365607790|FG006|Overall Study|Study Terminated by Sponsor|0|||
105985981|NCT03235089|365607791|FG000|Overall Study|Lost to Follow-up|1|||
105985982|NCT03235089|365607792|FG001|Overall Study|Lost to Follow-up|1|||
105985983|NCT03235089|365607791|FG000|Overall Study|Physician Decision|2|||
105985984|NCT03235089|365607792|FG001|Overall Study|Physician Decision|2|||
105985985|NCT03576716|365607802|FG000|Overall Study|Withdrawal by Subject|0|||
105985986|NCT03576716|365607803|FG001|Overall Study|Withdrawal by Subject|1|||
105985987|NCT02188849|365607804|FG000|Overall Study|Lost to Follow-up|3|||
105985988|NCT02188849|365607805|FG001|Overall Study|Lost to Follow-up|8|||
105985989|NCT00504894|365607812|FG000|Overall Study|fMRI technical problems|1|||
105985990|NCT00504894|365607813|FG001|Overall Study|fMRI technical problems|1|||
105985991|NCT00504894|365607814|FG002|Overall Study|fMRI technical problems|0|||
105985992|NCT00504894|365607812|FG000|Overall Study|Withdrawal by Subject|0|||
105985993|NCT00504894|365607813|FG001|Overall Study|Withdrawal by Subject|1|||
105985994|NCT00504894|365607814|FG002|Overall Study|Withdrawal by Subject|0|||
105985995|NCT00504894|365607812|FG000|Overall Study|Infusion technical problems|0|||
105985996|NCT00504894|365607813|FG001|Overall Study|Infusion technical problems|1|||
105985997|NCT00504894|365607814|FG002|Overall Study|Infusion technical problems|0|||
105985998|NCT00504894|365607812|FG000|Overall Study|poor subject data|2|||
105985999|NCT00504894|365607813|FG001|Overall Study|poor subject data|0|||
105986000|NCT00504894|365607814|FG002|Overall Study|poor subject data|0|||
105986001|NCT00566254|365607816|FG000|Overall Study|Adverse Event|3|||
105986002|NCT00566254|365607817|FG001|Overall Study|Adverse Event|1|||
105986003|NCT00566254|365607816|FG000|Overall Study|Protocol Violation|1|||
105986004|NCT00566254|365607817|FG001|Overall Study|Protocol Violation|3|||
105986005|NCT00566254|365607816|FG000|Overall Study|Withdrawal by Subject|1|||
105986006|NCT00566254|365607817|FG001|Overall Study|Withdrawal by Subject|2|||
105986007|NCT00566254|365607816|FG000|Overall Study|Lack of Efficacy|5|||
105986008|NCT00566254|365607817|FG001|Overall Study|Lack of Efficacy|6|||
105986009|NCT00566254|365607816|FG000|Overall Study|Other|0|||
105986010|NCT00566254|365607817|FG001|Overall Study|Other|2|||
105986011|NCT00761527|365607818|FG000|Overall Study|Adverse Event|3|||
105986012|NCT00761527|365607818|FG000|Overall Study|Poor Compliance|8|||
105986013|NCT00761527|365607818|FG000|Overall Study|Lost to Follow-up|9|||
105986014|NCT00761527|365607818|FG000|Overall Study|Unknown reason|2|||
105986015|NCT01748825|365607819|FG000|Dose Escalation|Refused further treatment|2|||
105986016|NCT01748825|365607820|FG001|Dose Escalation|Refused further treatment|2|||
105986017|NCT01748825|365607821|FG002|Dose Escalation|Refused further treatment|0|||
105986018|NCT01748825|365607822|FG003|Dose Escalation|Refused further treatment|0|||
105986019|NCT01748825|365607823|FG004|Dose Escalation|Refused further treatment|1|||
105986020|NCT01748825|365607824|FG005|Dose Escalation|Refused further treatment|2|||
105986021|NCT01748825|365607825|FG006|Dose Escalation|Refused further treatment|0|||
105986022|NCT01748825|365607826|FG007|Dose Escalation|Refused further treatment|0|||
105986023|NCT01748825|365607827|FG008|Dose Escalation|Refused further treatment|0|||
105986024|NCT01748825|365607828|FG009|Dose Escalation|Refused further treatment|0|||
105986025|NCT01748825|365607819|FG000|Dose Escalation|Switched to alternative treatment|0|||
105986026|NCT01748825|365607820|FG001|Dose Escalation|Switched to alternative treatment|0|||
105986027|NCT01748825|365607821|FG002|Dose Escalation|Switched to alternative treatment|0|||
105986028|NCT01748825|365607822|FG003|Dose Escalation|Switched to alternative treatment|1|||
105986029|NCT01748825|365607823|FG004|Dose Escalation|Switched to alternative treatment|0|||
105986030|NCT01748825|365607824|FG005|Dose Escalation|Switched to alternative treatment|0|||
105986031|NCT01748825|365607825|FG006|Dose Escalation|Switched to alternative treatment|0|||
105986032|NCT01748825|365607826|FG007|Dose Escalation|Switched to alternative treatment|0|||
105986033|NCT01748825|365607827|FG008|Dose Escalation|Switched to alternative treatment|0|||
105986034|NCT01748825|365607828|FG009|Dose Escalation|Switched to alternative treatment|0|||
105986035|NCT01748825|365607819|FG000|Dose Escalation|Adverse Event|0|||
105986036|NCT01748825|365607820|FG001|Dose Escalation|Adverse Event|0|||
105986037|NCT01748825|365607821|FG002|Dose Escalation|Adverse Event|0|||
105986038|NCT01748825|365607822|FG003|Dose Escalation|Adverse Event|0|||
105986039|NCT01748825|365607823|FG004|Dose Escalation|Adverse Event|0|||
105986040|NCT01748825|365607824|FG005|Dose Escalation|Adverse Event|0|||
105986041|NCT01748825|365607825|FG006|Dose Escalation|Adverse Event|1|||
105986042|NCT01748825|365607826|FG007|Dose Escalation|Adverse Event|0|||
105986043|NCT01748825|365607827|FG008|Dose Escalation|Adverse Event|0|||
105986044|NCT01748825|365607828|FG009|Dose Escalation|Adverse Event|0|||
105986045|NCT01748825|365607819|FG000|Dose Expansion|Refused further treatment|0|||
105986046|NCT01748825|365607820|FG001|Dose Expansion|Refused further treatment|0|||
105986047|NCT01748825|365607821|FG002|Dose Expansion|Refused further treatment|0|||
105986048|NCT01748825|365607822|FG003|Dose Expansion|Refused further treatment|0|||
105986049|NCT01748825|365607823|FG004|Dose Expansion|Refused further treatment|0|||
105986050|NCT01748825|365607824|FG005|Dose Expansion|Refused further treatment|0|||
105986051|NCT01748825|365607825|FG006|Dose Expansion|Refused further treatment|0|||
105986052|NCT01748825|365607826|FG007|Dose Expansion|Refused further treatment|0|||
105986053|NCT01748825|365607827|FG008|Dose Expansion|Refused further treatment|1|||
105986054|NCT01748825|365607828|FG009|Dose Expansion|Refused further treatment|1|||
105986055|NCT01748825|365607819|FG000|Dose Expansion|Switched to alternative treatment|0|||
105986056|NCT01748825|365607820|FG001|Dose Expansion|Switched to alternative treatment|0|||
105986057|NCT01748825|365607821|FG002|Dose Expansion|Switched to alternative treatment|0|||
105986058|NCT01748825|365607822|FG003|Dose Expansion|Switched to alternative treatment|0|||
105986059|NCT01748825|365607823|FG004|Dose Expansion|Switched to alternative treatment|0|||
105986060|NCT01748825|365607824|FG005|Dose Expansion|Switched to alternative treatment|0|||
105986061|NCT01748825|365607825|FG006|Dose Expansion|Switched to alternative treatment|0|||
105986062|NCT01748825|365607826|FG007|Dose Expansion|Switched to alternative treatment|0|||
105986063|NCT01748825|365607827|FG008|Dose Expansion|Switched to alternative treatment|0|||
105986064|NCT01748825|365607828|FG009|Dose Expansion|Switched to alternative treatment|1|||
105986065|NCT01748825|365607819|FG000|Dose Expansion|Adverse Event|0|||
105986066|NCT01748825|365607820|FG001|Dose Expansion|Adverse Event|0|||
105986067|NCT01748825|365607821|FG002|Dose Expansion|Adverse Event|0|||
105986068|NCT01748825|365607822|FG003|Dose Expansion|Adverse Event|0|||
105986069|NCT01748825|365607823|FG004|Dose Expansion|Adverse Event|0|||
105986070|NCT01748825|365607824|FG005|Dose Expansion|Adverse Event|0|||
105986071|NCT01748825|365607825|FG006|Dose Expansion|Adverse Event|0|||
105986072|NCT01748825|365607826|FG007|Dose Expansion|Adverse Event|0|||
105986073|NCT01748825|365607827|FG008|Dose Expansion|Adverse Event|0|||
105986074|NCT01748825|365607828|FG009|Dose Expansion|Adverse Event|3|||
105986075|NCT01748825|365607819|FG000|Dose Expansion|Physician Decision|0|||
105986076|NCT01748825|365607820|FG001|Dose Expansion|Physician Decision|0|||
105986077|NCT01748825|365607821|FG002|Dose Expansion|Physician Decision|0|||
105986078|NCT01748825|365607822|FG003|Dose Expansion|Physician Decision|0|||
105986079|NCT01748825|365607823|FG004|Dose Expansion|Physician Decision|0|||
105986080|NCT01748825|365607824|FG005|Dose Expansion|Physician Decision|0|||
105986081|NCT01748825|365607825|FG006|Dose Expansion|Physician Decision|0|||
105986082|NCT01748825|365607826|FG007|Dose Expansion|Physician Decision|0|||
105986083|NCT01748825|365607827|FG008|Dose Expansion|Physician Decision|1|||
105986084|NCT01748825|365607828|FG009|Dose Expansion|Physician Decision|0|||
105986085|NCT03848949|365607829|FG000|Overall Study|Lost to Follow-up|5|||
105986086|NCT03848949|365607830|FG001|Overall Study|Lost to Follow-up|7|||
105986087|NCT00619307|365607831|FG000|Overall Study|Adverse Event|0|||
105986088|NCT00619307|365607832|FG001|Overall Study|Adverse Event|1|||
105867885|NCT02797171|365167049|FG000|Overall Study|Not Randomized|0|||
105867886|NCT02797171|365167050|FG001|Overall Study|Not Randomized|0|||
105867887|NCT02797171|365167051|FG002|Overall Study|Not Randomized|0|||
105867888|NCT02797171|365167052|FG003|Overall Study|Not Randomized|0|||
105867889|NCT02797171|365167053|FG004|Overall Study|Not Randomized|0|||
105867890|NCT02797171|365167054|FG005|Overall Study|Not Randomized|1|||
105867891|NCT00626561|365167055|FG000|Overall Study|Withdrawal by Subject|2|||
105867892|NCT00626561|365167055|FG000|Overall Study|Disease Progression|2|||
105867893|NCT02370238|365167061|FG000|Overall Study|Death|42|||
105867894|NCT02370238|365167062|FG001|Overall Study|Death|35|||
105867895|NCT02370238|365167061|FG000|Overall Study|Lost to Follow-up|1|||
105867896|NCT02370238|365167062|FG001|Overall Study|Lost to Follow-up|3|||
105867897|NCT02370238|365167061|FG000|Overall Study|Withdrawal by Subject|2|||
105867898|NCT02370238|365167062|FG001|Overall Study|Withdrawal by Subject|6|||
105867899|NCT02370238|365167061|FG000|Overall Study|Other|2|||
105867900|NCT02370238|365167062|FG001|Overall Study|Other|1|||
105867901|NCT01807065|365167063|FG000|Overall Study|Receive no sip-T due to IV access|1|||
105867902|NCT01807065|365167064|FG001|Overall Study|Receive no sip-T due to IV access|1|||
105867903|NCT04342819|365167068|FG000|Overall Study|Declined|4|||
105867904|NCT04342819|365167068|FG000|Overall Study|Not meeeting selection criteria|1|||
105867905|NCT01750190|365167070|FG000|Overall Study|Adverse Event|47|||
105867906|NCT01750190|365167071|FG001|Overall Study|Adverse Event|19|||
105867907|NCT01750190|365167070|FG000|Overall Study|Death|38|||
105867908|NCT01750190|365167071|FG001|Overall Study|Death|11|||
105867909|NCT01750190|365167070|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
105867910|NCT01750190|365167071|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
105867911|NCT01750190|365167070|FG000|Overall Study|Lost to Follow-up|28|||
105867912|NCT01750190|365167071|FG001|Overall Study|Lost to Follow-up|7|||
105867913|NCT01750190|365167070|FG000|Overall Study|Physician Decision|16|||
105867914|NCT01750190|365167071|FG001|Overall Study|Physician Decision|17|||
105867915|NCT01750190|365167070|FG000|Overall Study|Protocol Violation|6|||
105867916|NCT01750190|365167071|FG001|Overall Study|Protocol Violation|5|||
105867917|NCT01750190|365167070|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
105867918|NCT01750190|365167071|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
105867919|NCT01750190|365167070|FG000|Overall Study|Withdrawal by Subject|83|||
105867920|NCT01750190|365167071|FG001|Overall Study|Withdrawal by Subject|89|||
105867921|NCT01750190|365167070|FG000|Overall Study|Kidney Transplant|8|||
105867922|NCT01750190|365167071|FG001|Overall Study|Kidney Transplant|4|||
105867923|NCT01750190|365167070|FG000|Overall Study|Dialysis|22|||
105867924|NCT01750190|365167071|FG001|Overall Study|Dialysis|8|||
105867925|NCT01750190|365167070|FG000|Overall Study|Other than Specified|13|||
105867926|NCT01750190|365167071|FG001|Overall Study|Other than Specified|4|||
105867927|NCT00911300|365167072|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
105867928|NCT00911300|365167073|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
105867929|NCT00911300|365167072|FG000|Overall Study|Death|1|||
105867930|NCT00911300|365167073|FG001|Overall Study|Death|0|||
105867931|NCT00911300|365167072|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
105867932|NCT00911300|365167073|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
105867933|NCT00911300|365167072|FG000|Overall Study|Adverse Event|14|||
105867934|NCT00911300|365167073|FG001|Overall Study|Adverse Event|6|||
105867935|NCT00911300|365167072|FG000|Overall Study|Protocol Violation|3|||
105867936|NCT00911300|365167073|FG001|Overall Study|Protocol Violation|2|||
105867937|NCT00911300|365167072|FG000|Overall Study|Consent Withdrawn|4|||
105867938|NCT00911300|365167073|FG001|Overall Study|Consent Withdrawn|12|||
105867939|NCT00911300|365167072|FG000|Overall Study|Coronary Angiography Performed|1|||
105867940|NCT00911300|365167073|FG001|Overall Study|Coronary Angiography Performed|0|||
105867941|NCT00911300|365167072|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
105867942|NCT00911300|365167073|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
105867943|NCT00911300|365167072|FG000|Overall Study|Received Commercial Treatment|1|||
105867944|NCT00911300|365167073|FG001|Overall Study|Received Commercial Treatment|0|||
105867945|NCT00911300|365167072|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
105867946|NCT00911300|365167073|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
105867947|NCT00911300|365167072|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
105867948|NCT00911300|365167073|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
105867949|NCT00911300|365167072|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
105867950|NCT00911300|365167073|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
105867951|NCT00911300|365167072|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
105867952|NCT00911300|365167073|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
105867953|NCT00911300|365167072|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
105867954|NCT00911300|365167073|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
105867955|NCT00911300|365167072|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
105867956|NCT00911300|365167073|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
105867957|NCT00911300|365167072|FG000|Overall Study|International Normalized Ratio Too High|0|||
105867958|NCT00911300|365167073|FG001|Overall Study|International Normalized Ratio Too High|1|||
105867959|NCT00911300|365167072|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
105867960|NCT00911300|365167073|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
105867961|NCT00911300|365167072|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
105867962|NCT00911300|365167073|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
105867963|NCT00911300|365167072|FG000|Overall Study|Physician Decision|0|||
105867964|NCT00911300|365167073|FG001|Overall Study|Physician Decision|1|||
105867965|NCT00911300|365167072|FG000|Overall Study|Treatment Stopped by Mistake|0|||
105867966|NCT00911300|365167073|FG001|Overall Study|Treatment Stopped by Mistake|1|||
105867967|NCT00911300|365167072|FG000|Overall Study|Randomized; No Study Medication Received|0|||
105867968|NCT00911300|365167073|FG001|Overall Study|Randomized; No Study Medication Received|2|||
105867969|NCT00545714|365167074|FG000|Induction Phase (6 Months)|Physician Decision|3|||
105867970|NCT00545714|365167074|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
105867971|NCT00545714|365167074|FG000|Induction Phase (6 Months)|Disease Progression|1|||
105867972|NCT00545714|365167074|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
105867973|NCT00545714|365167074|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
105867974|NCT00545714|365167074|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
105867975|NCT00545714|365167074|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
105867976|NCT00545714|365167074|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
105867977|NCT00545714|365167074|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
105867978|NCT00545714|365167074|FG000|Maintenance Phase (36 Months)|Death|2|||
105867979|NCT03138655|365167076|FG000|Overall Study|Adverse Event|2|||
105867980|NCT03138655|365167077|FG001|Overall Study|Adverse Event|1|||
105867981|NCT03138655|365167078|FG002|Overall Study|Adverse Event|2|||
105867982|NCT03138655|365167079|FG003|Overall Study|Adverse Event|1|||
105867983|NCT03138655|365167080|FG004|Overall Study|Adverse Event|1|||
105867984|NCT03138655|365167081|FG005|Overall Study|Adverse Event|4|||
105867985|NCT03138655|365167082|FG006|Overall Study|Adverse Event|2|||
105867986|NCT03138655|365167083|FG007|Overall Study|Adverse Event|2|||
105867987|NCT03138655|365167076|FG000|Overall Study|Withdrawal by Subject|0|||
105867988|NCT03138655|365167077|FG001|Overall Study|Withdrawal by Subject|1|||
105867989|NCT03138655|365167078|FG002|Overall Study|Withdrawal by Subject|0|||
105867990|NCT03138655|365167079|FG003|Overall Study|Withdrawal by Subject|0|||
105867991|NCT03138655|365167080|FG004|Overall Study|Withdrawal by Subject|0|||
105867992|NCT03138655|365167081|FG005|Overall Study|Withdrawal by Subject|0|||
105867993|NCT03138655|365167082|FG006|Overall Study|Withdrawal by Subject|1|||
105867994|NCT03138655|365167083|FG007|Overall Study|Withdrawal by Subject|0|||
105867995|NCT03138655|365167076|FG000|Overall Study|Reason not Specified|1|||
105867996|NCT03138655|365167077|FG001|Overall Study|Reason not Specified|0|||
105867997|NCT03138655|365167078|FG002|Overall Study|Reason not Specified|0|||
105867998|NCT03138655|365167079|FG003|Overall Study|Reason not Specified|2|||
105867999|NCT03138655|365167080|FG004|Overall Study|Reason not Specified|1|||
105868000|NCT03138655|365167081|FG005|Overall Study|Reason not Specified|1|||
105868001|NCT03138655|365167082|FG006|Overall Study|Reason not Specified|0|||
105868002|NCT03138655|365167083|FG007|Overall Study|Reason not Specified|0|||
105868003|NCT00535405|365167084|FG000|Overall Study|Adverse Event|6|||
105868004|NCT00535405|365167085|FG001|Overall Study|Adverse Event|8|||
105868005|NCT00535405|365167086|FG002|Overall Study|Adverse Event|3|||
105868006|NCT00535405|365167087|FG003|Overall Study|Adverse Event|8|||
105868007|NCT00535405|365167088|FG004|Overall Study|Adverse Event|6|||
105868008|NCT00535405|365167084|FG000|Overall Study|Lost to Follow-up|1|||
105868009|NCT00535405|365167085|FG001|Overall Study|Lost to Follow-up|3|||
105868010|NCT00535405|365167086|FG002|Overall Study|Lost to Follow-up|3|||
105868011|NCT00535405|365167087|FG003|Overall Study|Lost to Follow-up|2|||
105868012|NCT00535405|365167088|FG004|Overall Study|Lost to Follow-up|1|||
105868013|NCT00535405|365167084|FG000|Overall Study|Physician Decision|3|||
105868014|NCT00535405|365167085|FG001|Overall Study|Physician Decision|2|||
105868015|NCT00535405|365167086|FG002|Overall Study|Physician Decision|0|||
105868016|NCT00535405|365167087|FG003|Overall Study|Physician Decision|1|||
105868017|NCT00535405|365167088|FG004|Overall Study|Physician Decision|1|||
105868018|NCT00535405|365167084|FG000|Overall Study|Protocol Violation|2|||
105868019|NCT00535405|365167085|FG001|Overall Study|Protocol Violation|2|||
105868020|NCT00535405|365167086|FG002|Overall Study|Protocol Violation|2|||
105868021|NCT00535405|365167087|FG003|Overall Study|Protocol Violation|1|||
105986089|NCT00619307|365607831|FG000|Overall Study|Lost to Follow-up|0|||
105986090|NCT00619307|365607832|FG001|Overall Study|Lost to Follow-up|1|||
105986091|NCT00619307|365607831|FG000|Overall Study|Protocol Violation|3|||
105986092|NCT00619307|365607832|FG001|Overall Study|Protocol Violation|0|||
105986093|NCT00619307|365607831|FG000|Overall Study|Withdrew consent|1|||
105986094|NCT00619307|365607832|FG001|Overall Study|Withdrew consent|0|||
105986095|NCT00619307|365607831|FG000|Overall Study|Severe migraine|0|||
105986096|NCT00619307|365607832|FG001|Overall Study|Severe migraine|1|||
105986097|NCT00619307|365607831|FG000|Overall Study|MS attack plus steroids|0|||
105986098|NCT00619307|365607832|FG001|Overall Study|MS attack plus steroids|1|||
105986099|NCT00765063|365609944|FG000|Overall Study|Lack of Efficacy|5|||
105986100|NCT00765063|365609944|FG000|Overall Study|Withdrawal by Subject|1|||
105986101|NCT00765063|365609944|FG000|Overall Study|Other|16|||
105986102|NCT00765063|365609944|FG000|Overall Study|Protocol Violation|6|||
105986103|NCT00765063|365609944|FG000|Overall Study|Adverse Event|4|||
105986104|NCT03614325|365609945|FG000|Overall Study|Withdrawal by Subject|0|||
105986105|NCT03614325|365609946|FG001|Overall Study|Withdrawal by Subject|2|||
105986106|NCT03614325|365609945|FG000|Overall Study|Surgery Cancelled|2|||
105986107|NCT03614325|365609946|FG001|Overall Study|Surgery Cancelled|1|||
105986108|NCT03614325|365609945|FG000|Overall Study|Lost to Follow-up|2|||
105986109|NCT03614325|365609946|FG001|Overall Study|Lost to Follow-up|1|||
105986110|NCT03614325|365609945|FG000|Overall Study|Surgery never scheduled|1|||
105986111|NCT03614325|365609946|FG001|Overall Study|Surgery never scheduled|0|||
105986112|NCT00321464|365609947|FG000|Overall Study|Death|169|||
105986113|NCT00321464|365609948|FG001|Overall Study|Death|174|||
105986114|NCT00321464|365609947|FG000|Overall Study|Disease progression|124|||
105986115|NCT00321464|365609948|FG001|Overall Study|Disease progression|124|||
105986116|NCT00321464|365609947|FG000|Overall Study|Withdrawal by Subject|117|||
105986117|NCT00321464|365609948|FG001|Overall Study|Withdrawal by Subject|118|||
105986118|NCT00321464|365609947|FG000|Overall Study|Participant request|57|||
105986119|NCT00321464|365609948|FG001|Overall Study|Participant request|61|||
105986120|NCT00321464|365609947|FG000|Overall Study|Adverse Event|43|||
105986121|NCT00321464|365609948|FG001|Overall Study|Adverse Event|28|||
105986122|NCT00321464|365609947|FG000|Overall Study|Physician Decision|15|||
105986123|NCT00321464|365609948|FG001|Overall Study|Physician Decision|14|||
105986124|NCT00321464|365609947|FG000|Overall Study|Noncompliance|4|||
105986125|NCT00321464|365609948|FG001|Overall Study|Noncompliance|10|||
105986126|NCT00321464|365609947|FG000|Overall Study|Lost to Follow-up|7|||
105986127|NCT00321464|365609948|FG001|Overall Study|Lost to Follow-up|8|||
105986128|NCT00321464|365609947|FG000|Overall Study|Protocol deviation|0|||
105986129|NCT00321464|365609948|FG001|Overall Study|Protocol deviation|2|||
105986130|NCT00321464|365609947|FG000|Overall Study|Ineligibility determined|2|||
105986131|NCT00321464|365609948|FG001|Overall Study|Ineligibility determined|1|||
105986132|NCT00321464|365609947|FG000|Overall Study|Other|21|||
105986133|NCT00321464|365609948|FG001|Overall Study|Other|18|||
105986134|NCT00652951|365609949|FG000|Booster Phase|Adverse event, non-fatal|0|||
105986135|NCT00652951|365609950|FG001|Booster Phase|Adverse event, non-fatal|1|||
105986136|NCT00652951|365609951|FG002|Booster Phase|Adverse event, non-fatal|0|||
105986137|NCT00652951|365609949|FG000|Booster Phase|Other|1|||
105986138|NCT00652951|365609950|FG001|Booster Phase|Other|0|||
105986139|NCT00652951|365609951|FG002|Booster Phase|Other|0|||
105986140|NCT01754493|365609952|FG000|Overall Study|Adverse Event|1|||
105986141|NCT01754493|365609952|FG000|Overall Study|Lost to Follow-up|3|||
105986142|NCT01754493|365609952|FG000|Overall Study|Withdrawal by Subject|1|||
105986143|NCT01754493|365609952|FG000|Overall Study|Moved out of town|1|||
105986144|NCT01754493|365609952|FG000|Overall Study|Scheduling conflict|1|||
105986145|NCT02489942|365609953|FG000|Overall Study|Request by patient|602|||
105986146|NCT02489942|365609953|FG000|Overall Study|Improvement/remission|157|||
105986147|NCT02489942|365609953|FG000|Overall Study|No change/Progressive disease|263|||
105986148|NCT02489942|365609953|FG000|Overall Study|Adverse Event|522|||
105986149|NCT02489942|365609953|FG000|Overall Study|Other personal reasons|1218|||
105986150|NCT02489942|365609953|FG000|Overall Study|Lost to Follow-up|456|||
105986151|NCT02489942|365609953|FG000|Overall Study|Not continuously investigated|7|||
105986152|NCT02489942|365609953|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
105986153|NCT02489942|365609953|FG000|Overall Study|Multiple registration|1|||
105986154|NCT02489942|365609953|FG000|Overall Study|No patient visit after entry|100|||
105986155|NCT02489942|365609953|FG000|Overall Study|No treatment with Jardiance|2|||
105986156|NCT02489942|365609953|FG000|Overall Study|Patient received Jardiance before registration|1|||
105986157|NCT02489942|365609953|FG000|Overall Study|No CRF collected|86|||
105986158|NCT00858208|365609954|FG000|Overall Study|Adverse Event|3|||
105986159|NCT00858208|365609954|FG000|Overall Study|Lost to Follow-up|26|||
105986160|NCT00858208|365609954|FG000|Overall Study|Participant refused|40|||
105986161|NCT00858208|365609954|FG000|Overall Study|Other|10|||
105986162|NCT02702180|365609955|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
105986163|NCT02702180|365609956|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
105986164|NCT02702180|365609957|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105986165|NCT02702180|365609955|FG000|Double-blind Treatment Period|Adverse Event|0|||
105986166|NCT02702180|365609956|FG001|Double-blind Treatment Period|Adverse Event|0|||
105986167|NCT02702180|365609957|FG002|Double-blind Treatment Period|Adverse Event|1|||
105986168|NCT02702180|365609955|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
105986169|NCT02702180|365609956|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
105986170|NCT02702180|365609957|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
105986171|NCT02702180|365609955|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105986172|NCT02702180|365609956|FG001|Double-blind Treatment Period|Protocol Violation|0|||
105986173|NCT02702180|365609957|FG002|Double-blind Treatment Period|Protocol Violation|2|||
105986174|NCT02702180|365609955|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
105986175|NCT02702180|365609956|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
105986176|NCT02702180|365609957|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
105986177|NCT02702180|365609955|FG000|Open-label Treatment Period|Withdrawn in error|0|||
105986178|NCT02702180|365609956|FG001|Open-label Treatment Period|Withdrawn in error|0|||
105986179|NCT02702180|365609957|FG002|Open-label Treatment Period|Withdrawn in error|1|||
105986180|NCT01393639|365609958|FG000|Overall Study|Protocol Violation|0|||
105986181|NCT01393639|365609959|FG001|Overall Study|Protocol Violation|0|||
105986182|NCT01393639|365609960|FG002|Overall Study|Protocol Violation|0|||
105986183|NCT01393639|365609961|FG003|Overall Study|Protocol Violation|1|||
105986184|NCT01393639|365609962|FG004|Overall Study|Protocol Violation|0|||
105986185|NCT01393639|365609963|FG005|Overall Study|Protocol Violation|0|||
105986186|NCT01393639|365609964|FG006|Overall Study|Protocol Violation|0|||
105986187|NCT01393639|365609958|FG000|Overall Study|Other|0|||
105986188|NCT01393639|365609959|FG001|Overall Study|Other|2|||
105986189|NCT01393639|365609960|FG002|Overall Study|Other|0|||
105986190|NCT01393639|365609961|FG003|Overall Study|Other|2|||
105986191|NCT01393639|365609962|FG004|Overall Study|Other|1|||
105986192|NCT01393639|365609963|FG005|Overall Study|Other|0|||
105986193|NCT01393639|365609964|FG006|Overall Study|Other|1|||
105986194|NCT01393639|365609958|FG000|Overall Study|Withdrawal by Subject|1|||
105986195|NCT01393639|365609959|FG001|Overall Study|Withdrawal by Subject|1|||
105986196|NCT01393639|365609960|FG002|Overall Study|Withdrawal by Subject|0|||
105986197|NCT01393639|365609961|FG003|Overall Study|Withdrawal by Subject|0|||
105986198|NCT01393639|365609962|FG004|Overall Study|Withdrawal by Subject|0|||
105986199|NCT01393639|365609963|FG005|Overall Study|Withdrawal by Subject|0|||
105986200|NCT01393639|365609964|FG006|Overall Study|Withdrawal by Subject|1|||
105986201|NCT01393639|365609958|FG000|Overall Study|Medication error without associated AE|0|||
105986202|NCT01393639|365609959|FG001|Overall Study|Medication error without associated AE|0|||
105986203|NCT01393639|365609960|FG002|Overall Study|Medication error without associated AE|0|||
105986204|NCT01393639|365609961|FG003|Overall Study|Medication error without associated AE|0|||
105986205|NCT01393639|365609962|FG004|Overall Study|Medication error without associated AE|0|||
105986206|NCT01393639|365609963|FG005|Overall Study|Medication error without associated AE|0|||
105986207|NCT01393639|365609964|FG006|Overall Study|Medication error without associated AE|1|||
105986208|NCT01393639|365609958|FG000|Overall Study|Lost to Follow-up|0|||
105986209|NCT01393639|365609959|FG001|Overall Study|Lost to Follow-up|1|||
105986210|NCT01393639|365609960|FG002|Overall Study|Lost to Follow-up|0|||
105986211|NCT01393639|365609961|FG003|Overall Study|Lost to Follow-up|0|||
105986212|NCT01393639|365609962|FG004|Overall Study|Lost to Follow-up|0|||
105986213|NCT01393639|365609963|FG005|Overall Study|Lost to Follow-up|0|||
105986214|NCT01393639|365609964|FG006|Overall Study|Lost to Follow-up|1|||
105986215|NCT01393639|365609958|FG000|Overall Study|Lack of Efficacy|0|||
105986216|NCT01393639|365609959|FG001|Overall Study|Lack of Efficacy|0|||
105986217|NCT01393639|365609960|FG002|Overall Study|Lack of Efficacy|0|||
105986218|NCT01393639|365609961|FG003|Overall Study|Lack of Efficacy|0|||
105986219|NCT01393639|365609962|FG004|Overall Study|Lack of Efficacy|0|||
105986220|NCT01393639|365609963|FG005|Overall Study|Lack of Efficacy|0|||
105986221|NCT01393639|365609964|FG006|Overall Study|Lack of Efficacy|1|||
105986222|NCT01393639|365609958|FG000|Overall Study|Adverse Event|2|||
105986223|NCT01393639|365609959|FG001|Overall Study|Adverse Event|3|||
105986224|NCT01393639|365609960|FG002|Overall Study|Adverse Event|1|||
105986225|NCT01393639|365609961|FG003|Overall Study|Adverse Event|2|||
105986226|NCT01393639|365609962|FG004|Overall Study|Adverse Event|0|||
105986227|NCT01393639|365609963|FG005|Overall Study|Adverse Event|2|||
105986228|NCT01393639|365609964|FG006|Overall Study|Adverse Event|3|||
105986229|NCT00372697|365609976|FG000|Overall Study|Protocol Violation|1|||
105986230|NCT00372697|365609977|FG001|Overall Study|Protocol Violation|1|||
105986231|NCT03221842|365609978|FG000|Period 1 (Open-label)|Adverse Event|4|||
105986232|NCT03221842|365609979|FG001|Period 1 (Open-label)|Adverse Event|0|||
105986233|NCT03221842|365609978|FG000|Period 1 (Open-label)|Physician Decision|2|||
105986234|NCT03221842|365609979|FG001|Period 1 (Open-label)|Physician Decision|0|||
105986235|NCT03221842|365609978|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
105986236|NCT03221842|365609979|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
105986237|NCT03221842|365609978|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
105986238|NCT03221842|365609979|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
105986239|NCT03221842|365609978|FG000|Period 1 (Open-label)|Other|2|||
105986240|NCT03221842|365609979|FG001|Period 1 (Open-label)|Other|0|||
105986241|NCT03221842|365609978|FG000|Period 2 (Randomized, Blinded)|Death|0|||
105986242|NCT03221842|365609979|FG001|Period 2 (Randomized, Blinded)|Death|1|||
105986243|NCT03221842|365609978|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
105986244|NCT03221842|365609979|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
105986245|NCT02504580|365609981|FG000|Overall Study|Other|1|||
105986246|NCT02504580|365609982|FG001|Overall Study|Other|0|||
105986247|NCT02504580|365609983|FG002|Overall Study|Other|0|||
105986248|NCT02504580|365609984|FG003|Overall Study|Other|2|||
105986249|NCT02504580|365609985|FG004|Overall Study|Other|1|||
105986250|NCT02504580|365609986|FG005|Overall Study|Other|1|||
105986251|NCT02504580|365609987|FG006|Overall Study|Other|1|||
105986252|NCT02504580|365609988|FG007|Overall Study|Other|2|||
105986253|NCT02504580|365609989|FG008|Overall Study|Other|0|||
105986254|NCT02504580|365609990|FG009|Overall Study|Other|0|||
105986255|NCT02504580|365609991|FG010|Overall Study|Other|0|||
105986256|NCT02504580|365609992|FG011|Overall Study|Other|2|||
105986257|NCT02504580|365609981|FG000|Overall Study|Subject refusal to continue|0|||
105986258|NCT02504580|365609982|FG001|Overall Study|Subject refusal to continue|1|||
105986259|NCT02504580|365609983|FG002|Overall Study|Subject refusal to continue|0|||
105986260|NCT02504580|365609984|FG003|Overall Study|Subject refusal to continue|0|||
105986261|NCT02504580|365609985|FG004|Overall Study|Subject refusal to continue|0|||
105986262|NCT02504580|365609986|FG005|Overall Study|Subject refusal to continue|0|||
105986263|NCT02504580|365609987|FG006|Overall Study|Subject refusal to continue|0|||
105986264|NCT02504580|365609988|FG007|Overall Study|Subject refusal to continue|0|||
105986265|NCT02504580|365609989|FG008|Overall Study|Subject refusal to continue|0|||
105986266|NCT02504580|365609990|FG009|Overall Study|Subject refusal to continue|0|||
105986267|NCT02504580|365609991|FG010|Overall Study|Subject refusal to continue|0|||
105986268|NCT02504580|365609992|FG011|Overall Study|Subject refusal to continue|0|||
105986269|NCT00704288|365609993|FG000|Overall Treatment Period|Adverse Event|11|||
105986270|NCT00704288|365609994|FG001|Overall Treatment Period|Adverse Event|8|||
105986271|NCT00704288|365609995|FG002|Overall Treatment Period|Adverse Event|22|||
105986272|NCT00704288|365609993|FG000|Overall Treatment Period|Death|0|||
105986273|NCT00704288|365609994|FG001|Overall Treatment Period|Death|0|||
105986274|NCT00704288|365609995|FG002|Overall Treatment Period|Death|1|||
105986275|NCT00704288|365609993|FG000|Overall Treatment Period|Physician Decision|0|||
105986276|NCT00704288|365609994|FG001|Overall Treatment Period|Physician Decision|2|||
105986277|NCT00704288|365609995|FG002|Overall Treatment Period|Physician Decision|0|||
105986278|NCT00704288|365609993|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
105986279|NCT00704288|365609994|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
105986280|NCT00704288|365609995|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
105986281|NCT00704288|365609993|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
105986282|NCT00704288|365609994|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
105986283|NCT00704288|365609995|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
105986284|NCT00704288|365609993|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
105986285|NCT00704288|365609994|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
105986286|NCT00704288|365609995|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
105986287|NCT00704288|365609993|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
105986288|NCT00704288|365609994|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
105986289|NCT00704288|365609995|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
105986290|NCT00704288|365609993|FG000|Overall Treatment Period|Roll-over to another study|1|||
105986291|NCT00704288|365609994|FG001|Overall Treatment Period|Roll-over to another study|0|||
105986292|NCT00704288|365609995|FG002|Overall Treatment Period|Roll-over to another study|4|||
105986293|NCT00704288|365609993|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
105986294|NCT00704288|365609994|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
105986295|NCT00704288|365609995|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
105986296|NCT00704288|365609993|FG000|Extended Post Treatment Follow Up Period|Death|41|||
105986297|NCT00704288|365609994|FG001|Extended Post Treatment Follow Up Period|Death|50|||
105986298|NCT00704288|365609995|FG002|Extended Post Treatment Follow Up Period|Death|93|||
105986299|NCT00704288|365609993|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
105986300|NCT00704288|365609994|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
105986301|NCT00704288|365609995|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
105986302|NCT00704288|365609993|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
105986303|NCT00704288|365609994|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
105986304|NCT00704288|365609995|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
105986305|NCT00704288|365609993|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
105986306|NCT00704288|365609994|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
105986307|NCT00704288|365609995|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
105986308|NCT01055314|365609996|FG000|Overall Study|Adverse Event|7|||
105986309|NCT01055314|365609997|FG001|Overall Study|Adverse Event|4|||
105986310|NCT01055314|365609996|FG000|Overall Study|Death|2|||
105986311|NCT01055314|365609997|FG001|Overall Study|Death|1|||
105986312|NCT01055314|365609996|FG000|Overall Study|Lack of Efficacy|11|||
105986313|NCT01055314|365609997|FG001|Overall Study|Lack of Efficacy|19|||
105986314|NCT01055314|365609996|FG000|Overall Study|Physician Decision|10|||
105986315|NCT01055314|365609997|FG001|Overall Study|Physician Decision|5|||
105986316|NCT01055314|365609996|FG000|Overall Study|Withdrawal by Subject|1|||
105986317|NCT01055314|365609997|FG001|Overall Study|Withdrawal by Subject|0|||
105986318|NCT01055314|365609996|FG000|Overall Study|Ineligible|3|||
105986319|NCT01055314|365609997|FG001|Overall Study|Ineligible|5|||
105986320|NCT01055314|365609996|FG000|Overall Study|Refusal of further protocol therapy|10|||
105986321|NCT01055314|365609997|FG001|Overall Study|Refusal of further protocol therapy|4|||
105986322|NCT01055314|365609996|FG000|Overall Study|No treatment|1|||
105986323|NCT01055314|365609997|FG001|Overall Study|No treatment|0|||
105986324|NCT02462720|365609998|FG000|Part 2|Withdrawal by Subject|1|||
105986325|NCT02462720|365609999|FG001|Part 2|Withdrawal by Subject|0|||
105986326|NCT02462720|365609998|FG000|Part 2|Protocol Violation|0|||
105986327|NCT02462720|365609999|FG001|Part 2|Protocol Violation|1|||
105986328|NCT00527982|365610002|FG000|Overall Study|Physician Decision|1|||
105986329|NCT00527982|365610003|FG001|Overall Study|Physician Decision|0|||
105986330|NCT04680975|365610014|FG000|Overall Study|Adverse Event|3|||
105986331|NCT04680975|365610014|FG000|Overall Study|Death|1|||
105986332|NCT04680975|365610014|FG000|Overall Study|Progressive Disease|1|||
105986333|NCT04680975|365610014|FG000|Overall Study|Withdrawal by Subject|1|||
105986334|NCT01192412|365610015|FG000|Overall Study|Lost to Follow-up|2|||
105986335|NCT01192412|365610016|FG001|Overall Study|Lost to Follow-up|1|||
105986336|NCT01192412|365610015|FG000|Overall Study|Withdrawal by Subject|2|||
105986337|NCT01192412|365610016|FG001|Overall Study|Withdrawal by Subject|1|||
105986338|NCT01359943|365610017|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
105986339|NCT01359943|365610018|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
105986340|NCT01359943|365610019|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
105986341|NCT01359943|365610017|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
105986342|NCT01359943|365610018|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
105986343|NCT01359943|365610019|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
105986344|NCT01359943|365610017|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
105986345|NCT01359943|365610018|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
105986346|NCT01359943|365610019|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
105986347|NCT01359943|365610017|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
105986348|NCT01359943|365610018|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
105986349|NCT01359943|365610019|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
105986350|NCT01359943|365610017|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
105986351|NCT01359943|365610018|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
105986352|NCT01359943|365610019|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
105986353|NCT01359943|365610017|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
105986354|NCT01359943|365610018|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
105986355|NCT01359943|365610019|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
105986356|NCT01359943|365610017|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
105986357|NCT01359943|365610018|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
105986358|NCT01359943|365610019|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
105986359|NCT01359943|365610017|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
105986360|NCT01359943|365610018|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
105986361|NCT01359943|365610019|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
105986362|NCT01359943|365610017|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
105986363|NCT01359943|365610018|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
105986364|NCT01359943|365610019|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
105986365|NCT01359943|365610017|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
105986366|NCT01359943|365610018|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
105986367|NCT01359943|365610019|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
105986368|NCT01359943|365610017|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
105986369|NCT01359943|365610018|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
105986370|NCT01359943|365610019|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
105986371|NCT01359943|365610017|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
105986372|NCT01359943|365610018|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
105986373|NCT01359943|365610019|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
105986374|NCT01359943|365610017|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
105986375|NCT01359943|365610018|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
105986376|NCT01359943|365610019|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
105986377|NCT01359943|365610017|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
105986378|NCT01359943|365610018|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
105986379|NCT01359943|365610019|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
105986380|NCT01359943|365610017|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
105986381|NCT01359943|365610018|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
105986382|NCT01359943|365610019|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
105986383|NCT01329939|365610024|FG000|Overall Study|Lost to Follow-up|3|||
105986384|NCT01329939|365610025|FG001|Overall Study|Lost to Follow-up|0|||
105986385|NCT01329939|365610026|FG002|Overall Study|Lost to Follow-up|1|||
105986386|NCT01329939|365610027|FG003|Overall Study|Lost to Follow-up|2|||
105986387|NCT01329939|365610024|FG000|Overall Study|Withdrawal by Subject|0|||
105986388|NCT01329939|365610025|FG001|Overall Study|Withdrawal by Subject|1|||
105986389|NCT01329939|365610026|FG002|Overall Study|Withdrawal by Subject|0|||
105986390|NCT01329939|365610027|FG003|Overall Study|Withdrawal by Subject|0|||
105986391|NCT01329939|365610024|FG000|Overall Study|Adverse Event|0|||
105986392|NCT01329939|365610025|FG001|Overall Study|Adverse Event|0|||
105986393|NCT01329939|365610026|FG002|Overall Study|Adverse Event|0|||
105986394|NCT01329939|365610027|FG003|Overall Study|Adverse Event|3|||
105986395|NCT00320424|365610028|FG000|Overall Study|Adverse Event|3|||
105986396|NCT00320424|365610028|FG000|Overall Study|Other|3|||
105986397|NCT02942485|365610029|FG000|Overall Study|Lost to Follow-up|1|||
105986398|NCT02942485|365610030|FG001|Overall Study|Lost to Follow-up|0|||
105986399|NCT00989963|365610031|FG000|Overall Study|Adverse Event|1|||
105986400|NCT00989963|365610032|FG001|Overall Study|Adverse Event|1|||
105986401|NCT00989963|365610033|FG002|Overall Study|Adverse Event|1|||
105986402|NCT01240200|365610038|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
105986403|NCT01240200|365610039|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
105986404|NCT00719680|365610041|FG000|Overall Study|Adverse Event|1|||
105986405|NCT00719680|365610041|FG000|Overall Study|Lost to Follow-up|1|||
105986406|NCT00719680|365610041|FG000|Overall Study|Withdrawal by Subject|3|||
105986407|NCT02540668|365610042|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
105986408|NCT02540668|365610043|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
105986409|NCT03270891|365610044|FG000|Overall Study|Lost to Follow-up|3|||
105986410|NCT03270891|365610045|FG001|Overall Study|Lost to Follow-up|6|||
105986411|NCT03270891|365610046|FG002|Overall Study|Lost to Follow-up|0|||
105986412|NCT03270891|365610044|FG000|Overall Study|Withdrawal by Subject|1|||
105986413|NCT03270891|365610045|FG001|Overall Study|Withdrawal by Subject|0|||
105986414|NCT03270891|365610046|FG002|Overall Study|Withdrawal by Subject|0|||
105986415|NCT03270891|365610044|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
105986416|NCT03270891|365610045|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
105986417|NCT03270891|365610046|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
105986418|NCT04071158|365610048|FG000|Overall Study|Lost to Follow-up|1|||
105986419|NCT04071158|365610049|FG001|Overall Study|Lost to Follow-up|2|||
105986420|NCT04071158|365610050|FG002|Overall Study|Lost to Follow-up|3|||
105986421|NCT04071158|365610051|FG003|Overall Study|Lost to Follow-up|3|||
105986422|NCT04071158|365610052|FG004|Overall Study|Lost to Follow-up|5|||
105986423|NCT04071158|365610048|FG000|Overall Study|Randomized but not treated|2|||
105986424|NCT04071158|365610049|FG001|Overall Study|Randomized but not treated|2|||
105986425|NCT04071158|365610050|FG002|Overall Study|Randomized but not treated|0|||
105986426|NCT04071158|365610051|FG003|Overall Study|Randomized but not treated|0|||
105986427|NCT04071158|365610052|FG004|Overall Study|Randomized but not treated|0|||
105986428|NCT01178099|365610053|FG000|Overall Study|Physician Decision|0|||
105986429|NCT01178099|365610054|FG001|Overall Study|Physician Decision|1|||
105986430|NCT01286740|365610055|FG000|Overall Study|Enrolled but not treated|1|||
105986431|NCT01286740|365610055|FG000|Overall Study|Protocol Violation|1|||
105986432|NCT01966445|365610059|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105986433|NCT01966445|365610060|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105986434|NCT01966445|365610061|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105986435|NCT01966445|365610062|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
105986436|NCT01966445|365610063|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105986437|NCT01966445|365610064|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
105986438|NCT01966445|365610065|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
105986439|NCT01966445|365610059|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
105986440|NCT01966445|365610060|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
105986441|NCT01966445|365610061|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
105986442|NCT01966445|365610062|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
105986443|NCT01966445|365610063|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
105986444|NCT01966445|365610064|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
105986445|NCT01966445|365610065|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
105986446|NCT01966445|365610059|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
105986447|NCT01966445|365610060|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
105986448|NCT01966445|365610061|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
105986449|NCT01966445|365610062|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
105986450|NCT01966445|365610063|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
105986451|NCT01966445|365610064|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
105986452|NCT01966445|365610065|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
105986453|NCT01966445|365610059|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105986454|NCT01966445|365610060|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105986455|NCT01966445|365610061|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105986456|NCT01966445|365610062|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105986457|NCT01966445|365610063|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105986458|NCT01966445|365610064|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
105986459|NCT01966445|365610065|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
105986460|NCT01966445|365610059|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105986461|NCT01966445|365610060|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105986462|NCT01966445|365610061|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105986463|NCT01966445|365610062|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105986464|NCT01966445|365610063|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105986465|NCT01966445|365610064|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
105986466|NCT01966445|365610065|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
105986467|NCT01374178|365610066|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
105986468|NCT01374178|365610067|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
105986469|NCT01374178|365610066|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
105986470|NCT01374178|365610067|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
105986471|NCT02760810|365610070|FG000|Overall Study|Protocol Violation|1|||
105986472|NCT00599638|365610071|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
105986473|NCT00599638|365610072|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
105986474|NCT00599638|365610073|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
105986475|NCT00599638|365610074|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
105986476|NCT00599638|365610071|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
105986477|NCT00599638|365610072|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
105986478|NCT00599638|365610073|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
105986479|NCT00599638|365610074|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
105986480|NCT00599638|365610071|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
105986481|NCT00599638|365610072|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
105986482|NCT00599638|365610073|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
105986483|NCT00599638|365610074|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
105986484|NCT00599638|365610071|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
105986485|NCT00599638|365610072|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
105986486|NCT00599638|365610073|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
105986487|NCT00599638|365610074|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
105986488|NCT00599638|365610071|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
105986489|NCT00599638|365610072|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
105986490|NCT00599638|365610073|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
105986491|NCT00599638|365610074|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
105986492|NCT00599638|365610071|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
105986493|NCT00599638|365610072|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
105986494|NCT00599638|365610073|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
105986495|NCT00599638|365610074|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
105986496|NCT00599638|365610071|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
105986497|NCT00599638|365610072|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
105986498|NCT00599638|365610073|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
105986499|NCT00599638|365610074|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
105986500|NCT00599638|365610071|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
105986501|NCT00599638|365610072|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
105986502|NCT00599638|365610073|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
105986503|NCT00599638|365610074|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
105986504|NCT00599638|365610071|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
105986505|NCT00599638|365610072|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
105986506|NCT00599638|365610073|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
105986507|NCT00599638|365610074|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
105868022|NCT00535405|365167088|FG004|Overall Study|Protocol Violation|0|||
105868023|NCT00535405|365167084|FG000|Overall Study|Withdrawal by Subject|5|||
105868024|NCT00535405|365167085|FG001|Overall Study|Withdrawal by Subject|11|||
105868025|NCT00535405|365167086|FG002|Overall Study|Withdrawal by Subject|10|||
105868026|NCT00535405|365167087|FG003|Overall Study|Withdrawal by Subject|10|||
105868027|NCT00535405|365167088|FG004|Overall Study|Withdrawal by Subject|8|||
105868028|NCT04868500|365167089|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
105868029|NCT04868500|365167090|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
105868030|NCT04868500|365167089|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
105868031|NCT04868500|365167090|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
105868032|NCT03076775|365167093|FG000|Overall Study|Lost to Follow-up|1|||
105868033|NCT03076775|365167094|FG001|Overall Study|Lost to Follow-up|0|||
105868034|NCT01332292|365167095|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
105868035|NCT01332292|365167096|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
105868036|NCT01332292|365167095|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
105868037|NCT01332292|365167096|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
105868038|NCT01332292|365167095|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
105868039|NCT01332292|365167096|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
105868040|NCT00396565|365167097|FG000|Overall Study|Physician Decision|3|||
105868041|NCT00396565|365167098|FG001|Overall Study|Physician Decision|1|||
105868042|NCT00396565|365167099|FG002|Overall Study|Physician Decision|2|||
105868043|NCT00396565|365167097|FG000|Overall Study|Adverse Event|5|||
105868044|NCT00396565|365167098|FG001|Overall Study|Adverse Event|13|||
105868045|NCT00396565|365167099|FG002|Overall Study|Adverse Event|3|||
105868046|NCT00396565|365167097|FG000|Overall Study|Withdrawal by Subject|8|||
105868047|NCT00396565|365167098|FG001|Overall Study|Withdrawal by Subject|13|||
105868048|NCT00396565|365167099|FG002|Overall Study|Withdrawal by Subject|1|||
105868049|NCT00396565|365167097|FG000|Overall Study|Lack of Efficacy|32|||
105868050|NCT00396565|365167098|FG001|Overall Study|Lack of Efficacy|64|||
105868051|NCT00396565|365167099|FG002|Overall Study|Lack of Efficacy|11|||
105868052|NCT00940316|365167100|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
105868053|NCT00940316|365167101|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
105868054|NCT00940316|365167102|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
105868055|NCT00940316|365167100|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
105868056|NCT00940316|365167101|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
105868057|NCT00940316|365167102|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
105868058|NCT00940316|365167100|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
105868059|NCT00940316|365167101|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
105868060|NCT00940316|365167102|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
105868061|NCT00940316|365167100|FG000|Treated After Cycle 5|Adverse Event|0|||
105868062|NCT00940316|365167101|FG001|Treated After Cycle 5|Adverse Event|0|||
105868063|NCT00940316|365167102|FG002|Treated After Cycle 5|Adverse Event|1|||
105868064|NCT00940316|365167100|FG000|Treated After Cycle 5|Progressive disease|0|||
105868065|NCT00940316|365167101|FG001|Treated After Cycle 5|Progressive disease|1|||
105868066|NCT00940316|365167102|FG002|Treated After Cycle 5|Progressive disease|0|||
105868067|NCT05299528|365167103|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105868068|NCT05299528|365167104|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
105868069|NCT05299528|365167105|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105868070|NCT05299528|365167106|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105868071|NCT05299528|365167107|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105868072|NCT05299528|365167108|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105868073|NCT05299528|365167109|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
105868074|NCT05299528|365167103|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105868075|NCT05299528|365167104|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105868076|NCT05299528|365167105|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105868077|NCT05299528|365167106|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105868078|NCT05299528|365167107|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105868079|NCT05299528|365167108|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
105868080|NCT05299528|365167109|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
105868081|NCT05299528|365167103|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
105868082|NCT05299528|365167104|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
105868083|NCT05299528|365167105|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
105868084|NCT05299528|365167106|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
105868085|NCT05299528|365167107|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
105868086|NCT05299528|365167108|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
105868087|NCT05299528|365167109|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
105868088|NCT03910673|365167111|FG000|Overall Study|Adverse Event|0|||
105868089|NCT03910673|365167112|FG001|Overall Study|Adverse Event|0|||
105868090|NCT03910673|365167113|FG002|Overall Study|Adverse Event|0|||
105868091|NCT03910673|365167114|FG003|Overall Study|Adverse Event|2|||
105868092|NCT03910673|365167115|FG004|Overall Study|Adverse Event|0|||
105868093|NCT03404674|365167116|FG000|Overall Study|Inability to Attend Future Visits|0|||
105868094|NCT03404674|365167117|FG001|Overall Study|Inability to Attend Future Visits|1|||
105868095|NCT03404674|365167118|FG002|Overall Study|Inability to Attend Future Visits|1|||
105868096|NCT03404674|365167119|FG003|Overall Study|Inability to Attend Future Visits|0|||
105868097|NCT03404674|365167120|FG004|Overall Study|Inability to Attend Future Visits|0|||
105868098|NCT03404674|365167121|FG005|Overall Study|Inability to Attend Future Visits|0|||
105868099|NCT03404674|365167116|FG000|Overall Study|Behavioral Problems|0|||
105868100|NCT03404674|365167117|FG001|Overall Study|Behavioral Problems|0|||
105868101|NCT03404674|365167118|FG002|Overall Study|Behavioral Problems|1|||
105868102|NCT03404674|365167119|FG003|Overall Study|Behavioral Problems|0|||
105868103|NCT03404674|365167120|FG004|Overall Study|Behavioral Problems|0|||
105868104|NCT03404674|365167121|FG005|Overall Study|Behavioral Problems|0|||
105868105|NCT03404674|365167116|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
105868106|NCT03404674|365167117|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
105868107|NCT03404674|365167118|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
105868108|NCT03404674|365167119|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
105868109|NCT03404674|365167120|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
105868110|NCT03404674|365167121|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
105868111|NCT00996489|365167122|FG000|Overall Study|Device failure|45|||
105868112|NCT00996489|365167122|FG000|Overall Study|Discontinued|116|||
105868113|NCT00490841|365167123|FG000|Overall Study|Death|5|||
105868114|NCT00490841|365167123|FG000|Overall Study|Withdrawal by Subject|4|||
105986508|NCT02895945|365610078|FG000|Overall Study|Physician Decision|2|||
105868115|NCT00490841|365167123|FG000|Overall Study|Lost to Follow-up|1|||
105868116|NCT00490841|365167123|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
105868117|NCT01277211|365167124|FG000|Overall Study|Adverse Event|60|||
105868118|NCT01277211|365167125|FG001|Overall Study|Adverse Event|22|||
105868119|NCT01277211|365167124|FG000|Overall Study|Pregnancy|9|||
105868120|NCT01277211|365167125|FG001|Overall Study|Pregnancy|4|||
105868121|NCT01277211|365167124|FG000|Overall Study|Lost to Follow-up|14|||
105868122|NCT01277211|365167125|FG001|Overall Study|Lost to Follow-up|9|||
105868123|NCT01277211|365167124|FG000|Overall Study|Did not wish to continue|17|||
105868124|NCT01277211|365167125|FG001|Overall Study|Did not wish to continue|0|||
105868125|NCT01277211|365167124|FG000|Overall Study|Withdrew Consent|9|||
105868126|NCT01277211|365167125|FG001|Overall Study|Withdrew Consent|9|||
105868127|NCT01277211|365167124|FG000|Overall Study|Non-compliance with protocol|13|||
105868128|NCT01277211|365167125|FG001|Overall Study|Non-compliance with protocol|4|||
105868129|NCT01277211|365167124|FG000|Overall Study|Did not meet protocol eligibility|1|||
105868130|NCT01277211|365167125|FG001|Overall Study|Did not meet protocol eligibility|0|||
105868131|NCT01277211|365167124|FG000|Overall Study|Administrative|3|||
105868132|NCT01277211|365167125|FG001|Overall Study|Administrative|0|||
105868133|NCT01277211|365167124|FG000|Overall Study|Pregnancy wish|0|||
105868134|NCT01277211|365167125|FG001|Overall Study|Pregnancy wish|2|||
105868135|NCT01277211|365167124|FG000|Overall Study|Discontinued prior to treatment|24|||
105868136|NCT01277211|365167125|FG001|Overall Study|Discontinued prior to treatment|13|||
105868137|NCT00770328|365167126|FG000|Overall Study|Adverse Event|11|||
105868138|NCT00770328|365167127|FG001|Overall Study|Adverse Event|2|||
105868139|NCT00770328|365167126|FG000|Overall Study|Lost to Follow-up|2|||
105868140|NCT00770328|365167127|FG001|Overall Study|Lost to Follow-up|2|||
105868141|NCT04502212|365167130|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
105868142|NCT04502212|365167130|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
105868143|NCT01911273|365167133|FG000|Overall Study|Progression of Disease|1|||
105868144|NCT01911273|365167134|FG001|Overall Study|Progression of Disease|0|||
105868145|NCT01911273|365167133|FG000|Overall Study|Withdrawal by Subject|0|||
105868146|NCT01911273|365167134|FG001|Overall Study|Withdrawal by Subject|2|||
105868147|NCT03086551|365167146|FG000|First Intervention|Failure to meet inclusion criterion|1|||
105868148|NCT03086551|365167147|FG001|First Intervention|Failure to meet inclusion criterion|0|||
105868149|NCT03086551|365167146|FG000|First Intervention|Lost to Follow-up|0|||
105868150|NCT03086551|365167147|FG001|First Intervention|Lost to Follow-up|1|||
105868151|NCT03086551|365167146|FG000|Washout|Lost to Follow-up|1|||
105868152|NCT03086551|365167147|FG001|Washout|Lost to Follow-up|2|||
105868153|NCT03086551|365167146|FG000|Washout|Withdrawal by Subject|2|||
105868154|NCT03086551|365167147|FG001|Washout|Withdrawal by Subject|1|||
105868155|NCT03736031|365167151|FG000|Overall Study|Death|2|||
105868156|NCT03736031|365167152|FG001|Overall Study|Death|4|||
105868157|NCT03736031|365167151|FG000|Overall Study|Lost to Follow-up|21|||
105868158|NCT03736031|365167152|FG001|Overall Study|Lost to Follow-up|2|||
105868159|NCT03736031|365167151|FG000|Overall Study|Withdrawal by Subject|9|||
105868160|NCT03736031|365167152|FG001|Overall Study|Withdrawal by Subject|0|||
105868161|NCT00625872|365167155|FG000|Overall Study|Withdrawal by Subject|1|||
105868162|NCT00625872|365167156|FG001|Overall Study|Withdrawal by Subject|0|||
105868163|NCT00625872|365167155|FG000|Overall Study|Does not meet inclusion criteria|1|||
105868164|NCT00625872|365167156|FG001|Overall Study|Does not meet inclusion criteria|0|||
105868165|NCT00625872|365167155|FG000|Overall Study|Terminated by sponsor|2|||
105868166|NCT00625872|365167156|FG001|Overall Study|Terminated by sponsor|5|||
105986509|NCT02895945|365610079|FG001|Overall Study|Physician Decision|1|||
105986510|NCT02479139|365610087|FG000|Overall Study|Lost to Follow-up|2|||
105986511|NCT02479139|365610088|FG001|Overall Study|Lost to Follow-up|4|||
105986512|NCT02479139|365610089|FG002|Overall Study|Lost to Follow-up|4|||
105986513|NCT02479139|365610090|FG003|Overall Study|Lost to Follow-up|2|||
105986514|NCT02479139|365610091|FG004|Overall Study|Lost to Follow-up|3|||
105986515|NCT02479139|365610092|FG005|Overall Study|Lost to Follow-up|5|||
105986516|NCT02479139|365610087|FG000|Overall Study|Withdrew Consent|5|||
105986517|NCT02479139|365610088|FG001|Overall Study|Withdrew Consent|6|||
105986518|NCT02479139|365610089|FG002|Overall Study|Withdrew Consent|1|||
105986519|NCT02479139|365610090|FG003|Overall Study|Withdrew Consent|4|||
105986520|NCT02479139|365610091|FG004|Overall Study|Withdrew Consent|1|||
105986521|NCT02479139|365610092|FG005|Overall Study|Withdrew Consent|1|||
105986522|NCT02479139|365610087|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105986523|NCT02479139|365610088|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105986524|NCT02479139|365610089|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
105986525|NCT02479139|365610090|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105986526|NCT02479139|365610091|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105986527|NCT02479139|365610092|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
105986528|NCT02479139|365610087|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105986529|NCT02479139|365610088|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105986530|NCT02479139|365610089|FG002|Overall Study|Other Miscellaneous Reasons|1|||
105986531|NCT02479139|365610090|FG003|Overall Study|Other Miscellaneous Reasons|1|||
105986532|NCT02479139|365610091|FG004|Overall Study|Other Miscellaneous Reasons|1|||
105986533|NCT02479139|365610092|FG005|Overall Study|Other Miscellaneous Reasons|0|||
105986534|NCT03178669|365610093|FG000|Overall Study|Adverse Event|4|||
105986535|NCT03178669|365610094|FG001|Overall Study|Adverse Event|1|||
105986536|NCT03178669|365610095|FG002|Overall Study|Adverse Event|4|||
105986537|NCT03178669|365610096|FG003|Overall Study|Adverse Event|2|||
105986538|NCT03178669|365610097|FG004|Overall Study|Adverse Event|2|||
105986539|NCT03178669|365610093|FG000|Overall Study|Lack of Efficacy|0|||
105986540|NCT03178669|365610094|FG001|Overall Study|Lack of Efficacy|0|||
105986541|NCT03178669|365610095|FG002|Overall Study|Lack of Efficacy|2|||
105986542|NCT03178669|365610096|FG003|Overall Study|Lack of Efficacy|0|||
105986543|NCT03178669|365610097|FG004|Overall Study|Lack of Efficacy|1|||
105986544|NCT03178669|365610093|FG000|Overall Study|Physician Decision|0|||
105986545|NCT03178669|365610094|FG001|Overall Study|Physician Decision|0|||
105986546|NCT03178669|365610095|FG002|Overall Study|Physician Decision|0|||
105986547|NCT03178669|365610096|FG003|Overall Study|Physician Decision|0|||
105986548|NCT03178669|365610097|FG004|Overall Study|Physician Decision|1|||
105986549|NCT03178669|365610093|FG000|Overall Study|Withdrawal by Subject|1|||
105986550|NCT03178669|365610094|FG001|Overall Study|Withdrawal by Subject|0|||
105986551|NCT03178669|365610095|FG002|Overall Study|Withdrawal by Subject|1|||
105986552|NCT03178669|365610096|FG003|Overall Study|Withdrawal by Subject|1|||
105986553|NCT03178669|365610097|FG004|Overall Study|Withdrawal by Subject|0|||
105986554|NCT03178669|365610093|FG000|Overall Study|Lost to Follow-up|0|||
105986555|NCT03178669|365610094|FG001|Overall Study|Lost to Follow-up|0|||
105986556|NCT03178669|365610095|FG002|Overall Study|Lost to Follow-up|0|||
105986557|NCT03178669|365610096|FG003|Overall Study|Lost to Follow-up|1|||
105986558|NCT03178669|365610097|FG004|Overall Study|Lost to Follow-up|0|||
105986559|NCT01727336|365610098|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
105986560|NCT01727336|365610099|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
105868167|NCT00625872|365167155|FG000|Overall Study|Randomized but not treated|0|||
105868168|NCT00625872|365167156|FG001|Overall Study|Randomized but not treated|1|||
105986561|NCT01727336|365610100|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
105986562|NCT01727336|365610101|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
105986563|NCT01727336|365610102|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
105986564|NCT01727336|365610103|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
105986565|NCT01727336|365610098|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
105986566|NCT01727336|365610099|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
105986567|NCT01727336|365610100|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
105986568|NCT01727336|365610101|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
105986569|NCT01727336|365610102|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
105986570|NCT01727336|365610103|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
105986571|NCT01727336|365610098|FG000|Part 2 Blinded|Death|0|||
105986572|NCT01727336|365610099|FG001|Part 2 Blinded|Death|0|||
105986573|NCT01727336|365610100|FG002|Part 2 Blinded|Death|0|||
105986574|NCT01727336|365610101|FG003|Part 2 Blinded|Death|0|||
105986575|NCT01727336|365610102|FG004|Part 2 Blinded|Death|20|||
105986576|NCT01727336|365610103|FG005|Part 2 Blinded|Death|16|||
105986577|NCT01727336|365610098|FG000|Part 2 Blinded|Lack of Efficacy|0|||
105986578|NCT01727336|365610099|FG001|Part 2 Blinded|Lack of Efficacy|0|||
105986579|NCT01727336|365610100|FG002|Part 2 Blinded|Lack of Efficacy|0|||
105986580|NCT01727336|365610101|FG003|Part 2 Blinded|Lack of Efficacy|0|||
105986581|NCT01727336|365610102|FG004|Part 2 Blinded|Lack of Efficacy|42|||
105986582|NCT01727336|365610103|FG005|Part 2 Blinded|Lack of Efficacy|44|||
105986583|NCT01727336|365610098|FG000|Part 2 Blinded|Lost to Follow-up|0|||
105986584|NCT01727336|365610099|FG001|Part 2 Blinded|Lost to Follow-up|0|||
105986585|NCT01727336|365610100|FG002|Part 2 Blinded|Lost to Follow-up|0|||
105986586|NCT01727336|365610101|FG003|Part 2 Blinded|Lost to Follow-up|0|||
105986587|NCT01727336|365610102|FG004|Part 2 Blinded|Lost to Follow-up|0|||
105986588|NCT01727336|365610103|FG005|Part 2 Blinded|Lost to Follow-up|1|||
105986589|NCT01727336|365610098|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
105986590|NCT01727336|365610099|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
105986591|NCT01727336|365610100|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
105986592|NCT01727336|365610101|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
105986593|NCT01727336|365610102|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
105986594|NCT01727336|365610103|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
105986595|NCT01727336|365610098|FG000|Part 2 Blinded|use of prohibited medications|0|||
105986596|NCT01727336|365610099|FG001|Part 2 Blinded|use of prohibited medications|0|||
105986597|NCT01727336|365610100|FG002|Part 2 Blinded|use of prohibited medications|0|||
105986598|NCT01727336|365610101|FG003|Part 2 Blinded|use of prohibited medications|0|||
105986599|NCT01727336|365610102|FG004|Part 2 Blinded|use of prohibited medications|1|||
105986600|NCT01727336|365610103|FG005|Part 2 Blinded|use of prohibited medications|3|||
105986601|NCT00989781|365610108|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
105986602|NCT00989781|365610109|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
105986603|NCT01331291|365610110|FG000|Overall Study|Lack of Efficacy|2|||
105986604|NCT01331291|365610111|FG001|Overall Study|Lack of Efficacy|8|||
105986605|NCT01331291|365610110|FG000|Overall Study|Death|0|||
105986606|NCT01331291|365610111|FG001|Overall Study|Death|1|||
105986607|NCT00778895|365610114|FG000|Active Phase|Adverse Event|3|||
105986608|NCT00778895|365610115|FG001|Active Phase|Adverse Event|1|||
105986609|NCT00778895|365610116|FG002|Active Phase|Adverse Event|0|||
105986610|NCT00778895|365610114|FG000|Active Phase|Withdrawal by Subject|1|||
105986611|NCT00778895|365610115|FG001|Active Phase|Withdrawal by Subject|4|||
105986612|NCT00778895|365610116|FG002|Active Phase|Withdrawal by Subject|0|||
105986613|NCT00778895|365610114|FG000|Active Phase|Lost to Follow-up|1|||
105986614|NCT00778895|365610115|FG001|Active Phase|Lost to Follow-up|1|||
105986615|NCT00778895|365610116|FG002|Active Phase|Lost to Follow-up|0|||
105986616|NCT00778895|365610114|FG000|Active Phase|Other|2|||
105986617|NCT00778895|365610115|FG001|Active Phase|Other|0|||
105986618|NCT00778895|365610116|FG002|Active Phase|Other|0|||
105986619|NCT00778895|365610114|FG000|ESFU Phase|Adverse Event|2|||
105986620|NCT00778895|365610115|FG001|ESFU Phase|Adverse Event|1|||
105986621|NCT00778895|365610116|FG002|ESFU Phase|Adverse Event|0|||
105986622|NCT00778895|365610114|FG000|ESFU Phase|Withdrawal by Subject|1|||
105986623|NCT00778895|365610115|FG001|ESFU Phase|Withdrawal by Subject|4|||
105986624|NCT00778895|365610116|FG002|ESFU Phase|Withdrawal by Subject|0|||
105986625|NCT00778895|365610114|FG000|ESFU Phase|Lost to Follow-up|6|||
105986626|NCT00778895|365610115|FG001|ESFU Phase|Lost to Follow-up|7|||
105986627|NCT00778895|365610116|FG002|ESFU Phase|Lost to Follow-up|2|||
105986628|NCT00778895|365610114|FG000|ESFU Phase|Other|2|||
105986629|NCT00778895|365610115|FG001|ESFU Phase|Other|0|||
105986630|NCT00778895|365610116|FG002|ESFU Phase|Other|0|||
105986631|NCT02540993|365610117|FG000|Overall Study|Lost to Follow-up|5|||
105986632|NCT02540993|365610118|FG001|Overall Study|Lost to Follow-up|3|||
105986633|NCT02540993|365610117|FG000|Overall Study|Withdrawal by Subject|4|||
105986634|NCT02540993|365610118|FG001|Overall Study|Withdrawal by Subject|6|||
105986635|NCT02540993|365610117|FG000|Overall Study|GCP violations|33|||
105986636|NCT02540993|365610118|FG001|Overall Study|GCP violations|27|||
105986637|NCT05096312|365610123|FG000|Overall Study|Lost to Follow-up|2|||
105986638|NCT05096312|365610124|FG001|Overall Study|Lost to Follow-up|4|||
105986639|NCT05096312|365610123|FG000|Overall Study|Adverse Event|1|||
105986640|NCT05096312|365610124|FG001|Overall Study|Adverse Event|0|||
105986641|NCT03135210|365610125|FG000|Overall Study|Death|0|||
105986642|NCT03135210|365610126|FG001|Overall Study|Death|1|||
105986643|NCT00820222|365610128|FG000|Overall Study|Lost to Follow-up|10|||
105986644|NCT00820222|365610129|FG001|Overall Study|Lost to Follow-up|9|||
105986645|NCT00820222|365610128|FG000|Overall Study|Withdrawal by Subject|19|||
105986646|NCT00820222|365610129|FG001|Overall Study|Withdrawal by Subject|21|||
105986647|NCT00820222|365610128|FG000|Overall Study|Physician Decision|93|||
105986648|NCT00820222|365610129|FG001|Overall Study|Physician Decision|88|||
105986649|NCT00820222|365610128|FG000|Overall Study|Sponsor Terminated Study|43|||
105986650|NCT00820222|365610129|FG001|Overall Study|Sponsor Terminated Study|65|||
105986651|NCT00820222|365610128|FG000|Overall Study|Unkown|11|||
105986652|NCT00820222|365610129|FG001|Overall Study|Unkown|7|||
105986653|NCT04311463|365610130|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
105986654|NCT04311463|365610131|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
105986655|NCT04311463|365610130|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
105986656|NCT04311463|365610131|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
105986657|NCT04311463|365610130|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
105986658|NCT04311463|365610131|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
105986659|NCT00293020|365610136|FG000|Overall Study|Withdrawal by Subject|34|||
105986660|NCT00293020|365610136|FG000|Overall Study|Adverse Event|30|||
105986661|NCT00293020|365610136|FG000|Overall Study|Death|32|||
105986662|NCT00293020|365610136|FG000|Overall Study|Lack of Efficacy|12|||
105986663|NCT00293020|365610136|FG000|Overall Study|Lost to Follow-up|4|||
105986664|NCT00293020|365610136|FG000|Overall Study|Protocol Violation|6|||
105986665|NCT00293020|365610136|FG000|Overall Study|Physician Decision|21|||
105986666|NCT00293020|365610136|FG000|Overall Study|Other Reason|22|||
105986667|NCT00293020|365610136|FG000|Overall Study|No dose taken|1|||
105986668|NCT02249182|365610141|FG000|Treatment Phase|Lost to Follow-up|4|||
105986669|NCT02249182|365610142|FG001|Treatment Phase|Lost to Follow-up|0|||
105986670|NCT02249182|365610143|FG002|Treatment Phase|Lost to Follow-up|0|||
105986671|NCT02249182|365610144|FG003|Treatment Phase|Lost to Follow-up|0|||
105986672|NCT02249182|365610145|FG004|Treatment Phase|Lost to Follow-up|0|||
105986673|NCT03916484|365610146|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
105986674|NCT03916484|365610147|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
105986675|NCT03916484|365610148|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
105986676|NCT03916484|365610149|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
105986677|NCT03916484|365610146|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
105986678|NCT03916484|365610147|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
105986679|NCT03916484|365610148|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
105986680|NCT03916484|365610149|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
105986681|NCT04378114|365610152|FG000|Overall Study|Withdrawal by Subject|5|||
105986682|NCT01364389|365610153|FG000|Overall Study|Withdrawal by Subject|0|||
105986683|NCT01364389|365610154|FG001|Overall Study|Withdrawal by Subject|1|||
105986684|NCT01364389|365610155|FG002|Overall Study|Withdrawal by Subject|0|||
105986685|NCT01364389|365610153|FG000|Overall Study|Protocol deviation|0|||
105986686|NCT01364389|365610154|FG001|Overall Study|Protocol deviation|0|||
105986687|NCT01364389|365610155|FG002|Overall Study|Protocol deviation|1|||
105986688|NCT01364389|365610153|FG000|Overall Study|Administrative problems|1|||
105986689|NCT01364389|365610154|FG001|Overall Study|Administrative problems|0|||
105986690|NCT01364389|365610155|FG002|Overall Study|Administrative problems|0|||
105986691|NCT01364389|365610153|FG000|Overall Study|Adverse Event|1|||
105986692|NCT01364389|365610154|FG001|Overall Study|Adverse Event|0|||
105986693|NCT01364389|365610155|FG002|Overall Study|Adverse Event|0|||
105986694|NCT00495625|365612138|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
105986695|NCT00511134|365612139|FG000|Overall Study|Withdrawal by Subject|0|||
105986696|NCT00511134|365612140|FG001|Overall Study|Withdrawal by Subject|2|||
105986697|NCT02397057|365612141|FG000|Overall Study|Withdrawal by Subject|6|||
105986698|NCT02397057|365612142|FG001|Overall Study|Withdrawal by Subject|7|||
105986699|NCT02397057|365612141|FG000|Overall Study|Lost to Follow-up|4|||
105986700|NCT02397057|365612142|FG001|Overall Study|Lost to Follow-up|3|||
105986701|NCT02397057|365612141|FG000|Overall Study|Death|1|||
105986702|NCT02397057|365612142|FG001|Overall Study|Death|0|||
105986703|NCT02397057|365612141|FG000|Overall Study|Adverse Event|0|||
105986704|NCT02397057|365612142|FG001|Overall Study|Adverse Event|1|||
105986705|NCT02397057|365612141|FG000|Overall Study|Physician Decision|0|||
105986706|NCT02397057|365612142|FG001|Overall Study|Physician Decision|1|||
105986707|NCT02397057|365612141|FG000|Overall Study|Subject did not receive study drug|0|||
105986708|NCT02397057|365612142|FG001|Overall Study|Subject did not receive study drug|1|||
105986709|NCT02207491|365612143|FG000|Overall Study|Adverse Event|20|||
105986710|NCT02207491|365612144|FG001|Overall Study|Adverse Event|4|||
105986711|NCT02207491|365612143|FG000|Overall Study|Withdrawal by Subject|3|||
105986712|NCT02207491|365612144|FG001|Overall Study|Withdrawal by Subject|2|||
105986713|NCT02207491|365612143|FG000|Overall Study|Non-compliant|0|||
105986714|NCT02207491|365612144|FG001|Overall Study|Non-compliant|1|||
105986715|NCT02207491|365612143|FG000|Overall Study|Lost to Follow-up|0|||
105986716|NCT02207491|365612144|FG001|Overall Study|Lost to Follow-up|1|||
105986717|NCT02207491|365612143|FG000|Overall Study|Lack of Efficacy|3|||
105986718|NCT02207491|365612144|FG001|Overall Study|Lack of Efficacy|0|||
105986719|NCT02207491|365612143|FG000|Overall Study|Physician Decision|2|||
105986720|NCT02207491|365612144|FG001|Overall Study|Physician Decision|0|||
105986721|NCT02207491|365612143|FG000|Overall Study|Protocol Violation|3|||
105986722|NCT02207491|365612144|FG001|Overall Study|Protocol Violation|5|||
105986723|NCT00793325|365612145|FG000|Overall Study|Protocol Violation|18|||
105986724|NCT00793325|365612145|FG000|Overall Study|Lost to Follow-up|1|||
105986725|NCT00753454|365612146|FG000|Overall Study|Adverse Event|4|||
105986726|NCT00753454|365612146|FG000|Overall Study|Lack of Efficacy|1|||
105986727|NCT00753454|365612146|FG000|Overall Study|Lost to Follow-up|3|||
105986728|NCT00753454|365612146|FG000|Overall Study|Withdrawal by Subject|5|||
105986729|NCT00753454|365612146|FG000|Overall Study|Investigator Decision|1|||
105986730|NCT00666965|365612155|FG000|Overall Study|Adverse Event|0|||
105986731|NCT00666965|365612156|FG001|Overall Study|Adverse Event|2|||
105986732|NCT00666965|365612157|FG002|Overall Study|Adverse Event|1|||
105986733|NCT00666965|365612158|FG003|Overall Study|Adverse Event|9|||
105986734|NCT00666965|365612155|FG000|Overall Study|Lack of Efficacy|1|||
105986735|NCT00666965|365612156|FG001|Overall Study|Lack of Efficacy|1|||
105986736|NCT00666965|365612157|FG002|Overall Study|Lack of Efficacy|0|||
105986737|NCT00666965|365612158|FG003|Overall Study|Lack of Efficacy|0|||
105986738|NCT00666965|365612155|FG000|Overall Study|Protocol Violation|0|||
105986739|NCT00666965|365612156|FG001|Overall Study|Protocol Violation|0|||
105986740|NCT00666965|365612157|FG002|Overall Study|Protocol Violation|0|||
105986741|NCT00666965|365612158|FG003|Overall Study|Protocol Violation|2|||
105986742|NCT00666965|365612155|FG000|Overall Study|Discontinuation criteria|2|||
105986743|NCT00666965|365612156|FG001|Overall Study|Discontinuation criteria|1|||
105986744|NCT00666965|365612157|FG002|Overall Study|Discontinuation criteria|1|||
105986745|NCT00666965|365612158|FG003|Overall Study|Discontinuation criteria|2|||
105986746|NCT00666965|365612155|FG000|Overall Study|Withdrawal by Subject|0|||
105986747|NCT00666965|365612156|FG001|Overall Study|Withdrawal by Subject|0|||
105986748|NCT00666965|365612157|FG002|Overall Study|Withdrawal by Subject|0|||
105986749|NCT00666965|365612158|FG003|Overall Study|Withdrawal by Subject|2|||
105986750|NCT02202538|365612163|FG000|Overall Study|Withdrawal by Subject|5|||
105986751|NCT02202538|365612163|FG000|Overall Study|Did not meet all inclusion criteria|2|||
105986752|NCT02202538|365612163|FG000|Overall Study|Investigator Decision|1|||
105986753|NCT01457846|365612165|FG000|Overall Study|Death before treatment|1|||
105986754|NCT01457846|365612166|FG001|Overall Study|Death before treatment|2|||
105986755|NCT01457846|365612165|FG000|Overall Study|Did not receive treatment|0|||
105986756|NCT01457846|365612166|FG001|Overall Study|Did not receive treatment|1|||
105986757|NCT01457846|365612165|FG000|Overall Study|Death|27|||
105986758|NCT01457846|365612166|FG001|Overall Study|Death|16|||
105986759|NCT01457846|365612165|FG000|Overall Study|Unclassified reason for not completed|11|||
105986760|NCT01457846|365612166|FG001|Overall Study|Unclassified reason for not completed|10|||
105986761|NCT01457846|365612165|FG000|Overall Study|Withdrawal by Subject|1|||
105986762|NCT01457846|365612166|FG001|Overall Study|Withdrawal by Subject|1|||
105986763|NCT01457846|365612165|FG000|Overall Study|Lost to Follow-up|1|||
105986764|NCT01457846|365612166|FG001|Overall Study|Lost to Follow-up|0|||
105986765|NCT02161757|365612167|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
105986766|NCT02161757|365612168|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
105986767|NCT02161757|365612169|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
105986768|NCT02161757|365612167|FG000|Treatment Through Study Completion|Adverse Event|1|||
105986769|NCT02161757|365612168|FG001|Treatment Through Study Completion|Adverse Event|1|||
105986770|NCT02161757|365612169|FG002|Treatment Through Study Completion|Adverse Event|0|||
105986771|NCT02161757|365612167|FG000|Treatment Through Study Completion|Protocol Violation|0|||
105986772|NCT02161757|365612168|FG001|Treatment Through Study Completion|Protocol Violation|1|||
105986773|NCT02161757|365612169|FG002|Treatment Through Study Completion|Protocol Violation|2|||
105986774|NCT02161757|365612167|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
105986775|NCT02161757|365612168|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
105986776|NCT02161757|365612169|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
105986777|NCT02161757|365612167|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
105986778|NCT02161757|365612168|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
105986779|NCT02161757|365612169|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
105986780|NCT02161757|365612167|FG000|Treatment Through Study Completion|Other|20|||
105986781|NCT02161757|365612168|FG001|Treatment Through Study Completion|Other|19|||
105986782|NCT02161757|365612169|FG002|Treatment Through Study Completion|Other|12|||
105986783|NCT02161757|365612167|FG000|Treatment Through Study Completion|Death|2|||
105986784|NCT02161757|365612168|FG001|Treatment Through Study Completion|Death|1|||
105986785|NCT02161757|365612169|FG002|Treatment Through Study Completion|Death|1|||
105986786|NCT01361178|365612170|FG000|Overall Study|Death|13|||
105986787|NCT01361178|365612171|FG001|Overall Study|Death|0|||
105986788|NCT00383162|365612172|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
105986789|NCT00383162|365612173|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
105986790|NCT00383162|365612172|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
105986791|NCT00383162|365612173|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
105986792|NCT00383162|365612172|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
105986793|NCT00383162|365612173|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
105986794|NCT00383162|365612172|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
105986795|NCT00383162|365612173|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
105986796|NCT00383162|365612172|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
105986797|NCT00383162|365612173|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
105986798|NCT00383162|365612172|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
105986799|NCT00383162|365612173|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
105986800|NCT00383162|365612172|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
105986801|NCT00383162|365612173|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
105986802|NCT00383162|365612172|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
105986803|NCT00383162|365612173|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
105986804|NCT00383162|365612172|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
105986805|NCT00383162|365612173|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
105986806|NCT03916081|365612176|FG000|Overall Study|Adverse Event|1|||
105986807|NCT03916081|365612177|FG001|Overall Study|Adverse Event|0|||
105986808|NCT03916081|365612178|FG002|Overall Study|Adverse Event|0|||
105986809|NCT03916081|365612176|FG000|Overall Study|Physician Decision|0|||
105986810|NCT03916081|365612177|FG001|Overall Study|Physician Decision|0|||
105986811|NCT03916081|365612178|FG002|Overall Study|Physician Decision|1|||
105868169|NCT01260701|365167158|FG000|Overall Study|Adverse Event|9|||
105868170|NCT01260701|365167158|FG000|Overall Study|Withdrawal by Subject|2|||
105868171|NCT01260701|365167158|FG000|Overall Study|Progression|53|||
105868172|NCT01260701|365167158|FG000|Overall Study|Death|2|||
105868173|NCT01260701|365167158|FG000|Overall Study|Not protocol specified|3|||
105868174|NCT01260701|365167158|FG000|Overall Study|Under review|1|||
105868175|NCT01260701|365167158|FG000|Overall Study|Ineligible|4|||
105868176|NCT01260701|365167158|FG000|Overall Study|Did not begin protocol therapy|1|||
105868177|NCT00306995|365167160|FG000|Study Part I|Withdrawal by Subject|0|||
105868178|NCT00306995|365167161|FG001|Study Part I|Withdrawal by Subject|0|||
105868179|NCT00306995|365167162|FG002|Study Part I|Withdrawal by Subject|0|||
105986812|NCT03916081|365612176|FG000|Overall Study|Lost to Follow-up|0|||
105986813|NCT03916081|365612177|FG001|Overall Study|Lost to Follow-up|1|||
105986814|NCT03916081|365612178|FG002|Overall Study|Lost to Follow-up|0|||
105986815|NCT03916081|365612176|FG000|Overall Study|Withdrawal by Subject|3|||
105986816|NCT03916081|365612177|FG001|Overall Study|Withdrawal by Subject|0|||
105986817|NCT03916081|365612178|FG002|Overall Study|Withdrawal by Subject|1|||
105986818|NCT03916081|365612176|FG000|Overall Study|Worsening of AD|0|||
105986819|NCT03916081|365612177|FG001|Overall Study|Worsening of AD|0|||
105986820|NCT03916081|365612178|FG002|Overall Study|Worsening of AD|1|||
105986821|NCT00465647|365612181|FG000|Overall Study|Administrative|2|||
105986822|NCT00465647|365612182|FG001|Overall Study|Administrative|2|||
105986823|NCT00465647|365612183|FG002|Overall Study|Administrative|3|||
105986824|NCT00465647|365612184|FG003|Overall Study|Administrative|2|||
105986825|NCT00465647|365612181|FG000|Overall Study|Adverse Event|2|||
105986826|NCT00465647|365612182|FG001|Overall Study|Adverse Event|0|||
105986827|NCT00465647|365612183|FG002|Overall Study|Adverse Event|3|||
105986828|NCT00465647|365612184|FG003|Overall Study|Adverse Event|2|||
105986829|NCT00465647|365612181|FG000|Overall Study|Withdrawal by Subject|1|||
105986830|NCT00465647|365612182|FG001|Overall Study|Withdrawal by Subject|2|||
105986831|NCT00465647|365612183|FG002|Overall Study|Withdrawal by Subject|2|||
105986832|NCT00465647|365612184|FG003|Overall Study|Withdrawal by Subject|7|||
105986833|NCT00465647|365612181|FG000|Overall Study|"The other reasons included loss of IV"|8|||
105986834|NCT00465647|365612182|FG001|Overall Study|"The other reasons included loss of IV"|4|||
105986835|NCT00465647|365612183|FG002|Overall Study|"The other reasons included loss of IV"|3|||
105986836|NCT00465647|365612184|FG003|Overall Study|"The other reasons included loss of IV"|2|||
105986837|NCT01240135|365612185|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
105986838|NCT01240135|365612186|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
105986839|NCT01240135|365612185|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
105986840|NCT01240135|365612186|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
105986841|NCT01887353|365612187|FG000|Overall Study|Study stopped early|4|||
105986842|NCT01887353|365612188|FG001|Overall Study|Study stopped early|3|||
105986843|NCT01371305|365612189|FG000|Overall Study|Adverse Event|0|||
105986844|NCT01371305|365612190|FG001|Overall Study|Adverse Event|0|||
105986845|NCT01371305|365612191|FG002|Overall Study|Adverse Event|0|||
105986846|NCT01371305|365612192|FG003|Overall Study|Adverse Event|2|||
105986847|NCT01371305|365612193|FG004|Overall Study|Adverse Event|1|||
105986848|NCT01371305|365612194|FG005|Overall Study|Adverse Event|0|||
105986849|NCT01371305|365612189|FG000|Overall Study|Study terminated by sponsor|0|||
105986850|NCT01371305|365612190|FG001|Overall Study|Study terminated by sponsor|0|||
105986851|NCT01371305|365612191|FG002|Overall Study|Study terminated by sponsor|0|||
105986852|NCT01371305|365612192|FG003|Overall Study|Study terminated by sponsor|0|||
105986853|NCT01371305|365612193|FG004|Overall Study|Study terminated by sponsor|3|||
105986854|NCT01371305|365612194|FG005|Overall Study|Study terminated by sponsor|1|||
105986855|NCT01371305|365612189|FG000|Overall Study|Subject request|0|||
105986856|NCT01371305|365612190|FG001|Overall Study|Subject request|0|||
105986857|NCT01371305|365612191|FG002|Overall Study|Subject request|0|||
105986858|NCT01371305|365612192|FG003|Overall Study|Subject request|0|||
105868180|NCT00306995|365167163|FG003|Study Part I|Withdrawal by Subject|0|||
105986859|NCT01371305|365612193|FG004|Overall Study|Subject request|0|||
105986860|NCT01371305|365612194|FG005|Overall Study|Subject request|1|||
105986861|NCT03624127|365612195|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
105868181|NCT00306995|365167164|FG004|Study Part I|Withdrawal by Subject|0|||
105868182|NCT00306995|365167165|FG005|Study Part I|Withdrawal by Subject|0|||
105868183|NCT00306995|365167166|FG006|Study Part I|Withdrawal by Subject|1|||
105868184|NCT00306995|365167160|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
105868185|NCT00306995|365167161|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
105868186|NCT00306995|365167162|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
105868187|NCT00306995|365167163|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
105868188|NCT00306995|365167164|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
105868189|NCT00306995|365167165|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
105868190|NCT00306995|365167166|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
105868191|NCT00733005|365169564|FG000|Overall Study|Adverse Event|0|||
105868192|NCT00733005|365169565|FG001|Overall Study|Adverse Event|1|||
105868193|NCT00733005|365169564|FG000|Overall Study|Treatment Failure|0|||
105868194|NCT00733005|365169565|FG001|Overall Study|Treatment Failure|1|||
105868195|NCT00733005|365169564|FG000|Overall Study|Withdrawal by Subject|0|||
105868196|NCT00733005|365169565|FG001|Overall Study|Withdrawal by Subject|1|||
105868197|NCT00733005|365169564|FG000|Overall Study|Protocol Violation|2|||
105868198|NCT00733005|365169565|FG001|Overall Study|Protocol Violation|0|||
105868199|NCT01769456|365169566|FG000|Overall Study|Lost to Follow-up|19|||
105868200|NCT01769456|365169566|FG000|Overall Study|Withdrawal by Subject|3|||
105868201|NCT01769456|365169566|FG000|Overall Study|Did not receive PCC intervention|6|||
105868202|NCT01769456|365169566|FG000|Overall Study|Moved out of the area|3|||
105868203|NCT01769456|365169566|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
105868204|NCT01769456|365169566|FG000|Overall Study|Parental request to youth to withdraw|1|||
105868205|NCT05244122|365169571|FG000|Overall Study|Withdrawal by Subject|318|||
105868206|NCT03410056|365169572|FG000|Overall Study|Decision by Sponsor|0|||
105868207|NCT03410056|365169573|FG001|Overall Study|Decision by Sponsor|0|||
105868208|NCT03410056|365169574|FG002|Overall Study|Decision by Sponsor|3|||
105868209|NCT03410056|365169575|FG003|Overall Study|Decision by Sponsor|0|||
105868210|NCT03410056|365169576|FG004|Overall Study|Decision by Sponsor|0|||
105868211|NCT03410056|365169577|FG005|Overall Study|Decision by Sponsor|0|||
105868212|NCT03410056|365169578|FG006|Overall Study|Decision by Sponsor|0|||
105868213|NCT03410056|365169572|FG000|Overall Study|Withdrawal by Subject|0|||
105868214|NCT03410056|365169573|FG001|Overall Study|Withdrawal by Subject|2|||
105868215|NCT03410056|365169574|FG002|Overall Study|Withdrawal by Subject|5|||
105868216|NCT03410056|365169575|FG003|Overall Study|Withdrawal by Subject|5|||
105868217|NCT03410056|365169576|FG004|Overall Study|Withdrawal by Subject|0|||
105868218|NCT03410056|365169577|FG005|Overall Study|Withdrawal by Subject|0|||
105868219|NCT03410056|365169578|FG006|Overall Study|Withdrawal by Subject|0|||
105868220|NCT00266630|365169579|FG000|Overall Study|Adverse Event|8|||
105868221|NCT00266630|365169580|FG001|Overall Study|Adverse Event|6|||
105868222|NCT00266630|365169579|FG000|Overall Study|Lack of Efficacy|1|||
105868223|NCT00266630|365169580|FG001|Overall Study|Lack of Efficacy|4|||
105868224|NCT00266630|365169579|FG000|Overall Study|Entry Criteria not met|1|||
105868225|NCT00266630|365169580|FG001|Overall Study|Entry Criteria not met|0|||
105868226|NCT00266630|365169579|FG000|Overall Study|Protocol Violation|1|||
105868227|NCT00266630|365169580|FG001|Overall Study|Protocol Violation|3|||
105868228|NCT00266630|365169579|FG000|Overall Study|Physician Decision|1|||
105868229|NCT00266630|365169580|FG001|Overall Study|Physician Decision|2|||
105868230|NCT00266630|365169579|FG000|Overall Study|Withdrawal by Subject|10|||
105868231|NCT00266630|365169580|FG001|Overall Study|Withdrawal by Subject|2|||
105868232|NCT00266630|365169579|FG000|Overall Study|Lost to Follow-up|1|||
105868233|NCT00266630|365169580|FG001|Overall Study|Lost to Follow-up|0|||
105868234|NCT00266630|365169579|FG000|Overall Study|Other|19|||
105868235|NCT00266630|365169580|FG001|Overall Study|Other|11|||
105868236|NCT03284723|365169581|FG000|Overall Study|Death|0|||
105868237|NCT03284723|365169582|FG001|Overall Study|Death|0|||
105868238|NCT03284723|365169583|FG002|Overall Study|Death|0|||
105868239|NCT03284723|365169584|FG003|Overall Study|Death|1|||
105868240|NCT03284723|365169585|FG004|Overall Study|Death|0|||
105868241|NCT03284723|365169586|FG005|Overall Study|Death|0|||
105868242|NCT03284723|365169587|FG006|Overall Study|Death|1|||
105868243|NCT03284723|365169588|FG007|Overall Study|Death|0|||
105868244|NCT03284723|365169589|FG008|Overall Study|Death|0|||
105868245|NCT03284723|365169590|FG009|Overall Study|Death|2|||
105868246|NCT03284723|365169591|FG010|Overall Study|Death|1|||
105868247|NCT03284723|365169592|FG011|Overall Study|Death|0|||
105868248|NCT03284723|365169581|FG000|Overall Study|Lost to Follow-up|0|||
105868249|NCT03284723|365169582|FG001|Overall Study|Lost to Follow-up|0|||
105868250|NCT03284723|365169583|FG002|Overall Study|Lost to Follow-up|0|||
105868251|NCT03284723|365169584|FG003|Overall Study|Lost to Follow-up|0|||
105868252|NCT03284723|365169585|FG004|Overall Study|Lost to Follow-up|0|||
105868253|NCT03284723|365169586|FG005|Overall Study|Lost to Follow-up|2|||
105868254|NCT03284723|365169587|FG006|Overall Study|Lost to Follow-up|1|||
105868255|NCT03284723|365169588|FG007|Overall Study|Lost to Follow-up|0|||
105868256|NCT03284723|365169589|FG008|Overall Study|Lost to Follow-up|0|||
105868257|NCT03284723|365169590|FG009|Overall Study|Lost to Follow-up|2|||
105986862|NCT03624127|365612196|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
105986863|NCT03624127|365612197|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
105986864|NCT03624127|365612195|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
105986865|NCT03624127|365612196|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
105986866|NCT03624127|365612197|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
105986867|NCT03624127|365612195|FG000|Treatment Week 0 - Week 16|Death|0|||
105986868|NCT03624127|365612196|FG001|Treatment Week 0 - Week 16|Death|1|||
105986869|NCT03624127|365612197|FG002|Treatment Week 0 - Week 16|Death|0|||
105986870|NCT03624127|365612195|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
105986871|NCT03624127|365612196|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
105986872|NCT03624127|365612197|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
105986873|NCT03624127|365612195|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
105986874|NCT03624127|365612196|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
105986875|NCT03624127|365612197|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
105986876|NCT03624127|365612195|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
105986877|NCT03624127|365612196|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
105986878|NCT03624127|365612197|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
105986879|NCT03624127|365612195|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
105986880|NCT03624127|365612196|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
105986881|NCT03624127|365612197|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
105986882|NCT03624127|365612195|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
105986883|NCT03624127|365612196|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
105986884|NCT03624127|365612197|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
105986885|NCT03624127|365612195|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
105986886|NCT03624127|365612196|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
105986887|NCT03624127|365612197|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
105986888|NCT03624127|365612195|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
105986889|NCT03624127|365612196|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
105986890|NCT03624127|365612197|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
105986891|NCT03624127|365612195|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
105986892|NCT03624127|365612196|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
105986893|NCT03624127|365612197|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
105986894|NCT03624127|365612195|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
105986895|NCT03624127|365612196|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
105986896|NCT03624127|365612197|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
105986897|NCT03624127|365612195|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
105986898|NCT03624127|365612196|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
105986899|NCT03624127|365612197|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
105986900|NCT03624127|365612195|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
105986901|NCT03624127|365612196|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
105986902|NCT03624127|365612197|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
105986903|NCT03624127|365612195|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
105986904|NCT03624127|365612196|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
105986905|NCT03624127|365612197|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
105986906|NCT03624127|365612195|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
105986907|NCT03624127|365612196|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
105986908|NCT03624127|365612197|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
105986909|NCT03624127|365612195|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
105986910|NCT03624127|365612196|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
105986911|NCT03624127|365612197|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
105986912|NCT03624127|365612195|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
105986913|NCT03624127|365612196|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
105986914|NCT03624127|365612197|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
105986915|NCT03624127|365612195|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
105986916|NCT03624127|365612196|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
105986917|NCT03624127|365612197|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
105986918|NCT03624127|365612195|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
105986919|NCT03624127|365612196|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
105986920|NCT03624127|365612197|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
105986921|NCT03624127|365612195|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
105986922|NCT03624127|365612196|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
105986923|NCT03624127|365612197|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
105986924|NCT00235716|365612198|FG000|Overall Study|Death|26|||
105986925|NCT00235716|365612199|FG001|Overall Study|Death|39|||
105986926|NCT00235716|365612200|FG002|Overall Study|Death|32|||
105986927|NCT00235716|365612201|FG003|Overall Study|Death|31|||
105986928|NCT00235716|365612198|FG000|Overall Study|Withdrawal by Subject|23|||
105986929|NCT00235716|365612199|FG001|Overall Study|Withdrawal by Subject|19|||
105986930|NCT00235716|365612200|FG002|Overall Study|Withdrawal by Subject|17|||
105986931|NCT00235716|365612201|FG003|Overall Study|Withdrawal by Subject|18|||
105986932|NCT00235716|365612198|FG000|Overall Study|Lost to Follow-up|12|||
105986933|NCT00235716|365612199|FG001|Overall Study|Lost to Follow-up|7|||
105986934|NCT00235716|365612200|FG002|Overall Study|Lost to Follow-up|14|||
105986935|NCT00235716|365612201|FG003|Overall Study|Lost to Follow-up|10|||
105986936|NCT00235716|365612198|FG000|Overall Study|Adverse Event|1|||
105986937|NCT00235716|365612199|FG001|Overall Study|Adverse Event|1|||
105986938|NCT00235716|365612200|FG002|Overall Study|Adverse Event|1|||
105986939|NCT00235716|365612201|FG003|Overall Study|Adverse Event|0|||
105986940|NCT00235716|365612198|FG000|Overall Study|Physician Decision|0|||
105986941|NCT00235716|365612199|FG001|Overall Study|Physician Decision|1|||
105986942|NCT00235716|365612200|FG002|Overall Study|Physician Decision|1|||
105986943|NCT00235716|365612201|FG003|Overall Study|Physician Decision|3|||
105986944|NCT04390841|365612202|FG000|Overall Study|Withdrawal by Subject|2|||
105986945|NCT00559988|365612203|FG000|Overall Study|Death|147|||
105986946|NCT00559988|365612204|FG001|Overall Study|Death|140|||
105986947|NCT00559988|365612203|FG000|Overall Study|Withdrawal by Subject|152|||
105986948|NCT00559988|365612204|FG001|Overall Study|Withdrawal by Subject|139|||
105986949|NCT00559988|365612203|FG000|Overall Study|Lost to Follow-up|42|||
105986950|NCT00559988|365612204|FG001|Overall Study|Lost to Follow-up|56|||
105986951|NCT00559988|365612203|FG000|Overall Study|ICD device explanted|10|||
105986952|NCT00559988|365612204|FG001|Overall Study|ICD device explanted|17|||
105986953|NCT02891382|365612207|FG000|Overall Study|Lost to Follow-up|3|||
105986954|NCT02891382|365612208|FG001|Overall Study|Lost to Follow-up|4|||
105986955|NCT02891382|365612209|FG002|Overall Study|Lost to Follow-up|5|||
105986956|NCT02891382|365612210|FG003|Overall Study|Lost to Follow-up|3|||
105986957|NCT02891382|365612211|FG004|Overall Study|Lost to Follow-up|4|||
105986958|NCT01455194|365612212|FG000|Overall Study|Screen Failure|20|||
105986959|NCT01455194|365612213|FG001|Overall Study|Screen Failure|0|||
105986960|NCT01455194|365612214|FG002|Overall Study|Screen Failure|0|||
105986961|NCT01455194|365612215|FG003|Overall Study|Screen Failure|0|||
105986962|NCT01455194|365612212|FG000|Overall Study|Randomisation Failure|90|||
105986963|NCT01455194|365612213|FG001|Overall Study|Randomisation Failure|0|||
105986964|NCT01455194|365612214|FG002|Overall Study|Randomisation Failure|0|||
105986965|NCT01455194|365612215|FG003|Overall Study|Randomisation Failure|0|||
105986966|NCT01455194|365612212|FG000|Overall Study|Deterioration in asthma|12|||
105986967|NCT01455194|365612213|FG001|Overall Study|Deterioration in asthma|6|||
105986968|NCT01455194|365612214|FG002|Overall Study|Deterioration in asthma|14|||
105868258|NCT03284723|365169591|FG010|Overall Study|Lost to Follow-up|0|||
105868259|NCT03284723|365169592|FG011|Overall Study|Lost to Follow-up|0|||
105868260|NCT03284723|365169581|FG000|Overall Study|Study Terminated By Sponsor|0|||
105868261|NCT03284723|365169582|FG001|Overall Study|Study Terminated By Sponsor|0|||
105868262|NCT03284723|365169583|FG002|Overall Study|Study Terminated By Sponsor|0|||
105986969|NCT01455194|365612215|FG003|Overall Study|Deterioration in asthma|9|||
105986970|NCT01455194|365612212|FG000|Overall Study|Adverse Event|1|||
105986971|NCT01455194|365612213|FG001|Overall Study|Adverse Event|1|||
105986972|NCT01455194|365612214|FG002|Overall Study|Adverse Event|1|||
105986973|NCT01455194|365612215|FG003|Overall Study|Adverse Event|3|||
105986974|NCT01455194|365612212|FG000|Overall Study|Withdrawal by Subject|21|||
105986975|NCT01455194|365612213|FG001|Overall Study|Withdrawal by Subject|16|||
105986976|NCT01455194|365612214|FG002|Overall Study|Withdrawal by Subject|12|||
105986977|NCT01455194|365612215|FG003|Overall Study|Withdrawal by Subject|9|||
105986978|NCT01455194|365612212|FG000|Overall Study|Lost to Follow-up|2|||
105986979|NCT01455194|365612213|FG001|Overall Study|Lost to Follow-up|0|||
105986980|NCT01455194|365612214|FG002|Overall Study|Lost to Follow-up|1|||
105986981|NCT01455194|365612215|FG003|Overall Study|Lost to Follow-up|1|||
105986982|NCT01455194|365612212|FG000|Overall Study|Pregnancy|0|||
105986983|NCT01455194|365612213|FG001|Overall Study|Pregnancy|1|||
105986984|NCT01455194|365612214|FG002|Overall Study|Pregnancy|1|||
105986985|NCT01455194|365612215|FG003|Overall Study|Pregnancy|0|||
105986986|NCT01455194|365612212|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
105986987|NCT01455194|365612213|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
105986988|NCT01455194|365612214|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
105986989|NCT01455194|365612215|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
105986990|NCT01455194|365612212|FG000|Overall Study|Miscellaneous|4|||
105986991|NCT01455194|365612213|FG001|Overall Study|Miscellaneous|5|||
105986992|NCT01455194|365612214|FG002|Overall Study|Miscellaneous|1|||
105986993|NCT01455194|365612215|FG003|Overall Study|Miscellaneous|4|||
105986994|NCT04356040|365612218|FG000|Overall Study|Death|2|||
105986995|NCT04356040|365612219|FG001|Overall Study|Death|0|||
105986996|NCT04356040|365612218|FG000|Overall Study|Lost to Follow-up|1|||
105986997|NCT04356040|365612219|FG001|Overall Study|Lost to Follow-up|0|||
105986998|NCT04356040|365612218|FG000|Overall Study|Physician Decision|0|||
105986999|NCT04356040|365612219|FG001|Overall Study|Physician Decision|1|||
105987000|NCT04356040|365612218|FG000|Overall Study|Withdrawal by Subject|13|||
105987001|NCT04356040|365612219|FG001|Overall Study|Withdrawal by Subject|1|||
105987002|NCT04356040|365612218|FG000|Overall Study|Enrollment Pause|10|||
105987003|NCT04356040|365612219|FG001|Overall Study|Enrollment Pause|0|||
105987004|NCT04356040|365612218|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
105987005|NCT04356040|365612219|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
105987006|NCT04356040|365612218|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
105987007|NCT04356040|365612219|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
105987008|NCT04356040|365612218|FG000|Overall Study|PI left institution|3|||
105987009|NCT04356040|365612219|FG001|Overall Study|PI left institution|0|||
105987010|NCT00416455|365612220|FG000|Overall Study|PET / CT not done|3|||
105987011|NCT00416455|365612221|FG001|Overall Study|PET / CT not done|5|||
105987012|NCT00416455|365612220|FG000|Overall Study|PET / CT poor quality|2|||
105987013|NCT00416455|365612221|FG001|Overall Study|PET / CT poor quality|1|||
105987014|NCT00416455|365612220|FG000|Overall Study|Inadequate pathology|11|||
105987015|NCT00416455|365612221|FG001|Overall Study|Inadequate pathology|2|||
105987016|NCT01128946|365612225|FG000|Period I|Protocol Violation|0|||
105987017|NCT01128946|365612226|FG001|Period I|Protocol Violation|1|||
105987018|NCT01128946|365612227|FG002|Period I|Protocol Violation|0|||
105987019|NCT01128946|365612228|FG003|Period I|Protocol Violation|0|||
105987020|NCT01128946|365612225|FG000|Period I|Withdrawal by Subject|0|||
105987021|NCT01128946|365612226|FG001|Period I|Withdrawal by Subject|0|||
105987022|NCT01128946|365612227|FG002|Period I|Withdrawal by Subject|1|||
105987023|NCT01128946|365612228|FG003|Period I|Withdrawal by Subject|1|||
105987024|NCT01128946|365612225|FG000|Period II|Protocol Violation|0|||
105987025|NCT01128946|365612226|FG001|Period II|Protocol Violation|1|||
105987026|NCT01128946|365612227|FG002|Period II|Protocol Violation|0|||
105987027|NCT01128946|365612228|FG003|Period II|Protocol Violation|0|||
105987028|NCT01128946|365612225|FG000|Period II|Withdrawal by Subject|0|||
105987029|NCT01128946|365612226|FG001|Period II|Withdrawal by Subject|0|||
105987030|NCT01128946|365612227|FG002|Period II|Withdrawal by Subject|0|||
105987031|NCT01128946|365612228|FG003|Period II|Withdrawal by Subject|1|||
105987032|NCT01128946|365612225|FG000|Period III|Protocol Violation|1|||
105987033|NCT01128946|365612226|FG001|Period III|Protocol Violation|0|||
105987034|NCT01128946|365612227|FG002|Period III|Protocol Violation|0|||
105987035|NCT01128946|365612228|FG003|Period III|Protocol Violation|0|||
105987036|NCT00621140|365612229|FG000|Overall Study|Adverse Event|4|||
105987037|NCT00621140|365612230|FG001|Overall Study|Adverse Event|5|||
105987038|NCT00621140|365612229|FG000|Overall Study|Lost to Follow-up|1|||
105987039|NCT00621140|365612230|FG001|Overall Study|Lost to Follow-up|2|||
105987040|NCT00621140|365612229|FG000|Overall Study|Withdrawal by Subject|4|||
105987041|NCT00621140|365612230|FG001|Overall Study|Withdrawal by Subject|6|||
105987042|NCT00621140|365612229|FG000|Overall Study|Other incl. lack of efficacy|6|||
105987043|NCT00621140|365612230|FG001|Overall Study|Other incl. lack of efficacy|5|||
105987044|NCT00360568|365612231|FG000|Overall Study|Adverse Event|1|||
105987045|NCT00360568|365612232|FG001|Overall Study|Adverse Event|2|||
105987046|NCT00360568|365612231|FG000|Overall Study|Lack of Efficacy|1|||
105987047|NCT00360568|365612232|FG001|Overall Study|Lack of Efficacy|0|||
105987048|NCT00360568|365612231|FG000|Overall Study|Withdrawal by Subject|0|||
105987049|NCT00360568|365612232|FG001|Overall Study|Withdrawal by Subject|3|||
105987050|NCT03565237|365612238|FG000|Overall Study|Non-compliance of Investigational Product|1|||
105987051|NCT03565237|365612238|FG000|Overall Study|Physician Decision|1|||
105987052|NCT02873338|365612239|FG000|Overall Study|Adverse Event|0|||
105987053|NCT02873338|365612240|FG001|Overall Study|Adverse Event|2|||
105987054|NCT02873338|365612241|FG002|Overall Study|Adverse Event|1|||
105987055|NCT02873338|365612239|FG000|Overall Study|Death|2|||
105987056|NCT02873338|365612240|FG001|Overall Study|Death|1|||
105987057|NCT02873338|365612241|FG002|Overall Study|Death|1|||
105987058|NCT02873338|365612239|FG000|Overall Study|Withdrawal by Subject|2|||
105987059|NCT02873338|365612240|FG001|Overall Study|Withdrawal by Subject|1|||
105987060|NCT02873338|365612241|FG002|Overall Study|Withdrawal by Subject|3|||
105987061|NCT02873338|365612239|FG000|Overall Study|Lack of Efficacy|0|||
105987062|NCT02873338|365612240|FG001|Overall Study|Lack of Efficacy|2|||
105987063|NCT02873338|365612241|FG002|Overall Study|Lack of Efficacy|0|||
105987064|NCT02873338|365612239|FG000|Overall Study|Other or Missing|14|||
105987065|NCT02873338|365612240|FG001|Overall Study|Other or Missing|15|||
105987066|NCT02873338|365612241|FG002|Overall Study|Other or Missing|13|||
105987067|NCT03657095|365612242|FG000|Overall Study|Withdrawal by Subject|1|||
105987068|NCT03657095|365612243|FG001|Overall Study|Withdrawal by Subject|1|||
105987069|NCT03657095|365612242|FG000|Overall Study|Adverse Event|0|||
105987070|NCT03657095|365612243|FG001|Overall Study|Adverse Event|3|||
105987071|NCT03657095|365612242|FG000|Overall Study|Study Terminated by Sponsor|58|||
105987072|NCT03657095|365612243|FG001|Overall Study|Study Terminated by Sponsor|49|||
105987073|NCT01008449|365612244|FG000|Overall Study|Lost to Follow-up|29|||
105987074|NCT01008449|365612245|FG001|Overall Study|Lost to Follow-up|19|||
105987075|NCT00847197|365612246|FG000|Overall Study|Adverse Event|21|||
105987076|NCT00847197|365612247|FG001|Overall Study|Adverse Event|3|||
105987077|NCT00847197|365612246|FG000|Overall Study|Protocol Violation|0|||
105987078|NCT00847197|365612247|FG001|Overall Study|Protocol Violation|1|||
105987079|NCT00847197|365612246|FG000|Overall Study|Withdrawal by Subject|3|||
105987080|NCT00847197|365612247|FG001|Overall Study|Withdrawal by Subject|1|||
105987081|NCT01140061|365612248|FG000|Part I|Adverse Event|1|||
105987082|NCT01140061|365612249|FG001|Part I|Adverse Event|0|||
105987083|NCT01140061|365612250|FG002|Part I|Adverse Event|0|||
105987084|NCT01140061|365612251|FG003|Part I|Adverse Event|0|||
105987085|NCT01140061|365612252|FG004|Part I|Adverse Event|0|||
105987086|NCT01140061|365612253|FG005|Part I|Adverse Event|0|||
105987087|NCT01140061|365612254|FG006|Part I|Adverse Event|0|||
105987088|NCT01140061|365612255|FG007|Part I|Adverse Event|0|||
105987089|NCT01140061|365612256|FG008|Part I|Adverse Event|0|||
105987090|NCT01140061|365612257|FG009|Part I|Adverse Event|0|||
105987091|NCT01140061|365612248|FG000|Extension|Laboratory Adverse Event|0|||
105987092|NCT01140061|365612249|FG001|Extension|Laboratory Adverse Event|0|||
105987093|NCT01140061|365612250|FG002|Extension|Laboratory Adverse Event|0|||
105987094|NCT01140061|365612251|FG003|Extension|Laboratory Adverse Event|0|||
105987095|NCT01140061|365612252|FG004|Extension|Laboratory Adverse Event|0|||
105987096|NCT01140061|365612253|FG005|Extension|Laboratory Adverse Event|0|||
105987097|NCT01140061|365612254|FG006|Extension|Laboratory Adverse Event|0|||
105987098|NCT01140061|365612255|FG007|Extension|Laboratory Adverse Event|0|||
105987099|NCT01140061|365612256|FG008|Extension|Laboratory Adverse Event|0|||
105987100|NCT01140061|365612257|FG009|Extension|Laboratory Adverse Event|1|||
105987101|NCT00622388|365612258|FG000|Overall Study|Disease Progression|47|||
105987102|NCT00622388|365612258|FG000|Overall Study|Adverse Event|6|||
105987103|NCT00622388|365612258|FG000|Overall Study|Protocol Violation|3|||
105987104|NCT00622388|365612258|FG000|Overall Study|Participant Refusal|1|||
105987105|NCT00622388|365612258|FG000|Overall Study|Death|3|||
105987106|NCT00622388|365612258|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
105987107|NCT00622388|365612258|FG000|Overall Study|Took Prohibited Medication|2|||
105987108|NCT00622388|365612258|FG000|Overall Study|Withdrew Consent|1|||
105987109|NCT00622388|365612258|FG000|Overall Study|Insurance Expired|1|||
105987110|NCT01894243|365612259|FG000|Overall Study|Adverse Event|0|||
105987111|NCT01894243|365612260|FG001|Overall Study|Adverse Event|1|||
105987112|NCT01894243|365612261|FG002|Overall Study|Adverse Event|2|||
105987113|NCT01894243|365612259|FG000|Overall Study|Death|0|||
105987114|NCT01894243|365612260|FG001|Overall Study|Death|0|||
105987115|NCT01894243|365612261|FG002|Overall Study|Death|3|||
105987116|NCT01894243|365612259|FG000|Overall Study|Lack of Efficacy|3|||
105987117|NCT01894243|365612260|FG001|Overall Study|Lack of Efficacy|3|||
105987118|NCT01894243|365612261|FG002|Overall Study|Lack of Efficacy|1|||
105987119|NCT01894243|365612259|FG000|Overall Study|Condition under investigation worsened|8|||
105987120|NCT01894243|365612260|FG001|Overall Study|Condition under investigation worsened|6|||
105987121|NCT01894243|365612261|FG002|Overall Study|Condition under investigation worsened|2|||
105987122|NCT01894243|365612259|FG000|Overall Study|Subject decision|1|||
105987123|NCT01894243|365612260|FG001|Overall Study|Subject decision|0|||
105987124|NCT01894243|365612261|FG002|Overall Study|Subject decision|0|||
105987125|NCT01894243|365612259|FG000|Overall Study|Other|1|||
105987126|NCT01894243|365612260|FG001|Overall Study|Other|0|||
105987127|NCT01894243|365612261|FG002|Overall Study|Other|0|||
105987128|NCT01299116|365612262|FG000|Overall Study|Lost to Follow-up|65|||
105987129|NCT01299116|365612263|FG001|Overall Study|Lost to Follow-up|9|||
105987130|NCT01299116|365612264|FG002|Overall Study|Lost to Follow-up|11|||
105987131|NCT00830180|365612266|FG000|Overall Study|Adverse Event|6|||
105987132|NCT00830180|365612266|FG000|Overall Study|Death|11|||
105987133|NCT00830180|365612266|FG000|Overall Study|Insufficient clinical response|1|||
105987134|NCT00830180|365612266|FG000|Overall Study|Withdrawal by Subject|5|||
105987135|NCT00830180|365612266|FG000|Overall Study|Progressive disease|2|||
105987136|NCT00830180|365612266|FG000|Overall Study|Other - Unspecified|1|||
105987137|NCT02687581|365612267|FG000|Overall Study|Withdrawal by Subject|1|||
105987138|NCT02687581|365612268|FG001|Overall Study|Withdrawal by Subject|0|||
105987139|NCT02687581|365612269|FG002|Overall Study|Withdrawal by Subject|0|||
105987140|NCT02687581|365612270|FG003|Overall Study|Withdrawal by Subject|1|||
105987141|NCT02687581|365612267|FG000|Overall Study|Lost to Follow-up|2|||
105987142|NCT02687581|365612268|FG001|Overall Study|Lost to Follow-up|2|||
105987143|NCT02687581|365612269|FG002|Overall Study|Lost to Follow-up|0|||
105987144|NCT02687581|365612270|FG003|Overall Study|Lost to Follow-up|0|||
105987145|NCT02687581|365612267|FG000|Overall Study|the device is too small for the patient.|1|||
105987146|NCT02687581|365612268|FG001|Overall Study|the device is too small for the patient.|0|||
105987147|NCT02687581|365612269|FG002|Overall Study|the device is too small for the patient.|0|||
105987148|NCT02687581|365612270|FG003|Overall Study|the device is too small for the patient.|0|||
105987149|NCT01114438|365612273|FG000|Overall Study|Adverse Event|10|||
105987150|NCT01114438|365612273|FG000|Overall Study|concomitant medication|1|||
105987151|NCT01114438|365612273|FG000|Overall Study|Physician Decision|1|||
105987152|NCT01114438|365612273|FG000|Overall Study|Withdrawal by Subject|2|||
105987153|NCT00488826|365612276|FG000|Overall Study|Withdrawal by Subject|40|||
105987154|NCT00488826|365612277|FG001|Overall Study|Withdrawal by Subject|35|||
105987155|NCT00488826|365612278|FG002|Overall Study|Withdrawal by Subject|19|||
105987156|NCT00488826|365612276|FG000|Overall Study|Protocol Violation|0|||
105987157|NCT00488826|365612277|FG001|Overall Study|Protocol Violation|0|||
105987158|NCT00488826|365612278|FG002|Overall Study|Protocol Violation|2|||
105987159|NCT00488826|365612276|FG000|Overall Study|Adverse Event|9|||
105987160|NCT00488826|365612277|FG001|Overall Study|Adverse Event|15|||
105987161|NCT00488826|365612278|FG002|Overall Study|Adverse Event|4|||
105987162|NCT00488826|365612276|FG000|Overall Study|Lost to Follow-up|5|||
105987163|NCT00488826|365612277|FG001|Overall Study|Lost to Follow-up|1|||
105987164|NCT00488826|365612278|FG002|Overall Study|Lost to Follow-up|0|||
105987165|NCT00488826|365612276|FG000|Overall Study|Protocol Deviations|2|||
105987166|NCT00488826|365612277|FG001|Overall Study|Protocol Deviations|1|||
105987167|NCT00488826|365612278|FG002|Overall Study|Protocol Deviations|1|||
105987168|NCT02725866|365612279|FG000|Overall Study|Failure to return|6|||
105987169|NCT02725866|365612279|FG000|Overall Study|Withdrew consent|3|||
105987170|NCT02725866|365612279|FG000|Overall Study|Insufficient virological response|1|||
105987171|NCT02725866|365612279|FG000|Overall Study|Other, not specified|4|||
105987172|NCT04667104|365612284|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
105987173|NCT04667104|365612285|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
105987174|NCT04667104|365612286|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
105987175|NCT03043651|365612288|FG000|Overall Study|Death|1|||
105987176|NCT03043651|365612288|FG000|Overall Study|Progressive Disease|2|||
105987177|NCT03043651|365612288|FG000|Overall Study|Adverse Event|2|||
105987178|NCT03043651|365612288|FG000|Overall Study|Withdrawal by Subject|4|||
105987179|NCT03043651|365612288|FG000|Overall Study|Study Terminated by Sponsor|39|||
105987180|NCT02974842|365612289|FG000|Overall Study|Withdrawal by Subject|4|||
105987181|NCT02974842|365612289|FG000|Overall Study|Screen failures|4|||
105987182|NCT00605345|365612294|FG000|Overall Study|Withdrawal by Subject|1|||
105987183|NCT00605345|365612295|FG001|Overall Study|Withdrawal by Subject|0|||
105987184|NCT00605345|365612294|FG000|Overall Study|Adverse Event|0|||
105987185|NCT00605345|365612295|FG001|Overall Study|Adverse Event|1|||
105987186|NCT00605345|365612294|FG000|Overall Study|Protocol Violation|0|||
105987187|NCT00605345|365612295|FG001|Overall Study|Protocol Violation|2|||
105987188|NCT02577016|365612302|FG000|Overall Study|Adverse Event|2|||
105987189|NCT02577016|365612303|FG001|Overall Study|Adverse Event|1|||
105987190|NCT02577016|365612302|FG000|Overall Study|Physician Decision|0|||
105987191|NCT02577016|365612303|FG001|Overall Study|Physician Decision|1|||
105987192|NCT03824587|365612304|FG000|Run-in Period|Screen Failure|0|||
105868263|NCT03284723|365169584|FG003|Overall Study|Study Terminated By Sponsor|0|||
105987193|NCT03824587|365612305|FG001|Run-in Period|Screen Failure|275|||
105987194|NCT03824587|365612304|FG000|Treatment Period|Adverse Event|4|||
105987195|NCT03824587|365612305|FG001|Treatment Period|Adverse Event|1|||
105987196|NCT03824587|365612304|FG000|Treatment Period|Withdrawal by Subject|0|||
105987197|NCT03824587|365612305|FG001|Treatment Period|Withdrawal by Subject|1|||
105987198|NCT03824587|365612304|FG000|Treatment Period|Kidney Transplant|1|||
105987199|NCT03824587|365612305|FG001|Treatment Period|Kidney Transplant|1|||
105987200|NCT00812565|365612306|FG000|Overall Study|Did Not Receive Study Medication|1|||
105987201|NCT00812565|365612307|FG001|Overall Study|Did Not Receive Study Medication|1|||
105987202|NCT00812565|365612308|FG002|Overall Study|Did Not Receive Study Medication|0|||
105987203|NCT00812565|365612309|FG003|Overall Study|Did Not Receive Study Medication|0|||
105987204|NCT00812565|365612310|FG004|Overall Study|Did Not Receive Study Medication|0|||
105987205|NCT00812565|365612311|FG005|Overall Study|Did Not Receive Study Medication|0|||
105987206|NCT00812565|365612312|FG006|Overall Study|Did Not Receive Study Medication|0|||
105987207|NCT00812565|365612313|FG007|Overall Study|Did Not Receive Study Medication|0|||
105987208|NCT00812565|365612306|FG000|Overall Study|Adverse Event|0|||
105987209|NCT00812565|365612307|FG001|Overall Study|Adverse Event|0|||
105987210|NCT00812565|365612308|FG002|Overall Study|Adverse Event|0|||
105987211|NCT00812565|365612309|FG003|Overall Study|Adverse Event|2|||
105987212|NCT00812565|365612310|FG004|Overall Study|Adverse Event|0|||
105987213|NCT00812565|365612311|FG005|Overall Study|Adverse Event|0|||
105987214|NCT00812565|365612312|FG006|Overall Study|Adverse Event|0|||
105987215|NCT00812565|365612313|FG007|Overall Study|Adverse Event|1|||
105987216|NCT00812565|365612306|FG000|Overall Study|Did Not Come to Study Visit|1|||
105868264|NCT03284723|365169585|FG004|Overall Study|Study Terminated By Sponsor|1|||
105868265|NCT03284723|365169586|FG005|Overall Study|Study Terminated By Sponsor|0|||
105868266|NCT03284723|365169587|FG006|Overall Study|Study Terminated By Sponsor|0|||
105868267|NCT03284723|365169588|FG007|Overall Study|Study Terminated By Sponsor|0|||
105868268|NCT03284723|365169589|FG008|Overall Study|Study Terminated By Sponsor|1|||
105868269|NCT03284723|365169590|FG009|Overall Study|Study Terminated By Sponsor|1|||
105868270|NCT03284723|365169591|FG010|Overall Study|Study Terminated By Sponsor|1|||
105868271|NCT03284723|365169592|FG011|Overall Study|Study Terminated By Sponsor|1|||
105868272|NCT03284723|365169581|FG000|Overall Study|Withdrawal by Subject|0|||
105868273|NCT03284723|365169582|FG001|Overall Study|Withdrawal by Subject|0|||
105868274|NCT03284723|365169583|FG002|Overall Study|Withdrawal by Subject|0|||
105868275|NCT03284723|365169584|FG003|Overall Study|Withdrawal by Subject|0|||
105868276|NCT03284723|365169585|FG004|Overall Study|Withdrawal by Subject|5|||
105868277|NCT03284723|365169586|FG005|Overall Study|Withdrawal by Subject|3|||
105868278|NCT03284723|365169587|FG006|Overall Study|Withdrawal by Subject|1|||
105868279|NCT03284723|365169588|FG007|Overall Study|Withdrawal by Subject|0|||
105868280|NCT03284723|365169589|FG008|Overall Study|Withdrawal by Subject|6|||
105868281|NCT03284723|365169590|FG009|Overall Study|Withdrawal by Subject|0|||
105868282|NCT03284723|365169591|FG010|Overall Study|Withdrawal by Subject|3|||
105868283|NCT03284723|365169592|FG011|Overall Study|Withdrawal by Subject|1|||
105868284|NCT03284723|365169581|FG000|Overall Study|Other|1|||
105868285|NCT03284723|365169582|FG001|Overall Study|Other|0|||
105868286|NCT03284723|365169583|FG002|Overall Study|Other|1|||
105868287|NCT03284723|365169584|FG003|Overall Study|Other|0|||
105868288|NCT03284723|365169585|FG004|Overall Study|Other|1|||
105868289|NCT03284723|365169586|FG005|Overall Study|Other|0|||
105868290|NCT03284723|365169587|FG006|Overall Study|Other|0|||
105868291|NCT03284723|365169588|FG007|Overall Study|Other|0|||
105868292|NCT03284723|365169589|FG008|Overall Study|Other|0|||
105868293|NCT03284723|365169590|FG009|Overall Study|Other|0|||
105868294|NCT03284723|365169591|FG010|Overall Study|Other|1|||
105868295|NCT03284723|365169592|FG011|Overall Study|Other|0|||
105868296|NCT03284723|365169581|FG000|Overall Study|Adverse Event|0|||
105868297|NCT03284723|365169582|FG001|Overall Study|Adverse Event|0|||
105868298|NCT03284723|365169583|FG002|Overall Study|Adverse Event|0|||
105868299|NCT03284723|365169584|FG003|Overall Study|Adverse Event|0|||
105868300|NCT03284723|365169585|FG004|Overall Study|Adverse Event|0|||
105868301|NCT03284723|365169586|FG005|Overall Study|Adverse Event|0|||
105868302|NCT03284723|365169587|FG006|Overall Study|Adverse Event|0|||
105868303|NCT03284723|365169588|FG007|Overall Study|Adverse Event|0|||
105868304|NCT03284723|365169589|FG008|Overall Study|Adverse Event|1|||
105868305|NCT03284723|365169590|FG009|Overall Study|Adverse Event|0|||
105868306|NCT03284723|365169591|FG010|Overall Study|Adverse Event|0|||
105868307|NCT03284723|365169592|FG011|Overall Study|Adverse Event|0|||
105868308|NCT03022084|365169595|FG000|Overall Study|Lost to Follow-up|2|||
105868309|NCT03022084|365169596|FG001|Overall Study|Lost to Follow-up|3|||
105868310|NCT01762800|365169597|FG000|Overall Study|Adverse Event|8|||
105868311|NCT01762800|365169598|FG001|Overall Study|Adverse Event|13|||
105868312|NCT01762800|365169597|FG000|Overall Study|Lack of Efficacy|3|||
105868313|NCT01762800|365169598|FG001|Overall Study|Lack of Efficacy|2|||
105868314|NCT01762800|365169597|FG000|Overall Study|Study Closed/Terminated|0|||
105868315|NCT01762800|365169598|FG001|Overall Study|Study Closed/Terminated|1|||
105868316|NCT01762800|365169597|FG000|Overall Study|Physician Decision|1|||
105868317|NCT01762800|365169598|FG001|Overall Study|Physician Decision|1|||
105868318|NCT01762800|365169597|FG000|Overall Study|Withdrawal by Subject|7|||
105868319|NCT01762800|365169598|FG001|Overall Study|Withdrawal by Subject|4|||
105868320|NCT05377749|365169599|FG000|3 Weeks|Lost to Follow-up|2|||
105868321|NCT05377749|365169600|FG001|3 Weeks|Lost to Follow-up|4|||
105868322|NCT05377749|365169599|FG000|3 Weeks|Withdrawal by Subject|1|||
105868323|NCT05377749|365169600|FG001|3 Weeks|Withdrawal by Subject|1|||
105868324|NCT01383707|365169601|FG000|Overall Study|Consent withdrawal|6|||
105868325|NCT01383707|365169601|FG000|Overall Study|Death|19|||
105868326|NCT01383707|365169601|FG000|Overall Study|Other|8|||
105868327|NCT01383707|365169601|FG000|Overall Study|Sponsor's decision|2|||
105868328|NCT01383707|365169601|FG000|Overall Study|Adverse Event|14|||
105868329|NCT01383707|365169601|FG000|Overall Study|Progressive disease|23|||
105868330|NCT01625988|365169609|FG000|Overall Study|Lost to Follow-up|5|||
105868331|NCT01625988|365169610|FG001|Overall Study|Lost to Follow-up|6|||
105868332|NCT01625988|365169609|FG000|Overall Study|Withdrawal by Subject|8|||
105868333|NCT01625988|365169610|FG001|Overall Study|Withdrawal by Subject|3|||
105868334|NCT01625988|365169609|FG000|Overall Study|Adverse Event|0|||
105868335|NCT01625988|365169610|FG001|Overall Study|Adverse Event|1|||
105868336|NCT01625988|365169609|FG000|Overall Study|Lack of Efficacy|0|||
105868337|NCT01625988|365169610|FG001|Overall Study|Lack of Efficacy|1|||
105868338|NCT01625988|365169609|FG000|Overall Study|Randomized Inappropriately|1|||
105868339|NCT01625988|365169610|FG001|Overall Study|Randomized Inappropriately|0|||
105868340|NCT01625988|365169609|FG000|Overall Study|Protocol Violation|0|||
105868341|NCT01625988|365169610|FG001|Overall Study|Protocol Violation|2|||
105868342|NCT01427608|365169611|FG000|Overall Study|Death|1|||
105868343|NCT01427608|365169612|FG001|Overall Study|Death|0|||
105868344|NCT01427608|365169611|FG000|Overall Study|Withdrawal by Subject|7|||
105868345|NCT01427608|365169612|FG001|Overall Study|Withdrawal by Subject|3|||
105868346|NCT01427608|365169611|FG000|Overall Study|Relapsed-all cause|13|||
105868347|NCT01427608|365169612|FG001|Overall Study|Relapsed-all cause|34|||
105868348|NCT01427608|365169611|FG000|Overall Study|Events not attributed to study meds|0|||
105868349|NCT01427608|365169612|FG001|Overall Study|Events not attributed to study meds|1|||
105868350|NCT00661193|365169613|FG000|Overall Study|Adverse Event|2|||
105868351|NCT00661193|365169614|FG001|Overall Study|Adverse Event|1|||
105868352|NCT00661193|365169613|FG000|Overall Study|Withdrawal by Subject|3|||
105868353|NCT00661193|365169614|FG001|Overall Study|Withdrawal by Subject|1|||
105868354|NCT00661193|365169613|FG000|Overall Study|Progression|27|||
105868355|NCT00661193|365169614|FG001|Overall Study|Progression|24|||
105868356|NCT00661193|365169613|FG000|Overall Study|Not protocol specified|1|||
105868357|NCT00661193|365169614|FG001|Overall Study|Not protocol specified|0|||
105868358|NCT00398866|365169615|FG000|Overall Study|Adverse Event|1|||
105868359|NCT00398866|365169616|FG001|Overall Study|Adverse Event|0|||
105868360|NCT00398866|365169617|FG002|Overall Study|Adverse Event|0|||
105868361|NCT00398866|365169615|FG000|Overall Study|Lack of Efficacy|0|||
105868362|NCT00398866|365169616|FG001|Overall Study|Lack of Efficacy|0|||
105868363|NCT00398866|365169617|FG002|Overall Study|Lack of Efficacy|1|||
105868364|NCT00398866|365169615|FG000|Overall Study|Lost to Follow-up|7|||
105868365|NCT00398866|365169616|FG001|Overall Study|Lost to Follow-up|6|||
105868366|NCT00398866|365169617|FG002|Overall Study|Lost to Follow-up|4|||
105868367|NCT00398866|365169615|FG000|Overall Study|Withdrawal by Subject|5|||
105868368|NCT00398866|365169616|FG001|Overall Study|Withdrawal by Subject|1|||
105868369|NCT00398866|365169617|FG002|Overall Study|Withdrawal by Subject|2|||
105868370|NCT00398866|365169615|FG000|Overall Study|Unable to complete requirements of study|1|||
105868371|NCT00398866|365169616|FG001|Overall Study|Unable to complete requirements of study|1|||
105868372|NCT00398866|365169617|FG002|Overall Study|Unable to complete requirements of study|1|||
105868373|NCT03126435|365169618|FG000|Overall Study|Death|90|||
105868374|NCT03126435|365169619|FG001|Overall Study|Death|84|||
105868375|NCT03126435|365169618|FG000|Overall Study|Lost to Follow-up|4|||
105868376|NCT03126435|365169619|FG001|Overall Study|Lost to Follow-up|3|||
105868377|NCT03126435|365169618|FG000|Overall Study|Physician Decision|0|||
105868378|NCT03126435|365169619|FG001|Overall Study|Physician Decision|1|||
105868379|NCT03126435|365169618|FG000|Overall Study|Withdrawal by Subject|6|||
105868380|NCT03126435|365169619|FG001|Overall Study|Withdrawal by Subject|12|||
105868381|NCT03126435|365169618|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
105868382|NCT03126435|365169619|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
105868383|NCT02276807|365169620|FG000|Overall Study|Withdrawal by Subject|8|||
105868384|NCT02276807|365169621|FG001|Overall Study|Withdrawal by Subject|7|||
105868385|NCT02276807|365169620|FG000|Overall Study|Lost to Follow-up|10|||
105868386|NCT02276807|365169621|FG001|Overall Study|Lost to Follow-up|10|||
105868387|NCT00445432|365169623|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
105868388|NCT00445432|365169624|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
105868389|NCT00445432|365169625|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
105868390|NCT00445432|365169626|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
105868391|NCT00445432|365169623|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
105868392|NCT00445432|365169624|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
105868393|NCT00445432|365169625|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
105868394|NCT00445432|365169626|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
105868395|NCT00445432|365169623|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
105868396|NCT00445432|365169624|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
105868397|NCT00445432|365169625|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
105868398|NCT00445432|365169626|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
105868399|NCT00445432|365169623|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
105868400|NCT00445432|365169624|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
105868401|NCT00445432|365169625|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
105868402|NCT00445432|365169626|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
105868403|NCT00445432|365169623|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
105868404|NCT00445432|365169624|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
105868405|NCT00445432|365169625|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
105868406|NCT00445432|365169626|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
105868407|NCT00445432|365169623|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
105868408|NCT00445432|365169624|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
105868409|NCT00445432|365169625|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
105868410|NCT00445432|365169626|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
105868411|NCT00445432|365169623|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
105868412|NCT00445432|365169624|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
105868413|NCT00445432|365169625|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
105868414|NCT00445432|365169626|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
105868415|NCT00524420|365169627|FG000|Overall Study|Lack of Efficacy|1|||
105868416|NCT00524420|365169628|FG001|Overall Study|Lack of Efficacy|0|||
105868417|NCT00577863|365169629|FG000|Overall Study|Adverse Event|4|||
105868418|NCT00577863|365169630|FG001|Overall Study|Adverse Event|2|||
105868419|NCT00577863|365169629|FG000|Overall Study|Death|1|||
105868420|NCT00577863|365169630|FG001|Overall Study|Death|0|||
105868421|NCT00577863|365169629|FG000|Overall Study|Lost to Follow-up|2|||
105868422|NCT00577863|365169630|FG001|Overall Study|Lost to Follow-up|2|||
105868423|NCT00577863|365169629|FG000|Overall Study|Entry Criteria Exclusion|1|||
105868424|NCT00577863|365169630|FG001|Overall Study|Entry Criteria Exclusion|0|||
105868425|NCT00577863|365169629|FG000|Overall Study|Withdrawal by Subject|0|||
105868426|NCT00577863|365169630|FG001|Overall Study|Withdrawal by Subject|2|||
105868427|NCT00577863|365169629|FG000|Overall Study|Sponsor Decision|2|||
105868428|NCT00577863|365169630|FG001|Overall Study|Sponsor Decision|7|||
105868429|NCT00577863|365169629|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
105868430|NCT00577863|365169630|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
105868431|NCT01090414|365169631|FG000|Study 101-99|Progressive Disease|28|||
105868432|NCT01090414|365169632|FG001|Study 101-99|Progressive Disease|48|||
105868433|NCT01090414|365169633|FG002|Study 101-99|Progressive Disease|10|||
105868434|NCT01090414|365169634|FG003|Study 101-99|Progressive Disease|4|||
105868435|NCT01090414|365169631|FG000|Study 101-99|Adverse Event|10|||
105868436|NCT01090414|365169632|FG001|Study 101-99|Adverse Event|28|||
105868437|NCT01090414|365169633|FG002|Study 101-99|Adverse Event|18|||
105868438|NCT01090414|365169634|FG003|Study 101-99|Adverse Event|0|||
105868439|NCT01090414|365169631|FG000|Study 101-99|Investigator Request|1|||
105868440|NCT01090414|365169632|FG001|Study 101-99|Investigator Request|11|||
105868441|NCT01090414|365169633|FG002|Study 101-99|Investigator Request|4|||
105868442|NCT01090414|365169634|FG003|Study 101-99|Investigator Request|0|||
105868443|NCT01090414|365169631|FG000|Study 101-99|Death|3|||
105868444|NCT01090414|365169632|FG001|Study 101-99|Death|8|||
105868445|NCT01090414|365169633|FG002|Study 101-99|Death|1|||
105868446|NCT01090414|365169634|FG003|Study 101-99|Death|0|||
105868447|NCT01090414|365169631|FG000|Study 101-99|Sponsor Discontinued Study|0|||
105868448|NCT01090414|365169632|FG001|Study 101-99|Sponsor Discontinued Study|7|||
105868449|NCT01090414|365169633|FG002|Study 101-99|Sponsor Discontinued Study|5|||
105868450|NCT01090414|365169634|FG003|Study 101-99|Sponsor Discontinued Study|0|||
105868451|NCT01090414|365169631|FG000|Study 101-99|Other (Unknown Reasons)|3|||
105868452|NCT01090414|365169632|FG001|Study 101-99|Other (Unknown Reasons)|3|||
105868453|NCT01090414|365169633|FG002|Study 101-99|Other (Unknown Reasons)|0|||
105868454|NCT01090414|365169634|FG003|Study 101-99|Other (Unknown Reasons)|0|||
105868455|NCT01090414|365169631|FG000|Study 101-99|Withdrew Consent|0|||
105868456|NCT01090414|365169632|FG001|Study 101-99|Withdrew Consent|2|||
105868457|NCT01090414|365169633|FG002|Study 101-99|Withdrew Consent|3|||
105868458|NCT01090414|365169634|FG003|Study 101-99|Withdrew Consent|1|||
105868459|NCT01090414|365169631|FG000|Study 101-99|Participant Request|3|||
105868460|NCT01090414|365169632|FG001|Study 101-99|Participant Request|1|||
105868461|NCT01090414|365169633|FG002|Study 101-99|Participant Request|0|||
105868462|NCT01090414|365169634|FG003|Study 101-99|Participant Request|0|||
105868463|NCT03639779|365169639|FG000|Overall Study|Lost to Follow-up|1|||
105868464|NCT02413229|365169642|FG000|Overall Study|Adverse Event|0|||
105868465|NCT02413229|365169643|FG001|Overall Study|Adverse Event|0|||
105868466|NCT02413229|365169644|FG002|Overall Study|Adverse Event|0|||
105868467|NCT02413229|365169645|FG003|Overall Study|Adverse Event|1|||
105868468|NCT02413229|365169646|FG004|Overall Study|Adverse Event|0|||
105868469|NCT02413229|365169647|FG005|Overall Study|Adverse Event|0|||
105868470|NCT02413229|365169648|FG006|Overall Study|Adverse Event|0|||
105868471|NCT02413229|365169649|FG007|Overall Study|Adverse Event|1|||
105868472|NCT02413229|365169642|FG000|Overall Study|Lost to Follow-up|0|||
105868473|NCT02413229|365169643|FG001|Overall Study|Lost to Follow-up|0|||
105868474|NCT02413229|365169644|FG002|Overall Study|Lost to Follow-up|1|||
105868475|NCT02413229|365169645|FG003|Overall Study|Lost to Follow-up|0|||
105868476|NCT02413229|365169646|FG004|Overall Study|Lost to Follow-up|2|||
105868477|NCT02413229|365169647|FG005|Overall Study|Lost to Follow-up|0|||
105868478|NCT02413229|365169648|FG006|Overall Study|Lost to Follow-up|0|||
105868479|NCT02413229|365169649|FG007|Overall Study|Lost to Follow-up|0|||
105868480|NCT02413229|365169642|FG000|Overall Study|Withdrawal by Subject|1|||
105868481|NCT02413229|365169643|FG001|Overall Study|Withdrawal by Subject|1|||
105868482|NCT02413229|365169644|FG002|Overall Study|Withdrawal by Subject|0|||
105868483|NCT02413229|365169645|FG003|Overall Study|Withdrawal by Subject|0|||
105868484|NCT02413229|365169646|FG004|Overall Study|Withdrawal by Subject|1|||
105868485|NCT02413229|365169647|FG005|Overall Study|Withdrawal by Subject|0|||
105868486|NCT02413229|365169648|FG006|Overall Study|Withdrawal by Subject|0|||
105868487|NCT02413229|365169649|FG007|Overall Study|Withdrawal by Subject|2|||
105868488|NCT02413229|365169642|FG000|Overall Study|Progressive Disease|0|||
105868489|NCT02413229|365169643|FG001|Overall Study|Progressive Disease|0|||
105868490|NCT02413229|365169644|FG002|Overall Study|Progressive Disease|0|||
105868491|NCT02413229|365169645|FG003|Overall Study|Progressive Disease|0|||
105868492|NCT02413229|365169646|FG004|Overall Study|Progressive Disease|0|||
105868493|NCT02413229|365169647|FG005|Overall Study|Progressive Disease|0|||
105868494|NCT02413229|365169648|FG006|Overall Study|Progressive Disease|0|||
105868495|NCT02413229|365169649|FG007|Overall Study|Progressive Disease|1|||
105868496|NCT00470535|365169650|FG000|Overall Study|Disease Progression|13|||
105868497|NCT00470535|365169650|FG000|Overall Study|Withdrawal by Subject|1|||
105868498|NCT00470535|365169650|FG000|Overall Study|Adverse Event|1|||
105868499|NCT00470535|365169650|FG000|Overall Study|Death|1|||
105868500|NCT00470535|365169650|FG000|Overall Study|Other|2|||
105868501|NCT01026194|365169651|FG000|Period 1：Double Blind Period|Adverse Event|2|||
105868502|NCT01026194|365169652|FG001|Period 1：Double Blind Period|Adverse Event|1|||
105868503|NCT01026194|365169651|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
105868504|NCT01026194|365169652|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
105868505|NCT01026194|365169651|FG000|Period 1：Double Blind Period|Physician Decision|0|||
105868506|NCT01026194|365169652|FG001|Period 1：Double Blind Period|Physician Decision|4|||
105868507|NCT01026194|365169651|FG000|Period 2：Open-label Period|Adverse Event|4|||
105868508|NCT01026194|365169652|FG001|Period 2：Open-label Period|Adverse Event|5|||
105868509|NCT01026194|365169651|FG000|Period 2：Open-label Period|Physician Decision|3|||
105868510|NCT01026194|365169652|FG001|Period 2：Open-label Period|Physician Decision|1|||
105868511|NCT01026194|365169651|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
105868512|NCT01026194|365169652|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
105868513|NCT05219448|365169653|FG000|Overall Study|Lost to Follow-up|9|||
105868514|NCT05219448|365169654|FG001|Overall Study|Lost to Follow-up|0|||
105868515|NCT02955212|365169657|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
105868516|NCT02955212|365169658|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
105868517|NCT02955212|365169657|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
105868518|NCT02955212|365169658|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
105868519|NCT02955212|365169657|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
105868520|NCT02955212|365169658|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
105868521|NCT02955212|365169657|FG000|Period 1: Double-blind Treatment Period|Other|3|||
105868522|NCT02955212|365169658|FG001|Period 1: Double-blind Treatment Period|Other|2|||
105868523|NCT02955212|365169657|FG000|Period 2: Open-label Extension|Adverse Event|11|||
105868524|NCT02955212|365169658|FG001|Period 2: Open-label Extension|Adverse Event|7|||
105868525|NCT02955212|365169657|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
105868526|NCT02955212|365169658|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
105868527|NCT02955212|365169657|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
105868528|NCT02955212|365169658|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
105868529|NCT02955212|365169657|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
105868530|NCT02955212|365169658|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
105868531|NCT02955212|365169657|FG000|Period 2: Open-label Extension|Other|2|||
105868532|NCT02955212|365169658|FG001|Period 2: Open-label Extension|Other|4|||
105868533|NCT02287922|365169659|FG000|Overall Study|Adverse Event|1|||
105868534|NCT02287922|365169660|FG001|Overall Study|Adverse Event|1|||
105868535|NCT02287922|365169661|FG002|Overall Study|Adverse Event|3|||
105868536|NCT02287922|365169662|FG003|Overall Study|Adverse Event|4|||
105868537|NCT02287922|365169659|FG000|Overall Study|Withdrawal by Subject|1|||
105868538|NCT02287922|365169660|FG001|Overall Study|Withdrawal by Subject|1|||
105868539|NCT02287922|365169661|FG002|Overall Study|Withdrawal by Subject|1|||
105868540|NCT02287922|365169662|FG003|Overall Study|Withdrawal by Subject|2|||
105868541|NCT02287922|365169659|FG000|Overall Study|Lost to Follow-up|0|||
105868542|NCT02287922|365169660|FG001|Overall Study|Lost to Follow-up|0|||
105868543|NCT02287922|365169661|FG002|Overall Study|Lost to Follow-up|1|||
105868544|NCT02287922|365169662|FG003|Overall Study|Lost to Follow-up|0|||
105868545|NCT02287922|365169659|FG000|Overall Study|Sponsor's decision|0|||
105868546|NCT02287922|365169660|FG001|Overall Study|Sponsor's decision|0|||
105868547|NCT02287922|365169661|FG002|Overall Study|Sponsor's decision|0|||
105868548|NCT02287922|365169662|FG003|Overall Study|Sponsor's decision|1|||
105868549|NCT02287922|365169659|FG000|Overall Study|Other|1|||
105868550|NCT02287922|365169660|FG001|Overall Study|Other|0|||
105868551|NCT02287922|365169661|FG002|Overall Study|Other|2|||
105868552|NCT02287922|365169662|FG003|Overall Study|Other|0|||
105868553|NCT04428034|365169663|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
105868554|NCT00560391|365169665|FG000|Overall Study|Still on treatment|0|||
105868555|NCT00560391|365169666|FG001|Overall Study|Still on treatment|0|||
105868556|NCT00560391|365169667|FG002|Overall Study|Still on treatment|0|||
105868557|NCT00560391|365169668|FG003|Overall Study|Still on treatment|1|||
105868558|NCT00560391|365169669|FG004|Overall Study|Still on treatment|2|||
105868559|NCT04176250|365169670|FG000|Overall Study|Adverse Event|0|||
105868560|NCT04176250|365169671|FG001|Overall Study|Adverse Event|1|||
105868561|NCT04176250|365169672|FG002|Overall Study|Adverse Event|0|||
105868562|NCT04176250|365169673|FG003|Overall Study|Adverse Event|1|||
105868563|NCT04176250|365169674|FG004|Overall Study|Adverse Event|0|||
105868564|NCT04176250|365169675|FG005|Overall Study|Adverse Event|1|||
105868565|NCT04176250|365169670|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
105868566|NCT04176250|365169671|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
105987217|NCT00812565|365612307|FG001|Overall Study|Did Not Come to Study Visit|0|||
105987218|NCT00812565|365612308|FG002|Overall Study|Did Not Come to Study Visit|0|||
105868567|NCT04176250|365169672|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
105868568|NCT04176250|365169673|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
105987219|NCT00812565|365612309|FG003|Overall Study|Did Not Come to Study Visit|0|||
105987220|NCT00812565|365612310|FG004|Overall Study|Did Not Come to Study Visit|0|||
105987221|NCT00812565|365612311|FG005|Overall Study|Did Not Come to Study Visit|0|||
105987222|NCT00812565|365612312|FG006|Overall Study|Did Not Come to Study Visit|0|||
105987223|NCT00812565|365612313|FG007|Overall Study|Did Not Come to Study Visit|0|||
105868569|NCT04176250|365169674|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
105987224|NCT00812565|365612306|FG000|Overall Study|Withdrawal of Consent|1|||
105868570|NCT04176250|365169675|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
105868571|NCT04176250|365169670|FG000|Overall Study|Withdrawal by Subject|0|||
105868572|NCT04176250|365169671|FG001|Overall Study|Withdrawal by Subject|0|||
105868573|NCT04176250|365169672|FG002|Overall Study|Withdrawal by Subject|0|||
105868574|NCT04176250|365169673|FG003|Overall Study|Withdrawal by Subject|0|||
105868575|NCT04176250|365169674|FG004|Overall Study|Withdrawal by Subject|0|||
105868576|NCT04176250|365169675|FG005|Overall Study|Withdrawal by Subject|1|||
105868577|NCT04176250|365169670|FG000|Overall Study|Randomized in error|0|||
105868578|NCT04176250|365169671|FG001|Overall Study|Randomized in error|0|||
105868579|NCT04176250|365169672|FG002|Overall Study|Randomized in error|0|||
105868580|NCT04176250|365169673|FG003|Overall Study|Randomized in error|0|||
105868581|NCT04176250|365169674|FG004|Overall Study|Randomized in error|1|||
105868582|NCT04176250|365169675|FG005|Overall Study|Randomized in error|0|||
105868583|NCT03519087|365169684|FG000|Clinic Evaluation|Physician Decision|15|||
105868584|NCT03519087|365169685|FG001|Clinic Evaluation|Physician Decision|18|||
105868585|NCT03519087|365169686|FG002|Clinic Evaluation|Physician Decision|0|||
105868586|NCT03519087|365169687|FG003|Clinic Evaluation|Physician Decision|0|||
105868587|NCT03519087|365169688|FG004|Clinic Evaluation|Physician Decision|0|||
105868588|NCT03519087|365169684|FG000|Clinic Evaluation|Protocol Violation|1|||
105868589|NCT03519087|365169685|FG001|Clinic Evaluation|Protocol Violation|0|||
105868590|NCT03519087|365169686|FG002|Clinic Evaluation|Protocol Violation|0|||
105868591|NCT03519087|365169687|FG003|Clinic Evaluation|Protocol Violation|0|||
105868592|NCT03519087|365169688|FG004|Clinic Evaluation|Protocol Violation|0|||
105868593|NCT03519087|365169684|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
105868594|NCT03519087|365169685|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
105868595|NCT03519087|365169686|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
105868596|NCT03519087|365169687|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
105987225|NCT00812565|365612307|FG001|Overall Study|Withdrawal of Consent|0|||
105987226|NCT00812565|365612308|FG002|Overall Study|Withdrawal of Consent|0|||
105987227|NCT00812565|365612309|FG003|Overall Study|Withdrawal of Consent|0|||
105868597|NCT03519087|365169688|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
105868598|NCT03519087|365169684|FG000|Re-randomization for Treatment|Not appropriate|2|||
105868599|NCT03519087|365169685|FG001|Re-randomization for Treatment|Not appropriate|3|||
105868600|NCT03519087|365169686|FG002|Re-randomization for Treatment|Not appropriate|0|||
105868601|NCT03519087|365169687|FG003|Re-randomization for Treatment|Not appropriate|0|||
105868602|NCT03519087|365169688|FG004|Re-randomization for Treatment|Not appropriate|0|||
105987228|NCT00812565|365612310|FG004|Overall Study|Withdrawal of Consent|1|||
105987229|NCT00812565|365612311|FG005|Overall Study|Withdrawal of Consent|0|||
105987230|NCT00812565|365612312|FG006|Overall Study|Withdrawal of Consent|0|||
105987231|NCT00812565|365612313|FG007|Overall Study|Withdrawal of Consent|0|||
105987232|NCT00812565|365612306|FG000|Overall Study|Reason Not Specified|0|||
105987233|NCT00812565|365612307|FG001|Overall Study|Reason Not Specified|0|||
105987234|NCT00812565|365612308|FG002|Overall Study|Reason Not Specified|0|||
105987235|NCT00812565|365612309|FG003|Overall Study|Reason Not Specified|0|||
105987236|NCT00812565|365612310|FG004|Overall Study|Reason Not Specified|0|||
105987237|NCT00812565|365612311|FG005|Overall Study|Reason Not Specified|1|||
105987238|NCT00812565|365612312|FG006|Overall Study|Reason Not Specified|0|||
105987239|NCT00812565|365612313|FG007|Overall Study|Reason Not Specified|0|||
105987240|NCT00422383|365612314|FG000|Overall Study|Adverse Event|5|||
105987241|NCT00422383|365612315|FG001|Overall Study|Adverse Event|3|||
105987242|NCT00422383|365612316|FG002|Overall Study|Adverse Event|1|||
105987243|NCT00422383|365612317|FG003|Overall Study|Adverse Event|1|||
105868603|NCT03519087|365169684|FG000|Laboratory Testing|Lost to Follow-up|0|||
105868604|NCT03519087|365169685|FG001|Laboratory Testing|Lost to Follow-up|0|||
105987244|NCT00422383|365612318|FG004|Overall Study|Adverse Event|0|||
105868605|NCT03519087|365169686|FG002|Laboratory Testing|Lost to Follow-up|2|||
105868606|NCT03519087|365169687|FG003|Laboratory Testing|Lost to Follow-up|3|||
105987245|NCT00422383|365612314|FG000|Overall Study|Lack of Efficacy|4|||
105987246|NCT00422383|365612315|FG001|Overall Study|Lack of Efficacy|4|||
105987247|NCT00422383|365612316|FG002|Overall Study|Lack of Efficacy|2|||
105987248|NCT00422383|365612317|FG003|Overall Study|Lack of Efficacy|1|||
105987249|NCT00422383|365612318|FG004|Overall Study|Lack of Efficacy|1|||
105987250|NCT00422383|365612314|FG000|Overall Study|Lost to Follow-up|0|||
105987251|NCT00422383|365612315|FG001|Overall Study|Lost to Follow-up|1|||
105987252|NCT00422383|365612316|FG002|Overall Study|Lost to Follow-up|0|||
105987253|NCT00422383|365612317|FG003|Overall Study|Lost to Follow-up|0|||
105987254|NCT00422383|365612318|FG004|Overall Study|Lost to Follow-up|1|||
105987255|NCT00422383|365612314|FG000|Overall Study|Protocol Violation|1|||
105987256|NCT00422383|365612315|FG001|Overall Study|Protocol Violation|1|||
105987257|NCT00422383|365612316|FG002|Overall Study|Protocol Violation|1|||
105987258|NCT00422383|365612317|FG003|Overall Study|Protocol Violation|0|||
105987259|NCT00422383|365612318|FG004|Overall Study|Protocol Violation|0|||
105987260|NCT00422383|365612314|FG000|Overall Study|Withdrawal by Subject|5|||
105987261|NCT00422383|365612315|FG001|Overall Study|Withdrawal by Subject|5|||
105987262|NCT00422383|365612316|FG002|Overall Study|Withdrawal by Subject|0|||
105987263|NCT00422383|365612317|FG003|Overall Study|Withdrawal by Subject|0|||
105987264|NCT00422383|365612318|FG004|Overall Study|Withdrawal by Subject|1|||
105987265|NCT03755661|365612323|FG000|Overall Study|Lost to Follow-up|1|||
105987266|NCT03755661|365612324|FG001|Overall Study|Lost to Follow-up|0|||
105987267|NCT02277119|365612325|FG000|Overall Study|Lack of Efficacy|1|||
105987268|NCT02277119|365612326|FG001|Overall Study|Lack of Efficacy|1|||
105987269|NCT02277119|365612327|FG002|Overall Study|Lack of Efficacy|1|||
105987270|NCT02277119|365612325|FG000|Overall Study|Protocol Violation|2|||
105987271|NCT02277119|365612326|FG001|Overall Study|Protocol Violation|3|||
105987272|NCT02277119|365612327|FG002|Overall Study|Protocol Violation|7|||
105987273|NCT04699461|365612328|FG000|Overall Study|Withdrawal by Subject|1|||
105987274|NCT04699461|365612329|FG001|Overall Study|Withdrawal by Subject|0|||
105987275|NCT04699461|365612328|FG000|Overall Study|Study termination by sponsor|2|||
105987276|NCT04699461|365612329|FG001|Overall Study|Study termination by sponsor|1|||
105987277|NCT04699461|365612328|FG000|Overall Study|Death|1|||
105987278|NCT04699461|365612329|FG001|Overall Study|Death|0|||
105987279|NCT04699461|365612328|FG000|Overall Study|Radiographic progression|0|||
105987280|NCT04699461|365612329|FG001|Overall Study|Radiographic progression|1|||
105987281|NCT01793883|365612330|FG000|Overall Study|Withdrawal by Subject|3|||
105987282|NCT01793883|365612331|FG001|Overall Study|Withdrawal by Subject|7|||
105987283|NCT01793883|365612332|FG002|Overall Study|Withdrawal by Subject|3|||
105987284|NCT01793883|365612330|FG000|Overall Study|Subject noncompliance|0|||
105987285|NCT01793883|365612331|FG001|Overall Study|Subject noncompliance|1|||
105987286|NCT01793883|365612332|FG002|Overall Study|Subject noncompliance|1|||
105987287|NCT01793883|365612330|FG000|Overall Study|Lost to Follow-up|5|||
105987288|NCT01793883|365612331|FG001|Overall Study|Lost to Follow-up|1|||
105987289|NCT01793883|365612332|FG002|Overall Study|Lost to Follow-up|3|||
105987290|NCT01793883|365612330|FG000|Overall Study|Randomized in error|1|||
105987291|NCT01793883|365612331|FG001|Overall Study|Randomized in error|0|||
105987292|NCT01793883|365612332|FG002|Overall Study|Randomized in error|0|||
105987293|NCT01793883|365612330|FG000|Overall Study|Unable to complete spriometry|1|||
105987294|NCT01793883|365612331|FG001|Overall Study|Unable to complete spriometry|0|||
105987295|NCT01793883|365612332|FG002|Overall Study|Unable to complete spriometry|0|||
105987296|NCT01793883|365612330|FG000|Overall Study|Unable to complete measurements|1|||
105987297|NCT01793883|365612331|FG001|Overall Study|Unable to complete measurements|0|||
105987298|NCT01793883|365612332|FG002|Overall Study|Unable to complete measurements|0|||
105987299|NCT01793883|365612330|FG000|Overall Study|Met exclusion criteria|1|||
105987300|NCT01793883|365612331|FG001|Overall Study|Met exclusion criteria|0|||
105987301|NCT01793883|365612332|FG002|Overall Study|Met exclusion criteria|0|||
105987302|NCT01793883|365612330|FG000|Overall Study|Dosing error|0|||
105987303|NCT01793883|365612331|FG001|Overall Study|Dosing error|1|||
105987304|NCT01793883|365612332|FG002|Overall Study|Dosing error|0|||
105987305|NCT01793883|365612330|FG000|Overall Study|Respiratory distress during spirometry|0|||
105987306|NCT01793883|365612331|FG001|Overall Study|Respiratory distress during spirometry|0|||
105987307|NCT01793883|365612332|FG002|Overall Study|Respiratory distress during spirometry|1|||
105987308|NCT02478255|365612333|FG000|Overall Study|Physician Decision|6|||
105987309|NCT02478255|365612334|FG001|Overall Study|Physician Decision|0|||
105987310|NCT02478255|365612333|FG000|Overall Study|Withdrawal by Subject|2|||
105987311|NCT02478255|365612334|FG001|Overall Study|Withdrawal by Subject|0|||
105987312|NCT03068767|365612340|FG000|Overall Study|Lost to Follow-up|7|||
105987313|NCT03068767|365612341|FG001|Overall Study|Lost to Follow-up|3|||
105987314|NCT03068767|365612340|FG000|Overall Study|Protocol Violation|3|||
105987315|NCT03068767|365612341|FG001|Overall Study|Protocol Violation|0|||
105987316|NCT01730586|365612344|FG000|Overall Study|Progressive Disease|2|||
105987317|NCT01730586|365612344|FG000|Overall Study|Inadequate Trial|8|||
105987318|NCT01730586|365612344|FG000|Overall Study|Adverse Event|2|||
105987319|NCT01730586|365612344|FG000|Overall Study|Hospice|1|||
105987320|NCT02921087|365612345|FG000|Overall Study|Withdrawal by Subject|0|||
105987321|NCT02921087|365612346|FG001|Overall Study|Withdrawal by Subject|1|||
105987322|NCT00687531|365612347|FG000|Overall Study|Did not meet protocol eligibility|104|||
105987323|NCT00687531|365612347|FG000|Overall Study|Adverse Event|5|||
105987324|NCT00687531|365612347|FG000|Overall Study|Lost to Follow-up|26|||
105987325|NCT00852241|365612348|FG000|Overall Study|Physician Decision|18|||
105987326|NCT01216683|365614445|FG000|Induction|Never started treatment|0|||
105987327|NCT01216683|365614446|FG001|Induction|Never started treatment|6|||
105987328|NCT01216683|365614447|FG002|Induction|Never started treatment|3|||
105987329|NCT01216683|365614445|FG000|Induction|Lack of Efficacy|4|||
105987330|NCT01216683|365614446|FG001|Induction|Lack of Efficacy|3|||
105987331|NCT01216683|365614447|FG002|Induction|Lack of Efficacy|7|||
105987332|NCT01216683|365614445|FG000|Induction|Adverse Event|0|||
105987333|NCT01216683|365614446|FG001|Induction|Adverse Event|5|||
105987334|NCT01216683|365614447|FG002|Induction|Adverse Event|5|||
105987335|NCT01216683|365614445|FG000|Induction|Death|0|||
105987336|NCT01216683|365614446|FG001|Induction|Death|0|||
105987337|NCT01216683|365614447|FG002|Induction|Death|2|||
105987338|NCT01216683|365614445|FG000|Induction|Withdrawal by Subject|0|||
105987339|NCT01216683|365614446|FG001|Induction|Withdrawal by Subject|4|||
105987340|NCT01216683|365614447|FG002|Induction|Withdrawal by Subject|2|||
105987341|NCT01216683|365614445|FG000|Induction|Other disease|0|||
105987342|NCT01216683|365614446|FG001|Induction|Other disease|1|||
105987343|NCT01216683|365614447|FG002|Induction|Other disease|2|||
105987344|NCT01216683|365614445|FG000|Continuation|Lack of Efficacy|3|||
105987345|NCT01216683|365614446|FG001|Continuation|Lack of Efficacy|2|||
105987346|NCT01216683|365614447|FG002|Continuation|Lack of Efficacy|7|||
105987347|NCT01216683|365614445|FG000|Continuation|Adverse Event|5|||
105987348|NCT01216683|365614446|FG001|Continuation|Adverse Event|3|||
105987349|NCT01216683|365614447|FG002|Continuation|Adverse Event|16|||
105987350|NCT01216683|365614445|FG000|Continuation|Death|1|||
105987351|NCT01216683|365614446|FG001|Continuation|Death|0|||
105987352|NCT01216683|365614447|FG002|Continuation|Death|2|||
105987353|NCT01216683|365614445|FG000|Continuation|Withdrawal by Subject|4|||
105987354|NCT01216683|365614446|FG001|Continuation|Withdrawal by Subject|5|||
105987355|NCT01216683|365614447|FG002|Continuation|Withdrawal by Subject|9|||
105987356|NCT01216683|365614445|FG000|Continuation|Other diseases|0|||
105987357|NCT01216683|365614446|FG001|Continuation|Other diseases|2|||
105987358|NCT01216683|365614447|FG002|Continuation|Other diseases|1|||
105987359|NCT01216683|365614445|FG000|Continuation|Physician Decision|1|||
105987360|NCT01216683|365614446|FG001|Continuation|Physician Decision|0|||
105987361|NCT01216683|365614447|FG002|Continuation|Physician Decision|1|||
105987362|NCT01216683|365614445|FG000|Continuation|Non-compliance|1|||
105987363|NCT01216683|365614446|FG001|Continuation|Non-compliance|0|||
105987364|NCT01216683|365614447|FG002|Continuation|Non-compliance|1|||
105987365|NCT01216683|365614445|FG000|Continuation|Insurance change|0|||
105987366|NCT01216683|365614446|FG001|Continuation|Insurance change|1|||
105987367|NCT01216683|365614447|FG002|Continuation|Insurance change|0|||
105987368|NCT01216683|365614445|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
105987369|NCT01216683|365614446|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
105987370|NCT01216683|365614447|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
105987371|NCT01216683|365614445|FG000|Continuation|Not reported|0|||
105987372|NCT01216683|365614446|FG001|Continuation|Not reported|0|||
105987373|NCT01216683|365614447|FG002|Continuation|Not reported|1|||
105987374|NCT01216683|365614445|FG000|Continuation|Never started treatment|0|||
105987375|NCT01216683|365614446|FG001|Continuation|Never started treatment|1|||
105987376|NCT01216683|365614447|FG002|Continuation|Never started treatment|5|||
105868607|NCT03519087|365169688|FG004|Laboratory Testing|Lost to Follow-up|6|||
105868608|NCT03519087|365169684|FG000|Laboratory Testing|Protocol Violation|0|||
105987377|NCT03495102|365614448|FG000|Overall Study|Adverse Event|5|||
105987378|NCT03495102|365614449|FG001|Overall Study|Adverse Event|7|||
105868609|NCT03519087|365169685|FG001|Laboratory Testing|Protocol Violation|0|||
105987379|NCT03495102|365614450|FG002|Overall Study|Adverse Event|10|||
105987380|NCT03495102|365614448|FG000|Overall Study|Death|3|||
105868610|NCT03519087|365169686|FG002|Laboratory Testing|Protocol Violation|0|||
105868611|NCT03519087|365169687|FG003|Laboratory Testing|Protocol Violation|1|||
105987381|NCT03495102|365614449|FG001|Overall Study|Death|4|||
105987382|NCT03495102|365614450|FG002|Overall Study|Death|4|||
105987383|NCT03495102|365614448|FG000|Overall Study|Lost to Follow-up|15|||
105987384|NCT03495102|365614449|FG001|Overall Study|Lost to Follow-up|16|||
105987385|NCT03495102|365614450|FG002|Overall Study|Lost to Follow-up|17|||
105987386|NCT03495102|365614448|FG000|Overall Study|Physician Decision|2|||
105868612|NCT03519087|365169688|FG004|Laboratory Testing|Protocol Violation|0|||
105868613|NCT02374346|365169690|FG000|Overall Study|operated or discharged during weekend|48|||
105868614|NCT04807400|365169691|FG000|Overall Study|Adverse Event|2|||
105868615|NCT04807400|365169692|FG001|Overall Study|Adverse Event|3|||
105868616|NCT04807400|365169693|FG002|Overall Study|Adverse Event|3|||
105868617|NCT04807400|365169691|FG000|Overall Study|Death|2|||
105868618|NCT04807400|365169692|FG001|Overall Study|Death|0|||
105868619|NCT04807400|365169693|FG002|Overall Study|Death|0|||
105868620|NCT04807400|365169691|FG000|Overall Study|Lost to Follow-up|8|||
105868621|NCT04807400|365169692|FG001|Overall Study|Lost to Follow-up|6|||
105868622|NCT04807400|365169693|FG002|Overall Study|Lost to Follow-up|6|||
105868623|NCT04807400|365169691|FG000|Overall Study|Non-Compliance With Study Drug|0|||
105868624|NCT04807400|365169692|FG001|Overall Study|Non-Compliance With Study Drug|4|||
105868625|NCT04807400|365169693|FG002|Overall Study|Non-Compliance With Study Drug|1|||
105868626|NCT04807400|365169691|FG000|Overall Study|Participant Decision|20|||
105868627|NCT04807400|365169692|FG001|Overall Study|Participant Decision|19|||
105868628|NCT04807400|365169693|FG002|Overall Study|Participant Decision|26|||
105868629|NCT04807400|365169691|FG000|Overall Study|Physician Decision|0|||
105868630|NCT04807400|365169692|FG001|Overall Study|Physician Decision|1|||
105868631|NCT04807400|365169693|FG002|Overall Study|Physician Decision|0|||
105868632|NCT04807400|365169691|FG000|Overall Study|Protocol Violation|4|||
105868633|NCT04807400|365169692|FG001|Overall Study|Protocol Violation|3|||
105868634|NCT04807400|365169693|FG002|Overall Study|Protocol Violation|7|||
105868635|NCT04807400|365169691|FG000|Overall Study|Withdrawal by Subject|13|||
105868636|NCT04807400|365169692|FG001|Overall Study|Withdrawal by Subject|9|||
105868637|NCT04807400|365169693|FG002|Overall Study|Withdrawal by Subject|20|||
105868638|NCT04807400|365169691|FG000|Overall Study|Mis-randomized|1|||
105868639|NCT04807400|365169692|FG001|Overall Study|Mis-randomized|0|||
105868640|NCT04807400|365169693|FG002|Overall Study|Mis-randomized|0|||
105868641|NCT04194645|365169694|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105987387|NCT03495102|365614449|FG001|Overall Study|Physician Decision|0|||
105987388|NCT03495102|365614450|FG002|Overall Study|Physician Decision|2|||
105868642|NCT04194645|365169695|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868643|NCT04194645|365169696|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868644|NCT04194645|365169697|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868645|NCT04194645|365169698|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868646|NCT04194645|365169699|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868647|NCT04194645|365169700|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868648|NCT04194645|365169701|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868649|NCT04194645|365169702|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868650|NCT04194645|365169703|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
105868651|NCT04194645|365169704|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868652|NCT04194645|365169705|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868653|NCT04194645|365169706|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868654|NCT04194645|365169707|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868655|NCT04194645|365169708|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
105868656|NCT00796757|365169709|FG000|Overall Study|Withdrawal by Subject|14|||
105868657|NCT00796757|365169709|FG000|Overall Study|Death|61|||
105868658|NCT00796757|365169709|FG000|Overall Study|Protocol Violation|1|||
105868659|NCT00796757|365169709|FG000|Overall Study|Participant noncompliance|1|||
105868660|NCT00796757|365169709|FG000|Overall Study|Investigator's decision|2|||
105868661|NCT00796757|365169709|FG000|Overall Study|Other|7|||
105868662|NCT01130493|365169712|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
105868663|NCT01130493|365169713|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
105868664|NCT01130493|365169714|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
105868665|NCT01130493|365169712|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
105868666|NCT01130493|365169713|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
105868667|NCT01130493|365169714|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
105868668|NCT01130493|365169712|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
105868669|NCT01130493|365169713|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
105868670|NCT01130493|365169714|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
105868671|NCT01130493|365169712|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
105868672|NCT01130493|365169713|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
105868673|NCT01130493|365169714|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
105868674|NCT01130493|365169712|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
105868675|NCT01130493|365169713|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
105868676|NCT01130493|365169714|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
105868677|NCT01130493|365169712|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
105868678|NCT01130493|365169713|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
105868679|NCT01130493|365169714|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
105868680|NCT01130493|365169712|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
105868681|NCT01130493|365169713|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
105868682|NCT01130493|365169714|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
105868683|NCT01130493|365169712|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
105868684|NCT01130493|365169713|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
105868685|NCT01130493|365169714|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
105868686|NCT01130493|365169712|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
105868687|NCT01130493|365169713|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
105868688|NCT01130493|365169714|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
105868689|NCT01130493|365169712|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
105868690|NCT01130493|365169713|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
105868691|NCT01130493|365169714|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
105868692|NCT01130493|365169712|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
105868693|NCT01130493|365169713|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
105868694|NCT01130493|365169714|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
105868695|NCT01130493|365169712|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
105868696|NCT01130493|365169713|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
105868697|NCT01130493|365169714|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
105868698|NCT01130493|365169712|FG000|Part 2: OLE|Adverse Event|0|||
105868699|NCT01130493|365169713|FG001|Part 2: OLE|Adverse Event|2|||
105868700|NCT01130493|365169714|FG002|Part 2: OLE|Adverse Event|1|||
105868701|NCT01130493|365169712|FG000|Part 2: OLE|Withdrawal by Subject|0|||
105868702|NCT01130493|365169713|FG001|Part 2: OLE|Withdrawal by Subject|1|||
105868703|NCT01130493|365169714|FG002|Part 2: OLE|Withdrawal by Subject|4|||
105868704|NCT04650204|365169718|FG000|Overall Study|Study was Terminated|2|||
105868705|NCT04650204|365169719|FG001|Overall Study|Study was Terminated|1|||
105868706|NCT01330303|365169720|FG000|Period 1|Adverse Event|1|||
105868707|NCT01330303|365169721|FG001|Period 1|Adverse Event|0|||
105868708|NCT01330303|365169720|FG000|Period 1|Protocol Violation|0|||
105868709|NCT01330303|365169721|FG001|Period 1|Protocol Violation|1|||
105868710|NCT01330303|365169720|FG000|Period 1|Withdrawal by Subject|0|||
105868711|NCT01330303|365169721|FG001|Period 1|Withdrawal by Subject|1|||
105868712|NCT02536846|365169722|FG000|Overall Study|Withdrawal by Subject|1|||
105868713|NCT00951496|365169723|FG000|Overall Study|Did not initiate study treatment|10|||
105868714|NCT00951496|365169724|FG001|Overall Study|Did not initiate study treatment|8|||
105868715|NCT00951496|365169725|FG002|Overall Study|Did not initiate study treatment|13|||
105868716|NCT02593110|365169726|FG000|Overall Study|Withdrawal by Subject|0|||
105868717|NCT02593110|365169727|FG001|Overall Study|Withdrawal by Subject|3|||
105868718|NCT02593110|365169728|FG002|Overall Study|Withdrawal by Subject|3|||
105868719|NCT02593110|365169729|FG003|Overall Study|Withdrawal by Subject|2|||
105868720|NCT02593110|365169726|FG000|Overall Study|Death|0|||
105868721|NCT02593110|365169727|FG001|Overall Study|Death|0|||
105868722|NCT02593110|365169728|FG002|Overall Study|Death|1|||
105868723|NCT02593110|365169729|FG003|Overall Study|Death|0|||
105868724|NCT02123446|365169731|FG000|Washout Period (1 Day)|Physician Decision|1|||
105868725|NCT02123446|365169732|FG001|Washout Period (1 Day)|Physician Decision|0|||
105868726|NCT04604795|365169733|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
105868727|NCT04604795|365169734|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
105868728|NCT04604795|365169735|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105868729|NCT04604795|365169736|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105868730|NCT04604795|365169737|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105868731|NCT04604795|365169738|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105868732|NCT04604795|365169739|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105868733|NCT04604795|365169740|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105868734|NCT04604795|365169741|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105868735|NCT04604795|365169742|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
105868736|NCT04604795|365169733|FG000|Part B: Up to Day 14|Adverse Event|0|||
105868737|NCT04604795|365169734|FG001|Part B: Up to Day 14|Adverse Event|0|||
105868738|NCT04604795|365169735|FG002|Part B: Up to Day 14|Adverse Event|0|||
105868739|NCT04604795|365169736|FG003|Part B: Up to Day 14|Adverse Event|0|||
105868740|NCT04604795|365169737|FG004|Part B: Up to Day 14|Adverse Event|2|||
105868741|NCT04604795|365169738|FG005|Part B: Up to Day 14|Adverse Event|1|||
105868742|NCT04604795|365169739|FG006|Part B: Up to Day 14|Adverse Event|0|||
105868743|NCT04604795|365169740|FG007|Part B: Up to Day 14|Adverse Event|0|||
105868744|NCT04604795|365169741|FG008|Part B: Up to Day 14|Adverse Event|0|||
105868745|NCT04604795|365169742|FG009|Part B: Up to Day 14|Adverse Event|0|||
105868746|NCT04604795|365169733|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868747|NCT04604795|365169734|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868748|NCT04604795|365169735|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868749|NCT04604795|365169736|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868750|NCT04604795|365169737|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868751|NCT04604795|365169738|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868752|NCT04604795|365169739|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868753|NCT04604795|365169740|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868754|NCT04604795|365169741|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
105868755|NCT04604795|365169742|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
105868756|NCT04604795|365169733|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868757|NCT04604795|365169734|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868758|NCT04604795|365169735|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868759|NCT04604795|365169736|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868760|NCT04604795|365169737|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868761|NCT04604795|365169738|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868762|NCT04604795|365169739|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868763|NCT04604795|365169740|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868764|NCT04604795|365169741|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
105868765|NCT04604795|365169742|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
105868766|NCT04604795|365169733|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868767|NCT04604795|365169734|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868768|NCT04604795|365169735|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868769|NCT04604795|365169736|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868770|NCT04604795|365169737|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868771|NCT04604795|365169738|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868772|NCT04604795|365169739|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868773|NCT04604795|365169740|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868774|NCT04604795|365169741|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
105868775|NCT04604795|365169742|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
105868776|NCT04604795|365169733|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868777|NCT04604795|365169734|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868778|NCT04604795|365169735|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868779|NCT04604795|365169736|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868780|NCT04604795|365169737|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868781|NCT04604795|365169738|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868782|NCT04604795|365169739|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868783|NCT04604795|365169740|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868784|NCT04604795|365169741|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
105868785|NCT04604795|365169742|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
105868786|NCT02096744|365169743|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
105868787|NCT02096744|365169744|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
105868788|NCT02096744|365169743|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
105868789|NCT02096744|365169744|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
105868790|NCT02096744|365169743|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
105868791|NCT02096744|365169744|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
105868792|NCT01070953|365169745|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
105868793|NCT01070953|365169745|FG000|Participants for Safety Evaluation|Off-label use|283|||
105868794|NCT01070953|365169745|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
105868795|NCT01070953|365169745|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
105868796|NCT01070953|365169745|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
105868797|NCT01070953|365169745|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
105868798|NCT01070953|365169745|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
105868799|NCT01070953|365169745|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
105868800|NCT01070953|365169745|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
105868801|NCT01070953|365169745|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
105868802|NCT02445963|365169746|FG000|Overall Study|Lost to Follow-up|1|||
105868803|NCT02445963|365169747|FG001|Overall Study|Lost to Follow-up|0|||
105868804|NCT02445963|365169748|FG002|Overall Study|Lost to Follow-up|0|||
105868805|NCT02445963|365169749|FG003|Overall Study|Lost to Follow-up|0|||
105868806|NCT02445963|365169746|FG000|Overall Study|Change in employment|1|||
105868807|NCT02445963|365169747|FG001|Overall Study|Change in employment|0|||
105868808|NCT02445963|365169748|FG002|Overall Study|Change in employment|0|||
105868809|NCT02445963|365169749|FG003|Overall Study|Change in employment|0|||
105868810|NCT02445963|365169746|FG000|Overall Study|Symptoms post-vaccination|0|||
105868811|NCT02445963|365169747|FG001|Overall Study|Symptoms post-vaccination|0|||
105868812|NCT02445963|365169748|FG002|Overall Study|Symptoms post-vaccination|1|||
105868813|NCT02445963|365169749|FG003|Overall Study|Symptoms post-vaccination|0|||
105868814|NCT01893346|365169753|FG000|Overall Study|Lost to Follow-up|0|||
105868815|NCT01893346|365169754|FG001|Overall Study|Lost to Follow-up|1|||
105868816|NCT01893346|365169755|FG002|Overall Study|Lost to Follow-up|0|||
105868817|NCT01893346|365169756|FG003|Overall Study|Lost to Follow-up|0|||
105868818|NCT01893346|365169753|FG000|Overall Study|Protocol Violation|1|||
105868819|NCT01893346|365169754|FG001|Overall Study|Protocol Violation|0|||
105868820|NCT01893346|365169755|FG002|Overall Study|Protocol Violation|0|||
105868821|NCT01893346|365169756|FG003|Overall Study|Protocol Violation|0|||
105868822|NCT01893346|365169753|FG000|Overall Study|Withdrawal by Subject|2|||
105868823|NCT01893346|365169754|FG001|Overall Study|Withdrawal by Subject|0|||
105868824|NCT01893346|365169755|FG002|Overall Study|Withdrawal by Subject|0|||
105868825|NCT01893346|365169756|FG003|Overall Study|Withdrawal by Subject|0|||
105868826|NCT01855828|365169757|FG000|Overall Study|Adverse Event|1|||
105868827|NCT01855828|365169757|FG000|Overall Study|Withdrawal by Subject|1|||
105868828|NCT01954745|365169762|FG000|Overall Study|Radiological Progression|11|||
105868829|NCT01954745|365169762|FG000|Overall Study|Clinical Progression|5|||
105868830|NCT01954745|365169762|FG000|Overall Study|Adverse Event|2|||
105868831|NCT01954745|365169762|FG000|Overall Study|Death|1|||
105868832|NCT00352417|365169766|FG000|Overall Study|Adverse Event|1|||
105868833|NCT00352417|365169767|FG001|Overall Study|Adverse Event|0|||
105868834|NCT00352417|365169766|FG000|Overall Study|Protocol Violation|0|||
105868835|NCT00352417|365169767|FG001|Overall Study|Protocol Violation|2|||
105868836|NCT00352417|365169766|FG000|Overall Study|Withdrawal by Subject|1|||
105868837|NCT00352417|365169767|FG001|Overall Study|Withdrawal by Subject|2|||
105868838|NCT00352417|365169766|FG000|Overall Study|Lost to Follow-up|1|||
105868839|NCT00352417|365169767|FG001|Overall Study|Lost to Follow-up|0|||
105868840|NCT00352417|365169766|FG000|Overall Study|Schedule Change|2|||
105868841|NCT00352417|365169767|FG001|Overall Study|Schedule Change|1|||
105868842|NCT00720382|365169768|FG000|Overall Study|Adverse Event|54|||
105868843|NCT00720382|365169769|FG001|Overall Study|Adverse Event|17|||
105868844|NCT00720382|365169768|FG000|Overall Study|Lack of Efficacy|18|||
105868845|NCT00720382|365169769|FG001|Overall Study|Lack of Efficacy|7|||
105868846|NCT00720382|365169768|FG000|Overall Study|Non-Compliance|15|||
105868847|NCT00720382|365169769|FG001|Overall Study|Non-Compliance|5|||
105868848|NCT00720382|365169768|FG000|Overall Study|Withdrawal by Subject|47|||
105868849|NCT00720382|365169769|FG001|Overall Study|Withdrawal by Subject|11|||
105868850|NCT00720382|365169768|FG000|Overall Study|Lost to Follow-up|28|||
105868851|NCT00720382|365169769|FG001|Overall Study|Lost to Follow-up|14|||
105868852|NCT00720382|365169768|FG000|Overall Study|administrative|14|||
105868853|NCT00720382|365169769|FG001|Overall Study|administrative|5|||
105868854|NCT01059786|365171531|FG000|Overall Study|Did not receive 6 cycles.|0|||
105868855|NCT01059786|365171532|FG001|Overall Study|Did not receive 6 cycles.|0|||
105868856|NCT01059786|365171533|FG002|Overall Study|Did not receive 6 cycles.|4|||
105868857|NCT01059786|365171534|FG003|Overall Study|Did not receive 6 cycles.|1|||
105868858|NCT01059786|365171535|FG004|Overall Study|Did not receive 6 cycles.|0|||
105868859|NCT01277601|365171536|FG000|Overall Study|Adverse Event|5|||
105868860|NCT01277601|365171537|FG001|Overall Study|Adverse Event|3|||
105868861|NCT01277601|365171538|FG002|Overall Study|Adverse Event|0|||
105868862|NCT01277601|365171539|FG003|Overall Study|Adverse Event|7|||
105868863|NCT01277601|365171536|FG000|Overall Study|Withdrawal by Subject|18|||
105868864|NCT01277601|365171537|FG001|Overall Study|Withdrawal by Subject|21|||
105868865|NCT01277601|365171538|FG002|Overall Study|Withdrawal by Subject|8|||
105868866|NCT01277601|365171539|FG003|Overall Study|Withdrawal by Subject|17|||
105868867|NCT01277601|365171536|FG000|Overall Study|Lost to Follow-up|7|||
105868868|NCT01277601|365171537|FG001|Overall Study|Lost to Follow-up|9|||
105868869|NCT01277601|365171538|FG002|Overall Study|Lost to Follow-up|4|||
105868870|NCT01277601|365171539|FG003|Overall Study|Lost to Follow-up|2|||
105868871|NCT01277601|365171536|FG000|Overall Study|Physician Decision|3|||
105868872|NCT01277601|365171537|FG001|Overall Study|Physician Decision|5|||
105868873|NCT01277601|365171538|FG002|Overall Study|Physician Decision|1|||
105868874|NCT01277601|365171539|FG003|Overall Study|Physician Decision|6|||
105868875|NCT01277601|365171536|FG000|Overall Study|Pregnancy|2|||
105868876|NCT01277601|365171537|FG001|Overall Study|Pregnancy|2|||
105868877|NCT01277601|365171538|FG002|Overall Study|Pregnancy|4|||
105868878|NCT01277601|365171539|FG003|Overall Study|Pregnancy|1|||
105868879|NCT01277601|365171536|FG000|Overall Study|Noncompliance with Study Drug|1|||
105868880|NCT01277601|365171537|FG001|Overall Study|Noncompliance with Study Drug|3|||
105868881|NCT01277601|365171538|FG002|Overall Study|Noncompliance with Study Drug|2|||
105868882|NCT01277601|365171539|FG003|Overall Study|Noncompliance with Study Drug|0|||
105868883|NCT01277601|365171536|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
105868884|NCT01277601|365171537|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
105868885|NCT01277601|365171538|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
105868886|NCT01277601|365171539|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
105868887|NCT01277601|365171536|FG000|Overall Study|Protocol Violation|0|||
105868888|NCT01277601|365171537|FG001|Overall Study|Protocol Violation|2|||
105868889|NCT01277601|365171538|FG002|Overall Study|Protocol Violation|5|||
105868890|NCT01277601|365171539|FG003|Overall Study|Protocol Violation|0|||
105868891|NCT01277601|365171536|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
105868892|NCT01277601|365171537|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
105868893|NCT01277601|365171538|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
105868894|NCT01277601|365171539|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
105868895|NCT02243605|365171544|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
105868896|NCT02243605|365171545|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
105868897|NCT02243605|365171544|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
105868898|NCT02243605|365171545|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
105868899|NCT02243605|365171544|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
105868900|NCT02243605|365171545|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
105868901|NCT02243605|365171544|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
105868902|NCT02243605|365171545|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
105868903|NCT02243605|365171544|FG000|Stage 2 - Final Analysis Population|Progression|0|||
105868904|NCT02243605|365171545|FG001|Stage 2 - Final Analysis Population|Progression|1|||
105868905|NCT02465398|365171547|FG000|Overall Study|Death|7|||
105868906|NCT02465398|365171547|FG000|Overall Study|Revision|7|||
105868907|NCT02465398|365171547|FG000|Overall Study|did not receive study device|1|||
105868908|NCT02465398|365171547|FG000|Overall Study|Withdrawal by Subject|1|||
105868909|NCT02465398|365171547|FG000|Overall Study|Lost to Follow-up|14|||
105868910|NCT00064987|365171552|FG000|Overall Study|Physician Decision|3|||
105868911|NCT00064987|365171553|FG001|Overall Study|Physician Decision|0|||
105868912|NCT02969382|365171554|FG000|Overall Study|Adverse Event|8|||
105868913|NCT02969382|365171555|FG001|Overall Study|Adverse Event|10|||
105868914|NCT02969382|365171554|FG000|Overall Study|Lack of Efficacy|4|||
105868915|NCT02969382|365171555|FG001|Overall Study|Lack of Efficacy|5|||
105868916|NCT02969382|365171554|FG000|Overall Study|Death|0|||
105868917|NCT02969382|365171555|FG001|Overall Study|Death|1|||
105868918|NCT02969382|365171554|FG000|Overall Study|PROTOCOL DEVIATION|0|||
105868919|NCT02969382|365171555|FG001|Overall Study|PROTOCOL DEVIATION|1|||
105868920|NCT02969382|365171554|FG000|Overall Study|Withdrawal by Subject|14|||
105868921|NCT02969382|365171555|FG001|Overall Study|Withdrawal by Subject|9|||
105868922|NCT02548156|365171556|FG000|Washout Period 1|Lost to Follow-up|0|||
105868923|NCT02548156|365171557|FG001|Washout Period 1|Lost to Follow-up|0|||
105868924|NCT02548156|365171558|FG002|Washout Period 1|Lost to Follow-up|0|||
105868925|NCT02548156|365171559|FG003|Washout Period 1|Lost to Follow-up|0|||
105868926|NCT02548156|365171560|FG004|Washout Period 1|Lost to Follow-up|1|||
105868927|NCT02548156|365171561|FG005|Washout Period 1|Lost to Follow-up|0|||
105868928|NCT00853099|365171562|FG000|Double-blind Period|Adverse Event|7|||
105868929|NCT00853099|365171563|FG001|Double-blind Period|Adverse Event|9|||
105868930|NCT00853099|365171564|FG002|Double-blind Period|Adverse Event|13|||
105868931|NCT00853099|365171565|FG003|Double-blind Period|Adverse Event|0|||
105868932|NCT00853099|365171562|FG000|Double-blind Period|Withdrawal by Subject|2|||
105868933|NCT00853099|365171563|FG001|Double-blind Period|Withdrawal by Subject|3|||
105868934|NCT00853099|365171564|FG002|Double-blind Period|Withdrawal by Subject|0|||
105868935|NCT00853099|365171565|FG003|Double-blind Period|Withdrawal by Subject|0|||
105868936|NCT00853099|365171562|FG000|Double-blind Period|Lack of Efficacy|14|||
105868937|NCT00853099|365171563|FG001|Double-blind Period|Lack of Efficacy|17|||
105868938|NCT00853099|365171564|FG002|Double-blind Period|Lack of Efficacy|16|||
105868939|NCT00853099|365171565|FG003|Double-blind Period|Lack of Efficacy|0|||
105868940|NCT00853099|365171562|FG000|Double-blind Period|Other|0|||
105868941|NCT00853099|365171563|FG001|Double-blind Period|Other|0|||
105868942|NCT00853099|365171564|FG002|Double-blind Period|Other|1|||
105868943|NCT00853099|365171565|FG003|Double-blind Period|Other|0|||
105868944|NCT00853099|365171562|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
105868945|NCT00853099|365171563|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
105868946|NCT00853099|365171564|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
105868947|NCT00853099|365171565|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
105868948|NCT00853099|365171562|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
105868949|NCT00853099|365171563|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
105868950|NCT00853099|365171564|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
105868951|NCT00853099|365171565|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
105868952|NCT00853099|365171562|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
105868953|NCT00853099|365171563|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
105868954|NCT00853099|365171564|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
105868955|NCT00853099|365171565|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
105868956|NCT00853099|365171562|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
105868957|NCT00853099|365171563|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
105868958|NCT00853099|365171564|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
105868959|NCT00853099|365171565|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
105868960|NCT00853099|365171562|FG000|Double-blind + Open-label Periods|Other|0|||
105868961|NCT00853099|365171563|FG001|Double-blind + Open-label Periods|Other|0|||
105868962|NCT00853099|365171564|FG002|Double-blind + Open-label Periods|Other|0|||
105868963|NCT00853099|365171565|FG003|Double-blind + Open-label Periods|Other|6|||
105868964|NCT02121652|365171573|FG000|Overall Study|Lost to Follow-up|2|||
105868965|NCT02121652|365171574|FG001|Overall Study|Lost to Follow-up|1|||
105868966|NCT02121652|365171573|FG000|Overall Study|Death|1|||
105868967|NCT02121652|365171574|FG001|Overall Study|Death|0|||
105868968|NCT02121652|365171573|FG000|Overall Study|Withdrawal by Subject|3|||
105868969|NCT02121652|365171574|FG001|Overall Study|Withdrawal by Subject|3|||
105868970|NCT02738138|365171576|FG000|Overall Study|Adverse Event|0|||
105868971|NCT02738138|365171577|FG001|Overall Study|Adverse Event|1|||
105868972|NCT02738138|365171576|FG000|Overall Study|Lost to Follow-up|2|||
105868973|NCT02738138|365171577|FG001|Overall Study|Lost to Follow-up|0|||
105868974|NCT02738138|365171576|FG000|Overall Study|Other - not further specified|1|||
105868975|NCT02738138|365171577|FG001|Overall Study|Other - not further specified|0|||
105868976|NCT02203357|365171585|FG000|Overall Study|Lost to Follow-up|58|||
105868977|NCT02203357|365171586|FG001|Overall Study|Lost to Follow-up|66|||
105868978|NCT02203357|365171587|FG002|Overall Study|Lost to Follow-up|70|||
105868979|NCT03154125|365171589|FG000|Overall Study|Lost to Follow-up|11|||
105868980|NCT03154125|365171590|FG001|Overall Study|Lost to Follow-up|11|||
105868981|NCT03154125|365171591|FG002|Overall Study|Lost to Follow-up|0|||
105868982|NCT03154125|365171589|FG000|Overall Study|Withdrawal by Subject|49|||
105868983|NCT03154125|365171590|FG001|Overall Study|Withdrawal by Subject|55|||
105868984|NCT03154125|365171591|FG002|Overall Study|Withdrawal by Subject|8|||
105868985|NCT03154125|365171589|FG000|Overall Study|Physician Decision|13|||
105868986|NCT03154125|365171590|FG001|Overall Study|Physician Decision|6|||
105868987|NCT03154125|365171591|FG002|Overall Study|Physician Decision|0|||
105868988|NCT03154125|365171589|FG000|Overall Study|Protocol Violation|3|||
105868989|NCT03154125|365171590|FG001|Overall Study|Protocol Violation|5|||
105868990|NCT03154125|365171591|FG002|Overall Study|Protocol Violation|0|||
105868991|NCT00799058|365171594|FG000|Overall Study|Withdrawal by Subject|2|||
105868992|NCT00799058|365171595|FG001|Overall Study|Withdrawal by Subject|2|||
105868993|NCT00799058|365171596|FG002|Overall Study|Withdrawal by Subject|2|||
105868994|NCT00799058|365171594|FG000|Overall Study|Lost to Follow-up|1|||
105868995|NCT00799058|365171595|FG001|Overall Study|Lost to Follow-up|2|||
105868996|NCT00799058|365171596|FG002|Overall Study|Lost to Follow-up|1|||
105868997|NCT00799058|365171594|FG000|Overall Study|Adverse Event|0|||
105868998|NCT00799058|365171595|FG001|Overall Study|Adverse Event|2|||
105868999|NCT00799058|365171596|FG002|Overall Study|Adverse Event|0|||
105869000|NCT00799058|365171594|FG000|Overall Study|Pregnancy|1|||
105869001|NCT00799058|365171595|FG001|Overall Study|Pregnancy|0|||
105869002|NCT00799058|365171596|FG002|Overall Study|Pregnancy|0|||
105869003|NCT00799058|365171594|FG000|Overall Study|Not adherent|3|||
105869004|NCT00799058|365171595|FG001|Overall Study|Not adherent|2|||
105869005|NCT00799058|365171596|FG002|Overall Study|Not adherent|1|||
105869006|NCT00799058|365171594|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
105869007|NCT00799058|365171595|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
105869008|NCT00799058|365171596|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
105869009|NCT00799058|365171594|FG000|Overall Study|IP dispensing error|1|||
105869010|NCT00799058|365171595|FG001|Overall Study|IP dispensing error|0|||
105869011|NCT00799058|365171596|FG002|Overall Study|IP dispensing error|0|||
105869012|NCT00799058|365171594|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
105869013|NCT00799058|365171595|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
105869014|NCT00799058|365171596|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
105869015|NCT00799058|365171594|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
105869016|NCT00799058|365171595|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
105869017|NCT00799058|365171596|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
105869018|NCT00799058|365171594|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
105869019|NCT00799058|365171595|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
105869020|NCT00799058|365171596|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
105869021|NCT00799058|365171594|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
105869022|NCT00799058|365171595|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
105869023|NCT00799058|365171596|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
105869024|NCT02088697|365171599|FG000|Period I|Physician Decision|1|||
105869025|NCT02088697|365171600|FG001|Period I|Physician Decision|4|||
105869026|NCT02088697|365171599|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
105869027|NCT02088697|365171600|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
105869028|NCT01295320|365171601|FG000|Overall Study|Adverse Event|2|||
105869029|NCT01295320|365171601|FG000|Overall Study|Lost to Follow-up|4|||
105869030|NCT01295320|365171601|FG000|Overall Study|Withdrawal by Subject|2|||
105869031|NCT01295320|365171601|FG000|Overall Study|Subject was bedridden|1|||
105869032|NCT01295320|365171601|FG000|Overall Study|Unable to travel|1|||
105869033|NCT01995513|365171602|FG000|Period 1: First Open Label Treatment|Other|34|||
105869034|NCT01995513|365171603|FG001|Period 1: First Open Label Treatment|Other|0|||
105869035|NCT01995513|365171604|FG002|Period 1: First Open Label Treatment|Other|0|||
105869036|NCT01995513|365171605|FG003|Period 1: First Open Label Treatment|Other|0|||
105869037|NCT01995513|365171602|FG000|Period 1: First Open Label Treatment|Death|14|||
105869038|NCT01995513|365171603|FG001|Period 1: First Open Label Treatment|Death|0|||
105869039|NCT01995513|365171604|FG002|Period 1: First Open Label Treatment|Death|0|||
105869040|NCT01995513|365171605|FG003|Period 1: First Open Label Treatment|Death|0|||
105869041|NCT01995513|365171602|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
105869042|NCT01995513|365171603|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
105869043|NCT01995513|365171604|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
105869044|NCT01995513|365171605|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
105987389|NCT03495102|365614448|FG000|Overall Study|Withdrawal by Subject|25|||
105987390|NCT03495102|365614449|FG001|Overall Study|Withdrawal by Subject|36|||
105987391|NCT03495102|365614450|FG002|Overall Study|Withdrawal by Subject|18|||
105987392|NCT03495102|365614448|FG000|Overall Study|Protocol Violation|1|||
105987393|NCT03495102|365614449|FG001|Overall Study|Protocol Violation|1|||
105987394|NCT03495102|365614450|FG002|Overall Study|Protocol Violation|0|||
105987395|NCT03495102|365614448|FG000|Overall Study|Site Closure|3|||
105987396|NCT03495102|365614449|FG001|Overall Study|Site Closure|1|||
105987397|NCT03495102|365614450|FG002|Overall Study|Site Closure|2|||
105987398|NCT03495102|365614448|FG000|Overall Study|Non-compliance|1|||
105987399|NCT03495102|365614449|FG001|Overall Study|Non-compliance|0|||
105987400|NCT03495102|365614450|FG002|Overall Study|Non-compliance|0|||
105869045|NCT01995513|365171602|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
105987401|NCT03495102|365614448|FG000|Overall Study|Participant Duplicated at Another Site|0|||
105869046|NCT01995513|365171603|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
105869047|NCT01995513|365171604|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
105869048|NCT01995513|365171605|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
105869049|NCT01995513|365171602|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
105869050|NCT01995513|365171603|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
105869051|NCT01995513|365171604|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
105869052|NCT01995513|365171605|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
105869053|NCT01995513|365171602|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
105869054|NCT01995513|365171603|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
105869055|NCT01995513|365171604|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
105869056|NCT01995513|365171605|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
105869057|NCT01995513|365171602|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
105869058|NCT01995513|365171603|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
105869059|NCT01995513|365171604|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
105869060|NCT01995513|365171605|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
105869061|NCT01995513|365171602|FG000|Period 1: Second Open Label Treatment|Other|0|||
105869062|NCT01995513|365171603|FG001|Period 1: Second Open Label Treatment|Other|2|||
105869063|NCT01995513|365171604|FG002|Period 1: Second Open Label Treatment|Other|0|||
105869213|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
105869214|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
105869215|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
105869216|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
105869217|NCT00662649|365171624|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
105869218|NCT00662649|365171625|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
105869219|NCT00662649|365171626|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
105869220|NCT00662649|365171627|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
105869221|NCT00662649|365171628|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
105869222|NCT03594071|365171629|FG000|Overall Study|Re-operation|3|||
105869223|NCT03594071|365171629|FG000|Overall Study|Missed visit|2|||
105869224|NCT03022370|365171630|FG000|Overall Study|Death|6|||
105869225|NCT03022370|365171631|FG001|Overall Study|Death|12|||
105869226|NCT03022370|365171630|FG000|Overall Study|Lost to Follow-up|174|||
105869227|NCT03022370|365171631|FG001|Overall Study|Lost to Follow-up|109|||
105869228|NCT00668317|365171632|FG000|Overall Study|Adverse Event|2|||
105869229|NCT02454933|365171637|FG000|Overall Study|Progressive disease|10|||
105869230|NCT02454933|365171638|FG001|Overall Study|Progressive disease|7|||
105869231|NCT02454933|365171637|FG000|Overall Study|Adverse Event|1|||
105869232|NCT02454933|365171638|FG001|Overall Study|Adverse Event|1|||
105869233|NCT02454933|365171637|FG000|Overall Study|Withdrawal by Subject|0|||
105869234|NCT02454933|365171638|FG001|Overall Study|Withdrawal by Subject|3|||
105869235|NCT02454933|365171637|FG000|Overall Study|Lost to Follow-up|1|||
105869236|NCT02454933|365171638|FG001|Overall Study|Lost to Follow-up|0|||
105869237|NCT03668808|365171639|FG000|First Intervention|Withdrawal by Subject|2|||
105869238|NCT03668808|365171640|FG001|First Intervention|Withdrawal by Subject|2|||
105869239|NCT01526655|365171645|FG000|Overall Study|Withdrawal by Subject|0|||
105869240|NCT01526655|365171646|FG001|Overall Study|Withdrawal by Subject|1|||
105869241|NCT01308424|365171666|FG000|Baseline Eligibility|Screen Failures|71|||
105869242|NCT01308424|365171667|FG001|Baseline Eligibility|Screen Failures|0|||
105869243|NCT01308424|365171668|FG002|Baseline Eligibility|Screen Failures|0|||
105869244|NCT01308424|365171666|FG000|Randomization|Adverse Event|0|||
105869245|NCT01308424|365171667|FG001|Randomization|Adverse Event|1|||
105869246|NCT01308424|365171668|FG002|Randomization|Adverse Event|1|||
105869247|NCT01308424|365171666|FG000|Randomization|Lost to Follow-up|0|||
105869248|NCT01308424|365171667|FG001|Randomization|Lost to Follow-up|1|||
105869249|NCT01308424|365171668|FG002|Randomization|Lost to Follow-up|0|||
105869250|NCT01308424|365171666|FG000|Randomization|Physician Decision|0|||
105869251|NCT01308424|365171667|FG001|Randomization|Physician Decision|1|||
105869252|NCT01308424|365171668|FG002|Randomization|Physician Decision|1|||
105869253|NCT00344448|365171671|FG000|Screening|Withdrawal by Subject|0|||
105869254|NCT00344448|365171672|FG001|Screening|Withdrawal by Subject|1|||
105869255|NCT00344448|365171671|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
105869256|NCT00344448|365171672|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
105869257|NCT00344448|365171671|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
105869258|NCT00344448|365171672|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
105869259|NCT00344448|365171671|FG000|Open Label|Withdrawal by Subject|1|||
105869260|NCT00344448|365171672|FG001|Open Label|Withdrawal by Subject|1|||
105869261|NCT00344448|365171671|FG000|Open Label|Study terminated|1|||
105869262|NCT00344448|365171672|FG001|Open Label|Study terminated|0|||
105869263|NCT03151304|365171676|FG000|Overall Study|Termination of study by Sponsor|23|||
105869264|NCT03151304|365171676|FG000|Overall Study|missing|3|||
105869265|NCT03151304|365171676|FG000|Overall Study|Withdrawal by Subject|8|||
105869266|NCT03151304|365171676|FG000|Overall Study|multiple reasons|30|||
105869267|NCT03656744|365171677|FG000|Overall Study|Adverse Event|1|||
105869268|NCT03656744|365171678|FG001|Overall Study|Adverse Event|4|||
105869269|NCT03656744|365171679|FG002|Overall Study|Adverse Event|1|||
105869270|NCT03656744|365171677|FG000|Overall Study|Protocol Violation|1|||
105869271|NCT03656744|365171678|FG001|Overall Study|Protocol Violation|0|||
105869272|NCT03656744|365171679|FG002|Overall Study|Protocol Violation|0|||
105869273|NCT03656744|365171677|FG000|Overall Study|Lost to Follow-up|2|||
105869274|NCT03656744|365171678|FG001|Overall Study|Lost to Follow-up|2|||
105869275|NCT03656744|365171679|FG002|Overall Study|Lost to Follow-up|0|||
105869276|NCT03656744|365171677|FG000|Overall Study|Withdrawal by Subject|0|||
105869277|NCT03656744|365171678|FG001|Overall Study|Withdrawal by Subject|1|||
105869278|NCT03656744|365171679|FG002|Overall Study|Withdrawal by Subject|0|||
105869279|NCT03656744|365171677|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
105869280|NCT03656744|365171678|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
105869281|NCT03656744|365171679|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
105869282|NCT01783886|365171680|FG000|Overall Study|Lost to Follow-up|0|||
105869283|NCT01783886|365171681|FG001|Overall Study|Lost to Follow-up|3|||
105869284|NCT01783886|365171682|FG002|Overall Study|Lost to Follow-up|0|||
105869285|NCT01783886|365171680|FG000|Overall Study|Protocol deviation|0|||
105630752|NCT05039021|364314229|FG000|Overall Study|Death|1|||
105630753|NCT05039021|364314229|FG000|Overall Study|Lost to Follow-up|3|||
105630754|NCT04518943|364314230|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
105630755|NCT04518943|364314231|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
105630756|NCT04518943|364314232|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
105630757|NCT04518943|364314233|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
105630758|NCT04518943|364314234|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
105630759|NCT04518943|364314235|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
105630760|NCT04518943|364314236|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
105630761|NCT04518943|364314237|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
105630762|NCT04518943|364314238|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
105630763|NCT04518943|364314239|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
105630764|NCT04518943|364314240|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
105630765|NCT04518943|364314241|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
105630766|NCT04518943|364314242|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
105630767|NCT04518943|364314243|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
105630768|NCT04518943|364314244|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
105630769|NCT04518943|364314245|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
105630770|NCT05412004|364314246|FG000|Overall Study|Adverse Event|0|||
105630771|NCT05412004|364314247|FG001|Overall Study|Adverse Event|2|||
105630772|NCT05412004|364314248|FG002|Overall Study|Adverse Event|1|||
105630773|NCT05412004|364314249|FG003|Overall Study|Adverse Event|5|||
105630774|NCT05412004|364314246|FG000|Overall Study|Assigned Treatment by Mistake|5|||
105630775|NCT05412004|364314247|FG001|Overall Study|Assigned Treatment by Mistake|10|||
105630776|NCT05412004|364314248|FG002|Overall Study|Assigned Treatment by Mistake|2|||
105630777|NCT05412004|364314249|FG003|Overall Study|Assigned Treatment by Mistake|5|||
105630778|NCT05412004|364314246|FG000|Overall Study|Lost to Follow-up|3|||
105630779|NCT05412004|364314247|FG001|Overall Study|Lost to Follow-up|0|||
105630780|NCT05412004|364314248|FG002|Overall Study|Lost to Follow-up|0|||
105630781|NCT05412004|364314249|FG003|Overall Study|Lost to Follow-up|0|||
105630782|NCT05412004|364314246|FG000|Overall Study|Patient could not travel to site|0|||
105630783|NCT05412004|364314247|FG001|Overall Study|Patient could not travel to site|1|||
105630784|NCT05412004|364314248|FG002|Overall Study|Patient could not travel to site|0|||
105630785|NCT05412004|364314249|FG003|Overall Study|Patient could not travel to site|0|||
105630786|NCT05412004|364314246|FG000|Overall Study|Physician Decision|0|||
105630787|NCT05412004|364314247|FG001|Overall Study|Physician Decision|1|||
105630788|NCT05412004|364314248|FG002|Overall Study|Physician Decision|0|||
105630789|NCT05412004|364314249|FG003|Overall Study|Physician Decision|0|||
105630790|NCT05412004|364314246|FG000|Overall Study|Pregnancy|0|||
105630791|NCT05412004|364314247|FG001|Overall Study|Pregnancy|1|||
105630792|NCT05412004|364314248|FG002|Overall Study|Pregnancy|0|||
105869286|NCT01783886|365171681|FG001|Overall Study|Protocol deviation|0|||
105869287|NCT01783886|365171682|FG002|Overall Study|Protocol deviation|2|||
105869288|NCT01783886|365171680|FG000|Overall Study|Withdrawal of consent by participant|1|||
105630793|NCT05412004|364314249|FG003|Overall Study|Pregnancy|0|||
105630794|NCT05412004|364314246|FG000|Overall Study|Protocol Violation|1|||
105630795|NCT05412004|364314247|FG001|Overall Study|Protocol Violation|0|||
105630796|NCT05412004|364314248|FG002|Overall Study|Protocol Violation|0|||
105630797|NCT05412004|364314249|FG003|Overall Study|Protocol Violation|0|||
105630798|NCT05412004|364314246|FG000|Overall Study|Withdrawal by Subject|4|||
105630799|NCT05412004|364314247|FG001|Overall Study|Withdrawal by Subject|19|||
105630800|NCT05412004|364314248|FG002|Overall Study|Withdrawal by Subject|4|||
105630801|NCT05412004|364314249|FG003|Overall Study|Withdrawal by Subject|14|||
105630802|NCT05412004|364314246|FG000|Overall Study|Screen Failure|0|||
105630803|NCT05412004|364314247|FG001|Overall Study|Screen Failure|0|||
105630804|NCT05412004|364314248|FG002|Overall Study|Screen Failure|0|||
105630805|NCT05412004|364314249|FG003|Overall Study|Screen Failure|1|||
105630806|NCT05412004|364314246|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
105630807|NCT05412004|364314247|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
105630808|NCT05412004|364314248|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
105630809|NCT05412004|364314249|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
105630810|NCT00968149|364314250|FG000|Overall Study|Adverse Event|5|||
105630811|NCT00968149|364314251|FG001|Overall Study|Adverse Event|1|||
105630812|NCT00968149|364314250|FG000|Overall Study|Lack of Efficacy|0|||
105630813|NCT00968149|364314251|FG001|Overall Study|Lack of Efficacy|4|||
105630814|NCT00968149|364314250|FG000|Overall Study|Lost to Follow-up|0|||
105630815|NCT00968149|364314251|FG001|Overall Study|Lost to Follow-up|1|||
105630816|NCT00968149|364314250|FG000|Overall Study|Protocol Violation|4|||
105630817|NCT00968149|364314251|FG001|Overall Study|Protocol Violation|0|||
105630818|NCT00968149|364314250|FG000|Overall Study|Withdrawal by Subject|2|||
105630819|NCT00968149|364314251|FG001|Overall Study|Withdrawal by Subject|0|||
105630820|NCT03699163|364314252|FG000|Overall Study|Physician Decision|12|||
105630821|NCT03699163|364314253|FG001|Overall Study|Physician Decision|0|||
105630822|NCT03699163|364314252|FG000|Overall Study|failed QC measures|205|||
105630823|NCT03699163|364314253|FG001|Overall Study|failed QC measures|206|||
105630824|NCT01574716|364314261|FG000|Part 1|Death|3|||
105630825|NCT01574716|364314262|FG001|Part 1|Death|1|||
105630826|NCT01574716|364314263|FG002|Part 1|Death|8|||
105630827|NCT01574716|364314264|FG003|Part 1|Death|0|||
105630828|NCT01574716|364314265|FG004|Part 1|Death|0|||
105630829|NCT01574716|364314261|FG000|Part 1|Discontinuation of study by sponsor|0|||
105630830|NCT01574716|364314262|FG001|Part 1|Discontinuation of study by sponsor|0|||
105630831|NCT01574716|364314263|FG002|Part 1|Discontinuation of study by sponsor|1|||
105630832|NCT01574716|364314264|FG003|Part 1|Discontinuation of study by sponsor|0|||
105630833|NCT01574716|364314265|FG004|Part 1|Discontinuation of study by sponsor|0|||
105630834|NCT01574716|364314261|FG000|Part 1|Withdrawal by Subject|0|||
105630835|NCT01574716|364314262|FG001|Part 1|Withdrawal by Subject|2|||
105630836|NCT01574716|364314263|FG002|Part 1|Withdrawal by Subject|0|||
105630837|NCT01574716|364314264|FG003|Part 1|Withdrawal by Subject|0|||
105630838|NCT01574716|364314265|FG004|Part 1|Withdrawal by Subject|0|||
105630839|NCT01574716|364314261|FG000|Part 1|Lost to Follow-up|0|||
105630840|NCT01574716|364314262|FG001|Part 1|Lost to Follow-up|1|||
105630841|NCT01574716|364314263|FG002|Part 1|Lost to Follow-up|0|||
105630842|NCT01574716|364314264|FG003|Part 1|Lost to Follow-up|0|||
105630843|NCT01574716|364314265|FG004|Part 1|Lost to Follow-up|0|||
105630844|NCT01574716|364314261|FG000|Part 2|Progressive disease|0|||
105630845|NCT01574716|364314262|FG001|Part 2|Progressive disease|0|||
105630846|NCT01574716|364314263|FG002|Part 2|Progressive disease|0|||
105630847|NCT01574716|364314264|FG003|Part 2|Progressive disease|1|||
105630848|NCT01574716|364314265|FG004|Part 2|Progressive disease|0|||
105630849|NCT01574716|364314261|FG000|Part 2|Death|0|||
105630850|NCT01574716|364314262|FG001|Part 2|Death|0|||
105630851|NCT01574716|364314263|FG002|Part 2|Death|0|||
105630852|NCT01574716|364314264|FG003|Part 2|Death|76|||
105630853|NCT01574716|364314265|FG004|Part 2|Death|35|||
105630854|NCT01574716|364314261|FG000|Part 2|Discontinuation of study by sponsor|0|||
105630855|NCT01574716|364314262|FG001|Part 2|Discontinuation of study by sponsor|0|||
105630856|NCT01574716|364314263|FG002|Part 2|Discontinuation of study by sponsor|0|||
105630857|NCT01574716|364314264|FG003|Part 2|Discontinuation of study by sponsor|51|||
105630858|NCT01574716|364314265|FG004|Part 2|Discontinuation of study by sponsor|31|||
105630859|NCT01574716|364314261|FG000|Part 2|Withdrawal by Subject|0|||
105630860|NCT01574716|364314262|FG001|Part 2|Withdrawal by Subject|0|||
105630861|NCT01574716|364314263|FG002|Part 2|Withdrawal by Subject|0|||
105630862|NCT01574716|364314264|FG003|Part 2|Withdrawal by Subject|5|||
105630863|NCT01574716|364314265|FG004|Part 2|Withdrawal by Subject|4|||
105630864|NCT01574716|364314261|FG000|Part 2|Brain metastases|0|||
105630865|NCT01574716|364314262|FG001|Part 2|Brain metastases|0|||
105630866|NCT01574716|364314263|FG002|Part 2|Brain metastases|0|||
105630867|NCT01574716|364314264|FG003|Part 2|Brain metastases|1|||
105630868|NCT01574716|364314265|FG004|Part 2|Brain metastases|0|||
105630869|NCT01574716|364314261|FG000|Part 2|Lost to Follow-up|0|||
105630870|NCT01574716|364314262|FG001|Part 2|Lost to Follow-up|0|||
105630871|NCT01574716|364314263|FG002|Part 2|Lost to Follow-up|0|||
105630872|NCT01574716|364314264|FG003|Part 2|Lost to Follow-up|3|||
105630873|NCT01574716|364314265|FG004|Part 2|Lost to Follow-up|0|||
105630874|NCT02633215|364314266|FG000|Overall Study|Lost to Follow-up|2|||
105630875|NCT02633215|364314267|FG001|Overall Study|Lost to Follow-up|3|||
105630876|NCT03709706|364314269|FG000|Overall Study|Adverse Event|0|||
105630877|NCT03709706|364314270|FG001|Overall Study|Adverse Event|1|||
105630878|NCT03709706|364314269|FG000|Overall Study|Physician Decision|14|||
105630879|NCT03709706|364314270|FG001|Overall Study|Physician Decision|8|||
105630880|NCT03709706|364314269|FG000|Overall Study|Withdrawal by Subject|2|||
105630881|NCT03709706|364314270|FG001|Overall Study|Withdrawal by Subject|1|||
105630882|NCT03709706|364314269|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
105630883|NCT03709706|364314270|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
105630884|NCT04868617|364314271|FG000|Overall Study|Death|1|||
105630885|NCT04868617|364314272|FG001|Overall Study|Death|0|||
105630886|NCT04868617|364314271|FG000|Overall Study|Adverse Event|1|||
105630887|NCT04868617|364314272|FG001|Overall Study|Adverse Event|0|||
105630888|NCT04868617|364314271|FG000|Overall Study|Withdrawal by Subject|1|||
105630889|NCT04868617|364314272|FG001|Overall Study|Withdrawal by Subject|0|||
105630890|NCT04868617|364314271|FG000|Overall Study|Device deficiency|1|||
105630891|NCT04868617|364314272|FG001|Overall Study|Device deficiency|0|||
105630892|NCT03183050|364314273|FG000|Overall Study|Lost to Follow-up|23|||
105630893|NCT02754596|364314282|FG000|Overall Study|Withdrawal by Subject|3|||
105630894|NCT02754596|364314283|FG001|Overall Study|Withdrawal by Subject|4|||
105630895|NCT02754596|364314284|FG002|Overall Study|Withdrawal by Subject|0|||
105630896|NCT02754596|364314282|FG000|Overall Study|Physician Decision|1|||
105630897|NCT02754596|364314283|FG001|Overall Study|Physician Decision|1|||
105630898|NCT02754596|364314284|FG002|Overall Study|Physician Decision|1|||
105630899|NCT02754596|364314282|FG000|Overall Study|Lost to Follow-up|1|||
105630900|NCT02754596|364314283|FG001|Overall Study|Lost to Follow-up|1|||
105630901|NCT02754596|364314284|FG002|Overall Study|Lost to Follow-up|2|||
105630902|NCT02754596|364314282|FG000|Overall Study|Death|0|||
105630903|NCT02754596|364314283|FG001|Overall Study|Death|2|||
105630904|NCT02754596|364314284|FG002|Overall Study|Death|0|||
105630905|NCT02754596|364314282|FG000|Overall Study|Adverse Event|1|||
105630906|NCT02754596|364314283|FG001|Overall Study|Adverse Event|0|||
105630907|NCT02754596|364314284|FG002|Overall Study|Adverse Event|1|||
105630908|NCT02754596|364314282|FG000|Overall Study|Other|1|||
105630909|NCT02754596|364314283|FG001|Overall Study|Other|0|||
105630910|NCT02754596|364314284|FG002|Overall Study|Other|0|||
105630911|NCT02107261|364314285|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
105630912|NCT02107261|364314286|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
105630913|NCT02107261|364314285|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
105630914|NCT02107261|364314286|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
105630915|NCT05018143|364314288|FG000|Overall Study|Lost to Follow-up|5|||
105630916|NCT05018143|364314289|FG001|Overall Study|Lost to Follow-up|4|||
105630917|NCT05018143|364314288|FG000|Overall Study|Withdrawal by Subject|0|||
105630918|NCT05018143|364314289|FG001|Overall Study|Withdrawal by Subject|1|||
105987547|NCT03464019|365614487|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
105987548|NCT03464019|365614488|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
105987549|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
105987550|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
105987551|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
105630925|NCT05155306|364314291|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
105630926|NCT05155306|364314292|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
105630927|NCT05155306|364314293|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
105630928|NCT05155306|364314294|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
105630929|NCT05155306|364314291|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
105630930|NCT05155306|364314292|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
105630931|NCT05155306|364314293|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
105630932|NCT05155306|364314294|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
105630933|NCT03477175|364314297|FG000|Overall Study|Unable to travel due to COVID-19|0|||
105630934|NCT03477175|364314298|FG001|Overall Study|Unable to travel due to COVID-19|1|||
105630935|NCT03477175|364314297|FG000|Overall Study|Physician Decision|1|||
105630936|NCT03477175|364314298|FG001|Overall Study|Physician Decision|0|||
105630937|NCT03477175|364314297|FG000|Overall Study|Transitioned to commercial drug|6|||
105630938|NCT03477175|364314298|FG001|Overall Study|Transitioned to commercial drug|6|||
105630939|NCT03477175|364314297|FG000|Overall Study|Lost to Follow-up|1|||
105630940|NCT03477175|364314298|FG001|Overall Study|Lost to Follow-up|1|||
105630941|NCT03477175|364314297|FG000|Overall Study|Withdrawal by Subject|3|||
105630942|NCT03477175|364314298|FG001|Overall Study|Withdrawal by Subject|1|||
105630943|NCT03477175|364314297|FG000|Overall Study|Adverse Event|1|||
105630944|NCT03477175|364314298|FG001|Overall Study|Adverse Event|5|||
105630945|NCT03477175|364314297|FG000|Overall Study|Disease Progression|7|||
105630946|NCT03477175|364314298|FG001|Overall Study|Disease Progression|7|||
105630947|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
105630948|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
105630949|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
105630950|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
105630951|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
105630952|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
105630953|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
105630954|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
105630955|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
105630956|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
105630957|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
105630958|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
105630959|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630960|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
105630961|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630962|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630963|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630964|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
105630965|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630966|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
105630967|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630968|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630969|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630970|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
105630971|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630972|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630973|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
105630974|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630975|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630976|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
105630977|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
105630978|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
105630979|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
105630980|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
105630981|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
105630982|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
105630983|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
105630984|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
105630985|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
105630986|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
105630987|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
105630988|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
105630989|NCT03524092|364314299|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
105630990|NCT03524092|364314300|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
105630991|NCT03524092|364314301|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
105630992|NCT03524092|364314302|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
105630993|NCT03524092|364314303|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
105630994|NCT03524092|364314304|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
105630995|NCT03524092|364314299|FG000|Loss of Response Rescue Period|Adverse Event|0|||
105630996|NCT03524092|364314300|FG001|Loss of Response Rescue Period|Adverse Event|0|||
105630997|NCT03524092|364314301|FG002|Loss of Response Rescue Period|Adverse Event|0|||
105630998|NCT03524092|364314302|FG003|Loss of Response Rescue Period|Adverse Event|2|||
105630999|NCT03524092|364314303|FG004|Loss of Response Rescue Period|Adverse Event|0|||
105631000|NCT03524092|364314304|FG005|Loss of Response Rescue Period|Adverse Event|0|||
105631001|NCT03524092|364314299|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631002|NCT03524092|364314300|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631003|NCT03524092|364314301|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631004|NCT03524092|364314302|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
105631005|NCT03524092|364314303|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631006|NCT03524092|364314304|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
105631007|NCT03524092|364314299|FG000|Loss of Response Rescue Period|Pregnancy|0|||
105631008|NCT03524092|364314300|FG001|Loss of Response Rescue Period|Pregnancy|0|||
105631009|NCT03524092|364314301|FG002|Loss of Response Rescue Period|Pregnancy|0|||
105631010|NCT03524092|364314302|FG003|Loss of Response Rescue Period|Pregnancy|1|||
105631011|NCT03524092|364314303|FG004|Loss of Response Rescue Period|Pregnancy|0|||
105631012|NCT03524092|364314304|FG005|Loss of Response Rescue Period|Pregnancy|0|||
105631013|NCT03524092|364314299|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631014|NCT03524092|364314300|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631015|NCT03524092|364314301|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631016|NCT03524092|364314302|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
105631017|NCT03524092|364314303|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631018|NCT03524092|364314304|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
105631019|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631020|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631021|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631022|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631023|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
105631024|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
105631025|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631026|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631027|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631028|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631029|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
105631030|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
105631031|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631032|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631033|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631034|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631035|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
105631036|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
105631037|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631038|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631039|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631040|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631041|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
105631042|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
105631043|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631044|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631045|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631046|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631047|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
105631048|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
105631049|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631050|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631051|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631052|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631053|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
105631054|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
105631055|NCT03524092|364314299|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631056|NCT03524092|364314300|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631057|NCT03524092|364314301|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631058|NCT03524092|364314302|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631059|NCT03524092|364314303|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
105631060|NCT03524092|364314304|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
105631061|NCT03524092|364314299|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631062|NCT03524092|364314300|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631063|NCT03524092|364314301|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631064|NCT03524092|364314302|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631065|NCT03524092|364314303|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
105631066|NCT03524092|364314304|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
105631067|NCT03524092|364314299|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631068|NCT03524092|364314300|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631069|NCT03524092|364314301|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631070|NCT03524092|364314302|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631071|NCT03524092|364314303|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
105631072|NCT03524092|364314304|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
105631073|NCT03524092|364314299|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631074|NCT03524092|364314300|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631075|NCT03524092|364314301|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631076|NCT03524092|364314302|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631077|NCT03524092|364314303|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
105631078|NCT03524092|364314304|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
105631079|NCT03524092|364314299|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631080|NCT03524092|364314300|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631081|NCT03524092|364314301|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631082|NCT03524092|364314302|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631083|NCT03524092|364314303|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
105631084|NCT03524092|364314304|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
105631085|NCT05139992|364314305|FG000|Overall Study|Withdrawal by Subject|12|||
105631086|NCT05139992|364314305|FG000|Overall Study|Lost to Follow-up|6|||
105631087|NCT01208974|364314306|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
105631088|NCT01208974|364314307|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
105631089|NCT01208974|364314308|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
105631090|NCT01208974|364314309|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
105631091|NCT01208974|364314306|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
105631092|NCT01208974|364314307|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
105631093|NCT01208974|364314308|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
105631094|NCT01208974|364314309|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
105631095|NCT01208974|364314306|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
105631096|NCT01208974|364314307|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
105631097|NCT01208974|364314308|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
105631098|NCT01208974|364314309|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
105631099|NCT05521516|364314310|FG000|Overall Study|Withdrawal by Subject|1|||
105631100|NCT05521516|364314311|FG001|Overall Study|Withdrawal by Subject|1|||
105631101|NCT03593226|364314312|FG000|Overall Study|Disease progression|6|||
105631102|NCT03593226|364314313|FG001|Overall Study|Disease progression|13|||
105631103|NCT03593226|364314314|FG002|Overall Study|Disease progression|5|||
105631104|NCT03593226|364314315|FG003|Overall Study|Disease progression|6|||
105631105|NCT03593226|364314312|FG000|Overall Study|Adverse Event|0|||
105631106|NCT03593226|364314313|FG001|Overall Study|Adverse Event|1|||
105631107|NCT03593226|364314314|FG002|Overall Study|Adverse Event|0|||
105631108|NCT03593226|364314315|FG003|Overall Study|Adverse Event|0|||
105631109|NCT03593226|364314312|FG000|Overall Study|Withdrawal by Subject|0|||
105631110|NCT03593226|364314313|FG001|Overall Study|Withdrawal by Subject|4|||
105631111|NCT03593226|364314314|FG002|Overall Study|Withdrawal by Subject|1|||
105631112|NCT03593226|364314315|FG003|Overall Study|Withdrawal by Subject|0|||
105631113|NCT03593226|364314312|FG000|Overall Study|Physician Decision|0|||
105631114|NCT03593226|364314313|FG001|Overall Study|Physician Decision|1|||
105631115|NCT03593226|364314314|FG002|Overall Study|Physician Decision|0|||
105631116|NCT03593226|364314315|FG003|Overall Study|Physician Decision|0|||
105631117|NCT03593226|364314312|FG000|Overall Study|Clinical disease progression|0|||
105631118|NCT03593226|364314313|FG001|Overall Study|Clinical disease progression|0|||
105631119|NCT03593226|364314314|FG002|Overall Study|Clinical disease progression|1|||
105631120|NCT03593226|364314315|FG003|Overall Study|Clinical disease progression|0|||
105631121|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
105631122|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
105631123|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
105631124|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
105631125|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
105631126|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
105631127|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
105631128|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
105631129|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
105631130|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
105631131|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
105631132|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
105631133|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
105631134|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
105631135|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
105631136|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
105631137|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
105631138|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
105631139|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
105631140|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
105631141|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
105631142|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631143|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631144|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631145|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631146|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631147|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
105631148|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
105631149|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
105631150|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631151|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631152|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631153|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631154|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
105631155|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
105631156|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631157|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631158|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631159|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631160|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
105631161|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
105631162|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
105631163|NCT03656718|364314316|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631164|NCT03656718|364314317|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631165|NCT03656718|364314318|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631166|NCT03656718|364314319|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631167|NCT03656718|364314320|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631168|NCT03656718|364314321|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
105631169|NCT03656718|364314322|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
105631170|NCT03656718|364314316|FG000|Treatment Period Part C|Disease progression|0|||
105631171|NCT03656718|364314317|FG001|Treatment Period Part C|Disease progression|0|||
105631172|NCT03656718|364314318|FG002|Treatment Period Part C|Disease progression|0|||
105631173|NCT03656718|364314319|FG003|Treatment Period Part C|Disease progression|0|||
105631174|NCT03656718|364314320|FG004|Treatment Period Part C|Disease progression|12|||
105631175|NCT03656718|364314321|FG005|Treatment Period Part C|Disease progression|0|||
105631176|NCT03656718|364314322|FG006|Treatment Period Part C|Disease progression|0|||
105631177|NCT03656718|364314316|FG000|Treatment Period Part C|Death|0|||
105631178|NCT03656718|364314317|FG001|Treatment Period Part C|Death|0|||
105631179|NCT03656718|364314318|FG002|Treatment Period Part C|Death|0|||
105631180|NCT03656718|364314319|FG003|Treatment Period Part C|Death|0|||
105631181|NCT03656718|364314320|FG004|Treatment Period Part C|Death|1|||
105631182|NCT03656718|364314321|FG005|Treatment Period Part C|Death|0|||
105631183|NCT03656718|364314322|FG006|Treatment Period Part C|Death|0|||
105631184|NCT03656718|364314316|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631185|NCT03656718|364314317|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631186|NCT03656718|364314318|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631187|NCT03656718|364314319|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631188|NCT03656718|364314320|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
105631189|NCT03656718|364314321|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631190|NCT03656718|364314322|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
105631191|NCT03656718|364314316|FG000|Treatment Period Part C|Other reasons|0|||
105631192|NCT03656718|364314317|FG001|Treatment Period Part C|Other reasons|0|||
105631193|NCT03656718|364314318|FG002|Treatment Period Part C|Other reasons|0|||
105631194|NCT03656718|364314319|FG003|Treatment Period Part C|Other reasons|0|||
105631195|NCT03656718|364314320|FG004|Treatment Period Part C|Other reasons|1|||
105631196|NCT03656718|364314321|FG005|Treatment Period Part C|Other reasons|0|||
105631197|NCT03656718|364314322|FG006|Treatment Period Part C|Other reasons|0|||
105631198|NCT03656718|364314316|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
105631199|NCT03656718|364314317|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
105631200|NCT03656718|364314318|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
105631201|NCT03656718|364314319|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
105631202|NCT03656718|364314320|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
105631203|NCT03656718|364314321|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
105631204|NCT03656718|364314322|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
105631205|NCT03789110|364314323|FG000|Overall Study|Adverse Event|2|||
105631206|NCT03789110|364314323|FG000|Overall Study|Physician Decision|1|||
105869289|NCT01783886|365171681|FG001|Overall Study|Withdrawal of consent by participant|3|||
105631207|NCT03789110|364314323|FG000|Overall Study|Withdrawal by Subject|2|||
105631208|NCT03789110|364314323|FG000|Overall Study|Lack of Efficacy|22|||
105631209|NCT03789110|364314323|FG000|Overall Study|still on treatment|3|||
105631210|NCT00227266|364314324|FG000|Overall Study|Withdrawal by Subject|0|||
105631211|NCT00227266|364314325|FG001|Overall Study|Withdrawal by Subject|0|||
105631212|NCT00227266|364314326|FG002|Overall Study|Withdrawal by Subject|1|||
105631213|NCT00227266|364314324|FG000|Overall Study|Protocol Violation|1|||
105631214|NCT00227266|364314325|FG001|Overall Study|Protocol Violation|0|||
105631215|NCT00227266|364314326|FG002|Overall Study|Protocol Violation|1|||
105631216|NCT00227266|364314324|FG000|Overall Study|Excessive weight gain|0|||
105631217|NCT00227266|364314325|FG001|Overall Study|Excessive weight gain|0|||
105631218|NCT00227266|364314326|FG002|Overall Study|Excessive weight gain|2|||
105631219|NCT03959423|364314327|FG000|Overall Study|Withdrawal by Subject|2|||
105631220|NCT03959423|364314328|FG001|Overall Study|Withdrawal by Subject|3|||
105631221|NCT03959423|364314327|FG000|Overall Study|Physician Decision|0|||
105631222|NCT03959423|364314328|FG001|Overall Study|Physician Decision|1|||
105631223|NCT03959423|364314327|FG000|Overall Study|Lost to Follow-up|1|||
105631224|NCT03959423|364314328|FG001|Overall Study|Lost to Follow-up|0|||
105631225|NCT03959423|364314327|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
105631226|NCT03959423|364314328|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
105631227|NCT04039113|364314329|FG000|Overall Study|Withdrawal by Subject|8|||
105631228|NCT04039113|364314330|FG001|Overall Study|Withdrawal by Subject|11|||
105631229|NCT04039113|364314329|FG000|Overall Study|Lost to Follow-up|1|||
105631230|NCT04039113|364314330|FG001|Overall Study|Lost to Follow-up|1|||
105631231|NCT04039113|364314329|FG000|Overall Study|Adverse Event|2|||
105631232|NCT04039113|364314330|FG001|Overall Study|Adverse Event|2|||
105631233|NCT04039113|364314329|FG000|Overall Study|Death|2|||
105631234|NCT04039113|364314330|FG001|Overall Study|Death|4|||
105631235|NCT04039113|364314329|FG000|Overall Study|Site Closure|6|||
105631236|NCT04039113|364314330|FG001|Overall Study|Site Closure|0|||
105631237|NCT04039113|364314329|FG000|Overall Study|Failure to meet randomisation criteria|4|||
105631238|NCT04039113|364314330|FG001|Overall Study|Failure to meet randomisation criteria|0|||
105631239|NCT00353496|364314331|FG000|Overall Study|Adverse Event|1|||
105631240|NCT00353496|364314332|FG001|Overall Study|Adverse Event|0|||
105631241|NCT00353496|364314331|FG000|Overall Study|Protocol Violation|2|||
105631242|NCT00353496|364314332|FG001|Overall Study|Protocol Violation|2|||
105631243|NCT00353496|364314331|FG000|Overall Study|Withdrawal by Subject|3|||
105631244|NCT00353496|364314332|FG001|Overall Study|Withdrawal by Subject|4|||
105631245|NCT00353496|364314331|FG000|Overall Study|Physician Decision|6|||
105631246|NCT00353496|364314332|FG001|Overall Study|Physician Decision|9|||
105631247|NCT00353496|364314331|FG000|Overall Study|Not otherwise specified|4|||
105631248|NCT00353496|364314332|FG001|Overall Study|Not otherwise specified|2|||
105631249|NCT01470144|364314333|FG000|Overall Study|Adverse Event|2|||
105631250|NCT01470144|364314333|FG000|Overall Study|Death|1|||
105631251|NCT01470144|364314333|FG000|Overall Study|Lung transplant|6|||
105631252|NCT01470144|364314333|FG000|Overall Study|Patient's and investigator's decision|1|||
105631253|NCT03776812|364315035|FG000|Overall Study|Death|27|||
105631254|NCT03776812|364315036|FG001|Overall Study|Death|19|||
105631255|NCT03776812|364315037|FG002|Overall Study|Death|29|||
105631256|NCT03776812|364315035|FG000|Overall Study|Withdrawal by Subject|1|||
105631257|NCT03776812|364315036|FG001|Overall Study|Withdrawal by Subject|7|||
105631258|NCT03776812|364315037|FG002|Overall Study|Withdrawal by Subject|1|||
105631259|NCT03776812|364315035|FG000|Overall Study|Lost to Follow-up|0|||
105631260|NCT03776812|364315036|FG001|Overall Study|Lost to Follow-up|1|||
105631261|NCT03776812|364315037|FG002|Overall Study|Lost to Follow-up|0|||
105631262|NCT03776812|364315035|FG000|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
105631263|NCT03776812|364315036|FG001|Overall Study|Still on study as of March 22, 2021 data cutoff date|33|||
105631264|NCT03776812|364315037|FG002|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
105631265|NCT01260896|364315040|FG000|First Intervention|Withdrawn Due to Emesis|2|||
105631266|NCT01260896|364315041|FG001|First Intervention|Withdrawn Due to Emesis|0|||
105631267|NCT03357952|364315050|FG000|Overall Study|Withdrawal by Subject|0|||
105631268|NCT03357952|364315051|FG001|Overall Study|Withdrawal by Subject|1|||
105631269|NCT03357952|364315050|FG000|Overall Study|Sponsor Decision|9|||
105631270|NCT03357952|364315051|FG001|Overall Study|Sponsor Decision|0|||
105631271|NCT04018495|364315052|FG000|Overall Study|Physician Decision|1|||
105631272|NCT04121741|364315053|FG000|Overall Study|Protocol Violation|1|||
105631273|NCT04121741|364315054|FG001|Overall Study|Protocol Violation|0|||
105631274|NCT04121741|364315055|FG002|Overall Study|Protocol Violation|0|||
105631275|NCT04121741|364315056|FG003|Overall Study|Protocol Violation|0|||
105631276|NCT04121741|364315057|FG004|Overall Study|Protocol Violation|0|||
105631277|NCT04121741|364315058|FG005|Overall Study|Protocol Violation|0|||
105631278|NCT04088227|364315059|FG000|Overall Study|Withdrawal by Subject|1|||
105631279|NCT04088227|364315060|FG001|Overall Study|Withdrawal by Subject|0|||
105631280|NCT04088227|364315059|FG000|Overall Study|Surgery postponed >5weeks|1|||
105631281|NCT04088227|364315060|FG001|Overall Study|Surgery postponed >5weeks|0|||
105631282|NCT04517435|364315077|FG000|Overall Study|Withdrawal by Subject|0|||
105631283|NCT04517435|364315078|FG001|Overall Study|Withdrawal by Subject|0|||
105631284|NCT04517435|364315079|FG002|Overall Study|Withdrawal by Subject|1|||
105631285|NCT04517435|364315077|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
105631286|NCT04517435|364315078|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
105631287|NCT04517435|364315079|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
105631288|NCT01038778|364315080|FG000|Overall Study|Withdrawal by Subject|0|||
105631289|NCT01038778|364315081|FG001|Overall Study|Withdrawal by Subject|2|||
105631290|NCT01038778|364315082|FG002|Overall Study|Withdrawal by Subject|3|||
105631291|NCT04926740|364315083|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
105631292|NCT04926740|364315084|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
105631293|NCT04926740|364315083|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
105631294|NCT04926740|364315084|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
105631295|NCT03211247|364315085|FG000|Overall Study|Adverse Event|8|||
105631296|NCT03211247|364315086|FG001|Overall Study|Adverse Event|0|||
105631297|NCT03211247|364315087|FG002|Overall Study|Adverse Event|1|||
105631298|NCT03211247|364315088|FG003|Overall Study|Adverse Event|0|||
105631299|NCT03211247|364315089|FG004|Overall Study|Adverse Event|0|||
105631300|NCT03211247|364315085|FG000|Overall Study|Lost to Follow-up|2|||
105631301|NCT03211247|364315086|FG001|Overall Study|Lost to Follow-up|1|||
105631302|NCT03211247|364315087|FG002|Overall Study|Lost to Follow-up|0|||
105631303|NCT03211247|364315088|FG003|Overall Study|Lost to Follow-up|0|||
105631304|NCT03211247|364315089|FG004|Overall Study|Lost to Follow-up|0|||
105631305|NCT03211247|364315085|FG000|Overall Study|Physician Decision|1|||
105631306|NCT03211247|364315086|FG001|Overall Study|Physician Decision|2|||
105631307|NCT03211247|364315087|FG002|Overall Study|Physician Decision|0|||
105631308|NCT03211247|364315088|FG003|Overall Study|Physician Decision|0|||
105631309|NCT03211247|364315089|FG004|Overall Study|Physician Decision|0|||
105631310|NCT03211247|364315085|FG000|Overall Study|Non-compliance with study drug|2|||
105631311|NCT03211247|364315086|FG001|Overall Study|Non-compliance with study drug|0|||
105631312|NCT03211247|364315087|FG002|Overall Study|Non-compliance with study drug|0|||
105631313|NCT03211247|364315088|FG003|Overall Study|Non-compliance with study drug|0|||
105631314|NCT03211247|364315089|FG004|Overall Study|Non-compliance with study drug|0|||
105631315|NCT03211247|364315085|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
105631316|NCT03211247|364315086|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
105631317|NCT03211247|364315087|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
105631318|NCT03211247|364315088|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
105631319|NCT03211247|364315089|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
105631320|NCT03211247|364315085|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
105631321|NCT03211247|364315086|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
105631322|NCT03211247|364315087|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
105631323|NCT03211247|364315088|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
105631324|NCT03211247|364315089|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
105631325|NCT03211247|364315085|FG000|Overall Study|Protocol Violation|0|||
105631326|NCT03211247|364315086|FG001|Overall Study|Protocol Violation|1|||
105631327|NCT03211247|364315087|FG002|Overall Study|Protocol Violation|0|||
105631328|NCT03211247|364315088|FG003|Overall Study|Protocol Violation|0|||
105631329|NCT03211247|364315089|FG004|Overall Study|Protocol Violation|0|||
105631330|NCT00747565|364315090|FG000|Overall Study|Withdrawal by Subject|10|||
105631331|NCT00747565|364315091|FG001|Overall Study|Withdrawal by Subject|6|||
105631332|NCT00747565|364315090|FG000|Overall Study|Lost to Follow-up|4|||
105631333|NCT00747565|364315091|FG001|Overall Study|Lost to Follow-up|1|||
105631334|NCT03777657|364315092|FG000|Overall Study|Death|397|||
105631335|NCT03777657|364315093|FG001|Overall Study|Death|431|||
105631336|NCT03777657|364315092|FG000|Overall Study|Study Closed by Sponsor|77|||
105631337|NCT03777657|364315093|FG001|Overall Study|Study Closed by Sponsor|38|||
105631338|NCT03777657|364315092|FG000|Overall Study|Withdrawal by Subject|20|||
105631339|NCT03777657|364315093|FG001|Overall Study|Withdrawal by Subject|17|||
105631340|NCT03777657|364315092|FG000|Overall Study|Lost to Follow-up|6|||
105631341|NCT03777657|364315093|FG001|Overall Study|Lost to Follow-up|10|||
105631342|NCT00545545|364315096|FG000|Overall Study|Progressive Neoplastic Disease|1|||
105631343|NCT00545545|364315097|FG001|Overall Study|Progressive Neoplastic Disease|5|||
105631344|NCT00545545|364315098|FG002|Overall Study|Progressive Neoplastic Disease|0|||
105631345|NCT00545545|364315099|FG003|Overall Study|Progressive Neoplastic Disease|4|||
105631346|NCT00545545|364315100|FG004|Overall Study|Progressive Neoplastic Disease|8|||
105631347|NCT00545545|364315101|FG005|Overall Study|Progressive Neoplastic Disease|7|||
105631348|NCT00545545|364315096|FG000|Overall Study|Withdrawal by Subject|0|||
105631349|NCT00545545|364315097|FG001|Overall Study|Withdrawal by Subject|1|||
105631350|NCT00545545|364315098|FG002|Overall Study|Withdrawal by Subject|0|||
105631351|NCT00545545|364315099|FG003|Overall Study|Withdrawal by Subject|0|||
105631352|NCT00545545|364315100|FG004|Overall Study|Withdrawal by Subject|0|||
105631353|NCT00545545|364315101|FG005|Overall Study|Withdrawal by Subject|0|||
105631354|NCT00545545|364315096|FG000|Overall Study|Physician Decision|1|||
105631355|NCT00545545|364315097|FG001|Overall Study|Physician Decision|0|||
105631356|NCT00545545|364315098|FG002|Overall Study|Physician Decision|0|||
105631357|NCT00545545|364315099|FG003|Overall Study|Physician Decision|0|||
105631358|NCT00545545|364315100|FG004|Overall Study|Physician Decision|0|||
105631359|NCT00545545|364315101|FG005|Overall Study|Physician Decision|1|||
105631360|NCT00545545|364315096|FG000|Overall Study|Irinotecan intolerance|1|||
105631361|NCT00545545|364315097|FG001|Overall Study|Irinotecan intolerance|1|||
105631362|NCT00545545|364315098|FG002|Overall Study|Irinotecan intolerance|0|||
105631363|NCT00545545|364315099|FG003|Overall Study|Irinotecan intolerance|0|||
105631364|NCT00545545|364315100|FG004|Overall Study|Irinotecan intolerance|0|||
105631365|NCT00545545|364315101|FG005|Overall Study|Irinotecan intolerance|0|||
105631366|NCT00545545|364315096|FG000|Overall Study|No target lesions to track post surgery|0|||
105631367|NCT00545545|364315097|FG001|Overall Study|No target lesions to track post surgery|0|||
105631368|NCT00545545|364315098|FG002|Overall Study|No target lesions to track post surgery|0|||
105631369|NCT00545545|364315099|FG003|Overall Study|No target lesions to track post surgery|0|||
105631370|NCT00545545|364315100|FG004|Overall Study|No target lesions to track post surgery|1|||
105631371|NCT00545545|364315101|FG005|Overall Study|No target lesions to track post surgery|1|||
105631372|NCT02500576|364315102|FG000|Overall Study|Adverse Event|0|||
105631373|NCT02500576|364315103|FG001|Overall Study|Adverse Event|1|||
105631374|NCT02500576|364315102|FG000|Overall Study|Death|2|||
105631375|NCT02500576|364315103|FG001|Overall Study|Death|1|||
105631376|NCT02500576|364315102|FG000|Overall Study|Lack of Efficacy|5|||
105631377|NCT02500576|364315103|FG001|Overall Study|Lack of Efficacy|5|||
105631378|NCT02500576|364315102|FG000|Overall Study|Withdrawal by Subject|1|||
105631379|NCT02500576|364315103|FG001|Overall Study|Withdrawal by Subject|1|||
105631380|NCT03691493|364315106|FG000|Overall Study|Withdrawal by Subject|1|||
105631381|NCT05827068|364315107|FG000|Overall Study|Lost to Follow-up|1|||
105631382|NCT05827068|364315108|FG001|Overall Study|Lost to Follow-up|4|||
105631383|NCT05827068|364315109|FG002|Overall Study|Lost to Follow-up|1|||
105631384|NCT05827068|364315110|FG003|Overall Study|Lost to Follow-up|1|||
105631385|NCT05827068|364315111|FG004|Overall Study|Lost to Follow-up|2|||
105631386|NCT05827068|364315112|FG005|Overall Study|Lost to Follow-up|4|||
105631387|NCT05827068|364315113|FG006|Overall Study|Lost to Follow-up|1|||
105631388|NCT05827068|364315107|FG000|Overall Study|Withdrawal by Subject|4|||
105631389|NCT05827068|364315108|FG001|Overall Study|Withdrawal by Subject|0|||
105631390|NCT05827068|364315109|FG002|Overall Study|Withdrawal by Subject|1|||
105631391|NCT05827068|364315110|FG003|Overall Study|Withdrawal by Subject|2|||
105631392|NCT05827068|364315111|FG004|Overall Study|Withdrawal by Subject|3|||
105631393|NCT05827068|364315112|FG005|Overall Study|Withdrawal by Subject|0|||
105631394|NCT05827068|364315113|FG006|Overall Study|Withdrawal by Subject|1|||
105631395|NCT05827068|364315107|FG000|Overall Study|Physician Decision|0|||
105631396|NCT05827068|364315108|FG001|Overall Study|Physician Decision|0|||
105631397|NCT05827068|364315109|FG002|Overall Study|Physician Decision|0|||
105631398|NCT05827068|364315110|FG003|Overall Study|Physician Decision|0|||
105631399|NCT05827068|364315111|FG004|Overall Study|Physician Decision|1|||
105631400|NCT05827068|364315112|FG005|Overall Study|Physician Decision|0|||
105631401|NCT05827068|364315113|FG006|Overall Study|Physician Decision|1|||
105631402|NCT05827068|364315107|FG000|Overall Study|Other Than Specified|0|||
105631403|NCT05827068|364315108|FG001|Overall Study|Other Than Specified|1|||
105631404|NCT05827068|364315109|FG002|Overall Study|Other Than Specified|0|||
105631405|NCT05827068|364315110|FG003|Overall Study|Other Than Specified|0|||
105631406|NCT05827068|364315111|FG004|Overall Study|Other Than Specified|0|||
105631407|NCT05827068|364315112|FG005|Overall Study|Other Than Specified|0|||
105631408|NCT05827068|364315113|FG006|Overall Study|Other Than Specified|0|||
105631409|NCT04300023|364315123|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
105631410|NCT04300023|364315124|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
105631411|NCT01855750|364315125|FG000|Overall Study|Death|78|||
105631412|NCT01855750|364315126|FG001|Overall Study|Death|78|||
105631413|NCT01855750|364315125|FG000|Overall Study|Lost to Follow-up|9|||
105631414|NCT01855750|364315126|FG001|Overall Study|Lost to Follow-up|23|||
105631415|NCT01855750|364315125|FG000|Overall Study|Withdrawal by Subject|35|||
105631416|NCT01855750|364315126|FG001|Overall Study|Withdrawal by Subject|28|||
105631417|NCT01855750|364315125|FG000|Overall Study|Sponsor ends the study|297|||
105631418|NCT01855750|364315126|FG001|Overall Study|Sponsor ends the study|290|||
105631419|NCT04977583|364316169|FG000|Overall Study|Lost to Follow-up|8|||
105631420|NCT04977583|364316170|FG001|Overall Study|Lost to Follow-up|4|||
105631421|NCT04977583|364316171|FG002|Overall Study|Lost to Follow-up|13|||
105631422|NCT04977583|364316169|FG000|Overall Study|Withdrawal by Subject|3|||
105631423|NCT04977583|364316170|FG001|Overall Study|Withdrawal by Subject|2|||
105631424|NCT04977583|364316171|FG002|Overall Study|Withdrawal by Subject|1|||
105869290|NCT01783886|365171682|FG002|Overall Study|Withdrawal of consent by participant|4|||
105631425|NCT02422615|364316174|FG000|Treatment Period|Progressive disease|314|||
105631426|NCT02422615|364316175|FG001|Treatment Period|Progressive disease|200|||
105631427|NCT02422615|364316174|FG000|Treatment Period|Adverse Event|51|||
105631428|NCT02422615|364316175|FG001|Treatment Period|Adverse Event|9|||
105631429|NCT02422615|364316174|FG000|Treatment Period|Physician Decision|32|||
105631430|NCT02422615|364316175|FG001|Treatment Period|Physician Decision|8|||
105869291|NCT01783886|365171680|FG000|Overall Study|Adverse Event|4|||
105631431|NCT02422615|364316174|FG000|Treatment Period|Subject/guardian decision|38|||
105631432|NCT02422615|364316175|FG001|Treatment Period|Subject/guardian decision|8|||
105631433|NCT02422615|364316174|FG000|Treatment Period|Death|2|||
105631434|NCT02422615|364316175|FG001|Treatment Period|Death|1|||
105631435|NCT02422615|364316174|FG000|Treatment Period|Technical problems|0|||
105631436|NCT02422615|364316175|FG001|Treatment Period|Technical problems|1|||
105631437|NCT02422615|364316174|FG000|Treatment Period|Protocol deviation|1|||
105631438|NCT02422615|364316175|FG001|Treatment Period|Protocol deviation|1|||
105631439|NCT02422615|364316174|FG000|Treatment Period|Study terminated as per protocol|46|||
105631440|NCT02422615|364316175|FG001|Treatment Period|Study terminated as per protocol|14|||
105631441|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
105631442|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105631443|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Death|2|||
105631444|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Death|1|||
105631445|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
105631446|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105631447|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
105631448|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
105631449|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
105631450|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
105631451|NCT02422615|364316174|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
105631452|NCT02422615|364316175|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
105631453|NCT00557492|364316176|FG000|Overall Study|Change in health insurance|1|||
105631454|NCT00945321|364316177|FG000|Period 1|Adverse Event|0|||
105631455|NCT00945321|364316178|FG001|Period 1|Adverse Event|0|||
105631456|NCT00945321|364316179|FG002|Period 1|Adverse Event|0|||
105631457|NCT00945321|364316180|FG003|Period 1|Adverse Event|0|||
105631458|NCT00945321|364316181|FG004|Period 1|Adverse Event|1|||
105631459|NCT00945321|364316182|FG005|Period 1|Adverse Event|0|||
105631460|NCT00945321|364316177|FG000|Period 4|Lost to Follow-up|0|||
105631461|NCT00945321|364316178|FG001|Period 4|Lost to Follow-up|0|||
105631462|NCT00945321|364316179|FG002|Period 4|Lost to Follow-up|0|||
105631463|NCT00945321|364316180|FG003|Period 4|Lost to Follow-up|0|||
105631464|NCT00945321|364316181|FG004|Period 4|Lost to Follow-up|0|||
105631465|NCT00945321|364316182|FG005|Period 4|Lost to Follow-up|1|||
105631466|NCT01105975|364316183|FG000|Overall Study|Adverse Event|2|||
105631467|NCT01105975|364316184|FG001|Overall Study|Adverse Event|1|||
105631468|NCT01105975|364316185|FG002|Overall Study|Adverse Event|5|||
105631469|NCT01105975|364316186|FG003|Overall Study|Adverse Event|1|||
105631470|NCT01105975|364316187|FG004|Overall Study|Adverse Event|0|||
105631471|NCT01105975|364316188|FG005|Overall Study|Adverse Event|1|||
105631472|NCT01105975|364316189|FG006|Overall Study|Adverse Event|2|||
105631473|NCT01105975|364316190|FG007|Overall Study|Adverse Event|4|||
105631474|NCT01105975|364316191|FG008|Overall Study|Adverse Event|1|||
105631475|NCT01105975|364316192|FG009|Overall Study|Adverse Event|4|||
105631476|NCT01105975|364316183|FG000|Overall Study|Withdrawal by Subject|2|||
105631477|NCT01105975|364316184|FG001|Overall Study|Withdrawal by Subject|2|||
105631478|NCT01105975|364316185|FG002|Overall Study|Withdrawal by Subject|2|||
105631479|NCT01105975|364316186|FG003|Overall Study|Withdrawal by Subject|0|||
105631480|NCT01105975|364316187|FG004|Overall Study|Withdrawal by Subject|4|||
105631481|NCT01105975|364316188|FG005|Overall Study|Withdrawal by Subject|1|||
105631482|NCT01105975|364316189|FG006|Overall Study|Withdrawal by Subject|2|||
105631483|NCT01105975|364316190|FG007|Overall Study|Withdrawal by Subject|1|||
105631484|NCT01105975|364316191|FG008|Overall Study|Withdrawal by Subject|0|||
105631485|NCT01105975|364316192|FG009|Overall Study|Withdrawal by Subject|3|||
105631486|NCT01105975|364316183|FG000|Overall Study|Lost to Follow-up|1|||
105631487|NCT01105975|364316184|FG001|Overall Study|Lost to Follow-up|0|||
105631488|NCT01105975|364316185|FG002|Overall Study|Lost to Follow-up|0|||
105631489|NCT01105975|364316186|FG003|Overall Study|Lost to Follow-up|1|||
105631490|NCT01105975|364316187|FG004|Overall Study|Lost to Follow-up|1|||
105631491|NCT01105975|364316188|FG005|Overall Study|Lost to Follow-up|0|||
105631492|NCT01105975|364316189|FG006|Overall Study|Lost to Follow-up|0|||
105631493|NCT01105975|364316190|FG007|Overall Study|Lost to Follow-up|0|||
105631494|NCT01105975|364316191|FG008|Overall Study|Lost to Follow-up|1|||
105631495|NCT01105975|364316192|FG009|Overall Study|Lost to Follow-up|0|||
105631496|NCT01105975|364316183|FG000|Overall Study|Physician Decision|0|||
105631497|NCT01105975|364316184|FG001|Overall Study|Physician Decision|0|||
105631498|NCT01105975|364316185|FG002|Overall Study|Physician Decision|0|||
105631499|NCT01105975|364316186|FG003|Overall Study|Physician Decision|0|||
105631500|NCT01105975|364316187|FG004|Overall Study|Physician Decision|0|||
105631501|NCT01105975|364316188|FG005|Overall Study|Physician Decision|0|||
105631502|NCT01105975|364316189|FG006|Overall Study|Physician Decision|2|||
105631503|NCT01105975|364316190|FG007|Overall Study|Physician Decision|0|||
105631504|NCT01105975|364316191|FG008|Overall Study|Physician Decision|0|||
105631505|NCT01105975|364316192|FG009|Overall Study|Physician Decision|0|||
105631506|NCT01105975|364316183|FG000|Overall Study|Protocol Violation|0|||
105631507|NCT01105975|364316184|FG001|Overall Study|Protocol Violation|2|||
105631508|NCT01105975|364316185|FG002|Overall Study|Protocol Violation|2|||
105631509|NCT01105975|364316186|FG003|Overall Study|Protocol Violation|0|||
105631510|NCT01105975|364316187|FG004|Overall Study|Protocol Violation|1|||
105631511|NCT01105975|364316188|FG005|Overall Study|Protocol Violation|1|||
105631512|NCT01105975|364316189|FG006|Overall Study|Protocol Violation|1|||
105631513|NCT01105975|364316190|FG007|Overall Study|Protocol Violation|1|||
105631514|NCT01105975|364316191|FG008|Overall Study|Protocol Violation|2|||
105631515|NCT01105975|364316192|FG009|Overall Study|Protocol Violation|2|||
105631516|NCT01105975|364316183|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631517|NCT01105975|364316184|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631518|NCT01105975|364316185|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105631519|NCT01105975|364316186|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631520|NCT01105975|364316187|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631521|NCT01105975|364316188|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
105631522|NCT01105975|364316189|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105631523|NCT01105975|364316190|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
105631524|NCT01105975|364316191|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
105631525|NCT01105975|364316192|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
105631526|NCT03653364|364316193|FG000|Overall Study|Withdrawal by Subject|1|||
105631527|NCT03653364|364316193|FG000|Overall Study|Enrolled in Error|1|||
105631528|NCT03653364|364316193|FG000|Overall Study|Death|1|||
105631529|NCT01566890|364316202|FG000|Overall Study|Adverse Event|1|||
105631530|NCT01566890|364316203|FG001|Overall Study|Adverse Event|0|||
105631531|NCT01566890|364316204|FG002|Overall Study|Adverse Event|0|||
105631532|NCT01566890|364316205|FG003|Overall Study|Adverse Event|0|||
105631533|NCT01566890|364316206|FG004|Overall Study|Adverse Event|0|||
105631534|NCT01566890|364316202|FG000|Overall Study|Withdrawal by Subject|3|||
105631535|NCT01566890|364316203|FG001|Overall Study|Withdrawal by Subject|1|||
105631536|NCT01566890|364316204|FG002|Overall Study|Withdrawal by Subject|1|||
105631537|NCT01566890|364316205|FG003|Overall Study|Withdrawal by Subject|1|||
105631538|NCT01566890|364316206|FG004|Overall Study|Withdrawal by Subject|0|||
105631539|NCT01566890|364316202|FG000|Overall Study|Screen failure|6|||
105631540|NCT01566890|364316203|FG001|Overall Study|Screen failure|0|||
105631541|NCT01566890|364316204|FG002|Overall Study|Screen failure|1|||
105631542|NCT01566890|364316205|FG003|Overall Study|Screen failure|1|||
105631543|NCT01566890|364316206|FG004|Overall Study|Screen failure|0|||
105631544|NCT01566890|364316202|FG000|Overall Study|Incomplete CEU data|1|||
105631545|NCT01566890|364316203|FG001|Overall Study|Incomplete CEU data|3|||
105631546|NCT01566890|364316204|FG002|Overall Study|Incomplete CEU data|5|||
105631547|NCT01566890|364316205|FG003|Overall Study|Incomplete CEU data|8|||
105631548|NCT01566890|364316206|FG004|Overall Study|Incomplete CEU data|0|||
105631549|NCT01566890|364316202|FG000|Overall Study|Lost to Follow-up|0|||
105631550|NCT01566890|364316203|FG001|Overall Study|Lost to Follow-up|0|||
105631551|NCT01566890|364316204|FG002|Overall Study|Lost to Follow-up|4|||
105631552|NCT01566890|364316205|FG003|Overall Study|Lost to Follow-up|4|||
105631553|NCT01566890|364316206|FG004|Overall Study|Lost to Follow-up|0|||
105631554|NCT01566890|364316202|FG000|Overall Study|Other|0|||
105631555|NCT01566890|364316203|FG001|Overall Study|Other|0|||
105631556|NCT01566890|364316204|FG002|Overall Study|Other|0|||
105631557|NCT01566890|364316205|FG003|Overall Study|Other|0|||
105631558|NCT01566890|364316206|FG004|Overall Study|Other|7|||
105631559|NCT02284113|364316207|FG000|Overall Study|Adverse Event|1|||
105631560|NCT02284113|364316208|FG001|Overall Study|Adverse Event|0|||
105631561|NCT02284113|364316207|FG000|Overall Study|non-compliance|0|||
105631562|NCT02284113|364316208|FG001|Overall Study|non-compliance|1|||
105631563|NCT02284113|364316207|FG000|Overall Study|Withdrawal by Subject|0|||
105631564|NCT02284113|364316208|FG001|Overall Study|Withdrawal by Subject|1|||
105631565|NCT02284113|364316207|FG000|Overall Study|not provided|0|||
105631566|NCT02284113|364316208|FG001|Overall Study|not provided|1|||
105631567|NCT02284113|364316207|FG000|Overall Study|surgery cancelled|2|||
105631568|NCT02284113|364316208|FG001|Overall Study|surgery cancelled|0|||
105631569|NCT00003222|364316215|FG000|Overall Study|Physician Decision|0|||
105631570|NCT00003222|364316216|FG001|Overall Study|Physician Decision|1|||
105631571|NCT03885232|364316219|FG000|Overall Study|Lost to Follow-up|74|||
105631572|NCT03885232|364316220|FG001|Overall Study|Lost to Follow-up|32|||
105631573|NCT03885232|364316219|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
105631574|NCT03885232|364316220|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
105631575|NCT03473223|364316221|FG000|Overall Study|Lost to Follow-up|1|||
105631576|NCT03473223|364316222|FG001|Overall Study|Lost to Follow-up|1|||
105631577|NCT03473223|364316221|FG000|Overall Study|Withdrawal by Subject|47|||
105631578|NCT03473223|364316222|FG001|Overall Study|Withdrawal by Subject|42|||
105631579|NCT03473223|364316221|FG000|Overall Study|Indirect contact|32|||
105631580|NCT03473223|364316222|FG001|Overall Study|Indirect contact|29|||
105631581|NCT03473223|364316221|FG000|Overall Study|Other (Not specified)|32|||
105631582|NCT03473223|364316222|FG001|Overall Study|Other (Not specified)|20|||
105631583|NCT04755595|364316223|FG000|Overall Study|Lost to Follow-up|1|||
105631584|NCT02078648|364316224|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
105631585|NCT02078648|364316225|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
105631586|NCT02078648|364316224|FG000|Overall Study|Adverse Event|0|||
105631587|NCT02078648|364316225|FG001|Overall Study|Adverse Event|1|||
105631588|NCT02078648|364316224|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
105631589|NCT02078648|364316225|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
105631590|NCT02078648|364316224|FG000|Overall Study|Withdrawal by Subject|3|||
105631591|NCT02078648|364316225|FG001|Overall Study|Withdrawal by Subject|1|||
105631592|NCT02078648|364316224|FG000|Overall Study|Investigator Decision|5|||
105631593|NCT02078648|364316225|FG001|Overall Study|Investigator Decision|7|||
105631594|NCT02078648|364316224|FG000|Overall Study|Death|1|||
105631595|NCT02078648|364316225|FG001|Overall Study|Death|1|||
105631596|NCT02078648|364316224|FG000|Overall Study|Undefined|0|||
105631597|NCT02078648|364316225|FG001|Overall Study|Undefined|1|||
105631598|NCT05464732|364316226|FG000|Overall Study|Lost to Follow-up|0|||
105631599|NCT05464732|364316227|FG001|Overall Study|Lost to Follow-up|1|||
105631600|NCT05464732|364316226|FG000|Overall Study|Adverse Event|1|||
105631601|NCT05464732|364316227|FG001|Overall Study|Adverse Event|0|||
105631602|NCT04882917|364316231|FG000|Overall Study|Adverse Event|0|||
105631603|NCT04882917|364316232|FG001|Overall Study|Adverse Event|1|||
105631604|NCT04882917|364316233|FG002|Overall Study|Adverse Event|2|||
105631605|NCT04882917|364316234|FG003|Overall Study|Adverse Event|2|||
105631606|NCT04882917|364316231|FG000|Overall Study|Withdrawal by Subject|1|||
105631607|NCT04882917|364316232|FG001|Overall Study|Withdrawal by Subject|0|||
105631608|NCT04882917|364316233|FG002|Overall Study|Withdrawal by Subject|2|||
105631609|NCT04882917|364316234|FG003|Overall Study|Withdrawal by Subject|1|||
105631610|NCT04882917|364316231|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
105631611|NCT04882917|364316232|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
105631612|NCT04882917|364316233|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
105631613|NCT04882917|364316234|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
105631614|NCT00319020|364316235|FG000|Overall Study|Death|2|||
105631615|NCT00319020|364316236|FG001|Overall Study|Death|2|||
105631616|NCT00319020|364316235|FG000|Overall Study|Withdrawal by Subject|4|||
105631617|NCT00319020|364316236|FG001|Overall Study|Withdrawal by Subject|1|||
105631618|NCT00319020|364316235|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
105631619|NCT00319020|364316236|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
105631620|NCT00319020|364316235|FG000|Overall Study|Administrative reason|0|||
105631621|NCT00319020|364316236|FG001|Overall Study|Administrative reason|5|||
105631622|NCT00319020|364316235|FG000|Overall Study|Disease progression|0|||
105631623|NCT00319020|364316236|FG001|Overall Study|Disease progression|2|||
105631624|NCT00319020|364316235|FG000|Overall Study|Transplant|0|||
105631625|NCT00319020|364316236|FG001|Overall Study|Transplant|1|||
105631626|NCT00319020|364316235|FG000|Overall Study|Treatment failure|0|||
105631627|NCT00319020|364316236|FG001|Overall Study|Treatment failure|1|||
105631628|NCT00319020|364316235|FG000|Overall Study|Adverse Event|0|||
105631629|NCT00319020|364316236|FG001|Overall Study|Adverse Event|1|||
105631630|NCT05786612|364316238|FG000|Overall Study|Adverse Event|1|||
105631631|NCT05786612|364316239|FG001|Overall Study|Adverse Event|2|||
105631632|NCT05786612|364316238|FG000|Overall Study|one screening failure|0|||
105631633|NCT05786612|364316239|FG001|Overall Study|one screening failure|2|||
105631634|NCT00748709|364316242|FG000|Overall Study|Progressive disease|15|||
105631635|NCT00748709|364316242|FG000|Overall Study|Drug reducing Toxity|2|||
105631636|NCT00748709|364316242|FG000|Overall Study|Other Adverse Event|1|||
105631637|NCT00748709|364316242|FG000|Overall Study|Withdrawal by Subject|1|||
105631638|NCT00748709|364316242|FG000|Overall Study|Other Reasons|1|||
105631639|NCT05485805|364316245|FG000|Overall Study|Withdrawal by Subject|1|||
105631640|NCT05485805|364316246|FG001|Overall Study|Withdrawal by Subject|2|||
105631641|NCT05485805|364316247|FG002|Overall Study|Withdrawal by Subject|2|||
105631642|NCT05485805|364316248|FG003|Overall Study|Withdrawal by Subject|0|||
105631643|NCT05485805|364316249|FG004|Overall Study|Withdrawal by Subject|2|||
105631644|NCT05485805|364316245|FG000|Overall Study|Adverse Event|0|||
105631645|NCT05485805|364316246|FG001|Overall Study|Adverse Event|1|||
105631646|NCT05485805|364316247|FG002|Overall Study|Adverse Event|0|||
105631647|NCT05485805|364316248|FG003|Overall Study|Adverse Event|0|||
105631648|NCT05485805|364316249|FG004|Overall Study|Adverse Event|0|||
105631649|NCT05485805|364316245|FG000|Overall Study|Lost to Follow-up|1|||
105631650|NCT05485805|364316246|FG001|Overall Study|Lost to Follow-up|1|||
105631651|NCT05485805|364316247|FG002|Overall Study|Lost to Follow-up|3|||
105631652|NCT05485805|364316248|FG003|Overall Study|Lost to Follow-up|1|||
105631653|NCT05485805|364316249|FG004|Overall Study|Lost to Follow-up|0|||
105631654|NCT04218357|364316250|FG000|1st Allocation|Withdrawal by Subject|1|||
105631655|NCT04218357|364316251|FG001|1st Allocation|Withdrawal by Subject|0|||
105631656|NCT06140290|364316252|FG000|Period 1|Adverse Event|1|||
105631657|NCT06140290|364316253|FG001|Period 1|Adverse Event|0|||
105631658|NCT06140290|364316252|FG000|Period 2|Assigned but not treated|0|||
105631659|NCT06140290|364316253|FG001|Period 2|Assigned but not treated|1|||
105631660|NCT06140290|364316252|FG000|Period 2|Withdrawal by Subject|0|||
105631661|NCT06140290|364316253|FG001|Period 2|Withdrawal by Subject|1|||
105631662|NCT03140670|364316923|FG000|Overall Study|Withdrawal by Subject|2|||
105631663|NCT03140670|364316923|FG000|Overall Study|Lost to Follow-up|1|||
105631664|NCT03140670|364316923|FG000|Overall Study|Physician Decision|1|||
105631665|NCT00220805|364316924|FG000|Overall Study|Adverse Event|1|||
105631666|NCT00220805|364316925|FG001|Overall Study|Adverse Event|3|||
105631667|NCT00220805|364316924|FG000|Overall Study|Withdrawal by Subject|3|||
105631668|NCT00220805|364316925|FG001|Overall Study|Withdrawal by Subject|0|||
105631669|NCT00220805|364316924|FG000|Overall Study|Lack of Efficacy|1|||
105631670|NCT00220805|364316925|FG001|Overall Study|Lack of Efficacy|0|||
105631671|NCT00220805|364316924|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
105631672|NCT00220805|364316925|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
105631673|NCT00536120|364316926|FG000|Overall Study|Lost to Follow-up|1|||
105631674|NCT00536120|364316927|FG001|Overall Study|Lost to Follow-up|0|||
105631675|NCT00536120|364316926|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
105631676|NCT00536120|364316927|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
105631677|NCT00536120|364316926|FG000|Overall Study|Non-compliance|1|||
105631678|NCT00536120|364316927|FG001|Overall Study|Non-compliance|0|||
105631679|NCT00536120|364316926|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
105631680|NCT00536120|364316927|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
105631681|NCT00536120|364316926|FG000|Overall Study|Steroid Use|0|||
105631682|NCT00536120|364316927|FG001|Overall Study|Steroid Use|2|||
105631683|NCT00536120|364316926|FG000|Overall Study|Missed Study Visit|0|||
105631684|NCT00536120|364316927|FG001|Overall Study|Missed Study Visit|1|||
105631685|NCT01982682|364316930|FG000|Overall Study|Physician Decision|1|||
105631686|NCT00146172|364316931|FG000|Overall Study|Adverse Event|0|||
105631687|NCT00146172|364316932|FG001|Overall Study|Adverse Event|0|||
105631688|NCT00146172|364316933|FG002|Overall Study|Adverse Event|1|||
105631689|NCT00146172|364316934|FG003|Overall Study|Adverse Event|1|||
105631690|NCT00146172|364316935|FG004|Overall Study|Adverse Event|0|||
105631691|NCT00146172|364316936|FG005|Overall Study|Adverse Event|2|||
105631692|NCT00146172|364316937|FG006|Overall Study|Adverse Event|3|||
105631693|NCT00146172|364316938|FG007|Overall Study|Adverse Event|10|||
105631694|NCT00146172|364316931|FG000|Overall Study|Lost to Follow-up|0|||
105631695|NCT00146172|364316932|FG001|Overall Study|Lost to Follow-up|0|||
105631696|NCT00146172|364316933|FG002|Overall Study|Lost to Follow-up|0|||
105631697|NCT00146172|364316934|FG003|Overall Study|Lost to Follow-up|0|||
105631698|NCT00146172|364316935|FG004|Overall Study|Lost to Follow-up|0|||
105631699|NCT00146172|364316936|FG005|Overall Study|Lost to Follow-up|0|||
105631700|NCT00146172|364316937|FG006|Overall Study|Lost to Follow-up|0|||
105631701|NCT00146172|364316938|FG007|Overall Study|Lost to Follow-up|1|||
105631702|NCT00146172|364316931|FG000|Overall Study|Disease Progression|2|||
105631703|NCT00146172|364316932|FG001|Overall Study|Disease Progression|4|||
105631704|NCT00146172|364316933|FG002|Overall Study|Disease Progression|2|||
105631705|NCT00146172|364316934|FG003|Overall Study|Disease Progression|5|||
105631706|NCT00146172|364316935|FG004|Overall Study|Disease Progression|2|||
105631707|NCT00146172|364316936|FG005|Overall Study|Disease Progression|2|||
105631708|NCT00146172|364316937|FG006|Overall Study|Disease Progression|1|||
105631709|NCT00146172|364316938|FG007|Overall Study|Disease Progression|22|||
105631710|NCT00146172|364316931|FG000|Overall Study|Death|0|||
105631711|NCT00146172|364316932|FG001|Overall Study|Death|0|||
105631712|NCT00146172|364316933|FG002|Overall Study|Death|0|||
105631713|NCT00146172|364316934|FG003|Overall Study|Death|0|||
105631714|NCT00146172|364316935|FG004|Overall Study|Death|0|||
105631715|NCT00146172|364316936|FG005|Overall Study|Death|0|||
105631716|NCT00146172|364316937|FG006|Overall Study|Death|1|||
105631717|NCT00146172|364316938|FG007|Overall Study|Death|0|||
105631718|NCT00146172|364316931|FG000|Overall Study|Physician Decision|0|||
105631719|NCT00146172|364316932|FG001|Overall Study|Physician Decision|0|||
105631720|NCT00146172|364316933|FG002|Overall Study|Physician Decision|0|||
105631721|NCT00146172|364316934|FG003|Overall Study|Physician Decision|0|||
105631722|NCT00146172|364316935|FG004|Overall Study|Physician Decision|0|||
105631723|NCT00146172|364316936|FG005|Overall Study|Physician Decision|0|||
105631724|NCT00146172|364316937|FG006|Overall Study|Physician Decision|0|||
105631725|NCT00146172|364316938|FG007|Overall Study|Physician Decision|1|||
105631726|NCT00146172|364316931|FG000|Overall Study|Withdrawal by Subject|0|||
105631727|NCT00146172|364316932|FG001|Overall Study|Withdrawal by Subject|0|||
105631728|NCT00146172|364316933|FG002|Overall Study|Withdrawal by Subject|0|||
105631729|NCT00146172|364316934|FG003|Overall Study|Withdrawal by Subject|0|||
105631730|NCT00146172|364316935|FG004|Overall Study|Withdrawal by Subject|0|||
105631731|NCT00146172|364316936|FG005|Overall Study|Withdrawal by Subject|1|||
105631732|NCT00146172|364316937|FG006|Overall Study|Withdrawal by Subject|1|||
105631733|NCT00146172|364316938|FG007|Overall Study|Withdrawal by Subject|4|||
105631734|NCT00146172|364316931|FG000|Overall Study|Symptomatic Deterioration|1|||
105631735|NCT00146172|364316932|FG001|Overall Study|Symptomatic Deterioration|0|||
105631736|NCT00146172|364316933|FG002|Overall Study|Symptomatic Deterioration|1|||
105631737|NCT00146172|364316934|FG003|Overall Study|Symptomatic Deterioration|0|||
105631738|NCT00146172|364316935|FG004|Overall Study|Symptomatic Deterioration|1|||
105631739|NCT00146172|364316936|FG005|Overall Study|Symptomatic Deterioration|2|||
105631740|NCT00146172|364316937|FG006|Overall Study|Symptomatic Deterioration|0|||
105631741|NCT00146172|364316938|FG007|Overall Study|Symptomatic Deterioration|2|||
105631742|NCT00623194|364316940|FG000|Overall Study|Lack of Efficacy|1|||
105631743|NCT00623194|364316940|FG000|Overall Study|Protocol Violation|3|||
105631744|NCT00623194|364316940|FG000|Overall Study|Unclassified|1|||
105631745|NCT03170648|364316943|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
105631746|NCT03170648|364316943|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
105631747|NCT03660930|364316944|FG000|Overall Study|Adverse Event|0|||
105631748|NCT03660930|364316945|FG001|Overall Study|Adverse Event|0|||
105631749|NCT03660930|364316946|FG002|Overall Study|Adverse Event|0|||
105631750|NCT03660930|364316947|FG003|Overall Study|Adverse Event|2|||
105631751|NCT03660930|364316948|FG004|Overall Study|Adverse Event|0|||
105631752|NCT03660930|364316949|FG005|Overall Study|Adverse Event|1|||
105631753|NCT03660930|364316950|FG006|Overall Study|Adverse Event|0|||
105631754|NCT03660930|364316951|FG007|Overall Study|Adverse Event|0|||
105631755|NCT03660930|364316944|FG000|Overall Study|Withdrawal by Subject|0|||
105631756|NCT03660930|364316945|FG001|Overall Study|Withdrawal by Subject|0|||
105631757|NCT03660930|364316946|FG002|Overall Study|Withdrawal by Subject|0|||
105631758|NCT03660930|364316947|FG003|Overall Study|Withdrawal by Subject|0|||
105631759|NCT03660930|364316948|FG004|Overall Study|Withdrawal by Subject|0|||
105631760|NCT03660930|364316949|FG005|Overall Study|Withdrawal by Subject|1|||
105631761|NCT03660930|364316950|FG006|Overall Study|Withdrawal by Subject|0|||
105631762|NCT03660930|364316951|FG007|Overall Study|Withdrawal by Subject|0|||
105631763|NCT03509909|364316953|FG000|Overall Study|Withdrawal by Subject|16|||
105631764|NCT03509909|364316954|FG001|Overall Study|Withdrawal by Subject|9|||
105631765|NCT03509909|364316953|FG000|Overall Study|Lost to Follow-up|3|||
105631766|NCT03509909|364316954|FG001|Overall Study|Lost to Follow-up|4|||
105631767|NCT03509909|364316953|FG000|Overall Study|Adverse Event|2|||
105631768|NCT03509909|364316954|FG001|Overall Study|Adverse Event|0|||
105631769|NCT01983683|364316962|FG000|Overall Study|Withdrawal by Subject|14|||
105631770|NCT01983683|364316963|FG001|Overall Study|Withdrawal by Subject|18|||
105631771|NCT01983683|364316962|FG000|Overall Study|Death|11|||
105631772|NCT01983683|364316963|FG001|Overall Study|Death|15|||
105631773|NCT01983683|364316962|FG000|Overall Study|Physician Decision|8|||
105631774|NCT01983683|364316963|FG001|Overall Study|Physician Decision|9|||
105631775|NCT01983683|364316962|FG000|Overall Study|Lost to Follow-up|4|||
105631776|NCT01983683|364316963|FG001|Overall Study|Lost to Follow-up|8|||
105631777|NCT01983683|364316962|FG000|Overall Study|Sponsor Decision|1|||
105631778|NCT01983683|364316963|FG001|Overall Study|Sponsor Decision|1|||
105631779|NCT02678689|364316964|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
105631780|NCT02678689|364316965|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
105631781|NCT03160885|364316966|FG000|Initial Treatment Period|Not dosed|2|||
105631782|NCT03160885|364316967|FG001|Initial Treatment Period|Not dosed|0|||
105631783|NCT03160885|364316968|FG002|Initial Treatment Period|Not dosed|0|||
105631784|NCT03160885|364316969|FG003|Initial Treatment Period|Not dosed|0|||
105631785|NCT03160885|364316970|FG004|Initial Treatment Period|Not dosed|0|||
105631786|NCT03160885|364316971|FG005|Initial Treatment Period|Not dosed|0|||
105631787|NCT03160885|364316972|FG006|Initial Treatment Period|Not dosed|0|||
105631788|NCT03160885|364316966|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
105631789|NCT03160885|364316967|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
105631790|NCT03160885|364316968|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631791|NCT03160885|364316969|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631792|NCT03160885|364316970|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631793|NCT03160885|364316971|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631794|NCT03160885|364316972|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
105631795|NCT03160885|364316966|FG000|Open-label Treatment|Not dosed|0|||
105631796|NCT03160885|364316967|FG001|Open-label Treatment|Not dosed|0|||
105631797|NCT03160885|364316968|FG002|Open-label Treatment|Not dosed|0|||
105631798|NCT03160885|364316969|FG003|Open-label Treatment|Not dosed|0|||
105631799|NCT03160885|364316970|FG004|Open-label Treatment|Not dosed|0|||
105631800|NCT03160885|364316971|FG005|Open-label Treatment|Not dosed|0|||
105631801|NCT03160885|364316972|FG006|Open-label Treatment|Not dosed|2|||
105631802|NCT03160885|364316966|FG000|Open-label Treatment|Discontinued IMP|0|||
105869292|NCT01783886|365171681|FG001|Overall Study|Adverse Event|5|||
105869293|NCT01783886|365171682|FG002|Overall Study|Adverse Event|4|||
105631803|NCT03160885|364316967|FG001|Open-label Treatment|Discontinued IMP|0|||
105631804|NCT03160885|364316968|FG002|Open-label Treatment|Discontinued IMP|0|||
105869294|NCT04542057|365171683|FG000|Overall Study|Death|3|||
105869295|NCT04542057|365171684|FG001|Overall Study|Death|1|||
105869296|NCT04542057|365171683|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
105631805|NCT03160885|364316969|FG003|Open-label Treatment|Discontinued IMP|0|||
105631806|NCT03160885|364316970|FG004|Open-label Treatment|Discontinued IMP|0|||
105631807|NCT03160885|364316971|FG005|Open-label Treatment|Discontinued IMP|0|||
105631808|NCT03160885|364316972|FG006|Open-label Treatment|Discontinued IMP|131|||
105631809|NCT03160885|364316966|FG000|Open-label Treatment|Completed Week 50|0|||
105631810|NCT03160885|364316967|FG001|Open-label Treatment|Completed Week 50|0|||
105631811|NCT03160885|364316968|FG002|Open-label Treatment|Completed Week 50|0|||
105869297|NCT04542057|365171684|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
105631812|NCT03160885|364316969|FG003|Open-label Treatment|Completed Week 50|0|||
105631813|NCT03160885|364316970|FG004|Open-label Treatment|Completed Week 50|0|||
105631814|NCT03160885|364316971|FG005|Open-label Treatment|Completed Week 50|0|||
105631815|NCT03160885|364316972|FG006|Open-label Treatment|Completed Week 50|4|||
105631816|NCT03160885|364316966|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631817|NCT03160885|364316967|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631818|NCT03160885|364316968|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631819|NCT03160885|364316969|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
105631820|NCT03160885|364316970|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631821|NCT03160885|364316971|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631822|NCT03160885|364316972|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
105631823|NCT03160885|364316966|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
105631824|NCT03160885|364316967|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
105631825|NCT03160885|364316968|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
105631826|NCT03160885|364316969|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
105631827|NCT03160885|364316970|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
105631828|NCT03160885|364316971|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
105631829|NCT03160885|364316972|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
105631830|NCT03160885|364316966|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105631831|NCT03160885|364316967|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105631832|NCT03160885|364316968|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
105631833|NCT03160885|364316969|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
105631834|NCT03160885|364316970|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
105631835|NCT03160885|364316971|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
105631836|NCT03160885|364316972|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
105631837|NCT03160885|364316966|FG000|Maintenance Treatment Period|Completed Week 50|0|||
105631838|NCT03160885|364316967|FG001|Maintenance Treatment Period|Completed Week 50|0|||
105631839|NCT03160885|364316968|FG002|Maintenance Treatment Period|Completed Week 50|1|||
105631840|NCT03160885|364316969|FG003|Maintenance Treatment Period|Completed Week 50|0|||
105631841|NCT03160885|364316970|FG004|Maintenance Treatment Period|Completed Week 50|0|||
105631842|NCT03160885|364316971|FG005|Maintenance Treatment Period|Completed Week 50|0|||
105631843|NCT03160885|364316972|FG006|Maintenance Treatment Period|Completed Week 50|0|||
105631844|NCT03425682|364316973|FG000|Overall Study|Lost to Follow-up|2|||
105631845|NCT03425682|364316974|FG001|Overall Study|Lost to Follow-up|4|||
105631846|NCT03425682|364316973|FG000|Overall Study|Withdrawal by Subject|0|||
105631847|NCT03425682|364316974|FG001|Overall Study|Withdrawal by Subject|3|||
105631848|NCT03425682|364316973|FG000|Overall Study|Subject did not meet I/E|4|||
105631849|NCT03425682|364316974|FG001|Overall Study|Subject did not meet I/E|10|||
105631850|NCT03978637|364316978|FG000|Overall Study|Death|0|||
105631851|NCT03978637|364316979|FG001|Overall Study|Death|2|||
105631852|NCT03978637|364316980|FG002|Overall Study|Death|2|||
105631853|NCT03978637|364316981|FG003|Overall Study|Death|0|||
105631854|NCT03978637|364316978|FG000|Overall Study|Withdrawal by Subject|0|||
105631855|NCT03978637|364316979|FG001|Overall Study|Withdrawal by Subject|0|||
105631856|NCT03978637|364316980|FG002|Overall Study|Withdrawal by Subject|1|||
105631857|NCT03978637|364316981|FG003|Overall Study|Withdrawal by Subject|0|||
105631858|NCT03978637|364316978|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
105631859|NCT03978637|364316979|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
105631860|NCT03978637|364316980|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
105631861|NCT03978637|364316981|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
105631862|NCT03277989|364316985|FG000|Overall Study|Lost to Follow-up|6|||
105631863|NCT03277989|364316985|FG000|Overall Study|Adverse Event|6|||
105631864|NCT03277989|364316985|FG000|Overall Study|Withdrawal by Subject|3|||
105631865|NCT03277989|364316985|FG000|Overall Study|Didn't Receive Study Device|7|||
105631866|NCT03277989|364316985|FG000|Overall Study|Site Closure|26|||
105631867|NCT03277989|364316985|FG000|Overall Study|Sponsor Closure|107|||
105631868|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
105631869|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
105631870|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
105631871|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
105631872|NCT03227861|364316988|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
105631873|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
105631874|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
105631875|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
105631876|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
105869298|NCT04542057|365171683|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
105869299|NCT04542057|365171684|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
105631877|NCT03227861|364316988|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
105631878|NCT00490139|364316993|FG000|Overall Study|Lost to Follow-up|249|||
105631879|NCT00490139|364316994|FG001|Overall Study|Lost to Follow-up|216|||
105631880|NCT00490139|364316995|FG002|Overall Study|Lost to Follow-up|205|||
105631881|NCT00490139|364316996|FG003|Overall Study|Lost to Follow-up|229|||
105631882|NCT00490139|364316993|FG000|Overall Study|Withdrawal by Subject|333|||
105631883|NCT00490139|364316994|FG001|Overall Study|Withdrawal by Subject|322|||
105631884|NCT00490139|364316995|FG002|Overall Study|Withdrawal by Subject|396|||
105631885|NCT00490139|364316996|FG003|Overall Study|Withdrawal by Subject|295|||
105631886|NCT00490139|364316993|FG000|Overall Study|Patient did not sign ICF 12|169|||
105631887|NCT00490139|364316994|FG001|Overall Study|Patient did not sign ICF 12|176|||
105631888|NCT00490139|364316995|FG002|Overall Study|Patient did not sign ICF 12|139|||
105631889|NCT00490139|364316996|FG003|Overall Study|Patient did not sign ICF 12|167|||
105631890|NCT00490139|364316993|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
105631891|NCT00490139|364316994|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
105631892|NCT00490139|364316995|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
105631893|NCT00490139|364316996|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
105631894|NCT00490139|364316993|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
105631895|NCT00490139|364316994|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
105631896|NCT00490139|364316995|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
105631897|NCT00490139|364316996|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
105631898|NCT00490139|364316993|FG000|Overall Study|Other reasons as defined per protocol|98|||
105631899|NCT00490139|364316994|FG001|Overall Study|Other reasons as defined per protocol|84|||
105631900|NCT00490139|364316995|FG002|Overall Study|Other reasons as defined per protocol|82|||
105631901|NCT00490139|364316996|FG003|Overall Study|Other reasons as defined per protocol|105|||
105631902|NCT04484623|364316998|FG000|Overall Study|Lost to Follow-up|0|||
105631903|NCT04484623|364316999|FG001|Overall Study|Lost to Follow-up|1|||
105631904|NCT04484623|364316998|FG000|Overall Study|Protocol Deviation|1|||
105631905|NCT04484623|364316999|FG001|Overall Study|Protocol Deviation|0|||
105631906|NCT04484623|364316998|FG000|Overall Study|Physician Decision|1|||
105631907|NCT04484623|364316999|FG001|Overall Study|Physician Decision|0|||
105631908|NCT04484623|364316998|FG000|Overall Study|Withdrawal by Subject|11|||
105631909|NCT04484623|364316999|FG001|Overall Study|Withdrawal by Subject|8|||
105631910|NCT04484623|364316998|FG000|Overall Study|Ongoing|94|||
105631911|NCT04484623|364316999|FG001|Overall Study|Ongoing|84|||
105631912|NCT05293717|364317000|FG000|Overall Study|Physician Decision|1|||
105631913|NCT03876457|364318253|FG000|Overall Study|Lost to Follow-up|1|||
105631914|NCT03876457|364318254|FG001|Overall Study|Lost to Follow-up|3|||
105631915|NCT01036724|364318255|FG000|Overall Study|Adverse Event|1|||
105631916|NCT01036724|364318256|FG001|Overall Study|Adverse Event|2|||
105631917|NCT01036724|364318255|FG000|Overall Study|Lack of Efficacy|1|||
105631918|NCT01036724|364318256|FG001|Overall Study|Lack of Efficacy|1|||
105631919|NCT01036724|364318255|FG000|Overall Study|Protocol Violation|4|||
105631920|NCT01036724|364318256|FG001|Overall Study|Protocol Violation|5|||
105631921|NCT01596972|364318257|FG000|Overall Study|Physician Decision|1|||
105631922|NCT01596972|364318258|FG001|Overall Study|Physician Decision|9|||
105631923|NCT01596972|364318257|FG000|Overall Study|Lost to Follow-up|0|||
105631924|NCT01596972|364318258|FG001|Overall Study|Lost to Follow-up|4|||
105631925|NCT01596972|364318257|FG000|Overall Study|Withdrawal by Subject|0|||
105631926|NCT01596972|364318258|FG001|Overall Study|Withdrawal by Subject|1|||
105631927|NCT02438137|364318264|FG000|Overall Study|Lost to Follow-up|3|||
105631928|NCT02438137|364318265|FG001|Overall Study|Lost to Follow-up|2|||
105631929|NCT02438137|364318264|FG000|Overall Study|Adverse Event|1|||
105631930|NCT02438137|364318265|FG001|Overall Study|Adverse Event|0|||
105631931|NCT02438137|364318264|FG000|Overall Study|Withdrawal by Subject|4|||
105631932|NCT02438137|364318265|FG001|Overall Study|Withdrawal by Subject|3|||
105631933|NCT02438137|364318264|FG000|Overall Study|Physician Decision|0|||
105631934|NCT02438137|364318265|FG001|Overall Study|Physician Decision|1|||
105631935|NCT02291913|364318266|FG000|Overall Study|Progressive Disease|32|||
105631936|NCT02291913|364318266|FG000|Overall Study|Adverse Event|11|||
105631937|NCT02291913|364318266|FG000|Overall Study|Death|2|||
105631938|NCT02291913|364318266|FG000|Overall Study|Physician Decision|1|||
105631939|NCT02291913|364318266|FG000|Overall Study|Withdrawal by Subject|1|||
105631940|NCT02291913|364318266|FG000|Overall Study|Protocol Violation|1|||
105631941|NCT01637402|364318267|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
105631942|NCT01637402|364318268|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
105631943|NCT01637402|364318267|FG000|Standard Dose Regimen|Adverse Event|1|||
105631944|NCT01637402|364318268|FG001|Standard Dose Regimen|Adverse Event|0|||
105631945|NCT01637402|364318267|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
105631946|NCT01637402|364318268|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
105631947|NCT01637402|364318267|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
105631948|NCT01637402|364318268|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
105631949|NCT01637402|364318267|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
105631950|NCT01637402|364318268|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
105631951|NCT01637402|364318267|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
105631952|NCT01637402|364318268|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
105631953|NCT04876417|364318271|FG000|Overall Study|Lost to Follow-up|5|||
105631954|NCT04876417|364318272|FG001|Overall Study|Lost to Follow-up|8|||
105631955|NCT04876417|364318273|FG002|Overall Study|Lost to Follow-up|0|||
105631956|NCT04876417|364318274|FG003|Overall Study|Lost to Follow-up|0|||
105631957|NCT02285270|364318275|FG000|Overall Study|Lost to Follow-up|1|||
105631958|NCT02285270|364318275|FG000|Overall Study|Physician Decision|3|||
105631959|NCT02285270|364318275|FG000|Overall Study|Determined to be ineligible|1|||
105631960|NCT02111096|364318276|FG000|Overall Study|Adverse Event|4|||
105631961|NCT02111096|364318277|FG001|Overall Study|Adverse Event|1|||
105631962|NCT02111096|364318278|FG002|Overall Study|Adverse Event|2|||
105631963|NCT02111096|364318276|FG000|Overall Study|Non-Compliance with Study Drug|1|||
105631964|NCT02111096|364318277|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105631965|NCT02111096|364318278|FG002|Overall Study|Non-Compliance with Study Drug|0|||
105631966|NCT02111096|364318276|FG000|Overall Study|Lost to Follow Up|1|||
105631967|NCT02111096|364318277|FG001|Overall Study|Lost to Follow Up|1|||
105631968|NCT02111096|364318278|FG002|Overall Study|Lost to Follow Up|1|||
105631969|NCT02111096|364318276|FG000|Overall Study|Physician Decision|0|||
105631970|NCT02111096|364318277|FG001|Overall Study|Physician Decision|1|||
105631971|NCT02111096|364318278|FG002|Overall Study|Physician Decision|0|||
105631972|NCT02111096|364318276|FG000|Overall Study|Protocol Violation|1|||
105631973|NCT02111096|364318277|FG001|Overall Study|Protocol Violation|0|||
105631974|NCT02111096|364318278|FG002|Overall Study|Protocol Violation|1|||
105631975|NCT02111096|364318276|FG000|Overall Study|Terminated by Sponsor|53|||
105631976|NCT02111096|364318277|FG001|Overall Study|Terminated by Sponsor|35|||
105631977|NCT02111096|364318278|FG002|Overall Study|Terminated by Sponsor|54|||
105631978|NCT02111096|364318276|FG000|Overall Study|Withdrawal by Subject|4|||
105631979|NCT02111096|364318277|FG001|Overall Study|Withdrawal by Subject|2|||
105631980|NCT02111096|364318278|FG002|Overall Study|Withdrawal by Subject|8|||
105631981|NCT03801148|364318279|FG000|Period 1 (2 Days)|Adverse Event|1|||
105631982|NCT03801148|364318280|FG001|Period 1 (2 Days)|Adverse Event|1|||
105631983|NCT03801148|364318281|FG002|Period 1 (2 Days)|Adverse Event|0|||
105631984|NCT03801148|364318282|FG003|Period 1 (2 Days)|Adverse Event|0|||
105631985|NCT03801148|364318279|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
105631986|NCT03801148|364318280|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
105631987|NCT03801148|364318281|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
105631988|NCT03801148|364318282|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
105631989|NCT03801148|364318279|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105631990|NCT03801148|364318280|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105631991|NCT03801148|364318281|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
105631992|NCT03801148|364318282|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
105631993|NCT03801148|364318279|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
105631994|NCT03801148|364318280|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
105631995|NCT03801148|364318281|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
105631996|NCT03801148|364318282|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
105631997|NCT03621735|364318283|FG000|Overall Study|Withdrawal by Subject|13|||
105631998|NCT03621735|364318284|FG001|Overall Study|Withdrawal by Subject|13|||
105631999|NCT04334317|364318285|FG000|Overall Study|Adverse Event|1|||
105632000|NCT04334317|364318286|FG001|Overall Study|Adverse Event|2|||
105632001|NCT04334317|364318287|FG002|Overall Study|Adverse Event|0|||
105632002|NCT04334317|364318288|FG003|Overall Study|Adverse Event|0|||
105632003|NCT04334317|364318285|FG000|Overall Study|Protocol Deviation|0|||
105632004|NCT04334317|364318286|FG001|Overall Study|Protocol Deviation|1|||
105632005|NCT04334317|364318287|FG002|Overall Study|Protocol Deviation|0|||
105632006|NCT04334317|364318288|FG003|Overall Study|Protocol Deviation|0|||
105632007|NCT04334317|364318285|FG000|Overall Study|Withdrawal by Subject|2|||
105632008|NCT04334317|364318286|FG001|Overall Study|Withdrawal by Subject|2|||
105632009|NCT04334317|364318287|FG002|Overall Study|Withdrawal by Subject|0|||
105632010|NCT04334317|364318288|FG003|Overall Study|Withdrawal by Subject|0|||
105632011|NCT00605306|364318291|FG000|Overall Study|Adverse Event|0|||
105632012|NCT00605306|364318292|FG001|Overall Study|Adverse Event|1|||
105632013|NCT00372775|364318293|FG000|Overall Study|Adverse Event|8|||
105632014|NCT00372775|364318293|FG000|Overall Study|Death|15|||
105632015|NCT00372775|364318293|FG000|Overall Study|Objective progression or relapse|30|||
105632016|NCT00372775|364318293|FG000|Overall Study|Global deterioration of health status|6|||
105632017|NCT00372775|364318293|FG000|Overall Study|Withdrawal by Subject|1|||
105632018|NCT00372775|364318293|FG000|Overall Study|Other|1|||
105632019|NCT00372775|364318293|FG000|Overall Study|Not Treated|2|||
105632020|NCT00686595|364318296|FG000|Overall Study|Adverse Event|3|||
105632021|NCT00686595|364318296|FG000|Overall Study|Protocol Violation|1|||
105632022|NCT00686595|364318296|FG000|Overall Study|Lost to Follow-up|1|||
105632023|NCT00686595|364318296|FG000|Overall Study|Lack of Efficacy|1|||
105632024|NCT00686595|364318296|FG000|Overall Study|Poor Compliance|1|||
105632025|NCT01970007|364318300|FG000|Overall Study|Death|5|||
105632026|NCT01970007|364318300|FG000|Overall Study|Withdrawal by Subject|23|||
105632027|NCT01970007|364318300|FG000|Overall Study|Lost to Follow-up|24|||
105632028|NCT01970007|364318300|FG000|Overall Study|"Other endpoint"|3|||
105632029|NCT00754065|364318301|FG000|Overall Study|Never received treatment|12|||
105632030|NCT00754065|364318302|FG001|Overall Study|Never received treatment|2|||
105632031|NCT00754065|364318301|FG000|Overall Study|Adverse Event|19|||
105632032|NCT00754065|364318302|FG001|Overall Study|Adverse Event|25|||
105632033|NCT00754065|364318301|FG000|Overall Study|Lost to Follow-up|7|||
105632034|NCT00754065|364318302|FG001|Overall Study|Lost to Follow-up|11|||
105632035|NCT00754065|364318301|FG000|Overall Study|Protocol Violation|12|||
105632036|NCT00754065|364318302|FG001|Overall Study|Protocol Violation|10|||
105632037|NCT00754065|364318301|FG000|Overall Study|Withdrawal by Subject|4|||
105632038|NCT00754065|364318302|FG001|Overall Study|Withdrawal by Subject|5|||
105632039|NCT00754065|364318301|FG000|Overall Study|Pregnancy|6|||
105632040|NCT00754065|364318302|FG001|Overall Study|Pregnancy|0|||
105632041|NCT00754065|364318301|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
105632042|NCT00754065|364318302|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
105632043|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
105632044|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
105632045|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
105632046|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
105632047|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
105632048|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
105632049|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
105632050|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
105632051|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
105632052|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
105632053|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
105632054|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
105632055|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
105632056|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
105632057|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
105632058|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
105632059|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
105632060|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
105632061|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
105632062|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
105632063|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
105632064|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
105632065|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
105632066|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
105632067|NCT01074294|364318304|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
105632068|NCT01074294|364318305|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
105632069|NCT01074294|364318306|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
105632070|NCT01074294|364318307|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
105632071|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
105632072|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
105632073|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
105632074|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
105632075|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
105632076|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
105632077|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
105632078|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
105632079|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
105632080|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
105632081|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
105632082|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
105632083|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
105632084|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
105632085|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
105632086|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
105632087|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
105632088|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
105632089|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
105632090|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
105632091|NCT01074294|364318304|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
105869300|NCT04542057|365171683|FG000|Overall Study|Adverse Event|15|||
105869301|NCT04542057|365171684|FG001|Overall Study|Adverse Event|6|||
105869302|NCT04542057|365171683|FG000|Overall Study|COVID-19 adverse event|6|||
105632092|NCT01074294|364318305|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
105632093|NCT01074294|364318306|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
105869303|NCT04542057|365171684|FG001|Overall Study|COVID-19 adverse event|4|||
105632094|NCT01074294|364318307|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
105632095|NCT01394276|364318308|FG000|Overall Study|Related Adverse event (AEs)|15|||
105632096|NCT01394276|364318308|FG000|Overall Study|Not related AEs|9|||
105632097|NCT01394276|364318308|FG000|Overall Study|Remission of disease|2|||
105632098|NCT01394276|364318308|FG000|Overall Study|Insufficient therapeutic effect|17|||
105632099|NCT01394276|364318308|FG000|Overall Study|Insufficient compliance|9|||
105632100|NCT01394276|364318308|FG000|Overall Study|Lost to Follow-up|5|||
105632101|NCT01394276|364318308|FG000|Overall Study|Participant moved to another site|1|||
105632102|NCT01394276|364318308|FG000|Overall Study|Pregnancy|1|||
105632103|NCT01394276|364318308|FG000|Overall Study|unavailability of drug at the Hospital|2|||
105632104|NCT01394276|364318308|FG000|Overall Study|Symptoms of concurrent diseases|1|||
105632105|NCT01315132|364318312|FG000|Overall Study|not treated due to disease progression|1|||
105632106|NCT02787005|364318313|FG000|Overall Study|Adverse Event|24|||
105632107|NCT02787005|364318314|FG001|Overall Study|Adverse Event|9|||
105632108|NCT02787005|364318315|FG002|Overall Study|Adverse Event|9|||
105632109|NCT02787005|364318316|FG003|Overall Study|Adverse Event|7|||
105632110|NCT02787005|364318317|FG004|Overall Study|Adverse Event|2|||
105632111|NCT02787005|364318313|FG000|Overall Study|Death|100|||
105632112|NCT02787005|364318314|FG001|Overall Study|Death|53|||
105632113|NCT02787005|364318315|FG002|Overall Study|Death|48|||
105632114|NCT02787005|364318316|FG003|Overall Study|Death|69|||
105632115|NCT02787005|364318317|FG004|Overall Study|Death|38|||
105632116|NCT02787005|364318313|FG000|Overall Study|Sponsor Decision|7|||
105632117|NCT02787005|364318314|FG001|Overall Study|Sponsor Decision|4|||
105632118|NCT02787005|364318315|FG002|Overall Study|Sponsor Decision|0|||
105632119|NCT02787005|364318316|FG003|Overall Study|Sponsor Decision|4|||
105632120|NCT02787005|364318317|FG004|Overall Study|Sponsor Decision|5|||
105632121|NCT02787005|364318313|FG000|Overall Study|Withdrawal by Subject|2|||
105632122|NCT02787005|364318314|FG001|Overall Study|Withdrawal by Subject|1|||
105632123|NCT02787005|364318315|FG002|Overall Study|Withdrawal by Subject|1|||
105632124|NCT02787005|364318316|FG003|Overall Study|Withdrawal by Subject|0|||
105632125|NCT02787005|364318317|FG004|Overall Study|Withdrawal by Subject|1|||
105632126|NCT02787005|364318313|FG000|Overall Study|Screen Failure|0|||
105632127|NCT02787005|364318314|FG001|Overall Study|Screen Failure|2|||
105632128|NCT02787005|364318315|FG002|Overall Study|Screen Failure|0|||
105632129|NCT02787005|364318316|FG003|Overall Study|Screen Failure|0|||
105632130|NCT02787005|364318317|FG004|Overall Study|Screen Failure|1|||
105632131|NCT02787005|364318313|FG000|Overall Study|Lost to Follow-up|0|||
105632132|NCT02787005|364318314|FG001|Overall Study|Lost to Follow-up|0|||
105632133|NCT02787005|364318315|FG002|Overall Study|Lost to Follow-up|0|||
105632134|NCT02787005|364318316|FG003|Overall Study|Lost to Follow-up|1|||
105632135|NCT02787005|364318317|FG004|Overall Study|Lost to Follow-up|0|||
105632136|NCT02397096|364318318|FG000|Day 1 to Week 24|Adverse Event|7|||
105632137|NCT02397096|364318319|FG001|Day 1 to Week 24|Adverse Event|1|||
105632138|NCT02397096|364318318|FG000|Day 1 to Week 24|Death|1|||
105632139|NCT02397096|364318319|FG001|Day 1 to Week 24|Death|0|||
105632140|NCT02397096|364318318|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
105632141|NCT02397096|364318319|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
105632142|NCT02397096|364318318|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
105632143|NCT02397096|364318319|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
105632144|NCT02397096|364318318|FG000|Day 1 to Week 24|Physician Decision|2|||
105632145|NCT02397096|364318319|FG001|Day 1 to Week 24|Physician Decision|3|||
105632146|NCT02397096|364318318|FG000|Day 1 to Week 24|Protocol Violation|1|||
105632147|NCT02397096|364318319|FG001|Day 1 to Week 24|Protocol Violation|4|||
105632148|NCT02397096|364318318|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
105632149|NCT02397096|364318319|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
105632150|NCT02397096|364318318|FG000|Day 1 to Week 24|Randomized, not treated|3|||
105632151|NCT02397096|364318319|FG001|Day 1 to Week 24|Randomized, not treated|0|||
105632152|NCT02397096|364318318|FG000|Week 24 to Week 48|Adverse Event|6|||
105632153|NCT02397096|364318319|FG001|Week 24 to Week 48|Adverse Event|2|||
105632154|NCT02397096|364318318|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
105632155|NCT02397096|364318319|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
105632156|NCT02397096|364318318|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
105632157|NCT02397096|364318319|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
105632158|NCT02397096|364318318|FG000|Week 24 to Week 48|Physician Decision|2|||
105632159|NCT02397096|364318319|FG001|Week 24 to Week 48|Physician Decision|1|||
105632160|NCT02397096|364318318|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
105632161|NCT02397096|364318319|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
105632162|NCT02397096|364318318|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
105632163|NCT02397096|364318319|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
105632164|NCT02397096|364318318|FG000|Study Extension 1|Adverse Event|7|||
105632165|NCT02397096|364318319|FG001|Study Extension 1|Adverse Event|5|||
105632166|NCT02397096|364318318|FG000|Study Extension 1|Death|1|||
105632167|NCT02397096|364318319|FG001|Study Extension 1|Death|0|||
105632168|NCT02397096|364318318|FG000|Study Extension 1|Lack of Efficacy|2|||
105632169|NCT02397096|364318319|FG001|Study Extension 1|Lack of Efficacy|5|||
105632170|NCT02397096|364318318|FG000|Study Extension 1|Lost to Follow-up|2|||
105632171|NCT02397096|364318319|FG001|Study Extension 1|Lost to Follow-up|3|||
105632172|NCT02397096|364318318|FG000|Study Extension 1|Non-compliance with study drug|3|||
105632173|NCT02397096|364318319|FG001|Study Extension 1|Non-compliance with study drug|0|||
105632174|NCT02397096|364318318|FG000|Study Extension 1|Physician Decision|4|||
105632175|NCT02397096|364318319|FG001|Study Extension 1|Physician Decision|2|||
105632176|NCT02397096|364318318|FG000|Study Extension 1|Pregnancy|1|||
105632177|NCT02397096|364318319|FG001|Study Extension 1|Pregnancy|0|||
105632178|NCT02397096|364318318|FG000|Study Extension 1|Protocol Violation|0|||
105632179|NCT02397096|364318319|FG001|Study Extension 1|Protocol Violation|1|||
105632180|NCT02397096|364318318|FG000|Study Extension 1|Withdrawal by Subject|21|||
105632181|NCT02397096|364318319|FG001|Study Extension 1|Withdrawal by Subject|7|||
105632182|NCT02397096|364318318|FG000|Study Extension 2|Adverse Event|3|||
105632183|NCT02397096|364318319|FG001|Study Extension 2|Adverse Event|3|||
105632184|NCT02397096|364318318|FG000|Study Extension 2|Availability of study medication locally|152|||
105632185|NCT02397096|364318319|FG001|Study Extension 2|Availability of study medication locally|64|||
105632186|NCT02397096|364318318|FG000|Study Extension 2|Death|2|||
105632187|NCT02397096|364318319|FG001|Study Extension 2|Death|0|||
105632188|NCT02397096|364318318|FG000|Study Extension 2|Lack of Efficacy|1|||
105632189|NCT02397096|364318319|FG001|Study Extension 2|Lack of Efficacy|0|||
105632190|NCT02397096|364318318|FG000|Study Extension 2|Lost to Follow-up|2|||
105632191|NCT02397096|364318319|FG001|Study Extension 2|Lost to Follow-up|1|||
105632192|NCT02397096|364318318|FG000|Study Extension 2|Non-compliance with study drug|1|||
105632193|NCT02397096|364318319|FG001|Study Extension 2|Non-compliance with study drug|0|||
105632194|NCT02397096|364318318|FG000|Study Extension 2|Physician Decision|2|||
105632195|NCT02397096|364318319|FG001|Study Extension 2|Physician Decision|5|||
105632196|NCT02397096|364318318|FG000|Study Extension 2|Pregnancy|1|||
105632197|NCT02397096|364318319|FG001|Study Extension 2|Pregnancy|0|||
105632198|NCT02397096|364318318|FG000|Study Extension 2|Withdrawal by Subject|10|||
105632199|NCT02397096|364318319|FG001|Study Extension 2|Withdrawal by Subject|3|||
105632200|NCT02397096|364318318|FG000|Study Extension 3|Adverse Event|1|||
105632201|NCT02397096|364318319|FG001|Study Extension 3|Adverse Event|0|||
105632202|NCT02397096|364318318|FG000|Study Extension 3|Availability of study medication locally|11|||
105632203|NCT02397096|364318319|FG001|Study Extension 3|Availability of study medication locally|3|||
105632204|NCT02397096|364318318|FG000|Study Extension 3|Lost to Follow-up|1|||
105632205|NCT02397096|364318319|FG001|Study Extension 3|Lost to Follow-up|0|||
105632206|NCT02397096|364318318|FG000|Study Extension 3|Withdrawal by Subject|2|||
105632207|NCT02397096|364318319|FG001|Study Extension 3|Withdrawal by Subject|1|||
105632208|NCT04795167|364318322|FG000|Overall Study|Death|1|||
105632209|NCT04795167|364318323|FG001|Overall Study|Death|18|||
105632210|NCT04795167|364318324|FG002|Overall Study|Death|1|||
105632211|NCT04795167|364318322|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
105632212|NCT04795167|364318323|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
105632213|NCT04795167|364318324|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
105632214|NCT03840902|364318325|FG000|Overall Study|Randomized but not treated|1|||
105632215|NCT03840902|364318326|FG001|Overall Study|Randomized but not treated|1|||
105632216|NCT04337931|364318328|FG000|Overall Study|Death|4|||
105632217|NCT04337931|364318329|FG001|Overall Study|Death|1|||
105632218|NCT04337931|364318330|FG002|Overall Study|Death|7|||
105632219|NCT04337931|364318328|FG000|Overall Study|Withdrawal by Subject|0|||
105632220|NCT04337931|364318329|FG001|Overall Study|Withdrawal by Subject|1|||
105632221|NCT04337931|364318330|FG002|Overall Study|Withdrawal by Subject|0|||
105632222|NCT04337931|364318328|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
105632223|NCT04337931|364318329|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
105632224|NCT04337931|364318330|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
105632225|NCT04337931|364318328|FG000|Overall Study|Study terminated by sponsor|3|||
105632226|NCT04337931|364318329|FG001|Overall Study|Study terminated by sponsor|6|||
105632227|NCT04337931|364318330|FG002|Overall Study|Study terminated by sponsor|2|||
105632228|NCT04337931|364318328|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
105632229|NCT04337931|364318329|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
105632230|NCT04337931|364318330|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
105869304|NCT04542057|365171683|FG000|Overall Study|Lack of Efficacy|2|||
105632231|NCT04337931|364318328|FG000|Overall Study|Colorectal cancer treatment|1|||
105632232|NCT04337931|364318329|FG001|Overall Study|Colorectal cancer treatment|0|||
105632233|NCT04337931|364318330|FG002|Overall Study|Colorectal cancer treatment|0|||
105632234|NCT04337931|364318328|FG000|Overall Study|Participant decision|0|||
105632235|NCT04337931|364318329|FG001|Overall Study|Participant decision|1|||
105632236|NCT04337931|364318330|FG002|Overall Study|Participant decision|0|||
105632237|NCT04153890|364318333|FG000|Overall Study|Lost to Follow-up|9|||
105632238|NCT04153890|364318334|FG001|Overall Study|Lost to Follow-up|0|||
105632239|NCT04153890|364318335|FG002|Overall Study|Lost to Follow-up|9|||
105632240|NCT04153890|364318336|FG003|Overall Study|Lost to Follow-up|0|||
105632241|NCT04153890|364318333|FG000|Overall Study|Death|0|||
105632242|NCT04153890|364318334|FG001|Overall Study|Death|2|||
105632243|NCT04153890|364318335|FG002|Overall Study|Death|0|||
105632244|NCT04153890|364318336|FG003|Overall Study|Death|0|||
105869305|NCT04542057|365171684|FG001|Overall Study|Lack of Efficacy|5|||
105632245|NCT04153890|364318333|FG000|Overall Study|Withdrawal by Subject|0|||
105632246|NCT04153890|364318334|FG001|Overall Study|Withdrawal by Subject|0|||
105632247|NCT04153890|364318335|FG002|Overall Study|Withdrawal by Subject|0|||
105632248|NCT04153890|364318336|FG003|Overall Study|Withdrawal by Subject|2|||
105632249|NCT02307682|364318339|FG000|Overall Study|Adverse Event|9|||
105632250|NCT02307682|364318340|FG001|Overall Study|Adverse Event|8|||
105632251|NCT02307682|364318341|FG002|Overall Study|Adverse Event|12|||
105632252|NCT02307682|364318339|FG000|Overall Study|Lack of Efficacy|1|||
105632253|NCT02307682|364318340|FG001|Overall Study|Lack of Efficacy|0|||
105632254|NCT02307682|364318341|FG002|Overall Study|Lack of Efficacy|1|||
105632255|NCT02307682|364318339|FG000|Overall Study|Physician Decision|2|||
105632256|NCT02307682|364318340|FG001|Overall Study|Physician Decision|2|||
105632257|NCT02307682|364318341|FG002|Overall Study|Physician Decision|8|||
105632258|NCT02307682|364318339|FG000|Overall Study|Progressive Disease|1|||
105632259|NCT02307682|364318340|FG001|Overall Study|Progressive Disease|0|||
105632260|NCT02307682|364318341|FG002|Overall Study|Progressive Disease|0|||
105632261|NCT02307682|364318339|FG000|Overall Study|Withdrawal by Subject|26|||
105632262|NCT02307682|364318340|FG001|Overall Study|Withdrawal by Subject|34|||
105632263|NCT02307682|364318341|FG002|Overall Study|Withdrawal by Subject|23|||
105632264|NCT02307682|364318339|FG000|Overall Study|Death|9|||
105632265|NCT02307682|364318340|FG001|Overall Study|Death|7|||
105632266|NCT02307682|364318341|FG002|Overall Study|Death|12|||
105632267|NCT02307682|364318339|FG000|Overall Study|Lost to Follow-up|1|||
105632268|NCT02307682|364318340|FG001|Overall Study|Lost to Follow-up|5|||
105869306|NCT04542057|365171683|FG000|Overall Study|Study terminated by sponsor|1|||
105869307|NCT04542057|365171684|FG001|Overall Study|Study terminated by sponsor|0|||
105869308|NCT04542057|365171683|FG000|Overall Study|Investigator discretion|2|||
105869309|NCT04542057|365171684|FG001|Overall Study|Investigator discretion|1|||
105869310|NCT04542057|365171683|FG000|Overall Study|Withdrawal by Subject|52|||
105869311|NCT04542057|365171684|FG001|Overall Study|Withdrawal by Subject|30|||
105869312|NCT04542057|365171683|FG000|Overall Study|Lost to Follow-up|8|||
105869313|NCT04542057|365171684|FG001|Overall Study|Lost to Follow-up|11|||
105869314|NCT04542057|365171683|FG000|Overall Study|Other|2|||
105869315|NCT04542057|365171684|FG001|Overall Study|Other|2|||
105869316|NCT00104572|365171685|FG000|Overall Study|Withdrawal by Subject|3|||
105869317|NCT00104572|365171686|FG001|Overall Study|Withdrawal by Subject|3|||
105869318|NCT00104572|365171687|FG002|Overall Study|Withdrawal by Subject|0|||
105869319|NCT02324582|365171688|FG000|Overall Study|Screen Failures|0|||
105869320|NCT02324582|365171689|FG001|Overall Study|Screen Failures|5|||
105869321|NCT02290405|365171690|FG000|Overall Study|Withdrawal by Subject|1|||
105869322|NCT02290405|365171691|FG001|Overall Study|Withdrawal by Subject|0|||
105869323|NCT03541317|365171692|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
105869324|NCT03541317|365171693|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105869325|NCT03541317|365171694|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105869326|NCT03541317|365171695|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105869327|NCT03541317|365171696|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105869328|NCT03541317|365171697|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
105632269|NCT02307682|364318341|FG002|Overall Study|Lost to Follow-up|6|||
105632270|NCT02307682|364318339|FG000|Overall Study|Protocol Deviation|0|||
105632271|NCT02307682|364318340|FG001|Overall Study|Protocol Deviation|0|||
105632272|NCT02307682|364318341|FG002|Overall Study|Protocol Deviation|2|||
105632273|NCT02307682|364318339|FG000|Overall Study|Other|1|||
105632274|NCT02307682|364318340|FG001|Overall Study|Other|1|||
105632275|NCT02307682|364318341|FG002|Overall Study|Other|0|||
105632276|NCT02549352|364318344|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
105632277|NCT02549352|364318345|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
105632278|NCT02549352|364318344|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
105632279|NCT02549352|364318345|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
105632280|NCT02549352|364318344|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
105632281|NCT02549352|364318345|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
105632282|NCT02549352|364318344|FG000|12-month Follow-up|Withdrawal by Subject|4|||
105632283|NCT02549352|364318345|FG001|12-month Follow-up|Withdrawal by Subject|5|||
105632284|NCT02549352|364318344|FG000|12-month Follow-up|Lost to Follow-up|3|||
105632285|NCT02549352|364318345|FG001|12-month Follow-up|Lost to Follow-up|2|||
105869329|NCT02969044|365171700|FG000|Overall Study|Withdrawal by Subject|2|||
105869330|NCT02969044|365171701|FG001|Overall Study|Withdrawal by Subject|6|||
105632286|NCT02549352|364318344|FG000|12-month Follow-up|Death|0|||
105632287|NCT02549352|364318345|FG001|12-month Follow-up|Death|1|||
105632288|NCT02549352|364318344|FG000|12-month Follow-up|Protocol Violation|0|||
105632289|NCT02549352|364318345|FG001|12-month Follow-up|Protocol Violation|1|||
105632290|NCT02549352|364318344|FG000|12-month Follow-up|Other|1|||
105869331|NCT02969044|365171700|FG000|Overall Study|Adverse Event|3|||
105632291|NCT02549352|364318345|FG001|12-month Follow-up|Other|3|||
105632292|NCT05704725|364318346|FG000|Overall Study|Lost to Follow-up|0|||
105632293|NCT05704725|364318347|FG001|Overall Study|Lost to Follow-up|1|||
105632294|NCT05704725|364318346|FG000|Overall Study|Withdrawal by Subject|1|||
105869332|NCT02969044|365171701|FG001|Overall Study|Adverse Event|0|||
105632295|NCT05704725|364318347|FG001|Overall Study|Withdrawal by Subject|0|||
105632296|NCT03002194|364319258|FG000|Overall Study|Lost to Follow-up|6|||
105632297|NCT03002194|364319258|FG000|Overall Study|Adverse Event|1|||
105632298|NCT03002194|364319258|FG000|Overall Study|Lack of Efficacy|1|||
105632299|NCT03002194|364319258|FG000|Overall Study|Withdrawal by Subject|2|||
105632300|NCT01288443|364319261|FG000|Overall Study|Adverse Event|0|||
105632301|NCT01288443|364319262|FG001|Overall Study|Adverse Event|0|||
105632302|NCT01288443|364319263|FG002|Overall Study|Adverse Event|1|||
105632303|NCT01288443|364319264|FG003|Overall Study|Adverse Event|1|||
105632304|NCT01288443|364319265|FG004|Overall Study|Adverse Event|3|||
105632305|NCT01288443|364319266|FG005|Overall Study|Adverse Event|1|||
105632306|NCT01288443|364319261|FG000|Overall Study|Poor compliance to protocol|0|||
105632307|NCT01288443|364319262|FG001|Overall Study|Poor compliance to protocol|0|||
105632308|NCT01288443|364319263|FG002|Overall Study|Poor compliance to protocol|0|||
105632309|NCT01288443|364319264|FG003|Overall Study|Poor compliance to protocol|0|||
105632310|NCT01288443|364319265|FG004|Overall Study|Poor compliance to protocol|0|||
105632311|NCT01288443|364319266|FG005|Overall Study|Poor compliance to protocol|1|||
105632312|NCT01288443|364319261|FG000|Overall Study|Participant Moved|0|||
105632313|NCT01288443|364319262|FG001|Overall Study|Participant Moved|0|||
105632314|NCT01288443|364319263|FG002|Overall Study|Participant Moved|0|||
105632315|NCT01288443|364319264|FG003|Overall Study|Participant Moved|1|||
105632316|NCT01288443|364319265|FG004|Overall Study|Participant Moved|2|||
105632317|NCT01288443|364319266|FG005|Overall Study|Participant Moved|1|||
105632318|NCT01288443|364319261|FG000|Overall Study|Consent withdrawn by Participant|0|||
105632319|NCT01288443|364319262|FG001|Overall Study|Consent withdrawn by Participant|0|||
105632320|NCT01288443|364319263|FG002|Overall Study|Consent withdrawn by Participant|0|||
105632321|NCT01288443|364319264|FG003|Overall Study|Consent withdrawn by Participant|0|||
105632322|NCT01288443|364319265|FG004|Overall Study|Consent withdrawn by Participant|0|||
105632323|NCT01288443|364319266|FG005|Overall Study|Consent withdrawn by Participant|1|||
105632324|NCT01288443|364319261|FG000|Overall Study|Lost to Follow-up|0|||
105632325|NCT01288443|364319262|FG001|Overall Study|Lost to Follow-up|1|||
105632326|NCT01288443|364319263|FG002|Overall Study|Lost to Follow-up|0|||
105632327|NCT01288443|364319264|FG003|Overall Study|Lost to Follow-up|0|||
105632328|NCT01288443|364319265|FG004|Overall Study|Lost to Follow-up|0|||
105632329|NCT01288443|364319266|FG005|Overall Study|Lost to Follow-up|0|||
105632330|NCT01288443|364319261|FG000|Overall Study|Study drug auto-injector administration|0|||
105632331|NCT01288443|364319262|FG001|Overall Study|Study drug auto-injector administration|0|||
105632332|NCT01288443|364319263|FG002|Overall Study|Study drug auto-injector administration|0|||
105632333|NCT01288443|364319264|FG003|Overall Study|Study drug auto-injector administration|0|||
105632334|NCT01288443|364319265|FG004|Overall Study|Study drug auto-injector administration|1|||
105632335|NCT01288443|364319266|FG005|Overall Study|Study drug auto-injector administration|1|||
105632336|NCT01288443|364319261|FG000|Overall Study|Other than above|0|||
105632337|NCT01288443|364319262|FG001|Overall Study|Other than above|0|||
105632338|NCT01288443|364319263|FG002|Overall Study|Other than above|0|||
105632339|NCT01288443|364319264|FG003|Overall Study|Other than above|2|||
105632340|NCT01288443|364319265|FG004|Overall Study|Other than above|1|||
105632341|NCT01288443|364319266|FG005|Overall Study|Other than above|0|||
105632342|NCT01092416|364319268|FG000|Enrollment|Atherectomy device not inserted|3|||
105632343|NCT01092416|364319268|FG000|30-Day Follow-up|Death|2|||
105632344|NCT01092416|364319268|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
105632345|NCT01092416|364319268|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
105632346|NCT01092416|364319268|FG000|12-Month Follow-up|Death|16|||
105632347|NCT01092416|364319268|FG000|12-Month Follow-up|Lost to Follow-up|4|||
105632348|NCT01092416|364319268|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
105632349|NCT01092416|364319268|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
105632350|NCT01092416|364319268|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
105632351|NCT00366249|364319269|FG000|Overall Study|Adverse Event|53|||
105632352|NCT00366249|364319270|FG001|Overall Study|Adverse Event|28|||
105632353|NCT00366249|364319269|FG000|Overall Study|Death|0|||
105632354|NCT00366249|364319270|FG001|Overall Study|Death|1|||
105632355|NCT00366249|364319269|FG000|Overall Study|Physician Decision|5|||
105632356|NCT00366249|364319270|FG001|Overall Study|Physician Decision|2|||
105632357|NCT00366249|364319269|FG000|Overall Study|Lost to Follow-up|2|||
105632358|NCT00366249|364319270|FG001|Overall Study|Lost to Follow-up|0|||
105632359|NCT00366249|364319269|FG000|Overall Study|Protocol Violation|1|||
105632360|NCT00366249|364319270|FG001|Overall Study|Protocol Violation|2|||
105632361|NCT00366249|364319269|FG000|Overall Study|Withdrawal by Subject|18|||
105632362|NCT00366249|364319270|FG001|Overall Study|Withdrawal by Subject|4|||
105632363|NCT00366249|364319269|FG000|Overall Study|Lack of Efficacy|21|||
105632364|NCT00366249|364319270|FG001|Overall Study|Lack of Efficacy|21|||
105632365|NCT00366249|364319269|FG000|Overall Study|Most due to osteomylitis status|31|||
105632366|NCT00366249|364319270|FG001|Overall Study|Most due to osteomylitis status|20|||
105632367|NCT00246805|364319271|FG000|Phase 1|Lost to Follow-up|1|||
105632368|NCT00246805|364319272|FG001|Phase 1|Lost to Follow-up|0|||
105632369|NCT00609869|364319273|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
105632370|NCT00609869|364319273|FG000|Overall Study|Severe hematologic toxicity|1|||
105632371|NCT00609869|364319273|FG000|Overall Study|Withdrawal by Subject|1|||
105632372|NCT00609869|364319273|FG000|Overall Study|Seizures|1|||
105632373|NCT00609869|364319273|FG000|Overall Study|Severe tumor flare reaction|1|||
105632374|NCT00609869|364319273|FG000|Overall Study|Hepatitis B infection|1|||
105632375|NCT00609869|364319273|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
105632376|NCT00609869|364319273|FG000|Overall Study|Mantle cell: not evaluable|4|||
105632377|NCT01627561|364319274|FG000|Overall Study|Lost to Follow-up|1|||
105632378|NCT01627561|364319275|FG001|Overall Study|Lost to Follow-up|0|||
105632379|NCT01627561|364319274|FG000|Overall Study|Withdrawal by Subject|0|||
105632380|NCT01627561|364319275|FG001|Overall Study|Withdrawal by Subject|1|||
105632381|NCT01627561|364319274|FG000|Overall Study|Migrated/moved from study area|0|||
105632382|NCT01627561|364319275|FG001|Overall Study|Migrated/moved from study area|2|||
105632383|NCT02941549|364319276|FG000|Overall Study|Adverse Event|1|||
105632384|NCT02941549|364319277|FG001|Overall Study|Adverse Event|0|||
105632385|NCT02941549|364319278|FG002|Overall Study|Adverse Event|0|||
105632386|NCT02941549|364319276|FG000|Overall Study|Withdrawal by Subject|2|||
105632387|NCT02941549|364319277|FG001|Overall Study|Withdrawal by Subject|1|||
105632388|NCT02941549|364319278|FG002|Overall Study|Withdrawal by Subject|2|||
105632389|NCT01579318|364319281|FG000|Overall Study|Disease Progression|1|||
105632390|NCT02347332|364319285|FG000|Overall Study|Not treated|5|||
105632391|NCT02347332|364319286|FG001|Overall Study|Not treated|2|||
105632392|NCT02347332|364319285|FG000|Overall Study|Progressive disease|141|||
105632393|NCT02347332|364319286|FG001|Overall Study|Progressive disease|159|||
105632394|NCT02347332|364319285|FG000|Overall Study|Adverse Event|50|||
105632395|NCT02347332|364319286|FG001|Overall Study|Adverse Event|41|||
105632396|NCT02347332|364319285|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
105632397|NCT02347332|364319286|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
105632398|NCT02347332|364319285|FG000|Overall Study|Protocol Violation|1|||
105869333|NCT02517463|365171702|FG000|Overall Study|Lost to Follow-up|5|||
105869334|NCT02517463|365171703|FG001|Overall Study|Lost to Follow-up|2|||
105869335|NCT00489827|365171704|FG000|Overall Study|Intraoperative exclusion criteria|1|||
105632399|NCT02347332|364319286|FG001|Overall Study|Protocol Violation|1|||
105632400|NCT02347332|364319285|FG000|Overall Study|Lost to Follow-up|2|||
105632401|NCT02347332|364319286|FG001|Overall Study|Lost to Follow-up|1|||
105632402|NCT02347332|364319285|FG000|Overall Study|Physician Decision|4|||
105632403|NCT02347332|364319286|FG001|Overall Study|Physician Decision|3|||
105632404|NCT02347332|364319285|FG000|Overall Study|Withdrawal by Subject|20|||
105632405|NCT02347332|364319286|FG001|Overall Study|Withdrawal by Subject|14|||
105632406|NCT02347332|364319285|FG000|Overall Study|Protocol requirement|1|||
105632407|NCT02347332|364319286|FG001|Overall Study|Protocol requirement|1|||
105632408|NCT02347332|364319285|FG000|Overall Study|Switch Post-Trial program|0|||
105632409|NCT02347332|364319286|FG001|Overall Study|Switch Post-Trial program|1|||
105632410|NCT02502526|364319287|FG000|Overall Study|Lost to Follow-up|2|||
105632411|NCT02502526|364319288|FG001|Overall Study|Lost to Follow-up|2|||
105632412|NCT02502526|364319289|FG002|Overall Study|Lost to Follow-up|3|||
105632413|NCT02502526|364319287|FG000|Overall Study|Withdrawal by Subject|0|||
105632414|NCT02502526|364319288|FG001|Overall Study|Withdrawal by Subject|1|||
105632415|NCT02502526|364319289|FG002|Overall Study|Withdrawal by Subject|1|||
105632416|NCT02502526|364319287|FG000|Overall Study|Disqualified due to cataract grading|0|||
105632417|NCT02502526|364319288|FG001|Overall Study|Disqualified due to cataract grading|0|||
105632418|NCT02502526|364319289|FG002|Overall Study|Disqualified due to cataract grading|1|||
105632419|NCT02502526|364319287|FG000|Overall Study|Enrollment suspension|4|||
105632420|NCT02502526|364319288|FG001|Overall Study|Enrollment suspension|1|||
105632421|NCT02502526|364319289|FG002|Overall Study|Enrollment suspension|1|||
105632422|NCT00918333|364319290|FG000|Overall Study|Drug not taken per protocol|1|||
105632423|NCT00918333|364319291|FG001|Overall Study|Drug not taken per protocol|0|||
105632424|NCT00918333|364319290|FG000|Overall Study|Inadequate amount of drugs provided|1|||
105632425|NCT00918333|364319291|FG001|Overall Study|Inadequate amount of drugs provided|4|||
105632426|NCT00918333|364319290|FG000|Overall Study|Ineligible|1|||
105632427|NCT00918333|364319291|FG001|Overall Study|Ineligible|0|||
105632428|NCT00918333|364319290|FG000|Overall Study|Withdrawal by Subject|0|||
105632429|NCT00918333|364319291|FG001|Overall Study|Withdrawal by Subject|1|||
105632430|NCT00112359|364319294|FG000|Overall Study|Unrelated adverse event|16|||
105632431|NCT00112359|364319295|FG001|Overall Study|Unrelated adverse event|8|||
105632432|NCT00112359|364319294|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
105632433|NCT00112359|364319295|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
105632434|NCT00112359|364319294|FG000|Overall Study|Related adverse event|5|||
105632435|NCT00112359|364319295|FG001|Overall Study|Related adverse event|3|||
105632436|NCT00112359|364319294|FG000|Overall Study|Lost to Follow-up|0|||
105632437|NCT00112359|364319295|FG001|Overall Study|Lost to Follow-up|1|||
105632438|NCT00112359|364319294|FG000|Overall Study|Personal/administrative|1|||
105632439|NCT00112359|364319295|FG001|Overall Study|Personal/administrative|1|||
105632440|NCT00112359|364319294|FG000|Overall Study|Other|3|||
105632441|NCT00112359|364319295|FG001|Overall Study|Other|0|||
105632442|NCT00857766|364319296|FG000|Overall Study|Adverse Event|13|||
105869336|NCT00489827|365171705|FG001|Overall Study|Intraoperative exclusion criteria|1|||
105632443|NCT00857766|364319297|FG001|Overall Study|Adverse Event|12|||
105632444|NCT00857766|364319296|FG000|Overall Study|Protocol Violation|11|||
105632445|NCT00857766|364319297|FG001|Overall Study|Protocol Violation|11|||
105632446|NCT00857766|364319296|FG000|Overall Study|Lost to Follow-up|1|||
105632447|NCT00857766|364319297|FG001|Overall Study|Lost to Follow-up|0|||
105632448|NCT00857766|364319296|FG000|Overall Study|Investigator Discretion|2|||
105632449|NCT00857766|364319297|FG001|Overall Study|Investigator Discretion|3|||
105632450|NCT00857766|364319296|FG000|Overall Study|Participant Withdrew Consent|4|||
105632451|NCT00857766|364319297|FG001|Overall Study|Participant Withdrew Consent|4|||
105632452|NCT01961609|364319298|FG000|Initiation|Missing|3|||
105632453|NCT01961609|364319299|FG001|Initiation|Missing|2|||
105632454|NCT01961609|364319300|FG002|Initiation|Missing|0|||
105632455|NCT01961609|364319301|FG003|Initiation|Missing|0|||
105632456|NCT01961609|364319298|FG000|Initiation|Protocol deviation|1|||
105632457|NCT01961609|364319299|FG001|Initiation|Protocol deviation|0|||
105632458|NCT01961609|364319300|FG002|Initiation|Protocol deviation|0|||
105632459|NCT01961609|364319301|FG003|Initiation|Protocol deviation|0|||
105632460|NCT01961609|364319298|FG000|Initiation|Death|0|||
105632461|NCT01961609|364319299|FG001|Initiation|Death|1|||
105632462|NCT01961609|364319300|FG002|Initiation|Death|0|||
105632463|NCT01961609|364319301|FG003|Initiation|Death|0|||
105632464|NCT01961609|364319298|FG000|Initiation|Administrative problems|1|||
105632465|NCT01961609|364319299|FG001|Initiation|Administrative problems|0|||
105632466|NCT01961609|364319300|FG002|Initiation|Administrative problems|0|||
105632467|NCT01961609|364319301|FG003|Initiation|Administrative problems|0|||
105632468|NCT01961609|364319298|FG000|Initiation|Withdrawal by Subject|1|||
105632469|NCT01961609|364319299|FG001|Initiation|Withdrawal by Subject|2|||
105632470|NCT01961609|364319300|FG002|Initiation|Withdrawal by Subject|0|||
105632471|NCT01961609|364319301|FG003|Initiation|Withdrawal by Subject|0|||
105632472|NCT01961609|364319298|FG000|Initiation|Lack of Efficacy|2|||
105632473|NCT01961609|364319299|FG001|Initiation|Lack of Efficacy|1|||
105632474|NCT01961609|364319300|FG002|Initiation|Lack of Efficacy|0|||
105632475|NCT01961609|364319301|FG003|Initiation|Lack of Efficacy|0|||
105632476|NCT01961609|364319298|FG000|Initiation|Abnormal lab values|0|||
105632477|NCT01961609|364319299|FG001|Initiation|Abnormal lab values|1|||
105632478|NCT01961609|364319300|FG002|Initiation|Abnormal lab values|0|||
105632479|NCT01961609|364319301|FG003|Initiation|Abnormal lab values|0|||
105632480|NCT01961609|364319298|FG000|Initiation|Adverse Event|3|||
105632481|NCT01961609|364319299|FG001|Initiation|Adverse Event|5|||
105632482|NCT01961609|364319300|FG002|Initiation|Adverse Event|0|||
105632483|NCT01961609|364319301|FG003|Initiation|Adverse Event|0|||
105632484|NCT01961609|364319298|FG000|Initiation|Randomized but not treated|1|||
105632485|NCT01961609|364319299|FG001|Initiation|Randomized but not treated|1|||
105632486|NCT01961609|364319300|FG002|Initiation|Randomized but not treated|0|||
105632487|NCT01961609|364319301|FG003|Initiation|Randomized but not treated|0|||
105632488|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
105632489|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
105632490|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
105632491|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
105632492|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
105632493|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
105632494|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
105632495|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
105632496|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
105632497|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
105632498|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
105632499|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
105632500|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
105632501|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
105632502|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
105632503|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
105632504|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
105632505|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
105632506|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
105632507|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
105632508|NCT01961609|364319298|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
105632509|NCT01961609|364319299|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
105632510|NCT01961609|364319300|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
105632511|NCT01961609|364319301|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
105632512|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
105632513|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
105632514|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
105869337|NCT00489827|365171704|FG000|Overall Study|Intraoperative exclusion criteria|1|||
105632515|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
105632516|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
105632517|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
105632518|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
105632519|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
105632520|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
105632521|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
105632522|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
105632523|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
105632524|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
105632525|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
105632526|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
105632527|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
105632528|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
105632529|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
105632530|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
105632531|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
105632532|NCT01961609|364319298|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
105632533|NCT01961609|364319299|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
105632534|NCT01961609|364319300|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
105632535|NCT01961609|364319301|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
105632536|NCT01753999|364319302|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
105632537|NCT01753999|364319303|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
105632538|NCT01753999|364319302|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
105632539|NCT01753999|364319303|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
105632540|NCT01753999|364319302|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
105632541|NCT01753999|364319303|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
105632542|NCT01753999|364319302|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
105632543|NCT01753999|364319303|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
105632544|NCT01753999|364319302|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
105632545|NCT01753999|364319303|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
105632546|NCT01753999|364319302|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
105632547|NCT01753999|364319303|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
105632548|NCT04436289|364319304|FG000|Overall Study|Death prior to hospital discharge|8|||
105632549|NCT04436289|364319305|FG001|Overall Study|Death prior to hospital discharge|5|||
105632550|NCT04436289|364319306|FG002|Overall Study|Death prior to hospital discharge|0|||
105632551|NCT04436289|364319307|FG003|Overall Study|Death prior to hospital discharge|1|||
105632552|NCT04436289|364319304|FG000|Overall Study|Withdrawal by Subject|0|||
105632553|NCT04436289|364319305|FG001|Overall Study|Withdrawal by Subject|1|||
105632554|NCT04436289|364319306|FG002|Overall Study|Withdrawal by Subject|4|||
105632555|NCT04436289|364319307|FG003|Overall Study|Withdrawal by Subject|0|||
105632556|NCT04436289|364319304|FG000|Overall Study|Extended hospital stay|0|||
105632557|NCT04436289|364319305|FG001|Overall Study|Extended hospital stay|1|||
105632558|NCT04436289|364319306|FG002|Overall Study|Extended hospital stay|0|||
105632559|NCT04436289|364319307|FG003|Overall Study|Extended hospital stay|0|||
105632560|NCT04436289|364319304|FG000|Overall Study|Lost to Follow-up|0|||
105632561|NCT04436289|364319305|FG001|Overall Study|Lost to Follow-up|4|||
105632562|NCT04436289|364319306|FG002|Overall Study|Lost to Follow-up|1|||
105632563|NCT04436289|364319307|FG003|Overall Study|Lost to Follow-up|3|||
105632564|NCT02972359|364319309|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
105632565|NCT02972359|364319309|FG000|Overall Study|Lack of Efficacy|1|||
105632566|NCT02972359|364319309|FG000|Overall Study|Adverse Event|4|||
105632567|NCT02972359|364319309|FG000|Overall Study|Death|1|||
105632568|NCT02972359|364319309|FG000|Overall Study|Withdrawal by Subject|30|||
105632569|NCT02972359|364319309|FG000|Overall Study|Protocol Violation|1|||
105632570|NCT02972359|364319309|FG000|Overall Study|Lost to Follow-up|26|||
105632571|NCT02972359|364319309|FG000|Overall Study|Other reasons|5|||
105632572|NCT02972359|364319309|FG000|Overall Study|Missing|1|||
105632573|NCT01371994|364319313|FG000|Overall Study|Adverse Event|3|||
105632574|NCT01371994|364319314|FG001|Overall Study|Adverse Event|6|||
105632575|NCT01371994|364319313|FG000|Overall Study|Lack of Efficacy|3|||
105632576|NCT01371994|364319314|FG001|Overall Study|Lack of Efficacy|0|||
105632577|NCT01371994|364319313|FG000|Overall Study|Withdrawal by Subject|13|||
105632578|NCT01371994|364319314|FG001|Overall Study|Withdrawal by Subject|7|||
105632579|NCT01371994|364319313|FG000|Overall Study|Lost to Follow-up|1|||
105632580|NCT01371994|364319314|FG001|Overall Study|Lost to Follow-up|1|||
105632581|NCT01371994|364319313|FG000|Overall Study|Protocol Violation|24|||
105632582|NCT01371994|364319314|FG001|Overall Study|Protocol Violation|17|||
105632583|NCT01371994|364319313|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
105632584|NCT01371994|364319314|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
105632585|NCT01371994|364319313|FG000|Overall Study|Physician Decision|1|||
105632586|NCT01371994|364319314|FG001|Overall Study|Physician Decision|1|||
105632587|NCT01371994|364319313|FG000|Overall Study|Miscellaneous Reasons|6|||
105632588|NCT01371994|364319314|FG001|Overall Study|Miscellaneous Reasons|4|||
105632589|NCT01675492|364319317|FG000|Overall Study|study completed early - product approval|42|||
105632590|NCT04021862|364319318|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632591|NCT04021862|364319319|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
105632592|NCT04021862|364319320|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632593|NCT04021862|364319321|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632594|NCT04021862|364319322|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632595|NCT04021862|364319323|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
105632596|NCT04021862|364319318|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
105632597|NCT04021862|364319319|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632598|NCT04021862|364319320|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632599|NCT04021862|364319321|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632600|NCT04021862|364319322|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632601|NCT04021862|364319323|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
105632602|NCT04021862|364319318|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632603|NCT04021862|364319319|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632604|NCT04021862|364319320|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
105632605|NCT04021862|364319321|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632606|NCT04021862|364319322|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632607|NCT04021862|364319323|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
105632608|NCT04021862|364319318|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
105632609|NCT04021862|364319319|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
105632610|NCT04021862|364319320|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
105632611|NCT04021862|364319321|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
105632612|NCT04021862|364319322|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
105632613|NCT04021862|364319323|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
105632614|NCT04021862|364319318|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632615|NCT04021862|364319319|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632616|NCT04021862|364319320|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632617|NCT04021862|364319321|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
105632618|NCT04021862|364319322|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632619|NCT04021862|364319323|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
105632620|NCT02415127|364319324|FG000|Overall Study|Adverse Event|1|||
105632621|NCT02415127|364319325|FG001|Overall Study|Adverse Event|0|||
105632622|NCT05525572|364319327|FG000|Overall Study|Lost to Follow-up|2|||
105632623|NCT05025384|364319328|FG000|Overall Study|Physician Decision|5|||
105632624|NCT05025384|364319329|FG001|Overall Study|Physician Decision|6|||
105632625|NCT04057131|364319330|FG000|Overall Study|Protocol Violation|24|||
105632626|NCT03170349|364319336|FG000|From Implant to the 30-Day Visit|Death|1|||
105632627|NCT03170349|364319336|FG000|From 30-Day to 6-Month Visit|Death|3|||
105632628|NCT03170349|364319336|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
105632629|NCT03170349|364319336|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
105632630|NCT03170349|364319336|FG000|From 6-Month to 1-Year Visit|Death|6|||
105632631|NCT03170349|364319336|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
105632632|NCT03170349|364319336|FG000|From 1-Year to 2-Year Visit|Death|13|||
105632633|NCT03170349|364319336|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
105632634|NCT03170349|364319336|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
105632635|NCT03170349|364319336|FG000|From 2-Year to 3-Year Visit|Death|10|||
105632636|NCT03170349|364319336|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
105632637|NCT03170349|364319336|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
105632638|NCT03170349|364319336|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
105632639|NCT01958021|364319339|FG000|Treatment|Progressive disease|206|||
105632640|NCT01958021|364319340|FG001|Treatment|Progressive disease|265|||
105632641|NCT01958021|364319339|FG000|Treatment|Adverse Event|38|||
105632642|NCT01958021|364319340|FG001|Treatment|Adverse Event|10|||
105632643|NCT01958021|364319339|FG000|Treatment|Subject/guardian decision|29|||
105632644|NCT01958021|364319340|FG001|Treatment|Subject/guardian decision|25|||
105632645|NCT01958021|364319339|FG000|Treatment|Physician Decision|28|||
105632646|NCT01958021|364319340|FG001|Treatment|Physician Decision|21|||
105632647|NCT01958021|364319339|FG000|Treatment|Death|6|||
105632648|NCT01958021|364319340|FG001|Treatment|Death|1|||
105632649|NCT01958021|364319339|FG000|Treatment|Protocol deviation|3|||
105632650|NCT01958021|364319340|FG001|Treatment|Protocol deviation|1|||
105632651|NCT01958021|364319339|FG000|Treatment|Sponsor decision|24|||
105632652|NCT01958021|364319340|FG001|Treatment|Sponsor decision|11|||
105632653|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
105632654|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
105632655|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Death|1|||
105632656|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Death|0|||
105632657|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
105869338|NCT00489827|365171705|FG001|Overall Study|Intraoperative exclusion criteria|1|||
105632658|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
105632659|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
105632660|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
105632661|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
105632662|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
105632663|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
105632664|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
105632665|NCT01958021|364319339|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
105632666|NCT01958021|364319340|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
105632667|NCT05470114|364319341|FG000|Overall Study|Withdrawal by Subject|1|||
105632668|NCT05470114|364319342|FG001|Overall Study|Withdrawal by Subject|0|||
105632669|NCT05470114|364319341|FG000|Overall Study|Lost to Follow-up|1|||
105632670|NCT05470114|364319342|FG001|Overall Study|Lost to Follow-up|0|||
105632671|NCT02325466|364320488|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
105632672|NCT02325466|364320489|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
105632673|NCT02325466|364320490|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
105632674|NCT02325466|364320488|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
105632675|NCT02325466|364320489|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
105632676|NCT02325466|364320490|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
105632677|NCT02325466|364320488|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
105632678|NCT02325466|364320489|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
105632679|NCT02325466|364320490|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
105632680|NCT02325466|364320488|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
105632681|NCT02325466|364320489|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
105632682|NCT02325466|364320490|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
105632683|NCT02325466|364320488|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
105632684|NCT02325466|364320489|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
105632685|NCT02325466|364320490|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
105632686|NCT02325466|364320488|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
105632687|NCT02325466|364320489|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
105632688|NCT02325466|364320490|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
105632689|NCT02325466|364320488|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
105632690|NCT02325466|364320489|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
105632691|NCT02325466|364320490|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
105632692|NCT02325466|364320488|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
105632693|NCT02325466|364320489|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
105632694|NCT02325466|364320490|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
105632695|NCT02325466|364320488|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
105632696|NCT02325466|364320489|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
105632697|NCT02325466|364320490|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
105632698|NCT01812759|364320491|FG000|Overall Study|Physician Decision|0|||
105632699|NCT01812759|364320492|FG001|Overall Study|Physician Decision|0|||
105632700|NCT01812759|364320493|FG002|Overall Study|Physician Decision|1|||
105632701|NCT00360269|364320494|FG000|Overall Study|Lost to Follow-up|7|||
105632702|NCT00360269|364320495|FG001|Overall Study|Lost to Follow-up|9|||
105632703|NCT00360269|364320494|FG000|Overall Study|Physician Decision|1|||
105632704|NCT00360269|364320495|FG001|Overall Study|Physician Decision|2|||
105632705|NCT00360269|364320494|FG000|Overall Study|Adverse Event|1|||
105632706|NCT00360269|364320495|FG001|Overall Study|Adverse Event|0|||
105632707|NCT00360269|364320494|FG000|Overall Study|Withdrawal by Subject|1|||
105632708|NCT00360269|364320495|FG001|Overall Study|Withdrawal by Subject|1|||
105632709|NCT01184326|364320496|FG000|Overall Study|Adverse Event|1|||
105632710|NCT01184326|364320497|FG001|Overall Study|Adverse Event|2|||
105632711|NCT01184326|364320498|FG002|Overall Study|Adverse Event|0|||
105632712|NCT01184326|364320496|FG000|Overall Study|Death|0|||
105632713|NCT01184326|364320497|FG001|Overall Study|Death|0|||
105632714|NCT01184326|364320498|FG002|Overall Study|Death|1|||
105632715|NCT01184326|364320496|FG000|Overall Study|Withdrawal by Subject|0|||
105632716|NCT01184326|364320497|FG001|Overall Study|Withdrawal by Subject|0|||
105632717|NCT01184326|364320498|FG002|Overall Study|Withdrawal by Subject|1|||
105632718|NCT01184326|364320496|FG000|Overall Study|Physician Decision|1|||
105632719|NCT01184326|364320497|FG001|Overall Study|Physician Decision|1|||
105632720|NCT01184326|364320498|FG002|Overall Study|Physician Decision|0|||
105632721|NCT01184326|364320496|FG000|Overall Study|Disease Progression|1|||
105632722|NCT01184326|364320497|FG001|Overall Study|Disease Progression|3|||
105632723|NCT01184326|364320498|FG002|Overall Study|Disease Progression|12|||
105632724|NCT01268306|364320499|FG000|Overall Study|Lost to Follow-up|1|||
105632725|NCT04545619|364320501|FG000|Overall Study|due to equipment challenges|1|||
105632726|NCT01988402|364320509|FG000|Overall Study|Adverse Event|1|||
105632727|NCT01988402|364320510|FG001|Overall Study|Adverse Event|2|||
105632728|NCT01988402|364320509|FG000|Overall Study|Withdrawal by Subject|1|||
105869339|NCT01184079|365171708|FG000|Overall Study|Lost to Follow-up|14|||
105632729|NCT01988402|364320510|FG001|Overall Study|Withdrawal by Subject|0|||
105869340|NCT01184079|365171709|FG001|Overall Study|Lost to Follow-up|2|||
105869341|NCT01862484|365171710|FG000|Overall Study|Lack of Efficacy|1|||
105632730|NCT00571649|364320513|FG000|Treatment Period|Adverse Event|438|||
105632731|NCT00571649|364320514|FG001|Treatment Period|Adverse Event|385|||
105632732|NCT00571649|364320513|FG000|Treatment Period|Clinical endpoint reached|50|||
105632733|NCT00571649|364320514|FG001|Treatment Period|Clinical endpoint reached|56|||
105632734|NCT00571649|364320513|FG000|Treatment Period|Withdrawal by Subject|285|||
105632735|NCT00571649|364320514|FG001|Treatment Period|Withdrawal by Subject|255|||
105632736|NCT00571649|364320513|FG000|Treatment Period|Death|76|||
105632737|NCT00571649|364320514|FG001|Treatment Period|Death|59|||
105632738|NCT00571649|364320513|FG000|Treatment Period|Physician Decision|8|||
105632739|NCT00571649|364320514|FG001|Treatment Period|Physician Decision|9|||
105632740|NCT00571649|364320513|FG000|Treatment Period|Lost to Follow-up|43|||
105632741|NCT00571649|364320514|FG001|Treatment Period|Lost to Follow-up|41|||
105632742|NCT00571649|364320513|FG000|Treatment Period|Non-compliant with study medication|88|||
105632743|NCT00571649|364320514|FG001|Treatment Period|Non-compliant with study medication|89|||
105632744|NCT00571649|364320513|FG000|Treatment Period|Patient convenience|11|||
105632745|NCT00571649|364320514|FG001|Treatment Period|Patient convenience|13|||
105632746|NCT00571649|364320513|FG000|Treatment Period|Protocol Violation|90|||
105632747|NCT00571649|364320514|FG001|Treatment Period|Protocol Violation|92|||
105632748|NCT00571649|364320513|FG000|Treatment Period|Technical problems|3|||
105632749|NCT00571649|364320514|FG001|Treatment Period|Technical problems|5|||
105632750|NCT00571649|364320513|FG000|Follow-up Period|Adverse Event|46|||
105632751|NCT00571649|364320514|FG001|Follow-up Period|Adverse Event|40|||
105632752|NCT00571649|364320513|FG000|Follow-up Period|Clinical endpoint reached|5|||
105632753|NCT00571649|364320514|FG001|Follow-up Period|Clinical endpoint reached|2|||
105632754|NCT00571649|364320513|FG000|Follow-up Period|Withdrawal by Subject|119|||
105632755|NCT00571649|364320514|FG001|Follow-up Period|Withdrawal by Subject|115|||
105632756|NCT00571649|364320513|FG000|Follow-up Period|Death|132|||
105632757|NCT00571649|364320514|FG001|Follow-up Period|Death|133|||
105632758|NCT00571649|364320513|FG000|Follow-up Period|Physician Decision|7|||
105632759|NCT00571649|364320514|FG001|Follow-up Period|Physician Decision|13|||
105632760|NCT00571649|364320513|FG000|Follow-up Period|Lost to Follow-up|95|||
105632761|NCT00571649|364320514|FG001|Follow-up Period|Lost to Follow-up|92|||
105632762|NCT00571649|364320513|FG000|Follow-up Period|Patient convenience|136|||
105632763|NCT00571649|364320514|FG001|Follow-up Period|Patient convenience|121|||
105632764|NCT00571649|364320513|FG000|Follow-up Period|Protocol Violation|5|||
105632765|NCT00571649|364320514|FG001|Follow-up Period|Protocol Violation|12|||
105632766|NCT01218659|364320515|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
105632767|NCT01218659|364320516|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
105632768|NCT01218659|364320517|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
105632769|NCT01218659|364320515|FG000|18-Month Randomized Period|Did not receive study drug|0|||
105632770|NCT01218659|364320516|FG001|18-Month Randomized Period|Did not receive study drug|3|||
105632771|NCT01218659|364320517|FG002|18-Month Randomized Period|Did not receive study drug|0|||
105632772|NCT01218659|364320515|FG000|12-Month OLE|Withdrawal by Subject|0|||
105632773|NCT01218659|364320516|FG001|12-Month OLE|Withdrawal by Subject|0|||
105632774|NCT01218659|364320517|FG002|12-Month OLE|Withdrawal by Subject|2|||
105632775|NCT01218659|364320515|FG000|12-Month OLE|Physician Decision|0|||
105632776|NCT01218659|364320516|FG001|12-Month OLE|Physician Decision|0|||
105632777|NCT01218659|364320517|FG002|12-Month OLE|Physician Decision|1|||
105632778|NCT01218659|364320515|FG000|12-Month OLE|Lost to Follow-up|0|||
105632779|NCT01218659|364320516|FG001|12-Month OLE|Lost to Follow-up|0|||
105632780|NCT01218659|364320517|FG002|12-Month OLE|Lost to Follow-up|1|||
105632781|NCT01218659|364320515|FG000|12-Month OLE|Pregnancy|0|||
105632782|NCT01218659|364320516|FG001|12-Month OLE|Pregnancy|0|||
105632783|NCT01218659|364320517|FG002|12-Month OLE|Pregnancy|1|||
105632784|NCT01218659|364320515|FG000|12-Month OLE|Lack of Efficacy|0|||
105632785|NCT01218659|364320516|FG001|12-Month OLE|Lack of Efficacy|0|||
105632786|NCT01218659|364320517|FG002|12-Month OLE|Lack of Efficacy|1|||
105632787|NCT01218659|364320515|FG000|12-Month OLE|Declined to participate in the OLE|0|||
105632788|NCT01218659|364320516|FG001|12-Month OLE|Declined to participate in the OLE|0|||
105632789|NCT01218659|364320517|FG002|12-Month OLE|Declined to participate in the OLE|4|||
105632790|NCT00776009|364320522|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
105632791|NCT00776009|364320523|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
105632792|NCT00776009|364320524|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
105632793|NCT00776009|364320525|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
105632794|NCT00776009|364320526|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
105632795|NCT00776009|364320527|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
105632796|NCT00776009|364320522|FG000|Period 1: First Intervention|Protocol Violation|0|||
105632797|NCT00776009|364320523|FG001|Period 1: First Intervention|Protocol Violation|1|||
105632798|NCT00776009|364320524|FG002|Period 1: First Intervention|Protocol Violation|0|||
105632799|NCT00776009|364320525|FG003|Period 1: First Intervention|Protocol Violation|0|||
105632800|NCT00776009|364320526|FG004|Period 1: First Intervention|Protocol Violation|1|||
105632801|NCT00776009|364320527|FG005|Period 1: First Intervention|Protocol Violation|0|||
105632802|NCT00776009|364320522|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632803|NCT00776009|364320523|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632804|NCT00776009|364320524|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632805|NCT00776009|364320525|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632806|NCT00776009|364320526|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
105632807|NCT00776009|364320527|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
105632808|NCT00776009|364320522|FG000|Period 2: Second Intervention|Protocol Violation|1|||
105632809|NCT00776009|364320523|FG001|Period 2: Second Intervention|Protocol Violation|0|||
105632810|NCT00776009|364320524|FG002|Period 2: Second Intervention|Protocol Violation|1|||
105632811|NCT00776009|364320525|FG003|Period 2: Second Intervention|Protocol Violation|0|||
105632812|NCT00776009|364320526|FG004|Period 2: Second Intervention|Protocol Violation|0|||
105632813|NCT00776009|364320527|FG005|Period 2: Second Intervention|Protocol Violation|0|||
105632814|NCT00776009|364320522|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
105632815|NCT00776009|364320523|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632816|NCT00776009|364320524|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632817|NCT00776009|364320525|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632818|NCT00776009|364320526|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632819|NCT00776009|364320527|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
105632820|NCT01640951|364320532|FG000|Overall Study|Adverse Event|8|||
105632821|NCT01640951|364320533|FG001|Overall Study|Adverse Event|3|||
105632822|NCT01640951|364320534|FG002|Overall Study|Adverse Event|10|||
105632823|NCT01640951|364320535|FG003|Overall Study|Adverse Event|6|||
105632824|NCT01640951|364320536|FG004|Overall Study|Adverse Event|1|||
105632825|NCT01640951|364320537|FG005|Overall Study|Adverse Event|11|||
105632826|NCT01640951|364320538|FG006|Overall Study|Adverse Event|1|||
105632827|NCT01640951|364320539|FG007|Overall Study|Adverse Event|3|||
105632828|NCT01640951|364320532|FG000|Overall Study|Lack of Efficacy|20|||
105632829|NCT01640951|364320533|FG001|Overall Study|Lack of Efficacy|1|||
105632830|NCT01640951|364320534|FG002|Overall Study|Lack of Efficacy|7|||
105632831|NCT01640951|364320535|FG003|Overall Study|Lack of Efficacy|14|||
105632832|NCT01640951|364320536|FG004|Overall Study|Lack of Efficacy|0|||
105632833|NCT01640951|364320537|FG005|Overall Study|Lack of Efficacy|6|||
105632834|NCT01640951|364320538|FG006|Overall Study|Lack of Efficacy|5|||
105632835|NCT01640951|364320539|FG007|Overall Study|Lack of Efficacy|6|||
105632836|NCT01640951|364320532|FG000|Overall Study|Lost to Follow-up|1|||
105632837|NCT01640951|364320533|FG001|Overall Study|Lost to Follow-up|0|||
105632838|NCT01640951|364320534|FG002|Overall Study|Lost to Follow-up|6|||
105632839|NCT01640951|364320535|FG003|Overall Study|Lost to Follow-up|2|||
105632840|NCT01640951|364320536|FG004|Overall Study|Lost to Follow-up|2|||
105632841|NCT01640951|364320537|FG005|Overall Study|Lost to Follow-up|3|||
105632842|NCT01640951|364320538|FG006|Overall Study|Lost to Follow-up|1|||
105632843|NCT01640951|364320539|FG007|Overall Study|Lost to Follow-up|1|||
105632844|NCT01640951|364320532|FG000|Overall Study|Non-compliance with study treatment|0|||
105632845|NCT01640951|364320533|FG001|Overall Study|Non-compliance with study treatment|0|||
105632846|NCT01640951|364320534|FG002|Overall Study|Non-compliance with study treatment|1|||
105632847|NCT01640951|364320535|FG003|Overall Study|Non-compliance with study treatment|1|||
105632848|NCT01640951|364320536|FG004|Overall Study|Non-compliance with study treatment|1|||
105632849|NCT01640951|364320537|FG005|Overall Study|Non-compliance with study treatment|4|||
105632850|NCT01640951|364320538|FG006|Overall Study|Non-compliance with study treatment|1|||
105632851|NCT01640951|364320539|FG007|Overall Study|Non-compliance with study treatment|0|||
105632852|NCT01640951|364320532|FG000|Overall Study|Physician Decision|2|||
105632853|NCT01640951|364320533|FG001|Overall Study|Physician Decision|5|||
105632854|NCT01640951|364320534|FG002|Overall Study|Physician Decision|2|||
105632855|NCT01640951|364320535|FG003|Overall Study|Physician Decision|2|||
105632856|NCT01640951|364320536|FG004|Overall Study|Physician Decision|2|||
105632857|NCT01640951|364320537|FG005|Overall Study|Physician Decision|3|||
105632858|NCT01640951|364320538|FG006|Overall Study|Physician Decision|3|||
105632859|NCT01640951|364320539|FG007|Overall Study|Physician Decision|0|||
105632860|NCT01640951|364320532|FG000|Overall Study|Pregnancy|3|||
105632861|NCT01640951|364320533|FG001|Overall Study|Pregnancy|0|||
105632862|NCT01640951|364320534|FG002|Overall Study|Pregnancy|0|||
105632863|NCT01640951|364320535|FG003|Overall Study|Pregnancy|4|||
105632864|NCT01640951|364320536|FG004|Overall Study|Pregnancy|0|||
105632865|NCT01640951|364320537|FG005|Overall Study|Pregnancy|0|||
105632866|NCT01640951|364320538|FG006|Overall Study|Pregnancy|2|||
105632867|NCT01640951|364320539|FG007|Overall Study|Pregnancy|0|||
105632868|NCT01640951|364320532|FG000|Overall Study|Protocol Deviation|0|||
105632869|NCT01640951|364320533|FG001|Overall Study|Protocol Deviation|1|||
105632870|NCT01640951|364320534|FG002|Overall Study|Protocol Deviation|2|||
105632871|NCT01640951|364320535|FG003|Overall Study|Protocol Deviation|1|||
105632872|NCT01640951|364320536|FG004|Overall Study|Protocol Deviation|0|||
105632873|NCT01640951|364320537|FG005|Overall Study|Protocol Deviation|1|||
105632874|NCT01640951|364320538|FG006|Overall Study|Protocol Deviation|0|||
105632875|NCT01640951|364320539|FG007|Overall Study|Protocol Deviation|0|||
105632876|NCT01640951|364320532|FG000|Overall Study|Subject/Guardian decision|12|||
105632877|NCT01640951|364320533|FG001|Overall Study|Subject/Guardian decision|4|||
105632878|NCT01640951|364320534|FG002|Overall Study|Subject/Guardian decision|13|||
105632879|NCT01640951|364320535|FG003|Overall Study|Subject/Guardian decision|15|||
105632880|NCT01640951|364320536|FG004|Overall Study|Subject/Guardian decision|7|||
105632881|NCT01640951|364320537|FG005|Overall Study|Subject/Guardian decision|19|||
105632882|NCT01640951|364320538|FG006|Overall Study|Subject/Guardian decision|5|||
105632883|NCT01640951|364320539|FG007|Overall Study|Subject/Guardian decision|4|||
105632884|NCT01640951|364320532|FG000|Overall Study|Death|0|||
105632885|NCT01640951|364320533|FG001|Overall Study|Death|1|||
105632886|NCT01640951|364320534|FG002|Overall Study|Death|1|||
105632887|NCT01640951|364320535|FG003|Overall Study|Death|0|||
105632888|NCT01640951|364320536|FG004|Overall Study|Death|0|||
105632889|NCT01640951|364320537|FG005|Overall Study|Death|0|||
105632890|NCT01640951|364320538|FG006|Overall Study|Death|0|||
105632891|NCT01640951|364320539|FG007|Overall Study|Death|2|||
105632892|NCT00582972|364320540|FG000|Overall Study|Protocol Violation|2|||
105632893|NCT03066609|364320541|FG000|INDUCTION|Pregnancy|0|||
105632894|NCT03066609|364320542|FG001|INDUCTION|Pregnancy|0|||
105632895|NCT03066609|364320543|FG002|INDUCTION|Pregnancy|1|||
105632896|NCT03066609|364320544|FG003|INDUCTION|Pregnancy|0|||
105632897|NCT03066609|364320541|FG000|INDUCTION|Lack of Efficacy|0|||
105632898|NCT03066609|364320542|FG001|INDUCTION|Lack of Efficacy|0|||
105632899|NCT03066609|364320543|FG002|INDUCTION|Lack of Efficacy|1|||
105632900|NCT03066609|364320544|FG003|INDUCTION|Lack of Efficacy|0|||
105632901|NCT03066609|364320541|FG000|INDUCTION|Adverse Event|2|||
105632902|NCT03066609|364320542|FG001|INDUCTION|Adverse Event|2|||
105632903|NCT03066609|364320543|FG002|INDUCTION|Adverse Event|0|||
105632904|NCT03066609|364320544|FG003|INDUCTION|Adverse Event|0|||
105632905|NCT03066609|364320541|FG000|MAINTENANCE|Adverse Event|0|||
105632906|NCT03066609|364320542|FG001|MAINTENANCE|Adverse Event|0|||
105632907|NCT03066609|364320543|FG002|MAINTENANCE|Adverse Event|0|||
105632908|NCT03066609|364320544|FG003|MAINTENANCE|Adverse Event|1|||
105632909|NCT03066609|364320541|FG000|MAINTENANCE|Withdrawal by Subject|4|||
105632910|NCT03066609|364320542|FG001|MAINTENANCE|Withdrawal by Subject|2|||
105632911|NCT03066609|364320543|FG002|MAINTENANCE|Withdrawal by Subject|1|||
105632912|NCT03066609|364320544|FG003|MAINTENANCE|Withdrawal by Subject|1|||
105632913|NCT03066609|364320541|FG000|MAINTENANCE|Lost to Follow-up|0|||
105632914|NCT03066609|364320542|FG001|MAINTENANCE|Lost to Follow-up|1|||
105632915|NCT03066609|364320543|FG002|MAINTENANCE|Lost to Follow-up|1|||
105632916|NCT03066609|364320544|FG003|MAINTENANCE|Lost to Follow-up|0|||
105632917|NCT03066609|364320541|FG000|MAINTENANCE|Pregnancy|1|||
105632918|NCT03066609|364320542|FG001|MAINTENANCE|Pregnancy|0|||
105632919|NCT03066609|364320543|FG002|MAINTENANCE|Pregnancy|0|||
105632920|NCT03066609|364320544|FG003|MAINTENANCE|Pregnancy|0|||
105632921|NCT03066609|364320541|FG000|MAINTENANCE|Lack of Efficacy|2|||
105632922|NCT03066609|364320542|FG001|MAINTENANCE|Lack of Efficacy|1|||
105632923|NCT03066609|364320543|FG002|MAINTENANCE|Lack of Efficacy|0|||
105632924|NCT03066609|364320544|FG003|MAINTENANCE|Lack of Efficacy|1|||
105632925|NCT03066609|364320541|FG000|OVERALL STUDY|Adverse Event|2|||
105632926|NCT03066609|364320542|FG001|OVERALL STUDY|Adverse Event|2|||
105632927|NCT03066609|364320543|FG002|OVERALL STUDY|Adverse Event|0|||
105632928|NCT03066609|364320544|FG003|OVERALL STUDY|Adverse Event|1|||
105632929|NCT03066609|364320541|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
105632930|NCT03066609|364320542|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
105632931|NCT03066609|364320543|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
105632932|NCT03066609|364320544|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
105632933|NCT03066609|364320541|FG000|OVERALL STUDY|Lost to Follow-up|1|||
105632934|NCT03066609|364320542|FG001|OVERALL STUDY|Lost to Follow-up|1|||
105632935|NCT03066609|364320543|FG002|OVERALL STUDY|Lost to Follow-up|1|||
105632936|NCT03066609|364320544|FG003|OVERALL STUDY|Lost to Follow-up|1|||
105632937|NCT03066609|364320541|FG000|OVERALL STUDY|Pregnancy|1|||
105632938|NCT03066609|364320542|FG001|OVERALL STUDY|Pregnancy|0|||
105632939|NCT03066609|364320543|FG002|OVERALL STUDY|Pregnancy|1|||
105632940|NCT03066609|364320544|FG003|OVERALL STUDY|Pregnancy|0|||
105632941|NCT03066609|364320541|FG000|OVERALL STUDY|Lack of Efficacy|2|||
105632942|NCT03066609|364320542|FG001|OVERALL STUDY|Lack of Efficacy|1|||
105632943|NCT03066609|364320543|FG002|OVERALL STUDY|Lack of Efficacy|1|||
105632944|NCT03066609|364320544|FG003|OVERALL STUDY|Lack of Efficacy|1|||
105632945|NCT03066609|364320541|FG000|OVERALL STUDY|discontinued follow up|0|||
105632946|NCT03066609|364320542|FG001|OVERALL STUDY|discontinued follow up|2|||
105632947|NCT03066609|364320543|FG002|OVERALL STUDY|discontinued follow up|0|||
105632948|NCT03066609|364320544|FG003|OVERALL STUDY|discontinued follow up|0|||
105632949|NCT03355573|364320545|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
105632950|NCT03355573|364320545|FG000|Overall Study|Sponsor's decision|1|||
105632951|NCT03355573|364320545|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
105632952|NCT03355573|364320545|FG000|Overall Study|PI's decision|2|||
105632953|NCT03355573|364320545|FG000|Overall Study|Withdrawal by Subject|23|||
105632954|NCT03355573|364320545|FG000|Overall Study|Lost to Follow-up|4|||
105632955|NCT03355573|364320545|FG000|Overall Study|Lack of Efficacy|2|||
105632956|NCT03355573|364320545|FG000|Overall Study|Adverse Event, non-fatal|17|||
105632957|NCT03355573|364320545|FG000|Overall Study|Adverse Event, serious fatal|2|||
105632958|NCT01211184|364320554|FG000|Overall Study|Withdrawal by Subject|0|||
105632959|NCT01211184|364320555|FG001|Overall Study|Withdrawal by Subject|2|||
105632960|NCT01211184|364320556|FG002|Overall Study|Withdrawal by Subject|1|||
105632961|NCT01421667|364320557|FG000|Overall Study|Withdrawal by Subject|0|||
105632962|NCT01421667|364320558|FG001|Overall Study|Withdrawal by Subject|1|||
105632963|NCT01421667|364320559|FG002|Overall Study|Withdrawal by Subject|2|||
105632964|NCT01421667|364320560|FG003|Overall Study|Withdrawal by Subject|1|||
105632965|NCT01421667|364320557|FG000|Overall Study|Lost to Follow-up|0|||
105632966|NCT01421667|364320558|FG001|Overall Study|Lost to Follow-up|1|||
105632967|NCT01421667|364320559|FG002|Overall Study|Lost to Follow-up|0|||
105632968|NCT01421667|364320560|FG003|Overall Study|Lost to Follow-up|0|||
105632969|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
105632970|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
105632971|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
105632972|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
105632973|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
105632974|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
105632975|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
105632976|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
105632977|NCT00982644|364320561|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
105632978|NCT00982644|364320562|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
105632979|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
105632980|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
105632981|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
105632982|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
105632983|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
105632984|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
105632985|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
105632986|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
105632987|NCT00982644|364320561|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
105632988|NCT00982644|364320562|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
105632989|NCT00822120|364320563|FG000|Initial Registration|Adverse Event|1|||
105632990|NCT00822120|364320564|FG001|Initial Registration|Adverse Event|0|||
105632991|NCT00822120|364320565|FG002|Initial Registration|Adverse Event|0|||
105632992|NCT00822120|364320566|FG003|Initial Registration|Adverse Event|0|||
105632993|NCT00822120|364320567|FG004|Initial Registration|Adverse Event|0|||
105632994|NCT00822120|364320568|FG005|Initial Registration|Adverse Event|0|||
105632995|NCT00822120|364320563|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
105632996|NCT00822120|364320564|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105632997|NCT00822120|364320565|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105632998|NCT00822120|364320566|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105632999|NCT00822120|364320567|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105633000|NCT00822120|364320568|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
105633001|NCT00822120|364320563|FG000|Initial Registration|Reasons not Protocol Specified|2|||
105633002|NCT00822120|364320564|FG001|Initial Registration|Reasons not Protocol Specified|0|||
105633003|NCT00822120|364320565|FG002|Initial Registration|Reasons not Protocol Specified|0|||
105633004|NCT00822120|364320566|FG003|Initial Registration|Reasons not Protocol Specified|0|||
105633005|NCT00822120|364320567|FG004|Initial Registration|Reasons not Protocol Specified|0|||
105633006|NCT00822120|364320568|FG005|Initial Registration|Reasons not Protocol Specified|0|||
105633007|NCT00822120|364320563|FG000|Initial Registration|Ineligible|22|||
105633008|NCT00822120|364320564|FG001|Initial Registration|Ineligible|1|||
105633009|NCT00822120|364320565|FG002|Initial Registration|Ineligible|0|||
105633010|NCT00822120|364320566|FG003|Initial Registration|Ineligible|0|||
105633011|NCT00822120|364320567|FG004|Initial Registration|Ineligible|0|||
105633012|NCT00822120|364320568|FG005|Initial Registration|Ineligible|0|||
105633013|NCT00822120|364320563|FG000|PET-directed Therapy|Adverse Event|0|||
105633014|NCT00822120|364320564|FG001|PET-directed Therapy|Adverse Event|0|||
105633015|NCT00822120|364320565|FG002|PET-directed Therapy|Adverse Event|0|||
105633016|NCT00822120|364320566|FG003|PET-directed Therapy|Adverse Event|1|||
105633017|NCT00822120|364320567|FG004|PET-directed Therapy|Adverse Event|0|||
105633018|NCT00822120|364320568|FG005|PET-directed Therapy|Adverse Event|0|||
105633019|NCT00822120|364320563|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633020|NCT00822120|364320564|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633021|NCT00822120|364320565|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633022|NCT00822120|364320566|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
105633023|NCT00822120|364320567|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633024|NCT00822120|364320568|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
105633025|NCT00822120|364320563|FG000|PET-directed Therapy|Death|0|||
105633026|NCT00822120|364320564|FG001|PET-directed Therapy|Death|0|||
105633027|NCT00822120|364320565|FG002|PET-directed Therapy|Death|0|||
105633028|NCT00822120|364320566|FG003|PET-directed Therapy|Death|2|||
105633029|NCT00822120|364320567|FG004|PET-directed Therapy|Death|0|||
105633030|NCT00822120|364320568|FG005|PET-directed Therapy|Death|0|||
105633031|NCT00822120|364320563|FG000|PET-directed Therapy|Protocol Violation|0|||
105633032|NCT00822120|364320564|FG001|PET-directed Therapy|Protocol Violation|0|||
105633033|NCT00822120|364320565|FG002|PET-directed Therapy|Protocol Violation|0|||
105633034|NCT00822120|364320566|FG003|PET-directed Therapy|Protocol Violation|6|||
105633035|NCT00822120|364320567|FG004|PET-directed Therapy|Protocol Violation|0|||
105633036|NCT00822120|364320568|FG005|PET-directed Therapy|Protocol Violation|0|||
105633037|NCT01218009|364320569|FG000|Overall Study|Protocol Violation|2|||
105633038|NCT01218009|364320570|FG001|Overall Study|Protocol Violation|1|||
105633039|NCT01218009|364320569|FG000|Overall Study|Withdrawal by Subject|3|||
105633040|NCT01218009|364320570|FG001|Overall Study|Withdrawal by Subject|1|||
105633041|NCT01218009|364320569|FG000|Overall Study|Sponsor terminated study|161|||
105633042|NCT01218009|364320570|FG001|Overall Study|Sponsor terminated study|163|||
105633043|NCT00503906|364320573|FG000|Overall Study|Withdrawal by Subject|1|||
105633044|NCT01324310|364320574|FG000|Overall Study|Adverse Event|1|||
105633045|NCT01324310|364320574|FG000|Overall Study|Disease Progression|1|||
105633046|NCT04060212|364320576|FG000|Overall Study|Withdrawal by Subject|7|||
105633047|NCT00174252|364320577|FG000|Overall Study|Protocol Violation|2|||
105633048|NCT01171976|364320578|FG000|Overall Study|Protocol Violation|0|||
105633049|NCT01171976|364320579|FG001|Overall Study|Protocol Violation|0|||
105633050|NCT01171976|364320580|FG002|Overall Study|Protocol Violation|1|||
105633051|NCT01171976|364320578|FG000|Overall Study|Death|2|||
105633052|NCT01171976|364320579|FG001|Overall Study|Death|4|||
105633053|NCT01171976|364320580|FG002|Overall Study|Death|1|||
105633054|NCT01171976|364320578|FG000|Overall Study|Lost to Follow-up|4|||
105633055|NCT01171976|364320579|FG001|Overall Study|Lost to Follow-up|0|||
105633056|NCT01171976|364320580|FG002|Overall Study|Lost to Follow-up|2|||
105633057|NCT01171976|364320578|FG000|Overall Study|Withdrawal by Subject|1|||
105633058|NCT01171976|364320579|FG001|Overall Study|Withdrawal by Subject|5|||
105869342|NCT01862484|365171711|FG001|Overall Study|Lack of Efficacy|1|||
105869343|NCT01862484|365171710|FG000|Overall Study|Lost to Follow-up|1|||
105869344|NCT01862484|365171711|FG001|Overall Study|Lost to Follow-up|2|||
105869345|NCT01862484|365171710|FG000|Overall Study|Protocol Violation|0|||
105869346|NCT01862484|365171711|FG001|Overall Study|Protocol Violation|2|||
105869347|NCT01862484|365171710|FG000|Overall Study|Withdrawal by Subject|0|||
105869348|NCT01862484|365171711|FG001|Overall Study|Withdrawal by Subject|3|||
105869349|NCT02201277|365171713|FG000|Overall Study|Death|3|||
105869350|NCT02201277|365171714|FG001|Overall Study|Death|4|||
105869351|NCT02201277|365171713|FG000|Overall Study|Lost to Follow-up|2|||
105869352|NCT02201277|365171714|FG001|Overall Study|Lost to Follow-up|1|||
105869353|NCT02201277|365171713|FG000|Overall Study|Failed retrieval|1|||
105869354|NCT02201277|365171714|FG001|Overall Study|Failed retrieval|0|||
105869355|NCT02201277|365171713|FG000|Overall Study|Physician Decision|1|||
105869356|NCT02201277|365171714|FG001|Overall Study|Physician Decision|0|||
105869357|NCT00489255|365171715|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
105869358|NCT00489255|365171716|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
105869359|NCT00489255|365171715|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
105869360|NCT00489255|365171716|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
105869361|NCT00489255|365171715|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
105869362|NCT00489255|365171716|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
105869363|NCT00489255|365171715|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
105869364|NCT00489255|365171716|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
105869365|NCT00489255|365171715|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
105869366|NCT00489255|365171716|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
105869367|NCT00489255|365171715|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
105869368|NCT00489255|365171716|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
105869369|NCT00489255|365171715|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
105869370|NCT00489255|365171716|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
105869371|NCT00489255|365171715|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
105869372|NCT00489255|365171716|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
105869373|NCT00489255|365171715|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
105869374|NCT00489255|365171716|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
105869375|NCT00489255|365171715|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
105869376|NCT00489255|365171716|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
105869377|NCT02215967|365171719|FG000|Overall Study|Patient became ineligible for treatment|0|||
105869378|NCT02215967|365171720|FG001|Overall Study|Patient became ineligible for treatment|0|||
105869379|NCT02215967|365171721|FG002|Overall Study|Patient became ineligible for treatment|0|||
105869380|NCT02215967|365171722|FG003|Overall Study|Patient became ineligible for treatment|3|||
105869381|NCT02215967|365171719|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
105869382|NCT02215967|365171720|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
105633059|NCT01171976|364320580|FG002|Overall Study|Withdrawal by Subject|6|||
105633060|NCT01171976|364320578|FG000|Overall Study|Abnormal test result|1|||
105869383|NCT02215967|365171721|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
105869384|NCT02215967|365171722|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
105869385|NCT04460885|365174430|FG000|Overall Study|Withdrawal by Subject|6|||
105633061|NCT01171976|364320579|FG001|Overall Study|Abnormal test result|0|||
105633062|NCT01171976|364320580|FG002|Overall Study|Abnormal test result|0|||
105633063|NCT01171976|364320578|FG000|Overall Study|Adverse Event|6|||
105633064|NCT01171976|364320579|FG001|Overall Study|Adverse Event|2|||
105633065|NCT01171976|364320580|FG002|Overall Study|Adverse Event|5|||
105633066|NCT02844439|364320581|FG000|Overall Study|Withdrawal by Subject|1|||
105633067|NCT02844439|364320581|FG000|Overall Study|Lost to Follow-up|2|||
105633068|NCT02844439|364320581|FG000|Overall Study|Termination by Sponsor|4|||
105633069|NCT02844439|364320581|FG000|Overall Study|Death|28|||
105633070|NCT02844439|364320581|FG000|Overall Study|Other|5|||
105633071|NCT03304587|364320584|FG000|Overall Study|Headache after intervention|0|||
105633072|NCT03304587|364320585|FG001|Overall Study|Headache after intervention|1|||
105633073|NCT03304587|364320584|FG000|Overall Study|Withdrawal by Subject|1|||
105633074|NCT03304587|364320585|FG001|Overall Study|Withdrawal by Subject|0|||
105633075|NCT01458366|364320587|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
105633076|NCT01458366|364320588|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
105633077|NCT01458366|364320589|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
105633078|NCT01458366|364320590|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
105633079|NCT01458366|364320591|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
105633080|NCT01458366|364320587|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
105633081|NCT01458366|364320588|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
105633082|NCT01458366|364320589|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
105633083|NCT01458366|364320590|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
105633084|NCT01458366|364320591|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
105633085|NCT01387516|364320592|FG000|Overall Study|Lost to Follow-up|4|||
105633086|NCT01387516|364320593|FG001|Overall Study|Lost to Follow-up|4|||
105633087|NCT01387516|364320594|FG002|Overall Study|Lost to Follow-up|2|||
105633088|NCT01387516|364320595|FG003|Overall Study|Lost to Follow-up|3|||
105633089|NCT01387516|364320592|FG000|Overall Study|Withdrawal by Subject|1|||
105633090|NCT01387516|364320593|FG001|Overall Study|Withdrawal by Subject|1|||
105633091|NCT01387516|364320594|FG002|Overall Study|Withdrawal by Subject|2|||
105633092|NCT01387516|364320595|FG003|Overall Study|Withdrawal by Subject|0|||
105633093|NCT01387516|364320592|FG000|Overall Study|Death|0|||
105633094|NCT01387516|364320593|FG001|Overall Study|Death|0|||
105633095|NCT01387516|364320594|FG002|Overall Study|Death|0|||
105633096|NCT01387516|364320595|FG003|Overall Study|Death|1|||
105633097|NCT02337686|364320597|FG000|Overall Study|Adverse Event|1|||
105633098|NCT03516942|364320598|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
105633099|NCT03516942|364320598|FG000|Registration Through Baseline Survey Com|Death|8|||
105633100|NCT03516942|364320598|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
105633101|NCT03516942|364320598|FG000|T0: Baseline|LOST|13|||
105633102|NCT03516942|364320598|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
105633103|NCT03516942|364320598|FG000|T1: 3 Months Survey|Death|10|||
105633104|NCT03516942|364320598|FG000|T1: 3 Months Survey|Lost|163|||
105633105|NCT03516942|364320598|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
105633106|NCT03516942|364320598|FG000|T2: 6 Month Survey|Death|14|||
105633107|NCT03516942|364320598|FG000|T2: 6 Month Survey|Lost|180|||
105633108|NCT03516942|364320598|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
105633109|NCT03516942|364320598|FG000|T3: 12 Month Survey|Death|19|||
105633110|NCT03516942|364320598|FG000|T3: 12 Month Survey|Lost|209|||
105633111|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633112|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633113|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633114|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
105633115|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633116|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633117|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633118|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633119|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633120|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
105633121|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
105633122|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105869386|NCT04460885|365174431|FG001|Overall Study|Withdrawal by Subject|8|||
105869387|NCT04460885|365174430|FG000|Overall Study|Site closure|1|||
105633123|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633124|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
105633125|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633126|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633127|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633128|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633129|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633130|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
105633131|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Death|1|||
105633132|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Death|2|||
105633133|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Death|3|||
105633134|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Death|5|||
105633135|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Death|4|||
105633136|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Death|0|||
105633137|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Death|0|||
105633138|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Death|0|||
105633139|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Death|0|||
105633140|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Death|0|||
105633141|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633142|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
105633143|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633144|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633145|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
105633146|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633147|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633148|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633149|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633150|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
105633151|NCT02401815|364320599|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
105633152|NCT02401815|364320600|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633153|NCT02401815|364320601|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633154|NCT02401815|364320602|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633155|NCT02401815|364320603|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
105633156|NCT02401815|364320604|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633157|NCT02401815|364320605|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633158|NCT02401815|364320606|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633159|NCT02401815|364320607|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633160|NCT02401815|364320608|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
105633161|NCT02401815|364320599|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633162|NCT02401815|364320600|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633163|NCT02401815|364320601|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633164|NCT02401815|364320602|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633165|NCT02401815|364320603|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633166|NCT02401815|364320604|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
105633167|NCT02401815|364320605|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633168|NCT02401815|364320606|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633169|NCT02401815|364320607|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633170|NCT02401815|364320608|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
105633171|NCT02401815|364320599|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633172|NCT02401815|364320600|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633173|NCT02401815|364320601|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633174|NCT02401815|364320602|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633175|NCT02401815|364320603|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633176|NCT02401815|364320604|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633177|NCT02401815|364320605|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
105633178|NCT02401815|364320606|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633179|NCT02401815|364320607|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633180|NCT02401815|364320608|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633181|NCT02401815|364320599|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633182|NCT02401815|364320600|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633183|NCT02401815|364320601|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633184|NCT02401815|364320602|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633185|NCT02401815|364320603|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633186|NCT02401815|364320604|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
105633187|NCT02401815|364320605|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
105633188|NCT02401815|364320606|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633189|NCT02401815|364320607|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633190|NCT02401815|364320608|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
105633191|NCT02401815|364320599|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633192|NCT02401815|364320600|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633193|NCT02401815|364320601|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633194|NCT02401815|364320602|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633195|NCT02401815|364320603|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633196|NCT02401815|364320604|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
105633197|NCT02401815|364320605|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633198|NCT02401815|364320606|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633199|NCT02401815|364320607|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633200|NCT02401815|364320608|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
105633201|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633202|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633203|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633204|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633205|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633206|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633207|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
105633208|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
105633209|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
105633210|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
105633211|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633212|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633213|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633214|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633215|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633216|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633217|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633218|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
105633219|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
105633220|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
105633221|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105869388|NCT04460885|365174431|FG001|Overall Study|Site closure|0|||
105869389|NCT04460885|365174430|FG000|Overall Study|Death|5|||
105869390|NCT04460885|365174431|FG001|Overall Study|Death|4|||
105869391|NCT04460885|365174430|FG000|Overall Study|Physician Decision|2|||
105869392|NCT04460885|365174431|FG001|Overall Study|Physician Decision|1|||
105869393|NCT04460885|365174430|FG000|Overall Study|Lost to Follow-up|4|||
105869394|NCT04460885|365174431|FG001|Overall Study|Lost to Follow-up|4|||
105869395|NCT04559347|365174432|FG000|Overall Study|Death|1|||
105869396|NCT04559347|365174433|FG001|Overall Study|Death|0|||
105869397|NCT04559347|365174432|FG000|Overall Study|Thoracotomy conversion|1|||
105869398|NCT04559347|365174433|FG001|Overall Study|Thoracotomy conversion|1|||
105869399|NCT04559347|365174432|FG000|Overall Study|Provider unavailable|2|||
105869400|NCT04559347|365174433|FG001|Overall Study|Provider unavailable|1|||
105869401|NCT04559347|365174432|FG000|Overall Study|Other|2|||
105869402|NCT04559347|365174433|FG001|Overall Study|Other|1|||
105869403|NCT04324073|365174434|FG000|Overall Study|withdrew consent|0|||
105869404|NCT04324073|365174435|FG001|Overall Study|withdrew consent|4|||
105869405|NCT04324073|365174436|FG002|Overall Study|withdrew consent|2|||
105869406|NCT04324073|365174437|FG003|Overall Study|withdrew consent|8|||
105869407|NCT02586688|365174438|FG000|Overall Study|Lost to Follow-up|2|||
105869408|NCT02586688|365174439|FG001|Overall Study|Lost to Follow-up|1|||
105869409|NCT02586688|365174438|FG000|Overall Study|Withdrawal by Subject|1|||
105869410|NCT02586688|365174439|FG001|Overall Study|Withdrawal by Subject|1|||
105869411|NCT02586688|365174438|FG000|Overall Study|Adverse Event|3|||
105869412|NCT02586688|365174439|FG001|Overall Study|Adverse Event|1|||
105869413|NCT03999996|365174440|FG000|Prior to Booster|Adverse Event|2|||
105869414|NCT03999996|365174441|FG001|Prior to Booster|Adverse Event|0|||
105869415|NCT03999996|365174442|FG002|Prior to Booster|Adverse Event|0|||
105869416|NCT03999996|365174443|FG003|Prior to Booster|Adverse Event|0|||
105869417|NCT03999996|365174440|FG000|Prior to Booster|Lost to Follow-up|17|||
105869418|NCT03999996|365174441|FG001|Prior to Booster|Lost to Follow-up|22|||
105869419|NCT03999996|365174442|FG002|Prior to Booster|Lost to Follow-up|0|||
105869420|NCT03999996|365174443|FG003|Prior to Booster|Lost to Follow-up|0|||
105869421|NCT03999996|365174440|FG000|Prior to Booster|Withdrawal of Consent|51|||
105869422|NCT03999996|365174441|FG001|Prior to Booster|Withdrawal of Consent|8|||
105869423|NCT03999996|365174442|FG002|Prior to Booster|Withdrawal of Consent|0|||
105869424|NCT03999996|365174443|FG003|Prior to Booster|Withdrawal of Consent|0|||
105869425|NCT03999996|365174440|FG000|Prior to Booster|Death|0|||
105869426|NCT03999996|365174441|FG001|Prior to Booster|Death|1|||
105869427|NCT03999996|365174442|FG002|Prior to Booster|Death|0|||
105869428|NCT03999996|365174443|FG003|Prior to Booster|Death|0|||
105869429|NCT03999996|365174440|FG000|Prior to Booster|Reason Not Specified|27|||
105869430|NCT03999996|365174441|FG001|Prior to Booster|Reason Not Specified|4|||
105869431|NCT03999996|365174442|FG002|Prior to Booster|Reason Not Specified|0|||
105869432|NCT03999996|365174443|FG003|Prior to Booster|Reason Not Specified|0|||
105869433|NCT03999996|365174440|FG000|Booster Phase|Lost to Follow-up|0|||
105869434|NCT03999996|365174441|FG001|Booster Phase|Lost to Follow-up|0|||
105869435|NCT03999996|365174442|FG002|Booster Phase|Lost to Follow-up|3|||
105869436|NCT03999996|365174443|FG003|Booster Phase|Lost to Follow-up|3|||
105869437|NCT03999996|365174440|FG000|Booster Phase|Withdrawal of Consent|0|||
105869438|NCT03999996|365174441|FG001|Booster Phase|Withdrawal of Consent|0|||
105869439|NCT03999996|365174442|FG002|Booster Phase|Withdrawal of Consent|0|||
105633222|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633223|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633224|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633225|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633226|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633227|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633228|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633229|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
105633230|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
105633231|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633232|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633233|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633234|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633235|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633236|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633237|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633238|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633239|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
105633240|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
105633241|NCT02401815|364320599|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105869440|NCT03999996|365174443|FG003|Booster Phase|Withdrawal of Consent|1|||
105869441|NCT03999996|365174440|FG000|Booster Phase|Reason Not Specified|0|||
105869442|NCT03999996|365174441|FG001|Booster Phase|Reason Not Specified|0|||
105869443|NCT03999996|365174442|FG002|Booster Phase|Reason Not Specified|0|||
105869444|NCT03999996|365174443|FG003|Booster Phase|Reason Not Specified|1|||
105869445|NCT04848480|365174446|FG000|Main Phase (26 Weeks)|Death|1|||
105869446|NCT04848480|365174447|FG001|Main Phase (26 Weeks)|Death|0|||
105869447|NCT04848480|365174446|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
105869448|NCT04848480|365174447|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
105869449|NCT04848480|365174446|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
105869450|NCT04848480|365174447|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
105869451|NCT04848480|365174446|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
105869452|NCT04848480|365174447|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
105869453|NCT04848480|365174446|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
105869454|NCT04848480|365174447|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
105869455|NCT04848480|365174446|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
105869456|NCT04848480|365174447|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
105869457|NCT03573830|365174450|FG000|Overall Study|Dropped without completing treatment|0|||
105869458|NCT03573830|365174451|FG001|Overall Study|Dropped without completing treatment|7|||
105869459|NCT03573830|365174450|FG000|Overall Study|Lost to Follow-up|4|||
105869460|NCT03573830|365174451|FG001|Overall Study|Lost to Follow-up|0|||
105869461|NCT00678210|365174454|FG000|Overall Study|Adverse Event|1|||
105869462|NCT00678210|365174455|FG001|Overall Study|Adverse Event|2|||
105869463|NCT00678210|365174456|FG002|Overall Study|Adverse Event|3|||
105869464|NCT00678210|365174457|FG003|Overall Study|Adverse Event|3|||
105869465|NCT00678210|365174454|FG000|Overall Study|Lack of Efficacy|2|||
105869466|NCT00678210|365174455|FG001|Overall Study|Lack of Efficacy|3|||
105869467|NCT00678210|365174456|FG002|Overall Study|Lack of Efficacy|1|||
105869468|NCT00678210|365174457|FG003|Overall Study|Lack of Efficacy|9|||
105869469|NCT00678210|365174454|FG000|Overall Study|Lost to Follow-up|4|||
105869470|NCT00678210|365174455|FG001|Overall Study|Lost to Follow-up|2|||
105869471|NCT00678210|365174456|FG002|Overall Study|Lost to Follow-up|0|||
105869472|NCT00678210|365174457|FG003|Overall Study|Lost to Follow-up|1|||
105869473|NCT00678210|365174454|FG000|Overall Study|Withdrawal by Subject|3|||
105869474|NCT00678210|365174455|FG001|Overall Study|Withdrawal by Subject|4|||
105869475|NCT00678210|365174456|FG002|Overall Study|Withdrawal by Subject|1|||
105869476|NCT00678210|365174457|FG003|Overall Study|Withdrawal by Subject|7|||
105869477|NCT00678210|365174454|FG000|Overall Study|Other|1|||
105869478|NCT00678210|365174455|FG001|Overall Study|Other|0|||
105633242|NCT02401815|364320600|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633243|NCT02401815|364320601|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633244|NCT02401815|364320602|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105869479|NCT00678210|365174456|FG002|Overall Study|Other|1|||
105869480|NCT00678210|365174457|FG003|Overall Study|Other|0|||
105869481|NCT03779334|365174458|FG000|Overall Study|Withdrawal by Subject|3|||
105869482|NCT03779334|365174459|FG001|Overall Study|Withdrawal by Subject|0|||
105869483|NCT03779334|365174460|FG002|Overall Study|Withdrawal by Subject|0|||
105869484|NCT03779334|365174458|FG000|Overall Study|Ongoing in Study|5|||
105869485|NCT03779334|365174459|FG001|Overall Study|Ongoing in Study|13|||
105869486|NCT03779334|365174460|FG002|Overall Study|Ongoing in Study|5|||
105869487|NCT02653625|365174461|FG000|Overall Study|Adverse Event|1|||
105633245|NCT02401815|364320603|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633246|NCT02401815|364320604|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633247|NCT02401815|364320605|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633248|NCT02401815|364320606|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
105633249|NCT02401815|364320607|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
105633250|NCT02401815|364320608|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
105633251|NCT04551066|364320611|FG000|Overall Study|Death|5|||
105633252|NCT04551066|364320612|FG001|Overall Study|Death|3|||
105633253|NCT04551066|364320611|FG000|Overall Study|Lost to Follow-up|1|||
105633254|NCT04551066|364320612|FG001|Overall Study|Lost to Follow-up|0|||
105633255|NCT04551066|364320611|FG000|Overall Study|Sponsor Decision|103|||
105633256|NCT04551066|364320612|FG001|Overall Study|Sponsor Decision|117|||
105633257|NCT04551066|364320611|FG000|Overall Study|Withdrawal by Subject|8|||
105633258|NCT04551066|364320612|FG001|Overall Study|Withdrawal by Subject|2|||
105633259|NCT04551066|364320611|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
105633260|NCT04551066|364320612|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
105633261|NCT04551066|364320611|FG000|Overall Study|Adverse Event|2|||
105633262|NCT04551066|364320612|FG001|Overall Study|Adverse Event|0|||
105633263|NCT04551066|364320611|FG000|Overall Study|Physician Decision|2|||
105633264|NCT04551066|364320612|FG001|Overall Study|Physician Decision|0|||
105633265|NCT04551066|364320611|FG000|Overall Study|Protocol Violation|1|||
105633266|NCT04551066|364320612|FG001|Overall Study|Protocol Violation|0|||
105633267|NCT04551066|364320611|FG000|Overall Study|Lack of Efficacy|0|||
105633268|NCT04551066|364320612|FG001|Overall Study|Lack of Efficacy|1|||
105633269|NCT04551066|364320611|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
105633270|NCT04551066|364320612|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
105633271|NCT04701203|364320613|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
105633272|NCT04701203|364320614|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
105633273|NCT04701203|364320615|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
105633274|NCT04701203|364320613|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
105633275|NCT04701203|364320614|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
105633276|NCT04701203|364320615|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
105633277|NCT04701203|364320613|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
105633278|NCT04701203|364320614|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
105633279|NCT04701203|364320615|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
105633280|NCT04701203|364320613|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
105633281|NCT04701203|364320614|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
105633282|NCT04701203|364320615|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
105633283|NCT02798471|364320618|FG000|Overall Study|Adverse Event|7|||
105633284|NCT02798471|364320619|FG001|Overall Study|Adverse Event|2|||
105633285|NCT02798471|364320618|FG000|Overall Study|Physician Decision|3|||
105633286|NCT02798471|364320619|FG001|Overall Study|Physician Decision|7|||
105633287|NCT02798471|364320618|FG000|Overall Study|Death|2|||
105633288|NCT02798471|364320619|FG001|Overall Study|Death|3|||
105633289|NCT02798471|364320618|FG000|Overall Study|Lost to Follow-up|0|||
105633290|NCT02798471|364320619|FG001|Overall Study|Lost to Follow-up|1|||
105633291|NCT02798471|364320618|FG000|Overall Study|Other|5|||
105633292|NCT02798471|364320619|FG001|Overall Study|Other|3|||
105633293|NCT02798471|364320618|FG000|Overall Study|Subject withdrew consent|0|||
105633294|NCT02798471|364320619|FG001|Overall Study|Subject withdrew consent|6|||
105633295|NCT02798471|364320618|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
105633296|NCT02798471|364320619|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
105633297|NCT02798471|364320618|FG000|Overall Study|Randomized, but not treated|0|||
105633298|NCT02798471|364320619|FG001|Overall Study|Randomized, but not treated|2|||
105633299|NCT01266642|364320620|FG000|Overall Study|Protocol Violation|0|||
105633300|NCT01266642|364320621|FG001|Overall Study|Protocol Violation|1|||
105633301|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
105633302|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
105633303|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
105633304|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
105633305|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
105633306|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
105633307|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
105633308|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
105633309|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
105633310|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
105633311|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
105633312|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
105633313|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
105633314|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
105633315|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
105633316|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
105633317|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
105633318|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
105633319|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
105633320|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
105633321|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
105633322|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
105633323|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
105633324|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
105633325|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
105633326|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Other|1|||
105633327|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Other|0|||
105633328|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Other|0|||
105633329|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Other|0|||
105633330|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Other|0|||
105633331|NCT02386098|364322309|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
105633332|NCT02386098|364322310|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
105633333|NCT02386098|364322311|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
105633334|NCT02386098|364322312|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
105633335|NCT02386098|364322313|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
105633336|NCT04503681|364322319|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
105633337|NCT04503681|364322320|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
105633338|NCT02760654|364322321|FG000|Overall Study|Lost to Follow-up|3|||
105633339|NCT02760654|364322322|FG001|Overall Study|Lost to Follow-up|3|||
105633340|NCT02760654|364322321|FG000|Overall Study|Withdrawal by Subject|4|||
105633341|NCT02760654|364322322|FG001|Overall Study|Withdrawal by Subject|3|||
105633342|NCT00210106|364322323|FG000|Overall Study|Death|1|||
105633343|NCT00210106|364322323|FG000|Overall Study|Protocol Violation|13|||
105633344|NCT00786864|364322324|FG000|Overall Study|Lost to Follow-up|0|||
105633345|NCT00786864|364322325|FG001|Overall Study|Lost to Follow-up|1|||
105633346|NCT00786864|364322324|FG000|Overall Study|Sustained serious back injury|1|||
105633347|NCT00786864|364322325|FG001|Overall Study|Sustained serious back injury|0|||
105633348|NCT01084694|364322326|FG000|Overall Study|Withdrawal by Subject|2|||
105633349|NCT01084694|364322327|FG001|Overall Study|Withdrawal by Subject|1|||
105633350|NCT01084694|364322326|FG000|Overall Study|Death|2|||
105633351|NCT01084694|364322327|FG001|Overall Study|Death|12|||
105633352|NCT01084694|364322326|FG000|Overall Study|eligibility not maintained|2|||
105633353|NCT01084694|364322327|FG001|Overall Study|eligibility not maintained|7|||
105633354|NCT00065182|364322336|FG000|Overall Study|Adverse Event|24|||
105633355|NCT00065182|364322337|FG001|Overall Study|Adverse Event|17|||
105633356|NCT00065182|364322336|FG000|Overall Study|Lost to Follow-up|0|||
105633357|NCT00065182|364322337|FG001|Overall Study|Lost to Follow-up|4|||
105633358|NCT00065182|364322336|FG000|Overall Study|Protocol Violation|3|||
105633359|NCT00065182|364322337|FG001|Overall Study|Protocol Violation|4|||
105633360|NCT00065182|364322336|FG000|Overall Study|Serious adverse events (SAE)|1|||
105633361|NCT00065182|364322337|FG001|Overall Study|Serious adverse events (SAE)|0|||
105633362|NCT00065182|364322336|FG000|Overall Study|Sponsor Decision|11|||
105633363|NCT00065182|364322337|FG001|Overall Study|Sponsor Decision|7|||
105633364|NCT00065182|364322336|FG000|Overall Study|Withdrawal by Subject|8|||
105633365|NCT00065182|364322337|FG001|Overall Study|Withdrawal by Subject|3|||
105633366|NCT00065182|364322336|FG000|Overall Study|No clinical benefit|1|||
105633367|NCT00065182|364322337|FG001|Overall Study|No clinical benefit|0|||
105633368|NCT00065182|364322336|FG000|Overall Study|Death|0|||
105633369|NCT00065182|364322337|FG001|Overall Study|Death|1|||
105633370|NCT00065182|364322336|FG000|Overall Study|Decline in Status|0|||
105633371|NCT00065182|364322337|FG001|Overall Study|Decline in Status|1|||
105633372|NCT04213807|364322338|FG000|Overall Study|Physician Decision|0|||
105633373|NCT04213807|364322339|FG001|Overall Study|Physician Decision|0|||
105633374|NCT04213807|364322340|FG002|Overall Study|Physician Decision|1|||
105633375|NCT00336505|364322343|FG000|Overall Study|Adverse Event|10|||
105633376|NCT00336505|364322344|FG001|Overall Study|Adverse Event|9|||
105633377|NCT00336505|364322343|FG000|Overall Study|Lack of Efficacy|8|||
105633378|NCT00336505|364322344|FG001|Overall Study|Lack of Efficacy|4|||
105633379|NCT00336505|364322343|FG000|Overall Study|Lost to Follow-up|7|||
105633380|NCT00336505|364322344|FG001|Overall Study|Lost to Follow-up|4|||
105633381|NCT00336505|364322343|FG000|Overall Study|Withdrawal by Subject|5|||
105633382|NCT00336505|364322344|FG001|Overall Study|Withdrawal by Subject|3|||
105633383|NCT00336505|364322343|FG000|Overall Study|Other|7|||
105633384|NCT00336505|364322344|FG001|Overall Study|Other|7|||
105633385|NCT01561300|364322345|FG000|Run in on Placebo|Adverse Event|1|||
105633386|NCT01561300|364322346|FG001|Run in on Placebo|Adverse Event|0|||
105633387|NCT00890591|364322347|FG000|Overall Study|Lack of Efficacy|20|||
105633388|NCT03601715|364322348|FG000|Second Intervention|Lost to Follow-up|1|||
105633389|NCT03601715|364322349|FG001|Second Intervention|Lost to Follow-up|1|||
105633390|NCT03601715|364322350|FG002|Second Intervention|Lost to Follow-up|0|||
105633391|NCT00713596|364322351|FG000|Overall Study|Study was terminated|2|||
105633392|NCT00713596|364322352|FG001|Overall Study|Study was terminated|3|||
105633393|NCT00713596|364322353|FG002|Overall Study|Study was terminated|2|||
105633394|NCT03170882|364322354|FG000|Overall Study|Death|17|||
105633395|NCT03170882|364322355|FG001|Overall Study|Death|29|||
105633396|NCT03170882|364322354|FG000|Overall Study|Lost to Follow-up|0|||
105633397|NCT03170882|364322355|FG001|Overall Study|Lost to Follow-up|1|||
105633398|NCT03170882|364322354|FG000|Overall Study|Withdrawal by Subject|4|||
105633399|NCT03170882|364322355|FG001|Overall Study|Withdrawal by Subject|7|||
105633400|NCT03170882|364322354|FG000|Overall Study|Reason not Specified|28|||
105633401|NCT03170882|364322355|FG001|Overall Study|Reason not Specified|36|||
105633402|NCT03683576|364322374|FG000|Overall Study|Withdrawal by Subject|2|||
105633403|NCT03683576|364322375|FG001|Overall Study|Withdrawal by Subject|0|||
105633404|NCT03683576|364322376|FG002|Overall Study|Withdrawal by Subject|8|||
105633405|NCT03683576|364322377|FG003|Overall Study|Withdrawal by Subject|3|||
105633406|NCT03683576|364322374|FG000|Overall Study|Adverse Event|3|||
105633407|NCT03683576|364322375|FG001|Overall Study|Adverse Event|0|||
105633408|NCT03683576|364322376|FG002|Overall Study|Adverse Event|0|||
105633409|NCT03683576|364322377|FG003|Overall Study|Adverse Event|4|||
105633410|NCT03683576|364322374|FG000|Overall Study|Lack of Efficacy|1|||
105633411|NCT03683576|364322375|FG001|Overall Study|Lack of Efficacy|0|||
105633412|NCT03683576|364322376|FG002|Overall Study|Lack of Efficacy|1|||
105633413|NCT03683576|364322377|FG003|Overall Study|Lack of Efficacy|1|||
105633414|NCT03683576|364322374|FG000|Overall Study|Lost to Follow-up|0|||
105633415|NCT03683576|364322375|FG001|Overall Study|Lost to Follow-up|1|||
105633416|NCT03683576|364322376|FG002|Overall Study|Lost to Follow-up|2|||
105633417|NCT03683576|364322377|FG003|Overall Study|Lost to Follow-up|0|||
105633418|NCT03683576|364322374|FG000|Overall Study|Other, Not Specified|0|||
105633419|NCT03683576|364322375|FG001|Overall Study|Other, Not Specified|2|||
105633420|NCT03683576|364322376|FG002|Overall Study|Other, Not Specified|0|||
105633421|NCT03683576|364322377|FG003|Overall Study|Other, Not Specified|0|||
105633422|NCT03683576|364322374|FG000|Overall Study|Protocol Violation|0|||
105633423|NCT03683576|364322375|FG001|Overall Study|Protocol Violation|1|||
105633424|NCT03683576|364322376|FG002|Overall Study|Protocol Violation|1|||
105633425|NCT03683576|364322377|FG003|Overall Study|Protocol Violation|0|||
105633426|NCT03500549|364322380|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
105633427|NCT03500549|364322381|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
105633428|NCT03500549|364322380|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
105633429|NCT03500549|364322381|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
105633430|NCT01400958|364322384|FG000|Overall Study|Physician Decision|0|||
105633431|NCT01400958|364322385|FG001|Overall Study|Physician Decision|1|||
105633432|NCT01400958|364322384|FG000|Overall Study|Withdrawal by Subject|0|||
105633433|NCT01400958|364322385|FG001|Overall Study|Withdrawal by Subject|1|||
105633434|NCT01400958|364322384|FG000|Overall Study|Adverse Event|1|||
105633435|NCT01400958|364322385|FG001|Overall Study|Adverse Event|0|||
105633436|NCT01738438|364322386|FG000|Overall Study|Disease Progression|32|||
105633437|NCT01738438|364322386|FG000|Overall Study|Adverse Event|3|||
105633438|NCT02928172|364322387|FG000|Overall Study|Device did not record data|1|||
105633439|NCT01532999|364322388|FG000|Overall Study|Lost to Follow-up|14|||
105633440|NCT01532999|364322389|FG001|Overall Study|Lost to Follow-up|8|||
105633441|NCT01532999|364322388|FG000|Overall Study|Physician Decision|1|||
105633442|NCT01532999|364322389|FG001|Overall Study|Physician Decision|2|||
105633443|NCT01532999|364322388|FG000|Overall Study|Withdrawal by Subject|5|||
105633444|NCT01532999|364322389|FG001|Overall Study|Withdrawal by Subject|0|||
105633445|NCT01532999|364322388|FG000|Overall Study|Relocated|2|||
105633446|NCT01532999|364322389|FG001|Overall Study|Relocated|0|||
105633447|NCT01532999|364322388|FG000|Overall Study|should not have been randomized|1|||
105633448|NCT01532999|364322389|FG001|Overall Study|should not have been randomized|0|||
105633449|NCT01532999|364322388|FG000|Overall Study|substantial noncompliance|2|||
105633450|NCT01532999|364322389|FG001|Overall Study|substantial noncompliance|0|||
105633451|NCT01532999|364322388|FG000|Overall Study|no show for week 9 assessments|6|||
105633452|NCT01532999|364322389|FG001|Overall Study|no show for week 9 assessments|4|||
105633453|NCT01532999|364322388|FG000|Overall Study|Adverse Event|0|||
105633454|NCT01532999|364322389|FG001|Overall Study|Adverse Event|1|||
105633455|NCT01532999|364322388|FG000|Overall Study|incarcerated|0|||
105633456|NCT01532999|364322389|FG001|Overall Study|incarcerated|1|||
105633457|NCT01532999|364322388|FG000|Overall Study|New job|0|||
105633458|NCT01532999|364322389|FG001|Overall Study|New job|2|||
105633459|NCT00918203|364322390|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
105633460|NCT00918203|364322391|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
105633461|NCT00918203|364322392|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
105633462|NCT00918203|364322390|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
105633463|NCT00918203|364322391|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
105633464|NCT00918203|364322392|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
105633465|NCT00918203|364322390|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
105633466|NCT00918203|364322391|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
105633467|NCT00918203|364322392|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
105633468|NCT00918203|364322390|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
105633469|NCT00918203|364322391|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
105633470|NCT00918203|364322392|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
105633471|NCT00309166|364322395|FG000|Overall Study|Adverse event, non-fatal|1|||
105633472|NCT00309166|364322396|FG001|Overall Study|Adverse event, non-fatal|0|||
105633473|NCT00309166|364322395|FG000|Overall Study|Withdrawal by Subject|4|||
105633474|NCT00309166|364322396|FG001|Overall Study|Withdrawal by Subject|3|||
105633475|NCT00701701|364322399|FG000|Overall Study|Withdrawal by Subject|0|||
105633476|NCT00701701|364322400|FG001|Overall Study|Withdrawal by Subject|1|||
105633477|NCT00701701|364322399|FG000|Overall Study|Adverse Event|0|||
105633478|NCT00701701|364322400|FG001|Overall Study|Adverse Event|1|||
105633479|NCT02598661|364322401|FG000|Overall Study|Death|27|||
105633480|NCT02598661|364322402|FG001|Overall Study|Death|34|||
105633481|NCT02598661|364322403|FG002|Overall Study|Death|14|||
105633482|NCT02598661|364322404|FG003|Overall Study|Death|1|||
105633483|NCT02598661|364322405|FG004|Overall Study|Death|0|||
105633484|NCT02598661|364322401|FG000|Overall Study|Lost to Follow-up|2|||
105633485|NCT02598661|364322402|FG001|Overall Study|Lost to Follow-up|3|||
105633486|NCT02598661|364322403|FG002|Overall Study|Lost to Follow-up|2|||
105633487|NCT02598661|364322404|FG003|Overall Study|Lost to Follow-up|0|||
105633488|NCT02598661|364322405|FG004|Overall Study|Lost to Follow-up|0|||
105633489|NCT02598661|364322401|FG000|Overall Study|Withdrawal by Subject|13|||
105633490|NCT02598661|364322402|FG001|Overall Study|Withdrawal by Subject|24|||
105633491|NCT02598661|364322403|FG002|Overall Study|Withdrawal by Subject|14|||
105633492|NCT02598661|364322404|FG003|Overall Study|Withdrawal by Subject|1|||
105633493|NCT02598661|364322405|FG004|Overall Study|Withdrawal by Subject|1|||
105633494|NCT02598661|364322401|FG000|Overall Study|Adverse Event|0|||
105633495|NCT02598661|364322402|FG001|Overall Study|Adverse Event|0|||
105633496|NCT02598661|364322403|FG002|Overall Study|Adverse Event|1|||
105633497|NCT02598661|364322404|FG003|Overall Study|Adverse Event|0|||
105633498|NCT02598661|364322405|FG004|Overall Study|Adverse Event|0|||
105633499|NCT02598661|364322401|FG000|Overall Study|Randomized, Never Treated|0|||
105633500|NCT02598661|364322402|FG001|Overall Study|Randomized, Never Treated|0|||
105633501|NCT02598661|364322403|FG002|Overall Study|Randomized, Never Treated|0|||
105633502|NCT02598661|364322404|FG003|Overall Study|Randomized, Never Treated|0|||
105633503|NCT02598661|364322405|FG004|Overall Study|Randomized, Never Treated|1|||
105633504|NCT02016872|364322408|FG000|Overall Study|Withdrawal by Subject|10|||
105633505|NCT02016872|364322408|FG000|Overall Study|Death Progression|2|||
105633506|NCT02016872|364322408|FG000|Overall Study|No FMISO scan|1|||
105633507|NCT02016872|364322408|FG000|Overall Study|Ineligible|2|||
105633508|NCT05251363|364322417|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
105633509|NCT05251363|364322417|FG000|Overall Study After Implant Period|Death|9|||
105633510|NCT05251363|364322417|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
105633511|NCT05251363|364322417|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
105633512|NCT05251363|364322417|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
105633513|NCT05251363|364322417|FG000|Overall Study After Implant Period|Physician Decision|1|||
105633514|NCT05251363|364322417|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
105633515|NCT02761187|364322418|FG000|Overall Study|Too ill to Participate|13|||
105633516|NCT02761187|364322419|FG001|Overall Study|Too ill to Participate|8|||
105633517|NCT02761187|364322418|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
105633518|NCT02761187|364322419|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
105633519|NCT02761187|364322418|FG000|Overall Study|Patient withdrew consent|64|||
105633520|NCT02761187|364322419|FG001|Overall Study|Patient withdrew consent|58|||
105633521|NCT02761187|364322418|FG000|Overall Study|Physician discretion|4|||
105633522|NCT02761187|364322419|FG001|Overall Study|Physician discretion|8|||
105633523|NCT02761187|364322418|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
105633524|NCT02761187|364322419|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
105633525|NCT02761187|364322418|FG000|Overall Study|On Hospice|20|||
105633526|NCT02761187|364322419|FG001|Overall Study|On Hospice|26|||
105633527|NCT02761187|364322418|FG000|Overall Study|Deceased|474|||
105633528|NCT02761187|364322419|FG001|Overall Study|Deceased|642|||
105633529|NCT02761187|364322418|FG000|Overall Study|Lost to Follow-up|73|||
105633530|NCT02761187|364322419|FG001|Overall Study|Lost to Follow-up|63|||
105633531|NCT02761187|364322418|FG000|Overall Study|Due to study discontinued at site|100|||
105633532|NCT02761187|364322419|FG001|Overall Study|Due to study discontinued at site|85|||
105633533|NCT02761187|364322418|FG000|Overall Study|Reason not Specified|1484|||
105633534|NCT02761187|364322419|FG001|Overall Study|Reason not Specified|937|||
105633535|NCT03835754|364322422|FG000|Overall Study|Death|4|||
105633536|NCT02517268|364322428|FG000|Overall Study|Withdrawal by Subject|1|||
105633537|NCT02517268|364322429|FG001|Overall Study|Withdrawal by Subject|0|||
105633538|NCT05630833|364322430|FG000|Overall Study|Adverse Event|3|||
105633539|NCT05630833|364322431|FG001|Overall Study|Adverse Event|0|||
105633540|NCT05630833|364322430|FG000|Overall Study|Lack of Efficacy|0|||
105633541|NCT05630833|364322431|FG001|Overall Study|Lack of Efficacy|1|||
105633542|NCT05630833|364322430|FG000|Overall Study|Lost to Follow-up|1|||
105633543|NCT05630833|364322431|FG001|Overall Study|Lost to Follow-up|0|||
105633544|NCT05630833|364322430|FG000|Overall Study|Withdrawal by Subject|3|||
105633545|NCT05630833|364322431|FG001|Overall Study|Withdrawal by Subject|1|||
105633546|NCT04445831|364322432|FG000|Overall Study|Withdrawal by Subject|2|||
105633547|NCT04445831|364322433|FG001|Overall Study|Withdrawal by Subject|1|||
105633548|NCT04445831|364322434|FG002|Overall Study|Withdrawal by Subject|1|||
105633549|NCT04445831|364322435|FG003|Overall Study|Withdrawal by Subject|0|||
105633550|NCT04445831|364322436|FG004|Overall Study|Withdrawal by Subject|0|||
105633551|NCT04445831|364322437|FG005|Overall Study|Withdrawal by Subject|0|||
105633552|NCT04445831|364322438|FG006|Overall Study|Withdrawal by Subject|0|||
105633553|NCT04445831|364322432|FG000|Overall Study|Subject withdrawal by caregiver|0|||
105633554|NCT04445831|364322433|FG001|Overall Study|Subject withdrawal by caregiver|1|||
105633555|NCT04445831|364322434|FG002|Overall Study|Subject withdrawal by caregiver|0|||
105633556|NCT04445831|364322435|FG003|Overall Study|Subject withdrawal by caregiver|0|||
105633557|NCT04445831|364322436|FG004|Overall Study|Subject withdrawal by caregiver|0|||
105633558|NCT04445831|364322437|FG005|Overall Study|Subject withdrawal by caregiver|0|||
105633559|NCT04445831|364322438|FG006|Overall Study|Subject withdrawal by caregiver|0|||
105633560|NCT02751528|364322450|FG000|Overall Study|Withdrawal by Subject|1|||
105633561|NCT02751528|364322450|FG000|Overall Study|Adverse Event|1|||
105633562|NCT05810285|364322452|FG000|Overall Study|Death|4|||
105633563|NCT05810285|364322453|FG001|Overall Study|Death|21|||
105633564|NCT05810285|364322452|FG000|Overall Study|Adverse Event|18|||
105633565|NCT05810285|364322453|FG001|Overall Study|Adverse Event|16|||
105633566|NCT04649047|364322454|FG000|Overall Study|Withdrawal by Subject|3|||
105633567|NCT02488408|364322455|FG000|Part A|Adverse Event|2|||
105633568|NCT02488408|364322456|FG001|Part A|Adverse Event|0|||
105633569|NCT02488408|364322457|FG002|Part A|Adverse Event|0|||
105633570|NCT02488408|364322458|FG003|Part A|Adverse Event|0|||
105633571|NCT02488408|364322459|FG004|Part A|Adverse Event|0|||
105633572|NCT02488408|364322460|FG005|Part A|Adverse Event|0|||
105633573|NCT02488408|364322461|FG006|Part A|Adverse Event|0|||
105633574|NCT02488408|364322462|FG007|Part A|Adverse Event|0|||
105633575|NCT02488408|364322463|FG008|Part A|Adverse Event|0|||
105633576|NCT02488408|364322464|FG009|Part A|Adverse Event|0|||
105633577|NCT02488408|364322455|FG000|Part A|Death|1|||
105633578|NCT02488408|364322456|FG001|Part A|Death|5|||
105633579|NCT02488408|364322457|FG002|Part A|Death|0|||
105633580|NCT02488408|364322458|FG003|Part A|Death|0|||
105633581|NCT02488408|364322459|FG004|Part A|Death|3|||
105633582|NCT02488408|364322460|FG005|Part A|Death|0|||
105633583|NCT02488408|364322461|FG006|Part A|Death|0|||
105633584|NCT02488408|364322462|FG007|Part A|Death|0|||
105633585|NCT02488408|364322463|FG008|Part A|Death|0|||
105633586|NCT02488408|364322464|FG009|Part A|Death|0|||
105633587|NCT02488408|364322455|FG000|Part A|Disease Progression|2|||
105633588|NCT02488408|364322456|FG001|Part A|Disease Progression|8|||
105633589|NCT02488408|364322457|FG002|Part A|Disease Progression|2|||
105633590|NCT02488408|364322458|FG003|Part A|Disease Progression|3|||
105633591|NCT02488408|364322459|FG004|Part A|Disease Progression|4|||
105633592|NCT02488408|364322460|FG005|Part A|Disease Progression|0|||
105633593|NCT02488408|364322461|FG006|Part A|Disease Progression|0|||
105633594|NCT02488408|364322462|FG007|Part A|Disease Progression|0|||
105633595|NCT02488408|364322463|FG008|Part A|Disease Progression|0|||
105633596|NCT02488408|364322464|FG009|Part A|Disease Progression|0|||
105633597|NCT02488408|364322455|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
105633598|NCT02488408|364322456|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
105633599|NCT02488408|364322457|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
105633600|NCT02488408|364322458|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
105633601|NCT02488408|364322459|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
105633602|NCT02488408|364322460|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
105633603|NCT02488408|364322461|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
105633604|NCT02488408|364322462|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
105633605|NCT02488408|364322463|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
105633606|NCT02488408|364322464|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
105633607|NCT02488408|364322455|FG000|Part A|Investigator Decision|0|||
105633608|NCT02488408|364322456|FG001|Part A|Investigator Decision|1|||
105633609|NCT02488408|364322457|FG002|Part A|Investigator Decision|1|||
105633610|NCT02488408|364322458|FG003|Part A|Investigator Decision|0|||
105633611|NCT02488408|364322459|FG004|Part A|Investigator Decision|0|||
105633612|NCT02488408|364322460|FG005|Part A|Investigator Decision|0|||
105633613|NCT02488408|364322461|FG006|Part A|Investigator Decision|0|||
105633614|NCT02488408|364322462|FG007|Part A|Investigator Decision|0|||
105633615|NCT02488408|364322463|FG008|Part A|Investigator Decision|0|||
105633616|NCT02488408|364322464|FG009|Part A|Investigator Decision|0|||
105633617|NCT02488408|364322455|FG000|Part A|Withdrawal by Subject|0|||
105633618|NCT02488408|364322456|FG001|Part A|Withdrawal by Subject|0|||
105633619|NCT02488408|364322457|FG002|Part A|Withdrawal by Subject|2|||
105633620|NCT02488408|364322458|FG003|Part A|Withdrawal by Subject|0|||
105633621|NCT02488408|364322459|FG004|Part A|Withdrawal by Subject|0|||
105633622|NCT02488408|364322460|FG005|Part A|Withdrawal by Subject|0|||
105633623|NCT02488408|364322461|FG006|Part A|Withdrawal by Subject|0|||
105633624|NCT02488408|364322462|FG007|Part A|Withdrawal by Subject|0|||
105633625|NCT02488408|364322463|FG008|Part A|Withdrawal by Subject|0|||
105633626|NCT02488408|364322464|FG009|Part A|Withdrawal by Subject|0|||
105633627|NCT02488408|364322455|FG000|Part A|Other|1|||
105633628|NCT02488408|364322456|FG001|Part A|Other|0|||
105633629|NCT02488408|364322457|FG002|Part A|Other|0|||
105633630|NCT02488408|364322458|FG003|Part A|Other|0|||
105633631|NCT02488408|364322459|FG004|Part A|Other|0|||
105633632|NCT02488408|364322460|FG005|Part A|Other|0|||
105633633|NCT02488408|364322461|FG006|Part A|Other|0|||
105633634|NCT02488408|364322462|FG007|Part A|Other|0|||
105633635|NCT02488408|364322463|FG008|Part A|Other|0|||
105633636|NCT02488408|364322464|FG009|Part A|Other|0|||
105633637|NCT02488408|364322455|FG000|Part B|Adverse Event|0|||
105633638|NCT02488408|364322456|FG001|Part B|Adverse Event|0|||
105633639|NCT02488408|364322457|FG002|Part B|Adverse Event|0|||
105633640|NCT02488408|364322458|FG003|Part B|Adverse Event|0|||
105633641|NCT02488408|364322459|FG004|Part B|Adverse Event|0|||
105633642|NCT02488408|364322460|FG005|Part B|Adverse Event|2|||
105633643|NCT02488408|364322461|FG006|Part B|Adverse Event|2|||
105633644|NCT02488408|364322462|FG007|Part B|Adverse Event|7|||
105633645|NCT02488408|364322463|FG008|Part B|Adverse Event|2|||
105633646|NCT02488408|364322464|FG009|Part B|Adverse Event|2|||
105633647|NCT02488408|364322455|FG000|Part B|Death|0|||
105633648|NCT02488408|364322456|FG001|Part B|Death|0|||
105633649|NCT02488408|364322457|FG002|Part B|Death|0|||
105633650|NCT02488408|364322458|FG003|Part B|Death|0|||
105633651|NCT02488408|364322459|FG004|Part B|Death|0|||
105633652|NCT02488408|364322460|FG005|Part B|Death|3|||
105633653|NCT02488408|364322461|FG006|Part B|Death|1|||
105633654|NCT02488408|364322462|FG007|Part B|Death|2|||
105633655|NCT02488408|364322463|FG008|Part B|Death|2|||
105633656|NCT02488408|364322464|FG009|Part B|Death|2|||
105633657|NCT02488408|364322455|FG000|Part B|Death due to Disease Progression|0|||
105633658|NCT02488408|364322456|FG001|Part B|Death due to Disease Progression|0|||
105633659|NCT02488408|364322457|FG002|Part B|Death due to Disease Progression|0|||
105633660|NCT02488408|364322458|FG003|Part B|Death due to Disease Progression|0|||
105633661|NCT02488408|364322459|FG004|Part B|Death due to Disease Progression|0|||
105633662|NCT02488408|364322460|FG005|Part B|Death due to Disease Progression|2|||
105633663|NCT02488408|364322461|FG006|Part B|Death due to Disease Progression|2|||
105633664|NCT02488408|364322462|FG007|Part B|Death due to Disease Progression|1|||
105633665|NCT02488408|364322463|FG008|Part B|Death due to Disease Progression|1|||
105633666|NCT02488408|364322464|FG009|Part B|Death due to Disease Progression|1|||
105633667|NCT02488408|364322455|FG000|Part B|Disease Progression|0|||
105633668|NCT02488408|364322456|FG001|Part B|Disease Progression|0|||
105633669|NCT02488408|364322457|FG002|Part B|Disease Progression|0|||
105633670|NCT02488408|364322458|FG003|Part B|Disease Progression|0|||
105633671|NCT02488408|364322459|FG004|Part B|Disease Progression|0|||
105633672|NCT02488408|364322460|FG005|Part B|Disease Progression|6|||
105633673|NCT02488408|364322461|FG006|Part B|Disease Progression|9|||
105633674|NCT02488408|364322462|FG007|Part B|Disease Progression|7|||
105633675|NCT02488408|364322463|FG008|Part B|Disease Progression|9|||
105633676|NCT02488408|364322464|FG009|Part B|Disease Progression|11|||
105633677|NCT02488408|364322455|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
105633678|NCT02488408|364322456|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
105633679|NCT02488408|364322457|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
105633680|NCT02488408|364322458|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
105633681|NCT02488408|364322459|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
105633682|NCT02488408|364322460|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
105633683|NCT02488408|364322461|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
105633684|NCT02488408|364322462|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
105633685|NCT02488408|364322463|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
105633686|NCT02488408|364322464|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
105633687|NCT02488408|364322455|FG000|Part B|Investigator Decision|0|||
105633688|NCT02488408|364322456|FG001|Part B|Investigator Decision|0|||
105633689|NCT02488408|364322457|FG002|Part B|Investigator Decision|0|||
105633690|NCT02488408|364322458|FG003|Part B|Investigator Decision|0|||
105633691|NCT02488408|364322459|FG004|Part B|Investigator Decision|0|||
105869488|NCT02653625|365174461|FG000|Overall Study|Non-compliance with Study Drug|1|||
105869489|NCT02653625|365174461|FG000|Overall Study|Protocol Violation|1|||
105869490|NCT02653625|365174461|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
105869491|NCT00764881|365174467|FG000|Overall Study|Adverse Event|5|||
105633692|NCT02488408|364322460|FG005|Part B|Investigator Decision|0|||
105633693|NCT02488408|364322461|FG006|Part B|Investigator Decision|1|||
105869492|NCT00764881|365174468|FG001|Overall Study|Adverse Event|1|||
105633694|NCT02488408|364322462|FG007|Part B|Investigator Decision|0|||
105633695|NCT02488408|364322463|FG008|Part B|Investigator Decision|2|||
105869493|NCT00764881|365174467|FG000|Overall Study|Withdrawal by Subject|1|||
105869494|NCT00764881|365174468|FG001|Overall Study|Withdrawal by Subject|3|||
105633696|NCT02488408|364322464|FG009|Part B|Investigator Decision|1|||
105633697|NCT00719888|364322465|FG000|Overall Study|Death|24|||
105633698|NCT00719888|364322466|FG001|Overall Study|Death|9|||
105633699|NCT00719888|364322465|FG000|Overall Study|Relapse|8|||
105633700|NCT00719888|364322466|FG001|Overall Study|Relapse|3|||
105633701|NCT00719888|364322465|FG000|Overall Study|Physician Decision|1|||
105633702|NCT00719888|364322466|FG001|Overall Study|Physician Decision|0|||
105633703|NCT00719888|364322465|FG000|Overall Study|Withdrawal by Subject|1|||
105633704|NCT00719888|364322466|FG001|Overall Study|Withdrawal by Subject|0|||
105633705|NCT03664804|364322467|FG000|Overall Study|Withdrawal by Subject|7|||
105633706|NCT03459196|364323996|FG000|Overall Study|Subject didn't receive study catheter|2|||
105633707|NCT04530487|364323997|FG000|Overall Study|Death|1|||
105633708|NCT00655499|364324004|FG000|Overall Study|not eligible|4|||
105633709|NCT03752684|364324006|FG000|Overall Study|Lost to Follow-up|4|||
105633710|NCT03352713|364324009|FG000|Overall Study|Lost to Follow-up|8|||
105633711|NCT03352713|364324009|FG000|Overall Study|Withdrawn by investigator|5|||
105633712|NCT03352713|364324009|FG000|Overall Study|Completed 0 EMAs|8|||
105633713|NCT03352713|364324009|FG000|Overall Study|Device incompatible/stolen|5|||
105633714|NCT00048932|364324010|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
105633715|NCT00048932|364324011|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
105633716|NCT00048932|364324012|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
105633717|NCT00048932|364324010|FG000|Double Blind Period (DB)|Adverse Event|51|||
105633718|NCT00048932|364324011|FG001|Double Blind Period (DB)|Adverse Event|19|||
105633719|NCT00048932|364324012|FG002|Double Blind Period (DB)|Adverse Event|0|||
105633720|NCT00048932|364324010|FG000|Double Blind Period (DB)|Death|5|||
105633721|NCT00048932|364324011|FG001|Double Blind Period (DB)|Death|3|||
105633722|NCT00048932|364324012|FG002|Double Blind Period (DB)|Death|0|||
105633723|NCT00048932|364324010|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
105633724|NCT00048932|364324011|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
105633725|NCT00048932|364324012|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
105633726|NCT00048932|364324010|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
105633727|NCT00048932|364324011|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
105633728|NCT00048932|364324012|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
105633729|NCT00048932|364324010|FG000|Double Blind Period (DB)|Relocation|1|||
105633730|NCT00048932|364324011|FG001|Double Blind Period (DB)|Relocation|0|||
105633731|NCT00048932|364324012|FG002|Double Blind Period (DB)|Relocation|0|||
105633732|NCT00048932|364324010|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
105633733|NCT00048932|364324011|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
105633734|NCT00048932|364324012|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
105633735|NCT00048932|364324010|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
105633736|NCT00048932|364324011|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
105633737|NCT00048932|364324012|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
105633738|NCT00048932|364324010|FG000|Double Blind Period (DB)|Pregnancy|1|||
105633739|NCT00048932|364324011|FG001|Double Blind Period (DB)|Pregnancy|0|||
105633740|NCT00048932|364324012|FG002|Double Blind Period (DB)|Pregnancy|0|||
105633741|NCT00048932|364324010|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
105633742|NCT00048932|364324011|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
105633743|NCT00048932|364324012|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
105633744|NCT00048932|364324010|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
105633745|NCT00048932|364324011|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
105633746|NCT00048932|364324012|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
105633747|NCT00048932|364324010|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
105633748|NCT00048932|364324011|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
105633749|NCT00048932|364324012|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
105633750|NCT00048932|364324010|FG000|Open Label Period (OL)|Death|0|||
105633751|NCT00048932|364324011|FG001|Open Label Period (OL)|Death|0|||
105633752|NCT00048932|364324012|FG002|Open Label Period (OL)|Death|25|||
105633753|NCT00048932|364324010|FG000|Open Label Period (OL)|Adverse Event|0|||
105633754|NCT00048932|364324011|FG001|Open Label Period (OL)|Adverse Event|0|||
105633755|NCT00048932|364324012|FG002|Open Label Period (OL)|Adverse Event|103|||
105633756|NCT00048932|364324010|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
105633757|NCT00048932|364324011|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
105633758|NCT00048932|364324012|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
105633759|NCT00048932|364324010|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
105633760|NCT00048932|364324011|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
105633761|NCT00048932|364324012|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
105633762|NCT00048932|364324010|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
105633763|NCT00048932|364324011|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
105633764|NCT00048932|364324012|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
105633765|NCT00048932|364324010|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
105633766|NCT00048932|364324011|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
105633767|NCT00048932|364324012|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
105633768|NCT00048932|364324010|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
105633769|NCT00048932|364324011|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
105633770|NCT00048932|364324012|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
105633771|NCT00048932|364324010|FG000|Open Label Period (OL)|Pregnancy|0|||
105633772|NCT00048932|364324011|FG001|Open Label Period (OL)|Pregnancy|0|||
105633773|NCT00048932|364324012|FG002|Open Label Period (OL)|Pregnancy|6|||
105633774|NCT00048932|364324010|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
105633775|NCT00048932|364324011|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
105633776|NCT00048932|364324012|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
105633777|NCT00048932|364324010|FG000|Open Label Period (OL)|Investigator Retiring|0|||
105633778|NCT00048932|364324011|FG001|Open Label Period (OL)|Investigator Retiring|0|||
105633779|NCT00048932|364324012|FG002|Open Label Period (OL)|Investigator Retiring|2|||
105633780|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
105633781|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
105633782|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
105633783|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Relocated|0|||
105633784|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Relocated|0|||
105633785|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Relocated|6|||
105633786|NCT00048932|364324010|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
105633787|NCT00048932|364324011|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
105633788|NCT00048932|364324012|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
105633789|NCT00048932|364324010|FG000|Open Label Period (OL)|Site Closure|0|||
105633790|NCT00048932|364324011|FG001|Open Label Period (OL)|Site Closure|0|||
105633791|NCT00048932|364324012|FG002|Open Label Period (OL)|Site Closure|3|||
105633792|NCT00048932|364324010|FG000|Open Label Period (OL)|Trial Terminated|0|||
105633793|NCT00048932|364324011|FG001|Open Label Period (OL)|Trial Terminated|0|||
105633794|NCT00048932|364324012|FG002|Open Label Period (OL)|Trial Terminated|1|||
105633795|NCT00048932|364324010|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
105633796|NCT00048932|364324011|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
105633797|NCT00048932|364324012|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
105633798|NCT00048932|364324010|FG000|Open Label Period (OL)|Patient Decision|0|||
105633799|NCT00048932|364324011|FG001|Open Label Period (OL)|Patient Decision|0|||
105633800|NCT00048932|364324012|FG002|Open Label Period (OL)|Patient Decision|4|||
105633801|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
105633802|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
105633803|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
105633804|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
105633805|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
105633806|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
105633807|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
105633808|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
105633809|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
105633810|NCT00048932|364324010|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
105633811|NCT00048932|364324011|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
105633812|NCT00048932|364324012|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
105633813|NCT00048932|364324010|FG000|Open Label Period (OL)|Investigator Decision|0|||
105633814|NCT00048932|364324011|FG001|Open Label Period (OL)|Investigator Decision|0|||
105633815|NCT00048932|364324012|FG002|Open Label Period (OL)|Investigator Decision|4|||
105633816|NCT00048932|364324010|FG000|Open Label Period (OL)|Site Staff Issues|0|||
105633817|NCT00048932|364324011|FG001|Open Label Period (OL)|Site Staff Issues|0|||
105633818|NCT00048932|364324012|FG002|Open Label Period (OL)|Site Staff Issues|2|||
105633819|NCT00048932|364324010|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
105633820|NCT00048932|364324011|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
105633821|NCT00048932|364324012|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
105633822|NCT00048932|364324010|FG000|Open Label Period (OL)|Participant Surgery|0|||
105633823|NCT00048932|364324011|FG001|Open Label Period (OL)|Participant Surgery|0|||
105633824|NCT00048932|364324012|FG002|Open Label Period (OL)|Participant Surgery|1|||
105633825|NCT04989816|364324016|FG000|Overall Study|Death|77|||
105633826|NCT04989816|364324016|FG000|Overall Study|Lost to Follow-up|3|||
105633827|NCT03214081|364324017|FG000|Overall Study|Case Report Forms Uncollected|9|||
105633828|NCT03214081|364324017|FG000|Overall Study|Protocol Deviation|54|||
105633829|NCT01964300|364324018|FG000|Overall Study|Ineligible after enrollment|0|||
105633830|NCT01964300|364324019|FG001|Overall Study|Ineligible after enrollment|1|||
105633831|NCT01964300|364324018|FG000|Overall Study|Adverse Event|1|||
105633832|NCT01964300|364324019|FG001|Overall Study|Adverse Event|1|||
105633833|NCT01964300|364324018|FG000|Overall Study|Lack of Efficacy|3|||
105633834|NCT01964300|364324019|FG001|Overall Study|Lack of Efficacy|5|||
105633835|NCT01964300|364324018|FG000|Overall Study|Withdrawal by Subject|0|||
105633836|NCT01964300|364324019|FG001|Overall Study|Withdrawal by Subject|1|||
105633837|NCT01964300|364324018|FG000|Overall Study|To receive alternative therapy|1|||
105633838|NCT01964300|364324019|FG001|Overall Study|To receive alternative therapy|2|||
105633839|NCT01964300|364324018|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
105633840|NCT01964300|364324019|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
105633841|NCT01964300|364324018|FG000|Overall Study|Weight criteria not met|0|||
105633842|NCT01964300|364324019|FG001|Overall Study|Weight criteria not met|1|||
105633843|NCT03442777|364324029|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
105633844|NCT03442777|364324030|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
105633845|NCT03442777|364324031|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
105633846|NCT04162210|364324036|FG000|Overall Study|Lost to Follow-up|4|||
105633847|NCT04162210|364324037|FG001|Overall Study|Lost to Follow-up|1|||
105633848|NCT04162210|364324036|FG000|Overall Study|Withdrawal by Subject|17|||
105633849|NCT04162210|364324037|FG001|Overall Study|Withdrawal by Subject|9|||
105633850|NCT04162210|364324036|FG000|Overall Study|Ongoing|113|||
105633851|NCT04162210|364324037|FG001|Overall Study|Ongoing|59|||
105633852|NCT01128595|364324038|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105633853|NCT01128595|364324039|FG001|Treatment Period 3|Withdrawal by Subject|1|||
105633854|NCT01128595|364324040|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105633855|NCT01128595|364324041|FG003|Treatment Period 3|Withdrawal by Subject|0|||
105633856|NCT01750684|364324042|FG000|Overall Study|Death|1|||
105633857|NCT01750684|364324043|FG001|Overall Study|Death|0|||
105633858|NCT01750684|364324042|FG000|Overall Study|Non-compliance with Study Drug|0|||
105633859|NCT01750684|364324043|FG001|Overall Study|Non-compliance with Study Drug|1|||
105633860|NCT01750684|364324042|FG000|Overall Study|Withdrawn by Sponsor|0|||
105633861|NCT01750684|364324043|FG001|Overall Study|Withdrawn by Sponsor|1|||
105633862|NCT01750684|364324042|FG000|Overall Study|Protocol Violation|1|||
105633863|NCT01750684|364324043|FG001|Overall Study|Protocol Violation|0|||
105633864|NCT02568215|364324048|FG000|Overall Study|Death|1|||
105633865|NCT02568215|364324049|FG001|Overall Study|Death|2|||
105633866|NCT02568215|364324050|FG002|Overall Study|Death|0|||
105633867|NCT02568215|364324048|FG000|Overall Study|Physician Decision|2|||
105633868|NCT02568215|364324049|FG001|Overall Study|Physician Decision|2|||
105633869|NCT02568215|364324050|FG002|Overall Study|Physician Decision|2|||
105633870|NCT02568215|364324048|FG000|Overall Study|Lost to Follow-up|29|||
105633871|NCT02568215|364324049|FG001|Overall Study|Lost to Follow-up|32|||
105633872|NCT02568215|364324050|FG002|Overall Study|Lost to Follow-up|41|||
105633873|NCT02568215|364324048|FG000|Overall Study|Withdrawal by Subject|21|||
105633874|NCT02568215|364324049|FG001|Overall Study|Withdrawal by Subject|19|||
105633875|NCT02568215|364324050|FG002|Overall Study|Withdrawal by Subject|22|||
105633876|NCT02568215|364324048|FG000|Overall Study|Protocol Violation|1|||
105633877|NCT02568215|364324049|FG001|Overall Study|Protocol Violation|1|||
105633878|NCT02568215|364324050|FG002|Overall Study|Protocol Violation|0|||
105633879|NCT02568215|364324048|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
105633880|NCT02568215|364324049|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
105633881|NCT02568215|364324050|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
105633882|NCT02568215|364324048|FG000|Overall Study|Other|0|||
105633883|NCT02568215|364324049|FG001|Overall Study|Other|1|||
105633884|NCT02568215|364324050|FG002|Overall Study|Other|4|||
105633885|NCT02185794|364324052|FG000|Overall Study|Enrolled but Never Dosed|1|||
105633886|NCT02185794|364324053|FG001|Overall Study|Enrolled but Never Dosed|6|||
105633887|NCT02185794|364324054|FG002|Overall Study|Enrolled but Never Dosed|3|||
105633888|NCT02185794|364324055|FG003|Overall Study|Enrolled but Never Dosed|1|||
105633889|NCT02185794|364324056|FG004|Overall Study|Enrolled but Never Dosed|1|||
105633890|NCT02185794|364324057|FG005|Overall Study|Enrolled but Never Dosed|0|||
105633891|NCT02185794|364324052|FG000|Overall Study|Investigator's Discretion|1|||
105633892|NCT02185794|364324053|FG001|Overall Study|Investigator's Discretion|0|||
105633893|NCT02185794|364324054|FG002|Overall Study|Investigator's Discretion|1|||
105633894|NCT02185794|364324055|FG003|Overall Study|Investigator's Discretion|2|||
105633895|NCT02185794|364324056|FG004|Overall Study|Investigator's Discretion|2|||
105633896|NCT02185794|364324057|FG005|Overall Study|Investigator's Discretion|15|||
105633897|NCT02185794|364324052|FG000|Overall Study|Withdrew Consent|2|||
105633898|NCT02185794|364324053|FG001|Overall Study|Withdrew Consent|5|||
105633899|NCT02185794|364324054|FG002|Overall Study|Withdrew Consent|10|||
105633900|NCT02185794|364324055|FG003|Overall Study|Withdrew Consent|2|||
105633901|NCT02185794|364324056|FG004|Overall Study|Withdrew Consent|0|||
105633902|NCT02185794|364324057|FG005|Overall Study|Withdrew Consent|0|||
105633903|NCT02185794|364324052|FG000|Overall Study|Lost to Follow-up|1|||
105633904|NCT02185794|364324053|FG001|Overall Study|Lost to Follow-up|2|||
105633905|NCT02185794|364324054|FG002|Overall Study|Lost to Follow-up|2|||
105633906|NCT02185794|364324055|FG003|Overall Study|Lost to Follow-up|3|||
105633907|NCT02185794|364324056|FG004|Overall Study|Lost to Follow-up|0|||
105633908|NCT02185794|364324057|FG005|Overall Study|Lost to Follow-up|1|||
105633909|NCT03244800|364324058|FG000|Overall Study|Adverse Event|0|||
105633910|NCT03244800|364324059|FG001|Overall Study|Adverse Event|1|||
105633911|NCT03244800|364324060|FG002|Overall Study|Adverse Event|0|||
105633912|NCT03244800|364324061|FG003|Overall Study|Adverse Event|1|||
105633913|NCT03244800|364324058|FG000|Overall Study|Withdrew treatment|0|||
105633914|NCT03244800|364324059|FG001|Overall Study|Withdrew treatment|0|||
105633915|NCT03244800|364324060|FG002|Overall Study|Withdrew treatment|0|||
105633916|NCT03244800|364324061|FG003|Overall Study|Withdrew treatment|1|||
105633917|NCT03478969|364324067|FG000|Overall Study|Withdrawal by Subject|4|||
105633918|NCT03478969|364324068|FG001|Overall Study|Withdrawal by Subject|7|||
105633919|NCT03478969|364324069|FG002|Overall Study|Withdrawal by Subject|6|||
105633920|NCT03478969|364324067|FG000|Overall Study|Adverse Event|2|||
105633921|NCT03478969|364324068|FG001|Overall Study|Adverse Event|0|||
105633922|NCT03478969|364324069|FG002|Overall Study|Adverse Event|1|||
105633923|NCT03478969|364324067|FG000|Overall Study|Pregnancy|1|||
105633924|NCT03478969|364324068|FG001|Overall Study|Pregnancy|0|||
105633925|NCT03478969|364324069|FG002|Overall Study|Pregnancy|0|||
105633926|NCT03478969|364324067|FG000|Overall Study|Personal Reasons|1|||
105633927|NCT03478969|364324068|FG001|Overall Study|Personal Reasons|0|||
105633928|NCT03478969|364324069|FG002|Overall Study|Personal Reasons|1|||
105633929|NCT03478969|364324067|FG000|Overall Study|Covid-19|1|||
105633930|NCT03478969|364324068|FG001|Overall Study|Covid-19|4|||
105633931|NCT03478969|364324069|FG002|Overall Study|Covid-19|3|||
105633932|NCT03478969|364324067|FG000|Overall Study|Multiple Reasons|0|||
105633933|NCT03478969|364324068|FG001|Overall Study|Multiple Reasons|1|||
105633934|NCT03478969|364324069|FG002|Overall Study|Multiple Reasons|1|||
105633935|NCT03478969|364324067|FG000|Overall Study|Eligibility Criteria|0|||
105633936|NCT03478969|364324068|FG001|Overall Study|Eligibility Criteria|0|||
105633937|NCT03478969|364324069|FG002|Overall Study|Eligibility Criteria|5|||
105633938|NCT03478969|364324067|FG000|Overall Study|Lost to Follow-up|0|||
105633939|NCT03478969|364324068|FG001|Overall Study|Lost to Follow-up|0|||
105633940|NCT03478969|364324069|FG002|Overall Study|Lost to Follow-up|1|||
105633941|NCT03220724|364324070|FG000|Overall Study|Lost to Follow-up|2|||
105633942|NCT03220724|364324071|FG001|Overall Study|Lost to Follow-up|2|||
105633943|NCT03220724|364324072|FG002|Overall Study|Lost to Follow-up|0|||
105633944|NCT03220724|364324073|FG003|Overall Study|Lost to Follow-up|3|||
105633945|NCT03220724|364324074|FG004|Overall Study|Lost to Follow-up|1|||
105633946|NCT03220724|364324075|FG005|Overall Study|Lost to Follow-up|0|||
105633947|NCT03220724|364324076|FG006|Overall Study|Lost to Follow-up|2|||
105633948|NCT03220724|364324077|FG007|Overall Study|Lost to Follow-up|1|||
105633949|NCT03220724|364324078|FG008|Overall Study|Lost to Follow-up|0|||
105633950|NCT03220724|364324070|FG000|Overall Study|Withdrawal by Subject|1|||
105633951|NCT03220724|364324071|FG001|Overall Study|Withdrawal by Subject|0|||
105633952|NCT03220724|364324072|FG002|Overall Study|Withdrawal by Subject|1|||
105633953|NCT03220724|364324073|FG003|Overall Study|Withdrawal by Subject|0|||
105633954|NCT03220724|364324074|FG004|Overall Study|Withdrawal by Subject|0|||
105633955|NCT03220724|364324075|FG005|Overall Study|Withdrawal by Subject|0|||
105633956|NCT03220724|364324076|FG006|Overall Study|Withdrawal by Subject|0|||
105633957|NCT03220724|364324077|FG007|Overall Study|Withdrawal by Subject|0|||
105633958|NCT03220724|364324078|FG008|Overall Study|Withdrawal by Subject|0|||
105633959|NCT01185600|364324083|FG000|Overall Study|Adverse Event|1|||
105633960|NCT01185600|364324084|FG001|Overall Study|Adverse Event|1|||
105633961|NCT01185600|364324083|FG000|Overall Study|Death|0|||
105633962|NCT01185600|364324084|FG001|Overall Study|Death|1|||
105633963|NCT01185600|364324083|FG000|Overall Study|Lost to Follow-up|0|||
105633964|NCT01185600|364324084|FG001|Overall Study|Lost to Follow-up|5|||
105633965|NCT01185600|364324083|FG000|Overall Study|Physician Decision|29|||
105633966|NCT01185600|364324084|FG001|Overall Study|Physician Decision|35|||
105633967|NCT01185600|364324083|FG000|Overall Study|Withdrawal by Subject|1|||
105633968|NCT01185600|364324084|FG001|Overall Study|Withdrawal by Subject|1|||
105633969|NCT01185600|364324083|FG000|Overall Study|Hold by DSMB|1|||
105633970|NCT01185600|364324084|FG001|Overall Study|Hold by DSMB|2|||
105633971|NCT00724126|364324085|FG000|Overall Study|Adverse Event|2|||
105633972|NCT00724126|364324086|FG001|Overall Study|Adverse Event|0|||
105633973|NCT00724126|364324085|FG000|Overall Study|Withdrawal by Subject|8|||
105633974|NCT00724126|364324086|FG001|Overall Study|Withdrawal by Subject|6|||
105633975|NCT00724126|364324085|FG000|Overall Study|Lost to Follow-up|6|||
105633976|NCT00724126|364324086|FG001|Overall Study|Lost to Follow-up|6|||
105633977|NCT00724126|364324085|FG000|Overall Study|Noncompliance|2|||
105633978|NCT00724126|364324086|FG001|Overall Study|Noncompliance|1|||
105869495|NCT00764881|365174467|FG000|Overall Study|Protocol Violation|2|||
105633979|NCT00724126|364324085|FG000|Overall Study|Subject randomized although ineligible|1|||
105633980|NCT00724126|364324086|FG001|Overall Study|Subject randomized although ineligible|1|||
105633981|NCT00724126|364324085|FG000|Overall Study|Subject had to leave vicinity of site|0|||
105633982|NCT00724126|364324086|FG001|Overall Study|Subject had to leave vicinity of site|1|||
105633983|NCT01436175|364324087|FG000|Overall Study|Adverse Event|111|||
105633984|NCT01436175|364324087|FG000|Overall Study|Protocol Violation|49|||
105633985|NCT01436175|364324087|FG000|Overall Study|Withdrawal by Subject|108|||
105633986|NCT01436175|364324087|FG000|Overall Study|Lost to Follow-up|89|||
105633987|NCT01436175|364324087|FG000|Overall Study|Lack of Efficacy|24|||
105633988|NCT01436175|364324087|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
105633989|NCT01436175|364324087|FG000|Overall Study|Other|826|||
105633990|NCT03418922|364324089|FG000|Overall Study|Withdrawal by Subject|0|||
105633991|NCT03418922|364324090|FG001|Overall Study|Withdrawal by Subject|2|||
105633992|NCT03418922|364324089|FG000|Overall Study|Adverse Event|2|||
105633993|NCT03418922|364324090|FG001|Overall Study|Adverse Event|2|||
105633994|NCT03418922|364324089|FG000|Overall Study|Death|0|||
105633995|NCT03418922|364324090|FG001|Overall Study|Death|1|||
105633996|NCT03418922|364324089|FG000|Overall Study|Physician Decision|0|||
105633997|NCT03418922|364324090|FG001|Overall Study|Physician Decision|1|||
105633998|NCT03577106|364324091|FG000|Overall Study|Withdrawal by Subject|3|||
105633999|NCT02797132|364324092|FG000|Part A (15 Days)|Adverse Event|1|||
105634000|NCT02797132|364324092|FG000|Part B (24 Weeks)|Adverse Event|3|||
105634001|NCT01313884|364324094|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
105634002|NCT00263757|364324095|FG000|Overall Study|Withdrawal by Subject|5|||
105634003|NCT00263757|364324096|FG001|Overall Study|Withdrawal by Subject|4|||
105634004|NCT00263757|364324095|FG000|Overall Study|Screen failure|0|||
105634005|NCT00263757|364324096|FG001|Overall Study|Screen failure|1|||
105634006|NCT00263757|364324095|FG000|Overall Study|Adverse Event|3|||
105634007|NCT00263757|364324096|FG001|Overall Study|Adverse Event|3|||
105634008|NCT03712371|364324099|FG000|Overall Study|Lack of Efficacy|0|||
105634009|NCT03712371|364324100|FG001|Overall Study|Lack of Efficacy|0|||
105634010|NCT03712371|364324101|FG002|Overall Study|Lack of Efficacy|0|||
105634011|NCT03712371|364324102|FG003|Overall Study|Lack of Efficacy|1|||
105634012|NCT03521154|364324104|FG000|Overall Study|Ongoing study at data cut-off|111|||
105634013|NCT03521154|364324105|FG001|Overall Study|Ongoing study at data cut-off|52|||
105634014|NCT02964741|364324108|FG000|Overall Study|Protocol Violation|1|||
105634015|NCT02964741|364324109|FG001|Overall Study|Protocol Violation|0|||
105634016|NCT02964741|364324110|FG002|Overall Study|Protocol Violation|0|||
105634017|NCT02964741|364324108|FG000|Overall Study|Withdrawal by Subject|0|||
105634018|NCT02964741|364324109|FG001|Overall Study|Withdrawal by Subject|1|||
105634019|NCT02964741|364324110|FG002|Overall Study|Withdrawal by Subject|0|||
105634020|NCT02964741|364324108|FG000|Overall Study|claustrophobia|1|||
105634021|NCT02964741|364324109|FG001|Overall Study|claustrophobia|0|||
105634022|NCT02964741|364324110|FG002|Overall Study|claustrophobia|0|||
105634023|NCT01212744|364324114|FG000|Overall Study|Withdrawal by Subject|1|||
105634024|NCT02167451|364324116|FG000|Overall Study|Withdrawal by Subject|1|||
105634025|NCT04191824|364324117|FG000|Overall Study|Death|13|||
105634026|NCT04191824|364324118|FG001|Overall Study|Death|12|||
105634027|NCT04191824|364324117|FG000|Overall Study|Lost to Follow-up|456|||
105634028|NCT04191824|364324118|FG001|Overall Study|Lost to Follow-up|435|||
105634029|NCT04191824|364324117|FG000|Overall Study|Physician Decision|2|||
105634030|NCT04191824|364324118|FG001|Overall Study|Physician Decision|1|||
105634031|NCT04191824|364324117|FG000|Overall Study|Protocol Violation|0|||
105634032|NCT04191824|364324118|FG001|Overall Study|Protocol Violation|2|||
105634033|NCT04191824|364324117|FG000|Overall Study|Withdrawal by Subject|16|||
105634034|NCT04191824|364324118|FG001|Overall Study|Withdrawal by Subject|18|||
105634035|NCT04191824|364324117|FG000|Overall Study|Early site closure|24|||
105634036|NCT04191824|364324118|FG001|Overall Study|Early site closure|22|||
105634037|NCT04937504|364324119|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
105634038|NCT04937504|364324120|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
105634039|NCT04937504|364324119|FG000|9 Months Assessment|Lost to Follow-up|3|||
105634040|NCT04937504|364324120|FG001|9 Months Assessment|Lost to Follow-up|2|||
105634041|NCT04306367|364324121|FG000|Overall Study|Progression of Disease|9|||
105634042|NCT04306367|364324121|FG000|Overall Study|Adverse Event|3|||
105634043|NCT04306367|364324121|FG000|Overall Study|Withdrawal by Subject|1|||
105634044|NCT05613907|364324122|FG000|Overall Study|Lost to Follow-up|5|||
105634045|NCT05613907|364324122|FG000|Overall Study|Death|3|||
105634046|NCT05613907|364324122|FG000|Overall Study|Withdrawal by Subject|2|||
105634047|NCT04912856|364324123|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
105634048|NCT04912856|364324124|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
105634049|NCT04912856|364324123|FG000|Overall Study|Not reported in synoptic CSR.|0|||
105634050|NCT04912856|364324124|FG001|Overall Study|Not reported in synoptic CSR.|1|||
105634051|NCT05349838|364324129|FG000|Overall Study|Virological Failure|1|||
105634052|NCT05349838|364324130|FG001|Overall Study|Virological Failure|2|||
105634053|NCT05349838|364324129|FG000|Overall Study|Withdrawal by Subject|2|||
105634054|NCT05349838|364324130|FG001|Overall Study|Withdrawal by Subject|3|||
105634055|NCT05349838|364324129|FG000|Overall Study|Adverse Event|3|||
105634056|NCT05349838|364324130|FG001|Overall Study|Adverse Event|1|||
105634057|NCT05349838|364324129|FG000|Overall Study|Lost to Follow-up|1|||
105634058|NCT05349838|364324130|FG001|Overall Study|Lost to Follow-up|2|||
105634059|NCT05349838|364324129|FG000|Overall Study|Other reasons|5|||
105634060|NCT05349838|364324130|FG001|Overall Study|Other reasons|1|||
105634061|NCT05037513|364324131|FG000|Intervention Period|Lost to Follow-up|1|||
105634062|NCT05037513|364324132|FG001|Intervention Period|Lost to Follow-up|2|||
105634063|NCT05037513|364324131|FG000|Follow Up Period|Lost to Follow-up|16|||
105634064|NCT05037513|364324132|FG001|Follow Up Period|Lost to Follow-up|21|||
105634065|NCT05037513|364324131|FG000|Follow Up Period|Death|0|||
105634066|NCT05037513|364324132|FG001|Follow Up Period|Death|1|||
105634067|NCT05037513|364324131|FG000|Follow Up Period|Incarcerated|4|||
105634068|NCT05037513|364324132|FG001|Follow Up Period|Incarcerated|2|||
105634069|NCT05886777|364324133|FG000|Overall Study|Lost to Follow-up|1|||
105634070|NCT05886777|364324134|FG001|Overall Study|Lost to Follow-up|0|||
105634071|NCT05886777|364324135|FG002|Overall Study|Lost to Follow-up|2|||
105634072|NCT05886777|364324136|FG003|Overall Study|Lost to Follow-up|1|||
105634073|NCT05886777|364324137|FG004|Overall Study|Lost to Follow-up|0|||
105634074|NCT05886777|364324138|FG005|Overall Study|Lost to Follow-up|2|||
105634075|NCT05886777|364324139|FG006|Overall Study|Lost to Follow-up|0|||
105634076|NCT05886777|364324133|FG000|Overall Study|Other|0|||
105634077|NCT05886777|364324134|FG001|Overall Study|Other|2|||
105634078|NCT05886777|364324135|FG002|Overall Study|Other|1|||
105634079|NCT05886777|364324136|FG003|Overall Study|Other|0|||
105634080|NCT05886777|364324137|FG004|Overall Study|Other|0|||
105634081|NCT05886777|364324138|FG005|Overall Study|Other|0|||
105634082|NCT05886777|364324139|FG006|Overall Study|Other|0|||
105634083|NCT05886777|364324133|FG000|Overall Study|Withdrawal by Subject|1|||
105634084|NCT05886777|364324134|FG001|Overall Study|Withdrawal by Subject|0|||
105634085|NCT05886777|364324135|FG002|Overall Study|Withdrawal by Subject|1|||
105634086|NCT05886777|364324136|FG003|Overall Study|Withdrawal by Subject|4|||
105634087|NCT05886777|364324137|FG004|Overall Study|Withdrawal by Subject|3|||
105634088|NCT05886777|364324138|FG005|Overall Study|Withdrawal by Subject|1|||
105634089|NCT05886777|364324139|FG006|Overall Study|Withdrawal by Subject|1|||
105634090|NCT05886777|364324133|FG000|Overall Study|Protocol Violation|0|||
105634091|NCT05886777|364324134|FG001|Overall Study|Protocol Violation|0|||
105634092|NCT05886777|364324135|FG002|Overall Study|Protocol Violation|1|||
105634093|NCT05886777|364324136|FG003|Overall Study|Protocol Violation|0|||
105634094|NCT05886777|364324137|FG004|Overall Study|Protocol Violation|0|||
105634095|NCT05886777|364324138|FG005|Overall Study|Protocol Violation|0|||
105634096|NCT05886777|364324139|FG006|Overall Study|Protocol Violation|0|||
105634097|NCT05886777|364324133|FG000|Overall Study|No longer met eligibility criteria|0|||
105634098|NCT05886777|364324134|FG001|Overall Study|No longer met eligibility criteria|1|||
105634099|NCT05886777|364324135|FG002|Overall Study|No longer met eligibility criteria|0|||
105634100|NCT05886777|364324136|FG003|Overall Study|No longer met eligibility criteria|0|||
105634101|NCT05886777|364324137|FG004|Overall Study|No longer met eligibility criteria|0|||
105634102|NCT05886777|364324138|FG005|Overall Study|No longer met eligibility criteria|0|||
105634103|NCT05886777|364324139|FG006|Overall Study|No longer met eligibility criteria|0|||
105634104|NCT00229658|364325971|FG000|Overall Study|Administrative|2|||
105634105|NCT00229658|364325972|FG001|Overall Study|Administrative|1|||
105634106|NCT00229658|364325971|FG000|Overall Study|Investigator decision|13|||
105634107|NCT00229658|364325972|FG001|Overall Study|Investigator decision|10|||
105634108|NCT00229658|364325971|FG000|Overall Study|Other|80|||
105634109|NCT00229658|364325972|FG001|Overall Study|Other|60|||
105634110|NCT00229658|364325971|FG000|Overall Study|Lost to Follow-up|82|||
105634111|NCT00229658|364325972|FG001|Overall Study|Lost to Follow-up|55|||
105634112|NCT00229658|364325971|FG000|Overall Study|Serious Adverse Event|2|||
105634113|NCT00229658|364325972|FG001|Overall Study|Serious Adverse Event|2|||
105634114|NCT00229658|364325971|FG000|Overall Study|Withdrawal of consent|46|||
105634115|NCT00229658|364325972|FG001|Overall Study|Withdrawal of consent|39|||
105634116|NCT00463229|364325973|FG000|Overall Study|Lost to Follow-up|5|||
105634117|NCT00463229|364325974|FG001|Overall Study|Lost to Follow-up|7|||
105634118|NCT00463229|364325973|FG000|Overall Study|Death|4|||
105634119|NCT00463229|364325974|FG001|Overall Study|Death|3|||
105634120|NCT01500200|364325975|FG000|Stage 1|Adverse Event|1|||
105634121|NCT01500200|364325976|FG001|Stage 1|Adverse Event|4|||
105634122|NCT01500200|364325977|FG002|Stage 1|Adverse Event|5|||
105634123|NCT01500200|364325978|FG003|Stage 1|Adverse Event|0|||
105634124|NCT01500200|364325979|FG004|Stage 1|Adverse Event|0|||
105634125|NCT01500200|364325980|FG005|Stage 1|Adverse Event|0|||
105634126|NCT01500200|364325975|FG000|Stage 1|Lost to Follow-up|2|||
105634127|NCT01500200|364325976|FG001|Stage 1|Lost to Follow-up|2|||
105634128|NCT01500200|364325977|FG002|Stage 1|Lost to Follow-up|1|||
105634129|NCT01500200|364325978|FG003|Stage 1|Lost to Follow-up|0|||
105634130|NCT01500200|364325979|FG004|Stage 1|Lost to Follow-up|0|||
105634131|NCT01500200|364325980|FG005|Stage 1|Lost to Follow-up|0|||
105634132|NCT01500200|364325975|FG000|Stage 1|Withdrawal by Subject|3|||
105634133|NCT01500200|364325976|FG001|Stage 1|Withdrawal by Subject|0|||
105634134|NCT01500200|364325977|FG002|Stage 1|Withdrawal by Subject|0|||
105634135|NCT01500200|364325978|FG003|Stage 1|Withdrawal by Subject|0|||
105634136|NCT01500200|364325979|FG004|Stage 1|Withdrawal by Subject|0|||
105634137|NCT01500200|364325980|FG005|Stage 1|Withdrawal by Subject|0|||
105634138|NCT01500200|364325975|FG000|Stage 1|Noncompliance with Study Drug|1|||
105634139|NCT01500200|364325976|FG001|Stage 1|Noncompliance with Study Drug|0|||
105869496|NCT00764881|365174468|FG001|Overall Study|Protocol Violation|2|||
105869497|NCT00764881|365174467|FG000|Overall Study|Lost to Follow-up|2|||
105869498|NCT00764881|365174468|FG001|Overall Study|Lost to Follow-up|0|||
105869499|NCT00764881|365174467|FG000|Overall Study|Noncompliant|1|||
105634140|NCT01500200|364325977|FG002|Stage 1|Noncompliance with Study Drug|0|||
105634141|NCT01500200|364325978|FG003|Stage 1|Noncompliance with Study Drug|0|||
105634142|NCT01500200|364325979|FG004|Stage 1|Noncompliance with Study Drug|0|||
105634143|NCT01500200|364325980|FG005|Stage 1|Noncompliance with Study Drug|0|||
105634144|NCT01500200|364325975|FG000|Stage 1|Physician Decision|1|||
105634145|NCT01500200|364325976|FG001|Stage 1|Physician Decision|0|||
105869500|NCT00764881|365174468|FG001|Overall Study|Noncompliant|0|||
105634146|NCT01500200|364325977|FG002|Stage 1|Physician Decision|0|||
105634147|NCT01500200|364325978|FG003|Stage 1|Physician Decision|0|||
105634148|NCT01500200|364325979|FG004|Stage 1|Physician Decision|0|||
105634149|NCT01500200|364325980|FG005|Stage 1|Physician Decision|0|||
105634150|NCT01500200|364325975|FG000|Stage 2|Adverse Event|0|||
105634151|NCT01500200|364325976|FG001|Stage 2|Adverse Event|0|||
105634152|NCT01500200|364325977|FG002|Stage 2|Adverse Event|0|||
105634153|NCT01500200|364325978|FG003|Stage 2|Adverse Event|0|||
105634154|NCT01500200|364325979|FG004|Stage 2|Adverse Event|5|||
105634155|NCT01500200|364325980|FG005|Stage 2|Adverse Event|4|||
105634156|NCT01952366|364325981|FG000|Overall Study|Death|22|||
105634157|NCT01952366|364325981|FG000|Overall Study|Withdrawal by Subject|9|||
105634158|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
105634159|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
105634160|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
105634161|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
105634162|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
105634163|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
105634164|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
105634165|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
105634166|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
105634167|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
105634168|NCT01767467|364325982|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
105634169|NCT01767467|364325983|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
105634170|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
105634171|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
105869501|NCT00764881|365174467|FG000|Overall Study|Accidentally discontinued study drug|1|||
105869502|NCT00764881|365174468|FG001|Overall Study|Accidentally discontinued study drug|0|||
105869503|NCT00764881|365174467|FG000|Overall Study|Wished to become pregnant|1|||
105869504|NCT00764881|365174468|FG001|Overall Study|Wished to become pregnant|0|||
105869505|NCT00764881|365174467|FG000|Overall Study|Carcinoma detected|1|||
105869506|NCT00764881|365174468|FG001|Overall Study|Carcinoma detected|0|||
105869507|NCT00764881|365174467|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
105869508|NCT00764881|365174468|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
105869509|NCT00764881|365174467|FG000|Overall Study|no treatment or no observation|2|||
105869510|NCT00764881|365174468|FG001|Overall Study|no treatment or no observation|2|||
105869511|NCT01214655|365174469|FG000|Part A|Progressive Disease|7|||
105869512|NCT01214655|365174470|FG001|Part A|Progressive Disease|0|||
105869513|NCT01214655|365174471|FG002|Part A|Progressive Disease|0|||
105869514|NCT01214655|365174469|FG000|Part A|Physician Decision|1|||
105869515|NCT01214655|365174470|FG001|Part A|Physician Decision|0|||
105634172|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
105634173|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
105634174|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
105634175|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
105634176|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
105634177|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
105634178|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
105634179|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
105634180|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
105634181|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
105634182|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
105634183|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
105634184|NCT01767467|364325982|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
105634185|NCT01767467|364325983|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
105634186|NCT01359150|364325984|FG000|Overall Study|Lack of Efficacy|1|||
105634187|NCT01359150|364325985|FG001|Overall Study|Lack of Efficacy|1|||
105634188|NCT01359150|364325984|FG000|Overall Study|Withdrawal by Subject|1|||
105634189|NCT01359150|364325985|FG001|Overall Study|Withdrawal by Subject|1|||
105634190|NCT01359150|364325984|FG000|Overall Study|Adverse Event|4|||
105634191|NCT01359150|364325985|FG001|Overall Study|Adverse Event|3|||
105634192|NCT01359150|364325984|FG000|Overall Study|Other|1|||
105634193|NCT01359150|364325985|FG001|Overall Study|Other|0|||
105634194|NCT04860505|364325986|FG000|Overall Study|Lost to Follow-up|2|||
105634195|NCT02406092|364326001|FG000|Overall Study|Screen failure|10|||
105634196|NCT02406092|364326002|FG001|Overall Study|Screen failure|7|||
105634197|NCT02406092|364326001|FG000|Overall Study|Death|22|||
105634198|NCT02406092|364326002|FG001|Overall Study|Death|5|||
105634199|NCT02406092|364326001|FG000|Overall Study|Lost to Follow-up|4|||
105869516|NCT01214655|365174471|FG002|Part A|Physician Decision|0|||
105869517|NCT01214655|365174469|FG000|Part B|Progressive disease|0|||
105634200|NCT02406092|364326002|FG001|Overall Study|Lost to Follow-up|1|||
105634201|NCT02406092|364326001|FG000|Overall Study|Adverse Event|1|||
105634202|NCT02406092|364326002|FG001|Overall Study|Adverse Event|0|||
105869518|NCT01214655|365174470|FG001|Part B|Progressive disease|10|||
105869519|NCT01214655|365174471|FG002|Part B|Progressive disease|0|||
105869520|NCT01214655|365174469|FG000|Part B|Death|0|||
105869521|NCT01214655|365174470|FG001|Part B|Death|1|||
105634203|NCT02406092|364326001|FG000|Overall Study|Withdrawal by Subject|1|||
105634204|NCT02406092|364326002|FG001|Overall Study|Withdrawal by Subject|0|||
105634205|NCT00293397|364326003|FG000|Overall Study|Death|2|||
105634206|NCT03631407|364326006|FG000|Overall Study|Withdrawal by Subject|3|||
105634207|NCT03631407|364326007|FG001|Overall Study|Withdrawal by Subject|2|||
105634208|NCT03631407|364326006|FG000|Overall Study|Sponsor Decision|0|||
105634209|NCT03631407|364326007|FG001|Overall Study|Sponsor Decision|2|||
105634210|NCT03631407|364326006|FG000|Overall Study|Death|16|||
105634211|NCT03631407|364326007|FG001|Overall Study|Death|16|||
105634212|NCT03631407|364326006|FG000|Overall Study|Randomized by mistake without study treatment|1|||
105634213|NCT03631407|364326007|FG001|Overall Study|Randomized by mistake without study treatment|0|||
105634214|NCT03041233|364326008|FG000|Overall Study|Death|5|||
105634215|NCT03041233|364326008|FG000|Overall Study|Physician Decision|1|||
105634216|NCT03041233|364326008|FG000|Overall Study|Lost to Follow-up|16|||
105634217|NCT03041233|364326008|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
105634218|NCT03041233|364326008|FG000|Overall Study|Sponsor Request|1|||
105634219|NCT03041233|364326008|FG000|Overall Study|Duplicate subject|1|||
105634220|NCT03041233|364326008|FG000|Overall Study|Re-ablation|1|||
105634221|NCT00811941|364326009|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
105634222|NCT00811941|364326010|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
105634223|NCT00811941|364326009|FG000|All Treated Patients|Adverse Event|2|||
105634224|NCT00811941|364326010|FG001|All Treated Patients|Adverse Event|43|||
105634225|NCT00811941|364326009|FG000|All Treated Patients|Lack of Efficacy|2|||
105634226|NCT00811941|364326010|FG001|All Treated Patients|Lack of Efficacy|3|||
105634227|NCT00811941|364326009|FG000|All Treated Patients|Non-compliance|1|||
105634228|NCT00811941|364326010|FG001|All Treated Patients|Non-compliance|8|||
105634229|NCT00811941|364326009|FG000|All Treated Patients|Protocol Violation|5|||
105634230|NCT00811941|364326010|FG001|All Treated Patients|Protocol Violation|17|||
105634231|NCT00811941|364326009|FG000|All Treated Patients|Withdrawal by Subject|35|||
105634232|NCT00811941|364326010|FG001|All Treated Patients|Withdrawal by Subject|94|||
105634233|NCT00811941|364326009|FG000|All Treated Patients|Lost to Follow-up|3|||
105634234|NCT00811941|364326010|FG001|All Treated Patients|Lost to Follow-up|12|||
105634235|NCT00811941|364326009|FG000|All Treated Patients|Other Reason|4|||
105634236|NCT00811941|364326010|FG001|All Treated Patients|Other Reason|14|||
105634237|NCT03802994|364326011|FG000|Overall Study|Lost to Follow-up|0|||
105634238|NCT03802994|364326012|FG001|Overall Study|Lost to Follow-up|2|||
105634239|NCT03802994|364326013|FG002|Overall Study|Lost to Follow-up|3|||
105634240|NCT03802994|364326014|FG003|Overall Study|Lost to Follow-up|2|||
105634241|NCT03802994|364326015|FG004|Overall Study|Lost to Follow-up|2|||
105634242|NCT05580003|364326018|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634243|NCT05580003|364326019|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634244|NCT05580003|364326020|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634245|NCT05580003|364326021|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634246|NCT05580003|364326022|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634247|NCT05580003|364326023|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634248|NCT05580003|364326024|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
105634249|NCT05580003|364326025|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634250|NCT05580003|364326026|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634251|NCT05580003|364326027|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634252|NCT05580003|364326028|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634253|NCT05580003|364326029|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634254|NCT05580003|364326030|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634255|NCT05580003|364326031|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634256|NCT05580003|364326032|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634257|NCT05580003|364326033|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634258|NCT05580003|364326034|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634259|NCT05580003|364326035|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634260|NCT05580003|364326036|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634261|NCT05580003|364326037|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634262|NCT05580003|364326038|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105869522|NCT01214655|365174471|FG002|Part B|Death|0|||
105869523|NCT01214655|365174469|FG000|Part B|Withdrawal by Subject|0|||
105634263|NCT05580003|364326039|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634264|NCT05580003|364326040|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634265|NCT05580003|364326041|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634266|NCT05580003|364326042|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634267|NCT05580003|364326043|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634268|NCT05580003|364326044|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634269|NCT05580003|364326045|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
105634270|NCT05580003|364326018|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634271|NCT05580003|364326019|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634272|NCT05580003|364326020|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634273|NCT05580003|364326021|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634274|NCT05580003|364326022|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634275|NCT05580003|364326023|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
105634276|NCT05580003|364326024|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634277|NCT05580003|364326025|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634278|NCT05580003|364326026|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634279|NCT05580003|364326027|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634280|NCT05580003|364326028|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634281|NCT05580003|364326029|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634282|NCT05580003|364326030|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634283|NCT05580003|364326031|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634284|NCT05580003|364326032|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634285|NCT05580003|364326033|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634286|NCT05580003|364326034|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634287|NCT05580003|364326035|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634288|NCT05580003|364326036|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634289|NCT05580003|364326037|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634290|NCT05580003|364326038|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634291|NCT05580003|364326039|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634292|NCT05580003|364326040|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634293|NCT05580003|364326041|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634294|NCT05580003|364326042|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634295|NCT05580003|364326043|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634296|NCT05580003|364326044|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634297|NCT05580003|364326045|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
105634298|NCT05580003|364326018|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634299|NCT05580003|364326019|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634300|NCT05580003|364326020|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634301|NCT05580003|364326021|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
105634302|NCT05580003|364326022|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634303|NCT05580003|364326023|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634304|NCT05580003|364326024|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634305|NCT05580003|364326025|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634306|NCT05580003|364326026|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634307|NCT05580003|364326027|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634308|NCT05580003|364326028|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634309|NCT05580003|364326029|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634310|NCT05580003|364326030|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634311|NCT05580003|364326031|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634312|NCT05580003|364326032|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634313|NCT05580003|364326033|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634314|NCT05580003|364326034|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634315|NCT05580003|364326035|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634316|NCT05580003|364326036|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634317|NCT05580003|364326037|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634318|NCT05580003|364326038|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634319|NCT05580003|364326039|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634320|NCT05580003|364326040|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634321|NCT05580003|364326041|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634322|NCT05580003|364326042|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634323|NCT05580003|364326043|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634324|NCT05580003|364326044|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634325|NCT05580003|364326045|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
105634326|NCT05580003|364326018|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634327|NCT05580003|364326019|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
105634328|NCT05580003|364326020|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634329|NCT05580003|364326021|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634330|NCT05580003|364326022|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634331|NCT05580003|364326023|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634332|NCT05580003|364326024|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634333|NCT05580003|364326025|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634334|NCT05580003|364326026|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634335|NCT05580003|364326027|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634336|NCT05580003|364326028|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634337|NCT05580003|364326029|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634338|NCT05580003|364326030|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634339|NCT05580003|364326031|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634340|NCT05580003|364326032|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634341|NCT05580003|364326033|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634342|NCT05580003|364326034|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634343|NCT05580003|364326035|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634344|NCT05580003|364326036|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634345|NCT05580003|364326037|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634346|NCT05580003|364326038|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634347|NCT05580003|364326039|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634348|NCT05580003|364326040|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634349|NCT05580003|364326041|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634350|NCT05580003|364326042|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105869524|NCT01214655|365174470|FG001|Part B|Withdrawal by Subject|2|||
105869525|NCT01214655|365174471|FG002|Part B|Withdrawal by Subject|0|||
105869526|NCT01214655|365174469|FG000|Part C|Progressive Disease|0|||
105869527|NCT01214655|365174470|FG001|Part C|Progressive Disease|0|||
105869528|NCT01214655|365174471|FG002|Part C|Progressive Disease|5|||
105869529|NCT01214655|365174469|FG000|Part C|Death|0|||
105869530|NCT01214655|365174470|FG001|Part C|Death|0|||
105869531|NCT01214655|365174471|FG002|Part C|Death|1|||
105869532|NCT01214655|365174469|FG000|Part C|Physician Decision|0|||
105869533|NCT01214655|365174470|FG001|Part C|Physician Decision|0|||
105869534|NCT01214655|365174471|FG002|Part C|Physician Decision|1|||
105869535|NCT00517881|365174472|FG000|Overall Study|Protocol Violation|2|||
105869536|NCT00517881|365174472|FG000|Overall Study|Adverse Event|1|||
105869537|NCT00517881|365174472|FG000|Overall Study|Renal transplantation|2|||
105869538|NCT00113763|365174473|FG000|Overall Study|Adverse Event|5|||
105869539|NCT00113763|365174474|FG001|Overall Study|Adverse Event|2|||
105869540|NCT00113763|365174473|FG000|Overall Study|Disease Progression|28|||
105869541|NCT00113763|365174474|FG001|Overall Study|Disease Progression|14|||
105869542|NCT00113763|365174473|FG000|Overall Study|Lost to Follow-up|10|||
105869543|NCT00113763|365174474|FG001|Overall Study|Lost to Follow-up|0|||
105869544|NCT00113763|365174473|FG000|Overall Study|Withdrawal by Subject|1|||
105869545|NCT00113763|365174474|FG001|Overall Study|Withdrawal by Subject|4|||
105869546|NCT00113763|365174473|FG000|Overall Study|Other|27|||
105869547|NCT00113763|365174474|FG001|Overall Study|Other|6|||
105869548|NCT00113763|365174473|FG000|Overall Study|Non-compliance|1|||
105869549|NCT00113763|365174474|FG001|Overall Study|Non-compliance|0|||
105869550|NCT00113763|365174473|FG000|Overall Study|Ongoing|1|||
105869551|NCT00113763|365174474|FG001|Overall Study|Ongoing|0|||
105869552|NCT00886015|365174479|FG000|Overall Study|Death|0|||
105869553|NCT00886015|365174480|FG001|Overall Study|Death|2|||
105869554|NCT01977417|365174482|FG000|Overall Study|Adverse Event|1|||
105869555|NCT01977417|365174483|FG001|Overall Study|Adverse Event|0|||
105869556|NCT01977417|365174482|FG000|Overall Study|Withdrawal by Subject|2|||
105869557|NCT01977417|365174483|FG001|Overall Study|Withdrawal by Subject|4|||
105869558|NCT01977417|365174482|FG000|Overall Study|Female enrollment goal met|0|||
105869559|NCT01977417|365174483|FG001|Overall Study|Female enrollment goal met|2|||
105869560|NCT01692626|365174484|FG000|Overall Study|Death|0|||
105869561|NCT01692626|365174485|FG001|Overall Study|Death|1|||
105869562|NCT01692626|365174484|FG000|Overall Study|Adverse Event|2|||
105869563|NCT01692626|365174485|FG001|Overall Study|Adverse Event|3|||
105869564|NCT01692626|365174484|FG000|Overall Study|Protocol Violation|1|||
105869565|NCT01692626|365174485|FG001|Overall Study|Protocol Violation|2|||
105869566|NCT01692626|365174484|FG000|Overall Study|Withdrawal by Subject|1|||
105869567|NCT01692626|365174485|FG001|Overall Study|Withdrawal by Subject|0|||
105869568|NCT04909853|365174486|FG000|Part 1|Assigned but not treated|0|||
105869569|NCT04909853|365174487|FG001|Part 1|Assigned but not treated|0|||
105869570|NCT04909853|365174488|FG002|Part 1|Assigned but not treated|1|||
105869571|NCT04909853|365174489|FG003|Part 1|Assigned but not treated|0|||
105869572|NCT04909853|365174486|FG000|Part 2|Adverse Event|0|||
105869573|NCT04909853|365174487|FG001|Part 2|Adverse Event|0|||
105869574|NCT04909853|365174488|FG002|Part 2|Adverse Event|0|||
105869575|NCT04909853|365174489|FG003|Part 2|Adverse Event|1|||
105634351|NCT05580003|364326043|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105869576|NCT04054765|365174494|FG000|Baseline|Withdrawal by Subject|5|||
105869577|NCT04054765|365174495|FG001|Baseline|Withdrawal by Subject|3|||
105869578|NCT04054765|365174494|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
105869579|NCT04054765|365174495|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
105869580|NCT04054765|365174494|FG000|3-month Follow up|Withdrawal by Subject|0|||
105869581|NCT04054765|365174495|FG001|3-month Follow up|Withdrawal by Subject|3|||
105869582|NCT04054765|365174494|FG000|6-month Follow up|Lost to Follow-up|32|||
105869583|NCT04054765|365174495|FG001|6-month Follow up|Lost to Follow-up|32|||
105869584|NCT00855894|365174496|FG000|Overall Study|Death|31|||
105869585|NCT00855894|365174496|FG000|Overall Study|Patient's decision|1|||
105869586|NCT00855894|365174496|FG000|Overall Study|Disease progression|1|||
105869587|NCT01811472|365174505|FG000|Overall Study|Adverse Event|1|||
105869588|NCT01811472|365174506|FG001|Overall Study|Adverse Event|0|||
105869589|NCT01811472|365174507|FG002|Overall Study|Adverse Event|4|||
105869590|NCT01811472|365174505|FG000|Overall Study|Lost to Follow-up|0|||
105634352|NCT05580003|364326044|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634353|NCT05580003|364326045|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
105634354|NCT05580003|364326018|FG000|Part 2 (up to 10 Days)|Other|0|||
105634355|NCT05580003|364326019|FG001|Part 2 (up to 10 Days)|Other|0|||
105634356|NCT05580003|364326020|FG002|Part 2 (up to 10 Days)|Other|0|||
105634357|NCT05580003|364326021|FG003|Part 2 (up to 10 Days)|Other|0|||
105634358|NCT05580003|364326022|FG004|Part 2 (up to 10 Days)|Other|0|||
105634359|NCT05580003|364326023|FG005|Part 2 (up to 10 Days)|Other|0|||
105634360|NCT05580003|364326024|FG006|Part 2 (up to 10 Days)|Other|0|||
105634361|NCT05580003|364326025|FG007|Part 2 (up to 10 Days)|Other|0|||
105634362|NCT05580003|364326026|FG008|Part 2 (up to 10 Days)|Other|0|||
105634363|NCT05580003|364326027|FG009|Part 2 (up to 10 Days)|Other|1|||
105634364|NCT05580003|364326028|FG010|Part 2 (up to 10 Days)|Other|0|||
105634365|NCT05580003|364326029|FG011|Part 2 (up to 10 Days)|Other|0|||
105634366|NCT05580003|364326030|FG012|Part 2 (up to 10 Days)|Other|0|||
105634367|NCT05580003|364326031|FG013|Part 2 (up to 10 Days)|Other|0|||
105634368|NCT05580003|364326032|FG014|Part 2 (up to 10 Days)|Other|0|||
105634369|NCT05580003|364326033|FG015|Part 2 (up to 10 Days)|Other|0|||
105634370|NCT05580003|364326034|FG016|Part 2 (up to 10 Days)|Other|0|||
105634371|NCT05580003|364326035|FG017|Part 2 (up to 10 Days)|Other|0|||
105634372|NCT05580003|364326036|FG018|Part 2 (up to 10 Days)|Other|0|||
105634373|NCT05580003|364326037|FG019|Part 2 (up to 10 Days)|Other|0|||
105634374|NCT05580003|364326038|FG020|Part 2 (up to 10 Days)|Other|0|||
105634375|NCT05580003|364326039|FG021|Part 2 (up to 10 Days)|Other|0|||
105634376|NCT05580003|364326040|FG022|Part 2 (up to 10 Days)|Other|0|||
105634377|NCT05580003|364326041|FG023|Part 2 (up to 10 Days)|Other|0|||
105634378|NCT05580003|364326042|FG024|Part 2 (up to 10 Days)|Other|0|||
105634379|NCT05580003|364326043|FG025|Part 2 (up to 10 Days)|Other|0|||
105634380|NCT05580003|364326044|FG026|Part 2 (up to 10 Days)|Other|0|||
105634381|NCT05580003|364326045|FG027|Part 2 (up to 10 Days)|Other|0|||
105634382|NCT05580003|364326018|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634383|NCT05580003|364326019|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634384|NCT05580003|364326020|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634385|NCT05580003|364326021|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634386|NCT05580003|364326022|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634387|NCT05580003|364326023|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634388|NCT05580003|364326024|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634389|NCT05580003|364326025|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634390|NCT05580003|364326026|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634391|NCT05580003|364326027|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634392|NCT05580003|364326028|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634393|NCT05580003|364326029|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634394|NCT05580003|364326030|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634395|NCT05580003|364326031|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634396|NCT05580003|364326032|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634397|NCT05580003|364326033|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634398|NCT05580003|364326034|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634399|NCT05580003|364326035|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634400|NCT05580003|364326036|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634401|NCT05580003|364326037|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
105634402|NCT05580003|364326038|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634403|NCT05580003|364326039|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634404|NCT05580003|364326040|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634405|NCT05580003|364326041|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634406|NCT05580003|364326042|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634407|NCT05580003|364326043|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634408|NCT05580003|364326044|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634409|NCT05580003|364326045|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
105634410|NCT05580003|364326018|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634411|NCT05580003|364326019|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634412|NCT05580003|364326020|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634413|NCT05580003|364326021|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634414|NCT05580003|364326022|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634415|NCT05580003|364326023|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634416|NCT05580003|364326024|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634417|NCT05580003|364326025|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634418|NCT05580003|364326026|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634419|NCT05580003|364326027|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634420|NCT05580003|364326028|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634421|NCT05580003|364326029|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634422|NCT05580003|364326030|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634423|NCT05580003|364326031|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634424|NCT05580003|364326032|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634425|NCT05580003|364326033|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105869591|NCT01811472|365174506|FG001|Overall Study|Lost to Follow-up|0|||
105634426|NCT05580003|364326034|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634427|NCT05580003|364326035|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634428|NCT05580003|364326036|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634429|NCT05580003|364326037|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634430|NCT05580003|364326038|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
105634431|NCT05580003|364326039|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634432|NCT05580003|364326040|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634433|NCT05580003|364326041|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634434|NCT05580003|364326042|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634435|NCT05580003|364326043|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634436|NCT05580003|364326044|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634437|NCT05580003|364326045|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
105634438|NCT05580003|364326018|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634439|NCT05580003|364326019|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634440|NCT05580003|364326020|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634441|NCT05580003|364326021|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634442|NCT05580003|364326022|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634443|NCT05580003|364326023|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634444|NCT05580003|364326024|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634445|NCT05580003|364326025|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634446|NCT05580003|364326026|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634447|NCT05580003|364326027|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634448|NCT05580003|364326028|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634449|NCT05580003|364326029|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634450|NCT05580003|364326030|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634451|NCT05580003|364326031|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634452|NCT05580003|364326032|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634453|NCT05580003|364326033|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634454|NCT05580003|364326034|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634455|NCT05580003|364326035|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634456|NCT05580003|364326036|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634457|NCT05580003|364326037|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634458|NCT05580003|364326038|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634459|NCT05580003|364326039|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
105634460|NCT05580003|364326040|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634461|NCT05580003|364326041|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634462|NCT05580003|364326042|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634463|NCT05580003|364326043|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634464|NCT05580003|364326044|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634465|NCT05580003|364326045|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
105634466|NCT05580003|364326018|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634467|NCT05580003|364326019|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634468|NCT05580003|364326020|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634469|NCT05580003|364326021|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634470|NCT05580003|364326022|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634471|NCT05580003|364326023|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634472|NCT05580003|364326024|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634473|NCT05580003|364326025|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634474|NCT05580003|364326026|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634475|NCT05580003|364326027|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634476|NCT05580003|364326028|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634477|NCT05580003|364326029|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634478|NCT05580003|364326030|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634479|NCT05580003|364326031|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634480|NCT05580003|364326032|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634481|NCT05580003|364326033|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634482|NCT05580003|364326034|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634483|NCT05580003|364326035|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634484|NCT05580003|364326036|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634485|NCT05580003|364326037|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634486|NCT05580003|364326038|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634487|NCT05580003|364326039|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634488|NCT05580003|364326040|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634489|NCT05580003|364326041|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634490|NCT05580003|364326042|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634491|NCT05580003|364326043|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634492|NCT05580003|364326044|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
105634493|NCT05580003|364326045|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
105634494|NCT05580003|364326018|FG000|Part 6 Period 2 (Day 1)|Other|0|||
105634495|NCT05580003|364326019|FG001|Part 6 Period 2 (Day 1)|Other|0|||
105634496|NCT05580003|364326020|FG002|Part 6 Period 2 (Day 1)|Other|0|||
105634497|NCT05580003|364326021|FG003|Part 6 Period 2 (Day 1)|Other|0|||
105634498|NCT05580003|364326022|FG004|Part 6 Period 2 (Day 1)|Other|0|||
105634499|NCT05580003|364326023|FG005|Part 6 Period 2 (Day 1)|Other|0|||
105634500|NCT05580003|364326024|FG006|Part 6 Period 2 (Day 1)|Other|0|||
105634501|NCT05580003|364326025|FG007|Part 6 Period 2 (Day 1)|Other|0|||
105634502|NCT05580003|364326026|FG008|Part 6 Period 2 (Day 1)|Other|0|||
105634503|NCT05580003|364326027|FG009|Part 6 Period 2 (Day 1)|Other|0|||
105634504|NCT05580003|364326028|FG010|Part 6 Period 2 (Day 1)|Other|0|||
105634505|NCT05580003|364326029|FG011|Part 6 Period 2 (Day 1)|Other|0|||
105634506|NCT05580003|364326030|FG012|Part 6 Period 2 (Day 1)|Other|0|||
105634507|NCT05580003|364326031|FG013|Part 6 Period 2 (Day 1)|Other|0|||
105634508|NCT05580003|364326032|FG014|Part 6 Period 2 (Day 1)|Other|0|||
105634509|NCT05580003|364326033|FG015|Part 6 Period 2 (Day 1)|Other|0|||
105634510|NCT05580003|364326034|FG016|Part 6 Period 2 (Day 1)|Other|0|||
105634511|NCT05580003|364326035|FG017|Part 6 Period 2 (Day 1)|Other|0|||
105634512|NCT05580003|364326036|FG018|Part 6 Period 2 (Day 1)|Other|0|||
105634513|NCT05580003|364326037|FG019|Part 6 Period 2 (Day 1)|Other|0|||
105634514|NCT05580003|364326038|FG020|Part 6 Period 2 (Day 1)|Other|0|||
105634515|NCT05580003|364326039|FG021|Part 6 Period 2 (Day 1)|Other|0|||
105634516|NCT05580003|364326040|FG022|Part 6 Period 2 (Day 1)|Other|0|||
105634517|NCT05580003|364326041|FG023|Part 6 Period 2 (Day 1)|Other|0|||
105634518|NCT05580003|364326042|FG024|Part 6 Period 2 (Day 1)|Other|1|||
105634519|NCT05580003|364326043|FG025|Part 6 Period 2 (Day 1)|Other|0|||
105634520|NCT05580003|364326044|FG026|Part 6 Period 2 (Day 1)|Other|0|||
105634521|NCT05580003|364326045|FG027|Part 6 Period 2 (Day 1)|Other|0|||
105634522|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
105634523|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
105634524|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
105634525|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
105634526|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
105634527|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
105634528|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634529|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634530|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634531|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634532|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
105634533|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
105634534|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634535|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634536|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634537|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634538|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
105634539|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
105634540|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
105634541|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
105634542|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
105634543|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
105634544|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
105634545|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
105634546|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634547|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634548|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634549|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634550|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
105634551|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
105634552|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
105634553|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
105634554|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
105634555|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
105634556|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
105634557|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
105634558|NCT02392234|364326046|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
105634559|NCT02392234|364326047|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
105634560|NCT02392234|364326048|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
105634561|NCT02392234|364326049|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
105634562|NCT02392234|364326050|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
105634563|NCT02392234|364326051|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
105634564|NCT02392234|364326046|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
105634565|NCT02392234|364326047|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634566|NCT02392234|364326048|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634567|NCT02392234|364326049|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634568|NCT02392234|364326050|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634569|NCT02392234|364326051|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
105634570|NCT02029235|364326052|FG000|Overall Study|Non-compliance with study meds or diary|4|||
105634571|NCT02029235|364326053|FG001|Overall Study|Non-compliance with study meds or diary|1|||
105634572|NCT02816398|364326055|FG000|Overall Study|Death|5|||
105634573|NCT02816398|364326055|FG000|Overall Study|Lack of Efficacy|8|||
105634574|NCT02816398|364326055|FG000|Overall Study|Lost to Follow-up|1|||
105634575|NCT06303167|364326056|FG000|Overall Study|Ineligible|1|||
105634576|NCT06303167|364326056|FG000|Overall Study|Never start protocol therapy|2|||
105634577|NCT06303167|364326056|FG000|Overall Study|Disease progression|16|||
105634578|NCT02052440|364326057|FG000|Overall Study|Withdrawal by Subject|0|||
105634579|NCT02052440|364326058|FG001|Overall Study|Withdrawal by Subject|1|||
105634580|NCT01367236|364326059|FG000|Overall Study|Withdrawal by Subject|3|||
105634581|NCT01367236|364326060|FG001|Overall Study|Withdrawal by Subject|1|||
105634582|NCT03611075|364326068|FG000|Overall Study|Physician Decision|0|||
105634583|NCT03611075|364326069|FG001|Overall Study|Physician Decision|1|||
105634584|NCT03611075|364326070|FG002|Overall Study|Physician Decision|1|||
105634585|NCT03611075|364326071|FG003|Overall Study|Physician Decision|0|||
105634586|NCT03611075|364326072|FG004|Overall Study|Physician Decision|0|||
105634587|NCT03611075|364326073|FG005|Overall Study|Physician Decision|0|||
105634588|NCT03611075|364326074|FG006|Overall Study|Physician Decision|0|||
105634589|NCT03611075|364326075|FG007|Overall Study|Physician Decision|0|||
105634590|NCT03611075|364326076|FG008|Overall Study|Physician Decision|0|||
105634591|NCT03611075|364326068|FG000|Overall Study|Lost to Follow-up|1|||
105634592|NCT03611075|364326069|FG001|Overall Study|Lost to Follow-up|0|||
105634593|NCT03611075|364326070|FG002|Overall Study|Lost to Follow-up|0|||
105634594|NCT03611075|364326071|FG003|Overall Study|Lost to Follow-up|2|||
105634595|NCT03611075|364326072|FG004|Overall Study|Lost to Follow-up|0|||
105634596|NCT03611075|364326073|FG005|Overall Study|Lost to Follow-up|0|||
105634597|NCT03611075|364326074|FG006|Overall Study|Lost to Follow-up|0|||
105634598|NCT03611075|364326075|FG007|Overall Study|Lost to Follow-up|0|||
105634599|NCT03611075|364326076|FG008|Overall Study|Lost to Follow-up|0|||
105634600|NCT03611075|364326068|FG000|Overall Study|Withdrawal by Subject|0|||
105634601|NCT03611075|364326069|FG001|Overall Study|Withdrawal by Subject|1|||
105634602|NCT03611075|364326070|FG002|Overall Study|Withdrawal by Subject|1|||
105634603|NCT03611075|364326071|FG003|Overall Study|Withdrawal by Subject|1|||
105634604|NCT03611075|364326072|FG004|Overall Study|Withdrawal by Subject|0|||
105634605|NCT03611075|364326073|FG005|Overall Study|Withdrawal by Subject|0|||
105634606|NCT03611075|364326074|FG006|Overall Study|Withdrawal by Subject|1|||
105634607|NCT03611075|364326075|FG007|Overall Study|Withdrawal by Subject|0|||
105634608|NCT03611075|364326076|FG008|Overall Study|Withdrawal by Subject|0|||
105634609|NCT03611075|364326068|FG000|Overall Study|Reason unknown|0|||
105634610|NCT03611075|364326069|FG001|Overall Study|Reason unknown|0|||
105634611|NCT03611075|364326070|FG002|Overall Study|Reason unknown|0|||
105634612|NCT03611075|364326071|FG003|Overall Study|Reason unknown|1|||
105634613|NCT03611075|364326072|FG004|Overall Study|Reason unknown|0|||
105634614|NCT03611075|364326073|FG005|Overall Study|Reason unknown|0|||
105634615|NCT03611075|364326074|FG006|Overall Study|Reason unknown|1|||
105634616|NCT03611075|364326075|FG007|Overall Study|Reason unknown|0|||
105634617|NCT03611075|364326076|FG008|Overall Study|Reason unknown|0|||
105634618|NCT00676091|364326077|FG000|Infant Series|Parent or legal guardian request|10|||
105634619|NCT00676091|364326078|FG001|Infant Series|Parent or legal guardian request|8|||
105634620|NCT00676091|364326077|FG000|Infant Series|Protocol Violation|6|||
105634621|NCT00676091|364326078|FG001|Infant Series|Protocol Violation|3|||
105634622|NCT00676091|364326077|FG000|Infant Series|Adverse Event|2|||
105634623|NCT00676091|364326078|FG001|Infant Series|Adverse Event|3|||
105634624|NCT00676091|364326077|FG000|Infant Series|Failed to return|1|||
105634625|NCT00676091|364326078|FG001|Infant Series|Failed to return|3|||
105634626|NCT00676091|364326077|FG000|Infant Series|Lost to Follow-up|1|||
105634627|NCT00676091|364326078|FG001|Infant Series|Lost to Follow-up|0|||
105634628|NCT00676091|364326077|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
105634629|NCT00676091|364326078|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
105634630|NCT00676091|364326077|FG000|After Infant Series|Adverse Event|0|||
105634631|NCT00676091|364326078|FG001|After Infant Series|Adverse Event|1|||
105634632|NCT00676091|364326077|FG000|After Infant Series|Protocol Violation|0|||
105634633|NCT00676091|364326078|FG001|After Infant Series|Protocol Violation|1|||
105634634|NCT00676091|364326077|FG000|After Infant Series|Failed to return|1|||
105634635|NCT00676091|364326078|FG001|After Infant Series|Failed to return|1|||
105634636|NCT00676091|364326077|FG000|Toddler Dose|Failed to return|2|||
105634637|NCT00676091|364326078|FG001|Toddler Dose|Failed to return|0|||
105634638|NCT00676091|364326077|FG000|Toddler Dose|Parent or legal guardian request|1|||
105634639|NCT00676091|364326078|FG001|Toddler Dose|Parent or legal guardian request|0|||
105634640|NCT02063659|364326079|FG000|Double-Blind Treatment Period|Adverse Event|1|||
105634641|NCT02063659|364326080|FG001|Double-Blind Treatment Period|Adverse Event|2|||
105634642|NCT02063659|364326081|FG002|Double-Blind Treatment Period|Adverse Event|0|||
105634643|NCT02063659|364326082|FG003|Double-Blind Treatment Period|Adverse Event|0|||
105634644|NCT02063659|364326079|FG000|Double-Blind Treatment Period|Physician Decision|1|||
105869592|NCT01811472|365174507|FG002|Overall Study|Lost to Follow-up|1|||
105634645|NCT02063659|364326080|FG001|Double-Blind Treatment Period|Physician Decision|0|||
105634646|NCT02063659|364326081|FG002|Double-Blind Treatment Period|Physician Decision|0|||
105634647|NCT02063659|364326082|FG003|Double-Blind Treatment Period|Physician Decision|0|||
105634648|NCT02063659|364326079|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
105634649|NCT02063659|364326080|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
105869593|NCT01811472|365174505|FG000|Overall Study|Subject/guardian decision|1|||
105869594|NCT01811472|365174506|FG001|Overall Study|Subject/guardian decision|0|||
105869595|NCT01811472|365174507|FG002|Overall Study|Subject/guardian decision|0|||
105869596|NCT03288714|365174510|FG000|Overall Study|Lost to Follow-up|2|||
105869597|NCT03288714|365174511|FG001|Overall Study|Lost to Follow-up|1|||
105869598|NCT03288714|365174510|FG000|Overall Study|Non-compliance with study schedule|2|||
105869599|NCT03288714|365174511|FG001|Overall Study|Non-compliance with study schedule|0|||
105869600|NCT03288714|365174510|FG000|Overall Study|Withdrawal by Subject|3|||
105869601|NCT03288714|365174511|FG001|Overall Study|Withdrawal by Subject|1|||
105869602|NCT03288714|365174510|FG000|Overall Study|Clinical Worsening|2|||
105869603|NCT03288714|365174511|FG001|Overall Study|Clinical Worsening|1|||
105869604|NCT03288714|365174510|FG000|Overall Study|Adverse Event|1|||
105869605|NCT03288714|365174511|FG001|Overall Study|Adverse Event|0|||
105869606|NCT01023035|365174512|FG000|Treatment Period|Adverse Event|27|||
105869607|NCT01023035|365174513|FG001|Treatment Period|Adverse Event|32|||
105869608|NCT01023035|365174514|FG002|Treatment Period|Adverse Event|50|||
105869609|NCT01023035|365174512|FG000|Treatment Period|Non-Medical Reasons|19|||
105869610|NCT01023035|365174513|FG001|Treatment Period|Non-Medical Reasons|22|||
105869611|NCT01023035|365174514|FG002|Treatment Period|Non-Medical Reasons|44|||
105869612|NCT01023035|365174512|FG000|Treatment Period|Treatment Failure|26|||
105869613|NCT01023035|365174513|FG001|Treatment Period|Treatment Failure|31|||
105869614|NCT01023035|365174514|FG002|Treatment Period|Treatment Failure|24|||
105869615|NCT01023035|365174512|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
105869616|NCT01023035|365174513|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
105869617|NCT01023035|365174514|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
105869618|NCT01023035|365174512|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
105869619|NCT01023035|365174513|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
105869620|NCT01023035|365174514|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
105869621|NCT03280264|365174515|FG000|Overall Study|Adverse Event|1|||
105869622|NCT03280264|365174515|FG000|Overall Study|Physician Decision|1|||
105869623|NCT03280264|365174515|FG000|Overall Study|Withdrawal by Subject|1|||
105869624|NCT01153425|365174518|FG000|Overall Study|Withdrawal by Subject|3|||
105869625|NCT01153425|365174519|FG001|Overall Study|Withdrawal by Subject|3|||
105869626|NCT00970593|365174522|FG000|Overall Study|Adverse Event|1|||
105869627|NCT00970593|365174523|FG001|Overall Study|Adverse Event|1|||
105869628|NCT00970593|365174524|FG002|Overall Study|Adverse Event|0|||
105869629|NCT00970593|365174525|FG003|Overall Study|Adverse Event|0|||
105869630|NCT00970593|365174526|FG004|Overall Study|Adverse Event|0|||
105869631|NCT00970593|365174527|FG005|Overall Study|Adverse Event|0|||
105869632|NCT00970593|365174528|FG006|Overall Study|Adverse Event|0|||
105869633|NCT00970593|365174522|FG000|Overall Study|Discontinuation of study by sponsor|0|||
105869634|NCT00970593|365174523|FG001|Overall Study|Discontinuation of study by sponsor|0|||
105869635|NCT00970593|365174524|FG002|Overall Study|Discontinuation of study by sponsor|5|||
105869636|NCT00970593|365174525|FG003|Overall Study|Discontinuation of study by sponsor|0|||
105869637|NCT00970593|365174526|FG004|Overall Study|Discontinuation of study by sponsor|0|||
105869638|NCT00970593|365174527|FG005|Overall Study|Discontinuation of study by sponsor|0|||
105869639|NCT00970593|365174528|FG006|Overall Study|Discontinuation of study by sponsor|2|||
105869640|NCT00970593|365174522|FG000|Overall Study|Withdrawal by Subject|0|||
105869641|NCT00970593|365174523|FG001|Overall Study|Withdrawal by Subject|0|||
105869642|NCT00970593|365174524|FG002|Overall Study|Withdrawal by Subject|1|||
105869643|NCT00970593|365174525|FG003|Overall Study|Withdrawal by Subject|0|||
105869644|NCT00970593|365174526|FG004|Overall Study|Withdrawal by Subject|0|||
105869645|NCT00970593|365174527|FG005|Overall Study|Withdrawal by Subject|0|||
105869646|NCT00970593|365174528|FG006|Overall Study|Withdrawal by Subject|0|||
105869647|NCT02009722|365174535|FG000|Overall Study|Protocol Violation|1|||
105869648|NCT02009722|365174536|FG001|Overall Study|Protocol Violation|2|||
105869649|NCT02009722|365174535|FG000|Overall Study|Did not receive intervention|0|||
105869650|NCT02009722|365174536|FG001|Overall Study|Did not receive intervention|1|||
105869651|NCT00699816|365174539|FG000|Overall Study|Protocol Violation|1|||
105869652|NCT00699816|365174540|FG001|Overall Study|Protocol Violation|3|||
105869653|NCT02070965|365174543|FG000|Overall Study|Lost to Follow-up|0|||
105869654|NCT02070965|365174544|FG001|Overall Study|Lost to Follow-up|1|||
105869655|NCT02070965|365174545|FG002|Overall Study|Lost to Follow-up|0|||
105869656|NCT02070965|365174543|FG000|Overall Study|Withdrawal by Subject|1|||
105634650|NCT02063659|364326081|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
105869657|NCT02070965|365174544|FG001|Overall Study|Withdrawal by Subject|1|||
105869658|NCT02070965|365174545|FG002|Overall Study|Withdrawal by Subject|1|||
105869659|NCT02070965|365174543|FG000|Overall Study|Subject moved|1|||
105869660|NCT02070965|365174544|FG001|Overall Study|Subject moved|0|||
105869661|NCT02070965|365174545|FG002|Overall Study|Subject moved|0|||
105634651|NCT02063659|364326082|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
105634652|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
105634653|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
105634654|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
105634655|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
105634656|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105634657|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105634658|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
105634659|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
105634660|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105634661|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105634662|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
105634663|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
105634664|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
105634665|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
105634666|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
105634667|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
105634668|NCT02063659|364326079|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105634669|NCT02063659|364326080|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105634670|NCT02063659|364326081|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
105634671|NCT02063659|364326082|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
105634672|NCT02408887|364326083|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
105634673|NCT02408887|364326084|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
105869662|NCT00280735|365174546|FG000|Overall Study|Adverse Event|5|||
105869663|NCT00280735|365174546|FG000|Overall Study|Lack of Efficacy|3|||
105869664|NCT00280735|365174546|FG000|Overall Study|Withdrawal by Subject|8|||
105869665|NCT00280735|365174546|FG000|Overall Study|Intercurrent Illness|2|||
105869666|NCT04753216|365174547|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
105869667|NCT04753216|365174547|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
105869668|NCT04753216|365174547|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
105869669|NCT02001987|365174549|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
105869670|NCT02001987|365174549|FG000|Core Study Period (24 Weeks)|Death|1|||
105869671|NCT02001987|365174549|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
105869672|NCT02001987|365174549|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
105869673|NCT02001987|365174549|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
105869674|NCT02001987|365174549|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
105869675|NCT02001987|365174549|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
105869676|NCT02001987|365174549|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
105869677|NCT02001987|365174549|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
105869678|NCT02001987|365174549|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
105869679|NCT02001987|365174549|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
105869680|NCT02001987|365174549|FG000|LTE Period (52 Weeks)|Other|3|||
105869681|NCT01965860|365174550|FG000|Overall Study|Pregnancy|1|||
105869682|NCT01965860|365174551|FG001|Overall Study|Pregnancy|0|||
105869683|NCT01965860|365174552|FG002|Overall Study|Pregnancy|1|||
105869684|NCT01965860|365174550|FG000|Overall Study|Logistics|1|||
105869685|NCT01965860|365174551|FG001|Overall Study|Logistics|0|||
105869686|NCT01965860|365174552|FG002|Overall Study|Logistics|0|||
105869687|NCT02790437|365174553|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
105869688|NCT02790437|365174554|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
105869689|NCT02790437|365174553|FG000|Overall Study|Adverse Event|1|||
105869690|NCT02790437|365174554|FG001|Overall Study|Adverse Event|0|||
105869691|NCT02790437|365174553|FG000|Overall Study|Withdrawal by Subject|1|||
105869692|NCT02790437|365174554|FG001|Overall Study|Withdrawal by Subject|0|||
105869693|NCT03645863|365174559|FG000|Overall Study|Withdrawal by Subject|1|||
105869694|NCT03645863|365174560|FG001|Overall Study|Withdrawal by Subject|0|||
105869695|NCT03645863|365174561|FG002|Overall Study|Withdrawal by Subject|0|||
105869696|NCT02016183|365174562|FG000|Overall Study|Case Report Forms Uncollected|13|||
105634674|NCT02408887|364326083|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
105634675|NCT02408887|364326084|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
105634676|NCT00914966|364326085|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
105634677|NCT00914966|364326085|FG000|Step 1: 1500 Units|Physician Decision|1|||
105634678|NCT00914966|364326085|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
105634679|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
105869697|NCT02016183|365174562|FG000|Overall Study|Protocol Violation|52|||
105869698|NCT03142191|365174563|FG000|Placebo Controlled Period|Death|0|||
105869699|NCT03142191|365174564|FG001|Placebo Controlled Period|Death|1|||
105869700|NCT03142191|365174565|FG002|Placebo Controlled Period|Death|1|||
105634680|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
105634681|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
105869701|NCT03142191|365174566|FG003|Placebo Controlled Period|Death|0|||
105634682|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105634683|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
105634684|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
105634685|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
105634686|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
105634687|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
105634688|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
105634689|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
105634690|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
105634691|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
105634692|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
105634693|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
105634694|NCT03333109|364326086|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
105634695|NCT03333109|364326087|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
105634696|NCT03333109|364326088|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
105634697|NCT03333109|364326086|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
105634698|NCT03333109|364326087|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
105634699|NCT03333109|364326088|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
105634700|NCT03333109|364326086|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
105634701|NCT03333109|364326087|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
105634702|NCT03333109|364326088|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
105634703|NCT00589875|364326091|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
105634704|NCT00589875|364326091|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
105634705|NCT03488719|364326092|FG000|Overall Study|Adverse Event|0|||
105634706|NCT03488719|364326093|FG001|Overall Study|Adverse Event|4|||
105634707|NCT03488719|364326094|FG002|Overall Study|Adverse Event|2|||
105634708|NCT03488719|364326092|FG000|Overall Study|Other|0|||
105634709|NCT03488719|364326093|FG001|Overall Study|Other|0|||
105634710|NCT03488719|364326094|FG002|Overall Study|Other|5|||
105634711|NCT03610581|364326099|FG000|Overall Study|Study terminated by sponsor|2|||
105634712|NCT03610581|364326100|FG001|Overall Study|Study terminated by sponsor|0|||
105634713|NCT03610581|364326099|FG000|Overall Study|Other|0|||
105634714|NCT03610581|364326100|FG001|Overall Study|Other|1|||
105869702|NCT03142191|365174567|FG004|Placebo Controlled Period|Death|0|||
105869703|NCT03142191|365174563|FG000|Placebo Controlled Period|Adverse Event|4|||
105869704|NCT03142191|365174564|FG001|Placebo Controlled Period|Adverse Event|5|||
105869705|NCT03142191|365174565|FG002|Placebo Controlled Period|Adverse Event|1|||
105869706|NCT03142191|365174566|FG003|Placebo Controlled Period|Adverse Event|0|||
105869707|NCT03142191|365174567|FG004|Placebo Controlled Period|Adverse Event|0|||
105869708|NCT03142191|365174563|FG000|Placebo Controlled Period|Progressive Disease|1|||
105869709|NCT03142191|365174564|FG001|Placebo Controlled Period|Progressive Disease|0|||
105869710|NCT03142191|365174565|FG002|Placebo Controlled Period|Progressive Disease|1|||
105869711|NCT03142191|365174566|FG003|Placebo Controlled Period|Progressive Disease|0|||
105869712|NCT03142191|365174567|FG004|Placebo Controlled Period|Progressive Disease|0|||
105869713|NCT03142191|365174563|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
105869714|NCT03142191|365174564|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
105869715|NCT03142191|365174565|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
105869716|NCT03142191|365174566|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
105869717|NCT03142191|365174567|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
105869718|NCT03142191|365174563|FG000|Placebo Controlled Period|Other Reasons|1|||
105869719|NCT03142191|365174564|FG001|Placebo Controlled Period|Other Reasons|0|||
105869720|NCT03142191|365174565|FG002|Placebo Controlled Period|Other Reasons|0|||
105869721|NCT03142191|365174566|FG003|Placebo Controlled Period|Other Reasons|0|||
105869722|NCT03142191|365174567|FG004|Placebo Controlled Period|Other Reasons|0|||
105869723|NCT03142191|365174563|FG000|Active Treatment Extension Period|Death|2|||
105869724|NCT03142191|365174564|FG001|Active Treatment Extension Period|Death|1|||
105869725|NCT03142191|365174565|FG002|Active Treatment Extension Period|Death|1|||
105869726|NCT03142191|365174566|FG003|Active Treatment Extension Period|Death|1|||
105869727|NCT03142191|365174567|FG004|Active Treatment Extension Period|Death|0|||
105869728|NCT03142191|365174563|FG000|Active Treatment Extension Period|Adverse Event|6|||
105869729|NCT03142191|365174564|FG001|Active Treatment Extension Period|Adverse Event|5|||
105869730|NCT03142191|365174565|FG002|Active Treatment Extension Period|Adverse Event|4|||
105869731|NCT03142191|365174566|FG003|Active Treatment Extension Period|Adverse Event|1|||
105869732|NCT03142191|365174567|FG004|Active Treatment Extension Period|Adverse Event|0|||
105869733|NCT03142191|365174563|FG000|Active Treatment Extension Period|Progressive Disease|10|||
105869734|NCT03142191|365174564|FG001|Active Treatment Extension Period|Progressive Disease|5|||
105869735|NCT03142191|365174565|FG002|Active Treatment Extension Period|Progressive Disease|4|||
105869736|NCT03142191|365174566|FG003|Active Treatment Extension Period|Progressive Disease|1|||
105869737|NCT03142191|365174567|FG004|Active Treatment Extension Period|Progressive Disease|2|||
105634715|NCT03610581|364326099|FG000|Overall Study|Withdrawal by Subject|1|||
105634716|NCT03610581|364326100|FG001|Overall Study|Withdrawal by Subject|0|||
105634717|NCT02609048|364326101|FG000|Overall Study|Adverse Event|3|||
105634718|NCT02609048|364326102|FG001|Overall Study|Adverse Event|0|||
105634719|NCT02609048|364326103|FG002|Overall Study|Adverse Event|0|||
105634720|NCT02609048|364326101|FG000|Overall Study|Randomized but never treated|1|||
105634721|NCT02609048|364326102|FG001|Overall Study|Randomized but never treated|1|||
105634722|NCT02609048|364326103|FG002|Overall Study|Randomized but never treated|1|||
105634723|NCT02609048|364326101|FG000|Overall Study|Withdrawal of informed consent|1|||
105634724|NCT02609048|364326102|FG001|Overall Study|Withdrawal of informed consent|0|||
105634725|NCT02609048|364326103|FG002|Overall Study|Withdrawal of informed consent|0|||
105634726|NCT02609048|364326101|FG000|Overall Study|Reason not specified|6|||
105634727|NCT02609048|364326102|FG001|Overall Study|Reason not specified|9|||
105634728|NCT02609048|364326103|FG002|Overall Study|Reason not specified|9|||
105634729|NCT02830204|364326104|FG000|Overall Study|Death|9|||
105634730|NCT02830204|364326104|FG000|Overall Study|Withdrawal by Subject|1|||
105634731|NCT01690624|364326105|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
105634732|NCT01690624|364326106|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
105634733|NCT01690624|364326107|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
105634734|NCT01690624|364326108|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
105634735|NCT01690624|364326105|FG000|Overall Study|Adverse event (other than DLT)|3|||
105634736|NCT01690624|364326106|FG001|Overall Study|Adverse event (other than DLT)|1|||
105634737|NCT01690624|364326107|FG002|Overall Study|Adverse event (other than DLT)|1|||
105634738|NCT01690624|364326108|FG003|Overall Study|Adverse event (other than DLT)|1|||
105634739|NCT01690624|364326105|FG000|Overall Study|Withdrawal by Subject|0|||
105634740|NCT01690624|364326106|FG001|Overall Study|Withdrawal by Subject|0|||
105634741|NCT01690624|364326107|FG002|Overall Study|Withdrawal by Subject|1|||
105634742|NCT01690624|364326108|FG003|Overall Study|Withdrawal by Subject|0|||
105634743|NCT01690624|364326105|FG000|Overall Study|Sponsor is ending trial|0|||
105634744|NCT01690624|364326106|FG001|Overall Study|Sponsor is ending trial|0|||
105634745|NCT01690624|364326107|FG002|Overall Study|Sponsor is ending trial|0|||
105634746|NCT01690624|364326108|FG003|Overall Study|Sponsor is ending trial|1|||
105634747|NCT01690624|364326105|FG000|Overall Study|Physician Decision|0|||
105634748|NCT01690624|364326106|FG001|Overall Study|Physician Decision|0|||
105634749|NCT01690624|364326107|FG002|Overall Study|Physician Decision|0|||
105634750|NCT01690624|364326108|FG003|Overall Study|Physician Decision|1|||
105634751|NCT01690624|364326105|FG000|Overall Study|Withdrawal by Subject|0|||
105634752|NCT01690624|364326106|FG001|Overall Study|Withdrawal by Subject|1|||
105634753|NCT01690624|364326107|FG002|Overall Study|Withdrawal by Subject|0|||
105634754|NCT01690624|364326108|FG003|Overall Study|Withdrawal by Subject|0|||
105634755|NCT01690624|364326105|FG000|Overall Study|Lack of Efficacy|1|||
105634756|NCT01690624|364326106|FG001|Overall Study|Lack of Efficacy|1|||
105634757|NCT01690624|364326107|FG002|Overall Study|Lack of Efficacy|3|||
105634758|NCT01690624|364326108|FG003|Overall Study|Lack of Efficacy|0|||
105634759|NCT03789656|364326113|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
105634760|NCT03789656|364326114|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
105634761|NCT03789656|364326115|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
105634762|NCT03789656|364326116|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
105634763|NCT03789656|364326117|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
105634764|NCT03789656|364326113|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
105634765|NCT03789656|364326114|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
105634766|NCT03789656|364326115|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
105634767|NCT03789656|364326116|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
105634768|NCT03789656|364326117|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
105634769|NCT03789656|364326113|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
105634770|NCT03789656|364326114|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
105634771|NCT03789656|364326115|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
105634772|NCT03789656|364326116|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
105634773|NCT03789656|364326117|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
105634774|NCT03789656|364326113|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
105869738|NCT03142191|365174563|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
105869739|NCT03142191|365174564|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
105869740|NCT03142191|365174565|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
105634775|NCT03789656|364326114|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
105634776|NCT03789656|364326115|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
105634777|NCT03789656|364326116|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
105634778|NCT03789656|364326117|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
105634779|NCT05071430|364326119|FG000|Overall Study|Adverse Event|1|||
105634780|NCT05071430|364326120|FG001|Overall Study|Adverse Event|2|||
105869741|NCT03142191|365174566|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
105869742|NCT03142191|365174567|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
105634781|NCT05071430|364326119|FG000|Overall Study|Lost to Follow-up|4|||
105634782|NCT05071430|364326120|FG001|Overall Study|Lost to Follow-up|4|||
105634783|NCT05071430|364326119|FG000|Overall Study|Protocol Violation|1|||
105634784|NCT05071430|364326120|FG001|Overall Study|Protocol Violation|0|||
105634785|NCT05071430|364326119|FG000|Overall Study|Withdrawal by Subject|3|||
105634786|NCT05071430|364326120|FG001|Overall Study|Withdrawal by Subject|2|||
105634787|NCT05071430|364326119|FG000|Overall Study|Other|1|||
105634788|NCT05071430|364326120|FG001|Overall Study|Other|1|||
105634789|NCT05325294|364326126|FG000|Overall Study|Adverse Event|3|||
105634790|NCT05325294|364326127|FG001|Overall Study|Adverse Event|3|||
105634791|NCT05325294|364326126|FG000|Overall Study|Physician Decision|0|||
105634792|NCT05325294|364326127|FG001|Overall Study|Physician Decision|1|||
105634793|NCT05325294|364326126|FG000|Overall Study|Withdrawal by Subject|0|||
105634794|NCT05325294|364326127|FG001|Overall Study|Withdrawal by Subject|3|||
105634795|NCT05325294|364326126|FG000|Overall Study|Lost to Follow-up|1|||
105634796|NCT05325294|364326127|FG001|Overall Study|Lost to Follow-up|0|||
105634797|NCT05325294|364326126|FG000|Overall Study|Sponsor Request|0|||
105634798|NCT05325294|364326127|FG001|Overall Study|Sponsor Request|2|||
105634799|NCT03773107|364326129|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
105634800|NCT03773107|364326130|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
105634801|NCT03773107|364326131|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
105634802|NCT03773107|364326132|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
105634803|NCT01563185|364326134|FG000|Overall Study|Withdrawal by Subject|1|||
105634804|NCT01563185|364326134|FG000|Overall Study|Non-Compliance with study drug|1|||
105634805|NCT04577651|364326135|FG000|Overall Study|Screen Failure|7|||
105634806|NCT04577651|364326135|FG000|Overall Study|Adverse Event|1|||
105634807|NCT04577651|364326135|FG000|Overall Study|Death|1|||
105634808|NCT04577651|364326135|FG000|Overall Study|Physician Decision|1|||
105634809|NCT04577651|364326135|FG000|Overall Study|Withdrawal by Subject|3|||
105634810|NCT02722434|364327346|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
105634811|NCT02722434|364327347|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
105634812|NCT02722434|364327346|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
105634813|NCT02722434|364327347|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
105634814|NCT04559698|364327357|FG000|Overall Study|Lost to Follow-up|14|||
105634815|NCT04559698|364327358|FG001|Overall Study|Lost to Follow-up|15|||
105634816|NCT04559698|364327357|FG000|Overall Study|Withdrawal by Subject|0|||
105634817|NCT04559698|364327358|FG001|Overall Study|Withdrawal by Subject|1|||
105634818|NCT02200705|364327359|FG000|Overall Study|Excluded|12|||
105634819|NCT02200705|364327359|FG000|Overall Study|Death|21|||
105634820|NCT02200705|364327359|FG000|Overall Study|Withdrawal by Subject|22|||
105634821|NCT02200705|364327359|FG000|Overall Study|Lost to Follow-up|13|||
105634822|NCT02200705|364327359|FG000|Overall Study|Physician Decision|5|||
105634823|NCT02200705|364327359|FG000|Overall Study|Adverse Event|2|||
105634824|NCT05070429|364327361|FG000|Overall Study|Death|0|||
105634825|NCT05070429|364327362|FG001|Overall Study|Death|4|||
105634826|NCT05070429|364327361|FG000|Overall Study|Withdrawal by Subject|2|||
105634827|NCT05070429|364327362|FG001|Overall Study|Withdrawal by Subject|1|||
105634828|NCT05070429|364327361|FG000|Overall Study|Other|15|||
105634829|NCT05070429|364327362|FG001|Overall Study|Other|5|||
105634830|NCT02962284|364327363|FG000|Overall Study|Death|2|||
105634831|NCT02962284|364327364|FG001|Overall Study|Death|0|||
105634832|NCT02962284|364327363|FG000|Overall Study|Progressive disease|2|||
105634833|NCT02962284|364327364|FG001|Overall Study|Progressive disease|3|||
105634834|NCT02962284|364327363|FG000|Overall Study|Withdrawal by Subject|1|||
105634835|NCT02962284|364327364|FG001|Overall Study|Withdrawal by Subject|0|||
105634836|NCT00371345|364327368|FG000|Overall Study|Disease Progression|21|||
105634837|NCT00371345|364327369|FG001|Overall Study|Disease Progression|35|||
105634838|NCT00371345|364327368|FG000|Overall Study|Study Drug Toxicity|1|||
105634839|NCT00371345|364327369|FG001|Overall Study|Study Drug Toxicity|7|||
105634840|NCT00371345|364327368|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
105869743|NCT03142191|365174563|FG000|Active Treatment Extension Period|Physician Decision|2|||
105869744|NCT03142191|365174564|FG001|Active Treatment Extension Period|Physician Decision|0|||
105634841|NCT00371345|364327369|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
105634842|NCT00371345|364327368|FG000|Overall Study|Participant Request|1|||
105634843|NCT00371345|364327369|FG001|Overall Study|Participant Request|1|||
105634844|NCT00371345|364327368|FG000|Overall Study|Participant Withdrew Consent|0|||
105634845|NCT00371345|364327369|FG001|Overall Study|Participant Withdrew Consent|1|||
105634846|NCT00739934|364327373|FG000|Voriconazole IV|Adverse Event|6|||
105634847|NCT00739934|364327373|FG000|Voriconazole Oral|Other|3|||
105634848|NCT03451422|364327374|FG000|Overall Study|Lost to Follow-up|0|||
105634849|NCT03451422|364327375|FG001|Overall Study|Lost to Follow-up|0|||
105634850|NCT03451422|364327376|FG002|Overall Study|Lost to Follow-up|0|||
105634851|NCT03451422|364327377|FG003|Overall Study|Lost to Follow-up|0|||
105634852|NCT03451422|364327378|FG004|Overall Study|Lost to Follow-up|0|||
105634853|NCT03451422|364327379|FG005|Overall Study|Lost to Follow-up|1|||
105634854|NCT03451422|364327374|FG000|Overall Study|Decision by sponsor|1|||
105869745|NCT03142191|365174565|FG002|Active Treatment Extension Period|Physician Decision|0|||
105634855|NCT03451422|364327375|FG001|Overall Study|Decision by sponsor|0|||
105634856|NCT03451422|364327376|FG002|Overall Study|Decision by sponsor|1|||
105634857|NCT03451422|364327377|FG003|Overall Study|Decision by sponsor|0|||
105634858|NCT03451422|364327378|FG004|Overall Study|Decision by sponsor|0|||
105634859|NCT03451422|364327379|FG005|Overall Study|Decision by sponsor|0|||
105634860|NCT03451422|364327374|FG000|Overall Study|Withdrawal by Subject|0|||
105634861|NCT03451422|364327375|FG001|Overall Study|Withdrawal by Subject|0|||
105634862|NCT03451422|364327376|FG002|Overall Study|Withdrawal by Subject|2|||
105634863|NCT03451422|364327377|FG003|Overall Study|Withdrawal by Subject|3|||
105634864|NCT03451422|364327378|FG004|Overall Study|Withdrawal by Subject|2|||
105634865|NCT03451422|364327379|FG005|Overall Study|Withdrawal by Subject|1|||
105634866|NCT00442104|364327381|FG000|Overall Study|Adverse Event|5|||
105634867|NCT00442104|364327381|FG000|Overall Study|Death|2|||
105634868|NCT00442104|364327381|FG000|Overall Study|Lost to Follow-up|3|||
105634869|NCT00442104|364327381|FG000|Overall Study|Withdrawal by Subject|5|||
105634870|NCT00442104|364327381|FG000|Overall Study|Insufficient Clinical Response|10|||
105634871|NCT00442104|364327381|FG000|Overall Study|Other|21|||
105634872|NCT00442104|364327381|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
105634873|NCT01478594|364327382|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
105634874|NCT01478594|364327383|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
105634875|NCT01478594|364327382|FG000|Overall Study|Death|45|||
105634876|NCT01478594|364327383|FG001|Overall Study|Death|18|||
105634877|NCT01478594|364327382|FG000|Overall Study|Lost to Follow-up|3|||
105634878|NCT01478594|364327383|FG001|Overall Study|Lost to Follow-up|1|||
105634879|NCT01478594|364327382|FG000|Overall Study|Withdrawal by Subject|9|||
105634880|NCT01478594|364327383|FG001|Overall Study|Withdrawal by Subject|3|||
105634881|NCT01478594|364327382|FG000|Overall Study|Study Closed by Sponsor|8|||
105634882|NCT01478594|364327383|FG001|Overall Study|Study Closed by Sponsor|5|||
105634883|NCT02788981|364327389|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
105634884|NCT02788981|364327390|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
105869746|NCT03142191|365174566|FG003|Active Treatment Extension Period|Physician Decision|0|||
105869747|NCT03142191|365174567|FG004|Active Treatment Extension Period|Physician Decision|0|||
105869748|NCT03142191|365174563|FG000|Active Treatment Extension Period|Other Reasons|3|||
105869749|NCT03142191|365174564|FG001|Active Treatment Extension Period|Other Reasons|3|||
105869750|NCT03142191|365174565|FG002|Active Treatment Extension Period|Other Reasons|3|||
105869751|NCT03142191|365174566|FG003|Active Treatment Extension Period|Other Reasons|8|||
105869752|NCT03142191|365174567|FG004|Active Treatment Extension Period|Other Reasons|3|||
105869753|NCT03142191|365174563|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
105869754|NCT03142191|365174564|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
105869755|NCT03142191|365174565|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
105869756|NCT03142191|365174566|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
105869757|NCT03142191|365174567|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
105869758|NCT00129545|365174579|FG000|Overall Study|Death|5|||
105869759|NCT00129545|365174580|FG001|Overall Study|Death|60|||
105869760|NCT00129545|365174581|FG002|Overall Study|Death|44|||
105869761|NCT00129545|365174579|FG000|Overall Study|Withdrawal by Subject|3|||
105869762|NCT00129545|365174580|FG001|Overall Study|Withdrawal by Subject|18|||
105869763|NCT00129545|365174581|FG002|Overall Study|Withdrawal by Subject|44|||
105869764|NCT00129545|365174579|FG000|Overall Study|Lost to Follow-up|2|||
105869765|NCT00129545|365174580|FG001|Overall Study|Lost to Follow-up|22|||
105869766|NCT00129545|365174581|FG002|Overall Study|Lost to Follow-up|13|||
105869767|NCT00129545|365174579|FG000|Overall Study|Physician Decision|0|||
105869768|NCT00129545|365174580|FG001|Overall Study|Physician Decision|3|||
105869769|NCT00129545|365174581|FG002|Overall Study|Physician Decision|10|||
105869770|NCT00129545|365174579|FG000|Overall Study|Device not implanted|16|||
105869771|NCT00129545|365174580|FG001|Overall Study|Device not implanted|61|||
105869772|NCT00129545|365174581|FG002|Overall Study|Device not implanted|0|||
105869773|NCT02289729|365174586|FG000|Overall Study|Lack of Efficacy|3|||
105869774|NCT02289729|365174586|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
105869775|NCT02289729|365174586|FG000|Overall Study|Withdrawal by Subject|1|||
105869776|NCT02289729|365174586|FG000|Overall Study|Death|1|||
105869777|NCT01329900|365174587|FG000|Overall Study|Elevated creatinine/renal function|1|||
105869778|NCT03172494|365174595|FG000|Overall Study|Adverse Event|5|||
105869779|NCT03172494|365174596|FG001|Overall Study|Adverse Event|1|||
105869780|NCT03172494|365174597|FG002|Overall Study|Adverse Event|15|||
105634885|NCT01342367|364327391|FG000|Overall Study|Death|1|||
105634886|NCT01342367|364327392|FG001|Overall Study|Death|0|||
105634887|NCT01342367|364327391|FG000|Overall Study|Withdrawal by Subject|1|||
105634888|NCT01342367|364327392|FG001|Overall Study|Withdrawal by Subject|2|||
105634889|NCT00249769|364327393|FG000|Overall Study|Withdrawal by Subject|1|||
105869781|NCT03172494|365174595|FG000|Overall Study|Protocol Violation|3|||
105869782|NCT03172494|365174596|FG001|Overall Study|Protocol Violation|2|||
105869783|NCT03172494|365174597|FG002|Overall Study|Protocol Violation|1|||
105869784|NCT03172494|365174595|FG000|Overall Study|Lack of Efficacy|0|||
105869785|NCT03172494|365174596|FG001|Overall Study|Lack of Efficacy|0|||
105869786|NCT03172494|365174597|FG002|Overall Study|Lack of Efficacy|4|||
105869787|NCT03172494|365174595|FG000|Overall Study|Pregnancy|0|||
105634890|NCT00249769|364327394|FG001|Overall Study|Withdrawal by Subject|10|||
105634891|NCT00249769|364327395|FG002|Overall Study|Withdrawal by Subject|6|||
105634892|NCT00249769|364327393|FG000|Overall Study|Migration from Study Area|1|||
105634893|NCT00249769|364327394|FG001|Overall Study|Migration from Study Area|3|||
105634894|NCT00249769|364327395|FG002|Overall Study|Migration from Study Area|14|||
105634895|NCT00249769|364327393|FG000|Overall Study|Miscellaneous|0|||
105634896|NCT00249769|364327394|FG001|Overall Study|Miscellaneous|2|||
105634897|NCT00249769|364327395|FG002|Overall Study|Miscellaneous|2|||
105634898|NCT00249769|364327393|FG000|Overall Study|Adverse Event|0|||
105634899|NCT00249769|364327394|FG001|Overall Study|Adverse Event|0|||
105634900|NCT00249769|364327395|FG002|Overall Study|Adverse Event|1|||
105634901|NCT00249769|364327393|FG000|Overall Study|Physician Decision|0|||
105634902|NCT00249769|364327394|FG001|Overall Study|Physician Decision|0|||
105634903|NCT00249769|364327395|FG002|Overall Study|Physician Decision|2|||
105634904|NCT00249769|364327393|FG000|Overall Study|Lost to Follow-up|0|||
105634905|NCT00249769|364327394|FG001|Overall Study|Lost to Follow-up|0|||
105634906|NCT00249769|364327395|FG002|Overall Study|Lost to Follow-up|3|||
105634907|NCT02157116|364327396|FG000|Overall Study|Withdrawal by Subject|4|||
105634908|NCT02157116|364327396|FG000|Overall Study|Physician Decision|3|||
105634909|NCT02157116|364327396|FG000|Overall Study|Failed Screening|2|||
105634910|NCT00640159|364327397|FG000|Overall Study|Lost to Follow-up|2|||
105634911|NCT01536093|364327398|FG000|Overall Study|Death|1|||
105634912|NCT01536093|364327399|FG001|Overall Study|Death|2|||
105634913|NCT01536093|364327398|FG000|Overall Study|absence of maternal colostrum|2|||
105634914|NCT01536093|364327399|FG001|Overall Study|absence of maternal colostrum|0|||
105634915|NCT01536093|364327398|FG000|Overall Study|Withdrawal by Subject|0|||
105634916|NCT01536093|364327399|FG001|Overall Study|Withdrawal by Subject|1|||
105634917|NCT04971733|364327400|FG000|Overall Study|Adverse Event|1|||
105634918|NCT04971733|364327401|FG001|Overall Study|Adverse Event|1|||
105634919|NCT04971733|364327400|FG000|Overall Study|Subject choice|2|||
105634920|NCT04971733|364327401|FG001|Overall Study|Subject choice|0|||
105634921|NCT04971733|364327400|FG000|Overall Study|Withdrawal by Subject|1|||
105634922|NCT04971733|364327401|FG001|Overall Study|Withdrawal by Subject|0|||
105634923|NCT04971733|364327400|FG000|Overall Study|Other|1|||
105634924|NCT04971733|364327401|FG001|Overall Study|Other|0|||
105634925|NCT04638816|364327402|FG000|Overall Study|Withdrawal by Subject|0|||
105634926|NCT04638816|364327403|FG001|Overall Study|Withdrawal by Subject|1|||
105634927|NCT04638816|364327402|FG000|Overall Study|Lost to Follow-up|0|||
105634928|NCT04638816|364327403|FG001|Overall Study|Lost to Follow-up|1|||
105634929|NCT02251652|364327407|FG000|Overall Study|Withdrawal by Subject|1|||
105634930|NCT02275611|364327410|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
105634931|NCT02275611|364327411|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
105634932|NCT02275611|364327412|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
105634933|NCT02275611|364327413|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
105634934|NCT00523419|364327414|FG000|Overall Study|Adverse Event|1|||
105634935|NCT00523419|364327414|FG000|Overall Study|Withdrawal by Subject|1|||
105634936|NCT00523419|364327414|FG000|Overall Study|Physician Decision|2|||
105634937|NCT00523419|364327414|FG000|Overall Study|Progressive Disease|22|||
105634938|NCT00523419|364327414|FG000|Overall Study|Death due to Study Disease|4|||
105634939|NCT00523419|364327414|FG000|Overall Study|Death due to Adverse Event|2|||
105634940|NCT00943917|364327417|FG000|Stage I|Adverse Event|1|||
105634941|NCT00943917|364327418|FG001|Stage I|Adverse Event|2|||
105634942|NCT00943917|364327419|FG002|Stage I|Adverse Event|2|||
105634943|NCT00943917|364327420|FG003|Stage I|Adverse Event|0|||
105634944|NCT00943917|364327421|FG004|Stage I|Adverse Event|0|||
105634945|NCT00943917|364327422|FG005|Stage I|Adverse Event|0|||
105634946|NCT00943917|364327423|FG006|Stage I|Adverse Event|0|||
105634947|NCT00943917|364327424|FG007|Stage I|Adverse Event|0|||
105634948|NCT00943917|364327425|FG008|Stage I|Adverse Event|0|||
105634949|NCT00943917|364327426|FG009|Stage I|Adverse Event|0|||
105634950|NCT00943917|364327427|FG010|Stage I|Adverse Event|0|||
105634951|NCT00943917|364327428|FG011|Stage I|Adverse Event|0|||
105634952|NCT00943917|364327429|FG012|Stage I|Adverse Event|0|||
105634953|NCT00943917|364327430|FG013|Stage I|Adverse Event|0|||
105634954|NCT00943917|364327431|FG014|Stage I|Adverse Event|0|||
105634955|NCT00943917|364327417|FG000|Stage I|Lost to Follow-up|0|||
105634956|NCT00943917|364327418|FG001|Stage I|Lost to Follow-up|0|||
105634957|NCT00943917|364327419|FG002|Stage I|Lost to Follow-up|1|||
105634958|NCT00943917|364327420|FG003|Stage I|Lost to Follow-up|0|||
105634959|NCT00943917|364327421|FG004|Stage I|Lost to Follow-up|0|||
105634960|NCT00943917|364327422|FG005|Stage I|Lost to Follow-up|0|||
105634961|NCT00943917|364327423|FG006|Stage I|Lost to Follow-up|0|||
105634962|NCT00943917|364327424|FG007|Stage I|Lost to Follow-up|0|||
105634963|NCT00943917|364327425|FG008|Stage I|Lost to Follow-up|0|||
105634964|NCT00943917|364327426|FG009|Stage I|Lost to Follow-up|0|||
105634965|NCT00943917|364327427|FG010|Stage I|Lost to Follow-up|0|||
105634966|NCT00943917|364327428|FG011|Stage I|Lost to Follow-up|0|||
105634967|NCT00943917|364327429|FG012|Stage I|Lost to Follow-up|0|||
105634968|NCT00943917|364327430|FG013|Stage I|Lost to Follow-up|0|||
105634969|NCT00943917|364327431|FG014|Stage I|Lost to Follow-up|0|||
105634970|NCT00943917|364327417|FG000|Stage I|hyperglycemia|0|||
105634971|NCT00943917|364327418|FG001|Stage I|hyperglycemia|0|||
105634972|NCT00943917|364327419|FG002|Stage I|hyperglycemia|1|||
105634973|NCT00943917|364327420|FG003|Stage I|hyperglycemia|0|||
105634974|NCT00943917|364327421|FG004|Stage I|hyperglycemia|0|||
105634975|NCT00943917|364327422|FG005|Stage I|hyperglycemia|0|||
105634976|NCT00943917|364327423|FG006|Stage I|hyperglycemia|0|||
105634977|NCT00943917|364327424|FG007|Stage I|hyperglycemia|0|||
105634978|NCT00943917|364327425|FG008|Stage I|hyperglycemia|0|||
105634979|NCT00943917|364327426|FG009|Stage I|hyperglycemia|0|||
105634980|NCT00943917|364327427|FG010|Stage I|hyperglycemia|0|||
105634981|NCT00943917|364327428|FG011|Stage I|hyperglycemia|0|||
105634982|NCT00943917|364327429|FG012|Stage I|hyperglycemia|0|||
105634983|NCT00943917|364327430|FG013|Stage I|hyperglycemia|0|||
105634984|NCT00943917|364327431|FG014|Stage I|hyperglycemia|0|||
105634985|NCT00943917|364327417|FG000|Stage I|A1C elevation|1|||
105634986|NCT00943917|364327418|FG001|Stage I|A1C elevation|0|||
105634987|NCT00943917|364327419|FG002|Stage I|A1C elevation|0|||
105634988|NCT00943917|364327420|FG003|Stage I|A1C elevation|0|||
105634989|NCT00943917|364327421|FG004|Stage I|A1C elevation|0|||
105634990|NCT00943917|364327422|FG005|Stage I|A1C elevation|0|||
105634991|NCT00943917|364327423|FG006|Stage I|A1C elevation|0|||
105634992|NCT00943917|364327424|FG007|Stage I|A1C elevation|0|||
105634993|NCT00943917|364327425|FG008|Stage I|A1C elevation|0|||
105634994|NCT00943917|364327426|FG009|Stage I|A1C elevation|0|||
105634995|NCT00943917|364327427|FG010|Stage I|A1C elevation|0|||
105634996|NCT00943917|364327428|FG011|Stage I|A1C elevation|0|||
105634997|NCT00943917|364327429|FG012|Stage I|A1C elevation|0|||
105634998|NCT00943917|364327430|FG013|Stage I|A1C elevation|0|||
105634999|NCT00943917|364327431|FG014|Stage I|A1C elevation|0|||
105635000|NCT00943917|364327417|FG000|Stage I|Withdrawal by Subject|2|||
105635001|NCT00943917|364327418|FG001|Stage I|Withdrawal by Subject|1|||
105635002|NCT00943917|364327419|FG002|Stage I|Withdrawal by Subject|2|||
105635003|NCT00943917|364327420|FG003|Stage I|Withdrawal by Subject|0|||
105635004|NCT00943917|364327421|FG004|Stage I|Withdrawal by Subject|0|||
105635005|NCT00943917|364327422|FG005|Stage I|Withdrawal by Subject|0|||
105635006|NCT00943917|364327423|FG006|Stage I|Withdrawal by Subject|0|||
105635007|NCT00943917|364327424|FG007|Stage I|Withdrawal by Subject|0|||
105635008|NCT00943917|364327425|FG008|Stage I|Withdrawal by Subject|0|||
105635009|NCT00943917|364327426|FG009|Stage I|Withdrawal by Subject|0|||
105635010|NCT00943917|364327427|FG010|Stage I|Withdrawal by Subject|0|||
105635011|NCT00943917|364327428|FG011|Stage I|Withdrawal by Subject|0|||
105635012|NCT00943917|364327429|FG012|Stage I|Withdrawal by Subject|0|||
105635013|NCT00943917|364327430|FG013|Stage I|Withdrawal by Subject|0|||
105635014|NCT00943917|364327431|FG014|Stage I|Withdrawal by Subject|0|||
105635015|NCT00943917|364327417|FG000|Stage II|Adverse Event|0|||
105635016|NCT00943917|364327418|FG001|Stage II|Adverse Event|0|||
105635017|NCT00943917|364327419|FG002|Stage II|Adverse Event|0|||
105635018|NCT00943917|364327420|FG003|Stage II|Adverse Event|0|||
105635019|NCT00943917|364327421|FG004|Stage II|Adverse Event|0|||
105635020|NCT00943917|364327422|FG005|Stage II|Adverse Event|1|||
105635021|NCT00943917|364327423|FG006|Stage II|Adverse Event|3|||
105635022|NCT00943917|364327424|FG007|Stage II|Adverse Event|0|||
105635023|NCT00943917|364327425|FG008|Stage II|Adverse Event|1|||
105635024|NCT00943917|364327426|FG009|Stage II|Adverse Event|0|||
105635025|NCT00943917|364327427|FG010|Stage II|Adverse Event|0|||
105635026|NCT00943917|364327428|FG011|Stage II|Adverse Event|0|||
105635027|NCT00943917|364327429|FG012|Stage II|Adverse Event|0|||
105635028|NCT00943917|364327430|FG013|Stage II|Adverse Event|0|||
105635029|NCT00943917|364327431|FG014|Stage II|Adverse Event|0|||
105635030|NCT00943917|364327417|FG000|Stage II|Withdrawal by Subject|0|||
105635031|NCT00943917|364327418|FG001|Stage II|Withdrawal by Subject|0|||
105635032|NCT00943917|364327419|FG002|Stage II|Withdrawal by Subject|0|||
105635033|NCT00943917|364327420|FG003|Stage II|Withdrawal by Subject|0|||
105635034|NCT00943917|364327421|FG004|Stage II|Withdrawal by Subject|0|||
105635035|NCT00943917|364327422|FG005|Stage II|Withdrawal by Subject|1|||
105635036|NCT00943917|364327423|FG006|Stage II|Withdrawal by Subject|0|||
105635037|NCT00943917|364327424|FG007|Stage II|Withdrawal by Subject|0|||
105635038|NCT00943917|364327425|FG008|Stage II|Withdrawal by Subject|0|||
105635039|NCT00943917|364327426|FG009|Stage II|Withdrawal by Subject|0|||
105635040|NCT00943917|364327427|FG010|Stage II|Withdrawal by Subject|0|||
105635041|NCT00943917|364327428|FG011|Stage II|Withdrawal by Subject|0|||
105635042|NCT00943917|364327429|FG012|Stage II|Withdrawal by Subject|0|||
105635043|NCT00943917|364327430|FG013|Stage II|Withdrawal by Subject|0|||
105635044|NCT00943917|364327431|FG014|Stage II|Withdrawal by Subject|0|||
105635045|NCT00943917|364327417|FG000|Stage II|Pregnancy|0|||
105635046|NCT00943917|364327418|FG001|Stage II|Pregnancy|0|||
105635047|NCT00943917|364327419|FG002|Stage II|Pregnancy|0|||
105635048|NCT00943917|364327420|FG003|Stage II|Pregnancy|0|||
105635049|NCT00943917|364327421|FG004|Stage II|Pregnancy|0|||
105635050|NCT00943917|364327422|FG005|Stage II|Pregnancy|1|||
105635051|NCT00943917|364327423|FG006|Stage II|Pregnancy|0|||
105635052|NCT00943917|364327424|FG007|Stage II|Pregnancy|0|||
105635053|NCT00943917|364327425|FG008|Stage II|Pregnancy|0|||
105635054|NCT00943917|364327426|FG009|Stage II|Pregnancy|0|||
105635055|NCT00943917|364327427|FG010|Stage II|Pregnancy|0|||
105635056|NCT00943917|364327428|FG011|Stage II|Pregnancy|0|||
105635057|NCT00943917|364327429|FG012|Stage II|Pregnancy|0|||
105635058|NCT00943917|364327430|FG013|Stage II|Pregnancy|0|||
105635059|NCT00943917|364327431|FG014|Stage II|Pregnancy|0|||
105635060|NCT00943917|364327417|FG000|Stage II Continuation|Adverse Event|0|||
105635061|NCT00943917|364327418|FG001|Stage II Continuation|Adverse Event|0|||
105635062|NCT00943917|364327419|FG002|Stage II Continuation|Adverse Event|0|||
105635063|NCT00943917|364327420|FG003|Stage II Continuation|Adverse Event|0|||
105635064|NCT00943917|364327421|FG004|Stage II Continuation|Adverse Event|0|||
105635065|NCT00943917|364327422|FG005|Stage II Continuation|Adverse Event|0|||
105635066|NCT00943917|364327423|FG006|Stage II Continuation|Adverse Event|0|||
105635067|NCT00943917|364327424|FG007|Stage II Continuation|Adverse Event|0|||
105635068|NCT00943917|364327425|FG008|Stage II Continuation|Adverse Event|0|||
105635069|NCT00943917|364327426|FG009|Stage II Continuation|Adverse Event|0|||
105635070|NCT00943917|364327427|FG010|Stage II Continuation|Adverse Event|0|||
105635071|NCT00943917|364327428|FG011|Stage II Continuation|Adverse Event|1|||
105635072|NCT00943917|364327429|FG012|Stage II Continuation|Adverse Event|2|||
105635073|NCT00943917|364327430|FG013|Stage II Continuation|Adverse Event|1|||
105635074|NCT00943917|364327431|FG014|Stage II Continuation|Adverse Event|1|||
105635075|NCT00943917|364327417|FG000|Stage II Continuation|Withdrawal by Subject|0|||
105635076|NCT00943917|364327418|FG001|Stage II Continuation|Withdrawal by Subject|0|||
105635077|NCT00943917|364327419|FG002|Stage II Continuation|Withdrawal by Subject|0|||
105635078|NCT00943917|364327420|FG003|Stage II Continuation|Withdrawal by Subject|0|||
105635079|NCT00943917|364327421|FG004|Stage II Continuation|Withdrawal by Subject|0|||
105635080|NCT00943917|364327422|FG005|Stage II Continuation|Withdrawal by Subject|0|||
105635081|NCT00943917|364327423|FG006|Stage II Continuation|Withdrawal by Subject|0|||
105635082|NCT00943917|364327424|FG007|Stage II Continuation|Withdrawal by Subject|0|||
105635083|NCT00943917|364327425|FG008|Stage II Continuation|Withdrawal by Subject|0|||
105635084|NCT00943917|364327426|FG009|Stage II Continuation|Withdrawal by Subject|0|||
105635085|NCT00943917|364327427|FG010|Stage II Continuation|Withdrawal by Subject|0|||
105635086|NCT00943917|364327428|FG011|Stage II Continuation|Withdrawal by Subject|0|||
105635087|NCT00943917|364327429|FG012|Stage II Continuation|Withdrawal by Subject|0|||
105635088|NCT00943917|364327430|FG013|Stage II Continuation|Withdrawal by Subject|1|||
105635089|NCT00943917|364327431|FG014|Stage II Continuation|Withdrawal by Subject|3|||
105635090|NCT00943917|364327417|FG000|Stage II Continuation|Protocol Violation|0|||
105635091|NCT00943917|364327418|FG001|Stage II Continuation|Protocol Violation|0|||
105635092|NCT00943917|364327419|FG002|Stage II Continuation|Protocol Violation|0|||
105635093|NCT00943917|364327420|FG003|Stage II Continuation|Protocol Violation|0|||
105635094|NCT00943917|364327421|FG004|Stage II Continuation|Protocol Violation|0|||
105635095|NCT00943917|364327422|FG005|Stage II Continuation|Protocol Violation|0|||
105635096|NCT00943917|364327423|FG006|Stage II Continuation|Protocol Violation|0|||
105635097|NCT00943917|364327424|FG007|Stage II Continuation|Protocol Violation|0|||
105635098|NCT00943917|364327425|FG008|Stage II Continuation|Protocol Violation|0|||
105635099|NCT00943917|364327426|FG009|Stage II Continuation|Protocol Violation|1|||
105635100|NCT00943917|364327427|FG010|Stage II Continuation|Protocol Violation|0|||
105635101|NCT00943917|364327428|FG011|Stage II Continuation|Protocol Violation|1|||
105635102|NCT00943917|364327429|FG012|Stage II Continuation|Protocol Violation|0|||
105635103|NCT00943917|364327430|FG013|Stage II Continuation|Protocol Violation|0|||
105635104|NCT00943917|364327431|FG014|Stage II Continuation|Protocol Violation|0|||
105635105|NCT00943917|364327417|FG000|Stage II Continuation|hypoglycemia|0|||
105635106|NCT00943917|364327418|FG001|Stage II Continuation|hypoglycemia|0|||
105635107|NCT00943917|364327419|FG002|Stage II Continuation|hypoglycemia|0|||
105635108|NCT00943917|364327420|FG003|Stage II Continuation|hypoglycemia|0|||
105635109|NCT00943917|364327421|FG004|Stage II Continuation|hypoglycemia|0|||
105635110|NCT00943917|364327422|FG005|Stage II Continuation|hypoglycemia|0|||
105635111|NCT00943917|364327423|FG006|Stage II Continuation|hypoglycemia|0|||
105635112|NCT00943917|364327424|FG007|Stage II Continuation|hypoglycemia|0|||
105635113|NCT00943917|364327425|FG008|Stage II Continuation|hypoglycemia|0|||
105635114|NCT00943917|364327426|FG009|Stage II Continuation|hypoglycemia|0|||
105635115|NCT00943917|364327427|FG010|Stage II Continuation|hypoglycemia|0|||
105635116|NCT00943917|364327428|FG011|Stage II Continuation|hypoglycemia|0|||
105635117|NCT00943917|364327429|FG012|Stage II Continuation|hypoglycemia|1|||
105635118|NCT00943917|364327430|FG013|Stage II Continuation|hypoglycemia|0|||
105869788|NCT03172494|365174596|FG001|Overall Study|Pregnancy|1|||
105869789|NCT03172494|365174597|FG002|Overall Study|Pregnancy|0|||
105635119|NCT00943917|364327431|FG014|Stage II Continuation|hypoglycemia|0|||
105635120|NCT00943917|364327417|FG000|Stage II Continuation|A1C elevation|0|||
105635121|NCT00943917|364327418|FG001|Stage II Continuation|A1C elevation|0|||
105635122|NCT00943917|364327419|FG002|Stage II Continuation|A1C elevation|0|||
105635123|NCT00943917|364327420|FG003|Stage II Continuation|A1C elevation|0|||
105635124|NCT00943917|364327421|FG004|Stage II Continuation|A1C elevation|0|||
105635125|NCT00943917|364327422|FG005|Stage II Continuation|A1C elevation|0|||
105635126|NCT00943917|364327423|FG006|Stage II Continuation|A1C elevation|0|||
105635127|NCT00943917|364327424|FG007|Stage II Continuation|A1C elevation|0|||
105635128|NCT00943917|364327425|FG008|Stage II Continuation|A1C elevation|0|||
105635129|NCT00943917|364327426|FG009|Stage II Continuation|A1C elevation|0|||
105869790|NCT03172494|365174595|FG000|Overall Study|Withdrawal by Subject|10|||
105635130|NCT00943917|364327427|FG010|Stage II Continuation|A1C elevation|0|||
105635131|NCT00943917|364327428|FG011|Stage II Continuation|A1C elevation|0|||
105635132|NCT00943917|364327429|FG012|Stage II Continuation|A1C elevation|0|||
105635133|NCT00943917|364327430|FG013|Stage II Continuation|A1C elevation|1|||
105635134|NCT00943917|364327431|FG014|Stage II Continuation|A1C elevation|0|||
105635135|NCT02646618|364327436|FG000|Overall Study|Lost to Follow-up|10|||
105635136|NCT02646618|364327437|FG001|Overall Study|Lost to Follow-up|14|||
105635137|NCT00390884|364327438|FG000|Overall Study|Withdrawal by Subject|2|||
105635138|NCT00390884|364327439|FG001|Overall Study|Withdrawal by Subject|2|||
105635139|NCT01588951|364327446|FG000|Overall Study|Ineligible in retrospect|0|||
105635140|NCT01588951|364327447|FG001|Overall Study|Ineligible in retrospect|0|||
105635141|NCT01588951|364327448|FG002|Overall Study|Ineligible in retrospect|1|||
105635142|NCT01593020|364327451|FG000|Overall Study|Adverse Event|1|||
105635143|NCT01593020|364327452|FG001|Overall Study|Adverse Event|1|||
105635144|NCT01593020|364327451|FG000|Overall Study|Death|0|||
105635145|NCT01593020|364327452|FG001|Overall Study|Death|1|||
105635146|NCT01593020|364327451|FG000|Overall Study|Ineligible|1|||
105635147|NCT01593020|364327452|FG001|Overall Study|Ineligible|0|||
105635148|NCT04686266|364327453|FG000|Overall Study|Withdrawal by Subject|0|||
105635149|NCT04686266|364327454|FG001|Overall Study|Withdrawal by Subject|1|||
105635150|NCT03976323|364327459|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
105635151|NCT03976323|364327460|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
105635152|NCT03976323|364327461|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
105635153|NCT03976323|364327459|FG000|Induction Phase|Death|80|||
105635154|NCT03976323|364327460|FG001|Induction Phase|Death|0|||
105635155|NCT03976323|364327461|FG002|Induction Phase|Death|0|||
105635156|NCT03976323|364327459|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
105635157|NCT03976323|364327460|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
105635158|NCT03976323|364327461|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
105635159|NCT03976323|364327459|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105635160|NCT03976323|364327460|FG001|Maintenance Phase|Withdrawal by Subject|9|||
105635161|NCT03976323|364327461|FG002|Maintenance Phase|Withdrawal by Subject|3|||
105635162|NCT03976323|364327459|FG000|Maintenance Phase|Physician Decision|0|||
105635163|NCT03976323|364327460|FG001|Maintenance Phase|Physician Decision|0|||
105635164|NCT03976323|364327461|FG002|Maintenance Phase|Physician Decision|1|||
105635165|NCT03976323|364327459|FG000|Maintenance Phase|Death|0|||
105635166|NCT03976323|364327460|FG001|Maintenance Phase|Death|228|||
105635167|NCT03976323|364327461|FG002|Maintenance Phase|Death|234|||
105635168|NCT02434328|364327462|FG000|Overall Study|Adverse Event|9|||
105635169|NCT02434328|364327463|FG001|Overall Study|Adverse Event|4|||
105635170|NCT02434328|364327462|FG000|Overall Study|Lack of Efficacy|0|||
105635171|NCT02434328|364327463|FG001|Overall Study|Lack of Efficacy|2|||
105635172|NCT02434328|364327462|FG000|Overall Study|Physician Decision|0|||
105635173|NCT02434328|364327463|FG001|Overall Study|Physician Decision|1|||
105635174|NCT02434328|364327462|FG000|Overall Study|Withdrawal by Subject|12|||
105635175|NCT02434328|364327463|FG001|Overall Study|Withdrawal by Subject|21|||
105635176|NCT02434328|364327462|FG000|Overall Study|Death|4|||
105635177|NCT02434328|364327463|FG001|Overall Study|Death|7|||
105635178|NCT02434328|364327462|FG000|Overall Study|Lost to Follow-up|1|||
105635179|NCT02434328|364327463|FG001|Overall Study|Lost to Follow-up|6|||
105635180|NCT02434328|364327462|FG000|Overall Study|Other|4|||
105635181|NCT02434328|364327463|FG001|Overall Study|Other|1|||
105635182|NCT00647387|364327467|FG000|Overall Study|Lost to Follow-up|6|||
105635183|NCT00647387|364327467|FG000|Overall Study|Unsuccessful implant|5|||
105635184|NCT00647387|364327467|FG000|Overall Study|Device explanted|3|||
105635185|NCT00647387|364327467|FG000|Overall Study|Other Reason|3|||
105635186|NCT00647387|364327467|FG000|Overall Study|Death|2|||
105635187|NCT02969356|364327469|FG000|Overall Study|Adverse Event|7|||
105635188|NCT02969356|364327469|FG000|Overall Study|Consent withdrawn|2|||
105635189|NCT02969356|364327469|FG000|Overall Study|Lost to Follow-up|3|||
105635190|NCT02969356|364327469|FG000|Overall Study|Did not need to be reinjected|6|||
105635191|NCT02969356|364327469|FG000|Overall Study|Personal reasons|5|||
105635192|NCT00302211|364327470|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
105635193|NCT00302211|364327471|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
105635194|NCT00302211|364327472|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
105635195|NCT00302211|364327473|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
105635196|NCT00302211|364327474|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
105635197|NCT00302211|364327470|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
105635198|NCT00302211|364327471|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
105635199|NCT00302211|364327472|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
105635200|NCT00302211|364327473|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
105635201|NCT00302211|364327474|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
105635202|NCT00302211|364327470|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
105635203|NCT00302211|364327471|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
105635204|NCT00302211|364327472|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
105635205|NCT00302211|364327473|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
105635206|NCT00302211|364327474|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
105635207|NCT00302211|364327470|FG000|Double Blind Period (New Patients)|Disease progression|0|||
105635208|NCT00302211|364327471|FG001|Double Blind Period (New Patients)|Disease progression|1|||
105635209|NCT00302211|364327472|FG002|Double Blind Period (New Patients)|Disease progression|1|||
105635210|NCT00302211|364327473|FG003|Double Blind Period (New Patients)|Disease progression|0|||
105635211|NCT00302211|364327474|FG004|Double Blind Period (New Patients)|Disease progression|0|||
105635212|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
105635213|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
105635214|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
105635215|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
105635216|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
105635217|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
105635218|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
105635219|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
105635220|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
105635221|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
105635222|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
105635223|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
105635224|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
105635225|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
105635226|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
105635227|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
105635228|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
105635229|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
105635230|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
105635231|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
105635232|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Death|0|||
105635233|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Death|0|||
105635234|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Death|0|||
105635235|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Death|1|||
105635236|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Death|1|||
105635237|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
105635238|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
105635239|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
105635240|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
105635241|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
105635242|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
105635243|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
105635244|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
105635245|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
105635246|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
105635247|NCT00302211|364327470|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
105635248|NCT00302211|364327471|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
105635249|NCT00302211|364327472|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
105635250|NCT00302211|364327473|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
105635251|NCT00302211|364327474|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
105635252|NCT04439318|364327475|FG000|Overall Study|Ineligible|1|||
105635253|NCT04439318|364327475|FG000|Overall Study|Never Started Treatment|3|||
105635254|NCT04439318|364327475|FG000|Overall Study|Adverse Event|10|||
105635255|NCT04439318|364327475|FG000|Overall Study|Death|2|||
105635256|NCT04439318|364327475|FG000|Overall Study|Disease Progression|25|||
105635257|NCT04439318|364327475|FG000|Overall Study|Other Complicating Disease|2|||
105635258|NCT04439318|364327475|FG000|Overall Study|Withdrawal by Subject|4|||
105635259|NCT04439318|364327475|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
105635260|NCT04439318|364327475|FG000|Overall Study|Non-Compliance|1|||
105635261|NCT04439318|364327475|FG000|Overall Study|Still on Treatment|1|||
105635262|NCT05864209|364329345|FG000|Overall Study|Lost to Follow-up|2|||
105635263|NCT05864209|364329346|FG001|Overall Study|Lost to Follow-up|3|||
105869791|NCT03172494|365174596|FG001|Overall Study|Withdrawal by Subject|8|||
105869792|NCT03172494|365174597|FG002|Overall Study|Withdrawal by Subject|8|||
105869793|NCT03172494|365174595|FG000|Overall Study|Severe hypoglycaemic episode|0|||
105869794|NCT03172494|365174596|FG001|Overall Study|Severe hypoglycaemic episode|0|||
105869795|NCT03172494|365174597|FG002|Overall Study|Severe hypoglycaemic episode|1|||
105869796|NCT03172494|365174595|FG000|Overall Study|Non-compliance towards treatment|2|||
105869797|NCT03172494|365174596|FG001|Overall Study|Non-compliance towards treatment|0|||
105869798|NCT03172494|365174597|FG002|Overall Study|Non-compliance towards treatment|0|||
105869799|NCT00143390|365174603|FG000|Overall Study|Death|2|||
105635312|NCT03762850|364329353|FG000|Overall Study|Death|0|||
105635313|NCT03762850|364329354|FG001|Overall Study|Death|1|||
105635314|NCT03762850|364329353|FG000|Overall Study|Lost to Follow-up|0|||
105635315|NCT03762850|364329354|FG001|Overall Study|Lost to Follow-up|1|||
105635316|NCT03762850|364329353|FG000|Overall Study|Physician Decision|0|||
105635317|NCT03762850|364329354|FG001|Overall Study|Physician Decision|1|||
105635318|NCT03762850|364329353|FG000|Overall Study|Withdrawal by Subject|4|||
105635319|NCT03762850|364329354|FG001|Overall Study|Withdrawal by Subject|9|||
105635320|NCT00597376|364329366|FG000|Overall Study|Withdrawal by Subject|4|||
105635321|NCT00597376|364329367|FG001|Overall Study|Withdrawal by Subject|3|||
105635322|NCT00597376|364329366|FG000|Overall Study|Adverse Event|4|||
105635323|NCT00597376|364329367|FG001|Overall Study|Adverse Event|1|||
105635324|NCT00747006|364329368|FG000|Overall Study|Adverse Event|1|||
105635325|NCT00747006|364329369|FG001|Overall Study|Adverse Event|0|||
105635326|NCT00747006|364329370|FG002|Overall Study|Adverse Event|0|||
105635327|NCT00747006|364329368|FG000|Overall Study|Lost to Follow-up|0|||
105635328|NCT00747006|364329369|FG001|Overall Study|Lost to Follow-up|1|||
105635329|NCT00747006|364329370|FG002|Overall Study|Lost to Follow-up|0|||
105635330|NCT00747006|364329368|FG000|Overall Study|Physician Decision|2|||
105635331|NCT00747006|364329369|FG001|Overall Study|Physician Decision|0|||
105635332|NCT00747006|364329370|FG002|Overall Study|Physician Decision|1|||
105635333|NCT00357994|364329371|FG000|Overall Study|Adverse Event|1|||
105635334|NCT00357994|364329372|FG001|Overall Study|Adverse Event|2|||
105635335|NCT00357994|364329371|FG000|Overall Study|Lack of Efficacy|0|||
105635336|NCT00357994|364329372|FG001|Overall Study|Lack of Efficacy|1|||
105635337|NCT00357994|364329371|FG000|Overall Study|Protocol Violation|1|||
105635338|NCT00357994|364329372|FG001|Overall Study|Protocol Violation|0|||
105635339|NCT00692913|364329377|FG000|Overall Study|Adverse Event|8|||
105635340|NCT00692913|364329378|FG001|Overall Study|Adverse Event|4|||
105869800|NCT00143390|365174604|FG001|Overall Study|Death|0|||
105635341|NCT00692913|364329377|FG000|Overall Study|Lost to Follow-up|3|||
105635342|NCT00692913|364329378|FG001|Overall Study|Lost to Follow-up|5|||
105635343|NCT00692913|364329377|FG000|Overall Study|Physician Decision|2|||
105635344|NCT00692913|364329378|FG001|Overall Study|Physician Decision|0|||
105635345|NCT00692913|364329377|FG000|Overall Study|Protocol Violation|1|||
105635346|NCT00692913|364329378|FG001|Overall Study|Protocol Violation|1|||
105635347|NCT00692913|364329377|FG000|Overall Study|Withdrawal by Subject|15|||
105869801|NCT00143390|365174603|FG000|Overall Study|Not meeting entry criteria|2|||
105869802|NCT00143390|365174604|FG001|Overall Study|Not meeting entry criteria|5|||
105869803|NCT00143390|365174603|FG000|Overall Study|Withdrawal by Subject|4|||
105869804|NCT00143390|365174604|FG001|Overall Study|Withdrawal by Subject|4|||
105869805|NCT00143390|365174603|FG000|Overall Study|Progressive disease|119|||
105869806|NCT00143390|365174604|FG001|Overall Study|Progressive disease|115|||
105869807|NCT00143390|365174603|FG000|Overall Study|Protocol Violation|2|||
105869808|NCT00143390|365174604|FG001|Overall Study|Protocol Violation|0|||
105869809|NCT00143390|365174603|FG000|Overall Study|Study termination|10|||
105869810|NCT00143390|365174604|FG001|Overall Study|Study termination|15|||
105869811|NCT00143390|365174603|FG000|Overall Study|Adverse Event|9|||
105869812|NCT00143390|365174604|FG001|Overall Study|Adverse Event|8|||
105869813|NCT00143390|365174603|FG000|Overall Study|Other|1|||
105869814|NCT00143390|365174604|FG001|Overall Study|Other|2|||
105869815|NCT00041132|365174605|FG000|Overall Study|Adverse Event|19|||
105869816|NCT00041132|365174605|FG000|Overall Study|Death|1|||
105869817|NCT00041132|365174605|FG000|Overall Study|Not Eligible|7|||
105869818|NCT00041132|365174605|FG000|Overall Study|Withdrawal by Subject|1|||
105869819|NCT00041132|365174605|FG000|Overall Study|Physician Decision|2|||
105869820|NCT02764151|365174611|FG000|Overall Study|Subject refused further follow-up|0|||
105869821|NCT02764151|365174612|FG001|Overall Study|Subject refused further follow-up|0|||
105869822|NCT02764151|365174613|FG002|Overall Study|Subject refused further follow-up|0|||
105869823|NCT02764151|365174614|FG003|Overall Study|Subject refused further follow-up|1|||
105869824|NCT02764151|365174611|FG000|Overall Study|Other|0|||
105869825|NCT02764151|365174612|FG001|Overall Study|Other|0|||
105869826|NCT02764151|365174613|FG002|Overall Study|Other|0|||
105869827|NCT02764151|365174614|FG003|Overall Study|Other|2|||
105869828|NCT00281957|365174616|FG000|Overall Study|Adverse Event|7|||
105869829|NCT00281957|365174617|FG001|Overall Study|Adverse Event|2|||
105869830|NCT00281957|365174616|FG000|Overall Study|Death|1|||
105869831|NCT00281957|365174617|FG001|Overall Study|Death|0|||
105869832|NCT00281957|365174616|FG000|Overall Study|Progression/relapse|47|||
105869833|NCT00281957|365174617|FG001|Overall Study|Progression/relapse|35|||
105869834|NCT00281957|365174616|FG000|Overall Study|Not protocol specified|8|||
105869835|NCT00281957|365174617|FG001|Overall Study|Not protocol specified|1|||
105869836|NCT00281957|365174616|FG000|Overall Study|Not eligible|1|||
105869837|NCT00281957|365174617|FG001|Overall Study|Not eligible|2|||
105869838|NCT00281957|365174616|FG000|Overall Study|Did not start treatment|3|||
105869839|NCT00281957|365174617|FG001|Overall Study|Did not start treatment|1|||
105869840|NCT00281957|365174616|FG000|Overall Study|Refusal unrelated to adverse events|0|||
105635348|NCT00692913|364329378|FG001|Overall Study|Withdrawal by Subject|20|||
105635349|NCT04017611|364329379|FG000|Overall Study|Withdrawn prior to completion|1|||
105635350|NCT00754325|364329380|FG000|Initial Treatment|Continuing Active Treatment|4|||
105635351|NCT00754325|364329381|FG001|Initial Treatment|Continuing Active Treatment|5|||
105635352|NCT00754325|364329380|FG000|Initial Treatment|Adverse Event|7|||
105635353|NCT00754325|364329381|FG001|Initial Treatment|Adverse Event|6|||
105635354|NCT00754325|364329380|FG000|Initial Treatment|Withdrawal by Subject|2|||
105635355|NCT00754325|364329381|FG001|Initial Treatment|Withdrawal by Subject|2|||
105635356|NCT00754325|364329380|FG000|Initial Treatment|Physician Decision|2|||
105635357|NCT00754325|364329381|FG001|Initial Treatment|Physician Decision|0|||
105635358|NCT00754325|364329380|FG000|Initial Treatment|Sponsor Request|0|||
105635359|NCT00754325|364329381|FG001|Initial Treatment|Sponsor Request|1|||
105635360|NCT00754325|364329380|FG000|Initial Treatment|Disease Progression|35|||
105635361|NCT00754325|364329381|FG001|Initial Treatment|Disease Progression|35|||
105635362|NCT01641900|364329382|FG000|Overall Study|Withdrawal by Subject|2|||
105635363|NCT01641900|364329383|FG001|Overall Study|Withdrawal by Subject|2|||
105635364|NCT00512252|364329388|FG000|Overall Study|Lost to Follow-up|0|||
105635365|NCT00512252|364329389|FG001|Overall Study|Lost to Follow-up|0|||
105635366|NCT00512252|364329390|FG002|Overall Study|Lost to Follow-up|1|||
105635367|NCT00512252|364329388|FG000|Overall Study|Protocol Violation|0|||
105635368|NCT00512252|364329389|FG001|Overall Study|Protocol Violation|0|||
105635369|NCT00512252|364329390|FG002|Overall Study|Protocol Violation|1|||
105635370|NCT00512252|364329388|FG000|Overall Study|Death|0|||
105635371|NCT00512252|364329389|FG001|Overall Study|Death|0|||
105635372|NCT00512252|364329390|FG002|Overall Study|Death|1|||
105635373|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
105635374|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
105635375|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
105635376|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
105635377|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
105635378|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
105635379|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
105635380|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
105635381|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
105635382|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
105635383|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
105635384|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
105635385|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
105635386|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
105635387|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
105635388|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
105635389|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
105635390|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
105635391|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
105635392|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
105635393|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
105635394|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
105635395|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
105635396|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
105635397|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
105635398|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
105635399|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
105635400|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
105635401|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
105635402|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
105635403|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635404|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635405|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635406|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635407|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
105635408|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
105635409|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
105635410|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
105635411|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
105635412|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
105635413|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
105635414|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
105635415|NCT03732807|364329391|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635416|NCT03732807|364329392|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635417|NCT03732807|364329393|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635418|NCT03732807|364329394|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635419|NCT03732807|364329395|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635420|NCT03732807|364329396|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
105635421|NCT03732807|364329397|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
105635422|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
105635423|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
105635424|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
105635425|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
105635426|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
105635427|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
105635428|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
105635429|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
105635430|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
105635431|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
105635432|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
105635433|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
105635434|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
105635435|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
105635436|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
105635437|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
105635438|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
105635439|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
105635440|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
105635441|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
105635442|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
105635443|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635444|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
105635445|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635446|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635447|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635448|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635449|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
105635450|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
105635451|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
105635452|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
105635453|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
105635454|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
105635455|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
105635456|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
105635457|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
105635458|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
105635459|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
105635460|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
105635461|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
105635462|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
105635463|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
105635464|NCT03732807|364329391|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
105635465|NCT03732807|364329392|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
105635466|NCT03732807|364329393|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
105635467|NCT03732807|364329394|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
105635468|NCT03732807|364329395|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
105635469|NCT03732807|364329396|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
105635470|NCT03732807|364329397|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
105635471|NCT05405244|364329398|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
105635472|NCT05405244|364329399|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
105635473|NCT05405244|364329398|FG000|Washout (2 Weeks)|Adverse Event|2|||
105869841|NCT00281957|365174617|FG001|Overall Study|Refusal unrelated to adverse events|1|||
105869842|NCT00077207|365176814|FG000|Overall Study|Adverse Event|5|||
105869843|NCT00077207|365176814|FG000|Overall Study|Lack of Efficacy|12|||
105869844|NCT00077207|365176814|FG000|Overall Study|Physician Decision|6|||
105869845|NCT00077207|365176814|FG000|Overall Study|Withdrawal by Subject|6|||
105869846|NCT00077207|365176814|FG000|Overall Study|Ineligible|1|||
105869847|NCT01895777|365176815|FG000|Overall Study|Adverse Event|1|||
105869848|NCT01895777|365176816|FG001|Overall Study|Adverse Event|2|||
105635474|NCT05405244|364329399|FG001|Washout (2 Weeks)|Adverse Event|0|||
105635475|NCT05405244|364329398|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
105635476|NCT05405244|364329399|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
105869849|NCT01895777|365176815|FG000|Overall Study|Lost to Follow-up|2|||
105635477|NCT01779700|364329400|FG000|Overall Study|Adverse Event|4|||
105635478|NCT01779700|364329401|FG001|Overall Study|Adverse Event|3|||
105635479|NCT01779700|364329400|FG000|Overall Study|Withdrawal by Subject|0|||
105635480|NCT01779700|364329401|FG001|Overall Study|Withdrawal by Subject|2|||
105635481|NCT02463448|364329402|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
105635482|NCT02463448|364329402|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
105635483|NCT02463448|364329402|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
105635484|NCT02463448|364329402|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
105635485|NCT00093496|364329403|FG000|Overall Study|Protocol Violation|1|||
105635486|NCT00093496|364329404|FG001|Overall Study|Protocol Violation|3|||
105635487|NCT00795184|364329409|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
105635488|NCT00795184|364329410|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
105635489|NCT00683800|364329411|FG000|Overall Study|Adverse Event|195|||
105635490|NCT00683800|364329412|FG001|Overall Study|Adverse Event|102|||
105635491|NCT00683800|364329411|FG000|Overall Study|Death|0|||
105635492|NCT00683800|364329412|FG001|Overall Study|Death|1|||
105635493|NCT00683800|364329411|FG000|Overall Study|Lost to Follow-up|57|||
105635494|NCT00683800|364329412|FG001|Overall Study|Lost to Follow-up|44|||
105635495|NCT00683800|364329411|FG000|Overall Study|Other|5|||
105635496|NCT00683800|364329412|FG001|Overall Study|Other|2|||
105635497|NCT00683800|364329411|FG000|Overall Study|Protocol Violation|13|||
105635498|NCT00683800|364329412|FG001|Overall Study|Protocol Violation|16|||
105635499|NCT00683800|364329411|FG000|Overall Study|Withdrawal by Subject|66|||
105635500|NCT00683800|364329412|FG001|Overall Study|Withdrawal by Subject|64|||
105635501|NCT00683800|364329411|FG000|Overall Study|Lack of Efficacy|61|||
105635502|NCT00683800|364329412|FG001|Overall Study|Lack of Efficacy|104|||
105635503|NCT00683800|364329411|FG000|Overall Study|Randomized, not treated|35|||
105635504|NCT00683800|364329412|FG001|Overall Study|Randomized, not treated|33|||
105635505|NCT00205179|364329415|FG000|Overall Study|Death|0|||
105635506|NCT00205179|364329416|FG001|Overall Study|Death|2|||
105635507|NCT00205179|364329415|FG000|Overall Study|Physician Decision|1|||
105635508|NCT00205179|364329416|FG001|Overall Study|Physician Decision|1|||
105635509|NCT00205179|364329415|FG000|Overall Study|Adverse Event|1|||
105635510|NCT00205179|364329416|FG001|Overall Study|Adverse Event|1|||
105635511|NCT00586313|364329417|FG000|Overall Study|Lack of Efficacy|2|||
105635512|NCT01932970|364329441|FG000|Overall Study|Withdrawal by Subject|5|||
105635513|NCT01932970|364329441|FG000|Overall Study|Death|1|||
105635514|NCT01932970|364329441|FG000|Overall Study|Lost to Follow-up|2|||
105635515|NCT01932970|364329441|FG000|Overall Study|Protocol Specified Criteria|10|||
105635516|NCT01700205|364329442|FG000|Overall Study|Withdrawal by Subject|13|||
105635517|NCT01700205|364329443|FG001|Overall Study|Withdrawal by Subject|13|||
105635518|NCT01700205|364329442|FG000|Overall Study|Protocol Violation|2|||
105635519|NCT01700205|364329443|FG001|Overall Study|Protocol Violation|2|||
105635520|NCT03489369|364329446|FG000|Overall Study|Documented Progressive Disease|3|||
105635521|NCT03489369|364329447|FG001|Overall Study|Documented Progressive Disease|2|||
105635522|NCT03489369|364329448|FG002|Overall Study|Documented Progressive Disease|3|||
105635523|NCT03489369|364329449|FG003|Overall Study|Documented Progressive Disease|6|||
105635524|NCT03489369|364329446|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
105635525|NCT03489369|364329447|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
105635526|NCT03489369|364329448|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
105635527|NCT03489369|364329449|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
105635528|NCT01968967|364329450|FG000|Treatment Period|Other|22|||
105635529|NCT01968967|364329451|FG001|Treatment Period|Other|22|||
105635530|NCT01968967|364329452|FG002|Treatment Period|Other|0|||
105635531|NCT01968967|364329453|FG003|Treatment Period|Other|0|||
105635532|NCT01968967|364329454|FG004|Treatment Period|Other|0|||
105635533|NCT01968967|364329450|FG000|Treatment Period|Withdrawal by Subject|71|||
105635534|NCT01968967|364329451|FG001|Treatment Period|Withdrawal by Subject|61|||
105635535|NCT01968967|364329452|FG002|Treatment Period|Withdrawal by Subject|0|||
105635536|NCT01968967|364329453|FG003|Treatment Period|Withdrawal by Subject|0|||
105635537|NCT01968967|364329454|FG004|Treatment Period|Withdrawal by Subject|0|||
105635538|NCT01968967|364329450|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
105635539|NCT01968967|364329451|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
105635540|NCT01968967|364329452|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
105635541|NCT01968967|364329453|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
105635542|NCT01968967|364329454|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
105635543|NCT01968967|364329450|FG000|Treatment Period|Lost to Follow-up|26|||
105635544|NCT01968967|364329451|FG001|Treatment Period|Lost to Follow-up|31|||
105635545|NCT01968967|364329452|FG002|Treatment Period|Lost to Follow-up|0|||
105635546|NCT01968967|364329453|FG003|Treatment Period|Lost to Follow-up|0|||
105635547|NCT01968967|364329454|FG004|Treatment Period|Lost to Follow-up|0|||
105635548|NCT01968967|364329450|FG000|Treatment Period|Protocol Violation|1|||
105635549|NCT01968967|364329451|FG001|Treatment Period|Protocol Violation|2|||
105635550|NCT01968967|364329452|FG002|Treatment Period|Protocol Violation|0|||
105635551|NCT01968967|364329453|FG003|Treatment Period|Protocol Violation|0|||
105635552|NCT01968967|364329454|FG004|Treatment Period|Protocol Violation|0|||
105635553|NCT01968967|364329450|FG000|Treatment Period|Adverse Event|9|||
105635554|NCT01968967|364329451|FG001|Treatment Period|Adverse Event|8|||
105635555|NCT01968967|364329452|FG002|Treatment Period|Adverse Event|0|||
105635556|NCT01968967|364329453|FG003|Treatment Period|Adverse Event|0|||
105635557|NCT01968967|364329454|FG004|Treatment Period|Adverse Event|0|||
105635558|NCT01968967|364329450|FG000|Treatment Period|Death|9|||
105635559|NCT01968967|364329451|FG001|Treatment Period|Death|2|||
105635560|NCT01968967|364329452|FG002|Treatment Period|Death|0|||
105635561|NCT01968967|364329453|FG003|Treatment Period|Death|0|||
105635562|NCT01968967|364329454|FG004|Treatment Period|Death|0|||
105635563|NCT01968967|364329450|FG000|Treatment Period|Randomized Not Treated|6|||
105869850|NCT01895777|365176816|FG001|Overall Study|Lost to Follow-up|0|||
105869851|NCT01895777|365176815|FG000|Overall Study|Not treated|1|||
105869852|NCT01895777|365176816|FG001|Overall Study|Not treated|0|||
105869853|NCT01895777|365176815|FG000|Overall Study|Other reasons|3|||
105869854|NCT01895777|365176816|FG001|Overall Study|Other reasons|2|||
105869855|NCT01895777|365176815|FG000|Overall Study|Non-compliance with the CTP|2|||
105869856|NCT01895777|365176816|FG001|Overall Study|Non-compliance with the CTP|1|||
105869857|NCT02064296|365176823|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
105869858|NCT02064296|365176824|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
105869859|NCT02064296|365176825|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
105869860|NCT02064296|365176823|FG000|Intervention|Withdrawal by Subject|0|||
105869861|NCT02064296|365176824|FG001|Intervention|Withdrawal by Subject|1|||
105869862|NCT02064296|365176825|FG002|Intervention|Withdrawal by Subject|2|||
105869863|NCT01202175|365176833|FG000|Overall Study|Lost to Follow-up|2|||
105869864|NCT01202175|365176833|FG000|Overall Study|Withdrawal by Subject|1|||
105869865|NCT01202175|365176833|FG000|Overall Study|Adverse Event|2|||
105869866|NCT04720053|365176834|FG000|Overall Study|Lost to Follow-up|12|||
105869867|NCT03908125|365176835|FG000|Overall Study|Withdrawal by Subject|92|||
105869868|NCT03908125|365176835|FG000|Overall Study|Lost to Follow-up|8|||
105869869|NCT02815995|365176836|FG000|Overall Study|Disease Progression|3|||
105869870|NCT02815995|365176837|FG001|Overall Study|Disease Progression|7|||
105869871|NCT02815995|365176838|FG002|Overall Study|Disease Progression|2|||
105869872|NCT02815995|365176839|FG003|Overall Study|Disease Progression|4|||
105869873|NCT02815995|365176840|FG004|Overall Study|Disease Progression|3|||
105869874|NCT02815995|365176841|FG005|Overall Study|Disease Progression|9|||
105869875|NCT02815995|365176842|FG006|Overall Study|Disease Progression|3|||
105869876|NCT02815995|365176843|FG007|Overall Study|Disease Progression|1|||
105869877|NCT02815995|365176836|FG000|Overall Study|Adverse Event|1|||
105869878|NCT02815995|365176837|FG001|Overall Study|Adverse Event|2|||
105869879|NCT02815995|365176838|FG002|Overall Study|Adverse Event|2|||
105869880|NCT02815995|365176839|FG003|Overall Study|Adverse Event|0|||
105869881|NCT02815995|365176840|FG004|Overall Study|Adverse Event|0|||
105869882|NCT02815995|365176841|FG005|Overall Study|Adverse Event|1|||
105869883|NCT02815995|365176842|FG006|Overall Study|Adverse Event|0|||
105869884|NCT02815995|365176843|FG007|Overall Study|Adverse Event|0|||
105869885|NCT02815995|365176836|FG000|Overall Study|Pregnancy|0|||
105869886|NCT02815995|365176837|FG001|Overall Study|Pregnancy|0|||
105869887|NCT02815995|365176838|FG002|Overall Study|Pregnancy|0|||
105869888|NCT02815995|365176839|FG003|Overall Study|Pregnancy|0|||
105869889|NCT02815995|365176840|FG004|Overall Study|Pregnancy|0|||
105869890|NCT02815995|365176841|FG005|Overall Study|Pregnancy|0|||
105869891|NCT02815995|365176842|FG006|Overall Study|Pregnancy|1|||
105869892|NCT02815995|365176843|FG007|Overall Study|Pregnancy|0|||
105869893|NCT00114140|365176844|FG000|Overall Study|Protocol Violation|7|||
105869894|NCT02942017|365176845|FG000|Overall Study|Adverse Event|0|||
105869895|NCT02942017|365176846|FG001|Overall Study|Adverse Event|1|||
105869896|NCT02942017|365176845|FG000|Overall Study|Withdrawal by Subject|0|||
105869897|NCT02942017|365176846|FG001|Overall Study|Withdrawal by Subject|1|||
105869898|NCT02942017|365176845|FG000|Overall Study|Lost to Follow-up|1|||
105869899|NCT02942017|365176846|FG001|Overall Study|Lost to Follow-up|1|||
105869900|NCT02942017|365176845|FG000|Overall Study|Randomized but not dosed|1|||
105869901|NCT02942017|365176846|FG001|Overall Study|Randomized but not dosed|3|||
105869902|NCT02288325|365176851|FG000|Run-in Period|Adverse Event|48|||
105869903|NCT02288325|365176852|FG001|Run-in Period|Adverse Event|0|||
105869904|NCT02288325|365176853|FG002|Run-in Period|Adverse Event|0|||
105869905|NCT02288325|365176851|FG000|Run-in Period|Lack of Efficacy|16|||
105869906|NCT02288325|365176852|FG001|Run-in Period|Lack of Efficacy|0|||
105869907|NCT02288325|365176853|FG002|Run-in Period|Lack of Efficacy|0|||
105635564|NCT01968967|364329451|FG001|Treatment Period|Randomized Not Treated|5|||
105635565|NCT01968967|364329452|FG002|Treatment Period|Randomized Not Treated|0|||
105635566|NCT01968967|364329453|FG003|Treatment Period|Randomized Not Treated|0|||
105869908|NCT02288325|365176851|FG000|Run-in Period|Withdrawal of Consent|28|||
105869909|NCT02288325|365176852|FG001|Run-in Period|Withdrawal of Consent|0|||
105869910|NCT02288325|365176853|FG002|Run-in Period|Withdrawal of Consent|0|||
105869911|NCT02288325|365176851|FG000|Run-in Period|Lost to Follow-up|25|||
105869912|NCT02288325|365176852|FG001|Run-in Period|Lost to Follow-up|0|||
105869913|NCT02288325|365176853|FG002|Run-in Period|Lost to Follow-up|0|||
105869914|NCT02288325|365176851|FG000|Run-in Period|Protocol Violation|17|||
105869915|NCT02288325|365176852|FG001|Run-in Period|Protocol Violation|0|||
105869916|NCT02288325|365176853|FG002|Run-in Period|Protocol Violation|0|||
105635567|NCT01968967|364329454|FG004|Treatment Period|Randomized Not Treated|0|||
105635568|NCT01968967|364329450|FG000|Extension Period|Withdrew Consent|0|||
105635569|NCT01968967|364329451|FG001|Extension Period|Withdrew Consent|0|||
105635570|NCT01968967|364329452|FG002|Extension Period|Withdrew Consent|2|||
105635571|NCT01968967|364329453|FG003|Extension Period|Withdrew Consent|0|||
105635572|NCT01968967|364329454|FG004|Extension Period|Withdrew Consent|5|||
105635573|NCT01787032|364329459|FG000|Overall Study|Protocol Violation|0|||
105635574|NCT01787032|364329460|FG001|Overall Study|Protocol Violation|0|||
105635575|NCT01787032|364329461|FG002|Overall Study|Protocol Violation|0|||
105635576|NCT01787032|364329462|FG003|Overall Study|Protocol Violation|0|||
105635577|NCT01787032|364329463|FG004|Overall Study|Protocol Violation|1|||
105635578|NCT01787032|364329464|FG005|Overall Study|Protocol Violation|1|||
105635579|NCT01953692|364329467|FG000|Overall Study|Adverse Event|5|||
105635580|NCT01953692|364329468|FG001|Overall Study|Adverse Event|2|||
105635581|NCT01953692|364329469|FG002|Overall Study|Adverse Event|4|||
105635582|NCT01953692|364329470|FG003|Overall Study|Adverse Event|2|||
105635583|NCT01953692|364329471|FG004|Overall Study|Adverse Event|1|||
105635584|NCT01953692|364329472|FG005|Overall Study|Adverse Event|2|||
105635585|NCT01953692|364329473|FG006|Overall Study|Adverse Event|0|||
105635586|NCT01953692|364329474|FG007|Overall Study|Adverse Event|0|||
105635587|NCT01953692|364329475|FG008|Overall Study|Adverse Event|0|||
105635588|NCT01953692|364329467|FG000|Overall Study|Clinical Progression|0|||
105635589|NCT01953692|364329468|FG001|Overall Study|Clinical Progression|15|||
105635590|NCT01953692|364329469|FG002|Overall Study|Clinical Progression|7|||
105635591|NCT01953692|364329470|FG003|Overall Study|Clinical Progression|5|||
105635592|NCT01953692|364329471|FG004|Overall Study|Clinical Progression|0|||
105635593|NCT01953692|364329472|FG005|Overall Study|Clinical Progression|7|||
105635594|NCT01953692|364329473|FG006|Overall Study|Clinical Progression|20|||
105635595|NCT01953692|364329474|FG007|Overall Study|Clinical Progression|3|||
105635596|NCT01953692|364329475|FG008|Overall Study|Clinical Progression|3|||
105635597|NCT01953692|364329467|FG000|Overall Study|Death|5|||
105635598|NCT01953692|364329468|FG001|Overall Study|Death|0|||
105635599|NCT01953692|364329469|FG002|Overall Study|Death|2|||
105635600|NCT01953692|364329470|FG003|Overall Study|Death|2|||
105635601|NCT01953692|364329471|FG004|Overall Study|Death|1|||
105635602|NCT01953692|364329472|FG005|Overall Study|Death|3|||
105635603|NCT01953692|364329473|FG006|Overall Study|Death|6|||
105635604|NCT01953692|364329474|FG007|Overall Study|Death|2|||
105635605|NCT01953692|364329475|FG008|Overall Study|Death|1|||
105635606|NCT01953692|364329467|FG000|Overall Study|Excluded Medication|1|||
105635607|NCT01953692|364329468|FG001|Overall Study|Excluded Medication|0|||
105635608|NCT01953692|364329469|FG002|Overall Study|Excluded Medication|0|||
105635609|NCT01953692|364329470|FG003|Overall Study|Excluded Medication|0|||
105635610|NCT01953692|364329471|FG004|Overall Study|Excluded Medication|0|||
105635611|NCT01953692|364329472|FG005|Overall Study|Excluded Medication|0|||
105635612|NCT01953692|364329473|FG006|Overall Study|Excluded Medication|0|||
105635613|NCT01953692|364329474|FG007|Overall Study|Excluded Medication|0|||
105635614|NCT01953692|364329475|FG008|Overall Study|Excluded Medication|0|||
105635615|NCT01953692|364329467|FG000|Overall Study|Lost to Follow-up|1|||
105635616|NCT01953692|364329468|FG001|Overall Study|Lost to Follow-up|0|||
105635617|NCT01953692|364329469|FG002|Overall Study|Lost to Follow-up|3|||
105635618|NCT01953692|364329470|FG003|Overall Study|Lost to Follow-up|1|||
105635619|NCT01953692|364329471|FG004|Overall Study|Lost to Follow-up|0|||
105635620|NCT01953692|364329472|FG005|Overall Study|Lost to Follow-up|1|||
105635621|NCT01953692|364329473|FG006|Overall Study|Lost to Follow-up|0|||
105635622|NCT01953692|364329474|FG007|Overall Study|Lost to Follow-up|0|||
105635623|NCT01953692|364329475|FG008|Overall Study|Lost to Follow-up|0|||
105635624|NCT01953692|364329467|FG000|Overall Study|Physician Decision|11|||
105635625|NCT01953692|364329468|FG001|Overall Study|Physician Decision|4|||
105635626|NCT01953692|364329469|FG002|Overall Study|Physician Decision|2|||
105635627|NCT01953692|364329470|FG003|Overall Study|Physician Decision|2|||
105635628|NCT01953692|364329471|FG004|Overall Study|Physician Decision|1|||
105635629|NCT01953692|364329472|FG005|Overall Study|Physician Decision|2|||
105635630|NCT01953692|364329473|FG006|Overall Study|Physician Decision|4|||
105635631|NCT01953692|364329474|FG007|Overall Study|Physician Decision|1|||
105635632|NCT01953692|364329475|FG008|Overall Study|Physician Decision|0|||
105635633|NCT01953692|364329467|FG000|Overall Study|Protocol Violation|0|||
105635634|NCT01953692|364329468|FG001|Overall Study|Protocol Violation|2|||
105635635|NCT01953692|364329469|FG002|Overall Study|Protocol Violation|1|||
105635636|NCT01953692|364329470|FG003|Overall Study|Protocol Violation|0|||
105635637|NCT01953692|364329471|FG004|Overall Study|Protocol Violation|0|||
105635638|NCT01953692|364329472|FG005|Overall Study|Protocol Violation|0|||
105635639|NCT01953692|364329473|FG006|Overall Study|Protocol Violation|0|||
105635640|NCT01953692|364329474|FG007|Overall Study|Protocol Violation|1|||
105635641|NCT01953692|364329475|FG008|Overall Study|Protocol Violation|0|||
105635642|NCT01953692|364329467|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635643|NCT01953692|364329468|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635644|NCT01953692|364329469|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635645|NCT01953692|364329470|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635646|NCT01953692|364329471|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635647|NCT01953692|364329472|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635648|NCT01953692|364329473|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635649|NCT01953692|364329474|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
105635650|NCT01953692|364329475|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
105635651|NCT01953692|364329467|FG000|Overall Study|Withdrawal by Subject|4|||
105635652|NCT01953692|364329468|FG001|Overall Study|Withdrawal by Subject|2|||
105635653|NCT01953692|364329469|FG002|Overall Study|Withdrawal by Subject|1|||
105635654|NCT01953692|364329470|FG003|Overall Study|Withdrawal by Subject|2|||
105635655|NCT01953692|364329471|FG004|Overall Study|Withdrawal by Subject|0|||
105635656|NCT01953692|364329472|FG005|Overall Study|Withdrawal by Subject|3|||
105635657|NCT01953692|364329473|FG006|Overall Study|Withdrawal by Subject|2|||
105635658|NCT01953692|364329474|FG007|Overall Study|Withdrawal by Subject|1|||
105635659|NCT01953692|364329475|FG008|Overall Study|Withdrawal by Subject|1|||
105635660|NCT01759862|364329479|FG000|Overall Study|Physician Decision|3|||
105635661|NCT01759862|364329480|FG001|Overall Study|Physician Decision|1|||
105635662|NCT01759862|364329479|FG000|Overall Study|Adverse Event|0|||
105635663|NCT01759862|364329480|FG001|Overall Study|Adverse Event|1|||
105635664|NCT01160354|364329481|FG000|Overall Study|Death|0|||
105635665|NCT01160354|364329482|FG001|Overall Study|Death|1|||
105635666|NCT01160354|364329483|FG002|Overall Study|Death|1|||
105635667|NCT01328496|364329486|FG000|Overall Study|Significant Change in Health Status|1|||
105635668|NCT01328496|364329487|FG001|Overall Study|Significant Change in Health Status|0|||
105635669|NCT00756574|364329493|FG000|Overall Study|Withdrawal by Subject|9|||
105635670|NCT00756574|364329494|FG001|Overall Study|Withdrawal by Subject|7|||
105635671|NCT00756574|364329493|FG000|Overall Study|Lost to Follow-up|4|||
105635672|NCT00756574|364329494|FG001|Overall Study|Lost to Follow-up|4|||
105635673|NCT02743819|364329496|FG000|Overall Study|Lack of Efficacy|5|||
105635674|NCT02743819|364329496|FG000|Overall Study|Death|2|||
105635675|NCT02743819|364329496|FG000|Overall Study|Adverse Event|1|||
105635676|NCT00274261|364329497|FG000|Overall Study|Adverse Event|19|||
105635677|NCT00274261|364329498|FG001|Overall Study|Adverse Event|11|||
105635678|NCT00274261|364329497|FG000|Overall Study|Pregnancy|114|||
105635679|NCT00274261|364329498|FG001|Overall Study|Pregnancy|83|||
105635680|NCT00274261|364329497|FG000|Overall Study|Withdrawal by Subject|179|||
105635681|NCT00274261|364329498|FG001|Overall Study|Withdrawal by Subject|126|||
105635682|NCT00274261|364329497|FG000|Overall Study|Protocol Violation|71|||
105635683|NCT00274261|364329498|FG001|Overall Study|Protocol Violation|42|||
105635684|NCT00274261|364329497|FG000|Overall Study|Lost to Follow-up|106|||
105635685|NCT00274261|364329498|FG001|Overall Study|Lost to Follow-up|75|||
105635686|NCT00553332|364329504|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
105635687|NCT02744066|364329506|FG000|Overall Study|Withdrawal by parent|0|||
105635688|NCT02744066|364329507|FG001|Overall Study|Withdrawal by parent|1|||
105635689|NCT02744066|364329506|FG000|Overall Study|Discharged from NICU prior to completion|0|||
105635690|NCT02744066|364329507|FG001|Overall Study|Discharged from NICU prior to completion|4|||
105635691|NCT03102034|364329508|FG000|Overall Study|Withdrawal by Subject|1|||
105635692|NCT03102034|364329509|FG001|Overall Study|Withdrawal by Subject|0|||
105635693|NCT04066075|364329516|FG000|Overall Study|Lost to Follow-up|3|||
105635694|NCT04066075|364329517|FG001|Overall Study|Lost to Follow-up|3|||
105635695|NCT04066075|364329516|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
105635696|NCT04066075|364329517|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
105635697|NCT04066075|364329516|FG000|Overall Study|Withdrawal by Subject|2|||
105635698|NCT04066075|364329517|FG001|Overall Study|Withdrawal by Subject|2|||
105635699|NCT02208362|364329518|FG000|Overall Study|Participant did not complete treatment|0|||
105635700|NCT02208362|364329519|FG001|Overall Study|Participant did not complete treatment|1|||
105635701|NCT02208362|364329520|FG002|Overall Study|Participant did not complete treatment|0|||
105635702|NCT02208362|364329521|FG003|Overall Study|Participant did not complete treatment|0|||
105635703|NCT02208362|364329522|FG004|Overall Study|Participant did not complete treatment|0|||
105635704|NCT02208362|364329523|FG005|Overall Study|Participant did not complete treatment|0|||
105635705|NCT02208362|364329524|FG006|Overall Study|Participant did not complete treatment|1|||
105635706|NCT02208362|364329525|FG007|Overall Study|Participant did not complete treatment|1|||
105635707|NCT02208362|364329526|FG008|Overall Study|Participant did not complete treatment|2|||
105635708|NCT02208362|364329527|FG009|Overall Study|Participant did not complete treatment|0|||
105635709|NCT02208362|364329528|FG010|Overall Study|Participant did not complete treatment|1|||
105635710|NCT02208362|364329529|FG011|Overall Study|Participant did not complete treatment|0|||
105635711|NCT02208362|364329518|FG000|Overall Study|Participant received disallowed treatment|0|||
105635712|NCT02208362|364329519|FG001|Overall Study|Participant received disallowed treatment|0|||
105635713|NCT02208362|364329520|FG002|Overall Study|Participant received disallowed treatment|0|||
105635714|NCT02208362|364329521|FG003|Overall Study|Participant received disallowed treatment|0|||
105635715|NCT02208362|364329522|FG004|Overall Study|Participant received disallowed treatment|0|||
105635716|NCT02208362|364329523|FG005|Overall Study|Participant received disallowed treatment|0|||
105635717|NCT02208362|364329524|FG006|Overall Study|Participant received disallowed treatment|0|||
105635718|NCT02208362|364329525|FG007|Overall Study|Participant received disallowed treatment|0|||
105635719|NCT02208362|364329526|FG008|Overall Study|Participant received disallowed treatment|1|||
105635720|NCT02208362|364329527|FG009|Overall Study|Participant received disallowed treatment|0|||
105635721|NCT02208362|364329528|FG010|Overall Study|Participant received disallowed treatment|0|||
105635722|NCT02208362|364329529|FG011|Overall Study|Participant received disallowed treatment|0|||
105635723|NCT05432986|364329530|FG000|Overall Study|Withdrawal by Subject|2|||
105635724|NCT05432986|364329530|FG000|Overall Study|incomplete measurement|7|||
105635725|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
105635726|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
105635727|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
105635728|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
105635729|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
105635730|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
105635731|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
105635732|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
105635733|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
105635734|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
105635735|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Death|0|||
105635736|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Death|0|||
105635737|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Death|0|||
105635738|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Death|0|||
105635739|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Death|0|||
105635740|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Death|0|||
105635741|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Death|0|||
105635742|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Death|0|||
105635743|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Death|1|||
105635744|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Death|0|||
105635745|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
105635746|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635747|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
105635748|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635749|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635750|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635751|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635752|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635753|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
105635754|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
105635755|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635756|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635757|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635758|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635759|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
105635760|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635761|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635762|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
105635763|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
105635764|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
105635765|NCT02036970|364330924|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635766|NCT02036970|364330925|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635767|NCT02036970|364330926|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635768|NCT02036970|364330927|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
105635769|NCT02036970|364330928|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635770|NCT02036970|364330929|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635771|NCT02036970|364330930|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635772|NCT02036970|364330931|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635773|NCT02036970|364330932|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635774|NCT02036970|364330933|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
105635775|NCT02036970|364330924|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
105635776|NCT02036970|364330925|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
105635777|NCT02036970|364330926|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
105635778|NCT02036970|364330927|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
105635779|NCT02036970|364330928|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
105635780|NCT02036970|364330929|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
105635781|NCT02036970|364330930|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
105635782|NCT02036970|364330931|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
105635783|NCT02036970|364330932|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
105635784|NCT02036970|364330933|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
105635785|NCT02036970|364330924|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635786|NCT02036970|364330925|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635787|NCT02036970|364330926|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635788|NCT02036970|364330927|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635789|NCT02036970|364330928|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635790|NCT02036970|364330929|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635791|NCT02036970|364330930|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635792|NCT02036970|364330931|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
105635793|NCT02036970|364330932|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635794|NCT02036970|364330933|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
105635795|NCT02036970|364330924|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635796|NCT02036970|364330925|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
105635797|NCT02036970|364330926|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
105635798|NCT02036970|364330927|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635799|NCT02036970|364330928|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635800|NCT02036970|364330929|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635801|NCT02036970|364330930|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635802|NCT02036970|364330931|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635803|NCT02036970|364330932|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
105635804|NCT02036970|364330933|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
105635805|NCT02036970|364330924|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635806|NCT02036970|364330925|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
105635807|NCT02036970|364330926|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
105635808|NCT02036970|364330927|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
105635809|NCT02036970|364330928|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635810|NCT02036970|364330929|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635811|NCT02036970|364330930|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635812|NCT02036970|364330931|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635813|NCT02036970|364330932|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
105635814|NCT02036970|364330933|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
105635815|NCT04705051|364330934|FG000|Overall Study|Enrolled but not treated|1|||
105635816|NCT04705051|364330934|FG000|Overall Study|Study terminated by sponsor|23|||
105635817|NCT03116464|364330940|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
105635818|NCT01372085|364330946|FG000|Washout Period 2|Physician Decision|0|||
105635819|NCT01372085|364330947|FG001|Washout Period 2|Physician Decision|0|||
105635820|NCT01372085|364330948|FG002|Washout Period 2|Physician Decision|0|||
105635821|NCT01372085|364330949|FG003|Washout Period 2|Physician Decision|0|||
105635822|NCT01372085|364330950|FG004|Washout Period 2|Physician Decision|1|||
105635823|NCT01372085|364330951|FG005|Washout Period 2|Physician Decision|0|||
105635824|NCT01372085|364330952|FG006|Washout Period 2|Physician Decision|0|||
105635825|NCT01372085|364330953|FG007|Washout Period 2|Physician Decision|0|||
105635826|NCT01372085|364330954|FG008|Washout Period 2|Physician Decision|0|||
105635827|NCT01372085|364330955|FG009|Washout Period 2|Physician Decision|0|||
105635828|NCT01372085|364330946|FG000|Washout Period 3|Withdrawal by Subject|0|||
105635829|NCT01372085|364330947|FG001|Washout Period 3|Withdrawal by Subject|0|||
105635830|NCT01372085|364330948|FG002|Washout Period 3|Withdrawal by Subject|0|||
105635831|NCT01372085|364330949|FG003|Washout Period 3|Withdrawal by Subject|0|||
105635832|NCT01372085|364330950|FG004|Washout Period 3|Withdrawal by Subject|0|||
105635833|NCT01372085|364330951|FG005|Washout Period 3|Withdrawal by Subject|2|||
105635834|NCT01372085|364330952|FG006|Washout Period 3|Withdrawal by Subject|0|||
105635835|NCT01372085|364330953|FG007|Washout Period 3|Withdrawal by Subject|0|||
105635836|NCT01372085|364330954|FG008|Washout Period 3|Withdrawal by Subject|0|||
105635837|NCT01372085|364330955|FG009|Washout Period 3|Withdrawal by Subject|0|||
105635838|NCT02824198|364330956|FG000|Overall Study|Non-compliance with the protocol|5|||
105635839|NCT02824198|364330957|FG001|Overall Study|Non-compliance with the protocol|1|||
105635840|NCT02824198|364330956|FG000|Overall Study|Lost to Follow-up|5|||
105635841|NCT02824198|364330957|FG001|Overall Study|Lost to Follow-up|2|||
105635842|NCT02824198|364330956|FG000|Overall Study|Withdrawal by Subject|5|||
105635843|NCT02824198|364330957|FG001|Overall Study|Withdrawal by Subject|0|||
105635844|NCT00777049|364330958|FG000|Overall Study|Withdrawal by Subject|1|||
105635845|NCT00777049|364330959|FG001|Overall Study|Withdrawal by Subject|0|||
105635846|NCT00777049|364330958|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
105635847|NCT00777049|364330959|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
105635848|NCT00562094|364330960|FG000|Overall Study|Lost to Follow-up|62|||
105635849|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
105635850|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
105635851|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
105635852|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Death|0|||
105635853|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Death|2|||
105635854|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Death|1|||
105635855|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
105635856|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
105635857|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
105635858|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
105635859|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
105635860|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
105635861|NCT00790569|364330963|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
105635862|NCT00790569|364330964|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
105635863|NCT00790569|364330965|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
105635864|NCT00790569|364330963|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
105635865|NCT00790569|364330964|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
105635866|NCT00790569|364330965|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
105635867|NCT03274076|364330967|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
105635868|NCT03274076|364330968|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
105635869|NCT03274076|364330969|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
105635870|NCT03274076|364330970|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
105635871|NCT03274076|364330967|FG000|24 Weeks Open Label|Adverse Event|0|||
105635872|NCT03274076|364330968|FG001|24 Weeks Open Label|Adverse Event|0|||
105635873|NCT03274076|364330969|FG002|24 Weeks Open Label|Adverse Event|2|||
105635874|NCT03274076|364330970|FG003|24 Weeks Open Label|Adverse Event|0|||
105635875|NCT03274076|364330967|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
105635876|NCT03274076|364330968|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
105635877|NCT03274076|364330969|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
105635878|NCT03274076|364330970|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
105635879|NCT00975585|364330971|FG000|Overall Study|Adverse Event|0|||
105635880|NCT00975585|364330972|FG001|Overall Study|Adverse Event|4|||
105635881|NCT00975585|364330971|FG000|Overall Study|Lost to Follow-up|3|||
105635882|NCT00975585|364330972|FG001|Overall Study|Lost to Follow-up|5|||
105635883|NCT00975585|364330971|FG000|Overall Study|Withdrawal by Subject|2|||
105635884|NCT00975585|364330972|FG001|Overall Study|Withdrawal by Subject|1|||
105635885|NCT00975585|364330971|FG000|Overall Study|Lens issue|2|||
105635886|NCT00975585|364330972|FG001|Overall Study|Lens issue|2|||
105635887|NCT01953224|364330973|FG000|Overall Study|Lost to Follow-up|1|||
105635888|NCT01953224|364330974|FG001|Overall Study|Lost to Follow-up|1|||
105635889|NCT01953224|364330973|FG000|Overall Study|Withdrawal by Subject|1|||
105635890|NCT01953224|364330974|FG001|Overall Study|Withdrawal by Subject|2|||
105635891|NCT02079649|364330976|FG000|Overall Study|Lost to Follow-up|0|||
105635892|NCT02079649|364330977|FG001|Overall Study|Lost to Follow-up|0|||
105635893|NCT02079649|364330978|FG002|Overall Study|Lost to Follow-up|0|||
105635894|NCT02079649|364330979|FG003|Overall Study|Lost to Follow-up|1|||
105635895|NCT02079649|364330976|FG000|Overall Study|Withdrawal by Subject|0|||
105635896|NCT02079649|364330977|FG001|Overall Study|Withdrawal by Subject|0|||
105635897|NCT02079649|364330978|FG002|Overall Study|Withdrawal by Subject|0|||
105635898|NCT02079649|364330979|FG003|Overall Study|Withdrawal by Subject|1|||
105635899|NCT02079649|364330976|FG000|Overall Study|Randomization error (prior to treatment)|1|||
105635900|NCT02079649|364330977|FG001|Overall Study|Randomization error (prior to treatment)|0|||
105635901|NCT02079649|364330978|FG002|Overall Study|Randomization error (prior to treatment)|1|||
105635902|NCT02079649|364330979|FG003|Overall Study|Randomization error (prior to treatment)|0|||
105635903|NCT03113409|364330984|FG000|Overall Study|Withdrawal by Subject|5|||
105635904|NCT03113409|364330985|FG001|Overall Study|Withdrawal by Subject|0|||
105635905|NCT03113409|364330986|FG002|Overall Study|Withdrawal by Subject|0|||
105635906|NCT00388726|364330987|FG000|Overall Study|Adverse Event|50|||
105635907|NCT00388726|364330988|FG001|Overall Study|Adverse Event|24|||
105635908|NCT00388726|364330987|FG000|Overall Study|Progressive Disease|336|||
105635909|NCT00388726|364330988|FG001|Overall Study|Progressive Disease|153|||
105635910|NCT00388726|364330987|FG000|Overall Study|Clinical Progression|61|||
105635911|NCT00388726|364330988|FG001|Overall Study|Clinical Progression|36|||
105635912|NCT00388726|364330987|FG000|Overall Study|Withdrawal by Subject|10|||
105635913|NCT00388726|364330988|FG001|Overall Study|Withdrawal by Subject|7|||
105635914|NCT00388726|364330987|FG000|Overall Study|Administrative|6|||
105635915|NCT00388726|364330988|FG001|Overall Study|Administrative|9|||
105635916|NCT00388726|364330987|FG000|Overall Study|Physician Decision|18|||
105635917|NCT00388726|364330988|FG001|Overall Study|Physician Decision|13|||
105635918|NCT00388726|364330987|FG000|Overall Study|Death|3|||
105635919|NCT00388726|364330988|FG001|Overall Study|Death|2|||
105635920|NCT01437319|364330989|FG000|Phase I|Lost to Follow-up|2|||
105635921|NCT01437319|364330990|FG001|Phase I|Lost to Follow-up|0|||
105635922|NCT01437319|364330991|FG002|Phase I|Lost to Follow-up|0|||
105635923|NCT01437319|364330989|FG000|Phase I|Protocol Violation|1|||
105635924|NCT01437319|364330990|FG001|Phase I|Protocol Violation|0|||
105635925|NCT01437319|364330991|FG002|Phase I|Protocol Violation|0|||
105635926|NCT01437319|364330989|FG000|Phase I|Study related symptoms/complaints|27|||
105635927|NCT01437319|364330990|FG001|Phase I|Study related symptoms/complaints|0|||
105635928|NCT01437319|364330991|FG002|Phase I|Study related symptoms/complaints|0|||
105635929|NCT01437319|364330989|FG000|Phase I|Withdrawal by Subject|25|||
105635930|NCT01437319|364330990|FG001|Phase I|Withdrawal by Subject|0|||
105635931|NCT01437319|364330991|FG002|Phase I|Withdrawal by Subject|0|||
105635932|NCT01437319|364330989|FG000|Phase II|Withdrawal by Subject|0|||
105635933|NCT01437319|364330990|FG001|Phase II|Withdrawal by Subject|8|||
105635934|NCT01437319|364330991|FG002|Phase II|Withdrawal by Subject|16|||
105635935|NCT01437319|364330989|FG000|Phase II|Lost to Follow-up|0|||
105635936|NCT01437319|364330990|FG001|Phase II|Lost to Follow-up|7|||
105635937|NCT01437319|364330991|FG002|Phase II|Lost to Follow-up|2|||
105635938|NCT01437319|364330989|FG000|Phase II|Study related symptoms/complaints|0|||
105635939|NCT01437319|364330990|FG001|Phase II|Study related symptoms/complaints|28|||
105635940|NCT01437319|364330991|FG002|Phase II|Study related symptoms/complaints|19|||
105635941|NCT01437319|364330989|FG000|Phase II|Protocol Violation|0|||
105635942|NCT01437319|364330990|FG001|Phase II|Protocol Violation|1|||
105635943|NCT01437319|364330991|FG002|Phase II|Protocol Violation|0|||
105635944|NCT01499849|364330992|FG000|Overall Study|Adverse Event|28|||
105635945|NCT01499849|364330993|FG001|Overall Study|Adverse Event|32|||
105635946|NCT01499849|364330992|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
105635947|NCT01499849|364330993|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
105635948|NCT01499849|364330992|FG000|Overall Study|Withdrawal by Subject|43|||
105635949|NCT01499849|364330993|FG001|Overall Study|Withdrawal by Subject|43|||
105635950|NCT01499849|364330992|FG000|Overall Study|Death|5|||
105635951|NCT01499849|364330993|FG001|Overall Study|Death|7|||
105635952|NCT01499849|364330992|FG000|Overall Study|Disease Progression|11|||
105635953|NCT01499849|364330993|FG001|Overall Study|Disease Progression|10|||
105635954|NCT01499849|364330992|FG000|Overall Study|Protocol Violation|11|||
105635955|NCT01499849|364330993|FG001|Overall Study|Protocol Violation|11|||
105635956|NCT01499849|364330992|FG000|Overall Study|Physician Decision|20|||
105635957|NCT01499849|364330993|FG001|Overall Study|Physician Decision|19|||
105635958|NCT01499849|364330992|FG000|Overall Study|Lack of Efficacy|3|||
105635959|NCT01499849|364330993|FG001|Overall Study|Lack of Efficacy|4|||
105635960|NCT01499849|364330992|FG000|Overall Study|Lost to Follow-up|6|||
105635961|NCT01499849|364330993|FG001|Overall Study|Lost to Follow-up|3|||
105635962|NCT01499849|364330992|FG000|Overall Study|Other Reasons|27|||
105635963|NCT01499849|364330993|FG001|Overall Study|Other Reasons|30|||
105635964|NCT00853593|364330994|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
105635965|NCT00853593|364330994|FG000|Overall Study|Model 4396 lead not attempted|29|||
105635966|NCT00853593|364330994|FG000|Overall Study|Implant not attempted|4|||
105635967|NCT03611556|364330995|FG000|Overall Study|Death|7|||
105635968|NCT03611556|364330996|FG001|Overall Study|Death|7|||
105635969|NCT03611556|364330997|FG002|Overall Study|Death|3|||
105635970|NCT03611556|364330998|FG003|Overall Study|Death|8|||
105635971|NCT03611556|364330999|FG004|Overall Study|Death|47|||
105635972|NCT03611556|364331000|FG005|Overall Study|Death|32|||
105635973|NCT03611556|364331001|FG006|Overall Study|Death|53|||
105635974|NCT03611556|364330995|FG000|Overall Study|Withdrawal by Subject|0|||
105635975|NCT03611556|364330996|FG001|Overall Study|Withdrawal by Subject|0|||
105635976|NCT03611556|364330997|FG002|Overall Study|Withdrawal by Subject|0|||
105635977|NCT03611556|364330998|FG003|Overall Study|Withdrawal by Subject|0|||
105635978|NCT03611556|364330999|FG004|Overall Study|Withdrawal by Subject|4|||
105635979|NCT03611556|364331000|FG005|Overall Study|Withdrawal by Subject|2|||
105635980|NCT03611556|364331001|FG006|Overall Study|Withdrawal by Subject|4|||
105635981|NCT03611556|364330995|FG000|Overall Study|Sponsor decision|0|||
105635982|NCT03611556|364330996|FG001|Overall Study|Sponsor decision|0|||
105635983|NCT03611556|364330997|FG002|Overall Study|Sponsor decision|0|||
105635984|NCT03611556|364330998|FG003|Overall Study|Sponsor decision|0|||
105635985|NCT03611556|364330999|FG004|Overall Study|Sponsor decision|9|||
105635986|NCT03611556|364331000|FG005|Overall Study|Sponsor decision|4|||
105635987|NCT03611556|364331001|FG006|Overall Study|Sponsor decision|12|||
105635988|NCT03611556|364330995|FG000|Overall Study|Reasons|0|||
105635989|NCT03611556|364330996|FG001|Overall Study|Reasons|0|||
105635990|NCT03611556|364330997|FG002|Overall Study|Reasons|0|||
105635991|NCT03611556|364330998|FG003|Overall Study|Reasons|0|||
105635992|NCT03611556|364330999|FG004|Overall Study|Reasons|2|||
105635993|NCT03611556|364331000|FG005|Overall Study|Reasons|0|||
105635994|NCT03611556|364331001|FG006|Overall Study|Reasons|1|||
105635995|NCT03229408|364331006|FG000|Overall Study|Withdrawal by Subject|4|||
105635996|NCT03229408|364331007|FG001|Overall Study|Withdrawal by Subject|1|||
105635997|NCT03229408|364331006|FG000|Overall Study|Adverse Event|2|||
105635998|NCT03229408|364331007|FG001|Overall Study|Adverse Event|0|||
105635999|NCT03229408|364331006|FG000|Overall Study|Pregnancy|0|||
105636000|NCT03229408|364331007|FG001|Overall Study|Pregnancy|1|||
105636001|NCT03229408|364331006|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
105636002|NCT03229408|364331007|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
105636003|NCT04200664|364331008|FG000|Overall Study|Withdrawal by Subject|1|||
105636004|NCT04200664|364331009|FG001|Overall Study|Withdrawal by Subject|0|||
105636005|NCT04200664|364331010|FG002|Overall Study|Withdrawal by Subject|0|||
105636006|NCT02426138|364331012|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105869917|NCT02288325|365176851|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
105869918|NCT02288325|365176852|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
105636007|NCT02426138|364331013|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
105636008|NCT02453282|364331018|FG000|Overall Study|Death|275|||
105636009|NCT02453282|364331019|FG001|Overall Study|Death|277|||
105636010|NCT02453282|364331020|FG002|Overall Study|Death|296|||
105636011|NCT02453282|364331018|FG000|Overall Study|Lost to Follow-up|1|||
105636012|NCT02453282|364331019|FG001|Overall Study|Lost to Follow-up|0|||
105636013|NCT02453282|364331020|FG002|Overall Study|Lost to Follow-up|2|||
105636014|NCT02453282|364331018|FG000|Overall Study|Withdrawal by Subject|12|||
105636015|NCT02453282|364331019|FG001|Overall Study|Withdrawal by Subject|10|||
105636016|NCT02453282|364331020|FG002|Overall Study|Withdrawal by Subject|11|||
105636017|NCT02453282|364331018|FG000|Overall Study|Participants ongoing at data cut-off|85|||
105636018|NCT02453282|364331019|FG001|Overall Study|Participants ongoing at data cut-off|84|||
105636019|NCT02453282|364331020|FG002|Overall Study|Participants ongoing at data cut-off|62|||
105636020|NCT02453282|364331018|FG000|Overall Study|Other|1|||
105636021|NCT02453282|364331019|FG001|Overall Study|Other|1|||
105636022|NCT02453282|364331020|FG002|Overall Study|Other|1|||
105636023|NCT00687219|364331021|FG000|Overall Study|Adverse Event|8|||
105636024|NCT00687219|364331021|FG000|Overall Study|Discontinuance criteria met|7|||
105636025|NCT00687219|364331021|FG000|Overall Study|HCV-RNA positive conversion|34|||
105636026|NCT00687219|364331021|FG000|Overall Study|Withdrawal by Subject|1|||
105636027|NCT00687219|364331021|FG000|Overall Study|Lack of Efficacy|1|||
105636028|NCT02235298|364331030|FG000|Overall Study|Lost to Follow-up|6|||
105636029|NCT02235298|364331031|FG001|Overall Study|Lost to Follow-up|5|||
105636030|NCT02235298|364331030|FG000|Overall Study|Adverse Event|2|||
105636031|NCT02235298|364331031|FG001|Overall Study|Adverse Event|2|||
105636032|NCT02235298|364331030|FG000|Overall Study|Withdrawal by Subject|0|||
105636033|NCT02235298|364331031|FG001|Overall Study|Withdrawal by Subject|1|||
105636034|NCT01827839|364331032|FG000|Overall Study|Adverse Event|1|||
105636035|NCT01827839|364331032|FG000|Overall Study|Consent Withdrawal|2|||
105636036|NCT00467272|364331037|FG000|Overall Study|Pneumonia|2|||
105636037|NCT00467272|364331037|FG000|Overall Study|Thrombophlebitis|1|||
105636038|NCT02454959|364331038|FG000|Overall Study|Protocol-Specified Criteria|3|||
105636039|NCT02454959|364331038|FG000|Overall Study|Physician Decision|1|||
105636040|NCT02454959|364331038|FG000|Overall Study|Withdrawal by Subject|3|||
105636041|NCT02454959|364331038|FG000|Overall Study|Adverse Event|2|||
105636042|NCT02350634|364331039|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
105636043|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
105636044|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
105636045|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
105636046|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
105636047|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
105636048|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
105636049|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
105636050|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
105636051|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
105636052|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
105636053|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
105636054|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
105636055|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
105636056|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
105636057|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
105636058|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
105636059|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
105636060|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
105636061|NCT02222493|364331050|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
105636062|NCT02222493|364331051|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
105636063|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
105636064|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
105636065|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
105636066|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
105636067|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
105636068|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
105636069|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
105636070|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
105636071|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
105636072|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
105636073|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
105636074|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
105636075|NCT02222493|364331050|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
105636076|NCT02222493|364331051|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
105636077|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
105636078|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
105636079|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
105636080|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
105636081|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
105636082|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
105636083|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
105636084|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
105636085|NCT02222493|364331050|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
105636086|NCT02222493|364331051|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
105636087|NCT02130557|364331052|FG000|Overall Study|Withdrawal by Subject|12|||
105636088|NCT02130557|364331053|FG001|Overall Study|Withdrawal by Subject|12|||
105636089|NCT02130557|364331052|FG000|Overall Study|Investigator Request|0|||
105636090|NCT02130557|364331053|FG001|Overall Study|Investigator Request|2|||
105636091|NCT02130557|364331052|FG000|Overall Study|Deceased|14|||
105636092|NCT02130557|364331053|FG001|Overall Study|Deceased|14|||
105636093|NCT02130557|364331052|FG000|Overall Study|Lost to Follow-up|6|||
105636094|NCT02130557|364331053|FG001|Overall Study|Lost to Follow-up|7|||
105636095|NCT02130557|364331052|FG000|Overall Study|Other|2|||
105636096|NCT02130557|364331053|FG001|Overall Study|Other|1|||
105636097|NCT02130557|364331052|FG000|Overall Study|Missing|2|||
105636098|NCT02130557|364331053|FG001|Overall Study|Missing|1|||
105636099|NCT03924869|364331054|FG000|Overall Study|Death|66|||
105636100|NCT03924869|364331055|FG001|Overall Study|Death|53|||
105636101|NCT03924869|364331054|FG000|Overall Study|Lost to Follow-up|2|||
105636102|NCT03924869|364331055|FG001|Overall Study|Lost to Follow-up|0|||
105636103|NCT03924869|364331054|FG000|Overall Study|Physician Decision|0|||
105636104|NCT03924869|364331055|FG001|Overall Study|Physician Decision|3|||
105636105|NCT03924869|364331054|FG000|Overall Study|Withdrawal by Subject|5|||
105636106|NCT03924869|364331055|FG001|Overall Study|Withdrawal by Subject|1|||
105636107|NCT03924869|364331054|FG000|Overall Study|Participants Ongoing|154|||
105636108|NCT03924869|364331055|FG001|Overall Study|Participants Ongoing|164|||
105636109|NCT05824559|364331059|FG000|Overall Study|Adverse Event|2|||
105636110|NCT05824559|364331059|FG000|Overall Study|Physician Decision|2|||
105636111|NCT05824559|364331059|FG000|Overall Study|Progressive Disease|16|||
105636112|NCT05824559|364331059|FG000|Overall Study|Study Terminated by Sponsor|1|||
105636113|NCT05824559|364331059|FG000|Overall Study|Withdrawal by Subject|2|||
105636114|NCT02409680|364331060|FG000|Overall Study|Lost to Follow-up|15|||
105636115|NCT02409680|364331061|FG001|Overall Study|Lost to Follow-up|30|||
105636116|NCT03343704|364331062|FG000|Overall Study|Refused to complete follow up|0|||
105636117|NCT03343704|364331063|FG001|Overall Study|Refused to complete follow up|1|||
105636118|NCT03343704|364331062|FG000|Overall Study|Death|0|||
105636119|NCT03343704|364331063|FG001|Overall Study|Death|1|||
105636120|NCT03343704|364331062|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
105636121|NCT03343704|364331063|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
105636122|NCT04535414|364331064|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
105636123|NCT04535414|364331065|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
105636124|NCT04535414|364331064|FG000|Overall Study|Cancelled appointment|1|||
105636125|NCT04535414|364331065|FG001|Overall Study|Cancelled appointment|0|||
105636126|NCT04535414|364331064|FG000|Overall Study|cancelled - food in stomach|2|||
105636127|NCT04535414|364331065|FG001|Overall Study|cancelled - food in stomach|0|||
105636128|NCT04535414|364331064|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
105636129|NCT04535414|364331065|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
105636130|NCT04535414|364331064|FG000|Overall Study|Withdrawal by Subject|0|||
105636131|NCT04535414|364331065|FG001|Overall Study|Withdrawal by Subject|1|||
105636132|NCT03662659|364331066|FG000|Pre-treatment|Participant no longer met study criteria|1|||
105636133|NCT03662659|364331067|FG001|Pre-treatment|Participant no longer met study criteria|1|||
105636134|NCT03662659|364331066|FG000|Pre-treatment|Other reasons|1|||
105636135|NCT03662659|364331067|FG001|Pre-treatment|Other reasons|0|||
105636136|NCT03662659|364331066|FG000|Treatment|Completed Treatment|0|||
105636137|NCT03662659|364331067|FG001|Treatment|Completed Treatment|2|||
105636138|NCT03662659|364331066|FG000|Treatment|Disease Progression|85|||
105636139|NCT03662659|364331067|FG001|Treatment|Disease Progression|97|||
105636140|NCT03662659|364331066|FG000|Treatment|Study Drug Toxicity|19|||
105636141|NCT03662659|364331067|FG001|Treatment|Study Drug Toxicity|9|||
105869919|NCT02288325|365176853|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
105869920|NCT02288325|365176851|FG000|Run-in Period|Reason not Specified|8|||
105869921|NCT02288325|365176852|FG001|Run-in Period|Reason not Specified|0|||
105636142|NCT03662659|364331066|FG000|Treatment|Death|11|||
105636143|NCT03662659|364331067|FG001|Treatment|Death|9|||
105636144|NCT03662659|364331066|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
105636145|NCT03662659|364331067|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
105636146|NCT03662659|364331066|FG000|Treatment|Withdrawal by Subject|1|||
105636147|NCT03662659|364331067|FG001|Treatment|Withdrawal by Subject|1|||
105636148|NCT03662659|364331066|FG000|Treatment|Poor/Non-compliance|1|||
105636149|NCT03662659|364331067|FG001|Treatment|Poor/Non-compliance|0|||
105636150|NCT03662659|364331066|FG000|Treatment|Participant no longer meets study criteria|1|||
105636151|NCT03662659|364331067|FG001|Treatment|Participant no longer meets study criteria|0|||
105636152|NCT03662659|364331066|FG000|Treatment|Other reasons|10|||
105636153|NCT03662659|364331067|FG001|Treatment|Other reasons|8|||
105636154|NCT03662659|364331066|FG000|Treatment|Administrative reasons by sponsor|1|||
105636155|NCT03662659|364331067|FG001|Treatment|Administrative reasons by sponsor|0|||
105636156|NCT03662659|364331066|FG000|Treatment|maximum clinical benefit|0|||
105636157|NCT03662659|364331067|FG001|Treatment|maximum clinical benefit|2|||
105636158|NCT03083366|364332736|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
105636159|NCT03083366|364332737|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
105636160|NCT03083366|364332736|FG000|Enrollment Period|Lack of Efficacy|1|||
105636161|NCT03083366|364332737|FG001|Enrollment Period|Lack of Efficacy|0|||
105636162|NCT05029284|364332742|FG000|Overall Study|Lost to Follow-up|1|||
105636163|NCT02972034|364332743|FG000|Overall Study|Death|11|||
105636164|NCT02972034|364332744|FG001|Overall Study|Death|1|||
105636165|NCT02972034|364332745|FG002|Overall Study|Death|3|||
105636166|NCT02972034|364332746|FG003|Overall Study|Death|3|||
105636167|NCT02972034|364332747|FG004|Overall Study|Death|2|||
105636168|NCT02972034|364332748|FG005|Overall Study|Death|2|||
105636169|NCT02972034|364332749|FG006|Overall Study|Death|3|||
105636170|NCT02972034|364332750|FG007|Overall Study|Death|4|||
105636171|NCT02972034|364332751|FG008|Overall Study|Death|8|||
105636172|NCT02972034|364332752|FG009|Overall Study|Death|11|||
105636173|NCT02972034|364332753|FG010|Overall Study|Death|3|||
105636174|NCT02972034|364332754|FG011|Overall Study|Death|2|||
105636175|NCT02972034|364332755|FG012|Overall Study|Death|11|||
105636176|NCT02972034|364332756|FG013|Overall Study|Death|10|||
105636177|NCT02972034|364332757|FG014|Overall Study|Death|9|||
105636178|NCT02972034|364332743|FG000|Overall Study|Lost to Follow-up|0|||
105636179|NCT02972034|364332744|FG001|Overall Study|Lost to Follow-up|0|||
105636180|NCT02972034|364332745|FG002|Overall Study|Lost to Follow-up|0|||
105636181|NCT02972034|364332746|FG003|Overall Study|Lost to Follow-up|0|||
105636182|NCT02972034|364332747|FG004|Overall Study|Lost to Follow-up|1|||
105636183|NCT02972034|364332748|FG005|Overall Study|Lost to Follow-up|0|||
105636184|NCT02972034|364332749|FG006|Overall Study|Lost to Follow-up|0|||
105636185|NCT02972034|364332750|FG007|Overall Study|Lost to Follow-up|1|||
105636186|NCT02972034|364332751|FG008|Overall Study|Lost to Follow-up|0|||
105636187|NCT02972034|364332752|FG009|Overall Study|Lost to Follow-up|0|||
105636188|NCT02972034|364332753|FG010|Overall Study|Lost to Follow-up|0|||
105636189|NCT02972034|364332754|FG011|Overall Study|Lost to Follow-up|0|||
105636190|NCT02972034|364332755|FG012|Overall Study|Lost to Follow-up|0|||
105636191|NCT02972034|364332756|FG013|Overall Study|Lost to Follow-up|0|||
105636192|NCT02972034|364332757|FG014|Overall Study|Lost to Follow-up|1|||
105636193|NCT02972034|364332743|FG000|Overall Study|Physician Decision|0|||
105636194|NCT02972034|364332744|FG001|Overall Study|Physician Decision|0|||
105636195|NCT02972034|364332745|FG002|Overall Study|Physician Decision|0|||
105636196|NCT02972034|364332746|FG003|Overall Study|Physician Decision|0|||
105636197|NCT02972034|364332747|FG004|Overall Study|Physician Decision|0|||
105636198|NCT02972034|364332748|FG005|Overall Study|Physician Decision|0|||
105636199|NCT02972034|364332749|FG006|Overall Study|Physician Decision|0|||
105636200|NCT02972034|364332750|FG007|Overall Study|Physician Decision|1|||
105636201|NCT02972034|364332751|FG008|Overall Study|Physician Decision|0|||
105636202|NCT02972034|364332752|FG009|Overall Study|Physician Decision|0|||
105636203|NCT02972034|364332753|FG010|Overall Study|Physician Decision|1|||
105636204|NCT02972034|364332754|FG011|Overall Study|Physician Decision|0|||
105636205|NCT02972034|364332755|FG012|Overall Study|Physician Decision|0|||
105636206|NCT02972034|364332756|FG013|Overall Study|Physician Decision|0|||
105636207|NCT02972034|364332757|FG014|Overall Study|Physician Decision|0|||
105636208|NCT02972034|364332743|FG000|Overall Study|Sponsor Decision|0|||
105636209|NCT02972034|364332744|FG001|Overall Study|Sponsor Decision|0|||
105636210|NCT02972034|364332745|FG002|Overall Study|Sponsor Decision|0|||
105636211|NCT02972034|364332746|FG003|Overall Study|Sponsor Decision|1|||
105636212|NCT02972034|364332747|FG004|Overall Study|Sponsor Decision|0|||
105636213|NCT02972034|364332748|FG005|Overall Study|Sponsor Decision|0|||
105636214|NCT02972034|364332749|FG006|Overall Study|Sponsor Decision|1|||
105636215|NCT02972034|364332750|FG007|Overall Study|Sponsor Decision|1|||
105636216|NCT02972034|364332751|FG008|Overall Study|Sponsor Decision|1|||
105636217|NCT02972034|364332752|FG009|Overall Study|Sponsor Decision|2|||
105636218|NCT02972034|364332753|FG010|Overall Study|Sponsor Decision|2|||
105636219|NCT02972034|364332754|FG011|Overall Study|Sponsor Decision|0|||
105636220|NCT02972034|364332755|FG012|Overall Study|Sponsor Decision|1|||
105636221|NCT02972034|364332756|FG013|Overall Study|Sponsor Decision|0|||
105636222|NCT02972034|364332757|FG014|Overall Study|Sponsor Decision|1|||
105636223|NCT02972034|364332743|FG000|Overall Study|Withdrawal by Subject|3|||
105636224|NCT02972034|364332744|FG001|Overall Study|Withdrawal by Subject|0|||
105636225|NCT02972034|364332745|FG002|Overall Study|Withdrawal by Subject|0|||
105636226|NCT02972034|364332746|FG003|Overall Study|Withdrawal by Subject|0|||
105636227|NCT02972034|364332747|FG004|Overall Study|Withdrawal by Subject|1|||
105636228|NCT02972034|364332748|FG005|Overall Study|Withdrawal by Subject|1|||
105636229|NCT02972034|364332749|FG006|Overall Study|Withdrawal by Subject|0|||
105636230|NCT02972034|364332750|FG007|Overall Study|Withdrawal by Subject|0|||
105636231|NCT02972034|364332751|FG008|Overall Study|Withdrawal by Subject|1|||
105636232|NCT02972034|364332752|FG009|Overall Study|Withdrawal by Subject|1|||
105636233|NCT02972034|364332753|FG010|Overall Study|Withdrawal by Subject|2|||
105636234|NCT02972034|364332754|FG011|Overall Study|Withdrawal by Subject|1|||
105636235|NCT02972034|364332755|FG012|Overall Study|Withdrawal by Subject|1|||
105636236|NCT02972034|364332756|FG013|Overall Study|Withdrawal by Subject|1|||
105636237|NCT02972034|364332757|FG014|Overall Study|Withdrawal by Subject|0|||
105636238|NCT02972034|364332743|FG000|Overall Study|Screen Failure|0|||
105636239|NCT02972034|364332744|FG001|Overall Study|Screen Failure|0|||
105636240|NCT02972034|364332745|FG002|Overall Study|Screen Failure|0|||
105636241|NCT02972034|364332746|FG003|Overall Study|Screen Failure|0|||
105636242|NCT02972034|364332747|FG004|Overall Study|Screen Failure|0|||
105636243|NCT02972034|364332748|FG005|Overall Study|Screen Failure|0|||
105636244|NCT02972034|364332749|FG006|Overall Study|Screen Failure|0|||
105636245|NCT02972034|364332750|FG007|Overall Study|Screen Failure|0|||
105636246|NCT02972034|364332751|FG008|Overall Study|Screen Failure|0|||
105636247|NCT02972034|364332752|FG009|Overall Study|Screen Failure|0|||
105636248|NCT02972034|364332753|FG010|Overall Study|Screen Failure|0|||
105636249|NCT02972034|364332754|FG011|Overall Study|Screen Failure|0|||
105636250|NCT02972034|364332755|FG012|Overall Study|Screen Failure|1|||
105636251|NCT02972034|364332756|FG013|Overall Study|Screen Failure|0|||
105636252|NCT02972034|364332757|FG014|Overall Study|Screen Failure|0|||
105636253|NCT03861052|364332758|FG000|Overall Study|Adverse Event|1|||
105636254|NCT03861052|364332759|FG001|Overall Study|Adverse Event|1|||
105636255|NCT03861052|364332760|FG002|Overall Study|Adverse Event|2|||
105636256|NCT03861052|364332761|FG003|Overall Study|Adverse Event|4|||
105636257|NCT03861052|364332758|FG000|Overall Study|Lost to Follow-up|0|||
105636258|NCT03861052|364332759|FG001|Overall Study|Lost to Follow-up|0|||
105636259|NCT03861052|364332760|FG002|Overall Study|Lost to Follow-up|0|||
105636260|NCT03861052|364332761|FG003|Overall Study|Lost to Follow-up|1|||
105636261|NCT03861052|364332758|FG000|Overall Study|Physician Decision|0|||
105636262|NCT03861052|364332759|FG001|Overall Study|Physician Decision|1|||
105636263|NCT03861052|364332760|FG002|Overall Study|Physician Decision|0|||
105636264|NCT03861052|364332761|FG003|Overall Study|Physician Decision|0|||
105636265|NCT03861052|364332758|FG000|Overall Study|Withdrawal by Subject|2|||
105636266|NCT03861052|364332759|FG001|Overall Study|Withdrawal by Subject|5|||
105636267|NCT03861052|364332760|FG002|Overall Study|Withdrawal by Subject|3|||
105636268|NCT03861052|364332761|FG003|Overall Study|Withdrawal by Subject|0|||
105636269|NCT03861052|364332758|FG000|Overall Study|Relocation to other city|1|||
105636270|NCT03861052|364332759|FG001|Overall Study|Relocation to other city|0|||
105636271|NCT03861052|364332760|FG002|Overall Study|Relocation to other city|0|||
105636272|NCT03861052|364332761|FG003|Overall Study|Relocation to other city|0|||
105636273|NCT03678688|364332762|FG000|Overall Study|Reason not Specified|0|||
105636274|NCT03678688|364332763|FG001|Overall Study|Reason not Specified|0|||
105636275|NCT03678688|364332764|FG002|Overall Study|Reason not Specified|3|||
105636276|NCT03678688|364332765|FG003|Overall Study|Reason not Specified|0|||
105636277|NCT03678688|364332766|FG004|Overall Study|Reason not Specified|1|||
105636278|NCT03678688|364332767|FG005|Overall Study|Reason not Specified|0|||
105636279|NCT03678688|364332768|FG006|Overall Study|Reason not Specified|0|||
105636280|NCT03678688|364332769|FG007|Overall Study|Reason not Specified|0|||
105636281|NCT03678688|364332770|FG008|Overall Study|Reason not Specified|0|||
105636282|NCT03678688|364332762|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
105636283|NCT03678688|364332763|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
105636284|NCT03678688|364332764|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
105636285|NCT03678688|364332765|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
105636286|NCT03678688|364332766|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
105636287|NCT03678688|364332767|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
105636288|NCT03678688|364332768|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
105636289|NCT03678688|364332769|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
105636290|NCT03678688|364332770|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
105636291|NCT03678688|364332762|FG000|Overall Study|Covid Related Adverse Event|0|||
105636292|NCT03678688|364332763|FG001|Overall Study|Covid Related Adverse Event|0|||
105636293|NCT03678688|364332764|FG002|Overall Study|Covid Related Adverse Event|0|||
105636294|NCT03678688|364332765|FG003|Overall Study|Covid Related Adverse Event|0|||
105636295|NCT03678688|364332766|FG004|Overall Study|Covid Related Adverse Event|0|||
105636296|NCT03678688|364332767|FG005|Overall Study|Covid Related Adverse Event|3|||
105636297|NCT03678688|364332768|FG006|Overall Study|Covid Related Adverse Event|1|||
105636298|NCT03678688|364332769|FG007|Overall Study|Covid Related Adverse Event|1|||
105636299|NCT03678688|364332770|FG008|Overall Study|Covid Related Adverse Event|0|||
105636300|NCT03678688|364332762|FG000|Overall Study|Physician Decision|0|||
105636301|NCT03678688|364332763|FG001|Overall Study|Physician Decision|0|||
105636302|NCT03678688|364332764|FG002|Overall Study|Physician Decision|0|||
105636303|NCT03678688|364332765|FG003|Overall Study|Physician Decision|0|||
105636304|NCT03678688|364332766|FG004|Overall Study|Physician Decision|0|||
105636305|NCT03678688|364332767|FG005|Overall Study|Physician Decision|1|||
105636306|NCT03678688|364332768|FG006|Overall Study|Physician Decision|0|||
105636307|NCT03678688|364332769|FG007|Overall Study|Physician Decision|0|||
105636308|NCT03678688|364332770|FG008|Overall Study|Physician Decision|0|||
105636309|NCT03678688|364332762|FG000|Overall Study|Withdrawal by Subject|0|||
105636310|NCT03678688|364332763|FG001|Overall Study|Withdrawal by Subject|0|||
105636311|NCT03678688|364332764|FG002|Overall Study|Withdrawal by Subject|0|||
105636312|NCT03678688|364332765|FG003|Overall Study|Withdrawal by Subject|0|||
105636313|NCT03678688|364332766|FG004|Overall Study|Withdrawal by Subject|0|||
105636314|NCT03678688|364332767|FG005|Overall Study|Withdrawal by Subject|0|||
105636315|NCT03678688|364332768|FG006|Overall Study|Withdrawal by Subject|2|||
105636316|NCT03678688|364332769|FG007|Overall Study|Withdrawal by Subject|1|||
105636317|NCT03678688|364332770|FG008|Overall Study|Withdrawal by Subject|0|||
105636318|NCT00551421|364332771|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
105636319|NCT03136159|364332772|FG000|Overall Study|chorioamnionitis|2|||
105636320|NCT03136159|364332773|FG001|Overall Study|chorioamnionitis|0|||
105636321|NCT03136159|364332772|FG000|Overall Study|vertical skin incision|1|||
105636322|NCT03136159|364332773|FG001|Overall Study|vertical skin incision|0|||
105636323|NCT03136159|364332772|FG000|Overall Study|additional dressing|1|||
105636324|NCT03136159|364332773|FG001|Overall Study|additional dressing|0|||
105636325|NCT03136159|364332772|FG000|Overall Study|never got dressing placed|1|||
105636326|NCT03136159|364332773|FG001|Overall Study|never got dressing placed|0|||
105636327|NCT04131556|364332774|FG000|Overall Study|Adverse Event|1|||
105636328|NCT04131556|364332774|FG000|Overall Study|Withdrawal by Subject|1|||
105636329|NCT03137459|364332775|FG000|2-month Assessment|Withdrawal by Subject|13|||
105636330|NCT03137459|364332776|FG001|2-month Assessment|Withdrawal by Subject|3|||
105636331|NCT03137459|364332775|FG000|2-month Assessment|Unable to reach|42|||
105636332|NCT03137459|364332776|FG001|2-month Assessment|Unable to reach|32|||
105636333|NCT03137459|364332775|FG000|2-month Assessment|Refused assessment|7|||
105636334|NCT03137459|364332776|FG001|2-month Assessment|Refused assessment|5|||
105636335|NCT03137459|364332775|FG000|2-month Assessment|Acutely ill|6|||
105636336|NCT03137459|364332776|FG001|2-month Assessment|Acutely ill|2|||
105636337|NCT03137459|364332775|FG000|4-month Assessment|Death|4|||
105636338|NCT03137459|364332776|FG001|4-month Assessment|Death|2|||
105636339|NCT03137459|364332775|FG000|4-month Assessment|Withdrawal by Subject|4|||
105636340|NCT03137459|364332776|FG001|4-month Assessment|Withdrawal by Subject|2|||
105636341|NCT03137459|364332775|FG000|4-month Assessment|Unable to reach|44|||
105636342|NCT03137459|364332776|FG001|4-month Assessment|Unable to reach|29|||
105636343|NCT03137459|364332775|FG000|4-month Assessment|Refused assessment|24|||
105636344|NCT03137459|364332776|FG001|4-month Assessment|Refused assessment|10|||
105636345|NCT03137459|364332775|FG000|4-month Assessment|Acutely ill|2|||
105636346|NCT03137459|364332776|FG001|4-month Assessment|Acutely ill|3|||
105636347|NCT03137459|364332775|FG000|6-months|Lost to Follow-up|14|||
105636348|NCT03137459|364332776|FG001|6-months|Lost to Follow-up|11|||
105636349|NCT03137459|364332775|FG000|6-months|Death|0|||
105636350|NCT03137459|364332776|FG001|6-months|Death|2|||
105636351|NCT03137459|364332775|FG000|6-months|Refused assessment|6|||
105636352|NCT03137459|364332776|FG001|6-months|Refused assessment|3|||
105636353|NCT03137459|364332775|FG000|6-months|Acutely ill|1|||
105636354|NCT03137459|364332776|FG001|6-months|Acutely ill|1|||
105636355|NCT00985088|364332777|FG000|Overall Study|Serious Adverse Event|1|||
105636356|NCT00985088|364332778|FG001|Overall Study|Serious Adverse Event|1|||
105636357|NCT00985088|364332779|FG002|Overall Study|Serious Adverse Event|0|||
105636358|NCT00985088|364332780|FG003|Overall Study|Serious Adverse Event|0|||
105636359|NCT00985088|364332781|FG004|Overall Study|Serious Adverse Event|0|||
105636360|NCT00985088|364332782|FG005|Overall Study|Serious Adverse Event|0|||
105636361|NCT00985088|364332783|FG006|Overall Study|Serious Adverse Event|0|||
105636362|NCT00985088|364332784|FG007|Overall Study|Serious Adverse Event|1|||
105636363|NCT00985088|364332777|FG000|Overall Study|Adverse Event|0|||
105636364|NCT00985088|364332778|FG001|Overall Study|Adverse Event|0|||
105636365|NCT00985088|364332779|FG002|Overall Study|Adverse Event|1|||
105636366|NCT00985088|364332780|FG003|Overall Study|Adverse Event|0|||
105636367|NCT00985088|364332781|FG004|Overall Study|Adverse Event|0|||
105636368|NCT00985088|364332782|FG005|Overall Study|Adverse Event|0|||
105636369|NCT00985088|364332783|FG006|Overall Study|Adverse Event|0|||
105636370|NCT00985088|364332784|FG007|Overall Study|Adverse Event|0|||
105636371|NCT00985088|364332777|FG000|Overall Study|Withdrawal by Subject|4|||
105636372|NCT00985088|364332778|FG001|Overall Study|Withdrawal by Subject|0|||
105636373|NCT00985088|364332779|FG002|Overall Study|Withdrawal by Subject|0|||
105636374|NCT00985088|364332780|FG003|Overall Study|Withdrawal by Subject|1|||
105636375|NCT00985088|364332781|FG004|Overall Study|Withdrawal by Subject|3|||
105636376|NCT00985088|364332782|FG005|Overall Study|Withdrawal by Subject|2|||
105636377|NCT00985088|364332783|FG006|Overall Study|Withdrawal by Subject|1|||
105636378|NCT00985088|364332784|FG007|Overall Study|Withdrawal by Subject|2|||
105636379|NCT00985088|364332777|FG000|Overall Study|Migrated/moved from study area|0|||
105636380|NCT00985088|364332778|FG001|Overall Study|Migrated/moved from study area|0|||
105636381|NCT00985088|364332779|FG002|Overall Study|Migrated/moved from study area|1|||
105636382|NCT00985088|364332780|FG003|Overall Study|Migrated/moved from study area|0|||
105636383|NCT00985088|364332781|FG004|Overall Study|Migrated/moved from study area|0|||
105636384|NCT00985088|364332782|FG005|Overall Study|Migrated/moved from study area|0|||
105636385|NCT00985088|364332783|FG006|Overall Study|Migrated/moved from study area|0|||
105636386|NCT00985088|364332784|FG007|Overall Study|Migrated/moved from study area|1|||
105636387|NCT00985088|364332777|FG000|Overall Study|Lost to Follow-up|6|||
105636388|NCT00985088|364332778|FG001|Overall Study|Lost to Follow-up|1|||
105636389|NCT00985088|364332779|FG002|Overall Study|Lost to Follow-up|2|||
105636390|NCT00985088|364332780|FG003|Overall Study|Lost to Follow-up|6|||
105636391|NCT00985088|364332781|FG004|Overall Study|Lost to Follow-up|6|||
105636392|NCT00985088|364332782|FG005|Overall Study|Lost to Follow-up|5|||
105636393|NCT00985088|364332783|FG006|Overall Study|Lost to Follow-up|3|||
105636394|NCT00985088|364332784|FG007|Overall Study|Lost to Follow-up|2|||
105636395|NCT02232737|364332785|FG000|Overall Study|Lost to Follow-up|18|||
105636396|NCT02232737|364332786|FG001|Overall Study|Lost to Follow-up|28|||
105636397|NCT02232737|364332787|FG002|Overall Study|Lost to Follow-up|33|||
105636398|NCT02232737|364332785|FG000|Overall Study|Personal reasons|7|||
105636399|NCT02232737|364332786|FG001|Overall Study|Personal reasons|8|||
105636400|NCT02232737|364332787|FG002|Overall Study|Personal reasons|14|||
105636401|NCT02232737|364332785|FG000|Overall Study|Adverse Event|6|||
105636402|NCT02232737|364332786|FG001|Overall Study|Adverse Event|3|||
105636403|NCT02232737|364332787|FG002|Overall Study|Adverse Event|8|||
105636404|NCT02232737|364332785|FG000|Overall Study|Incarcerated|2|||
105636405|NCT02232737|364332786|FG001|Overall Study|Incarcerated|1|||
105636406|NCT02232737|364332787|FG002|Overall Study|Incarcerated|2|||
105636407|NCT02232737|364332785|FG000|Overall Study|Withdrawal by Subject|0|||
105636408|NCT02232737|364332786|FG001|Overall Study|Withdrawal by Subject|1|||
105636409|NCT02232737|364332787|FG002|Overall Study|Withdrawal by Subject|2|||
105636410|NCT02232737|364332785|FG000|Overall Study|Death|0|||
105636411|NCT02232737|364332786|FG001|Overall Study|Death|1|||
105636412|NCT02232737|364332787|FG002|Overall Study|Death|1|||
105636413|NCT02232737|364332785|FG000|Overall Study|Physician Decision|1|||
105636414|NCT02232737|364332786|FG001|Overall Study|Physician Decision|3|||
105636415|NCT02232737|364332787|FG002|Overall Study|Physician Decision|1|||
105636416|NCT02232737|364332785|FG000|Overall Study|Protocol Violation|1|||
105636417|NCT02232737|364332786|FG001|Overall Study|Protocol Violation|0|||
105636418|NCT02232737|364332787|FG002|Overall Study|Protocol Violation|1|||
105636419|NCT02232737|364332785|FG000|Overall Study|Reason unknown|1|||
105636420|NCT02232737|364332786|FG001|Overall Study|Reason unknown|0|||
105636421|NCT02232737|364332787|FG002|Overall Study|Reason unknown|0|||
105636422|NCT05171816|364332791|FG000|Overall Study|Death|18|||
105636423|NCT05171816|364332792|FG001|Overall Study|Death|16|||
105636424|NCT00491400|364332793|FG000|Overall Study|Withdrawal by Subject|5|||
105636425|NCT00491400|364332794|FG001|Overall Study|Withdrawal by Subject|4|||
105636426|NCT02132949|364332795|FG000|Overall Study|Death|7|||
105636427|NCT02132949|364332796|FG001|Overall Study|Death|13|||
105636428|NCT02132949|364332795|FG000|Overall Study|Lost to Follow-up|14|||
105636429|NCT02132949|364332796|FG001|Overall Study|Lost to Follow-up|4|||
105636430|NCT02132949|364332795|FG000|Overall Study|Withdrawal by Subject|6|||
105636431|NCT02132949|364332796|FG001|Overall Study|Withdrawal by Subject|5|||
105636432|NCT02132949|364332795|FG000|Overall Study|Noncompliance|5|||
105636433|NCT02132949|364332796|FG001|Overall Study|Noncompliance|1|||
105636434|NCT02132949|364332795|FG000|Overall Study|Physician Decision|3|||
105636435|NCT02132949|364332796|FG001|Overall Study|Physician Decision|1|||
105636436|NCT02132949|364332795|FG000|Overall Study|Disease Progression|3|||
105636437|NCT02132949|364332796|FG001|Overall Study|Disease Progression|0|||
105636438|NCT02132949|364332795|FG000|Overall Study|Adverse Event|2|||
105636439|NCT02132949|364332796|FG001|Overall Study|Adverse Event|1|||
105636440|NCT02132949|364332795|FG000|Overall Study|Withdrew Prior to Treatment|1|||
105636441|NCT02132949|364332796|FG001|Overall Study|Withdrew Prior to Treatment|2|||
105636442|NCT02132949|364332795|FG000|Overall Study|Reason Unspecified|0|||
105636443|NCT02132949|364332796|FG001|Overall Study|Reason Unspecified|1|||
105636444|NCT00599196|364332799|FG000|Overall Study|Lack of Efficacy|22|||
105636445|NCT00599196|364332799|FG000|Overall Study|Adverse Event|93|||
105636446|NCT00599196|364332799|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
105636447|NCT00599196|364332799|FG000|Overall Study|Subject withdrew consent|43|||
105636448|NCT00599196|364332799|FG000|Overall Study|Study ended per sponsor|197|||
105636449|NCT00599196|364332799|FG000|Overall Study|Lost to Follow-up|17|||
105636450|NCT00599196|364332799|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
105636451|NCT00599196|364332799|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
105636452|NCT00599196|364332799|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
105636453|NCT00599196|364332799|FG000|Overall Study|Other: Pt Moved To Australia|1|||
105636454|NCT00599196|364332799|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
105636455|NCT00599196|364332799|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
105636456|NCT00622700|364332819|FG000|Core Treatment Period|Randomized but Not Treated|0|||
105636457|NCT00622700|364332820|FG001|Core Treatment Period|Randomized but Not Treated|2|||
105636458|NCT00622700|364332821|FG002|Core Treatment Period|Randomized but Not Treated|2|||
105636459|NCT00622700|364332822|FG003|Core Treatment Period|Randomized but Not Treated|0|||
105636460|NCT00622700|364332823|FG004|Core Treatment Period|Randomized but Not Treated|0|||
105636461|NCT00622700|364332824|FG005|Core Treatment Period|Randomized but Not Treated|0|||
105636462|NCT00622700|364332825|FG006|Core Treatment Period|Randomized but Not Treated|0|||
105636463|NCT00622700|364332819|FG000|Core Treatment Period|Adverse Event|18|||
105636464|NCT00622700|364332820|FG001|Core Treatment Period|Adverse Event|25|||
105636465|NCT00622700|364332821|FG002|Core Treatment Period|Adverse Event|18|||
105636466|NCT00622700|364332822|FG003|Core Treatment Period|Adverse Event|0|||
105636467|NCT00622700|364332823|FG004|Core Treatment Period|Adverse Event|0|||
105636468|NCT00622700|364332824|FG005|Core Treatment Period|Adverse Event|0|||
105636469|NCT00622700|364332825|FG006|Core Treatment Period|Adverse Event|0|||
105636470|NCT00622700|364332819|FG000|Core Treatment Period|Lack of Efficacy|19|||
105636471|NCT00622700|364332820|FG001|Core Treatment Period|Lack of Efficacy|6|||
105636472|NCT00622700|364332821|FG002|Core Treatment Period|Lack of Efficacy|12|||
105636473|NCT00622700|364332822|FG003|Core Treatment Period|Lack of Efficacy|0|||
105636474|NCT00622700|364332823|FG004|Core Treatment Period|Lack of Efficacy|0|||
105636475|NCT00622700|364332824|FG005|Core Treatment Period|Lack of Efficacy|0|||
105636476|NCT00622700|364332825|FG006|Core Treatment Period|Lack of Efficacy|0|||
105636477|NCT00622700|364332819|FG000|Core Treatment Period|Lost to Follow-up|1|||
105636478|NCT00622700|364332820|FG001|Core Treatment Period|Lost to Follow-up|1|||
105636479|NCT00622700|364332821|FG002|Core Treatment Period|Lost to Follow-up|1|||
105636480|NCT00622700|364332822|FG003|Core Treatment Period|Lost to Follow-up|0|||
105636481|NCT00622700|364332823|FG004|Core Treatment Period|Lost to Follow-up|0|||
105636482|NCT00622700|364332824|FG005|Core Treatment Period|Lost to Follow-up|0|||
105636483|NCT00622700|364332825|FG006|Core Treatment Period|Lost to Follow-up|0|||
105636484|NCT00622700|364332819|FG000|Core Treatment Period|Death|1|||
105636485|NCT00622700|364332820|FG001|Core Treatment Period|Death|0|||
105636486|NCT00622700|364332821|FG002|Core Treatment Period|Death|0|||
105636487|NCT00622700|364332822|FG003|Core Treatment Period|Death|0|||
105636488|NCT00622700|364332823|FG004|Core Treatment Period|Death|0|||
105636489|NCT00622700|364332824|FG005|Core Treatment Period|Death|0|||
105636490|NCT00622700|364332825|FG006|Core Treatment Period|Death|0|||
105636491|NCT00622700|364332819|FG000|Core Treatment Period|Progressive Disease|3|||
105636492|NCT00622700|364332820|FG001|Core Treatment Period|Progressive Disease|1|||
105636493|NCT00622700|364332821|FG002|Core Treatment Period|Progressive Disease|0|||
105636494|NCT00622700|364332822|FG003|Core Treatment Period|Progressive Disease|0|||
105636495|NCT00622700|364332823|FG004|Core Treatment Period|Progressive Disease|0|||
105636496|NCT00622700|364332824|FG005|Core Treatment Period|Progressive Disease|0|||
105636497|NCT00622700|364332825|FG006|Core Treatment Period|Progressive Disease|0|||
105636498|NCT00622700|364332819|FG000|Core Treatment Period|Withdrawal by Subject|12|||
105636499|NCT00622700|364332820|FG001|Core Treatment Period|Withdrawal by Subject|18|||
105636500|NCT00622700|364332821|FG002|Core Treatment Period|Withdrawal by Subject|15|||
105636501|NCT00622700|364332822|FG003|Core Treatment Period|Withdrawal by Subject|0|||
105636502|NCT00622700|364332823|FG004|Core Treatment Period|Withdrawal by Subject|0|||
105636503|NCT00622700|364332824|FG005|Core Treatment Period|Withdrawal by Subject|0|||
105636504|NCT00622700|364332825|FG006|Core Treatment Period|Withdrawal by Subject|0|||
105636505|NCT00622700|364332819|FG000|Core Treatment Period|Other than specified above|2|||
105636506|NCT00622700|364332820|FG001|Core Treatment Period|Other than specified above|2|||
105636507|NCT00622700|364332821|FG002|Core Treatment Period|Other than specified above|5|||
105636508|NCT00622700|364332822|FG003|Core Treatment Period|Other than specified above|0|||
105636509|NCT00622700|364332823|FG004|Core Treatment Period|Other than specified above|0|||
105636510|NCT00622700|364332824|FG005|Core Treatment Period|Other than specified above|0|||
105636511|NCT00622700|364332825|FG006|Core Treatment Period|Other than specified above|0|||
105636512|NCT00622700|364332819|FG000|Extension Treatment Period|Adverse Event|0|||
105636513|NCT00622700|364332820|FG001|Extension Treatment Period|Adverse Event|0|||
105636514|NCT00622700|364332821|FG002|Extension Treatment Period|Adverse Event|0|||
105636515|NCT00622700|364332822|FG003|Extension Treatment Period|Adverse Event|5|||
105636516|NCT00622700|364332823|FG004|Extension Treatment Period|Adverse Event|9|||
105636517|NCT00622700|364332824|FG005|Extension Treatment Period|Adverse Event|6|||
105636518|NCT00622700|364332825|FG006|Extension Treatment Period|Adverse Event|8|||
105636519|NCT00622700|364332819|FG000|Extension Treatment Period|Lack of Efficacy|0|||
105636520|NCT00622700|364332820|FG001|Extension Treatment Period|Lack of Efficacy|0|||
105636521|NCT00622700|364332821|FG002|Extension Treatment Period|Lack of Efficacy|0|||
105636522|NCT00622700|364332822|FG003|Extension Treatment Period|Lack of Efficacy|2|||
105636523|NCT00622700|364332823|FG004|Extension Treatment Period|Lack of Efficacy|8|||
105636524|NCT00622700|364332824|FG005|Extension Treatment Period|Lack of Efficacy|1|||
105636525|NCT00622700|364332825|FG006|Extension Treatment Period|Lack of Efficacy|9|||
105636526|NCT00622700|364332819|FG000|Extension Treatment Period|Protocol Violation|0|||
105636527|NCT00622700|364332820|FG001|Extension Treatment Period|Protocol Violation|0|||
105636528|NCT00622700|364332821|FG002|Extension Treatment Period|Protocol Violation|0|||
105636529|NCT00622700|364332822|FG003|Extension Treatment Period|Protocol Violation|0|||
105636530|NCT00622700|364332823|FG004|Extension Treatment Period|Protocol Violation|0|||
105636531|NCT00622700|364332824|FG005|Extension Treatment Period|Protocol Violation|2|||
105636532|NCT00622700|364332825|FG006|Extension Treatment Period|Protocol Violation|0|||
105636533|NCT00622700|364332819|FG000|Extension Treatment Period|Lost to Follow-up|0|||
105636534|NCT00622700|364332820|FG001|Extension Treatment Period|Lost to Follow-up|0|||
105636535|NCT00622700|364332821|FG002|Extension Treatment Period|Lost to Follow-up|0|||
105636536|NCT00622700|364332822|FG003|Extension Treatment Period|Lost to Follow-up|0|||
105636537|NCT00622700|364332823|FG004|Extension Treatment Period|Lost to Follow-up|1|||
105636538|NCT00622700|364332824|FG005|Extension Treatment Period|Lost to Follow-up|0|||
105636539|NCT00622700|364332825|FG006|Extension Treatment Period|Lost to Follow-up|0|||
105636540|NCT00622700|364332819|FG000|Extension Treatment Period|Progressive Disease|0|||
105636541|NCT00622700|364332820|FG001|Extension Treatment Period|Progressive Disease|0|||
105636542|NCT00622700|364332821|FG002|Extension Treatment Period|Progressive Disease|0|||
105636543|NCT00622700|364332822|FG003|Extension Treatment Period|Progressive Disease|1|||
105636544|NCT00622700|364332823|FG004|Extension Treatment Period|Progressive Disease|2|||
105636545|NCT00622700|364332824|FG005|Extension Treatment Period|Progressive Disease|0|||
105636546|NCT00622700|364332825|FG006|Extension Treatment Period|Progressive Disease|2|||
105636547|NCT00622700|364332819|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
105636548|NCT00622700|364332820|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105636549|NCT00622700|364332821|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
105636550|NCT00622700|364332822|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
105636551|NCT00622700|364332823|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
105636552|NCT00622700|364332824|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
105636553|NCT00622700|364332825|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
105636554|NCT00622700|364332819|FG000|Extension Treatment Period|Missing|0|||
105636555|NCT00622700|364332820|FG001|Extension Treatment Period|Missing|0|||
105636556|NCT00622700|364332821|FG002|Extension Treatment Period|Missing|0|||
105636557|NCT00622700|364332822|FG003|Extension Treatment Period|Missing|2|||
105636558|NCT00622700|364332823|FG004|Extension Treatment Period|Missing|3|||
105636559|NCT00622700|364332824|FG005|Extension Treatment Period|Missing|1|||
105636560|NCT00622700|364332825|FG006|Extension Treatment Period|Missing|0|||
105636561|NCT00622700|364332819|FG000|Extension Treatment Period|Other than specified above|0|||
105636562|NCT00622700|364332820|FG001|Extension Treatment Period|Other than specified above|0|||
105636563|NCT00622700|364332821|FG002|Extension Treatment Period|Other than specified above|0|||
105636564|NCT00622700|364332822|FG003|Extension Treatment Period|Other than specified above|0|||
105636565|NCT00622700|364332823|FG004|Extension Treatment Period|Other than specified above|0|||
105636566|NCT00622700|364332824|FG005|Extension Treatment Period|Other than specified above|1|||
105636567|NCT00622700|364332825|FG006|Extension Treatment Period|Other than specified above|1|||
105636568|NCT00942266|364332826|FG000|Overall Study|Withdrawal by Subject|1|||
105636569|NCT00942266|364332827|FG001|Overall Study|Withdrawal by Subject|0|||
105636570|NCT00942266|364332826|FG000|Overall Study|Adverse Event|2|||
105636571|NCT00942266|364332827|FG001|Overall Study|Adverse Event|1|||
105636572|NCT00942266|364332826|FG000|Overall Study|Disease Progression|38|||
105636573|NCT00942266|364332827|FG001|Overall Study|Disease Progression|11|||
105636574|NCT00942266|364332826|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
105636575|NCT00942266|364332827|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
105636576|NCT00942266|364332826|FG000|Overall Study|Intercurrent illness|0|||
105636577|NCT00942266|364332827|FG001|Overall Study|Intercurrent illness|1|||
105636578|NCT00942266|364332826|FG000|Overall Study|Physician Decision|2|||
105636579|NCT00942266|364332827|FG001|Overall Study|Physician Decision|0|||
105636580|NCT00942266|364332826|FG000|Overall Study|medical deterioration (pneumonia)|0|||
105636581|NCT00942266|364332827|FG001|Overall Study|medical deterioration (pneumonia)|1|||
105636582|NCT02630966|364332832|FG000|Overall Study|Adverse Event|1|||
105636583|NCT02630966|364332833|FG001|Overall Study|Adverse Event|3|||
105636584|NCT02630966|364332832|FG000|Overall Study|Significant Protocol Deviation|0|||
105636585|NCT02630966|364332833|FG001|Overall Study|Significant Protocol Deviation|2|||
105636586|NCT02630966|364332832|FG000|Overall Study|Voluntary Withdrawal|1|||
105636587|NCT02630966|364332833|FG001|Overall Study|Voluntary Withdrawal|1|||
105636588|NCT02630966|364332832|FG000|Overall Study|Lack of Efficacy|0|||
105636589|NCT02630966|364332833|FG001|Overall Study|Lack of Efficacy|2|||
105636590|NCT00600353|364332834|FG000|Overall Study|history of malignancy within 5 years|1|||
105636591|NCT00600353|364332835|FG001|Overall Study|history of malignancy within 5 years|0|||
105636592|NCT00600353|364332834|FG000|Overall Study|History of prepartive regimen|0|||
105636593|NCT00600353|364332835|FG001|Overall Study|History of prepartive regimen|1|||
105636594|NCT04035447|364332836|FG000|Treatment Period|Lost to Follow-up|6|||
105636595|NCT04035447|364332837|FG001|Treatment Period|Lost to Follow-up|5|||
105636596|NCT04035447|364332836|FG000|Treatment Period|Physician Decision|0|||
105636597|NCT04035447|364332837|FG001|Treatment Period|Physician Decision|2|||
105636598|NCT05966155|364332838|FG000|Overall Study|Death|1|||
105636599|NCT05966155|364332839|FG001|Overall Study|Death|2|||
105636600|NCT05966155|364332838|FG000|Overall Study|Lost to Follow-up|63|||
105636601|NCT05966155|364332839|FG001|Overall Study|Lost to Follow-up|67|||
105636602|NCT05966155|364332838|FG000|Overall Study|Protocol Violation|1|||
105636603|NCT05966155|364332839|FG001|Overall Study|Protocol Violation|0|||
105636604|NCT05966155|364332838|FG000|Overall Study|Withdrawal by Subject|8|||
105636605|NCT05966155|364332839|FG001|Overall Study|Withdrawal by Subject|9|||
105636606|NCT05966155|364332838|FG000|Overall Study|Enrolled Erroneously|0|||
105636607|NCT05966155|364332839|FG001|Overall Study|Enrolled Erroneously|1|||
105636608|NCT05966155|364332838|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
105636609|NCT05966155|364332839|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
105636610|NCT01638000|364332842|FG000|Overall Study|Randomized but Never Received Drug|7|||
105636611|NCT01638000|364332843|FG001|Overall Study|Randomized but Never Received Drug|10|||
105636612|NCT01638000|364332842|FG000|Overall Study|Adverse Event|14|||
105636613|NCT01638000|364332843|FG001|Overall Study|Adverse Event|16|||
105636614|NCT01638000|364332842|FG000|Overall Study|Lack of Efficacy|5|||
105636615|NCT01638000|364332843|FG001|Overall Study|Lack of Efficacy|6|||
105636616|NCT01638000|364332842|FG000|Overall Study|Protocol Violation|11|||
105636617|NCT01638000|364332843|FG001|Overall Study|Protocol Violation|13|||
105636618|NCT01638000|364332842|FG000|Overall Study|Withdrawal by Subject|21|||
105636619|NCT01638000|364332843|FG001|Overall Study|Withdrawal by Subject|24|||
105636620|NCT01638000|364332842|FG000|Overall Study|Miscellaneous|2|||
105636621|NCT01638000|364332843|FG001|Overall Study|Miscellaneous|2|||
105636622|NCT04541589|364332844|FG000|Treatment Period|Adverse Event|8|||
105636623|NCT04541589|364332845|FG001|Treatment Period|Adverse Event|2|||
105636624|NCT04541589|364332844|FG000|Treatment Period|Physician Decision|3|||
105636625|NCT04541589|364332845|FG001|Treatment Period|Physician Decision|1|||
105636626|NCT04541589|364332844|FG000|Treatment Period|Subject decision|7|||
105636627|NCT04541589|364332845|FG001|Treatment Period|Subject decision|4|||
105636628|NCT04541589|364332844|FG000|Treatment Period|Withdrawal by Subject|1|||
105636629|NCT04541589|364332845|FG001|Treatment Period|Withdrawal by Subject|0|||
105636630|NCT04541589|364332844|FG000|Safety Follow-up Period|Adverse Event|2|||
105636631|NCT04541589|364332845|FG001|Safety Follow-up Period|Adverse Event|1|||
105636632|NCT04541589|364332844|FG000|Safety Follow-up Period|Physician Decision|1|||
105636633|NCT04541589|364332845|FG001|Safety Follow-up Period|Physician Decision|0|||
105636634|NCT04541589|364332844|FG000|Safety Follow-up Period|Subject decision|5|||
105636635|NCT04541589|364332845|FG001|Safety Follow-up Period|Subject decision|3|||
105636636|NCT04541589|364332844|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
105636637|NCT04541589|364332845|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
105636638|NCT03890289|364332846|FG000|Overall Study|Adverse Event|1|||
105636639|NCT03890289|364332846|FG000|Overall Study|Physician Decision|1|||
105636640|NCT03890289|364332846|FG000|Overall Study|Lack of Efficacy|2|||
105636641|NCT03362190|364332847|FG000|Overall Study|Adverse Event|0|||
105636642|NCT03362190|364332848|FG001|Overall Study|Adverse Event|0|||
105636643|NCT03362190|364332849|FG002|Overall Study|Adverse Event|0|||
105636644|NCT03362190|364332850|FG003|Overall Study|Adverse Event|1|||
105636645|NCT03362190|364332847|FG000|Overall Study|Withdrawal by Subject|0|||
105636646|NCT03362190|364332848|FG001|Overall Study|Withdrawal by Subject|0|||
105636647|NCT03362190|364332849|FG002|Overall Study|Withdrawal by Subject|0|||
105636648|NCT03362190|364332850|FG003|Overall Study|Withdrawal by Subject|1|||
105636649|NCT03775486|364332851|FG000|Initial Therapy Phase|Other reason provided|0|||
105636650|NCT03775486|364332852|FG001|Initial Therapy Phase|Other reason provided|15|||
105636651|NCT03775486|364332851|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
105636652|NCT03775486|364332852|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
105636653|NCT03775486|364332851|FG000|Initial Therapy Phase|Protocol Violation|0|||
105636654|NCT03775486|364332852|FG001|Initial Therapy Phase|Protocol Violation|2|||
105636655|NCT03775486|364332851|FG000|Initial Therapy Phase|Adverse Event|0|||
105636656|NCT03775486|364332852|FG001|Initial Therapy Phase|Adverse Event|34|||
105636657|NCT03775486|364332851|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
105636658|NCT03775486|364332852|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
105636659|NCT03775486|364332851|FG000|Maintenance Phase|Withdrawal by Subject|13|||
105636660|NCT03775486|364332852|FG001|Maintenance Phase|Withdrawal by Subject|12|||
105636661|NCT03775486|364332851|FG000|Maintenance Phase|Death|44|||
105636662|NCT03775486|364332852|FG001|Maintenance Phase|Death|45|||
105636663|NCT00989196|364332853|FG000|Treatment Period|Lost to Follow-up|1|||
105636664|NCT00989196|364332854|FG001|Treatment Period|Lost to Follow-up|0|||
105636665|NCT01000805|364332855|FG000|Overall Study|Adverse Event|21|||
105636666|NCT01000805|364332856|FG001|Overall Study|Adverse Event|9|||
105636667|NCT01000805|364332855|FG000|Overall Study|Lack of Efficacy|5|||
105636668|NCT01000805|364332856|FG001|Overall Study|Lack of Efficacy|16|||
105636669|NCT01000805|364332855|FG000|Overall Study|Lost to Follow-up|16|||
105636670|NCT01000805|364332856|FG001|Overall Study|Lost to Follow-up|21|||
105636671|NCT01000805|364332855|FG000|Overall Study|Physician Decision|0|||
105636672|NCT01000805|364332856|FG001|Overall Study|Physician Decision|1|||
105636673|NCT01000805|364332855|FG000|Overall Study|Protocol Violation|12|||
105636674|NCT01000805|364332856|FG001|Overall Study|Protocol Violation|8|||
105636675|NCT01000805|364332855|FG000|Overall Study|Withdrawal by Subject|16|||
105636676|NCT01000805|364332856|FG001|Overall Study|Withdrawal by Subject|6|||
105636677|NCT01000805|364332855|FG000|Overall Study|Sponsor Decision|0|||
105636678|NCT01000805|364332856|FG001|Overall Study|Sponsor Decision|1|||
105636679|NCT02542943|364332860|FG000|Overall Study|Lost to Follow-up|1|||
105636680|NCT02542943|364332861|FG001|Overall Study|Lost to Follow-up|0|||
105636681|NCT02542943|364332862|FG002|Overall Study|Lost to Follow-up|0|||
105636682|NCT02542943|364332860|FG000|Overall Study|Withdrawal by Subject|0|||
105636683|NCT02542943|364332861|FG001|Overall Study|Withdrawal by Subject|1|||
105636684|NCT02542943|364332862|FG002|Overall Study|Withdrawal by Subject|0|||
105636685|NCT03598907|364332865|FG000|Overall Study|Physician Decision|14|||
105636686|NCT03598907|364332866|FG001|Overall Study|Physician Decision|19|||
105636687|NCT02485925|364332869|FG000|Overall Study|Withdrawal by Subject|3|||
105636688|NCT02485925|364332869|FG000|Overall Study|Death|1|||
105636689|NCT02485925|364332869|FG000|Overall Study|Lost to Follow-up|11|||
105636690|NCT04001829|364334224|FG000|Overall Study|Never start protocol therapy|5|||
105636691|NCT04001829|364334225|FG001|Overall Study|Never start protocol therapy|5|||
105636692|NCT04001829|364334224|FG000|Overall Study|Adverse Event|11|||
105636693|NCT04001829|364334225|FG001|Overall Study|Adverse Event|7|||
105636694|NCT04001829|364334224|FG000|Overall Study|Alternative therapy|1|||
105636695|NCT04001829|364334225|FG001|Overall Study|Alternative therapy|2|||
105636696|NCT04001829|364334224|FG000|Overall Study|Disease progression/relapse|2|||
105636697|NCT04001829|364334225|FG001|Overall Study|Disease progression/relapse|1|||
105636698|NCT04001829|364334224|FG000|Overall Study|Other complicating disease|1|||
105636699|NCT04001829|364334225|FG001|Overall Study|Other complicating disease|0|||
105636700|NCT04001829|364334224|FG000|Overall Study|Withdrawal by Subject|1|||
105636701|NCT04001829|364334225|FG001|Overall Study|Withdrawal by Subject|4|||
105636702|NCT04001829|364334224|FG000|Overall Study|Ineligible|2|||
105636703|NCT04001829|364334225|FG001|Overall Study|Ineligible|2|||
105636704|NCT04001829|364334224|FG000|Overall Study|Reason missing due to delinquent data|1|||
105636705|NCT04001829|364334225|FG001|Overall Study|Reason missing due to delinquent data|0|||
105636706|NCT01278030|364334226|FG000|Overall Study|Withdrawal by Subject|8|||
105636707|NCT01278030|364334227|FG001|Overall Study|Withdrawal by Subject|4|||
105636708|NCT01737398|364334228|FG000|Overall Study|Adverse event or SAE|16|||
105636709|NCT01737398|364334229|FG001|Overall Study|Adverse event or SAE|1|||
105636710|NCT01737398|364334228|FG000|Overall Study|Stopping rule met|2|||
105636711|NCT01737398|364334229|FG001|Overall Study|Stopping rule met|1|||
105636712|NCT01737398|364334228|FG000|Overall Study|Voluntary withdrawal|2|||
105636713|NCT01737398|364334229|FG001|Overall Study|Voluntary withdrawal|3|||
105636714|NCT01737398|364334228|FG000|Overall Study|Ineligibility|1|||
105636715|NCT01737398|364334229|FG001|Overall Study|Ineligibility|0|||
105636716|NCT01737398|364334228|FG000|Overall Study|Liver transplant|1|||
105636717|NCT01737398|364334229|FG001|Overall Study|Liver transplant|0|||
105636718|NCT01737398|364334228|FG000|Overall Study|Disease progression|2|||
105636719|NCT01737398|364334229|FG001|Overall Study|Disease progression|3|||
105636720|NCT01737398|364334228|FG000|Overall Study|Sponsor's decision|2|||
105636721|NCT01737398|364334229|FG001|Overall Study|Sponsor's decision|0|||
105636722|NCT03437733|364334230|FG000|Overall Study|Eligibility criteria not met|0|||
105636723|NCT03437733|364334231|FG001|Overall Study|Eligibility criteria not met|3|||
105636724|NCT04921358|364334232|FG000|Overall Study|Withdrawal by Subject|6|||
105636725|NCT04921358|364334233|FG001|Overall Study|Withdrawal by Subject|13|||
105636726|NCT04921358|364334232|FG000|Overall Study|Lost to Follow-up|3|||
105636727|NCT04921358|364334233|FG001|Overall Study|Lost to Follow-up|6|||
105636728|NCT04921358|364334232|FG000|Overall Study|Study Terminated by Sponsor|86|||
105636729|NCT04921358|364334233|FG001|Overall Study|Study Terminated by Sponsor|89|||
105636730|NCT04921358|364334232|FG000|Overall Study|Death|92|||
105636731|NCT04921358|364334233|FG001|Overall Study|Death|82|||
105636732|NCT02698475|364334234|FG000|Main Study Period|Lack of Efficacy|1|||
105636733|NCT02698475|364334234|FG000|Main Study Period|Protocol Violation|2|||
105636734|NCT02698475|364334234|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
105636735|NCT02698475|364334234|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
105636736|NCT02698475|364334234|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
105636737|NCT02698475|364334234|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
105636738|NCT02698475|364334234|FG000|Long-Term Extension Period|Other|1|||
105636739|NCT01555138|364334235|FG000|Overall Study|Death|0|||
105636740|NCT01555138|364334236|FG001|Overall Study|Death|1|||
105636741|NCT01555138|364334235|FG000|Overall Study|Lost to Follow-up|1|||
105636742|NCT01555138|364334236|FG001|Overall Study|Lost to Follow-up|0|||
105636743|NCT01555138|364334235|FG000|Overall Study|Abnormal Lab reults|1|||
105636744|NCT01555138|364334236|FG001|Overall Study|Abnormal Lab reults|3|||
105636745|NCT01555138|364334235|FG000|Overall Study|Lack of Efficacy|2|||
105636746|NCT01555138|364334236|FG001|Overall Study|Lack of Efficacy|2|||
105636747|NCT01555138|364334235|FG000|Overall Study|Protocol Violation|5|||
105636748|NCT01555138|364334236|FG001|Overall Study|Protocol Violation|3|||
105636749|NCT01555138|364334235|FG000|Overall Study|Administrative problems|8|||
105636750|NCT01555138|364334236|FG001|Overall Study|Administrative problems|0|||
105636751|NCT01555138|364334235|FG000|Overall Study|Withdrawal by Subject|16|||
105636752|NCT01555138|364334236|FG001|Overall Study|Withdrawal by Subject|15|||
105636753|NCT01555138|364334235|FG000|Overall Study|Adverse Event|14|||
105636754|NCT01555138|364334236|FG001|Overall Study|Adverse Event|14|||
105636755|NCT02357966|364334240|FG000|Overall Study|Death|0|||
105636756|NCT02357966|364334241|FG001|Overall Study|Death|0|||
105636757|NCT02357966|364334242|FG002|Overall Study|Death|1|||
105636758|NCT02357966|364334243|FG003|Overall Study|Death|0|||
105636759|NCT02357966|364334244|FG004|Overall Study|Death|2|||
105636760|NCT02357966|364334245|FG005|Overall Study|Death|0|||
105636761|NCT02357966|364334240|FG000|Overall Study|Physician Decision|1|||
105636762|NCT02357966|364334241|FG001|Overall Study|Physician Decision|0|||
105636763|NCT02357966|364334242|FG002|Overall Study|Physician Decision|0|||
105636764|NCT02357966|364334243|FG003|Overall Study|Physician Decision|0|||
105636765|NCT02357966|364334244|FG004|Overall Study|Physician Decision|1|||
105636766|NCT02357966|364334245|FG005|Overall Study|Physician Decision|0|||
105636767|NCT00705406|364334246|FG000|Overall Study|Lost to Follow-up|3|||
105636768|NCT00705406|364334247|FG001|Overall Study|Lost to Follow-up|3|||
105636769|NCT00705406|364334246|FG000|Overall Study|Did not receive study drug|1|||
105636770|NCT00705406|364334247|FG001|Overall Study|Did not receive study drug|2|||
105636771|NCT01079806|364334248|FG000|Day 1 to Week 96|Adverse Event|0|||
105636772|NCT01079806|364334249|FG001|Day 1 to Week 96|Adverse Event|3|||
105636773|NCT01079806|364334248|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
105636774|NCT01079806|364334249|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
105636775|NCT01079806|364334248|FG000|Day 1 to Week 96|Pregnancy|0|||
105636776|NCT01079806|364334249|FG001|Day 1 to Week 96|Pregnancy|1|||
105636777|NCT01079806|364334248|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
105636778|NCT01079806|364334249|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
105636779|NCT01079806|364334248|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
105636780|NCT01079806|364334249|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
105636781|NCT01079806|364334248|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
105636782|NCT01079806|364334249|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
105636783|NCT01079806|364334248|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
105636784|NCT01079806|364334249|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
105636785|NCT01079806|364334248|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
105636786|NCT01079806|364334249|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
105636787|NCT01079806|364334248|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
105636788|NCT01079806|364334249|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
105636789|NCT01079806|364334248|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
105636790|NCT01079806|364334249|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
105636791|NCT00019604|364334250|FG000|Overall Study|Death|1|||
105636792|NCT00019604|364334250|FG000|Overall Study|Progressive disease|23|||
105636793|NCT00019604|364334250|FG000|Overall Study|Refused treatment|1|||
105636794|NCT00019604|364334250|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
105636795|NCT00019604|364334250|FG000|Overall Study|Going to have liver transplant|1|||
105636796|NCT00019604|364334250|FG000|Overall Study|Move to a different study|1|||
105636797|NCT00019604|364334250|FG000|Overall Study|Non compliant on systemic CH|1|||
105636798|NCT00019604|364334250|FG000|Overall Study|Non compliant|1|||
105636799|NCT00019604|364334250|FG000|Overall Study|Resectable disease|1|||
105636800|NCT00019604|364334250|FG000|Overall Study|Started new chemo regimen|1|||
105636801|NCT00019604|364334250|FG000|Overall Study|Pt going to immunotherapy study|1|||
105636802|NCT00019604|364334250|FG000|Overall Study|Too much disease|1|||
105636803|NCT00019604|364334250|FG000|Overall Study|Unable to evaluate|1|||
105636804|NCT00019604|364334250|FG000|Overall Study|Details for other not available|4|||
105636805|NCT03205566|364334258|FG000|Phase 1|Protocol Violation|1|||
105636806|NCT03205566|364334259|FG001|Phase 1|Protocol Violation|1|||
105636807|NCT03739866|364334260|FG000|Overall Study|Lost to Follow-up|0|||
105636808|NCT03739866|364334261|FG001|Overall Study|Lost to Follow-up|0|||
105636809|NCT03739866|364334262|FG002|Overall Study|Lost to Follow-up|0|||
105636810|NCT03739866|364334263|FG003|Overall Study|Lost to Follow-up|1|||
105636811|NCT03739866|364334264|FG004|Overall Study|Lost to Follow-up|0|||
105636812|NCT03739866|364334265|FG005|Overall Study|Lost to Follow-up|0|||
105636813|NCT03739866|364334266|FG006|Overall Study|Lost to Follow-up|0|||
105636814|NCT03739866|364334267|FG007|Overall Study|Lost to Follow-up|0|||
105636815|NCT03739866|364334260|FG000|Overall Study|Enrolled but not treated|0|||
105636816|NCT03739866|364334261|FG001|Overall Study|Enrolled but not treated|0|||
105636817|NCT03739866|364334262|FG002|Overall Study|Enrolled but not treated|1|||
105636818|NCT03739866|364334263|FG003|Overall Study|Enrolled but not treated|0|||
105636819|NCT03739866|364334264|FG004|Overall Study|Enrolled but not treated|1|||
105636820|NCT03739866|364334265|FG005|Overall Study|Enrolled but not treated|0|||
105636821|NCT03739866|364334266|FG006|Overall Study|Enrolled but not treated|0|||
105636822|NCT03739866|364334267|FG007|Overall Study|Enrolled but not treated|0|||
105636823|NCT00853580|364334268|FG000|Overall Study|Lost to Follow-up|3|||
105636824|NCT00853580|364334269|FG001|Overall Study|Lost to Follow-up|5|||
105636825|NCT00853580|364334268|FG000|Overall Study|Protocol Violation|2|||
105636826|NCT00853580|364334269|FG001|Overall Study|Protocol Violation|1|||
105636827|NCT00853580|364334268|FG000|Overall Study|Withdrawal by Subject|2|||
105636828|NCT00853580|364334269|FG001|Overall Study|Withdrawal by Subject|8|||
105636829|NCT00853580|364334268|FG000|Overall Study|Commenced contraindicated therapy|0|||
105636830|NCT00853580|364334269|FG001|Overall Study|Commenced contraindicated therapy|2|||
105636831|NCT01034306|364334270|FG000|Overall Study|Adverse Event|1|||
105636832|NCT01034306|364334271|FG001|Overall Study|Adverse Event|0|||
105636833|NCT01034306|364334270|FG000|Overall Study|Lost to Follow-up|0|||
105636834|NCT01034306|364334271|FG001|Overall Study|Lost to Follow-up|1|||
105636835|NCT01034306|364334270|FG000|Overall Study|Withdrawal by Subject|2|||
105636836|NCT01034306|364334271|FG001|Overall Study|Withdrawal by Subject|2|||
105636837|NCT01034306|364334270|FG000|Overall Study|hospitalized and decided to stop|1|||
105636838|NCT01034306|364334271|FG001|Overall Study|hospitalized and decided to stop|0|||
105636839|NCT01034306|364334270|FG000|Overall Study|Noncomplience|1|||
105636840|NCT01034306|364334271|FG001|Overall Study|Noncomplience|0|||
105636841|NCT02040870|364334276|FG000|Overall Study|Completed treatment phase|6|||
105636842|NCT02040870|364334276|FG000|Overall Study|Adverse Event|7|||
105636843|NCT02040870|364334276|FG000|Overall Study|Progressive disease|58|||
105636844|NCT02040870|364334276|FG000|Overall Study|Physician Decision|6|||
105636845|NCT02040870|364334276|FG000|Overall Study|Subject/guardian decision|10|||
105636846|NCT02040870|364334276|FG000|Overall Study|Lost to Follow-up|3|||
105636847|NCT02040870|364334276|FG000|Overall Study|Death|13|||
105636848|NCT01957163|364334286|FG000|Overall Study|Adverse Event|5|||
105636849|NCT01957163|364334287|FG001|Overall Study|Adverse Event|2|||
105636850|NCT01957163|364334288|FG002|Overall Study|Adverse Event|4|||
105636851|NCT01957163|364334286|FG000|Overall Study|Lack of Efficacy|5|||
105636852|NCT01957163|364334287|FG001|Overall Study|Lack of Efficacy|4|||
105636853|NCT01957163|364334288|FG002|Overall Study|Lack of Efficacy|9|||
105636854|NCT01957163|364334286|FG000|Overall Study|Protocol Violation|1|||
105636855|NCT01957163|364334287|FG001|Overall Study|Protocol Violation|2|||
105636856|NCT01957163|364334288|FG002|Overall Study|Protocol Violation|0|||
105636857|NCT01957163|364334286|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
105636858|NCT01957163|364334287|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
105636859|NCT01957163|364334288|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
105636860|NCT01957163|364334286|FG000|Overall Study|Lost to Follow-up|0|||
105636861|NCT01957163|364334287|FG001|Overall Study|Lost to Follow-up|1|||
105636862|NCT01957163|364334288|FG002|Overall Study|Lost to Follow-up|0|||
105636863|NCT01957163|364334286|FG000|Overall Study|Withdrawal by Subject|4|||
105636864|NCT01957163|364334287|FG001|Overall Study|Withdrawal by Subject|2|||
105636865|NCT01957163|364334288|FG002|Overall Study|Withdrawal by Subject|4|||
105636866|NCT03582475|364334291|FG000|Treatment Period|Withdrawal by Subject|0|||
105636867|NCT03582475|364334292|FG001|Treatment Period|Withdrawal by Subject|1|||
105636868|NCT03582475|364334291|FG000|Follow-up Period|Withdrawal by Subject|0|||
105636869|NCT03582475|364334292|FG001|Follow-up Period|Withdrawal by Subject|1|||
105636870|NCT02686658|364334293|FG000|Overall Study|Adverse Event|0|||
105636871|NCT02686658|364334294|FG001|Overall Study|Adverse Event|0|||
105636872|NCT02686658|364334295|FG002|Overall Study|Adverse Event|1|||
105636873|NCT02686658|364334296|FG003|Overall Study|Adverse Event|1|||
105636874|NCT02686658|364334297|FG004|Overall Study|Adverse Event|2|||
105636875|NCT02686658|364334298|FG005|Overall Study|Adverse Event|1|||
105636876|NCT02686658|364334293|FG000|Overall Study|Investigator decision|0|||
105636877|NCT02686658|364334294|FG001|Overall Study|Investigator decision|0|||
105636878|NCT02686658|364334295|FG002|Overall Study|Investigator decision|0|||
105636879|NCT02686658|364334296|FG003|Overall Study|Investigator decision|1|||
105636880|NCT02686658|364334297|FG004|Overall Study|Investigator decision|2|||
105636881|NCT02686658|364334298|FG005|Overall Study|Investigator decision|1|||
105636882|NCT02686658|364334293|FG000|Overall Study|Sponsor decision|1|||
105636883|NCT02686658|364334294|FG001|Overall Study|Sponsor decision|2|||
105636884|NCT02686658|364334295|FG002|Overall Study|Sponsor decision|1|||
105636885|NCT02686658|364334296|FG003|Overall Study|Sponsor decision|5|||
105636886|NCT02686658|364334297|FG004|Overall Study|Sponsor decision|13|||
105636887|NCT02686658|364334298|FG005|Overall Study|Sponsor decision|2|||
105636888|NCT02686658|364334293|FG000|Overall Study|Lost to Follow-up|0|||
105636889|NCT02686658|364334294|FG001|Overall Study|Lost to Follow-up|0|||
105636890|NCT02686658|364334295|FG002|Overall Study|Lost to Follow-up|2|||
105636891|NCT02686658|364334296|FG003|Overall Study|Lost to Follow-up|0|||
105636892|NCT02686658|364334297|FG004|Overall Study|Lost to Follow-up|0|||
105636893|NCT02686658|364334298|FG005|Overall Study|Lost to Follow-up|1|||
105636894|NCT02686658|364334293|FG000|Overall Study|Death|1|||
105636895|NCT02686658|364334294|FG001|Overall Study|Death|0|||
105636896|NCT02686658|364334295|FG002|Overall Study|Death|0|||
105636897|NCT02686658|364334296|FG003|Overall Study|Death|1|||
105636898|NCT02686658|364334297|FG004|Overall Study|Death|1|||
105636899|NCT02686658|364334298|FG005|Overall Study|Death|1|||
105636900|NCT02686658|364334293|FG000|Overall Study|Withdrawal by Subject|2|||
105869922|NCT02288325|365176853|FG002|Run-in Period|Reason not Specified|0|||
105869923|NCT02288325|365176851|FG000|Stabilization Period|Adverse Event|13|||
105636901|NCT02686658|364334294|FG001|Overall Study|Withdrawal by Subject|5|||
105636902|NCT02686658|364334295|FG002|Overall Study|Withdrawal by Subject|4|||
105636903|NCT02686658|364334296|FG003|Overall Study|Withdrawal by Subject|4|||
105636904|NCT02686658|364334297|FG004|Overall Study|Withdrawal by Subject|17|||
105636905|NCT02686658|364334298|FG005|Overall Study|Withdrawal by Subject|8|||
105636906|NCT02686658|364334293|FG000|Overall Study|Placed in hospice care|0|||
105636907|NCT02686658|364334294|FG001|Overall Study|Placed in hospice care|0|||
105636908|NCT02686658|364334295|FG002|Overall Study|Placed in hospice care|1|||
105636909|NCT02686658|364334296|FG003|Overall Study|Placed in hospice care|0|||
105636910|NCT02686658|364334297|FG004|Overall Study|Placed in hospice care|0|||
105636911|NCT02686658|364334298|FG005|Overall Study|Placed in hospice care|0|||
105869924|NCT02288325|365176852|FG001|Stabilization Period|Adverse Event|0|||
105636912|NCT02686658|364334293|FG000|Overall Study|Participant non-compliance|0|||
105636913|NCT02686658|364334294|FG001|Overall Study|Participant non-compliance|0|||
105636914|NCT02686658|364334295|FG002|Overall Study|Participant non-compliance|0|||
105636915|NCT02686658|364334296|FG003|Overall Study|Participant non-compliance|0|||
105636916|NCT02686658|364334297|FG004|Overall Study|Participant non-compliance|0|||
105636917|NCT02686658|364334298|FG005|Overall Study|Participant non-compliance|1|||
105636918|NCT02686658|364334293|FG000|Overall Study|Concern over coronavirus disease care|0|||
105636919|NCT02686658|364334294|FG001|Overall Study|Concern over coronavirus disease care|0|||
105636920|NCT02686658|364334295|FG002|Overall Study|Concern over coronavirus disease care|0|||
105636921|NCT02686658|364334296|FG003|Overall Study|Concern over coronavirus disease care|0|||
105636922|NCT02686658|364334297|FG004|Overall Study|Concern over coronavirus disease care|2|||
105636923|NCT02686658|364334298|FG005|Overall Study|Concern over coronavirus disease care|1|||
105636924|NCT02628626|364334299|FG000|Overall Study|Withdrawal by Subject|2|||
105636925|NCT02628626|364334300|FG001|Overall Study|Withdrawal by Subject|2|||
105636926|NCT00614614|364334301|FG000|Primary Vaccination Phase|Adverse Event|6|||
105636927|NCT00614614|364334302|FG001|Primary Vaccination Phase|Adverse Event|0|||
105636928|NCT00614614|364334303|FG002|Primary Vaccination Phase|Adverse Event|0|||
105636929|NCT00614614|364334304|FG003|Primary Vaccination Phase|Adverse Event|0|||
105636930|NCT00614614|364334305|FG004|Primary Vaccination Phase|Adverse Event|0|||
105636931|NCT00614614|364334301|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
105636932|NCT00614614|364334302|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
105636933|NCT00614614|364334303|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
105636934|NCT00614614|364334304|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
105636935|NCT00614614|364334305|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
105636936|NCT00614614|364334301|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
105636937|NCT00614614|364334302|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
105636938|NCT00614614|364334303|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
105636939|NCT00614614|364334304|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
105636940|NCT00614614|364334305|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
105636941|NCT00614614|364334301|FG000|Primary Vaccination Phase|Protocol Violation|9|||
105636942|NCT00614614|364334302|FG001|Primary Vaccination Phase|Protocol Violation|3|||
105636943|NCT00614614|364334303|FG002|Primary Vaccination Phase|Protocol Violation|0|||
105636944|NCT00614614|364334304|FG003|Primary Vaccination Phase|Protocol Violation|0|||
105636945|NCT00614614|364334305|FG004|Primary Vaccination Phase|Protocol Violation|0|||
105636946|NCT00614614|364334301|FG000|Primary Vaccination Phase|Other|4|||
105636947|NCT00614614|364334302|FG001|Primary Vaccination Phase|Other|0|||
105636948|NCT00614614|364334303|FG002|Primary Vaccination Phase|Other|0|||
105636949|NCT00614614|364334304|FG003|Primary Vaccination Phase|Other|0|||
105636950|NCT00614614|364334305|FG004|Primary Vaccination Phase|Other|0|||
105636951|NCT00614614|364334301|FG000|Booster Vaccination Phase|Adverse Event|0|||
105636952|NCT00614614|364334302|FG001|Booster Vaccination Phase|Adverse Event|0|||
105636953|NCT00614614|364334303|FG002|Booster Vaccination Phase|Adverse Event|1|||
105636954|NCT00614614|364334304|FG003|Booster Vaccination Phase|Adverse Event|1|||
105636955|NCT00614614|364334305|FG004|Booster Vaccination Phase|Adverse Event|0|||
105636956|NCT00614614|364334301|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
105636957|NCT00614614|364334302|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
105636958|NCT00614614|364334303|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
105636959|NCT00614614|364334304|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
105636960|NCT00614614|364334305|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
105636961|NCT00614614|364334301|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
105636962|NCT00614614|364334302|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
105636963|NCT00614614|364334303|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
105636964|NCT00614614|364334304|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
105636965|NCT00614614|364334305|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
105636966|NCT00614614|364334301|FG000|Booster Vaccination Phase|Protocol Violation|0|||
105636967|NCT00614614|364334302|FG001|Booster Vaccination Phase|Protocol Violation|0|||
105636968|NCT00614614|364334303|FG002|Booster Vaccination Phase|Protocol Violation|2|||
105636969|NCT00614614|364334304|FG003|Booster Vaccination Phase|Protocol Violation|3|||
105636970|NCT00614614|364334305|FG004|Booster Vaccination Phase|Protocol Violation|0|||
105636971|NCT00614614|364334301|FG000|Booster Vaccination Phase|Other|0|||
105636972|NCT00614614|364334302|FG001|Booster Vaccination Phase|Other|1|||
105636973|NCT00614614|364334303|FG002|Booster Vaccination Phase|Other|3|||
105636974|NCT00614614|364334304|FG003|Booster Vaccination Phase|Other|2|||
105636975|NCT00614614|364334305|FG004|Booster Vaccination Phase|Other|1|||
105636976|NCT00145470|364334306|FG000|Overall Study|Adverse Event|19|||
105636977|NCT00145470|364334307|FG001|Overall Study|Adverse Event|25|||
105636978|NCT00145470|364334306|FG000|Overall Study|Lack of Efficacy|27|||
105636979|NCT00145470|364334307|FG001|Overall Study|Lack of Efficacy|13|||
105636980|NCT00145470|364334306|FG000|Overall Study|Withdrawal by Subject|36|||
105636981|NCT00145470|364334307|FG001|Overall Study|Withdrawal by Subject|34|||
105636982|NCT00145470|364334306|FG000|Overall Study|Lost to Follow-up|21|||
105636983|NCT00145470|364334307|FG001|Overall Study|Lost to Follow-up|17|||
105636984|NCT00145470|364334306|FG000|Overall Study|Reason Not Reported|9|||
105636985|NCT00145470|364334307|FG001|Overall Study|Reason Not Reported|9|||
105636986|NCT00933270|364334308|FG000|Overall Study|Withdrawal by Subject|26|||
105636987|NCT00933270|364334308|FG000|Overall Study|Insufficient Follow-up|10|||
105636988|NCT00933270|364334308|FG000|Overall Study|Lost to Follow-up|14|||
105636989|NCT00933270|364334308|FG000|Overall Study|Adverse Event|1|||
105636990|NCT00933270|364334308|FG000|Overall Study|Missed Visit|2|||
105636991|NCT00933270|364334308|FG000|Overall Study|Death|24|||
105636992|NCT00933270|364334308|FG000|Overall Study|Moved or would not return|10|||
105636993|NCT03476798|364334310|FG000|Overall Study|Death|1|||
105636994|NCT03476798|364334310|FG000|Overall Study|Withdrawal by Subject|2|||
105636995|NCT03476798|364334310|FG000|Overall Study|Protocol Violation|2|||
105636996|NCT04602728|364334320|FG000|Overall Study|Lost to Follow-up|4|||
105636997|NCT04602728|364334321|FG001|Overall Study|Lost to Follow-up|4|||
105636998|NCT02831049|364334324|FG000|Overall Study|Lost to Follow-up|0|||
105636999|NCT02831049|364334325|FG001|Overall Study|Lost to Follow-up|0|||
105637000|NCT02831049|364334326|FG002|Overall Study|Lost to Follow-up|1|||
105637001|NCT02831049|364334324|FG000|Overall Study|Withdrawal by Subject|0|||
105637002|NCT02831049|364334325|FG001|Overall Study|Withdrawal by Subject|1|||
105637003|NCT02831049|364334326|FG002|Overall Study|Withdrawal by Subject|1|||
105637004|NCT02831049|364334324|FG000|Overall Study|Pandemic shutdown|1|||
105637005|NCT02831049|364334325|FG001|Overall Study|Pandemic shutdown|0|||
105637006|NCT02831049|364334326|FG002|Overall Study|Pandemic shutdown|0|||
105637007|NCT00491894|364334327|FG000|Overall Study|Adverse Event|14|||
105637008|NCT00491894|364334327|FG000|Overall Study|Withdrawal by Subject|5|||
105637009|NCT00491894|364334327|FG000|Overall Study|Death|3|||
105637010|NCT00491894|364334327|FG000|Overall Study|Lost to Follow-up|3|||
105637011|NCT00491894|364334327|FG000|Overall Study|Lack of Efficacy|2|||
105637012|NCT00491894|364334327|FG000|Overall Study|Other-Failed to meet any criteria|2|||
105637013|NCT00491894|364334327|FG000|Overall Study|Physician Decision|2|||
105637014|NCT00491894|364334327|FG000|Overall Study|Protocol Violation|2|||
105637015|NCT00491894|364334327|FG000|Overall Study|Other-Intake of prohibited medication|1|||
105637016|NCT03009344|364335627|FG000|Overall Study|Lack of Efficacy|5|||
105637017|NCT03009344|364335627|FG000|Overall Study|Withdrawal by Subject|1|||
105637018|NCT03009344|364335627|FG000|Overall Study|Adverse Event|1|||
105637019|NCT00925548|364335628|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
105637020|NCT00925548|364335629|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
105637021|NCT00667017|364335630|FG000|Overall Study|Withdrawal by Subject|1|||
105637022|NCT02148705|364335631|FG000|Overall Study|Death|2|||
105637023|NCT02148705|364335632|FG001|Overall Study|Death|0|||
105637024|NCT02148705|364335633|FG002|Overall Study|Death|0|||
105637025|NCT02148705|364335631|FG000|Overall Study|Lost to Follow-up|13|||
105637026|NCT02148705|364335632|FG001|Overall Study|Lost to Follow-up|4|||
105637027|NCT02148705|364335633|FG002|Overall Study|Lost to Follow-up|10|||
105637028|NCT02148705|364335631|FG000|Overall Study|Withdrawal by Subject|3|||
105637029|NCT02148705|364335632|FG001|Overall Study|Withdrawal by Subject|0|||
105637030|NCT02148705|364335633|FG002|Overall Study|Withdrawal by Subject|2|||
105637031|NCT02148705|364335631|FG000|Overall Study|Not Treated|0|||
105637032|NCT02148705|364335632|FG001|Overall Study|Not Treated|1|||
105637033|NCT02148705|364335633|FG002|Overall Study|Not Treated|5|||
105637034|NCT00345046|364335634|FG000|Overall Study|Protocol Violation|1|||
105637035|NCT00345046|364335635|FG001|Overall Study|Protocol Violation|1|||
105637036|NCT00345046|364335636|FG002|Overall Study|Protocol Violation|2|||
105637037|NCT03689946|364335637|FG000|Overall Study|Withdrawal by Subject|3|||
105637038|NCT03689946|364335637|FG000|Overall Study|Lost to Follow-up|3|||
105637039|NCT03689946|364335637|FG000|Overall Study|Data corruption|2|||
105637040|NCT01613417|364335638|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
105637041|NCT01613417|364335639|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
105637042|NCT04608409|364335640|FG000|Overall Study|Physician Decision|1|||
105637043|NCT04608409|364335641|FG001|Overall Study|Physician Decision|1|||
105637044|NCT04608409|364335642|FG002|Overall Study|Physician Decision|2|||
105637045|NCT04497415|364335649|FG000|Overall Study|Lost to Follow-up|43|||
105637046|NCT04497415|364335650|FG001|Overall Study|Lost to Follow-up|27|||
105637047|NCT02827201|364335651|FG000|Overall Study|Death|1|||
105637048|NCT02827201|364335652|FG001|Overall Study|Death|2|||
105637049|NCT02827201|364335651|FG000|Overall Study|Patients not treated|1|||
105637050|NCT02827201|364335652|FG001|Overall Study|Patients not treated|1|||
105637051|NCT04237792|364335654|FG000|Treatment (Day 1)|Adverse Event|1|||
105637052|NCT04237792|364335655|FG001|Treatment (Day 1)|Adverse Event|0|||
105637053|NCT04237792|364335656|FG002|Treatment (Day 1)|Adverse Event|0|||
105637054|NCT04237792|364335657|FG003|Treatment (Day 1)|Adverse Event|0|||
105637055|NCT04237792|364335658|FG004|Treatment (Day 1)|Adverse Event|1|||
105637056|NCT04237792|364335659|FG005|Treatment (Day 1)|Adverse Event|1|||
105869925|NCT02288325|365176853|FG002|Stabilization Period|Adverse Event|0|||
105637057|NCT04237792|364335654|FG000|Treatment (Day 1)|Other|0|||
105637058|NCT04237792|364335655|FG001|Treatment (Day 1)|Other|0|||
105637059|NCT04237792|364335656|FG002|Treatment (Day 1)|Other|1|||
105637060|NCT04237792|364335657|FG003|Treatment (Day 1)|Other|0|||
105637061|NCT04237792|364335658|FG004|Treatment (Day 1)|Other|0|||
105637062|NCT04237792|364335659|FG005|Treatment (Day 1)|Other|1|||
105869926|NCT02288325|365176851|FG000|Stabilization Period|Lack of Efficacy|22|||
105637063|NCT04237792|364335654|FG000|Treatment (Day 1)|Not treated|1|||
105637064|NCT04237792|364335655|FG001|Treatment (Day 1)|Not treated|1|||
105637065|NCT04237792|364335656|FG002|Treatment (Day 1)|Not treated|2|||
105637066|NCT04237792|364335657|FG003|Treatment (Day 1)|Not treated|1|||
105637067|NCT04237792|364335658|FG004|Treatment (Day 1)|Not treated|0|||
105637068|NCT04237792|364335659|FG005|Treatment (Day 1)|Not treated|1|||
105637069|NCT04693637|364335660|FG000|Overall Study|Death|4|||
105637070|NCT04693637|364335660|FG000|Overall Study|Withdrawal by Subject|3|||
105637071|NCT04693637|364335660|FG000|Overall Study|Physician Decision|2|||
105637072|NCT04693637|364335660|FG000|Overall Study|Lost to Follow-up|1|||
105637073|NCT02085941|364335661|FG000|Overall Study|Lack of Efficacy|1|||
105637074|NCT02085941|364335662|FG001|Overall Study|Lack of Efficacy|0|||
105637075|NCT02085941|364335661|FG000|Overall Study|Death|6|||
105637076|NCT02085941|364335662|FG001|Overall Study|Death|1|||
105637077|NCT02085941|364335661|FG000|Overall Study|Lost to Follow-up|1|||
105637078|NCT02085941|364335662|FG001|Overall Study|Lost to Follow-up|0|||
105637079|NCT02085941|364335661|FG000|Overall Study|Physician Decision|0|||
105637080|NCT02085941|364335662|FG001|Overall Study|Physician Decision|2|||
105637081|NCT04652726|364335666|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
105637082|NCT04652726|364335667|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
105637083|NCT04652726|364335668|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
105637084|NCT04652726|364335666|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
105637085|NCT04652726|364335667|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
105637086|NCT04652726|364335668|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
105637087|NCT02022657|364335669|FG000|Overall Study|Withdrawal by Subject|2|||
105637088|NCT02022657|364335670|FG001|Overall Study|Withdrawal by Subject|0|||
105637089|NCT02022657|364335671|FG002|Overall Study|Withdrawal by Subject|1|||
105637090|NCT02022657|364335672|FG003|Overall Study|Withdrawal by Subject|0|||
105637091|NCT02022657|364335673|FG004|Overall Study|Withdrawal by Subject|0|||
105637092|NCT02022657|364335674|FG005|Overall Study|Withdrawal by Subject|0|||
105637093|NCT02022657|364335669|FG000|Overall Study|Physician Decision|0|||
105637094|NCT02022657|364335670|FG001|Overall Study|Physician Decision|0|||
105637095|NCT02022657|364335671|FG002|Overall Study|Physician Decision|0|||
105637096|NCT02022657|364335672|FG003|Overall Study|Physician Decision|0|||
105637097|NCT02022657|364335673|FG004|Overall Study|Physician Decision|0|||
105637098|NCT02022657|364335674|FG005|Overall Study|Physician Decision|1|||
105637099|NCT03381274|364335675|FG000|Overall Study|Death|2|||
105637100|NCT03381274|364335676|FG001|Overall Study|Death|9|||
105637101|NCT03381274|364335677|FG002|Overall Study|Death|3|||
105637102|NCT03381274|364335678|FG003|Overall Study|Death|2|||
105637103|NCT03381274|364335679|FG004|Overall Study|Death|3|||
105637104|NCT03381274|364335675|FG000|Overall Study|Lost to Follow-up|0|||
105637105|NCT03381274|364335676|FG001|Overall Study|Lost to Follow-up|0|||
105637106|NCT03381274|364335677|FG002|Overall Study|Lost to Follow-up|0|||
105637107|NCT03381274|364335678|FG003|Overall Study|Lost to Follow-up|1|||
105637108|NCT03381274|364335679|FG004|Overall Study|Lost to Follow-up|0|||
105637109|NCT03381274|364335675|FG000|Overall Study|Withdrawal by Subject|2|||
105637110|NCT03381274|364335676|FG001|Overall Study|Withdrawal by Subject|1|||
105637111|NCT03381274|364335677|FG002|Overall Study|Withdrawal by Subject|3|||
105637112|NCT03381274|364335678|FG003|Overall Study|Withdrawal by Subject|1|||
105637113|NCT03381274|364335679|FG004|Overall Study|Withdrawal by Subject|0|||
105637114|NCT03381274|364335675|FG000|Overall Study|Other|1|||
105637115|NCT03381274|364335676|FG001|Overall Study|Other|11|||
105637116|NCT03381274|364335677|FG002|Overall Study|Other|0|||
105637117|NCT03381274|364335678|FG003|Overall Study|Other|2|||
105637118|NCT03381274|364335679|FG004|Overall Study|Other|2|||
105637119|NCT00836498|364335680|FG000|Overall Study|Adverse Event|1|||
105637120|NCT00836498|364335681|FG001|Overall Study|Adverse Event|0|||
105637121|NCT00836498|364335680|FG000|Overall Study|Lost to Follow-up|1|||
105637122|NCT00836498|364335681|FG001|Overall Study|Lost to Follow-up|0|||
105637123|NCT00836498|364335680|FG000|Overall Study|Withdrawal by Subject|2|||
105637124|NCT00836498|364335681|FG001|Overall Study|Withdrawal by Subject|1|||
105637125|NCT01728324|364335682|FG000|Termination of DBV|Adverse Event|14|||
105637126|NCT01728324|364335683|FG001|Termination of DBV|Adverse Event|13|||
105637127|NCT01728324|364335684|FG002|Termination of DBV|Adverse Event|4|||
105637128|NCT01728324|364335682|FG000|Termination of DBV|Lack of Efficacy|14|||
105637129|NCT01728324|364335683|FG001|Termination of DBV|Lack of Efficacy|12|||
105637130|NCT01728324|364335684|FG002|Termination of DBV|Lack of Efficacy|8|||
105637131|NCT01728324|364335682|FG000|Termination of DBV|Withdrawal by Subject|9|||
105637132|NCT01728324|364335683|FG001|Termination of DBV|Withdrawal by Subject|6|||
105637133|NCT01728324|364335684|FG002|Termination of DBV|Withdrawal by Subject|2|||
105637134|NCT01728324|364335682|FG000|Termination of DBV|Other than stated|1|||
105637135|NCT01728324|364335683|FG001|Termination of DBV|Other than stated|3|||
105637136|NCT01728324|364335684|FG002|Termination of DBV|Other than stated|0|||
105637137|NCT01728324|364335682|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
105637138|NCT01728324|364335683|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
105637139|NCT01728324|364335684|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
105637140|NCT01728324|364335682|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
105637141|NCT01728324|364335683|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
105637142|NCT01728324|364335684|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
105637143|NCT01728324|364335682|FG000|Termination of FDV|Adverse Event|14|||
105637144|NCT01728324|364335683|FG001|Termination of FDV|Adverse Event|13|||
105637145|NCT01728324|364335684|FG002|Termination of FDV|Adverse Event|4|||
105637146|NCT01728324|364335682|FG000|Termination of FDV|Lack of Efficacy|14|||
105637147|NCT01728324|364335683|FG001|Termination of FDV|Lack of Efficacy|12|||
105637148|NCT01728324|364335684|FG002|Termination of FDV|Lack of Efficacy|8|||
105637149|NCT01728324|364335682|FG000|Termination of FDV|Withdrawal by Subject|9|||
105637150|NCT01728324|364335683|FG001|Termination of FDV|Withdrawal by Subject|6|||
105637151|NCT01728324|364335684|FG002|Termination of FDV|Withdrawal by Subject|2|||
105637152|NCT01728324|364335682|FG000|Termination of FDV|Other than stated|1|||
105637153|NCT01728324|364335683|FG001|Termination of FDV|Other than stated|3|||
105637154|NCT01728324|364335684|FG002|Termination of FDV|Other than stated|0|||
105637155|NCT01728324|364335682|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
105637156|NCT01728324|364335683|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
105637157|NCT01728324|364335684|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
105637158|NCT01728324|364335682|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
105637159|NCT01728324|364335683|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
105637160|NCT01728324|364335684|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
105637161|NCT01728324|364335682|FG000|Termination of RBV|Adverse Event|15|||
105637162|NCT01728324|364335683|FG001|Termination of RBV|Adverse Event|16|||
105637163|NCT01728324|364335684|FG002|Termination of RBV|Adverse Event|5|||
105637164|NCT01728324|364335682|FG000|Termination of RBV|Lack of Efficacy|14|||
105637165|NCT01728324|364335683|FG001|Termination of RBV|Lack of Efficacy|11|||
105637166|NCT01728324|364335684|FG002|Termination of RBV|Lack of Efficacy|7|||
105637167|NCT01728324|364335682|FG000|Termination of RBV|Withdrawal by Subject|9|||
105637168|NCT01728324|364335683|FG001|Termination of RBV|Withdrawal by Subject|5|||
105637169|NCT01728324|364335684|FG002|Termination of RBV|Withdrawal by Subject|2|||
105637170|NCT01728324|364335682|FG000|Termination of RBV|Other than stated|1|||
105637171|NCT01728324|364335683|FG001|Termination of RBV|Other than stated|3|||
105637172|NCT01728324|364335684|FG002|Termination of RBV|Other than stated|1|||
105637173|NCT01728324|364335682|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
105637174|NCT01728324|364335683|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
105637175|NCT01728324|364335684|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
105637176|NCT01728324|364335682|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
105637177|NCT01728324|364335683|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
105637178|NCT01728324|364335684|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
105637179|NCT01619059|364335685|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
105637180|NCT01619059|364335686|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
105637181|NCT01619059|364335685|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
105637182|NCT01619059|364335686|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
105637183|NCT01619059|364335685|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
105637184|NCT01619059|364335686|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
105637185|NCT01619059|364335685|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
105637186|NCT01619059|364335686|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
105637187|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
105637188|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
105637189|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
105637190|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
105637191|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
105637192|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
105637193|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Death|1|||
105637194|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Death|0|||
105637195|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
105637196|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
105637197|NCT01619059|364335685|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
105637198|NCT01619059|364335686|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
105637199|NCT03335488|364335689|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
105637200|NCT03335488|364335690|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
105637201|NCT03335488|364335689|FG000|Safety Extension Period|Adverse Event|1|||
105637202|NCT03335488|364335690|FG001|Safety Extension Period|Adverse Event|0|||
105637203|NCT03335488|364335689|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
105637204|NCT03335488|364335690|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
105637205|NCT02022670|364335691|FG000|Overall Study|Adverse Event|1|||
105637206|NCT02022670|364335692|FG001|Overall Study|Adverse Event|0|||
105637207|NCT02022670|364335693|FG002|Overall Study|Adverse Event|1|||
105637208|NCT04102098|364335694|FG000|Main Study Period|Ongoing in study|302|||
105637209|NCT04102098|364335695|FG001|Main Study Period|Ongoing in study|291|||
105637210|NCT04102098|364335694|FG000|Main Study Period|Death|20|||
105637211|NCT04102098|364335695|FG001|Main Study Period|Death|27|||
105637212|NCT04102098|364335694|FG000|Main Study Period|Lost to Follow-up|1|||
105637213|NCT04102098|364335695|FG001|Main Study Period|Lost to Follow-up|1|||
105637214|NCT04102098|364335694|FG000|Main Study Period|Physician Decision|0|||
105637215|NCT04102098|364335695|FG001|Main Study Period|Physician Decision|1|||
105637216|NCT04102098|364335694|FG000|Main Study Period|Withdrawal by Subject|11|||
105637217|NCT04102098|364335695|FG001|Main Study Period|Withdrawal by Subject|14|||
105637218|NCT04102098|364335694|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
105637219|NCT04102098|364335695|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
105637220|NCT04102098|364335694|FG000|Crossover: AS Who Crossed Over|Death|11|||
105637221|NCT04102098|364335695|FG001|Crossover: AS Who Crossed Over|Death|0|||
105637222|NCT04102098|364335694|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
105637223|NCT04102098|364335695|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
105637224|NCT01822756|364335698|FG000|Overall Study|Adverse Event|0|||
105637225|NCT01822756|364335699|FG001|Overall Study|Adverse Event|0|||
105637226|NCT01822756|364335700|FG002|Overall Study|Adverse Event|0|||
105637227|NCT01822756|364335701|FG003|Overall Study|Adverse Event|2|||
105637228|NCT01822756|364335702|FG004|Overall Study|Adverse Event|0|||
105637229|NCT01822756|364335698|FG000|Overall Study|Disease progression|11|||
105637230|NCT01822756|364335699|FG001|Overall Study|Disease progression|1|||
105637231|NCT01822756|364335700|FG002|Overall Study|Disease progression|7|||
105637232|NCT01822756|364335701|FG003|Overall Study|Disease progression|2|||
105637233|NCT01822756|364335702|FG004|Overall Study|Disease progression|6|||
105637234|NCT01822756|364335698|FG000|Overall Study|Death|2|||
105637235|NCT01822756|364335699|FG001|Overall Study|Death|2|||
105637236|NCT01822756|364335700|FG002|Overall Study|Death|1|||
105637237|NCT01822756|364335701|FG003|Overall Study|Death|0|||
105637238|NCT01822756|364335702|FG004|Overall Study|Death|0|||
105637239|NCT01822756|364335698|FG000|Overall Study|Lost to Follow-up|1|||
105637240|NCT01822756|364335699|FG001|Overall Study|Lost to Follow-up|0|||
105637241|NCT01822756|364335700|FG002|Overall Study|Lost to Follow-up|1|||
105637242|NCT01822756|364335701|FG003|Overall Study|Lost to Follow-up|0|||
105637243|NCT01822756|364335702|FG004|Overall Study|Lost to Follow-up|1|||
105637244|NCT01822756|364335698|FG000|Overall Study|Physician Decision|0|||
105637245|NCT01822756|364335699|FG001|Overall Study|Physician Decision|1|||
105637246|NCT01822756|364335700|FG002|Overall Study|Physician Decision|0|||
105637247|NCT01822756|364335701|FG003|Overall Study|Physician Decision|0|||
105637248|NCT01822756|364335702|FG004|Overall Study|Physician Decision|0|||
105637249|NCT01822756|364335698|FG000|Overall Study|disease progression & patient preference|2|||
105637250|NCT01822756|364335699|FG001|Overall Study|disease progression & patient preference|0|||
105637251|NCT01822756|364335700|FG002|Overall Study|disease progression & patient preference|1|||
105637252|NCT01822756|364335701|FG003|Overall Study|disease progression & patient preference|0|||
105637253|NCT01822756|364335702|FG004|Overall Study|disease progression & patient preference|0|||
105637254|NCT01989104|364335703|FG000|Overall Study|Withdrawal by Subject|3|||
105637255|NCT01989104|364335704|FG001|Overall Study|Withdrawal by Subject|0|||
105637256|NCT01989104|364335705|FG002|Overall Study|Withdrawal by Subject|0|||
105637257|NCT01989104|364335706|FG003|Overall Study|Withdrawal by Subject|0|||
105637258|NCT01989104|364335707|FG004|Overall Study|Withdrawal by Subject|0|||
105637259|NCT02542293|364335714|FG000|Overall Study|Death|367|||
105637260|NCT02542293|364335715|FG001|Overall Study|Death|377|||
105637261|NCT02542293|364335714|FG000|Overall Study|Withdrawal by Subject|8|||
105637262|NCT02542293|364335715|FG001|Overall Study|Withdrawal by Subject|19|||
105637263|NCT03697603|364335722|FG000|Overall Study|Adverse Event|3|||
105637264|NCT03697603|364335723|FG001|Overall Study|Adverse Event|18|||
105637265|NCT03697603|364335724|FG002|Overall Study|Adverse Event|3|||
105637266|NCT03697603|364335722|FG000|Overall Study|Physician Decision|1|||
105637267|NCT03697603|364335723|FG001|Overall Study|Physician Decision|0|||
105637268|NCT03697603|364335724|FG002|Overall Study|Physician Decision|2|||
105637269|NCT03697603|364335722|FG000|Overall Study|Protocol Violation|3|||
105637270|NCT03697603|364335723|FG001|Overall Study|Protocol Violation|8|||
105637271|NCT03697603|364335724|FG002|Overall Study|Protocol Violation|5|||
105637272|NCT03697603|364335722|FG000|Overall Study|Withdrawal by Subject|5|||
105637273|NCT03697603|364335723|FG001|Overall Study|Withdrawal by Subject|1|||
105637274|NCT03697603|364335724|FG002|Overall Study|Withdrawal by Subject|1|||
105637275|NCT03697603|364335722|FG000|Overall Study|Protocol Violation|0|||
105637276|NCT03697603|364335723|FG001|Overall Study|Protocol Violation|0|||
105637277|NCT03697603|364335724|FG002|Overall Study|Protocol Violation|1|||
105637278|NCT01683409|364335730|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
105637279|NCT01683409|364335731|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
105637280|NCT01683409|364335732|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
105637281|NCT01683409|364335733|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
105637282|NCT01683409|364335734|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
105637283|NCT01683409|364335730|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
105637284|NCT01683409|364335731|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
105637285|NCT01683409|364335732|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
105637286|NCT01683409|364335733|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
105637287|NCT01683409|364335734|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
105637288|NCT01683409|364335730|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
105637289|NCT01683409|364335731|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
105637290|NCT01683409|364335732|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
105637291|NCT01683409|364335733|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
105637292|NCT01683409|364335734|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
105637293|NCT01683409|364335730|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
105637294|NCT01683409|364335731|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
105637295|NCT01683409|364335732|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
105637296|NCT01683409|364335733|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
105637297|NCT01683409|364335734|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
105637298|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
105637299|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
105637300|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
105637301|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
105637302|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
105637303|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
105637304|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
105637305|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
105637306|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
105637307|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
105637308|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
105637309|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
105637310|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
105637311|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
105637312|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
105637313|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
105637314|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
105637315|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
105637316|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
105637317|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
105637318|NCT01683409|364335730|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
105637319|NCT01683409|364335731|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
105637320|NCT01683409|364335732|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
105637321|NCT01683409|364335733|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
105637322|NCT01683409|364335734|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
105637323|NCT01683409|364335730|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
105637324|NCT01683409|364335731|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
105637325|NCT01683409|364335732|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
105637326|NCT01683409|364335733|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
105637327|NCT01683409|364335734|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
105637328|NCT01683409|364335730|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
105637329|NCT01683409|364335731|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
105637330|NCT01683409|364335732|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
105637331|NCT01683409|364335733|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
105637332|NCT01683409|364335734|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
105637333|NCT01706159|364335737|FG000|Overall Study|Withdrawal Criteria|2|||
105637334|NCT01706159|364335738|FG001|Overall Study|Withdrawal Criteria|1|||
105637335|NCT01706159|364335737|FG000|Overall Study|Unclassified|6|||
105637336|NCT01706159|364335738|FG001|Overall Study|Unclassified|1|||
105637337|NCT04821271|364335740|FG000|Period 1|Withdrawal by Subject|2|||
105637338|NCT04821271|364335741|FG001|Period 1|Withdrawal by Subject|0|||
105637339|NCT01701401|364335743|FG000|Overall Study|Randomized But Not Treated|3|||
105637340|NCT01701401|364335744|FG001|Overall Study|Randomized But Not Treated|1|||
105637341|NCT01701401|364335745|FG002|Overall Study|Randomized But Not Treated|0|||
105637342|NCT01701401|364335746|FG003|Overall Study|Randomized But Not Treated|1|||
105637343|NCT01701401|364335743|FG000|Overall Study|Lost to Follow-up|5|||
105637344|NCT01701401|364335744|FG001|Overall Study|Lost to Follow-up|5|||
105637345|NCT01701401|364335745|FG002|Overall Study|Lost to Follow-up|1|||
105637346|NCT01701401|364335746|FG003|Overall Study|Lost to Follow-up|3|||
105637347|NCT01701401|364335743|FG000|Overall Study|Withdrew Consent|0|||
105637348|NCT01701401|364335744|FG001|Overall Study|Withdrew Consent|3|||
105637349|NCT01701401|364335745|FG002|Overall Study|Withdrew Consent|1|||
105637350|NCT01701401|364335746|FG003|Overall Study|Withdrew Consent|2|||
105637351|NCT01701401|364335743|FG000|Overall Study|Lack of Efficacy|1|||
105637352|NCT01701401|364335744|FG001|Overall Study|Lack of Efficacy|0|||
105637353|NCT01701401|364335745|FG002|Overall Study|Lack of Efficacy|2|||
105637354|NCT01701401|364335746|FG003|Overall Study|Lack of Efficacy|0|||
105637355|NCT01701401|364335743|FG000|Overall Study|Adverse Event|1|||
105637356|NCT01701401|364335744|FG001|Overall Study|Adverse Event|0|||
105637357|NCT01701401|364335745|FG002|Overall Study|Adverse Event|0|||
105637358|NCT01701401|364335746|FG003|Overall Study|Adverse Event|0|||
105637359|NCT01701401|364335743|FG000|Overall Study|Protocol Violation|0|||
105637360|NCT01701401|364335744|FG001|Overall Study|Protocol Violation|0|||
105637361|NCT01701401|364335745|FG002|Overall Study|Protocol Violation|1|||
105637362|NCT01701401|364335746|FG003|Overall Study|Protocol Violation|0|||
105637363|NCT05995977|364335749|FG000|Overall Study|Withdrawal by Subject|1|||
105637364|NCT05995977|364335750|FG001|Overall Study|Withdrawal by Subject|4|||
105637365|NCT05995977|364335749|FG000|Overall Study|Lost to Follow-up|2|||
105637366|NCT05995977|364335750|FG001|Overall Study|Lost to Follow-up|0|||
105637367|NCT04181788|364335751|FG000|TREATMENT|Adverse Event|0|||
105637368|NCT04181788|364335752|FG001|TREATMENT|Adverse Event|2|||
105637369|NCT04181788|364335753|FG002|TREATMENT|Adverse Event|1|||
105637370|NCT04181788|364335754|FG003|TREATMENT|Adverse Event|0|||
105637371|NCT04181788|364335755|FG004|TREATMENT|Adverse Event|1|||
105637372|NCT04181788|364335756|FG005|TREATMENT|Adverse Event|3|||
105637373|NCT04181788|364335751|FG000|TREATMENT|Death|0|||
105637374|NCT04181788|364335752|FG001|TREATMENT|Death|0|||
105637375|NCT04181788|364335753|FG002|TREATMENT|Death|0|||
105637376|NCT04181788|364335754|FG003|TREATMENT|Death|0|||
105637377|NCT04181788|364335755|FG004|TREATMENT|Death|8|||
105637378|NCT04181788|364335756|FG005|TREATMENT|Death|8|||
105637379|NCT04181788|364335751|FG000|TREATMENT|Physician Decision|0|||
105637380|NCT04181788|364335752|FG001|TREATMENT|Physician Decision|0|||
105637381|NCT04181788|364335753|FG002|TREATMENT|Physician Decision|0|||
105637382|NCT04181788|364335754|FG003|TREATMENT|Physician Decision|0|||
105637383|NCT04181788|364335755|FG004|TREATMENT|Physician Decision|0|||
105637384|NCT04181788|364335756|FG005|TREATMENT|Physician Decision|1|||
105637385|NCT04181788|364335751|FG000|TREATMENT|Progressive disease|3|||
105637386|NCT04181788|364335752|FG001|TREATMENT|Progressive disease|3|||
105637387|NCT04181788|364335753|FG002|TREATMENT|Progressive disease|5|||
105637388|NCT04181788|364335754|FG003|TREATMENT|Progressive disease|7|||
105637389|NCT04181788|364335755|FG004|TREATMENT|Progressive disease|20|||
105637390|NCT04181788|364335756|FG005|TREATMENT|Progressive disease|38|||
105637391|NCT04181788|364335751|FG000|TREATMENT|Global deterioration of health status|0|||
105637392|NCT04181788|364335752|FG001|TREATMENT|Global deterioration of health status|2|||
105637393|NCT04181788|364335753|FG002|TREATMENT|Global deterioration of health status|0|||
105637394|NCT04181788|364335754|FG003|TREATMENT|Global deterioration of health status|0|||
105637395|NCT04181788|364335755|FG004|TREATMENT|Global deterioration of health status|2|||
105637396|NCT04181788|364335756|FG005|TREATMENT|Global deterioration of health status|8|||
105637397|NCT04181788|364335751|FG000|TREATMENT|Withdrawal by Subject|1|||
105637398|NCT04181788|364335752|FG001|TREATMENT|Withdrawal by Subject|2|||
105637399|NCT04181788|364335753|FG002|TREATMENT|Withdrawal by Subject|0|||
105637400|NCT04181788|364335754|FG003|TREATMENT|Withdrawal by Subject|0|||
105637401|NCT04181788|364335755|FG004|TREATMENT|Withdrawal by Subject|3|||
105637402|NCT04181788|364335756|FG005|TREATMENT|Withdrawal by Subject|5|||
105637403|NCT04181788|364335751|FG000|TREATMENT|Other unspecified|0|||
105637404|NCT04181788|364335752|FG001|TREATMENT|Other unspecified|0|||
105637405|NCT04181788|364335753|FG002|TREATMENT|Other unspecified|0|||
105637406|NCT04181788|364335754|FG003|TREATMENT|Other unspecified|0|||
105637407|NCT04181788|364335755|FG004|TREATMENT|Other unspecified|0|||
105637408|NCT04181788|364335756|FG005|TREATMENT|Other unspecified|2|||
105637409|NCT04181788|364335751|FG000|TREATMENT|Ongoing|0|||
105637410|NCT04181788|364335752|FG001|TREATMENT|Ongoing|3|||
105637411|NCT04181788|364335753|FG002|TREATMENT|Ongoing|0|||
105637412|NCT04181788|364335754|FG003|TREATMENT|Ongoing|5|||
105637413|NCT04181788|364335755|FG004|TREATMENT|Ongoing|7|||
105637414|NCT04181788|364335756|FG005|TREATMENT|Ongoing|15|||
105637415|NCT04181788|364335751|FG000|FOLLOW-UP|Death|0|||
105637416|NCT04181788|364335752|FG001|FOLLOW-UP|Death|0|||
105637417|NCT04181788|364335753|FG002|FOLLOW-UP|Death|1|||
105637418|NCT04181788|364335754|FG003|FOLLOW-UP|Death|2|||
105637419|NCT04181788|364335755|FG004|FOLLOW-UP|Death|8|||
105637420|NCT04181788|364335756|FG005|FOLLOW-UP|Death|20|||
105637421|NCT04181788|364335751|FG000|FOLLOW-UP|Lost to Follow-up|0|||
105637422|NCT04181788|364335752|FG001|FOLLOW-UP|Lost to Follow-up|0|||
105637423|NCT04181788|364335753|FG002|FOLLOW-UP|Lost to Follow-up|0|||
105637424|NCT04181788|364335754|FG003|FOLLOW-UP|Lost to Follow-up|0|||
105637425|NCT04181788|364335755|FG004|FOLLOW-UP|Lost to Follow-up|0|||
105637426|NCT04181788|364335756|FG005|FOLLOW-UP|Lost to Follow-up|2|||
105637427|NCT04181788|364335751|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
105637428|NCT04181788|364335752|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
105637429|NCT04181788|364335753|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
105637430|NCT04181788|364335754|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
105637431|NCT04181788|364335755|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
105637432|NCT04181788|364335756|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
105637433|NCT04181788|364335751|FG000|FOLLOW-UP|Other unspecified|0|||
105637434|NCT04181788|364335752|FG001|FOLLOW-UP|Other unspecified|1|||
105637435|NCT04181788|364335753|FG002|FOLLOW-UP|Other unspecified|0|||
105869927|NCT02288325|365176852|FG001|Stabilization Period|Lack of Efficacy|0|||
105637436|NCT04181788|364335754|FG003|FOLLOW-UP|Other unspecified|0|||
105637437|NCT04181788|364335755|FG004|FOLLOW-UP|Other unspecified|0|||
105637438|NCT04181788|364335756|FG005|FOLLOW-UP|Other unspecified|3|||
105637439|NCT04181788|364335751|FG000|FOLLOW-UP|Ongoing|0|||
105637440|NCT04181788|364335752|FG001|FOLLOW-UP|Ongoing|0|||
105637441|NCT04181788|364335753|FG002|FOLLOW-UP|Ongoing|1|||
105637442|NCT04181788|364335754|FG003|FOLLOW-UP|Ongoing|3|||
105637443|NCT04181788|364335755|FG004|FOLLOW-UP|Ongoing|2|||
105637444|NCT04181788|364335756|FG005|FOLLOW-UP|Ongoing|2|||
105637445|NCT04186247|364335757|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
105637446|NCT04186247|364335758|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
105637447|NCT04186247|364335759|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
105637448|NCT04186247|364335760|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
105637449|NCT04186247|364335761|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
105637450|NCT04118894|364335768|FG000|Overall Study|Lost to Follow-up|21|||
105637451|NCT04118894|364335768|FG000|Overall Study|Withdrawal by Subject|10|||
105637452|NCT04118894|364335768|FG000|Overall Study|Adverse Event|4|||
105659259|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
105659260|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Death|0|||
105659261|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Death|0|||
105659262|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Death|1|||
105659263|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
105659264|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
105659265|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
105659266|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
105659267|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
105659268|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
105659269|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
105659270|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
105659271|NCT00665223|364415764|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
105659272|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
105659273|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
105659274|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
105659275|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Death|0|||
105659276|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Death|1|||
105659277|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Death|0|||
105659278|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
105659279|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
105659280|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
105659281|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
105659282|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
105659283|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
105659284|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
105659285|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
105659286|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
105659287|NCT00665223|364415762|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
105659288|NCT00665223|364415763|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
105659289|NCT00665223|364415764|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
105659290|NCT01278615|364415765|FG000|Overall Study|Withdrawal by Subject|2|||
105659291|NCT00905359|364415766|FG000|Overall Study|Lost to Follow-up|17|||
105659292|NCT00905359|364415767|FG001|Overall Study|Lost to Follow-up|10|||
105659293|NCT00905359|364415766|FG000|Overall Study|Death|2|||
105659294|NCT00905359|364415767|FG001|Overall Study|Death|0|||
105659295|NCT00905359|364415766|FG000|Overall Study|Withdrawal consent|5|||
105659296|NCT00905359|364415767|FG001|Overall Study|Withdrawal consent|6|||
105659297|NCT00591591|364415768|FG000|Overall Study|Withdrawal by Subject|1|||
105659298|NCT00591591|364415769|FG001|Overall Study|Withdrawal by Subject|37|||
105659299|NCT00591591|364415768|FG000|Overall Study|Lack of Efficacy|10|||
105659300|NCT00591591|364415769|FG001|Overall Study|Lack of Efficacy|2|||
105659301|NCT01880437|364415774|FG000|Overall Study|Death|12|||
105659302|NCT01880437|364415775|FG001|Overall Study|Death|4|||
105659303|NCT01880437|364415776|FG002|Overall Study|Death|17|||
105659304|NCT01880437|364415774|FG000|Overall Study|Study terminated by Sponsor|3|||
105659305|NCT01880437|364415775|FG001|Overall Study|Study terminated by Sponsor|0|||
105659306|NCT01880437|364415776|FG002|Overall Study|Study terminated by Sponsor|2|||
105659307|NCT01932762|364417266|FG000|Overall Study|Withdrawal by Subject|1|||
105659308|NCT01932762|364417267|FG001|Overall Study|Withdrawal by Subject|2|||
105659309|NCT01932762|364417268|FG002|Overall Study|Withdrawal by Subject|0|||
105659310|NCT01932762|364417269|FG003|Overall Study|Withdrawal by Subject|0|||
105659311|NCT01932762|364417266|FG000|Overall Study|Lost to Follow-up|4|||
105659312|NCT01932762|364417267|FG001|Overall Study|Lost to Follow-up|0|||
105659313|NCT01932762|364417268|FG002|Overall Study|Lost to Follow-up|0|||
105659314|NCT01932762|364417269|FG003|Overall Study|Lost to Follow-up|1|||
105659315|NCT01932762|364417266|FG000|Overall Study|Physician Decision|1|||
105659316|NCT01932762|364417267|FG001|Overall Study|Physician Decision|0|||
105659317|NCT01932762|364417268|FG002|Overall Study|Physician Decision|0|||
105659318|NCT01932762|364417269|FG003|Overall Study|Physician Decision|0|||
105659319|NCT00412880|364417275|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
105659320|NCT00412880|364417275|FG000|Overall Study|Consent withdrawn|1|||
105659321|NCT00412880|364417275|FG000|Overall Study|Adverse Event|1|||
105659322|NCT00412880|364417275|FG000|Overall Study|Progressive disease|20|||
105659323|NCT01660256|364417276|FG000|Overall Study|Adverse Event|4|||
105659324|NCT01660256|364417277|FG001|Overall Study|Adverse Event|0|||
105659325|NCT01660256|364417278|FG002|Overall Study|Adverse Event|2|||
105659326|NCT01660256|364417276|FG000|Overall Study|Withdrawal by Subject|1|||
105659327|NCT01660256|364417277|FG001|Overall Study|Withdrawal by Subject|0|||
105659328|NCT01660256|364417278|FG002|Overall Study|Withdrawal by Subject|2|||
105659329|NCT00551135|364417280|FG000|Overall Study|Adverse Event|1|||
105659330|NCT00551135|364417281|FG001|Overall Study|Adverse Event|0|||
105637453|NCT00378898|364336859|FG000|Overall Study|Withdrawal by Subject|10|||
105637454|NCT00378898|364336860|FG001|Overall Study|Withdrawal by Subject|5|||
105637455|NCT00378898|364336859|FG000|Overall Study|Protocol Violation|1|||
105637456|NCT00378898|364336860|FG001|Overall Study|Protocol Violation|1|||
105637457|NCT03823703|364336862|FG000|Overall Study|Sponsor request|0|||
105637458|NCT03823703|364336863|FG001|Overall Study|Sponsor request|3|||
105637459|NCT03823703|364336864|FG002|Overall Study|Sponsor request|4|||
105637460|NCT03823703|364336862|FG000|Overall Study|Adverse Event|3|||
105637461|NCT03823703|364336863|FG001|Overall Study|Adverse Event|1|||
105637462|NCT03823703|364336864|FG002|Overall Study|Adverse Event|0|||
105637463|NCT03823703|364336862|FG000|Overall Study|Withdrawal by Subject|0|||
105637464|NCT03823703|364336863|FG001|Overall Study|Withdrawal by Subject|1|||
105637465|NCT03823703|364336864|FG002|Overall Study|Withdrawal by Subject|0|||
105637466|NCT00458783|364336865|FG000|Overall Study|Protocol Violation|1228|||
105637467|NCT00458783|364336866|FG001|Overall Study|Protocol Violation|1220|||
105637468|NCT06571695|364336867|FG000|Overall Study|Lost to Follow-up|1|||
105637469|NCT06571695|364336868|FG001|Overall Study|Lost to Follow-up|6|||
105637470|NCT02637063|364336871|FG000|Overall Study|Lost to Follow-up|3|||
105637471|NCT02637063|364336872|FG001|Overall Study|Lost to Follow-up|2|||
105637472|NCT02637063|364336873|FG002|Overall Study|Lost to Follow-up|3|||
105637473|NCT02637063|364336871|FG000|Overall Study|Withdrawal by Subject|2|||
105637474|NCT02637063|364336872|FG001|Overall Study|Withdrawal by Subject|2|||
105637475|NCT02637063|364336873|FG002|Overall Study|Withdrawal by Subject|3|||
105637476|NCT01808534|364336876|FG000|Overall Study|Disease progression|3|||
105637477|NCT01808534|364336876|FG000|Overall Study|Physician Decision|1|||
105637478|NCT01532648|364336882|FG000|Overall Study|Lost to Follow-up|3|||
105637479|NCT01532648|364336883|FG001|Overall Study|Lost to Follow-up|4|||
105637480|NCT01532648|364336882|FG000|Overall Study|Lack of Efficacy|4|||
105637481|NCT01532648|364336883|FG001|Overall Study|Lack of Efficacy|1|||
105637482|NCT01532648|364336882|FG000|Overall Study|Protocol Violation|1|||
105637483|NCT01532648|364336883|FG001|Overall Study|Protocol Violation|1|||
105637484|NCT01532648|364336882|FG000|Overall Study|Adverse Event|12|||
105637485|NCT01532648|364336883|FG001|Overall Study|Adverse Event|9|||
105637486|NCT01532648|364336882|FG000|Overall Study|Withdrawal by Subject|16|||
105637487|NCT01532648|364336883|FG001|Overall Study|Withdrawal by Subject|2|||
105637488|NCT01737021|364336886|FG000|Overall Study|Lost to Follow-up|5|||
105637489|NCT01737021|364336887|FG001|Overall Study|Lost to Follow-up|3|||
105637490|NCT02310581|364336888|FG000|Overall Study|Adverse Event|1|||
105637491|NCT02310581|364336889|FG001|Overall Study|Adverse Event|1|||
105637492|NCT02310581|364336890|FG002|Overall Study|Adverse Event|1|||
105637493|NCT02310581|364336891|FG003|Overall Study|Adverse Event|0|||
105637494|NCT02310581|364336888|FG000|Overall Study|Withdrawal by Subject|2|||
105637495|NCT02310581|364336889|FG001|Overall Study|Withdrawal by Subject|1|||
105637496|NCT02310581|364336890|FG002|Overall Study|Withdrawal by Subject|0|||
105637497|NCT02310581|364336891|FG003|Overall Study|Withdrawal by Subject|1|||
105637498|NCT04652869|364336892|FG000|Overall Study|Withdrawal by Subject|0|||
105637499|NCT04652869|364336893|FG001|Overall Study|Withdrawal by Subject|2|||
105637500|NCT04652869|364336894|FG002|Overall Study|Withdrawal by Subject|0|||
105637501|NCT02605174|364336895|FG000|Overall Study|Adverse Event|0|||
105637502|NCT02605174|364336896|FG001|Overall Study|Adverse Event|0|||
105637503|NCT02605174|364336897|FG002|Overall Study|Adverse Event|1|||
105637504|NCT02605174|364336898|FG003|Overall Study|Adverse Event|0|||
105637505|NCT02605174|364336899|FG004|Overall Study|Adverse Event|4|||
105637506|NCT02605174|364336900|FG005|Overall Study|Adverse Event|0|||
105637507|NCT02605174|364336901|FG006|Overall Study|Adverse Event|0|||
105637508|NCT02605174|364336895|FG000|Overall Study|Lost to Follow-up|20|||
105637509|NCT02605174|364336896|FG001|Overall Study|Lost to Follow-up|7|||
105637510|NCT02605174|364336897|FG002|Overall Study|Lost to Follow-up|27|||
105637511|NCT02605174|364336898|FG003|Overall Study|Lost to Follow-up|10|||
105637512|NCT02605174|364336899|FG004|Overall Study|Lost to Follow-up|20|||
105637513|NCT02605174|364336900|FG005|Overall Study|Lost to Follow-up|10|||
105637514|NCT02605174|364336901|FG006|Overall Study|Lost to Follow-up|29|||
105637515|NCT02605174|364336895|FG000|Overall Study|Protocol Violation|10|||
105637516|NCT02605174|364336896|FG001|Overall Study|Protocol Violation|4|||
105637517|NCT02605174|364336897|FG002|Overall Study|Protocol Violation|14|||
105637518|NCT02605174|364336898|FG003|Overall Study|Protocol Violation|6|||
105637519|NCT02605174|364336899|FG004|Overall Study|Protocol Violation|7|||
105637520|NCT02605174|364336900|FG005|Overall Study|Protocol Violation|7|||
105637521|NCT02605174|364336901|FG006|Overall Study|Protocol Violation|12|||
105637522|NCT02605174|364336895|FG000|Overall Study|Pregnancy|1|||
105637523|NCT02605174|364336896|FG001|Overall Study|Pregnancy|0|||
105637524|NCT02605174|364336897|FG002|Overall Study|Pregnancy|0|||
105637525|NCT02605174|364336898|FG003|Overall Study|Pregnancy|2|||
105637526|NCT02605174|364336899|FG004|Overall Study|Pregnancy|0|||
105637527|NCT02605174|364336900|FG005|Overall Study|Pregnancy|0|||
105637528|NCT02605174|364336901|FG006|Overall Study|Pregnancy|0|||
105637529|NCT02605174|364336895|FG000|Overall Study|Withdrawal by Subject|9|||
105637530|NCT02605174|364336896|FG001|Overall Study|Withdrawal by Subject|6|||
105637531|NCT02605174|364336897|FG002|Overall Study|Withdrawal by Subject|14|||
105637532|NCT02605174|364336898|FG003|Overall Study|Withdrawal by Subject|11|||
105637533|NCT02605174|364336899|FG004|Overall Study|Withdrawal by Subject|6|||
105637534|NCT02605174|364336900|FG005|Overall Study|Withdrawal by Subject|4|||
105637535|NCT02605174|364336901|FG006|Overall Study|Withdrawal by Subject|15|||
105637536|NCT02605174|364336895|FG000|Overall Study|Physician Decision|2|||
105637537|NCT02605174|364336896|FG001|Overall Study|Physician Decision|0|||
105637538|NCT02605174|364336897|FG002|Overall Study|Physician Decision|0|||
105637539|NCT02605174|364336898|FG003|Overall Study|Physician Decision|0|||
105637540|NCT02605174|364336899|FG004|Overall Study|Physician Decision|0|||
105637541|NCT02605174|364336900|FG005|Overall Study|Physician Decision|0|||
105637542|NCT02605174|364336901|FG006|Overall Study|Physician Decision|3|||
105637543|NCT02605174|364336895|FG000|Overall Study|Randomization Failure|22|||
105637544|NCT02605174|364336896|FG001|Overall Study|Randomization Failure|6|||
105637545|NCT02605174|364336897|FG002|Overall Study|Randomization Failure|20|||
105637546|NCT02605174|364336898|FG003|Overall Study|Randomization Failure|7|||
105637547|NCT02605174|364336899|FG004|Overall Study|Randomization Failure|16|||
105637548|NCT02605174|364336900|FG005|Overall Study|Randomization Failure|11|||
105637549|NCT02605174|364336901|FG006|Overall Study|Randomization Failure|30|||
105637550|NCT04250636|364336904|FG000|Overall Study|Lost to Follow-up|2|||
105637551|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
105637552|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
105637553|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
105637554|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
105637555|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
105637556|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
105637557|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
105637558|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
105637559|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
105637560|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
105637561|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
105637562|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
105637563|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Other|1|||
105637564|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Other|0|||
105637565|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Other|0|||
105637566|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
105637567|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
105637568|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
105637569|NCT00887224|364336905|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
105637570|NCT00887224|364336906|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
105637571|NCT00887224|364336907|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
105637572|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
105637573|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
105637574|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
105637575|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
105637576|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
105637577|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
105637578|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
105637579|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
105637580|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
105637581|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
105637582|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
105637583|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
105637584|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Other|1|||
105637585|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Other|0|||
105637586|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Other|0|||
105637587|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
105637588|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
105637589|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
105637590|NCT00887224|364336905|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
105637591|NCT00887224|364336906|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
105637592|NCT00887224|364336907|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
105637593|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
105637594|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
105637595|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
105637596|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
105637597|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
105637598|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
105637599|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
105637600|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
105637601|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
105637602|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
105637603|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
105637604|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
105637605|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Other|30|||
105637606|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Other|0|||
105637607|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Other|0|||
105637608|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
105637609|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
105637610|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
105637611|NCT00887224|364336905|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
105637612|NCT00887224|364336906|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
105637613|NCT00887224|364336907|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
105637614|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Adverse Event|0|||
105637615|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Adverse Event|7|||
105637616|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Adverse Event|2|||
105637617|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Failed to return|0|||
105637618|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Failed to return|2|||
105637619|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Failed to return|2|||
105637620|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
105637621|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
105637622|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
105637623|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
105637624|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
105637625|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
105637626|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Other|0|||
105637627|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Other|2|||
105637628|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Other|0|||
105637629|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
105637630|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
105637631|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
105637632|NCT00887224|364336905|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
105637633|NCT00887224|364336906|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
105637634|NCT00887224|364336907|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
105637635|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
105637636|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
105637637|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
105637638|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
105637639|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
105637640|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
105637641|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
105637642|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
105637643|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
105637644|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
105637645|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
105637646|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
105637647|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
105637648|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
105637649|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
105637650|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
105637651|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
105637652|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
105637653|NCT00887224|364336905|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
105637654|NCT00887224|364336906|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
105637655|NCT00887224|364336907|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
105637656|NCT03883828|364336908|FG000|Overall Study|Did not start radiotherapy|1|||
105637657|NCT03883828|364336909|FG001|Overall Study|Did not start radiotherapy|2|||
105637658|NCT03675321|364336913|FG000|Overall Study|Lack of Efficacy|2|||
105637659|NCT03675321|364336914|FG001|Overall Study|Lack of Efficacy|2|||
105637660|NCT03675321|364336913|FG000|Overall Study|Withdrawal by Subject|1|||
105637661|NCT03675321|364336914|FG001|Overall Study|Withdrawal by Subject|3|||
105637662|NCT02000752|364336917|FG000|Overall Study|Dystocic delivery|19|||
105637663|NCT02000752|364336918|FG001|Overall Study|Dystocic delivery|8|||
105637664|NCT02000752|364336917|FG000|Overall Study|Shift Changes|12|||
105637665|NCT02000752|364336918|FG001|Overall Study|Shift Changes|5|||
105637666|NCT04938453|364336921|FG000|Washout Period 1|Adverse Event|1|||
105637667|NCT04938453|364336922|FG001|Washout Period 1|Adverse Event|0|||
105637668|NCT04938453|364336921|FG000|Washout Period 1|Physician Decision|0|||
105637669|NCT04938453|364336922|FG001|Washout Period 1|Physician Decision|1|||
105637670|NCT00734578|364336924|FG000|Overall Study|Adverse Event|4|||
105637671|NCT00734578|364336925|FG001|Overall Study|Adverse Event|6|||
105637672|NCT00734578|364336926|FG002|Overall Study|Adverse Event|1|||
105637673|NCT00734578|364336924|FG000|Overall Study|Protocol Violation|8|||
105637674|NCT00734578|364336925|FG001|Overall Study|Protocol Violation|6|||
105637675|NCT00734578|364336926|FG002|Overall Study|Protocol Violation|3|||
105637676|NCT00734578|364336924|FG000|Overall Study|Withdrawal by Subject|7|||
105637677|NCT00734578|364336925|FG001|Overall Study|Withdrawal by Subject|8|||
105637678|NCT00734578|364336926|FG002|Overall Study|Withdrawal by Subject|11|||
105637679|NCT00734578|364336924|FG000|Overall Study|Lost to Follow-up|9|||
105637680|NCT00734578|364336925|FG001|Overall Study|Lost to Follow-up|3|||
105637681|NCT00734578|364336926|FG002|Overall Study|Lost to Follow-up|5|||
105637682|NCT00734578|364336924|FG000|Overall Study|Lack of Efficacy|3|||
105637683|NCT00734578|364336925|FG001|Overall Study|Lack of Efficacy|2|||
105637684|NCT00734578|364336926|FG002|Overall Study|Lack of Efficacy|5|||
105637685|NCT00734578|364336924|FG000|Overall Study|Randomized in error|1|||
105637686|NCT00734578|364336925|FG001|Overall Study|Randomized in error|0|||
105637687|NCT00734578|364336926|FG002|Overall Study|Randomized in error|0|||
105637688|NCT00734578|364336924|FG000|Overall Study|Exclusion criteria|1|||
105637689|NCT00734578|364336925|FG001|Overall Study|Exclusion criteria|0|||
105637690|NCT00734578|364336926|FG002|Overall Study|Exclusion criteria|0|||
105637691|NCT01124045|364336930|FG000|Overall Study|Lost to Follow-up|0|||
105637692|NCT01124045|364336931|FG001|Overall Study|Lost to Follow-up|1|||
105637693|NCT01124045|364336930|FG000|Overall Study|Physician Decision|0|||
105869928|NCT02288325|365176853|FG002|Stabilization Period|Lack of Efficacy|0|||
105869929|NCT02288325|365176851|FG000|Stabilization Period|Withdrawal of Consent|23|||
105869930|NCT02288325|365176852|FG001|Stabilization Period|Withdrawal of Consent|0|||
105869931|NCT02288325|365176853|FG002|Stabilization Period|Withdrawal of Consent|0|||
105869932|NCT02288325|365176851|FG000|Stabilization Period|Lost to Follow-up|12|||
105869933|NCT02288325|365176852|FG001|Stabilization Period|Lost to Follow-up|0|||
105869934|NCT02288325|365176853|FG002|Stabilization Period|Lost to Follow-up|0|||
105869935|NCT02288325|365176851|FG000|Stabilization Period|Protocol Violation|8|||
105869936|NCT02288325|365176852|FG001|Stabilization Period|Protocol Violation|0|||
105869937|NCT02288325|365176853|FG002|Stabilization Period|Protocol Violation|0|||
105869938|NCT02288325|365176851|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
105869939|NCT02288325|365176852|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
105869940|NCT02288325|365176853|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
105869941|NCT02288325|365176851|FG000|Stabilization Period|Reason not Specified|15|||
105869942|NCT02288325|365176852|FG001|Stabilization Period|Reason not Specified|0|||
105869943|NCT02288325|365176853|FG002|Stabilization Period|Reason not Specified|0|||
105869944|NCT02288325|365176851|FG000|Double-blind Treatment Period|Adverse Event|0|||
105869945|NCT02288325|365176852|FG001|Double-blind Treatment Period|Adverse Event|2|||
105869946|NCT02288325|365176853|FG002|Double-blind Treatment Period|Adverse Event|5|||
105869947|NCT02288325|365176851|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
105869948|NCT02288325|365176852|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
105869949|NCT02288325|365176853|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
105869950|NCT02288325|365176851|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
105869951|NCT02288325|365176852|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
105869952|NCT02288325|365176853|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
105869953|NCT02288325|365176851|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105869954|NCT02288325|365176852|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105869955|NCT02288325|365176853|FG002|Double-blind Treatment Period|Protocol Violation|2|||
105869956|NCT02288325|365176851|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
105869957|NCT02288325|365176852|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
105869958|NCT02288325|365176853|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
105869959|NCT02288325|365176851|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
105869960|NCT02288325|365176852|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
105869961|NCT02288325|365176853|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
105869962|NCT03885661|365176854|FG000|Overall Study|Withdrawal by Subject|0|||
105869963|NCT03885661|365176855|FG001|Overall Study|Withdrawal by Subject|1|||
105869964|NCT03885661|365176854|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
105869965|NCT03885661|365176855|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
105869966|NCT02232984|365176856|FG000|Overall Study|Withdrawal by Subject|5|||
105869967|NCT02232984|365176856|FG000|Overall Study|Death|1|||
105869968|NCT02232984|365176856|FG000|Overall Study|Investigator withdrawal|10|||
105869969|NCT02232984|365176856|FG000|Overall Study|Device implant unsuccessful|53|||
105869970|NCT02232984|365176856|FG000|Overall Study|not disclosed by site|7|||
105869971|NCT02232984|365176856|FG000|Overall Study|Protocol Violation|1|||
105869972|NCT05211726|365176859|FG000|Overall Study|Withdrawal by Subject|2|||
105869973|NCT05211726|365176860|FG001|Overall Study|Withdrawal by Subject|3|||
105869974|NCT05211726|365176859|FG000|Overall Study|Protocol Violation|0|||
105869975|NCT05211726|365176860|FG001|Overall Study|Protocol Violation|1|||
105869976|NCT03762239|365176861|FG000|Overall Study|Appointment to the doctor|1|||
105637694|NCT01124045|364336931|FG001|Overall Study|Physician Decision|2|||
105637695|NCT01530334|364336933|FG000|Overall Study|Adverse Event|3|||
105637696|NCT01530334|364336933|FG000|Overall Study|unknown reason|1|||
105637697|NCT01530334|364336933|FG000|Overall Study|Progressive disease|47|||
105869977|NCT03762239|365176862|FG001|Overall Study|Appointment to the doctor|1|||
105869978|NCT01137071|365176863|FG000|Overall Study|Disease Progression|11|||
105869979|NCT01137071|365176863|FG000|Overall Study|Withdrawal by Subject|2|||
105637698|NCT01629589|364336934|FG000|Overall Study|Protocol Violation|4|||
105637699|NCT01629589|364336935|FG001|Overall Study|Protocol Violation|2|||
105637700|NCT01629589|364336934|FG000|Overall Study|Lost to Follow-up|2|||
105637701|NCT01629589|364336935|FG001|Overall Study|Lost to Follow-up|1|||
105637702|NCT01629589|364336934|FG000|Overall Study|Withdrawal by Subject|2|||
105637703|NCT01629589|364336935|FG001|Overall Study|Withdrawal by Subject|3|||
105637704|NCT01629589|364336934|FG000|Overall Study|Did not receive study vaccine|0|||
105637705|NCT01629589|364336935|FG001|Overall Study|Did not receive study vaccine|1|||
105637706|NCT02113449|364336939|FG000|Overall Study|Adverse Event|4|||
105637707|NCT03162614|364336940|FG000|Overall Study|Lost to Follow-up|2|||
105637708|NCT03162614|364336941|FG001|Overall Study|Lost to Follow-up|1|||
105637709|NCT03162614|364336942|FG002|Overall Study|Lost to Follow-up|1|||
105637710|NCT03162614|364336943|FG003|Overall Study|Lost to Follow-up|1|||
105637711|NCT03162614|364336944|FG004|Overall Study|Lost to Follow-up|2|||
105637712|NCT03162614|364336945|FG005|Overall Study|Lost to Follow-up|0|||
105637713|NCT03162614|364336940|FG000|Overall Study|Protocol Violation|0|||
105637714|NCT03162614|364336941|FG001|Overall Study|Protocol Violation|1|||
105637715|NCT03162614|364336942|FG002|Overall Study|Protocol Violation|0|||
105637716|NCT03162614|364336943|FG003|Overall Study|Protocol Violation|1|||
105637717|NCT03162614|364336944|FG004|Overall Study|Protocol Violation|0|||
105637718|NCT03162614|364336945|FG005|Overall Study|Protocol Violation|0|||
105637719|NCT03162614|364336940|FG000|Overall Study|Withdrawal by Subject|2|||
105637720|NCT03162614|364336941|FG001|Overall Study|Withdrawal by Subject|1|||
105637721|NCT03162614|364336942|FG002|Overall Study|Withdrawal by Subject|1|||
105637722|NCT03162614|364336943|FG003|Overall Study|Withdrawal by Subject|1|||
105637723|NCT03162614|364336944|FG004|Overall Study|Withdrawal by Subject|0|||
105637724|NCT03162614|364336945|FG005|Overall Study|Withdrawal by Subject|0|||
105637725|NCT03162614|364336940|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
105637726|NCT03162614|364336941|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
105637727|NCT03162614|364336942|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
105637728|NCT03162614|364336943|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
105637729|NCT03162614|364336944|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
105637730|NCT03162614|364336945|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
105637731|NCT03567616|364336948|FG000|Overall Study|Disease progression|4|||
105637732|NCT03567616|364336948|FG000|Overall Study|Withdrawal by Subject|1|||
105637733|NCT03567616|364336948|FG000|Overall Study|Physician Decision|1|||
105637734|NCT03567616|364336948|FG000|Overall Study|Death|1|||
105637735|NCT03567616|364336948|FG000|Overall Study|Adverse Event|1|||
105637736|NCT00109031|364336949|FG000|Overall Study|Adverse Event|0|||
105637737|NCT00109031|364336950|FG001|Overall Study|Adverse Event|0|||
105637738|NCT00109031|364336951|FG002|Overall Study|Adverse Event|1|||
105637739|NCT00109031|364336952|FG003|Overall Study|Adverse Event|0|||
105637740|NCT00109031|364336949|FG000|Overall Study|Withdrawal by Subject|0|||
105637741|NCT00109031|364336950|FG001|Overall Study|Withdrawal by Subject|1|||
105637742|NCT00109031|364336951|FG002|Overall Study|Withdrawal by Subject|0|||
105637743|NCT00109031|364336952|FG003|Overall Study|Withdrawal by Subject|0|||
105637744|NCT00109031|364336949|FG000|Overall Study|Physician Decision|0|||
105637745|NCT00109031|364336950|FG001|Overall Study|Physician Decision|1|||
105637746|NCT00109031|364336951|FG002|Overall Study|Physician Decision|0|||
105637747|NCT00109031|364336952|FG003|Overall Study|Physician Decision|0|||
105637748|NCT00109031|364336949|FG000|Overall Study|Protocol Violation|0|||
105637749|NCT00109031|364336950|FG001|Overall Study|Protocol Violation|0|||
105637750|NCT00109031|364336951|FG002|Overall Study|Protocol Violation|1|||
105637751|NCT00109031|364336952|FG003|Overall Study|Protocol Violation|0|||
105637752|NCT02309294|364336969|FG000|Overall Study|Withdrawal by Subject|2|||
105637753|NCT03520036|364336970|FG000|Overall Study|Adverse Event|1|||
105637754|NCT03520036|364336971|FG001|Overall Study|Adverse Event|2|||
105637755|NCT03520036|364336972|FG002|Overall Study|Adverse Event|0|||
105637756|NCT03520036|364336970|FG000|Overall Study|Protocol Violation|1|||
105637757|NCT03520036|364336971|FG001|Overall Study|Protocol Violation|0|||
105637758|NCT03520036|364336972|FG002|Overall Study|Protocol Violation|0|||
105637759|NCT03520036|364336970|FG000|Overall Study|Withdrawal by Subject|0|||
105637760|NCT03520036|364336971|FG001|Overall Study|Withdrawal by Subject|1|||
105637761|NCT03520036|364336972|FG002|Overall Study|Withdrawal by Subject|4|||
105637762|NCT03520036|364336970|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
105637763|NCT03520036|364336971|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
105637764|NCT03520036|364336972|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
105637765|NCT01227421|364336973|FG000|Overall Study|Lost to Follow-up|6|||
105637766|NCT01227421|364336974|FG001|Overall Study|Lost to Follow-up|7|||
105637767|NCT01227421|364336975|FG002|Overall Study|Lost to Follow-up|5|||
105637768|NCT01227421|364336973|FG000|Overall Study|Adverse Event|2|||
105637769|NCT01227421|364336974|FG001|Overall Study|Adverse Event|7|||
105637770|NCT01227421|364336975|FG002|Overall Study|Adverse Event|2|||
105637771|NCT01227421|364336973|FG000|Overall Study|Withdrawal by Subject|1|||
105637772|NCT01227421|364336974|FG001|Overall Study|Withdrawal by Subject|2|||
105637773|NCT01227421|364336975|FG002|Overall Study|Withdrawal by Subject|1|||
105637774|NCT01227421|364336973|FG000|Overall Study|Protocol Violation|1|||
105637775|NCT01227421|364336974|FG001|Overall Study|Protocol Violation|1|||
105637776|NCT01227421|364336975|FG002|Overall Study|Protocol Violation|2|||
105637777|NCT01227421|364336973|FG000|Overall Study|Randomized in error|1|||
105637778|NCT01227421|364336974|FG001|Overall Study|Randomized in error|1|||
105637779|NCT01227421|364336975|FG002|Overall Study|Randomized in error|0|||
105637780|NCT01218594|364336978|FG000|Overall Study|Death|1|||
105637781|NCT01218594|364336978|FG000|Overall Study|Withdrawal by Subject|3|||
105637782|NCT01218594|364336978|FG000|Overall Study|Adverse Event|2|||
105637783|NCT01218594|364336978|FG000|Overall Study|Physician Decision|6|||
105637784|NCT00570505|364336979|FG000|Overall Study|Adverse Event|7|||
105637785|NCT00570505|364336979|FG000|Overall Study|Withdrawal by Subject|7|||
105637786|NCT00570505|364336979|FG000|Overall Study|Lost to Follow-up|23|||
105637787|NCT00570505|364336979|FG000|Overall Study|Other loss to follow-up|4|||
105637788|NCT05426109|364336983|FG000|Overall Study|Withdrawal by Subject|0|||
105637789|NCT05426109|364336984|FG001|Overall Study|Withdrawal by Subject|1|||
105637790|NCT05865392|364336985|FG000|Overall Study|Withdrawal by Subject|4|||
105637791|NCT05865392|364336986|FG001|Overall Study|Withdrawal by Subject|0|||
105637792|NCT05865392|364336985|FG000|Overall Study|Didn't meet inclusion criteria|4|||
105637793|NCT05865392|364336986|FG001|Overall Study|Didn't meet inclusion criteria|0|||
105637794|NCT02710669|364338452|FG000|Overall Study|Physician Decision|2|||
105637795|NCT02710669|364338453|FG001|Overall Study|Physician Decision|1|||
105637796|NCT02710669|364338454|FG002|Overall Study|Physician Decision|0|||
105637797|NCT02710669|364338452|FG000|Overall Study|Institutional delays (including COVID)|2|||
105637798|NCT02710669|364338453|FG001|Overall Study|Institutional delays (including COVID)|2|||
105637799|NCT02710669|364338454|FG002|Overall Study|Institutional delays (including COVID)|0|||
105637800|NCT02710669|364338452|FG000|Overall Study|arrived in afib/aflutter|10|||
105637801|NCT02710669|364338453|FG001|Overall Study|arrived in afib/aflutter|8|||
105637802|NCT02710669|364338454|FG002|Overall Study|arrived in afib/aflutter|2|||
105637803|NCT04323800|364338455|FG000|Overall Study|Withdrawal by Subject|4|||
105637804|NCT04323800|364338456|FG001|Overall Study|Withdrawal by Subject|4|||
105637805|NCT04323800|364338455|FG000|Overall Study|Incomplete transfusion|1|||
105637806|NCT04323800|364338456|FG001|Overall Study|Incomplete transfusion|0|||
105637807|NCT04323800|364338455|FG000|Overall Study|Other|0|||
105637808|NCT04323800|364338456|FG001|Overall Study|Other|1|||
105637809|NCT04323800|364338455|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
105637810|NCT04323800|364338456|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
105637811|NCT00489554|364338457|FG000|Overall Study|Adverse Event|2|||
105637812|NCT00489554|364338457|FG000|Overall Study|Withdrawal by Subject|1|||
105637813|NCT00489554|364338457|FG000|Overall Study|Lost to Follow-up|1|||
105637814|NCT01732757|364338458|FG000|Overall Study|Lost to Follow-up|1|||
105637815|NCT01732757|364338459|FG001|Overall Study|Lost to Follow-up|0|||
105637816|NCT01732757|364338460|FG002|Overall Study|Lost to Follow-up|0|||
105637817|NCT01567852|364338461|FG000|Overall Study|Withdrawal by Subject|3|||
105637818|NCT01567852|364338462|FG001|Overall Study|Withdrawal by Subject|6|||
105869980|NCT01137071|365176863|FG000|Overall Study|Wrongly Included|1|||
105869981|NCT04660331|365176866|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
105869982|NCT04660331|365176867|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
105869983|NCT04660331|365176868|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
105869984|NCT03452943|365176869|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
105869985|NCT03452943|365176870|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
105869986|NCT03452943|365176869|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
105869987|NCT03452943|365176870|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
105869988|NCT03452943|365176869|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
105869989|NCT03452943|365176870|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
105869990|NCT03452943|365176869|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
105869991|NCT03452943|365176870|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
105869992|NCT03452943|365176869|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
105869993|NCT03452943|365176870|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
105869994|NCT03452943|365176869|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
105869995|NCT03452943|365176870|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
105869996|NCT01841593|365176871|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
105869997|NCT01841593|365176872|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
105869998|NCT01841593|365176871|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
105869999|NCT01841593|365176872|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
105870000|NCT00307086|365176879|FG000|Overall Study|ineligible|5|||
105870001|NCT04728802|365176880|FG000|Overall Study|Withdrawal by Subject|4|||
105870002|NCT04728802|365176881|FG001|Overall Study|Withdrawal by Subject|20|||
105870003|NCT04728802|365176880|FG000|Overall Study|Physician Decision|7|||
105870004|NCT04728802|365176881|FG001|Overall Study|Physician Decision|7|||
105870005|NCT04728802|365176880|FG000|Overall Study|Protocol Violation|10|||
105870006|NCT04728802|365176881|FG001|Overall Study|Protocol Violation|4|||
105870007|NCT04728802|365176880|FG000|Overall Study|Transfer|1|||
105870008|NCT04728802|365176881|FG001|Overall Study|Transfer|0|||
105870009|NCT04728802|365176880|FG000|Overall Study|Death|4|||
105870010|NCT04728802|365176881|FG001|Overall Study|Death|5|||
105870011|NCT04728802|365176880|FG000|Overall Study|Other|3|||
105637819|NCT01567852|364338461|FG000|Overall Study|ECT discontinued|1|||
105637820|NCT01567852|364338462|FG001|Overall Study|ECT discontinued|1|||
105637821|NCT02372799|364338466|FG000|Treatment Period|Adverse Event|3|||
105637822|NCT02372799|364338467|FG001|Treatment Period|Adverse Event|10|||
105637823|NCT02372799|364338468|FG002|Treatment Period|Adverse Event|6|||
105637824|NCT02372799|364338466|FG000|Treatment Period|Insufficient therapeutic response|2|||
105637825|NCT02372799|364338467|FG001|Treatment Period|Insufficient therapeutic response|2|||
105637826|NCT02372799|364338468|FG002|Treatment Period|Insufficient therapeutic response|0|||
105637827|NCT02372799|364338466|FG000|Treatment Period|Withdrawal by Subject|10|||
105637828|NCT02372799|364338467|FG001|Treatment Period|Withdrawal by Subject|10|||
105637829|NCT02372799|364338468|FG002|Treatment Period|Withdrawal by Subject|2|||
105637830|NCT02372799|364338466|FG000|Treatment Period|Lost to Follow-up|11|||
105637831|NCT02372799|364338467|FG001|Treatment Period|Lost to Follow-up|5|||
105637832|NCT02372799|364338468|FG002|Treatment Period|Lost to Follow-up|3|||
105637833|NCT02372799|364338466|FG000|Treatment Period|Protocol Violation|3|||
105637834|NCT02372799|364338467|FG001|Treatment Period|Protocol Violation|0|||
105637835|NCT02372799|364338468|FG002|Treatment Period|Protocol Violation|0|||
105637836|NCT02372799|364338466|FG000|Treatment Period|Non-compliance with study drug|4|||
105637837|NCT02372799|364338467|FG001|Treatment Period|Non-compliance with study drug|4|||
105637838|NCT02372799|364338468|FG002|Treatment Period|Non-compliance with study drug|4|||
105637839|NCT02372799|364338466|FG000|Treatment Period|Miscellaneous Reasons|1|||
105637840|NCT02372799|364338467|FG001|Treatment Period|Miscellaneous Reasons|1|||
105637841|NCT02372799|364338468|FG002|Treatment Period|Miscellaneous Reasons|0|||
105637842|NCT02372799|364338466|FG000|Down-taper Period|Lost to Follow-up|1|||
105637843|NCT02372799|364338467|FG001|Down-taper Period|Lost to Follow-up|2|||
105637844|NCT02372799|364338468|FG002|Down-taper Period|Lost to Follow-up|2|||
105637845|NCT00089609|364338469|FG000|Overall Study|Withdrawal by Subject|3|||
105637846|NCT00089609|364338470|FG001|Overall Study|Withdrawal by Subject|1|||
105637847|NCT01214200|364338471|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
105637848|NCT01214200|364338471|FG000|Overall Study|Withdrawal by Subject|2|||
105637849|NCT01823224|364338472|FG000|Overall Study|Lost to Follow-up|5|||
105637850|NCT01823224|364338473|FG001|Overall Study|Lost to Follow-up|6|||
105637851|NCT01823224|364338472|FG000|Overall Study|didn't qualify|1|||
105637852|NCT01823224|364338473|FG001|Overall Study|didn't qualify|2|||
105637853|NCT01823224|364338472|FG000|Overall Study|pharmacy error|0|||
105637854|NCT01823224|364338473|FG001|Overall Study|pharmacy error|1|||
105637855|NCT01823224|364338472|FG000|Overall Study|missed med dose|0|||
105637856|NCT01823224|364338473|FG001|Overall Study|missed med dose|1|||
105637857|NCT01823224|364338472|FG000|Overall Study|Withdrawal by Subject|0|||
105637858|NCT01823224|364338473|FG001|Overall Study|Withdrawal by Subject|1|||
105637859|NCT00745875|364338476|FG000|Overall Study|Continuing study treatment|4|||
105637860|NCT00745875|364338477|FG001|Overall Study|Continuing study treatment|4|||
105637861|NCT01833455|364338480|FG000|Overall Study|Withdrawal by Subject|1|||
105637862|NCT01833455|364338481|FG001|Overall Study|Withdrawal by Subject|0|||
105637863|NCT03041090|364338482|FG000|Overall Study|technical error|0|||
105637864|NCT03041090|364338483|FG001|Overall Study|technical error|3|||
105637865|NCT03960645|364338484|FG000|Overall Study|Protocol Violation|1|||
105637866|NCT03960645|364338485|FG001|Overall Study|Protocol Violation|0|||
105637867|NCT01536704|364338489|FG000|Washout Period 1|Withdrawal by Subject|1|||
105637868|NCT01536704|364338490|FG001|Washout Period 1|Withdrawal by Subject|2|||
105637869|NCT01536704|364338491|FG002|Washout Period 1|Withdrawal by Subject|0|||
105637870|NCT01536704|364338492|FG003|Washout Period 1|Withdrawal by Subject|0|||
105637871|NCT01536704|364338489|FG000|Washout Period 2|Adverse Event|1|||
105637872|NCT01536704|364338490|FG001|Washout Period 2|Adverse Event|0|||
105637873|NCT01536704|364338491|FG002|Washout Period 2|Adverse Event|0|||
105637874|NCT01536704|364338492|FG003|Washout Period 2|Adverse Event|0|||
105637875|NCT01536704|364338489|FG000|Washout Period 2|Withdrawal by Subject|0|||
105637876|NCT01536704|364338490|FG001|Washout Period 2|Withdrawal by Subject|0|||
105637877|NCT01536704|364338491|FG002|Washout Period 2|Withdrawal by Subject|0|||
105637878|NCT01536704|364338492|FG003|Washout Period 2|Withdrawal by Subject|1|||
105637879|NCT01536704|364338489|FG000|Period 3|Adverse Event|0|||
105637880|NCT01536704|364338490|FG001|Period 3|Adverse Event|0|||
105637881|NCT01536704|364338491|FG002|Period 3|Adverse Event|0|||
105637882|NCT01536704|364338492|FG003|Period 3|Adverse Event|1|||
105637883|NCT01536704|364338489|FG000|Washout Period 3|Adverse Event|0|||
105637884|NCT01536704|364338490|FG001|Washout Period 3|Adverse Event|0|||
105637885|NCT01536704|364338491|FG002|Washout Period 3|Adverse Event|1|||
105637886|NCT01536704|364338492|FG003|Washout Period 3|Adverse Event|0|||
105637887|NCT04658784|364338493|FG000|6-month Follow-up|Lost to Follow-up|2|||
105637888|NCT04658784|364338494|FG001|6-month Follow-up|Lost to Follow-up|5|||
105637889|NCT02575365|364338495|FG000|Overall Study|Lost to Follow-up|4|||
105637890|NCT01009645|364338503|FG000|Overall Study|Lost to Follow-up|2|||
105637891|NCT01009645|364338504|FG001|Overall Study|Lost to Follow-up|8|||
105637892|NCT01009645|364338505|FG002|Overall Study|Lost to Follow-up|4|||
105637893|NCT01009645|364338506|FG003|Overall Study|Lost to Follow-up|5|||
105637894|NCT03345979|364338507|FG000|Overall Study|Withdrawal by Subject|20|||
105637895|NCT03345979|364338508|FG001|Overall Study|Withdrawal by Subject|31|||
105637896|NCT03345979|364338507|FG000|Overall Study|Adverse Event|10|||
105637897|NCT03345979|364338508|FG001|Overall Study|Adverse Event|11|||
105637898|NCT03345979|364338507|FG000|Overall Study|Lost to Follow-up|8|||
105637899|NCT03345979|364338508|FG001|Overall Study|Lost to Follow-up|9|||
105637900|NCT03345979|364338507|FG000|Overall Study|Lack of Efficacy|4|||
105637901|NCT03345979|364338508|FG001|Overall Study|Lack of Efficacy|2|||
105637902|NCT03345979|364338507|FG000|Overall Study|Protocol Violation|1|||
105637903|NCT03345979|364338508|FG001|Overall Study|Protocol Violation|3|||
105637904|NCT03345979|364338507|FG000|Overall Study|Physician Decision|0|||
105637905|NCT03345979|364338508|FG001|Overall Study|Physician Decision|2|||
105637906|NCT00999596|364338511|FG000|Overall Study|Statistical population not required|101|||
105637907|NCT02095145|364338512|FG000|Overall Study|Withdrawal by Subject|1|||
105637908|NCT02095145|364338513|FG001|Overall Study|Withdrawal by Subject|0|||
105637909|NCT02630186|364338514|FG000|Overall Study|Withdrawal by Subject|1|||
105637910|NCT03176407|364338515|FG000|Overall Study|Protocol Violation|1|||
105637911|NCT03176407|364338515|FG000|Overall Study|human failure|1|||
105637912|NCT03176407|364338515|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
105637913|NCT02128269|364338516|FG000|Treatment Period|Adverse Event|1|||
105637914|NCT02128269|364338516|FG000|Treatment Period|Physician Decision|1|||
105637915|NCT01021748|364338517|FG000|Overall Study|Adverse Event|2|||
105637916|NCT01021748|364338518|FG001|Overall Study|Adverse Event|1|||
105637917|NCT01021748|364338519|FG002|Overall Study|Adverse Event|2|||
105637918|NCT01021748|364338520|FG003|Overall Study|Adverse Event|0|||
105637919|NCT01021748|364338521|FG004|Overall Study|Adverse Event|2|||
105637920|NCT01021748|364338522|FG005|Overall Study|Adverse Event|0|||
105637921|NCT01021748|364338523|FG006|Overall Study|Adverse Event|1|||
105637922|NCT01021748|364338524|FG007|Overall Study|Adverse Event|0|||
105637923|NCT01021748|364338525|FG008|Overall Study|Adverse Event|7|||
105637924|NCT01021748|364338517|FG000|Overall Study|Physician Decision|1|||
105637925|NCT01021748|364338518|FG001|Overall Study|Physician Decision|0|||
105637926|NCT01021748|364338519|FG002|Overall Study|Physician Decision|1|||
105637927|NCT01021748|364338520|FG003|Overall Study|Physician Decision|1|||
105637928|NCT01021748|364338521|FG004|Overall Study|Physician Decision|0|||
105637929|NCT01021748|364338522|FG005|Overall Study|Physician Decision|0|||
105637930|NCT01021748|364338523|FG006|Overall Study|Physician Decision|1|||
105637931|NCT01021748|364338524|FG007|Overall Study|Physician Decision|1|||
105637932|NCT01021748|364338525|FG008|Overall Study|Physician Decision|2|||
105637933|NCT01021748|364338517|FG000|Overall Study|Progressive Disease|3|||
105637934|NCT01021748|364338518|FG001|Overall Study|Progressive Disease|3|||
105637935|NCT01021748|364338519|FG002|Overall Study|Progressive Disease|4|||
105637936|NCT01021748|364338520|FG003|Overall Study|Progressive Disease|6|||
105637937|NCT01021748|364338521|FG004|Overall Study|Progressive Disease|7|||
105637938|NCT01021748|364338522|FG005|Overall Study|Progressive Disease|3|||
105637939|NCT01021748|364338523|FG006|Overall Study|Progressive Disease|0|||
105637940|NCT01021748|364338524|FG007|Overall Study|Progressive Disease|5|||
105637941|NCT01021748|364338525|FG008|Overall Study|Progressive Disease|6|||
105637942|NCT01021748|364338517|FG000|Overall Study|Withdrawal by Subject|0|||
105637943|NCT01021748|364338518|FG001|Overall Study|Withdrawal by Subject|0|||
105637944|NCT01021748|364338519|FG002|Overall Study|Withdrawal by Subject|0|||
105637945|NCT01021748|364338520|FG003|Overall Study|Withdrawal by Subject|0|||
105637946|NCT01021748|364338521|FG004|Overall Study|Withdrawal by Subject|0|||
105637947|NCT01021748|364338522|FG005|Overall Study|Withdrawal by Subject|0|||
105637948|NCT01021748|364338523|FG006|Overall Study|Withdrawal by Subject|1|||
105637949|NCT01021748|364338524|FG007|Overall Study|Withdrawal by Subject|0|||
105637950|NCT01021748|364338525|FG008|Overall Study|Withdrawal by Subject|1|||
105637951|NCT01021748|364338517|FG000|Overall Study|Not Treated|0|||
105637952|NCT01021748|364338518|FG001|Overall Study|Not Treated|1|||
105637953|NCT01021748|364338519|FG002|Overall Study|Not Treated|0|||
105637954|NCT01021748|364338520|FG003|Overall Study|Not Treated|0|||
105637955|NCT01021748|364338521|FG004|Overall Study|Not Treated|0|||
105637956|NCT01021748|364338522|FG005|Overall Study|Not Treated|0|||
105637957|NCT01021748|364338523|FG006|Overall Study|Not Treated|0|||
105637958|NCT01021748|364338524|FG007|Overall Study|Not Treated|0|||
105637959|NCT01021748|364338525|FG008|Overall Study|Not Treated|0|||
105637960|NCT01829711|364338529|FG000|Overall Study|Lost to Follow-up|2|||
105637961|NCT01829711|364338529|FG000|Overall Study|Withdrawal by Subject|3|||
105637962|NCT01829711|364338529|FG000|Overall Study|Death|4|||
105637963|NCT01829711|364338529|FG000|Overall Study|Started new therapies|17|||
105637964|NCT01829711|364338529|FG000|Overall Study|Adverse Event|3|||
105637965|NCT01829711|364338529|FG000|Overall Study|Due to progression of disease|13|||
105637966|NCT01829711|364338529|FG000|Overall Study|Due to lack of response|1|||
105637967|NCT02309515|364338532|FG000|Overall Study|Withdrawal by Subject|0|||
105637968|NCT02309515|364338533|FG001|Overall Study|Withdrawal by Subject|1|||
105637969|NCT01999335|364338536|FG000|Overall Study|Discontinued before receiving treatment|0|||
105637970|NCT01999335|364338537|FG001|Overall Study|Discontinued before receiving treatment|0|||
105637971|NCT01999335|364338538|FG002|Overall Study|Discontinued before receiving treatment|0|||
105637972|NCT01999335|364338539|FG003|Overall Study|Discontinued before receiving treatment|0|||
105637973|NCT01999335|364338540|FG004|Overall Study|Discontinued before receiving treatment|2|||
105637974|NCT01303510|364338541|FG000|Overall Study|Lost to Follow-up|1|||
105637975|NCT01303510|364338542|FG001|Overall Study|Lost to Follow-up|0|||
105637976|NCT01485887|364338543|FG000|Overall Study|Withdrawal by Subject|2|||
105637977|NCT01485887|364338543|FG000|Overall Study|Adverse Event|8|||
105637978|NCT01485887|364338543|FG000|Overall Study|Deterioration of primary disease|1|||
105637979|NCT01485887|364338543|FG000|Overall Study|Primary disease markedly improved|1|||
105637980|NCT02404441|364338544|FG000|Phase 1 Part|Adverse Event|1|||
105637981|NCT02404441|364338545|FG001|Phase 1 Part|Adverse Event|0|||
105637982|NCT02404441|364338546|FG002|Phase 1 Part|Adverse Event|0|||
105637983|NCT02404441|364338547|FG003|Phase 1 Part|Adverse Event|0|||
105637984|NCT02404441|364338548|FG004|Phase 1 Part|Adverse Event|0|||
105637985|NCT02404441|364338549|FG005|Phase 1 Part|Adverse Event|0|||
105637986|NCT02404441|364338550|FG006|Phase 1 Part|Adverse Event|0|||
105637987|NCT02404441|364338551|FG007|Phase 1 Part|Adverse Event|0|||
105637988|NCT02404441|364338552|FG008|Phase 1 Part|Adverse Event|0|||
105637989|NCT02404441|364338553|FG009|Phase 1 Part|Adverse Event|0|||
105637990|NCT02404441|364338544|FG000|Phase 1 Part|Physician Decision|0|||
105637991|NCT02404441|364338545|FG001|Phase 1 Part|Physician Decision|1|||
105637992|NCT02404441|364338546|FG002|Phase 1 Part|Physician Decision|0|||
105637993|NCT02404441|364338547|FG003|Phase 1 Part|Physician Decision|0|||
105637994|NCT02404441|364338548|FG004|Phase 1 Part|Physician Decision|0|||
105637995|NCT02404441|364338549|FG005|Phase 1 Part|Physician Decision|0|||
105637996|NCT02404441|364338550|FG006|Phase 1 Part|Physician Decision|0|||
105637997|NCT02404441|364338551|FG007|Phase 1 Part|Physician Decision|0|||
105637998|NCT02404441|364338552|FG008|Phase 1 Part|Physician Decision|0|||
105637999|NCT02404441|364338553|FG009|Phase 1 Part|Physician Decision|0|||
105638000|NCT02404441|364338544|FG000|Phase 1 Part|Progressive Disease|14|||
105638001|NCT02404441|364338545|FG001|Phase 1 Part|Progressive Disease|11|||
105638002|NCT02404441|364338546|FG002|Phase 1 Part|Progressive Disease|7|||
105638003|NCT02404441|364338547|FG003|Phase 1 Part|Progressive Disease|6|||
105638004|NCT02404441|364338548|FG004|Phase 1 Part|Progressive Disease|9|||
105638005|NCT02404441|364338549|FG005|Phase 1 Part|Progressive Disease|0|||
105638006|NCT02404441|364338550|FG006|Phase 1 Part|Progressive Disease|0|||
105638007|NCT02404441|364338551|FG007|Phase 1 Part|Progressive Disease|0|||
105638008|NCT02404441|364338552|FG008|Phase 1 Part|Progressive Disease|0|||
105638009|NCT02404441|364338553|FG009|Phase 1 Part|Progressive Disease|0|||
105638010|NCT02404441|364338544|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
105638011|NCT02404441|364338545|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
105638012|NCT02404441|364338546|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
105638013|NCT02404441|364338547|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
105638014|NCT02404441|364338548|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
105638015|NCT02404441|364338549|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
105638016|NCT02404441|364338550|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
105638017|NCT02404441|364338551|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
105638018|NCT02404441|364338552|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
105638019|NCT02404441|364338553|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
105638020|NCT02404441|364338544|FG000|Phase 1 Part|Death|1|||
105638021|NCT02404441|364338545|FG001|Phase 1 Part|Death|1|||
105638022|NCT02404441|364338546|FG002|Phase 1 Part|Death|1|||
105638023|NCT02404441|364338547|FG003|Phase 1 Part|Death|0|||
105638024|NCT02404441|364338548|FG004|Phase 1 Part|Death|1|||
105638025|NCT02404441|364338549|FG005|Phase 1 Part|Death|0|||
105638026|NCT02404441|364338550|FG006|Phase 1 Part|Death|0|||
105638027|NCT02404441|364338551|FG007|Phase 1 Part|Death|0|||
105638028|NCT02404441|364338552|FG008|Phase 1 Part|Death|0|||
105638029|NCT02404441|364338553|FG009|Phase 1 Part|Death|0|||
105638030|NCT02404441|364338544|FG000|Phase 2 Part|Adverse Event|0|||
105638031|NCT02404441|364338545|FG001|Phase 2 Part|Adverse Event|0|||
105638032|NCT02404441|364338546|FG002|Phase 2 Part|Adverse Event|0|||
105638033|NCT02404441|364338547|FG003|Phase 2 Part|Adverse Event|0|||
105638034|NCT02404441|364338548|FG004|Phase 2 Part|Adverse Event|0|||
105638035|NCT02404441|364338549|FG005|Phase 2 Part|Adverse Event|2|||
105638036|NCT02404441|364338550|FG006|Phase 2 Part|Adverse Event|3|||
105638037|NCT02404441|364338551|FG007|Phase 2 Part|Adverse Event|3|||
105638038|NCT02404441|364338552|FG008|Phase 2 Part|Adverse Event|6|||
105638039|NCT02404441|364338553|FG009|Phase 2 Part|Adverse Event|1|||
105638040|NCT02404441|364338544|FG000|Phase 2 Part|Physician Decision|0|||
105638041|NCT02404441|364338545|FG001|Phase 2 Part|Physician Decision|0|||
105638042|NCT02404441|364338546|FG002|Phase 2 Part|Physician Decision|0|||
105638043|NCT02404441|364338547|FG003|Phase 2 Part|Physician Decision|0|||
105638044|NCT02404441|364338548|FG004|Phase 2 Part|Physician Decision|0|||
105638045|NCT02404441|364338549|FG005|Phase 2 Part|Physician Decision|7|||
105638046|NCT02404441|364338550|FG006|Phase 2 Part|Physician Decision|9|||
105638047|NCT02404441|364338551|FG007|Phase 2 Part|Physician Decision|2|||
105638048|NCT02404441|364338552|FG008|Phase 2 Part|Physician Decision|1|||
105638049|NCT02404441|364338553|FG009|Phase 2 Part|Physician Decision|3|||
105638050|NCT02404441|364338544|FG000|Phase 2 Part|Progressive disease|0|||
105638051|NCT02404441|364338545|FG001|Phase 2 Part|Progressive disease|0|||
105638052|NCT02404441|364338546|FG002|Phase 2 Part|Progressive disease|0|||
105638053|NCT02404441|364338547|FG003|Phase 2 Part|Progressive disease|0|||
105638054|NCT02404441|364338548|FG004|Phase 2 Part|Progressive disease|0|||
105638055|NCT02404441|364338549|FG005|Phase 2 Part|Progressive disease|43|||
105638056|NCT02404441|364338550|FG006|Phase 2 Part|Progressive disease|32|||
105638057|NCT02404441|364338551|FG007|Phase 2 Part|Progressive disease|31|||
105638058|NCT02404441|364338552|FG008|Phase 2 Part|Progressive disease|39|||
105638059|NCT02404441|364338553|FG009|Phase 2 Part|Progressive disease|27|||
105638060|NCT02404441|364338544|FG000|Phase 2 Part|Subject/guardian decision|0|||
105638061|NCT02404441|364338545|FG001|Phase 2 Part|Subject/guardian decision|0|||
105638062|NCT02404441|364338546|FG002|Phase 2 Part|Subject/guardian decision|0|||
105638063|NCT02404441|364338547|FG003|Phase 2 Part|Subject/guardian decision|0|||
105638064|NCT02404441|364338548|FG004|Phase 2 Part|Subject/guardian decision|0|||
105638065|NCT02404441|364338549|FG005|Phase 2 Part|Subject/guardian decision|3|||
105638066|NCT02404441|364338550|FG006|Phase 2 Part|Subject/guardian decision|9|||
105638067|NCT02404441|364338551|FG007|Phase 2 Part|Subject/guardian decision|0|||
105638068|NCT02404441|364338552|FG008|Phase 2 Part|Subject/guardian decision|3|||
105638069|NCT02404441|364338553|FG009|Phase 2 Part|Subject/guardian decision|2|||
105638070|NCT02404441|364338544|FG000|Phase 2 Part|Death|0|||
105638071|NCT02404441|364338545|FG001|Phase 2 Part|Death|0|||
105638072|NCT02404441|364338546|FG002|Phase 2 Part|Death|0|||
105638073|NCT02404441|364338547|FG003|Phase 2 Part|Death|0|||
105638074|NCT02404441|364338548|FG004|Phase 2 Part|Death|0|||
105638075|NCT02404441|364338549|FG005|Phase 2 Part|Death|4|||
105638076|NCT02404441|364338550|FG006|Phase 2 Part|Death|8|||
105638077|NCT02404441|364338551|FG007|Phase 2 Part|Death|4|||
105638078|NCT02404441|364338552|FG008|Phase 2 Part|Death|10|||
105638079|NCT02404441|364338553|FG009|Phase 2 Part|Death|9|||
105638080|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638081|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638082|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638083|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
105638084|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638085|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638086|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
105638087|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638088|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
105638089|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638090|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638091|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638092|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638093|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
105638094|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Death|1|||
105638095|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Death|2|||
105638096|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Death|0|||
105638097|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Death|1|||
105638098|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Death|0|||
105638099|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Death|0|||
105638100|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Death|0|||
105638101|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
105638102|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
105638103|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
105638104|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
105638105|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
105638106|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
105638107|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
105638108|NCT02234141|364338554|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638109|NCT02234141|364338555|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
105638110|NCT02234141|364338556|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638111|NCT02234141|364338557|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638112|NCT02234141|364338558|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638113|NCT02234141|364338559|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638114|NCT02234141|364338560|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
105638115|NCT02234141|364338554|FG000|Long-Term Treatment Period|Death|0|||
105638116|NCT02234141|364338555|FG001|Long-Term Treatment Period|Death|0|||
105638117|NCT02234141|364338556|FG002|Long-Term Treatment Period|Death|0|||
105638118|NCT02234141|364338557|FG003|Long-Term Treatment Period|Death|0|||
105638119|NCT02234141|364338558|FG004|Long-Term Treatment Period|Death|0|||
105638120|NCT02234141|364338559|FG005|Long-Term Treatment Period|Death|1|||
105638121|NCT02234141|364338560|FG006|Long-Term Treatment Period|Death|0|||
105870012|NCT04728802|365176881|FG001|Overall Study|Other|0|||
105870013|NCT00262028|365176882|FG000|Overall Study|Withdrawal by Subject|6|||
105638122|NCT02234141|364338554|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
105638123|NCT02234141|364338555|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
105638124|NCT02234141|364338556|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
105638125|NCT02234141|364338557|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
105638126|NCT02234141|364338558|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
105638127|NCT02234141|364338559|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
105870014|NCT00262028|365176883|FG001|Overall Study|Withdrawal by Subject|3|||
105638128|NCT02234141|364338560|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
105638129|NCT02234141|364338554|FG000|Long-Term Treatment Period|Adverse Event|4|||
105638130|NCT02234141|364338555|FG001|Long-Term Treatment Period|Adverse Event|0|||
105638131|NCT02234141|364338556|FG002|Long-Term Treatment Period|Adverse Event|5|||
105638132|NCT02234141|364338557|FG003|Long-Term Treatment Period|Adverse Event|0|||
105638133|NCT02234141|364338558|FG004|Long-Term Treatment Period|Adverse Event|1|||
105638134|NCT02234141|364338559|FG005|Long-Term Treatment Period|Adverse Event|1|||
105638135|NCT02234141|364338560|FG006|Long-Term Treatment Period|Adverse Event|1|||
105638136|NCT02234141|364338554|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
105638137|NCT02234141|364338555|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
105638138|NCT02234141|364338556|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
105638139|NCT02234141|364338557|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
105638140|NCT02234141|364338558|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
105638141|NCT02234141|364338559|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
105638142|NCT02234141|364338560|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
105638143|NCT02234141|364338554|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
105638144|NCT02234141|364338555|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
105638145|NCT02234141|364338556|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
105638146|NCT02234141|364338557|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
105638147|NCT02234141|364338558|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
105638148|NCT02234141|364338559|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
105638149|NCT02234141|364338560|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
105638150|NCT03057600|364338561|FG000|Overall Study|Adverse Event|0|||
105638151|NCT03057600|364338562|FG001|Overall Study|Adverse Event|0|||
105638152|NCT03057600|364338563|FG002|Overall Study|Adverse Event|4|||
105638153|NCT03057600|364338564|FG003|Overall Study|Adverse Event|0|||
105638154|NCT03057600|364338561|FG000|Overall Study|Radiologic Disease Progression|8|||
105638155|NCT03057600|364338562|FG001|Overall Study|Radiologic Disease Progression|7|||
105638156|NCT03057600|364338563|FG002|Overall Study|Radiologic Disease Progression|13|||
105638157|NCT03057600|364338564|FG003|Overall Study|Radiologic Disease Progression|10|||
105638158|NCT03057600|364338561|FG000|Overall Study|Symptomatic Deterioration|0|||
105638159|NCT03057600|364338562|FG001|Overall Study|Symptomatic Deterioration|1|||
105638160|NCT03057600|364338563|FG002|Overall Study|Symptomatic Deterioration|1|||
105638161|NCT03057600|364338564|FG003|Overall Study|Symptomatic Deterioration|0|||
105638162|NCT03057600|364338561|FG000|Overall Study|Investigator Decision|0|||
105638163|NCT03057600|364338562|FG001|Overall Study|Investigator Decision|0|||
105638164|NCT03057600|364338563|FG002|Overall Study|Investigator Decision|1|||
105638165|NCT03057600|364338564|FG003|Overall Study|Investigator Decision|0|||
105638166|NCT03057600|364338561|FG000|Overall Study|Study Termination by Sponsor|0|||
105638167|NCT03057600|364338562|FG001|Overall Study|Study Termination by Sponsor|0|||
105638168|NCT03057600|364338563|FG002|Overall Study|Study Termination by Sponsor|0|||
105638169|NCT03057600|364338564|FG003|Overall Study|Study Termination by Sponsor|2|||
105638170|NCT03057600|364338561|FG000|Overall Study|Withdrawal by Subject|0|||
105638171|NCT03057600|364338562|FG001|Overall Study|Withdrawal by Subject|1|||
105638172|NCT03057600|364338563|FG002|Overall Study|Withdrawal by Subject|0|||
105638173|NCT03057600|364338564|FG003|Overall Study|Withdrawal by Subject|0|||
105638174|NCT03057600|364338561|FG000|Overall Study|Other, Not Specified|1|||
105638175|NCT03057600|364338562|FG001|Overall Study|Other, Not Specified|1|||
105638176|NCT03057600|364338563|FG002|Overall Study|Other, Not Specified|1|||
105638177|NCT03057600|364338564|FG003|Overall Study|Other, Not Specified|1|||
105638178|NCT02095678|364338565|FG000|Overall Study|Withdrawal by Subject|0|||
105638179|NCT02095678|364338566|FG001|Overall Study|Withdrawal by Subject|1|||
105638180|NCT02095678|364338565|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
105638181|NCT02095678|364338566|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
105638182|NCT02095678|364338565|FG000|Overall Study|lesion impacted by previous treatment|1|||
105638183|NCT02095678|364338566|FG001|Overall Study|lesion impacted by previous treatment|1|||
105638184|NCT02095678|364338565|FG000|Overall Study|No Confirmed Diagnosis|0|||
105638185|NCT02095678|364338566|FG001|Overall Study|No Confirmed Diagnosis|3|||
105638186|NCT02095678|364338565|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
105638187|NCT02095678|364338566|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
105638188|NCT02095678|364338565|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
105638189|NCT02095678|364338566|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
105638190|NCT03418545|364338567|FG000|Overall Study|Withdrawal by Participant|2|||
105638191|NCT03418545|364338568|FG001|Overall Study|Withdrawal by Participant|4|||
105638192|NCT03418545|364338567|FG000|Overall Study|Lost to Follow-up|3|||
105638193|NCT03418545|364338568|FG001|Overall Study|Lost to Follow-up|5|||
105638194|NCT03418545|364338567|FG000|Overall Study|Reason Not Specified|0|||
105638195|NCT03418545|364338568|FG001|Overall Study|Reason Not Specified|1|||
105638196|NCT03418545|364338567|FG000|Overall Study|Missing Completion Status|0|||
105638197|NCT03418545|364338568|FG001|Overall Study|Missing Completion Status|1|||
105638198|NCT01170208|364338569|FG000|Overall Study|Withdrawal by Subject|5|||
105638199|NCT01170208|364338570|FG001|Overall Study|Withdrawal by Subject|0|||
105638200|NCT01170208|364338571|FG002|Overall Study|Withdrawal by Subject|1|||
105638201|NCT01170208|364338569|FG000|Overall Study|Protocol Violation|1|||
105638202|NCT01170208|364338570|FG001|Overall Study|Protocol Violation|0|||
105638203|NCT01170208|364338571|FG002|Overall Study|Protocol Violation|1|||
105638204|NCT02161458|364338579|FG000|Overall Study|Withdrawal by Subject|0|||
105638205|NCT02161458|364338580|FG001|Overall Study|Withdrawal by Subject|4|||
105638206|NCT02161458|364338581|FG002|Overall Study|Withdrawal by Subject|4|||
105638207|NCT02161458|364338582|FG003|Overall Study|Withdrawal by Subject|0|||
105638208|NCT02161458|364338579|FG000|Overall Study|Lost to Follow-up|0|||
105638209|NCT02161458|364338580|FG001|Overall Study|Lost to Follow-up|2|||
105638210|NCT02161458|364338581|FG002|Overall Study|Lost to Follow-up|1|||
105638211|NCT02161458|364338582|FG003|Overall Study|Lost to Follow-up|0|||
105638212|NCT02384382|364338583|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
105638213|NCT02384382|364338583|FG000|Overall Study|Death|1|||
105638214|NCT02384382|364338583|FG000|Overall Study|Adverse Event|1|||
105638215|NCT02384382|364338583|FG000|Overall Study|Disease progression|16|||
105638216|NCT00705159|364338596|FG000|Overall Study|Withdrawal by Subject|0|||
105638217|NCT00705159|364338597|FG001|Overall Study|Withdrawal by Subject|1|||
105638218|NCT00705159|364338598|FG002|Overall Study|Withdrawal by Subject|1|||
105638219|NCT00705159|364338599|FG003|Overall Study|Withdrawal by Subject|1|||
105638220|NCT00705159|364338596|FG000|Overall Study|Protocol Violation|0|||
105638221|NCT00705159|364338597|FG001|Overall Study|Protocol Violation|1|||
105638222|NCT00705159|364338598|FG002|Overall Study|Protocol Violation|0|||
105638223|NCT00705159|364338599|FG003|Overall Study|Protocol Violation|0|||
105638224|NCT00705159|364338596|FG000|Overall Study|Adverse Event|0|||
105638225|NCT00705159|364338597|FG001|Overall Study|Adverse Event|0|||
105638226|NCT00705159|364338598|FG002|Overall Study|Adverse Event|1|||
105638227|NCT00705159|364338599|FG003|Overall Study|Adverse Event|0|||
105638228|NCT00705159|364338596|FG000|Overall Study|Lost to Follow-up|0|||
105638229|NCT00705159|364338597|FG001|Overall Study|Lost to Follow-up|0|||
105638230|NCT00705159|364338598|FG002|Overall Study|Lost to Follow-up|3|||
105638231|NCT00705159|364338599|FG003|Overall Study|Lost to Follow-up|2|||
105638232|NCT00705159|364338596|FG000|Overall Study|Screen Failure|0|||
105638233|NCT00705159|364338597|FG001|Overall Study|Screen Failure|0|||
105638234|NCT00705159|364338598|FG002|Overall Study|Screen Failure|0|||
105638235|NCT00705159|364338599|FG003|Overall Study|Screen Failure|1|||
105638236|NCT02091752|364338602|FG000|Overall Study|Study terminated by Sponsor|2|||
105638237|NCT02091752|364338602|FG000|Overall Study|Adverse Event|1|||
105638238|NCT00983294|364338603|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
105638239|NCT00983294|364338603|FG000|Colchicine With Azithromycin|Adverse Event|1|||
105638240|NCT04029090|364338604|FG000|Overall Study|Protocol Violation|1|||
105638241|NCT04029090|364338605|FG001|Overall Study|Protocol Violation|0|||
105638242|NCT04029090|364338606|FG002|Overall Study|Protocol Violation|0|||
105638243|NCT04029090|364338604|FG000|Overall Study|Withdrawal by Subject|0|||
105638244|NCT04029090|364338605|FG001|Overall Study|Withdrawal by Subject|1|||
105638245|NCT04029090|364338606|FG002|Overall Study|Withdrawal by Subject|0|||
105638246|NCT00680771|364338607|FG000|Overall Study|Withdrawal by Subject|1|||
105638247|NCT00680771|364338608|FG001|Overall Study|Withdrawal by Subject|0|||
105638248|NCT00680771|364338607|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
105638249|NCT00680771|364338608|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
105638250|NCT00680771|364338607|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
105638251|NCT00680771|364338608|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
105638252|NCT01604824|364338609|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638253|NCT01604824|364338610|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638254|NCT01604824|364338611|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638255|NCT01604824|364338612|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638256|NCT01604824|364338613|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
105638257|NCT01604824|364338614|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
105638258|NCT01604824|364338609|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638259|NCT01604824|364338610|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638260|NCT01604824|364338611|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638261|NCT01604824|364338612|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638262|NCT01604824|364338613|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
105638263|NCT01604824|364338614|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
105638264|NCT01316913|364338615|FG000|Overall Study|Adverse Event|17|||
105638265|NCT01316913|364338616|FG001|Overall Study|Adverse Event|20|||
105638266|NCT01316913|364338617|FG002|Overall Study|Adverse Event|15|||
105638267|NCT01316913|364338618|FG003|Overall Study|Adverse Event|11|||
105638268|NCT01316913|364338615|FG000|Overall Study|Lack of Efficacy|22|||
105870015|NCT00262028|365176884|FG002|Overall Study|Withdrawal by Subject|6|||
105870016|NCT00262028|365176885|FG003|Overall Study|Withdrawal by Subject|5|||
105638269|NCT01316913|364338616|FG001|Overall Study|Lack of Efficacy|12|||
105638270|NCT01316913|364338617|FG002|Overall Study|Lack of Efficacy|9|||
105638271|NCT01316913|364338618|FG003|Overall Study|Lack of Efficacy|13|||
105638272|NCT01316913|364338615|FG000|Overall Study|Protocol Violation|1|||
105638273|NCT01316913|364338616|FG001|Overall Study|Protocol Violation|4|||
105638274|NCT01316913|364338617|FG002|Overall Study|Protocol Violation|4|||
105638275|NCT01316913|364338618|FG003|Overall Study|Protocol Violation|1|||
105638276|NCT01316913|364338615|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
105638277|NCT01316913|364338616|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
105638278|NCT01316913|364338617|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
105638279|NCT01316913|364338618|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
105638280|NCT01316913|364338615|FG000|Overall Study|Lost to Follow-up|0|||
105870017|NCT00262028|365176886|FG004|Overall Study|Withdrawal by Subject|2|||
105870018|NCT00262028|365176887|FG005|Overall Study|Withdrawal by Subject|3|||
105870019|NCT00262028|365176888|FG006|Overall Study|Withdrawal by Subject|5|||
105870020|NCT00262028|365176889|FG007|Overall Study|Withdrawal by Subject|7|||
105870021|NCT00262028|365176890|FG008|Overall Study|Withdrawal by Subject|2|||
105870022|NCT00262028|365176882|FG000|Overall Study|Lost to Follow-up|7|||
105870023|NCT00262028|365176883|FG001|Overall Study|Lost to Follow-up|7|||
105870024|NCT00262028|365176884|FG002|Overall Study|Lost to Follow-up|5|||
105870025|NCT00262028|365176885|FG003|Overall Study|Lost to Follow-up|5|||
105870026|NCT00262028|365176886|FG004|Overall Study|Lost to Follow-up|4|||
105870027|NCT00262028|365176887|FG005|Overall Study|Lost to Follow-up|3|||
105870028|NCT00262028|365176888|FG006|Overall Study|Lost to Follow-up|3|||
105870029|NCT00262028|365176889|FG007|Overall Study|Lost to Follow-up|5|||
105870030|NCT00262028|365176890|FG008|Overall Study|Lost to Follow-up|6|||
105870031|NCT00262028|365176882|FG000|Overall Study|Administrative Reason|11|||
105870032|NCT00262028|365176883|FG001|Overall Study|Administrative Reason|14|||
105870033|NCT00262028|365176884|FG002|Overall Study|Administrative Reason|9|||
105870034|NCT00262028|365176885|FG003|Overall Study|Administrative Reason|12|||
105870035|NCT00262028|365176886|FG004|Overall Study|Administrative Reason|6|||
105870036|NCT00262028|365176887|FG005|Overall Study|Administrative Reason|7|||
105870037|NCT00262028|365176888|FG006|Overall Study|Administrative Reason|4|||
105870038|NCT00262028|365176889|FG007|Overall Study|Administrative Reason|6|||
105870039|NCT00262028|365176890|FG008|Overall Study|Administrative Reason|10|||
105870040|NCT00262028|365176882|FG000|Overall Study|Protocol Violation|0|||
105870041|NCT00262028|365176883|FG001|Overall Study|Protocol Violation|0|||
105870042|NCT00262028|365176884|FG002|Overall Study|Protocol Violation|0|||
105870043|NCT00262028|365176885|FG003|Overall Study|Protocol Violation|1|||
105870044|NCT00262028|365176886|FG004|Overall Study|Protocol Violation|0|||
105870045|NCT00262028|365176887|FG005|Overall Study|Protocol Violation|0|||
105870046|NCT00262028|365176888|FG006|Overall Study|Protocol Violation|0|||
105870047|NCT00262028|365176889|FG007|Overall Study|Protocol Violation|0|||
105870048|NCT00262028|365176890|FG008|Overall Study|Protocol Violation|0|||
105870049|NCT00262028|365176882|FG000|Overall Study|Unable to classify|0|||
105870050|NCT00262028|365176883|FG001|Overall Study|Unable to classify|3|||
105870051|NCT00262028|365176884|FG002|Overall Study|Unable to classify|0|||
105870052|NCT00262028|365176885|FG003|Overall Study|Unable to classify|0|||
105870053|NCT00262028|365176886|FG004|Overall Study|Unable to classify|0|||
105870054|NCT00262028|365176887|FG005|Overall Study|Unable to classify|0|||
105870055|NCT00262028|365176888|FG006|Overall Study|Unable to classify|0|||
105870056|NCT00262028|365176889|FG007|Overall Study|Unable to classify|0|||
105870057|NCT00262028|365176890|FG008|Overall Study|Unable to classify|1|||
105870058|NCT02308124|365176892|FG000|Overall Study|Lost to Follow-up|6|||
105870059|NCT02308124|365176893|FG001|Overall Study|Lost to Follow-up|6|||
105870060|NCT02308124|365176894|FG002|Overall Study|Lost to Follow-up|6|||
105870061|NCT02308124|365176892|FG000|Overall Study|Adverse Event|0|||
105870062|NCT02308124|365176893|FG001|Overall Study|Adverse Event|2|||
105870063|NCT02308124|365176894|FG002|Overall Study|Adverse Event|2|||
105870064|NCT04388553|365176900|FG000|Overall Study|Protocol Violation|1|||
105870065|NCT04388553|365176901|FG001|Overall Study|Protocol Violation|0|||
105870066|NCT02553772|365176916|FG000|Overall Study|Adverse Event|2|||
105870067|NCT02553772|365176917|FG001|Overall Study|Adverse Event|3|||
105870068|NCT02553772|365176916|FG000|Overall Study|Lost to Follow-up|2|||
105870069|NCT02553772|365176917|FG001|Overall Study|Lost to Follow-up|1|||
105870070|NCT02553772|365176916|FG000|Overall Study|Withdrawal of Consent|1|||
105870071|NCT02553772|365176917|FG001|Overall Study|Withdrawal of Consent|1|||
105870072|NCT02553772|365176916|FG000|Overall Study|Lack of Efficacy|1|||
105870073|NCT02553772|365176917|FG001|Overall Study|Lack of Efficacy|0|||
105870074|NCT02553772|365176916|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105870075|NCT02553772|365176917|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105870076|NCT00786409|365176918|FG000|Overall Study|Withdrawal by Subject|2|||
105870077|NCT00786409|365176918|FG000|Overall Study|Adverse Event|2|||
105870078|NCT00786409|365176918|FG000|Overall Study|Pregnancy|2|||
105870079|NCT00786409|365176918|FG000|Overall Study|Lost to Follow-up|1|||
105870080|NCT00610129|365176919|FG000|Overall Study|Not treated since patients ineligible|3|||
105870081|NCT01876446|365176922|FG000|Overall Study|Death|0|||
105870082|NCT01876446|365176923|FG001|Overall Study|Death|1|||
105870083|NCT01876446|365176922|FG000|Overall Study|Withdrawal by Subject|1|||
105870084|NCT01876446|365176923|FG001|Overall Study|Withdrawal by Subject|2|||
105870085|NCT01876446|365176922|FG000|Overall Study|Physician Decision|1|||
105870086|NCT01876446|365176923|FG001|Overall Study|Physician Decision|3|||
105870087|NCT03180645|365176925|FG000|Overall Study|Adverse Event|0|||
105638281|NCT01316913|364338616|FG001|Overall Study|Lost to Follow-up|1|||
105638282|NCT01316913|364338617|FG002|Overall Study|Lost to Follow-up|0|||
105638283|NCT01316913|364338618|FG003|Overall Study|Lost to Follow-up|2|||
105638284|NCT01316913|364338615|FG000|Overall Study|Withdrawal by Subject|10|||
105638285|NCT01316913|364338616|FG001|Overall Study|Withdrawal by Subject|9|||
105638286|NCT01316913|364338617|FG002|Overall Study|Withdrawal by Subject|10|||
105638287|NCT01316913|364338618|FG003|Overall Study|Withdrawal by Subject|6|||
105638288|NCT01801007|364338619|FG000|Overall Study|Adverse Event|2|||
105638289|NCT01801007|364338619|FG000|Overall Study|Lost to Follow-up|4|||
105638290|NCT01801007|364338619|FG000|Overall Study|Withdrawal by Subject|5|||
105638291|NCT03659136|364338629|FG000|Overall Study|Not treated|2|||
105638292|NCT03659136|364338630|FG001|Overall Study|Not treated|0|||
105638293|NCT03659136|364338629|FG000|Overall Study|Covid-19 related|1|||
105638294|NCT03659136|364338630|FG001|Overall Study|Covid-19 related|1|||
105638295|NCT03659136|364338629|FG000|Overall Study|Withdrawal by Subject|1|||
105638296|NCT03659136|364338630|FG001|Overall Study|Withdrawal by Subject|6|||
105638297|NCT03659136|364338629|FG000|Overall Study|Adverse Event|4|||
105638298|NCT03659136|364338630|FG001|Overall Study|Adverse Event|6|||
105638299|NCT03659136|364338629|FG000|Overall Study|Progressive disease|37|||
105638300|NCT03659136|364338630|FG001|Overall Study|Progressive disease|31|||
105638301|NCT03659136|364338629|FG000|Overall Study|Study closure|2|||
105638302|NCT03659136|364338630|FG001|Overall Study|Study closure|2|||
105638303|NCT03659136|364338629|FG000|Overall Study|Sponsor decision/recommendation|3|||
105638304|NCT03659136|364338630|FG001|Overall Study|Sponsor decision/recommendation|2|||
105638305|NCT03659136|364338629|FG000|Overall Study|Switched to other drug/therapy|2|||
105638306|NCT03659136|364338630|FG001|Overall Study|Switched to other drug/therapy|2|||
105638307|NCT03659136|364338629|FG000|Overall Study|Lack of clinical benefit|0|||
105638308|NCT03659136|364338630|FG001|Overall Study|Lack of clinical benefit|1|||
105638309|NCT00492050|364338631|FG000|Overall Study|Adverse Event|1|||
105638310|NCT00492050|364338631|FG000|Overall Study|Lack of Efficacy|1|||
105638311|NCT00492050|364338631|FG000|Overall Study|Withdrawal by Subject|3|||
105638312|NCT00492050|364338631|FG000|Overall Study|Unable to collect SCT|2|||
105638313|NCT00492050|364338631|FG000|Overall Study|Progressive Disease|2|||
105638314|NCT00799409|364340136|FG000|Overall Study|Withdrawal by Subject|1|||
105638315|NCT00799409|364340137|FG001|Overall Study|Withdrawal by Subject|0|||
105638316|NCT00799409|364340138|FG002|Overall Study|Withdrawal by Subject|0|||
105638317|NCT00799409|364340136|FG000|Overall Study|Lost to Follow-up|1|||
105638318|NCT00799409|364340137|FG001|Overall Study|Lost to Follow-up|0|||
105638319|NCT00799409|364340138|FG002|Overall Study|Lost to Follow-up|0|||
105638320|NCT00799409|364340136|FG000|Overall Study|Optimal Dose Not Achieved|2|||
105638321|NCT00799409|364340137|FG001|Overall Study|Optimal Dose Not Achieved|0|||
105638322|NCT00799409|364340138|FG002|Overall Study|Optimal Dose Not Achieved|0|||
105638323|NCT00799409|364340136|FG000|Overall Study|Failure to follow study protocol)|1|||
105638324|NCT00799409|364340137|FG001|Overall Study|Failure to follow study protocol)|0|||
105638325|NCT00799409|364340138|FG002|Overall Study|Failure to follow study protocol)|0|||
105638326|NCT00799409|364340136|FG000|Overall Study|Did not attend lab school day 1|1|||
105638327|NCT00799409|364340137|FG001|Overall Study|Did not attend lab school day 1|0|||
105638328|NCT00799409|364340138|FG002|Overall Study|Did not attend lab school day 1|0|||
105638329|NCT00799409|364340136|FG000|Overall Study|medication compliance|1|||
105638330|NCT00799409|364340137|FG001|Overall Study|medication compliance|0|||
105638331|NCT00799409|364340138|FG002|Overall Study|medication compliance|0|||
105638332|NCT03964974|364340140|FG000|Overall Study|Lost to Follow-up|3|||
105638333|NCT03964974|364340141|FG001|Overall Study|Lost to Follow-up|2|||
105638334|NCT03964974|364340140|FG000|Overall Study|Withdrawal by Subject|0|||
105638335|NCT03964974|364340141|FG001|Overall Study|Withdrawal by Subject|3|||
105638336|NCT00535626|364340142|FG000|Overall Study|Death|15|||
105638337|NCT00535626|364340142|FG000|Overall Study|Lost to Follow-up|29|||
105638338|NCT00535626|364340142|FG000|Overall Study|Withdrawal by Subject|20|||
105638339|NCT00535626|364340142|FG000|Overall Study|Removal/revision of study component|8|||
105638340|NCT00535626|364340142|FG000|Overall Study|Subject terminated|31|||
105638341|NCT00535626|364340142|FG000|Overall Study|Unable to return|2|||
105638342|NCT01970878|364340144|FG000|Overall Study|Withdrawal by Subject|11|||
105638343|NCT01970878|364340145|FG001|Overall Study|Withdrawal by Subject|10|||
105638344|NCT01970878|364340146|FG002|Overall Study|Withdrawal by Subject|14|||
105638345|NCT01970878|364340147|FG003|Overall Study|Withdrawal by Subject|7|||
105638346|NCT01970878|364340144|FG000|Overall Study|Lost to Follow-up|1|||
105638347|NCT01970878|364340145|FG001|Overall Study|Lost to Follow-up|3|||
105638348|NCT01970878|364340146|FG002|Overall Study|Lost to Follow-up|2|||
105638349|NCT01970878|364340147|FG003|Overall Study|Lost to Follow-up|4|||
105638350|NCT01970878|364340144|FG000|Overall Study|Administrative Reasons|1|||
105638351|NCT01970878|364340145|FG001|Overall Study|Administrative Reasons|0|||
105638352|NCT01970878|364340146|FG002|Overall Study|Administrative Reasons|0|||
105638353|NCT01970878|364340147|FG003|Overall Study|Administrative Reasons|4|||
105638354|NCT01970878|364340144|FG000|Overall Study|Lack of Efficacy|2|||
105638355|NCT01970878|364340145|FG001|Overall Study|Lack of Efficacy|1|||
105638356|NCT01970878|364340146|FG002|Overall Study|Lack of Efficacy|2|||
105638357|NCT01970878|364340147|FG003|Overall Study|Lack of Efficacy|0|||
105638358|NCT01970878|364340144|FG000|Overall Study|Adverse Event|12|||
105638359|NCT01970878|364340145|FG001|Overall Study|Adverse Event|7|||
105638360|NCT01970878|364340146|FG002|Overall Study|Adverse Event|4|||
105638361|NCT01970878|364340147|FG003|Overall Study|Adverse Event|3|||
105638362|NCT01970878|364340144|FG000|Overall Study|Protocol Specified Criteria|10|||
105638363|NCT01970878|364340145|FG001|Overall Study|Protocol Specified Criteria|4|||
105638364|NCT01970878|364340146|FG002|Overall Study|Protocol Specified Criteria|3|||
105638365|NCT01970878|364340147|FG003|Overall Study|Protocol Specified Criteria|6|||
105638366|NCT01970878|364340144|FG000|Overall Study|Physician Decision|0|||
105638367|NCT01970878|364340145|FG001|Overall Study|Physician Decision|1|||
105638368|NCT01970878|364340146|FG002|Overall Study|Physician Decision|1|||
105638369|NCT01970878|364340147|FG003|Overall Study|Physician Decision|0|||
105638370|NCT01970878|364340144|FG000|Overall Study|No Completion Status|0|||
105638371|NCT01970878|364340145|FG001|Overall Study|No Completion Status|1|||
105638372|NCT01970878|364340146|FG002|Overall Study|No Completion Status|0|||
105638373|NCT01970878|364340147|FG003|Overall Study|No Completion Status|0|||
105638374|NCT04809623|364340148|FG000|Overall Study|Study Terminated by Sponsor|1|||
105638375|NCT04809623|364340149|FG001|Overall Study|Study Terminated by Sponsor|0|||
105638376|NCT01380145|364340150|FG000|Overall Study|Progressive disease|4|||
105638377|NCT02634307|364340153|FG000|Overall Study|Adverse Event|50|||
105638378|NCT02634307|364340154|FG001|Overall Study|Adverse Event|24|||
105638379|NCT02634307|364340155|FG002|Overall Study|Adverse Event|14|||
105638380|NCT02634307|364340153|FG000|Overall Study|Lost to Follow-up|21|||
105638381|NCT02634307|364340154|FG001|Overall Study|Lost to Follow-up|5|||
105638382|NCT02634307|364340155|FG002|Overall Study|Lost to Follow-up|6|||
105638383|NCT02634307|364340153|FG000|Overall Study|Pregnancy|5|||
105638384|NCT02634307|364340154|FG001|Overall Study|Pregnancy|1|||
105638385|NCT02634307|364340155|FG002|Overall Study|Pregnancy|3|||
105638386|NCT02634307|364340153|FG000|Overall Study|Withdrawal by Subject|38|||
105638387|NCT02634307|364340154|FG001|Overall Study|Withdrawal by Subject|24|||
105638388|NCT02634307|364340155|FG002|Overall Study|Withdrawal by Subject|18|||
105638389|NCT02634307|364340153|FG000|Overall Study|Non-Compliance with Study Drug|0|||
105638390|NCT02634307|364340154|FG001|Overall Study|Non-Compliance with Study Drug|2|||
105638391|NCT02634307|364340155|FG002|Overall Study|Non-Compliance with Study Drug|2|||
105638392|NCT02634307|364340153|FG000|Overall Study|Lack of Efficacy|1|||
105638393|NCT02634307|364340154|FG001|Overall Study|Lack of Efficacy|5|||
105638394|NCT02634307|364340155|FG002|Overall Study|Lack of Efficacy|3|||
105638395|NCT02634307|364340153|FG000|Overall Study|Physician Decision|7|||
105638396|NCT02634307|364340154|FG001|Overall Study|Physician Decision|5|||
105638397|NCT02634307|364340155|FG002|Overall Study|Physician Decision|5|||
105638398|NCT02634307|364340153|FG000|Overall Study|Reason not Specified|3|||
105638399|NCT02634307|364340154|FG001|Overall Study|Reason not Specified|5|||
105638400|NCT02634307|364340155|FG002|Overall Study|Reason not Specified|10|||
105638401|NCT01673594|364340156|FG000|Overall Study|Adverse Event|3|||
105638402|NCT01673594|364340157|FG001|Overall Study|Adverse Event|1|||
105638403|NCT01673594|364340156|FG000|Overall Study|Lost to Follow-up|1|||
105638404|NCT01673594|364340157|FG001|Overall Study|Lost to Follow-up|0|||
105638405|NCT01673594|364340156|FG000|Overall Study|Physician Decision|2|||
105638406|NCT01673594|364340157|FG001|Overall Study|Physician Decision|4|||
105638407|NCT01673594|364340156|FG000|Overall Study|Withdrawal by Subject|0|||
105638408|NCT01673594|364340157|FG001|Overall Study|Withdrawal by Subject|1|||
105638409|NCT02202317|364340163|FG000|Overall Study|Lost to Follow-up|1|||
105638410|NCT01353274|364340164|FG000|Overall Study|No case report form (CRF) collected|28|||
105638411|NCT01256359|364340165|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
105638412|NCT01256359|364340166|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
105638413|NCT01256359|364340165|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
105638414|NCT01256359|364340166|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
105638415|NCT03737110|364340167|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
105638416|NCT03737110|364340168|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
105638417|NCT03737110|364340169|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
105638418|NCT03737110|364340170|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
105638419|NCT03737110|364340171|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
105638420|NCT03737110|364340172|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
105638421|NCT03737110|364340167|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
105638422|NCT03737110|364340168|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638423|NCT03737110|364340169|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638424|NCT03737110|364340170|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638425|NCT03737110|364340171|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638426|NCT03737110|364340172|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
105638427|NCT03737110|364340167|FG000|Run-in (RI) Period|Adverse Event|4|||
105638428|NCT03737110|364340168|FG001|Run-in (RI) Period|Adverse Event|0|||
105638429|NCT03737110|364340169|FG002|Run-in (RI) Period|Adverse Event|0|||
105638430|NCT03737110|364340170|FG003|Run-in (RI) Period|Adverse Event|0|||
105638431|NCT03737110|364340171|FG004|Run-in (RI) Period|Adverse Event|0|||
105638432|NCT03737110|364340172|FG005|Run-in (RI) Period|Adverse Event|0|||
105638433|NCT03737110|364340167|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638434|NCT03737110|364340168|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
105638435|NCT03737110|364340169|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638436|NCT03737110|364340170|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638437|NCT03737110|364340171|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638438|NCT03737110|364340172|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
105638439|NCT03737110|364340167|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638440|NCT03737110|364340168|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638441|NCT03737110|364340169|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
105638442|NCT03737110|364340170|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638443|NCT03737110|364340171|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638444|NCT03737110|364340172|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
105638445|NCT03737110|364340167|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638446|NCT03737110|364340168|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638447|NCT03737110|364340169|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638448|NCT03737110|364340170|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
105638449|NCT03737110|364340171|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638450|NCT03737110|364340172|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
105638451|NCT03737110|364340167|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
105638452|NCT03737110|364340168|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
105638453|NCT03737110|364340169|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
105638454|NCT03737110|364340170|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
105638455|NCT03737110|364340171|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
105638456|NCT03737110|364340172|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
105638457|NCT03737110|364340167|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638458|NCT03737110|364340168|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638459|NCT03737110|364340169|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638460|NCT03737110|364340170|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638461|NCT03737110|364340171|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
105638462|NCT03737110|364340172|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
105638463|NCT00403494|364340173|FG000|Overall Study|Adverse Event|10|||
105638464|NCT00403494|364340174|FG001|Overall Study|Adverse Event|8|||
105638465|NCT00403494|364340173|FG000|Overall Study|Withdrew Consent|3|||
105638466|NCT00403494|364340174|FG001|Overall Study|Withdrew Consent|2|||
105638467|NCT00403494|364340173|FG000|Overall Study|Inappropriately enrolled|0|||
105638468|NCT00403494|364340174|FG001|Overall Study|Inappropriately enrolled|1|||
105638469|NCT00403494|364340173|FG000|Overall Study|Lost to Follow-up|0|||
105638470|NCT00403494|364340174|FG001|Overall Study|Lost to Follow-up|2|||
105638471|NCT00403494|364340173|FG000|Overall Study|Protocol noncompliance|0|||
105638472|NCT00403494|364340174|FG001|Overall Study|Protocol noncompliance|1|||
105638473|NCT00403494|364340173|FG000|Overall Study|Death|1|||
105638474|NCT00403494|364340174|FG001|Overall Study|Death|0|||
105638475|NCT00403494|364340173|FG000|Overall Study|Sponsor Request|1|||
105638476|NCT00403494|364340174|FG001|Overall Study|Sponsor Request|0|||
105638477|NCT00273052|364340180|FG000|Overall Study|Withdrawal by Subject|16|||
105638478|NCT00273052|364340181|FG001|Overall Study|Withdrawal by Subject|19|||
105638479|NCT00273052|364340180|FG000|Overall Study|Adverse Event|21|||
105638480|NCT00273052|364340181|FG001|Overall Study|Adverse Event|19|||
105638481|NCT00273052|364340180|FG000|Overall Study|Protocol Violation|14|||
105638482|NCT00273052|364340181|FG001|Overall Study|Protocol Violation|18|||
105638483|NCT00273052|364340180|FG000|Overall Study|Lost to Follow-up|7|||
105638484|NCT00273052|364340181|FG001|Overall Study|Lost to Follow-up|25|||
105638485|NCT00273052|364340180|FG000|Overall Study|Lack of Efficacy|6|||
105638486|NCT00273052|364340181|FG001|Overall Study|Lack of Efficacy|4|||
105638487|NCT00273052|364340180|FG000|Overall Study|Non-Compliance|3|||
105638488|NCT00273052|364340181|FG001|Overall Study|Non-Compliance|1|||
105638489|NCT00273052|364340180|FG000|Overall Study|Other|2|||
105638490|NCT00273052|364340181|FG001|Overall Study|Other|0|||
105638491|NCT00273052|364340180|FG000|Overall Study|Worsening serum lipid levels|0|||
105638492|NCT00273052|364340181|FG001|Overall Study|Worsening serum lipid levels|2|||
105638493|NCT00454194|364340185|FG000|Overall Study|Adverse Event|7|||
105638494|NCT00454194|364340186|FG001|Overall Study|Adverse Event|2|||
105638495|NCT00454194|364340185|FG000|Overall Study|Withdrawal by Subject|12|||
105638496|NCT00454194|364340186|FG001|Overall Study|Withdrawal by Subject|8|||
105638497|NCT00454194|364340185|FG000|Overall Study|Other Medical Problems|1|||
105638498|NCT00454194|364340186|FG001|Overall Study|Other Medical Problems|2|||
105638499|NCT00454194|364340185|FG000|Overall Study|Other Unspecified Reason|2|||
105638500|NCT00454194|364340186|FG001|Overall Study|Other Unspecified Reason|2|||
105638501|NCT03781375|364340189|FG000|Double-blind Phase|Adverse Event|0|||
105638502|NCT03781375|364340190|FG001|Double-blind Phase|Adverse Event|1|||
105638503|NCT03781375|364340189|FG000|Double-blind Phase|Lack of Response|6|||
105638504|NCT03781375|364340190|FG001|Double-blind Phase|Lack of Response|2|||
105638505|NCT03781375|364340189|FG000|Double-blind Phase|Other|1|||
105638506|NCT03781375|364340190|FG001|Double-blind Phase|Other|3|||
105638507|NCT03781375|364340189|FG000|Open-label Phase|Protocol Issues|0|||
105638508|NCT03781375|364340190|FG001|Open-label Phase|Protocol Issues|1|||
105638509|NCT03781375|364340189|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
105638510|NCT03781375|364340190|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
105638511|NCT03781375|364340189|FG000|Open-label Phase|Other|2|||
105638512|NCT03781375|364340190|FG001|Open-label Phase|Other|2|||
105638513|NCT01074242|364340197|FG000|Overall Study|Case report before date of contract|40|||
105638514|NCT01074242|364340197|FG000|Overall Study|Lost to Follow-up|1|||
105638515|NCT01074242|364340197|FG000|Overall Study|Case report unclear|6|||
105638516|NCT01074242|364340197|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
105638517|NCT01074242|364340197|FG000|Overall Study|Duplicate Case Report Form|5|||
105638518|NCT00526994|364340200|FG000|Overall Study|Lost to Follow-up|98|||
105638519|NCT00526994|364340201|FG001|Overall Study|Lost to Follow-up|108|||
105638520|NCT00526994|364340202|FG002|Overall Study|Lost to Follow-up|96|||
105638521|NCT00526994|364340200|FG000|Overall Study|Death|4|||
105638522|NCT00526994|364340201|FG001|Overall Study|Death|3|||
105638523|NCT00526994|364340202|FG002|Overall Study|Death|3|||
105638524|NCT00526994|364340200|FG000|Overall Study|Withdrawal by Subject|2|||
105638525|NCT00526994|364340201|FG001|Overall Study|Withdrawal by Subject|7|||
105638526|NCT00526994|364340202|FG002|Overall Study|Withdrawal by Subject|5|||
105638527|NCT00526994|364340200|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
105638528|NCT00526994|364340201|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
105638529|NCT00526994|364340202|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
105638530|NCT03026166|364340203|FG000|Overall Study|Death|22|||
105638531|NCT03026166|364340204|FG001|Overall Study|Death|7|||
105638532|NCT03026166|364340203|FG000|Overall Study|Physician Decision|2|||
105638533|NCT03026166|364340204|FG001|Overall Study|Physician Decision|0|||
105638534|NCT03026166|364340203|FG000|Overall Study|Withdrawal by Subject|1|||
105638535|NCT03026166|364340204|FG001|Overall Study|Withdrawal by Subject|2|||
105638536|NCT03026166|364340203|FG000|Overall Study|Lost to Follow-up|1|||
105638537|NCT03026166|364340204|FG001|Overall Study|Lost to Follow-up|0|||
105638538|NCT03026166|364340203|FG000|Overall Study|Study Terminated by Sponsor|3|||
105638539|NCT03026166|364340204|FG001|Overall Study|Study Terminated by Sponsor|3|||
105638540|NCT03026166|364340203|FG000|Overall Study|Other|1|||
105638541|NCT03026166|364340204|FG001|Overall Study|Other|0|||
105638542|NCT03035942|364340207|FG000|Overall Study|Adverse Event|8|||
105638543|NCT03035942|364340208|FG001|Overall Study|Adverse Event|4|||
105638544|NCT03035942|364340209|FG002|Overall Study|Adverse Event|5|||
105638545|NCT05270460|364340210|FG000|Overall Study|Adverse Event|0|||
105638546|NCT05270460|364340211|FG001|Overall Study|Adverse Event|1|||
105638547|NCT05270460|364340212|FG002|Overall Study|Adverse Event|0|||
105638548|NCT05270460|364340210|FG000|Overall Study|Early Termination|0|||
105638549|NCT05270460|364340211|FG001|Overall Study|Early Termination|1|||
105638550|NCT05270460|364340212|FG002|Overall Study|Early Termination|0|||
105638551|NCT03692871|364340214|FG000|Overall Study|Death|1|||
105638552|NCT03692871|364340215|FG001|Overall Study|Death|1|||
105638553|NCT03692871|364340214|FG000|Overall Study|Lost to Follow-up|24|||
105638554|NCT03692871|364340215|FG001|Overall Study|Lost to Follow-up|9|||
105638555|NCT03692871|364340214|FG000|Overall Study|Physician Decision|22|||
105638556|NCT03692871|364340215|FG001|Overall Study|Physician Decision|7|||
105638557|NCT03692871|364340214|FG000|Overall Study|Protocol Deviation|1|||
105638558|NCT03692871|364340215|FG001|Overall Study|Protocol Deviation|0|||
105638559|NCT03692871|364340214|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
105638560|NCT03692871|364340215|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
105638561|NCT01065779|364340217|FG000|Overall Study|Duplicate Investigation|1|||
105638562|NCT01065779|364340217|FG000|Overall Study|Investigation Before Contract Date|37|||
105638563|NCT01065779|364340217|FG000|Overall Study|Non-enrollment Period Administration|10|||
105638564|NCT01065779|364340217|FG000|Overall Study|Not Administered With Study Drug|17|||
105638565|NCT01065779|364340217|FG000|Overall Study|Failed to Follow-up|10|||
105638566|NCT01065779|364340217|FG000|Overall Study|Inclusion Criteria Violation|7|||
105638567|NCT02157948|364340221|FG000|Overall Study|Withdrawal by Subject|4|||
105638568|NCT02157948|364340222|FG001|Overall Study|Withdrawal by Subject|5|||
105638569|NCT02157948|364340221|FG000|Overall Study|Lost to Follow-up|3|||
105638570|NCT02157948|364340222|FG001|Overall Study|Lost to Follow-up|2|||
105638571|NCT02157948|364340221|FG000|Overall Study|Protocol Specified Criteria|2|||
105638572|NCT02157948|364340222|FG001|Overall Study|Protocol Specified Criteria|1|||
105638573|NCT02157948|364340221|FG000|Overall Study|Decision by Sponsor|0|||
105638574|NCT02157948|364340222|FG001|Overall Study|Decision by Sponsor|1|||
105638575|NCT02852824|364340225|FG000|Overall Study|Withdrawal by Subject|1|||
105638576|NCT02852824|364340226|FG001|Overall Study|Withdrawal by Subject|0|||
105638577|NCT02852824|364340227|FG002|Overall Study|Withdrawal by Subject|0|||
105638578|NCT02852824|364340228|FG003|Overall Study|Withdrawal by Subject|0|||
105638579|NCT02852824|364340229|FG004|Overall Study|Withdrawal by Subject|0|||
105638580|NCT02852824|364340230|FG005|Overall Study|Withdrawal by Subject|0|||
105638581|NCT02852824|364340231|FG006|Overall Study|Withdrawal by Subject|0|||
105638582|NCT02852824|364340225|FG000|Overall Study|Adverse Event|0|||
105638583|NCT02852824|364340226|FG001|Overall Study|Adverse Event|0|||
105638584|NCT02852824|364340227|FG002|Overall Study|Adverse Event|0|||
105638585|NCT02852824|364340228|FG003|Overall Study|Adverse Event|0|||
105638586|NCT02852824|364340229|FG004|Overall Study|Adverse Event|2|||
105638587|NCT02852824|364340230|FG005|Overall Study|Adverse Event|0|||
105638588|NCT02852824|364340231|FG006|Overall Study|Adverse Event|0|||
105638589|NCT05169684|364340232|FG000|Overall Study|Adverse Event|1|||
105638590|NCT05169684|364340233|FG001|Overall Study|Adverse Event|3|||
105638591|NCT05169684|364340232|FG000|Overall Study|Physician Decision|0|||
105638592|NCT05169684|364340233|FG001|Overall Study|Physician Decision|1|||
105638593|NCT05169684|364340232|FG000|Overall Study|Progressive Disease|1|||
105638594|NCT05169684|364340233|FG001|Overall Study|Progressive Disease|1|||
105638595|NCT05169684|364340232|FG000|Overall Study|Participant request to discontinue treatment|0|||
105638596|NCT05169684|364340233|FG001|Overall Study|Participant request to discontinue treatment|1|||
105638597|NCT05169684|364340232|FG000|Overall Study|Other Reason|0|||
105638598|NCT05169684|364340233|FG001|Overall Study|Other Reason|1|||
105638599|NCT01668719|364340234|FG000|Phase I|On treatment|1|||
105638600|NCT01668719|364340235|FG001|Phase I|On treatment|0|||
105638601|NCT01668719|364340236|FG002|Phase I|On treatment|0|||
105638602|NCT01668719|364340234|FG000|Phase I|Adverse Event|2|||
105638603|NCT01668719|364340235|FG001|Phase I|Adverse Event|0|||
105638604|NCT01668719|364340236|FG002|Phase I|Adverse Event|0|||
105638605|NCT01668719|364340234|FG000|Phase I|Progression/relapse|1|||
105638606|NCT01668719|364340235|FG001|Phase I|Progression/relapse|0|||
105638607|NCT01668719|364340236|FG002|Phase I|Progression/relapse|0|||
105638608|NCT01668719|364340234|FG000|Phase I|not protocol specified|2|||
105638609|NCT01668719|364340235|FG001|Phase I|not protocol specified|0|||
105638610|NCT01668719|364340236|FG002|Phase I|not protocol specified|0|||
105638611|NCT01668719|364340234|FG000|Phase II|On treatment|0|||
105638612|NCT01668719|364340235|FG001|Phase II|On treatment|4|||
105638613|NCT01668719|364340236|FG002|Phase II|On treatment|3|||
105638614|NCT01668719|364340234|FG000|Phase II|Adverse Event|0|||
105638615|NCT01668719|364340235|FG001|Phase II|Adverse Event|18|||
105638616|NCT01668719|364340236|FG002|Phase II|Adverse Event|18|||
105638617|NCT01668719|364340234|FG000|Phase II|Refusal unrelated to adverse event|0|||
105638618|NCT01668719|364340235|FG001|Phase II|Refusal unrelated to adverse event|4|||
105638619|NCT01668719|364340236|FG002|Phase II|Refusal unrelated to adverse event|1|||
105638620|NCT01668719|364340234|FG000|Phase II|Progression/relapse|0|||
105638621|NCT01668719|364340235|FG001|Phase II|Progression/relapse|13|||
105638622|NCT01668719|364340236|FG002|Phase II|Progression/relapse|17|||
105638623|NCT01668719|364340234|FG000|Phase II|Death|0|||
105638624|NCT01668719|364340235|FG001|Phase II|Death|0|||
105638625|NCT01668719|364340236|FG002|Phase II|Death|2|||
105638626|NCT01668719|364340234|FG000|Phase II|not protocol specified|0|||
105638627|NCT01668719|364340235|FG001|Phase II|not protocol specified|13|||
105638628|NCT01668719|364340236|FG002|Phase II|not protocol specified|7|||
105638629|NCT00452114|364340239|FG000|Overall Study|Physician Decision|3|||
105638630|NCT00452114|364340240|FG001|Overall Study|Physician Decision|3|||
105638631|NCT03905642|364340241|FG000|Overall Study|Withdrawal by Subject|3|||
105638632|NCT03905642|364340241|FG000|Overall Study|Pregnancy|1|||
105638633|NCT03905642|364340241|FG000|Overall Study|Adverse Event|1|||
105638634|NCT03905642|364340241|FG000|Overall Study|Lack of Efficacy|1|||
105638635|NCT03905642|364340241|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
105638636|NCT03786471|364340252|FG000|Overall Study|Death|254|||
105638637|NCT03786471|364340253|FG001|Overall Study|Death|223|||
105638638|NCT03786471|364340254|FG002|Overall Study|Death|37|||
105638639|NCT03786471|364340252|FG000|Overall Study|Lost to Follow-up|63|||
105638640|NCT03786471|364340253|FG001|Overall Study|Lost to Follow-up|50|||
105638641|NCT03786471|364340254|FG002|Overall Study|Lost to Follow-up|15|||
105638642|NCT03786471|364340252|FG000|Overall Study|Withdrawal by Subject|99|||
105638643|NCT03786471|364340253|FG001|Overall Study|Withdrawal by Subject|81|||
105638644|NCT03786471|364340254|FG002|Overall Study|Withdrawal by Subject|11|||
105638645|NCT00949117|364341709|FG000|Overall Study|Lack of Efficacy|2|||
105638646|NCT00949117|364341710|FG001|Overall Study|Lack of Efficacy|3|||
105638647|NCT00949117|364341709|FG000|Overall Study|Protocol Violation|1|||
105638648|NCT00949117|364341710|FG001|Overall Study|Protocol Violation|1|||
105638649|NCT00949117|364341709|FG000|Overall Study|Adverse Event|0|||
105638650|NCT00949117|364341710|FG001|Overall Study|Adverse Event|1|||
105638651|NCT02014402|364341711|FG000|Overall Study|Adverse Event|1|||
105638652|NCT02014402|364341712|FG001|Overall Study|Adverse Event|0|||
105638653|NCT02014402|364341713|FG002|Overall Study|Adverse Event|0|||
105638654|NCT02014402|364341714|FG003|Overall Study|Adverse Event|0|||
105638655|NCT02014402|364341711|FG000|Overall Study|Withdrawal by Subject|1|||
105638656|NCT02014402|364341712|FG001|Overall Study|Withdrawal by Subject|2|||
105638657|NCT02014402|364341713|FG002|Overall Study|Withdrawal by Subject|2|||
105638658|NCT02014402|364341714|FG003|Overall Study|Withdrawal by Subject|1|||
105638659|NCT02014402|364341711|FG000|Overall Study|Subject did not have transportation|0|||
105638660|NCT02014402|364341712|FG001|Overall Study|Subject did not have transportation|1|||
105659331|NCT00551135|364417282|FG002|Overall Study|Adverse Event|1|||
105638661|NCT02014402|364341713|FG002|Overall Study|Subject did not have transportation|0|||
105638662|NCT02014402|364341714|FG003|Overall Study|Subject did not have transportation|0|||
105638663|NCT02014402|364341711|FG000|Overall Study|Lost to Follow-up|0|||
105638664|NCT02014402|364341712|FG001|Overall Study|Lost to Follow-up|0|||
105638665|NCT02014402|364341713|FG002|Overall Study|Lost to Follow-up|1|||
105638666|NCT02014402|364341714|FG003|Overall Study|Lost to Follow-up|2|||
105638667|NCT01523392|364341715|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105638668|NCT01523392|364341716|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105638669|NCT01523392|364341715|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
105638670|NCT01523392|364341716|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
105638671|NCT01523392|364341715|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
105638672|NCT01523392|364341716|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
105638673|NCT02038049|364341721|FG000|Overall Study|Lost to Follow-up|1|||
105638674|NCT02038049|364341722|FG001|Overall Study|Lost to Follow-up|0|||
105638675|NCT02771366|364341723|FG000|Period 1|Withdrawal by Subject|0|||
105638676|NCT02771366|364341724|FG001|Period 1|Withdrawal by Subject|2|||
105638677|NCT02771366|364341723|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
105638678|NCT02771366|364341724|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
105638679|NCT00671853|364341727|FG000|Overall Study|Lack of Efficacy|3|||
105638680|NCT00671853|364341728|FG001|Overall Study|Lack of Efficacy|7|||
105638681|NCT00671853|364341727|FG000|Overall Study|Adverse Event|7|||
105638682|NCT00671853|364341728|FG001|Overall Study|Adverse Event|1|||
105638683|NCT00671853|364341727|FG000|Overall Study|Withdrawal by Subject|1|||
105638684|NCT00671853|364341728|FG001|Overall Study|Withdrawal by Subject|5|||
105638685|NCT00671853|364341727|FG000|Overall Study|Lost to Follow-up|8|||
105638686|NCT00671853|364341728|FG001|Overall Study|Lost to Follow-up|8|||
105638687|NCT00671853|364341727|FG000|Overall Study|Physician Decision|0|||
105638688|NCT00671853|364341728|FG001|Overall Study|Physician Decision|2|||
105638689|NCT00671853|364341727|FG000|Overall Study|Non-adherence with study procedures|1|||
105638690|NCT00671853|364341728|FG001|Overall Study|Non-adherence with study procedures|4|||
105638691|NCT02660086|364341729|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
105638692|NCT02660086|364341730|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
105638693|NCT02660086|364341729|FG000|Overall Study- 12-month|Left full-time employment|12|||
105638694|NCT02660086|364341730|FG001|Overall Study- 12-month|Left full-time employment|20|||
105638695|NCT02660086|364341729|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
105638696|NCT02660086|364341730|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
105638697|NCT02660086|364341729|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
105638698|NCT02660086|364341730|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
105638699|NCT02660086|364341729|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
105638700|NCT02660086|364341730|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
105638701|NCT02660086|364341729|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
105638702|NCT02660086|364341730|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
105638703|NCT01719172|364341731|FG000|Overall Study|Lost to Follow-up|1|||
105638704|NCT01719172|364341731|FG000|Overall Study|Death|1|||
105638705|NCT01583166|364341732|FG000|Overall Study|Withdrawal by Subject|4|||
105638706|NCT01583166|364341733|FG001|Overall Study|Withdrawal by Subject|6|||
105638707|NCT03403036|364341734|FG000|Overall Study|Lack of Efficacy|5|||
105638708|NCT02701296|364341735|FG000|Overall Study|Incomplete Data|0|||
105638709|NCT02701296|364341736|FG001|Overall Study|Incomplete Data|2|||
105638710|NCT01409837|364341737|FG000|Overall Study|Withdrawal by Subject|2|||
105638711|NCT01409837|364341738|FG001|Overall Study|Withdrawal by Subject|1|||
105638712|NCT01409837|364341737|FG000|Overall Study|Lost to Follow-up|1|||
105638713|NCT01409837|364341738|FG001|Overall Study|Lost to Follow-up|0|||
105638714|NCT01409837|364341737|FG000|Overall Study|Physician Decision|0|||
105638715|NCT01409837|364341738|FG001|Overall Study|Physician Decision|1|||
105638716|NCT00240994|364341741|FG000|Overall Study|Lost to Follow-up|1|||
105638717|NCT00240994|364341741|FG000|Overall Study|Protocol Violation|1|||
105638718|NCT00240994|364341741|FG000|Overall Study|Graft failure|1|||
105638719|NCT00670488|364341743|FG000|Overall Study|Adverse Event|0|||
105638720|NCT00670488|364341744|FG001|Overall Study|Adverse Event|7|||
105638721|NCT00670488|364341745|FG002|Overall Study|Adverse Event|0|||
105638722|NCT00670488|364341746|FG003|Overall Study|Adverse Event|3|||
105638723|NCT00670488|364341747|FG004|Overall Study|Adverse Event|1|||
105638724|NCT00670488|364341748|FG005|Overall Study|Adverse Event|1|||
105638725|NCT00670488|364341749|FG006|Overall Study|Adverse Event|5|||
105638726|NCT00670488|364341750|FG007|Overall Study|Adverse Event|1|||
105638727|NCT00670488|364341751|FG008|Overall Study|Adverse Event|0|||
105638728|NCT00670488|364341752|FG009|Overall Study|Adverse Event|1|||
105638729|NCT00670488|364341743|FG000|Overall Study|Physician Decision|1|||
105638730|NCT00670488|364341744|FG001|Overall Study|Physician Decision|9|||
105638731|NCT00670488|364341745|FG002|Overall Study|Physician Decision|0|||
105638732|NCT00670488|364341746|FG003|Overall Study|Physician Decision|1|||
105638733|NCT00670488|364341747|FG004|Overall Study|Physician Decision|0|||
105638734|NCT00670488|364341748|FG005|Overall Study|Physician Decision|0|||
105638735|NCT00670488|364341749|FG006|Overall Study|Physician Decision|0|||
105638736|NCT00670488|364341750|FG007|Overall Study|Physician Decision|0|||
105638737|NCT00670488|364341751|FG008|Overall Study|Physician Decision|0|||
105638738|NCT00670488|364341752|FG009|Overall Study|Physician Decision|0|||
105638739|NCT00670488|364341743|FG000|Overall Study|Progressive Disease|2|||
105638740|NCT00670488|364341744|FG001|Overall Study|Progressive Disease|41|||
105638741|NCT00670488|364341745|FG002|Overall Study|Progressive Disease|3|||
105638742|NCT00670488|364341746|FG003|Overall Study|Progressive Disease|2|||
105638743|NCT00670488|364341747|FG004|Overall Study|Progressive Disease|2|||
105638744|NCT00670488|364341748|FG005|Overall Study|Progressive Disease|4|||
105638745|NCT00670488|364341749|FG006|Overall Study|Progressive Disease|11|||
105638746|NCT00670488|364341750|FG007|Overall Study|Progressive Disease|2|||
105638747|NCT00670488|364341751|FG008|Overall Study|Progressive Disease|2|||
105638748|NCT00670488|364341752|FG009|Overall Study|Progressive Disease|1|||
105638749|NCT00670488|364341743|FG000|Overall Study|Withdrawal by Subject|0|||
105638750|NCT00670488|364341744|FG001|Overall Study|Withdrawal by Subject|1|||
105638751|NCT00670488|364341745|FG002|Overall Study|Withdrawal by Subject|0|||
105638752|NCT00670488|364341746|FG003|Overall Study|Withdrawal by Subject|1|||
105638753|NCT00670488|364341747|FG004|Overall Study|Withdrawal by Subject|0|||
105638754|NCT00670488|364341748|FG005|Overall Study|Withdrawal by Subject|0|||
105638755|NCT00670488|364341749|FG006|Overall Study|Withdrawal by Subject|1|||
105638756|NCT00670488|364341750|FG007|Overall Study|Withdrawal by Subject|0|||
105638757|NCT00670488|364341751|FG008|Overall Study|Withdrawal by Subject|1|||
105638758|NCT00670488|364341752|FG009|Overall Study|Withdrawal by Subject|0|||
105638759|NCT00310037|364341753|FG000|Overall Study|Adverse Event|7|||
105638760|NCT00310037|364341754|FG001|Overall Study|Adverse Event|14|||
105638761|NCT00310037|364341753|FG000|Overall Study|Withdrawal by Subject|4|||
105638762|NCT00310037|364341754|FG001|Overall Study|Withdrawal by Subject|3|||
105638763|NCT00310037|364341753|FG000|Overall Study|Progression|6|||
105638764|NCT00310037|364341754|FG001|Overall Study|Progression|0|||
105638765|NCT00310037|364341753|FG000|Overall Study|Non-protocol treatment|1|||
105638766|NCT00310037|364341754|FG001|Overall Study|Non-protocol treatment|0|||
105638767|NCT02169414|364341758|FG000|Overall Study|Withdrawal by Subject|1|||
105638768|NCT02169414|364341759|FG001|Overall Study|Withdrawal by Subject|0|||
105638769|NCT02169414|364341760|FG002|Overall Study|Withdrawal by Subject|0|||
105638770|NCT02169414|364341761|FG003|Overall Study|Withdrawal by Subject|0|||
105638771|NCT02169414|364341758|FG000|Overall Study|Adverse Event|0|||
105638772|NCT02169414|364341759|FG001|Overall Study|Adverse Event|1|||
105638773|NCT02169414|364341760|FG002|Overall Study|Adverse Event|0|||
105638774|NCT02169414|364341761|FG003|Overall Study|Adverse Event|0|||
105638775|NCT03374254|364341762|FG000|Overall Study|Death|5|||
105638776|NCT03374254|364341763|FG001|Overall Study|Death|16|||
105638777|NCT03374254|364341764|FG002|Overall Study|Death|13|||
105638778|NCT03374254|364341765|FG003|Overall Study|Death|11|||
105638779|NCT03374254|364341766|FG004|Overall Study|Death|9|||
105638780|NCT03374254|364341767|FG005|Overall Study|Death|12|||
105638781|NCT03374254|364341768|FG006|Overall Study|Death|11|||
105638782|NCT03374254|364341769|FG007|Overall Study|Death|6|||
105638783|NCT03374254|364341770|FG008|Overall Study|Death|7|||
105638784|NCT03374254|364341762|FG000|Overall Study|Lost to Follow-up|0|||
105638785|NCT03374254|364341763|FG001|Overall Study|Lost to Follow-up|0|||
105638786|NCT03374254|364341764|FG002|Overall Study|Lost to Follow-up|0|||
105638787|NCT03374254|364341765|FG003|Overall Study|Lost to Follow-up|0|||
105638788|NCT03374254|364341766|FG004|Overall Study|Lost to Follow-up|0|||
105638789|NCT03374254|364341767|FG005|Overall Study|Lost to Follow-up|0|||
105638790|NCT03374254|364341768|FG006|Overall Study|Lost to Follow-up|2|||
105638791|NCT03374254|364341769|FG007|Overall Study|Lost to Follow-up|0|||
105638792|NCT03374254|364341770|FG008|Overall Study|Lost to Follow-up|0|||
105638793|NCT03374254|364341762|FG000|Overall Study|Sponsor Decision|1|||
105638794|NCT03374254|364341763|FG001|Overall Study|Sponsor Decision|0|||
105638795|NCT03374254|364341764|FG002|Overall Study|Sponsor Decision|2|||
105638796|NCT03374254|364341765|FG003|Overall Study|Sponsor Decision|3|||
105638797|NCT03374254|364341766|FG004|Overall Study|Sponsor Decision|2|||
105638798|NCT03374254|364341767|FG005|Overall Study|Sponsor Decision|3|||
105638799|NCT03374254|364341768|FG006|Overall Study|Sponsor Decision|3|||
105638800|NCT03374254|364341769|FG007|Overall Study|Sponsor Decision|3|||
105638801|NCT03374254|364341770|FG008|Overall Study|Sponsor Decision|4|||
105638802|NCT03374254|364341762|FG000|Overall Study|Withdrawal by Subject|0|||
105638803|NCT03374254|364341763|FG001|Overall Study|Withdrawal by Subject|0|||
105638804|NCT03374254|364341764|FG002|Overall Study|Withdrawal by Subject|0|||
105638805|NCT03374254|364341765|FG003|Overall Study|Withdrawal by Subject|2|||
105638806|NCT03374254|364341766|FG004|Overall Study|Withdrawal by Subject|0|||
105638807|NCT03374254|364341767|FG005|Overall Study|Withdrawal by Subject|1|||
105638808|NCT03374254|364341768|FG006|Overall Study|Withdrawal by Subject|0|||
105638809|NCT03374254|364341769|FG007|Overall Study|Withdrawal by Subject|0|||
105638810|NCT03374254|364341770|FG008|Overall Study|Withdrawal by Subject|0|||
105638811|NCT04803734|364341771|FG000|Overall Study|Withdrawal by Subject|0|||
105638812|NCT04803734|364341772|FG001|Overall Study|Withdrawal by Subject|1|||
105638813|NCT04803734|364341771|FG000|Overall Study|Protocol Violation|0|||
105638814|NCT04803734|364341772|FG001|Overall Study|Protocol Violation|1|||
105638815|NCT00195819|364341776|FG000|Double-Blind|Withdrawal by Subject|1|||
105638816|NCT00195819|364341777|FG001|Double-Blind|Withdrawal by Subject|0|||
105638817|NCT00195819|364341776|FG000|Double-Blind|Moved|1|||
105638818|NCT00195819|364341777|FG001|Double-Blind|Moved|0|||
105638819|NCT00195819|364341776|FG000|Open-label|Adverse Event|0|||
105638820|NCT00195819|364341777|FG001|Open-label|Adverse Event|9|||
105638821|NCT00195819|364341776|FG000|Open-label|Lack of Efficacy|0|||
105638822|NCT00195819|364341777|FG001|Open-label|Lack of Efficacy|2|||
105638823|NCT00195819|364341776|FG000|Open-label|Pregnancy|0|||
105638824|NCT00195819|364341777|FG001|Open-label|Pregnancy|1|||
105638825|NCT00195819|364341776|FG000|Open-label|Protocol Violation|0|||
105638826|NCT00195819|364341777|FG001|Open-label|Protocol Violation|2|||
105638827|NCT00195819|364341776|FG000|Open-label|Moved|0|||
105638828|NCT00195819|364341777|FG001|Open-label|Moved|1|||
105638829|NCT00195819|364341776|FG000|Open-label|Withdrawal by Subject|0|||
105638830|NCT00195819|364341777|FG001|Open-label|Withdrawal by Subject|5|||
105638831|NCT01858688|364341778|FG000|Overall Study|Withdrawal by Subject|8|||
105638832|NCT01858688|364341778|FG000|Overall Study|Participant began another therapy|3|||
105638833|NCT01858688|364341778|FG000|Overall Study|Physician Decision|2|||
105638834|NCT01858688|364341778|FG000|Overall Study|Progressive Disease|2|||
105638835|NCT01858688|364341778|FG000|Overall Study|Reason not reproted|5|||
105638836|NCT00822900|364341782|FG000|Overall Study|Withdrawal by Subject|14|||
105638837|NCT00822900|364341783|FG001|Overall Study|Withdrawal by Subject|14|||
105638838|NCT00822900|364341782|FG000|Overall Study|Lost to Follow-up|9|||
105638839|NCT00822900|364341783|FG001|Overall Study|Lost to Follow-up|9|||
105638840|NCT00822900|364341782|FG000|Overall Study|Death|83|||
105638841|NCT00822900|364341783|FG001|Overall Study|Death|69|||
105638842|NCT00822900|364341782|FG000|Overall Study|Became a ward of the state|2|||
105638843|NCT00822900|364341783|FG001|Overall Study|Became a ward of the state|1|||
105638844|NCT01972776|364341790|FG000|Part 1|Withdrawal by Subject|0|||
105638845|NCT01972776|364341791|FG001|Part 1|Withdrawal by Subject|0|||
105638846|NCT01972776|364341792|FG002|Part 1|Withdrawal by Subject|1|||
105638847|NCT01972776|364341793|FG003|Part 1|Withdrawal by Subject|0|||
105638848|NCT01972776|364341794|FG004|Part 1|Withdrawal by Subject|0|||
105638849|NCT01972776|364341795|FG005|Part 1|Withdrawal by Subject|0|||
105638850|NCT01972776|364341790|FG000|Part 1|Adverse Event|0|||
105638851|NCT01972776|364341791|FG001|Part 1|Adverse Event|0|||
105638852|NCT01972776|364341792|FG002|Part 1|Adverse Event|1|||
105638853|NCT01972776|364341793|FG003|Part 1|Adverse Event|1|||
105638854|NCT01972776|364341794|FG004|Part 1|Adverse Event|0|||
105638855|NCT01972776|364341795|FG005|Part 1|Adverse Event|0|||
105638856|NCT01972776|364341790|FG000|Part 2|Adverse Event|0|||
105638857|NCT01972776|364341791|FG001|Part 2|Adverse Event|0|||
105638858|NCT01972776|364341792|FG002|Part 2|Adverse Event|0|||
105638859|NCT01972776|364341793|FG003|Part 2|Adverse Event|0|||
105638860|NCT01972776|364341794|FG004|Part 2|Adverse Event|3|||
105638861|NCT01972776|364341795|FG005|Part 2|Adverse Event|0|||
105638862|NCT01972776|364341790|FG000|Part 2|Administrative problems|0|||
105638863|NCT01972776|364341791|FG001|Part 2|Administrative problems|0|||
105638864|NCT01972776|364341792|FG002|Part 2|Administrative problems|0|||
105638865|NCT01972776|364341793|FG003|Part 2|Administrative problems|0|||
105638866|NCT01972776|364341794|FG004|Part 2|Administrative problems|10|||
105638867|NCT01972776|364341795|FG005|Part 2|Administrative problems|7|||
105638868|NCT01220999|364341797|FG000|Overall Study|Progressive disease|0|||
105638869|NCT01220999|364341798|FG001|Overall Study|Progressive disease|0|||
105638870|NCT01220999|364341799|FG002|Overall Study|Progressive disease|1|||
105638871|NCT01220999|364341800|FG003|Overall Study|Progressive disease|0|||
105638872|NCT01220999|364341801|FG004|Overall Study|Progressive disease|0|||
105638873|NCT00380250|364341803|FG000|Overall Study|Withdrawal by Subject|39|||
105638874|NCT00380250|364341804|FG001|Overall Study|Withdrawal by Subject|28|||
105638875|NCT00380250|364341803|FG000|Overall Study|Adverse Event|20|||
105638876|NCT00380250|364341804|FG001|Overall Study|Adverse Event|9|||
105638877|NCT00380250|364341803|FG000|Overall Study|Lack of Efficacy|10|||
105638878|NCT00380250|364341804|FG001|Overall Study|Lack of Efficacy|8|||
105638879|NCT00380250|364341803|FG000|Overall Study|Protocol Violation|15|||
105638880|NCT00380250|364341804|FG001|Overall Study|Protocol Violation|5|||
105638881|NCT00380250|364341803|FG000|Overall Study|Lost to Follow-up|14|||
105638882|NCT00380250|364341804|FG001|Overall Study|Lost to Follow-up|5|||
105638883|NCT00380250|364341803|FG000|Overall Study|Physician Decision|1|||
105638884|NCT00380250|364341804|FG001|Overall Study|Physician Decision|0|||
105638885|NCT03288506|364341806|FG000|Overall Study|Withdrawal by Subject|52|||
105638886|NCT02833948|364341811|FG000|Overall Study|Death|2|||
105638887|NCT02833948|364341812|FG001|Overall Study|Death|3|||
105638888|NCT02833948|364341811|FG000|Overall Study|were not scanned|8|||
105638889|NCT02833948|364341812|FG001|Overall Study|were not scanned|13|||
105638890|NCT02833948|364341811|FG000|Overall Study|scans could not be evaluated|5|||
105638891|NCT02833948|364341812|FG001|Overall Study|scans could not be evaluated|2|||
105638892|NCT05484661|364341814|FG000|Overall Study|Withdrawal by Subject|1|||
105638893|NCT05484661|364341815|FG001|Overall Study|Withdrawal by Subject|0|||
105638894|NCT03775213|364341816|FG000|Overall Study|Withdrawal by Subject|51|||
105638895|NCT03775213|364341817|FG001|Overall Study|Withdrawal by Subject|53|||
105638896|NCT03775213|364341816|FG000|Overall Study|Incomplete Survey|7|||
105638897|NCT03775213|364341817|FG001|Overall Study|Incomplete Survey|7|||
105638898|NCT01880736|364341824|FG000|Overall Study|Adverse Event|0|||
105870088|NCT03180645|365176926|FG001|Overall Study|Adverse Event|1|||
105870089|NCT03180645|365176927|FG002|Overall Study|Adverse Event|2|||
105870090|NCT00995774|365176937|FG000|Training Period 2|Withdrawal by Subject|2|||
105870091|NCT00995774|365176938|FG001|Training Period 2|Withdrawal by Subject|0|||
105870092|NCT01808573|365176939|FG000|Overall Study|Death|212|||
105870093|NCT01808573|365176940|FG001|Overall Study|Death|240|||
105870094|NCT01808573|365176939|FG000|Overall Study|Withdrawal by Subject|12|||
105870095|NCT01808573|365176940|FG001|Overall Study|Withdrawal by Subject|10|||
105870096|NCT01808573|365176939|FG000|Overall Study|Lost to Follow-up|3|||
105870097|NCT01808573|365176940|FG001|Overall Study|Lost to Follow-up|0|||
105870098|NCT01808573|365176939|FG000|Overall Study|Discontinuation of study by sponsor|79|||
105870099|NCT01808573|365176940|FG001|Overall Study|Discontinuation of study by sponsor|64|||
105870100|NCT01808573|365176939|FG000|Overall Study|Randomized in Error|1|||
105870101|NCT01808573|365176940|FG001|Overall Study|Randomized in Error|0|||
105870102|NCT00822692|365176941|FG000|Overall Study|Lost to Follow-up|17|||
105870103|NCT00822692|365176942|FG001|Overall Study|Lost to Follow-up|25|||
105870104|NCT01523002|365176945|FG000|Period 1|Withdrawal by Subject|1|||
105870105|NCT01523002|365176946|FG001|Period 1|Withdrawal by Subject|3|||
105870106|NCT01523002|365176945|FG000|Period 1|Lost to Follow-up|1|||
105870107|NCT01523002|365176946|FG001|Period 1|Lost to Follow-up|0|||
105870108|NCT01523002|365176945|FG000|Period 1|Adverse Event|0|||
105870109|NCT01523002|365176946|FG001|Period 1|Adverse Event|8|||
105870110|NCT01523002|365176945|FG000|Period 2|Withdrawal by Subject|4|||
105870111|NCT01523002|365176946|FG001|Period 2|Withdrawal by Subject|1|||
105870112|NCT01523002|365176945|FG000|Period 2|Adverse Event|2|||
105870113|NCT01523002|365176946|FG001|Period 2|Adverse Event|5|||
105870114|NCT01523002|365176945|FG000|Period 3|Withdrawal by Subject|1|||
105870115|NCT01523002|365176946|FG001|Period 3|Withdrawal by Subject|0|||
105870116|NCT01523002|365176945|FG000|Period 3|Adverse Event|3|||
105870117|NCT01523002|365176946|FG001|Period 3|Adverse Event|0|||
105870118|NCT01256502|365176947|FG000|Overall Study|Had scaffold removed|4|||
105870119|NCT01256502|365176947|FG000|Overall Study|Personal reasons|5|||
105870120|NCT01256502|365176947|FG000|Overall Study|Protocol deviation|1|||
105870121|NCT03281876|365176948|FG000|Overall Study|Adverse Event|4|||
105870122|NCT03281876|365176949|FG001|Overall Study|Adverse Event|15|||
105870123|NCT03281876|365176948|FG000|Overall Study|Lost to Follow-up|1|||
105870124|NCT03281876|365176949|FG001|Overall Study|Lost to Follow-up|4|||
105870125|NCT03281876|365176948|FG000|Overall Study|Withdrawal by Subject|11|||
105870126|NCT03281876|365176949|FG001|Overall Study|Withdrawal by Subject|15|||
105870127|NCT03281876|365176948|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
105870128|NCT03281876|365176949|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
105870129|NCT03281876|365176948|FG000|Overall Study|OTHER|5|||
105870130|NCT03281876|365176949|FG001|Overall Study|OTHER|5|||
105870131|NCT03953612|365176950|FG000|Overall Study|Randomized but did not start|1|||
105870132|NCT03953612|365176951|FG001|Overall Study|Randomized but did not start|1|||
105870133|NCT03953612|365176952|FG002|Overall Study|Randomized but did not start|1|||
105870134|NCT03953612|365176950|FG000|Overall Study|Withdrawal by Subject|2|||
105870135|NCT03953612|365176951|FG001|Overall Study|Withdrawal by Subject|1|||
105870136|NCT03953612|365176952|FG002|Overall Study|Withdrawal by Subject|0|||
105870137|NCT00456300|365176953|FG000|Overall Study|Adverse Event|1|||
105870138|NCT00456300|365176954|FG001|Overall Study|Adverse Event|0|||
105870139|NCT03485352|365176955|FG000|Overall Study|Lost to Follow-up|9|||
105870140|NCT02452476|365176956|FG000|Overall Study|Death|4|||
105870141|NCT02452476|365176957|FG001|Overall Study|Death|7|||
105870142|NCT02452476|365176956|FG000|Overall Study|Lost to Follow-up|1|||
105870143|NCT02452476|365176957|FG001|Overall Study|Lost to Follow-up|1|||
105870144|NCT02452476|365176956|FG000|Overall Study|Physician Decision|1|||
105870145|NCT02452476|365176957|FG001|Overall Study|Physician Decision|1|||
105870146|NCT02452476|365176956|FG000|Overall Study|Not treated|5|||
105870147|NCT02452476|365176957|FG001|Overall Study|Not treated|1|||
105870148|NCT01478373|365176959|FG000|Treatment Phase|Protocol Violation|1|||
105870149|NCT01478373|365176959|FG000|Survival Phase|Adverse Event|8|||
105870150|NCT01478373|365176959|FG000|Survival Phase|Protocol Violation|1|||
105870151|NCT01478373|365176959|FG000|Survival Phase|crossover to another study|2|||
105870152|NCT01478373|365176959|FG000|Survival Phase|Progressive Disease|27|||
105870153|NCT01512160|365176961|FG000|Overall Study|Lost to Follow-up|1|||
105870154|NCT01512160|365176962|FG001|Overall Study|Lost to Follow-up|0|||
105870155|NCT01512160|365176963|FG002|Overall Study|Lost to Follow-up|0|||
105870156|NCT01512160|365176964|FG003|Overall Study|Lost to Follow-up|0|||
105870157|NCT01512160|365176961|FG000|Overall Study|Withdrawal by Subject|1|||
105870158|NCT01512160|365176962|FG001|Overall Study|Withdrawal by Subject|0|||
105870159|NCT01512160|365176963|FG002|Overall Study|Withdrawal by Subject|0|||
105870160|NCT01512160|365176964|FG003|Overall Study|Withdrawal by Subject|1|||
105870161|NCT01074944|365176967|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
105870162|NCT01074944|365176968|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
105870163|NCT01074944|365176969|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
105870164|NCT01074944|365176970|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
105870165|NCT01074944|365176971|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
105870166|NCT01074944|365176967|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
105638899|NCT01880736|364341825|FG001|Overall Study|Adverse Event|0|||
105638900|NCT01880736|364341826|FG002|Overall Study|Adverse Event|0|||
105638901|NCT01880736|364341827|FG003|Overall Study|Adverse Event|1|||
105638902|NCT01880736|364341824|FG000|Overall Study|Withdrawal Criteria|1|||
105638903|NCT01880736|364341825|FG001|Overall Study|Withdrawal Criteria|2|||
105638904|NCT01880736|364341826|FG002|Overall Study|Withdrawal Criteria|1|||
105638905|NCT01880736|364341827|FG003|Overall Study|Withdrawal Criteria|5|||
105638906|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
105638907|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
105638908|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
105638909|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
105638910|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
105638911|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
105638912|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
105638913|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
105638914|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
105638915|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
105638916|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
105638917|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
105638918|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
105638919|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
105638920|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
105870167|NCT01074944|365176968|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
105870168|NCT01074944|365176969|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
105870169|NCT01074944|365176970|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
105870170|NCT01074944|365176971|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
105870171|NCT01074944|365176967|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
105870172|NCT01074944|365176968|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
105870173|NCT01074944|365176969|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
105870174|NCT01074944|365176970|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
105870175|NCT01074944|365176971|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
105870176|NCT01074944|365176967|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
105870177|NCT01074944|365176968|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
105870178|NCT01074944|365176969|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
105870179|NCT01074944|365176970|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
105870180|NCT01074944|365176971|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
105870181|NCT01074944|365176967|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
105870182|NCT01074944|365176968|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
105870183|NCT01074944|365176969|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
105870184|NCT01074944|365176970|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
105870185|NCT01074944|365176971|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
105870186|NCT01074944|365176967|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
105870187|NCT01074944|365176968|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
105870188|NCT01074944|365176969|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
105870189|NCT01074944|365176970|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
105870190|NCT01074944|365176971|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
105870191|NCT01074944|365176967|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
105870192|NCT01074944|365176968|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
105870193|NCT01074944|365176969|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
105870194|NCT01074944|365176970|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
105870195|NCT01074944|365176971|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
105870196|NCT01074944|365176967|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
105870197|NCT01074944|365176968|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
105870198|NCT01074944|365176969|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
105870199|NCT01074944|365176970|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
105870200|NCT01074944|365176971|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
105870201|NCT01074944|365176967|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
105870202|NCT01074944|365176968|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
105870203|NCT01074944|365176969|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
105870204|NCT01074944|365176970|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
105870205|NCT01074944|365176971|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
105870206|NCT01074944|365176967|FG000|Long Term Treatment|Adverse Event|0|||
105870207|NCT01074944|365176968|FG001|Long Term Treatment|Adverse Event|0|||
105870208|NCT01074944|365176969|FG002|Long Term Treatment|Adverse Event|0|||
105870209|NCT01074944|365176970|FG003|Long Term Treatment|Adverse Event|3|||
105870210|NCT01074944|365176971|FG004|Long Term Treatment|Adverse Event|0|||
105870211|NCT01074944|365176967|FG000|Long Term Treatment|Lost to Follow-up|0|||
105638921|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
105638922|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
105638923|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
105638924|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
105638925|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
105638926|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
105638927|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
105638928|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
105638929|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
105638930|NCT02203032|364341831|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
105638931|NCT02203032|364341832|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
105638932|NCT02203032|364341833|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
105638933|NCT02203032|364341834|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
105638934|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
105638935|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
105638936|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
105638937|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
105638938|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
105638939|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
105638940|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
105638941|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
105638942|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
105638943|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
105638944|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
105638945|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
105638946|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
105638947|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
105638948|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
105638949|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
105638950|NCT02203032|364341831|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
105638951|NCT02203032|364341832|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
105638952|NCT02203032|364341833|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
105638953|NCT02203032|364341834|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
105638954|NCT01915914|364341835|FG000|Acute Phase|Withdrawal by Subject|4|||
105638955|NCT01915914|364341836|FG001|Acute Phase|Withdrawal by Subject|0|||
105638956|NCT01915914|364341837|FG002|Acute Phase|Withdrawal by Subject|0|||
105638957|NCT01915914|364341838|FG003|Acute Phase|Withdrawal by Subject|0|||
105638958|NCT01915914|364341835|FG000|Acute Phase|Lost to Follow-up|4|||
105638959|NCT01915914|364341836|FG001|Acute Phase|Lost to Follow-up|0|||
105638960|NCT01915914|364341837|FG002|Acute Phase|Lost to Follow-up|0|||
105638961|NCT01915914|364341838|FG003|Acute Phase|Lost to Follow-up|0|||
105638962|NCT01915914|364341835|FG000|Acute Phase|Physician Decision|1|||
105638963|NCT01915914|364341836|FG001|Acute Phase|Physician Decision|0|||
105638964|NCT01915914|364341837|FG002|Acute Phase|Physician Decision|0|||
105638965|NCT01915914|364341838|FG003|Acute Phase|Physician Decision|0|||
105638966|NCT01915914|364341835|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
105638967|NCT01915914|364341836|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
105638968|NCT01915914|364341837|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
105638969|NCT01915914|364341838|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
105638970|NCT01915914|364341835|FG000|Acute Phase|"Not Achieved treatment success"|1|||
105638971|NCT01915914|364341836|FG001|Acute Phase|"Not Achieved treatment success"|0|||
105638972|NCT01915914|364341837|FG002|Acute Phase|"Not Achieved treatment success"|0|||
105638973|NCT01915914|364341838|FG003|Acute Phase|"Not Achieved treatment success"|0|||
105638974|NCT01915914|364341835|FG000|Acute Phase|Missing|1|||
105638975|NCT01915914|364341836|FG001|Acute Phase|Missing|0|||
105638976|NCT01915914|364341837|FG002|Acute Phase|Missing|0|||
105638977|NCT01915914|364341838|FG003|Acute Phase|Missing|0|||
105638978|NCT01915914|364341835|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105638979|NCT01915914|364341836|FG001|Maintenance Phase|Withdrawal by Subject|1|||
105638980|NCT01915914|364341837|FG002|Maintenance Phase|Withdrawal by Subject|1|||
105638981|NCT01915914|364341838|FG003|Maintenance Phase|Withdrawal by Subject|0|||
105638982|NCT01915914|364341835|FG000|Maintenance Phase|Lost to Follow-up|0|||
105638983|NCT01915914|364341836|FG001|Maintenance Phase|Lost to Follow-up|4|||
105638984|NCT01915914|364341837|FG002|Maintenance Phase|Lost to Follow-up|1|||
105638985|NCT01915914|364341838|FG003|Maintenance Phase|Lost to Follow-up|0|||
105638986|NCT01915914|364341835|FG000|Maintenance Phase|Missing|0|||
105638987|NCT01915914|364341836|FG001|Maintenance Phase|Missing|1|||
105638988|NCT01915914|364341837|FG002|Maintenance Phase|Missing|0|||
105638989|NCT01915914|364341838|FG003|Maintenance Phase|Missing|0|||
105638990|NCT01915914|364341835|FG000|Follow-up Phase|Withdrawal by Subject|0|||
105638991|NCT01915914|364341836|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105659332|NCT00551135|364417283|FG003|Overall Study|Adverse Event|1|||
105638992|NCT01915914|364341837|FG002|Follow-up Phase|Withdrawal by Subject|0|||
105638993|NCT01915914|364341838|FG003|Follow-up Phase|Withdrawal by Subject|1|||
105638994|NCT01915914|364341835|FG000|Follow-up Phase|Physician Decision|0|||
105638995|NCT01915914|364341836|FG001|Follow-up Phase|Physician Decision|0|||
105638996|NCT01915914|364341837|FG002|Follow-up Phase|Physician Decision|0|||
105638997|NCT01915914|364341838|FG003|Follow-up Phase|Physician Decision|1|||
105638998|NCT00960206|364341839|FG000|Overall Study|Death|7|||
105638999|NCT00960206|364341840|FG001|Overall Study|Death|4|||
105639000|NCT00960206|364341841|FG002|Overall Study|Death|1|||
105639001|NCT00960206|364341839|FG000|Overall Study|Unwilling/Unable to return|1|||
105639002|NCT00960206|364341840|FG001|Overall Study|Unwilling/Unable to return|2|||
105639003|NCT00960206|364341841|FG002|Overall Study|Unwilling/Unable to return|0|||
105639004|NCT00960206|364341839|FG000|Overall Study|Lost to Follow-up|8|||
105639005|NCT00960206|364341840|FG001|Overall Study|Lost to Follow-up|14|||
105639006|NCT00960206|364341841|FG002|Overall Study|Lost to Follow-up|8|||
105639007|NCT00960206|364341839|FG000|Overall Study|Withdrawal by Subject|2|||
105639008|NCT00960206|364341840|FG001|Overall Study|Withdrawal by Subject|4|||
105639009|NCT00960206|364341841|FG002|Overall Study|Withdrawal by Subject|0|||
105639010|NCT00960206|364341839|FG000|Overall Study|Revision of study component|2|||
105639011|NCT00960206|364341840|FG001|Overall Study|Revision of study component|2|||
105639012|NCT00960206|364341841|FG002|Overall Study|Revision of study component|2|||
105639013|NCT00960206|364341839|FG000|Overall Study|Missing 10 year data|20|||
105639014|NCT00960206|364341840|FG001|Overall Study|Missing 10 year data|1|||
105639015|NCT00960206|364341841|FG002|Overall Study|Missing 10 year data|1|||
105639016|NCT02326220|364341844|FG000|Double-blind Treatment Period|Adverse Event|1|||
105639017|NCT02326220|364341845|FG001|Double-blind Treatment Period|Adverse Event|2|||
105639018|NCT02326220|364341846|FG002|Double-blind Treatment Period|Adverse Event|0|||
105639019|NCT02326220|364341844|FG000|Double-blind Treatment Period|Protocol Violation|0|||
105639020|NCT02326220|364341845|FG001|Double-blind Treatment Period|Protocol Violation|1|||
105639021|NCT02326220|364341846|FG002|Double-blind Treatment Period|Protocol Violation|0|||
105639022|NCT02326220|364341844|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
105639023|NCT02326220|364341845|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
105639024|NCT02326220|364341846|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105639025|NCT02326220|364341844|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
105639026|NCT02326220|364341845|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105639027|NCT02326220|364341846|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
105639028|NCT02326220|364341844|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105639029|NCT02326220|364341845|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
105639030|NCT02326220|364341846|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
105639031|NCT02659540|364341847|FG000|Overall Study|Adverse Event|3|||
105639032|NCT02659540|364341848|FG001|Overall Study|Adverse Event|2|||
105639033|NCT02659540|364341847|FG000|Overall Study|Death|1|||
105639034|NCT02659540|364341848|FG001|Overall Study|Death|0|||
105639035|NCT02659540|364341847|FG000|Overall Study|Progressive disease|2|||
105639036|NCT02659540|364341848|FG001|Overall Study|Progressive disease|6|||
105639037|NCT03890484|364341849|FG000|Overall Study|Lost to Follow-up|1|||
105639038|NCT03890484|364341850|FG001|Overall Study|Lost to Follow-up|1|||
105639039|NCT00070707|364343869|FG000|Overall Study|Adverse Event|1|||
105639040|NCT00070707|364343870|FG001|Overall Study|Adverse Event|2|||
105639041|NCT00070707|364343869|FG000|Overall Study|Lack of Efficacy|4|||
105639042|NCT00070707|364343870|FG001|Overall Study|Lack of Efficacy|1|||
105639043|NCT00070707|364343869|FG000|Overall Study|Protocol Violation|8|||
105639044|NCT00070707|364343870|FG001|Overall Study|Protocol Violation|4|||
105639045|NCT00070707|364343869|FG000|Overall Study|Unrelated to Study Medication|1|||
105639046|NCT00070707|364343870|FG001|Overall Study|Unrelated to Study Medication|0|||
105639047|NCT01779050|364343871|FG000|Overall Study|Withdrawal by Subject|1|||
105639048|NCT01779050|364343872|FG001|Overall Study|Withdrawal by Subject|0|||
105639049|NCT03292406|364343876|FG000|Overall Study|Progressive Disease|6|||
105639050|NCT03292406|364343877|FG001|Overall Study|Progressive Disease|3|||
105639051|NCT03292406|364343878|FG002|Overall Study|Progressive Disease|4|||
105639052|NCT03292406|364343876|FG000|Overall Study|Adverse Event|7|||
105639053|NCT03292406|364343877|FG001|Overall Study|Adverse Event|1|||
105639054|NCT03292406|364343878|FG002|Overall Study|Adverse Event|4|||
105639055|NCT03292406|364343876|FG000|Overall Study|Withdrawal by Subject|0|||
105639056|NCT03292406|364343877|FG001|Overall Study|Withdrawal by Subject|7|||
105639057|NCT03292406|364343878|FG002|Overall Study|Withdrawal by Subject|2|||
105639058|NCT03292406|364343876|FG000|Overall Study|Protocol Violation|0|||
105639059|NCT03292406|364343877|FG001|Overall Study|Protocol Violation|1|||
105639060|NCT03292406|364343878|FG002|Overall Study|Protocol Violation|1|||
105639061|NCT03292406|364343876|FG000|Overall Study|Other|0|||
105639062|NCT03292406|364343877|FG001|Overall Study|Other|1|||
105639063|NCT03292406|364343878|FG002|Overall Study|Other|2|||
105639064|NCT03851094|364343883|FG000|Overall Study|Withdrawal by Subject|0|||
105639065|NCT03851094|364343884|FG001|Overall Study|Withdrawal by Subject|1|||
105639066|NCT03851094|364343883|FG000|Overall Study|Participant lost device|0|||
105639067|NCT03851094|364343884|FG001|Overall Study|Participant lost device|1|||
105639068|NCT03851094|364343883|FG000|Overall Study|Participant returned device|0|||
105639069|NCT03851094|364343884|FG001|Overall Study|Participant returned device|2|||
105639070|NCT01332266|364343885|FG000|Phase 1b|Death|3|||
105639071|NCT01332266|364343886|FG001|Phase 1b|Death|3|||
105639072|NCT01332266|364343887|FG002|Phase 1b|Death|2|||
105639073|NCT01332266|364343888|FG003|Phase 1b|Death|0|||
105639074|NCT01332266|364343889|FG004|Phase 1b|Death|0|||
105639075|NCT01332266|364343885|FG000|Phase 1b|Lost to Follow-up|0|||
105639076|NCT01332266|364343886|FG001|Phase 1b|Lost to Follow-up|1|||
105639077|NCT01332266|364343887|FG002|Phase 1b|Lost to Follow-up|0|||
105639078|NCT01332266|364343888|FG003|Phase 1b|Lost to Follow-up|0|||
105639079|NCT01332266|364343889|FG004|Phase 1b|Lost to Follow-up|0|||
105639080|NCT01332266|364343885|FG000|Phase 1b|Withdrawal by Subject|1|||
105639081|NCT01332266|364343886|FG001|Phase 1b|Withdrawal by Subject|1|||
105639082|NCT01332266|364343887|FG002|Phase 1b|Withdrawal by Subject|1|||
105639083|NCT01332266|364343888|FG003|Phase 1b|Withdrawal by Subject|0|||
105639084|NCT01332266|364343889|FG004|Phase 1b|Withdrawal by Subject|0|||
105639085|NCT01332266|364343885|FG000|Phase 2|Death|0|||
105639086|NCT01332266|364343886|FG001|Phase 2|Death|0|||
105639087|NCT01332266|364343887|FG002|Phase 2|Death|0|||
105639088|NCT01332266|364343888|FG003|Phase 2|Death|33|||
105639089|NCT01332266|364343889|FG004|Phase 2|Death|36|||
105639090|NCT01332266|364343885|FG000|Phase 2|Lost to Follow-up|0|||
105639091|NCT01332266|364343886|FG001|Phase 2|Lost to Follow-up|0|||
105639092|NCT01332266|364343887|FG002|Phase 2|Lost to Follow-up|0|||
105639093|NCT01332266|364343888|FG003|Phase 2|Lost to Follow-up|2|||
105639094|NCT01332266|364343889|FG004|Phase 2|Lost to Follow-up|0|||
105639095|NCT01332266|364343885|FG000|Phase 2|Physician Decision|0|||
105639096|NCT01332266|364343886|FG001|Phase 2|Physician Decision|0|||
105639097|NCT01332266|364343887|FG002|Phase 2|Physician Decision|0|||
105639098|NCT01332266|364343888|FG003|Phase 2|Physician Decision|3|||
105639099|NCT01332266|364343889|FG004|Phase 2|Physician Decision|1|||
105639100|NCT01332266|364343885|FG000|Phase 2|Symptomatic deterioration|0|||
105639101|NCT01332266|364343886|FG001|Phase 2|Symptomatic deterioration|0|||
105639102|NCT01332266|364343887|FG002|Phase 2|Symptomatic deterioration|0|||
105639103|NCT01332266|364343888|FG003|Phase 2|Symptomatic deterioration|0|||
105639104|NCT01332266|364343889|FG004|Phase 2|Symptomatic deterioration|1|||
105639105|NCT01332266|364343885|FG000|Phase 2|Progression Disease|0|||
105639106|NCT01332266|364343886|FG001|Phase 2|Progression Disease|0|||
105639107|NCT01332266|364343887|FG002|Phase 2|Progression Disease|0|||
105639108|NCT01332266|364343888|FG003|Phase 2|Progression Disease|2|||
105639109|NCT01332266|364343889|FG004|Phase 2|Progression Disease|1|||
105639110|NCT01332266|364343885|FG000|Phase 2|Withdrawal by Subject|0|||
105639111|NCT01332266|364343886|FG001|Phase 2|Withdrawal by Subject|0|||
105639112|NCT01332266|364343887|FG002|Phase 2|Withdrawal by Subject|0|||
105639113|NCT01332266|364343888|FG003|Phase 2|Withdrawal by Subject|2|||
105639114|NCT01332266|364343889|FG004|Phase 2|Withdrawal by Subject|2|||
105639115|NCT03865732|364343890|FG000|Overall Study|Adverse Event|0|||
105639116|NCT03865732|364343891|FG001|Overall Study|Adverse Event|1|||
105639117|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
105639118|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
105639119|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Death|2|||
105639120|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
105639121|NCT01698918|364343892|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
105639122|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
105639123|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
105639124|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Death|1|||
105639125|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
105639126|NCT01698918|364343892|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
105639127|NCT01019135|364343893|FG000|Overall Study|Did not receive allocated intervention|12|||
105639128|NCT01019135|364343894|FG001|Overall Study|Did not receive allocated intervention|6|||
105639129|NCT01019135|364343895|FG002|Overall Study|Did not receive allocated intervention|25|||
105639130|NCT01019135|364343893|FG000|Overall Study|Did not attend CR|8|||
105639131|NCT01019135|364343894|FG001|Overall Study|Did not attend CR|13|||
105870212|NCT01074944|365176968|FG001|Long Term Treatment|Lost to Follow-up|0|||
105639132|NCT01019135|364343895|FG002|Overall Study|Did not attend CR|6|||
105639133|NCT00439218|364343896|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
105639134|NCT05124210|364343897|FG000|Overall Study|Lost to Follow-up|1|||
105639135|NCT05124210|364343898|FG001|Overall Study|Lost to Follow-up|0|||
105639136|NCT05124210|364343897|FG000|Overall Study|Withdrawal by Subject|1|||
105639137|NCT05124210|364343898|FG001|Overall Study|Withdrawal by Subject|0|||
105639138|NCT00768755|364343899|FG000|Phase 1|Death|6|||
105639139|NCT00768755|364343900|FG001|Phase 1|Death|0|||
105639140|NCT00768755|364343901|FG002|Phase 1|Death|0|||
105639141|NCT00768755|364343902|FG003|Phase 1|Death|0|||
105639142|NCT00768755|364343899|FG000|Phase 1|Other|4|||
105639143|NCT00768755|364343900|FG001|Phase 1|Other|0|||
105639144|NCT00768755|364343901|FG002|Phase 1|Other|0|||
105639145|NCT00768755|364343902|FG003|Phase 1|Other|0|||
105639146|NCT00768755|364343899|FG000|Phase 2|Death|0|||
105639147|NCT00768755|364343900|FG001|Phase 2|Death|37|||
105639148|NCT00768755|364343901|FG002|Phase 2|Death|48|||
105639149|NCT00768755|364343902|FG003|Phase 2|Death|31|||
105639150|NCT00768755|364343899|FG000|Phase 2|Protocol Violation|0|||
105639151|NCT00768755|364343900|FG001|Phase 2|Protocol Violation|2|||
105639152|NCT00768755|364343901|FG002|Phase 2|Protocol Violation|0|||
105639153|NCT00768755|364343902|FG003|Phase 2|Protocol Violation|1|||
105639154|NCT00768755|364343899|FG000|Phase 2|Lost to Follow-up|0|||
105639155|NCT00768755|364343900|FG001|Phase 2|Lost to Follow-up|1|||
105639156|NCT00768755|364343901|FG002|Phase 2|Lost to Follow-up|1|||
105639157|NCT00768755|364343902|FG003|Phase 2|Lost to Follow-up|4|||
105639158|NCT00768755|364343899|FG000|Phase 2|Withdrawal by Subject|0|||
105639159|NCT00768755|364343900|FG001|Phase 2|Withdrawal by Subject|1|||
105639160|NCT00768755|364343901|FG002|Phase 2|Withdrawal by Subject|0|||
105639161|NCT00768755|364343902|FG003|Phase 2|Withdrawal by Subject|1|||
105639162|NCT00768755|364343899|FG000|Phase 2|Other|0|||
105639163|NCT00768755|364343900|FG001|Phase 2|Other|1|||
105639164|NCT00768755|364343901|FG002|Phase 2|Other|2|||
105870213|NCT01074944|365176969|FG002|Long Term Treatment|Lost to Follow-up|0|||
105639165|NCT00768755|364343902|FG003|Phase 2|Other|4|||
105639166|NCT00768755|364343899|FG000|Phase 2|Study Terminated by Sponsor|0|||
105639167|NCT00768755|364343900|FG001|Phase 2|Study Terminated by Sponsor|13|||
105639168|NCT00768755|364343901|FG002|Phase 2|Study Terminated by Sponsor|7|||
105639169|NCT00768755|364343902|FG003|Phase 2|Study Terminated by Sponsor|14|||
105639170|NCT00768755|364343899|FG000|Phase 2|Randomized but not treated|0|||
105639171|NCT00768755|364343900|FG001|Phase 2|Randomized but not treated|0|||
105639172|NCT00768755|364343901|FG002|Phase 2|Randomized but not treated|0|||
105639173|NCT00768755|364343902|FG003|Phase 2|Randomized but not treated|2|||
105639174|NCT00878189|364343905|FG000|Overall Study|Death|0|||
105639175|NCT00878189|364343906|FG001|Overall Study|Death|1|||
105639176|NCT00878189|364343907|FG002|Overall Study|Death|0|||
105639177|NCT00878189|364343908|FG003|Overall Study|Death|1|||
105639178|NCT00878189|364343909|FG004|Overall Study|Death|0|||
105639179|NCT00878189|364343910|FG005|Overall Study|Death|0|||
105639180|NCT00878189|364343911|FG006|Overall Study|Death|0|||
105639181|NCT00878189|364343912|FG007|Overall Study|Death|0|||
105639182|NCT00878189|364343913|FG008|Overall Study|Death|1|||
105639183|NCT00878189|364343905|FG000|Overall Study|Participant Refused to Follow-up|0|||
105639184|NCT00878189|364343906|FG001|Overall Study|Participant Refused to Follow-up|0|||
105639185|NCT00878189|364343907|FG002|Overall Study|Participant Refused to Follow-up|0|||
105639186|NCT00878189|364343908|FG003|Overall Study|Participant Refused to Follow-up|0|||
105639187|NCT00878189|364343909|FG004|Overall Study|Participant Refused to Follow-up|0|||
105639188|NCT00878189|364343910|FG005|Overall Study|Participant Refused to Follow-up|4|||
105639189|NCT00878189|364343911|FG006|Overall Study|Participant Refused to Follow-up|0|||
105639190|NCT00878189|364343912|FG007|Overall Study|Participant Refused to Follow-up|0|||
105639191|NCT00878189|364343913|FG008|Overall Study|Participant Refused to Follow-up|0|||
105639192|NCT00878189|364343905|FG000|Overall Study|Other|3|||
105639193|NCT00878189|364343906|FG001|Overall Study|Other|2|||
105639194|NCT00878189|364343907|FG002|Overall Study|Other|4|||
105639195|NCT00878189|364343908|FG003|Overall Study|Other|7|||
105639196|NCT00878189|364343909|FG004|Overall Study|Other|4|||
105639197|NCT00878189|364343910|FG005|Overall Study|Other|18|||
105639198|NCT00878189|364343911|FG006|Overall Study|Other|15|||
105639199|NCT00878189|364343912|FG007|Overall Study|Other|3|||
105639200|NCT00878189|364343913|FG008|Overall Study|Other|4|||
105639201|NCT00878189|364343905|FG000|Overall Study|Lost to Follow-up|0|||
105639202|NCT00878189|364343906|FG001|Overall Study|Lost to Follow-up|0|||
105639203|NCT00878189|364343907|FG002|Overall Study|Lost to Follow-up|0|||
105639204|NCT00878189|364343908|FG003|Overall Study|Lost to Follow-up|0|||
105639205|NCT00878189|364343909|FG004|Overall Study|Lost to Follow-up|0|||
105639206|NCT00878189|364343910|FG005|Overall Study|Lost to Follow-up|1|||
105639207|NCT00878189|364343911|FG006|Overall Study|Lost to Follow-up|1|||
105639208|NCT00878189|364343912|FG007|Overall Study|Lost to Follow-up|0|||
105639209|NCT00878189|364343913|FG008|Overall Study|Lost to Follow-up|0|||
105639210|NCT00878189|364343905|FG000|Overall Study|Objection Progression or Relapse|0|||
105639211|NCT00878189|364343906|FG001|Overall Study|Objection Progression or Relapse|0|||
105639212|NCT00878189|364343907|FG002|Overall Study|Objection Progression or Relapse|0|||
105639213|NCT00878189|364343908|FG003|Overall Study|Objection Progression or Relapse|0|||
105639214|NCT00878189|364343909|FG004|Overall Study|Objection Progression or Relapse|0|||
105639215|NCT00878189|364343910|FG005|Overall Study|Objection Progression or Relapse|0|||
105639216|NCT00878189|364343911|FG006|Overall Study|Objection Progression or Relapse|0|||
105639217|NCT00878189|364343912|FG007|Overall Study|Objection Progression or Relapse|0|||
105639218|NCT00878189|364343913|FG008|Overall Study|Objection Progression or Relapse|3|||
105639219|NCT02007070|364343914|FG000|Overall Study|Adverse Event|4|||
105639220|NCT02007070|364343914|FG000|Overall Study|Clinical Progression|4|||
105639221|NCT02007070|364343914|FG000|Overall Study|Death|1|||
105639222|NCT02007070|364343914|FG000|Overall Study|Protocol Violation|2|||
105639223|NCT02007070|364343914|FG000|Overall Study|Physician Decision|1|||
105639224|NCT02007070|364343914|FG000|Overall Study|Progressive Disease|21|||
105639225|NCT05260437|364343918|FG000|Overall Study|Lost to Follow-up|5|||
105639226|NCT05260437|364343919|FG001|Overall Study|Lost to Follow-up|2|||
105639227|NCT05260437|364343920|FG002|Overall Study|Lost to Follow-up|1|||
105639228|NCT05260437|364343921|FG003|Overall Study|Lost to Follow-up|2|||
105639229|NCT05260437|364343922|FG004|Overall Study|Lost to Follow-up|2|||
105639230|NCT05260437|364343918|FG000|Overall Study|Withdrawal by Subject|3|||
105639231|NCT05260437|364343919|FG001|Overall Study|Withdrawal by Subject|0|||
105639232|NCT05260437|364343920|FG002|Overall Study|Withdrawal by Subject|4|||
105639233|NCT05260437|364343921|FG003|Overall Study|Withdrawal by Subject|5|||
105639234|NCT05260437|364343922|FG004|Overall Study|Withdrawal by Subject|0|||
105639235|NCT05260437|364343918|FG000|Overall Study|Vaccine Not Administered|0|||
105639236|NCT05260437|364343919|FG001|Overall Study|Vaccine Not Administered|1|||
105639237|NCT05260437|364343920|FG002|Overall Study|Vaccine Not Administered|0|||
105639238|NCT05260437|364343921|FG003|Overall Study|Vaccine Not Administered|0|||
105639239|NCT05260437|364343922|FG004|Overall Study|Vaccine Not Administered|0|||
105639240|NCT00910962|364343925|FG000|Overall Study|Adverse Event|5|||
105639241|NCT00910962|364343926|FG001|Overall Study|Adverse Event|20|||
105639242|NCT00910962|364343927|FG002|Overall Study|Adverse Event|17|||
105639243|NCT00910962|364343925|FG000|Overall Study|Protocol Violation|1|||
105639244|NCT00910962|364343926|FG001|Overall Study|Protocol Violation|3|||
105639245|NCT00910962|364343927|FG002|Overall Study|Protocol Violation|3|||
105639246|NCT00910962|364343925|FG000|Overall Study|Lost to Follow-up|0|||
105639247|NCT00910962|364343926|FG001|Overall Study|Lost to Follow-up|3|||
105639248|NCT00910962|364343927|FG002|Overall Study|Lost to Follow-up|1|||
105639249|NCT00910962|364343925|FG000|Overall Study|Physician Decision|0|||
105639250|NCT00910962|364343926|FG001|Overall Study|Physician Decision|6|||
105639251|NCT00910962|364343927|FG002|Overall Study|Physician Decision|6|||
105639252|NCT00910962|364343925|FG000|Overall Study|Withdrawal by Subject|25|||
105639253|NCT00910962|364343926|FG001|Overall Study|Withdrawal by Subject|32|||
105639254|NCT00910962|364343927|FG002|Overall Study|Withdrawal by Subject|32|||
105639255|NCT00910962|364343925|FG000|Overall Study|Reached defined stopping criteria|12|||
105639256|NCT00910962|364343926|FG001|Overall Study|Reached defined stopping criteria|14|||
105639257|NCT00910962|364343927|FG002|Overall Study|Reached defined stopping criteria|17|||
105639258|NCT03547154|364343930|FG000|Overall Study|Disease Progression/Recurrence|6|||
105639259|NCT03547154|364343931|FG001|Overall Study|Disease Progression/Recurrence|14|||
105639260|NCT03547154|364343930|FG000|Overall Study|Adverse Event|26|||
105639261|NCT03547154|364343931|FG001|Overall Study|Adverse Event|31|||
105639262|NCT03547154|364343930|FG000|Overall Study|Protocol Violation|6|||
105639263|NCT03547154|364343931|FG001|Overall Study|Protocol Violation|1|||
105639264|NCT03547154|364343930|FG000|Overall Study|Physician Decision|4|||
105639265|NCT03547154|364343931|FG001|Overall Study|Physician Decision|3|||
105639266|NCT03547154|364343930|FG000|Overall Study|Insufficient Therapeutic Response|13|||
105639267|NCT03547154|364343931|FG001|Overall Study|Insufficient Therapeutic Response|10|||
105639268|NCT03547154|364343930|FG000|Overall Study|Withdrawal by Subject|10|||
105639269|NCT03547154|364343931|FG001|Overall Study|Withdrawal by Subject|6|||
105639270|NCT03547154|364343930|FG000|Overall Study|Not Selected|0|||
105639271|NCT03547154|364343931|FG001|Overall Study|Not Selected|1|||
105639272|NCT03547154|364343930|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
105639273|NCT03547154|364343931|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
105639274|NCT02706483|364343932|FG000|Overall Study|Adverse Event|97|||
105639275|NCT02706483|364343932|FG000|Overall Study|Death|1|||
105639276|NCT02706483|364343932|FG000|Overall Study|Lack of Efficacy|39|||
105639277|NCT02706483|364343932|FG000|Overall Study|Lost to Follow-up|101|||
105639278|NCT02706483|364343932|FG000|Overall Study|Non-compliance with study drug|15|||
105639279|NCT02706483|364343932|FG000|Overall Study|Physician Decision|6|||
105639280|NCT02706483|364343932|FG000|Overall Study|Pregnancy|6|||
105639281|NCT02706483|364343932|FG000|Overall Study|Protocol Violation|18|||
105639282|NCT02706483|364343932|FG000|Overall Study|Withdrawal by Subject|136|||
105639283|NCT02706483|364343932|FG000|Overall Study|Non-compliance with visits|6|||
105639284|NCT02706483|364343932|FG000|Overall Study|Site closure|4|||
105639285|NCT02706483|364343932|FG000|Overall Study|Subject moved|1|||
105639286|NCT04660799|364343933|FG000|Overall Study|Progressive Disease|1|||
105639287|NCT04660799|364343934|FG001|Overall Study|Progressive Disease|1|||
105639288|NCT04660799|364343933|FG000|Overall Study|Death|2|||
105639289|NCT04660799|364343934|FG001|Overall Study|Death|1|||
105639290|NCT04660799|364343933|FG000|Overall Study|Adverse Event|2|||
105639291|NCT04660799|364343934|FG001|Overall Study|Adverse Event|1|||
105639292|NCT04660799|364343933|FG000|Overall Study|Withdrawal by Subject|2|||
105639293|NCT04660799|364343934|FG001|Overall Study|Withdrawal by Subject|5|||
105639294|NCT00701415|364343935|FG000|Overall Study|Adverse Event|0|||
105639295|NCT00701415|364343936|FG001|Overall Study|Adverse Event|1|||
105639296|NCT00701415|364343935|FG000|Overall Study|Social/family issues and needle phobia|1|||
105639297|NCT00701415|364343936|FG001|Overall Study|Social/family issues and needle phobia|0|||
105639298|NCT02382640|364343939|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
105639299|NCT02382640|364343940|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
105639300|NCT02382640|364343941|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
105639301|NCT02382640|364343942|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
105639302|NCT01560429|364343943|FG000|Overall Study|Protocol Violation|3|||
105639303|NCT01560429|364343944|FG001|Overall Study|Protocol Violation|6|||
105639304|NCT03861234|364343945|FG000|Overall Study|Not treated|0|||
105639305|NCT03861234|364343946|FG001|Overall Study|Not treated|0|||
105639306|NCT03861234|364343947|FG002|Overall Study|Not treated|0|||
105639307|NCT03861234|364343948|FG003|Overall Study|Not treated|0|||
105639308|NCT03861234|364343949|FG004|Overall Study|Not treated|0|||
105639309|NCT03861234|364343950|FG005|Overall Study|Not treated|1|||
105639310|NCT03861234|364343951|FG006|Overall Study|Not treated|0|||
105639311|NCT03861234|364343952|FG007|Overall Study|Not treated|0|||
105639312|NCT03861234|364343945|FG000|Overall Study|Adverse Event|0|||
105639313|NCT03861234|364343946|FG001|Overall Study|Adverse Event|0|||
105639314|NCT03861234|364343947|FG002|Overall Study|Adverse Event|0|||
105639315|NCT03861234|364343948|FG003|Overall Study|Adverse Event|0|||
105639316|NCT03861234|364343949|FG004|Overall Study|Adverse Event|0|||
105639317|NCT03861234|364343950|FG005|Overall Study|Adverse Event|1|||
105639318|NCT03861234|364343951|FG006|Overall Study|Adverse Event|0|||
105639319|NCT03861234|364343952|FG007|Overall Study|Adverse Event|0|||
105639320|NCT03861234|364343945|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
105639321|NCT03861234|364343946|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
105639322|NCT03861234|364343947|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
105639323|NCT03861234|364343948|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
105639324|NCT03861234|364343949|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
105639325|NCT03861234|364343950|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
105639326|NCT03861234|364343951|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
105639327|NCT03861234|364343952|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
105639328|NCT03861234|364343945|FG000|Overall Study|As per sponsor decision|0|||
105639329|NCT03861234|364343946|FG001|Overall Study|As per sponsor decision|0|||
105639330|NCT03861234|364343947|FG002|Overall Study|As per sponsor decision|0|||
105639331|NCT03861234|364343948|FG003|Overall Study|As per sponsor decision|0|||
105639332|NCT03861234|364343949|FG004|Overall Study|As per sponsor decision|0|||
105639333|NCT03861234|364343950|FG005|Overall Study|As per sponsor decision|0|||
105639334|NCT03861234|364343951|FG006|Overall Study|As per sponsor decision|1|||
105639335|NCT03861234|364343952|FG007|Overall Study|As per sponsor decision|0|||
105639336|NCT03861234|364343945|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
105639337|NCT03861234|364343946|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
105639338|NCT03861234|364343947|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
105639339|NCT03861234|364343948|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
105639340|NCT03861234|364343949|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
105639341|NCT03861234|364343950|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
105639342|NCT03861234|364343951|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
105639343|NCT03861234|364343952|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
105639344|NCT00641537|364343953|FG000|96-week Period|Adverse Event|0|||
105639345|NCT00641537|364343954|FG001|96-week Period|Adverse Event|1|||
105639346|NCT00641537|364343955|FG002|96-week Period|Adverse Event|3|||
105639347|NCT00641537|364343956|FG003|96-week Period|Adverse Event|0|||
105639348|NCT00641537|364343957|FG004|96-week Period|Adverse Event|2|||
105639349|NCT00641537|364343958|FG005|96-week Period|Adverse Event|0|||
105639350|NCT00641537|364343959|FG006|96-week Period|Adverse Event|0|||
105639351|NCT00641537|364343960|FG007|96-week Period|Adverse Event|0|||
105639352|NCT00641537|364343953|FG000|96-week Period|Lost to Follow-up|3|||
105639353|NCT00641537|364343954|FG001|96-week Period|Lost to Follow-up|1|||
105639354|NCT00641537|364343955|FG002|96-week Period|Lost to Follow-up|2|||
105639355|NCT00641537|364343956|FG003|96-week Period|Lost to Follow-up|2|||
105639356|NCT00641537|364343957|FG004|96-week Period|Lost to Follow-up|4|||
105639357|NCT00641537|364343958|FG005|96-week Period|Lost to Follow-up|0|||
105639358|NCT00641537|364343959|FG006|96-week Period|Lost to Follow-up|1|||
105639359|NCT00641537|364343960|FG007|96-week Period|Lost to Follow-up|0|||
105639360|NCT00641537|364343953|FG000|96-week Period|Protocol Violation|0|||
105639361|NCT00641537|364343954|FG001|96-week Period|Protocol Violation|1|||
105639362|NCT00641537|364343955|FG002|96-week Period|Protocol Violation|0|||
105639363|NCT00641537|364343956|FG003|96-week Period|Protocol Violation|1|||
105639364|NCT00641537|364343957|FG004|96-week Period|Protocol Violation|0|||
105639365|NCT00641537|364343958|FG005|96-week Period|Protocol Violation|1|||
105639366|NCT00641537|364343959|FG006|96-week Period|Protocol Violation|0|||
105639367|NCT00641537|364343960|FG007|96-week Period|Protocol Violation|0|||
105639368|NCT00641537|364343953|FG000|96-week Period|Death|2|||
105639369|NCT00641537|364343954|FG001|96-week Period|Death|0|||
105639370|NCT00641537|364343955|FG002|96-week Period|Death|1|||
105639371|NCT00641537|364343956|FG003|96-week Period|Death|0|||
105639372|NCT00641537|364343957|FG004|96-week Period|Death|0|||
105639373|NCT00641537|364343958|FG005|96-week Period|Death|0|||
105639374|NCT00641537|364343959|FG006|96-week Period|Death|0|||
105639375|NCT00641537|364343960|FG007|96-week Period|Death|0|||
105639376|NCT00641537|364343953|FG000|96-week Period|Other|4|||
105639377|NCT00641537|364343954|FG001|96-week Period|Other|7|||
105639378|NCT00641537|364343955|FG002|96-week Period|Other|14|||
105639379|NCT00641537|364343956|FG003|96-week Period|Other|9|||
105639380|NCT00641537|364343957|FG004|96-week Period|Other|11|||
105639381|NCT00641537|364343958|FG005|96-week Period|Other|6|||
105639382|NCT00641537|364343959|FG006|96-week Period|Other|4|||
105639383|NCT00641537|364343960|FG007|96-week Period|Other|6|||
105639384|NCT00641537|364343953|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
105639385|NCT00641537|364343954|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
105639386|NCT00641537|364343955|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
105639387|NCT00641537|364343956|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
105639388|NCT00641537|364343957|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
105639389|NCT00641537|364343958|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
105639390|NCT00641537|364343959|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
105639391|NCT00641537|364343960|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
105639392|NCT00641537|364343953|FG000|24-Week Supplemental Follow-up Period|Other|0|||
105639393|NCT00641537|364343954|FG001|24-Week Supplemental Follow-up Period|Other|2|||
105639394|NCT00641537|364343955|FG002|24-Week Supplemental Follow-up Period|Other|2|||
105639395|NCT00641537|364343956|FG003|24-Week Supplemental Follow-up Period|Other|1|||
105639396|NCT00641537|364343957|FG004|24-Week Supplemental Follow-up Period|Other|3|||
105639397|NCT00641537|364343958|FG005|24-Week Supplemental Follow-up Period|Other|0|||
105639398|NCT00641537|364343959|FG006|24-Week Supplemental Follow-up Period|Other|1|||
105639399|NCT00641537|364343960|FG007|24-Week Supplemental Follow-up Period|Other|1|||
105639400|NCT00875706|364343961|FG000|Overall Study|Withdrawal by Subject|1|||
105639401|NCT00875706|364343962|FG001|Overall Study|Withdrawal by Subject|0|||
105639402|NCT00875706|364343963|FG002|Overall Study|Withdrawal by Subject|0|||
105639403|NCT01860079|364343964|FG000|Overall Study|Physician Decision|14|||
105639404|NCT01860079|364343965|FG001|Overall Study|Physician Decision|22|||
105639405|NCT00786188|364343966|FG000|Overall Study|Adverse Event|3|||
105639406|NCT00786188|364343967|FG001|Overall Study|Adverse Event|1|||
105639407|NCT00786188|364343966|FG000|Overall Study|Withdrawal by Subject|2|||
105639408|NCT00786188|364343967|FG001|Overall Study|Withdrawal by Subject|0|||
105639409|NCT00326183|364343968|FG000|Overall Study|Lost to Follow-up|104|||
105639410|NCT00326183|364343969|FG001|Overall Study|Lost to Follow-up|56|||
105639411|NCT00326183|364343968|FG000|Overall Study|Protocol Violation|6|||
105639412|NCT00326183|364343969|FG001|Overall Study|Protocol Violation|3|||
105639413|NCT00326183|364343968|FG000|Overall Study|Withdrawal by Subject|35|||
105639414|NCT00326183|364343969|FG001|Overall Study|Withdrawal by Subject|7|||
105639415|NCT00326183|364343968|FG000|Overall Study|Subject Moved|7|||
105639416|NCT00326183|364343969|FG001|Overall Study|Subject Moved|4|||
105639417|NCT00326183|364343968|FG000|Overall Study|Other|47|||
105639418|NCT00326183|364343969|FG001|Overall Study|Other|13|||
105639419|NCT00326183|364343968|FG000|Overall Study|Adverse Event|1|||
105639420|NCT00326183|364343969|FG001|Overall Study|Adverse Event|0|||
105639421|NCT02279732|364343970|FG000|Overall Study|Death|23|||
105639422|NCT02279732|364343971|FG001|Overall Study|Death|20|||
105639423|NCT02279732|364343970|FG000|Overall Study|Disease Progression|13|||
105639424|NCT02279732|364343971|FG001|Overall Study|Disease Progression|3|||
105639425|NCT02279732|364343970|FG000|Overall Study|Withdrawal by Subject|2|||
105639426|NCT02279732|364343971|FG001|Overall Study|Withdrawal by Subject|7|||
105639427|NCT02279732|364343970|FG000|Overall Study|Adverse Event|1|||
105639428|NCT02279732|364343971|FG001|Overall Study|Adverse Event|2|||
105639429|NCT02279732|364343970|FG000|Overall Study|Administrative Reason By Sponsor|0|||
105639430|NCT02279732|364343971|FG001|Overall Study|Administrative Reason By Sponsor|2|||
105639431|NCT02279732|364343970|FG000|Overall Study|Study Drug Toxicity|2|||
105639432|NCT02279732|364343971|FG001|Overall Study|Study Drug Toxicity|0|||
105639433|NCT02279732|364343970|FG000|Overall Study|Lost to Follow-up|0|||
105639434|NCT02279732|364343971|FG001|Overall Study|Lost to Follow-up|1|||
105639435|NCT02279732|364343970|FG000|Overall Study|Maximum Clinical Benefit|1|||
105639436|NCT02279732|364343971|FG001|Overall Study|Maximum Clinical Benefit|0|||
105639437|NCT02279732|364343970|FG000|Overall Study|Subject Requested to Discontinue|0|||
105639438|NCT02279732|364343971|FG001|Overall Study|Subject Requested to Discontinue|1|||
105639439|NCT02279732|364343970|FG000|Overall Study|Other|53|||
105639440|NCT02279732|364343971|FG001|Overall Study|Other|67|||
105639441|NCT02279732|364343970|FG000|Overall Study|Other|3|||
105639442|NCT02279732|364343971|FG001|Overall Study|Other|3|||
105639443|NCT02008916|364343976|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
105639444|NCT02008916|364343977|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
105639445|NCT02008916|364343978|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
105639446|NCT02008916|364343976|FG000|Week 16 - 156|Adverse Event|4|||
105639447|NCT02008916|364343977|FG001|Week 16 - 156|Adverse Event|2|||
105639448|NCT02008916|364343978|FG002|Week 16 - 156|Adverse Event|3|||
105639449|NCT02008916|364343976|FG000|Week 16 - 156|Withdrawal by Subject|7|||
105639450|NCT02008916|364343977|FG001|Week 16 - 156|Withdrawal by Subject|3|||
105639451|NCT02008916|364343978|FG002|Week 16 - 156|Withdrawal by Subject|5|||
105639452|NCT02008916|364343976|FG000|Week 16 - 156|No longer requires treatment|0|||
105639453|NCT02008916|364343977|FG001|Week 16 - 156|No longer requires treatment|1|||
105639454|NCT02008916|364343978|FG002|Week 16 - 156|No longer requires treatment|0|||
105639455|NCT02008916|364343976|FG000|Week 16 - 156|Lost to Follow-up|5|||
105639456|NCT02008916|364343977|FG001|Week 16 - 156|Lost to Follow-up|0|||
105639457|NCT02008916|364343978|FG002|Week 16 - 156|Lost to Follow-up|0|||
105639458|NCT02008916|364343976|FG000|Week 16 - 156|Lack of Efficacy|3|||
105639459|NCT02008916|364343977|FG001|Week 16 - 156|Lack of Efficacy|5|||
105639460|NCT02008916|364343978|FG002|Week 16 - 156|Lack of Efficacy|2|||
105639461|NCT02008916|364343976|FG000|Week 16 - 156|Pregnancy|0|||
105639462|NCT02008916|364343977|FG001|Week 16 - 156|Pregnancy|1|||
105639463|NCT02008916|364343978|FG002|Week 16 - 156|Pregnancy|0|||
105639464|NCT02008916|364343976|FG000|Week 16 - 156|Physician Decision|0|||
105639465|NCT02008916|364343977|FG001|Week 16 - 156|Physician Decision|1|||
105639466|NCT02008916|364343978|FG002|Week 16 - 156|Physician Decision|0|||
105639467|NCT03803475|364343979|FG000|Overall Study|Physician Decision|1|||
105639468|NCT03347396|364343981|FG000|Part A (26 Weeks)|Adverse Event|1|||
105639469|NCT03347396|364343982|FG001|Part A (26 Weeks)|Adverse Event|0|||
105639470|NCT03347396|364343981|FG000|Part A (26 Weeks)|Death|0|||
105639471|NCT03347396|364343982|FG001|Part A (26 Weeks)|Death|1|||
105639472|NCT03347396|364343981|FG000|Part B (149 Weeks)|Adverse Event|1|||
105639473|NCT03347396|364343982|FG001|Part B (149 Weeks)|Adverse Event|1|||
105639474|NCT03347396|364343981|FG000|Part B (149 Weeks)|Death|1|||
105639475|NCT03347396|364343982|FG001|Part B (149 Weeks)|Death|0|||
105639476|NCT01263496|364343983|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
105639477|NCT01263496|364343984|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639478|NCT01263496|364343985|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639479|NCT01263496|364343986|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639480|NCT01263496|364343987|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639481|NCT01263496|364343988|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639482|NCT01263496|364343989|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639483|NCT01263496|364343990|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639484|NCT01263496|364343991|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
105639485|NCT01263496|364343983|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639486|NCT01263496|364343984|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639487|NCT01263496|364343985|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639488|NCT01263496|364343986|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
105639489|NCT01263496|364343987|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
105639490|NCT01263496|364343988|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639491|NCT01263496|364343989|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639492|NCT01263496|364343990|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639493|NCT01263496|364343991|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
105639494|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
105639495|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
105639496|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
105639497|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
105639498|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
105639499|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
105639500|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
105639501|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
105639502|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
105639503|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639504|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
105639505|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639506|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639507|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639508|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639509|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639510|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639511|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
105639512|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105639513|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105639514|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105639515|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
105639516|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
105639517|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105639518|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105639519|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
105639520|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
105639521|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
105639522|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
105639523|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
105639524|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105639525|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
105639526|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105639527|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105639528|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
105639529|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
105639530|NCT01263496|364343983|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639531|NCT01263496|364343984|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639532|NCT01263496|364343985|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639533|NCT01263496|364343986|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639534|NCT01263496|364343987|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639535|NCT01263496|364343988|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639536|NCT01263496|364343989|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639537|NCT01263496|364343990|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
105639538|NCT01263496|364343991|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
105639539|NCT02950961|364343995|FG000|Overall Study|Study had to stop due to COVID.|7|||
105639540|NCT03055988|364343998|FG000|Period 1|Adverse Event|0|||
105639541|NCT03055988|364343999|FG001|Period 1|Adverse Event|1|||
105639542|NCT03055988|364343998|FG000|Period 1|Lost to Follow-up|1|||
105639543|NCT03055988|364343999|FG001|Period 1|Lost to Follow-up|0|||
105639544|NCT03055988|364343998|FG000|Period 1|Withdrawal by Subject|0|||
105639545|NCT03055988|364343999|FG001|Period 1|Withdrawal by Subject|4|||
105639546|NCT03055988|364343998|FG000|Period 2|Adverse Event|0|||
105639547|NCT03055988|364343999|FG001|Period 2|Adverse Event|1|||
105639548|NCT03055988|364343998|FG000|Period 2|Other than listed|1|||
105639549|NCT03055988|364343999|FG001|Period 2|Other than listed|1|||
105639550|NCT04748341|364344000|FG000|Overall Study|Lost to Follow-up|1|||
105639551|NCT04748341|364344001|FG001|Overall Study|Lost to Follow-up|1|||
105639552|NCT00392197|364344004|FG000|Overall Study|Adverse Event|4|||
105639553|NCT00392197|364344005|FG001|Overall Study|Adverse Event|12|||
105639554|NCT00392197|364344004|FG000|Overall Study|Lack of Efficacy|3|||
105639555|NCT00392197|364344005|FG001|Overall Study|Lack of Efficacy|4|||
105639556|NCT00392197|364344004|FG000|Overall Study|Lost to Follow-up|0|||
105639557|NCT00392197|364344005|FG001|Overall Study|Lost to Follow-up|1|||
105639558|NCT00392197|364344004|FG000|Overall Study|Physician Decision|3|||
105639559|NCT00392197|364344005|FG001|Overall Study|Physician Decision|2|||
105639560|NCT00392197|364344004|FG000|Overall Study|Protocol Violation|7|||
105639561|NCT00392197|364344005|FG001|Overall Study|Protocol Violation|5|||
105639562|NCT00392197|364344004|FG000|Overall Study|Withdrawal by Subject|4|||
105639563|NCT00392197|364344005|FG001|Overall Study|Withdrawal by Subject|6|||
105639564|NCT02432274|364344007|FG000|Overall Study|Death|2|||
105639565|NCT02432274|364344008|FG001|Overall Study|Death|6|||
105639566|NCT02432274|364344009|FG002|Overall Study|Death|7|||
105639567|NCT02432274|364344010|FG003|Overall Study|Death|0|||
105639568|NCT02432274|364344011|FG004|Overall Study|Death|27|||
105639569|NCT02432274|364344012|FG005|Overall Study|Death|7|||
105639570|NCT02432274|364344013|FG006|Overall Study|Death|9|||
105639571|NCT02432274|364344014|FG007|Overall Study|Death|14|||
105639572|NCT02432274|364344007|FG000|Overall Study|Withdrawal of Consent|0|||
105639573|NCT02432274|364344008|FG001|Overall Study|Withdrawal of Consent|0|||
105639574|NCT02432274|364344009|FG002|Overall Study|Withdrawal of Consent|0|||
105639575|NCT02432274|364344010|FG003|Overall Study|Withdrawal of Consent|0|||
105639576|NCT02432274|364344011|FG004|Overall Study|Withdrawal of Consent|2|||
105639577|NCT02432274|364344012|FG005|Overall Study|Withdrawal of Consent|0|||
105639578|NCT02432274|364344013|FG006|Overall Study|Withdrawal of Consent|1|||
105639579|NCT02432274|364344014|FG007|Overall Study|Withdrawal of Consent|2|||
105639580|NCT00090519|364344015|FG000|Overall Study|Adverse Event|5|||
105639581|NCT00090519|364344016|FG001|Overall Study|Adverse Event|4|||
105639582|NCT00090519|364344015|FG000|Overall Study|Death|9|||
105639583|NCT00090519|364344016|FG001|Overall Study|Death|9|||
105639584|NCT00090519|364344015|FG000|Overall Study|Lost to Follow-up|26|||
105639585|NCT00090519|364344016|FG001|Overall Study|Lost to Follow-up|29|||
105639586|NCT00090519|364344015|FG000|Overall Study|Withdrawal by Subject|28|||
105639587|NCT00090519|364344016|FG001|Overall Study|Withdrawal by Subject|29|||
105639588|NCT00090519|364344015|FG000|Overall Study|Physician Decision|2|||
105639589|NCT00090519|364344016|FG001|Overall Study|Physician Decision|3|||
105639590|NCT00090519|364344015|FG000|Overall Study|Sponsor Decision|3|||
105639591|NCT00090519|364344016|FG001|Overall Study|Sponsor Decision|1|||
105639592|NCT00116649|364344017|FG000|Overall Study|Adverse Event|20|||
105639593|NCT00116649|364344017|FG000|Overall Study|Lack of Efficacy|1|||
105639594|NCT00116649|364344017|FG000|Overall Study|Lost to Follow-up|32|||
105639595|NCT00116649|364344017|FG000|Overall Study|Withdrawal by Subject|68|||
105639596|NCT00116649|364344017|FG000|Overall Study|Local Skin Reaction|9|||
105639597|NCT00116649|364344017|FG000|Overall Study|Various Reasons|18|||
105639598|NCT00116649|364344017|FG000|Overall Study|Protocol Specified|7|||
105639599|NCT02114515|364344026|FG000|Overall Study|Lost to Follow-up|52|||
105639600|NCT02114515|364344027|FG001|Overall Study|Lost to Follow-up|55|||
105639601|NCT02114515|364344026|FG000|Overall Study|Death|12|||
105639602|NCT02114515|364344027|FG001|Overall Study|Death|12|||
105639603|NCT02114515|364344026|FG000|Overall Study|Withdrawal by Subject|4|||
105639604|NCT02114515|364344027|FG001|Overall Study|Withdrawal by Subject|22|||
105639605|NCT02114515|364344026|FG000|Overall Study|Other|65|||
105639606|NCT02114515|364344027|FG001|Overall Study|Other|61|||
105639607|NCT01075152|364344031|FG000|Overall Study|Withdrawal by Subject|1|||
105639608|NCT01075152|364344032|FG001|Overall Study|Withdrawal by Subject|0|||
105639609|NCT04820491|364344033|FG000|Overall Study|Withdrawal by Subject|1|||
105639610|NCT04820491|364344034|FG001|Overall Study|Withdrawal by Subject|0|||
105639611|NCT00443820|364345504|FG000|Overall Study|Adverse Event|1|||
105639612|NCT00443820|364345505|FG001|Overall Study|Adverse Event|1|||
105639613|NCT00443820|364345506|FG002|Overall Study|Adverse Event|0|||
105639614|NCT00443820|364345507|FG003|Overall Study|Adverse Event|0|||
105639615|NCT00443820|364345504|FG000|Overall Study|Lack of Efficacy|3|||
105639616|NCT00443820|364345505|FG001|Overall Study|Lack of Efficacy|2|||
105639617|NCT00443820|364345506|FG002|Overall Study|Lack of Efficacy|1|||
105639618|NCT00443820|364345507|FG003|Overall Study|Lack of Efficacy|1|||
105639619|NCT00443820|364345504|FG000|Overall Study|Protocol Violation|2|||
105639620|NCT00443820|364345505|FG001|Overall Study|Protocol Violation|1|||
105639621|NCT00443820|364345506|FG002|Overall Study|Protocol Violation|2|||
105639622|NCT00443820|364345507|FG003|Overall Study|Protocol Violation|1|||
105639623|NCT00443820|364345504|FG000|Overall Study|Withdrawal by Subject|6|||
105639624|NCT00443820|364345505|FG001|Overall Study|Withdrawal by Subject|7|||
105639625|NCT00443820|364345506|FG002|Overall Study|Withdrawal by Subject|8|||
105639626|NCT00443820|364345507|FG003|Overall Study|Withdrawal by Subject|9|||
105639627|NCT00443820|364345504|FG000|Overall Study|Lost to Follow-up|9|||
105639628|NCT00443820|364345505|FG001|Overall Study|Lost to Follow-up|8|||
105639629|NCT00443820|364345506|FG002|Overall Study|Lost to Follow-up|6|||
105639630|NCT00443820|364345507|FG003|Overall Study|Lost to Follow-up|5|||
105639631|NCT00443820|364345504|FG000|Overall Study|Administrative problems|0|||
105639632|NCT00443820|364345505|FG001|Overall Study|Administrative problems|0|||
105639633|NCT00443820|364345506|FG002|Overall Study|Administrative problems|0|||
105639634|NCT00443820|364345507|FG003|Overall Study|Administrative problems|1|||
105639635|NCT00443820|364345504|FG000|Overall Study|Death|0|||
105639636|NCT00443820|364345505|FG001|Overall Study|Death|0|||
105639637|NCT00443820|364345506|FG002|Overall Study|Death|1|||
105639638|NCT00443820|364345507|FG003|Overall Study|Death|0|||
105639639|NCT04633200|364345509|FG000|Overall Study|Lost to Follow-up|3|||
105639640|NCT04633200|364345510|FG001|Overall Study|Lost to Follow-up|5|||
105639641|NCT03490032|364345513|FG000|Overall Study|family issue (child custody)|1|||
105639642|NCT03490032|364345514|FG001|Overall Study|family issue (child custody)|0|||
105639643|NCT03490032|364345515|FG002|Overall Study|family issue (child custody)|0|||
105639644|NCT01947491|364345516|FG000|Overall Study|Lost to Follow-up|5|||
105639645|NCT01947491|364345517|FG001|Overall Study|Lost to Follow-up|3|||
105639646|NCT01947491|364345518|FG002|Overall Study|Lost to Follow-up|1|||
105639647|NCT01947491|364345519|FG003|Overall Study|Lost to Follow-up|2|||
105639648|NCT01947491|364345516|FG000|Overall Study|Lack of Efficacy|1|||
105639649|NCT01947491|364345517|FG001|Overall Study|Lack of Efficacy|0|||
105639650|NCT01947491|364345518|FG002|Overall Study|Lack of Efficacy|0|||
105639651|NCT01947491|364345519|FG003|Overall Study|Lack of Efficacy|1|||
105639652|NCT01947491|364345516|FG000|Overall Study|Protocol Violation|1|||
105639653|NCT01947491|364345517|FG001|Overall Study|Protocol Violation|0|||
105639654|NCT01947491|364345518|FG002|Overall Study|Protocol Violation|0|||
105639655|NCT01947491|364345519|FG003|Overall Study|Protocol Violation|0|||
105639656|NCT01947491|364345516|FG000|Overall Study|Withdrawal by Subject|1|||
105639657|NCT01947491|364345517|FG001|Overall Study|Withdrawal by Subject|1|||
105639658|NCT01947491|364345518|FG002|Overall Study|Withdrawal by Subject|1|||
105639659|NCT01947491|364345519|FG003|Overall Study|Withdrawal by Subject|0|||
105639660|NCT01947491|364345516|FG000|Overall Study|Worsening of condition|0|||
105639661|NCT01947491|364345517|FG001|Overall Study|Worsening of condition|1|||
105639662|NCT01947491|364345518|FG002|Overall Study|Worsening of condition|0|||
105639663|NCT01947491|364345519|FG003|Overall Study|Worsening of condition|0|||
105639664|NCT01947491|364345516|FG000|Overall Study|Adverse Event|0|||
105639665|NCT01947491|364345517|FG001|Overall Study|Adverse Event|1|||
105639666|NCT01947491|364345518|FG002|Overall Study|Adverse Event|0|||
105639667|NCT01947491|364345519|FG003|Overall Study|Adverse Event|2|||
105639668|NCT01951703|364345522|FG000|First Intervention|Withdrawal by Subject|1|||
105639669|NCT01951703|364345523|FG001|First Intervention|Withdrawal by Subject|0|||
105639670|NCT01951703|364345522|FG000|First Intervention|Subject was not compliant|1|||
105639671|NCT01951703|364345523|FG001|First Intervention|Subject was not compliant|1|||
105639672|NCT01951703|364345522|FG000|First Intervention|Physician Decision|1|||
105639673|NCT01951703|364345523|FG001|First Intervention|Physician Decision|0|||
105639674|NCT01951703|364345522|FG000|Second Intervention|Protocol Violation|0|||
105639675|NCT01951703|364345523|FG001|Second Intervention|Protocol Violation|1|||
105639676|NCT01951703|364345522|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
105639677|NCT01951703|364345523|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
105639678|NCT01852045|364345524|FG000|Overall Study|Adverse Event|1|||
105639679|NCT01852045|364345525|FG001|Overall Study|Adverse Event|0|||
105639680|NCT01852045|364345526|FG002|Overall Study|Adverse Event|0|||
105639681|NCT01852045|364345524|FG000|Overall Study|Lack of Efficacy|3|||
105639682|NCT01852045|364345525|FG001|Overall Study|Lack of Efficacy|0|||
105639683|NCT01852045|364345526|FG002|Overall Study|Lack of Efficacy|0|||
105639684|NCT01852045|364345524|FG000|Overall Study|Lost to Follow-up|0|||
105639685|NCT01852045|364345525|FG001|Overall Study|Lost to Follow-up|1|||
105639686|NCT01852045|364345526|FG002|Overall Study|Lost to Follow-up|1|||
105639687|NCT01852045|364345524|FG000|Overall Study|Withdrawal by Subject|1|||
105639688|NCT01852045|364345525|FG001|Overall Study|Withdrawal by Subject|0|||
105639689|NCT01852045|364345526|FG002|Overall Study|Withdrawal by Subject|1|||
105639690|NCT01852045|364345524|FG000|Overall Study|Other Miscellaneous Reasons|1|||
105639691|NCT01852045|364345525|FG001|Overall Study|Other Miscellaneous Reasons|3|||
105639692|NCT01852045|364345526|FG002|Overall Study|Other Miscellaneous Reasons|2|||
105639693|NCT00704340|364345527|FG000|Overall Study|Lost to Follow-up|2|||
105639694|NCT00704340|364345528|FG001|Overall Study|Lost to Follow-up|1|||
105639695|NCT00704340|364345527|FG000|Overall Study|Death|0|||
105639696|NCT00704340|364345528|FG001|Overall Study|Death|1|||
105639697|NCT00620854|364345529|FG000|Washout 1|Withdrawal by Subject|0|||
105639698|NCT00620854|364345530|FG001|Washout 1|Withdrawal by Subject|0|||
105639699|NCT00620854|364345531|FG002|Washout 1|Withdrawal by Subject|1|||
105639700|NCT00620854|364345532|FG003|Washout 1|Withdrawal by Subject|1|||
105639701|NCT00620854|364345533|FG004|Washout 1|Withdrawal by Subject|0|||
105639702|NCT00620854|364345534|FG005|Washout 1|Withdrawal by Subject|0|||
105639703|NCT03137784|364345535|FG000|Overall Study|Adverse Event|1|||
105639704|NCT03137784|364345536|FG001|Overall Study|Adverse Event|1|||
105639705|NCT03137784|364345537|FG002|Overall Study|Adverse Event|0|||
105639706|NCT03137784|364345538|FG003|Overall Study|Adverse Event|0|||
105639707|NCT03137784|364345539|FG004|Overall Study|Adverse Event|0|||
105639708|NCT03137784|364345540|FG005|Overall Study|Adverse Event|0|||
105639709|NCT03137784|364345535|FG000|Overall Study|Subject/guardian decision|1|||
105639710|NCT03137784|364345536|FG001|Overall Study|Subject/guardian decision|0|||
105639711|NCT03137784|364345537|FG002|Overall Study|Subject/guardian decision|0|||
105639712|NCT03137784|364345538|FG003|Overall Study|Subject/guardian decision|0|||
105639713|NCT03137784|364345539|FG004|Overall Study|Subject/guardian decision|0|||
105639714|NCT03137784|364345540|FG005|Overall Study|Subject/guardian decision|0|||
105639715|NCT03137784|364345535|FG000|Overall Study|Non-compliance with study treatment|0|||
105639716|NCT03137784|364345536|FG001|Overall Study|Non-compliance with study treatment|0|||
105639717|NCT03137784|364345537|FG002|Overall Study|Non-compliance with study treatment|0|||
105639718|NCT03137784|364345538|FG003|Overall Study|Non-compliance with study treatment|0|||
105639719|NCT03137784|364345539|FG004|Overall Study|Non-compliance with study treatment|1|||
105639720|NCT03137784|364345540|FG005|Overall Study|Non-compliance with study treatment|0|||
105639721|NCT00487240|364345541|FG000|Overall Study|Withdrawal by Subject|12|||
105639722|NCT00487240|364345542|FG001|Overall Study|Withdrawal by Subject|6|||
105639723|NCT00487240|364345541|FG000|Overall Study|Lost to Follow-up|7|||
105639724|NCT00487240|364345542|FG001|Overall Study|Lost to Follow-up|6|||
105639725|NCT00487240|364345541|FG000|Overall Study|Adverse Event|0|||
105639726|NCT00487240|364345542|FG001|Overall Study|Adverse Event|4|||
105639727|NCT00487240|364345541|FG000|Overall Study|Protocol Violation|5|||
105639728|NCT00487240|364345542|FG001|Overall Study|Protocol Violation|5|||
105639729|NCT00487240|364345541|FG000|Overall Study|Entry Criteria Not Met|3|||
105639730|NCT00487240|364345542|FG001|Overall Study|Entry Criteria Not Met|4|||
105639731|NCT00487240|364345541|FG000|Overall Study|Sponsor Decision|2|||
105639732|NCT00487240|364345542|FG001|Overall Study|Sponsor Decision|1|||
105639733|NCT00487240|364345541|FG000|Overall Study|Physician Decision|2|||
105639734|NCT00487240|364345542|FG001|Overall Study|Physician Decision|0|||
105639735|NCT01205126|364345545|FG000|Titration Phase|Adverse Event|5|||
105639736|NCT01205126|364345546|FG001|Titration Phase|Adverse Event|3|||
105639737|NCT01205126|364345545|FG000|Titration Phase|Withdrawal by Subject|5|||
105639738|NCT01205126|364345546|FG001|Titration Phase|Withdrawal by Subject|5|||
105639739|NCT01205126|364345545|FG000|Titration Phase|Lost to Follow-up|2|||
105639740|NCT01205126|364345546|FG001|Titration Phase|Lost to Follow-up|2|||
105639741|NCT01205126|364345545|FG000|Titration Phase|No stable titration dose|1|||
105639742|NCT01205126|364345546|FG001|Titration Phase|No stable titration dose|0|||
105639743|NCT01205126|364345545|FG000|Titration Phase|More than maximum dosage required|2|||
105639744|NCT01205126|364345546|FG001|Titration Phase|More than maximum dosage required|3|||
105639745|NCT01205126|364345545|FG000|Titration Phase|Other|8|||
105639746|NCT01205126|364345546|FG001|Titration Phase|Other|6|||
105639747|NCT01205126|364345545|FG000|Between Titration & Maintenance Phase|Other|0|||
105639748|NCT01205126|364345546|FG001|Between Titration & Maintenance Phase|Other|4|||
105639749|NCT01205126|364345545|FG000|Maintenance Phase|Adverse Event|3|||
105639750|NCT01205126|364345546|FG001|Maintenance Phase|Adverse Event|7|||
105639751|NCT01205126|364345545|FG000|Maintenance Phase|Death|4|||
105639752|NCT01205126|364345546|FG001|Maintenance Phase|Death|4|||
105639753|NCT01205126|364345545|FG000|Maintenance Phase|More than the maximum dosage required|5|||
105639754|NCT01205126|364345546|FG001|Maintenance Phase|More than the maximum dosage required|5|||
105639755|NCT01205126|364345545|FG000|Maintenance Phase|Prohibited drugs used|1|||
105639756|NCT01205126|364345546|FG001|Maintenance Phase|Prohibited drugs used|0|||
105639757|NCT01205126|364345545|FG000|Maintenance Phase|Other|11|||
105639758|NCT01205126|364345546|FG001|Maintenance Phase|Other|8|||
105639759|NCT01205126|364345545|FG000|Maintenance Phase|Lost to Follow-up|5|||
105639760|NCT01205126|364345546|FG001|Maintenance Phase|Lost to Follow-up|5|||
105639761|NCT01205126|364345545|FG000|Maintenance Phase|Withdrawal by Subject|8|||
105639762|NCT01205126|364345546|FG001|Maintenance Phase|Withdrawal by Subject|11|||
105639763|NCT00486954|364345547|FG000|Pilot Part|Adverse Event|4|||
105639764|NCT00486954|364345548|FG001|Pilot Part|Adverse Event|0|||
105639765|NCT00486954|364345549|FG002|Pilot Part|Adverse Event|5|||
105639766|NCT00486954|364345550|FG003|Pilot Part|Adverse Event|0|||
105639767|NCT00486954|364345551|FG004|Pilot Part|Adverse Event|0|||
105639768|NCT00486954|364345547|FG000|Pilot Part|Disease Progression|2|||
105639769|NCT00486954|364345548|FG001|Pilot Part|Disease Progression|0|||
105639770|NCT00486954|364345549|FG002|Pilot Part|Disease Progression|1|||
105639771|NCT00486954|364345550|FG003|Pilot Part|Disease Progression|0|||
105639772|NCT00486954|364345551|FG004|Pilot Part|Disease Progression|0|||
105639773|NCT00486954|364345547|FG000|Randomized Part|Lost to Follow-up|0|||
105639774|NCT00486954|364345548|FG001|Randomized Part|Lost to Follow-up|0|||
105639775|NCT00486954|364345549|FG002|Randomized Part|Lost to Follow-up|0|||
105639776|NCT00486954|364345550|FG003|Randomized Part|Lost to Follow-up|0|||
105639777|NCT00486954|364345551|FG004|Randomized Part|Lost to Follow-up|1|||
105639778|NCT00486954|364345547|FG000|Randomized Part|Withdrawal by Subject|0|||
105639779|NCT00486954|364345548|FG001|Randomized Part|Withdrawal by Subject|0|||
105639780|NCT00486954|364345549|FG002|Randomized Part|Withdrawal by Subject|0|||
105639781|NCT00486954|364345550|FG003|Randomized Part|Withdrawal by Subject|1|||
105639782|NCT00486954|364345551|FG004|Randomized Part|Withdrawal by Subject|0|||
105639783|NCT00486954|364345547|FG000|Randomized Part|Sponsor Terminated Study|0|||
105639784|NCT00486954|364345548|FG001|Randomized Part|Sponsor Terminated Study|0|||
105639785|NCT00486954|364345549|FG002|Randomized Part|Sponsor Terminated Study|0|||
105639786|NCT00486954|364345550|FG003|Randomized Part|Sponsor Terminated Study|19|||
105639787|NCT00486954|364345551|FG004|Randomized Part|Sponsor Terminated Study|13|||
105639788|NCT01428583|364345552|FG000|Overall Study|Adverse Event|75|||
105639789|NCT01428583|364345552|FG000|Overall Study|Withdrawal by Subject|51|||
105639790|NCT01428583|364345552|FG000|Overall Study|Lack of Efficacy|37|||
105639791|NCT01428583|364345552|FG000|Overall Study|Lost to Follow-up|17|||
105639792|NCT01428583|364345552|FG000|Overall Study|Death|1|||
105639793|NCT01428583|364345552|FG000|Overall Study|Pregnancy|1|||
105639794|NCT01428583|364345552|FG000|Overall Study|Protocol Violation|1|||
105639795|NCT01428583|364345552|FG000|Overall Study|Physician Decision|12|||
105639796|NCT01428583|364345552|FG000|Overall Study|Non-compliant|25|||
105639797|NCT01428583|364345552|FG000|Overall Study|Confirmed positive urine drug test|8|||
105639798|NCT01428583|364345552|FG000|Overall Study|Sponsor's request|3|||
105639799|NCT01428583|364345552|FG000|Overall Study|Other|6|||
105639800|NCT00703092|364345555|FG000|Overall Study|Withdrawal by Subject|2|||
105639801|NCT02708498|364345556|FG000|Overall Study|Death|20|||
105639802|NCT02708498|364345557|FG001|Overall Study|Death|19|||
105639803|NCT02708498|364345558|FG002|Overall Study|Death|0|||
105639804|NCT02708498|364345559|FG003|Overall Study|Death|0|||
105639805|NCT02708498|364345560|FG004|Overall Study|Death|1|||
105639806|NCT02708498|364345561|FG005|Overall Study|Death|0|||
105639807|NCT02708498|364345562|FG006|Overall Study|Death|0|||
105639808|NCT02708498|364345563|FG007|Overall Study|Death|0|||
105639809|NCT02708498|364345556|FG000|Overall Study|Unknown reason, missing data|0|||
105639810|NCT02708498|364345557|FG001|Overall Study|Unknown reason, missing data|0|||
105639811|NCT02708498|364345558|FG002|Overall Study|Unknown reason, missing data|62|||
105639812|NCT02708498|364345559|FG003|Overall Study|Unknown reason, missing data|51|||
105639813|NCT02708498|364345560|FG004|Overall Study|Unknown reason, missing data|195|||
105639814|NCT02708498|364345561|FG005|Overall Study|Unknown reason, missing data|132|||
105639815|NCT02708498|364345562|FG006|Overall Study|Unknown reason, missing data|0|||
105639816|NCT02708498|364345563|FG007|Overall Study|Unknown reason, missing data|0|||
105639817|NCT01480258|364345567|FG000|Infant Series|Protocol Violation|2|||
105639818|NCT01480258|364345568|FG001|Infant Series|Protocol Violation|0|||
105639819|NCT01480258|364345567|FG000|Infant Series|Physician Decision|0|||
105639820|NCT01480258|364345568|FG001|Infant Series|Physician Decision|1|||
105639821|NCT01480258|364345567|FG000|Infant Series|Not Vaccinated|3|||
105639822|NCT01480258|364345568|FG001|Infant Series|Not Vaccinated|0|||
105639823|NCT01480258|364345567|FG000|Infant Series|Adverse Event|1|||
105639824|NCT01480258|364345568|FG001|Infant Series|Adverse Event|1|||
105639825|NCT01480258|364345567|FG000|Infant Series|Withdrawal by Subject|1|||
105639826|NCT01480258|364345568|FG001|Infant Series|Withdrawal by Subject|6|||
105639827|NCT01480258|364345567|FG000|Interim Period|Lost to Follow-up|0|||
105639828|NCT01480258|364345568|FG001|Interim Period|Lost to Follow-up|2|||
105639829|NCT01480258|364345567|FG000|Interim Period|Physician Decision|1|||
105639830|NCT01480258|364345568|FG001|Interim Period|Physician Decision|0|||
105639831|NCT01480258|364345567|FG000|Interim Period|Protocol Violation|0|||
105639832|NCT01480258|364345568|FG001|Interim Period|Protocol Violation|1|||
105639833|NCT01480258|364345567|FG000|Interim Period|Withdrawal by Subject|9|||
105639834|NCT01480258|364345568|FG001|Interim Period|Withdrawal by Subject|6|||
105639835|NCT03316170|364345569|FG000|Overall Study|Death|1|||
105639836|NCT03316170|364345570|FG001|Overall Study|Death|0|||
105639837|NCT03316170|364345569|FG000|Overall Study|Lost to Follow-up|6|||
105639838|NCT03316170|364345570|FG001|Overall Study|Lost to Follow-up|7|||
105639839|NCT01836523|364345571|FG000|Overall Study|Adverse Event|15|||
105639840|NCT01836523|364345572|FG001|Overall Study|Adverse Event|41|||
105639841|NCT01836523|364345573|FG002|Overall Study|Adverse Event|49|||
105639842|NCT01836523|364345574|FG003|Overall Study|Adverse Event|14|||
105639843|NCT01836523|364345571|FG000|Overall Study|Protocol Violation|6|||
105639844|NCT01836523|364345572|FG001|Overall Study|Protocol Violation|3|||
105639845|NCT01836523|364345573|FG002|Overall Study|Protocol Violation|2|||
105639846|NCT01836523|364345574|FG003|Overall Study|Protocol Violation|4|||
105639847|NCT01836523|364345571|FG000|Overall Study|Met Withdrawal Criteria|13|||
105639848|NCT01836523|364345572|FG001|Overall Study|Met Withdrawal Criteria|13|||
105639849|NCT01836523|364345573|FG002|Overall Study|Met Withdrawal Criteria|21|||
105639850|NCT01836523|364345574|FG003|Overall Study|Met Withdrawal Criteria|27|||
105639851|NCT01836523|364345571|FG000|Overall Study|Unclassified|17|||
105639852|NCT01836523|364345572|FG001|Overall Study|Unclassified|28|||
105639853|NCT01836523|364345573|FG002|Overall Study|Unclassified|19|||
105639854|NCT01836523|364345574|FG003|Overall Study|Unclassified|29|||
105639855|NCT00923078|364345581|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
105639856|NCT00923078|364345582|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
105639857|NCT00923078|364345583|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
105639858|NCT00923078|364345581|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
105639859|NCT00923078|364345582|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
105639860|NCT00923078|364345583|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
105639861|NCT04361617|364345584|FG000|Overall Study|Withdrawal by Subject|0|||
105639862|NCT04361617|364345585|FG001|Overall Study|Withdrawal by Subject|1|||
105639863|NCT04679675|364345587|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
105639864|NCT04679675|364345588|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
105639865|NCT04679675|364345589|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
105639866|NCT04679675|364345590|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
105639867|NCT04679675|364345587|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
105639868|NCT04679675|364345588|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
105639869|NCT04679675|364345589|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
105639870|NCT04679675|364345590|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
105639871|NCT00681109|364345591|FG000|Overall Study|Lost to Follow-up|2|||
105639872|NCT00681109|364345592|FG001|Overall Study|Lost to Follow-up|6|||
105639873|NCT00681109|364345593|FG002|Overall Study|Lost to Follow-up|0|||
105639874|NCT03456856|364345594|FG000|Overall Study|Lost to Follow-up|2|||
105639875|NCT03456856|364345594|FG000|Overall Study|Withdrawal by Subject|1|||
105639876|NCT02037568|364345595|FG000|Overall Study|Withdrawal by Subject|17|||
105639877|NCT02037568|364345596|FG001|Overall Study|Withdrawal by Subject|24|||
105639878|NCT02037568|364345595|FG000|Overall Study|Lost to Follow-up|16|||
105639879|NCT02037568|364345596|FG001|Overall Study|Lost to Follow-up|13|||
105639880|NCT02037568|364345595|FG000|Overall Study|Screen Failure|3|||
105639881|NCT02037568|364345596|FG001|Overall Study|Screen Failure|1|||
105639882|NCT02037568|364345595|FG000|Overall Study|Patient did not receive transplant|0|||
105639883|NCT02037568|364345596|FG001|Overall Study|Patient did not receive transplant|1|||
105639884|NCT00621842|364345597|FG000|Overall Study|Adverse Event|6|||
105639885|NCT00621842|364345597|FG000|Overall Study|Withdrawal by Subject|7|||
105639886|NCT00621842|364345597|FG000|Overall Study|Protocol Violation|4|||
105639887|NCT00621842|364345597|FG000|Overall Study|Lack of Efficacy|2|||
105639888|NCT00068107|364345600|FG000|Overall Study|end-stage renal disease|6|||
105639889|NCT00068107|364345600|FG000|Overall Study|Death|2|||
105639890|NCT00068107|364345600|FG000|Overall Study|Withdrawal by Subject|1|||
105639891|NCT01419184|364345601|FG000|Overall Study|Site data not available|3|||
105639892|NCT01419184|364345602|FG001|Overall Study|Site data not available|2|||
105639893|NCT01419184|364345601|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
105639894|NCT01419184|364345602|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
105639895|NCT01419184|364345601|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
105639896|NCT01419184|364345602|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
105639897|NCT01419184|364345601|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
105639898|NCT01419184|364345602|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
105639899|NCT01419184|364345601|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
105639900|NCT01419184|364345602|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
105639901|NCT01419184|364345601|FG000|Overall Study|Participant randomized, not treated|1|||
105639902|NCT01419184|364345602|FG001|Overall Study|Participant randomized, not treated|0|||
105639903|NCT02644122|364345603|FG000|Overall Study|Withdrawal by Subject|1|||
105639904|NCT02060487|364345606|FG000|Overall Study|Other|1|||
105639905|NCT02060487|364345607|FG001|Overall Study|Other|2|||
105639906|NCT02060487|364345608|FG002|Overall Study|Other|1|||
105639907|NCT02060487|364345606|FG000|Overall Study|Lack of Efficacy|0|||
105639908|NCT02060487|364345607|FG001|Overall Study|Lack of Efficacy|1|||
105639909|NCT02060487|364345608|FG002|Overall Study|Lack of Efficacy|0|||
105639910|NCT02060487|364345606|FG000|Overall Study|Withdrawal by Subject|3|||
105639911|NCT02060487|364345607|FG001|Overall Study|Withdrawal by Subject|10|||
105639912|NCT02060487|364345608|FG002|Overall Study|Withdrawal by Subject|4|||
105639913|NCT02060487|364345606|FG000|Overall Study|Study Terminated By Sponsor|87|||
105639914|NCT02060487|364345607|FG001|Overall Study|Study Terminated By Sponsor|89|||
105639915|NCT02060487|364345608|FG002|Overall Study|Study Terminated By Sponsor|100|||
105639916|NCT02060487|364345606|FG000|Overall Study|Randomized in error|1|||
105639917|NCT02060487|364345607|FG001|Overall Study|Randomized in error|0|||
105639918|NCT02060487|364345608|FG002|Overall Study|Randomized in error|0|||
105639919|NCT02060487|364345606|FG000|Overall Study|Protocol Violation|0|||
105639920|NCT02060487|364345607|FG001|Overall Study|Protocol Violation|1|||
105639921|NCT02060487|364345608|FG002|Overall Study|Protocol Violation|1|||
105639922|NCT02060487|364345606|FG000|Overall Study|Lost to Follow-up|3|||
105639923|NCT02060487|364345607|FG001|Overall Study|Lost to Follow-up|0|||
105639924|NCT02060487|364345608|FG002|Overall Study|Lost to Follow-up|2|||
105639925|NCT02060487|364345606|FG000|Overall Study|Death|34|||
105639926|NCT02060487|364345607|FG001|Overall Study|Death|25|||
105639927|NCT02060487|364345608|FG002|Overall Study|Death|19|||
105639928|NCT02060487|364345606|FG000|Overall Study|Adverse Event|0|||
105639929|NCT02060487|364345607|FG001|Overall Study|Adverse Event|0|||
105639930|NCT02060487|364345608|FG002|Overall Study|Adverse Event|1|||
105639931|NCT01856569|364345616|FG000|Overall Study|Other|1|||
105639932|NCT01856569|364345616|FG000|Overall Study|Changed Site/Structure|1|||
105639933|NCT01856569|364345616|FG000|Overall Study|Lost to Follow-up|3|||
105639934|NCT01856569|364345616|FG000|Overall Study|Did not met inclusion criteria|8|||
105639935|NCT00824408|364345618|FG000|Run-in Phase|Progressive disease|4|||
105639936|NCT00824408|364345619|FG001|Run-in Phase|Progressive disease|4|||
105639937|NCT00824408|364345620|FG002|Run-in Phase|Progressive disease|0|||
105639938|NCT00824408|364345621|FG003|Run-in Phase|Progressive disease|0|||
105639939|NCT00824408|364345622|FG004|Run-in Phase|Progressive disease|0|||
105639940|NCT00824408|364345618|FG000|Run-in Phase|Adverse Event|1|||
105639941|NCT00824408|364345619|FG001|Run-in Phase|Adverse Event|1|||
105639942|NCT00824408|364345620|FG002|Run-in Phase|Adverse Event|0|||
105639943|NCT00824408|364345621|FG003|Run-in Phase|Adverse Event|0|||
105639944|NCT00824408|364345622|FG004|Run-in Phase|Adverse Event|0|||
105639945|NCT00824408|364345618|FG000|Run-in Phase|Refused to continue medication|1|||
105639946|NCT00824408|364345619|FG001|Run-in Phase|Refused to continue medication|0|||
105639947|NCT00824408|364345620|FG002|Run-in Phase|Refused to continue medication|0|||
105639948|NCT00824408|364345621|FG003|Run-in Phase|Refused to continue medication|0|||
105639949|NCT00824408|364345622|FG004|Run-in Phase|Refused to continue medication|0|||
105639950|NCT00824408|364345618|FG000|Run-in Phase|Other reason not defined above|0|||
105639951|NCT00824408|364345619|FG001|Run-in Phase|Other reason not defined above|1|||
105639952|NCT00824408|364345620|FG002|Run-in Phase|Other reason not defined above|0|||
105639953|NCT00824408|364345621|FG003|Run-in Phase|Other reason not defined above|0|||
105639954|NCT00824408|364345622|FG004|Run-in Phase|Other reason not defined above|0|||
105639955|NCT00824408|364345618|FG000|Randomized Phase|Not treated|0|||
105639956|NCT00824408|364345619|FG001|Randomized Phase|Not treated|0|||
105639957|NCT00824408|364345620|FG002|Randomized Phase|Not treated|1|||
105639958|NCT00824408|364345621|FG003|Randomized Phase|Not treated|1|||
105639959|NCT00824408|364345622|FG004|Randomized Phase|Not treated|1|||
105639960|NCT00824408|364345618|FG000|Randomized Phase|Progressive disease|0|||
105639961|NCT00824408|364345619|FG001|Randomized Phase|Progressive disease|0|||
105639962|NCT00824408|364345620|FG002|Randomized Phase|Progressive disease|25|||
105639963|NCT00824408|364345621|FG003|Randomized Phase|Progressive disease|36|||
105639964|NCT00824408|364345622|FG004|Randomized Phase|Progressive disease|34|||
105639965|NCT00824408|364345618|FG000|Randomized Phase|Adverse Event|0|||
105639966|NCT00824408|364345619|FG001|Randomized Phase|Adverse Event|0|||
105639967|NCT00824408|364345620|FG002|Randomized Phase|Adverse Event|4|||
105639968|NCT00824408|364345621|FG003|Randomized Phase|Adverse Event|5|||
105639969|NCT00824408|364345622|FG004|Randomized Phase|Adverse Event|5|||
105639970|NCT00824408|364345618|FG000|Randomized Phase|Refused to continue medication|0|||
105639971|NCT00824408|364345619|FG001|Randomized Phase|Refused to continue medication|0|||
105639972|NCT00824408|364345620|FG002|Randomized Phase|Refused to continue medication|2|||
105639973|NCT00824408|364345621|FG003|Randomized Phase|Refused to continue medication|2|||
105639974|NCT00824408|364345622|FG004|Randomized Phase|Refused to continue medication|2|||
105639975|NCT00824408|364345618|FG000|Randomized Phase|Other reason not defined above|0|||
105639976|NCT00824408|364345619|FG001|Randomized Phase|Other reason not defined above|0|||
105639977|NCT00824408|364345620|FG002|Randomized Phase|Other reason not defined above|4|||
105639978|NCT00824408|364345621|FG003|Randomized Phase|Other reason not defined above|2|||
105639979|NCT00824408|364345622|FG004|Randomized Phase|Other reason not defined above|4|||
105639980|NCT05445557|364345626|FG000|Double Blind Part|Lost to Follow-up|1|||
105639981|NCT02241785|364345638|FG000|Overall Study|Sponsor Termination|43|||
105639982|NCT02241785|364345638|FG000|Overall Study|Withdrawal by Subject|1|||
105639983|NCT02241785|364345638|FG000|Overall Study|Lost to Follow-up|2|||
105639984|NCT02241785|364345638|FG000|Overall Study|Adverse Event|1|||
105639985|NCT01964547|364345639|FG000|Overall Study|Adverse Event|8|||
105639986|NCT01964547|364345640|FG001|Overall Study|Adverse Event|2|||
105639987|NCT01964547|364345639|FG000|Overall Study|Withdrawal by Subject|4|||
105639988|NCT01964547|364345640|FG001|Overall Study|Withdrawal by Subject|7|||
105639989|NCT01964547|364345639|FG000|Overall Study|Lost to Follow-up|0|||
105639990|NCT01964547|364345640|FG001|Overall Study|Lost to Follow-up|1|||
105639991|NCT01964547|364345639|FG000|Overall Study|Withdrawal by Investigator|0|||
105639992|NCT01964547|364345640|FG001|Overall Study|Withdrawal by Investigator|1|||
105639993|NCT02161146|364345641|FG000|Overall Study|Adverse Event|1|||
105639994|NCT02161146|364345642|FG001|Overall Study|Adverse Event|1|||
105639995|NCT02161146|364345643|FG002|Overall Study|Adverse Event|0|||
105639996|NCT02161146|364345644|FG003|Overall Study|Adverse Event|1|||
105639997|NCT02161146|364345645|FG004|Overall Study|Adverse Event|0|||
105639998|NCT02161146|364345641|FG000|Overall Study|Lost to Follow-up|0|||
105639999|NCT02161146|364345642|FG001|Overall Study|Lost to Follow-up|1|||
105640000|NCT02161146|364345643|FG002|Overall Study|Lost to Follow-up|0|||
105640001|NCT02161146|364345644|FG003|Overall Study|Lost to Follow-up|0|||
105640002|NCT02161146|364345645|FG004|Overall Study|Lost to Follow-up|0|||
105640003|NCT02161146|364345641|FG000|Overall Study|Personal Reasons|0|||
105640004|NCT02161146|364345642|FG001|Overall Study|Personal Reasons|1|||
105640005|NCT02161146|364345643|FG002|Overall Study|Personal Reasons|0|||
105640006|NCT02161146|364345644|FG003|Overall Study|Personal Reasons|2|||
105640007|NCT02161146|364345645|FG004|Overall Study|Personal Reasons|1|||
105640008|NCT02161146|364345641|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105640009|NCT02161146|364345642|FG001|Overall Study|Other Miscellaneous Reasons|1|||
105640010|NCT02161146|364345643|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105640011|NCT02161146|364345644|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105640012|NCT02161146|364345645|FG004|Overall Study|Other Miscellaneous Reasons|0|||
105640013|NCT01736475|364345646|FG000|Overall Study|Adverse Event|4|||
105640014|NCT01736475|364345647|FG001|Overall Study|Adverse Event|0|||
105640015|NCT01736475|364345646|FG000|Overall Study|Withdrawal by Subject|2|||
105640016|NCT01736475|364345647|FG001|Overall Study|Withdrawal by Subject|0|||
105640017|NCT01736475|364345646|FG000|Overall Study|Protocol Violation|4|||
105640018|NCT01736475|364345647|FG001|Overall Study|Protocol Violation|0|||
105640019|NCT01736475|364345646|FG000|Overall Study|Other - Screen failure|1|||
105640020|NCT01736475|364345647|FG001|Overall Study|Other - Screen failure|0|||
105640021|NCT01736475|364345646|FG000|Overall Study|Other - Surgical procedure|1|||
105640022|NCT01736475|364345647|FG001|Overall Study|Other - Surgical procedure|0|||
105640023|NCT02807857|364345648|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
105640024|NCT02807857|364345648|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
105640025|NCT02807857|364345648|FG000|Follow-Up Set|Withdrawal by Subject|8|||
105640026|NCT02807857|364345648|FG000|Follow-Up Set|Lost to Follow-up|7|||
105640027|NCT02807857|364345648|FG000|Follow-Up Set|Physician Decision|6|||
105640028|NCT02807857|364345648|FG000|Follow-Up Set|Adverse Event|3|||
105640029|NCT02807857|364345648|FG000|Follow-Up Set|Death|27|||
105640030|NCT02807857|364345648|FG000|Follow-Up Set|Relocation|2|||
105640031|NCT02106325|364345650|FG000|Phase 1|Lost to Follow-up|2|||
105640032|NCT02106325|364345651|FG001|Phase 1|Lost to Follow-up|2|||
105640033|NCT02106325|364345650|FG000|Phase 2|Lost to Follow-up|2|||
105640034|NCT02106325|364345651|FG001|Phase 2|Lost to Follow-up|3|||
105640035|NCT02106325|364345650|FG000|Phase 3|Lost to Follow-up|2|||
105640036|NCT02106325|364345651|FG001|Phase 3|Lost to Follow-up|1|||
105640037|NCT01079949|364345652|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
105640038|NCT01079949|364345653|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
105640039|NCT01079949|364345652|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
105640040|NCT01079949|364345653|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
105640041|NCT01079949|364345652|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
105640042|NCT01079949|364345653|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
105640043|NCT01079949|364345652|FG000|Overall Study|Randomized but not treated|1|||
105640044|NCT01079949|364345653|FG001|Overall Study|Randomized but not treated|0|||
105640045|NCT01529632|364345654|FG000|Overall Study|Administrative problem|2|||
105640046|NCT01529632|364345655|FG001|Overall Study|Administrative problem|1|||
105640047|NCT01529632|364345654|FG000|Overall Study|Protocol Violation|0|||
105640048|NCT01529632|364345655|FG001|Overall Study|Protocol Violation|1|||
105640049|NCT01529632|364345654|FG000|Overall Study|Adverse Event|1|||
105640050|NCT01529632|364345655|FG001|Overall Study|Adverse Event|1|||
105640051|NCT02334215|364345656|FG000|Overall Study|Death|1|||
105640052|NCT02334215|364345657|FG001|Overall Study|Death|1|||
105640053|NCT02334215|364345658|FG002|Overall Study|Death|0|||
105640054|NCT02334215|364345656|FG000|Overall Study|Lost to Follow-up|1|||
105640055|NCT02334215|364345657|FG001|Overall Study|Lost to Follow-up|0|||
105640056|NCT02334215|364345658|FG002|Overall Study|Lost to Follow-up|4|||
105640057|NCT02334215|364345656|FG000|Overall Study|Withdrawal by Subject|2|||
105640058|NCT02334215|364345657|FG001|Overall Study|Withdrawal by Subject|2|||
105640059|NCT02334215|364345658|FG002|Overall Study|Withdrawal by Subject|1|||
105640060|NCT02334215|364345656|FG000|Overall Study|Not released from incarceration on time|3|||
105640061|NCT02334215|364345657|FG001|Overall Study|Not released from incarceration on time|3|||
105640062|NCT02334215|364345658|FG002|Overall Study|Not released from incarceration on time|3|||
105640063|NCT02334215|364345656|FG000|Overall Study|Incarcerated|0|||
105640064|NCT02334215|364345657|FG001|Overall Study|Incarcerated|0|||
105640065|NCT02334215|364345658|FG002|Overall Study|Incarcerated|7|||
105640066|NCT04919499|364345659|FG000|Overall Study|Adverse Event|0|||
105640067|NCT04919499|364345660|FG001|Overall Study|Adverse Event|0|||
105640068|NCT04919499|364345661|FG002|Overall Study|Adverse Event|0|||
105640069|NCT04919499|364345662|FG003|Overall Study|Adverse Event|0|||
105640070|NCT04919499|364345663|FG004|Overall Study|Adverse Event|2|||
105640071|NCT04919499|364345659|FG000|Overall Study|Not treated|0|||
105640072|NCT04919499|364345660|FG001|Overall Study|Not treated|0|||
105640073|NCT04919499|364345661|FG002|Overall Study|Not treated|0|||
105640074|NCT04919499|364345662|FG003|Overall Study|Not treated|1|||
105640075|NCT04919499|364345663|FG004|Overall Study|Not treated|0|||
105640076|NCT04520256|364345664|FG000|Overall Study|Lost to Follow-up|6|||
105640077|NCT04520256|364345665|FG001|Overall Study|Lost to Follow-up|4|||
105640078|NCT04520256|364345666|FG002|Overall Study|Lost to Follow-up|2|||
105640079|NCT04520256|364345667|FG003|Overall Study|Lost to Follow-up|3|||
105640080|NCT04520256|364345668|FG004|Overall Study|Lost to Follow-up|6|||
105640081|NCT04520256|364345669|FG005|Overall Study|Lost to Follow-up|6|||
105640082|NCT04520256|364345670|FG006|Overall Study|Lost to Follow-up|4|||
105640083|NCT04520256|364345671|FG007|Overall Study|Lost to Follow-up|6|||
105640084|NCT04520256|364345672|FG008|Overall Study|Lost to Follow-up|1|||
105640085|NCT04520256|364345673|FG009|Overall Study|Lost to Follow-up|3|||
105640086|NCT04520256|364345674|FG010|Overall Study|Lost to Follow-up|3|||
105640087|NCT04520256|364345675|FG011|Overall Study|Lost to Follow-up|2|||
105640088|NCT04520256|364345676|FG012|Overall Study|Lost to Follow-up|5|||
105640089|NCT04520256|364345677|FG013|Overall Study|Lost to Follow-up|3|||
105640090|NCT04520256|364345678|FG014|Overall Study|Lost to Follow-up|3|||
105640091|NCT04520256|364345679|FG015|Overall Study|Lost to Follow-up|6|||
105640092|NCT04520256|364345680|FG016|Overall Study|Lost to Follow-up|6|||
105640093|NCT04520256|364345681|FG017|Overall Study|Lost to Follow-up|4|||
105640094|NCT04520256|364345682|FG018|Overall Study|Lost to Follow-up|3|||
105640095|NCT04520256|364345683|FG019|Overall Study|Lost to Follow-up|3|||
105640096|NCT04520256|364345684|FG020|Overall Study|Lost to Follow-up|7|||
105640097|NCT04520256|364345685|FG021|Overall Study|Lost to Follow-up|3|||
105640098|NCT04520256|364345686|FG022|Overall Study|Lost to Follow-up|3|||
105640099|NCT04520256|364345687|FG023|Overall Study|Lost to Follow-up|8|||
105640100|NCT04520256|364345688|FG024|Overall Study|Lost to Follow-up|5|||
105640101|NCT04520256|364345689|FG025|Overall Study|Lost to Follow-up|4|||
105640102|NCT04520256|364345690|FG026|Overall Study|Lost to Follow-up|3|||
105640103|NCT04520256|364345691|FG027|Overall Study|Lost to Follow-up|4|||
105640104|NCT04520256|364345692|FG028|Overall Study|Lost to Follow-up|3|||
105640105|NCT04520256|364345693|FG029|Overall Study|Lost to Follow-up|4|||
105640106|NCT04520256|364345694|FG030|Overall Study|Lost to Follow-up|4|||
105640107|NCT04520256|364345695|FG031|Overall Study|Lost to Follow-up|4|||
105640108|NCT02556918|364347611|FG000|Overall Study|Protocol Violation|5|||
105640109|NCT02556918|364347612|FG001|Overall Study|Protocol Violation|6|||
105640110|NCT02556918|364347611|FG000|Overall Study|Withdrawal by Subject|4|||
105640111|NCT02556918|364347612|FG001|Overall Study|Withdrawal by Subject|4|||
105640112|NCT01190124|364347613|FG000|Overall Study|Death|3|||
105640113|NCT01190124|364347614|FG001|Overall Study|Death|0|||
105640114|NCT01190124|364347615|FG002|Overall Study|Death|0|||
105640115|NCT01190124|364347613|FG000|Overall Study|Therapeutic Failure|12|||
105640116|NCT01190124|364347614|FG001|Overall Study|Therapeutic Failure|0|||
105640117|NCT01190124|364347615|FG002|Overall Study|Therapeutic Failure|1|||
105640118|NCT01190124|364347613|FG000|Overall Study|Lost to Follow-up|2|||
105640119|NCT01190124|364347614|FG001|Overall Study|Lost to Follow-up|0|||
105640120|NCT01190124|364347615|FG002|Overall Study|Lost to Follow-up|0|||
105640121|NCT00047385|364347617|FG000|Overall Study|Death before any screening|2|||
105640122|NCT00047385|364347618|FG001|Overall Study|Death before any screening|5|||
105640123|NCT00047385|364347617|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
105640124|NCT00047385|364347618|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
105640125|NCT00047385|364347617|FG000|Overall Study|Eligible for screening but had no screen|260|||
105640126|NCT00047385|364347618|FG001|Overall Study|Eligible for screening but had no screen|492|||
105640127|NCT03392194|364347620|FG000|Overall Study|Withdrawal by Subject|1|||
105640128|NCT03392194|364347621|FG001|Overall Study|Withdrawal by Subject|2|||
105640129|NCT03392194|364347620|FG000|Overall Study|Conflicts with personal schedule|1|||
105640130|NCT03392194|364347621|FG001|Overall Study|Conflicts with personal schedule|0|||
105640131|NCT02392507|364347622|FG000|Induction Regimen|Death|3|||
105640132|NCT02392507|364347622|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
105640133|NCT02392507|364347622|FG000|Induction Regimen|Physician Decision|1|||
105640134|NCT02392507|364347622|FG000|Induction Regimen|Withdrawal by Subject|2|||
105640135|NCT02392507|364347622|FG000|Maintenance Regimen|Death|1|||
105640136|NCT02392507|364347622|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
105640137|NCT02736188|364347623|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
105640138|NCT02736188|364347623|FG000|Overall Study|Adverse Event|1|||
105640139|NCT02736188|364347623|FG000|Overall Study|Withdrawal by Subject|1|||
105640140|NCT02736188|364347623|FG000|Overall Study|Other|6|||
105640141|NCT02245620|364347625|FG000|Overall Study|Physician Decision|1|||
105640142|NCT02245620|364347626|FG001|Overall Study|Physician Decision|1|||
105640143|NCT00787176|364347627|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
105640144|NCT00787176|364347628|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
105640145|NCT00787176|364347629|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
105659333|NCT00551135|364417280|FG000|Overall Study|Lost to Follow-up|0|||
105640146|NCT00787176|364347630|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
105640147|NCT00895245|364347631|FG000|Overall Study|Lack of Efficacy|6|||
105640148|NCT02203799|364347633|FG000|Overall Study|Withdrawal by Subject|3|||
105640149|NCT02106884|364347634|FG000|Overall Study|Change of diagnosis/exclusion|0|||
105640150|NCT02106884|364347635|FG001|Overall Study|Change of diagnosis/exclusion|1|||
105640151|NCT03006393|364347636|FG000|Overall Study|Withdrawal by Subject|1|||
105640152|NCT03006393|364347637|FG001|Overall Study|Withdrawal by Subject|1|||
105640153|NCT03006393|364347636|FG000|Overall Study|Pregnancy|0|||
105640154|NCT03006393|364347637|FG001|Overall Study|Pregnancy|1|||
105640155|NCT03006393|364347636|FG000|Overall Study|Lost to Follow-up|0|||
105640156|NCT03006393|364347637|FG001|Overall Study|Lost to Follow-up|1|||
105640157|NCT01584648|364347640|FG000|Overall Study|Death|136|||
105640158|NCT01584648|364347641|FG001|Overall Study|Death|146|||
105640159|NCT01584648|364347640|FG000|Overall Study|Lost to Follow-up|9|||
105640160|NCT01584648|364347641|FG001|Overall Study|Lost to Follow-up|9|||
105640161|NCT01584648|364347640|FG000|Overall Study|Investigator discretion|3|||
105640162|NCT01584648|364347641|FG001|Overall Study|Investigator discretion|2|||
105640163|NCT01584648|364347640|FG000|Overall Study|Withdrew consent|13|||
105640164|NCT01584648|364347641|FG001|Overall Study|Withdrew consent|4|||
105640165|NCT01584648|364347640|FG000|Overall Study|Study closed/terminated|50|||
105640166|NCT01584648|364347641|FG001|Overall Study|Study closed/terminated|23|||
105640167|NCT01584648|364347640|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
105640168|NCT01584648|364347641|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
105640169|NCT00659373|364347642|FG000|Overall Study|Withdrawal by Subject|3|||
105640170|NCT00659373|364347643|FG001|Overall Study|Withdrawal by Subject|5|||
105640171|NCT00659373|364347642|FG000|Overall Study|Assessment Missed|2|||
105640172|NCT00659373|364347643|FG001|Overall Study|Assessment Missed|2|||
105640173|NCT03042767|364347646|FG000|Overall Study|Lost to Follow-up|1|||
105640174|NCT03042767|364347647|FG001|Overall Study|Lost to Follow-up|2|||
105640175|NCT02362789|364347650|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
105640176|NCT02362789|364347651|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
105640177|NCT02362789|364347652|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
105640178|NCT02362789|364347650|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
105640179|NCT02362789|364347651|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
105640180|NCT02362789|364347652|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
105640181|NCT02362789|364347650|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
105640182|NCT02362789|364347651|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
105640183|NCT02362789|364347652|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
105640184|NCT02362789|364347650|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
105640185|NCT02362789|364347651|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
105640186|NCT02362789|364347652|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
105640187|NCT02362789|364347650|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
105640188|NCT02362789|364347651|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
105640189|NCT02362789|364347652|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
105640190|NCT00042939|364347653|FG000|Overall Study|Adverse Event|6|||
105640191|NCT00042939|364347654|FG001|Overall Study|Adverse Event|7|||
105640192|NCT00042939|364347653|FG000|Overall Study|Death|3|||
105640193|NCT00042939|364347654|FG001|Overall Study|Death|2|||
105640194|NCT00042939|364347653|FG000|Overall Study|Withdrawal by Subject|3|||
105640195|NCT00042939|364347654|FG001|Overall Study|Withdrawal by Subject|4|||
105640196|NCT00042939|364347653|FG000|Overall Study|Other disease|1|||
105640197|NCT00042939|364347654|FG001|Overall Study|Other disease|0|||
105640198|NCT00042939|364347653|FG000|Overall Study|Ineligible|2|||
105640199|NCT00042939|364347654|FG001|Overall Study|Ineligible|2|||
105640200|NCT00042939|364347653|FG000|Overall Study|Deterioration of health|3|||
105640201|NCT00042939|364347654|FG001|Overall Study|Deterioration of health|4|||
105640202|NCT00042939|364347653|FG000|Overall Study|QOL diminished|1|||
105640203|NCT00042939|364347654|FG001|Overall Study|QOL diminished|0|||
105640204|NCT00042939|364347653|FG000|Overall Study|Rising ca 19-9|1|||
105640205|NCT00042939|364347654|FG001|Overall Study|Rising ca 19-9|0|||
105640206|NCT00042939|364347653|FG000|Overall Study|Patient non-compliance|1|||
105640207|NCT00042939|364347654|FG001|Overall Study|Patient non-compliance|0|||
105640208|NCT00042939|364347653|FG000|Overall Study|Still on treatment|1|||
105640209|NCT00042939|364347654|FG001|Overall Study|Still on treatment|0|||
105640210|NCT00042939|364347653|FG000|Overall Study|Treatment break > 4 weeks|0|||
105640211|NCT00042939|364347654|FG001|Overall Study|Treatment break > 4 weeks|1|||
105640212|NCT00042939|364347653|FG000|Overall Study|Did not start treatment|2|||
105640213|NCT00042939|364347654|FG001|Overall Study|Did not start treatment|1|||
105640214|NCT00721734|364347656|FG000|Overall Study|Progressive Disease|3|||
105640215|NCT00721734|364347657|FG001|Overall Study|Progressive Disease|10|||
105640216|NCT00721734|364347658|FG002|Overall Study|Progressive Disease|4|||
105870214|NCT01074944|365176970|FG003|Long Term Treatment|Lost to Follow-up|2|||
105640217|NCT00721734|364347659|FG003|Overall Study|Progressive Disease|5|||
105640218|NCT00721734|364347660|FG004|Overall Study|Progressive Disease|2|||
105640219|NCT00721734|364347656|FG000|Overall Study|Adverse Event|3|||
105870215|NCT01074944|365176971|FG004|Long Term Treatment|Lost to Follow-up|0|||
105640220|NCT00721734|364347657|FG001|Overall Study|Adverse Event|1|||
105640221|NCT00721734|364347658|FG002|Overall Study|Adverse Event|4|||
105640222|NCT00721734|364347659|FG003|Overall Study|Adverse Event|0|||
105640223|NCT00721734|364347660|FG004|Overall Study|Adverse Event|3|||
105640224|NCT00721734|364347656|FG000|Overall Study|Withdrawal by Subject|2|||
105640225|NCT00721734|364347657|FG001|Overall Study|Withdrawal by Subject|1|||
105640226|NCT00721734|364347658|FG002|Overall Study|Withdrawal by Subject|0|||
105640227|NCT00721734|364347659|FG003|Overall Study|Withdrawal by Subject|0|||
105640228|NCT00721734|364347660|FG004|Overall Study|Withdrawal by Subject|1|||
105640229|NCT00721734|364347656|FG000|Overall Study|Other|0|||
105640230|NCT00721734|364347657|FG001|Overall Study|Other|0|||
105640231|NCT00721734|364347658|FG002|Overall Study|Other|0|||
105640232|NCT00721734|364347659|FG003|Overall Study|Other|1|||
105640233|NCT00721734|364347660|FG004|Overall Study|Other|0|||
105640234|NCT04617847|364347661|FG000|Overall Study|Withdrawal by Subject|1|||
105640235|NCT04617847|364347662|FG001|Overall Study|Withdrawal by Subject|0|||
105640236|NCT04617847|364347661|FG000|Overall Study|Adverse Event|0|||
105640237|NCT04617847|364347662|FG001|Overall Study|Adverse Event|2|||
105640238|NCT04617847|364347661|FG000|Overall Study|Death|0|||
105640239|NCT04617847|364347662|FG001|Overall Study|Death|1|||
105640240|NCT04617847|364347661|FG000|Overall Study|Termination of Study by Sponsor|2|||
105640241|NCT04617847|364347662|FG001|Overall Study|Termination of Study by Sponsor|21|||
105640242|NCT01989689|364347663|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
105640243|NCT01989689|364347664|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
105640244|NCT01989689|364347663|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
105640245|NCT01989689|364347664|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
105640246|NCT02066636|364347665|FG000|Overall Study|Disease progression|51|||
105640247|NCT02066636|364347666|FG001|Overall Study|Disease progression|60|||
105640248|NCT02066636|364347667|FG002|Overall Study|Disease progression|700|||
105640249|NCT02066636|364347665|FG000|Overall Study|Study drug toxicity|13|||
105640250|NCT02066636|364347666|FG001|Overall Study|Study drug toxicity|2|||
105640251|NCT02066636|364347667|FG002|Overall Study|Study drug toxicity|58|||
105640252|NCT02066636|364347665|FG000|Overall Study|Death|4|||
105640253|NCT02066636|364347666|FG001|Overall Study|Death|2|||
105640254|NCT02066636|364347667|FG002|Overall Study|Death|158|||
105640255|NCT02066636|364347665|FG000|Overall Study|Adverse event unrelated to study drug|6|||
105640256|NCT02066636|364347666|FG001|Overall Study|Adverse event unrelated to study drug|4|||
105640257|NCT02066636|364347667|FG002|Overall Study|Adverse event unrelated to study drug|45|||
105640258|NCT02066636|364347665|FG000|Overall Study|Participant request to discontinue treatment|12|||
105640259|NCT02066636|364347666|FG001|Overall Study|Participant request to discontinue treatment|12|||
105640260|NCT02066636|364347667|FG002|Overall Study|Participant request to discontinue treatment|70|||
105640261|NCT02066636|364347665|FG000|Overall Study|Participant withdrew consent|10|||
105640262|NCT02066636|364347666|FG001|Overall Study|Participant withdrew consent|18|||
105640263|NCT02066636|364347667|FG002|Overall Study|Participant withdrew consent|61|||
105640264|NCT02066636|364347665|FG000|Overall Study|Lost to Follow-up|0|||
105640265|NCT02066636|364347666|FG001|Overall Study|Lost to Follow-up|2|||
105640266|NCT02066636|364347667|FG002|Overall Study|Lost to Follow-up|2|||
105640267|NCT02066636|364347665|FG000|Overall Study|Maximum clinical benefit|2|||
105640268|NCT02066636|364347666|FG001|Overall Study|Maximum clinical benefit|2|||
105640269|NCT02066636|364347667|FG002|Overall Study|Maximum clinical benefit|3|||
105640270|NCT02066636|364347665|FG000|Overall Study|Poor/non-compliance|2|||
105640271|NCT02066636|364347666|FG001|Overall Study|Poor/non-compliance|1|||
105640272|NCT02066636|364347667|FG002|Overall Study|Poor/non-compliance|1|||
105640273|NCT02066636|364347665|FG000|Overall Study|Participant no loner meets study criteria|3|||
105640274|NCT02066636|364347666|FG001|Overall Study|Participant no loner meets study criteria|2|||
105640275|NCT02066636|364347667|FG002|Overall Study|Participant no loner meets study criteria|28|||
105640276|NCT02066636|364347665|FG000|Overall Study|Administrative reasons by sponsor|8|||
105640277|NCT02066636|364347666|FG001|Overall Study|Administrative reasons by sponsor|5|||
105640278|NCT02066636|364347667|FG002|Overall Study|Administrative reasons by sponsor|0|||
105640279|NCT02066636|364347665|FG000|Overall Study|Other reasons|16|||
105640280|NCT02066636|364347666|FG001|Overall Study|Other reasons|15|||
105640281|NCT02066636|364347667|FG002|Overall Study|Other reasons|50|||
105640282|NCT00391170|364347668|FG000|Overall Study|Withdrawal by Subject|1|||
105640283|NCT00391170|364347669|FG001|Overall Study|Withdrawal by Subject|0|||
105640284|NCT00391170|364347668|FG000|Overall Study|Adverse Event|3|||
105640285|NCT00391170|364347669|FG001|Overall Study|Adverse Event|2|||
105640286|NCT00391170|364347668|FG000|Overall Study|Physician Decision|2|||
105640287|NCT00391170|364347669|FG001|Overall Study|Physician Decision|2|||
105640288|NCT00103857|364347684|FG000|54-Week Base Study|Adverse Event|12|||
105640289|NCT00103857|364347685|FG001|54-Week Base Study|Adverse Event|9|||
105640290|NCT00103857|364347686|FG002|54-Week Base Study|Adverse Event|11|||
105640291|NCT00103857|364347687|FG003|54-Week Base Study|Adverse Event|6|||
105640292|NCT00103857|364347688|FG004|54-Week Base Study|Adverse Event|5|||
105640293|NCT00103857|364347689|FG005|54-Week Base Study|Adverse Event|11|||
105640294|NCT00103857|364347690|FG006|54-Week Base Study|Adverse Event|3|||
105640295|NCT00103857|364347684|FG000|54-Week Base Study|Death|0|||
105640296|NCT00103857|364347685|FG001|54-Week Base Study|Death|0|||
105640297|NCT00103857|364347686|FG002|54-Week Base Study|Death|0|||
105640298|NCT00103857|364347687|FG003|54-Week Base Study|Death|0|||
105640299|NCT00103857|364347688|FG004|54-Week Base Study|Death|1|||
105640300|NCT00103857|364347689|FG005|54-Week Base Study|Death|1|||
105640301|NCT00103857|364347690|FG006|54-Week Base Study|Death|0|||
105640302|NCT00103857|364347684|FG000|54-Week Base Study|Lack of Efficacy|11|||
105640303|NCT00103857|364347685|FG001|54-Week Base Study|Lack of Efficacy|14|||
105640304|NCT00103857|364347686|FG002|54-Week Base Study|Lack of Efficacy|8|||
105640305|NCT00103857|364347687|FG003|54-Week Base Study|Lack of Efficacy|4|||
105640306|NCT00103857|364347688|FG004|54-Week Base Study|Lack of Efficacy|3|||
105640307|NCT00103857|364347689|FG005|54-Week Base Study|Lack of Efficacy|14|||
105640308|NCT00103857|364347690|FG006|54-Week Base Study|Lack of Efficacy|19|||
105640309|NCT00103857|364347684|FG000|54-Week Base Study|Lost to Follow-up|5|||
105640310|NCT00103857|364347685|FG001|54-Week Base Study|Lost to Follow-up|4|||
105640311|NCT00103857|364347686|FG002|54-Week Base Study|Lost to Follow-up|7|||
105640312|NCT00103857|364347687|FG003|54-Week Base Study|Lost to Follow-up|5|||
105640313|NCT00103857|364347688|FG004|54-Week Base Study|Lost to Follow-up|10|||
105640314|NCT00103857|364347689|FG005|54-Week Base Study|Lost to Follow-up|9|||
105640315|NCT00103857|364347690|FG006|54-Week Base Study|Lost to Follow-up|3|||
105640316|NCT00103857|364347684|FG000|54-Week Base Study|Physician Decision|1|||
105640317|NCT00103857|364347685|FG001|54-Week Base Study|Physician Decision|1|||
105640318|NCT00103857|364347686|FG002|54-Week Base Study|Physician Decision|0|||
105640319|NCT00103857|364347687|FG003|54-Week Base Study|Physician Decision|0|||
105640320|NCT00103857|364347688|FG004|54-Week Base Study|Physician Decision|1|||
105640321|NCT00103857|364347689|FG005|54-Week Base Study|Physician Decision|0|||
105640322|NCT00103857|364347690|FG006|54-Week Base Study|Physician Decision|0|||
105640323|NCT00103857|364347684|FG000|54-Week Base Study|Pregnancy|1|||
105640324|NCT00103857|364347685|FG001|54-Week Base Study|Pregnancy|0|||
105640325|NCT00103857|364347686|FG002|54-Week Base Study|Pregnancy|0|||
105640326|NCT00103857|364347687|FG003|54-Week Base Study|Pregnancy|0|||
105640327|NCT00103857|364347688|FG004|54-Week Base Study|Pregnancy|1|||
105640328|NCT00103857|364347689|FG005|54-Week Base Study|Pregnancy|0|||
105640329|NCT00103857|364347690|FG006|54-Week Base Study|Pregnancy|1|||
105640330|NCT00103857|364347684|FG000|54-Week Base Study|Protocol Violation|6|||
105640331|NCT00103857|364347685|FG001|54-Week Base Study|Protocol Violation|4|||
105640332|NCT00103857|364347686|FG002|54-Week Base Study|Protocol Violation|2|||
105640333|NCT00103857|364347687|FG003|54-Week Base Study|Protocol Violation|4|||
105640334|NCT00103857|364347688|FG004|54-Week Base Study|Protocol Violation|0|||
105640335|NCT00103857|364347689|FG005|54-Week Base Study|Protocol Violation|3|||
105640336|NCT00103857|364347690|FG006|54-Week Base Study|Protocol Violation|3|||
105640337|NCT00103857|364347684|FG000|54-Week Base Study|Withdrawal by Subject|17|||
105640338|NCT00103857|364347685|FG001|54-Week Base Study|Withdrawal by Subject|16|||
105640339|NCT00103857|364347686|FG002|54-Week Base Study|Withdrawal by Subject|16|||
105640340|NCT00103857|364347687|FG003|54-Week Base Study|Withdrawal by Subject|15|||
105640341|NCT00103857|364347688|FG004|54-Week Base Study|Withdrawal by Subject|10|||
105640342|NCT00103857|364347689|FG005|54-Week Base Study|Withdrawal by Subject|15|||
105640343|NCT00103857|364347690|FG006|54-Week Base Study|Withdrawal by Subject|4|||
105640344|NCT00103857|364347684|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
105640345|NCT00103857|364347685|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
105640346|NCT00103857|364347686|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
105640347|NCT00103857|364347687|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
105640348|NCT00103857|364347688|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
105640349|NCT00103857|364347689|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
105640350|NCT00103857|364347690|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
105640351|NCT00103857|364347684|FG000|54-Week Base Study|patient moved|0|||
105640352|NCT00103857|364347685|FG001|54-Week Base Study|patient moved|1|||
105640353|NCT00103857|364347686|FG002|54-Week Base Study|patient moved|1|||
105640354|NCT00103857|364347687|FG003|54-Week Base Study|patient moved|2|||
105640355|NCT00103857|364347688|FG004|54-Week Base Study|patient moved|3|||
105640356|NCT00103857|364347689|FG005|54-Week Base Study|patient moved|1|||
105640357|NCT00103857|364347690|FG006|54-Week Base Study|patient moved|0|||
105640358|NCT00103857|364347684|FG000|54-Week Base Study|non-compliance with study procedures|1|||
105640359|NCT00103857|364347685|FG001|54-Week Base Study|non-compliance with study procedures|2|||
105640360|NCT00103857|364347686|FG002|54-Week Base Study|non-compliance with study procedures|0|||
105640361|NCT00103857|364347687|FG003|54-Week Base Study|non-compliance with study procedures|0|||
105640362|NCT00103857|364347688|FG004|54-Week Base Study|non-compliance with study procedures|0|||
105640363|NCT00103857|364347689|FG005|54-Week Base Study|non-compliance with study procedures|2|||
105640364|NCT00103857|364347690|FG006|54-Week Base Study|non-compliance with study procedures|0|||
105640365|NCT00103857|364347684|FG000|54-Week Base Study|patient incarcerated|0|||
105640366|NCT00103857|364347685|FG001|54-Week Base Study|patient incarcerated|0|||
105640367|NCT00103857|364347686|FG002|54-Week Base Study|patient incarcerated|0|||
105640368|NCT00103857|364347687|FG003|54-Week Base Study|patient incarcerated|0|||
105640369|NCT00103857|364347688|FG004|54-Week Base Study|patient incarcerated|1|||
105640370|NCT00103857|364347689|FG005|54-Week Base Study|patient incarcerated|1|||
105640371|NCT00103857|364347690|FG006|54-Week Base Study|patient incarcerated|0|||
105640372|NCT00103857|364347684|FG000|54-Week Base Study|laboratory reporting error|0|||
105640373|NCT00103857|364347685|FG001|54-Week Base Study|laboratory reporting error|0|||
105640374|NCT00103857|364347686|FG002|54-Week Base Study|laboratory reporting error|0|||
105640375|NCT00103857|364347687|FG003|54-Week Base Study|laboratory reporting error|0|||
105640376|NCT00103857|364347688|FG004|54-Week Base Study|laboratory reporting error|1|||
105640377|NCT00103857|364347689|FG005|54-Week Base Study|laboratory reporting error|0|||
105640378|NCT00103857|364347690|FG006|54-Week Base Study|laboratory reporting error|0|||
105640379|NCT00103857|364347684|FG000|54-Week Base Study|site error|0|||
105640380|NCT00103857|364347685|FG001|54-Week Base Study|site error|0|||
105640381|NCT00103857|364347686|FG002|54-Week Base Study|site error|0|||
105640382|NCT00103857|364347687|FG003|54-Week Base Study|site error|0|||
105640383|NCT00103857|364347688|FG004|54-Week Base Study|site error|0|||
105640384|NCT00103857|364347689|FG005|54-Week Base Study|site error|1|||
105640385|NCT00103857|364347690|FG006|54-Week Base Study|site error|0|||
105640386|NCT00103857|364347684|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
105640387|NCT00103857|364347685|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640388|NCT00103857|364347686|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640389|NCT00103857|364347687|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640390|NCT00103857|364347688|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640391|NCT00103857|364347689|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640392|NCT00103857|364347690|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
105640393|NCT00103857|364347684|FG000|50-Week Extension Study|Adverse Event|2|||
105640394|NCT00103857|364347685|FG001|50-Week Extension Study|Adverse Event|3|||
105640395|NCT00103857|364347686|FG002|50-Week Extension Study|Adverse Event|2|||
105640396|NCT00103857|364347687|FG003|50-Week Extension Study|Adverse Event|0|||
105640397|NCT00103857|364347688|FG004|50-Week Extension Study|Adverse Event|1|||
105640398|NCT00103857|364347689|FG005|50-Week Extension Study|Adverse Event|1|||
105640399|NCT00103857|364347690|FG006|50-Week Extension Study|Adverse Event|0|||
105640400|NCT00103857|364347684|FG000|50-Week Extension Study|Death|0|||
105640401|NCT00103857|364347685|FG001|50-Week Extension Study|Death|0|||
105640402|NCT00103857|364347686|FG002|50-Week Extension Study|Death|0|||
105640403|NCT00103857|364347687|FG003|50-Week Extension Study|Death|1|||
105640404|NCT00103857|364347688|FG004|50-Week Extension Study|Death|0|||
105640405|NCT00103857|364347689|FG005|50-Week Extension Study|Death|1|||
105640406|NCT00103857|364347690|FG006|50-Week Extension Study|Death|0|||
105640407|NCT00103857|364347684|FG000|50-Week Extension Study|Lack of Efficacy|26|||
105640408|NCT00103857|364347685|FG001|50-Week Extension Study|Lack of Efficacy|15|||
105640409|NCT00103857|364347686|FG002|50-Week Extension Study|Lack of Efficacy|13|||
105640410|NCT00103857|364347687|FG003|50-Week Extension Study|Lack of Efficacy|16|||
105640411|NCT00103857|364347688|FG004|50-Week Extension Study|Lack of Efficacy|8|||
105640412|NCT00103857|364347689|FG005|50-Week Extension Study|Lack of Efficacy|8|||
105640413|NCT00103857|364347690|FG006|50-Week Extension Study|Lack of Efficacy|0|||
105640414|NCT00103857|364347684|FG000|50-Week Extension Study|Lost to Follow-up|4|||
105640415|NCT00103857|364347685|FG001|50-Week Extension Study|Lost to Follow-up|0|||
105640416|NCT00103857|364347686|FG002|50-Week Extension Study|Lost to Follow-up|1|||
105640417|NCT00103857|364347687|FG003|50-Week Extension Study|Lost to Follow-up|4|||
105640418|NCT00103857|364347688|FG004|50-Week Extension Study|Lost to Follow-up|3|||
105640419|NCT00103857|364347689|FG005|50-Week Extension Study|Lost to Follow-up|3|||
105640420|NCT00103857|364347690|FG006|50-Week Extension Study|Lost to Follow-up|0|||
105640421|NCT00103857|364347684|FG000|50-Week Extension Study|Physician Decision|0|||
105640422|NCT00103857|364347685|FG001|50-Week Extension Study|Physician Decision|1|||
105640423|NCT00103857|364347686|FG002|50-Week Extension Study|Physician Decision|1|||
105640424|NCT00103857|364347687|FG003|50-Week Extension Study|Physician Decision|0|||
105640425|NCT00103857|364347688|FG004|50-Week Extension Study|Physician Decision|0|||
105640426|NCT00103857|364347689|FG005|50-Week Extension Study|Physician Decision|0|||
105640427|NCT00103857|364347690|FG006|50-Week Extension Study|Physician Decision|0|||
105640428|NCT00103857|364347684|FG000|50-Week Extension Study|Pregnancy|0|||
105640429|NCT00103857|364347685|FG001|50-Week Extension Study|Pregnancy|0|||
105640430|NCT00103857|364347686|FG002|50-Week Extension Study|Pregnancy|1|||
105640431|NCT00103857|364347687|FG003|50-Week Extension Study|Pregnancy|0|||
105640432|NCT00103857|364347688|FG004|50-Week Extension Study|Pregnancy|1|||
105640433|NCT00103857|364347689|FG005|50-Week Extension Study|Pregnancy|0|||
105640434|NCT00103857|364347690|FG006|50-Week Extension Study|Pregnancy|0|||
105640435|NCT00103857|364347684|FG000|50-Week Extension Study|Protocol Violation|1|||
105640436|NCT00103857|364347685|FG001|50-Week Extension Study|Protocol Violation|1|||
105640437|NCT00103857|364347686|FG002|50-Week Extension Study|Protocol Violation|1|||
105640438|NCT00103857|364347687|FG003|50-Week Extension Study|Protocol Violation|2|||
105640439|NCT00103857|364347688|FG004|50-Week Extension Study|Protocol Violation|0|||
105640440|NCT00103857|364347689|FG005|50-Week Extension Study|Protocol Violation|1|||
105640441|NCT00103857|364347690|FG006|50-Week Extension Study|Protocol Violation|0|||
105640442|NCT00103857|364347684|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
105640443|NCT00103857|364347685|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
105640444|NCT00103857|364347686|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
105640445|NCT00103857|364347687|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
105640446|NCT00103857|364347688|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
105640447|NCT00103857|364347689|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
105640448|NCT00103857|364347690|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
105640449|NCT00103857|364347684|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
105640450|NCT00103857|364347685|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
105640451|NCT00103857|364347686|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
105640452|NCT00103857|364347687|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
105640453|NCT00103857|364347688|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
105640454|NCT00103857|364347689|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
105640455|NCT00103857|364347690|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
105640456|NCT00103857|364347684|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
105640457|NCT00103857|364347685|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
105640458|NCT00103857|364347686|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
105640459|NCT00103857|364347687|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
105640460|NCT00103857|364347688|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
105640461|NCT00103857|364347689|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
105640462|NCT00103857|364347690|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
105640463|NCT00103857|364347684|FG000|50-Week Extension Study|patient moved|0|||
105640464|NCT00103857|364347685|FG001|50-Week Extension Study|patient moved|0|||
105640465|NCT00103857|364347686|FG002|50-Week Extension Study|patient moved|1|||
105640466|NCT00103857|364347687|FG003|50-Week Extension Study|patient moved|2|||
105640467|NCT00103857|364347688|FG004|50-Week Extension Study|patient moved|0|||
105640468|NCT00103857|364347689|FG005|50-Week Extension Study|patient moved|0|||
105640469|NCT00103857|364347690|FG006|50-Week Extension Study|patient moved|0|||
105640470|NCT00103857|364347684|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640471|NCT00103857|364347685|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640472|NCT00103857|364347686|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
105640473|NCT00103857|364347687|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640474|NCT00103857|364347688|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640475|NCT00103857|364347689|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640476|NCT00103857|364347690|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
105640477|NCT00103857|364347684|FG000|50-Week Extension Study|reason unspecified|0|||
105640478|NCT00103857|364347685|FG001|50-Week Extension Study|reason unspecified|0|||
105640479|NCT00103857|364347686|FG002|50-Week Extension Study|reason unspecified|0|||
105640480|NCT00103857|364347687|FG003|50-Week Extension Study|reason unspecified|0|||
105640481|NCT00103857|364347688|FG004|50-Week Extension Study|reason unspecified|1|||
105640482|NCT00103857|364347689|FG005|50-Week Extension Study|reason unspecified|0|||
105640483|NCT00103857|364347690|FG006|50-Week Extension Study|reason unspecified|0|||
105640484|NCT02691702|364347691|FG000|Overall Study|Adverse Event|1|||
105640485|NCT02691702|364347692|FG001|Overall Study|Adverse Event|0|||
105640486|NCT02691702|364347693|FG002|Overall Study|Adverse Event|0|||
105640487|NCT02691702|364347694|FG003|Overall Study|Adverse Event|0|||
105640488|NCT02691702|364347695|FG004|Overall Study|Adverse Event|0|||
105640489|NCT02691702|364347696|FG005|Overall Study|Adverse Event|0|||
105640490|NCT02691702|364347697|FG006|Overall Study|Adverse Event|0|||
105640491|NCT02691702|364347698|FG007|Overall Study|Adverse Event|0|||
105640492|NCT02691702|364347699|FG008|Overall Study|Adverse Event|1|||
105640493|NCT02691702|364347700|FG009|Overall Study|Adverse Event|0|||
105640494|NCT02691702|364347701|FG010|Overall Study|Adverse Event|1|||
105640495|NCT02691702|364347691|FG000|Overall Study|Lost to Follow-up|0|||
105640496|NCT02691702|364347692|FG001|Overall Study|Lost to Follow-up|0|||
105640497|NCT02691702|364347693|FG002|Overall Study|Lost to Follow-up|1|||
105640498|NCT02691702|364347694|FG003|Overall Study|Lost to Follow-up|0|||
105640499|NCT02691702|364347695|FG004|Overall Study|Lost to Follow-up|0|||
105640500|NCT02691702|364347696|FG005|Overall Study|Lost to Follow-up|2|||
105640501|NCT02691702|364347697|FG006|Overall Study|Lost to Follow-up|0|||
105640502|NCT02691702|364347698|FG007|Overall Study|Lost to Follow-up|0|||
105640503|NCT02691702|364347699|FG008|Overall Study|Lost to Follow-up|0|||
105640504|NCT02691702|364347700|FG009|Overall Study|Lost to Follow-up|0|||
105640505|NCT02691702|364347701|FG010|Overall Study|Lost to Follow-up|1|||
105640506|NCT02691702|364347691|FG000|Overall Study|Withdrawal by Subject|1|||
105640507|NCT02691702|364347692|FG001|Overall Study|Withdrawal by Subject|1|||
105640508|NCT02691702|364347693|FG002|Overall Study|Withdrawal by Subject|0|||
105640509|NCT02691702|364347694|FG003|Overall Study|Withdrawal by Subject|0|||
105640510|NCT02691702|364347695|FG004|Overall Study|Withdrawal by Subject|0|||
105640511|NCT02691702|364347696|FG005|Overall Study|Withdrawal by Subject|1|||
105640512|NCT02691702|364347697|FG006|Overall Study|Withdrawal by Subject|2|||
105640513|NCT02691702|364347698|FG007|Overall Study|Withdrawal by Subject|0|||
105640514|NCT02691702|364347699|FG008|Overall Study|Withdrawal by Subject|0|||
105640515|NCT02691702|364347700|FG009|Overall Study|Withdrawal by Subject|0|||
105640516|NCT02691702|364347701|FG010|Overall Study|Withdrawal by Subject|0|||
105640517|NCT02691702|364347691|FG000|Overall Study|Other|0|||
105640518|NCT02691702|364347692|FG001|Overall Study|Other|0|||
105640519|NCT02691702|364347693|FG002|Overall Study|Other|0|||
105640520|NCT02691702|364347694|FG003|Overall Study|Other|0|||
105640521|NCT02691702|364347695|FG004|Overall Study|Other|0|||
105640522|NCT02691702|364347696|FG005|Overall Study|Other|0|||
105640523|NCT02691702|364347697|FG006|Overall Study|Other|1|||
105640524|NCT02691702|364347698|FG007|Overall Study|Other|0|||
105640525|NCT02691702|364347699|FG008|Overall Study|Other|1|||
105640526|NCT02691702|364347700|FG009|Overall Study|Other|0|||
105640527|NCT02691702|364347701|FG010|Overall Study|Other|0|||
105640528|NCT02691702|364347691|FG000|Overall Study|Protocol Violation|0|||
105640529|NCT02691702|364347692|FG001|Overall Study|Protocol Violation|0|||
105640530|NCT02691702|364347693|FG002|Overall Study|Protocol Violation|0|||
105640531|NCT02691702|364347694|FG003|Overall Study|Protocol Violation|0|||
105640532|NCT02691702|364347695|FG004|Overall Study|Protocol Violation|0|||
105640533|NCT02691702|364347696|FG005|Overall Study|Protocol Violation|0|||
105640534|NCT02691702|364347697|FG006|Overall Study|Protocol Violation|0|||
105640535|NCT02691702|364347698|FG007|Overall Study|Protocol Violation|0|||
105640536|NCT02691702|364347699|FG008|Overall Study|Protocol Violation|0|||
105640537|NCT02691702|364347700|FG009|Overall Study|Protocol Violation|2|||
105640538|NCT02691702|364347701|FG010|Overall Study|Protocol Violation|0|||
105640539|NCT03539055|364347702|FG000|Overall Study|Death|4|||
105640540|NCT03539055|364347702|FG000|Overall Study|Lost to Follow-up|1|||
105640541|NCT03539055|364347702|FG000|Overall Study|Withdrawal by Subject|2|||
105640542|NCT03539055|364347702|FG000|Overall Study|Screen Fail|7|||
105640543|NCT03539055|364347702|FG000|Overall Study|Drug Intolerance|2|||
105640544|NCT03541369|364347703|FG000|Overall Study|Death|0|||
105640545|NCT03541369|364347704|FG001|Overall Study|Death|0|||
105640546|NCT03541369|364347705|FG002|Overall Study|Death|0|||
105640547|NCT03541369|364347706|FG003|Overall Study|Death|0|||
105640548|NCT03541369|364347707|FG004|Overall Study|Death|1|||
105640549|NCT03541369|364347708|FG005|Overall Study|Death|1|||
105640550|NCT03541369|364347709|FG006|Overall Study|Death|0|||
105640551|NCT03541369|364347710|FG007|Overall Study|Death|2|||
105640552|NCT03541369|364347711|FG008|Overall Study|Death|1|||
105640553|NCT03541369|364347712|FG009|Overall Study|Death|2|||
105640554|NCT03541369|364347713|FG010|Overall Study|Death|1|||
105640555|NCT03541369|364347714|FG011|Overall Study|Death|0|||
105640556|NCT03541369|364347715|FG012|Overall Study|Death|2|||
105640557|NCT03541369|364347716|FG013|Overall Study|Death|1|||
105640558|NCT03541369|364347717|FG014|Overall Study|Death|1|||
105640559|NCT03541369|364347718|FG015|Overall Study|Death|1|||
105640560|NCT03541369|364347719|FG016|Overall Study|Death|0|||
105640561|NCT03541369|364347720|FG017|Overall Study|Death|1|||
105640562|NCT03541369|364347703|FG000|Overall Study|Decision by sponsor|0|||
105640563|NCT03541369|364347704|FG001|Overall Study|Decision by sponsor|0|||
105640564|NCT03541369|364347705|FG002|Overall Study|Decision by sponsor|0|||
105640565|NCT03541369|364347706|FG003|Overall Study|Decision by sponsor|1|||
105640566|NCT03541369|364347707|FG004|Overall Study|Decision by sponsor|0|||
105640567|NCT03541369|364347708|FG005|Overall Study|Decision by sponsor|2|||
105640568|NCT03541369|364347709|FG006|Overall Study|Decision by sponsor|0|||
105640569|NCT03541369|364347710|FG007|Overall Study|Decision by sponsor|1|||
105640570|NCT03541369|364347711|FG008|Overall Study|Decision by sponsor|2|||
105640571|NCT03541369|364347712|FG009|Overall Study|Decision by sponsor|0|||
105640572|NCT03541369|364347713|FG010|Overall Study|Decision by sponsor|0|||
105640573|NCT03541369|364347714|FG011|Overall Study|Decision by sponsor|0|||
105640574|NCT03541369|364347715|FG012|Overall Study|Decision by sponsor|2|||
105640575|NCT03541369|364347716|FG013|Overall Study|Decision by sponsor|2|||
105640576|NCT03541369|364347717|FG014|Overall Study|Decision by sponsor|0|||
105640577|NCT03541369|364347718|FG015|Overall Study|Decision by sponsor|1|||
105870216|NCT01074944|365176967|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
105640578|NCT03541369|364347719|FG016|Overall Study|Decision by sponsor|1|||
105640579|NCT03541369|364347720|FG017|Overall Study|Decision by sponsor|1|||
105640580|NCT03541369|364347703|FG000|Overall Study|Withdrawal by Subject|0|||
105640581|NCT03541369|364347704|FG001|Overall Study|Withdrawal by Subject|0|||
105640582|NCT03541369|364347705|FG002|Overall Study|Withdrawal by Subject|0|||
105640583|NCT03541369|364347706|FG003|Overall Study|Withdrawal by Subject|0|||
105640584|NCT03541369|364347707|FG004|Overall Study|Withdrawal by Subject|0|||
105870217|NCT01074944|365176968|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
105640585|NCT03541369|364347708|FG005|Overall Study|Withdrawal by Subject|0|||
105640586|NCT03541369|364347709|FG006|Overall Study|Withdrawal by Subject|1|||
105640587|NCT03541369|364347710|FG007|Overall Study|Withdrawal by Subject|0|||
105640588|NCT03541369|364347711|FG008|Overall Study|Withdrawal by Subject|0|||
105640589|NCT03541369|364347712|FG009|Overall Study|Withdrawal by Subject|0|||
105640590|NCT03541369|364347713|FG010|Overall Study|Withdrawal by Subject|0|||
105640591|NCT03541369|364347714|FG011|Overall Study|Withdrawal by Subject|1|||
105640592|NCT03541369|364347715|FG012|Overall Study|Withdrawal by Subject|0|||
105640593|NCT03541369|364347716|FG013|Overall Study|Withdrawal by Subject|0|||
105640594|NCT03541369|364347717|FG014|Overall Study|Withdrawal by Subject|3|||
105640595|NCT03541369|364347718|FG015|Overall Study|Withdrawal by Subject|0|||
105659334|NCT00551135|364417281|FG001|Overall Study|Lost to Follow-up|0|||
105640596|NCT03541369|364347719|FG016|Overall Study|Withdrawal by Subject|4|||
105640597|NCT03541369|364347720|FG017|Overall Study|Withdrawal by Subject|2|||
105640598|NCT03541369|364347703|FG000|Overall Study|Lost to Follow-up|0|||
105640599|NCT03541369|364347704|FG001|Overall Study|Lost to Follow-up|0|||
105640600|NCT03541369|364347705|FG002|Overall Study|Lost to Follow-up|0|||
105640601|NCT03541369|364347706|FG003|Overall Study|Lost to Follow-up|0|||
105640602|NCT03541369|364347707|FG004|Overall Study|Lost to Follow-up|1|||
105640603|NCT03541369|364347708|FG005|Overall Study|Lost to Follow-up|0|||
105640604|NCT03541369|364347709|FG006|Overall Study|Lost to Follow-up|0|||
105640605|NCT03541369|364347710|FG007|Overall Study|Lost to Follow-up|0|||
105640606|NCT03541369|364347711|FG008|Overall Study|Lost to Follow-up|1|||
105640607|NCT03541369|364347712|FG009|Overall Study|Lost to Follow-up|0|||
105640608|NCT03541369|364347713|FG010|Overall Study|Lost to Follow-up|0|||
105640609|NCT03541369|364347714|FG011|Overall Study|Lost to Follow-up|0|||
105640610|NCT03541369|364347715|FG012|Overall Study|Lost to Follow-up|1|||
105640611|NCT03541369|364347716|FG013|Overall Study|Lost to Follow-up|0|||
105640612|NCT03541369|364347717|FG014|Overall Study|Lost to Follow-up|0|||
105640613|NCT03541369|364347718|FG015|Overall Study|Lost to Follow-up|0|||
105640614|NCT03541369|364347719|FG016|Overall Study|Lost to Follow-up|0|||
105640615|NCT03541369|364347720|FG017|Overall Study|Lost to Follow-up|0|||
105640616|NCT04867382|364347721|FG000|Overall Study|Did not complete the survey|2|||
105640617|NCT04867382|364347722|FG001|Overall Study|Did not complete the survey|1|||
105640618|NCT03065400|364347725|FG000|Overall Study|Adverse Event|1|||
105640619|NCT03065400|364347725|FG000|Overall Study|Physician Decision|3|||
105640620|NCT03065400|364347725|FG000|Overall Study|Withdrawal by Subject|1|||
105640621|NCT03065400|364347725|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
105640622|NCT00266656|364347726|FG000|Overall Study|Death|1|||
105640623|NCT00266656|364347727|FG001|Overall Study|Death|0|||
105640624|NCT00266656|364347726|FG000|Overall Study|Lost to Follow-up|4|||
105640625|NCT00266656|364347727|FG001|Overall Study|Lost to Follow-up|1|||
105640626|NCT00266656|364347726|FG000|Overall Study|Withdrawal by Subject|4|||
105640627|NCT00266656|364347727|FG001|Overall Study|Withdrawal by Subject|2|||
105640628|NCT00266656|364347726|FG000|Overall Study|Did Not Reach Final Height|4|||
105640629|NCT00266656|364347727|FG001|Overall Study|Did Not Reach Final Height|8|||
105640630|NCT00266656|364347726|FG000|Overall Study|Parent/Caregiver Decision|1|||
105640631|NCT00266656|364347727|FG001|Overall Study|Parent/Caregiver Decision|2|||
105640632|NCT02915783|364347729|FG000|Overall Study|Death|21|||
105640633|NCT02915783|364347729|FG000|Overall Study|Lost to Follow-up|1|||
105640634|NCT02915783|364347729|FG000|Overall Study|Withdrawal by Subject|2|||
105640635|NCT01156675|364347730|FG000|Overall Study|Death|5|||
105640636|NCT01156675|364347731|FG001|Overall Study|Death|3|||
105640637|NCT01156675|364347732|FG002|Overall Study|Death|0|||
105640638|NCT01156675|364347730|FG000|Overall Study|No data|29|||
105640639|NCT01156675|364347731|FG001|Overall Study|No data|22|||
105640640|NCT01156675|364347732|FG002|Overall Study|No data|2|||
105640641|NCT00912964|364347733|FG000|Overall Study|Eligibility criterion not met|1|||
105640642|NCT00912964|364347734|FG001|Overall Study|Eligibility criterion not met|1|||
105640643|NCT00912964|364347735|FG002|Overall Study|Eligibility criterion not met|0|||
105640644|NCT00912964|364347733|FG000|Overall Study|Adverse Event|15|||
105640645|NCT00912964|364347734|FG001|Overall Study|Adverse Event|18|||
105640646|NCT00912964|364347735|FG002|Overall Study|Adverse Event|12|||
105640647|NCT00912964|364347733|FG000|Overall Study|Lack of Efficacy|11|||
105640648|NCT00912964|364347734|FG001|Overall Study|Lack of Efficacy|4|||
105640649|NCT00912964|364347735|FG002|Overall Study|Lack of Efficacy|3|||
105640650|NCT00912964|364347733|FG000|Overall Study|Withdrawal by Subject|20|||
105640651|NCT00912964|364347734|FG001|Overall Study|Withdrawal by Subject|12|||
105640652|NCT00912964|364347735|FG002|Overall Study|Withdrawal by Subject|18|||
105640653|NCT00912964|364347733|FG000|Overall Study|Lost to Follow-up|4|||
105640654|NCT00912964|364347734|FG001|Overall Study|Lost to Follow-up|3|||
105640655|NCT00912964|364347735|FG002|Overall Study|Lost to Follow-up|3|||
105640656|NCT00912964|364347733|FG000|Overall Study|Protocol Violation|5|||
105640657|NCT00912964|364347734|FG001|Overall Study|Protocol Violation|3|||
105640658|NCT00912964|364347735|FG002|Overall Study|Protocol Violation|8|||
105640659|NCT00912964|364347733|FG000|Overall Study|Taking exclusionary medications|7|||
105640660|NCT00912964|364347734|FG001|Overall Study|Taking exclusionary medications|4|||
105640661|NCT00912964|364347735|FG002|Overall Study|Taking exclusionary medications|8|||
105640662|NCT00912964|364347733|FG000|Overall Study|Medical History|1|||
105640663|NCT00912964|364347734|FG001|Overall Study|Medical History|0|||
105640664|NCT00912964|364347735|FG002|Overall Study|Medical History|0|||
105640665|NCT00912964|364347733|FG000|Overall Study|Non-compliance with study procedures|2|||
105640666|NCT00912964|364347734|FG001|Overall Study|Non-compliance with study procedures|0|||
105640667|NCT00912964|364347735|FG002|Overall Study|Non-compliance with study procedures|0|||
105640668|NCT00912964|364347733|FG000|Overall Study|Violation of exclusion criterion|0|||
105640669|NCT00912964|364347734|FG001|Overall Study|Violation of exclusion criterion|0|||
105640670|NCT00912964|364347735|FG002|Overall Study|Violation of exclusion criterion|2|||
105640671|NCT00912964|364347733|FG000|Overall Study|Randomized but never received study drug|0|||
105659335|NCT00551135|364417282|FG002|Overall Study|Lost to Follow-up|0|||
105640672|NCT00912964|364347734|FG001|Overall Study|Randomized but never received study drug|1|||
105640673|NCT00912964|364347735|FG002|Overall Study|Randomized but never received study drug|0|||
105640674|NCT02147093|364347736|FG000|Period 1|Lost to Follow-up|0|||
105640675|NCT02147093|364347737|FG001|Period 1|Lost to Follow-up|1|||
105640676|NCT02147093|364347736|FG000|Period 2|Protocol Violation|2|||
105640677|NCT02147093|364347737|FG001|Period 2|Protocol Violation|0|||
105640678|NCT03246724|364347738|FG000|Overall Study|Withdrawal by Subject|5|||
105640679|NCT03246724|364347739|FG001|Overall Study|Withdrawal by Subject|2|||
105640680|NCT03246724|364347740|FG002|Overall Study|Withdrawal by Subject|4|||
105640681|NCT03246724|364347741|FG003|Overall Study|Withdrawal by Subject|2|||
105640682|NCT03246724|364347738|FG000|Overall Study|Ineligible on day of surgery|7|||
105640683|NCT03246724|364347739|FG001|Overall Study|Ineligible on day of surgery|2|||
105640684|NCT03246724|364347740|FG002|Overall Study|Ineligible on day of surgery|0|||
105640685|NCT03246724|364347741|FG003|Overall Study|Ineligible on day of surgery|3|||
105640686|NCT03246724|364347738|FG000|Overall Study|Study completed before surgical date|2|||
105640687|NCT03246724|364347739|FG001|Overall Study|Study completed before surgical date|1|||
105640688|NCT03246724|364347740|FG002|Overall Study|Study completed before surgical date|8|||
105640689|NCT03246724|364347741|FG003|Overall Study|Study completed before surgical date|1|||
105640690|NCT03246724|364347738|FG000|Overall Study|Transferred to other arm|0|||
105640691|NCT03246724|364347739|FG001|Overall Study|Transferred to other arm|0|||
105640692|NCT03246724|364347740|FG002|Overall Study|Transferred to other arm|1|||
105640693|NCT03246724|364347741|FG003|Overall Study|Transferred to other arm|0|||
105640694|NCT03246724|364347738|FG000|Overall Study|Unable to obtain medication timely|0|||
105640695|NCT03246724|364347739|FG001|Overall Study|Unable to obtain medication timely|2|||
105640696|NCT03246724|364347740|FG002|Overall Study|Unable to obtain medication timely|2|||
105640697|NCT03246724|364347741|FG003|Overall Study|Unable to obtain medication timely|1|||
105640698|NCT03246724|364347738|FG000|Overall Study|Re-consented to participate|0|||
105640699|NCT03246724|364347739|FG001|Overall Study|Re-consented to participate|0|||
105640700|NCT03246724|364347740|FG002|Overall Study|Re-consented to participate|0|||
105640701|NCT03246724|364347741|FG003|Overall Study|Re-consented to participate|1|||
105640702|NCT00845520|364347744|FG000|Overall Study|Death|1|||
105640703|NCT00845520|364347745|FG001|Overall Study|Death|2|||
105640704|NCT00845520|364347746|FG002|Overall Study|Death|0|||
105640705|NCT00845520|364347744|FG000|Overall Study|Lost to Follow-up|1|||
105640706|NCT00845520|364347745|FG001|Overall Study|Lost to Follow-up|0|||
105640707|NCT00845520|364347746|FG002|Overall Study|Lost to Follow-up|0|||
105640708|NCT00845520|364347744|FG000|Overall Study|Adverse Event|0|||
105640709|NCT00845520|364347745|FG001|Overall Study|Adverse Event|0|||
105640710|NCT00845520|364347746|FG002|Overall Study|Adverse Event|1|||
105640711|NCT02613403|364347747|FG000|Overall Study|Lost to Follow-up|0|||
105640712|NCT02613403|364347748|FG001|Overall Study|Lost to Follow-up|1|||
105640713|NCT02613403|364347749|FG002|Overall Study|Lost to Follow-up|0|||
105640714|NCT02613403|364347750|FG003|Overall Study|Lost to Follow-up|0|||
105640715|NCT02613403|364347751|FG004|Overall Study|Lost to Follow-up|0|||
105640716|NCT02613403|364347747|FG000|Overall Study|Withdrawal by Subject|2|||
105640717|NCT02613403|364347748|FG001|Overall Study|Withdrawal by Subject|0|||
105640718|NCT02613403|364347749|FG002|Overall Study|Withdrawal by Subject|0|||
105640719|NCT02613403|364347750|FG003|Overall Study|Withdrawal by Subject|0|||
105640720|NCT02613403|364347751|FG004|Overall Study|Withdrawal by Subject|0|||
105640721|NCT02470806|364347752|FG000|Overall Study|Lost to Follow-up|1|||
105640722|NCT02470806|364347753|FG001|Overall Study|Lost to Follow-up|1|||
105640723|NCT02470806|364347752|FG000|Overall Study|Adverse Event|5|||
105640724|NCT02470806|364347753|FG001|Overall Study|Adverse Event|2|||
105640725|NCT02470806|364347752|FG000|Overall Study|Protocol Violation|4|||
105640726|NCT02470806|364347753|FG001|Overall Study|Protocol Violation|11|||
105640727|NCT02470806|364347752|FG000|Overall Study|Physician Decision|0|||
105640728|NCT02470806|364347753|FG001|Overall Study|Physician Decision|3|||
105640729|NCT02470806|364347752|FG000|Overall Study|Withdrawal by Subject|3|||
105640730|NCT02470806|364347753|FG001|Overall Study|Withdrawal by Subject|10|||
105640731|NCT02470806|364347752|FG000|Overall Study|Lack of Efficacy|5|||
105640732|NCT02470806|364347753|FG001|Overall Study|Lack of Efficacy|15|||
105640733|NCT00513071|364347754|FG000|Overall Study|Adverse Event|1|||
105640734|NCT00513071|364347754|FG000|Overall Study|Withdrawal by Subject|1|||
105640735|NCT00513071|364347754|FG000|Overall Study|Physician Decision|3|||
105640736|NCT02699099|364347756|FG000|Overall Study|Adverse Event|1|||
105640737|NCT02699099|364347757|FG001|Overall Study|Adverse Event|0|||
105640738|NCT02699099|364347758|FG002|Overall Study|Adverse Event|2|||
105640739|NCT02699099|364347756|FG000|Overall Study|Lost to Follow-up|0|||
105640740|NCT02699099|364347757|FG001|Overall Study|Lost to Follow-up|1|||
105640741|NCT02699099|364347758|FG002|Overall Study|Lost to Follow-up|0|||
105640742|NCT02699099|364347756|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
105640743|NCT02699099|364347757|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
105640744|NCT02699099|364347758|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
105640745|NCT00667732|364347759|FG000|Run -In (8 Weeks)|Adverse Event|4|||
105640746|NCT00667732|364347760|FG001|Run -In (8 Weeks)|Adverse Event|0|||
105640747|NCT00667732|364347761|FG002|Run -In (8 Weeks)|Adverse Event|0|||
105640748|NCT00667732|364347759|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
105640749|NCT00667732|364347760|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
105640750|NCT00667732|364347761|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
105640751|NCT00667732|364347759|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
105640752|NCT00667732|364347760|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
105640753|NCT00667732|364347761|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
105640754|NCT01240590|364347767|FG000|Phase I|Refused further treatment|0|||
105640755|NCT01240590|364347768|FG001|Phase I|Refused further treatment|0|||
105640756|NCT01240590|364347769|FG002|Phase I|Refused further treatment|3|||
105640757|NCT01240590|364347770|FG003|Phase I|Refused further treatment|0|||
105640758|NCT01240590|364347771|FG004|Phase I|Refused further treatment|0|||
105640759|NCT01240590|364347767|FG000|Phase II|Refused further treatment|0|||
105640760|NCT01240590|364347768|FG001|Phase II|Refused further treatment|0|||
105640761|NCT01240590|364347769|FG002|Phase II|Refused further treatment|0|||
105640762|NCT01240590|364347770|FG003|Phase II|Refused further treatment|2|||
105640763|NCT01240590|364347771|FG004|Phase II|Refused further treatment|1|||
105640764|NCT02144285|364347772|FG000|Overall Study|Withdrawal by Subject|0|||
105640765|NCT02144285|364347773|FG001|Overall Study|Withdrawal by Subject|0|||
105640766|NCT02144285|364347774|FG002|Overall Study|Withdrawal by Subject|0|||
105640767|NCT02144285|364347775|FG003|Overall Study|Withdrawal by Subject|0|||
105640768|NCT02144285|364347776|FG004|Overall Study|Withdrawal by Subject|1|||
105640769|NCT02144285|364347777|FG005|Overall Study|Withdrawal by Subject|0|||
105640770|NCT02144285|364347778|FG006|Overall Study|Withdrawal by Subject|0|||
105640771|NCT02144285|364347779|FG007|Overall Study|Withdrawal by Subject|0|||
105640772|NCT02144285|364347780|FG008|Overall Study|Withdrawal by Subject|0|||
105640773|NCT02144285|364347781|FG009|Overall Study|Withdrawal by Subject|0|||
105640774|NCT04895085|364347783|FG000|Overall Study|Death|1|||
105640775|NCT04895085|364347783|FG000|Overall Study|Withdrawal by Subject|1|||
105640776|NCT04895085|364347783|FG000|Overall Study|No longer eligible: Moved from area|1|||
105640777|NCT05184062|364347784|FG000|Overall Study|Lost to Follow-up|5|||
105640778|NCT05184062|364347785|FG001|Overall Study|Lost to Follow-up|1|||
105640779|NCT05184062|364347784|FG000|Overall Study|Withdrawal by Subject|1|||
105640780|NCT05184062|364347785|FG001|Overall Study|Withdrawal by Subject|0|||
105640781|NCT03769090|364349296|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
105640782|NCT03769090|364349297|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
105640783|NCT03769090|364349298|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
105640784|NCT03769090|364349296|FG000|Overall Study|Withdrawal by Subject|52|||
105640785|NCT03769090|364349297|FG001|Overall Study|Withdrawal by Subject|62|||
105640786|NCT03769090|364349298|FG002|Overall Study|Withdrawal by Subject|74|||
105640787|NCT03769090|364349296|FG000|Overall Study|Death|4|||
105640788|NCT03769090|364349297|FG001|Overall Study|Death|2|||
105640789|NCT03769090|364349298|FG002|Overall Study|Death|2|||
105640790|NCT03769090|364349296|FG000|Overall Study|Adverse Event|7|||
105640791|NCT03769090|364349297|FG001|Overall Study|Adverse Event|7|||
105640792|NCT03769090|364349298|FG002|Overall Study|Adverse Event|8|||
105640793|NCT03769090|364349296|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
105640794|NCT03769090|364349297|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
105640795|NCT03769090|364349298|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
105640796|NCT03769090|364349296|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
105640797|NCT03769090|364349297|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
105640798|NCT03769090|364349298|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
105640799|NCT03769090|364349296|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
105640800|NCT03769090|364349297|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
105640801|NCT03769090|364349298|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
105640802|NCT03769090|364349296|FG000|Overall Study|Protocol Violation|5|||
105640803|NCT03769090|364349297|FG001|Overall Study|Protocol Violation|6|||
105640804|NCT03769090|364349298|FG002|Overall Study|Protocol Violation|8|||
105640805|NCT03769090|364349296|FG000|Overall Study|Pregnancy|1|||
105640806|NCT03769090|364349297|FG001|Overall Study|Pregnancy|0|||
105640807|NCT03769090|364349298|FG002|Overall Study|Pregnancy|3|||
105640808|NCT03769090|364349296|FG000|Overall Study|Lost to Follow-up|19|||
105640809|NCT03769090|364349297|FG001|Overall Study|Lost to Follow-up|25|||
105640810|NCT03769090|364349298|FG002|Overall Study|Lost to Follow-up|21|||
105640811|NCT03769090|364349296|FG000|Overall Study|Condition under investigation worsened|2|||
105640812|NCT03769090|364349297|FG001|Overall Study|Condition under investigation worsened|0|||
105640813|NCT03769090|364349298|FG002|Overall Study|Condition under investigation worsened|1|||
105640814|NCT03769090|364349296|FG000|Overall Study|Lack of Efficacy|1|||
105640815|NCT03769090|364349297|FG001|Overall Study|Lack of Efficacy|2|||
105640816|NCT03769090|364349298|FG002|Overall Study|Lack of Efficacy|2|||
105640817|NCT03769090|364349296|FG000|Overall Study|Other reasons|8|||
105640818|NCT03769090|364349297|FG001|Overall Study|Other reasons|12|||
105640819|NCT03769090|364349298|FG002|Overall Study|Other reasons|15|||
105640820|NCT02713594|364349299|FG000|Overall Study|Withdrawal by Subject|32|||
105640821|NCT02713594|364349300|FG001|Overall Study|Withdrawal by Subject|22|||
105640822|NCT02713594|364349299|FG000|Overall Study|Lost to Follow-up|358|||
105640823|NCT02713594|364349300|FG001|Overall Study|Lost to Follow-up|374|||
105640824|NCT02354417|364349301|FG000|Overall Study|Physician Decision|1|||
105640825|NCT00587171|364349302|FG000|Overall Study|Lost to Follow-up|1|||
105640826|NCT00587171|364349303|FG001|Overall Study|Lost to Follow-up|1|||
105640827|NCT01148017|364349304|FG000|Overall Study|Withdrawal by Subject|31|||
105640828|NCT01148017|364349305|FG001|Overall Study|Withdrawal by Subject|14|||
105640829|NCT01148017|364349306|FG002|Overall Study|Withdrawal by Subject|0|||
105640830|NCT01148017|364349307|FG003|Overall Study|Withdrawal by Subject|0|||
105640831|NCT01148017|364349304|FG000|Overall Study|Lost to Follow-up|23|||
105640832|NCT01148017|364349305|FG001|Overall Study|Lost to Follow-up|10|||
105640833|NCT01148017|364349306|FG002|Overall Study|Lost to Follow-up|0|||
105640834|NCT01148017|364349307|FG003|Overall Study|Lost to Follow-up|0|||
105640835|NCT01148017|364349304|FG000|Overall Study|Inappropriate enrollment|1|||
105640836|NCT01148017|364349305|FG001|Overall Study|Inappropriate enrollment|0|||
105640837|NCT01148017|364349306|FG002|Overall Study|Inappropriate enrollment|0|||
105640838|NCT01148017|364349307|FG003|Overall Study|Inappropriate enrollment|0|||
105640839|NCT01148017|364349304|FG000|Overall Study|Administrative reason|22|||
105640840|NCT01148017|364349305|FG001|Overall Study|Administrative reason|9|||
105640841|NCT01148017|364349306|FG002|Overall Study|Administrative reason|0|||
105640842|NCT01148017|364349307|FG003|Overall Study|Administrative reason|0|||
105640843|NCT01148017|364349304|FG000|Overall Study|Unable to classify|3|||
105640844|NCT01148017|364349305|FG001|Overall Study|Unable to classify|1|||
105640845|NCT01148017|364349306|FG002|Overall Study|Unable to classify|0|||
105640846|NCT01148017|364349307|FG003|Overall Study|Unable to classify|0|||
105640847|NCT02236611|364349309|FG000|Overall Study|Adverse Event|10|||
105640848|NCT02236611|364349310|FG001|Overall Study|Adverse Event|16|||
105640849|NCT02236611|364349309|FG000|Overall Study|Lack of Efficacy|4|||
105640850|NCT02236611|364349310|FG001|Overall Study|Lack of Efficacy|7|||
105640851|NCT02236611|364349309|FG000|Overall Study|Lost to Follow-up|0|||
105640852|NCT02236611|364349310|FG001|Overall Study|Lost to Follow-up|2|||
105640853|NCT02236611|364349309|FG000|Overall Study|Protocol deviation|3|||
105640854|NCT02236611|364349310|FG001|Overall Study|Protocol deviation|5|||
105640855|NCT02236611|364349309|FG000|Overall Study|Withdrew consent|9|||
105640856|NCT02236611|364349310|FG001|Overall Study|Withdrew consent|4|||
105640857|NCT00569166|364349314|FG000|Overall Study|Withdrawal by Subject|7|||
105640858|NCT00569166|364349315|FG001|Overall Study|Withdrawal by Subject|5|||
105640859|NCT00569166|364349316|FG002|Overall Study|Withdrawal by Subject|3|||
105640860|NCT00569166|364349314|FG000|Overall Study|Lost to Follow-up|2|||
105640861|NCT00569166|364349315|FG001|Overall Study|Lost to Follow-up|1|||
105640862|NCT00569166|364349316|FG002|Overall Study|Lost to Follow-up|1|||
105640863|NCT00022672|364349317|FG000|Main Phase: 24 Months|Adverse Event|6|||
105640864|NCT00022672|364349318|FG001|Main Phase: 24 Months|Adverse Event|0|||
105640865|NCT00022672|364349317|FG000|Main Phase: 24 Months|Death|0|||
105640866|NCT00022672|364349318|FG001|Main Phase: 24 Months|Death|3|||
105640867|NCT00022672|364349317|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
105640868|NCT00022672|364349318|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
105640869|NCT00022672|364349317|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
105640870|NCT00022672|364349318|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
105640871|NCT00022672|364349317|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
105640872|NCT00022672|364349318|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
105640873|NCT00022672|364349317|FG000|Main Phase: 24 Months|Refused Treatment|3|||
105640874|NCT00022672|364349318|FG001|Main Phase: 24 Months|Refused Treatment|4|||
105640875|NCT00022672|364349317|FG000|Main Phase: 24 Months|Failure to Return|1|||
105640876|NCT00022672|364349318|FG001|Main Phase: 24 Months|Failure to Return|1|||
105640877|NCT00022672|364349317|FG000|Main Phase: 24 Months|Other|1|||
105640878|NCT00022672|364349318|FG001|Main Phase: 24 Months|Other|0|||
105640879|NCT00022672|364349317|FG000|Extension Phase|Adverse Event|1|||
105640880|NCT00022672|364349318|FG001|Extension Phase|Adverse Event|3|||
105640881|NCT00022672|364349317|FG000|Extension Phase|Death|0|||
105640882|NCT00022672|364349318|FG001|Extension Phase|Death|1|||
105640883|NCT00022672|364349317|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
105640884|NCT00022672|364349318|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
105640885|NCT00022672|364349317|FG000|Extension Phase|Refused Treatment|0|||
105640886|NCT00022672|364349318|FG001|Extension Phase|Refused Treatment|2|||
105640887|NCT00022672|364349317|FG000|Extension Phase|Other|1|||
105640888|NCT00022672|364349318|FG001|Extension Phase|Other|1|||
105640889|NCT01450007|364349319|FG000|Overall Study|Late exclusion before treatment|2|||
105640890|NCT01450007|364349320|FG001|Overall Study|Late exclusion before treatment|3|||
105640891|NCT01450007|364349321|FG002|Overall Study|Late exclusion before treatment|2|||
105640892|NCT01450007|364349319|FG000|Overall Study|Protocol Violation|0|||
105640893|NCT01450007|364349320|FG001|Overall Study|Protocol Violation|1|||
105640894|NCT01450007|364349321|FG002|Overall Study|Protocol Violation|1|||
105640895|NCT01450007|364349319|FG000|Overall Study|Adverse Event|0|||
105640896|NCT01450007|364349320|FG001|Overall Study|Adverse Event|1|||
105640897|NCT01450007|364349321|FG002|Overall Study|Adverse Event|0|||
105640898|NCT00308308|364349322|FG000|Overall Study|Adverse Event|17|||
105640899|NCT00308308|364349323|FG001|Overall Study|Adverse Event|2|||
105640900|NCT00308308|364349322|FG000|Overall Study|Lost to Follow-up|5|||
105640901|NCT00308308|364349323|FG001|Overall Study|Lost to Follow-up|5|||
105640902|NCT00308308|364349322|FG000|Overall Study|Physician Decision|15|||
105640903|NCT00308308|364349323|FG001|Overall Study|Physician Decision|7|||
105640904|NCT00308308|364349322|FG000|Overall Study|Protocol Violation|3|||
105640905|NCT00308308|364349323|FG001|Overall Study|Protocol Violation|14|||
105640906|NCT00308308|364349322|FG000|Overall Study|Withdrawal by Subject|47|||
105640907|NCT00308308|364349323|FG001|Overall Study|Withdrawal by Subject|19|||
105640908|NCT00308308|364349322|FG000|Overall Study|Various|7|||
105640909|NCT00308308|364349323|FG001|Overall Study|Various|5|||
105640910|NCT00308308|364349322|FG000|Overall Study|Randomized but not dosed|8|||
105640911|NCT00308308|364349323|FG001|Overall Study|Randomized but not dosed|16|||
105640912|NCT00308308|364349322|FG000|Overall Study|Other|1|||
105640913|NCT00308308|364349323|FG001|Overall Study|Other|0|||
105640914|NCT03142932|364349324|FG000|Overall Study|Lost to Follow-up|2|||
105640915|NCT03142932|364349325|FG001|Overall Study|Lost to Follow-up|11|||
105640916|NCT04070105|364349330|FG000|Overall Study|Lost to Follow-up|0|||
105640917|NCT04070105|364349331|FG001|Overall Study|Lost to Follow-up|0|||
105640918|NCT04070105|364349332|FG002|Overall Study|Lost to Follow-up|0|||
105640919|NCT04070105|364349333|FG003|Overall Study|Lost to Follow-up|0|||
105640920|NCT04070105|364349334|FG004|Overall Study|Lost to Follow-up|0|||
105640921|NCT04070105|364349335|FG005|Overall Study|Lost to Follow-up|1|||
105640922|NCT04766996|364349336|FG000|Overall Study|Withdrawal by Subject|1|||
105640923|NCT04766996|364349337|FG001|Overall Study|Withdrawal by Subject|0|||
105640924|NCT04766996|364349338|FG002|Overall Study|Withdrawal by Subject|13|||
105640925|NCT01918033|364349339|FG000|Overall Study|Adverse Event|1|||
105640926|NCT01918033|364349340|FG001|Overall Study|Adverse Event|0|||
105640927|NCT01918033|364349341|FG002|Overall Study|Adverse Event|2|||
105640928|NCT01918033|364349339|FG000|Overall Study|Lost to Follow-up|0|||
105640929|NCT01918033|364349340|FG001|Overall Study|Lost to Follow-up|1|||
105640930|NCT01918033|364349341|FG002|Overall Study|Lost to Follow-up|0|||
105640931|NCT01918033|364349339|FG000|Overall Study|Protocol Violation|2|||
105640932|NCT01918033|364349340|FG001|Overall Study|Protocol Violation|0|||
105640933|NCT01918033|364349341|FG002|Overall Study|Protocol Violation|1|||
105640934|NCT01918033|364349339|FG000|Overall Study|Withdrawal by Subject|2|||
105640935|NCT01918033|364349340|FG001|Overall Study|Withdrawal by Subject|1|||
105640936|NCT01918033|364349341|FG002|Overall Study|Withdrawal by Subject|0|||
105640937|NCT03184987|364349342|FG000|Overall Study|Withdrawal by Subject|0|||
105640938|NCT03184987|364349343|FG001|Overall Study|Withdrawal by Subject|1|||
105640939|NCT03184987|364349344|FG002|Overall Study|Withdrawal by Subject|2|||
105640940|NCT03184987|364349342|FG000|Overall Study|Physician Decision|0|||
105640941|NCT03184987|364349343|FG001|Overall Study|Physician Decision|0|||
105640942|NCT03184987|364349344|FG002|Overall Study|Physician Decision|1|||
105640943|NCT03184987|364349342|FG000|Overall Study|Adverse Event|1|||
105640944|NCT03184987|364349343|FG001|Overall Study|Adverse Event|0|||
105640945|NCT03184987|364349344|FG002|Overall Study|Adverse Event|1|||
105640946|NCT03259568|364349348|FG000|Overall Study|Participant performance was low|3|||
105640947|NCT04248868|364349349|FG000|Overall Study|Death|1|||
105640948|NCT04248868|364349349|FG000|Overall Study|Lost to Follow-up|3|||
105640949|NCT04248868|364349349|FG000|Overall Study|Protocol Violation|2|||
105640950|NCT02208843|364349352|FG000|Overall Study|Clinical symptoms of progression|2|||
105640951|NCT02208843|364349352|FG000|Overall Study|Progression disease according to RECIST|24|||
105640952|NCT02208843|364349352|FG000|Overall Study|Adverse Event|12|||
105640953|NCT02208843|364349352|FG000|Overall Study|Protocol Violation|1|||
105640954|NCT02208843|364349352|FG000|Overall Study|Withdrawal by Subject|1|||
105640955|NCT02208843|364349352|FG000|Overall Study|Switched to commercial afatinib|20|||
105640956|NCT01976507|364349353|FG000|Overall Study|Adverse Event|6|||
105640957|NCT01976507|364349353|FG000|Overall Study|ablation not done, drug not given|1|||
105640958|NCT01794299|364349354|FG000|Overall Study|ATIR manufacturing not possible|1|||
105640959|NCT01794299|364349354|FG000|Overall Study|Death|14|||
105640960|NCT01794299|364349354|FG000|Overall Study|Graft failure|1|||
105640961|NCT01794299|364349354|FG000|Overall Study|ATIR batch rejected|2|||
105640962|NCT01794299|364349354|FG000|Overall Study|Relapse|2|||
105640963|NCT01794299|364349354|FG000|Overall Study|Discontinued from active follow-up|1|||
105640964|NCT01794299|364349354|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
105640965|NCT01029704|364349355|FG000|Overall Study|Adverse Event|0|||
105640966|NCT01029704|364349356|FG001|Overall Study|Adverse Event|0|||
105640967|NCT01029704|364349357|FG002|Overall Study|Adverse Event|0|||
105640968|NCT01029704|364349358|FG003|Overall Study|Adverse Event|0|||
105640969|NCT01029704|364349359|FG004|Overall Study|Adverse Event|0|||
105640970|NCT01029704|364349360|FG005|Overall Study|Adverse Event|0|||
105640971|NCT01029704|364349361|FG006|Overall Study|Adverse Event|1|||
105640972|NCT01029704|364349362|FG007|Overall Study|Adverse Event|1|||
105640973|NCT01029704|364349363|FG008|Overall Study|Adverse Event|0|||
105640974|NCT01029704|364349355|FG000|Overall Study|Withdrawal by Subject|0|||
105640975|NCT01029704|364349356|FG001|Overall Study|Withdrawal by Subject|0|||
105640976|NCT01029704|364349357|FG002|Overall Study|Withdrawal by Subject|0|||
105640977|NCT01029704|364349358|FG003|Overall Study|Withdrawal by Subject|0|||
105640978|NCT01029704|364349359|FG004|Overall Study|Withdrawal by Subject|2|||
105640979|NCT01029704|364349360|FG005|Overall Study|Withdrawal by Subject|1|||
105640980|NCT01029704|364349361|FG006|Overall Study|Withdrawal by Subject|1|||
105640981|NCT01029704|364349362|FG007|Overall Study|Withdrawal by Subject|1|||
105640982|NCT01029704|364349363|FG008|Overall Study|Withdrawal by Subject|0|||
105640983|NCT01029704|364349355|FG000|Overall Study|Lost to Follow-up|0|||
105640984|NCT01029704|364349356|FG001|Overall Study|Lost to Follow-up|0|||
105640985|NCT01029704|364349357|FG002|Overall Study|Lost to Follow-up|0|||
105640986|NCT01029704|364349358|FG003|Overall Study|Lost to Follow-up|0|||
105640987|NCT01029704|364349359|FG004|Overall Study|Lost to Follow-up|0|||
105640988|NCT01029704|364349360|FG005|Overall Study|Lost to Follow-up|0|||
105640989|NCT01029704|364349361|FG006|Overall Study|Lost to Follow-up|1|||
105640990|NCT01029704|364349362|FG007|Overall Study|Lost to Follow-up|1|||
105640991|NCT01029704|364349363|FG008|Overall Study|Lost to Follow-up|1|||
105640992|NCT01029704|364349355|FG000|Overall Study|Lack of Efficacy|0|||
105640993|NCT01029704|364349356|FG001|Overall Study|Lack of Efficacy|0|||
105640994|NCT01029704|364349357|FG002|Overall Study|Lack of Efficacy|0|||
105640995|NCT01029704|364349358|FG003|Overall Study|Lack of Efficacy|0|||
105640996|NCT01029704|364349359|FG004|Overall Study|Lack of Efficacy|2|||
105640997|NCT01029704|364349360|FG005|Overall Study|Lack of Efficacy|3|||
105640998|NCT01029704|364349361|FG006|Overall Study|Lack of Efficacy|1|||
105640999|NCT01029704|364349362|FG007|Overall Study|Lack of Efficacy|2|||
105641000|NCT01029704|364349363|FG008|Overall Study|Lack of Efficacy|0|||
105641001|NCT01029704|364349355|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
105641002|NCT01029704|364349356|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
105641003|NCT01029704|364349357|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
105641004|NCT01029704|364349358|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
105641005|NCT01029704|364349359|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
105641006|NCT01029704|364349360|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
105641007|NCT01029704|364349361|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
105641008|NCT01029704|364349362|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
105641009|NCT01029704|364349363|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
105641010|NCT02410278|364349368|FG000|Run-in Period|Adverse Event|5|||
105641011|NCT02410278|364349369|FG001|Run-in Period|Adverse Event|0|||
105641012|NCT02410278|364349370|FG002|Run-in Period|Adverse Event|0|||
105641013|NCT02410278|364349368|FG000|Run-in Period|GSRS Threshold Not Met|30|||
105641014|NCT02410278|364349369|FG001|Run-in Period|GSRS Threshold Not Met|0|||
105641015|NCT02410278|364349370|FG002|Run-in Period|GSRS Threshold Not Met|0|||
105641016|NCT02410278|364349368|FG000|Run-in Period|Lost to Follow-up|1|||
105641017|NCT02410278|364349369|FG001|Run-in Period|Lost to Follow-up|0|||
105641018|NCT02410278|364349370|FG002|Run-in Period|Lost to Follow-up|0|||
105641019|NCT02410278|364349368|FG000|Run-in Period|Withdrawal by Subject|1|||
105641020|NCT02410278|364349369|FG001|Run-in Period|Withdrawal by Subject|0|||
105641021|NCT02410278|364349370|FG002|Run-in Period|Withdrawal by Subject|0|||
105641022|NCT02410278|364349368|FG000|Run-in Period|Pregnancy|1|||
105641023|NCT02410278|364349369|FG001|Run-in Period|Pregnancy|0|||
105641024|NCT02410278|364349370|FG002|Run-in Period|Pregnancy|0|||
105641025|NCT02410278|364349368|FG000|Study Treatment Period|Adverse Event|0|||
105641026|NCT02410278|364349369|FG001|Study Treatment Period|Adverse Event|6|||
105641027|NCT02410278|364349370|FG002|Study Treatment Period|Adverse Event|3|||
105641028|NCT02410278|364349368|FG000|Study Treatment Period|Physician Decision|0|||
105641029|NCT02410278|364349369|FG001|Study Treatment Period|Physician Decision|0|||
105641030|NCT02410278|364349370|FG002|Study Treatment Period|Physician Decision|1|||
105641031|NCT02410278|364349368|FG000|Study Treatment Period|Withdrawal by Subject|0|||
105641032|NCT02410278|364349369|FG001|Study Treatment Period|Withdrawal by Subject|1|||
105641033|NCT02410278|364349370|FG002|Study Treatment Period|Withdrawal by Subject|0|||
105641034|NCT02410278|364349368|FG000|Study Treatment Period|Other|0|||
105641035|NCT02410278|364349369|FG001|Study Treatment Period|Other|3|||
105641036|NCT02410278|364349370|FG002|Study Treatment Period|Other|0|||
105641037|NCT02410278|364349368|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
105641038|NCT02410278|364349369|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
105641039|NCT02410278|364349370|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
105641040|NCT00148122|364349371|FG000|Overall Study|Withdrawal by Subject|2|||
105641041|NCT02137785|364349374|FG000|Overall Study|Lost to Follow-up|1|||
105641042|NCT02137785|364349375|FG001|Overall Study|Lost to Follow-up|0|||
105641043|NCT02137785|364349374|FG000|Overall Study|Withdrawal by Subject|1|||
105641044|NCT02137785|364349375|FG001|Overall Study|Withdrawal by Subject|4|||
105641045|NCT02137785|364349374|FG000|Overall Study|subject moved out of state|1|||
105641046|NCT02137785|364349375|FG001|Overall Study|subject moved out of state|0|||
105641047|NCT05376397|364349376|FG000|Overall Study|Lost to Follow-up|1|||
105641048|NCT01328756|364349377|FG000|Overall Study|Protocol Violation|4|||
105641049|NCT01328756|364349377|FG000|Overall Study|Adverse Event|39|||
105641050|NCT01328756|364349377|FG000|Overall Study|Lack of Efficacy|5|||
105641051|NCT01328756|364349377|FG000|Overall Study|Withdrawal by Subject|41|||
105641052|NCT01328756|364349377|FG000|Overall Study|Lost to Follow-up|5|||
105641053|NCT01328756|364349377|FG000|Overall Study|Other|29|||
105641054|NCT01137682|364349378|FG000|Overall Study|Adverse Event-CORE|2|||
105641055|NCT01137682|364349379|FG001|Overall Study|Adverse Event-CORE|4|||
105641056|NCT01137682|364349380|FG002|Overall Study|Adverse Event-CORE|0|||
105641057|NCT01137682|364349378|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
105641058|NCT01137682|364349379|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
105641059|NCT01137682|364349380|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
105641060|NCT01137682|364349378|FG000|Overall Study|Administrative problems-CORE|2|||
105641061|NCT01137682|364349379|FG001|Overall Study|Administrative problems-CORE|1|||
105641062|NCT01137682|364349380|FG002|Overall Study|Administrative problems-CORE|0|||
105641063|NCT01137682|364349378|FG000|Overall Study|Protocol Violation-CORE|0|||
105641064|NCT01137682|364349379|FG001|Overall Study|Protocol Violation-CORE|1|||
105641065|NCT01137682|364349380|FG002|Overall Study|Protocol Violation-CORE|1|||
105641066|NCT01137682|364349378|FG000|Overall Study|Adverse Event-Extension|4|||
105641067|NCT01137682|364349379|FG001|Overall Study|Adverse Event-Extension|8|||
105641068|NCT01137682|364349380|FG002|Overall Study|Adverse Event-Extension|7|||
105641069|NCT01137682|364349378|FG000|Overall Study|Lack of Efficacy-Extension|15|||
105641070|NCT01137682|364349379|FG001|Overall Study|Lack of Efficacy-Extension|9|||
105641071|NCT01137682|364349380|FG002|Overall Study|Lack of Efficacy-Extension|13|||
105641072|NCT01137682|364349378|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
105641073|NCT01137682|364349379|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
105641074|NCT01137682|364349380|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
105641075|NCT01137682|364349378|FG000|Overall Study|Lost to Follow Up-Extension|0|||
105641076|NCT01137682|364349379|FG001|Overall Study|Lost to Follow Up-Extension|1|||
105641077|NCT01137682|364349380|FG002|Overall Study|Lost to Follow Up-Extension|0|||
105641078|NCT01137682|364349378|FG000|Overall Study|Administrative problems-Extension|0|||
105641079|NCT01137682|364349379|FG001|Overall Study|Administrative problems-Extension|2|||
105641080|NCT01137682|364349380|FG002|Overall Study|Administrative problems-Extension|0|||
105641081|NCT01137682|364349378|FG000|Overall Study|Death-Extension|2|||
105641082|NCT01137682|364349379|FG001|Overall Study|Death-Extension|0|||
105641083|NCT01137682|364349380|FG002|Overall Study|Death-Extension|0|||
105641084|NCT01137682|364349378|FG000|Overall Study|Protocol Violation-Extension|2|||
105641085|NCT01137682|364349379|FG001|Overall Study|Protocol Violation-Extension|1|||
105641086|NCT01137682|364349380|FG002|Overall Study|Protocol Violation-Extension|0|||
105641087|NCT01137682|364349378|FG000|Overall Study|Did not enter extension|2|||
105641088|NCT01137682|364349379|FG001|Overall Study|Did not enter extension|3|||
105641089|NCT01137682|364349380|FG002|Overall Study|Did not enter extension|2|||
105641090|NCT01137682|364349378|FG000|Overall Study|Did not receive treatment in extension|0|||
105641091|NCT01137682|364349379|FG001|Overall Study|Did not receive treatment in extension|0|||
105641092|NCT01137682|364349380|FG002|Overall Study|Did not receive treatment in extension|1|||
105641093|NCT02449902|364349381|FG000|Overall Study|Adverse Event|0|||
105641094|NCT02449902|364349382|FG001|Overall Study|Adverse Event|1|||
105641095|NCT02449902|364349381|FG000|Overall Study|Withdrawal by Subject|0|||
105641096|NCT02449902|364349382|FG001|Overall Study|Withdrawal by Subject|1|||
105641097|NCT00795639|364349384|FG000|Overall Study|Death|1|||
105641098|NCT00795639|364349385|FG001|Overall Study|Death|6|||
105641099|NCT00795639|364349384|FG000|Overall Study|Withdrawal by Subject|1|||
105641100|NCT00795639|364349385|FG001|Overall Study|Withdrawal by Subject|3|||
105641101|NCT00795639|364349384|FG000|Overall Study|Pregnancy|1|||
105641102|NCT00795639|364349385|FG001|Overall Study|Pregnancy|0|||
105641103|NCT00795639|364349384|FG000|Overall Study|Adverse Event|5|||
105641104|NCT00795639|364349385|FG001|Overall Study|Adverse Event|2|||
105641105|NCT00795639|364349384|FG000|Overall Study|Other|0|||
105641106|NCT00795639|364349385|FG001|Overall Study|Other|2|||
105641107|NCT00795639|364349384|FG000|Overall Study|Terminated by sponsor|13|||
105641108|NCT00795639|364349385|FG001|Overall Study|Terminated by sponsor|12|||
105641109|NCT00795639|364349384|FG000|Overall Study|Randomized and not treated|0|||
105641110|NCT00795639|364349385|FG001|Overall Study|Randomized and not treated|1|||
105641111|NCT02525744|364349386|FG000|Period 1|Physician Decision|0|||
105641112|NCT02525744|364349387|FG001|Period 1|Physician Decision|0|||
105641113|NCT02525744|364349388|FG002|Period 1|Physician Decision|1|||
105641114|NCT02525744|364349389|FG003|Period 1|Physician Decision|0|||
105641115|NCT02525744|364349386|FG000|Period 3|Adverse Event|0|||
105641116|NCT02525744|364349387|FG001|Period 3|Adverse Event|1|||
105641117|NCT02525744|364349388|FG002|Period 3|Adverse Event|0|||
105641118|NCT02525744|364349389|FG003|Period 3|Adverse Event|0|||
105641119|NCT02525744|364349386|FG000|Period 4|Withdrawal by Subject|1|||
105641120|NCT02525744|364349387|FG001|Period 4|Withdrawal by Subject|0|||
105641121|NCT02525744|364349388|FG002|Period 4|Withdrawal by Subject|0|||
105641122|NCT02525744|364349389|FG003|Period 4|Withdrawal by Subject|0|||
105641123|NCT02525744|364349386|FG000|Period 5|Physician Decision|1|||
105641124|NCT02525744|364349387|FG001|Period 5|Physician Decision|0|||
105641125|NCT02525744|364349388|FG002|Period 5|Physician Decision|0|||
105641126|NCT02525744|364349389|FG003|Period 5|Physician Decision|0|||
105641127|NCT00879710|364349390|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
105641128|NCT00879710|364349391|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
105641129|NCT00879710|364349392|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
105641130|NCT00879710|364349393|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
105641131|NCT00879710|364349390|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
105641132|NCT00879710|364349391|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
105641133|NCT00879710|364349392|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
105641134|NCT00879710|364349393|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
105641135|NCT03200574|364349398|FG000|Overall Study|Death|4|||
105641136|NCT03200574|364349398|FG000|Overall Study|Withdrawal by Subject|8|||
105641137|NCT03200574|364349398|FG000|Overall Study|Long-Term need for anticoagulation|1|||
105641138|NCT03200574|364349398|FG000|Overall Study|Relocation|2|||
105641139|NCT03200574|364349398|FG000|Overall Study|Lost to Follow-up|2|||
105641140|NCT04183491|364349399|FG000|Overall Study|Withdrawal by Subject|0|||
105641141|NCT04183491|364349400|FG001|Overall Study|Withdrawal by Subject|0|||
105641142|NCT04183491|364349401|FG002|Overall Study|Withdrawal by Subject|1|||
105641143|NCT04183491|364349402|FG003|Overall Study|Withdrawal by Subject|0|||
105641144|NCT04183491|364349403|FG004|Overall Study|Withdrawal by Subject|0|||
105641145|NCT04183491|364349404|FG005|Overall Study|Withdrawal by Subject|1|||
105641146|NCT04183491|364349405|FG006|Overall Study|Withdrawal by Subject|0|||
105641147|NCT01262456|364349406|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
105641148|NCT01262456|364349407|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
105641149|NCT01262456|364349408|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
105641150|NCT01262456|364349406|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
105641151|NCT01262456|364349407|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
105641152|NCT01262456|364349408|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
105641153|NCT01262456|364349406|FG000|3-Month Double-Blind Period|Adverse Event|6|||
105641154|NCT01262456|364349407|FG001|3-Month Double-Blind Period|Adverse Event|4|||
105641155|NCT01262456|364349408|FG002|3-Month Double-Blind Period|Adverse Event|8|||
105641156|NCT01262456|364349406|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
105641157|NCT01262456|364349407|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
105641158|NCT01262456|364349408|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
105641159|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
105641160|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
105641161|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
105641162|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
105641163|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
105641164|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
105641165|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
105641166|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
105641167|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
105641168|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
105641169|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
105641170|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
105641171|NCT01262456|364349406|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
105641172|NCT01262456|364349407|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
105641173|NCT01262456|364349408|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
105641174|NCT03938272|364349409|FG000|Overall Study|Withdrawal by Subject|1|||
105641175|NCT03938272|364349410|FG001|Overall Study|Withdrawal by Subject|0|||
105641176|NCT03938272|364349409|FG000|Overall Study|Physician Decision|0|||
105641177|NCT03938272|364349410|FG001|Overall Study|Physician Decision|2|||
105641178|NCT03938272|364349409|FG000|Overall Study|Study termination by sponsor|10|||
105641179|NCT03938272|364349410|FG001|Overall Study|Study termination by sponsor|8|||
105641180|NCT00886834|364349411|FG000|Overall Study|Protocol Violation|0|||
105641181|NCT00886834|364349412|FG001|Overall Study|Protocol Violation|3|||
105641182|NCT04085614|364349413|FG000|Overall Study|Protocol Violation|9|||
105641183|NCT04085614|364349414|FG001|Overall Study|Protocol Violation|6|||
105641184|NCT03150589|364349415|FG000|Overall Study|Withdrawal by Subject|16|||
105641185|NCT03150589|364349416|FG001|Overall Study|Withdrawal by Subject|9|||
105641186|NCT03150589|364349415|FG000|Overall Study|Adverse Event|7|||
105641187|NCT03150589|364349416|FG001|Overall Study|Adverse Event|6|||
105641188|NCT03150589|364349415|FG000|Overall Study|Protocol Violation|4|||
105641189|NCT03150589|364349416|FG001|Overall Study|Protocol Violation|3|||
105641190|NCT03150589|364349415|FG000|Overall Study|Lost to Follow-up|3|||
105641191|NCT03150589|364349416|FG001|Overall Study|Lost to Follow-up|3|||
105641192|NCT03150589|364349415|FG000|Overall Study|Death|2|||
105641193|NCT03150589|364349416|FG001|Overall Study|Death|3|||
105641194|NCT03150589|364349415|FG000|Overall Study|IP non-compliance and other reasons|12|||
105641195|NCT03150589|364349416|FG001|Overall Study|IP non-compliance and other reasons|3|||
105641196|NCT02399449|364349421|FG000|Overall Study|Withdrawal by Subject|3|||
105641197|NCT02399449|364349422|FG001|Overall Study|Withdrawal by Subject|9|||
105641198|NCT02399449|364349421|FG000|Overall Study|Physician Decision|0|||
105641199|NCT02399449|364349422|FG001|Overall Study|Physician Decision|1|||
105641200|NCT02159352|364349423|FG000|Overall Study|Adverse Event|3|||
105641201|NCT02159352|364349424|FG001|Overall Study|Adverse Event|1|||
105641202|NCT02159352|364349423|FG000|Overall Study|Withdrawal by Subject|0|||
105641203|NCT02159352|364349424|FG001|Overall Study|Withdrawal by Subject|1|||
105641204|NCT00529529|364349425|FG000|Overall Study|Adverse Event|12|||
105641205|NCT00529529|364349426|FG001|Overall Study|Adverse Event|17|||
105641206|NCT00529529|364349427|FG002|Overall Study|Adverse Event|8|||
105641207|NCT00529529|364349425|FG000|Overall Study|Subject withdrew consent|12|||
105641208|NCT00529529|364349426|FG001|Overall Study|Subject withdrew consent|9|||
105641209|NCT00529529|364349427|FG002|Overall Study|Subject withdrew consent|12|||
105641210|NCT00529529|364349425|FG000|Overall Study|Protocol deviation|8|||
105641211|NCT00529529|364349426|FG001|Overall Study|Protocol deviation|12|||
105641212|NCT00529529|364349427|FG002|Overall Study|Protocol deviation|5|||
105641213|NCT00529529|364349425|FG000|Overall Study|Lost to Follow-up|5|||
105641214|NCT00529529|364349426|FG001|Overall Study|Lost to Follow-up|3|||
105641215|NCT00529529|364349427|FG002|Overall Study|Lost to Follow-up|1|||
105641216|NCT00529529|364349425|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
105641217|NCT00529529|364349426|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105641218|NCT00529529|364349427|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
105641219|NCT00529529|364349425|FG000|Overall Study|Death|2|||
105641220|NCT00529529|364349426|FG001|Overall Study|Death|0|||
105641221|NCT00529529|364349427|FG002|Overall Study|Death|0|||
105641222|NCT00529529|364349425|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105641223|NCT00529529|364349426|FG001|Overall Study|Abnormal test procedure result(s)|0|||
105641224|NCT00529529|364349427|FG002|Overall Study|Abnormal test procedure result(s)|0|||
105641225|NCT00529529|364349425|FG000|Overall Study|Administrative problems|1|||
105641226|NCT00529529|364349426|FG001|Overall Study|Administrative problems|0|||
105641227|NCT00529529|364349427|FG002|Overall Study|Administrative problems|3|||
105641228|NCT00428714|364349429|FG000|Overall Study|Progressive Disease|28|||
105641229|NCT00428714|364349430|FG001|Overall Study|Progressive Disease|36|||
105641230|NCT00428714|364349429|FG000|Overall Study|Withdrawal by Subject|0|||
105641231|NCT00428714|364349430|FG001|Overall Study|Withdrawal by Subject|3|||
105641232|NCT00428714|364349429|FG000|Overall Study|Adverse Event|0|||
105641233|NCT00428714|364349430|FG001|Overall Study|Adverse Event|2|||
105641234|NCT00428714|364349429|FG000|Overall Study|Physician Decision|1|||
105641235|NCT00428714|364349430|FG001|Overall Study|Physician Decision|1|||
105641236|NCT00428714|364349429|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
105641237|NCT00428714|364349430|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
105641238|NCT00428714|364349429|FG000|Overall Study|Death due to other then PD|1|||
105641239|NCT00428714|364349430|FG001|Overall Study|Death due to other then PD|0|||
105641240|NCT03060525|364349431|FG000|Overall Study|moved out of state|1|||
105641241|NCT03060525|364349432|FG001|Overall Study|moved out of state|1|||
105641242|NCT03060525|364349433|FG002|Overall Study|moved out of state|1|||
105641243|NCT03060525|364349434|FG003|Overall Study|moved out of state|1|||
105641244|NCT03060525|364349431|FG000|Overall Study|unable to meet time commitment required of study|2|||
105641245|NCT03060525|364349432|FG001|Overall Study|unable to meet time commitment required of study|3|||
105641246|NCT03060525|364349433|FG002|Overall Study|unable to meet time commitment required of study|3|||
105641247|NCT03060525|364349434|FG003|Overall Study|unable to meet time commitment required of study|1|||
105641248|NCT03060525|364349431|FG000|Overall Study|no longer interested in doing intervention|0|||
105641249|NCT03060525|364349432|FG001|Overall Study|no longer interested in doing intervention|0|||
105641250|NCT03060525|364349433|FG002|Overall Study|no longer interested in doing intervention|0|||
105641251|NCT03060525|364349434|FG003|Overall Study|no longer interested in doing intervention|1|||
105641252|NCT02189759|364349448|FG000|Overall Study|Lost to Follow-up|0|||
105641253|NCT02189759|364349449|FG001|Overall Study|Lost to Follow-up|0|||
105641254|NCT02189759|364349450|FG002|Overall Study|Lost to Follow-up|2|||
105641255|NCT02189759|364349451|FG003|Overall Study|Lost to Follow-up|5|||
105641256|NCT01147471|364349452|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
105641257|NCT01147471|364349453|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
105641258|NCT01147471|364349452|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
105641259|NCT01147471|364349453|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
105641260|NCT01147471|364349452|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
105641261|NCT01147471|364349453|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
105641262|NCT01147471|364349452|FG000|3 Month Follow Up|Lost to Follow-up|1|||
105641263|NCT01147471|364349453|FG001|3 Month Follow Up|Lost to Follow-up|1|||
105641264|NCT01147471|364349452|FG000|3 Month Follow Up|Physician Decision|0|||
105641265|NCT01147471|364349453|FG001|3 Month Follow Up|Physician Decision|1|||
105641266|NCT01147471|364349452|FG000|6 Month Follow Up|Lost to Follow-up|4|||
105641267|NCT01147471|364349453|FG001|6 Month Follow Up|Lost to Follow-up|2|||
105641268|NCT01662505|364349458|FG000|Overall Study|Progressive disease|6|||
105641269|NCT01662505|364349459|FG001|Overall Study|Progressive disease|1|||
105641270|NCT01662505|364349460|FG002|Overall Study|Progressive disease|5|||
105641271|NCT01662505|364349458|FG000|Overall Study|Refused cont. medication|0|||
105641272|NCT01662505|364349459|FG001|Overall Study|Refused cont. medication|0|||
105641273|NCT01662505|364349460|FG002|Overall Study|Refused cont. medication|1|||
105641274|NCT01662505|364349458|FG000|Overall Study|Not specified above|1|||
105641275|NCT01662505|364349459|FG001|Overall Study|Not specified above|3|||
105641276|NCT01662505|364349460|FG002|Overall Study|Not specified above|2|||
105641277|NCT00731692|364351263|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
105641278|NCT00731692|364351264|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
105641279|NCT00731692|364351265|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
105641280|NCT00731692|364351263|FG000|Core Study (36 Months)|Physician Decision|1|||
105641281|NCT00731692|364351264|FG001|Core Study (36 Months)|Physician Decision|0|||
105641282|NCT00731692|364351265|FG002|Core Study (36 Months)|Physician Decision|2|||
105641283|NCT00731692|364351263|FG000|Core Study (36 Months)|Death|2|||
105641284|NCT00731692|364351264|FG001|Core Study (36 Months)|Death|1|||
105641285|NCT00731692|364351265|FG002|Core Study (36 Months)|Death|2|||
105641286|NCT00731692|364351263|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
105641287|NCT00731692|364351264|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
105641288|NCT00731692|364351265|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
105641289|NCT00731692|364351263|FG000|Core Study (36 Months)|Administrative|2|||
105641290|NCT00731692|364351264|FG001|Core Study (36 Months)|Administrative|2|||
105641291|NCT00731692|364351265|FG002|Core Study (36 Months)|Administrative|6|||
105641292|NCT00731692|364351263|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
105641293|NCT00731692|364351264|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
105641294|NCT00731692|364351265|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
105641295|NCT00731692|364351263|FG000|Core Study (36 Months)|Protocol Violation|4|||
105641296|NCT00731692|364351264|FG001|Core Study (36 Months)|Protocol Violation|5|||
105641297|NCT00731692|364351265|FG002|Core Study (36 Months)|Protocol Violation|8|||
105641298|NCT00731692|364351263|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
105641299|NCT00731692|364351264|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
105641300|NCT00731692|364351265|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
105641301|NCT00731692|364351263|FG000|Core Study (36 Months)|Adverse Event|25|||
105641302|NCT00731692|364351264|FG001|Core Study (36 Months)|Adverse Event|28|||
105641303|NCT00731692|364351265|FG002|Core Study (36 Months)|Adverse Event|29|||
105641304|NCT00731692|364351263|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
105641305|NCT00731692|364351264|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
105641306|NCT00731692|364351265|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
105641307|NCT00731692|364351263|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
105641308|NCT00731692|364351264|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
105641309|NCT00731692|364351265|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
105641310|NCT00731692|364351263|FG000|Extension Phase|Abnormal test procedure|0|||
105641311|NCT00731692|364351264|FG001|Extension Phase|Abnormal test procedure|0|||
105641312|NCT00731692|364351265|FG002|Extension Phase|Abnormal test procedure|1|||
105641313|NCT00731692|364351263|FG000|Extension Phase|Abnormal lab values|0|||
105641314|NCT00731692|364351264|FG001|Extension Phase|Abnormal lab values|0|||
105641315|NCT00731692|364351265|FG002|Extension Phase|Abnormal lab values|1|||
105641316|NCT00731692|364351263|FG000|Extension Phase|Lost to Follow-up|0|||
105641317|NCT00731692|364351264|FG001|Extension Phase|Lost to Follow-up|1|||
105641318|NCT00731692|364351265|FG002|Extension Phase|Lost to Follow-up|4|||
105641319|NCT00731692|364351263|FG000|Extension Phase|Withdrawal by Subject|4|||
105641320|NCT00731692|364351264|FG001|Extension Phase|Withdrawal by Subject|5|||
105641321|NCT00731692|364351265|FG002|Extension Phase|Withdrawal by Subject|3|||
105641322|NCT00731692|364351263|FG000|Extension Phase|Adverse Event|1|||
105641323|NCT00731692|364351264|FG001|Extension Phase|Adverse Event|1|||
105641324|NCT00731692|364351265|FG002|Extension Phase|Adverse Event|15|||
105641325|NCT03493282|364351267|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
105641326|NCT03493282|364351268|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
105641327|NCT03493282|364351269|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
105641328|NCT03493282|364351267|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
105641329|NCT03493282|364351268|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
105641330|NCT03493282|364351269|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
105641331|NCT00670449|364351270|FG000|Overall Study|Adverse Event|6|||
105641332|NCT00670449|364351271|FG001|Overall Study|Adverse Event|2|||
105641333|NCT00670449|364351272|FG002|Overall Study|Adverse Event|8|||
105641334|NCT00670449|364351273|FG003|Overall Study|Adverse Event|5|||
105641335|NCT00670449|364351270|FG000|Overall Study|Protocol Deviation|1|||
105641336|NCT00670449|364351271|FG001|Overall Study|Protocol Deviation|2|||
105641337|NCT00670449|364351272|FG002|Overall Study|Protocol Deviation|0|||
105641338|NCT00670449|364351273|FG003|Overall Study|Protocol Deviation|1|||
105641339|NCT00670449|364351270|FG000|Overall Study|Administrative Problems|0|||
105641340|NCT00670449|364351271|FG001|Overall Study|Administrative Problems|2|||
105641341|NCT00670449|364351272|FG002|Overall Study|Administrative Problems|0|||
105641342|NCT00670449|364351273|FG003|Overall Study|Administrative Problems|1|||
105641343|NCT00670449|364351270|FG000|Overall Study|Subject Withdrew Consent|0|||
105641344|NCT00670449|364351271|FG001|Overall Study|Subject Withdrew Consent|2|||
105641345|NCT00670449|364351272|FG002|Overall Study|Subject Withdrew Consent|0|||
105641346|NCT00670449|364351273|FG003|Overall Study|Subject Withdrew Consent|1|||
105641347|NCT00670449|364351270|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
105641348|NCT00670449|364351271|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105641349|NCT00670449|364351272|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
105641350|NCT00670449|364351273|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
105641351|NCT00670449|364351270|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
105641352|NCT00670449|364351271|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
105641353|NCT00670449|364351272|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
105641354|NCT00670449|364351273|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
105641355|NCT01128959|364351278|FG000|Lead in Period|Adverse Event|3|||
105641356|NCT01128959|364351278|FG000|Treatment Period|Adverse Event|3|||
105641357|NCT01128959|364351278|FG000|Treatment Period|Withdrawal by Subject|1|||
105641358|NCT02338999|364351279|FG000|First Intervention|Withdrawal by Subject|3|||
105641359|NCT02338999|364351280|FG001|First Intervention|Withdrawal by Subject|1|||
105641360|NCT02338999|364351279|FG000|Washout Period|Withdrawal by Subject|0|||
105641361|NCT02338999|364351280|FG001|Washout Period|Withdrawal by Subject|2|||
105641362|NCT02338999|364351279|FG000|Second Intervention|Withdrawal by Subject|0|||
105641363|NCT02338999|364351280|FG001|Second Intervention|Withdrawal by Subject|2|||
105641364|NCT02958553|364351283|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
105641365|NCT02958553|364351283|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
105641366|NCT03340961|364351284|FG000|Overall Study|Adverse Event|1|||
105641367|NCT03340961|364351285|FG001|Overall Study|Adverse Event|3|||
105641368|NCT03340961|364351286|FG002|Overall Study|Adverse Event|2|||
105641369|NCT03340961|364351287|FG003|Overall Study|Adverse Event|4|||
105641370|NCT03340961|364351284|FG000|Overall Study|Lost to Follow-up|0|||
105641371|NCT03340961|364351285|FG001|Overall Study|Lost to Follow-up|1|||
105641372|NCT03340961|364351286|FG002|Overall Study|Lost to Follow-up|0|||
105641373|NCT03340961|364351287|FG003|Overall Study|Lost to Follow-up|1|||
105641374|NCT03340961|364351284|FG000|Overall Study|Withdrawal by Subject|3|||
105641375|NCT03340961|364351285|FG001|Overall Study|Withdrawal by Subject|2|||
105641376|NCT03340961|364351286|FG002|Overall Study|Withdrawal by Subject|4|||
105641377|NCT03340961|364351287|FG003|Overall Study|Withdrawal by Subject|7|||
105641378|NCT03340961|364351284|FG000|Overall Study|Use of prohibited treatment|0|||
105641379|NCT03340961|364351285|FG001|Overall Study|Use of prohibited treatment|3|||
105641380|NCT03340961|364351286|FG002|Overall Study|Use of prohibited treatment|2|||
105641381|NCT03340961|364351287|FG003|Overall Study|Use of prohibited treatment|4|||
105641382|NCT03340961|364351284|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
105641383|NCT03340961|364351285|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
105641384|NCT03340961|364351286|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
105641385|NCT03340961|364351287|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
105641386|NCT03340961|364351284|FG000|Overall Study|Subject developed an exclusion criterion|0|||
105641387|NCT03340961|364351285|FG001|Overall Study|Subject developed an exclusion criterion|1|||
105641388|NCT03340961|364351286|FG002|Overall Study|Subject developed an exclusion criterion|0|||
105641389|NCT03340961|364351287|FG003|Overall Study|Subject developed an exclusion criterion|0|||
105641390|NCT03340961|364351284|FG000|Overall Study|Protocol Violation|1|||
105641391|NCT03340961|364351285|FG001|Overall Study|Protocol Violation|0|||
105641392|NCT03340961|364351286|FG002|Overall Study|Protocol Violation|1|||
105641393|NCT03340961|364351287|FG003|Overall Study|Protocol Violation|0|||
105641394|NCT03340961|364351284|FG000|Overall Study|Adverse Event|1|||
105641395|NCT03340961|364351285|FG001|Overall Study|Adverse Event|1|||
105641396|NCT03340961|364351286|FG002|Overall Study|Adverse Event|0|||
105641397|NCT03340961|364351287|FG003|Overall Study|Adverse Event|0|||
105641398|NCT03340961|364351284|FG000|Overall Study|Lack of Efficacy|0|||
105641399|NCT03340961|364351285|FG001|Overall Study|Lack of Efficacy|0|||
105641400|NCT03340961|364351286|FG002|Overall Study|Lack of Efficacy|0|||
105641401|NCT03340961|364351287|FG003|Overall Study|Lack of Efficacy|1|||
105641402|NCT01802333|364351288|FG000|Overall Study|Ineligible|2|||
105641403|NCT01802333|364351289|FG001|Overall Study|Ineligible|6|||
105641404|NCT01802333|364351290|FG002|Overall Study|Ineligible|8|||
105641405|NCT01802333|364351288|FG000|Overall Study|Adverse Event|1|||
105641406|NCT01802333|364351289|FG001|Overall Study|Adverse Event|8|||
105641407|NCT01802333|364351290|FG002|Overall Study|Adverse Event|8|||
105641408|NCT01802333|364351288|FG000|Overall Study|Withdrawal by Subject|6|||
105641409|NCT01802333|364351289|FG001|Overall Study|Withdrawal by Subject|6|||
105641410|NCT01802333|364351290|FG002|Overall Study|Withdrawal by Subject|5|||
105641411|NCT01802333|364351288|FG000|Overall Study|Progression/relapse|1|||
105641412|NCT01802333|364351289|FG001|Overall Study|Progression/relapse|3|||
105641413|NCT01802333|364351290|FG002|Overall Study|Progression/relapse|0|||
105641414|NCT01802333|364351288|FG000|Overall Study|Death|7|||
105641415|NCT01802333|364351289|FG001|Overall Study|Death|14|||
105641416|NCT01802333|364351290|FG002|Overall Study|Death|13|||
105641417|NCT01802333|364351288|FG000|Overall Study|Other - not protocol specified|32|||
105641418|NCT01802333|364351289|FG001|Overall Study|Other - not protocol specified|22|||
105641419|NCT01802333|364351290|FG002|Overall Study|Other - not protocol specified|24|||
105641420|NCT01802333|364351288|FG000|Overall Study|Did not start treatment|0|||
105641421|NCT01802333|364351289|FG001|Overall Study|Did not start treatment|2|||
105641422|NCT01802333|364351290|FG002|Overall Study|Did not start treatment|5|||
105641423|NCT02224755|364351292|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
105641424|NCT02224755|364351293|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
105641425|NCT02224755|364351292|FG000|Two Year Follow up Post-implant|Death|103|||
105641426|NCT02224755|364351293|FG001|Two Year Follow up Post-implant|Death|98|||
105641427|NCT02224755|364351292|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
105641428|NCT02224755|364351293|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
105641429|NCT02224755|364351292|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
105641430|NCT02224755|364351293|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
105641431|NCT02224755|364351292|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
105641432|NCT02224755|364351293|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
105641433|NCT02067663|364351294|FG000|Overall Study|Lost to Follow-up|13|||
105641434|NCT02067663|364351295|FG001|Overall Study|Lost to Follow-up|14|||
105641435|NCT01437540|364351297|FG000|Overall Study|Not listed below|7|||
105641436|NCT01437540|364351298|FG001|Overall Study|Not listed below|6|||
105641437|NCT01437540|364351297|FG000|Overall Study|COPD exacerbation|13|||
105641438|NCT01437540|364351298|FG001|Overall Study|COPD exacerbation|3|||
105641439|NCT01437540|364351297|FG000|Overall Study|Lost to Follow-up|3|||
105641440|NCT01437540|364351298|FG001|Overall Study|Lost to Follow-up|5|||
105641441|NCT01437540|364351297|FG000|Overall Study|Lack of Efficacy|23|||
105641442|NCT01437540|364351298|FG001|Overall Study|Lack of Efficacy|11|||
105641443|NCT01437540|364351297|FG000|Overall Study|Protocol Violation|24|||
105641444|NCT01437540|364351298|FG001|Overall Study|Protocol Violation|12|||
105641445|NCT01437540|364351297|FG000|Overall Study|Adverse Event|26|||
105641446|NCT01437540|364351298|FG001|Overall Study|Adverse Event|13|||
105641447|NCT01437540|364351297|FG000|Overall Study|Withdrawal by Subject|31|||
105641448|NCT01437540|364351298|FG001|Overall Study|Withdrawal by Subject|15|||
105641449|NCT00929526|364351301|FG000|Overall Study|Withdrawal by Subject|1|||
105641450|NCT00929526|364351302|FG001|Overall Study|Withdrawal by Subject|11|||
105641451|NCT00929526|364351301|FG000|Overall Study|Lost to Follow-up|8|||
105641452|NCT00929526|364351302|FG001|Overall Study|Lost to Follow-up|12|||
105641453|NCT00929526|364351301|FG000|Overall Study|Other|8|||
105641454|NCT00929526|364351302|FG001|Overall Study|Other|6|||
105641455|NCT02547974|364351303|FG000|Overall Study|Withdrawal by Subject|1|||
105641456|NCT02547974|364351304|FG001|Overall Study|Withdrawal by Subject|0|||
105641457|NCT02547974|364351305|FG002|Overall Study|Withdrawal by Subject|0|||
105641458|NCT02547974|364351306|FG003|Overall Study|Withdrawal by Subject|0|||
105641459|NCT00624377|364351307|FG000|Overall Study|Lost to Follow-up|355|||
105641460|NCT00624377|364351307|FG000|Overall Study|Withdrawal by Subject|100|||
105641461|NCT00624377|364351307|FG000|Overall Study|Adverse Event|14|||
105641462|NCT00624377|364351307|FG000|Overall Study|Other|91|||
105641463|NCT00624377|364351307|FG000|Overall Study|Non-evaluable population|84|||
105641464|NCT00603798|364351308|FG000|Overall Study|Adverse Event|4|||
105641465|NCT00603798|364351309|FG001|Overall Study|Adverse Event|2|||
105641466|NCT00603798|364351310|FG002|Overall Study|Adverse Event|1|||
105641467|NCT00603798|364351308|FG000|Overall Study|Withdrawal by Subject|4|||
105641468|NCT00603798|364351309|FG001|Overall Study|Withdrawal by Subject|3|||
105641469|NCT00603798|364351310|FG002|Overall Study|Withdrawal by Subject|4|||
105641470|NCT00603798|364351308|FG000|Overall Study|Lost to Follow-up|1|||
105641471|NCT00603798|364351309|FG001|Overall Study|Lost to Follow-up|0|||
105641472|NCT00603798|364351310|FG002|Overall Study|Lost to Follow-up|1|||
105641473|NCT00603798|364351308|FG000|Overall Study|Non-compliance with study procedures|0|||
105641474|NCT00603798|364351309|FG001|Overall Study|Non-compliance with study procedures|1|||
105641475|NCT00603798|364351310|FG002|Overall Study|Non-compliance with study procedures|0|||
105641476|NCT00603798|364351308|FG000|Overall Study|Not due to AE|1|||
105641477|NCT00603798|364351309|FG001|Overall Study|Not due to AE|1|||
105641478|NCT00603798|364351310|FG002|Overall Study|Not due to AE|4|||
105641479|NCT00889863|364351318|FG000|Part I: Open Label|Death|1|||
105641480|NCT00889863|364351319|FG001|Part I: Open Label|Death|0|||
105641481|NCT00889863|364351318|FG000|Part I: Open Label|Adverse Event|4|||
105641482|NCT00889863|364351319|FG001|Part I: Open Label|Adverse Event|0|||
105641483|NCT00889863|364351318|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
105641484|NCT00889863|364351319|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
105641485|NCT00889863|364351318|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
105641486|NCT00889863|364351319|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
105641487|NCT00889863|364351318|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
105641488|NCT00889863|364351319|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
105641489|NCT00889863|364351318|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
105641490|NCT00889863|364351319|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
105641491|NCT00889863|364351318|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
105641492|NCT00889863|364351319|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
105641493|NCT00441168|364351320|FG000|Treatment Period|Death|3|||
105641494|NCT00441168|364351321|FG001|Treatment Period|Death|0|||
105641495|NCT00441168|364351320|FG000|Treatment Period|Adverse Event|1|||
105641496|NCT00441168|364351321|FG001|Treatment Period|Adverse Event|2|||
105641497|NCT00441168|364351320|FG000|Treatment Period|Progressive Disease|0|||
105641498|NCT00441168|364351321|FG001|Treatment Period|Progressive Disease|2|||
105641499|NCT00441168|364351320|FG000|Treatment Period|Protocol Violation|0|||
105641500|NCT00441168|364351321|FG001|Treatment Period|Protocol Violation|1|||
105641501|NCT00441168|364351320|FG000|Treatment Period|Lost to Follow-up|0|||
105641502|NCT00441168|364351321|FG001|Treatment Period|Lost to Follow-up|1|||
105641503|NCT00441168|364351320|FG000|Treatment Period|Withdrawal by Subject|3|||
105641504|NCT00441168|364351321|FG001|Treatment Period|Withdrawal by Subject|0|||
105641505|NCT00441168|364351320|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
105641506|NCT00441168|364351321|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
105641507|NCT00441168|364351320|FG000|Treatment Period|refractory disease|1|||
105641508|NCT00441168|364351321|FG001|Treatment Period|refractory disease|0|||
105641509|NCT00441168|364351320|FG000|Follow-up Period|Death|3|||
105641510|NCT00441168|364351321|FG001|Follow-up Period|Death|0|||
105641511|NCT00441168|364351320|FG000|Follow-up Period|Lost to Follow-up|5|||
105641512|NCT00441168|364351321|FG001|Follow-up Period|Lost to Follow-up|6|||
105641513|NCT00441168|364351320|FG000|Follow-up Period|Withdrawal by Subject|3|||
105641514|NCT00441168|364351321|FG001|Follow-up Period|Withdrawal by Subject|0|||
105641515|NCT00441168|364351320|FG000|Follow-up Period|Other|1|||
105641516|NCT00441168|364351321|FG001|Follow-up Period|Other|3|||
105641517|NCT01228734|364351330|FG000|Overall Study|Randomized, but not treated|0|||
105641518|NCT01228734|364351331|FG001|Overall Study|Randomized, but not treated|4|||
105641519|NCT00807599|364351334|FG000|Overall Study|Not treated on protocol study|0|||
105641520|NCT00807599|364351335|FG001|Overall Study|Not treated on protocol study|0|||
105641521|NCT00807599|364351336|FG002|Overall Study|Not treated on protocol study|2|||
105641522|NCT00807599|364351334|FG000|Overall Study|Adverse Event|0|||
105641523|NCT00807599|364351335|FG001|Overall Study|Adverse Event|0|||
105641524|NCT00807599|364351336|FG002|Overall Study|Adverse Event|5|||
105641525|NCT00807599|364351334|FG000|Overall Study|Inadequate response to induction|0|||
105641526|NCT00807599|364351335|FG001|Overall Study|Inadequate response to induction|0|||
105641527|NCT00807599|364351336|FG002|Overall Study|Inadequate response to induction|9|||
105641528|NCT00807599|364351334|FG000|Overall Study|Withdrawal by Subject|0|||
105641529|NCT00807599|364351335|FG001|Overall Study|Withdrawal by Subject|0|||
105641530|NCT00807599|364351336|FG002|Overall Study|Withdrawal by Subject|1|||
105641531|NCT01757288|364351341|FG000|Overall Study|Consent withdrawal|0|||
105641532|NCT01757288|364351342|FG001|Overall Study|Consent withdrawal|4|||
105641533|NCT01757288|364351343|FG002|Overall Study|Consent withdrawal|4|||
105641534|NCT01757288|364351341|FG000|Overall Study|Patient off study, IRB hold.|0|||
105641535|NCT01757288|364351342|FG001|Overall Study|Patient off study, IRB hold.|0|||
105641536|NCT01757288|364351343|FG002|Overall Study|Patient off study, IRB hold.|1|||
105641537|NCT01757288|364351341|FG000|Overall Study|Patient death prior to starting treatment|0|||
105641538|NCT01757288|364351342|FG001|Overall Study|Patient death prior to starting treatment|0|||
105641539|NCT01757288|364351343|FG002|Overall Study|Patient death prior to starting treatment|1|||
105641540|NCT01757288|364351341|FG000|Overall Study|Wrong medication administered|0|||
105641541|NCT01757288|364351342|FG001|Overall Study|Wrong medication administered|1|||
105641542|NCT01757288|364351343|FG002|Overall Study|Wrong medication administered|0|||
105641543|NCT01757288|364351341|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
105641544|NCT01757288|364351342|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
105641545|NCT01757288|364351343|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
105641546|NCT01757288|364351341|FG000|Overall Study|Not meeting protocol constraints|0|||
105641547|NCT01757288|364351342|FG001|Overall Study|Not meeting protocol constraints|1|||
105641548|NCT01757288|364351343|FG002|Overall Study|Not meeting protocol constraints|1|||
105641549|NCT01757288|364351341|FG000|Overall Study|Multiple missed appointments|0|||
105641550|NCT01757288|364351342|FG001|Overall Study|Multiple missed appointments|1|||
105641551|NCT01757288|364351343|FG002|Overall Study|Multiple missed appointments|0|||
105641552|NCT01757288|364351341|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
105641553|NCT01757288|364351342|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
105641554|NCT01757288|364351343|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
105641555|NCT01757288|364351341|FG000|Overall Study|>2 weeks treatment break|0|||
105641556|NCT01757288|364351342|FG001|Overall Study|>2 weeks treatment break|0|||
105641557|NCT01757288|364351343|FG002|Overall Study|>2 weeks treatment break|1|||
105641558|NCT02825550|364351344|FG000|Overall Study|Physician Decision|1|||
105641559|NCT01365546|364351345|FG000|Overall Study|Withdrawal by Subject|1|||
105641560|NCT01365546|364351345|FG000|Overall Study|Screen failure|9|||
105641561|NCT01365546|364351345|FG000|Overall Study|Study termination|1|||
105641562|NCT00761267|364351351|FG000|Overall Study|Death|1|||
105641563|NCT00761267|364351352|FG001|Overall Study|Death|2|||
105641564|NCT00761267|364351353|FG002|Overall Study|Death|5|||
105641565|NCT00761267|364351351|FG000|Overall Study|Lost to Follow-up|0|||
105641566|NCT00761267|364351352|FG001|Overall Study|Lost to Follow-up|0|||
105641567|NCT00761267|364351353|FG002|Overall Study|Lost to Follow-up|1|||
105641568|NCT00761267|364351351|FG000|Overall Study|Randomized but not treated|1|||
105641569|NCT00761267|364351352|FG001|Overall Study|Randomized but not treated|1|||
105641570|NCT00761267|364351353|FG002|Overall Study|Randomized but not treated|0|||
105641571|NCT00761267|364351351|FG000|Overall Study|Withdrawal by Subject|0|||
105641572|NCT00761267|364351352|FG001|Overall Study|Withdrawal by Subject|1|||
105641573|NCT00761267|364351353|FG002|Overall Study|Withdrawal by Subject|0|||
105641574|NCT04492475|364351354|FG000|Overall Study|Enrolled but not treated|8|||
105641575|NCT04492475|364351355|FG001|Overall Study|Enrolled but not treated|8|||
105641576|NCT04492475|364351354|FG000|Overall Study|Withdrawal by Subject|4|||
105641577|NCT04492475|364351355|FG001|Overall Study|Withdrawal by Subject|0|||
105641578|NCT04492475|364351354|FG000|Overall Study|Became ineligible after enrollment|2|||
105641579|NCT04492475|364351355|FG001|Overall Study|Became ineligible after enrollment|0|||
105641580|NCT02538094|364351358|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
105641581|NCT02538094|364351359|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
105641582|NCT02538094|364351358|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
105641583|NCT02538094|364351359|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
105641584|NCT03989232|364351360|FG000|Overall Study|Lost to Follow-up|3|||
105641585|NCT03989232|364351361|FG001|Overall Study|Lost to Follow-up|10|||
105641586|NCT03989232|364351360|FG000|Overall Study|Withdrawal by Subject|6|||
105641587|NCT03989232|364351361|FG001|Overall Study|Withdrawal by Subject|6|||
105641588|NCT03989232|364351360|FG000|Overall Study|Death|1|||
105641589|NCT03989232|364351361|FG001|Overall Study|Death|2|||
105641590|NCT02170207|364351366|FG000|Overall Study|Case report forms unavailable|5|||
105641591|NCT03122860|364351367|FG000|Overall Study|Discontinued Before Treatment|1|||
105641592|NCT03122860|364351368|FG001|Overall Study|Discontinued Before Treatment|1|||
105641593|NCT03122860|364351369|FG002|Overall Study|Discontinued Before Treatment|2|||
105641594|NCT03122860|364351370|FG003|Overall Study|Discontinued Before Treatment|0|||
105641595|NCT03122860|364351371|FG004|Overall Study|Discontinued Before Treatment|1|||
105641596|NCT03122860|364351372|FG005|Overall Study|Discontinued Before Treatment|0|||
105641597|NCT03122860|364351367|FG000|Overall Study|Adverse Event|1|||
105641598|NCT03122860|364351368|FG001|Overall Study|Adverse Event|0|||
105641599|NCT03122860|364351369|FG002|Overall Study|Adverse Event|1|||
105641600|NCT03122860|364351370|FG003|Overall Study|Adverse Event|1|||
105641601|NCT03122860|364351371|FG004|Overall Study|Adverse Event|0|||
105641602|NCT03122860|364351372|FG005|Overall Study|Adverse Event|0|||
105641603|NCT03122860|364351367|FG000|Overall Study|Lost to Follow-up|5|||
105641604|NCT03122860|364351368|FG001|Overall Study|Lost to Follow-up|2|||
105641605|NCT03122860|364351369|FG002|Overall Study|Lost to Follow-up|3|||
105641606|NCT03122860|364351370|FG003|Overall Study|Lost to Follow-up|3|||
105641607|NCT03122860|364351371|FG004|Overall Study|Lost to Follow-up|5|||
105641608|NCT03122860|364351372|FG005|Overall Study|Lost to Follow-up|4|||
105641609|NCT03122860|364351367|FG000|Overall Study|Subject Non-Compliance|0|||
105641610|NCT03122860|364351368|FG001|Overall Study|Subject Non-Compliance|0|||
105641611|NCT03122860|364351369|FG002|Overall Study|Subject Non-Compliance|1|||
105641612|NCT03122860|364351370|FG003|Overall Study|Subject Non-Compliance|0|||
105641613|NCT03122860|364351371|FG004|Overall Study|Subject Non-Compliance|0|||
105641614|NCT03122860|364351372|FG005|Overall Study|Subject Non-Compliance|0|||
105641615|NCT03122860|364351367|FG000|Overall Study|Withdrawal by Subject|3|||
105641616|NCT03122860|364351368|FG001|Overall Study|Withdrawal by Subject|2|||
105641617|NCT03122860|364351369|FG002|Overall Study|Withdrawal by Subject|5|||
105641618|NCT03122860|364351370|FG003|Overall Study|Withdrawal by Subject|7|||
105641619|NCT03122860|364351371|FG004|Overall Study|Withdrawal by Subject|9|||
105641620|NCT03122860|364351372|FG005|Overall Study|Withdrawal by Subject|8|||
105641621|NCT03875729|364351373|FG000|Overall Study|Adverse Event|0|||
105641622|NCT03875729|364351374|FG001|Overall Study|Adverse Event|5|||
105641623|NCT03875729|364351373|FG000|Overall Study|Withdrawal by Subject|8|||
105641624|NCT03875729|364351374|FG001|Overall Study|Withdrawal by Subject|11|||
105641625|NCT03875729|364351373|FG000|Overall Study|Pregnancy|0|||
105641626|NCT03875729|364351374|FG001|Overall Study|Pregnancy|1|||
105641627|NCT03875729|364351373|FG000|Overall Study|Lost to Follow-up|0|||
105641628|NCT03875729|364351374|FG001|Overall Study|Lost to Follow-up|5|||
105641629|NCT03875729|364351373|FG000|Overall Study|Personal reasons|2|||
105641630|NCT03875729|364351374|FG001|Overall Study|Personal reasons|0|||
105641631|NCT00337610|364351377|FG000|Overall Study|Adverse Event|2|||
105641632|NCT00337610|364351378|FG001|Overall Study|Adverse Event|2|||
105641633|NCT00337610|364351377|FG000|Overall Study|Death|0|||
105641634|NCT00337610|364351378|FG001|Overall Study|Death|1|||
105641635|NCT00337610|364351377|FG000|Overall Study|Lack of Efficacy|6|||
105641636|NCT00337610|364351378|FG001|Overall Study|Lack of Efficacy|3|||
105641637|NCT00337610|364351377|FG000|Overall Study|Lost to Follow-up|3|||
105641638|NCT00337610|364351378|FG001|Overall Study|Lost to Follow-up|3|||
105641639|NCT00337610|364351377|FG000|Overall Study|Withdrawal by Subject|6|||
105641640|NCT00337610|364351378|FG001|Overall Study|Withdrawal by Subject|5|||
105641641|NCT03205488|364351379|FG000|Overall Study|Adverse Event|1|||
105641642|NCT03205488|364351380|FG001|Overall Study|Adverse Event|2|||
105641643|NCT03205488|364351381|FG002|Overall Study|Adverse Event|4|||
105641644|NCT03205488|364351379|FG000|Overall Study|Protocol Violation|0|||
105641645|NCT03205488|364351380|FG001|Overall Study|Protocol Violation|0|||
105641646|NCT03205488|364351381|FG002|Overall Study|Protocol Violation|1|||
105641647|NCT01005914|364351384|FG000|Overall Study|Adverse Event|4|||
105641648|NCT01005914|364351384|FG000|Overall Study|Death|4|||
105641649|NCT01005914|364351384|FG000|Overall Study|Lack of Efficacy|1|||
105641650|NCT01005914|364351384|FG000|Overall Study|Withdrawal by Subject|1|||
105641651|NCT00632736|364351386|FG000|Overall Study|Adverse Event|104|||
105641652|NCT00632736|364351386|FG000|Overall Study|Lost to Follow-up|15|||
105641653|NCT00632736|364351386|FG000|Overall Study|Protocol Violation|14|||
105641654|NCT00632736|364351386|FG000|Overall Study|Withdrawal by Subject|99|||
105641655|NCT00632736|364351386|FG000|Overall Study|Lack of Efficacy|5|||
105641656|NCT00632736|364351386|FG000|Overall Study|Sponsor terminated study|5|||
105641657|NCT00632736|364351386|FG000|Overall Study|Non-compliance|10|||
105641658|NCT00632736|364351386|FG000|Overall Study|Other|16|||
105659336|NCT00551135|364417283|FG003|Overall Study|Lost to Follow-up|1|||
105641659|NCT02513667|364351387|FG000|Overall Study|Withdrawal by Subject|0|||
105641660|NCT02513667|364351388|FG001|Overall Study|Withdrawal by Subject|1|||
105641661|NCT01323790|364351389|FG000|Overall Study|Other|3|||
105641662|NCT01323790|364351390|FG001|Overall Study|Other|2|||
105641663|NCT01323790|364351391|FG002|Overall Study|Other|1|||
105641664|NCT01323790|364351389|FG000|Overall Study|Lost to Follow-up|11|||
105641665|NCT01323790|364351390|FG001|Overall Study|Lost to Follow-up|9|||
105641666|NCT01323790|364351391|FG002|Overall Study|Lost to Follow-up|9|||
105641667|NCT01323790|364351389|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
105641668|NCT01323790|364351390|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
105641669|NCT01323790|364351391|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
105641670|NCT01323790|364351389|FG000|Overall Study|Lack of Efficacy|3|||
105641671|NCT01323790|364351390|FG001|Overall Study|Lack of Efficacy|0|||
105641672|NCT01323790|364351391|FG002|Overall Study|Lack of Efficacy|3|||
105641673|NCT01323790|364351389|FG000|Overall Study|Adverse Event|11|||
105641674|NCT01323790|364351390|FG001|Overall Study|Adverse Event|24|||
105641675|NCT01323790|364351391|FG002|Overall Study|Adverse Event|12|||
105641676|NCT01323790|364351389|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105641677|NCT01323790|364351390|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
105641678|NCT01323790|364351391|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
105641679|NCT01323790|364351389|FG000|Overall Study|Withdrawal by Subject|23|||
105641680|NCT01323790|364351390|FG001|Overall Study|Withdrawal by Subject|20|||
105641681|NCT01323790|364351391|FG002|Overall Study|Withdrawal by Subject|13|||
105641682|NCT01323790|364351389|FG000|Overall Study|Did Not Receive Treatment|2|||
105641683|NCT01323790|364351390|FG001|Overall Study|Did Not Receive Treatment|0|||
105641684|NCT01323790|364351391|FG002|Overall Study|Did Not Receive Treatment|1|||
105641685|NCT01323790|364351389|FG000|Overall Study|Severe non-compliance with protocol|2|||
105641686|NCT01323790|364351390|FG001|Overall Study|Severe non-compliance with protocol|2|||
105641687|NCT01323790|364351391|FG002|Overall Study|Severe non-compliance with protocol|2|||
105641688|NCT00655824|364351393|FG000|Overall Study|Adverse Event|3|||
105641689|NCT00655824|364351393|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
105641690|NCT00655824|364351393|FG000|Overall Study|Protocol Violation|1|||
105641691|NCT00655824|364351393|FG000|Overall Study|Withdrawal by Subject|4|||
105641692|NCT00655824|364351393|FG000|Overall Study|Deterioration of Trial Disease|2|||
105641693|NCT02978716|364351394|FG000|Overall Study|Death|25|||
105641694|NCT02978716|364351395|FG001|Overall Study|Death|13|||
105641695|NCT02978716|364351396|FG002|Overall Study|Death|20|||
105641696|NCT02978716|364351394|FG000|Overall Study|Lost to Follow-up|0|||
105641697|NCT02978716|364351395|FG001|Overall Study|Lost to Follow-up|0|||
105641698|NCT02978716|364351396|FG002|Overall Study|Lost to Follow-up|1|||
105641699|NCT02978716|364351394|FG000|Overall Study|Withdrawal by Subject|6|||
105641700|NCT02978716|364351395|FG001|Overall Study|Withdrawal by Subject|4|||
105641701|NCT02978716|364351396|FG002|Overall Study|Withdrawal by Subject|5|||
105641702|NCT02978716|364351394|FG000|Overall Study|Sponsor terminated|2|||
105641703|NCT02978716|364351395|FG001|Overall Study|Sponsor terminated|13|||
105641704|NCT02978716|364351396|FG002|Overall Study|Sponsor terminated|9|||
105641705|NCT02978716|364351394|FG000|Overall Study|Other|1|||
105641706|NCT02978716|364351395|FG001|Overall Study|Other|3|||
105641707|NCT02978716|364351396|FG002|Overall Study|Other|0|||
105641708|NCT01766206|364351401|FG000|Overall Study|Withdrawal by Subject|22|||
105641709|NCT01766206|364351401|FG000|Overall Study|Lost to Follow-up|10|||
105641710|NCT01766206|364351401|FG000|Overall Study|Inappropriate enrollment|18|||
105641711|NCT01766206|364351401|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
105641712|NCT02993926|364351402|FG000|Enantone Treatment Phase|Adverse Event|1|||
105641713|NCT02993926|364351403|FG001|Enantone Treatment Phase|Adverse Event|0|||
105641714|NCT02993926|364351404|FG002|Enantone Treatment Phase|Adverse Event|0|||
105641715|NCT02993926|364351402|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
105641716|NCT02993926|364351403|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
105641717|NCT02993926|364351404|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
105641718|NCT02993926|364351402|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
105641719|NCT02993926|364351403|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
105641720|NCT02993926|364351404|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
105641721|NCT02993926|364351402|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
105641722|NCT02993926|364351403|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
105641723|NCT02993926|364351404|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
105641724|NCT01084772|364351405|FG000|Baseline|Withdrawal by Subject|7|||
105641725|NCT01084772|364351406|FG001|Baseline|Withdrawal by Subject|6|||
105641726|NCT01084772|364351405|FG000|3 Months|Death|1|||
105641727|NCT01084772|364351406|FG001|3 Months|Death|0|||
105641728|NCT01084772|364351405|FG000|3 Months|Study Termination|2|||
105641729|NCT01084772|364351406|FG001|3 Months|Study Termination|2|||
105641730|NCT01084772|364351405|FG000|1 Year|Withdrawal by Subject|0|||
105641731|NCT01084772|364351406|FG001|1 Year|Withdrawal by Subject|1|||
105641732|NCT01084772|364351405|FG000|1 Year|Lost to Follow-up|3|||
105641733|NCT01084772|364351406|FG001|1 Year|Lost to Follow-up|0|||
105641734|NCT01084772|364351405|FG000|1 Year|Study Termination|0|||
105641735|NCT01084772|364351406|FG001|1 Year|Study Termination|7|||
105641736|NCT01084772|364351405|FG000|2 Years|Withdrawal by Subject|1|||
105641737|NCT01084772|364351406|FG001|2 Years|Withdrawal by Subject|0|||
105641738|NCT01084772|364351405|FG000|2 Years|Lost to Follow-up|5|||
105641739|NCT01084772|364351406|FG001|2 Years|Lost to Follow-up|2|||
105641740|NCT01084772|364351405|FG000|2 Years|Study Termination|3|||
105641741|NCT01084772|364351406|FG001|2 Years|Study Termination|2|||
105641742|NCT00518206|364351408|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
105641743|NCT00518206|364351409|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
105641744|NCT00518206|364351408|FG000|Overall Study|Withdrawal by Subject|2|||
105641745|NCT00518206|364351409|FG001|Overall Study|Withdrawal by Subject|0|||
105641746|NCT00518206|364351408|FG000|Overall Study|Drug Supply Issue|1|||
105641747|NCT00518206|364351409|FG001|Overall Study|Drug Supply Issue|0|||
105641748|NCT00518206|364351408|FG000|Overall Study|Reason Unknown|1|||
105641749|NCT00518206|364351409|FG001|Overall Study|Reason Unknown|0|||
105641750|NCT00518206|364351408|FG000|Overall Study|Completion Status Unknown|1|||
105641751|NCT00518206|364351409|FG001|Overall Study|Completion Status Unknown|0|||
105641752|NCT01294644|364351410|FG000|Overall Study|Adverse Event|2|||
105641753|NCT01294644|364351411|FG001|Overall Study|Adverse Event|0|||
105641754|NCT01294644|364351412|FG002|Overall Study|Adverse Event|1|||
105641755|NCT01294644|364351410|FG000|Overall Study|Withdrawal by Subject|3|||
105641756|NCT01294644|364351411|FG001|Overall Study|Withdrawal by Subject|7|||
105641757|NCT01294644|364351412|FG002|Overall Study|Withdrawal by Subject|4|||
105641758|NCT01294644|364351410|FG000|Overall Study|Lost to Follow-up|3|||
105641759|NCT01294644|364351411|FG001|Overall Study|Lost to Follow-up|2|||
105641760|NCT01294644|364351412|FG002|Overall Study|Lost to Follow-up|5|||
105641761|NCT01294644|364351410|FG000|Overall Study|Miscellaneous Reason|2|||
105641762|NCT01294644|364351411|FG001|Overall Study|Miscellaneous Reason|1|||
105641763|NCT01294644|364351412|FG002|Overall Study|Miscellaneous Reason|4|||
105641764|NCT00413283|364352880|FG000|Overall Study|Withdrawal by Subject|1|||
105641765|NCT00413283|364352881|FG001|Overall Study|Withdrawal by Subject|0|||
105641766|NCT00413283|364352882|FG002|Overall Study|Withdrawal by Subject|0|||
105641767|NCT00413283|364352883|FG003|Overall Study|Withdrawal by Subject|1|||
105641768|NCT00413283|364352880|FG000|Overall Study|Death|0|||
105641769|NCT00413283|364352881|FG001|Overall Study|Death|0|||
105641770|NCT00413283|364352882|FG002|Overall Study|Death|1|||
105641771|NCT00413283|364352883|FG003|Overall Study|Death|1|||
105641772|NCT00413283|364352880|FG000|Overall Study|Adverse Event|0|||
105641773|NCT00413283|364352881|FG001|Overall Study|Adverse Event|0|||
105641774|NCT00413283|364352882|FG002|Overall Study|Adverse Event|0|||
105641775|NCT00413283|364352883|FG003|Overall Study|Adverse Event|1|||
105641776|NCT00413283|364352880|FG000|Overall Study|Ineligibility determined|0|||
105641777|NCT00413283|364352881|FG001|Overall Study|Ineligibility determined|0|||
105641778|NCT00413283|364352882|FG002|Overall Study|Ineligibility determined|0|||
105641779|NCT00413283|364352883|FG003|Overall Study|Ineligibility determined|1|||
105641780|NCT00413283|364352880|FG000|Overall Study|Protocol deviation|0|||
105641781|NCT00413283|364352881|FG001|Overall Study|Protocol deviation|1|||
105641782|NCT00413283|364352882|FG002|Overall Study|Protocol deviation|0|||
105641783|NCT00413283|364352883|FG003|Overall Study|Protocol deviation|0|||
105641784|NCT00413283|364352880|FG000|Overall Study|Requirement for alternative therapy|0|||
105641785|NCT00413283|364352881|FG001|Overall Study|Requirement for alternative therapy|2|||
105641786|NCT00413283|364352882|FG002|Overall Study|Requirement for alternative therapy|0|||
105641787|NCT00413283|364352883|FG003|Overall Study|Requirement for alternative therapy|0|||
105641788|NCT00413283|364352880|FG000|Overall Study|Other|0|||
105641789|NCT00413283|364352881|FG001|Overall Study|Other|0|||
105641790|NCT00413283|364352882|FG002|Overall Study|Other|1|||
105641791|NCT00413283|364352883|FG003|Overall Study|Other|0|||
105641792|NCT02002689|364352888|FG000|Overall Study|Disease Progression|7|||
105641793|NCT02002689|364352888|FG000|Overall Study|Adverse Event|3|||
105641794|NCT01377844|364352889|FG000|Overall Study|Withdrawal by Subject|25|||
105641795|NCT01377844|364352890|FG001|Overall Study|Withdrawal by Subject|28|||
105641796|NCT01377844|364352889|FG000|Overall Study|Protocol Violation|2|||
105641797|NCT01377844|364352890|FG001|Overall Study|Protocol Violation|3|||
105641798|NCT01377844|364352889|FG000|Overall Study|Adverse Event|3|||
105641799|NCT01377844|364352890|FG001|Overall Study|Adverse Event|0|||
105641800|NCT01377844|364352889|FG000|Overall Study|Physician Decision|6|||
105641801|NCT01377844|364352890|FG001|Overall Study|Physician Decision|3|||
105641802|NCT01377844|364352889|FG000|Overall Study|Study terminated by Sponsor|0|||
105641803|NCT01377844|364352890|FG001|Overall Study|Study terminated by Sponsor|1|||
105641804|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
105641805|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105641806|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105641807|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105641808|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
105641809|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105641810|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105641811|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105641812|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
105641813|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105641814|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105641815|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105641816|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
105641817|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105641818|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105641819|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105641820|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
105641821|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105641822|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105641823|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105641824|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
105641825|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105641826|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105641827|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105641828|NCT01185340|364352892|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
105641829|NCT01185340|364352893|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105641830|NCT01185340|364352894|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105641831|NCT01185340|364352895|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105641832|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
105641833|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
105641834|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
105641835|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
105641836|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
105641837|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
105641838|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
105641839|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
105641840|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
105641841|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
105641842|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
105641843|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
105641844|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105641845|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
105641846|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105641847|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
105641848|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
105641849|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105641850|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
105641851|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105641852|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
105641853|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
105641854|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
105641855|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
105641856|NCT01185340|364352892|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105641857|NCT01185340|364352893|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105641858|NCT01185340|364352894|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
105641859|NCT01185340|364352895|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
105641860|NCT00087516|364352896|FG000|Overall Study|Adverse Event|10|||
105641861|NCT00087516|364352897|FG001|Overall Study|Adverse Event|10|||
105641862|NCT00087516|364352898|FG002|Overall Study|Adverse Event|3|||
105641863|NCT00087516|364352899|FG003|Overall Study|Adverse Event|6|||
105641864|NCT00087516|364352896|FG000|Overall Study|Lack of Efficacy|82|||
105641865|NCT00087516|364352897|FG001|Overall Study|Lack of Efficacy|80|||
105641866|NCT00087516|364352898|FG002|Overall Study|Lack of Efficacy|39|||
105641867|NCT00087516|364352899|FG003|Overall Study|Lack of Efficacy|29|||
105641868|NCT00087516|364352896|FG000|Overall Study|Lost to Follow-up|8|||
105641869|NCT00087516|364352897|FG001|Overall Study|Lost to Follow-up|6|||
105641870|NCT00087516|364352898|FG002|Overall Study|Lost to Follow-up|5|||
105641871|NCT00087516|364352899|FG003|Overall Study|Lost to Follow-up|5|||
105641872|NCT00087516|364352896|FG000|Overall Study|Protocol Violation|4|||
105641873|NCT00087516|364352897|FG001|Overall Study|Protocol Violation|8|||
105641874|NCT00087516|364352898|FG002|Overall Study|Protocol Violation|3|||
105641875|NCT00087516|364352899|FG003|Overall Study|Protocol Violation|6|||
105641876|NCT00087516|364352896|FG000|Overall Study|Withdrawal by Subject|16|||
105641877|NCT00087516|364352897|FG001|Overall Study|Withdrawal by Subject|27|||
105641878|NCT00087516|364352898|FG002|Overall Study|Withdrawal by Subject|11|||
105641879|NCT00087516|364352899|FG003|Overall Study|Withdrawal by Subject|12|||
105641880|NCT00087516|364352896|FG000|Overall Study|Site terminated|0|||
105641881|NCT00087516|364352897|FG001|Overall Study|Site terminated|2|||
105641882|NCT00087516|364352898|FG002|Overall Study|Site terminated|1|||
105641883|NCT00087516|364352899|FG003|Overall Study|Site terminated|0|||
105641884|NCT00087516|364352896|FG000|Overall Study|Protocol specified discontinuation|35|||
105641885|NCT00087516|364352897|FG001|Overall Study|Protocol specified discontinuation|33|||
105641886|NCT00087516|364352898|FG002|Overall Study|Protocol specified discontinuation|33|||
105641887|NCT00087516|364352899|FG003|Overall Study|Protocol specified discontinuation|26|||
105641888|NCT00087516|364352896|FG000|Overall Study|Patient moved|3|||
105641889|NCT00087516|364352897|FG001|Overall Study|Patient moved|2|||
105641890|NCT00087516|364352898|FG002|Overall Study|Patient moved|1|||
105641891|NCT00087516|364352899|FG003|Overall Study|Patient moved|0|||
105641892|NCT00087516|364352896|FG000|Overall Study|Patient was non-compliant|3|||
105641893|NCT00087516|364352897|FG001|Overall Study|Patient was non-compliant|1|||
105641894|NCT00087516|364352898|FG002|Overall Study|Patient was non-compliant|0|||
105641895|NCT00087516|364352899|FG003|Overall Study|Patient was non-compliant|0|||
105641896|NCT00087516|364352896|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
105641897|NCT00087516|364352897|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
105641898|NCT00087516|364352898|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
105641899|NCT00087516|364352899|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
105641900|NCT00087516|364352896|FG000|Overall Study|Other|0|||
105641901|NCT00087516|364352897|FG001|Overall Study|Other|0|||
105641902|NCT00087516|364352898|FG002|Overall Study|Other|1|||
105641903|NCT00087516|364352899|FG003|Overall Study|Other|0|||
105641904|NCT01848483|364352900|FG000|Overall Study|Death|2|||
105641905|NCT01848483|364352901|FG001|Overall Study|Death|1|||
105641906|NCT01848483|364352900|FG000|Overall Study|Lost to Follow-up|6|||
105641907|NCT01848483|364352901|FG001|Overall Study|Lost to Follow-up|8|||
105641908|NCT01848483|364352900|FG000|Overall Study|Withdrawal by Subject|1|||
105641909|NCT01848483|364352901|FG001|Overall Study|Withdrawal by Subject|0|||
105641910|NCT01848483|364352900|FG000|Overall Study|Incarceration|2|||
105641911|NCT01848483|364352901|FG001|Overall Study|Incarceration|2|||
105641912|NCT01853384|364352902|FG000|Randomized|Adverse Event|5|||
105641913|NCT01853384|364352903|FG001|Randomized|Adverse Event|3|||
105641914|NCT01853384|364352902|FG000|Randomized|Death|1|||
105641915|NCT01853384|364352903|FG001|Randomized|Death|2|||
105641916|NCT01853384|364352902|FG000|Randomized|Lost to Follow-up|1|||
105641917|NCT01853384|364352903|FG001|Randomized|Lost to Follow-up|1|||
105641918|NCT01853384|364352902|FG000|Randomized|Withdrawal by Subject|5|||
105641919|NCT01853384|364352903|FG001|Randomized|Withdrawal by Subject|3|||
105641920|NCT01853384|364352902|FG000|Randomized|Sponsor Decision|47|||
105641921|NCT01853384|364352903|FG001|Randomized|Sponsor Decision|34|||
105641922|NCT01853384|364352902|FG000|Randomized|Other|3|||
105641923|NCT01853384|364352903|FG001|Randomized|Other|3|||
105641924|NCT01853384|364352902|FG000|Completed Follow up Visit 1|Early Termination|13|||
105641925|NCT01853384|364352903|FG001|Completed Follow up Visit 1|Early Termination|9|||
105641926|NCT01853384|364352902|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
105641927|NCT01853384|364352903|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
105641928|NCT01853384|364352902|FG000|Completed Follow up Visit 2|Adverse Event|1|||
105641929|NCT01853384|364352903|FG001|Completed Follow up Visit 2|Adverse Event|0|||
105641930|NCT01853384|364352902|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
105641931|NCT01853384|364352903|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
105641932|NCT01853384|364352902|FG000|Completed Follow up Visit 2|Death|1|||
105641933|NCT01853384|364352903|FG001|Completed Follow up Visit 2|Death|0|||
105641934|NCT01853384|364352902|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
105641935|NCT01853384|364352903|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
105641936|NCT00638456|364352904|FG000|Overall Study|Withdrawal by Subject|6|||
105641937|NCT00638456|364352905|FG001|Overall Study|Withdrawal by Subject|2|||
105641938|NCT03236779|364352906|FG000|Overall Study|Lost to Follow-up|13|||
105641939|NCT03236779|364352907|FG001|Overall Study|Lost to Follow-up|21|||
105641940|NCT00805792|364352910|FG000|Overall Study|Death|3|||
105641941|NCT00805792|364352910|FG000|Overall Study|Lost to Follow-up|2|||
105641942|NCT01416285|364352913|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
105641943|NCT01416285|364352914|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
105641944|NCT02165202|364352915|FG000|Oral Phase|Refused further participation|5|||
105641945|NCT02165202|364352916|FG001|Oral Phase|Refused further participation|1|||
105641946|NCT02165202|364352915|FG000|Oral Phase|Study product Related Toxicity|1|||
105641947|NCT02165202|364352916|FG001|Oral Phase|Study product Related Toxicity|0|||
105641948|NCT02165202|364352915|FG000|Oral Phase|Unable to contact Participant|1|||
105641949|NCT02165202|364352916|FG001|Oral Phase|Unable to contact Participant|1|||
105641950|NCT02165202|364352915|FG000|Oral Phase|Clinical reasons|1|||
105641951|NCT02165202|364352916|FG001|Oral Phase|Clinical reasons|0|||
105641952|NCT02165202|364352915|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
105641953|NCT02165202|364352916|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
105641954|NCT02165202|364352915|FG000|Oral Phase|CMC advised termination|1|||
105641955|NCT02165202|364352916|FG001|Oral Phase|CMC advised termination|0|||
105641956|NCT02165202|364352915|FG000|Oral Phase|Relocated, no follow-up planned|1|||
105641957|NCT02165202|364352916|FG001|Oral Phase|Relocated, no follow-up planned|0|||
105641958|NCT02165202|364352915|FG000|Oral Phase|Abnormal EKG|0|||
105641959|NCT02165202|364352916|FG001|Oral Phase|Abnormal EKG|1|||
105641960|NCT02165202|364352915|FG000|Injection Phase|Abnormal Lab Value|5|||
105641961|NCT02165202|364352916|FG001|Injection Phase|Abnormal Lab Value|1|||
105641962|NCT02165202|364352915|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
105641963|NCT02165202|364352916|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
105641964|NCT02165202|364352915|FG000|Injection Phase|Unable to attend within Visit Window|1|||
105641965|NCT02165202|364352916|FG001|Injection Phase|Unable to attend within Visit Window|0|||
105641966|NCT02165202|364352915|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
105641967|NCT02165202|364352916|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
105641968|NCT02165202|364352915|FG000|Injection Phase|End of Study|2|||
105641969|NCT02165202|364352916|FG001|Injection Phase|End of Study|1|||
105641970|NCT02165202|364352915|FG000|Injection Phase|Study Product related Toxicity|1|||
105641971|NCT02165202|364352916|FG001|Injection Phase|Study Product related Toxicity|0|||
105641972|NCT02165202|364352915|FG000|Injection Phase|No longer interested|0|||
105641973|NCT02165202|364352916|FG001|Injection Phase|No longer interested|1|||
105641974|NCT02165202|364352915|FG000|Injection Phase|Participant unwilling to comply|1|||
105641975|NCT02165202|364352916|FG001|Injection Phase|Participant unwilling to comply|0|||
105641976|NCT03052517|364352917|FG000|Overall Study|Study Terminated By Sponsor|928|||
105641977|NCT03052517|364352918|FG001|Overall Study|Study Terminated By Sponsor|938|||
105641978|NCT03052517|364352919|FG002|Overall Study|Study Terminated By Sponsor|296|||
105641979|NCT03052517|364352917|FG000|Overall Study|Subject/Guardian Decision|50|||
105641980|NCT03052517|364352918|FG001|Overall Study|Subject/Guardian Decision|45|||
105641981|NCT03052517|364352919|FG002|Overall Study|Subject/Guardian Decision|22|||
105641982|NCT03052517|364352917|FG000|Overall Study|Lack of Efficacy|23|||
105641983|NCT03052517|364352918|FG001|Overall Study|Lack of Efficacy|14|||
105641984|NCT03052517|364352919|FG002|Overall Study|Lack of Efficacy|7|||
105641985|NCT03052517|364352917|FG000|Overall Study|Adverse Event|6|||
105641986|NCT03052517|364352918|FG001|Overall Study|Adverse Event|5|||
105641987|NCT03052517|364352919|FG002|Overall Study|Adverse Event|0|||
105641988|NCT03052517|364352917|FG000|Overall Study|Physician Decision|4|||
105641989|NCT03052517|364352918|FG001|Overall Study|Physician Decision|5|||
105641990|NCT03052517|364352919|FG002|Overall Study|Physician Decision|1|||
105641991|NCT03052517|364352917|FG000|Overall Study|Death|3|||
105641992|NCT03052517|364352918|FG001|Overall Study|Death|0|||
105641993|NCT03052517|364352919|FG002|Overall Study|Death|1|||
105641994|NCT03052517|364352917|FG000|Overall Study|Lost to Follow-up|2|||
105641995|NCT03052517|364352918|FG001|Overall Study|Lost to Follow-up|4|||
105641996|NCT03052517|364352919|FG002|Overall Study|Lost to Follow-up|0|||
105641997|NCT03052517|364352917|FG000|Overall Study|Pregnancy|1|||
105641998|NCT03052517|364352918|FG001|Overall Study|Pregnancy|0|||
105641999|NCT03052517|364352919|FG002|Overall Study|Pregnancy|1|||
105642000|NCT03052517|364352917|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
105642001|NCT03052517|364352918|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
105642002|NCT03052517|364352919|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
105642003|NCT03052517|364352917|FG000|Overall Study|Technical Problems|0|||
105642004|NCT03052517|364352918|FG001|Overall Study|Technical Problems|1|||
105642005|NCT03052517|364352919|FG002|Overall Study|Technical Problems|0|||
105642006|NCT01640288|364352922|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
105642007|NCT01640288|364352923|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
105642008|NCT01640288|364352922|FG000|Overall Study|Screen Failure|20|||
105642009|NCT01640288|364352923|FG001|Overall Study|Screen Failure|18|||
105642010|NCT01640288|364352922|FG000|Overall Study|Withdrawn by PI|5|||
105642011|NCT01640288|364352923|FG001|Overall Study|Withdrawn by PI|0|||
105642012|NCT01640288|364352922|FG000|Overall Study|Withdrawal by Subject|1|||
105642013|NCT01640288|364352923|FG001|Overall Study|Withdrawal by Subject|0|||
105642014|NCT01005602|364352924|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
105642015|NCT01005602|364352925|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
105642016|NCT00749944|364352926|FG000|Overall Study|Lost to Follow-up|2|||
105642017|NCT00749944|364352927|FG001|Overall Study|Lost to Follow-up|1|||
105642018|NCT00749944|364352926|FG000|Overall Study|Other|1|||
105642019|NCT00749944|364352927|FG001|Overall Study|Other|0|||
105642020|NCT00749944|364352926|FG000|Overall Study|Withdrawal by Subject|2|||
105642021|NCT00749944|364352927|FG001|Overall Study|Withdrawal by Subject|0|||
105642022|NCT01393600|364352928|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
105642023|NCT01393600|364352929|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
105642024|NCT01393600|364352930|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
105642025|NCT01393600|364352931|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
105642026|NCT01393600|364352928|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
105642027|NCT01393600|364352929|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
105642028|NCT01393600|364352930|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
105642029|NCT01393600|364352931|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
105642030|NCT01393600|364352928|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
105642031|NCT01393600|364352929|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
105642032|NCT01393600|364352930|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
105642033|NCT01393600|364352931|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
105642034|NCT01393600|364352928|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
105642035|NCT01393600|364352929|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
105642036|NCT01393600|364352930|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
105642037|NCT01393600|364352931|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
105642038|NCT01393600|364352928|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
105642039|NCT01393600|364352929|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
105642040|NCT01393600|364352930|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
105642041|NCT01393600|364352931|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
105642042|NCT01393600|364352928|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
105642043|NCT01393600|364352929|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
105642044|NCT01393600|364352930|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
105642045|NCT01393600|364352931|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
105642046|NCT01393600|364352928|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
105642047|NCT01393600|364352929|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
105642048|NCT01393600|364352930|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
105642049|NCT01393600|364352931|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
105642050|NCT02291861|364352932|FG000|Overall Study|Adverse Event|2|||
105642051|NCT02291861|364352933|FG001|Overall Study|Adverse Event|4|||
105642052|NCT02291861|364352934|FG002|Overall Study|Adverse Event|1|||
105642053|NCT02291861|364352935|FG003|Overall Study|Adverse Event|2|||
105642054|NCT02291861|364352932|FG000|Overall Study|Death|0|||
105642055|NCT02291861|364352933|FG001|Overall Study|Death|0|||
105642056|NCT02291861|364352934|FG002|Overall Study|Death|1|||
105642057|NCT02291861|364352935|FG003|Overall Study|Death|1|||
105642058|NCT02291861|364352932|FG000|Overall Study|Protocol Violation|1|||
105642059|NCT02291861|364352933|FG001|Overall Study|Protocol Violation|0|||
105642060|NCT02291861|364352934|FG002|Overall Study|Protocol Violation|0|||
105642061|NCT02291861|364352935|FG003|Overall Study|Protocol Violation|1|||
105642062|NCT02291861|364352932|FG000|Overall Study|Withdrawal by Subject|1|||
105642063|NCT02291861|364352933|FG001|Overall Study|Withdrawal by Subject|2|||
105642064|NCT02291861|364352934|FG002|Overall Study|Withdrawal by Subject|1|||
105642065|NCT02291861|364352935|FG003|Overall Study|Withdrawal by Subject|4|||
105642066|NCT02291861|364352932|FG000|Overall Study|Noncompliance|1|||
105642067|NCT02291861|364352933|FG001|Overall Study|Noncompliance|1|||
105642068|NCT02291861|364352934|FG002|Overall Study|Noncompliance|2|||
105642069|NCT02291861|364352935|FG003|Overall Study|Noncompliance|1|||
105642070|NCT02291861|364352932|FG000|Overall Study|Lost to Follow-up|2|||
105642071|NCT02291861|364352933|FG001|Overall Study|Lost to Follow-up|1|||
105642072|NCT02291861|364352934|FG002|Overall Study|Lost to Follow-up|4|||
105642073|NCT02291861|364352935|FG003|Overall Study|Lost to Follow-up|0|||
105642074|NCT02291861|364352932|FG000|Overall Study|Other|0|||
105642075|NCT02291861|364352933|FG001|Overall Study|Other|0|||
105642076|NCT02291861|364352934|FG002|Overall Study|Other|0|||
105642077|NCT02291861|364352935|FG003|Overall Study|Other|1|||
105642078|NCT00930644|364352936|FG000|Overall Study|Withdrawal by Subject|4|||
105642079|NCT00930644|364352936|FG000|Overall Study|Physician Decision|2|||
105642080|NCT00930644|364352936|FG000|Overall Study|Death|1|||
105642081|NCT00930644|364352936|FG000|Overall Study|Adverse Event|16|||
105642082|NCT02988713|364352939|FG000|Overall Study|Withdrawal by Subject|1|||
105642083|NCT02988713|364352939|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
105642084|NCT02823574|364352940|FG000|Randomization|Disease Progression|0|||
105642085|NCT02823574|364352941|FG001|Randomization|Disease Progression|0|||
105642086|NCT02823574|364352942|FG002|Randomization|Disease Progression|1|||
105642087|NCT02823574|364352943|FG003|Randomization|Disease Progression|0|||
105642088|NCT02823574|364352940|FG000|Randomization|AE unrelated to Study Drug|1|||
105642089|NCT02823574|364352941|FG001|Randomization|AE unrelated to Study Drug|0|||
105642090|NCT02823574|364352942|FG002|Randomization|AE unrelated to Study Drug|0|||
105642091|NCT02823574|364352943|FG003|Randomization|AE unrelated to Study Drug|0|||
105642092|NCT02823574|364352940|FG000|Treatment Period|Poor/Non Compliance|1|||
105642093|NCT02823574|364352941|FG001|Treatment Period|Poor/Non Compliance|0|||
105642094|NCT02823574|364352942|FG002|Treatment Period|Poor/Non Compliance|0|||
105642095|NCT02823574|364352943|FG003|Treatment Period|Poor/Non Compliance|1|||
105642096|NCT02823574|364352940|FG000|Treatment Period|Maximum Clinical Benefit|8|||
105642097|NCT02823574|364352941|FG001|Treatment Period|Maximum Clinical Benefit|4|||
105642098|NCT02823574|364352942|FG002|Treatment Period|Maximum Clinical Benefit|7|||
105642099|NCT02823574|364352943|FG003|Treatment Period|Maximum Clinical Benefit|1|||
105642100|NCT02823574|364352940|FG000|Treatment Period|Lost to Follow-up|1|||
105642101|NCT02823574|364352941|FG001|Treatment Period|Lost to Follow-up|1|||
105642102|NCT02823574|364352942|FG002|Treatment Period|Lost to Follow-up|0|||
105642103|NCT02823574|364352943|FG003|Treatment Period|Lost to Follow-up|0|||
105642104|NCT02823574|364352940|FG000|Treatment Period|Participant withdrew consent|4|||
105642105|NCT02823574|364352941|FG001|Treatment Period|Participant withdrew consent|0|||
105642106|NCT02823574|364352942|FG002|Treatment Period|Participant withdrew consent|0|||
105642107|NCT02823574|364352943|FG003|Treatment Period|Participant withdrew consent|1|||
105642108|NCT02823574|364352940|FG000|Treatment Period|Participant request to discontinue|5|||
105642109|NCT02823574|364352941|FG001|Treatment Period|Participant request to discontinue|0|||
105642110|NCT02823574|364352942|FG002|Treatment Period|Participant request to discontinue|3|||
105642111|NCT02823574|364352943|FG003|Treatment Period|Participant request to discontinue|2|||
105642112|NCT02823574|364352940|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
105642113|NCT02823574|364352941|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
105642114|NCT02823574|364352942|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
105642115|NCT02823574|364352943|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
105642116|NCT02823574|364352940|FG000|Treatment Period|Study Drug Toxicity|11|||
105642117|NCT02823574|364352941|FG001|Treatment Period|Study Drug Toxicity|2|||
105642118|NCT02823574|364352942|FG002|Treatment Period|Study Drug Toxicity|14|||
105642119|NCT02823574|364352943|FG003|Treatment Period|Study Drug Toxicity|4|||
105642120|NCT02823574|364352940|FG000|Treatment Period|Disease Progression|113|||
105642121|NCT02823574|364352941|FG001|Treatment Period|Disease Progression|64|||
105642122|NCT02823574|364352942|FG002|Treatment Period|Disease Progression|82|||
105642123|NCT02823574|364352943|FG003|Treatment Period|Disease Progression|43|||
105642124|NCT02823574|364352940|FG000|Treatment Period|Other reasons|5|||
105642125|NCT02823574|364352941|FG001|Treatment Period|Other reasons|9|||
105642126|NCT02823574|364352942|FG002|Treatment Period|Other reasons|3|||
105642127|NCT02823574|364352943|FG003|Treatment Period|Other reasons|6|||
105642128|NCT02823574|364352940|FG000|Treatment Period|Participant no longer meets study criteria|0|||
105642129|NCT02823574|364352941|FG001|Treatment Period|Participant no longer meets study criteria|0|||
105642130|NCT02823574|364352942|FG002|Treatment Period|Participant no longer meets study criteria|1|||
105642131|NCT02823574|364352943|FG003|Treatment Period|Participant no longer meets study criteria|0|||
105642132|NCT02823574|364352940|FG000|Treatment Period|Death|0|||
105642133|NCT02823574|364352941|FG001|Treatment Period|Death|0|||
105642134|NCT02823574|364352942|FG002|Treatment Period|Death|3|||
105642135|NCT02823574|364352943|FG003|Treatment Period|Death|1|||
105642136|NCT03909100|364352946|FG000|Overall Study|Protocol Deviation|2|||
105642137|NCT03909100|364352946|FG000|Overall Study|Technical Problems|4|||
105642138|NCT03909100|364352946|FG000|Overall Study|Withdrawal by Subject|4|||
105642139|NCT03909100|364352946|FG000|Overall Study|Lost to Follow-up|1|||
105642140|NCT03909100|364352946|FG000|Overall Study|Reason not Specified|4|||
105642141|NCT02671266|364352947|FG000|Overall Study|Withdrawal by Subject|1|||
105642142|NCT02671266|364352948|FG001|Overall Study|Withdrawal by Subject|1|||
105642143|NCT00666705|364352951|FG000|Overall Study|Withdrawal by Subject|1|||
105642144|NCT00687297|364352952|FG000|Randomization|Withdrawal by Subject|2|||
105642145|NCT00687297|364352953|FG001|Randomization|Withdrawal by Subject|0|||
105642146|NCT00687297|364352952|FG000|Randomization|Withdrew before treatment, ineligible|1|||
105642147|NCT00687297|364352953|FG001|Randomization|Withdrew before treatment, ineligible|1|||
105642148|NCT00687297|364352952|FG000|Induction|Withdrawal by Subject|4|||
105642149|NCT00687297|364352953|FG001|Induction|Withdrawal by Subject|4|||
105642150|NCT00687297|364352952|FG000|Induction|Adverse Event|16|||
105642151|NCT00687297|364352953|FG001|Induction|Adverse Event|15|||
105642152|NCT00687297|364352952|FG000|Induction|Death|7|||
105642153|NCT00687297|364352953|FG001|Induction|Death|11|||
105642154|NCT00687297|364352952|FG000|Induction|Lack of Efficacy|17|||
105642155|NCT00687297|364352953|FG001|Induction|Lack of Efficacy|21|||
105642156|NCT00687297|364352952|FG000|Induction|Ineligible|0|||
105642157|NCT00687297|364352953|FG001|Induction|Ineligible|1|||
105642158|NCT00687297|364352952|FG000|Induction|Patient Noncompliance|1|||
105642159|NCT00687297|364352953|FG001|Induction|Patient Noncompliance|0|||
105642160|NCT00687297|364352952|FG000|Induction|Physician Decision|0|||
105642161|NCT00687297|364352953|FG001|Induction|Physician Decision|2|||
105642162|NCT00687297|364352952|FG000|Induction|Other|0|||
105642163|NCT00687297|364352953|FG001|Induction|Other|1|||
105642164|NCT03128099|364352954|FG000|Overall Study|High dose task was too long|0|||
105642165|NCT03128099|364352955|FG001|Overall Study|High dose task was too long|4|||
105642166|NCT03128099|364352956|FG002|Overall Study|High dose task was too long|0|||
105642167|NCT03128099|364352954|FG000|Overall Study|Participant got a full time job.|1|||
105642168|NCT03128099|364352955|FG001|Overall Study|Participant got a full time job.|0|||
105642169|NCT03128099|364352956|FG002|Overall Study|Participant got a full time job.|0|||
105642170|NCT03128099|364352954|FG000|Overall Study|Became homeless and lost contact|1|||
105642171|NCT03128099|364352955|FG001|Overall Study|Became homeless and lost contact|0|||
105642172|NCT03128099|364352956|FG002|Overall Study|Became homeless and lost contact|0|||
105642173|NCT03128099|364352954|FG000|Overall Study|Did not complete all the assessments|0|||
105642174|NCT03128099|364352955|FG001|Overall Study|Did not complete all the assessments|0|||
105642175|NCT03128099|364352956|FG002|Overall Study|Did not complete all the assessments|1|||
105642176|NCT00089791|364352957|FG000|Overall Study|Physician Decision|6|||
105642177|NCT00089791|364352958|FG001|Overall Study|Physician Decision|3|||
105642178|NCT00089791|364352957|FG000|Overall Study|Adverse Event|81|||
105642179|NCT00089791|364352958|FG001|Overall Study|Adverse Event|93|||
105642180|NCT00089791|364352957|FG000|Overall Study|Withdrawal by Subject|403|||
105642181|NCT00089791|364352958|FG001|Overall Study|Withdrawal by Subject|344|||
105642182|NCT00089791|364352957|FG000|Overall Study|Death|78|||
105642183|NCT00089791|364352958|FG001|Overall Study|Death|62|||
105642184|NCT00089791|364352957|FG000|Overall Study|Disease progression|7|||
105642185|NCT00089791|364352958|FG001|Overall Study|Disease progression|3|||
105642186|NCT00089791|364352957|FG000|Overall Study|Ineligibility determined|12|||
105642187|NCT00089791|364352958|FG001|Overall Study|Ineligibility determined|9|||
105642188|NCT00089791|364352957|FG000|Overall Study|Lost to Follow-up|57|||
105642189|NCT00089791|364352958|FG001|Overall Study|Lost to Follow-up|57|||
105642190|NCT00089791|364352957|FG000|Overall Study|Noncompliance|17|||
105642191|NCT00089791|364352958|FG001|Overall Study|Noncompliance|13|||
105642192|NCT00089791|364352957|FG000|Overall Study|Other|20|||
105642193|NCT00089791|364352958|FG001|Overall Study|Other|32|||
105642194|NCT00089791|364352957|FG000|Overall Study|Protocol deviation|12|||
105642195|NCT00089791|364352958|FG001|Overall Study|Protocol deviation|10|||
105642196|NCT00089791|364352957|FG000|Overall Study|Requirement for alternative therapy|7|||
105642197|NCT00089791|364352958|FG001|Overall Study|Requirement for alternative therapy|4|||
105642198|NCT03695185|364352959|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
105642199|NCT03695185|364352959|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
105642200|NCT03695185|364352959|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
105642201|NCT03695185|364352959|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
105642202|NCT03695185|364352959|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
105642203|NCT03695185|364352959|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
105642204|NCT01405508|364352971|FG000|Overall Study|AE, non-serious non-fatal|1|||
105642205|NCT01405508|364352972|FG001|Overall Study|AE, non-serious non-fatal|1|||
105642206|NCT01405508|364352973|FG002|Overall Study|AE, non-serious non-fatal|0|||
105642207|NCT01405508|364352974|FG003|Overall Study|AE, non-serious non-fatal|0|||
105642208|NCT00476957|364352975|FG000|Overall Study|Lost to Follow-up|176|||
105642209|NCT00476957|364352976|FG001|Overall Study|Lost to Follow-up|193|||
105642210|NCT01000649|364352977|FG000|Overall Study|Adverse Event|5|||
105642211|NCT01000649|364352978|FG001|Overall Study|Adverse Event|1|||
105642212|NCT01000649|364352979|FG002|Overall Study|Adverse Event|2|||
105642213|NCT01000649|364352980|FG003|Overall Study|Adverse Event|4|||
105642214|NCT01000649|364352977|FG000|Overall Study|Lost to Follow-up|0|||
105642215|NCT01000649|364352978|FG001|Overall Study|Lost to Follow-up|2|||
105642216|NCT01000649|364352979|FG002|Overall Study|Lost to Follow-up|0|||
105642217|NCT01000649|364352980|FG003|Overall Study|Lost to Follow-up|2|||
105642218|NCT00346398|364352981|FG000|Overall Study|Lost to Follow-up|3|||
105642219|NCT00346398|364352982|FG001|Overall Study|Lost to Follow-up|0|||
105642220|NCT00346398|364352981|FG000|Overall Study|Withdrawal by Subject|0|||
105642221|NCT00346398|364352982|FG001|Overall Study|Withdrawal by Subject|2|||
105642222|NCT03652610|364352983|FG000|Overall Study|Lost to Follow-up|1|||
105642223|NCT03652610|364352984|FG001|Overall Study|Lost to Follow-up|0|||
105642224|NCT03652610|364352983|FG000|Overall Study|Withdrawal by Subject|3|||
105642225|NCT03652610|364352984|FG001|Overall Study|Withdrawal by Subject|5|||
105642226|NCT02707952|364352985|FG000|Overall Study|Adverse Event|1|||
105642227|NCT02707952|364352986|FG001|Overall Study|Adverse Event|0|||
105642228|NCT02707952|364352987|FG002|Overall Study|Adverse Event|0|||
105642229|NCT02707952|364352988|FG003|Overall Study|Adverse Event|0|||
105642230|NCT02707952|364352985|FG000|Overall Study|Lost to Follow-up|1|||
105642231|NCT02707952|364352986|FG001|Overall Study|Lost to Follow-up|0|||
105642232|NCT02707952|364352987|FG002|Overall Study|Lost to Follow-up|0|||
105642233|NCT02707952|364352988|FG003|Overall Study|Lost to Follow-up|0|||
105642234|NCT02707952|364352985|FG000|Overall Study|Withdrawal by Subject|0|||
105642235|NCT02707952|364352986|FG001|Overall Study|Withdrawal by Subject|1|||
105642236|NCT02707952|364352987|FG002|Overall Study|Withdrawal by Subject|2|||
105642237|NCT02707952|364352988|FG003|Overall Study|Withdrawal by Subject|0|||
105642238|NCT04108858|364352989|FG000|Overall Study|Adverse Event|1|||
105642239|NCT01240785|364352990|FG000|Overall Study|Lost to Follow-up|1|||
105642240|NCT01240785|364352991|FG001|Overall Study|Lost to Follow-up|0|||
105642241|NCT01240785|364352990|FG000|Overall Study|Protocol Violation|0|||
105642242|NCT01240785|364352991|FG001|Overall Study|Protocol Violation|3|||
105642243|NCT00237809|364352992|FG000|Overall Study|Lost to Follow-up|11|||
105642244|NCT00237809|364352993|FG001|Overall Study|Lost to Follow-up|10|||
105642245|NCT00237809|364352994|FG002|Overall Study|Lost to Follow-up|9|||
105642246|NCT00237809|364352995|FG003|Overall Study|Lost to Follow-up|9|||
105642247|NCT00696241|364352999|FG000|Overall Study|Adverse Event|11|||
105642248|NCT00696241|364353000|FG001|Overall Study|Adverse Event|3|||
105642249|NCT00696241|364353001|FG002|Overall Study|Adverse Event|6|||
105642250|NCT00696241|364353002|FG003|Overall Study|Adverse Event|4|||
105642251|NCT00696241|364353003|FG004|Overall Study|Adverse Event|5|||
105642252|NCT00696241|364352999|FG000|Overall Study|Protocol Violation|1|||
105642253|NCT00696241|364353000|FG001|Overall Study|Protocol Violation|1|||
105642254|NCT00696241|364353001|FG002|Overall Study|Protocol Violation|2|||
105642255|NCT00696241|364353002|FG003|Overall Study|Protocol Violation|0|||
105642256|NCT00696241|364353003|FG004|Overall Study|Protocol Violation|3|||
105642257|NCT00696241|364352999|FG000|Overall Study|Lost to Follow-up|1|||
105642258|NCT00696241|364353000|FG001|Overall Study|Lost to Follow-up|4|||
105642259|NCT00696241|364353001|FG002|Overall Study|Lost to Follow-up|1|||
105642260|NCT00696241|364353002|FG003|Overall Study|Lost to Follow-up|2|||
105642261|NCT00696241|364353003|FG004|Overall Study|Lost to Follow-up|0|||
105642262|NCT00696241|364352999|FG000|Overall Study|Withdrawal by Subject|4|||
105642263|NCT00696241|364353000|FG001|Overall Study|Withdrawal by Subject|8|||
105642264|NCT00696241|364353001|FG002|Overall Study|Withdrawal by Subject|6|||
105642265|NCT00696241|364353002|FG003|Overall Study|Withdrawal by Subject|1|||
105642266|NCT00696241|364353003|FG004|Overall Study|Withdrawal by Subject|0|||
105642267|NCT00696241|364352999|FG000|Overall Study|Lack of Efficacy|1|||
105642268|NCT00696241|364353000|FG001|Overall Study|Lack of Efficacy|5|||
105642269|NCT00696241|364353001|FG002|Overall Study|Lack of Efficacy|4|||
105642270|NCT00696241|364353002|FG003|Overall Study|Lack of Efficacy|5|||
105642271|NCT00696241|364353003|FG004|Overall Study|Lack of Efficacy|3|||
105642272|NCT00696241|364352999|FG000|Overall Study|Other|6|||
105642273|NCT00696241|364353000|FG001|Overall Study|Other|1|||
105642274|NCT00696241|364353001|FG002|Overall Study|Other|5|||
105642275|NCT00696241|364353002|FG003|Overall Study|Other|2|||
105642276|NCT00696241|364353003|FG004|Overall Study|Other|1|||
105642277|NCT02203513|364353004|FG000|Overall Study|Refused further treatment|2|||
105642278|NCT02203513|364353005|FG001|Overall Study|Refused further treatment|0|||
105642279|NCT02203513|364353006|FG002|Overall Study|Refused further treatment|1|||
105642280|NCT02203513|364353007|FG003|Overall Study|Refused further treatment|0|||
105642281|NCT02203513|364353008|FG004|Overall Study|Refused further treatment|0|||
105642282|NCT02203513|364353004|FG000|Overall Study|Switched to alternative treatment|3|||
105642283|NCT02203513|364353005|FG001|Overall Study|Switched to alternative treatment|4|||
105642284|NCT02203513|364353006|FG002|Overall Study|Switched to alternative treatment|0|||
105642285|NCT02203513|364353007|FG003|Overall Study|Switched to alternative treatment|0|||
105642286|NCT02203513|364353008|FG004|Overall Study|Switched to alternative treatment|4|||
105642287|NCT02203513|364353004|FG000|Overall Study|Did not receive investigational product (IP)|0|||
105642288|NCT02203513|364353005|FG001|Overall Study|Did not receive investigational product (IP)|1|||
105642289|NCT02203513|364353006|FG002|Overall Study|Did not receive investigational product (IP)|0|||
105642290|NCT02203513|364353007|FG003|Overall Study|Did not receive investigational product (IP)|0|||
105642291|NCT02203513|364353008|FG004|Overall Study|Did not receive investigational product (IP)|0|||
105642292|NCT02203513|364353004|FG000|Overall Study|Death (unrelated to study therapy)|1|||
105642293|NCT02203513|364353005|FG001|Overall Study|Death (unrelated to study therapy)|3|||
105642294|NCT02203513|364353006|FG002|Overall Study|Death (unrelated to study therapy)|1|||
105642295|NCT02203513|364353007|FG003|Overall Study|Death (unrelated to study therapy)|0|||
105642296|NCT02203513|364353008|FG004|Overall Study|Death (unrelated to study therapy)|2|||
105642297|NCT02203513|364353004|FG000|Overall Study|Lost to Follow-up|0|||
105642298|NCT02203513|364353005|FG001|Overall Study|Lost to Follow-up|0|||
105642299|NCT02203513|364353006|FG002|Overall Study|Lost to Follow-up|1|||
105642300|NCT02203513|364353007|FG003|Overall Study|Lost to Follow-up|1|||
105642301|NCT02203513|364353008|FG004|Overall Study|Lost to Follow-up|0|||
105642302|NCT00871715|364353009|FG000|Overall Study|Withdrawal by Subject|6|||
105642303|NCT00871715|364353010|FG001|Overall Study|Withdrawal by Subject|10|||
105642304|NCT00871715|364353011|FG002|Overall Study|Withdrawal by Subject|15|||
105642305|NCT00871715|364353009|FG000|Overall Study|Physician Decision|6|||
105642306|NCT00871715|364353010|FG001|Overall Study|Physician Decision|0|||
105642307|NCT00871715|364353011|FG002|Overall Study|Physician Decision|2|||
105642308|NCT00871715|364353009|FG000|Overall Study|Lost to Follow-up|3|||
105642309|NCT00871715|364353010|FG001|Overall Study|Lost to Follow-up|6|||
105642310|NCT00871715|364353011|FG002|Overall Study|Lost to Follow-up|9|||
105642311|NCT01681511|364353014|FG000|Overall Study|No Treatment Received|1|||
105642312|NCT01681511|364353015|FG001|Overall Study|No Treatment Received|3|||
105642313|NCT01681511|364353014|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
105642314|NCT01681511|364353015|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
105642315|NCT01681511|364353014|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
105642316|NCT01681511|364353015|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
105642317|NCT01681511|364353014|FG000|Overall Study|No Daily Urine Sample Collected|0|||
105642318|NCT01681511|364353015|FG001|Overall Study|No Daily Urine Sample Collected|1|||
105642319|NCT01681511|364353014|FG000|Overall Study|No post-catheter sample collected|11|||
105642320|NCT01681511|364353015|FG001|Overall Study|No post-catheter sample collected|4|||
105642321|NCT04447287|364353016|FG000|Period 1: Run-in Period|Adverse Event|3|||
105642322|NCT04447287|364353017|FG001|Period 1: Run-in Period|Adverse Event|0|||
105642323|NCT04447287|364353018|FG002|Period 1: Run-in Period|Adverse Event|0|||
105642324|NCT04447287|364353016|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
105642325|NCT04447287|364353017|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
105642326|NCT04447287|364353018|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
105642327|NCT04447287|364353016|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
105642328|NCT04447287|364353017|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
105642329|NCT04447287|364353018|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
105870218|NCT01074944|365176969|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
105642330|NCT03075878|364353019|FG000|Overall Study|Physician Decision|1|||
105642331|NCT02188459|364353020|FG000|Overall Study|Lost to Follow-up|3|||
105642332|NCT02188459|364353021|FG001|Overall Study|Lost to Follow-up|4|||
105642333|NCT02188459|364353020|FG000|Overall Study|Early Termination|0|||
105642334|NCT02188459|364353021|FG001|Overall Study|Early Termination|3|||
105642335|NCT00824850|364353024|FG000|Overall Study|Withdrawal by Subject|0|||
105642336|NCT00824850|364353025|FG001|Overall Study|Withdrawal by Subject|1|||
105642337|NCT02367794|364353026|FG000|Overall Study|Death|252|||
105642338|NCT02367794|364353027|FG001|Overall Study|Death|245|||
105642339|NCT02367794|364353028|FG002|Overall Study|Death|243|||
105642340|NCT02367794|364353026|FG000|Overall Study|Lost to Follow-up|1|||
105642341|NCT02367794|364353027|FG001|Overall Study|Lost to Follow-up|2|||
105642342|NCT02367794|364353028|FG002|Overall Study|Lost to Follow-up|2|||
105642343|NCT02367794|364353026|FG000|Overall Study|Physician Decision|0|||
105642344|NCT02367794|364353027|FG001|Overall Study|Physician Decision|5|||
105642345|NCT02367794|364353028|FG002|Overall Study|Physician Decision|3|||
105642346|NCT02367794|364353026|FG000|Overall Study|Protocol Violation|1|||
105642347|NCT02367794|364353027|FG001|Overall Study|Protocol Violation|0|||
105642348|NCT02367794|364353028|FG002|Overall Study|Protocol Violation|1|||
105642349|NCT02367794|364353026|FG000|Overall Study|Withdrawal by Subject|25|||
105642350|NCT02367794|364353027|FG001|Overall Study|Withdrawal by Subject|12|||
105642351|NCT02367794|364353028|FG002|Overall Study|Withdrawal by Subject|20|||
105642352|NCT02367794|364353026|FG000|Overall Study|Brain metastasis|1|||
105642353|NCT02367794|364353027|FG001|Overall Study|Brain metastasis|0|||
105642354|NCT02367794|364353028|FG002|Overall Study|Brain metastasis|0|||
105642355|NCT02367794|364353026|FG000|Overall Study|Randomized in error|0|||
105642356|NCT02367794|364353027|FG001|Overall Study|Randomized in error|0|||
105642357|NCT02367794|364353028|FG002|Overall Study|Randomized in error|1|||
105642358|NCT02367794|364353026|FG000|Overall Study|Patient unable to receive carboplatin|0|||
105642359|NCT02367794|364353027|FG001|Overall Study|Patient unable to receive carboplatin|0|||
105642360|NCT02367794|364353028|FG002|Overall Study|Patient unable to receive carboplatin|1|||
105642361|NCT02367794|364353026|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
105642362|NCT02367794|364353027|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
105642363|NCT02367794|364353028|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
105642364|NCT02367794|364353026|FG000|Overall Study|Adverse Event|0|||
105642365|NCT02367794|364353027|FG001|Overall Study|Adverse Event|0|||
105642366|NCT02367794|364353028|FG002|Overall Study|Adverse Event|2|||
105642367|NCT02367794|364353026|FG000|Overall Study|Study Terminated By Sponsor|0|||
105642368|NCT02367794|364353027|FG001|Overall Study|Study Terminated By Sponsor|1|||
105642369|NCT02367794|364353028|FG002|Overall Study|Study Terminated By Sponsor|1|||
105642370|NCT02367794|364353026|FG000|Overall Study|Moved to Roll-Over Study|0|||
105642371|NCT02367794|364353027|FG001|Overall Study|Moved to Roll-Over Study|15|||
105642372|NCT02367794|364353028|FG002|Overall Study|Moved to Roll-Over Study|13|||
105642373|NCT02367794|364353026|FG000|Overall Study|Sponsor Request|60|||
105642374|NCT02367794|364353027|FG001|Overall Study|Sponsor Request|57|||
105642375|NCT02367794|364353028|FG002|Overall Study|Sponsor Request|45|||
105642376|NCT02367794|364353026|FG000|Overall Study|Moved into PTAP Study|0|||
105642377|NCT02367794|364353027|FG001|Overall Study|Moved into PTAP Study|2|||
105642378|NCT02367794|364353028|FG002|Overall Study|Moved into PTAP Study|3|||
105642379|NCT02367794|364353026|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
105642380|NCT02367794|364353027|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
105642381|NCT02367794|364353028|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
105642382|NCT02367794|364353026|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
105642383|NCT02367794|364353027|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
105642384|NCT02367794|364353028|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
105642385|NCT02367794|364353026|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
105642386|NCT02367794|364353027|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
105642387|NCT02367794|364353028|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
105642388|NCT02367794|364353026|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
105642389|NCT02367794|364353027|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
105642390|NCT02367794|364353028|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
105642391|NCT02935894|364353034|FG000|Overall Study|Subject dismissed|1|||
105642392|NCT02158806|364353035|FG000|Overall Study|Death|2|||
105642393|NCT02158806|364353036|FG001|Overall Study|Death|0|||
105642394|NCT02158806|364353035|FG000|Overall Study|Withdrawal by Subject|2|||
105642395|NCT02158806|364353036|FG001|Overall Study|Withdrawal by Subject|0|||
105642396|NCT02158806|364353035|FG000|Overall Study|Lost to Follow-up|0|||
105642397|NCT02158806|364353036|FG001|Overall Study|Lost to Follow-up|3|||
105642398|NCT02158806|364353035|FG000|Overall Study|Moved out of area|0|||
105642399|NCT02158806|364353036|FG001|Overall Study|Moved out of area|1|||
105642400|NCT02158806|364353035|FG000|Overall Study|Transferred to palliative care|0|||
105642401|NCT02158806|364353036|FG001|Overall Study|Transferred to palliative care|1|||
105642402|NCT00451906|364354939|FG000|Overall Study|Adverse Event|515|||
105642403|NCT00451906|364354939|FG000|Overall Study|Lost to Follow-up|31|||
105642404|NCT00451906|364354939|FG000|Overall Study|Withdrawal by Subject|111|||
105642405|NCT00451906|364354939|FG000|Overall Study|Protocol Violation|21|||
105642406|NCT00451906|364354939|FG000|Overall Study|Progressive disease|1328|||
105642407|NCT00451906|364354939|FG000|Overall Study|Termination of the study|108|||
105642408|NCT00451906|364354939|FG000|Overall Study|Other Reasons|121|||
105642409|NCT00451906|364354939|FG000|Overall Study|Did not complete final visit|4|||
105642410|NCT00484198|364354944|FG000|Overall Study|Participant Withdrew Consent|12|||
105642411|NCT00484198|364354945|FG001|Overall Study|Participant Withdrew Consent|21|||
105642412|NCT00484198|364354946|FG002|Overall Study|Participant Withdrew Consent|47|||
105642413|NCT00484198|364354947|FG003|Overall Study|Participant Withdrew Consent|59|||
105642414|NCT00484198|364354944|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
105642415|NCT00484198|364354945|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
105642416|NCT00484198|364354946|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
105642417|NCT00484198|364354947|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
105642418|NCT00484198|364354944|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
105642419|NCT00484198|364354945|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
105642420|NCT00484198|364354946|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
105642421|NCT00484198|364354947|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
105642422|NCT00484198|364354944|FG000|Overall Study|Adverse Event|3|||
105642423|NCT00484198|364354945|FG001|Overall Study|Adverse Event|11|||
105642424|NCT00484198|364354946|FG002|Overall Study|Adverse Event|32|||
105642425|NCT00484198|364354947|FG003|Overall Study|Adverse Event|31|||
105642426|NCT00484198|364354944|FG000|Overall Study|Protocol Violation|0|||
105642427|NCT00484198|364354945|FG001|Overall Study|Protocol Violation|5|||
105642428|NCT00484198|364354946|FG002|Overall Study|Protocol Violation|6|||
105642429|NCT00484198|364354947|FG003|Overall Study|Protocol Violation|8|||
105642430|NCT00484198|364354944|FG000|Overall Study|Other|7|||
105642431|NCT00484198|364354945|FG001|Overall Study|Other|10|||
105642432|NCT00484198|364354946|FG002|Overall Study|Other|31|||
105642433|NCT00484198|364354947|FG003|Overall Study|Other|28|||
105642434|NCT01686152|364354948|FG000|Overall Study|Withdrawal by Subject|11|||
105642435|NCT01686152|364354949|FG001|Overall Study|Withdrawal by Subject|11|||
105642436|NCT01686152|364354950|FG002|Overall Study|Withdrawal by Subject|3|||
105642437|NCT01686152|364354948|FG000|Overall Study|Drug Code Unblinded|0|||
105642438|NCT01686152|364354949|FG001|Overall Study|Drug Code Unblinded|1|||
105642439|NCT01686152|364354950|FG002|Overall Study|Drug Code Unblinded|0|||
105642440|NCT01686152|364354948|FG000|Overall Study|Protocol Violation|6|||
105642441|NCT01686152|364354949|FG001|Overall Study|Protocol Violation|1|||
105642442|NCT01686152|364354950|FG002|Overall Study|Protocol Violation|0|||
105642443|NCT01686152|364354948|FG000|Overall Study|Adverse Event|12|||
105642444|NCT01686152|364354949|FG001|Overall Study|Adverse Event|11|||
105642445|NCT01686152|364354950|FG002|Overall Study|Adverse Event|0|||
105642446|NCT01686152|364354948|FG000|Overall Study|Lack of Efficacy|0|||
105642447|NCT01686152|364354949|FG001|Overall Study|Lack of Efficacy|0|||
105642448|NCT01686152|364354950|FG002|Overall Study|Lack of Efficacy|1|||
105642449|NCT01686152|364354948|FG000|Overall Study|IP Non-compliance|5|||
105642450|NCT01686152|364354949|FG001|Overall Study|IP Non-compliance|5|||
105642451|NCT01686152|364354950|FG002|Overall Study|IP Non-compliance|0|||
105642452|NCT01686152|364354948|FG000|Overall Study|Lost to Follow-up|7|||
105642453|NCT01686152|364354949|FG001|Overall Study|Lost to Follow-up|6|||
105642454|NCT01686152|364354950|FG002|Overall Study|Lost to Follow-up|5|||
105642455|NCT02935673|364354954|FG000|Overall Study|Adverse Event|0|||
105642456|NCT02935673|364354955|FG001|Overall Study|Adverse Event|1|||
105642457|NCT02935673|364354956|FG002|Overall Study|Adverse Event|0|||
105642458|NCT02935673|364354954|FG000|Overall Study|Withdrawal by Subject|1|||
105642459|NCT02935673|364354955|FG001|Overall Study|Withdrawal by Subject|2|||
105642460|NCT02935673|364354956|FG002|Overall Study|Withdrawal by Subject|0|||
105642461|NCT00813709|364354959|FG000|Double Blind Period|Adverse Event|4|||
105642462|NCT00813709|364354960|FG001|Double Blind Period|Adverse Event|1|||
105642463|NCT00813709|364354961|FG002|Double Blind Period|Adverse Event|4|||
105642464|NCT00813709|364354962|FG003|Double Blind Period|Adverse Event|0|||
105642465|NCT00813709|364354963|FG004|Double Blind Period|Adverse Event|0|||
105642466|NCT00813709|364354964|FG005|Double Blind Period|Adverse Event|0|||
105642467|NCT00813709|364354959|FG000|Double Blind Period|Lost to Follow-up|3|||
105642468|NCT00813709|364354960|FG001|Double Blind Period|Lost to Follow-up|2|||
105642469|NCT00813709|364354961|FG002|Double Blind Period|Lost to Follow-up|2|||
105642470|NCT00813709|364354962|FG003|Double Blind Period|Lost to Follow-up|0|||
105642471|NCT00813709|364354963|FG004|Double Blind Period|Lost to Follow-up|0|||
105642472|NCT00813709|364354964|FG005|Double Blind Period|Lost to Follow-up|0|||
105642473|NCT00813709|364354959|FG000|Double Blind Period|Switched to open label phase|9|||
105642474|NCT00813709|364354960|FG001|Double Blind Period|Switched to open label phase|26|||
105642475|NCT00813709|364354961|FG002|Double Blind Period|Switched to open label phase|18|||
105642476|NCT00813709|364354962|FG003|Double Blind Period|Switched to open label phase|0|||
105642477|NCT00813709|364354963|FG004|Double Blind Period|Switched to open label phase|0|||
105642478|NCT00813709|364354964|FG005|Double Blind Period|Switched to open label phase|0|||
105642479|NCT00813709|364354959|FG000|Double Blind Period|Randomized but not treated|1|||
105642480|NCT00813709|364354960|FG001|Double Blind Period|Randomized but not treated|3|||
105642481|NCT00813709|364354961|FG002|Double Blind Period|Randomized but not treated|1|||
105642482|NCT00813709|364354962|FG003|Double Blind Period|Randomized but not treated|0|||
105642483|NCT00813709|364354963|FG004|Double Blind Period|Randomized but not treated|0|||
105642484|NCT00813709|364354964|FG005|Double Blind Period|Randomized but not treated|0|||
105642485|NCT00813709|364354959|FG000|Double Blind Period|Other|14|||
105642486|NCT00813709|364354960|FG001|Double Blind Period|Other|9|||
105642487|NCT00813709|364354961|FG002|Double Blind Period|Other|6|||
105642488|NCT00813709|364354962|FG003|Double Blind Period|Other|0|||
105642489|NCT00813709|364354963|FG004|Double Blind Period|Other|0|||
105642490|NCT00813709|364354964|FG005|Double Blind Period|Other|0|||
105642491|NCT00813709|364354959|FG000|Open Label Period|Adverse Event|0|||
105642492|NCT00813709|364354960|FG001|Open Label Period|Adverse Event|0|||
105642493|NCT00813709|364354961|FG002|Open Label Period|Adverse Event|0|||
105642494|NCT00813709|364354962|FG003|Open Label Period|Adverse Event|5|||
105642495|NCT00813709|364354963|FG004|Open Label Period|Adverse Event|4|||
105642496|NCT00813709|364354964|FG005|Open Label Period|Adverse Event|3|||
105642497|NCT00813709|364354959|FG000|Open Label Period|Lack of Efficacy|0|||
105642498|NCT00813709|364354960|FG001|Open Label Period|Lack of Efficacy|0|||
105642499|NCT00813709|364354961|FG002|Open Label Period|Lack of Efficacy|0|||
105642500|NCT00813709|364354962|FG003|Open Label Period|Lack of Efficacy|3|||
105642501|NCT00813709|364354963|FG004|Open Label Period|Lack of Efficacy|1|||
105642502|NCT00813709|364354964|FG005|Open Label Period|Lack of Efficacy|1|||
105642503|NCT00813709|364354959|FG000|Open Label Period|Randomized but not treated|0|||
105642504|NCT00813709|364354960|FG001|Open Label Period|Randomized but not treated|0|||
105642505|NCT00813709|364354961|FG002|Open Label Period|Randomized but not treated|0|||
105642506|NCT00813709|364354962|FG003|Open Label Period|Randomized but not treated|1|||
105642507|NCT00813709|364354963|FG004|Open Label Period|Randomized but not treated|0|||
105642508|NCT00813709|364354964|FG005|Open Label Period|Randomized but not treated|1|||
105642509|NCT00813709|364354959|FG000|Open Label Period|Other|0|||
105642510|NCT00813709|364354960|FG001|Open Label Period|Other|0|||
105642511|NCT00813709|364354961|FG002|Open Label Period|Other|0|||
105642512|NCT00813709|364354962|FG003|Open Label Period|Other|11|||
105642513|NCT00813709|364354963|FG004|Open Label Period|Other|5|||
105642514|NCT00813709|364354964|FG005|Open Label Period|Other|6|||
105642515|NCT02753075|364354965|FG000|Overall Study|Adverse Event|2|||
105642516|NCT02753075|364354966|FG001|Overall Study|Adverse Event|1|||
105642517|NCT02753075|364354967|FG002|Overall Study|Adverse Event|0|||
105642518|NCT02753075|364354965|FG000|Overall Study|Lost to Follow-up|2|||
105642519|NCT02753075|364354966|FG001|Overall Study|Lost to Follow-up|0|||
105642520|NCT02753075|364354967|FG002|Overall Study|Lost to Follow-up|0|||
105642521|NCT02753075|364354965|FG000|Overall Study|Withdrawal of Consent|1|||
105642522|NCT02753075|364354966|FG001|Overall Study|Withdrawal of Consent|1|||
105642523|NCT02753075|364354967|FG002|Overall Study|Withdrawal of Consent|3|||
105642524|NCT02753075|364354965|FG000|Overall Study|Physician Decision|3|||
105642525|NCT02753075|364354966|FG001|Overall Study|Physician Decision|1|||
105642526|NCT02753075|364354967|FG002|Overall Study|Physician Decision|0|||
105642527|NCT01102426|364354976|FG000|Overall Study|Randomized but not treated|4|||
105642528|NCT01102426|364354977|FG001|Overall Study|Randomized but not treated|1|||
105642529|NCT01102426|364354976|FG000|Overall Study|Adverse Events (treatment-related)|15|||
105642530|NCT01102426|364354977|FG001|Overall Study|Adverse Events (treatment-related)|8|||
105642531|NCT01102426|364354976|FG000|Overall Study|Physician Decision|9|||
105642532|NCT01102426|364354977|FG001|Overall Study|Physician Decision|6|||
105642533|NCT01102426|364354976|FG000|Overall Study|Progressive Disease|85|||
105642534|NCT01102426|364354977|FG001|Overall Study|Progressive Disease|44|||
105642535|NCT01102426|364354976|FG000|Overall Study|Adverse Events (unrelated to|9|||
105642536|NCT01102426|364354977|FG001|Overall Study|Adverse Events (unrelated to|1|||
105642537|NCT01102426|364354976|FG000|Overall Study|Patient Refusal|24|||
105642538|NCT01102426|364354977|FG001|Overall Study|Patient Refusal|12|||
105642539|NCT01102426|364354976|FG000|Overall Study|Death (due to adverse events|0|||
105642540|NCT01102426|364354977|FG001|Overall Study|Death (due to adverse events|1|||
105642541|NCT01102426|364354976|FG000|Overall Study|Death (non-related to the study|19|||
105642542|NCT01102426|364354977|FG001|Overall Study|Death (non-related to the study|8|||
105642543|NCT03344458|364354978|FG000|Overall Study|Physician Decision|1|||
105642544|NCT03344458|364354978|FG000|Overall Study|Withdrawal by Subject|16|||
105642545|NCT03344458|364354978|FG000|Overall Study|Other reasons|10|||
105642546|NCT03344458|364354978|FG000|Overall Study|Lost to Follow-up|9|||
105642547|NCT03344458|364354978|FG000|Overall Study|Protocol Violation|3|||
105642548|NCT01393964|364354980|FG000|Overall Study|Disease Progression|4|||
105642549|NCT01393964|364354981|FG001|Overall Study|Disease Progression|3|||
105642550|NCT01393964|364354982|FG002|Overall Study|Disease Progression|5|||
105642551|NCT01393964|364354980|FG000|Overall Study|Study drug toxicity|1|||
105642552|NCT01393964|364354981|FG001|Overall Study|Study drug toxicity|0|||
105642553|NCT01393964|364354982|FG002|Overall Study|Study drug toxicity|0|||
105642554|NCT01393964|364354980|FG000|Overall Study|Withdrawal by Subject|0|||
105642555|NCT01393964|364354981|FG001|Overall Study|Withdrawal by Subject|0|||
105642556|NCT01393964|364354982|FG002|Overall Study|Withdrawal by Subject|1|||
105642557|NCT01393964|364354980|FG000|Overall Study|Adverse event unrelated to study drug|0|||
105642558|NCT01393964|364354981|FG001|Overall Study|Adverse event unrelated to study drug|3|||
105642559|NCT01393964|364354982|FG002|Overall Study|Adverse event unrelated to study drug|0|||
105642560|NCT01393964|364354980|FG000|Overall Study|Subject request stop study treatment|0|||
105642561|NCT01393964|364354981|FG001|Overall Study|Subject request stop study treatment|1|||
105642562|NCT01393964|364354982|FG002|Overall Study|Subject request stop study treatment|0|||
105642563|NCT01393964|364354980|FG000|Overall Study|Subject decided to move to transplant|1|||
105642564|NCT01393964|364354981|FG001|Overall Study|Subject decided to move to transplant|0|||
105642565|NCT01393964|364354982|FG002|Overall Study|Subject decided to move to transplant|0|||
105642566|NCT01393964|364354980|FG000|Overall Study|Subject switched to commercial supply|1|||
105642567|NCT01393964|364354981|FG001|Overall Study|Subject switched to commercial supply|0|||
105642568|NCT01393964|364354982|FG002|Overall Study|Subject switched to commercial supply|2|||
105642569|NCT01393964|364354980|FG000|Overall Study|Subject plateaued in terms of effect|1|||
105642570|NCT01393964|364354981|FG001|Overall Study|Subject plateaued in terms of effect|0|||
105642571|NCT01393964|364354982|FG002|Overall Study|Subject plateaued in terms of effect|0|||
105642572|NCT01393964|364354980|FG000|Overall Study|Investigator removed subject from study|0|||
105642573|NCT01393964|364354981|FG001|Overall Study|Investigator removed subject from study|1|||
105642574|NCT01393964|364354982|FG002|Overall Study|Investigator removed subject from study|0|||
105642575|NCT01393964|364354980|FG000|Overall Study|Subject converted to roll-over study|0|||
105642576|NCT01393964|364354981|FG001|Overall Study|Subject converted to roll-over study|1|||
105642577|NCT01393964|364354982|FG002|Overall Study|Subject converted to roll-over study|0|||
105642578|NCT01393964|364354980|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
105642579|NCT01393964|364354981|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
105642580|NCT01393964|364354982|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
105642581|NCT03265132|364354983|FG000|Overall Study|Adverse Event|0|||
105642582|NCT03265132|364354984|FG001|Overall Study|Adverse Event|1|||
105642583|NCT03265132|364354983|FG000|Overall Study|Lack of Efficacy|0|||
105642584|NCT03265132|364354984|FG001|Overall Study|Lack of Efficacy|2|||
105642585|NCT03265132|364354983|FG000|Overall Study|Progressive disease|0|||
105642586|NCT03265132|364354984|FG001|Overall Study|Progressive disease|2|||
105642587|NCT03265132|364354983|FG000|Overall Study|Withdrawal by Subject|0|||
105642588|NCT03265132|364354984|FG001|Overall Study|Withdrawal by Subject|1|||
105642589|NCT00088166|364354985|FG000|Overall Study|Adverse Event|11|||
105642590|NCT00088166|364354986|FG001|Overall Study|Adverse Event|9|||
105642591|NCT00088166|364354985|FG000|Overall Study|Death|3|||
105642592|NCT00088166|364354986|FG001|Overall Study|Death|1|||
105642593|NCT00088166|364354985|FG000|Overall Study|Lost to Follow-up|0|||
105642594|NCT00088166|364354986|FG001|Overall Study|Lost to Follow-up|1|||
105642595|NCT00088166|364354985|FG000|Overall Study|Physician Decision|4|||
105642596|NCT00088166|364354986|FG001|Overall Study|Physician Decision|1|||
105642597|NCT00088166|364354985|FG000|Overall Study|Protocol Violation|1|||
105642598|NCT00088166|364354986|FG001|Overall Study|Protocol Violation|5|||
105642599|NCT00088166|364354985|FG000|Overall Study|Patient deterioration|29|||
105642600|NCT00088166|364354986|FG001|Overall Study|Patient deterioration|39|||
105642601|NCT00088166|364354985|FG000|Overall Study|Withdrawal by Subject|5|||
105642602|NCT00088166|364354986|FG001|Overall Study|Withdrawal by Subject|5|||
105642603|NCT03131713|364354987|FG000|Overall Study|Lost to Follow-up|5|||
105642604|NCT03131713|364354988|FG001|Overall Study|Lost to Follow-up|0|||
105642605|NCT02542696|364354999|FG000|Overall Study|Adverse Event|167|||
105642606|NCT02542696|364354999|FG000|Overall Study|Lack of Efficacy|26|||
105642607|NCT02542696|364354999|FG000|Overall Study|Lost to Follow-up|6|||
105642608|NCT02542696|364354999|FG000|Overall Study|Withdrawal by Subject|104|||
105642609|NCT02542696|364354999|FG000|Overall Study|Protocol Violation|5|||
105642610|NCT02542696|364354999|FG000|Overall Study|Death|8|||
105642611|NCT02542696|364354999|FG000|Overall Study|DECREASED OFF TIME|1|||
105642612|NCT02542696|364354999|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
105642613|NCT02542696|364354999|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
105642614|NCT02542696|364354999|FG000|Overall Study|MEDICAL HISTORY|1|||
105642615|NCT02542696|364354999|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
105642616|NCT02542696|364354999|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
105642617|NCT02542696|364354999|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
105642618|NCT02542696|364354999|FG000|Overall Study|SPONSOR DECISION|3|||
105642619|NCT02542696|364354999|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
105642620|NCT02542696|364354999|FG000|Overall Study|SUBJECT DECISION|2|||
105642621|NCT02584257|364355000|FG000|Period 1|Withdrawal by Subject|0|||
105642622|NCT02584257|364355001|FG001|Period 1|Withdrawal by Subject|0|||
105642623|NCT02584257|364355002|FG002|Period 1|Withdrawal by Subject|0|||
105642624|NCT02584257|364355003|FG003|Period 1|Withdrawal by Subject|0|||
105642625|NCT02584257|364355004|FG004|Period 1|Withdrawal by Subject|0|||
105642626|NCT02584257|364355005|FG005|Period 1|Withdrawal by Subject|0|||
105642627|NCT02584257|364355006|FG006|Period 1|Withdrawal by Subject|1|||
105642628|NCT02584257|364355007|FG007|Period 1|Withdrawal by Subject|0|||
105642629|NCT02584257|364355008|FG008|Period 1|Withdrawal by Subject|0|||
105642630|NCT02584257|364355000|FG000|Period 2|Physician Decision|1|||
105642631|NCT02584257|364355001|FG001|Period 2|Physician Decision|0|||
105642632|NCT02584257|364355002|FG002|Period 2|Physician Decision|0|||
105642633|NCT02584257|364355003|FG003|Period 2|Physician Decision|0|||
105642634|NCT02584257|364355004|FG004|Period 2|Physician Decision|0|||
105642635|NCT02584257|364355005|FG005|Period 2|Physician Decision|0|||
105642636|NCT02584257|364355006|FG006|Period 2|Physician Decision|0|||
105642637|NCT02584257|364355007|FG007|Period 2|Physician Decision|0|||
105642638|NCT02584257|364355008|FG008|Period 2|Physician Decision|0|||
105642639|NCT02584257|364355000|FG000|Period 2|Adverse Event|0|||
105642640|NCT02584257|364355001|FG001|Period 2|Adverse Event|1|||
105642641|NCT02584257|364355002|FG002|Period 2|Adverse Event|0|||
105642642|NCT02584257|364355003|FG003|Period 2|Adverse Event|0|||
105642643|NCT02584257|364355004|FG004|Period 2|Adverse Event|0|||
105642644|NCT02584257|364355005|FG005|Period 2|Adverse Event|0|||
105642645|NCT02584257|364355006|FG006|Period 2|Adverse Event|0|||
105642646|NCT02584257|364355007|FG007|Period 2|Adverse Event|0|||
105642647|NCT02584257|364355008|FG008|Period 2|Adverse Event|0|||
105642648|NCT01543204|364355009|FG000|Overall Study|Non-compliance|1|||
105642649|NCT01543204|364355009|FG000|Overall Study|Adverse Event|1|||
105642650|NCT01543204|364355009|FG000|Overall Study|Withdrawal by Subject|4|||
105642651|NCT01543204|364355009|FG000|Overall Study|Requirement for Alternative Therapy|1|||
105642652|NCT01543204|364355009|FG000|Overall Study|Lost to Follow-up|1|||
105642653|NCT03146845|364355010|FG000|Overall Study|Reference ulcer healed|1|||
105642654|NCT03146845|364355011|FG001|Overall Study|Reference ulcer healed|0|||
105642655|NCT03146845|364355010|FG000|Overall Study|Physician Decision|1|||
105642656|NCT03146845|364355011|FG001|Overall Study|Physician Decision|0|||
105642657|NCT03146845|364355010|FG000|Overall Study|Adverse Event|1|||
105642658|NCT03146845|364355011|FG001|Overall Study|Adverse Event|0|||
105642659|NCT03146845|364355010|FG000|Overall Study|Withdrawal by Subject|2|||
105642660|NCT03146845|364355011|FG001|Overall Study|Withdrawal by Subject|0|||
105642661|NCT03146845|364355010|FG000|Overall Study|Noncompliance|0|||
105642662|NCT03146845|364355011|FG001|Overall Study|Noncompliance|1|||
105642663|NCT03146845|364355010|FG000|Overall Study|Protocol Violation|0|||
105642664|NCT03146845|364355011|FG001|Overall Study|Protocol Violation|2|||
105642665|NCT03146845|364355010|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
105642666|NCT03146845|364355011|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
105642667|NCT01535261|364355015|FG000|Overall Study|Physician Decision|8|||
105642668|NCT01535261|364355015|FG000|Overall Study|Protocol Violation|3|||
105642669|NCT01535261|364355015|FG000|Overall Study|Death|5|||
105642670|NCT01535261|364355015|FG000|Overall Study|Lost to Follow-up|8|||
105642671|NCT01535261|364355015|FG000|Overall Study|Withdrawal by Subject|14|||
105642672|NCT01535261|364355015|FG000|Overall Study|Adverse Event|12|||
105642673|NCT03326856|364355018|FG000|Overall Study|Lost to Follow-up|1|||
105642674|NCT03326856|364355019|FG001|Overall Study|Lost to Follow-up|1|||
105642675|NCT03326856|364355020|FG002|Overall Study|Lost to Follow-up|0|||
105642676|NCT03326856|364355021|FG003|Overall Study|Lost to Follow-up|0|||
105642677|NCT03326856|364355022|FG004|Overall Study|Lost to Follow-up|0|||
105642678|NCT00472082|364355023|FG000|Overall Study|Study prematurely terminated|5|||
105642679|NCT02206607|364355024|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
105642680|NCT02206607|364355025|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
105642681|NCT02206607|364355026|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
105642682|NCT02206607|364355027|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
105642683|NCT02206607|364355028|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
105642684|NCT02206607|364355024|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
105642685|NCT02206607|364355025|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
105642686|NCT02206607|364355026|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
105642687|NCT02206607|364355027|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
105642688|NCT02206607|364355028|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
105642689|NCT02991118|364355029|FG000|Overall Study|Death|3|||
105642690|NCT02991118|364355030|FG001|Overall Study|Death|8|||
105642691|NCT02991118|364355029|FG000|Overall Study|Protocol Violation|0|||
105642692|NCT02991118|364355030|FG001|Overall Study|Protocol Violation|3|||
105642693|NCT02991118|364355029|FG000|Overall Study|Physician Decision|0|||
105642694|NCT02991118|364355030|FG001|Overall Study|Physician Decision|1|||
105642695|NCT02991118|364355029|FG000|Overall Study|Moved out of the country|0|||
105642696|NCT02991118|364355030|FG001|Overall Study|Moved out of the country|1|||
105642697|NCT02991118|364355029|FG000|Overall Study|Adverse Event|2|||
105642698|NCT02991118|364355030|FG001|Overall Study|Adverse Event|2|||
105642699|NCT02991118|364355029|FG000|Overall Study|Withdrawal by Subject|1|||
105642700|NCT02991118|364355030|FG001|Overall Study|Withdrawal by Subject|7|||
105642701|NCT02991118|364355029|FG000|Overall Study|Could not attend study visits|0|||
105642702|NCT02991118|364355030|FG001|Overall Study|Could not attend study visits|1|||
105642703|NCT02991118|364355029|FG000|Overall Study|Lost to Follow-up|1|||
105642704|NCT02991118|364355030|FG001|Overall Study|Lost to Follow-up|9|||
105642705|NCT01777932|364355034|FG000|Overall Study|Disease progression|136|||
105642706|NCT01777932|364355034|FG000|Overall Study|Death|3|||
105642707|NCT01777932|364355034|FG000|Overall Study|Adverse Event|34|||
105642708|NCT01777932|364355034|FG000|Overall Study|Lost to Follow-up|3|||
105642709|NCT01777932|364355034|FG000|Overall Study|Investigator decision|10|||
105642710|NCT01777932|364355034|FG000|Overall Study|Reimbursement limit|9|||
105642711|NCT01777932|364355034|FG000|Overall Study|Patient refused further treatment|10|||
105642712|NCT02514824|364355035|FG000|Overall Study|Withdrawal by Subject|1|||
105642713|NCT02514824|364355036|FG001|Overall Study|Withdrawal by Subject|0|||
105642714|NCT02514824|364355037|FG002|Overall Study|Withdrawal by Subject|0|||
105642715|NCT02514824|364355038|FG003|Overall Study|Withdrawal by Subject|0|||
105642716|NCT02514824|364355035|FG000|Overall Study|Dose-Limiting Toxicity|0|||
105642717|NCT02514824|364355036|FG001|Overall Study|Dose-Limiting Toxicity|1|||
105642718|NCT02514824|364355037|FG002|Overall Study|Dose-Limiting Toxicity|0|||
105642719|NCT02514824|364355038|FG003|Overall Study|Dose-Limiting Toxicity|0|||
105642720|NCT01138657|364355039|FG000|Overall Study|Adverse Event|3|||
105642721|NCT01138657|364355040|FG001|Overall Study|Adverse Event|10|||
105642722|NCT01138657|364355039|FG000|Overall Study|Lack of Efficacy|2|||
105642723|NCT01138657|364355040|FG001|Overall Study|Lack of Efficacy|1|||
105642724|NCT01138657|364355039|FG000|Overall Study|Lost to Follow-up|0|||
105642725|NCT01138657|364355040|FG001|Overall Study|Lost to Follow-up|3|||
105642726|NCT01138657|364355039|FG000|Overall Study|Miscellaneous Reasons|3|||
105642727|NCT01138657|364355040|FG001|Overall Study|Miscellaneous Reasons|4|||
105642728|NCT02574286|364355041|FG000|Overall Study|Adverse Event|3|||
105642729|NCT02574286|364355041|FG000|Overall Study|Withdrawal by Subject|2|||
105642730|NCT02764320|364355042|FG000|Overall Study|Withdrawal by Subject|35|||
105642731|NCT02764320|364355043|FG001|Overall Study|Withdrawal by Subject|38|||
105642732|NCT02764320|364355042|FG000|Overall Study|Protocol Violation|11|||
105642733|NCT02764320|364355043|FG001|Overall Study|Protocol Violation|6|||
105642734|NCT02764320|364355042|FG000|Overall Study|Adverse Event|2|||
105642735|NCT02764320|364355043|FG001|Overall Study|Adverse Event|0|||
105642736|NCT02764320|364355042|FG000|Overall Study|Health Issues unable to continue|2|||
105642737|NCT02764320|364355043|FG001|Overall Study|Health Issues unable to continue|0|||
105642738|NCT02764320|364355042|FG000|Overall Study|Did not meet inclusion criteria|1|||
105642739|NCT02764320|364355043|FG001|Overall Study|Did not meet inclusion criteria|0|||
105642740|NCT02764320|364355042|FG000|Overall Study|Subject moved|0|||
105642741|NCT02764320|364355043|FG001|Overall Study|Subject moved|2|||
105642742|NCT02764320|364355042|FG000|Overall Study|Overused medication unavailable|0|||
105642743|NCT02764320|364355043|FG001|Overall Study|Overused medication unavailable|1|||
105642744|NCT02764320|364355042|FG000|Overall Study|Seeking care outside site|0|||
105642745|NCT02764320|364355043|FG001|Overall Study|Seeking care outside site|1|||
105642746|NCT02764320|364355042|FG000|Overall Study|Technology barriers|0|||
105642747|NCT02764320|364355043|FG001|Overall Study|Technology barriers|1|||
105642748|NCT02516202|364355047|FG000|Overall Study|Withdrawal by Subject|1|||
105642749|NCT02516202|364355048|FG001|Overall Study|Withdrawal by Subject|0|||
105642750|NCT02516202|364355049|FG002|Overall Study|Withdrawal by Subject|1|||
105642751|NCT02516202|364355047|FG000|Overall Study|Lost to Follow-up|1|||
105642752|NCT02516202|364355048|FG001|Overall Study|Lost to Follow-up|1|||
105642753|NCT02516202|364355049|FG002|Overall Study|Lost to Follow-up|1|||
105642754|NCT02516202|364355047|FG000|Overall Study|Stopped Follow-up|0|||
105642755|NCT02516202|364355048|FG001|Overall Study|Stopped Follow-up|0|||
105642756|NCT02516202|364355049|FG002|Overall Study|Stopped Follow-up|1|||
105642757|NCT00409747|364355054|FG000|Overall Study|Withdrawal by Subject|1|||
105642758|NCT00636168|364355055|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
105642759|NCT00636168|364355056|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
105642760|NCT00636168|364355055|FG000|Randomized to Study Drug|Adverse Event|1|||
105642761|NCT00636168|364355056|FG001|Randomized to Study Drug|Adverse Event|0|||
105642762|NCT00636168|364355055|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
105642763|NCT00636168|364355056|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
105642764|NCT00636168|364355055|FG000|Treated With Study Drug|Recurrence of disease|135|||
105642765|NCT00636168|364355056|FG001|Treated With Study Drug|Recurrence of disease|282|||
105642766|NCT00636168|364355055|FG000|Treated With Study Drug|Adverse Event|250|||
105642767|NCT00636168|364355056|FG001|Treated With Study Drug|Adverse Event|22|||
105642768|NCT00636168|364355055|FG000|Treated With Study Drug|Participant withdrew consent|16|||
105642769|NCT00636168|364355056|FG001|Treated With Study Drug|Participant withdrew consent|21|||
105642770|NCT00636168|364355055|FG000|Treated With Study Drug|Poor/non-compliance|1|||
105642771|NCT00636168|364355056|FG001|Treated With Study Drug|Poor/non-compliance|3|||
105642772|NCT00636168|364355055|FG000|Treated With Study Drug|Death|3|||
105642773|NCT00636168|364355056|FG001|Treated With Study Drug|Death|0|||
105642774|NCT00636168|364355055|FG000|Treated With Study Drug|Pregnancy|1|||
105642775|NCT00636168|364355056|FG001|Treated With Study Drug|Pregnancy|0|||
105642776|NCT00636168|364355055|FG000|Treated With Study Drug|No longer meets study criteria|1|||
105642777|NCT00636168|364355056|FG001|Treated With Study Drug|No longer meets study criteria|0|||
105642778|NCT00636168|364355055|FG000|Treated With Study Drug|Other reason|1|||
105642779|NCT00636168|364355056|FG001|Treated With Study Drug|Other reason|3|||
105642780|NCT00636168|364355055|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
105642781|NCT00636168|364355056|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
105642782|NCT00636168|364355055|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
105642783|NCT00636168|364355056|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
105642784|NCT00636168|364355055|FG000|Long Term Follow-Up|Death|8|||
105642785|NCT00636168|364355056|FG001|Long Term Follow-Up|Death|9|||
105642786|NCT02006641|364355057|FG000|Overall Study|Withdrawal before treatment|2|||
105642787|NCT02006641|364355058|FG001|Overall Study|Withdrawal before treatment|5|||
105642788|NCT02006641|364355059|FG002|Overall Study|Withdrawal before treatment|3|||
105642789|NCT02006641|364355057|FG000|Overall Study|Adverse Event|15|||
105642790|NCT02006641|364355058|FG001|Overall Study|Adverse Event|11|||
105642791|NCT02006641|364355059|FG002|Overall Study|Adverse Event|15|||
105642792|NCT02006641|364355057|FG000|Overall Study|Protocol Violation|0|||
105642793|NCT02006641|364355058|FG001|Overall Study|Protocol Violation|2|||
105642794|NCT02006641|364355059|FG002|Overall Study|Protocol Violation|2|||
105642795|NCT02006641|364355057|FG000|Overall Study|Lost to Follow-up|0|||
105642796|NCT02006641|364355058|FG001|Overall Study|Lost to Follow-up|1|||
105642797|NCT02006641|364355059|FG002|Overall Study|Lost to Follow-up|0|||
105642798|NCT02006641|364355057|FG000|Overall Study|Withdrawal by Subject|7|||
105642799|NCT02006641|364355058|FG001|Overall Study|Withdrawal by Subject|12|||
105642800|NCT02006641|364355059|FG002|Overall Study|Withdrawal by Subject|11|||
105642801|NCT02006641|364355057|FG000|Overall Study|Other reason: patient didn't show up|1|||
105642802|NCT02006641|364355058|FG001|Overall Study|Other reason: patient didn't show up|0|||
105642803|NCT02006641|364355059|FG002|Overall Study|Other reason: patient didn't show up|0|||
105642804|NCT02006641|364355057|FG000|Overall Study|Other reason:patient didn't want to come|0|||
105642805|NCT02006641|364355058|FG001|Overall Study|Other reason:patient didn't want to come|0|||
105642806|NCT02006641|364355059|FG002|Overall Study|Other reason:patient didn't want to come|1|||
105642807|NCT02006641|364355057|FG000|Overall Study|Other reason: patient has moved|1|||
105642808|NCT02006641|364355058|FG001|Overall Study|Other reason: patient has moved|0|||
105642809|NCT02006641|364355059|FG002|Overall Study|Other reason: patient has moved|1|||
105642810|NCT02006641|364355057|FG000|Overall Study|Other reason: caregiver in hospital|0|||
105642811|NCT02006641|364355058|FG001|Overall Study|Other reason: caregiver in hospital|1|||
105642812|NCT02006641|364355059|FG002|Overall Study|Other reason: caregiver in hospital|0|||
105642813|NCT02006641|364355057|FG000|Overall Study|Other reason: patient's wife has died|0|||
105642814|NCT02006641|364355058|FG001|Overall Study|Other reason: patient's wife has died|0|||
105642815|NCT02006641|364355059|FG002|Overall Study|Other reason: patient's wife has died|1|||
105642816|NCT02006641|364355057|FG000|Overall Study|Other reason: hospitalisation|0|||
105642817|NCT02006641|364355058|FG001|Overall Study|Other reason: hospitalisation|1|||
105642818|NCT02006641|364355059|FG002|Overall Study|Other reason: hospitalisation|0|||
105642819|NCT02006641|364355057|FG000|Overall Study|Other reason: caregiver impossibility|0|||
105642820|NCT02006641|364355058|FG001|Overall Study|Other reason: caregiver impossibility|0|||
105642821|NCT02006641|364355059|FG002|Overall Study|Other reason: caregiver impossibility|1|||
105642822|NCT02006641|364355057|FG000|Overall Study|Other reason: protocol non-compliance|0|||
105642823|NCT02006641|364355058|FG001|Overall Study|Other reason: protocol non-compliance|0|||
105642824|NCT02006641|364355059|FG002|Overall Study|Other reason: protocol non-compliance|1|||
105642825|NCT02132195|364355064|FG000|Initial Assignment|Relapsed|14|||
105642826|NCT02132195|364355065|FG001|Initial Assignment|Relapsed|0|||
105642827|NCT02132195|364355066|FG002|Initial Assignment|Relapsed|0|||
105642828|NCT02132195|364355064|FG000|Rescue Therapy|Relapsed|0|||
105642829|NCT02132195|364355065|FG001|Rescue Therapy|Relapsed|0|||
105642830|NCT02132195|364355066|FG002|Rescue Therapy|Relapsed|7|||
105642831|NCT02132195|364355064|FG000|Rescue Therapy|Physician Decision|0|||
105642832|NCT02132195|364355065|FG001|Rescue Therapy|Physician Decision|0|||
105642833|NCT02132195|364355066|FG002|Rescue Therapy|Physician Decision|1|||
105642834|NCT02132195|364355064|FG000|Rescue Therapy|Withdrawal by Subject|0|||
105642835|NCT02132195|364355065|FG001|Rescue Therapy|Withdrawal by Subject|0|||
105642836|NCT02132195|364355066|FG002|Rescue Therapy|Withdrawal by Subject|1|||
105642837|NCT02132195|364355064|FG000|Rescue Therapy|Adverse Event|0|||
105642838|NCT02132195|364355065|FG001|Rescue Therapy|Adverse Event|0|||
105642839|NCT02132195|364355066|FG002|Rescue Therapy|Adverse Event|2|||
105642840|NCT02102724|364355069|FG000|Overall Study|Lost to Follow-up|1|||
105642841|NCT02102724|364355070|FG001|Overall Study|Lost to Follow-up|0|||
105642842|NCT02102724|364355069|FG000|Overall Study|surgery for brain aneurysm|1|||
105642843|NCT02102724|364355070|FG001|Overall Study|surgery for brain aneurysm|1|||
105642844|NCT00736502|364355071|FG000|Overall Study|Adverse Event|22|||
105642845|NCT00736502|364355071|FG000|Overall Study|Lack of Efficacy|16|||
105642846|NCT00736502|364355071|FG000|Overall Study|Lost to Follow-up|27|||
105642847|NCT01307800|364355072|FG000|Overall Study|Adverse Event|9|||
105642848|NCT01307800|364355073|FG001|Overall Study|Adverse Event|8|||
105642849|NCT01307800|364355074|FG002|Overall Study|Adverse Event|10|||
105642850|NCT01307800|364355075|FG003|Overall Study|Adverse Event|14|||
105642851|NCT01307800|364355072|FG000|Overall Study|Entry Criteria Not Met|0|||
105642852|NCT01307800|364355073|FG001|Overall Study|Entry Criteria Not Met|0|||
105642853|NCT01307800|364355074|FG002|Overall Study|Entry Criteria Not Met|0|||
105642854|NCT01307800|364355075|FG003|Overall Study|Entry Criteria Not Met|2|||
105642855|NCT01307800|364355072|FG000|Overall Study|Lost to Follow-up|5|||
105642856|NCT01307800|364355073|FG001|Overall Study|Lost to Follow-up|6|||
105642857|NCT01307800|364355074|FG002|Overall Study|Lost to Follow-up|2|||
105642858|NCT01307800|364355075|FG003|Overall Study|Lost to Follow-up|8|||
105642859|NCT01307800|364355072|FG000|Overall Study|Perceived Lack of Efficacy|24|||
105642860|NCT01307800|364355073|FG001|Overall Study|Perceived Lack of Efficacy|23|||
105642861|NCT01307800|364355074|FG002|Overall Study|Perceived Lack of Efficacy|20|||
105642862|NCT01307800|364355075|FG003|Overall Study|Perceived Lack of Efficacy|33|||
105642863|NCT01307800|364355072|FG000|Overall Study|Protocol Violation|0|||
105642864|NCT01307800|364355073|FG001|Overall Study|Protocol Violation|3|||
105642865|NCT01307800|364355074|FG002|Overall Study|Protocol Violation|4|||
105642866|NCT01307800|364355075|FG003|Overall Study|Protocol Violation|5|||
105642867|NCT01307800|364355072|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
105642868|NCT01307800|364355073|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
105642869|NCT01307800|364355074|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
105642870|NCT01307800|364355075|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
105642871|NCT01307800|364355072|FG000|Overall Study|Sponsor Decision|6|||
105642872|NCT01307800|364355073|FG001|Overall Study|Sponsor Decision|9|||
105642873|NCT01307800|364355074|FG002|Overall Study|Sponsor Decision|12|||
105642874|NCT01307800|364355075|FG003|Overall Study|Sponsor Decision|28|||
105642875|NCT01307800|364355072|FG000|Overall Study|Withdrawal by Subject|10|||
105642876|NCT01307800|364355073|FG001|Overall Study|Withdrawal by Subject|11|||
105642877|NCT01307800|364355074|FG002|Overall Study|Withdrawal by Subject|8|||
105642878|NCT01307800|364355075|FG003|Overall Study|Withdrawal by Subject|15|||
105642879|NCT01307800|364355072|FG000|Overall Study|Participant Moved|0|||
105642880|NCT01307800|364355073|FG001|Overall Study|Participant Moved|2|||
105642881|NCT01307800|364355074|FG002|Overall Study|Participant Moved|1|||
105642882|NCT01307800|364355075|FG003|Overall Study|Participant Moved|3|||
105642883|NCT01334606|364355076|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
105642884|NCT02255474|364355077|FG000|Overall Study|Lost to Follow-up|1|||
105642885|NCT02255474|364355078|FG001|Overall Study|Lost to Follow-up|1|||
105642886|NCT02255474|364355079|FG002|Overall Study|Lost to Follow-up|3|||
105642887|NCT02255474|364355077|FG000|Overall Study|Withdrawal by Subject|1|||
105642888|NCT02255474|364355078|FG001|Overall Study|Withdrawal by Subject|1|||
105642889|NCT02255474|364355079|FG002|Overall Study|Withdrawal by Subject|0|||
105642890|NCT00882050|364355081|FG000|Overall Study|Physician Decision|1|||
105642891|NCT00882050|364355082|FG001|Overall Study|Physician Decision|0|||
105642892|NCT00882050|364355083|FG002|Overall Study|Physician Decision|0|||
105642893|NCT02010684|364355084|FG000|Overall Study|Lost to Follow-up|8|||
105642894|NCT02010684|364355085|FG001|Overall Study|Lost to Follow-up|18|||
105642895|NCT02010684|364355084|FG000|Overall Study|Withdrawal by Subject|4|||
105642896|NCT02010684|364355085|FG001|Overall Study|Withdrawal by Subject|5|||
105642897|NCT02548585|364355086|FG000|Overall Study|Withdrawal by Subject|0|||
105642898|NCT02548585|364355087|FG001|Overall Study|Withdrawal by Subject|0|||
105642899|NCT02548585|364355088|FG002|Overall Study|Withdrawal by Subject|0|||
105642900|NCT02548585|364355089|FG003|Overall Study|Withdrawal by Subject|0|||
105642901|NCT02548585|364355090|FG004|Overall Study|Withdrawal by Subject|0|||
105642902|NCT02548585|364355091|FG005|Overall Study|Withdrawal by Subject|1|||
105642903|NCT02548585|364355092|FG006|Overall Study|Withdrawal by Subject|0|||
105642904|NCT02548585|364355086|FG000|Overall Study|Lost to Follow-up|1|||
105642905|NCT02548585|364355087|FG001|Overall Study|Lost to Follow-up|0|||
105642906|NCT02548585|364355088|FG002|Overall Study|Lost to Follow-up|0|||
105642907|NCT02548585|364355089|FG003|Overall Study|Lost to Follow-up|0|||
105642908|NCT02548585|364355090|FG004|Overall Study|Lost to Follow-up|0|||
105642909|NCT02548585|364355091|FG005|Overall Study|Lost to Follow-up|0|||
105642910|NCT02548585|364355092|FG006|Overall Study|Lost to Follow-up|0|||
105642911|NCT02548585|364355086|FG000|Overall Study|Other|1|||
105642912|NCT02548585|364355087|FG001|Overall Study|Other|0|||
105642913|NCT02548585|364355088|FG002|Overall Study|Other|0|||
105642914|NCT02548585|364355089|FG003|Overall Study|Other|2|||
105642915|NCT02548585|364355090|FG004|Overall Study|Other|3|||
105642916|NCT02548585|364355091|FG005|Overall Study|Other|0|||
105642917|NCT02548585|364355092|FG006|Overall Study|Other|1|||
105642918|NCT02548585|364355086|FG000|Overall Study|Randomized but not treated|0|||
105642919|NCT02548585|364355087|FG001|Overall Study|Randomized but not treated|0|||
105642920|NCT02548585|364355088|FG002|Overall Study|Randomized but not treated|0|||
105642921|NCT02548585|364355089|FG003|Overall Study|Randomized but not treated|0|||
105642922|NCT02548585|364355090|FG004|Overall Study|Randomized but not treated|0|||
105642923|NCT02548585|364355091|FG005|Overall Study|Randomized but not treated|1|||
105642924|NCT02548585|364355092|FG006|Overall Study|Randomized but not treated|0|||
105642925|NCT02612285|364355093|FG000|Overall Study|Withdrawal by Subject|1|||
105642926|NCT01986348|364355094|FG000|Overall Study|Death|8|||
105642927|NCT01986348|364355095|FG001|Overall Study|Death|22|||
105642928|NCT01986348|364355096|FG002|Overall Study|Death|10|||
105642929|NCT01986348|364355097|FG003|Overall Study|Death|21|||
105642930|NCT01986348|364355094|FG000|Overall Study|Lost to Follow-up|0|||
105642931|NCT01986348|364355095|FG001|Overall Study|Lost to Follow-up|0|||
105642932|NCT01986348|364355096|FG002|Overall Study|Lost to Follow-up|0|||
105642933|NCT01986348|364355097|FG003|Overall Study|Lost to Follow-up|2|||
105642934|NCT01986348|364355094|FG000|Overall Study|Physician Decision|0|||
105642935|NCT01986348|364355095|FG001|Overall Study|Physician Decision|0|||
105642936|NCT01986348|364355096|FG002|Overall Study|Physician Decision|0|||
105642937|NCT01986348|364355097|FG003|Overall Study|Physician Decision|1|||
105642938|NCT01986348|364355094|FG000|Overall Study|Progressive Disease|0|||
105642939|NCT01986348|364355095|FG001|Overall Study|Progressive Disease|0|||
105642940|NCT01986348|364355096|FG002|Overall Study|Progressive Disease|2|||
105642941|NCT01986348|364355097|FG003|Overall Study|Progressive Disease|0|||
105642942|NCT01986348|364355094|FG000|Overall Study|Withdrawal by Participant|0|||
105642943|NCT01986348|364355095|FG001|Overall Study|Withdrawal by Participant|1|||
105642944|NCT01986348|364355096|FG002|Overall Study|Withdrawal by Participant|2|||
105642945|NCT01986348|364355097|FG003|Overall Study|Withdrawal by Participant|1|||
105642946|NCT01986348|364355094|FG000|Overall Study|Study Terminated by Sponsor|0|||
105642947|NCT01986348|364355095|FG001|Overall Study|Study Terminated by Sponsor|0|||
105642948|NCT01986348|364355096|FG002|Overall Study|Study Terminated by Sponsor|0|||
105642949|NCT01986348|364355097|FG003|Overall Study|Study Terminated by Sponsor|3|||
105642950|NCT01986348|364355094|FG000|Overall Study|Other-unspecified|0|||
105642951|NCT01986348|364355095|FG001|Overall Study|Other-unspecified|1|||
105642952|NCT01986348|364355096|FG002|Overall Study|Other-unspecified|0|||
105642953|NCT01986348|364355097|FG003|Overall Study|Other-unspecified|2|||
105642954|NCT00805441|364355098|FG000|Overall Study|Adverse Event|5|||
105642955|NCT00805441|364355099|FG001|Overall Study|Adverse Event|2|||
105642956|NCT00805441|364355098|FG000|Overall Study|Lack of Efficacy|0|||
105642957|NCT00805441|364355099|FG001|Overall Study|Lack of Efficacy|2|||
105642958|NCT00805441|364355098|FG000|Overall Study|Protocol Violation|4|||
105642959|NCT00805441|364355099|FG001|Overall Study|Protocol Violation|8|||
105642960|NCT00805441|364355098|FG000|Overall Study|Lost to Follow-up|10|||
105642961|NCT00805441|364355099|FG001|Overall Study|Lost to Follow-up|13|||
105642962|NCT00805441|364355098|FG000|Overall Study|Withdrawal by Subject|15|||
105642963|NCT00805441|364355099|FG001|Overall Study|Withdrawal by Subject|9|||
105642964|NCT00805441|364355098|FG000|Overall Study|Physician Decision|0|||
105642965|NCT00805441|364355099|FG001|Overall Study|Physician Decision|1|||
105642966|NCT00805441|364355098|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
105642967|NCT00805441|364355099|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
105642968|NCT03242863|364355106|FG000|Study Week 1|Withdrawal by Subject|0|||
105642969|NCT03242863|364355107|FG001|Study Week 1|Withdrawal by Subject|1|||
105642970|NCT03242863|364355108|FG002|Study Week 1|Withdrawal by Subject|0|||
105642971|NCT03242863|364355109|FG003|Study Week 1|Withdrawal by Subject|0|||
105642972|NCT03242863|364355110|FG004|Study Week 1|Withdrawal by Subject|3|||
105642973|NCT03242863|364355111|FG005|Study Week 1|Withdrawal by Subject|0|||
105642974|NCT05487300|364357116|FG000|Overall Study|Withdrawal by Subject|1|||
105642975|NCT05487300|364357117|FG001|Overall Study|Withdrawal by Subject|0|||
105642976|NCT01286311|364357119|FG000|Overall Study|Physician did not want outreach sent|14|||
105642977|NCT01286311|364357120|FG001|Overall Study|Physician did not want outreach sent|0|||
105642978|NCT00403845|364357121|FG000|Treatment Period 1|Subject withdrew consent|1|||
105642979|NCT00403845|364357122|FG001|Treatment Period 1|Subject withdrew consent|0|||
105642980|NCT00403845|364357123|FG002|Treatment Period 1|Subject withdrew consent|0|||
105642981|NCT00403845|364357124|FG003|Treatment Period 1|Subject withdrew consent|0|||
105642982|NCT00403845|364357121|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
105642983|NCT00403845|364357122|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
105642984|NCT00403845|364357123|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
105642985|NCT00403845|364357124|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
105642986|NCT00403845|364357121|FG000|Treatment Period 2|Subject withdrew consent|1|||
105642987|NCT00403845|364357122|FG001|Treatment Period 2|Subject withdrew consent|0|||
105642988|NCT00403845|364357123|FG002|Treatment Period 2|Subject withdrew consent|0|||
105642989|NCT00403845|364357124|FG003|Treatment Period 2|Subject withdrew consent|0|||
105642990|NCT00403845|364357121|FG000|Treatment Period 3|Subject withdrew consent|0|||
105642991|NCT00403845|364357122|FG001|Treatment Period 3|Subject withdrew consent|0|||
105642992|NCT00403845|364357123|FG002|Treatment Period 3|Subject withdrew consent|0|||
105642993|NCT00403845|364357124|FG003|Treatment Period 3|Subject withdrew consent|1|||
105642994|NCT00403845|364357121|FG000|Treatment Period 3|Adverse Event|0|||
105642995|NCT00403845|364357122|FG001|Treatment Period 3|Adverse Event|0|||
105642996|NCT00403845|364357123|FG002|Treatment Period 3|Adverse Event|0|||
105642997|NCT00403845|364357124|FG003|Treatment Period 3|Adverse Event|1|||
105642998|NCT04328467|364357127|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
105642999|NCT04328467|364357128|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
105643000|NCT04328467|364357129|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
105643001|NCT03409276|364357130|FG000|Overall Study|Withdrawal by Subject|0|||
105643002|NCT03409276|364357131|FG001|Overall Study|Withdrawal by Subject|0|||
105643003|NCT03409276|364357132|FG002|Overall Study|Withdrawal by Subject|0|||
105643004|NCT03409276|364357133|FG003|Overall Study|Withdrawal by Subject|0|||
105643005|NCT03409276|364357134|FG004|Overall Study|Withdrawal by Subject|1|||
105643006|NCT03409276|364357130|FG000|Overall Study|Lost to Follow-up|0|||
105643007|NCT03409276|364357131|FG001|Overall Study|Lost to Follow-up|0|||
105643008|NCT03409276|364357132|FG002|Overall Study|Lost to Follow-up|0|||
105643009|NCT03409276|364357133|FG003|Overall Study|Lost to Follow-up|2|||
105643010|NCT03409276|364357134|FG004|Overall Study|Lost to Follow-up|2|||
105643011|NCT02011568|364357135|FG000|Overall Study|Withdrawal by Subject|8|||
105643012|NCT02011568|364357136|FG001|Overall Study|Withdrawal by Subject|10|||
105643013|NCT02011568|364357135|FG000|Overall Study|Physician Decision|1|||
105870219|NCT01074944|365176970|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
105643014|NCT02011568|364357136|FG001|Overall Study|Physician Decision|3|||
105643015|NCT02152384|364357137|FG000|Period 1|Withdrawal by Subject|0|||
105643016|NCT02152384|364357138|FG001|Period 1|Withdrawal by Subject|1|||
105643017|NCT02152384|364357137|FG000|Period 1|Adverse Event|1|||
105643018|NCT02152384|364357138|FG001|Period 1|Adverse Event|1|||
105643019|NCT01322386|364357141|FG000|Overall Study|Protocol Violation|0|||
105643020|NCT01322386|364357142|FG001|Overall Study|Protocol Violation|1|||
105643021|NCT01322386|364357141|FG000|Overall Study|Physician Decision|0|||
105643022|NCT01322386|364357142|FG001|Overall Study|Physician Decision|1|||
105643023|NCT01109979|364357148|FG000|Overall Study|Physician Decision|2|||
105643024|NCT01109979|364357149|FG001|Overall Study|Physician Decision|0|||
105643025|NCT01109979|364357148|FG000|Overall Study|Withdrawal by Subject|0|||
105643026|NCT01109979|364357149|FG001|Overall Study|Withdrawal by Subject|1|||
105643027|NCT01670877|364357151|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643028|NCT01670877|364357152|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
105643029|NCT01670877|364357153|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643030|NCT01670877|364357154|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643031|NCT01670877|364357155|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643032|NCT01670877|364357156|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
105643033|NCT01670877|364357151|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643034|NCT01670877|364357152|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643035|NCT01670877|364357153|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
105643036|NCT01670877|364357154|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643037|NCT01670877|364357155|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643038|NCT01670877|364357156|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
105643039|NCT01670877|364357151|FG000|Part I and Part 2|Grade 2 vomiting|0|||
105643040|NCT01670877|364357152|FG001|Part I and Part 2|Grade 2 vomiting|0|||
105643041|NCT01670877|364357153|FG002|Part I and Part 2|Grade 2 vomiting|0|||
105643042|NCT01670877|364357154|FG003|Part I and Part 2|Grade 2 vomiting|1|||
105643043|NCT01670877|364357155|FG004|Part I and Part 2|Grade 2 vomiting|0|||
105643044|NCT01670877|364357156|FG005|Part I and Part 2|Grade 2 vomiting|0|||
105643045|NCT01670877|364357151|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643046|NCT01670877|364357152|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643047|NCT01670877|364357153|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643048|NCT01670877|364357154|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
105643049|NCT01670877|364357155|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643050|NCT01670877|364357156|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
105643051|NCT01670877|364357151|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643052|NCT01670877|364357152|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643053|NCT01670877|364357153|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643054|NCT01670877|364357154|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
105643055|NCT01670877|364357155|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643056|NCT01670877|364357156|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
105643057|NCT02009332|364357159|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643058|NCT02009332|364357160|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
105643059|NCT02009332|364357161|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643060|NCT02009332|364357162|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643061|NCT02009332|364357163|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643062|NCT02009332|364357164|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
105643063|NCT02009332|364357159|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643064|NCT02009332|364357160|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643065|NCT02009332|364357161|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643066|NCT02009332|364357162|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643067|NCT02009332|364357163|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
105643068|NCT02009332|364357164|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
105643069|NCT02009332|364357159|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643070|NCT02009332|364357160|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643071|NCT02009332|364357161|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643072|NCT02009332|364357162|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643073|NCT02009332|364357163|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
105643074|NCT02009332|364357164|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
105643075|NCT00648895|364357165|FG000|Overall Study|Lack of Efficacy|0|||
105643076|NCT00648895|364357166|FG001|Overall Study|Lack of Efficacy|1|||
105643077|NCT00274287|364357167|FG000|Overall Study|Withdrawal by Subject|1|||
105643078|NCT00274287|364357167|FG000|Overall Study|subject non-compliance|1|||
105643079|NCT00244751|364357168|FG000|Overall Study|Adverse Event|7|||
105643080|NCT00244751|364357169|FG001|Overall Study|Adverse Event|7|||
105643081|NCT00244751|364357170|FG002|Overall Study|Adverse Event|5|||
105643082|NCT00244751|364357168|FG000|Overall Study|Lost to Follow-up|0|||
105643083|NCT00244751|364357169|FG001|Overall Study|Lost to Follow-up|1|||
105643084|NCT00244751|364357170|FG002|Overall Study|Lost to Follow-up|0|||
105643085|NCT00244751|364357168|FG000|Overall Study|Protocol Violation|1|||
105643086|NCT00244751|364357169|FG001|Overall Study|Protocol Violation|0|||
105643087|NCT00244751|364357170|FG002|Overall Study|Protocol Violation|1|||
105643088|NCT00244751|364357168|FG000|Overall Study|Withdrawal by Subject|7|||
105643089|NCT00244751|364357169|FG001|Overall Study|Withdrawal by Subject|5|||
105643090|NCT00244751|364357170|FG002|Overall Study|Withdrawal by Subject|3|||
105643091|NCT00244751|364357168|FG000|Overall Study|Elevated liver enzymes|1|||
105643092|NCT00244751|364357169|FG001|Overall Study|Elevated liver enzymes|0|||
105643093|NCT00244751|364357170|FG002|Overall Study|Elevated liver enzymes|0|||
105643094|NCT00244751|364357168|FG000|Overall Study|Lack of compliance with protocol|0|||
105643095|NCT00244751|364357169|FG001|Overall Study|Lack of compliance with protocol|1|||
105643096|NCT00244751|364357170|FG002|Overall Study|Lack of compliance with protocol|0|||
105643097|NCT00244751|364357168|FG000|Overall Study|Safety reasons|0|||
105643098|NCT00244751|364357169|FG001|Overall Study|Safety reasons|1|||
105643099|NCT00244751|364357170|FG002|Overall Study|Safety reasons|0|||
105643100|NCT00244751|364357168|FG000|Overall Study|Participant randomized by mistake|0|||
105643101|NCT00244751|364357169|FG001|Overall Study|Participant randomized by mistake|0|||
105643102|NCT00244751|364357170|FG002|Overall Study|Participant randomized by mistake|1|||
105643103|NCT02077374|364357177|FG000|Overall Study|Withdrawal by Subject|0|||
105643104|NCT02077374|364357178|FG001|Overall Study|Withdrawal by Subject|1|||
105643105|NCT02077374|364357177|FG000|Overall Study|Protocol Violation|0|||
105643106|NCT02077374|364357178|FG001|Overall Study|Protocol Violation|1|||
105643107|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
105643108|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
105643109|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
105643110|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
105643111|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
105643112|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Adverse Event|0|||
105643113|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Adverse Event|1|||
105643114|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Adverse Event|1|||
105643115|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Adverse Event|0|||
105643116|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Adverse Event|0|||
105643117|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
105643118|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
105643119|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
105643120|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
105643121|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
105643122|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Physician Decision|1|||
105643123|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Physician Decision|0|||
105643124|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Physician Decision|0|||
105643125|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Physician Decision|0|||
105643126|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Physician Decision|0|||
105643127|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
105643128|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
105643129|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
105643130|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
105643131|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
105643132|NCT00446095|364357179|FG000|Phase II (8 Weeks)|Ongoing|0|||
105643133|NCT00446095|364357180|FG001|Phase II (8 Weeks)|Ongoing|0|||
105643134|NCT00446095|364357181|FG002|Phase II (8 Weeks)|Ongoing|1|||
105643135|NCT00446095|364357182|FG003|Phase II (8 Weeks)|Ongoing|0|||
105643136|NCT00446095|364357183|FG004|Phase II (8 Weeks)|Ongoing|0|||
105643137|NCT00446095|364357179|FG000|Phase I (28 Days)|Adverse Event|0|||
105643138|NCT00446095|364357180|FG001|Phase I (28 Days)|Adverse Event|0|||
105643139|NCT00446095|364357181|FG002|Phase I (28 Days)|Adverse Event|0|||
105643140|NCT00446095|364357182|FG003|Phase I (28 Days)|Adverse Event|1|||
105643141|NCT00446095|364357183|FG004|Phase I (28 Days)|Adverse Event|0|||
105643142|NCT00446095|364357179|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
105643143|NCT00446095|364357180|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
105643144|NCT00446095|364357181|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
105643145|NCT00446095|364357182|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
105643146|NCT00446095|364357183|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
105643147|NCT01930188|364357184|FG000|Overall Study|unclassified|4|||
105643148|NCT01930188|364357185|FG001|Overall Study|unclassified|5|||
105643149|NCT01930188|364357186|FG002|Overall Study|unclassified|3|||
105643150|NCT01930188|364357184|FG000|Overall Study|Missing follow-up information|2|||
105643151|NCT01930188|364357185|FG001|Overall Study|Missing follow-up information|2|||
105643152|NCT01930188|364357186|FG002|Overall Study|Missing follow-up information|3|||
105643153|NCT01930188|364357184|FG000|Overall Study|Lost to Follow-up|5|||
105643154|NCT01930188|364357185|FG001|Overall Study|Lost to Follow-up|2|||
105643155|NCT01930188|364357186|FG002|Overall Study|Lost to Follow-up|2|||
105643156|NCT01930188|364357184|FG000|Overall Study|Death|2|||
105643157|NCT01930188|364357185|FG001|Overall Study|Death|1|||
105643158|NCT01930188|364357186|FG002|Overall Study|Death|3|||
105643159|NCT01930188|364357184|FG000|Overall Study|Withdrawal by Subject|9|||
105643160|NCT01930188|364357185|FG001|Overall Study|Withdrawal by Subject|11|||
105643161|NCT01930188|364357186|FG002|Overall Study|Withdrawal by Subject|8|||
105643162|NCT03979040|364357189|FG000|Overall Study|Withdrawal by Subject|24|||
105643163|NCT03979040|364357190|FG001|Overall Study|Withdrawal by Subject|32|||
105643164|NCT03979040|364357189|FG000|Overall Study|randomized but never started treatment|32|||
105643165|NCT03979040|364357190|FG001|Overall Study|randomized but never started treatment|39|||
105643166|NCT03979040|364357189|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
105643167|NCT03979040|364357190|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
105643168|NCT02607956|364357191|FG000|Double-Blinded Phase|Withdrew Consent|17|||
105643169|NCT02607956|364357192|FG001|Double-Blinded Phase|Withdrew Consent|19|||
105643170|NCT02607956|364357193|FG002|Double-Blinded Phase|Withdrew Consent|0|||
105643171|NCT02607956|364357194|FG003|Double-Blinded Phase|Withdrew Consent|0|||
105643172|NCT02607956|364357191|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
105643173|NCT02607956|364357192|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
105643174|NCT02607956|364357193|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
105643175|NCT02607956|364357194|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
105643176|NCT02607956|364357191|FG000|Double-Blinded Phase|Randomized but never treated|7|||
105643177|NCT02607956|364357192|FG001|Double-Blinded Phase|Randomized but never treated|5|||
105643178|NCT02607956|364357193|FG002|Double-Blinded Phase|Randomized but never treated|0|||
105643179|NCT02607956|364357194|FG003|Double-Blinded Phase|Randomized but never treated|0|||
105643180|NCT02607956|364357191|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
105643181|NCT02607956|364357192|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
105643182|NCT02607956|364357193|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
105643183|NCT02607956|364357194|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
105643184|NCT02607956|364357191|FG000|Double-Blinded Phase|Death|4|||
105643185|NCT02607956|364357192|FG001|Double-Blinded Phase|Death|4|||
105643186|NCT02607956|364357193|FG002|Double-Blinded Phase|Death|0|||
105643187|NCT02607956|364357194|FG003|Double-Blinded Phase|Death|0|||
105643188|NCT02607956|364357191|FG000|Double-Blinded Phase|Adverse Event|4|||
105643189|NCT02607956|364357192|FG001|Double-Blinded Phase|Adverse Event|3|||
105643190|NCT02607956|364357193|FG002|Double-Blinded Phase|Adverse Event|0|||
105643191|NCT02607956|364357194|FG003|Double-Blinded Phase|Adverse Event|0|||
105643192|NCT02607956|364357191|FG000|Double-Blinded Phase|Protocol Violation|3|||
105643193|NCT02607956|364357192|FG001|Double-Blinded Phase|Protocol Violation|1|||
105643194|NCT02607956|364357193|FG002|Double-Blinded Phase|Protocol Violation|0|||
105643195|NCT02607956|364357194|FG003|Double-Blinded Phase|Protocol Violation|0|||
105643196|NCT02607956|364357191|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
105643197|NCT02607956|364357192|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
105643198|NCT02607956|364357193|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
105643199|NCT02607956|364357194|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
105643200|NCT02607956|364357191|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
105643201|NCT02607956|364357192|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
105643202|NCT02607956|364357193|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
105643203|NCT02607956|364357194|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
105643204|NCT02607956|364357191|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
105643205|NCT02607956|364357192|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
105643206|NCT02607956|364357193|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
105643207|NCT02607956|364357194|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
105643208|NCT02607956|364357191|FG000|Open-Label Extension Phase|Death|0|||
105643209|NCT02607956|364357192|FG001|Open-Label Extension Phase|Death|0|||
105643210|NCT02607956|364357193|FG002|Open-Label Extension Phase|Death|1|||
105643211|NCT02607956|364357194|FG003|Open-Label Extension Phase|Death|3|||
105643212|NCT02607956|364357191|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
105643213|NCT02607956|364357192|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
105643214|NCT02607956|364357193|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
105643215|NCT02607956|364357194|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
105643216|NCT02607956|364357191|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
105643217|NCT02607956|364357192|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
105643218|NCT02607956|364357193|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
105643219|NCT02607956|364357194|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
105643220|NCT02607956|364357191|FG000|Open-Label Extension Phase|Protocol Violation|0|||
105643221|NCT02607956|364357192|FG001|Open-Label Extension Phase|Protocol Violation|0|||
105643222|NCT02607956|364357193|FG002|Open-Label Extension Phase|Protocol Violation|0|||
105643223|NCT02607956|364357194|FG003|Open-Label Extension Phase|Protocol Violation|2|||
105643224|NCT02607956|364357191|FG000|Open-Label Extension Phase|Pregnancy|0|||
105643225|NCT02607956|364357192|FG001|Open-Label Extension Phase|Pregnancy|0|||
105643226|NCT02607956|364357193|FG002|Open-Label Extension Phase|Pregnancy|0|||
105643227|NCT02607956|364357194|FG003|Open-Label Extension Phase|Pregnancy|1|||
105643228|NCT01916109|364357195|FG000|Overall Study|Withdrawal by Subject|1|||
105643229|NCT04749797|364357200|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
105643230|NCT04749797|364357201|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
105643231|NCT04749797|364357202|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
105643232|NCT03072862|364357203|FG000|Overall Study|Withdrawal by Subject|4|||
105643233|NCT03072862|364357203|FG000|Overall Study|Lost to Follow-up|6|||
105643234|NCT03072862|364357203|FG000|Overall Study|Protocol Violation|4|||
105643235|NCT03072862|364357203|FG000|Overall Study|Physician Decision|2|||
105643236|NCT03072862|364357203|FG000|Overall Study|Death|1|||
105643237|NCT03072862|364357203|FG000|Overall Study|Adverse Event|1|||
105643238|NCT01441596|364357204|FG000|Overall Study|Other reason not defined below|0|||
105643239|NCT01441596|364357205|FG001|Overall Study|Other reason not defined below|2|||
105643240|NCT01441596|364357206|FG002|Overall Study|Other reason not defined below|1|||
105643241|NCT01441596|364357204|FG000|Overall Study|Withdrawal by Subject|4|||
105643242|NCT01441596|364357205|FG001|Overall Study|Withdrawal by Subject|0|||
105643243|NCT01441596|364357206|FG002|Overall Study|Withdrawal by Subject|2|||
105643244|NCT01441596|364357204|FG000|Overall Study|Not treated|0|||
105643245|NCT01441596|364357205|FG001|Overall Study|Not treated|1|||
105643246|NCT01441596|364357206|FG002|Overall Study|Not treated|1|||
105643247|NCT03015220|364357209|FG000|Overall Study|Withdrawal by Subject|3|||
105643248|NCT03015220|364357210|FG001|Overall Study|Withdrawal by Subject|2|||
105643249|NCT03015220|364357211|FG002|Overall Study|Withdrawal by Subject|2|||
105643250|NCT03015220|364357212|FG003|Overall Study|Withdrawal by Subject|2|||
105643251|NCT03015220|364357209|FG000|Overall Study|Lost to Follow-up|0|||
105643252|NCT03015220|364357210|FG001|Overall Study|Lost to Follow-up|0|||
105643253|NCT03015220|364357211|FG002|Overall Study|Lost to Follow-up|1|||
105643254|NCT03015220|364357212|FG003|Overall Study|Lost to Follow-up|0|||
105643255|NCT01115309|364357214|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
105643256|NCT01115309|364357214|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
105643257|NCT01115309|364357214|FG000|Long-term Follow-up|Lost to Follow-up|6|||
105643258|NCT00589628|364357217|FG000|Overall Study|Lost to Follow-up|0|||
105643259|NCT00589628|364357218|FG001|Overall Study|Lost to Follow-up|1|||
105643260|NCT02260154|364357219|FG000|Overall Study|Screening failure|2|||
105643261|NCT03032198|364357227|FG000|Overall Study|Screen Fail|1|||
105643262|NCT00866619|364357228|FG000|Overall Study|Adverse Event|112|||
105643263|NCT00866619|364357229|FG001|Overall Study|Adverse Event|106|||
105643264|NCT00866619|364357230|FG002|Overall Study|Adverse Event|47|||
105643265|NCT00866619|364357231|FG003|Overall Study|Adverse Event|44|||
105643266|NCT00866619|364357228|FG000|Overall Study|Protocol Violation|2|||
105643267|NCT00866619|364357229|FG001|Overall Study|Protocol Violation|39|||
105643268|NCT00866619|364357230|FG002|Overall Study|Protocol Violation|2|||
105643269|NCT00866619|364357231|FG003|Overall Study|Protocol Violation|17|||
105643270|NCT00866619|364357228|FG000|Overall Study|Withdrawal by Subject|587|||
105643271|NCT00866619|364357229|FG001|Overall Study|Withdrawal by Subject|295|||
105643272|NCT00866619|364357230|FG002|Overall Study|Withdrawal by Subject|272|||
105643273|NCT00866619|364357231|FG003|Overall Study|Withdrawal by Subject|144|||
105643274|NCT00866619|364357228|FG000|Overall Study|Lost to Follow-up|1145|||
105643275|NCT00866619|364357229|FG001|Overall Study|Lost to Follow-up|830|||
105643276|NCT00866619|364357230|FG002|Overall Study|Lost to Follow-up|568|||
105643277|NCT00866619|364357231|FG003|Overall Study|Lost to Follow-up|425|||
105643278|NCT00645411|364357232|FG000|Overall Study|Adverse Event|0|||
105643279|NCT00645411|364357233|FG001|Overall Study|Adverse Event|0|||
105643280|NCT00645411|364357234|FG002|Overall Study|Adverse Event|0|||
105643281|NCT00645411|364357235|FG003|Overall Study|Adverse Event|2|||
105643282|NCT00645411|364357232|FG000|Overall Study|Withdrawal by Subject|2|||
105643283|NCT00645411|364357233|FG001|Overall Study|Withdrawal by Subject|1|||
105643284|NCT00645411|364357234|FG002|Overall Study|Withdrawal by Subject|19|||
105643285|NCT00645411|364357235|FG003|Overall Study|Withdrawal by Subject|21|||
105643286|NCT00645411|364357232|FG000|Overall Study|Lost to Follow-up|10|||
105643287|NCT00645411|364357233|FG001|Overall Study|Lost to Follow-up|5|||
105643288|NCT00645411|364357234|FG002|Overall Study|Lost to Follow-up|124|||
105643289|NCT00645411|364357235|FG003|Overall Study|Lost to Follow-up|75|||
105643290|NCT00645411|364357232|FG000|Overall Study|Protocol Violation|1|||
105643291|NCT00645411|364357233|FG001|Overall Study|Protocol Violation|0|||
105643292|NCT00645411|364357234|FG002|Overall Study|Protocol Violation|1|||
105643293|NCT00645411|364357235|FG003|Overall Study|Protocol Violation|0|||
105643294|NCT00645411|364357232|FG000|Overall Study|Inappropriate enrollment|0|||
105643295|NCT00645411|364357233|FG001|Overall Study|Inappropriate enrollment|0|||
105643296|NCT00645411|364357234|FG002|Overall Study|Inappropriate enrollment|4|||
105643297|NCT00645411|364357235|FG003|Overall Study|Inappropriate enrollment|1|||
105643298|NCT00645411|364357232|FG000|Overall Study|Unable to classify|0|||
105643299|NCT00645411|364357233|FG001|Overall Study|Unable to classify|0|||
105643300|NCT00645411|364357234|FG002|Overall Study|Unable to classify|3|||
105643301|NCT00645411|364357235|FG003|Overall Study|Unable to classify|4|||
105643302|NCT02923349|364357237|FG000|Overall Study|Other|1|||
105643303|NCT02923349|364357238|FG001|Overall Study|Other|2|||
105643304|NCT02923349|364357239|FG002|Overall Study|Other|4|||
105643305|NCT02923349|364357240|FG003|Overall Study|Other|1|||
105643306|NCT02923349|364357241|FG004|Overall Study|Other|3|||
105643307|NCT02923349|364357242|FG005|Overall Study|Other|0|||
105643308|NCT02923349|364357243|FG006|Overall Study|Other|1|||
105643309|NCT02923349|364357237|FG000|Overall Study|Withdrawal by Subject|2|||
105643310|NCT02923349|364357238|FG001|Overall Study|Withdrawal by Subject|2|||
105643311|NCT02923349|364357239|FG002|Overall Study|Withdrawal by Subject|8|||
105643312|NCT02923349|364357240|FG003|Overall Study|Withdrawal by Subject|10|||
105643313|NCT02923349|364357241|FG004|Overall Study|Withdrawal by Subject|12|||
105643314|NCT02923349|364357242|FG005|Overall Study|Withdrawal by Subject|3|||
105643315|NCT02923349|364357243|FG006|Overall Study|Withdrawal by Subject|0|||
105643316|NCT02923349|364357237|FG000|Overall Study|Physician Decision|0|||
105643317|NCT02923349|364357238|FG001|Overall Study|Physician Decision|0|||
105643318|NCT02923349|364357239|FG002|Overall Study|Physician Decision|0|||
105643319|NCT02923349|364357240|FG003|Overall Study|Physician Decision|1|||
105643320|NCT02923349|364357241|FG004|Overall Study|Physician Decision|1|||
105643321|NCT02923349|364357242|FG005|Overall Study|Physician Decision|0|||
105643322|NCT02923349|364357243|FG006|Overall Study|Physician Decision|2|||
105643323|NCT02923349|364357237|FG000|Overall Study|Lost to Follow-up|0|||
105643324|NCT02923349|364357238|FG001|Overall Study|Lost to Follow-up|0|||
105643325|NCT02923349|364357239|FG002|Overall Study|Lost to Follow-up|3|||
105643326|NCT02923349|364357240|FG003|Overall Study|Lost to Follow-up|0|||
105643327|NCT02923349|364357241|FG004|Overall Study|Lost to Follow-up|1|||
105643328|NCT02923349|364357242|FG005|Overall Study|Lost to Follow-up|1|||
105643329|NCT02923349|364357243|FG006|Overall Study|Lost to Follow-up|0|||
105643330|NCT02923349|364357237|FG000|Overall Study|Death|1|||
105643331|NCT02923349|364357238|FG001|Overall Study|Death|0|||
105643332|NCT02923349|364357239|FG002|Overall Study|Death|2|||
105643333|NCT02923349|364357240|FG003|Overall Study|Death|4|||
105643334|NCT02923349|364357241|FG004|Overall Study|Death|2|||
105643335|NCT02923349|364357242|FG005|Overall Study|Death|3|||
105643336|NCT02923349|364357243|FG006|Overall Study|Death|0|||
105643337|NCT00800176|364357246|FG000|Overall Study|Adverse Event|2|||
105643338|NCT00800176|364357247|FG001|Overall Study|Adverse Event|1|||
105643339|NCT00800176|364357248|FG002|Overall Study|Adverse Event|0|||
105643340|NCT00800176|364357249|FG003|Overall Study|Adverse Event|2|||
105643341|NCT00800176|364357250|FG004|Overall Study|Adverse Event|1|||
105643342|NCT00800176|364357251|FG005|Overall Study|Adverse Event|1|||
105643343|NCT00800176|364357246|FG000|Overall Study|Refused treatment|3|||
105643344|NCT00800176|364357247|FG001|Overall Study|Refused treatment|2|||
105643345|NCT00800176|364357248|FG002|Overall Study|Refused treatment|0|||
105643346|NCT00800176|364357249|FG003|Overall Study|Refused treatment|0|||
105643347|NCT00800176|364357250|FG004|Overall Study|Refused treatment|1|||
105643348|NCT00800176|364357251|FG005|Overall Study|Refused treatment|4|||
105643349|NCT00800176|364357246|FG000|Overall Study|Failure to return|3|||
105643350|NCT00800176|364357247|FG001|Overall Study|Failure to return|3|||
105643351|NCT00800176|364357248|FG002|Overall Study|Failure to return|0|||
105643352|NCT00800176|364357249|FG003|Overall Study|Failure to return|2|||
105643353|NCT00800176|364357250|FG004|Overall Study|Failure to return|0|||
105643354|NCT00800176|364357251|FG005|Overall Study|Failure to return|0|||
105643355|NCT00800176|364357246|FG000|Overall Study|Other|1|||
105643356|NCT00800176|364357247|FG001|Overall Study|Other|0|||
105643357|NCT00800176|364357248|FG002|Overall Study|Other|0|||
105643358|NCT00800176|364357249|FG003|Overall Study|Other|0|||
105643359|NCT00800176|364357250|FG004|Overall Study|Other|2|||
105643360|NCT00800176|364357251|FG005|Overall Study|Other|0|||
105643361|NCT03100370|364357254|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643362|NCT03100370|364357255|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643363|NCT03100370|364357256|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643364|NCT03100370|364357257|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
105643365|NCT03100370|364357258|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643366|NCT03100370|364357259|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
105643367|NCT03820024|364357260|FG000|Overall Study|Physician Decision|1|||
105643368|NCT03820024|364357261|FG001|Overall Study|Physician Decision|2|||
105643369|NCT03138499|364357262|FG000|Overall Study|Lost to Follow-up|1|||
105643370|NCT03138499|364357263|FG001|Overall Study|Lost to Follow-up|0|||
105643371|NCT03138499|364357262|FG000|Overall Study|Participants withdrew consent|1|||
105643372|NCT03138499|364357263|FG001|Overall Study|Participants withdrew consent|0|||
105643373|NCT03138499|364357262|FG000|Overall Study|Participant discontinued study before treatment|0|||
105643374|NCT03138499|364357263|FG001|Overall Study|Participant discontinued study before treatment|1|||
105643375|NCT03138499|364357262|FG000|Overall Study|Disease Progression|2|||
105643376|NCT03138499|364357263|FG001|Overall Study|Disease Progression|6|||
105643377|NCT03138499|364357262|FG000|Overall Study|Study drug toxicity|2|||
105643378|NCT03138499|364357263|FG001|Overall Study|Study drug toxicity|2|||
105643379|NCT03138499|364357262|FG000|Overall Study|Participant request to discontinue study treatment|1|||
105643380|NCT03138499|364357263|FG001|Overall Study|Participant request to discontinue study treatment|1|||
105643381|NCT03138499|364357262|FG000|Overall Study|Other reasons|2|||
105643382|NCT03138499|364357263|FG001|Overall Study|Other reasons|0|||
105643383|NCT02892019|364357264|FG000|Overall Study|randomized but not treated|0|||
105643384|NCT02892019|364357265|FG001|Overall Study|randomized but not treated|1|||
105643385|NCT02892019|364357264|FG000|Overall Study|Withdrawal by Subject|0|||
105643386|NCT02892019|364357265|FG001|Overall Study|Withdrawal by Subject|1|||
105643387|NCT02892019|364357264|FG000|Overall Study|Adverse Event|1|||
105643388|NCT02892019|364357265|FG001|Overall Study|Adverse Event|1|||
105643389|NCT00689351|364357266|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
105643390|NCT00689351|364357267|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
105643391|NCT00689351|364357266|FG000|Infant Series of Dosing|Adverse Event|1|||
105643392|NCT00689351|364357267|FG001|Infant Series of Dosing|Adverse Event|0|||
105643393|NCT00689351|364357266|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
105643394|NCT00689351|364357267|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
105643395|NCT00689351|364357266|FG000|After Infant Series|Parent/legal guardian request|1|||
105643396|NCT00689351|364357267|FG001|After Infant Series|Parent/legal guardian request|0|||
105643397|NCT01313663|364357268|FG000|Overall Study|Study Closed/Terminated|2|||
105643398|NCT01313663|364357269|FG001|Overall Study|Study Closed/Terminated|4|||
105643399|NCT01313663|364357268|FG000|Overall Study|Lost to Follow-up|0|||
105643400|NCT01313663|364357269|FG001|Overall Study|Lost to Follow-up|1|||
105643401|NCT01313663|364357268|FG000|Overall Study|Physician Decision|0|||
105643402|NCT01313663|364357269|FG001|Overall Study|Physician Decision|2|||
105643403|NCT01313663|364357268|FG000|Overall Study|Withdrawal by Subject|2|||
105643404|NCT01313663|364357269|FG001|Overall Study|Withdrawal by Subject|1|||
105643405|NCT01229176|364357271|FG000|Overall Study|Withdrawal by Subject|0|||
105643406|NCT01229176|364357272|FG001|Overall Study|Withdrawal by Subject|0|||
105643407|NCT01229176|364357273|FG002|Overall Study|Withdrawal by Subject|0|||
105643408|NCT01229176|364357274|FG003|Overall Study|Withdrawal by Subject|1|||
105643409|NCT01229176|364357275|FG004|Overall Study|Withdrawal by Subject|1|||
105643410|NCT01229176|364357276|FG005|Overall Study|Withdrawal by Subject|1|||
105643411|NCT01229176|364357277|FG006|Overall Study|Withdrawal by Subject|0|||
105643412|NCT01229176|364357278|FG007|Overall Study|Withdrawal by Subject|1|||
105643413|NCT01229176|364357271|FG000|Overall Study|Lost to Follow-up|0|||
105643414|NCT01229176|364357272|FG001|Overall Study|Lost to Follow-up|3|||
105643415|NCT01229176|364357273|FG002|Overall Study|Lost to Follow-up|0|||
105643416|NCT01229176|364357274|FG003|Overall Study|Lost to Follow-up|0|||
105643417|NCT01229176|364357275|FG004|Overall Study|Lost to Follow-up|1|||
105643418|NCT01229176|364357276|FG005|Overall Study|Lost to Follow-up|1|||
105643419|NCT01229176|364357277|FG006|Overall Study|Lost to Follow-up|0|||
105643420|NCT01229176|364357278|FG007|Overall Study|Lost to Follow-up|2|||
105643421|NCT01867307|364357281|FG000|Overall Study|Protocol Violation|2|||
105643422|NCT01867307|364357282|FG001|Overall Study|Protocol Violation|0|||
105643423|NCT01867307|364357281|FG000|Overall Study|Other Adverse Event|1|||
105643424|NCT01867307|364357282|FG001|Overall Study|Other Adverse Event|3|||
105643425|NCT01884571|364357287|FG000|Overall Study|Adverse Event|1|||
105643426|NCT01884571|364357287|FG000|Overall Study|Death|2|||
105643427|NCT01884571|364357287|FG000|Overall Study|Withdrawal by Subject|2|||
105643428|NCT01884571|364357287|FG000|Overall Study|Disease progression|3|||
105643429|NCT00853957|364357288|FG000|Overall Study|Adverse Event|9|||
105643430|NCT00853957|364357289|FG001|Overall Study|Adverse Event|3|||
105643431|NCT00853957|364357288|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105643432|NCT00853957|364357289|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105643433|NCT00853957|364357288|FG000|Overall Study|Subject withdrew consent|4|||
105643434|NCT00853957|364357289|FG001|Overall Study|Subject withdrew consent|5|||
105643435|NCT00853957|364357288|FG000|Overall Study|Lost to Follow-up|1|||
105643436|NCT00853957|364357289|FG001|Overall Study|Lost to Follow-up|6|||
105643437|NCT00853957|364357288|FG000|Overall Study|Protocol deviation|0|||
105643438|NCT00853957|364357289|FG001|Overall Study|Protocol deviation|3|||
105643439|NCT04097535|364357299|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
105643440|NCT02880293|364358833|FG000|Overall Study|Inevaluable|5|||
105643441|NCT01277302|364358836|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
105643442|NCT01277302|364358837|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
105643443|NCT01277302|364358838|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
105643444|NCT01277302|364358836|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
105643445|NCT01277302|364358837|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
105643446|NCT01277302|364358838|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
105643447|NCT01277302|364358836|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
105643448|NCT01277302|364358837|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
105643449|NCT01277302|364358838|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
105643450|NCT01277302|364358836|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
105643451|NCT01277302|364358837|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
105643452|NCT01277302|364358838|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
105643453|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
105643454|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
105643455|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
105643456|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
105643457|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
105643458|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
105643459|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
105643460|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
105643461|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
105643462|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
105870220|NCT01074944|365176971|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
105643463|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
105659337|NCT00551135|364417280|FG000|Overall Study|Other|3|||
105870221|NCT01074944|365176967|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
105643464|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
105643465|NCT01277302|364358836|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
105643466|NCT01277302|364358837|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
105643467|NCT01277302|364358838|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
105643468|NCT03332589|364358839|FG000|Overall Study|Lack of Efficacy|2|||
105643469|NCT03332589|364358840|FG001|Overall Study|Lack of Efficacy|0|||
105643470|NCT03332589|364358841|FG002|Overall Study|Lack of Efficacy|0|||
105643471|NCT03332589|364358839|FG000|Overall Study|Adverse Event|1|||
105643472|NCT03332589|364358840|FG001|Overall Study|Adverse Event|0|||
105643473|NCT03332589|364358841|FG002|Overall Study|Adverse Event|0|||
105643474|NCT03332589|364358839|FG000|Overall Study|Death|1|||
105643475|NCT03332589|364358840|FG001|Overall Study|Death|0|||
105643476|NCT03332589|364358841|FG002|Overall Study|Death|0|||
105643477|NCT00108355|364358845|FG000|Overall Study|Peritonitis at index paracentesis|1|||
105643478|NCT00108355|364358846|FG001|Overall Study|Peritonitis at index paracentesis|1|||
105643479|NCT00108355|364358845|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
105643480|NCT00108355|364358846|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
105643481|NCT02507297|364358847|FG000|Overall Study|Withdrawal by Subject|1|||
105643482|NCT02507297|364358848|FG001|Overall Study|Withdrawal by Subject|0|||
105643483|NCT02507297|364358847|FG000|Overall Study|Lost to Follow-up|0|||
105643484|NCT02507297|364358848|FG001|Overall Study|Lost to Follow-up|1|||
105643485|NCT00647699|364358849|FG000|Overall Study|Lost to Follow-up|5|||
105643486|NCT00647699|364358850|FG001|Overall Study|Lost to Follow-up|4|||
105643487|NCT00647699|364358849|FG000|Overall Study|Withdrawal by Subject|3|||
105643488|NCT00647699|364358850|FG001|Overall Study|Withdrawal by Subject|8|||
105643489|NCT03029585|364358853|FG000|Overall Study|Death|1|||
105643490|NCT03029585|364358854|FG001|Overall Study|Death|1|||
105643491|NCT03029585|364358853|FG000|Overall Study|Withdrawal by Subject|1|||
105643492|NCT03029585|364358854|FG001|Overall Study|Withdrawal by Subject|0|||
105643493|NCT01304940|364358856|FG000|Overall Study|not meet symptom severity requirement|3|||
105643494|NCT01304940|364358857|FG001|Overall Study|not meet symptom severity requirement|0|||
105643495|NCT00278395|364358858|FG000|Overall Study|Adverse Event|2|||
105643496|NCT00278395|364358858|FG000|Overall Study|Nonevaluable|1|||
105643497|NCT00246129|364358863|FG000|Overall Study|Lost to Follow-up|1|||
105643498|NCT00246129|364358864|FG001|Overall Study|Lost to Follow-up|0|||
105643499|NCT00246129|364358863|FG000|Overall Study|Death|2|||
105643500|NCT00246129|364358864|FG001|Overall Study|Death|1|||
105643501|NCT00246129|364358863|FG000|Overall Study|suffered primary non-function|1|||
105643502|NCT00246129|364358864|FG001|Overall Study|suffered primary non-function|0|||
105643503|NCT00246129|364358863|FG000|Overall Study|grafts failed|3|||
105643504|NCT00246129|364358864|FG001|Overall Study|grafts failed|1|||
105643505|NCT03740737|364358865|FG000|Overall Study|Protocol deviation|13|||
105643506|NCT03740737|364358866|FG001|Overall Study|Protocol deviation|0|||
105643507|NCT03740737|364358865|FG000|Overall Study|Adverse Event|2|||
105643508|NCT03740737|364358866|FG001|Overall Study|Adverse Event|0|||
105643509|NCT03740737|364358865|FG000|Overall Study|Lost to Follow-up|1|||
105643510|NCT03740737|364358866|FG001|Overall Study|Lost to Follow-up|0|||
105643511|NCT03740737|364358865|FG000|Overall Study|Randomization failure|1|||
105643512|NCT03740737|364358866|FG001|Overall Study|Randomization failure|0|||
105643513|NCT03740737|364358865|FG000|Overall Study|Participant withdrew consent|1|||
105643514|NCT03740737|364358866|FG001|Overall Study|Participant withdrew consent|0|||
105643515|NCT03740737|364358865|FG000|Overall Study|Participant withdrew from trial|2|||
105643516|NCT03740737|364358866|FG001|Overall Study|Participant withdrew from trial|1|||
105643517|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
105643518|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
105643519|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
105643520|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
105643521|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
105643522|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
105643523|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
105643524|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
105643525|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
105643526|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
105643527|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
105643528|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
105643529|NCT03928743|364358867|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
105643530|NCT03928743|364358868|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
105643531|NCT03928743|364358869|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
105643532|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
105643533|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
105643534|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
105643535|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
105643536|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
105643537|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
105643538|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
105643539|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
105643540|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
105643541|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
105643542|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
105643543|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
105643544|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
105643545|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
105643546|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
105643547|NCT03928743|364358867|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
105643548|NCT03928743|364358868|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
105643549|NCT03928743|364358869|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
105643550|NCT05005247|364358870|FG000|Overall Study|Withdrawal by Subject|0|||
105643551|NCT05005247|364358871|FG001|Overall Study|Withdrawal by Subject|1|||
105643552|NCT05005247|364358872|FG002|Overall Study|Withdrawal by Subject|0|||
105643553|NCT01381549|364358878|FG000|Overall Study|Ineligible: No organisms isolated|0|||
105643554|NCT01381549|364358879|FG001|Overall Study|Ineligible: No organisms isolated|0|||
105643555|NCT01381549|364358880|FG002|Overall Study|Ineligible: No organisms isolated|1|||
105643556|NCT02889900|364358881|FG000|Overall Study|Adverse Event|11|||
105643557|NCT02889900|364358881|FG000|Overall Study|Condition under investigation worsened|32|||
105643558|NCT02889900|364358881|FG000|Overall Study|Other|5|||
105643559|NCT02889900|364358881|FG000|Overall Study|Withdrawal by Subject|7|||
105643560|NCT02889900|364358881|FG000|Overall Study|Not treated|2|||
105643561|NCT00080119|364358884|FG000|Overall Study|Discontinued because of study closure|0|||
105643562|NCT00080119|364358885|FG001|Overall Study|Discontinued because of study closure|0|||
105643563|NCT00080119|364358886|FG002|Overall Study|Discontinued because of study closure|130|||
105643564|NCT00080119|364358887|FG003|Overall Study|Discontinued because of study closure|141|||
105643565|NCT00080119|364358884|FG000|Overall Study|Unable to get to clinic|24|||
105643566|NCT00080119|364358885|FG001|Overall Study|Unable to get to clinic|24|||
105643567|NCT00080119|364358886|FG002|Overall Study|Unable to get to clinic|7|||
105643568|NCT00080119|364358887|FG003|Overall Study|Unable to get to clinic|1|||
105643569|NCT00080119|364358884|FG000|Overall Study|Consent withdrawn|13|||
105643570|NCT00080119|364358885|FG001|Overall Study|Consent withdrawn|17|||
105643571|NCT00080119|364358886|FG002|Overall Study|Consent withdrawn|4|||
105643572|NCT00080119|364358887|FG003|Overall Study|Consent withdrawn|6|||
105643573|NCT00080119|364358884|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
105643574|NCT00080119|364358885|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
105643575|NCT00080119|364358886|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
105643576|NCT00080119|364358887|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
105643577|NCT00080119|364358884|FG000|Overall Study|Lost to Follow-up|16|||
105643578|NCT00080119|364358885|FG001|Overall Study|Lost to Follow-up|19|||
105643579|NCT00080119|364358886|FG002|Overall Study|Lost to Follow-up|19|||
105643580|NCT00080119|364358887|FG003|Overall Study|Lost to Follow-up|14|||
105643581|NCT00871494|364358891|FG000|Overall Study|Protocol Violation|5|||
105643582|NCT00871494|364358891|FG000|Overall Study|Lack of Efficacy|4|||
105643583|NCT00871494|364358891|FG000|Overall Study|Adverse Event|4|||
105643584|NCT00871494|364358891|FG000|Overall Study|Lost to Follow-up|1|||
105643585|NCT04410445|364358892|FG000|Overall Study|Lost to Follow-up|3|||
105643586|NCT04410445|364358893|FG001|Overall Study|Lost to Follow-up|9|||
105643587|NCT04410445|364358892|FG000|Overall Study|Withdrawal by Subject|27|||
105643588|NCT04410445|364358893|FG001|Overall Study|Withdrawal by Subject|15|||
105643589|NCT01320683|364358894|FG000|Overall Study|Positive antibody response|1|||
105643590|NCT01123356|364358895|FG000|Overall Study|Adverse Event|2|||
105643591|NCT01123356|364358895|FG000|Overall Study|Lack of Efficacy|4|||
105643592|NCT01123356|364358895|FG000|Overall Study|Withdrawal by Subject|1|||
105643593|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
105643594|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
105643595|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643596|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643597|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643598|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643599|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
105643600|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
105643601|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
105643602|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105643603|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105643604|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105643605|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105659338|NCT00551135|364417281|FG001|Overall Study|Other|2|||
105643606|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
105643607|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
105643608|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
105643609|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643610|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643611|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643612|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643613|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
105643614|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643615|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
105643616|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643617|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643618|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643619|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643620|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
105643621|NCT03136861|364358903|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
105643622|NCT03136861|364358904|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
105643623|NCT03136861|364358905|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643624|NCT03136861|364358906|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643625|NCT03136861|364358907|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643626|NCT03136861|364358908|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643627|NCT03136861|364358909|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
105643628|NCT03136861|364358903|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
105643629|NCT03136861|364358904|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
105643630|NCT03136861|364358905|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
105643631|NCT03136861|364358906|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
105643632|NCT03136861|364358907|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
105643633|NCT03136861|364358908|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
105643634|NCT03136861|364358909|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
105643635|NCT03136861|364358903|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643636|NCT03136861|364358904|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643637|NCT03136861|364358905|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
105643638|NCT03136861|364358906|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643639|NCT03136861|364358907|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643640|NCT03136861|364358908|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643641|NCT03136861|364358909|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
105643642|NCT03136861|364358903|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643643|NCT03136861|364358904|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643644|NCT03136861|364358905|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
105643645|NCT03136861|364358906|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643646|NCT03136861|364358907|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643647|NCT03136861|364358908|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643648|NCT03136861|364358909|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
105643649|NCT03390166|364358910|FG000|Overall Study|Death|0|||
105643650|NCT03390166|364358911|FG001|Overall Study|Death|1|||
105643651|NCT03390166|364358910|FG000|Overall Study|Lost to Follow-up|6|||
105643652|NCT03390166|364358911|FG001|Overall Study|Lost to Follow-up|4|||
105643653|NCT03390166|364358910|FG000|Overall Study|Physician Decision|2|||
105643654|NCT03390166|364358911|FG001|Overall Study|Physician Decision|1|||
105643655|NCT03390166|364358910|FG000|Overall Study|Move from study area|3|||
105643656|NCT03390166|364358911|FG001|Overall Study|Move from study area|2|||
105870222|NCT01074944|365176968|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
105643657|NCT03390166|364358910|FG000|Overall Study|To militarycamp for conscript|1|||
105643658|NCT03390166|364358911|FG001|Overall Study|To militarycamp for conscript|0|||
105643659|NCT03390166|364358910|FG000|Overall Study|To drug therapy course|0|||
105643660|NCT03390166|364358911|FG001|Overall Study|To drug therapy course|1|||
105643661|NCT03390166|364358910|FG000|Overall Study|Move to work oversea|0|||
105643662|NCT03390166|364358911|FG001|Overall Study|Move to work oversea|1|||
105643663|NCT03693989|364358915|FG000|Overall Study|Protocol Violation|3|||
105643664|NCT03693989|364358916|FG001|Overall Study|Protocol Violation|4|||
105643665|NCT01052272|364358917|FG000|Overall Study|Death|0|||
105643666|NCT01052272|364358918|FG001|Overall Study|Death|0|||
105643667|NCT01052272|364358919|FG002|Overall Study|Death|1|||
105643668|NCT01052272|364358920|FG003|Overall Study|Death|1|||
105643669|NCT01052272|364358917|FG000|Overall Study|Physician Decision|0|||
105643670|NCT01052272|364358918|FG001|Overall Study|Physician Decision|1|||
105643671|NCT01052272|364358919|FG002|Overall Study|Physician Decision|0|||
105643672|NCT01052272|364358920|FG003|Overall Study|Physician Decision|0|||
105643673|NCT01052272|364358917|FG000|Overall Study|patient refuses follow-up|5|||
105643674|NCT01052272|364358918|FG001|Overall Study|patient refuses follow-up|4|||
105643675|NCT01052272|364358919|FG002|Overall Study|patient refuses follow-up|2|||
105643676|NCT01052272|364358920|FG003|Overall Study|patient refuses follow-up|4|||
105643677|NCT01052272|364358917|FG000|Overall Study|Withdrawal by Subject|0|||
105643678|NCT01052272|364358918|FG001|Overall Study|Withdrawal by Subject|2|||
105643679|NCT01052272|364358919|FG002|Overall Study|Withdrawal by Subject|3|||
105643680|NCT01052272|364358920|FG003|Overall Study|Withdrawal by Subject|2|||
105643681|NCT01052272|364358917|FG000|Overall Study|placed in long-term care|0|||
105643682|NCT01052272|364358918|FG001|Overall Study|placed in long-term care|0|||
105643683|NCT01052272|364358919|FG002|Overall Study|placed in long-term care|1|||
105643684|NCT01052272|364358920|FG003|Overall Study|placed in long-term care|0|||
105643685|NCT01052272|364358917|FG000|Overall Study|decline in health|0|||
105643686|NCT01052272|364358918|FG001|Overall Study|decline in health|0|||
105643687|NCT01052272|364358919|FG002|Overall Study|decline in health|1|||
105643688|NCT01052272|364358920|FG003|Overall Study|decline in health|0|||
105643689|NCT00113529|364358921|FG000|Overall Study|Adverse Event|4|||
105643690|NCT00113529|364358921|FG000|Overall Study|Lack of Efficacy|20|||
105643691|NCT00113529|364358921|FG000|Overall Study|Decision of sponsor|6|||
105643692|NCT00113529|364358921|FG000|Overall Study|Withdrawal by Subject|4|||
105643693|NCT01722097|364358922|FG000|Overall Study|Patient sheets not returned|6|||
105643694|NCT01722097|364358923|FG001|Overall Study|Patient sheets not returned|5|||
105643695|NCT04908488|364358928|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
105643696|NCT04908488|364358929|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
105643697|NCT04908488|364358928|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
105643698|NCT04908488|364358929|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
105643699|NCT01014013|364358935|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
105643700|NCT01014013|364358936|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
105643701|NCT01014013|364358935|FG000|Overall Study|Clinical adverse experience|4|||
105643702|NCT01014013|364358936|FG001|Overall Study|Clinical adverse experience|2|||
105643703|NCT01014013|364358935|FG000|Overall Study|Laboratory adverse experience|1|||
105643704|NCT01014013|364358936|FG001|Overall Study|Laboratory adverse experience|1|||
105643705|NCT01014013|364358935|FG000|Overall Study|Protocol Violation|1|||
105643706|NCT01014013|364358936|FG001|Overall Study|Protocol Violation|3|||
105643707|NCT01014013|364358935|FG000|Overall Study|Withdrawal by Subject|7|||
105643708|NCT01014013|364358936|FG001|Overall Study|Withdrawal by Subject|4|||
105643709|NCT01014013|364358935|FG000|Overall Study|Clinical/microbiologic failure|1|||
105643710|NCT01014013|364358936|FG001|Overall Study|Clinical/microbiologic failure|2|||
105643711|NCT01014013|364358935|FG000|Overall Study|Pathogen culture = no growth|26|||
105643712|NCT01014013|364358936|FG001|Overall Study|Pathogen culture = no growth|34|||
105643713|NCT01014013|364358935|FG000|Overall Study|Negative urine culture|2|||
105643714|NCT01014013|364358936|FG001|Overall Study|Negative urine culture|0|||
105643715|NCT01014013|364358935|FG000|Overall Study|Pathogen resistant|7|||
105643716|NCT01014013|364358936|FG001|Overall Study|Pathogen resistant|4|||
105643717|NCT01014013|364358935|FG000|Overall Study|Physician Decision|0|||
105643718|NCT01014013|364358936|FG001|Overall Study|Physician Decision|1|||
105643719|NCT01014013|364358935|FG000|Overall Study|Another antibiotic therapy required|0|||
105643720|NCT01014013|364358936|FG001|Overall Study|Another antibiotic therapy required|1|||
105643721|NCT01014013|364358935|FG000|Overall Study|Appendectomy|1|||
105643722|NCT01014013|364358936|FG001|Overall Study|Appendectomy|0|||
105643723|NCT01014013|364358935|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
105643724|NCT01014013|364358936|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
105643725|NCT00595959|364358937|FG000|Overall Study|Withdrawal by Subject|1|||
105643726|NCT00595959|364358937|FG000|Overall Study|Lost to Follow-up|1|||
105643727|NCT01020435|364358945|FG000|Overall Study|Lost to Follow-up|0|||
105643728|NCT01020435|364358946|FG001|Overall Study|Lost to Follow-up|1|||
105643729|NCT02291549|364358949|FG000|Overall Study|Lost to Follow-up|1|||
105643730|NCT02291549|364358950|FG001|Overall Study|Lost to Follow-up|0|||
105643731|NCT02291549|364358949|FG000|Overall Study|Withdrawal by Subject|0|||
105643732|NCT02291549|364358950|FG001|Overall Study|Withdrawal by Subject|1|||
105643733|NCT01794689|364358951|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
105643734|NCT01794689|364358952|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
105643735|NCT01794689|364358953|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
105643736|NCT01794689|364358954|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
105643737|NCT01794689|364358951|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
105643738|NCT01794689|364358952|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
105643739|NCT01794689|364358953|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
105643740|NCT01794689|364358954|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
105643741|NCT01794689|364358951|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
105643742|NCT01794689|364358952|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
105643743|NCT01794689|364358953|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
105643744|NCT01794689|364358954|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
105643745|NCT01794689|364358951|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
105643746|NCT01794689|364358952|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
105643747|NCT01794689|364358953|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
105643748|NCT01794689|364358954|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
105643749|NCT01528605|364358956|FG000|Overall Study|Lost to Follow-up|1|||
105643750|NCT01528605|364358957|FG001|Overall Study|Lost to Follow-up|0|||
105643751|NCT01528605|364358958|FG002|Overall Study|Lost to Follow-up|1|||
105643752|NCT01528605|364358959|FG003|Overall Study|Lost to Follow-up|1|||
105643753|NCT01528605|364358960|FG004|Overall Study|Lost to Follow-up|0|||
105643754|NCT01528605|364358961|FG005|Overall Study|Lost to Follow-up|0|||
105643755|NCT01528605|364358956|FG000|Overall Study|Death|1|||
105643756|NCT01528605|364358957|FG001|Overall Study|Death|0|||
105643757|NCT01528605|364358958|FG002|Overall Study|Death|0|||
105643758|NCT01528605|364358959|FG003|Overall Study|Death|0|||
105643759|NCT01528605|364358960|FG004|Overall Study|Death|0|||
105643760|NCT01528605|364358961|FG005|Overall Study|Death|0|||
105643761|NCT02561195|364358962|FG000|Vaccination 1 to 3|Adverse Event|4|||
105643762|NCT02561195|364358963|FG001|Vaccination 1 to 3|Adverse Event|5|||
105643763|NCT02561195|364358964|FG002|Vaccination 1 to 3|Adverse Event|0|||
105643764|NCT02561195|364358965|FG003|Vaccination 1 to 3|Adverse Event|3|||
105643765|NCT02561195|364358966|FG004|Vaccination 1 to 3|Adverse Event|4|||
105643766|NCT02561195|364358967|FG005|Vaccination 1 to 3|Adverse Event|0|||
105643767|NCT02561195|364358968|FG006|Vaccination 1 to 3|Adverse Event|0|||
105643768|NCT02561195|364358969|FG007|Vaccination 1 to 3|Adverse Event|0|||
105643769|NCT02561195|364358970|FG008|Vaccination 1 to 3|Adverse Event|0|||
105643770|NCT02561195|364358971|FG009|Vaccination 1 to 3|Adverse Event|0|||
105643771|NCT02561195|364358972|FG010|Vaccination 1 to 3|Adverse Event|0|||
105643772|NCT02561195|364358973|FG011|Vaccination 1 to 3|Adverse Event|0|||
105643773|NCT02561195|364358974|FG012|Vaccination 1 to 3|Adverse Event|0|||
105643774|NCT02561195|364358975|FG013|Vaccination 1 to 3|Adverse Event|0|||
105643775|NCT02561195|364358962|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
105643776|NCT02561195|364358963|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
105643777|NCT02561195|364358964|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
105643778|NCT02561195|364358965|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
105643779|NCT02561195|364358966|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
105643780|NCT02561195|364358967|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
105643781|NCT02561195|364358968|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
105643782|NCT02561195|364358969|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
105643783|NCT02561195|364358970|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
105643784|NCT02561195|364358971|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
105643785|NCT02561195|364358972|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
105643786|NCT02561195|364358973|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
105643787|NCT02561195|364358974|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
105643788|NCT02561195|364358975|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
105643789|NCT02561195|364358962|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643790|NCT02561195|364358963|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
105643791|NCT02561195|364358964|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643792|NCT02561195|364358965|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
105643793|NCT02561195|364358966|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
105643794|NCT02561195|364358967|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
105643795|NCT02561195|364358968|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643796|NCT02561195|364358969|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643797|NCT02561195|364358970|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643798|NCT02561195|364358971|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643799|NCT02561195|364358972|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643800|NCT02561195|364358973|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643801|NCT02561195|364358974|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643802|NCT02561195|364358975|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
105643803|NCT02561195|364358962|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
105643804|NCT02561195|364358963|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
105643805|NCT02561195|364358964|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
105643806|NCT02561195|364358965|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
105643807|NCT02561195|364358966|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
105643808|NCT02561195|364358967|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
105643809|NCT02561195|364358968|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
105643810|NCT02561195|364358969|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
105643811|NCT02561195|364358970|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
105643812|NCT02561195|364358971|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
105643813|NCT02561195|364358972|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
105870223|NCT01074944|365176969|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
105643814|NCT02561195|364358973|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
105643815|NCT02561195|364358974|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
105643816|NCT02561195|364358975|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
105643817|NCT02561195|364358962|FG000|Vaccination 1 to 3|Other|7|||
105643818|NCT02561195|364358963|FG001|Vaccination 1 to 3|Other|3|||
105643819|NCT02561195|364358964|FG002|Vaccination 1 to 3|Other|1|||
105643820|NCT02561195|364358965|FG003|Vaccination 1 to 3|Other|7|||
105643821|NCT02561195|364358966|FG004|Vaccination 1 to 3|Other|5|||
105643822|NCT02561195|364358967|FG005|Vaccination 1 to 3|Other|1|||
105643823|NCT02561195|364358968|FG006|Vaccination 1 to 3|Other|0|||
105643824|NCT02561195|364358969|FG007|Vaccination 1 to 3|Other|0|||
105643825|NCT02561195|364358970|FG008|Vaccination 1 to 3|Other|0|||
105643826|NCT02561195|364358971|FG009|Vaccination 1 to 3|Other|0|||
105643827|NCT02561195|364358972|FG010|Vaccination 1 to 3|Other|0|||
105643828|NCT02561195|364358973|FG011|Vaccination 1 to 3|Other|0|||
105643829|NCT02561195|364358974|FG012|Vaccination 1 to 3|Other|0|||
105643830|NCT02561195|364358975|FG013|Vaccination 1 to 3|Other|0|||
105643831|NCT02561195|364358962|FG000|Vaccination 1 to 3|Protocol Violation|1|||
105643832|NCT02561195|364358963|FG001|Vaccination 1 to 3|Protocol Violation|0|||
105643833|NCT02561195|364358964|FG002|Vaccination 1 to 3|Protocol Violation|1|||
105643834|NCT02561195|364358965|FG003|Vaccination 1 to 3|Protocol Violation|2|||
105643835|NCT02561195|364358966|FG004|Vaccination 1 to 3|Protocol Violation|5|||
105643836|NCT02561195|364358967|FG005|Vaccination 1 to 3|Protocol Violation|2|||
105643837|NCT02561195|364358968|FG006|Vaccination 1 to 3|Protocol Violation|0|||
105643838|NCT02561195|364358969|FG007|Vaccination 1 to 3|Protocol Violation|0|||
105643839|NCT02561195|364358970|FG008|Vaccination 1 to 3|Protocol Violation|0|||
105643840|NCT02561195|364358971|FG009|Vaccination 1 to 3|Protocol Violation|0|||
105643841|NCT02561195|364358972|FG010|Vaccination 1 to 3|Protocol Violation|0|||
105643842|NCT02561195|364358973|FG011|Vaccination 1 to 3|Protocol Violation|0|||
105643843|NCT02561195|364358974|FG012|Vaccination 1 to 3|Protocol Violation|0|||
105643844|NCT02561195|364358975|FG013|Vaccination 1 to 3|Protocol Violation|0|||
105643845|NCT02561195|364358962|FG000|Vaccination 1 to 3|Death|2|||
105643846|NCT02561195|364358963|FG001|Vaccination 1 to 3|Death|1|||
105643847|NCT02561195|364358964|FG002|Vaccination 1 to 3|Death|0|||
105643848|NCT02561195|364358965|FG003|Vaccination 1 to 3|Death|2|||
105643849|NCT02561195|364358966|FG004|Vaccination 1 to 3|Death|0|||
105643850|NCT02561195|364358967|FG005|Vaccination 1 to 3|Death|0|||
105643851|NCT02561195|364358968|FG006|Vaccination 1 to 3|Death|0|||
105643852|NCT02561195|364358969|FG007|Vaccination 1 to 3|Death|0|||
105643853|NCT02561195|364358970|FG008|Vaccination 1 to 3|Death|0|||
105643854|NCT02561195|364358971|FG009|Vaccination 1 to 3|Death|0|||
105643855|NCT02561195|364358972|FG010|Vaccination 1 to 3|Death|0|||
105643856|NCT02561195|364358973|FG011|Vaccination 1 to 3|Death|0|||
105643857|NCT02561195|364358974|FG012|Vaccination 1 to 3|Death|0|||
105643858|NCT02561195|364358975|FG013|Vaccination 1 to 3|Death|0|||
105643859|NCT02561195|364358962|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
105643860|NCT02561195|364358963|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
105643861|NCT02561195|364358964|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
105643862|NCT02561195|364358965|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
105643863|NCT02561195|364358966|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
105643864|NCT02561195|364358967|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643865|NCT02561195|364358968|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643866|NCT02561195|364358969|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643867|NCT02561195|364358970|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643868|NCT02561195|364358971|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643869|NCT02561195|364358972|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643870|NCT02561195|364358973|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643871|NCT02561195|364358974|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643872|NCT02561195|364358975|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
105643873|NCT02561195|364358962|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
105643874|NCT02561195|364358963|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
105643875|NCT02561195|364358964|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
105643876|NCT02561195|364358965|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
105643877|NCT02561195|364358966|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
105643878|NCT02561195|364358967|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
105643879|NCT02561195|364358968|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
105643880|NCT02561195|364358969|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
105643881|NCT02561195|364358970|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
105643882|NCT02561195|364358971|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
105643883|NCT02561195|364358972|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
105643884|NCT02561195|364358973|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
105643885|NCT02561195|364358974|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
105643886|NCT02561195|364358975|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
105643887|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643888|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643889|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643890|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643891|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643892|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643893|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643894|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643895|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
105643896|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
105643897|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
105643898|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
105643899|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
105643900|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
105643901|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643902|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643903|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643904|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643905|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643906|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643907|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643908|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643909|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643910|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643911|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643912|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643913|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
105643914|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
105643915|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Death|0|||
105643916|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Death|0|||
105643917|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Death|0|||
105643918|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Death|0|||
105643919|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Death|0|||
105643920|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Death|0|||
105643921|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Death|0|||
105643922|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Death|0|||
105643923|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Death|0|||
105643924|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Death|1|||
105643925|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Death|0|||
105643926|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Death|0|||
105643927|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Death|0|||
105643928|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Death|0|||
105643929|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643930|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643931|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643932|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643933|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643934|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643935|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
105643936|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
105643937|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643938|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
105643939|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
105643940|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
105643941|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
105643942|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
105643943|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643944|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643945|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643946|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643947|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643948|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643949|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643950|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643951|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643952|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643953|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
105643954|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
105643955|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
105643956|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
105643957|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Other|0|||
105643958|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Other|0|||
105643959|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Other|0|||
105643960|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Other|0|||
105643961|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Other|0|||
105643962|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Other|0|||
105659339|NCT00551135|364417282|FG002|Overall Study|Other|1|||
105643963|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Other|0|||
105643964|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Other|0|||
105643965|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Other|0|||
105643966|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Other|0|||
105643967|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Other|2|||
105643968|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Other|2|||
105643969|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Other|1|||
105643970|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Other|0|||
105643971|NCT02561195|364358962|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643972|NCT02561195|364358963|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643973|NCT02561195|364358964|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643974|NCT02561195|364358965|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643975|NCT02561195|364358966|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643976|NCT02561195|364358967|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643977|NCT02561195|364358968|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
105643978|NCT02561195|364358969|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643979|NCT02561195|364358970|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643980|NCT02561195|364358971|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643981|NCT02561195|364358972|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
105643982|NCT02561195|364358973|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
105643983|NCT02561195|364358974|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
105643984|NCT02561195|364358975|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
105643985|NCT04433091|364358986|FG000|Overall Study|Lost to Follow-up|1|||
105643986|NCT04433091|364358987|FG001|Overall Study|Lost to Follow-up|0|||
105643987|NCT04433091|364358986|FG000|Overall Study|Withdrawn .|2|||
105643988|NCT04433091|364358987|FG001|Overall Study|Withdrawn .|4|||
105643989|NCT02196259|364360300|FG000|Overall Study|Researcher choice|0|||
105643990|NCT02196259|364360301|FG001|Overall Study|Researcher choice|0|||
105643991|NCT02196259|364360302|FG002|Overall Study|Researcher choice|1|||
105643992|NCT02196259|364360300|FG000|Overall Study|Partial data analysis|0|||
105643993|NCT02196259|364360301|FG001|Overall Study|Partial data analysis|3|||
105643994|NCT02196259|364360302|FG002|Overall Study|Partial data analysis|0|||
105643995|NCT04783389|364360303|FG000|Overall Study|Withdrawal by Subject|2|||
105643996|NCT04783389|364360304|FG001|Overall Study|Withdrawal by Subject|0|||
105643997|NCT04783389|364360305|FG002|Overall Study|Withdrawal by Subject|0|||
105643998|NCT04783389|364360303|FG000|Overall Study|Termination of Study by Sponsor|10|||
105643999|NCT04783389|364360304|FG001|Overall Study|Termination of Study by Sponsor|12|||
105644000|NCT04783389|364360305|FG002|Overall Study|Termination of Study by Sponsor|14|||
105644001|NCT00215943|364360306|FG000|Overall Study|Disease Progression|3|||
105644002|NCT00215943|364360307|FG001|Overall Study|Disease Progression|5|||
105644003|NCT00215943|364360306|FG000|Overall Study|Alternate therapy|0|||
105644004|NCT00215943|364360307|FG001|Overall Study|Alternate therapy|1|||
105644005|NCT00215943|364360306|FG000|Overall Study|Adverse Event|3|||
105644006|NCT00215943|364360307|FG001|Overall Study|Adverse Event|6|||
105644007|NCT00215943|364360306|FG000|Overall Study|Other disease|0|||
105644008|NCT00215943|364360307|FG001|Overall Study|Other disease|1|||
105644009|NCT00215943|364360306|FG000|Overall Study|Other complications|3|||
105644010|NCT00215943|364360307|FG001|Overall Study|Other complications|1|||
105644011|NCT03469258|364360308|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
105644012|NCT04311983|364360309|FG000|Overall Study|Lost to Follow-up|421|||
105644013|NCT04311983|364360310|FG001|Overall Study|Lost to Follow-up|456|||
105644014|NCT04311983|364360309|FG000|Overall Study|Incomplete survey|7|||
105644015|NCT04311983|364360310|FG001|Overall Study|Incomplete survey|9|||
105644016|NCT04311983|364360309|FG000|Overall Study|Death|1|||
105644017|NCT04311983|364360310|FG001|Overall Study|Death|0|||
105644018|NCT02981953|364360311|FG000|Overall Study|Death|9|||
105644019|NCT02981953|364360311|FG000|Overall Study|Withdrawal by Subject|1|||
105644020|NCT02981953|364360311|FG000|Overall Study|Withdrawal to non-compliance|1|||
105644021|NCT01248715|364360315|FG000|Overall Study|Not influenza positive|501|||
105644022|NCT01248715|364360316|FG001|Overall Study|Not influenza positive|510|||
105644023|NCT04271254|364360323|FG000|Overall Study|Withdrawal by Subject|3|||
105644024|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
105644025|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
105644026|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
105644027|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
105644028|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
105644029|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
105644030|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
105644031|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
105644032|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
105644033|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
105644034|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
105644035|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
105644036|NCT01345253|364360324|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
105644037|NCT01345253|364360325|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
105644038|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
105644039|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
105644040|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
105644041|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
105644042|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
105644043|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
105644044|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
105644045|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
105644046|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
105644047|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
105644048|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
105644049|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
105644050|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
105644051|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
105644052|NCT01345253|364360324|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
105644053|NCT01345253|364360325|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
105644054|NCT05361304|364360326|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
105644055|NCT05361304|364360327|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
105644056|NCT05361304|364360326|FG000|Overall Study|COVID-19 Related|1|||
105644057|NCT05361304|364360327|FG001|Overall Study|COVID-19 Related|2|||
105644058|NCT05361304|364360326|FG000|Overall Study|Withdrawal by Subject|1|||
105644059|NCT05361304|364360327|FG001|Overall Study|Withdrawal by Subject|0|||
105644060|NCT01767376|364360328|FG000|Overall Study|Lost to Follow-up|3|||
105644061|NCT01767376|364360329|FG001|Overall Study|Lost to Follow-up|2|||
105644062|NCT01767376|364360330|FG002|Overall Study|Lost to Follow-up|0|||
105644063|NCT01767376|364360328|FG000|Overall Study|Withdrawal by Subject|1|||
105644064|NCT01767376|364360329|FG001|Overall Study|Withdrawal by Subject|1|||
105644065|NCT01767376|364360330|FG002|Overall Study|Withdrawal by Subject|0|||
105644066|NCT01113541|364360334|FG000|Overall Study|Withdrawal by Subject|1|||
105644067|NCT01113541|364360334|FG000|Overall Study|Protocol Violation|1|||
105644068|NCT01113541|364360334|FG000|Overall Study|Study Terminated by Sponsor|7|||
105644069|NCT01113541|364360334|FG000|Overall Study|Adverse Event|4|||
105644070|NCT02309892|364360335|FG000|Overall Study|Physician Decision|1|||
105644071|NCT02309892|364360336|FG001|Overall Study|Physician Decision|0|||
105644072|NCT02309892|364360337|FG002|Overall Study|Physician Decision|0|||
105644073|NCT02309892|364360338|FG003|Overall Study|Physician Decision|0|||
105644074|NCT02309892|364360339|FG004|Overall Study|Physician Decision|0|||
105644075|NCT02309892|364360340|FG005|Overall Study|Physician Decision|0|||
105644076|NCT02309892|364360341|FG006|Overall Study|Physician Decision|0|||
105644077|NCT02309892|364360335|FG000|Overall Study|Adverse Event|1|||
105644078|NCT02309892|364360336|FG001|Overall Study|Adverse Event|0|||
105644079|NCT02309892|364360337|FG002|Overall Study|Adverse Event|1|||
105644080|NCT02309892|364360338|FG003|Overall Study|Adverse Event|0|||
105644081|NCT02309892|364360339|FG004|Overall Study|Adverse Event|0|||
105644082|NCT02309892|364360340|FG005|Overall Study|Adverse Event|0|||
105644083|NCT02309892|364360341|FG006|Overall Study|Adverse Event|0|||
105644084|NCT02309892|364360335|FG000|Overall Study|Progressive Disease|0|||
105644085|NCT02309892|364360336|FG001|Overall Study|Progressive Disease|1|||
105644086|NCT02309892|364360337|FG002|Overall Study|Progressive Disease|0|||
105644087|NCT02309892|364360338|FG003|Overall Study|Progressive Disease|0|||
105644088|NCT02309892|364360339|FG004|Overall Study|Progressive Disease|1|||
105644089|NCT02309892|364360340|FG005|Overall Study|Progressive Disease|0|||
105644090|NCT02309892|364360341|FG006|Overall Study|Progressive Disease|0|||
105644091|NCT02309892|364360335|FG000|Overall Study|Death|0|||
105644092|NCT02309892|364360336|FG001|Overall Study|Death|0|||
105644093|NCT02309892|364360337|FG002|Overall Study|Death|0|||
105644094|NCT02309892|364360338|FG003|Overall Study|Death|0|||
105644095|NCT02309892|364360339|FG004|Overall Study|Death|0|||
105644096|NCT02309892|364360340|FG005|Overall Study|Death|1|||
105644097|NCT02309892|364360341|FG006|Overall Study|Death|0|||
105644098|NCT03262389|364360342|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
105644099|NCT03262389|364360342|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
105644100|NCT03262389|364360342|FG000|Overall Study|opted out of PET/MR|1|||
105644101|NCT02721147|364360343|FG000|Overall Study|Lost to Follow-up|2|||
105644102|NCT02721147|364360344|FG001|Overall Study|Lost to Follow-up|0|||
105644103|NCT02721147|364360345|FG002|Overall Study|Lost to Follow-up|0|||
105644104|NCT04739306|364360346|FG000|Main Study Period|Adverse Event|6|||
105644105|NCT04739306|364360347|FG001|Main Study Period|Adverse Event|7|||
105644106|NCT04739306|364360346|FG000|Main Study Period|Lost to Follow-up|4|||
105644107|NCT04739306|364360347|FG001|Main Study Period|Lost to Follow-up|6|||
105644108|NCT04739306|364360346|FG000|Main Study Period|Physician Decision|1|||
105644109|NCT04739306|364360347|FG001|Main Study Period|Physician Decision|1|||
105644110|NCT04739306|364360346|FG000|Main Study Period|Withdrawal by Subject|8|||
105644111|NCT04739306|364360347|FG001|Main Study Period|Withdrawal by Subject|6|||
105644112|NCT04739306|364360346|FG000|Main Study Period|Protocol Violation|0|||
105644113|NCT04739306|364360347|FG001|Main Study Period|Protocol Violation|1|||
105644114|NCT04739306|364360346|FG000|Main Study Period|War in Ukraine|1|||
105644115|NCT04739306|364360347|FG001|Main Study Period|War in Ukraine|1|||
105644116|NCT00096278|364360353|FG000|Overall Study|No follow-up data|15|||
105644117|NCT00096278|364360354|FG001|Overall Study|No follow-up data|18|||
105644118|NCT00096278|364360353|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
105644119|NCT00096278|364360354|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
105644120|NCT04421456|364360355|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
105644121|NCT04421456|364360356|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
105644122|NCT04421456|364360357|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
105644123|NCT04421456|364360355|FG000|Randomized Treatment Period|Adverse Event|0|||
105644124|NCT04421456|364360356|FG001|Randomized Treatment Period|Adverse Event|1|||
105644125|NCT04421456|364360357|FG002|Randomized Treatment Period|Adverse Event|0|||
105644126|NCT04421456|364360355|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
105644127|NCT04421456|364360356|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
105644128|NCT04421456|364360357|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
105644129|NCT04421456|364360355|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
105644130|NCT04421456|364360356|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
105644131|NCT04421456|364360357|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
105644132|NCT04421456|364360355|FG000|Randomized Treatment Period|Participant non-compliance|1|||
105644133|NCT04421456|364360356|FG001|Randomized Treatment Period|Participant non-compliance|1|||
105644134|NCT04421456|364360357|FG002|Randomized Treatment Period|Participant non-compliance|2|||
105644135|NCT04421456|364360355|FG000|Randomized Treatment Period|Other|0|||
105644136|NCT04421456|364360356|FG001|Randomized Treatment Period|Other|1|||
105644137|NCT04421456|364360357|FG002|Randomized Treatment Period|Other|3|||
105644138|NCT00963924|364360358|FG000|Overall Study|Adverse Event|1|||
105644139|NCT00963924|364360359|FG001|Overall Study|Adverse Event|0|||
105644140|NCT00963924|364360358|FG000|Overall Study|Withdrawal by Subject|0|||
105644141|NCT00963924|364360359|FG001|Overall Study|Withdrawal by Subject|1|||
105644142|NCT00963924|364360358|FG000|Overall Study|Changed antipsychotic|0|||
105644143|NCT00963924|364360359|FG001|Overall Study|Changed antipsychotic|1|||
105644144|NCT00963924|364360358|FG000|Overall Study|Lost to Follow-up|0|||
105644145|NCT00963924|364360359|FG001|Overall Study|Lost to Follow-up|1|||
105644146|NCT03031782|364360363|FG000|Treatment Period 1|Lack of Efficacy|3|||
105644147|NCT03031782|364360364|FG001|Treatment Period 1|Lack of Efficacy|0|||
105644148|NCT03031782|364360365|FG002|Treatment Period 1|Lack of Efficacy|0|||
105644149|NCT03031782|364360366|FG003|Treatment Period 1|Lack of Efficacy|0|||
105644150|NCT03031782|364360367|FG004|Treatment Period 1|Lack of Efficacy|0|||
105644151|NCT03031782|364360363|FG000|Treatment Period 2|Physician Decision|0|||
105644152|NCT03031782|364360364|FG001|Treatment Period 2|Physician Decision|1|||
105644153|NCT03031782|364360365|FG002|Treatment Period 2|Physician Decision|0|||
105644154|NCT03031782|364360366|FG003|Treatment Period 2|Physician Decision|0|||
105644155|NCT03031782|364360367|FG004|Treatment Period 2|Physician Decision|3|||
105644156|NCT03031782|364360363|FG000|Treatment Period 2|Lack of Efficacy|0|||
105644157|NCT03031782|364360364|FG001|Treatment Period 2|Lack of Efficacy|1|||
105644158|NCT03031782|364360365|FG002|Treatment Period 2|Lack of Efficacy|0|||
105644159|NCT03031782|364360366|FG003|Treatment Period 2|Lack of Efficacy|0|||
105644160|NCT03031782|364360367|FG004|Treatment Period 2|Lack of Efficacy|1|||
105644161|NCT03031782|364360363|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105644162|NCT03031782|364360364|FG001|Treatment Period 2|Withdrawal by Subject|3|||
105644163|NCT03031782|364360365|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105644164|NCT03031782|364360366|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105644165|NCT03031782|364360367|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105644166|NCT03031782|364360363|FG000|Treatment Period 2|Adverse Event|0|||
105644167|NCT03031782|364360364|FG001|Treatment Period 2|Adverse Event|1|||
105644168|NCT03031782|364360365|FG002|Treatment Period 2|Adverse Event|2|||
105644169|NCT03031782|364360366|FG003|Treatment Period 2|Adverse Event|0|||
105644170|NCT03031782|364360367|FG004|Treatment Period 2|Adverse Event|0|||
105644171|NCT03031782|364360363|FG000|Treatment Period 3|Withdrawal by Subject|0|||
105644172|NCT03031782|364360364|FG001|Treatment Period 3|Withdrawal by Subject|0|||
105644173|NCT03031782|364360365|FG002|Treatment Period 3|Withdrawal by Subject|0|||
105644174|NCT03031782|364360366|FG003|Treatment Period 3|Withdrawal by Subject|1|||
105644175|NCT03031782|364360367|FG004|Treatment Period 3|Withdrawal by Subject|0|||
105644176|NCT00657709|364360369|FG000|Overall Study|AE or Death|7|||
105644177|NCT00657709|364360370|FG001|Overall Study|AE or Death|7|||
105644178|NCT00657709|364360371|FG002|Overall Study|AE or Death|6|||
105644179|NCT00657709|364360372|FG003|Overall Study|AE or Death|7|||
105644180|NCT00657709|364360373|FG004|Overall Study|AE or Death|1|||
105644181|NCT00657709|364360369|FG000|Overall Study|Withdrawal by Subject|7|||
105644182|NCT00657709|364360370|FG001|Overall Study|Withdrawal by Subject|15|||
105644183|NCT00657709|364360371|FG002|Overall Study|Withdrawal by Subject|15|||
105644184|NCT00657709|364360372|FG003|Overall Study|Withdrawal by Subject|5|||
105644185|NCT00657709|364360373|FG004|Overall Study|Withdrawal by Subject|9|||
105644186|NCT00657709|364360369|FG000|Overall Study|Lost to Follow-up|9|||
105644187|NCT00657709|364360370|FG001|Overall Study|Lost to Follow-up|9|||
105644188|NCT00657709|364360371|FG002|Overall Study|Lost to Follow-up|7|||
105644189|NCT00657709|364360372|FG003|Overall Study|Lost to Follow-up|1|||
105644190|NCT00657709|364360373|FG004|Overall Study|Lost to Follow-up|21|||
105644191|NCT00657709|364360369|FG000|Overall Study|Protocol Violation|0|||
105644192|NCT00657709|364360370|FG001|Overall Study|Protocol Violation|2|||
105644193|NCT00657709|364360371|FG002|Overall Study|Protocol Violation|0|||
105644194|NCT00657709|364360372|FG003|Overall Study|Protocol Violation|1|||
105644195|NCT00657709|364360373|FG004|Overall Study|Protocol Violation|2|||
105644196|NCT00442559|364360374|FG000|Overall Study|Lost to Follow-up|32|||
105644197|NCT00442559|364360375|FG001|Overall Study|Lost to Follow-up|34|||
105644198|NCT00442559|364360374|FG000|Overall Study|Protocol Violation|1|||
105644199|NCT00442559|364360375|FG001|Overall Study|Protocol Violation|1|||
105644200|NCT00442559|364360374|FG000|Overall Study|Withdrawal by Subject|1|||
105644201|NCT00442559|364360375|FG001|Overall Study|Withdrawal by Subject|0|||
105644202|NCT04765046|364360379|FG000|Overall Study|Screen Failure|2|||
105644203|NCT04765046|364360379|FG000|Overall Study|Withdrawal by Subject|4|||
105644204|NCT04765046|364360379|FG000|Overall Study|Physician Decision|4|||
105644205|NCT04765046|364360379|FG000|Overall Study|Surgery Cancelled|8|||
105644206|NCT03529942|364360380|FG000|Overall Study|Withdrawal by Subject|13|||
105644207|NCT03529942|364360380|FG000|Overall Study|Physician Decision|1|||
105644208|NCT03529942|364360380|FG000|Overall Study|Lost to Follow-up|7|||
105644209|NCT03529942|364360380|FG000|Overall Study|Needle inserted but no drug administered|1|||
105644210|NCT03529942|364360380|FG000|Overall Study|Personal reasons|1|||
105644211|NCT01287832|364360386|FG000|Overall Study|Adverse Event|1|||
105644212|NCT01287832|364360387|FG001|Overall Study|Adverse Event|0|||
105644213|NCT01287832|364360386|FG000|Overall Study|Death|0|||
105644214|NCT01287832|364360387|FG001|Overall Study|Death|1|||
105644215|NCT00321555|364360388|FG000|Overall Study|Developed antibodies|1|||
105644216|NCT00321555|364360388|FG000|Overall Study|Switched to alternative treatment|3|||
105644217|NCT00321555|364360388|FG000|Overall Study|Physician Decision|1|||
105644218|NCT00321555|364360388|FG000|Overall Study|Disease progression on study|1|||
105644219|NCT01670526|364360392|FG000|Overall Study|Withdrawal by Subject|3|||
105644220|NCT01670526|364360393|FG001|Overall Study|Withdrawal by Subject|1|||
105644221|NCT01670526|364360392|FG000|Overall Study|Lost to Follow-up|9|||
105644222|NCT01670526|364360393|FG001|Overall Study|Lost to Follow-up|5|||
105644223|NCT01697956|364360394|FG000|Overall Study|Protocol Violation|1|||
105644224|NCT01697956|364360395|FG001|Overall Study|Protocol Violation|1|||
105644225|NCT01970527|364360396|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
105644226|NCT01970527|364360397|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
105644227|NCT01970527|364360396|FG000|Treatment|Disease progression|0|||
105644228|NCT01970527|364360397|FG001|Treatment|Disease progression|1|||
105644229|NCT01970527|364360396|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
105644230|NCT01970527|364360397|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
105644231|NCT01970527|364360396|FG000|Treatment|Death|0|||
105644232|NCT01970527|364360397|FG001|Treatment|Death|1|||
105644233|NCT01970527|364360396|FG000|Follow-up Clinic Visit|Disease progression|1|||
105644234|NCT01970527|364360397|FG001|Follow-up Clinic Visit|Disease progression|1|||
105644235|NCT01970527|364360396|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
105644236|NCT01970527|364360397|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
105644237|NCT01970527|364360396|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
105644238|NCT01970527|364360397|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
105644239|NCT05700851|364360398|FG000|Overall Study|Received a kidney transplant|1|||
105644240|NCT05700851|364360398|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
105644241|NCT05700851|364360398|FG000|Overall Study|Withdrawal by Subject|1|||
105644242|NCT03560206|364360399|FG000|Overall Study|Lost to Follow-up|19|||
105644243|NCT03560206|364360400|FG001|Overall Study|Lost to Follow-up|11|||
105644244|NCT03560206|364360399|FG000|Overall Study|Withdrawal by Subject|2|||
105644245|NCT03560206|364360400|FG001|Overall Study|Withdrawal by Subject|4|||
105644246|NCT03560206|364360399|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
105644247|NCT03560206|364360400|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
105644248|NCT03560206|364360399|FG000|Overall Study|Busy schedule|14|||
105644249|NCT03560206|364360400|FG001|Overall Study|Busy schedule|2|||
105644250|NCT03560206|364360399|FG000|Overall Study|patients' new health condition such as cancer|10|||
105644251|NCT03560206|364360400|FG001|Overall Study|patients' new health condition such as cancer|1|||
105644252|NCT03987074|364360401|FG000|Overall Study|Withdrew Consent|1|||
105644253|NCT03987074|364360402|FG001|Overall Study|Withdrew Consent|1|||
105644254|NCT03987074|364360403|FG002|Overall Study|Withdrew Consent|0|||
105644255|NCT03987074|364360404|FG003|Overall Study|Withdrew Consent|2|||
105644256|NCT03987074|364360405|FG004|Overall Study|Withdrew Consent|1|||
105644257|NCT03987074|364360401|FG000|Overall Study|Adverse Event|2|||
105644258|NCT03987074|364360402|FG001|Overall Study|Adverse Event|1|||
105644259|NCT03987074|364360403|FG002|Overall Study|Adverse Event|0|||
105644260|NCT03987074|364360404|FG003|Overall Study|Adverse Event|0|||
105644261|NCT03987074|364360405|FG004|Overall Study|Adverse Event|1|||
105644262|NCT03987074|364360401|FG000|Overall Study|Lost to Follow-up|0|||
105644263|NCT03987074|364360402|FG001|Overall Study|Lost to Follow-up|0|||
105644264|NCT03987074|364360403|FG002|Overall Study|Lost to Follow-up|1|||
105644265|NCT03987074|364360404|FG003|Overall Study|Lost to Follow-up|1|||
105644266|NCT03987074|364360405|FG004|Overall Study|Lost to Follow-up|0|||
105644267|NCT03987074|364360401|FG000|Overall Study|Investigator's Discretion|0|||
105644268|NCT03987074|364360402|FG001|Overall Study|Investigator's Discretion|0|||
105644269|NCT03987074|364360403|FG002|Overall Study|Investigator's Discretion|0|||
105644270|NCT03987074|364360404|FG003|Overall Study|Investigator's Discretion|1|||
105644271|NCT03987074|364360405|FG004|Overall Study|Investigator's Discretion|0|||
105644272|NCT02138838|364360406|FG000|Overall Study|Study Closure|7|||
105644273|NCT02138838|364360407|FG001|Overall Study|Study Closure|6|||
105644274|NCT02138838|364360406|FG000|Overall Study|Withdrawal by Subject|1|||
105644275|NCT02138838|364360407|FG001|Overall Study|Withdrawal by Subject|5|||
105644276|NCT02009865|364360418|FG000|Overall Study|Adverse Event|0|||
105644277|NCT02009865|364360419|FG001|Overall Study|Adverse Event|2|||
105644278|NCT02009865|364360418|FG000|Overall Study|Protocol Violation|0|||
105644279|NCT02009865|364360419|FG001|Overall Study|Protocol Violation|2|||
105644280|NCT02009865|364360418|FG000|Overall Study|Withdrawal by Subject|1|||
105644281|NCT02009865|364360419|FG001|Overall Study|Withdrawal by Subject|1|||
105644282|NCT00990314|364360420|FG000|Overall Study|Death|2|||
105644283|NCT00990314|364360420|FG000|Overall Study|Adverse Event|2|||
105644284|NCT00990314|364360420|FG000|Overall Study|Withdrawal by Subject|3|||
105644285|NCT00990314|364360420|FG000|Overall Study|Non-Compliance|1|||
105644286|NCT00990314|364360420|FG000|Overall Study|Physician Decision|3|||
105644287|NCT00990314|364360420|FG000|Overall Study|Lack of Efficacy|1|||
105644288|NCT01760876|364360421|FG000|Overall Study|Non-cardiac death (head injury)|1|||
105644289|NCT01760876|364360421|FG000|Overall Study|Carcinoma of prostate|1|||
105644290|NCT01760876|364360421|FG000|Overall Study|Impaired renal function|1|||
105644291|NCT01760876|364360421|FG000|Overall Study|Major depression|1|||
105644292|NCT01760876|364360421|FG000|Overall Study|Very poor baseline OCT quality|2|||
105644293|NCT00091572|364360424|FG000|Overall Study|Lost to Follow-up|1|||
105644294|NCT00091572|364360425|FG001|Overall Study|Lost to Follow-up|1|||
105644295|NCT00091572|364360424|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
105644296|NCT00091572|364360425|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
105644297|NCT00091572|364360424|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
105644298|NCT00091572|364360425|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
105644299|NCT00091572|364360424|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
105644300|NCT00091572|364360425|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
105644301|NCT00091572|364360424|FG000|Overall Study|Other Reason|6|||
105644302|NCT00091572|364360425|FG001|Overall Study|Other Reason|13|||
105644303|NCT00091572|364360424|FG000|Overall Study|Ongoing (still on treatment)|8|||
105644304|NCT00091572|364360425|FG001|Overall Study|Ongoing (still on treatment)|12|||
105644305|NCT00091572|364360424|FG000|Overall Study|Major Protocol Violation|2|||
105644306|NCT00091572|364360425|FG001|Overall Study|Major Protocol Violation|0|||
105644307|NCT00091572|364360424|FG000|Overall Study|Toxicity (Related AE)|53|||
105644308|NCT00091572|364360425|FG001|Overall Study|Toxicity (Related AE)|9|||
105644309|NCT02942771|364360427|FG000|Overall Study|Adverse Event|1|||
105644310|NCT02942771|364360428|FG001|Overall Study|Adverse Event|0|||
105644311|NCT02942771|364360429|FG002|Overall Study|Adverse Event|0|||
105644312|NCT02942771|364360430|FG003|Overall Study|Adverse Event|0|||
105644313|NCT02942771|364360431|FG004|Overall Study|Adverse Event|2|||
105644314|NCT02942771|364360427|FG000|Overall Study|Lost to Follow-up|1|||
105644315|NCT02942771|364360428|FG001|Overall Study|Lost to Follow-up|0|||
105644316|NCT02942771|364360429|FG002|Overall Study|Lost to Follow-up|0|||
105644317|NCT02942771|364360430|FG003|Overall Study|Lost to Follow-up|0|||
105644318|NCT02942771|364360431|FG004|Overall Study|Lost to Follow-up|0|||
105644319|NCT02942771|364360427|FG000|Overall Study|Withdrawal by Subject|1|||
105644320|NCT02942771|364360428|FG001|Overall Study|Withdrawal by Subject|0|||
105644321|NCT02942771|364360429|FG002|Overall Study|Withdrawal by Subject|0|||
105644322|NCT02942771|364360430|FG003|Overall Study|Withdrawal by Subject|0|||
105644323|NCT02942771|364360431|FG004|Overall Study|Withdrawal by Subject|2|||
105644324|NCT01898299|364360432|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
105644325|NCT01898299|364360433|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
105644326|NCT01199302|364360434|FG000|Overall Study|Adverse Event|1|||
105644327|NCT01199302|364360435|FG001|Overall Study|Adverse Event|1|||
105644328|NCT01199302|364360436|FG002|Overall Study|Adverse Event|2|||
105644329|NCT01199302|364360437|FG003|Overall Study|Adverse Event|0|||
105644330|NCT01199302|364360434|FG000|Overall Study|Withdrawal by Subject|2|||
105644331|NCT01199302|364360435|FG001|Overall Study|Withdrawal by Subject|2|||
105644332|NCT01199302|364360436|FG002|Overall Study|Withdrawal by Subject|3|||
105644333|NCT01199302|364360437|FG003|Overall Study|Withdrawal by Subject|0|||
105644334|NCT01199302|364360434|FG000|Overall Study|Disease Progression|3|||
105644335|NCT01199302|364360435|FG001|Overall Study|Disease Progression|4|||
105644336|NCT01199302|364360436|FG002|Overall Study|Disease Progression|4|||
105644337|NCT01199302|364360437|FG003|Overall Study|Disease Progression|2|||
105644338|NCT01199302|364360434|FG000|Overall Study|Study Termination|13|||
105644339|NCT01199302|364360435|FG001|Overall Study|Study Termination|8|||
105644340|NCT01199302|364360436|FG002|Overall Study|Study Termination|11|||
105644341|NCT01199302|364360437|FG003|Overall Study|Study Termination|9|||
105644342|NCT01199302|364360434|FG000|Overall Study|Lost to Follow-up|0|||
105644343|NCT01199302|364360435|FG001|Overall Study|Lost to Follow-up|1|||
105644344|NCT01199302|364360436|FG002|Overall Study|Lost to Follow-up|0|||
105644345|NCT01199302|364360437|FG003|Overall Study|Lost to Follow-up|0|||
105644346|NCT01199302|364360434|FG000|Overall Study|Other|1|||
105644347|NCT01199302|364360435|FG001|Overall Study|Other|0|||
105644348|NCT01199302|364360436|FG002|Overall Study|Other|0|||
105644349|NCT01199302|364360437|FG003|Overall Study|Other|0|||
105644350|NCT02340806|364360438|FG000|Overall Study|Protocol Violation|2|||
105644351|NCT02340806|364360439|FG001|Overall Study|Protocol Violation|0|||
105644352|NCT02340806|364360438|FG000|Overall Study|epidural catheter replaced|2|||
105644353|NCT02340806|364360439|FG001|Overall Study|epidural catheter replaced|1|||
105644354|NCT02340806|364360438|FG000|Overall Study|history of chronic pain medication|1|||
105644355|NCT02340806|364360439|FG001|Overall Study|history of chronic pain medication|0|||
105644356|NCT02340806|364360438|FG000|Overall Study|re-dose < 90 min of CSE|1|||
105644357|NCT02340806|364360439|FG001|Overall Study|re-dose < 90 min of CSE|3|||
105644358|NCT00452452|364360442|FG000|Overall Study|Protocol Violation|0|||
105644359|NCT00452452|364360443|FG001|Overall Study|Protocol Violation|0|||
105644360|NCT00452452|364360444|FG002|Overall Study|Protocol Violation|1|||
105644361|NCT00452452|364360442|FG000|Overall Study|Withdrawal by Subject|1|||
105644362|NCT00452452|364360443|FG001|Overall Study|Withdrawal by Subject|0|||
105644363|NCT00452452|364360444|FG002|Overall Study|Withdrawal by Subject|0|||
105644364|NCT00452452|364360442|FG000|Overall Study|Lost to Follow-up|1|||
105644365|NCT00452452|364360443|FG001|Overall Study|Lost to Follow-up|0|||
105644366|NCT00452452|364360444|FG002|Overall Study|Lost to Follow-up|0|||
105644367|NCT01634165|364360445|FG000|Period 2|Adverse Event|0|||
105644368|NCT01634165|364360446|FG001|Period 2|Adverse Event|1|||
105644369|NCT01634165|364360447|FG002|Period 2|Adverse Event|0|||
105644370|NCT01634165|364360448|FG003|Period 2|Adverse Event|0|||
105644371|NCT03070301|364360449|FG000|Overall Study|Progression of disease|16|||
105644372|NCT03070301|364360449|FG000|Overall Study|Physician Decision|3|||
105644373|NCT03070301|364360449|FG000|Overall Study|Withdrawal by Subject|1|||
105644374|NCT01276509|364361887|FG000|Overall Study|Adverse Event|9|||
105644375|NCT01276509|364361888|FG001|Overall Study|Adverse Event|8|||
105644376|NCT01276509|364361889|FG002|Overall Study|Adverse Event|4|||
105644377|NCT01276509|364361890|FG003|Overall Study|Adverse Event|3|||
105644378|NCT01276509|364361887|FG000|Overall Study|Lack of Efficacy|2|||
105644379|NCT01276509|364361888|FG001|Overall Study|Lack of Efficacy|1|||
105644380|NCT01276509|364361889|FG002|Overall Study|Lack of Efficacy|1|||
105644381|NCT01276509|364361890|FG003|Overall Study|Lack of Efficacy|2|||
105644382|NCT01276509|364361887|FG000|Overall Study|Pregnancy|1|||
105644383|NCT01276509|364361888|FG001|Overall Study|Pregnancy|0|||
105644384|NCT01276509|364361889|FG002|Overall Study|Pregnancy|0|||
105644385|NCT01276509|364361890|FG003|Overall Study|Pregnancy|0|||
105644386|NCT01276509|364361887|FG000|Overall Study|Withdrawal by Subject|1|||
105644387|NCT01276509|364361888|FG001|Overall Study|Withdrawal by Subject|2|||
105644388|NCT01276509|364361889|FG002|Overall Study|Withdrawal by Subject|0|||
105644389|NCT01276509|364361890|FG003|Overall Study|Withdrawal by Subject|0|||
105644390|NCT01276509|364361887|FG000|Overall Study|Other|0|||
105644391|NCT01276509|364361888|FG001|Overall Study|Other|1|||
105644392|NCT01276509|364361889|FG002|Overall Study|Other|0|||
105644393|NCT01276509|364361890|FG003|Overall Study|Other|0|||
105644394|NCT00264576|364361894|FG000|Overall Study|Lost to Follow-up|1|||
105644395|NCT00264576|364361895|FG001|Overall Study|Lost to Follow-up|1|||
105644396|NCT01668355|364361898|FG000|Overall Study|Death|3|||
105644397|NCT01668355|364361899|FG001|Overall Study|Death|1|||
105644398|NCT01668355|364361898|FG000|Overall Study|Withdrawal by Subject|6|||
105644399|NCT01668355|364361899|FG001|Overall Study|Withdrawal by Subject|1|||
105644400|NCT02659059|364361900|FG000|Overall Study|Other reasons|6|||
105644401|NCT02659059|364361901|FG001|Overall Study|Other reasons|1|||
105644402|NCT02659059|364361900|FG000|Overall Study|Disease Progression|143|||
105644403|NCT02659059|364361901|FG001|Overall Study|Disease Progression|16|||
105644404|NCT02659059|364361900|FG000|Overall Study|Study Drug toxicity|56|||
105644405|NCT02659059|364361901|FG001|Overall Study|Study Drug toxicity|9|||
105644406|NCT02659059|364361900|FG000|Overall Study|Death|3|||
105644407|NCT02659059|364361901|FG001|Overall Study|Death|1|||
105644408|NCT02659059|364361900|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
105644409|NCT02659059|364361901|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
105644410|NCT02659059|364361900|FG000|Overall Study|Participant request to discontinue study treatment|5|||
105644411|NCT02659059|364361901|FG001|Overall Study|Participant request to discontinue study treatment|0|||
105644412|NCT02659059|364361900|FG000|Overall Study|Participant withdrew consent|6|||
105644413|NCT02659059|364361901|FG001|Overall Study|Participant withdrew consent|1|||
105644414|NCT02830893|364361902|FG000|Overall Study|Relocation to out of the country|1|||
105644415|NCT02830893|364361903|FG001|Overall Study|Relocation to out of the country|0|||
105644416|NCT02830893|364361902|FG000|Overall Study|Lost to Follow-up|0|||
105644417|NCT02830893|364361903|FG001|Overall Study|Lost to Follow-up|2|||
105644418|NCT02830893|364361902|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
105644419|NCT02830893|364361903|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
105644420|NCT03976102|364361904|FG000|Overall Study|Withdrawal by Subject|4|||
105644421|NCT03976102|364361905|FG001|Overall Study|Withdrawal by Subject|4|||
105644422|NCT03976102|364361904|FG000|Overall Study|Adverse Event|2|||
105644423|NCT03976102|364361905|FG001|Overall Study|Adverse Event|4|||
105644424|NCT03976102|364361904|FG000|Overall Study|Not related to Covid-19|9|||
105644425|NCT03976102|364361905|FG001|Overall Study|Not related to Covid-19|13|||
105644426|NCT03976102|364361904|FG000|Overall Study|Lost to Follow-up|0|||
105644427|NCT03976102|364361905|FG001|Overall Study|Lost to Follow-up|2|||
105644428|NCT03976102|364361904|FG000|Overall Study|Death|3|||
105644429|NCT03976102|364361905|FG001|Overall Study|Death|2|||
105644430|NCT03976102|364361904|FG000|Overall Study|Physician Decision|1|||
105644431|NCT03976102|364361905|FG001|Overall Study|Physician Decision|1|||
105644432|NCT04820023|364361910|FG000|Overall Study|Death|0|||
105644433|NCT04820023|364361911|FG001|Overall Study|Death|0|||
105644434|NCT04820023|364361912|FG002|Overall Study|Death|0|||
105644435|NCT04820023|364361913|FG003|Overall Study|Death|0|||
105644436|NCT04820023|364361914|FG004|Overall Study|Death|0|||
105644437|NCT04820023|364361915|FG005|Overall Study|Death|0|||
105644438|NCT04820023|364361916|FG006|Overall Study|Death|1|||
105644439|NCT04820023|364361917|FG007|Overall Study|Death|0|||
105644440|NCT04820023|364361918|FG008|Overall Study|Death|1|||
105644441|NCT04820023|364361910|FG000|Overall Study|Withdrawal by Subject|1|||
105644442|NCT04820023|364361911|FG001|Overall Study|Withdrawal by Subject|2|||
105644443|NCT04820023|364361912|FG002|Overall Study|Withdrawal by Subject|2|||
105644444|NCT04820023|364361913|FG003|Overall Study|Withdrawal by Subject|1|||
105644445|NCT04820023|364361914|FG004|Overall Study|Withdrawal by Subject|4|||
105644446|NCT04820023|364361915|FG005|Overall Study|Withdrawal by Subject|3|||
105644447|NCT04820023|364361916|FG006|Overall Study|Withdrawal by Subject|3|||
105644448|NCT04820023|364361917|FG007|Overall Study|Withdrawal by Subject|6|||
105644449|NCT04820023|364361918|FG008|Overall Study|Withdrawal by Subject|5|||
105644450|NCT04820023|364361910|FG000|Overall Study|Progressive Disease|3|||
105644451|NCT04820023|364361911|FG001|Overall Study|Progressive Disease|0|||
105644452|NCT04820023|364361912|FG002|Overall Study|Progressive Disease|2|||
105644453|NCT04820023|364361913|FG003|Overall Study|Progressive Disease|2|||
105644454|NCT04820023|364361914|FG004|Overall Study|Progressive Disease|2|||
105644455|NCT04820023|364361915|FG005|Overall Study|Progressive Disease|0|||
105644456|NCT04820023|364361916|FG006|Overall Study|Progressive Disease|1|||
105644457|NCT04820023|364361917|FG007|Overall Study|Progressive Disease|1|||
105644458|NCT04820023|364361918|FG008|Overall Study|Progressive Disease|0|||
105644459|NCT04820023|364361910|FG000|Overall Study|New anti-cancer therapy|0|||
105644460|NCT04820023|364361911|FG001|Overall Study|New anti-cancer therapy|0|||
105644461|NCT04820023|364361912|FG002|Overall Study|New anti-cancer therapy|0|||
105644462|NCT04820023|364361913|FG003|Overall Study|New anti-cancer therapy|0|||
105644463|NCT04820023|364361914|FG004|Overall Study|New anti-cancer therapy|2|||
105644464|NCT04820023|364361915|FG005|Overall Study|New anti-cancer therapy|0|||
105644465|NCT04820023|364361916|FG006|Overall Study|New anti-cancer therapy|0|||
105644466|NCT04820023|364361917|FG007|Overall Study|New anti-cancer therapy|0|||
105644467|NCT04820023|364361918|FG008|Overall Study|New anti-cancer therapy|0|||
105644468|NCT04820023|364361910|FG000|Overall Study|Other|0|||
105644469|NCT04820023|364361911|FG001|Overall Study|Other|1|||
105644470|NCT04820023|364361912|FG002|Overall Study|Other|0|||
105644471|NCT04820023|364361913|FG003|Overall Study|Other|0|||
105644472|NCT04820023|364361914|FG004|Overall Study|Other|0|||
105644473|NCT04820023|364361915|FG005|Overall Study|Other|0|||
105644474|NCT04820023|364361916|FG006|Overall Study|Other|0|||
105644475|NCT04820023|364361917|FG007|Overall Study|Other|2|||
105644476|NCT04820023|364361918|FG008|Overall Study|Other|0|||
105644477|NCT01562275|364361919|FG000|Stage 1|Adverse Event|0|||
105644478|NCT01562275|364361920|FG001|Stage 1|Adverse Event|0|||
105644479|NCT01562275|364361921|FG002|Stage 1|Adverse Event|0|||
105644480|NCT01562275|364361922|FG003|Stage 1|Adverse Event|1|||
105644481|NCT01562275|364361923|FG004|Stage 1|Adverse Event|1|||
105644482|NCT01562275|364361924|FG005|Stage 1|Adverse Event|0|||
105644483|NCT01562275|364361925|FG006|Stage 1|Adverse Event|0|||
105644484|NCT01562275|364361926|FG007|Stage 1|Adverse Event|0|||
105644485|NCT01562275|364361927|FG008|Stage 1|Adverse Event|0|||
105644486|NCT01562275|364361928|FG009|Stage 1|Adverse Event|1|||
105644487|NCT01562275|364361929|FG010|Stage 1|Adverse Event|0|||
105644488|NCT01562275|364361930|FG011|Stage 1|Adverse Event|0|||
105644489|NCT01562275|364361931|FG012|Stage 1|Adverse Event|0|||
105644490|NCT01562275|364361919|FG000|Stage 1|Death|1|||
105644491|NCT01562275|364361920|FG001|Stage 1|Death|0|||
105644492|NCT01562275|364361921|FG002|Stage 1|Death|0|||
105644493|NCT01562275|364361922|FG003|Stage 1|Death|0|||
105644494|NCT01562275|364361923|FG004|Stage 1|Death|0|||
105644495|NCT01562275|364361924|FG005|Stage 1|Death|0|||
105644496|NCT01562275|364361925|FG006|Stage 1|Death|0|||
105644497|NCT01562275|364361926|FG007|Stage 1|Death|0|||
105644498|NCT01562275|364361927|FG008|Stage 1|Death|0|||
105644499|NCT01562275|364361928|FG009|Stage 1|Death|0|||
105644500|NCT01562275|364361929|FG010|Stage 1|Death|0|||
105644501|NCT01562275|364361930|FG011|Stage 1|Death|0|||
105644502|NCT01562275|364361931|FG012|Stage 1|Death|0|||
105644503|NCT01562275|364361919|FG000|Stage 1|Non Compliance|0|||
105644504|NCT01562275|364361920|FG001|Stage 1|Non Compliance|0|||
105644505|NCT01562275|364361921|FG002|Stage 1|Non Compliance|1|||
105644506|NCT01562275|364361922|FG003|Stage 1|Non Compliance|0|||
105644507|NCT01562275|364361923|FG004|Stage 1|Non Compliance|0|||
105644508|NCT01562275|364361924|FG005|Stage 1|Non Compliance|0|||
105644509|NCT01562275|364361925|FG006|Stage 1|Non Compliance|0|||
105644510|NCT01562275|364361926|FG007|Stage 1|Non Compliance|0|||
105644511|NCT01562275|364361927|FG008|Stage 1|Non Compliance|0|||
105644512|NCT01562275|364361928|FG009|Stage 1|Non Compliance|0|||
105644513|NCT01562275|364361929|FG010|Stage 1|Non Compliance|0|||
105644514|NCT01562275|364361930|FG011|Stage 1|Non Compliance|0|||
105644515|NCT01562275|364361931|FG012|Stage 1|Non Compliance|0|||
105644516|NCT01562275|364361919|FG000|Stage 1|Physician Decision|0|||
105644517|NCT01562275|364361920|FG001|Stage 1|Physician Decision|0|||
105644518|NCT01562275|364361921|FG002|Stage 1|Physician Decision|0|||
105644519|NCT01562275|364361922|FG003|Stage 1|Physician Decision|0|||
105644520|NCT01562275|364361923|FG004|Stage 1|Physician Decision|1|||
105644521|NCT01562275|364361924|FG005|Stage 1|Physician Decision|0|||
105644522|NCT01562275|364361925|FG006|Stage 1|Physician Decision|1|||
105644523|NCT01562275|364361926|FG007|Stage 1|Physician Decision|0|||
105644524|NCT01562275|364361927|FG008|Stage 1|Physician Decision|1|||
105644525|NCT01562275|364361928|FG009|Stage 1|Physician Decision|0|||
105644526|NCT01562275|364361929|FG010|Stage 1|Physician Decision|0|||
105644527|NCT01562275|364361930|FG011|Stage 1|Physician Decision|0|||
105644528|NCT01562275|364361931|FG012|Stage 1|Physician Decision|0|||
105644529|NCT01562275|364361919|FG000|Stage 1|Progression of Disease|2|||
105644530|NCT01562275|364361920|FG001|Stage 1|Progression of Disease|6|||
105644531|NCT01562275|364361921|FG002|Stage 1|Progression of Disease|2|||
105644532|NCT01562275|364361922|FG003|Stage 1|Progression of Disease|1|||
105644533|NCT01562275|364361923|FG004|Stage 1|Progression of Disease|2|||
105644534|NCT01562275|364361924|FG005|Stage 1|Progression of Disease|4|||
105644535|NCT01562275|364361925|FG006|Stage 1|Progression of Disease|1|||
105644536|NCT01562275|364361926|FG007|Stage 1|Progression of Disease|7|||
105644537|NCT01562275|364361927|FG008|Stage 1|Progression of Disease|2|||
105644538|NCT01562275|364361928|FG009|Stage 1|Progression of Disease|5|||
105644539|NCT01562275|364361929|FG010|Stage 1|Progression of Disease|3|||
105644540|NCT01562275|364361930|FG011|Stage 1|Progression of Disease|0|||
105644541|NCT01562275|364361931|FG012|Stage 1|Progression of Disease|0|||
105644542|NCT01562275|364361919|FG000|Stage 1|Withdrawal by Subject|0|||
105644543|NCT01562275|364361920|FG001|Stage 1|Withdrawal by Subject|1|||
105644544|NCT01562275|364361921|FG002|Stage 1|Withdrawal by Subject|0|||
105644545|NCT01562275|364361922|FG003|Stage 1|Withdrawal by Subject|2|||
105644546|NCT01562275|364361923|FG004|Stage 1|Withdrawal by Subject|0|||
105644547|NCT01562275|364361924|FG005|Stage 1|Withdrawal by Subject|0|||
105644548|NCT01562275|364361925|FG006|Stage 1|Withdrawal by Subject|1|||
105644549|NCT01562275|364361926|FG007|Stage 1|Withdrawal by Subject|0|||
105644550|NCT01562275|364361927|FG008|Stage 1|Withdrawal by Subject|0|||
105644551|NCT01562275|364361928|FG009|Stage 1|Withdrawal by Subject|1|||
105644552|NCT01562275|364361929|FG010|Stage 1|Withdrawal by Subject|0|||
105644553|NCT01562275|364361930|FG011|Stage 1|Withdrawal by Subject|0|||
105644554|NCT01562275|364361931|FG012|Stage 1|Withdrawal by Subject|0|||
105644555|NCT01562275|364361919|FG000|Stage 2|Death|0|||
105644556|NCT01562275|364361920|FG001|Stage 2|Death|0|||
105644557|NCT01562275|364361921|FG002|Stage 2|Death|0|||
105644558|NCT01562275|364361922|FG003|Stage 2|Death|0|||
105644559|NCT01562275|364361923|FG004|Stage 2|Death|0|||
105644560|NCT01562275|364361924|FG005|Stage 2|Death|0|||
105644561|NCT01562275|364361925|FG006|Stage 2|Death|0|||
105644562|NCT01562275|364361926|FG007|Stage 2|Death|0|||
105644563|NCT01562275|364361927|FG008|Stage 2|Death|0|||
105644564|NCT01562275|364361928|FG009|Stage 2|Death|0|||
105644565|NCT01562275|364361929|FG010|Stage 2|Death|0|||
105644566|NCT01562275|364361930|FG011|Stage 2|Death|2|||
105644567|NCT01562275|364361931|FG012|Stage 2|Death|1|||
105644568|NCT01562275|364361919|FG000|Stage 2|Progression of Disease|0|||
105644569|NCT01562275|364361920|FG001|Stage 2|Progression of Disease|0|||
105644570|NCT01562275|364361921|FG002|Stage 2|Progression of Disease|0|||
105644571|NCT01562275|364361922|FG003|Stage 2|Progression of Disease|0|||
105644572|NCT01562275|364361923|FG004|Stage 2|Progression of Disease|0|||
105644573|NCT01562275|364361924|FG005|Stage 2|Progression of Disease|0|||
105644574|NCT01562275|364361925|FG006|Stage 2|Progression of Disease|0|||
105644575|NCT01562275|364361926|FG007|Stage 2|Progression of Disease|0|||
105644576|NCT01562275|364361927|FG008|Stage 2|Progression of Disease|0|||
105644577|NCT01562275|364361928|FG009|Stage 2|Progression of Disease|0|||
105644578|NCT01562275|364361929|FG010|Stage 2|Progression of Disease|0|||
105644579|NCT01562275|364361930|FG011|Stage 2|Progression of Disease|12|||
105644580|NCT01562275|364361931|FG012|Stage 2|Progression of Disease|4|||
105644581|NCT02065895|364361932|FG000|Overall Study|Protocol Violation|1|||
105644582|NCT02065895|364361933|FG001|Overall Study|Protocol Violation|0|||
105644583|NCT02065895|364361934|FG002|Overall Study|Protocol Violation|0|||
105644584|NCT02065895|364361935|FG003|Overall Study|Protocol Violation|1|||
105644585|NCT02065895|364361936|FG004|Overall Study|Protocol Violation|0|||
105644586|NCT02065895|364361937|FG005|Overall Study|Protocol Violation|0|||
105644587|NCT02065895|364361932|FG000|Overall Study|Scheduling conflicts|0|||
105644588|NCT02065895|364361933|FG001|Overall Study|Scheduling conflicts|1|||
105644589|NCT02065895|364361934|FG002|Overall Study|Scheduling conflicts|0|||
105644590|NCT02065895|364361935|FG003|Overall Study|Scheduling conflicts|0|||
105644591|NCT02065895|364361936|FG004|Overall Study|Scheduling conflicts|0|||
105644592|NCT02065895|364361937|FG005|Overall Study|Scheduling conflicts|0|||
105644593|NCT00578344|364361951|FG000|Overall Study|Insurance problems|1|||
105644594|NCT00578344|364361951|FG000|Overall Study|Graft failure|1|||
105644595|NCT00990184|364361952|FG000|Overall Study|Physician Decision|1|||
105644596|NCT01655498|364361953|FG000|Overall Study|Unrelated health issue|2|||
105644597|NCT01655498|364361953|FG000|Overall Study|Protocol Violation|2|||
105644598|NCT01655498|364361953|FG000|Overall Study|Withdrawal by Subject|1|||
105644599|NCT02446015|364361954|FG000|Overall Study|Adverse Event|0|||
105644600|NCT02446015|364361955|FG001|Overall Study|Adverse Event|1|||
105644601|NCT02446015|364361954|FG000|Overall Study|Withdrawal by Subject|1|||
105644602|NCT02446015|364361955|FG001|Overall Study|Withdrawal by Subject|0|||
105644603|NCT01072149|364361956|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644604|NCT01072149|364361957|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644605|NCT01072149|364361958|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
105644606|NCT01072149|364361959|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644607|NCT01072149|364361960|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644608|NCT01072149|364361961|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644609|NCT01072149|364361962|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644610|NCT01072149|364361963|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644611|NCT01072149|364361964|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644612|NCT01072149|364361965|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644613|NCT01072149|364361966|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644614|NCT01072149|364361967|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644615|NCT01072149|364361968|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644616|NCT01072149|364361969|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644617|NCT01072149|364361970|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644618|NCT01072149|364361971|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644619|NCT01072149|364361972|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644620|NCT01072149|364361973|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
105644621|NCT01072149|364361956|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644622|NCT01072149|364361957|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644623|NCT01072149|364361958|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644624|NCT01072149|364361959|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644625|NCT01072149|364361960|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644626|NCT01072149|364361961|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644627|NCT01072149|364361962|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644628|NCT01072149|364361963|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644629|NCT01072149|364361964|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644630|NCT01072149|364361965|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644631|NCT01072149|364361966|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644632|NCT01072149|364361967|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644633|NCT01072149|364361968|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644634|NCT01072149|364361969|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644635|NCT01072149|364361970|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644636|NCT01072149|364361971|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644637|NCT01072149|364361972|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
105644638|NCT01072149|364361973|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
105644639|NCT01072149|364361956|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644640|NCT01072149|364361957|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644641|NCT01072149|364361958|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644642|NCT01072149|364361959|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644643|NCT01072149|364361960|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644644|NCT01072149|364361961|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644645|NCT01072149|364361962|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644646|NCT01072149|364361963|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644647|NCT01072149|364361964|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644648|NCT01072149|364361965|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644649|NCT01072149|364361966|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
105644650|NCT01072149|364361967|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644651|NCT01072149|364361968|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644652|NCT01072149|364361969|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644653|NCT01072149|364361970|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644654|NCT01072149|364361971|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644655|NCT01072149|364361972|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644656|NCT01072149|364361973|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
105644657|NCT01072149|364361956|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644658|NCT01072149|364361957|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
105644659|NCT01072149|364361958|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644660|NCT01072149|364361959|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644661|NCT01072149|364361960|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644662|NCT01072149|364361961|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644663|NCT01072149|364361962|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644664|NCT01072149|364361963|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644665|NCT01072149|364361964|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644666|NCT01072149|364361965|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644667|NCT01072149|364361966|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644668|NCT01072149|364361967|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644669|NCT01072149|364361968|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644670|NCT01072149|364361969|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644671|NCT01072149|364361970|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644672|NCT01072149|364361971|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644673|NCT01072149|364361972|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644674|NCT01072149|364361973|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
105644675|NCT01072149|364361956|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644676|NCT01072149|364361957|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644677|NCT01072149|364361958|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
105644678|NCT01072149|364361959|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644679|NCT01072149|364361960|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644680|NCT01072149|364361961|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644681|NCT01072149|364361962|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644682|NCT01072149|364361963|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644683|NCT01072149|364361964|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644684|NCT01072149|364361965|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644685|NCT01072149|364361966|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644686|NCT01072149|364361967|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644687|NCT01072149|364361968|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644688|NCT01072149|364361969|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644689|NCT01072149|364361970|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644690|NCT01072149|364361971|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644691|NCT01072149|364361972|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644692|NCT01072149|364361973|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
105644693|NCT01072149|364361956|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644694|NCT01072149|364361957|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644695|NCT01072149|364361958|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644696|NCT01072149|364361959|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644697|NCT01072149|364361960|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644698|NCT01072149|364361961|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644699|NCT01072149|364361962|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644700|NCT01072149|364361963|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
105644701|NCT01072149|364361964|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644702|NCT01072149|364361965|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644703|NCT01072149|364361966|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644704|NCT01072149|364361967|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644705|NCT01072149|364361968|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644706|NCT01072149|364361969|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644707|NCT01072149|364361970|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644708|NCT01072149|364361971|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644709|NCT01072149|364361972|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644710|NCT01072149|364361973|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
105644711|NCT01072149|364361956|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
105644712|NCT01072149|364361957|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
105644713|NCT01072149|364361958|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
105644714|NCT01072149|364361959|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
105644715|NCT01072149|364361960|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
105644716|NCT01072149|364361961|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
105644717|NCT01072149|364361962|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
105644718|NCT01072149|364361963|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
105644719|NCT01072149|364361964|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
105644720|NCT01072149|364361965|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
105644721|NCT01072149|364361966|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
105644722|NCT01072149|364361967|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
105644723|NCT01072149|364361968|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
105644724|NCT01072149|364361969|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
105644725|NCT01072149|364361970|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
105644726|NCT01072149|364361971|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
105644727|NCT01072149|364361972|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
105644728|NCT01072149|364361973|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
105644729|NCT01072149|364361956|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644730|NCT01072149|364361957|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644731|NCT01072149|364361958|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644732|NCT01072149|364361959|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644733|NCT01072149|364361960|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644734|NCT01072149|364361961|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644735|NCT01072149|364361962|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644736|NCT01072149|364361963|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644737|NCT01072149|364361964|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644738|NCT01072149|364361965|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644739|NCT01072149|364361966|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644740|NCT01072149|364361967|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644741|NCT01072149|364361968|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644742|NCT01072149|364361969|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644743|NCT01072149|364361970|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644744|NCT01072149|364361971|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
105644745|NCT01072149|364361972|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644746|NCT01072149|364361973|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
105644747|NCT01072149|364361956|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
105644748|NCT01072149|364361957|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
105644749|NCT01072149|364361958|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
105644750|NCT01072149|364361959|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
105644751|NCT01072149|364361960|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
105644752|NCT01072149|364361961|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
105644753|NCT01072149|364361962|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
105644754|NCT01072149|364361963|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
105644755|NCT01072149|364361964|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
105644756|NCT01072149|364361965|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
105644757|NCT01072149|364361966|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
105644758|NCT01072149|364361967|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
105644759|NCT01072149|364361968|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
105644760|NCT01072149|364361969|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
105644761|NCT01072149|364361970|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
105644762|NCT01072149|364361971|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
105644763|NCT01072149|364361972|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
105644764|NCT01072149|364361973|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
105644765|NCT01072149|364361956|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644766|NCT01072149|364361957|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644767|NCT01072149|364361958|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644768|NCT01072149|364361959|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644769|NCT01072149|364361960|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644770|NCT01072149|364361961|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644771|NCT01072149|364361962|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644772|NCT01072149|364361963|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644773|NCT01072149|364361964|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644774|NCT01072149|364361965|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644775|NCT01072149|364361966|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644776|NCT01072149|364361967|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644777|NCT01072149|364361968|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
105644778|NCT01072149|364361969|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644779|NCT01072149|364361970|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644780|NCT01072149|364361971|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644781|NCT01072149|364361972|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644782|NCT01072149|364361973|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
105644783|NCT01072149|364361956|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644784|NCT01072149|364361957|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644785|NCT01072149|364361958|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
105644786|NCT01072149|364361959|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644787|NCT01072149|364361960|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644788|NCT01072149|364361961|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644789|NCT01072149|364361962|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644790|NCT01072149|364361963|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644791|NCT01072149|364361964|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644792|NCT01072149|364361965|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644793|NCT01072149|364361966|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644794|NCT01072149|364361967|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644795|NCT01072149|364361968|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644796|NCT01072149|364361969|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
105644797|NCT01072149|364361970|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644798|NCT01072149|364361971|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644799|NCT01072149|364361972|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644800|NCT01072149|364361973|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
105644801|NCT02784834|364361974|FG000|Overall Study|Lack of Efficacy|1|||
105644802|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
105644803|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
105644804|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
105644805|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
105644806|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Adverse Event|7|||
105644807|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Adverse Event|8|||
105644808|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Adverse Event|8|||
105644809|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Adverse Event|9|||
105644810|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
105644811|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
105644812|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
105644813|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
105644814|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
105644815|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
105644816|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
105644817|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
105644818|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Pregnancy|0|||
105644819|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Pregnancy|2|||
105644820|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Pregnancy|2|||
105644821|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Pregnancy|0|||
105644822|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Non-compliance|1|||
105644823|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Non-compliance|0|||
105644824|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Non-compliance|0|||
105644825|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Non-compliance|3|||
105644826|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Other|3|||
105644827|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Other|0|||
105644828|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Other|3|||
105644829|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Other|2|||
105644830|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
105644831|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
105644832|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
105644833|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
105644834|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
105644835|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
105644836|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
105644837|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
105644838|NCT02143713|364361975|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
105644839|NCT02143713|364361976|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
105644840|NCT02143713|364361977|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
105644841|NCT02143713|364361978|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
105644842|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
105644843|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
105644844|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
105644845|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
105644846|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
105644847|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
105644848|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
105644849|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
105644850|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
105644851|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
105644852|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
105644853|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
105644854|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
105644855|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
105644856|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
105644857|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
105644858|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
105644859|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
105644860|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
105644861|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
105644862|NCT02143713|364361975|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
105644863|NCT02143713|364361976|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
105644864|NCT02143713|364361977|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
105644865|NCT02143713|364361978|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
105644866|NCT01768572|364361979|FG000|Overall Study|Adverse Event|7|||
105644867|NCT01768572|364361980|FG001|Overall Study|Adverse Event|8|||
105644868|NCT01768572|364361981|FG002|Overall Study|Adverse Event|4|||
105644869|NCT01768572|364361979|FG000|Overall Study|Lack of Efficacy|1|||
105644870|NCT01768572|364361980|FG001|Overall Study|Lack of Efficacy|3|||
105644871|NCT01768572|364361981|FG002|Overall Study|Lack of Efficacy|1|||
105644872|NCT01768572|364361979|FG000|Overall Study|Other, Not due to an adverse event|1|||
105644873|NCT01768572|364361980|FG001|Overall Study|Other, Not due to an adverse event|1|||
105644874|NCT01768572|364361981|FG002|Overall Study|Other, Not due to an adverse event|1|||
105644875|NCT01279447|364361984|FG000|Overall Study|Lost to Follow-up|3|||
105644876|NCT01279447|364361985|FG001|Overall Study|Lost to Follow-up|1|||
105644877|NCT01215253|364361986|FG000|Overall Study|Withdrawal by Subject|57|||
105644878|NCT01215253|364361987|FG001|Overall Study|Withdrawal by Subject|35|||
105644879|NCT01215253|364361986|FG000|Overall Study|Physician Decision|9|||
105644880|NCT01215253|364361987|FG001|Overall Study|Physician Decision|12|||
105644881|NCT01215253|364361986|FG000|Overall Study|Lost to Follow-up|6|||
105644882|NCT01215253|364361987|FG001|Overall Study|Lost to Follow-up|4|||
105644883|NCT01215253|364361986|FG000|Overall Study|Other|14|||
105644884|NCT01215253|364361987|FG001|Overall Study|Other|12|||
105644885|NCT01919489|364361988|FG000|Overall Study|Rejected the need of injections|4|||
105644886|NCT01919489|364361989|FG001|Overall Study|Rejected the need of injections|7|||
105644887|NCT01919489|364361988|FG000|Overall Study|Adverse Event|10|||
105644888|NCT01919489|364361989|FG001|Overall Study|Adverse Event|0|||
105644889|NCT01919489|364361988|FG000|Overall Study|Hospital readmission|2|||
105644890|NCT01919489|364361989|FG001|Overall Study|Hospital readmission|9|||
105644891|NCT01919489|364361988|FG000|Overall Study|Death|2|||
105644892|NCT01919489|364361989|FG001|Overall Study|Death|1|||
105644893|NCT01919489|364361988|FG000|Overall Study|Lost to Follow-up|38|||
105644894|NCT01919489|364361989|FG001|Overall Study|Lost to Follow-up|27|||
105644895|NCT03761849|364361992|FG000|Overall Study|transferred to OpenLabelExtension|35|||
105644896|NCT03761849|364361993|FG001|Overall Study|transferred to OpenLabelExtension|34|||
105644897|NCT03761849|364361994|FG002|Overall Study|transferred to OpenLabelExtension|36|||
105644898|NCT03761849|364361995|FG003|Overall Study|transferred to OpenLabelExtension|0|||
105644899|NCT03761849|364361996|FG004|Overall Study|transferred to OpenLabelExtension|0|||
105644900|NCT03761849|364361997|FG005|Overall Study|transferred to OpenLabelExtension|0|||
105644901|NCT03761849|364361992|FG000|Overall Study|Adverse Event|1|||
105644902|NCT03761849|364361993|FG001|Overall Study|Adverse Event|0|||
105644903|NCT03761849|364361994|FG002|Overall Study|Adverse Event|0|||
105644904|NCT03761849|364361995|FG003|Overall Study|Adverse Event|0|||
105644905|NCT03761849|364361996|FG004|Overall Study|Adverse Event|2|||
105644906|NCT03761849|364361997|FG005|Overall Study|Adverse Event|3|||
105644907|NCT03761849|364361992|FG000|Overall Study|Withdrawal by Subject|0|||
105644908|NCT03761849|364361993|FG001|Overall Study|Withdrawal by Subject|0|||
105644909|NCT03761849|364361994|FG002|Overall Study|Withdrawal by Subject|0|||
105644910|NCT03761849|364361995|FG003|Overall Study|Withdrawal by Subject|41|||
105644911|NCT03761849|364361996|FG004|Overall Study|Withdrawal by Subject|43|||
105644912|NCT03761849|364361997|FG005|Overall Study|Withdrawal by Subject|35|||
105644913|NCT03761849|364361992|FG000|Overall Study|Lost to Follow-up|0|||
105644914|NCT03761849|364361993|FG001|Overall Study|Lost to Follow-up|1|||
105644915|NCT03761849|364361994|FG002|Overall Study|Lost to Follow-up|0|||
105644916|NCT03761849|364361995|FG003|Overall Study|Lost to Follow-up|2|||
105644917|NCT03761849|364361996|FG004|Overall Study|Lost to Follow-up|4|||
105644918|NCT03761849|364361997|FG005|Overall Study|Lost to Follow-up|5|||
105644919|NCT03761849|364361992|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
105644920|NCT03761849|364361993|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
105644921|NCT03761849|364361994|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
105644922|NCT03761849|364361995|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
105644923|NCT03761849|364361996|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
105644924|NCT03761849|364361997|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
105644925|NCT03761849|364361992|FG000|Overall Study|Physician Decision|0|||
105644926|NCT03761849|364361993|FG001|Overall Study|Physician Decision|0|||
105644927|NCT03761849|364361994|FG002|Overall Study|Physician Decision|0|||
105644928|NCT03761849|364361995|FG003|Overall Study|Physician Decision|1|||
105644929|NCT03761849|364361996|FG004|Overall Study|Physician Decision|4|||
105644930|NCT03761849|364361997|FG005|Overall Study|Physician Decision|4|||
105644931|NCT03761849|364361992|FG000|Overall Study|Death|0|||
105644932|NCT03761849|364361993|FG001|Overall Study|Death|0|||
105644933|NCT03761849|364361994|FG002|Overall Study|Death|0|||
105644934|NCT03761849|364361995|FG003|Overall Study|Death|1|||
105644935|NCT03761849|364361996|FG004|Overall Study|Death|1|||
105644936|NCT03761849|364361997|FG005|Overall Study|Death|3|||
105644937|NCT03761849|364361992|FG000|Overall Study|Protocol Violation|0|||
105644938|NCT03761849|364361993|FG001|Overall Study|Protocol Violation|0|||
105644939|NCT03761849|364361994|FG002|Overall Study|Protocol Violation|0|||
105644940|NCT03761849|364361995|FG003|Overall Study|Protocol Violation|2|||
105644941|NCT03761849|364361996|FG004|Overall Study|Protocol Violation|2|||
105644942|NCT03761849|364361997|FG005|Overall Study|Protocol Violation|1|||
105644943|NCT03761849|364361992|FG000|Overall Study|Participant could not come to site|0|||
105644944|NCT03761849|364361993|FG001|Overall Study|Participant could not come to site|0|||
105644945|NCT03761849|364361994|FG002|Overall Study|Participant could not come to site|0|||
105644946|NCT03761849|364361995|FG003|Overall Study|Participant could not come to site|0|||
105644947|NCT03761849|364361996|FG004|Overall Study|Participant could not come to site|1|||
105644948|NCT03761849|364361997|FG005|Overall Study|Participant could not come to site|0|||
105644949|NCT03761849|364361992|FG000|Overall Study|SF- safety Finding|0|||
105644950|NCT03761849|364361993|FG001|Overall Study|SF- safety Finding|0|||
105644951|NCT03761849|364361994|FG002|Overall Study|SF- safety Finding|0|||
105644952|NCT03761849|364361995|FG003|Overall Study|SF- safety Finding|0|||
105644953|NCT03761849|364361996|FG004|Overall Study|SF- safety Finding|0|||
105644954|NCT03761849|364361997|FG005|Overall Study|SF- safety Finding|1|||
105644955|NCT03761849|364361992|FG000|Overall Study|Patient did not attend visit|0|||
105644956|NCT03761849|364361993|FG001|Overall Study|Patient did not attend visit|0|||
105644957|NCT03761849|364361994|FG002|Overall Study|Patient did not attend visit|0|||
105644958|NCT03761849|364361995|FG003|Overall Study|Patient did not attend visit|0|||
105644959|NCT03761849|364361996|FG004|Overall Study|Patient did not attend visit|0|||
105644960|NCT03761849|364361997|FG005|Overall Study|Patient did not attend visit|1|||
105644961|NCT03840993|364362001|FG000|Overall Study|Adverse Event|1|||
105644962|NCT03840993|364362002|FG001|Overall Study|Adverse Event|0|||
105644963|NCT03840993|364362001|FG000|Overall Study|Lost to Follow-up|4|||
105644964|NCT03840993|364362002|FG001|Overall Study|Lost to Follow-up|0|||
105644965|NCT03840993|364362001|FG000|Overall Study|Physician Decision|0|||
105644966|NCT03840993|364362002|FG001|Overall Study|Physician Decision|1|||
105644967|NCT03840993|364362001|FG000|Overall Study|Pregnancy|0|||
105644968|NCT03840993|364362002|FG001|Overall Study|Pregnancy|1|||
105644969|NCT03840993|364362001|FG000|Overall Study|Withdrawal by Subject|1|||
105644970|NCT03840993|364362002|FG001|Overall Study|Withdrawal by Subject|3|||
105644971|NCT03840993|364362001|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
105644972|NCT03840993|364362002|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
105644973|NCT03884478|364362003|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
105644974|NCT03884478|364362004|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
105644975|NCT03884478|364362005|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
105644976|NCT03884478|364362003|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
105644977|NCT03884478|364362004|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
105644978|NCT03884478|364362005|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
105644979|NCT03884478|364362003|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
105644980|NCT03884478|364362004|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
105644981|NCT03884478|364362005|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
105644982|NCT03884478|364362003|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
105644983|NCT03884478|364362004|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
105644984|NCT03884478|364362005|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
105644985|NCT02213094|364362008|FG000|Overall Study|Adverse Event|1|||
105644986|NCT02213094|364362009|FG001|Overall Study|Adverse Event|0|||
105644987|NCT01090739|364362010|FG000|Enrollment|Withdrawal by Subject|24|||
105644988|NCT01090739|364362010|FG000|Enrollment|Protocol Violation|14|||
105644989|NCT01090739|364362010|FG000|Enrollment|Lost to Follow-up|5|||
105644990|NCT01090739|364362010|FG000|Enrollment|Physician Decision|5|||
105644991|NCT01090739|364362010|FG000|Enrollment|Sponsor termination of site|4|||
105644992|NCT01090739|364362010|FG000|Enrollment|Study implant limit reached|2|||
105644993|NCT01090739|364362010|FG000|Enrollment|Adverse Event|1|||
105644994|NCT01090739|364362010|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
105644995|NCT01090739|364362010|FG000|12 Month Follow-up|Lost to Follow-up|1|||
105644996|NCT01090739|364362010|FG000|12 Month Follow-up|Physician Decision|1|||
105644997|NCT01090739|364362010|FG000|12 Month Follow-up|Death|1|||
105644998|NCT01090739|364362010|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
105644999|NCT01090739|364362010|FG000|24 Month Follow-up|Lost to Follow-up|1|||
105645000|NCT01090739|364362010|FG000|24 Month Follow-up|Death|1|||
105645001|NCT01090739|364362010|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
105645002|NCT01090739|364362010|FG000|36 Month Follow-up|Visit still pending|17|||
105645003|NCT00988429|364362011|FG000|Overall Study|Adverse Event|9|||
105645004|NCT00988429|364362012|FG001|Overall Study|Adverse Event|21|||
105645005|NCT00988429|364362013|FG002|Overall Study|Adverse Event|45|||
105645006|NCT00988429|364362011|FG000|Overall Study|Lack of Efficacy|0|||
105645007|NCT00988429|364362012|FG001|Overall Study|Lack of Efficacy|0|||
105645008|NCT00988429|364362013|FG002|Overall Study|Lack of Efficacy|1|||
105645009|NCT00988429|364362011|FG000|Overall Study|Non-Compliance with Study Drug|5|||
105645010|NCT00988429|364362012|FG001|Overall Study|Non-Compliance with Study Drug|1|||
105645011|NCT00988429|364362013|FG002|Overall Study|Non-Compliance with Study Drug|3|||
105645012|NCT00988429|364362011|FG000|Overall Study|Physician Decision|1|||
105645013|NCT00988429|364362012|FG001|Overall Study|Physician Decision|0|||
105645014|NCT00988429|364362013|FG002|Overall Study|Physician Decision|3|||
105645015|NCT00988429|364362011|FG000|Overall Study|Pregnancy|2|||
105645016|NCT00988429|364362012|FG001|Overall Study|Pregnancy|1|||
105645017|NCT00988429|364362013|FG002|Overall Study|Pregnancy|0|||
105645018|NCT00988429|364362011|FG000|Overall Study|Protocol Violation|4|||
105645019|NCT00988429|364362012|FG001|Overall Study|Protocol Violation|3|||
105645020|NCT00988429|364362013|FG002|Overall Study|Protocol Violation|3|||
105645021|NCT00988429|364362011|FG000|Overall Study|Withdrawal by Subject|7|||
105645022|NCT00988429|364362012|FG001|Overall Study|Withdrawal by Subject|7|||
105645023|NCT00988429|364362013|FG002|Overall Study|Withdrawal by Subject|12|||
105645024|NCT00988429|364362011|FG000|Overall Study|Administrative Reasons|1|||
105645025|NCT00988429|364362012|FG001|Overall Study|Administrative Reasons|2|||
105645026|NCT00988429|364362013|FG002|Overall Study|Administrative Reasons|1|||
105645027|NCT00988429|364362011|FG000|Overall Study|other reasons|8|||
105645028|NCT00988429|364362012|FG001|Overall Study|other reasons|8|||
105645029|NCT00988429|364362013|FG002|Overall Study|other reasons|1|||
105645030|NCT02964234|364362014|FG000|Overall Study|Lost to Follow-up|22|||
105645031|NCT02964234|364362015|FG001|Overall Study|Lost to Follow-up|13|||
105645032|NCT01074229|364362016|FG000|Overall Study|Lost to Follow-up|1|||
105645033|NCT01074229|364362017|FG001|Overall Study|Lost to Follow-up|0|||
105645034|NCT01074229|364362018|FG002|Overall Study|Lost to Follow-up|0|||
105645035|NCT01074229|364362016|FG000|Overall Study|Change to open surgical procedure|1|||
105645036|NCT01074229|364362017|FG001|Overall Study|Change to open surgical procedure|3|||
105645037|NCT01074229|364362018|FG002|Overall Study|Change to open surgical procedure|4|||
105645038|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
105645039|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
105645040|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
105645041|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
105645042|NCT02163499|364362019|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
105645043|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
105645044|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
105645045|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
105645046|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
105645047|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
105645048|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
105645049|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
105645050|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
105645051|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
105645052|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Death|8|||
105645053|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
105645054|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
105645055|NCT02163499|364362019|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
105645056|NCT00857311|364362020|FG000|Overall Study|Lost to Follow-up|1|||
105645057|NCT00857311|364362021|FG001|Overall Study|Lost to Follow-up|0|||
105645058|NCT00857311|364362022|FG002|Overall Study|Lost to Follow-up|0|||
105645059|NCT00857311|364362023|FG003|Overall Study|Lost to Follow-up|0|||
105645060|NCT00828139|364362028|FG000|Overall Study|Adverse Event|8|||
105645061|NCT00828139|364362029|FG001|Overall Study|Adverse Event|1|||
105645062|NCT00828139|364362030|FG002|Overall Study|Adverse Event|10|||
105645063|NCT00828139|364362031|FG003|Overall Study|Adverse Event|5|||
105645064|NCT00828139|364362028|FG000|Overall Study|Death|2|||
105645065|NCT00828139|364362029|FG001|Overall Study|Death|1|||
105645066|NCT00828139|364362030|FG002|Overall Study|Death|0|||
105645067|NCT00828139|364362031|FG003|Overall Study|Death|2|||
105645068|NCT00828139|364362028|FG000|Overall Study|Refusal unrelated to toxicity|3|||
105645069|NCT00828139|364362029|FG001|Overall Study|Refusal unrelated to toxicity|4|||
105645070|NCT00828139|364362030|FG002|Overall Study|Refusal unrelated to toxicity|5|||
105645071|NCT00828139|364362031|FG003|Overall Study|Refusal unrelated to toxicity|3|||
105645072|NCT00828139|364362028|FG000|Overall Study|Disease Progression|24|||
105645073|NCT00828139|364362029|FG001|Overall Study|Disease Progression|33|||
105645074|NCT00828139|364362030|FG002|Overall Study|Disease Progression|35|||
105645075|NCT00828139|364362031|FG003|Overall Study|Disease Progression|39|||
105645076|NCT00828139|364362028|FG000|Overall Study|Other|4|||
105645077|NCT00828139|364362029|FG001|Overall Study|Other|2|||
105645078|NCT00828139|364362030|FG002|Overall Study|Other|5|||
105645079|NCT00828139|364362031|FG003|Overall Study|Other|2|||
105645080|NCT01714947|364362032|FG000|Part B|Progressive Disease|3|||
105645081|NCT00700999|364362034|FG000|Overall Study|Lost to Follow-up|7|||
105645082|NCT00700999|364362035|FG001|Overall Study|Lost to Follow-up|7|||
105645083|NCT00700999|364362034|FG000|Overall Study|Excluded - did not meet study criteria|0|||
105645084|NCT00700999|364362035|FG001|Overall Study|Excluded - did not meet study criteria|1|||
105645085|NCT00700999|364362034|FG000|Overall Study|Withdrawal by Subject|8|||
105645086|NCT00700999|364362035|FG001|Overall Study|Withdrawal by Subject|1|||
105645087|NCT01280656|364362038|FG000|Overall Study|Adverse Event|1|||
105645088|NCT01280656|364362039|FG001|Overall Study|Adverse Event|14|||
105645089|NCT01280656|364362040|FG002|Overall Study|Adverse Event|13|||
105645090|NCT01280656|364362038|FG000|Overall Study|Lack of Efficacy|1|||
105645091|NCT01280656|364362039|FG001|Overall Study|Lack of Efficacy|22|||
105645092|NCT01280656|364362040|FG002|Overall Study|Lack of Efficacy|38|||
105645093|NCT01280656|364362038|FG000|Overall Study|Treatment shortening (RGT)|0|||
105645094|NCT01280656|364362039|FG001|Overall Study|Treatment shortening (RGT)|4|||
105645095|NCT01280656|364362040|FG002|Overall Study|Treatment shortening (RGT)|5|||
105645096|NCT01280656|364362038|FG000|Overall Study|Other|1|||
105645097|NCT01280656|364362039|FG001|Overall Study|Other|7|||
105645098|NCT01280656|364362040|FG002|Overall Study|Other|7|||
105645099|NCT02555397|364362045|FG000|Overall Study|Withdrawal by Subject|1|||
105645100|NCT02555397|364362046|FG001|Overall Study|Withdrawal by Subject|0|||
105645101|NCT02555397|364362047|FG002|Overall Study|Withdrawal by Subject|0|||
105645102|NCT02555397|364362048|FG003|Overall Study|Withdrawal by Subject|0|||
105645103|NCT02555397|364362049|FG004|Overall Study|Withdrawal by Subject|0|||
105645104|NCT00617708|364362050|FG000|Overall Study|Adverse Event|0|||
105645105|NCT00617708|364362051|FG001|Overall Study|Adverse Event|6|||
105645106|NCT00617708|364362052|FG002|Overall Study|Adverse Event|9|||
105645107|NCT00617708|364362050|FG000|Overall Study|Withdrawal by Subject|1|||
105645108|NCT00617708|364362051|FG001|Overall Study|Withdrawal by Subject|1|||
105645109|NCT00617708|364362052|FG002|Overall Study|Withdrawal by Subject|7|||
105645110|NCT00617708|364362050|FG000|Overall Study|Death|0|||
105645111|NCT00617708|364362051|FG001|Overall Study|Death|6|||
105645112|NCT00617708|364362052|FG002|Overall Study|Death|5|||
105645113|NCT00617708|364362050|FG000|Overall Study|Progression/Relapse|7|||
105645114|NCT00617708|364362051|FG001|Overall Study|Progression/Relapse|40|||
105645115|NCT00617708|364362052|FG002|Overall Study|Progression/Relapse|36|||
105645116|NCT00617708|364362050|FG000|Overall Study|Not protocol specified|1|||
105645117|NCT00617708|364362051|FG001|Overall Study|Not protocol specified|4|||
105645118|NCT00617708|364362052|FG002|Overall Study|Not protocol specified|2|||
105645119|NCT00617708|364362050|FG000|Overall Study|Not eligible|1|||
105645120|NCT00617708|364362051|FG001|Overall Study|Not eligible|3|||
105645121|NCT00617708|364362052|FG002|Overall Study|Not eligible|5|||
105645122|NCT01123200|364362055|FG000|Overall Study|Withdrawal by Subject|1|||
105645123|NCT03840200|364363471|FG000|Overall Study|Death|6|||
105645124|NCT03840200|364363472|FG001|Overall Study|Death|3|||
105645125|NCT03840200|364363473|FG002|Overall Study|Death|6|||
105645126|NCT03840200|364363474|FG003|Overall Study|Death|10|||
105645127|NCT03840200|364363471|FG000|Overall Study|Reason Not Specified|2|||
105645128|NCT03840200|364363472|FG001|Overall Study|Reason Not Specified|2|||
105645129|NCT03840200|364363473|FG002|Overall Study|Reason Not Specified|1|||
105645130|NCT03840200|364363474|FG003|Overall Study|Reason Not Specified|15|||
105645131|NCT03840200|364363471|FG000|Overall Study|Physician Decision|0|||
105645132|NCT03840200|364363472|FG001|Overall Study|Physician Decision|0|||
105645133|NCT03840200|364363473|FG002|Overall Study|Physician Decision|0|||
105645134|NCT03840200|364363474|FG003|Overall Study|Physician Decision|2|||
105645135|NCT03840200|364363471|FG000|Overall Study|Progressive Disease|0|||
105645136|NCT03840200|364363472|FG001|Overall Study|Progressive Disease|0|||
105645137|NCT03840200|364363473|FG002|Overall Study|Progressive Disease|0|||
105645138|NCT03840200|364363474|FG003|Overall Study|Progressive Disease|1|||
105645139|NCT03840200|364363471|FG000|Overall Study|Withdrawal by Subject|0|||
105645140|NCT03840200|364363472|FG001|Overall Study|Withdrawal by Subject|1|||
105645141|NCT03840200|364363473|FG002|Overall Study|Withdrawal by Subject|0|||
105645142|NCT03840200|364363474|FG003|Overall Study|Withdrawal by Subject|2|||
105645143|NCT05522777|364363475|FG000|Overall Study|Lack of Efficacy|1|||
105645144|NCT05522777|364363475|FG000|Overall Study|Withdrawal by Subject|1|||
105645145|NCT05379400|364363480|FG000|Overall Study|Lost to Follow-up|1|||
105645146|NCT05379400|364363481|FG001|Overall Study|Lost to Follow-up|1|||
105645147|NCT03020914|364363482|FG000|Overall Study|Surgery Cancelled|1|||
105645148|NCT03020914|364363483|FG001|Overall Study|Surgery Cancelled|0|||
105645149|NCT00092456|364363489|FG000|Overall Study|Adverse Event|0|||
105645150|NCT00092456|364363490|FG001|Overall Study|Adverse Event|0|||
105645151|NCT00092456|364363491|FG002|Overall Study|Adverse Event|1|||
105645152|NCT00092456|364363492|FG003|Overall Study|Adverse Event|1|||
105645153|NCT00092456|364363489|FG000|Overall Study|Lost to Follow-up|2|||
105645154|NCT00092456|364363490|FG001|Overall Study|Lost to Follow-up|2|||
105645155|NCT00092456|364363491|FG002|Overall Study|Lost to Follow-up|1|||
105645156|NCT00092456|364363492|FG003|Overall Study|Lost to Follow-up|2|||
105645157|NCT00092456|364363489|FG000|Overall Study|Protocol Violation|5|||
105645158|NCT00092456|364363490|FG001|Overall Study|Protocol Violation|7|||
105645159|NCT00092456|364363491|FG002|Overall Study|Protocol Violation|8|||
105645160|NCT00092456|364363492|FG003|Overall Study|Protocol Violation|6|||
105645161|NCT00092456|364363489|FG000|Overall Study|Withdrawal by Subject|13|||
105645162|NCT00092456|364363490|FG001|Overall Study|Withdrawal by Subject|5|||
105645163|NCT00092456|364363491|FG002|Overall Study|Withdrawal by Subject|16|||
105645164|NCT00092456|364363492|FG003|Overall Study|Withdrawal by Subject|6|||
105645165|NCT00092456|364363489|FG000|Overall Study|Moved|1|||
105645166|NCT00092456|364363490|FG001|Overall Study|Moved|1|||
105645167|NCT00092456|364363491|FG002|Overall Study|Moved|0|||
105645168|NCT00092456|364363492|FG003|Overall Study|Moved|1|||
105645169|NCT00092456|364363489|FG000|Overall Study|Other|4|||
105645170|NCT00092456|364363490|FG001|Overall Study|Other|2|||
105645171|NCT00092456|364363491|FG002|Overall Study|Other|3|||
105645172|NCT00092456|364363492|FG003|Overall Study|Other|0|||
105645173|NCT02164578|364363493|FG000|Treatment Period|Withdrawal by Subject|3|||
105645174|NCT02164578|364363494|FG001|Treatment Period|Withdrawal by Subject|3|||
105645175|NCT02164578|364363493|FG000|Treatment Period|Adverse Event|13|||
105645176|NCT02164578|364363494|FG001|Treatment Period|Adverse Event|6|||
105645177|NCT02164578|364363493|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
105645178|NCT02164578|364363494|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
105645179|NCT02164578|364363493|FG000|Treatment Period|Protocol Violation|0|||
105645180|NCT02164578|364363494|FG001|Treatment Period|Protocol Violation|2|||
105645181|NCT02164578|364363493|FG000|Extension Period|Withdrawal by Subject|2|||
105645182|NCT02164578|364363494|FG001|Extension Period|Withdrawal by Subject|0|||
105645183|NCT02164578|364363493|FG000|Extension Period|Adverse Event|4|||
105645184|NCT02164578|364363494|FG001|Extension Period|Adverse Event|0|||
105645185|NCT02164578|364363493|FG000|Extension Period|Expiry of study medication|1|||
105645186|NCT02164578|364363494|FG001|Extension Period|Expiry of study medication|0|||
105645187|NCT02164578|364363493|FG000|Extension Period|Protocol Violation|0|||
105645188|NCT02164578|364363494|FG001|Extension Period|Protocol Violation|1|||
105645189|NCT01018992|364363495|FG000|Overall Study|Adverse Event|8|||
105645190|NCT01018992|364363496|FG001|Overall Study|Adverse Event|3|||
105645191|NCT01018992|364363495|FG000|Overall Study|Withdrawal by Subject|3|||
105645192|NCT01018992|364363496|FG001|Overall Study|Withdrawal by Subject|8|||
105645193|NCT01018992|364363495|FG000|Overall Study|Protocol Violation|0|||
105645194|NCT01018992|364363496|FG001|Overall Study|Protocol Violation|4|||
105645195|NCT01018992|364363495|FG000|Overall Study|Lost to Follow-up|5|||
105645196|NCT01018992|364363496|FG001|Overall Study|Lost to Follow-up|1|||
105645197|NCT00476151|364363497|FG000|Overall Study|Adverse Event|0|||
105645198|NCT00476151|364363498|FG001|Overall Study|Adverse Event|2|||
105645199|NCT00476151|364363497|FG000|Overall Study|Protocol Violation|1|||
105645200|NCT00476151|364363498|FG001|Overall Study|Protocol Violation|3|||
105645201|NCT00476151|364363497|FG000|Overall Study|Withdrawal by Subject|2|||
105645202|NCT00476151|364363498|FG001|Overall Study|Withdrawal by Subject|0|||
105645203|NCT00476151|364363497|FG000|Overall Study|Physician Decision|0|||
105645204|NCT00476151|364363498|FG001|Overall Study|Physician Decision|2|||
105645205|NCT00267956|364363505|FG000|Controlled Period|Adverse Event|4|||
105645206|NCT00267956|364363506|FG001|Controlled Period|Adverse Event|1|||
105645207|NCT00267956|364363507|FG002|Controlled Period|Adverse Event|0|||
105645208|NCT00267956|364363508|FG003|Controlled Period|Adverse Event|0|||
105645209|NCT00267956|364363505|FG000|Controlled Period|Lack of Efficacy|4|||
105645210|NCT00267956|364363506|FG001|Controlled Period|Lack of Efficacy|2|||
105645211|NCT00267956|364363507|FG002|Controlled Period|Lack of Efficacy|0|||
105645212|NCT00267956|364363508|FG003|Controlled Period|Lack of Efficacy|0|||
105645213|NCT00267956|364363505|FG000|Controlled Period|Lost to Follow-up|2|||
105645214|NCT00267956|364363506|FG001|Controlled Period|Lost to Follow-up|0|||
105645215|NCT00267956|364363507|FG002|Controlled Period|Lost to Follow-up|0|||
105645216|NCT00267956|364363508|FG003|Controlled Period|Lost to Follow-up|0|||
105645217|NCT00267956|364363505|FG000|Controlled Period|Withdrew consent|3|||
105645218|NCT00267956|364363506|FG001|Controlled Period|Withdrew consent|1|||
105645219|NCT00267956|364363507|FG002|Controlled Period|Withdrew consent|0|||
105645220|NCT00267956|364363508|FG003|Controlled Period|Withdrew consent|0|||
105645221|NCT00267956|364363505|FG000|After Controlled Period|Adverse Event|0|||
105645222|NCT00267956|364363506|FG001|After Controlled Period|Adverse Event|0|||
105645223|NCT00267956|364363507|FG002|After Controlled Period|Adverse Event|2|||
105645224|NCT00267956|364363508|FG003|After Controlled Period|Adverse Event|1|||
105645225|NCT00267956|364363505|FG000|After Controlled Period|Lack of Efficacy|0|||
105645226|NCT00267956|364363506|FG001|After Controlled Period|Lack of Efficacy|0|||
105645227|NCT00267956|364363507|FG002|After Controlled Period|Lack of Efficacy|1|||
105645228|NCT00267956|364363508|FG003|After Controlled Period|Lack of Efficacy|1|||
105645229|NCT00267956|364363505|FG000|After Controlled Period|Lost to Follow-up|0|||
105645230|NCT00267956|364363506|FG001|After Controlled Period|Lost to Follow-up|0|||
105645231|NCT00267956|364363507|FG002|After Controlled Period|Lost to Follow-up|1|||
105645232|NCT00267956|364363508|FG003|After Controlled Period|Lost to Follow-up|0|||
105645233|NCT00267956|364363505|FG000|After Controlled Period|Withdrew consent|0|||
105645234|NCT00267956|364363506|FG001|After Controlled Period|Withdrew consent|0|||
105645235|NCT00267956|364363507|FG002|After Controlled Period|Withdrew consent|1|||
105645236|NCT00267956|364363508|FG003|After Controlled Period|Withdrew consent|0|||
105645237|NCT02005484|364363511|FG000|Overall Study|Death|1|||
105645238|NCT02005484|364363511|FG000|Overall Study|Disease progression|1|||
105645239|NCT02005484|364363511|FG000|Overall Study|Changed to a Different Study|1|||
105645240|NCT02005484|364363511|FG000|Overall Study|Sponsor decision|1|||
105645241|NCT01129011|364363512|FG000|Overall Study|Adverse Event|20|||
105645242|NCT01129011|364363513|FG001|Overall Study|Adverse Event|30|||
105645243|NCT01129011|364363512|FG000|Overall Study|Withdrawal by Subject|24|||
105645244|NCT01129011|364363513|FG001|Overall Study|Withdrawal by Subject|8|||
105645245|NCT01129011|364363512|FG000|Overall Study|Lost to Follow-up|6|||
105645246|NCT01129011|364363513|FG001|Overall Study|Lost to Follow-up|7|||
105645247|NCT01129011|364363512|FG000|Overall Study|Duodenal Ulcer|2|||
105645248|NCT01129011|364363513|FG001|Overall Study|Duodenal Ulcer|8|||
105645249|NCT01129011|364363512|FG000|Overall Study|misc|7|||
105645250|NCT01129011|364363513|FG001|Overall Study|misc|4|||
105645251|NCT02246647|364363514|FG000|Overall Study|Withdrawal by Subject|1|||
105645252|NCT02246647|364363515|FG001|Overall Study|Withdrawal by Subject|1|||
105645253|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
105645254|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
105645255|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645256|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645257|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645258|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645259|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
105645260|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
105645261|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
105645262|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
105645263|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105645264|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105645265|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105645266|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
105645267|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
105645268|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105645269|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
105645270|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105645271|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105645272|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105659340|NCT00551135|364417283|FG003|Overall Study|Other|2|||
105645273|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
105645274|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645275|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
105645276|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645277|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645278|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645279|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645280|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
105645281|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
105645282|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
105645283|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
105645284|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105645285|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105645286|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105645287|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
105645288|NCT03745651|364363516|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
105645289|NCT03745651|364363517|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
105645290|NCT03745651|364363518|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
105645291|NCT03745651|364363519|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
105645292|NCT03745651|364363520|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
105645293|NCT03745651|364363521|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
105645294|NCT03745651|364363522|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
105645295|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645296|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645297|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645298|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645299|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645300|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
105645301|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
105645302|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105645303|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105645304|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105645305|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
105645306|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
105645307|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
105645308|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
105645309|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105645310|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105645311|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
105645312|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
105645313|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
105645314|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
105645315|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
105645316|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105645317|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105645318|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105645319|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
105645320|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
105645321|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
105645322|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
105645323|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645324|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645325|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645326|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
105645327|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645328|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
105645329|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
105645330|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645331|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645332|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645333|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645334|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105870224|NCT01074944|365176970|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
105870225|NCT01074944|365176971|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
105645335|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
105645336|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
105645337|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105645338|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105645339|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
105645340|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
105645341|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
105645342|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
105645343|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
105645344|NCT03745651|364363516|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
105645345|NCT03745651|364363517|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
105645346|NCT03745651|364363518|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
105645347|NCT03745651|364363519|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
105645348|NCT03745651|364363520|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
105645349|NCT03745651|364363521|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
105645350|NCT03745651|364363522|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
105645351|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
105645352|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
105645353|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
105645354|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
105645355|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
105645356|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
105645357|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
105645358|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
105645359|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
105645360|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
105645361|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
105645362|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
105645363|NCT01494467|364363535|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
105645364|NCT01494467|364363536|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
105645365|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
105645366|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
105645367|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
105645368|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
105645369|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
105645370|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
105645371|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
105645372|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
105645373|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
105645374|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
105645375|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
105645376|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
105645377|NCT01494467|364363535|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
105645378|NCT01494467|364363536|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
105645379|NCT00417885|364363537|FG000|Overall Study|Adverse Event|1|||
105645380|NCT00417885|364363537|FG000|Overall Study|Objective Progression or Relapse|3|||
105645381|NCT00417885|364363537|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
105645382|NCT03436797|364363538|FG000|Main Study|Withdrawal by Subject|2|||
105645383|NCT03436797|364363538|FG000|Main Study|Adverse Event|4|||
105645384|NCT03436797|364363538|FG000|Main Study|Lost to Follow-up|1|||
105645385|NCT03436797|364363538|FG000|Main Study|Death|1|||
105645386|NCT03436797|364363538|FG000|Main Study|Non-Specific|2|||
105645387|NCT03436797|364363538|FG000|Extended Dosing|Patient decision|1|||
105645388|NCT01912599|364363539|FG000|Overall Study|Withdrawal by Subject|0|||
105645389|NCT01912599|364363540|FG001|Overall Study|Withdrawal by Subject|1|||
105645390|NCT03386344|364363541|FG000|Overall Study|Adverse Event|6|||
105645391|NCT03386344|364363542|FG001|Overall Study|Adverse Event|3|||
105645392|NCT03386344|364363543|FG002|Overall Study|Adverse Event|1|||
105645393|NCT03386344|364363541|FG000|Overall Study|Poor Compliance to Protocol|0|||
105645394|NCT03386344|364363542|FG001|Overall Study|Poor Compliance to Protocol|1|||
105645395|NCT03386344|364363543|FG002|Overall Study|Poor Compliance to Protocol|0|||
105645396|NCT03386344|364363541|FG000|Overall Study|Study Terminated by Sponsor|101|||
105645397|NCT03386344|364363542|FG001|Overall Study|Study Terminated by Sponsor|102|||
105645398|NCT03386344|364363543|FG002|Overall Study|Study Terminated by Sponsor|106|||
105645399|NCT03386344|364363541|FG000|Overall Study|Lost to Follow-up|3|||
105645400|NCT03386344|364363542|FG001|Overall Study|Lost to Follow-up|2|||
105645401|NCT03386344|364363543|FG002|Overall Study|Lost to Follow-up|1|||
105870226|NCT01074944|365176967|FG000|Long Term Treatment|Withdrawal by Subject|0|||
105645402|NCT03386344|364363541|FG000|Overall Study|At the Participant's own Request|7|||
105645403|NCT03386344|364363542|FG001|Overall Study|At the Participant's own Request|7|||
105645404|NCT03386344|364363543|FG002|Overall Study|At the Participant's own Request|8|||
105645405|NCT03386344|364363541|FG000|Overall Study|Reason not Specified|0|||
105645406|NCT03386344|364363542|FG001|Overall Study|Reason not Specified|1|||
105645407|NCT03386344|364363543|FG002|Overall Study|Reason not Specified|0|||
105645408|NCT01280721|364363544|FG000|Overall Study|Adverse Event|4|||
105645409|NCT01280721|364363544|FG000|Overall Study|Physician Decision|3|||
105645410|NCT01280721|364363544|FG000|Overall Study|Withdrawal by Subject|6|||
105645411|NCT01280721|364363544|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
105645412|NCT01280721|364363544|FG000|Overall Study|No tolerability for the lowest dose|2|||
105645413|NCT03349476|364363546|FG000|Overall Study|Physician Decision|3|||
105645414|NCT05104242|364363553|FG000|Overall Study|Withdrawal by Subject|1|||
105645415|NCT05104242|364363554|FG001|Overall Study|Withdrawal by Subject|5|||
105645416|NCT05104242|364363553|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
105645417|NCT05104242|364363554|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
105645418|NCT01864200|364363555|FG000|Overall Study|Lost to Follow-up|1|||
105645419|NCT01864200|364363556|FG001|Overall Study|Lost to Follow-up|3|||
105645420|NCT01864200|364363555|FG000|Overall Study|Protocol Violation|1|||
105645421|NCT01864200|364363556|FG001|Overall Study|Protocol Violation|0|||
105645422|NCT00316121|364363557|FG000|Overall Study|Death|1|||
105645423|NCT00316121|364363558|FG001|Overall Study|Death|0|||
105645424|NCT00316121|364363557|FG000|Overall Study|Lost to Follow-up|14|||
105645425|NCT00316121|364363558|FG001|Overall Study|Lost to Follow-up|8|||
105645426|NCT00316121|364363557|FG000|Overall Study|Withdrawal by Subject|2|||
105645427|NCT00316121|364363558|FG001|Overall Study|Withdrawal by Subject|0|||
105645428|NCT00316121|364363557|FG000|Overall Study|Reason is missing|1|||
105645429|NCT00316121|364363558|FG001|Overall Study|Reason is missing|0|||
105645430|NCT00316121|364363557|FG000|Overall Study|Subject relocated|1|||
105645431|NCT00316121|364363558|FG001|Overall Study|Subject relocated|1|||
105645432|NCT00316121|364363557|FG000|Overall Study|Subject refused to return|1|||
105645433|NCT00316121|364363558|FG001|Overall Study|Subject refused to return|0|||
105645434|NCT00316121|364363557|FG000|Overall Study|Subject no show for visit x 3|1|||
105645435|NCT00316121|364363558|FG001|Overall Study|Subject no show for visit x 3|0|||
105645436|NCT00316121|364363557|FG000|Overall Study|Subject did not have 24 month visit|1|||
105645437|NCT00316121|364363558|FG001|Overall Study|Subject did not have 24 month visit|0|||
105645438|NCT00424476|364363559|FG000|Overall Study|Withdrawal by Subject|7|||
105645439|NCT00424476|364363560|FG001|Overall Study|Withdrawal by Subject|6|||
105645440|NCT00424476|364363561|FG002|Overall Study|Withdrawal by Subject|3|||
105645441|NCT00424476|364363559|FG000|Overall Study|Adverse Event|19|||
105645442|NCT00424476|364363560|FG001|Overall Study|Adverse Event|16|||
105645443|NCT00424476|364363561|FG002|Overall Study|Adverse Event|15|||
105645444|NCT00424476|364363559|FG000|Overall Study|Lack of Efficacy|16|||
105645445|NCT00424476|364363560|FG001|Overall Study|Lack of Efficacy|12|||
105645446|NCT00424476|364363561|FG002|Overall Study|Lack of Efficacy|12|||
105645447|NCT00424476|364363559|FG000|Overall Study|Lack of Compliance|1|||
105645448|NCT00424476|364363560|FG001|Overall Study|Lack of Compliance|1|||
105645449|NCT00424476|364363561|FG002|Overall Study|Lack of Compliance|1|||
105645450|NCT00424476|364363559|FG000|Overall Study|Lost to Follow-up|4|||
105645451|NCT00424476|364363560|FG001|Overall Study|Lost to Follow-up|6|||
105645452|NCT00424476|364363561|FG002|Overall Study|Lost to Follow-up|3|||
105645453|NCT00424476|364363559|FG000|Overall Study|Protocol Violation|7|||
105645454|NCT00424476|364363560|FG001|Overall Study|Protocol Violation|2|||
105645455|NCT00424476|364363561|FG002|Overall Study|Protocol Violation|3|||
105645456|NCT00424476|364363559|FG000|Overall Study|Physician Decision|3|||
105645457|NCT00424476|364363560|FG001|Overall Study|Physician Decision|2|||
105645458|NCT00424476|364363561|FG002|Overall Study|Physician Decision|3|||
105645459|NCT00424476|364363559|FG000|Overall Study|Other|4|||
105645460|NCT00424476|364363560|FG001|Overall Study|Other|3|||
105645461|NCT00424476|364363561|FG002|Overall Study|Other|9|||
105645462|NCT00901459|364363562|FG000|Overall Study|Withdrawal by Subject|6|||
105645463|NCT03708744|364363565|FG000|Overall Study|Withdrawal by Subject|0|||
105645464|NCT03708744|364363566|FG001|Overall Study|Withdrawal by Subject|0|||
105645465|NCT03708744|364363567|FG002|Overall Study|Withdrawal by Subject|1|||
105645466|NCT03708744|364363568|FG003|Overall Study|Withdrawal by Subject|0|||
105645467|NCT04930263|364363569|FG000|Overall Study|Withdrawal by Subject|3|||
105645468|NCT04930263|364363570|FG001|Overall Study|Withdrawal by Subject|5|||
105645469|NCT02604199|364363576|FG000|Overall Study|Pregnancy|0|||
105645470|NCT02604199|364363577|FG001|Overall Study|Pregnancy|0|||
105645471|NCT02604199|364363578|FG002|Overall Study|Pregnancy|0|||
105645472|NCT02604199|364363579|FG003|Overall Study|Pregnancy|1|||
105645473|NCT02604199|364363576|FG000|Overall Study|Study terminated by sponsor|0|||
105645474|NCT02604199|364363577|FG001|Overall Study|Study terminated by sponsor|2|||
105645475|NCT02604199|364363578|FG002|Overall Study|Study terminated by sponsor|0|||
105645476|NCT02604199|364363579|FG003|Overall Study|Study terminated by sponsor|2|||
105645477|NCT02604199|364363576|FG000|Overall Study|Withdrawal by Subject|0|||
105645478|NCT02604199|364363577|FG001|Overall Study|Withdrawal by Subject|1|||
105645479|NCT02604199|364363578|FG002|Overall Study|Withdrawal by Subject|0|||
105645480|NCT02604199|364363579|FG003|Overall Study|Withdrawal by Subject|0|||
105645481|NCT02991456|364363581|FG000|Overall Study|Adverse Event|2|||
105645482|NCT02991456|364363582|FG001|Overall Study|Adverse Event|0|||
105645483|NCT02991456|364363581|FG000|Overall Study|Lost to Follow-up|0|||
105645484|NCT02991456|364363582|FG001|Overall Study|Lost to Follow-up|2|||
105645485|NCT02991456|364363581|FG000|Overall Study|Withdrawal by Subject|1|||
105645486|NCT02991456|364363582|FG001|Overall Study|Withdrawal by Subject|0|||
105645487|NCT02924051|364363585|FG000|Overall Study|Withdrawal by Subject|1|||
105645488|NCT02924051|364363586|FG001|Overall Study|Withdrawal by Subject|9|||
105645489|NCT00512902|364363587|FG000|Overall Study|Adverse Event|7|||
105645490|NCT00512902|364363587|FG000|Overall Study|Lost to Follow-up|1|||
105645491|NCT03905512|364363588|FG000|Overall Study|Withdrawal by Subject|9|||
105645492|NCT03905512|364363589|FG001|Overall Study|Withdrawal by Subject|8|||
105645493|NCT03905512|364363588|FG000|Overall Study|Adverse Event|1|||
105645494|NCT03905512|364363589|FG001|Overall Study|Adverse Event|2|||
105645495|NCT03905512|364363588|FG000|Overall Study|Lost to Follow-up|4|||
105645496|NCT03905512|364363589|FG001|Overall Study|Lost to Follow-up|3|||
105645497|NCT03905512|364363588|FG000|Overall Study|Other than Specified|7|||
105645498|NCT03905512|364363589|FG001|Overall Study|Other than Specified|4|||
105645499|NCT03547167|364363590|FG000|Overall Study|Withdrawal by Subject|34|||
105645500|NCT03547167|364363591|FG001|Overall Study|Withdrawal by Subject|12|||
105645501|NCT03547167|364363590|FG000|Overall Study|Screen Failure|0|||
105645502|NCT03547167|364363591|FG001|Overall Study|Screen Failure|1|||
105645503|NCT03547167|364363590|FG000|Overall Study|Lost to Follow-up|59|||
105645504|NCT03547167|364363591|FG001|Overall Study|Lost to Follow-up|15|||
105645505|NCT03547167|364363590|FG000|Overall Study|Death|4|||
105645506|NCT03547167|364363591|FG001|Overall Study|Death|2|||
105645507|NCT00070317|364363594|FG000|Overall Study|Inevaluable (Never Treated)|1|||
105645508|NCT00070317|364363594|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
105645509|NCT00070317|364363594|FG000|Overall Study|Ineligible required test not done|1|||
105645510|NCT00070317|364363594|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
105645511|NCT00070317|364363594|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
105645512|NCT01429285|364363595|FG000|Overall Study|Protocol Violation|9|||
105645513|NCT01429285|364363596|FG001|Overall Study|Protocol Violation|4|||
105645514|NCT01429285|364363595|FG000|Overall Study|Missing Data|5|||
105645515|NCT01429285|364363596|FG001|Overall Study|Missing Data|3|||
105645516|NCT01429285|364363595|FG000|Overall Study|Erroneously Enrolled Twice|8|||
105645517|NCT01429285|364363596|FG001|Overall Study|Erroneously Enrolled Twice|2|||
105645518|NCT00738400|364363597|FG000|Overall Study|Adverse Event|3|||
105645519|NCT00738400|364363598|FG001|Overall Study|Adverse Event|1|||
105645520|NCT00738400|364363597|FG000|Overall Study|Withdrawal by Subject|0|||
105645521|NCT00738400|364363598|FG001|Overall Study|Withdrawal by Subject|1|||
105645522|NCT00738400|364363597|FG000|Overall Study|Lack of Efficacy|0|||
105645523|NCT00738400|364363598|FG001|Overall Study|Lack of Efficacy|1|||
105645524|NCT00738400|364363597|FG000|Overall Study|Lost to Follow-up|0|||
105645525|NCT00738400|364363598|FG001|Overall Study|Lost to Follow-up|3|||
105645526|NCT00738400|364363597|FG000|Overall Study|Protocol Violation|1|||
105645527|NCT00738400|364363598|FG001|Overall Study|Protocol Violation|0|||
105645528|NCT00738400|364363597|FG000|Overall Study|Non-compliant with study medication|0|||
105645529|NCT00738400|364363598|FG001|Overall Study|Non-compliant with study medication|1|||
105645530|NCT02674399|364363599|FG000|Overall Study|Lost to Follow-up|2|||
105645531|NCT02674399|364363600|FG001|Overall Study|Lost to Follow-up|0|||
105645532|NCT00508144|364363601|FG000|Overall Study|Not eligible|6|||
105645533|NCT00508144|364363601|FG000|Overall Study|Death|5|||
105645534|NCT01517282|364363604|FG000|Overall Study|Consent withdrawn|0|||
105645535|NCT01517282|364363605|FG001|Overall Study|Consent withdrawn|1|||
105645536|NCT01517282|364363606|FG002|Overall Study|Consent withdrawn|1|||
105645537|NCT01517282|364363607|FG003|Overall Study|Consent withdrawn|1|||
105645538|NCT01517282|364363604|FG000|Overall Study|Physician Decision|1|||
105645539|NCT01517282|364363605|FG001|Overall Study|Physician Decision|0|||
105645540|NCT01517282|364363606|FG002|Overall Study|Physician Decision|0|||
105645541|NCT01517282|364363607|FG003|Overall Study|Physician Decision|0|||
105645542|NCT01159600|364363608|FG000|Overall Study|Not treated|0|||
105645543|NCT01159600|364363609|FG001|Overall Study|Not treated|0|||
105645544|NCT01159600|364363610|FG002|Overall Study|Not treated|1|||
105645545|NCT01159600|364363611|FG003|Overall Study|Not treated|0|||
105645546|NCT01159600|364363612|FG004|Overall Study|Not treated|0|||
105645547|NCT01159600|364363613|FG005|Overall Study|Not treated|1|||
105645548|NCT01159600|364363614|FG006|Overall Study|Not treated|2|||
105645549|NCT01159600|364363615|FG007|Overall Study|Not treated|2|||
105645550|NCT01159600|364363608|FG000|Overall Study|Adverse Event|7|||
105645551|NCT01159600|364363609|FG001|Overall Study|Adverse Event|2|||
105645552|NCT01159600|364363610|FG002|Overall Study|Adverse Event|5|||
105645553|NCT01159600|364363611|FG003|Overall Study|Adverse Event|1|||
105645554|NCT01159600|364363612|FG004|Overall Study|Adverse Event|8|||
105645555|NCT01159600|364363613|FG005|Overall Study|Adverse Event|6|||
105645556|NCT01159600|364363614|FG006|Overall Study|Adverse Event|7|||
105645557|NCT01159600|364363615|FG007|Overall Study|Adverse Event|5|||
105645558|NCT01159600|364363608|FG000|Overall Study|Lack of Efficacy|0|||
105645559|NCT01159600|364363609|FG001|Overall Study|Lack of Efficacy|0|||
105645560|NCT01159600|364363610|FG002|Overall Study|Lack of Efficacy|0|||
105645561|NCT01159600|364363611|FG003|Overall Study|Lack of Efficacy|0|||
105645562|NCT01159600|364363612|FG004|Overall Study|Lack of Efficacy|2|||
105645563|NCT01159600|364363613|FG005|Overall Study|Lack of Efficacy|0|||
105645564|NCT01159600|364363614|FG006|Overall Study|Lack of Efficacy|0|||
105645565|NCT01159600|364363615|FG007|Overall Study|Lack of Efficacy|1|||
105645566|NCT01159600|364363608|FG000|Overall Study|Non compliant with protocol|2|||
105645567|NCT01159600|364363609|FG001|Overall Study|Non compliant with protocol|1|||
105645568|NCT01159600|364363610|FG002|Overall Study|Non compliant with protocol|0|||
105645569|NCT01159600|364363611|FG003|Overall Study|Non compliant with protocol|0|||
105645570|NCT01159600|364363612|FG004|Overall Study|Non compliant with protocol|2|||
105645571|NCT01159600|364363613|FG005|Overall Study|Non compliant with protocol|0|||
105645572|NCT01159600|364363614|FG006|Overall Study|Non compliant with protocol|2|||
105645573|NCT01159600|364363615|FG007|Overall Study|Non compliant with protocol|0|||
105645574|NCT01159600|364363608|FG000|Overall Study|Lost to Follow-up|2|||
105645575|NCT01159600|364363609|FG001|Overall Study|Lost to Follow-up|3|||
105645576|NCT01159600|364363610|FG002|Overall Study|Lost to Follow-up|4|||
105645577|NCT01159600|364363611|FG003|Overall Study|Lost to Follow-up|3|||
105645578|NCT01159600|364363612|FG004|Overall Study|Lost to Follow-up|3|||
105645579|NCT01159600|364363613|FG005|Overall Study|Lost to Follow-up|0|||
105645580|NCT01159600|364363614|FG006|Overall Study|Lost to Follow-up|3|||
105645581|NCT01159600|364363615|FG007|Overall Study|Lost to Follow-up|2|||
105645582|NCT01159600|364363608|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
105645583|NCT01159600|364363609|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
105645584|NCT01159600|364363610|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
105645585|NCT01159600|364363611|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
105645586|NCT01159600|364363612|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
105645587|NCT01159600|364363613|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
105645588|NCT01159600|364363614|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
105645589|NCT01159600|364363615|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
105645590|NCT01159600|364363608|FG000|Overall Study|Other reason not defined above|3|||
105645591|NCT01159600|364363609|FG001|Overall Study|Other reason not defined above|0|||
105645592|NCT01159600|364363610|FG002|Overall Study|Other reason not defined above|4|||
105645593|NCT01159600|364363611|FG003|Overall Study|Other reason not defined above|2|||
105645594|NCT01159600|364363612|FG004|Overall Study|Other reason not defined above|5|||
105645595|NCT01159600|364363613|FG005|Overall Study|Other reason not defined above|7|||
105645596|NCT01159600|364363614|FG006|Overall Study|Other reason not defined above|3|||
105645597|NCT01159600|364363615|FG007|Overall Study|Other reason not defined above|3|||
105645598|NCT00747149|364364935|FG000|Overall Study|Adverse Event|0|||
105645599|NCT00747149|364364936|FG001|Overall Study|Adverse Event|15|||
105645600|NCT00747149|364364935|FG000|Overall Study|Lost to Follow-up|0|||
105645601|NCT00747149|364364936|FG001|Overall Study|Lost to Follow-up|10|||
105645602|NCT00747149|364364935|FG000|Overall Study|Withdrawal by Subject|0|||
105645603|NCT00747149|364364936|FG001|Overall Study|Withdrawal by Subject|6|||
105645604|NCT00747149|364364935|FG000|Overall Study|Did not receive treatment|0|||
105645605|NCT00747149|364364936|FG001|Overall Study|Did not receive treatment|1|||
105645606|NCT00747149|364364935|FG000|Overall Study|Incorrect enrollment|0|||
105645607|NCT00747149|364364936|FG001|Overall Study|Incorrect enrollment|6|||
105645608|NCT00747149|364364935|FG000|Overall Study|Severe non-compliance to protocol|0|||
105645609|NCT00747149|364364936|FG001|Overall Study|Severe non-compliance to protocol|1|||
105645610|NCT00747149|364364935|FG000|Overall Study|Not reported|1|||
105645611|NCT00747149|364364936|FG001|Overall Study|Not reported|4|||
105645612|NCT04369664|364364937|FG000|Overall Study|Physician Decision|1|||
105645613|NCT04369664|364364938|FG001|Overall Study|Physician Decision|0|||
105645614|NCT03072238|364364939|FG000|Overall Study|Withdrawal by Subject|44|||
105645615|NCT03072238|364364940|FG001|Overall Study|Withdrawal by Subject|64|||
105645616|NCT03072238|364364939|FG000|Overall Study|Lost to Follow-up|14|||
105645617|NCT03072238|364364940|FG001|Overall Study|Lost to Follow-up|5|||
105645618|NCT03072238|364364939|FG000|Overall Study|Physician Decision|4|||
105645619|NCT03072238|364364940|FG001|Overall Study|Physician Decision|6|||
105645620|NCT03072238|364364939|FG000|Overall Study|Death|351|||
105645621|NCT03072238|364364940|FG001|Overall Study|Death|318|||
105645622|NCT03072238|364364939|FG000|Overall Study|Progressive Disease|3|||
105645623|NCT03072238|364364940|FG001|Overall Study|Progressive Disease|4|||
105645624|NCT03072238|364364939|FG000|Overall Study|Reason Not Specified|138|||
105645625|NCT03072238|364364940|FG001|Overall Study|Reason Not Specified|150|||
105645626|NCT02489799|364364941|FG000|Overall Study|Lost to Follow-up|4|||
105645627|NCT02489799|364364942|FG001|Overall Study|Lost to Follow-up|1|||
105645628|NCT02489799|364364941|FG000|Overall Study|Failure to Maintain Eligibility|4|||
105645629|NCT02489799|364364942|FG001|Overall Study|Failure to Maintain Eligibility|6|||
105645630|NCT02489799|364364941|FG000|Overall Study|Withdrawal by Subject|1|||
105645631|NCT02489799|364364942|FG001|Overall Study|Withdrawal by Subject|1|||
105645632|NCT02489799|364364941|FG000|Overall Study|Death|0|||
105645633|NCT02489799|364364942|FG001|Overall Study|Death|1|||
105645634|NCT04909593|364364943|FG000|Overall Study|Withdrawal by Subject|1|||
105645635|NCT01241448|364364944|FG000|Overall Study|Adverse Event|1|||
105645636|NCT01241448|364364945|FG001|Overall Study|Adverse Event|0|||
105645637|NCT01241448|364364946|FG002|Overall Study|Adverse Event|2|||
105645638|NCT01241448|364364947|FG003|Overall Study|Adverse Event|2|||
105645639|NCT01241448|364364944|FG000|Overall Study|Lost to Follow-up|2|||
105645640|NCT01241448|364364945|FG001|Overall Study|Lost to Follow-up|1|||
105645641|NCT01241448|364364946|FG002|Overall Study|Lost to Follow-up|1|||
105645642|NCT01241448|364364947|FG003|Overall Study|Lost to Follow-up|1|||
105645643|NCT01241448|364364944|FG000|Overall Study|Physician Decision|0|||
105645644|NCT01241448|364364945|FG001|Overall Study|Physician Decision|2|||
105645645|NCT01241448|364364946|FG002|Overall Study|Physician Decision|0|||
105645646|NCT01241448|364364947|FG003|Overall Study|Physician Decision|0|||
105645647|NCT01241448|364364944|FG000|Overall Study|Protocol Violation|10|||
105645648|NCT01241448|364364945|FG001|Overall Study|Protocol Violation|5|||
105645649|NCT01241448|364364946|FG002|Overall Study|Protocol Violation|3|||
105645650|NCT01241448|364364947|FG003|Overall Study|Protocol Violation|6|||
105645651|NCT01241448|364364944|FG000|Overall Study|Sponsor Decision|17|||
105645652|NCT01241448|364364945|FG001|Overall Study|Sponsor Decision|14|||
105645653|NCT01241448|364364946|FG002|Overall Study|Sponsor Decision|12|||
105645654|NCT01241448|364364947|FG003|Overall Study|Sponsor Decision|6|||
105645655|NCT01241448|364364944|FG000|Overall Study|Withdrawal by Subject|4|||
105645656|NCT01241448|364364945|FG001|Overall Study|Withdrawal by Subject|5|||
105645657|NCT01241448|364364946|FG002|Overall Study|Withdrawal by Subject|3|||
105645658|NCT01241448|364364947|FG003|Overall Study|Withdrawal by Subject|6|||
105645659|NCT01241448|364364944|FG000|Overall Study|Excluded due to data integrity issues|3|||
105645660|NCT01241448|364364945|FG001|Overall Study|Excluded due to data integrity issues|2|||
105645661|NCT01241448|364364946|FG002|Overall Study|Excluded due to data integrity issues|2|||
105645662|NCT01241448|364364947|FG003|Overall Study|Excluded due to data integrity issues|2|||
105645663|NCT02400749|364364948|FG000|Week 0 -16|Withdrawal by Subject|5|||
105645664|NCT02400749|364364949|FG001|Week 0 -16|Withdrawal by Subject|5|||
105645665|NCT02400749|364364948|FG000|Week 0 -16|Adverse Event|3|||
105645666|NCT02400749|364364949|FG001|Week 0 -16|Adverse Event|1|||
105645667|NCT02400749|364364948|FG000|Week 0 -16|Lost to Follow-up|2|||
105645668|NCT02400749|364364949|FG001|Week 0 -16|Lost to Follow-up|0|||
105645669|NCT02400749|364364948|FG000|Week 0 -16|Protocol Violation|1|||
105645670|NCT02400749|364364949|FG001|Week 0 -16|Protocol Violation|0|||
105645671|NCT02400749|364364948|FG000|Week 17 - 32|Withdrawal by Subject|3|||
105645672|NCT02400749|364364949|FG001|Week 17 - 32|Withdrawal by Subject|2|||
105645673|NCT02400749|364364948|FG000|Week 17 - 32|Adverse Event|2|||
105645674|NCT02400749|364364949|FG001|Week 17 - 32|Adverse Event|1|||
105645675|NCT00307489|364364950|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
105645676|NCT00307489|364364951|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
105645677|NCT00307489|364364950|FG000|Baseline Through Week 48|Physician Decision|1|||
105645678|NCT00307489|364364951|FG001|Baseline Through Week 48|Physician Decision|0|||
105645679|NCT00307489|364364950|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
105645680|NCT00307489|364364951|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
105645681|NCT00307489|364364950|FG000|Week 48 Through Week 168|Adverse Event|1|||
105645682|NCT00307489|364364951|FG001|Week 48 Through Week 168|Adverse Event|0|||
105645683|NCT00307489|364364950|FG000|Week 48 Through Week 168|Physician Decision|1|||
105645684|NCT00307489|364364951|FG001|Week 48 Through Week 168|Physician Decision|0|||
105645685|NCT00307489|364364950|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
105645686|NCT00307489|364364951|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
105645687|NCT00307489|364364950|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
105645688|NCT00307489|364364951|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
105645689|NCT00307489|364364950|FG000|Week 48 Through Week 168|Death|0|||
105645690|NCT00307489|364364951|FG001|Week 48 Through Week 168|Death|1|||
105645691|NCT00307489|364364950|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
105645692|NCT00307489|364364951|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
105645693|NCT00307489|364364950|FG000|Week 48 Through Week 168|Seroconversion|1|||
105645694|NCT00307489|364364951|FG001|Week 48 Through Week 168|Seroconversion|0|||
105645695|NCT04425252|364364952|FG000|Overall Study|Withdrawal by Subject|2|||
105645696|NCT04425252|364364953|FG001|Overall Study|Withdrawal by Subject|1|||
105645697|NCT04425252|364364952|FG000|Overall Study|Lost to Follow-up|1|||
105645698|NCT04425252|364364953|FG001|Overall Study|Lost to Follow-up|0|||
105645699|NCT04425252|364364952|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
105645700|NCT04425252|364364953|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
105645701|NCT01945593|364364955|FG000|Overall Study|Adverse Event|0|||
105645702|NCT01945593|364364956|FG001|Overall Study|Adverse Event|0|||
105645703|NCT01945593|364364957|FG002|Overall Study|Adverse Event|0|||
105645704|NCT01945593|364364958|FG003|Overall Study|Adverse Event|5|||
105645705|NCT01945593|364364955|FG000|Overall Study|Physician Decision|0|||
105645706|NCT01945593|364364956|FG001|Overall Study|Physician Decision|0|||
105645707|NCT01945593|364364957|FG002|Overall Study|Physician Decision|1|||
105645708|NCT01945593|364364958|FG003|Overall Study|Physician Decision|1|||
105645709|NCT01945593|364364955|FG000|Overall Study|Withdrawal by Subject|0|||
105645710|NCT01945593|364364956|FG001|Overall Study|Withdrawal by Subject|2|||
105645711|NCT01945593|364364957|FG002|Overall Study|Withdrawal by Subject|0|||
105645712|NCT01945593|364364958|FG003|Overall Study|Withdrawal by Subject|4|||
105645713|NCT01945593|364364955|FG000|Overall Study|Protocol Violation|0|||
105645714|NCT01945593|364364956|FG001|Overall Study|Protocol Violation|2|||
105645715|NCT01945593|364364957|FG002|Overall Study|Protocol Violation|1|||
105645716|NCT01945593|364364958|FG003|Overall Study|Protocol Violation|3|||
105645717|NCT01945593|364364955|FG000|Overall Study|Death|0|||
105645718|NCT01945593|364364956|FG001|Overall Study|Death|0|||
105645719|NCT01945593|364364957|FG002|Overall Study|Death|1|||
105645720|NCT01945593|364364958|FG003|Overall Study|Death|0|||
105645721|NCT01945593|364364955|FG000|Overall Study|Other: Terminated|0|||
105645722|NCT01945593|364364956|FG001|Overall Study|Other: Terminated|0|||
105645723|NCT01945593|364364957|FG002|Overall Study|Other: Terminated|0|||
105645724|NCT01945593|364364958|FG003|Overall Study|Other: Terminated|1|||
105645725|NCT01945593|364364955|FG000|Overall Study|Other: Surgical Procedure|0|||
105645726|NCT01945593|364364956|FG001|Overall Study|Other: Surgical Procedure|2|||
105645727|NCT01945593|364364957|FG002|Overall Study|Other: Surgical Procedure|0|||
105645728|NCT01945593|364364958|FG003|Overall Study|Other: Surgical Procedure|6|||
105645729|NCT01945593|364364955|FG000|Overall Study|Other: Screen Failure|0|||
105645730|NCT01945593|364364956|FG001|Overall Study|Other: Screen Failure|2|||
105645731|NCT01945593|364364957|FG002|Overall Study|Other: Screen Failure|0|||
105645732|NCT01945593|364364958|FG003|Overall Study|Other: Screen Failure|0|||
105645733|NCT00841321|364364959|FG000|Overall Study|Lost to Follow-up|1|||
105645734|NCT00841321|364364960|FG001|Overall Study|Lost to Follow-up|1|||
105645735|NCT00841321|364364959|FG000|Overall Study|Adverse Event|0|||
105645736|NCT00841321|364364960|FG001|Overall Study|Adverse Event|2|||
105645737|NCT00379210|364364961|FG000|Overall Study|Withdrawal by Subject|10|||
105645738|NCT00379210|364364962|FG001|Overall Study|Withdrawal by Subject|7|||
105645739|NCT03651271|364364963|FG000|Overall Study|Death|4|||
105645740|NCT03651271|364364964|FG001|Overall Study|Death|37|||
105645741|NCT03651271|364364965|FG002|Overall Study|Death|0|||
105645742|NCT03651271|364364966|FG003|Overall Study|Death|2|||
105645743|NCT03651271|364364967|FG004|Overall Study|Death|6|||
105645744|NCT03651271|364364963|FG000|Overall Study|Lost to Follow-up|1|||
105645745|NCT03651271|364364964|FG001|Overall Study|Lost to Follow-up|5|||
105645746|NCT03651271|364364965|FG002|Overall Study|Lost to Follow-up|0|||
105645747|NCT03651271|364364966|FG003|Overall Study|Lost to Follow-up|1|||
105645748|NCT03651271|364364967|FG004|Overall Study|Lost to Follow-up|0|||
105645749|NCT03651271|364364963|FG000|Overall Study|Physician Decision|0|||
105645750|NCT03651271|364364964|FG001|Overall Study|Physician Decision|2|||
105645751|NCT03651271|364364965|FG002|Overall Study|Physician Decision|0|||
105645752|NCT03651271|364364966|FG003|Overall Study|Physician Decision|0|||
105645753|NCT03651271|364364967|FG004|Overall Study|Physician Decision|0|||
105645754|NCT03651271|364364963|FG000|Overall Study|Withdrawal by Subject|1|||
105645755|NCT03651271|364364964|FG001|Overall Study|Withdrawal by Subject|15|||
105645756|NCT03651271|364364965|FG002|Overall Study|Withdrawal by Subject|0|||
105645757|NCT03651271|364364966|FG003|Overall Study|Withdrawal by Subject|0|||
105645758|NCT03651271|364364967|FG004|Overall Study|Withdrawal by Subject|1|||
105645759|NCT03651271|364364963|FG000|Overall Study|Patient medically unable to continue|0|||
105645760|NCT03651271|364364964|FG001|Overall Study|Patient medically unable to continue|0|||
105645761|NCT03651271|364364965|FG002|Overall Study|Patient medically unable to continue|0|||
105645762|NCT03651271|364364966|FG003|Overall Study|Patient medically unable to continue|1|||
105645763|NCT03651271|364364967|FG004|Overall Study|Patient medically unable to continue|0|||
105645764|NCT03444155|364364972|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
105645765|NCT03444155|364364973|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
105645766|NCT00821093|364364974|FG000|Overall Study|Adverse Event|20|||
105645767|NCT00821093|364364975|FG001|Overall Study|Adverse Event|12|||
105645768|NCT00821093|364364974|FG000|Overall Study|Withdrawal by Subject|9|||
105645769|NCT00821093|364364975|FG001|Overall Study|Withdrawal by Subject|13|||
105645770|NCT00821093|364364974|FG000|Overall Study|Lost to Follow-up|9|||
105645771|NCT00821093|364364975|FG001|Overall Study|Lost to Follow-up|3|||
105645772|NCT00821093|364364974|FG000|Overall Study|Protocol deviation|3|||
105645773|NCT00821093|364364975|FG001|Overall Study|Protocol deviation|6|||
105645774|NCT00821093|364364974|FG000|Overall Study|Abnormal laboratory value(s)|2|||
105645775|NCT00821093|364364975|FG001|Overall Study|Abnormal laboratory value(s)|0|||
105645776|NCT00821093|364364974|FG000|Overall Study|Lack of Efficacy|2|||
105645777|NCT00821093|364364975|FG001|Overall Study|Lack of Efficacy|2|||
105645778|NCT00821093|364364974|FG000|Overall Study|Death|2|||
105645779|NCT00821093|364364975|FG001|Overall Study|Death|1|||
105645780|NCT00821093|364364974|FG000|Overall Study|Abnormal test procedure result(s)|1|||
105645781|NCT00821093|364364975|FG001|Overall Study|Abnormal test procedure result(s)|1|||
105645782|NCT00821093|364364974|FG000|Overall Study|Administrative problems|1|||
105870227|NCT01074944|365176968|FG001|Long Term Treatment|Withdrawal by Subject|0|||
105645783|NCT00821093|364364975|FG001|Overall Study|Administrative problems|2|||
105645784|NCT01601821|364364977|FG000|Overall Study|Death|2|||
105645785|NCT01601821|364364978|FG001|Overall Study|Death|5|||
105645786|NCT01601821|364364977|FG000|Overall Study|Protocol Violation|2|||
105645787|NCT01601821|364364978|FG001|Overall Study|Protocol Violation|2|||
105645788|NCT01601821|364364977|FG000|Overall Study|Lost to Follow-up|6|||
105645789|NCT01601821|364364978|FG001|Overall Study|Lost to Follow-up|14|||
105645790|NCT01601821|364364977|FG000|Overall Study|Withdrawal by Subject|1|||
105645791|NCT01601821|364364978|FG001|Overall Study|Withdrawal by Subject|0|||
105645792|NCT01601821|364364977|FG000|Overall Study|Graft Loss|6|||
105645793|NCT01601821|364364978|FG001|Overall Study|Graft Loss|6|||
105645794|NCT01601821|364364977|FG000|Overall Study|Study Events|7|||
105645795|NCT01601821|364364978|FG001|Overall Study|Study Events|1|||
105645796|NCT01601821|364364977|FG000|Overall Study|Other|5|||
105645797|NCT01601821|364364978|FG001|Overall Study|Other|1|||
105645798|NCT02446912|364364979|FG000|Overall Study|Adverse Event|3|||
105645799|NCT02446912|364364980|FG001|Overall Study|Adverse Event|13|||
105645800|NCT02446912|364364981|FG002|Overall Study|Adverse Event|5|||
105645801|NCT02446912|364364979|FG000|Overall Study|Condition under investigation worsened|0|||
105645802|NCT02446912|364364980|FG001|Overall Study|Condition under investigation worsened|1|||
105645803|NCT02446912|364364981|FG002|Overall Study|Condition under investigation worsened|1|||
105645804|NCT02446912|364364979|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105645805|NCT02446912|364364980|FG001|Overall Study|Study-specific withdrawal criteria|0|||
105645806|NCT02446912|364364981|FG002|Overall Study|Study-specific withdrawal criteria|0|||
105645807|NCT02446912|364364979|FG000|Overall Study|Lack of Efficacy|1|||
105645808|NCT02446912|364364980|FG001|Overall Study|Lack of Efficacy|4|||
105645809|NCT02446912|364364981|FG002|Overall Study|Lack of Efficacy|7|||
105645810|NCT02446912|364364979|FG000|Overall Study|Lost to Follow-up|0|||
105645811|NCT02446912|364364980|FG001|Overall Study|Lost to Follow-up|0|||
105645812|NCT02446912|364364981|FG002|Overall Study|Lost to Follow-up|2|||
105645813|NCT02446912|364364979|FG000|Overall Study|Severe non-compliance to protocol|1|||
105645814|NCT02446912|364364980|FG001|Overall Study|Severe non-compliance to protocol|0|||
105645815|NCT02446912|364364981|FG002|Overall Study|Severe non-compliance to protocol|1|||
105645816|NCT02446912|364364979|FG000|Overall Study|Withdrawal by Subject|10|||
105645817|NCT02446912|364364980|FG001|Overall Study|Withdrawal by Subject|15|||
105645818|NCT02446912|364364981|FG002|Overall Study|Withdrawal by Subject|15|||
105645819|NCT02446912|364364979|FG000|Overall Study|Miscellaneous|2|||
105645820|NCT02446912|364364980|FG001|Overall Study|Miscellaneous|2|||
105645821|NCT02446912|364364981|FG002|Overall Study|Miscellaneous|4|||
105645822|NCT02877680|364364982|FG000|Overall Study|Lost to Follow-up|1|||
105645823|NCT02877680|364364983|FG001|Overall Study|Lost to Follow-up|1|||
105645824|NCT01133678|364364984|FG000|Overall Study|Death|1|||
105645825|NCT01133678|364364985|FG001|Overall Study|Death|1|||
105645826|NCT01901302|364364986|FG000|Overall Study|Adverse Event|2|||
105645827|NCT01901302|364364987|FG001|Overall Study|Adverse Event|1|||
105645828|NCT01901302|364364986|FG000|Overall Study|Lack of Efficacy|0|||
105645829|NCT01901302|364364987|FG001|Overall Study|Lack of Efficacy|2|||
105645830|NCT01901302|364364986|FG000|Overall Study|Study Terminated by Sponsor|23|||
105645831|NCT01901302|364364987|FG001|Overall Study|Study Terminated by Sponsor|20|||
105645832|NCT01901302|364364986|FG000|Overall Study|Withdrawal by Subject|2|||
105645833|NCT01901302|364364987|FG001|Overall Study|Withdrawal by Subject|0|||
105645834|NCT00753896|364364989|FG000|Overall Study|Adverse Event|4|||
105645835|NCT00753896|364364989|FG000|Overall Study|Death|1|||
105645836|NCT00753896|364364989|FG000|Overall Study|Lost to Follow-up|2|||
105645837|NCT00753896|364364989|FG000|Overall Study|Protocol Violation|1|||
105645838|NCT00753896|364364989|FG000|Overall Study|Withdrawal by Subject|4|||
105645839|NCT00753896|364364989|FG000|Overall Study|Entry Criteria Not Met|4|||
105645840|NCT02959866|364364990|FG000|Overall Study|Withdrawal by Subject|1|||
105645841|NCT00952523|364364991|FG000|Overall Study|Withdrawal by Subject|7|||
105645842|NCT00848198|364364992|FG000|Overall Study|Incomplete Case Report Forms|15|||
105645843|NCT01029925|364364996|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
105645844|NCT01029925|364364996|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
105645845|NCT01029925|364364996|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
105645846|NCT05265247|364364997|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
105645847|NCT05265247|364364998|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
105645848|NCT05265247|364364997|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
105645849|NCT05265247|364364998|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
105645850|NCT05265247|364364997|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
105645851|NCT05265247|364364998|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
105645852|NCT00134056|364365006|FG000|Randomization|Not eligible for assigned treatment|22|||
105645853|NCT00134056|364365007|FG001|Randomization|Not eligible for assigned treatment|20|||
105645854|NCT00134056|364365006|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
105645855|NCT00134056|364365007|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
105645856|NCT00134056|364365006|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
105645857|NCT00134056|364365007|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
105645858|NCT00134056|364365006|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
105645859|NCT00134056|364365007|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
105645860|NCT00134056|364365006|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
105645861|NCT00134056|364365007|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
105645862|NCT03166215|364365008|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
105645863|NCT03166215|364365009|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
105645864|NCT03166215|364365010|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
105645865|NCT03166215|364365008|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
105645866|NCT03166215|364365009|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
105645867|NCT03166215|364365010|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
105645868|NCT01536795|364365012|FG000|Overall Study|Lost to Follow-up|0|||
105645869|NCT01536795|364365013|FG001|Overall Study|Lost to Follow-up|2|||
105645870|NCT01536795|364365012|FG000|Overall Study|Lack of Efficacy|1|||
105645871|NCT01536795|364365013|FG001|Overall Study|Lack of Efficacy|0|||
105645872|NCT01812837|364365014|FG000|Overall Study|Lost to Follow-up|1|||
105645873|NCT01812837|364365015|FG001|Overall Study|Lost to Follow-up|1|||
105645874|NCT01812837|364365016|FG002|Overall Study|Lost to Follow-up|0|||
105645875|NCT01812837|364365014|FG000|Overall Study|Protocol Violation|1|||
105645876|NCT01812837|364365015|FG001|Overall Study|Protocol Violation|0|||
105645877|NCT01812837|364365016|FG002|Overall Study|Protocol Violation|0|||
105645878|NCT04598776|364365019|FG000|Overall Study|Protocol Violation|5|||
105645879|NCT04598776|364365019|FG000|Overall Study|Physician Decision|4|||
105645880|NCT06312566|364365023|FG000|Overall Study|Protocol Violation|0|||
105645881|NCT06312566|364365024|FG001|Overall Study|Protocol Violation|1|||
105645882|NCT02632045|364365025|FG000|Overall Study|Withdrawal by Subject|1|||
105645883|NCT02632045|364365026|FG001|Overall Study|Withdrawal by Subject|2|||
105645884|NCT05878522|364365027|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645885|NCT05878522|364365028|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645886|NCT05878522|364365029|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645887|NCT05878522|364365030|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645888|NCT05878522|364365031|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645889|NCT05878522|364365032|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645890|NCT05878522|364365033|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645891|NCT05878522|364365034|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645892|NCT05878522|364365035|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
105645893|NCT05878522|364365036|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645894|NCT05878522|364365037|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645895|NCT05878522|364365038|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
105645896|NCT05878522|364365027|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
105645897|NCT05878522|364365028|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645898|NCT05878522|364365029|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645899|NCT05878522|364365030|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645900|NCT05878522|364365031|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645901|NCT05878522|364365032|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645902|NCT05878522|364365033|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645903|NCT05878522|364365034|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645904|NCT05878522|364365035|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645905|NCT05878522|364365036|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
105645906|NCT05878522|364365037|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645907|NCT05878522|364365038|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
105645908|NCT05878522|364365027|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645909|NCT05878522|364365028|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
105645910|NCT05878522|364365029|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645911|NCT05878522|364365030|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
105645912|NCT05878522|364365031|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645913|NCT05878522|364365032|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645914|NCT05878522|364365033|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645915|NCT05878522|364365034|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645916|NCT05878522|364365035|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645917|NCT05878522|364365036|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645918|NCT05878522|364365037|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645919|NCT05878522|364365038|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
105645920|NCT05878522|364365027|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645921|NCT05878522|364365028|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645922|NCT05878522|364365029|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645923|NCT05878522|364365030|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645924|NCT05878522|364365031|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
105645925|NCT05878522|364365032|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645926|NCT05878522|364365033|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645927|NCT05878522|364365034|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645928|NCT05878522|364365035|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645929|NCT05878522|364365036|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645930|NCT05878522|364365037|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645931|NCT05878522|364365038|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
105645932|NCT01613599|364365039|FG000|Overall Study|Death|9|||
105645933|NCT01613599|364365039|FG000|Overall Study|Lost to Follow-up|5|||
105645934|NCT01613599|364365039|FG000|Overall Study|Withdrawal by Subject|8|||
105645935|NCT01613599|364365039|FG000|Overall Study|Reason not specified|3|||
105645936|NCT03503188|364365040|FG000|Overall Study|Non eligible in the sub study|0|||
105645937|NCT03503188|364365041|FG001|Overall Study|Non eligible in the sub study|1|||
105645938|NCT01699178|364365042|FG000|Overall Study|Adverse Event|1|||
105645939|NCT01699178|364365043|FG001|Overall Study|Adverse Event|5|||
105645940|NCT01699178|364365042|FG000|Overall Study|Lost to Follow-up|1|||
105645941|NCT01699178|364365043|FG001|Overall Study|Lost to Follow-up|6|||
105645942|NCT01699178|364365042|FG000|Overall Study|Non-compliance with Study Drug|3|||
105645943|NCT01699178|364365043|FG001|Overall Study|Non-compliance with Study Drug|1|||
105645944|NCT01699178|364365042|FG000|Overall Study|Physician Decision|1|||
105645945|NCT01699178|364365043|FG001|Overall Study|Physician Decision|0|||
105645946|NCT01699178|364365042|FG000|Overall Study|Withdrawal by Subject|4|||
105645947|NCT01699178|364365043|FG001|Overall Study|Withdrawal by Subject|12|||
105645948|NCT01699178|364365042|FG000|Overall Study|Hematocrit >54%|1|||
105645949|NCT01699178|364365043|FG001|Overall Study|Hematocrit >54%|1|||
105645950|NCT01699178|364365042|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
105645951|NCT01699178|364365043|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
105645952|NCT01699178|364365042|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
105645953|NCT01699178|364365043|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
105645954|NCT03005106|364365046|FG000|Overall Study|Lost to Follow-up|16|||
105645955|NCT03005106|364365046|FG000|Overall Study|Adverse Event|1|||
105645956|NCT03005106|364365046|FG000|Overall Study|Physician Decision|1|||
105645957|NCT03005106|364365046|FG000|Overall Study|Death|2|||
105645958|NCT03019289|364365049|FG000|Overall Study|Adverse Event|1|||
105645959|NCT03019289|364365050|FG001|Overall Study|Adverse Event|0|||
105645960|NCT03019289|364365051|FG002|Overall Study|Adverse Event|0|||
105645961|NCT03019289|364365052|FG003|Overall Study|Adverse Event|0|||
105645962|NCT03019289|364365053|FG004|Overall Study|Adverse Event|0|||
105645963|NCT03019289|364365054|FG005|Overall Study|Adverse Event|0|||
105645964|NCT03019289|364365055|FG006|Overall Study|Adverse Event|0|||
105645965|NCT03019289|364365056|FG007|Overall Study|Adverse Event|0|||
105645966|NCT03019289|364365057|FG008|Overall Study|Adverse Event|1|||
105645967|NCT03019289|364365049|FG000|Overall Study|Other|1|||
105645968|NCT03019289|364365050|FG001|Overall Study|Other|0|||
105645969|NCT03019289|364365051|FG002|Overall Study|Other|0|||
105645970|NCT03019289|364365052|FG003|Overall Study|Other|0|||
105645971|NCT03019289|364365053|FG004|Overall Study|Other|0|||
105645972|NCT03019289|364365054|FG005|Overall Study|Other|0|||
105645973|NCT03019289|364365055|FG006|Overall Study|Other|0|||
105645974|NCT03019289|364365056|FG007|Overall Study|Other|0|||
105645975|NCT03019289|364365057|FG008|Overall Study|Other|0|||
105645976|NCT00537914|364365058|FG000|Overall Study|Death|1|||
105645977|NCT00537914|364365058|FG000|Overall Study|Adverse Event|7|||
105645978|NCT00537914|364365058|FG000|Overall Study|Treatment failure|10|||
105645979|NCT00537914|364365058|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
105645980|NCT00537914|364365058|FG000|Overall Study|Lost to Follow-up|19|||
105645981|NCT00537914|364365058|FG000|Overall Study|Withdrawal of informed consent|59|||
105645982|NCT02312258|364365059|FG000|Overall Study|Lost to Follow-up|8|||
105645983|NCT02312258|364365060|FG001|Overall Study|Lost to Follow-up|8|||
105645984|NCT02312258|364365059|FG000|Overall Study|Withdrawal by Patient|49|||
105645985|NCT02312258|364365060|FG001|Overall Study|Withdrawal by Patient|76|||
105645986|NCT02312258|364365059|FG000|Overall Study|Reason not Specified|107|||
105645987|NCT02312258|364365060|FG001|Overall Study|Reason not Specified|159|||
105645988|NCT02312258|364365059|FG000|Overall Study|Missing|2|||
105645989|NCT02312258|364365060|FG001|Overall Study|Missing|1|||
105645990|NCT02312258|364365059|FG000|Overall Study|Death|115|||
105645991|NCT02312258|364365060|FG001|Overall Study|Death|181|||
105645992|NCT01468597|364365062|FG000|Overall Study|Found ineligible|17|||
105645993|NCT01468597|364365062|FG000|Overall Study|concomitant valves|12|||
105645994|NCT01468597|364365062|FG000|Overall Study|off-pump CABG|1|||
105645995|NCT01468597|364365062|FG000|Overall Study|no platelet function data|5|||
105645996|NCT01885559|364365070|FG000|Overall Study|Lost to Follow-up|15|||
105645997|NCT01885559|364365071|FG001|Overall Study|Lost to Follow-up|16|||
105645998|NCT01885559|364365070|FG000|Overall Study|Less than full participation|9|||
105645999|NCT01885559|364365071|FG001|Overall Study|Less than full participation|19|||
105646000|NCT01885559|364365070|FG000|Overall Study|Protocol Violation|0|||
105646001|NCT01885559|364365071|FG001|Overall Study|Protocol Violation|1|||
105646002|NCT01549951|364365076|FG000|Overall Study|Adverse Event|15|||
105646003|NCT01549951|364365076|FG000|Overall Study|Withdrawal by Subject|2|||
105646004|NCT01549951|364365076|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
105646005|NCT01549951|364365076|FG000|Overall Study|Progressive disease|29|||
105646006|NCT01549951|364365076|FG000|Overall Study|Symptomatic deterioration|1|||
105646007|NCT01549951|364365076|FG000|Overall Study|Other|2|||
105646008|NCT02312245|364365079|FG000|Overall Study|Death|0|||
105646009|NCT02312245|364365080|FG001|Overall Study|Death|0|||
105646010|NCT02312245|364365081|FG002|Overall Study|Death|0|||
105646011|NCT02312245|364365082|FG003|Overall Study|Death|1|||
105646012|NCT02312245|364365079|FG000|Overall Study|Withdrawal by Subject|1|||
105646013|NCT02312245|364365080|FG001|Overall Study|Withdrawal by Subject|1|||
105646014|NCT02312245|364365081|FG002|Overall Study|Withdrawal by Subject|0|||
105646015|NCT02312245|364365082|FG003|Overall Study|Withdrawal by Subject|2|||
105646016|NCT02312245|364365079|FG000|Overall Study|Alternative Therapy|1|||
105646017|NCT02312245|364365080|FG001|Overall Study|Alternative Therapy|0|||
105646018|NCT02312245|364365081|FG002|Overall Study|Alternative Therapy|0|||
105646019|NCT02312245|364365082|FG003|Overall Study|Alternative Therapy|0|||
105646020|NCT02312245|364365079|FG000|Overall Study|Progression|0|||
105646021|NCT02312245|364365080|FG001|Overall Study|Progression|0|||
105646022|NCT02312245|364365081|FG002|Overall Study|Progression|0|||
105646023|NCT02312245|364365082|FG003|Overall Study|Progression|5|||
105646024|NCT02312245|364365079|FG000|Overall Study|Patient went to hospice|0|||
105646025|NCT02312245|364365080|FG001|Overall Study|Patient went to hospice|0|||
105646026|NCT02312245|364365081|FG002|Overall Study|Patient went to hospice|0|||
105646027|NCT02312245|364365082|FG003|Overall Study|Patient went to hospice|1|||
105646028|NCT02312245|364365079|FG000|Overall Study|Ineligible|1|||
105646029|NCT02312245|364365080|FG001|Overall Study|Ineligible|0|||
105646030|NCT02312245|364365081|FG002|Overall Study|Ineligible|0|||
105646031|NCT02312245|364365082|FG003|Overall Study|Ineligible|0|||
105646032|NCT01661972|364365083|FG000|Overall Study|Adverse Event|1|||
105646033|NCT01661972|364365084|FG001|Overall Study|Adverse Event|2|||
105646034|NCT01661972|364365083|FG000|Overall Study|Death during Treatment period|1|||
105646035|NCT01661972|364365084|FG001|Overall Study|Death during Treatment period|1|||
105646036|NCT01661972|364365083|FG000|Overall Study|Withdrawal by Subject|0|||
105646037|NCT01661972|364365084|FG001|Overall Study|Withdrawal by Subject|1|||
105646038|NCT03122548|364365087|FG000|Overall Study|Death|2|||
105646039|NCT03122548|364365087|FG000|Overall Study|Progression - subject went into hospice|1|||
105646040|NCT03122548|364365087|FG000|Overall Study|Study Terminated by Sponsor|2|||
105646041|NCT01186809|364365090|FG000|Overall Study|Death|30|||
105646042|NCT05006703|364366866|FG000|Overall Study|Withdrawal by Subject|1|||
105646043|NCT05006703|364366867|FG001|Overall Study|Withdrawal by Subject|0|||
105646044|NCT05006703|364366866|FG000|Overall Study|Lost to Follow-up|13|||
105646045|NCT05006703|364366867|FG001|Overall Study|Lost to Follow-up|5|||
105646046|NCT02121808|364366870|FG000|Overall Study|Technical problem|3|||
105646047|NCT00538629|364366872|FG000|Overall Study|At subject's request|1|||
105646048|NCT00538629|364366872|FG000|Overall Study|Adverse Event|2|||
105646049|NCT00538629|364366872|FG000|Overall Study|Lack of Efficacy|12|||
105646050|NCT00538629|364366872|FG000|Overall Study|Lost to Follow-up|6|||
105646051|NCT00538629|364366872|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
105646052|NCT01540474|364366877|FG000|Vaccination Period|Lost to Follow-up|0|||
105646053|NCT01540474|364366878|FG001|Vaccination Period|Lost to Follow-up|1|||
105646054|NCT01540474|364366879|FG002|Vaccination Period|Lost to Follow-up|0|||
105646055|NCT01540474|364366880|FG003|Vaccination Period|Lost to Follow-up|0|||
105646056|NCT04454125|364366881|FG000|Overall Study|Lost to Follow-up|0|||
105646057|NCT04454125|364366882|FG001|Overall Study|Lost to Follow-up|1|||
105646058|NCT01587703|364366883|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
105646059|NCT01587703|364366884|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646060|NCT01587703|364366885|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646061|NCT01587703|364366886|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646062|NCT01587703|364366887|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646063|NCT01587703|364366888|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646064|NCT01587703|364366889|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646065|NCT01587703|364366890|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646066|NCT01587703|364366891|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646067|NCT01587703|364366892|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646068|NCT01587703|364366893|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646069|NCT01587703|364366894|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646070|NCT01587703|364366895|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646071|NCT01587703|364366896|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646072|NCT01587703|364366897|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646073|NCT01587703|364366898|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646074|NCT01587703|364366899|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646075|NCT01587703|364366900|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646076|NCT01587703|364366901|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
105646077|NCT01587703|364366883|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646078|NCT01587703|364366884|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646079|NCT01587703|364366885|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646080|NCT01587703|364366886|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105870228|NCT01074944|365176969|FG002|Long Term Treatment|Withdrawal by Subject|0|||
105870229|NCT01074944|365176970|FG003|Long Term Treatment|Withdrawal by Subject|2|||
105646081|NCT01587703|364366887|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646082|NCT01587703|364366888|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
105646083|NCT01587703|364366889|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646084|NCT01587703|364366890|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
105646085|NCT01587703|364366891|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646086|NCT01587703|364366892|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646087|NCT01587703|364366893|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646088|NCT01587703|364366894|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646089|NCT01587703|364366895|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646090|NCT01587703|364366896|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646091|NCT01587703|364366897|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646092|NCT01587703|364366898|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646093|NCT01587703|364366899|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646094|NCT01587703|364366900|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646095|NCT01587703|364366901|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
105646096|NCT01587703|364366883|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646097|NCT01587703|364366884|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646098|NCT01587703|364366885|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646099|NCT01587703|364366886|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646100|NCT01587703|364366887|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646101|NCT01587703|364366888|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646102|NCT01587703|364366889|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
105646103|NCT01587703|364366890|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646104|NCT01587703|364366891|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646105|NCT01587703|364366892|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646106|NCT01587703|364366893|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646107|NCT01587703|364366894|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646108|NCT01587703|364366895|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646109|NCT01587703|364366896|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646110|NCT01587703|364366897|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646111|NCT01587703|364366898|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646112|NCT01587703|364366899|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646113|NCT01587703|364366900|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646114|NCT01587703|364366901|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
105646115|NCT01587703|364366883|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
105646116|NCT01587703|364366884|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
105646117|NCT01587703|364366885|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
105646118|NCT01587703|364366886|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
105646119|NCT01587703|364366887|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
105646120|NCT01587703|364366888|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
105646121|NCT01587703|364366889|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
105646122|NCT01587703|364366890|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
105646123|NCT01587703|364366891|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646124|NCT01587703|364366892|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646125|NCT01587703|364366893|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646126|NCT01587703|364366894|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646127|NCT01587703|364366895|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646128|NCT01587703|364366896|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646129|NCT01587703|364366897|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646130|NCT01587703|364366898|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646131|NCT01587703|364366899|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646132|NCT01587703|364366900|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646133|NCT01587703|364366901|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
105646134|NCT01587703|364366883|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646135|NCT01587703|364366884|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646136|NCT01587703|364366885|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646137|NCT01587703|364366886|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646138|NCT01587703|364366887|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646139|NCT01587703|364366888|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646140|NCT01587703|364366889|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646141|NCT01587703|364366890|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646142|NCT01587703|364366891|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
105646143|NCT01587703|364366892|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
105646144|NCT01587703|364366893|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
105646145|NCT01587703|364366894|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646146|NCT01587703|364366895|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646147|NCT01587703|364366896|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646148|NCT01587703|364366897|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646149|NCT01587703|364366898|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646150|NCT01587703|364366899|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646151|NCT01587703|364366900|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646152|NCT01587703|364366901|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
105646153|NCT01587703|364366883|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646154|NCT01587703|364366884|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646155|NCT01587703|364366885|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646156|NCT01587703|364366886|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646157|NCT01587703|364366887|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646158|NCT01587703|364366888|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646159|NCT01587703|364366889|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646160|NCT01587703|364366890|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646161|NCT01587703|364366891|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
105646162|NCT01587703|364366892|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646163|NCT01587703|364366893|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
105646164|NCT01587703|364366894|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646165|NCT01587703|364366895|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646166|NCT01587703|364366896|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646167|NCT01587703|364366897|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646168|NCT01587703|364366898|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646169|NCT01587703|364366899|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646170|NCT01587703|364366900|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646171|NCT01587703|364366901|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
105646172|NCT01587703|364366883|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646173|NCT01587703|364366884|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646174|NCT01587703|364366885|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646175|NCT01587703|364366886|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646176|NCT01587703|364366887|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646177|NCT01587703|364366888|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646178|NCT01587703|364366889|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646179|NCT01587703|364366890|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646180|NCT01587703|364366891|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646181|NCT01587703|364366892|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
105646182|NCT01587703|364366893|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
105646183|NCT01587703|364366894|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646184|NCT01587703|364366895|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646185|NCT01587703|364366896|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646186|NCT01587703|364366897|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646187|NCT01587703|364366898|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646188|NCT01587703|364366899|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646189|NCT01587703|364366900|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646190|NCT01587703|364366901|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
105646191|NCT01587703|364366883|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646192|NCT01587703|364366884|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646193|NCT01587703|364366885|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646194|NCT01587703|364366886|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646195|NCT01587703|364366887|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646196|NCT01587703|364366888|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646197|NCT01587703|364366889|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646198|NCT01587703|364366890|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646199|NCT01587703|364366891|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
105646200|NCT01587703|364366892|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646201|NCT01587703|364366893|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646202|NCT01587703|364366894|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646203|NCT01587703|364366895|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646204|NCT01587703|364366896|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646205|NCT01587703|364366897|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646206|NCT01587703|364366898|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646207|NCT01587703|364366899|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646208|NCT01587703|364366900|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646209|NCT01587703|364366901|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
105646210|NCT01587703|364366883|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646211|NCT01587703|364366884|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646212|NCT01587703|364366885|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646213|NCT01587703|364366886|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646214|NCT01587703|364366887|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646215|NCT01587703|364366888|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646216|NCT01587703|364366889|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646217|NCT01587703|364366890|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646218|NCT01587703|364366891|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646219|NCT01587703|364366892|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646220|NCT01587703|364366893|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646221|NCT01587703|364366894|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646222|NCT01587703|364366895|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646223|NCT01587703|364366896|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646224|NCT01587703|364366897|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646225|NCT01587703|364366898|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646226|NCT01587703|364366899|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646227|NCT01587703|364366900|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
105646228|NCT01587703|364366901|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
105646229|NCT01587703|364366883|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646230|NCT01587703|364366884|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646231|NCT01587703|364366885|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646232|NCT01587703|364366886|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646233|NCT01587703|364366887|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646234|NCT01587703|364366888|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646235|NCT01587703|364366889|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646236|NCT01587703|364366890|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646237|NCT01587703|364366891|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646238|NCT01587703|364366892|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646239|NCT01587703|364366893|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646240|NCT01587703|364366894|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646241|NCT01587703|364366895|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646242|NCT01587703|364366896|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646243|NCT01587703|364366897|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646244|NCT01587703|364366898|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646245|NCT01587703|364366899|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
105646246|NCT01587703|364366900|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
105646247|NCT01587703|364366901|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
105646248|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646249|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646250|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646251|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646252|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646253|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646254|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646255|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646256|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646257|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646258|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646259|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646260|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646261|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646262|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646263|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
105646264|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646265|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646266|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
105646267|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646268|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646269|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646270|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646271|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646272|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646273|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646274|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646275|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646276|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646277|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646278|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
105646279|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646280|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646281|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
105646282|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646283|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646284|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646285|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
105646286|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646287|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646288|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646289|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646290|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646291|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646292|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646293|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646294|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646295|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646296|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646297|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
105646298|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
105646299|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
105646300|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
105646301|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
105646302|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
105646303|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646304|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
105646305|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646306|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646307|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646308|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646309|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646310|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646311|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646312|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646313|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646314|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646315|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646316|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
105646317|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
105646318|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
105646319|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
105646320|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
105646321|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
105646322|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646323|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
105646324|NCT01587703|364366883|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646325|NCT01587703|364366884|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646326|NCT01587703|364366885|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646327|NCT01587703|364366886|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646328|NCT01587703|364366887|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646329|NCT01587703|364366888|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646330|NCT01587703|364366889|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646331|NCT01587703|364366890|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646332|NCT01587703|364366891|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646333|NCT01587703|364366892|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646334|NCT01587703|364366893|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646335|NCT01587703|364366894|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
105646336|NCT01587703|364366895|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646337|NCT01587703|364366896|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646338|NCT01587703|364366897|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646339|NCT01587703|364366898|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646340|NCT01587703|364366899|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646341|NCT01587703|364366900|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646342|NCT01587703|364366901|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
105646343|NCT01922102|364366902|FG000|Overall Study|Withdrawal by Subject|7|||
105646344|NCT01922102|364366903|FG001|Overall Study|Withdrawal by Subject|3|||
105646345|NCT01922102|364366904|FG002|Overall Study|Withdrawal by Subject|7|||
105646346|NCT01922102|364366902|FG000|Overall Study|Physician Decision|0|||
105646347|NCT01922102|364366903|FG001|Overall Study|Physician Decision|2|||
105646348|NCT01922102|364366904|FG002|Overall Study|Physician Decision|1|||
105646349|NCT01922102|364366902|FG000|Overall Study|Adverse Event|1|||
105646350|NCT01922102|364366903|FG001|Overall Study|Adverse Event|2|||
105646351|NCT01922102|364366904|FG002|Overall Study|Adverse Event|0|||
105646352|NCT01922102|364366902|FG000|Overall Study|Lost to Follow-up|1|||
105646353|NCT01922102|364366903|FG001|Overall Study|Lost to Follow-up|0|||
105646354|NCT01922102|364366904|FG002|Overall Study|Lost to Follow-up|0|||
105646355|NCT01922102|364366902|FG000|Overall Study|Administrative problems|0|||
105646356|NCT01922102|364366903|FG001|Overall Study|Administrative problems|2|||
105646357|NCT01922102|364366904|FG002|Overall Study|Administrative problems|0|||
105646358|NCT01799993|364366905|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
105646359|NCT01799993|364366906|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
105646360|NCT01799993|364366905|FG000|Overall Study|Death|61|||
105646361|NCT01799993|364366906|FG001|Overall Study|Death|45|||
105646362|NCT01799993|364366905|FG000|Overall Study|Withdrawal by Subject|23|||
105646363|NCT01799993|364366906|FG001|Overall Study|Withdrawal by Subject|24|||
105646364|NCT01799993|364366905|FG000|Overall Study|Lost to Follow-up|5|||
105646365|NCT01799993|364366906|FG001|Overall Study|Lost to Follow-up|8|||
105646366|NCT01799993|364366905|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
105646367|NCT01799993|364366906|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
105646368|NCT01799993|364366905|FG000|Overall Study|Protocol driven decision point|0|||
105646369|NCT01799993|364366906|FG001|Overall Study|Protocol driven decision point|3|||
105646370|NCT01799993|364366905|FG000|Overall Study|Protocol Violation|1|||
105646371|NCT01799993|364366906|FG001|Overall Study|Protocol Violation|1|||
105646372|NCT01799993|364366905|FG000|Overall Study|Deterioration of general conditions|2|||
105646373|NCT01799993|364366906|FG001|Overall Study|Deterioration of general conditions|0|||
105646374|NCT01799993|364366905|FG000|Overall Study|Screen failure|0|||
105646375|NCT01799993|364366906|FG001|Overall Study|Screen failure|1|||
105646376|NCT01799993|364366905|FG000|Overall Study|Adverse Event|1|||
105646377|NCT01799993|364366906|FG001|Overall Study|Adverse Event|0|||
105646378|NCT01799993|364366905|FG000|Overall Study|Lack of Efficacy|1|||
105646379|NCT01799993|364366906|FG001|Overall Study|Lack of Efficacy|0|||
105646380|NCT01799993|364366905|FG000|Overall Study|Recovery|0|||
105646381|NCT01799993|364366906|FG001|Overall Study|Recovery|1|||
105646382|NCT01799993|364366905|FG000|Overall Study|Logistical difficulties|1|||
105646383|NCT01799993|364366906|FG001|Overall Study|Logistical difficulties|0|||
105646384|NCT01799993|364366905|FG000|Overall Study|Protocol deviation|1|||
105646385|NCT01799993|364366906|FG001|Overall Study|Protocol deviation|0|||
105646386|NCT01799993|364366905|FG000|Overall Study|Non-compliance with medical device|1|||
105646387|NCT01799993|364366906|FG001|Overall Study|Non-compliance with medical device|0|||
105646388|NCT01799993|364366905|FG000|Overall Study|Withdrawal by parent/guardian|0|||
105646389|NCT01799993|364366906|FG001|Overall Study|Withdrawal by parent/guardian|1|||
105646390|NCT01799993|364366905|FG000|Overall Study|Other|1|||
105646391|NCT01799993|364366906|FG001|Overall Study|Other|0|||
105646392|NCT01799993|364366905|FG000|Overall Study|Subject didn't return for follow-up|0|||
105646393|NCT01799993|364366906|FG001|Overall Study|Subject didn't return for follow-up|1|||
105646394|NCT01816165|364366907|FG000|Overall Study|Adverse Event|1|||
105646395|NCT01816165|364366908|FG001|Overall Study|Adverse Event|0|||
105646396|NCT01816165|364366909|FG002|Overall Study|Adverse Event|0|||
105646397|NCT01816165|364366910|FG003|Overall Study|Adverse Event|0|||
105646398|NCT00759681|364366913|FG000|Overall Study|Death|2|||
105646399|NCT00759681|364366914|FG001|Overall Study|Death|5|||
105646400|NCT00759681|364366913|FG000|Overall Study|Lost to Follow-up|8|||
105646401|NCT00759681|364366914|FG001|Overall Study|Lost to Follow-up|5|||
105646402|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
105646403|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
105646404|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
105646405|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
105646406|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
105646407|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
105646408|NCT03557307|364366917|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
105646409|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
105646410|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Death|3|||
105646411|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
105646412|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
105646413|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
105646414|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
105646415|NCT03557307|364366917|FG000|Period 2: Maintenance Phase|other|3|||
105646416|NCT01322347|364366918|FG000|Overall Study|Adverse Event|7|||
105646417|NCT01322347|364366919|FG001|Overall Study|Adverse Event|2|||
105646418|NCT01322347|364366918|FG000|Overall Study|Death|5|||
105646419|NCT01322347|364366919|FG001|Overall Study|Death|3|||
105646420|NCT01322347|364366918|FG000|Overall Study|Physician Decision|2|||
105646421|NCT01322347|364366919|FG001|Overall Study|Physician Decision|1|||
105646422|NCT01322347|364366918|FG000|Overall Study|Protocol Violation|5|||
105646423|NCT01322347|364366919|FG001|Overall Study|Protocol Violation|2|||
105646424|NCT01322347|364366918|FG000|Overall Study|Withdrawal by Subject|1|||
105646425|NCT01322347|364366919|FG001|Overall Study|Withdrawal by Subject|4|||
105646426|NCT01322347|364366918|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
105646427|NCT01322347|364366919|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
105646428|NCT01322347|364366918|FG000|Overall Study|blood transfusion|5|||
105646429|NCT01322347|364366919|FG001|Overall Study|blood transfusion|5|||
105646430|NCT01322347|364366918|FG000|Overall Study|sponsor decision|1|||
105646431|NCT01322347|364366919|FG001|Overall Study|sponsor decision|3|||
105646432|NCT01322347|364366918|FG000|Overall Study|ineligible|6|||
105646433|NCT01322347|364366919|FG001|Overall Study|ineligible|3|||
105646434|NCT01322347|364366918|FG000|Overall Study|kidney transplant|3|||
105646435|NCT01322347|364366919|FG001|Overall Study|kidney transplant|1|||
105646436|NCT01322347|364366918|FG000|Overall Study|study drug withheld > 12 wks|0|||
105646437|NCT01322347|364366919|FG001|Overall Study|study drug withheld > 12 wks|1|||
105646438|NCT01322347|364366918|FG000|Overall Study|moved/changed dialysis|2|||
105646439|NCT01322347|364366919|FG001|Overall Study|moved/changed dialysis|4|||
105646440|NCT04883541|364366920|FG000|Overall Study|Not attending regular yoga class|16|||
105646441|NCT04883541|364366921|FG001|Overall Study|Not attending regular yoga class|0|||
105646442|NCT04883541|364366920|FG000|Overall Study|Not attending the pregnancy school|0|||
105646443|NCT04883541|364366921|FG001|Overall Study|Not attending the pregnancy school|9|||
105646444|NCT00590759|364366926|FG000|Overall Study|Death|52|||
105646445|NCT00590759|364366926|FG000|Overall Study|Lost to Follow-up|28|||
105646446|NCT03345407|364366927|FG000|Overall Study|Withdrawal by Subject|11|||
105646447|NCT03345407|364366928|FG001|Overall Study|Withdrawal by Subject|1|||
105646448|NCT03345407|364366929|FG002|Overall Study|Withdrawal by Subject|5|||
105646449|NCT03345407|364366930|FG003|Overall Study|Withdrawal by Subject|6|||
105646450|NCT03345407|364366931|FG004|Overall Study|Withdrawal by Subject|3|||
105646451|NCT03345407|364366932|FG005|Overall Study|Withdrawal by Subject|6|||
105646452|NCT03345407|364366933|FG006|Overall Study|Withdrawal by Subject|16|||
105646453|NCT03345407|364366927|FG000|Overall Study|Physician Decision|3|||
105646454|NCT03345407|364366928|FG001|Overall Study|Physician Decision|1|||
105646455|NCT03345407|364366929|FG002|Overall Study|Physician Decision|0|||
105646456|NCT03345407|364366930|FG003|Overall Study|Physician Decision|0|||
105646457|NCT03345407|364366931|FG004|Overall Study|Physician Decision|1|||
105646458|NCT03345407|364366932|FG005|Overall Study|Physician Decision|2|||
105646459|NCT03345407|364366933|FG006|Overall Study|Physician Decision|3|||
105646460|NCT03345407|364366927|FG000|Overall Study|Lost to Follow-up|2|||
105646461|NCT03345407|364366928|FG001|Overall Study|Lost to Follow-up|0|||
105646462|NCT03345407|364366929|FG002|Overall Study|Lost to Follow-up|1|||
105646463|NCT03345407|364366930|FG003|Overall Study|Lost to Follow-up|0|||
105646464|NCT03345407|364366931|FG004|Overall Study|Lost to Follow-up|1|||
105646465|NCT03345407|364366932|FG005|Overall Study|Lost to Follow-up|2|||
105646466|NCT03345407|364366933|FG006|Overall Study|Lost to Follow-up|3|||
105646467|NCT03345407|364366927|FG000|Overall Study|Protocol-defined stopping criteria|9|||
105646468|NCT03345407|364366928|FG001|Overall Study|Protocol-defined stopping criteria|0|||
105646469|NCT03345407|364366929|FG002|Overall Study|Protocol-defined stopping criteria|0|||
105646470|NCT03345407|364366930|FG003|Overall Study|Protocol-defined stopping criteria|0|||
105646471|NCT03345407|364366931|FG004|Overall Study|Protocol-defined stopping criteria|2|||
105646472|NCT03345407|364366932|FG005|Overall Study|Protocol-defined stopping criteria|1|||
105646473|NCT03345407|364366933|FG006|Overall Study|Protocol-defined stopping criteria|1|||
105646474|NCT03345407|364366927|FG000|Overall Study|Protocol Violation|2|||
105646475|NCT03345407|364366928|FG001|Overall Study|Protocol Violation|0|||
105646476|NCT03345407|364366929|FG002|Overall Study|Protocol Violation|0|||
105646477|NCT03345407|364366930|FG003|Overall Study|Protocol Violation|0|||
105646478|NCT03345407|364366931|FG004|Overall Study|Protocol Violation|1|||
105646479|NCT03345407|364366932|FG005|Overall Study|Protocol Violation|0|||
105646480|NCT03345407|364366933|FG006|Overall Study|Protocol Violation|3|||
105646481|NCT03345407|364366927|FG000|Overall Study|Lack of Efficacy|1|||
105646482|NCT03345407|364366928|FG001|Overall Study|Lack of Efficacy|1|||
105646483|NCT03345407|364366929|FG002|Overall Study|Lack of Efficacy|1|||
105646484|NCT03345407|364366930|FG003|Overall Study|Lack of Efficacy|1|||
105646485|NCT03345407|364366931|FG004|Overall Study|Lack of Efficacy|1|||
105646486|NCT03345407|364366932|FG005|Overall Study|Lack of Efficacy|0|||
105646487|NCT03345407|364366933|FG006|Overall Study|Lack of Efficacy|3|||
105646488|NCT03345407|364366927|FG000|Overall Study|Adverse Event|4|||
105646489|NCT03345407|364366928|FG001|Overall Study|Adverse Event|0|||
105646490|NCT03345407|364366929|FG002|Overall Study|Adverse Event|5|||
105646491|NCT03345407|364366930|FG003|Overall Study|Adverse Event|4|||
105646492|NCT03345407|364366931|FG004|Overall Study|Adverse Event|6|||
105646493|NCT03345407|364366932|FG005|Overall Study|Adverse Event|5|||
105646494|NCT03345407|364366933|FG006|Overall Study|Adverse Event|16|||
105646495|NCT01077284|364366938|FG000|Overall Study|Adverse Event|2|||
105646496|NCT01077284|364366939|FG001|Overall Study|Adverse Event|0|||
105646497|NCT01077284|364366940|FG002|Overall Study|Adverse Event|1|||
105646498|NCT01077284|364366938|FG000|Overall Study|Lost to Follow-up|1|||
105646499|NCT01077284|364366939|FG001|Overall Study|Lost to Follow-up|2|||
105646500|NCT01077284|364366940|FG002|Overall Study|Lost to Follow-up|0|||
105646501|NCT01077284|364366938|FG000|Overall Study|Withdrawal by Subject|2|||
105646502|NCT01077284|364366939|FG001|Overall Study|Withdrawal by Subject|3|||
105646503|NCT01077284|364366940|FG002|Overall Study|Withdrawal by Subject|1|||
105646504|NCT01077284|364366938|FG000|Overall Study|Other|0|||
105646505|NCT01077284|364366939|FG001|Overall Study|Other|0|||
105646506|NCT01077284|364366940|FG002|Overall Study|Other|1|||
105646507|NCT01180400|364366941|FG000|Overall Study|Withdrawal by Subject|5|||
105646508|NCT01180400|364366942|FG001|Overall Study|Withdrawal by Subject|6|||
105646509|NCT01180400|364366941|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
105646510|NCT01180400|364366942|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
105646511|NCT01180400|364366941|FG000|Overall Study|Adverse Event|12|||
105646512|NCT01180400|364366942|FG001|Overall Study|Adverse Event|10|||
105646513|NCT01180400|364366941|FG000|Overall Study|Severe non-compliance to protocol|1|||
105646514|NCT01180400|364366942|FG001|Overall Study|Severe non-compliance to protocol|2|||
105646515|NCT01180400|364366941|FG000|Overall Study|Condition under investigation worsened|2|||
105646516|NCT01180400|364366942|FG001|Overall Study|Condition under investigation worsened|1|||
105646517|NCT01180400|364366941|FG000|Overall Study|Lack of Efficacy|2|||
105646518|NCT01180400|364366942|FG001|Overall Study|Lack of Efficacy|0|||
105646519|NCT01180400|364366941|FG000|Overall Study|Study-specific withdrawal criteria|1|||
105646520|NCT01180400|364366942|FG001|Overall Study|Study-specific withdrawal criteria|2|||
105646521|NCT01180400|364366941|FG000|Overall Study|Lost to Follow-up|2|||
105646522|NCT01180400|364366942|FG001|Overall Study|Lost to Follow-up|3|||
105646523|NCT01180400|364366941|FG000|Overall Study|Other|0|||
105646524|NCT01180400|364366942|FG001|Overall Study|Other|1|||
105646525|NCT02812706|364366943|FG000|Phase 1|Adverse Event|0|||
105646526|NCT02812706|364366944|FG001|Phase 1|Adverse Event|2|||
105646527|NCT02812706|364366945|FG002|Phase 1|Adverse Event|0|||
105646528|NCT02812706|364366943|FG000|Phase 1|Progressive disease|3|||
105646529|NCT02812706|364366944|FG001|Phase 1|Progressive disease|3|||
105646530|NCT02812706|364366945|FG002|Phase 1|Progressive disease|0|||
105646531|NCT02812706|364366943|FG000|Phase 2|Adverse Event|0|||
105646532|NCT02812706|364366944|FG001|Phase 2|Adverse Event|0|||
105646533|NCT02812706|364366945|FG002|Phase 2|Adverse Event|2|||
105646534|NCT02812706|364366943|FG000|Phase 2|Progressive disease|0|||
105646535|NCT02812706|364366944|FG001|Phase 2|Progressive disease|0|||
105646536|NCT02812706|364366945|FG002|Phase 2|Progressive disease|22|||
105646537|NCT02812706|364366943|FG000|Phase 2|Other-Unspecified|0|||
105646538|NCT02812706|364366944|FG001|Phase 2|Other-Unspecified|0|||
105646539|NCT02812706|364366945|FG002|Phase 2|Other-Unspecified|4|||
105646540|NCT01989156|364366946|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
105646541|NCT01989156|364366947|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
105646542|NCT01989156|364366948|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
105646543|NCT01989156|364366946|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
105646544|NCT01989156|364366947|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
105646545|NCT01989156|364366948|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
105646546|NCT01989156|364366946|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
105646547|NCT01989156|364366947|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
105646548|NCT01989156|364366948|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
105646549|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
105646550|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
105646551|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
105646552|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
105646553|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
105646554|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
105646555|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
105646556|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
105646557|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
105646558|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
105646559|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
105646560|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
105646561|NCT01989156|364366946|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
105646562|NCT01989156|364366947|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
105646563|NCT01989156|364366948|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
105646564|NCT00665392|364366949|FG000|Overall Study|not treated|1|||
105646565|NCT05740371|364366951|FG000|Overall Study|Death|1|||
105646566|NCT03953079|364366952|FG000|Core Study|Withdrawal by Subject|1|||
105646567|NCT03953079|364366953|FG001|Core Study|Withdrawal by Subject|2|||
105646568|NCT03953079|364366954|FG002|Core Study|Withdrawal by Subject|1|||
105646569|NCT03953079|364366952|FG000|Core Study|COVID-19|0|||
105646570|NCT03953079|364366953|FG001|Core Study|COVID-19|1|||
105646571|NCT03953079|364366954|FG002|Core Study|COVID-19|0|||
105646572|NCT03953079|364366952|FG000|Core Study|Difficulties leaving the house|0|||
105646573|NCT03953079|364366953|FG001|Core Study|Difficulties leaving the house|1|||
105646574|NCT03953079|364366954|FG002|Core Study|Difficulties leaving the house|0|||
105646575|NCT03953079|364366952|FG000|Extension Study|Withdrawal by Subject|1|||
105646576|NCT03953079|364366953|FG001|Extension Study|Withdrawal by Subject|0|||
105646577|NCT03953079|364366954|FG002|Extension Study|Withdrawal by Subject|0|||
105646578|NCT03953079|364366952|FG000|Extension Study|Received Rescue Treatment|5|||
105646579|NCT03953079|364366953|FG001|Extension Study|Received Rescue Treatment|6|||
105646580|NCT03953079|364366954|FG002|Extension Study|Received Rescue Treatment|5|||
105646581|NCT00141271|364366956|FG000|Overall Study|Adverse Event|31|||
105646582|NCT00141271|364366957|FG001|Overall Study|Adverse Event|19|||
105646583|NCT00141271|364366958|FG002|Overall Study|Adverse Event|17|||
105646584|NCT00141271|364366956|FG000|Overall Study|Laboratory Abnormality|2|||
105646585|NCT00141271|364366957|FG001|Overall Study|Laboratory Abnormality|1|||
105646586|NCT00141271|364366958|FG002|Overall Study|Laboratory Abnormality|1|||
105646587|NCT00141271|364366956|FG000|Overall Study|Lack of Efficacy|7|||
105646588|NCT00141271|364366957|FG001|Overall Study|Lack of Efficacy|7|||
105646589|NCT00141271|364366958|FG002|Overall Study|Lack of Efficacy|3|||
105646590|NCT00141271|364366956|FG000|Overall Study|Lost to Follow-up|15|||
105646591|NCT00141271|364366957|FG001|Overall Study|Lost to Follow-up|15|||
105646592|NCT00141271|364366958|FG002|Overall Study|Lost to Follow-up|21|||
105646593|NCT00141271|364366956|FG000|Overall Study|Withdrawal by Subject|14|||
105646594|NCT00141271|364366957|FG001|Overall Study|Withdrawal by Subject|9|||
105646595|NCT00141271|364366958|FG002|Overall Study|Withdrawal by Subject|10|||
105646596|NCT00141271|364366956|FG000|Overall Study|Other|11|||
105646597|NCT00141271|364366957|FG001|Overall Study|Other|12|||
105646598|NCT00141271|364366958|FG002|Overall Study|Other|5|||
105646599|NCT01052714|364366961|FG000|Overall Study|Adverse Event|6|||
105646600|NCT01052714|364366962|FG001|Overall Study|Adverse Event|3|||
105646601|NCT01052714|364366963|FG002|Overall Study|Adverse Event|0|||
105646602|NCT01052714|364366961|FG000|Overall Study|Death|1|||
105646603|NCT01052714|364366962|FG001|Overall Study|Death|2|||
105646604|NCT01052714|364366963|FG002|Overall Study|Death|0|||
105646605|NCT01052714|364366961|FG000|Overall Study|Lost to Follow-up|2|||
105646606|NCT01052714|364366962|FG001|Overall Study|Lost to Follow-up|3|||
105646607|NCT01052714|364366963|FG002|Overall Study|Lost to Follow-up|0|||
105646608|NCT01052714|364366961|FG000|Overall Study|Physician Decision|9|||
105646609|NCT01052714|364366962|FG001|Overall Study|Physician Decision|9|||
105646610|NCT01052714|364366963|FG002|Overall Study|Physician Decision|1|||
105646611|NCT01052714|364366961|FG000|Overall Study|Withdrawal by Subject|7|||
105646612|NCT01052714|364366962|FG001|Overall Study|Withdrawal by Subject|12|||
105646613|NCT01052714|364366963|FG002|Overall Study|Withdrawal by Subject|1|||
105646614|NCT00525915|364366971|FG000|Overall Study|Non-Compliance|0|||
105646615|NCT00525915|364366972|FG001|Overall Study|Non-Compliance|1|||
105646616|NCT00525915|364366971|FG000|Overall Study|Disease Progression|5|||
105646617|NCT00525915|364366972|FG001|Overall Study|Disease Progression|6|||
105646618|NCT00525915|364366971|FG000|Overall Study|Withdrawal by Subject|1|||
105646619|NCT00525915|364366972|FG001|Overall Study|Withdrawal by Subject|0|||
105646620|NCT00525915|364366971|FG000|Overall Study|Refused Surgery|1|||
105646621|NCT00525915|364366972|FG001|Overall Study|Refused Surgery|2|||
105646622|NCT00525915|364366971|FG000|Overall Study|Unrelated illness|1|||
105646623|NCT00525915|364366972|FG001|Overall Study|Unrelated illness|0|||
105646624|NCT00732498|364366973|FG000|Overall Study|Ineligible|1|||
105646625|NCT00732498|364366973|FG000|Overall Study|Adverse Event|2|||
105646626|NCT00732498|364366973|FG000|Overall Study|Physician Decision|3|||
105646627|NCT02332889|364366979|FG000|Overall Study|Physician Decision|1|||
105646628|NCT02135445|364366981|FG000|Overall Study|Lost to Follow-up|1|||
105646629|NCT02135445|364366982|FG001|Overall Study|Lost to Follow-up|0|||
105646630|NCT02135445|364366981|FG000|Overall Study|Withdrawal by Subject|1|||
105646631|NCT02135445|364366982|FG001|Overall Study|Withdrawal by Subject|0|||
105646632|NCT04448561|364366988|FG000|Overall Study|Noncompliance|1|||
105646633|NCT04448561|364366989|FG001|Overall Study|Noncompliance|0|||
105646634|NCT03978130|364368188|FG000|Overall Study|Lost to Follow-up|13|||
105646635|NCT03978130|364368189|FG001|Overall Study|Lost to Follow-up|14|||
105646636|NCT03978130|364368188|FG000|Overall Study|Withdrawal by Subject|12|||
105646637|NCT03978130|364368189|FG001|Overall Study|Withdrawal by Subject|2|||
105646638|NCT03978130|364368188|FG000|Overall Study|Adverse Event|2|||
105646639|NCT03978130|364368189|FG001|Overall Study|Adverse Event|1|||
105646640|NCT05356130|364368190|FG000|Overall Study|Withdrawal by Subject|0|||
105646641|NCT05356130|364368191|FG001|Overall Study|Withdrawal by Subject|0|||
105646642|NCT05356130|364368192|FG002|Overall Study|Withdrawal by Subject|3|||
105646643|NCT03141177|364368193|FG000|Overall Study|Death|62|||
105646644|NCT03141177|364368194|FG001|Overall Study|Death|13|||
105646645|NCT03141177|364368195|FG002|Overall Study|Death|84|||
105646646|NCT03141177|364368193|FG000|Overall Study|Participant withdrew consent|9|||
105646647|NCT03141177|364368194|FG001|Overall Study|Participant withdrew consent|2|||
105646648|NCT03141177|364368195|FG002|Overall Study|Participant withdrew consent|13|||
105646649|NCT03141177|364368193|FG000|Overall Study|Not reported|1|||
105646650|NCT03141177|364368194|FG001|Overall Study|Not reported|0|||
105646651|NCT03141177|364368195|FG002|Overall Study|Not reported|1|||
105646652|NCT03141177|364368193|FG000|Overall Study|Lost to Follow-up|2|||
105646653|NCT03141177|364368194|FG001|Overall Study|Lost to Follow-up|1|||
105646654|NCT03141177|364368195|FG002|Overall Study|Lost to Follow-up|1|||
105646655|NCT03141177|364368193|FG000|Overall Study|Other reasons|4|||
105646656|NCT03141177|364368194|FG001|Overall Study|Other reasons|0|||
105646657|NCT03141177|364368195|FG002|Overall Study|Other reasons|11|||
105646658|NCT03141177|364368193|FG000|Overall Study|Participants did not start treatment period|3|||
105646659|NCT03141177|364368194|FG001|Overall Study|Participants did not start treatment period|0|||
105646660|NCT03141177|364368195|FG002|Overall Study|Participants did not start treatment period|8|||
105646661|NCT04620733|364368198|FG000|Overall Study|Adverse Event|4|||
105646662|NCT04620733|364368199|FG001|Overall Study|Adverse Event|3|||
105646663|NCT04620733|364368198|FG000|Overall Study|Withdrawal by Subject|2|||
105646664|NCT04620733|364368199|FG001|Overall Study|Withdrawal by Subject|5|||
105646665|NCT04620733|364368198|FG000|Overall Study|Lost to Follow-up|1|||
105646666|NCT04620733|364368199|FG001|Overall Study|Lost to Follow-up|1|||
105646667|NCT04620733|364368198|FG000|Overall Study|Protocol Deviation|1|||
105646668|NCT04620733|364368199|FG001|Overall Study|Protocol Deviation|1|||
105646669|NCT04620733|364368198|FG000|Overall Study|Reason Not Specified|0|||
105646670|NCT04620733|364368199|FG001|Overall Study|Reason Not Specified|1|||
105646671|NCT01350102|364368202|FG000|Overall Study|Adverse Event|0|||
105646672|NCT01350102|364368203|FG001|Overall Study|Adverse Event|0|||
105646673|NCT01350102|364368204|FG002|Overall Study|Adverse Event|1|||
105646674|NCT01350102|364368205|FG003|Overall Study|Adverse Event|0|||
105646675|NCT02136797|364368208|FG000|Overall Study|Not Treated|8|||
105646676|NCT03924193|364368214|FG000|Overall Study|Adverse Event|10|||
105646677|NCT03924193|364368215|FG001|Overall Study|Adverse Event|0|||
105646678|NCT03924193|364368216|FG002|Overall Study|Adverse Event|10|||
105646679|NCT03924193|364368214|FG000|Overall Study|Withdrawal by Subject|5|||
105646680|NCT03924193|364368215|FG001|Overall Study|Withdrawal by Subject|10|||
105646681|NCT03924193|364368216|FG002|Overall Study|Withdrawal by Subject|2|||
105646682|NCT01863368|364368217|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
105646683|NCT01863368|364368218|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
105646684|NCT01863368|364368217|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
105646685|NCT01863368|364368218|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
105646686|NCT01863368|364368217|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
105646687|NCT01863368|364368218|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
105646688|NCT01863368|364368217|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
105646689|NCT01863368|364368218|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
105646690|NCT01863368|364368217|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
105646691|NCT01863368|364368218|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
105646692|NCT01863368|364368217|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
105646693|NCT01863368|364368218|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
105870230|NCT01074944|365176971|FG004|Long Term Treatment|Withdrawal by Subject|0|||
105870231|NCT01074944|365176967|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
105870232|NCT01074944|365176968|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
105870233|NCT01074944|365176969|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
105870234|NCT01074944|365176970|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
105870235|NCT01074944|365176971|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
105870236|NCT01074944|365176967|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
105870237|NCT01074944|365176968|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
105870238|NCT01074944|365176969|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
105870239|NCT01074944|365176970|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
105870240|NCT01074944|365176971|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
105870241|NCT00852202|365176972|FG000|Overall Study|Adverse Event|2|||
105870242|NCT00852202|365176973|FG001|Overall Study|Adverse Event|3|||
105870243|NCT00852202|365176974|FG002|Overall Study|Adverse Event|7|||
105870244|NCT00852202|365176972|FG000|Overall Study|Lack of Efficacy|4|||
105870245|NCT00852202|365176973|FG001|Overall Study|Lack of Efficacy|1|||
105870246|NCT00852202|365176974|FG002|Overall Study|Lack of Efficacy|2|||
105870247|NCT00852202|365176972|FG000|Overall Study|Protocol Violation|2|||
105870248|NCT00852202|365176973|FG001|Overall Study|Protocol Violation|2|||
105870249|NCT00852202|365176974|FG002|Overall Study|Protocol Violation|7|||
105870250|NCT00852202|365176972|FG000|Overall Study|Withdrawal by Subject|3|||
105870251|NCT00852202|365176973|FG001|Overall Study|Withdrawal by Subject|1|||
105870252|NCT00852202|365176974|FG002|Overall Study|Withdrawal by Subject|2|||
105870253|NCT00852202|365176972|FG000|Overall Study|Lost to Follow-up|5|||
105870254|NCT00852202|365176973|FG001|Overall Study|Lost to Follow-up|5|||
105870255|NCT00852202|365176974|FG002|Overall Study|Lost to Follow-up|6|||
105870256|NCT00852202|365176972|FG000|Overall Study|pregnancy,moving away and surgery|1|||
105646694|NCT04049578|364368220|FG000|Overall Study|Physician Decision|1|||
105646695|NCT02092285|364368223|FG000|Induction Phase|Adverse Event|7|||
105646696|NCT02092285|364368223|FG000|Induction Phase|Physician Decision|4|||
105870257|NCT00852202|365176973|FG001|Overall Study|pregnancy,moving away and surgery|0|||
105870258|NCT00852202|365176974|FG002|Overall Study|pregnancy,moving away and surgery|2|||
105870259|NCT01408043|365176977|FG000|Overall Study|unable to collect cells|1|||
105870260|NCT01998841|365176984|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
105870261|NCT01998841|365176985|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
105870262|NCT01998841|365176986|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
105870263|NCT01998841|365176987|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105870264|NCT01998841|365176988|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105870265|NCT01998841|365176984|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105870266|NCT01998841|365176985|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105870267|NCT01998841|365176986|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
105870268|NCT01998841|365176987|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
105870269|NCT01998841|365176988|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
105870270|NCT03629184|365176989|FG000|Overall Study|Withdrawal by Subject|2|||
105870271|NCT03629184|365176990|FG001|Overall Study|Withdrawal by Subject|1|||
105870272|NCT03629184|365176989|FG000|Overall Study|Physician Decision|1|||
105870273|NCT03629184|365176990|FG001|Overall Study|Physician Decision|0|||
105870274|NCT02552121|365176991|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
105870275|NCT02552121|365176992|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105870276|NCT02552121|365176993|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105870277|NCT02552121|365176994|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105870278|NCT02552121|365176995|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105870279|NCT02552121|365176996|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105870280|NCT02552121|365176997|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105870281|NCT02552121|365176998|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
105870282|NCT02552121|365176991|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
105870283|NCT02552121|365176992|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105870284|NCT02552121|365176993|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105870285|NCT02552121|365176994|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105870286|NCT02552121|365176995|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105870287|NCT02552121|365176996|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105870288|NCT02552121|365176997|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105870289|NCT02552121|365176998|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
105870290|NCT02552121|365176991|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105870291|NCT02552121|365176992|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
105870292|NCT02552121|365176993|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105870293|NCT02552121|365176994|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105870294|NCT02552121|365176995|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105870295|NCT02552121|365176996|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105870296|NCT02552121|365176997|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105870297|NCT02552121|365176998|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
105870298|NCT02552121|365176991|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105870299|NCT02552121|365176992|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
105870300|NCT02552121|365176993|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105870301|NCT02552121|365176994|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105870302|NCT02552121|365176995|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105870303|NCT02552121|365176996|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105870304|NCT02552121|365176997|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105870305|NCT02552121|365176998|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
105870306|NCT02552121|365176991|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105870307|NCT02552121|365176992|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
105870308|NCT02552121|365176993|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105870309|NCT02552121|365176994|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105870310|NCT02552121|365176995|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105870311|NCT02552121|365176996|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105870312|NCT02552121|365176997|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105870313|NCT02552121|365176998|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
105870314|NCT02552121|365176991|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105870315|NCT02552121|365176992|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
105870316|NCT02552121|365176993|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105870317|NCT02552121|365176994|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105870318|NCT02552121|365176995|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105870319|NCT02552121|365176996|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105870320|NCT02552121|365176997|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105870321|NCT02552121|365176998|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
105870322|NCT02552121|365176991|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
105646697|NCT02092285|364368223|FG000|Induction Phase|Pregnancy|1|||
105870323|NCT02552121|365176992|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
105870324|NCT02552121|365176993|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
105870325|NCT02552121|365176994|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
105870326|NCT02552121|365176995|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
105870327|NCT02552121|365176996|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
105870328|NCT02552121|365176997|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
105870329|NCT02552121|365176998|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
105870330|NCT02552121|365176991|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
105870331|NCT02552121|365176992|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
105870332|NCT02552121|365176993|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
105870333|NCT02552121|365176994|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
105870334|NCT02552121|365176995|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
105870335|NCT02552121|365176996|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
105870336|NCT02552121|365176997|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
105870337|NCT02552121|365176998|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
105870338|NCT02552121|365176991|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
105870339|NCT02552121|365176992|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
105870340|NCT02552121|365176993|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
105870341|NCT02552121|365176994|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
105870342|NCT02552121|365176995|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
105870343|NCT02552121|365176996|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
105870344|NCT02552121|365176997|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
105870345|NCT02552121|365176998|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
105870346|NCT02552121|365176991|FG000|Part 2: Cohort Expansion|Death|0|||
105870347|NCT02552121|365176992|FG001|Part 2: Cohort Expansion|Death|0|||
105870348|NCT02552121|365176993|FG002|Part 2: Cohort Expansion|Death|1|||
105870349|NCT02552121|365176994|FG003|Part 2: Cohort Expansion|Death|0|||
105870350|NCT02552121|365176995|FG004|Part 2: Cohort Expansion|Death|0|||
105870351|NCT02552121|365176996|FG005|Part 2: Cohort Expansion|Death|0|||
105870352|NCT02552121|365176997|FG006|Part 2: Cohort Expansion|Death|0|||
105870353|NCT02552121|365176998|FG007|Part 2: Cohort Expansion|Death|0|||
105870354|NCT02575833|365176999|FG000|Overall Study|Withdrawal by Subject|0|||
105870355|NCT02575833|365177000|FG001|Overall Study|Withdrawal by Subject|1|||
105870356|NCT02575833|365176999|FG000|Overall Study|Lost to Follow-up|1|||
105870357|NCT02575833|365177000|FG001|Overall Study|Lost to Follow-up|0|||
105870358|NCT01128179|365177005|FG000|Overall Study|Death|1|||
105870359|NCT01128179|365177006|FG001|Overall Study|Death|0|||
105870360|NCT01128179|365177005|FG000|Overall Study|Protocol Violation|1|||
105870361|NCT01128179|365177006|FG001|Overall Study|Protocol Violation|0|||
105870362|NCT01682811|365177007|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105870363|NCT01682811|365177008|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105870364|NCT01682811|365177009|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105870365|NCT01682811|365177010|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105870366|NCT01682811|365177011|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
105870367|NCT01682811|365177012|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105870368|NCT01682811|365177013|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
105870369|NCT01682811|365177007|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
105870370|NCT01682811|365177008|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
105870371|NCT01682811|365177009|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
105646698|NCT02092285|364368223|FG000|Induction Phase|Relapse/Recurrence|7|||
105646699|NCT02092285|364368223|FG000|Induction Phase|Withdrawal by Subject|2|||
105646700|NCT02092285|364368223|FG000|Induction Phase|Lack of Efficacy|14|||
105646701|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
105646702|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
105646703|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
105646704|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
105646705|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
105646706|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
105646707|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
105646708|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
105646709|NCT02092285|364368223|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
105646710|NCT00304278|364368227|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
105870372|NCT01682811|365177010|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
105870373|NCT01682811|365177011|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
105870374|NCT01682811|365177012|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
105870375|NCT01682811|365177013|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
105870376|NCT01682811|365177007|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
105870377|NCT01682811|365177008|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
105870378|NCT01682811|365177009|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
105870379|NCT01682811|365177010|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
105646711|NCT00304278|364368227|FG000|Overall Study|PT had medical condition preventing TX|1|||
105646712|NCT00409006|364368229|FG000|Overall Study|Death|15|||
105870380|NCT01682811|365177011|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
105870381|NCT01682811|365177012|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
105870382|NCT01682811|365177013|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
105646713|NCT00409006|364368230|FG001|Overall Study|Death|6|||
105646714|NCT00409006|364368229|FG000|Overall Study|Lost to Follow-up|1|||
105646715|NCT00409006|364368230|FG001|Overall Study|Lost to Follow-up|2|||
105646716|NCT00409006|364368229|FG000|Overall Study|Withdrawal by Subject|3|||
105646717|NCT00409006|364368230|FG001|Overall Study|Withdrawal by Subject|2|||
105646718|NCT00409006|364368229|FG000|Overall Study|Physician Decision|1|||
105646719|NCT00409006|364368230|FG001|Overall Study|Physician Decision|2|||
105646720|NCT03694210|364368231|FG000|Overall Study|Death|1|||
105646721|NCT03694210|364368231|FG000|Overall Study|Screen Failure|7|||
105646722|NCT00228813|364368234|FG000|Overall Study|Death|4|||
105646723|NCT04025762|364368235|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
105646724|NCT04025762|364368236|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
105646725|NCT03451292|364368237|FG000|Overall Study|Death|44|||
105646726|NCT03451292|364368238|FG001|Overall Study|Death|59|||
105646727|NCT03451292|364368237|FG000|Overall Study|Withdrawal by Subject|18|||
105646728|NCT03451292|364368238|FG001|Overall Study|Withdrawal by Subject|13|||
105646729|NCT03451292|364368237|FG000|Overall Study|Transplantation|18|||
105646730|NCT03451292|364368238|FG001|Overall Study|Transplantation|12|||
105646731|NCT03451292|364368237|FG000|Overall Study|Lost to Follow-up|4|||
105646732|NCT03451292|364368238|FG001|Overall Study|Lost to Follow-up|12|||
105646733|NCT03451292|364368237|FG000|Overall Study|Physician Decision|4|||
105646734|NCT03451292|364368238|FG001|Overall Study|Physician Decision|3|||
105646735|NCT03451292|364368237|FG000|Overall Study|Adverse Event|3|||
105646736|NCT03451292|364368238|FG001|Overall Study|Adverse Event|3|||
105646737|NCT03451292|364368237|FG000|Overall Study|Non-compliance with Study Drug|2|||
105646738|NCT03451292|364368238|FG001|Overall Study|Non-compliance with Study Drug|0|||
105646739|NCT00608959|364368239|FG000|Part 1|Did not meet eligibility criteria|1|||
105646740|NCT01975701|364368243|FG000|Overall Study|Lost to Follow-up|1|||
105646741|NCT01975701|364368243|FG000|Overall Study|Death|23|||
105646742|NCT01975701|364368243|FG000|Overall Study|Physician Decision|1|||
105646743|NCT00668746|364368249|FG000|Overall Study|Lost to Follow-up|2|||
105646744|NCT00668746|364368250|FG001|Overall Study|Lost to Follow-up|1|||
105646745|NCT02109172|364368251|FG000|Overall Study|Withdrawal by Subject|1|||
105646746|NCT02109172|364368252|FG001|Overall Study|Withdrawal by Subject|0|||
105646747|NCT02109172|364368253|FG002|Overall Study|Withdrawal by Subject|0|||
105646748|NCT02109172|364368254|FG003|Overall Study|Withdrawal by Subject|1|||
105646749|NCT02109172|364368255|FG004|Overall Study|Withdrawal by Subject|0|||
105646750|NCT02109172|364368256|FG005|Overall Study|Withdrawal by Subject|0|||
105646751|NCT02109172|364368251|FG000|Overall Study|Adverse Event|0|||
105646752|NCT02109172|364368252|FG001|Overall Study|Adverse Event|0|||
105646753|NCT02109172|364368253|FG002|Overall Study|Adverse Event|1|||
105646754|NCT02109172|364368254|FG003|Overall Study|Adverse Event|0|||
105646755|NCT02109172|364368255|FG004|Overall Study|Adverse Event|0|||
105646756|NCT02109172|364368256|FG005|Overall Study|Adverse Event|1|||
105646757|NCT02109172|364368251|FG000|Overall Study|Death|0|||
105646758|NCT02109172|364368252|FG001|Overall Study|Death|0|||
105646759|NCT02109172|364368253|FG002|Overall Study|Death|0|||
105646760|NCT02109172|364368254|FG003|Overall Study|Death|0|||
105646761|NCT02109172|364368255|FG004|Overall Study|Death|1|||
105646762|NCT02109172|364368256|FG005|Overall Study|Death|0|||
105646763|NCT03605745|364368259|FG000|Overall Study|Study was terminated for business reasons|47|||
105646764|NCT01131325|364368264|FG000|Overall Study|Adverse Event|1|||
105646765|NCT01131325|364368264|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
105646766|NCT00555620|364368265|FG000|Overall Study|Death|0|||
105646767|NCT00555620|364368266|FG001|Overall Study|Death|1|||
105646768|NCT00555620|364368267|FG002|Overall Study|Death|0|||
105646769|NCT00555620|364368268|FG003|Overall Study|Death|0|||
105646770|NCT00555620|364368269|FG004|Overall Study|Death|0|||
105646771|NCT00555620|364368270|FG005|Overall Study|Death|1|||
105646772|NCT00555620|364368265|FG000|Overall Study|Study terminated by sponsor|0|||
105646773|NCT00555620|364368266|FG001|Overall Study|Study terminated by sponsor|0|||
105646774|NCT00555620|364368267|FG002|Overall Study|Study terminated by sponsor|1|||
105646775|NCT00555620|364368268|FG003|Overall Study|Study terminated by sponsor|0|||
105646776|NCT00555620|364368269|FG004|Overall Study|Study terminated by sponsor|0|||
105646777|NCT00555620|364368270|FG005|Overall Study|Study terminated by sponsor|0|||
105646778|NCT00555620|364368265|FG000|Overall Study|Adverse Event|0|||
105646779|NCT00555620|364368266|FG001|Overall Study|Adverse Event|0|||
105646780|NCT00555620|364368267|FG002|Overall Study|Adverse Event|1|||
105646781|NCT00555620|364368268|FG003|Overall Study|Adverse Event|5|||
105646782|NCT00555620|364368269|FG004|Overall Study|Adverse Event|0|||
105646783|NCT00555620|364368270|FG005|Overall Study|Adverse Event|1|||
105646784|NCT00555620|364368265|FG000|Overall Study|Objective progression or relapse|6|||
105646785|NCT00555620|364368266|FG001|Overall Study|Objective progression or relapse|5|||
105646786|NCT00555620|364368267|FG002|Overall Study|Objective progression or relapse|12|||
105646787|NCT00555620|364368268|FG003|Overall Study|Objective progression or relapse|17|||
105646788|NCT00555620|364368269|FG004|Overall Study|Objective progression or relapse|3|||
105646789|NCT00555620|364368270|FG005|Overall Study|Objective progression or relapse|16|||
105646790|NCT00555620|364368265|FG000|Overall Study|Participant refused treatment|0|||
105646791|NCT00555620|364368266|FG001|Overall Study|Participant refused treatment|1|||
105646792|NCT00555620|364368267|FG002|Overall Study|Participant refused treatment|1|||
105646793|NCT00555620|364368268|FG003|Overall Study|Participant refused treatment|0|||
105646794|NCT00555620|364368269|FG004|Overall Study|Participant refused treatment|0|||
105646795|NCT00555620|364368270|FG005|Overall Study|Participant refused treatment|1|||
105646796|NCT00555620|364368265|FG000|Overall Study|Other|0|||
105646797|NCT00555620|364368266|FG001|Overall Study|Other|0|||
105646798|NCT00555620|364368267|FG002|Overall Study|Other|0|||
105646799|NCT00555620|364368268|FG003|Overall Study|Other|1|||
105646800|NCT00555620|364368269|FG004|Overall Study|Other|0|||
105646801|NCT00555620|364368270|FG005|Overall Study|Other|3|||
105646802|NCT00396409|364368271|FG000|Period 1 - 2007|Adverse Event|0|||
105646803|NCT00396409|364368272|FG001|Period 1 - 2007|Adverse Event|1|||
105646804|NCT00396409|364368271|FG000|Period 1 - 2007|Lack of Efficacy|0|||
105646805|NCT00396409|364368272|FG001|Period 1 - 2007|Lack of Efficacy|1|||
105646806|NCT00396409|364368271|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
105646807|NCT00396409|364368272|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
105646808|NCT00396409|364368271|FG000|Period 1 - 2007|Lost to Follow-up|2|||
105646809|NCT00396409|364368272|FG001|Period 1 - 2007|Lost to Follow-up|3|||
105646810|NCT00396409|364368271|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
105646811|NCT00396409|364368272|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
105646812|NCT00396409|364368271|FG000|Period 2 - 2008|Protocol Violation|1|||
105646813|NCT00396409|364368272|FG001|Period 2 - 2008|Protocol Violation|0|||
105646814|NCT00396409|364368271|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
105646815|NCT00396409|364368272|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
105646816|NCT00396409|364368271|FG000|Period 2 - 2008|Lost to Follow-up|3|||
105646817|NCT00396409|364368272|FG001|Period 2 - 2008|Lost to Follow-up|1|||
105646818|NCT05203822|364368273|FG000|Overall Study|Adverse Event|1|||
105646819|NCT05203822|364368273|FG000|Overall Study|Withdrawal by Subject|1|||
105646820|NCT00376259|364368274|FG000|Overall Study|Sponsor request - study termination|21|||
105646821|NCT00376259|364368275|FG001|Overall Study|Sponsor request - study termination|21|||
105646822|NCT00376259|364368274|FG000|Overall Study|Patient request|1|||
105646823|NCT00376259|364368275|FG001|Overall Study|Patient request|0|||
105646824|NCT01877720|364368276|FG000|Overall Study|Adverse Event|1|||
105646825|NCT01877720|364368277|FG001|Overall Study|Adverse Event|0|||
105646826|NCT00447499|364368278|FG000|Overall Study|Adverse Event|1|||
105646827|NCT00447499|364368278|FG000|Overall Study|Patient Decision|4|||
105646828|NCT00447499|364368278|FG000|Overall Study|Sponsor Decision|1|||
105646829|NCT00447499|364368278|FG000|Overall Study|Physician Decision|1|||
105646830|NCT01263223|364368281|FG000|Period 2|Withdrawal by Subject|0|||
105646831|NCT01263223|364368282|FG001|Period 2|Withdrawal by Subject|1|||
105646832|NCT01263223|364368281|FG000|7-day Follow-up|Withdrawal by Subject|0|||
105646833|NCT01263223|364368282|FG001|7-day Follow-up|Withdrawal by Subject|1|||
105646834|NCT01263223|364368281|FG000|7-day Follow-up|Lost to Follow-up|1|||
105646835|NCT01263223|364368282|FG001|7-day Follow-up|Lost to Follow-up|0|||
105646836|NCT03614923|364368283|FG000|Overall Study|Withdrawal by Subject|2|||
105646837|NCT03614923|364368284|FG001|Overall Study|Withdrawal by Subject|1|||
105646838|NCT03614923|364368285|FG002|Overall Study|Withdrawal by Subject|1|||
105646839|NCT03614923|364368283|FG000|Overall Study|Adverse Event|0|||
105646840|NCT03614923|364368284|FG001|Overall Study|Adverse Event|2|||
105646841|NCT03614923|364368285|FG002|Overall Study|Adverse Event|1|||
105646842|NCT03614923|364368283|FG000|Overall Study|Lost to Follow-up|1|||
105646843|NCT03614923|364368284|FG001|Overall Study|Lost to Follow-up|0|||
105646844|NCT03614923|364368285|FG002|Overall Study|Lost to Follow-up|1|||
105646845|NCT03614923|364368283|FG000|Overall Study|Lack of Efficacy|2|||
105646846|NCT03614923|364368284|FG001|Overall Study|Lack of Efficacy|0|||
105646847|NCT03614923|364368285|FG002|Overall Study|Lack of Efficacy|1|||
105646848|NCT03614923|364368283|FG000|Overall Study|Non-compliance|0|||
105646849|NCT03614923|364368284|FG001|Overall Study|Non-compliance|1|||
105646850|NCT03614923|364368285|FG002|Overall Study|Non-compliance|0|||
105646851|NCT03614923|364368283|FG000|Overall Study|Other|0|||
105646852|NCT03614923|364368284|FG001|Overall Study|Other|1|||
105646853|NCT03614923|364368285|FG002|Overall Study|Other|1|||
105646854|NCT03034772|364368286|FG000|Overall Study|Adverse Event|0|||
105646855|NCT03034772|364368287|FG001|Overall Study|Adverse Event|1|||
105646856|NCT03034772|364368286|FG000|Overall Study|Withdrawal by Subject|0|||
105646857|NCT03034772|364368287|FG001|Overall Study|Withdrawal by Subject|1|||
105646858|NCT01136733|364368288|FG000|Phase 1b|Adverse Event|0|||
105646859|NCT01136733|364368289|FG001|Phase 1b|Adverse Event|3|||
105646860|NCT01136733|364368290|FG002|Phase 1b|Adverse Event|1|||
105646861|NCT01136733|364368291|FG003|Phase 1b|Adverse Event|0|||
105646862|NCT01136733|364368292|FG004|Phase 1b|Adverse Event|0|||
105646863|NCT01136733|364368293|FG005|Phase 1b|Adverse Event|0|||
105646864|NCT01136733|364368294|FG006|Phase 1b|Adverse Event|0|||
105646865|NCT01136733|364368288|FG000|Phase 1b|Participant Choice|0|||
105646866|NCT01136733|364368289|FG001|Phase 1b|Participant Choice|0|||
105646867|NCT01136733|364368290|FG002|Phase 1b|Participant Choice|1|||
105646868|NCT01136733|364368291|FG003|Phase 1b|Participant Choice|0|||
105646869|NCT01136733|364368292|FG004|Phase 1b|Participant Choice|0|||
105646870|NCT01136733|364368293|FG005|Phase 1b|Participant Choice|0|||
105646871|NCT01136733|364368294|FG006|Phase 1b|Participant Choice|0|||
105646872|NCT01136733|364368288|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
105646873|NCT01136733|364368289|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
105646874|NCT01136733|364368290|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
105646875|NCT01136733|364368291|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
105646876|NCT01136733|364368292|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
105646877|NCT01136733|364368293|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
105646878|NCT01136733|364368294|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
105646879|NCT01136733|364368288|FG000|Phase 1b|Clinical Progression|1|||
105646880|NCT01136733|364368289|FG001|Phase 1b|Clinical Progression|1|||
105646881|NCT01136733|364368290|FG002|Phase 1b|Clinical Progression|0|||
105646882|NCT01136733|364368291|FG003|Phase 1b|Clinical Progression|0|||
105646883|NCT01136733|364368292|FG004|Phase 1b|Clinical Progression|0|||
105646884|NCT01136733|364368293|FG005|Phase 1b|Clinical Progression|0|||
105646885|NCT01136733|364368294|FG006|Phase 1b|Clinical Progression|0|||
105646886|NCT01136733|364368288|FG000|Phase 2|Disease Progression|0|||
105646887|NCT01136733|364368289|FG001|Phase 2|Disease Progression|0|||
105646888|NCT01136733|364368290|FG002|Phase 2|Disease Progression|0|||
105646889|NCT01136733|364368291|FG003|Phase 2|Disease Progression|0|||
105646890|NCT01136733|364368292|FG004|Phase 2|Disease Progression|30|||
105646891|NCT01136733|364368293|FG005|Phase 2|Disease Progression|32|||
105646892|NCT01136733|364368294|FG006|Phase 2|Disease Progression|38|||
105646893|NCT01136733|364368288|FG000|Phase 2|Adverse Event|0|||
105646894|NCT01136733|364368289|FG001|Phase 2|Adverse Event|0|||
105646895|NCT01136733|364368290|FG002|Phase 2|Adverse Event|0|||
105646896|NCT01136733|364368291|FG003|Phase 2|Adverse Event|0|||
105646897|NCT01136733|364368292|FG004|Phase 2|Adverse Event|11|||
105646898|NCT01136733|364368293|FG005|Phase 2|Adverse Event|13|||
105646899|NCT01136733|364368294|FG006|Phase 2|Adverse Event|5|||
105646900|NCT01136733|364368288|FG000|Phase 2|Participant Choice|0|||
105646901|NCT01136733|364368289|FG001|Phase 2|Participant Choice|0|||
105646902|NCT01136733|364368290|FG002|Phase 2|Participant Choice|0|||
105646903|NCT01136733|364368291|FG003|Phase 2|Participant Choice|0|||
105646904|NCT01136733|364368292|FG004|Phase 2|Participant Choice|3|||
105646905|NCT01136733|364368293|FG005|Phase 2|Participant Choice|0|||
105646906|NCT01136733|364368294|FG006|Phase 2|Participant Choice|1|||
105646907|NCT01136733|364368288|FG000|Phase 2|Administrative-Withdrew Consent|0|||
105646908|NCT01136733|364368289|FG001|Phase 2|Administrative-Withdrew Consent|0|||
105646909|NCT01136733|364368290|FG002|Phase 2|Administrative-Withdrew Consent|0|||
105646910|NCT01136733|364368291|FG003|Phase 2|Administrative-Withdrew Consent|0|||
105646911|NCT01136733|364368292|FG004|Phase 2|Administrative-Withdrew Consent|1|||
105646912|NCT01136733|364368293|FG005|Phase 2|Administrative-Withdrew Consent|0|||
105646913|NCT01136733|364368294|FG006|Phase 2|Administrative-Withdrew Consent|0|||
105646914|NCT01136733|364368288|FG000|Phase 2|Other|0|||
105646915|NCT01136733|364368289|FG001|Phase 2|Other|0|||
105646916|NCT01136733|364368290|FG002|Phase 2|Other|0|||
105646917|NCT01136733|364368291|FG003|Phase 2|Other|0|||
105646918|NCT01136733|364368292|FG004|Phase 2|Other|6|||
105646919|NCT01136733|364368293|FG005|Phase 2|Other|7|||
105646920|NCT01136733|364368294|FG006|Phase 2|Other|6|||
105646921|NCT04175834|364368295|FG000|Overall Study|Withdrawal by Subject|1|||
105646922|NCT04175834|364368296|FG001|Overall Study|Withdrawal by Subject|0|||
105646923|NCT02030847|364368297|FG000|Overall Study|Death|10|||
105646924|NCT02030847|364368297|FG000|Overall Study|Disease Progression|15|||
105646925|NCT02030847|364368297|FG000|Overall Study|New Cancer Therapy|8|||
105646926|NCT02030847|364368297|FG000|Overall Study|Physician Decision|3|||
105646927|NCT02030847|364368297|FG000|Overall Study|Withdrawal by Subject|1|||
105646928|NCT03184519|364368298|FG000|Overall Study|Lost to Follow-up|6|||
105646929|NCT03184519|364368298|FG000|Overall Study|Physician Decision|21|||
105646930|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
105646931|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
105646932|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
105646933|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
105646934|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Death|0|||
105646935|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Death|0|||
105646936|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Death|1|||
105646937|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Death|0|||
105646938|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
105646939|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
105646940|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
105646941|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
105646942|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
105646943|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
105646944|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
105646945|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
105646946|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
105646947|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
105646948|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
105646949|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
105646950|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
105646951|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
105646952|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
105646953|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
105646954|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
105646955|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
105646956|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
105646957|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
105646958|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Other|2|||
105646959|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Other|0|||
105646960|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Other|0|||
105646961|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Other|0|||
105646962|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
105646963|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
105646964|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
105646965|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
105646966|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
105646967|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
105646968|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
105646969|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
105646970|NCT03845517|364368302|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
105646971|NCT03845517|364368303|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
105646972|NCT03845517|364368304|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
105646973|NCT03845517|364368305|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
105646974|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
105646975|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
105646976|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
105646977|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
105646978|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Death|0|||
105646979|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Death|0|||
105646980|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Death|1|||
105646981|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Death|1|||
105646982|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
105646983|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
105646984|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
105646985|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
105646986|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
105646987|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
105646988|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
105646989|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
105646990|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
105646991|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
105646992|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
105646993|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
105646994|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Other|1|||
105646995|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Other|0|||
105646996|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Other|1|||
105646997|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Other|0|||
105646998|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
105646999|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
105647000|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
105647001|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
105647002|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
105647003|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
105647004|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
105647005|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
105647006|NCT03845517|364368302|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
105647007|NCT03845517|364368303|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
105647008|NCT03845517|364368304|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
105647009|NCT03845517|364368305|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
105647010|NCT01190436|364368307|FG000|Overall Study|Lost to Follow-up|35|||
105647011|NCT01190436|364368307|FG000|Overall Study|Other|4|||
105647012|NCT02256553|364368308|FG000|Period I|Adverse Event|5|||
105647013|NCT02256553|364368308|FG000|Period I|Protocol Violation|1|||
105647014|NCT02256553|364368308|FG000|Period II|Adverse Event|1|||
105647015|NCT02256553|364368308|FG000|Period II|Subject Moved|1|||
105647016|NCT02256553|364368308|FG000|Period III|Adverse Event|3|||
105647017|NCT02865083|364368309|FG000|Overall Study|Early Termination|3|||
105647018|NCT02865083|364368310|FG001|Overall Study|Early Termination|1|||
105647019|NCT03449979|364368311|FG000|Overall Study|Technical difficulty|0|||
105647020|NCT03449979|364368312|FG001|Overall Study|Technical difficulty|0|||
105647021|NCT03449979|364368313|FG002|Overall Study|Technical difficulty|0|||
105647022|NCT03449979|364368314|FG003|Overall Study|Technical difficulty|1|||
105647023|NCT02632747|364368315|FG000|Wash-out Period|Adverse Event|1|||
105647024|NCT02632747|364368316|FG001|Wash-out Period|Adverse Event|0|||
105647025|NCT01020487|364369885|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
105647026|NCT01020487|364369886|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
105647027|NCT01020487|364369887|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
105647028|NCT01020487|364369885|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
105647029|NCT01020487|364369886|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
105647030|NCT01020487|364369887|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
105647031|NCT01020487|364369885|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
105647032|NCT01020487|364369886|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
105647033|NCT01020487|364369887|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
105647034|NCT01020487|364369885|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
105647035|NCT01020487|364369886|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
105647036|NCT01020487|364369887|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
105647037|NCT01020487|364369885|FG000|Part 2 Open-label Period|Adverse Event|0|||
105647038|NCT01020487|364369886|FG001|Part 2 Open-label Period|Adverse Event|4|||
105647039|NCT01020487|364369887|FG002|Part 2 Open-label Period|Adverse Event|1|||
105647040|NCT01825785|364369888|FG000|Overall Study|Adverse Event|0|||
105647041|NCT01825785|364369889|FG001|Overall Study|Adverse Event|0|||
105647042|NCT01825785|364369890|FG002|Overall Study|Adverse Event|0|||
105647043|NCT01825785|364369891|FG003|Overall Study|Adverse Event|0|||
105647044|NCT01825785|364369892|FG004|Overall Study|Adverse Event|1|||
105647045|NCT01825785|364369893|FG005|Overall Study|Adverse Event|0|||
105647046|NCT01825785|364369894|FG006|Overall Study|Adverse Event|0|||
105647047|NCT01825785|364369888|FG000|Overall Study|Withdrawal by Subject|0|||
105647048|NCT01825785|364369889|FG001|Overall Study|Withdrawal by Subject|0|||
105647049|NCT01825785|364369890|FG002|Overall Study|Withdrawal by Subject|0|||
105647050|NCT01825785|364369891|FG003|Overall Study|Withdrawal by Subject|0|||
105647051|NCT01825785|364369892|FG004|Overall Study|Withdrawal by Subject|1|||
105647052|NCT01825785|364369893|FG005|Overall Study|Withdrawal by Subject|1|||
105647053|NCT01825785|364369894|FG006|Overall Study|Withdrawal by Subject|0|||
105647054|NCT00355784|364369895|FG000|Overall Study|Withdrawal by Subject|0|||
105647055|NCT00355784|364369896|FG001|Overall Study|Withdrawal by Subject|0|||
105647056|NCT00355784|364369897|FG002|Overall Study|Withdrawal by Subject|2|||
105647057|NCT01807234|364369898|FG000|Overall Study|Lost to Follow-up|2|||
105647058|NCT01807234|364369899|FG001|Overall Study|Lost to Follow-up|5|||
105647059|NCT01807234|364369900|FG002|Overall Study|Lost to Follow-up|1|||
105647060|NCT01807234|364369901|FG003|Overall Study|Lost to Follow-up|1|||
105647061|NCT01807234|364369902|FG004|Overall Study|Lost to Follow-up|1|||
105647062|NCT01807234|364369903|FG005|Overall Study|Lost to Follow-up|2|||
105647063|NCT01807234|364369898|FG000|Overall Study|Withdrawal by Subject|3|||
105647064|NCT01807234|364369899|FG001|Overall Study|Withdrawal by Subject|1|||
105647065|NCT01807234|364369900|FG002|Overall Study|Withdrawal by Subject|1|||
105647066|NCT01807234|364369901|FG003|Overall Study|Withdrawal by Subject|1|||
105647067|NCT01807234|364369902|FG004|Overall Study|Withdrawal by Subject|2|||
105647068|NCT01807234|364369903|FG005|Overall Study|Withdrawal by Subject|1|||
105647069|NCT01807234|364369898|FG000|Overall Study|Lack of Efficacy|0|||
105647070|NCT01807234|364369899|FG001|Overall Study|Lack of Efficacy|0|||
105647071|NCT01807234|364369900|FG002|Overall Study|Lack of Efficacy|0|||
105647072|NCT01807234|364369901|FG003|Overall Study|Lack of Efficacy|0|||
105647073|NCT01807234|364369902|FG004|Overall Study|Lack of Efficacy|1|||
105647074|NCT01807234|364369903|FG005|Overall Study|Lack of Efficacy|1|||
105647075|NCT03672188|364369904|FG000|Overall Study|Withdrawal by Subject|0|||
105647076|NCT03672188|364369905|FG001|Overall Study|Withdrawal by Subject|0|||
105647077|NCT03672188|364369906|FG002|Overall Study|Withdrawal by Subject|0|||
105647078|NCT03672188|364369907|FG003|Overall Study|Withdrawal by Subject|3|||
105647079|NCT03672188|364369908|FG004|Overall Study|Withdrawal by Subject|0|||
105647080|NCT03672188|364369909|FG005|Overall Study|Withdrawal by Subject|0|||
105647081|NCT03672188|364369910|FG006|Overall Study|Withdrawal by Subject|0|||
105647082|NCT03672188|364369911|FG007|Overall Study|Withdrawal by Subject|0|||
105647083|NCT03672188|364369912|FG008|Overall Study|Withdrawal by Subject|0|||
105647084|NCT03672188|364369913|FG009|Overall Study|Withdrawal by Subject|0|||
105647085|NCT03672188|364369914|FG010|Overall Study|Withdrawal by Subject|0|||
105647086|NCT03672188|364369915|FG011|Overall Study|Withdrawal by Subject|0|||
105647087|NCT03672188|364369916|FG012|Overall Study|Withdrawal by Subject|0|||
105647088|NCT03672188|364369917|FG013|Overall Study|Withdrawal by Subject|0|||
105647089|NCT03672188|364369918|FG014|Overall Study|Withdrawal by Subject|0|||
105647090|NCT03672188|364369904|FG000|Overall Study|Death|0|||
105647091|NCT03672188|364369905|FG001|Overall Study|Death|0|||
105647092|NCT03672188|364369906|FG002|Overall Study|Death|0|||
105647093|NCT03672188|364369907|FG003|Overall Study|Death|0|||
105647094|NCT03672188|364369908|FG004|Overall Study|Death|0|||
105647095|NCT03672188|364369909|FG005|Overall Study|Death|0|||
105647096|NCT03672188|364369910|FG006|Overall Study|Death|0|||
105647097|NCT03672188|364369911|FG007|Overall Study|Death|0|||
105647098|NCT03672188|364369912|FG008|Overall Study|Death|0|||
105647099|NCT03672188|364369913|FG009|Overall Study|Death|0|||
105870383|NCT01682811|365177007|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
105647100|NCT03672188|364369914|FG010|Overall Study|Death|0|||
105647101|NCT03672188|364369915|FG011|Overall Study|Death|0|||
105647102|NCT03672188|364369916|FG012|Overall Study|Death|1|||
105647103|NCT03672188|364369917|FG013|Overall Study|Death|0|||
105647104|NCT03672188|364369918|FG014|Overall Study|Death|0|||
105647105|NCT03672188|364369904|FG000|Overall Study|Lost to Follow-up|0|||
105647106|NCT03672188|364369905|FG001|Overall Study|Lost to Follow-up|0|||
105647107|NCT03672188|364369906|FG002|Overall Study|Lost to Follow-up|1|||
105647108|NCT03672188|364369907|FG003|Overall Study|Lost to Follow-up|0|||
105647109|NCT03672188|364369908|FG004|Overall Study|Lost to Follow-up|0|||
105647110|NCT03672188|364369909|FG005|Overall Study|Lost to Follow-up|0|||
105647111|NCT03672188|364369910|FG006|Overall Study|Lost to Follow-up|0|||
105647112|NCT03672188|364369911|FG007|Overall Study|Lost to Follow-up|0|||
105647113|NCT03672188|364369912|FG008|Overall Study|Lost to Follow-up|0|||
105647114|NCT03672188|364369913|FG009|Overall Study|Lost to Follow-up|0|||
105647115|NCT03672188|364369914|FG010|Overall Study|Lost to Follow-up|0|||
105647116|NCT03672188|364369915|FG011|Overall Study|Lost to Follow-up|0|||
105647117|NCT03672188|364369916|FG012|Overall Study|Lost to Follow-up|0|||
105647118|NCT03672188|364369917|FG013|Overall Study|Lost to Follow-up|0|||
105647119|NCT03672188|364369918|FG014|Overall Study|Lost to Follow-up|0|||
105647120|NCT03696342|364369919|FG000|Overall Study|Lost to Follow-up|1|||
105647121|NCT03696342|364369920|FG001|Overall Study|Lost to Follow-up|0|||
105647122|NCT01012999|364369925|FG000|Overall Study|Protocol Violation|1|||
105647123|NCT03360071|364369927|FG000|Overall Study|Lost to Follow-up|1|||
105647124|NCT03360071|364369928|FG001|Overall Study|Lost to Follow-up|0|||
105647125|NCT00946088|364369929|FG000|Overall Study|Withdrawal by Subject|0|||
105647126|NCT00946088|364369930|FG001|Overall Study|Withdrawal by Subject|1|||
105647127|NCT02368691|364369931|FG000|Overall Study|Death|13|||
105647128|NCT02368691|364369931|FG000|Overall Study|Lack of Efficacy|15|||
105647129|NCT02368691|364369931|FG000|Overall Study|Physician Decision|4|||
105647130|NCT04239911|364369932|FG000|Overall Study|Lost to Follow-up|2|||
105647131|NCT04239911|364369933|FG001|Overall Study|Lost to Follow-up|1|||
105647132|NCT00584909|364369934|FG000|Overall Study|Adverse Event|4|||
105647133|NCT00460434|364369935|FG000|Overall Study|Lost to Follow-up|3|||
105647134|NCT00460434|364369936|FG001|Overall Study|Lost to Follow-up|7|||
105647135|NCT02092909|364369937|FG000|Overall Study|Adverse Event|0|||
105647136|NCT02092909|364369938|FG001|Overall Study|Adverse Event|0|||
105647137|NCT02092909|364369939|FG002|Overall Study|Adverse Event|4|||
105647138|NCT02092909|364369940|FG003|Overall Study|Adverse Event|2|||
105647139|NCT02092909|364369937|FG000|Overall Study|Lack of Efficacy|0|||
105647140|NCT02092909|364369938|FG001|Overall Study|Lack of Efficacy|2|||
105647141|NCT02092909|364369939|FG002|Overall Study|Lack of Efficacy|1|||
105647142|NCT02092909|364369940|FG003|Overall Study|Lack of Efficacy|0|||
105647143|NCT02092909|364369937|FG000|Overall Study|Withdrawal by Subject|0|||
105647144|NCT02092909|364369938|FG001|Overall Study|Withdrawal by Subject|0|||
105647145|NCT02092909|364369939|FG002|Overall Study|Withdrawal by Subject|2|||
105647146|NCT02092909|364369940|FG003|Overall Study|Withdrawal by Subject|1|||
105647147|NCT02092909|364369937|FG000|Overall Study|Study terminated by Sponsor|0|||
105647148|NCT02092909|364369938|FG001|Overall Study|Study terminated by Sponsor|0|||
105647149|NCT02092909|364369939|FG002|Overall Study|Study terminated by Sponsor|0|||
105647150|NCT02092909|364369940|FG003|Overall Study|Study terminated by Sponsor|2|||
105647151|NCT02092909|364369937|FG000|Overall Study|Miscellaneous|1|||
105647152|NCT02092909|364369938|FG001|Overall Study|Miscellaneous|1|||
105647153|NCT02092909|364369939|FG002|Overall Study|Miscellaneous|2|||
105647154|NCT02092909|364369940|FG003|Overall Study|Miscellaneous|1|||
105647155|NCT04626128|364369943|FG000|Overall Study|Withdrawal by Subject|0|||
105647156|NCT04626128|364369944|FG001|Overall Study|Withdrawal by Subject|1|||
105647157|NCT04626128|364369945|FG002|Overall Study|Withdrawal by Subject|0|||
105647158|NCT04626128|364369946|FG003|Overall Study|Withdrawal by Subject|0|||
105647159|NCT01182285|364369947|FG000|First Intervention Week 1-10|Disease progression|1|||
105647160|NCT01182285|364369948|FG001|First Intervention Week 1-10|Disease progression|0|||
105647161|NCT01182285|364369949|FG002|First Intervention Week 1-10|Disease progression|0|||
105647162|NCT01182285|364369947|FG000|First Intervention Week 1-10|Adverse Event|1|||
105647163|NCT01182285|364369948|FG001|First Intervention Week 1-10|Adverse Event|0|||
105647164|NCT01182285|364369949|FG002|First Intervention Week 1-10|Adverse Event|0|||
105647165|NCT01182285|364369947|FG000|First Intervention Week 1-10|Non-compliance|1|||
105647166|NCT01182285|364369948|FG001|First Intervention Week 1-10|Non-compliance|0|||
105647167|NCT01182285|364369949|FG002|First Intervention Week 1-10|Non-compliance|0|||
105647168|NCT01182285|364369947|FG000|Third Intervention Week 11-52|Disease Progression|0|||
105647169|NCT01182285|364369948|FG001|Third Intervention Week 11-52|Disease Progression|0|||
105647170|NCT01182285|364369949|FG002|Third Intervention Week 11-52|Disease Progression|6|||
105647171|NCT01182285|364369947|FG000|Third Intervention Week 11-52|Other|0|||
105647172|NCT01182285|364369948|FG001|Third Intervention Week 11-52|Other|0|||
105647173|NCT01182285|364369949|FG002|Third Intervention Week 11-52|Other|2|||
105647174|NCT00248794|364369952|FG000|Overall Study|Lost to Follow-up|6|||
105647175|NCT00248794|364369953|FG001|Overall Study|Lost to Follow-up|8|||
105647176|NCT00248794|364369954|FG002|Overall Study|Lost to Follow-up|3|||
105647177|NCT00203502|364369955|FG000|Overall Study|Death|1|||
105647178|NCT01951105|364369956|FG000|Overall Study|Adverse Event|0|||
105647179|NCT01951105|364369957|FG001|Overall Study|Adverse Event|5|||
105647180|NCT01951105|364369958|FG002|Overall Study|Adverse Event|0|||
105647181|NCT01951105|364369956|FG000|Overall Study|Lost to Follow-up|0|||
105647182|NCT01951105|364369957|FG001|Overall Study|Lost to Follow-up|1|||
105647183|NCT01951105|364369958|FG002|Overall Study|Lost to Follow-up|0|||
105647184|NCT01951105|364369956|FG000|Overall Study|Protocol Violation|1|||
105647185|NCT01951105|364369957|FG001|Overall Study|Protocol Violation|1|||
105647186|NCT01951105|364369958|FG002|Overall Study|Protocol Violation|1|||
105647187|NCT01951105|364369956|FG000|Overall Study|Withdrawal by Subject|0|||
105647188|NCT01951105|364369957|FG001|Overall Study|Withdrawal by Subject|3|||
105647189|NCT01951105|364369958|FG002|Overall Study|Withdrawal by Subject|1|||
105647190|NCT04175392|364369959|FG000|Overall Study|Withdrawal by Subject|3|||
105647191|NCT04175392|364369960|FG001|Overall Study|Withdrawal by Subject|2|||
105647192|NCT02069379|364369961|FG000|Baseline Measurements|Lost to Follow-up|1|||
105647193|NCT02069379|364369962|FG001|Baseline Measurements|Lost to Follow-up|0|||
105647194|NCT02069379|364369963|FG002|Baseline Measurements|Lost to Follow-up|0|||
105647195|NCT02069379|364369964|FG003|Baseline Measurements|Lost to Follow-up|0|||
105647196|NCT02069379|364369961|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
105647197|NCT02069379|364369962|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
105647198|NCT02069379|364369963|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
105647199|NCT02069379|364369964|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
105647200|NCT02069379|364369961|FG000|First Treatment Arm|Lost to Follow-up|0|||
105647201|NCT02069379|364369962|FG001|First Treatment Arm|Lost to Follow-up|1|||
105647202|NCT02069379|364369963|FG002|First Treatment Arm|Lost to Follow-up|1|||
105647203|NCT02069379|364369964|FG003|First Treatment Arm|Lost to Follow-up|0|||
105647204|NCT02069379|364369961|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
105647205|NCT02069379|364369962|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
105647206|NCT02069379|364369963|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
105647207|NCT02069379|364369964|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
105647208|NCT02069379|364369961|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
105647209|NCT02069379|364369962|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
105647210|NCT02069379|364369963|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
105647211|NCT02069379|364369964|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
105647212|NCT02069379|364369961|FG000|Second Treatment Arm|Lost to Follow-up|0|||
105647213|NCT02069379|364369962|FG001|Second Treatment Arm|Lost to Follow-up|0|||
105647214|NCT02069379|364369963|FG002|Second Treatment Arm|Lost to Follow-up|1|||
105647215|NCT02069379|364369964|FG003|Second Treatment Arm|Lost to Follow-up|0|||
105647216|NCT01469819|364369965|FG000|Overall Study|Withdrawal by Subject|1|||
105647217|NCT01469819|364369965|FG000|Overall Study|Did not meet inclusionary criteria|2|||
105647218|NCT01469819|364369965|FG000|Overall Study|Could not swallow SmartPill|2|||
105647219|NCT01469819|364369965|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
105647220|NCT02727998|364369966|FG000|Overall Study|Lost to Follow-up|3|||
105647221|NCT02727998|364369967|FG001|Overall Study|Lost to Follow-up|3|||
105647222|NCT02727998|364369966|FG000|Overall Study|Withdrawal by Subject|0|||
105647223|NCT02727998|364369967|FG001|Overall Study|Withdrawal by Subject|1|||
105647224|NCT00561678|364369968|FG000|Overall Study|Withdrawal by Subject|4|||
105647225|NCT00561678|364369969|FG001|Overall Study|Withdrawal by Subject|3|||
105647226|NCT00561678|364369968|FG000|Overall Study|surgery cancelled|1|||
105647227|NCT00561678|364369969|FG001|Overall Study|surgery cancelled|1|||
105647228|NCT00561678|364369968|FG000|Overall Study|surgery rescheduled to different site|2|||
105647229|NCT00561678|364369969|FG001|Overall Study|surgery rescheduled to different site|2|||
105647230|NCT00561678|364369968|FG000|Overall Study|anesthesia provider refusal|1|||
105647231|NCT00561678|364369969|FG001|Overall Study|anesthesia provider refusal|0|||
105647232|NCT01358175|364369970|FG000|Overall Study|Death|1|||
105647233|NCT01358175|364369971|FG001|Overall Study|Death|0|||
105647234|NCT01358175|364369972|FG002|Overall Study|Death|1|||
105647235|NCT01358175|364369970|FG000|Overall Study|Withdrawal by Subject|9|||
105647236|NCT01358175|364369971|FG001|Overall Study|Withdrawal by Subject|5|||
105647237|NCT01358175|364369972|FG002|Overall Study|Withdrawal by Subject|10|||
105647238|NCT01358175|364369970|FG000|Overall Study|Technical issues|0|||
105647239|NCT01358175|364369971|FG001|Overall Study|Technical issues|1|||
105647240|NCT01358175|364369972|FG002|Overall Study|Technical issues|0|||
105647241|NCT01358175|364369970|FG000|Overall Study|Pregnancy|0|||
105647242|NCT01358175|364369971|FG001|Overall Study|Pregnancy|1|||
105647243|NCT01358175|364369972|FG002|Overall Study|Pregnancy|0|||
105647244|NCT01358175|364369970|FG000|Overall Study|Physician Decision|1|||
105647245|NCT01358175|364369971|FG001|Overall Study|Physician Decision|0|||
105647246|NCT01358175|364369972|FG002|Overall Study|Physician Decision|0|||
105647247|NCT01358175|364369970|FG000|Overall Study|Non Compliance with Study Treatment|0|||
105647248|NCT01358175|364369971|FG001|Overall Study|Non Compliance with Study Treatment|1|||
105647249|NCT01358175|364369972|FG002|Overall Study|Non Compliance with Study Treatment|1|||
105647250|NCT01358175|364369970|FG000|Overall Study|Lost to Follow-up|1|||
105647251|NCT01358175|364369971|FG001|Overall Study|Lost to Follow-up|1|||
105647252|NCT01358175|364369972|FG002|Overall Study|Lost to Follow-up|3|||
105647253|NCT01358175|364369970|FG000|Overall Study|Lack of Efficacy|3|||
105647254|NCT01358175|364369971|FG001|Overall Study|Lack of Efficacy|8|||
105647255|NCT01358175|364369972|FG002|Overall Study|Lack of Efficacy|6|||
105647256|NCT01358175|364369970|FG000|Overall Study|Adverse Event|6|||
105647257|NCT01358175|364369971|FG001|Overall Study|Adverse Event|11|||
105647258|NCT01358175|364369972|FG002|Overall Study|Adverse Event|11|||
105647259|NCT02379078|364369973|FG000|Overall Study|Lost to Follow-up|33|||
105647260|NCT02379078|364369974|FG001|Overall Study|Lost to Follow-up|30|||
105647261|NCT02379078|364369973|FG000|Overall Study|Withdrawal by Subject|6|||
105647262|NCT02379078|364369974|FG001|Overall Study|Withdrawal by Subject|5|||
105647263|NCT03481725|364369975|FG000|Overall Study|Withdrawal by Subject|1|||
105647264|NCT03481725|364369976|FG001|Overall Study|Withdrawal by Subject|0|||
105647265|NCT05072795|364369979|FG000|Overall Study|Lost to Follow-up|5|||
105647266|NCT00472199|364369980|FG000|Overall Study|Adverse Event|19|||
105647267|NCT00472199|364369981|FG001|Overall Study|Adverse Event|23|||
105647268|NCT00472199|364369980|FG000|Overall Study|Lack of Efficacy|4|||
105647269|NCT00472199|364369981|FG001|Overall Study|Lack of Efficacy|25|||
105647270|NCT00472199|364369980|FG000|Overall Study|Lost to Follow-up|2|||
105647271|NCT00472199|364369981|FG001|Overall Study|Lost to Follow-up|4|||
105647272|NCT00472199|364369980|FG000|Overall Study|Protocol Violation|3|||
105647273|NCT00472199|364369981|FG001|Overall Study|Protocol Violation|2|||
105647274|NCT00472199|364369980|FG000|Overall Study|Withdrawal by Subject|6|||
105647275|NCT00472199|364369981|FG001|Overall Study|Withdrawal by Subject|5|||
105647276|NCT00472199|364369980|FG000|Overall Study|personal reason|0|||
105647277|NCT00472199|364369981|FG001|Overall Study|personal reason|1|||
105647278|NCT00472199|364369980|FG000|Overall Study|patient was asymptomatic|1|||
105647279|NCT00472199|364369981|FG001|Overall Study|patient was asymptomatic|0|||
105647280|NCT01107912|364369982|FG000|Period 1|Adverse Event|0|||
105647281|NCT01107912|364369983|FG001|Period 1|Adverse Event|0|||
105647282|NCT01107912|364369984|FG002|Period 1|Adverse Event|0|||
105647283|NCT01107912|364369985|FG003|Period 1|Adverse Event|0|||
105647284|NCT01107912|364369986|FG004|Period 1|Adverse Event|2|||
105647285|NCT01107912|364369987|FG005|Period 1|Adverse Event|0|||
105647286|NCT01107912|364369982|FG000|Period 1|Physician Decision|0|||
105647287|NCT01107912|364369983|FG001|Period 1|Physician Decision|0|||
105647288|NCT01107912|364369984|FG002|Period 1|Physician Decision|0|||
105647289|NCT01107912|364369985|FG003|Period 1|Physician Decision|0|||
105647290|NCT01107912|364369986|FG004|Period 1|Physician Decision|1|||
105647291|NCT01107912|364369987|FG005|Period 1|Physician Decision|0|||
105647292|NCT01107912|364369982|FG000|Period 1|Withdrawal by Subject|1|||
105647293|NCT01107912|364369983|FG001|Period 1|Withdrawal by Subject|0|||
105647294|NCT01107912|364369984|FG002|Period 1|Withdrawal by Subject|0|||
105647295|NCT01107912|364369985|FG003|Period 1|Withdrawal by Subject|0|||
105647296|NCT01107912|364369986|FG004|Period 1|Withdrawal by Subject|0|||
105647297|NCT01107912|364369987|FG005|Period 1|Withdrawal by Subject|0|||
105647298|NCT01107912|364369982|FG000|Period 2|Physician Decision|0|||
105647299|NCT01107912|364369983|FG001|Period 2|Physician Decision|0|||
105647300|NCT01107912|364369984|FG002|Period 2|Physician Decision|1|||
105647301|NCT01107912|364369985|FG003|Period 2|Physician Decision|0|||
105647302|NCT01107912|364369986|FG004|Period 2|Physician Decision|0|||
105647303|NCT01107912|364369987|FG005|Period 2|Physician Decision|0|||
105647304|NCT01107912|364369982|FG000|Period 3|Adverse Event|0|||
105647305|NCT01107912|364369983|FG001|Period 3|Adverse Event|1|||
105647306|NCT01107912|364369984|FG002|Period 3|Adverse Event|1|||
105647307|NCT01107912|364369985|FG003|Period 3|Adverse Event|0|||
105647308|NCT01107912|364369986|FG004|Period 3|Adverse Event|0|||
105647309|NCT01107912|364369987|FG005|Period 3|Adverse Event|0|||
105647310|NCT01107912|364369982|FG000|Period 3|Withdrawal by Subject|0|||
105647311|NCT01107912|364369983|FG001|Period 3|Withdrawal by Subject|0|||
105647312|NCT01107912|364369984|FG002|Period 3|Withdrawal by Subject|0|||
105647313|NCT01107912|364369985|FG003|Period 3|Withdrawal by Subject|1|||
105647314|NCT01107912|364369986|FG004|Period 3|Withdrawal by Subject|0|||
105647315|NCT01107912|364369987|FG005|Period 3|Withdrawal by Subject|0|||
105647316|NCT02522299|364369994|FG000|Overall Study|Adverse Event|2|||
105647317|NCT02522299|364369995|FG001|Overall Study|Adverse Event|0|||
105647318|NCT02522299|364369994|FG000|Overall Study|Physician Decision|0|||
105647319|NCT02522299|364369995|FG001|Overall Study|Physician Decision|1|||
105647320|NCT02522299|364369994|FG000|Overall Study|Withdrawal by Subject|2|||
105647321|NCT02522299|364369995|FG001|Overall Study|Withdrawal by Subject|0|||
105647322|NCT01426217|364369996|FG000|Overall Study|lost sample|8|||
105647323|NCT01426217|364369997|FG001|Overall Study|lost sample|14|||
105647324|NCT05008224|364369998|FG000|Overall Study|Death|3|||
105647325|NCT05008224|364369998|FG000|Overall Study|Lost to Follow-up|2|||
105647326|NCT05008224|364369998|FG000|Overall Study|Did Not Continue on Extension Study|39|||
105647327|NCT05008224|364369998|FG000|Overall Study|Transferred to Extension Study|100|||
105647328|NCT05008224|364369998|FG000|Overall Study|Withdrawal by Subject|2|||
105647329|NCT05234632|364369999|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
105647330|NCT05234632|364370000|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
105647331|NCT05234632|364369999|FG000|Overall Study|Withdrawal by Subject|2|||
105647332|NCT05234632|364370000|FG001|Overall Study|Withdrawal by Subject|0|||
105647333|NCT05234632|364369999|FG000|Overall Study|Adverse Event|0|||
105647334|NCT05234632|364370000|FG001|Overall Study|Adverse Event|4|||
105647335|NCT05234632|364369999|FG000|Overall Study|Physician Decision|1|||
105647336|NCT05234632|364370000|FG001|Overall Study|Physician Decision|1|||
105647337|NCT05234632|364369999|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
105647338|NCT05234632|364370000|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
105647339|NCT05234632|364369999|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
105647340|NCT05234632|364370000|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
105647341|NCT00658632|364370001|FG000|Overall Study|Adverse Event|13|||
105647342|NCT00658632|364370002|FG001|Overall Study|Adverse Event|11|||
105647343|NCT00658632|364370001|FG000|Overall Study|Lost to Follow-up|25|||
105647344|NCT00658632|364370002|FG001|Overall Study|Lost to Follow-up|23|||
105647345|NCT00658632|364370001|FG000|Overall Study|Withdrawal by Subject|10|||
105647346|NCT00658632|364370002|FG001|Overall Study|Withdrawal by Subject|7|||
105647347|NCT00658632|364370001|FG000|Overall Study|Lack of Efficacy|0|||
105647348|NCT00658632|364370002|FG001|Overall Study|Lack of Efficacy|1|||
105647349|NCT00658632|364370001|FG000|Overall Study|Withdrawal of consent|8|||
105647350|NCT00658632|364370002|FG001|Overall Study|Withdrawal of consent|14|||
105647351|NCT00658632|364370001|FG000|Overall Study|Pregnancy|1|||
105647352|NCT00658632|364370002|FG001|Overall Study|Pregnancy|1|||
105647353|NCT00658632|364370001|FG000|Overall Study|Other|7|||
105647354|NCT00658632|364370002|FG001|Overall Study|Other|8|||
105647355|NCT02058992|364370005|FG000|Overall Study|Lost to Follow-up|4|||
105647356|NCT02058992|364370005|FG000|Overall Study|Protocol Violation|92|||
105647357|NCT02058992|364370005|FG000|Overall Study|CRF Uncollected|20|||
105647358|NCT03747575|364370006|FG000|Overall Study|Withdrawal by Subject|6|||
105647359|NCT03747575|364370007|FG001|Overall Study|Withdrawal by Subject|3|||
105647360|NCT03747575|364370006|FG000|Overall Study|Lost to Follow-up|3|||
105647361|NCT03747575|364370007|FG001|Overall Study|Lost to Follow-up|3|||
105647362|NCT03747575|364370006|FG000|Overall Study|Adverse Event|0|||
105647363|NCT03747575|364370007|FG001|Overall Study|Adverse Event|1|||
105647364|NCT02577315|364370016|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
105647365|NCT02577315|364370017|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
105647366|NCT03686176|364370018|FG000|Overall Study|Procedure cancelled|1|||
105647367|NCT03686176|364370019|FG001|Overall Study|Procedure cancelled|0|||
105647368|NCT03686176|364370020|FG002|Overall Study|Procedure cancelled|0|||
105647369|NCT03686176|364370018|FG000|Overall Study|VR Malfunction|1|||
105647370|NCT03686176|364370019|FG001|Overall Study|VR Malfunction|0|||
105647371|NCT03686176|364370020|FG002|Overall Study|VR Malfunction|0|||
105647372|NCT00390806|364370021|FG000|Overall Study|Lost to Follow-up|7|||
105647373|NCT00390806|364370022|FG001|Overall Study|Lost to Follow-up|6|||
105647374|NCT00390806|364370021|FG000|Overall Study|Protocol Violation|2|||
105647375|NCT00390806|364370022|FG001|Overall Study|Protocol Violation|2|||
105647376|NCT00390806|364370021|FG000|Overall Study|Withdrawal by Subject|12|||
105647377|NCT00390806|364370022|FG001|Overall Study|Withdrawal by Subject|15|||
105647378|NCT00390806|364370021|FG000|Overall Study|Investigator Decision|4|||
105647379|NCT00390806|364370022|FG001|Overall Study|Investigator Decision|6|||
105647380|NCT00390806|364370021|FG000|Overall Study|Death|1|||
105647381|NCT00390806|364370022|FG001|Overall Study|Death|0|||
105647382|NCT00390806|364370021|FG000|Overall Study|Physician Decision|0|||
105647383|NCT00390806|364370022|FG001|Overall Study|Physician Decision|1|||
105647384|NCT00390806|364370021|FG000|Overall Study|Ongoing|4|||
105647385|NCT00390806|364370022|FG001|Overall Study|Ongoing|2|||
105647386|NCT04853394|364370023|FG000|Follow-up Interviews|Lost to Follow-up|22|||
105647387|NCT04853394|364370024|FG001|Follow-up Interviews|Lost to Follow-up|15|||
105647388|NCT04212299|364370025|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
105647389|NCT01268488|364371418|FG000|Overall Study|Adverse Event|3|||
105647390|NCT01268488|364371418|FG000|Overall Study|Physician Decision|2|||
105647391|NCT01894620|364371422|FG000|Overall Study|Withdrawal by Subject|0|||
105647392|NCT01894620|364371423|FG001|Overall Study|Withdrawal by Subject|1|||
105647393|NCT00147745|364371424|FG000|Overall Study|Withdrawal by Subject|1|||
105647394|NCT00147745|364371425|FG001|Overall Study|Withdrawal by Subject|0|||
105647395|NCT00147745|364371426|FG002|Overall Study|Withdrawal by Subject|0|||
105647396|NCT01106586|364371427|FG000|Overall Study|Adverse Event|9|||
105647397|NCT01106586|364371428|FG001|Overall Study|Adverse Event|15|||
105647398|NCT01106586|364371427|FG000|Overall Study|Death|1|||
105647399|NCT01106586|364371428|FG001|Overall Study|Death|3|||
105647400|NCT01106586|364371427|FG000|Overall Study|Pregnancy|2|||
105647401|NCT01106586|364371428|FG001|Overall Study|Pregnancy|2|||
105647402|NCT01106586|364371427|FG000|Overall Study|Lack of Efficacy|1|||
105647403|NCT01106586|364371428|FG001|Overall Study|Lack of Efficacy|0|||
105647404|NCT01106586|364371427|FG000|Overall Study|Investigator's Discretion|5|||
105647405|NCT01106586|364371428|FG001|Overall Study|Investigator's Discretion|8|||
105647406|NCT01106586|364371427|FG000|Overall Study|Withdrew Consent|18|||
105647407|NCT01106586|364371428|FG001|Overall Study|Withdrew Consent|30|||
105647408|NCT01106586|364371427|FG000|Overall Study|Lost to Follow-up|24|||
105647409|NCT01106586|364371428|FG001|Overall Study|Lost to Follow-up|20|||
105647410|NCT01106586|364371427|FG000|Overall Study|Participant Noncompliance|12|||
105647411|NCT01106586|364371428|FG001|Overall Study|Participant Noncompliance|10|||
105647412|NCT01106586|364371427|FG000|Overall Study|Protocol Violation|1|||
105647413|NCT01106586|364371428|FG001|Overall Study|Protocol Violation|0|||
105647414|NCT01106586|364371427|FG000|Overall Study|Participant Transferred to Another Study|212|||
105647415|NCT01106586|364371428|FG001|Overall Study|Participant Transferred to Another Study|197|||
105647416|NCT01721109|364371436|FG000|Overall Study|Lack of Efficacy|1|||
105647417|NCT01721109|364371436|FG000|Overall Study|Non- Compliance with Study Drug|3|||
105647418|NCT01721109|364371436|FG000|Overall Study|Withdrew Consent|1|||
105647419|NCT01721109|364371436|FG000|Overall Study|Lost to Follow-up|2|||
105647420|NCT04362176|364371437|FG000|Overall Study|Lost to Follow-up|5|||
105647421|NCT04362176|364371438|FG001|Overall Study|Lost to Follow-up|8|||
105647422|NCT04362176|364371437|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
105647423|NCT04362176|364371438|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
105647424|NCT00742560|364371439|FG000|Overall Study|Adverse Event|0|||
105647425|NCT00742560|364371440|FG001|Overall Study|Adverse Event|0|||
105647426|NCT00742560|364371441|FG002|Overall Study|Adverse Event|1|||
105647427|NCT00742560|364371442|FG003|Overall Study|Adverse Event|1|||
105647428|NCT00742560|364371443|FG004|Overall Study|Adverse Event|1|||
105647429|NCT00742560|364371439|FG000|Overall Study|Death|0|||
105647430|NCT00742560|364371440|FG001|Overall Study|Death|2|||
105647431|NCT00742560|364371441|FG002|Overall Study|Death|0|||
105647432|NCT00742560|364371442|FG003|Overall Study|Death|2|||
105647433|NCT00742560|364371443|FG004|Overall Study|Death|3|||
105647434|NCT00742560|364371439|FG000|Overall Study|Subject's Decision|1|||
105647435|NCT00742560|364371440|FG001|Overall Study|Subject's Decision|0|||
105647436|NCT00742560|364371441|FG002|Overall Study|Subject's Decision|2|||
105647437|NCT00742560|364371442|FG003|Overall Study|Subject's Decision|3|||
105647438|NCT00742560|364371443|FG004|Overall Study|Subject's Decision|3|||
105647439|NCT00742560|364371439|FG000|Overall Study|Investigator's Decision|0|||
105647440|NCT00742560|364371440|FG001|Overall Study|Investigator's Decision|0|||
105647441|NCT00742560|364371441|FG002|Overall Study|Investigator's Decision|4|||
105647442|NCT00742560|364371442|FG003|Overall Study|Investigator's Decision|1|||
105647443|NCT00742560|364371443|FG004|Overall Study|Investigator's Decision|0|||
105647444|NCT00742560|364371439|FG000|Overall Study|Disease Progression|1|||
105647445|NCT00742560|364371440|FG001|Overall Study|Disease Progression|0|||
105647446|NCT00742560|364371441|FG002|Overall Study|Disease Progression|5|||
105647447|NCT00742560|364371442|FG003|Overall Study|Disease Progression|17|||
105647448|NCT00742560|364371443|FG004|Overall Study|Disease Progression|16|||
105647449|NCT00742560|364371439|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
105647450|NCT00742560|364371440|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
105647451|NCT00742560|364371441|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
105647452|NCT00742560|364371442|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
105647453|NCT00742560|364371443|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
105647454|NCT00742560|364371439|FG000|Overall Study|Other|0|||
105647455|NCT00742560|364371440|FG001|Overall Study|Other|1|||
105647456|NCT00742560|364371441|FG002|Overall Study|Other|8|||
105647457|NCT00742560|364371442|FG003|Overall Study|Other|9|||
105647458|NCT00742560|364371443|FG004|Overall Study|Other|9|||
105647459|NCT00742560|364371439|FG000|Overall Study|MIssing|0|||
105647460|NCT00742560|364371440|FG001|Overall Study|MIssing|0|||
105647461|NCT00742560|364371441|FG002|Overall Study|MIssing|0|||
105647462|NCT00742560|364371442|FG003|Overall Study|MIssing|0|||
105647463|NCT00742560|364371443|FG004|Overall Study|MIssing|1|||
105647464|NCT02510560|364371444|FG000|Overall Study|Discontinued from Treatment|27|||
105647465|NCT02510560|364371445|FG001|Overall Study|Discontinued from Treatment|18|||
105647466|NCT02510560|364371446|FG002|Overall Study|Discontinued from Treatment|19|||
105647467|NCT02510560|364371444|FG000|Overall Study|Other|4|||
105647468|NCT02510560|364371445|FG001|Overall Study|Other|4|||
105647469|NCT02510560|364371446|FG002|Overall Study|Other|3|||
105647470|NCT03504397|364371447|FG000|Overall Study|Progressive Disease|151|||
105647471|NCT03504397|364371448|FG001|Overall Study|Progressive Disease|199|||
105647472|NCT03504397|364371447|FG000|Overall Study|Withdrawal by Subject|29|||
105647473|NCT03504397|364371448|FG001|Overall Study|Withdrawal by Subject|17|||
105647474|NCT03504397|364371447|FG000|Overall Study|Lost to Follow-up|1|||
105647475|NCT03504397|364371448|FG001|Overall Study|Lost to Follow-up|0|||
105647476|NCT03504397|364371447|FG000|Overall Study|Death|14|||
105647477|NCT03504397|364371448|FG001|Overall Study|Death|16|||
105647478|NCT03504397|364371447|FG000|Overall Study|Adverse Event|40|||
105647479|NCT03504397|364371448|FG001|Overall Study|Adverse Event|14|||
105647480|NCT03504397|364371447|FG000|Overall Study|miscellaneous|17|||
105647481|NCT03504397|364371448|FG001|Overall Study|miscellaneous|15|||
105647482|NCT03504397|364371447|FG000|Overall Study|Protocol deviation|1|||
105647483|NCT03504397|364371448|FG001|Overall Study|Protocol deviation|0|||
105647484|NCT03504397|364371447|FG000|Overall Study|Participants who did not take the study drug|4|||
105647485|NCT03504397|364371448|FG001|Overall Study|Participants who did not take the study drug|4|||
105647486|NCT03003962|364371450|FG000|Overall Study|Withdrawal by Subject|5|||
105647487|NCT03003962|364371451|FG001|Overall Study|Withdrawal by Subject|17|||
105647488|NCT03003962|364371450|FG000|Overall Study|Death|274|||
105647489|NCT03003962|364371451|FG001|Overall Study|Death|277|||
105647490|NCT03003962|364371450|FG000|Overall Study|Participants ongoing at DCO|55|||
105647491|NCT03003962|364371451|FG001|Overall Study|Participants ongoing at DCO|40|||
105647492|NCT02252172|364371452|FG000|Overall Study|Lost to Follow-up|3|||
105647493|NCT02252172|364371453|FG001|Overall Study|Lost to Follow-up|1|||
105647494|NCT02252172|364371452|FG000|Overall Study|Ongoing|276|||
105647495|NCT02252172|364371453|FG001|Overall Study|Ongoing|298|||
105647496|NCT01075815|364371456|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
105647497|NCT01075815|364371457|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
105647498|NCT01075815|364371456|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
105647499|NCT01075815|364371457|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
105647500|NCT01075815|364371456|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
105647501|NCT01075815|364371457|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
105647502|NCT02066389|364371460|FG000|Overall Study|Adverse Event|1|||
105647503|NCT02066389|364371461|FG001|Overall Study|Adverse Event|1|||
105647504|NCT02066389|364371462|FG002|Overall Study|Adverse Event|1|||
105647505|NCT02066389|364371463|FG003|Overall Study|Adverse Event|1|||
105647506|NCT02066389|364371464|FG004|Overall Study|Adverse Event|5|||
105647507|NCT02066389|364371465|FG005|Overall Study|Adverse Event|1|||
105647508|NCT02066389|364371460|FG000|Overall Study|Withdrawal by Subject|4|||
105647509|NCT02066389|364371461|FG001|Overall Study|Withdrawal by Subject|0|||
105647510|NCT02066389|364371462|FG002|Overall Study|Withdrawal by Subject|5|||
105647511|NCT02066389|364371463|FG003|Overall Study|Withdrawal by Subject|1|||
105647512|NCT02066389|364371464|FG004|Overall Study|Withdrawal by Subject|1|||
105647513|NCT02066389|364371465|FG005|Overall Study|Withdrawal by Subject|2|||
105647514|NCT02066389|364371460|FG000|Overall Study|Lost to Follow-up|0|||
105647515|NCT02066389|364371461|FG001|Overall Study|Lost to Follow-up|0|||
105647516|NCT02066389|364371462|FG002|Overall Study|Lost to Follow-up|0|||
105647517|NCT02066389|364371463|FG003|Overall Study|Lost to Follow-up|1|||
105647518|NCT02066389|364371464|FG004|Overall Study|Lost to Follow-up|1|||
105647519|NCT02066389|364371465|FG005|Overall Study|Lost to Follow-up|1|||
105647520|NCT02066389|364371460|FG000|Overall Study|Randomized in Error|0|||
105647521|NCT02066389|364371461|FG001|Overall Study|Randomized in Error|0|||
105647522|NCT02066389|364371462|FG002|Overall Study|Randomized in Error|0|||
105647523|NCT02066389|364371463|FG003|Overall Study|Randomized in Error|0|||
105647524|NCT02066389|364371464|FG004|Overall Study|Randomized in Error|0|||
105647525|NCT02066389|364371465|FG005|Overall Study|Randomized in Error|1|||
105647526|NCT01755598|364371466|FG000|Overall Study|Other|109|||
105647527|NCT01755598|364371467|FG001|Overall Study|Other|109|||
105647528|NCT01755598|364371466|FG000|Overall Study|Lost to Follow-up|32|||
105647529|NCT01755598|364371467|FG001|Overall Study|Lost to Follow-up|43|||
105647530|NCT01755598|364371466|FG000|Overall Study|Migrated/moved from study area|76|||
105647531|NCT01755598|364371467|FG001|Overall Study|Migrated/moved from study area|65|||
105647532|NCT01755598|364371466|FG000|Overall Study|Withdrawal by Subject|22|||
105647533|NCT01755598|364371467|FG001|Overall Study|Withdrawal by Subject|31|||
105647534|NCT01755598|364371466|FG000|Overall Study|Protocol Violation|7|||
105647535|NCT01755598|364371467|FG001|Overall Study|Protocol Violation|7|||
105647536|NCT01755598|364371466|FG000|Overall Study|Adverse Event|19|||
105647537|NCT01755598|364371467|FG001|Overall Study|Adverse Event|28|||
105647538|NCT01855399|364371470|FG000|6 Month|Lost to Follow-up|12|||
105647539|NCT01855399|364371471|FG001|6 Month|Lost to Follow-up|9|||
105647540|NCT01855399|364371470|FG000|6 Month|Withdrawal by Subject|8|||
105647541|NCT01855399|364371471|FG001|6 Month|Withdrawal by Subject|6|||
105647542|NCT01855399|364371470|FG000|12 Month|Lost to Follow-up|7|||
105647543|NCT01855399|364371471|FG001|12 Month|Lost to Follow-up|11|||
105647544|NCT00321672|364371472|FG000|Overall Study|Withdrawal by Subject|5|||
105647545|NCT00321672|364371473|FG001|Overall Study|Withdrawal by Subject|1|||
105647546|NCT00321672|364371474|FG002|Overall Study|Withdrawal by Subject|2|||
105647547|NCT00321672|364371475|FG003|Overall Study|Withdrawal by Subject|0|||
105647548|NCT00321672|364371472|FG000|Overall Study|Noncompliance|1|||
105647549|NCT00321672|364371473|FG001|Overall Study|Noncompliance|2|||
105647550|NCT00321672|364371474|FG002|Overall Study|Noncompliance|1|||
105647551|NCT00321672|364371475|FG003|Overall Study|Noncompliance|0|||
105647552|NCT00321672|364371472|FG000|Overall Study|Adverse Event|1|||
105647553|NCT00321672|364371473|FG001|Overall Study|Adverse Event|1|||
105647554|NCT00321672|364371474|FG002|Overall Study|Adverse Event|0|||
105647555|NCT00321672|364371475|FG003|Overall Study|Adverse Event|0|||
105647556|NCT00321672|364371472|FG000|Overall Study|Lack of Efficacy|1|||
105647557|NCT00321672|364371473|FG001|Overall Study|Lack of Efficacy|1|||
105647558|NCT00321672|364371474|FG002|Overall Study|Lack of Efficacy|0|||
105647559|NCT00321672|364371475|FG003|Overall Study|Lack of Efficacy|0|||
105647560|NCT00321672|364371472|FG000|Overall Study|Lost to Follow-up|2|||
105647561|NCT00321672|364371473|FG001|Overall Study|Lost to Follow-up|0|||
105647562|NCT00321672|364371474|FG002|Overall Study|Lost to Follow-up|4|||
105647563|NCT00321672|364371475|FG003|Overall Study|Lost to Follow-up|2|||
105647564|NCT00321672|364371472|FG000|Overall Study|Death|1|||
105647565|NCT00321672|364371473|FG001|Overall Study|Death|0|||
105647566|NCT00321672|364371474|FG002|Overall Study|Death|0|||
105647567|NCT00321672|364371475|FG003|Overall Study|Death|0|||
105647568|NCT00321672|364371472|FG000|Overall Study|Too far to travel for visits|1|||
105647569|NCT00321672|364371473|FG001|Overall Study|Too far to travel for visits|0|||
105647570|NCT00321672|364371474|FG002|Overall Study|Too far to travel for visits|0|||
105647571|NCT00321672|364371475|FG003|Overall Study|Too far to travel for visits|0|||
105647572|NCT00321672|364371472|FG000|Overall Study|Incarcerated|0|||
105647573|NCT00321672|364371473|FG001|Overall Study|Incarcerated|0|||
105647574|NCT00321672|364371474|FG002|Overall Study|Incarcerated|2|||
105647575|NCT00321672|364371475|FG003|Overall Study|Incarcerated|0|||
105647576|NCT00321672|364371472|FG000|Overall Study|Moved out of state|0|||
105647577|NCT00321672|364371473|FG001|Overall Study|Moved out of state|1|||
105647578|NCT00321672|364371474|FG002|Overall Study|Moved out of state|1|||
105647579|NCT00321672|364371475|FG003|Overall Study|Moved out of state|0|||
105647580|NCT00321672|364371472|FG000|Overall Study|Protocol Violation|0|||
105647581|NCT00321672|364371473|FG001|Overall Study|Protocol Violation|0|||
105647582|NCT00321672|364371474|FG002|Overall Study|Protocol Violation|1|||
105647583|NCT00321672|364371475|FG003|Overall Study|Protocol Violation|0|||
105647584|NCT00321672|364371472|FG000|Overall Study|Diagnosis of testicular cancer|0|||
105647585|NCT00321672|364371473|FG001|Overall Study|Diagnosis of testicular cancer|1|||
105647586|NCT00321672|364371474|FG002|Overall Study|Diagnosis of testicular cancer|0|||
105647587|NCT00321672|364371475|FG003|Overall Study|Diagnosis of testicular cancer|0|||
105647588|NCT00321672|364371472|FG000|Overall Study|Extensive travel required for new job|0|||
105647589|NCT00321672|364371473|FG001|Overall Study|Extensive travel required for new job|1|||
105647590|NCT00321672|364371474|FG002|Overall Study|Extensive travel required for new job|0|||
105647591|NCT00321672|364371475|FG003|Overall Study|Extensive travel required for new job|0|||
105647592|NCT03615404|364371476|FG000|Overall Study|Death|1|||
105647593|NCT03615404|364371476|FG000|Overall Study|vaccine did not pass quality assurance|1|||
105647594|NCT00936065|364371477|FG000|Overall Study|Adverse Event|1|||
105647595|NCT00936065|364371478|FG001|Overall Study|Adverse Event|0|||
105647596|NCT00936065|364371479|FG002|Overall Study|Adverse Event|1|||
105647597|NCT00936065|364371477|FG000|Overall Study|Lack of Efficacy|1|||
105647598|NCT00936065|364371478|FG001|Overall Study|Lack of Efficacy|0|||
105647599|NCT00936065|364371479|FG002|Overall Study|Lack of Efficacy|1|||
105647600|NCT00936065|364371477|FG000|Overall Study|Lost to Follow-up|1|||
105647601|NCT00936065|364371478|FG001|Overall Study|Lost to Follow-up|0|||
105647602|NCT00936065|364371479|FG002|Overall Study|Lost to Follow-up|0|||
105647603|NCT00936065|364371477|FG000|Overall Study|Protocol Violation|1|||
105647604|NCT00936065|364371478|FG001|Overall Study|Protocol Violation|2|||
105647605|NCT00936065|364371479|FG002|Overall Study|Protocol Violation|1|||
105647606|NCT00936065|364371477|FG000|Overall Study|Withdrawal by Subject|0|||
105647607|NCT00936065|364371478|FG001|Overall Study|Withdrawal by Subject|2|||
105647608|NCT00936065|364371479|FG002|Overall Study|Withdrawal by Subject|4|||
105647609|NCT02389894|364371480|FG000|Overall Study|Death|4|||
105647610|NCT02389894|364371481|FG001|Overall Study|Death|5|||
105647611|NCT02389894|364371482|FG002|Overall Study|Death|3|||
105647612|NCT02389894|364371480|FG000|Overall Study|Withdrawal by Subject|2|||
105647613|NCT02389894|364371481|FG001|Overall Study|Withdrawal by Subject|4|||
105647614|NCT02389894|364371482|FG002|Overall Study|Withdrawal by Subject|5|||
105647615|NCT02389894|364371480|FG000|Overall Study|Lost to Follow-up|2|||
105647616|NCT02389894|364371481|FG001|Overall Study|Lost to Follow-up|1|||
105647617|NCT02389894|364371482|FG002|Overall Study|Lost to Follow-up|1|||
105647618|NCT00145496|364371483|FG000|Overall Study|Adverse Event|42|||
105647619|NCT00145496|364371484|FG001|Overall Study|Adverse Event|30|||
105647620|NCT00145496|364371483|FG000|Overall Study|Lack of Efficacy|12|||
105647621|NCT00145496|364371484|FG001|Overall Study|Lack of Efficacy|7|||
105647622|NCT00145496|364371483|FG000|Overall Study|Withdrawal by Subject|32|||
105647623|NCT00145496|364371484|FG001|Overall Study|Withdrawal by Subject|26|||
105647624|NCT00145496|364371483|FG000|Overall Study|Lost to Follow-up|12|||
105647625|NCT00145496|364371484|FG001|Overall Study|Lost to Follow-up|5|||
105647626|NCT00145496|364371483|FG000|Overall Study|Other|25|||
105647627|NCT00145496|364371484|FG001|Overall Study|Other|13|||
105647628|NCT00448344|364371485|FG000|Overall Study|Lost to Follow-up|20|||
105647629|NCT00448344|364371486|FG001|Overall Study|Lost to Follow-up|22|||
105647630|NCT00448344|364371485|FG000|Overall Study|Withdrawal by Subject|6|||
105647631|NCT00448344|364371486|FG001|Overall Study|Withdrawal by Subject|8|||
105647632|NCT00448344|364371485|FG000|Overall Study|Death|3|||
105647633|NCT00448344|364371486|FG001|Overall Study|Death|4|||
105647634|NCT00448344|364371485|FG000|Overall Study|Physician Decision|1|||
105647635|NCT00448344|364371486|FG001|Overall Study|Physician Decision|2|||
105647636|NCT03689452|364371493|FG000|Overall Study|Lost to Follow-up|1|||
105647637|NCT03689452|364371494|FG001|Overall Study|Lost to Follow-up|1|||
105647638|NCT02676778|364371495|FG000|Overall Study|Disease Progression|7|||
105647639|NCT02676778|364371496|FG001|Overall Study|Disease Progression|3|||
105647640|NCT02676778|364371497|FG002|Overall Study|Disease Progression|1|||
105647641|NCT02676778|364371495|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
105647642|NCT02676778|364371496|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
105647643|NCT02676778|364371497|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
105647644|NCT02676778|364371495|FG000|Overall Study|Withdrawal by Subject|3|||
105647645|NCT02676778|364371496|FG001|Overall Study|Withdrawal by Subject|2|||
105647646|NCT02676778|364371497|FG002|Overall Study|Withdrawal by Subject|0|||
105647647|NCT02676778|364371495|FG000|Overall Study|Other|4|||
105647648|NCT02676778|364371496|FG001|Overall Study|Other|3|||
105647649|NCT02676778|364371497|FG002|Overall Study|Other|0|||
105647650|NCT02676778|364371495|FG000|Overall Study|Adverse Event|2|||
105647651|NCT02676778|364371496|FG001|Overall Study|Adverse Event|3|||
105647652|NCT02676778|364371497|FG002|Overall Study|Adverse Event|0|||
105647653|NCT03394508|364371501|FG000|Overall Study|Protocol Violation|0|||
105647654|NCT03394508|364371502|FG001|Overall Study|Protocol Violation|3|||
105647655|NCT03394508|364371501|FG000|Overall Study|Lost to Follow-up|1|||
105647656|NCT03394508|364371502|FG001|Overall Study|Lost to Follow-up|0|||
105647657|NCT01288729|364371503|FG000|Overall Study|Withdrawal by Subject|1|||
105647658|NCT01288729|364371504|FG001|Overall Study|Withdrawal by Subject|0|||
105647659|NCT03214198|364371505|FG000|Overall Study|Case Report Forms Uncollected|18|||
105647660|NCT03214198|364371505|FG000|Overall Study|Protocol Deviation|18|||
105647661|NCT00267865|364371506|FG000|Induction Treatment|Died before completing.|2|||
105647662|NCT00267865|364371506|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
105647663|NCT01636778|364371509|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
105647664|NCT01636778|364371510|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
105647665|NCT01636778|364371511|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
105647666|NCT01636778|364371509|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
105647667|NCT01636778|364371510|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
105647668|NCT01636778|364371511|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
105647669|NCT01636778|364371509|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
105647670|NCT01636778|364371510|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
105647671|NCT01636778|364371511|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
105647672|NCT01636778|364371509|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
105647673|NCT01636778|364371510|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
105647674|NCT01636778|364371511|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
105647675|NCT01636778|364371509|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
105647676|NCT01636778|364371510|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
105647677|NCT01636778|364371511|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
105647678|NCT01636778|364371509|FG000|Follow-up Period After Part 2|Other|0|||
105647679|NCT01636778|364371510|FG001|Follow-up Period After Part 2|Other|0|||
105647680|NCT01636778|364371511|FG002|Follow-up Period After Part 2|Other|1|||
105647681|NCT01636778|364371509|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
105647682|NCT01636778|364371510|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
105647683|NCT01636778|364371511|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
105647684|NCT01636778|364371509|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
105647685|NCT01636778|364371510|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
105647686|NCT01636778|364371511|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
105647687|NCT01945086|364371517|FG000|Overall Study|Withdrawal by Subject|1|||
105647688|NCT01945086|364371518|FG001|Overall Study|Withdrawal by Subject|0|||
105647689|NCT01945086|364371519|FG002|Overall Study|Withdrawal by Subject|1|||
105647690|NCT01945086|364371517|FG000|Overall Study|Adverse Event|0|||
105647691|NCT01945086|364371518|FG001|Overall Study|Adverse Event|0|||
105647692|NCT01945086|364371519|FG002|Overall Study|Adverse Event|1|||
105647693|NCT00748098|364371522|FG000|First Treatment Intervention Period|Adverse Event|1|||
105647694|NCT00748098|364371523|FG001|First Treatment Intervention Period|Adverse Event|1|||
105647695|NCT00748098|364371522|FG000|First Treatment Intervention Period|Protocol Violation|1|||
105647696|NCT00748098|364371523|FG001|First Treatment Intervention Period|Protocol Violation|0|||
105647697|NCT00748098|364371522|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
105647698|NCT00748098|364371523|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
105647699|NCT00748098|364371522|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
105647700|NCT00748098|364371523|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
105647701|NCT00748098|364371522|FG000|First Taper Period|Protocol Violation|1|||
105647702|NCT00748098|364371523|FG001|First Taper Period|Protocol Violation|0|||
105647703|NCT00748098|364371522|FG000|First Taper Period|Withdrawal by Subject|2|||
105647704|NCT00748098|364371523|FG001|First Taper Period|Withdrawal by Subject|0|||
105647705|NCT00748098|364371522|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
105647706|NCT00748098|364371523|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
105647707|NCT00748098|364371522|FG000|1-Week Washout Period|Adverse Event|0|||
105647708|NCT00748098|364371523|FG001|1-Week Washout Period|Adverse Event|1|||
105647709|NCT00748098|364371522|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
105647710|NCT00748098|364371523|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
105647711|NCT00748098|364371522|FG000|Second Treatment Intervention Period|Adverse Event|4|||
105647712|NCT00748098|364371523|FG001|Second Treatment Intervention Period|Adverse Event|1|||
105647713|NCT00748098|364371522|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
105647714|NCT00748098|364371523|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
105647715|NCT00748098|364371522|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
105659420|NCT00002597|364417320|FG001|Overall Study|Protocol Violation|17|||
105647716|NCT00748098|364371523|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
105647717|NCT02442622|364371526|FG000|Overall Study|Withdrawal by Subject|3|||
105647718|NCT02442622|364371527|FG001|Overall Study|Withdrawal by Subject|1|||
105647719|NCT00383500|364371528|FG000|Overall Study|Withdrawal by Subject|8|||
105647720|NCT00383500|364371529|FG001|Overall Study|Withdrawal by Subject|3|||
105647721|NCT00383500|364371530|FG002|Overall Study|Withdrawal by Subject|0|||
105647722|NCT00383500|364371528|FG000|Overall Study|Lost to Follow-up|0|||
105647723|NCT00383500|364371529|FG001|Overall Study|Lost to Follow-up|0|||
105647724|NCT00383500|364371530|FG002|Overall Study|Lost to Follow-up|2|||
105647725|NCT04341584|364371533|FG000|Overall Study|Withdrew consent|0|||
105647726|NCT04341584|364371534|FG001|Overall Study|Withdrew consent|2|||
105647727|NCT04341584|364371535|FG002|Overall Study|Withdrew consent|2|||
105647728|NCT04341584|364371536|FG003|Overall Study|Withdrew consent|1|||
105647729|NCT00760877|364373300|FG000|Overall Study|Protocol Violation|1|||
105647730|NCT00760877|364373301|FG001|Overall Study|Protocol Violation|0|||
105647731|NCT00760877|364373300|FG000|Overall Study|Non-compliance with protocol treatment|2|||
105647732|NCT00760877|364373301|FG001|Overall Study|Non-compliance with protocol treatment|1|||
105647733|NCT00760877|364373300|FG000|Overall Study|Pregnancy|1|||
105647734|NCT00760877|364373301|FG001|Overall Study|Pregnancy|4|||
105647735|NCT00760877|364373300|FG000|Overall Study|Death|2|||
105647736|NCT00760877|364373301|FG001|Overall Study|Death|1|||
105647737|NCT00760877|364373300|FG000|Overall Study|Withdrawal by Subject|7|||
105647738|NCT00760877|364373301|FG001|Overall Study|Withdrawal by Subject|3|||
105647739|NCT00760877|364373300|FG000|Overall Study|Adverse Event|19|||
105647740|NCT00760877|364373301|FG001|Overall Study|Adverse Event|12|||
105647741|NCT00760877|364373300|FG000|Overall Study|Participant diagnosed with AML|0|||
105647742|NCT00760877|364373301|FG001|Overall Study|Participant diagnosed with AML|1|||
105647743|NCT00760877|364373300|FG000|Overall Study|Participant not eligible to cross-over|0|||
105647744|NCT00760877|364373301|FG001|Overall Study|Participant not eligible to cross-over|1|||
105647745|NCT00760877|364373300|FG000|Overall Study|Physician Decision|1|||
105647746|NCT00760877|364373301|FG001|Overall Study|Physician Decision|2|||
105647747|NCT00760877|364373300|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
105647748|NCT00760877|364373301|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
105647749|NCT00760877|364373300|FG000|Overall Study|Treatment failure|1|||
105647750|NCT00760877|364373301|FG001|Overall Study|Treatment failure|0|||
105647751|NCT00711555|364373302|FG000|Overall Study|Adverse Event|3|||
105647752|NCT00946998|364373303|FG000|Overall Study|Exited prior to first outcome assessment|5|||
105647753|NCT00946998|364373304|FG001|Overall Study|Exited prior to first outcome assessment|3|||
105647754|NCT00489489|364373307|FG000|Overall Study|Not treated due to protocol violation|0|||
105647755|NCT00489489|364373308|FG001|Overall Study|Not treated due to protocol violation|1|||
105647756|NCT00489489|364373309|FG002|Overall Study|Not treated due to protocol violation|1|||
105647757|NCT00489489|364373307|FG000|Overall Study|Adverse Event|1|||
105647758|NCT00489489|364373308|FG001|Overall Study|Adverse Event|1|||
105647759|NCT00489489|364373309|FG002|Overall Study|Adverse Event|1|||
105647760|NCT00489489|364373307|FG000|Overall Study|Protocol Violation|1|||
105647761|NCT00489489|364373308|FG001|Overall Study|Protocol Violation|0|||
105647762|NCT00489489|364373309|FG002|Overall Study|Protocol Violation|1|||
105647763|NCT00489489|364373307|FG000|Overall Study|Progressive disease|0|||
105647764|NCT00489489|364373308|FG001|Overall Study|Progressive disease|1|||
105647765|NCT00489489|364373309|FG002|Overall Study|Progressive disease|0|||
105647766|NCT00489489|364373307|FG000|Overall Study|Participant did not wish to continue|1|||
105647767|NCT00489489|364373308|FG001|Overall Study|Participant did not wish to continue|1|||
105647768|NCT00489489|364373309|FG002|Overall Study|Participant did not wish to continue|0|||
105647769|NCT00489489|364373307|FG000|Overall Study|Other than above|0|||
105647770|NCT00489489|364373308|FG001|Overall Study|Other than above|1|||
105647771|NCT00489489|364373309|FG002|Overall Study|Other than above|0|||
105647772|NCT04851587|364373312|FG000|Overall Study|Lost to Follow-up|18|||
105647773|NCT03050372|364373313|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
105647774|NCT03050372|364373314|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
105647775|NCT03050372|364373313|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
105647776|NCT03050372|364373314|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
105647777|NCT03602053|364373315|FG000|Overall Study|Withdrawal by Subject|7|||
105647778|NCT03602053|364373316|FG001|Overall Study|Withdrawal by Subject|9|||
105647779|NCT03602053|364373317|FG002|Overall Study|Withdrawal by Subject|7|||
105647780|NCT03602053|364373315|FG000|Overall Study|Lost to Follow-up|5|||
105647781|NCT03602053|364373316|FG001|Overall Study|Lost to Follow-up|6|||
105647782|NCT03602053|364373317|FG002|Overall Study|Lost to Follow-up|0|||
105647783|NCT03602053|364373315|FG000|Overall Study|Protocol Violation|3|||
105647784|NCT03602053|364373316|FG001|Overall Study|Protocol Violation|0|||
105647785|NCT03602053|364373317|FG002|Overall Study|Protocol Violation|4|||
105647786|NCT03602053|364373315|FG000|Overall Study|Physician Decision|1|||
105647787|NCT03602053|364373316|FG001|Overall Study|Physician Decision|0|||
105647788|NCT03602053|364373317|FG002|Overall Study|Physician Decision|0|||
105647789|NCT03602053|364373315|FG000|Overall Study|migration|2|||
105647790|NCT03602053|364373316|FG001|Overall Study|migration|3|||
105647791|NCT03602053|364373317|FG002|Overall Study|migration|0|||
105647792|NCT03602053|364373315|FG000|Overall Study|Other|1|||
105647793|NCT03602053|364373316|FG001|Overall Study|Other|0|||
105647794|NCT03602053|364373317|FG002|Overall Study|Other|0|||
105647795|NCT03320941|364373329|FG000|Overall Study|subject/guardian decision|0|||
105647796|NCT03320941|364373330|FG001|Overall Study|subject/guardian decision|0|||
105647797|NCT03320941|364373331|FG002|Overall Study|subject/guardian decision|0|||
105647798|NCT03320941|364373332|FG003|Overall Study|subject/guardian decision|1|||
105647799|NCT03320941|364373333|FG004|Overall Study|subject/guardian decision|0|||
105647800|NCT03960437|364373336|FG000|Overall Study|Removed by PI|4|||
105647801|NCT03960437|364373336|FG000|Overall Study|Lost to Follow-up|2|||
105647802|NCT03960437|364373336|FG000|Overall Study|Withdrawal by Subject|1|||
105647803|NCT03960437|364373336|FG000|Overall Study|Death|2|||
105647804|NCT00473512|364373340|FG000|Period 1 (Phase 1)|Adverse Event|0|||
105647805|NCT00473512|364373341|FG001|Period 1 (Phase 1)|Adverse Event|0|||
105647806|NCT00473512|364373342|FG002|Period 1 (Phase 1)|Adverse Event|0|||
105647807|NCT00473512|364373343|FG003|Period 1 (Phase 1)|Adverse Event|5|||
105647808|NCT00473512|364373344|FG004|Period 1 (Phase 1)|Adverse Event|0|||
105647809|NCT00473512|364373340|FG000|Period 1 (Phase 1)|Death|0|||
105647810|NCT00473512|364373341|FG001|Period 1 (Phase 1)|Death|0|||
105647811|NCT00473512|364373342|FG002|Period 1 (Phase 1)|Death|0|||
105647812|NCT00473512|364373343|FG003|Period 1 (Phase 1)|Death|1|||
105647813|NCT00473512|364373344|FG004|Period 1 (Phase 1)|Death|0|||
105647814|NCT00473512|364373340|FG000|Period 1 (Phase 1)|Disease Progression|1|||
105647815|NCT00473512|364373341|FG001|Period 1 (Phase 1)|Disease Progression|1|||
105647816|NCT00473512|364373342|FG002|Period 1 (Phase 1)|Disease Progression|0|||
105647817|NCT00473512|364373343|FG003|Period 1 (Phase 1)|Disease Progression|10|||
105647818|NCT00473512|364373344|FG004|Period 1 (Phase 1)|Disease Progression|1|||
105647819|NCT00473512|364373340|FG000|Period 1 (Phase 1)|Other|0|||
105647820|NCT00473512|364373341|FG001|Period 1 (Phase 1)|Other|0|||
105647821|NCT00473512|364373342|FG002|Period 1 (Phase 1)|Other|0|||
105647822|NCT00473512|364373343|FG003|Period 1 (Phase 1)|Other|1|||
105647823|NCT00473512|364373344|FG004|Period 1 (Phase 1)|Other|0|||
105647824|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Adverse Event|0|||
105647825|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Adverse Event|0|||
105647826|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Adverse Event|0|||
105647827|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Adverse Event|1|||
105647828|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Adverse Event|0|||
105647829|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Death|0|||
105647830|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Death|0|||
105647831|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Death|0|||
105647832|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Death|1|||
105647833|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Death|1|||
105647834|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Disease Progression|0|||
105647835|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Disease Progression|2|||
105647836|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Disease Progression|2|||
105647837|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Disease Progression|17|||
105647838|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Disease Progression|1|||
105647839|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
105647840|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
105647841|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
105647842|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
105647843|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
105647844|NCT00473512|364373340|FG000|Period 2 (Phase 2)|Other|1|||
105647845|NCT00473512|364373341|FG001|Period 2 (Phase 2)|Other|0|||
105647846|NCT00473512|364373342|FG002|Period 2 (Phase 2)|Other|0|||
105647847|NCT00473512|364373343|FG003|Period 2 (Phase 2)|Other|3|||
105647848|NCT00473512|364373344|FG004|Period 2 (Phase 2)|Other|0|||
105647849|NCT01636258|364373345|FG000|Overall Study|Lost to Follow-up|1|||
105647850|NCT01636258|364373346|FG001|Overall Study|Lost to Follow-up|0|||
105647851|NCT01369147|364373350|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
105647852|NCT01369147|364373351|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
105647853|NCT01369147|364373352|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
105647854|NCT02722278|364373353|FG000|Overall Study|Withdrawal by Subject|5|||
105647855|NCT02722278|364373354|FG001|Overall Study|Withdrawal by Subject|3|||
105647856|NCT02722278|364373353|FG000|Overall Study|Adverse Event|4|||
105647857|NCT02722278|364373354|FG001|Overall Study|Adverse Event|1|||
105647858|NCT02722278|364373353|FG000|Overall Study|Lost to Follow-up|2|||
105647859|NCT02722278|364373354|FG001|Overall Study|Lost to Follow-up|0|||
105647860|NCT02722278|364373353|FG000|Overall Study|Protocol Violation|1|||
105647861|NCT02722278|364373354|FG001|Overall Study|Protocol Violation|0|||
105647862|NCT02722278|364373353|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
105647863|NCT02722278|364373354|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
105647864|NCT02722278|364373353|FG000|Overall Study|Subject declined after tx assignment|0|||
105647865|NCT02722278|364373354|FG001|Overall Study|Subject declined after tx assignment|1|||
105647866|NCT02722278|364373353|FG000|Overall Study|Site closure not study related|0|||
105647867|NCT02722278|364373354|FG001|Overall Study|Site closure not study related|1|||
105647868|NCT02023099|364373355|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
105647869|NCT02023099|364373356|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
105647870|NCT02023099|364373357|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
105647871|NCT02023099|364373355|FG000|Overall Study|Withdrawn Consent|3|||
105647872|NCT02023099|364373356|FG001|Overall Study|Withdrawn Consent|0|||
105647873|NCT02023099|364373357|FG002|Overall Study|Withdrawn Consent|1|||
105647874|NCT02023099|364373355|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
105647875|NCT02023099|364373356|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
105647876|NCT02023099|364373357|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
105647877|NCT02592434|364373358|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
105647878|NCT02592434|364373359|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
105647879|NCT02592434|364373360|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
105647880|NCT02592434|364373358|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
105647881|NCT02592434|364373359|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
105647882|NCT02592434|364373360|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
105647883|NCT02592434|364373358|FG000|Open-Label Phase (18 Weeks)|Other|3|||
105647884|NCT02592434|364373359|FG001|Open-Label Phase (18 Weeks)|Other|0|||
105647885|NCT02592434|364373360|FG002|Open-Label Phase (18 Weeks)|Other|0|||
105647886|NCT02592434|364373358|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
105647887|NCT02592434|364373359|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
105647888|NCT02592434|364373360|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
105647889|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
105647890|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
105647891|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
105647892|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
105647893|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
105647894|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
105647895|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Other|0|||
105647896|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Other|1|||
105647897|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Other|0|||
105647898|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
105647899|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
105647900|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
105647901|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
105647902|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
105647903|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
105647904|NCT02592434|364373358|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
105647905|NCT02592434|364373359|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
105647906|NCT02592434|364373360|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
105647907|NCT01525875|364373361|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
105647908|NCT01525875|364373362|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
105647909|NCT01525875|364373361|FG000|Open-label Period|Lost to Follow-up|0|||
105647910|NCT01525875|364373362|FG001|Open-label Period|Lost to Follow-up|2|||
105647911|NCT01103141|364373363|FG000|Overall Study|Death|0|||
105647912|NCT01103141|364373364|FG001|Overall Study|Death|1|||
105647913|NCT01103141|364373363|FG000|Overall Study|Lost to Follow-up|2|||
105647914|NCT01103141|364373364|FG001|Overall Study|Lost to Follow-up|1|||
105647915|NCT01762345|364373365|FG000|Overall Study|Adverse Event|5|||
105647916|NCT01762345|364373365|FG000|Overall Study|Protocol Violation|2|||
105647917|NCT01403805|364373366|FG000|Overall Study|Withdrawal by Subject|0|||
105647918|NCT01403805|364373367|FG001|Overall Study|Withdrawal by Subject|4|||
105647919|NCT01403805|364373366|FG000|Overall Study|Lost to Follow-up|0|||
105647920|NCT01403805|364373367|FG001|Overall Study|Lost to Follow-up|2|||
105647921|NCT01403805|364373366|FG000|Overall Study|Death|0|||
105647922|NCT01403805|364373367|FG001|Overall Study|Death|1|||
105647923|NCT01124916|364373372|FG000|Overall Study|Lost to Follow-up|3|||
105647924|NCT01124916|364373373|FG001|Overall Study|Lost to Follow-up|2|||
105647925|NCT00938041|364373374|FG000|Overall Study|Lost to Follow-up|6|||
105647926|NCT00938041|364373374|FG000|Overall Study|Received Alternative Therapy|1|||
105647927|NCT00938041|364373374|FG000|Overall Study|Progressive Disease|5|||
105647928|NCT00938041|364373374|FG000|Overall Study|Death|12|||
105647929|NCT00938041|364373374|FG000|Overall Study|Adrenal Insufficiency|3|||
105647930|NCT02475733|364373379|FG000|Overall Study|Withdrawal by Subject|1|||
105647931|NCT02475733|364373380|FG001|Overall Study|Withdrawal by Subject|0|||
105647932|NCT02475733|364373379|FG000|Overall Study|Physician Decision|1|||
105647933|NCT02475733|364373380|FG001|Overall Study|Physician Decision|0|||
105647934|NCT00510783|364373385|FG000|Overall Study|Lost to Follow-up|29|||
105647935|NCT00510783|364373386|FG001|Overall Study|Lost to Follow-up|25|||
105647936|NCT00510783|364373385|FG000|Overall Study|Withdrawal by Subject|2|||
105647937|NCT00510783|364373386|FG001|Overall Study|Withdrawal by Subject|3|||
105647938|NCT00510783|364373385|FG000|Overall Study|Protocol Violation|0|||
105647939|NCT00510783|364373386|FG001|Overall Study|Protocol Violation|1|||
105647940|NCT02305797|364373387|FG000|Overall Study|Adverse Event|11|||
105647941|NCT02305797|364373388|FG001|Overall Study|Adverse Event|2|||
105647942|NCT02305797|364373387|FG000|Overall Study|Withdrawal by Subject|9|||
105647943|NCT02305797|364373388|FG001|Overall Study|Withdrawal by Subject|10|||
105647944|NCT02305797|364373387|FG000|Overall Study|Lack of Efficacy|6|||
105647945|NCT02305797|364373388|FG001|Overall Study|Lack of Efficacy|0|||
105647946|NCT02305797|364373387|FG000|Overall Study|Lost to Follow-up|5|||
105647947|NCT02305797|364373388|FG001|Overall Study|Lost to Follow-up|11|||
105647948|NCT02305797|364373387|FG000|Overall Study|Pregnancy|0|||
105647949|NCT02305797|364373388|FG001|Overall Study|Pregnancy|2|||
105647950|NCT02305797|364373387|FG000|Overall Study|Noncompliance|14|||
105647951|NCT02305797|364373388|FG001|Overall Study|Noncompliance|12|||
105647952|NCT02305797|364373387|FG000|Overall Study|Reason not collected|0|||
105647953|NCT02305797|364373388|FG001|Overall Study|Reason not collected|1|||
105647954|NCT00422162|364373389|FG000|Overall Study|Adverse Event|11|||
105647955|NCT00422162|364373390|FG001|Overall Study|Adverse Event|9|||
105647956|NCT00422162|364373389|FG000|Overall Study|Lack of Efficacy|4|||
105647957|NCT00422162|364373390|FG001|Overall Study|Lack of Efficacy|10|||
105647958|NCT00422162|364373389|FG000|Overall Study|Withdrawal by Subject|7|||
105647959|NCT00422162|364373390|FG001|Overall Study|Withdrawal by Subject|6|||
105647960|NCT00422162|364373389|FG000|Overall Study|Lost to Follow-up|1|||
105647961|NCT00422162|364373390|FG001|Overall Study|Lost to Follow-up|2|||
105647962|NCT00422162|364373389|FG000|Overall Study|Non-Compliant with Protocol|1|||
105647963|NCT00422162|364373390|FG001|Overall Study|Non-Compliant with Protocol|1|||
105647964|NCT00422162|364373389|FG000|Overall Study|Other|0|||
105647965|NCT00422162|364373390|FG001|Overall Study|Other|1|||
105647966|NCT00422162|364373389|FG000|Overall Study|Didn't Receive Treatment|0|||
105647967|NCT00422162|364373390|FG001|Overall Study|Didn't Receive Treatment|1|||
105647968|NCT05274906|364373391|FG000|Overall Study|Withdrawal by Subject|2|||
105647969|NCT05274906|364373392|FG001|Overall Study|Withdrawal by Subject|1|||
105647970|NCT03508830|364373393|FG000|Overall Study|Withdrawal by Subject|3|||
105647971|NCT03508830|364373394|FG001|Overall Study|Withdrawal by Subject|4|||
105647972|NCT03508830|364373393|FG000|Overall Study|Physician Decision|2|||
105647973|NCT03508830|364373394|FG001|Overall Study|Physician Decision|2|||
105647974|NCT03906240|364373397|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
105647975|NCT03906240|364373398|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
105647976|NCT03906240|364373397|FG000|Overall Study|Lost to Follow-up|1|||
105647977|NCT03906240|364373398|FG001|Overall Study|Lost to Follow-up|0|||
105647978|NCT03906240|364373397|FG000|Overall Study|Withdrawal by Subject|0|||
105647979|NCT03906240|364373398|FG001|Overall Study|Withdrawal by Subject|1|||
105647980|NCT04908800|364373403|FG000|Overall Study|Adverse Event|0|||
105647981|NCT04908800|364373404|FG001|Overall Study|Adverse Event|0|||
105647982|NCT04908800|364373405|FG002|Overall Study|Adverse Event|0|||
105647983|NCT04908800|364373406|FG003|Overall Study|Adverse Event|0|||
105647984|NCT04908800|364373407|FG004|Overall Study|Adverse Event|0|||
105647985|NCT04908800|364373408|FG005|Overall Study|Adverse Event|0|||
105647986|NCT04908800|364373409|FG006|Overall Study|Adverse Event|0|||
105647987|NCT04908800|364373410|FG007|Overall Study|Adverse Event|0|||
105647988|NCT04908800|364373411|FG008|Overall Study|Adverse Event|0|||
105647989|NCT04908800|364373412|FG009|Overall Study|Adverse Event|0|||
105647990|NCT04908800|364373413|FG010|Overall Study|Adverse Event|1|||
105647991|NCT04908800|364373414|FG011|Overall Study|Adverse Event|0|||
105647992|NCT04908800|364373415|FG012|Overall Study|Adverse Event|0|||
105647993|NCT00157209|364373416|FG000|Overall Study|Ongoing at data cut-off|10|||
105647994|NCT00157209|364373417|FG001|Overall Study|Ongoing at data cut-off|0|||
105647995|NCT04474691|364373418|FG000|Overall Study|Withdrawal by Subject|9|||
105647996|NCT01047306|364373419|FG000|Overall Study|Withdrawal by Subject|2|||
105647997|NCT01047306|364373420|FG001|Overall Study|Withdrawal by Subject|0|||
105647998|NCT01047306|364373419|FG000|Overall Study|Lost to Follow-up|1|||
105647999|NCT01047306|364373420|FG001|Overall Study|Lost to Follow-up|0|||
105648000|NCT01878253|364373421|FG000|Overall Study|Death|1|||
105648001|NCT01878253|364373421|FG000|Overall Study|SIdus System Removal|3|||
105648002|NCT01878253|364373421|FG000|Overall Study|Withdrawal by Subject|1|||
105648003|NCT01878253|364373421|FG000|Overall Study|Lost to Follow-up|2|||
105648004|NCT01878253|364373421|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
105648005|NCT03647709|364373422|FG000|Overall Study|Lost to Follow-up|5|||
105648006|NCT03647709|364373422|FG000|Overall Study|Physician Decision|6|||
105648007|NCT03647709|364373422|FG000|Overall Study|Withdrawal by Subject|3|||
105648008|NCT00850993|364373423|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
105648009|NCT00850993|364373424|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
105648010|NCT00850993|364373425|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
105648011|NCT00850993|364373426|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
105648012|NCT03839355|364373427|FG000|Overall Study|Withdrawal by Subject|1|||
105648013|NCT03839355|364373428|FG001|Overall Study|Withdrawal by Subject|0|||
105648014|NCT02809677|364373435|FG000|Overall Study|Withdrawal by Subject|8|||
105648015|NCT04736472|364373436|FG000|Overall Study|Lost to Follow-up|1|||
105648016|NCT04736472|364373437|FG001|Overall Study|Lost to Follow-up|0|||
105648017|NCT04736472|364373438|FG002|Overall Study|Lost to Follow-up|0|||
105648018|NCT04736472|364373436|FG000|Overall Study|Withdrawal by Subject|2|||
105648019|NCT04736472|364373437|FG001|Overall Study|Withdrawal by Subject|0|||
105648020|NCT04736472|364373438|FG002|Overall Study|Withdrawal by Subject|0|||
105648021|NCT04736472|364373436|FG000|Overall Study|Protocol Violation|48|||
105648022|NCT04736472|364373437|FG001|Overall Study|Protocol Violation|0|||
105648023|NCT04736472|364373438|FG002|Overall Study|Protocol Violation|6|||
105648024|NCT02374476|364373439|FG000|VT Induced Ablation|Screening Failures|36|||
105648025|NCT02374476|364373440|FG001|VT Induced Ablation|Screening Failures|0|||
105648026|NCT02374476|364373441|FG002|VT Induced Ablation|Screening Failures|0|||
105648027|NCT02374476|364373439|FG000|Arm Assignment|Withdrawal by Subject|0|||
105648028|NCT02374476|364373440|FG001|Arm Assignment|Withdrawal by Subject|0|||
105648029|NCT02374476|364373441|FG002|Arm Assignment|Withdrawal by Subject|1|||
105648030|NCT03219216|364373442|FG000|Overall Study|Lost to Follow-up|0|||
105648031|NCT03219216|364373443|FG001|Overall Study|Lost to Follow-up|1|||
105648032|NCT03305458|364373444|FG000|Overall Study|Withdrawal by Subject|50|||
105648033|NCT03305458|364373445|FG001|Overall Study|Withdrawal by Subject|46|||
105648034|NCT03305458|364373446|FG002|Overall Study|Withdrawal by Subject|93|||
105648035|NCT03305458|364373444|FG000|Overall Study|Lost to Follow-up|85|||
105648036|NCT03305458|364373445|FG001|Overall Study|Lost to Follow-up|85|||
105648037|NCT03305458|364373446|FG002|Overall Study|Lost to Follow-up|35|||
105648038|NCT02332824|364373447|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
105648039|NCT02332824|364373448|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
105648040|NCT02332824|364373449|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
105648041|NCT02332824|364373450|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
105648042|NCT02332824|364373451|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
105648043|NCT02332824|364373452|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
105648044|NCT02332824|364373447|FG000|Overall Study|Voluntary Withdrawal|1|||
105648045|NCT02332824|364373448|FG001|Overall Study|Voluntary Withdrawal|0|||
105648046|NCT02332824|364373449|FG002|Overall Study|Voluntary Withdrawal|0|||
105648047|NCT02332824|364373450|FG003|Overall Study|Voluntary Withdrawal|0|||
105648048|NCT02332824|364373451|FG004|Overall Study|Voluntary Withdrawal|0|||
105648049|NCT02332824|364373452|FG005|Overall Study|Voluntary Withdrawal|0|||
105648050|NCT02332824|364373447|FG000|Overall Study|Inconvenient schedule|1|||
105648051|NCT02332824|364373448|FG001|Overall Study|Inconvenient schedule|1|||
105648052|NCT02332824|364373449|FG002|Overall Study|Inconvenient schedule|0|||
105648053|NCT02332824|364373450|FG003|Overall Study|Inconvenient schedule|0|||
105648054|NCT02332824|364373451|FG004|Overall Study|Inconvenient schedule|0|||
105648055|NCT02332824|364373452|FG005|Overall Study|Inconvenient schedule|0|||
105648056|NCT02332824|364373447|FG000|Overall Study|Transfer|0|||
105648057|NCT02332824|364373448|FG001|Overall Study|Transfer|0|||
105648058|NCT02332824|364373449|FG002|Overall Study|Transfer|1|||
105648059|NCT02332824|364373450|FG003|Overall Study|Transfer|1|||
105648060|NCT02332824|364373451|FG004|Overall Study|Transfer|0|||
105648061|NCT02332824|364373452|FG005|Overall Study|Transfer|0|||
105648062|NCT00914732|364373453|FG000|Overall Study|Lost to Follow-up|6|||
105648063|NCT00914732|364373454|FG001|Overall Study|Lost to Follow-up|7|||
105648064|NCT00914732|364373455|FG002|Overall Study|Lost to Follow-up|9|||
105648065|NCT00914732|364373453|FG000|Overall Study|Withdrawal by Subject|3|||
105648066|NCT00914732|364373454|FG001|Overall Study|Withdrawal by Subject|0|||
105648067|NCT00914732|364373455|FG002|Overall Study|Withdrawal by Subject|2|||
105648068|NCT00914732|364373453|FG000|Overall Study|Adverse Event|1|||
105648069|NCT00914732|364373454|FG001|Overall Study|Adverse Event|0|||
105648070|NCT00914732|364373455|FG002|Overall Study|Adverse Event|0|||
105648071|NCT02130401|364373456|FG000|Overall Study|Poor enrollment|6|||
105648072|NCT03840148|364373457|FG000|Study Drug Disposition|Adverse Event|13|||
105648073|NCT03840148|364373458|FG001|Study Drug Disposition|Adverse Event|2|||
105648074|NCT03840148|364373457|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
105648075|NCT03840148|364373458|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
105648076|NCT03840148|364373457|FG000|Study Drug Disposition|Lack of Efficacy|3|||
105648077|NCT03840148|364373458|FG001|Study Drug Disposition|Lack of Efficacy|0|||
105648078|NCT03840148|364373457|FG000|Study Drug Disposition|Physician Decision|2|||
105648079|NCT03840148|364373458|FG001|Study Drug Disposition|Physician Decision|0|||
105648080|NCT03840148|364373457|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
105648081|NCT03840148|364373458|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
105648082|NCT03840148|364373457|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
105648083|NCT03840148|364373458|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
105648084|NCT03840148|364373457|FG000|Study Completion Disposition|Physician Decision|2|||
105648085|NCT03840148|364373458|FG001|Study Completion Disposition|Physician Decision|0|||
105648086|NCT03840148|364373457|FG000|Study Completion Disposition|Covid-19 related|2|||
105648087|NCT03840148|364373458|FG001|Study Completion Disposition|Covid-19 related|0|||
105648088|NCT03840148|364373457|FG000|Study Completion Disposition|Lost to Follow-up|1|||
105648089|NCT03840148|364373458|FG001|Study Completion Disposition|Lost to Follow-up|1|||
105648090|NCT03840148|364373457|FG000|Study Completion Disposition|Death|1|||
105648091|NCT03840148|364373458|FG001|Study Completion Disposition|Death|0|||
105648092|NCT03840148|364373457|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
105648093|NCT03840148|364373458|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
105648094|NCT04394624|364373462|FG000|Overall Study|Adverse Event|6|||
105648095|NCT04394624|364373463|FG001|Overall Study|Adverse Event|0|||
105648096|NCT04394624|364373462|FG000|Overall Study|Progressive disease|24|||
105648097|NCT04394624|364373463|FG001|Overall Study|Progressive disease|0|||
105648098|NCT04394624|364373462|FG000|Overall Study|Not related to COVID-19|1|||
105648099|NCT04394624|364373463|FG001|Overall Study|Not related to COVID-19|0|||
105648100|NCT01774929|364373464|FG000|Overall Study|Adverse Event|3|||
105648101|NCT04374253|364373466|FG000|Overall Study|Adverse Event|0|||
105648102|NCT04374253|364373467|FG001|Overall Study|Adverse Event|26|||
105648103|NCT04374253|364373468|FG002|Overall Study|Adverse Event|2|||
105648104|NCT04374253|364373469|FG003|Overall Study|Adverse Event|12|||
105648105|NCT04374253|364373466|FG000|Overall Study|Study terminated by sponsor|13|||
105648106|NCT04374253|364373467|FG001|Overall Study|Study terminated by sponsor|593|||
105648107|NCT04374253|364373468|FG002|Overall Study|Study terminated by sponsor|21|||
105648108|NCT04374253|364373469|FG003|Overall Study|Study terminated by sponsor|567|||
105648109|NCT04374253|364373466|FG000|Overall Study|Withdrawal by Subject|0|||
105648110|NCT04374253|364373467|FG001|Overall Study|Withdrawal by Subject|55|||
105648111|NCT04374253|364373468|FG002|Overall Study|Withdrawal by Subject|3|||
105648112|NCT04374253|364373469|FG003|Overall Study|Withdrawal by Subject|40|||
105648113|NCT04374253|364373466|FG000|Overall Study|Physician Decision|1|||
105648114|NCT04374253|364373467|FG001|Overall Study|Physician Decision|10|||
105648115|NCT04374253|364373468|FG002|Overall Study|Physician Decision|1|||
105648116|NCT04374253|364373469|FG003|Overall Study|Physician Decision|10|||
105648117|NCT04374253|364373466|FG000|Overall Study|Protocol Violation|0|||
105648118|NCT04374253|364373467|FG001|Overall Study|Protocol Violation|0|||
105648119|NCT04374253|364373468|FG002|Overall Study|Protocol Violation|0|||
105648120|NCT04374253|364373469|FG003|Overall Study|Protocol Violation|2|||
105648121|NCT04374253|364373466|FG000|Overall Study|Death|0|||
105648122|NCT04374253|364373467|FG001|Overall Study|Death|3|||
105648123|NCT04374253|364373468|FG002|Overall Study|Death|1|||
105648124|NCT04374253|364373469|FG003|Overall Study|Death|1|||
105648125|NCT04374253|364373466|FG000|Overall Study|Lack of Efficacy|0|||
105648126|NCT04374253|364373467|FG001|Overall Study|Lack of Efficacy|0|||
105648127|NCT04374253|364373468|FG002|Overall Study|Lack of Efficacy|0|||
105648128|NCT04374253|364373469|FG003|Overall Study|Lack of Efficacy|1|||
105648129|NCT04374253|364373466|FG000|Overall Study|Lost to Follow-up|1|||
105648130|NCT04374253|364373467|FG001|Overall Study|Lost to Follow-up|1|||
105648131|NCT04374253|364373468|FG002|Overall Study|Lost to Follow-up|0|||
105648132|NCT04374253|364373469|FG003|Overall Study|Lost to Follow-up|2|||
105648133|NCT04374253|364373466|FG000|Overall Study|Reason Not Specified|0|||
105648134|NCT04374253|364373467|FG001|Overall Study|Reason Not Specified|8|||
105648135|NCT04374253|364373468|FG002|Overall Study|Reason Not Specified|0|||
105648136|NCT04374253|364373469|FG003|Overall Study|Reason Not Specified|8|||
105648137|NCT04413149|364374842|FG000|Overall Study|Death|10|||
105648138|NCT04413149|364374843|FG001|Overall Study|Death|5|||
105648139|NCT04413149|364374842|FG000|Overall Study|Lung transplantation|1|||
105648140|NCT04413149|364374843|FG001|Overall Study|Lung transplantation|0|||
105648141|NCT02878590|364374844|FG000|Overall Study|Withdrawal by Subject|2|||
105648142|NCT01730118|364374845|FG000|Dose Escalation|Death on study|5|||
105648143|NCT01730118|364374846|FG001|Dose Escalation|Death on study|7|||
105648144|NCT01730118|364374847|FG002|Dose Escalation|Death on study|2|||
105648145|NCT01730118|364374848|FG003|Dose Escalation|Death on study|6|||
105648146|NCT01730118|364374849|FG004|Dose Escalation|Death on study|0|||
105648147|NCT01730118|364374850|FG005|Dose Escalation|Death on study|0|||
105648148|NCT01730118|364374851|FG006|Dose Escalation|Death on study|0|||
105648149|NCT01730118|364374845|FG000|Dose Escalation|Died before treatment|0|||
105648150|NCT01730118|364374846|FG001|Dose Escalation|Died before treatment|0|||
105648151|NCT01730118|364374847|FG002|Dose Escalation|Died before treatment|0|||
105648152|NCT01730118|364374848|FG003|Dose Escalation|Died before treatment|0|||
105648153|NCT01730118|364374849|FG004|Dose Escalation|Died before treatment|0|||
105648154|NCT01730118|364374850|FG005|Dose Escalation|Died before treatment|0|||
105648155|NCT01730118|364374851|FG006|Dose Escalation|Died before treatment|1|||
105648156|NCT01730118|364374845|FG000|Dose Escalation|Chose to start a different treatment|1|||
105648157|NCT01730118|364374846|FG001|Dose Escalation|Chose to start a different treatment|0|||
105648158|NCT01730118|364374847|FG002|Dose Escalation|Chose to start a different treatment|0|||
105648159|NCT01730118|364374848|FG003|Dose Escalation|Chose to start a different treatment|0|||
105648160|NCT01730118|364374849|FG004|Dose Escalation|Chose to start a different treatment|0|||
105648161|NCT01730118|364374850|FG005|Dose Escalation|Chose to start a different treatment|0|||
105648162|NCT01730118|364374851|FG006|Dose Escalation|Chose to start a different treatment|0|||
105648163|NCT01730118|364374845|FG000|Dose Escalation|Withdrawal by Subject|0|||
105648164|NCT01730118|364374846|FG001|Dose Escalation|Withdrawal by Subject|0|||
105648165|NCT01730118|364374847|FG002|Dose Escalation|Withdrawal by Subject|1|||
105648166|NCT01730118|364374848|FG003|Dose Escalation|Withdrawal by Subject|0|||
105648167|NCT01730118|364374849|FG004|Dose Escalation|Withdrawal by Subject|0|||
105648168|NCT01730118|364374850|FG005|Dose Escalation|Withdrawal by Subject|0|||
105648169|NCT01730118|364374851|FG006|Dose Escalation|Withdrawal by Subject|0|||
105648170|NCT01730118|364374845|FG000|Dose Escalation|Disease progression prior to treatment|0|||
105648171|NCT01730118|364374846|FG001|Dose Escalation|Disease progression prior to treatment|0|||
105648172|NCT01730118|364374847|FG002|Dose Escalation|Disease progression prior to treatment|0|||
105648173|NCT01730118|364374848|FG003|Dose Escalation|Disease progression prior to treatment|0|||
105648174|NCT01730118|364374849|FG004|Dose Escalation|Disease progression prior to treatment|0|||
105648175|NCT01730118|364374850|FG005|Dose Escalation|Disease progression prior to treatment|0|||
105648176|NCT01730118|364374851|FG006|Dose Escalation|Disease progression prior to treatment|1|||
105648177|NCT01730118|364374845|FG000|Dose Expansion|Death|0|||
105648178|NCT01730118|364374846|FG001|Dose Expansion|Death|0|||
105648179|NCT01730118|364374847|FG002|Dose Expansion|Death|0|||
105648180|NCT01730118|364374848|FG003|Dose Expansion|Death|0|||
105648181|NCT01730118|364374849|FG004|Dose Expansion|Death|1|||
105648182|NCT01730118|364374850|FG005|Dose Expansion|Death|0|||
105648183|NCT01730118|364374851|FG006|Dose Expansion|Death|0|||
105648184|NCT01730118|364374845|FG000|Dose Expansion|Other medical condition|0|||
105648185|NCT01730118|364374846|FG001|Dose Expansion|Other medical condition|0|||
105648186|NCT01730118|364374847|FG002|Dose Expansion|Other medical condition|0|||
105648187|NCT01730118|364374848|FG003|Dose Expansion|Other medical condition|0|||
105648188|NCT01730118|364374849|FG004|Dose Expansion|Other medical condition|1|||
105648189|NCT01730118|364374850|FG005|Dose Expansion|Other medical condition|0|||
105648190|NCT01730118|364374851|FG006|Dose Expansion|Other medical condition|0|||
105648191|NCT01730118|364374845|FG000|Dose Expansion|Withdrawal by Subject|0|||
105648192|NCT01730118|364374846|FG001|Dose Expansion|Withdrawal by Subject|0|||
105648193|NCT01730118|364374847|FG002|Dose Expansion|Withdrawal by Subject|0|||
105648194|NCT01730118|364374848|FG003|Dose Expansion|Withdrawal by Subject|0|||
105648195|NCT01730118|364374849|FG004|Dose Expansion|Withdrawal by Subject|1|||
105648196|NCT01730118|364374850|FG005|Dose Expansion|Withdrawal by Subject|0|||
105648197|NCT01730118|364374851|FG006|Dose Expansion|Withdrawal by Subject|0|||
105648198|NCT01730118|364374845|FG000|Dose Expansion|Disease progression|0|||
105648199|NCT01730118|364374846|FG001|Dose Expansion|Disease progression|0|||
105648200|NCT01730118|364374847|FG002|Dose Expansion|Disease progression|0|||
105648201|NCT01730118|364374848|FG003|Dose Expansion|Disease progression|0|||
105648202|NCT01730118|364374849|FG004|Dose Expansion|Disease progression|0|||
105648203|NCT01730118|364374850|FG005|Dose Expansion|Disease progression|1|||
105648204|NCT01730118|364374851|FG006|Dose Expansion|Disease progression|0|||
105648205|NCT01730118|364374845|FG000|Dose Expansion|Inability to return|0|||
105648206|NCT01730118|364374846|FG001|Dose Expansion|Inability to return|0|||
105648207|NCT01730118|364374847|FG002|Dose Expansion|Inability to return|0|||
105648208|NCT01730118|364374848|FG003|Dose Expansion|Inability to return|0|||
105648209|NCT01730118|364374849|FG004|Dose Expansion|Inability to return|0|||
105648210|NCT01730118|364374850|FG005|Dose Expansion|Inability to return|1|||
105648211|NCT01730118|364374851|FG006|Dose Expansion|Inability to return|0|||
105648212|NCT01730118|364374845|FG000|Dose Expansion|Physician Decision|0|||
105648213|NCT01730118|364374846|FG001|Dose Expansion|Physician Decision|0|||
105648214|NCT01730118|364374847|FG002|Dose Expansion|Physician Decision|0|||
105648215|NCT01730118|364374848|FG003|Dose Expansion|Physician Decision|0|||
105648216|NCT01730118|364374849|FG004|Dose Expansion|Physician Decision|0|||
105648217|NCT01730118|364374850|FG005|Dose Expansion|Physician Decision|1|||
105648218|NCT01730118|364374851|FG006|Dose Expansion|Physician Decision|0|||
105648219|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
105648220|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
105648221|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
105648222|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
105648223|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
105648224|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
105648225|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
105648226|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
105648227|NCT05066230|364374853|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
105648228|NCT05066230|364374854|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
105648229|NCT05066230|364374853|FG000|After Week 48|Adverse Event|1|||
105648230|NCT05066230|364374854|FG001|After Week 48|Adverse Event|0|||
105648231|NCT05066230|364374853|FG000|After Week 48|Non-compliance with study schedule|1|||
105648232|NCT05066230|364374854|FG001|After Week 48|Non-compliance with study schedule|0|||
105648233|NCT05066230|364374853|FG000|After Week 48|Withdrawal by Subject|0|||
105648234|NCT05066230|364374854|FG001|After Week 48|Withdrawal by Subject|1|||
105648235|NCT05066230|364374853|FG000|After Week 48|Lost to Follow-up|3|||
105648236|NCT05066230|364374854|FG001|After Week 48|Lost to Follow-up|3|||
105648237|NCT05066230|364374853|FG000|After Week 48|Sponsor Request|115|||
105648238|NCT05066230|364374854|FG001|After Week 48|Sponsor Request|111|||
105648239|NCT04523571|364374855|FG000|Received 2 Doses|Withdrawal by Subject|0|||
105648240|NCT04523571|364374856|FG001|Received 2 Doses|Withdrawal by Subject|0|||
105648241|NCT04523571|364374857|FG002|Received 2 Doses|Withdrawal by Subject|0|||
105648242|NCT04523571|364374858|FG003|Received 2 Doses|Withdrawal by Subject|1|||
105648243|NCT04523571|364374859|FG004|Received 2 Doses|Withdrawal by Subject|1|||
105648244|NCT04523571|364374860|FG005|Received 2 Doses|Withdrawal by Subject|0|||
105648245|NCT04523571|364374855|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
105648246|NCT04523571|364374856|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
105648247|NCT04523571|364374857|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
105648248|NCT04523571|364374858|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
105648249|NCT04523571|364374859|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
105648250|NCT04523571|364374860|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
105648251|NCT04523571|364374855|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648252|NCT04523571|364374856|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648253|NCT04523571|364374857|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648254|NCT04523571|364374858|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648255|NCT04523571|364374859|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
105648256|NCT04523571|364374860|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
105648257|NCT04523571|364374855|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
105648258|NCT04523571|364374856|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
105648259|NCT04523571|364374857|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
105648260|NCT04523571|364374858|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
105648261|NCT04523571|364374859|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
105648262|NCT04523571|364374860|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
105648263|NCT00515112|364374861|FG000|Overall Study|Death|0|||
105648264|NCT00515112|364374862|FG001|Overall Study|Death|1|||
105648265|NCT00515112|364374861|FG000|Overall Study|The study was terminated|3|||
105648266|NCT00515112|364374862|FG001|Overall Study|The study was terminated|2|||
105648267|NCT01375777|364374869|FG000|Overall Study|Withdrawal by Subject|0|||
105648268|NCT01375777|364374870|FG001|Overall Study|Withdrawal by Subject|2|||
105648269|NCT01375777|364374871|FG002|Overall Study|Withdrawal by Subject|1|||
105648270|NCT01375777|364374872|FG003|Overall Study|Withdrawal by Subject|0|||
105648271|NCT01375777|364374873|FG004|Overall Study|Withdrawal by Subject|1|||
105648272|NCT01375777|364374874|FG005|Overall Study|Withdrawal by Subject|1|||
105648273|NCT01375777|364374875|FG006|Overall Study|Withdrawal by Subject|1|||
105648274|NCT01375777|364374876|FG007|Overall Study|Withdrawal by Subject|2|||
105648275|NCT01375777|364374877|FG008|Overall Study|Withdrawal by Subject|1|||
105648276|NCT01375777|364374869|FG000|Overall Study|Lost to Follow-up|1|||
105648277|NCT01375777|364374870|FG001|Overall Study|Lost to Follow-up|0|||
105648278|NCT01375777|364374871|FG002|Overall Study|Lost to Follow-up|0|||
105648279|NCT01375777|364374872|FG003|Overall Study|Lost to Follow-up|0|||
105648280|NCT01375777|364374873|FG004|Overall Study|Lost to Follow-up|0|||
105648281|NCT01375777|364374874|FG005|Overall Study|Lost to Follow-up|0|||
105648282|NCT01375777|364374875|FG006|Overall Study|Lost to Follow-up|1|||
105648283|NCT01375777|364374876|FG007|Overall Study|Lost to Follow-up|0|||
105648284|NCT01375777|364374877|FG008|Overall Study|Lost to Follow-up|0|||
105648285|NCT01375777|364374869|FG000|Overall Study|Other|1|||
105648286|NCT01375777|364374870|FG001|Overall Study|Other|1|||
105648287|NCT01375777|364374871|FG002|Overall Study|Other|0|||
105648288|NCT01375777|364374872|FG003|Overall Study|Other|0|||
105648289|NCT01375777|364374873|FG004|Overall Study|Other|0|||
105648290|NCT01375777|364374874|FG005|Overall Study|Other|0|||
105648291|NCT01375777|364374875|FG006|Overall Study|Other|0|||
105648292|NCT01375777|364374876|FG007|Overall Study|Other|0|||
105648293|NCT01375777|364374877|FG008|Overall Study|Other|1|||
105648294|NCT02409732|364374878|FG000|Overall Study|Withdrawal by Subject|4|||
105648295|NCT02409732|364374878|FG000|Overall Study|Lost to Follow-up|2|||
105648296|NCT01090076|364374879|FG000|Overall Study|Death|1|||
105648297|NCT01090076|364374880|FG001|Overall Study|Death|1|||
105648298|NCT01090076|364374879|FG000|Overall Study|Withdrawal by Subject|0|||
105648299|NCT01090076|364374880|FG001|Overall Study|Withdrawal by Subject|1|||
105648300|NCT01870999|364374882|FG000|Overall Study|Adverse Event|0|||
105648301|NCT01870999|364374883|FG001|Overall Study|Adverse Event|4|||
105648302|NCT01870999|364374884|FG002|Overall Study|Adverse Event|1|||
105648303|NCT01870999|364374882|FG000|Overall Study|Subject met withdrawal criteria|3|||
105648304|NCT01870999|364374883|FG001|Overall Study|Subject met withdrawal criteria|2|||
105648305|NCT01870999|364374884|FG002|Overall Study|Subject met withdrawal criteria|0|||
105648306|NCT01870999|364374882|FG000|Overall Study|Subject withdrawn by Investigator|1|||
105648307|NCT01870999|364374883|FG001|Overall Study|Subject withdrawn by Investigator|0|||
105648308|NCT01870999|364374884|FG002|Overall Study|Subject withdrawn by Investigator|0|||
105648309|NCT01870999|364374882|FG000|Overall Study|Withdrawal by Subject|0|||
105648310|NCT01870999|364374883|FG001|Overall Study|Withdrawal by Subject|2|||
105648311|NCT01870999|364374884|FG002|Overall Study|Withdrawal by Subject|5|||
105648312|NCT01870999|364374882|FG000|Overall Study|Protocol Violation|0|||
105648313|NCT01870999|364374883|FG001|Overall Study|Protocol Violation|0|||
105648314|NCT01870999|364374884|FG002|Overall Study|Protocol Violation|1|||
105648315|NCT03314233|364374888|FG000|Overall Study|No longer eligible at time of delivery|1|||
105648316|NCT01114217|364374889|FG000|Overall Study|Adverse Event|5|||
105648317|NCT01114217|364374890|FG001|Overall Study|Adverse Event|3|||
105648318|NCT01114217|364374889|FG000|Overall Study|Lost to Follow-up|17|||
105648319|NCT01114217|364374890|FG001|Overall Study|Lost to Follow-up|33|||
105648320|NCT01114217|364374889|FG000|Overall Study|Withdrawal by Subject|21|||
105648321|NCT01114217|364374890|FG001|Overall Study|Withdrawal by Subject|28|||
105648322|NCT01114217|364374889|FG000|Overall Study|Other-Clerical Error|3|||
105648323|NCT01114217|364374890|FG001|Overall Study|Other-Clerical Error|0|||
105648324|NCT01114217|364374889|FG000|Overall Study|Other-Early termination|6|||
105648325|NCT01114217|364374890|FG001|Overall Study|Other-Early termination|10|||
105648326|NCT01114217|364374889|FG000|Overall Study|Other-Procedure|1|||
105648327|NCT01114217|364374890|FG001|Overall Study|Other-Procedure|1|||
105648328|NCT01114217|364374889|FG000|Overall Study|Other-Pregnancy|2|||
105648329|NCT01114217|364374890|FG001|Overall Study|Other-Pregnancy|4|||
105648330|NCT01114217|364374889|FG000|Overall Study|Other-Protocol Violation|1|||
105648331|NCT01114217|364374890|FG001|Overall Study|Other-Protocol Violation|3|||
105648332|NCT01114217|364374889|FG000|Overall Study|Other-Lack of Efficacy|1|||
105648333|NCT01114217|364374890|FG001|Overall Study|Other-Lack of Efficacy|0|||
105648334|NCT01114217|364374889|FG000|Overall Study|Other-Non Compliance|2|||
105648335|NCT01114217|364374890|FG001|Overall Study|Other-Non Compliance|0|||
105648336|NCT01114217|364374889|FG000|Overall Study|Other-Physician Decision|1|||
105648337|NCT01114217|364374890|FG001|Overall Study|Other-Physician Decision|1|||
105648338|NCT01114217|364374889|FG000|Overall Study|Other-Sponsor Decision|10|||
105648339|NCT01114217|364374890|FG001|Overall Study|Other-Sponsor Decision|12|||
105648340|NCT01114217|364374889|FG000|Overall Study|Other-Study Termination|0|||
105648341|NCT01114217|364374890|FG001|Overall Study|Other-Study Termination|1|||
105648342|NCT01114217|364374889|FG000|Overall Study|Other-Study Withdrawn|1|||
105648343|NCT01114217|364374890|FG001|Overall Study|Other-Study Withdrawn|1|||
105648344|NCT01114217|364374889|FG000|Overall Study|Other-Site Stopped Communicating|2|||
105648345|NCT01114217|364374890|FG001|Overall Study|Other-Site Stopped Communicating|0|||
105648346|NCT01114217|364374889|FG000|Overall Study|Other-Lost to Follow-up|1|||
105648347|NCT01114217|364374890|FG001|Overall Study|Other-Lost to Follow-up|0|||
105648348|NCT01114217|364374889|FG000|Overall Study|Other-Withdrawal by Subject|1|||
105648349|NCT01114217|364374890|FG001|Overall Study|Other-Withdrawal by Subject|1|||
105648350|NCT02465866|364374895|FG000|Period 3|Withdrawal by Subject|0|||
105648351|NCT02465866|364374896|FG001|Period 3|Withdrawal by Subject|1|||
105648352|NCT02465866|364374897|FG002|Period 3|Withdrawal by Subject|0|||
105648353|NCT02465866|364374898|FG003|Period 3|Withdrawal by Subject|0|||
105648354|NCT01757171|364374899|FG000|Overall Study|Adverse Event|5|||
105648355|NCT01757171|364374900|FG001|Overall Study|Adverse Event|1|||
105648356|NCT01757171|364374899|FG000|Overall Study|Disease Progression|1|||
105648357|NCT01757171|364374900|FG001|Overall Study|Disease Progression|0|||
105648358|NCT01757171|364374899|FG000|Overall Study|Hospitalization|1|||
105648359|NCT01757171|364374900|FG001|Overall Study|Hospitalization|0|||
105648360|NCT01757171|364374899|FG000|Overall Study|ECOG decline|1|||
105648361|NCT01757171|364374900|FG001|Overall Study|ECOG decline|0|||
105648362|NCT01446042|364374905|FG000|Overall Study|Withdrawal by Subject|12|||
105648363|NCT01446042|364374906|FG001|Overall Study|Withdrawal by Subject|2|||
105648364|NCT01446042|364374907|FG002|Overall Study|Withdrawal by Subject|4|||
105648365|NCT01446042|364374905|FG000|Overall Study|Adverse Event|1|||
105648366|NCT01446042|364374906|FG001|Overall Study|Adverse Event|0|||
105648367|NCT01446042|364374907|FG002|Overall Study|Adverse Event|4|||
105648368|NCT01446042|364374905|FG000|Overall Study|Lost to Follow-up|5|||
105648369|NCT01446042|364374906|FG001|Overall Study|Lost to Follow-up|0|||
105648370|NCT01446042|364374907|FG002|Overall Study|Lost to Follow-up|0|||
105648371|NCT01446042|364374905|FG000|Overall Study|Other reasons|2|||
105648372|NCT01446042|364374906|FG001|Overall Study|Other reasons|1|||
105648373|NCT01446042|364374907|FG002|Overall Study|Other reasons|1|||
105648374|NCT03751280|364374911|FG000|Overall Study|Adverse Event|0|||
105648375|NCT03751280|364374912|FG001|Overall Study|Adverse Event|1|||
105648376|NCT03751280|364374911|FG000|Overall Study|Lost to Follow-up|3|||
105870384|NCT01682811|365177008|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
105648377|NCT03751280|364374912|FG001|Overall Study|Lost to Follow-up|5|||
105648378|NCT03751280|364374911|FG000|Overall Study|Physician Decision|0|||
105648379|NCT03751280|364374912|FG001|Overall Study|Physician Decision|2|||
105648380|NCT03751280|364374911|FG000|Overall Study|Protocol Violation|0|||
105648381|NCT03751280|364374912|FG001|Overall Study|Protocol Violation|2|||
105648382|NCT03751280|364374911|FG000|Overall Study|Withdrawal by Subject|5|||
105648383|NCT03751280|364374912|FG001|Overall Study|Withdrawal by Subject|2|||
105648384|NCT00460577|364374914|FG000|Overall Study|Protocol Violation|2|||
105648385|NCT00460577|364374915|FG001|Overall Study|Protocol Violation|6|||
105648386|NCT00296504|364374916|FG000|Interim Analysis|Withdrawal by Subject|8|||
105648387|NCT00296504|364374917|FG001|Interim Analysis|Withdrawal by Subject|0|||
105648388|NCT00296504|364374918|FG002|Interim Analysis|Withdrawal by Subject|12|||
105648389|NCT00296504|364374919|FG003|Interim Analysis|Withdrawal by Subject|0|||
105648390|NCT00296504|364374920|FG004|Interim Analysis|Withdrawal by Subject|5|||
105648391|NCT00296504|364374921|FG005|Interim Analysis|Withdrawal by Subject|5|||
105648392|NCT00296504|364374922|FG006|Interim Analysis|Withdrawal by Subject|9|||
105648393|NCT00296504|364374923|FG007|Interim Analysis|Withdrawal by Subject|3|||
105648394|NCT00296504|364374924|FG008|Interim Analysis|Withdrawal by Subject|0|||
105648395|NCT00296504|364374916|FG000|Interim Analysis|Lost to Follow-up|13|||
105648396|NCT00296504|364374917|FG001|Interim Analysis|Lost to Follow-up|3|||
105648397|NCT00296504|364374918|FG002|Interim Analysis|Lost to Follow-up|26|||
105648398|NCT00296504|364374919|FG003|Interim Analysis|Lost to Follow-up|8|||
105648399|NCT00296504|364374920|FG004|Interim Analysis|Lost to Follow-up|14|||
105648400|NCT00296504|364374921|FG005|Interim Analysis|Lost to Follow-up|4|||
105648401|NCT00296504|364374922|FG006|Interim Analysis|Lost to Follow-up|11|||
105648402|NCT00296504|364374923|FG007|Interim Analysis|Lost to Follow-up|4|||
105648403|NCT00296504|364374924|FG008|Interim Analysis|Lost to Follow-up|0|||
105648404|NCT00296504|364374916|FG000|Interim Analysis|Clinical Progression|1|||
105648405|NCT00296504|364374917|FG001|Interim Analysis|Clinical Progression|0|||
105648406|NCT00296504|364374918|FG002|Interim Analysis|Clinical Progression|1|||
105648407|NCT00296504|364374919|FG003|Interim Analysis|Clinical Progression|1|||
105648408|NCT00296504|364374920|FG004|Interim Analysis|Clinical Progression|0|||
105648409|NCT00296504|364374921|FG005|Interim Analysis|Clinical Progression|2|||
105648410|NCT00296504|364374922|FG006|Interim Analysis|Clinical Progression|1|||
105648411|NCT00296504|364374923|FG007|Interim Analysis|Clinical Progression|2|||
105648412|NCT00296504|364374924|FG008|Interim Analysis|Clinical Progression|0|||
105648413|NCT00296504|364374916|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
105648414|NCT00296504|364374917|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
105648415|NCT00296504|364374918|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
105648416|NCT00296504|364374919|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
105648417|NCT00296504|364374920|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
105648418|NCT00296504|364374921|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
105648419|NCT00296504|364374922|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
105648420|NCT00296504|364374923|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
105648421|NCT00296504|364374924|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
105648422|NCT00296504|364374916|FG000|Interim Analysis|Adverse Event|0|||
105648423|NCT00296504|364374917|FG001|Interim Analysis|Adverse Event|0|||
105648424|NCT00296504|364374918|FG002|Interim Analysis|Adverse Event|13|||
105648425|NCT00296504|364374919|FG003|Interim Analysis|Adverse Event|4|||
105648426|NCT00296504|364374920|FG004|Interim Analysis|Adverse Event|6|||
105648427|NCT00296504|364374921|FG005|Interim Analysis|Adverse Event|3|||
105648428|NCT00296504|364374922|FG006|Interim Analysis|Adverse Event|4|||
105648429|NCT00296504|364374923|FG007|Interim Analysis|Adverse Event|5|||
105648430|NCT00296504|364374924|FG008|Interim Analysis|Adverse Event|0|||
105648431|NCT00296504|364374916|FG000|Interim Analysis|Protocol Violation|0|||
105648432|NCT00296504|364374917|FG001|Interim Analysis|Protocol Violation|0|||
105648433|NCT00296504|364374918|FG002|Interim Analysis|Protocol Violation|2|||
105648434|NCT00296504|364374919|FG003|Interim Analysis|Protocol Violation|0|||
105648435|NCT00296504|364374920|FG004|Interim Analysis|Protocol Violation|1|||
105648436|NCT00296504|364374921|FG005|Interim Analysis|Protocol Violation|0|||
105648437|NCT00296504|364374922|FG006|Interim Analysis|Protocol Violation|0|||
105648438|NCT00296504|364374923|FG007|Interim Analysis|Protocol Violation|1|||
105648439|NCT00296504|364374924|FG008|Interim Analysis|Protocol Violation|0|||
105648440|NCT00296504|364374916|FG000|Interim Analysis|Insufficient CD4 Response|0|||
105648441|NCT00296504|364374917|FG001|Interim Analysis|Insufficient CD4 Response|0|||
105648442|NCT00296504|364374918|FG002|Interim Analysis|Insufficient CD4 Response|0|||
105648443|NCT00296504|364374919|FG003|Interim Analysis|Insufficient CD4 Response|0|||
105648444|NCT00296504|364374920|FG004|Interim Analysis|Insufficient CD4 Response|1|||
105648445|NCT00296504|364374921|FG005|Interim Analysis|Insufficient CD4 Response|1|||
105648446|NCT00296504|364374922|FG006|Interim Analysis|Insufficient CD4 Response|0|||
105648447|NCT00296504|364374923|FG007|Interim Analysis|Insufficient CD4 Response|0|||
105648448|NCT00296504|364374924|FG008|Interim Analysis|Insufficient CD4 Response|0|||
105648449|NCT00296504|364374916|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
105648450|NCT00296504|364374917|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
105648451|NCT00296504|364374918|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
105648452|NCT00296504|364374919|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
105648453|NCT00296504|364374920|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
105648454|NCT00296504|364374921|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
105648455|NCT00296504|364374922|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
105648456|NCT00296504|364374923|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
105648457|NCT00296504|364374924|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
105648458|NCT00296504|364374916|FG000|Interim Analysis|Pregnancy|4|||
105648459|NCT00296504|364374917|FG001|Interim Analysis|Pregnancy|1|||
105648460|NCT00296504|364374918|FG002|Interim Analysis|Pregnancy|4|||
105648461|NCT00296504|364374919|FG003|Interim Analysis|Pregnancy|2|||
105648462|NCT00296504|364374920|FG004|Interim Analysis|Pregnancy|0|||
105648463|NCT00296504|364374921|FG005|Interim Analysis|Pregnancy|1|||
105648464|NCT00296504|364374922|FG006|Interim Analysis|Pregnancy|1|||
105648465|NCT00296504|364374923|FG007|Interim Analysis|Pregnancy|1|||
105648466|NCT00296504|364374924|FG008|Interim Analysis|Pregnancy|0|||
105648467|NCT00296504|364374916|FG000|Interim Analysis|Death|1|||
105648468|NCT00296504|364374917|FG001|Interim Analysis|Death|0|||
105648469|NCT00296504|364374918|FG002|Interim Analysis|Death|3|||
105648470|NCT00296504|364374919|FG003|Interim Analysis|Death|0|||
105648471|NCT00296504|364374920|FG004|Interim Analysis|Death|0|||
105648472|NCT00296504|364374921|FG005|Interim Analysis|Death|0|||
105648473|NCT00296504|364374922|FG006|Interim Analysis|Death|0|||
105648474|NCT00296504|364374923|FG007|Interim Analysis|Death|0|||
105648475|NCT00296504|364374924|FG008|Interim Analysis|Death|0|||
105648476|NCT00296504|364374916|FG000|Interim Analysis|Participant Non-compliant|0|||
105648477|NCT00296504|364374917|FG001|Interim Analysis|Participant Non-compliant|1|||
105648478|NCT00296504|364374918|FG002|Interim Analysis|Participant Non-compliant|2|||
105648479|NCT00296504|364374919|FG003|Interim Analysis|Participant Non-compliant|1|||
105648480|NCT00296504|364374920|FG004|Interim Analysis|Participant Non-compliant|1|||
105648481|NCT00296504|364374921|FG005|Interim Analysis|Participant Non-compliant|3|||
105648482|NCT00296504|364374922|FG006|Interim Analysis|Participant Non-compliant|6|||
105648483|NCT00296504|364374923|FG007|Interim Analysis|Participant Non-compliant|2|||
105648484|NCT00296504|364374924|FG008|Interim Analysis|Participant Non-compliant|0|||
105648485|NCT00296504|364374916|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648486|NCT00296504|364374917|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648487|NCT00296504|364374918|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
105648488|NCT00296504|364374919|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648489|NCT00296504|364374920|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648490|NCT00296504|364374921|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
105648491|NCT00296504|364374922|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648492|NCT00296504|364374923|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648493|NCT00296504|364374924|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
105648494|NCT00296504|364374916|FG000|Interim Analysis|To Simplify Treatment|0|||
105648495|NCT00296504|364374917|FG001|Interim Analysis|To Simplify Treatment|0|||
105648496|NCT00296504|364374918|FG002|Interim Analysis|To Simplify Treatment|1|||
105648497|NCT00296504|364374919|FG003|Interim Analysis|To Simplify Treatment|0|||
105648498|NCT00296504|364374920|FG004|Interim Analysis|To Simplify Treatment|0|||
105648499|NCT00296504|364374921|FG005|Interim Analysis|To Simplify Treatment|0|||
105648500|NCT00296504|364374922|FG006|Interim Analysis|To Simplify Treatment|2|||
105648501|NCT00296504|364374923|FG007|Interim Analysis|To Simplify Treatment|0|||
105648502|NCT00296504|364374924|FG008|Interim Analysis|To Simplify Treatment|0|||
105648503|NCT00296504|364374916|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648504|NCT00296504|364374917|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648505|NCT00296504|364374918|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
105648506|NCT00296504|364374919|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648507|NCT00296504|364374920|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648508|NCT00296504|364374921|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648509|NCT00296504|364374922|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648510|NCT00296504|364374923|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648511|NCT00296504|364374924|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
105648512|NCT00296504|364374916|FG000|Interim Analysis|Participant Moved|1|||
105648513|NCT00296504|364374917|FG001|Interim Analysis|Participant Moved|0|||
105648514|NCT00296504|364374918|FG002|Interim Analysis|Participant Moved|1|||
105648515|NCT00296504|364374919|FG003|Interim Analysis|Participant Moved|0|||
105648516|NCT00296504|364374920|FG004|Interim Analysis|Participant Moved|0|||
105648517|NCT00296504|364374921|FG005|Interim Analysis|Participant Moved|1|||
105648518|NCT00296504|364374922|FG006|Interim Analysis|Participant Moved|1|||
105648519|NCT00296504|364374923|FG007|Interim Analysis|Participant Moved|0|||
105648520|NCT00296504|364374924|FG008|Interim Analysis|Participant Moved|0|||
105648521|NCT00296504|364374916|FG000|Interim Analysis|Participant Was Incarcerated|2|||
105648522|NCT00296504|364374917|FG001|Interim Analysis|Participant Was Incarcerated|0|||
105648523|NCT00296504|364374918|FG002|Interim Analysis|Participant Was Incarcerated|1|||
105648524|NCT00296504|364374919|FG003|Interim Analysis|Participant Was Incarcerated|0|||
105648525|NCT00296504|364374920|FG004|Interim Analysis|Participant Was Incarcerated|0|||
105648526|NCT00296504|364374921|FG005|Interim Analysis|Participant Was Incarcerated|0|||
105648527|NCT00296504|364374922|FG006|Interim Analysis|Participant Was Incarcerated|0|||
105648528|NCT00296504|364374923|FG007|Interim Analysis|Participant Was Incarcerated|0|||
105648529|NCT00296504|364374924|FG008|Interim Analysis|Participant Was Incarcerated|0|||
105648530|NCT00296504|364374916|FG000|Interim Analysis|Resistance to FPV|0|||
105648531|NCT00296504|364374917|FG001|Interim Analysis|Resistance to FPV|0|||
105648532|NCT00296504|364374918|FG002|Interim Analysis|Resistance to FPV|1|||
105648533|NCT00296504|364374919|FG003|Interim Analysis|Resistance to FPV|0|||
105648534|NCT00296504|364374920|FG004|Interim Analysis|Resistance to FPV|0|||
105648535|NCT00296504|364374921|FG005|Interim Analysis|Resistance to FPV|0|||
105648536|NCT00296504|364374922|FG006|Interim Analysis|Resistance to FPV|0|||
105648537|NCT00296504|364374923|FG007|Interim Analysis|Resistance to FPV|0|||
105648538|NCT00296504|364374924|FG008|Interim Analysis|Resistance to FPV|0|||
105648539|NCT00296504|364374916|FG000|Interim Analysis|Physician Decision|0|||
105648540|NCT00296504|364374917|FG001|Interim Analysis|Physician Decision|0|||
105648541|NCT00296504|364374918|FG002|Interim Analysis|Physician Decision|1|||
105648542|NCT00296504|364374919|FG003|Interim Analysis|Physician Decision|0|||
105648543|NCT00296504|364374920|FG004|Interim Analysis|Physician Decision|0|||
105648544|NCT00296504|364374921|FG005|Interim Analysis|Physician Decision|0|||
105648545|NCT00296504|364374922|FG006|Interim Analysis|Physician Decision|0|||
105648546|NCT00296504|364374923|FG007|Interim Analysis|Physician Decision|0|||
105648547|NCT00296504|364374924|FG008|Interim Analysis|Physician Decision|0|||
105648548|NCT00296504|364374916|FG000|Interim Analysis|Principle Investigator Discretion|2|||
105648549|NCT00296504|364374917|FG001|Interim Analysis|Principle Investigator Discretion|0|||
105648550|NCT00296504|364374918|FG002|Interim Analysis|Principle Investigator Discretion|1|||
105648551|NCT00296504|364374919|FG003|Interim Analysis|Principle Investigator Discretion|1|||
105648552|NCT00296504|364374920|FG004|Interim Analysis|Principle Investigator Discretion|0|||
105648553|NCT00296504|364374921|FG005|Interim Analysis|Principle Investigator Discretion|0|||
105648554|NCT00296504|364374922|FG006|Interim Analysis|Principle Investigator Discretion|0|||
105648555|NCT00296504|364374923|FG007|Interim Analysis|Principle Investigator Discretion|0|||
105648556|NCT00296504|364374924|FG008|Interim Analysis|Principle Investigator Discretion|0|||
105648557|NCT00296504|364374916|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
105648558|NCT00296504|364374917|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
105648559|NCT00296504|364374918|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
105648560|NCT00296504|364374919|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
105648561|NCT00296504|364374920|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
105648562|NCT00296504|364374921|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
105648563|NCT00296504|364374922|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
105648564|NCT00296504|364374923|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
105648565|NCT00296504|364374924|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
105648566|NCT00296504|364374916|FG000|Interim Analysis|Non-adherence|2|||
105648567|NCT00296504|364374917|FG001|Interim Analysis|Non-adherence|0|||
105648568|NCT00296504|364374918|FG002|Interim Analysis|Non-adherence|0|||
105648569|NCT00296504|364374919|FG003|Interim Analysis|Non-adherence|0|||
105648570|NCT00296504|364374920|FG004|Interim Analysis|Non-adherence|1|||
105648571|NCT00296504|364374921|FG005|Interim Analysis|Non-adherence|0|||
105648572|NCT00296504|364374922|FG006|Interim Analysis|Non-adherence|0|||
105648573|NCT00296504|364374923|FG007|Interim Analysis|Non-adherence|1|||
105648574|NCT00296504|364374924|FG008|Interim Analysis|Non-adherence|0|||
105648575|NCT00296504|364374916|FG000|Interim Analysis|Site Closing|1|||
105648576|NCT00296504|364374917|FG001|Interim Analysis|Site Closing|0|||
105648577|NCT00296504|364374918|FG002|Interim Analysis|Site Closing|0|||
105648578|NCT00296504|364374919|FG003|Interim Analysis|Site Closing|0|||
105648579|NCT00296504|364374920|FG004|Interim Analysis|Site Closing|0|||
105648580|NCT00296504|364374921|FG005|Interim Analysis|Site Closing|1|||
105648581|NCT00296504|364374922|FG006|Interim Analysis|Site Closing|2|||
105648582|NCT00296504|364374923|FG007|Interim Analysis|Site Closing|0|||
105648583|NCT00296504|364374924|FG008|Interim Analysis|Site Closing|0|||
105648584|NCT00296504|364374916|FG000|Interim Analysis|Lack of Personnel at Site|1|||
105648585|NCT00296504|364374917|FG001|Interim Analysis|Lack of Personnel at Site|0|||
105648586|NCT00296504|364374918|FG002|Interim Analysis|Lack of Personnel at Site|0|||
105648587|NCT00296504|364374919|FG003|Interim Analysis|Lack of Personnel at Site|0|||
105648588|NCT00296504|364374920|FG004|Interim Analysis|Lack of Personnel at Site|0|||
105648589|NCT00296504|364374921|FG005|Interim Analysis|Lack of Personnel at Site|0|||
105648590|NCT00296504|364374922|FG006|Interim Analysis|Lack of Personnel at Site|0|||
105648591|NCT00296504|364374923|FG007|Interim Analysis|Lack of Personnel at Site|0|||
105648592|NCT00296504|364374924|FG008|Interim Analysis|Lack of Personnel at Site|0|||
105648593|NCT00296504|364374916|FG000|Interim Analysis|Missed Schedule Date|1|||
105648594|NCT00296504|364374917|FG001|Interim Analysis|Missed Schedule Date|0|||
105648595|NCT00296504|364374918|FG002|Interim Analysis|Missed Schedule Date|0|||
105648596|NCT00296504|364374919|FG003|Interim Analysis|Missed Schedule Date|0|||
105648597|NCT00296504|364374920|FG004|Interim Analysis|Missed Schedule Date|0|||
105648598|NCT00296504|364374921|FG005|Interim Analysis|Missed Schedule Date|0|||
105648599|NCT00296504|364374922|FG006|Interim Analysis|Missed Schedule Date|0|||
105648600|NCT00296504|364374923|FG007|Interim Analysis|Missed Schedule Date|0|||
105648601|NCT00296504|364374924|FG008|Interim Analysis|Missed Schedule Date|0|||
105648602|NCT00296504|364374916|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
105648603|NCT00296504|364374917|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
105648604|NCT00296504|364374918|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
105648605|NCT00296504|364374919|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
105648606|NCT00296504|364374920|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
105648607|NCT00296504|364374921|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
105648608|NCT00296504|364374922|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
105648609|NCT00296504|364374923|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
105648610|NCT00296504|364374924|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
105648611|NCT00296504|364374916|FG000|Interim Analysis|Participant Stopped|0|||
105648612|NCT00296504|364374917|FG001|Interim Analysis|Participant Stopped|0|||
105648613|NCT00296504|364374918|FG002|Interim Analysis|Participant Stopped|0|||
105648614|NCT00296504|364374919|FG003|Interim Analysis|Participant Stopped|0|||
105648615|NCT00296504|364374920|FG004|Interim Analysis|Participant Stopped|1|||
105648616|NCT00296504|364374921|FG005|Interim Analysis|Participant Stopped|0|||
105648617|NCT00296504|364374922|FG006|Interim Analysis|Participant Stopped|0|||
105648618|NCT00296504|364374923|FG007|Interim Analysis|Participant Stopped|0|||
105648619|NCT00296504|364374924|FG008|Interim Analysis|Participant Stopped|0|||
105648620|NCT00296504|364374916|FG000|Interim Analysis|Physician and Participant Decision|0|||
105648621|NCT00296504|364374917|FG001|Interim Analysis|Physician and Participant Decision|0|||
105648622|NCT00296504|364374918|FG002|Interim Analysis|Physician and Participant Decision|0|||
105648623|NCT00296504|364374919|FG003|Interim Analysis|Physician and Participant Decision|0|||
105648624|NCT00296504|364374920|FG004|Interim Analysis|Physician and Participant Decision|0|||
105648625|NCT00296504|364374921|FG005|Interim Analysis|Physician and Participant Decision|1|||
105648626|NCT00296504|364374922|FG006|Interim Analysis|Physician and Participant Decision|0|||
105648627|NCT00296504|364374923|FG007|Interim Analysis|Physician and Participant Decision|0|||
105648628|NCT00296504|364374924|FG008|Interim Analysis|Physician and Participant Decision|0|||
105648629|NCT00296504|364374916|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
105648630|NCT00296504|364374917|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
105648631|NCT00296504|364374918|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
105648632|NCT00296504|364374919|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
105648633|NCT00296504|364374920|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
105648634|NCT00296504|364374921|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
105648635|NCT00296504|364374922|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
105648636|NCT00296504|364374923|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
105648637|NCT00296504|364374924|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
105648638|NCT00296504|364374916|FG000|Interim Analysis|Study Ended|0|||
105648639|NCT00296504|364374917|FG001|Interim Analysis|Study Ended|0|||
105648640|NCT00296504|364374918|FG002|Interim Analysis|Study Ended|0|||
105648641|NCT00296504|364374919|FG003|Interim Analysis|Study Ended|0|||
105648642|NCT00296504|364374920|FG004|Interim Analysis|Study Ended|0|||
105648643|NCT00296504|364374921|FG005|Interim Analysis|Study Ended|0|||
105648644|NCT00296504|364374922|FG006|Interim Analysis|Study Ended|1|||
105648645|NCT00296504|364374923|FG007|Interim Analysis|Study Ended|0|||
105648646|NCT00296504|364374924|FG008|Interim Analysis|Study Ended|0|||
105648647|NCT00296504|364374916|FG000|Interim Analysis|Participant Needed Interferon|0|||
105648648|NCT00296504|364374917|FG001|Interim Analysis|Participant Needed Interferon|0|||
105648649|NCT00296504|364374918|FG002|Interim Analysis|Participant Needed Interferon|0|||
105648650|NCT00296504|364374919|FG003|Interim Analysis|Participant Needed Interferon|0|||
105648651|NCT00296504|364374920|FG004|Interim Analysis|Participant Needed Interferon|0|||
105648652|NCT00296504|364374921|FG005|Interim Analysis|Participant Needed Interferon|0|||
105648653|NCT00296504|364374922|FG006|Interim Analysis|Participant Needed Interferon|0|||
105648654|NCT00296504|364374923|FG007|Interim Analysis|Participant Needed Interferon|1|||
105648655|NCT00296504|364374924|FG008|Interim Analysis|Participant Needed Interferon|0|||
105648656|NCT00296504|364374916|FG000|Interim Analysis|Ongoing|32|||
105648657|NCT00296504|364374917|FG001|Interim Analysis|Ongoing|12|||
105648658|NCT00296504|364374918|FG002|Interim Analysis|Ongoing|16|||
105648659|NCT00296504|364374919|FG003|Interim Analysis|Ongoing|22|||
105648660|NCT00296504|364374920|FG004|Interim Analysis|Ongoing|0|||
105648661|NCT00296504|364374921|FG005|Interim Analysis|Ongoing|0|||
105648662|NCT00296504|364374922|FG006|Interim Analysis|Ongoing|30|||
105648663|NCT00296504|364374923|FG007|Interim Analysis|Ongoing|1|||
105648664|NCT00296504|364374924|FG008|Interim Analysis|Ongoing|0|||
105648665|NCT00296504|364374916|FG000|Final Analysis|Withdrawal by Subject|0|||
105648666|NCT00296504|364374917|FG001|Final Analysis|Withdrawal by Subject|0|||
105648667|NCT00296504|364374918|FG002|Final Analysis|Withdrawal by Subject|0|||
105648668|NCT00296504|364374919|FG003|Final Analysis|Withdrawal by Subject|0|||
105648669|NCT00296504|364374920|FG004|Final Analysis|Withdrawal by Subject|0|||
105648670|NCT00296504|364374921|FG005|Final Analysis|Withdrawal by Subject|0|||
105648671|NCT00296504|364374922|FG006|Final Analysis|Withdrawal by Subject|0|||
105648672|NCT00296504|364374923|FG007|Final Analysis|Withdrawal by Subject|0|||
105648673|NCT00296504|364374924|FG008|Final Analysis|Withdrawal by Subject|1|||
105648674|NCT00296504|364374916|FG000|Final Analysis|Lost to Follow-up|0|||
105648675|NCT00296504|364374917|FG001|Final Analysis|Lost to Follow-up|0|||
105648676|NCT00296504|364374918|FG002|Final Analysis|Lost to Follow-up|0|||
105648677|NCT00296504|364374919|FG003|Final Analysis|Lost to Follow-up|0|||
105648678|NCT00296504|364374920|FG004|Final Analysis|Lost to Follow-up|0|||
105648679|NCT00296504|364374921|FG005|Final Analysis|Lost to Follow-up|0|||
105648680|NCT00296504|364374922|FG006|Final Analysis|Lost to Follow-up|0|||
105648681|NCT00296504|364374923|FG007|Final Analysis|Lost to Follow-up|0|||
105648682|NCT00296504|364374924|FG008|Final Analysis|Lost to Follow-up|5|||
105648683|NCT00296504|364374916|FG000|Final Analysis|Insufficient Viral Load Response|0|||
105648684|NCT00296504|364374917|FG001|Final Analysis|Insufficient Viral Load Response|0|||
105648685|NCT00296504|364374918|FG002|Final Analysis|Insufficient Viral Load Response|0|||
105648686|NCT00296504|364374919|FG003|Final Analysis|Insufficient Viral Load Response|0|||
105648687|NCT00296504|364374920|FG004|Final Analysis|Insufficient Viral Load Response|0|||
105648688|NCT00296504|364374921|FG005|Final Analysis|Insufficient Viral Load Response|0|||
105648689|NCT00296504|364374922|FG006|Final Analysis|Insufficient Viral Load Response|0|||
105648690|NCT00296504|364374923|FG007|Final Analysis|Insufficient Viral Load Response|0|||
105648691|NCT00296504|364374924|FG008|Final Analysis|Insufficient Viral Load Response|6|||
105648692|NCT00296504|364374916|FG000|Final Analysis|Adverse Event|0|||
105648693|NCT00296504|364374917|FG001|Final Analysis|Adverse Event|0|||
105648694|NCT00296504|364374918|FG002|Final Analysis|Adverse Event|0|||
105648695|NCT00296504|364374919|FG003|Final Analysis|Adverse Event|0|||
105648696|NCT00296504|364374920|FG004|Final Analysis|Adverse Event|0|||
105648697|NCT00296504|364374921|FG005|Final Analysis|Adverse Event|0|||
105648698|NCT00296504|364374922|FG006|Final Analysis|Adverse Event|0|||
105648699|NCT00296504|364374923|FG007|Final Analysis|Adverse Event|0|||
105648700|NCT00296504|364374924|FG008|Final Analysis|Adverse Event|2|||
105648701|NCT00296504|364374916|FG000|Final Analysis|Pregnancy|0|||
105648702|NCT00296504|364374917|FG001|Final Analysis|Pregnancy|0|||
105648703|NCT00296504|364374918|FG002|Final Analysis|Pregnancy|0|||
105648704|NCT00296504|364374919|FG003|Final Analysis|Pregnancy|0|||
105648705|NCT00296504|364374920|FG004|Final Analysis|Pregnancy|0|||
105648706|NCT00296504|364374921|FG005|Final Analysis|Pregnancy|0|||
105648707|NCT00296504|364374922|FG006|Final Analysis|Pregnancy|0|||
105648708|NCT00296504|364374923|FG007|Final Analysis|Pregnancy|0|||
105648709|NCT00296504|364374924|FG008|Final Analysis|Pregnancy|4|||
105648710|NCT00296504|364374916|FG000|Final Analysis|Tuberculosis|0|||
105648711|NCT00296504|364374917|FG001|Final Analysis|Tuberculosis|0|||
105648712|NCT00296504|364374918|FG002|Final Analysis|Tuberculosis|0|||
105648713|NCT00296504|364374919|FG003|Final Analysis|Tuberculosis|0|||
105648714|NCT00296504|364374920|FG004|Final Analysis|Tuberculosis|0|||
105648715|NCT00296504|364374921|FG005|Final Analysis|Tuberculosis|0|||
105648716|NCT00296504|364374922|FG006|Final Analysis|Tuberculosis|0|||
105648717|NCT00296504|364374923|FG007|Final Analysis|Tuberculosis|0|||
105648718|NCT00296504|364374924|FG008|Final Analysis|Tuberculosis|1|||
105648719|NCT00296504|364374916|FG000|Final Analysis|Participant Moved to Another Country|0|||
105648720|NCT00296504|364374917|FG001|Final Analysis|Participant Moved to Another Country|0|||
105648721|NCT00296504|364374918|FG002|Final Analysis|Participant Moved to Another Country|0|||
105648722|NCT00296504|364374919|FG003|Final Analysis|Participant Moved to Another Country|0|||
105648723|NCT00296504|364374920|FG004|Final Analysis|Participant Moved to Another Country|0|||
105648724|NCT00296504|364374921|FG005|Final Analysis|Participant Moved to Another Country|0|||
105648725|NCT00296504|364374922|FG006|Final Analysis|Participant Moved to Another Country|0|||
105648726|NCT00296504|364374923|FG007|Final Analysis|Participant Moved to Another Country|0|||
105648727|NCT00296504|364374924|FG008|Final Analysis|Participant Moved to Another Country|1|||
105648728|NCT00296504|364374916|FG000|Final Analysis|Poor Adherence|0|||
105648729|NCT00296504|364374917|FG001|Final Analysis|Poor Adherence|0|||
105648730|NCT00296504|364374918|FG002|Final Analysis|Poor Adherence|0|||
105648731|NCT00296504|364374919|FG003|Final Analysis|Poor Adherence|0|||
105648732|NCT00296504|364374920|FG004|Final Analysis|Poor Adherence|0|||
105648733|NCT00296504|364374921|FG005|Final Analysis|Poor Adherence|0|||
105648734|NCT00296504|364374922|FG006|Final Analysis|Poor Adherence|0|||
105648735|NCT00296504|364374923|FG007|Final Analysis|Poor Adherence|0|||
105648736|NCT00296504|364374924|FG008|Final Analysis|Poor Adherence|1|||
105648737|NCT01348763|364374930|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
105648738|NCT01348763|364374930|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
105648739|NCT02213458|364374941|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
105648740|NCT02213458|364374942|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
105648741|NCT02213458|364374941|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
105648742|NCT02213458|364374942|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
105648743|NCT02213458|364374941|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
105648744|NCT02213458|364374942|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
105648745|NCT02213458|364374941|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
105648746|NCT02213458|364374942|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
105648747|NCT02213458|364374941|FG000|Overall Study|Refused re-consent|6|||
105648748|NCT02213458|364374942|FG001|Overall Study|Refused re-consent|0|||
105648749|NCT02213458|364374941|FG000|Overall Study|Lost to Follow-up|2|||
105648750|NCT02213458|364374942|FG001|Overall Study|Lost to Follow-up|2|||
105648751|NCT02213458|364374941|FG000|Overall Study|Withdrawal by Subject|26|||
105648752|NCT02213458|364374942|FG001|Overall Study|Withdrawal by Subject|8|||
105648753|NCT01257698|364374944|FG000|Overall Study|Protocol Violation|4|||
105648754|NCT01257698|364374945|FG001|Overall Study|Protocol Violation|0|||
105648755|NCT03802513|364374946|FG000|Overall Study|Lost to Follow-up|1|||
105648756|NCT01622088|364374957|FG000|Overall Study|Adverse Event|20|||
105648757|NCT01622088|364374957|FG000|Overall Study|Lost to Follow-up|1|||
105648758|NCT01622088|364374957|FG000|Overall Study|Withdrawal by Subject|20|||
105648759|NCT01622088|364374957|FG000|Overall Study|Investigator Decision|1|||
105648760|NCT01622088|364374957|FG000|Overall Study|Death|53|||
105648761|NCT01622088|364374957|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
105648762|NCT03045302|364374958|FG000|Overall Study|Pre-treatment adverse event|1|||
105648763|NCT05287178|364374959|FG000|Overall Study|Lost to Follow-up|2|||
105648764|NCT01648699|364374960|FG000|Overall Study|Death|1|||
105648765|NCT01648699|364374960|FG000|Overall Study|Lost to Follow-up|2|||
105648766|NCT01648699|364374960|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
105648767|NCT02038803|364374965|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
105648768|NCT02038803|364374965|FG000|Overall Study|Lost to Follow-up|1|||
105648769|NCT04799587|364374966|FG000|Overall Study|Withdrawal by Subject|0|||
105648770|NCT04799587|364374967|FG001|Overall Study|Withdrawal by Subject|1|||
105648771|NCT00728884|364374968|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
105648772|NCT00728884|364374968|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
105648773|NCT00348283|364374969|FG000|Induction|Adverse Event|0|||
105648774|NCT00348283|364374970|FG001|Induction|Adverse Event|2|||
105648775|NCT00348283|364374969|FG000|Induction|Protocol Violation|0|||
105648776|NCT00348283|364374970|FG001|Induction|Protocol Violation|4|||
105648777|NCT00348283|364374969|FG000|Double Blind|Adverse Event|2|||
105648778|NCT00348283|364374970|FG001|Double Blind|Adverse Event|5|||
105648779|NCT00348283|364374969|FG000|Double Blind|Withdrawal by Subject|1|||
105648780|NCT00348283|364374970|FG001|Double Blind|Withdrawal by Subject|1|||
105648781|NCT00348283|364374969|FG000|Double Blind|Protocol Violation|0|||
105648782|NCT00348283|364374970|FG001|Double Blind|Protocol Violation|1|||
105648783|NCT00348283|364374969|FG000|Double Blind|Lack of Efficacy|2|||
105648784|NCT00348283|364374970|FG001|Double Blind|Lack of Efficacy|2|||
105648785|NCT00348283|364374969|FG000|Double Blind|Pregnancy|0|||
105648786|NCT00348283|364374970|FG001|Double Blind|Pregnancy|1|||
105648787|NCT00348283|364374969|FG000|Open Label|Adverse Event|0|||
105648788|NCT00348283|364374970|FG001|Open Label|Adverse Event|8|||
105648789|NCT00348283|364374969|FG000|Open Label|Withdrawal by Subject|0|||
105648790|NCT00348283|364374970|FG001|Open Label|Withdrawal by Subject|4|||
105648791|NCT00348283|364374969|FG000|Open Label|Lost to Follow-up|0|||
105648792|NCT00348283|364374970|FG001|Open Label|Lost to Follow-up|1|||
105648793|NCT00348283|364374969|FG000|Open Label|Lack of Efficacy|0|||
105648794|NCT00348283|364374970|FG001|Open Label|Lack of Efficacy|13|||
105648795|NCT00348283|364374969|FG000|Open Label|Administrative reasons|0|||
105648796|NCT00348283|364374970|FG001|Open Label|Administrative reasons|5|||
105648797|NCT00348283|364374969|FG000|Open Label|Subject moved to the United States|0|||
105648798|NCT00348283|364374970|FG001|Open Label|Subject moved to the United States|1|||
105648799|NCT00348283|364374969|FG000|Open Label|Pregnancy|0|||
105648800|NCT00348283|364374970|FG001|Open Label|Pregnancy|1|||
105648801|NCT00348283|364374969|FG000|Open Label|Sponsor decision|0|||
105648802|NCT00348283|364374970|FG001|Open Label|Sponsor decision|1|||
105648803|NCT02133131|364374971|FG000|Overall Study|Adverse Event|0|||
105648804|NCT02133131|364374972|FG001|Overall Study|Adverse Event|0|||
105648805|NCT02133131|364374973|FG002|Overall Study|Adverse Event|0|||
105648806|NCT02133131|364374974|FG003|Overall Study|Adverse Event|1|||
105648807|NCT02133131|364374975|FG004|Overall Study|Adverse Event|0|||
105648808|NCT02133131|364374976|FG005|Overall Study|Adverse Event|0|||
105648809|NCT02133131|364374977|FG006|Overall Study|Adverse Event|0|||
105648810|NCT02133131|364374971|FG000|Overall Study|Lost to Follow-up|1|||
105648811|NCT02133131|364374972|FG001|Overall Study|Lost to Follow-up|0|||
105648812|NCT02133131|364374973|FG002|Overall Study|Lost to Follow-up|0|||
105648813|NCT02133131|364374974|FG003|Overall Study|Lost to Follow-up|1|||
105648814|NCT02133131|364374975|FG004|Overall Study|Lost to Follow-up|0|||
105648815|NCT02133131|364374976|FG005|Overall Study|Lost to Follow-up|0|||
105648816|NCT02133131|364374977|FG006|Overall Study|Lost to Follow-up|0|||
105648817|NCT02133131|364374971|FG000|Overall Study|Status not recorded|4|||
105648818|NCT02133131|364374972|FG001|Overall Study|Status not recorded|5|||
105648819|NCT02133131|364374973|FG002|Overall Study|Status not recorded|1|||
105648820|NCT02133131|364374974|FG003|Overall Study|Status not recorded|4|||
105648821|NCT02133131|364374975|FG004|Overall Study|Status not recorded|0|||
105648822|NCT02133131|364374976|FG005|Overall Study|Status not recorded|0|||
105648823|NCT02133131|364374977|FG006|Overall Study|Status not recorded|0|||
105648824|NCT02133131|364374971|FG000|Overall Study|Ongoing in study|0|||
105648825|NCT02133131|364374972|FG001|Overall Study|Ongoing in study|0|||
105648826|NCT02133131|364374973|FG002|Overall Study|Ongoing in study|0|||
105648827|NCT02133131|364374974|FG003|Overall Study|Ongoing in study|0|||
105648828|NCT02133131|364374975|FG004|Overall Study|Ongoing in study|15|||
105648829|NCT02133131|364374976|FG005|Overall Study|Ongoing in study|14|||
105648830|NCT02133131|364374977|FG006|Overall Study|Ongoing in study|11|||
105648831|NCT02133131|364374971|FG000|Overall Study|Protocol Violation|0|||
105648832|NCT02133131|364374972|FG001|Overall Study|Protocol Violation|0|||
105648833|NCT02133131|364374973|FG002|Overall Study|Protocol Violation|0|||
105648834|NCT02133131|364374974|FG003|Overall Study|Protocol Violation|0|||
105648835|NCT02133131|364374975|FG004|Overall Study|Protocol Violation|0|||
105648836|NCT02133131|364374976|FG005|Overall Study|Protocol Violation|0|||
105648837|NCT02133131|364374977|FG006|Overall Study|Protocol Violation|1|||
105648838|NCT00990821|364374980|FG000|Overall Study|Withdrawal by Subject|0|||
105648839|NCT00990821|364374981|FG001|Overall Study|Withdrawal by Subject|2|||
105648840|NCT00990821|364374982|FG002|Overall Study|Withdrawal by Subject|0|||
105648841|NCT00990821|364374983|FG003|Overall Study|Withdrawal by Subject|0|||
105648842|NCT00990821|364374984|FG004|Overall Study|Withdrawal by Subject|3|||
105648843|NCT00990821|364374985|FG005|Overall Study|Withdrawal by Subject|3|||
105648844|NCT00990821|364374986|FG006|Overall Study|Withdrawal by Subject|1|||
105648845|NCT00990821|364374987|FG007|Overall Study|Withdrawal by Subject|0|||
105648846|NCT00990821|364374988|FG008|Overall Study|Withdrawal by Subject|0|||
105648847|NCT00990821|364374989|FG009|Overall Study|Withdrawal by Subject|1|||
105648848|NCT00990821|364374990|FG010|Overall Study|Withdrawal by Subject|3|||
105648849|NCT00990821|364374991|FG011|Overall Study|Withdrawal by Subject|5|||
105648850|NCT00990821|364374992|FG012|Overall Study|Withdrawal by Subject|2|||
105648851|NCT00990821|364374993|FG013|Overall Study|Withdrawal by Subject|1|||
105648852|NCT03530345|364374994|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
105648853|NCT03530345|364374995|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
105648854|NCT03530345|364374994|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
105648855|NCT03530345|364374995|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
105648856|NCT03530345|364374994|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
105648857|NCT03530345|364374995|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
105648858|NCT03530345|364374994|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
105648859|NCT03530345|364374995|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
105648860|NCT00308113|364374998|FG000|Overall Study|Protocol closure|0|||
105648861|NCT00308113|364374999|FG001|Overall Study|Protocol closure|0|||
105648862|NCT00308113|364375000|FG002|Overall Study|Protocol closure|0|||
105648863|NCT00308113|364375001|FG003|Overall Study|Protocol closure|1|||
105648864|NCT02316171|364375004|FG000|Overall Study|difficulties with urinary catheter|1|||
105648865|NCT02316171|364375005|FG001|Overall Study|difficulties with urinary catheter|0|||
105648866|NCT02316171|364375006|FG002|Overall Study|difficulties with urinary catheter|0|||
105648867|NCT02316171|364375007|FG003|Overall Study|difficulties with urinary catheter|0|||
105648868|NCT00170950|364375008|FG000|Overall Study|Death|236|||
105648869|NCT00170950|364375009|FG001|Overall Study|Death|274|||
105648870|NCT00170950|364375008|FG000|Overall Study|Withdrawal by Subject|496|||
105648871|NCT00170950|364375009|FG001|Overall Study|Withdrawal by Subject|498|||
105648872|NCT00170950|364375008|FG000|Overall Study|Lost to Follow-up|134|||
105648873|NCT00170950|364375009|FG001|Overall Study|Lost to Follow-up|115|||
105648874|NCT00170950|364375008|FG000|Overall Study|Missing|2|||
105648875|NCT00170950|364375009|FG001|Overall Study|Missing|1|||
105648876|NCT00170950|364375008|FG000|Overall Study|Termination Data Not Recorded|17|||
105648877|NCT00170950|364375009|FG001|Overall Study|Termination Data Not Recorded|22|||
105648878|NCT04050722|364376883|FG000|Overall Study|Withdrawal by Subject|1|||
105648879|NCT04050722|364376884|FG001|Overall Study|Withdrawal by Subject|0|||
105648880|NCT02762500|364376885|FG000|Overall Study|Lack of Efficacy|1|||
105648881|NCT02762500|364376886|FG001|Overall Study|Lack of Efficacy|0|||
105648882|NCT02762500|364376885|FG000|Overall Study|Withdrawal by Subject|1|||
105648883|NCT02762500|364376886|FG001|Overall Study|Withdrawal by Subject|1|||
105648884|NCT02762500|364376885|FG000|Overall Study|Adverse Event|0|||
105648885|NCT02762500|364376886|FG001|Overall Study|Adverse Event|2|||
105648886|NCT03087851|364376887|FG000|Overall Study|Withdraw on medical grounds|0|||
105648887|NCT03087851|364376888|FG001|Overall Study|Withdraw on medical grounds|1|||
105648888|NCT03087851|364376889|FG002|Overall Study|Withdraw on medical grounds|2|||
105648889|NCT00443755|364376890|FG000|Overall Study|Withdrawal by Subject|2|||
105648890|NCT00443755|364376891|FG001|Overall Study|Withdrawal by Subject|1|||
105648891|NCT00678899|364376892|FG000|Overall Study|Adverse Event|1|||
105648892|NCT04385849|364376893|FG000|Overall Study|Lost to Follow-up|1|||
105648893|NCT04385849|364376894|FG001|Overall Study|Lost to Follow-up|0|||
105648894|NCT05878990|364376895|FG000|Overall Study|Lost to Follow-up|7|||
105648895|NCT05878990|364376895|FG000|Overall Study|Withdrawal by Subject|1|||
105648896|NCT00839306|364376896|FG000|Overall Study|Adverse Event|3|||
105648897|NCT00839306|364376897|FG001|Overall Study|Adverse Event|5|||
105648898|NCT00839306|364376896|FG000|Overall Study|Lost to Follow-up|6|||
105648899|NCT00839306|364376897|FG001|Overall Study|Lost to Follow-up|9|||
105648900|NCT00839306|364376896|FG000|Overall Study|Withdrawal by Subject|5|||
105648901|NCT00839306|364376897|FG001|Overall Study|Withdrawal by Subject|7|||
105648902|NCT00839306|364376896|FG000|Overall Study|Lack of Efficacy|5|||
105648903|NCT00839306|364376897|FG001|Overall Study|Lack of Efficacy|4|||
105648904|NCT00839306|364376896|FG000|Overall Study|Other|6|||
105648905|NCT00839306|364376897|FG001|Overall Study|Other|18|||
105648906|NCT02339506|364376902|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
105648907|NCT02339506|364376903|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
105648908|NCT02339506|364376902|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
105648909|NCT02339506|364376903|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
105648910|NCT01234675|364376904|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
105648911|NCT01234675|364376905|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
105648912|NCT01234675|364376904|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105648913|NCT01234675|364376905|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
105648914|NCT00609245|364376906|FG000|Overall Study|Adverse Event|1|||
105648915|NCT00331799|364376907|FG000|Overall Study|Withdrawal by Subject|2|||
105648916|NCT00331799|364376907|FG000|Overall Study|Sedation|1|||
105648917|NCT04203199|364376910|FG000|First Intervention Period|Lost to Follow-up|0|||
105648918|NCT04203199|364376911|FG001|First Intervention Period|Lost to Follow-up|1|||
105648919|NCT04203199|364376910|FG000|Second Intervention Period|Medication change|1|||
105648920|NCT04203199|364376911|FG001|Second Intervention Period|Medication change|0|||
105648921|NCT02068352|364376915|FG000|Overall Study|Lost to Follow-up|0|||
105648922|NCT02068352|364376916|FG001|Overall Study|Lost to Follow-up|2|||
105648923|NCT02068352|364376917|FG002|Overall Study|Lost to Follow-up|0|||
105648924|NCT02068352|364376915|FG000|Overall Study|Adverse Event|4|||
105648925|NCT02068352|364376916|FG001|Overall Study|Adverse Event|2|||
105648926|NCT02068352|364376917|FG002|Overall Study|Adverse Event|7|||
105648927|NCT02068352|364376915|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
105648928|NCT02068352|364376916|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
105648929|NCT02068352|364376917|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
105648930|NCT02068352|364376915|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
105648931|NCT02068352|364376916|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
105648932|NCT02068352|364376917|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
105648933|NCT02068352|364376915|FG000|Overall Study|Protocol Deviation|0|||
105648934|NCT02068352|364376916|FG001|Overall Study|Protocol Deviation|0|||
105648935|NCT02068352|364376917|FG002|Overall Study|Protocol Deviation|1|||
105648936|NCT01838499|364376922|FG000|Overall Study|Protocol Violation|0|||
105648937|NCT01838499|364376923|FG001|Overall Study|Protocol Violation|1|||
105648938|NCT01838499|364376922|FG000|Overall Study|Lost to Follow-up|2|||
105648939|NCT01838499|364376923|FG001|Overall Study|Lost to Follow-up|4|||
105648940|NCT01838499|364376922|FG000|Overall Study|Lack of Efficacy|1|||
105648941|NCT01838499|364376923|FG001|Overall Study|Lack of Efficacy|2|||
105648942|NCT01838499|364376922|FG000|Overall Study|Adverse Event|2|||
105648943|NCT01838499|364376923|FG001|Overall Study|Adverse Event|1|||
105648944|NCT01838499|364376922|FG000|Overall Study|Withdrawal by Subject|19|||
105648945|NCT01838499|364376923|FG001|Overall Study|Withdrawal by Subject|9|||
105648946|NCT01107353|364376934|FG000|Overall Study|Positive Drug Screen|1|||
105648947|NCT01107353|364376935|FG001|Overall Study|Positive Drug Screen|0|||
105648948|NCT00809783|364376936|FG000|Overall Study|Death|1|||
105648949|NCT00809783|364376937|FG001|Overall Study|Death|0|||
105648950|NCT00809783|364376938|FG002|Overall Study|Death|0|||
105648951|NCT00809783|364376936|FG000|Overall Study|Adverse Event|34|||
105648952|NCT00809783|364376937|FG001|Overall Study|Adverse Event|52|||
105648953|NCT00809783|364376938|FG002|Overall Study|Adverse Event|71|||
105648954|NCT00809783|364376936|FG000|Overall Study|Lack of Efficacy|39|||
105648955|NCT00809783|364376937|FG001|Overall Study|Lack of Efficacy|52|||
105648956|NCT00809783|364376938|FG002|Overall Study|Lack of Efficacy|63|||
105648957|NCT00809783|364376936|FG000|Overall Study|Lost to Follow-up|0|||
105648958|NCT00809783|364376937|FG001|Overall Study|Lost to Follow-up|3|||
105648959|NCT00809783|364376938|FG002|Overall Study|Lost to Follow-up|4|||
105648960|NCT00809783|364376936|FG000|Overall Study|Withdrawal by Subject|47|||
105648961|NCT00809783|364376937|FG001|Overall Study|Withdrawal by Subject|72|||
105648962|NCT00809783|364376938|FG002|Overall Study|Withdrawal by Subject|64|||
105648963|NCT00809783|364376936|FG000|Overall Study|Protocol Violation|2|||
105648964|NCT00809783|364376937|FG001|Overall Study|Protocol Violation|6|||
105648965|NCT00809783|364376938|FG002|Overall Study|Protocol Violation|5|||
105648966|NCT00809783|364376936|FG000|Overall Study|Randomized, but not treated|3|||
105648967|NCT00809783|364376937|FG001|Overall Study|Randomized, but not treated|0|||
105648968|NCT00809783|364376938|FG002|Overall Study|Randomized, but not treated|2|||
105648969|NCT00809783|364376936|FG000|Overall Study|Study Terminated by Sponsor|378|||
105648970|NCT00809783|364376937|FG001|Overall Study|Study Terminated by Sponsor|626|||
105648971|NCT00809783|364376938|FG002|Overall Study|Study Terminated by Sponsor|565|||
105648972|NCT00809783|364376936|FG000|Overall Study|Other|21|||
105648973|NCT00809783|364376937|FG001|Overall Study|Other|21|||
105648974|NCT00809783|364376938|FG002|Overall Study|Other|16|||
105648975|NCT01745380|364376939|FG000|Overall Study|Lost to Follow-up|1|||
105648976|NCT01745380|364376940|FG001|Overall Study|Lost to Follow-up|0|||
105648977|NCT01745380|364376939|FG000|Overall Study|Lack of Efficacy|0|||
105648978|NCT01745380|364376940|FG001|Overall Study|Lack of Efficacy|1|||
105648979|NCT02660034|364376943|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
105648980|NCT02660034|364376944|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
105648981|NCT02660034|364376945|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
105648982|NCT02660034|364376946|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
105648983|NCT02660034|364376947|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
105648984|NCT02660034|364376948|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
105648985|NCT02660034|364376949|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
105648986|NCT02660034|364376950|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
105648987|NCT02660034|364376951|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
105648988|NCT02660034|364376952|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
105648989|NCT02660034|364376953|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
105648990|NCT02660034|364376954|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
105648991|NCT02660034|364376955|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
105648992|NCT02660034|364376956|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
105648993|NCT02660034|364376943|FG000|Overall Study|Progressive Disease (Clinical)|7|||
105648994|NCT02660034|364376944|FG001|Overall Study|Progressive Disease (Clinical)|8|||
105648995|NCT02660034|364376945|FG002|Overall Study|Progressive Disease (Clinical)|3|||
105648996|NCT02660034|364376946|FG003|Overall Study|Progressive Disease (Clinical)|9|||
105648997|NCT02660034|364376947|FG004|Overall Study|Progressive Disease (Clinical)|3|||
105648998|NCT02660034|364376948|FG005|Overall Study|Progressive Disease (Clinical)|0|||
105648999|NCT02660034|364376949|FG006|Overall Study|Progressive Disease (Clinical)|0|||
105649000|NCT02660034|364376950|FG007|Overall Study|Progressive Disease (Clinical)|0|||
105649001|NCT02660034|364376951|FG008|Overall Study|Progressive Disease (Clinical)|0|||
105649002|NCT02660034|364376952|FG009|Overall Study|Progressive Disease (Clinical)|0|||
105649003|NCT02660034|364376953|FG010|Overall Study|Progressive Disease (Clinical)|0|||
105649004|NCT02660034|364376954|FG011|Overall Study|Progressive Disease (Clinical)|0|||
105649005|NCT02660034|364376955|FG012|Overall Study|Progressive Disease (Clinical)|0|||
105649006|NCT02660034|364376956|FG013|Overall Study|Progressive Disease (Clinical)|0|||
105649007|NCT02660034|364376943|FG000|Overall Study|Lost to Follow-up|0|||
105649008|NCT02660034|364376944|FG001|Overall Study|Lost to Follow-up|0|||
105649009|NCT02660034|364376945|FG002|Overall Study|Lost to Follow-up|1|||
105649010|NCT02660034|364376946|FG003|Overall Study|Lost to Follow-up|1|||
105649011|NCT02660034|364376947|FG004|Overall Study|Lost to Follow-up|0|||
105649012|NCT02660034|364376948|FG005|Overall Study|Lost to Follow-up|0|||
105649013|NCT02660034|364376949|FG006|Overall Study|Lost to Follow-up|0|||
105649014|NCT02660034|364376950|FG007|Overall Study|Lost to Follow-up|0|||
105649015|NCT02660034|364376951|FG008|Overall Study|Lost to Follow-up|0|||
105649016|NCT02660034|364376952|FG009|Overall Study|Lost to Follow-up|1|||
105649017|NCT02660034|364376953|FG010|Overall Study|Lost to Follow-up|1|||
105649018|NCT02660034|364376954|FG011|Overall Study|Lost to Follow-up|1|||
105649019|NCT02660034|364376955|FG012|Overall Study|Lost to Follow-up|0|||
105649020|NCT02660034|364376956|FG013|Overall Study|Lost to Follow-up|0|||
105649021|NCT02660034|364376943|FG000|Overall Study|Participant moved into special access scheme|1|||
105649022|NCT02660034|364376944|FG001|Overall Study|Participant moved into special access scheme|2|||
105649023|NCT02660034|364376945|FG002|Overall Study|Participant moved into special access scheme|0|||
105649024|NCT02660034|364376946|FG003|Overall Study|Participant moved into special access scheme|0|||
105649025|NCT02660034|364376947|FG004|Overall Study|Participant moved into special access scheme|0|||
105649026|NCT02660034|364376948|FG005|Overall Study|Participant moved into special access scheme|0|||
105649027|NCT02660034|364376949|FG006|Overall Study|Participant moved into special access scheme|0|||
105649028|NCT02660034|364376950|FG007|Overall Study|Participant moved into special access scheme|0|||
105649029|NCT02660034|364376951|FG008|Overall Study|Participant moved into special access scheme|0|||
105649030|NCT02660034|364376952|FG009|Overall Study|Participant moved into special access scheme|0|||
105649031|NCT02660034|364376953|FG010|Overall Study|Participant moved into special access scheme|0|||
105649032|NCT02660034|364376954|FG011|Overall Study|Participant moved into special access scheme|0|||
105649033|NCT02660034|364376955|FG012|Overall Study|Participant moved into special access scheme|0|||
105649034|NCT02660034|364376956|FG013|Overall Study|Participant moved into special access scheme|0|||
105649035|NCT02660034|364376943|FG000|Overall Study|Adverse Event|1|||
105649036|NCT02660034|364376944|FG001|Overall Study|Adverse Event|0|||
105649037|NCT02660034|364376945|FG002|Overall Study|Adverse Event|0|||
105649038|NCT02660034|364376946|FG003|Overall Study|Adverse Event|0|||
105649039|NCT02660034|364376947|FG004|Overall Study|Adverse Event|0|||
105649040|NCT02660034|364376948|FG005|Overall Study|Adverse Event|0|||
105649041|NCT02660034|364376949|FG006|Overall Study|Adverse Event|0|||
105649042|NCT02660034|364376950|FG007|Overall Study|Adverse Event|0|||
105649043|NCT02660034|364376951|FG008|Overall Study|Adverse Event|0|||
105649044|NCT02660034|364376952|FG009|Overall Study|Adverse Event|0|||
105649045|NCT02660034|364376953|FG010|Overall Study|Adverse Event|0|||
105649046|NCT02660034|364376954|FG011|Overall Study|Adverse Event|0|||
105649047|NCT02660034|364376955|FG012|Overall Study|Adverse Event|0|||
105649048|NCT02660034|364376956|FG013|Overall Study|Adverse Event|0|||
105649049|NCT02660034|364376943|FG000|Overall Study|Sponsor Decision|0|||
105649050|NCT02660034|364376944|FG001|Overall Study|Sponsor Decision|1|||
105649051|NCT02660034|364376945|FG002|Overall Study|Sponsor Decision|2|||
105649052|NCT02660034|364376946|FG003|Overall Study|Sponsor Decision|2|||
105649053|NCT02660034|364376947|FG004|Overall Study|Sponsor Decision|3|||
105649054|NCT02660034|364376948|FG005|Overall Study|Sponsor Decision|0|||
105649055|NCT02660034|364376949|FG006|Overall Study|Sponsor Decision|0|||
105649056|NCT02660034|364376950|FG007|Overall Study|Sponsor Decision|0|||
105649057|NCT02660034|364376951|FG008|Overall Study|Sponsor Decision|0|||
105649058|NCT02660034|364376952|FG009|Overall Study|Sponsor Decision|0|||
105649059|NCT02660034|364376953|FG010|Overall Study|Sponsor Decision|0|||
105649060|NCT02660034|364376954|FG011|Overall Study|Sponsor Decision|0|||
105649061|NCT02660034|364376955|FG012|Overall Study|Sponsor Decision|0|||
105649062|NCT02660034|364376956|FG013|Overall Study|Sponsor Decision|1|||
105649063|NCT02660034|364376943|FG000|Overall Study|Withdrawal by Subject|0|||
105649064|NCT02660034|364376944|FG001|Overall Study|Withdrawal by Subject|0|||
105649065|NCT02660034|364376945|FG002|Overall Study|Withdrawal by Subject|0|||
105649066|NCT02660034|364376946|FG003|Overall Study|Withdrawal by Subject|0|||
105649067|NCT02660034|364376947|FG004|Overall Study|Withdrawal by Subject|0|||
105649068|NCT02660034|364376948|FG005|Overall Study|Withdrawal by Subject|0|||
105649069|NCT02660034|364376949|FG006|Overall Study|Withdrawal by Subject|1|||
105649070|NCT02660034|364376950|FG007|Overall Study|Withdrawal by Subject|1|||
105649071|NCT02660034|364376951|FG008|Overall Study|Withdrawal by Subject|1|||
105649072|NCT02660034|364376952|FG009|Overall Study|Withdrawal by Subject|0|||
105649073|NCT02660034|364376953|FG010|Overall Study|Withdrawal by Subject|0|||
105649074|NCT02660034|364376954|FG011|Overall Study|Withdrawal by Subject|1|||
105649075|NCT02660034|364376955|FG012|Overall Study|Withdrawal by Subject|2|||
105649076|NCT02660034|364376956|FG013|Overall Study|Withdrawal by Subject|0|||
105649077|NCT02660034|364376943|FG000|Overall Study|Death|0|||
105649078|NCT02660034|364376944|FG001|Overall Study|Death|0|||
105649079|NCT02660034|364376945|FG002|Overall Study|Death|0|||
105649080|NCT02660034|364376946|FG003|Overall Study|Death|0|||
105649081|NCT02660034|364376947|FG004|Overall Study|Death|0|||
105649082|NCT02660034|364376948|FG005|Overall Study|Death|13|||
105649083|NCT02660034|364376949|FG006|Overall Study|Death|14|||
105649084|NCT02660034|364376950|FG007|Overall Study|Death|10|||
105649085|NCT02660034|364376951|FG008|Overall Study|Death|9|||
105649086|NCT02660034|364376952|FG009|Overall Study|Death|21|||
105649087|NCT02660034|364376953|FG010|Overall Study|Death|17|||
105649088|NCT02660034|364376954|FG011|Overall Study|Death|15|||
105649089|NCT02660034|364376955|FG012|Overall Study|Death|18|||
105649090|NCT02660034|364376956|FG013|Overall Study|Death|7|||
105649091|NCT02660034|364376943|FG000|Overall Study|Physician Decision|0|||
105649092|NCT02660034|364376944|FG001|Overall Study|Physician Decision|0|||
105649093|NCT02660034|364376945|FG002|Overall Study|Physician Decision|0|||
105649094|NCT02660034|364376946|FG003|Overall Study|Physician Decision|0|||
105649095|NCT02660034|364376947|FG004|Overall Study|Physician Decision|0|||
105649096|NCT02660034|364376948|FG005|Overall Study|Physician Decision|0|||
105649097|NCT02660034|364376949|FG006|Overall Study|Physician Decision|0|||
105649098|NCT02660034|364376950|FG007|Overall Study|Physician Decision|0|||
105649099|NCT02660034|364376951|FG008|Overall Study|Physician Decision|0|||
105649100|NCT02660034|364376952|FG009|Overall Study|Physician Decision|0|||
105649101|NCT02660034|364376953|FG010|Overall Study|Physician Decision|0|||
105649102|NCT02660034|364376954|FG011|Overall Study|Physician Decision|0|||
105649103|NCT02660034|364376955|FG012|Overall Study|Physician Decision|0|||
105649104|NCT02660034|364376956|FG013|Overall Study|Physician Decision|1|||
105649105|NCT02660034|364376943|FG000|Overall Study|Participants transferred to LTE|0|||
105649106|NCT02660034|364376944|FG001|Overall Study|Participants transferred to LTE|0|||
105649107|NCT02660034|364376945|FG002|Overall Study|Participants transferred to LTE|0|||
105649108|NCT02660034|364376946|FG003|Overall Study|Participants transferred to LTE|0|||
105649109|NCT02660034|364376947|FG004|Overall Study|Participants transferred to LTE|0|||
105649110|NCT02660034|364376948|FG005|Overall Study|Participants transferred to LTE|10|||
105649111|NCT02660034|364376949|FG006|Overall Study|Participants transferred to LTE|8|||
105649112|NCT02660034|364376950|FG007|Overall Study|Participants transferred to LTE|8|||
105649113|NCT02660034|364376951|FG008|Overall Study|Participants transferred to LTE|10|||
105649114|NCT02660034|364376952|FG009|Overall Study|Participants transferred to LTE|1|||
105649115|NCT02660034|364376953|FG010|Overall Study|Participants transferred to LTE|2|||
105649116|NCT02660034|364376954|FG011|Overall Study|Participants transferred to LTE|4|||
105649117|NCT02660034|364376955|FG012|Overall Study|Participants transferred to LTE|1|||
105649118|NCT02660034|364376956|FG013|Overall Study|Participants transferred to LTE|1|||
105649119|NCT02995733|364376962|FG000|Overall Study|Study site closed|9|||
105649120|NCT02995733|364376963|FG001|Overall Study|Study site closed|10|||
105649121|NCT02995733|364376962|FG000|Overall Study|Death|3|||
105649122|NCT02995733|364376963|FG001|Overall Study|Death|4|||
105649123|NCT02995733|364376962|FG000|Overall Study|Withdrawal by Subject|6|||
105649124|NCT02995733|364376963|FG001|Overall Study|Withdrawal by Subject|2|||
105649125|NCT02995733|364376962|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
105649126|NCT02995733|364376963|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
105649127|NCT02995733|364376962|FG000|Overall Study|Lost to Follow-up|48|||
105649128|NCT02995733|364376963|FG001|Overall Study|Lost to Follow-up|37|||
105649129|NCT02995733|364376962|FG000|Overall Study|Other|0|||
105649130|NCT02995733|364376963|FG001|Overall Study|Other|1|||
105649131|NCT01183013|364376966|FG000|Overall Study|Adverse Event|6|||
105649132|NCT01183013|364376967|FG001|Overall Study|Adverse Event|8|||
105649133|NCT01183013|364376968|FG002|Overall Study|Adverse Event|5|||
105649134|NCT01183013|364376969|FG003|Overall Study|Adverse Event|5|||
105649135|NCT01183013|364376970|FG004|Overall Study|Adverse Event|10|||
105649136|NCT01183013|364376971|FG005|Overall Study|Adverse Event|10|||
105649137|NCT01183013|364376972|FG006|Overall Study|Adverse Event|6|||
105649138|NCT01183013|364376966|FG000|Overall Study|Lack of Efficacy|3|||
105649139|NCT01183013|364376967|FG001|Overall Study|Lack of Efficacy|2|||
105649140|NCT01183013|364376968|FG002|Overall Study|Lack of Efficacy|1|||
105649141|NCT01183013|364376969|FG003|Overall Study|Lack of Efficacy|2|||
105649142|NCT01183013|364376970|FG004|Overall Study|Lack of Efficacy|1|||
105649143|NCT01183013|364376971|FG005|Overall Study|Lack of Efficacy|2|||
105649144|NCT01183013|364376972|FG006|Overall Study|Lack of Efficacy|0|||
105649145|NCT01183013|364376966|FG000|Overall Study|Protocol Violation|5|||
105649146|NCT01183013|364376967|FG001|Overall Study|Protocol Violation|2|||
105649147|NCT01183013|364376968|FG002|Overall Study|Protocol Violation|4|||
105649148|NCT01183013|364376969|FG003|Overall Study|Protocol Violation|0|||
105649149|NCT01183013|364376970|FG004|Overall Study|Protocol Violation|4|||
105649150|NCT01183013|364376971|FG005|Overall Study|Protocol Violation|3|||
105649151|NCT01183013|364376972|FG006|Overall Study|Protocol Violation|3|||
105649152|NCT01183013|364376966|FG000|Overall Study|Lost to Follow-up|7|||
105649153|NCT01183013|364376967|FG001|Overall Study|Lost to Follow-up|3|||
105649154|NCT01183013|364376968|FG002|Overall Study|Lost to Follow-up|4|||
105649155|NCT01183013|364376969|FG003|Overall Study|Lost to Follow-up|3|||
105649156|NCT01183013|364376970|FG004|Overall Study|Lost to Follow-up|2|||
105649157|NCT01183013|364376971|FG005|Overall Study|Lost to Follow-up|6|||
105649158|NCT01183013|364376972|FG006|Overall Study|Lost to Follow-up|5|||
105649159|NCT01183013|364376966|FG000|Overall Study|Withdrawal by Subject|9|||
105649160|NCT01183013|364376967|FG001|Overall Study|Withdrawal by Subject|13|||
105649161|NCT01183013|364376968|FG002|Overall Study|Withdrawal by Subject|10|||
105649162|NCT01183013|364376969|FG003|Overall Study|Withdrawal by Subject|8|||
105649163|NCT01183013|364376970|FG004|Overall Study|Withdrawal by Subject|7|||
105649164|NCT01183013|364376971|FG005|Overall Study|Withdrawal by Subject|9|||
105649165|NCT01183013|364376972|FG006|Overall Study|Withdrawal by Subject|10|||
105649166|NCT01183013|364376966|FG000|Overall Study|Reasons other than stated above|15|||
105649167|NCT01183013|364376967|FG001|Overall Study|Reasons other than stated above|11|||
105649168|NCT01183013|364376968|FG002|Overall Study|Reasons other than stated above|17|||
105649169|NCT01183013|364376969|FG003|Overall Study|Reasons other than stated above|12|||
105649170|NCT01183013|364376970|FG004|Overall Study|Reasons other than stated above|12|||
105649171|NCT01183013|364376971|FG005|Overall Study|Reasons other than stated above|15|||
105649172|NCT01183013|364376972|FG006|Overall Study|Reasons other than stated above|13|||
105649173|NCT04879823|364376976|FG000|Overall Study|Physician Decision|3|||
105649174|NCT04879823|364376977|FG001|Overall Study|Physician Decision|1|||
105649175|NCT04879823|364376976|FG000|Overall Study|Protocol Violation|2|||
105649176|NCT04879823|364376977|FG001|Overall Study|Protocol Violation|3|||
105649177|NCT04879823|364376976|FG000|Overall Study|Lost to Follow-up|43|||
105649178|NCT04879823|364376977|FG001|Overall Study|Lost to Follow-up|35|||
105649179|NCT04468633|364376978|FG000|Overall Study|Withdrawal by Subject|4|||
105649180|NCT04468633|364376979|FG001|Overall Study|Withdrawal by Subject|0|||
105649181|NCT01498445|364376982|FG000|Overall Study|Lack of Efficacy|0|||
105649182|NCT01498445|364376983|FG001|Overall Study|Lack of Efficacy|0|||
105649183|NCT01498445|364376984|FG002|Overall Study|Lack of Efficacy|1|||
105649184|NCT01498445|364376985|FG003|Overall Study|Lack of Efficacy|2|||
105649185|NCT01498445|364376986|FG004|Overall Study|Lack of Efficacy|0|||
105649186|NCT01498445|364376987|FG005|Overall Study|Lack of Efficacy|0|||
105649187|NCT01498445|364376982|FG000|Overall Study|Screen Failure|0|||
105649188|NCT01498445|364376983|FG001|Overall Study|Screen Failure|0|||
105649189|NCT01498445|364376984|FG002|Overall Study|Screen Failure|0|||
105649190|NCT01498445|364376985|FG003|Overall Study|Screen Failure|0|||
105649191|NCT01498445|364376986|FG004|Overall Study|Screen Failure|1|||
105649192|NCT01498445|364376987|FG005|Overall Study|Screen Failure|1|||
105649193|NCT03209492|364376990|FG000|Overall Study|Case Report Forms Uncollected|5|||
105649194|NCT02105688|364376991|FG000|Part A: Double-Blind|Adverse Event|1|||
105649195|NCT02105688|364376992|FG001|Part A: Double-Blind|Adverse Event|0|||
105649196|NCT02105688|364376991|FG000|Part A: Double-Blind|Death|0|||
105649197|NCT02105688|364376992|FG001|Part A: Double-Blind|Death|1|||
105649198|NCT02105688|364376991|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
105649199|NCT02105688|364376992|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
105649200|NCT02105688|364376991|FG000|Part A: Double-Blind|Physician Decision|0|||
105649201|NCT02105688|364376992|FG001|Part A: Double-Blind|Physician Decision|1|||
105649202|NCT02105688|364376991|FG000|Part A: Double-Blind|Status Unknown|0|||
105649203|NCT02105688|364376992|FG001|Part A: Double-Blind|Status Unknown|2|||
105649204|NCT02105688|364376991|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
105649205|NCT02105688|364376992|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
105649206|NCT02105688|364376991|FG000|Part B: Observational Follow-up|Death|2|||
105649207|NCT02105688|364376992|FG001|Part B: Observational Follow-up|Death|1|||
105649208|NCT02105688|364376991|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
105649209|NCT02105688|364376992|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
105649210|NCT02105688|364376991|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
105649211|NCT02105688|364376992|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
105649212|NCT02105688|364376991|FG000|Part B: Observational Follow-up|Physician Decision|3|||
105649213|NCT02105688|364376992|FG001|Part B: Observational Follow-up|Physician Decision|1|||
105649214|NCT02498418|364377015|FG000|Overall Study|Lack of Efficacy|0|||
105649215|NCT02498418|364377016|FG001|Overall Study|Lack of Efficacy|0|||
105649216|NCT02498418|364377017|FG002|Overall Study|Lack of Efficacy|1|||
105649217|NCT02498418|364377015|FG000|Overall Study|Withdrawal by Subject|2|||
105649218|NCT02498418|364377016|FG001|Overall Study|Withdrawal by Subject|0|||
105649219|NCT02498418|364377017|FG002|Overall Study|Withdrawal by Subject|3|||
105649220|NCT02498418|364377015|FG000|Overall Study|Lost to Follow-up|0|||
105649221|NCT02498418|364377016|FG001|Overall Study|Lost to Follow-up|1|||
105649222|NCT02498418|364377017|FG002|Overall Study|Lost to Follow-up|1|||
105649223|NCT02498418|364377015|FG000|Overall Study|Participant taken prohibited medication|0|||
105649224|NCT02498418|364377016|FG001|Overall Study|Participant taken prohibited medication|1|||
105649225|NCT02498418|364377017|FG002|Overall Study|Participant taken prohibited medication|1|||
105649226|NCT03575572|364377019|FG000|Overall Study|Withdrawal by Subject|2|||
105649227|NCT03575572|364377019|FG000|Overall Study|Physician Decision|2|||
105649228|NCT04393779|364377020|FG000|Overall Study|Death|1|||
105649229|NCT04393779|364377020|FG000|Overall Study|Device reintervention or explant|4|||
105649230|NCT02267746|364377021|FG000|Overall Study|Adverse Event|0|||
105649231|NCT02267746|364377022|FG001|Overall Study|Adverse Event|2|||
105649232|NCT02267746|364377023|FG002|Overall Study|Adverse Event|1|||
105649233|NCT02267746|364377021|FG000|Overall Study|Protocol Violation|8|||
105649234|NCT02267746|364377022|FG001|Overall Study|Protocol Violation|7|||
105649235|NCT02267746|364377023|FG002|Overall Study|Protocol Violation|3|||
105649236|NCT02267746|364377021|FG000|Overall Study|Lack of Efficacy|11|||
105649237|NCT02267746|364377022|FG001|Overall Study|Lack of Efficacy|11|||
105649238|NCT02267746|364377023|FG002|Overall Study|Lack of Efficacy|15|||
105649239|NCT02267746|364377021|FG000|Overall Study|Protocol Violation|1|||
105649240|NCT02267746|364377022|FG001|Overall Study|Protocol Violation|2|||
105649241|NCT02267746|364377023|FG002|Overall Study|Protocol Violation|1|||
105649242|NCT02267746|364377021|FG000|Overall Study|Miscellaneous|1|||
105649243|NCT02267746|364377022|FG001|Overall Study|Miscellaneous|0|||
105649244|NCT02267746|364377023|FG002|Overall Study|Miscellaneous|1|||
105649245|NCT04372186|364377028|FG000|Overall Study|Death|24|||
105649246|NCT04372186|364377029|FG001|Overall Study|Death|11|||
105649247|NCT04372186|364377028|FG000|Overall Study|Transferred to a different facility for care|0|||
105649248|NCT04372186|364377029|FG001|Overall Study|Transferred to a different facility for care|2|||
105649249|NCT02116582|364377030|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
105649250|NCT02116582|364377030|FG000|Overall Study|Adverse Event|22|||
105649251|NCT02116582|364377030|FG000|Overall Study|Death|9|||
105649252|NCT02116582|364377030|FG000|Overall Study|Progressive Disease|148|||
105649253|NCT02116582|364377030|FG000|Overall Study|Protocol Violation|3|||
105649254|NCT02116582|364377030|FG000|Overall Study|Withdrawal by Subject|8|||
105649255|NCT02116582|364377030|FG000|Overall Study|Other: Miscellaneous|11|||
105649256|NCT02116582|364377030|FG000|Overall Study|Lost to Follow-up|1|||
105649257|NCT02116582|364377030|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
105649258|NCT03861078|364377031|FG000|Overall Study|COVID-19 shut down|4|||
105649259|NCT03861078|364377031|FG000|Overall Study|Lost to Follow-up|1|||
105649260|NCT03861078|364377031|FG000|Overall Study|Protocol Violation|2|||
105649261|NCT03861078|364377031|FG000|Overall Study|lack of venous access|1|||
105649262|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
105649263|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
105649264|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
105649265|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
105649266|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
105649267|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
105649268|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
105649269|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
105649270|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
105649271|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
105649272|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
105649273|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
105649274|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
105649275|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
105649276|NCT02971683|364377032|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
105649277|NCT02971683|364377033|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
105649278|NCT02971683|364377032|FG000|Open-Label|Lost to Follow-up|1|||
105649279|NCT02971683|364377033|FG001|Open-Label|Lost to Follow-up|0|||
105649280|NCT02971683|364377032|FG000|Open-Label|Participants withdrew consent|0|||
105649281|NCT02971683|364377033|FG001|Open-Label|Participants withdrew consent|2|||
105649282|NCT02971683|364377032|FG000|Open-Label|Participant request to discontinue study treatment|1|||
105649283|NCT02971683|364377033|FG001|Open-Label|Participant request to discontinue study treatment|0|||
105649284|NCT02971683|364377032|FG000|Open-Label|Lack of Efficacy|2|||
105649285|NCT02971683|364377033|FG001|Open-Label|Lack of Efficacy|0|||
105649286|NCT02971683|364377032|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
105649287|NCT02971683|364377033|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
105649288|NCT02971683|364377032|FG000|Long-Term Open Label|Participant withdrew consent|1|||
105649289|NCT02971683|364377033|FG001|Long-Term Open Label|Participant withdrew consent|0|||
105649290|NCT02971683|364377032|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
105649291|NCT02971683|364377033|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
105649292|NCT02971683|364377032|FG000|Long-Term Open Label|Adverse Event|1|||
105649293|NCT02971683|364377033|FG001|Long-Term Open Label|Adverse Event|2|||
105649294|NCT02971683|364377032|FG000|Long-Term Open Label|Lack of Efficacy|1|||
105649295|NCT02971683|364377033|FG001|Long-Term Open Label|Lack of Efficacy|1|||
105649296|NCT05431543|364377043|FG000|Overall Study|Medical History|1|||
105649297|NCT05431543|364377044|FG001|Overall Study|Medical History|0|||
105649298|NCT05431543|364377045|FG002|Overall Study|Medical History|0|||
105649299|NCT00440037|364377046|FG000|Overall Study|Withdrawal by Subject|6|||
105649300|NCT00440037|364377046|FG000|Overall Study|Administrative decision|3|||
105649301|NCT00498797|364377047|FG000|Overall Study|Withdrawal by Subject|4|||
105649302|NCT00498797|364377048|FG001|Overall Study|Withdrawal by Subject|2|||
105649303|NCT00498797|364377047|FG000|Overall Study|Adverse Event|12|||
105649304|NCT00498797|364377048|FG001|Overall Study|Adverse Event|5|||
105649305|NCT00498797|364377047|FG000|Overall Study|Condition under investigation worsened|19|||
105649306|NCT00498797|364377048|FG001|Overall Study|Condition under investigation worsened|21|||
105649307|NCT00498797|364377047|FG000|Overall Study|Other|3|||
105649308|NCT00498797|364377048|FG001|Overall Study|Other|1|||
105649309|NCT03928821|364377049|FG000|Overall Study|Death|0|||
105649310|NCT03928821|364377050|FG001|Overall Study|Death|1|||
105649311|NCT03928821|364377051|FG002|Overall Study|Death|0|||
105649312|NCT03928821|364377052|FG003|Overall Study|Death|0|||
105649313|NCT03928821|364377049|FG000|Overall Study|Lost to Follow-up|0|||
105649314|NCT03928821|364377050|FG001|Overall Study|Lost to Follow-up|2|||
105649315|NCT03928821|364377051|FG002|Overall Study|Lost to Follow-up|3|||
105649316|NCT03928821|364377052|FG003|Overall Study|Lost to Follow-up|0|||
105649317|NCT03928821|364377049|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
105649318|NCT03928821|364377050|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
105649319|NCT03928821|364377051|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
105649320|NCT03928821|364377052|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
105649321|NCT00985621|364377053|FG000|Overall Study|Adverse Event|2|||
105649322|NCT00985621|364377054|FG001|Overall Study|Adverse Event|3|||
105649323|NCT00985621|364377055|FG002|Overall Study|Adverse Event|4|||
105649324|NCT00985621|364377056|FG003|Overall Study|Adverse Event|16|||
105649325|NCT00985621|364377053|FG000|Overall Study|Lack of Efficacy|10|||
105649326|NCT00985621|364377054|FG001|Overall Study|Lack of Efficacy|6|||
105649327|NCT00985621|364377055|FG002|Overall Study|Lack of Efficacy|5|||
105649328|NCT00985621|364377056|FG003|Overall Study|Lack of Efficacy|12|||
105649329|NCT00985621|364377053|FG000|Overall Study|Lost to Follow-up|2|||
105649330|NCT00985621|364377054|FG001|Overall Study|Lost to Follow-up|3|||
105649331|NCT00985621|364377055|FG002|Overall Study|Lost to Follow-up|4|||
105649332|NCT00985621|364377056|FG003|Overall Study|Lost to Follow-up|4|||
105649333|NCT00985621|364377053|FG000|Overall Study|Study Terminated by Sponsor|89|||
105649334|NCT00985621|364377054|FG001|Overall Study|Study Terminated by Sponsor|108|||
105649335|NCT00985621|364377055|FG002|Overall Study|Study Terminated by Sponsor|99|||
105649336|NCT00985621|364377056|FG003|Overall Study|Study Terminated by Sponsor|92|||
105649337|NCT00985621|364377053|FG000|Overall Study|Protocol Violation|1|||
105649338|NCT00985621|364377054|FG001|Overall Study|Protocol Violation|1|||
105870385|NCT01682811|365177009|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
105649339|NCT00985621|364377055|FG002|Overall Study|Protocol Violation|1|||
105649340|NCT00985621|364377056|FG003|Overall Study|Protocol Violation|0|||
105649341|NCT00985621|364377053|FG000|Overall Study|Withdrawal by Subject|8|||
105649342|NCT00985621|364377054|FG001|Overall Study|Withdrawal by Subject|10|||
105649343|NCT00985621|364377055|FG002|Overall Study|Withdrawal by Subject|8|||
105649344|NCT00985621|364377056|FG003|Overall Study|Withdrawal by Subject|12|||
105649345|NCT00985621|364377053|FG000|Overall Study|Other|1|||
105649346|NCT00985621|364377054|FG001|Overall Study|Other|0|||
105649347|NCT00985621|364377055|FG002|Overall Study|Other|0|||
105649348|NCT00985621|364377056|FG003|Overall Study|Other|0|||
105649349|NCT00985621|364377053|FG000|Overall Study|Randomized but not Treated|1|||
105649350|NCT00985621|364377054|FG001|Overall Study|Randomized but not Treated|0|||
105649351|NCT00985621|364377055|FG002|Overall Study|Randomized but not Treated|2|||
105649352|NCT00985621|364377056|FG003|Overall Study|Randomized but not Treated|1|||
105649353|NCT01911819|364377057|FG000|Overall Study|Adverse Event|0|||
105870386|NCT01682811|365177010|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
105649354|NCT01911819|364377058|FG001|Overall Study|Adverse Event|1|||
105649355|NCT01911819|364377059|FG002|Overall Study|Adverse Event|0|||
105649356|NCT01911819|364377057|FG000|Overall Study|Withdrawal by Subject|1|||
105649357|NCT01911819|364377058|FG001|Overall Study|Withdrawal by Subject|1|||
105649358|NCT01911819|364377059|FG002|Overall Study|Withdrawal by Subject|0|||
105649359|NCT01524887|364377061|FG000|Overall Study|Withdrawal by Subject|6|||
105649360|NCT01524887|364377062|FG001|Overall Study|Withdrawal by Subject|2|||
105649361|NCT01524887|364377063|FG002|Overall Study|Withdrawal by Subject|3|||
105649362|NCT01524887|364377061|FG000|Overall Study|Adverse Event|5|||
105649363|NCT01524887|364377062|FG001|Overall Study|Adverse Event|1|||
105649364|NCT01524887|364377063|FG002|Overall Study|Adverse Event|1|||
105649365|NCT01524887|364377061|FG000|Overall Study|Protocol Violation|0|||
105649366|NCT01524887|364377062|FG001|Overall Study|Protocol Violation|0|||
105649367|NCT01524887|364377063|FG002|Overall Study|Protocol Violation|1|||
105649368|NCT01524887|364377061|FG000|Overall Study|Study termination|73|||
105649369|NCT01524887|364377062|FG001|Overall Study|Study termination|87|||
105649370|NCT01524887|364377063|FG002|Overall Study|Study termination|79|||
105649371|NCT01524887|364377061|FG000|Overall Study|Withdrawal by Caregiver|0|||
105649372|NCT01524887|364377062|FG001|Overall Study|Withdrawal by Caregiver|0|||
105649373|NCT01524887|364377063|FG002|Overall Study|Withdrawal by Caregiver|2|||
105649374|NCT01524887|364377061|FG000|Overall Study|Use of prohibited medication|1|||
105649375|NCT01524887|364377062|FG001|Overall Study|Use of prohibited medication|0|||
105649376|NCT01524887|364377063|FG002|Overall Study|Use of prohibited medication|0|||
105649377|NCT02785900|364377064|FG000|Overall Study|Study Termination by Sponsor|64|||
105649378|NCT02785900|364377065|FG001|Overall Study|Study Termination by Sponsor|81|||
105649379|NCT02785900|364377064|FG000|Overall Study|Death|46|||
105649380|NCT02785900|364377065|FG001|Overall Study|Death|32|||
105649381|NCT02785900|364377064|FG000|Overall Study|Withdrawal by Subject|4|||
105649382|NCT02785900|364377065|FG001|Overall Study|Withdrawal by Subject|8|||
105649383|NCT02785900|364377064|FG000|Overall Study|Physician Decision|3|||
105649384|NCT02785900|364377065|FG001|Overall Study|Physician Decision|2|||
105649385|NCT01808144|364377066|FG000|Overall Study|Death|1|||
105649386|NCT01808144|364377067|FG001|Overall Study|Death|0|||
105649387|NCT01808144|364377066|FG000|Overall Study|Withdrawal by Subject|16|||
105649388|NCT01808144|364377067|FG001|Overall Study|Withdrawal by Subject|23|||
105649389|NCT01808144|364377066|FG000|Overall Study|Lost to Follow-up|6|||
105649390|NCT01808144|364377067|FG001|Overall Study|Lost to Follow-up|3|||
105649391|NCT01808144|364377066|FG000|Overall Study|Protocol Violation|6|||
105649392|NCT01808144|364377067|FG001|Overall Study|Protocol Violation|6|||
105649393|NCT01808144|364377066|FG000|Overall Study|Gout flare|0|||
105649394|NCT01808144|364377067|FG001|Overall Study|Gout flare|1|||
105649395|NCT01808144|364377066|FG000|Overall Study|Adverse Event|11|||
105649396|NCT01808144|364377067|FG001|Overall Study|Adverse Event|15|||
105649397|NCT04380688|364377068|FG000|Overall Study|Death|2|||
105649398|NCT04380688|364377069|FG001|Overall Study|Death|2|||
105649399|NCT04380688|364377068|FG000|Overall Study|Lost to Follow-up|2|||
105649400|NCT04380688|364377069|FG001|Overall Study|Lost to Follow-up|4|||
105649401|NCT04380688|364377068|FG000|Overall Study|Withdrawal by Subject|3|||
105649402|NCT04380688|364377069|FG001|Overall Study|Withdrawal by Subject|3|||
105649403|NCT02081196|364378501|FG000|Overall Study|Lost to Follow-up|1|||
105649404|NCT00961298|364378502|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
105649405|NCT00961298|364378502|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
105649406|NCT00961298|364378502|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
105649407|NCT01904019|364378504|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
105649408|NCT01904019|364378504|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
105649409|NCT01904019|364378504|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
105649410|NCT01904019|364378504|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
105649411|NCT01904019|364378504|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
105649412|NCT01904019|364378504|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
105649413|NCT01537120|364378505|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
105649414|NCT01537120|364378505|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
105649415|NCT05335005|364378509|FG000|Overall Study|Lost to Follow-up|1|||
105649416|NCT01503515|364378510|FG000|Overall Study|Adverse Event|4|||
105649417|NCT01503515|364378511|FG001|Overall Study|Adverse Event|5|||
105649418|NCT01503515|364378510|FG000|Overall Study|Death|0|||
105649419|NCT01503515|364378511|FG001|Overall Study|Death|1|||
105649420|NCT01503515|364378510|FG000|Overall Study|Physician Decision|14|||
105649421|NCT01503515|364378511|FG001|Overall Study|Physician Decision|23|||
105649422|NCT01503515|364378510|FG000|Overall Study|Withdrawal by Subject|0|||
105649423|NCT01503515|364378511|FG001|Overall Study|Withdrawal by Subject|1|||
105649424|NCT01503515|364378510|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
105649425|NCT01503515|364378511|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
105649426|NCT01503515|364378510|FG000|Overall Study|Ineligible|1|||
105649427|NCT01503515|364378511|FG001|Overall Study|Ineligible|1|||
105649428|NCT00755716|364378512|FG000|Overall Study|Adverse Event|1|||
105649429|NCT00755716|364378513|FG001|Overall Study|Adverse Event|4|||
105649430|NCT00755716|364378514|FG002|Overall Study|Adverse Event|1|||
105649431|NCT00755716|364378512|FG000|Overall Study|Lack of Efficacy|2|||
105649432|NCT00755716|364378513|FG001|Overall Study|Lack of Efficacy|0|||
105649433|NCT00755716|364378514|FG002|Overall Study|Lack of Efficacy|0|||
105649434|NCT00755716|364378512|FG000|Overall Study|Lost to Follow-up|5|||
105649435|NCT00755716|364378513|FG001|Overall Study|Lost to Follow-up|3|||
105649436|NCT00755716|364378514|FG002|Overall Study|Lost to Follow-up|1|||
105649437|NCT00755716|364378512|FG000|Overall Study|work schedule issues|0|||
105649438|NCT00755716|364378513|FG001|Overall Study|work schedule issues|1|||
105649439|NCT00755716|364378514|FG002|Overall Study|work schedule issues|1|||
105649440|NCT02101554|364378515|FG000|Overall Study|Protocol Violation|0|||
105649441|NCT02101554|364378516|FG001|Overall Study|Protocol Violation|1|||
105649442|NCT02101554|364378517|FG002|Overall Study|Protocol Violation|0|||
105649443|NCT02101554|364378515|FG000|Overall Study|Insufficient Clinical Response|0|||
105649444|NCT02101554|364378516|FG001|Overall Study|Insufficient Clinical Response|2|||
105649445|NCT02101554|364378517|FG002|Overall Study|Insufficient Clinical Response|0|||
105649446|NCT02101554|364378515|FG000|Overall Study|Adverse Event|2|||
105649447|NCT02101554|364378516|FG001|Overall Study|Adverse Event|1|||
105649448|NCT02101554|364378517|FG002|Overall Study|Adverse Event|1|||
105649449|NCT02101554|364378515|FG000|Overall Study|Lost to Follow-up|0|||
105649450|NCT02101554|364378516|FG001|Overall Study|Lost to Follow-up|1|||
105649451|NCT02101554|364378517|FG002|Overall Study|Lost to Follow-up|0|||
105649452|NCT02101554|364378515|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
105649453|NCT02101554|364378516|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
105649454|NCT02101554|364378517|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
105649455|NCT00726388|364378522|FG000|Overall Study|Withdrawal by Subject|5|||
105649456|NCT00726388|364378522|FG000|Overall Study|Adverse Event|3|||
105649457|NCT00726388|364378522|FG000|Overall Study|Lost to Follow-up|10|||
105649458|NCT00726388|364378522|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
105649459|NCT00726388|364378522|FG000|Overall Study|Other|5|||
105649460|NCT00726388|364378522|FG000|Overall Study|Enrolled, Not Treated|79|||
105649461|NCT00644332|364378523|FG000|Overall Study|Adverse Event|11|||
105649462|NCT00644332|364378523|FG000|Overall Study|Withdrawal by Subject|6|||
105649463|NCT00644332|364378523|FG000|Overall Study|Completion Status Unknown|2|||
105649464|NCT00644332|364378523|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
105649465|NCT00644332|364378523|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
105649466|NCT02706834|364378527|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
105649467|NCT02706834|364378528|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
105649468|NCT02706834|364378529|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
105649469|NCT02706834|364378530|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
105649470|NCT02706834|364378531|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
105649471|NCT02706834|364378532|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
105649472|NCT02706834|364378533|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
105649473|NCT02706834|364378534|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
105649474|NCT02706834|364378535|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
105649475|NCT02706834|364378536|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
105649476|NCT02706834|364378537|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
105649477|NCT02706834|364378527|FG000|Overall Study|Lost to Follow-up|0|||
105649478|NCT02706834|364378528|FG001|Overall Study|Lost to Follow-up|0|||
105649479|NCT02706834|364378529|FG002|Overall Study|Lost to Follow-up|1|||
105649480|NCT02706834|364378530|FG003|Overall Study|Lost to Follow-up|0|||
105649481|NCT02706834|364378531|FG004|Overall Study|Lost to Follow-up|0|||
105649482|NCT02706834|364378532|FG005|Overall Study|Lost to Follow-up|0|||
105649483|NCT02706834|364378533|FG006|Overall Study|Lost to Follow-up|0|||
105649484|NCT02706834|364378534|FG007|Overall Study|Lost to Follow-up|0|||
105649485|NCT02706834|364378535|FG008|Overall Study|Lost to Follow-up|0|||
105649486|NCT02706834|364378536|FG009|Overall Study|Lost to Follow-up|0|||
105649487|NCT02706834|364378537|FG010|Overall Study|Lost to Follow-up|0|||
105649488|NCT02706834|364378527|FG000|Overall Study|Voluntary Withdrawal|1|||
105649489|NCT02706834|364378528|FG001|Overall Study|Voluntary Withdrawal|0|||
105649490|NCT02706834|364378529|FG002|Overall Study|Voluntary Withdrawal|0|||
105649491|NCT02706834|364378530|FG003|Overall Study|Voluntary Withdrawal|0|||
105649492|NCT02706834|364378531|FG004|Overall Study|Voluntary Withdrawal|0|||
105649493|NCT02706834|364378532|FG005|Overall Study|Voluntary Withdrawal|0|||
105649494|NCT02706834|364378533|FG006|Overall Study|Voluntary Withdrawal|0|||
105649495|NCT02706834|364378534|FG007|Overall Study|Voluntary Withdrawal|0|||
105649496|NCT02706834|364378535|FG008|Overall Study|Voluntary Withdrawal|0|||
105649497|NCT02706834|364378536|FG009|Overall Study|Voluntary Withdrawal|1|||
105649498|NCT02706834|364378537|FG010|Overall Study|Voluntary Withdrawal|0|||
105649499|NCT02706834|364378527|FG000|Overall Study|Other Reason Not Specified|1|||
105649500|NCT02706834|364378528|FG001|Overall Study|Other Reason Not Specified|0|||
105649501|NCT02706834|364378529|FG002|Overall Study|Other Reason Not Specified|0|||
105649502|NCT02706834|364378530|FG003|Overall Study|Other Reason Not Specified|0|||
105649503|NCT02706834|364378531|FG004|Overall Study|Other Reason Not Specified|1|||
105649504|NCT02706834|364378532|FG005|Overall Study|Other Reason Not Specified|0|||
105649505|NCT02706834|364378533|FG006|Overall Study|Other Reason Not Specified|0|||
105649506|NCT02706834|364378534|FG007|Overall Study|Other Reason Not Specified|0|||
105649507|NCT02706834|364378535|FG008|Overall Study|Other Reason Not Specified|0|||
105649508|NCT02706834|364378536|FG009|Overall Study|Other Reason Not Specified|0|||
105649509|NCT02706834|364378537|FG010|Overall Study|Other Reason Not Specified|0|||
105649510|NCT00762723|364378538|FG000|Overall Study|Study Terminated slow enrollement|5|||
105649511|NCT00762723|364378539|FG001|Overall Study|Study Terminated slow enrollement|5|||
105649512|NCT00762723|364378540|FG002|Overall Study|Study Terminated slow enrollement|3|||
105649513|NCT00507429|364378543|FG000|Treatment Phase|Disease Progression|12|||
105649514|NCT00507429|364378544|FG001|Treatment Phase|Disease Progression|5|||
105649515|NCT00507429|364378543|FG000|Treatment Phase|Adverse Event|12|||
105649516|NCT00507429|364378544|FG001|Treatment Phase|Adverse Event|5|||
105649517|NCT00507429|364378543|FG000|Treatment Phase|Withdrawal by Subject|3|||
105649518|NCT00507429|364378544|FG001|Treatment Phase|Withdrawal by Subject|3|||
105649519|NCT00507429|364378543|FG000|Treatment Phase|Physician Decision|4|||
105649520|NCT00507429|364378544|FG001|Treatment Phase|Physician Decision|2|||
105649521|NCT00507429|364378543|FG000|Treatment Phase|Other|6|||
105649522|NCT00507429|364378544|FG001|Treatment Phase|Other|3|||
105649523|NCT00507429|364378543|FG000|Maintenance Phase|Progressive Disease|14|||
105649524|NCT00507429|364378544|FG001|Maintenance Phase|Progressive Disease|0|||
105649525|NCT00627523|364378548|FG000|Overall Study|Lack of Efficacy|1|||
105649526|NCT00627523|364378549|FG001|Overall Study|Lack of Efficacy|0|||
105649527|NCT00627523|364378548|FG000|Overall Study|Withdrawal by Subject|0|||
105649528|NCT00627523|364378549|FG001|Overall Study|Withdrawal by Subject|2|||
105649529|NCT00627523|364378548|FG000|Overall Study|Other|1|||
105649530|NCT00627523|364378549|FG001|Overall Study|Other|0|||
105649531|NCT02543294|364378551|FG000|Overall Study|Lost to Follow-up|3|||
105649532|NCT02543294|364378551|FG000|Overall Study|Physician Decision|2|||
105649533|NCT02543294|364378551|FG000|Overall Study|Withdrawal by Subject|7|||
105649534|NCT01038128|364378556|FG000|Overall Study|Lack of Efficacy|1|||
105649535|NCT01038128|364378556|FG000|Overall Study|Lost to Follow-up|1|||
105649536|NCT01038128|364378556|FG000|Overall Study|Withdrawal by Subject|2|||
105649537|NCT01753323|364378561|FG000|Overall Study|Lack of Efficacy|0|||
105649538|NCT01753323|364378562|FG001|Overall Study|Lack of Efficacy|0|||
105649539|NCT01753323|364378563|FG002|Overall Study|Lack of Efficacy|8|||
105649540|NCT01753323|364378561|FG000|Overall Study|Protocol deviation|1|||
105649541|NCT01753323|364378562|FG001|Overall Study|Protocol deviation|0|||
105649542|NCT01753323|364378563|FG002|Overall Study|Protocol deviation|0|||
105649543|NCT01753323|364378561|FG000|Overall Study|Adverse Event|0|||
105649544|NCT01753323|364378562|FG001|Overall Study|Adverse Event|0|||
105649545|NCT01753323|364378563|FG002|Overall Study|Adverse Event|1|||
105649546|NCT00116584|364378566|FG000|Overall Study|Withdrawal by Subject|1|||
105649547|NCT00116584|364378567|FG001|Overall Study|Withdrawal by Subject|0|||
105649548|NCT00116584|364378566|FG000|Overall Study|Protocol Violation|1|||
105649549|NCT00116584|364378567|FG001|Overall Study|Protocol Violation|1|||
105649550|NCT01882088|364378568|FG000|Overall Study|Intolerance of esophageal manometry|1|||
105649551|NCT01882088|364378568|FG000|Overall Study|no possibility to place the catheter|1|||
105649552|NCT01882088|364378568|FG000|Overall Study|Protocol Violation|1|||
105649553|NCT01882088|364378568|FG000|Overall Study|inadequate pH-impedance tracings|2|||
105649554|NCT01838447|364378569|FG000|Overall Study|Change in surgical plan|1|||
105649555|NCT01838447|364378570|FG001|Overall Study|Change in surgical plan|2|||
105649556|NCT01838447|364378569|FG000|Overall Study|Withdrawal by Subject|1|||
105649557|NCT01838447|364378570|FG001|Overall Study|Withdrawal by Subject|1|||
105649558|NCT01533181|364378571|FG000|Overall Study|Disease progression pre-active treatment|0|||
105649559|NCT01533181|364378572|FG001|Overall Study|Disease progression pre-active treatment|1|||
105649560|NCT01533181|364378571|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
105649561|NCT01533181|364378572|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
105649562|NCT01695993|364378573|FG000|Overall Study|Lost to Follow-up|2|||
105649563|NCT01695993|364378574|FG001|Overall Study|Lost to Follow-up|1|||
105649564|NCT01695993|364378575|FG002|Overall Study|Lost to Follow-up|3|||
105649565|NCT01695993|364378573|FG000|Overall Study|Withdrawal by Subject|2|||
105649566|NCT01695993|364378574|FG001|Overall Study|Withdrawal by Subject|2|||
105649567|NCT01695993|364378575|FG002|Overall Study|Withdrawal by Subject|2|||
105649568|NCT01695993|364378573|FG000|Overall Study|To ill to continue|1|||
105649569|NCT01695993|364378574|FG001|Overall Study|To ill to continue|2|||
105649570|NCT01695993|364378575|FG002|Overall Study|To ill to continue|0|||
105649571|NCT01695993|364378573|FG000|Overall Study|Changed Medical Facility|0|||
105649572|NCT01695993|364378574|FG001|Overall Study|Changed Medical Facility|0|||
105649573|NCT01695993|364378575|FG002|Overall Study|Changed Medical Facility|1|||
105649574|NCT01078571|364378578|FG000|Overall Study|Adverse Event|36|||
105649575|NCT01078571|364378578|FG000|Overall Study|Lack of effectiveness|36|||
105649576|NCT01078571|364378578|FG000|Overall Study|Reason not reported|21|||
105649577|NCT01078571|364378578|FG000|Overall Study|Withdrawal by Subject|12|||
105649578|NCT01078571|364378578|FG000|Overall Study|Lost to Follow-up|8|||
105649579|NCT01078571|364378578|FG000|Overall Study|Protocol Violation|2|||
105649580|NCT04043806|364378580|FG000|Overall Study|Commercial drug is available for participants|13|||
105649581|NCT04043806|364378580|FG000|Overall Study|Physician Decision|2|||
105649582|NCT04043806|364378580|FG000|Overall Study|Other|12|||
105649583|NCT04043806|364378580|FG000|Overall Study|Adverse Event|2|||
105649584|NCT04043806|364378580|FG000|Overall Study|Lost to Follow-up|6|||
105649585|NCT04043806|364378580|FG000|Overall Study|Other non-compliance|2|||
105649586|NCT04043806|364378580|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
105649587|NCT04043806|364378580|FG000|Overall Study|Never Dosed|1|||
105649588|NCT00449033|364378581|FG000|Treatment Period|Adverse Event|117|||
105649589|NCT00449033|364378582|FG001|Treatment Period|Adverse Event|83|||
105649590|NCT00449033|364378581|FG000|Treatment Period|Death|21|||
105649591|NCT00449033|364378582|FG001|Treatment Period|Death|12|||
105649592|NCT00449033|364378581|FG000|Treatment Period|Lost to Follow-up|0|||
105649593|NCT00449033|364378582|FG001|Treatment Period|Lost to Follow-up|2|||
105649594|NCT00449033|364378581|FG000|Treatment Period|Physician Decision|4|||
105649595|NCT00449033|364378582|FG001|Treatment Period|Physician Decision|5|||
105649596|NCT00449033|364378581|FG000|Treatment Period|Protocol Violation|8|||
105649597|NCT00449033|364378582|FG001|Treatment Period|Protocol Violation|7|||
105649598|NCT00449033|364378581|FG000|Treatment Period|Disease Progression|231|||
105649599|NCT00449033|364378582|FG001|Treatment Period|Disease Progression|288|||
105649600|NCT00449033|364378581|FG000|Treatment Period|Consent Withdrawn|36|||
105649601|NCT00449033|364378582|FG001|Treatment Period|Consent Withdrawn|20|||
105649602|NCT00449033|364378581|FG000|Treatment Period|Amended Protocol Criteria|22|||
105649603|NCT00449033|364378582|FG001|Treatment Period|Amended Protocol Criteria|18|||
105649604|NCT00449033|364378581|FG000|Treatment Period|Non-compliance|7|||
105649605|NCT00449033|364378582|FG001|Treatment Period|Non-compliance|8|||
105649606|NCT00449033|364378581|FG000|Treatment Period|Second Malignancy|0|||
105649607|NCT00449033|364378582|FG001|Treatment Period|Second Malignancy|1|||
105649608|NCT00449033|364378581|FG000|Treatment Period|Reason Missing|0|||
105649609|NCT00449033|364378582|FG001|Treatment Period|Reason Missing|4|||
105649610|NCT00449033|364378581|FG000|Treatment Period|Treatment Ongoing|6|||
105649611|NCT00449033|364378582|FG001|Treatment Period|Treatment Ongoing|4|||
105649612|NCT00449033|364378581|FG000|Follow-up Period|Death|299|||
105649613|NCT00449033|364378582|FG001|Follow-up Period|Death|311|||
105649614|NCT00449033|364378581|FG000|Follow-up Period|Lost to Follow-up|6|||
105649615|NCT00449033|364378582|FG001|Follow-up Period|Lost to Follow-up|10|||
105649616|NCT00449033|364378581|FG000|Follow-up Period|Reason Missing|120|||
105649617|NCT00449033|364378582|FG001|Follow-up Period|Reason Missing|113|||
105649618|NCT02268526|364378583|FG000|Overall Study|Adverse Event|0|||
105649619|NCT02268526|364378584|FG001|Overall Study|Adverse Event|2|||
105649620|NCT02268526|364378585|FG002|Overall Study|Adverse Event|1|||
105649621|NCT02268526|364378583|FG000|Overall Study|Death|1|||
105649622|NCT02268526|364378584|FG001|Overall Study|Death|11|||
105649623|NCT02268526|364378585|FG002|Overall Study|Death|0|||
105649624|NCT02268526|364378583|FG000|Overall Study|protocol deviation|0|||
105649625|NCT02268526|364378584|FG001|Overall Study|protocol deviation|1|||
105649626|NCT02268526|364378585|FG002|Overall Study|protocol deviation|0|||
105649627|NCT02268526|364378583|FG000|Overall Study|Physician Decision|0|||
105649628|NCT02268526|364378584|FG001|Overall Study|Physician Decision|0|||
105649629|NCT02268526|364378585|FG002|Overall Study|Physician Decision|1|||
105649630|NCT02268526|364378583|FG000|Overall Study|Subject/guardian decision|0|||
105649631|NCT02268526|364378584|FG001|Overall Study|Subject/guardian decision|7|||
105649632|NCT02268526|364378585|FG002|Overall Study|Subject/guardian decision|3|||
105649633|NCT00596960|364378586|FG000|Overall Study|Death|1|||
105649634|NCT00596960|364378587|FG001|Overall Study|Death|2|||
105649635|NCT00596960|364378586|FG000|Overall Study|Lost to Follow-up|6|||
105649636|NCT00596960|364378587|FG001|Overall Study|Lost to Follow-up|5|||
105649637|NCT00596960|364378586|FG000|Overall Study|Withdrawal by Subject|1|||
105649638|NCT00596960|364378587|FG001|Overall Study|Withdrawal by Subject|0|||
105649639|NCT00596960|364378586|FG000|Overall Study|Incarcerated|2|||
105649640|NCT00596960|364378587|FG001|Overall Study|Incarcerated|0|||
105649641|NCT00596960|364378586|FG000|Overall Study|Physician Decision|1|||
105649642|NCT00596960|364378587|FG001|Overall Study|Physician Decision|0|||
105649643|NCT00596960|364378586|FG000|Overall Study|Protocol Violation|0|||
105649644|NCT00596960|364378587|FG001|Overall Study|Protocol Violation|1|||
105649645|NCT00596960|364378586|FG000|Overall Study|No alcohol use data|0|||
105649646|NCT00596960|364378587|FG001|Overall Study|No alcohol use data|1|||
105649647|NCT00794573|364378600|FG000|Overall Study|Death|3|||
105649648|NCT00794573|364378601|FG001|Overall Study|Death|0|||
105649649|NCT00794573|364378600|FG000|Overall Study|Withdrawal by Subject|9|||
105649650|NCT00794573|364378601|FG001|Overall Study|Withdrawal by Subject|12|||
105649651|NCT00794573|364378600|FG000|Overall Study|Lost to Follow-up|26|||
105649652|NCT00794573|364378601|FG001|Overall Study|Lost to Follow-up|33|||
105649653|NCT00257556|364378602|FG000|Overall Study|Adverse Event|1|||
105649654|NCT00257556|364378603|FG001|Overall Study|Adverse Event|4|||
105649655|NCT00257556|364378602|FG000|Overall Study|Physician Decision|6|||
105649656|NCT00257556|364378603|FG001|Overall Study|Physician Decision|0|||
105649657|NCT00257556|364378602|FG000|Overall Study|Did not meet hCG criterion|3|||
105649658|NCT00257556|364378603|FG001|Overall Study|Did not meet hCG criterion|0|||
105649659|NCT00257556|364378602|FG000|Overall Study|other reason|4|||
105649660|NCT00257556|364378603|FG001|Overall Study|other reason|6|||
105649661|NCT04839289|364378606|FG000|Overall Study|Withdrawal by Subject|1|||
105649662|NCT04839289|364378607|FG001|Overall Study|Withdrawal by Subject|0|||
105649663|NCT00603278|364378608|FG000|Overall Study|Lack of Efficacy|35|||
105649664|NCT00603278|364378609|FG001|Overall Study|Lack of Efficacy|10|||
105649665|NCT00603278|364378610|FG002|Overall Study|Lack of Efficacy|11|||
105649666|NCT00603278|364378611|FG003|Overall Study|Lack of Efficacy|8|||
105649667|NCT00603278|364378612|FG004|Overall Study|Lack of Efficacy|7|||
105649668|NCT00603278|364378613|FG005|Overall Study|Lack of Efficacy|14|||
105649669|NCT00603278|364378608|FG000|Overall Study|Adverse Event|0|||
105649670|NCT00603278|364378609|FG001|Overall Study|Adverse Event|3|||
105649671|NCT00603278|364378610|FG002|Overall Study|Adverse Event|1|||
105649672|NCT00603278|364378611|FG003|Overall Study|Adverse Event|0|||
105649673|NCT00603278|364378612|FG004|Overall Study|Adverse Event|2|||
105649674|NCT00603278|364378613|FG005|Overall Study|Adverse Event|1|||
105649675|NCT00603278|364378608|FG000|Overall Study|Withdrawal by Subject|2|||
105649676|NCT00603278|364378609|FG001|Overall Study|Withdrawal by Subject|3|||
105649677|NCT00603278|364378610|FG002|Overall Study|Withdrawal by Subject|1|||
105649678|NCT00603278|364378611|FG003|Overall Study|Withdrawal by Subject|2|||
105649679|NCT00603278|364378612|FG004|Overall Study|Withdrawal by Subject|1|||
105649680|NCT00603278|364378613|FG005|Overall Study|Withdrawal by Subject|2|||
105649681|NCT00603278|364378608|FG000|Overall Study|Protocol Violation|3|||
105649682|NCT00603278|364378609|FG001|Overall Study|Protocol Violation|0|||
105649683|NCT00603278|364378610|FG002|Overall Study|Protocol Violation|1|||
105649684|NCT00603278|364378611|FG003|Overall Study|Protocol Violation|1|||
105649685|NCT00603278|364378612|FG004|Overall Study|Protocol Violation|0|||
105649686|NCT00603278|364378613|FG005|Overall Study|Protocol Violation|1|||
105649687|NCT00603278|364378608|FG000|Overall Study|Physician Decision|0|||
105649688|NCT00603278|364378609|FG001|Overall Study|Physician Decision|1|||
105649689|NCT00603278|364378610|FG002|Overall Study|Physician Decision|0|||
105649690|NCT00603278|364378611|FG003|Overall Study|Physician Decision|0|||
105649691|NCT00603278|364378612|FG004|Overall Study|Physician Decision|2|||
105649692|NCT00603278|364378613|FG005|Overall Study|Physician Decision|1|||
105649693|NCT00603278|364378608|FG000|Overall Study|Lost to Follow-up|1|||
105649694|NCT00603278|364378609|FG001|Overall Study|Lost to Follow-up|0|||
105649695|NCT00603278|364378610|FG002|Overall Study|Lost to Follow-up|0|||
105649696|NCT00603278|364378611|FG003|Overall Study|Lost to Follow-up|0|||
105649697|NCT00603278|364378612|FG004|Overall Study|Lost to Follow-up|1|||
105649698|NCT00603278|364378613|FG005|Overall Study|Lost to Follow-up|0|||
105649699|NCT01207453|364378614|FG000|First Intervention|Adverse Event|2|||
105649700|NCT01207453|364378615|FG001|First Intervention|Adverse Event|1|||
105649701|NCT01207453|364378614|FG000|Washout|Adverse Event|1|||
105649702|NCT01207453|364378615|FG001|Washout|Adverse Event|0|||
105649703|NCT01207453|364378614|FG000|Washout|Lost to Follow-up|1|||
105649704|NCT01207453|364378615|FG001|Washout|Lost to Follow-up|0|||
105649705|NCT01207453|364378614|FG000|2nd Intervention|Adverse Event|1|||
105649706|NCT01207453|364378615|FG001|2nd Intervention|Adverse Event|2|||
105649707|NCT01207453|364378614|FG000|2nd Intervention|Lost to Follow-up|1|||
105649708|NCT01207453|364378615|FG001|2nd Intervention|Lost to Follow-up|0|||
105649709|NCT04382053|364378620|FG000|Overall Study|Death|6|||
105649710|NCT04382053|364378621|FG001|Overall Study|Death|8|||
105649711|NCT04382053|364378620|FG000|Overall Study|Lost to Follow-up|0|||
105649712|NCT04382053|364378621|FG001|Overall Study|Lost to Follow-up|2|||
105649713|NCT04382053|364378620|FG000|Overall Study|Protocol Deviation|1|||
105649714|NCT04382053|364378621|FG001|Overall Study|Protocol Deviation|2|||
105649715|NCT04382053|364378620|FG000|Overall Study|Withdrawal by Subject|2|||
105649716|NCT04382053|364378621|FG001|Overall Study|Withdrawal by Subject|1|||
105649717|NCT01399905|364378625|FG000|Overall Study|Withdrawal by Subject|1|||
105649718|NCT01399905|364378626|FG001|Overall Study|Withdrawal by Subject|1|||
105649719|NCT00417989|364378629|FG000|Overall Study|Withdrawal by Subject|13|||
105649720|NCT00417989|364378630|FG001|Overall Study|Withdrawal by Subject|13|||
105649721|NCT00417989|364378629|FG000|Overall Study|Lost to Follow-up|1|||
105649722|NCT00417989|364378630|FG001|Overall Study|Lost to Follow-up|6|||
105649723|NCT00417989|364378629|FG000|Overall Study|Protocol Violation|1|||
105649724|NCT00417989|364378630|FG001|Overall Study|Protocol Violation|0|||
105649725|NCT00417989|364378629|FG000|Overall Study|Death|0|||
105649726|NCT00417989|364378630|FG001|Overall Study|Death|1|||
105649727|NCT00417989|364378629|FG000|Overall Study|Physician Decision|5|||
105649728|NCT00417989|364378630|FG001|Overall Study|Physician Decision|2|||
105649729|NCT01032200|364378633|FG000|Overall Study|Death|1|||
105649730|NCT01032200|364378634|FG001|Overall Study|Death|1|||
105649731|NCT01032200|364378633|FG000|Overall Study|Withdrawal by Subject|1|||
105649732|NCT01032200|364378634|FG001|Overall Study|Withdrawal by Subject|3|||
105649733|NCT01032200|364378633|FG000|Overall Study|Toxicity|0|||
105649734|NCT01032200|364378634|FG001|Overall Study|Toxicity|2|||
105649735|NCT01032200|364378633|FG000|Overall Study|Progression|1|||
105649736|NCT01032200|364378634|FG001|Overall Study|Progression|0|||
105649737|NCT01032200|364378633|FG000|Overall Study|Multiple|1|||
105649738|NCT01032200|364378634|FG001|Overall Study|Multiple|1|||
105649739|NCT04295499|364378640|FG000|Overall Study|moving out of state|1|||
105649740|NCT04295499|364378641|FG001|Overall Study|moving out of state|0|||
105649741|NCT04295499|364378640|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
105649742|NCT04295499|364378641|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
105649743|NCT01116440|364380209|FG000|Treatment|Withdrawal by Subject|2|||
105649744|NCT01116440|364380210|FG001|Treatment|Withdrawal by Subject|2|||
105649745|NCT01116440|364380209|FG000|Treatment|Lost to Follow-up|1|||
105649746|NCT01116440|364380210|FG001|Treatment|Lost to Follow-up|1|||
105649747|NCT01116440|364380209|FG000|Treatment|Protocol Violation|0|||
105649748|NCT01116440|364380210|FG001|Treatment|Protocol Violation|2|||
105649749|NCT01116440|364380209|FG000|Treatment|Lack of Efficacy|0|||
105649750|NCT01116440|364380210|FG001|Treatment|Lack of Efficacy|1|||
105649751|NCT01116440|364380209|FG000|Treatment|Adverse Event|0|||
105649752|NCT01116440|364380210|FG001|Treatment|Adverse Event|1|||
105649753|NCT01116440|364380209|FG000|Withdrawal|Withdrawal by Subject|0|||
105649754|NCT01116440|364380210|FG001|Withdrawal|Withdrawal by Subject|1|||
105649755|NCT01116440|364380209|FG000|Withdrawal|Lost to Follow-up|0|||
105649756|NCT01116440|364380210|FG001|Withdrawal|Lost to Follow-up|1|||
105649757|NCT01116440|364380209|FG000|Follow-up|Lost to Follow-up|0|||
105649758|NCT01116440|364380210|FG001|Follow-up|Lost to Follow-up|1|||
105649759|NCT01116440|364380209|FG000|Follow-up|Withdrawal by Subject|0|||
105649760|NCT01116440|364380210|FG001|Follow-up|Withdrawal by Subject|1|||
105649761|NCT00511147|364380213|FG000|Overall Study|Withdrawal by Subject|1|||
105649762|NCT00511147|364380213|FG000|Overall Study|Disease progression|5|||
105649763|NCT00511147|364380213|FG000|Overall Study|Required platelet transfusion|1|||
105649764|NCT02798861|364380216|FG000|Overall Study|Lost to Follow-up|22|||
105649765|NCT02798861|364380216|FG000|Overall Study|Withdrawal by Subject|1|||
105649766|NCT00907517|364380217|FG000|Overall Study|Progressive Disease|3|||
105649767|NCT00907517|364380218|FG001|Overall Study|Progressive Disease|3|||
105649768|NCT00907517|364380219|FG002|Overall Study|Progressive Disease|4|||
105649769|NCT00907517|364380220|FG003|Overall Study|Progressive Disease|4|||
105649770|NCT00907517|364380221|FG004|Overall Study|Progressive Disease|4|||
105649771|NCT00907517|364380217|FG000|Overall Study|Symptomatic Deterioration|0|||
105649772|NCT00907517|364380218|FG001|Overall Study|Symptomatic Deterioration|0|||
105649773|NCT00907517|364380219|FG002|Overall Study|Symptomatic Deterioration|0|||
105649774|NCT00907517|364380220|FG003|Overall Study|Symptomatic Deterioration|0|||
105649775|NCT00907517|364380221|FG004|Overall Study|Symptomatic Deterioration|1|||
105649776|NCT02986659|364380222|FG000|First Intervention Period|Adverse Event|3|||
105649777|NCT02986659|364380223|FG001|First Intervention Period|Adverse Event|1|||
105649778|NCT02986659|364380222|FG000|First Intervention Period|Lost to Follow-up|1|||
105649779|NCT02986659|364380223|FG001|First Intervention Period|Lost to Follow-up|0|||
105649780|NCT02986659|364380222|FG000|First Intervention Period|Withdrawal by Subject|0|||
105649781|NCT02986659|364380223|FG001|First Intervention Period|Withdrawal by Subject|1|||
105649782|NCT02986659|364380222|FG000|Second Intervention Period|Adverse Event|0|||
105649783|NCT02986659|364380223|FG001|Second Intervention Period|Adverse Event|6|||
105649784|NCT01797705|364380225|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
105649785|NCT01797705|364380225|FG000|Overall Study|Withdrawal by Subject|1|||
105649786|NCT00168805|364380226|FG000|Overall Study|Adverse Event|7|||
105649787|NCT00168805|364380227|FG001|Overall Study|Adverse Event|11|||
105649788|NCT00168805|364380228|FG002|Overall Study|Adverse Event|16|||
105649789|NCT00168805|364380226|FG000|Overall Study|Protocol Violation|12|||
105649790|NCT00168805|364380227|FG001|Overall Study|Protocol Violation|11|||
105649791|NCT00168805|364380228|FG002|Overall Study|Protocol Violation|8|||
105649792|NCT00168805|364380226|FG000|Overall Study|Lost to Follow-up|12|||
105649793|NCT00168805|364380227|FG001|Overall Study|Lost to Follow-up|17|||
105649794|NCT00168805|364380228|FG002|Overall Study|Lost to Follow-up|11|||
105649795|NCT00168805|364380226|FG000|Overall Study|Withdrawal by Subject|16|||
105649796|NCT00168805|364380227|FG001|Overall Study|Withdrawal by Subject|18|||
105649797|NCT00168805|364380228|FG002|Overall Study|Withdrawal by Subject|21|||
105649798|NCT00168805|364380226|FG000|Overall Study|Other|24|||
105649799|NCT00168805|364380227|FG001|Overall Study|Other|21|||
105649800|NCT00168805|364380228|FG002|Overall Study|Other|22|||
105649801|NCT00168805|364380226|FG000|Treatment|Adverse Event|25|||
105649802|NCT00168805|364380227|FG001|Treatment|Adverse Event|26|||
105649803|NCT00168805|364380228|FG002|Treatment|Adverse Event|32|||
105649804|NCT00168805|364380226|FG000|Treatment|Protocol Violation|3|||
105649805|NCT00168805|364380227|FG001|Treatment|Protocol Violation|5|||
105649806|NCT00168805|364380228|FG002|Treatment|Protocol Violation|5|||
105649807|NCT00168805|364380226|FG000|Treatment|Withdrawal by Subject|3|||
105649808|NCT00168805|364380227|FG001|Treatment|Withdrawal by Subject|7|||
105649809|NCT00168805|364380228|FG002|Treatment|Withdrawal by Subject|8|||
105649810|NCT00168805|364380226|FG000|Treatment|Other|18|||
105649811|NCT00168805|364380227|FG001|Treatment|Other|18|||
105649812|NCT00168805|364380228|FG002|Treatment|Other|17|||
105649813|NCT01837719|364380232|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
105649814|NCT01837719|364380232|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
105649815|NCT01703988|364380233|FG000|Overall Study|Investigator Judgment|0|||
105649816|NCT01703988|364380234|FG001|Overall Study|Investigator Judgment|0|||
105649817|NCT01703988|364380235|FG002|Overall Study|Investigator Judgment|0|||
105649818|NCT01703988|364380236|FG003|Overall Study|Investigator Judgment|1|||
105649819|NCT06247488|364380237|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
105649820|NCT06247488|364380238|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649821|NCT06247488|364380239|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649822|NCT06247488|364380240|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649823|NCT06247488|364380241|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649824|NCT06247488|364380242|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
105649825|NCT06247488|364380237|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649826|NCT06247488|364380238|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649827|NCT06247488|364380239|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649828|NCT06247488|364380240|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
105649829|NCT06247488|364380241|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649830|NCT06247488|364380242|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
105649831|NCT06247488|364380237|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
105649832|NCT06247488|364380238|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649833|NCT06247488|364380239|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649834|NCT06247488|364380240|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649835|NCT06247488|364380241|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649836|NCT06247488|364380242|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
105649837|NCT06247488|364380237|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649838|NCT06247488|364380238|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649839|NCT06247488|364380239|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649840|NCT06247488|364380240|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
105649841|NCT06247488|364380241|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649842|NCT06247488|364380242|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
105649843|NCT06247488|364380237|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649844|NCT06247488|364380238|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649845|NCT06247488|364380239|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649846|NCT06247488|364380240|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649847|NCT06247488|364380241|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
105649848|NCT06247488|364380242|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
105649849|NCT06247488|364380237|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
105649850|NCT06247488|364380238|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
105649851|NCT06247488|364380239|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
105649852|NCT06247488|364380240|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
105649853|NCT06247488|364380241|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
105649854|NCT06247488|364380242|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
105649855|NCT06247488|364380237|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649856|NCT06247488|364380238|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649857|NCT06247488|364380239|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649858|NCT06247488|364380240|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649859|NCT06247488|364380241|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
105649860|NCT06247488|364380242|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
105649861|NCT03785210|364380243|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
105649862|NCT03785210|364380244|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
105649863|NCT02402465|364380245|FG000|Overall Study|Withdrawal by Subject|0|||
105649864|NCT02402465|364380246|FG001|Overall Study|Withdrawal by Subject|0|||
105649865|NCT02402465|364380247|FG002|Overall Study|Withdrawal by Subject|0|||
105649866|NCT02402465|364380248|FG003|Overall Study|Withdrawal by Subject|0|||
105649867|NCT02402465|364380249|FG004|Overall Study|Withdrawal by Subject|0|||
105649868|NCT02402465|364380250|FG005|Overall Study|Withdrawal by Subject|1|||
105649869|NCT02402465|364380245|FG000|Overall Study|Lost to Follow-up|0|||
105649870|NCT02402465|364380246|FG001|Overall Study|Lost to Follow-up|1|||
105649871|NCT02402465|364380247|FG002|Overall Study|Lost to Follow-up|0|||
105649872|NCT02402465|364380248|FG003|Overall Study|Lost to Follow-up|0|||
105649873|NCT02402465|364380249|FG004|Overall Study|Lost to Follow-up|1|||
105649874|NCT02402465|364380250|FG005|Overall Study|Lost to Follow-up|0|||
105649875|NCT01732588|364380251|FG000|First Intervention (7 Days)|Adverse Event|0|||
105649876|NCT01732588|364380252|FG001|First Intervention (7 Days)|Adverse Event|1|||
105649877|NCT01732588|364380253|FG002|First Intervention (7 Days)|Adverse Event|0|||
105649878|NCT02005029|364380254|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
105649879|NCT02005029|364380255|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
105649880|NCT05012397|364380260|FG000|Overall Study|Death|10|||
105649881|NCT05012397|364380260|FG000|Overall Study|Physician Decision|9|||
105649882|NCT05012397|364380260|FG000|Overall Study|Withdrawal by Subject|5|||
105649883|NCT05012397|364380260|FG000|Overall Study|Lost to Follow-up|2|||
105649884|NCT00730925|364380263|FG000|Overall Study|Progressive Disease|21|||
105649885|NCT00730925|364380263|FG000|Overall Study|Dose reducing Event|2|||
105649886|NCT00730925|364380263|FG000|Overall Study|Other Averse Event|7|||
105649887|NCT00730925|364380263|FG000|Overall Study|Protocol Violation|1|||
105649888|NCT00730925|364380263|FG000|Overall Study|Withdrawal by Subject|1|||
105649889|NCT00730925|364380263|FG000|Overall Study|Switch to combination therapy|8|||
105649890|NCT00730925|364380263|FG000|Overall Study|Other|1|||
105649891|NCT01732627|364380264|FG000|Overall Study|Withdrawal by Subject|1|||
105649892|NCT01732627|364380265|FG001|Overall Study|Withdrawal by Subject|0|||
105649893|NCT02567227|364380266|FG000|9 Weeks|Adverse Event|5|||
105649894|NCT02567227|364380267|FG001|9 Weeks|Adverse Event|5|||
105649895|NCT02567227|364380266|FG000|9 Weeks|Withdrawal by Subject|18|||
105649896|NCT02567227|364380267|FG001|9 Weeks|Withdrawal by Subject|8|||
105649897|NCT02567227|364380266|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
105649898|NCT02567227|364380267|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
105649899|NCT02567227|364380266|FG000|6 Month|Death|2|||
105649900|NCT02567227|364380267|FG001|6 Month|Death|0|||
105649901|NCT02567227|364380266|FG000|6 Month|Lost to Follow-up|43|||
105649902|NCT02567227|364380267|FG001|6 Month|Lost to Follow-up|40|||
105649903|NCT02567227|364380266|FG000|12 Months|Lost to Follow-up|31|||
105649904|NCT02567227|364380267|FG001|12 Months|Lost to Follow-up|32|||
105649905|NCT02567227|364380266|FG000|12 Months|Death|0|||
105649906|NCT02567227|364380267|FG001|12 Months|Death|2|||
105649907|NCT04057937|364380268|FG000|Placebo-controlled Phase|Adverse Event|3|||
105649908|NCT04057937|364380269|FG001|Placebo-controlled Phase|Adverse Event|0|||
105649909|NCT04057937|364380268|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
105649910|NCT04057937|364380269|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
105649911|NCT04057937|364380268|FG000|Active-treatment Phase|Pregnancy|0|||
105649912|NCT04057937|364380269|FG001|Active-treatment Phase|Pregnancy|1|||
105649913|NCT04057937|364380268|FG000|Active-treatment Phase|Physician Decision|0|||
105649914|NCT04057937|364380269|FG001|Active-treatment Phase|Physician Decision|1|||
105649915|NCT00005908|364380271|FG000|Overall Study|Withdrawal by Subject|1|||
105649916|NCT00005908|364380272|FG001|Overall Study|Withdrawal by Subject|0|||
105649917|NCT00274846|364380288|FG000|Overall Study|Did not receive adequate NK cells|1|||
105649918|NCT03023878|364380298|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
105649919|NCT03023878|364380298|FG000|Pre-Study Run-In Period|Death|1|||
105649920|NCT03023878|364380298|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
105649921|NCT03023878|364380298|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
105649922|NCT03023878|364380298|FG000|Treatment Period|Disease Progression|1|||
105649923|NCT03023878|364380298|FG000|Treatment Period|Withdrawal by Subject|1|||
105649924|NCT03023878|364380298|FG000|Treatment Period|Adverse Event|1|||
105649925|NCT03023878|364380298|FG000|Long Term Follow-Up Period|Death|2|||
105649926|NCT02784535|364380300|FG000|Overall Study|Adverse Event|1|||
105649927|NCT02784535|364380301|FG001|Overall Study|Adverse Event|0|||
105649928|NCT02784535|364380300|FG000|Overall Study|Withdrawal by Subject|0|||
105649929|NCT02784535|364380301|FG001|Overall Study|Withdrawal by Subject|1|||
105649930|NCT02784535|364380300|FG000|Overall Study|Physician Decision|0|||
105649931|NCT02784535|364380301|FG001|Overall Study|Physician Decision|1|||
105649932|NCT03873038|364380305|FG000|Part 2|Withdrawal by Subject|0|||
105649933|NCT03873038|364380306|FG001|Part 2|Withdrawal by Subject|0|||
105649934|NCT03873038|364380307|FG002|Part 2|Withdrawal by Subject|0|||
105649935|NCT03873038|364380308|FG003|Part 2|Withdrawal by Subject|0|||
105649936|NCT03873038|364380309|FG004|Part 2|Withdrawal by Subject|0|||
105649937|NCT03873038|364380310|FG005|Part 2|Withdrawal by Subject|1|||
105649938|NCT03873038|364380305|FG000|Part 2|Unknon|0|||
105649939|NCT03873038|364380306|FG001|Part 2|Unknon|0|||
105649940|NCT03873038|364380307|FG002|Part 2|Unknon|0|||
105649941|NCT03873038|364380308|FG003|Part 2|Unknon|0|||
105649942|NCT03873038|364380309|FG004|Part 2|Unknon|1|||
105649943|NCT03873038|364380310|FG005|Part 2|Unknon|0|||
105649944|NCT00905255|364380311|FG000|Overall Study|Adverse Event|7|||
105649945|NCT00905255|364380312|FG001|Overall Study|Adverse Event|5|||
105649946|NCT00905255|364380311|FG000|Overall Study|Withdrawal by Subject|5|||
105649947|NCT00905255|364380312|FG001|Overall Study|Withdrawal by Subject|4|||
105649948|NCT00905255|364380311|FG000|Overall Study|Familial and Personal Reasons|1|||
105649949|NCT00905255|364380312|FG001|Overall Study|Familial and Personal Reasons|0|||
105649950|NCT03849300|364380313|FG000|Overall Study|move out to different area|1|||
105649951|NCT03849300|364380314|FG001|Overall Study|move out to different area|3|||
105649952|NCT03849300|364380315|FG002|Overall Study|move out to different area|1|||
105649953|NCT03849300|364380316|FG003|Overall Study|move out to different area|4|||
105649954|NCT03849300|364380313|FG000|Overall Study|scheduling/transportation conflict|4|||
105649955|NCT03849300|364380314|FG001|Overall Study|scheduling/transportation conflict|4|||
105649956|NCT03849300|364380315|FG002|Overall Study|scheduling/transportation conflict|3|||
105649957|NCT03849300|364380316|FG003|Overall Study|scheduling/transportation conflict|2|||
105649958|NCT04150250|364380322|FG000|Overall Study|Lost to Follow-up|0|||
105649959|NCT04150250|364380323|FG001|Overall Study|Lost to Follow-up|2|||
105649960|NCT01804140|364380328|FG000|Overall Study|No sampling or biopsy procedures done|114|||
105649961|NCT00547300|364380329|FG000|Overall Study|Study was Administratively Terminated|25|||
105649962|NCT00547300|364380330|FG001|Overall Study|Study was Administratively Terminated|24|||
105649963|NCT00547300|364380329|FG000|Overall Study|Did not Meet Entry Criteria|0|||
105649964|NCT00547300|364380330|FG001|Overall Study|Did not Meet Entry Criteria|2|||
105649965|NCT00230971|364380331|FG000|Randomization|No study drug administered|3|||
105649966|NCT00230971|364380332|FG001|Randomization|No study drug administered|3|||
105870387|NCT01682811|365177011|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
105649967|NCT00230971|364380331|FG000|Baseline Participants|Lost to Follow-up|5|||
105649968|NCT00230971|364380332|FG001|Baseline Participants|Lost to Follow-up|12|||
105649969|NCT00230971|364380331|FG000|Baseline Participants|Death|6|||
105649970|NCT00230971|364380332|FG001|Baseline Participants|Death|5|||
105649971|NCT00230971|364380331|FG000|Baseline Participants|Withdrawal by Subject|7|||
105649972|NCT00230971|364380332|FG001|Baseline Participants|Withdrawal by Subject|1|||
105649973|NCT00230971|364380331|FG000|Baseline Participants|Adverse Event|1|||
105649974|NCT00230971|364380332|FG001|Baseline Participants|Adverse Event|0|||
105649975|NCT00230971|364380331|FG000|Baseline Participants|No bacteria observed|1|||
105649976|NCT00230971|364380332|FG001|Baseline Participants|No bacteria observed|0|||
105649977|NCT00230971|364380331|FG000|Baseline Participants|Failure to return|1|||
105649978|NCT00230971|364380332|FG001|Baseline Participants|Failure to return|1|||
105649979|NCT00230971|364380331|FG000|Baseline Participants|Reintervention|1|||
105649980|NCT00230971|364380332|FG001|Baseline Participants|Reintervention|0|||
105649981|NCT03302559|364380333|FG000|Overall Study|Adverse Event|2|||
105649982|NCT03302559|364380333|FG000|Overall Study|Lost to Follow-up|1|||
105649983|NCT03302559|364380333|FG000|Overall Study|Withdrew Consent|3|||
105649984|NCT00497198|364380336|FG000|Overall Study|Adverse Event|4|||
105649985|NCT00497198|364380337|FG001|Overall Study|Adverse Event|2|||
105649986|NCT00497198|364380336|FG000|Overall Study|Physician Decision|1|||
105649987|NCT00497198|364380337|FG001|Overall Study|Physician Decision|2|||
105649988|NCT00497198|364380336|FG000|Overall Study|Withdrawal by Subject|0|||
105649989|NCT00497198|364380337|FG001|Overall Study|Withdrawal by Subject|1|||
105649990|NCT04267393|364380348|FG000|Randomization|Adverse Event|1|||
105649991|NCT04267393|364380349|FG001|Randomization|Adverse Event|0|||
105649992|NCT04267393|364380350|FG002|Randomization|Adverse Event|0|||
105649993|NCT04267393|364380348|FG000|Randomization|Administrative Reasons by Sponsor|0|||
105649994|NCT04267393|364380349|FG001|Randomization|Administrative Reasons by Sponsor|1|||
105649995|NCT04267393|364380350|FG002|Randomization|Administrative Reasons by Sponsor|0|||
105649996|NCT04267393|364380348|FG000|Treatment Period|Adverse Event|0|||
105649997|NCT04267393|364380349|FG001|Treatment Period|Adverse Event|2|||
105649998|NCT04267393|364380350|FG002|Treatment Period|Adverse Event|3|||
105649999|NCT04267393|364380348|FG000|Treatment Period|Participant Withdrew Consent|0|||
105650000|NCT04267393|364380349|FG001|Treatment Period|Participant Withdrew Consent|0|||
105650001|NCT04267393|364380350|FG002|Treatment Period|Participant Withdrew Consent|1|||
105650002|NCT04267393|364380348|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
105650003|NCT04267393|364380349|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
105650004|NCT04267393|364380350|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
105650005|NCT02799745|364380351|FG000|Overall Study|Participant moved out of state|1|||
105650006|NCT02799745|364380352|FG001|Overall Study|Participant moved out of state|0|||
105650007|NCT02799745|364380351|FG000|Overall Study|Discontinued due to planned surgery|1|||
105650008|NCT02799745|364380352|FG001|Overall Study|Discontinued due to planned surgery|0|||
105650009|NCT02799745|364380351|FG000|Overall Study|Withdrawal by Subject|16|||
105650010|NCT02799745|364380352|FG001|Overall Study|Withdrawal by Subject|25|||
105650011|NCT02799745|364380351|FG000|Overall Study|Protocol Deviation|4|||
105650012|NCT02799745|364380352|FG001|Overall Study|Protocol Deviation|5|||
105650013|NCT02799745|364380351|FG000|Overall Study|Progressive Disease|28|||
105650014|NCT02799745|364380352|FG001|Overall Study|Progressive Disease|38|||
105650015|NCT02799745|364380351|FG000|Overall Study|Lost to Follow-up|3|||
105650016|NCT02799745|364380352|FG001|Overall Study|Lost to Follow-up|2|||
105650017|NCT02799745|364380351|FG000|Overall Study|Death|3|||
105650018|NCT02799745|364380352|FG001|Overall Study|Death|0|||
105650019|NCT02799745|364380351|FG000|Overall Study|Adverse Event|0|||
105650020|NCT02799745|364380352|FG001|Overall Study|Adverse Event|1|||
105650021|NCT02661490|364381970|FG000|Overall Study|Lost to Follow-up|0|||
105650022|NCT02661490|364381971|FG001|Overall Study|Lost to Follow-up|1|||
105650023|NCT02661490|364381972|FG002|Overall Study|Lost to Follow-up|0|||
105650024|NCT02661490|364381973|FG003|Overall Study|Lost to Follow-up|0|||
105650025|NCT02661490|364381974|FG004|Overall Study|Lost to Follow-up|2|||
105650026|NCT02661490|364381970|FG000|Overall Study|Withdrawal by Subject|2|||
105650027|NCT02661490|364381971|FG001|Overall Study|Withdrawal by Subject|0|||
105650028|NCT02661490|364381972|FG002|Overall Study|Withdrawal by Subject|2|||
105650029|NCT02661490|364381973|FG003|Overall Study|Withdrawal by Subject|0|||
105650030|NCT02661490|364381974|FG004|Overall Study|Withdrawal by Subject|0|||
105650031|NCT02661490|364381970|FG000|Overall Study|Death|1|||
105650032|NCT02661490|364381971|FG001|Overall Study|Death|1|||
105650033|NCT02661490|364381972|FG002|Overall Study|Death|0|||
105650034|NCT02661490|364381973|FG003|Overall Study|Death|1|||
105650035|NCT02661490|364381974|FG004|Overall Study|Death|0|||
105650036|NCT02661490|364381970|FG000|Overall Study|Reason not Specified|0|||
105650037|NCT02661490|364381971|FG001|Overall Study|Reason not Specified|0|||
105650038|NCT02661490|364381972|FG002|Overall Study|Reason not Specified|0|||
105650039|NCT02661490|364381973|FG003|Overall Study|Reason not Specified|0|||
105650040|NCT02661490|364381974|FG004|Overall Study|Reason not Specified|1|||
105650041|NCT03322514|364381975|FG000|Overall Study|Withdrawal by Subject|1|||
105650042|NCT03322514|364381976|FG001|Overall Study|Withdrawal by Subject|1|||
105650043|NCT01193283|364381977|FG000|Overall Study|Death|1|||
105650044|NCT01370018|364381978|FG000|Overall Study|Did not meet criteria for analysis|1|||
105650045|NCT03772041|364381979|FG000|Overall Study|Adverse Event|8|||
105650046|NCT03772041|364381980|FG001|Overall Study|Adverse Event|3|||
105650047|NCT03772041|364381979|FG000|Overall Study|Withdrawal by Subject|0|||
105650048|NCT03772041|364381980|FG001|Overall Study|Withdrawal by Subject|2|||
105650049|NCT03772041|364381979|FG000|Overall Study|Protocol Violation|4|||
105650050|NCT03772041|364381980|FG001|Overall Study|Protocol Violation|2|||
105650051|NCT03772041|364381979|FG000|Overall Study|Physician Decision|2|||
105650052|NCT03772041|364381980|FG001|Overall Study|Physician Decision|3|||
105650053|NCT02720198|364381981|FG000|Overall Study|Withdrawal by Subject|0|||
105650054|NCT02720198|364381982|FG001|Overall Study|Withdrawal by Subject|1|||
105650055|NCT01061775|364381983|FG000|Overall Study|Physician Decision|2|||
105650056|NCT01061775|364381983|FG000|Overall Study|Lost to Follow-up|1|||
105650057|NCT03334747|364381984|FG000|Treatment Phase|Technical problems|0|||
105650058|NCT03334747|364381985|FG001|Treatment Phase|Technical problems|0|||
105650059|NCT03334747|364381986|FG002|Treatment Phase|Technical problems|0|||
105650060|NCT03334747|364381987|FG003|Treatment Phase|Technical problems|0|||
105650061|NCT03334747|364381988|FG004|Treatment Phase|Technical problems|1|||
105650062|NCT03334747|364381989|FG005|Treatment Phase|Technical problems|0|||
105650063|NCT03334747|364381990|FG006|Treatment Phase|Technical problems|0|||
105650064|NCT03334747|364381991|FG007|Treatment Phase|Technical problems|0|||
105650065|NCT03334747|364381992|FG008|Treatment Phase|Technical problems|0|||
105650066|NCT03334747|364381984|FG000|Treatment Phase|Subject/guardian decision|1|||
105650067|NCT03334747|364381985|FG001|Treatment Phase|Subject/guardian decision|0|||
105650068|NCT03334747|364381986|FG002|Treatment Phase|Subject/guardian decision|0|||
105650069|NCT03334747|364381987|FG003|Treatment Phase|Subject/guardian decision|0|||
105650070|NCT03334747|364381988|FG004|Treatment Phase|Subject/guardian decision|0|||
105650071|NCT03334747|364381989|FG005|Treatment Phase|Subject/guardian decision|1|||
105650072|NCT03334747|364381990|FG006|Treatment Phase|Subject/guardian decision|0|||
105650073|NCT03334747|364381991|FG007|Treatment Phase|Subject/guardian decision|0|||
105650074|NCT03334747|364381992|FG008|Treatment Phase|Subject/guardian decision|0|||
105650075|NCT03334747|364381984|FG000|Follow-Up Phase|Subject/guardian decision|0|||
105650076|NCT03334747|364381985|FG001|Follow-Up Phase|Subject/guardian decision|0|||
105650077|NCT03334747|364381986|FG002|Follow-Up Phase|Subject/guardian decision|0|||
105650078|NCT03334747|364381987|FG003|Follow-Up Phase|Subject/guardian decision|0|||
105650079|NCT03334747|364381988|FG004|Follow-Up Phase|Subject/guardian decision|0|||
105650080|NCT03334747|364381989|FG005|Follow-Up Phase|Subject/guardian decision|0|||
105650081|NCT03334747|364381990|FG006|Follow-Up Phase|Subject/guardian decision|1|||
105650082|NCT03334747|364381991|FG007|Follow-Up Phase|Subject/guardian decision|0|||
105650083|NCT03334747|364381992|FG008|Follow-Up Phase|Subject/guardian decision|1|||
105650084|NCT02029521|364381995|FG000|Overall Study|Protocol Violation|1|||
105650085|NCT02029521|364381996|FG001|Overall Study|Protocol Violation|0|||
105650086|NCT02029521|364381995|FG000|Overall Study|Withdrawal by Subject|1|||
105650087|NCT02029521|364381996|FG001|Overall Study|Withdrawal by Subject|1|||
105650088|NCT01072396|364381997|FG000|Period One|Adverse Event|1|||
105650089|NCT01072396|364381998|FG001|Period One|Adverse Event|1|||
105650090|NCT01072396|364381997|FG000|Period One|Protocol Violation|2|||
105650091|NCT01072396|364381998|FG001|Period One|Protocol Violation|1|||
105650092|NCT01072396|364381997|FG000|Period One|Withdrawal by Subject|2|||
105650093|NCT01072396|364381998|FG001|Period One|Withdrawal by Subject|0|||
105650094|NCT01072396|364381997|FG000|Washout Period|Missing termination information|0|||
105650095|NCT01072396|364381998|FG001|Washout Period|Missing termination information|1|||
105650096|NCT01072396|364381997|FG000|Period Two|Adverse Event|0|||
105650097|NCT01072396|364381998|FG001|Period Two|Adverse Event|3|||
105650098|NCT01072396|364381997|FG000|Period Two|Lost to Follow-up|1|||
105650099|NCT01072396|364381998|FG001|Period Two|Lost to Follow-up|0|||
105650100|NCT04748445|364382001|FG000|Overall Study|No longer met eligibility criteria|12|||
105650101|NCT04748445|364382001|FG000|Overall Study|Other|36|||
105650102|NCT04748445|364382001|FG000|Overall Study|Withdrawal by Subject|553|||
105650103|NCT04748445|364382001|FG000|Overall Study|Lost to Follow-up|30|||
105650104|NCT04736602|364382002|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
105650105|NCT04736602|364382002|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
105650106|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Adverse Event|3|||
105650107|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Adverse Event|0|||
105650108|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
105650109|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
105650110|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Disease Progression|23|||
105650111|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Disease Progression|22|||
105650112|NCT01379521|364382003|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
105650113|NCT01379521|364382004|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
105650114|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
105650115|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
105650116|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
105650117|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
105650118|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
105650119|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
105650120|NCT01379521|364382003|FG000|Overall Study -Treatment Period|Death|2|||
105650121|NCT01379521|364382004|FG001|Overall Study -Treatment Period|Death|1|||
105650122|NCT01379521|364382003|FG000|Post-Treatment Evaluations|Disease Progression|22|||
105650123|NCT01379521|364382004|FG001|Post-Treatment Evaluations|Disease Progression|20|||
105650124|NCT01379521|364382003|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
105650125|NCT01379521|364382004|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
105650126|NCT01379521|364382003|FG000|Post-Treatment Evaluations|Death|1|||
105650127|NCT01379521|364382004|FG001|Post-Treatment Evaluations|Death|0|||
105650128|NCT01026103|364382005|FG000|Overall Study|Physician Decision|1|||
105650129|NCT01026103|364382005|FG000|Overall Study|did not receive study device bc of error|1|||
105650130|NCT00105521|364382007|FG000|Overall Study|Other|1|||
105650131|NCT00105521|364382008|FG001|Overall Study|Other|1|||
105650132|NCT00105521|364382009|FG002|Overall Study|Other|2|||
105650133|NCT00105521|364382010|FG003|Overall Study|Other|0|||
105650134|NCT00105521|364382007|FG000|Overall Study|Adverse Event|10|||
105650135|NCT00105521|364382008|FG001|Overall Study|Adverse Event|4|||
105650136|NCT00105521|364382009|FG002|Overall Study|Adverse Event|10|||
105650137|NCT00105521|364382010|FG003|Overall Study|Adverse Event|8|||
105650138|NCT00105521|364382007|FG000|Overall Study|Withdrawal by Subject|1|||
105650139|NCT00105521|364382008|FG001|Overall Study|Withdrawal by Subject|0|||
105650140|NCT00105521|364382009|FG002|Overall Study|Withdrawal by Subject|1|||
105650141|NCT00105521|364382010|FG003|Overall Study|Withdrawal by Subject|4|||
105650142|NCT00105521|364382007|FG000|Overall Study|Lack of Efficacy|0|||
105650143|NCT00105521|364382008|FG001|Overall Study|Lack of Efficacy|0|||
105650144|NCT00105521|364382009|FG002|Overall Study|Lack of Efficacy|0|||
105650145|NCT00105521|364382010|FG003|Overall Study|Lack of Efficacy|1|||
105650146|NCT00105521|364382007|FG000|Overall Study|Protocol Violation|3|||
105650147|NCT00105521|364382008|FG001|Overall Study|Protocol Violation|5|||
105650148|NCT00105521|364382009|FG002|Overall Study|Protocol Violation|4|||
105650149|NCT00105521|364382010|FG003|Overall Study|Protocol Violation|4|||
105650150|NCT00105521|364382007|FG000|Overall Study|Lost to Follow-up|0|||
105650151|NCT00105521|364382008|FG001|Overall Study|Lost to Follow-up|1|||
105650152|NCT00105521|364382009|FG002|Overall Study|Lost to Follow-up|0|||
105650153|NCT00105521|364382010|FG003|Overall Study|Lost to Follow-up|0|||
105650154|NCT02504502|364382011|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
105650155|NCT02504502|364382012|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
105650156|NCT02504502|364382011|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
105650157|NCT02504502|364382012|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
105650158|NCT00762502|364382013|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
105650159|NCT00762502|364382014|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
105650160|NCT00762502|364382015|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
105650161|NCT00762502|364382013|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
105650162|NCT00762502|364382014|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
105650163|NCT00762502|364382015|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
105650164|NCT00762502|364382013|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
105650165|NCT00762502|364382014|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
105650166|NCT00762502|364382015|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
105650167|NCT03042559|364382016|FG000|Overall Study|drop out|1|||
105650168|NCT03042559|364382017|FG001|Overall Study|drop out|1|||
105650169|NCT00428441|364382022|FG000|Overall Study|Lost to Follow-up|1|||
105650170|NCT00404547|364382025|FG000|Overall Study|Adverse Event|39|||
105650171|NCT00404547|364382026|FG001|Overall Study|Adverse Event|6|||
105650172|NCT00404547|364382025|FG000|Overall Study|Withdrawal by Subject|19|||
105650173|NCT00404547|364382026|FG001|Overall Study|Withdrawal by Subject|2|||
105650174|NCT00404547|364382025|FG000|Overall Study|Protocol Violation|0|||
105650175|NCT00404547|364382026|FG001|Overall Study|Protocol Violation|1|||
105650176|NCT00404547|364382025|FG000|Overall Study|Lost to Follow-up|20|||
105650177|NCT00404547|364382026|FG001|Overall Study|Lost to Follow-up|9|||
105650178|NCT00404547|364382025|FG000|Overall Study|Lack of compliance|5|||
105650179|NCT00404547|364382026|FG001|Overall Study|Lack of compliance|1|||
105650180|NCT00404547|364382025|FG000|Overall Study|Other|4|||
105650181|NCT00404547|364382026|FG001|Overall Study|Other|0|||
105650182|NCT00404547|364382025|FG000|Overall Study|Reason not stated|3|||
105650183|NCT00404547|364382026|FG001|Overall Study|Reason not stated|6|||
105650184|NCT01475370|364382027|FG000|Overall Study|Exacerbation of primary disease|2|||
105650185|NCT01475370|364382028|FG001|Overall Study|Exacerbation of primary disease|2|||
105650186|NCT01475370|364382029|FG002|Overall Study|Exacerbation of primary disease|2|||
105650187|NCT01475370|364382027|FG000|Overall Study|Study drug administration difficult|0|||
105650188|NCT01475370|364382028|FG001|Overall Study|Study drug administration difficult|1|||
105650189|NCT01475370|364382029|FG002|Overall Study|Study drug administration difficult|1|||
105650190|NCT01475370|364382027|FG000|Overall Study|Other than specified|1|||
105650191|NCT01475370|364382028|FG001|Overall Study|Other than specified|0|||
105650192|NCT01475370|364382029|FG002|Overall Study|Other than specified|0|||
105650193|NCT02538471|364382030|FG000|Overall Study|Progression of disease|2|||
105650194|NCT02131155|364382031|FG000|Overall Study|Adverse Event|1|||
105650195|NCT02131155|364382032|FG001|Overall Study|Adverse Event|0|||
105650196|NCT02131155|364382031|FG000|Overall Study|Treatment completed|1|||
105650197|NCT02131155|364382032|FG001|Overall Study|Treatment completed|0|||
105650198|NCT02131155|364382031|FG000|Overall Study|Primary tumour recurrence|2|||
105650199|NCT02131155|364382032|FG001|Overall Study|Primary tumour recurrence|1|||
105650200|NCT02131155|364382031|FG000|Overall Study|Refused to continue study medication|1|||
105650201|NCT02131155|364382032|FG001|Overall Study|Refused to continue study medication|0|||
105650202|NCT02131155|364382031|FG000|Overall Study|Study early termination|20|||
105650203|NCT02131155|364382032|FG001|Overall Study|Study early termination|10|||
105650204|NCT01675050|364382035|FG000|Period One Treatment|Withdrawal by Subject|1|||
105650205|NCT01675050|364382036|FG001|Period One Treatment|Withdrawal by Subject|0|||
105650206|NCT01887418|364382037|FG000|Overall Study|Travelling difficulties|0|||
105650207|NCT01887418|364382038|FG001|Overall Study|Travelling difficulties|0|||
105650208|NCT01887418|364382039|FG002|Overall Study|Travelling difficulties|1|||
105650209|NCT00475735|364382040|FG000|Treatment Period 1|Adverse Event|2|||
105650210|NCT00475735|364382041|FG001|Treatment Period 1|Adverse Event|0|||
105650211|NCT00475735|364382042|FG002|Treatment Period 1|Adverse Event|0|||
105650212|NCT00475735|364382043|FG003|Treatment Period 1|Adverse Event|0|||
105650213|NCT00475735|364382044|FG004|Treatment Period 1|Adverse Event|0|||
105650214|NCT00475735|364382045|FG005|Treatment Period 1|Adverse Event|0|||
105650215|NCT00475735|364382040|FG000|Treatment Period 1|Lack of Efficacy|1|||
105650216|NCT00475735|364382041|FG001|Treatment Period 1|Lack of Efficacy|0|||
105650217|NCT00475735|364382042|FG002|Treatment Period 1|Lack of Efficacy|0|||
105650218|NCT00475735|364382043|FG003|Treatment Period 1|Lack of Efficacy|0|||
105650219|NCT00475735|364382044|FG004|Treatment Period 1|Lack of Efficacy|0|||
105650220|NCT00475735|364382045|FG005|Treatment Period 1|Lack of Efficacy|0|||
105650221|NCT00475735|364382040|FG000|Treatment Period 1|Lost to Follow-up|0|||
105650222|NCT00475735|364382041|FG001|Treatment Period 1|Lost to Follow-up|0|||
105650223|NCT00475735|364382042|FG002|Treatment Period 1|Lost to Follow-up|0|||
105650224|NCT00475735|364382043|FG003|Treatment Period 1|Lost to Follow-up|0|||
105650225|NCT00475735|364382044|FG004|Treatment Period 1|Lost to Follow-up|0|||
105650226|NCT00475735|364382045|FG005|Treatment Period 1|Lost to Follow-up|1|||
105650227|NCT00475735|364382040|FG000|Treatment Period 1|Protocol Violation|0|||
105650228|NCT00475735|364382041|FG001|Treatment Period 1|Protocol Violation|0|||
105650229|NCT00475735|364382042|FG002|Treatment Period 1|Protocol Violation|0|||
105650230|NCT00475735|364382043|FG003|Treatment Period 1|Protocol Violation|1|||
105650231|NCT00475735|364382044|FG004|Treatment Period 1|Protocol Violation|0|||
105650232|NCT00475735|364382045|FG005|Treatment Period 1|Protocol Violation|0|||
105650233|NCT00475735|364382040|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105650234|NCT00475735|364382041|FG001|Treatment Period 1|Withdrawal by Subject|1|||
105650235|NCT00475735|364382042|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105650236|NCT00475735|364382043|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105650237|NCT00475735|364382044|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105650238|NCT00475735|364382045|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105650239|NCT00475735|364382040|FG000|Treatment Period 1|DC due to AE but continuing|0|||
105650240|NCT00475735|364382041|FG001|Treatment Period 1|DC due to AE but continuing|0|||
105650241|NCT00475735|364382042|FG002|Treatment Period 1|DC due to AE but continuing|0|||
105650242|NCT00475735|364382043|FG003|Treatment Period 1|DC due to AE but continuing|1|||
105650243|NCT00475735|364382044|FG004|Treatment Period 1|DC due to AE but continuing|2|||
105650244|NCT00475735|364382045|FG005|Treatment Period 1|DC due to AE but continuing|2|||
105650245|NCT00475735|364382040|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650246|NCT00475735|364382041|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
105650247|NCT00475735|364382042|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650248|NCT00475735|364382043|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650249|NCT00475735|364382044|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650250|NCT00475735|364382045|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
105650251|NCT00475735|364382040|FG000|Treatment Washout|Lost to Follow-up|0|||
105650252|NCT00475735|364382041|FG001|Treatment Washout|Lost to Follow-up|1|||
105650253|NCT00475735|364382042|FG002|Treatment Washout|Lost to Follow-up|0|||
105650254|NCT00475735|364382043|FG003|Treatment Washout|Lost to Follow-up|0|||
105650255|NCT00475735|364382044|FG004|Treatment Washout|Lost to Follow-up|0|||
105650256|NCT00475735|364382045|FG005|Treatment Washout|Lost to Follow-up|0|||
105650257|NCT00475735|364382040|FG000|Treatment Washout|Protocol Violation|0|||
105650258|NCT00475735|364382041|FG001|Treatment Washout|Protocol Violation|1|||
105650259|NCT00475735|364382042|FG002|Treatment Washout|Protocol Violation|0|||
105650260|NCT00475735|364382043|FG003|Treatment Washout|Protocol Violation|0|||
105650261|NCT00475735|364382044|FG004|Treatment Washout|Protocol Violation|0|||
105650262|NCT00475735|364382045|FG005|Treatment Washout|Protocol Violation|0|||
105650263|NCT00475735|364382040|FG000|Treatment Period 2|Adverse Event|0|||
105650264|NCT00475735|364382041|FG001|Treatment Period 2|Adverse Event|1|||
105650265|NCT00475735|364382042|FG002|Treatment Period 2|Adverse Event|0|||
105650266|NCT00475735|364382043|FG003|Treatment Period 2|Adverse Event|2|||
105650267|NCT00475735|364382044|FG004|Treatment Period 2|Adverse Event|0|||
105650268|NCT00475735|364382045|FG005|Treatment Period 2|Adverse Event|0|||
105650269|NCT00475735|364382040|FG000|Treatment Period 2|Lack of Efficacy|0|||
105650270|NCT00475735|364382041|FG001|Treatment Period 2|Lack of Efficacy|0|||
105650271|NCT00475735|364382042|FG002|Treatment Period 2|Lack of Efficacy|0|||
105650272|NCT00475735|364382043|FG003|Treatment Period 2|Lack of Efficacy|0|||
105650273|NCT00475735|364382044|FG004|Treatment Period 2|Lack of Efficacy|0|||
105650274|NCT00475735|364382045|FG005|Treatment Period 2|Lack of Efficacy|1|||
105650275|NCT00475735|364382040|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105650276|NCT00475735|364382041|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105650277|NCT00475735|364382042|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105650278|NCT00475735|364382043|FG003|Treatment Period 2|Withdrawal by Subject|0|||
105650279|NCT00475735|364382044|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105650280|NCT00475735|364382045|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105650281|NCT03132753|364382048|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
105650282|NCT03132753|364382049|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
105650283|NCT03132753|364382048|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
105650284|NCT03132753|364382049|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
105650285|NCT00084747|364382050|FG000|Overall Study|Relapsed|8|||
105650286|NCT00084747|364382050|FG000|Overall Study|Death|3|||
105650287|NCT00084747|364382050|FG000|Overall Study|Withdrawal by Subject|2|||
105650288|NCT03794609|364382055|FG000|Overall Study|Other|10|||
105650289|NCT03794609|364382055|FG000|Overall Study|Withdrawal by Subject|66|||
105650290|NCT03794609|364382055|FG000|Overall Study|The child is enrolled in an interventional study|70|||
105650291|NCT03794609|364382055|FG000|Overall Study|Inclusion/exclusion criteria|8|||
105650292|NCT03794609|364382055|FG000|Overall Study|At sponsor's request|151|||
105650293|NCT03794609|364382055|FG000|Overall Study|Physician Decision|1|||
105650294|NCT03794609|364382055|FG000|Overall Study|Lost to Follow-up|5|||
105650295|NCT02744898|364382056|FG000|Overall Study|Progressive Disease|2|||
105650296|NCT02744898|364382056|FG000|Overall Study|Physician Decision|1|||
105650297|NCT02744898|364382056|FG000|Overall Study|Toxicity|1|||
105650298|NCT04543942|364382057|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
105650299|NCT04543942|364382058|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
105650300|NCT04543942|364382057|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
105650301|NCT04543942|364382058|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
105650302|NCT02205476|364382059|FG000|Overall Study|Study termination by Sponsor|7|||
105650303|NCT02205476|364382060|FG001|Overall Study|Study termination by Sponsor|3|||
105650304|NCT02350127|364382068|FG000|4-Month Assessment|Withdrawal by Subject|10|||
105650305|NCT02350127|364382069|FG001|4-Month Assessment|Withdrawal by Subject|9|||
105650306|NCT02350127|364382068|FG000|4-Month Assessment|Death|1|||
105650307|NCT02350127|364382069|FG001|4-Month Assessment|Death|0|||
105650308|NCT02350127|364382068|FG000|8-Month Assessment|Death|1|||
105650309|NCT02350127|364382069|FG001|8-Month Assessment|Death|1|||
105650310|NCT02350127|364382068|FG000|8-Month Assessment|Withdrawal by Subject|5|||
105650311|NCT02350127|364382069|FG001|8-Month Assessment|Withdrawal by Subject|8|||
105650312|NCT02097056|364382070|FG000|Overall Study|Protocol Violation|2|||
105650313|NCT02097056|364382070|FG000|Overall Study|Withdrawal by Subject|15|||
105650314|NCT02097056|364382070|FG000|Overall Study|Lost to Follow-up|2|||
105650315|NCT02097056|364382070|FG000|Overall Study|Adverse Event|37|||
105650316|NCT02097056|364382070|FG000|Overall Study|Other|2|||
105650317|NCT01323309|364382079|FG000|Overall Study|Death|9|||
105650318|NCT01323309|364382080|FG001|Overall Study|Death|15|||
105650319|NCT01323309|364382081|FG002|Overall Study|Death|5|||
105650320|NCT01323309|364382079|FG000|Overall Study|Lost to Follow-up|11|||
105650321|NCT01323309|364382080|FG001|Overall Study|Lost to Follow-up|14|||
105650322|NCT01323309|364382081|FG002|Overall Study|Lost to Follow-up|24|||
105650323|NCT01323309|364382079|FG000|Overall Study|Withdrawal by Subject|14|||
105650324|NCT01323309|364382080|FG001|Overall Study|Withdrawal by Subject|14|||
105650325|NCT01323309|364382081|FG002|Overall Study|Withdrawal by Subject|18|||
105650326|NCT01323309|364382079|FG000|Overall Study|Disease progression|5|||
105650327|NCT01323309|364382080|FG001|Overall Study|Disease progression|11|||
105650328|NCT01323309|364382081|FG002|Overall Study|Disease progression|4|||
105650329|NCT02625922|364382082|FG000|Overall Study|Non-availability of IMP|1|||
105650330|NCT02625922|364382083|FG001|Overall Study|Non-availability of IMP|1|||
105650331|NCT02625922|364382082|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
105650332|NCT02625922|364382083|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
105650333|NCT00910871|364382084|FG000|Overall Study|Adverse Event|5|||
105650334|NCT00910871|364382084|FG000|Overall Study|Death|12|||
105650335|NCT00910871|364382084|FG000|Overall Study|Lost to Follow-up|8|||
105650336|NCT00910871|364382084|FG000|Overall Study|Protocol Violation|11|||
105650337|NCT00910871|364382084|FG000|Overall Study|Withdrawal by Subject|12|||
105650338|NCT00910871|364382084|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
105650339|NCT00910871|364382084|FG000|Overall Study|Undefined|1|||
105650340|NCT00050167|364382088|FG000|Overall Study|not eligible not invasive|1|||
105650341|NCT00050167|364382089|FG001|Overall Study|not eligible not invasive|1|||
105650342|NCT00676663|364382090|FG000|Overall Study|Death|43|||
105650343|NCT00676663|364382091|FG001|Overall Study|Death|27|||
105650344|NCT00676663|364382090|FG000|Overall Study|Withdrew Consent|1|||
105650345|NCT00676663|364382091|FG001|Overall Study|Withdrew Consent|8|||
105650346|NCT00676663|364382090|FG000|Overall Study|Lost to Follow-up|1|||
105650347|NCT00676663|364382091|FG001|Overall Study|Lost to Follow-up|3|||
105650348|NCT01544153|364382092|FG000|Overall Study|Under 18|0|||
105650349|NCT01544153|364382093|FG001|Overall Study|Under 18|1|||
105650350|NCT01544153|364382094|FG002|Overall Study|Under 18|0|||
105650351|NCT01544153|364382095|FG003|Overall Study|Under 18|0|||
105650352|NCT01544153|364382092|FG000|Overall Study|Non-smoker|0|||
105650353|NCT01544153|364382093|FG001|Overall Study|Non-smoker|0|||
105650354|NCT01544153|364382094|FG002|Overall Study|Non-smoker|1|||
105650355|NCT01544153|364382095|FG003|Overall Study|Non-smoker|0|||
105650356|NCT00884793|364382096|FG000|Overall Study|Withdrawal by Subject|1|||
105650357|NCT03169530|364382097|FG000|Overall Study|Study ended by NIH|15|||
105650358|NCT03169530|364382098|FG001|Overall Study|Study ended by NIH|17|||
105650359|NCT00714688|364382106|FG000|Overall Study|Lack of Efficacy|14|||
105650360|NCT00714688|364382107|FG001|Overall Study|Lack of Efficacy|1|||
105650361|NCT00714688|364382108|FG002|Overall Study|Lack of Efficacy|4|||
105650362|NCT00714688|364382106|FG000|Overall Study|Withdrawal by Subject|4|||
105650363|NCT00714688|364382107|FG001|Overall Study|Withdrawal by Subject|3|||
105650364|NCT00714688|364382108|FG002|Overall Study|Withdrawal by Subject|3|||
105650365|NCT00714688|364382106|FG000|Overall Study|Lost to Follow-up|5|||
105650366|NCT00714688|364382107|FG001|Overall Study|Lost to Follow-up|2|||
105650367|NCT00714688|364382108|FG002|Overall Study|Lost to Follow-up|0|||
105650368|NCT00714688|364382106|FG000|Overall Study|Adverse Event|2|||
105650369|NCT00714688|364382107|FG001|Overall Study|Adverse Event|15|||
105650370|NCT00714688|364382108|FG002|Overall Study|Adverse Event|19|||
105650371|NCT00714688|364382106|FG000|Overall Study|Subject Non-compliant|3|||
105650372|NCT00714688|364382107|FG001|Overall Study|Subject Non-compliant|5|||
105650373|NCT00714688|364382108|FG002|Overall Study|Subject Non-compliant|5|||
105650374|NCT00714688|364382106|FG000|Overall Study|Ineligible to Continue the Study|0|||
105650375|NCT00714688|364382107|FG001|Overall Study|Ineligible to Continue the Study|1|||
105650376|NCT00714688|364382108|FG002|Overall Study|Ineligible to Continue the Study|1|||
105650377|NCT00714688|364382106|FG000|Overall Study|Sponsor's Decision|0|||
105650378|NCT00714688|364382107|FG001|Overall Study|Sponsor's Decision|2|||
105650379|NCT00714688|364382108|FG002|Overall Study|Sponsor's Decision|0|||
105650380|NCT00714688|364382106|FG000|Overall Study|Other|1|||
105650381|NCT00714688|364382107|FG001|Overall Study|Other|6|||
105650382|NCT00714688|364382108|FG002|Overall Study|Other|5|||
105650383|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
105650384|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
105650385|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
105650386|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
105650387|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
105650388|NCT00500539|364382109|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
105650389|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
105650390|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
105650391|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
105650392|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
105650393|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Death|1|||
105650394|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
105650395|NCT00500539|364382109|FG000|Follow-up Period (16 Weeks)|Missing|3|||
105650396|NCT00774306|364384056|FG000|Overall Study|Adverse Event|3|||
105650397|NCT00774306|364384057|FG001|Overall Study|Adverse Event|0|||
105650398|NCT00774306|364384058|FG002|Overall Study|Adverse Event|0|||
105650399|NCT00774306|364384059|FG003|Overall Study|Adverse Event|0|||
105650400|NCT00774306|364384056|FG000|Overall Study|Protocol Violation|2|||
105650401|NCT00774306|364384057|FG001|Overall Study|Protocol Violation|0|||
105650402|NCT00774306|364384058|FG002|Overall Study|Protocol Violation|3|||
105650403|NCT00774306|364384059|FG003|Overall Study|Protocol Violation|0|||
105650404|NCT00774306|364384056|FG000|Overall Study|Withdrawal by Subject|6|||
105650405|NCT00774306|364384057|FG001|Overall Study|Withdrawal by Subject|1|||
105650406|NCT00774306|364384058|FG002|Overall Study|Withdrawal by Subject|1|||
105650407|NCT00774306|364384059|FG003|Overall Study|Withdrawal by Subject|0|||
105650408|NCT00774306|364384056|FG000|Overall Study|Lost to Follow-up|6|||
105650409|NCT00774306|364384057|FG001|Overall Study|Lost to Follow-up|0|||
105650410|NCT00774306|364384058|FG002|Overall Study|Lost to Follow-up|4|||
105650411|NCT00774306|364384059|FG003|Overall Study|Lost to Follow-up|5|||
105650412|NCT00774306|364384056|FG000|Overall Study|Death|1|||
105650413|NCT00774306|364384057|FG001|Overall Study|Death|1|||
105650414|NCT00774306|364384058|FG002|Overall Study|Death|0|||
105650415|NCT00774306|364384059|FG003|Overall Study|Death|0|||
105650416|NCT03568708|364384062|FG000|Overall Study|Withdrawal by Subject|1|||
105650417|NCT03568708|364384063|FG001|Overall Study|Withdrawal by Subject|1|||
105650418|NCT03568708|364384062|FG000|Overall Study|Lost to Follow-up|0|||
105650419|NCT03568708|364384063|FG001|Overall Study|Lost to Follow-up|1|||
105650420|NCT01126879|364384066|FG000|Overall Study|Progressive Disease|3|||
105650421|NCT01126879|364384067|FG001|Overall Study|Progressive Disease|1|||
105650422|NCT01126879|364384066|FG000|Overall Study|Withdrawal by Subject|1|||
105650423|NCT01126879|364384067|FG001|Overall Study|Withdrawal by Subject|0|||
105650424|NCT01126879|364384066|FG000|Overall Study|Adverse Event|0|||
105650425|NCT01126879|364384067|FG001|Overall Study|Adverse Event|1|||
105650426|NCT01126879|364384066|FG000|Overall Study|Physician Decision|1|||
105650427|NCT01126879|364384067|FG001|Overall Study|Physician Decision|0|||
105650428|NCT00126555|364384074|FG000|Overall Study|Withdrawal by Subject|1|||
105650429|NCT00126555|364384074|FG000|Overall Study|Adverse Event|2|||
105650430|NCT00126555|364384074|FG000|Overall Study|Progressive Disease|3|||
105650431|NCT02186015|364384080|FG000|Overall Study|Physician Decision|1|||
105650432|NCT02186015|364384081|FG001|Overall Study|Physician Decision|0|||
105650433|NCT00139659|364384086|FG000|Overall Study|Adverse Event|12|||
105650434|NCT00139659|364384087|FG001|Overall Study|Adverse Event|1|||
105650435|NCT00139659|364384086|FG000|Overall Study|Lack of Efficacy|1|||
105650436|NCT00139659|364384087|FG001|Overall Study|Lack of Efficacy|1|||
105650437|NCT00139659|364384086|FG000|Overall Study|Lost to Follow-up|7|||
105650438|NCT00139659|364384087|FG001|Overall Study|Lost to Follow-up|3|||
105650439|NCT00139659|364384086|FG000|Overall Study|Reason not Specified|6|||
105650440|NCT00139659|364384087|FG001|Overall Study|Reason not Specified|3|||
105650441|NCT00139659|364384086|FG000|Overall Study|Withdrawal by Subject|14|||
105650442|NCT00139659|364384087|FG001|Overall Study|Withdrawal by Subject|10|||
105650443|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
105650444|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
105650445|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Adverse Event|4|||
105650446|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Adverse Event|1|||
105650447|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
105650448|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
105650449|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Physician Decision|0|||
105650450|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Physician Decision|2|||
105650451|NCT02162771|364384088|FG000|Core Study Period (Part 2)|Death|1|||
105650452|NCT02162771|364384089|FG001|Core Study Period (Part 2)|Death|0|||
105650453|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
105650454|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
105650455|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
105650456|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
105650457|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Death|2|||
105650458|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Death|1|||
105650459|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
105650460|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
105650461|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
105650462|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
105650463|NCT02162771|364384088|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
105650464|NCT02162771|364384089|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
105650465|NCT01190228|364384094|FG000|Overall Study|Protocol Violation|4|||
105650466|NCT01190228|364384095|FG001|Overall Study|Protocol Violation|0|||
105650467|NCT01190228|364384096|FG002|Overall Study|Protocol Violation|0|||
105650468|NCT01190228|364384094|FG000|Overall Study|Withdrawal by Subject|1|||
105650469|NCT01190228|364384095|FG001|Overall Study|Withdrawal by Subject|0|||
105650470|NCT01190228|364384096|FG002|Overall Study|Withdrawal by Subject|0|||
105650471|NCT00607789|364384100|FG000|Overall Study|Adverse Event|3|||
105650472|NCT00607789|364384101|FG001|Overall Study|Adverse Event|0|||
105650473|NCT00607789|364384100|FG000|Overall Study|Lack of Efficacy|0|||
105650474|NCT00607789|364384101|FG001|Overall Study|Lack of Efficacy|1|||
105650475|NCT00607789|364384100|FG000|Overall Study|Inadequate adherence|3|||
105650476|NCT00607789|364384101|FG001|Overall Study|Inadequate adherence|0|||
105650477|NCT00607789|364384100|FG000|Overall Study|Lost to Follow-up|0|||
105650478|NCT00607789|364384101|FG001|Overall Study|Lost to Follow-up|5|||
105650479|NCT00607789|364384100|FG000|Overall Study|Withdrawal by Subject|1|||
105650480|NCT00607789|364384101|FG001|Overall Study|Withdrawal by Subject|0|||
105650481|NCT04414397|364384102|FG000|Control Period|Withdrawal by Subject|2|||
105650482|NCT04414397|364384103|FG001|Control Period|Withdrawal by Subject|2|||
105650483|NCT04414397|364384102|FG000|Control Period|Lost to Follow-up|0|||
105650484|NCT04414397|364384103|FG001|Control Period|Lost to Follow-up|4|||
105650485|NCT04414397|364384102|FG000|Control Period|Protocol deviation|0|||
105650486|NCT04414397|364384103|FG001|Control Period|Protocol deviation|1|||
105650487|NCT04414397|364384102|FG000|Post-Control Period|Withdrawal by Subject|3|||
105650488|NCT04414397|364384103|FG001|Post-Control Period|Withdrawal by Subject|6|||
105650489|NCT04414397|364384102|FG000|Post-Control Period|Lost to Follow-up|4|||
105650490|NCT04414397|364384103|FG001|Post-Control Period|Lost to Follow-up|9|||
105650491|NCT04414397|364384102|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
105650492|NCT04414397|364384103|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
105650493|NCT04414397|364384102|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
105650494|NCT04414397|364384103|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
105650495|NCT01313299|364384105|FG000|Overall Study|Adverse Event|3|||
105650496|NCT01313299|364384106|FG001|Overall Study|Adverse Event|1|||
105650497|NCT01313299|364384107|FG002|Overall Study|Adverse Event|1|||
105650498|NCT01313299|364384105|FG000|Overall Study|Lost to Follow-up|1|||
105650499|NCT01313299|364384106|FG001|Overall Study|Lost to Follow-up|0|||
105650500|NCT01313299|364384107|FG002|Overall Study|Lost to Follow-up|0|||
105650501|NCT01313299|364384105|FG000|Overall Study|Protocol Violation|2|||
105650502|NCT01313299|364384106|FG001|Overall Study|Protocol Violation|0|||
105650503|NCT01313299|364384107|FG002|Overall Study|Protocol Violation|0|||
105650504|NCT01313299|364384105|FG000|Overall Study|Withdrawal by Subject|1|||
105650505|NCT01313299|364384106|FG001|Overall Study|Withdrawal by Subject|0|||
105650506|NCT01313299|364384107|FG002|Overall Study|Withdrawal by Subject|2|||
105650507|NCT01313299|364384105|FG000|Overall Study|Family reason and moved out of state|0|||
105650508|NCT01313299|364384106|FG001|Overall Study|Family reason and moved out of state|2|||
105650509|NCT01313299|364384107|FG002|Overall Study|Family reason and moved out of state|0|||
105650510|NCT01313299|364384105|FG000|Overall Study|Lack of subject compliance|0|||
105650511|NCT01313299|364384106|FG001|Overall Study|Lack of subject compliance|0|||
105650512|NCT01313299|364384107|FG002|Overall Study|Lack of subject compliance|1|||
105650513|NCT02391545|364384108|FG000|Overall Study|Death|0|||
105650514|NCT02391545|364384109|FG001|Overall Study|Death|2|||
105650515|NCT02391545|364384108|FG000|Overall Study|Lost to Follow-up|0|||
105650516|NCT02391545|364384109|FG001|Overall Study|Lost to Follow-up|1|||
105650517|NCT02391545|364384108|FG000|Overall Study|Termination of study by sponsor|20|||
105650518|NCT02391545|364384109|FG001|Overall Study|Termination of study by sponsor|20|||
105650519|NCT02391545|364384108|FG000|Overall Study|Withdrawal by Subject|0|||
105650520|NCT02391545|364384109|FG001|Overall Study|Withdrawal by Subject|1|||
105650521|NCT02391545|364384108|FG000|Overall Study|Other Reasons|6|||
105650522|NCT02391545|364384109|FG001|Overall Study|Other Reasons|4|||
105650523|NCT04089332|364384110|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
105650524|NCT04089332|364384110|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
105650525|NCT04089332|364384110|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
105650526|NCT04754594|364384114|FG000|Blinded Period|Withdrawal by Subject|4|||
105650527|NCT04754594|364384115|FG001|Blinded Period|Withdrawal by Subject|9|||
105650528|NCT04754594|364384116|FG002|Blinded Period|Withdrawal by Subject|0|||
105650529|NCT04754594|364384117|FG003|Blinded Period|Withdrawal by Subject|0|||
105650530|NCT04754594|364384114|FG000|Blinded Period|Protocol Violation|2|||
105650531|NCT04754594|364384115|FG001|Blinded Period|Protocol Violation|2|||
105650532|NCT04754594|364384116|FG002|Blinded Period|Protocol Violation|0|||
105650533|NCT04754594|364384117|FG003|Blinded Period|Protocol Violation|0|||
105650534|NCT04754594|364384114|FG000|Blinded Period|Lost to Follow-up|1|||
105650535|NCT04754594|364384115|FG001|Blinded Period|Lost to Follow-up|1|||
105650536|NCT04754594|364384116|FG002|Blinded Period|Lost to Follow-up|0|||
105650537|NCT04754594|364384117|FG003|Blinded Period|Lost to Follow-up|0|||
105650538|NCT04754594|364384114|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
105650539|NCT04754594|364384115|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
105650540|NCT04754594|364384116|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
105650541|NCT04754594|364384117|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
105650542|NCT04754594|364384114|FG000|Unblinded Period|Withdrawal by Subject|6|||
105650543|NCT04754594|364384115|FG001|Unblinded Period|Withdrawal by Subject|8|||
105650544|NCT04754594|364384116|FG002|Unblinded Period|Withdrawal by Subject|0|||
105650545|NCT04754594|364384117|FG003|Unblinded Period|Withdrawal by Subject|0|||
105650546|NCT04754594|364384114|FG000|Unblinded Period|Lost to Follow-up|5|||
105650547|NCT04754594|364384115|FG001|Unblinded Period|Lost to Follow-up|3|||
105650548|NCT04754594|364384116|FG002|Unblinded Period|Lost to Follow-up|0|||
105650549|NCT04754594|364384117|FG003|Unblinded Period|Lost to Follow-up|0|||
105650550|NCT04754594|364384114|FG000|Unblinded Period|Protocol Violation|2|||
105650551|NCT04754594|364384115|FG001|Unblinded Period|Protocol Violation|4|||
105650552|NCT04754594|364384116|FG002|Unblinded Period|Protocol Violation|0|||
105650553|NCT04754594|364384117|FG003|Unblinded Period|Protocol Violation|0|||
105650554|NCT04754594|364384114|FG000|Unblinded Period|Other|3|||
105650555|NCT04754594|364384115|FG001|Unblinded Period|Other|0|||
105650556|NCT04754594|364384116|FG002|Unblinded Period|Other|0|||
105650557|NCT04754594|364384117|FG003|Unblinded Period|Other|0|||
105650558|NCT04754594|364384114|FG000|Infant Participants|Withdrawal by Subject|0|||
105650559|NCT04754594|364384115|FG001|Infant Participants|Withdrawal by Subject|0|||
105650560|NCT04754594|364384116|FG002|Infant Participants|Withdrawal by Subject|9|||
105650561|NCT04754594|364384117|FG003|Infant Participants|Withdrawal by Subject|17|||
105650562|NCT04754594|364384114|FG000|Infant Participants|Lost to Follow-up|0|||
105650563|NCT04754594|364384115|FG001|Infant Participants|Lost to Follow-up|0|||
105650564|NCT04754594|364384116|FG002|Infant Participants|Lost to Follow-up|4|||
105650565|NCT04754594|364384117|FG003|Infant Participants|Lost to Follow-up|10|||
105650566|NCT04754594|364384114|FG000|Infant Participants|Death|0|||
105650567|NCT04754594|364384115|FG001|Infant Participants|Death|0|||
105650568|NCT04754594|364384116|FG002|Infant Participants|Death|1|||
105650569|NCT04754594|364384117|FG003|Infant Participants|Death|1|||
105650570|NCT04754594|364384114|FG000|Infant Participants|Other|0|||
105650571|NCT04754594|364384115|FG001|Infant Participants|Other|0|||
105650572|NCT04754594|364384116|FG002|Infant Participants|Other|1|||
105650573|NCT04754594|364384117|FG003|Infant Participants|Other|1|||
105650574|NCT00495612|364384120|FG000|Overall Study|Lost to Follow-up|1|||
105650575|NCT00495612|364384121|FG001|Overall Study|Lost to Follow-up|0|||
105650576|NCT00495612|364384120|FG000|Overall Study|Subject's Decision to Withdraw|3|||
105650577|NCT00495612|364384121|FG001|Overall Study|Subject's Decision to Withdraw|0|||
105650578|NCT06016127|364384122|FG000|Overall Study|Withdrawal by Subject|4|||
105650579|NCT06016127|364384123|FG001|Overall Study|Withdrawal by Subject|3|||
105650580|NCT02588027|364384128|FG000|Overall Study|Withdrawal by Subject|1|||
105650581|NCT02588027|364384129|FG001|Overall Study|Withdrawal by Subject|3|||
105650582|NCT02588027|364384128|FG000|Overall Study|Protocol Violation|4|||
105650583|NCT02588027|364384129|FG001|Overall Study|Protocol Violation|1|||
105650584|NCT02849509|364384130|FG000|Overall Study|Worsening of disease under study|1|||
105650585|NCT02849509|364384131|FG001|Overall Study|Worsening of disease under study|1|||
105650586|NCT02849509|364384132|FG002|Overall Study|Worsening of disease under study|1|||
105650587|NCT02849509|364384130|FG000|Overall Study|Worsening of other pre-existing disease|0|||
105650588|NCT02849509|364384131|FG001|Overall Study|Worsening of other pre-existing disease|1|||
105650589|NCT02849509|364384132|FG002|Overall Study|Worsening of other pre-existing disease|2|||
105650590|NCT02849509|364384130|FG000|Overall Study|Other adverse event|36|||
105650591|NCT02849509|364384131|FG001|Overall Study|Other adverse event|41|||
105650592|NCT02849509|364384132|FG002|Overall Study|Other adverse event|8|||
105650593|NCT02849509|364384130|FG000|Overall Study|Withdrawal by Subject|6|||
105650594|NCT02849509|364384131|FG001|Overall Study|Withdrawal by Subject|17|||
105650595|NCT02849509|364384132|FG002|Overall Study|Withdrawal by Subject|12|||
105650596|NCT02849509|364384130|FG000|Overall Study|Lost to Follow-up|27|||
105650597|NCT02849509|364384131|FG001|Overall Study|Lost to Follow-up|67|||
105650598|NCT02849509|364384132|FG002|Overall Study|Lost to Follow-up|36|||
105650599|NCT02849509|364384130|FG000|Overall Study|Other, reason not specified|14|||
105650600|NCT02849509|364384131|FG001|Overall Study|Other, reason not specified|29|||
105650601|NCT02849509|364384132|FG002|Overall Study|Other, reason not specified|25|||
105650602|NCT02849509|364384130|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
105650603|NCT02849509|364384131|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
105650604|NCT02849509|364384132|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
105650605|NCT00975130|364384133|FG000|Study Part 1|Adverse Event|150|||
105650606|NCT00975130|364384134|FG001|Study Part 1|Adverse Event|0|||
105650607|NCT00975130|364384135|FG002|Study Part 1|Adverse Event|0|||
105650608|NCT00975130|364384133|FG000|Study Part 1|Lost to Follow-up|19|||
105650609|NCT00975130|364384134|FG001|Study Part 1|Lost to Follow-up|0|||
105650610|NCT00975130|364384135|FG002|Study Part 1|Lost to Follow-up|0|||
105650611|NCT00975130|364384133|FG000|Study Part 1|Withdrawal by Subject|61|||
105650612|NCT00975130|364384134|FG001|Study Part 1|Withdrawal by Subject|0|||
105650613|NCT00975130|364384135|FG002|Study Part 1|Withdrawal by Subject|0|||
105650614|NCT00975130|364384133|FG000|Study Part 1|Protocol Violation|13|||
105650615|NCT00975130|364384134|FG001|Study Part 1|Protocol Violation|0|||
105650616|NCT00975130|364384135|FG002|Study Part 1|Protocol Violation|0|||
105650617|NCT00975130|364384133|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
105650618|NCT00975130|364384134|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
105650619|NCT00975130|364384135|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
105650620|NCT00975130|364384133|FG000|Study Part 1|Administrative|4|||
105650621|NCT00975130|364384134|FG001|Study Part 1|Administrative|0|||
105650622|NCT00975130|364384135|FG002|Study Part 1|Administrative|0|||
105650623|NCT00975130|364384133|FG000|Study Part 1|Withdrew Consent|24|||
105650624|NCT00975130|364384134|FG001|Study Part 1|Withdrew Consent|0|||
105650625|NCT00975130|364384135|FG002|Study Part 1|Withdrew Consent|0|||
105650626|NCT00975130|364384133|FG000|Study Part 2|Adverse Event|0|||
105650627|NCT00975130|364384134|FG001|Study Part 2|Adverse Event|14|||
105650628|NCT00975130|364384135|FG002|Study Part 2|Adverse Event|7|||
105650629|NCT00975130|364384133|FG000|Study Part 2|Lost to Follow-up|0|||
105650630|NCT00975130|364384134|FG001|Study Part 2|Lost to Follow-up|0|||
105650631|NCT00975130|364384135|FG002|Study Part 2|Lost to Follow-up|1|||
105650632|NCT00975130|364384133|FG000|Study Part 2|Withdrawal by Subject|0|||
105650633|NCT00975130|364384134|FG001|Study Part 2|Withdrawal by Subject|13|||
105650634|NCT00975130|364384135|FG002|Study Part 2|Withdrawal by Subject|5|||
105650635|NCT00975130|364384133|FG000|Study Part 2|Withdrew Consent|0|||
105650636|NCT00975130|364384134|FG001|Study Part 2|Withdrew Consent|6|||
105650637|NCT00975130|364384135|FG002|Study Part 2|Withdrew Consent|2|||
105650638|NCT00975130|364384133|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
105650639|NCT00975130|364384134|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
105650640|NCT00975130|364384135|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
105650641|NCT00975130|364384133|FG000|Study Part 2|Administrative|0|||
105650642|NCT00975130|364384134|FG001|Study Part 2|Administrative|1|||
105650643|NCT00975130|364384135|FG002|Study Part 2|Administrative|0|||
105650644|NCT00975130|364384133|FG000|Study Part 2|Protocol Violation|0|||
105650645|NCT00975130|364384134|FG001|Study Part 2|Protocol Violation|0|||
105650646|NCT00975130|364384135|FG002|Study Part 2|Protocol Violation|1|||
105650647|NCT01261793|364384136|FG000|Overall Study|Lack of Efficacy|44|||
105650648|NCT01261793|364384137|FG001|Overall Study|Lack of Efficacy|37|||
105650649|NCT01261793|364384138|FG002|Overall Study|Lack of Efficacy|32|||
105650650|NCT01261793|364384136|FG000|Overall Study|Protocol Violation|3|||
105650651|NCT01261793|364384137|FG001|Overall Study|Protocol Violation|5|||
105650652|NCT01261793|364384138|FG002|Overall Study|Protocol Violation|6|||
105650653|NCT01261793|364384136|FG000|Overall Study|Lost to Follow-up|10|||
105650654|NCT01261793|364384137|FG001|Overall Study|Lost to Follow-up|3|||
105650655|NCT01261793|364384138|FG002|Overall Study|Lost to Follow-up|7|||
105650656|NCT01261793|364384136|FG000|Overall Study|Withdrawal by Subject|12|||
105650657|NCT01261793|364384137|FG001|Overall Study|Withdrawal by Subject|14|||
105650658|NCT01261793|364384138|FG002|Overall Study|Withdrawal by Subject|14|||
105650659|NCT01261793|364384136|FG000|Overall Study|Death|3|||
105650660|NCT01261793|364384137|FG001|Overall Study|Death|1|||
105650661|NCT01261793|364384138|FG002|Overall Study|Death|0|||
105650662|NCT01261793|364384136|FG000|Overall Study|Adverse Event|9|||
105650663|NCT01261793|364384137|FG001|Overall Study|Adverse Event|24|||
105650664|NCT01261793|364384138|FG002|Overall Study|Adverse Event|19|||
105650665|NCT01261793|364384136|FG000|Overall Study|Patient non-availability|1|||
105650666|NCT01261793|364384137|FG001|Overall Study|Patient non-availability|1|||
105650667|NCT01261793|364384138|FG002|Overall Study|Patient non-availability|1|||
105650668|NCT01261793|364384136|FG000|Overall Study|Suspected pregnancy|1|||
105650669|NCT01261793|364384137|FG001|Overall Study|Suspected pregnancy|1|||
105650670|NCT01261793|364384138|FG002|Overall Study|Suspected pregnancy|0|||
105650671|NCT01261793|364384136|FG000|Overall Study|Patient non-compliance|1|||
105650672|NCT01261793|364384137|FG001|Overall Study|Patient non-compliance|0|||
105650673|NCT01261793|364384138|FG002|Overall Study|Patient non-compliance|1|||
105650674|NCT01261793|364384136|FG000|Overall Study|Patient pregnant|1|||
105650675|NCT01261793|364384137|FG001|Overall Study|Patient pregnant|0|||
105650676|NCT01261793|364384138|FG002|Overall Study|Patient pregnant|0|||
105650677|NCT01261793|364384136|FG000|Overall Study|Outside the study area|0|||
105650678|NCT01261793|364384137|FG001|Overall Study|Outside the study area|2|||
105650679|NCT01261793|364384138|FG002|Overall Study|Outside the study area|1|||
105650680|NCT01261793|364384136|FG000|Overall Study|Lack of efficacy & patient not available|0|||
105650681|NCT01261793|364384137|FG001|Overall Study|Lack of efficacy & patient not available|1|||
105650682|NCT01261793|364384138|FG002|Overall Study|Lack of efficacy & patient not available|0|||
105650683|NCT01261793|364384136|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
105650684|NCT01261793|364384137|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
105650685|NCT01261793|364384138|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
105650686|NCT01261793|364384136|FG000|Overall Study|Randomization error|0|||
105650687|NCT01261793|364384137|FG001|Overall Study|Randomization error|1|||
105650688|NCT01261793|364384138|FG002|Overall Study|Randomization error|0|||
105650689|NCT01261793|364384136|FG000|Overall Study|Patient unable to start IV line|0|||
105650690|NCT01261793|364384137|FG001|Overall Study|Patient unable to start IV line|0|||
105650691|NCT01261793|364384138|FG002|Overall Study|Patient unable to start IV line|1|||
105650692|NCT00577096|364384139|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
105650693|NCT00577096|364384140|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
105650694|NCT00577096|364384139|FG000|Short Term Participation|Withdrawal by Subject|3|||
105650695|NCT00577096|364384140|FG001|Short Term Participation|Withdrawal by Subject|5|||
105650696|NCT00577096|364384139|FG000|Short Term Participation|Death|1|||
105650697|NCT00577096|364384140|FG001|Short Term Participation|Death|1|||
105650698|NCT00734851|364384141|FG000|Overall Study|Withdrawal by Subject|2|||
105650699|NCT00734851|364384141|FG000|Overall Study|Lost to Follow-up|1|||
105650700|NCT00734851|364384141|FG000|Overall Study|Physician Decision|18|||
105650701|NCT01770509|364384142|FG000|Overall Study|Injury|0|||
105650702|NCT01770509|364384143|FG001|Overall Study|Injury|1|||
105650703|NCT01770509|364384142|FG000|Overall Study|Lost to Follow-up|1|||
105650704|NCT01770509|364384143|FG001|Overall Study|Lost to Follow-up|2|||
105650705|NCT00818519|364384144|FG000|Overall Study|Adverse Event|2|||
105650706|NCT00818519|364384145|FG001|Overall Study|Adverse Event|2|||
105650707|NCT00818519|364384144|FG000|Overall Study|Lost to Follow-up|4|||
105650708|NCT00818519|364384145|FG001|Overall Study|Lost to Follow-up|6|||
105650709|NCT00818519|364384144|FG000|Overall Study|Protocol Violation|2|||
105650710|NCT00818519|364384145|FG001|Overall Study|Protocol Violation|1|||
105650711|NCT00818519|364384144|FG000|Overall Study|Pregnancy|0|||
105650712|NCT00818519|364384145|FG001|Overall Study|Pregnancy|1|||
105650713|NCT00818519|364384144|FG000|Overall Study|Withdrawal by Subject|4|||
105650714|NCT00818519|364384145|FG001|Overall Study|Withdrawal by Subject|9|||
105650715|NCT00818519|364384144|FG000|Overall Study|participant recovered completely|1|||
105650716|NCT00818519|364384145|FG001|Overall Study|participant recovered completely|0|||
105650717|NCT00818519|364384144|FG000|Overall Study|participant will leave for long tme|1|||
105650718|NCT00818519|364384145|FG001|Overall Study|participant will leave for long tme|0|||
105650719|NCT00832650|364384149|FG000|Overall Study|Randomized but not treated|0|||
105650720|NCT00832650|364384150|FG001|Overall Study|Randomized but not treated|0|||
105650721|NCT00832650|364384151|FG002|Overall Study|Randomized but not treated|1|||
105650722|NCT01196741|364384157|FG000|Overall Study|Disease progression|34|||
105650723|NCT01196741|364384158|FG001|Overall Study|Disease progression|14|||
105650724|NCT01196741|364384157|FG000|Overall Study|Adverse Event|10|||
105650725|NCT01196741|364384158|FG001|Overall Study|Adverse Event|6|||
105650726|NCT01196741|364384157|FG000|Overall Study|Serious Adverse Event|3|||
105650727|NCT01196741|364384158|FG001|Overall Study|Serious Adverse Event|1|||
105650728|NCT01196741|364384157|FG000|Overall Study|Dose limiting Adverse Event|2|||
105650729|NCT01196741|364384158|FG001|Overall Study|Dose limiting Adverse Event|1|||
105650730|NCT01196741|364384157|FG000|Overall Study|Withdrawal by Subject|3|||
105650731|NCT01196741|364384158|FG001|Overall Study|Withdrawal by Subject|0|||
105650732|NCT01196741|364384157|FG000|Overall Study|Other reason|3|||
105650733|NCT01196741|364384158|FG001|Overall Study|Other reason|3|||
105650734|NCT01196741|364384157|FG000|Overall Study|Other|3|||
105650735|NCT01196741|364384158|FG001|Overall Study|Other|2|||
105650736|NCT01196741|364384157|FG000|Overall Study|Protocol Violation|2|||
105650737|NCT01196741|364384158|FG001|Overall Study|Protocol Violation|1|||
105650738|NCT03562117|364384161|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
105650739|NCT03562117|364384162|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
105650740|NCT03562117|364384163|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
105650741|NCT01294358|364384164|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
105650742|NCT01294358|364384165|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
105650743|NCT01294358|364384166|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
105650744|NCT01294358|364384167|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
105650745|NCT01294358|364384168|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
105650746|NCT01294358|364384164|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
105650747|NCT01294358|364384165|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
105650748|NCT01294358|364384166|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
105650749|NCT01294358|364384167|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
105650750|NCT01294358|364384168|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
105650751|NCT01294358|364384164|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
105650752|NCT01294358|364384165|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
105650753|NCT01294358|364384166|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
105650754|NCT01294358|364384167|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
105650755|NCT01294358|364384168|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
105650756|NCT01294358|364384164|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
105650757|NCT01294358|364384165|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
105650758|NCT01294358|364384166|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
105650759|NCT01294358|364384167|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
105650760|NCT01294358|364384168|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
105650761|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
105650762|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
105650763|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
105650764|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Other|1|||
105650765|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Other|0|||
105650766|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Other|0|||
105650767|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Physician Decision|3|||
105650768|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Physician Decision|0|||
105650769|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Physician Decision|0|||
105650770|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
105650771|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
105650772|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
105650773|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
105650774|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
105650775|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
105650776|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Adverse Event|18|||
105650777|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Adverse Event|0|||
105650778|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Adverse Event|0|||
105650779|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
105650780|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
105650781|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
105650782|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
105650783|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
105650784|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
105650785|NCT03030599|364384169|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
105650786|NCT03030599|364384170|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
105650787|NCT03030599|364384171|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
105650788|NCT03030599|364384169|FG000|Stable Dose|Protocol deviation|3|||
105650789|NCT03030599|364384170|FG001|Stable Dose|Protocol deviation|0|||
105650790|NCT03030599|364384171|FG002|Stable Dose|Protocol deviation|0|||
105650791|NCT03030599|364384169|FG000|Stable Dose|Adverse Event|1|||
105650792|NCT03030599|364384170|FG001|Stable Dose|Adverse Event|0|||
105650793|NCT03030599|364384171|FG002|Stable Dose|Adverse Event|0|||
105650794|NCT03030599|364384169|FG000|Stable Dose|Lost to Follow-up|1|||
105650795|NCT03030599|364384170|FG001|Stable Dose|Lost to Follow-up|0|||
105650796|NCT03030599|364384171|FG002|Stable Dose|Lost to Follow-up|0|||
105650797|NCT03030599|364384169|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
105650798|NCT03030599|364384170|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
105650799|NCT03030599|364384171|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
105650800|NCT03030599|364384169|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
105650801|NCT03030599|364384170|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
105650802|NCT03030599|364384171|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
105650803|NCT03030599|364384169|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
105650804|NCT03030599|364384170|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
105650805|NCT03030599|364384171|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
105650806|NCT03030599|364384169|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
105650807|NCT03030599|364384170|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
105650808|NCT03030599|364384171|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
105650809|NCT03030599|364384169|FG000|Open-label Extension|Adverse Event|3|||
105650810|NCT03030599|364384170|FG001|Open-label Extension|Adverse Event|0|||
105650811|NCT03030599|364384171|FG002|Open-label Extension|Adverse Event|0|||
105650812|NCT03030599|364384169|FG000|Open-label Extension|Lost to Follow-up|2|||
105650813|NCT03030599|364384170|FG001|Open-label Extension|Lost to Follow-up|0|||
105650814|NCT03030599|364384171|FG002|Open-label Extension|Lost to Follow-up|0|||
105650815|NCT03030599|364384169|FG000|Open-label Extension|Lack of Efficacy|1|||
105650816|NCT03030599|364384170|FG001|Open-label Extension|Lack of Efficacy|0|||
105650817|NCT03030599|364384171|FG002|Open-label Extension|Lack of Efficacy|0|||
105650818|NCT03030599|364384169|FG000|Open-label Extension|Other Reason|1|||
105650819|NCT03030599|364384170|FG001|Open-label Extension|Other Reason|0|||
105650820|NCT03030599|364384171|FG002|Open-label Extension|Other Reason|0|||
105650821|NCT03356145|364384172|FG000|Overall Study|Withdrawal by Subject|2|||
105650822|NCT03356145|364384173|FG001|Overall Study|Withdrawal by Subject|1|||
105650823|NCT03356145|364384172|FG000|Overall Study|Did not meet inclusion criteria|1|||
105650824|NCT03356145|364384173|FG001|Overall Study|Did not meet inclusion criteria|0|||
105650825|NCT03613454|364384174|FG000|Overall Study|Protocol Violation|1|||
105650826|NCT03613454|364384175|FG001|Overall Study|Protocol Violation|0|||
105650827|NCT03613454|364384174|FG000|Overall Study|Protocol Violation|0|||
105650828|NCT03613454|364384175|FG001|Overall Study|Protocol Violation|1|||
105650829|NCT02963922|364384176|FG000|Overall Study|Adverse Event|15|||
105650830|NCT02963922|364384177|FG001|Overall Study|Adverse Event|6|||
105650831|NCT02963922|364384176|FG000|Overall Study|Protocol deviation|6|||
105650832|NCT02963922|364384177|FG001|Overall Study|Protocol deviation|6|||
105650833|NCT02963922|364384176|FG000|Overall Study|Lack of Efficacy|1|||
105650834|NCT02963922|364384177|FG001|Overall Study|Lack of Efficacy|1|||
105650835|NCT02963922|364384176|FG000|Overall Study|Lost to Follow-up|2|||
105650836|NCT02963922|364384177|FG001|Overall Study|Lost to Follow-up|3|||
105650837|NCT02963922|364384176|FG000|Overall Study|Other|8|||
105650838|NCT02963922|364384177|FG001|Overall Study|Other|14|||
105650839|NCT00655668|364384196|FG000|Overall Study|Adverse Event|6|||
105650840|NCT00655668|364384196|FG000|Overall Study|Death|5|||
105650841|NCT00655668|364384196|FG000|Overall Study|Disease Progression|27|||
105650842|NCT00655668|364384196|FG000|Overall Study|Study Terminated|9|||
105650843|NCT00655668|364384196|FG000|Overall Study|Other|1|||
105650844|NCT00655668|364384196|FG000|Overall Study|New Lymphoma Treatment Started|4|||
105650845|NCT00655668|364384196|FG000|Overall Study|Withdrawal by Subject|2|||
105650846|NCT03740919|364384197|FG000|Lead-in Period|Lost to Follow-up|1|||
105650847|NCT03740919|364384198|FG001|Lead-in Period|Lost to Follow-up|0|||
105650848|NCT03740919|364384199|FG002|Lead-in Period|Lost to Follow-up|0|||
105650849|NCT03740919|364384200|FG003|Lead-in Period|Lost to Follow-up|0|||
105650850|NCT03740919|364384197|FG000|Lead-in Period|Physician Decision|2|||
105650851|NCT03740919|364384198|FG001|Lead-in Period|Physician Decision|0|||
105650852|NCT03740919|364384199|FG002|Lead-in Period|Physician Decision|0|||
105650853|NCT03740919|364384200|FG003|Lead-in Period|Physician Decision|0|||
105650854|NCT03740919|364384197|FG000|Lead-in Period|Protocol Violation|1|||
105650855|NCT03740919|364384198|FG001|Lead-in Period|Protocol Violation|0|||
105650856|NCT03740919|364384199|FG002|Lead-in Period|Protocol Violation|0|||
105650857|NCT03740919|364384200|FG003|Lead-in Period|Protocol Violation|0|||
105650858|NCT03740919|364384197|FG000|Lead-in Period|Withdrawal by Subject|10|||
105650859|NCT03740919|364384198|FG001|Lead-in Period|Withdrawal by Subject|0|||
105650860|NCT03740919|364384199|FG002|Lead-in Period|Withdrawal by Subject|0|||
105650861|NCT03740919|364384200|FG003|Lead-in Period|Withdrawal by Subject|0|||
105650862|NCT03740919|364384197|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
105650863|NCT03740919|364384198|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
105650864|NCT03740919|364384199|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
105650865|NCT03740919|364384200|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
105650866|NCT03740919|364384197|FG000|Lead-in Period|Study Task Too Burdensome|1|||
105650867|NCT03740919|364384198|FG001|Lead-in Period|Study Task Too Burdensome|0|||
105650868|NCT03740919|364384199|FG002|Lead-in Period|Study Task Too Burdensome|0|||
105650869|NCT03740919|364384200|FG003|Lead-in Period|Study Task Too Burdensome|0|||
105650870|NCT03740919|364384197|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
105650871|NCT03740919|364384198|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
105650872|NCT03740919|364384199|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
105650873|NCT03740919|364384200|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
105650874|NCT03740919|364384197|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
105650875|NCT03740919|364384198|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
105650876|NCT03740919|364384199|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
105650877|NCT03740919|364384200|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
105650878|NCT03740919|364384197|FG000|Treatment Period|Adverse Event|0|||
105650879|NCT03740919|364384198|FG001|Treatment Period|Adverse Event|0|||
105650880|NCT03740919|364384199|FG002|Treatment Period|Adverse Event|2|||
105650881|NCT03740919|364384200|FG003|Treatment Period|Adverse Event|0|||
105650882|NCT03740919|364384197|FG000|Treatment Period|Protocol Violation|0|||
105650883|NCT03740919|364384198|FG001|Treatment Period|Protocol Violation|1|||
105650884|NCT03740919|364384199|FG002|Treatment Period|Protocol Violation|0|||
105650885|NCT03740919|364384200|FG003|Treatment Period|Protocol Violation|0|||
105650886|NCT03740919|364384197|FG000|Treatment Period|Withdrawal by Subject|0|||
105650887|NCT03740919|364384198|FG001|Treatment Period|Withdrawal by Subject|7|||
105650888|NCT03740919|364384199|FG002|Treatment Period|Withdrawal by Subject|6|||
105650889|NCT03740919|364384200|FG003|Treatment Period|Withdrawal by Subject|2|||
105650890|NCT03740919|364384197|FG000|Treatment Period|Terminated by Sponsor|0|||
105650891|NCT03740919|364384198|FG001|Treatment Period|Terminated by Sponsor|1|||
105650892|NCT03740919|364384199|FG002|Treatment Period|Terminated by Sponsor|0|||
105650893|NCT03740919|364384200|FG003|Treatment Period|Terminated by Sponsor|0|||
105650894|NCT03740919|364384197|FG000|Treatment Period|Issue with Insulin Pump|0|||
105650895|NCT03740919|364384198|FG001|Treatment Period|Issue with Insulin Pump|1|||
105650896|NCT03740919|364384199|FG002|Treatment Period|Issue with Insulin Pump|0|||
105650897|NCT03740919|364384200|FG003|Treatment Period|Issue with Insulin Pump|0|||
105650898|NCT03740919|364384197|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
105650899|NCT03740919|364384198|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
105650900|NCT03740919|364384199|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
105650901|NCT03740919|364384200|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
105650902|NCT03740919|364384197|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
105650903|NCT03740919|364384198|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
105650904|NCT03740919|364384199|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
105650905|NCT03740919|364384200|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
105650906|NCT03740919|364384197|FG000|Treatment Period|Not Completing Diary|0|||
105650907|NCT03740919|364384198|FG001|Treatment Period|Not Completing Diary|0|||
105650908|NCT03740919|364384199|FG002|Treatment Period|Not Completing Diary|1|||
105650909|NCT03740919|364384200|FG003|Treatment Period|Not Completing Diary|0|||
105650910|NCT03740919|364384197|FG000|Treatment Period|Insulin Painful to Participant|0|||
105650911|NCT03740919|364384198|FG001|Treatment Period|Insulin Painful to Participant|0|||
105650912|NCT03740919|364384199|FG002|Treatment Period|Insulin Painful to Participant|1|||
105650913|NCT03740919|364384200|FG003|Treatment Period|Insulin Painful to Participant|0|||
105650914|NCT04222088|364384204|FG000|Overall Study|Lost to Follow-up|5|||
105650915|NCT04222088|364384205|FG001|Overall Study|Lost to Follow-up|1|||
105650916|NCT04222088|364384204|FG000|Overall Study|Withdrawal by Subject|4|||
105650917|NCT04222088|364384205|FG001|Overall Study|Withdrawal by Subject|0|||
105650918|NCT00595764|364384206|FG000|Overall Study|Protocol Violation|24|||
105650919|NCT00595764|364384207|FG001|Overall Study|Protocol Violation|19|||
105650920|NCT00595764|364384206|FG000|Overall Study|Missed Medication >1 week|10|||
105650921|NCT00595764|364384207|FG001|Overall Study|Missed Medication >1 week|17|||
105650922|NCT00595764|364384206|FG000|Overall Study|Missed 3 PM visits|1|||
105650923|NCT00595764|364384207|FG001|Overall Study|Missed 3 PM visits|7|||
105650924|NCT00595764|364384206|FG000|Overall Study|Withdrawal by Subject|4|||
105650925|NCT00595764|364384207|FG001|Overall Study|Withdrawal by Subject|0|||
105650926|NCT01071317|364384208|FG000|Overall Study|Lost to Follow-up|2|||
105650927|NCT01071317|364384209|FG001|Overall Study|Lost to Follow-up|2|||
105650928|NCT02418819|364384210|FG000|Overall Study|Adverse Event|0|||
105650929|NCT02418819|364384211|FG001|Overall Study|Adverse Event|0|||
105650930|NCT02418819|364384212|FG002|Overall Study|Adverse Event|1|||
105650931|NCT02418819|364384213|FG003|Overall Study|Adverse Event|0|||
105650932|NCT02418819|364384210|FG000|Overall Study|Lost to Follow-up|1|||
105650933|NCT02418819|364384211|FG001|Overall Study|Lost to Follow-up|0|||
105650934|NCT02418819|364384212|FG002|Overall Study|Lost to Follow-up|0|||
105650935|NCT02418819|364384213|FG003|Overall Study|Lost to Follow-up|0|||
105650936|NCT02418819|364384210|FG000|Overall Study|No longer meets eligibility criteria|0|||
105650937|NCT02418819|364384211|FG001|Overall Study|No longer meets eligibility criteria|0|||
105650938|NCT02418819|364384212|FG002|Overall Study|No longer meets eligibility criteria|1|||
105650939|NCT02418819|364384213|FG003|Overall Study|No longer meets eligibility criteria|0|||
105650940|NCT02418819|364384210|FG000|Overall Study|No longer willing to participate|0|||
105650941|NCT02418819|364384211|FG001|Overall Study|No longer willing to participate|0|||
105650942|NCT02418819|364384212|FG002|Overall Study|No longer willing to participate|2|||
105650943|NCT02418819|364384213|FG003|Overall Study|No longer willing to participate|1|||
105650944|NCT04743999|364384217|FG000|3-month Questionnaire|Death|1|||
105650945|NCT04743999|364384217|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
105650946|NCT04743999|364384217|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
105650947|NCT04743999|364384217|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
105650948|NCT01721759|364384218|FG000|Treatment Period|Disease Progression|85|||
105650949|NCT01721759|364384218|FG000|Treatment Period|Study drug toxicity|14|||
105650950|NCT01721759|364384218|FG000|Treatment Period|Death|1|||
105650951|NCT01721759|364384218|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
105650952|NCT01721759|364384218|FG000|Treatment Period|Participant request to withdraw|3|||
105650953|NCT01721759|364384218|FG000|Treatment Period|Other Reasons|3|||
105650954|NCT01721759|364384218|FG000|End of Study Period|Participant Withdrew Consent|5|||
105650955|NCT01721759|364384218|FG000|End of Study Period|Death|101|||
105650956|NCT01721759|364384218|FG000|End of Study Period|Lost to Follow-up|1|||
105650957|NCT01721759|364384218|FG000|End of Study Period|Other Reasons|10|||
105650958|NCT00464737|364384219|FG000|Overall Study|Adverse Event|12|||
105650959|NCT00464737|364384220|FG001|Overall Study|Adverse Event|17|||
105650960|NCT00464737|364384221|FG002|Overall Study|Adverse Event|33|||
105650961|NCT00464737|364384219|FG000|Overall Study|Lack of Efficacy|7|||
105650962|NCT00464737|364384220|FG001|Overall Study|Lack of Efficacy|7|||
105650963|NCT00464737|364384221|FG002|Overall Study|Lack of Efficacy|4|||
105650964|NCT00464737|364384219|FG000|Overall Study|Withdrawal by Subject|5|||
105650965|NCT00464737|364384220|FG001|Overall Study|Withdrawal by Subject|3|||
105650966|NCT00464737|364384221|FG002|Overall Study|Withdrawal by Subject|5|||
105650967|NCT00464737|364384219|FG000|Overall Study|Protocol Violation|1|||
105650968|NCT00464737|364384220|FG001|Overall Study|Protocol Violation|1|||
105650969|NCT00464737|364384221|FG002|Overall Study|Protocol Violation|5|||
105650970|NCT00464737|364384219|FG000|Overall Study|Non-compliance|0|||
105650971|NCT00464737|364384220|FG001|Overall Study|Non-compliance|1|||
105650972|NCT00464737|364384221|FG002|Overall Study|Non-compliance|1|||
105650973|NCT00464737|364384219|FG000|Overall Study|Lost to Follow-up|5|||
105650974|NCT00464737|364384220|FG001|Overall Study|Lost to Follow-up|2|||
105650975|NCT00464737|364384221|FG002|Overall Study|Lost to Follow-up|5|||
105650976|NCT00464737|364384219|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
105650977|NCT00464737|364384220|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
105650978|NCT00464737|364384221|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
105650979|NCT00464737|364384219|FG000|Overall Study|Other: Subject left town; family illness|1|||
105650980|NCT00464737|364384220|FG001|Overall Study|Other: Subject left town; family illness|0|||
105650981|NCT00464737|364384221|FG002|Overall Study|Other: Subject left town; family illness|0|||
105650982|NCT00464737|364384219|FG000|Overall Study|Other: Study demands too great|0|||
105650983|NCT00464737|364384220|FG001|Overall Study|Other: Study demands too great|1|||
105650984|NCT00464737|364384221|FG002|Overall Study|Other: Study demands too great|0|||
105650985|NCT00464737|364384219|FG000|Overall Study|Other: Personal family reasons|0|||
105650986|NCT00464737|364384220|FG001|Overall Study|Other: Personal family reasons|0|||
105650987|NCT00464737|364384221|FG002|Overall Study|Other: Personal family reasons|1|||
105650988|NCT00464737|364384219|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
105650989|NCT00464737|364384220|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
105650990|NCT00464737|364384221|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
105650991|NCT00580047|364384226|FG000|Overall Study|Lost to Follow-up|1|||
105650992|NCT00580047|364384227|FG001|Overall Study|Lost to Follow-up|1|||
105650993|NCT00580047|364384228|FG002|Overall Study|Lost to Follow-up|0|||
105650994|NCT00580047|364384226|FG000|Overall Study|Withdrawal by Subject|1|||
105650995|NCT00580047|364384227|FG001|Overall Study|Withdrawal by Subject|1|||
105650996|NCT00580047|364384228|FG002|Overall Study|Withdrawal by Subject|2|||
105650997|NCT00580047|364384226|FG000|Overall Study|Withdrawal by Subject|1|||
105650998|NCT00580047|364384227|FG001|Overall Study|Withdrawal by Subject|0|||
105650999|NCT00580047|364384228|FG002|Overall Study|Withdrawal by Subject|0|||
105651000|NCT01894256|364384229|FG000|Part A|Adverse Event|0|||
105651001|NCT01894256|364384230|FG001|Part A|Adverse Event|1|||
105651002|NCT01894256|364384231|FG002|Part A|Adverse Event|0|||
105651003|NCT01894256|364384229|FG000|Part B|Death|0|||
105651004|NCT01894256|364384230|FG001|Part B|Death|1|||
105651005|NCT01894256|364384231|FG002|Part B|Death|1|||
105651006|NCT01894256|364384229|FG000|Part B|Withdrawal by Subject|0|||
105651007|NCT01894256|364384230|FG001|Part B|Withdrawal by Subject|1|||
105651008|NCT01894256|364384231|FG002|Part B|Withdrawal by Subject|0|||
105651009|NCT01894256|364384229|FG000|Part B|Lack of Efficacy|15|||
105651010|NCT01894256|364384230|FG001|Part B|Lack of Efficacy|12|||
105651011|NCT01894256|364384231|FG002|Part B|Lack of Efficacy|13|||
105651012|NCT03640754|364384232|FG000|Overall Study|Withdrawal by Subject|1|||
105651013|NCT03640754|364384233|FG001|Overall Study|Withdrawal by Subject|0|||
105651014|NCT03640754|364384232|FG000|Overall Study|Lost to Follow-up|0|||
105651015|NCT03640754|364384233|FG001|Overall Study|Lost to Follow-up|1|||
105651016|NCT03993054|364384241|FG000|Overall Study|PI Decision|1|||
105651017|NCT01002547|364385719|FG000|Overall Study|Withdrawal by Subject|4|||
105651018|NCT01002547|364385720|FG001|Overall Study|Withdrawal by Subject|0|||
105651019|NCT01002547|364385721|FG002|Overall Study|Withdrawal by Subject|5|||
105651020|NCT01002547|364385719|FG000|Overall Study|Lost to Follow-up|2|||
105651021|NCT01002547|364385720|FG001|Overall Study|Lost to Follow-up|1|||
105651022|NCT01002547|364385721|FG002|Overall Study|Lost to Follow-up|1|||
105651023|NCT01002547|364385719|FG000|Overall Study|Physician Decision|1|||
105651024|NCT01002547|364385720|FG001|Overall Study|Physician Decision|0|||
105651025|NCT01002547|364385721|FG002|Overall Study|Physician Decision|0|||
105651026|NCT01002547|364385719|FG000|Overall Study|Death|0|||
105651027|NCT01002547|364385720|FG001|Overall Study|Death|2|||
105651028|NCT01002547|364385721|FG002|Overall Study|Death|2|||
105651029|NCT01002547|364385719|FG000|Overall Study|Adverse Event|1|||
105651030|NCT01002547|364385720|FG001|Overall Study|Adverse Event|0|||
105651031|NCT01002547|364385721|FG002|Overall Study|Adverse Event|0|||
105651032|NCT00705614|364385728|FG000|Initial Intervention|Adverse Event|40|||
105651033|NCT00705614|364385729|FG001|Initial Intervention|Adverse Event|21|||
105651034|NCT00705614|364385728|FG000|Initial Intervention|Lost to Follow-up|310|||
105651035|NCT00705614|364385729|FG001|Initial Intervention|Lost to Follow-up|191|||
105651036|NCT00705614|364385728|FG000|Initial Intervention|Withdrawal by Subject|114|||
105651037|NCT00705614|364385729|FG001|Initial Intervention|Withdrawal by Subject|71|||
105651038|NCT00705614|364385728|FG000|Initial Intervention|Administrative Reason|51|||
105651039|NCT00705614|364385729|FG001|Initial Intervention|Administrative Reason|38|||
105651040|NCT00705614|364385728|FG000|Initial Intervention|Status completion unknown|3|||
105651041|NCT00705614|364385729|FG001|Initial Intervention|Status completion unknown|0|||
105651042|NCT00705614|364385728|FG000|Switch to Remicade|Adverse Event|0|||
105651043|NCT00705614|364385729|FG001|Switch to Remicade|Adverse Event|5|||
105651044|NCT00705614|364385728|FG000|Switch to Remicade|Lost to Follow-up|0|||
105651045|NCT00705614|364385729|FG001|Switch to Remicade|Lost to Follow-up|23|||
105651046|NCT00705614|364385728|FG000|Switch to Remicade|Withdrawal by Subject|0|||
105651047|NCT00705614|364385729|FG001|Switch to Remicade|Withdrawal by Subject|12|||
105651048|NCT00705614|364385728|FG000|Switch to Remicade|Administrative Reason|0|||
105651049|NCT00705614|364385729|FG001|Switch to Remicade|Administrative Reason|9|||
105651050|NCT00676195|364385730|FG000|Overall Study|Lost to Follow-up|1|||
105651051|NCT00676195|364385730|FG000|Overall Study|Adverse Event|1|||
105651052|NCT00676195|364385730|FG000|Overall Study|Physician Decision|1|||
105651053|NCT00925288|364385731|FG000|Overall Study|Lost to Follow-up|9|||
105651054|NCT00925288|364385732|FG001|Overall Study|Lost to Follow-up|7|||
105651055|NCT02093897|364385733|FG000|Overall Study|Physician Decision|1|||
105651056|NCT02093897|364385733|FG000|Overall Study|Planned age group closure - no's reached|17|||
105651057|NCT02093897|364385733|FG000|Overall Study|Adverse event, non-fatal|1|||
105651058|NCT00088452|364385734|FG000|Overall Study|Did not receive intervention|1|||
105651059|NCT00088452|364385735|FG001|Overall Study|Did not receive intervention|0|||
105651060|NCT00088452|364385736|FG002|Overall Study|Did not receive intervention|1|||
105651061|NCT01232569|364385739|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
105651062|NCT01232569|364385740|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
105651063|NCT01232569|364385741|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
105651064|NCT01232569|364385742|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
105651065|NCT01232569|364385739|FG000|Double-blind Treatment Period|Escape|2|||
105651066|NCT01232569|364385740|FG001|Double-blind Treatment Period|Escape|2|||
105651067|NCT01232569|364385741|FG002|Double-blind Treatment Period|Escape|0|||
105651068|NCT01232569|364385742|FG003|Double-blind Treatment Period|Escape|0|||
105651069|NCT01232569|364385739|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
105651070|NCT01232569|364385740|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
105651071|NCT01232569|364385741|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
105651072|NCT01232569|364385742|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
105651073|NCT01232569|364385739|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
105651074|NCT01232569|364385740|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
105651075|NCT01232569|364385741|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
105651076|NCT01232569|364385742|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
105651077|NCT01232569|364385739|FG000|Double-blind Treatment Period|Physician Decision|1|||
105651078|NCT01232569|364385740|FG001|Double-blind Treatment Period|Physician Decision|0|||
105651079|NCT01232569|364385741|FG002|Double-blind Treatment Period|Physician Decision|0|||
105651080|NCT01232569|364385742|FG003|Double-blind Treatment Period|Physician Decision|0|||
105651081|NCT01232569|364385739|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
105651082|NCT01232569|364385740|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
105651083|NCT01232569|364385741|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
105651084|NCT01232569|364385742|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
105651085|NCT01232569|364385739|FG000|Double-blind Treatment Period|Death|2|||
105651086|NCT01232569|364385740|FG001|Double-blind Treatment Period|Death|0|||
105651087|NCT01232569|364385741|FG002|Double-blind Treatment Period|Death|0|||
105651088|NCT01232569|364385742|FG003|Double-blind Treatment Period|Death|0|||
105651089|NCT03675308|364385743|FG000|Overall Study|Adverse Event|3|||
105651090|NCT03675308|364385744|FG001|Overall Study|Adverse Event|2|||
105651091|NCT03675308|364385743|FG000|Overall Study|Withdrawal by Subject|6|||
105651092|NCT03675308|364385744|FG001|Overall Study|Withdrawal by Subject|4|||
105651093|NCT03675308|364385743|FG000|Overall Study|Lost to Follow-up|3|||
105651094|NCT03675308|364385744|FG001|Overall Study|Lost to Follow-up|0|||
105651095|NCT03675308|364385743|FG000|Overall Study|Lack of Efficacy|1|||
105651096|NCT03675308|364385744|FG001|Overall Study|Lack of Efficacy|1|||
105651097|NCT03675308|364385743|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
105651098|NCT03675308|364385744|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
105651099|NCT03675308|364385743|FG000|Overall Study|Other|0|||
105651100|NCT03675308|364385744|FG001|Overall Study|Other|1|||
105651101|NCT00814632|364385745|FG000|Overall Study|Lack of Efficacy|2|||
105651102|NCT04816708|364385753|FG000|Overall Study|Lost to Follow-up|10|||
105651103|NCT04816708|364385754|FG001|Overall Study|Lost to Follow-up|4|||
105651104|NCT00111839|364385760|FG000|Overall Study|Disease Progression|30|||
105651105|NCT00111839|364385761|FG001|Overall Study|Disease Progression|33|||
105651106|NCT00111839|364385762|FG002|Overall Study|Disease Progression|33|||
105651107|NCT00111839|364385760|FG000|Overall Study|Adverse Event|5|||
105651108|NCT00111839|364385761|FG001|Overall Study|Adverse Event|3|||
105651109|NCT00111839|364385762|FG002|Overall Study|Adverse Event|1|||
105651110|NCT00111839|364385760|FG000|Overall Study|Protocol Violation|2|||
105651111|NCT00111839|364385761|FG001|Overall Study|Protocol Violation|4|||
105651112|NCT00111839|364385762|FG002|Overall Study|Protocol Violation|2|||
105651113|NCT00111839|364385760|FG000|Overall Study|Death|1|||
105651114|NCT00111839|364385761|FG001|Overall Study|Death|1|||
105651115|NCT00111839|364385762|FG002|Overall Study|Death|6|||
105651116|NCT00111839|364385760|FG000|Overall Study|Withdrawal by Subject|2|||
105651117|NCT00111839|364385761|FG001|Overall Study|Withdrawal by Subject|2|||
105651118|NCT00111839|364385762|FG002|Overall Study|Withdrawal by Subject|2|||
105651119|NCT00111839|364385760|FG000|Overall Study|Lost to Follow-up|1|||
105651120|NCT00111839|364385761|FG001|Overall Study|Lost to Follow-up|0|||
105651121|NCT00111839|364385762|FG002|Overall Study|Lost to Follow-up|0|||
105651122|NCT00111839|364385760|FG000|Overall Study|Logistical Constraint|1|||
105651123|NCT00111839|364385761|FG001|Overall Study|Logistical Constraint|0|||
105651124|NCT00111839|364385762|FG002|Overall Study|Logistical Constraint|0|||
105651125|NCT00111839|364385760|FG000|Overall Study|Other|6|||
105651126|NCT00111839|364385761|FG001|Overall Study|Other|3|||
105651127|NCT00111839|364385762|FG002|Overall Study|Other|3|||
105651128|NCT00111839|364385760|FG000|Overall Study|Randomized but Not Treated|0|||
105651129|NCT00111839|364385761|FG001|Overall Study|Randomized but Not Treated|0|||
105651130|NCT00111839|364385762|FG002|Overall Study|Randomized but Not Treated|2|||
105651131|NCT02123797|364385765|FG000|Baseline Intervention|Death|9|||
105651132|NCT02123797|364385766|FG001|Baseline Intervention|Death|16|||
105651133|NCT02123797|364385767|FG002|Baseline Intervention|Death|0|||
105651134|NCT02123797|364385768|FG003|Baseline Intervention|Death|0|||
105651135|NCT02123797|364385769|FG004|Baseline Intervention|Death|0|||
105651136|NCT02123797|364385765|FG000|Baseline Intervention|Withdrawal by Subject|2|||
105651137|NCT02123797|364385766|FG001|Baseline Intervention|Withdrawal by Subject|8|||
105651138|NCT02123797|364385767|FG002|Baseline Intervention|Withdrawal by Subject|0|||
105651139|NCT02123797|364385768|FG003|Baseline Intervention|Withdrawal by Subject|0|||
105651140|NCT02123797|364385769|FG004|Baseline Intervention|Withdrawal by Subject|0|||
105651141|NCT02123797|364385765|FG000|Baseline Intervention|Relocation|2|||
105651142|NCT02123797|364385766|FG001|Baseline Intervention|Relocation|0|||
105651143|NCT02123797|364385767|FG002|Baseline Intervention|Relocation|0|||
105651144|NCT02123797|364385768|FG003|Baseline Intervention|Relocation|0|||
105651145|NCT02123797|364385769|FG004|Baseline Intervention|Relocation|0|||
105651146|NCT02123797|364385765|FG000|Baseline Intervention|Out of window for initial survey|6|||
105651147|NCT02123797|364385766|FG001|Baseline Intervention|Out of window for initial survey|13|||
105651148|NCT02123797|364385767|FG002|Baseline Intervention|Out of window for initial survey|0|||
105651149|NCT02123797|364385768|FG003|Baseline Intervention|Out of window for initial survey|0|||
105651150|NCT02123797|364385769|FG004|Baseline Intervention|Out of window for initial survey|0|||
105651151|NCT02123797|364385765|FG000|Baseline Intervention|Lost to Follow-up|0|||
105651152|NCT02123797|364385766|FG001|Baseline Intervention|Lost to Follow-up|5|||
105651153|NCT02123797|364385767|FG002|Baseline Intervention|Lost to Follow-up|0|||
105651154|NCT02123797|364385768|FG003|Baseline Intervention|Lost to Follow-up|0|||
105651155|NCT02123797|364385769|FG004|Baseline Intervention|Lost to Follow-up|0|||
105651156|NCT02123797|364385765|FG000|Baseline Intervention|Other Disease|3|||
105651157|NCT02123797|364385766|FG001|Baseline Intervention|Other Disease|0|||
105651158|NCT02123797|364385767|FG002|Baseline Intervention|Other Disease|0|||
105651159|NCT02123797|364385768|FG003|Baseline Intervention|Other Disease|0|||
105651160|NCT02123797|364385769|FG004|Baseline Intervention|Other Disease|0|||
105651161|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
105651162|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
105651163|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
105651164|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
105651165|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
105651166|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
105651167|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
105651168|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
105651169|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
105651170|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
105651171|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
105651172|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
105651173|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651174|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651175|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651176|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
105651177|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
105651178|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
105651179|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
105651180|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
105651181|NCT02123797|364385765|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
105651182|NCT02123797|364385766|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
105651183|NCT02123797|364385767|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
105651184|NCT02123797|364385768|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
105651185|NCT02123797|364385769|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
105651186|NCT02123797|364385765|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
105651187|NCT02123797|364385766|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
105651188|NCT02123797|364385767|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
105651189|NCT02123797|364385768|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
105651190|NCT02123797|364385769|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
105651191|NCT02123797|364385765|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
105651192|NCT02123797|364385766|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
105651193|NCT02123797|364385767|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
105651194|NCT02123797|364385768|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
105651195|NCT02123797|364385769|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
105651196|NCT02123797|364385765|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
105651197|NCT02123797|364385766|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
105651198|NCT02123797|364385767|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651199|NCT02123797|364385768|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651200|NCT02123797|364385769|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
105651201|NCT02123797|364385765|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
105651202|NCT02123797|364385766|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
105651203|NCT02123797|364385767|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
105651204|NCT02123797|364385768|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
105651205|NCT02123797|364385769|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
105651206|NCT00377312|364385770|FG000|Overall Study|Adverse Event|1|||
105651207|NCT00377312|364385771|FG001|Overall Study|Adverse Event|1|||
105651208|NCT01572493|364385772|FG000|Overall Study|Physician Decision|1|||
105651209|NCT01572493|364385773|FG001|Overall Study|Physician Decision|0|||
105651210|NCT01572493|364385774|FG002|Overall Study|Physician Decision|0|||
105651211|NCT01572493|364385775|FG003|Overall Study|Physician Decision|0|||
105651212|NCT01572493|364385776|FG004|Overall Study|Physician Decision|0|||
105651213|NCT01572493|364385777|FG005|Overall Study|Physician Decision|0|||
105651214|NCT01572493|364385778|FG006|Overall Study|Physician Decision|0|||
105651215|NCT01572493|364385779|FG007|Overall Study|Physician Decision|0|||
105651216|NCT01572493|364385780|FG008|Overall Study|Physician Decision|0|||
105651217|NCT01572493|364385772|FG000|Overall Study|Switched to alternative treatment|0|||
105651218|NCT01572493|364385773|FG001|Overall Study|Switched to alternative treatment|1|||
105651219|NCT01572493|364385774|FG002|Overall Study|Switched to alternative treatment|2|||
105651220|NCT01572493|364385775|FG003|Overall Study|Switched to alternative treatment|1|||
105651221|NCT01572493|364385776|FG004|Overall Study|Switched to alternative treatment|2|||
105651222|NCT01572493|364385777|FG005|Overall Study|Switched to alternative treatment|0|||
105651223|NCT01572493|364385778|FG006|Overall Study|Switched to alternative treatment|2|||
105651224|NCT01572493|364385779|FG007|Overall Study|Switched to alternative treatment|0|||
105651225|NCT01572493|364385780|FG008|Overall Study|Switched to alternative treatment|2|||
105651226|NCT01572493|364385772|FG000|Overall Study|Death|0|||
105651227|NCT01572493|364385773|FG001|Overall Study|Death|0|||
105651228|NCT01572493|364385774|FG002|Overall Study|Death|0|||
105651229|NCT01572493|364385775|FG003|Overall Study|Death|1|||
105651230|NCT01572493|364385776|FG004|Overall Study|Death|0|||
105651231|NCT01572493|364385777|FG005|Overall Study|Death|1|||
105651232|NCT01572493|364385778|FG006|Overall Study|Death|0|||
105651233|NCT01572493|364385779|FG007|Overall Study|Death|0|||
105651234|NCT01572493|364385780|FG008|Overall Study|Death|0|||
105651235|NCT01572493|364385772|FG000|Overall Study|Adverse Event|0|||
105651236|NCT01572493|364385773|FG001|Overall Study|Adverse Event|0|||
105651237|NCT01572493|364385774|FG002|Overall Study|Adverse Event|0|||
105651238|NCT01572493|364385775|FG003|Overall Study|Adverse Event|0|||
105651239|NCT01572493|364385776|FG004|Overall Study|Adverse Event|0|||
105651240|NCT01572493|364385777|FG005|Overall Study|Adverse Event|0|||
105651241|NCT01572493|364385778|FG006|Overall Study|Adverse Event|1|||
105651242|NCT01572493|364385779|FG007|Overall Study|Adverse Event|0|||
105651243|NCT01572493|364385780|FG008|Overall Study|Adverse Event|0|||
105651244|NCT02889809|364385781|FG000|Overall Study|Withdrawal by Subject|30|||
105651245|NCT02889809|364385782|FG001|Overall Study|Withdrawal by Subject|21|||
105651246|NCT02889809|364385781|FG000|Overall Study|Lost to Follow-up|1|||
105651247|NCT02889809|364385782|FG001|Overall Study|Lost to Follow-up|1|||
105651248|NCT02889809|364385781|FG000|Overall Study|Site Closed|12|||
105870388|NCT01682811|365177012|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
105651249|NCT02889809|364385782|FG001|Overall Study|Site Closed|11|||
105651250|NCT01066897|364385783|FG000|Overall Study|Withdrawal by Subject|1|||
105651251|NCT01066897|364385784|FG001|Overall Study|Withdrawal by Subject|0|||
105651252|NCT01066897|364385783|FG000|Overall Study|stopped study after developing the flu.|1|||
105651253|NCT01066897|364385784|FG001|Overall Study|stopped study after developing the flu.|0|||
105651254|NCT03997409|364385785|FG000|Overall Study|Protocol Violation|1|||
105651255|NCT03997409|364385786|FG001|Overall Study|Protocol Violation|1|||
105651256|NCT03997409|364385787|FG002|Overall Study|Protocol Violation|0|||
105651257|NCT03997409|364385785|FG000|Overall Study|Withdrawal by Subject|3|||
105651258|NCT03997409|364385786|FG001|Overall Study|Withdrawal by Subject|0|||
105651259|NCT03997409|364385787|FG002|Overall Study|Withdrawal by Subject|0|||
105651260|NCT03997409|364385785|FG000|Overall Study|Lost to Follow-up|0|||
105651261|NCT03997409|364385786|FG001|Overall Study|Lost to Follow-up|0|||
105651262|NCT03997409|364385787|FG002|Overall Study|Lost to Follow-up|1|||
105651263|NCT03319719|364385793|FG000|Overall Study|Lost to Follow-up|1|||
105651264|NCT03303521|364385797|FG000|Overall Study|Withdrawal by Subject|2|||
105651265|NCT03303521|364385798|FG001|Overall Study|Withdrawal by Subject|0|||
105651266|NCT03303521|364385797|FG000|Overall Study|Death|1|||
105651267|NCT03303521|364385798|FG001|Overall Study|Death|0|||
105651268|NCT03303521|364385797|FG000|Overall Study|Kidney transplantation|0|||
105651269|NCT03303521|364385798|FG001|Overall Study|Kidney transplantation|1|||
105651270|NCT03303521|364385797|FG000|Overall Study|Investigational product discontinuation|0|||
105651271|NCT03303521|364385798|FG001|Overall Study|Investigational product discontinuation|1|||
105651272|NCT03303521|364385797|FG000|Overall Study|Transferred to non-study dialysis center|1|||
105651273|NCT03303521|364385798|FG001|Overall Study|Transferred to non-study dialysis center|0|||
105651274|NCT03303521|364385797|FG000|Overall Study|Non-comliance to study protocol|0|||
105651275|NCT03303521|364385798|FG001|Overall Study|Non-comliance to study protocol|1|||
105651276|NCT03303521|364385797|FG000|Overall Study|Adverse Event|1|||
105651277|NCT03303521|364385798|FG001|Overall Study|Adverse Event|0|||
105651278|NCT01485991|364385799|FG000|Overall Study|Adverse Event|0|||
105651279|NCT01485991|364385800|FG001|Overall Study|Adverse Event|4|||
105651280|NCT01485991|364385799|FG000|Overall Study|Lost to Follow-up|13|||
105651281|NCT01485991|364385800|FG001|Overall Study|Lost to Follow-up|10|||
105651282|NCT01485991|364385799|FG000|Overall Study|Withdrawal by Subject|13|||
105651283|NCT01485991|364385800|FG001|Overall Study|Withdrawal by Subject|20|||
105651284|NCT01485991|364385799|FG000|Overall Study|randomized but not treated|6|||
105651285|NCT01485991|364385800|FG001|Overall Study|randomized but not treated|2|||
105651286|NCT00125853|364385801|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
105651287|NCT00125853|364385802|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
105651288|NCT02359552|364385810|FG000|Overall Study|Lost to Follow-up|3|||
105651289|NCT02359552|364385811|FG001|Overall Study|Lost to Follow-up|4|||
105651290|NCT00776984|364385812|FG000|Overall Study|Adverse Event|8|||
105651291|NCT00776984|364385813|FG001|Overall Study|Adverse Event|2|||
105651292|NCT00776984|364385812|FG000|Overall Study|Protocol Violation|4|||
105651293|NCT00776984|364385813|FG001|Overall Study|Protocol Violation|2|||
105651294|NCT00776984|364385812|FG000|Overall Study|Lost to Follow-up|2|||
105651295|NCT00776984|364385813|FG001|Overall Study|Lost to Follow-up|0|||
105651296|NCT00776984|364385812|FG000|Overall Study|Withdrawal by Subject|12|||
105651297|NCT00776984|364385813|FG001|Overall Study|Withdrawal by Subject|7|||
105651298|NCT00776984|364385812|FG000|Overall Study|Lack of Efficacy|0|||
105651299|NCT00776984|364385813|FG001|Overall Study|Lack of Efficacy|1|||
105651300|NCT00776984|364385812|FG000|Overall Study|Other|5|||
105651301|NCT00776984|364385813|FG001|Overall Study|Other|9|||
105651302|NCT02391116|364385816|FG000|Treatment|Withdrawal by Subject|1|||
105651303|NCT02391116|364385816|FG000|Treatment|Protocol Violation|1|||
105651304|NCT02391116|364385816|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
105651305|NCT02391116|364385816|FG000|Treatment|AE with Clinical PD|3|||
105651306|NCT02391116|364385816|FG000|Safety Follow-up|Adverse Event|1|||
105651307|NCT02391116|364385816|FG000|Safety Follow-up|Withdrawal by Subject|4|||
105651308|NCT02391116|364385816|FG000|Safety Follow-up|Switching to Other Therapy|4|||
105651309|NCT02391116|364385816|FG000|Safety Follow-up|No Follow Up|1|||
105651310|NCT02391116|364385816|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
105651311|NCT02391116|364385816|FG000|Active Follow-up|Withdrawal by Subject|1|||
105651312|NCT02391116|364385816|FG000|Active Follow-up|Switching to Other Therapy|2|||
105651313|NCT02391116|364385816|FG000|Survival Follow-up|Withdrawal by Subject|3|||
105651314|NCT02391116|364385816|FG000|Survival Follow-up|Switching to Other Therapy|1|||
105651315|NCT01247922|364385820|FG000|Overall Study|Disease progression|4|||
105651316|NCT02335242|364385821|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
105651317|NCT02335242|364385822|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
105651318|NCT02335242|364385821|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
105651319|NCT02335242|364385822|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
105651320|NCT02335242|364385821|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
105651321|NCT02335242|364385822|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
105651322|NCT01332318|364385823|FG000|Overall Study|Adverse Event|0|||
105651323|NCT01332318|364385824|FG001|Overall Study|Adverse Event|3|||
105651324|NCT01332318|364385825|FG002|Overall Study|Adverse Event|0|||
105651325|NCT01332318|364385826|FG003|Overall Study|Adverse Event|0|||
105651326|NCT01332318|364385823|FG000|Overall Study|Withdrawal by Subject|1|||
105651327|NCT01332318|364385824|FG001|Overall Study|Withdrawal by Subject|1|||
105651328|NCT01332318|364385825|FG002|Overall Study|Withdrawal by Subject|0|||
105651329|NCT01332318|364385826|FG003|Overall Study|Withdrawal by Subject|1|||
105651330|NCT01332318|364385823|FG000|Overall Study|Protocol Violation|1|||
105651331|NCT01332318|364385824|FG001|Overall Study|Protocol Violation|0|||
105651332|NCT01332318|364385825|FG002|Overall Study|Protocol Violation|1|||
105651333|NCT01332318|364385826|FG003|Overall Study|Protocol Violation|1|||
105651334|NCT00942188|364385828|FG000|Overall Study|Adverse Event|0|||
105651335|NCT00942188|364385829|FG001|Overall Study|Adverse Event|3|||
105651336|NCT00942188|364385830|FG002|Overall Study|Adverse Event|2|||
105651337|NCT00942188|364385831|FG003|Overall Study|Adverse Event|0|||
105651338|NCT00942188|364385828|FG000|Overall Study|Lack of Efficacy|0|||
105651339|NCT00942188|364385829|FG001|Overall Study|Lack of Efficacy|0|||
105651340|NCT00942188|364385830|FG002|Overall Study|Lack of Efficacy|0|||
105651341|NCT00942188|364385831|FG003|Overall Study|Lack of Efficacy|1|||
105651342|NCT00942188|364385828|FG000|Overall Study|Protocol Violation|1|||
105651343|NCT00942188|364385829|FG001|Overall Study|Protocol Violation|1|||
105651344|NCT00942188|364385830|FG002|Overall Study|Protocol Violation|0|||
105651345|NCT00942188|364385831|FG003|Overall Study|Protocol Violation|0|||
105651346|NCT00942188|364385828|FG000|Overall Study|Lost to Follow-up|2|||
105651347|NCT00942188|364385829|FG001|Overall Study|Lost to Follow-up|1|||
105651348|NCT00942188|364385830|FG002|Overall Study|Lost to Follow-up|2|||
105651349|NCT00942188|364385831|FG003|Overall Study|Lost to Follow-up|0|||
105651350|NCT00942188|364385828|FG000|Overall Study|Withdrawal by Subject|1|||
105651351|NCT00942188|364385829|FG001|Overall Study|Withdrawal by Subject|3|||
105651352|NCT00942188|364385830|FG002|Overall Study|Withdrawal by Subject|4|||
105651353|NCT00942188|364385831|FG003|Overall Study|Withdrawal by Subject|2|||
105651354|NCT00942188|364385828|FG000|Overall Study|Physician Decision|0|||
105651355|NCT00942188|364385829|FG001|Overall Study|Physician Decision|0|||
105651356|NCT00942188|364385830|FG002|Overall Study|Physician Decision|1|||
105651357|NCT00942188|364385831|FG003|Overall Study|Physician Decision|0|||
105651358|NCT00942188|364385828|FG000|Overall Study|Sponsor Decision|0|||
105651359|NCT00942188|364385829|FG001|Overall Study|Sponsor Decision|2|||
105651360|NCT00942188|364385830|FG002|Overall Study|Sponsor Decision|0|||
105651361|NCT00942188|364385831|FG003|Overall Study|Sponsor Decision|1|||
105651362|NCT02273180|364385832|FG000|Overall Study|Adverse Event|2|||
105651363|NCT02273180|364385833|FG001|Overall Study|Adverse Event|2|||
105651364|NCT02273180|364385832|FG000|Overall Study|Lack of Efficacy|1|||
105651365|NCT02273180|364385833|FG001|Overall Study|Lack of Efficacy|0|||
105651366|NCT02273180|364385832|FG000|Overall Study|Protocol Violation|1|||
105651367|NCT02273180|364385833|FG001|Overall Study|Protocol Violation|7|||
105651368|NCT02273180|364385832|FG000|Overall Study|Randomized but not treated|1|||
105651369|NCT02273180|364385833|FG001|Overall Study|Randomized but not treated|0|||
105651370|NCT02273180|364385832|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
105651371|NCT02273180|364385833|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
105651372|NCT02273180|364385832|FG000|Overall Study|Other than specified above|21|||
105651373|NCT02273180|364385833|FG001|Overall Study|Other than specified above|10|||
105651374|NCT01786551|364385834|FG000|Overall Study|Participant withdrew consent|2|||
105651375|NCT00663923|364385835|FG000|Overall Study|Lost to Follow-up|2|||
105651376|NCT04853238|364385837|FG000|Overall Study|Death|4|||
105651377|NCT04853238|364385838|FG001|Overall Study|Death|0|||
105651378|NCT04853238|364385839|FG002|Overall Study|Death|2|||
105651379|NCT04853238|364385837|FG000|Overall Study|Lost to Follow-up|16|||
105651380|NCT04853238|364385838|FG001|Overall Study|Lost to Follow-up|2|||
105651381|NCT04853238|364385839|FG002|Overall Study|Lost to Follow-up|37|||
105651382|NCT04853238|364385837|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
105651383|NCT04853238|364385838|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
105651384|NCT04853238|364385839|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
105651385|NCT04853238|364385837|FG000|Overall Study|Withdrawal by Subject|6|||
105651386|NCT04853238|364385838|FG001|Overall Study|Withdrawal by Subject|0|||
105651387|NCT04853238|364385839|FG002|Overall Study|Withdrawal by Subject|21|||
105651388|NCT04853238|364385837|FG000|Overall Study|Physician Decision|0|||
105651389|NCT04853238|364385838|FG001|Overall Study|Physician Decision|0|||
105651390|NCT04853238|364385839|FG002|Overall Study|Physician Decision|2|||
105651391|NCT04853238|364385837|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
105651392|NCT04853238|364385838|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
105651393|NCT04853238|364385839|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
105651394|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
105651395|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
105651396|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
105651397|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
105651398|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
105651399|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
105659498|NCT02635386|364417348|FG001|Overall Study|Moved Out of State|1|||
105651400|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
105651401|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
105651402|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
105651403|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
105651404|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
105651405|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
105651406|NCT02294461|364385840|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
105651407|NCT02294461|364385841|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
105651408|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
105651409|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
105651410|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
105651411|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
105651412|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
105651413|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
105651414|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
105651415|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
105651416|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
105651417|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
105651418|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
105651419|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
105651420|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
105651421|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
105651422|NCT02294461|364385840|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
105651423|NCT02294461|364385841|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
105651424|NCT02859558|364387210|FG000|Step 1|Not Eligible|0|||
105651425|NCT02859558|364387211|FG001|Step 1|Not Eligible|0|||
105651426|NCT02859558|364387212|FG002|Step 1|Not Eligible|0|||
105651427|NCT02859558|364387213|FG003|Step 1|Not Eligible|0|||
105651428|NCT02859558|364387214|FG004|Step 1|Not Eligible|3|||
105651429|NCT02859558|364387210|FG000|Step 1|Lost to Follow-up|1|||
105651430|NCT02859558|364387211|FG001|Step 1|Lost to Follow-up|3|||
105651431|NCT02859558|364387212|FG002|Step 1|Lost to Follow-up|3|||
105651432|NCT02859558|364387213|FG003|Step 1|Lost to Follow-up|0|||
105651433|NCT02859558|364387214|FG004|Step 1|Lost to Follow-up|0|||
105651434|NCT02859558|364387210|FG000|Step 1|Did Not Return to Clinic|2|||
105651435|NCT02859558|364387211|FG001|Step 1|Did Not Return to Clinic|3|||
105651436|NCT02859558|364387212|FG002|Step 1|Did Not Return to Clinic|4|||
105651437|NCT02859558|364387213|FG003|Step 1|Did Not Return to Clinic|0|||
105651438|NCT02859558|364387214|FG004|Step 1|Did Not Return to Clinic|0|||
105651439|NCT02859558|364387210|FG000|Step 1|Moved|0|||
105651440|NCT02859558|364387211|FG001|Step 1|Moved|1|||
105651441|NCT02859558|364387212|FG002|Step 1|Moved|1|||
105651442|NCT02859558|364387213|FG003|Step 1|Moved|0|||
105651443|NCT02859558|364387214|FG004|Step 1|Moved|0|||
105651444|NCT02859558|364387210|FG000|Step 1|Withdrawal By Participant|1|||
105651445|NCT02859558|364387211|FG001|Step 1|Withdrawal By Participant|2|||
105651446|NCT02859558|364387212|FG002|Step 1|Withdrawal By Participant|1|||
105651447|NCT02859558|364387213|FG003|Step 1|Withdrawal By Participant|0|||
105651448|NCT02859558|364387214|FG004|Step 1|Withdrawal By Participant|0|||
105651449|NCT02859558|364387210|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
105651450|NCT02859558|364387211|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
105651451|NCT02859558|364387212|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
105651452|NCT02859558|364387213|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
105651453|NCT02859558|364387214|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
105651454|NCT02859558|364387210|FG000|Step 1|Incarceration|0|||
105651455|NCT02859558|364387211|FG001|Step 1|Incarceration|1|||
105651456|NCT02859558|364387212|FG002|Step 1|Incarceration|0|||
105651457|NCT02859558|364387213|FG003|Step 1|Incarceration|0|||
105651458|NCT02859558|364387214|FG004|Step 1|Incarceration|0|||
105651459|NCT02859558|364387210|FG000|Step 1|Non-Adherence to Study Drug|2|||
105651460|NCT02859558|364387211|FG001|Step 1|Non-Adherence to Study Drug|0|||
105651461|NCT02859558|364387212|FG002|Step 1|Non-Adherence to Study Drug|1|||
105651462|NCT02859558|364387213|FG003|Step 1|Non-Adherence to Study Drug|0|||
105651463|NCT02859558|364387214|FG004|Step 1|Non-Adherence to Study Drug|0|||
105651464|NCT02859558|364387210|FG000|Step 1|Non-Adherence to Study Requirements|3|||
105651465|NCT02859558|364387211|FG001|Step 1|Non-Adherence to Study Requirements|1|||
105651466|NCT02859558|364387212|FG002|Step 1|Non-Adherence to Study Requirements|0|||
105651467|NCT02859558|364387213|FG003|Step 1|Non-Adherence to Study Requirements|0|||
105651468|NCT02859558|364387214|FG004|Step 1|Non-Adherence to Study Requirements|0|||
105651469|NCT02859558|364387210|FG000|Step 1|Virologic Failure|2|||
105651470|NCT02859558|364387211|FG001|Step 1|Virologic Failure|1|||
105651471|NCT02859558|364387212|FG002|Step 1|Virologic Failure|1|||
105651472|NCT02859558|364387213|FG003|Step 1|Virologic Failure|0|||
105651473|NCT02859558|364387214|FG004|Step 1|Virologic Failure|0|||
105651474|NCT02859558|364387210|FG000|Step 2|Active On Study|23|||
105651475|NCT02859558|364387211|FG001|Step 2|Active On Study|38|||
105651476|NCT02859558|364387212|FG002|Step 2|Active On Study|20|||
105651477|NCT02859558|364387213|FG003|Step 2|Active On Study|0|||
105651478|NCT02859558|364387214|FG004|Step 2|Active On Study|0|||
105651479|NCT02859558|364387210|FG000|Step 2|Did Not Return to Clinic|2|||
105651480|NCT02859558|364387211|FG001|Step 2|Did Not Return to Clinic|0|||
105651481|NCT02859558|364387212|FG002|Step 2|Did Not Return to Clinic|0|||
105651482|NCT02859558|364387213|FG003|Step 2|Did Not Return to Clinic|0|||
105651483|NCT02859558|364387214|FG004|Step 2|Did Not Return to Clinic|0|||
105651484|NCT02859558|364387210|FG000|Step 2|Unexpected Closure of Site|0|||
105651485|NCT02859558|364387211|FG001|Step 2|Unexpected Closure of Site|1|||
105651486|NCT02859558|364387212|FG002|Step 2|Unexpected Closure of Site|1|||
105651487|NCT02859558|364387213|FG003|Step 2|Unexpected Closure of Site|0|||
105651488|NCT02859558|364387214|FG004|Step 2|Unexpected Closure of Site|0|||
105651489|NCT01123642|364387217|FG000|Overall Study|Lost to Follow-up|23|||
105651490|NCT01123642|364387217|FG000|Overall Study|Withdrawal by Subject|9|||
105651491|NCT01123642|364387217|FG000|Overall Study|ineligible at baseline assessment|36|||
105651492|NCT01184859|364387218|FG000|Period 1: Single Dose|Insufficient urine production|0|||
105651493|NCT01184859|364387219|FG001|Period 1: Single Dose|Insufficient urine production|1|||
105651494|NCT01184859|364387220|FG002|Period 1: Single Dose|Insufficient urine production|0|||
105651495|NCT01184859|364387221|FG003|Period 1: Single Dose|Insufficient urine production|0|||
105651496|NCT01184859|364387222|FG004|Period 1: Single Dose|Insufficient urine production|0|||
105651497|NCT01184859|364387218|FG000|Period 1: Single Dose|Protocol Violation|0|||
105651498|NCT01184859|364387219|FG001|Period 1: Single Dose|Protocol Violation|1|||
105651499|NCT01184859|364387220|FG002|Period 1: Single Dose|Protocol Violation|0|||
105651500|NCT01184859|364387221|FG003|Period 1: Single Dose|Protocol Violation|0|||
105651501|NCT01184859|364387222|FG004|Period 1: Single Dose|Protocol Violation|0|||
105651502|NCT01184859|364387218|FG000|Period 1: Single Dose|Adverse Event|0|||
105651503|NCT01184859|364387219|FG001|Period 1: Single Dose|Adverse Event|0|||
105651504|NCT01184859|364387220|FG002|Period 1: Single Dose|Adverse Event|0|||
105651505|NCT01184859|364387221|FG003|Period 1: Single Dose|Adverse Event|0|||
105651506|NCT01184859|364387222|FG004|Period 1: Single Dose|Adverse Event|1|||
105651507|NCT01184859|364387218|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
105651508|NCT01184859|364387219|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
105651509|NCT01184859|364387220|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
105651510|NCT01184859|364387221|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
105651511|NCT01184859|364387222|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
105651512|NCT01184859|364387218|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
105651513|NCT01184859|364387219|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
105651514|NCT01184859|364387220|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
105651515|NCT01184859|364387221|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
105651516|NCT01184859|364387222|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
105651517|NCT03098797|364387224|FG000|Part 2 Open Label Extension|Adverse Event|2|||
105651518|NCT03098797|364387225|FG001|Part 2 Open Label Extension|Adverse Event|0|||
105651519|NCT02329223|364387228|FG000|Overall Study|Withdrawal by Subject|1|||
105651520|NCT02329223|364387229|FG001|Overall Study|Withdrawal by Subject|2|||
105651521|NCT02329223|364387230|FG002|Overall Study|Withdrawal by Subject|5|||
105651522|NCT02329223|364387228|FG000|Overall Study|Physician Decision|0|||
105651523|NCT02329223|364387229|FG001|Overall Study|Physician Decision|0|||
105651524|NCT02329223|364387230|FG002|Overall Study|Physician Decision|1|||
105651525|NCT02329223|364387228|FG000|Overall Study|Adverse Event|0|||
105651526|NCT02329223|364387229|FG001|Overall Study|Adverse Event|1|||
105651527|NCT02329223|364387230|FG002|Overall Study|Adverse Event|0|||
105651528|NCT04044352|364387231|FG000|Overall Study|Lost to Follow-up|9|||
105651529|NCT04044352|364387231|FG000|Overall Study|Withdrawal by Subject|2|||
105651530|NCT00651937|364387232|FG000|Overall Study|Withdrawal by Subject|4|||
105651531|NCT00651937|364387233|FG001|Overall Study|Withdrawal by Subject|1|||
105651532|NCT02176356|364387237|FG000|Overall Study|Screen Failure|14|||
105651533|NCT02176356|364387237|FG000|Overall Study|Lost to Follow-up|4|||
105651534|NCT02176356|364387237|FG000|Overall Study|Personal Reasons|3|||
105651535|NCT02176356|364387237|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105651536|NCT00506922|364387243|FG000|Overall Study|Physician Decision|0|||
105651537|NCT00506922|364387244|FG001|Overall Study|Physician Decision|0|||
105651538|NCT00506922|364387245|FG002|Overall Study|Physician Decision|0|||
105651539|NCT00506922|364387246|FG003|Overall Study|Physician Decision|2|||
105651540|NCT00506922|364387247|FG004|Overall Study|Physician Decision|0|||
105651541|NCT00506922|364387243|FG000|Overall Study|Withdrawal by Subject|0|||
105651542|NCT00506922|364387244|FG001|Overall Study|Withdrawal by Subject|0|||
105651543|NCT00506922|364387245|FG002|Overall Study|Withdrawal by Subject|0|||
105651544|NCT00506922|364387246|FG003|Overall Study|Withdrawal by Subject|0|||
105651545|NCT00506922|364387247|FG004|Overall Study|Withdrawal by Subject|1|||
105651546|NCT00792259|364387248|FG000|Overall Study|Poor Quality Scans|1|||
105651547|NCT00792259|364387249|FG001|Overall Study|Poor Quality Scans|0|||
105651548|NCT00792259|364387250|FG002|Overall Study|Poor Quality Scans|0|||
105651549|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
105651550|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
105659499|NCT02635386|364417349|FG002|Overall Study|Moved Out of State|0|||
105651551|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
105651552|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
105651553|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
105651554|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
105651555|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
105651556|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
105651557|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
105651558|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
105651559|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
105651560|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
105651561|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
105651562|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
105651563|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
105651564|NCT00332488|364387251|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
105651565|NCT00332488|364387252|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
105651566|NCT00332488|364387253|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
105651567|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
105651568|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
105651569|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
105651570|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
105651571|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
105651572|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
105651573|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
105651574|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
105651575|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
105651576|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
105651577|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
105651578|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
105651579|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
105651580|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
105651581|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
105651582|NCT00332488|364387251|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
105651583|NCT00332488|364387252|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
105651584|NCT00332488|364387253|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
105651585|NCT00371462|364387254|FG000|Overall Study|Withdrawal by Subject|1|||
105651586|NCT00371462|364387255|FG001|Overall Study|Withdrawal by Subject|0|||
105651587|NCT00371462|364387254|FG000|Overall Study|Other|7|||
105651588|NCT00371462|364387255|FG001|Overall Study|Other|8|||
105651589|NCT03721978|364387256|FG000|Overall Study|Withdrawal by Subject|6|||
105651590|NCT03721978|364387257|FG001|Overall Study|Withdrawal by Subject|1|||
105651591|NCT03721978|364387256|FG000|Overall Study|Adverse Event|1|||
105651592|NCT03721978|364387257|FG001|Overall Study|Adverse Event|1|||
105651593|NCT03721978|364387256|FG000|Overall Study|Progressive Disease|1|||
105651594|NCT03721978|364387257|FG001|Overall Study|Progressive Disease|0|||
105651595|NCT03721978|364387256|FG000|Overall Study|Lost to Follow-up|5|||
105651596|NCT03721978|364387257|FG001|Overall Study|Lost to Follow-up|1|||
105651597|NCT03721978|364387256|FG000|Overall Study|Reason not Specified|0|||
105651598|NCT03721978|364387257|FG001|Overall Study|Reason not Specified|2|||
105651599|NCT05244226|364387258|FG000|Overall Study|Adverse Event|1|||
105651600|NCT05244226|364387259|FG001|Overall Study|Adverse Event|0|||
105651601|NCT05244226|364387260|FG002|Overall Study|Adverse Event|0|||
105651602|NCT05244226|364387258|FG000|Overall Study|Lost to Follow-up|0|||
105651603|NCT05244226|364387259|FG001|Overall Study|Lost to Follow-up|0|||
105651604|NCT05244226|364387260|FG002|Overall Study|Lost to Follow-up|1|||
105651605|NCT05244226|364387258|FG000|Overall Study|Protocol Violation|0|||
105651606|NCT05244226|364387259|FG001|Overall Study|Protocol Violation|2|||
105651607|NCT05244226|364387260|FG002|Overall Study|Protocol Violation|2|||
105651608|NCT04357964|364387264|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
105651609|NCT04357964|364387265|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
105651610|NCT04357964|364387264|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
105651611|NCT04357964|364387265|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
105651612|NCT04357964|364387264|FG000|Overall Study|Adipose sample was insufficient quality|0|||
105651613|NCT04357964|364387265|FG001|Overall Study|Adipose sample was insufficient quality|1|||
105651614|NCT00733226|364387266|FG000|Overall Study|Withdrawal by Subject|1|||
105870389|NCT01682811|365177013|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
105651615|NCT00733226|364387267|FG001|Overall Study|Withdrawal by Subject|0|||
105651616|NCT00733226|364387266|FG000|Overall Study|Lost to Follow-up|2|||
105651617|NCT00733226|364387267|FG001|Overall Study|Lost to Follow-up|0|||
105651618|NCT00733226|364387266|FG000|Overall Study|moved to another place|2|||
105651619|NCT00733226|364387267|FG001|Overall Study|moved to another place|0|||
105651620|NCT02388932|364387270|FG000|Overall Study|Death|1|||
105651621|NCT03681353|364387276|FG000|Overall Study|Lost to Follow-up|2|||
105651622|NCT03681353|364387276|FG000|Overall Study|Withdrawal by Subject|3|||
105651623|NCT03681353|364387276|FG000|Overall Study|withdrawn by PI|2|||
105651624|NCT02679079|364387277|FG000|Overall Study|Adverse Event|2|||
105651625|NCT02679079|364387278|FG001|Overall Study|Adverse Event|0|||
105651626|NCT02679079|364387279|FG002|Overall Study|Adverse Event|2|||
105651627|NCT02679079|364387277|FG000|Overall Study|Protocol Violation|0|||
105651628|NCT02679079|364387278|FG001|Overall Study|Protocol Violation|1|||
105651629|NCT02679079|364387279|FG002|Overall Study|Protocol Violation|0|||
105651630|NCT02679079|364387277|FG000|Overall Study|Withdrawal by Subject|2|||
105651631|NCT02679079|364387278|FG001|Overall Study|Withdrawal by Subject|1|||
105651632|NCT02679079|364387279|FG002|Overall Study|Withdrawal by Subject|0|||
105651633|NCT02775214|364387282|FG000|Overall Study|Withdrawal by Subject|2|||
105651634|NCT02775214|364387283|FG001|Overall Study|Withdrawal by Subject|0|||
105651635|NCT00382408|364387284|FG000|Overall Study|Did not meet protocol requirement|3|||
105651636|NCT00382408|364387285|FG001|Overall Study|Did not meet protocol requirement|3|||
105651637|NCT00382408|364387284|FG000|Overall Study|Protocol Violation|2|||
105651638|NCT00382408|364387285|FG001|Overall Study|Protocol Violation|2|||
105651639|NCT00382408|364387284|FG000|Overall Study|Physician Decision|1|||
105651640|NCT00382408|364387285|FG001|Overall Study|Physician Decision|0|||
105651641|NCT00382408|364387284|FG000|Overall Study|Withdrawal by Subject|17|||
105651642|NCT00382408|364387285|FG001|Overall Study|Withdrawal by Subject|6|||
105651643|NCT00382408|364387284|FG000|Overall Study|Pregnancy|2|||
105651644|NCT00382408|364387285|FG001|Overall Study|Pregnancy|0|||
105651645|NCT00382408|364387284|FG000|Overall Study|Lost to Follow-up|19|||
105651646|NCT00382408|364387285|FG001|Overall Study|Lost to Follow-up|8|||
105651647|NCT00382408|364387284|FG000|Overall Study|Other|100|||
105651648|NCT00382408|364387285|FG001|Overall Study|Other|35|||
105651649|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
105651650|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
105651651|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
105651652|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
105651653|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
105651654|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
105651655|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
105651656|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
105651657|NCT00352053|364387288|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
105651658|NCT00352053|364387289|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
105651659|NCT00352053|364387288|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
105651660|NCT00352053|364387289|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
105651661|NCT00352053|364387288|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
105651662|NCT00352053|364387289|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
105651663|NCT00352053|364387288|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
105651664|NCT00352053|364387289|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
105651665|NCT00352053|364387288|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
105651666|NCT00352053|364387289|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
105651667|NCT00352053|364387288|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
105651668|NCT00352053|364387289|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
105651669|NCT00352053|364387288|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
105651670|NCT00352053|364387289|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
105651671|NCT00352053|364387288|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
105651672|NCT00352053|364387289|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
105651673|NCT00352053|364387288|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
105651674|NCT00352053|364387289|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
105651675|NCT01145417|364387290|FG000|Overall Study|Death|1|||
105651676|NCT01145417|364387291|FG001|Overall Study|Death|0|||
105651677|NCT01145417|364387290|FG000|Overall Study|Lost to Follow-up|2|||
105651678|NCT01145417|364387291|FG001|Overall Study|Lost to Follow-up|1|||
105651679|NCT01145417|364387290|FG000|Overall Study|Withdrawal by Subject|1|||
105651680|NCT01145417|364387291|FG001|Overall Study|Withdrawal by Subject|2|||
105651681|NCT01145417|364387290|FG000|Overall Study|Pregnancy|1|||
105651682|NCT01145417|364387291|FG001|Overall Study|Pregnancy|0|||
105651683|NCT01145417|364387290|FG000|Overall Study|Adverse Event|0|||
105651684|NCT01145417|364387291|FG001|Overall Study|Adverse Event|1|||
105651685|NCT01145417|364387290|FG000|Overall Study|Study terminated by sponsor|35|||
105651686|NCT01145417|364387291|FG001|Overall Study|Study terminated by sponsor|43|||
105651687|NCT01145417|364387290|FG000|Overall Study|Other|1|||
105651688|NCT01145417|364387291|FG001|Overall Study|Other|0|||
105651689|NCT01797562|364387292|FG000|Overall Study|Protocol Violation|5|||
105651690|NCT00632931|364387295|FG000|Part 1, Period 1|Protocol Violation|1|||
105659500|NCT02635386|364417350|FG003|Overall Study|Moved Out of State|0|||
105651691|NCT00632931|364387296|FG001|Part 1, Period 1|Protocol Violation|0|||
105651692|NCT00632931|364387297|FG002|Part 1, Period 1|Protocol Violation|0|||
105651693|NCT00632931|364387295|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
105651694|NCT00632931|364387296|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
105651695|NCT00632931|364387297|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
105651696|NCT00632931|364387295|FG000|Part 2|Adverse Event|0|||
105651697|NCT00632931|364387296|FG001|Part 2|Adverse Event|0|||
105651698|NCT00632931|364387297|FG002|Part 2|Adverse Event|3|||
105651699|NCT00632931|364387295|FG000|Part 2|Death|0|||
105651700|NCT00632931|364387296|FG001|Part 2|Death|0|||
105651701|NCT00632931|364387297|FG002|Part 2|Death|1|||
105651702|NCT00632931|364387295|FG000|Part 2|Lack of Efficacy|0|||
105651703|NCT00632931|364387296|FG001|Part 2|Lack of Efficacy|0|||
105651704|NCT00632931|364387297|FG002|Part 2|Lack of Efficacy|17|||
105651705|NCT00632931|364387295|FG000|Part 2|Withdrawal by Subject|0|||
105651706|NCT00632931|364387296|FG001|Part 2|Withdrawal by Subject|0|||
105651707|NCT00632931|364387297|FG002|Part 2|Withdrawal by Subject|3|||
105651708|NCT03341312|364387298|FG000|Period 1|Withdrawal by Subject|0|||
105651709|NCT03341312|364387299|FG001|Period 1|Withdrawal by Subject|1|||
105651710|NCT03341312|364387300|FG002|Period 1|Withdrawal by Subject|0|||
105651711|NCT03341312|364387301|FG003|Period 1|Withdrawal by Subject|0|||
105651712|NCT04491006|364387305|FG000|Overall Study|Adverse Event|0|||
105651713|NCT04491006|364387306|FG001|Overall Study|Adverse Event|3|||
105651714|NCT04491006|364387307|FG002|Overall Study|Adverse Event|5|||
105651715|NCT04491006|364387305|FG000|Overall Study|Withdrawal by Subject|1|||
105651716|NCT04491006|364387306|FG001|Overall Study|Withdrawal by Subject|0|||
105651717|NCT04491006|364387307|FG002|Overall Study|Withdrawal by Subject|2|||
105651718|NCT02581189|364387311|FG000|Overall Study|Failure to return|36|||
105651719|NCT02581189|364387311|FG000|Overall Study|Withdrew consent|5|||
105651720|NCT02581189|364387311|FG000|Overall Study|Death|3|||
105651721|NCT02581189|364387311|FG000|Overall Study|Insufficient virological response|2|||
105651722|NCT02581189|364387311|FG000|Overall Study|Other, not specified|7|||
105651723|NCT05372913|364387312|FG000|Overall Study|Withdrawal by Subject|0|||
105651724|NCT05372913|364387313|FG001|Overall Study|Withdrawal by Subject|2|||
105651725|NCT05372913|364387312|FG000|Overall Study|Protocol Violation|2|||
105651726|NCT05372913|364387313|FG001|Overall Study|Protocol Violation|2|||
105651727|NCT05372913|364387312|FG000|Overall Study|Adverse Event|0|||
105651728|NCT05372913|364387313|FG001|Overall Study|Adverse Event|1|||
105651729|NCT03193216|364387314|FG000|Overall Study|Lost to Follow-up|1|||
105651730|NCT03193216|364387315|FG001|Overall Study|Lost to Follow-up|0|||
105651731|NCT03193216|364387314|FG000|Overall Study|Withdrawal by Subject|5|||
105651732|NCT03193216|364387315|FG001|Overall Study|Withdrawal by Subject|0|||
105651733|NCT03193216|364387314|FG000|Overall Study|Physician Decision|4|||
105651734|NCT03193216|364387315|FG001|Overall Study|Physician Decision|0|||
105651735|NCT05135156|364387316|FG000|Overall Study|Lost to Follow-up|0|||
105651736|NCT05135156|364387317|FG001|Overall Study|Lost to Follow-up|0|||
105651737|NCT05135156|364387318|FG002|Overall Study|Lost to Follow-up|2|||
105651738|NCT03461211|364387321|FG000|Overall Study|Adverse Event|1|||
105651739|NCT03461211|364387322|FG001|Overall Study|Adverse Event|1|||
105651740|NCT03461211|364387321|FG000|Overall Study|Lack of Efficacy|0|||
105651741|NCT03461211|364387322|FG001|Overall Study|Lack of Efficacy|1|||
105651742|NCT01284634|364387323|FG000|Overall Study|Adverse Event|1|||
105651743|NCT01284634|364387324|FG001|Overall Study|Adverse Event|0|||
105651744|NCT01284634|364387325|FG002|Overall Study|Adverse Event|2|||
105651745|NCT01284634|364387326|FG003|Overall Study|Adverse Event|1|||
105651746|NCT03807700|364387327|FG000|Overall Study|Withdrawal by Subject|2|||
105651747|NCT03807700|364387328|FG001|Overall Study|Withdrawal by Subject|1|||
105651748|NCT01059526|364387329|FG000|Overall Study|Patient enrolled but not treated|20|||
105651749|NCT01059526|364387330|FG001|Overall Study|Patient enrolled but not treated|17|||
105651750|NCT01059526|364387329|FG000|Overall Study|Adverse Event|2|||
105651751|NCT01059526|364387330|FG001|Overall Study|Adverse Event|2|||
105651752|NCT01059526|364387329|FG000|Overall Study|Protocol Violation|0|||
105651753|NCT01059526|364387330|FG001|Overall Study|Protocol Violation|1|||
105651754|NCT01059526|364387329|FG000|Overall Study|Withdrawal by Subject|3|||
105651755|NCT01059526|364387330|FG001|Overall Study|Withdrawal by Subject|1|||
105651756|NCT01059526|364387329|FG000|Overall Study|Lost to Follow-up|4|||
105651757|NCT01059526|364387330|FG001|Overall Study|Lost to Follow-up|1|||
105651758|NCT01059526|364387329|FG000|Overall Study|Patient found to be dermatographic|1|||
105651759|NCT01059526|364387330|FG001|Overall Study|Patient found to be dermatographic|0|||
105651760|NCT02720081|364387331|FG000|Overall Study|Adverse Event|0|||
105651761|NCT02720081|364387332|FG001|Overall Study|Adverse Event|3|||
105651762|NCT02720081|364387331|FG000|Overall Study|Protocol Violation|4|||
105651763|NCT02720081|364387332|FG001|Overall Study|Protocol Violation|1|||
105651764|NCT02316847|364387334|FG000|Overall Study|Adverse Event|0|||
105651765|NCT02316847|364387335|FG001|Overall Study|Adverse Event|3|||
105651766|NCT02316847|364387334|FG000|Overall Study|Lost to Follow-up|0|||
105651767|NCT02316847|364387335|FG001|Overall Study|Lost to Follow-up|2|||
105651768|NCT02316847|364387334|FG000|Overall Study|Physician Decision|0|||
105651769|NCT02316847|364387335|FG001|Overall Study|Physician Decision|1|||
105651770|NCT02316847|364387334|FG000|Overall Study|Pregnancy|0|||
105651771|NCT02316847|364387335|FG001|Overall Study|Pregnancy|1|||
105651772|NCT02316847|364387334|FG000|Overall Study|Withdrawal by Subject|2|||
105651773|NCT02316847|364387335|FG001|Overall Study|Withdrawal by Subject|9|||
105651774|NCT02316847|364387334|FG000|Overall Study|Noncompliance with study drug|0|||
105651775|NCT02316847|364387335|FG001|Overall Study|Noncompliance with study drug|3|||
105651776|NCT02316847|364387334|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
105651777|NCT02316847|364387335|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
105651778|NCT02845375|364387336|FG000|Overall Study|upper airway obstruction|1|||
105651779|NCT02845375|364387337|FG001|Overall Study|upper airway obstruction|2|||
105651780|NCT02845375|364387338|FG002|Overall Study|upper airway obstruction|1|||
105651781|NCT02236598|364387339|FG000|Overall Study|Adverse Event|0|||
105651782|NCT02236598|364387340|FG001|Overall Study|Adverse Event|1|||
105651783|NCT02236598|364387339|FG000|Overall Study|Withdrawal by Subject|0|||
105651784|NCT02236598|364387340|FG001|Overall Study|Withdrawal by Subject|1|||
105651785|NCT00191984|364387341|FG000|Overall Study|Disease Progression|21|||
105651786|NCT00191984|364387341|FG000|Overall Study|Adverse Event|4|||
105651787|NCT00191984|364387341|FG000|Overall Study|Death|2|||
105651788|NCT00191984|364387341|FG000|Overall Study|Entry Criteria Exclusion|1|||
105651789|NCT00191984|364387341|FG000|Overall Study|Withdrawal by Subject|7|||
105651790|NCT00191984|364387341|FG000|Overall Study|Physician Decision|4|||
105651791|NCT04194541|364387342|FG000|Day 1 Through 13|Lost to Follow-up|3|||
105651792|NCT04194541|364387342|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
105651793|NCT04194541|364387342|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
105651794|NCT01536535|364387351|FG000|Overall Study|Withdrawal by Subject|10|||
105651795|NCT01536535|364387352|FG001|Overall Study|Withdrawal by Subject|5|||
105651796|NCT01536535|364387351|FG000|Overall Study|Lost to Follow-up|4|||
105651797|NCT01536535|364387352|FG001|Overall Study|Lost to Follow-up|6|||
105651798|NCT01536535|364387351|FG000|Overall Study|Physician Decision|1|||
105651799|NCT01536535|364387352|FG001|Overall Study|Physician Decision|1|||
105651800|NCT01536535|364387351|FG000|Overall Study|Participant moved|0|||
105651801|NCT01536535|364387352|FG001|Overall Study|Participant moved|1|||
105651802|NCT00635570|364388875|FG000|Overall Study|Lost to Follow-up|8|||
105651803|NCT00635570|364388876|FG001|Overall Study|Lost to Follow-up|8|||
105651804|NCT00635570|364388875|FG000|Overall Study|Withdrawal by Subject|1|||
105651805|NCT00635570|364388876|FG001|Overall Study|Withdrawal by Subject|1|||
105651806|NCT00635570|364388875|FG000|Overall Study|Adverse Event|2|||
105651807|NCT00635570|364388876|FG001|Overall Study|Adverse Event|0|||
105651808|NCT00635570|364388875|FG000|Overall Study|Physician Decision|1|||
105651809|NCT00635570|364388876|FG001|Overall Study|Physician Decision|0|||
105651810|NCT00635570|364388875|FG000|Overall Study|Did not complete survey|2|||
105651811|NCT00635570|364388876|FG001|Overall Study|Did not complete survey|1|||
105651812|NCT00635570|364388875|FG000|Overall Study|Early termination(No sexual activity)|1|||
105651813|NCT00635570|364388876|FG001|Overall Study|Early termination(No sexual activity)|1|||
105651814|NCT02514577|364388880|FG000|Overall Study|Lost to Follow-up|6|||
105651815|NCT02514577|364388881|FG001|Overall Study|Lost to Follow-up|6|||
105651816|NCT02514577|364388880|FG000|Overall Study|Protocol Violation|1|||
105651817|NCT02514577|364388881|FG001|Overall Study|Protocol Violation|0|||
105651818|NCT02514577|364388880|FG000|Overall Study|Withdrawal by Subject|6|||
105651819|NCT02514577|364388881|FG001|Overall Study|Withdrawal by Subject|6|||
105651820|NCT02514577|364388880|FG000|Overall Study|Adverse Event|1|||
105651821|NCT02514577|364388881|FG001|Overall Study|Adverse Event|1|||
105651822|NCT02675998|364388882|FG000|8-Week Treatment Period|Adverse Event|6|||
105651823|NCT02675998|364388883|FG001|8-Week Treatment Period|Adverse Event|5|||
105651824|NCT02675998|364388884|FG002|8-Week Treatment Period|Adverse Event|6|||
105651825|NCT02675998|364388885|FG003|8-Week Treatment Period|Adverse Event|0|||
105651826|NCT02675998|364388882|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
105651827|NCT02675998|364388883|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
105651828|NCT02675998|364388884|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
105651829|NCT02675998|364388885|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
105651830|NCT02675998|364388882|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
105651831|NCT02675998|364388883|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
105651832|NCT02675998|364388884|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
105651833|NCT02675998|364388885|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
105651834|NCT02675998|364388882|FG000|8-Week Treatment Period|Physician Decision|1|||
105651835|NCT02675998|364388883|FG001|8-Week Treatment Period|Physician Decision|0|||
105651836|NCT02675998|364388884|FG002|8-Week Treatment Period|Physician Decision|2|||
105651837|NCT02675998|364388885|FG003|8-Week Treatment Period|Physician Decision|0|||
105651838|NCT02675998|364388882|FG000|8-Week Treatment Period|GI side Effects|1|||
105651839|NCT02675998|364388883|FG001|8-Week Treatment Period|GI side Effects|4|||
105651840|NCT02675998|364388884|FG002|8-Week Treatment Period|GI side Effects|2|||
105651841|NCT02675998|364388885|FG003|8-Week Treatment Period|GI side Effects|0|||
105651842|NCT02675998|364388882|FG000|8-Week Treatment Period|Protocol Violation|1|||
105651843|NCT02675998|364388883|FG001|8-Week Treatment Period|Protocol Violation|1|||
105651844|NCT02675998|364388884|FG002|8-Week Treatment Period|Protocol Violation|1|||
105651845|NCT02675998|364388885|FG003|8-Week Treatment Period|Protocol Violation|0|||
105651846|NCT02675998|364388882|FG000|8-Week Treatment Period|Other|3|||
105651847|NCT02675998|364388883|FG001|8-Week Treatment Period|Other|1|||
105651848|NCT02675998|364388884|FG002|8-Week Treatment Period|Other|2|||
105651849|NCT02675998|364388885|FG003|8-Week Treatment Period|Other|0|||
105651850|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
105651851|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
105651852|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
105651853|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
105651854|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
105651855|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
105651856|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
105651857|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
105651858|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
105651859|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
105651860|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
105651861|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
105651862|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
105651863|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
105651864|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
105651865|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
105651866|NCT02675998|364388882|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
105651867|NCT02675998|364388883|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
105651868|NCT02675998|364388884|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
105651869|NCT02675998|364388885|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
105651870|NCT02916706|364388886|FG000|Overall Study|Adverse Event|0|||
105651871|NCT02916706|364388887|FG001|Overall Study|Adverse Event|1|||
105651872|NCT02916706|364388886|FG000|Overall Study|Lost to Follow-up|0|||
105651873|NCT02916706|364388887|FG001|Overall Study|Lost to Follow-up|1|||
105651874|NCT02916706|364388886|FG000|Overall Study|Physician Decision|1|||
105651875|NCT02916706|364388887|FG001|Overall Study|Physician Decision|0|||
105651876|NCT02916706|364388886|FG000|Overall Study|Protocol Violation|3|||
105651877|NCT02916706|364388887|FG001|Overall Study|Protocol Violation|1|||
105651878|NCT02916706|364388886|FG000|Overall Study|Withdrawal by Subject|6|||
105651879|NCT02916706|364388887|FG001|Overall Study|Withdrawal by Subject|9|||
105651880|NCT02916706|364388886|FG000|Overall Study|Other|5|||
105651881|NCT02916706|364388887|FG001|Overall Study|Other|19|||
105651882|NCT01194271|364388890|FG000|Overall Study|Withdrawal by Subject|1|||
105651883|NCT01194271|364388890|FG000|Overall Study|Ineligible, Screen Failure|1|||
105651884|NCT01194271|364388890|FG000|Overall Study|Death|1|||
105651885|NCT00381797|364388893|FG000|Overall Study|Withdrawal by Subject|1|||
105651886|NCT00381797|364388894|FG001|Overall Study|Withdrawal by Subject|1|||
105651887|NCT00381797|364388895|FG002|Overall Study|Withdrawal by Subject|0|||
105651888|NCT00381797|364388896|FG003|Overall Study|Withdrawal by Subject|0|||
105651889|NCT00381797|364388897|FG004|Overall Study|Withdrawal by Subject|2|||
105651890|NCT00381797|364388893|FG000|Overall Study|Ineligible|0|||
105651891|NCT00381797|364388894|FG001|Overall Study|Ineligible|0|||
105651892|NCT00381797|364388895|FG002|Overall Study|Ineligible|0|||
105651893|NCT00381797|364388896|FG003|Overall Study|Ineligible|1|||
105651894|NCT00381797|364388897|FG004|Overall Study|Ineligible|0|||
105651895|NCT00443898|364388898|FG000|Overall Study|Adverse Event|0|||
105651896|NCT00443898|364388899|FG001|Overall Study|Adverse Event|0|||
105651897|NCT00443898|364388900|FG002|Overall Study|Adverse Event|1|||
105651898|NCT00443898|364388901|FG003|Overall Study|Adverse Event|1|||
105651899|NCT00443898|364388898|FG000|Overall Study|Lack of Efficacy|2|||
105651900|NCT00443898|364388899|FG001|Overall Study|Lack of Efficacy|3|||
105651901|NCT00443898|364388900|FG002|Overall Study|Lack of Efficacy|3|||
105651902|NCT00443898|364388901|FG003|Overall Study|Lack of Efficacy|1|||
105651903|NCT00443898|364388898|FG000|Overall Study|Protocol Violation|1|||
105651904|NCT00443898|364388899|FG001|Overall Study|Protocol Violation|1|||
105651905|NCT00443898|364388900|FG002|Overall Study|Protocol Violation|1|||
105651906|NCT00443898|364388901|FG003|Overall Study|Protocol Violation|0|||
105651907|NCT00443898|364388898|FG000|Overall Study|Withdrawal by Subject|11|||
105651908|NCT00443898|364388899|FG001|Overall Study|Withdrawal by Subject|10|||
105651909|NCT00443898|364388900|FG002|Overall Study|Withdrawal by Subject|10|||
105651910|NCT00443898|364388901|FG003|Overall Study|Withdrawal by Subject|6|||
105651911|NCT00443898|364388898|FG000|Overall Study|Lost to Follow-up|10|||
105651912|NCT00443898|364388899|FG001|Overall Study|Lost to Follow-up|10|||
105651913|NCT00443898|364388900|FG002|Overall Study|Lost to Follow-up|14|||
105651914|NCT00443898|364388901|FG003|Overall Study|Lost to Follow-up|10|||
105651915|NCT00443898|364388898|FG000|Overall Study|Death|0|||
105870390|NCT01290302|365179050|FG000|Overall Study|Adverse Event|2|||
105651916|NCT00443898|364388899|FG001|Overall Study|Death|1|||
105651917|NCT00443898|364388900|FG002|Overall Study|Death|0|||
105651918|NCT00443898|364388901|FG003|Overall Study|Death|0|||
105651919|NCT00958711|364388902|FG000|Overall Study|Withdrawal by Subject|0|||
105651920|NCT00958711|364388903|FG001|Overall Study|Withdrawal by Subject|4|||
105651921|NCT00958711|364388902|FG000|Overall Study|Physician Decision|5|||
105651922|NCT00958711|364388903|FG001|Overall Study|Physician Decision|7|||
105651923|NCT00958711|364388902|FG000|Overall Study|Lost to Follow-up|4|||
105651924|NCT00958711|364388903|FG001|Overall Study|Lost to Follow-up|1|||
105651925|NCT00958711|364388902|FG000|Overall Study|Other|2|||
105651926|NCT00958711|364388903|FG001|Overall Study|Other|5|||
105651927|NCT00958711|364388902|FG000|Overall Study|Death|1|||
105651928|NCT00958711|364388903|FG001|Overall Study|Death|2|||
105651929|NCT00958711|364388902|FG000|Overall Study|Adverse Event|1|||
105651930|NCT00958711|364388903|FG001|Overall Study|Adverse Event|2|||
105651931|NCT03722485|364388904|FG000|Overall Study|Withdrawal by Subject|1|||
105651932|NCT03722485|364388905|FG001|Overall Study|Withdrawal by Subject|0|||
105651933|NCT03722485|364388904|FG000|Overall Study|Adverse Event|0|||
105651934|NCT03722485|364388905|FG001|Overall Study|Adverse Event|2|||
105651935|NCT03722485|364388904|FG000|Overall Study|subject discharged prior to study completion|1|||
105651936|NCT03722485|364388905|FG001|Overall Study|subject discharged prior to study completion|5|||
105651937|NCT03722485|364388904|FG000|Overall Study|eligibility criteria not met|2|||
105651938|NCT03722485|364388905|FG001|Overall Study|eligibility criteria not met|0|||
105651939|NCT00349622|364388906|FG000|Overall Study|Death|168|||
105651940|NCT00349622|364388907|FG001|Overall Study|Death|86|||
105651941|NCT00349622|364388906|FG000|Overall Study|Lost to Follow-up|5|||
105651942|NCT00349622|364388907|FG001|Overall Study|Lost to Follow-up|1|||
105651943|NCT00349622|364388906|FG000|Overall Study|Withdrawal by Subject|5|||
105651944|NCT00349622|364388907|FG001|Overall Study|Withdrawal by Subject|9|||
105651945|NCT00508274|364388912|FG000|Overall Study|Adverse Event|5|||
105651946|NCT00508274|364388912|FG000|Overall Study|Death|7|||
105651947|NCT00508274|364388912|FG000|Overall Study|Disease progression|32|||
105651948|NCT00508274|364388912|FG000|Overall Study|Withdrawal by Subject|1|||
105651949|NCT00508274|364388912|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
105651950|NCT00508274|364388912|FG000|Overall Study|Missing|3|||
105651951|NCT01902381|364388913|FG000|Overall Study|Withdrawal by Subject|1|||
105651952|NCT02229396|364388918|FG000|Overall Study|Adverse Event|6|||
105651953|NCT02229396|364388919|FG001|Overall Study|Adverse Event|12|||
105651954|NCT02229396|364388920|FG002|Overall Study|Adverse Event|12|||
105651955|NCT02229396|364388918|FG000|Overall Study|Death|2|||
105651956|NCT02229396|364388919|FG001|Overall Study|Death|3|||
105651957|NCT02229396|364388920|FG002|Overall Study|Death|1|||
105651958|NCT02229396|364388918|FG000|Overall Study|Lost to Follow-up|14|||
105651959|NCT02229396|364388919|FG001|Overall Study|Lost to Follow-up|14|||
105651960|NCT02229396|364388920|FG002|Overall Study|Lost to Follow-up|21|||
105651961|NCT02229396|364388918|FG000|Overall Study|Protocol Violation|2|||
105651962|NCT02229396|364388919|FG001|Overall Study|Protocol Violation|1|||
105651963|NCT02229396|364388920|FG002|Overall Study|Protocol Violation|0|||
105651964|NCT02229396|364388918|FG000|Overall Study|Patient Incorrectly Randomized|0|||
105651965|NCT02229396|364388919|FG001|Overall Study|Patient Incorrectly Randomized|0|||
105651966|NCT02229396|364388920|FG002|Overall Study|Patient Incorrectly Randomized|1|||
105651967|NCT02229396|364388918|FG000|Overall Study|Other|10|||
105651968|NCT02229396|364388919|FG001|Overall Study|Other|18|||
105651969|NCT02229396|364388920|FG002|Overall Study|Other|15|||
105651970|NCT02229396|364388918|FG000|Overall Study|Withdrawal by Subject|42|||
105651971|NCT02229396|364388919|FG001|Overall Study|Withdrawal by Subject|28|||
105651972|NCT02229396|364388920|FG002|Overall Study|Withdrawal by Subject|41|||
105651973|NCT02229396|364388918|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
105651974|NCT02229396|364388919|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
105651975|NCT02229396|364388920|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
105651976|NCT02229396|364388918|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
105651977|NCT02229396|364388919|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
105651978|NCT02229396|364388920|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
105651979|NCT02396953|364388921|FG000|Overall Study|Withdrawal by Subject|0|||
105651980|NCT02396953|364388922|FG001|Overall Study|Withdrawal by Subject|0|||
105651981|NCT02396953|364388923|FG002|Overall Study|Withdrawal by Subject|1|||
105651982|NCT02396953|364388921|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
105651983|NCT02396953|364388922|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
105651984|NCT02396953|364388923|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
105651985|NCT02396953|364388921|FG000|Overall Study|Personal Reasons|1|||
105651986|NCT02396953|364388922|FG001|Overall Study|Personal Reasons|1|||
105651987|NCT02396953|364388923|FG002|Overall Study|Personal Reasons|0|||
105651988|NCT01812707|364388927|FG000|Overall Study|Adverse Event|0|||
105651989|NCT01812707|364388928|FG001|Overall Study|Adverse Event|0|||
105651990|NCT01812707|364388929|FG002|Overall Study|Adverse Event|0|||
105651991|NCT01812707|364388930|FG003|Overall Study|Adverse Event|2|||
105651992|NCT01812707|364388927|FG000|Overall Study|Poor compliance to protocol|1|||
105651993|NCT01812707|364388928|FG001|Overall Study|Poor compliance to protocol|0|||
105651994|NCT01812707|364388929|FG002|Overall Study|Poor compliance to protocol|0|||
105651995|NCT01812707|364388930|FG003|Overall Study|Poor compliance to protocol|0|||
105651996|NCT01812707|364388927|FG000|Overall Study|Consent withdrawn by participant|1|||
105651997|NCT01812707|364388928|FG001|Overall Study|Consent withdrawn by participant|0|||
105651998|NCT01812707|364388929|FG002|Overall Study|Consent withdrawn by participant|0|||
105651999|NCT01812707|364388930|FG003|Overall Study|Consent withdrawn by participant|0|||
105652000|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
105652001|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652002|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652003|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652004|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652005|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652006|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652007|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652008|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652009|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
105652010|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652011|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652012|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652013|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652014|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652015|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
105652016|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652017|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652018|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652019|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
105652020|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
105652021|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652022|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652023|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652024|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652025|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652026|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652027|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652028|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652029|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
105652030|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105652031|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105652032|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652033|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652034|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652035|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652036|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105652037|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652038|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
105652039|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
105652040|NCT01697592|364388931|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652041|NCT01697592|364388932|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
105652042|NCT01697592|364388933|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
105652043|NCT01697592|364388934|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
105652044|NCT01697592|364388935|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652045|NCT01697592|364388936|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652046|NCT01697592|364388937|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
105652047|NCT01697592|364388938|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652048|NCT01697592|364388939|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
105652049|NCT01697592|364388940|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
105652050|NCT01697592|364388931|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
105652051|NCT01697592|364388932|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652052|NCT01697592|364388933|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652053|NCT01697592|364388934|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
105652054|NCT01697592|364388935|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652055|NCT01697592|364388936|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652056|NCT01697592|364388937|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652057|NCT01697592|364388938|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652058|NCT01697592|364388939|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652059|NCT01697592|364388940|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
105652060|NCT01697592|364388931|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
105652061|NCT01697592|364388932|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652062|NCT01697592|364388933|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652063|NCT01697592|364388934|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652064|NCT01697592|364388935|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652065|NCT01697592|364388936|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
105652066|NCT01697592|364388937|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652067|NCT01697592|364388938|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
105652068|NCT01697592|364388939|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652069|NCT01697592|364388940|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
105652070|NCT01697592|364388931|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
105652071|NCT01697592|364388932|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
105652072|NCT01697592|364388933|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
105652073|NCT01697592|364388934|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
105652074|NCT01697592|364388935|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
105652075|NCT01697592|364388936|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
105652076|NCT01697592|364388937|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
105652077|NCT01697592|364388938|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
105652078|NCT01697592|364388939|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
105652079|NCT01697592|364388940|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
105652080|NCT01631825|364388941|FG000|Overall Study|Adverse Event|42|||
105652081|NCT01631825|364388941|FG000|Overall Study|Lack of Efficacy|7|||
105652082|NCT01631825|364388941|FG000|Overall Study|Withdrawal by Subject|9|||
105652083|NCT01631825|364388941|FG000|Overall Study|Protocol Violation|4|||
105652084|NCT01631825|364388941|FG000|Overall Study|Discontinuation criteria|1|||
105652085|NCT01631825|364388941|FG000|Overall Study|Physician Decision|2|||
105652086|NCT02110225|364388942|FG000|Overall Study|Lost to Follow-up|0|||
105652087|NCT02110225|364388943|FG001|Overall Study|Lost to Follow-up|1|||
105652088|NCT02110225|364388944|FG002|Overall Study|Lost to Follow-up|0|||
105652089|NCT03972137|364388948|FG000|Overall Study|Lost to Follow-up|2|||
105652090|NCT03972137|364388948|FG000|Overall Study|Withdrawal by Subject|4|||
105652091|NCT03029234|364388949|FG000|Overall Study|Sponsor Decision|1|||
105652092|NCT03029234|364388949|FG000|Overall Study|Withdrawal by Subject|5|||
105652093|NCT03029234|364388949|FG000|Overall Study|Death|91|||
105652094|NCT03029234|364388949|FG000|Overall Study|Lost to Follow-up|2|||
105652095|NCT03275402|364388957|FG000|Overall Study|Death|17|||
105652096|NCT03275402|364388957|FG000|Overall Study|Study terminated by sponsor|21|||
105652097|NCT03275402|364388957|FG000|Overall Study|Withdrawal by Subject|1|||
105652098|NCT02254681|364388962|FG000|Overall Study|Lack of Efficacy|6|||
105652099|NCT00396097|364388963|FG000|Overall Study|Withdrawal by Subject|17|||
105652100|NCT00396097|364388964|FG001|Overall Study|Withdrawal by Subject|17|||
105652101|NCT00396097|364388963|FG000|Overall Study|Lost to Follow-up|4|||
105652102|NCT00396097|364388964|FG001|Overall Study|Lost to Follow-up|9|||
105652103|NCT00396097|364388963|FG000|Overall Study|Other|3|||
105652104|NCT00396097|364388964|FG001|Overall Study|Other|5|||
105652105|NCT00396097|364388963|FG000|Overall Study|Protocol Violation|0|||
105652106|NCT00396097|364388964|FG001|Overall Study|Protocol Violation|6|||
105652107|NCT00396097|364388963|FG000|Overall Study|Adverse Event|1|||
105652108|NCT00396097|364388964|FG001|Overall Study|Adverse Event|5|||
105652109|NCT00396097|364388963|FG000|Overall Study|Insufficient Clinical Response|1|||
105652110|NCT00396097|364388964|FG001|Overall Study|Insufficient Clinical Response|4|||
105652111|NCT01525641|364388965|FG000|Overall Study|Case report form not collected|25|||
105652112|NCT01525641|364388965|FG000|Overall Study|No visit since the first visit|16|||
105652113|NCT01525641|364388965|FG000|Overall Study|Adverse Event|73|||
105652114|NCT01525641|364388965|FG000|Overall Study|Lack of Efficacy|24|||
105652115|NCT01525641|364388965|FG000|Overall Study|Improvement|5|||
105652116|NCT01525641|364388965|FG000|Overall Study|Lost to follow-up (relocation)|1|||
105652117|NCT01525641|364388965|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
105652118|NCT01525641|364388965|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
105652119|NCT01525641|364388965|FG000|Overall Study|Other than stated above|7|||
105652120|NCT01264887|364388977|FG000|Overall Study|Adverse Event|5|||
105652121|NCT01264887|364388977|FG000|Overall Study|Death|7|||
105652122|NCT01264887|364388977|FG000|Overall Study|Lack of Efficacy|5|||
105652123|NCT01264887|364388977|FG000|Overall Study|Physician Decision|4|||
105652124|NCT01264887|364388977|FG000|Overall Study|Withdrawal by Subject|6|||
105652125|NCT01264887|364388977|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
105652126|NCT01264887|364388977|FG000|Overall Study|Other|2|||
105652127|NCT00745121|364388978|FG000|Overall Study|Death|3|||
105652128|NCT00745121|364388979|FG001|Overall Study|Death|0|||
105652129|NCT00745121|364388978|FG000|Overall Study|Adverse Event|1|||
105652130|NCT00745121|364388979|FG001|Overall Study|Adverse Event|0|||
105652131|NCT00745121|364388978|FG000|Overall Study|Lost to Follow-up|1|||
105652132|NCT00745121|364388979|FG001|Overall Study|Lost to Follow-up|0|||
105652133|NCT00745121|364388978|FG000|Overall Study|Withdrawal by Subject|4|||
105652134|NCT00745121|364388979|FG001|Overall Study|Withdrawal by Subject|2|||
105652135|NCT00297778|364388980|FG000|Overall Study|Adverse Event|16|||
105652136|NCT00297778|364388981|FG001|Overall Study|Adverse Event|10|||
105652137|NCT00297778|364388980|FG000|Overall Study|Withdrawal by Subject|1|||
105652138|NCT00297778|364388981|FG001|Overall Study|Withdrawal by Subject|5|||
105652139|NCT00297778|364388980|FG000|Overall Study|Lack of Efficacy|2|||
105652140|NCT00297778|364388981|FG001|Overall Study|Lack of Efficacy|1|||
105652141|NCT00297778|364388980|FG000|Overall Study|Non-compliant with trial protocol|0|||
105652142|NCT00297778|364388981|FG001|Overall Study|Non-compliant with trial protocol|3|||
105652143|NCT00297778|364388980|FG000|Overall Study|Other|0|||
105652144|NCT00297778|364388981|FG001|Overall Study|Other|1|||
105652145|NCT01820637|364388984|FG000|Overall Study|Death|2|||
105652146|NCT01820637|364388984|FG000|Overall Study|Withdrawal by Subject|1|||
105652147|NCT00583115|364388985|FG000|Overall Study|Death|1|||
105652148|NCT00264498|364388986|FG000|Randomized Treatment|Death|0|||
105652149|NCT00264498|364388987|FG001|Randomized Treatment|Death|3|||
105652150|NCT00264498|364388986|FG000|Randomized Treatment|Withdrawal by Subject|0|||
105652151|NCT00264498|364388987|FG001|Randomized Treatment|Withdrawal by Subject|1|||
105652152|NCT00264498|364388986|FG000|Randomized Treatment|Objective disease Progression|13|||
105652153|NCT00264498|364388987|FG001|Randomized Treatment|Objective disease Progression|14|||
105652154|NCT00264498|364388986|FG000|Randomized Treatment|Physician Decision|1|||
105652155|NCT00264498|364388987|FG001|Randomized Treatment|Physician Decision|0|||
105652156|NCT00264498|364388986|FG000|Randomized Treatment|Incorrectly randomized|1|||
105652157|NCT00264498|364388987|FG001|Randomized Treatment|Incorrectly randomized|0|||
105652158|NCT00264498|364388986|FG000|Randomized Treatment|Study Closure|1|||
105652159|NCT00264498|364388987|FG001|Randomized Treatment|Study Closure|0|||
105652160|NCT00264498|364388986|FG000|Randomized Treatment|Protocol Violation|1|||
105652161|NCT00264498|364388987|FG001|Randomized Treatment|Protocol Violation|0|||
105652162|NCT00264498|364388986|FG000|Crossover Treatment|Death|1|||
105652163|NCT00264498|364388987|FG001|Crossover Treatment|Death|3|||
105652164|NCT00264498|364388986|FG000|Crossover Treatment|Objective disease progression|4|||
105652165|NCT00264498|364388987|FG001|Crossover Treatment|Objective disease progression|5|||
105652166|NCT00264498|364388986|FG000|Crossover Treatment|Study closure|0|||
105652167|NCT00264498|364388987|FG001|Crossover Treatment|Study closure|1|||
105652168|NCT00264498|364388986|FG000|Crossover Treatment|Withdrawal by Subject|1|||
105652169|NCT00264498|364388987|FG001|Crossover Treatment|Withdrawal by Subject|0|||
105652170|NCT02382406|364388988|FG000|Study Treatment|Disease Progression|8|||
105652171|NCT02382406|364388989|FG001|Study Treatment|Disease Progression|0|||
105652172|NCT02382406|364388990|FG002|Study Treatment|Disease Progression|20|||
105652173|NCT02382406|364388988|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
105652174|NCT02382406|364388989|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
105652175|NCT02382406|364388990|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
105652176|NCT02382406|364388988|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
105652177|NCT02382406|364388989|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
105652178|NCT02382406|364388990|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
105652179|NCT02382406|364388988|FG000|Study Treatment|symptomatic deterioration|1|||
105652180|NCT02382406|364388989|FG001|Study Treatment|symptomatic deterioration|0|||
105652181|NCT02382406|364388990|FG002|Study Treatment|symptomatic deterioration|1|||
105652182|NCT02382406|364388988|FG000|Study Treatment|Death|0|||
105652183|NCT02382406|364388989|FG001|Study Treatment|Death|0|||
105652184|NCT02382406|364388990|FG002|Study Treatment|Death|2|||
105652185|NCT02382406|364388988|FG000|Follow up|Death|11|||
105652186|NCT02382406|364388989|FG001|Follow up|Death|0|||
105652187|NCT02382406|364388990|FG002|Follow up|Death|19|||
105652188|NCT02382406|364388988|FG000|Follow up|Symptomatic deterioration|1|||
105652189|NCT02382406|364388989|FG001|Follow up|Symptomatic deterioration|0|||
105652190|NCT02382406|364388990|FG002|Follow up|Symptomatic deterioration|1|||
105652191|NCT02382406|364388988|FG000|Follow up|Patient Refused Follow-up|1|||
105652192|NCT02382406|364388989|FG001|Follow up|Patient Refused Follow-up|0|||
105652193|NCT02382406|364388990|FG002|Follow up|Patient Refused Follow-up|0|||
105652194|NCT02382406|364388988|FG000|Follow up|Study Terminated|1|||
105652195|NCT02382406|364388989|FG001|Follow up|Study Terminated|0|||
105652196|NCT02382406|364388990|FG002|Follow up|Study Terminated|8|||
105652197|NCT02382406|364388988|FG000|Follow up|Withdrawal by Subject|0|||
105652198|NCT02382406|364388989|FG001|Follow up|Withdrawal by Subject|0|||
105652199|NCT02382406|364388990|FG002|Follow up|Withdrawal by Subject|2|||
105652200|NCT01713998|364388991|FG000|Overall Study|Lost to Follow-up|2|||
105652201|NCT01713998|364388992|FG001|Overall Study|Lost to Follow-up|0|||
105652202|NCT01713998|364388993|FG002|Overall Study|Lost to Follow-up|2|||
105652203|NCT01713998|364388991|FG000|Overall Study|Withdrawal by Subject|1|||
105652204|NCT01713998|364388992|FG001|Overall Study|Withdrawal by Subject|0|||
105652205|NCT01713998|364388993|FG002|Overall Study|Withdrawal by Subject|0|||
105652206|NCT03638258|364388994|FG000|Overall Study|Adverse Event|1|||
105652207|NCT03638258|364388995|FG001|Overall Study|Adverse Event|0|||
105652208|NCT03638258|364388996|FG002|Overall Study|Adverse Event|2|||
105652209|NCT03638258|364388994|FG000|Overall Study|Lost to Follow-up|2|||
105652210|NCT03638258|364388995|FG001|Overall Study|Lost to Follow-up|4|||
105652211|NCT03638258|364388996|FG002|Overall Study|Lost to Follow-up|5|||
105652212|NCT03638258|364388994|FG000|Overall Study|Pregnancy|0|||
105652213|NCT03638258|364388995|FG001|Overall Study|Pregnancy|0|||
105652214|NCT03638258|364388996|FG002|Overall Study|Pregnancy|1|||
105652215|NCT03638258|364388994|FG000|Overall Study|Protocol Violation|0|||
105652216|NCT03638258|364388995|FG001|Overall Study|Protocol Violation|0|||
105652217|NCT03638258|364388996|FG002|Overall Study|Protocol Violation|1|||
105652218|NCT03638258|364388994|FG000|Overall Study|Withdrawal by Subject|4|||
105652219|NCT03638258|364388995|FG001|Overall Study|Withdrawal by Subject|5|||
105652220|NCT03638258|364388996|FG002|Overall Study|Withdrawal by Subject|12|||
105652221|NCT03638258|364388994|FG000|Overall Study|Lack of Efficacy|0|||
105652222|NCT03638258|364388995|FG001|Overall Study|Lack of Efficacy|0|||
105652223|NCT03638258|364388996|FG002|Overall Study|Lack of Efficacy|2|||
105652224|NCT03048058|364388998|FG000|Overall Study|Lost to Follow-up|4|||
105652225|NCT03048058|364388999|FG001|Overall Study|Lost to Follow-up|0|||
105652226|NCT03048058|364388998|FG000|Overall Study|Withdrawal by Subject|0|||
105652227|NCT03048058|364388999|FG001|Overall Study|Withdrawal by Subject|4|||
105652228|NCT01527500|364389000|FG000|Part A|Administrative|11|||
105652229|NCT01527500|364389001|FG001|Part A|Administrative|7|||
105652230|NCT01527500|364389000|FG000|Part A|Adverse Event|4|||
105652231|NCT01527500|364389001|FG001|Part A|Adverse Event|2|||
105652232|NCT01527500|364389000|FG000|Part A|Death|4|||
105652233|NCT01527500|364389001|FG001|Part A|Death|1|||
105652234|NCT01527500|364389000|FG000|Part A|Lost to Follow-up|0|||
105652235|NCT01527500|364389001|FG001|Part A|Lost to Follow-up|1|||
105652236|NCT01527500|364389000|FG000|Part A|Protocol Deviation|9|||
105652237|NCT01527500|364389001|FG001|Part A|Protocol Deviation|2|||
105652238|NCT01527500|364389000|FG000|Part A|Withdrawal by Subject|2|||
105652239|NCT01527500|364389001|FG001|Part A|Withdrawal by Subject|0|||
105652240|NCT01527500|364389000|FG000|Part B|Adverse Event|1|||
105652241|NCT01527500|364389001|FG001|Part B|Adverse Event|0|||
105652242|NCT01287416|364389002|FG000|Pre-post Training|Withdrawal by Subject|17|||
105652243|NCT01287416|364389003|FG001|Pre-post Training|Withdrawal by Subject|24|||
105652244|NCT01287416|364389002|FG000|Pre-post Training|Lost to Follow-up|5|||
105652245|NCT01287416|364389003|FG001|Pre-post Training|Lost to Follow-up|1|||
105652246|NCT01287416|364389002|FG000|6 Month Follow-up|Lost to Follow-up|3|||
105652247|NCT01287416|364389003|FG001|6 Month Follow-up|Lost to Follow-up|2|||
105652248|NCT01747629|364389006|FG000|Overall Study|Adverse Event|1|||
105652249|NCT01747629|364389007|FG001|Overall Study|Adverse Event|2|||
105652250|NCT01747629|364389006|FG000|Overall Study|Withdrawal by Subject|2|||
105652251|NCT01747629|364389007|FG001|Overall Study|Withdrawal by Subject|2|||
105652252|NCT01747629|364389006|FG000|Overall Study|Noncompliance|1|||
105652253|NCT01747629|364389007|FG001|Overall Study|Noncompliance|1|||
105652254|NCT01747629|364389006|FG000|Overall Study|Inclusion criteria not met|1|||
105652255|NCT01747629|364389007|FG001|Overall Study|Inclusion criteria not met|0|||
105652256|NCT01747629|364389006|FG000|Overall Study|Not treated|1|||
105652257|NCT01747629|364389007|FG001|Overall Study|Not treated|0|||
105652258|NCT01747629|364389006|FG000|Overall Study|Other|2|||
105652259|NCT01747629|364389007|FG001|Overall Study|Other|1|||
105652260|NCT02016690|364389008|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
105652261|NCT02016690|364389008|FG000|Overall Study|Excluded from SAS: Duplication|2|||
105652262|NCT02016690|364389008|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
105652263|NCT02016690|364389008|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
105652264|NCT02016690|364389008|FG000|Overall Study|Did not meet inclusion criteria|13|||
105652265|NCT02016690|364389008|FG000|Overall Study|Hospitalized for RSV at study start|3|||
105652266|NCT02865135|364389009|FG000|Overall Study|Death|0|||
105652267|NCT02865135|364389010|FG001|Overall Study|Death|1|||
105652268|NCT02865135|364389011|FG002|Overall Study|Death|0|||
105652269|NCT02865135|364389009|FG000|Overall Study|Progression|6|||
105652270|NCT02865135|364389010|FG001|Overall Study|Progression|2|||
105652271|NCT02865135|364389011|FG002|Overall Study|Progression|2|||
105652272|NCT01078584|364389013|FG000|Overall Study|Final Status Unknown|1073|||
105652273|NCT01078584|364389013|FG000|Overall Study|Lost to Follow-up|670|||
105652274|NCT01078584|364389013|FG000|Overall Study|Non-serious Adverse Event|577|||
105652275|NCT01078584|364389013|FG000|Overall Study|Withdrawal of Consent|244|||
105652276|NCT01078584|364389013|FG000|Overall Study|Physician Withdrew from Study|90|||
105652277|NCT01078584|364389013|FG000|Overall Study|Non-compliance|67|||
105652278|NCT01078584|364389013|FG000|Overall Study|Blood Pressure Controlled|49|||
105652279|NCT01078584|364389013|FG000|Overall Study|Physician Switched Medication|26|||
105652280|NCT01078584|364389013|FG000|Overall Study|Physician Discontinued Patient|12|||
105652281|NCT01078584|364389013|FG000|Overall Study|Lack of Efficacy|98|||
105652282|NCT01078584|364389013|FG000|Overall Study|Protocol Violation|75|||
105652283|NCT01078584|364389013|FG000|Overall Study|Serious Adverse Event|27|||
105652284|NCT01078584|364389013|FG000|Overall Study|Multiple Reasons|2|||
105652285|NCT01121185|364389014|FG000|Overall Study|Not infused|0|||
105652286|NCT01121185|364389015|FG001|Overall Study|Not infused|1|||
105652287|NCT01121185|364389014|FG000|Overall Study|Not transplanted|1|||
105652288|NCT01121185|364389015|FG001|Overall Study|Not transplanted|0|||
105652289|NCT01077622|364389016|FG000|Overall Study|Physician Decision|2|||
105652290|NCT01077622|364389016|FG000|Overall Study|Withdrawal by Subject|1|||
105652291|NCT01177228|364389017|FG000|Overall Study|Positive tuberculosis test|0|||
105652292|NCT01177228|364389018|FG001|Overall Study|Positive tuberculosis test|1|||
105652293|NCT01177228|364389019|FG002|Overall Study|Positive tuberculosis test|0|||
105652294|NCT01177228|364389020|FG003|Overall Study|Positive tuberculosis test|0|||
105652295|NCT01177228|364389017|FG000|Overall Study|Worsening disease activity|1|||
105652296|NCT01177228|364389018|FG001|Overall Study|Worsening disease activity|0|||
105652297|NCT01177228|364389019|FG002|Overall Study|Worsening disease activity|0|||
105652298|NCT01177228|364389020|FG003|Overall Study|Worsening disease activity|0|||
105652299|NCT01177228|364389017|FG000|Overall Study|Withdrawal by Subject|0|||
105652300|NCT01177228|364389018|FG001|Overall Study|Withdrawal by Subject|1|||
105652301|NCT01177228|364389019|FG002|Overall Study|Withdrawal by Subject|0|||
105652302|NCT01177228|364389020|FG003|Overall Study|Withdrawal by Subject|0|||
105652303|NCT01180790|364389021|FG000|Overall Study|Adverse Event|1|||
105652304|NCT01180790|364389022|FG001|Overall Study|Adverse Event|1|||
105652305|NCT01180790|364389023|FG002|Overall Study|Adverse Event|2|||
105652306|NCT01180790|364389024|FG003|Overall Study|Adverse Event|0|||
105652307|NCT01180790|364389025|FG004|Overall Study|Adverse Event|1|||
105652308|NCT01180790|364389026|FG005|Overall Study|Adverse Event|3|||
105652309|NCT01180790|364389027|FG006|Overall Study|Adverse Event|0|||
105652310|NCT01180790|364389021|FG000|Overall Study|Withdrawal by Subject|3|||
105652311|NCT01180790|364389022|FG001|Overall Study|Withdrawal by Subject|0|||
105652312|NCT01180790|364389023|FG002|Overall Study|Withdrawal by Subject|5|||
105652313|NCT01180790|364389024|FG003|Overall Study|Withdrawal by Subject|0|||
105652314|NCT01180790|364389025|FG004|Overall Study|Withdrawal by Subject|2|||
105652315|NCT01180790|364389026|FG005|Overall Study|Withdrawal by Subject|1|||
105652316|NCT01180790|364389027|FG006|Overall Study|Withdrawal by Subject|0|||
105652317|NCT01180790|364389021|FG000|Overall Study|Lost to Follow-up|3|||
105652318|NCT01180790|364389022|FG001|Overall Study|Lost to Follow-up|1|||
105652319|NCT01180790|364389023|FG002|Overall Study|Lost to Follow-up|0|||
105652320|NCT01180790|364389024|FG003|Overall Study|Lost to Follow-up|2|||
105652321|NCT01180790|364389025|FG004|Overall Study|Lost to Follow-up|1|||
105652322|NCT01180790|364389026|FG005|Overall Study|Lost to Follow-up|0|||
105652323|NCT01180790|364389027|FG006|Overall Study|Lost to Follow-up|1|||
105652324|NCT01180790|364389021|FG000|Overall Study|Physician Decision|1|||
105652325|NCT01180790|364389022|FG001|Overall Study|Physician Decision|0|||
105652326|NCT01180790|364389023|FG002|Overall Study|Physician Decision|0|||
105652327|NCT01180790|364389024|FG003|Overall Study|Physician Decision|1|||
105652328|NCT01180790|364389025|FG004|Overall Study|Physician Decision|0|||
105652329|NCT01180790|364389026|FG005|Overall Study|Physician Decision|0|||
105652330|NCT01180790|364389027|FG006|Overall Study|Physician Decision|0|||
105652331|NCT01180790|364389021|FG000|Overall Study|Lack of Efficacy|1|||
105652332|NCT01180790|364389022|FG001|Overall Study|Lack of Efficacy|2|||
105652333|NCT01180790|364389023|FG002|Overall Study|Lack of Efficacy|5|||
105652334|NCT01180790|364389024|FG003|Overall Study|Lack of Efficacy|6|||
105652335|NCT01180790|364389025|FG004|Overall Study|Lack of Efficacy|1|||
105652336|NCT01180790|364389026|FG005|Overall Study|Lack of Efficacy|3|||
105652337|NCT01180790|364389027|FG006|Overall Study|Lack of Efficacy|0|||
105652338|NCT01180790|364389021|FG000|Overall Study|compliance|0|||
105652339|NCT01180790|364389022|FG001|Overall Study|compliance|1|||
105652340|NCT01180790|364389023|FG002|Overall Study|compliance|0|||
105652341|NCT01180790|364389024|FG003|Overall Study|compliance|0|||
105652342|NCT01180790|364389025|FG004|Overall Study|compliance|0|||
105652343|NCT01180790|364389026|FG005|Overall Study|compliance|0|||
105652344|NCT01180790|364389027|FG006|Overall Study|compliance|0|||
105652345|NCT01180790|364389021|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652346|NCT01180790|364389022|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652347|NCT01180790|364389023|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
105652348|NCT01180790|364389024|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652349|NCT01180790|364389025|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652350|NCT01180790|364389026|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652351|NCT01180790|364389027|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
105652352|NCT02040532|364389028|FG000|Overall Study|Lost to Follow-up|1|||
105652353|NCT02040532|364389028|FG000|Overall Study|Physician Decision|4|||
105652354|NCT02040532|364389028|FG000|Overall Study|Adverse Event|4|||
105652355|NCT02040532|364389028|FG000|Overall Study|Withdrawal by Subject|3|||
105652356|NCT02820298|364389031|FG000|Overall Study|Withdrawal by Subject|0|||
105652357|NCT02820298|364389032|FG001|Overall Study|Withdrawal by Subject|1|||
105652358|NCT02820298|364389031|FG000|Overall Study|Physician Decision|1|||
105652359|NCT02820298|364389032|FG001|Overall Study|Physician Decision|0|||
105652360|NCT02820298|364389031|FG000|Overall Study|Protocol Violation|0|||
105652361|NCT02820298|364389032|FG001|Overall Study|Protocol Violation|1|||
105652362|NCT00562484|364389033|FG000|Overall Study|Adverse Event|6|||
105652363|NCT00562484|364389034|FG001|Overall Study|Adverse Event|1|||
105652364|NCT00562484|364389033|FG000|Overall Study|Protocol Violation|11|||
105652365|NCT00562484|364389034|FG001|Overall Study|Protocol Violation|2|||
105652366|NCT00562484|364389033|FG000|Overall Study|Withdrawal by Subject|12|||
105652367|NCT00562484|364389034|FG001|Overall Study|Withdrawal by Subject|9|||
105652368|NCT00562484|364389033|FG000|Overall Study|Moved away from the study area|20|||
105652369|NCT00562484|364389034|FG001|Overall Study|Moved away from the study area|9|||
105652370|NCT00562484|364389033|FG000|Overall Study|Lost to Follow-up|132|||
105652371|NCT00562484|364389034|FG001|Overall Study|Lost to Follow-up|71|||
105652372|NCT00562484|364389033|FG000|Overall Study|Reason not provided or not specified|25|||
105652373|NCT00562484|364389034|FG001|Overall Study|Reason not provided or not specified|12|||
105652374|NCT03749616|364389035|FG000|Overall Study|Lost to Follow-up|4|||
105652375|NCT03749616|364389036|FG001|Overall Study|Lost to Follow-up|7|||
105652376|NCT03749616|364389035|FG000|Overall Study|Screen Failure|1|||
105652377|NCT03749616|364389036|FG001|Overall Study|Screen Failure|1|||
105652378|NCT03749616|364389035|FG000|Overall Study|Withdrawal by Subject|2|||
105652379|NCT03749616|364389036|FG001|Overall Study|Withdrawal by Subject|0|||
105652380|NCT00919061|364389037|FG000|Overall Study|Adverse Event|1|||
105652381|NCT00919061|364389037|FG000|Overall Study|Withdrawal by Subject|1|||
105652382|NCT00837096|364390436|FG000|Overall Study|Physician Decision|1|||
105652383|NCT00837096|364390437|FG001|Overall Study|Physician Decision|1|||
105652384|NCT00837096|364390436|FG000|Overall Study|Not reported|9|||
105652385|NCT00837096|364390437|FG001|Overall Study|Not reported|8|||
105652386|NCT01084239|364390440|FG000|28-Day Follow-up|Lost to Follow-up|4|||
105652387|NCT01084239|364390441|FG001|28-Day Follow-up|Lost to Follow-up|9|||
105652388|NCT00550771|364390442|FG000|Overall Study|Adverse Event|11|||
105652389|NCT00550771|364390443|FG001|Overall Study|Adverse Event|3|||
105652390|NCT00550771|364390442|FG000|Overall Study|Discontinued for study-related reasons|0|||
105652391|NCT00550771|364390443|FG001|Overall Study|Discontinued for study-related reasons|1|||
105652392|NCT00550771|364390442|FG000|Overall Study|Physician Decision|2|||
105652393|NCT00550771|364390443|FG001|Overall Study|Physician Decision|0|||
105652394|NCT00550771|364390442|FG000|Overall Study|Withdrawal by Subject|0|||
105652395|NCT00550771|364390443|FG001|Overall Study|Withdrawal by Subject|1|||
105652396|NCT00550771|364390442|FG000|Overall Study|Protocol Violation|4|||
105652397|NCT00550771|364390443|FG001|Overall Study|Protocol Violation|5|||
105652398|NCT01011049|364390448|FG000|Overall Study|Protocol Violation|0|||
105652399|NCT01011049|364390449|FG001|Overall Study|Protocol Violation|0|||
105652400|NCT01011049|364390450|FG002|Overall Study|Protocol Violation|2|||
105652401|NCT01011049|364390451|FG003|Overall Study|Protocol Violation|0|||
105652402|NCT01011049|364390448|FG000|Overall Study|Lost to Follow-up|1|||
105652403|NCT01011049|364390449|FG001|Overall Study|Lost to Follow-up|2|||
105652404|NCT01011049|364390450|FG002|Overall Study|Lost to Follow-up|1|||
105652405|NCT01011049|364390451|FG003|Overall Study|Lost to Follow-up|0|||
105652406|NCT01011049|364390448|FG000|Overall Study|Withdrawal by Subject|0|||
105652407|NCT01011049|364390449|FG001|Overall Study|Withdrawal by Subject|0|||
105652408|NCT01011049|364390450|FG002|Overall Study|Withdrawal by Subject|1|||
105652409|NCT01011049|364390451|FG003|Overall Study|Withdrawal by Subject|0|||
105652410|NCT02435381|364390452|FG000|Overall Study|Lost to Follow-up|2|||
105652411|NCT02435381|364390453|FG001|Overall Study|Lost to Follow-up|1|||
105652412|NCT00833898|364390454|FG000|Overall Study|Withdrawal by Subject|33|||
105652413|NCT00833898|364390455|FG001|Overall Study|Withdrawal by Subject|27|||
105652414|NCT00833898|364390454|FG000|Overall Study|Lost to Follow-up|7|||
105652415|NCT00833898|364390455|FG001|Overall Study|Lost to Follow-up|7|||
105652416|NCT00833898|364390454|FG000|Overall Study|Patient did not receive transplant|0|||
105652417|NCT00833898|364390455|FG001|Overall Study|Patient did not receive transplant|2|||
105652418|NCT05109117|364390456|FG000|Overall Study|Lost to Follow-up|1|||
105652419|NCT05109117|364390456|FG000|Overall Study|Discontinued for non-compliance|1|||
105652420|NCT03220776|364390457|FG000|Overall Study|Claustrophobia|0|||
105652421|NCT03220776|364390458|FG001|Overall Study|Claustrophobia|1|||
105652422|NCT03220776|364390459|FG002|Overall Study|Claustrophobia|1|||
105652423|NCT03220776|364390460|FG003|Overall Study|Claustrophobia|0|||
105652424|NCT03220776|364390461|FG004|Overall Study|Claustrophobia|1|||
105652425|NCT03220776|364390462|FG005|Overall Study|Claustrophobia|0|||
105652426|NCT03220776|364390457|FG000|Overall Study|MRI Equipment Failure|1|||
105652427|NCT03220776|364390458|FG001|Overall Study|MRI Equipment Failure|0|||
105652428|NCT03220776|364390459|FG002|Overall Study|MRI Equipment Failure|0|||
105652429|NCT03220776|364390460|FG003|Overall Study|MRI Equipment Failure|0|||
105652430|NCT03220776|364390461|FG004|Overall Study|MRI Equipment Failure|0|||
105652431|NCT03220776|364390462|FG005|Overall Study|MRI Equipment Failure|0|||
105652432|NCT03220776|364390457|FG000|Overall Study|Inclimate Weather|0|||
105652433|NCT03220776|364390458|FG001|Overall Study|Inclimate Weather|0|||
105652434|NCT03220776|364390459|FG002|Overall Study|Inclimate Weather|0|||
105652435|NCT03220776|364390460|FG003|Overall Study|Inclimate Weather|0|||
105652436|NCT03220776|364390461|FG004|Overall Study|Inclimate Weather|0|||
105652437|NCT03220776|364390462|FG005|Overall Study|Inclimate Weather|1|||
105652438|NCT03220776|364390457|FG000|Overall Study|Physician Decision|0|||
105652439|NCT03220776|364390458|FG001|Overall Study|Physician Decision|0|||
105652440|NCT03220776|364390459|FG002|Overall Study|Physician Decision|0|||
105652441|NCT03220776|364390460|FG003|Overall Study|Physician Decision|1|||
105652442|NCT03220776|364390461|FG004|Overall Study|Physician Decision|0|||
105652443|NCT03220776|364390462|FG005|Overall Study|Physician Decision|0|||
105652444|NCT03220776|364390457|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652445|NCT03220776|364390458|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652446|NCT03220776|364390459|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652447|NCT03220776|364390460|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
105652448|NCT03220776|364390461|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652449|NCT03220776|364390462|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
105652450|NCT03220776|364390457|FG000|Overall Study|Protocol Violation|0|||
105652451|NCT03220776|364390458|FG001|Overall Study|Protocol Violation|0|||
105652452|NCT03220776|364390459|FG002|Overall Study|Protocol Violation|0|||
105652453|NCT03220776|364390460|FG003|Overall Study|Protocol Violation|2|||
105652454|NCT03220776|364390461|FG004|Overall Study|Protocol Violation|0|||
105652455|NCT03220776|364390462|FG005|Overall Study|Protocol Violation|1|||
105652456|NCT03220776|364390457|FG000|Overall Study|Withdrawal by Subject|1|||
105652457|NCT03220776|364390458|FG001|Overall Study|Withdrawal by Subject|0|||
105652458|NCT03220776|364390459|FG002|Overall Study|Withdrawal by Subject|0|||
105652459|NCT03220776|364390460|FG003|Overall Study|Withdrawal by Subject|0|||
105652460|NCT03220776|364390461|FG004|Overall Study|Withdrawal by Subject|0|||
105652461|NCT03220776|364390462|FG005|Overall Study|Withdrawal by Subject|0|||
105652462|NCT03168425|364390463|FG000|Overall Study|Lost to Follow-up|5|||
105652463|NCT03168425|364390464|FG001|Overall Study|Lost to Follow-up|8|||
105652464|NCT03168425|364390463|FG000|Overall Study|unable to confirm post op opioids|2|||
105652465|NCT03168425|364390464|FG001|Overall Study|unable to confirm post op opioids|3|||
105652466|NCT00744796|364390465|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
105652467|NCT00588341|364390469|FG000|Overall Study|Withdrawal by Subject|3|||
105652468|NCT00588341|364390469|FG000|Overall Study|Not treated due to metastatic disease|1|||
105652469|NCT00588341|364390469|FG000|Overall Study|Patient ineligible|1|||
105652470|NCT02642159|364390470|FG000|Overall Study|Randomized but not treated|1|||
105652471|NCT02642159|364390471|FG001|Overall Study|Randomized but not treated|0|||
105652472|NCT02642159|364390470|FG000|Overall Study|Adverse Event|10|||
105652473|NCT02642159|364390471|FG001|Overall Study|Adverse Event|4|||
105652474|NCT02642159|364390470|FG000|Overall Study|Withdrawal by Subject|9|||
105652475|NCT02642159|364390471|FG001|Overall Study|Withdrawal by Subject|1|||
105652476|NCT02642159|364390470|FG000|Overall Study|Poor compliance to study protocol|1|||
105652477|NCT02642159|364390471|FG001|Overall Study|Poor compliance to study protocol|0|||
105652478|NCT02642159|364390470|FG000|Overall Study|Other than specified above|10|||
105652479|NCT02642159|364390471|FG001|Overall Study|Other than specified above|3|||
105652480|NCT00679549|364390476|FG000|Overall Study|dropout|2|||
105652481|NCT00679549|364390477|FG001|Overall Study|dropout|4|||
105652482|NCT00679549|364390476|FG000|Overall Study|missing outcome echocardiograms|4|||
105652483|NCT00679549|364390477|FG001|Overall Study|missing outcome echocardiograms|5|||
105652484|NCT02282917|364390486|FG000|Overall Study|Withdrawal by Subject|1|||
105652485|NCT02282917|364390486|FG000|Overall Study|Screen Failure/Not Eligible|1|||
105652486|NCT03340766|364390497|FG000|Overall Study|Withdrawal by Subject|2|||
105652487|NCT03340766|364390498|FG001|Overall Study|Withdrawal by Subject|1|||
105652488|NCT03340766|364390499|FG002|Overall Study|Withdrawal by Subject|3|||
105652489|NCT03340766|364390497|FG000|Overall Study|Lost to Follow-up|0|||
105652490|NCT03340766|364390498|FG001|Overall Study|Lost to Follow-up|0|||
105652491|NCT03340766|364390499|FG002|Overall Study|Lost to Follow-up|1|||
105652492|NCT03340766|364390497|FG000|Overall Study|Death|6|||
105652493|NCT03340766|364390498|FG001|Overall Study|Death|7|||
105652494|NCT03340766|364390499|FG002|Overall Study|Death|4|||
105652495|NCT01876823|364390500|FG000|Overall Study|Withdrawal by Subject|5|||
105652496|NCT01876823|364390500|FG000|Overall Study|Physician Decision|2|||
105652497|NCT01876823|364390500|FG000|Overall Study|Patients moved|2|||
105652498|NCT02256488|364390503|FG000|Overall Study|Lost to Follow-up|6|||
105652499|NCT02256488|364390504|FG001|Overall Study|Lost to Follow-up|6|||
105652500|NCT02256488|364390505|FG002|Overall Study|Lost to Follow-up|9|||
105652501|NCT02256488|364390506|FG003|Overall Study|Lost to Follow-up|3|||
105652502|NCT02256488|364390503|FG000|Overall Study|OTHER|1|||
105652503|NCT02256488|364390504|FG001|Overall Study|OTHER|0|||
105652504|NCT02256488|364390505|FG002|Overall Study|OTHER|1|||
105652505|NCT02256488|364390506|FG003|Overall Study|OTHER|1|||
105652506|NCT02256488|364390503|FG000|Overall Study|Withdrawal by Subject|1|||
105652507|NCT02256488|364390504|FG001|Overall Study|Withdrawal by Subject|0|||
105652508|NCT02256488|364390505|FG002|Overall Study|Withdrawal by Subject|0|||
105652509|NCT02256488|364390506|FG003|Overall Study|Withdrawal by Subject|2|||
105652510|NCT02864147|364390510|FG000|Overall Study|Withdrawal by Subject|3|||
105652511|NCT02864147|364390511|FG001|Overall Study|Withdrawal by Subject|2|||
105652512|NCT02864147|364390512|FG002|Overall Study|Withdrawal by Subject|1|||
105652513|NCT02864147|364390510|FG000|Overall Study|Lost to Follow-up|0|||
105652514|NCT02864147|364390511|FG001|Overall Study|Lost to Follow-up|4|||
105652515|NCT02864147|364390512|FG002|Overall Study|Lost to Follow-up|0|||
105652516|NCT02864147|364390510|FG000|Overall Study|Adverse Event|0|||
105652517|NCT02864147|364390511|FG001|Overall Study|Adverse Event|1|||
105652518|NCT02864147|364390512|FG002|Overall Study|Adverse Event|0|||
105652519|NCT02864147|364390510|FG000|Overall Study|Pregnancy|4|||
105652520|NCT02864147|364390511|FG001|Overall Study|Pregnancy|0|||
105652521|NCT02864147|364390512|FG002|Overall Study|Pregnancy|0|||
105870391|NCT01290302|365179051|FG001|Overall Study|Adverse Event|0|||
105652522|NCT02864147|364390510|FG000|Overall Study|Physician Decision|0|||
105652523|NCT02864147|364390511|FG001|Overall Study|Physician Decision|0|||
105652524|NCT02864147|364390512|FG002|Overall Study|Physician Decision|1|||
105652525|NCT02864147|364390510|FG000|Overall Study|Opted for excisional procedures|0|||
105652526|NCT02864147|364390511|FG001|Overall Study|Opted for excisional procedures|0|||
105652527|NCT02864147|364390512|FG002|Overall Study|Opted for excisional procedures|3|||
105652528|NCT00240097|364390513|FG000|Part I|Adverse Event|1|||
105652529|NCT00240097|364390513|FG000|Part I|Death|1|||
105652530|NCT00240097|364390513|FG000|Part I|histology|1|||
105652531|NCT00240097|364390513|FG000|Part I|unevaluable|1|||
105652532|NCT00240097|364390513|FG000|Part II|did not continue from Part I|23|||
105870392|NCT01290302|365179050|FG000|Overall Study|Withdrawal by Subject|1|||
105652533|NCT02383927|364390514|FG000|Overall Study|Disease Progression|8|||
105652534|NCT02383927|364390515|FG001|Overall Study|Disease Progression|8|||
105652535|NCT02383927|364390516|FG002|Overall Study|Disease Progression|15|||
105652536|NCT02383927|364390517|FG003|Overall Study|Disease Progression|4|||
105652537|NCT02383927|364390514|FG000|Overall Study|Physician Decision|0|||
105652538|NCT02383927|364390515|FG001|Overall Study|Physician Decision|0|||
105652539|NCT02383927|364390516|FG002|Overall Study|Physician Decision|2|||
105652540|NCT02383927|364390517|FG003|Overall Study|Physician Decision|0|||
105652541|NCT02383927|364390514|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
105652542|NCT02383927|364390515|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
105652543|NCT02383927|364390516|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
105652544|NCT02383927|364390517|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
105652545|NCT02383927|364390514|FG000|Overall Study|Adverse Event|4|||
105652546|NCT02383927|364390515|FG001|Overall Study|Adverse Event|1|||
105652547|NCT02383927|364390516|FG002|Overall Study|Adverse Event|3|||
105652548|NCT02383927|364390517|FG003|Overall Study|Adverse Event|5|||
105652549|NCT02383927|364390514|FG000|Overall Study|Miscellaneous|1|||
105652550|NCT02383927|364390515|FG001|Overall Study|Miscellaneous|0|||
105652551|NCT02383927|364390516|FG002|Overall Study|Miscellaneous|0|||
105652552|NCT02383927|364390517|FG003|Overall Study|Miscellaneous|1|||
105652553|NCT02383927|364390514|FG000|Overall Study|Withdrawal by Subject|0|||
105652554|NCT02383927|364390515|FG001|Overall Study|Withdrawal by Subject|1|||
105652555|NCT02383927|364390516|FG002|Overall Study|Withdrawal by Subject|4|||
105652556|NCT02383927|364390517|FG003|Overall Study|Withdrawal by Subject|0|||
105652557|NCT00981578|364390518|FG000|Overall Study|Death|1|||
105652558|NCT00981578|364390518|FG000|Overall Study|Withdrawal by Subject|2|||
105652559|NCT01592383|364390521|FG000|Overall Study|Adverse Event|1|||
105652560|NCT04582864|364390524|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
105652561|NCT04582864|364390524|FG000|Overall Study|Death|1|||
105652562|NCT01064856|364390526|FG000|Double-blind (DB) Period|Adverse Event|1|||
105652563|NCT01064856|364390527|FG001|Double-blind (DB) Period|Adverse Event|0|||
105652564|NCT01064856|364390528|FG002|Double-blind (DB) Period|Adverse Event|0|||
105652565|NCT01064856|364390529|FG003|Double-blind (DB) Period|Adverse Event|0|||
105652566|NCT01064856|364390526|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
105652567|NCT01064856|364390527|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
105652568|NCT01064856|364390528|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
105652569|NCT01064856|364390529|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
105652570|NCT01064856|364390526|FG000|Open-label (OL) Period|Adverse Event|0|||
105652571|NCT01064856|364390527|FG001|Open-label (OL) Period|Adverse Event|0|||
105652572|NCT01064856|364390528|FG002|Open-label (OL) Period|Adverse Event|12|||
105652573|NCT01064856|364390529|FG003|Open-label (OL) Period|Adverse Event|6|||
105652574|NCT01064856|364390526|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
105652575|NCT01064856|364390527|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
105652576|NCT01064856|364390528|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
105652577|NCT01064856|364390529|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
105652578|NCT01064856|364390526|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
105652579|NCT01064856|364390527|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
105652580|NCT01064856|364390528|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
105652581|NCT01064856|364390529|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
105652582|NCT01064856|364390526|FG000|Open-label (OL) Period|Other|0|||
105652583|NCT01064856|364390527|FG001|Open-label (OL) Period|Other|0|||
105652584|NCT01064856|364390528|FG002|Open-label (OL) Period|Other|7|||
105652585|NCT01064856|364390529|FG003|Open-label (OL) Period|Other|7|||
105652586|NCT01780584|364390532|FG000|Overall Study|Death|1|||
105652587|NCT01780584|364390533|FG001|Overall Study|Death|0|||
105652588|NCT01780584|364390534|FG002|Overall Study|Death|1|||
105652589|NCT01780584|364390532|FG000|Overall Study|Adverse Event|0|||
105652590|NCT01780584|364390533|FG001|Overall Study|Adverse Event|1|||
105652591|NCT01780584|364390534|FG002|Overall Study|Adverse Event|0|||
105652592|NCT01780584|364390532|FG000|Overall Study|Protocol Violation|0|||
105652593|NCT01780584|364390533|FG001|Overall Study|Protocol Violation|0|||
105652594|NCT01780584|364390534|FG002|Overall Study|Protocol Violation|1|||
105652595|NCT00702520|364390535|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
105652596|NCT00702520|364390536|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
105652597|NCT00702520|364390537|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
105652598|NCT00702520|364390538|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
105652599|NCT00702520|364390535|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
105652600|NCT00702520|364390536|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
105652601|NCT00702520|364390537|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
105652602|NCT00702520|364390538|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
105652603|NCT00702520|364390535|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
105652604|NCT00702520|364390536|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
105652605|NCT00702520|364390537|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
105652606|NCT00702520|364390538|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
105652607|NCT02481934|364390541|FG000|Overall Study|Death|2|||
105652608|NCT01204775|364390544|FG000|Overall Study|Poor/non-compliance|0|||
105652609|NCT01204775|364390545|FG001|Overall Study|Poor/non-compliance|1|||
105652610|NCT01204775|364390544|FG000|Overall Study|Withdrawal by Subject|1|||
105652611|NCT01204775|364390545|FG001|Overall Study|Withdrawal by Subject|0|||
105652612|NCT04783519|364390546|FG000|Overall Study|Withdrawal by Subject|2|||
105652613|NCT04783519|364390547|FG001|Overall Study|Withdrawal by Subject|7|||
105652614|NCT04783519|364390548|FG002|Overall Study|Withdrawal by Subject|3|||
105652615|NCT04783519|364390546|FG000|Overall Study|Lost to Follow-up|9|||
105652616|NCT04783519|364390547|FG001|Overall Study|Lost to Follow-up|7|||
105652617|NCT04783519|364390548|FG002|Overall Study|Lost to Follow-up|6|||
105652618|NCT05041439|364390549|FG000|Overall Study|Withdrawal by Subject|1|||
105652619|NCT05041439|364390550|FG001|Overall Study|Withdrawal by Subject|1|||
105652620|NCT05041439|364390549|FG000|Overall Study|Death|1|||
105652621|NCT05041439|364390550|FG001|Overall Study|Death|0|||
105652622|NCT00727259|364390551|FG000|Overall Study|Not all questionnaires completed|1055|||
105652623|NCT01021683|364390552|FG000|Overall Study|Lack of Efficacy|12|||
105652624|NCT01021683|364390552|FG000|Overall Study|Recovery of neutrophil count|51|||
105652625|NCT01021683|364390552|FG000|Overall Study|Other|8|||
105652626|NCT00509925|364390553|FG000|Overall Study|Personal reasons|0|||
105652627|NCT00509925|364390554|FG001|Overall Study|Personal reasons|1|||
105652628|NCT00645099|364390555|FG000|Overall Study|Lack of Efficacy|15|||
105652629|NCT00645099|364390556|FG001|Overall Study|Lack of Efficacy|6|||
105652630|NCT00645099|364390555|FG000|Overall Study|Withdrawal by Subject|30|||
105652631|NCT00645099|364390556|FG001|Overall Study|Withdrawal by Subject|22|||
105652632|NCT00645099|364390555|FG000|Overall Study|Lost to Follow-up|6|||
105652633|NCT00645099|364390556|FG001|Overall Study|Lost to Follow-up|4|||
105652634|NCT00645099|364390555|FG000|Overall Study|Adverse Event|11|||
105652635|NCT00645099|364390556|FG001|Overall Study|Adverse Event|5|||
105652636|NCT00645099|364390555|FG000|Overall Study|Other|9|||
105652637|NCT00645099|364390556|FG001|Overall Study|Other|5|||
105652638|NCT01201915|364390557|FG000|Overall Study|Adverse Event|2|||
105652639|NCT01201915|364390558|FG001|Overall Study|Adverse Event|1|||
105652640|NCT01201915|364390559|FG002|Overall Study|Adverse Event|1|||
105652641|NCT01201915|364390557|FG000|Overall Study|Lost to Follow-up|0|||
105652642|NCT01201915|364390558|FG001|Overall Study|Lost to Follow-up|4|||
105652643|NCT01201915|364390559|FG002|Overall Study|Lost to Follow-up|0|||
105652644|NCT01201915|364390557|FG000|Overall Study|Physician Decision|3|||
105652645|NCT01201915|364390558|FG001|Overall Study|Physician Decision|0|||
105652646|NCT01201915|364390559|FG002|Overall Study|Physician Decision|0|||
105652647|NCT01201915|364390557|FG000|Overall Study|Subject Decision|3|||
105652648|NCT01201915|364390558|FG001|Overall Study|Subject Decision|3|||
105652649|NCT01201915|364390559|FG002|Overall Study|Subject Decision|5|||
105652650|NCT01201915|364390557|FG000|Overall Study|Target Lesion Progression|0|||
105652651|NCT01201915|364390558|FG001|Overall Study|Target Lesion Progression|3|||
105652652|NCT01201915|364390559|FG002|Overall Study|Target Lesion Progression|0|||
105652653|NCT02154516|364390560|FG000|Overall Study|Withdrawal by Subject|0|||
105652654|NCT02154516|364390561|FG001|Overall Study|Withdrawal by Subject|1|||
105652655|NCT02154516|364390560|FG000|Overall Study|Lost to Follow-up|1|||
105652656|NCT02154516|364390561|FG001|Overall Study|Lost to Follow-up|0|||
105652657|NCT02154516|364390560|FG000|Overall Study|Removal/revision of device|1|||
105652658|NCT02154516|364390561|FG001|Overall Study|Removal/revision of device|0|||
105652659|NCT02154516|364390560|FG000|Overall Study|Death|2|||
105652660|NCT02154516|364390561|FG001|Overall Study|Death|1|||
105652661|NCT03406507|364390562|FG000|Extension Period|Lack of Efficacy|0|||
105652662|NCT03406507|364390563|FG001|Extension Period|Lack of Efficacy|1|||
105652663|NCT02965599|364390564|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
105652664|NCT02965599|364390565|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
105652665|NCT04435522|364390571|FG000|Overall Study|Withdrawal by Subject|2|||
105652666|NCT04944784|364390574|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
105652667|NCT04944784|364390575|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
105652668|NCT04944784|364390576|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
105652669|NCT04944784|364390577|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
105652670|NCT04944784|364390574|FG000|Double-blind Period|Adverse Event|20|||
105652671|NCT04944784|364390575|FG001|Double-blind Period|Adverse Event|4|||
105652672|NCT04944784|364390576|FG002|Double-blind Period|Adverse Event|0|||
105652673|NCT04944784|364390577|FG003|Double-blind Period|Adverse Event|0|||
105652674|NCT04944784|364390574|FG000|Double-blind Period|Withdrawal by Subject|15|||
105652675|NCT04944784|364390575|FG001|Double-blind Period|Withdrawal by Subject|4|||
105652676|NCT04944784|364390576|FG002|Double-blind Period|Withdrawal by Subject|0|||
105652677|NCT04944784|364390577|FG003|Double-blind Period|Withdrawal by Subject|0|||
105652678|NCT04944784|364390574|FG000|Double-blind Period|Death|7|||
105652679|NCT04944784|364390575|FG001|Double-blind Period|Death|2|||
105652680|NCT04944784|364390576|FG002|Double-blind Period|Death|0|||
105652681|NCT04944784|364390577|FG003|Double-blind Period|Death|0|||
105652682|NCT04944784|364390574|FG000|Double-blind Period|Physician Decision|2|||
105652683|NCT04944784|364390575|FG001|Double-blind Period|Physician Decision|1|||
105652684|NCT04944784|364390576|FG002|Double-blind Period|Physician Decision|0|||
105652685|NCT04944784|364390577|FG003|Double-blind Period|Physician Decision|0|||
105652686|NCT04944784|364390574|FG000|Double-blind Period|Lack of Efficacy|0|||
105652687|NCT04944784|364390575|FG001|Double-blind Period|Lack of Efficacy|1|||
105652688|NCT04944784|364390576|FG002|Double-blind Period|Lack of Efficacy|0|||
105652689|NCT04944784|364390577|FG003|Double-blind Period|Lack of Efficacy|0|||
105652690|NCT04944784|364390574|FG000|Double-blind Period|Sponsor Request|2|||
105652691|NCT04944784|364390575|FG001|Double-blind Period|Sponsor Request|1|||
105652692|NCT04944784|364390576|FG002|Double-blind Period|Sponsor Request|0|||
105652693|NCT04944784|364390577|FG003|Double-blind Period|Sponsor Request|0|||
105652694|NCT04944784|364390574|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
105652695|NCT04944784|364390575|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
105652696|NCT04944784|364390576|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
105652697|NCT04944784|364390577|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
105652698|NCT04944784|364390574|FG000|Double-blind Period|Participant Choice|1|||
105652699|NCT04944784|364390575|FG001|Double-blind Period|Participant Choice|1|||
105652700|NCT04944784|364390576|FG002|Double-blind Period|Participant Choice|0|||
105652701|NCT04944784|364390577|FG003|Double-blind Period|Participant Choice|0|||
105652702|NCT04944784|364390574|FG000|Double-blind Period|Progressive Disease|2|||
105652703|NCT04944784|364390575|FG001|Double-blind Period|Progressive Disease|2|||
105652704|NCT04944784|364390576|FG002|Double-blind Period|Progressive Disease|0|||
105652705|NCT04944784|364390577|FG003|Double-blind Period|Progressive Disease|0|||
105652706|NCT04944784|364390574|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
105652707|NCT04944784|364390575|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
105652708|NCT04944784|364390576|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
105652709|NCT04944784|364390577|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
105652710|NCT04944784|364390574|FG000|Active Drug Period|Adverse Event|0|||
105652711|NCT04944784|364390575|FG001|Active Drug Period|Adverse Event|0|||
105652712|NCT04944784|364390576|FG002|Active Drug Period|Adverse Event|3|||
105652713|NCT04944784|364390577|FG003|Active Drug Period|Adverse Event|6|||
105652714|NCT04944784|364390574|FG000|Active Drug Period|Withdrawal by Subject|0|||
105652715|NCT04944784|364390575|FG001|Active Drug Period|Withdrawal by Subject|0|||
105652716|NCT04944784|364390576|FG002|Active Drug Period|Withdrawal by Subject|4|||
105652717|NCT04944784|364390577|FG003|Active Drug Period|Withdrawal by Subject|7|||
105652718|NCT04944784|364390574|FG000|Active Drug Period|Death|0|||
105652719|NCT04944784|364390575|FG001|Active Drug Period|Death|0|||
105652720|NCT04944784|364390576|FG002|Active Drug Period|Death|3|||
105652721|NCT04944784|364390577|FG003|Active Drug Period|Death|4|||
105652722|NCT04944784|364390574|FG000|Active Drug Period|Lack of Efficacy|0|||
105652723|NCT04944784|364390575|FG001|Active Drug Period|Lack of Efficacy|0|||
105652724|NCT04944784|364390576|FG002|Active Drug Period|Lack of Efficacy|2|||
105652725|NCT04944784|364390577|FG003|Active Drug Period|Lack of Efficacy|2|||
105652726|NCT04944784|364390574|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
105652727|NCT04944784|364390575|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
105652728|NCT04944784|364390576|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
105652729|NCT04944784|364390577|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
105652730|NCT04944784|364390574|FG000|Active Drug Period|Participant Choice|0|||
105652731|NCT04944784|364390575|FG001|Active Drug Period|Participant Choice|0|||
105652732|NCT04944784|364390576|FG002|Active Drug Period|Participant Choice|0|||
105652733|NCT04944784|364390577|FG003|Active Drug Period|Participant Choice|1|||
105652734|NCT04944784|364390574|FG000|Active Drug Period|Progressive Disease|0|||
105652735|NCT04944784|364390575|FG001|Active Drug Period|Progressive Disease|0|||
105652736|NCT04944784|364390576|FG002|Active Drug Period|Progressive Disease|4|||
105652737|NCT04944784|364390577|FG003|Active Drug Period|Progressive Disease|4|||
105652738|NCT04944784|364390574|FG000|Active Drug Period|Lost to Follow-up|0|||
105652739|NCT04944784|364390575|FG001|Active Drug Period|Lost to Follow-up|0|||
105652740|NCT04944784|364390576|FG002|Active Drug Period|Lost to Follow-up|0|||
105652741|NCT04944784|364390577|FG003|Active Drug Period|Lost to Follow-up|1|||
105652742|NCT05294328|364390580|FG000|Overall Study|Adverse Event|1|||
105652743|NCT05294328|364390581|FG001|Overall Study|Adverse Event|0|||
105652744|NCT05294328|364390582|FG002|Overall Study|Adverse Event|0|||
105652745|NCT05294328|364390580|FG000|Overall Study|Physician Decision|1|||
105652746|NCT05294328|364390581|FG001|Overall Study|Physician Decision|1|||
105652747|NCT05294328|364390582|FG002|Overall Study|Physician Decision|0|||
105652748|NCT05294328|364390580|FG000|Overall Study|Withdrawal by Subject|0|||
105652749|NCT05294328|364390581|FG001|Overall Study|Withdrawal by Subject|2|||
105652750|NCT05294328|364390582|FG002|Overall Study|Withdrawal by Subject|1|||
105652751|NCT05294328|364390580|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
105652752|NCT05294328|364390581|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
105652753|NCT05294328|364390582|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
105652754|NCT01568112|364390583|FG000|Overall Study|Randomized But Not Treated|0|||
105652755|NCT01568112|364390584|FG001|Overall Study|Randomized But Not Treated|1|||
105652756|NCT01568112|364390585|FG002|Overall Study|Randomized But Not Treated|0|||
105652757|NCT01568112|364390586|FG003|Overall Study|Randomized But Not Treated|0|||
105652758|NCT01568112|364390583|FG000|Overall Study|Withdrew due to Adverse Event|2|||
105652759|NCT01568112|364390584|FG001|Overall Study|Withdrew due to Adverse Event|4|||
105652760|NCT01568112|364390585|FG002|Overall Study|Withdrew due to Adverse Event|6|||
105652761|NCT01568112|364390586|FG003|Overall Study|Withdrew due to Adverse Event|3|||
105652762|NCT01568112|364390583|FG000|Overall Study|Lost to Follow-up|0|||
105652763|NCT01568112|364390584|FG001|Overall Study|Lost to Follow-up|0|||
105652764|NCT01568112|364390585|FG002|Overall Study|Lost to Follow-up|0|||
105652765|NCT01568112|364390586|FG003|Overall Study|Lost to Follow-up|1|||
105652766|NCT01568112|364390583|FG000|Overall Study|Withdrawal by Subject|2|||
105652767|NCT01568112|364390584|FG001|Overall Study|Withdrawal by Subject|3|||
105652768|NCT01568112|364390585|FG002|Overall Study|Withdrawal by Subject|0|||
105652769|NCT01568112|364390586|FG003|Overall Study|Withdrawal by Subject|7|||
105652770|NCT01568112|364390583|FG000|Overall Study|Withdrawal by Physician|1|||
105652771|NCT01568112|364390584|FG001|Overall Study|Withdrawal by Physician|0|||
105652772|NCT01568112|364390585|FG002|Overall Study|Withdrawal by Physician|1|||
105652773|NCT01568112|364390586|FG003|Overall Study|Withdrawal by Physician|1|||
105652774|NCT02056873|364390587|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
105652775|NCT01772147|364392398|FG000|Overall Study|Adverse Event|13|||
105652776|NCT01772147|364392399|FG001|Overall Study|Adverse Event|10|||
105652777|NCT01772147|364392400|FG002|Overall Study|Adverse Event|6|||
105652778|NCT01772147|364392398|FG000|Overall Study|Withdrew Consent|7|||
105652779|NCT01772147|364392399|FG001|Overall Study|Withdrew Consent|8|||
105652780|NCT01772147|364392400|FG002|Overall Study|Withdrew Consent|4|||
105652781|NCT01772147|364392398|FG000|Overall Study|Lost to Follow-up|1|||
105652782|NCT01772147|364392399|FG001|Overall Study|Lost to Follow-up|0|||
105652783|NCT01772147|364392400|FG002|Overall Study|Lost to Follow-up|1|||
105652784|NCT01772147|364392398|FG000|Overall Study|Protocol Deviation|2|||
105652785|NCT01772147|364392399|FG001|Overall Study|Protocol Deviation|1|||
105652786|NCT01772147|364392400|FG002|Overall Study|Protocol Deviation|1|||
105652787|NCT01772147|364392398|FG000|Overall Study|Lack of Efficacy|8|||
105652788|NCT01772147|364392399|FG001|Overall Study|Lack of Efficacy|6|||
105652789|NCT01772147|364392400|FG002|Overall Study|Lack of Efficacy|6|||
105652790|NCT02956278|364392402|FG000|Overall Study|Withdrawal by Subject|6|||
105652791|NCT02956278|364392403|FG001|Overall Study|Withdrawal by Subject|2|||
105652792|NCT02956278|364392404|FG002|Overall Study|Withdrawal by Subject|0|||
105652793|NCT00434577|364392405|FG000|Months 0-3|Serious Adverse Event|0|||
105652794|NCT00434577|364392406|FG001|Months 0-3|Serious Adverse Event|0|||
105652795|NCT00434577|364392407|FG002|Months 0-3|Serious Adverse Event|1|||
105652796|NCT00434577|364392408|FG003|Months 0-3|Serious Adverse Event|0|||
105652797|NCT00434577|364392409|FG004|Months 0-3|Serious Adverse Event|0|||
105652798|NCT00434577|364392405|FG000|Months 0-3|Adverse Event|0|||
105652799|NCT00434577|364392406|FG001|Months 0-3|Adverse Event|1|||
105652800|NCT00434577|364392407|FG002|Months 0-3|Adverse Event|1|||
105652801|NCT00434577|364392408|FG003|Months 0-3|Adverse Event|0|||
105652802|NCT00434577|364392409|FG004|Months 0-3|Adverse Event|0|||
105652803|NCT00434577|364392405|FG000|Months 0-3|Lost to Follow-up|0|||
105652804|NCT00434577|364392406|FG001|Months 0-3|Lost to Follow-up|0|||
105652805|NCT00434577|364392407|FG002|Months 0-3|Lost to Follow-up|0|||
105652806|NCT00434577|364392408|FG003|Months 0-3|Lost to Follow-up|0|||
105652807|NCT00434577|364392409|FG004|Months 0-3|Lost to Follow-up|2|||
105652808|NCT00434577|364392405|FG000|Months 0-3|Protocol Violation|1|||
105652809|NCT00434577|364392406|FG001|Months 0-3|Protocol Violation|0|||
105652810|NCT00434577|364392407|FG002|Months 0-3|Protocol Violation|1|||
105652811|NCT00434577|364392408|FG003|Months 0-3|Protocol Violation|0|||
105652812|NCT00434577|364392409|FG004|Months 0-3|Protocol Violation|0|||
105652813|NCT00434577|364392405|FG000|Months 0-3|Withdrawal by Subject|2|||
105652814|NCT00434577|364392406|FG001|Months 0-3|Withdrawal by Subject|1|||
105652815|NCT00434577|364392407|FG002|Months 0-3|Withdrawal by Subject|1|||
105652816|NCT00434577|364392408|FG003|Months 0-3|Withdrawal by Subject|1|||
105652817|NCT00434577|364392409|FG004|Months 0-3|Withdrawal by Subject|1|||
105652818|NCT01967719|364392410|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
105652819|NCT01967719|364392411|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
105652820|NCT01967719|364392412|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
105652821|NCT01967719|364392413|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
105652822|NCT01967719|364392410|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
105652823|NCT01967719|364392411|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
105652824|NCT01967719|364392412|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
105652825|NCT01967719|364392413|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
105652826|NCT00796614|364392419|FG000|Overall Study|Adverse Event|1|||
105652827|NCT00796614|364392420|FG001|Overall Study|Adverse Event|2|||
105652828|NCT00796614|364392421|FG002|Overall Study|Adverse Event|0|||
105652829|NCT00796614|364392422|FG003|Overall Study|Adverse Event|0|||
105652830|NCT00796614|364392419|FG000|Overall Study|Protocol Violation|0|||
105652831|NCT00796614|364392420|FG001|Overall Study|Protocol Violation|0|||
105652832|NCT00796614|364392421|FG002|Overall Study|Protocol Violation|2|||
105652833|NCT00796614|364392422|FG003|Overall Study|Protocol Violation|0|||
105652834|NCT00796614|364392419|FG000|Overall Study|Lost to Follow-up|2|||
105652835|NCT00796614|364392420|FG001|Overall Study|Lost to Follow-up|2|||
105652836|NCT00796614|364392421|FG002|Overall Study|Lost to Follow-up|1|||
105652837|NCT00796614|364392422|FG003|Overall Study|Lost to Follow-up|0|||
105652838|NCT00796614|364392419|FG000|Overall Study|Withdrawal by Subject|1|||
105652839|NCT00796614|364392420|FG001|Overall Study|Withdrawal by Subject|0|||
105652840|NCT00796614|364392421|FG002|Overall Study|Withdrawal by Subject|0|||
105652841|NCT00796614|364392422|FG003|Overall Study|Withdrawal by Subject|1|||
105652842|NCT00796614|364392419|FG000|Overall Study|Other than stated|1|||
105652843|NCT00796614|364392420|FG001|Overall Study|Other than stated|0|||
105652844|NCT00796614|364392421|FG002|Overall Study|Other than stated|0|||
105652845|NCT00796614|364392422|FG003|Overall Study|Other than stated|0|||
105652846|NCT00961896|364392423|FG000|Overall Study|Abnormal laboratory value|0|||
105652847|NCT00961896|364392424|FG001|Overall Study|Abnormal laboratory value|0|||
105652848|NCT00961896|364392425|FG002|Overall Study|Abnormal laboratory value|1|||
105652849|NCT00957996|364392426|FG000|Overall Study|Death|4|||
105652850|NCT00957996|364392427|FG001|Overall Study|Death|10|||
105652851|NCT00957996|364392426|FG000|Overall Study|Lost to Follow-up|4|||
105652852|NCT00957996|364392427|FG001|Overall Study|Lost to Follow-up|7|||
105652853|NCT00957996|364392426|FG000|Overall Study|Withdrawal by Subject|9|||
105652854|NCT00957996|364392427|FG001|Overall Study|Withdrawal by Subject|2|||
105652855|NCT00957996|364392426|FG000|Overall Study|Adverse Event|2|||
105652856|NCT00957996|364392427|FG001|Overall Study|Adverse Event|1|||
105652857|NCT00957996|364392426|FG000|Overall Study|Physician Decision|1|||
105652858|NCT00957996|364392427|FG001|Overall Study|Physician Decision|1|||
105652859|NCT00957996|364392426|FG000|Overall Study|Influenza-related complication|0|||
105652860|NCT00957996|364392427|FG001|Overall Study|Influenza-related complication|1|||
105652861|NCT00957996|364392426|FG000|Overall Study|Missing|1|||
105652862|NCT00957996|364392427|FG001|Overall Study|Missing|0|||
105652863|NCT00957996|364392426|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
105652864|NCT00957996|364392427|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
105652865|NCT00488319|364392432|FG000|Overall Study|Adverse Event|1|||
105652866|NCT00488319|364392433|FG001|Overall Study|Adverse Event|2|||
105652867|NCT00488319|364392434|FG002|Overall Study|Adverse Event|23|||
105652868|NCT00488319|364392432|FG000|Overall Study|Lack of Efficacy|6|||
105652869|NCT00488319|364392433|FG001|Overall Study|Lack of Efficacy|12|||
105652870|NCT00488319|364392434|FG002|Overall Study|Lack of Efficacy|27|||
105652871|NCT00488319|364392432|FG000|Overall Study|Lost to Follow-up|3|||
105652872|NCT00488319|364392433|FG001|Overall Study|Lost to Follow-up|5|||
105652873|NCT00488319|364392434|FG002|Overall Study|Lost to Follow-up|16|||
105652874|NCT00488319|364392432|FG000|Overall Study|Withdrawal by Subject|5|||
105652875|NCT00488319|364392433|FG001|Overall Study|Withdrawal by Subject|20|||
105652876|NCT00488319|364392434|FG002|Overall Study|Withdrawal by Subject|44|||
105652877|NCT00488319|364392432|FG000|Overall Study|Other reasons for withdrawal|0|||
105652878|NCT00488319|364392433|FG001|Overall Study|Other reasons for withdrawal|4|||
105652879|NCT00488319|364392434|FG002|Overall Study|Other reasons for withdrawal|12|||
105652880|NCT02815735|364392435|FG000|First Intervention (4 Weeks)|Discomfort|1|||
105652881|NCT02815735|364392436|FG001|First Intervention (4 Weeks)|Discomfort|0|||
105652882|NCT02815735|364392435|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
105652883|NCT02815735|364392436|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
105652884|NCT02815735|364392435|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
105652885|NCT02815735|364392436|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
105652886|NCT02815735|364392435|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
105652887|NCT02815735|364392436|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
105652888|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
105652889|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
105652890|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
105652891|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
105652892|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
105652893|NCT00520403|364392440|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
105652894|NCT00520403|364392440|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
105652895|NCT00520403|364392440|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
105652896|NCT00405912|364392441|FG000|Overall Study|Withdrawal by Subject|12|||
105652897|NCT00405912|364392442|FG001|Overall Study|Withdrawal by Subject|11|||
105652898|NCT00405912|364392443|FG002|Overall Study|Withdrawal by Subject|12|||
105652899|NCT00405912|364392441|FG000|Overall Study|Lost to Follow-up|4|||
105652900|NCT00405912|364392442|FG001|Overall Study|Lost to Follow-up|8|||
105652901|NCT00405912|364392443|FG002|Overall Study|Lost to Follow-up|4|||
105652902|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
105652903|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
105652904|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
105652905|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
105652906|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
105652907|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
105652908|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
105652909|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
105652910|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Death|6|||
105652911|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Death|2|||
105652912|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Death|2|||
105652913|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Death|9|||
105652914|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
105652915|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
105652916|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
105652917|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
105652918|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
105652919|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
105652920|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
105652921|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
105652922|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
105652923|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
105652924|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
105652925|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
105652926|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
105652927|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
105652928|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
105652929|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
105652930|NCT03730662|364392444|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
105652931|NCT03730662|364392445|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
105652932|NCT03730662|364392446|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
105652933|NCT03730662|364392447|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
105652934|NCT03730662|364392444|FG000|Variable Treatment Period|Adverse Event|1|||
105652935|NCT03730662|364392445|FG001|Variable Treatment Period|Adverse Event|2|||
105652936|NCT03730662|364392446|FG002|Variable Treatment Period|Adverse Event|0|||
105652937|NCT03730662|364392447|FG003|Variable Treatment Period|Adverse Event|7|||
105652938|NCT03730662|364392444|FG000|Variable Treatment Period|Death|9|||
105652939|NCT03730662|364392445|FG001|Variable Treatment Period|Death|0|||
105652940|NCT03730662|364392446|FG002|Variable Treatment Period|Death|6|||
105652941|NCT03730662|364392447|FG003|Variable Treatment Period|Death|26|||
105652942|NCT03730662|364392444|FG000|Variable Treatment Period|Lost to Follow-up|2|||
105652943|NCT03730662|364392445|FG001|Variable Treatment Period|Lost to Follow-up|1|||
105652944|NCT03730662|364392446|FG002|Variable Treatment Period|Lost to Follow-up|4|||
105652945|NCT03730662|364392447|FG003|Variable Treatment Period|Lost to Follow-up|11|||
105652946|NCT03730662|364392444|FG000|Variable Treatment Period|Personal Reason|0|||
105652947|NCT03730662|364392445|FG001|Variable Treatment Period|Personal Reason|2|||
105652948|NCT03730662|364392446|FG002|Variable Treatment Period|Personal Reason|1|||
105652949|NCT03730662|364392447|FG003|Variable Treatment Period|Personal Reason|6|||
105652950|NCT03730662|364392444|FG000|Variable Treatment Period|Physician Decision|0|||
105652951|NCT03730662|364392445|FG001|Variable Treatment Period|Physician Decision|0|||
105652952|NCT03730662|364392446|FG002|Variable Treatment Period|Physician Decision|0|||
105652953|NCT03730662|364392447|FG003|Variable Treatment Period|Physician Decision|3|||
105652954|NCT03730662|364392444|FG000|Variable Treatment Period|Protocol Violation|0|||
105652955|NCT03730662|364392445|FG001|Variable Treatment Period|Protocol Violation|1|||
105652956|NCT03730662|364392446|FG002|Variable Treatment Period|Protocol Violation|1|||
105652957|NCT03730662|364392447|FG003|Variable Treatment Period|Protocol Violation|1|||
105652958|NCT03730662|364392444|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
105652959|NCT03730662|364392445|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
105652960|NCT03730662|364392446|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
105652961|NCT03730662|364392447|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
105652962|NCT05060237|364392448|FG000|Overall Study|Withdrawal by Subject|4|||
105652963|NCT05060237|364392448|FG000|Overall Study|Screening failure|8|||
105652964|NCT03226353|364392449|FG000|Overall Study|Withdrawal by Subject|1|||
105652965|NCT03226353|364392449|FG000|Overall Study|Screen Failure|5|||
105652966|NCT03441789|364392451|FG000|Overall Study|Withdrawal by Subject|1|||
105652967|NCT03441789|364392452|FG001|Overall Study|Withdrawal by Subject|1|||
105652968|NCT03441789|364392451|FG000|Overall Study|Adverse Event|0|||
105652969|NCT03441789|364392452|FG001|Overall Study|Adverse Event|1|||
105652970|NCT03441789|364392451|FG000|Overall Study|Protocol Violation|0|||
105652971|NCT03441789|364392452|FG001|Overall Study|Protocol Violation|1|||
105652972|NCT03441789|364392451|FG000|Overall Study|Lost to Follow-up|0|||
105652973|NCT03441789|364392452|FG001|Overall Study|Lost to Follow-up|1|||
105652974|NCT00498433|364392453|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
105652975|NCT00498433|364392454|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
105652976|NCT00498433|364392455|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
105652977|NCT00498433|364392453|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
105652978|NCT00498433|364392454|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
105652979|NCT00498433|364392455|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
105652980|NCT00498433|364392453|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
105652981|NCT00498433|364392454|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
105652982|NCT00498433|364392455|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
105652983|NCT00498433|364392453|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
105652984|NCT00498433|364392454|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
105652985|NCT00498433|364392455|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
105652986|NCT01514864|364392457|FG000|Overall Study|Disease progression|7|||
105652987|NCT01514864|364392458|FG001|Overall Study|Disease progression|5|||
105652988|NCT01514864|364392457|FG000|Overall Study|Study drug toxicity|2|||
105652989|NCT01514864|364392458|FG001|Overall Study|Study drug toxicity|0|||
105652990|NCT01960114|364392459|FG000|Overall Study|Adverse Event|1|||
105652991|NCT01960114|364392460|FG001|Overall Study|Adverse Event|0|||
105652992|NCT01960114|364392459|FG000|Overall Study|Could not swallow study medication|0|||
105652993|NCT01960114|364392460|FG001|Overall Study|Could not swallow study medication|1|||
105652994|NCT02253147|364392464|FG000|Overall Study|Protocol Violation|30|||
105652995|NCT02253147|364392464|FG000|Overall Study|Did not consent to study extension|9|||
105652996|NCT02253147|364392464|FG000|Overall Study|Conditional re-treatment at W52|5|||
105652997|NCT02253147|364392464|FG000|Overall Study|Lost to Follow-up|2|||
105652998|NCT02253147|364392464|FG000|Overall Study|Withdrawal by Subject|1|||
105652999|NCT00922441|364392465|FG000|Overall Study|Protocol Violation|0|||
105653000|NCT00922441|364392466|FG001|Overall Study|Protocol Violation|0|||
105653001|NCT00922441|364392467|FG002|Overall Study|Protocol Violation|2|||
105653002|NCT00922441|364392465|FG000|Overall Study|Withdrawal by Subject|0|||
105653003|NCT00922441|364392466|FG001|Overall Study|Withdrawal by Subject|0|||
105653004|NCT00922441|364392467|FG002|Overall Study|Withdrawal by Subject|1|||
105653005|NCT02469077|364392472|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
105653006|NCT02469077|364392473|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
105653007|NCT02469077|364392472|FG000|Post Randomization/Intervention Period|Relocated|1|||
105653008|NCT02469077|364392473|FG001|Post Randomization/Intervention Period|Relocated|1|||
105653009|NCT02469077|364392472|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
105653010|NCT02469077|364392473|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
105653011|NCT02469077|364392472|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
105653012|NCT02469077|364392473|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
105653013|NCT02959177|364392474|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
105653014|NCT02959177|364392475|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
105653015|NCT02959177|364392476|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
105653016|NCT02959177|364392474|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
105653017|NCT02959177|364392475|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
105653018|NCT02959177|364392476|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
105653019|NCT02959177|364392474|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
105653020|NCT02959177|364392475|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
105653021|NCT02959177|364392476|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
105653022|NCT02959177|364392474|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
105653023|NCT02959177|364392475|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
105653024|NCT02959177|364392476|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
105653025|NCT02959177|364392474|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
105653026|NCT02959177|364392475|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
105653027|NCT02959177|364392476|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
105653028|NCT02959177|364392474|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
105653029|NCT02959177|364392475|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
105653030|NCT02959177|364392476|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
105653031|NCT02959177|364392474|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
105653032|NCT02959177|364392475|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
105653033|NCT02959177|364392476|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
105653034|NCT04531813|364392477|FG000|Overall Study|Protocol Violation|1|||
105653035|NCT04531813|364392477|FG000|Overall Study|Withdrawal by Subject|1|||
105653036|NCT02853305|364392478|FG000|Overall Study|Death|287|||
105653037|NCT02853305|364392479|FG001|Overall Study|Death|249|||
105653038|NCT02853305|364392480|FG002|Overall Study|Death|300|||
105653039|NCT02853305|364392478|FG000|Overall Study|Withdrawal by Subject|2|||
105653040|NCT02853305|364392479|FG001|Overall Study|Withdrawal by Subject|8|||
105653041|NCT02853305|364392480|FG002|Overall Study|Withdrawal by Subject|3|||
105653042|NCT02853305|364392478|FG000|Overall Study|Transferred to Extension Study|46|||
105653043|NCT02853305|364392479|FG001|Overall Study|Transferred to Extension Study|30|||
105653044|NCT02853305|364392480|FG002|Overall Study|Transferred to Extension Study|25|||
105653045|NCT02853305|364392478|FG000|Overall Study|Did Not Continue on Extension Study|16|||
105653046|NCT02853305|364392479|FG001|Overall Study|Did Not Continue on Extension Study|20|||
105653047|NCT02853305|364392480|FG002|Overall Study|Did Not Continue on Extension Study|24|||
105653048|NCT02381652|364392481|FG000|Overall Study|Withdrawal by Subject|0|||
105653049|NCT02381652|364392482|FG001|Overall Study|Withdrawal by Subject|0|||
105653050|NCT02381652|364392483|FG002|Overall Study|Withdrawal by Subject|1|||
105653051|NCT01654289|364392490|FG000|Overall Study|Withdrawal by Subject|10|||
105653052|NCT01654289|364392491|FG001|Overall Study|Withdrawal by Subject|8|||
105653053|NCT01654289|364392492|FG002|Overall Study|Withdrawal by Subject|5|||
105653054|NCT01654289|364392490|FG000|Overall Study|Withdrew from intervention only|17|||
105653055|NCT01654289|364392491|FG001|Overall Study|Withdrew from intervention only|20|||
105653056|NCT01654289|364392492|FG002|Overall Study|Withdrew from intervention only|0|||
105653057|NCT03746483|364392493|FG000|Overall Study|Adverse Event|0|||
105653058|NCT03746483|364392494|FG001|Overall Study|Adverse Event|1|||
105653059|NCT03746483|364392493|FG000|Overall Study|Lack of Efficacy|3|||
105653060|NCT03746483|364392494|FG001|Overall Study|Lack of Efficacy|2|||
105653061|NCT03746483|364392493|FG000|Overall Study|Lost to Follow-up|1|||
105653062|NCT03746483|364392494|FG001|Overall Study|Lost to Follow-up|0|||
105653063|NCT03746483|364392493|FG000|Overall Study|Protocol Violation|2|||
105653064|NCT03746483|364392494|FG001|Overall Study|Protocol Violation|0|||
105653065|NCT01924806|364392495|FG000|Overall Study|Physician Decision|2|||
105653066|NCT01924806|364392496|FG001|Overall Study|Physician Decision|1|||
105653067|NCT03635775|364392499|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
105653068|NCT03635775|364392500|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
105653069|NCT03635775|364392501|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
105653070|NCT03635775|364392502|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
105653071|NCT00385697|364392503|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
105653072|NCT00385697|364392504|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
105653073|NCT00385697|364392505|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
105653074|NCT00385697|364392506|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
105653075|NCT00385697|364392507|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
105653076|NCT00385697|364392503|FG000|Open-label Segment 1|Lost to Follow-up|1|||
105653077|NCT00385697|364392504|FG001|Open-label Segment 1|Lost to Follow-up|0|||
105653078|NCT00385697|364392505|FG002|Open-label Segment 1|Lost to Follow-up|0|||
105653079|NCT00385697|364392506|FG003|Open-label Segment 1|Lost to Follow-up|0|||
105653080|NCT00385697|364392507|FG004|Open-label Segment 1|Lost to Follow-up|0|||
105653081|NCT00385697|364392503|FG000|Double-blind Segment 2|Adverse Event|0|||
105653082|NCT00385697|364392504|FG001|Double-blind Segment 2|Adverse Event|3|||
105653083|NCT00385697|364392505|FG002|Double-blind Segment 2|Adverse Event|1|||
105653084|NCT00385697|364392506|FG003|Double-blind Segment 2|Adverse Event|0|||
105653085|NCT00385697|364392507|FG004|Double-blind Segment 2|Adverse Event|0|||
105653086|NCT00385697|364392503|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
105653087|NCT00385697|364392504|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
105653088|NCT00385697|364392505|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
105653089|NCT00385697|364392506|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
105653090|NCT00385697|364392507|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
105653091|NCT00385697|364392503|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
105653092|NCT00385697|364392504|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
105653093|NCT00385697|364392505|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
105653094|NCT00385697|364392506|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
105653095|NCT00385697|364392507|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
105653096|NCT00385697|364392503|FG000|Double-blind Segment 2|Other|0|||
105653097|NCT00385697|364392504|FG001|Double-blind Segment 2|Other|2|||
105653098|NCT00385697|364392505|FG002|Double-blind Segment 2|Other|0|||
105653099|NCT00385697|364392506|FG003|Double-blind Segment 2|Other|0|||
105653100|NCT00385697|364392507|FG004|Double-blind Segment 2|Other|0|||
105653101|NCT01920178|364392509|FG000|Overall Study|Lost to Follow-up|2|||
105653102|NCT01920178|364392510|FG001|Overall Study|Lost to Follow-up|1|||
105653103|NCT01919398|364392511|FG000|Overall Study|Progressive Disease|0|||
105653104|NCT01919398|364392512|FG001|Overall Study|Progressive Disease|0|||
105653105|NCT01919398|364392513|FG002|Overall Study|Progressive Disease|4|||
105653106|NCT01363297|364392515|FG000|Overall Study|Other|0|||
105653107|NCT01363297|364392516|FG001|Overall Study|Other|0|||
105653108|NCT01363297|364392517|FG002|Overall Study|Other|0|||
105653109|NCT01363297|364392518|FG003|Overall Study|Other|0|||
105653110|NCT01363297|364392519|FG004|Overall Study|Other|1|||
105653111|NCT01363297|364392515|FG000|Overall Study|Death|3|||
105653112|NCT01363297|364392516|FG001|Overall Study|Death|6|||
105653113|NCT01363297|364392517|FG002|Overall Study|Death|6|||
105653114|NCT01363297|364392518|FG003|Overall Study|Death|10|||
105653115|NCT01363297|364392519|FG004|Overall Study|Death|30|||
105653116|NCT02515097|364392520|FG000|Overall Study|Lost to Follow-up|4|||
105653117|NCT02515097|364392521|FG001|Overall Study|Lost to Follow-up|2|||
105653118|NCT02515097|364392520|FG000|Overall Study|Withdrawal by Subject|1|||
105653119|NCT02515097|364392521|FG001|Overall Study|Withdrawal by Subject|3|||
105653120|NCT02515097|364392520|FG000|Overall Study|Adverse Event|2|||
105653121|NCT02515097|364392521|FG001|Overall Study|Adverse Event|1|||
105653122|NCT04688086|364392522|FG000|Overall Study|Lost to Follow-up|164|||
105653123|NCT04688086|364392522|FG000|Overall Study|Imaging error;|64|||
105653124|NCT03915951|364392527|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
105653125|NCT03915951|364392528|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
105653126|NCT03915951|364392527|FG000|Overall Study|Adverse Event|12|||
105653127|NCT03915951|364392528|FG001|Overall Study|Adverse Event|6|||
105653128|NCT03915951|364392527|FG000|Overall Study|Disease progression (radiological)|17|||
105653129|NCT03915951|364392528|FG001|Overall Study|Disease progression (radiological)|15|||
105653130|NCT03915951|364392527|FG000|Overall Study|Disease progression (clinical)|4|||
105659501|NCT02635386|364417351|FG004|Overall Study|Moved Out of State|0|||
105653131|NCT03915951|364392528|FG001|Overall Study|Disease progression (clinical)|1|||
105653132|NCT03915951|364392527|FG000|Overall Study|Patient decision|0|||
105653133|NCT03915951|364392528|FG001|Overall Study|Patient decision|4|||
105653134|NCT03915951|364392527|FG000|Overall Study|Investigator decision|0|||
105653135|NCT03915951|364392528|FG001|Overall Study|Investigator decision|1|||
105653136|NCT03915951|364392527|FG000|Overall Study|Consent withdrawn|1|||
105653137|NCT03915951|364392528|FG001|Overall Study|Consent withdrawn|1|||
105653138|NCT03915951|364392527|FG000|Overall Study|Death|0|||
105653139|NCT03915951|364392528|FG001|Overall Study|Death|3|||
105653140|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
105653141|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
105653142|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
105653143|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
105653144|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
105653145|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
105653146|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
105653147|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
105653148|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
105653149|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
105653150|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
105653151|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
105653152|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
105653153|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
105653154|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
105653155|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
105653156|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
105653157|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
105653158|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
105653159|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
105653160|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
105653161|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
105653162|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
105653163|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
105653164|NCT02269917|364392532|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
105653165|NCT02269917|364392533|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
105653166|NCT02269917|364392534|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
105653167|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
105653168|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
105653169|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
105653170|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
105653171|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
105653172|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
105653173|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
105653174|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
105653175|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
105653176|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
105653177|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
105653178|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
105653179|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
105653180|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
105653181|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
105653182|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
105653183|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
105653184|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
105653185|NCT02269917|364392532|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
105653186|NCT02269917|364392533|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
105653187|NCT02269917|364392534|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
105653188|NCT01679613|364392540|FG000|Overall Study|other than stated above|0|||
105653189|NCT01679613|364392541|FG001|Overall Study|other than stated above|1|||
105653190|NCT01679613|364392542|FG002|Overall Study|other than stated above|2|||
105653191|NCT01679613|364392543|FG003|Overall Study|other than stated above|2|||
105653192|NCT02473913|364392545|FG000|Overall Study|Lost to Follow-up|3|||
105653193|NCT02473913|364392546|FG001|Overall Study|Lost to Follow-up|3|||
105653194|NCT01190449|364392554|FG000|Overall Study|Ineligible|0|||
105653195|NCT01190449|364392555|FG001|Overall Study|Ineligible|4|||
105653196|NCT02250183|364392556|FG000|Overall Study|Withdrawal by Subject|2|||
105653197|NCT02250183|364392556|FG000|Overall Study|Adverse Event|5|||
105653198|NCT02250183|364392556|FG000|Overall Study|Lost to Follow-up|1|||
105653199|NCT00951171|364392560|FG000|Overall Study|Adverse Event|2|||
105653200|NCT00951171|364392561|FG001|Overall Study|Adverse Event|0|||
105653201|NCT04130061|364392562|FG000|Overall Study|OR team forgot to request membrane|1|||
105653202|NCT04130061|364392563|FG001|Overall Study|OR team forgot to request membrane|0|||
105653203|NCT00275301|364394963|FG000|Overall Study|Adverse Event|5|||
105653204|NCT00848393|364394970|FG000|Overall Study|Protocol Violation|0|||
105653205|NCT00848393|364394971|FG001|Overall Study|Protocol Violation|0|||
105653206|NCT00848393|364394972|FG002|Overall Study|Protocol Violation|1|||
105653207|NCT00848393|364394970|FG000|Overall Study|surgical complications unrelated to stud|0|||
105653208|NCT00848393|364394971|FG001|Overall Study|surgical complications unrelated to stud|0|||
105653209|NCT00848393|364394972|FG002|Overall Study|surgical complications unrelated to stud|2|||
105653210|NCT02561078|364394973|FG000|Overall Study|Adverse Event|5|||
105653211|NCT02561078|364394974|FG001|Overall Study|Adverse Event|2|||
105653212|NCT02561078|364394973|FG000|Overall Study|Death|2|||
105653213|NCT02561078|364394974|FG001|Overall Study|Death|1|||
105653214|NCT02561078|364394973|FG000|Overall Study|Lost to Follow-up|2|||
105653215|NCT02561078|364394974|FG001|Overall Study|Lost to Follow-up|6|||
105653216|NCT02561078|364394973|FG000|Overall Study|Non-Compliance with Study Drug|6|||
105653217|NCT02561078|364394974|FG001|Overall Study|Non-Compliance with Study Drug|3|||
105653218|NCT02561078|364394973|FG000|Overall Study|Physician Decision|2|||
105653219|NCT02561078|364394974|FG001|Overall Study|Physician Decision|3|||
105653220|NCT02561078|364394973|FG000|Overall Study|Withdrawal by Subject|13|||
105653221|NCT02561078|364394974|FG001|Overall Study|Withdrawal by Subject|10|||
105653222|NCT00043186|364394975|FG000|Overall Study|Physician Decision|0|||
105653223|NCT00043186|364394976|FG001|Overall Study|Physician Decision|0|||
105653224|NCT00043186|364394977|FG002|Overall Study|Physician Decision|3|||
105653225|NCT00043186|364394978|FG003|Overall Study|Physician Decision|0|||
105653226|NCT00043186|364394979|FG004|Overall Study|Physician Decision|1|||
105653227|NCT00043186|364394980|FG005|Overall Study|Physician Decision|0|||
105653228|NCT00043186|364394981|FG006|Overall Study|Physician Decision|0|||
105653229|NCT00043186|364394982|FG007|Overall Study|Physician Decision|1|||
105653230|NCT00043186|364394983|FG008|Overall Study|Physician Decision|1|||
105653231|NCT00043186|364394975|FG000|Overall Study|Adverse Event|2|||
105653232|NCT00043186|364394976|FG001|Overall Study|Adverse Event|2|||
105653233|NCT00043186|364394977|FG002|Overall Study|Adverse Event|2|||
105653234|NCT00043186|364394978|FG003|Overall Study|Adverse Event|3|||
105653235|NCT00043186|364394979|FG004|Overall Study|Adverse Event|2|||
105653236|NCT00043186|364394980|FG005|Overall Study|Adverse Event|1|||
105653237|NCT00043186|364394981|FG006|Overall Study|Adverse Event|2|||
105653238|NCT00043186|364394982|FG007|Overall Study|Adverse Event|1|||
105653239|NCT00043186|364394983|FG008|Overall Study|Adverse Event|3|||
105653240|NCT00043186|364394975|FG000|Overall Study|Withdrawal by Subject|11|||
105653241|NCT00043186|364394976|FG001|Overall Study|Withdrawal by Subject|8|||
105653242|NCT00043186|364394977|FG002|Overall Study|Withdrawal by Subject|11|||
105653243|NCT00043186|364394978|FG003|Overall Study|Withdrawal by Subject|13|||
105653244|NCT00043186|364394979|FG004|Overall Study|Withdrawal by Subject|14|||
105653245|NCT00043186|364394980|FG005|Overall Study|Withdrawal by Subject|6|||
105653246|NCT00043186|364394981|FG006|Overall Study|Withdrawal by Subject|12|||
105653247|NCT00043186|364394982|FG007|Overall Study|Withdrawal by Subject|9|||
105653248|NCT00043186|364394983|FG008|Overall Study|Withdrawal by Subject|10|||
105653249|NCT00043186|364394975|FG000|Overall Study|Death|0|||
105653250|NCT00043186|364394976|FG001|Overall Study|Death|0|||
105653251|NCT00043186|364394977|FG002|Overall Study|Death|1|||
105653252|NCT00043186|364394978|FG003|Overall Study|Death|0|||
105653253|NCT00043186|364394979|FG004|Overall Study|Death|0|||
105653254|NCT00043186|364394980|FG005|Overall Study|Death|0|||
105653255|NCT00043186|364394981|FG006|Overall Study|Death|2|||
105653256|NCT00043186|364394982|FG007|Overall Study|Death|0|||
105653257|NCT00043186|364394983|FG008|Overall Study|Death|0|||
105653258|NCT00043186|364394975|FG000|Overall Study|Disease progression|1|||
105653259|NCT00043186|364394976|FG001|Overall Study|Disease progression|0|||
105653260|NCT00043186|364394977|FG002|Overall Study|Disease progression|0|||
105653261|NCT00043186|364394978|FG003|Overall Study|Disease progression|3|||
105653262|NCT00043186|364394979|FG004|Overall Study|Disease progression|0|||
105653263|NCT00043186|364394980|FG005|Overall Study|Disease progression|0|||
105870393|NCT01290302|365179051|FG001|Overall Study|Withdrawal by Subject|0|||
105653264|NCT00043186|364394981|FG006|Overall Study|Disease progression|0|||
105653265|NCT00043186|364394982|FG007|Overall Study|Disease progression|4|||
105653266|NCT00043186|364394983|FG008|Overall Study|Disease progression|0|||
105653267|NCT00043186|364394975|FG000|Overall Study|Ineligibility determined|0|||
105653268|NCT00043186|364394976|FG001|Overall Study|Ineligibility determined|0|||
105653269|NCT00043186|364394977|FG002|Overall Study|Ineligibility determined|0|||
105653270|NCT00043186|364394978|FG003|Overall Study|Ineligibility determined|0|||
105653271|NCT00043186|364394979|FG004|Overall Study|Ineligibility determined|0|||
105653272|NCT00043186|364394980|FG005|Overall Study|Ineligibility determined|0|||
105653273|NCT00043186|364394981|FG006|Overall Study|Ineligibility determined|0|||
105653274|NCT00043186|364394982|FG007|Overall Study|Ineligibility determined|0|||
105653275|NCT00043186|364394983|FG008|Overall Study|Ineligibility determined|1|||
105653276|NCT00043186|364394975|FG000|Overall Study|Lost to Follow-up|3|||
105653277|NCT00043186|364394976|FG001|Overall Study|Lost to Follow-up|5|||
105870394|NCT01290302|365179050|FG000|Overall Study|Physician Decision|0|||
105653278|NCT00043186|364394977|FG002|Overall Study|Lost to Follow-up|1|||
105653279|NCT00043186|364394978|FG003|Overall Study|Lost to Follow-up|1|||
105653280|NCT00043186|364394979|FG004|Overall Study|Lost to Follow-up|1|||
105653281|NCT00043186|364394980|FG005|Overall Study|Lost to Follow-up|1|||
105653282|NCT00043186|364394981|FG006|Overall Study|Lost to Follow-up|1|||
105653283|NCT00043186|364394982|FG007|Overall Study|Lost to Follow-up|1|||
105653284|NCT00043186|364394983|FG008|Overall Study|Lost to Follow-up|2|||
105653285|NCT00043186|364394975|FG000|Overall Study|Noncompliance|0|||
105653286|NCT00043186|364394976|FG001|Overall Study|Noncompliance|0|||
105653287|NCT00043186|364394977|FG002|Overall Study|Noncompliance|1|||
105653288|NCT00043186|364394978|FG003|Overall Study|Noncompliance|1|||
105653289|NCT00043186|364394979|FG004|Overall Study|Noncompliance|0|||
105653290|NCT00043186|364394980|FG005|Overall Study|Noncompliance|0|||
105653291|NCT00043186|364394981|FG006|Overall Study|Noncompliance|0|||
105653292|NCT00043186|364394982|FG007|Overall Study|Noncompliance|0|||
105653293|NCT00043186|364394983|FG008|Overall Study|Noncompliance|0|||
105653294|NCT00043186|364394975|FG000|Overall Study|Other|0|||
105653295|NCT00043186|364394976|FG001|Overall Study|Other|0|||
105653296|NCT00043186|364394977|FG002|Overall Study|Other|1|||
105653297|NCT00043186|364394978|FG003|Overall Study|Other|1|||
105653298|NCT00043186|364394979|FG004|Overall Study|Other|0|||
105653299|NCT00043186|364394980|FG005|Overall Study|Other|0|||
105653300|NCT00043186|364394981|FG006|Overall Study|Other|0|||
105653301|NCT00043186|364394982|FG007|Overall Study|Other|0|||
105653302|NCT00043186|364394983|FG008|Overall Study|Other|0|||
105653303|NCT00719212|364394984|FG000|Overall Study|Death|41|||
105653304|NCT00719212|364394984|FG000|Overall Study|Lost to Follow-up|2|||
105653305|NCT00719212|364394984|FG000|Overall Study|Withdrawal by Subject|1|||
105653306|NCT02151643|364394985|FG000|Overall Study|Adverse Event|2|||
105653307|NCT02151643|364394986|FG001|Overall Study|Adverse Event|0|||
105653308|NCT02151643|364394987|FG002|Overall Study|Adverse Event|1|||
105653309|NCT02151643|364394988|FG003|Overall Study|Adverse Event|4|||
105653310|NCT02151643|364394989|FG004|Overall Study|Adverse Event|0|||
105653311|NCT02151643|364394985|FG000|Overall Study|Withdrawal by Subject|0|||
105653312|NCT02151643|364394986|FG001|Overall Study|Withdrawal by Subject|1|||
105653313|NCT02151643|364394987|FG002|Overall Study|Withdrawal by Subject|1|||
105653314|NCT02151643|364394988|FG003|Overall Study|Withdrawal by Subject|1|||
105653315|NCT02151643|364394989|FG004|Overall Study|Withdrawal by Subject|1|||
105653316|NCT02151643|364394985|FG000|Overall Study|Hyperphosphataemia|1|||
105653317|NCT02151643|364394986|FG001|Overall Study|Hyperphosphataemia|0|||
105653318|NCT02151643|364394987|FG002|Overall Study|Hyperphosphataemia|0|||
105653319|NCT02151643|364394988|FG003|Overall Study|Hyperphosphataemia|0|||
105653320|NCT02151643|364394989|FG004|Overall Study|Hyperphosphataemia|1|||
105653321|NCT02151643|364394985|FG000|Overall Study|High Ferritin levels|3|||
105653322|NCT02151643|364394986|FG001|Overall Study|High Ferritin levels|3|||
105653323|NCT02151643|364394987|FG002|Overall Study|High Ferritin levels|2|||
105653324|NCT02151643|364394988|FG003|Overall Study|High Ferritin levels|2|||
105653325|NCT02151643|364394989|FG004|Overall Study|High Ferritin levels|1|||
105653326|NCT03296566|364394990|FG000|Overall Study|Lost to Follow-up|19|||
105653327|NCT03296566|364394991|FG001|Overall Study|Lost to Follow-up|46|||
105653328|NCT03296566|364394990|FG000|Overall Study|Withdrawal by Subject|0|||
105653329|NCT03296566|364394991|FG001|Overall Study|Withdrawal by Subject|3|||
105653330|NCT01990313|364394992|FG000|Overall Study|Lost to Follow-up|1|||
105653331|NCT03226106|364394993|FG000|Overall Study|Withdrawal by Subject|2|||
105653332|NCT03226106|364394994|FG001|Overall Study|Withdrawal by Subject|0|||
105653333|NCT03226106|364394993|FG000|Overall Study|Adverse Event|1|||
105653334|NCT03226106|364394994|FG001|Overall Study|Adverse Event|0|||
105653335|NCT03226106|364394993|FG000|Overall Study|Lost to Follow-up|2|||
105653336|NCT03226106|364394994|FG001|Overall Study|Lost to Follow-up|0|||
105653337|NCT03022578|364394996|FG000|Overall Study|Adverse Event|1|||
105653338|NCT03022578|364394996|FG000|Overall Study|Lack of Efficacy|2|||
105653339|NCT03022578|364394996|FG000|Overall Study|Withdrawal by Subject|1|||
105653340|NCT00510198|364394997|FG000|Overall Study|Withdrawal by Subject|5|||
105653341|NCT00510198|364394998|FG001|Overall Study|Withdrawal by Subject|4|||
105653342|NCT00329550|364394999|FG000|Overall Study|Adverse Event|3|||
105653343|NCT00329550|364395000|FG001|Overall Study|Adverse Event|4|||
105653344|NCT00329550|364395001|FG002|Overall Study|Adverse Event|2|||
105653345|NCT00329550|364394999|FG000|Overall Study|Withdrawal of Consent|1|||
105653346|NCT00329550|364395000|FG001|Overall Study|Withdrawal of Consent|0|||
105653347|NCT00329550|364395001|FG002|Overall Study|Withdrawal of Consent|1|||
105653348|NCT00329550|364394999|FG000|Overall Study|Due to Relocation|0|||
105653349|NCT00329550|364395000|FG001|Overall Study|Due to Relocation|0|||
105653350|NCT00329550|364395001|FG002|Overall Study|Due to Relocation|1|||
105653351|NCT04150341|364395006|FG000|Overall Study|Physician Decision|0|||
105653352|NCT04150341|364395007|FG001|Overall Study|Physician Decision|0|||
105653353|NCT04150341|364395008|FG002|Overall Study|Physician Decision|1|||
105653354|NCT04150341|364395009|FG003|Overall Study|Physician Decision|0|||
105653355|NCT04150341|364395010|FG004|Overall Study|Physician Decision|0|||
105653356|NCT04150341|364395011|FG005|Overall Study|Physician Decision|0|||
105653357|NCT04150341|364395006|FG000|Overall Study|Adverse Event|0|||
105653358|NCT04150341|364395007|FG001|Overall Study|Adverse Event|0|||
105653359|NCT04150341|364395008|FG002|Overall Study|Adverse Event|0|||
105653360|NCT04150341|364395009|FG003|Overall Study|Adverse Event|0|||
105653361|NCT04150341|364395010|FG004|Overall Study|Adverse Event|1|||
105653362|NCT04150341|364395011|FG005|Overall Study|Adverse Event|0|||
105653363|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
105653364|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
105653365|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
105653366|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
105653367|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Death|0|||
105653368|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Death|1|||
105653369|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
105653370|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
105653371|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
105653372|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
105653373|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
105653374|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
105653375|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
105653376|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
105653377|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
105653378|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
105653379|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
105653380|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
105653381|NCT01309243|364395018|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
105653382|NCT01309243|364395019|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
105653383|NCT01309243|364395018|FG000|Extension Phase|Lost to Follow-up|6|||
105653384|NCT01309243|364395019|FG001|Extension Phase|Lost to Follow-up|0|||
105653385|NCT00917462|364395022|FG000|Overall Study|Clinical Deterioration|1|||
105653386|NCT01402063|364395023|FG000|Overall Study|Withdrawal by Subject|3|||
105653387|NCT01402063|364395024|FG001|Overall Study|Withdrawal by Subject|3|||
105653388|NCT01441583|364395025|FG000|Overall Study|Withdrawal by Subject|1|||
105653389|NCT01441583|364395026|FG001|Overall Study|Withdrawal by Subject|1|||
105653390|NCT01441583|364395027|FG002|Overall Study|Withdrawal by Subject|1|||
105653391|NCT01441583|364395025|FG000|Overall Study|Death|1|||
105653392|NCT01441583|364395026|FG001|Overall Study|Death|0|||
105653393|NCT01441583|364395027|FG002|Overall Study|Death|4|||
105653394|NCT01441583|364395025|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
105653395|NCT01441583|364395026|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
105653396|NCT01441583|364395027|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
105653397|NCT01191697|364395028|FG000|Overall Study|Death|1|||
105653398|NCT01191697|364395028|FG000|Overall Study|Physician Decision|2|||
105653399|NCT01191697|364395028|FG000|Overall Study|Pursue chemoradiation|2|||
105653400|NCT01191697|364395028|FG000|Overall Study|Break from chemotherapy|2|||
105653401|NCT01191697|364395028|FG000|Overall Study|Withdrawal by Subject|1|||
105653402|NCT01191697|364395028|FG000|Overall Study|Surveillance|1|||
105653403|NCT01191697|364395028|FG000|Overall Study|Adverse Event|2|||
105653404|NCT01191697|364395028|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
105653405|NCT01191697|364395028|FG000|Overall Study|Not completed but analyzed|25|||
105653406|NCT02396758|364395030|FG000|Overall Study|Withdrawal by Subject|2|||
105653407|NCT02396758|364395031|FG001|Overall Study|Withdrawal by Subject|0|||
105653408|NCT02396758|364395032|FG002|Overall Study|Withdrawal by Subject|0|||
105653409|NCT02396758|364395033|FG003|Overall Study|Withdrawal by Subject|1|||
105653410|NCT02396758|364395030|FG000|Overall Study|Lost to Follow-up|8|||
105653411|NCT02396758|364395031|FG001|Overall Study|Lost to Follow-up|5|||
105653412|NCT02396758|364395032|FG002|Overall Study|Lost to Follow-up|3|||
105653413|NCT02396758|364395033|FG003|Overall Study|Lost to Follow-up|3|||
105653414|NCT02396758|364395030|FG000|Overall Study|Death|1|||
105653415|NCT02396758|364395031|FG001|Overall Study|Death|1|||
105653416|NCT02396758|364395032|FG002|Overall Study|Death|0|||
105653417|NCT02396758|364395033|FG003|Overall Study|Death|1|||
105653418|NCT02396758|364395030|FG000|Overall Study|Randomized but not treated|1|||
105653419|NCT02396758|364395031|FG001|Overall Study|Randomized but not treated|0|||
105653420|NCT02396758|364395032|FG002|Overall Study|Randomized but not treated|1|||
105653421|NCT02396758|364395033|FG003|Overall Study|Randomized but not treated|0|||
105653422|NCT02176018|364395034|FG000|Overall Study|Adverse Event|0|||
105653423|NCT02176018|364395035|FG001|Overall Study|Adverse Event|2|||
105653424|NCT02176018|364395034|FG000|Overall Study|Lost to Follow-up|3|||
105653425|NCT02176018|364395035|FG001|Overall Study|Lost to Follow-up|1|||
105653426|NCT02176018|364395034|FG000|Overall Study|Protocol Violation|1|||
105653427|NCT02176018|364395035|FG001|Overall Study|Protocol Violation|1|||
105653428|NCT02176018|364395034|FG000|Overall Study|Withdrawal by Subject|1|||
105653429|NCT02176018|364395035|FG001|Overall Study|Withdrawal by Subject|2|||
105653430|NCT05153499|364395036|FG000|Overall Study|Withdrawal by Subject|1|||
105653431|NCT05153499|364395037|FG001|Overall Study|Withdrawal by Subject|0|||
105653432|NCT05153499|364395036|FG000|Overall Study|Clinical Hold|1|||
105653433|NCT05153499|364395037|FG001|Overall Study|Clinical Hold|0|||
105653434|NCT05153499|364395036|FG000|Overall Study|Study Termination|6|||
105653435|NCT05153499|364395037|FG001|Overall Study|Study Termination|5|||
105653436|NCT00265096|364395038|FG000|Overall Study|Adverse Event|14|||
105653437|NCT00265096|364395039|FG001|Overall Study|Adverse Event|18|||
105653438|NCT00265096|364395040|FG002|Overall Study|Adverse Event|18|||
105653439|NCT00265096|364395038|FG000|Overall Study|Lost to Follow-up|2|||
105653440|NCT00265096|364395039|FG001|Overall Study|Lost to Follow-up|5|||
105653441|NCT00265096|364395040|FG002|Overall Study|Lost to Follow-up|3|||
105653442|NCT00265096|364395038|FG000|Overall Study|Death|0|||
105653443|NCT00265096|364395039|FG001|Overall Study|Death|1|||
105653444|NCT00265096|364395040|FG002|Overall Study|Death|2|||
105653445|NCT00265096|364395038|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
105653446|NCT00265096|364395039|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
105653447|NCT00265096|364395040|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
105653448|NCT00265096|364395038|FG000|Overall Study|Other|11|||
105653449|NCT00265096|364395039|FG001|Overall Study|Other|19|||
105653450|NCT00265096|364395040|FG002|Overall Study|Other|10|||
105653451|NCT03022045|364395041|FG000|Overall Study|Adverse Event|0|||
105653452|NCT03022045|364395042|FG001|Overall Study|Adverse Event|1|||
105653453|NCT03022045|364395041|FG000|Overall Study|Withdrawal by Subject|1|||
105653454|NCT03022045|364395042|FG001|Overall Study|Withdrawal by Subject|1|||
105653455|NCT00666835|364395043|FG000|Overall Study|Withdrawal by Subject|5|||
105653456|NCT00666835|364395044|FG001|Overall Study|Withdrawal by Subject|2|||
105653457|NCT00666835|364395043|FG000|Overall Study|Lack of Efficacy|0|||
105653458|NCT00666835|364395044|FG001|Overall Study|Lack of Efficacy|1|||
105653459|NCT00666835|364395043|FG000|Overall Study|Incl./excl. not fulfilled|7|||
105653460|NCT00666835|364395044|FG001|Overall Study|Incl./excl. not fulfilled|2|||
105653461|NCT00666835|364395043|FG000|Overall Study|Adverse Event|7|||
105653462|NCT00666835|364395044|FG001|Overall Study|Adverse Event|6|||
105653463|NCT00666835|364395043|FG000|Overall Study|Protocol Violation|2|||
105653464|NCT00666835|364395044|FG001|Overall Study|Protocol Violation|0|||
105653465|NCT00666835|364395043|FG000|Overall Study|Death|15|||
105653466|NCT00666835|364395044|FG001|Overall Study|Death|4|||
105653467|NCT00666835|364395043|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
105653468|NCT00666835|364395044|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
105653469|NCT00666835|364395043|FG000|Overall Study|Hemoglobulin concentration|4|||
105653470|NCT00666835|364395044|FG001|Overall Study|Hemoglobulin concentration|3|||
105653471|NCT00666835|364395043|FG000|Overall Study|Planned operation|2|||
105653472|NCT00666835|364395044|FG001|Overall Study|Planned operation|0|||
105653473|NCT00666835|364395043|FG000|Overall Study|Physician Decision|1|||
105653474|NCT00666835|364395044|FG001|Overall Study|Physician Decision|2|||
105653475|NCT02499835|364395045|FG000|Overall Study|Withdrawal by Subject|1|||
105653476|NCT02499835|364395046|FG001|Overall Study|Withdrawal by Subject|0|||
105653477|NCT02499835|364395047|FG002|Overall Study|Withdrawal by Subject|0|||
105653478|NCT02499835|364395048|FG003|Overall Study|Withdrawal by Subject|1|||
105653479|NCT02499835|364395045|FG000|Overall Study|Physician Decision|0|||
105653480|NCT02499835|364395046|FG001|Overall Study|Physician Decision|3|||
105653481|NCT02499835|364395047|FG002|Overall Study|Physician Decision|18|||
105653482|NCT02499835|364395048|FG003|Overall Study|Physician Decision|7|||
105653483|NCT02499835|364395045|FG000|Overall Study|Adverse Event|0|||
105653484|NCT02499835|364395046|FG001|Overall Study|Adverse Event|0|||
105653485|NCT02499835|364395047|FG002|Overall Study|Adverse Event|0|||
105653486|NCT02499835|364395048|FG003|Overall Study|Adverse Event|1|||
105653487|NCT02499835|364395045|FG000|Overall Study|Disease progression|2|||
105653488|NCT02499835|364395046|FG001|Overall Study|Disease progression|1|||
105653489|NCT02499835|364395047|FG002|Overall Study|Disease progression|0|||
105653490|NCT02499835|364395048|FG003|Overall Study|Disease progression|7|||
105653491|NCT00899379|364395049|FG000|Overall Study|Adverse Event|2|||
105653492|NCT00899379|364395050|FG001|Overall Study|Adverse Event|2|||
105653493|NCT00899379|364395051|FG002|Overall Study|Adverse Event|1|||
105653494|NCT00899379|364395052|FG003|Overall Study|Adverse Event|1|||
105653495|NCT00899379|364395053|FG004|Overall Study|Adverse Event|2|||
105653496|NCT00899379|364395049|FG000|Overall Study|Lack of Efficacy|0|||
105653497|NCT00899379|364395050|FG001|Overall Study|Lack of Efficacy|4|||
105653498|NCT00899379|364395051|FG002|Overall Study|Lack of Efficacy|3|||
105653499|NCT00899379|364395052|FG003|Overall Study|Lack of Efficacy|0|||
105653500|NCT00899379|364395053|FG004|Overall Study|Lack of Efficacy|1|||
105653501|NCT00899379|364395049|FG000|Overall Study|Lost to Follow-up|9|||
105653502|NCT00899379|364395050|FG001|Overall Study|Lost to Follow-up|3|||
105653503|NCT00899379|364395051|FG002|Overall Study|Lost to Follow-up|0|||
105653504|NCT00899379|364395052|FG003|Overall Study|Lost to Follow-up|6|||
105653505|NCT00899379|364395053|FG004|Overall Study|Lost to Follow-up|2|||
105653506|NCT00899379|364395049|FG000|Overall Study|Protocol Violation|0|||
105653507|NCT00899379|364395050|FG001|Overall Study|Protocol Violation|0|||
105653508|NCT00899379|364395051|FG002|Overall Study|Protocol Violation|1|||
105653509|NCT00899379|364395052|FG003|Overall Study|Protocol Violation|1|||
105653510|NCT00899379|364395053|FG004|Overall Study|Protocol Violation|0|||
105653511|NCT00899379|364395049|FG000|Overall Study|Withdrawal by Subject|2|||
105653512|NCT00899379|364395050|FG001|Overall Study|Withdrawal by Subject|4|||
105653513|NCT00899379|364395051|FG002|Overall Study|Withdrawal by Subject|2|||
105653514|NCT00899379|364395052|FG003|Overall Study|Withdrawal by Subject|3|||
105653515|NCT00899379|364395053|FG004|Overall Study|Withdrawal by Subject|6|||
105653516|NCT00899379|364395049|FG000|Overall Study|Pregnancy|0|||
105653517|NCT00899379|364395050|FG001|Overall Study|Pregnancy|0|||
105653518|NCT00899379|364395051|FG002|Overall Study|Pregnancy|1|||
105653519|NCT00899379|364395052|FG003|Overall Study|Pregnancy|0|||
105653520|NCT00899379|364395053|FG004|Overall Study|Pregnancy|1|||
105653521|NCT00899379|364395049|FG000|Overall Study|Patient Uncooperative|0|||
105653522|NCT00899379|364395050|FG001|Overall Study|Patient Uncooperative|1|||
105653523|NCT00899379|364395051|FG002|Overall Study|Patient Uncooperative|0|||
105653524|NCT00899379|364395052|FG003|Overall Study|Patient Uncooperative|1|||
105653525|NCT00899379|364395053|FG004|Overall Study|Patient Uncooperative|2|||
105653526|NCT00899379|364395049|FG000|Overall Study|Abnormal Baseline ECG|0|||
105653527|NCT00899379|364395050|FG001|Overall Study|Abnormal Baseline ECG|0|||
105653528|NCT00899379|364395051|FG002|Overall Study|Abnormal Baseline ECG|0|||
105653529|NCT00899379|364395052|FG003|Overall Study|Abnormal Baseline ECG|1|||
105653530|NCT00899379|364395053|FG004|Overall Study|Abnormal Baseline ECG|0|||
105653531|NCT00899379|364395049|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105653532|NCT00899379|364395050|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105653533|NCT00899379|364395051|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105653534|NCT00899379|364395052|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653535|NCT00899379|364395053|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653536|NCT00899379|364395049|FG000|Overall Study|Not Completed/Entered Extn|5|||
105653537|NCT00899379|364395050|FG001|Overall Study|Not Completed/Entered Extn|1|||
105653538|NCT00899379|364395051|FG002|Overall Study|Not Completed/Entered Extn|6|||
105653539|NCT00899379|364395052|FG003|Overall Study|Not Completed/Entered Extn|4|||
105653540|NCT00899379|364395053|FG004|Overall Study|Not Completed/Entered Extn|3|||
105653541|NCT00899379|364395049|FG000|Overall Study|Study Terminated|3|||
105653542|NCT00899379|364395050|FG001|Overall Study|Study Terminated|0|||
105653543|NCT00899379|364395051|FG002|Overall Study|Study Terminated|3|||
105653544|NCT00899379|364395052|FG003|Overall Study|Study Terminated|3|||
105653545|NCT00899379|364395053|FG004|Overall Study|Study Terminated|1|||
105653546|NCT00899379|364395049|FG000|Overall Study|Lost to Follow-up|3|||
105653547|NCT00899379|364395050|FG001|Overall Study|Lost to Follow-up|1|||
105653548|NCT00899379|364395051|FG002|Overall Study|Lost to Follow-up|0|||
105653549|NCT00899379|364395052|FG003|Overall Study|Lost to Follow-up|2|||
105653550|NCT00899379|364395053|FG004|Overall Study|Lost to Follow-up|5|||
105653551|NCT00899379|364395049|FG000|Overall Study|Withdrawal by Subject|4|||
105653552|NCT00899379|364395050|FG001|Overall Study|Withdrawal by Subject|7|||
105653553|NCT00899379|364395051|FG002|Overall Study|Withdrawal by Subject|4|||
105653554|NCT00899379|364395052|FG003|Overall Study|Withdrawal by Subject|7|||
105653555|NCT00899379|364395053|FG004|Overall Study|Withdrawal by Subject|2|||
105653556|NCT00899379|364395049|FG000|Overall Study|Pregnancy|1|||
105653557|NCT00899379|364395050|FG001|Overall Study|Pregnancy|0|||
105653558|NCT00899379|364395051|FG002|Overall Study|Pregnancy|0|||
105653559|NCT00899379|364395052|FG003|Overall Study|Pregnancy|0|||
105653560|NCT00899379|364395053|FG004|Overall Study|Pregnancy|0|||
105653561|NCT00899379|364395049|FG000|Overall Study|Patient Uncooperative|0|||
105653562|NCT00899379|364395050|FG001|Overall Study|Patient Uncooperative|0|||
105653563|NCT00899379|364395051|FG002|Overall Study|Patient Uncooperative|0|||
105653564|NCT00899379|364395052|FG003|Overall Study|Patient Uncooperative|1|||
105653565|NCT00899379|364395053|FG004|Overall Study|Patient Uncooperative|0|||
105653566|NCT00899379|364395049|FG000|Overall Study|Abnormal Prestudy Labs|0|||
105653567|NCT00899379|364395050|FG001|Overall Study|Abnormal Prestudy Labs|0|||
105653568|NCT00899379|364395051|FG002|Overall Study|Abnormal Prestudy Labs|0|||
105653569|NCT00899379|364395052|FG003|Overall Study|Abnormal Prestudy Labs|0|||
105653570|NCT00899379|364395053|FG004|Overall Study|Abnormal Prestudy Labs|2|||
105653571|NCT00899379|364395049|FG000|Overall Study|Abnormal Baseline ECG|0|||
105653572|NCT00899379|364395050|FG001|Overall Study|Abnormal Baseline ECG|0|||
105653573|NCT00899379|364395051|FG002|Overall Study|Abnormal Baseline ECG|1|||
105653574|NCT00899379|364395052|FG003|Overall Study|Abnormal Baseline ECG|1|||
105653575|NCT00899379|364395053|FG004|Overall Study|Abnormal Baseline ECG|0|||
105870395|NCT01290302|365179051|FG001|Overall Study|Physician Decision|2|||
105870396|NCT01290302|365179050|FG000|Overall Study|Expiration of time for screening window|1|||
105653576|NCT00899379|364395049|FG000|Overall Study|No Attack Pretreatment|3|||
105653577|NCT00899379|364395050|FG001|Overall Study|No Attack Pretreatment|5|||
105653578|NCT00899379|364395051|FG002|Overall Study|No Attack Pretreatment|5|||
105653579|NCT00899379|364395052|FG003|Overall Study|No Attack Pretreatment|6|||
105653580|NCT00899379|364395053|FG004|Overall Study|No Attack Pretreatment|4|||
105870397|NCT01290302|365179051|FG001|Overall Study|Expiration of time for screening window|0|||
105653581|NCT00899379|364395049|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
105653582|NCT00899379|364395050|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653583|NCT00899379|364395051|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653584|NCT00899379|364395052|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653585|NCT00899379|364395053|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
105653586|NCT00899379|364395049|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
105653587|NCT00899379|364395050|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
105653588|NCT00899379|364395051|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
105653589|NCT00899379|364395052|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
105653590|NCT00899379|364395053|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
105653591|NCT01780545|364395058|FG000|Overall Study|Withdrawal by Subject|3|||
105653592|NCT01780545|364395059|FG001|Overall Study|Withdrawal by Subject|1|||
105653593|NCT01780545|364395058|FG000|Overall Study|Lost to Follow-up|1|||
105653594|NCT01780545|364395059|FG001|Overall Study|Lost to Follow-up|1|||
105653595|NCT01732926|364395065|FG000|Overall Study|Study Terminated by Sponsor|168|||
105653596|NCT01732926|364395066|FG001|Overall Study|Study Terminated by Sponsor|80|||
105653597|NCT01732926|364395065|FG000|Overall Study|Withdrawal by Subject|46|||
105653598|NCT01732926|364395066|FG001|Overall Study|Withdrawal by Subject|8|||
105653599|NCT01732926|364395065|FG000|Overall Study|Physician Decision|24|||
105653600|NCT01732926|364395066|FG001|Overall Study|Physician Decision|11|||
105653601|NCT01732926|364395065|FG000|Overall Study|Other Reason|21|||
105653602|NCT01732926|364395066|FG001|Overall Study|Other Reason|4|||
105653603|NCT01732926|364395065|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
105653604|NCT01732926|364395066|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
105653605|NCT01732926|364395065|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
105653606|NCT01732926|364395066|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
105653607|NCT02262364|364395067|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
105653608|NCT00797511|364395069|FG000|Overall Study|Withdrawal by Subject|1|||
105653609|NCT00053352|364395073|FG000|Overall Study|Lost to Follow-up|0|||
105653610|NCT00053352|364395074|FG001|Overall Study|Lost to Follow-up|1|||
105653611|NCT00053352|364395073|FG000|Overall Study|Physician Decision|11|||
105653612|NCT00053352|364395074|FG001|Overall Study|Physician Decision|1|||
105653613|NCT00053352|364395073|FG000|Overall Study|Withdrawal by Subject|1|||
105653614|NCT00053352|364395074|FG001|Overall Study|Withdrawal by Subject|0|||
105653615|NCT00053352|364395073|FG000|Overall Study|Ineligible|8|||
105653616|NCT00053352|364395074|FG001|Overall Study|Ineligible|8|||
105653617|NCT00053352|364395073|FG000|Overall Study|Disease at new site|1|||
105653618|NCT00053352|364395074|FG001|Overall Study|Disease at new site|0|||
105653619|NCT02621047|364395075|FG000|Overall Study|Adverse Event|0|||
105653620|NCT02621047|364395076|FG001|Overall Study|Adverse Event|0|||
105653621|NCT02621047|364395077|FG002|Overall Study|Adverse Event|1|||
105653622|NCT01037413|364395078|FG000|Part A: Skin Testing|Adverse Event|1|||
105653623|NCT01037413|364395079|FG001|Part A: Skin Testing|Adverse Event|0|||
105653624|NCT01037413|364395078|FG000|Part A: Skin Testing|Protocol Violation|1|||
105653625|NCT01037413|364395079|FG001|Part A: Skin Testing|Protocol Violation|0|||
105653626|NCT01037413|364395078|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
105653627|NCT01037413|364395079|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
105653628|NCT01037413|364395078|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
105653629|NCT01037413|364395079|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
105653630|NCT02204319|364395083|FG000|Overall Study|Pregnancy|1|||
105653631|NCT02204319|364395083|FG000|Overall Study|Withdrawal by Subject|2|||
105653632|NCT01177137|364395084|FG000|Overall Study|Withdrawal by Subject|10|||
105653633|NCT01177137|364395085|FG001|Overall Study|Withdrawal by Subject|10|||
105653634|NCT01177137|364395086|FG002|Overall Study|Withdrawal by Subject|2|||
105653635|NCT01340300|364395095|FG000|Overall Study|Lost to Follow-up|3|||
105653636|NCT01340300|364395096|FG001|Overall Study|Lost to Follow-up|0|||
105653637|NCT01340300|364395097|FG002|Overall Study|Lost to Follow-up|5|||
105653638|NCT01340300|364395098|FG003|Overall Study|Lost to Follow-up|10|||
105653639|NCT01340300|364395095|FG000|Overall Study|Withdrawal by Subject|5|||
105653640|NCT01340300|364395096|FG001|Overall Study|Withdrawal by Subject|6|||
105653641|NCT01340300|364395097|FG002|Overall Study|Withdrawal by Subject|6|||
105653642|NCT01340300|364395098|FG003|Overall Study|Withdrawal by Subject|3|||
105653643|NCT01340300|364395095|FG000|Overall Study|Adverse Event|1|||
105653644|NCT01340300|364395096|FG001|Overall Study|Adverse Event|0|||
105653645|NCT01340300|364395097|FG002|Overall Study|Adverse Event|4|||
105653646|NCT01340300|364395098|FG003|Overall Study|Adverse Event|0|||
105653647|NCT01340300|364395095|FG000|Overall Study|Physician Decision|0|||
105653648|NCT01340300|364395096|FG001|Overall Study|Physician Decision|1|||
105653649|NCT01340300|364395097|FG002|Overall Study|Physician Decision|0|||
105653650|NCT01340300|364395098|FG003|Overall Study|Physician Decision|0|||
105653651|NCT01340300|364395095|FG000|Overall Study|Unrelated sickness|0|||
105653652|NCT01340300|364395096|FG001|Overall Study|Unrelated sickness|2|||
105653653|NCT01340300|364395097|FG002|Overall Study|Unrelated sickness|0|||
105653654|NCT01340300|364395098|FG003|Overall Study|Unrelated sickness|1|||
105653655|NCT02460562|364395100|FG000|Overall Study|Lost to Follow-up|15|||
105653656|NCT02460562|364395101|FG001|Overall Study|Lost to Follow-up|16|||
105653657|NCT01093222|364395102|FG000|Overall Study|Ineligible|6|||
105653658|NCT01093222|364395102|FG000|Overall Study|Adverse Event|7|||
105653659|NCT01093222|364395102|FG000|Overall Study|Progression/relapse|24|||
105653660|NCT01093222|364395102|FG000|Overall Study|Death|2|||
105653661|NCT01093222|364395102|FG000|Overall Study|Not protocol specified|1|||
105653662|NCT02137239|364395105|FG000|Overall Study|Discontinued Study Treatment|0|||
105653663|NCT02137239|364395106|FG001|Overall Study|Discontinued Study Treatment|3|||
105653664|NCT02137239|364395105|FG000|Overall Study|Withdrew Consent|1|||
105653665|NCT02137239|364395106|FG001|Overall Study|Withdrew Consent|1|||
105653666|NCT02137239|364395105|FG000|Overall Study|Adverse Event|2|||
105653667|NCT02137239|364395106|FG001|Overall Study|Adverse Event|2|||
105653668|NCT00187135|364395107|FG000|Visit One|Withdrawal by Subject|1|||
105653669|NCT00187135|364395108|FG001|Visit One|Withdrawal by Subject|0|||
105653670|NCT00187135|364395109|FG002|Visit One|Withdrawal by Subject|0|||
105653671|NCT00187135|364395110|FG003|Visit One|Withdrawal by Subject|0|||
105653672|NCT00187135|364395111|FG004|Visit One|Withdrawal by Subject|0|||
105653673|NCT00187135|364395112|FG005|Visit One|Withdrawal by Subject|1|||
105653674|NCT00187135|364395107|FG000|Visit One|Physician Decision|3|||
105653675|NCT00187135|364395108|FG001|Visit One|Physician Decision|1|||
105653676|NCT00187135|364395109|FG002|Visit One|Physician Decision|0|||
105653677|NCT00187135|364395110|FG003|Visit One|Physician Decision|0|||
105653678|NCT00187135|364395111|FG004|Visit One|Physician Decision|0|||
105653679|NCT00187135|364395112|FG005|Visit One|Physician Decision|1|||
105653680|NCT00187135|364395107|FG000|Visit Two|Death|0|||
105653681|NCT00187135|364395108|FG001|Visit Two|Death|0|||
105653682|NCT00187135|364395109|FG002|Visit Two|Death|0|||
105653683|NCT00187135|364395110|FG003|Visit Two|Death|1|||
105653684|NCT00187135|364395111|FG004|Visit Two|Death|0|||
105653685|NCT00187135|364395112|FG005|Visit Two|Death|1|||
105653686|NCT00187135|364395107|FG000|Visit Two|Physician Decision|1|||
105653687|NCT00187135|364395108|FG001|Visit Two|Physician Decision|0|||
105653688|NCT00187135|364395109|FG002|Visit Two|Physician Decision|0|||
105653689|NCT00187135|364395110|FG003|Visit Two|Physician Decision|0|||
105653690|NCT00187135|364395111|FG004|Visit Two|Physician Decision|0|||
105653691|NCT00187135|364395112|FG005|Visit Two|Physician Decision|0|||
105653692|NCT00187135|364395107|FG000|Visit Two|Withdrawal by Subject|1|||
105653693|NCT00187135|364395108|FG001|Visit Two|Withdrawal by Subject|1|||
105653694|NCT00187135|364395109|FG002|Visit Two|Withdrawal by Subject|1|||
105653695|NCT00187135|364395110|FG003|Visit Two|Withdrawal by Subject|0|||
105653696|NCT00187135|364395111|FG004|Visit Two|Withdrawal by Subject|1|||
105653697|NCT00187135|364395112|FG005|Visit Two|Withdrawal by Subject|1|||
105653698|NCT00187135|364395107|FG000|Visit Two|Study Discontinued|3|||
105653699|NCT00187135|364395108|FG001|Visit Two|Study Discontinued|2|||
105653700|NCT00187135|364395109|FG002|Visit Two|Study Discontinued|1|||
105653701|NCT00187135|364395110|FG003|Visit Two|Study Discontinued|7|||
105653702|NCT00187135|364395111|FG004|Visit Two|Study Discontinued|5|||
105653703|NCT00187135|364395112|FG005|Visit Two|Study Discontinued|6|||
105653704|NCT00187135|364395107|FG000|Visit Three|Death|0|||
105653705|NCT00187135|364395108|FG001|Visit Three|Death|0|||
105653706|NCT00187135|364395109|FG002|Visit Three|Death|1|||
105653707|NCT00187135|364395110|FG003|Visit Three|Death|0|||
105653708|NCT00187135|364395111|FG004|Visit Three|Death|1|||
105653709|NCT00187135|364395112|FG005|Visit Three|Death|0|||
105653710|NCT00187135|364395107|FG000|Visit Three|Withdrawal by Subject|0|||
105653711|NCT00187135|364395108|FG001|Visit Three|Withdrawal by Subject|1|||
105653712|NCT00187135|364395109|FG002|Visit Three|Withdrawal by Subject|1|||
105653713|NCT00187135|364395110|FG003|Visit Three|Withdrawal by Subject|2|||
105653714|NCT00187135|364395111|FG004|Visit Three|Withdrawal by Subject|0|||
105653715|NCT00187135|364395112|FG005|Visit Three|Withdrawal by Subject|0|||
105653716|NCT00187135|364395107|FG000|Visit Three|Study Discontinued|7|||
105653717|NCT00187135|364395108|FG001|Visit Three|Study Discontinued|6|||
105653718|NCT00187135|364395109|FG002|Visit Three|Study Discontinued|7|||
105653719|NCT00187135|364395110|FG003|Visit Three|Study Discontinued|7|||
105653720|NCT00187135|364395111|FG004|Visit Three|Study Discontinued|7|||
105653721|NCT00187135|364395112|FG005|Visit Three|Study Discontinued|6|||
105653722|NCT01951261|364395113|FG000|Overall Study|Death|1|||
105653723|NCT01951261|364395114|FG001|Overall Study|Death|0|||
105653724|NCT01951261|364395113|FG000|Overall Study|Lost to Follow-up|4|||
105653725|NCT01951261|364395114|FG001|Overall Study|Lost to Follow-up|3|||
105653726|NCT01951261|364395113|FG000|Overall Study|Protocol Violation|4|||
105653727|NCT01951261|364395114|FG001|Overall Study|Protocol Violation|3|||
105653728|NCT01670188|364395115|FG000|Overall Study|Death|0|||
105653729|NCT01670188|364395116|FG001|Overall Study|Death|1|||
105653730|NCT01954771|364395117|FG000|Overall Study|Missing HbA1c of end-point|1|||
105653731|NCT01954771|364395118|FG001|Overall Study|Missing HbA1c of end-point|1|||
105653732|NCT01954771|364395119|FG002|Overall Study|Missing HbA1c of end-point|0|||
105653733|NCT01954771|364395117|FG000|Overall Study|Missing CGMS of end-point|1|||
105653734|NCT01954771|364395118|FG001|Overall Study|Missing CGMS of end-point|1|||
105653735|NCT01954771|364395119|FG002|Overall Study|Missing CGMS of end-point|0|||
105653736|NCT01954771|364395117|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
105653737|NCT01954771|364395118|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
105653738|NCT01954771|364395119|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
105653739|NCT03175198|364395120|FG000|Overall Study|Adverse Event|480|||
105653740|NCT03175198|364395120|FG000|Overall Study|No actual visit|120|||
105653741|NCT03175198|364395120|FG000|Overall Study|Registration rule not followed|4|||
105653742|NCT03175198|364395120|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
105653743|NCT03175198|364395120|FG000|Overall Study|Other personal reason|509|||
105653744|NCT03175198|364395120|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
105653745|NCT03175198|364395120|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
105653746|NCT03175198|364395120|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
105653747|NCT03175198|364395120|FG000|Overall Study|To conduct invasive treatment of operation|53|||
105653748|NCT03175198|364395120|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
105653749|NCT03280108|364395121|FG000|Overall Study|Lost to Follow-up|2|||
105653750|NCT03280108|364395122|FG001|Overall Study|Lost to Follow-up|0|||
105653751|NCT02996097|364395123|FG000|Overall Study|Lost to Follow-up|11|||
105653752|NCT02996097|364395124|FG001|Overall Study|Lost to Follow-up|11|||
105653753|NCT02201771|364395125|FG000|Overall Study|Death|3|||
105653754|NCT02201771|364395126|FG001|Overall Study|Death|2|||
105653755|NCT02201771|364395127|FG002|Overall Study|Death|0|||
105653756|NCT02201771|364395125|FG000|Overall Study|Protocol Violation|10|||
105653757|NCT02201771|364395126|FG001|Overall Study|Protocol Violation|8|||
105653758|NCT02201771|364395127|FG002|Overall Study|Protocol Violation|10|||
105653759|NCT01200485|364395131|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
105653760|NCT01200485|364395132|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
105653761|NCT01200485|364395133|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
105653762|NCT01200485|364395131|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
105653763|NCT01200485|364395132|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
105653764|NCT01200485|364395133|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
105653765|NCT06080438|364395134|FG000|Overall Study|Lost to Follow-up|2|||
105653766|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
105653767|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
105653768|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
105653769|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
105653770|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
105653771|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
105653772|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
105653773|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
105653774|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
105653775|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
105653776|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
105653777|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
105653778|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
105653779|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
105653780|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
105653781|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
105653782|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
105653783|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
105653784|NCT03569475|364395135|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
105653785|NCT03569475|364395136|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
105653786|NCT03569475|364395137|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
105653787|NCT03569475|364395135|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
105653788|NCT03569475|364395136|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
105653789|NCT03569475|364395137|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
105653790|NCT03569475|364395135|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
105653791|NCT03569475|364395136|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
105653792|NCT03569475|364395137|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
105653793|NCT02132117|364395138|FG000|Overall Study|Adverse Event|6|||
105653794|NCT02132117|364395139|FG001|Overall Study|Adverse Event|1|||
105653795|NCT02132117|364395138|FG000|Overall Study|Lost to Follow-up|2|||
105653796|NCT02132117|364395139|FG001|Overall Study|Lost to Follow-up|2|||
105653797|NCT02132117|364395138|FG000|Overall Study|Personal Reasons|1|||
105653798|NCT02132117|364395139|FG001|Overall Study|Personal Reasons|2|||
105653799|NCT02132117|364395138|FG000|Overall Study|Other Miscellaneous Reasons|2|||
105653800|NCT02132117|364395139|FG001|Overall Study|Other Miscellaneous Reasons|0|||
105653801|NCT01678898|364395140|FG000|PB-102-F01|Adverse Event|0|||
105653802|NCT01678898|364395141|FG001|PB-102-F01|Adverse Event|1|||
105653803|NCT01678898|364395142|FG002|PB-102-F01|Adverse Event|0|||
105653804|NCT01678898|364395140|FG000|PB-102-F01|Physician Decision|0|||
105653805|NCT01678898|364395141|FG001|PB-102-F01|Physician Decision|1|||
105653806|NCT01678898|364395142|FG002|PB-102-F01|Physician Decision|0|||
105653807|NCT01544309|364395145|FG000|Overall Study|Withdrawal by Subject|12|||
105653808|NCT01544309|364395146|FG001|Overall Study|Withdrawal by Subject|7|||
105653809|NCT01544309|364395145|FG000|Overall Study|Protocol Violation|2|||
105653810|NCT01544309|364395146|FG001|Overall Study|Protocol Violation|1|||
105653811|NCT01544309|364395145|FG000|Overall Study|Physician Decision|4|||
105653812|NCT01544309|364395146|FG001|Overall Study|Physician Decision|1|||
105653813|NCT01544309|364395145|FG000|Overall Study|Not performed pre-dose examination|1|||
105653814|NCT01544309|364395146|FG001|Overall Study|Not performed pre-dose examination|2|||
105653815|NCT01544309|364395145|FG000|Overall Study|Administered prohibit prior medication|1|||
105653816|NCT01544309|364395146|FG001|Overall Study|Administered prohibit prior medication|0|||
105653817|NCT01395914|364395147|FG000|Overall Study|Unrelated to study drug AE|6|||
105653818|NCT01395914|364395148|FG001|Overall Study|Unrelated to study drug AE|1|||
105653819|NCT01395914|364395147|FG000|Overall Study|Death|23|||
105653820|NCT01395914|364395148|FG001|Overall Study|Death|17|||
105653821|NCT01395914|364395147|FG000|Overall Study|Other|9|||
105653822|NCT01395914|364395148|FG001|Overall Study|Other|3|||
105653823|NCT01395914|364395147|FG000|Overall Study|Withdrawal by patient|27|||
105653824|NCT01395914|364395148|FG001|Overall Study|Withdrawal by patient|14|||
105653825|NCT01395914|364395147|FG000|Overall Study|Study drug-related AE|1|||
105653826|NCT01395914|364395148|FG001|Overall Study|Study drug-related AE|0|||
105653827|NCT01395914|364395147|FG000|Overall Study|Lost to Follow-up|6|||
105653828|NCT01395914|364395148|FG001|Overall Study|Lost to Follow-up|2|||
105653829|NCT00511836|364396930|FG000|Double-blind Period|Lost to Follow-up|1|||
105653830|NCT00511836|364396931|FG001|Double-blind Period|Lost to Follow-up|0|||
105653831|NCT02166047|364396932|FG000|Overall Study|Withdrawal by Participant|0|||
105653832|NCT02166047|364396933|FG001|Overall Study|Withdrawal by Participant|1|||
105653833|NCT02166047|364396934|FG002|Overall Study|Withdrawal by Participant|2|||
105653834|NCT02166047|364396935|FG003|Overall Study|Withdrawal by Participant|0|||
105653835|NCT02166047|364396936|FG004|Overall Study|Withdrawal by Participant|0|||
105653836|NCT02166047|364396937|FG005|Overall Study|Withdrawal by Participant|0|||
105653837|NCT02166047|364396938|FG006|Overall Study|Withdrawal by Participant|1|||
105653838|NCT02166047|364396939|FG007|Overall Study|Withdrawal by Participant|0|||
105653839|NCT02166047|364396940|FG008|Overall Study|Withdrawal by Participant|0|||
105653840|NCT02166047|364396941|FG009|Overall Study|Withdrawal by Participant|0|||
105653841|NCT02166047|364396942|FG010|Overall Study|Withdrawal by Participant|0|||
105653842|NCT02166047|364396943|FG011|Overall Study|Withdrawal by Participant|0|||
105653843|NCT02166047|364396932|FG000|Overall Study|Adverse Event|0|||
105653844|NCT02166047|364396933|FG001|Overall Study|Adverse Event|0|||
105653845|NCT02166047|364396934|FG002|Overall Study|Adverse Event|0|||
105653846|NCT02166047|364396935|FG003|Overall Study|Adverse Event|0|||
105653847|NCT02166047|364396936|FG004|Overall Study|Adverse Event|1|||
105653848|NCT02166047|364396937|FG005|Overall Study|Adverse Event|0|||
105653849|NCT02166047|364396938|FG006|Overall Study|Adverse Event|1|||
105653850|NCT02166047|364396939|FG007|Overall Study|Adverse Event|0|||
105653851|NCT02166047|364396940|FG008|Overall Study|Adverse Event|0|||
105653852|NCT02166047|364396941|FG009|Overall Study|Adverse Event|0|||
105653853|NCT02166047|364396942|FG010|Overall Study|Adverse Event|2|||
105653854|NCT02166047|364396943|FG011|Overall Study|Adverse Event|0|||
105653855|NCT02847637|364396945|FG000|Overall Study|Withdrawal by Subject|0|||
105653856|NCT02847637|364396946|FG001|Overall Study|Withdrawal by Subject|1|||
105653857|NCT02847637|364396947|FG002|Overall Study|Withdrawal by Subject|1|||
105653858|NCT02847637|364396948|FG003|Overall Study|Withdrawal by Subject|0|||
105653859|NCT02847637|364396945|FG000|Overall Study|Lost to Follow-up|1|||
105653860|NCT02847637|364396946|FG001|Overall Study|Lost to Follow-up|1|||
105653861|NCT02847637|364396947|FG002|Overall Study|Lost to Follow-up|0|||
105653862|NCT02847637|364396948|FG003|Overall Study|Lost to Follow-up|0|||
105653863|NCT01040403|364396949|FG000|Overall Study|Adverse Event|10|||
105653864|NCT01040403|364396949|FG000|Overall Study|Protocol Violation|2|||
105653865|NCT01040403|364396949|FG000|Overall Study|Lost to Follow-up|1|||
105653866|NCT01040403|364396949|FG000|Overall Study|Not treated|1|||
105653867|NCT01040403|364396949|FG000|Overall Study|Other reason not defined above|6|||
105653868|NCT03036150|364396950|FG000|Overall Study|Withdrawal by Subject|8|||
105653869|NCT03036150|364396951|FG001|Overall Study|Withdrawal by Subject|3|||
105653870|NCT03036150|364396950|FG000|Overall Study|Lost to Follow-up|2|||
105653871|NCT03036150|364396951|FG001|Overall Study|Lost to Follow-up|2|||
105653872|NCT01990664|364396954|FG000|Overall Study|Lost to Follow-up|2|||
105653873|NCT01990664|364396955|FG001|Overall Study|Lost to Follow-up|6|||
105653874|NCT01990664|364396954|FG000|Overall Study|Withdrawal by Subject|2|||
105653875|NCT01990664|364396955|FG001|Overall Study|Withdrawal by Subject|3|||
105653876|NCT01990664|364396954|FG000|Overall Study|Protocol Violation|1|||
105653877|NCT01990664|364396955|FG001|Overall Study|Protocol Violation|0|||
105870398|NCT02090725|365179052|FG000|Overall Study|Withdrawal by Subject|1|||
105653878|NCT01990664|364396954|FG000|Overall Study|Lens Discomfort|1|||
105653879|NCT01990664|364396955|FG001|Overall Study|Lens Discomfort|1|||
105653880|NCT01990664|364396954|FG000|Overall Study|Lens Handling Difficulties|1|||
105653881|NCT01990664|364396955|FG001|Overall Study|Lens Handling Difficulties|0|||
105653882|NCT01990664|364396954|FG000|Overall Study|Unsatisfactory Visual Response|0|||
105653883|NCT01990664|364396955|FG001|Overall Study|Unsatisfactory Visual Response|1|||
105653884|NCT00570921|364396956|FG000|Overall Study|Protocol Violation|1|||
105653885|NCT00570921|364396956|FG000|Overall Study|Physician Decision|1|||
105653886|NCT03891641|364396957|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
105653887|NCT03891641|364396958|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
105653888|NCT00784277|364396959|FG000|IR Treatment|Adverse Event|4|||
105653889|NCT00784277|364396960|FG001|IR Treatment|Adverse Event|8|||
105870399|NCT02090725|365179052|FG000|Overall Study|participants moved from area|3|||
105653890|NCT00784277|364396961|FG002|IR Treatment|Adverse Event|19|||
105653891|NCT00784277|364396962|FG003|IR Treatment|Adverse Event|35|||
105653892|NCT00784277|364396963|FG004|IR Treatment|Adverse Event|0|||
105653893|NCT00784277|364396964|FG005|IR Treatment|Adverse Event|0|||
105653894|NCT00784277|364396965|FG006|IR Treatment|Adverse Event|0|||
105653895|NCT00784277|364396959|FG000|IR Treatment|Lack of Efficacy|4|||
105653896|NCT00784277|364396960|FG001|IR Treatment|Lack of Efficacy|4|||
105653897|NCT00784277|364396961|FG002|IR Treatment|Lack of Efficacy|1|||
105653898|NCT00784277|364396962|FG003|IR Treatment|Lack of Efficacy|0|||
105653899|NCT00784277|364396963|FG004|IR Treatment|Lack of Efficacy|0|||
105653900|NCT00784277|364396964|FG005|IR Treatment|Lack of Efficacy|0|||
105653901|NCT00784277|364396965|FG006|IR Treatment|Lack of Efficacy|0|||
105653902|NCT00784277|364396959|FG000|IR Treatment|Lost to Follow-up|1|||
105653903|NCT00784277|364396960|FG001|IR Treatment|Lost to Follow-up|0|||
105653904|NCT00784277|364396961|FG002|IR Treatment|Lost to Follow-up|1|||
105653905|NCT00784277|364396962|FG003|IR Treatment|Lost to Follow-up|0|||
105653906|NCT00784277|364396963|FG004|IR Treatment|Lost to Follow-up|0|||
105653907|NCT00784277|364396964|FG005|IR Treatment|Lost to Follow-up|0|||
105653908|NCT00784277|364396965|FG006|IR Treatment|Lost to Follow-up|0|||
105653909|NCT00784277|364396959|FG000|IR Treatment|Withdrawal by Subject|5|||
105653910|NCT00784277|364396960|FG001|IR Treatment|Withdrawal by Subject|1|||
105653911|NCT00784277|364396961|FG002|IR Treatment|Withdrawal by Subject|4|||
105653912|NCT00784277|364396962|FG003|IR Treatment|Withdrawal by Subject|6|||
105653913|NCT00784277|364396963|FG004|IR Treatment|Withdrawal by Subject|0|||
105653914|NCT00784277|364396964|FG005|IR Treatment|Withdrawal by Subject|0|||
105653915|NCT00784277|364396965|FG006|IR Treatment|Withdrawal by Subject|0|||
105653916|NCT00784277|364396959|FG000|IR Treatment|Resolution Of Pain|0|||
105653917|NCT00784277|364396960|FG001|IR Treatment|Resolution Of Pain|1|||
105653918|NCT00784277|364396961|FG002|IR Treatment|Resolution Of Pain|0|||
105653919|NCT00784277|364396962|FG003|IR Treatment|Resolution Of Pain|0|||
105653920|NCT00784277|364396963|FG004|IR Treatment|Resolution Of Pain|0|||
105653921|NCT00784277|364396964|FG005|IR Treatment|Resolution Of Pain|0|||
105653922|NCT00784277|364396965|FG006|IR Treatment|Resolution Of Pain|0|||
105653923|NCT00784277|364396959|FG000|IR Treatment|Other|2|||
105653924|NCT00784277|364396960|FG001|IR Treatment|Other|3|||
105653925|NCT00784277|364396961|FG002|IR Treatment|Other|3|||
105653926|NCT00784277|364396962|FG003|IR Treatment|Other|2|||
105653927|NCT00784277|364396963|FG004|IR Treatment|Other|0|||
105653928|NCT00784277|364396964|FG005|IR Treatment|Other|0|||
105653929|NCT00784277|364396965|FG006|IR Treatment|Other|0|||
105653930|NCT00784277|364396959|FG000|ER Treatment|Adverse Event|0|||
105653931|NCT00784277|364396960|FG001|ER Treatment|Adverse Event|0|||
105653932|NCT00784277|364396961|FG002|ER Treatment|Adverse Event|0|||
105653933|NCT00784277|364396962|FG003|ER Treatment|Adverse Event|0|||
105653934|NCT00784277|364396963|FG004|ER Treatment|Adverse Event|1|||
105653935|NCT00784277|364396964|FG005|ER Treatment|Adverse Event|7|||
105653936|NCT00784277|364396965|FG006|ER Treatment|Adverse Event|7|||
105653937|NCT00784277|364396959|FG000|ER Treatment|Lack of Efficacy|0|||
105653938|NCT00784277|364396960|FG001|ER Treatment|Lack of Efficacy|0|||
105653939|NCT00784277|364396961|FG002|ER Treatment|Lack of Efficacy|0|||
105653940|NCT00784277|364396962|FG003|ER Treatment|Lack of Efficacy|0|||
105653941|NCT00784277|364396963|FG004|ER Treatment|Lack of Efficacy|3|||
105653942|NCT00784277|364396964|FG005|ER Treatment|Lack of Efficacy|4|||
105653943|NCT00784277|364396965|FG006|ER Treatment|Lack of Efficacy|0|||
105653944|NCT00784277|364396959|FG000|ER Treatment|Lost to Follow-up|0|||
105653945|NCT00784277|364396960|FG001|ER Treatment|Lost to Follow-up|0|||
105653946|NCT00784277|364396961|FG002|ER Treatment|Lost to Follow-up|0|||
105653947|NCT00784277|364396962|FG003|ER Treatment|Lost to Follow-up|0|||
105653948|NCT00784277|364396963|FG004|ER Treatment|Lost to Follow-up|0|||
105653949|NCT00784277|364396964|FG005|ER Treatment|Lost to Follow-up|2|||
105653950|NCT00784277|364396965|FG006|ER Treatment|Lost to Follow-up|0|||
105653951|NCT00784277|364396959|FG000|ER Treatment|Withdrawal by Subject|0|||
105653952|NCT00784277|364396960|FG001|ER Treatment|Withdrawal by Subject|0|||
105653953|NCT00784277|364396961|FG002|ER Treatment|Withdrawal by Subject|0|||
105653954|NCT00784277|364396962|FG003|ER Treatment|Withdrawal by Subject|0|||
105653955|NCT00784277|364396963|FG004|ER Treatment|Withdrawal by Subject|2|||
105653956|NCT00784277|364396964|FG005|ER Treatment|Withdrawal by Subject|5|||
105653957|NCT00784277|364396965|FG006|ER Treatment|Withdrawal by Subject|3|||
105653958|NCT00784277|364396959|FG000|ER Treatment|Study Medication Non-Compliant|0|||
105653959|NCT00784277|364396960|FG001|ER Treatment|Study Medication Non-Compliant|0|||
105653960|NCT00784277|364396961|FG002|ER Treatment|Study Medication Non-Compliant|0|||
105653961|NCT00784277|364396962|FG003|ER Treatment|Study Medication Non-Compliant|0|||
105653962|NCT00784277|364396963|FG004|ER Treatment|Study Medication Non-Compliant|2|||
105653963|NCT00784277|364396964|FG005|ER Treatment|Study Medication Non-Compliant|3|||
105653964|NCT00784277|364396965|FG006|ER Treatment|Study Medication Non-Compliant|3|||
105653965|NCT00784277|364396959|FG000|ER Treatment|Other|0|||
105653966|NCT00784277|364396960|FG001|ER Treatment|Other|0|||
105653967|NCT00784277|364396961|FG002|ER Treatment|Other|0|||
105653968|NCT00784277|364396962|FG003|ER Treatment|Other|0|||
105653969|NCT00784277|364396963|FG004|ER Treatment|Other|1|||
105653970|NCT00784277|364396964|FG005|ER Treatment|Other|3|||
105653971|NCT00784277|364396965|FG006|ER Treatment|Other|2|||
105653972|NCT02212301|364396966|FG000|Period 1|Lost to Follow-up|0|||
105653973|NCT02212301|364396967|FG001|Period 1|Lost to Follow-up|1|||
105653974|NCT00578318|364396973|FG000|Overall Study|Lost to Follow-up|2|||
105653975|NCT00578318|364396974|FG001|Overall Study|Lost to Follow-up|0|||
105653976|NCT00578318|364396973|FG000|Overall Study|Physician Decision|1|||
105653977|NCT00578318|364396974|FG001|Overall Study|Physician Decision|0|||
105653978|NCT02025985|364396975|FG000|Overall Study|Consent withdrawn|0|||
105653979|NCT02025985|364396976|FG001|Overall Study|Consent withdrawn|0|||
105653980|NCT02025985|364396977|FG002|Overall Study|Consent withdrawn|1|||
105653981|NCT02025985|364396978|FG003|Overall Study|Consent withdrawn|0|||
105653982|NCT02025985|364396979|FG004|Overall Study|Consent withdrawn|0|||
105653983|NCT02025985|364396975|FG000|Overall Study|Termination of study by Sponsor|4|||
105653984|NCT02025985|364396976|FG001|Overall Study|Termination of study by Sponsor|3|||
105653985|NCT02025985|364396977|FG002|Overall Study|Termination of study by Sponsor|1|||
105653986|NCT02025985|364396978|FG003|Overall Study|Termination of study by Sponsor|1|||
105653987|NCT02025985|364396979|FG004|Overall Study|Termination of study by Sponsor|3|||
105653988|NCT02025985|364396975|FG000|Overall Study|Death|21|||
105653989|NCT02025985|364396976|FG001|Overall Study|Death|20|||
105653990|NCT02025985|364396977|FG002|Overall Study|Death|23|||
105653991|NCT02025985|364396978|FG003|Overall Study|Death|20|||
105653992|NCT02025985|364396979|FG004|Overall Study|Death|17|||
105653993|NCT03041701|364396980|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
105653994|NCT03041701|364396981|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
105653995|NCT03041701|364396982|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
105653996|NCT03041701|364396980|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
105653997|NCT03041701|364396981|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
105653998|NCT03041701|364396982|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
105653999|NCT01978236|364396988|FG000|Overall Study|Discontinued due to study close|2|||
105654000|NCT02506881|364396989|FG000|First Intervention (Day 1)|Protocol Violation|0|||
105654001|NCT02506881|364396990|FG001|First Intervention (Day 1)|Protocol Violation|0|||
105654002|NCT02506881|364396991|FG002|First Intervention (Day 1)|Protocol Violation|1|||
105654003|NCT02506881|364396992|FG003|First Intervention (Day 1)|Protocol Violation|0|||
105654004|NCT02506881|364396989|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
105654005|NCT02506881|364396990|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
105654006|NCT02506881|364396991|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
105654007|NCT02506881|364396992|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
105654008|NCT02506881|364396989|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
105654009|NCT02506881|364396990|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
105654010|NCT02506881|364396991|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
105654011|NCT02506881|364396992|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
105654012|NCT02175745|364397003|FG000|Overall Study|Not Eligible|1|||
105654013|NCT03120949|364397004|FG000|Overall Study|randomized in error|1|||
105654014|NCT03120949|364397005|FG001|Overall Study|randomized in error|0|||
105654015|NCT03120949|364397004|FG000|Overall Study|Death|13|||
105654016|NCT03120949|364397005|FG001|Overall Study|Death|13|||
105654017|NCT03120949|364397004|FG000|Overall Study|Lost to Follow-up|23|||
105654018|NCT03120949|364397005|FG001|Overall Study|Lost to Follow-up|13|||
105654019|NCT03120949|364397004|FG000|Overall Study|Withdrawal by Subject|139|||
105654020|NCT03120949|364397005|FG001|Overall Study|Withdrawal by Subject|124|||
105654021|NCT03120949|364397004|FG000|Overall Study|Covid-19|43|||
105654022|NCT03120949|364397005|FG001|Overall Study|Covid-19|34|||
105654023|NCT03120949|364397004|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
105654024|NCT03120949|364397005|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
105654025|NCT03120949|364397004|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
105654026|NCT03120949|364397005|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
105654027|NCT03120949|364397004|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
105654028|NCT03120949|364397005|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
105654029|NCT03120949|364397004|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
105654030|NCT03120949|364397005|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
105654031|NCT03120949|364397004|FG000|Overall Study|Site was closed|2|||
105654032|NCT03120949|364397005|FG001|Overall Study|Site was closed|3|||
105654033|NCT03120949|364397004|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
105654034|NCT03120949|364397005|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
105654035|NCT03120949|364397004|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
105654036|NCT03120949|364397005|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
105659502|NCT02635386|364417347|FG000|Overall Study|Noncompliant|0|||
105654037|NCT03120949|364397004|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
105654038|NCT03120949|364397005|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
105654039|NCT03120949|364397004|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
105654040|NCT03120949|364397005|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
105654041|NCT03120949|364397004|FG000|Overall Study|Other: Adverse Event|0|||
105654042|NCT03120949|364397005|FG001|Overall Study|Other: Adverse Event|1|||
105654043|NCT03120949|364397004|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
105654044|NCT03120949|364397005|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
105654045|NCT03120949|364397004|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
105654046|NCT03120949|364397005|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
105654047|NCT03120949|364397004|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
105654048|NCT03120949|364397005|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
105654049|NCT03120949|364397004|FG000|Overall Study|Personal Reasons|0|||
105654050|NCT03120949|364397005|FG001|Overall Study|Personal Reasons|1|||
105654051|NCT03120949|364397004|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
105654052|NCT03120949|364397005|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
105654053|NCT03120949|364397004|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
105654054|NCT03120949|364397005|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
105654055|NCT03120949|364397004|FG000|Overall Study|Compliance With Medication|0|||
105654056|NCT03120949|364397005|FG001|Overall Study|Compliance With Medication|1|||
105654057|NCT03120949|364397004|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
105654058|NCT03120949|364397005|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
105654059|NCT03120949|364397004|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
105654060|NCT03120949|364397005|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
105654061|NCT03120949|364397004|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
105654062|NCT03120949|364397005|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
105654063|NCT00312845|364397007|FG000|Overall Study|Adverse Event|19|||
105654064|NCT00312845|364397008|FG001|Overall Study|Adverse Event|5|||
105654065|NCT00312845|364397007|FG000|Overall Study|Death|2|||
105654066|NCT00312845|364397008|FG001|Overall Study|Death|2|||
105654067|NCT00312845|364397007|FG000|Overall Study|Withdrawal by Subject|14|||
105654068|NCT00312845|364397008|FG001|Overall Study|Withdrawal by Subject|6|||
105654069|NCT00312845|364397007|FG000|Overall Study|Disease Progression|56|||
105654070|NCT00312845|364397008|FG001|Overall Study|Disease Progression|77|||
105654071|NCT00312845|364397007|FG000|Overall Study|Lost to Follow-up|2|||
105654072|NCT00312845|364397008|FG001|Overall Study|Lost to Follow-up|0|||
105654073|NCT00312845|364397007|FG000|Overall Study|Other|6|||
105654074|NCT00312845|364397008|FG001|Overall Study|Other|5|||
105654075|NCT04088500|364397011|FG000|Overall Study|Reason unknown|1|||
105654076|NCT04088500|364397011|FG000|Overall Study|Participant withdrew consent|1|||
105654077|NCT04088500|364397011|FG000|Overall Study|Disease progression|3|||
105654078|NCT04206384|364397012|FG000|Overall Study|Withdrawal by Subject|8|||
105654079|NCT04206384|364397012|FG000|Overall Study|Adverse Event|2|||
105654080|NCT01208870|364397013|FG000|Overall Study|Lost to Follow-up|2|||
105654081|NCT01208870|364397014|FG001|Overall Study|Lost to Follow-up|8|||
105654082|NCT03015181|364397015|FG000|Overall Study|Enrolled, but product never administered|1|||
105654083|NCT03015181|364397016|FG001|Overall Study|Enrolled, but product never administered|0|||
105654084|NCT03015181|364397017|FG002|Overall Study|Enrolled, but product never administered|0|||
105654085|NCT03015181|364397018|FG003|Overall Study|Enrolled, but product never administered|0|||
105654086|NCT03015181|364397019|FG004|Overall Study|Enrolled, but product never administered|0|||
105654087|NCT03015181|364397020|FG005|Overall Study|Enrolled, but product never administered|0|||
105654088|NCT03015181|364397021|FG006|Overall Study|Enrolled, but product never administered|0|||
105654089|NCT03015181|364397015|FG000|Overall Study|Withdrawal by Subject|0|||
105654090|NCT03015181|364397016|FG001|Overall Study|Withdrawal by Subject|0|||
105654091|NCT03015181|364397017|FG002|Overall Study|Withdrawal by Subject|0|||
105654092|NCT03015181|364397018|FG003|Overall Study|Withdrawal by Subject|0|||
105654093|NCT03015181|364397019|FG004|Overall Study|Withdrawal by Subject|0|||
105654094|NCT03015181|364397020|FG005|Overall Study|Withdrawal by Subject|1|||
105654095|NCT03015181|364397021|FG006|Overall Study|Withdrawal by Subject|0|||
105654096|NCT03015181|364397015|FG000|Overall Study|Physician Decision|0|||
105654097|NCT03015181|364397016|FG001|Overall Study|Physician Decision|0|||
105654098|NCT03015181|364397017|FG002|Overall Study|Physician Decision|0|||
105654099|NCT03015181|364397018|FG003|Overall Study|Physician Decision|0|||
105654100|NCT03015181|364397019|FG004|Overall Study|Physician Decision|0|||
105654101|NCT03015181|364397020|FG005|Overall Study|Physician Decision|0|||
105654102|NCT03015181|364397021|FG006|Overall Study|Physician Decision|1|||
105654103|NCT01091519|364397025|FG000|Overall Study|Adverse Event|12|||
105654104|NCT01091519|364397026|FG001|Overall Study|Adverse Event|16|||
105654105|NCT01091519|364397025|FG000|Overall Study|Death|1|||
105654106|NCT01091519|364397026|FG001|Overall Study|Death|0|||
105654107|NCT01091519|364397025|FG000|Overall Study|Lack of Efficacy|16|||
105654108|NCT01091519|364397026|FG001|Overall Study|Lack of Efficacy|19|||
105654109|NCT01091519|364397025|FG000|Overall Study|Lost to Follow-up|14|||
105654110|NCT01091519|364397026|FG001|Overall Study|Lost to Follow-up|24|||
105654111|NCT01091519|364397025|FG000|Overall Study|Withdrawal by Subject|2|||
105654112|NCT01091519|364397026|FG001|Overall Study|Withdrawal by Subject|2|||
105654113|NCT01091519|364397025|FG000|Overall Study|Other|6|||
105654114|NCT01091519|364397026|FG001|Overall Study|Other|8|||
105654115|NCT01091519|364397025|FG000|Overall Study|Randomized not treated|4|||
105654116|NCT01091519|364397026|FG001|Overall Study|Randomized not treated|4|||
105654117|NCT04159805|364397027|FG000|Overall Study|Withdrawal by Subject|0|||
105654118|NCT04159805|364397028|FG001|Overall Study|Withdrawal by Subject|2|||
105654119|NCT04159805|364397029|FG002|Overall Study|Withdrawal by Subject|2|||
105654120|NCT04167085|364397030|FG000|Baseline|Withdrawal by Subject|2|||
105654121|NCT04167085|364397031|FG001|Baseline|Withdrawal by Subject|1|||
105654122|NCT04167085|364397030|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
105654123|NCT04167085|364397031|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
105654124|NCT00006436|364397037|FG000|Overall Study|Refused further treatment|2|||
105654125|NCT00006436|364397037|FG000|Overall Study|Declined to participate (before treatment started)|1|||
105654126|NCT00316589|364397038|FG000|Overall Study|Withdrawal by Subject|0|||
105654127|NCT00316589|364397039|FG001|Overall Study|Withdrawal by Subject|5|||
105654128|NCT00316589|364397040|FG002|Overall Study|Withdrawal by Subject|0|||
105654129|NCT00316589|364397041|FG003|Overall Study|Withdrawal by Subject|1|||
105654130|NCT00316589|364397038|FG000|Overall Study|Subject unwilling/unable to comply|0|||
105654131|NCT00316589|364397039|FG001|Overall Study|Subject unwilling/unable to comply|6|||
105654132|NCT00316589|364397040|FG002|Overall Study|Subject unwilling/unable to comply|0|||
105654133|NCT00316589|364397041|FG003|Overall Study|Subject unwilling/unable to comply|2|||
105654134|NCT00316589|364397038|FG000|Overall Study|Adverse Event|1|||
105654135|NCT00316589|364397039|FG001|Overall Study|Adverse Event|0|||
105654136|NCT00316589|364397040|FG002|Overall Study|Adverse Event|0|||
105654137|NCT00316589|364397041|FG003|Overall Study|Adverse Event|1|||
105654138|NCT00316589|364397038|FG000|Overall Study|Physician Decision|0|||
105654139|NCT00316589|364397039|FG001|Overall Study|Physician Decision|1|||
105654140|NCT00316589|364397040|FG002|Overall Study|Physician Decision|0|||
105654141|NCT00316589|364397041|FG003|Overall Study|Physician Decision|0|||
105654142|NCT00316589|364397038|FG000|Overall Study|Other reason|0|||
105654143|NCT00316589|364397039|FG001|Overall Study|Other reason|12|||
105654144|NCT00316589|364397040|FG002|Overall Study|Other reason|1|||
105654145|NCT00316589|364397041|FG003|Overall Study|Other reason|1|||
105654146|NCT01482819|364397042|FG000|Overall Study|Lost to Follow-up|2|||
105654147|NCT03325608|364397048|FG000|Overall Study|Lost to Follow-up|23|||
105654148|NCT03325608|364397049|FG001|Overall Study|Lost to Follow-up|23|||
105654149|NCT03325608|364397050|FG002|Overall Study|Lost to Follow-up|30|||
105654150|NCT03325608|364397051|FG003|Overall Study|Lost to Follow-up|30|||
105654151|NCT03325608|364397048|FG000|Overall Study|Death of Caregiver|0|||
105654152|NCT03325608|364397049|FG001|Overall Study|Death of Caregiver|0|||
105654153|NCT03325608|364397050|FG002|Overall Study|Death of Caregiver|2|||
105654154|NCT03325608|364397051|FG003|Overall Study|Death of Caregiver|2|||
105654155|NCT03325608|364397048|FG000|Overall Study|Death of Care Recipient|34|||
105654156|NCT03325608|364397049|FG001|Overall Study|Death of Care Recipient|34|||
105654157|NCT03325608|364397050|FG002|Overall Study|Death of Care Recipient|28|||
105654158|NCT03325608|364397051|FG003|Overall Study|Death of Care Recipient|28|||
105654159|NCT03325608|364397048|FG000|Overall Study|Withdrawal by Subject|49|||
105654160|NCT03325608|364397049|FG001|Overall Study|Withdrawal by Subject|49|||
105654161|NCT03325608|364397050|FG002|Overall Study|Withdrawal by Subject|35|||
105654162|NCT03325608|364397051|FG003|Overall Study|Withdrawal by Subject|35|||
105654163|NCT03325608|364397048|FG000|Overall Study|Ineligible|7|||
105654164|NCT03325608|364397049|FG001|Overall Study|Ineligible|7|||
105654165|NCT03325608|364397050|FG002|Overall Study|Ineligible|5|||
105654166|NCT03325608|364397051|FG003|Overall Study|Ineligible|5|||
105654167|NCT02188784|364397052|FG000|Overall Study|Death|3|||
105654168|NCT02188784|364397053|FG001|Overall Study|Death|1|||
105654169|NCT02188784|364397052|FG000|Overall Study|Lost to Follow-up|1|||
105654170|NCT02188784|364397053|FG001|Overall Study|Lost to Follow-up|0|||
105654171|NCT02188784|364397052|FG000|Overall Study|Withdrawal by Subject|3|||
105654172|NCT02188784|364397053|FG001|Overall Study|Withdrawal by Subject|9|||
105654173|NCT02188784|364397052|FG000|Overall Study|Physician Decision|2|||
105654174|NCT02188784|364397053|FG001|Overall Study|Physician Decision|3|||
105654175|NCT00276016|364397054|FG000|Intervention 1|Withdrawal by Subject|0|||
105654176|NCT00276016|364397055|FG001|Intervention 1|Withdrawal by Subject|1|||
105654177|NCT00276016|364397056|FG002|Intervention 1|Withdrawal by Subject|0|||
105654178|NCT00276016|364397057|FG003|Intervention 1|Withdrawal by Subject|0|||
105654179|NCT00276016|364397058|FG004|Intervention 1|Withdrawal by Subject|0|||
105654180|NCT00276016|364397059|FG005|Intervention 1|Withdrawal by Subject|0|||
105654181|NCT03151551|364397060|FG000|Open-Label Treatment Period|Adverse Event|0|||
105654182|NCT03151551|364397061|FG001|Open-Label Treatment Period|Adverse Event|2|||
105654183|NCT03151551|364397060|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
105654184|NCT03151551|364397061|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
105654185|NCT03151551|364397060|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
105654186|NCT03151551|364397061|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
105654187|NCT03151551|364397060|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
105654188|NCT03151551|364397061|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
105654189|NCT03151551|364397060|FG000|Open-Label Treatment Period|Physician Decision|3|||
105654190|NCT03151551|364397061|FG001|Open-Label Treatment Period|Physician Decision|0|||
105654191|NCT03151551|364397060|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
105654192|NCT03151551|364397061|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
105654193|NCT03151551|364397060|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
105654194|NCT03151551|364397061|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
105654195|NCT03151551|364397060|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
105654196|NCT03151551|364397061|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
105654197|NCT03151551|364397060|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
105654198|NCT03151551|364397061|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
105654199|NCT03151551|364397060|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
105654200|NCT03151551|364397061|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
105654201|NCT01374971|364397064|FG000|Overall Study|Withdrawal by Subject|1|||
105654202|NCT00514813|364397067|FG000|Overall Study|Study terminated|14|||
105654203|NCT00514813|364397068|FG001|Overall Study|Study terminated|74|||
105654204|NCT00514813|364397069|FG002|Overall Study|Study terminated|40|||
105654205|NCT00514813|364397070|FG003|Overall Study|Study terminated|2|||
105654206|NCT00514813|364397067|FG000|Overall Study|Adverse Event|0|||
105654207|NCT00514813|364397068|FG001|Overall Study|Adverse Event|2|||
105654208|NCT00514813|364397069|FG002|Overall Study|Adverse Event|2|||
105654209|NCT00514813|364397070|FG003|Overall Study|Adverse Event|0|||
105654210|NCT00514813|364397067|FG000|Overall Study|Protocol Violation|1|||
105654211|NCT00514813|364397068|FG001|Overall Study|Protocol Violation|0|||
105654212|NCT00514813|364397069|FG002|Overall Study|Protocol Violation|0|||
105654213|NCT00514813|364397070|FG003|Overall Study|Protocol Violation|0|||
105654214|NCT00514813|364397067|FG000|Overall Study|Withdrawal by Subject|0|||
105654215|NCT00514813|364397068|FG001|Overall Study|Withdrawal by Subject|1|||
105654216|NCT00514813|364397069|FG002|Overall Study|Withdrawal by Subject|0|||
105654217|NCT00514813|364397070|FG003|Overall Study|Withdrawal by Subject|0|||
105654218|NCT00514813|364397067|FG000|Overall Study|Lack of Efficacy|0|||
105654219|NCT00514813|364397068|FG001|Overall Study|Lack of Efficacy|1|||
105654220|NCT00514813|364397069|FG002|Overall Study|Lack of Efficacy|0|||
105654221|NCT00514813|364397070|FG003|Overall Study|Lack of Efficacy|0|||
105654222|NCT00514813|364397067|FG000|Overall Study|Kidney transplant|0|||
105654223|NCT00514813|364397068|FG001|Overall Study|Kidney transplant|6|||
105654224|NCT00514813|364397069|FG002|Overall Study|Kidney transplant|2|||
105654225|NCT00514813|364397070|FG003|Overall Study|Kidney transplant|0|||
105654226|NCT00514813|364397067|FG000|Overall Study|Death|0|||
105654227|NCT00514813|364397068|FG001|Overall Study|Death|2|||
105654228|NCT00514813|364397069|FG002|Overall Study|Death|3|||
105654229|NCT00514813|364397070|FG003|Overall Study|Death|2|||
105654230|NCT02979613|364397071|FG000|Double-Blind Phase|Withdrew Consent|2|||
105654231|NCT02979613|364397072|FG001|Double-Blind Phase|Withdrew Consent|4|||
105654232|NCT02979613|364397071|FG000|Double-Blind Phase|Pregnancy|2|||
105654233|NCT02979613|364397072|FG001|Double-Blind Phase|Pregnancy|2|||
105654234|NCT02979613|364397071|FG000|Double-Blind Phase|Adverse Event|2|||
105654235|NCT02979613|364397072|FG001|Double-Blind Phase|Adverse Event|0|||
105654236|NCT02979613|364397071|FG000|Double-Blind Phase|Lost to Follow-up|1|||
105654237|NCT02979613|364397072|FG001|Double-Blind Phase|Lost to Follow-up|1|||
105654238|NCT02979613|364397071|FG000|Double-Blind Phase|Protocol Violation|1|||
105654239|NCT02979613|364397072|FG001|Double-Blind Phase|Protocol Violation|1|||
105654240|NCT02979613|364397071|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
105654241|NCT02979613|364397072|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
105654242|NCT02979613|364397071|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
105654243|NCT02979613|364397072|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
105654244|NCT02979613|364397071|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
105654245|NCT02979613|364397072|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
105654246|NCT02979613|364397071|FG000|Open-Label Extension (OLE) Phase|Death|0|||
105654247|NCT02979613|364397072|FG001|Open-Label Extension (OLE) Phase|Death|1|||
105654248|NCT02979613|364397071|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
105654249|NCT02979613|364397072|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
105654250|NCT01075100|364397077|FG000|Overall Study|Adverse Event|15|||
105654251|NCT01075100|364397078|FG001|Overall Study|Adverse Event|18|||
105654252|NCT01075100|364397077|FG000|Overall Study|Patient Request|4|||
105654253|NCT01075100|364397078|FG001|Overall Study|Patient Request|4|||
105654254|NCT01075100|364397077|FG000|Overall Study|Investigator Request|2|||
105654255|NCT01075100|364397078|FG001|Overall Study|Investigator Request|1|||
105654256|NCT01075100|364397077|FG000|Overall Study|Disease Progression|25|||
105654257|NCT01075100|364397078|FG001|Overall Study|Disease Progression|29|||
105654258|NCT01075100|364397077|FG000|Overall Study|Other|3|||
105654259|NCT01075100|364397078|FG001|Overall Study|Other|1|||
105654260|NCT03282799|364397079|FG000|Overall Study|Pregnancy|1|||
105654261|NCT03282799|364397080|FG001|Overall Study|Pregnancy|0|||
105654262|NCT03282799|364397079|FG000|Overall Study|Physician Decision|1|||
105654263|NCT03282799|364397080|FG001|Overall Study|Physician Decision|0|||
105654264|NCT00509821|364398338|FG000|Study Period 1 (Induction)|Death|0|||
105654265|NCT00509821|364398339|FG001|Study Period 1 (Induction)|Death|1|||
105654266|NCT00509821|364398338|FG000|Study Period 1 (Induction)|Adverse Event|0|||
105654267|NCT00509821|364398339|FG001|Study Period 1 (Induction)|Adverse Event|2|||
105654268|NCT00509821|364398338|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
105654269|NCT00509821|364398339|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
105654270|NCT00740597|364398340|FG000|Overall Study|insurance would not cover treatment|1|||
105654271|NCT00552513|364398344|FG000|Overall Study|Lost to Follow-up|5|||
105654272|NCT00552513|364398345|FG001|Overall Study|Lost to Follow-up|1|||
105654273|NCT01816685|364398346|FG000|Overall Study|Lost to Follow-up|7|||
105654274|NCT01816685|364398347|FG001|Overall Study|Lost to Follow-up|9|||
105654275|NCT01816685|364398346|FG000|Overall Study|Surgery Cancelled|3|||
105654276|NCT01816685|364398347|FG001|Overall Study|Surgery Cancelled|2|||
105654277|NCT02720185|364398348|FG000|Overall Study|Lost to Follow-up|1|||
105654278|NCT01157351|364398349|FG000|Overall Study|Adverse Event|5|||
105654279|NCT01157351|364398350|FG001|Overall Study|Adverse Event|4|||
105654280|NCT01157351|364398349|FG000|Overall Study|Death|1|||
105654281|NCT01157351|364398350|FG001|Overall Study|Death|0|||
105654282|NCT01157351|364398349|FG000|Overall Study|Lost to Follow-up|53|||
105654283|NCT01157351|364398350|FG001|Overall Study|Lost to Follow-up|55|||
105654284|NCT01157351|364398349|FG000|Overall Study|Withdrawal by Subject|37|||
105654285|NCT01157351|364398350|FG001|Overall Study|Withdrawal by Subject|27|||
105654286|NCT01157351|364398349|FG000|Overall Study|Physician Decision|5|||
105654287|NCT01157351|364398350|FG001|Overall Study|Physician Decision|4|||
105654288|NCT01157351|364398349|FG000|Overall Study|Protocol Violation|0|||
105654289|NCT01157351|364398350|FG001|Overall Study|Protocol Violation|1|||
105654290|NCT01157351|364398349|FG000|Overall Study|Other|32|||
105654291|NCT01157351|364398350|FG001|Overall Study|Other|36|||
105654292|NCT01157351|364398349|FG000|Overall Study|Noncompliance with Study Drug|0|||
105654293|NCT01157351|364398350|FG001|Overall Study|Noncompliance with Study Drug|3|||
105654294|NCT01157351|364398349|FG000|Overall Study|Randomized but not Treated|4|||
105654295|NCT01157351|364398350|FG001|Overall Study|Randomized but not Treated|2|||
105654296|NCT00560313|364398351|FG000|Overall Study|Adverse Events or Death|2|||
105654297|NCT00560313|364398351|FG000|Overall Study|Withdrawal by Subject|2|||
105654298|NCT00560313|364398351|FG000|Overall Study|Lost to Follow-up|1|||
105654299|NCT00560313|364398351|FG000|Overall Study|Protocol Violation|1|||
105654300|NCT01231464|364398352|FG000|Overall Study|Adverse Event|0|||
105654301|NCT01231464|364398353|FG001|Overall Study|Adverse Event|1|||
105654302|NCT01231464|364398352|FG000|Overall Study|Protocol Violation|1|||
105654303|NCT01231464|364398353|FG001|Overall Study|Protocol Violation|2|||
105654304|NCT01231464|364398352|FG000|Overall Study|Lost to Follow-up|1|||
105654305|NCT01231464|364398353|FG001|Overall Study|Lost to Follow-up|2|||
105654306|NCT01231464|364398352|FG000|Overall Study|Withdrawal by Subject|3|||
105654307|NCT01231464|364398353|FG001|Overall Study|Withdrawal by Subject|2|||
105654308|NCT03449134|364398354|FG000|52-Week Treatment Period|Death|2|||
105654309|NCT03449134|364398355|FG001|52-Week Treatment Period|Death|1|||
105654310|NCT03449134|364398356|FG002|52-Week Treatment Period|Death|0|||
105654311|NCT03449134|364398354|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
105654312|NCT03449134|364398355|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
105654313|NCT03449134|364398356|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
105654314|NCT03449134|364398354|FG000|52-Week Treatment Period|Physician Decision|2|||
105654315|NCT03449134|364398355|FG001|52-Week Treatment Period|Physician Decision|3|||
105654316|NCT03449134|364398356|FG002|52-Week Treatment Period|Physician Decision|3|||
105654317|NCT03449134|364398354|FG000|52-Week Treatment Period|Screen Failure|1|||
105654318|NCT03449134|364398355|FG001|52-Week Treatment Period|Screen Failure|0|||
105654319|NCT03449134|364398356|FG002|52-Week Treatment Period|Screen Failure|1|||
105654320|NCT03449134|364398354|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
105654321|NCT03449134|364398355|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
105654322|NCT03449134|364398356|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
105870400|NCT01499095|365179053|FG000|Overall Study|Randomized But Not Treated|1|||
105654323|NCT03449134|364398354|FG000|52-Week Treatment Period|Site Closure|1|||
105654324|NCT03449134|364398355|FG001|52-Week Treatment Period|Site Closure|0|||
105654325|NCT03449134|364398356|FG002|52-Week Treatment Period|Site Closure|0|||
105654326|NCT01589523|364398363|FG000|Overall Study|Withdrawal by Subject|1|||
105654327|NCT02507687|364398369|FG000|Overall Study|Adverse Event|3|||
105654328|NCT02507687|364398370|FG001|Overall Study|Adverse Event|2|||
105654329|NCT02507687|364398371|FG002|Overall Study|Adverse Event|2|||
105654330|NCT02507687|364398372|FG003|Overall Study|Adverse Event|2|||
105654331|NCT02507687|364398369|FG000|Overall Study|Withdrawal by Subject|1|||
105654332|NCT02507687|364398370|FG001|Overall Study|Withdrawal by Subject|4|||
105654333|NCT02507687|364398371|FG002|Overall Study|Withdrawal by Subject|6|||
105654334|NCT02507687|364398372|FG003|Overall Study|Withdrawal by Subject|6|||
105654335|NCT02507687|364398369|FG000|Overall Study|Protocol Violation|1|||
105870401|NCT01499095|365179054|FG001|Overall Study|Randomized But Not Treated|1|||
105654336|NCT02507687|364398370|FG001|Overall Study|Protocol Violation|0|||
105654337|NCT02507687|364398371|FG002|Overall Study|Protocol Violation|2|||
105654338|NCT02507687|364398372|FG003|Overall Study|Protocol Violation|0|||
105654339|NCT02507687|364398369|FG000|Overall Study|Lost to Follow-up|0|||
105654340|NCT02507687|364398370|FG001|Overall Study|Lost to Follow-up|0|||
105654341|NCT02507687|364398371|FG002|Overall Study|Lost to Follow-up|2|||
105654342|NCT02507687|364398372|FG003|Overall Study|Lost to Follow-up|1|||
105654343|NCT02507687|364398369|FG000|Overall Study|Screen Failure|0|||
105654344|NCT02507687|364398370|FG001|Overall Study|Screen Failure|0|||
105654345|NCT02507687|364398371|FG002|Overall Study|Screen Failure|1|||
105654346|NCT02507687|364398372|FG003|Overall Study|Screen Failure|0|||
105654347|NCT02507687|364398369|FG000|Overall Study|Other, Not Specified|0|||
105654348|NCT02507687|364398370|FG001|Overall Study|Other, Not Specified|0|||
105654349|NCT02507687|364398371|FG002|Overall Study|Other, Not Specified|2|||
105654350|NCT02507687|364398372|FG003|Overall Study|Other, Not Specified|4|||
105654351|NCT01580995|364398373|FG000|Overall Study|Lost to Follow-up|2|||
105654352|NCT01580995|364398374|FG001|Overall Study|Lost to Follow-up|2|||
105654353|NCT00598871|364398375|FG000|Overall Study|Adverse Event|0|||
105654354|NCT00598871|364398376|FG001|Overall Study|Adverse Event|1|||
105654355|NCT04140266|364398377|FG000|Overall Study|Physician Decision|2|||
105654356|NCT04140266|364398378|FG001|Overall Study|Physician Decision|0|||
105654357|NCT04140266|364398377|FG000|Overall Study|Withdrawal by Subject|4|||
105654358|NCT04140266|364398378|FG001|Overall Study|Withdrawal by Subject|2|||
105654359|NCT00730847|364398379|FG000|Overall Study|Adverse Event|1|||
105654360|NCT00730847|364398379|FG000|Overall Study|Protocol Violation|2|||
105654361|NCT00730847|364398379|FG000|Overall Study|Withdrawal by Subject|16|||
105654362|NCT00730847|364398379|FG000|Overall Study|Lost to Follow-up|67|||
105654363|NCT00730847|364398379|FG000|Overall Study|Unknown completion status|21|||
105654364|NCT00730847|364398379|FG000|Overall Study|Other|24|||
105654365|NCT04544865|364398386|FG000|Overall Study|Death|0|||
105654366|NCT04544865|364398387|FG001|Overall Study|Death|2|||
105654367|NCT04544865|364398386|FG000|Overall Study|Lost to Follow-up|11|||
105654368|NCT04544865|364398387|FG001|Overall Study|Lost to Follow-up|7|||
105654369|NCT04544865|364398386|FG000|Overall Study|Withdrawal by Subject|0|||
105654370|NCT04544865|364398387|FG001|Overall Study|Withdrawal by Subject|1|||
105654371|NCT04544865|364398386|FG000|Overall Study|Other|0|||
105654372|NCT04544865|364398387|FG001|Overall Study|Other|1|||
105654373|NCT00702650|364398388|FG000|Overall Study|Withdrawal by Subject|9|||
105654374|NCT00702650|364398388|FG000|Overall Study|Non-Compliance of Study Drug|3|||
105654375|NCT00702650|364398388|FG000|Overall Study|Lost to Follow-up|2|||
105654376|NCT00702650|364398388|FG000|Overall Study|Non-Compliance with Site Directives|1|||
105654377|NCT00702650|364398388|FG000|Overall Study|Sponsor Request|1|||
105654378|NCT00702650|364398388|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
105654379|NCT00702650|364398388|FG000|Overall Study|Adverse Event|3|||
105654380|NCT01649297|364398389|FG000|Overall Study|Adverse Event|5|||
105654381|NCT01649297|364398390|FG001|Overall Study|Adverse Event|5|||
105654382|NCT01649297|364398391|FG002|Overall Study|Adverse Event|4|||
105654383|NCT01649297|364398392|FG003|Overall Study|Adverse Event|13|||
105654384|NCT01649297|364398393|FG004|Overall Study|Adverse Event|1|||
105654385|NCT01649297|364398389|FG000|Overall Study|Lack of Efficacy|0|||
105654386|NCT01649297|364398390|FG001|Overall Study|Lack of Efficacy|0|||
105654387|NCT01649297|364398391|FG002|Overall Study|Lack of Efficacy|0|||
105654388|NCT01649297|364398392|FG003|Overall Study|Lack of Efficacy|0|||
105654389|NCT01649297|364398393|FG004|Overall Study|Lack of Efficacy|1|||
105654390|NCT01649297|364398389|FG000|Overall Study|Non compliant with Protocol|1|||
105654391|NCT01649297|364398390|FG001|Overall Study|Non compliant with Protocol|0|||
105654392|NCT01649297|364398391|FG002|Overall Study|Non compliant with Protocol|3|||
105654393|NCT01649297|364398392|FG003|Overall Study|Non compliant with Protocol|2|||
105654394|NCT01649297|364398393|FG004|Overall Study|Non compliant with Protocol|1|||
105654395|NCT01649297|364398389|FG000|Overall Study|Lost to Follow-up|1|||
105654396|NCT01649297|364398390|FG001|Overall Study|Lost to Follow-up|1|||
105654397|NCT01649297|364398391|FG002|Overall Study|Lost to Follow-up|4|||
105654398|NCT01649297|364398392|FG003|Overall Study|Lost to Follow-up|3|||
105654399|NCT01649297|364398393|FG004|Overall Study|Lost to Follow-up|0|||
105654400|NCT01649297|364398389|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
105654401|NCT01649297|364398390|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
105654402|NCT01649297|364398391|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
105654403|NCT01649297|364398392|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
105654404|NCT01649297|364398393|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
105654405|NCT01649297|364398389|FG000|Overall Study|For other reason|4|||
105654406|NCT01649297|364398390|FG001|Overall Study|For other reason|1|||
105654407|NCT01649297|364398391|FG002|Overall Study|For other reason|2|||
105654408|NCT01649297|364398392|FG003|Overall Study|For other reason|0|||
105654409|NCT01649297|364398393|FG004|Overall Study|For other reason|0|||
105654410|NCT00523549|364398395|FG000|Overall Study|Adverse Event|6|||
105654411|NCT00523549|364398396|FG001|Overall Study|Adverse Event|3|||
105654412|NCT00523549|364398395|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105654413|NCT00523549|364398396|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105654414|NCT00523549|364398395|FG000|Overall Study|Protocol Deviation|3|||
105654415|NCT00523549|364398396|FG001|Overall Study|Protocol Deviation|1|||
105654416|NCT00523549|364398395|FG000|Overall Study|Patient withdrew consent|7|||
105654417|NCT00523549|364398396|FG001|Overall Study|Patient withdrew consent|6|||
105654418|NCT00523549|364398395|FG000|Overall Study|Lost to Follow-up|3|||
105654419|NCT00523549|364398396|FG001|Overall Study|Lost to Follow-up|5|||
105654420|NCT00439647|364398397|FG000|Overall Study|Withdrawal by Subject|25|||
105654421|NCT00439647|364398398|FG001|Overall Study|Withdrawal by Subject|22|||
105654422|NCT00439647|364398397|FG000|Overall Study|Death|15|||
105654423|NCT00439647|364398398|FG001|Overall Study|Death|18|||
105654424|NCT00439647|364398397|FG000|Overall Study|Adverse Event|11|||
105654425|NCT00439647|364398398|FG001|Overall Study|Adverse Event|11|||
105654426|NCT00439647|364398397|FG000|Overall Study|Lost to Follow-up|4|||
105654427|NCT00439647|364398398|FG001|Overall Study|Lost to Follow-up|12|||
105654428|NCT00439647|364398397|FG000|Overall Study|Protocol Violation|3|||
105654429|NCT00439647|364398398|FG001|Overall Study|Protocol Violation|4|||
105654430|NCT00439647|364398397|FG000|Overall Study|Lack of Efficacy|0|||
105654431|NCT00439647|364398398|FG001|Overall Study|Lack of Efficacy|4|||
105654432|NCT00843115|364398399|FG000|Overall Study|Death|4|||
105654433|NCT00843115|364398399|FG000|Overall Study|Adverse Event|30|||
105654434|NCT00843115|364398399|FG000|Overall Study|Lost to Follow-up|4|||
105654435|NCT00843115|364398399|FG000|Overall Study|Withdrawal by Subject|17|||
105654436|NCT00843115|364398399|FG000|Overall Study|Family wanted meds stopped|1|||
105654437|NCT00843115|364398399|FG000|Overall Study|Family does not want continuation|1|||
105654438|NCT00843115|364398399|FG000|Overall Study|Patient forgot to take meds|1|||
105654439|NCT00843115|364398399|FG000|Overall Study|Does not meet entrance criteria|1|||
105654440|NCT00843115|364398399|FG000|Overall Study|Physician Decision|1|||
105654441|NCT00843115|364398399|FG000|Overall Study|Family discontinued meds|1|||
105654442|NCT00843115|364398399|FG000|Overall Study|patient took for 2 days then stopped|1|||
105654443|NCT00843115|364398399|FG000|Overall Study|patient never took the medication|1|||
105654444|NCT00843115|364398399|FG000|Overall Study|hospitalized due to deterioration|1|||
105654445|NCT00843115|364398399|FG000|Overall Study|week 12 not done|1|||
105654446|NCT00843115|364398399|FG000|Overall Study|Syndrome De Glissement|1|||
105654447|NCT01388478|364398400|FG000|Overall Study|Adverse Event|4|||
105654448|NCT01388478|364398400|FG000|Overall Study|Withdrawal by Subject|1|||
105654449|NCT00931918|364398401|FG000|Overall Study|Adverse Event|4|||
105654450|NCT00931918|364398402|FG001|Overall Study|Adverse Event|6|||
105654451|NCT00931918|364398401|FG000|Overall Study|Progressive Disease|2|||
105654452|NCT00931918|364398402|FG001|Overall Study|Progressive Disease|1|||
105654453|NCT00931918|364398401|FG000|Overall Study|Symptomatic Deterioration|1|||
105654454|NCT00931918|364398402|FG001|Overall Study|Symptomatic Deterioration|0|||
105654455|NCT00931918|364398401|FG000|Overall Study|Withdrawal by Patient|3|||
105654456|NCT00931918|364398402|FG001|Overall Study|Withdrawal by Patient|4|||
105654457|NCT00931918|364398401|FG000|Overall Study|Other Reason not Specified|4|||
105654458|NCT00931918|364398402|FG001|Overall Study|Other Reason not Specified|4|||
105654459|NCT00931918|364398401|FG000|Overall Study|Did not receive study drug|3|||
105654460|NCT00931918|364398402|FG001|Overall Study|Did not receive study drug|2|||
105654461|NCT00496626|364398403|FG000|Overall Study|Lost to Follow-up|0|||
105654462|NCT00496626|364398404|FG001|Overall Study|Lost to Follow-up|1|||
105654463|NCT00496626|364398403|FG000|Overall Study|Protocol Violation|1|||
105654464|NCT00496626|364398404|FG001|Overall Study|Protocol Violation|0|||
105654465|NCT00496626|364398403|FG000|Overall Study|Withdrawal by Subject|5|||
105654466|NCT00496626|364398404|FG001|Overall Study|Withdrawal by Subject|4|||
105654467|NCT00496626|364398403|FG000|Overall Study|Relocated|0|||
105654468|NCT00496626|364398404|FG001|Overall Study|Relocated|1|||
105654469|NCT03371485|364398405|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
105654470|NCT03371485|364398405|FG000|2-year Follow-up|Death|5|||
105654471|NCT03544229|364398408|FG000|Overall Study|Adverse Event|1|||
105654472|NCT03544229|364398409|FG001|Overall Study|Adverse Event|0|||
105654473|NCT03544229|364398410|FG002|Overall Study|Adverse Event|1|||
105654474|NCT03544229|364398411|FG003|Overall Study|Adverse Event|0|||
105654475|NCT03544229|364398408|FG000|Overall Study|Protocol Deviation|0|||
105654476|NCT03544229|364398409|FG001|Overall Study|Protocol Deviation|0|||
105654477|NCT03544229|364398410|FG002|Overall Study|Protocol Deviation|1|||
105654478|NCT03544229|364398411|FG003|Overall Study|Protocol Deviation|0|||
105654479|NCT03544229|364398408|FG000|Overall Study|Lost to Follow-up|3|||
105654480|NCT03544229|364398409|FG001|Overall Study|Lost to Follow-up|0|||
105654481|NCT03544229|364398410|FG002|Overall Study|Lost to Follow-up|0|||
105654482|NCT03544229|364398411|FG003|Overall Study|Lost to Follow-up|2|||
105654483|NCT03544229|364398408|FG000|Overall Study|Voluntary Withdrawal|2|||
105654484|NCT03544229|364398409|FG001|Overall Study|Voluntary Withdrawal|1|||
105654485|NCT03544229|364398410|FG002|Overall Study|Voluntary Withdrawal|3|||
105654486|NCT03544229|364398411|FG003|Overall Study|Voluntary Withdrawal|0|||
105654487|NCT03544229|364398408|FG000|Overall Study|Lack of Efficacy|0|||
105654488|NCT03544229|364398409|FG001|Overall Study|Lack of Efficacy|1|||
105654489|NCT03544229|364398410|FG002|Overall Study|Lack of Efficacy|0|||
105654490|NCT03544229|364398411|FG003|Overall Study|Lack of Efficacy|0|||
105654491|NCT00527514|364398412|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
105654492|NCT00527514|364398412|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
105654493|NCT00527514|364398412|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
105654494|NCT00527514|364398412|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
105654495|NCT00527514|364398412|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
105654496|NCT00527514|364398412|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
105654497|NCT00527514|364398412|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
105654498|NCT00576823|364398430|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
105654499|NCT00576823|364398431|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
105654500|NCT00576823|364398432|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
105654501|NCT00576823|364398430|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
105654502|NCT00576823|364398431|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
105654503|NCT00576823|364398432|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
105654504|NCT00839332|364398436|FG000|Phase 1|Disease Progression|38|||
105654505|NCT00839332|364398437|FG001|Phase 1|Disease Progression|0|||
105654506|NCT00839332|364398438|FG002|Phase 1|Disease Progression|0|||
105654507|NCT00839332|364398436|FG000|Phase 1|Adverse Event|6|||
105654508|NCT00839332|364398437|FG001|Phase 1|Adverse Event|0|||
105654509|NCT00839332|364398438|FG002|Phase 1|Adverse Event|0|||
105654510|NCT00839332|364398436|FG000|Phase 1|Withdrawal by Subject|4|||
105654511|NCT00839332|364398437|FG001|Phase 1|Withdrawal by Subject|0|||
105654512|NCT00839332|364398438|FG002|Phase 1|Withdrawal by Subject|0|||
105654513|NCT00839332|364398436|FG000|Phase 1|Physician Decision|2|||
105654514|NCT00839332|364398437|FG001|Phase 1|Physician Decision|0|||
105654515|NCT00839332|364398438|FG002|Phase 1|Physician Decision|0|||
105654516|NCT00839332|364398436|FG000|Phase 2|Protocol Violation|0|||
105654517|NCT00839332|364398437|FG001|Phase 2|Protocol Violation|1|||
105654518|NCT00839332|364398438|FG002|Phase 2|Protocol Violation|0|||
105654519|NCT00839332|364398436|FG000|Phase 2|Disease Progression|0|||
105654520|NCT00839332|364398437|FG001|Phase 2|Disease Progression|46|||
105654521|NCT00839332|364398438|FG002|Phase 2|Disease Progression|21|||
105654522|NCT00839332|364398436|FG000|Phase 2|Adverse Event|0|||
105654523|NCT00839332|364398437|FG001|Phase 2|Adverse Event|8|||
105654524|NCT00839332|364398438|FG002|Phase 2|Adverse Event|6|||
105654525|NCT00839332|364398436|FG000|Phase 2|Death|0|||
105654526|NCT00839332|364398437|FG001|Phase 2|Death|4|||
105654527|NCT00839332|364398438|FG002|Phase 2|Death|2|||
105654528|NCT00839332|364398436|FG000|Phase 2|Withdrawal by Subject|0|||
105654529|NCT00839332|364398437|FG001|Phase 2|Withdrawal by Subject|5|||
105654530|NCT00839332|364398438|FG002|Phase 2|Withdrawal by Subject|8|||
105654531|NCT00839332|364398436|FG000|Phase 2|Physician Decision|0|||
105654532|NCT00839332|364398437|FG001|Phase 2|Physician Decision|4|||
105654533|NCT00839332|364398438|FG002|Phase 2|Physician Decision|1|||
105654534|NCT00839332|364398436|FG000|Phase 2|Lost to Follow-up|0|||
105654535|NCT00839332|364398437|FG001|Phase 2|Lost to Follow-up|0|||
105654536|NCT00839332|364398438|FG002|Phase 2|Lost to Follow-up|1|||
105654537|NCT00640042|364398439|FG000|Enrollment|Did not receive study drug|83|||
105654538|NCT02109107|364398444|FG000|Overall Study|Lost to Follow-up|2|||
105654539|NCT02573883|364398448|FG000|Six Month Follow Up|Lost to Follow-up|1|||
105654540|NCT02573883|364398449|FG001|Six Month Follow Up|Lost to Follow-up|0|||
105654541|NCT02573883|364398450|FG002|Six Month Follow Up|Lost to Follow-up|0|||
105654542|NCT02573883|364398451|FG003|Six Month Follow Up|Lost to Follow-up|0|||
105654543|NCT02573883|364398448|FG000|One Year Follow Up|Lost to Follow-up|2|||
105654544|NCT02573883|364398449|FG001|One Year Follow Up|Lost to Follow-up|1|||
105654545|NCT02573883|364398450|FG002|One Year Follow Up|Lost to Follow-up|0|||
105654546|NCT02573883|364398451|FG003|One Year Follow Up|Lost to Follow-up|0|||
105654547|NCT03078751|364398452|FG000|Overall Study|Adverse Event|4|||
105654548|NCT03078751|364398453|FG001|Overall Study|Adverse Event|0|||
105654549|NCT03078751|364398452|FG000|Overall Study|Physician Decision|1|||
105654550|NCT03078751|364398453|FG001|Overall Study|Physician Decision|0|||
105654551|NCT03078751|364398452|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
105654552|NCT03078751|364398453|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
105654553|NCT03078751|364398452|FG000|Overall Study|Subject/guardian decision|8|||
105654554|NCT03078751|364398453|FG001|Overall Study|Subject/guardian decision|1|||
105654555|NCT03078751|364398452|FG000|Overall Study|Untreated|0|||
105654556|NCT03078751|364398453|FG001|Overall Study|Untreated|4|||
105654557|NCT00118703|364398454|FG000|Overall Study|Protocol Violation|1|||
105654558|NCT00118703|364398455|FG001|Overall Study|Protocol Violation|0|||
105654559|NCT00118703|364398454|FG000|Overall Study|Adverse Event|1|||
105654560|NCT00118703|364398455|FG001|Overall Study|Adverse Event|1|||
105654561|NCT00118703|364398454|FG000|Overall Study|Participant took two different treatment|0|||
105654562|NCT00118703|364398455|FG001|Overall Study|Participant took two different treatment|1|||
105654563|NCT00118703|364398454|FG000|Overall Study|Withdrawal by Subject|2|||
105654564|NCT00118703|364398455|FG001|Overall Study|Withdrawal by Subject|5|||
105654565|NCT00118703|364398454|FG000|Overall Study|Lost to Follow-up|1|||
105654566|NCT00118703|364398455|FG001|Overall Study|Lost to Follow-up|2|||
105654567|NCT03512288|364398460|FG000|Overall Study|Adverse Event|1|||
105654568|NCT03512288|364398461|FG001|Overall Study|Adverse Event|0|||
105654569|NCT03512288|364398460|FG000|Overall Study|Lost to Follow-up|12|||
105654570|NCT03512288|364398461|FG001|Overall Study|Lost to Follow-up|15|||
105654571|NCT03512288|364398460|FG000|Overall Study|Physician Decision|0|||
105654572|NCT03512288|364398461|FG001|Overall Study|Physician Decision|2|||
105654573|NCT03512288|364398460|FG000|Overall Study|Protocol Violation|6|||
105654574|NCT03512288|364398461|FG001|Overall Study|Protocol Violation|4|||
105654575|NCT03512288|364398460|FG000|Overall Study|Medication error without associated adverse event|1|||
105654576|NCT03512288|364398461|FG001|Overall Study|Medication error without associated adverse event|0|||
105654577|NCT03512288|364398460|FG000|Overall Study|No longer met eligibility criteria|5|||
105654578|NCT03512288|364398461|FG001|Overall Study|No longer met eligibility criteria|2|||
105654579|NCT03512288|364398460|FG000|Overall Study|Withdrawal by parent/guardian|14|||
105654580|NCT03512288|364398461|FG001|Overall Study|Withdrawal by parent/guardian|18|||
105654581|NCT03512288|364398460|FG000|Overall Study|Other|1|||
105654582|NCT03512288|364398461|FG001|Overall Study|Other|1|||
105654583|NCT03512288|364398460|FG000|Overall Study|Randomized but not treated|1|||
105654584|NCT03512288|364398461|FG001|Overall Study|Randomized but not treated|1|||
105654585|NCT00424177|364398464|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
105654586|NCT00424177|364398464|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
105654587|NCT00424177|364398464|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
105654588|NCT00424177|364398464|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
105654589|NCT00424177|364398464|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
105654590|NCT00424177|364398464|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
105654591|NCT00424177|364398464|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
105654592|NCT00424177|364398464|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
105654593|NCT00424177|364398464|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
105654594|NCT00424177|364398464|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
105654595|NCT02551692|364398465|FG000|Overall Study|Lost to Follow-up|0|||
105654596|NCT02551692|364398466|FG001|Overall Study|Lost to Follow-up|1|||
105654597|NCT02551692|364398467|FG002|Overall Study|Lost to Follow-up|4|||
105654598|NCT02551692|364398465|FG000|Overall Study|Withdrawal by Subject|1|||
105654599|NCT02551692|364398466|FG001|Overall Study|Withdrawal by Subject|0|||
105654600|NCT02551692|364398467|FG002|Overall Study|Withdrawal by Subject|1|||
105654601|NCT00496834|364398476|FG000|Overall Study|Withdrawal by Subject|4|||
105654602|NCT00496834|364398477|FG001|Overall Study|Withdrawal by Subject|6|||
105654603|NCT00496834|364398476|FG000|Overall Study|Contraindicated medication administered|0|||
105654604|NCT00496834|364398477|FG001|Overall Study|Contraindicated medication administered|1|||
105654605|NCT00496834|364398476|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
105654606|NCT00496834|364398477|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
105654607|NCT00496834|364398476|FG000|Overall Study|Adverse Event|5|||
105654608|NCT00496834|364398477|FG001|Overall Study|Adverse Event|3|||
105654609|NCT00496834|364398476|FG000|Overall Study|IP administration violation|2|||
105654610|NCT00496834|364398477|FG001|Overall Study|IP administration violation|0|||
105654611|NCT00496834|364398476|FG000|Overall Study|Lost to Follow-up|2|||
105654612|NCT00496834|364398477|FG001|Overall Study|Lost to Follow-up|0|||
105654613|NCT00496834|364398476|FG000|Overall Study|Blood Pressure control failure|2|||
105654614|NCT00496834|364398477|FG001|Overall Study|Blood Pressure control failure|1|||
105654615|NCT04088136|364398480|FG000|Overall Study|Withdrawal by Subject|5|||
105654616|NCT04088136|364398481|FG001|Overall Study|Withdrawal by Subject|0|||
105654617|NCT04088136|364398480|FG000|Overall Study|Lack of Efficacy|0|||
105654618|NCT04088136|364398481|FG001|Overall Study|Lack of Efficacy|1|||
105654619|NCT01960348|364399763|FG000|Overall Study|Adverse event, not serious|2|||
105654620|NCT01960348|364399764|FG001|Overall Study|Adverse event, not serious|2|||
105654621|NCT01960348|364399763|FG000|Overall Study|Adverse event, serious fatal|6|||
105654622|NCT01960348|364399764|FG001|Overall Study|Adverse event, serious fatal|5|||
105654623|NCT01960348|364399763|FG000|Overall Study|Adverse event, serious non-fatal|0|||
105654624|NCT01960348|364399764|FG001|Overall Study|Adverse event, serious non-fatal|3|||
105654625|NCT01960348|364399763|FG000|Overall Study|Withdrawal by Subject|1|||
105654626|NCT01960348|364399764|FG001|Overall Study|Withdrawal by Subject|11|||
105654627|NCT01960348|364399763|FG000|Overall Study|Physician Decision|0|||
105654628|NCT01960348|364399764|FG001|Overall Study|Physician Decision|1|||
105654629|NCT01960348|364399763|FG000|Overall Study|Protocol Violation|1|||
105654630|NCT01960348|364399764|FG001|Overall Study|Protocol Violation|0|||
105654631|NCT05446714|364399770|FG000|Overall Study|Lost to Follow-up|1|||
105654632|NCT05446714|364399771|FG001|Overall Study|Lost to Follow-up|3|||
105654633|NCT05446714|364399772|FG002|Overall Study|Lost to Follow-up|2|||
105654634|NCT05446714|364399770|FG000|Overall Study|Protocol Violation|2|||
105654635|NCT05446714|364399771|FG001|Overall Study|Protocol Violation|0|||
105654636|NCT05446714|364399772|FG002|Overall Study|Protocol Violation|0|||
105654637|NCT00197106|364399775|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
105654638|NCT00197106|364399776|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
105654639|NCT00197106|364399777|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
105654640|NCT00197106|364399775|FG000|Overall Treatment Period|Lack of Efficacy|0|||
105654641|NCT00197106|364399776|FG001|Overall Treatment Period|Lack of Efficacy|1|||
105654642|NCT00197106|364399777|FG002|Overall Treatment Period|Lack of Efficacy|0|||
105654643|NCT00197106|364399775|FG000|Overall Treatment Period|Lost to Follow-up|0|||
105654644|NCT00197106|364399776|FG001|Overall Treatment Period|Lost to Follow-up|0|||
105654645|NCT00197106|364399777|FG002|Overall Treatment Period|Lost to Follow-up|2|||
105654646|NCT00197106|364399775|FG000|Overall Treatment Period|Protocol Violation|0|||
105654647|NCT00197106|364399776|FG001|Overall Treatment Period|Protocol Violation|0|||
105654648|NCT00197106|364399777|FG002|Overall Treatment Period|Protocol Violation|2|||
105654649|NCT00197106|364399775|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
105654650|NCT00197106|364399776|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
105654651|NCT00197106|364399777|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
105654652|NCT03511378|364399780|FG000|Overall Study|Withdrawal by Subject|2|||
105654653|NCT03511378|364399781|FG001|Overall Study|Withdrawal by Subject|2|||
105654654|NCT03511378|364399780|FG000|Overall Study|Patient not coming or schedule visit|1|||
105654655|NCT03511378|364399781|FG001|Overall Study|Patient not coming or schedule visit|0|||
105654656|NCT05006417|364399784|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
105654657|NCT00280683|364399785|FG000|Overall Study|Withdrawal by Subject|1|||
105654658|NCT00280683|364399786|FG001|Overall Study|Withdrawal by Subject|2|||
105654659|NCT00280683|364399785|FG000|Overall Study|Adverse Event|1|||
105654660|NCT00280683|364399786|FG001|Overall Study|Adverse Event|1|||
105654661|NCT02705625|364399789|FG000|Overall Study|Protocol Violation|1|||
105654662|NCT02705625|364399790|FG001|Overall Study|Protocol Violation|0|||
105654663|NCT02705625|364399791|FG002|Overall Study|Protocol Violation|0|||
105654664|NCT02705625|364399789|FG000|Overall Study|Adverse Event|6|||
105654665|NCT02705625|364399790|FG001|Overall Study|Adverse Event|5|||
105654666|NCT02705625|364399791|FG002|Overall Study|Adverse Event|2|||
105654667|NCT02705625|364399789|FG000|Overall Study|Death|0|||
105654668|NCT02705625|364399790|FG001|Overall Study|Death|0|||
105654669|NCT02705625|364399791|FG002|Overall Study|Death|1|||
105654670|NCT02705625|364399789|FG000|Overall Study|Withdrawal by Subject|1|||
105654671|NCT02705625|364399790|FG001|Overall Study|Withdrawal by Subject|4|||
105654672|NCT02705625|364399791|FG002|Overall Study|Withdrawal by Subject|5|||
105654673|NCT02705625|364399789|FG000|Overall Study|Lost to Follow-up|0|||
105654674|NCT02705625|364399790|FG001|Overall Study|Lost to Follow-up|0|||
105654675|NCT02705625|364399791|FG002|Overall Study|Lost to Follow-up|1|||
105654676|NCT02705625|364399789|FG000|Overall Study|Non-compliance|0|||
105654677|NCT02705625|364399790|FG001|Overall Study|Non-compliance|1|||
105654678|NCT02705625|364399791|FG002|Overall Study|Non-compliance|1|||
105654679|NCT02705625|364399789|FG000|Overall Study|Overdosing|0|||
105654680|NCT02705625|364399790|FG001|Overall Study|Overdosing|0|||
105654681|NCT02705625|364399791|FG002|Overall Study|Overdosing|1|||
105654682|NCT02158247|364399792|FG000|Overall Study|Invisible vocal cords|5|||
105654683|NCT01649557|364399796|FG000|Overall Study|Lost to Follow-up|5|||
105654684|NCT01649557|364399797|FG001|Overall Study|Lost to Follow-up|0|||
105654685|NCT01649557|364399798|FG002|Overall Study|Lost to Follow-up|3|||
105654686|NCT01649557|364399796|FG000|Overall Study|Adverse Event|7|||
105654687|NCT01649557|364399797|FG001|Overall Study|Adverse Event|5|||
105654688|NCT01649557|364399798|FG002|Overall Study|Adverse Event|1|||
105654689|NCT01649557|364399796|FG000|Overall Study|Met withdrawal criteria|4|||
105654690|NCT01649557|364399797|FG001|Overall Study|Met withdrawal criteria|0|||
105654691|NCT01649557|364399798|FG002|Overall Study|Met withdrawal criteria|0|||
105654692|NCT01649557|364399796|FG000|Overall Study|Physician Decision|8|||
105654693|NCT01649557|364399797|FG001|Overall Study|Physician Decision|2|||
105654694|NCT01649557|364399798|FG002|Overall Study|Physician Decision|1|||
105654695|NCT01649557|364399796|FG000|Overall Study|Withdrawal by Subject|15|||
105654696|NCT01649557|364399797|FG001|Overall Study|Withdrawal by Subject|5|||
105654697|NCT01649557|364399798|FG002|Overall Study|Withdrawal by Subject|4|||
105654698|NCT01649557|364399796|FG000|Overall Study|Protocol deviation|0|||
105654699|NCT01649557|364399797|FG001|Overall Study|Protocol deviation|2|||
105654700|NCT01649557|364399798|FG002|Overall Study|Protocol deviation|0|||
105654701|NCT01649557|364399796|FG000|Overall Study|Lack of Efficacy|5|||
105654702|NCT01649557|364399797|FG001|Overall Study|Lack of Efficacy|0|||
105654703|NCT01649557|364399798|FG002|Overall Study|Lack of Efficacy|0|||
105654704|NCT03924947|364399800|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654705|NCT03924947|364399801|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654706|NCT03924947|364399802|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
105654707|NCT03924947|364399803|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654708|NCT03924947|364399804|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654709|NCT03924947|364399805|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
105654710|NCT01685047|364399808|FG000|Overall Study|Withdrawal by Subject|20|||
105654711|NCT01685047|364399808|FG000|Overall Study|Death|26|||
105654712|NCT01685047|364399808|FG000|Overall Study|Lost to Follow-up|8|||
105654713|NCT01685047|364399808|FG000|Overall Study|Physician Decision|25|||
105654714|NCT01685047|364399808|FG000|Overall Study|Adverse Event|5|||
105654715|NCT01685047|364399808|FG000|Overall Study|patient withdrawn by sponsor|1|||
105654716|NCT02490878|364399812|FG000|Overall Study|deemed ineligible|0|||
105654717|NCT02490878|364399813|FG001|Overall Study|deemed ineligible|1|||
105654718|NCT02490878|364399812|FG000|Overall Study|progression prior to treatment|0|||
105654719|NCT02490878|364399813|FG001|Overall Study|progression prior to treatment|1|||
105870402|NCT01499095|365179053|FG000|Overall Study|Adverse Event|12|||
105870403|NCT01499095|365179054|FG001|Overall Study|Adverse Event|7|||
105654720|NCT02490878|364399812|FG000|Overall Study|only submitted baseline QOL|0|||
105654721|NCT02490878|364399813|FG001|Overall Study|only submitted baseline QOL|1|||
105654722|NCT02973477|364399819|FG000|First Intervention|Lost to Follow-up|0|||
105654723|NCT02973477|364399820|FG001|First Intervention|Lost to Follow-up|2|||
105654724|NCT02973477|364399819|FG000|Washout|Withdrawal by Subject|1|||
105654725|NCT02973477|364399820|FG001|Washout|Withdrawal by Subject|0|||
105654726|NCT02973477|364399819|FG000|Second Intervention|Lost to Follow-up|1|||
105654727|NCT02973477|364399820|FG001|Second Intervention|Lost to Follow-up|0|||
105654728|NCT01885936|364399821|FG000|Overall Study|Withdrawal by Subject|1|||
105654729|NCT01885936|364399822|FG001|Overall Study|Withdrawal by Subject|0|||
105654730|NCT00317603|364399825|FG000|Overall Study|Progressive Disease|3|||
105654731|NCT02741713|364399827|FG000|Overall Study|Surgery type changed intra-operatively|2|||
105654732|NCT02741713|364399828|FG001|Overall Study|Surgery type changed intra-operatively|1|||
105654733|NCT00619983|364399829|FG000|Test Drug Alone|Withdrawal by Subject|1|||
105654734|NCT00619983|364399830|FG001|Test Drug Alone|Withdrawal by Subject|0|||
105654735|NCT00619983|364399831|FG002|Test Drug Alone|Withdrawal by Subject|0|||
105654736|NCT00619983|364399832|FG003|Test Drug Alone|Withdrawal by Subject|1|||
105654737|NCT00619983|364399829|FG000|Test Drug Alone|Failure of daily diary device|1|||
105654738|NCT00619983|364399830|FG001|Test Drug Alone|Failure of daily diary device|1|||
105654739|NCT00619983|364399831|FG002|Test Drug Alone|Failure of daily diary device|2|||
105654740|NCT00619983|364399832|FG003|Test Drug Alone|Failure of daily diary device|2|||
105654741|NCT02172950|364399833|FG000|Overall Study|Physician Decision|3|||
105654742|NCT02172950|364399834|FG001|Overall Study|Physician Decision|3|||
105654743|NCT02172950|364399833|FG000|Overall Study|Lack of Efficacy|1|||
105654744|NCT02172950|364399834|FG001|Overall Study|Lack of Efficacy|0|||
105654745|NCT02172950|364399833|FG000|Overall Study|Adverse Event|4|||
105654746|NCT02172950|364399834|FG001|Overall Study|Adverse Event|1|||
105654747|NCT02172950|364399833|FG000|Overall Study|Withdrawal by Subject|10|||
105654748|NCT02172950|364399834|FG001|Overall Study|Withdrawal by Subject|0|||
105654749|NCT02172950|364399833|FG000|Overall Study|Protocol Violation|1|||
105654750|NCT02172950|364399834|FG001|Overall Study|Protocol Violation|0|||
105654751|NCT02172950|364399833|FG000|Overall Study|Lost to Follow-up|1|||
105654752|NCT02172950|364399834|FG001|Overall Study|Lost to Follow-up|0|||
105654753|NCT02172950|364399833|FG000|Overall Study|Death|1|||
105654754|NCT02172950|364399834|FG001|Overall Study|Death|0|||
105654755|NCT02172950|364399833|FG000|Overall Study|Patient traveling|1|||
105654756|NCT02172950|364399834|FG001|Overall Study|Patient traveling|0|||
105654757|NCT02172950|364399833|FG000|Overall Study|Patient went to other country|1|||
105654758|NCT02172950|364399834|FG001|Overall Study|Patient went to other country|0|||
105654759|NCT02172950|364399833|FG000|Overall Study|Patient relocated overseas|1|||
105654760|NCT02172950|364399834|FG001|Overall Study|Patient relocated overseas|1|||
105654761|NCT02172950|364399833|FG000|Overall Study|Patient moving|1|||
105654762|NCT02172950|364399834|FG001|Overall Study|Patient moving|0|||
105654763|NCT00809341|364399835|FG000|Overall Study|Physician Decision|0|||
105654764|NCT00809341|364399836|FG001|Overall Study|Physician Decision|1|||
105654765|NCT00225277|364399841|FG000|Overall Study|Adverse Event|30|||
105654766|NCT00225277|364399842|FG001|Overall Study|Adverse Event|34|||
105654767|NCT00225277|364399841|FG000|Overall Study|Lack of Efficacy|4|||
105654768|NCT00225277|364399842|FG001|Overall Study|Lack of Efficacy|1|||
105654769|NCT00225277|364399841|FG000|Overall Study|Lost to Follow-up|4|||
105654770|NCT00225277|364399842|FG001|Overall Study|Lost to Follow-up|6|||
105654771|NCT00225277|364399841|FG000|Overall Study|Physician Decision|6|||
105654772|NCT00225277|364399842|FG001|Overall Study|Physician Decision|8|||
105654773|NCT00225277|364399841|FG000|Overall Study|Protocol Violation|6|||
105654774|NCT00225277|364399842|FG001|Overall Study|Protocol Violation|3|||
105654775|NCT00225277|364399841|FG000|Overall Study|Withdrawal by Subject|40|||
105654776|NCT00225277|364399842|FG001|Overall Study|Withdrawal by Subject|34|||
105654777|NCT00225277|364399841|FG000|Overall Study|Other|7|||
105654778|NCT00225277|364399842|FG001|Overall Study|Other|9|||
105654779|NCT04582669|364399854|FG000|Overall Study|Subject missed appointment(s).|1|||
105654780|NCT04582669|364399855|FG001|Overall Study|Subject missed appointment(s).|0|||
105654781|NCT04582669|364399856|FG002|Overall Study|Subject missed appointment(s).|1|||
105654782|NCT04582669|364399857|FG003|Overall Study|Subject missed appointment(s).|2|||
105654783|NCT04582669|364399854|FG000|Overall Study|Protocol Violation|0|||
105654784|NCT04582669|364399855|FG001|Overall Study|Protocol Violation|1|||
105654785|NCT04582669|364399856|FG002|Overall Study|Protocol Violation|1|||
105654786|NCT04582669|364399857|FG003|Overall Study|Protocol Violation|0|||
105654787|NCT02171130|364399858|FG000|Overall Study|Death|1|||
105654788|NCT02171130|364399858|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
105654789|NCT02171130|364399858|FG000|Overall Study|Discontinued; Site Termination|5|||
105654790|NCT02171130|364399858|FG000|Overall Study|Withdrawal by Subject|3|||
105654791|NCT02171130|364399858|FG000|Overall Study|Physician Decision|1|||
105654792|NCT02171130|364399858|FG000|Overall Study|Lost to Follow-up|1|||
105654793|NCT02171130|364399858|FG000|Overall Study|Met Exclusion Criteria|1|||
105654794|NCT00591409|364399859|FG000|Overall Study|Not Treated|0|||
105654795|NCT00591409|364399860|FG001|Overall Study|Not Treated|0|||
105654796|NCT00591409|364399861|FG002|Overall Study|Not Treated|0|||
105654797|NCT00591409|364399862|FG003|Overall Study|Not Treated|0|||
105654798|NCT00591409|364399863|FG004|Overall Study|Not Treated|1|||
105654799|NCT00591409|364399864|FG005|Overall Study|Not Treated|0|||
105654800|NCT00591409|364399865|FG006|Overall Study|Not Treated|0|||
105654801|NCT00591409|364399866|FG007|Overall Study|Not Treated|0|||
105654802|NCT00591409|364399867|FG008|Overall Study|Not Treated|0|||
105654803|NCT00591409|364399868|FG009|Overall Study|Not Treated|1|||
105654804|NCT02215954|364399869|FG000|Overall Study|Adverse Event|0|||
105654805|NCT02215954|364399870|FG001|Overall Study|Adverse Event|0|||
105654806|NCT02215954|364399871|FG002|Overall Study|Adverse Event|1|||
105654807|NCT02215954|364399869|FG000|Overall Study|Withdrawal by Subject|0|||
105654808|NCT02215954|364399870|FG001|Overall Study|Withdrawal by Subject|0|||
105654809|NCT02215954|364399871|FG002|Overall Study|Withdrawal by Subject|2|||
105654810|NCT02215954|364399869|FG000|Overall Study|Not exposed|1|||
105654811|NCT02215954|364399870|FG001|Overall Study|Not exposed|1|||
105654812|NCT02215954|364399871|FG002|Overall Study|Not exposed|3|||
105654813|NCT03503162|364399872|FG000|Overall Study|did not meet eligibility|1|||
105654814|NCT00920699|364399881|FG000|Overall Study|Withdrawal by Subject|2|||
105654815|NCT00920699|364399882|FG001|Overall Study|Withdrawal by Subject|0|||
105654816|NCT00920699|364399883|FG002|Overall Study|Withdrawal by Subject|2|||
105654817|NCT00920699|364399881|FG000|Overall Study|no longer met eligibility|0|||
105654818|NCT00920699|364399882|FG001|Overall Study|no longer met eligibility|1|||
105654819|NCT00920699|364399883|FG002|Overall Study|no longer met eligibility|0|||
105654820|NCT00920699|364399881|FG000|Overall Study|Lost to Follow-up|0|||
105654821|NCT00920699|364399882|FG001|Overall Study|Lost to Follow-up|0|||
105654822|NCT00920699|364399883|FG002|Overall Study|Lost to Follow-up|2|||
105654823|NCT03723915|364399884|FG000|Screening|Failed to meet screening requirements.|2|||
105654824|NCT03723915|364399884|FG000|On Treatment|Failed to meet treatment requirements|2|||
105654825|NCT00740870|364399886|FG000|Overall Study|Not Catheterized|4|||
105654826|NCT00740870|364399886|FG000|Overall Study|Further testing contraindicated implant|17|||
105654827|NCT04947436|364399887|FG000|Overall Study|Lost to Follow-up|3|||
105654828|NCT04947436|364399888|FG001|Overall Study|Lost to Follow-up|7|||
105654829|NCT04947436|364399889|FG002|Overall Study|Lost to Follow-up|5|||
105654830|NCT04947436|364399887|FG000|Overall Study|Death|1|||
105654831|NCT04947436|364399888|FG001|Overall Study|Death|1|||
105654832|NCT04947436|364399889|FG002|Overall Study|Death|1|||
105654833|NCT02630706|364399893|FG000|Overall Study|Adverse Event|2|||
105654834|NCT02630706|364399894|FG001|Overall Study|Adverse Event|1|||
105654835|NCT02630706|364399895|FG002|Overall Study|Adverse Event|1|||
105654836|NCT02630706|364399893|FG000|Overall Study|Lost to Follow-up|0|||
105654837|NCT02630706|364399894|FG001|Overall Study|Lost to Follow-up|1|||
105654838|NCT02630706|364399895|FG002|Overall Study|Lost to Follow-up|2|||
105654839|NCT02630706|364399893|FG000|Overall Study|Physician Decision|1|||
105654840|NCT02630706|364399894|FG001|Overall Study|Physician Decision|1|||
105654841|NCT02630706|364399895|FG002|Overall Study|Physician Decision|0|||
105654842|NCT02630706|364399893|FG000|Overall Study|Pregnancy|0|||
105654843|NCT02630706|364399894|FG001|Overall Study|Pregnancy|1|||
105654844|NCT02630706|364399895|FG002|Overall Study|Pregnancy|0|||
105654845|NCT02630706|364399893|FG000|Overall Study|Withdrawal by Subject|4|||
105654846|NCT02630706|364399894|FG001|Overall Study|Withdrawal by Subject|5|||
105654847|NCT02630706|364399895|FG002|Overall Study|Withdrawal by Subject|7|||
105654848|NCT02161185|364399900|FG000|Treatment Phase|Administrative/Other|7|||
105654849|NCT00372255|364399902|FG000|Overall Study|Withdrawn for other reasons|2|||
105654850|NCT00372255|364399903|FG001|Overall Study|Withdrawn for other reasons|1|||
105654851|NCT02864342|364399904|FG000|Overall Study|Eligibility Criteria Deviation|2|||
105654852|NCT02864342|364399905|FG001|Overall Study|Eligibility Criteria Deviation|3|||
105654853|NCT02864342|364399904|FG000|Overall Study|Withdrawal by Subject|4|||
105654854|NCT02864342|364399905|FG001|Overall Study|Withdrawal by Subject|2|||
105654855|NCT02864342|364399904|FG000|Overall Study|Device Technology Issue|6|||
105654856|NCT02864342|364399905|FG001|Overall Study|Device Technology Issue|7|||
105654857|NCT02864342|364399904|FG000|Overall Study|Death|0|||
105654858|NCT02864342|364399905|FG001|Overall Study|Death|1|||
105654859|NCT02864342|364399904|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
105654860|NCT02864342|364399905|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
105654861|NCT02864342|364399904|FG000|Overall Study|Lost to Follow-up|1|||
105654862|NCT02864342|364399905|FG001|Overall Study|Lost to Follow-up|5|||
105654863|NCT02864342|364399904|FG000|Overall Study|Lost Device|1|||
105654864|NCT02864342|364399905|FG001|Overall Study|Lost Device|0|||
105654865|NCT02864342|364399904|FG000|Overall Study|Adverse Event|1|||
105870404|NCT01499095|365179053|FG000|Overall Study|Lack of Efficacy|2|||
105870405|NCT01499095|365179054|FG001|Overall Study|Lack of Efficacy|1|||
105870406|NCT01499095|365179053|FG000|Overall Study|Protocol Violation|6|||
105654866|NCT02864342|364399905|FG001|Overall Study|Adverse Event|0|||
105654867|NCT00808899|364399906|FG000|Overall Study|Death|1|||
105654868|NCT00808899|364399906|FG000|Overall Study|Physician Decision|3|||
105654869|NCT02517528|364401740|FG000|Overall Study|Withdrawal by Subject|1|||
105654870|NCT03440047|364401743|FG000|Overall Study|Withdrawal by Subject|2|||
105654871|NCT01181609|364401744|FG000|Overall Study|Adverse Event|1|||
105654872|NCT01181609|364401744|FG000|Overall Study|Withdrawal by Subject|1|||
105870407|NCT01499095|365179054|FG001|Overall Study|Protocol Violation|7|||
105654873|NCT01181609|364401744|FG000|Overall Study|Lost to Follow-up|1|||
105654874|NCT01181609|364401744|FG000|Overall Study|Death|50|||
105654875|NCT00684203|364401756|FG000|Overall Study|Adverse Event|6|||
105654876|NCT00684203|364401757|FG001|Overall Study|Adverse Event|4|||
105654877|NCT00684203|364401758|FG002|Overall Study|Adverse Event|8|||
105654878|NCT00684203|364401759|FG003|Overall Study|Adverse Event|0|||
105654879|NCT00684203|364401760|FG004|Overall Study|Adverse Event|0|||
105654880|NCT00684203|364401761|FG005|Overall Study|Adverse Event|0|||
105654881|NCT00684203|364401756|FG000|Overall Study|Protocol-defined clinical event|3|||
105654882|NCT00684203|364401757|FG001|Overall Study|Protocol-defined clinical event|1|||
105654883|NCT00684203|364401758|FG002|Overall Study|Protocol-defined clinical event|0|||
105654884|NCT00684203|364401759|FG003|Overall Study|Protocol-defined clinical event|0|||
105654885|NCT00684203|364401760|FG004|Overall Study|Protocol-defined clinical event|0|||
105654886|NCT00684203|364401761|FG005|Overall Study|Protocol-defined clinical event|0|||
105654887|NCT00684203|364401756|FG000|Overall Study|Withdrawal by Subject|0|||
105654888|NCT00684203|364401757|FG001|Overall Study|Withdrawal by Subject|2|||
105654889|NCT00684203|364401758|FG002|Overall Study|Withdrawal by Subject|1|||
105654890|NCT00684203|364401759|FG003|Overall Study|Withdrawal by Subject|0|||
105654891|NCT00684203|364401760|FG004|Overall Study|Withdrawal by Subject|0|||
105654892|NCT00684203|364401761|FG005|Overall Study|Withdrawal by Subject|0|||
105654893|NCT00684203|364401756|FG000|Overall Study|Did not meet protocol eligibility|0|||
105654894|NCT00684203|364401757|FG001|Overall Study|Did not meet protocol eligibility|1|||
105654895|NCT00684203|364401758|FG002|Overall Study|Did not meet protocol eligibility|0|||
105654896|NCT00684203|364401759|FG003|Overall Study|Did not meet protocol eligibility|0|||
105654897|NCT00684203|364401760|FG004|Overall Study|Did not meet protocol eligibility|0|||
105654898|NCT00684203|364401761|FG005|Overall Study|Did not meet protocol eligibility|0|||
105654899|NCT00721214|364401763|FG000|Overall Study|Chose another center for transplant|1|||
105654900|NCT00721214|364401763|FG000|Overall Study|Death|3|||
105654901|NCT00983905|364401764|FG000|Theophylline Alone|Adverse Event|1|||
105654902|NCT00983905|364401764|FG000|Colchicine Alone|Adverse Event|2|||
105654903|NCT01243411|364401765|FG000|Overall Study|Withdrawal by Subject|18|||
105654904|NCT01243411|364401765|FG000|Overall Study|Lost to Follow-up|10|||
105654905|NCT01243411|364401765|FG000|Overall Study|Adverse Event|5|||
105654906|NCT01243411|364401765|FG000|Overall Study|Other|8|||
105654907|NCT01169636|364401766|FG000|Overall Study|Adverse Event|0|||
105654908|NCT01169636|364401767|FG001|Overall Study|Adverse Event|0|||
105654909|NCT01169636|364401768|FG002|Overall Study|Adverse Event|1|||
105654910|NCT01169636|364401769|FG003|Overall Study|Adverse Event|1|||
105654911|NCT01169636|364401770|FG004|Overall Study|Adverse Event|0|||
105654912|NCT01169636|364401766|FG000|Overall Study|Screen failure|0|||
105654913|NCT01169636|364401767|FG001|Overall Study|Screen failure|0|||
105654914|NCT01169636|364401768|FG002|Overall Study|Screen failure|2|||
105654915|NCT01169636|364401769|FG003|Overall Study|Screen failure|0|||
105654916|NCT01169636|364401770|FG004|Overall Study|Screen failure|0|||
105654917|NCT01169636|364401766|FG000|Overall Study|Withdrawal by Subject|0|||
105654918|NCT01169636|364401767|FG001|Overall Study|Withdrawal by Subject|0|||
105654919|NCT01169636|364401768|FG002|Overall Study|Withdrawal by Subject|0|||
105654920|NCT01169636|364401769|FG003|Overall Study|Withdrawal by Subject|0|||
105654921|NCT01169636|364401770|FG004|Overall Study|Withdrawal by Subject|3|||
105654922|NCT01951378|364401771|FG000|Overall Study|Study Terminated-Not completed|23|||
105654923|NCT01951378|364401772|FG001|Overall Study|Study Terminated-Not completed|17|||
105654924|NCT00494026|364401773|FG000|Overall Study|Sponsor Decision|4|||
105654925|NCT02466243|364401775|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
105654926|NCT02466243|364401776|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
105654927|NCT02466243|364401775|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
105654928|NCT02466243|364401776|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
105654929|NCT02466243|364401775|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
105654930|NCT02466243|364401776|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
105654931|NCT02466243|364401775|FG000|Part B Open-label Treatment Period|Missing|2|||
105654932|NCT02466243|364401776|FG001|Part B Open-label Treatment Period|Missing|2|||
105654933|NCT00477464|364401777|FG000|Overall Study|Lost to Follow-up|1|||
105654934|NCT00477464|364401777|FG000|Overall Study|Death|36|||
105654935|NCT00477464|364401777|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
105654936|NCT00784147|364401780|FG000|Overall Study|Lost to Follow-up|2|||
105654937|NCT00784147|364401781|FG001|Overall Study|Lost to Follow-up|4|||
105654938|NCT00784147|364401780|FG000|Overall Study|Withdrawal by Subject|1|||
105654939|NCT00784147|364401781|FG001|Overall Study|Withdrawal by Subject|3|||
105654940|NCT00784147|364401780|FG000|Overall Study|Physician Decision|2|||
105654941|NCT00784147|364401781|FG001|Overall Study|Physician Decision|1|||
105654942|NCT00784147|364401780|FG000|Overall Study|Protocol Violation|1|||
105654943|NCT00784147|364401781|FG001|Overall Study|Protocol Violation|1|||
105654944|NCT00784147|364401780|FG000|Overall Study|Death|2|||
105654945|NCT00784147|364401781|FG001|Overall Study|Death|0|||
105654946|NCT02973802|364401782|FG000|Overall Study|Lost to Follow-up|1|||
105654947|NCT02973802|364401782|FG000|Overall Study|Withdrawal by Subject|1|||
105654948|NCT00706914|364401783|FG000|Overall Study|Lack of Efficacy|0|||
105654949|NCT00706914|364401784|FG001|Overall Study|Lack of Efficacy|1|||
105654950|NCT00706914|364401785|FG002|Overall Study|Lack of Efficacy|0|||
105654951|NCT00706914|364401783|FG000|Overall Study|Lost to Follow-up|1|||
105654952|NCT00706914|364401784|FG001|Overall Study|Lost to Follow-up|0|||
105654953|NCT00706914|364401785|FG002|Overall Study|Lost to Follow-up|0|||
105654954|NCT00706914|364401783|FG000|Overall Study|Adverse Event|2|||
105654955|NCT00706914|364401784|FG001|Overall Study|Adverse Event|2|||
105654956|NCT00706914|364401785|FG002|Overall Study|Adverse Event|0|||
105654957|NCT00706914|364401783|FG000|Overall Study|Protocol Violation|3|||
105654958|NCT00706914|364401784|FG001|Overall Study|Protocol Violation|1|||
105654959|NCT00706914|364401785|FG002|Overall Study|Protocol Violation|1|||
105654960|NCT02330562|364401786|FG000|Overall Study|Adverse Event|0|||
105654961|NCT02330562|364401787|FG001|Overall Study|Adverse Event|0|||
105654962|NCT02330562|364401788|FG002|Overall Study|Adverse Event|3|||
105654963|NCT02330562|364401789|FG003|Overall Study|Adverse Event|0|||
105654964|NCT02330562|364401790|FG004|Overall Study|Adverse Event|3|||
105654965|NCT02330562|364401791|FG005|Overall Study|Adverse Event|1|||
105654966|NCT02330562|364401792|FG006|Overall Study|Adverse Event|0|||
105654967|NCT02330562|364401793|FG007|Overall Study|Adverse Event|0|||
105654968|NCT02330562|364401794|FG008|Overall Study|Adverse Event|0|||
105654969|NCT02330562|364401795|FG009|Overall Study|Adverse Event|1|||
105654970|NCT02330562|364401796|FG010|Overall Study|Adverse Event|1|||
105654971|NCT02330562|364401786|FG000|Overall Study|Participant decision|1|||
105654972|NCT02330562|364401787|FG001|Overall Study|Participant decision|0|||
105654973|NCT02330562|364401788|FG002|Overall Study|Participant decision|4|||
105654974|NCT02330562|364401789|FG003|Overall Study|Participant decision|1|||
105654975|NCT02330562|364401790|FG004|Overall Study|Participant decision|5|||
105654976|NCT02330562|364401791|FG005|Overall Study|Participant decision|2|||
105654977|NCT02330562|364401792|FG006|Overall Study|Participant decision|0|||
105654978|NCT02330562|364401793|FG007|Overall Study|Participant decision|0|||
105654979|NCT02330562|364401794|FG008|Overall Study|Participant decision|0|||
105654980|NCT02330562|364401795|FG009|Overall Study|Participant decision|3|||
105654981|NCT02330562|364401796|FG010|Overall Study|Participant decision|0|||
105654982|NCT02330562|364401786|FG000|Overall Study|Disease progression|5|||
105654983|NCT02330562|364401787|FG001|Overall Study|Disease progression|3|||
105654984|NCT02330562|364401788|FG002|Overall Study|Disease progression|20|||
105654985|NCT02330562|364401789|FG003|Overall Study|Disease progression|28|||
105654986|NCT02330562|364401790|FG004|Overall Study|Disease progression|23|||
105654987|NCT02330562|364401791|FG005|Overall Study|Disease progression|7|||
105654988|NCT02330562|364401792|FG006|Overall Study|Disease progression|1|||
105654989|NCT02330562|364401793|FG007|Overall Study|Disease progression|1|||
105654990|NCT02330562|364401794|FG008|Overall Study|Disease progression|1|||
105654991|NCT02330562|364401795|FG009|Overall Study|Disease progression|0|||
105654992|NCT02330562|364401796|FG010|Overall Study|Disease progression|5|||
105654993|NCT02330562|364401786|FG000|Overall Study|Other reasons|0|||
105654994|NCT02330562|364401787|FG001|Overall Study|Other reasons|0|||
105654995|NCT02330562|364401788|FG002|Overall Study|Other reasons|0|||
105654996|NCT02330562|364401789|FG003|Overall Study|Other reasons|1|||
105654997|NCT02330562|364401790|FG004|Overall Study|Other reasons|0|||
105654998|NCT02330562|364401791|FG005|Overall Study|Other reasons|0|||
105654999|NCT02330562|364401792|FG006|Overall Study|Other reasons|0|||
105655000|NCT02330562|364401793|FG007|Overall Study|Other reasons|0|||
105655001|NCT02330562|364401794|FG008|Overall Study|Other reasons|0|||
105655002|NCT02330562|364401795|FG009|Overall Study|Other reasons|0|||
105655003|NCT02330562|364401796|FG010|Overall Study|Other reasons|0|||
105655004|NCT02330562|364401786|FG000|Overall Study|Withdrawal by Subject|0|||
105655005|NCT02330562|364401787|FG001|Overall Study|Withdrawal by Subject|0|||
105655006|NCT02330562|364401788|FG002|Overall Study|Withdrawal by Subject|0|||
105655007|NCT02330562|364401789|FG003|Overall Study|Withdrawal by Subject|0|||
105655008|NCT02330562|364401790|FG004|Overall Study|Withdrawal by Subject|0|||
105655009|NCT02330562|364401791|FG005|Overall Study|Withdrawal by Subject|0|||
105655010|NCT02330562|364401792|FG006|Overall Study|Withdrawal by Subject|0|||
105655011|NCT02330562|364401793|FG007|Overall Study|Withdrawal by Subject|0|||
105655012|NCT02330562|364401794|FG008|Overall Study|Withdrawal by Subject|0|||
105655013|NCT02330562|364401795|FG009|Overall Study|Withdrawal by Subject|1|||
105655014|NCT02330562|364401796|FG010|Overall Study|Withdrawal by Subject|0|||
105655015|NCT00875615|364401797|FG000|Overall Study|Withdrawal by Subject|1|||
105655016|NCT00943722|364401798|FG000|Base Study|Adverse Event|0|||
105655017|NCT00943722|364401799|FG001|Base Study|Adverse Event|0|||
105655018|NCT00943722|364401800|FG002|Base Study|Adverse Event|0|||
105655019|NCT00943722|364401801|FG003|Base Study|Adverse Event|1|||
105655020|NCT00943722|364401802|FG004|Base Study|Adverse Event|0|||
105655021|NCT00943722|364401803|FG005|Base Study|Adverse Event|0|||
105655022|NCT00943722|364401804|FG006|Base Study|Adverse Event|0|||
105655023|NCT00943722|364401798|FG000|Base Study|Lost to Follow-up|12|||
105655024|NCT00943722|364401799|FG001|Base Study|Lost to Follow-up|8|||
105655025|NCT00943722|364401800|FG002|Base Study|Lost to Follow-up|10|||
105655026|NCT00943722|364401801|FG003|Base Study|Lost to Follow-up|8|||
105655027|NCT00943722|364401802|FG004|Base Study|Lost to Follow-up|11|||
105655028|NCT00943722|364401803|FG005|Base Study|Lost to Follow-up|0|||
105655029|NCT00943722|364401804|FG006|Base Study|Lost to Follow-up|0|||
105655030|NCT00943722|364401798|FG000|Base Study|Physician Decision|1|||
105655031|NCT00943722|364401799|FG001|Base Study|Physician Decision|0|||
105655032|NCT00943722|364401800|FG002|Base Study|Physician Decision|0|||
105655033|NCT00943722|364401801|FG003|Base Study|Physician Decision|0|||
105655034|NCT00943722|364401802|FG004|Base Study|Physician Decision|1|||
105655035|NCT00943722|364401803|FG005|Base Study|Physician Decision|0|||
105655036|NCT00943722|364401804|FG006|Base Study|Physician Decision|0|||
105655037|NCT00943722|364401798|FG000|Base Study|Pregnancy|0|||
105655038|NCT00943722|364401799|FG001|Base Study|Pregnancy|0|||
105655039|NCT00943722|364401800|FG002|Base Study|Pregnancy|1|||
105655040|NCT00943722|364401801|FG003|Base Study|Pregnancy|0|||
105655041|NCT00943722|364401802|FG004|Base Study|Pregnancy|2|||
105655042|NCT00943722|364401803|FG005|Base Study|Pregnancy|0|||
105655043|NCT00943722|364401804|FG006|Base Study|Pregnancy|0|||
105655044|NCT00943722|364401798|FG000|Base Study|Protocol Violation|0|||
105655045|NCT00943722|364401799|FG001|Base Study|Protocol Violation|1|||
105655046|NCT00943722|364401800|FG002|Base Study|Protocol Violation|0|||
105655047|NCT00943722|364401801|FG003|Base Study|Protocol Violation|0|||
105655048|NCT00943722|364401802|FG004|Base Study|Protocol Violation|2|||
105655049|NCT00943722|364401803|FG005|Base Study|Protocol Violation|0|||
105655050|NCT00943722|364401804|FG006|Base Study|Protocol Violation|0|||
105655051|NCT00943722|364401798|FG000|Base Study|Withdrawal by Subject|12|||
105655052|NCT00943722|364401799|FG001|Base Study|Withdrawal by Subject|13|||
105655053|NCT00943722|364401800|FG002|Base Study|Withdrawal by Subject|2|||
105655054|NCT00943722|364401801|FG003|Base Study|Withdrawal by Subject|13|||
105655055|NCT00943722|364401802|FG004|Base Study|Withdrawal by Subject|8|||
105655056|NCT00943722|364401803|FG005|Base Study|Withdrawal by Subject|0|||
105655057|NCT00943722|364401804|FG006|Base Study|Withdrawal by Subject|0|||
105655058|NCT00943722|364401798|FG000|Base Study|Month 12 visit not completed|0|||
105655059|NCT00943722|364401799|FG001|Base Study|Month 12 visit not completed|0|||
105655060|NCT00943722|364401800|FG002|Base Study|Month 12 visit not completed|0|||
105655061|NCT00943722|364401801|FG003|Base Study|Month 12 visit not completed|0|||
105655062|NCT00943722|364401802|FG004|Base Study|Month 12 visit not completed|2|||
105655063|NCT00943722|364401803|FG005|Base Study|Month 12 visit not completed|0|||
105655064|NCT00943722|364401804|FG006|Base Study|Month 12 visit not completed|0|||
105655065|NCT00943722|364401798|FG000|First Extension Study: EXT 1|Adverse Event|0|||
105655066|NCT00943722|364401799|FG001|First Extension Study: EXT 1|Adverse Event|0|||
105655067|NCT00943722|364401800|FG002|First Extension Study: EXT 1|Adverse Event|0|||
105655068|NCT00943722|364401801|FG003|First Extension Study: EXT 1|Adverse Event|0|||
105655069|NCT00943722|364401802|FG004|First Extension Study: EXT 1|Adverse Event|0|||
105655070|NCT00943722|364401803|FG005|First Extension Study: EXT 1|Adverse Event|1|||
105655071|NCT00943722|364401804|FG006|First Extension Study: EXT 1|Adverse Event|0|||
105655072|NCT00943722|364401798|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655073|NCT00943722|364401799|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655074|NCT00943722|364401800|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655075|NCT00943722|364401801|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655076|NCT00943722|364401802|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
105655077|NCT00943722|364401803|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
105655078|NCT00943722|364401804|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
105655079|NCT00943722|364401798|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655080|NCT00943722|364401799|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655081|NCT00943722|364401800|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655082|NCT00943722|364401801|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655083|NCT00943722|364401802|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
105655084|NCT00943722|364401803|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
105655085|NCT00943722|364401804|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
105655086|NCT00943722|364401798|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
105655087|NCT00943722|364401799|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
105655088|NCT00943722|364401800|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
105655089|NCT00943722|364401801|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
105655090|NCT00943722|364401802|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
105655091|NCT00943722|364401803|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
105655092|NCT00943722|364401804|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
105655093|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
105870408|NCT01499095|365179053|FG000|Overall Study|Received Rescue Therapy|32|||
105655094|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
105655095|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
105655096|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
105655097|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
105655098|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
105655099|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
105655100|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655101|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105870409|NCT01499095|365179054|FG001|Overall Study|Received Rescue Therapy|40|||
105655102|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655103|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655104|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
105655105|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
105655106|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
105655107|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
105655108|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
105655109|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
105655110|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
105655111|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
105655112|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
105655113|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
105655114|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
105655115|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
105655116|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
105655117|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
105655118|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
105655119|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
105655120|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
105655121|NCT00943722|364401798|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655122|NCT00943722|364401799|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655123|NCT00943722|364401800|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655124|NCT00943722|364401801|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655125|NCT00943722|364401802|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
105655126|NCT00943722|364401803|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
105655127|NCT00943722|364401804|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
105655128|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
105655129|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
105655130|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
105655131|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
105655132|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
105655133|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
105655134|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
105655135|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
105655136|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
105655137|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
105655138|NCT01772823|364401805|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
105655139|NCT01772823|364401806|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
105655140|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
105655141|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
105655142|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
105655143|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
105655144|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
105655145|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
105655146|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
105655147|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
105655148|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
105655149|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
105655150|NCT01772823|364401805|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
105655151|NCT01772823|364401806|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
105655152|NCT01772823|364401805|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
105655153|NCT01772823|364401806|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
105655154|NCT01772823|364401805|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
105655155|NCT01772823|364401806|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
105655156|NCT01772823|364401805|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
105655157|NCT01772823|364401806|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
105655158|NCT01772823|364401805|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
105655159|NCT01772823|364401806|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
105655160|NCT00805285|364401807|FG000|Overall Study|Lack of Efficacy|1|||
105655161|NCT03712449|364401811|FG000|Overall Study|Withdraw Consent|0|||
105655162|NCT03712449|364401812|FG001|Overall Study|Withdraw Consent|1|||
105655163|NCT00666198|364401815|FG000|Overall Study|Protocol Violation|10|||
105655164|NCT00666198|364401815|FG000|Overall Study|No Visit After First Day of Treatment|13|||
105655165|NCT00666198|364401815|FG000|Overall Study|Safety Not Assessable|6|||
105655166|NCT00666198|364401815|FG000|Overall Study|No Drug Administration|4|||
105655167|NCT02544113|364401819|FG000|Overall Study|Death|3|||
105655168|NCT02544113|364401820|FG001|Overall Study|Death|4|||
105655169|NCT01049984|364401822|FG000|Overall Study|Withdrawal by Subject|1|||
105655170|NCT01049984|364401823|FG001|Overall Study|Withdrawal by Subject|5|||
105655171|NCT01049984|364401822|FG000|Overall Study|Protocol Violation|3|||
105655172|NCT01049984|364401823|FG001|Overall Study|Protocol Violation|4|||
105655173|NCT01049984|364401822|FG000|Overall Study|Lost to Follow-up|2|||
105655174|NCT01049984|364401823|FG001|Overall Study|Lost to Follow-up|1|||
105655175|NCT01049984|364401822|FG000|Overall Study|Adverse Event|13|||
105655176|NCT01049984|364401823|FG001|Overall Study|Adverse Event|7|||
105655177|NCT01049984|364401822|FG000|Overall Study|Treatment failure|0|||
105655178|NCT01049984|364401823|FG001|Overall Study|Treatment failure|2|||
105655179|NCT00451555|364401824|FG000|Overall Study|Protocol Violation|2|||
105655180|NCT00451555|364401825|FG001|Overall Study|Protocol Violation|2|||
105655181|NCT00451555|364401824|FG000|Overall Study|Adverse Event|3|||
105655182|NCT00451555|364401825|FG001|Overall Study|Adverse Event|1|||
105655183|NCT00451555|364401824|FG000|Overall Study|Withdrawal by Subject|6|||
105655184|NCT00451555|364401825|FG001|Overall Study|Withdrawal by Subject|0|||
105655185|NCT00451555|364401824|FG000|Overall Study|Physician Decision|2|||
105655186|NCT00451555|364401825|FG001|Overall Study|Physician Decision|1|||
105655187|NCT02512861|364401828|FG000|Overall Study|Protocol Violation|3|||
105655188|NCT02512861|364401829|FG001|Overall Study|Protocol Violation|7|||
105655189|NCT02512861|364401828|FG000|Overall Study|Physician Decision|3|||
105655190|NCT02512861|364401829|FG001|Overall Study|Physician Decision|1|||
105655191|NCT02512861|364401828|FG000|Overall Study|Withdrawal by Subject|0|||
105655192|NCT02512861|364401829|FG001|Overall Study|Withdrawal by Subject|1|||
105655193|NCT03214250|364401834|FG000|Overall Study|Death|5|||
105655194|NCT03214250|364401835|FG001|Overall Study|Death|5|||
105655195|NCT03214250|364401836|FG002|Overall Study|Death|7|||
105655196|NCT03214250|364401837|FG003|Overall Study|Death|4|||
105655197|NCT03214250|364401838|FG004|Overall Study|Death|23|||
105655198|NCT03214250|364401839|FG005|Overall Study|Death|23|||
105655199|NCT03214250|364401840|FG006|Overall Study|Death|24|||
105655200|NCT03214250|364401834|FG000|Overall Study|Lost to Follow-up|0|||
105655201|NCT03214250|364401835|FG001|Overall Study|Lost to Follow-up|0|||
105655202|NCT03214250|364401836|FG002|Overall Study|Lost to Follow-up|0|||
105655203|NCT03214250|364401837|FG003|Overall Study|Lost to Follow-up|1|||
105655204|NCT03214250|364401838|FG004|Overall Study|Lost to Follow-up|1|||
105655205|NCT03214250|364401839|FG005|Overall Study|Lost to Follow-up|2|||
105655206|NCT03214250|364401840|FG006|Overall Study|Lost to Follow-up|0|||
105655207|NCT03214250|364401834|FG000|Overall Study|Other|0|||
105655208|NCT03214250|364401835|FG001|Overall Study|Other|0|||
105655209|NCT03214250|364401836|FG002|Overall Study|Other|0|||
105655210|NCT03214250|364401837|FG003|Overall Study|Other|0|||
105655211|NCT03214250|364401838|FG004|Overall Study|Other|1|||
105655212|NCT03214250|364401839|FG005|Overall Study|Other|1|||
105655213|NCT03214250|364401840|FG006|Overall Study|Other|2|||
105655214|NCT03214250|364401834|FG000|Overall Study|Remains on Study|2|||
105655215|NCT03214250|364401835|FG001|Overall Study|Remains on Study|2|||
105655216|NCT03214250|364401836|FG002|Overall Study|Remains on Study|0|||
105655217|NCT03214250|364401837|FG003|Overall Study|Remains on Study|1|||
105655218|NCT03214250|364401838|FG004|Overall Study|Remains on Study|7|||
105655219|NCT03214250|364401839|FG005|Overall Study|Remains on Study|5|||
105655220|NCT03214250|364401840|FG006|Overall Study|Remains on Study|3|||
105655221|NCT03214250|364401834|FG000|Overall Study|Withdrawal by Subject|0|||
105655222|NCT03214250|364401835|FG001|Overall Study|Withdrawal by Subject|0|||
105655223|NCT03214250|364401836|FG002|Overall Study|Withdrawal by Subject|1|||
105655224|NCT03214250|364401837|FG003|Overall Study|Withdrawal by Subject|2|||
105655225|NCT03214250|364401838|FG004|Overall Study|Withdrawal by Subject|5|||
105655226|NCT03214250|364401839|FG005|Overall Study|Withdrawal by Subject|0|||
105655227|NCT03214250|364401840|FG006|Overall Study|Withdrawal by Subject|2|||
105655228|NCT00427778|364401841|FG000|First Intervention (4 Weeks)|no longer interested|1|||
105655229|NCT00427778|364401842|FG001|First Intervention (4 Weeks)|no longer interested|0|||
105655230|NCT00427778|364401841|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
105655231|NCT00427778|364401842|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
105655232|NCT00427778|364401841|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
105655233|NCT00427778|364401842|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
105655234|NCT00427778|364401841|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
105655235|NCT00427778|364401842|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
105655236|NCT01836198|364401846|FG000|Part A, Period 2|Protocol Violation|0|||
105655237|NCT01836198|364401847|FG001|Part A, Period 2|Protocol Violation|1|||
105655238|NCT01836198|364401848|FG002|Part A, Period 2|Protocol Violation|0|||
105655239|NCT03187353|364401849|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
105655240|NCT03187353|364401850|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
105655241|NCT03187353|364401849|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
105655242|NCT03187353|364401850|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
105655243|NCT03187353|364401849|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
105655244|NCT03187353|364401850|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
105655245|NCT03187353|364401849|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
105655246|NCT03187353|364401850|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
105655247|NCT03187353|364401849|FG000|Washout (2 Weeks)|Adverse Event|2|||
105655248|NCT03187353|364401850|FG001|Washout (2 Weeks)|Adverse Event|0|||
105655249|NCT03187353|364401849|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
105655250|NCT03187353|364401850|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
105655251|NCT01281917|364401851|FG000|Overall Study|Withdrawal by Subject|1|||
105655252|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
105655253|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
105655254|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
105655255|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
105655256|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
105655257|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
105655258|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Rejections|0|||
105655259|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Rejections|0|||
105655260|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Rejections|55|||
105655261|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
105655262|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
105655263|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
105655264|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
105655265|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
105655266|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
105655267|NCT00634920|364401854|FG000|Period 1 - Pre-Randomization|Other issues|0|||
105655268|NCT00634920|364401855|FG001|Period 1 - Pre-Randomization|Other issues|0|||
105655269|NCT00634920|364401856|FG002|Period 1 - Pre-Randomization|Other issues|6|||
105655270|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
105655271|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
105655272|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
105655273|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|Rejection|11|||
105655274|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|Rejection|5|||
105655275|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|Rejection|0|||
105655276|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|Death|2|||
105655277|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|Death|5|||
105655278|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|Death|0|||
105655279|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
105655280|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
105655281|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
105655282|NCT00634920|364401854|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
105655283|NCT00634920|364401855|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
105655284|NCT00634920|364401856|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
105655285|NCT02101268|364401857|FG000|Randomized Treatment Phase|Subject Decision|8|||
105655286|NCT02101268|364401858|FG001|Randomized Treatment Phase|Subject Decision|4|||
105655287|NCT02101268|364401859|FG002|Randomized Treatment Phase|Subject Decision|0|||
105655288|NCT02101268|364401860|FG003|Randomized Treatment Phase|Subject Decision|0|||
105655289|NCT02101268|364401857|FG000|Randomized Treatment Phase|Physician Decision|4|||
105655290|NCT02101268|364401858|FG001|Randomized Treatment Phase|Physician Decision|1|||
105655291|NCT02101268|364401859|FG002|Randomized Treatment Phase|Physician Decision|0|||
105655292|NCT02101268|364401860|FG003|Randomized Treatment Phase|Physician Decision|0|||
105655293|NCT02101268|364401857|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
105655294|NCT02101268|364401858|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
105655295|NCT02101268|364401859|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
105655296|NCT02101268|364401860|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
105655297|NCT02101268|364401857|FG000|Randomized Treatment Phase|Adverse Event|6|||
105655298|NCT02101268|364401858|FG001|Randomized Treatment Phase|Adverse Event|0|||
105655299|NCT02101268|364401859|FG002|Randomized Treatment Phase|Adverse Event|0|||
105655300|NCT02101268|364401860|FG003|Randomized Treatment Phase|Adverse Event|0|||
105655301|NCT02101268|364401857|FG000|Randomized Treatment Phase|Death|5|||
105655302|NCT02101268|364401858|FG001|Randomized Treatment Phase|Death|4|||
105655303|NCT02101268|364401859|FG002|Randomized Treatment Phase|Death|0|||
105655304|NCT02101268|364401860|FG003|Randomized Treatment Phase|Death|0|||
105655305|NCT02101268|364401857|FG000|Randomized Treatment Phase|Disease Progression|4|||
105655306|NCT02101268|364401858|FG001|Randomized Treatment Phase|Disease Progression|1|||
105655307|NCT02101268|364401859|FG002|Randomized Treatment Phase|Disease Progression|0|||
105655308|NCT02101268|364401860|FG003|Randomized Treatment Phase|Disease Progression|0|||
105655309|NCT02101268|364401857|FG000|Extended Treatment Phase|Subject Decision|0|||
105655310|NCT02101268|364401858|FG001|Extended Treatment Phase|Subject Decision|0|||
105655311|NCT02101268|364401859|FG002|Extended Treatment Phase|Subject Decision|3|||
105655312|NCT02101268|364401860|FG003|Extended Treatment Phase|Subject Decision|2|||
105655313|NCT02101268|364401857|FG000|Extended Treatment Phase|Physician Decision|0|||
105655314|NCT02101268|364401858|FG001|Extended Treatment Phase|Physician Decision|0|||
105655315|NCT02101268|364401859|FG002|Extended Treatment Phase|Physician Decision|5|||
105655316|NCT02101268|364401860|FG003|Extended Treatment Phase|Physician Decision|2|||
105655317|NCT02101268|364401857|FG000|Extended Treatment Phase|Adverse Event|0|||
105655318|NCT02101268|364401858|FG001|Extended Treatment Phase|Adverse Event|0|||
105655319|NCT02101268|364401859|FG002|Extended Treatment Phase|Adverse Event|14|||
105655320|NCT02101268|364401860|FG003|Extended Treatment Phase|Adverse Event|18|||
105655321|NCT02101268|364401857|FG000|Extended Treatment Phase|Death|0|||
105655322|NCT02101268|364401858|FG001|Extended Treatment Phase|Death|0|||
105655323|NCT02101268|364401859|FG002|Extended Treatment Phase|Death|5|||
105655324|NCT02101268|364401860|FG003|Extended Treatment Phase|Death|1|||
105655325|NCT02101268|364401857|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
105655326|NCT02101268|364401858|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
105655327|NCT02101268|364401859|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
105655328|NCT02101268|364401860|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
105655329|NCT02101268|364401857|FG000|Extended Treatment Phase|Disease Progression|0|||
105655330|NCT02101268|364401858|FG001|Extended Treatment Phase|Disease Progression|0|||
105655331|NCT02101268|364401859|FG002|Extended Treatment Phase|Disease Progression|13|||
105655332|NCT02101268|364401860|FG003|Extended Treatment Phase|Disease Progression|6|||
105655333|NCT02101268|364401857|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
105655334|NCT02101268|364401858|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
105655335|NCT02101268|364401859|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
105655336|NCT02101268|364401860|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
105655337|NCT01193218|364401861|FG000|0-12 Weeks|Adverse Event|6|||
105655338|NCT01193218|364401862|FG001|0-12 Weeks|Adverse Event|0|||
105655339|NCT01193218|364401863|FG002|0-12 Weeks|Adverse Event|1|||
105655340|NCT01193218|364401864|FG003|0-12 Weeks|Adverse Event|0|||
105655341|NCT01193218|364401865|FG004|0-12 Weeks|Adverse Event|0|||
105655342|NCT01193218|364401866|FG005|0-12 Weeks|Adverse Event|2|||
105655343|NCT01193218|364401867|FG006|0-12 Weeks|Adverse Event|2|||
105655344|NCT01193218|364401868|FG007|0-12 Weeks|Adverse Event|0|||
105655345|NCT01193218|364401861|FG000|0-12 Weeks|Protocol Violation|0|||
105655346|NCT01193218|364401862|FG001|0-12 Weeks|Protocol Violation|0|||
105655347|NCT01193218|364401863|FG002|0-12 Weeks|Protocol Violation|0|||
105655348|NCT01193218|364401864|FG003|0-12 Weeks|Protocol Violation|0|||
105655349|NCT01193218|364401865|FG004|0-12 Weeks|Protocol Violation|1|||
105655350|NCT01193218|364401866|FG005|0-12 Weeks|Protocol Violation|1|||
105655351|NCT01193218|364401867|FG006|0-12 Weeks|Protocol Violation|0|||
105655352|NCT01193218|364401868|FG007|0-12 Weeks|Protocol Violation|0|||
105655353|NCT01193218|364401861|FG000|0-12 Weeks|Withdrawal by Subject|3|||
105655354|NCT01193218|364401862|FG001|0-12 Weeks|Withdrawal by Subject|0|||
105655355|NCT01193218|364401863|FG002|0-12 Weeks|Withdrawal by Subject|2|||
105655356|NCT01193218|364401864|FG003|0-12 Weeks|Withdrawal by Subject|0|||
105655357|NCT01193218|364401865|FG004|0-12 Weeks|Withdrawal by Subject|0|||
105655358|NCT01193218|364401866|FG005|0-12 Weeks|Withdrawal by Subject|0|||
105655359|NCT01193218|364401867|FG006|0-12 Weeks|Withdrawal by Subject|1|||
105655360|NCT01193218|364401868|FG007|0-12 Weeks|Withdrawal by Subject|0|||
105655361|NCT01193218|364401861|FG000|12-52 Weeks|Adverse Event|1|||
105655362|NCT01193218|364401862|FG001|12-52 Weeks|Adverse Event|0|||
105655363|NCT01193218|364401863|FG002|12-52 Weeks|Adverse Event|1|||
105655364|NCT01193218|364401864|FG003|12-52 Weeks|Adverse Event|2|||
105655365|NCT01193218|364401865|FG004|12-52 Weeks|Adverse Event|3|||
105655366|NCT01193218|364401866|FG005|12-52 Weeks|Adverse Event|3|||
105655367|NCT01193218|364401867|FG006|12-52 Weeks|Adverse Event|1|||
105655368|NCT01193218|364401868|FG007|12-52 Weeks|Adverse Event|2|||
105655369|NCT01193218|364401861|FG000|12-52 Weeks|Lack of Efficacy|0|||
105655370|NCT01193218|364401862|FG001|12-52 Weeks|Lack of Efficacy|0|||
105655371|NCT01193218|364401863|FG002|12-52 Weeks|Lack of Efficacy|0|||
105655372|NCT01193218|364401864|FG003|12-52 Weeks|Lack of Efficacy|0|||
105655373|NCT01193218|364401865|FG004|12-52 Weeks|Lack of Efficacy|0|||
105655374|NCT01193218|364401866|FG005|12-52 Weeks|Lack of Efficacy|0|||
105655375|NCT01193218|364401867|FG006|12-52 Weeks|Lack of Efficacy|1|||
105655376|NCT01193218|364401868|FG007|12-52 Weeks|Lack of Efficacy|0|||
105655377|NCT01193218|364401861|FG000|12-52 Weeks|Withdrawal by Subject|3|||
105655378|NCT01193218|364401862|FG001|12-52 Weeks|Withdrawal by Subject|0|||
105655379|NCT01193218|364401863|FG002|12-52 Weeks|Withdrawal by Subject|3|||
105655380|NCT01193218|364401864|FG003|12-52 Weeks|Withdrawal by Subject|0|||
105655381|NCT01193218|364401865|FG004|12-52 Weeks|Withdrawal by Subject|0|||
105655382|NCT01193218|364401866|FG005|12-52 Weeks|Withdrawal by Subject|2|||
105655383|NCT01193218|364401867|FG006|12-52 Weeks|Withdrawal by Subject|1|||
105655384|NCT01193218|364401868|FG007|12-52 Weeks|Withdrawal by Subject|2|||
105655385|NCT01193218|364401861|FG000|12-52 Weeks|Other reason than above|1|||
105655386|NCT01193218|364401862|FG001|12-52 Weeks|Other reason than above|0|||
105655387|NCT01193218|364401863|FG002|12-52 Weeks|Other reason than above|0|||
105655388|NCT01193218|364401864|FG003|12-52 Weeks|Other reason than above|1|||
105655389|NCT01193218|364401865|FG004|12-52 Weeks|Other reason than above|1|||
105655390|NCT01193218|364401866|FG005|12-52 Weeks|Other reason than above|0|||
105655391|NCT01193218|364401867|FG006|12-52 Weeks|Other reason than above|0|||
105655392|NCT01193218|364401868|FG007|12-52 Weeks|Other reason than above|0|||
105655393|NCT01013740|364401869|FG000|Overall Study|Lost to Follow-up|3|||
105655394|NCT01013740|364401870|FG001|Overall Study|Lost to Follow-up|5|||
105655395|NCT01013740|364401869|FG000|Overall Study|Physician Decision|2|||
105655396|NCT01013740|364401870|FG001|Overall Study|Physician Decision|0|||
105655397|NCT01013740|364401869|FG000|Overall Study|Withdrawal by Subject|2|||
105655398|NCT01013740|364401870|FG001|Overall Study|Withdrawal by Subject|10|||
105655399|NCT01013740|364401869|FG000|Overall Study|study close / terminated : done in error|2|||
105655400|NCT01013740|364401870|FG001|Overall Study|study close / terminated : done in error|1|||
105655401|NCT01013740|364401869|FG000|Overall Study|Missing|2|||
105655402|NCT01013740|364401870|FG001|Overall Study|Missing|1|||
105655403|NCT01013740|364401869|FG000|Overall Study|Ongoing: Study records not completed|0|||
105655404|NCT01013740|364401870|FG001|Overall Study|Ongoing: Study records not completed|2|||
105655405|NCT00607997|364401871|FG000|Overall Study|Lack of Efficacy|6|||
105655406|NCT00607997|364401872|FG001|Overall Study|Lack of Efficacy|20|||
105655407|NCT00607997|364401873|FG002|Overall Study|Lack of Efficacy|14|||
105655408|NCT00607997|364401874|FG003|Overall Study|Lack of Efficacy|10|||
105655409|NCT00607997|364401871|FG000|Overall Study|Death|8|||
105655410|NCT00607997|364401872|FG001|Overall Study|Death|5|||
105655411|NCT00607997|364401873|FG002|Overall Study|Death|2|||
105655412|NCT00607997|364401874|FG003|Overall Study|Death|5|||
105655413|NCT00607997|364401871|FG000|Overall Study|Adverse Event|3|||
105655414|NCT00607997|364401872|FG001|Overall Study|Adverse Event|1|||
105655415|NCT00607997|364401873|FG002|Overall Study|Adverse Event|2|||
105655416|NCT00607997|364401874|FG003|Overall Study|Adverse Event|0|||
105655417|NCT00607997|364401871|FG000|Overall Study|Physician Decision|4|||
105655418|NCT00607997|364401872|FG001|Overall Study|Physician Decision|1|||
105655419|NCT00607997|364401873|FG002|Overall Study|Physician Decision|0|||
105655420|NCT00607997|364401874|FG003|Overall Study|Physician Decision|0|||
105655421|NCT00607997|364401871|FG000|Overall Study|Relapse, recurrent illness|4|||
105655422|NCT00607997|364401872|FG001|Overall Study|Relapse, recurrent illness|0|||
105655423|NCT00607997|364401873|FG002|Overall Study|Relapse, recurrent illness|2|||
105655424|NCT00607997|364401874|FG003|Overall Study|Relapse, recurrent illness|0|||
105655425|NCT00607997|364401871|FG000|Overall Study|Other without explanation|2|||
105655426|NCT00607997|364401872|FG001|Overall Study|Other without explanation|0|||
105655427|NCT00607997|364401873|FG002|Overall Study|Other without explanation|4|||
105655428|NCT00607997|364401874|FG003|Overall Study|Other without explanation|1|||
105655429|NCT01209286|364401876|FG000|Overall Study|Adverse Event|4|||
105655430|NCT01209286|364401877|FG001|Overall Study|Adverse Event|3|||
105655431|NCT01209286|364401878|FG002|Overall Study|Adverse Event|1|||
105655432|NCT01209286|364401876|FG000|Overall Study|Hematological Relapse After Remission|0|||
105655433|NCT01209286|364401877|FG001|Overall Study|Hematological Relapse After Remission|1|||
105655434|NCT01209286|364401878|FG002|Overall Study|Hematological Relapse After Remission|1|||
105655435|NCT01209286|364401876|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
105655436|NCT01209286|364401877|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
105655437|NCT01209286|364401878|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
105655438|NCT01209286|364401876|FG000|Overall Study|Physician Decision|0|||
105655439|NCT01209286|364401877|FG001|Overall Study|Physician Decision|2|||
105655440|NCT01209286|364401878|FG002|Overall Study|Physician Decision|0|||
105655441|NCT01209286|364401876|FG000|Overall Study|Other|0|||
105655442|NCT01209286|364401877|FG001|Overall Study|Other|1|||
105655443|NCT01209286|364401878|FG002|Overall Study|Other|0|||
105655444|NCT03796208|364401879|FG000|Overall Study|Withdrawal by Subject|3|||
105655445|NCT03796208|364401880|FG001|Overall Study|Withdrawal by Subject|0|||
105655446|NCT03796208|364401879|FG000|Overall Study|Loss of pregnancy|1|||
105655447|NCT03796208|364401880|FG001|Overall Study|Loss of pregnancy|1|||
105655448|NCT03796208|364401879|FG000|Overall Study|Changed prenatal clinics|0|||
105655449|NCT03796208|364401880|FG001|Overall Study|Changed prenatal clinics|5|||
105655450|NCT03796208|364401879|FG000|Overall Study|Lost to Follow-up|20|||
105655451|NCT03796208|364401880|FG001|Overall Study|Lost to Follow-up|16|||
105655452|NCT02881047|364401883|FG000|Overall Study|Adverse Event|1|||
105655453|NCT02881047|364401883|FG000|Overall Study|Withdrawal by Subject|1|||
105655454|NCT01424189|364401889|FG000|Overall Study|Adverse Event|1|||
105655455|NCT01424189|364401890|FG001|Overall Study|Adverse Event|0|||
105655456|NCT01424189|364401889|FG000|Overall Study|Lost to Follow-up|4|||
105655457|NCT01424189|364401890|FG001|Overall Study|Lost to Follow-up|1|||
105655458|NCT01424189|364401889|FG000|Overall Study|Withdrawal by Subject|4|||
105655459|NCT01424189|364401890|FG001|Overall Study|Withdrawal by Subject|4|||
105655460|NCT01424189|364401889|FG000|Overall Study|Subject moved|1|||
105655461|NCT01424189|364401890|FG001|Overall Study|Subject moved|0|||
105655462|NCT01424189|364401889|FG000|Overall Study|Death|3|||
105655463|NCT01424189|364401890|FG001|Overall Study|Death|1|||
105655464|NCT01705145|364401891|FG000|Part B|Adverse Event|1|||
105655465|NCT01024036|364401900|FG000|Blinded Treatment|Adverse Event|1|||
105655466|NCT01024036|364401901|FG001|Blinded Treatment|Adverse Event|1|||
105655467|NCT01024036|364401900|FG000|Blinded Treatment|Lack of Efficacy|16|||
105655468|NCT01024036|364401901|FG001|Blinded Treatment|Lack of Efficacy|14|||
105655469|NCT01024036|364401900|FG000|Blinded Treatment|Physician Decision|1|||
105655470|NCT01024036|364401901|FG001|Blinded Treatment|Physician Decision|0|||
105655471|NCT01024036|364401900|FG000|Blinded Treatment|Death|0|||
105655472|NCT01024036|364401901|FG001|Blinded Treatment|Death|2|||
105655473|NCT01024036|364401900|FG000|Blinded Treatment|Withdrawal by Subject|4|||
105655474|NCT01024036|364401901|FG001|Blinded Treatment|Withdrawal by Subject|3|||
105655475|NCT01024036|364401900|FG000|Unblinded Treatment|Adverse Event|0|||
105655476|NCT01024036|364401901|FG001|Unblinded Treatment|Adverse Event|1|||
105655477|NCT01024036|364401900|FG000|Unblinded Treatment|Lack of Efficacy|0|||
105655478|NCT01024036|364401901|FG001|Unblinded Treatment|Lack of Efficacy|2|||
105655479|NCT01024036|364401900|FG000|Follow-Up Period|Lost to Follow-up|1|||
105655480|NCT01024036|364401901|FG001|Follow-Up Period|Lost to Follow-up|1|||
105655481|NCT01024036|364401900|FG000|Follow-Up Period|Withdrawal by Subject|0|||
105655482|NCT01024036|364401901|FG001|Follow-Up Period|Withdrawal by Subject|1|||
105655483|NCT01024036|364401900|FG000|Follow-Up Period|Adverse Event|4|||
105655484|NCT01024036|364401901|FG001|Follow-Up Period|Adverse Event|1|||
105655485|NCT00361842|364401902|FG000|Overall Study|Withdrawal by Subject|2|||
105655486|NCT00361842|364401903|FG001|Overall Study|Withdrawal by Subject|3|||
105655487|NCT00361842|364401902|FG000|Overall Study|Death|2|||
105655488|NCT00361842|364401903|FG001|Overall Study|Death|1|||
105655489|NCT00361842|364401902|FG000|Overall Study|Disease progression|19|||
105655490|NCT00361842|364401903|FG001|Overall Study|Disease progression|20|||
105655491|NCT00361842|364401902|FG000|Overall Study|Adverse Event|2|||
105655492|NCT00361842|364401903|FG001|Overall Study|Adverse Event|3|||
105655493|NCT00361842|364401902|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
105655494|NCT00361842|364401903|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
105655495|NCT00361842|364401902|FG000|Overall Study|Other|1|||
105655496|NCT00361842|364401903|FG001|Overall Study|Other|0|||
105870410|NCT01499095|365179053|FG000|Overall Study|Diverse Reasons|22|||
105870411|NCT01499095|365179054|FG001|Overall Study|Diverse Reasons|25|||
105870412|NCT01499095|365179053|FG000|Overall Study|Lost to Follow-up|6|||
105870413|NCT01499095|365179054|FG001|Overall Study|Lost to Follow-up|4|||
105870414|NCT01499095|365179053|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
105870415|NCT01499095|365179054|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
105870416|NCT01499095|365179053|FG000|Overall Study|Hypoglycemia|3|||
105870417|NCT01499095|365179054|FG001|Overall Study|Hypoglycemia|1|||
105870418|NCT01499095|365179053|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
105870419|NCT01499095|365179054|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
105870420|NCT01499095|365179053|FG000|Overall Study|Change in Injection Schedule|2|||
105870421|NCT01499095|365179054|FG001|Overall Study|Change in Injection Schedule|0|||
105870422|NCT01499095|365179053|FG000|Overall Study|Perceived Lack of Efficacy|1|||
105870423|NCT01499095|365179054|FG001|Overall Study|Perceived Lack of Efficacy|1|||
105870424|NCT04358081|365179056|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
105870425|NCT04358081|365179057|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
105870426|NCT04358081|365179058|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
105870427|NCT04358081|365179056|FG000|Treatment Phase of Study|Adverse Event|1|||
105870428|NCT04358081|365179057|FG001|Treatment Phase of Study|Adverse Event|0|||
105870429|NCT04358081|365179058|FG002|Treatment Phase of Study|Adverse Event|1|||
105870430|NCT04358081|365179056|FG000|Treatment Phase of Study|Physician Decision|2|||
105870431|NCT04358081|365179057|FG001|Treatment Phase of Study|Physician Decision|0|||
105870432|NCT04358081|365179058|FG002|Treatment Phase of Study|Physician Decision|1|||
105870433|NCT04358081|365179056|FG000|Treatment Phase of Study|Protocol Violation|1|||
105870434|NCT04358081|365179057|FG001|Treatment Phase of Study|Protocol Violation|0|||
105870435|NCT04358081|365179058|FG002|Treatment Phase of Study|Protocol Violation|0|||
105870436|NCT04358081|365179056|FG000|Study Completion Phase|Death|0|||
105870437|NCT04358081|365179057|FG001|Study Completion Phase|Death|0|||
105870438|NCT04358081|365179058|FG002|Study Completion Phase|Death|1|||
105870439|NCT04358081|365179056|FG000|Study Completion Phase|Lost to Follow-up|1|||
105870440|NCT04358081|365179057|FG001|Study Completion Phase|Lost to Follow-up|0|||
105870441|NCT04358081|365179058|FG002|Study Completion Phase|Lost to Follow-up|1|||
105870442|NCT03657797|365179061|FG000|Overall Study|Lost to Follow-up|0|||
105870443|NCT03657797|365179062|FG001|Overall Study|Lost to Follow-up|1|||
105870444|NCT03657797|365179063|FG002|Overall Study|Lost to Follow-up|1|||
105870445|NCT03657797|365179064|FG003|Overall Study|Lost to Follow-up|0|||
105870446|NCT03657797|365179061|FG000|Overall Study|Physician Decision|0|||
105870447|NCT03657797|365179062|FG001|Overall Study|Physician Decision|1|||
105870448|NCT03657797|365179063|FG002|Overall Study|Physician Decision|0|||
105870449|NCT03657797|365179064|FG003|Overall Study|Physician Decision|0|||
105870450|NCT03657797|365179061|FG000|Overall Study|Withdrawal by Subject|0|||
105870451|NCT03657797|365179062|FG001|Overall Study|Withdrawal by Subject|1|||
105870452|NCT03657797|365179063|FG002|Overall Study|Withdrawal by Subject|2|||
105870453|NCT03657797|365179064|FG003|Overall Study|Withdrawal by Subject|0|||
105870454|NCT03657797|365179061|FG000|Overall Study|Adverse Event|0|||
105870455|NCT03657797|365179062|FG001|Overall Study|Adverse Event|0|||
105870456|NCT03657797|365179063|FG002|Overall Study|Adverse Event|2|||
105870457|NCT03657797|365179064|FG003|Overall Study|Adverse Event|0|||
105655497|NCT00361842|364401902|FG000|Overall Study|Other|0|||
105655498|NCT00361842|364401903|FG001|Overall Study|Other|2|||
105655499|NCT04814992|364401908|FG000|Overall Study|Withdrawal by Subject|6|||
105870458|NCT00725283|365179067|FG000|Overall Study|Missing Code|3|||
105870459|NCT00725283|365179067|FG000|Overall Study|Death|5|||
105655500|NCT04814992|364401909|FG001|Overall Study|Withdrawal by Subject|3|||
105655501|NCT04814992|364401908|FG000|Overall Study|Lost to Follow-up|1|||
105655502|NCT04814992|364401909|FG001|Overall Study|Lost to Follow-up|4|||
105655503|NCT02212197|364401910|FG000|Overall Study|Need for radiotherapy|1|||
105655504|NCT02212197|364401911|FG001|Overall Study|Need for radiotherapy|0|||
105655505|NCT02212197|364401912|FG002|Overall Study|Need for radiotherapy|0|||
105655506|NCT01260142|364401913|FG000|Treatment Period 1|Study on hold|1|||
105655507|NCT01260142|364401914|FG001|Treatment Period 1|Study on hold|1|||
105655508|NCT01260142|364401915|FG002|Treatment Period 1|Study on hold|0|||
105655509|NCT01260142|364401916|FG003|Treatment Period 1|Study on hold|0|||
105655510|NCT01260142|364401917|FG004|Treatment Period 1|Study on hold|1|||
105655511|NCT01260142|364401918|FG005|Treatment Period 1|Study on hold|2|||
105655512|NCT01260142|364401913|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655513|NCT01260142|364401914|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655514|NCT01260142|364401915|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655515|NCT01260142|364401916|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655516|NCT01260142|364401917|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
105655517|NCT01260142|364401918|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
105655518|NCT01260142|364401913|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105655519|NCT01260142|364401914|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105655520|NCT01260142|364401915|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105655521|NCT01260142|364401916|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105655522|NCT01260142|364401917|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105655523|NCT01260142|364401918|FG005|Treatment Period 1|Withdrawal by Subject|1|||
105655524|NCT01494298|364401919|FG000|Overall Study|Protocol Violation|2|||
105655525|NCT01494298|364401920|FG001|Overall Study|Protocol Violation|8|||
105655526|NCT01393613|364401921|FG000|Overall Study|Adverse Event|11|||
105655527|NCT01393613|364401922|FG001|Overall Study|Adverse Event|11|||
105655528|NCT01393613|364401923|FG002|Overall Study|Adverse Event|13|||
105655529|NCT01393613|364401924|FG003|Overall Study|Adverse Event|22|||
105655530|NCT01393613|364401921|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
105655531|NCT01393613|364401922|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
105655532|NCT01393613|364401923|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
105655533|NCT01393613|364401924|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
105655534|NCT01393613|364401921|FG000|Overall Study|Physician Decision|2|||
105655535|NCT01393613|364401922|FG001|Overall Study|Physician Decision|0|||
105655536|NCT01393613|364401923|FG002|Overall Study|Physician Decision|0|||
105655537|NCT01393613|364401924|FG003|Overall Study|Physician Decision|1|||
105655538|NCT01393613|364401921|FG000|Overall Study|Withdrawal by Subject|15|||
105655539|NCT01393613|364401922|FG001|Overall Study|Withdrawal by Subject|25|||
105655540|NCT01393613|364401923|FG002|Overall Study|Withdrawal by Subject|23|||
105655541|NCT01393613|364401924|FG003|Overall Study|Withdrawal by Subject|21|||
105655542|NCT01393613|364401921|FG000|Overall Study|Protocol Deviation|2|||
105655543|NCT01393613|364401922|FG001|Overall Study|Protocol Deviation|1|||
105655544|NCT01393613|364401923|FG002|Overall Study|Protocol Deviation|0|||
105655545|NCT01393613|364401924|FG003|Overall Study|Protocol Deviation|0|||
105655546|NCT01393613|364401921|FG000|Overall Study|Lack of Efficacy|9|||
105655547|NCT01393613|364401922|FG001|Overall Study|Lack of Efficacy|20|||
105655548|NCT01393613|364401923|FG002|Overall Study|Lack of Efficacy|16|||
105655549|NCT01393613|364401924|FG003|Overall Study|Lack of Efficacy|21|||
105655550|NCT03821064|364401927|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
105655551|NCT01283971|364401928|FG000|Overall Study|Adverse Event|3|||
105655552|NCT01283971|364401929|FG001|Overall Study|Adverse Event|5|||
105655553|NCT01283971|364401928|FG000|Overall Study|Insufficient therapeutic responses|3|||
105655554|NCT01283971|364401929|FG001|Overall Study|Insufficient therapeutic responses|3|||
105655555|NCT01283971|364401928|FG000|Overall Study|Protocol Violation|5|||
105655556|NCT01283971|364401929|FG001|Overall Study|Protocol Violation|1|||
105655557|NCT01283971|364401928|FG000|Overall Study|Refused treatment|3|||
105655558|NCT01283971|364401929|FG001|Overall Study|Refused treatment|1|||
105655559|NCT01283971|364401928|FG000|Overall Study|Failure to return|0|||
105655560|NCT01283971|364401929|FG001|Overall Study|Failure to return|1|||
105655561|NCT01283971|364401928|FG000|Overall Study|Administrative reasons|1|||
105655562|NCT01283971|364401929|FG001|Overall Study|Administrative reasons|1|||
105655563|NCT01502371|364401930|FG000|Overall Study|Withdrawal by Subject|1|||
105655564|NCT01502371|364401931|FG001|Overall Study|Withdrawal by Subject|2|||
105655565|NCT01502371|364401932|FG002|Overall Study|Withdrawal by Subject|1|||
105655566|NCT01502371|364401933|FG003|Overall Study|Withdrawal by Subject|1|||
105655567|NCT01502371|364401934|FG004|Overall Study|Withdrawal by Subject|1|||
105655568|NCT01502371|364401930|FG000|Overall Study|Adverse Event|2|||
105655569|NCT01502371|364401931|FG001|Overall Study|Adverse Event|1|||
105655570|NCT01502371|364401932|FG002|Overall Study|Adverse Event|0|||
105655571|NCT01502371|364401933|FG003|Overall Study|Adverse Event|4|||
105655572|NCT01502371|364401934|FG004|Overall Study|Adverse Event|3|||
105655573|NCT01502371|364401930|FG000|Overall Study|Treatment Failure|22|||
105655574|NCT01502371|364401931|FG001|Overall Study|Treatment Failure|20|||
105655575|NCT01502371|364401932|FG002|Overall Study|Treatment Failure|12|||
105655576|NCT01502371|364401933|FG003|Overall Study|Treatment Failure|19|||
105655577|NCT01502371|364401934|FG004|Overall Study|Treatment Failure|30|||
105655578|NCT01502371|364401930|FG000|Overall Study|Lack of Efficacy|3|||
105655579|NCT01502371|364401931|FG001|Overall Study|Lack of Efficacy|3|||
105655580|NCT01502371|364401932|FG002|Overall Study|Lack of Efficacy|2|||
105655581|NCT01502371|364401933|FG003|Overall Study|Lack of Efficacy|2|||
105655582|NCT01502371|364401934|FG004|Overall Study|Lack of Efficacy|4|||
105655583|NCT01502371|364401930|FG000|Overall Study|Physician Decision|3|||
105655584|NCT01502371|364401931|FG001|Overall Study|Physician Decision|0|||
105655585|NCT01502371|364401932|FG002|Overall Study|Physician Decision|0|||
105655586|NCT01502371|364401933|FG003|Overall Study|Physician Decision|0|||
105655587|NCT01502371|364401934|FG004|Overall Study|Physician Decision|1|||
105655588|NCT01502371|364401930|FG000|Overall Study|Noncompliance with Study Drug|0|||
105655589|NCT01502371|364401931|FG001|Overall Study|Noncompliance with Study Drug|0|||
105655590|NCT01502371|364401932|FG002|Overall Study|Noncompliance with Study Drug|1|||
105655591|NCT01502371|364401933|FG003|Overall Study|Noncompliance with Study Drug|2|||
105655592|NCT01502371|364401934|FG004|Overall Study|Noncompliance with Study Drug|1|||
105655593|NCT01502371|364401930|FG000|Overall Study|Technical Problems|1|||
105655594|NCT01502371|364401931|FG001|Overall Study|Technical Problems|0|||
105655595|NCT01502371|364401932|FG002|Overall Study|Technical Problems|2|||
105655596|NCT01502371|364401933|FG003|Overall Study|Technical Problems|4|||
105655597|NCT01502371|364401934|FG004|Overall Study|Technical Problems|1|||
105655598|NCT01502371|364401930|FG000|Overall Study|Protocol Violation|9|||
105655599|NCT01502371|364401931|FG001|Overall Study|Protocol Violation|5|||
105655600|NCT01502371|364401932|FG002|Overall Study|Protocol Violation|6|||
105655601|NCT01502371|364401933|FG003|Overall Study|Protocol Violation|5|||
105655602|NCT01502371|364401934|FG004|Overall Study|Protocol Violation|10|||
105655603|NCT01502371|364401930|FG000|Overall Study|Excluded Medication|0|||
105655604|NCT01502371|364401931|FG001|Overall Study|Excluded Medication|1|||
105655605|NCT01502371|364401932|FG002|Overall Study|Excluded Medication|1|||
105655606|NCT01502371|364401933|FG003|Overall Study|Excluded Medication|0|||
105655607|NCT01502371|364401934|FG004|Overall Study|Excluded Medication|1|||
105655608|NCT01929876|364403496|FG000|Period 2|Non-Compliance|1|||
105655609|NCT01036165|364403499|FG000|Overall Study|Adverse Event|6|||
105655610|NCT01036165|364403499|FG000|Overall Study|Lost to Follow-up|2|||
105655611|NCT01036165|364403499|FG000|Overall Study|Withdrawal by Subject|3|||
105655612|NCT01036165|364403499|FG000|Overall Study|Device Related Issues|3|||
105655613|NCT01036165|364403499|FG000|Overall Study|Problems finding proper area to inject|1|||
105655614|NCT01167192|364403501|FG000|Overall Study|Adverse Event|1|||
105655615|NCT01167192|364403501|FG000|Overall Study|Death|1|||
105655616|NCT01167192|364403501|FG000|Overall Study|Withdrawal by Subject|1|||
105655617|NCT01167192|364403501|FG000|Overall Study|Insurance denial|1|||
105655618|NCT02246218|364403502|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
105655619|NCT02246218|364403503|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
105655620|NCT02246218|364403502|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
105655621|NCT02246218|364403503|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
105655622|NCT02246218|364403502|FG000|Overall Study|Adverse Event|1|||
105655623|NCT02246218|364403503|FG001|Overall Study|Adverse Event|1|||
105655624|NCT02246218|364403502|FG000|Overall Study|Lost to Follow-up|1|||
105655625|NCT02246218|364403503|FG001|Overall Study|Lost to Follow-up|0|||
105655626|NCT03927222|364403504|FG000|Overall Study|Progression|3|||
105655627|NCT03927222|364403504|FG000|Overall Study|CMV testing results inconclusive|1|||
105655628|NCT03927222|364403504|FG000|Overall Study|Unable to generate enough vaccines|1|||
105655629|NCT03927222|364403504|FG000|Overall Study|Early study termination|1|||
105655630|NCT00866918|364403508|FG000|Overall Study|Death|1|||
105655631|NCT00866918|364403509|FG001|Overall Study|Death|5|||
105655632|NCT00866918|364403508|FG000|Overall Study|Lack of Efficacy|1|||
105655633|NCT00866918|364403509|FG001|Overall Study|Lack of Efficacy|1|||
105655634|NCT00866918|364403508|FG000|Overall Study|Physician Decision|10|||
105655635|NCT00866918|364403509|FG001|Overall Study|Physician Decision|2|||
105655636|NCT00866918|364403508|FG000|Overall Study|Ineligible|2|||
105655637|NCT00866918|364403509|FG001|Overall Study|Ineligible|4|||
105655638|NCT00866918|364403508|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
105655639|NCT00866918|364403509|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
105655640|NCT00866918|364403508|FG000|Overall Study|Secondary malignancy|1|||
105655641|NCT00866918|364403509|FG001|Overall Study|Secondary malignancy|0|||
105655642|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
105655643|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
105655644|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
105655645|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
105655646|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
105655647|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Death|1|||
105655648|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Death|0|||
105655649|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Death|0|||
105655650|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Death|0|||
105655651|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Death|0|||
105655652|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
105655653|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
105655654|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
105655655|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
105655656|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
105655657|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
105655658|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
105655659|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
105655660|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
105655661|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
105655662|NCT03974100|364403512|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
105655663|NCT03974100|364403513|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
105655664|NCT03974100|364403514|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
105655665|NCT03974100|364403515|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
105655666|NCT03974100|364403516|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
105655667|NCT03974100|364403512|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
105655668|NCT03974100|364403513|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
105655669|NCT03974100|364403514|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
105655670|NCT03974100|364403515|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
105655671|NCT03974100|364403516|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
105655672|NCT03974100|364403512|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
105655673|NCT03974100|364403513|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
105655674|NCT03974100|364403514|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
105655675|NCT03974100|364403515|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
105655676|NCT03974100|364403516|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
105655677|NCT00001941|364403517|FG000|Overall Study|not treated- rapidly progressing disease|0|||
105655678|NCT00001941|364403518|FG001|Overall Study|not treated- rapidly progressing disease|0|||
105655679|NCT00001941|364403519|FG002|Overall Study|not treated- rapidly progressing disease|0|||
105655680|NCT00001941|364403520|FG003|Overall Study|not treated- rapidly progressing disease|0|||
105655681|NCT00001941|364403521|FG004|Overall Study|not treated- rapidly progressing disease|1|||
105655682|NCT02287883|364403525|FG000|Overall Study|Death|8|||
105655683|NCT02287883|364403526|FG001|Overall Study|Death|7|||
105655684|NCT02287883|364403525|FG000|Overall Study|No longer eligible|222|||
105655685|NCT02287883|364403526|FG001|Overall Study|No longer eligible|182|||
105655686|NCT02287883|364403525|FG000|Overall Study|Non-response to survey|229|||
105655687|NCT02287883|364403526|FG001|Overall Study|Non-response to survey|237|||
105655688|NCT03410108|364403527|FG000|Overall Study|Ongoing|41|||
105655689|NCT03410108|364403527|FG000|Overall Study|Adverse Event|4|||
105655690|NCT03410108|364403527|FG000|Overall Study|Progressive Disease|58|||
105655691|NCT03410108|364403527|FG000|Overall Study|Withdrawal by Subject|1|||
105655692|NCT00802438|364403532|FG000|Overall Study|Screen Failure|20|||
105655693|NCT00802438|364403532|FG000|Overall Study|Withdrawal by Subject|7|||
105655694|NCT00802438|364403532|FG000|Overall Study|Physician Decision|1|||
105655695|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
105655696|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105655697|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105655698|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105655699|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
105655700|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
105655701|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105655702|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105655703|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105655704|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
105655705|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
105655706|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105655707|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105655708|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105655709|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
105655710|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
105655711|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105655712|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105655713|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105655714|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
105655715|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
105655716|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105655717|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105655718|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105655719|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
105655720|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
105655721|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105655722|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105655723|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105655724|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
105655725|NCT01187407|364403533|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
105655726|NCT01187407|364403534|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105659503|NCT02635386|364417348|FG001|Overall Study|Noncompliant|2|||
105655727|NCT01187407|364403535|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105655728|NCT01187407|364403536|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105655729|NCT01187407|364403537|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
105655730|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
105655731|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
105655732|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
105655733|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
105655734|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
105655735|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
105655736|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
105655737|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
105655738|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
105655739|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
105655740|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
105655741|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
105655742|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
105655743|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
105655744|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
105655745|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105655746|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105655747|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
105655748|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
105655749|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
105655750|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
105655751|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
105655752|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
105655753|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
105655754|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
105655755|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
105655756|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
105655757|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
105655758|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
105655759|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
105655760|NCT01187407|364403533|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
105655761|NCT01187407|364403534|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
105655762|NCT01187407|364403535|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
105655763|NCT01187407|364403536|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
105655764|NCT01187407|364403537|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
105655765|NCT00819013|364403538|FG000|Overall Study|Not meeting continuing study eligibility|2|||
105655766|NCT00819013|364403539|FG001|Overall Study|Not meeting continuing study eligibility|1|||
105655767|NCT00819013|364403540|FG002|Overall Study|Not meeting continuing study eligibility|2|||
105655768|NCT00819013|364403541|FG003|Overall Study|Not meeting continuing study eligibility|1|||
105655769|NCT00819013|364403538|FG000|Overall Study|Adverse Event|0|||
105655770|NCT00819013|364403539|FG001|Overall Study|Adverse Event|0|||
105655771|NCT00819013|364403540|FG002|Overall Study|Adverse Event|1|||
105655772|NCT00819013|364403541|FG003|Overall Study|Adverse Event|0|||
105655773|NCT00819013|364403538|FG000|Overall Study|Withdrawal by Subject|1|||
105655774|NCT00819013|364403539|FG001|Overall Study|Withdrawal by Subject|0|||
105655775|NCT00819013|364403540|FG002|Overall Study|Withdrawal by Subject|1|||
105655776|NCT00819013|364403541|FG003|Overall Study|Withdrawal by Subject|0|||
105655777|NCT00819013|364403538|FG000|Overall Study|Lost to Follow-up|0|||
105655778|NCT00819013|364403539|FG001|Overall Study|Lost to Follow-up|0|||
105655779|NCT00819013|364403540|FG002|Overall Study|Lost to Follow-up|1|||
105655780|NCT00819013|364403541|FG003|Overall Study|Lost to Follow-up|2|||
105655781|NCT00819013|364403538|FG000|Overall Study|Death|0|||
105655782|NCT00819013|364403539|FG001|Overall Study|Death|0|||
105655783|NCT00819013|364403540|FG002|Overall Study|Death|0|||
105655784|NCT00819013|364403541|FG003|Overall Study|Death|1|||
105655785|NCT00363649|364403544|FG000|Overall Study|Withdrawal by Subject|1|||
105655786|NCT00363649|364403545|FG001|Overall Study|Withdrawal by Subject|1|||
105655787|NCT00363649|364403544|FG000|Overall Study|Adverse Event|6|||
105655788|NCT00363649|364403545|FG001|Overall Study|Adverse Event|0|||
105655789|NCT00338949|364403546|FG000|Subject Screening|Screen failures|11|||
105655790|NCT00338949|364403547|FG001|Subject Screening|Screen failures|11|||
105655791|NCT00338949|364403546|FG000|Randomization|Withdrawal by Subject|1|||
105655792|NCT00338949|364403547|FG001|Randomization|Withdrawal by Subject|0|||
105655793|NCT00338949|364403546|FG000|Randomization|Adverse Event|0|||
105655794|NCT00338949|364403547|FG001|Randomization|Adverse Event|5|||
105870460|NCT00725283|365179067|FG000|Overall Study|Other|6|||
105655795|NCT03188536|364403548|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
105655796|NCT03188536|364403548|FG000|Overall Study|Not participated/met inclusion criteria|1|||
105655797|NCT01930214|364403550|FG000|Overall Study|Death|4|||
105655798|NCT01930214|364403551|FG001|Overall Study|Death|4|||
105655799|NCT01930214|364403552|FG002|Overall Study|Death|11|||
105655800|NCT01930214|364403550|FG000|Overall Study|Lost to Follow-up|12|||
105655801|NCT01930214|364403551|FG001|Overall Study|Lost to Follow-up|13|||
105655802|NCT01930214|364403552|FG002|Overall Study|Lost to Follow-up|12|||
105655803|NCT01930214|364403550|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
105655804|NCT01930214|364403551|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
105655805|NCT01930214|364403552|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
105655806|NCT01930214|364403550|FG000|Overall Study|Physician Decision|2|||
105655807|NCT01930214|364403551|FG001|Overall Study|Physician Decision|0|||
105655808|NCT01930214|364403552|FG002|Overall Study|Physician Decision|0|||
105655809|NCT00025662|364403553|FG000|Overall Study|Withdrawal by Subject|2|||
105655810|NCT00025662|364403553|FG000|Overall Study|Technical failure of manipulation|1|||
105655811|NCT02604342|364403556|FG000|Overall Study|Death|32|||
105655812|NCT02604342|364403557|FG001|Overall Study|Death|16|||
105655813|NCT02604342|364403556|FG000|Overall Study|Progression of disease|1|||
105655814|NCT02604342|364403557|FG001|Overall Study|Progression of disease|0|||
105655815|NCT02604342|364403556|FG000|Overall Study|Withdrawal by Subject|5|||
105655816|NCT02604342|364403557|FG001|Overall Study|Withdrawal by Subject|6|||
105655817|NCT02604342|364403556|FG000|Overall Study|Other|1|||
105655818|NCT02604342|364403557|FG001|Overall Study|Other|0|||
105655819|NCT02604342|364403556|FG000|Overall Study|Study Termination by Sponsor|1|||
105655820|NCT02604342|364403557|FG001|Overall Study|Study Termination by Sponsor|0|||
105655821|NCT02604342|364403556|FG000|Overall Study|Lost to Follow-up|1|||
105655822|NCT02604342|364403557|FG001|Overall Study|Lost to Follow-up|1|||
105655823|NCT02604342|364403556|FG000|Overall Study|Physician Decision|2|||
105655824|NCT02604342|364403557|FG001|Overall Study|Physician Decision|0|||
105655825|NCT00130728|364403558|FG000|Overall Study|Death|258|||
105655826|NCT00130728|364403559|FG001|Overall Study|Death|258|||
105655827|NCT00130728|364403558|FG000|Overall Study|Lost to Follow-up|4|||
105655828|NCT00130728|364403559|FG001|Overall Study|Lost to Follow-up|0|||
105655829|NCT00130728|364403558|FG000|Overall Study|Withdrawal by Subject|0|||
105655830|NCT00130728|364403559|FG001|Overall Study|Withdrawal by Subject|2|||
105655831|NCT02725008|364403561|FG000|Overall Study|Lost to Follow-up|7|||
105655832|NCT02725008|364403562|FG001|Overall Study|Lost to Follow-up|9|||
105655833|NCT02725008|364403561|FG000|Overall Study|Withdrawal by Subject|2|||
105655834|NCT02725008|364403562|FG001|Overall Study|Withdrawal by Subject|2|||
105655835|NCT02725008|364403561|FG000|Overall Study|Admitted to hospital|0|||
105655836|NCT02725008|364403562|FG001|Overall Study|Admitted to hospital|1|||
105655837|NCT01560585|364403563|FG000|Overall Study|Physician Decision|3|||
105655838|NCT00519285|364403564|FG000|Overall Study|Adverse Event|127|||
105655839|NCT00519285|364403565|FG001|Overall Study|Adverse Event|266|||
105655840|NCT00519285|364403564|FG000|Overall Study|Disease progression|334|||
105655841|NCT00519285|364403565|FG001|Overall Study|Disease progression|186|||
105655842|NCT00519285|364403564|FG000|Overall Study|Physician Decision|75|||
105655843|NCT00519285|364403565|FG001|Overall Study|Physician Decision|47|||
105655844|NCT00519285|364403564|FG000|Overall Study|Participant's request|53|||
105655845|NCT00519285|364403565|FG001|Overall Study|Participant's request|84|||
105655846|NCT00519285|364403564|FG000|Overall Study|Consent withdrawn|4|||
105655847|NCT00519285|364403565|FG001|Overall Study|Consent withdrawn|5|||
105655848|NCT00519285|364403564|FG000|Overall Study|Poor compliance to protocol|5|||
105655849|NCT00519285|364403565|FG001|Overall Study|Poor compliance to protocol|7|||
105655850|NCT00519285|364403564|FG000|Overall Study|Reason unspecified|5|||
105655851|NCT00519285|364403565|FG001|Overall Study|Reason unspecified|8|||
105655852|NCT00519285|364403564|FG000|Overall Study|Not treated|8|||
105655853|NCT00519285|364403565|FG001|Overall Study|Not treated|7|||
105655854|NCT00519285|364403564|FG000|Overall Study|Treatment ongoing|1|||
105655855|NCT00519285|364403565|FG001|Overall Study|Treatment ongoing|2|||
105655856|NCT03028012|364403566|FG000|Overall Study|Lost to Follow-up|2|||
105655857|NCT03028012|364403567|FG001|Overall Study|Lost to Follow-up|3|||
105655858|NCT03028012|364403568|FG002|Overall Study|Lost to Follow-up|3|||
105655859|NCT01726517|364403569|FG000|Overall Study|Withdrawal by Subject|0|||
105655860|NCT01726517|364403570|FG001|Overall Study|Withdrawal by Subject|0|||
105655861|NCT01726517|364403571|FG002|Overall Study|Withdrawal by Subject|1|||
105655862|NCT01726517|364403572|FG003|Overall Study|Withdrawal by Subject|0|||
105655863|NCT01726517|364403573|FG004|Overall Study|Withdrawal by Subject|0|||
105655864|NCT03765164|364403575|FG000|Pre-intervention|Withdrawal by Subject|5|||
105655865|NCT03765164|364403576|FG001|Pre-intervention|Withdrawal by Subject|6|||
105655866|NCT01813305|364403577|FG000|Overall Study|Withdrawal by Subject|12|||
105655867|NCT01813305|364403578|FG001|Overall Study|Withdrawal by Subject|5|||
105655868|NCT01813305|364403577|FG000|Overall Study|Safety Concern|4|||
105655869|NCT01813305|364403578|FG001|Overall Study|Safety Concern|0|||
105655870|NCT01813305|364403577|FG000|Overall Study|Ulcer became worse|4|||
105655871|NCT01813305|364403578|FG001|Overall Study|Ulcer became worse|0|||
105655872|NCT01813305|364403577|FG000|Overall Study|Physician Decision|4|||
105655873|NCT01813305|364403578|FG001|Overall Study|Physician Decision|0|||
105655874|NCT01813305|364403577|FG000|Overall Study|Lost to Follow-up|3|||
105655875|NCT01813305|364403578|FG001|Overall Study|Lost to Follow-up|1|||
105655876|NCT01813305|364403577|FG000|Overall Study|Protocol Violation|1|||
105655877|NCT01813305|364403578|FG001|Overall Study|Protocol Violation|0|||
105655878|NCT01813305|364403577|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
105655879|NCT01813305|364403578|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
105655880|NCT01665599|364403582|FG000|Overall Study|Adverse Event|1|||
105655881|NCT01665599|364403582|FG000|Overall Study|Consent Withdrawn|1|||
105655882|NCT01665599|364403582|FG000|Overall Study|Investigator/Sponsor decision|1|||
105655883|NCT01665599|364403582|FG000|Overall Study|Death|1|||
105655884|NCT01665599|364403582|FG000|Overall Study|Lost to Follow-up|2|||
105655885|NCT01665599|364403582|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
105655886|NCT01665599|364403582|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
105655887|NCT01837797|364403587|FG000|Period 1|Adverse Event|9|||
105655888|NCT01837797|364403588|FG001|Period 1|Adverse Event|0|||
105655889|NCT01837797|364403589|FG002|Period 1|Adverse Event|0|||
105655890|NCT01837797|364403590|FG003|Period 1|Adverse Event|0|||
105655891|NCT01837797|364403591|FG004|Period 1|Adverse Event|0|||
105655892|NCT01837797|364403587|FG000|Period 1|Withdrawal by Subject|6|||
105655893|NCT01837797|364403588|FG001|Period 1|Withdrawal by Subject|0|||
105655894|NCT01837797|364403589|FG002|Period 1|Withdrawal by Subject|0|||
105655895|NCT01837797|364403590|FG003|Period 1|Withdrawal by Subject|0|||
105655896|NCT01837797|364403591|FG004|Period 1|Withdrawal by Subject|0|||
105655897|NCT01837797|364403587|FG000|Period 1|Administrative reasons|76|||
105655898|NCT01837797|364403588|FG001|Period 1|Administrative reasons|0|||
105655899|NCT01837797|364403589|FG002|Period 1|Administrative reasons|0|||
105655900|NCT01837797|364403590|FG003|Period 1|Administrative reasons|0|||
105655901|NCT01837797|364403591|FG004|Period 1|Administrative reasons|0|||
105655902|NCT01837797|364403587|FG000|Period 1|Withdrawal of consent before treatment|1|||
105655903|NCT01837797|364403588|FG001|Period 1|Withdrawal of consent before treatment|0|||
105655904|NCT01837797|364403589|FG002|Period 1|Withdrawal of consent before treatment|0|||
105655905|NCT01837797|364403590|FG003|Period 1|Withdrawal of consent before treatment|0|||
105655906|NCT01837797|364403591|FG004|Period 1|Withdrawal of consent before treatment|0|||
105655907|NCT01837797|364403587|FG000|Period 1|Other|10|||
105655908|NCT01837797|364403588|FG001|Period 1|Other|0|||
105655909|NCT01837797|364403589|FG002|Period 1|Other|0|||
105655910|NCT01837797|364403590|FG003|Period 1|Other|0|||
105655911|NCT01837797|364403591|FG004|Period 1|Other|0|||
105655912|NCT01837797|364403587|FG000|Period 2|Administrative or other reasons|0|||
105655913|NCT01837797|364403588|FG001|Period 2|Administrative or other reasons|5|||
105655914|NCT01837797|364403589|FG002|Period 2|Administrative or other reasons|2|||
105655915|NCT01837797|364403590|FG003|Period 2|Administrative or other reasons|4|||
105655916|NCT01837797|364403591|FG004|Period 2|Administrative or other reasons|0|||
105655917|NCT01837797|364403587|FG000|Period 2|Adverse Event|0|||
105655918|NCT01837797|364403588|FG001|Period 2|Adverse Event|0|||
105655919|NCT01837797|364403589|FG002|Period 2|Adverse Event|0|||
105655920|NCT01837797|364403590|FG003|Period 2|Adverse Event|1|||
105655921|NCT01837797|364403591|FG004|Period 2|Adverse Event|0|||
105655922|NCT01837797|364403587|FG000|Period 3|Adverse Event|0|||
105655923|NCT01837797|364403588|FG001|Period 3|Adverse Event|0|||
105655924|NCT01837797|364403589|FG002|Period 3|Adverse Event|0|||
105655925|NCT01837797|364403590|FG003|Period 3|Adverse Event|0|||
105655926|NCT01837797|364403591|FG004|Period 3|Adverse Event|1|||
105655927|NCT01837797|364403587|FG000|Period 3|Administrative reasons|0|||
105655928|NCT01837797|364403588|FG001|Period 3|Administrative reasons|0|||
105655929|NCT01837797|364403589|FG002|Period 3|Administrative reasons|0|||
105655930|NCT01837797|364403590|FG003|Period 3|Administrative reasons|0|||
105655931|NCT01837797|364403591|FG004|Period 3|Administrative reasons|20|||
105655932|NCT01837797|364403587|FG000|Period 3|Other|0|||
105655933|NCT01837797|364403588|FG001|Period 3|Other|0|||
105655934|NCT01837797|364403589|FG002|Period 3|Other|0|||
105655935|NCT01837797|364403590|FG003|Period 3|Other|0|||
105655936|NCT01837797|364403591|FG004|Period 3|Other|2|||
105655937|NCT00988117|364403592|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
105655938|NCT00988117|364403592|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
105655939|NCT01982448|364403593|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
105655940|NCT01982448|364403594|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
105655941|NCT01982448|364403593|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
105655942|NCT01982448|364403594|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
105655943|NCT01982448|364403593|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
105655944|NCT01982448|364403594|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
105655945|NCT01982448|364403593|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
105655946|NCT01982448|364403594|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
105655947|NCT01203956|364403596|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
105655948|NCT01203956|364403597|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
105655949|NCT00853021|364403598|FG000|Overall Study|Adverse Event|2|||
105655950|NCT00853021|364403598|FG000|Overall Study|Withdrawal by Subject|2|||
105655951|NCT00853021|364403598|FG000|Overall Study|Death|1|||
105655952|NCT01329419|364403599|FG000|Overall Study|Protocol Violation|235|||
105655953|NCT04522778|364403600|FG000|Overall Study|Patient did not want to wear the device|1|||
105655954|NCT04522778|364403601|FG001|Overall Study|Patient did not want to wear the device|0|||
105655955|NCT04522778|364403600|FG000|Overall Study|Lost to Follow-up|0|||
105655956|NCT04522778|364403601|FG001|Overall Study|Lost to Follow-up|1|||
105655957|NCT04052997|364403602|FG000|Overall Study|Withdrawal by Subject|17|||
105655958|NCT04052997|364403602|FG000|Overall Study|Physician Decision|50|||
105655959|NCT04052997|364403602|FG000|Overall Study|Death|43|||
105655960|NCT04052997|364403602|FG000|Overall Study|Lost to Follow-up|5|||
105655961|NCT04052997|364403602|FG000|Overall Study|Progression of Disease|1|||
105655962|NCT00069277|364403605|FG000|Overall Study|Adverse Event|3|||
105655963|NCT00069277|364403605|FG000|Overall Study|Withdrawal by Subject|1|||
105655964|NCT00069277|364403605|FG000|Overall Study|Progressive Disease|15|||
105655965|NCT00069277|364403605|FG000|Overall Study|Physician Decision|2|||
105655966|NCT01225159|364403606|FG000|Overall Study|Change operation|1|||
105655967|NCT01225159|364403607|FG001|Overall Study|Change operation|0|||
105655968|NCT02230306|364403608|FG000|Overall Study|Did not receive study treatment|1|||
105655969|NCT01220856|364403609|FG000|Overall Study|graft loss|3|||
105655970|NCT01220856|364403610|FG001|Overall Study|graft loss|3|||
105655971|NCT01220856|364403609|FG000|Overall Study|Lost to Follow-up|1|||
105655972|NCT01220856|364403610|FG001|Overall Study|Lost to Follow-up|0|||
105655973|NCT00691678|364403611|FG000|Overall Study|Adverse Event|5|||
105655974|NCT00691678|364403611|FG000|Overall Study|life events, pain|11|||
105655975|NCT01503164|364403612|FG000|Overall Study|Withdrawal by Subject|2|||
105655976|NCT01503164|364403613|FG001|Overall Study|Withdrawal by Subject|1|||
105655977|NCT00934700|364403616|FG000|Overall Study|missing scan|5|||
105655978|NCT00934700|364403617|FG001|Overall Study|missing scan|9|||
105655979|NCT00934700|364403616|FG000|Overall Study|Death|8|||
105655980|NCT00934700|364403617|FG001|Overall Study|Death|3|||
105655981|NCT01831726|364403618|FG000|Overall Study|Adverse Event|16|||
105655982|NCT01831726|364403618|FG000|Overall Study|Death|7|||
105655983|NCT01831726|364403618|FG000|Overall Study|Disease Progression|49|||
105655984|NCT01831726|364403618|FG000|Overall Study|Physician Decision|1|||
105655985|NCT01831726|364403618|FG000|Overall Study|Subject/guardian decision|7|||
105655986|NCT02998918|364403622|FG000|Overall Study|Withdrawal by Subject|1|||
105655987|NCT02998918|364403623|FG001|Overall Study|Withdrawal by Subject|0|||
105655988|NCT00443599|364403626|FG000|Overall Study|Physician Decision|2|||
105655989|NCT00443599|364403627|FG001|Overall Study|Physician Decision|1|||
105655990|NCT00443599|364403626|FG000|Overall Study|Death|1|||
105655991|NCT00443599|364403627|FG001|Overall Study|Death|1|||
105655992|NCT00443599|364403626|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
105655993|NCT00443599|364403627|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
105655994|NCT02598934|364403630|FG000|Overall Study|Adverse Event|11|||
105655995|NCT02598934|364403631|FG001|Overall Study|Adverse Event|13|||
105655996|NCT02598934|364403630|FG000|Overall Study|Failure to Return|3|||
105655997|NCT02598934|364403631|FG001|Overall Study|Failure to Return|3|||
105655998|NCT02598934|364403630|FG000|Overall Study|Withdrawal by Subject|2|||
105655999|NCT02598934|364403631|FG001|Overall Study|Withdrawal by Subject|3|||
105656000|NCT02598934|364403630|FG000|Overall Study|Administrative|2|||
105656001|NCT02598934|364403631|FG001|Overall Study|Administrative|1|||
105656002|NCT02598934|364403630|FG000|Overall Study|Protocol Violation|1|||
105656003|NCT02598934|364403631|FG001|Overall Study|Protocol Violation|2|||
105656004|NCT03049306|364403632|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
105656005|NCT03049306|364403633|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
105656006|NCT02154347|364403634|FG000|Double-blind Period|Adverse Event|1|||
105656007|NCT02154347|364403635|FG001|Double-blind Period|Adverse Event|2|||
105656008|NCT02154347|364403634|FG000|Double-blind Period|Lack of Efficacy|1|||
105656009|NCT02154347|364403635|FG001|Double-blind Period|Lack of Efficacy|0|||
105656010|NCT02154347|364403634|FG000|Double-blind Period|Physician Decision|0|||
105656011|NCT02154347|364403635|FG001|Double-blind Period|Physician Decision|1|||
105656012|NCT02154347|364403634|FG000|Double-blind Period|Withdrawal by Subject|1|||
105656013|NCT02154347|364403635|FG001|Double-blind Period|Withdrawal by Subject|1|||
105656014|NCT02154347|364403634|FG000|Open-label Period|Adverse Event|3|||
105656015|NCT02154347|364403635|FG001|Open-label Period|Adverse Event|4|||
105870461|NCT00725283|365179067|FG000|Overall Study|Withdrawal by Subject|10|||
105870462|NCT05256134|365179068|FG000|Overall Study|Study Terminated by Sponsor|11|||
105870463|NCT05256134|365179069|FG001|Overall Study|Study Terminated by Sponsor|10|||
105870464|NCT05256134|365179068|FG000|Overall Study|Withdrawal by Subject|1|||
105656016|NCT02154347|364403634|FG000|Open-label Period|Lack of Efficacy|4|||
105656017|NCT02154347|364403635|FG001|Open-label Period|Lack of Efficacy|19|||
105656018|NCT02154347|364403634|FG000|Open-label Period|Protocol Violation|0|||
105656019|NCT02154347|364403635|FG001|Open-label Period|Protocol Violation|1|||
105870465|NCT05256134|365179069|FG001|Overall Study|Withdrawal by Subject|3|||
105656020|NCT02154347|364403634|FG000|Open-label Period|Withdrawal by Subject|0|||
105656021|NCT02154347|364403635|FG001|Open-label Period|Withdrawal by Subject|1|||
105656022|NCT04811339|364403636|FG000|Overall Study|lack of transportation not wanting to return|4|||
105656023|NCT04811339|364403637|FG001|Overall Study|lack of transportation not wanting to return|8|||
105656024|NCT04811339|364403638|FG002|Overall Study|lack of transportation not wanting to return|0|||
105656025|NCT04811339|364403636|FG000|Overall Study|Adverse Event|3|||
105656026|NCT04811339|364403637|FG001|Overall Study|Adverse Event|0|||
105656027|NCT04811339|364403638|FG002|Overall Study|Adverse Event|0|||
105656028|NCT04811339|364403636|FG000|Overall Study|Lost to Follow-up|1|||
105656029|NCT04811339|364403637|FG001|Overall Study|Lost to Follow-up|0|||
105656030|NCT04811339|364403638|FG002|Overall Study|Lost to Follow-up|0|||
105656031|NCT04811339|364403636|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
105656032|NCT04811339|364403637|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
105656033|NCT04811339|364403638|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
105656034|NCT04811339|364403636|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
105656035|NCT04811339|364403637|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
105656036|NCT04811339|364403638|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
105656037|NCT04811339|364403636|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
105656038|NCT04811339|364403637|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
105656039|NCT04811339|364403638|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
105656040|NCT04811339|364403636|FG000|Overall Study|Withdrawal by Subject|0|||
105656041|NCT04811339|364403637|FG001|Overall Study|Withdrawal by Subject|3|||
105656042|NCT04811339|364403638|FG002|Overall Study|Withdrawal by Subject|0|||
105656043|NCT04811339|364403636|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
105656044|NCT04811339|364403637|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
105656045|NCT04811339|364403638|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
105656046|NCT04811339|364403636|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
105656047|NCT04811339|364403637|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
105656048|NCT04811339|364403638|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
105656049|NCT05896696|364403639|FG000|Overall Study|Screening Failure|7|||
105656050|NCT05896696|364403639|FG000|Overall Study|Withdrawal by Subject|2|||
105656051|NCT00143598|364403640|FG000|Overall Study|Lost to Follow-up|23|||
105656052|NCT00143598|364403641|FG001|Overall Study|Lost to Follow-up|21|||
105656053|NCT00143598|364403640|FG000|Overall Study|Withdrawal by Subject|33|||
105656054|NCT00143598|364403641|FG001|Overall Study|Withdrawal by Subject|37|||
105656055|NCT00143598|364403640|FG000|Overall Study|Death|36|||
105656056|NCT00143598|364403641|FG001|Overall Study|Death|36|||
105656057|NCT03900715|364403644|FG000|Overall Study|Protocol Deviation|1|||
105656058|NCT03900715|364403644|FG000|Overall Study|Lack of Efficacy|1|||
105656059|NCT03900715|364403644|FG000|Overall Study|Progressive Disease|6|||
105656060|NCT03900715|364403644|FG000|Overall Study|Adverse Event|2|||
105656061|NCT03900715|364403644|FG000|Overall Study|Other reasons|11|||
105656062|NCT02972242|364405768|FG000|Overall Study|Withdrawal by Subject|1|||
105656063|NCT02972242|364405769|FG001|Overall Study|Withdrawal by Subject|0|||
105656064|NCT04572997|364405770|FG000|Overall Study|Adverse Event|1|||
105656065|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
105656066|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
105656067|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
105656068|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
105656069|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
105656070|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
105656071|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
105656072|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
105656073|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
105656074|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
105656075|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
105656076|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
105656077|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
105656078|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
105656079|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
105656080|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
105656081|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
105656082|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
105656083|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
105656084|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
105656085|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
105656086|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
105656087|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
105656088|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
105656089|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
105656090|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
105656091|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
105656092|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
105656093|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
105656094|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
105656095|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
105656096|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
105656097|NCT00092521|364405771|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
105656098|NCT00092521|364405772|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
105656099|NCT00092521|364405773|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
105656100|NCT00092521|364405774|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
105656101|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
105656102|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
105656103|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
105656104|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
105656105|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
105656106|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
105656107|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
105656108|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
105656109|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
105656110|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
105656111|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
105656112|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
105656113|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Death|2|||
105656114|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Death|0|||
105656115|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Death|1|||
105656116|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Death|0|||
105656117|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
105656118|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
105656119|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
105656120|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
105656121|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
105656122|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
105656123|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
105656124|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
105656125|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
105656126|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
105656127|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
105656128|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
105656129|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Moved|32|||
105656130|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Moved|2|||
105656131|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Moved|28|||
105656132|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Moved|0|||
105656133|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
105656134|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
105656135|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
105656136|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
105656137|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Travel|2|||
105656138|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Travel|0|||
105656139|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Travel|0|||
105656140|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Travel|0|||
105656141|NCT00092521|364405771|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
105656142|NCT00092521|364405772|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
105656143|NCT00092521|364405773|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
105656144|NCT00092521|364405774|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
105656145|NCT00092521|364405771|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
105656146|NCT00092521|364405772|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
105656147|NCT00092521|364405773|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
105656148|NCT00092521|364405774|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
105656149|NCT00092521|364405771|FG000|Extension Study (Group 4)|Adverse Event|0|||
105656150|NCT00092521|364405772|FG001|Extension Study (Group 4)|Adverse Event|0|||
105656151|NCT00092521|364405773|FG002|Extension Study (Group 4)|Adverse Event|0|||
105656152|NCT00092521|364405774|FG003|Extension Study (Group 4)|Adverse Event|2|||
105656153|NCT00092521|364405771|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
105656154|NCT00092521|364405772|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
105656155|NCT00092521|364405773|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
105656156|NCT00092521|364405774|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
105656157|NCT00092521|364405771|FG000|Extension Study (Group 4)|Pregnancy|0|||
105656158|NCT00092521|364405772|FG001|Extension Study (Group 4)|Pregnancy|0|||
105656159|NCT00092521|364405773|FG002|Extension Study (Group 4)|Pregnancy|0|||
105656160|NCT00092521|364405774|FG003|Extension Study (Group 4)|Pregnancy|4|||
105656161|NCT00092521|364405771|FG000|Extension Study (Group 4)|Protocol Violation|0|||
105656162|NCT00092521|364405772|FG001|Extension Study (Group 4)|Protocol Violation|0|||
105656163|NCT00092521|364405773|FG002|Extension Study (Group 4)|Protocol Violation|0|||
105656164|NCT00092521|364405774|FG003|Extension Study (Group 4)|Protocol Violation|2|||
105656165|NCT00092521|364405771|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
105656166|NCT00092521|364405772|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
105656167|NCT00092521|364405773|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
105656168|NCT00092521|364405774|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
105656169|NCT00092521|364405771|FG000|Extension Study (Group 4)|Moved|0|||
105656170|NCT00092521|364405772|FG001|Extension Study (Group 4)|Moved|0|||
105656171|NCT00092521|364405773|FG002|Extension Study (Group 4)|Moved|0|||
105656172|NCT00092521|364405774|FG003|Extension Study (Group 4)|Moved|16|||
105656173|NCT00092521|364405771|FG000|Extension Study (Group 4)|Site Terminated|0|||
105656174|NCT00092521|364405772|FG001|Extension Study (Group 4)|Site Terminated|0|||
105656175|NCT00092521|364405773|FG002|Extension Study (Group 4)|Site Terminated|0|||
105656176|NCT00092521|364405774|FG003|Extension Study (Group 4)|Site Terminated|4|||
105656177|NCT00092521|364405771|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
105656178|NCT00092521|364405772|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
105656179|NCT00092521|364405773|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
105656180|NCT00092521|364405774|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
105656181|NCT03464383|364405775|FG000|Overall Study|Lost to Follow-up|1|||
105656182|NCT03464383|364405776|FG001|Overall Study|Lost to Follow-up|0|||
105656183|NCT03464383|364405777|FG002|Overall Study|Lost to Follow-up|0|||
105656184|NCT03464383|364405775|FG000|Overall Study|Withdrawal by Subject|0|||
105656185|NCT03464383|364405776|FG001|Overall Study|Withdrawal by Subject|1|||
105656186|NCT03464383|364405777|FG002|Overall Study|Withdrawal by Subject|0|||
105656187|NCT00381888|364405780|FG000|Overall Study|Death|1|||
105656188|NCT00381888|364405780|FG000|Overall Study|Withdrawal by Subject|1|||
105656189|NCT00381888|364405780|FG000|Overall Study|Physician Decision|1|||
105656190|NCT00381888|364405780|FG000|Overall Study|Protocol Violation|9|||
105656191|NCT00381888|364405780|FG000|Overall Study|Had laparoscopic surgery|2|||
105656192|NCT00381888|364405780|FG000|Overall Study|Surgery was cancelled|2|||
105656193|NCT00381888|364405780|FG000|Overall Study|Adverse Event|1|||
105656194|NCT00746785|364405781|FG000|Overall Study|Lost to Follow-up|29|||
105656195|NCT00746785|364405782|FG001|Overall Study|Lost to Follow-up|25|||
105656196|NCT00746785|364405783|FG002|Overall Study|Lost to Follow-up|27|||
105656197|NCT00113269|364405784|FG000|Overall Study|Not transplanted, donor issues|4|||
105656198|NCT00113269|364405785|FG001|Overall Study|Not transplanted, donor issues|0|||
105656199|NCT00113269|364405786|FG002|Overall Study|Not transplanted, donor issues|2|||
105656200|NCT00113269|364405787|FG003|Overall Study|Not transplanted, donor issues|2|||
105656201|NCT00113269|364405784|FG000|Overall Study|Not transplanted, recipient issues|2|||
105656202|NCT00113269|364405785|FG001|Overall Study|Not transplanted, recipient issues|1|||
105656203|NCT00113269|364405786|FG002|Overall Study|Not transplanted, recipient issues|7|||
105656204|NCT00113269|364405787|FG003|Overall Study|Not transplanted, recipient issues|4|||
105656205|NCT00113269|364405784|FG000|Overall Study|Early graft loss, technical|0|||
105656206|NCT00113269|364405785|FG001|Overall Study|Early graft loss, technical|0|||
105656207|NCT00113269|364405786|FG002|Overall Study|Early graft loss, technical|2|||
105656208|NCT00113269|364405787|FG003|Overall Study|Early graft loss, technical|0|||
105656209|NCT00113269|364405784|FG000|Overall Study|Death in operating room|0|||
105656210|NCT00113269|364405785|FG001|Overall Study|Death in operating room|0|||
105656211|NCT00113269|364405786|FG002|Overall Study|Death in operating room|0|||
105656212|NCT00113269|364405787|FG003|Overall Study|Death in operating room|1|||
105656213|NCT00113269|364405784|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
105656214|NCT00113269|364405785|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
105656215|NCT00113269|364405786|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
105656216|NCT00113269|364405787|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
105656217|NCT00113269|364405784|FG000|Overall Study|Adverse Event|2|||
105656218|NCT00113269|364405785|FG001|Overall Study|Adverse Event|7|||
105656219|NCT00113269|364405786|FG002|Overall Study|Adverse Event|11|||
105656220|NCT00113269|364405787|FG003|Overall Study|Adverse Event|7|||
105656221|NCT00113269|364405784|FG000|Overall Study|Withdrawal by Subject|4|||
105656222|NCT00113269|364405785|FG001|Overall Study|Withdrawal by Subject|3|||
105656223|NCT00113269|364405786|FG002|Overall Study|Withdrawal by Subject|4|||
105656224|NCT00113269|364405787|FG003|Overall Study|Withdrawal by Subject|2|||
105656225|NCT00113269|364405784|FG000|Overall Study|Graft loss|6|||
105656226|NCT00113269|364405785|FG001|Overall Study|Graft loss|6|||
105656227|NCT00113269|364405786|FG002|Overall Study|Graft loss|4|||
105656228|NCT00113269|364405787|FG003|Overall Study|Graft loss|9|||
105656229|NCT00113269|364405784|FG000|Overall Study|Protocol Violation|1|||
105656230|NCT00113269|364405785|FG001|Overall Study|Protocol Violation|0|||
105656231|NCT00113269|364405786|FG002|Overall Study|Protocol Violation|4|||
105656232|NCT00113269|364405787|FG003|Overall Study|Protocol Violation|2|||
105656233|NCT00113269|364405784|FG000|Overall Study|Lost to Follow-up|2|||
105656234|NCT00113269|364405785|FG001|Overall Study|Lost to Follow-up|3|||
105656235|NCT00113269|364405786|FG002|Overall Study|Lost to Follow-up|6|||
105656236|NCT00113269|364405787|FG003|Overall Study|Lost to Follow-up|3|||
105656237|NCT00113269|364405784|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
105656238|NCT00113269|364405785|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
105656239|NCT00113269|364405786|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
105656240|NCT00113269|364405787|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
105656241|NCT00113269|364405784|FG000|Overall Study|Discontinued due to rejection|0|||
105656242|NCT00113269|364405785|FG001|Overall Study|Discontinued due to rejection|0|||
105656243|NCT00113269|364405786|FG002|Overall Study|Discontinued due to rejection|1|||
105656244|NCT00113269|364405787|FG003|Overall Study|Discontinued due to rejection|0|||
105656245|NCT00113269|364405784|FG000|Overall Study|Moved|0|||
105656246|NCT00113269|364405785|FG001|Overall Study|Moved|1|||
105656247|NCT00113269|364405786|FG002|Overall Study|Moved|0|||
105656248|NCT00113269|364405787|FG003|Overall Study|Moved|3|||
105656249|NCT00113269|364405784|FG000|Overall Study|Received pancreas transplant|0|||
105656250|NCT00113269|364405785|FG001|Overall Study|Received pancreas transplant|0|||
105656251|NCT00113269|364405786|FG002|Overall Study|Received pancreas transplant|0|||
105656252|NCT00113269|364405787|FG003|Overall Study|Received pancreas transplant|2|||
105656253|NCT00113269|364405784|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
105656254|NCT00113269|364405785|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
105656255|NCT00113269|364405786|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
105656256|NCT00113269|364405787|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
105656257|NCT00113269|364405784|FG000|Overall Study|Did not meet eligibility criteria|1|||
105656258|NCT00113269|364405785|FG001|Overall Study|Did not meet eligibility criteria|0|||
105656259|NCT00113269|364405786|FG002|Overall Study|Did not meet eligibility criteria|0|||
105656260|NCT00113269|364405787|FG003|Overall Study|Did not meet eligibility criteria|1|||
105656261|NCT00113269|364405784|FG000|Overall Study|Unable to return for follow up|2|||
105656262|NCT00113269|364405785|FG001|Overall Study|Unable to return for follow up|1|||
105656263|NCT00113269|364405786|FG002|Overall Study|Unable to return for follow up|0|||
105656264|NCT00113269|364405787|FG003|Overall Study|Unable to return for follow up|0|||
105656265|NCT01171183|364405788|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
105656266|NCT01171183|364405789|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
105656267|NCT01171183|364405788|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
105656268|NCT01171183|364405789|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
105656269|NCT01171183|364405788|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
105656270|NCT01171183|364405789|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
105656271|NCT01171183|364405788|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
105656272|NCT01171183|364405789|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
105656273|NCT01171183|364405788|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
105656274|NCT01171183|364405789|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
105656275|NCT01171183|364405788|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
105656276|NCT01171183|364405789|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
105656277|NCT01066936|364405793|FG000|Overall Study|Death|2|||
105656278|NCT01066936|364405793|FG000|Overall Study|Device revised/removed|1|||
105656279|NCT01066936|364405793|FG000|Overall Study|Lost to Follow-up|3|||
105656280|NCT01066936|364405793|FG000|Overall Study|Withdrawal by Subject|4|||
105656281|NCT01093599|364405799|FG000|Overall Study|Lost to Follow-up|32|||
105656282|NCT01093599|364405800|FG001|Overall Study|Lost to Follow-up|46|||
105656283|NCT01703845|364405801|FG000|Overall Study|Adverse Event|1|||
105656284|NCT01703845|364405802|FG001|Overall Study|Adverse Event|0|||
105656285|NCT01703845|364405801|FG000|Overall Study|Protocol Violation|1|||
105656286|NCT01703845|364405802|FG001|Overall Study|Protocol Violation|0|||
105656287|NCT01703845|364405801|FG000|Overall Study|other than stated above|1|||
105656288|NCT01703845|364405802|FG001|Overall Study|other than stated above|0|||
105656289|NCT01845649|364405803|FG000|Overall Study|Adverse Event|7|||
105656290|NCT01845649|364405804|FG001|Overall Study|Adverse Event|10|||
105656291|NCT01845649|364405803|FG000|Overall Study|Lack of Efficacy|1|||
105656292|NCT01845649|364405804|FG001|Overall Study|Lack of Efficacy|1|||
105656293|NCT01845649|364405803|FG000|Overall Study|Lost to Follow-up|2|||
105656294|NCT01845649|364405804|FG001|Overall Study|Lost to Follow-up|2|||
105656295|NCT01845649|364405803|FG000|Overall Study|Withdrew Consent|12|||
105656296|NCT01845649|364405804|FG001|Overall Study|Withdrew Consent|4|||
105656297|NCT01845649|364405803|FG000|Overall Study|Protocol Deviation|7|||
105656298|NCT01845649|364405804|FG001|Overall Study|Protocol Deviation|4|||
105656299|NCT01845649|364405803|FG000|Overall Study|Reason not Specified|2|||
105656300|NCT01845649|364405804|FG001|Overall Study|Reason not Specified|1|||
105656301|NCT01983462|364405805|FG000|Overall Study|Adverse Event|1|||
105656302|NCT01983462|364405806|FG001|Overall Study|Adverse Event|0|||
105656303|NCT01983462|364405807|FG002|Overall Study|Adverse Event|0|||
105656304|NCT01222533|364405809|FG000|Overall Study|Adverse Event|5|||
105656305|NCT01222533|364405809|FG000|Overall Study|Withdrawal by Subject|5|||
105656306|NCT01222533|364405809|FG000|Overall Study|Other|4|||
105656307|NCT03418493|364405810|FG000|Overall Study|Adverse Event|1|||
105656308|NCT03418493|364405811|FG001|Overall Study|Adverse Event|0|||
105656309|NCT03418493|364405812|FG002|Overall Study|Adverse Event|0|||
105656310|NCT03418493|364405813|FG003|Overall Study|Adverse Event|0|||
105656311|NCT03418493|364405814|FG004|Overall Study|Adverse Event|0|||
105656312|NCT03418493|364405815|FG005|Overall Study|Adverse Event|0|||
105656313|NCT03418493|364405816|FG006|Overall Study|Adverse Event|0|||
105656314|NCT03418493|364405817|FG007|Overall Study|Adverse Event|0|||
105656315|NCT03418493|364405818|FG008|Overall Study|Adverse Event|0|||
105656316|NCT03418493|364405819|FG009|Overall Study|Adverse Event|0|||
105656317|NCT03418493|364405820|FG010|Overall Study|Adverse Event|0|||
105656318|NCT03418493|364405810|FG000|Overall Study|Protocol Violation|0|||
105656319|NCT03418493|364405811|FG001|Overall Study|Protocol Violation|0|||
105656320|NCT03418493|364405812|FG002|Overall Study|Protocol Violation|0|||
105656321|NCT03418493|364405813|FG003|Overall Study|Protocol Violation|0|||
105656322|NCT03418493|364405814|FG004|Overall Study|Protocol Violation|0|||
105656323|NCT03418493|364405815|FG005|Overall Study|Protocol Violation|0|||
105656324|NCT03418493|364405816|FG006|Overall Study|Protocol Violation|0|||
105656325|NCT03418493|364405817|FG007|Overall Study|Protocol Violation|0|||
105656326|NCT03418493|364405818|FG008|Overall Study|Protocol Violation|0|||
105656327|NCT03418493|364405819|FG009|Overall Study|Protocol Violation|1|||
105656328|NCT03418493|364405820|FG010|Overall Study|Protocol Violation|0|||
105656329|NCT00966979|364405824|FG000|Overall Study|Death|1|||
105656330|NCT00966979|364405824|FG000|Overall Study|Lost to Follow-up|6|||
105656331|NCT00966979|364405824|FG000|Overall Study|Withdrawal by Subject|14|||
105656332|NCT00966979|364405824|FG000|Overall Study|Adverse Event|5|||
105656333|NCT00966979|364405824|FG000|Overall Study|Sponsor terminated early|49|||
105656334|NCT00966979|364405824|FG000|Overall Study|Censored because surgery not done|2|||
105656335|NCT00966979|364405824|FG000|Overall Study|Censored because study device was not implanted|14|||
105656336|NCT00966979|364405824|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
105656337|NCT03713281|364405825|FG000|Overall Study|Lens handling difficuluties|2|||
105656338|NCT03713281|364405825|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
105656339|NCT03119688|364405826|FG000|Overall Study|Adverse Event|4|||
105656340|NCT01057251|364405828|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
105656341|NCT01057251|364405829|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
105656342|NCT01057251|364405828|FG000|Overall Study|Adverse Event|4|||
105656343|NCT01057251|364405829|FG001|Overall Study|Adverse Event|2|||
105656344|NCT01057251|364405828|FG000|Overall Study|Lack of Efficacy|2|||
105656345|NCT01057251|364405829|FG001|Overall Study|Lack of Efficacy|11|||
105656346|NCT01057251|364405828|FG000|Overall Study|Protocol Violation|6|||
105656347|NCT01057251|364405829|FG001|Overall Study|Protocol Violation|2|||
105656348|NCT01057251|364405828|FG000|Overall Study|Withdrawal by Subject|4|||
105656349|NCT01057251|364405829|FG001|Overall Study|Withdrawal by Subject|5|||
105656350|NCT01057251|364405828|FG000|Overall Study|Lost to Follow-up|7|||
105656351|NCT01057251|364405829|FG001|Overall Study|Lost to Follow-up|6|||
105656352|NCT01057251|364405828|FG000|Overall Study|Other Reason|1|||
105656353|NCT01057251|364405829|FG001|Overall Study|Other Reason|1|||
105656354|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
105656355|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
105656356|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
105656357|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
105656358|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
105656359|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
105656360|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
105656361|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
105656362|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
105656363|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
105656364|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
105656365|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
105656366|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
105656367|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
105656368|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
105656369|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
105656370|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
105656371|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
105656372|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
105656373|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
105656374|NCT02637856|364405830|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
105656375|NCT02637856|364405831|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
105656376|NCT02637856|364405830|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
105656377|NCT02637856|364405831|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
105656378|NCT02637856|364405830|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
105656379|NCT02637856|364405831|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
105656380|NCT03357471|364405837|FG000|Overall Study|Adverse Event|1|||
105656381|NCT03357471|364405838|FG001|Overall Study|Adverse Event|0|||
105656382|NCT03357471|364405837|FG000|Overall Study|Lost to Follow-up|1|||
105656383|NCT03357471|364405838|FG001|Overall Study|Lost to Follow-up|0|||
105656384|NCT03294941|364405839|FG000|Overall Study|Withdrawal by Subject|0|||
105656385|NCT03294941|364405840|FG001|Overall Study|Withdrawal by Subject|2|||
105656386|NCT01547117|364405844|FG000|Overall Study|Physician Decision|0|||
105656387|NCT01547117|364405845|FG001|Overall Study|Physician Decision|1|||
105656388|NCT01547117|364405846|FG002|Overall Study|Physician Decision|1|||
105656389|NCT01547117|364405847|FG003|Overall Study|Physician Decision|3|||
105656390|NCT01547117|364405844|FG000|Overall Study|Withdrawal by Subject|1|||
105656391|NCT01547117|364405845|FG001|Overall Study|Withdrawal by Subject|2|||
105656392|NCT01547117|364405846|FG002|Overall Study|Withdrawal by Subject|1|||
105656393|NCT01547117|364405847|FG003|Overall Study|Withdrawal by Subject|2|||
105656394|NCT01844726|364405851|FG000|Overall Study|Withdrawal by Subject|0|||
105656395|NCT01844726|364405852|FG001|Overall Study|Withdrawal by Subject|1|||
105656396|NCT01844726|364405851|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
105656397|NCT01844726|364405852|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
105656398|NCT00307164|364405855|FG000|Overall Study|Death|1|||
105656399|NCT00307164|364405856|FG001|Overall Study|Death|0|||
105656400|NCT00307164|364405855|FG000|Overall Study|Severe debilitation, unable to continue|1|||
105656401|NCT00307164|364405856|FG001|Overall Study|Severe debilitation, unable to continue|0|||
105656402|NCT00307164|364405855|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
105656403|NCT00307164|364405856|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
105656404|NCT00307164|364405855|FG000|Overall Study|Withdrawal by Subject|1|||
105656405|NCT00307164|364405856|FG001|Overall Study|Withdrawal by Subject|8|||
105656406|NCT00307164|364405855|FG000|Overall Study|Not compliant with requirements|4|||
105656407|NCT00307164|364405856|FG001|Overall Study|Not compliant with requirements|4|||
105656408|NCT00307164|364405855|FG000|Overall Study|Lost to Follow-up|6|||
105656409|NCT00307164|364405856|FG001|Overall Study|Lost to Follow-up|1|||
105656410|NCT01202409|364405860|FG000|Overall Study|Adverse Event|1|||
105656411|NCT01202409|364405860|FG000|Overall Study|Ineligible - KRAS mutants|7|||
105656412|NCT00858247|364405861|FG000|Baseline Assessment|Withdrawal by Subject|1|||
105656413|NCT00858247|364405862|FG001|Baseline Assessment|Withdrawal by Subject|1|||
105656414|NCT00858247|364405861|FG000|Baseline Assessment|Poor IV access|1|||
105656415|NCT00858247|364405862|FG001|Baseline Assessment|Poor IV access|0|||
105656416|NCT00858247|364405861|FG000|Baseline Assessment|Protocol Violation|0|||
105656417|NCT00858247|364405862|FG001|Baseline Assessment|Protocol Violation|1|||
105656418|NCT00858247|364405861|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
105656419|NCT00858247|364405862|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
105656420|NCT00337285|364405865|FG000|Overall Study|Withdrawal by Subject|42|||
105656421|NCT00337285|364405865|FG000|Overall Study|Lost to Follow-up|41|||
105656422|NCT00337285|364405865|FG000|Overall Study|Adverse Event|28|||
105656423|NCT00337285|364405865|FG000|Overall Study|Protocol Violation|27|||
105656424|NCT00337285|364405865|FG000|Overall Study|Lack of Efficacy|11|||
105656425|NCT00337285|364405865|FG000|Overall Study|Death|1|||
105656426|NCT00337285|364405865|FG000|Overall Study|Physician Decision|1|||
105656427|NCT00337285|364405865|FG000|Overall Study|Lack of protocol compliance|7|||
105656428|NCT01746108|364405868|FG000|Overall Study|Migrated /moved from study area|0|||
105656429|NCT01746108|364405869|FG001|Overall Study|Migrated /moved from study area|1|||
105656430|NCT01746108|364405870|FG002|Overall Study|Migrated /moved from study area|0|||
105656431|NCT01746108|364405868|FG000|Overall Study|Adverse event, non-fatal|0|||
105656432|NCT01746108|364405869|FG001|Overall Study|Adverse event, non-fatal|1|||
105656433|NCT01746108|364405870|FG002|Overall Study|Adverse event, non-fatal|0|||
105656434|NCT01746108|364405868|FG000|Overall Study|Withdrawal by Subject|0|||
105656435|NCT01746108|364405869|FG001|Overall Study|Withdrawal by Subject|1|||
105656436|NCT01746108|364405870|FG002|Overall Study|Withdrawal by Subject|0|||
105656437|NCT01746108|364405868|FG000|Overall Study|Lost to Follow-up|0|||
105656438|NCT01746108|364405869|FG001|Overall Study|Lost to Follow-up|1|||
105656439|NCT01746108|364405870|FG002|Overall Study|Lost to Follow-up|0|||
105656440|NCT01774019|364405871|FG000|Overall Study|No longer meets protocol criteria|2|||
105656441|NCT01774019|364405872|FG001|Overall Study|No longer meets protocol criteria|0|||
105656442|NCT01774019|364405871|FG000|Overall Study|Withdrawal by Subject|1|||
105656443|NCT01774019|364405872|FG001|Overall Study|Withdrawal by Subject|0|||
105656444|NCT01774019|364405871|FG000|Overall Study|Surgery delayed > 120 days|1|||
105656445|NCT01774019|364405872|FG001|Overall Study|Surgery delayed > 120 days|0|||
105656446|NCT01774019|364405871|FG000|Overall Study|Patient refused surgery|1|||
105656447|NCT01774019|364405872|FG001|Overall Study|Patient refused surgery|1|||
105656448|NCT01774019|364405871|FG000|Overall Study|Unable to implant study device|1|||
105656449|NCT01774019|364405872|FG001|Overall Study|Unable to implant study device|0|||
105656450|NCT01774019|364405871|FG000|Overall Study|Lost to Follow-up|0|||
105656451|NCT01774019|364405872|FG001|Overall Study|Lost to Follow-up|3|||
105656452|NCT00553605|364405873|FG000|Overall Study|Did not meet entrance criteria|1|||
105656453|NCT00553605|364405874|FG001|Overall Study|Did not meet entrance criteria|3|||
105656454|NCT00553605|364405873|FG000|Overall Study|Did not receive full dose|1|||
105656455|NCT00553605|364405874|FG001|Overall Study|Did not receive full dose|0|||
105656456|NCT00553605|364405873|FG000|Overall Study|Randomized but not treated|2|||
105656457|NCT00553605|364405874|FG001|Overall Study|Randomized but not treated|0|||
105656458|NCT03463577|364405882|FG000|Overall Study|Lost to Follow-up|238|||
105656459|NCT03463577|364405883|FG001|Overall Study|Lost to Follow-up|435|||
105656460|NCT03463577|364405884|FG002|Overall Study|Lost to Follow-up|0|||
105656461|NCT03463577|364405885|FG003|Overall Study|Lost to Follow-up|0|||
105656462|NCT03463577|364405886|FG004|Overall Study|Lost to Follow-up|0|||
105656463|NCT03463577|364405887|FG005|Overall Study|Lost to Follow-up|0|||
105656464|NCT03463577|364405882|FG000|Overall Study|With unknown pregnancy outcome|0|||
105656465|NCT03463577|364405883|FG001|Overall Study|With unknown pregnancy outcome|5|||
105656466|NCT03463577|364405884|FG002|Overall Study|With unknown pregnancy outcome|0|||
105656467|NCT03463577|364405885|FG003|Overall Study|With unknown pregnancy outcome|0|||
105656468|NCT03463577|364405886|FG004|Overall Study|With unknown pregnancy outcome|0|||
105656469|NCT03463577|364405887|FG005|Overall Study|With unknown pregnancy outcome|0|||
105656470|NCT03463577|364405882|FG000|Overall Study|Maternal death|2|||
105656471|NCT03463577|364405883|FG001|Overall Study|Maternal death|0|||
105656472|NCT03463577|364405884|FG002|Overall Study|Maternal death|0|||
105656473|NCT03463577|364405885|FG003|Overall Study|Maternal death|0|||
105656474|NCT03463577|364405886|FG004|Overall Study|Maternal death|0|||
105656475|NCT03463577|364405887|FG005|Overall Study|Maternal death|0|||
105656476|NCT03463577|364405882|FG000|Overall Study|Neonatal death|0|||
105656477|NCT03463577|364405883|FG001|Overall Study|Neonatal death|0|||
105656478|NCT03463577|364405884|FG002|Overall Study|Neonatal death|0|||
105656479|NCT03463577|364405885|FG003|Overall Study|Neonatal death|15|||
105656480|NCT03463577|364405886|FG004|Overall Study|Neonatal death|17|||
105656481|NCT03463577|364405887|FG005|Overall Study|Neonatal death|0|||
105656482|NCT00292981|364405888|FG000|Overall Study|Adverse Event|1|||
105656483|NCT00292981|364405888|FG000|Overall Study|Lost to Follow-up|13|||
105656484|NCT00292981|364405888|FG000|Overall Study|Withdrawal by Subject|22|||
105656485|NCT00292981|364405888|FG000|Overall Study|Other|3|||
105656486|NCT00594178|364405889|FG000|Overall Study|Physician Decision|5|||
105656487|NCT00611715|364405900|FG000|Overall Study|Disease Progression|24|||
105656488|NCT00611715|364405901|FG001|Overall Study|Disease Progression|4|||
105656489|NCT00611715|364405900|FG000|Overall Study|Withdrawal by Subject|5|||
105656490|NCT00611715|364405901|FG001|Overall Study|Withdrawal by Subject|1|||
105656491|NCT00611715|364405900|FG000|Overall Study|Adverse Event|9|||
105656492|NCT00611715|364405901|FG001|Overall Study|Adverse Event|1|||
105656493|NCT00611715|364405900|FG000|Overall Study|Death|1|||
105656494|NCT00611715|364405901|FG001|Overall Study|Death|0|||
105656495|NCT00611715|364405900|FG000|Overall Study|two patients are still on treatment|2|||
105656496|NCT00611715|364405901|FG001|Overall Study|two patients are still on treatment|0|||
105656497|NCT00727415|364405902|FG000|Phase I|Dose Limiting Toxicity|2|||
105656498|NCT04191148|364405903|FG000|Overall Study|Withdrawal by Subject|1|||
105656499|NCT04191148|364405904|FG001|Overall Study|Withdrawal by Subject|0|||
105656500|NCT04191148|364405903|FG000|Overall Study|Adverse Event|1|||
105656501|NCT04191148|364405904|FG001|Overall Study|Adverse Event|0|||
105656502|NCT01274559|364405907|FG000|Overall Study|Adverse Event|57|||
105656503|NCT01274559|364405908|FG001|Overall Study|Adverse Event|13|||
105656504|NCT01274559|364405907|FG000|Overall Study|Death|1|||
105656505|NCT01274559|364405908|FG001|Overall Study|Death|1|||
105656506|NCT01274559|364405907|FG000|Overall Study|Lost to Follow-up|3|||
105656507|NCT01274559|364405908|FG001|Overall Study|Lost to Follow-up|3|||
105656508|NCT01274559|364405907|FG000|Overall Study|Non-compliance with Study Drug|2|||
105656509|NCT01274559|364405908|FG001|Overall Study|Non-compliance with Study Drug|4|||
105656510|NCT01274559|364405907|FG000|Overall Study|Physician Decision|2|||
105656511|NCT01274559|364405908|FG001|Overall Study|Physician Decision|1|||
105656512|NCT01274559|364405907|FG000|Overall Study|Protocol Violation|28|||
105656513|NCT01274559|364405908|FG001|Overall Study|Protocol Violation|23|||
105656514|NCT01274559|364405907|FG000|Overall Study|Study Terminated by Sponsor|79|||
105656515|NCT01274559|364405908|FG001|Overall Study|Study Terminated by Sponsor|87|||
105656516|NCT01274559|364405907|FG000|Overall Study|Withdrawal by Subject|25|||
105656517|NCT01274559|364405908|FG001|Overall Study|Withdrawal by Subject|13|||
105656518|NCT00677092|364405909|FG000|Overall Study|Adverse Event|1|||
105656519|NCT00677092|364405909|FG000|Overall Study|Lost to Follow-up|1|||
105656520|NCT00677092|364405909|FG000|Overall Study|Withdrawal by Subject|3|||
105656521|NCT00677092|364405909|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
105656522|NCT00853229|364405912|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
105656523|NCT00853229|364405913|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
105656524|NCT04772313|364405914|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
105656525|NCT04772313|364405914|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
105656526|NCT02560389|364405915|FG000|Overall Study|Lost to Follow-up|1|||
105656527|NCT02560389|364405916|FG001|Overall Study|Lost to Follow-up|2|||
105656528|NCT02560389|364405917|FG002|Overall Study|Lost to Follow-up|2|||
105656529|NCT02560389|364405915|FG000|Overall Study|Tested positive for illicit substance|0|||
105656530|NCT02560389|364405916|FG001|Overall Study|Tested positive for illicit substance|1|||
105656531|NCT02560389|364405917|FG002|Overall Study|Tested positive for illicit substance|0|||
105656532|NCT00550446|364405924|FG000|Up To Week 12|Adverse Event|2|||
105656533|NCT00550446|364405925|FG001|Up To Week 12|Adverse Event|2|||
105656534|NCT00550446|364405926|FG002|Up To Week 12|Adverse Event|0|||
105656535|NCT00550446|364405927|FG003|Up To Week 12|Adverse Event|0|||
105656536|NCT00550446|364405928|FG004|Up To Week 12|Adverse Event|2|||
105656537|NCT00550446|364405929|FG005|Up To Week 12|Adverse Event|2|||
105656538|NCT00550446|364405930|FG006|Up To Week 12|Adverse Event|1|||
105656539|NCT00550446|364405931|FG007|Up To Week 12|Adverse Event|0|||
105656540|NCT00550446|364405932|FG008|Up To Week 12|Adverse Event|0|||
105656541|NCT00550446|364405933|FG009|Up To Week 12|Adverse Event|0|||
105656542|NCT00550446|364405934|FG010|Up To Week 12|Adverse Event|0|||
105656543|NCT00550446|364405924|FG000|Up To Week 12|Lack of Efficacy|3|||
105656544|NCT00550446|364405925|FG001|Up To Week 12|Lack of Efficacy|1|||
105656545|NCT00550446|364405926|FG002|Up To Week 12|Lack of Efficacy|0|||
105656546|NCT00550446|364405927|FG003|Up To Week 12|Lack of Efficacy|1|||
105656547|NCT00550446|364405928|FG004|Up To Week 12|Lack of Efficacy|0|||
105656548|NCT00550446|364405929|FG005|Up To Week 12|Lack of Efficacy|3|||
105656549|NCT00550446|364405930|FG006|Up To Week 12|Lack of Efficacy|3|||
105656550|NCT00550446|364405931|FG007|Up To Week 12|Lack of Efficacy|0|||
105656551|NCT00550446|364405932|FG008|Up To Week 12|Lack of Efficacy|0|||
105656552|NCT00550446|364405933|FG009|Up To Week 12|Lack of Efficacy|0|||
105656553|NCT00550446|364405934|FG010|Up To Week 12|Lack of Efficacy|0|||
105656554|NCT00550446|364405924|FG000|Up To Week 12|Lost to Follow-up|0|||
105656555|NCT00550446|364405925|FG001|Up To Week 12|Lost to Follow-up|1|||
105656556|NCT00550446|364405926|FG002|Up To Week 12|Lost to Follow-up|0|||
105656557|NCT00550446|364405927|FG003|Up To Week 12|Lost to Follow-up|0|||
105656558|NCT00550446|364405928|FG004|Up To Week 12|Lost to Follow-up|1|||
105656559|NCT00550446|364405929|FG005|Up To Week 12|Lost to Follow-up|1|||
105656560|NCT00550446|364405930|FG006|Up To Week 12|Lost to Follow-up|2|||
105656561|NCT00550446|364405931|FG007|Up To Week 12|Lost to Follow-up|0|||
105656562|NCT00550446|364405932|FG008|Up To Week 12|Lost to Follow-up|0|||
105656563|NCT00550446|364405933|FG009|Up To Week 12|Lost to Follow-up|0|||
105656564|NCT00550446|364405934|FG010|Up To Week 12|Lost to Follow-up|0|||
105656565|NCT00550446|364405924|FG000|Up To Week 12|Withdrawal by Subject|2|||
105656566|NCT00550446|364405925|FG001|Up To Week 12|Withdrawal by Subject|0|||
105656567|NCT00550446|364405926|FG002|Up To Week 12|Withdrawal by Subject|3|||
105656568|NCT00550446|364405927|FG003|Up To Week 12|Withdrawal by Subject|2|||
105656569|NCT00550446|364405928|FG004|Up To Week 12|Withdrawal by Subject|0|||
105656570|NCT00550446|364405929|FG005|Up To Week 12|Withdrawal by Subject|1|||
105656571|NCT00550446|364405930|FG006|Up To Week 12|Withdrawal by Subject|3|||
105656572|NCT00550446|364405931|FG007|Up To Week 12|Withdrawal by Subject|0|||
105656573|NCT00550446|364405932|FG008|Up To Week 12|Withdrawal by Subject|0|||
105656574|NCT00550446|364405933|FG009|Up To Week 12|Withdrawal by Subject|0|||
105656575|NCT00550446|364405934|FG010|Up To Week 12|Withdrawal by Subject|0|||
105656576|NCT00550446|364405924|FG000|Up To Week 12|Other|3|||
105656577|NCT00550446|364405925|FG001|Up To Week 12|Other|0|||
105656578|NCT00550446|364405926|FG002|Up To Week 12|Other|0|||
105656579|NCT00550446|364405927|FG003|Up To Week 12|Other|0|||
105656580|NCT00550446|364405928|FG004|Up To Week 12|Other|0|||
105656581|NCT00550446|364405929|FG005|Up To Week 12|Other|1|||
105656582|NCT00550446|364405930|FG006|Up To Week 12|Other|4|||
105656583|NCT00550446|364405931|FG007|Up To Week 12|Other|0|||
105656584|NCT00550446|364405932|FG008|Up To Week 12|Other|0|||
105656585|NCT00550446|364405933|FG009|Up To Week 12|Other|0|||
105656586|NCT00550446|364405934|FG010|Up To Week 12|Other|0|||
105656587|NCT00550446|364405924|FG000|Up To Week 12|Randomized not treated|0|||
105656588|NCT00550446|364405925|FG001|Up To Week 12|Randomized not treated|1|||
105656589|NCT00550446|364405926|FG002|Up To Week 12|Randomized not treated|1|||
105656590|NCT00550446|364405927|FG003|Up To Week 12|Randomized not treated|0|||
105656591|NCT00550446|364405928|FG004|Up To Week 12|Randomized not treated|0|||
105656592|NCT00550446|364405929|FG005|Up To Week 12|Randomized not treated|0|||
105656593|NCT00550446|364405930|FG006|Up To Week 12|Randomized not treated|0|||
105656594|NCT00550446|364405931|FG007|Up To Week 12|Randomized not treated|0|||
105656595|NCT00550446|364405932|FG008|Up To Week 12|Randomized not treated|0|||
105656596|NCT00550446|364405933|FG009|Up To Week 12|Randomized not treated|0|||
105656597|NCT00550446|364405934|FG010|Up To Week 12|Randomized not treated|0|||
105656598|NCT00550446|364405924|FG000|Post Week 12|Adverse Event|2|||
105656599|NCT00550446|364405925|FG001|Post Week 12|Adverse Event|1|||
105656600|NCT00550446|364405926|FG002|Post Week 12|Adverse Event|1|||
105656601|NCT00550446|364405927|FG003|Post Week 12|Adverse Event|1|||
105656602|NCT00550446|364405928|FG004|Post Week 12|Adverse Event|1|||
105656603|NCT00550446|364405929|FG005|Post Week 12|Adverse Event|1|||
105656604|NCT00550446|364405930|FG006|Post Week 12|Adverse Event|0|||
105656605|NCT00550446|364405931|FG007|Post Week 12|Adverse Event|0|||
105656606|NCT00550446|364405932|FG008|Post Week 12|Adverse Event|0|||
105656607|NCT00550446|364405933|FG009|Post Week 12|Adverse Event|4|||
105656608|NCT00550446|364405934|FG010|Post Week 12|Adverse Event|0|||
105656609|NCT00550446|364405924|FG000|Post Week 12|Lack of Efficacy|0|||
105656610|NCT00550446|364405925|FG001|Post Week 12|Lack of Efficacy|0|||
105656611|NCT00550446|364405926|FG002|Post Week 12|Lack of Efficacy|1|||
105656612|NCT00550446|364405927|FG003|Post Week 12|Lack of Efficacy|0|||
105656613|NCT00550446|364405928|FG004|Post Week 12|Lack of Efficacy|0|||
105656614|NCT00550446|364405929|FG005|Post Week 12|Lack of Efficacy|0|||
105656615|NCT00550446|364405930|FG006|Post Week 12|Lack of Efficacy|0|||
105656616|NCT00550446|364405931|FG007|Post Week 12|Lack of Efficacy|1|||
105656617|NCT00550446|364405932|FG008|Post Week 12|Lack of Efficacy|1|||
105656618|NCT00550446|364405933|FG009|Post Week 12|Lack of Efficacy|2|||
105656619|NCT00550446|364405934|FG010|Post Week 12|Lack of Efficacy|1|||
105656620|NCT00550446|364405924|FG000|Post Week 12|Lost to Follow-up|0|||
105656621|NCT00550446|364405925|FG001|Post Week 12|Lost to Follow-up|0|||
105656622|NCT00550446|364405926|FG002|Post Week 12|Lost to Follow-up|1|||
105656623|NCT00550446|364405927|FG003|Post Week 12|Lost to Follow-up|1|||
105656624|NCT00550446|364405928|FG004|Post Week 12|Lost to Follow-up|0|||
105656625|NCT00550446|364405929|FG005|Post Week 12|Lost to Follow-up|0|||
105656626|NCT00550446|364405930|FG006|Post Week 12|Lost to Follow-up|1|||
105656627|NCT00550446|364405931|FG007|Post Week 12|Lost to Follow-up|0|||
105656628|NCT00550446|364405932|FG008|Post Week 12|Lost to Follow-up|0|||
105656629|NCT00550446|364405933|FG009|Post Week 12|Lost to Follow-up|0|||
105656630|NCT00550446|364405934|FG010|Post Week 12|Lost to Follow-up|0|||
105656631|NCT00550446|364405924|FG000|Post Week 12|Withdrawal by Subject|0|||
105656632|NCT00550446|364405925|FG001|Post Week 12|Withdrawal by Subject|0|||
105656633|NCT00550446|364405926|FG002|Post Week 12|Withdrawal by Subject|0|||
105656634|NCT00550446|364405927|FG003|Post Week 12|Withdrawal by Subject|0|||
105656635|NCT00550446|364405928|FG004|Post Week 12|Withdrawal by Subject|1|||
105656636|NCT00550446|364405929|FG005|Post Week 12|Withdrawal by Subject|0|||
105656637|NCT00550446|364405930|FG006|Post Week 12|Withdrawal by Subject|0|||
105656638|NCT00550446|364405931|FG007|Post Week 12|Withdrawal by Subject|0|||
105656639|NCT00550446|364405932|FG008|Post Week 12|Withdrawal by Subject|0|||
105656640|NCT00550446|364405933|FG009|Post Week 12|Withdrawal by Subject|0|||
105656641|NCT00550446|364405934|FG010|Post Week 12|Withdrawal by Subject|0|||
105656642|NCT00550446|364405924|FG000|Post Week 12|Other|1|||
105656643|NCT00550446|364405925|FG001|Post Week 12|Other|1|||
105656644|NCT00550446|364405926|FG002|Post Week 12|Other|0|||
105656645|NCT00550446|364405927|FG003|Post Week 12|Other|1|||
105656646|NCT00550446|364405928|FG004|Post Week 12|Other|0|||
105656647|NCT00550446|364405929|FG005|Post Week 12|Other|0|||
105656648|NCT00550446|364405930|FG006|Post Week 12|Other|1|||
105656649|NCT00550446|364405931|FG007|Post Week 12|Other|0|||
105656650|NCT00550446|364405932|FG008|Post Week 12|Other|1|||
105656651|NCT00550446|364405933|FG009|Post Week 12|Other|1|||
105656652|NCT00550446|364405934|FG010|Post Week 12|Other|0|||
105656653|NCT02716298|364405935|FG000|First Intervention (1 Month)|Lens discomfort|1|||
105656654|NCT02716298|364405936|FG001|First Intervention (1 Month)|Lens discomfort|1|||
105656655|NCT02760485|364405937|FG000|Phase 1|Death|3|||
105656656|NCT02760485|364405938|FG001|Phase 1|Death|6|||
105656657|NCT02760485|364405939|FG002|Phase 1|Death|0|||
105656658|NCT02760485|364405937|FG000|Phase 1|Withdrawal by Subject|2|||
105656659|NCT02760485|364405938|FG001|Phase 1|Withdrawal by Subject|0|||
105656660|NCT02760485|364405939|FG002|Phase 1|Withdrawal by Subject|0|||
105656661|NCT02760485|364405937|FG000|Phase 1|Progressive Disease|1|||
105656662|NCT02760485|364405938|FG001|Phase 1|Progressive Disease|0|||
105656663|NCT02760485|364405939|FG002|Phase 1|Progressive Disease|0|||
105656664|NCT02760485|364405937|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
105656665|NCT02760485|364405938|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
105656666|NCT02760485|364405939|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
105656667|NCT02760485|364405937|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
105656668|NCT02760485|364405938|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
105656669|NCT02760485|364405939|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
105656670|NCT02760485|364405937|FG000|Phase 2|Death|0|||
105656671|NCT02760485|364405938|FG001|Phase 2|Death|0|||
105656672|NCT02760485|364405939|FG002|Phase 2|Death|12|||
105656673|NCT02760485|364405937|FG000|Phase 2|Withdrawal by Subject|0|||
105656674|NCT02760485|364405938|FG001|Phase 2|Withdrawal by Subject|0|||
105656675|NCT02760485|364405939|FG002|Phase 2|Withdrawal by Subject|3|||
105656676|NCT02760485|364405937|FG000|Phase 2|Progressive Disease|0|||
105656677|NCT02760485|364405938|FG001|Phase 2|Progressive Disease|0|||
105656678|NCT02760485|364405939|FG002|Phase 2|Progressive Disease|1|||
105656679|NCT02760485|364405937|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
105656680|NCT02760485|364405938|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
105656681|NCT02760485|364405939|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
105656682|NCT01349036|364405940|FG000|Overall Study|Disease progression|13|||
105656683|NCT01349036|364405941|FG001|Overall Study|Disease progression|22|||
105656684|NCT01349036|364405940|FG000|Overall Study|Other|1|||
105656685|NCT01349036|364405941|FG001|Overall Study|Other|0|||
105656686|NCT01349036|364405940|FG000|Overall Study|Withdrawal by Subject|0|||
105656687|NCT01349036|364405941|FG001|Overall Study|Withdrawal by Subject|2|||
105656688|NCT01878383|364407422|FG000|Overall Study|Lost to Follow-up|0|||
105656689|NCT01878383|364407423|FG001|Overall Study|Lost to Follow-up|1499|||
105656690|NCT00605566|364407424|FG000|Overall Study|Adverse Event|1|||
105656691|NCT00605566|364407424|FG000|Overall Study|Clinical deterioration|1|||
105656692|NCT00605566|364407424|FG000|Overall Study|Poor compliance in run-in period|1|||
105656693|NCT01101334|364407425|FG000|Overall Study|Adverse Event|9|||
105656694|NCT01101334|364407426|FG001|Overall Study|Adverse Event|4|||
105656695|NCT01101334|364407425|FG000|Overall Study|Death|7|||
105656696|NCT01101334|364407426|FG001|Overall Study|Death|1|||
105656697|NCT01101334|364407425|FG000|Overall Study|Withdrawal by Subject|4|||
105656698|NCT01101334|364407426|FG001|Overall Study|Withdrawal by Subject|3|||
105656699|NCT01101334|364407425|FG000|Overall Study|Withdrawal by Sponsor|1|||
105656700|NCT01101334|364407426|FG001|Overall Study|Withdrawal by Sponsor|1|||
105656701|NCT01101334|364407425|FG000|Overall Study|Progressive Disease|22|||
105656702|NCT01101334|364407426|FG001|Overall Study|Progressive Disease|35|||
105656703|NCT01101334|364407425|FG000|Overall Study|Other|2|||
105656704|NCT01101334|364407426|FG001|Overall Study|Other|1|||
105656705|NCT01904136|364407433|FG000|Overall Study|Physician Decision|0|||
105656706|NCT01904136|364407434|FG001|Overall Study|Physician Decision|0|||
105656707|NCT01904136|364407435|FG002|Overall Study|Physician Decision|0|||
105656708|NCT01904136|364407436|FG003|Overall Study|Physician Decision|0|||
105656709|NCT01904136|364407437|FG004|Overall Study|Physician Decision|0|||
105656710|NCT01904136|364407438|FG005|Overall Study|Physician Decision|1|||
105656711|NCT01904136|364407439|FG006|Overall Study|Physician Decision|0|||
105656712|NCT01904136|364407440|FG007|Overall Study|Physician Decision|0|||
105656713|NCT01904136|364407441|FG008|Overall Study|Physician Decision|0|||
105656714|NCT00695136|364407442|FG000|Overall Study|Withdrawal by Subject|1|||
105656715|NCT00695136|364407442|FG000|Overall Study|unrelated adverse event|1|||
105656716|NCT00853372|364407443|FG000|Overall Study|Death|30|||
105656717|NCT00853372|364407444|FG001|Overall Study|Death|26|||
105656718|NCT00853372|364407443|FG000|Overall Study|Lost to Follow-up|1|||
105656719|NCT00853372|364407444|FG001|Overall Study|Lost to Follow-up|2|||
105656720|NCT00853372|364407443|FG000|Overall Study|Full Consent Withdrawn|1|||
105656721|NCT00853372|364407444|FG001|Overall Study|Full Consent Withdrawn|1|||
105656722|NCT01821729|364407445|FG000|Overall Study|Withdrawal by Subject|1|||
105656723|NCT03596242|364407446|FG000|Overall Study|Lost to Follow-up|2|||
105656724|NCT03596242|364407447|FG001|Overall Study|Lost to Follow-up|2|||
105656725|NCT02509312|364407448|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
105656726|NCT02509312|364407449|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
105656727|NCT02509312|364407448|FG000|Overall Study|Obstetrician refusal|0|||
105656728|NCT02509312|364407449|FG001|Overall Study|Obstetrician refusal|1|||
105656729|NCT02509312|364407448|FG000|Overall Study|Patient elected for TOLAC|1|||
105656730|NCT02509312|364407449|FG001|Overall Study|Patient elected for TOLAC|0|||
105656731|NCT02509312|364407448|FG000|Overall Study|Cesarean deemed stat|1|||
105656732|NCT02509312|364407449|FG001|Overall Study|Cesarean deemed stat|0|||
105656733|NCT02509312|364407448|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
105656734|NCT02509312|364407449|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
105656735|NCT00713206|364407455|FG000|Overall Study|Lost to Follow-up|4|||
105656736|NCT00713206|364407456|FG001|Overall Study|Lost to Follow-up|4|||
105656737|NCT00713206|364407455|FG000|Overall Study|Death|1|||
105656738|NCT00713206|364407456|FG001|Overall Study|Death|0|||
105656739|NCT02561806|364407457|FG000|Induction Period|Adverse Event|0|||
105656740|NCT02561806|364407458|FG001|Induction Period|Adverse Event|2|||
105656741|NCT02561806|364407457|FG000|Induction Period|Lack of Efficacy|1|||
105656742|NCT02561806|364407458|FG001|Induction Period|Lack of Efficacy|0|||
105656743|NCT02561806|364407457|FG000|Induction Period|Withdrawal by Subject|0|||
105656744|NCT02561806|364407458|FG001|Induction Period|Withdrawal by Subject|2|||
105656745|NCT02561806|364407457|FG000|Induction Period|Site staff became unblinded|1|||
105656746|NCT02561806|364407458|FG001|Induction Period|Site staff became unblinded|0|||
105656747|NCT02561806|364407457|FG000|Induction Period|Randomized but not treated|0|||
105656748|NCT02561806|364407458|FG001|Induction Period|Randomized but not treated|1|||
105656749|NCT02561806|364407457|FG000|Maintenance Period|Adverse Event|2|||
105656750|NCT02561806|364407458|FG001|Maintenance Period|Adverse Event|1|||
105656751|NCT02561806|364407457|FG000|Maintenance Period|Lack of Efficacy|3|||
105656752|NCT02561806|364407458|FG001|Maintenance Period|Lack of Efficacy|1|||
105656753|NCT02561806|364407457|FG000|Maintenance Period|Lost to Follow-up|2|||
105656754|NCT02561806|364407458|FG001|Maintenance Period|Lost to Follow-up|2|||
105656755|NCT02561806|364407457|FG000|Maintenance Period|Protocol Violation|1|||
105656756|NCT02561806|364407458|FG001|Maintenance Period|Protocol Violation|0|||
105656757|NCT02561806|364407457|FG000|Maintenance Period|Withdrawal by Subject|5|||
105656758|NCT02561806|364407458|FG001|Maintenance Period|Withdrawal by Subject|3|||
105656759|NCT02561806|364407457|FG000|Maintenance Period|Site staff became unblinded|0|||
105656760|NCT02561806|364407458|FG001|Maintenance Period|Site staff became unblinded|1|||
105656761|NCT02561806|364407457|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
105656762|NCT02561806|364407458|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
105656763|NCT02561806|364407457|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
105656764|NCT02561806|364407458|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
105656765|NCT02547441|364407462|FG000|Double-Blind Study Period|Adverse Event|4|||
105656766|NCT02547441|364407463|FG001|Double-Blind Study Period|Adverse Event|9|||
105656767|NCT02547441|364407462|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
105656768|NCT02547441|364407463|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
105656769|NCT02547441|364407462|FG000|Double-Blind Study Period|Physician Decision|1|||
105656770|NCT02547441|364407463|FG001|Double-Blind Study Period|Physician Decision|0|||
105656771|NCT02547441|364407462|FG000|Double-Blind Study Period|Protocol Violation|1|||
105656772|NCT02547441|364407463|FG001|Double-Blind Study Period|Protocol Violation|2|||
105656773|NCT02547441|364407462|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
105656774|NCT02547441|364407463|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
105656775|NCT02547441|364407462|FG000|Double-Blind Study Period|Sponsor Decision|1|||
105656776|NCT02547441|364407463|FG001|Double-Blind Study Period|Sponsor Decision|0|||
105656777|NCT02547441|364407462|FG000|Open-Label Study Period|Adverse Event|10|||
105656778|NCT02547441|364407463|FG001|Open-Label Study Period|Adverse Event|11|||
105656779|NCT02547441|364407462|FG000|Open-Label Study Period|Lack of Efficacy|3|||
105656780|NCT02547441|364407463|FG001|Open-Label Study Period|Lack of Efficacy|2|||
105656781|NCT02547441|364407462|FG000|Open-Label Study Period|Lost to Follow-up|7|||
105656782|NCT02547441|364407463|FG001|Open-Label Study Period|Lost to Follow-up|8|||
105656783|NCT02547441|364407462|FG000|Open-Label Study Period|Physician Decision|1|||
105656784|NCT02547441|364407463|FG001|Open-Label Study Period|Physician Decision|0|||
105656785|NCT02547441|364407462|FG000|Open-Label Study Period|Protocol Violation|2|||
105656786|NCT02547441|364407463|FG001|Open-Label Study Period|Protocol Violation|0|||
105656787|NCT02547441|364407462|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
105656788|NCT02547441|364407463|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
105656789|NCT02547441|364407462|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
105656790|NCT02547441|364407463|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
105656791|NCT01657877|364407464|FG000|Overall Study|Withdrawal by Subject|4|||
105656792|NCT01657877|364407464|FG000|Overall Study|Protocol Violation|6|||
105656793|NCT01657877|364407464|FG000|Overall Study|Adverse Event|2|||
105656794|NCT01657877|364407464|FG000|Overall Study|Other Reason|2|||
105656795|NCT02299427|364407468|FG000|Overall Study|Withdrawal by Subject|1|||
105656796|NCT02299427|364407469|FG001|Overall Study|Withdrawal by Subject|0|||
105656797|NCT02299427|364407468|FG000|Overall Study|Lost to Follow-up|1|||
105656798|NCT02299427|364407469|FG001|Overall Study|Lost to Follow-up|3|||
105656799|NCT02299427|364407468|FG000|Overall Study|not adherent to dog website use|21|||
105656800|NCT02299427|364407469|FG001|Overall Study|not adherent to dog website use|0|||
105656801|NCT03318783|364407478|FG000|Overall Study|Withdrawal by Subject|0|||
105656802|NCT03318783|364407479|FG001|Overall Study|Withdrawal by Subject|1|||
105656803|NCT03318783|364407478|FG000|Overall Study|Death|0|||
105656804|NCT03318783|364407479|FG001|Overall Study|Death|1|||
105656805|NCT00545571|364407482|FG000|Overall Study|Administrative Reasons|1|||
105656806|NCT00545571|364407482|FG000|Overall Study|Adverse Event|2|||
105656807|NCT00545571|364407482|FG000|Overall Study|Death|5|||
105656808|NCT00545571|364407482|FG000|Overall Study|Lack of Efficacy|1|||
105656809|NCT00545571|364407482|FG000|Overall Study|Protocol Violation|2|||
105656810|NCT00545571|364407482|FG000|Overall Study|Refused Treatment|1|||
105656811|NCT00545571|364407482|FG000|Overall Study|Screen Failure|16|||
105656812|NCT00545571|364407482|FG000|Overall Study|Transfusion|12|||
105656813|NCT00545571|364407482|FG000|Overall Study|Early Termination of Study|24|||
105656814|NCT00545571|364407482|FG000|Overall Study|Kidney Transplantation|3|||
105656815|NCT03269695|364407483|FG000|Overall Study|Adverse Event|2|||
105656816|NCT03269695|364407484|FG001|Overall Study|Adverse Event|1|||
105656817|NCT03269695|364407483|FG000|Overall Study|Lack of Efficacy|0|||
105656818|NCT03269695|364407484|FG001|Overall Study|Lack of Efficacy|1|||
105656819|NCT03269695|364407483|FG000|Overall Study|Withdrawal by Subject|0|||
105656820|NCT03269695|364407484|FG001|Overall Study|Withdrawal by Subject|1|||
105656821|NCT00505414|364407486|FG000|Titration Phase|Adverse Event|0|||
105656822|NCT00505414|364407487|FG001|Titration Phase|Adverse Event|0|||
105656823|NCT00505414|364407488|FG002|Titration Phase|Adverse Event|0|||
105656824|NCT00505414|364407489|FG003|Titration Phase|Adverse Event|8|||
105656825|NCT00505414|364407490|FG004|Titration Phase|Adverse Event|3|||
105656826|NCT00505414|364407486|FG000|Titration Phase|Death|0|||
105656827|NCT00505414|364407487|FG001|Titration Phase|Death|0|||
105656828|NCT00505414|364407488|FG002|Titration Phase|Death|0|||
105656829|NCT00505414|364407489|FG003|Titration Phase|Death|2|||
105656830|NCT00505414|364407490|FG004|Titration Phase|Death|0|||
105656831|NCT00505414|364407486|FG000|Titration Phase|Lack of Efficacy|0|||
105656832|NCT00505414|364407487|FG001|Titration Phase|Lack of Efficacy|0|||
105656833|NCT00505414|364407488|FG002|Titration Phase|Lack of Efficacy|0|||
105656834|NCT00505414|364407489|FG003|Titration Phase|Lack of Efficacy|10|||
105656835|NCT00505414|364407490|FG004|Titration Phase|Lack of Efficacy|1|||
105656836|NCT00505414|364407486|FG000|Titration Phase|Protocol Violation|0|||
105656837|NCT00505414|364407487|FG001|Titration Phase|Protocol Violation|0|||
105656838|NCT00505414|364407488|FG002|Titration Phase|Protocol Violation|0|||
105656839|NCT00505414|364407489|FG003|Titration Phase|Protocol Violation|0|||
105656840|NCT00505414|364407490|FG004|Titration Phase|Protocol Violation|1|||
105656841|NCT00505414|364407486|FG000|Titration Phase|Withdrawal by Subject|0|||
105656842|NCT00505414|364407487|FG001|Titration Phase|Withdrawal by Subject|0|||
105656843|NCT00505414|364407488|FG002|Titration Phase|Withdrawal by Subject|0|||
105656844|NCT00505414|364407489|FG003|Titration Phase|Withdrawal by Subject|3|||
105656845|NCT00505414|364407490|FG004|Titration Phase|Withdrawal by Subject|4|||
105656846|NCT00505414|364407486|FG000|Titration Phase|Underlying disease and therapy required|0|||
105656847|NCT00505414|364407487|FG001|Titration Phase|Underlying disease and therapy required|0|||
105656848|NCT00505414|364407488|FG002|Titration Phase|Underlying disease and therapy required|0|||
105656849|NCT00505414|364407489|FG003|Titration Phase|Underlying disease and therapy required|7|||
105656850|NCT00505414|364407490|FG004|Titration Phase|Underlying disease and therapy required|3|||
105656851|NCT00505414|364407486|FG000|Maintenance Phase|Adverse Event|2|||
105656852|NCT00505414|364407487|FG001|Maintenance Phase|Adverse Event|2|||
105656853|NCT00505414|364407488|FG002|Maintenance Phase|Adverse Event|3|||
105656854|NCT00505414|364407489|FG003|Maintenance Phase|Adverse Event|0|||
105656855|NCT00505414|364407490|FG004|Maintenance Phase|Adverse Event|0|||
105656856|NCT00505414|364407486|FG000|Maintenance Phase|Death|2|||
105656857|NCT00505414|364407487|FG001|Maintenance Phase|Death|0|||
105656858|NCT00505414|364407488|FG002|Maintenance Phase|Death|1|||
105656859|NCT00505414|364407489|FG003|Maintenance Phase|Death|0|||
105656860|NCT00505414|364407490|FG004|Maintenance Phase|Death|0|||
105656861|NCT00505414|364407486|FG000|Maintenance Phase|Lack of Efficacy|2|||
105656862|NCT00505414|364407487|FG001|Maintenance Phase|Lack of Efficacy|1|||
105656863|NCT00505414|364407488|FG002|Maintenance Phase|Lack of Efficacy|1|||
105656864|NCT00505414|364407489|FG003|Maintenance Phase|Lack of Efficacy|0|||
105656865|NCT00505414|364407490|FG004|Maintenance Phase|Lack of Efficacy|0|||
105656866|NCT00505414|364407486|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105656867|NCT00505414|364407487|FG001|Maintenance Phase|Withdrawal by Subject|0|||
105656868|NCT00505414|364407488|FG002|Maintenance Phase|Withdrawal by Subject|1|||
105656869|NCT00505414|364407489|FG003|Maintenance Phase|Withdrawal by Subject|0|||
105656870|NCT00505414|364407490|FG004|Maintenance Phase|Withdrawal by Subject|0|||
105656871|NCT00505414|364407486|FG000|Maintenance Phase|underlying disease and therapy required|0|||
105656872|NCT00505414|364407487|FG001|Maintenance Phase|underlying disease and therapy required|2|||
105656873|NCT00505414|364407488|FG002|Maintenance Phase|underlying disease and therapy required|2|||
105656874|NCT00505414|364407489|FG003|Maintenance Phase|underlying disease and therapy required|0|||
105656875|NCT00505414|364407490|FG004|Maintenance Phase|underlying disease and therapy required|0|||
105656876|NCT04353817|364407491|FG000|Overall Study|Adverse Event|0|||
105656877|NCT04353817|364407492|FG001|Overall Study|Adverse Event|1|||
105656878|NCT04358068|364407493|FG000|Overall Study|Did not initiate study treatment|2|||
105656879|NCT04358068|364407494|FG001|Overall Study|Did not initiate study treatment|2|||
105656880|NCT01841112|364407498|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
105656881|NCT01841112|364407499|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
105656882|NCT01841112|364407500|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
105656883|NCT01841112|364407501|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
105656884|NCT01841112|364407502|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
105656885|NCT03811834|364407503|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
105656886|NCT01242371|364407504|FG000|Overall Study|Withdrawal by Subject|2|||
105656887|NCT01242371|364407505|FG001|Overall Study|Withdrawal by Subject|2|||
105656888|NCT01242371|364407504|FG000|Overall Study|Protocol Violation|0|||
105656889|NCT01242371|364407505|FG001|Overall Study|Protocol Violation|3|||
105656890|NCT00510146|364407506|FG000|Double-Blind Treatment|Adverse Event|30|||
105656891|NCT00510146|364407507|FG001|Double-Blind Treatment|Adverse Event|13|||
105656892|NCT00510146|364407506|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
105656893|NCT00510146|364407507|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
105656894|NCT00510146|364407506|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
105656895|NCT00510146|364407507|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
105656896|NCT00510146|364407506|FG000|Double-Blind Treatment|Physician Decision|6|||
105656897|NCT00510146|364407507|FG001|Double-Blind Treatment|Physician Decision|0|||
105656898|NCT00510146|364407506|FG000|Double-Blind Treatment|Protocol Violation|1|||
105656899|NCT00510146|364407507|FG001|Double-Blind Treatment|Protocol Violation|2|||
105656900|NCT00510146|364407506|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
105656901|NCT00510146|364407507|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
105656902|NCT00510146|364407506|FG000|Double-Blind Treatment|Clinical Relapse|0|||
105656903|NCT00510146|364407507|FG001|Double-Blind Treatment|Clinical Relapse|1|||
105656904|NCT00510146|364407506|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
105656905|NCT00510146|364407507|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
105656906|NCT00510146|364407506|FG000|Open-Label Treatment|Adverse Event|22|||
105656907|NCT00510146|364407507|FG001|Open-Label Treatment|Adverse Event|8|||
105656908|NCT00510146|364407506|FG000|Open-Label Treatment|Death|1|||
105656909|NCT00510146|364407507|FG001|Open-Label Treatment|Death|1|||
105656910|NCT00510146|364407506|FG000|Open-Label Treatment|Lack of Efficacy|4|||
105656911|NCT00510146|364407507|FG001|Open-Label Treatment|Lack of Efficacy|0|||
105656912|NCT00510146|364407506|FG000|Open-Label Treatment|Lost to Follow-up|10|||
105656913|NCT00510146|364407507|FG001|Open-Label Treatment|Lost to Follow-up|1|||
105656914|NCT00510146|364407506|FG000|Open-Label Treatment|Physician Decision|3|||
105656915|NCT00510146|364407507|FG001|Open-Label Treatment|Physician Decision|1|||
105656916|NCT00510146|364407506|FG000|Open-Label Treatment|Protocol Violation|4|||
105656917|NCT00510146|364407507|FG001|Open-Label Treatment|Protocol Violation|2|||
105656918|NCT00510146|364407506|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
105656919|NCT00510146|364407507|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
105656920|NCT00510146|364407506|FG000|Open-Label Treatment|Clinical Relapse|1|||
105656921|NCT00510146|364407507|FG001|Open-Label Treatment|Clinical Relapse|1|||
105656922|NCT00510146|364407506|FG000|Open-Label Treatment|Sponsor Decision|2|||
105656923|NCT00510146|364407507|FG001|Open-Label Treatment|Sponsor Decision|0|||
105656924|NCT04354168|364407510|FG000|Overall Study|Lost to Follow-up|22|||
105656925|NCT01438840|364407511|FG000|Core Study|Adverse Event|0|||
105656926|NCT01438840|364407512|FG001|Core Study|Adverse Event|3|||
105656927|NCT01438840|364407513|FG002|Core Study|Adverse Event|0|||
105656928|NCT01438840|364407511|FG000|Core Study|Lack of Efficacy|15|||
105656929|NCT01438840|364407512|FG001|Core Study|Lack of Efficacy|7|||
105656930|NCT01438840|364407513|FG002|Core Study|Lack of Efficacy|0|||
105656931|NCT01438840|364407511|FG000|Core Study|Withdrawal of consent|1|||
105656932|NCT01438840|364407512|FG001|Core Study|Withdrawal of consent|0|||
105656933|NCT01438840|364407513|FG002|Core Study|Withdrawal of consent|0|||
105656934|NCT01438840|364407511|FG000|Extension Phase|Adverse Event|0|||
105656935|NCT01438840|364407512|FG001|Extension Phase|Adverse Event|0|||
105656936|NCT01438840|364407513|FG002|Extension Phase|Adverse Event|3|||
105656937|NCT01438840|364407511|FG000|Extension Phase|Lost to Follow-up|0|||
105656938|NCT01438840|364407512|FG001|Extension Phase|Lost to Follow-up|0|||
105656939|NCT01438840|364407513|FG002|Extension Phase|Lost to Follow-up|1|||
105656940|NCT01438840|364407511|FG000|Extension Phase|Withdrawal by Subject|0|||
105656941|NCT01438840|364407512|FG001|Extension Phase|Withdrawal by Subject|0|||
105656942|NCT01438840|364407513|FG002|Extension Phase|Withdrawal by Subject|3|||
105656943|NCT01438840|364407511|FG000|Extension Phase|Lack of Efficacy|0|||
105656944|NCT01438840|364407512|FG001|Extension Phase|Lack of Efficacy|0|||
105656945|NCT01438840|364407513|FG002|Extension Phase|Lack of Efficacy|2|||
105656946|NCT01438840|364407511|FG000|Extension Phase|Other|0|||
105656947|NCT01438840|364407512|FG001|Extension Phase|Other|0|||
105656948|NCT01438840|364407513|FG002|Extension Phase|Other|1|||
105656949|NCT03589300|364407516|FG000|Overall Study|Adverse Event|2|||
105656950|NCT03589300|364407516|FG000|Overall Study|Death|4|||
105656951|NCT03589300|364407516|FG000|Overall Study|Lost to Follow-up|12|||
105656952|NCT03589300|364407516|FG000|Overall Study|Withdrawal by Subject|5|||
105656953|NCT00461123|364407517|FG000|Overall Study|Adverse Event|1|||
105656954|NCT00461123|364407518|FG001|Overall Study|Adverse Event|0|||
105656955|NCT00461123|364407517|FG000|Overall Study|Lost to Follow-up|1|||
105656956|NCT00461123|364407518|FG001|Overall Study|Lost to Follow-up|1|||
105656957|NCT00461123|364407517|FG000|Overall Study|Protocol Violation|3|||
105656958|NCT00461123|364407518|FG001|Overall Study|Protocol Violation|2|||
105656959|NCT00461123|364407517|FG000|Overall Study|Withdrawal by Subject|1|||
105656960|NCT00461123|364407518|FG001|Overall Study|Withdrawal by Subject|3|||
105656961|NCT02261285|364407519|FG000|Overall Study|Disease progression|0|||
105656962|NCT02261285|364407520|FG001|Overall Study|Disease progression|0|||
105656963|NCT02261285|364407521|FG002|Overall Study|Disease progression|1|||
105656964|NCT03738397|364407522|FG000|Overall Study|Adverse Event|3|||
105656965|NCT03738397|364407523|FG001|Overall Study|Adverse Event|7|||
105656966|NCT03738397|364407522|FG000|Overall Study|Withdrawal by Subject|8|||
105656967|NCT03738397|364407523|FG001|Overall Study|Withdrawal by Subject|11|||
105656968|NCT03738397|364407522|FG000|Overall Study|Lost to Follow-up|7|||
105656969|NCT03738397|364407523|FG001|Overall Study|Lost to Follow-up|5|||
105656970|NCT03738397|364407522|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
105656971|NCT03738397|364407523|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
105656972|NCT03738397|364407522|FG000|Overall Study|Other|4|||
105656973|NCT03738397|364407523|FG001|Overall Study|Other|6|||
105656974|NCT00904722|364407524|FG000|Overall Study|Physician Decision|1|||
105656975|NCT01891890|364407525|FG000|Overall Study|Lost to Follow-up|0|||
105656976|NCT01891890|364407526|FG001|Overall Study|Lost to Follow-up|0|||
105656977|NCT01891890|364407527|FG002|Overall Study|Lost to Follow-up|1|||
105656978|NCT01891890|364407525|FG000|Overall Study|Study ended before endpoint reached|7|||
105656979|NCT01891890|364407526|FG001|Overall Study|Study ended before endpoint reached|3|||
105656980|NCT01891890|364407527|FG002|Overall Study|Study ended before endpoint reached|6|||
105656981|NCT04969224|364407528|FG000|Overall Study|Adverse Event|1|||
105656982|NCT04969224|364407528|FG000|Overall Study|Enrolled but never dosed|1|||
105656983|NCT03605368|364407538|FG000|Overall Study|Lost to Follow-up|2|||
105656984|NCT03605368|364407539|FG001|Overall Study|Lost to Follow-up|1|||
105656985|NCT03605368|364407540|FG002|Overall Study|Lost to Follow-up|3|||
105656986|NCT03605368|364407541|FG003|Overall Study|Lost to Follow-up|2|||
105656987|NCT03605368|364407538|FG000|Overall Study|Withdrawal by Subject|0|||
105656988|NCT03605368|364407539|FG001|Overall Study|Withdrawal by Subject|0|||
105656989|NCT03605368|364407540|FG002|Overall Study|Withdrawal by Subject|4|||
105656990|NCT03605368|364407541|FG003|Overall Study|Withdrawal by Subject|3|||
105656991|NCT01215032|364407542|FG000|Overall Study|Adverse Event|3|||
105656992|NCT01215032|364407542|FG000|Overall Study|Lack of Efficacy|17|||
105656993|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
105656994|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
105656995|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
105656996|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
105656997|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
105656998|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
105656999|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
105657000|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
105657001|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
105657002|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
105657003|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
105657004|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
105657005|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
105657006|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
105657007|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
105657008|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
105657009|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
105657010|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
105657011|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
105657012|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
105657013|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
105657014|NCT01125566|364407543|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
105657015|NCT01125566|364407544|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
105657016|NCT01125566|364407545|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
105657017|NCT01125566|364407543|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
105657018|NCT01125566|364407544|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
105657019|NCT01125566|364407545|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
105657020|NCT01125566|364407543|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
105657021|NCT01125566|364407544|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
105657022|NCT01125566|364407545|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
105657023|NCT01125566|364407543|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
105657024|NCT01125566|364407544|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
105657025|NCT01125566|364407545|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
105657026|NCT01125566|364407543|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
105657027|NCT01125566|364407544|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
105657028|NCT01125566|364407545|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
105657029|NCT01020747|364407548|FG000|Overall Study|Withdrawal by Subject|1|||
105657030|NCT01222078|364407549|FG000|Overall Study|Early termination of the study|1|||
105657031|NCT02970305|364407551|FG000|Overall Study|Adverse Event|10|||
105657032|NCT02970305|364407552|FG001|Overall Study|Adverse Event|6|||
105657033|NCT02970305|364407551|FG000|Overall Study|Lack of Efficacy|1|||
105657034|NCT02970305|364407552|FG001|Overall Study|Lack of Efficacy|1|||
105657035|NCT02970305|364407551|FG000|Overall Study|Noncompliance with study drug|2|||
105657036|NCT02970305|364407552|FG001|Overall Study|Noncompliance with study drug|4|||
105657037|NCT02970305|364407551|FG000|Overall Study|Protocol Violation|2|||
105657038|NCT02970305|364407552|FG001|Overall Study|Protocol Violation|2|||
105657039|NCT02970305|364407551|FG000|Overall Study|Withdrawal by Subject|12|||
105657040|NCT02970305|364407552|FG001|Overall Study|Withdrawal by Subject|11|||
105657041|NCT02970305|364407551|FG000|Overall Study|Not further specified|1|||
105657042|NCT02970305|364407552|FG001|Overall Study|Not further specified|2|||
105657043|NCT02970305|364407551|FG000|Overall Study|Lost to Follow-up|1|||
105657044|NCT02970305|364407552|FG001|Overall Study|Lost to Follow-up|2|||
105657045|NCT00983892|364407553|FG000|Overall Study|Withdrawal by Subject|10|||
105657046|NCT00983892|364407554|FG001|Overall Study|Withdrawal by Subject|12|||
105657047|NCT02650466|364407555|FG000|Overall Study|Physician Decision|1|||
105657048|NCT02650466|364407555|FG000|Overall Study|Withdrawal by Subject|5|||
105657049|NCT02650466|364407555|FG000|Overall Study|Lost to Follow-up|1|||
105657050|NCT00573651|364407559|FG000|Overall Study|Lost to Follow-up|3|||
105657051|NCT00573651|364407559|FG000|Overall Study|Withdrawal by Subject|1|||
105657052|NCT02484547|364407560|FG000|Placebo-Controlled Period|Adverse Event|10|||
105657053|NCT02484547|364407561|FG001|Placebo-Controlled Period|Adverse Event|13|||
105657054|NCT02484547|364407562|FG002|Placebo-Controlled Period|Adverse Event|20|||
105657055|NCT02484547|364407563|FG003|Placebo-Controlled Period|Adverse Event|0|||
105657056|NCT02484547|364407564|FG004|Placebo-Controlled Period|Adverse Event|0|||
105657057|NCT02484547|364407565|FG005|Placebo-Controlled Period|Adverse Event|0|||
105657058|NCT02484547|364407566|FG006|Placebo-Controlled Period|Adverse Event|0|||
105657059|NCT02484547|364407560|FG000|Placebo-Controlled Period|Change of Treatment|0|||
105657060|NCT02484547|364407561|FG001|Placebo-Controlled Period|Change of Treatment|0|||
105657061|NCT02484547|364407562|FG002|Placebo-Controlled Period|Change of Treatment|1|||
105657062|NCT02484547|364407563|FG003|Placebo-Controlled Period|Change of Treatment|0|||
105657063|NCT02484547|364407564|FG004|Placebo-Controlled Period|Change of Treatment|0|||
105657064|NCT02484547|364407565|FG005|Placebo-Controlled Period|Change of Treatment|0|||
105657065|NCT02484547|364407566|FG006|Placebo-Controlled Period|Change of Treatment|0|||
105657066|NCT02484547|364407560|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
105657067|NCT02484547|364407561|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
105657068|NCT02484547|364407562|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
105657069|NCT02484547|364407563|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
105657070|NCT02484547|364407564|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
105657071|NCT02484547|364407565|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
105657072|NCT02484547|364407566|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
105657073|NCT02484547|364407560|FG000|Placebo-Controlled Period|Death|5|||
105657074|NCT02484547|364407561|FG001|Placebo-Controlled Period|Death|0|||
105657075|NCT02484547|364407562|FG002|Placebo-Controlled Period|Death|6|||
105657076|NCT02484547|364407563|FG003|Placebo-Controlled Period|Death|0|||
105657077|NCT02484547|364407564|FG004|Placebo-Controlled Period|Death|0|||
105657078|NCT02484547|364407565|FG005|Placebo-Controlled Period|Death|0|||
105657079|NCT02484547|364407566|FG006|Placebo-Controlled Period|Death|0|||
105657080|NCT02484547|364407560|FG000|Placebo-Controlled Period|Disease Progression|2|||
105657081|NCT02484547|364407561|FG001|Placebo-Controlled Period|Disease Progression|0|||
105657082|NCT02484547|364407562|FG002|Placebo-Controlled Period|Disease Progression|1|||
105657083|NCT02484547|364407563|FG003|Placebo-Controlled Period|Disease Progression|0|||
105657084|NCT02484547|364407564|FG004|Placebo-Controlled Period|Disease Progression|0|||
105657085|NCT02484547|364407565|FG005|Placebo-Controlled Period|Disease Progression|0|||
105657086|NCT02484547|364407566|FG006|Placebo-Controlled Period|Disease Progression|0|||
105657087|NCT02484547|364407560|FG000|Placebo-Controlled Period|Investigator Decision|2|||
105657088|NCT02484547|364407561|FG001|Placebo-Controlled Period|Investigator Decision|2|||
105657089|NCT02484547|364407562|FG002|Placebo-Controlled Period|Investigator Decision|5|||
105657090|NCT02484547|364407563|FG003|Placebo-Controlled Period|Investigator Decision|0|||
105657091|NCT02484547|364407564|FG004|Placebo-Controlled Period|Investigator Decision|0|||
105657092|NCT02484547|364407565|FG005|Placebo-Controlled Period|Investigator Decision|0|||
105657093|NCT02484547|364407566|FG006|Placebo-Controlled Period|Investigator Decision|0|||
105657094|NCT02484547|364407560|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
105657095|NCT02484547|364407561|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
105657096|NCT02484547|364407562|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
105657097|NCT02484547|364407563|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
105657098|NCT02484547|364407564|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
105657099|NCT02484547|364407565|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
105657100|NCT02484547|364407566|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
105657101|NCT02484547|364407560|FG000|Placebo-Controlled Period|Relocation|1|||
105657102|NCT02484547|364407561|FG001|Placebo-Controlled Period|Relocation|1|||
105657103|NCT02484547|364407562|FG002|Placebo-Controlled Period|Relocation|1|||
105657104|NCT02484547|364407563|FG003|Placebo-Controlled Period|Relocation|0|||
105657105|NCT02484547|364407564|FG004|Placebo-Controlled Period|Relocation|0|||
105657106|NCT02484547|364407565|FG005|Placebo-Controlled Period|Relocation|0|||
105657107|NCT02484547|364407566|FG006|Placebo-Controlled Period|Relocation|0|||
105657108|NCT02484547|364407560|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
105657109|NCT02484547|364407561|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
105657110|NCT02484547|364407562|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
105657111|NCT02484547|364407563|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
105657112|NCT02484547|364407564|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
105657113|NCT02484547|364407565|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
105657114|NCT02484547|364407566|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
105657115|NCT02484547|364407560|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
105657116|NCT02484547|364407561|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
105657117|NCT02484547|364407562|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
105657118|NCT02484547|364407563|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105657119|NCT02484547|364407564|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105657120|NCT02484547|364407565|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105657121|NCT02484547|364407566|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
105657122|NCT02484547|364407560|FG000|Placebo-Controlled Period|Reason not Specified|216|||
105657123|NCT02484547|364407561|FG001|Placebo-Controlled Period|Reason not Specified|194|||
105657124|NCT02484547|364407562|FG002|Placebo-Controlled Period|Reason not Specified|183|||
105657125|NCT02484547|364407563|FG003|Placebo-Controlled Period|Reason not Specified|0|||
105657126|NCT02484547|364407564|FG004|Placebo-Controlled Period|Reason not Specified|0|||
105657127|NCT02484547|364407565|FG005|Placebo-Controlled Period|Reason not Specified|0|||
105657128|NCT02484547|364407566|FG006|Placebo-Controlled Period|Reason not Specified|0|||
105657129|NCT02484547|364407560|FG000|Long-Term Extension Period|Adverse Event|0|||
105657130|NCT02484547|364407561|FG001|Long-Term Extension Period|Adverse Event|0|||
105657131|NCT02484547|364407562|FG002|Long-Term Extension Period|Adverse Event|0|||
105657132|NCT02484547|364407563|FG003|Long-Term Extension Period|Adverse Event|0|||
105657133|NCT02484547|364407564|FG004|Long-Term Extension Period|Adverse Event|1|||
105657134|NCT02484547|364407565|FG005|Long-Term Extension Period|Adverse Event|3|||
105657135|NCT02484547|364407566|FG006|Long-Term Extension Period|Adverse Event|2|||
105657136|NCT02484547|364407560|FG000|Long-Term Extension Period|Death|0|||
105657137|NCT02484547|364407561|FG001|Long-Term Extension Period|Death|0|||
105657138|NCT02484547|364407562|FG002|Long-Term Extension Period|Death|0|||
105657139|NCT02484547|364407563|FG003|Long-Term Extension Period|Death|0|||
105657140|NCT02484547|364407564|FG004|Long-Term Extension Period|Death|0|||
105657141|NCT02484547|364407565|FG005|Long-Term Extension Period|Death|3|||
105657142|NCT02484547|364407566|FG006|Long-Term Extension Period|Death|0|||
105657143|NCT02484547|364407560|FG000|Long-Term Extension Period|Disease Progression|0|||
105657144|NCT02484547|364407561|FG001|Long-Term Extension Period|Disease Progression|0|||
105657145|NCT02484547|364407562|FG002|Long-Term Extension Period|Disease Progression|0|||
105657146|NCT02484547|364407563|FG003|Long-Term Extension Period|Disease Progression|0|||
105657147|NCT02484547|364407564|FG004|Long-Term Extension Period|Disease Progression|2|||
105657148|NCT02484547|364407565|FG005|Long-Term Extension Period|Disease Progression|4|||
105657149|NCT02484547|364407566|FG006|Long-Term Extension Period|Disease Progression|0|||
105657150|NCT02484547|364407560|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
105657151|NCT02484547|364407561|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
105657152|NCT02484547|364407562|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
105657153|NCT02484547|364407563|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
105657154|NCT02484547|364407564|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
105657155|NCT02484547|364407565|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
105657156|NCT02484547|364407566|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
105657157|NCT02484547|364407560|FG000|Long-Term Extension Period|Loss of Capacity|0|||
105657158|NCT02484547|364407561|FG001|Long-Term Extension Period|Loss of Capacity|0|||
105657159|NCT02484547|364407562|FG002|Long-Term Extension Period|Loss of Capacity|0|||
105657160|NCT02484547|364407563|FG003|Long-Term Extension Period|Loss of Capacity|0|||
105657161|NCT02484547|364407564|FG004|Long-Term Extension Period|Loss of Capacity|1|||
105657162|NCT02484547|364407565|FG005|Long-Term Extension Period|Loss of Capacity|0|||
105657163|NCT02484547|364407566|FG006|Long-Term Extension Period|Loss of Capacity|0|||
105657164|NCT02484547|364407560|FG000|Long-Term Extension Period|Change of Treatment|0|||
105657165|NCT02484547|364407561|FG001|Long-Term Extension Period|Change of Treatment|0|||
105657166|NCT02484547|364407562|FG002|Long-Term Extension Period|Change of Treatment|0|||
105657167|NCT02484547|364407563|FG003|Long-Term Extension Period|Change of Treatment|0|||
105657168|NCT02484547|364407564|FG004|Long-Term Extension Period|Change of Treatment|0|||
105657169|NCT02484547|364407565|FG005|Long-Term Extension Period|Change of Treatment|0|||
105657170|NCT02484547|364407566|FG006|Long-Term Extension Period|Change of Treatment|1|||
105657171|NCT02484547|364407560|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
105657172|NCT02484547|364407561|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
105657173|NCT02484547|364407562|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
105657174|NCT02484547|364407563|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
105657175|NCT02484547|364407564|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
105657176|NCT02484547|364407565|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
105657177|NCT02484547|364407566|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
105657178|NCT02484547|364407560|FG000|Long-Term Extension Period|Investigator Decision|0|||
105657179|NCT02484547|364407561|FG001|Long-Term Extension Period|Investigator Decision|0|||
105657180|NCT02484547|364407562|FG002|Long-Term Extension Period|Investigator Decision|0|||
105657181|NCT02484547|364407563|FG003|Long-Term Extension Period|Investigator Decision|2|||
105657182|NCT02484547|364407564|FG004|Long-Term Extension Period|Investigator Decision|1|||
105657183|NCT02484547|364407565|FG005|Long-Term Extension Period|Investigator Decision|0|||
105657184|NCT02484547|364407566|FG006|Long-Term Extension Period|Investigator Decision|1|||
105657185|NCT02484547|364407560|FG000|Long-Term Extension Period|Relocation|0|||
105657186|NCT02484547|364407561|FG001|Long-Term Extension Period|Relocation|0|||
105657187|NCT02484547|364407562|FG002|Long-Term Extension Period|Relocation|0|||
105657188|NCT02484547|364407563|FG003|Long-Term Extension Period|Relocation|1|||
105657189|NCT02484547|364407564|FG004|Long-Term Extension Period|Relocation|1|||
105657190|NCT02484547|364407565|FG005|Long-Term Extension Period|Relocation|0|||
105657191|NCT02484547|364407566|FG006|Long-Term Extension Period|Relocation|0|||
105657192|NCT02484547|364407560|FG000|Long-Term Extension Period|Study Visit Burden|0|||
105657193|NCT02484547|364407561|FG001|Long-Term Extension Period|Study Visit Burden|0|||
105657194|NCT02484547|364407562|FG002|Long-Term Extension Period|Study Visit Burden|0|||
105657195|NCT02484547|364407563|FG003|Long-Term Extension Period|Study Visit Burden|2|||
105657196|NCT02484547|364407564|FG004|Long-Term Extension Period|Study Visit Burden|0|||
105657197|NCT02484547|364407565|FG005|Long-Term Extension Period|Study Visit Burden|0|||
105657198|NCT02484547|364407566|FG006|Long-Term Extension Period|Study Visit Burden|3|||
105657199|NCT02484547|364407560|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
105657200|NCT02484547|364407561|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
105657201|NCT02484547|364407562|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
105657202|NCT02484547|364407563|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
105657203|NCT02484547|364407564|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
105657204|NCT02484547|364407565|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
105657205|NCT02484547|364407566|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
105657206|NCT02484547|364407560|FG000|Long-Term Extension Period|Reason not Specified|0|||
105657207|NCT02484547|364407561|FG001|Long-Term Extension Period|Reason not Specified|0|||
105657208|NCT02484547|364407562|FG002|Long-Term Extension Period|Reason not Specified|0|||
105657209|NCT02484547|364407563|FG003|Long-Term Extension Period|Reason not Specified|119|||
105657210|NCT02484547|364407564|FG004|Long-Term Extension Period|Reason not Specified|117|||
105657211|NCT02484547|364407565|FG005|Long-Term Extension Period|Reason not Specified|223|||
105657212|NCT02484547|364407566|FG006|Long-Term Extension Period|Reason not Specified|231|||
105870466|NCT01130532|365179070|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
105870467|NCT01130532|365179071|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
105870468|NCT01130532|365179072|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
105870469|NCT01130532|365179073|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
105870470|NCT01130532|365179070|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
105870471|NCT01130532|365179071|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
105870472|NCT01130532|365179072|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
105870473|NCT01130532|365179073|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
105870474|NCT01130532|365179070|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
105870475|NCT01130532|365179071|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
105870476|NCT01130532|365179072|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
105870477|NCT01130532|365179073|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
105870478|NCT01130532|365179070|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
105870479|NCT01130532|365179071|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
105870480|NCT01130532|365179072|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
105870481|NCT01130532|365179073|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
105870482|NCT01130532|365179070|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
105870483|NCT01130532|365179071|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
105870484|NCT01130532|365179072|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
105870485|NCT01130532|365179073|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
105870486|NCT01130532|365179070|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
105870487|NCT01130532|365179071|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
105870488|NCT01130532|365179072|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
105870489|NCT01130532|365179073|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
105870490|NCT01130532|365179070|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
105870491|NCT01130532|365179071|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
105870492|NCT01130532|365179072|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
105870493|NCT01130532|365179073|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
105870494|NCT01130532|365179070|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
105870495|NCT01130532|365179071|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
105870496|NCT01130532|365179072|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
105870497|NCT01130532|365179073|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
105870498|NCT01130532|365179070|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
105870499|NCT01130532|365179071|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
105870500|NCT01130532|365179072|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
105870501|NCT01130532|365179073|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
105870502|NCT01130532|365179070|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
105870503|NCT01130532|365179071|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
105870504|NCT01130532|365179072|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
105870505|NCT01130532|365179073|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
105870506|NCT01130532|365179070|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
105870507|NCT01130532|365179071|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
105870508|NCT01130532|365179072|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
105870509|NCT01130532|365179073|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
105870510|NCT01567462|365179080|FG000|Overall Study|Withdrawal by Subject|4|||
105870511|NCT01567462|365179081|FG001|Overall Study|Withdrawal by Subject|7|||
105657213|NCT01227928|364407569|FG000|Overall Study|Lost to Follow-up|4|||
105657214|NCT01227928|364407570|FG001|Overall Study|Lost to Follow-up|2|||
105657215|NCT01227928|364407569|FG000|Overall Study|Withdrawal by Subject|4|||
105657216|NCT01227928|364407570|FG001|Overall Study|Withdrawal by Subject|3|||
105657217|NCT01227928|364407569|FG000|Overall Study|Death|14|||
105657218|NCT01227928|364407570|FG001|Overall Study|Death|12|||
105657219|NCT00474383|364407575|FG000|Main Study|Adverse Event|11|||
105657220|NCT00474383|364407576|FG001|Main Study|Adverse Event|0|||
105657221|NCT00474383|364407575|FG000|Main Study|Symptomatic Deterioration|1|||
105657222|NCT00474383|364407576|FG001|Main Study|Symptomatic Deterioration|0|||
105657223|NCT00474383|364407575|FG000|Main Study|Progressive Disease|23|||
105657224|NCT00474383|364407576|FG001|Main Study|Progressive Disease|0|||
105657225|NCT00474383|364407575|FG000|Main Study|Other|1|||
105657226|NCT00474383|364407576|FG001|Main Study|Other|0|||
105657227|NCT00474383|364407575|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
105657228|NCT00474383|364407576|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
105657229|NCT00474383|364407575|FG000|Extension|Progressive Disease|0|||
105657230|NCT00474383|364407576|FG001|Extension|Progressive Disease|5|||
105657231|NCT01268098|364409777|FG000|Overall Study|Adverse Event|1|||
105657232|NCT01268098|364409778|FG001|Overall Study|Adverse Event|0|||
105870512|NCT02847260|365179082|FG000|Overall Study|Adverse Event|3|||
105870513|NCT02847260|365179082|FG000|Overall Study|Withdrawal by Subject|2|||
105870514|NCT02847260|365179082|FG000|Overall Study|Clinical Deterioration|1|||
105657233|NCT02806505|364409779|FG000|Overall Study|Adverse event/intercurrent illness|1|||
105657234|NCT02806505|364409780|FG001|Overall Study|Adverse event/intercurrent illness|3|||
105657235|NCT02806505|364409779|FG000|Overall Study|Death|4|||
105657236|NCT02806505|364409780|FG001|Overall Study|Death|0|||
105657237|NCT02806505|364409779|FG000|Overall Study|Did not cooperate/refused treatment|3|||
105870515|NCT02847260|365179082|FG000|Overall Study|Physician Decision|1|||
105870516|NCT01842438|365179084|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
105870517|NCT01842438|365179085|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
105870518|NCT01842438|365179084|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
105870519|NCT01842438|365179085|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
105870520|NCT01842438|365179084|FG000|T2: 6month Follow-up|Death|0|||
105870521|NCT01842438|365179085|FG001|T2: 6month Follow-up|Death|1|||
105870522|NCT00782626|365179089|FG000|Overall Study|Adverse Event|1|||
105870523|NCT00782626|365179089|FG000|Overall Study|Progressive Disease|5|||
105870524|NCT00782626|365179089|FG000|Overall Study|Other Complicating Disease|1|||
105870525|NCT03642262|365179090|FG000|Period 1|Withdrawal by Subject|1|||
105870526|NCT03642262|365179091|FG001|Period 1|Withdrawal by Subject|1|||
105870527|NCT03642262|365179090|FG000|Period 1|Adverse Event|0|||
105870528|NCT03642262|365179091|FG001|Period 1|Adverse Event|1|||
105870529|NCT01050530|365179092|FG000|Overall Study|Adverse Event|6|||
105870530|NCT01050530|365179093|FG001|Overall Study|Adverse Event|3|||
105870531|NCT01050530|365179092|FG000|Overall Study|Lack of Efficacy|1|||
105870532|NCT01050530|365179093|FG001|Overall Study|Lack of Efficacy|4|||
105870533|NCT01050530|365179092|FG000|Overall Study|Withdrawal by Subject|0|||
105870534|NCT01050530|365179093|FG001|Overall Study|Withdrawal by Subject|3|||
105870535|NCT01050530|365179092|FG000|Overall Study|Protocol Violation|1|||
105870536|NCT01050530|365179093|FG001|Overall Study|Protocol Violation|0|||
105870537|NCT02556801|365179106|FG000|Overall Study|Lost to Follow-up|1|||
105870538|NCT02556801|365179107|FG001|Overall Study|Lost to Follow-up|0|||
105870539|NCT02556801|365179108|FG002|Overall Study|Lost to Follow-up|2|||
105870540|NCT02556801|365179109|FG003|Overall Study|Lost to Follow-up|0|||
105870541|NCT02556801|365179106|FG000|Overall Study|Withdrawal by Subject|1|||
105870542|NCT02556801|365179107|FG001|Overall Study|Withdrawal by Subject|1|||
105870543|NCT02556801|365179108|FG002|Overall Study|Withdrawal by Subject|1|||
105870544|NCT02556801|365179109|FG003|Overall Study|Withdrawal by Subject|0|||
105870545|NCT02556801|365179106|FG000|Overall Study|Protocol Violation|0|||
105870546|NCT02556801|365179107|FG001|Overall Study|Protocol Violation|3|||
105870547|NCT02556801|365179108|FG002|Overall Study|Protocol Violation|1|||
105870548|NCT02556801|365179109|FG003|Overall Study|Protocol Violation|1|||
105870549|NCT02556801|365179106|FG000|Overall Study|Adverse Event|0|||
105870550|NCT02556801|365179107|FG001|Overall Study|Adverse Event|2|||
105870551|NCT02556801|365179108|FG002|Overall Study|Adverse Event|0|||
105870552|NCT02556801|365179109|FG003|Overall Study|Adverse Event|3|||
105870553|NCT02556801|365179106|FG000|Overall Study|Pregnancy|0|||
105870554|NCT02556801|365179107|FG001|Overall Study|Pregnancy|1|||
105870555|NCT02556801|365179108|FG002|Overall Study|Pregnancy|0|||
105657238|NCT02806505|364409780|FG001|Overall Study|Did not cooperate/refused treatment|3|||
105657239|NCT02806505|364409779|FG000|Overall Study|Failure to return|0|||
105657240|NCT02806505|364409780|FG001|Overall Study|Failure to return|1|||
105657241|NCT02806505|364409779|FG000|Overall Study|Insufficient therapeutic response|2|||
105657242|NCT02806505|364409780|FG001|Overall Study|Insufficient therapeutic response|4|||
105657243|NCT04156399|364409785|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
105657244|NCT04156399|364409785|FG000|Overall Study|study suspension due to COVID pandemic|3|||
105657245|NCT04732871|364409786|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
105657246|NCT04732871|364409787|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
105657247|NCT04732871|364409788|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
105657248|NCT04732871|364409786|FG000|Overall Study|Lost to Follow-up|7|||
105657249|NCT04732871|364409787|FG001|Overall Study|Lost to Follow-up|4|||
105657250|NCT04732871|364409788|FG002|Overall Study|Lost to Follow-up|3|||
105657251|NCT04732871|364409786|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
105657252|NCT04732871|364409787|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
105657253|NCT04732871|364409788|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
105657254|NCT04732871|364409786|FG000|Overall Study|Migrated / moved from the study area|5|||
105657255|NCT04732871|364409787|FG001|Overall Study|Migrated / moved from the study area|0|||
105657256|NCT04732871|364409788|FG002|Overall Study|Migrated / moved from the study area|0|||
105657257|NCT04732871|364409786|FG000|Overall Study|Other|1|||
105657258|NCT04732871|364409787|FG001|Overall Study|Other|0|||
105657259|NCT04732871|364409788|FG002|Overall Study|Other|1|||
105657260|NCT04732871|364409786|FG000|Overall Study|Ongoing|6|||
105657261|NCT04732871|364409787|FG001|Overall Study|Ongoing|0|||
105657262|NCT04732871|364409788|FG002|Overall Study|Ongoing|1|||
105657263|NCT04732871|364409786|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
105657264|NCT04732871|364409787|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
105657265|NCT04732871|364409788|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
105657266|NCT03458728|364409789|FG000|Overall Study|Adverse Event|1|||
105657267|NCT03458728|364409790|FG001|Overall Study|Adverse Event|0|||
105870556|NCT02556801|365179109|FG003|Overall Study|Pregnancy|0|||
105870557|NCT02556801|365179106|FG000|Overall Study|Personal reasons patient|0|||
105870558|NCT02556801|365179107|FG001|Overall Study|Personal reasons patient|0|||
105870559|NCT02556801|365179108|FG002|Overall Study|Personal reasons patient|0|||
105870560|NCT02556801|365179109|FG003|Overall Study|Personal reasons patient|1|||
105657268|NCT03458728|364409789|FG000|Overall Study|Physician Decision|1|||
105657269|NCT03458728|364409790|FG001|Overall Study|Physician Decision|0|||
105657270|NCT03458728|364409789|FG000|Overall Study|Progressive disease - clinical assessment|1|||
105657271|NCT03458728|364409790|FG001|Overall Study|Progressive disease - clinical assessment|0|||
105657272|NCT03458728|364409789|FG000|Overall Study|Progressive disease - radiological progression|21|||
105657273|NCT03458728|364409790|FG001|Overall Study|Progressive disease - radiological progression|6|||
105657274|NCT03458728|364409789|FG000|Overall Study|Withdrawal by Subject|0|||
105657275|NCT03458728|364409790|FG001|Overall Study|Withdrawal by Subject|1|||
105657276|NCT01644188|364409791|FG000|Overall Study|Adverse Event|44|||
105657277|NCT01644188|364409792|FG001|Overall Study|Adverse Event|20|||
105657278|NCT01644188|364409791|FG000|Overall Study|Poor compliance to protocol|26|||
105657279|NCT01644188|364409792|FG001|Overall Study|Poor compliance to protocol|14|||
105657280|NCT01644188|364409791|FG000|Overall Study|Physician Decision|1|||
105657281|NCT01644188|364409792|FG001|Overall Study|Physician Decision|3|||
105657282|NCT01644188|364409791|FG000|Overall Study|Participant moved|7|||
105657283|NCT01644188|364409792|FG001|Overall Study|Participant moved|2|||
105657284|NCT01644188|364409791|FG000|Overall Study|Related to auto-injector administration|2|||
105657285|NCT01644188|364409792|FG001|Overall Study|Related to auto-injector administration|2|||
105657286|NCT01644188|364409791|FG000|Overall Study|Consent withdrawn by participant|14|||
105657287|NCT01644188|364409792|FG001|Overall Study|Consent withdrawn by participant|7|||
105657288|NCT01644188|364409791|FG000|Overall Study|Selection criteria finally not met|2|||
105657289|NCT01644188|364409792|FG001|Overall Study|Selection criteria finally not met|0|||
105657290|NCT01644188|364409791|FG000|Overall Study|Lost to Follow-up|1|||
105657291|NCT01644188|364409792|FG001|Overall Study|Lost to Follow-up|0|||
105657292|NCT01644188|364409791|FG000|Overall Study|Death|4|||
105657293|NCT01644188|364409792|FG001|Overall Study|Death|3|||
105657294|NCT01644188|364409791|FG000|Overall Study|Last visit outside protocol visit window|14|||
105657295|NCT01644188|364409792|FG001|Overall Study|Last visit outside protocol visit window|16|||
105657296|NCT01644188|364409791|FG000|Overall Study|Site closure|1|||
105657297|NCT01644188|364409792|FG001|Overall Study|Site closure|1|||
105657298|NCT01644188|364409791|FG000|Overall Study|Other than specified above|6|||
105657299|NCT01644188|364409792|FG001|Overall Study|Other than specified above|7|||
105657300|NCT00766142|364409793|FG000|Overall Study|Protocol Violation|4|||
105657301|NCT00761956|364409795|FG000|Overall Study|Lost to Follow-up|6|||
105657302|NCT00761956|364409796|FG001|Overall Study|Lost to Follow-up|11|||
105657303|NCT00761956|364409795|FG000|Overall Study|Withdrawal by Subject|3|||
105657304|NCT00761956|364409796|FG001|Overall Study|Withdrawal by Subject|8|||
105657305|NCT00761956|364409795|FG000|Overall Study|Death|0|||
105657306|NCT00761956|364409796|FG001|Overall Study|Death|1|||
105657307|NCT00761956|364409795|FG000|Overall Study|Adverse Event|26|||
105657308|NCT00761956|364409796|FG001|Overall Study|Adverse Event|34|||
105657309|NCT01755546|364409802|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
105657310|NCT01755546|364409802|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
105657311|NCT01755546|364409802|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
105657312|NCT01755546|364409802|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
105657313|NCT01755546|364409802|FG000|Titration Phase|Adverse Event|11|||
105657314|NCT01755546|364409802|FG000|Titration Phase|Lack of Efficacy|18|||
105657315|NCT01755546|364409802|FG000|Titration Phase|Protocol Violation|9|||
105657316|NCT01755546|364409802|FG000|Titration Phase|Lost to Follow-up|2|||
105657317|NCT01755546|364409802|FG000|Titration Phase|Other and Continuing|22|||
105657318|NCT01755546|364409802|FG000|Titration Phase|Withdrawal by Subject|8|||
105657319|NCT01755546|364409802|FG000|Long Term Treatment|Adverse Event|12|||
105657320|NCT01755546|364409802|FG000|Long Term Treatment|Lack of Efficacy|6|||
105657321|NCT01755546|364409802|FG000|Long Term Treatment|Protocol Violation|10|||
105657322|NCT01755546|364409802|FG000|Long Term Treatment|Withdrawal by Subject|35|||
105657323|NCT01755546|364409802|FG000|Long Term Treatment|Lost to Follow-up|17|||
105657324|NCT01755546|364409802|FG000|Long Term Treatment|other and ongoing|41|||
105657325|NCT02166476|364409803|FG000|Overall Study|Withdrawal by Subject|5|||
105657326|NCT02166476|364409804|FG001|Overall Study|Withdrawal by Subject|7|||
105657327|NCT02166476|364409803|FG000|Overall Study|Adverse Event|3|||
105657328|NCT02166476|364409804|FG001|Overall Study|Adverse Event|3|||
105657329|NCT02166476|364409803|FG000|Overall Study|Lost to Follow-up|5|||
105657330|NCT02166476|364409804|FG001|Overall Study|Lost to Follow-up|10|||
105657331|NCT02166476|364409803|FG000|Overall Study|Physician Decision|1|||
105657332|NCT02166476|364409804|FG001|Overall Study|Physician Decision|0|||
105657333|NCT02166476|364409803|FG000|Overall Study|Unable to Come for Visit|0|||
105657334|NCT02166476|364409804|FG001|Overall Study|Unable to Come for Visit|3|||
105657335|NCT01114139|364409806|FG000|Overall Study|Adverse Event|3|||
105657336|NCT01114139|364409807|FG001|Overall Study|Adverse Event|2|||
105657337|NCT01114139|364409806|FG000|Overall Study|Lost to Follow-up|15|||
105657338|NCT01114139|364409807|FG001|Overall Study|Lost to Follow-up|3|||
105657339|NCT01114139|364409806|FG000|Overall Study|Withdrawal by Subject|17|||
105657340|NCT01114139|364409807|FG001|Overall Study|Withdrawal by Subject|6|||
105657341|NCT01114139|364409806|FG000|Overall Study|Other-Missed 1 visit|1|||
105870561|NCT00322712|365179112|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
105657342|NCT01114139|364409807|FG001|Overall Study|Other-Missed 1 visit|0|||
105657343|NCT01114139|364409806|FG000|Overall Study|Other-Protocol Violation|1|||
105657344|NCT01114139|364409807|FG001|Overall Study|Other-Protocol Violation|0|||
105657345|NCT01114139|364409806|FG000|Overall Study|Other-Out of window for study drug dose|1|||
105657346|NCT01114139|364409807|FG001|Overall Study|Other-Out of window for study drug dose|0|||
105657347|NCT01114139|364409806|FG000|Overall Study|Other-Participant falsified records|0|||
105657348|NCT01114139|364409807|FG001|Overall Study|Other-Participant falsified records|1|||
105657349|NCT01114139|364409806|FG000|Overall Study|Other-Participant went on hospice|0|||
105657350|NCT01114139|364409807|FG001|Overall Study|Other-Participant went on hospice|1|||
105657351|NCT01114139|364409806|FG000|Overall Study|Other-Physician changed treatment|1|||
105657352|NCT01114139|364409807|FG001|Overall Study|Other-Physician changed treatment|0|||
105657353|NCT01114139|364409806|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
105657354|NCT01114139|364409807|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
105657355|NCT00639769|364409808|FG000|Overall Study|Death|2|||
105657356|NCT00639769|364409808|FG000|Overall Study|Adverse Event|7|||
105657357|NCT00639769|364409808|FG000|Overall Study|Lack of Efficacy|1|||
105657358|NCT00639769|364409808|FG000|Overall Study|Disease progression|26|||
105657359|NCT00639769|364409808|FG000|Overall Study|Withdrawal by Subject|4|||
105657360|NCT00863798|364409809|FG000|Overall Study|Adverse Event|5|||
105657361|NCT00863798|364409810|FG001|Overall Study|Adverse Event|2|||
105657362|NCT00863798|364409811|FG002|Overall Study|Adverse Event|4|||
105657363|NCT00863798|364409809|FG000|Overall Study|Participant failed to return|2|||
105657364|NCT00863798|364409810|FG001|Overall Study|Participant failed to return|1|||
105657365|NCT00863798|364409811|FG002|Overall Study|Participant failed to return|0|||
105657366|NCT00863798|364409809|FG000|Overall Study|Investigator request|1|||
105657367|NCT00863798|364409810|FG001|Overall Study|Investigator request|2|||
105657368|NCT00863798|364409811|FG002|Overall Study|Investigator request|1|||
105657369|NCT00863798|364409809|FG000|Overall Study|Lack of Efficacy|4|||
105657370|NCT00863798|364409810|FG001|Overall Study|Lack of Efficacy|3|||
105657371|NCT00863798|364409811|FG002|Overall Study|Lack of Efficacy|6|||
105657372|NCT00863798|364409809|FG000|Overall Study|Lost to Follow-up|6|||
105657373|NCT00863798|364409810|FG001|Overall Study|Lost to Follow-up|9|||
105657374|NCT00863798|364409811|FG002|Overall Study|Lost to Follow-up|5|||
105657375|NCT00863798|364409809|FG000|Overall Study|Other|2|||
105657376|NCT00863798|364409810|FG001|Overall Study|Other|3|||
105657377|NCT00863798|364409811|FG002|Overall Study|Other|1|||
105657378|NCT00863798|364409809|FG000|Overall Study|Protocol Violation|0|||
105657379|NCT00863798|364409810|FG001|Overall Study|Protocol Violation|1|||
105657380|NCT00863798|364409811|FG002|Overall Study|Protocol Violation|1|||
105657381|NCT00863798|364409809|FG000|Overall Study|Withdrawal by Subject|8|||
105657382|NCT00863798|364409810|FG001|Overall Study|Withdrawal by Subject|7|||
105657383|NCT00863798|364409811|FG002|Overall Study|Withdrawal by Subject|4|||
105657384|NCT00863798|364409809|FG000|Overall Study|Randomized not treated|4|||
105657385|NCT00863798|364409810|FG001|Overall Study|Randomized not treated|2|||
105657386|NCT00863798|364409811|FG002|Overall Study|Randomized not treated|3|||
105657387|NCT00195442|364409812|FG000|Overall Study|Less than expected therapeutic effect|38|||
105657388|NCT00195442|364409812|FG000|Overall Study|Lost to Follow-up|27|||
105657389|NCT00195442|364409812|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
105657390|NCT00195442|364409812|FG000|Overall Study|Intermittent product shortage|21|||
105657391|NCT00195442|364409812|FG000|Overall Study|Death|7|||
105657392|NCT00195442|364409812|FG000|Overall Study|No reason specified|4|||
105657393|NCT00195442|364409812|FG000|Overall Study|Poor cooperation|2|||
105657394|NCT00195442|364409812|FG000|Overall Study|Other|14|||
105657395|NCT00847132|364409815|FG000|Overall Study|Death|1|||
105657396|NCT00847132|364409816|FG001|Overall Study|Death|1|||
105657397|NCT03546816|364409817|FG000|Overall Study|Adverse Event|5|||
105657398|NCT03546816|364409818|FG001|Overall Study|Adverse Event|3|||
105657399|NCT03546816|364409817|FG000|Overall Study|Lack of Efficacy|2|||
105657400|NCT03546816|364409818|FG001|Overall Study|Lack of Efficacy|4|||
105657401|NCT03546816|364409817|FG000|Overall Study|Pregnancy|1|||
105657402|NCT03546816|364409818|FG001|Overall Study|Pregnancy|0|||
105657403|NCT03546816|364409817|FG000|Overall Study|Physician Decision|2|||
105657404|NCT03546816|364409818|FG001|Overall Study|Physician Decision|0|||
105657405|NCT03546816|364409817|FG000|Overall Study|Withdrawal by Subject|8|||
105657406|NCT03546816|364409818|FG001|Overall Study|Withdrawal by Subject|10|||
105657407|NCT03546816|364409817|FG000|Overall Study|Lost to Follow-up|3|||
105657408|NCT03546816|364409818|FG001|Overall Study|Lost to Follow-up|2|||
105657409|NCT03927690|364409819|FG000|Overall Study|Withdrawal by Subject|3|||
105657410|NCT03927690|364409820|FG001|Overall Study|Withdrawal by Subject|1|||
105657411|NCT03927690|364409821|FG002|Overall Study|Withdrawal by Subject|1|||
105657412|NCT03927690|364409819|FG000|Overall Study|Adverse Event|1|||
105657413|NCT03927690|364409820|FG001|Overall Study|Adverse Event|0|||
105657414|NCT03927690|364409821|FG002|Overall Study|Adverse Event|0|||
105657415|NCT03927690|364409819|FG000|Overall Study|Death|1|||
105657416|NCT03927690|364409820|FG001|Overall Study|Death|0|||
105657417|NCT03927690|364409821|FG002|Overall Study|Death|0|||
105657418|NCT03927690|364409819|FG000|Overall Study|Lost to Follow-up|2|||
105657419|NCT03927690|364409820|FG001|Overall Study|Lost to Follow-up|2|||
105657420|NCT03927690|364409821|FG002|Overall Study|Lost to Follow-up|1|||
105657421|NCT00913523|364409826|FG000|Overall Study|Withdrawal by Subject|3|||
105657422|NCT00913523|364409827|FG001|Overall Study|Withdrawal by Subject|2|||
105657423|NCT00913523|364409828|FG002|Overall Study|Withdrawal by Subject|2|||
105657424|NCT00913523|364409826|FG000|Overall Study|Lost to Follow-up|1|||
105657425|NCT00913523|364409827|FG001|Overall Study|Lost to Follow-up|1|||
105657426|NCT00913523|364409828|FG002|Overall Study|Lost to Follow-up|1|||
105657427|NCT00913523|364409826|FG000|Overall Study|Adverse Event|1|||
105657428|NCT00913523|364409827|FG001|Overall Study|Adverse Event|0|||
105657429|NCT00913523|364409828|FG002|Overall Study|Adverse Event|0|||
105657430|NCT00913523|364409826|FG000|Overall Study|Protocol Violation|5|||
105657431|NCT00913523|364409827|FG001|Overall Study|Protocol Violation|8|||
105657432|NCT00913523|364409828|FG002|Overall Study|Protocol Violation|8|||
105657433|NCT00913523|364409826|FG000|Overall Study|Pregnancy|1|||
105657434|NCT00913523|364409827|FG001|Overall Study|Pregnancy|3|||
105657435|NCT00913523|364409828|FG002|Overall Study|Pregnancy|0|||
105657436|NCT00913523|364409826|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
105657437|NCT00913523|364409827|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
105657438|NCT00913523|364409828|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
105657439|NCT03021551|364409829|FG000|Overall Study|Equipment Issues|2|||
105657440|NCT03021551|364409829|FG000|Overall Study|Protocol Violation|1|||
105657441|NCT03491215|364409833|FG000|Overall Study|Death|6|||
105657442|NCT03491215|364409834|FG001|Overall Study|Death|2|||
105657443|NCT03491215|364409835|FG002|Overall Study|Death|1|||
105657444|NCT03491215|364409836|FG003|Overall Study|Death|0|||
105657445|NCT03491215|364409833|FG000|Overall Study|Physician Decision|1|||
105657446|NCT03491215|364409834|FG001|Overall Study|Physician Decision|0|||
105657447|NCT03491215|364409835|FG002|Overall Study|Physician Decision|0|||
105657448|NCT03491215|364409836|FG003|Overall Study|Physician Decision|0|||
105657449|NCT01162135|364409837|FG000|Overall Study|Withdrawal by Subject|1|||
105657450|NCT01162135|364409837|FG000|Overall Study|Severe back pain|1|||
105657451|NCT01162135|364409837|FG000|Overall Study|Ineligible|1|||
105657452|NCT00468858|364409840|FG000|Overall Study|Adverse Event|0|||
105657453|NCT00468858|364409841|FG001|Overall Study|Adverse Event|1|||
105657454|NCT00468858|364409842|FG002|Overall Study|Adverse Event|0|||
105657455|NCT00468858|364409840|FG000|Overall Study|Withdrawal by Subject|7|||
105657456|NCT00468858|364409841|FG001|Overall Study|Withdrawal by Subject|4|||
105657457|NCT00468858|364409842|FG002|Overall Study|Withdrawal by Subject|5|||
105657458|NCT00468858|364409840|FG000|Overall Study|Relocation|1|||
105657459|NCT00468858|364409841|FG001|Overall Study|Relocation|3|||
105657460|NCT00468858|364409842|FG002|Overall Study|Relocation|3|||
105657461|NCT00468858|364409840|FG000|Overall Study|Lost to Follow-up|1|||
105657462|NCT00468858|364409841|FG001|Overall Study|Lost to Follow-up|2|||
105657463|NCT00468858|364409842|FG002|Overall Study|Lost to Follow-up|5|||
105657464|NCT00468858|364409840|FG000|Overall Study|Other|0|||
105657465|NCT00468858|364409841|FG001|Overall Study|Other|0|||
105657466|NCT00468858|364409842|FG002|Overall Study|Other|1|||
105657467|NCT01085812|364409843|FG000|Open-Label Period|Adverse Event|0|||
105657468|NCT01085812|364409844|FG001|Open-Label Period|Adverse Event|80|||
105657469|NCT01085812|364409843|FG000|Open-Label Period|Lack of Efficacy|0|||
105657470|NCT01085812|364409844|FG001|Open-Label Period|Lack of Efficacy|26|||
105657471|NCT01085812|364409843|FG000|Open-Label Period|Protocol Violation|0|||
105657472|NCT01085812|364409844|FG001|Open-Label Period|Protocol Violation|39|||
105657473|NCT01085812|364409843|FG000|Open-Label Period|Withdrawal by Subject|0|||
105657474|NCT01085812|364409844|FG001|Open-Label Period|Withdrawal by Subject|53|||
105657475|NCT01085812|364409843|FG000|Open-Label Period|Lost to Follow-up|0|||
105657476|NCT01085812|364409844|FG001|Open-Label Period|Lost to Follow-up|42|||
105657477|NCT01085812|364409843|FG000|Double-Blind Period|Adverse Event|3|||
105657478|NCT01085812|364409844|FG001|Double-Blind Period|Adverse Event|8|||
105657479|NCT01085812|364409843|FG000|Double-Blind Period|Protocol Violation|2|||
105657480|NCT01085812|364409844|FG001|Double-Blind Period|Protocol Violation|7|||
105657481|NCT01085812|364409843|FG000|Double-Blind Period|Withdrawal by Subject|11|||
105657482|NCT01085812|364409844|FG001|Double-Blind Period|Withdrawal by Subject|24|||
105657483|NCT01085812|364409843|FG000|Double-Blind Period|Lost to Follow-up|5|||
105870562|NCT02071225|365179113|FG000|Overall Study|Withdrawal of Consent|2|||
105657484|NCT01085812|364409844|FG001|Double-Blind Period|Lost to Follow-up|17|||
105657485|NCT01085812|364409843|FG000|Double-Blind Period|Other Reasons|0|||
105657486|NCT01085812|364409844|FG001|Double-Blind Period|Other Reasons|2|||
105657487|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
105657488|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
105657489|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
105657490|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
105657491|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
105657492|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
105657493|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
105657494|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
105657495|NCT01085812|364409843|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
105657496|NCT01085812|364409844|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
105657497|NCT01101997|364409845|FG000|Overall Study|Withdrawal by Subject|2|||
105657498|NCT00302159|364409852|FG000|Overall Study|pt declined before treatment started|1|||
105657499|NCT00302159|364409852|FG000|Overall Study|pt started Avastin|1|||
105657500|NCT03245619|364409853|FG000|Part A (Up to Day 22)|Physician Decision|4|||
105657501|NCT03245619|364409854|FG001|Part A (Up to Day 22)|Physician Decision|6|||
105657502|NCT03245619|364409855|FG002|Part A (Up to Day 22)|Physician Decision|6|||
105657503|NCT03245619|364409856|FG003|Part A (Up to Day 22)|Physician Decision|0|||
105657504|NCT03245619|364409857|FG004|Part A (Up to Day 22)|Physician Decision|0|||
105657505|NCT03245619|364409858|FG005|Part A (Up to Day 22)|Physician Decision|0|||
105657506|NCT03245619|364409859|FG006|Part A (Up to Day 22)|Physician Decision|0|||
105657507|NCT03245619|364409860|FG007|Part A (Up to Day 22)|Physician Decision|0|||
105657508|NCT03245619|364409861|FG008|Part A (Up to Day 22)|Physician Decision|0|||
105657509|NCT03245619|364409862|FG009|Part A (Up to Day 22)|Physician Decision|0|||
105657510|NCT03245619|364409863|FG010|Part A (Up to Day 22)|Physician Decision|0|||
105657511|NCT03245619|364409864|FG011|Part A (Up to Day 22)|Physician Decision|0|||
105657512|NCT03245619|364409865|FG012|Part A (Up to Day 22)|Physician Decision|0|||
105657513|NCT03245619|364409866|FG013|Part A (Up to Day 22)|Physician Decision|0|||
105657514|NCT03245619|364409867|FG014|Part A (Up to Day 22)|Physician Decision|0|||
105657515|NCT03245619|364409868|FG015|Part A (Up to Day 22)|Physician Decision|0|||
105657516|NCT03245619|364409869|FG016|Part A (Up to Day 22)|Physician Decision|0|||
105657517|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
105657518|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
105657519|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
105657520|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
105657521|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
105657522|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
105657523|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
105657524|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
105657525|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
105657526|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
105657527|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
105657528|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
105657529|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
105657530|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
105870563|NCT02071225|365179113|FG000|Overall Study|Protocol Deviation|1|||
105870564|NCT02071225|365179113|FG000|Overall Study|Lost to Follow-up|2|||
105870565|NCT02071225|365179113|FG000|Overall Study|Death|25|||
105870566|NCT01342081|365179120|FG000|Overall Study|Did not receive allocated intervention|0|||
105870567|NCT01342081|365179121|FG001|Overall Study|Did not receive allocated intervention|0|||
105870568|NCT01342081|365179122|FG002|Overall Study|Did not receive allocated intervention|1|||
105870569|NCT01342081|365179120|FG000|Overall Study|Adverse Event|1|||
105870570|NCT01342081|365179121|FG001|Overall Study|Adverse Event|0|||
105870571|NCT01342081|365179122|FG002|Overall Study|Adverse Event|0|||
105870572|NCT01342081|365179120|FG000|Overall Study|Physician Decision|0|||
105870573|NCT01342081|365179121|FG001|Overall Study|Physician Decision|1|||
105870574|NCT01342081|365179122|FG002|Overall Study|Physician Decision|0|||
105870575|NCT01342081|365179120|FG000|Overall Study|Withdrawal by Subject|1|||
105870576|NCT01342081|365179121|FG001|Overall Study|Withdrawal by Subject|1|||
105870577|NCT01342081|365179122|FG002|Overall Study|Withdrawal by Subject|0|||
105870578|NCT04747470|365179123|FG000|Overall Study|Death|0|||
105870579|NCT04747470|365179124|FG001|Overall Study|Death|3|||
105870580|NCT04747470|365179125|FG002|Overall Study|Death|2|||
105870581|NCT04747470|365179126|FG003|Overall Study|Death|2|||
105870582|NCT04747470|365179127|FG004|Overall Study|Death|2|||
105870583|NCT04747470|365179128|FG005|Overall Study|Death|0|||
105870584|NCT04747470|365179129|FG006|Overall Study|Death|0|||
105870585|NCT04747470|365179130|FG007|Overall Study|Death|0|||
105870586|NCT04747470|365179131|FG008|Overall Study|Death|0|||
105870587|NCT04747470|365179132|FG009|Overall Study|Death|0|||
105870588|NCT04747470|365179133|FG010|Overall Study|Death|0|||
105870589|NCT04747470|365179123|FG000|Overall Study|Withdrew Consent|0|||
105870590|NCT04747470|365179124|FG001|Overall Study|Withdrew Consent|0|||
105870591|NCT04747470|365179125|FG002|Overall Study|Withdrew Consent|0|||
105870592|NCT04747470|365179126|FG003|Overall Study|Withdrew Consent|1|||
105657531|NCT01664923|364409873|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
105657532|NCT01664923|364409874|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
105870593|NCT04747470|365179127|FG004|Overall Study|Withdrew Consent|0|||
105657533|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
105870594|NCT04747470|365179128|FG005|Overall Study|Withdrew Consent|0|||
105870595|NCT04747470|365179129|FG006|Overall Study|Withdrew Consent|0|||
105870596|NCT04747470|365179130|FG007|Overall Study|Withdrew Consent|0|||
105870597|NCT04747470|365179131|FG008|Overall Study|Withdrew Consent|0|||
105870598|NCT04747470|365179132|FG009|Overall Study|Withdrew Consent|0|||
105870599|NCT04747470|365179133|FG010|Overall Study|Withdrew Consent|0|||
105657534|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
105657535|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
105657536|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
105657537|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
105657538|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
105657539|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
105657540|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
105657541|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
105657542|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
105657543|NCT01664923|364409873|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
105657544|NCT01664923|364409874|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
105657545|NCT00394589|364409877|FG000|Overall Study|Adverse Event|2|||
105657546|NCT00394589|364409878|FG001|Overall Study|Adverse Event|1|||
105657547|NCT00394589|364409879|FG002|Overall Study|Adverse Event|2|||
105657548|NCT00394589|364409877|FG000|Overall Study|Lack of Efficacy|2|||
105657549|NCT00394589|364409878|FG001|Overall Study|Lack of Efficacy|2|||
105657550|NCT00394589|364409879|FG002|Overall Study|Lack of Efficacy|3|||
105657551|NCT00394589|364409877|FG000|Overall Study|Protocol Violation|4|||
105657552|NCT00394589|364409878|FG001|Overall Study|Protocol Violation|0|||
105657553|NCT00394589|364409879|FG002|Overall Study|Protocol Violation|2|||
105657554|NCT01114672|364409881|FG000|Overall Study|Death|0|||
105657555|NCT01114672|364409882|FG001|Overall Study|Death|1|||
105657556|NCT01114672|364409881|FG000|Overall Study|Withdrawal by Subject|2|||
105657557|NCT01114672|364409882|FG001|Overall Study|Withdrawal by Subject|1|||
105657558|NCT01114672|364409881|FG000|Overall Study|Lost to Follow-up|1|||
105657559|NCT01114672|364409882|FG001|Overall Study|Lost to Follow-up|0|||
105657560|NCT01114672|364409881|FG000|Overall Study|transplanted|1|||
105657561|NCT01114672|364409882|FG001|Overall Study|transplanted|0|||
105657562|NCT02777242|364409892|FG000|Overall Study|Other|2|||
105657563|NCT02777242|364409892|FG000|Overall Study|Lost to Follow-up|1|||
105657564|NCT02777242|364409892|FG000|Overall Study|Multiple|1|||
105657565|NCT02777242|364409892|FG000|Overall Study|Sponsor's request|1|||
105657566|NCT02777242|364409892|FG000|Overall Study|Withdrawal by Subject|1|||
105657567|NCT04545476|364409893|FG000|Overall Study|Lost to Follow-up|1|||
105657568|NCT04545476|364409894|FG001|Overall Study|Lost to Follow-up|1|||
105657569|NCT04545476|364409895|FG002|Overall Study|Lost to Follow-up|0|||
105657570|NCT04545476|364409896|FG003|Overall Study|Lost to Follow-up|0|||
105657571|NCT02427958|364409897|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
105657572|NCT02427958|364409897|FG000|Overall Study|Lost to Follow-up|6|||
105657573|NCT02427958|364409897|FG000|Overall Study|Withdrawal by Subject|14|||
105657574|NCT02427958|364409897|FG000|Overall Study|Lack of Efficacy|1|||
105657575|NCT01704547|364409905|FG000|Overall Study|Physician Decision|4|||
105657576|NCT01704547|364409905|FG000|Overall Study|Withdrawal by Subject|1|||
105657577|NCT00690378|364409906|FG000|Overall Study|Adverse Event|1|||
105657578|NCT00690378|364409907|FG001|Overall Study|Adverse Event|0|||
105657579|NCT00690378|364409906|FG000|Overall Study|Withdrawal by Subject|2|||
105657580|NCT00690378|364409907|FG001|Overall Study|Withdrawal by Subject|0|||
105657581|NCT00690378|364409906|FG000|Overall Study|Protocol Violation|1|||
105657582|NCT00690378|364409907|FG001|Overall Study|Protocol Violation|0|||
105657583|NCT00690378|364409906|FG000|Overall Study|Lost to Follow-up|2|||
105657584|NCT00690378|364409907|FG001|Overall Study|Lost to Follow-up|3|||
105657585|NCT00690378|364409906|FG000|Overall Study|Did not meet inc/exc criteria|13|||
105657586|NCT00690378|364409907|FG001|Overall Study|Did not meet inc/exc criteria|11|||
105657587|NCT00690378|364409906|FG000|Overall Study|Social problem|1|||
105657588|NCT00690378|364409907|FG001|Overall Study|Social problem|0|||
105657589|NCT04016805|364409908|FG000|Overall Study|Sponsor's Discretion|30|||
105657590|NCT04016805|364409909|FG001|Overall Study|Sponsor's Discretion|6|||
105657591|NCT04016805|364409910|FG002|Overall Study|Sponsor's Discretion|5|||
105657592|NCT00104637|364409911|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
105657593|NCT00104637|364409912|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
105870600|NCT04747470|365179123|FG000|Overall Study|Study Terminated by Sponsor|0|||
105870601|NCT04747470|365179124|FG001|Overall Study|Study Terminated by Sponsor|0|||
105870602|NCT04747470|365179125|FG002|Overall Study|Study Terminated by Sponsor|1|||
105657594|NCT01560871|364409913|FG000|Overall Study|transportation issues|2|||
105870603|NCT04747470|365179126|FG003|Overall Study|Study Terminated by Sponsor|0|||
105870604|NCT04747470|365179127|FG004|Overall Study|Study Terminated by Sponsor|2|||
105870605|NCT04747470|365179128|FG005|Overall Study|Study Terminated by Sponsor|0|||
105870606|NCT04747470|365179129|FG006|Overall Study|Study Terminated by Sponsor|0|||
105870607|NCT04747470|365179130|FG007|Overall Study|Study Terminated by Sponsor|0|||
105870608|NCT04747470|365179131|FG008|Overall Study|Study Terminated by Sponsor|0|||
105870609|NCT04747470|365179132|FG009|Overall Study|Study Terminated by Sponsor|0|||
105870610|NCT04747470|365179133|FG010|Overall Study|Study Terminated by Sponsor|0|||
105657595|NCT01560871|364409914|FG001|Overall Study|transportation issues|1|||
105657596|NCT01560871|364409913|FG000|Overall Study|relocation|1|||
105657597|NCT01560871|364409914|FG001|Overall Study|relocation|0|||
105657598|NCT01560871|364409913|FG000|Overall Study|readmission to a hospital|2|||
105870611|NCT01960257|365179136|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
105870612|NCT01960257|365179137|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
105870613|NCT01960257|365179138|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
105870614|NCT01960257|365179136|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
105870615|NCT01960257|365179137|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
105870616|NCT01960257|365179138|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
105870617|NCT01960257|365179136|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
105870618|NCT01960257|365179137|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
105870619|NCT01960257|365179138|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
105870620|NCT02906670|365179139|FG000|Cohort 1, QW|Radiological Progression|1|||
105870621|NCT02906670|365179140|FG001|Cohort 1, QW|Radiological Progression|0|||
105870622|NCT02906670|365179141|FG002|Cohort 1, QW|Radiological Progression|0|||
105870623|NCT02906670|365179142|FG003|Cohort 1, QW|Radiological Progression|0|||
105870624|NCT02906670|365179143|FG004|Cohort 1, QW|Radiological Progression|0|||
105870625|NCT02906670|365179144|FG005|Cohort 1, QW|Radiological Progression|0|||
105870626|NCT02906670|365179145|FG006|Cohort 1, QW|Radiological Progression|0|||
105870627|NCT02906670|365179146|FG007|Cohort 1, QW|Radiological Progression|0|||
105870628|NCT02906670|365179147|FG008|Cohort 1, QW|Radiological Progression|0|||
105870629|NCT02906670|365179148|FG009|Cohort 1, QW|Radiological Progression|0|||
105870630|NCT02906670|365179139|FG000|Cohort 2, QW|Radiological Progression|0|||
105870631|NCT02906670|365179140|FG001|Cohort 2, QW|Radiological Progression|1|||
105870632|NCT02906670|365179141|FG002|Cohort 2, QW|Radiological Progression|0|||
105870633|NCT02906670|365179142|FG003|Cohort 2, QW|Radiological Progression|0|||
105870634|NCT02906670|365179143|FG004|Cohort 2, QW|Radiological Progression|0|||
105870635|NCT02906670|365179144|FG005|Cohort 2, QW|Radiological Progression|0|||
105870636|NCT02906670|365179145|FG006|Cohort 2, QW|Radiological Progression|0|||
105657599|NCT01560871|364409914|FG001|Overall Study|readmission to a hospital|1|||
105657600|NCT01560871|364409913|FG000|Overall Study|Lost to Follow-up|1|||
105657601|NCT01560871|364409914|FG001|Overall Study|Lost to Follow-up|0|||
105657602|NCT00582114|364409917|FG000|Overall Study|Death|4|||
105657603|NCT00582114|364409918|FG001|Overall Study|Death|4|||
105657604|NCT00582114|364409917|FG000|Overall Study|Kidney Transplant|3|||
105657605|NCT00582114|364409918|FG001|Overall Study|Kidney Transplant|1|||
105657606|NCT00582114|364409917|FG000|Overall Study|Lost to Follow-up|7|||
105657607|NCT00582114|364409918|FG001|Overall Study|Lost to Follow-up|6|||
105870637|NCT02906670|365179146|FG007|Cohort 2, QW|Radiological Progression|0|||
105870638|NCT02906670|365179147|FG008|Cohort 2, QW|Radiological Progression|0|||
105870639|NCT02906670|365179148|FG009|Cohort 2, QW|Radiological Progression|0|||
105870640|NCT02906670|365179139|FG000|Cohort 3, QW|Radiological Progression|0|||
105870641|NCT02906670|365179140|FG001|Cohort 3, QW|Radiological Progression|0|||
105870642|NCT02906670|365179141|FG002|Cohort 3, QW|Radiological Progression|2|||
105870643|NCT02906670|365179142|FG003|Cohort 3, QW|Radiological Progression|0|||
105870644|NCT02906670|365179143|FG004|Cohort 3, QW|Radiological Progression|0|||
105870645|NCT02906670|365179144|FG005|Cohort 3, QW|Radiological Progression|0|||
105870646|NCT02906670|365179145|FG006|Cohort 3, QW|Radiological Progression|0|||
105870647|NCT02906670|365179146|FG007|Cohort 3, QW|Radiological Progression|0|||
105870648|NCT02906670|365179147|FG008|Cohort 3, QW|Radiological Progression|0|||
105870649|NCT02906670|365179148|FG009|Cohort 3, QW|Radiological Progression|0|||
105870650|NCT02906670|365179139|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870651|NCT02906670|365179140|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870652|NCT02906670|365179141|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
105870653|NCT02906670|365179142|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870654|NCT02906670|365179143|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870655|NCT02906670|365179144|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870656|NCT02906670|365179145|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870657|NCT02906670|365179146|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870658|NCT02906670|365179147|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870659|NCT02906670|365179148|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
105870660|NCT02906670|365179139|FG000|Cohort 4, Q2W|Radiological Progression|0|||
105870661|NCT02906670|365179140|FG001|Cohort 4, Q2W|Radiological Progression|0|||
105870662|NCT02906670|365179141|FG002|Cohort 4, Q2W|Radiological Progression|0|||
105870663|NCT02906670|365179142|FG003|Cohort 4, Q2W|Radiological Progression|0|||
105870664|NCT02906670|365179143|FG004|Cohort 4, Q2W|Radiological Progression|0|||
105870665|NCT02906670|365179144|FG005|Cohort 4, Q2W|Radiological Progression|1|||
105870666|NCT02906670|365179145|FG006|Cohort 4, Q2W|Radiological Progression|0|||
105870667|NCT02906670|365179146|FG007|Cohort 4, Q2W|Radiological Progression|0|||
105870668|NCT02906670|365179147|FG008|Cohort 4, Q2W|Radiological Progression|0|||
105870669|NCT02906670|365179148|FG009|Cohort 4, Q2W|Radiological Progression|0|||
105657608|NCT00582114|364409917|FG000|Overall Study|Withdrawal by Subject|8|||
105870670|NCT02906670|365179139|FG000|Cohort 4, Q2W|Clinical Progression|0|||
105870671|NCT02906670|365179140|FG001|Cohort 4, Q2W|Clinical Progression|0|||
105870672|NCT02906670|365179141|FG002|Cohort 4, Q2W|Clinical Progression|0|||
105870673|NCT02906670|365179142|FG003|Cohort 4, Q2W|Clinical Progression|0|||
105870674|NCT02906670|365179143|FG004|Cohort 4, Q2W|Clinical Progression|0|||
105870675|NCT02906670|365179144|FG005|Cohort 4, Q2W|Clinical Progression|2|||
105870676|NCT02906670|365179145|FG006|Cohort 4, Q2W|Clinical Progression|0|||
105870677|NCT02906670|365179146|FG007|Cohort 4, Q2W|Clinical Progression|0|||
105870678|NCT02906670|365179147|FG008|Cohort 4, Q2W|Clinical Progression|0|||
105870679|NCT02906670|365179148|FG009|Cohort 4, Q2W|Clinical Progression|0|||
105870680|NCT02906670|365179139|FG000|Cohort 5, Q2W|Radiological Progression|0|||
105870681|NCT02906670|365179140|FG001|Cohort 5, Q2W|Radiological Progression|0|||
105870682|NCT02906670|365179141|FG002|Cohort 5, Q2W|Radiological Progression|0|||
105870683|NCT02906670|365179142|FG003|Cohort 5, Q2W|Radiological Progression|0|||
105870684|NCT02906670|365179143|FG004|Cohort 5, Q2W|Radiological Progression|0|||
105870685|NCT02906670|365179144|FG005|Cohort 5, Q2W|Radiological Progression|0|||
105870686|NCT02906670|365179145|FG006|Cohort 5, Q2W|Radiological Progression|4|||
105870687|NCT02906670|365179146|FG007|Cohort 5, Q2W|Radiological Progression|0|||
105870688|NCT02906670|365179147|FG008|Cohort 5, Q2W|Radiological Progression|0|||
105870689|NCT02906670|365179148|FG009|Cohort 5, Q2W|Radiological Progression|0|||
105870690|NCT02906670|365179139|FG000|Cohort 5, Q2W|Clinical Progression|0|||
105870691|NCT02906670|365179140|FG001|Cohort 5, Q2W|Clinical Progression|0|||
105870692|NCT02906670|365179141|FG002|Cohort 5, Q2W|Clinical Progression|0|||
105870693|NCT02906670|365179142|FG003|Cohort 5, Q2W|Clinical Progression|0|||
105870694|NCT02906670|365179143|FG004|Cohort 5, Q2W|Clinical Progression|0|||
105870695|NCT02906670|365179144|FG005|Cohort 5, Q2W|Clinical Progression|0|||
105870696|NCT02906670|365179145|FG006|Cohort 5, Q2W|Clinical Progression|1|||
105870697|NCT02906670|365179146|FG007|Cohort 5, Q2W|Clinical Progression|0|||
105870698|NCT02906670|365179147|FG008|Cohort 5, Q2W|Clinical Progression|0|||
105870699|NCT02906670|365179148|FG009|Cohort 5, Q2W|Clinical Progression|0|||
105870700|NCT02906670|365179139|FG000|Cohort 5, Q2W|Adverse Event|0|||
105870701|NCT02906670|365179140|FG001|Cohort 5, Q2W|Adverse Event|0|||
105870702|NCT02906670|365179141|FG002|Cohort 5, Q2W|Adverse Event|0|||
105870703|NCT02906670|365179142|FG003|Cohort 5, Q2W|Adverse Event|0|||
105870704|NCT02906670|365179143|FG004|Cohort 5, Q2W|Adverse Event|0|||
105870705|NCT02906670|365179144|FG005|Cohort 5, Q2W|Adverse Event|0|||
105870706|NCT02906670|365179145|FG006|Cohort 5, Q2W|Adverse Event|1|||
105870707|NCT02906670|365179146|FG007|Cohort 5, Q2W|Adverse Event|0|||
105870708|NCT02906670|365179147|FG008|Cohort 5, Q2W|Adverse Event|0|||
105870709|NCT02906670|365179148|FG009|Cohort 5, Q2W|Adverse Event|0|||
105870710|NCT02906670|365179139|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870711|NCT02906670|365179140|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870712|NCT02906670|365179141|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870713|NCT02906670|365179142|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870714|NCT02906670|365179143|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870715|NCT02906670|365179144|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870716|NCT02906670|365179145|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
105870717|NCT02906670|365179146|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870718|NCT02906670|365179147|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870719|NCT02906670|365179148|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
105870720|NCT02906670|365179139|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
105870721|NCT02906670|365179140|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
105870722|NCT02906670|365179141|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
105870723|NCT02906670|365179142|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
105870724|NCT02906670|365179143|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
105870725|NCT02906670|365179144|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
105870726|NCT02906670|365179145|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
105870727|NCT02906670|365179146|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
105870728|NCT02906670|365179147|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
105870729|NCT02906670|365179148|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
105870730|NCT02906670|365179139|FG000|Cohort 5P, Q2W|Adverse Event|0|||
105870731|NCT02906670|365179140|FG001|Cohort 5P, Q2W|Adverse Event|0|||
105870732|NCT02906670|365179141|FG002|Cohort 5P, Q2W|Adverse Event|0|||
105870733|NCT02906670|365179142|FG003|Cohort 5P, Q2W|Adverse Event|0|||
105870734|NCT02906670|365179143|FG004|Cohort 5P, Q2W|Adverse Event|0|||
105870735|NCT02906670|365179144|FG005|Cohort 5P, Q2W|Adverse Event|0|||
105870736|NCT02906670|365179145|FG006|Cohort 5P, Q2W|Adverse Event|0|||
105870737|NCT02906670|365179146|FG007|Cohort 5P, Q2W|Adverse Event|1|||
105870738|NCT02906670|365179147|FG008|Cohort 5P, Q2W|Adverse Event|0|||
105870739|NCT02906670|365179148|FG009|Cohort 5P, Q2W|Adverse Event|0|||
105870740|NCT02906670|365179139|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
105870741|NCT02906670|365179140|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
105870742|NCT02906670|365179141|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
105870743|NCT02906670|365179142|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
105870744|NCT02906670|365179143|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
105870745|NCT02906670|365179144|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
105870746|NCT02906670|365179145|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
105870747|NCT02906670|365179146|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
105870748|NCT02906670|365179147|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
105870749|NCT02906670|365179148|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
105870750|NCT02906670|365179139|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
105870751|NCT02906670|365179140|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
105870752|NCT02906670|365179141|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
105870753|NCT02906670|365179142|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
105870754|NCT02906670|365179143|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
105870755|NCT02906670|365179144|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
105870756|NCT02906670|365179145|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
105870757|NCT02906670|365179146|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
105870758|NCT02906670|365179147|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
105870759|NCT02906670|365179148|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
105870760|NCT02906670|365179139|FG000|Cohort 4P, QW|Radiological Progression|0|||
105870761|NCT02906670|365179140|FG001|Cohort 4P, QW|Radiological Progression|0|||
105870762|NCT02906670|365179141|FG002|Cohort 4P, QW|Radiological Progression|0|||
105870763|NCT02906670|365179142|FG003|Cohort 4P, QW|Radiological Progression|3|||
105870764|NCT02906670|365179143|FG004|Cohort 4P, QW|Radiological Progression|0|||
105870765|NCT02906670|365179144|FG005|Cohort 4P, QW|Radiological Progression|0|||
105870766|NCT02906670|365179145|FG006|Cohort 4P, QW|Radiological Progression|0|||
105870767|NCT02906670|365179146|FG007|Cohort 4P, QW|Radiological Progression|0|||
105870768|NCT02906670|365179147|FG008|Cohort 4P, QW|Radiological Progression|0|||
105870769|NCT02906670|365179148|FG009|Cohort 4P, QW|Radiological Progression|0|||
105870770|NCT02906670|365179139|FG000|Cohort 7P, Q2W|Adverse Event|0|||
105870771|NCT02906670|365179140|FG001|Cohort 7P, Q2W|Adverse Event|0|||
105870772|NCT02906670|365179141|FG002|Cohort 7P, Q2W|Adverse Event|0|||
105870773|NCT02906670|365179142|FG003|Cohort 7P, Q2W|Adverse Event|0|||
105870774|NCT02906670|365179143|FG004|Cohort 7P, Q2W|Adverse Event|0|||
105870775|NCT02906670|365179144|FG005|Cohort 7P, Q2W|Adverse Event|0|||
105870776|NCT02906670|365179145|FG006|Cohort 7P, Q2W|Adverse Event|0|||
105870777|NCT02906670|365179146|FG007|Cohort 7P, Q2W|Adverse Event|0|||
105870778|NCT02906670|365179147|FG008|Cohort 7P, Q2W|Adverse Event|0|||
105870779|NCT02906670|365179148|FG009|Cohort 7P, Q2W|Adverse Event|1|||
105870780|NCT02906670|365179139|FG000|Cohort 7P, Q2W|Physician Decision|0|||
105870781|NCT02906670|365179140|FG001|Cohort 7P, Q2W|Physician Decision|0|||
105870782|NCT02906670|365179141|FG002|Cohort 7P, Q2W|Physician Decision|0|||
105870783|NCT02906670|365179142|FG003|Cohort 7P, Q2W|Physician Decision|0|||
105870784|NCT02906670|365179143|FG004|Cohort 7P, Q2W|Physician Decision|0|||
105870785|NCT02906670|365179144|FG005|Cohort 7P, Q2W|Physician Decision|0|||
105870786|NCT02906670|365179145|FG006|Cohort 7P, Q2W|Physician Decision|0|||
105870787|NCT02906670|365179146|FG007|Cohort 7P, Q2W|Physician Decision|0|||
105870788|NCT02906670|365179147|FG008|Cohort 7P, Q2W|Physician Decision|0|||
105870789|NCT02906670|365179148|FG009|Cohort 7P, Q2W|Physician Decision|1|||
105870790|NCT02906670|365179139|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870791|NCT02906670|365179140|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870792|NCT02906670|365179141|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870793|NCT02906670|365179142|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870794|NCT02906670|365179143|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870795|NCT02906670|365179144|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870796|NCT02906670|365179145|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870797|NCT02906670|365179146|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870798|NCT02906670|365179147|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
105870799|NCT02906670|365179148|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
105870800|NCT02906670|365179139|FG000|Cohort 5P, QW|Radiological Progression|0|||
105870801|NCT02906670|365179140|FG001|Cohort 5P, QW|Radiological Progression|0|||
105870802|NCT02906670|365179141|FG002|Cohort 5P, QW|Radiological Progression|0|||
105870803|NCT02906670|365179142|FG003|Cohort 5P, QW|Radiological Progression|0|||
105870804|NCT02906670|365179143|FG004|Cohort 5P, QW|Radiological Progression|3|||
105870805|NCT02906670|365179144|FG005|Cohort 5P, QW|Radiological Progression|0|||
105870806|NCT02906670|365179145|FG006|Cohort 5P, QW|Radiological Progression|0|||
105870807|NCT02906670|365179146|FG007|Cohort 5P, QW|Radiological Progression|0|||
105870808|NCT02906670|365179147|FG008|Cohort 5P, QW|Radiological Progression|0|||
105870809|NCT02906670|365179148|FG009|Cohort 5P, QW|Radiological Progression|0|||
105870810|NCT00666328|365179149|FG000|Overall Study|Death|2|||
105870811|NCT00666328|365179149|FG000|Overall Study|Lost to Follow-up|2|||
105870812|NCT00666328|365179149|FG000|Overall Study|No longer met eligibility criteria|1|||
105870813|NCT02208089|365179153|FG000|Overall Study|Withdrawal by Subject|1|||
105870814|NCT02208089|365179154|FG001|Overall Study|Withdrawal by Subject|0|||
105870815|NCT02208089|365179153|FG000|Overall Study|Lost to Follow-up|6|||
105870816|NCT02208089|365179154|FG001|Overall Study|Lost to Follow-up|0|||
105870817|NCT02729909|365179155|FG000|Overall Study|Lost to Follow-up|0|||
105870818|NCT02729909|365179156|FG001|Overall Study|Lost to Follow-up|1|||
105870819|NCT02729909|365179155|FG000|Overall Study|Lack of Efficacy|0|||
105657609|NCT00582114|364409918|FG001|Overall Study|Withdrawal by Subject|16|||
105657610|NCT00582114|364409917|FG000|Overall Study|Adverse Event|1|||
105657611|NCT00582114|364409918|FG001|Overall Study|Adverse Event|1|||
105657612|NCT00582114|364409917|FG000|Overall Study|Physician Decision|0|||
105657613|NCT00582114|364409918|FG001|Overall Study|Physician Decision|6|||
105657614|NCT00582114|364409917|FG000|Overall Study|Stopped by data safety monitoring board|19|||
105657615|NCT00582114|364409918|FG001|Overall Study|Stopped by data safety monitoring board|20|||
105657616|NCT03772613|364409919|FG000|Overall Study|Lost to Follow-up|0|||
105870820|NCT02729909|365179156|FG001|Overall Study|Lack of Efficacy|2|||
105870821|NCT02729909|365179155|FG000|Overall Study|Significant Protocol Deviation|0|||
105657617|NCT03772613|364409920|FG001|Overall Study|Lost to Follow-up|1|||
105870822|NCT02729909|365179156|FG001|Overall Study|Significant Protocol Deviation|2|||
105870823|NCT02729909|365179155|FG000|Overall Study|Voluntary Withdrawal|1|||
105870824|NCT02729909|365179156|FG001|Overall Study|Voluntary Withdrawal|0|||
105870825|NCT02905032|365179157|FG000|Overall Study|Withdrawal by Subject|2|||
105870826|NCT02905032|365179158|FG001|Overall Study|Withdrawal by Subject|0|||
105870827|NCT02905032|365179159|FG002|Overall Study|Withdrawal by Subject|0|||
105870828|NCT02905032|365179157|FG000|Overall Study|Protocol Violation|6|||
105870829|NCT02905032|365179158|FG001|Overall Study|Protocol Violation|12|||
105870830|NCT02905032|365179159|FG002|Overall Study|Protocol Violation|0|||
105870831|NCT00141778|365179160|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
105870832|NCT00141778|365179161|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
105870833|NCT00141778|365179162|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
105870834|NCT00141778|365179160|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
105870835|NCT00141778|365179161|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
105870836|NCT00141778|365179162|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
105870837|NCT00141778|365179160|FG000|Started Study Medication|Withdrawal by Subject|0|||
105870838|NCT00141778|365179161|FG001|Started Study Medication|Withdrawal by Subject|2|||
105870839|NCT00141778|365179162|FG002|Started Study Medication|Withdrawal by Subject|0|||
105870840|NCT00141778|365179160|FG000|Started Study Medication|Difficulty Swallowing|0|||
105870841|NCT00141778|365179161|FG001|Started Study Medication|Difficulty Swallowing|1|||
105870842|NCT00141778|365179162|FG002|Started Study Medication|Difficulty Swallowing|0|||
105870843|NCT00141778|365179160|FG000|Started Study Medication|Chest Discomfort|0|||
105870844|NCT00141778|365179161|FG001|Started Study Medication|Chest Discomfort|0|||
105870845|NCT00141778|365179162|FG002|Started Study Medication|Chest Discomfort|1|||
105870846|NCT02046603|365179167|FG000|Overall Study|Other|11|||
105870847|NCT02046603|365179168|FG001|Overall Study|Other|66|||
105870848|NCT02046603|365179167|FG000|Overall Study|Protocol Violation|0|||
105870849|NCT02046603|365179168|FG001|Overall Study|Protocol Violation|1|||
105870850|NCT02046603|365179167|FG000|Overall Study|Participant/legal guardian decision|1|||
105870851|NCT02046603|365179168|FG001|Overall Study|Participant/legal guardian decision|3|||
105870852|NCT02046603|365179167|FG000|Overall Study|Physician Decision|2|||
105870853|NCT02046603|365179168|FG001|Overall Study|Physician Decision|1|||
105870854|NCT02046603|365179167|FG000|Overall Study|Lost to Follow-up|1|||
105870855|NCT02046603|365179168|FG001|Overall Study|Lost to Follow-up|2|||
105870856|NCT02046603|365179167|FG000|Overall Study|Death|0|||
105870857|NCT02046603|365179168|FG001|Overall Study|Death|1|||
105870858|NCT02046603|365179167|FG000|Overall Study|Adverse Event|0|||
105870859|NCT02046603|365179168|FG001|Overall Study|Adverse Event|1|||
105870860|NCT05478252|365179169|FG000|Overall Study|Withdrawal by Subject|2|||
105870861|NCT05478252|365179170|FG001|Overall Study|Withdrawal by Subject|3|||
105870862|NCT05478252|365179169|FG000|Overall Study|Lost to Follow-up|4|||
105870863|NCT05478252|365179170|FG001|Overall Study|Lost to Follow-up|2|||
105870864|NCT05478252|365179169|FG000|Overall Study|Physician Decision|1|||
105870865|NCT05478252|365179170|FG001|Overall Study|Physician Decision|1|||
105870866|NCT05478252|365179169|FG000|Overall Study|Death|1|||
105870867|NCT05478252|365179170|FG001|Overall Study|Death|0|||
105870868|NCT02461160|365179171|FG000|Overall Study|Lost to Follow-up|0|||
105870869|NCT02461160|365179172|FG001|Overall Study|Lost to Follow-up|0|||
105870870|NCT02461160|365179173|FG002|Overall Study|Lost to Follow-up|0|||
105870871|NCT02461160|365179174|FG003|Overall Study|Lost to Follow-up|0|||
105870872|NCT02461160|365179175|FG004|Overall Study|Lost to Follow-up|0|||
105870873|NCT02461160|365179176|FG005|Overall Study|Lost to Follow-up|0|||
105870874|NCT02461160|365179177|FG006|Overall Study|Lost to Follow-up|0|||
105870875|NCT02461160|365179178|FG007|Overall Study|Lost to Follow-up|1|||
105870876|NCT02461160|365179179|FG008|Overall Study|Lost to Follow-up|0|||
105870877|NCT02461160|365179180|FG009|Overall Study|Lost to Follow-up|0|||
105870878|NCT02461160|365179181|FG010|Overall Study|Lost to Follow-up|0|||
105870879|NCT02461160|365179182|FG011|Overall Study|Lost to Follow-up|0|||
105870880|NCT02461160|365179183|FG012|Overall Study|Lost to Follow-up|0|||
105870881|NCT02854527|365179184|FG000|Overall Study|Adverse Event|0|||
105870882|NCT02854527|365179185|FG001|Overall Study|Adverse Event|0|||
105870883|NCT02854527|365179186|FG002|Overall Study|Adverse Event|0|||
105870884|NCT02854527|365179187|FG003|Overall Study|Adverse Event|0|||
105870885|NCT02854527|365179188|FG004|Overall Study|Adverse Event|1|||
105870886|NCT02854527|365179189|FG005|Overall Study|Adverse Event|0|||
105870887|NCT02854527|365179190|FG006|Overall Study|Adverse Event|0|||
105870888|NCT02854527|365179191|FG007|Overall Study|Adverse Event|0|||
105870889|NCT02854527|365179192|FG008|Overall Study|Adverse Event|0|||
105870890|NCT02854527|365179193|FG009|Overall Study|Adverse Event|0|||
105870891|NCT02854527|365179184|FG000|Overall Study|Lost to Follow-up|0|||
105870892|NCT02854527|365179185|FG001|Overall Study|Lost to Follow-up|0|||
105870893|NCT02854527|365179186|FG002|Overall Study|Lost to Follow-up|0|||
105870894|NCT02854527|365179187|FG003|Overall Study|Lost to Follow-up|1|||
105870895|NCT02854527|365179188|FG004|Overall Study|Lost to Follow-up|0|||
105870896|NCT02854527|365179189|FG005|Overall Study|Lost to Follow-up|0|||
105657618|NCT03772613|364409921|FG002|Overall Study|Lost to Follow-up|1|||
105870897|NCT02854527|365179190|FG006|Overall Study|Lost to Follow-up|0|||
105870898|NCT02854527|365179191|FG007|Overall Study|Lost to Follow-up|0|||
105870899|NCT02854527|365179192|FG008|Overall Study|Lost to Follow-up|0|||
105870900|NCT02854527|365179193|FG009|Overall Study|Lost to Follow-up|0|||
105870901|NCT00193050|365179194|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
105870902|NCT00193050|365179194|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
105870903|NCT00193050|365179194|FG000|Neoadjuvant Treatment|Physician Decision|2|||
105870904|NCT00193050|365179194|FG000|Neoadjuvant Treatment|Adverse Event|2|||
105870905|NCT00193050|365179194|FG000|Adjuvant|Physician Decision|5|||
105870906|NCT00193050|365179194|FG000|Adjuvant|Intercurrent Hospitalization|3|||
105870907|NCT00193050|365179194|FG000|Adjuvant|Lack of Efficacy|2|||
105870908|NCT00061932|365179195|FG000|Overall Study|Withdrawal by Subject|13|||
105870909|NCT00061932|365179196|FG001|Overall Study|Withdrawal by Subject|4|||
105870910|NCT02899962|365179197|FG000|Open-label Phase|Adverse Event|2|||
105870911|NCT02899962|365179198|FG001|Open-label Phase|Adverse Event|0|||
105870912|NCT02899962|365179199|FG002|Open-label Phase|Adverse Event|0|||
105870913|NCT02899962|365179197|FG000|Open-label Phase|Lost to Follow-up|9|||
105870914|NCT02899962|365179198|FG001|Open-label Phase|Lost to Follow-up|0|||
105870915|NCT02899962|365179199|FG002|Open-label Phase|Lost to Follow-up|0|||
105870916|NCT02899962|365179197|FG000|Open-label Phase|Other reasons|9|||
105870917|NCT02899962|365179198|FG001|Open-label Phase|Other reasons|0|||
105870918|NCT02899962|365179199|FG002|Open-label Phase|Other reasons|0|||
105870919|NCT02899962|365179197|FG000|Open-label Phase|Withdrawal by Subject|7|||
105870920|NCT02899962|365179198|FG001|Open-label Phase|Withdrawal by Subject|0|||
105870921|NCT02899962|365179199|FG002|Open-label Phase|Withdrawal by Subject|0|||
105870922|NCT02899962|365179197|FG000|Maintenance Phase|Adverse Event|0|||
105870923|NCT02899962|365179198|FG001|Maintenance Phase|Adverse Event|2|||
105870924|NCT02899962|365179199|FG002|Maintenance Phase|Adverse Event|1|||
105870925|NCT02899962|365179197|FG000|Maintenance Phase|Death|0|||
105870926|NCT02899962|365179198|FG001|Maintenance Phase|Death|0|||
105870927|NCT02899962|365179199|FG002|Maintenance Phase|Death|1|||
105870928|NCT02899962|365179197|FG000|Maintenance Phase|Lack of Efficacy|0|||
105870929|NCT02899962|365179198|FG001|Maintenance Phase|Lack of Efficacy|20|||
105870930|NCT02899962|365179199|FG002|Maintenance Phase|Lack of Efficacy|16|||
105870931|NCT02899962|365179197|FG000|Maintenance Phase|Lost to Follow-up|0|||
105870932|NCT02899962|365179198|FG001|Maintenance Phase|Lost to Follow-up|12|||
105870933|NCT02899962|365179199|FG002|Maintenance Phase|Lost to Follow-up|14|||
105870934|NCT02899962|365179197|FG000|Maintenance Phase|Other reasons|0|||
105870935|NCT02899962|365179198|FG001|Maintenance Phase|Other reasons|9|||
105870936|NCT02899962|365179199|FG002|Maintenance Phase|Other reasons|13|||
105870937|NCT02899962|365179197|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
105870938|NCT02899962|365179198|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
105870939|NCT02899962|365179199|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
105870940|NCT02899962|365179197|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
105870941|NCT02899962|365179198|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
105870942|NCT02899962|365179199|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
105870943|NCT02899962|365179197|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105870944|NCT02899962|365179198|FG001|Maintenance Phase|Withdrawal by Subject|30|||
105870945|NCT02899962|365179199|FG002|Maintenance Phase|Withdrawal by Subject|36|||
105870946|NCT01245283|365179200|FG000|Overall Study|Lost to Follow-up|14|||
105870947|NCT01245283|365179201|FG001|Overall Study|Lost to Follow-up|11|||
105870948|NCT01245283|365179202|FG002|Overall Study|Lost to Follow-up|11|||
105870949|NCT03567980|365179211|FG000|Overall Study|Adverse Event|1|||
105870950|NCT01610492|365179212|FG000|Overall Study|Adverse Event|1|||
105870951|NCT01610492|365179212|FG000|Overall Study|Lack of Efficacy|3|||
105870952|NCT01610492|365179212|FG000|Overall Study|Other: Reached stopping criteria|1|||
105870953|NCT01610492|365179212|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
105870954|NCT01982955|365179213|FG000|Overall Study|Randomized but not treated|0|||
105870955|NCT01982955|365179214|FG001|Overall Study|Randomized but not treated|0|||
105870956|NCT01982955|365179215|FG002|Overall Study|Randomized but not treated|0|||
105870957|NCT01982955|365179216|FG003|Overall Study|Randomized but not treated|1|||
105870958|NCT01982955|365179217|FG004|Overall Study|Randomized but not treated|0|||
105870959|NCT01742897|365179221|FG000|Overall Study|Adverse Event|3|||
105870960|NCT01742897|365179221|FG000|Overall Study|Withdrawal by Subject|1|||
105870961|NCT01742897|365179221|FG000|Overall Study|Other|1|||
105870962|NCT02404805|365179222|FG000|Overall Study|Withdrawal by Subject|1|||
105870963|NCT02404805|365179223|FG001|Overall Study|Withdrawal by Subject|0|||
105870964|NCT02404805|365179224|FG002|Overall Study|Withdrawal by Subject|0|||
105870965|NCT02404805|365179225|FG003|Overall Study|Withdrawal by Subject|0|||
105870966|NCT02404805|365179226|FG004|Overall Study|Withdrawal by Subject|0|||
105870967|NCT02404805|365179227|FG005|Overall Study|Withdrawal by Subject|0|||
105870968|NCT01625091|365179228|FG000|Intervention|Death|1|||
105870969|NCT01625091|365179229|FG001|Intervention|Death|1|||
105870970|NCT01625091|365179228|FG000|Intervention|Withdrawal by Subject|4|||
105870971|NCT01625091|365179229|FG001|Intervention|Withdrawal by Subject|1|||
105659504|NCT02635386|364417349|FG002|Overall Study|Noncompliant|1|||
105870972|NCT01625091|365179228|FG000|Intervention|Adverse Event|0|||
105870973|NCT01625091|365179229|FG001|Intervention|Adverse Event|2|||
105870974|NCT01625091|365179228|FG000|Intervention|Lost to Follow-up|4|||
105870975|NCT01625091|365179229|FG001|Intervention|Lost to Follow-up|4|||
105870976|NCT01625091|365179228|FG000|Intervention|Study termination|2|||
105870977|NCT01625091|365179229|FG001|Intervention|Study termination|3|||
105870978|NCT01625091|365179228|FG000|Post-intervention|Death|0|||
105870979|NCT01625091|365179229|FG001|Post-intervention|Death|1|||
105870980|NCT01625091|365179228|FG000|Post-intervention|Lost to Follow-up|2|||
105870981|NCT01625091|365179229|FG001|Post-intervention|Lost to Follow-up|0|||
105870982|NCT01625091|365179228|FG000|Post-intervention|Study termination|2|||
105870983|NCT01625091|365179229|FG001|Post-intervention|Study termination|1|||
105870984|NCT02163057|365179230|FG000|Overall Study|Participant Refusal to Continue|2|||
105870985|NCT02163057|365179231|FG001|Overall Study|Participant Refusal to Continue|2|||
105870986|NCT02163057|365179230|FG000|Overall Study|Participant Significant Noncompliance|0|||
105870987|NCT02163057|365179231|FG001|Overall Study|Participant Significant Noncompliance|1|||
105870988|NCT02163057|365179230|FG000|Overall Study|Progression of Disease|1|||
105870989|NCT02163057|365179231|FG001|Overall Study|Progression of Disease|2|||
105870990|NCT00768248|365179232|FG000|Overall Study|Research coordinator didn't collect data|1|||
105870991|NCT00768248|365179233|FG001|Overall Study|Research coordinator didn't collect data|1|||
105870992|NCT01168427|365179234|FG000|Overall Study|Patient exited prior to implant|1|||
105870993|NCT00445146|365179235|FG000|Overall Study|Withdrew Consent|29|||
105870994|NCT00445146|365179235|FG000|Overall Study|Lack of Efficacy|28|||
105870995|NCT00445146|365179235|FG000|Overall Study|Investigator's Discretion|22|||
105870996|NCT00445146|365179235|FG000|Overall Study|Adverse Event|13|||
105870997|NCT00445146|365179235|FG000|Overall Study|Lost to Follow-up|13|||
105870998|NCT00445146|365179235|FG000|Overall Study|Death|9|||
105870999|NCT00445146|365179235|FG000|Overall Study|Protocol Violation|4|||
105871000|NCT00445146|365179235|FG000|Overall Study|Pregnancy|1|||
105871001|NCT01256879|365179236|FG000|Overall Study|Withdrawal by Subject|1|||
105871002|NCT00397514|365179237|FG000|Overall Study|Withdrawal by Subject|1|||
105871003|NCT00397514|365179237|FG000|Overall Study|Pacing wire malfunction|1|||
105871004|NCT00397514|365179237|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
105871005|NCT00397514|365179237|FG000|Overall Study|early extubation|2|||
105871006|NCT00397514|365179237|FG000|Overall Study|poor echocardiographic windows|1|||
105871007|NCT00640315|365179238|FG000|Overall Study|Withdrawal by Subject|0|||
105871008|NCT00640315|365179239|FG001|Overall Study|Withdrawal by Subject|1|||
105871009|NCT00955617|365179241|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
105871010|NCT00955617|365179242|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
105871011|NCT00955617|365179241|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
105871012|NCT00955617|365179242|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
105871013|NCT00955617|365179241|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
105871014|NCT00955617|365179242|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
105871015|NCT00955617|365179241|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
105871016|NCT00955617|365179242|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
105871017|NCT02694328|365179243|FG000|Overall Study|Adverse Event|27|||
105871018|NCT02694328|365179244|FG001|Overall Study|Adverse Event|33|||
105871019|NCT02694328|365179243|FG000|Overall Study|Withdrawal by Subject|27|||
105871020|NCT02694328|365179244|FG001|Overall Study|Withdrawal by Subject|23|||
105871021|NCT02694328|365179243|FG000|Overall Study|Lost to Follow-up|26|||
105871022|NCT02694328|365179244|FG001|Overall Study|Lost to Follow-up|22|||
105871023|NCT02694328|365179243|FG000|Overall Study|Noncompliant with study drug|11|||
105871024|NCT02694328|365179244|FG001|Overall Study|Noncompliant with study drug|8|||
105871025|NCT02694328|365179243|FG000|Overall Study|Incarceration|1|||
105871026|NCT02694328|365179244|FG001|Overall Study|Incarceration|1|||
105871027|NCT02694328|365179243|FG000|Overall Study|Lack of Efficacy|1|||
105871028|NCT02694328|365179244|FG001|Overall Study|Lack of Efficacy|2|||
105871029|NCT02694328|365179243|FG000|Overall Study|Pregnancy|1|||
105871030|NCT02694328|365179244|FG001|Overall Study|Pregnancy|1|||
105871031|NCT02694328|365179243|FG000|Overall Study|Protocol Violation|6|||
105871032|NCT02694328|365179244|FG001|Overall Study|Protocol Violation|5|||
105871033|NCT02694328|365179243|FG000|Overall Study|Abnormal Laboratory Value|0|||
105871034|NCT02694328|365179244|FG001|Overall Study|Abnormal Laboratory Value|3|||
105871035|NCT03300817|365181074|FG000|Overall Study|Withdrawal by Subject|1|||
105871036|NCT03300817|365181074|FG000|Overall Study|Adverse Event|1|||
105871037|NCT03300817|365181074|FG000|Overall Study|Subject Found to be Ineligible|2|||
105871038|NCT00001521|365181079|FG000|Overall Study|Withdrawal by Subject|3|||
105871039|NCT00001521|365181080|FG001|Overall Study|Withdrawal by Subject|3|||
105871040|NCT00001521|365181079|FG000|Overall Study|Physician Decision|1|||
105871041|NCT00001521|365181080|FG001|Overall Study|Physician Decision|1|||
105871042|NCT00001521|365181079|FG000|Overall Study|Noncompliant|6|||
105871043|NCT00001521|365181080|FG001|Overall Study|Noncompliant|3|||
105871044|NCT04100018|365181081|FG000|Pre-Treatment Period|Not Reported|0|||
105871045|NCT04100018|365181082|FG001|Pre-Treatment Period|Not Reported|4|||
105871046|NCT04100018|365181081|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
105871047|NCT04100018|365181082|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
105871048|NCT04100018|365181081|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
105871049|NCT04100018|365181082|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
105871050|NCT04100018|365181081|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
105871051|NCT04100018|365181082|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
105871052|NCT04100018|365181081|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
105871053|NCT04100018|365181082|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
105871054|NCT04100018|365181081|FG000|Treatment Period|Ongoing Treatment|1|||
105871055|NCT04100018|365181082|FG001|Treatment Period|Ongoing Treatment|0|||
105871056|NCT04100018|365181081|FG000|Treatment Period|Other Reason|26|||
105871057|NCT04100018|365181082|FG001|Treatment Period|Other Reason|37|||
105871058|NCT04100018|365181081|FG000|Treatment Period|Completed treatment as per protocol|1|||
105871059|NCT04100018|365181082|FG001|Treatment Period|Completed treatment as per protocol|2|||
105871060|NCT04100018|365181081|FG000|Treatment Period|Maximum clinical benefit|3|||
105871061|NCT04100018|365181082|FG001|Treatment Period|Maximum clinical benefit|0|||
105871062|NCT04100018|365181081|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
105871063|NCT04100018|365181082|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
105871064|NCT04100018|365181081|FG000|Treatment Period|Study drug toxicity|67|||
105871065|NCT04100018|365181082|FG001|Treatment Period|Study drug toxicity|28|||
105871066|NCT04100018|365181081|FG000|Treatment Period|Disease Progression|284|||
105871067|NCT04100018|365181082|FG001|Treatment Period|Disease Progression|327|||
105871068|NCT04100018|365181081|FG000|Treatment Period|Administrative reasons by sponsor|16|||
105871069|NCT04100018|365181082|FG001|Treatment Period|Administrative reasons by sponsor|30|||
105871070|NCT04100018|365181081|FG000|Treatment Period|Poor/Non-Compliance|1|||
105871071|NCT04100018|365181082|FG001|Treatment Period|Poor/Non-Compliance|0|||
105871072|NCT04100018|365181081|FG000|Treatment Period|Lost to Follow-up|2|||
105871073|NCT04100018|365181082|FG001|Treatment Period|Lost to Follow-up|2|||
105871074|NCT04100018|365181081|FG000|Treatment Period|Death|16|||
105871075|NCT04100018|365181082|FG001|Treatment Period|Death|11|||
105871076|NCT04100018|365181081|FG000|Treatment Period|Participant withdrew consent|10|||
105871077|NCT04100018|365181082|FG001|Treatment Period|Participant withdrew consent|10|||
105871078|NCT04100018|365181081|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
105871079|NCT04100018|365181082|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
105871080|NCT04100018|365181081|FG000|Treatment Period|Adverse Event|14|||
105871081|NCT04100018|365181082|FG001|Treatment Period|Adverse Event|6|||
105871082|NCT04100018|365181081|FG000|Treatment Period|Lack of Efficacy|4|||
105871083|NCT04100018|365181082|FG001|Treatment Period|Lack of Efficacy|2|||
105871084|NCT02439216|365181089|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
105871085|NCT02439216|365181090|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105871086|NCT02439216|365181091|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105871087|NCT02439216|365181092|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105871088|NCT02439216|365181093|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105871089|NCT02439216|365181094|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105871090|NCT02439216|365181095|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105871091|NCT02439216|365181096|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105871092|NCT02439216|365181097|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
105871093|NCT02439216|365181089|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105871094|NCT02439216|365181090|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105871095|NCT02439216|365181091|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105871096|NCT02439216|365181092|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105871097|NCT02439216|365181093|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105871098|NCT02439216|365181094|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105871099|NCT02439216|365181095|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105871100|NCT02439216|365181096|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
105871101|NCT02439216|365181097|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
105871102|NCT02439216|365181089|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105871103|NCT02439216|365181090|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105871104|NCT02439216|365181091|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105871105|NCT02439216|365181092|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105871106|NCT02439216|365181093|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105871107|NCT02439216|365181094|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105871108|NCT02439216|365181095|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
105871109|NCT02439216|365181096|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
105871110|NCT02439216|365181097|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
105871111|NCT02439216|365181089|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105871112|NCT02439216|365181090|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105871113|NCT02439216|365181091|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105871114|NCT02439216|365181092|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105871115|NCT02439216|365181093|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105871116|NCT02439216|365181094|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105871117|NCT02439216|365181095|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105871118|NCT02439216|365181096|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
105871119|NCT02439216|365181097|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
105871120|NCT02439216|365181089|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105871121|NCT02439216|365181090|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105871122|NCT02439216|365181091|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105871123|NCT02439216|365181092|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105871124|NCT02439216|365181093|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105871125|NCT02439216|365181094|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105871126|NCT02439216|365181095|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
105871127|NCT02439216|365181096|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
105871128|NCT02439216|365181097|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
105871129|NCT02094300|365181102|FG000|Overall Study|Death|7|||
105871130|NCT02094300|365181102|FG000|Overall Study|Lost to Follow-up|10|||
105871131|NCT02094300|365181102|FG000|Overall Study|Still be eligible for follow-up|3|||
105871132|NCT01276041|365181103|FG000|Overall Study|Adverse Event|2|||
105871133|NCT01276041|365181103|FG000|Overall Study|Protocol Violation|1|||
105871134|NCT00485264|365181104|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
105871135|NCT00485264|365181105|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
105871136|NCT00485264|365181106|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
105871137|NCT00485264|365181107|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
105871138|NCT00485264|365181108|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
105871139|NCT00485264|365181109|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
105871140|NCT00485264|365181104|FG000|Overall Study|Death|1|||
105871141|NCT00485264|365181105|FG001|Overall Study|Death|0|||
105871142|NCT00485264|365181106|FG002|Overall Study|Death|0|||
105871143|NCT00485264|365181107|FG003|Overall Study|Death|0|||
105871144|NCT00485264|365181108|FG004|Overall Study|Death|1|||
105871145|NCT00485264|365181109|FG005|Overall Study|Death|0|||
105871146|NCT00485264|365181104|FG000|Overall Study|Adverse Event|1|||
105871147|NCT00485264|365181105|FG001|Overall Study|Adverse Event|0|||
105871148|NCT00485264|365181106|FG002|Overall Study|Adverse Event|2|||
105871149|NCT00485264|365181107|FG003|Overall Study|Adverse Event|3|||
105871150|NCT00485264|365181108|FG004|Overall Study|Adverse Event|1|||
105871151|NCT00485264|365181109|FG005|Overall Study|Adverse Event|3|||
105871152|NCT00485264|365181104|FG000|Overall Study|Pregnancy|4|||
105871153|NCT00485264|365181105|FG001|Overall Study|Pregnancy|0|||
105871154|NCT00485264|365181106|FG002|Overall Study|Pregnancy|0|||
105871155|NCT00485264|365181107|FG003|Overall Study|Pregnancy|0|||
105871156|NCT00485264|365181108|FG004|Overall Study|Pregnancy|0|||
105871157|NCT00485264|365181109|FG005|Overall Study|Pregnancy|0|||
105871158|NCT00485264|365181104|FG000|Overall Study|Disallowed Medication|0|||
105871159|NCT00485264|365181105|FG001|Overall Study|Disallowed Medication|0|||
105871160|NCT00485264|365181106|FG002|Overall Study|Disallowed Medication|0|||
105871161|NCT00485264|365181107|FG003|Overall Study|Disallowed Medication|0|||
105871162|NCT00485264|365181108|FG004|Overall Study|Disallowed Medication|0|||
105871163|NCT00485264|365181109|FG005|Overall Study|Disallowed Medication|1|||
105871164|NCT00485264|365181104|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
105871165|NCT00485264|365181105|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
105871166|NCT00485264|365181106|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
105871167|NCT00485264|365181107|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
105871168|NCT00485264|365181108|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
105871169|NCT00485264|365181109|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
105871170|NCT00485264|365181104|FG000|Overall Study|Lack of Efficacy|0|||
105871171|NCT00485264|365181105|FG001|Overall Study|Lack of Efficacy|1|||
105871172|NCT00485264|365181106|FG002|Overall Study|Lack of Efficacy|0|||
105871173|NCT00485264|365181107|FG003|Overall Study|Lack of Efficacy|0|||
105871174|NCT00485264|365181108|FG004|Overall Study|Lack of Efficacy|0|||
105871175|NCT00485264|365181109|FG005|Overall Study|Lack of Efficacy|0|||
105871176|NCT00485264|365181104|FG000|Overall Study|Guardian Consent Withdrawn|1|||
105871177|NCT00485264|365181105|FG001|Overall Study|Guardian Consent Withdrawn|0|||
105871178|NCT00485264|365181106|FG002|Overall Study|Guardian Consent Withdrawn|0|||
105871179|NCT00485264|365181107|FG003|Overall Study|Guardian Consent Withdrawn|0|||
105871180|NCT00485264|365181108|FG004|Overall Study|Guardian Consent Withdrawn|1|||
105871181|NCT00485264|365181109|FG005|Overall Study|Guardian Consent Withdrawn|0|||
105871182|NCT00485264|365181104|FG000|Overall Study|Physician Decision|0|||
105871183|NCT00485264|365181105|FG001|Overall Study|Physician Decision|2|||
105871184|NCT00485264|365181106|FG002|Overall Study|Physician Decision|0|||
105871185|NCT00485264|365181107|FG003|Overall Study|Physician Decision|0|||
105871186|NCT00485264|365181108|FG004|Overall Study|Physician Decision|0|||
105871187|NCT00485264|365181109|FG005|Overall Study|Physician Decision|0|||
105871188|NCT00485264|365181104|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105871189|NCT00485264|365181105|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105871190|NCT00485264|365181106|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
105871191|NCT00485264|365181107|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105871192|NCT00485264|365181108|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105871193|NCT00485264|365181109|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
105871194|NCT00485264|365181104|FG000|Overall Study|Not Able to Attend Clinic|5|||
105871195|NCT00485264|365181105|FG001|Overall Study|Not Able to Attend Clinic|0|||
105871196|NCT00485264|365181106|FG002|Overall Study|Not Able to Attend Clinic|0|||
105871197|NCT00485264|365181107|FG003|Overall Study|Not Able to Attend Clinic|1|||
105871198|NCT00485264|365181108|FG004|Overall Study|Not Able to Attend Clinic|1|||
105871199|NCT00485264|365181109|FG005|Overall Study|Not Able to Attend Clinic|2|||
105871200|NCT00485264|365181104|FG000|Overall Study|Non-Compliant|17|||
105871201|NCT00485264|365181105|FG001|Overall Study|Non-Compliant|2|||
105871202|NCT00485264|365181106|FG002|Overall Study|Non-Compliant|1|||
105871203|NCT00485264|365181107|FG003|Overall Study|Non-Compliant|0|||
105871204|NCT00485264|365181108|FG004|Overall Study|Non-Compliant|1|||
105871205|NCT00485264|365181109|FG005|Overall Study|Non-Compliant|0|||
105871206|NCT00485264|365181104|FG000|Overall Study|Lost to Follow-up|2|||
105871207|NCT00485264|365181105|FG001|Overall Study|Lost to Follow-up|1|||
105871208|NCT00485264|365181106|FG002|Overall Study|Lost to Follow-up|1|||
105871209|NCT00485264|365181107|FG003|Overall Study|Lost to Follow-up|0|||
105871210|NCT00485264|365181108|FG004|Overall Study|Lost to Follow-up|0|||
105871211|NCT00485264|365181109|FG005|Overall Study|Lost to Follow-up|1|||
105871212|NCT00485264|365181104|FG000|Overall Study|Other Reason|3|||
105871213|NCT00485264|365181105|FG001|Overall Study|Other Reason|0|||
105871214|NCT00485264|365181106|FG002|Overall Study|Other Reason|0|||
105871215|NCT00485264|365181107|FG003|Overall Study|Other Reason|0|||
105871216|NCT00485264|365181108|FG004|Overall Study|Other Reason|0|||
105871217|NCT00485264|365181109|FG005|Overall Study|Other Reason|0|||
105871218|NCT02515331|365181115|FG000|Overall Study|Withdrawal by Subject|0|||
105871219|NCT02515331|365181116|FG001|Overall Study|Withdrawal by Subject|0|||
105871220|NCT02515331|365181117|FG002|Overall Study|Withdrawal by Subject|1|||
105871221|NCT02515331|365181115|FG000|Overall Study|Protocol deviation|0|||
105871222|NCT02515331|365181116|FG001|Overall Study|Protocol deviation|0|||
105871223|NCT02515331|365181117|FG002|Overall Study|Protocol deviation|3|||
105871224|NCT02515331|365181115|FG000|Overall Study|Adverse Event|2|||
105871225|NCT02515331|365181116|FG001|Overall Study|Adverse Event|0|||
105871226|NCT02515331|365181117|FG002|Overall Study|Adverse Event|0|||
105871227|NCT00124748|365181118|FG000|Overall Study|Adverse Event|8|||
105871228|NCT00124748|365181119|FG001|Overall Study|Adverse Event|39|||
105871229|NCT00124748|365181118|FG000|Overall Study|Abnormal laboratory Value|2|||
105871230|NCT00124748|365181119|FG001|Overall Study|Abnormal laboratory Value|2|||
105871231|NCT00124748|365181118|FG000|Overall Study|Abnormal Procedure|0|||
105871232|NCT00124748|365181119|FG001|Overall Study|Abnormal Procedure|1|||
105871233|NCT00124748|365181118|FG000|Overall Study|Lack of Efficacy|20|||
105871234|NCT00124748|365181119|FG001|Overall Study|Lack of Efficacy|41|||
105871235|NCT00124748|365181118|FG000|Overall Study|No longer requires study drug|1|||
105871236|NCT00124748|365181119|FG001|Overall Study|No longer requires study drug|1|||
105871237|NCT00124748|365181118|FG000|Overall Study|Protocol Violation|3|||
105871238|NCT00124748|365181119|FG001|Overall Study|Protocol Violation|1|||
105871239|NCT00124748|365181118|FG000|Overall Study|Withdrawal by Subject|5|||
105871240|NCT00124748|365181119|FG001|Overall Study|Withdrawal by Subject|15|||
105871241|NCT00124748|365181118|FG000|Overall Study|Lost to Follow-up|2|||
105871242|NCT00124748|365181119|FG001|Overall Study|Lost to Follow-up|7|||
105871243|NCT00124748|365181118|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
105871244|NCT00124748|365181119|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
105871245|NCT00124748|365181118|FG000|Overall Study|Death|1|||
105871246|NCT00124748|365181119|FG001|Overall Study|Death|3|||
105871247|NCT01514461|365181120|FG000|Overall Study|Adverse Event|2|||
105871248|NCT01514461|365181121|FG001|Overall Study|Adverse Event|1|||
105871249|NCT01514461|365181122|FG002|Overall Study|Adverse Event|3|||
105871250|NCT01514461|365181120|FG000|Overall Study|Physician Decision|1|||
105871251|NCT01514461|365181121|FG001|Overall Study|Physician Decision|1|||
105871252|NCT01514461|365181122|FG002|Overall Study|Physician Decision|0|||
105871253|NCT01514461|365181120|FG000|Overall Study|Patient/guardian decision|1|||
105871254|NCT01514461|365181121|FG001|Overall Study|Patient/guardian decision|1|||
105871255|NCT01514461|365181122|FG002|Overall Study|Patient/guardian decision|1|||
105871256|NCT01514461|365181120|FG000|Overall Study|Death|1|||
105871257|NCT01514461|365181121|FG001|Overall Study|Death|0|||
105871258|NCT01514461|365181122|FG002|Overall Study|Death|0|||
105871259|NCT03889886|365181124|FG000|Overall Study|Other|0|||
105871260|NCT03889886|365181125|FG001|Overall Study|Other|1|||
105871261|NCT03889886|365181126|FG002|Overall Study|Other|0|||
105871262|NCT03889886|365181127|FG003|Overall Study|Other|1|||
105871263|NCT03889886|365181124|FG000|Overall Study|Withdrawal by Subject|0|||
105871264|NCT03889886|365181125|FG001|Overall Study|Withdrawal by Subject|0|||
105871265|NCT03889886|365181126|FG002|Overall Study|Withdrawal by Subject|1|||
105871266|NCT03889886|365181127|FG003|Overall Study|Withdrawal by Subject|0|||
105871267|NCT03889886|365181124|FG000|Overall Study|Adverse Event|0|||
105871268|NCT03889886|365181125|FG001|Overall Study|Adverse Event|0|||
105871269|NCT03889886|365181126|FG002|Overall Study|Adverse Event|0|||
105871270|NCT03889886|365181127|FG003|Overall Study|Adverse Event|6|||
105871271|NCT00758524|365181130|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
105871272|NCT00758524|365181131|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
105871273|NCT00758524|365181132|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
105871274|NCT00758524|365181133|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871275|NCT00758524|365181134|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
105871276|NCT00758524|365181135|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
105871277|NCT00758524|365181136|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871278|NCT00758524|365181137|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871279|NCT00758524|365181138|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871280|NCT00758524|365181139|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871281|NCT00758524|365181140|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871282|NCT00758524|365181141|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871283|NCT00758524|365181142|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871284|NCT00758524|365181143|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871285|NCT00758524|365181144|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871286|NCT00758524|365181145|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871287|NCT00758524|365181146|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
105871288|NCT00758524|365181130|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
105871289|NCT00758524|365181131|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871290|NCT00758524|365181132|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
105871291|NCT00758524|365181133|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
105871292|NCT00758524|365181134|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
105871293|NCT00758524|365181135|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
105871294|NCT00758524|365181136|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871295|NCT00758524|365181137|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871296|NCT00758524|365181138|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871297|NCT00758524|365181139|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871298|NCT00758524|365181140|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871299|NCT00758524|365181141|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871300|NCT00758524|365181142|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871301|NCT00758524|365181143|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871302|NCT00758524|365181144|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871303|NCT00758524|365181145|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871304|NCT00758524|365181146|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
105871305|NCT00758524|365181130|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
105871306|NCT00758524|365181131|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
105871307|NCT00758524|365181132|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
105871308|NCT00758524|365181133|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
105871309|NCT00758524|365181134|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
105871310|NCT00758524|365181135|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
105871311|NCT00758524|365181136|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871312|NCT00758524|365181137|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871313|NCT00758524|365181138|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871314|NCT00758524|365181139|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871315|NCT00758524|365181140|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871316|NCT00758524|365181141|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871317|NCT00758524|365181142|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871318|NCT00758524|365181143|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871319|NCT00758524|365181144|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871320|NCT00758524|365181145|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871321|NCT00758524|365181146|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
105871322|NCT00758524|365181130|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871323|NCT00758524|365181131|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
105871324|NCT00758524|365181132|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
105871325|NCT00758524|365181133|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871326|NCT00758524|365181134|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
105871327|NCT00758524|365181135|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
105871328|NCT00758524|365181136|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871329|NCT00758524|365181137|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871330|NCT00758524|365181138|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871331|NCT00758524|365181139|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871332|NCT00758524|365181140|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871333|NCT00758524|365181141|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871334|NCT00758524|365181142|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871335|NCT00758524|365181143|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871336|NCT00758524|365181144|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871337|NCT00758524|365181145|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871338|NCT00758524|365181146|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
105871339|NCT00758524|365181130|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871340|NCT00758524|365181131|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871341|NCT00758524|365181132|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
105871342|NCT00758524|365181133|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
105871343|NCT00758524|365181134|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871344|NCT00758524|365181135|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871345|NCT00758524|365181136|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871346|NCT00758524|365181137|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871347|NCT00758524|365181138|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871348|NCT00758524|365181139|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871349|NCT00758524|365181140|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871350|NCT00758524|365181141|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871351|NCT00758524|365181142|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871352|NCT00758524|365181143|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871353|NCT00758524|365181144|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871354|NCT00758524|365181145|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871355|NCT00758524|365181146|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
105871356|NCT00758524|365181130|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871357|NCT00758524|365181131|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871358|NCT00758524|365181132|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871359|NCT00758524|365181133|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871360|NCT00758524|365181134|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
105871361|NCT00758524|365181135|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871362|NCT00758524|365181136|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871363|NCT00758524|365181137|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871364|NCT00758524|365181138|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871365|NCT00758524|365181139|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871366|NCT00758524|365181140|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871367|NCT00758524|365181141|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871368|NCT00758524|365181142|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871369|NCT00758524|365181143|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871370|NCT00758524|365181144|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871371|NCT00758524|365181145|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871372|NCT00758524|365181146|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
105871373|NCT00758524|365181130|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871374|NCT00758524|365181131|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
105871375|NCT00758524|365181132|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871376|NCT00758524|365181133|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871377|NCT00758524|365181134|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871378|NCT00758524|365181135|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871379|NCT00758524|365181136|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871380|NCT00758524|365181137|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871381|NCT00758524|365181138|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871382|NCT00758524|365181139|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871383|NCT00758524|365181140|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871384|NCT00758524|365181141|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871385|NCT00758524|365181142|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871386|NCT00758524|365181143|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871387|NCT00758524|365181144|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871388|NCT00758524|365181145|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871389|NCT00758524|365181146|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
105871390|NCT00758524|365181130|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871391|NCT00758524|365181131|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
105871392|NCT00758524|365181132|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871393|NCT00758524|365181133|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871394|NCT00758524|365181134|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871395|NCT00758524|365181135|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871396|NCT00758524|365181136|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871397|NCT00758524|365181137|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871398|NCT00758524|365181138|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871399|NCT00758524|365181139|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871400|NCT00758524|365181140|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871401|NCT00758524|365181141|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871402|NCT00758524|365181142|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871403|NCT00758524|365181143|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871404|NCT00758524|365181144|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871405|NCT00758524|365181145|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871406|NCT00758524|365181146|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
105871407|NCT00758524|365181130|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871408|NCT00758524|365181131|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871409|NCT00758524|365181132|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871410|NCT00758524|365181133|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871411|NCT00758524|365181134|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871412|NCT00758524|365181135|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871413|NCT00758524|365181136|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871414|NCT00758524|365181137|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871415|NCT00758524|365181138|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
105871416|NCT00758524|365181139|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871417|NCT00758524|365181140|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871418|NCT00758524|365181141|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871419|NCT00758524|365181142|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871420|NCT00758524|365181143|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871421|NCT00758524|365181144|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871422|NCT00758524|365181145|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871423|NCT00758524|365181146|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
105871424|NCT00758524|365181130|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871425|NCT00758524|365181131|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871426|NCT00758524|365181132|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871427|NCT00758524|365181133|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871428|NCT00758524|365181134|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871429|NCT00758524|365181135|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871430|NCT00758524|365181136|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
105871431|NCT00758524|365181137|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871432|NCT00758524|365181138|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871433|NCT00758524|365181139|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871434|NCT00758524|365181140|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871435|NCT00758524|365181141|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871436|NCT00758524|365181142|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871437|NCT00758524|365181143|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871438|NCT00758524|365181144|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871439|NCT00758524|365181145|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871440|NCT00758524|365181146|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
105871441|NCT02440464|365181147|FG000|Overall Study|Withdrawal by Subject|3|||
105871442|NCT02440464|365181148|FG001|Overall Study|Withdrawal by Subject|2|||
105871443|NCT00276484|365181149|FG000|Overall Study|Adverse Event|4|||
105871444|NCT00276484|365181150|FG001|Overall Study|Adverse Event|7|||
105871445|NCT00276484|365181149|FG000|Overall Study|Lost to Follow-up|1|||
105871446|NCT00276484|365181150|FG001|Overall Study|Lost to Follow-up|1|||
105871447|NCT00276484|365181149|FG000|Overall Study|Protocol Violation|0|||
105871448|NCT00276484|365181150|FG001|Overall Study|Protocol Violation|1|||
105871449|NCT00276484|365181149|FG000|Overall Study|Withdrawal by Subject|4|||
105871450|NCT00276484|365181150|FG001|Overall Study|Withdrawal by Subject|3|||
105871451|NCT00276484|365181149|FG000|Overall Study|Could not take time off work|0|||
105871452|NCT00276484|365181150|FG001|Overall Study|Could not take time off work|1|||
105871453|NCT01626690|365181154|FG000|Overall Study|Protocol Violation|1|||
105871454|NCT01626690|365181155|FG001|Overall Study|Protocol Violation|0|||
105871455|NCT01626690|365181154|FG000|Overall Study|Adverse Event|1|||
105871456|NCT01626690|365181155|FG001|Overall Study|Adverse Event|0|||
105871457|NCT01942993|365181161|FG000|Overall Study|Lost to Follow-up|1|||
105871458|NCT01942993|365181161|FG000|Overall Study|Physician Decision|1|||
105871459|NCT01350271|365181162|FG000|Overall Study|Lost to Follow-up|21|||
105871460|NCT01350271|365181163|FG001|Overall Study|Lost to Follow-up|17|||
105871461|NCT01350271|365181164|FG002|Overall Study|Lost to Follow-up|26|||
105871462|NCT01349192|365181165|FG000|Overall Study|Protocol Violation|0|||
105871463|NCT01349192|365181166|FG001|Overall Study|Protocol Violation|1|||
105871464|NCT01349192|365181165|FG000|Overall Study|Withdrawal by Subject|0|||
105871465|NCT01349192|365181166|FG001|Overall Study|Withdrawal by Subject|2|||
105871466|NCT01349192|365181165|FG000|Overall Study|Lost to Follow-up|1|||
105871467|NCT01349192|365181166|FG001|Overall Study|Lost to Follow-up|3|||
105871468|NCT01349192|365181165|FG000|Overall Study|Failure to adhere to Protocol|2|||
105871469|NCT01349192|365181166|FG001|Overall Study|Failure to adhere to Protocol|0|||
105871470|NCT02038010|365181167|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
105871471|NCT02038010|365181168|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
105871472|NCT02038010|365181169|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
105871473|NCT02038010|365181170|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
105871474|NCT02038010|365181167|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
105871475|NCT02038010|365181168|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
105871476|NCT02038010|365181169|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
105871477|NCT02038010|365181170|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
105871478|NCT02038010|365181167|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
105871479|NCT02038010|365181168|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
105871480|NCT02038010|365181169|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
105871481|NCT02038010|365181170|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
105871482|NCT02038010|365181167|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
105871483|NCT02038010|365181168|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
105871484|NCT02038010|365181169|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
105871485|NCT02038010|365181170|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
105871486|NCT02038010|365181167|FG000|Follow Up|Death|4|||
105871487|NCT02038010|365181168|FG001|Follow Up|Death|3|||
105871488|NCT02038010|365181169|FG002|Follow Up|Death|0|||
105871489|NCT02038010|365181170|FG003|Follow Up|Death|0|||
105871490|NCT02038010|365181167|FG000|Follow Up|Other|3|||
105871491|NCT02038010|365181168|FG001|Follow Up|Other|0|||
105871492|NCT02038010|365181169|FG002|Follow Up|Other|0|||
105871493|NCT02038010|365181170|FG003|Follow Up|Other|0|||
105871494|NCT00769379|365181173|FG000|Overall Study|No follow up data mapped to Other.|3|||
105871495|NCT00769379|365181174|FG001|Overall Study|No follow up data mapped to Other.|13|||
105871496|NCT03735121|365181175|FG000|Overall Study|Death|3|||
105871497|NCT03735121|365181176|FG001|Overall Study|Death|6|||
105871498|NCT03735121|365181177|FG002|Overall Study|Death|8|||
105871499|NCT03735121|365181178|FG003|Overall Study|Death|37|||
105871500|NCT03735121|365181179|FG004|Overall Study|Death|86|||
105871501|NCT03735121|365181175|FG000|Overall Study|Withdrawal by Subject|1|||
105871502|NCT03735121|365181176|FG001|Overall Study|Withdrawal by Subject|1|||
105871503|NCT03735121|365181177|FG002|Overall Study|Withdrawal by Subject|3|||
105871504|NCT03735121|365181178|FG003|Overall Study|Withdrawal by Subject|4|||
105871505|NCT03735121|365181179|FG004|Overall Study|Withdrawal by Subject|2|||
105871506|NCT03735121|365181175|FG000|Overall Study|Progressive Disease|0|||
105871507|NCT03735121|365181176|FG001|Overall Study|Progressive Disease|0|||
105871508|NCT03735121|365181177|FG002|Overall Study|Progressive Disease|1|||
105871509|NCT03735121|365181178|FG003|Overall Study|Progressive Disease|0|||
105871510|NCT03735121|365181179|FG004|Overall Study|Progressive Disease|0|||
105871511|NCT03735121|365181175|FG000|Overall Study|Lost to Follow-up|0|||
105871512|NCT03735121|365181176|FG001|Overall Study|Lost to Follow-up|0|||
105871513|NCT03735121|365181177|FG002|Overall Study|Lost to Follow-up|0|||
105871514|NCT03735121|365181178|FG003|Overall Study|Lost to Follow-up|0|||
105871515|NCT03735121|365181179|FG004|Overall Study|Lost to Follow-up|1|||
105871516|NCT03735121|365181175|FG000|Overall Study|Ongoing|3|||
105871517|NCT03735121|365181176|FG001|Overall Study|Ongoing|3|||
105871518|NCT03735121|365181177|FG002|Overall Study|Ongoing|26|||
105871519|NCT03735121|365181178|FG003|Overall Study|Ongoing|83|||
105871520|NCT03735121|365181179|FG004|Overall Study|Ongoing|158|||
105871521|NCT03624192|365181181|FG000|Overall Study|Lost to Follow-up|1|||
105871522|NCT03624192|365181182|FG001|Overall Study|Lost to Follow-up|1|||
105871523|NCT04870710|365181188|FG000|Overall Study|Lost to Follow-up|3|||
105871524|NCT00111241|365181189|FG000|Overall Study|Lost to Follow-up|1|||
105871525|NCT00111241|365181190|FG001|Overall Study|Lost to Follow-up|0|||
105871526|NCT00111241|365181189|FG000|Overall Study|Withdrawal by Subject|4|||
105871527|NCT00111241|365181190|FG001|Overall Study|Withdrawal by Subject|0|||
105871528|NCT00111241|365181189|FG000|Overall Study|Protocol Violation|9|||
105871529|NCT00111241|365181190|FG001|Overall Study|Protocol Violation|8|||
105871530|NCT00111241|365181189|FG000|Overall Study|Adverse Event|1|||
105871531|NCT00111241|365181190|FG001|Overall Study|Adverse Event|0|||
105871532|NCT04338022|365181191|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
105871533|NCT04338022|365181192|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
105871534|NCT04338022|365181191|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
105871535|NCT04338022|365181192|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
105871536|NCT04338022|365181191|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
105871537|NCT04338022|365181192|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
105871538|NCT04338022|365181191|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
105871539|NCT04338022|365181192|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
105871540|NCT04338022|365181191|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
105871541|NCT04338022|365181192|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
105871542|NCT04338022|365181191|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
105871543|NCT04338022|365181192|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
105871544|NCT04338022|365181191|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
105871545|NCT04338022|365181192|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
105871546|NCT04338022|365181191|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
105871547|NCT04338022|365181192|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
105871548|NCT04338022|365181191|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
105871549|NCT04338022|365181192|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
105871550|NCT04338022|365181191|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
105871551|NCT04338022|365181192|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
105871552|NCT04338022|365181191|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
105871553|NCT04338022|365181192|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
105871554|NCT04338022|365181191|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
105871555|NCT04338022|365181192|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
105871556|NCT04338022|365181191|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
105871557|NCT04338022|365181192|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
105871558|NCT04338022|365181191|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
105871559|NCT04338022|365181192|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
105871560|NCT01042093|365181196|FG000|Overall Study|Protocol Violation|2|||
105871561|NCT01042093|365181197|FG001|Overall Study|Protocol Violation|2|||
105871562|NCT01042093|365181198|FG002|Overall Study|Protocol Violation|2|||
105871563|NCT01042093|365181199|FG003|Overall Study|Protocol Violation|3|||
105871564|NCT01042093|365181196|FG000|Overall Study|Withdrawal by Subject|0|||
105871565|NCT01042093|365181197|FG001|Overall Study|Withdrawal by Subject|0|||
105871566|NCT01042093|365181198|FG002|Overall Study|Withdrawal by Subject|0|||
105871567|NCT01042093|365181199|FG003|Overall Study|Withdrawal by Subject|1|||
105871568|NCT04233073|365181203|FG000|Overall Study|Death|5|||
105871569|NCT02198963|365181204|FG000|Overall Study|Adverse Event|1|||
105871570|NCT02198963|365181204|FG000|Overall Study|Withdrawal by Subject|6|||
105871571|NCT00243412|365181205|FG000|Overall Study|Death|0|||
105871572|NCT00243412|365181206|FG001|Overall Study|Death|1|||
105871573|NCT00243412|365181205|FG000|Overall Study|Adverse Event|4|||
105871574|NCT00243412|365181206|FG001|Overall Study|Adverse Event|2|||
105871575|NCT00243412|365181205|FG000|Overall Study|Lost to Follow-up|0|||
105871576|NCT00243412|365181206|FG001|Overall Study|Lost to Follow-up|1|||
105871577|NCT00243412|365181205|FG000|Overall Study|Physician Decision|1|||
105871578|NCT00243412|365181206|FG001|Overall Study|Physician Decision|1|||
105871579|NCT00243412|365181205|FG000|Overall Study|Withdrawal by Subject|4|||
105871580|NCT00243412|365181206|FG001|Overall Study|Withdrawal by Subject|5|||
105871581|NCT00243412|365181205|FG000|Overall Study|Other|1|||
105871582|NCT00243412|365181206|FG001|Overall Study|Other|1|||
105871583|NCT03200717|365181214|FG000|Overall Study|Progressive disease|24|||
105871584|NCT03200717|365181215|FG001|Overall Study|Progressive disease|5|||
105871585|NCT03200717|365181214|FG000|Overall Study|Adverse Event|11|||
105871586|NCT03200717|365181215|FG001|Overall Study|Adverse Event|8|||
105871587|NCT03200717|365181214|FG000|Overall Study|Physician Decision|3|||
105871588|NCT03200717|365181215|FG001|Overall Study|Physician Decision|2|||
105871589|NCT03200717|365181214|FG000|Overall Study|Death|2|||
105871590|NCT03200717|365181215|FG001|Overall Study|Death|0|||
105871591|NCT03200717|365181214|FG000|Overall Study|Subject/Guardian Decision|1|||
105871592|NCT03200717|365181215|FG001|Overall Study|Subject/Guardian Decision|0|||
105871593|NCT02586155|365181216|FG000|Overall Study|Adverse Event|2|||
105871594|NCT02586155|365181217|FG001|Overall Study|Adverse Event|3|||
105871595|NCT02586155|365181216|FG000|Overall Study|Withdrawal by Subject|31|||
105871596|NCT02586155|365181217|FG001|Overall Study|Withdrawal by Subject|24|||
105871597|NCT02586155|365181216|FG000|Overall Study|Lost to Follow-up|7|||
105871598|NCT02586155|365181217|FG001|Overall Study|Lost to Follow-up|13|||
105871599|NCT02586155|365181216|FG000|Overall Study|Death|61|||
105871600|NCT02586155|365181217|FG001|Overall Study|Death|72|||
105871601|NCT02586155|365181216|FG000|Overall Study|Other reasons|26|||
105871602|NCT02586155|365181217|FG001|Overall Study|Other reasons|15|||
105871603|NCT00739063|365181220|FG000|Overall Study|Screen failures|8|||
105871604|NCT05101343|365181221|FG000|Overall Study|Withdrawal by Subject|2|||
105871605|NCT05101343|365181222|FG001|Overall Study|Withdrawal by Subject|1|||
105871606|NCT03447743|365181223|FG000|Overall Study|Withdrawal by Subject|2|||
105871607|NCT03447743|365181223|FG000|Overall Study|Lost to Follow-up|3|||
105871608|NCT03447743|365181223|FG000|Overall Study|Adverse Event|1|||
105871609|NCT03447743|365181223|FG000|Overall Study|Did not meet criteria to continue|1|||
105871610|NCT02072980|365181224|FG000|Period 2, Second Wear|Adverse Event|0|||
105871611|NCT02072980|365181225|FG001|Period 2, Second Wear|Adverse Event|1|||
105871612|NCT02431364|365181226|FG000|Overall Study|Adverse Event|0|||
105871613|NCT02431364|365181227|FG001|Overall Study|Adverse Event|1|||
105871614|NCT02431364|365181228|FG002|Overall Study|Adverse Event|0|||
105871615|NCT02431364|365181229|FG003|Overall Study|Adverse Event|0|||
105871616|NCT02431364|365181230|FG004|Overall Study|Adverse Event|0|||
105871617|NCT02431364|365181226|FG000|Overall Study|Randomized but never treated|0|||
105871618|NCT02431364|365181227|FG001|Overall Study|Randomized but never treated|0|||
105871619|NCT02431364|365181228|FG002|Overall Study|Randomized but never treated|0|||
105871620|NCT02431364|365181229|FG003|Overall Study|Randomized but never treated|1|||
105871621|NCT02431364|365181230|FG004|Overall Study|Randomized but never treated|0|||
105871622|NCT03093259|365181231|FG000|Overall Study|Adverse Event|1|||
105871623|NCT03093259|365181232|FG001|Overall Study|Adverse Event|0|||
105871624|NCT03093259|365181231|FG000|Overall Study|Withdrawal by Subject|1|||
105871625|NCT03093259|365181232|FG001|Overall Study|Withdrawal by Subject|0|||
105871626|NCT00550459|365181236|FG000|Overall Study|Adverse Event|0|||
105871627|NCT00550459|365181237|FG001|Overall Study|Adverse Event|2|||
105871628|NCT00550459|365181236|FG000|Overall Study|Withdrawal by Subject|1|||
105871629|NCT00550459|365181237|FG001|Overall Study|Withdrawal by Subject|1|||
105871630|NCT02633787|365181238|FG000|Overall Study|Withdrawal by Subject|1|||
105871631|NCT00866359|365181239|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
105871632|NCT00866359|365181240|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
105871633|NCT00866359|365181241|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
105871634|NCT00866359|365181242|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
105871635|NCT00866359|365181239|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
105871636|NCT00866359|365181240|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
105871637|NCT00866359|365181241|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
105871638|NCT00866359|365181242|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
105871639|NCT00866359|365181239|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
105871640|NCT00866359|365181240|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
105871641|NCT00866359|365181241|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
105871642|NCT00866359|365181242|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
105871643|NCT00866359|365181239|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
105871644|NCT00866359|365181240|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
105871645|NCT00866359|365181241|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
105871646|NCT00866359|365181242|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
105871647|NCT00866359|365181239|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
105871648|NCT00866359|365181240|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
105871649|NCT00866359|365181241|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
105871650|NCT00866359|365181242|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
105871651|NCT00866359|365181239|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
105871652|NCT00866359|365181240|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
105871653|NCT00866359|365181241|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
105871654|NCT00866359|365181242|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
105871655|NCT01547390|365181246|FG000|Overall Study|Withdrawal by Subject|10|||
105871656|NCT01547390|365181247|FG001|Overall Study|Withdrawal by Subject|7|||
105871657|NCT01547390|365181246|FG000|Overall Study|termination of pregnancy|0|||
105871658|NCT01547390|365181247|FG001|Overall Study|termination of pregnancy|1|||
105871659|NCT01547390|365181246|FG000|Overall Study|Lost to Follow-up|0|||
105871660|NCT01547390|365181247|FG001|Overall Study|Lost to Follow-up|2|||
105871661|NCT01547390|365181246|FG000|Overall Study|Adverse Event|3|||
105871662|NCT01547390|365181247|FG001|Overall Study|Adverse Event|0|||
105871663|NCT01459783|365181248|FG000|Baseline to 6 Months|Death|1|||
105871664|NCT01459783|365181249|FG001|Baseline to 6 Months|Death|0|||
105871665|NCT01459783|365181248|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
105871666|NCT01459783|365181249|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
105871667|NCT01459783|365181248|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
105871668|NCT01459783|365181249|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
105871669|NCT01459783|365181248|FG000|6 Months to 12 Months|Death|0|||
105871670|NCT01459783|365181249|FG001|6 Months to 12 Months|Death|1|||
105871671|NCT01459783|365181248|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
105871672|NCT01459783|365181249|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
105871673|NCT01459783|365181248|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
105871674|NCT01459783|365181249|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
105871675|NCT01459783|365181248|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
105871676|NCT01459783|365181249|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
105871677|NCT02601014|365181250|FG000|Overall Study|Adverse Event|3|||
105871678|NCT02601014|365181251|FG001|Overall Study|Adverse Event|3|||
105871679|NCT02601014|365181250|FG000|Overall Study|Death|3|||
105871680|NCT02601014|365181251|FG001|Overall Study|Death|1|||
105871681|NCT02601014|365181250|FG000|Overall Study|Disease progression|4|||
105871682|NCT02601014|365181251|FG001|Overall Study|Disease progression|8|||
105871683|NCT04211831|365181252|FG000|Overall Study|Withdrawal by Subject|4|||
105871684|NCT04211831|365181253|FG001|Overall Study|Withdrawal by Subject|1|||
105871685|NCT04211831|365181254|FG002|Overall Study|Withdrawal by Subject|1|||
105871686|NCT04211831|365181252|FG000|Overall Study|Protocol Violation|0|||
105871687|NCT04211831|365181253|FG001|Overall Study|Protocol Violation|0|||
105871688|NCT04211831|365181254|FG002|Overall Study|Protocol Violation|1|||
105871689|NCT04211831|365181252|FG000|Overall Study|Adverse Event|0|||
105871690|NCT04211831|365181253|FG001|Overall Study|Adverse Event|1|||
105871691|NCT04211831|365181254|FG002|Overall Study|Adverse Event|0|||
105871692|NCT04211831|365181252|FG000|Overall Study|Lack of Efficacy|0|||
105871693|NCT04211831|365181253|FG001|Overall Study|Lack of Efficacy|0|||
105871694|NCT04211831|365181254|FG002|Overall Study|Lack of Efficacy|1|||
105871695|NCT04211831|365181252|FG000|Overall Study|Lost to Follow-up|0|||
105871696|NCT04211831|365181253|FG001|Overall Study|Lost to Follow-up|0|||
105871697|NCT04211831|365181254|FG002|Overall Study|Lost to Follow-up|2|||
105871698|NCT04211831|365181252|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
105871699|NCT04211831|365181253|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
105871700|NCT04211831|365181254|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
105871701|NCT04211831|365181252|FG000|Overall Study|Other|0|||
105871702|NCT04211831|365181253|FG001|Overall Study|Other|1|||
105871703|NCT04211831|365181254|FG002|Overall Study|Other|0|||
105871704|NCT00625820|365181257|FG000|Overall Study|Withdrawal by Subject|1|||
105871705|NCT00967330|365181258|FG000|Overall Study|Protocol Violation|3|||
105871706|NCT00967330|365181259|FG001|Overall Study|Protocol Violation|4|||
105871707|NCT00967330|365181258|FG000|Overall Study|Regular|10|||
105871708|NCT00967330|365181259|FG001|Overall Study|Regular|3|||
105871709|NCT00967330|365181258|FG000|Overall Study|Withdrawal by Subject|6|||
105871710|NCT00967330|365181259|FG001|Overall Study|Withdrawal by Subject|0|||
105871711|NCT00967330|365181258|FG000|Overall Study|Lost to Follow-up|1|||
105871712|NCT00967330|365181259|FG001|Overall Study|Lost to Follow-up|1|||
105871713|NCT00967330|365181258|FG000|Overall Study|Death|102|||
105871714|NCT00967330|365181259|FG001|Overall Study|Death|51|||
105871715|NCT00967330|365181258|FG000|Overall Study|Severe protocol deviation|0|||
105871716|NCT00967330|365181259|FG001|Overall Study|Severe protocol deviation|1|||
105871717|NCT01959295|365181267|FG000|Overall Study|Adverse Event|2|||
105871718|NCT01959295|365181268|FG001|Overall Study|Adverse Event|0|||
105871719|NCT01959295|365181267|FG000|Overall Study|Lost to Follow-up|0|||
105871720|NCT01959295|365181268|FG001|Overall Study|Lost to Follow-up|2|||
105871721|NCT01959295|365181267|FG000|Overall Study|Physician Decision|2|||
105871722|NCT01959295|365181268|FG001|Overall Study|Physician Decision|3|||
105871723|NCT01959295|365181267|FG000|Overall Study|Protocol Violation|16|||
105871724|NCT01959295|365181268|FG001|Overall Study|Protocol Violation|5|||
105871725|NCT01959295|365181267|FG000|Overall Study|Withdrawal by Subject|3|||
105871726|NCT01959295|365181268|FG001|Overall Study|Withdrawal by Subject|1|||
105871727|NCT01959295|365181267|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
105871728|NCT01959295|365181268|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
105871729|NCT03493685|365183465|FG000|Overall Study|Death|4|||
105871730|NCT03493685|365183466|FG001|Overall Study|Death|3|||
105871731|NCT03493685|365183465|FG000|Overall Study|Lost to Follow-up|3|||
105871732|NCT03493685|365183466|FG001|Overall Study|Lost to Follow-up|2|||
105871733|NCT03493685|365183465|FG000|Overall Study|Physician Decision|2|||
105871734|NCT03493685|365183466|FG001|Overall Study|Physician Decision|0|||
105871735|NCT03493685|365183465|FG000|Overall Study|Withdrawal by Subject|7|||
105871736|NCT03493685|365183466|FG001|Overall Study|Withdrawal by Subject|11|||
105871737|NCT04147234|365183467|FG000|Overall Study|Clinical deterioration|0|||
105871738|NCT04147234|365183468|FG001|Overall Study|Clinical deterioration|0|||
105871739|NCT04147234|365183469|FG002|Overall Study|Clinical deterioration|1|||
105871740|NCT04147234|365183470|FG003|Overall Study|Clinical deterioration|0|||
105871741|NCT04147234|365183471|FG004|Overall Study|Clinical deterioration|0|||
105871742|NCT04147234|365183472|FG005|Overall Study|Clinical deterioration|0|||
105871743|NCT04147234|365183473|FG006|Overall Study|Clinical deterioration|0|||
105871744|NCT04147234|365183467|FG000|Overall Study|Withdrawal by Subject|0|||
105871745|NCT04147234|365183468|FG001|Overall Study|Withdrawal by Subject|1|||
105871746|NCT04147234|365183469|FG002|Overall Study|Withdrawal by Subject|1|||
105871747|NCT04147234|365183470|FG003|Overall Study|Withdrawal by Subject|0|||
105871748|NCT04147234|365183471|FG004|Overall Study|Withdrawal by Subject|0|||
105871749|NCT04147234|365183472|FG005|Overall Study|Withdrawal by Subject|0|||
105871750|NCT04147234|365183473|FG006|Overall Study|Withdrawal by Subject|0|||
105871751|NCT04147234|365183467|FG000|Overall Study|Clinical disease progression|1|||
105871752|NCT04147234|365183468|FG001|Overall Study|Clinical disease progression|3|||
105871753|NCT04147234|365183469|FG002|Overall Study|Clinical disease progression|1|||
105871754|NCT04147234|365183470|FG003|Overall Study|Clinical disease progression|1|||
105871755|NCT04147234|365183471|FG004|Overall Study|Clinical disease progression|0|||
105871756|NCT04147234|365183472|FG005|Overall Study|Clinical disease progression|1|||
105871757|NCT04147234|365183473|FG006|Overall Study|Clinical disease progression|0|||
105871758|NCT04147234|365183467|FG000|Overall Study|Objective disease progression|6|||
105871759|NCT04147234|365183468|FG001|Overall Study|Objective disease progression|4|||
105871760|NCT04147234|365183469|FG002|Overall Study|Objective disease progression|3|||
105871761|NCT04147234|365183470|FG003|Overall Study|Objective disease progression|3|||
105871762|NCT04147234|365183471|FG004|Overall Study|Objective disease progression|5|||
105871763|NCT04147234|365183472|FG005|Overall Study|Objective disease progression|2|||
105871764|NCT04147234|365183473|FG006|Overall Study|Objective disease progression|3|||
105871765|NCT04147234|365183467|FG000|Overall Study|Adverse Event|0|||
105871766|NCT04147234|365183468|FG001|Overall Study|Adverse Event|0|||
105871767|NCT04147234|365183469|FG002|Overall Study|Adverse Event|0|||
105871768|NCT04147234|365183470|FG003|Overall Study|Adverse Event|0|||
105871769|NCT04147234|365183471|FG004|Overall Study|Adverse Event|1|||
105871770|NCT04147234|365183472|FG005|Overall Study|Adverse Event|0|||
105871771|NCT04147234|365183473|FG006|Overall Study|Adverse Event|0|||
105871772|NCT03620708|365183474|FG000|Overall Study|Lost to Follow-up|1|||
105871773|NCT03620708|365183475|FG001|Overall Study|Lost to Follow-up|1|||
105871774|NCT03620708|365183476|FG002|Overall Study|Lost to Follow-up|2|||
105871775|NCT03620708|365183474|FG000|Overall Study|Withdrawal by Subject|0|||
105871776|NCT03620708|365183475|FG001|Overall Study|Withdrawal by Subject|0|||
105871777|NCT03620708|365183476|FG002|Overall Study|Withdrawal by Subject|1|||
105871778|NCT01557504|365183477|FG000|Overall Study|Physician Decision|1|||
105871779|NCT01557504|365183478|FG001|Overall Study|Physician Decision|0|||
105871780|NCT02366689|365183487|FG000|Overall Study|Withdrawal by Subject|1|||
105871781|NCT02366689|365183488|FG001|Overall Study|Withdrawal by Subject|0|||
105871782|NCT02366689|365183489|FG002|Overall Study|Withdrawal by Subject|1|||
105871783|NCT02366689|365183487|FG000|Overall Study|Lost to Follow-up|3|||
105871784|NCT02366689|365183488|FG001|Overall Study|Lost to Follow-up|2|||
105871785|NCT02366689|365183489|FG002|Overall Study|Lost to Follow-up|0|||
105871786|NCT02366689|365183487|FG000|Overall Study|Pregnancy|0|||
105871787|NCT02366689|365183488|FG001|Overall Study|Pregnancy|1|||
105871788|NCT02366689|365183489|FG002|Overall Study|Pregnancy|1|||
105871789|NCT01290068|365183490|FG000|Overall Study|Adverse Event|1|||
105871790|NCT01290068|365183491|FG001|Overall Study|Adverse Event|3|||
105871791|NCT01290068|365183490|FG000|Overall Study|Lost to Follow-up|3|||
105871792|NCT01290068|365183491|FG001|Overall Study|Lost to Follow-up|0|||
105871793|NCT01290068|365183490|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
105871794|NCT01290068|365183491|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
105871795|NCT01290068|365183490|FG000|Overall Study|Other|3|||
105871796|NCT01290068|365183491|FG001|Overall Study|Other|1|||
105871797|NCT03718832|365183492|FG000|Analysis Sample|Withdrawal by Subject|18|||
105871798|NCT03718832|365183493|FG001|Analysis Sample|Withdrawal by Subject|15|||
105871799|NCT03718832|365183492|FG000|Analysis Sample|Legal hold on data|1|||
105871800|NCT03718832|365183493|FG001|Analysis Sample|Legal hold on data|0|||
105871801|NCT03718832|365183492|FG000|Analysis Sample|Participant from treated household|0|||
105871802|NCT03718832|365183493|FG001|Analysis Sample|Participant from treated household|1|||
105871803|NCT03718832|365183492|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
105871804|NCT03718832|365183493|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
105871841|NCT04882241|365183498|FG000|Overall Study|Ongoing in study|46|||
105871842|NCT04882241|365183499|FG001|Overall Study|Ongoing in study|48|||
105871843|NCT04882241|365183500|FG002|Overall Study|Ongoing in study|0|||
105871844|NCT04882241|365183501|FG003|Overall Study|Ongoing in study|0|||
105659505|NCT02635386|364417350|FG003|Overall Study|Noncompliant|1|||
105871845|NCT04882241|365183498|FG000|Overall Study|Death|13|||
105871846|NCT04882241|365183499|FG001|Overall Study|Death|13|||
105871847|NCT04882241|365183500|FG002|Overall Study|Death|0|||
105871848|NCT04882241|365183501|FG003|Overall Study|Death|0|||
105871849|NCT04688671|365183507|FG000|Overall Study|Adverse Event|3|||
105871850|NCT04688671|365183508|FG001|Overall Study|Adverse Event|1|||
105871851|NCT04688671|365183507|FG000|Overall Study|Withdrawal by Subject|3|||
105871852|NCT04688671|365183508|FG001|Overall Study|Withdrawal by Subject|1|||
105871853|NCT04688671|365183507|FG000|Overall Study|Lack of Efficacy|1|||
105871854|NCT04688671|365183508|FG001|Overall Study|Lack of Efficacy|1|||
105871855|NCT04688671|365183507|FG000|Overall Study|Protocol Violation|1|||
105871856|NCT04688671|365183508|FG001|Overall Study|Protocol Violation|0|||
105871857|NCT04688671|365183507|FG000|Overall Study|Lost to Follow-up|0|||
105871858|NCT04688671|365183508|FG001|Overall Study|Lost to Follow-up|1|||
105871859|NCT01973439|365183517|FG000|Overall Study|Lost samples from one PK Day|2|||
105871860|NCT01973439|365183517|FG000|Overall Study|Vomiting after commencing once daily|1|||
105871861|NCT01973439|365183517|FG000|Overall Study|PK curve incomplete|2|||
105871862|NCT02262325|365183521|FG000|Overall Study|Death|16|||
105871863|NCT02262325|365183521|FG000|Overall Study|Lost to Follow-up|1|||
105871864|NCT01071915|365183525|FG000|Overall Study|Adverse Event|3|||
105871865|NCT01071915|365183525|FG000|Overall Study|Physician Decision|2|||
105871866|NCT01071915|365183525|FG000|Overall Study|Withdrawal by Subject|2|||
105871867|NCT01071915|365183525|FG000|Overall Study|Miscellaneous Reasons|2|||
105871868|NCT01518322|365183526|FG000|Overall Study|FeNO measurement was missing|13|||
105871869|NCT00948155|365183534|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
105871870|NCT00948155|365183535|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
105871871|NCT00948155|365183534|FG000|Washout 14 Days|Lost to Follow-up|1|||
105871872|NCT00948155|365183535|FG001|Washout 14 Days|Lost to Follow-up|2|||
105871873|NCT05767905|365183541|FG000|Overall Study|Adverse Event|0|||
105871874|NCT05767905|365183542|FG001|Overall Study|Adverse Event|0|||
105871875|NCT05767905|365183543|FG002|Overall Study|Adverse Event|1|||
105871876|NCT04471428|365183544|FG000|Overall Study|Withdrawal by Subject|29|||
105871877|NCT04471428|365183545|FG001|Overall Study|Withdrawal by Subject|1|||
105871878|NCT04471428|365183544|FG000|Overall Study|Physician Decision|0|||
105871879|NCT04471428|365183545|FG001|Overall Study|Physician Decision|1|||
105871880|NCT04471428|365183544|FG000|Overall Study|Reason Not Specified|0|||
105871881|NCT04471428|365183545|FG001|Overall Study|Reason Not Specified|2|||
105871882|NCT04471428|365183544|FG000|Overall Study|Death|106|||
105871883|NCT04471428|365183545|FG001|Overall Study|Death|114|||
105871884|NCT04471428|365183544|FG000|Overall Study|Ongoing in the study|45|||
105871885|NCT04471428|365183545|FG001|Overall Study|Ongoing in the study|68|||
105871886|NCT05198518|365183548|FG000|Screening Visit|Deemed unable to participate|58|||
105871887|NCT05198518|365183549|FG001|Screening Visit|Deemed unable to participate|0|||
105871888|NCT05198518|365183550|FG002|Screening Visit|Deemed unable to participate|0|||
105871889|NCT02224157|365183551|FG000|Overall Study|Severe non-compliance to protocol|2|||
105871890|NCT02224157|365183552|FG001|Overall Study|Severe non-compliance to protocol|2|||
105871891|NCT02224157|365183551|FG000|Overall Study|Other|13|||
105871892|NCT02224157|365183552|FG001|Overall Study|Other|10|||
105871893|NCT02224157|365183551|FG000|Overall Study|Subject decision|58|||
105871894|NCT02224157|365183552|FG001|Overall Study|Subject decision|50|||
105871895|NCT02224157|365183551|FG000|Overall Study|Prematurely closed site|4|||
105871896|NCT02224157|365183552|FG001|Overall Study|Prematurely closed site|2|||
105871897|NCT02224157|365183551|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
105871898|NCT02224157|365183552|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
105871899|NCT02224157|365183551|FG000|Overall Study|Lost to Follow-up|27|||
105871900|NCT02224157|365183552|FG001|Overall Study|Lost to Follow-up|35|||
105871901|NCT02224157|365183551|FG000|Overall Study|Death|1|||
105871902|NCT02224157|365183552|FG001|Overall Study|Death|1|||
105871903|NCT02224157|365183551|FG000|Overall Study|Adverse Event|1|||
105871904|NCT02224157|365183552|FG001|Overall Study|Adverse Event|3|||
105871905|NCT01526057|365183558|FG000|Overall Study|Withdrawal by Subject|3|||
105871906|NCT01526057|365183559|FG001|Overall Study|Withdrawal by Subject|2|||
105871907|NCT01526057|365183560|FG002|Overall Study|Withdrawal by Subject|2|||
105871908|NCT01526057|365183558|FG000|Overall Study|Adverse Event|3|||
105871909|NCT01526057|365183559|FG001|Overall Study|Adverse Event|1|||
105871910|NCT01526057|365183560|FG002|Overall Study|Adverse Event|1|||
105871911|NCT01526057|365183558|FG000|Overall Study|Death|1|||
105871912|NCT01526057|365183559|FG001|Overall Study|Death|0|||
105871913|NCT01526057|365183560|FG002|Overall Study|Death|0|||
105871914|NCT01526057|365183558|FG000|Overall Study|Lost to Follow-up|1|||
105871915|NCT01526057|365183559|FG001|Overall Study|Lost to Follow-up|0|||
105871916|NCT01526057|365183560|FG002|Overall Study|Lost to Follow-up|1|||
105871917|NCT01526057|365183558|FG000|Overall Study|Other|1|||
105871918|NCT01526057|365183559|FG001|Overall Study|Other|0|||
105871919|NCT01526057|365183560|FG002|Overall Study|Other|1|||
105871920|NCT01526057|365183558|FG000|Overall Study|Protocol Violation|0|||
105871921|NCT01526057|365183559|FG001|Overall Study|Protocol Violation|0|||
105871922|NCT01526057|365183560|FG002|Overall Study|Protocol Violation|1|||
105871923|NCT06071754|365183572|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
105871924|NCT02273388|365183573|FG000|Overall Study|Adverse Event|0|||
105871925|NCT02273388|365183574|FG001|Overall Study|Adverse Event|0|||
105871926|NCT02273388|365183575|FG002|Overall Study|Adverse Event|0|||
105871927|NCT02273388|365183576|FG003|Overall Study|Adverse Event|0|||
105871928|NCT02273388|365183577|FG004|Overall Study|Adverse Event|0|||
105871929|NCT02273388|365183578|FG005|Overall Study|Adverse Event|0|||
105871930|NCT02273388|365183579|FG006|Overall Study|Adverse Event|1|||
105871931|NCT02273388|365183580|FG007|Overall Study|Adverse Event|2|||
105871932|NCT02273388|365183581|FG008|Overall Study|Adverse Event|0|||
105871933|NCT02273388|365183582|FG009|Overall Study|Adverse Event|0|||
105871934|NCT02273388|365183583|FG010|Overall Study|Adverse Event|0|||
105871935|NCT02273388|365183584|FG011|Overall Study|Adverse Event|0|||
105871936|NCT02273388|365183573|FG000|Overall Study|Adverse Event study disease worse|4|||
105871937|NCT02273388|365183574|FG001|Overall Study|Adverse Event study disease worse|3|||
105871938|NCT02273388|365183575|FG002|Overall Study|Adverse Event study disease worse|3|||
105871939|NCT02273388|365183576|FG003|Overall Study|Adverse Event study disease worse|2|||
105871940|NCT02273388|365183577|FG004|Overall Study|Adverse Event study disease worse|4|||
105871941|NCT02273388|365183578|FG005|Overall Study|Adverse Event study disease worse|3|||
105871942|NCT02273388|365183579|FG006|Overall Study|Adverse Event study disease worse|14|||
105871943|NCT02273388|365183580|FG007|Overall Study|Adverse Event study disease worse|6|||
105871944|NCT02273388|365183581|FG008|Overall Study|Adverse Event study disease worse|6|||
105871945|NCT02273388|365183582|FG009|Overall Study|Adverse Event study disease worse|5|||
105871946|NCT02273388|365183583|FG010|Overall Study|Adverse Event study disease worse|10|||
105871947|NCT02273388|365183584|FG011|Overall Study|Adverse Event study disease worse|1|||
105871948|NCT02273388|365183573|FG000|Overall Study|Sponsor decision|0|||
105871949|NCT02273388|365183574|FG001|Overall Study|Sponsor decision|0|||
105871950|NCT02273388|365183575|FG002|Overall Study|Sponsor decision|0|||
105871951|NCT02273388|365183576|FG003|Overall Study|Sponsor decision|0|||
105871952|NCT02273388|365183577|FG004|Overall Study|Sponsor decision|0|||
105871953|NCT02273388|365183578|FG005|Overall Study|Sponsor decision|0|||
105871954|NCT02273388|365183579|FG006|Overall Study|Sponsor decision|0|||
105871955|NCT02273388|365183580|FG007|Overall Study|Sponsor decision|0|||
105871956|NCT02273388|365183581|FG008|Overall Study|Sponsor decision|0|||
105871957|NCT02273388|365183582|FG009|Overall Study|Sponsor decision|0|||
105871958|NCT02273388|365183583|FG010|Overall Study|Sponsor decision|0|||
105871959|NCT02273388|365183584|FG011|Overall Study|Sponsor decision|1|||
105871960|NCT04331808|365183585|FG000|Overall Study|Withdrew consent|1|||
105871961|NCT04331808|365183586|FG001|Overall Study|Withdrew consent|0|||
105871962|NCT04331808|365183587|FG002|Overall Study|Withdrew consent|2|||
105871963|NCT04331808|365183588|FG003|Overall Study|Withdrew consent|3|||
105871964|NCT02443740|365183589|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871965|NCT02443740|365183590|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871966|NCT02443740|365183591|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871967|NCT02443740|365183592|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871968|NCT02443740|365183593|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871969|NCT02443740|365183594|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
105871970|NCT02443740|365183595|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871971|NCT02443740|365183596|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871972|NCT02443740|365183597|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871973|NCT02443740|365183598|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871974|NCT02443740|365183599|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
105871975|NCT02443740|365183589|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
105871976|NCT02443740|365183590|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871977|NCT02443740|365183591|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871978|NCT02443740|365183592|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871979|NCT02443740|365183593|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871980|NCT02443740|365183594|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871981|NCT02443740|365183595|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
105871982|NCT02443740|365183596|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871983|NCT02443740|365183597|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871984|NCT02443740|365183598|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871985|NCT02443740|365183599|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
105871986|NCT02443740|365183589|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871987|NCT02443740|365183590|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871988|NCT02443740|365183591|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871989|NCT02443740|365183592|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871990|NCT02443740|365183593|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871991|NCT02443740|365183594|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
105871992|NCT02443740|365183595|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871993|NCT02443740|365183596|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871994|NCT02443740|365183597|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871995|NCT02443740|365183598|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871996|NCT02443740|365183599|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
105871997|NCT01964976|365183600|FG000|Overall Study|Protocol Violation|31|||
105871998|NCT00683657|365183601|FG000|Overall Study|Adverse Event|0|||
105871999|NCT00683657|365183602|FG001|Overall Study|Adverse Event|1|||
105872000|NCT00683657|365183601|FG000|Overall Study|Subject Withdrew Consent|1|||
105872001|NCT00683657|365183602|FG001|Overall Study|Subject Withdrew Consent|0|||
105872002|NCT02348112|365183608|FG000|Overall Study|Withdrawal by Subject|32|||
105872003|NCT02348112|365183609|FG001|Overall Study|Withdrawal by Subject|29|||
105872004|NCT02348112|365183608|FG000|Overall Study|Lost to Follow-up|24|||
105872005|NCT02348112|365183609|FG001|Overall Study|Lost to Follow-up|20|||
105872006|NCT02348112|365183608|FG000|Overall Study|Physician Decision|17|||
105872007|NCT02348112|365183609|FG001|Overall Study|Physician Decision|15|||
105872008|NCT02348112|365183608|FG000|Overall Study|Site closed due to PI leaving|0|||
105872009|NCT02348112|365183609|FG001|Overall Study|Site closed due to PI leaving|30|||
105872010|NCT02348112|365183608|FG000|Overall Study|Sponsor withdrawal|0|||
105872011|NCT02348112|365183609|FG001|Overall Study|Sponsor withdrawal|7|||
105872012|NCT02348112|365183608|FG000|Overall Study|Death|0|||
105872013|NCT02348112|365183609|FG001|Overall Study|Death|1|||
105872014|NCT00972595|365183613|FG000|Period 1|Adverse Event|1|||
105872015|NCT00972595|365183614|FG001|Period 1|Adverse Event|0|||
105872016|NCT01461538|365183616|FG000|Overall Study|Death|15|||
105872017|NCT01461538|365183617|FG001|Overall Study|Death|6|||
105872018|NCT01461538|365183618|FG002|Overall Study|Death|2|||
105872019|NCT01461538|365183616|FG000|Overall Study|Study Stopped by Sponsor|2|||
105872020|NCT01461538|365183617|FG001|Overall Study|Study Stopped by Sponsor|1|||
105872021|NCT01461538|365183618|FG002|Overall Study|Study Stopped by Sponsor|0|||
105872022|NCT01461538|365183616|FG000|Overall Study|Withdrawal by Subject|1|||
105872023|NCT01461538|365183617|FG001|Overall Study|Withdrawal by Subject|1|||
105872024|NCT01461538|365183618|FG002|Overall Study|Withdrawal by Subject|0|||
105872025|NCT02201784|365183619|FG000|Overall Study|Failure to achieve adequate block|2|||
105872026|NCT02201784|365183620|FG001|Overall Study|Failure to achieve adequate block|0|||
105872027|NCT04779879|365183621|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105872028|NCT04779879|365183622|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105872029|NCT04779879|365183623|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105872030|NCT04779879|365183624|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
105872031|NCT04779879|365183625|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105872032|NCT04779879|365183626|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
105872033|NCT04779879|365183621|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
105872034|NCT04779879|365183622|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
105872035|NCT04779879|365183623|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
105872036|NCT04779879|365183624|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
105872037|NCT04779879|365183625|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
105872038|NCT04779879|365183626|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
105872039|NCT04779879|365183621|FG000|Part C: Up to Week 36|Death|0|||
105872040|NCT04779879|365183622|FG001|Part C: Up to Week 36|Death|0|||
105872041|NCT04779879|365183623|FG002|Part C: Up to Week 36|Death|0|||
105872042|NCT04779879|365183624|FG003|Part C: Up to Week 36|Death|0|||
105872043|NCT04779879|365183625|FG004|Part C: Up to Week 36|Death|0|||
105872044|NCT04779879|365183626|FG005|Part C: Up to Week 36|Death|1|||
105872045|NCT04779879|365183621|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
105872046|NCT04779879|365183622|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
105872047|NCT04779879|365183623|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
105872048|NCT04779879|365183624|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
105872049|NCT04779879|365183625|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
105872050|NCT04779879|365183626|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
105872051|NCT02456740|365183629|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
105872052|NCT02456740|365183630|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
105872053|NCT02456740|365183631|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
105872054|NCT02456740|365183632|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105872055|NCT02456740|365183633|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105872056|NCT02456740|365183634|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105872057|NCT02456740|365183635|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105872058|NCT02456740|365183636|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105872059|NCT02456740|365183637|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
105872060|NCT02456740|365183629|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
105872061|NCT02456740|365183630|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
105872062|NCT02456740|365183631|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
105872063|NCT02456740|365183632|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105872064|NCT02456740|365183633|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105872065|NCT02456740|365183634|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105872066|NCT02456740|365183635|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105872067|NCT02456740|365183636|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105872068|NCT02456740|365183637|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
105872069|NCT02456740|365183629|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
105872070|NCT02456740|365183630|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
105872071|NCT02456740|365183631|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
105872072|NCT02456740|365183632|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105872073|NCT02456740|365183633|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105872074|NCT02456740|365183634|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105872075|NCT02456740|365183635|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105872076|NCT02456740|365183636|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105872077|NCT02456740|365183637|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
105872078|NCT02456740|365183629|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105872079|NCT02456740|365183630|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105872080|NCT02456740|365183631|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105872081|NCT02456740|365183632|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
105872082|NCT02456740|365183633|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
105872083|NCT02456740|365183634|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105872084|NCT02456740|365183635|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105872085|NCT02456740|365183636|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
105872086|NCT02456740|365183637|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
105872087|NCT02456740|365183629|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105872088|NCT02456740|365183630|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105872089|NCT02456740|365183631|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
105872090|NCT02456740|365183632|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
105872091|NCT02456740|365183633|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
105872092|NCT02456740|365183634|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
105872093|NCT02456740|365183635|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
105872094|NCT02456740|365183636|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
105872095|NCT02456740|365183637|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
105872096|NCT02456740|365183629|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105872097|NCT02456740|365183630|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105872098|NCT02456740|365183631|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105872099|NCT02456740|365183632|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105872100|NCT02456740|365183633|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105872101|NCT02456740|365183634|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105872102|NCT02456740|365183635|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105872103|NCT02456740|365183636|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
105872104|NCT02456740|365183637|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
105872105|NCT02456740|365183629|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105872106|NCT02456740|365183630|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105872107|NCT02456740|365183631|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
105872108|NCT02456740|365183632|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
105872109|NCT02456740|365183633|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
105872110|NCT02456740|365183634|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
105872111|NCT02456740|365183635|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
105872112|NCT02456740|365183636|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
105872113|NCT02456740|365183637|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
105872114|NCT02623725|365183638|FG000|Overall Study|Non compliance with protocol|9|||
105872115|NCT02623725|365183639|FG001|Overall Study|Non compliance with protocol|3|||
105872116|NCT02623725|365183638|FG000|Overall Study|Serious adverse event|0|||
105872117|NCT02623725|365183639|FG001|Overall Study|Serious adverse event|2|||
105872118|NCT02623725|365183638|FG000|Overall Study|Withdrawal by Subject|7|||
105872119|NCT02623725|365183639|FG001|Overall Study|Withdrawal by Subject|1|||
105872120|NCT03759392|365183641|FG000|Overall Study|Adverse Event|12|||
105872121|NCT03759392|365183642|FG001|Overall Study|Adverse Event|4|||
105872122|NCT03759392|365183641|FG000|Overall Study|Death|2|||
105872123|NCT03759392|365183642|FG001|Overall Study|Death|1|||
105872124|NCT03759392|365183641|FG000|Overall Study|Withdrawal by Subject|2|||
105872125|NCT03759392|365183642|FG001|Overall Study|Withdrawal by Subject|0|||
105872126|NCT03759392|365183641|FG000|Overall Study|Protocol Violation|2|||
105872127|NCT03759392|365183642|FG001|Overall Study|Protocol Violation|0|||
105872128|NCT03759392|365183641|FG000|Overall Study|Physician Decision|0|||
105872129|NCT03759392|365183642|FG001|Overall Study|Physician Decision|1|||
105872130|NCT03759392|365183641|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
105872131|NCT03759392|365183642|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
105872132|NCT03759392|365183641|FG000|Overall Study|No longer able to take medicines|1|||
105872133|NCT03759392|365183642|FG001|Overall Study|No longer able to take medicines|0|||
105872134|NCT03759392|365183641|FG000|Overall Study|Stopped taking study drug|1|||
105872135|NCT03759392|365183642|FG001|Overall Study|Stopped taking study drug|0|||
105872136|NCT02548143|365183644|FG000|Overall Study|Adverse Event|1|||
105872137|NCT02548143|365183645|FG001|Overall Study|Adverse Event|0|||
105872138|NCT02548143|365183644|FG000|Overall Study|Withdrawal by Subject|0|||
105872139|NCT02548143|365183645|FG001|Overall Study|Withdrawal by Subject|1|||
105872140|NCT02603146|365185740|FG000|Overall Study|Lost to Follow-up|5|||
105872141|NCT02603146|365185741|FG001|Overall Study|Lost to Follow-up|6|||
105872142|NCT02603146|365185740|FG000|Overall Study|Withdrawal by Subject|8|||
105872143|NCT02603146|365185741|FG001|Overall Study|Withdrawal by Subject|10|||
105872144|NCT02603146|365185740|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
105872145|NCT02603146|365185741|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
105872146|NCT02603146|365185740|FG000|Overall Study|Participant moved|2|||
105872147|NCT02603146|365185741|FG001|Overall Study|Participant moved|0|||
105872148|NCT02603146|365185740|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
105872149|NCT02603146|365185741|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
105872150|NCT06082843|365185743|FG000|Overall Study|Withdrawal by Subject|0|||
105872151|NCT06082843|365185744|FG001|Overall Study|Withdrawal by Subject|2|||
105872152|NCT06082843|365185743|FG000|Overall Study|Study terminated by sponsor|12|||
105872153|NCT06082843|365185744|FG001|Overall Study|Study terminated by sponsor|8|||
105872154|NCT02848001|365185745|FG000|Overall Study|other reasons|0|||
105872155|NCT02848001|365185746|FG001|Overall Study|other reasons|0|||
105872156|NCT02848001|365185747|FG002|Overall Study|other reasons|1|||
105872157|NCT02848001|365185748|FG003|Overall Study|other reasons|0|||
105872158|NCT02848001|365185749|FG004|Overall Study|other reasons|4|||
105872159|NCT02848001|365185750|FG005|Overall Study|other reasons|1|||
105872160|NCT02848001|365185751|FG006|Overall Study|other reasons|0|||
105872161|NCT02848001|365185752|FG007|Overall Study|other reasons|2|||
105872162|NCT02848001|365185753|FG008|Overall Study|other reasons|2|||
105872163|NCT02848001|365185754|FG009|Overall Study|other reasons|3|||
105872164|NCT02848001|365185755|FG010|Overall Study|other reasons|0|||
105872165|NCT02848001|365185756|FG011|Overall Study|other reasons|1|||
105872166|NCT02848001|365185757|FG012|Overall Study|other reasons|1|||
105872167|NCT02848001|365185758|FG013|Overall Study|other reasons|0|||
105872168|NCT02848001|365185759|FG014|Overall Study|other reasons|0|||
105872169|NCT02848001|365185760|FG015|Overall Study|other reasons|2|||
105872170|NCT02848001|365185761|FG016|Overall Study|other reasons|1|||
105872171|NCT02848001|365185745|FG000|Overall Study|Lack of Efficacy|0|||
105872172|NCT02848001|365185746|FG001|Overall Study|Lack of Efficacy|1|||
105872173|NCT02848001|365185747|FG002|Overall Study|Lack of Efficacy|1|||
105872174|NCT02848001|365185748|FG003|Overall Study|Lack of Efficacy|2|||
105872175|NCT02848001|365185749|FG004|Overall Study|Lack of Efficacy|3|||
105872176|NCT02848001|365185750|FG005|Overall Study|Lack of Efficacy|0|||
105872177|NCT02848001|365185751|FG006|Overall Study|Lack of Efficacy|1|||
105872178|NCT02848001|365185752|FG007|Overall Study|Lack of Efficacy|0|||
105872179|NCT02848001|365185753|FG008|Overall Study|Lack of Efficacy|0|||
105872180|NCT02848001|365185754|FG009|Overall Study|Lack of Efficacy|1|||
105872181|NCT02848001|365185755|FG010|Overall Study|Lack of Efficacy|0|||
105872182|NCT02848001|365185756|FG011|Overall Study|Lack of Efficacy|2|||
105872183|NCT02848001|365185757|FG012|Overall Study|Lack of Efficacy|0|||
105872184|NCT02848001|365185758|FG013|Overall Study|Lack of Efficacy|2|||
105872185|NCT02848001|365185759|FG014|Overall Study|Lack of Efficacy|2|||
105872186|NCT02848001|365185760|FG015|Overall Study|Lack of Efficacy|0|||
105872187|NCT02848001|365185761|FG016|Overall Study|Lack of Efficacy|0|||
105872188|NCT02848001|365185745|FG000|Overall Study|Progressive Disease|2|||
105872189|NCT02848001|365185746|FG001|Overall Study|Progressive Disease|1|||
105872190|NCT02848001|365185747|FG002|Overall Study|Progressive Disease|0|||
105872191|NCT02848001|365185748|FG003|Overall Study|Progressive Disease|4|||
105872192|NCT02848001|365185749|FG004|Overall Study|Progressive Disease|3|||
105872193|NCT02848001|365185750|FG005|Overall Study|Progressive Disease|0|||
105872194|NCT02848001|365185751|FG006|Overall Study|Progressive Disease|4|||
105872195|NCT02848001|365185752|FG007|Overall Study|Progressive Disease|1|||
105872196|NCT02848001|365185753|FG008|Overall Study|Progressive Disease|0|||
105872197|NCT02848001|365185754|FG009|Overall Study|Progressive Disease|2|||
105872198|NCT02848001|365185755|FG010|Overall Study|Progressive Disease|3|||
105872199|NCT02848001|365185756|FG011|Overall Study|Progressive Disease|2|||
105872200|NCT02848001|365185757|FG012|Overall Study|Progressive Disease|1|||
105872201|NCT02848001|365185758|FG013|Overall Study|Progressive Disease|0|||
105872202|NCT02848001|365185759|FG014|Overall Study|Progressive Disease|2|||
105872203|NCT02848001|365185760|FG015|Overall Study|Progressive Disease|4|||
105872204|NCT02848001|365185761|FG016|Overall Study|Progressive Disease|0|||
105872205|NCT02848001|365185745|FG000|Overall Study|Adverse Event|0|||
105872206|NCT02848001|365185746|FG001|Overall Study|Adverse Event|0|||
105872207|NCT02848001|365185747|FG002|Overall Study|Adverse Event|0|||
105872208|NCT02848001|365185748|FG003|Overall Study|Adverse Event|0|||
105872209|NCT02848001|365185749|FG004|Overall Study|Adverse Event|2|||
105872210|NCT02848001|365185750|FG005|Overall Study|Adverse Event|0|||
105872211|NCT02848001|365185751|FG006|Overall Study|Adverse Event|0|||
105872212|NCT02848001|365185752|FG007|Overall Study|Adverse Event|0|||
105872213|NCT02848001|365185753|FG008|Overall Study|Adverse Event|0|||
105872214|NCT02848001|365185754|FG009|Overall Study|Adverse Event|1|||
105872215|NCT02848001|365185755|FG010|Overall Study|Adverse Event|0|||
105872216|NCT02848001|365185756|FG011|Overall Study|Adverse Event|1|||
105872217|NCT02848001|365185757|FG012|Overall Study|Adverse Event|1|||
105872218|NCT02848001|365185758|FG013|Overall Study|Adverse Event|0|||
105872219|NCT02848001|365185759|FG014|Overall Study|Adverse Event|2|||
105872220|NCT02848001|365185760|FG015|Overall Study|Adverse Event|0|||
105872221|NCT02848001|365185761|FG016|Overall Study|Adverse Event|0|||
105872222|NCT02848001|365185745|FG000|Overall Study|Death|0|||
105872223|NCT02848001|365185746|FG001|Overall Study|Death|0|||
105872224|NCT02848001|365185747|FG002|Overall Study|Death|0|||
105872225|NCT02848001|365185748|FG003|Overall Study|Death|1|||
105872226|NCT02848001|365185749|FG004|Overall Study|Death|3|||
105872227|NCT02848001|365185750|FG005|Overall Study|Death|1|||
105872228|NCT02848001|365185751|FG006|Overall Study|Death|2|||
105872229|NCT02848001|365185752|FG007|Overall Study|Death|3|||
105872230|NCT02848001|365185753|FG008|Overall Study|Death|4|||
105872231|NCT02848001|365185754|FG009|Overall Study|Death|1|||
105872232|NCT02848001|365185755|FG010|Overall Study|Death|0|||
105872233|NCT02848001|365185756|FG011|Overall Study|Death|1|||
105872234|NCT02848001|365185757|FG012|Overall Study|Death|3|||
105872235|NCT02848001|365185758|FG013|Overall Study|Death|0|||
105872236|NCT02848001|365185759|FG014|Overall Study|Death|2|||
105872237|NCT02848001|365185760|FG015|Overall Study|Death|3|||
105872238|NCT02848001|365185761|FG016|Overall Study|Death|0|||
105872239|NCT02848001|365185745|FG000|Overall Study|Physician Decision|0|||
105872240|NCT02848001|365185746|FG001|Overall Study|Physician Decision|0|||
105872241|NCT02848001|365185747|FG002|Overall Study|Physician Decision|0|||
105872242|NCT02848001|365185748|FG003|Overall Study|Physician Decision|0|||
105872243|NCT02848001|365185749|FG004|Overall Study|Physician Decision|0|||
105872244|NCT02848001|365185750|FG005|Overall Study|Physician Decision|0|||
105872245|NCT02848001|365185751|FG006|Overall Study|Physician Decision|0|||
105872246|NCT02848001|365185752|FG007|Overall Study|Physician Decision|0|||
105872247|NCT02848001|365185753|FG008|Overall Study|Physician Decision|1|||
105872248|NCT02848001|365185754|FG009|Overall Study|Physician Decision|1|||
105872249|NCT02848001|365185755|FG010|Overall Study|Physician Decision|0|||
105872250|NCT02848001|365185756|FG011|Overall Study|Physician Decision|0|||
105872251|NCT02848001|365185757|FG012|Overall Study|Physician Decision|2|||
105872252|NCT02848001|365185758|FG013|Overall Study|Physician Decision|0|||
105872253|NCT02848001|365185759|FG014|Overall Study|Physician Decision|0|||
105872254|NCT02848001|365185760|FG015|Overall Study|Physician Decision|0|||
105872255|NCT02848001|365185761|FG016|Overall Study|Physician Decision|0|||
105872256|NCT02848001|365185745|FG000|Overall Study|Withdrawal by Subject|0|||
105872257|NCT02848001|365185746|FG001|Overall Study|Withdrawal by Subject|0|||
105872258|NCT02848001|365185747|FG002|Overall Study|Withdrawal by Subject|0|||
105872259|NCT02848001|365185748|FG003|Overall Study|Withdrawal by Subject|0|||
105872260|NCT02848001|365185749|FG004|Overall Study|Withdrawal by Subject|0|||
105872261|NCT02848001|365185750|FG005|Overall Study|Withdrawal by Subject|1|||
105872262|NCT02848001|365185751|FG006|Overall Study|Withdrawal by Subject|1|||
105872263|NCT02848001|365185752|FG007|Overall Study|Withdrawal by Subject|1|||
105872264|NCT02848001|365185753|FG008|Overall Study|Withdrawal by Subject|0|||
105872265|NCT02848001|365185754|FG009|Overall Study|Withdrawal by Subject|0|||
105872266|NCT02848001|365185755|FG010|Overall Study|Withdrawal by Subject|0|||
105872267|NCT02848001|365185756|FG011|Overall Study|Withdrawal by Subject|0|||
105872268|NCT02848001|365185757|FG012|Overall Study|Withdrawal by Subject|0|||
105872269|NCT02848001|365185758|FG013|Overall Study|Withdrawal by Subject|0|||
105872270|NCT02848001|365185759|FG014|Overall Study|Withdrawal by Subject|0|||
105872271|NCT02848001|365185760|FG015|Overall Study|Withdrawal by Subject|0|||
105872272|NCT02848001|365185761|FG016|Overall Study|Withdrawal by Subject|0|||
105872273|NCT01368497|365185765|FG000|Overall Study|Lost to Follow-up|2|||
105872274|NCT02762929|365185766|FG000|Overall Study|Adverse Event|0|||
105872275|NCT02762929|365185767|FG001|Overall Study|Adverse Event|0|||
105872276|NCT02762929|365185768|FG002|Overall Study|Adverse Event|0|||
105872277|NCT02762929|365185769|FG003|Overall Study|Adverse Event|1|||
105872278|NCT02762929|365185770|FG004|Overall Study|Adverse Event|0|||
105872279|NCT02762929|365185771|FG005|Overall Study|Adverse Event|0|||
105872280|NCT02762929|365185766|FG000|Overall Study|Lost to Follow-up|1|||
105872281|NCT02762929|365185767|FG001|Overall Study|Lost to Follow-up|2|||
105872282|NCT02762929|365185768|FG002|Overall Study|Lost to Follow-up|0|||
105872283|NCT02762929|365185769|FG003|Overall Study|Lost to Follow-up|1|||
105872284|NCT02762929|365185770|FG004|Overall Study|Lost to Follow-up|0|||
105872285|NCT02762929|365185771|FG005|Overall Study|Lost to Follow-up|0|||
105872286|NCT02762929|365185766|FG000|Overall Study|Withdrawal by Subject|0|||
105872287|NCT02762929|365185767|FG001|Overall Study|Withdrawal by Subject|1|||
105872288|NCT02762929|365185768|FG002|Overall Study|Withdrawal by Subject|0|||
105872289|NCT02762929|365185769|FG003|Overall Study|Withdrawal by Subject|0|||
105872290|NCT02762929|365185770|FG004|Overall Study|Withdrawal by Subject|0|||
105872291|NCT02762929|365185771|FG005|Overall Study|Withdrawal by Subject|0|||
105872292|NCT02762929|365185766|FG000|Overall Study|exclusionary medication disclosed late|0|||
105872293|NCT02762929|365185767|FG001|Overall Study|exclusionary medication disclosed late|0|||
105872294|NCT02762929|365185768|FG002|Overall Study|exclusionary medication disclosed late|0|||
105872295|NCT02762929|365185769|FG003|Overall Study|exclusionary medication disclosed late|1|||
105872296|NCT02762929|365185770|FG004|Overall Study|exclusionary medication disclosed late|0|||
105872297|NCT02762929|365185771|FG005|Overall Study|exclusionary medication disclosed late|0|||
105872298|NCT00118157|365185772|FG000|Overall Study|Adverse Event|2|||
105872299|NCT00118157|365185772|FG000|Overall Study|Death|8|||
105872300|NCT00118157|365185772|FG000|Overall Study|Withdrawal by Subject|2|||
105872301|NCT02656303|365185773|FG000|Overall Study|Adverse Event|3|||
105872302|NCT02656303|365185774|FG001|Overall Study|Adverse Event|2|||
105872303|NCT02656303|365185775|FG002|Overall Study|Adverse Event|0|||
105872304|NCT02656303|365185773|FG000|Overall Study|Death|12|||
105872305|NCT02656303|365185774|FG001|Overall Study|Death|4|||
105872306|NCT02656303|365185775|FG002|Overall Study|Death|1|||
105872307|NCT02656303|365185773|FG000|Overall Study|Lack of Efficacy|1|||
105872308|NCT02656303|365185774|FG001|Overall Study|Lack of Efficacy|0|||
105872309|NCT02656303|365185775|FG002|Overall Study|Lack of Efficacy|0|||
105872310|NCT02656303|365185773|FG000|Overall Study|Non-Compliance with Study|1|||
105872311|NCT02656303|365185774|FG001|Overall Study|Non-Compliance with Study|1|||
105872312|NCT02656303|365185775|FG002|Overall Study|Non-Compliance with Study|0|||
105872313|NCT02656303|365185773|FG000|Overall Study|Investigator Decision|2|||
105872314|NCT02656303|365185774|FG001|Overall Study|Investigator Decision|1|||
105872315|NCT02656303|365185775|FG002|Overall Study|Investigator Decision|0|||
105872316|NCT02656303|365185773|FG000|Overall Study|Progressive Disease|25|||
105872317|NCT02656303|365185774|FG001|Overall Study|Progressive Disease|14|||
105872318|NCT02656303|365185775|FG002|Overall Study|Progressive Disease|10|||
105872319|NCT02656303|365185773|FG000|Overall Study|Study Terminated by Sponsor|20|||
105872320|NCT02656303|365185774|FG001|Overall Study|Study Terminated by Sponsor|7|||
105872321|NCT02656303|365185775|FG002|Overall Study|Study Terminated by Sponsor|5|||
105872322|NCT02656303|365185773|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
105872323|NCT02656303|365185774|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
105872324|NCT02656303|365185775|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
105872325|NCT02656303|365185773|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
105872326|NCT02656303|365185774|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
105872327|NCT02656303|365185775|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
105872328|NCT02656303|365185773|FG000|Overall Study|Reason not Specified|1|||
105872329|NCT02656303|365185774|FG001|Overall Study|Reason not Specified|1|||
105872330|NCT02656303|365185775|FG002|Overall Study|Reason not Specified|2|||
105872331|NCT05989672|365185778|FG000|Overall Study|Adverse Event|3|||
105872332|NCT05989672|365185779|FG001|Overall Study|Adverse Event|0|||
105872333|NCT05989672|365185780|FG002|Overall Study|Adverse Event|0|||
105872334|NCT00696423|365185781|FG000|Overall Study|Lost to Follow-up|0|||
105872335|NCT00696423|365185782|FG001|Overall Study|Lost to Follow-up|5|||
105872336|NCT00443729|365185783|FG000|Overall Study|Never Treated|0|||
105872337|NCT00443729|365185784|FG001|Overall Study|Never Treated|1|||
105872338|NCT00443729|365185783|FG000|Overall Study|Lack of Efficacy|4|||
105872339|NCT00443729|365185784|FG001|Overall Study|Lack of Efficacy|2|||
105872340|NCT00443729|365185783|FG000|Overall Study|Lost to Follow-up|0|||
105872341|NCT00443729|365185784|FG001|Overall Study|Lost to Follow-up|1|||
105872342|NCT00443729|365185783|FG000|Overall Study|Physician Decision|2|||
105872343|NCT00443729|365185784|FG001|Overall Study|Physician Decision|1|||
105872344|NCT00443729|365185783|FG000|Overall Study|Protocol Violation|1|||
105872345|NCT00443729|365185784|FG001|Overall Study|Protocol Violation|1|||
105872346|NCT00443729|365185783|FG000|Overall Study|Withdrawal by Subject|3|||
105872347|NCT00443729|365185784|FG001|Overall Study|Withdrawal by Subject|1|||
105872348|NCT03989102|365185785|FG000|Year 1|Withdrawal by Subject|6|||
105872349|NCT03989102|365185786|FG001|Year 1|Withdrawal by Subject|2|||
105872350|NCT03989102|365185787|FG002|Year 1|Withdrawal by Subject|7|||
105872351|NCT03989102|365185785|FG000|Year 1|Lost to Follow-up|5|||
105872352|NCT03989102|365185786|FG001|Year 1|Lost to Follow-up|2|||
105872353|NCT03989102|365185787|FG002|Year 1|Lost to Follow-up|5|||
105872354|NCT03989102|365185785|FG000|Year 1|Subject met withdrawal criteria|1|||
105872355|NCT03989102|365185786|FG001|Year 1|Subject met withdrawal criteria|0|||
105872356|NCT03989102|365185787|FG002|Year 1|Subject met withdrawal criteria|1|||
105872357|NCT03989102|365185785|FG000|Year 2|Lost to Follow-up|7|||
105872358|NCT03989102|365185786|FG001|Year 2|Lost to Follow-up|3|||
105872359|NCT03989102|365185787|FG002|Year 2|Lost to Follow-up|4|||
105872360|NCT03989102|365185785|FG000|Year 2|Withdrawal by Subject|3|||
105872361|NCT03989102|365185786|FG001|Year 2|Withdrawal by Subject|1|||
105872362|NCT03989102|365185787|FG002|Year 2|Withdrawal by Subject|2|||
105872363|NCT03989102|365185785|FG000|Year 2|Subject non-compliant|3|||
105872364|NCT03989102|365185786|FG001|Year 2|Subject non-compliant|2|||
105872365|NCT03989102|365185787|FG002|Year 2|Subject non-compliant|0|||
105872366|NCT03989102|365185785|FG000|Year 2|Travel|1|||
105872367|NCT03989102|365185786|FG001|Year 2|Travel|0|||
105872368|NCT03989102|365185787|FG002|Year 2|Travel|1|||
105872369|NCT03989102|365185785|FG000|Year 2|P16 missing|4|||
105872370|NCT03989102|365185786|FG001|Year 2|P16 missing|2|||
105872371|NCT03989102|365185787|FG002|Year 2|P16 missing|1|||
105872372|NCT03989102|365185785|FG000|Year 2|P11 missing|1|||
105872373|NCT03989102|365185786|FG001|Year 2|P11 missing|3|||
105872374|NCT03989102|365185787|FG002|Year 2|P11 missing|7|||
105872375|NCT03989102|365185785|FG000|Year 2|Definitive displacement outside the study site|0|||
105872376|NCT03989102|365185786|FG001|Year 2|Definitive displacement outside the study site|1|||
105872377|NCT03989102|365185787|FG002|Year 2|Definitive displacement outside the study site|0|||
105872378|NCT03989102|365185785|FG000|Year 2|Subject missed last study visit|0|||
105872379|NCT03989102|365185786|FG001|Year 2|Subject missed last study visit|1|||
105872380|NCT03989102|365185787|FG002|Year 2|Subject missed last study visit|0|||
105872381|NCT03989102|365185785|FG000|Year 2|Death|0|||
105872382|NCT03989102|365185786|FG001|Year 2|Death|1|||
105872383|NCT03989102|365185787|FG002|Year 2|Death|0|||
105872384|NCT03989102|365185785|FG000|Year 2|Subject not reachable|0|||
105872385|NCT03989102|365185786|FG001|Year 2|Subject not reachable|0|||
105872386|NCT03989102|365185787|FG002|Year 2|Subject not reachable|1|||
105872387|NCT03989102|365185785|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
105872388|NCT03989102|365185786|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
105872389|NCT03989102|365185787|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
105872390|NCT03989102|365185785|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
105872391|NCT03989102|365185786|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
105872392|NCT03989102|365185787|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
105872393|NCT03989102|365185785|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
105872394|NCT03989102|365185786|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
105872395|NCT03989102|365185787|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
105872396|NCT03989102|365185785|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
105872397|NCT03989102|365185786|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
105872398|NCT03989102|365185787|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
105872399|NCT03989102|365185785|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
105872400|NCT03989102|365185786|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
105872401|NCT03989102|365185787|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
105872402|NCT03989102|365185785|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
105872403|NCT03989102|365185786|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
105872404|NCT03989102|365185787|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
105872405|NCT01962103|365185790|FG000|Phase 1|Adverse Event|4|||
105872406|NCT01962103|365185791|FG001|Phase 1|Adverse Event|0|||
105872407|NCT01962103|365185792|FG002|Phase 1|Adverse Event|2|||
105872408|NCT01962103|365185793|FG003|Phase 1|Adverse Event|1|||
105872409|NCT01962103|365185794|FG004|Phase 1|Adverse Event|2|||
105872410|NCT01962103|365185795|FG005|Phase 1|Adverse Event|2|||
105872411|NCT01962103|365185796|FG006|Phase 1|Adverse Event|0|||
105872412|NCT01962103|365185797|FG007|Phase 1|Adverse Event|0|||
105872413|NCT01962103|365185798|FG008|Phase 1|Adverse Event|0|||
105872414|NCT01962103|365185790|FG000|Phase 1|Progressive Disease|8|||
105872415|NCT01962103|365185791|FG001|Phase 1|Progressive Disease|6|||
105872416|NCT01962103|365185792|FG002|Phase 1|Progressive Disease|8|||
105872417|NCT01962103|365185793|FG003|Phase 1|Progressive Disease|4|||
105872418|NCT01962103|365185794|FG004|Phase 1|Progressive Disease|5|||
105872419|NCT01962103|365185795|FG005|Phase 1|Progressive Disease|4|||
105872420|NCT01962103|365185796|FG006|Phase 1|Progressive Disease|0|||
105872421|NCT01962103|365185797|FG007|Phase 1|Progressive Disease|0|||
105872422|NCT01962103|365185798|FG008|Phase 1|Progressive Disease|0|||
105872423|NCT01962103|365185790|FG000|Phase 1|Withdrawal by Subject|0|||
105872424|NCT01962103|365185791|FG001|Phase 1|Withdrawal by Subject|0|||
105872425|NCT01962103|365185792|FG002|Phase 1|Withdrawal by Subject|0|||
105872426|NCT01962103|365185793|FG003|Phase 1|Withdrawal by Subject|2|||
105872427|NCT01962103|365185794|FG004|Phase 1|Withdrawal by Subject|0|||
105872428|NCT01962103|365185795|FG005|Phase 1|Withdrawal by Subject|0|||
105872429|NCT01962103|365185796|FG006|Phase 1|Withdrawal by Subject|0|||
105872430|NCT01962103|365185797|FG007|Phase 1|Withdrawal by Subject|0|||
105872431|NCT01962103|365185798|FG008|Phase 1|Withdrawal by Subject|0|||
105872432|NCT01962103|365185790|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
105872433|NCT01962103|365185791|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
105872434|NCT01962103|365185792|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
105872435|NCT01962103|365185793|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
105657619|NCT01182207|364409922|FG000|First Intervention|Positive Hepatitis Results|0|||
105657620|NCT01182207|364409923|FG001|First Intervention|Positive Hepatitis Results|1|||
105657621|NCT01182207|364409922|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
105872436|NCT01962103|365185794|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
105872437|NCT01962103|365185795|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
105872438|NCT01962103|365185796|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
105872439|NCT01962103|365185797|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
105872440|NCT01962103|365185798|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
105872441|NCT01962103|365185790|FG000|Phase 1|Physician Decision|0|||
105872442|NCT01962103|365185791|FG001|Phase 1|Physician Decision|0|||
105872443|NCT01962103|365185792|FG002|Phase 1|Physician Decision|0|||
105872444|NCT01962103|365185793|FG003|Phase 1|Physician Decision|1|||
105872445|NCT01962103|365185794|FG004|Phase 1|Physician Decision|0|||
105872446|NCT01962103|365185795|FG005|Phase 1|Physician Decision|0|||
105872447|NCT01962103|365185796|FG006|Phase 1|Physician Decision|0|||
105872448|NCT01962103|365185797|FG007|Phase 1|Physician Decision|0|||
105872449|NCT01962103|365185798|FG008|Phase 1|Physician Decision|0|||
105872450|NCT01962103|365185790|FG000|Phase 1|Symptomatic Deterioration|3|||
105872451|NCT01962103|365185791|FG001|Phase 1|Symptomatic Deterioration|2|||
105872452|NCT01962103|365185792|FG002|Phase 1|Symptomatic Deterioration|2|||
105872453|NCT01962103|365185793|FG003|Phase 1|Symptomatic Deterioration|2|||
105872454|NCT01962103|365185794|FG004|Phase 1|Symptomatic Deterioration|1|||
105872455|NCT01962103|365185795|FG005|Phase 1|Symptomatic Deterioration|1|||
105872456|NCT01962103|365185796|FG006|Phase 1|Symptomatic Deterioration|0|||
105872457|NCT01962103|365185797|FG007|Phase 1|Symptomatic Deterioration|0|||
105872458|NCT01962103|365185798|FG008|Phase 1|Symptomatic Deterioration|0|||
105872459|NCT01962103|365185790|FG000|Phase 1|Miscellaneous|1|||
105872460|NCT01962103|365185791|FG001|Phase 1|Miscellaneous|0|||
105872461|NCT01962103|365185792|FG002|Phase 1|Miscellaneous|0|||
105872462|NCT01962103|365185793|FG003|Phase 1|Miscellaneous|0|||
105872463|NCT01962103|365185794|FG004|Phase 1|Miscellaneous|0|||
105872464|NCT01962103|365185795|FG005|Phase 1|Miscellaneous|0|||
105872465|NCT01962103|365185796|FG006|Phase 1|Miscellaneous|0|||
105872466|NCT01962103|365185797|FG007|Phase 1|Miscellaneous|0|||
105872467|NCT01962103|365185798|FG008|Phase 1|Miscellaneous|0|||
105872468|NCT01962103|365185790|FG000|Phase 2|Adverse Event|0|||
105872469|NCT01962103|365185791|FG001|Phase 2|Adverse Event|0|||
105872470|NCT01962103|365185792|FG002|Phase 2|Adverse Event|0|||
105872471|NCT01962103|365185793|FG003|Phase 2|Adverse Event|0|||
105872472|NCT01962103|365185794|FG004|Phase 2|Adverse Event|0|||
105872473|NCT01962103|365185795|FG005|Phase 2|Adverse Event|0|||
105872474|NCT01962103|365185796|FG006|Phase 2|Adverse Event|1|||
105872475|NCT01962103|365185797|FG007|Phase 2|Adverse Event|0|||
105872476|NCT01962103|365185798|FG008|Phase 2|Adverse Event|3|||
105872477|NCT01962103|365185790|FG000|Phase 2|Progressive Disease|0|||
105872478|NCT01962103|365185791|FG001|Phase 2|Progressive Disease|0|||
105872479|NCT01962103|365185792|FG002|Phase 2|Progressive Disease|0|||
105872480|NCT01962103|365185793|FG003|Phase 2|Progressive Disease|0|||
105872481|NCT01962103|365185794|FG004|Phase 2|Progressive Disease|0|||
105872482|NCT01962103|365185795|FG005|Phase 2|Progressive Disease|0|||
105872483|NCT01962103|365185796|FG006|Phase 2|Progressive Disease|11|||
105872484|NCT01962103|365185797|FG007|Phase 2|Progressive Disease|12|||
105872485|NCT01962103|365185798|FG008|Phase 2|Progressive Disease|11|||
105872486|NCT01962103|365185790|FG000|Phase 2|Symptomatic Deterioration|0|||
105872487|NCT01962103|365185791|FG001|Phase 2|Symptomatic Deterioration|0|||
105872488|NCT01962103|365185792|FG002|Phase 2|Symptomatic Deterioration|0|||
105872489|NCT01962103|365185793|FG003|Phase 2|Symptomatic Deterioration|0|||
105872490|NCT01962103|365185794|FG004|Phase 2|Symptomatic Deterioration|0|||
105872491|NCT01962103|365185795|FG005|Phase 2|Symptomatic Deterioration|0|||
105872492|NCT01962103|365185796|FG006|Phase 2|Symptomatic Deterioration|2|||
105872493|NCT01962103|365185797|FG007|Phase 2|Symptomatic Deterioration|2|||
105872494|NCT01962103|365185798|FG008|Phase 2|Symptomatic Deterioration|0|||
105872495|NCT01321749|365185799|FG000|Overall Study|Lost to Follow-up|4|||
105872496|NCT01321749|365185800|FG001|Overall Study|Lost to Follow-up|11|||
105872497|NCT01321749|365185799|FG000|Overall Study|Protocol Violation|4|||
105872498|NCT01321749|365185800|FG001|Overall Study|Protocol Violation|7|||
105872499|NCT01321749|365185799|FG000|Overall Study|Withdrawal by Subject|5|||
105872500|NCT01321749|365185800|FG001|Overall Study|Withdrawal by Subject|4|||
105872501|NCT01866826|365185803|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
105872502|NCT01866826|365185804|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
105872503|NCT01866826|365185803|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
105872504|NCT01866826|365185804|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
105872505|NCT01866826|365185803|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
105872506|NCT01866826|365185804|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
105872507|NCT02288312|365185807|FG000|Overall Study|Pregnancy|1|||
105872508|NCT02288312|365185808|FG001|Overall Study|Pregnancy|0|||
105872509|NCT02288312|365185809|FG002|Overall Study|Pregnancy|0|||
105872510|NCT00742209|365185810|FG000|Overall Study|Adverse Event|11|||
105872511|NCT00742209|365185811|FG001|Overall Study|Adverse Event|4|||
105872512|NCT00742209|365185812|FG002|Overall Study|Adverse Event|17|||
105872513|NCT00742209|365185813|FG003|Overall Study|Adverse Event|16|||
105872514|NCT00742209|365185814|FG004|Overall Study|Adverse Event|13|||
105872515|NCT00742209|365185810|FG000|Overall Study|Participant Withdrew Consent|8|||
105872516|NCT00742209|365185811|FG001|Overall Study|Participant Withdrew Consent|4|||
105872517|NCT00742209|365185812|FG002|Overall Study|Participant Withdrew Consent|14|||
105872518|NCT00742209|365185813|FG003|Overall Study|Participant Withdrew Consent|7|||
105659506|NCT02635386|364417351|FG004|Overall Study|Noncompliant|1|||
105872519|NCT00742209|365185814|FG004|Overall Study|Participant Withdrew Consent|4|||
105872520|NCT00742209|365185810|FG000|Overall Study|Protocol Violation|6|||
105872521|NCT00742209|365185811|FG001|Overall Study|Protocol Violation|5|||
105872522|NCT00742209|365185812|FG002|Overall Study|Protocol Violation|4|||
105872523|NCT00742209|365185813|FG003|Overall Study|Protocol Violation|5|||
105872524|NCT00742209|365185814|FG004|Overall Study|Protocol Violation|3|||
105872525|NCT00742209|365185810|FG000|Overall Study|Lost to Follow-up|3|||
105872526|NCT00742209|365185811|FG001|Overall Study|Lost to Follow-up|4|||
105872527|NCT00742209|365185812|FG002|Overall Study|Lost to Follow-up|5|||
105872528|NCT00742209|365185813|FG003|Overall Study|Lost to Follow-up|5|||
105872529|NCT00742209|365185814|FG004|Overall Study|Lost to Follow-up|3|||
105872530|NCT00742209|365185810|FG000|Overall Study|Lack of Efficacy|6|||
105872531|NCT00742209|365185811|FG001|Overall Study|Lack of Efficacy|1|||
105872532|NCT00742209|365185812|FG002|Overall Study|Lack of Efficacy|1|||
105872533|NCT00742209|365185813|FG003|Overall Study|Lack of Efficacy|3|||
105872534|NCT00742209|365185814|FG004|Overall Study|Lack of Efficacy|1|||
105872535|NCT00742209|365185810|FG000|Overall Study|Investigator Discretion|0|||
105872536|NCT00742209|365185811|FG001|Overall Study|Investigator Discretion|0|||
105872537|NCT00742209|365185812|FG002|Overall Study|Investigator Discretion|5|||
105872538|NCT00742209|365185813|FG003|Overall Study|Investigator Discretion|1|||
105872539|NCT00742209|365185814|FG004|Overall Study|Investigator Discretion|1|||
105872540|NCT00725491|365185815|FG000|Overall Study|Adverse Event|3|||
105872541|NCT00725491|365185816|FG001|Overall Study|Adverse Event|2|||
105872542|NCT00725491|365185815|FG000|Overall Study|Pregnancy|0|||
105872543|NCT00725491|365185816|FG001|Overall Study|Pregnancy|3|||
105872544|NCT00725491|365185815|FG000|Overall Study|Risk for hyperstimulation|2|||
105872545|NCT00725491|365185816|FG001|Overall Study|Risk for hyperstimulation|9|||
105872546|NCT00725491|365185815|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
105872547|NCT00725491|365185816|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
105872548|NCT00725491|365185815|FG000|Overall Study|Fertilization failure|0|||
105872549|NCT00725491|365185816|FG001|Overall Study|Fertilization failure|1|||
105872550|NCT00725491|365185815|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
105872551|NCT00725491|365185816|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
105872552|NCT01495000|365185819|FG000|Overall Study|Lost to Follow-up|2|||
105872553|NCT01495000|365185820|FG001|Overall Study|Lost to Follow-up|2|||
105872554|NCT01495000|365185819|FG000|Overall Study|Protocol Violation|1|||
105872555|NCT01495000|365185820|FG001|Overall Study|Protocol Violation|0|||
105872556|NCT01495000|365185819|FG000|Overall Study|Withdrawal by Subject|10|||
105872557|NCT01495000|365185820|FG001|Overall Study|Withdrawal by Subject|10|||
105872558|NCT01431079|365185823|FG000|Overall Study|Lost to Follow-up|35|||
105872559|NCT01431079|365185824|FG001|Overall Study|Lost to Follow-up|39|||
105872560|NCT02548832|365185825|FG000|Overall Study|Lost to Follow-up|2|||
105872561|NCT02548832|365185826|FG001|Overall Study|Lost to Follow-up|2|||
105872562|NCT02548832|365185827|FG002|Overall Study|Lost to Follow-up|2|||
105872563|NCT03565900|365185830|FG000|Overall Study|Disposition Unknown|4|||
105872564|NCT03565900|365185831|FG001|Overall Study|Disposition Unknown|1|||
105872565|NCT03565900|365185830|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105872566|NCT03565900|365185831|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
105872567|NCT03565900|365185830|FG000|Overall Study|Withdrawal by Subject|4|||
105872568|NCT03565900|365185831|FG001|Overall Study|Withdrawal by Subject|5|||
105872569|NCT03565900|365185830|FG000|Overall Study|Randomized By Mistake|0|||
105872570|NCT03565900|365185831|FG001|Overall Study|Randomized By Mistake|2|||
105872571|NCT03565900|365185830|FG000|Overall Study|Physician Decision|7|||
105872572|NCT03565900|365185831|FG001|Overall Study|Physician Decision|11|||
105872573|NCT03565900|365185830|FG000|Overall Study|Death|9|||
105872574|NCT03565900|365185831|FG001|Overall Study|Death|7|||
105872575|NCT02968576|365185832|FG000|Overall Study|Pregnancy|0|||
105872576|NCT02968576|365185833|FG001|Overall Study|Pregnancy|1|||
105872577|NCT03345420|365185834|FG000|Overall Study|Withdrawal by Subject|1|||
105872578|NCT03359850|365185837|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
105872579|NCT03359850|365185838|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
105872580|NCT03359850|365185837|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
105872581|NCT03359850|365185838|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
105872582|NCT03359850|365185837|FG000|Extension Phase (Up to 28 Months)|Death|2|||
105872583|NCT03359850|365185838|FG001|Extension Phase (Up to 28 Months)|Death|4|||
105872584|NCT03359850|365185837|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
105872585|NCT03359850|365185838|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
105872586|NCT03359850|365185837|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
105872587|NCT03359850|365185838|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
105872588|NCT00942357|365185852|FG000|Overall Study|Ineligible|37|||
105872589|NCT00942357|365185853|FG001|Overall Study|Ineligible|40|||
105872590|NCT02002221|365185854|FG000|Overall Study|Adverse Event|2|||
105872591|NCT02002221|365185855|FG001|Overall Study|Adverse Event|1|||
105872592|NCT02002221|365185854|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
105872593|NCT02002221|365185855|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
105872594|NCT02002221|365185854|FG000|Overall Study|Patient withdrew consent|0|||
105872595|NCT02002221|365185855|FG001|Overall Study|Patient withdrew consent|1|||
105872596|NCT03749330|365185859|FG000|Overall Study|Clinicians left work in the CICU|0|||
105872597|NCT03749330|365185860|FG001|Overall Study|Clinicians left work in the CICU|2|||
105872598|NCT03749330|365185861|FG002|Overall Study|Clinicians left work in the CICU|0|||
105872599|NCT03749330|365185862|FG003|Overall Study|Clinicians left work in the CICU|0|||
105872600|NCT03749330|365185863|FG004|Overall Study|Clinicians left work in the CICU|0|||
105872601|NCT03749330|365185864|FG005|Overall Study|Clinicians left work in the CICU|0|||
105872602|NCT03571828|365185869|FG000|Overall Study|Withdrawal by Subject|1|||
105872603|NCT03571828|365185870|FG001|Overall Study|Withdrawal by Subject|0|||
105872604|NCT03571828|365185869|FG000|Overall Study|Decision by sponsor|5|||
105872605|NCT03571828|365185870|FG001|Overall Study|Decision by sponsor|1|||
105872606|NCT03571828|365185869|FG000|Overall Study|Death|2|||
105872607|NCT03571828|365185870|FG001|Overall Study|Death|0|||
105872608|NCT00245466|365185871|FG000|Overall Study|Adverse Event|2|||
105872609|NCT00245466|365185872|FG001|Overall Study|Adverse Event|8|||
105872610|NCT00245466|365185873|FG002|Overall Study|Adverse Event|4|||
105872611|NCT00245466|365185871|FG000|Overall Study|Low prostate specific antigen suppr|16|||
105872612|NCT00245466|365185872|FG001|Overall Study|Low prostate specific antigen suppr|14|||
105872613|NCT00245466|365185873|FG002|Overall Study|Low prostate specific antigen suppr|5|||
105872614|NCT00245466|365185871|FG000|Overall Study|Insufficient testosterone suppr|12|||
105872615|NCT00245466|365185872|FG001|Overall Study|Insufficient testosterone suppr|12|||
105872616|NCT00245466|365185873|FG002|Overall Study|Insufficient testosterone suppr|21|||
105872617|NCT00245466|365185871|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
105872618|NCT00245466|365185872|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
105872619|NCT00245466|365185873|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
105872620|NCT00245466|365185871|FG000|Overall Study|Withdrawal by Subject|2|||
105872621|NCT00245466|365185872|FG001|Overall Study|Withdrawal by Subject|2|||
105872622|NCT00245466|365185873|FG002|Overall Study|Withdrawal by Subject|1|||
105872623|NCT00245466|365185871|FG000|Overall Study|Lost to Follow-up|3|||
105872624|NCT00245466|365185872|FG001|Overall Study|Lost to Follow-up|0|||
105872625|NCT00245466|365185873|FG002|Overall Study|Lost to Follow-up|0|||
105872626|NCT00245466|365185871|FG000|Overall Study|Disease progression|0|||
105872627|NCT00245466|365185872|FG001|Overall Study|Disease progression|3|||
105872628|NCT00245466|365185873|FG002|Overall Study|Disease progression|1|||
105872629|NCT00245466|365185871|FG000|Overall Study|Protocol Violation|1|||
105872630|NCT00245466|365185872|FG001|Overall Study|Protocol Violation|2|||
105872631|NCT00245466|365185873|FG002|Overall Study|Protocol Violation|2|||
105872632|NCT00245466|365185871|FG000|Overall Study|Death|0|||
105872633|NCT00245466|365185872|FG001|Overall Study|Death|2|||
105872634|NCT00245466|365185873|FG002|Overall Study|Death|0|||
105872635|NCT00245466|365185871|FG000|Overall Study|Administrative reasons|0|||
105872636|NCT00245466|365185872|FG001|Overall Study|Administrative reasons|1|||
105872637|NCT00245466|365185873|FG002|Overall Study|Administrative reasons|0|||
105872638|NCT05064397|365185874|FG000|Overall Study|Adverse Event|4|||
105872639|NCT05064397|365185874|FG000|Overall Study|Lack of Efficacy|12|||
105872640|NCT05064397|365185874|FG000|Overall Study|Withdrawal by Subject|3|||
105872641|NCT05064397|365185874|FG000|Overall Study|Lost to Follow-up|1|||
105872642|NCT05064397|365185874|FG000|Overall Study|Other reasons|3|||
105872643|NCT01958437|365185875|FG000|Overall Study|Incidental MRI findings|0|||
105872644|NCT01958437|365185876|FG001|Overall Study|Incidental MRI findings|0|||
105872645|NCT01958437|365185877|FG002|Overall Study|Incidental MRI findings|1|||
105872646|NCT01958437|365185878|FG003|Overall Study|Incidental MRI findings|1|||
105872647|NCT01928472|365185881|FG000|Overall Study|Death|0|||
105872648|NCT01928472|365185882|FG001|Overall Study|Death|0|||
105872649|NCT01928472|365185883|FG002|Overall Study|Death|1|||
105872650|NCT01928472|365185884|FG003|Overall Study|Death|0|||
105872651|NCT01928472|365185881|FG000|Overall Study|Withdrawal by Subject|4|||
105872652|NCT01928472|365185882|FG001|Overall Study|Withdrawal by Subject|4|||
105872653|NCT01928472|365185883|FG002|Overall Study|Withdrawal by Subject|1|||
105872654|NCT01928472|365185884|FG003|Overall Study|Withdrawal by Subject|2|||
105872655|NCT01928472|365185881|FG000|Overall Study|Lost to Follow-up|2|||
105872656|NCT01928472|365185882|FG001|Overall Study|Lost to Follow-up|3|||
105872657|NCT01928472|365185883|FG002|Overall Study|Lost to Follow-up|4|||
105872658|NCT01928472|365185884|FG003|Overall Study|Lost to Follow-up|0|||
105872659|NCT01928472|365185881|FG000|Overall Study|Administrative Reason|2|||
105872660|NCT01928472|365185882|FG001|Overall Study|Administrative Reason|1|||
105872661|NCT01928472|365185883|FG002|Overall Study|Administrative Reason|0|||
105872662|NCT01928472|365185884|FG003|Overall Study|Administrative Reason|0|||
105872663|NCT01928472|365185881|FG000|Overall Study|Unclassified|0|||
105872664|NCT01928472|365185882|FG001|Overall Study|Unclassified|0|||
105872665|NCT01928472|365185883|FG002|Overall Study|Unclassified|1|||
105872666|NCT01928472|365185884|FG003|Overall Study|Unclassified|0|||
105872667|NCT06481709|365185886|FG000|Overall Study|Withdrawal by Subject|0|||
105872668|NCT06481709|365185887|FG001|Overall Study|Withdrawal by Subject|0|||
105872669|NCT06481709|365185888|FG002|Overall Study|Withdrawal by Subject|2|||
105872670|NCT06481709|365185889|FG003|Overall Study|Withdrawal by Subject|0|||
105872671|NCT03473925|365185890|FG000|Overall Study|Death|48|||
105872672|NCT03473925|365185891|FG001|Overall Study|Death|44|||
105872673|NCT03473925|365185890|FG000|Overall Study|Sponsor Decision|2|||
105872674|NCT03473925|365185891|FG001|Overall Study|Sponsor Decision|7|||
105872675|NCT03473925|365185890|FG000|Overall Study|Withdrawal by Subject|1|||
105872676|NCT03473925|365185891|FG001|Overall Study|Withdrawal by Subject|3|||
105872677|NCT03473925|365185890|FG000|Overall Study|Not Treated|1|||
105872678|NCT03473925|365185891|FG001|Overall Study|Not Treated|1|||
105872679|NCT02766335|365185892|FG000|Initial Registration|Adverse Event|6|||
105872680|NCT02766335|365185893|FG001|Initial Registration|Adverse Event|3|||
105872681|NCT02766335|365185894|FG002|Initial Registration|Adverse Event|0|||
105872682|NCT02766335|365185892|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
105872683|NCT02766335|365185893|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
105872684|NCT02766335|365185894|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
105872685|NCT02766335|365185892|FG000|Initial Registration|Progression/relapse|49|||
105872686|NCT02766335|365185893|FG001|Initial Registration|Progression/relapse|15|||
105872687|NCT02766335|365185894|FG002|Initial Registration|Progression/relapse|0|||
105872688|NCT02766335|365185892|FG000|Initial Registration|Death|1|||
105872689|NCT02766335|365185893|FG001|Initial Registration|Death|3|||
105872690|NCT02766335|365185894|FG002|Initial Registration|Death|0|||
105872691|NCT02766335|365185892|FG000|Initial Registration|not protocol specified|1|||
105872692|NCT02766335|365185893|FG001|Initial Registration|not protocol specified|9|||
105872693|NCT02766335|365185894|FG002|Initial Registration|not protocol specified|0|||
105872694|NCT02766335|365185892|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
105872695|NCT02766335|365185893|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
105872696|NCT02766335|365185894|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
105872697|NCT02766335|365185892|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
105872698|NCT02766335|365185893|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
105872699|NCT02766335|365185894|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
105872700|NCT01176513|365185901|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
105872701|NCT02286843|365185902|FG000|Overall Study|Not Treated|4|||
105872702|NCT02286843|365185902|FG000|Overall Study|Protocol Violation|1|||
105872703|NCT02286843|365185902|FG000|Overall Study|Withdrawal by Subject|1|||
105872704|NCT00613171|365185903|FG000|Overall Study|Adverse Event|7|||
105872705|NCT00613171|365185903|FG000|Overall Study|Withdrawal by Subject|3|||
105872706|NCT00613171|365185903|FG000|Overall Study|Reason not Specified|4|||
105872707|NCT01169350|365185904|FG000|Overall Study|Physician Decision|3|||
105872708|NCT01169350|365185904|FG000|Overall Study|Lost to Follow-up|2|||
105872709|NCT02466321|365185915|FG000|Overall Study|Death|26|||
105872710|NCT02466321|365185915|FG000|Overall Study|Revision|6|||
105872711|NCT02466321|365185915|FG000|Overall Study|Lost to Follow-up|60|||
105872712|NCT02466321|365185915|FG000|Overall Study|Did not receive study device|1|||
105872713|NCT01821807|365185917|FG000|Overall Study|Lost to Follow-up|3|||
105872714|NCT01821807|365185918|FG001|Overall Study|Lost to Follow-up|1|||
105872715|NCT04871776|365185920|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
105872716|NCT04871776|365185921|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
105872717|NCT04871776|365185922|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
105872718|NCT04871776|365185920|FG000|Overall Study|Did not meet eligibility criteria|1|||
105872719|NCT04871776|365185921|FG001|Overall Study|Did not meet eligibility criteria|1|||
105872720|NCT04871776|365185922|FG002|Overall Study|Did not meet eligibility criteria|1|||
105872721|NCT05620082|365185925|FG000|Overall Study|Discharged before study end|1|||
105872722|NCT05620082|365185926|FG001|Overall Study|Discharged before study end|4|||
105872723|NCT05620082|365185927|FG002|Overall Study|Discharged before study end|0|||
105872724|NCT05620082|365185925|FG000|Overall Study|Moved to a different ward|1|||
105872725|NCT05620082|365185926|FG001|Overall Study|Moved to a different ward|0|||
105872726|NCT05620082|365185927|FG002|Overall Study|Moved to a different ward|0|||
105872727|NCT05620082|365185925|FG000|Overall Study|Feeling too unwell|1|||
105872728|NCT05620082|365185926|FG001|Overall Study|Feeling too unwell|0|||
105872729|NCT05620082|365185927|FG002|Overall Study|Feeling too unwell|0|||
105872730|NCT00265759|365187054|FG000|Overall Study|Withdrawal by Subject|0|||
105872731|NCT00265759|365187055|FG001|Overall Study|Withdrawal by Subject|1|||
105872732|NCT00265759|365187056|FG002|Overall Study|Withdrawal by Subject|2|||
105872733|NCT00265759|365187057|FG003|Overall Study|Withdrawal by Subject|2|||
105872734|NCT00265759|365187054|FG000|Overall Study|Cancel|0|||
105872735|NCT00265759|365187055|FG001|Overall Study|Cancel|0|||
105872736|NCT00265759|365187056|FG002|Overall Study|Cancel|0|||
105872737|NCT00265759|365187057|FG003|Overall Study|Cancel|3|||
105872738|NCT00265759|365187054|FG000|Overall Study|Ineligible|0|||
105872739|NCT00265759|365187055|FG001|Overall Study|Ineligible|0|||
105872740|NCT00265759|365187056|FG002|Overall Study|Ineligible|0|||
105872741|NCT00265759|365187057|FG003|Overall Study|Ineligible|1|||
105872742|NCT00265759|365187054|FG000|Overall Study|Bilateral disease|0|||
105872743|NCT00265759|365187055|FG001|Overall Study|Bilateral disease|0|||
105872744|NCT00265759|365187056|FG002|Overall Study|Bilateral disease|0|||
105872745|NCT00265759|365187057|FG003|Overall Study|Bilateral disease|2|||
105872746|NCT00265759|365187054|FG000|Overall Study|Discontinued due to intolerability|0|||
105872747|NCT00265759|365187055|FG001|Overall Study|Discontinued due to intolerability|0|||
105872748|NCT00265759|365187056|FG002|Overall Study|Discontinued due to intolerability|0|||
105872749|NCT00265759|365187057|FG003|Overall Study|Discontinued due to intolerability|1|||
105872750|NCT00711243|365187061|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
105872751|NCT00711243|365187062|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
105872752|NCT00711243|365187063|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
105872753|NCT00711243|365187064|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
105872754|NCT00711243|365187065|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
105872755|NCT00711243|365187066|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
105872756|NCT00711243|365187061|FG000|Reached First Response/4 Cycles|Death|0|||
105872757|NCT00711243|365187062|FG001|Reached First Response/4 Cycles|Death|0|||
105872758|NCT00711243|365187063|FG002|Reached First Response/4 Cycles|Death|0|||
105872759|NCT00711243|365187064|FG003|Reached First Response/4 Cycles|Death|0|||
105872760|NCT00711243|365187065|FG004|Reached First Response/4 Cycles|Death|0|||
105872761|NCT00711243|365187066|FG005|Reached First Response/4 Cycles|Death|2|||
105872762|NCT00711243|365187061|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
105872763|NCT00711243|365187062|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
105872764|NCT00711243|365187063|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
105872765|NCT00711243|365187064|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
105872766|NCT00711243|365187065|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
105872767|NCT00711243|365187066|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
105872768|NCT00711243|365187061|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
105872769|NCT00711243|365187062|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
105872770|NCT00711243|365187063|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
105872771|NCT00711243|365187064|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
105872772|NCT00711243|365187065|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
105872773|NCT00711243|365187066|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
105872774|NCT00711243|365187061|FG000|Treated Cycle 5 After First Response|Death|0|||
105872775|NCT00711243|365187062|FG001|Treated Cycle 5 After First Response|Death|0|||
105872776|NCT00711243|365187063|FG002|Treated Cycle 5 After First Response|Death|0|||
105872777|NCT00711243|365187064|FG003|Treated Cycle 5 After First Response|Death|0|||
105872778|NCT00711243|365187065|FG004|Treated Cycle 5 After First Response|Death|0|||
105872779|NCT00711243|365187066|FG005|Treated Cycle 5 After First Response|Death|2|||
105872780|NCT00711243|365187061|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
105872781|NCT00711243|365187062|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
105872782|NCT00711243|365187063|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
105872783|NCT00711243|365187064|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
105872784|NCT00711243|365187065|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
105872785|NCT00711243|365187066|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
105872786|NCT00711243|365187061|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105872787|NCT00711243|365187062|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105872788|NCT00711243|365187063|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105872789|NCT00711243|365187064|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105872790|NCT00711243|365187065|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
105872791|NCT00711243|365187066|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
105872792|NCT01402570|365187067|FG000|Overall Study|Adverse Event|1|||
105872793|NCT02750618|365187068|FG000|Overall Study|Withdrawal by Subject|1|||
105872794|NCT02157935|365187076|FG000|Overall Study|Withdrawal by Subject|25|||
105872795|NCT02157935|365187077|FG001|Overall Study|Withdrawal by Subject|39|||
105872796|NCT02157935|365187076|FG000|Overall Study|Screen failure|1|||
105872797|NCT02157935|365187077|FG001|Overall Study|Screen failure|2|||
105872798|NCT02157935|365187076|FG000|Overall Study|Protocol Violation|1|||
105872799|NCT02157935|365187077|FG001|Overall Study|Protocol Violation|0|||
105872800|NCT02157935|365187076|FG000|Overall Study|Progressive disease|0|||
105872801|NCT02157935|365187077|FG001|Overall Study|Progressive disease|2|||
105872802|NCT02157935|365187076|FG000|Overall Study|Other|5|||
105872803|NCT02157935|365187077|FG001|Overall Study|Other|12|||
105872804|NCT02157935|365187076|FG000|Overall Study|Lack of Efficacy|0|||
105872805|NCT02157935|365187077|FG001|Overall Study|Lack of Efficacy|1|||
105872806|NCT02157935|365187076|FG000|Overall Study|Death|4|||
105872807|NCT02157935|365187077|FG001|Overall Study|Death|4|||
105872808|NCT02157935|365187076|FG000|Overall Study|Adverse Event|3|||
105872809|NCT02157935|365187077|FG001|Overall Study|Adverse Event|5|||
105872810|NCT03283566|365187078|FG000|Overall Study|Lost to Follow-up|1|||
105872811|NCT03283566|365187079|FG001|Overall Study|Lost to Follow-up|2|||
105872812|NCT00086684|365187080|FG000|Overall Study|Adverse Event|12|||
105872813|NCT00086684|365187081|FG001|Overall Study|Adverse Event|17|||
105872814|NCT00086684|365187082|FG002|Overall Study|Adverse Event|14|||
105872815|NCT00086684|365187080|FG000|Overall Study|Lack of Efficacy|6|||
105872816|NCT00086684|365187081|FG001|Overall Study|Lack of Efficacy|6|||
105872817|NCT00086684|365187082|FG002|Overall Study|Lack of Efficacy|5|||
105872818|NCT00086684|365187080|FG000|Overall Study|Lost to Follow-up|15|||
105872819|NCT00086684|365187081|FG001|Overall Study|Lost to Follow-up|8|||
105872820|NCT00086684|365187082|FG002|Overall Study|Lost to Follow-up|10|||
105872821|NCT00086684|365187080|FG000|Overall Study|Protocol Violation|8|||
105872822|NCT00086684|365187081|FG001|Overall Study|Protocol Violation|3|||
105872823|NCT00086684|365187082|FG002|Overall Study|Protocol Violation|0|||
105872824|NCT00086684|365187080|FG000|Overall Study|Withdrawal by Subject|0|||
105872825|NCT00086684|365187081|FG001|Overall Study|Withdrawal by Subject|4|||
105872826|NCT00086684|365187082|FG002|Overall Study|Withdrawal by Subject|10|||
105872827|NCT00086684|365187080|FG000|Overall Study|NONCOMPLIANCE|5|||
105872828|NCT00086684|365187081|FG001|Overall Study|NONCOMPLIANCE|7|||
105872829|NCT00086684|365187082|FG002|Overall Study|NONCOMPLIANCE|6|||
105872830|NCT00086684|365187080|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105872831|NCT00086684|365187081|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
105872832|NCT00086684|365187082|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
105872833|NCT00086684|365187080|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
105872834|NCT00086684|365187081|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
105872835|NCT00086684|365187082|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
105872836|NCT00086684|365187080|FG000|Overall Study|Other|4|||
105872837|NCT00086684|365187081|FG001|Overall Study|Other|2|||
105872838|NCT00086684|365187082|FG002|Overall Study|Other|3|||
105872839|NCT04515147|365187084|FG000|Overall Study|Withdrawal by Subject|1|||
105872840|NCT04515147|365187085|FG001|Overall Study|Withdrawal by Subject|0|||
105872841|NCT04515147|365187086|FG002|Overall Study|Withdrawal by Subject|10|||
105872842|NCT04515147|365187087|FG003|Overall Study|Withdrawal by Subject|18|||
105872843|NCT04515147|365187088|FG004|Overall Study|Withdrawal by Subject|1|||
105872844|NCT04515147|365187089|FG005|Overall Study|Withdrawal by Subject|8|||
105872845|NCT04515147|365187084|FG000|Overall Study|Lost to Follow-up|0|||
105872846|NCT04515147|365187085|FG001|Overall Study|Lost to Follow-up|1|||
105872847|NCT04515147|365187086|FG002|Overall Study|Lost to Follow-up|5|||
105872848|NCT04515147|365187087|FG003|Overall Study|Lost to Follow-up|6|||
105872849|NCT04515147|365187088|FG004|Overall Study|Lost to Follow-up|2|||
105872850|NCT04515147|365187089|FG005|Overall Study|Lost to Follow-up|1|||
105872851|NCT04515147|365187084|FG000|Overall Study|Adverse Event|0|||
105872852|NCT04515147|365187085|FG001|Overall Study|Adverse Event|0|||
105872853|NCT04515147|365187086|FG002|Overall Study|Adverse Event|0|||
105872854|NCT04515147|365187087|FG003|Overall Study|Adverse Event|2|||
105872855|NCT04515147|365187088|FG004|Overall Study|Adverse Event|0|||
105872856|NCT04515147|365187089|FG005|Overall Study|Adverse Event|0|||
105872857|NCT04515147|365187084|FG000|Overall Study|Miscellaneous|0|||
105872858|NCT04515147|365187085|FG001|Overall Study|Miscellaneous|0|||
105872859|NCT04515147|365187086|FG002|Overall Study|Miscellaneous|0|||
105872860|NCT04515147|365187087|FG003|Overall Study|Miscellaneous|1|||
105872861|NCT04515147|365187088|FG004|Overall Study|Miscellaneous|0|||
105872862|NCT04515147|365187089|FG005|Overall Study|Miscellaneous|1|||
105872863|NCT00654095|365187090|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
105872864|NCT00654095|365187090|FG000|Overall Study|Elevated triglyceride level (2)|1|||
105872865|NCT00654095|365187090|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
105872866|NCT00654095|365187090|FG000|Overall Study|Adverse Event|11|||
105872867|NCT00654095|365187090|FG000|Overall Study|Withdrawal by Subject|5|||
105872868|NCT00654095|365187090|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
105872869|NCT00654095|365187090|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
105872870|NCT00654095|365187090|FG000|Overall Study|Did not meet inclusion criteria|1|||
105872871|NCT02502149|365187091|FG000|Intermediate|Discontinued prematurely|1|||
105872872|NCT02502149|365187092|FG001|Intermediate|Discontinued prematurely|0|||
105872873|NCT02502149|365187093|FG002|Intermediate|Discontinued prematurely|0|||
105872874|NCT02502149|365187094|FG003|Intermediate|Discontinued prematurely|0|||
105872875|NCT02502149|365187095|FG004|Intermediate|Discontinued prematurely|0|||
105872876|NCT00958828|365187096|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
105872877|NCT00958828|365187097|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
105872878|NCT00958828|365187096|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
105872879|NCT00958828|365187097|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
105872880|NCT01269918|365187098|FG000|Overall Study|Did not receive study drug|0|||
105872881|NCT01269918|365187099|FG001|Overall Study|Did not receive study drug|3|||
105872882|NCT03743051|365187100|FG000|Overall Study|Adverse Event|5|||
105872883|NCT03743051|365187101|FG001|Overall Study|Adverse Event|9|||
105872884|NCT03743051|365187100|FG000|Overall Study|Death|27|||
105872885|NCT03743051|365187101|FG001|Overall Study|Death|26|||
105872886|NCT03743051|365187100|FG000|Overall Study|Lost to Follow-up|4|||
105872887|NCT03743051|365187101|FG001|Overall Study|Lost to Follow-up|8|||
105872888|NCT03743051|365187100|FG000|Overall Study|Withdrawal by Subject|32|||
105872889|NCT03743051|365187101|FG001|Overall Study|Withdrawal by Subject|19|||
105872890|NCT03743051|365187100|FG000|Overall Study|Physician Decision|10|||
105872891|NCT03743051|365187101|FG001|Overall Study|Physician Decision|15|||
105872892|NCT03743051|365187100|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
105872893|NCT03743051|365187101|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
105872894|NCT02137252|365187105|FG000|Overall Study|trial terminated early|2|||
105872895|NCT02137252|365187106|FG001|Overall Study|trial terminated early|1|||
105872896|NCT00711087|365187107|FG000|Overall Study|Lost to Follow-up|1|||
105872897|NCT00711087|365187108|FG001|Overall Study|Lost to Follow-up|0|||
105872898|NCT00856193|365187109|FG000|Period 2|Abnormal test procedure results|0|||
105872899|NCT00856193|365187110|FG001|Period 2|Abnormal test procedure results|1|||
105872900|NCT00856193|365187109|FG000|Period 2|Lost to Follow-up|0|||
105872901|NCT00856193|365187110|FG001|Period 2|Lost to Follow-up|1|||
105872902|NCT03305848|365187111|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
105872903|NCT03305848|365187111|FG000|Overall Study|Physician Decision|2|||
105872904|NCT02756611|365187112|FG000|Overall Study|Death|70|||
105872905|NCT02756611|365187112|FG000|Overall Study|Withdrawal by Subject|2|||
105872906|NCT02756611|365187112|FG000|Overall Study|Lost to Follow-up|3|||
105872907|NCT02756611|365187112|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
105872908|NCT02756611|365187112|FG000|Overall Study|Other|10|||
105872909|NCT03125798|365187113|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
105872910|NCT03125798|365187114|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
105872911|NCT03125798|365187113|FG000|Overall Study|Conversion to thoracotomy|7|||
105872912|NCT03125798|365187114|FG001|Overall Study|Conversion to thoracotomy|7|||
105872913|NCT02635984|365187116|FG000|Overall Study|Lost to Follow-up|2|||
105872914|NCT02635984|365187117|FG001|Overall Study|Lost to Follow-up|4|||
105872915|NCT02635984|365187116|FG000|Overall Study|Study Arm Closed|1|||
105872916|NCT02635984|365187117|FG001|Overall Study|Study Arm Closed|0|||
105872917|NCT01640249|365187120|FG000|Period 1|Withdrawal by Subject|1|||
105872918|NCT01640249|365187121|FG001|Period 1|Withdrawal by Subject|0|||
105872919|NCT01640249|365187122|FG002|Period 1|Withdrawal by Subject|0|||
105872920|NCT01640249|365187123|FG003|Period 1|Withdrawal by Subject|0|||
105872921|NCT01640249|365187124|FG004|Period 1|Withdrawal by Subject|0|||
105872922|NCT01640249|365187125|FG005|Period 1|Withdrawal by Subject|1|||
105872923|NCT01640249|365187126|FG006|Period 1|Withdrawal by Subject|0|||
105872924|NCT01870778|365187130|FG000|Overall Study|Withdrawal by Subject|8|||
105872925|NCT01870778|365187131|FG001|Overall Study|Withdrawal by Subject|7|||
105872926|NCT01870778|365187130|FG000|Overall Study|Lost to Follow-up|0|||
105872927|NCT01870778|365187131|FG001|Overall Study|Lost to Follow-up|2|||
105872928|NCT00065156|365187132|FG000|Overall Study|Adverse Event|37|||
105872929|NCT00065156|365187132|FG000|Overall Study|Lack of Efficacy|52|||
105872930|NCT00065156|365187132|FG000|Overall Study|Withdrawal by Subject|8|||
105872931|NCT00065156|365187132|FG000|Overall Study|Lost to Follow-up|1|||
105872932|NCT00065156|365187132|FG000|Overall Study|Death|11|||
105872933|NCT00065156|365187132|FG000|Overall Study|Study Closed by Sponsor|2|||
105872934|NCT00065156|365187132|FG000|Overall Study|Disease Progression|7|||
105872935|NCT00065156|365187132|FG000|Overall Study|Investigator Decision|2|||
105872936|NCT00065156|365187132|FG000|Overall Study|Non-Compliance|2|||
105872937|NCT00065156|365187132|FG000|Overall Study|Loss of Response|1|||
105872938|NCT00065156|365187132|FG000|Overall Study|Secondary Malign Disease|1|||
105872939|NCT00312338|365187133|FG000|Overall Study|Adverse Event|7|||
105872940|NCT00312338|365187134|FG001|Overall Study|Adverse Event|2|||
105872941|NCT00312338|365187133|FG000|Overall Study|Lost to Follow-up|9|||
105872942|NCT00312338|365187134|FG001|Overall Study|Lost to Follow-up|1|||
105872943|NCT00312338|365187133|FG000|Overall Study|Withdrawal by Subject|4|||
105872944|NCT00312338|365187134|FG001|Overall Study|Withdrawal by Subject|0|||
105872945|NCT00312338|365187133|FG000|Overall Study|Subsequent infection|2|||
105872946|NCT00312338|365187134|FG001|Overall Study|Subsequent infection|0|||
105872947|NCT00100828|365187135|FG000|Overall Study|Physician Decision|6|||
105872948|NCT04583735|365187136|FG000|Double-masked Treatment Period|Adverse Event|0|||
105872949|NCT04583735|365187137|FG001|Double-masked Treatment Period|Adverse Event|1|||
105872950|NCT04583735|365187136|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
105872951|NCT04583735|365187137|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
105872952|NCT04583735|365187136|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
105872953|NCT04583735|365187137|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
105872954|NCT04583735|365187136|FG000|Open-label Treatment Period|Adverse Event|1|||
105872955|NCT04583735|365187137|FG001|Open-label Treatment Period|Adverse Event|1|||
105872956|NCT04583735|365187136|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
105872957|NCT04583735|365187137|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
105872958|NCT04583735|365187136|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
105872959|NCT04583735|365187137|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
105872960|NCT00124917|365187138|FG000|Overall Study|Physician Decision|3|||
105872961|NCT03518008|365187139|FG000|Period 2, Second Week of Wear|Family emergency|0|||
105872962|NCT03518008|365187140|FG001|Period 2, Second Week of Wear|Family emergency|1|||
105872963|NCT01215136|365187141|FG000|Overall Study|Adverse Event|2|||
105872964|NCT01215136|365187142|FG001|Overall Study|Adverse Event|9|||
105872965|NCT01215136|365187141|FG000|Overall Study|Disease Progression|3|||
105872966|NCT01215136|365187142|FG001|Overall Study|Disease Progression|14|||
105872967|NCT01215136|365187141|FG000|Overall Study|Symptomatic Deterioration|1|||
105872968|NCT01215136|365187142|FG001|Overall Study|Symptomatic Deterioration|1|||
105872969|NCT01215136|365187141|FG000|Overall Study|Death|0|||
105872970|NCT01215136|365187142|FG001|Overall Study|Death|2|||
105872971|NCT01215136|365187141|FG000|Overall Study|Withdrawal by Subject|0|||
105872972|NCT01215136|365187142|FG001|Overall Study|Withdrawal by Subject|1|||
105872973|NCT01197911|365187144|FG000|Overall Study|Adverse Event|0|||
105872974|NCT01197911|365187145|FG001|Overall Study|Adverse Event|0|||
105872975|NCT01197911|365187146|FG002|Overall Study|Adverse Event|1|||
105872976|NCT01320293|365187149|FG000|Overall Study|Lack of Efficacy|1|||
105872977|NCT01320293|365187149|FG000|Overall Study|Adverse Event|1|||
105872978|NCT03483012|365187153|FG000|Overall Study|Lack of Efficacy|6|||
105872979|NCT00476190|365187154|FG000|Overall Study|Ineligible|1|||
105872980|NCT00476190|365187155|FG001|Overall Study|Ineligible|1|||
105659507|NCT02635386|364417347|FG000|Overall Study|side effects|0|||
105872981|NCT00476190|365187154|FG000|Overall Study|Induction Death|2|||
105872982|NCT00476190|365187155|FG001|Overall Study|Induction Death|0|||
105872983|NCT00476190|365187154|FG000|Overall Study|Induction Failure|2|||
105872984|NCT00476190|365187155|FG001|Overall Study|Induction Failure|4|||
105872985|NCT00476190|365187154|FG000|Overall Study|Lost to Follow-up|1|||
105872986|NCT00476190|365187155|FG001|Overall Study|Lost to Follow-up|0|||
105872987|NCT00476190|365187154|FG000|Overall Study|Relapse/Progression|5|||
105872988|NCT00476190|365187155|FG001|Overall Study|Relapse/Progression|2|||
105872989|NCT00476190|365187154|FG000|Overall Study|Remission Death|0|||
105872990|NCT00476190|365187155|FG001|Overall Study|Remission Death|1|||
105872991|NCT00476190|365187154|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
105872992|NCT00476190|365187155|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
105872993|NCT00476190|365187154|FG000|Overall Study|Withdrawal by Subject|6|||
105872994|NCT00476190|365187155|FG001|Overall Study|Withdrawal by Subject|2|||
105872995|NCT00476190|365187154|FG000|Overall Study|Other|9|||
105872996|NCT00476190|365187155|FG001|Overall Study|Other|10|||
105872997|NCT01147068|365187156|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
105872998|NCT01147068|365187157|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105872999|NCT01147068|365187158|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105873000|NCT01147068|365187159|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105873001|NCT01147068|365187160|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105873002|NCT01147068|365187161|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
105873003|NCT01147068|365187162|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
105873004|NCT01147068|365187156|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
105873005|NCT01147068|365187157|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
105873006|NCT01147068|365187158|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
105873007|NCT01147068|365187159|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
105873008|NCT01147068|365187160|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
105873009|NCT01147068|365187161|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
105873010|NCT01147068|365187162|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
105873011|NCT01147068|365187156|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
105873012|NCT01147068|365187157|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
105873013|NCT01147068|365187158|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
105873014|NCT01147068|365187159|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
105873015|NCT01147068|365187160|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
105873016|NCT01147068|365187161|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
105873017|NCT01147068|365187162|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
105873018|NCT01147068|365187156|FG000|Subjects That Received 2nd Dose|Other|0|||
105873019|NCT01147068|365187157|FG001|Subjects That Received 2nd Dose|Other|3|||
105873020|NCT01147068|365187158|FG002|Subjects That Received 2nd Dose|Other|3|||
105873021|NCT01147068|365187159|FG003|Subjects That Received 2nd Dose|Other|0|||
105873022|NCT01147068|365187160|FG004|Subjects That Received 2nd Dose|Other|1|||
105873023|NCT01147068|365187161|FG005|Subjects That Received 2nd Dose|Other|0|||
105873024|NCT01147068|365187162|FG006|Subjects That Received 2nd Dose|Other|0|||
105873025|NCT01147068|365187156|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
105873026|NCT01147068|365187157|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
105873027|NCT01147068|365187158|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
105873028|NCT01147068|365187159|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
105873029|NCT01147068|365187160|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
105873030|NCT01147068|365187161|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
105873031|NCT01147068|365187162|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
105873032|NCT01147068|365187156|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105873033|NCT01147068|365187157|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105873034|NCT01147068|365187158|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105873035|NCT01147068|365187159|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
105873036|NCT01147068|365187160|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105873037|NCT01147068|365187161|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105873038|NCT01147068|365187162|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
105873039|NCT01147068|365187156|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
105873040|NCT01147068|365187157|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
105873041|NCT01147068|365187158|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
105873042|NCT01147068|365187159|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
105873043|NCT01147068|365187160|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
105873044|NCT01147068|365187161|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
105873045|NCT01147068|365187162|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
105873046|NCT04782076|365187163|FG000|Overall Study|Family Emergency|1|||
105873047|NCT02860546|365187164|FG000|Overall Study|Clinical Progression|6|||
105873048|NCT02860546|365187164|FG000|Overall Study|Radiological Progression|12|||
105873049|NCT02189837|365187168|FG000|Overall Study|Withdrawal by Subject|2|||
105873050|NCT02189837|365187169|FG001|Overall Study|Withdrawal by Subject|1|||
105873051|NCT02189837|365187170|FG002|Overall Study|Withdrawal by Subject|3|||
105873052|NCT02189837|365187171|FG003|Overall Study|Withdrawal by Subject|1|||
105873053|NCT02189837|365187168|FG000|Overall Study|Sponsor Decision|0|||
105873054|NCT02189837|365187169|FG001|Overall Study|Sponsor Decision|0|||
105873055|NCT02189837|365187170|FG002|Overall Study|Sponsor Decision|0|||
105873056|NCT02189837|365187171|FG003|Overall Study|Sponsor Decision|1|||
105873057|NCT00931528|365188424|FG000|Overall Study|Protocol Violation|9|||
105873058|NCT00931528|365188425|FG001|Overall Study|Protocol Violation|12|||
105873059|NCT00931528|365188424|FG000|Overall Study|Withdrawal by Subject|4|||
105873060|NCT00931528|365188425|FG001|Overall Study|Withdrawal by Subject|12|||
105873061|NCT00931528|365188424|FG000|Overall Study|Lost to Follow-up|6|||
105873062|NCT00931528|365188425|FG001|Overall Study|Lost to Follow-up|13|||
105873063|NCT00931528|365188424|FG000|Overall Study|Assessment outside of Time Frame|22|||
105873064|NCT00931528|365188425|FG001|Overall Study|Assessment outside of Time Frame|23|||
105873065|NCT04173507|365188426|FG000|Overall Study|On Treatment|3|||
105873066|NCT04173507|365188426|FG000|Overall Study|Adverse Event|3|||
105873067|NCT04173507|365188426|FG000|Overall Study|Progression/Relapse|34|||
105873068|NCT04173507|365188426|FG000|Overall Study|Death|2|||
105873069|NCT01823328|365188427|FG000|Overall Study|Withdrawal by Subject|8|||
105873070|NCT01823328|365188428|FG001|Overall Study|Withdrawal by Subject|6|||
105873071|NCT04179838|365188431|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
105873072|NCT04179838|365188432|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
105873073|NCT04179838|365188431|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
105873074|NCT04179838|365188432|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
105873075|NCT02572570|365188435|FG000|Overall Study|Study Terminated|27|||
105873076|NCT02763046|365188436|FG000|Overall Study|Adverse Event|5|||
105873077|NCT02763046|365188437|FG001|Overall Study|Adverse Event|4|||
105873078|NCT02763046|365188438|FG002|Overall Study|Adverse Event|0|||
105873079|NCT02763046|365188436|FG000|Overall Study|Lack of Efficacy|1|||
105873080|NCT02763046|365188437|FG001|Overall Study|Lack of Efficacy|1|||
105873081|NCT02763046|365188438|FG002|Overall Study|Lack of Efficacy|3|||
105873082|NCT02763046|365188436|FG000|Overall Study|Physician Decision|1|||
105873083|NCT02763046|365188437|FG001|Overall Study|Physician Decision|0|||
105873084|NCT02763046|365188438|FG002|Overall Study|Physician Decision|1|||
105873085|NCT02763046|365188436|FG000|Overall Study|Subject/guardian decision|2|||
105873086|NCT02763046|365188437|FG001|Overall Study|Subject/guardian decision|0|||
105873087|NCT02763046|365188438|FG002|Overall Study|Subject/guardian decision|4|||
105873088|NCT00513695|365188439|FG000|Overall Study|Discontinued therapy|2|||
105873089|NCT00513695|365188439|FG000|Overall Study|Progression prior to surgery|3|||
105873090|NCT01417156|365188446|FG000|Overall Study|Adverse Event|12|||
105873091|NCT01417156|365188446|FG000|Overall Study|Protocol Violation|2|||
105873092|NCT02764762|365188449|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
105873093|NCT02764762|365188449|FG000|Overall Study|Lost to Follow-up|4|||
105873094|NCT02764762|365188449|FG000|Overall Study|Voluntary Withdrawal|8|||
105873095|NCT02764762|365188449|FG000|Overall Study|Site Termination|1|||
105873096|NCT02764762|365188449|FG000|Overall Study|Lack of Efficacy|16|||
105873097|NCT02764762|365188449|FG000|Overall Study|Reason not Specified|1|||
105873098|NCT03052751|365188450|FG000|Dosing Period 1|Adverse Event|0|||
105873099|NCT03052751|365188451|FG001|Dosing Period 1|Adverse Event|1|||
105873100|NCT03052751|365188452|FG002|Dosing Period 1|Adverse Event|0|||
105873101|NCT03052751|365188453|FG003|Dosing Period 1|Adverse Event|0|||
105873102|NCT03052751|365188454|FG004|Dosing Period 1|Adverse Event|0|||
105873103|NCT03052751|365188455|FG005|Dosing Period 1|Adverse Event|0|||
105873104|NCT03052751|365188450|FG000|Dosing Period 2|Adverse Event|0|||
105873105|NCT03052751|365188451|FG001|Dosing Period 2|Adverse Event|0|||
105873106|NCT03052751|365188452|FG002|Dosing Period 2|Adverse Event|3|||
105873107|NCT03052751|365188453|FG003|Dosing Period 2|Adverse Event|0|||
105873108|NCT03052751|365188454|FG004|Dosing Period 2|Adverse Event|0|||
105873109|NCT03052751|365188455|FG005|Dosing Period 2|Adverse Event|0|||
105873110|NCT03052751|365188450|FG000|Observation Period|Adverse Event|0|||
105873111|NCT03052751|365188451|FG001|Observation Period|Adverse Event|0|||
105873112|NCT03052751|365188452|FG002|Observation Period|Adverse Event|0|||
105873113|NCT03052751|365188453|FG003|Observation Period|Adverse Event|0|||
105873114|NCT03052751|365188454|FG004|Observation Period|Adverse Event|1|||
105873115|NCT03052751|365188455|FG005|Observation Period|Adverse Event|0|||
105873116|NCT01173523|365188458|FG000|Overall Study|Clinical Progression|1|||
105873117|NCT01173523|365188459|FG001|Overall Study|Clinical Progression|1|||
105873118|NCT01173523|365188458|FG000|Overall Study|Progressive Disease|10|||
105873119|NCT01173523|365188459|FG001|Overall Study|Progressive Disease|8|||
105873120|NCT01173523|365188458|FG000|Overall Study|Other|2|||
105873121|NCT01173523|365188459|FG001|Overall Study|Other|3|||
105873122|NCT01067105|365188460|FG000|Overall Study|Adverse Event|14|||
105873123|NCT01067105|365188460|FG000|Overall Study|Protocol Violation|48|||
105873124|NCT01067105|365188460|FG000|Overall Study|Withdrawal by Subject|36|||
105873125|NCT01067105|365188460|FG000|Overall Study|Lost to Follow-up|6|||
105873126|NCT01067105|365188460|FG000|Overall Study|Physician Decision|6|||
105873127|NCT01067105|365188460|FG000|Overall Study|Other|31|||
105873128|NCT02760004|365188462|FG000|Overall Study|Lost to Follow-up|13|||
105873129|NCT02760004|365188463|FG001|Overall Study|Lost to Follow-up|22|||
105873130|NCT02719184|365188466|FG000|Overall Study|Other than listed|1|||
105873131|NCT02719184|365188467|FG001|Overall Study|Other than listed|12|||
105873132|NCT02719184|365188468|FG002|Overall Study|Other than listed|13|||
105873133|NCT02719184|365188469|FG003|Overall Study|Other than listed|22|||
105873134|NCT02719184|365188470|FG004|Overall Study|Other than listed|9|||
105873135|NCT02719184|365188466|FG000|Overall Study|Withdrawal by Subject|5|||
105873136|NCT02719184|365188467|FG001|Overall Study|Withdrawal by Subject|3|||
105873137|NCT02719184|365188468|FG002|Overall Study|Withdrawal by Subject|6|||
105873138|NCT02719184|365188469|FG003|Overall Study|Withdrawal by Subject|6|||
105873139|NCT02719184|365188470|FG004|Overall Study|Withdrawal by Subject|0|||
105873140|NCT02719184|365188466|FG000|Overall Study|Lost to Follow-up|0|||
105873141|NCT02719184|365188467|FG001|Overall Study|Lost to Follow-up|4|||
105873142|NCT02719184|365188468|FG002|Overall Study|Lost to Follow-up|1|||
105873143|NCT02719184|365188469|FG003|Overall Study|Lost to Follow-up|3|||
105873144|NCT02719184|365188470|FG004|Overall Study|Lost to Follow-up|0|||
105873145|NCT02719184|365188466|FG000|Overall Study|Protocol Violation|0|||
105873146|NCT02719184|365188467|FG001|Overall Study|Protocol Violation|3|||
105873147|NCT02719184|365188468|FG002|Overall Study|Protocol Violation|0|||
105873148|NCT02719184|365188469|FG003|Overall Study|Protocol Violation|2|||
105873149|NCT02719184|365188470|FG004|Overall Study|Protocol Violation|0|||
105873150|NCT02719184|365188466|FG000|Overall Study|Adverse Event|0|||
105873151|NCT02719184|365188467|FG001|Overall Study|Adverse Event|0|||
105873152|NCT02719184|365188468|FG002|Overall Study|Adverse Event|0|||
105873153|NCT02719184|365188469|FG003|Overall Study|Adverse Event|3|||
105873154|NCT02719184|365188470|FG004|Overall Study|Adverse Event|0|||
105873155|NCT01439802|365188471|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
105873156|NCT01439802|365188471|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
105873157|NCT00840749|365188477|FG000|Overall Study|Death|1|||
105873158|NCT00840749|365188478|FG001|Overall Study|Death|2|||
105873159|NCT00840749|365188477|FG000|Overall Study|not treated on study arm|11|||
105873160|NCT00840749|365188478|FG001|Overall Study|not treated on study arm|11|||
105873161|NCT00840749|365188477|FG000|Overall Study|study closed|19|||
105873162|NCT00840749|365188478|FG001|Overall Study|study closed|14|||
105873163|NCT03534687|365188481|FG000|Overall Study|Lost to Follow-up|7|||
105873164|NCT03534687|365188482|FG001|Overall Study|Lost to Follow-up|2|||
105873165|NCT02569801|365188483|FG000|Overall Study|Withdrawal by Subject|9|||
105873166|NCT02569801|365188484|FG001|Overall Study|Withdrawal by Subject|9|||
105873167|NCT02569801|365188483|FG000|Overall Study|Sponsor Decision|13|||
105873168|NCT02569801|365188484|FG001|Overall Study|Sponsor Decision|14|||
105873169|NCT02569801|365188483|FG000|Overall Study|Progressive Disease|2|||
105873170|NCT02569801|365188484|FG001|Overall Study|Progressive Disease|7|||
105873171|NCT02569801|365188483|FG000|Overall Study|Lost to Follow-up|0|||
105873172|NCT02569801|365188484|FG001|Overall Study|Lost to Follow-up|1|||
105873173|NCT02569801|365188483|FG000|Overall Study|Death|12|||
105873174|NCT02569801|365188484|FG001|Overall Study|Death|4|||
105873175|NCT00428246|365188485|FG000|Overall Study|Withdrawal by Subject|0|||
105873176|NCT00428246|365188486|FG001|Overall Study|Withdrawal by Subject|0|||
105873177|NCT00428246|365188487|FG002|Overall Study|Withdrawal by Subject|1|||
105873178|NCT00428246|365188485|FG000|Overall Study|Adverse Event|1|||
105873179|NCT00428246|365188486|FG001|Overall Study|Adverse Event|0|||
105873180|NCT00428246|365188487|FG002|Overall Study|Adverse Event|0|||
105873181|NCT03776357|365188490|FG000|Overall Study|Lost to Follow-up|3|||
105873182|NCT00235755|365188498|FG000|4-Week Titration Phase|Adverse Event|6|||
105873183|NCT00235755|365188499|FG001|4-Week Titration Phase|Adverse Event|14|||
105873184|NCT00235755|365188500|FG002|4-Week Titration Phase|Adverse Event|20|||
105873185|NCT00235755|365188498|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
105873186|NCT00235755|365188499|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
105873187|NCT00235755|365188500|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
105873188|NCT00235755|365188498|FG000|4-Week Titration Phase|Protocol Violation|2|||
105873189|NCT00235755|365188499|FG001|4-Week Titration Phase|Protocol Violation|2|||
105873190|NCT00235755|365188500|FG002|4-Week Titration Phase|Protocol Violation|1|||
105873191|NCT00235755|365188498|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
105873192|NCT00235755|365188499|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
105873193|NCT00235755|365188500|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
105873194|NCT00235755|365188498|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
105873195|NCT00235755|365188499|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
105873196|NCT00235755|365188500|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
105659508|NCT02635386|364417348|FG001|Overall Study|side effects|0|||
105873197|NCT00235755|365188498|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
105873198|NCT00235755|365188499|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
105873199|NCT00235755|365188500|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
105873200|NCT00235755|365188498|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
105873201|NCT00235755|365188499|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
105873202|NCT00235755|365188500|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
105873203|NCT00235755|365188498|FG000|12-Week Maintenance Phase|Adverse Event|8|||
105873204|NCT00235755|365188499|FG001|12-Week Maintenance Phase|Adverse Event|12|||
105873205|NCT00235755|365188500|FG002|12-Week Maintenance Phase|Adverse Event|26|||
105873206|NCT00235755|365188498|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
105873207|NCT00235755|365188499|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
105873208|NCT00235755|365188500|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
105873209|NCT00235755|365188498|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
105873210|NCT00235755|365188499|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
105873211|NCT00235755|365188500|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
105873212|NCT00235755|365188498|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
105873213|NCT00235755|365188499|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
105873214|NCT00235755|365188500|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
105873215|NCT00235755|365188498|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
105873216|NCT00235755|365188499|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
105873217|NCT00235755|365188500|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
105873218|NCT00235755|365188498|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
105873219|NCT00235755|365188499|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
105873220|NCT00235755|365188500|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
105873221|NCT01125917|365188501|FG000|Overall Study|Adverse Event|43|||
105873222|NCT01125917|365188501|FG000|Overall Study|Lost to Follow-up|23|||
105873223|NCT01125917|365188501|FG000|Overall Study|Withdrawal by Subject|31|||
105873224|NCT01125917|365188501|FG000|Overall Study|Administrative|223|||
105873225|NCT01125917|365188501|FG000|Overall Study|Lack of Efficacy|19|||
105873226|NCT00838526|365188510|FG000|Overall Study|Adverse Event|3|||
105873227|NCT00838526|365188511|FG001|Overall Study|Adverse Event|12|||
105873228|NCT00838526|365188510|FG000|Overall Study|Lost to Follow-up|4|||
105873229|NCT00838526|365188511|FG001|Overall Study|Lost to Follow-up|12|||
105873230|NCT00838526|365188510|FG000|Overall Study|Withdrawal by Subject|4|||
105873231|NCT00838526|365188511|FG001|Overall Study|Withdrawal by Subject|5|||
105873232|NCT00838526|365188510|FG000|Overall Study|Lack of Efficacy|2|||
105873233|NCT00838526|365188511|FG001|Overall Study|Lack of Efficacy|3|||
105873234|NCT00838526|365188510|FG000|Overall Study|Other|11|||
105873235|NCT00838526|365188511|FG001|Overall Study|Other|7|||
105873236|NCT00931411|365188514|FG000|First Intervention - 42 Days|Adverse Event|2|||
105873237|NCT00931411|365188515|FG001|First Intervention - 42 Days|Adverse Event|3|||
105873238|NCT00931411|365188514|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
105873239|NCT00931411|365188515|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
105873240|NCT00931411|365188514|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
105873241|NCT00931411|365188515|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
105873242|NCT00470470|365188516|FG000|Overall Study|Adverse Event|2|||
105873243|NCT00470470|365188516|FG000|Overall Study|Death|2|||
105873244|NCT00470470|365188516|FG000|Overall Study|Not treated|1|||
105873245|NCT01149863|365188522|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
105873246|NCT01306305|365188523|FG000|Overall Study|Lost to Follow-up|1|||
105873247|NCT01306305|365188524|FG001|Overall Study|Lost to Follow-up|0|||
105873248|NCT01306305|365188523|FG000|Overall Study|Withdrew consent|1|||
105873249|NCT01306305|365188524|FG001|Overall Study|Withdrew consent|0|||
105873250|NCT00699998|365188525|FG000|Overall Study|Withdrawal by Subject|194|||
105873251|NCT00699998|365188526|FG001|Overall Study|Withdrawal by Subject|83|||
105873252|NCT00699998|365188527|FG002|Overall Study|Withdrawal by Subject|202|||
105873253|NCT00699998|365188528|FG003|Overall Study|Withdrawal by Subject|80|||
105873254|NCT00699998|365188525|FG000|Overall Study|Physician Decision|3|||
105873255|NCT00699998|365188526|FG001|Overall Study|Physician Decision|2|||
105873256|NCT00699998|365188527|FG002|Overall Study|Physician Decision|1|||
105873257|NCT00699998|365188528|FG003|Overall Study|Physician Decision|1|||
105873258|NCT00699998|365188525|FG000|Overall Study|Lost to Follow-up|2|||
105873259|NCT00699998|365188526|FG001|Overall Study|Lost to Follow-up|1|||
105873260|NCT00699998|365188527|FG002|Overall Study|Lost to Follow-up|3|||
105873261|NCT00699998|365188528|FG003|Overall Study|Lost to Follow-up|1|||
105873262|NCT04052620|365188529|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
105873263|NCT04052620|365188530|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
105873264|NCT04052620|365188529|FG000|Overall Study|Withdrawal by Subject|1|||
105873265|NCT04052620|365188530|FG001|Overall Study|Withdrawal by Subject|0|||
105873266|NCT04052620|365188529|FG000|Overall Study|Lost to Follow-up|1|||
105873267|NCT04052620|365188530|FG001|Overall Study|Lost to Follow-up|1|||
105873268|NCT04052620|365188529|FG000|Overall Study|Adverse Event|1|||
105873269|NCT04052620|365188530|FG001|Overall Study|Adverse Event|0|||
105873270|NCT04052620|365188529|FG000|Overall Study|Subject did not meet study Criteria|0|||
105873271|NCT04052620|365188530|FG001|Overall Study|Subject did not meet study Criteria|1|||
105873272|NCT04052620|365188529|FG000|Overall Study|Screened failure, randomized by mistake|0|||
105873273|NCT04052620|365188530|FG001|Overall Study|Screened failure, randomized by mistake|1|||
105873274|NCT04052620|365188529|FG000|Overall Study|Personal reasons|2|||
105873275|NCT04052620|365188530|FG001|Overall Study|Personal reasons|4|||
105873276|NCT04052620|365188529|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
105873277|NCT04052620|365188530|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
105873278|NCT00473590|365188531|FG000|Overall Study|Adverse Event|3|||
105873279|NCT00473590|365188532|FG001|Overall Study|Adverse Event|3|||
105873280|NCT00473590|365188531|FG000|Overall Study|Death|4|||
105873281|NCT00473590|365188532|FG001|Overall Study|Death|2|||
105873282|NCT00473590|365188531|FG000|Overall Study|Progression not resulting in death|24|||
105873283|NCT00473590|365188532|FG001|Overall Study|Progression not resulting in death|20|||
105873284|NCT00473590|365188531|FG000|Overall Study|Non-protocol-specified therapy|7|||
105873285|NCT00473590|365188532|FG001|Overall Study|Non-protocol-specified therapy|5|||
105873286|NCT00473590|365188531|FG000|Overall Study|Physician Decision|2|||
105873287|NCT00473590|365188532|FG001|Overall Study|Physician Decision|4|||
105873288|NCT00473590|365188531|FG000|Overall Study|Withdrawal by Subject|5|||
105873289|NCT00473590|365188532|FG001|Overall Study|Withdrawal by Subject|3|||
105873290|NCT00473590|365188531|FG000|Overall Study|Other|0|||
105873291|NCT00473590|365188532|FG001|Overall Study|Other|1|||
105873292|NCT01757275|365188533|FG000|Overall Study|Lost to Follow-up|1|||
105873293|NCT01757275|365188534|FG001|Overall Study|Lost to Follow-up|2|||
105873294|NCT01757275|365188533|FG000|Overall Study|Adverse Event|3|||
105873295|NCT01757275|365188534|FG001|Overall Study|Adverse Event|3|||
105873296|NCT01757275|365188533|FG000|Overall Study|Withdrawal by Subject|2|||
105873297|NCT01757275|365188534|FG001|Overall Study|Withdrawal by Subject|4|||
105873298|NCT01757275|365188533|FG000|Overall Study|Not treated|3|||
105873299|NCT01757275|365188534|FG001|Overall Study|Not treated|4|||
105873300|NCT00858273|365188535|FG000|Overall Study|Protocol Violation|3|||
105873301|NCT00858273|365188536|FG001|Overall Study|Protocol Violation|5|||
105873302|NCT01326845|365188538|FG000|Overall Study|Administrative Problems|5|||
105873303|NCT01326845|365188539|FG001|Overall Study|Administrative Problems|2|||
105873304|NCT01326845|365188538|FG000|Overall Study|Adverse Event|1|||
105873305|NCT01326845|365188539|FG001|Overall Study|Adverse Event|0|||
105873306|NCT01326845|365188538|FG000|Overall Study|Misisng|1|||
105873307|NCT01326845|365188539|FG001|Overall Study|Misisng|3|||
105873308|NCT00982657|365188540|FG000|Overall Study|Death|1|||
105873309|NCT00982657|365188541|FG001|Overall Study|Death|0|||
105873310|NCT00982657|365188542|FG002|Overall Study|Death|1|||
105873311|NCT00982657|365188543|FG003|Overall Study|Death|1|||
105873312|NCT00982657|365188540|FG000|Overall Study|Withdrawal by Subject|0|||
105873313|NCT00982657|365188541|FG001|Overall Study|Withdrawal by Subject|0|||
105873314|NCT00982657|365188542|FG002|Overall Study|Withdrawal by Subject|1|||
105873315|NCT00982657|365188543|FG003|Overall Study|Withdrawal by Subject|3|||
105873316|NCT00982657|365188540|FG000|Overall Study|Other|0|||
105873317|NCT00982657|365188541|FG001|Overall Study|Other|0|||
105873318|NCT00982657|365188542|FG002|Overall Study|Other|0|||
105873319|NCT00982657|365188543|FG003|Overall Study|Other|4|||
105873320|NCT00982657|365188540|FG000|Overall Study|On going at date of cut-off|0|||
105873321|NCT00982657|365188541|FG001|Overall Study|On going at date of cut-off|0|||
105873322|NCT00982657|365188542|FG002|Overall Study|On going at date of cut-off|0|||
105873323|NCT00982657|365188543|FG003|Overall Study|On going at date of cut-off|1|||
105873324|NCT02964247|365188544|FG000|Overall Study|Lost to Follow-up|2|||
105873325|NCT02964247|365188545|FG001|Overall Study|Lost to Follow-up|0|||
105873326|NCT02964247|365188544|FG000|Overall Study|Withdrawal by Subject|1|||
105873327|NCT02964247|365188545|FG001|Overall Study|Withdrawal by Subject|2|||
105873328|NCT01891864|365188546|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
105873329|NCT01891864|365188547|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
105873330|NCT01891864|365188548|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
105873331|NCT01891864|365188549|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
105873332|NCT01891864|365188550|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
105873333|NCT01891864|365188551|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
105873334|NCT01891864|365188546|FG000|Treatment Period 1|Physician Decision|0|||
105873335|NCT01891864|365188547|FG001|Treatment Period 1|Physician Decision|1|||
105873336|NCT01891864|365188548|FG002|Treatment Period 1|Physician Decision|0|||
105873337|NCT01891864|365188549|FG003|Treatment Period 1|Physician Decision|0|||
105873338|NCT01891864|365188550|FG004|Treatment Period 1|Physician Decision|0|||
105873339|NCT01891864|365188551|FG005|Treatment Period 1|Physician Decision|0|||
105873340|NCT01891864|365188546|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105873341|NCT01891864|365188547|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
105873342|NCT01891864|365188548|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105873343|NCT01891864|365188549|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105873344|NCT01891864|365188550|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105873345|NCT01891864|365188551|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
105873346|NCT01891864|365188546|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
105873347|NCT01891864|365188547|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
105873348|NCT01891864|365188548|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
105873349|NCT01891864|365188549|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
105873350|NCT01891864|365188550|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
105873351|NCT01891864|365188551|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
105873352|NCT01891864|365188546|FG000|Treatment Period 1|Withdrawal by Subject|2|||
105873353|NCT01891864|365188547|FG001|Treatment Period 1|Withdrawal by Subject|5|||
105873354|NCT01891864|365188548|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105873355|NCT01891864|365188549|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105873356|NCT01891864|365188550|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105873357|NCT01891864|365188551|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105873358|NCT01891864|365188546|FG000|Treatment Period 1|Lost to Follow-up|1|||
105873359|NCT01891864|365188547|FG001|Treatment Period 1|Lost to Follow-up|0|||
105873360|NCT01891864|365188548|FG002|Treatment Period 1|Lost to Follow-up|0|||
105873361|NCT01891864|365188549|FG003|Treatment Period 1|Lost to Follow-up|0|||
105873362|NCT01891864|365188550|FG004|Treatment Period 1|Lost to Follow-up|0|||
105873363|NCT01891864|365188551|FG005|Treatment Period 1|Lost to Follow-up|0|||
105873364|NCT01891864|365188546|FG000|Treatment Period 2|Protocol Violation|0|||
105873365|NCT01891864|365188547|FG001|Treatment Period 2|Protocol Violation|0|||
105873366|NCT01891864|365188548|FG002|Treatment Period 2|Protocol Violation|0|||
105873367|NCT01891864|365188549|FG003|Treatment Period 2|Protocol Violation|1|||
105873368|NCT01891864|365188550|FG004|Treatment Period 2|Protocol Violation|0|||
105873369|NCT01891864|365188551|FG005|Treatment Period 2|Protocol Violation|0|||
105873370|NCT01891864|365188546|FG000|Treatment Period 2|Physician Decision|0|||
105873371|NCT01891864|365188547|FG001|Treatment Period 2|Physician Decision|0|||
105873372|NCT01891864|365188548|FG002|Treatment Period 2|Physician Decision|1|||
105873373|NCT01891864|365188549|FG003|Treatment Period 2|Physician Decision|0|||
105873374|NCT01891864|365188550|FG004|Treatment Period 2|Physician Decision|0|||
105873375|NCT01891864|365188551|FG005|Treatment Period 2|Physician Decision|0|||
105873376|NCT01891864|365188546|FG000|Treatment Period 2|Site Termination|0|||
105873377|NCT01891864|365188547|FG001|Treatment Period 2|Site Termination|0|||
105873378|NCT01891864|365188548|FG002|Treatment Period 2|Site Termination|1|||
105873379|NCT01891864|365188549|FG003|Treatment Period 2|Site Termination|2|||
105873380|NCT01891864|365188550|FG004|Treatment Period 2|Site Termination|0|||
105873381|NCT01891864|365188551|FG005|Treatment Period 2|Site Termination|0|||
105873382|NCT01891864|365188546|FG000|Treatment Period 2|Lack of Efficacy|0|||
105873383|NCT01891864|365188547|FG001|Treatment Period 2|Lack of Efficacy|0|||
105873384|NCT01891864|365188548|FG002|Treatment Period 2|Lack of Efficacy|1|||
105873385|NCT01891864|365188549|FG003|Treatment Period 2|Lack of Efficacy|0|||
105873386|NCT01891864|365188550|FG004|Treatment Period 2|Lack of Efficacy|1|||
105873387|NCT01891864|365188551|FG005|Treatment Period 2|Lack of Efficacy|0|||
105873388|NCT01891864|365188546|FG000|Treatment Period 2|Adverse Event|0|||
105873389|NCT01891864|365188547|FG001|Treatment Period 2|Adverse Event|0|||
105873390|NCT01891864|365188548|FG002|Treatment Period 2|Adverse Event|1|||
105873391|NCT01891864|365188549|FG003|Treatment Period 2|Adverse Event|2|||
105873392|NCT01891864|365188550|FG004|Treatment Period 2|Adverse Event|0|||
105873393|NCT01891864|365188551|FG005|Treatment Period 2|Adverse Event|4|||
105873394|NCT01891864|365188546|FG000|Treatment Period 2|Termination of Site|0|||
105873395|NCT01891864|365188547|FG001|Treatment Period 2|Termination of Site|0|||
105873396|NCT01891864|365188548|FG002|Treatment Period 2|Termination of Site|0|||
105873397|NCT01891864|365188549|FG003|Treatment Period 2|Termination of Site|0|||
105873398|NCT01891864|365188550|FG004|Treatment Period 2|Termination of Site|2|||
105873399|NCT01891864|365188551|FG005|Treatment Period 2|Termination of Site|0|||
105873400|NCT01891864|365188546|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105873401|NCT01891864|365188547|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105873402|NCT01891864|365188548|FG002|Treatment Period 2|Withdrawal by Subject|3|||
105873403|NCT01891864|365188549|FG003|Treatment Period 2|Withdrawal by Subject|4|||
105873404|NCT01891864|365188550|FG004|Treatment Period 2|Withdrawal by Subject|1|||
105873405|NCT01891864|365188551|FG005|Treatment Period 2|Withdrawal by Subject|1|||
105873406|NCT01891864|365188546|FG000|Extension Period|Lack of Efficacy|0|||
105873407|NCT01891864|365188547|FG001|Extension Period|Lack of Efficacy|0|||
105873408|NCT01891864|365188548|FG002|Extension Period|Lack of Efficacy|0|||
105873409|NCT01891864|365188549|FG003|Extension Period|Lack of Efficacy|1|||
105873410|NCT01891864|365188550|FG004|Extension Period|Lack of Efficacy|1|||
105873411|NCT01891864|365188551|FG005|Extension Period|Lack of Efficacy|0|||
105873412|NCT01891864|365188546|FG000|Extension Period|Pregnancy|0|||
105873413|NCT01891864|365188547|FG001|Extension Period|Pregnancy|0|||
105873414|NCT01891864|365188548|FG002|Extension Period|Pregnancy|1|||
105873415|NCT01891864|365188549|FG003|Extension Period|Pregnancy|0|||
105873416|NCT01891864|365188550|FG004|Extension Period|Pregnancy|0|||
105657622|NCT01182207|364409923|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
105873417|NCT01891864|365188551|FG005|Extension Period|Pregnancy|0|||
105873418|NCT01891864|365188546|FG000|Extension Period|Adverse Event|0|||
105873419|NCT01891864|365188547|FG001|Extension Period|Adverse Event|0|||
105873420|NCT01891864|365188548|FG002|Extension Period|Adverse Event|4|||
105873421|NCT01891864|365188549|FG003|Extension Period|Adverse Event|2|||
105873422|NCT01891864|365188550|FG004|Extension Period|Adverse Event|2|||
105873423|NCT01891864|365188551|FG005|Extension Period|Adverse Event|0|||
105873424|NCT01891864|365188546|FG000|Extension Period|Withdrawal by Subject|0|||
105873425|NCT01891864|365188547|FG001|Extension Period|Withdrawal by Subject|0|||
105873426|NCT01891864|365188548|FG002|Extension Period|Withdrawal by Subject|1|||
105873427|NCT01891864|365188549|FG003|Extension Period|Withdrawal by Subject|2|||
105873428|NCT01891864|365188550|FG004|Extension Period|Withdrawal by Subject|4|||
105873429|NCT01891864|365188551|FG005|Extension Period|Withdrawal by Subject|0|||
105873430|NCT01891864|365188546|FG000|Extension Period|Lost to Follow-up|0|||
105873431|NCT01891864|365188547|FG001|Extension Period|Lost to Follow-up|0|||
105873432|NCT01891864|365188548|FG002|Extension Period|Lost to Follow-up|2|||
105873433|NCT01891864|365188549|FG003|Extension Period|Lost to Follow-up|0|||
105873434|NCT01891864|365188550|FG004|Extension Period|Lost to Follow-up|0|||
105873435|NCT01891864|365188551|FG005|Extension Period|Lost to Follow-up|0|||
105873436|NCT05373108|365188552|FG000|Overall Study|Withdrawal by Subject|2|||
105873437|NCT02892331|365188553|FG000|Overall Study|Withdrawal by Subject|0|||
105873438|NCT02892331|365188554|FG001|Overall Study|Withdrawal by Subject|1|||
105873439|NCT02892331|365188555|FG002|Overall Study|Withdrawal by Subject|1|||
105873440|NCT02892331|365188553|FG000|Overall Study|Sick family member|0|||
105873441|NCT02892331|365188554|FG001|Overall Study|Sick family member|0|||
105873442|NCT02892331|365188555|FG002|Overall Study|Sick family member|1|||
105873443|NCT02892331|365188553|FG000|Overall Study|Corona virus pandemic|1|||
105873444|NCT02892331|365188554|FG001|Overall Study|Corona virus pandemic|0|||
105873445|NCT02892331|365188555|FG002|Overall Study|Corona virus pandemic|1|||
105873446|NCT02892331|365188553|FG000|Overall Study|Lost to Follow-up|1|||
105873447|NCT02892331|365188554|FG001|Overall Study|Lost to Follow-up|0|||
105873448|NCT02892331|365188555|FG002|Overall Study|Lost to Follow-up|1|||
105873449|NCT02892331|365188553|FG000|Overall Study|Blood pressure was too elevated|0|||
105873450|NCT02892331|365188554|FG001|Overall Study|Blood pressure was too elevated|1|||
105873451|NCT02892331|365188555|FG002|Overall Study|Blood pressure was too elevated|0|||
105873452|NCT02892331|365188553|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
105873453|NCT02892331|365188554|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
105873454|NCT02892331|365188555|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
105873455|NCT01133067|365188556|FG000|Overall Study|Death|136|||
105873456|NCT01133067|365188556|FG000|Overall Study|Lost to Follow-up|3|||
105873457|NCT00752128|365188559|FG000|Overall Study|Withdrawal by Subject|4|||
105873458|NCT02166333|365188560|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
105873459|NCT02166333|365188561|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
105873460|NCT02166333|365188562|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
105873461|NCT02166333|365188563|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
105873462|NCT02166333|365188564|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
105873463|NCT02166333|365188565|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
105873464|NCT02166333|365188560|FG000|Stage 1|Death|4|||
105873465|NCT02166333|365188561|FG001|Stage 1|Death|0|||
105873466|NCT02166333|365188562|FG002|Stage 1|Death|2|||
105873467|NCT02166333|365188563|FG003|Stage 1|Death|0|||
105873468|NCT02166333|365188564|FG004|Stage 1|Death|3|||
105873469|NCT02166333|365188565|FG005|Stage 1|Death|2|||
105873470|NCT02166333|365188560|FG000|Stage 1|Lost to Follow-up|12|||
105873471|NCT02166333|365188561|FG001|Stage 1|Lost to Follow-up|0|||
105873472|NCT02166333|365188562|FG002|Stage 1|Lost to Follow-up|6|||
105873473|NCT02166333|365188563|FG003|Stage 1|Lost to Follow-up|0|||
105873474|NCT02166333|365188564|FG004|Stage 1|Lost to Follow-up|3|||
105873475|NCT02166333|365188565|FG005|Stage 1|Lost to Follow-up|3|||
105873476|NCT02166333|365188560|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
105873477|NCT02166333|365188561|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
105873478|NCT02166333|365188562|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
105873479|NCT02166333|365188563|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
105873480|NCT02166333|365188564|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
105873481|NCT02166333|365188565|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
105873482|NCT02166333|365188560|FG000|Stage 2|Death|4|||
105873483|NCT02166333|365188561|FG001|Stage 2|Death|2|||
105873484|NCT02166333|365188562|FG002|Stage 2|Death|1|||
105873485|NCT02166333|365188563|FG003|Stage 2|Death|0|||
105873486|NCT02166333|365188564|FG004|Stage 2|Death|0|||
105873487|NCT02166333|365188565|FG005|Stage 2|Death|1|||
105873488|NCT02166333|365188560|FG000|Stage 2|Lost to Follow-up|23|||
105873489|NCT02166333|365188561|FG001|Stage 2|Lost to Follow-up|4|||
105873490|NCT02166333|365188562|FG002|Stage 2|Lost to Follow-up|11|||
105873491|NCT02166333|365188563|FG003|Stage 2|Lost to Follow-up|9|||
105873492|NCT02166333|365188564|FG004|Stage 2|Lost to Follow-up|3|||
105873493|NCT02166333|365188565|FG005|Stage 2|Lost to Follow-up|6|||
105873494|NCT02286713|365188566|FG000|One Week Follow-Up|Death|1|||
105873495|NCT02286713|365188567|FG001|One Week Follow-Up|Death|0|||
105873496|NCT02286713|365188566|FG000|One Week Follow-Up|Lost to Follow-up|17|||
105873497|NCT02286713|365188567|FG001|One Week Follow-Up|Lost to Follow-up|21|||
105873498|NCT02286713|365188566|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
105873499|NCT02286713|365188567|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
105873500|NCT02286713|365188566|FG000|Three Month Follow-Up|Death|1|||
105873501|NCT02286713|365188567|FG001|Three Month Follow-Up|Death|1|||
105873502|NCT02286713|365188566|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
105873503|NCT02286713|365188567|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
105873504|NCT02286713|365188566|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
105873505|NCT02286713|365188567|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
105873506|NCT02286713|365188566|FG000|Six Month Follow-Up|Death|2|||
105873507|NCT02286713|365188567|FG001|Six Month Follow-Up|Death|0|||
105873508|NCT02286713|365188566|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
105873509|NCT02286713|365188567|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
105873510|NCT04314037|365188568|FG000|Treatment Period 2|Adverse Event|1|||
105873511|NCT04314037|365188569|FG001|Treatment Period 2|Adverse Event|0|||
105873512|NCT04314037|365188568|FG000|Treatment Period 3|Protocol Violation|1|||
105873513|NCT04314037|365188569|FG001|Treatment Period 3|Protocol Violation|0|||
105873514|NCT04314037|365188568|FG000|Treatment Period 3|Adverse Event|0|||
105873515|NCT04314037|365188569|FG001|Treatment Period 3|Adverse Event|1|||
105873516|NCT02654054|365188570|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
105873517|NCT02654054|365188571|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
105873518|NCT02654054|365188572|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
105873519|NCT02654054|365188570|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
105873520|NCT02654054|365188571|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
105873521|NCT02654054|365188572|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
105873522|NCT02654054|365188570|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
105873523|NCT02654054|365188571|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
105873524|NCT02654054|365188572|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
105873525|NCT02654054|365188570|FG000|Post-Treatment Follow-Up Period|Other|1|||
105873526|NCT02654054|365188571|FG001|Post-Treatment Follow-Up Period|Other|0|||
105873527|NCT02654054|365188572|FG002|Post-Treatment Follow-Up Period|Other|4|||
105873528|NCT02654054|365188570|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
105873529|NCT02654054|365188571|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
105873530|NCT02654054|365188572|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
105873531|NCT00420420|365188573|FG000|Overall Study|Adverse Event|5|||
105873532|NCT00420420|365188574|FG001|Overall Study|Adverse Event|3|||
105873533|NCT00420420|365188573|FG000|Overall Study|Protocol Violation|1|||
105873534|NCT00420420|365188574|FG001|Overall Study|Protocol Violation|1|||
105873535|NCT00420420|365188573|FG000|Overall Study|Withdrawal by Subject|1|||
105873536|NCT00420420|365188574|FG001|Overall Study|Withdrawal by Subject|0|||
105873537|NCT00420420|365188573|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
105873538|NCT00420420|365188574|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
105873539|NCT00856492|365188579|FG000|Overall Study|Ineligible or withdrew consent|1|||
105873540|NCT00856492|365188580|FG001|Overall Study|Ineligible or withdrew consent|1|||
105873541|NCT00856492|365188581|FG002|Overall Study|Ineligible or withdrew consent|2|||
105873542|NCT00324987|365190298|FG000|Overall Study|Adverse Event|2|||
105873543|NCT00324987|365190299|FG001|Overall Study|Adverse Event|1|||
105873544|NCT00324987|365190298|FG000|Overall Study|Withdrawal by Subject|1|||
105873545|NCT00324987|365190299|FG001|Overall Study|Withdrawal by Subject|1|||
105873546|NCT00324987|365190298|FG000|Overall Study|Progression|1|||
105873547|NCT00324987|365190299|FG001|Overall Study|Progression|1|||
105873548|NCT00324987|365190298|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
105873549|NCT00324987|365190299|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
105873550|NCT02058069|365190300|FG000|Overall Study|Exclusion due to implant size|5|||
105873551|NCT02058069|365190300|FG000|Overall Study|Withdrawal by Subject|6|||
105873552|NCT00897715|365190308|FG000|Overall Study|Lost to Follow-up|0|||
105873553|NCT00897715|365190309|FG001|Overall Study|Lost to Follow-up|1|||
105873554|NCT00897715|365190308|FG000|Overall Study|Physician Decision|1|||
105873555|NCT00897715|365190309|FG001|Overall Study|Physician Decision|0|||
105873556|NCT00897715|365190308|FG000|Overall Study|increased risk of infection|1|||
105873557|NCT00897715|365190309|FG001|Overall Study|increased risk of infection|0|||
105873558|NCT00707239|365190310|FG000|Overall Study|Adverse Event|5|||
105873559|NCT00707239|365190311|FG001|Overall Study|Adverse Event|3|||
105873560|NCT00707239|365190312|FG002|Overall Study|Adverse Event|2|||
105873561|NCT00707239|365190310|FG000|Overall Study|Death|3|||
105873562|NCT00707239|365190311|FG001|Overall Study|Death|1|||
105873563|NCT00707239|365190312|FG002|Overall Study|Death|3|||
105873564|NCT00707239|365190310|FG000|Overall Study|Physician Decision|1|||
105873565|NCT00707239|365190311|FG001|Overall Study|Physician Decision|1|||
105873566|NCT00707239|365190312|FG002|Overall Study|Physician Decision|2|||
105873567|NCT00707239|365190310|FG000|Overall Study|Protocol Violation|0|||
105873568|NCT00707239|365190311|FG001|Overall Study|Protocol Violation|0|||
105873569|NCT00707239|365190312|FG002|Overall Study|Protocol Violation|1|||
105873570|NCT00707239|365190310|FG000|Overall Study|Lack of Efficacy|1|||
105873571|NCT00707239|365190311|FG001|Overall Study|Lack of Efficacy|2|||
105873572|NCT00707239|365190312|FG002|Overall Study|Lack of Efficacy|0|||
105873573|NCT00707239|365190310|FG000|Overall Study|Randomized, but not treated|1|||
105873574|NCT00707239|365190311|FG001|Overall Study|Randomized, but not treated|1|||
105873575|NCT00707239|365190312|FG002|Overall Study|Randomized, but not treated|1|||
105873576|NCT00707239|365190310|FG000|Overall Study|Other|8|||
105873577|NCT00707239|365190311|FG001|Overall Study|Other|3|||
105873578|NCT00707239|365190312|FG002|Overall Study|Other|5|||
105873579|NCT03472014|365190315|FG000|Overall Study|Lost to Follow-up|4|||
105873580|NCT00110396|365190316|FG000|Overall Study|Adverse Event|15|||
105873581|NCT00110396|365190316|FG000|Overall Study|Lost to Follow-up|1|||
105873582|NCT00110396|365190316|FG000|Overall Study|Administration of plasmapheresis|1|||
105873583|NCT00110396|365190316|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
105873584|NCT00110396|365190316|FG000|Overall Study|Lack of Efficacy|1|||
105873585|NCT00110396|365190316|FG000|Overall Study|Decided not to continue treatment|1|||
105873586|NCT00110396|365190316|FG000|Overall Study|Patient non-compliance|1|||
105873587|NCT00110396|365190316|FG000|Overall Study|Patient refused to continue|1|||
105873588|NCT00110396|365190316|FG000|Overall Study|Patient refused to participate|1|||
105873589|NCT00110396|365190316|FG000|Overall Study|Patient will|1|||
105873590|NCT00110396|365190316|FG000|Overall Study|Patient's decision|1|||
105873591|NCT00110396|365190316|FG000|Overall Study|Participation in MS vaccine study|1|||
105873592|NCT00110396|365190316|FG000|Overall Study|Pregnancy|1|||
105873593|NCT00110396|365190316|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
105873594|NCT00110396|365190316|FG000|Overall Study|Protocol Violation|2|||
105873595|NCT00110396|365190316|FG000|Overall Study|Patient refused to come back|1|||
105873596|NCT00110396|365190316|FG000|Overall Study|The patient has refused|2|||
105873597|NCT00110396|365190316|FG000|Overall Study|The patient has refused to visit site|1|||
105873598|NCT00110396|365190316|FG000|Overall Study|Patient is to be administered copaxone|1|||
105873599|NCT02792517|365190317|FG000|Overall Study|Withdrawal by Subject|10|||
105873600|NCT02792517|365190317|FG000|Overall Study|Decision by Sponsor|7|||
105873601|NCT02792517|365190317|FG000|Overall Study|Lost to Follow-up|3|||
105873602|NCT00882518|365190318|FG000|Overall Study|Adverse Event|9|||
105873603|NCT00882518|365190319|FG001|Overall Study|Adverse Event|18|||
105873604|NCT00882518|365190318|FG000|Overall Study|Withdrawal by Subject|9|||
105873605|NCT00882518|365190319|FG001|Overall Study|Withdrawal by Subject|13|||
105873606|NCT00882518|365190318|FG000|Overall Study|Lack of Efficacy|12|||
105873607|NCT00882518|365190319|FG001|Overall Study|Lack of Efficacy|9|||
105873608|NCT00882518|365190318|FG000|Overall Study|Severe non-compliance to protocol|3|||
105873609|NCT00882518|365190319|FG001|Overall Study|Severe non-compliance to protocol|1|||
105873610|NCT00882518|365190318|FG000|Overall Study|Incorrect enrolment|4|||
105873611|NCT00882518|365190319|FG001|Overall Study|Incorrect enrolment|2|||
105873612|NCT00882518|365190318|FG000|Overall Study|Central lab closure for National day|1|||
105873613|NCT00882518|365190319|FG001|Overall Study|Central lab closure for National day|0|||
105873614|NCT00882518|365190318|FG000|Overall Study|Allocating random number by mistake|0|||
105873615|NCT00882518|365190319|FG001|Overall Study|Allocating random number by mistake|1|||
105873616|NCT02414958|365190320|FG000|Overall Study|Adverse Event|6|||
105873617|NCT02414958|365190321|FG001|Overall Study|Adverse Event|6|||
105873618|NCT02414958|365190322|FG002|Overall Study|Adverse Event|3|||
105873619|NCT02414958|365190320|FG000|Overall Study|Protocol Violation|10|||
105873620|NCT02414958|365190321|FG001|Overall Study|Protocol Violation|3|||
105873621|NCT02414958|365190322|FG002|Overall Study|Protocol Violation|1|||
105873622|NCT02414958|365190320|FG000|Overall Study|Lost to Follow-up|7|||
105873623|NCT02414958|365190321|FG001|Overall Study|Lost to Follow-up|4|||
105873624|NCT02414958|365190322|FG002|Overall Study|Lost to Follow-up|0|||
105873625|NCT02414958|365190320|FG000|Overall Study|Withdrawal by Subject|5|||
105873626|NCT02414958|365190321|FG001|Overall Study|Withdrawal by Subject|3|||
105873627|NCT02414958|365190322|FG002|Overall Study|Withdrawal by Subject|5|||
105873628|NCT02414958|365190320|FG000|Overall Study|Other than specified|4|||
105873629|NCT02414958|365190321|FG001|Overall Study|Other than specified|4|||
105873630|NCT02414958|365190322|FG002|Overall Study|Other than specified|5|||
105873631|NCT02059135|365190323|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
105873632|NCT02059135|365190324|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
105873633|NCT02059135|365190323|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
105873634|NCT02059135|365190324|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
105873635|NCT02059135|365190323|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
105873636|NCT02059135|365190324|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
105873637|NCT02059135|365190323|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
105873638|NCT02059135|365190324|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
105873639|NCT02059135|365190323|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
105873640|NCT02059135|365190324|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
105873641|NCT02059135|365190323|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
105873642|NCT02059135|365190324|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
105873643|NCT02059135|365190323|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
105873644|NCT02059135|365190324|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
105873645|NCT02059135|365190323|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
105873646|NCT02059135|365190324|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
105873647|NCT03335475|365190325|FG000|Overall Study|Did not wear accelerometer|4|||
105873648|NCT03335475|365190326|FG001|Overall Study|Did not wear accelerometer|0|||
105873649|NCT03335475|365190325|FG000|Overall Study|Withdrawal by Subject|0|||
105873650|NCT03335475|365190326|FG001|Overall Study|Withdrawal by Subject|1|||
105873651|NCT04620746|365190327|FG000|Overall Study|Adverse Event|2|||
105873652|NCT04620746|365190328|FG001|Overall Study|Adverse Event|0|||
105873653|NCT04620746|365190327|FG000|Overall Study|Uniterpretable skin test|1|||
105873654|NCT04620746|365190328|FG001|Overall Study|Uniterpretable skin test|0|||
105873655|NCT04620746|365190327|FG000|Overall Study|Withdrawal by Subject|0|||
105873656|NCT04620746|365190328|FG001|Overall Study|Withdrawal by Subject|1|||
105873657|NCT00789854|365190329|FG000|Overall Study|Adverse Event|28|||
105873658|NCT00789854|365190330|FG001|Overall Study|Adverse Event|23|||
105873659|NCT00789854|365190331|FG002|Overall Study|Adverse Event|18|||
105873660|NCT00789854|365190329|FG000|Overall Study|Lost to Follow-up|1|||
105873661|NCT00789854|365190330|FG001|Overall Study|Lost to Follow-up|1|||
105873662|NCT00789854|365190331|FG002|Overall Study|Lost to Follow-up|4|||
105873663|NCT00789854|365190329|FG000|Overall Study|Withdrawal by Subject|9|||
105873664|NCT00789854|365190330|FG001|Overall Study|Withdrawal by Subject|6|||
105873665|NCT00789854|365190331|FG002|Overall Study|Withdrawal by Subject|17|||
105873666|NCT00789854|365190329|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
105873667|NCT00789854|365190330|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
105873668|NCT00789854|365190331|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
105873669|NCT00789854|365190329|FG000|Overall Study|Severe non-compliance to the protocol|3|||
105873670|NCT00789854|365190330|FG001|Overall Study|Severe non-compliance to the protocol|0|||
105873671|NCT00789854|365190331|FG002|Overall Study|Severe non-compliance to the protocol|0|||
105873672|NCT00789854|365190329|FG000|Overall Study|Safety reasons|0|||
105873673|NCT00789854|365190330|FG001|Overall Study|Safety reasons|0|||
105873674|NCT00789854|365190331|FG002|Overall Study|Safety reasons|2|||
105873675|NCT00789854|365190329|FG000|Overall Study|Other|6|||
105873676|NCT00789854|365190330|FG001|Overall Study|Other|0|||
105873677|NCT00789854|365190331|FG002|Overall Study|Other|5|||
105873678|NCT03411863|365190332|FG000|Overall Study|Withdrawal by Subject|3|||
105873679|NCT03411863|365190333|FG001|Overall Study|Withdrawal by Subject|1|||
105873680|NCT03411863|365190332|FG000|Overall Study|Physician Decision|0|||
105873681|NCT03411863|365190333|FG001|Overall Study|Physician Decision|1|||
105873682|NCT04578535|365190334|FG000|Overall Study|Lost to Follow-up|1|||
105873683|NCT04578535|365190335|FG001|Overall Study|Lost to Follow-up|0|||
105873684|NCT04578535|365190336|FG002|Overall Study|Lost to Follow-up|0|||
105873685|NCT04578535|365190337|FG003|Overall Study|Lost to Follow-up|1|||
105873686|NCT04578535|365190338|FG004|Overall Study|Lost to Follow-up|0|||
105873687|NCT04578535|365190339|FG005|Overall Study|Lost to Follow-up|2|||
105873688|NCT04578535|365190334|FG000|Overall Study|Pregnancy|1|||
105873689|NCT04578535|365190335|FG001|Overall Study|Pregnancy|0|||
105873690|NCT04578535|365190336|FG002|Overall Study|Pregnancy|0|||
105873691|NCT04578535|365190337|FG003|Overall Study|Pregnancy|0|||
105873692|NCT04578535|365190338|FG004|Overall Study|Pregnancy|0|||
105873693|NCT04578535|365190339|FG005|Overall Study|Pregnancy|0|||
105873694|NCT04578535|365190334|FG000|Overall Study|Withdrawal by Subject|0|||
105873695|NCT04578535|365190335|FG001|Overall Study|Withdrawal by Subject|0|||
105873696|NCT04578535|365190336|FG002|Overall Study|Withdrawal by Subject|0|||
105873697|NCT04578535|365190337|FG003|Overall Study|Withdrawal by Subject|1|||
105873698|NCT04578535|365190338|FG004|Overall Study|Withdrawal by Subject|1|||
105873699|NCT04578535|365190339|FG005|Overall Study|Withdrawal by Subject|5|||
105873700|NCT04578535|365190334|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
105873701|NCT04578535|365190335|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
105873702|NCT04578535|365190336|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
105873703|NCT04578535|365190337|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
105873704|NCT04578535|365190338|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
105873705|NCT04578535|365190339|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
105873706|NCT05317312|365190340|FG000|Overall Study|Withdrawal by Subject|0|||
105873707|NCT05317312|365190341|FG001|Overall Study|Withdrawal by Subject|1|||
105873708|NCT05317312|365190342|FG002|Overall Study|Withdrawal by Subject|0|||
105873709|NCT05317312|365190343|FG003|Overall Study|Withdrawal by Subject|0|||
105873710|NCT05317312|365190340|FG000|Overall Study|Lost to Follow-up|0|||
105873711|NCT05317312|365190341|FG001|Overall Study|Lost to Follow-up|0|||
105873712|NCT05317312|365190342|FG002|Overall Study|Lost to Follow-up|0|||
105873713|NCT05317312|365190343|FG003|Overall Study|Lost to Follow-up|1|||
105873714|NCT05317312|365190340|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
105873715|NCT05317312|365190341|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
105873716|NCT05317312|365190342|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
105873717|NCT05317312|365190343|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
105873718|NCT03839628|365190344|FG000|Overall Study|Withdrawal by Subject|1|||
105873719|NCT03164551|365190345|FG000|Overall Study|Imaging discontinued prior completion|8|||
105873720|NCT03164551|365190346|FG001|Overall Study|Imaging discontinued prior completion|0|||
105873721|NCT03164551|365190345|FG000|Overall Study|Participant was non-compliant|1|||
105873722|NCT03164551|365190346|FG001|Overall Study|Participant was non-compliant|0|||
105873723|NCT03164551|365190345|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
105873724|NCT03164551|365190346|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
105873725|NCT03164551|365190345|FG000|Overall Study|Other|8|||
105873726|NCT03164551|365190346|FG001|Overall Study|Other|2|||
105873727|NCT02314026|365190353|FG000|Overall Study|Protocol Violation|28|||
105873728|NCT04421131|365190354|FG000|Overall Study|Lost to Follow-up|1|||
105873729|NCT04421131|365190354|FG000|Overall Study|Protocol Violation|2|||
105873730|NCT04421131|365190354|FG000|Overall Study|App crashed|5|||
105873731|NCT01532934|365190356|FG000|Overall Study|Lost to Follow-up|11|||
105873732|NCT01532934|365190357|FG001|Overall Study|Lost to Follow-up|11|||
105873733|NCT01532934|365190356|FG000|Overall Study|In controlled environment|3|||
105873734|NCT01532934|365190357|FG001|Overall Study|In controlled environment|2|||
105873735|NCT00729937|365190358|FG000|Overall Study|Lost to Follow-up|49|||
105873736|NCT00729937|365190359|FG001|Overall Study|Lost to Follow-up|58|||
105873737|NCT00729937|365190360|FG002|Overall Study|Lost to Follow-up|18|||
105873738|NCT00729937|365190361|FG003|Overall Study|Lost to Follow-up|33|||
105873739|NCT00729937|365190362|FG004|Overall Study|Lost to Follow-up|18|||
105873740|NCT00729937|365190363|FG005|Overall Study|Lost to Follow-up|23|||
105873741|NCT00729937|365190358|FG000|Overall Study|Physician Decision|7|||
105873742|NCT00729937|365190359|FG001|Overall Study|Physician Decision|16|||
105873743|NCT00729937|365190360|FG002|Overall Study|Physician Decision|2|||
105873744|NCT00729937|365190361|FG003|Overall Study|Physician Decision|0|||
105873745|NCT00729937|365190362|FG004|Overall Study|Physician Decision|5|||
105873746|NCT00729937|365190363|FG005|Overall Study|Physician Decision|8|||
105873747|NCT00729937|365190358|FG000|Overall Study|Death|1|||
105873748|NCT00729937|365190359|FG001|Overall Study|Death|0|||
105873749|NCT00729937|365190360|FG002|Overall Study|Death|1|||
105873750|NCT00729937|365190361|FG003|Overall Study|Death|0|||
105873751|NCT00729937|365190362|FG004|Overall Study|Death|0|||
105873752|NCT00729937|365190363|FG005|Overall Study|Death|1|||
105873753|NCT00729937|365190358|FG000|Overall Study|Withdrawal by Subject|3|||
105873754|NCT00729937|365190359|FG001|Overall Study|Withdrawal by Subject|5|||
105873755|NCT00729937|365190360|FG002|Overall Study|Withdrawal by Subject|6|||
105873756|NCT00729937|365190361|FG003|Overall Study|Withdrawal by Subject|0|||
105873757|NCT00729937|365190362|FG004|Overall Study|Withdrawal by Subject|4|||
105873758|NCT00729937|365190363|FG005|Overall Study|Withdrawal by Subject|2|||
105873759|NCT00729937|365190358|FG000|Overall Study|Randomized but not treated|12|||
105873760|NCT00729937|365190359|FG001|Overall Study|Randomized but not treated|6|||
105873761|NCT00729937|365190360|FG002|Overall Study|Randomized but not treated|1|||
105873762|NCT00729937|365190361|FG003|Overall Study|Randomized but not treated|0|||
105873763|NCT00729937|365190362|FG004|Overall Study|Randomized but not treated|1|||
105873764|NCT00729937|365190363|FG005|Overall Study|Randomized but not treated|3|||
105873765|NCT00729937|365190358|FG000|Overall Study|Did not meet eligibility criteria|2|||
105873766|NCT00729937|365190359|FG001|Overall Study|Did not meet eligibility criteria|1|||
105873767|NCT00729937|365190360|FG002|Overall Study|Did not meet eligibility criteria|0|||
105873768|NCT00729937|365190361|FG003|Overall Study|Did not meet eligibility criteria|0|||
105873769|NCT00729937|365190362|FG004|Overall Study|Did not meet eligibility criteria|0|||
105873770|NCT00729937|365190363|FG005|Overall Study|Did not meet eligibility criteria|0|||
105873771|NCT00729937|365190358|FG000|Overall Study|Incarcerated|0|||
105873772|NCT00729937|365190359|FG001|Overall Study|Incarcerated|2|||
105873773|NCT00729937|365190360|FG002|Overall Study|Incarcerated|1|||
105873774|NCT00729937|365190361|FG003|Overall Study|Incarcerated|1|||
105873775|NCT00729937|365190362|FG004|Overall Study|Incarcerated|0|||
105873776|NCT00729937|365190363|FG005|Overall Study|Incarcerated|0|||
105873777|NCT01522456|365190364|FG000|Overall Study|Adverse Event|2|||
105873778|NCT01522456|365190364|FG000|Overall Study|Lost to Follow-up|2|||
105873779|NCT01522456|365190364|FG000|Overall Study|Withdrawal by Subject|2|||
105873780|NCT01522456|365190364|FG000|Overall Study|Pregnancy|1|||
105873781|NCT01522456|365190364|FG000|Overall Study|Tolerability Assessment|1|||
105873782|NCT01406574|365190365|FG000|Overall Study|Adverse Event|0|||
105873783|NCT01406574|365190366|FG001|Overall Study|Adverse Event|0|||
105873784|NCT01406574|365190367|FG002|Overall Study|Adverse Event|1|||
105873785|NCT01406574|365190368|FG003|Overall Study|Adverse Event|3|||
105873786|NCT01406574|365190365|FG000|Overall Study|Physician Decision|0|||
105873787|NCT01406574|365190366|FG001|Overall Study|Physician Decision|0|||
105873788|NCT01406574|365190367|FG002|Overall Study|Physician Decision|0|||
105873789|NCT01406574|365190368|FG003|Overall Study|Physician Decision|1|||
105873790|NCT01406574|365190365|FG000|Overall Study|Withdrawal by Subject|0|||
105873791|NCT01406574|365190366|FG001|Overall Study|Withdrawal by Subject|1|||
105873792|NCT01406574|365190367|FG002|Overall Study|Withdrawal by Subject|0|||
105873793|NCT01406574|365190368|FG003|Overall Study|Withdrawal by Subject|0|||
105873794|NCT01406574|365190365|FG000|Overall Study|Definite progression of primary disease|1|||
105873795|NCT01406574|365190366|FG001|Overall Study|Definite progression of primary disease|0|||
105873796|NCT01406574|365190367|FG002|Overall Study|Definite progression of primary disease|0|||
105873797|NCT01406574|365190368|FG003|Overall Study|Definite progression of primary disease|0|||
105873798|NCT03552380|365190369|FG000|Study Treatment|Disease Progression|3|||
105873799|NCT03552380|365190370|FG001|Study Treatment|Disease Progression|4|||
105873800|NCT03552380|365190369|FG000|Study Treatment|Adverse Event|2|||
105873801|NCT03552380|365190370|FG001|Study Treatment|Adverse Event|2|||
105873802|NCT03552380|365190369|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
105659509|NCT02635386|364417349|FG002|Overall Study|side effects|1|||
105873803|NCT03552380|365190370|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
105873804|NCT03552380|365190369|FG000|Follow up|Death|3|||
105873805|NCT03552380|365190370|FG001|Follow up|Death|4|||
105873806|NCT03552380|365190369|FG000|Follow up|Site IRB terminated|0|||
105873807|NCT03552380|365190370|FG001|Follow up|Site IRB terminated|1|||
105873808|NCT00916383|365190375|FG000|Overall Study|Adverse Event|1|||
105873809|NCT00916383|365190375|FG000|Overall Study|Death|1|||
105873810|NCT00916383|365190375|FG000|Overall Study|Protocol Violation|1|||
105873811|NCT03367819|365190378|FG000|Overall Study|Adverse Event|4|||
105873812|NCT03367819|365190379|FG001|Overall Study|Adverse Event|4|||
105873813|NCT03367819|365190378|FG000|Overall Study|Progressive Disease|15|||
105873814|NCT03367819|365190379|FG001|Overall Study|Progressive Disease|13|||
105873815|NCT03367819|365190378|FG000|Overall Study|Withdrawal by Subject|1|||
105873816|NCT03367819|365190379|FG001|Overall Study|Withdrawal by Subject|0|||
105873817|NCT03367819|365190378|FG000|Overall Study|Other|4|||
105873818|NCT03367819|365190379|FG001|Overall Study|Other|2|||
105873819|NCT01565889|365190381|FG000|Part A|Withdrawal by Subject|1|||
105873820|NCT01565889|365190382|FG001|Part A|Withdrawal by Subject|0|||
105873821|NCT01565889|365190383|FG002|Part A|Withdrawal by Subject|0|||
105873822|NCT01565889|365190384|FG003|Part A|Withdrawal by Subject|0|||
105873823|NCT01565889|365190385|FG004|Part A|Withdrawal by Subject|0|||
105873824|NCT01565889|365190386|FG005|Part A|Withdrawal by Subject|0|||
105873825|NCT01565889|365190381|FG000|Part B|Withdrawal by Subject|0|||
105873826|NCT01565889|365190382|FG001|Part B|Withdrawal by Subject|0|||
105873827|NCT01565889|365190383|FG002|Part B|Withdrawal by Subject|0|||
105873828|NCT01565889|365190384|FG003|Part B|Withdrawal by Subject|0|||
105873829|NCT01565889|365190385|FG004|Part B|Withdrawal by Subject|0|||
105873830|NCT01565889|365190386|FG005|Part B|Withdrawal by Subject|1|||
105873831|NCT01565889|365190381|FG000|Part B|Lack of Efficacy|0|||
105873832|NCT01565889|365190382|FG001|Part B|Lack of Efficacy|0|||
105873833|NCT01565889|365190383|FG002|Part B|Lack of Efficacy|0|||
105873834|NCT01565889|365190384|FG003|Part B|Lack of Efficacy|0|||
105873835|NCT01565889|365190385|FG004|Part B|Lack of Efficacy|0|||
105873836|NCT01565889|365190386|FG005|Part B|Lack of Efficacy|2|||
105873837|NCT01565889|365190381|FG000|Part B|Lost to Follow-up|0|||
105873838|NCT01565889|365190382|FG001|Part B|Lost to Follow-up|0|||
105873839|NCT01565889|365190383|FG002|Part B|Lost to Follow-up|0|||
105873840|NCT01565889|365190384|FG003|Part B|Lost to Follow-up|0|||
105873841|NCT01565889|365190385|FG004|Part B|Lost to Follow-up|0|||
105873842|NCT01565889|365190386|FG005|Part B|Lost to Follow-up|1|||
105873843|NCT02524847|365190390|FG000|Overall Study|Adverse Event|4|||
105873844|NCT02524847|365190390|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
105873845|NCT02524847|365190390|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
105873846|NCT02524847|365190390|FG000|Overall Study|Death|1|||
105873847|NCT02524847|365190390|FG000|Overall Study|Reason not Specified|1|||
105873848|NCT04352101|365190391|FG000|Overall Study|Physician Decision|2|||
105873849|NCT04352101|365190392|FG001|Overall Study|Physician Decision|1|||
105873850|NCT00725920|365190393|FG000|Overall Study|Lack of Efficacy|3|||
105873851|NCT00725920|365190394|FG001|Overall Study|Lack of Efficacy|6|||
105873852|NCT03918629|365190398|FG000|Overall Study|Adverse Event|19|||
105873853|NCT03918629|365190399|FG001|Overall Study|Adverse Event|20|||
105873854|NCT03918629|365190398|FG000|Overall Study|Death|14|||
105873855|NCT03918629|365190399|FG001|Overall Study|Death|7|||
105873856|NCT03918629|365190398|FG000|Overall Study|Lost to Follow-up|36|||
105873857|NCT03918629|365190399|FG001|Overall Study|Lost to Follow-up|28|||
105873858|NCT03918629|365190398|FG000|Overall Study|Physician Decision|1|||
105873859|NCT03918629|365190399|FG001|Overall Study|Physician Decision|0|||
105873860|NCT03918629|365190398|FG000|Overall Study|Protocol Violation|7|||
105873861|NCT03918629|365190399|FG001|Overall Study|Protocol Violation|4|||
105873862|NCT03918629|365190398|FG000|Overall Study|Withdrawal by Subject|47|||
105873863|NCT03918629|365190399|FG001|Overall Study|Withdrawal by Subject|47|||
105873864|NCT03918629|365190398|FG000|Overall Study|Other|7|||
105873865|NCT03918629|365190399|FG001|Overall Study|Other|11|||
105873866|NCT03918629|365190398|FG000|Overall Study|Randomized but not vaccinated|2|||
105873867|NCT03918629|365190399|FG001|Overall Study|Randomized but not vaccinated|1|||
105873868|NCT01709500|365190401|FG000|Overall Study|Randomized but not treated|0|||
105873869|NCT01709500|365190402|FG001|Overall Study|Randomized but not treated|1|||
105873870|NCT01709500|365190401|FG000|Overall Study|Adverse Event|5|||
105873871|NCT01709500|365190402|FG001|Overall Study|Adverse Event|1|||
105873872|NCT01709500|365190401|FG000|Overall Study|Poor compliance to protocol|2|||
105873873|NCT01709500|365190402|FG001|Overall Study|Poor compliance to protocol|1|||
105873874|NCT01709500|365190401|FG000|Overall Study|Other|3|||
105873875|NCT01709500|365190402|FG001|Overall Study|Other|1|||
105873876|NCT01709500|365190401|FG000|Overall Study|Related to IMP administration|1|||
105873877|NCT01709500|365190402|FG001|Overall Study|Related to IMP administration|0|||
105873878|NCT01709500|365190401|FG000|Overall Study|Treatment ongoing|156|||
105873879|NCT01709500|365190402|FG001|Overall Study|Treatment ongoing|78|||
105873880|NCT04720105|365190405|FG000|Overall Study|Lack of Efficacy|1|||
105873881|NCT04720105|365190405|FG000|Overall Study|Lost to Follow-up|1|||
105873882|NCT04720105|365190405|FG000|Overall Study|Withdrawal by Subject|3|||
105873883|NCT00740636|365190408|FG000|Overall Study|Adverse Event|0|||
105873884|NCT00740636|365190409|FG001|Overall Study|Adverse Event|2|||
105873885|NCT00740636|365190408|FG000|Overall Study|Patient Ineligible|0|||
105873886|NCT00740636|365190409|FG001|Overall Study|Patient Ineligible|1|||
105873887|NCT00740636|365190408|FG000|Overall Study|Patient Not Treated|0|||
105873888|NCT00740636|365190409|FG001|Overall Study|Patient Not Treated|1|||
105873889|NCT00740636|365190408|FG000|Overall Study|Progressive Disease|1|||
105873890|NCT00740636|365190409|FG001|Overall Study|Progressive Disease|0|||
105873891|NCT00740636|365190408|FG000|Overall Study|Death|1|||
105873892|NCT00740636|365190409|FG001|Overall Study|Death|0|||
105873893|NCT03539302|365190410|FG000|Overall Study|Spontaneous cardio version|0|||
105873894|NCT03539302|365190411|FG001|Overall Study|Spontaneous cardio version|0|||
105873895|NCT03539302|365190412|FG002|Overall Study|Spontaneous cardio version|0|||
105873896|NCT03539302|365190413|FG003|Overall Study|Spontaneous cardio version|0|||
105873897|NCT03539302|365190414|FG004|Overall Study|Spontaneous cardio version|0|||
105873898|NCT03539302|365190415|FG005|Overall Study|Spontaneous cardio version|1|||
105873899|NCT03539302|365190416|FG006|Overall Study|Spontaneous cardio version|1|||
105873900|NCT00349973|365190422|FG000|Overall Study|Adverse Event|3|||
105873901|NCT00349973|365190423|FG001|Overall Study|Adverse Event|3|||
105873902|NCT00349973|365190422|FG000|Overall Study|Withdrawal by Subject|1|||
105873903|NCT00349973|365190423|FG001|Overall Study|Withdrawal by Subject|0|||
105873904|NCT00071110|365190425|FG000|Overall Study|Protocol Violation|0|||
105873905|NCT00071110|365190426|FG001|Overall Study|Protocol Violation|4|||
105873906|NCT04135937|365190427|FG000|Overall Study|Lost to Follow-up|2|||
105873907|NCT04135937|365190427|FG000|Overall Study|Withdrawal by Subject|1|||
105873908|NCT00273182|365190428|FG000|Overall Study|Death|450|||
105873909|NCT00273182|365190428|FG000|Overall Study|Lost to Follow-up|88|||
105873910|NCT00273182|365190428|FG000|Overall Study|Withdrawal by Subject|257|||
105873911|NCT00273182|365190428|FG000|Overall Study|Device/System Explant|154|||
105873912|NCT00273182|365190428|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
105873913|NCT03805412|365190431|FG000|Overall Study|Lost to Follow-up|0|||
105873914|NCT03805412|365190432|FG001|Overall Study|Lost to Follow-up|1|||
105873915|NCT03832686|365190433|FG000|Overall Study|Lost to Follow-up|6|||
105873916|NCT03832686|365190434|FG001|Overall Study|Lost to Follow-up|9|||
105873917|NCT03832686|365190433|FG000|Overall Study|Discontinued Intervention|5|||
105873918|NCT03832686|365190434|FG001|Overall Study|Discontinued Intervention|4|||
105873919|NCT04447027|365190435|FG000|Dose Escalation|Withdrawal by Subject|1|||
105873920|NCT04447027|365190436|FG001|Dose Escalation|Withdrawal by Subject|4|||
105873921|NCT04447027|365190437|FG002|Dose Escalation|Withdrawal by Subject|3|||
105873922|NCT04447027|365190438|FG003|Dose Escalation|Withdrawal by Subject|3|||
105873923|NCT04447027|365190439|FG004|Dose Escalation|Withdrawal by Subject|1|||
105873924|NCT04447027|365190440|FG005|Dose Escalation|Withdrawal by Subject|0|||
105873925|NCT04447027|365190441|FG006|Dose Escalation|Withdrawal by Subject|0|||
105873926|NCT04447027|365190442|FG007|Dose Escalation|Withdrawal by Subject|0|||
105873927|NCT04447027|365190443|FG008|Dose Escalation|Withdrawal by Subject|0|||
105873928|NCT04447027|365190435|FG000|Dose Escalation|Refused further treatment|0|||
105873929|NCT04447027|365190436|FG001|Dose Escalation|Refused further treatment|1|||
105873930|NCT04447027|365190437|FG002|Dose Escalation|Refused further treatment|1|||
105873931|NCT04447027|365190438|FG003|Dose Escalation|Refused further treatment|0|||
105873932|NCT04447027|365190439|FG004|Dose Escalation|Refused further treatment|0|||
105873933|NCT04447027|365190440|FG005|Dose Escalation|Refused further treatment|0|||
105873934|NCT04447027|365190441|FG006|Dose Escalation|Refused further treatment|0|||
105873935|NCT04447027|365190442|FG007|Dose Escalation|Refused further treatment|0|||
105873936|NCT04447027|365190443|FG008|Dose Escalation|Refused further treatment|0|||
105873937|NCT04447027|365190435|FG000|Dose Expansion|Withdrawal by Subject|0|||
105873938|NCT04447027|365190436|FG001|Dose Expansion|Withdrawal by Subject|0|||
105873939|NCT04447027|365190437|FG002|Dose Expansion|Withdrawal by Subject|0|||
105873940|NCT04447027|365190438|FG003|Dose Expansion|Withdrawal by Subject|0|||
105873941|NCT04447027|365190439|FG004|Dose Expansion|Withdrawal by Subject|0|||
105873942|NCT04447027|365190440|FG005|Dose Expansion|Withdrawal by Subject|2|||
105873943|NCT04447027|365190441|FG006|Dose Expansion|Withdrawal by Subject|0|||
105873944|NCT04447027|365190442|FG007|Dose Expansion|Withdrawal by Subject|2|||
105873945|NCT04447027|365190443|FG008|Dose Expansion|Withdrawal by Subject|0|||
105873946|NCT02235454|365190444|FG000|Overall Study|Withdrawal by Subject|2|||
105873947|NCT01622673|365190445|FG000|Treatment Period 1|Withdrawal by Subject|0|||
105873948|NCT01622673|365190446|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105873949|NCT01622673|365190447|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105873950|NCT01622673|365190448|FG003|Treatment Period 1|Withdrawal by Subject|1|||
105873951|NCT01622673|365190449|FG004|Treatment Period 1|Withdrawal by Subject|0|||
105873952|NCT01622673|365190450|FG005|Treatment Period 1|Withdrawal by Subject|0|||
105873953|NCT01622673|365190445|FG000|Treatment Period 1|Protocol Violation|0|||
105873954|NCT01622673|365190446|FG001|Treatment Period 1|Protocol Violation|1|||
105873955|NCT01622673|365190447|FG002|Treatment Period 1|Protocol Violation|0|||
105873956|NCT01622673|365190448|FG003|Treatment Period 1|Protocol Violation|0|||
105873957|NCT01622673|365190449|FG004|Treatment Period 1|Protocol Violation|0|||
105873958|NCT01622673|365190450|FG005|Treatment Period 1|Protocol Violation|0|||
105873959|NCT01622673|365190445|FG000|Treatment Period 2|Withdrawal by Subject|0|||
105873960|NCT01622673|365190446|FG001|Treatment Period 2|Withdrawal by Subject|0|||
105873961|NCT01622673|365190447|FG002|Treatment Period 2|Withdrawal by Subject|0|||
105873962|NCT01622673|365190448|FG003|Treatment Period 2|Withdrawal by Subject|1|||
105873963|NCT01622673|365190449|FG004|Treatment Period 2|Withdrawal by Subject|0|||
105873964|NCT01622673|365190450|FG005|Treatment Period 2|Withdrawal by Subject|0|||
105873965|NCT01622673|365190445|FG000|Treatment Period 3|Protocol Violation|0|||
105873966|NCT01622673|365190446|FG001|Treatment Period 3|Protocol Violation|1|||
105873967|NCT01622673|365190447|FG002|Treatment Period 3|Protocol Violation|0|||
105873968|NCT01622673|365190448|FG003|Treatment Period 3|Protocol Violation|0|||
105873969|NCT01622673|365190449|FG004|Treatment Period 3|Protocol Violation|0|||
105873970|NCT01622673|365190450|FG005|Treatment Period 3|Protocol Violation|0|||
105873971|NCT03641469|365190451|FG000|Overall Study|Ineligible|2|||
105873972|NCT03641469|365190451|FG000|Overall Study|Withdrawal by Subject|5|||
105873973|NCT03641469|365190451|FG000|Overall Study|Physician Decision|1|||
105873974|NCT03641469|365190451|FG000|Overall Study|Protocol Violation|1|||
105873975|NCT03641469|365190451|FG000|Overall Study|Lost to Follow-up|2|||
105873976|NCT05479435|365190452|FG000|Overall Study|Withdrawal by Subject|1|||
105873977|NCT05479435|365190453|FG001|Overall Study|Withdrawal by Subject|0|||
105873978|NCT05479435|365190454|FG002|Overall Study|Withdrawal by Subject|0|||
105873979|NCT05479435|365190452|FG000|Overall Study|Covid 19|0|||
105873980|NCT05479435|365190453|FG001|Overall Study|Covid 19|0|||
105873981|NCT05479435|365190454|FG002|Overall Study|Covid 19|2|||
105873982|NCT00868530|365190455|FG000|Overall Study|Adverse Event|3|||
105873983|NCT00868530|365190455|FG000|Overall Study|Lost to Follow-up|1|||
105873984|NCT05966584|365190456|FG000|Overall Study|Lost to Follow-up|1|||
105873985|NCT00709995|365192350|FG000|Overall Study|Adverse Event|4|||
105873986|NCT00709995|365192351|FG001|Overall Study|Adverse Event|2|||
105873987|NCT00709995|365192350|FG000|Overall Study|Withdrawal by Subject|1|||
105873988|NCT00709995|365192351|FG001|Overall Study|Withdrawal by Subject|3|||
105873989|NCT00638508|365192359|FG000|Overall Study|Physician Decision|5|||
105873990|NCT00638508|365192360|FG001|Overall Study|Physician Decision|2|||
105873991|NCT03499067|365192361|FG000|First Intervention|Physician Decision|2|||
105873992|NCT03499067|365192362|FG001|First Intervention|Physician Decision|1|||
105873993|NCT03499067|365192361|FG000|First Intervention|Withdrawal by Subject|3|||
105873994|NCT03499067|365192362|FG001|First Intervention|Withdrawal by Subject|6|||
105873995|NCT02222922|365192363|FG000|Overall Study|Death|0|||
105873996|NCT02222922|365192364|FG001|Overall Study|Death|0|||
105873997|NCT02222922|365192365|FG002|Overall Study|Death|0|||
105873998|NCT02222922|365192366|FG003|Overall Study|Death|0|||
105873999|NCT02222922|365192367|FG004|Overall Study|Death|13|||
105874000|NCT02222922|365192368|FG005|Overall Study|Death|0|||
105874001|NCT02222922|365192369|FG006|Overall Study|Death|0|||
105874002|NCT02222922|365192370|FG007|Overall Study|Death|0|||
105874003|NCT02222922|365192371|FG008|Overall Study|Death|2|||
105874004|NCT02222922|365192363|FG000|Overall Study|Lost to Follow-up|0|||
105874005|NCT02222922|365192364|FG001|Overall Study|Lost to Follow-up|0|||
105874006|NCT02222922|365192365|FG002|Overall Study|Lost to Follow-up|1|||
105874007|NCT02222922|365192366|FG003|Overall Study|Lost to Follow-up|0|||
105874008|NCT02222922|365192367|FG004|Overall Study|Lost to Follow-up|9|||
105874009|NCT02222922|365192368|FG005|Overall Study|Lost to Follow-up|1|||
105874010|NCT02222922|365192369|FG006|Overall Study|Lost to Follow-up|0|||
105874011|NCT02222922|365192370|FG007|Overall Study|Lost to Follow-up|0|||
105874012|NCT02222922|365192371|FG008|Overall Study|Lost to Follow-up|0|||
105874013|NCT02222922|365192363|FG000|Overall Study|Other|0|||
105874014|NCT02222922|365192364|FG001|Overall Study|Other|0|||
105874015|NCT02222922|365192365|FG002|Overall Study|Other|0|||
105874016|NCT02222922|365192366|FG003|Overall Study|Other|2|||
105874017|NCT02222922|365192367|FG004|Overall Study|Other|10|||
105874018|NCT02222922|365192368|FG005|Overall Study|Other|2|||
105874019|NCT02222922|365192369|FG006|Overall Study|Other|2|||
105874020|NCT02222922|365192370|FG007|Overall Study|Other|4|||
105874021|NCT02222922|365192371|FG008|Overall Study|Other|1|||
105874022|NCT02222922|365192363|FG000|Overall Study|Participant refused further follow-up|1|||
105874023|NCT02222922|365192364|FG001|Overall Study|Participant refused further follow-up|0|||
105874024|NCT02222922|365192365|FG002|Overall Study|Participant refused further follow-up|0|||
105874025|NCT02222922|365192366|FG003|Overall Study|Participant refused further follow-up|1|||
105874026|NCT02222922|365192367|FG004|Overall Study|Participant refused further follow-up|6|||
105874027|NCT02222922|365192368|FG005|Overall Study|Participant refused further follow-up|0|||
105874028|NCT02222922|365192369|FG006|Overall Study|Participant refused further follow-up|0|||
105874029|NCT02222922|365192370|FG007|Overall Study|Participant refused further follow-up|0|||
105874030|NCT02222922|365192371|FG008|Overall Study|Participant refused further follow-up|3|||
105874031|NCT01254643|365192372|FG000|Overall Study|Withdrawal by Subject|1|||
105874032|NCT03347110|365192373|FG000|Overall Study|Other (Participant is incarcerated)|1|||
105874033|NCT03347110|365192373|FG000|Overall Study|Withdrawal by Subject|9|||
105874034|NCT03347110|365192373|FG000|Overall Study|Lost to Follow-up|1|||
105874035|NCT03347110|365192373|FG000|Overall Study|Lack of Efficacy|2|||
105874036|NCT03347110|365192373|FG000|Overall Study|Adverse Event, non-fatal|9|||
105874037|NCT02105467|365192374|FG000|Period 1|Lost to Follow-up|1|||
105874038|NCT02105467|365192375|FG001|Period 1|Lost to Follow-up|0|||
105874039|NCT02105467|365192374|FG000|Period 1|Death|1|||
105874040|NCT02105467|365192375|FG001|Period 1|Death|0|||
105874041|NCT02105467|365192374|FG000|Period 2|Lost to Follow-up|1|||
105874042|NCT02105467|365192375|FG001|Period 2|Lost to Follow-up|0|||
105874043|NCT02105467|365192374|FG000|Period 2|Death|1|||
105874044|NCT02105467|365192375|FG001|Period 2|Death|0|||
105874045|NCT02105467|365192374|FG000|Period 2|Withdrawal by Subject|0|||
105874046|NCT02105467|365192375|FG001|Period 2|Withdrawal by Subject|2|||
105874047|NCT02105467|365192374|FG000|Period 3|Lost to Follow-up|0|||
105874048|NCT02105467|365192375|FG001|Period 3|Lost to Follow-up|1|||
105874049|NCT01125189|365192383|FG000|Treatment Period|Lack of Efficacy|15|||
105874050|NCT01125189|365192384|FG001|Treatment Period|Lack of Efficacy|18|||
105874051|NCT01125189|365192385|FG002|Treatment Period|Lack of Efficacy|25|||
105874052|NCT01125189|365192383|FG000|Treatment Period|Adverse Event|7|||
105874053|NCT01125189|365192384|FG001|Treatment Period|Adverse Event|8|||
105874054|NCT01125189|365192385|FG002|Treatment Period|Adverse Event|8|||
105874055|NCT01125189|365192383|FG000|Treatment Period|Withdrawal by Subject|3|||
105874056|NCT01125189|365192384|FG001|Treatment Period|Withdrawal by Subject|1|||
105874057|NCT01125189|365192385|FG002|Treatment Period|Withdrawal by Subject|1|||
105874058|NCT01125189|365192383|FG000|Treatment Period|Death|1|||
105874059|NCT01125189|365192384|FG001|Treatment Period|Death|0|||
105874060|NCT01125189|365192385|FG002|Treatment Period|Death|0|||
105874061|NCT01125189|365192383|FG000|Treatment Period|Lost to Follow-up|1|||
105874062|NCT01125189|365192384|FG001|Treatment Period|Lost to Follow-up|2|||
105874063|NCT01125189|365192385|FG002|Treatment Period|Lost to Follow-up|1|||
105874064|NCT01125189|365192383|FG000|Treatment Period|Poor compliance/noncompliance|0|||
105874065|NCT01125189|365192384|FG001|Treatment Period|Poor compliance/noncompliance|1|||
105874066|NCT01125189|365192385|FG002|Treatment Period|Poor compliance/noncompliance|0|||
105874067|NCT01125189|365192383|FG000|Treatment Period|Participants requested to discontinue|1|||
105874068|NCT01125189|365192384|FG001|Treatment Period|Participants requested to discontinue|3|||
105874069|NCT01125189|365192385|FG002|Treatment Period|Participants requested to discontinue|4|||
105874070|NCT01125189|365192383|FG000|Treatment Period|Other reasons|1|||
105874071|NCT01125189|365192384|FG001|Treatment Period|Other reasons|1|||
105874072|NCT01125189|365192385|FG002|Treatment Period|Other reasons|0|||
105874073|NCT01125189|365192383|FG000|Treatment Period|Completed 24 week treatment period only|2|||
105874074|NCT01125189|365192384|FG001|Treatment Period|Completed 24 week treatment period only|1|||
105874075|NCT01125189|365192385|FG002|Treatment Period|Completed 24 week treatment period only|2|||
105874076|NCT01125189|365192383|FG000|Follow up Period|Withdrawal by Subject|3|||
105874077|NCT01125189|365192384|FG001|Follow up Period|Withdrawal by Subject|2|||
105874078|NCT01125189|365192385|FG002|Follow up Period|Withdrawal by Subject|5|||
105874079|NCT01125189|365192383|FG000|Follow up Period|Death|1|||
105874080|NCT01125189|365192384|FG001|Follow up Period|Death|0|||
105874081|NCT01125189|365192385|FG002|Follow up Period|Death|0|||
105874082|NCT01125189|365192383|FG000|Follow up Period|Lost to Follow-up|12|||
105874083|NCT01125189|365192384|FG001|Follow up Period|Lost to Follow-up|9|||
105874084|NCT01125189|365192385|FG002|Follow up Period|Lost to Follow-up|6|||
105874085|NCT01125189|365192383|FG000|Follow up Period|Other reasons|4|||
105874086|NCT01125189|365192384|FG001|Follow up Period|Other reasons|4|||
105874087|NCT01125189|365192385|FG002|Follow up Period|Other reasons|5|||
105874088|NCT01651117|365192389|FG000|Overall Study|Death|2|||
105874089|NCT01651117|365192390|FG001|Overall Study|Death|3|||
105874090|NCT01651117|365192391|FG002|Overall Study|Death|2|||
105874091|NCT01651117|365192392|FG003|Overall Study|Death|2|||
105874092|NCT02714218|365192395|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105874093|NCT02714218|365192396|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
105874094|NCT02714218|365192397|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
105874095|NCT02714218|365192395|FG000|Pre-Treatment Period|Other reasons|0|||
105874096|NCT02714218|365192396|FG001|Pre-Treatment Period|Other reasons|1|||
105657623|NCT00746356|364409924|FG000|Overall Study|Withdrawal by Subject|2|||
105874097|NCT02714218|365192397|FG002|Pre-Treatment Period|Other reasons|0|||
105874098|NCT02714218|365192395|FG000|Treatment Period|Disease Progression|55|||
105874099|NCT02714218|365192396|FG001|Treatment Period|Disease Progression|52|||
105874100|NCT02714218|365192397|FG002|Treatment Period|Disease Progression|14|||
105874101|NCT02714218|365192395|FG000|Treatment Period|Study drug toxicity|46|||
105874102|NCT02714218|365192396|FG001|Treatment Period|Study drug toxicity|70|||
105874103|NCT02714218|365192397|FG002|Treatment Period|Study drug toxicity|6|||
105874104|NCT02714218|365192395|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
105874105|NCT02714218|365192396|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
105657624|NCT00746356|364409925|FG001|Overall Study|Withdrawal by Subject|3|||
105874106|NCT02714218|365192397|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
105874107|NCT02714218|365192395|FG000|Treatment Period|Request to discontinue treatment|1|||
105874108|NCT02714218|365192396|FG001|Treatment Period|Request to discontinue treatment|4|||
105874109|NCT02714218|365192397|FG002|Treatment Period|Request to discontinue treatment|1|||
105657625|NCT00746356|364409924|FG000|Overall Study|Death|7|||
105874110|NCT02714218|365192395|FG000|Treatment Period|Participant withdrew consent|2|||
105874111|NCT02714218|365192396|FG001|Treatment Period|Participant withdrew consent|2|||
105874112|NCT02714218|365192397|FG002|Treatment Period|Participant withdrew consent|0|||
105874113|NCT02714218|365192395|FG000|Treatment Period|Maximum clinical benefit|4|||
105874114|NCT02714218|365192396|FG001|Treatment Period|Maximum clinical benefit|2|||
105874115|NCT02714218|365192397|FG002|Treatment Period|Maximum clinical benefit|0|||
105874116|NCT02714218|365192395|FG000|Treatment Period|Administrative reason by sponsor|2|||
105874117|NCT02714218|365192396|FG001|Treatment Period|Administrative reason by sponsor|1|||
105874118|NCT02714218|365192397|FG002|Treatment Period|Administrative reason by sponsor|0|||
105874119|NCT02714218|365192395|FG000|Treatment Period|Other reasons|6|||
105874120|NCT02714218|365192396|FG001|Treatment Period|Other reasons|6|||
105874121|NCT02714218|365192397|FG002|Treatment Period|Other reasons|0|||
105874122|NCT02714218|365192395|FG000|Treatment Period|Completed treatment as per protocol|36|||
105874123|NCT02714218|365192396|FG001|Treatment Period|Completed treatment as per protocol|27|||
105874124|NCT02714218|365192397|FG002|Treatment Period|Completed treatment as per protocol|3|||
105874125|NCT02714218|365192395|FG000|Treatment Period|Not reported|9|||
105874126|NCT02714218|365192396|FG001|Treatment Period|Not reported|6|||
105874127|NCT02714218|365192397|FG002|Treatment Period|Not reported|0|||
105874128|NCT02088177|365192400|FG000|Overall Study|Lost to Follow-up|3|||
105874129|NCT01641640|365192401|FG000|Overall Study|Enrolled but not treated|1|||
105874130|NCT01641640|365192401|FG000|Overall Study|Efficacy failure|29|||
105874131|NCT01641640|365192401|FG000|Overall Study|Lost to Follow-up|3|||
105874132|NCT01641640|365192401|FG000|Overall Study|Withdrawal by Subject|2|||
105874133|NCT01641640|365192401|FG000|Overall Study|Adverse Event|1|||
105874134|NCT00289848|365192406|FG000|Overall Study|Adverse Event|6|||
105874135|NCT00289848|365192407|FG001|Overall Study|Adverse Event|4|||
105874136|NCT00289848|365192406|FG000|Overall Study|Death|1|||
105874137|NCT00289848|365192407|FG001|Overall Study|Death|0|||
105874138|NCT00289848|365192406|FG000|Overall Study|Lack of Efficacy|20|||
105874139|NCT00289848|365192407|FG001|Overall Study|Lack of Efficacy|24|||
105874140|NCT00289848|365192406|FG000|Overall Study|Lost to Follow-up|3|||
105874141|NCT00289848|365192407|FG001|Overall Study|Lost to Follow-up|1|||
105874142|NCT00289848|365192406|FG000|Overall Study|Protocol Violation|5|||
105874143|NCT00289848|365192407|FG001|Overall Study|Protocol Violation|2|||
105874144|NCT00289848|365192406|FG000|Overall Study|Withdrawal by Subject|5|||
105874145|NCT00289848|365192407|FG001|Overall Study|Withdrawal by Subject|11|||
105874146|NCT00289848|365192406|FG000|Overall Study|Patient Moved|6|||
105874147|NCT00289848|365192407|FG001|Overall Study|Patient Moved|2|||
105874148|NCT00289848|365192406|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
105874149|NCT00289848|365192407|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
105874150|NCT01234350|365192408|FG000|Overall Study|Adverse Event|277|||
105874151|NCT01234350|365192409|FG001|Overall Study|Adverse Event|92|||
105874152|NCT01234350|365192408|FG000|Overall Study|Withdrawal by Subject|61|||
105874153|NCT01234350|365192409|FG001|Overall Study|Withdrawal by Subject|36|||
105874154|NCT01234350|365192408|FG000|Overall Study|Lost to Follow-up|115|||
105874155|NCT01234350|365192409|FG001|Overall Study|Lost to Follow-up|47|||
105874156|NCT01234350|365192408|FG000|Overall Study|Covers a diverse set of reasons|234|||
105874157|NCT01234350|365192409|FG001|Overall Study|Covers a diverse set of reasons|92|||
105874158|NCT01778530|365192410|FG000|Overall Study|Progression on study|1|||
105874159|NCT01778530|365192410|FG000|Overall Study|Adverse event/side effect|1|||
105874160|NCT01199939|365192411|FG000|Overall Study|Adverse Event|4|||
105874161|NCT01199939|365192411|FG000|Overall Study|Protocol Violation|3|||
105874162|NCT01199939|365192411|FG000|Overall Study|Lost to Follow-up|2|||
105874163|NCT01199939|365192411|FG000|Overall Study|Reached a virologic endpoint|4|||
105874164|NCT00811733|365192414|FG000|Overall Study|Investigator Discretion|10|||
105874165|NCT00811733|365192415|FG001|Overall Study|Investigator Discretion|8|||
105874166|NCT00811733|365192414|FG000|Overall Study|Withdrawal by Subject|1|||
105874167|NCT00811733|365192415|FG001|Overall Study|Withdrawal by Subject|2|||
105874168|NCT00793871|365192417|FG000|Overall Study|Death|50|||
105874169|NCT00793871|365192417|FG000|Overall Study|Lost to Follow-up|3|||
105874170|NCT00793871|365192417|FG000|Overall Study|Study terminated by the Sponsor|7|||
105874171|NCT02500589|365192418|FG000|Overall Study|Withdrawal by Subject|11|||
105874172|NCT02500589|365192419|FG001|Overall Study|Withdrawal by Subject|14|||
105874173|NCT02500589|365192418|FG000|Overall Study|Lost to Follow-up|10|||
105874174|NCT02500589|365192419|FG001|Overall Study|Lost to Follow-up|12|||
105874175|NCT02500589|365192418|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
105874176|NCT02500589|365192419|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
105874177|NCT02500589|365192418|FG000|Overall Study|Death|7|||
105874178|NCT02500589|365192419|FG001|Overall Study|Death|5|||
105874179|NCT04341363|365192421|FG000|Overall Study|Adverse Event|1|||
105874180|NCT04341363|365192421|FG000|Overall Study|Withdrawal by Subject|1|||
105874181|NCT03652051|365192422|FG000|Stage 1|Adverse Event|0|||
105874182|NCT03652051|365192423|FG001|Stage 1|Adverse Event|5|||
105874183|NCT03652051|365192424|FG002|Stage 1|Adverse Event|7|||
105874184|NCT03652051|365192425|FG003|Stage 1|Adverse Event|1|||
105874185|NCT03652051|365192422|FG000|Stage 1|Withdrawal by Subject|0|||
105874186|NCT03652051|365192423|FG001|Stage 1|Withdrawal by Subject|0|||
105874187|NCT03652051|365192424|FG002|Stage 1|Withdrawal by Subject|1|||
105874188|NCT03652051|365192425|FG003|Stage 1|Withdrawal by Subject|0|||
105874189|NCT03652051|365192422|FG000|Stage 2|Adverse Event|0|||
105874190|NCT03652051|365192423|FG001|Stage 2|Adverse Event|2|||
105874191|NCT03652051|365192424|FG002|Stage 2|Adverse Event|1|||
105874192|NCT03652051|365192425|FG003|Stage 2|Adverse Event|0|||
105874193|NCT03652051|365192422|FG000|Stage 2|Protocol Violation|0|||
105874194|NCT03652051|365192423|FG001|Stage 2|Protocol Violation|1|||
105874195|NCT03652051|365192424|FG002|Stage 2|Protocol Violation|6|||
105874196|NCT03652051|365192425|FG003|Stage 2|Protocol Violation|0|||
105874197|NCT03652051|365192422|FG000|Stage 2|Lost to Follow-up|0|||
105874198|NCT03652051|365192423|FG001|Stage 2|Lost to Follow-up|2|||
105874199|NCT03652051|365192424|FG002|Stage 2|Lost to Follow-up|0|||
105874200|NCT03652051|365192425|FG003|Stage 2|Lost to Follow-up|3|||
105874201|NCT03652051|365192422|FG000|Stage 2|Withdrawal by Subject|0|||
105874202|NCT03652051|365192423|FG001|Stage 2|Withdrawal by Subject|11|||
105874203|NCT03652051|365192424|FG002|Stage 2|Withdrawal by Subject|9|||
105874204|NCT03652051|365192425|FG003|Stage 2|Withdrawal by Subject|3|||
105874205|NCT00395629|365192429|FG000|Core Study|Adverse Event|0|||
105874206|NCT00395629|365192430|FG001|Core Study|Adverse Event|3|||
105874207|NCT00395629|365192431|FG002|Core Study|Adverse Event|4|||
105874208|NCT00395629|365192429|FG000|Core Study|Abnormal laboratory value(s)|0|||
105874209|NCT00395629|365192430|FG001|Core Study|Abnormal laboratory value(s)|0|||
105874210|NCT00395629|365192431|FG002|Core Study|Abnormal laboratory value(s)|1|||
105874211|NCT00395629|365192429|FG000|Core Study|Protocol Violation|1|||
105874212|NCT00395629|365192430|FG001|Core Study|Protocol Violation|0|||
105874213|NCT00395629|365192431|FG002|Core Study|Protocol Violation|0|||
105874214|NCT00395629|365192429|FG000|Core Study|Withdrawal by Subject|0|||
105874215|NCT00395629|365192430|FG001|Core Study|Withdrawal by Subject|1|||
105874216|NCT00395629|365192431|FG002|Core Study|Withdrawal by Subject|1|||
105874217|NCT00395629|365192429|FG000|Core Study|Lost to Follow-up|0|||
105874218|NCT00395629|365192430|FG001|Core Study|Lost to Follow-up|0|||
105874219|NCT00395629|365192431|FG002|Core Study|Lost to Follow-up|1|||
105874220|NCT00395629|365192429|FG000|Extension Study|Adverse Event|0|||
105874221|NCT00395629|365192430|FG001|Extension Study|Adverse Event|0|||
105874222|NCT00395629|365192431|FG002|Extension Study|Adverse Event|2|||
105874223|NCT00395629|365192429|FG000|Extension Study|Administrative problems|0|||
105874224|NCT00395629|365192430|FG001|Extension Study|Administrative problems|0|||
105874225|NCT00395629|365192431|FG002|Extension Study|Administrative problems|1|||
105874226|NCT01051960|365192432|FG000|Overall Study|Adverse Event|1|||
105874227|NCT02394600|365192433|FG000|Overall Study|Adverse Event|3|||
105874228|NCT02394600|365192434|FG001|Overall Study|Adverse Event|0|||
105874229|NCT02394600|365192433|FG000|Overall Study|Lost to Follow-up|0|||
105874230|NCT02394600|365192434|FG001|Overall Study|Lost to Follow-up|1|||
105874231|NCT02394600|365192433|FG000|Overall Study|Withdrawal by Subject|0|||
105874232|NCT02394600|365192434|FG001|Overall Study|Withdrawal by Subject|1|||
105874233|NCT02394600|365192433|FG000|Overall Study|Protocol Violation|1|||
105874234|NCT02394600|365192434|FG001|Overall Study|Protocol Violation|0|||
105874235|NCT01836471|365192443|FG000|Overall Study|Pregnancy|1|||
105874236|NCT01836471|365192444|FG001|Overall Study|Pregnancy|0|||
105874237|NCT01836471|365192445|FG002|Overall Study|Pregnancy|0|||
105874238|NCT01836471|365192446|FG003|Overall Study|Pregnancy|0|||
105874239|NCT01836471|365192447|FG004|Overall Study|Pregnancy|0|||
105874240|NCT01836471|365192443|FG000|Overall Study|Withdrawal by Subject|3|||
105874241|NCT01836471|365192444|FG001|Overall Study|Withdrawal by Subject|4|||
105874242|NCT01836471|365192445|FG002|Overall Study|Withdrawal by Subject|1|||
105874243|NCT01836471|365192446|FG003|Overall Study|Withdrawal by Subject|0|||
105874244|NCT01836471|365192447|FG004|Overall Study|Withdrawal by Subject|2|||
105874245|NCT01836471|365192443|FG000|Overall Study|Physician Decision|0|||
105874246|NCT01836471|365192444|FG001|Overall Study|Physician Decision|1|||
105874247|NCT01836471|365192445|FG002|Overall Study|Physician Decision|0|||
105874248|NCT01836471|365192446|FG003|Overall Study|Physician Decision|0|||
105874249|NCT01836471|365192447|FG004|Overall Study|Physician Decision|0|||
105874250|NCT01836471|365192443|FG000|Overall Study|Lost to Follow-up|0|||
105874251|NCT01836471|365192444|FG001|Overall Study|Lost to Follow-up|0|||
105874252|NCT01836471|365192445|FG002|Overall Study|Lost to Follow-up|0|||
105874253|NCT01836471|365192446|FG003|Overall Study|Lost to Follow-up|1|||
105874254|NCT01836471|365192447|FG004|Overall Study|Lost to Follow-up|1|||
105874255|NCT01836471|365192443|FG000|Overall Study|Adverse Event|6|||
105874256|NCT01836471|365192444|FG001|Overall Study|Adverse Event|3|||
105874257|NCT01836471|365192445|FG002|Overall Study|Adverse Event|1|||
105874258|NCT01836471|365192446|FG003|Overall Study|Adverse Event|1|||
105874259|NCT01836471|365192447|FG004|Overall Study|Adverse Event|2|||
105874260|NCT01836471|365192443|FG000|Overall Study|Non compliance with tx|1|||
105874261|NCT01836471|365192444|FG001|Overall Study|Non compliance with tx|1|||
105874262|NCT01836471|365192445|FG002|Overall Study|Non compliance with tx|0|||
105874263|NCT01836471|365192446|FG003|Overall Study|Non compliance with tx|0|||
105874264|NCT01836471|365192447|FG004|Overall Study|Non compliance with tx|0|||
105657626|NCT00746356|364409925|FG001|Overall Study|Death|3|||
105874265|NCT01960413|365192449|FG000|Overall Study|Withdrawal by Subject|1|||
105874266|NCT01960413|365192450|FG001|Overall Study|Withdrawal by Subject|1|||
105874267|NCT01960413|365192449|FG000|Overall Study|Physician Decision|1|||
105874268|NCT01960413|365192450|FG001|Overall Study|Physician Decision|0|||
105874269|NCT01960413|365192449|FG000|Overall Study|Lost to Follow-up|2|||
105874270|NCT01960413|365192450|FG001|Overall Study|Lost to Follow-up|0|||
105874271|NCT02285361|365192453|FG000|Overall Study|Protocol Violation|43|||
105874272|NCT02285361|365192453|FG000|Overall Study|Lost to Follow-up|5|||
105874273|NCT02285361|365192453|FG000|Overall Study|Not taken GIOTRIF|2|||
105874274|NCT02285361|365192453|FG000|Overall Study|Consented prior to the contract date|1|||
105874275|NCT00031590|365192454|FG000|Overall Study|Adverse Event|1|||
105874276|NCT00031590|365192454|FG000|Overall Study|Withdrawal by parents|2|||
105874277|NCT01283464|365192458|FG000|Overall Study|Lost to Follow-up|0|||
105874278|NCT01283464|365192459|FG001|Overall Study|Lost to Follow-up|1|||
105874279|NCT01283464|365192458|FG000|Overall Study|Withdrawal by Subject|1|||
105874280|NCT01283464|365192459|FG001|Overall Study|Withdrawal by Subject|0|||
105874281|NCT01283464|365192458|FG000|Overall Study|Physician Decision|1|||
105874282|NCT01283464|365192459|FG001|Overall Study|Physician Decision|0|||
105874283|NCT03051100|365192460|FG000|Overall Study|Withdrawal by Subject|1|||
105874284|NCT03051100|365192461|FG001|Overall Study|Withdrawal by Subject|0|||
105874285|NCT03442751|365192462|FG000|Overall Study|Withdrawal by Subject|3|||
105874286|NCT03442751|365192463|FG001|Overall Study|Withdrawal by Subject|1|||
105874287|NCT03442751|365192462|FG000|Overall Study|Lost to Follow-up|3|||
105874288|NCT03442751|365192463|FG001|Overall Study|Lost to Follow-up|0|||
105874289|NCT02105987|365192466|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
105874290|NCT02105987|365192467|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105874291|NCT02105987|365192468|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105874292|NCT02105987|365192469|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105874293|NCT02105987|365192470|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105874294|NCT02105987|365192471|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
105874295|NCT02105987|365192466|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
105874296|NCT02105987|365192467|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
105874297|NCT02105987|365192468|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
105874298|NCT02105987|365192469|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
105874299|NCT02105987|365192470|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
105874300|NCT02105987|365192471|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
105874301|NCT02105987|365192466|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
105874302|NCT02105987|365192467|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
105874303|NCT02105987|365192468|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105874304|NCT02105987|365192469|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105874305|NCT02105987|365192470|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105874306|NCT02105987|365192471|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105874307|NCT02105987|365192466|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
105874308|NCT02105987|365192467|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
105874309|NCT02105987|365192468|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105874310|NCT02105987|365192469|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105874311|NCT02105987|365192470|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105874312|NCT02105987|365192471|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105874313|NCT02105987|365192466|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
105874314|NCT02105987|365192467|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
105874315|NCT02105987|365192468|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
105874316|NCT02105987|365192469|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
105874317|NCT02105987|365192470|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
105874318|NCT02105987|365192471|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
105874319|NCT02105987|365192466|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105874320|NCT02105987|365192467|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
105874321|NCT02105987|365192468|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105874322|NCT02105987|365192469|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105874323|NCT02105987|365192470|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105874324|NCT02105987|365192471|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
105874325|NCT02105987|365192466|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
105874326|NCT02105987|365192467|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
105874327|NCT02105987|365192468|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
105874328|NCT02105987|365192469|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
105874329|NCT02105987|365192470|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
105874330|NCT02105987|365192471|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
105657627|NCT00746356|364409924|FG000|Overall Study|Lost to Follow-up|1|||
105874331|NCT02105987|365192466|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
105874332|NCT02105987|365192467|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
105874333|NCT02105987|365192468|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
105874334|NCT02105987|365192469|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
105874335|NCT02105987|365192470|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
105874336|NCT02105987|365192471|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
105874337|NCT02105987|365192466|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105874338|NCT02105987|365192467|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105657628|NCT00746356|364409925|FG001|Overall Study|Lost to Follow-up|0|||
105657629|NCT00746356|364409924|FG000|Overall Study|Removal of Device|0|||
105874339|NCT02105987|365192468|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
105874340|NCT02105987|365192469|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
105874341|NCT02105987|365192470|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105874342|NCT02105987|365192471|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
105874343|NCT02105987|365192466|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105874344|NCT02105987|365192467|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105874345|NCT02105987|365192468|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
105874346|NCT02105987|365192469|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
105874347|NCT02105987|365192470|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105874348|NCT02105987|365192471|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
105874349|NCT02105987|365192466|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105874350|NCT02105987|365192467|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105874351|NCT02105987|365192468|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
105874352|NCT02105987|365192469|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105874353|NCT02105987|365192470|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105874354|NCT02105987|365192471|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
105874355|NCT02105987|365192466|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105874356|NCT02105987|365192467|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105874357|NCT02105987|365192468|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105874358|NCT02105987|365192469|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
105874359|NCT02105987|365192470|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105874360|NCT02105987|365192471|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
105874361|NCT02105987|365192466|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105874362|NCT02105987|365192467|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105874363|NCT02105987|365192468|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
105874364|NCT02105987|365192469|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105874365|NCT02105987|365192470|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105874366|NCT02105987|365192471|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
105874367|NCT02105987|365192466|FG000|Continuation Phase|Protocol Violation|0|||
105874368|NCT02105987|365192467|FG001|Continuation Phase|Protocol Violation|0|||
105874369|NCT02105987|365192468|FG002|Continuation Phase|Protocol Violation|0|||
105874370|NCT02105987|365192469|FG003|Continuation Phase|Protocol Violation|0|||
105874371|NCT02105987|365192470|FG004|Continuation Phase|Protocol Violation|1|||
105874372|NCT02105987|365192471|FG005|Continuation Phase|Protocol Violation|0|||
105874373|NCT00837148|365192472|FG000|Overall Study|Adverse Event|1|||
105874374|NCT00837148|365192472|FG000|Overall Study|Death|1|||
105874375|NCT02301169|365192473|FG000|Overall Study|Adverse Event|1|||
105874376|NCT02301169|365192474|FG001|Overall Study|Adverse Event|0|||
105874377|NCT00380874|365192475|FG000|Overall Study|Adverse Event|7|||
105874378|NCT00380874|365192476|FG001|Overall Study|Adverse Event|7|||
105874379|NCT00380874|365192475|FG000|Overall Study|Death|1|||
105874380|NCT00380874|365192476|FG001|Overall Study|Death|0|||
105874381|NCT00380874|365192475|FG000|Overall Study|Withdrawal by Subject|2|||
105874382|NCT00380874|365192476|FG001|Overall Study|Withdrawal by Subject|1|||
105874383|NCT00380874|365192475|FG000|Overall Study|Not related to study drug|3|||
105874384|NCT00380874|365192476|FG001|Overall Study|Not related to study drug|2|||
105874385|NCT01515423|365192477|FG000|Open Label Phase|Adverse Event|57|||
105874386|NCT01515423|365192478|FG001|Open Label Phase|Adverse Event|0|||
105874387|NCT01515423|365192479|FG002|Open Label Phase|Adverse Event|0|||
105874388|NCT01515423|365192477|FG000|Open Label Phase|Death|2|||
105874389|NCT01515423|365192478|FG001|Open Label Phase|Death|0|||
105874390|NCT01515423|365192479|FG002|Open Label Phase|Death|0|||
105874391|NCT01515423|365192477|FG000|Open Label Phase|Lack of Efficacy|117|||
105874392|NCT01515423|365192478|FG001|Open Label Phase|Lack of Efficacy|0|||
105874393|NCT01515423|365192479|FG002|Open Label Phase|Lack of Efficacy|0|||
105874394|NCT01515423|365192477|FG000|Open Label Phase|Lost to Follow-up|21|||
105874395|NCT01515423|365192478|FG001|Open Label Phase|Lost to Follow-up|0|||
105874396|NCT01515423|365192479|FG002|Open Label Phase|Lost to Follow-up|0|||
105874397|NCT01515423|365192477|FG000|Open Label Phase|Withdrawal by Subject|118|||
105874398|NCT01515423|365192478|FG001|Open Label Phase|Withdrawal by Subject|0|||
105657630|NCT00746356|364409925|FG001|Overall Study|Removal of Device|1|||
105657631|NCT00746356|364409924|FG000|Overall Study|Patient relocated|1|||
105874399|NCT01515423|365192479|FG002|Open Label Phase|Withdrawal by Subject|0|||
105874400|NCT01515423|365192477|FG000|Open Label Phase|excluded from DB Phase|70|||
105874401|NCT01515423|365192478|FG001|Open Label Phase|excluded from DB Phase|0|||
105874402|NCT01515423|365192479|FG002|Open Label Phase|excluded from DB Phase|0|||
105874403|NCT01515423|365192477|FG000|Open Label Phase|Other|28|||
105874404|NCT01515423|365192478|FG001|Open Label Phase|Other|0|||
105874405|NCT01515423|365192479|FG002|Open Label Phase|Other|0|||
105874406|NCT01515423|365192477|FG000|DOUBLE BLIND|Adverse Event|0|||
105874407|NCT01515423|365192478|FG001|DOUBLE BLIND|Adverse Event|15|||
105657632|NCT00746356|364409925|FG001|Overall Study|Patient relocated|0|||
105874408|NCT01515423|365192479|FG002|DOUBLE BLIND|Adverse Event|13|||
105874409|NCT01515423|365192477|FG000|DOUBLE BLIND|Death|0|||
105874410|NCT01515423|365192478|FG001|DOUBLE BLIND|Death|1|||
105874411|NCT01515423|365192479|FG002|DOUBLE BLIND|Death|2|||
105874412|NCT01515423|365192477|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
105874413|NCT01515423|365192478|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
105874414|NCT01515423|365192479|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
105874415|NCT01515423|365192477|FG000|DOUBLE BLIND|Pregnancy|0|||
105874416|NCT01515423|365192478|FG001|DOUBLE BLIND|Pregnancy|2|||
105874417|NCT01515423|365192479|FG002|DOUBLE BLIND|Pregnancy|0|||
105874418|NCT01515423|365192477|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
105874419|NCT01515423|365192478|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
105874420|NCT01515423|365192479|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
105874421|NCT01515423|365192477|FG000|DOUBLE BLIND|Other|0|||
105874422|NCT01515423|365192478|FG001|DOUBLE BLIND|Other|6|||
105874423|NCT01515423|365192479|FG002|DOUBLE BLIND|Other|12|||
105874424|NCT01515423|365192477|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
105874425|NCT01515423|365192478|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
105874426|NCT01515423|365192479|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
105874427|NCT01707290|365192484|FG000|Overall Study|Adverse event (AE)|1|||
105874428|NCT01707290|365192485|FG001|Overall Study|Adverse event (AE)|0|||
105874429|NCT01707290|365192484|FG000|Overall Study|Physician Decision|1|||
105874430|NCT01707290|365192485|FG001|Overall Study|Physician Decision|0|||
105874431|NCT01707290|365192484|FG000|Overall Study|Lost to Follow-up|3|||
105874432|NCT01707290|365192485|FG001|Overall Study|Lost to Follow-up|0|||
105874433|NCT01707290|365192484|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
105874434|NCT01707290|365192485|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
105874435|NCT01707290|365192484|FG000|Overall Study|Commercial drug available|60|||
105874436|NCT01707290|365192485|FG001|Overall Study|Commercial drug available|1|||
105874437|NCT01707290|365192484|FG000|Overall Study|Other unspecified|17|||
105874438|NCT01707290|365192485|FG001|Overall Study|Other unspecified|0|||
105874439|NCT02949973|365192488|FG000|Overall Study|Physician Decision|1|||
105874440|NCT02501928|365192489|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105874441|NCT02501928|365192490|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
105874442|NCT02501928|365192491|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
105874443|NCT02501928|365192492|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
105874444|NCT02501928|365192493|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
105874445|NCT02501928|365192494|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
105874446|NCT02291237|365192495|FG000|Overall Study|Study Terminated by Sponsor|72|||
105874447|NCT02291237|365192496|FG001|Overall Study|Study Terminated by Sponsor|67|||
105874448|NCT02291237|365192495|FG000|Overall Study|Adverse Event|1|||
105874449|NCT02291237|365192496|FG001|Overall Study|Adverse Event|3|||
105874450|NCT02291237|365192495|FG000|Overall Study|Investigator's Discretion|0|||
105874451|NCT02291237|365192496|FG001|Overall Study|Investigator's Discretion|3|||
105874452|NCT02291237|365192495|FG000|Overall Study|Withdrew Consent|11|||
105874453|NCT02291237|365192496|FG001|Overall Study|Withdrew Consent|11|||
105874454|NCT02291237|365192495|FG000|Overall Study|Lost to Follow-up|0|||
105874455|NCT02291237|365192496|FG001|Overall Study|Lost to Follow-up|2|||
105874456|NCT02291237|365192495|FG000|Overall Study|Subject Required Prohibited Medication|2|||
105874457|NCT02291237|365192496|FG001|Overall Study|Subject Required Prohibited Medication|0|||
105874458|NCT00258960|365192497|FG000|Overall Study|Death|2|||
105874459|NCT00258960|365192497|FG000|Overall Study|Disease Progression|7|||
105874460|NCT00258960|365192497|FG000|Overall Study|Adverse Event|4|||
105874461|NCT00258960|365192497|FG000|Overall Study|Physician Decision|1|||
105874462|NCT00258960|365192497|FG000|Overall Study|Withdrawal by Subject|1|||
105874463|NCT00258960|365192497|FG000|Overall Study|Mistake|2|||
105874464|NCT01112059|365192500|FG000|Overall Study|Withdrawal by Subject|1|||
105874465|NCT01112059|365192501|FG001|Overall Study|Withdrawal by Subject|0|||
105874466|NCT01401452|365192504|FG000|Overall Study|Adverse reaction|9|||
105874467|NCT01401452|365192504|FG000|Overall Study|Lost to Follow-up|12|||
105874468|NCT01401452|365192504|FG000|Overall Study|Lack of Efficacy|30|||
105874469|NCT01401452|365192504|FG000|Overall Study|Participant developed breast cancer|1|||
105874470|NCT01401452|365192504|FG000|Overall Study|Tx stopped due to financial reasons|1|||
105874471|NCT01401452|365192504|FG000|Overall Study|Tx stopped by psychiatrist|1|||
105874472|NCT01401452|365192504|FG000|Overall Study|No more visits within the 36 wk followup|4|||
105874473|NCT01401452|365192504|FG000|Overall Study|Subject did not come to follow up visits|2|||
105874474|NCT01401452|365192504|FG000|Overall Study|Subject didn't return for routine visits|1|||
105874475|NCT01401452|365192504|FG000|Overall Study|Subject moved to another city|1|||
105874476|NCT01401452|365192504|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
105657633|NCT04680637|364409948|FG000|Overall Study|Lost to Follow-up|0|||
105657634|NCT04680637|364409949|FG001|Overall Study|Lost to Follow-up|1|||
105874477|NCT01401452|365192504|FG000|Overall Study|Psoriatic arthritis|1|||
105874478|NCT01401452|365192504|FG000|Overall Study|Participant stopped Tx|2|||
105874479|NCT01401452|365192504|FG000|Overall Study|Discontinuation for personal reasons|1|||
105874480|NCT01401452|365192504|FG000|Overall Study|Treatment failure|1|||
105874481|NCT01401452|365192504|FG000|Overall Study|Unsatisfactory output|1|||
105874482|NCT01401452|365192504|FG000|Overall Study|Subject withdrew because of Tx success|1|||
105874483|NCT01401452|365192504|FG000|Overall Study|Subject chose to discontinue treatment|1|||
105874484|NCT01401452|365192504|FG000|Overall Study|Participant withdrew consent|1|||
105874485|NCT00584454|365192505|FG000|Overall Study|Adverse Event|1|||
105874486|NCT00584454|365192505|FG000|Overall Study|Relocation|1|||
105874487|NCT00584454|365192505|FG000|Overall Study|Clinical Hold|2|||
105874488|NCT02723344|365192506|FG000|Overall Study|Lost to Follow-up|0|||
105874489|NCT02723344|365192507|FG001|Overall Study|Lost to Follow-up|4|||
105874490|NCT01530464|365192512|FG000|Washout (24h)|Withdrawal by Subject|1|||
105874491|NCT01530464|365192513|FG001|Washout (24h)|Withdrawal by Subject|0|||
105874492|NCT01530464|365192512|FG000|Washout (24h)|Withdrawal by Subject|0|||
105874493|NCT01530464|365192513|FG001|Washout (24h)|Withdrawal by Subject|1|||
105874494|NCT02698163|365192514|FG000|Overall Study|Lost to Follow-up|0|||
105874495|NCT02698163|365192515|FG001|Overall Study|Lost to Follow-up|1|||
105874496|NCT02387840|365192516|FG000|Overall Study|Death|0|||
105874497|NCT02387840|365192517|FG001|Overall Study|Death|0|||
105874498|NCT02387840|365192518|FG002|Overall Study|Death|0|||
105874499|NCT02387840|365192519|FG003|Overall Study|Death|0|||
105874500|NCT02387840|365192520|FG004|Overall Study|Death|0|||
105874501|NCT02387840|365192521|FG005|Overall Study|Death|1|||
105874502|NCT04199104|365194118|FG000|Overall Study|Death|148|||
105874503|NCT04199104|365194119|FG001|Overall Study|Death|134|||
105874504|NCT04199104|365194118|FG000|Overall Study|Lost to Follow-up|1|||
105874505|NCT04199104|365194119|FG001|Overall Study|Lost to Follow-up|1|||
105874506|NCT04199104|365194118|FG000|Overall Study|Withdrawal by Subject|4|||
105874507|NCT04199104|365194119|FG001|Overall Study|Withdrawal by Subject|4|||
105874508|NCT04199104|365194118|FG000|Overall Study|Participants Ongoing|103|||
105874509|NCT04199104|365194119|FG001|Overall Study|Participants Ongoing|116|||
105874510|NCT05085834|365194127|FG000|Overall Study|Lost to Follow-up|9|||
105874511|NCT05085834|365194128|FG001|Overall Study|Lost to Follow-up|2|||
105874512|NCT05085834|365194127|FG000|Overall Study|Adverse Event|6|||
105874513|NCT05085834|365194128|FG001|Overall Study|Adverse Event|0|||
105874514|NCT05085834|365194127|FG000|Overall Study|Death|1|||
105874515|NCT05085834|365194128|FG001|Overall Study|Death|0|||
105874516|NCT05085834|365194127|FG000|Overall Study|Inability to swallow the pill|0|||
105874517|NCT05085834|365194128|FG001|Overall Study|Inability to swallow the pill|1|||
105874518|NCT00413699|365194129|FG000|Initial Period|Death|25|||
105874519|NCT00413699|365194130|FG001|Initial Period|Death|30|||
105874520|NCT00413699|365194131|FG002|Initial Period|Death|0|||
105874521|NCT00413699|365194129|FG000|Initial Period|Lack of Efficacy|59|||
105874522|NCT00413699|365194130|FG001|Initial Period|Lack of Efficacy|115|||
105874523|NCT00413699|365194131|FG002|Initial Period|Lack of Efficacy|0|||
105874524|NCT00413699|365194129|FG000|Initial Period|Lost to Follow-up|31|||
105874525|NCT00413699|365194130|FG001|Initial Period|Lost to Follow-up|101|||
105874526|NCT00413699|365194131|FG002|Initial Period|Lost to Follow-up|0|||
105874527|NCT00413699|365194129|FG000|Initial Period|Protocol Violation|38|||
105874528|NCT00413699|365194130|FG001|Initial Period|Protocol Violation|89|||
105874529|NCT00413699|365194131|FG002|Initial Period|Protocol Violation|0|||
105874530|NCT00413699|365194129|FG000|Initial Period|Pregnancy|10|||
105874531|NCT00413699|365194130|FG001|Initial Period|Pregnancy|8|||
105874532|NCT00413699|365194131|FG002|Initial Period|Pregnancy|0|||
105874533|NCT00413699|365194129|FG000|Initial Period|Did not meet entrance criteria|2|||
105874534|NCT00413699|365194130|FG001|Initial Period|Did not meet entrance criteria|2|||
105874535|NCT00413699|365194131|FG002|Initial Period|Did not meet entrance criteria|0|||
105874536|NCT00413699|365194129|FG000|Initial Period|Medication error without adverse event|0|||
105874537|NCT00413699|365194130|FG001|Initial Period|Medication error without adverse event|1|||
105874538|NCT00413699|365194131|FG002|Initial Period|Medication error without adverse event|0|||
105874539|NCT00413699|365194129|FG000|Initial Period|Study terminated by Sponsor|0|||
105874540|NCT00413699|365194130|FG001|Initial Period|Study terminated by Sponsor|1|||
105874541|NCT00413699|365194131|FG002|Initial Period|Study terminated by Sponsor|0|||
105874542|NCT00413699|365194129|FG000|Initial Period|Other|67|||
105874543|NCT00413699|365194130|FG001|Initial Period|Other|211|||
105874544|NCT00413699|365194131|FG002|Initial Period|Other|0|||
105874545|NCT00413699|365194129|FG000|Initial Period|Adverse event related to study drug|178|||
105874546|NCT00413699|365194130|FG001|Initial Period|Adverse event related to study drug|527|||
105874547|NCT00413699|365194131|FG002|Initial Period|Adverse event related to study drug|0|||
105657635|NCT04680637|364409950|FG002|Overall Study|Lost to Follow-up|0|||
105874548|NCT00413699|365194129|FG000|Initial Period|Adverse event not related to study drug|113|||
105874549|NCT00413699|365194130|FG001|Initial Period|Adverse event not related to study drug|248|||
105874550|NCT00413699|365194131|FG002|Initial Period|Adverse event not related to study drug|0|||
105874551|NCT00413699|365194129|FG000|Initial Period|Missing end of study page|0|||
105874552|NCT00413699|365194130|FG001|Initial Period|Missing end of study page|4|||
105874553|NCT00413699|365194131|FG002|Initial Period|Missing end of study page|0|||
105874554|NCT00413699|365194129|FG000|Initial Period|No longer willing to participate|116|||
105874555|NCT00413699|365194130|FG001|Initial Period|No longer willing to participate|368|||
105874556|NCT00413699|365194131|FG002|Initial Period|No longer willing to participate|0|||
105874557|NCT00413699|365194129|FG000|Extension Period|No Longer Willing to Participate|0|||
105874558|NCT00413699|365194130|FG001|Extension Period|No Longer Willing to Participate|0|||
105874559|NCT00413699|365194131|FG002|Extension Period|No Longer Willing to Participate|2|||
105874560|NCT00413699|365194129|FG000|Extension Period|Protocol Violation|0|||
105874561|NCT00413699|365194130|FG001|Extension Period|Protocol Violation|0|||
105874562|NCT00413699|365194131|FG002|Extension Period|Protocol Violation|1|||
105874563|NCT00413699|365194129|FG000|Extension Period|Adverse Event|0|||
105874564|NCT00413699|365194130|FG001|Extension Period|Adverse Event|0|||
105874565|NCT00413699|365194131|FG002|Extension Period|Adverse Event|2|||
105874566|NCT02115269|365194132|FG000|Overall Study|Lost to Follow-up|43|||
105874567|NCT02115269|365194132|FG000|Overall Study|Did not complete patient diary|3|||
105874568|NCT02115269|365194132|FG000|Overall Study|Moved to another city|7|||
105874569|NCT02115269|365194132|FG000|Overall Study|Withdrawal by Subject|2|||
105874570|NCT02115269|365194132|FG000|Overall Study|Didn't take study drug|2|||
105874571|NCT02810457|365194133|FG000|Overall Study|Randomised but no treatment received|2|||
105874572|NCT02810457|365194134|FG001|Overall Study|Randomised but no treatment received|1|||
105874573|NCT02810457|365194133|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
105874574|NCT02810457|365194134|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
105874575|NCT02810457|365194133|FG000|Overall Study|Adverse Event|37|||
105874576|NCT02810457|365194134|FG001|Overall Study|Adverse Event|43|||
105874577|NCT02810457|365194133|FG000|Overall Study|Patient decision|31|||
105874578|NCT02810457|365194134|FG001|Overall Study|Patient decision|35|||
105874579|NCT02810457|365194133|FG000|Overall Study|Patient lost to follow-up|2|||
105874580|NCT02810457|365194134|FG001|Overall Study|Patient lost to follow-up|2|||
105874581|NCT02810457|365194133|FG000|Overall Study|Death|39|||
105874582|NCT02810457|365194134|FG001|Overall Study|Death|28|||
105874583|NCT02810457|365194133|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
105874584|NCT02810457|365194134|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
105874585|NCT02810457|365194133|FG000|Overall Study|Clinical progression|15|||
105874586|NCT02810457|365194134|FG001|Overall Study|Clinical progression|16|||
105874587|NCT02810457|365194133|FG000|Overall Study|Investigator decision|3|||
105874588|NCT02810457|365194134|FG001|Overall Study|Investigator decision|2|||
105874589|NCT02810457|365194133|FG000|Overall Study|Patient ineligibility|3|||
105874590|NCT02810457|365194134|FG001|Overall Study|Patient ineligibility|0|||
105874591|NCT02810457|365194133|FG000|Overall Study|Miscalculated PD|1|||
105874592|NCT02810457|365194134|FG001|Overall Study|Miscalculated PD|0|||
105874593|NCT02810457|365194133|FG000|Overall Study|Physician Decision|0|||
105874594|NCT02810457|365194134|FG001|Overall Study|Physician Decision|1|||
105874595|NCT00818766|365194135|FG000|Overall Study|Could not be Contacted on Day 28|11|||
105874596|NCT00818766|365194136|FG001|Overall Study|Could not be Contacted on Day 28|10|||
105874597|NCT00818766|365194135|FG000|Overall Study|Death|1|||
105874598|NCT00818766|365194136|FG001|Overall Study|Death|0|||
105874599|NCT00818766|365194135|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
105874600|NCT00818766|365194136|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
105874601|NCT01996241|365194137|FG000|Overall Study|Lost to Follow-up|252|||
105874602|NCT01996241|365194138|FG001|Overall Study|Lost to Follow-up|235|||
105874603|NCT01103180|365194143|FG000|Overall Study|Withdrawal by Subject|8|||
105874604|NCT01103180|365194144|FG001|Overall Study|Withdrawal by Subject|13|||
105874605|NCT01103180|365194143|FG000|Overall Study|Lost to Follow-up|13|||
105874606|NCT01103180|365194144|FG001|Overall Study|Lost to Follow-up|7|||
105874607|NCT01103180|365194143|FG000|Overall Study|Physician Decision|1|||
105874608|NCT01103180|365194144|FG001|Overall Study|Physician Decision|0|||
105874609|NCT01103180|365194143|FG000|Overall Study|Protocol Violation|0|||
105874610|NCT01103180|365194144|FG001|Overall Study|Protocol Violation|1|||
105874611|NCT02717507|365194149|FG000|Overall Study|Lost to Follow-up|5|||
105874612|NCT02717507|365194150|FG001|Overall Study|Lost to Follow-up|8|||
105874613|NCT02717507|365194149|FG000|Overall Study|Pregnancy|1|||
105874614|NCT02717507|365194150|FG001|Overall Study|Pregnancy|1|||
105874615|NCT02717507|365194149|FG000|Overall Study|Protocol Violation|2|||
105874616|NCT02717507|365194150|FG001|Overall Study|Protocol Violation|2|||
105874617|NCT02717507|365194149|FG000|Overall Study|Withdrawal by Subject|20|||
105874618|NCT02717507|365194150|FG001|Overall Study|Withdrawal by Subject|20|||
105874619|NCT02717507|365194149|FG000|Overall Study|Relapse|1|||
105874620|NCT02717507|365194150|FG001|Overall Study|Relapse|1|||
105874621|NCT02717507|365194149|FG000|Overall Study|Cardiac Event|2|||
105874622|NCT02717507|365194150|FG001|Overall Study|Cardiac Event|6|||
105874623|NCT02493660|365194152|FG000|Overall Study|Physician Decision|0|||
105874624|NCT02493660|365194153|FG001|Overall Study|Physician Decision|1|||
105874625|NCT02493660|365194152|FG000|Overall Study|Adverse Event|4|||
105874626|NCT02493660|365194153|FG001|Overall Study|Adverse Event|2|||
105874627|NCT02493660|365194152|FG000|Overall Study|Withdrawal by Subject|2|||
105874628|NCT02493660|365194153|FG001|Overall Study|Withdrawal by Subject|3|||
105874629|NCT02493660|365194152|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
105874630|NCT02493660|365194153|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
105874631|NCT02493660|365194152|FG000|Overall Study|Protocol Violation|0|||
105874632|NCT02493660|365194153|FG001|Overall Study|Protocol Violation|1|||
105874633|NCT02493660|365194152|FG000|Overall Study|Death|0|||
105874634|NCT02493660|365194153|FG001|Overall Study|Death|1|||
105874635|NCT02493660|365194152|FG000|Overall Study|Lost to Follow-up|2|||
105874636|NCT02493660|365194153|FG001|Overall Study|Lost to Follow-up|4|||
105874637|NCT00370552|365194155|FG000|Overall Study|Adverse Event|2|||
105874638|NCT00370552|365194156|FG001|Overall Study|Adverse Event|2|||
105874639|NCT00370552|365194157|FG002|Overall Study|Adverse Event|2|||
105874640|NCT00370552|365194155|FG000|Overall Study|Disease progression|23|||
105874641|NCT00370552|365194156|FG001|Overall Study|Disease progression|23|||
105874642|NCT00370552|365194157|FG002|Overall Study|Disease progression|15|||
105874643|NCT00370552|365194155|FG000|Overall Study|Maximum clinical benefit|3|||
105874644|NCT00370552|365194156|FG001|Overall Study|Maximum clinical benefit|5|||
105874645|NCT00370552|365194157|FG002|Overall Study|Maximum clinical benefit|5|||
105874646|NCT00370552|365194155|FG000|Overall Study|Poor or noncompliance|0|||
105874647|NCT00370552|365194156|FG001|Overall Study|Poor or noncompliance|0|||
105874648|NCT00370552|365194157|FG002|Overall Study|Poor or noncompliance|1|||
105874649|NCT00370552|365194155|FG000|Overall Study|Study drug toxicity|11|||
105874650|NCT00370552|365194156|FG001|Overall Study|Study drug toxicity|8|||
105874651|NCT00370552|365194157|FG002|Overall Study|Study drug toxicity|6|||
105874652|NCT00370552|365194155|FG000|Overall Study|Withdrawal by Subject|2|||
105874653|NCT00370552|365194156|FG001|Overall Study|Withdrawal by Subject|0|||
105874654|NCT00370552|365194157|FG002|Overall Study|Withdrawal by Subject|1|||
105874655|NCT00370552|365194155|FG000|Overall Study|Still on treatment|1|||
105874656|NCT00370552|365194156|FG001|Overall Study|Still on treatment|3|||
105874657|NCT00370552|365194157|FG002|Overall Study|Still on treatment|2|||
105874658|NCT00370552|365194155|FG000|Overall Study|Never treated|1|||
105874659|NCT00370552|365194156|FG001|Overall Study|Never treated|0|||
105874660|NCT00370552|365194157|FG002|Overall Study|Never treated|0|||
105874661|NCT00370552|365194155|FG000|Overall Study|Physician Decision|1|||
105874662|NCT00370552|365194156|FG001|Overall Study|Physician Decision|1|||
105874663|NCT00370552|365194157|FG002|Overall Study|Physician Decision|0|||
105874664|NCT00370552|365194155|FG000|Overall Study|Investigator decision|2|||
105874665|NCT00370552|365194156|FG001|Overall Study|Investigator decision|1|||
105874666|NCT00370552|365194157|FG002|Overall Study|Investigator decision|0|||
105874667|NCT00370552|365194155|FG000|Overall Study|High risk of allergic reaction|0|||
105874668|NCT00370552|365194156|FG001|Overall Study|High risk of allergic reaction|1|||
105874669|NCT00370552|365194157|FG002|Overall Study|High risk of allergic reaction|0|||
105874670|NCT00370552|365194155|FG000|Overall Study|Planned radiation for palliation|0|||
105874671|NCT00370552|365194156|FG001|Overall Study|Planned radiation for palliation|1|||
105874672|NCT00370552|365194157|FG002|Overall Study|Planned radiation for palliation|0|||
105874673|NCT03500198|365194158|FG000|Overall Study|Lost to Follow-up|0|||
105874674|NCT03500198|365194159|FG001|Overall Study|Lost to Follow-up|1|||
105874675|NCT00595621|365194165|FG000|Open Label Run in|Adverse Event|1|||
105874676|NCT00595621|365194166|FG001|Open Label Run in|Adverse Event|0|||
105874677|NCT00595621|365194165|FG000|Open Label Run in|Physician Decision|1|||
105874678|NCT00595621|365194166|FG001|Open Label Run in|Physician Decision|0|||
105874679|NCT00595621|365194165|FG000|Open Label Run in|Withdrawal by Subject|1|||
105874680|NCT00595621|365194166|FG001|Open Label Run in|Withdrawal by Subject|0|||
105874681|NCT00595621|365194165|FG000|Randomization and Study|Adverse Event|2|||
105874682|NCT00595621|365194166|FG001|Randomization and Study|Adverse Event|0|||
105874683|NCT00595621|365194165|FG000|Randomization and Study|Withdrawal by Subject|0|||
105874684|NCT00595621|365194166|FG001|Randomization and Study|Withdrawal by Subject|1|||
105874685|NCT03817125|365194169|FG000|Overall Study|Adverse Event|1|||
105874686|NCT03817125|365194170|FG001|Overall Study|Adverse Event|0|||
105874687|NCT03817125|365194169|FG000|Overall Study|Physician Decision|0|||
105874688|NCT03817125|365194170|FG001|Overall Study|Physician Decision|1|||
105874689|NCT03817125|365194169|FG000|Overall Study|Lack of Efficacy|1|||
105874690|NCT03817125|365194170|FG001|Overall Study|Lack of Efficacy|5|||
105874691|NCT01062425|365194171|FG000|Overall Study|Protocol Violation|3|||
105874692|NCT01062425|365194172|FG001|Overall Study|Protocol Violation|6|||
105874693|NCT01998919|365194174|FG000|Overall Study|Death|2|||
105874694|NCT01998919|365194175|FG001|Overall Study|Death|2|||
105874695|NCT01998919|365194174|FG000|Overall Study|Adverse Event|0|||
105874696|NCT01998919|365194175|FG001|Overall Study|Adverse Event|5|||
105874697|NCT01998919|365194174|FG000|Overall Study|Disease progression|31|||
105874698|NCT01998919|365194175|FG001|Overall Study|Disease progression|22|||
105874699|NCT01998919|365194174|FG000|Overall Study|Withdrawal by Subject|2|||
105874700|NCT01998919|365194175|FG001|Overall Study|Withdrawal by Subject|4|||
105874701|NCT01998919|365194174|FG000|Overall Study|Lost to Follow-up|2|||
105874702|NCT01998919|365194175|FG001|Overall Study|Lost to Follow-up|0|||
105874703|NCT01998919|365194174|FG000|Overall Study|Other|5|||
105874704|NCT01998919|365194175|FG001|Overall Study|Other|2|||
105874705|NCT00116779|365194176|FG000|Overall Study|Adverse Event|4|||
105874706|NCT00116779|365194177|FG001|Overall Study|Adverse Event|2|||
105874707|NCT00116779|365194176|FG000|Overall Study|Protocol Violation|1|||
105874708|NCT00116779|365194177|FG001|Overall Study|Protocol Violation|4|||
105874709|NCT00116779|365194176|FG000|Overall Study|Withdrawal by Subject|4|||
105874710|NCT00116779|365194177|FG001|Overall Study|Withdrawal by Subject|1|||
105874711|NCT00116779|365194176|FG000|Overall Study|Inadequate testosterone suppression|7|||
105874712|NCT00116779|365194177|FG001|Overall Study|Inadequate testosterone suppression|9|||
105874713|NCT00116779|365194176|FG000|Overall Study|Physician Decision|3|||
105874714|NCT00116779|365194177|FG001|Overall Study|Physician Decision|1|||
105874715|NCT00116779|365194176|FG000|Overall Study|Elevated PSA levels|2|||
105874716|NCT00116779|365194177|FG001|Overall Study|Elevated PSA levels|2|||
105874717|NCT02383017|365194178|FG000|Overall Study|Injury Sustained Outside Study|1|||
105874718|NCT02383017|365194179|FG001|Overall Study|Injury Sustained Outside Study|0|||
105874719|NCT02383017|365194178|FG000|Overall Study|Compliance|3|||
105874720|NCT02383017|365194179|FG001|Overall Study|Compliance|2|||
105874721|NCT02383017|365194178|FG000|Overall Study|Found to be Hypogonadal|1|||
105874722|NCT02383017|365194179|FG001|Overall Study|Found to be Hypogonadal|0|||
105874723|NCT01037218|365194180|FG000|Overall Study|Adverse Event|4|||
105874724|NCT01037218|365194181|FG001|Overall Study|Adverse Event|2|||
105874725|NCT01037218|365194182|FG002|Overall Study|Adverse Event|2|||
105874726|NCT01037218|365194183|FG003|Overall Study|Adverse Event|1|||
105874727|NCT01037218|365194180|FG000|Overall Study|Lack of Efficacy|0|||
105874728|NCT01037218|365194181|FG001|Overall Study|Lack of Efficacy|2|||
105874729|NCT01037218|365194182|FG002|Overall Study|Lack of Efficacy|1|||
105874730|NCT01037218|365194183|FG003|Overall Study|Lack of Efficacy|5|||
105874731|NCT01037218|365194180|FG000|Overall Study|Lost to Follow-up|3|||
105874732|NCT01037218|365194181|FG001|Overall Study|Lost to Follow-up|5|||
105874733|NCT01037218|365194182|FG002|Overall Study|Lost to Follow-up|4|||
105874734|NCT01037218|365194183|FG003|Overall Study|Lost to Follow-up|2|||
105874735|NCT01037218|365194180|FG000|Overall Study|Withdrawal by Subject|6|||
105874736|NCT01037218|365194181|FG001|Overall Study|Withdrawal by Subject|7|||
105874737|NCT01037218|365194182|FG002|Overall Study|Withdrawal by Subject|7|||
105874738|NCT01037218|365194183|FG003|Overall Study|Withdrawal by Subject|4|||
105874739|NCT01037218|365194180|FG000|Overall Study|Partner Withdrew Consent|0|||
105874740|NCT01037218|365194181|FG001|Overall Study|Partner Withdrew Consent|3|||
105874741|NCT01037218|365194182|FG002|Overall Study|Partner Withdrew Consent|2|||
105874742|NCT01037218|365194183|FG003|Overall Study|Partner Withdrew Consent|1|||
105874743|NCT01037218|365194180|FG000|Overall Study|Protocol Violation|0|||
105874744|NCT01037218|365194181|FG001|Overall Study|Protocol Violation|0|||
105874745|NCT01037218|365194182|FG002|Overall Study|Protocol Violation|2|||
105874746|NCT01037218|365194183|FG003|Overall Study|Protocol Violation|2|||
105874747|NCT01037218|365194180|FG000|Overall Study|Various|3|||
105874748|NCT01037218|365194181|FG001|Overall Study|Various|2|||
105874749|NCT01037218|365194182|FG002|Overall Study|Various|3|||
105874750|NCT01037218|365194183|FG003|Overall Study|Various|1|||
105874751|NCT02676882|365194184|FG000|Overall Study|Adverse Event|1|||
105874752|NCT02676882|365194185|FG001|Overall Study|Adverse Event|0|||
105874753|NCT02676882|365194184|FG000|Overall Study|Lost to Follow-up|1|||
105874754|NCT02676882|365194185|FG001|Overall Study|Lost to Follow-up|0|||
105874755|NCT02676882|365194184|FG000|Overall Study|Withdrawal by Subject|1|||
105874756|NCT02676882|365194185|FG001|Overall Study|Withdrawal by Subject|2|||
105874757|NCT01068860|365194186|FG000|Overall Study|Withdrawal by Subject|0|||
105874758|NCT01068860|365194187|FG001|Overall Study|Withdrawal by Subject|0|||
105874759|NCT01068860|365194188|FG002|Overall Study|Withdrawal by Subject|0|||
105874760|NCT01068860|365194189|FG003|Overall Study|Withdrawal by Subject|0|||
105874761|NCT01068860|365194190|FG004|Overall Study|Withdrawal by Subject|0|||
105874762|NCT01068860|365194191|FG005|Overall Study|Withdrawal by Subject|2|||
105874763|NCT01068860|365194192|FG006|Overall Study|Withdrawal by Subject|0|||
105874764|NCT01068860|365194193|FG007|Overall Study|Withdrawal by Subject|0|||
105874765|NCT01068860|365194194|FG008|Overall Study|Withdrawal by Subject|0|||
105874766|NCT01068860|365194195|FG009|Overall Study|Withdrawal by Subject|3|||
105874767|NCT01068860|365194186|FG000|Overall Study|Administrative problems; misrandomized|0|||
105874768|NCT01068860|365194187|FG001|Overall Study|Administrative problems; misrandomized|0|||
105874769|NCT01068860|365194188|FG002|Overall Study|Administrative problems; misrandomized|0|||
105874770|NCT01068860|365194189|FG003|Overall Study|Administrative problems; misrandomized|1|||
105874771|NCT01068860|365194190|FG004|Overall Study|Administrative problems; misrandomized|0|||
105874772|NCT01068860|365194191|FG005|Overall Study|Administrative problems; misrandomized|0|||
105874773|NCT01068860|365194192|FG006|Overall Study|Administrative problems; misrandomized|0|||
105874774|NCT01068860|365194193|FG007|Overall Study|Administrative problems; misrandomized|0|||
105874775|NCT01068860|365194194|FG008|Overall Study|Administrative problems; misrandomized|0|||
105874776|NCT01068860|365194195|FG009|Overall Study|Administrative problems; misrandomized|1|||
105874777|NCT01068860|365194186|FG000|Overall Study|Lost to Follow-up|0|||
105874778|NCT01068860|365194187|FG001|Overall Study|Lost to Follow-up|1|||
105874779|NCT01068860|365194188|FG002|Overall Study|Lost to Follow-up|0|||
105874780|NCT01068860|365194189|FG003|Overall Study|Lost to Follow-up|0|||
105874781|NCT01068860|365194190|FG004|Overall Study|Lost to Follow-up|0|||
105874782|NCT01068860|365194191|FG005|Overall Study|Lost to Follow-up|0|||
105874783|NCT01068860|365194192|FG006|Overall Study|Lost to Follow-up|0|||
105874784|NCT01068860|365194193|FG007|Overall Study|Lost to Follow-up|0|||
105874785|NCT01068860|365194194|FG008|Overall Study|Lost to Follow-up|0|||
105874786|NCT01068860|365194195|FG009|Overall Study|Lost to Follow-up|0|||
105874787|NCT02568072|365194196|FG000|Overall Study|Unavailable for appointment|23|||
105874788|NCT02568072|365194196|FG000|Overall Study|Unable to contact|3|||
105874789|NCT02568072|365194196|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
105874790|NCT02568072|365194196|FG000|Overall Study|Withdrawal by Subject|1|||
105874791|NCT02568072|365194196|FG000|Overall Study|Sustained injury, marathon not run|24|||
105874792|NCT00460603|365194197|FG000|Phase 1|Death|1|||
105874793|NCT00460603|365194198|FG001|Phase 1|Death|0|||
105874794|NCT00460603|365194199|FG002|Phase 1|Death|0|||
105874795|NCT00460603|365194200|FG003|Phase 1|Death|2|||
105874796|NCT00460603|365194201|FG004|Phase 1|Death|0|||
105874797|NCT00460603|365194202|FG005|Phase 1|Death|0|||
105874798|NCT00460603|365194203|FG006|Phase 1|Death|0|||
105874799|NCT00460603|365194204|FG007|Phase 1|Death|0|||
105874800|NCT00460603|365194205|FG008|Phase 1|Death|1|||
105874801|NCT00460603|365194206|FG009|Phase 1|Death|0|||
105874802|NCT00460603|365194207|FG010|Phase 1|Death|0|||
105874803|NCT00460603|365194208|FG011|Phase 1|Death|0|||
105874804|NCT00460603|365194197|FG000|Phase 1|Adverse Event|3|||
105874805|NCT00460603|365194198|FG001|Phase 1|Adverse Event|1|||
105874806|NCT00460603|365194199|FG002|Phase 1|Adverse Event|1|||
105874807|NCT00460603|365194200|FG003|Phase 1|Adverse Event|2|||
105874808|NCT00460603|365194201|FG004|Phase 1|Adverse Event|0|||
105874809|NCT00460603|365194202|FG005|Phase 1|Adverse Event|0|||
105874810|NCT00460603|365194203|FG006|Phase 1|Adverse Event|3|||
105874811|NCT00460603|365194204|FG007|Phase 1|Adverse Event|0|||
105874812|NCT00460603|365194205|FG008|Phase 1|Adverse Event|4|||
105874813|NCT00460603|365194206|FG009|Phase 1|Adverse Event|0|||
105874814|NCT00460603|365194207|FG010|Phase 1|Adverse Event|0|||
105874815|NCT00460603|365194208|FG011|Phase 1|Adverse Event|0|||
105874816|NCT00460603|365194197|FG000|Phase 1|Lack of Efficacy|1|||
105874817|NCT00460603|365194198|FG001|Phase 1|Lack of Efficacy|0|||
105874818|NCT00460603|365194199|FG002|Phase 1|Lack of Efficacy|1|||
105874819|NCT00460603|365194200|FG003|Phase 1|Lack of Efficacy|2|||
105874820|NCT00460603|365194201|FG004|Phase 1|Lack of Efficacy|2|||
105874821|NCT00460603|365194202|FG005|Phase 1|Lack of Efficacy|2|||
105874822|NCT00460603|365194203|FG006|Phase 1|Lack of Efficacy|2|||
105874823|NCT00460603|365194204|FG007|Phase 1|Lack of Efficacy|2|||
105874824|NCT00460603|365194205|FG008|Phase 1|Lack of Efficacy|11|||
105874825|NCT00460603|365194206|FG009|Phase 1|Lack of Efficacy|0|||
105874826|NCT00460603|365194207|FG010|Phase 1|Lack of Efficacy|0|||
105874827|NCT00460603|365194208|FG011|Phase 1|Lack of Efficacy|0|||
105874828|NCT00460603|365194197|FG000|Phase 1|Withdrawal by Subject|1|||
105874829|NCT00460603|365194198|FG001|Phase 1|Withdrawal by Subject|2|||
105874830|NCT00460603|365194199|FG002|Phase 1|Withdrawal by Subject|1|||
105874831|NCT00460603|365194200|FG003|Phase 1|Withdrawal by Subject|1|||
105874832|NCT00460603|365194201|FG004|Phase 1|Withdrawal by Subject|3|||
105874833|NCT00460603|365194202|FG005|Phase 1|Withdrawal by Subject|0|||
105874834|NCT00460603|365194203|FG006|Phase 1|Withdrawal by Subject|1|||
105874835|NCT00460603|365194204|FG007|Phase 1|Withdrawal by Subject|0|||
105874836|NCT00460603|365194205|FG008|Phase 1|Withdrawal by Subject|2|||
105874837|NCT00460603|365194206|FG009|Phase 1|Withdrawal by Subject|0|||
105874838|NCT00460603|365194207|FG010|Phase 1|Withdrawal by Subject|0|||
105874839|NCT00460603|365194208|FG011|Phase 1|Withdrawal by Subject|0|||
105874840|NCT00460603|365194197|FG000|Phase 1|Other|0|||
105874841|NCT00460603|365194198|FG001|Phase 1|Other|3|||
105874842|NCT00460603|365194199|FG002|Phase 1|Other|1|||
105874843|NCT00460603|365194200|FG003|Phase 1|Other|1|||
105874844|NCT00460603|365194201|FG004|Phase 1|Other|1|||
105874845|NCT00460603|365194202|FG005|Phase 1|Other|2|||
105874846|NCT00460603|365194203|FG006|Phase 1|Other|0|||
105874847|NCT00460603|365194204|FG007|Phase 1|Other|1|||
105874848|NCT00460603|365194205|FG008|Phase 1|Other|0|||
105874849|NCT00460603|365194206|FG009|Phase 1|Other|0|||
105874850|NCT00460603|365194207|FG010|Phase 1|Other|0|||
105874851|NCT00460603|365194208|FG011|Phase 1|Other|0|||
105874852|NCT00460603|365194197|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874853|NCT00460603|365194198|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874854|NCT00460603|365194199|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874855|NCT00460603|365194200|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874856|NCT00460603|365194201|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874857|NCT00460603|365194202|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874858|NCT00460603|365194203|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105657636|NCT04680637|364409951|FG003|Overall Study|Lost to Follow-up|1|||
105657637|NCT04680637|364409948|FG000|Overall Study|Death|1|||
105657638|NCT04680637|364409949|FG001|Overall Study|Death|0|||
105874859|NCT00460603|365194204|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874860|NCT00460603|365194205|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874861|NCT00460603|365194206|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
105657639|NCT04680637|364409950|FG002|Overall Study|Death|0|||
105874862|NCT00460603|365194207|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874863|NCT00460603|365194208|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
105874864|NCT00460603|365194197|FG000|Phase 2|Adverse Event|0|||
105874865|NCT00460603|365194198|FG001|Phase 2|Adverse Event|0|||
105874866|NCT00460603|365194199|FG002|Phase 2|Adverse Event|0|||
105874867|NCT00460603|365194200|FG003|Phase 2|Adverse Event|0|||
105874868|NCT00460603|365194201|FG004|Phase 2|Adverse Event|0|||
105874869|NCT00460603|365194202|FG005|Phase 2|Adverse Event|0|||
105874870|NCT00460603|365194203|FG006|Phase 2|Adverse Event|0|||
105874871|NCT00460603|365194204|FG007|Phase 2|Adverse Event|0|||
105874872|NCT00460603|365194205|FG008|Phase 2|Adverse Event|0|||
105874873|NCT00460603|365194206|FG009|Phase 2|Adverse Event|12|||
105874874|NCT00460603|365194207|FG010|Phase 2|Adverse Event|9|||
105874875|NCT00460603|365194208|FG011|Phase 2|Adverse Event|10|||
105874876|NCT00460603|365194197|FG000|Phase 2|Death|0|||
105874877|NCT00460603|365194198|FG001|Phase 2|Death|0|||
105874878|NCT00460603|365194199|FG002|Phase 2|Death|0|||
105874879|NCT00460603|365194200|FG003|Phase 2|Death|0|||
105874880|NCT00460603|365194201|FG004|Phase 2|Death|0|||
105874881|NCT00460603|365194202|FG005|Phase 2|Death|0|||
105874882|NCT00460603|365194203|FG006|Phase 2|Death|0|||
105874883|NCT00460603|365194204|FG007|Phase 2|Death|0|||
105874884|NCT00460603|365194205|FG008|Phase 2|Death|0|||
105874885|NCT00460603|365194206|FG009|Phase 2|Death|4|||
105874886|NCT00460603|365194207|FG010|Phase 2|Death|2|||
105874887|NCT00460603|365194208|FG011|Phase 2|Death|2|||
105874888|NCT00460603|365194197|FG000|Phase 2|Protocol Violation|0|||
105874889|NCT00460603|365194198|FG001|Phase 2|Protocol Violation|0|||
105874890|NCT00460603|365194199|FG002|Phase 2|Protocol Violation|0|||
105874891|NCT00460603|365194200|FG003|Phase 2|Protocol Violation|0|||
105874892|NCT00460603|365194201|FG004|Phase 2|Protocol Violation|0|||
105874893|NCT00460603|365194202|FG005|Phase 2|Protocol Violation|0|||
105874894|NCT00460603|365194203|FG006|Phase 2|Protocol Violation|0|||
105874895|NCT00460603|365194204|FG007|Phase 2|Protocol Violation|0|||
105874896|NCT00460603|365194205|FG008|Phase 2|Protocol Violation|0|||
105874897|NCT00460603|365194206|FG009|Phase 2|Protocol Violation|1|||
105874898|NCT00460603|365194207|FG010|Phase 2|Protocol Violation|1|||
105874899|NCT00460603|365194208|FG011|Phase 2|Protocol Violation|0|||
105874900|NCT00460603|365194197|FG000|Phase 2|Lost to Follow-up|0|||
105874901|NCT00460603|365194198|FG001|Phase 2|Lost to Follow-up|0|||
105874902|NCT00460603|365194199|FG002|Phase 2|Lost to Follow-up|0|||
105874903|NCT00460603|365194200|FG003|Phase 2|Lost to Follow-up|0|||
105874904|NCT00460603|365194201|FG004|Phase 2|Lost to Follow-up|0|||
105874905|NCT00460603|365194202|FG005|Phase 2|Lost to Follow-up|0|||
105874906|NCT00460603|365194203|FG006|Phase 2|Lost to Follow-up|0|||
105874907|NCT00460603|365194204|FG007|Phase 2|Lost to Follow-up|0|||
105874908|NCT00460603|365194205|FG008|Phase 2|Lost to Follow-up|0|||
105874909|NCT00460603|365194206|FG009|Phase 2|Lost to Follow-up|1|||
105874910|NCT00460603|365194207|FG010|Phase 2|Lost to Follow-up|0|||
105874911|NCT00460603|365194208|FG011|Phase 2|Lost to Follow-up|0|||
105874912|NCT00460603|365194197|FG000|Phase 2|Other|0|||
105874913|NCT00460603|365194198|FG001|Phase 2|Other|0|||
105874914|NCT00460603|365194199|FG002|Phase 2|Other|0|||
105874915|NCT00460603|365194200|FG003|Phase 2|Other|0|||
105874916|NCT00460603|365194201|FG004|Phase 2|Other|0|||
105874917|NCT00460603|365194202|FG005|Phase 2|Other|0|||
105874918|NCT00460603|365194203|FG006|Phase 2|Other|0|||
105874919|NCT00460603|365194204|FG007|Phase 2|Other|0|||
105874920|NCT00460603|365194205|FG008|Phase 2|Other|0|||
105874921|NCT00460603|365194206|FG009|Phase 2|Other|6|||
105874922|NCT00460603|365194207|FG010|Phase 2|Other|16|||
105874923|NCT00460603|365194208|FG011|Phase 2|Other|7|||
105874924|NCT00460603|365194197|FG000|Phase 2|Objective Progression or Relapse|0|||
105874925|NCT00460603|365194198|FG001|Phase 2|Objective Progression or Relapse|0|||
105874926|NCT00460603|365194199|FG002|Phase 2|Objective Progression or Relapse|0|||
105874927|NCT00460603|365194200|FG003|Phase 2|Objective Progression or Relapse|0|||
105874928|NCT00460603|365194201|FG004|Phase 2|Objective Progression or Relapse|0|||
105874929|NCT00460603|365194202|FG005|Phase 2|Objective Progression or Relapse|0|||
105874930|NCT00460603|365194203|FG006|Phase 2|Objective Progression or Relapse|0|||
105874931|NCT00460603|365194204|FG007|Phase 2|Objective Progression or Relapse|0|||
105874932|NCT00460603|365194205|FG008|Phase 2|Objective Progression or Relapse|0|||
105874933|NCT00460603|365194206|FG009|Phase 2|Objective Progression or Relapse|9|||
105874934|NCT00460603|365194207|FG010|Phase 2|Objective Progression or Relapse|10|||
105874935|NCT00460603|365194208|FG011|Phase 2|Objective Progression or Relapse|17|||
105874936|NCT00460603|365194197|FG000|Phase 2|Global Deterioration of Health Status|0|||
105874937|NCT00460603|365194198|FG001|Phase 2|Global Deterioration of Health Status|0|||
105874938|NCT00460603|365194199|FG002|Phase 2|Global Deterioration of Health Status|0|||
105874939|NCT00460603|365194200|FG003|Phase 2|Global Deterioration of Health Status|0|||
105874940|NCT00460603|365194201|FG004|Phase 2|Global Deterioration of Health Status|0|||
105874941|NCT00460603|365194202|FG005|Phase 2|Global Deterioration of Health Status|0|||
105874942|NCT00460603|365194203|FG006|Phase 2|Global Deterioration of Health Status|0|||
105874943|NCT00460603|365194204|FG007|Phase 2|Global Deterioration of Health Status|0|||
105874944|NCT00460603|365194205|FG008|Phase 2|Global Deterioration of Health Status|0|||
105874945|NCT00460603|365194206|FG009|Phase 2|Global Deterioration of Health Status|0|||
105874946|NCT00460603|365194207|FG010|Phase 2|Global Deterioration of Health Status|1|||
105874947|NCT00460603|365194208|FG011|Phase 2|Global Deterioration of Health Status|0|||
105874948|NCT00460603|365194197|FG000|Phase 2|Withdrawal by Subject|0|||
105874949|NCT00460603|365194198|FG001|Phase 2|Withdrawal by Subject|0|||
105874950|NCT00460603|365194199|FG002|Phase 2|Withdrawal by Subject|0|||
105874951|NCT00460603|365194200|FG003|Phase 2|Withdrawal by Subject|0|||
105874952|NCT00460603|365194201|FG004|Phase 2|Withdrawal by Subject|0|||
105874953|NCT00460603|365194202|FG005|Phase 2|Withdrawal by Subject|0|||
105874954|NCT00460603|365194203|FG006|Phase 2|Withdrawal by Subject|0|||
105874955|NCT00460603|365194204|FG007|Phase 2|Withdrawal by Subject|0|||
105874956|NCT00460603|365194205|FG008|Phase 2|Withdrawal by Subject|0|||
105874957|NCT00460603|365194206|FG009|Phase 2|Withdrawal by Subject|5|||
105874958|NCT00460603|365194207|FG010|Phase 2|Withdrawal by Subject|4|||
105874959|NCT00460603|365194208|FG011|Phase 2|Withdrawal by Subject|5|||
105874960|NCT00460603|365194197|FG000|Phase 2|Randomized, but not treated|0|||
105874961|NCT00460603|365194198|FG001|Phase 2|Randomized, but not treated|0|||
105874962|NCT00460603|365194199|FG002|Phase 2|Randomized, but not treated|0|||
105874963|NCT00460603|365194200|FG003|Phase 2|Randomized, but not treated|0|||
105874964|NCT00460603|365194201|FG004|Phase 2|Randomized, but not treated|0|||
105874965|NCT00460603|365194202|FG005|Phase 2|Randomized, but not treated|0|||
105874966|NCT00460603|365194203|FG006|Phase 2|Randomized, but not treated|0|||
105874967|NCT00460603|365194204|FG007|Phase 2|Randomized, but not treated|0|||
105874968|NCT00460603|365194205|FG008|Phase 2|Randomized, but not treated|0|||
105874969|NCT00460603|365194206|FG009|Phase 2|Randomized, but not treated|3|||
105874970|NCT00460603|365194207|FG010|Phase 2|Randomized, but not treated|0|||
105874971|NCT00460603|365194208|FG011|Phase 2|Randomized, but not treated|0|||
105874972|NCT01321879|365194212|FG000|Overall Study|Lack of Efficacy|5|||
105874973|NCT01321879|365194212|FG000|Overall Study|Adverse Event|5|||
105874974|NCT01321879|365194212|FG000|Overall Study|Death|3|||
105874975|NCT01321879|365194212|FG000|Overall Study|Withdrawal by Subject|1|||
105874976|NCT02687451|365194213|FG000|Overall Study|Withdrawal by Subject|1|||
105874977|NCT02687451|365194214|FG001|Overall Study|Withdrawal by Subject|0|||
105874978|NCT02687451|365194215|FG002|Overall Study|Withdrawal by Subject|0|||
105874979|NCT02687451|365194216|FG003|Overall Study|Withdrawal by Subject|0|||
105874980|NCT02687451|365194217|FG004|Overall Study|Withdrawal by Subject|0|||
105874981|NCT02687451|365194218|FG005|Overall Study|Withdrawal by Subject|1|||
105874982|NCT00927589|365194219|FG000|Overall Study|Death|1|||
105874983|NCT00927589|365194219|FG000|Overall Study|Physician Decision|1|||
105874984|NCT00927589|365194219|FG000|Overall Study|Withdrawal by Subject|3|||
105874985|NCT00927589|365194219|FG000|Overall Study|Adverse Event|2|||
105874986|NCT00927589|365194219|FG000|Overall Study|Disease Progression|8|||
105874987|NCT00927589|365194219|FG000|Overall Study|Non-compliance|1|||
105874988|NCT03238651|365194220|FG000|Overall Study|Other|0|||
105874989|NCT03238651|365194221|FG001|Overall Study|Other|0|||
105874990|NCT03238651|365194222|FG002|Overall Study|Other|0|||
105874991|NCT03238651|365194223|FG003|Overall Study|Other|0|||
105874992|NCT03238651|365194224|FG004|Overall Study|Other|1|||
105874993|NCT03238651|365194220|FG000|Overall Study|Progressive Disease|2|||
105874994|NCT03238651|365194221|FG001|Overall Study|Progressive Disease|2|||
105874995|NCT03238651|365194222|FG002|Overall Study|Progressive Disease|2|||
105874996|NCT03238651|365194223|FG003|Overall Study|Progressive Disease|2|||
105874997|NCT03238651|365194224|FG004|Overall Study|Progressive Disease|0|||
105874998|NCT03238651|365194220|FG000|Overall Study|Withdrawal by Subject|0|||
105874999|NCT03238651|365194221|FG001|Overall Study|Withdrawal by Subject|1|||
105875000|NCT03238651|365194222|FG002|Overall Study|Withdrawal by Subject|0|||
105875001|NCT03238651|365194223|FG003|Overall Study|Withdrawal by Subject|1|||
105875002|NCT03238651|365194224|FG004|Overall Study|Withdrawal by Subject|0|||
105875003|NCT03238651|365194220|FG000|Overall Study|Adverse Event|1|||
105875004|NCT03238651|365194221|FG001|Overall Study|Adverse Event|3|||
105875005|NCT03238651|365194222|FG002|Overall Study|Adverse Event|2|||
105875006|NCT03238651|365194223|FG003|Overall Study|Adverse Event|0|||
105875007|NCT03238651|365194224|FG004|Overall Study|Adverse Event|0|||
105875008|NCT02550561|365194225|FG000|Overall Study|Lost to Follow-up|5|||
105875009|NCT02550561|365194225|FG000|Overall Study|Withdrawal by Subject|1|||
105875010|NCT01113892|365194226|FG000|Overall Study|Lost to Follow-up|2|||
105875011|NCT01113892|365194227|FG001|Overall Study|Lost to Follow-up|2|||
105875012|NCT01113892|365194226|FG000|Overall Study|Withdrawal by Subject|1|||
105875013|NCT01113892|365194227|FG001|Overall Study|Withdrawal by Subject|1|||
105875014|NCT01113892|365194226|FG000|Overall Study|Death|2|||
105875015|NCT01113892|365194227|FG001|Overall Study|Death|4|||
105875016|NCT01113892|365194226|FG000|Overall Study|Graft no longer evaluable|9|||
105875017|NCT01113892|365194227|FG001|Overall Study|Graft no longer evaluable|9|||
105875018|NCT05506046|365194236|FG000|Overall Study|Lost to Follow-up|89|||
105875019|NCT05506046|365194237|FG001|Overall Study|Lost to Follow-up|101|||
105875020|NCT05506046|365194238|FG002|Overall Study|Lost to Follow-up|102|||
105875021|NCT05506046|365194239|FG003|Overall Study|Lost to Follow-up|99|||
105875022|NCT00191477|365194240|FG000|Overall Study|Tumor Recurrence|49|||
105875023|NCT00191477|365194241|FG001|Overall Study|Tumor Recurrence|48|||
105875024|NCT00191477|365194240|FG000|Overall Study|Death, Study Disease|1|||
105875025|NCT00191477|365194241|FG001|Overall Study|Death, Study Disease|1|||
105875026|NCT00191477|365194240|FG000|Overall Study|Death, Other Cause|3|||
105875027|NCT00191477|365194241|FG001|Overall Study|Death, Other Cause|6|||
105875028|NCT00191477|365194240|FG000|Overall Study|Lost to Follow-up|23|||
105875029|NCT00191477|365194241|FG001|Overall Study|Lost to Follow-up|21|||
105875030|NCT00191477|365194240|FG000|Overall Study|Protocol Violation|1|||
105875031|NCT00191477|365194241|FG001|Overall Study|Protocol Violation|1|||
105875032|NCT00191477|365194240|FG000|Overall Study|Treatment Change|2|||
105875033|NCT00191477|365194241|FG001|Overall Study|Treatment Change|0|||
105875034|NCT00191477|365194240|FG000|Overall Study|Withdrawal by Subject|2|||
105875035|NCT00191477|365194241|FG001|Overall Study|Withdrawal by Subject|0|||
105875036|NCT00191477|365194240|FG000|Overall Study|Other|2|||
105875037|NCT00191477|365194241|FG001|Overall Study|Other|0|||
105875038|NCT00191477|365194240|FG000|Overall Study|Not Eligible|41|||
105875039|NCT00191477|365194241|FG001|Overall Study|Not Eligible|38|||
105875040|NCT00191477|365194240|FG000|Overall Study|Pathological Specimen Lost|1|||
105875041|NCT00191477|365194241|FG001|Overall Study|Pathological Specimen Lost|0|||
105875042|NCT00191477|365194240|FG000|Overall Study|Discontinued Prior to Instillation|13|||
105875043|NCT00191477|365194241|FG001|Overall Study|Discontinued Prior to Instillation|14|||
105875044|NCT00658723|365194256|FG000|Overall Study|Lost to Follow-up|0|||
105875045|NCT00658723|365194257|FG001|Overall Study|Lost to Follow-up|2|||
105875046|NCT00658723|365194258|FG002|Overall Study|Lost to Follow-up|2|||
105875047|NCT00658723|365194256|FG000|Overall Study|Death|2|||
105875048|NCT00658723|365194257|FG001|Overall Study|Death|1|||
105875049|NCT00658723|365194258|FG002|Overall Study|Death|4|||
105875050|NCT00658723|365194256|FG000|Overall Study|Scheduling Issue|1|||
105875051|NCT00658723|365194257|FG001|Overall Study|Scheduling Issue|1|||
105875052|NCT00658723|365194258|FG002|Overall Study|Scheduling Issue|0|||
105875053|NCT00658723|365194256|FG000|Overall Study|Withdrawal by Subject|1|||
105875054|NCT00658723|365194257|FG001|Overall Study|Withdrawal by Subject|0|||
105875055|NCT00658723|365194258|FG002|Overall Study|Withdrawal by Subject|1|||
105875056|NCT01546025|365194264|FG000|Overall Study|Lost to Follow-up|0|||
105875057|NCT01546025|365194265|FG001|Overall Study|Lost to Follow-up|1|||
105875058|NCT00679211|365196407|FG000|Overall Study|Progressive disease|82|||
105875059|NCT00679211|365196407|FG000|Overall Study|Adverse Event|7|||
105875060|NCT00679211|365196407|FG000|Overall Study|Withdrawal by Subject|2|||
105875061|NCT00679211|365196407|FG000|Overall Study|Physician Decision|5|||
105875062|NCT00679211|365196407|FG000|Overall Study|Refused to undergo protocol procedures|1|||
105875063|NCT00679211|365196407|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
105875064|NCT00679211|365196407|FG000|Overall Study|Other|1|||
105875065|NCT01730053|365196408|FG000|Overall Study|Participant moved|0|||
105875066|NCT01730053|365196409|FG001|Overall Study|Participant moved|0|||
105875067|NCT01730053|365196410|FG002|Overall Study|Participant moved|1|||
105875068|NCT01730053|365196411|FG003|Overall Study|Participant moved|0|||
105875069|NCT01730053|365196412|FG004|Overall Study|Participant moved|0|||
105875070|NCT01730053|365196413|FG005|Overall Study|Participant moved|0|||
105875071|NCT01730053|365196408|FG000|Overall Study|Physician Decision|0|||
105875072|NCT01730053|365196409|FG001|Overall Study|Physician Decision|0|||
105875073|NCT01730053|365196410|FG002|Overall Study|Physician Decision|0|||
105875074|NCT01730053|365196411|FG003|Overall Study|Physician Decision|1|||
105875075|NCT01730053|365196412|FG004|Overall Study|Physician Decision|0|||
105875076|NCT01730053|365196413|FG005|Overall Study|Physician Decision|0|||
105875077|NCT01730053|365196408|FG000|Overall Study|Adverse Event|2|||
105875078|NCT01730053|365196409|FG001|Overall Study|Adverse Event|6|||
105875079|NCT01730053|365196410|FG002|Overall Study|Adverse Event|3|||
105875080|NCT01730053|365196411|FG003|Overall Study|Adverse Event|3|||
105875081|NCT01730053|365196412|FG004|Overall Study|Adverse Event|2|||
105875082|NCT01730053|365196413|FG005|Overall Study|Adverse Event|2|||
105875083|NCT01730053|365196408|FG000|Overall Study|Poor compliance to protocol|1|||
105875084|NCT01730053|365196409|FG001|Overall Study|Poor compliance to protocol|2|||
105875085|NCT01730053|365196410|FG002|Overall Study|Poor compliance to protocol|2|||
105875086|NCT01730053|365196411|FG003|Overall Study|Poor compliance to protocol|0|||
105875087|NCT01730053|365196412|FG004|Overall Study|Poor compliance to protocol|0|||
105875088|NCT01730053|365196413|FG005|Overall Study|Poor compliance to protocol|2|||
105875089|NCT01730053|365196408|FG000|Overall Study|Other than specified|2|||
105875090|NCT01730053|365196409|FG001|Overall Study|Other than specified|6|||
105875091|NCT01730053|365196410|FG002|Overall Study|Other than specified|5|||
105875092|NCT01730053|365196411|FG003|Overall Study|Other than specified|4|||
105875093|NCT01730053|365196412|FG004|Overall Study|Other than specified|7|||
105875094|NCT01730053|365196413|FG005|Overall Study|Other than specified|9|||
105875095|NCT03511105|365196414|FG000|Overall Study|Adverse Event|1|||
105875096|NCT03511105|365196415|FG001|Overall Study|Adverse Event|0|||
105875097|NCT03511105|365196414|FG000|Overall Study|Withdrew consent|1|||
105875098|NCT03511105|365196415|FG001|Overall Study|Withdrew consent|0|||
105875099|NCT02832687|365196416|FG000|Overall Study|Adverse Event|0|||
105875100|NCT02832687|365196417|FG001|Overall Study|Adverse Event|2|||
105875101|NCT04231825|365196418|FG000|Overall Study|Protocol Violation|3|||
105875102|NCT04231825|365196419|FG001|Overall Study|Protocol Violation|3|||
105875103|NCT04231825|365196418|FG000|Overall Study|Lost to Follow-up|0|||
105875104|NCT04231825|365196419|FG001|Overall Study|Lost to Follow-up|1|||
105875105|NCT02019472|365196420|FG000|Overall Study|Adverse Event|14|||
105875106|NCT02019472|365196421|FG001|Overall Study|Adverse Event|23|||
105875107|NCT02019472|365196422|FG002|Overall Study|Adverse Event|17|||
105875108|NCT02019472|365196420|FG000|Overall Study|Death|0|||
105875109|NCT02019472|365196421|FG001|Overall Study|Death|1|||
105875110|NCT02019472|365196422|FG002|Overall Study|Death|1|||
105875111|NCT02019472|365196420|FG000|Overall Study|Lack of Efficacy|7|||
105875112|NCT02019472|365196421|FG001|Overall Study|Lack of Efficacy|4|||
105875113|NCT02019472|365196422|FG002|Overall Study|Lack of Efficacy|4|||
105875114|NCT02019472|365196420|FG000|Overall Study|Lost to Follow-up|0|||
105875115|NCT02019472|365196421|FG001|Overall Study|Lost to Follow-up|2|||
105875116|NCT02019472|365196422|FG002|Overall Study|Lost to Follow-up|1|||
105875117|NCT02019472|365196420|FG000|Overall Study|Physician Decision|1|||
105875118|NCT02019472|365196421|FG001|Overall Study|Physician Decision|2|||
105875119|NCT02019472|365196422|FG002|Overall Study|Physician Decision|0|||
105875120|NCT02019472|365196420|FG000|Overall Study|Pregnancy|1|||
105875121|NCT02019472|365196421|FG001|Overall Study|Pregnancy|2|||
105875122|NCT02019472|365196422|FG002|Overall Study|Pregnancy|2|||
105875123|NCT02019472|365196420|FG000|Overall Study|Withdrawal by Subject|11|||
105875124|NCT02019472|365196421|FG001|Overall Study|Withdrawal by Subject|10|||
105875125|NCT02019472|365196422|FG002|Overall Study|Withdrawal by Subject|11|||
105875126|NCT02019472|365196420|FG000|Overall Study|Other|3|||
105875127|NCT02019472|365196421|FG001|Overall Study|Other|8|||
105875128|NCT02019472|365196422|FG002|Overall Study|Other|6|||
105875129|NCT01662635|365196423|FG000|Overall Study|scarce samples for evaluation|30|||
105875130|NCT04570670|365196426|FG000|Overall Study|Withdrawal by Subject|1|||
105875131|NCT04570670|365196427|FG001|Overall Study|Withdrawal by Subject|0|||
105875132|NCT01002989|365196428|FG000|Overall Study|exclusion criteria, no consent|5|||
105875133|NCT02547428|365196435|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
105875134|NCT02547428|365196436|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
105875135|NCT02547428|365196435|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
105875136|NCT02547428|365196436|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
105875137|NCT02547428|365196435|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
105875138|NCT02547428|365196436|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
105875139|NCT02547428|365196435|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
105875140|NCT02547428|365196436|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
105875141|NCT02547428|365196435|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
105875142|NCT02547428|365196436|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
105875143|NCT02547428|365196435|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
105875144|NCT02547428|365196436|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
105875145|NCT02547428|365196435|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
105875146|NCT02547428|365196436|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
105875147|NCT02547428|365196435|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
105875148|NCT02547428|365196436|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
105875149|NCT01479465|365196437|FG000|Overall Study|Disease Progression|9|||
105875150|NCT01479465|365196438|FG001|Overall Study|Disease Progression|61|||
105875151|NCT01479465|365196439|FG002|Overall Study|Disease Progression|65|||
105875152|NCT01479465|365196440|FG003|Overall Study|Disease Progression|70|||
105875153|NCT01479465|365196437|FG000|Overall Study|Study Discontinued by Sponsor|0|||
105875154|NCT01479465|365196438|FG001|Overall Study|Study Discontinued by Sponsor|7|||
105875155|NCT01479465|365196439|FG002|Overall Study|Study Discontinued by Sponsor|5|||
105875156|NCT01479465|365196440|FG003|Overall Study|Study Discontinued by Sponsor|3|||
105875157|NCT01479465|365196437|FG000|Overall Study|Adverse Event|0|||
105875158|NCT01479465|365196438|FG001|Overall Study|Adverse Event|3|||
105875159|NCT01479465|365196439|FG002|Overall Study|Adverse Event|6|||
105875160|NCT01479465|365196440|FG003|Overall Study|Adverse Event|4|||
105875161|NCT01479465|365196437|FG000|Overall Study|Investigator Discretion|1|||
105875162|NCT01479465|365196438|FG001|Overall Study|Investigator Discretion|4|||
105875163|NCT01479465|365196439|FG002|Overall Study|Investigator Discretion|2|||
105875164|NCT01479465|365196440|FG003|Overall Study|Investigator Discretion|4|||
105875165|NCT01479465|365196437|FG000|Overall Study|Subject Request|1|||
105875166|NCT01479465|365196438|FG001|Overall Study|Subject Request|3|||
105875167|NCT01479465|365196439|FG002|Overall Study|Subject Request|4|||
105875168|NCT01479465|365196440|FG003|Overall Study|Subject Request|2|||
105875169|NCT01479465|365196437|FG000|Overall Study|Subject Withdrew Consent|0|||
105875170|NCT01479465|365196438|FG001|Overall Study|Subject Withdrew Consent|5|||
105875171|NCT01479465|365196439|FG002|Overall Study|Subject Withdrew Consent|2|||
105875172|NCT01479465|365196440|FG003|Overall Study|Subject Withdrew Consent|1|||
105875173|NCT01479465|365196437|FG000|Overall Study|Protocol Violation|0|||
105875174|NCT01479465|365196438|FG001|Overall Study|Protocol Violation|1|||
105875175|NCT01479465|365196439|FG002|Overall Study|Protocol Violation|1|||
105875176|NCT01479465|365196440|FG003|Overall Study|Protocol Violation|0|||
105875177|NCT01479465|365196437|FG000|Overall Study|Death|0|||
105875178|NCT01479465|365196438|FG001|Overall Study|Death|0|||
105875179|NCT01479465|365196439|FG002|Overall Study|Death|0|||
105875180|NCT01479465|365196440|FG003|Overall Study|Death|1|||
105875181|NCT01479465|365196437|FG000|Overall Study|Lost to Follow-up|0|||
105875182|NCT01479465|365196438|FG001|Overall Study|Lost to Follow-up|0|||
105875183|NCT01479465|365196439|FG002|Overall Study|Lost to Follow-up|1|||
105875184|NCT01479465|365196440|FG003|Overall Study|Lost to Follow-up|0|||
105875185|NCT01108718|365196443|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
105875186|NCT01108718|365196444|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
105875187|NCT01060072|365196445|FG000|Overall Study|Adverse Event|1|||
105875188|NCT01060072|365196446|FG001|Overall Study|Adverse Event|1|||
105875189|NCT01060072|365196445|FG000|Overall Study|Physician Decision|0|||
105875190|NCT01060072|365196446|FG001|Overall Study|Physician Decision|2|||
105875191|NCT01060072|365196445|FG000|Overall Study|Protocol Violation|0|||
105875192|NCT01060072|365196446|FG001|Overall Study|Protocol Violation|1|||
105875193|NCT01060072|365196445|FG000|Overall Study|Acute cholecystitis|1|||
105875194|NCT01060072|365196446|FG001|Overall Study|Acute cholecystitis|0|||
105875195|NCT01060072|365196445|FG000|Overall Study|Excluded Medications|0|||
105875196|NCT01060072|365196446|FG001|Overall Study|Excluded Medications|1|||
105875197|NCT01262872|365196447|FG000|Step 2|Death|0|||
105875198|NCT01262872|365196448|FG001|Step 2|Death|0|||
105875199|NCT01262872|365196449|FG002|Step 2|Death|0|||
105875200|NCT01262872|365196450|FG003|Step 2|Death|1|||
105875201|NCT01262872|365196451|FG004|Step 2|Death|0|||
105875202|NCT01262872|365196452|FG005|Step 2|Death|2|||
105875203|NCT01262872|365196453|FG006|Step 2|Death|2|||
105875204|NCT01262872|365196454|FG007|Step 2|Death|1|||
105875205|NCT01262872|365196447|FG000|Step 2|Protocol Violation|0|||
105875206|NCT01262872|365196448|FG001|Step 2|Protocol Violation|0|||
105875207|NCT01262872|365196449|FG002|Step 2|Protocol Violation|1|||
105875208|NCT01262872|365196450|FG003|Step 2|Protocol Violation|0|||
105875209|NCT01262872|365196451|FG004|Step 2|Protocol Violation|0|||
105875210|NCT01262872|365196452|FG005|Step 2|Protocol Violation|0|||
105875211|NCT01262872|365196453|FG006|Step 2|Protocol Violation|3|||
105875212|NCT01262872|365196454|FG007|Step 2|Protocol Violation|1|||
105875213|NCT01262872|365196447|FG000|Step 2|Withdrawal by Subject|0|||
105875214|NCT01262872|365196448|FG001|Step 2|Withdrawal by Subject|0|||
105875215|NCT01262872|365196449|FG002|Step 2|Withdrawal by Subject|4|||
105875216|NCT01262872|365196450|FG003|Step 2|Withdrawal by Subject|6|||
105875217|NCT01262872|365196451|FG004|Step 2|Withdrawal by Subject|3|||
105875218|NCT01262872|365196452|FG005|Step 2|Withdrawal by Subject|1|||
105875219|NCT01262872|365196453|FG006|Step 2|Withdrawal by Subject|2|||
105875220|NCT01262872|365196454|FG007|Step 2|Withdrawal by Subject|1|||
105875221|NCT01262872|365196447|FG000|Step 2|Migrated/moved from study area|0|||
105875222|NCT01262872|365196448|FG001|Step 2|Migrated/moved from study area|0|||
105875223|NCT01262872|365196449|FG002|Step 2|Migrated/moved from study area|4|||
105875224|NCT01262872|365196450|FG003|Step 2|Migrated/moved from study area|3|||
105875225|NCT01262872|365196451|FG004|Step 2|Migrated/moved from study area|2|||
105875226|NCT01262872|365196452|FG005|Step 2|Migrated/moved from study area|6|||
105875227|NCT01262872|365196453|FG006|Step 2|Migrated/moved from study area|2|||
105875228|NCT01262872|365196454|FG007|Step 2|Migrated/moved from study area|3|||
105875229|NCT03380429|365196455|FG000|Overall Study|Physician Decision|0|||
105875230|NCT03380429|365196456|FG001|Overall Study|Physician Decision|1|||
105875231|NCT03380429|365196457|FG002|Overall Study|Physician Decision|0|||
105875232|NCT03380429|365196458|FG003|Overall Study|Physician Decision|1|||
105875233|NCT03380429|365196459|FG004|Overall Study|Physician Decision|1|||
105875234|NCT03380429|365196455|FG000|Overall Study|Withdrawal by Subject|3|||
105875235|NCT03380429|365196456|FG001|Overall Study|Withdrawal by Subject|3|||
105875236|NCT03380429|365196457|FG002|Overall Study|Withdrawal by Subject|5|||
105875237|NCT03380429|365196458|FG003|Overall Study|Withdrawal by Subject|2|||
105875238|NCT03380429|365196459|FG004|Overall Study|Withdrawal by Subject|1|||
105875239|NCT03380429|365196455|FG000|Overall Study|Lost to Follow-up|0|||
105875240|NCT03380429|365196456|FG001|Overall Study|Lost to Follow-up|2|||
105875241|NCT03380429|365196457|FG002|Overall Study|Lost to Follow-up|4|||
105875242|NCT03380429|365196458|FG003|Overall Study|Lost to Follow-up|3|||
105875243|NCT03380429|365196459|FG004|Overall Study|Lost to Follow-up|1|||
105875244|NCT03380429|365196455|FG000|Overall Study|Protocol Violation|1|||
105875245|NCT03380429|365196456|FG001|Overall Study|Protocol Violation|0|||
105875246|NCT03380429|365196457|FG002|Overall Study|Protocol Violation|1|||
105875247|NCT03380429|365196458|FG003|Overall Study|Protocol Violation|0|||
105875248|NCT03380429|365196459|FG004|Overall Study|Protocol Violation|1|||
105875249|NCT03380429|365196455|FG000|Overall Study|Lack of Efficacy|0|||
105875250|NCT03380429|365196456|FG001|Overall Study|Lack of Efficacy|0|||
105875251|NCT03380429|365196457|FG002|Overall Study|Lack of Efficacy|0|||
105875252|NCT03380429|365196458|FG003|Overall Study|Lack of Efficacy|2|||
105875253|NCT03380429|365196459|FG004|Overall Study|Lack of Efficacy|1|||
105875254|NCT03380429|365196455|FG000|Overall Study|Adverse Event|1|||
105875255|NCT03380429|365196456|FG001|Overall Study|Adverse Event|1|||
105875256|NCT03380429|365196457|FG002|Overall Study|Adverse Event|1|||
105875257|NCT03380429|365196458|FG003|Overall Study|Adverse Event|2|||
105875258|NCT03380429|365196459|FG004|Overall Study|Adverse Event|0|||
105875259|NCT01198470|365196462|FG000|Overall Study|Adverse Event|2|||
105875260|NCT00765102|365196465|FG000|Overall Study|Progressive disease|18|||
105875261|NCT00765102|365196465|FG000|Overall Study|Adverse Event|6|||
105875262|NCT00765102|365196465|FG000|Overall Study|Physician Decision|4|||
105875263|NCT00765102|365196465|FG000|Overall Study|Withdrawal by Subject|2|||
105875264|NCT00765102|365196465|FG000|Overall Study|Protocol Violation|1|||
105875265|NCT01787292|365196466|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
105875266|NCT01787292|365196467|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
105875267|NCT01787292|365196466|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
105875268|NCT01787292|365196467|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
105875269|NCT03181633|365196468|FG000|Overall Study|Withdrawal by Subject|1|||
105875270|NCT03181633|365196468|FG000|Overall Study|Missing follow-up visit|1|||
105875271|NCT02962648|365196469|FG000|Overall Study|Withdrawal by Subject|3|||
105875272|NCT02962648|365196469|FG000|Overall Study|Lost to Follow-up|3|||
105875273|NCT02962648|365196469|FG000|Overall Study|Physician Decision|1|||
105875274|NCT02962648|365196469|FG000|Overall Study|Subject had problems with transportation|2|||
105875275|NCT01924689|365196470|FG000|Overall Study|Death|0|||
105875276|NCT01924689|365196471|FG001|Overall Study|Death|1|||
105875277|NCT01924689|365196472|FG002|Overall Study|Death|0|||
105875278|NCT01924689|365196473|FG003|Overall Study|Death|1|||
105875279|NCT01924689|365196474|FG004|Overall Study|Death|0|||
105875280|NCT01924689|365196475|FG005|Overall Study|Death|0|||
105875281|NCT01924689|365196470|FG000|Overall Study|Disease progression|0|||
105875282|NCT01924689|365196471|FG001|Overall Study|Disease progression|0|||
105875283|NCT01924689|365196472|FG002|Overall Study|Disease progression|2|||
105875284|NCT01924689|365196473|FG003|Overall Study|Disease progression|0|||
105875285|NCT01924689|365196474|FG004|Overall Study|Disease progression|3|||
105875286|NCT01924689|365196475|FG005|Overall Study|Disease progression|2|||
105875287|NCT01924689|365196470|FG000|Overall Study|New therapy or study|3|||
105875288|NCT01924689|365196471|FG001|Overall Study|New therapy or study|2|||
105875289|NCT01924689|365196472|FG002|Overall Study|New therapy or study|1|||
105875290|NCT01924689|365196473|FG003|Overall Study|New therapy or study|4|||
105875291|NCT01924689|365196474|FG004|Overall Study|New therapy or study|2|||
105875292|NCT01924689|365196475|FG005|Overall Study|New therapy or study|0|||
105875293|NCT01924689|365196470|FG000|Overall Study|Withdrawal of consent|0|||
105875294|NCT01924689|365196471|FG001|Overall Study|Withdrawal of consent|0|||
105875295|NCT01924689|365196472|FG002|Overall Study|Withdrawal of consent|1|||
105875296|NCT01924689|365196473|FG003|Overall Study|Withdrawal of consent|1|||
105875297|NCT01924689|365196474|FG004|Overall Study|Withdrawal of consent|0|||
105875298|NCT01924689|365196475|FG005|Overall Study|Withdrawal of consent|0|||
105875299|NCT01924689|365196470|FG000|Overall Study|Other|0|||
105875300|NCT01924689|365196471|FG001|Overall Study|Other|0|||
105875301|NCT01924689|365196472|FG002|Overall Study|Other|0|||
105875302|NCT01924689|365196473|FG003|Overall Study|Other|0|||
105875303|NCT01924689|365196474|FG004|Overall Study|Other|1|||
105875304|NCT01924689|365196475|FG005|Overall Study|Other|0|||
105875305|NCT01597778|365196477|FG000|Overall Study|Death|7|||
105875306|NCT01597778|365196478|FG001|Overall Study|Death|10|||
105875307|NCT01597778|365196477|FG000|Overall Study|Withdrawal by Subject|3|||
105875308|NCT01597778|365196478|FG001|Overall Study|Withdrawal by Subject|4|||
105875309|NCT01597778|365196477|FG000|Overall Study|Adverse Event|1|||
105875310|NCT01597778|365196478|FG001|Overall Study|Adverse Event|1|||
105875311|NCT01597778|365196477|FG000|Overall Study|Protocol Violation|1|||
105875312|NCT01597778|365196478|FG001|Overall Study|Protocol Violation|11|||
105875313|NCT01597778|365196477|FG000|Overall Study|Transplanted off protocol|2|||
105875314|NCT01597778|365196478|FG001|Overall Study|Transplanted off protocol|3|||
105875315|NCT04030299|365196480|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
105875316|NCT04030299|365196480|FG000|Overall Study|Withdrawal by Subject|3|||
105875317|NCT04616612|365196481|FG000|Overall Study|Lost to Follow-up|6|||
105875318|NCT04616612|365196482|FG001|Overall Study|Lost to Follow-up|3|||
105875319|NCT01597973|365196483|FG000|Overall Study|Found ineligible before study medication started|4|||
105875320|NCT01597973|365196484|FG001|Overall Study|Found ineligible before study medication started|2|||
105875321|NCT01597973|365196483|FG000|Overall Study|Eligible pathogen not confirmed|14|||
105875322|NCT01597973|365196484|FG001|Overall Study|Eligible pathogen not confirmed|15|||
105875323|NCT01597973|365196483|FG000|Overall Study|LAR not authorized to consent|0|||
105875324|NCT01597973|365196484|FG001|Overall Study|LAR not authorized to consent|1|||
105875325|NCT01597973|365196483|FG000|Overall Study|Ineligible due to early seizures|1|||
105875326|NCT01597973|365196484|FG001|Overall Study|Ineligible due to early seizures|0|||
105875327|NCT01597973|365196483|FG000|Overall Study|Ineligible due to non-target infection|1|||
105875328|NCT01597973|365196484|FG001|Overall Study|Ineligible due to non-target infection|1|||
105875329|NCT01288079|365196487|FG000|Overall Study|Withdrawal by Subject|2|||
105875330|NCT01288079|365196488|FG001|Overall Study|Withdrawal by Subject|4|||
105875331|NCT01288079|365196489|FG002|Overall Study|Withdrawal by Subject|1|||
105875332|NCT01288079|365196490|FG003|Overall Study|Withdrawal by Subject|0|||
105875333|NCT01288079|365196487|FG000|Overall Study|Adverse Event|2|||
105875334|NCT01288079|365196488|FG001|Overall Study|Adverse Event|1|||
105875335|NCT01288079|365196489|FG002|Overall Study|Adverse Event|2|||
105875336|NCT01288079|365196490|FG003|Overall Study|Adverse Event|3|||
105875337|NCT01288079|365196487|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
105875338|NCT01288079|365196488|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
105875339|NCT01288079|365196489|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
105875340|NCT01288079|365196490|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
105875341|NCT01288079|365196487|FG000|Overall Study|Condition under Investigation Worsened|0|||
105875342|NCT01288079|365196488|FG001|Overall Study|Condition under Investigation Worsened|0|||
105875343|NCT01288079|365196489|FG002|Overall Study|Condition under Investigation Worsened|0|||
105875344|NCT01288079|365196490|FG003|Overall Study|Condition under Investigation Worsened|1|||
105875345|NCT01288079|365196487|FG000|Overall Study|Lack of Efficacy|2|||
105875346|NCT01288079|365196488|FG001|Overall Study|Lack of Efficacy|2|||
105875347|NCT01288079|365196489|FG002|Overall Study|Lack of Efficacy|0|||
105875348|NCT01288079|365196490|FG003|Overall Study|Lack of Efficacy|2|||
105875349|NCT01288079|365196487|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
105875350|NCT01288079|365196488|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
105875351|NCT01288079|365196489|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
105875352|NCT01288079|365196490|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
105875353|NCT01288079|365196487|FG000|Overall Study|Lost to Follow-up|1|||
105875354|NCT01288079|365196488|FG001|Overall Study|Lost to Follow-up|1|||
105875355|NCT01288079|365196489|FG002|Overall Study|Lost to Follow-up|1|||
105875356|NCT01288079|365196490|FG003|Overall Study|Lost to Follow-up|0|||
105875357|NCT01288079|365196487|FG000|Overall Study|Other or Study Termination|11|||
105875358|NCT01288079|365196488|FG001|Overall Study|Other or Study Termination|15|||
105875359|NCT01288079|365196489|FG002|Overall Study|Other or Study Termination|14|||
105875360|NCT01288079|365196490|FG003|Overall Study|Other or Study Termination|8|||
105875361|NCT00908544|365196491|FG000|Overall Study|Withdrawal by Subject|2|||
105875362|NCT00908544|365196492|FG001|Overall Study|Withdrawal by Subject|4|||
105875363|NCT00908544|365196491|FG000|Overall Study|Lack of Efficacy|0|||
105875364|NCT00908544|365196492|FG001|Overall Study|Lack of Efficacy|1|||
105875365|NCT00908544|365196491|FG000|Overall Study|Pregnancy|1|||
105875366|NCT00908544|365196492|FG001|Overall Study|Pregnancy|0|||
105875367|NCT00908544|365196491|FG000|Overall Study|Relocation abroad|1|||
105875368|NCT00908544|365196492|FG001|Overall Study|Relocation abroad|1|||
105875369|NCT00908544|365196491|FG000|Overall Study|Unable to visit sutdy center|1|||
105875370|NCT00908544|365196492|FG001|Overall Study|Unable to visit sutdy center|0|||
105875371|NCT03170544|365196493|FG000|Part 1|Lost to Follow-up|1|||
105875372|NCT03170544|365196494|FG001|Part 1|Lost to Follow-up|0|||
105875373|NCT03170544|365196495|FG002|Part 1|Lost to Follow-up|0|||
105875374|NCT03170544|365196496|FG003|Part 1|Lost to Follow-up|0|||
105875375|NCT03170544|365196497|FG004|Part 1|Lost to Follow-up|0|||
105875376|NCT03170544|365196498|FG005|Part 1|Lost to Follow-up|0|||
105875377|NCT03170544|365196499|FG006|Part 1|Lost to Follow-up|0|||
105875378|NCT03170544|365196500|FG007|Part 1|Lost to Follow-up|0|||
105875379|NCT03170544|365196501|FG008|Part 1|Lost to Follow-up|0|||
105875380|NCT03170544|365196502|FG009|Part 1|Lost to Follow-up|0|||
105875381|NCT03170544|365196503|FG010|Part 1|Lost to Follow-up|0|||
105875382|NCT03170544|365196504|FG011|Part 1|Lost to Follow-up|0|||
105875383|NCT03170544|365196493|FG000|Part 1|Not treated|0|||
105875384|NCT03170544|365196494|FG001|Part 1|Not treated|0|||
105875385|NCT03170544|365196495|FG002|Part 1|Not treated|0|||
105875386|NCT03170544|365196496|FG003|Part 1|Not treated|1|||
105875387|NCT03170544|365196497|FG004|Part 1|Not treated|0|||
105875388|NCT03170544|365196498|FG005|Part 1|Not treated|0|||
105875389|NCT03170544|365196499|FG006|Part 1|Not treated|0|||
105875390|NCT03170544|365196500|FG007|Part 1|Not treated|0|||
105875391|NCT03170544|365196501|FG008|Part 1|Not treated|0|||
105875392|NCT03170544|365196502|FG009|Part 1|Not treated|0|||
105875393|NCT03170544|365196503|FG010|Part 1|Not treated|0|||
105875394|NCT03170544|365196504|FG011|Part 1|Not treated|0|||
105875395|NCT01213966|365196505|FG000|Overall Study|Protocol Violation|1|||
105875396|NCT01213966|365196506|FG001|Overall Study|Protocol Violation|0|||
105875397|NCT01213966|365196507|FG002|Overall Study|Protocol Violation|3|||
105875398|NCT01213966|365196508|FG003|Overall Study|Protocol Violation|1|||
105875399|NCT02174627|365196514|FG000|Overall Study|Missing|0|||
105875400|NCT02174627|365196515|FG001|Overall Study|Missing|1|||
105875401|NCT02174627|365196514|FG000|Overall Study|Incorrect enrolment before randomization|0|||
105875402|NCT02174627|365196515|FG001|Overall Study|Incorrect enrolment before randomization|1|||
105875403|NCT02174627|365196514|FG000|Overall Study|Participant decision|84|||
105875404|NCT02174627|365196515|FG001|Overall Study|Participant decision|128|||
105875405|NCT03591874|365196516|FG000|Overall Study|Adverse Event|4|||
105875406|NCT03591874|365196517|FG001|Overall Study|Adverse Event|0|||
105875407|NCT03591874|365196516|FG000|Overall Study|Withdrawal by Subject|2|||
105875408|NCT03591874|365196517|FG001|Overall Study|Withdrawal by Subject|1|||
105875409|NCT03591874|365196516|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
105875410|NCT03591874|365196517|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
105875411|NCT03591874|365196516|FG000|Overall Study|On Study at Time of Study Termination|12|||
105875412|NCT03591874|365196517|FG001|Overall Study|On Study at Time of Study Termination|6|||
105875413|NCT04564092|365196518|FG000|Overall Study|Withdrawal by Subject|1|||
105875414|NCT02269098|365196521|FG000|Overall Study|Lost to Follow-up|14|||
105875415|NCT02269098|365196522|FG001|Overall Study|Lost to Follow-up|9|||
105875416|NCT04495829|365196526|FG000|Overall Study|Lost to Follow-up|2|||
105875417|NCT04495829|365196526|FG000|Overall Study|Inclusion criterion not met|3|||
105875418|NCT02107131|365196529|FG000|Overall Study|Lost to Follow-up|4|||
105875419|NCT02107131|365196530|FG001|Overall Study|Lost to Follow-up|4|||
105875420|NCT02107131|365196529|FG000|Overall Study|Physician Decision|1|||
105875421|NCT02107131|365196530|FG001|Overall Study|Physician Decision|0|||
105875422|NCT02107131|365196529|FG000|Overall Study|Withdrawal by Subject|2|||
105875423|NCT02107131|365196530|FG001|Overall Study|Withdrawal by Subject|0|||
105875424|NCT02107131|365196529|FG000|Overall Study|mental instability|1|||
105875425|NCT02107131|365196530|FG001|Overall Study|mental instability|0|||
105875426|NCT02107131|365196529|FG000|Overall Study|Death|0|||
105875427|NCT02107131|365196530|FG001|Overall Study|Death|1|||
105875428|NCT02107131|365196529|FG000|Overall Study|Protocol Violation|0|||
105875429|NCT02107131|365196530|FG001|Overall Study|Protocol Violation|4|||
105875430|NCT00682786|365196531|FG000|Overall Study|Withdrawal by Subject|2|||
105875431|NCT00682786|365196532|FG001|Overall Study|Withdrawal by Subject|2|||
105875432|NCT00682786|365196531|FG000|Overall Study|Did not receive irinotecan|0|||
105875433|NCT00682786|365196532|FG001|Overall Study|Did not receive irinotecan|1|||
105875434|NCT02747108|365196533|FG000|Overall Study|Death|2|||
105875435|NCT02747108|365196534|FG001|Overall Study|Death|2|||
105875436|NCT02747108|365196533|FG000|Overall Study|Withdrawal by Subject|1|||
105875437|NCT02747108|365196534|FG001|Overall Study|Withdrawal by Subject|0|||
105875438|NCT02747108|365196533|FG000|Overall Study|Protocol Violation|2|||
105875439|NCT02747108|365196534|FG001|Overall Study|Protocol Violation|0|||
105875440|NCT01991743|365196536|FG000|Overall Study|external cephalic version not performed|0|||
105875441|NCT01991743|365196537|FG001|Overall Study|external cephalic version not performed|0|||
105875442|NCT01991743|365196538|FG002|Overall Study|external cephalic version not performed|1|||
105875443|NCT01991743|365196539|FG003|Overall Study|external cephalic version not performed|0|||
105875444|NCT03830333|365196541|FG000|Overall Study|Death|0|||
105875445|NCT03830333|365196542|FG001|Overall Study|Death|1|||
105875446|NCT03830333|365196541|FG000|Overall Study|Withdrawal by Subject|5|||
105875447|NCT03830333|365196542|FG001|Overall Study|Withdrawal by Subject|1|||
105875448|NCT03830333|365196541|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
105875449|NCT03830333|365196542|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
105875450|NCT04390113|365196550|FG000|Overall Study|Not Treated|0|||
105875451|NCT04390113|365196551|FG001|Overall Study|Not Treated|1|||
105875452|NCT04390113|365196550|FG000|Overall Study|Adverse Event|1|||
105875453|NCT04390113|365196551|FG001|Overall Study|Adverse Event|0|||
105875454|NCT04390113|365196550|FG000|Overall Study|Death|2|||
105875455|NCT04390113|365196551|FG001|Overall Study|Death|1|||
105875456|NCT04390113|365196550|FG000|Overall Study|Physician Decision|1|||
105875457|NCT04390113|365196551|FG001|Overall Study|Physician Decision|3|||
105875458|NCT04390113|365196550|FG000|Overall Study|Study Terminated by Sponsor|5|||
105875459|NCT04390113|365196551|FG001|Overall Study|Study Terminated by Sponsor|3|||
105875460|NCT04390113|365196550|FG000|Overall Study|Withdrawal by Subject|10|||
105875461|NCT04390113|365196551|FG001|Overall Study|Withdrawal by Subject|5|||
105875462|NCT04390113|365196550|FG000|Overall Study|Other|1|||
105875463|NCT04390113|365196551|FG001|Overall Study|Other|0|||
105875464|NCT04390113|365196550|FG000|Overall Study|Missing|0|||
105875465|NCT04390113|365196551|FG001|Overall Study|Missing|1|||
105875466|NCT02389829|365196552|FG000|Overall Study|Lost to Follow-up|0|||
105875467|NCT02389829|365196553|FG001|Overall Study|Lost to Follow-up|1|||
105875468|NCT02362360|365196554|FG000|Period 1|Lack of Efficacy|1|||
105875469|NCT02362360|365196555|FG001|Period 1|Lack of Efficacy|0|||
105875470|NCT02362360|365196554|FG000|Period 1|Withdrawal by Subject|2|||
105875471|NCT02362360|365196555|FG001|Period 1|Withdrawal by Subject|1|||
105875472|NCT04146012|365196556|FG000|Overall Study|Study Terminated|30|||
105875473|NCT04146012|365196557|FG001|Overall Study|Study Terminated|15|||
105875474|NCT03817190|365196558|FG000|Overall Study|Early Termination|13|||
105875475|NCT03817190|365196559|FG001|Overall Study|Early Termination|20|||
105875476|NCT03817190|365196558|FG000|Overall Study|Adverse Event|10|||
105875477|NCT03817190|365196559|FG001|Overall Study|Adverse Event|17|||
105875478|NCT03817190|365196558|FG000|Overall Study|Withdrawal by Subject|12|||
105875479|NCT03817190|365196559|FG001|Overall Study|Withdrawal by Subject|8|||
105875480|NCT03817190|365196558|FG000|Overall Study|Lost to Follow-up|11|||
105875481|NCT03817190|365196559|FG001|Overall Study|Lost to Follow-up|7|||
105875482|NCT03817190|365196558|FG000|Overall Study|Lack of Efficacy|7|||
105875483|NCT03817190|365196559|FG001|Overall Study|Lack of Efficacy|5|||
105875484|NCT03817190|365196558|FG000|Overall Study|Investigator Decision|5|||
105875485|NCT03817190|365196559|FG001|Overall Study|Investigator Decision|1|||
105875486|NCT03817190|365196558|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
105875487|NCT03817190|365196559|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
105875488|NCT03817190|365196558|FG000|Overall Study|Lack of Contact|1|||
105875489|NCT03817190|365196559|FG001|Overall Study|Lack of Contact|0|||
105875490|NCT03817190|365196558|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
105875491|NCT03817190|365196559|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
105875492|NCT03323398|365196562|FG000|Overall Study|Other than Specified|0|||
105875493|NCT03323398|365196563|FG001|Overall Study|Other than Specified|1|||
105875494|NCT03323398|365196564|FG002|Overall Study|Other than Specified|2|||
105875495|NCT03323398|365196565|FG003|Overall Study|Other than Specified|0|||
105875496|NCT03323398|365196566|FG004|Overall Study|Other than Specified|0|||
105875497|NCT03323398|365196567|FG005|Overall Study|Other than Specified|0|||
105875498|NCT03323398|365196568|FG006|Overall Study|Other than Specified|1|||
105657640|NCT04680637|364409951|FG003|Overall Study|Death|0|||
105875499|NCT03323398|365196569|FG007|Overall Study|Other than Specified|0|||
105875500|NCT03323398|365196570|FG008|Overall Study|Other than Specified|2|||
105875501|NCT03323398|365196562|FG000|Overall Study|Lost to Follow-up|1|||
105875502|NCT03323398|365196563|FG001|Overall Study|Lost to Follow-up|2|||
105875503|NCT03323398|365196564|FG002|Overall Study|Lost to Follow-up|1|||
105875504|NCT03323398|365196565|FG003|Overall Study|Lost to Follow-up|0|||
105875505|NCT03323398|365196566|FG004|Overall Study|Lost to Follow-up|0|||
105875506|NCT03323398|365196567|FG005|Overall Study|Lost to Follow-up|0|||
105875507|NCT03323398|365196568|FG006|Overall Study|Lost to Follow-up|0|||
105875508|NCT03323398|365196569|FG007|Overall Study|Lost to Follow-up|0|||
105875509|NCT03323398|365196570|FG008|Overall Study|Lost to Follow-up|0|||
105875510|NCT03323398|365196562|FG000|Overall Study|Death|4|||
105875511|NCT03323398|365196563|FG001|Overall Study|Death|6|||
105875512|NCT03323398|365196564|FG002|Overall Study|Death|2|||
105875513|NCT03323398|365196565|FG003|Overall Study|Death|2|||
105875514|NCT03323398|365196566|FG004|Overall Study|Death|1|||
105875515|NCT03323398|365196567|FG005|Overall Study|Death|2|||
105875516|NCT03323398|365196568|FG006|Overall Study|Death|0|||
105875517|NCT03323398|365196569|FG007|Overall Study|Death|0|||
105875518|NCT03323398|365196570|FG008|Overall Study|Death|6|||
105875519|NCT03323398|365196562|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
105875520|NCT03323398|365196563|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
105875521|NCT03323398|365196564|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
105875522|NCT03323398|365196565|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
105875523|NCT03323398|365196566|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
105875524|NCT03323398|365196567|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
105875525|NCT03323398|365196568|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
105875526|NCT03323398|365196569|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
105875527|NCT03323398|365196570|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
105875528|NCT03323398|365196562|FG000|Overall Study|Withdrawal by Subject|2|||
105875529|NCT03323398|365196563|FG001|Overall Study|Withdrawal by Subject|1|||
105875530|NCT03323398|365196564|FG002|Overall Study|Withdrawal by Subject|3|||
105875531|NCT03323398|365196565|FG003|Overall Study|Withdrawal by Subject|0|||
105875532|NCT03323398|365196566|FG004|Overall Study|Withdrawal by Subject|0|||
105875533|NCT03323398|365196567|FG005|Overall Study|Withdrawal by Subject|1|||
105875534|NCT03323398|365196568|FG006|Overall Study|Withdrawal by Subject|0|||
105875535|NCT03323398|365196569|FG007|Overall Study|Withdrawal by Subject|0|||
105875536|NCT03323398|365196570|FG008|Overall Study|Withdrawal by Subject|0|||
105875537|NCT03323398|365196562|FG000|Overall Study|Participant was Put on Hospice|0|||
105875538|NCT03323398|365196563|FG001|Overall Study|Participant was Put on Hospice|0|||
105875539|NCT03323398|365196564|FG002|Overall Study|Participant was Put on Hospice|0|||
105875540|NCT03323398|365196565|FG003|Overall Study|Participant was Put on Hospice|0|||
105875541|NCT03323398|365196566|FG004|Overall Study|Participant was Put on Hospice|0|||
105875542|NCT03323398|365196567|FG005|Overall Study|Participant was Put on Hospice|0|||
105875543|NCT03323398|365196568|FG006|Overall Study|Participant was Put on Hospice|1|||
105875544|NCT03323398|365196569|FG007|Overall Study|Participant was Put on Hospice|0|||
105875545|NCT03323398|365196570|FG008|Overall Study|Participant was Put on Hospice|0|||
105875546|NCT03323398|365196562|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
105875547|NCT03323398|365196563|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
105875548|NCT03323398|365196564|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
105875549|NCT03323398|365196565|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
105875550|NCT03323398|365196566|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
105875551|NCT03323398|365196567|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
105875552|NCT03323398|365196568|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
105875553|NCT03323398|365196569|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
105875554|NCT03323398|365196570|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
105875555|NCT02729025|365196574|FG000|Overall Study|Sponsor Decision|0|||
105875556|NCT02729025|365196575|FG001|Overall Study|Sponsor Decision|1|||
105875557|NCT01609790|365196576|FG000|Overall Study|Protocol Violation|1|||
105875558|NCT01609790|365196577|FG001|Overall Study|Protocol Violation|7|||
105875559|NCT01609790|365196578|FG002|Overall Study|Protocol Violation|8|||
105875560|NCT05016960|365198900|FG000|Overall Study|Withdrawal by Subject|1|||
105875561|NCT05016960|365198901|FG001|Overall Study|Withdrawal by Subject|9|||
105875562|NCT00739882|365198902|FG000|Double-blind Period|Adverse Event|1|||
105875563|NCT00739882|365198903|FG001|Double-blind Period|Adverse Event|2|||
105875564|NCT00739882|365198902|FG000|Double-blind Period|Protocol Violation|1|||
105875565|NCT00739882|365198903|FG001|Double-blind Period|Protocol Violation|0|||
105875566|NCT00739882|365198902|FG000|Double-blind Period|Lack of Efficacy|1|||
105875567|NCT00739882|365198903|FG001|Double-blind Period|Lack of Efficacy|1|||
105875568|NCT00739882|365198902|FG000|Double-blind Period|Other|16|||
105875569|NCT00739882|365198903|FG001|Double-blind Period|Other|8|||
105875570|NCT00739882|365198902|FG000|Open-label Period|Adverse Event|1|||
105875571|NCT00739882|365198903|FG001|Open-label Period|Adverse Event|0|||
105875572|NCT00739882|365198902|FG000|Open-label Period|Other|9|||
105875573|NCT00739882|365198903|FG001|Open-label Period|Other|5|||
105875574|NCT01168232|365198904|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
105875575|NCT01168232|365198904|FG000|Overall Study|Ineligible- Wrong cell type|6|||
105875576|NCT01168232|365198904|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
105875577|NCT01415518|365198905|FG000|Overall Study|Withdrawal by Subject|2|||
105875578|NCT01415518|365198906|FG001|Overall Study|Withdrawal by Subject|12|||
105875579|NCT01415518|365198905|FG000|Overall Study|Protocol Violation|6|||
105875580|NCT01415518|365198906|FG001|Overall Study|Protocol Violation|8|||
105875581|NCT01415518|365198905|FG000|Overall Study|Lost to Follow-up|3|||
105875582|NCT01415518|365198906|FG001|Overall Study|Lost to Follow-up|5|||
105875583|NCT01415518|365198905|FG000|Overall Study|Adverse Event|3|||
105875584|NCT01415518|365198906|FG001|Overall Study|Adverse Event|4|||
105875585|NCT01415518|365198905|FG000|Overall Study|Death|1|||
105875586|NCT01415518|365198906|FG001|Overall Study|Death|1|||
105875587|NCT01415518|365198905|FG000|Overall Study|Condition under Investigation Worsened|1|||
105875588|NCT01415518|365198906|FG001|Overall Study|Condition under Investigation Worsened|1|||
105875589|NCT01749826|365198907|FG000|Overall Study|Study Terminated|20|||
105875590|NCT01749826|365198908|FG001|Overall Study|Study Terminated|0|||
105875591|NCT01470248|365198911|FG000|Overall Study|Withdrawal by Subject|1|||
105875592|NCT03192488|365198912|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
105875593|NCT03192488|365198913|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
105875594|NCT03192488|365198914|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
105875595|NCT03192488|365198915|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
105875596|NCT03192488|365198916|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
105875597|NCT03192488|365198917|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
105875598|NCT03192488|365198912|FG000|Third Intervention (d1)|Adverse Event|0|||
105875599|NCT03192488|365198913|FG001|Third Intervention (d1)|Adverse Event|0|||
105875600|NCT03192488|365198914|FG002|Third Intervention (d1)|Adverse Event|0|||
105875601|NCT03192488|365198915|FG003|Third Intervention (d1)|Adverse Event|0|||
105875602|NCT03192488|365198916|FG004|Third Intervention (d1)|Adverse Event|1|||
105875603|NCT03192488|365198917|FG005|Third Intervention (d1)|Adverse Event|0|||
105875604|NCT02549859|365198922|FG000|Long-term 60 Hz DBS|Study Closed|1|||
105875605|NCT05140915|365198923|FG000|Overall Study|Lost to Follow-up|2|||
105875606|NCT05140915|365198924|FG001|Overall Study|Lost to Follow-up|1|||
105875607|NCT03664232|365198927|FG000|Overall Study|Withdrawal by Subject|0|||
105875608|NCT03664232|365198928|FG001|Overall Study|Withdrawal by Subject|1|||
105875609|NCT03664232|365198929|FG002|Overall Study|Withdrawal by Subject|0|||
105875610|NCT03664232|365198930|FG003|Overall Study|Withdrawal by Subject|1|||
105875611|NCT03664232|365198927|FG000|Overall Study|Adverse Event|0|||
105875612|NCT03664232|365198928|FG001|Overall Study|Adverse Event|0|||
105875613|NCT03664232|365198929|FG002|Overall Study|Adverse Event|1|||
105875614|NCT03664232|365198930|FG003|Overall Study|Adverse Event|0|||
105875615|NCT03664232|365198927|FG000|Overall Study|Other-Non-compliance with study drug|0|||
105875616|NCT03664232|365198928|FG001|Overall Study|Other-Non-compliance with study drug|1|||
105875617|NCT03664232|365198929|FG002|Overall Study|Other-Non-compliance with study drug|0|||
105875618|NCT03664232|365198930|FG003|Overall Study|Other-Non-compliance with study drug|2|||
105875619|NCT03664232|365198927|FG000|Overall Study|Other-Unspecified|0|||
105875620|NCT03664232|365198928|FG001|Overall Study|Other-Unspecified|3|||
105875621|NCT03664232|365198929|FG002|Overall Study|Other-Unspecified|0|||
105875622|NCT03664232|365198930|FG003|Overall Study|Other-Unspecified|1|||
105875623|NCT03664232|365198927|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
105875624|NCT03664232|365198928|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
105875625|NCT03664232|365198929|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
105875626|NCT03664232|365198930|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
105875627|NCT02392481|365198931|FG000|Overall Study|Adverse Event|0|||
105875628|NCT02392481|365198932|FG001|Overall Study|Adverse Event|0|||
105875629|NCT02392481|365198933|FG002|Overall Study|Adverse Event|1|||
105875630|NCT02392481|365198934|FG003|Overall Study|Adverse Event|2|||
105875631|NCT02392481|365198931|FG000|Overall Study|Withdrawal by Subject|0|||
105875632|NCT02392481|365198932|FG001|Overall Study|Withdrawal by Subject|0|||
105875633|NCT02392481|365198933|FG002|Overall Study|Withdrawal by Subject|1|||
105875634|NCT02392481|365198934|FG003|Overall Study|Withdrawal by Subject|0|||
105875635|NCT03334435|365198935|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
105875636|NCT03334435|365198936|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
105875637|NCT03334435|365198937|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
105875638|NCT03334435|365198938|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
105875639|NCT03334435|365198939|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
105875640|NCT03334435|365198940|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875641|NCT03334435|365198941|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875642|NCT03334435|365198942|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875643|NCT03334435|365198943|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875644|NCT03334435|365198944|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875645|NCT03334435|365198945|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875646|NCT03334435|365198946|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875647|NCT03334435|365198947|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875648|NCT03334435|365198948|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105875649|NCT03334435|365198949|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
105657641|NCT04680637|364409948|FG000|Overall Study|Withdrawal by Subject|7|||
105657642|NCT04680637|364409949|FG001|Overall Study|Withdrawal by Subject|10|||
105657643|NCT04680637|364409950|FG002|Overall Study|Withdrawal by Subject|17|||
105657644|NCT04680637|364409951|FG003|Overall Study|Withdrawal by Subject|15|||
105657645|NCT04680637|364409948|FG000|Overall Study|Decision by Sponsor|21|||
105657646|NCT04680637|364409949|FG001|Overall Study|Decision by Sponsor|15|||
105657647|NCT04680637|364409950|FG002|Overall Study|Decision by Sponsor|7|||
105657648|NCT04680637|364409951|FG003|Overall Study|Decision by Sponsor|32|||
105657649|NCT02037256|364409956|FG000|Overall Study|Protocol Violation|0|||
105657650|NCT02037256|364409957|FG001|Overall Study|Protocol Violation|1|||
105657651|NCT02037256|364409956|FG000|Overall Study|Withdrawn prior to Velcade|0|||
105657652|NCT02037256|364409957|FG001|Overall Study|Withdrawn prior to Velcade|2|||
105657653|NCT04599907|364409958|FG000|Overall Study|Withdrawal by Subject|1|||
105657654|NCT04599907|364409959|FG001|Overall Study|Withdrawal by Subject|7|||
105657655|NCT04599907|364409960|FG002|Overall Study|Withdrawal by Subject|6|||
105657656|NCT04599907|364409958|FG000|Overall Study|Lost to Follow-up|0|||
105657657|NCT04599907|364409959|FG001|Overall Study|Lost to Follow-up|1|||
105657658|NCT04599907|364409960|FG002|Overall Study|Lost to Follow-up|0|||
105657659|NCT00356759|364409961|FG000|Overall Study|Death|5|||
105657660|NCT00356759|364409962|FG001|Overall Study|Death|2|||
105657661|NCT00356759|364409961|FG000|Overall Study|Withdrawal by Subject|2|||
105657662|NCT00356759|364409962|FG001|Overall Study|Withdrawal by Subject|2|||
105657663|NCT00356759|364409961|FG000|Overall Study|Adverse Event|1|||
105657664|NCT00356759|364409962|FG001|Overall Study|Adverse Event|3|||
105875650|NCT03334435|365198935|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
105875651|NCT03334435|365198936|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
105875652|NCT03334435|365198937|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
105875653|NCT03334435|365198938|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
105875654|NCT03334435|365198939|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
105875655|NCT03334435|365198940|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875656|NCT03334435|365198941|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875657|NCT03334435|365198942|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875658|NCT03334435|365198943|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875659|NCT03334435|365198944|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875660|NCT03334435|365198945|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875661|NCT03334435|365198946|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875662|NCT03334435|365198947|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875663|NCT03334435|365198948|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875664|NCT03334435|365198949|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
105875665|NCT03334435|365198935|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
105875666|NCT03334435|365198936|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
105875667|NCT03334435|365198937|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
105875668|NCT03334435|365198938|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
105875669|NCT03334435|365198939|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
105875670|NCT03334435|365198940|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875671|NCT03334435|365198941|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875672|NCT03334435|365198942|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875673|NCT03334435|365198943|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875674|NCT03334435|365198944|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875675|NCT03334435|365198945|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875676|NCT03334435|365198946|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875677|NCT03334435|365198947|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105657665|NCT00356759|364409961|FG000|Overall Study|Lost to Follow-up|1|||
105657666|NCT00356759|364409962|FG001|Overall Study|Lost to Follow-up|1|||
105657667|NCT00356759|364409961|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
105657668|NCT00356759|364409962|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
105657669|NCT02930837|364409963|FG000|Overall Study|Adverse Event|6|||
105657670|NCT02930837|364409963|FG000|Overall Study|Lost to Follow-up|5|||
105657671|NCT02930837|364409963|FG000|Overall Study|Withdrawal by Subject|1|||
105657672|NCT02633397|364409964|FG000|Overall Study|Adverse Event|8|||
105657673|NCT02633397|364409965|FG001|Overall Study|Adverse Event|8|||
105657674|NCT02633397|364409964|FG000|Overall Study|Study Burden|4|||
105657675|NCT02633397|364409965|FG001|Overall Study|Study Burden|1|||
105657676|NCT02633397|364409964|FG000|Overall Study|Treatment interruption|2|||
105657677|NCT02633397|364409965|FG001|Overall Study|Treatment interruption|5|||
105657678|NCT02633397|364409964|FG000|Overall Study|Death|2|||
105657679|NCT02633397|364409965|FG001|Overall Study|Death|2|||
105657680|NCT02633397|364409964|FG000|Overall Study|Physician Decision|0|||
105657681|NCT02633397|364409965|FG001|Overall Study|Physician Decision|1|||
105657682|NCT03864341|364411854|FG000|Overall Study|Withdrawal by Subject|1|||
105657683|NCT01726049|364411856|FG000|Overall Study|Death|1|||
105657684|NCT01726049|364411857|FG001|Overall Study|Death|1|||
105657685|NCT01726049|364411856|FG000|Overall Study|Adverse Event|4|||
105657686|NCT01726049|364411857|FG001|Overall Study|Adverse Event|1|||
105657687|NCT01726049|364411856|FG000|Overall Study|refused second HC|0|||
105657688|NCT01726049|364411857|FG001|Overall Study|refused second HC|2|||
105657689|NCT00263211|364411858|FG000|Overall Study|Death|1|||
105657690|NCT00263211|364411859|FG001|Overall Study|Death|0|||
105657691|NCT00263211|364411858|FG000|Overall Study|Withdrawal by Subject|3|||
105657692|NCT00263211|364411859|FG001|Overall Study|Withdrawal by Subject|0|||
105657693|NCT00263211|364411858|FG000|Overall Study|Protocol Violation|1|||
105657694|NCT00263211|364411859|FG001|Overall Study|Protocol Violation|0|||
105657695|NCT00263211|364411858|FG000|Overall Study|Disease Progression|0|||
105657696|NCT00263211|364411859|FG001|Overall Study|Disease Progression|1|||
105657697|NCT03991988|364411865|FG000|Overall Study|Withdrawal by Subject|2|||
105657698|NCT03991988|364411866|FG001|Overall Study|Withdrawal by Subject|2|||
105657699|NCT03834623|364411867|FG000|Overall Study|Progression|0|||
105657700|NCT03834623|364411868|FG001|Overall Study|Progression|1|||
105657701|NCT01947517|364411869|FG000|Overall Study|Withdrawal by Subject|1|||
105657702|NCT01947517|364411870|FG001|Overall Study|Withdrawal by Subject|1|||
105657703|NCT00478647|364411871|FG000|Overall Study|Adverse Event|1|||
105657704|NCT00478647|364411871|FG000|Overall Study|Withdrawal by Subject|1|||
105657705|NCT00526097|364411872|FG000|Overall Study|Adverse Event|6|||
105657706|NCT00526097|364411873|FG001|Overall Study|Adverse Event|44|||
105657707|NCT00526097|364411872|FG000|Overall Study|Protocol Violation|4|||
105657708|NCT00526097|364411873|FG001|Overall Study|Protocol Violation|10|||
105657709|NCT00526097|364411872|FG000|Overall Study|Withdrawal by Subject|3|||
105657710|NCT00526097|364411873|FG001|Overall Study|Withdrawal by Subject|1|||
105657711|NCT00526097|364411872|FG000|Overall Study|Other|2|||
105657712|NCT00526097|364411873|FG001|Overall Study|Other|1|||
105657713|NCT00460564|364411874|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
105875678|NCT03334435|365198948|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875679|NCT03334435|365198949|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
105875680|NCT03334435|365198935|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
105875681|NCT03334435|365198936|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
105875682|NCT03334435|365198937|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
105875683|NCT03334435|365198938|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
105875684|NCT03334435|365198939|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
105875685|NCT03334435|365198940|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105875686|NCT03334435|365198941|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105875687|NCT03334435|365198942|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105657714|NCT00460564|364411875|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
105657715|NCT00460564|364411876|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657716|NCT00460564|364411877|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657717|NCT00460564|364411878|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657718|NCT00460564|364411879|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657719|NCT00460564|364411880|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657720|NCT00460564|364411881|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
105657721|NCT00460564|364411874|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
105657722|NCT00460564|364411875|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657723|NCT00460564|364411876|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657724|NCT00460564|364411877|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657725|NCT00460564|364411878|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657726|NCT00460564|364411879|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657727|NCT00460564|364411880|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657728|NCT00460564|364411881|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
105657729|NCT00460564|364411874|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657730|NCT00460564|364411875|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657731|NCT00460564|364411876|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657732|NCT00460564|364411877|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657733|NCT00460564|364411878|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
105657734|NCT00460564|364411879|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
105657735|NCT00460564|364411880|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
105657736|NCT00460564|364411881|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
105657737|NCT00460564|364411874|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105875688|NCT03334435|365198943|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105875689|NCT03334435|365198944|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105875690|NCT03334435|365198945|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105875691|NCT03334435|365198946|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105875692|NCT03334435|365198947|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105657738|NCT00460564|364411875|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657739|NCT00460564|364411876|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657740|NCT00460564|364411877|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657741|NCT00460564|364411878|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
105657742|NCT00460564|364411879|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
105657743|NCT00460564|364411880|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657744|NCT00460564|364411881|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
105657745|NCT00460564|364411874|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657746|NCT00460564|364411875|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657747|NCT00460564|364411876|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105875693|NCT03334435|365198948|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105875694|NCT03334435|365198949|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
105875695|NCT03334435|365198935|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
105875696|NCT03334435|365198936|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875697|NCT03334435|365198937|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
105875698|NCT03334435|365198938|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
105875699|NCT03334435|365198939|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
105875700|NCT03334435|365198940|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875701|NCT03334435|365198941|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875702|NCT03334435|365198942|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875703|NCT03334435|365198943|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875704|NCT03334435|365198944|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875705|NCT03334435|365198945|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875706|NCT03334435|365198946|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875707|NCT03334435|365198947|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875708|NCT03334435|365198948|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875709|NCT03334435|365198949|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
105875710|NCT03334435|365198935|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875711|NCT03334435|365198936|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875712|NCT03334435|365198937|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875713|NCT03334435|365198938|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
105875714|NCT03334435|365198939|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875715|NCT03334435|365198940|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875716|NCT03334435|365198941|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875717|NCT03334435|365198942|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875718|NCT03334435|365198943|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875719|NCT03334435|365198944|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875720|NCT03334435|365198945|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875721|NCT03334435|365198946|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875722|NCT03334435|365198947|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875723|NCT03334435|365198948|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875724|NCT03334435|365198949|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
105875725|NCT03334435|365198935|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875726|NCT03334435|365198936|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
105875727|NCT03334435|365198937|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
105875728|NCT03334435|365198938|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
105875729|NCT03334435|365198939|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
105875730|NCT03334435|365198940|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875731|NCT03334435|365198941|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875732|NCT03334435|365198942|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875733|NCT03334435|365198943|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875734|NCT03334435|365198944|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875735|NCT03334435|365198945|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875736|NCT03334435|365198946|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875737|NCT03334435|365198947|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875738|NCT03334435|365198948|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875739|NCT03334435|365198949|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
105875740|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105657748|NCT00460564|364411877|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657749|NCT00460564|364411878|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
105657750|NCT00460564|364411879|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657751|NCT00460564|364411880|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105875741|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105875742|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105875743|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105875744|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
105875745|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
105875746|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
105875747|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
105875748|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
105875749|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
105875750|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
105875751|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
105875752|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
105875753|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
105875754|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
105875755|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105875756|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105875757|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105875758|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105875759|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
105875760|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
105875761|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
105657752|NCT00460564|364411881|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
105657753|NCT00030823|364411884|FG000|Overall Study|Withdrawal by Subject|1|||
105657754|NCT00891046|364411888|FG000|Overall Study|Protocol Violation|1|||
105657755|NCT00891046|364411889|FG001|Overall Study|Protocol Violation|1|||
105657756|NCT00891046|364411890|FG002|Overall Study|Protocol Violation|0|||
105657757|NCT00891046|364411891|FG003|Overall Study|Protocol Violation|0|||
105657758|NCT00891046|364411892|FG004|Overall Study|Protocol Violation|1|||
105657759|NCT00891046|364411888|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
105657760|NCT00891046|364411889|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
105657761|NCT00891046|364411890|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
105657762|NCT00891046|364411891|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
105657763|NCT00891046|364411892|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
105657764|NCT00891046|364411888|FG000|Overall Study|Administrative problems|0|||
105657765|NCT00891046|364411889|FG001|Overall Study|Administrative problems|0|||
105657766|NCT00891046|364411890|FG002|Overall Study|Administrative problems|0|||
105657767|NCT00891046|364411891|FG003|Overall Study|Administrative problems|0|||
105657768|NCT00891046|364411892|FG004|Overall Study|Administrative problems|1|||
105657769|NCT00891046|364411888|FG000|Overall Study|Participant no longer required drug|0|||
105657770|NCT00891046|364411889|FG001|Overall Study|Participant no longer required drug|2|||
105657771|NCT00891046|364411890|FG002|Overall Study|Participant no longer required drug|0|||
105657772|NCT00891046|364411891|FG003|Overall Study|Participant no longer required drug|0|||
105875762|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
105875763|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
105875764|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
105875765|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
105875766|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
105875767|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
105875768|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
105875769|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
105875770|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105875771|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105875772|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105875773|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105875774|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105875775|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
105875776|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
105875777|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
105875778|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
105875779|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
105875780|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
105875781|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
105875782|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
105875783|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
105657773|NCT00891046|364411892|FG004|Overall Study|Participant no longer required drug|1|||
105657774|NCT00891046|364411888|FG000|Overall Study|Adverse Event|4|||
105875784|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
105875785|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105875786|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105875787|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105875788|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105875789|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
105875790|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
105875791|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
105875792|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
105875793|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
105875794|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
105875795|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
105875796|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
105875797|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
105875798|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
105875799|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
105875800|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105875801|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105875802|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105875803|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105875804|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105875805|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105875806|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
105875807|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
105875808|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
105875809|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
105875810|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
105875811|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
105875812|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
105875813|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
105875814|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
105875815|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875816|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875817|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875818|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875819|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875820|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875821|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875822|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875823|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875824|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875825|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105875826|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
105875827|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105657775|NCT00891046|364411889|FG001|Overall Study|Adverse Event|3|||
105657776|NCT00891046|364411890|FG002|Overall Study|Adverse Event|2|||
105657777|NCT00891046|364411891|FG003|Overall Study|Adverse Event|0|||
105657778|NCT00891046|364411892|FG004|Overall Study|Adverse Event|14|||
105657779|NCT00891046|364411888|FG000|Overall Study|Withdrawal by Subject|2|||
105657780|NCT00891046|364411889|FG001|Overall Study|Withdrawal by Subject|1|||
105657781|NCT00891046|364411890|FG002|Overall Study|Withdrawal by Subject|2|||
105657782|NCT00891046|364411891|FG003|Overall Study|Withdrawal by Subject|1|||
105657783|NCT00891046|364411892|FG004|Overall Study|Withdrawal by Subject|1|||
105657784|NCT00891046|364411888|FG000|Overall Study|Lost to Follow-up|0|||
105657785|NCT00891046|364411889|FG001|Overall Study|Lost to Follow-up|0|||
105657786|NCT00891046|364411890|FG002|Overall Study|Lost to Follow-up|0|||
105657787|NCT00891046|364411891|FG003|Overall Study|Lost to Follow-up|0|||
105657788|NCT00891046|364411892|FG004|Overall Study|Lost to Follow-up|1|||
105657789|NCT04333147|364411893|FG000|Overall Study|Adverse Event|43|||
105657790|NCT04333147|364411894|FG001|Overall Study|Adverse Event|40|||
105657791|NCT04333147|364411893|FG000|Overall Study|Lack of Efficacy|49|||
105657792|NCT04333147|364411894|FG001|Overall Study|Lack of Efficacy|48|||
105657793|NCT04333147|364411893|FG000|Overall Study|Lost to Follow-up|19|||
105657794|NCT04333147|364411894|FG001|Overall Study|Lost to Follow-up|16|||
105657795|NCT04333147|364411893|FG000|Overall Study|Physician Decision|17|||
105657796|NCT04333147|364411894|FG001|Overall Study|Physician Decision|20|||
105657797|NCT04333147|364411893|FG000|Overall Study|Withdrawal by Subject|65|||
105657798|NCT04333147|364411894|FG001|Overall Study|Withdrawal by Subject|68|||
105657799|NCT04333147|364411893|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
105657800|NCT04333147|364411894|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
105657801|NCT04333147|364411893|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
105657802|NCT04333147|364411894|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
105657803|NCT04333147|364411893|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
105657804|NCT04333147|364411894|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
105657805|NCT04984239|364411895|FG000|Overall Study|Lost to Follow-up|1|||
105657806|NCT00630552|364411909|FG000|Overall Study|Adverse Event|0|||
105657807|NCT00630552|364411910|FG001|Overall Study|Adverse Event|1|||
105657808|NCT00630552|364411911|FG002|Overall Study|Adverse Event|5|||
105657809|NCT00630552|364411912|FG003|Overall Study|Adverse Event|4|||
105657810|NCT00630552|364411913|FG004|Overall Study|Adverse Event|2|||
105657811|NCT00630552|364411909|FG000|Overall Study|Disease progression|5|||
105657812|NCT00630552|364411910|FG001|Overall Study|Disease progression|6|||
105657813|NCT00630552|364411911|FG002|Overall Study|Disease progression|27|||
105657814|NCT00630552|364411912|FG003|Overall Study|Disease progression|22|||
105657815|NCT00630552|364411913|FG004|Overall Study|Disease progression|31|||
105657816|NCT00630552|364411909|FG000|Overall Study|Never received IP|0|||
105657817|NCT00630552|364411910|FG001|Overall Study|Never received IP|0|||
105657818|NCT00630552|364411911|FG002|Overall Study|Never received IP|0|||
105657819|NCT00630552|364411912|FG003|Overall Study|Never received IP|2|||
105657820|NCT00630552|364411913|FG004|Overall Study|Never received IP|2|||
105657821|NCT00630552|364411909|FG000|Overall Study|Ineligibility determined|0|||
105657822|NCT00630552|364411910|FG001|Overall Study|Ineligibility determined|0|||
105657823|NCT00630552|364411911|FG002|Overall Study|Ineligibility determined|0|||
105657824|NCT00630552|364411912|FG003|Overall Study|Ineligibility determined|0|||
105657825|NCT00630552|364411913|FG004|Overall Study|Ineligibility determined|1|||
105657826|NCT00630552|364411909|FG000|Overall Study|Protocol Violation|0|||
105657827|NCT00630552|364411910|FG001|Overall Study|Protocol Violation|0|||
105657828|NCT00630552|364411911|FG002|Overall Study|Protocol Violation|0|||
105657829|NCT00630552|364411912|FG003|Overall Study|Protocol Violation|1|||
105657830|NCT00630552|364411913|FG004|Overall Study|Protocol Violation|0|||
105657831|NCT00630552|364411909|FG000|Overall Study|Physician Decision|0|||
105657832|NCT00630552|364411910|FG001|Overall Study|Physician Decision|0|||
105657833|NCT00630552|364411911|FG002|Overall Study|Physician Decision|0|||
105657834|NCT00630552|364411912|FG003|Overall Study|Physician Decision|0|||
105657835|NCT00630552|364411913|FG004|Overall Study|Physician Decision|1|||
105657836|NCT00630552|364411909|FG000|Overall Study|Death|0|||
105657837|NCT00630552|364411910|FG001|Overall Study|Death|0|||
105657838|NCT00630552|364411911|FG002|Overall Study|Death|1|||
105657839|NCT00630552|364411912|FG003|Overall Study|Death|2|||
105657840|NCT00630552|364411913|FG004|Overall Study|Death|2|||
105657841|NCT00630552|364411909|FG000|Overall Study|Withdrawal by Subject|0|||
105657842|NCT00630552|364411910|FG001|Overall Study|Withdrawal by Subject|0|||
105657843|NCT00630552|364411911|FG002|Overall Study|Withdrawal by Subject|0|||
105657844|NCT00630552|364411912|FG003|Overall Study|Withdrawal by Subject|1|||
105657845|NCT00630552|364411913|FG004|Overall Study|Withdrawal by Subject|0|||
105657846|NCT00630552|364411909|FG000|Overall Study|Other|0|||
105657847|NCT00630552|364411910|FG001|Overall Study|Other|0|||
105657848|NCT00630552|364411911|FG002|Overall Study|Other|4|||
105657849|NCT00630552|364411912|FG003|Overall Study|Other|2|||
105657850|NCT00630552|364411913|FG004|Overall Study|Other|0|||
105657851|NCT04606199|364411914|FG000|Overall Study|Withdrawal by Subject|2|||
105657852|NCT04349644|364411915|FG000|Allocation/Pretest|Lost to pretest|0|||
105657853|NCT04349644|364411916|FG001|Allocation/Pretest|Lost to pretest|3|||
105657854|NCT04349644|364411915|FG000|Posttest|Lost to posttest|0|||
105657855|NCT04349644|364411916|FG001|Posttest|Lost to posttest|8|||
105657856|NCT04349644|364411915|FG000|Posttest|Discontinued intervention|6|||
105657857|NCT04349644|364411916|FG001|Posttest|Discontinued intervention|0|||
105657858|NCT04349644|364411915|FG000|Follow-up|Lost to Follow-up|0|||
105657859|NCT04349644|364411916|FG001|Follow-up|Lost to Follow-up|2|||
105657860|NCT00408928|364411917|FG000|Overall Study|Withdrawal by Subject|1|||
105657861|NCT00408928|364411917|FG000|Overall Study|Death|1|||
105657862|NCT00408928|364411917|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
105657863|NCT02438371|364411918|FG000|Overall Study|Lost to Follow-up|3|||
105657864|NCT02438371|364411919|FG001|Overall Study|Lost to Follow-up|2|||
105657865|NCT02438371|364411918|FG000|Overall Study|Withdrawal by Subject|1|||
105657866|NCT02438371|364411919|FG001|Overall Study|Withdrawal by Subject|1|||
105657867|NCT01850823|364411923|FG000|Overall Study|Early Visit Window|0|||
105657868|NCT01850823|364411924|FG001|Overall Study|Early Visit Window|1|||
105875828|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
105875829|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
105657869|NCT01850823|364411925|FG002|Overall Study|Early Visit Window|4|||
105657870|NCT01850823|364411923|FG000|Overall Study|Enrolled in Error|0|||
105657871|NCT01850823|364411924|FG001|Overall Study|Enrolled in Error|1|||
105657872|NCT01850823|364411925|FG002|Overall Study|Enrolled in Error|2|||
105657873|NCT01850823|364411923|FG000|Overall Study|Lack of Efficacy|1|||
105875830|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875831|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875832|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875833|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875834|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875835|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
105875836|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875837|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875838|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875839|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875840|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875841|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875842|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
105657874|NCT01850823|364411924|FG001|Overall Study|Lack of Efficacy|0|||
105657875|NCT01850823|364411925|FG002|Overall Study|Lack of Efficacy|0|||
105657876|NCT01850823|364411923|FG000|Overall Study|Lost to Follow-up|0|||
105657877|NCT01850823|364411924|FG001|Overall Study|Lost to Follow-up|0|||
105657878|NCT01850823|364411925|FG002|Overall Study|Lost to Follow-up|1|||
105657879|NCT01850823|364411923|FG000|Overall Study|Restricted Medication|0|||
105657880|NCT01850823|364411924|FG001|Overall Study|Restricted Medication|0|||
105657881|NCT01850823|364411925|FG002|Overall Study|Restricted Medication|2|||
105657882|NCT01850823|364411923|FG000|Overall Study|Significant worstening of SAR|0|||
105657883|NCT01850823|364411924|FG001|Overall Study|Significant worstening of SAR|1|||
105657884|NCT01850823|364411925|FG002|Overall Study|Significant worstening of SAR|0|||
105657885|NCT01850823|364411923|FG000|Overall Study|Withdrawal by Subject|2|||
105657886|NCT01850823|364411924|FG001|Overall Study|Withdrawal by Subject|0|||
105657887|NCT01850823|364411925|FG002|Overall Study|Withdrawal by Subject|1|||
105657888|NCT01751165|364411926|FG000|Overall Study|Adverse event, serious fatal|1|||
105657889|NCT01751165|364411927|FG001|Overall Study|Adverse event, serious fatal|0|||
105657890|NCT01751165|364411928|FG002|Overall Study|Adverse event, serious fatal|1|||
105657891|NCT01751165|364411926|FG000|Overall Study|Withdrawal by Subject|0|||
105657892|NCT01751165|364411927|FG001|Overall Study|Withdrawal by Subject|0|||
105657893|NCT01751165|364411928|FG002|Overall Study|Withdrawal by Subject|1|||
105657894|NCT01751165|364411926|FG000|Overall Study|Serious adverse event|0|||
105657895|NCT01751165|364411927|FG001|Overall Study|Serious adverse event|2|||
105657896|NCT01751165|364411928|FG002|Overall Study|Serious adverse event|0|||
105657897|NCT01751165|364411926|FG000|Overall Study|Lost to Follow-up|1|||
105657898|NCT01751165|364411927|FG001|Overall Study|Lost to Follow-up|1|||
105657899|NCT01751165|364411928|FG002|Overall Study|Lost to Follow-up|1|||
105657900|NCT00988533|364411931|FG000|Overall Study|Lost to Follow-up|3|||
105657901|NCT02895360|364411936|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
105657902|NCT02895360|364411937|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657903|NCT02895360|364411938|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657904|NCT02895360|364411939|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657905|NCT02895360|364411940|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657906|NCT02895360|364411941|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
105657907|NCT02895360|364411936|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657908|NCT02895360|364411937|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
105657909|NCT02895360|364411938|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657910|NCT02895360|364411939|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657911|NCT02895360|364411940|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657912|NCT02895360|364411941|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
105657913|NCT02895360|364411936|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657914|NCT02895360|364411937|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657915|NCT02895360|364411938|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
105657916|NCT02895360|364411939|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657917|NCT02895360|364411940|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657918|NCT02895360|364411941|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
105657919|NCT02895360|364411936|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657920|NCT02895360|364411937|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657921|NCT02895360|364411938|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
105657922|NCT02895360|364411939|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657923|NCT02895360|364411940|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657924|NCT02895360|364411941|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
105657925|NCT02895360|364411936|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657926|NCT02895360|364411937|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657927|NCT02895360|364411938|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657928|NCT02895360|364411939|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
105657929|NCT02895360|364411940|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657930|NCT02895360|364411941|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
105657931|NCT02895360|364411936|FG000|Phase 2a|Adverse Event|0|||
105657932|NCT02895360|364411937|FG001|Phase 2a|Adverse Event|0|||
105657933|NCT02895360|364411938|FG002|Phase 2a|Adverse Event|0|||
105657934|NCT02895360|364411939|FG003|Phase 2a|Adverse Event|0|||
105657935|NCT02895360|364411940|FG004|Phase 2a|Adverse Event|0|||
105657936|NCT02895360|364411941|FG005|Phase 2a|Adverse Event|1|||
105875843|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
105875844|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
105875845|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105875846|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105875847|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105875848|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105875849|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105875850|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105875851|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105875852|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105875853|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105875854|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
105875855|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105875856|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
105875857|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105875858|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105875859|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
105875860|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875861|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875862|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875863|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875864|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875865|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
105875866|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
105875867|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875868|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875869|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875870|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
105875871|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
105875872|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
105875873|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
105875874|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
105875875|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875876|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875877|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875878|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875879|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875880|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
105875881|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875882|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875883|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875884|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875885|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
105875886|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105657937|NCT02895360|364411936|FG000|Phase 2a|Progressive disease|0|||
105657938|NCT02895360|364411937|FG001|Phase 2a|Progressive disease|0|||
105657939|NCT02895360|364411938|FG002|Phase 2a|Progressive disease|0|||
105657940|NCT02895360|364411939|FG003|Phase 2a|Progressive disease|0|||
105657941|NCT02895360|364411940|FG004|Phase 2a|Progressive disease|11|||
105657942|NCT02895360|364411941|FG005|Phase 2a|Progressive disease|11|||
105657943|NCT00916305|364411942|FG000|Overall Study|Lost to Follow-up|21|||
105657944|NCT00916305|364411943|FG001|Overall Study|Lost to Follow-up|27|||
105657945|NCT00916305|364411942|FG000|Overall Study|Withdrawal by Subject|0|||
105657946|NCT00916305|364411943|FG001|Overall Study|Withdrawal by Subject|1|||
105657947|NCT04051242|364411944|FG000|Overall Study|Withdrawal by Subject|1|||
105657948|NCT04051242|364411944|FG000|Overall Study|Physician Decision|1|||
105657949|NCT00107978|364411951|FG000|Overall Study|Adverse Event|1|||
105657950|NCT00107978|364411952|FG001|Overall Study|Adverse Event|5|||
105657951|NCT00107978|364411951|FG000|Overall Study|Death|3|||
105657952|NCT00107978|364411952|FG001|Overall Study|Death|3|||
105657953|NCT00107978|364411951|FG000|Overall Study|Lost to Follow-up|20|||
105657954|NCT00107978|364411952|FG001|Overall Study|Lost to Follow-up|28|||
105657955|NCT00107978|364411951|FG000|Overall Study|Withdrawal by Subject|4|||
105657956|NCT00107978|364411952|FG001|Overall Study|Withdrawal by Subject|9|||
105875887|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875888|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
105875889|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
105875890|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875891|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875892|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875893|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875894|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875895|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875896|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875897|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
105875898|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
105875899|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875900|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
105875901|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
105875902|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
105875903|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875904|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
105875905|NCT03334435|365198935|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875906|NCT03334435|365198936|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875907|NCT03334435|365198937|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875908|NCT03334435|365198938|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875909|NCT03334435|365198939|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875910|NCT03334435|365198940|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875911|NCT03334435|365198941|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875912|NCT03334435|365198942|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875913|NCT03334435|365198943|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875914|NCT03334435|365198944|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875915|NCT03334435|365198945|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875916|NCT03334435|365198946|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
105875917|NCT03334435|365198947|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
105875918|NCT03334435|365198948|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
105875919|NCT03334435|365198949|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
105875920|NCT03922321|365198950|FG000|Overall Study|Participant Moved|1|||
105875921|NCT03922321|365198950|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
105875922|NCT03597295|365198958|FG000|Overall Study|Death|70|||
105875923|NCT03597295|365198958|FG000|Overall Study|Lost to Follow-up|7|||
105875924|NCT04067050|365198959|FG000|One Month|Lost to Follow-up|4|||
105875925|NCT04067050|365198960|FG001|One Month|Lost to Follow-up|0|||
105875926|NCT04067050|365198959|FG000|Two Month|Lost to Follow-up|1|||
105875927|NCT04067050|365198960|FG001|Two Month|Lost to Follow-up|0|||
105875928|NCT04067050|365198959|FG000|Two Month|Adverse Event|1|||
105875929|NCT04067050|365198960|FG001|Two Month|Adverse Event|0|||
105875930|NCT00942084|365198971|FG000|Overall Study|Death|2|||
105875931|NCT02342678|365198972|FG000|Overall Study|Lost to Follow-up|0|||
105875932|NCT02342678|365198973|FG001|Overall Study|Lost to Follow-up|1|||
105875933|NCT02342678|365198972|FG000|Overall Study|Too busy to complete study|0|||
105875934|NCT02342678|365198973|FG001|Overall Study|Too busy to complete study|2|||
105875935|NCT02342678|365198972|FG000|Overall Study|Family illness/emergency|0|||
105875936|NCT02342678|365198973|FG001|Overall Study|Family illness/emergency|1|||
105875937|NCT02342678|365198972|FG000|Overall Study|Illness/medical reason|1|||
105875938|NCT02342678|365198973|FG001|Overall Study|Illness/medical reason|1|||
105875939|NCT03270657|365198974|FG000|Overall Study|Withdrawal by Subject|1|||
105875940|NCT00513240|365198975|FG000|Overall Study|Did not have intended surgery|3|||
105875941|NCT00513240|365198976|FG001|Overall Study|Did not have intended surgery|0|||
105875942|NCT00513240|365198975|FG000|Overall Study|Death|3|||
105875943|NCT00513240|365198976|FG001|Overall Study|Death|3|||
105875944|NCT00513240|365198975|FG000|Overall Study|Withdrawal by Subject|7|||
105875945|NCT00513240|365198976|FG001|Overall Study|Withdrawal by Subject|4|||
105875946|NCT00162981|365198979|FG000|Overall Study|Adverse Event|2|||
105875947|NCT00162981|365198980|FG001|Overall Study|Adverse Event|5|||
105875948|NCT00162981|365198979|FG000|Overall Study|Withdrawal by Subject|1|||
105875949|NCT00162981|365198980|FG001|Overall Study|Withdrawal by Subject|1|||
105875950|NCT00162981|365198979|FG000|Overall Study|Physician Decision|1|||
105875951|NCT00162981|365198980|FG001|Overall Study|Physician Decision|0|||
105875952|NCT03871543|365198982|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
105875953|NCT03871543|365198982|FG000|Period 1|Investigator Error|1|||
105875954|NCT03871543|365198982|FG000|Period 1|Protocol Violation|2|||
105875955|NCT03871543|365198982|FG000|Period 1|COVID-19 Related|1|||
105875956|NCT03871543|365198982|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
105875957|NCT03871543|365198982|FG000|Period 1|Withdrawal by Subject|10|||
105875958|NCT03871543|365198982|FG000|Period 2|Adverse Event|1|||
105875959|NCT03871543|365198982|FG000|Period 2|Withdrawal by Subject|1|||
105875960|NCT01894919|365198996|FG000|Overall Study|Withdrawal by Subject|1|||
105875961|NCT01894919|365198997|FG001|Overall Study|Withdrawal by Subject|0|||
105875962|NCT01894919|365198998|FG002|Overall Study|Withdrawal by Subject|0|||
105875963|NCT01894919|365198999|FG003|Overall Study|Withdrawal by Subject|0|||
105875964|NCT01894919|365199000|FG004|Overall Study|Withdrawal by Subject|1|||
105875965|NCT01894919|365199001|FG005|Overall Study|Withdrawal by Subject|0|||
105875966|NCT01894919|365199002|FG006|Overall Study|Withdrawal by Subject|0|||
105875967|NCT01894919|365199003|FG007|Overall Study|Withdrawal by Subject|0|||
105875968|NCT01894919|365199004|FG008|Overall Study|Withdrawal by Subject|0|||
105875969|NCT01894919|365199005|FG009|Overall Study|Withdrawal by Subject|1|||
105875970|NCT01894919|365199006|FG010|Overall Study|Withdrawal by Subject|1|||
105875971|NCT01894919|365199007|FG011|Overall Study|Withdrawal by Subject|0|||
105875972|NCT01894919|365199008|FG012|Overall Study|Withdrawal by Subject|0|||
105875973|NCT01894919|365198996|FG000|Overall Study|Adverse Event|0|||
105875974|NCT01894919|365198997|FG001|Overall Study|Adverse Event|0|||
105875975|NCT01894919|365198998|FG002|Overall Study|Adverse Event|0|||
105875976|NCT01894919|365198999|FG003|Overall Study|Adverse Event|0|||
105875977|NCT01894919|365199000|FG004|Overall Study|Adverse Event|0|||
105875978|NCT01894919|365199001|FG005|Overall Study|Adverse Event|0|||
105875979|NCT01894919|365199002|FG006|Overall Study|Adverse Event|0|||
105875980|NCT01894919|365199003|FG007|Overall Study|Adverse Event|0|||
105875981|NCT01894919|365199004|FG008|Overall Study|Adverse Event|0|||
105875982|NCT01894919|365199005|FG009|Overall Study|Adverse Event|0|||
105875983|NCT01894919|365199006|FG010|Overall Study|Adverse Event|1|||
105875984|NCT01894919|365199007|FG011|Overall Study|Adverse Event|0|||
105875985|NCT01894919|365199008|FG012|Overall Study|Adverse Event|0|||
105875986|NCT01894919|365198996|FG000|Overall Study|Other-Unspecified|1|||
105875987|NCT01894919|365198997|FG001|Overall Study|Other-Unspecified|0|||
105875988|NCT01894919|365198998|FG002|Overall Study|Other-Unspecified|0|||
105875989|NCT01894919|365198999|FG003|Overall Study|Other-Unspecified|0|||
105875990|NCT01894919|365199000|FG004|Overall Study|Other-Unspecified|0|||
105875991|NCT01894919|365199001|FG005|Overall Study|Other-Unspecified|0|||
105875992|NCT01894919|365199002|FG006|Overall Study|Other-Unspecified|0|||
105875993|NCT01894919|365199003|FG007|Overall Study|Other-Unspecified|0|||
105875994|NCT01894919|365199004|FG008|Overall Study|Other-Unspecified|0|||
105875995|NCT01894919|365199005|FG009|Overall Study|Other-Unspecified|0|||
105875996|NCT01894919|365199006|FG010|Overall Study|Other-Unspecified|0|||
105875997|NCT01894919|365199007|FG011|Overall Study|Other-Unspecified|0|||
105875998|NCT01894919|365199008|FG012|Overall Study|Other-Unspecified|0|||
105875999|NCT01894919|365198996|FG000|Overall Study|Lost to Follow-up|0|||
105876000|NCT01894919|365198997|FG001|Overall Study|Lost to Follow-up|0|||
105876001|NCT01894919|365198998|FG002|Overall Study|Lost to Follow-up|0|||
105876002|NCT01894919|365198999|FG003|Overall Study|Lost to Follow-up|0|||
105876003|NCT01894919|365199000|FG004|Overall Study|Lost to Follow-up|2|||
105876004|NCT01894919|365199001|FG005|Overall Study|Lost to Follow-up|0|||
105876005|NCT01894919|365199002|FG006|Overall Study|Lost to Follow-up|0|||
105876006|NCT01894919|365199003|FG007|Overall Study|Lost to Follow-up|0|||
105876007|NCT01894919|365199004|FG008|Overall Study|Lost to Follow-up|0|||
105876008|NCT01894919|365199005|FG009|Overall Study|Lost to Follow-up|0|||
105876009|NCT01894919|365199006|FG010|Overall Study|Lost to Follow-up|0|||
105876010|NCT01894919|365199007|FG011|Overall Study|Lost to Follow-up|0|||
105876011|NCT01894919|365199008|FG012|Overall Study|Lost to Follow-up|0|||
105876012|NCT00455403|365199009|FG000|Overall Study|Lost to Follow-up|2|||
105876013|NCT00455403|365199010|FG001|Overall Study|Lost to Follow-up|1|||
105876014|NCT00455403|365199009|FG000|Overall Study|Withdrawal by Subject|1|||
105876015|NCT00455403|365199010|FG001|Overall Study|Withdrawal by Subject|3|||
105876016|NCT00455403|365199009|FG000|Overall Study|Protocol Violation|0|||
105876017|NCT00455403|365199010|FG001|Overall Study|Protocol Violation|2|||
105876018|NCT02075203|365199011|FG000|Overall Study|Withdrawal by Subject|1|||
105876019|NCT02075203|365199012|FG001|Overall Study|Withdrawal by Subject|0|||
105876020|NCT02075203|365199013|FG002|Overall Study|Withdrawal by Subject|1|||
105876021|NCT02075203|365199011|FG000|Overall Study|Adverse Event|1|||
105876022|NCT02075203|365199012|FG001|Overall Study|Adverse Event|0|||
105876023|NCT02075203|365199013|FG002|Overall Study|Adverse Event|0|||
105876024|NCT02075203|365199011|FG000|Overall Study|participant refused to use contraception|1|||
105876025|NCT02075203|365199012|FG001|Overall Study|participant refused to use contraception|0|||
105876026|NCT02075203|365199013|FG002|Overall Study|participant refused to use contraception|0|||
105876027|NCT00350207|365199016|FG000|Overall Study|Adverse Event|5|||
105876028|NCT00350207|365199017|FG001|Overall Study|Adverse Event|2|||
105876029|NCT00350207|365199018|FG002|Overall Study|Adverse Event|2|||
105876030|NCT00350207|365199016|FG000|Overall Study|Lack of Efficacy|1|||
105876031|NCT00350207|365199017|FG001|Overall Study|Lack of Efficacy|0|||
105876032|NCT00350207|365199018|FG002|Overall Study|Lack of Efficacy|2|||
105876033|NCT00350207|365199016|FG000|Overall Study|Lost to Follow-up|1|||
105876034|NCT00350207|365199017|FG001|Overall Study|Lost to Follow-up|0|||
105876035|NCT00350207|365199018|FG002|Overall Study|Lost to Follow-up|1|||
105876036|NCT00350207|365199016|FG000|Overall Study|Withdrawal by Subject|0|||
105876037|NCT00350207|365199017|FG001|Overall Study|Withdrawal by Subject|1|||
105876038|NCT00350207|365199018|FG002|Overall Study|Withdrawal by Subject|1|||
105876039|NCT00350207|365199016|FG000|Overall Study|Other|1|||
105876040|NCT00350207|365199017|FG001|Overall Study|Other|3|||
105876041|NCT00350207|365199018|FG002|Overall Study|Other|1|||
105876042|NCT03711188|365199021|FG000|Overall Study|Disease progression|11|||
105876043|NCT03711188|365199021|FG000|Overall Study|Adverse Event|1|||
105876044|NCT01433471|365199022|FG000|Overall Study|Withdrawal by Subject|0|||
105876045|NCT01433471|365199023|FG001|Overall Study|Withdrawal by Subject|1|||
105876046|NCT00495391|365199026|FG000|Overall Study|Lack of Efficacy|34|||
105876047|NCT00495391|365199027|FG001|Overall Study|Lack of Efficacy|18|||
105876048|NCT00495391|365199026|FG000|Overall Study|Withdrawal by Subject|2|||
105876049|NCT00495391|365199027|FG001|Overall Study|Withdrawal by Subject|3|||
105876050|NCT03922308|365199029|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
105876051|NCT03922308|365199030|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
105876052|NCT03922308|365199031|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
105876053|NCT03922308|365199029|FG000|Overall Study|Lost to Follow-up|1|||
105876054|NCT03922308|365199030|FG001|Overall Study|Lost to Follow-up|0|||
105876055|NCT03922308|365199031|FG002|Overall Study|Lost to Follow-up|0|||
105876056|NCT03922308|365199029|FG000|Overall Study|Reason not Specified|0|||
105876057|NCT03922308|365199030|FG001|Overall Study|Reason not Specified|2|||
105876058|NCT03922308|365199031|FG002|Overall Study|Reason not Specified|1|||
105876059|NCT05005507|365199032|FG000|Overall Study|Premature termination of study|1|||
105876060|NCT02755103|365199033|FG000|Overall Study|Lost to Follow-up|17|||
105876061|NCT02755103|365199034|FG001|Overall Study|Lost to Follow-up|15|||
105876062|NCT02755103|365199033|FG000|Overall Study|Death|0|||
105876063|NCT02755103|365199034|FG001|Overall Study|Death|1|||
105876064|NCT02755103|365199033|FG000|Overall Study|Physician Decision|0|||
105876065|NCT02755103|365199034|FG001|Overall Study|Physician Decision|1|||
105876066|NCT02755103|365199033|FG000|Overall Study|Pregnancy|0|||
105876067|NCT02755103|365199034|FG001|Overall Study|Pregnancy|1|||
105876068|NCT02755103|365199033|FG000|Overall Study|Withdrawal by Subject|3|||
105876069|NCT02755103|365199034|FG001|Overall Study|Withdrawal by Subject|0|||
105876070|NCT02172664|365199043|FG000|Overall Study|Lost to Follow-up|4|||
105876071|NCT02172664|365199044|FG001|Overall Study|Lost to Follow-up|4|||
105876072|NCT02172664|365199043|FG000|Overall Study|Death|1|||
105876073|NCT02172664|365199044|FG001|Overall Study|Death|1|||
105876074|NCT02172664|365199043|FG000|Overall Study|Moved out of area|1|||
105876075|NCT02172664|365199044|FG001|Overall Study|Moved out of area|1|||
105876076|NCT00586703|365199049|FG000|Overall Study|Death|12|||
105876077|NCT01422213|365199050|FG000|Overall Study|Adverse Event|8|||
105876078|NCT01422213|365199051|FG001|Overall Study|Adverse Event|7|||
105876079|NCT01422213|365199052|FG002|Overall Study|Adverse Event|11|||
105876080|NCT01422213|365199050|FG000|Overall Study|Lack of Efficacy|10|||
105876081|NCT01422213|365199051|FG001|Overall Study|Lack of Efficacy|2|||
105876082|NCT01422213|365199052|FG002|Overall Study|Lack of Efficacy|2|||
105876083|NCT01422213|365199050|FG000|Overall Study|Non-compliance with study drug|0|||
105876084|NCT01422213|365199051|FG001|Overall Study|Non-compliance with study drug|1|||
105876085|NCT01422213|365199052|FG002|Overall Study|Non-compliance with study drug|0|||
105876086|NCT01422213|365199050|FG000|Overall Study|Protocol Violation|0|||
105876087|NCT01422213|365199051|FG001|Overall Study|Protocol Violation|2|||
105876088|NCT01422213|365199052|FG002|Overall Study|Protocol Violation|4|||
105876089|NCT01422213|365199050|FG000|Overall Study|Withdrawal of Consent|7|||
105876090|NCT01422213|365199051|FG001|Overall Study|Withdrawal of Consent|3|||
105876091|NCT01422213|365199052|FG002|Overall Study|Withdrawal of Consent|5|||
105876092|NCT01422213|365199050|FG000|Overall Study|Lost to Follow-up|3|||
105876093|NCT01422213|365199051|FG001|Overall Study|Lost to Follow-up|3|||
105876094|NCT01422213|365199052|FG002|Overall Study|Lost to Follow-up|5|||
105876095|NCT01422213|365199050|FG000|Overall Study|Administrative or Other Reason(s)|5|||
105876096|NCT01422213|365199051|FG001|Overall Study|Administrative or Other Reason(s)|4|||
105876097|NCT01422213|365199052|FG002|Overall Study|Administrative or Other Reason(s)|2|||
105876098|NCT01882985|365199055|FG000|Overall Study|Lost to Follow-up|1|||
105876099|NCT01882985|365199055|FG000|Overall Study|Withdrawal by Subject|1|||
105876100|NCT02857816|365199056|FG000|Overall Study|Screen Failure|33|||
105876101|NCT02857816|365199056|FG000|Overall Study|Withdrawal by Subject|4|||
105876102|NCT02857816|365199056|FG000|Overall Study|Lost to Follow-up|1|||
105876103|NCT01383174|365199063|FG000|3 Month Assessment|Death|0|||
105876104|NCT01383174|365199064|FG001|3 Month Assessment|Death|1|||
105876105|NCT01383174|365199063|FG000|3 Month Assessment|Lost to Follow-up|2|||
105876106|NCT01383174|365199064|FG001|3 Month Assessment|Lost to Follow-up|0|||
105876107|NCT01383174|365199063|FG000|3 Month Assessment|Refused to complete|4|||
105876108|NCT01383174|365199064|FG001|3 Month Assessment|Refused to complete|0|||
105876109|NCT01383174|365199063|FG000|6 Month Assessment|Lost to Follow-up|1|||
105876110|NCT01383174|365199064|FG001|6 Month Assessment|Lost to Follow-up|1|||
105876111|NCT01383174|365199063|FG000|6 Month Assessment|Refused to complete|4|||
105876112|NCT01383174|365199064|FG001|6 Month Assessment|Refused to complete|0|||
105876113|NCT05271175|365199065|FG000|One Week Follow up|Lost to Follow-up|10|||
105876114|NCT05271175|365199066|FG001|One Week Follow up|Lost to Follow-up|7|||
105876115|NCT05271175|365199067|FG002|One Week Follow up|Lost to Follow-up|5|||
105657957|NCT00107978|364411951|FG000|Overall Study|Protocol Violation|0|||
105876116|NCT05271175|365199065|FG000|One Month Follow up|Lost to Follow-up|12|||
105876117|NCT05271175|365199066|FG001|One Month Follow up|Lost to Follow-up|7|||
105876118|NCT05271175|365199067|FG002|One Month Follow up|Lost to Follow-up|9|||
105876119|NCT05271175|365199065|FG000|Six Months Follow up|Lost to Follow-up|8|||
105876120|NCT05271175|365199066|FG001|Six Months Follow up|Lost to Follow-up|2|||
105876121|NCT05271175|365199067|FG002|Six Months Follow up|Lost to Follow-up|2|||
105876122|NCT03296527|365199068|FG000|Overall Study|Adverse Event|15|||
105876123|NCT03296527|365199069|FG001|Overall Study|Adverse Event|33|||
105876124|NCT03296527|365199068|FG000|Overall Study|Protocol Deviation|4|||
105876125|NCT03296527|365199069|FG001|Overall Study|Protocol Deviation|0|||
105876126|NCT03296527|365199068|FG000|Overall Study|Participant withdrew consent|3|||
105876127|NCT03296527|365199069|FG001|Overall Study|Participant withdrew consent|1|||
105876128|NCT03296527|365199068|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
105876129|NCT03296527|365199069|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
105876130|NCT03296527|365199068|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
105876131|NCT03296527|365199069|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
105876132|NCT03296527|365199068|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
105876133|NCT03296527|365199069|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
105876134|NCT03296527|365199068|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
105876135|NCT03296527|365199069|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
105876136|NCT03296527|365199068|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
105876137|NCT03296527|365199069|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
105876138|NCT01129557|365199071|FG000|Overall Study|Adverse Event|1|||
105876139|NCT01129557|365199072|FG001|Overall Study|Adverse Event|2|||
105876140|NCT01129557|365199073|FG002|Overall Study|Adverse Event|2|||
105876141|NCT01129557|365199071|FG000|Overall Study|Novartis terminated study early|3|||
105876142|NCT01129557|365199072|FG001|Overall Study|Novartis terminated study early|3|||
105876143|NCT01129557|365199073|FG002|Overall Study|Novartis terminated study early|2|||
105876144|NCT01445730|365199074|FG000|Overall Study|Adverse Event|1|||
105876145|NCT01445730|365199074|FG000|Overall Study|For the advice of a dentist|1|||
105876146|NCT01445730|365199074|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
105876147|NCT01167140|365199075|FG000|Overall Study|Withdrawal by Subject|1|||
105876148|NCT02872714|365199080|FG000|Overall Study|Progressive Disease|1|||
105876149|NCT02872714|365199081|FG001|Overall Study|Progressive Disease|2|||
105876150|NCT02872714|365199082|FG002|Overall Study|Progressive Disease|0|||
105876151|NCT02872714|365199083|FG003|Overall Study|Progressive Disease|0|||
105876152|NCT02872714|365199084|FG004|Overall Study|Progressive Disease|0|||
105876153|NCT02872714|365199080|FG000|Overall Study|Death|87|||
105876154|NCT02872714|365199081|FG001|Overall Study|Death|36|||
105876155|NCT02872714|365199082|FG002|Overall Study|Death|8|||
105876156|NCT02872714|365199083|FG003|Overall Study|Death|81|||
105876157|NCT02872714|365199084|FG004|Overall Study|Death|2|||
105876158|NCT02872714|365199080|FG000|Overall Study|Lost to Follow-up|2|||
105876159|NCT02872714|365199081|FG001|Overall Study|Lost to Follow-up|1|||
105876160|NCT02872714|365199082|FG002|Overall Study|Lost to Follow-up|0|||
105876161|NCT02872714|365199083|FG003|Overall Study|Lost to Follow-up|3|||
105876162|NCT02872714|365199084|FG004|Overall Study|Lost to Follow-up|0|||
105876163|NCT02872714|365199080|FG000|Overall Study|Physician Decision|0|||
105876164|NCT02872714|365199081|FG001|Overall Study|Physician Decision|0|||
105876165|NCT02872714|365199082|FG002|Overall Study|Physician Decision|0|||
105876166|NCT02872714|365199083|FG003|Overall Study|Physician Decision|1|||
105876167|NCT02872714|365199084|FG004|Overall Study|Physician Decision|0|||
105876168|NCT02872714|365199080|FG000|Overall Study|Withdrawal by Subject|1|||
105876169|NCT02872714|365199081|FG001|Overall Study|Withdrawal by Subject|3|||
105876170|NCT02872714|365199082|FG002|Overall Study|Withdrawal by Subject|0|||
105876171|NCT02872714|365199083|FG003|Overall Study|Withdrawal by Subject|2|||
105876172|NCT02872714|365199084|FG004|Overall Study|Withdrawal by Subject|0|||
105876173|NCT02872714|365199080|FG000|Overall Study|Captured as Other|2|||
105876174|NCT02872714|365199081|FG001|Overall Study|Captured as Other|0|||
105876175|NCT02872714|365199082|FG002|Overall Study|Captured as Other|0|||
105876176|NCT02872714|365199083|FG003|Overall Study|Captured as Other|1|||
105876177|NCT02872714|365199084|FG004|Overall Study|Captured as Other|0|||
105876178|NCT02576847|365199090|FG000|Overall Study|Adverse Event|27|||
105876179|NCT02576847|365199090|FG000|Overall Study|Lost to Follow-up|22|||
105876180|NCT02576847|365199090|FG000|Overall Study|Physician Decision|1|||
105876181|NCT02576847|365199090|FG000|Overall Study|Pregnancy|1|||
105876182|NCT02576847|365199090|FG000|Overall Study|Protocol Violation|3|||
105876183|NCT02576847|365199090|FG000|Overall Study|Withdrawal by Subject|78|||
105876184|NCT02576847|365199090|FG000|Overall Study|Other|5|||
105876185|NCT04563754|365200926|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
105876186|NCT04563754|365200927|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
105987552|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
105876187|NCT04563754|365200928|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
105876188|NCT04563754|365200926|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
105876189|NCT04563754|365200927|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
105876190|NCT04563754|365200928|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
105876191|NCT04563754|365200926|FG000|Follow up|Lost to Follow-up|61|||
105876192|NCT04563754|365200927|FG001|Follow up|Lost to Follow-up|23|||
105876193|NCT04563754|365200928|FG002|Follow up|Lost to Follow-up|5|||
105876194|NCT04563754|365200926|FG000|Follow up|Death|0|||
105876195|NCT04563754|365200927|FG001|Follow up|Death|2|||
105876196|NCT04563754|365200928|FG002|Follow up|Death|0|||
105876197|NCT04563754|365200926|FG000|Follow up|Ongoing|0|||
105876198|NCT04563754|365200927|FG001|Follow up|Ongoing|28|||
105876199|NCT04563754|365200928|FG002|Follow up|Ongoing|0|||
105876200|NCT04075825|365200931|FG000|Overall Study|Withdrawal by Subject|6|||
105876201|NCT04075825|365200932|FG001|Overall Study|Withdrawal by Subject|8|||
105876202|NCT04075825|365200931|FG000|Overall Study|Physician Decision|3|||
105876203|NCT04075825|365200932|FG001|Overall Study|Physician Decision|1|||
105876204|NCT04075825|365200931|FG000|Overall Study|Lost to Follow-up|5|||
105876205|NCT04075825|365200932|FG001|Overall Study|Lost to Follow-up|1|||
105876206|NCT04075825|365200931|FG000|Overall Study|Participation in New Clinical Trial|1|||
105876207|NCT04075825|365200932|FG001|Overall Study|Participation in New Clinical Trial|1|||
105876208|NCT04075825|365200931|FG000|Overall Study|Reason Not Specified|2|||
105876209|NCT04075825|365200932|FG001|Overall Study|Reason Not Specified|2|||
105876210|NCT02513160|365200933|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
105876211|NCT02513160|365200934|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
105876212|NCT02513160|365200935|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
105876213|NCT02513160|365200936|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
105876214|NCT02513160|365200933|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
105876215|NCT02513160|365200934|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
105876216|NCT02513160|365200935|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
105876217|NCT02513160|365200936|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
105876218|NCT02513160|365200933|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
105876219|NCT02513160|365200934|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
105876220|NCT02513160|365200935|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
105876221|NCT02513160|365200936|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
105876222|NCT02513160|365200933|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
105657958|NCT00107978|364411952|FG001|Overall Study|Protocol Violation|1|||
105657959|NCT00107978|364411951|FG000|Overall Study|Other|5|||
105657960|NCT00107978|364411952|FG001|Overall Study|Other|4|||
105657961|NCT02669407|364411953|FG000|Overall Study|Physician Decision|3|||
105657962|NCT01874665|364411956|FG000|Overall Study|Adverse Event|6|||
105657963|NCT01874665|364411957|FG001|Overall Study|Adverse Event|2|||
105657964|NCT01874665|364411956|FG000|Overall Study|Withdrawal by Subject|4|||
105657965|NCT01874665|364411957|FG001|Overall Study|Withdrawal by Subject|1|||
105657966|NCT01874665|364411956|FG000|Overall Study|Physician Decision|3|||
105657967|NCT01874665|364411957|FG001|Overall Study|Physician Decision|0|||
105657968|NCT01874665|364411956|FG000|Overall Study|Clinical Progressive Disease|4|||
105657969|NCT01874665|364411957|FG001|Overall Study|Clinical Progressive Disease|3|||
105657970|NCT01874665|364411956|FG000|Overall Study|Study Terminated by Sponsor|0|||
105657971|NCT01874665|364411957|FG001|Overall Study|Study Terminated by Sponsor|2|||
105657972|NCT01874665|364411956|FG000|Overall Study|Documented Progressive Disease|11|||
105657973|NCT01874665|364411957|FG001|Overall Study|Documented Progressive Disease|7|||
105657974|NCT01874665|364411956|FG000|Overall Study|Other|2|||
105657975|NCT01874665|364411957|FG001|Overall Study|Other|0|||
105657976|NCT00350298|364411960|FG000|Overall Study|Death|7|||
105657977|NCT00350298|364411961|FG001|Overall Study|Death|8|||
105657978|NCT00350298|364411960|FG000|Overall Study|Lost to Follow-up|1|||
105657979|NCT00350298|364411961|FG001|Overall Study|Lost to Follow-up|2|||
105657980|NCT00350298|364411960|FG000|Overall Study|Withdrawal by Subject|1|||
105657981|NCT00350298|364411961|FG001|Overall Study|Withdrawal by Subject|3|||
105657982|NCT01588366|364411964|FG000|Overall Study|Adverse Event|0|||
105657983|NCT01588366|364411965|FG001|Overall Study|Adverse Event|1|||
105657984|NCT01588366|364411966|FG002|Overall Study|Adverse Event|0|||
105657985|NCT01588366|364411967|FG003|Overall Study|Adverse Event|1|||
105657986|NCT01588366|364411968|FG004|Overall Study|Adverse Event|0|||
105657987|NCT01588366|364411969|FG005|Overall Study|Adverse Event|2|||
105657988|NCT04962698|364411970|FG000|Motor Imagery|Technical difficulty|1|||
105657989|NCT04962698|364411971|FG001|Motor Imagery|Technical difficulty|0|||
105657990|NCT04962698|364411970|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
105657991|NCT04962698|364411971|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
105657992|NCT04962698|364411970|FG000|Kinesthetic MI|Technical difficulty|1|||
105657993|NCT04962698|364411971|FG001|Kinesthetic MI|Technical difficulty|0|||
105657994|NCT04962698|364411970|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
105657995|NCT04962698|364411971|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
105876223|NCT02513160|365200934|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
105876224|NCT02513160|365200935|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
105876225|NCT02513160|365200936|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
105876226|NCT02513160|365200933|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
105876227|NCT02513160|365200934|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
105876228|NCT02513160|365200935|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
105876229|NCT02513160|365200936|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
105876230|NCT02513160|365200933|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
105876231|NCT02513160|365200934|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
105876232|NCT02513160|365200935|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
105876233|NCT02513160|365200936|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
105876234|NCT02513160|365200933|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
105876235|NCT02513160|365200934|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
105876236|NCT02513160|365200935|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
105876237|NCT02513160|365200936|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
105876238|NCT02513160|365200933|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
105876239|NCT02513160|365200934|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
105876240|NCT02513160|365200935|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
105876241|NCT02513160|365200936|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
105876242|NCT02513160|365200933|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
105876243|NCT02513160|365200934|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
105876244|NCT02513160|365200935|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
105876245|NCT02513160|365200936|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
105876246|NCT02513160|365200933|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
105876247|NCT02513160|365200934|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
105876248|NCT02513160|365200935|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
105876249|NCT02513160|365200936|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
105876250|NCT02513160|365200933|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
105876251|NCT02513160|365200934|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
105876252|NCT02513160|365200935|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
105876253|NCT02513160|365200936|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
105876254|NCT02513160|365200933|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
105876255|NCT02513160|365200934|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
105876256|NCT02513160|365200935|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
105876257|NCT02513160|365200936|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
105876258|NCT04021914|365200937|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
105876259|NCT02844543|365200938|FG000|Overall Study|Withdrawal by Subject|4|||
105876260|NCT02844543|365200938|FG000|Overall Study|Did not meet eligibility criteria|1|||
105876261|NCT00485732|365200943|FG000|Overall Study|Protocol Violation|1|||
105876262|NCT00485732|365200944|FG001|Overall Study|Protocol Violation|3|||
105876263|NCT00485732|365200943|FG000|Overall Study|Withdrawal by Subject|5|||
105876264|NCT00485732|365200944|FG001|Overall Study|Withdrawal by Subject|4|||
105876265|NCT00485732|365200943|FG000|Overall Study|Lost to Follow-up|2|||
105876266|NCT00485732|365200944|FG001|Overall Study|Lost to Follow-up|2|||
105876267|NCT04796909|365200946|FG000|Overall Study|Withdrawal by Subject|1|||
105876268|NCT04796909|365200947|FG001|Overall Study|Withdrawal by Subject|1|||
105876269|NCT04162847|365200948|FG000|Overall Study|Withdrawal by Subject|7|||
105876270|NCT04162847|365200949|FG001|Overall Study|Withdrawal by Subject|1|||
105876271|NCT03428958|365200950|FG000|Overall Study|Adverse Event|0|||
105876272|NCT03428958|365200951|FG001|Overall Study|Adverse Event|0|||
105876273|NCT03428958|365200952|FG002|Overall Study|Adverse Event|0|||
105876274|NCT03428958|365200953|FG003|Overall Study|Adverse Event|1|||
105876275|NCT03428958|365200954|FG004|Overall Study|Adverse Event|0|||
105876276|NCT03428958|365200955|FG005|Overall Study|Adverse Event|2|||
105876277|NCT03428958|365200956|FG006|Overall Study|Adverse Event|1|||
105876278|NCT03428958|365200957|FG007|Overall Study|Adverse Event|0|||
105876279|NCT03428958|365200958|FG008|Overall Study|Adverse Event|0|||
105876280|NCT03428958|365200959|FG009|Overall Study|Adverse Event|0|||
105876281|NCT03428958|365200960|FG010|Overall Study|Adverse Event|0|||
105876282|NCT03428958|365200961|FG011|Overall Study|Adverse Event|0|||
105876283|NCT03428958|365200962|FG012|Overall Study|Adverse Event|0|||
105876284|NCT03428958|365200963|FG013|Overall Study|Adverse Event|0|||
105876285|NCT03428958|365200964|FG014|Overall Study|Adverse Event|0|||
105876286|NCT03428958|365200965|FG015|Overall Study|Adverse Event|0|||
105876287|NCT03428958|365200966|FG016|Overall Study|Adverse Event|0|||
105876288|NCT03428958|365200950|FG000|Overall Study|Clinical Progression|2|||
105876289|NCT03428958|365200951|FG001|Overall Study|Clinical Progression|3|||
105876290|NCT03428958|365200952|FG002|Overall Study|Clinical Progression|2|||
105876291|NCT03428958|365200953|FG003|Overall Study|Clinical Progression|1|||
105876292|NCT03428958|365200954|FG004|Overall Study|Clinical Progression|0|||
105876293|NCT03428958|365200955|FG005|Overall Study|Clinical Progression|2|||
105876294|NCT03428958|365200956|FG006|Overall Study|Clinical Progression|0|||
105876295|NCT03428958|365200957|FG007|Overall Study|Clinical Progression|0|||
105876296|NCT03428958|365200958|FG008|Overall Study|Clinical Progression|0|||
105876297|NCT03428958|365200959|FG009|Overall Study|Clinical Progression|0|||
105876298|NCT03428958|365200960|FG010|Overall Study|Clinical Progression|0|||
105876299|NCT03428958|365200961|FG011|Overall Study|Clinical Progression|0|||
105876300|NCT03428958|365200962|FG012|Overall Study|Clinical Progression|0|||
105876301|NCT03428958|365200963|FG013|Overall Study|Clinical Progression|0|||
105876302|NCT03428958|365200964|FG014|Overall Study|Clinical Progression|0|||
105876303|NCT03428958|365200965|FG015|Overall Study|Clinical Progression|0|||
105876304|NCT03428958|365200966|FG016|Overall Study|Clinical Progression|0|||
105876305|NCT03428958|365200950|FG000|Overall Study|Progression per RECIST|6|||
105876306|NCT03428958|365200951|FG001|Overall Study|Progression per RECIST|6|||
105876307|NCT03428958|365200952|FG002|Overall Study|Progression per RECIST|7|||
105876308|NCT03428958|365200953|FG003|Overall Study|Progression per RECIST|4|||
105876309|NCT03428958|365200954|FG004|Overall Study|Progression per RECIST|0|||
105876310|NCT03428958|365200955|FG005|Overall Study|Progression per RECIST|7|||
105876311|NCT03428958|365200956|FG006|Overall Study|Progression per RECIST|8|||
105876312|NCT03428958|365200957|FG007|Overall Study|Progression per RECIST|0|||
105876313|NCT03428958|365200958|FG008|Overall Study|Progression per RECIST|0|||
105876314|NCT03428958|365200959|FG009|Overall Study|Progression per RECIST|0|||
105876315|NCT03428958|365200960|FG010|Overall Study|Progression per RECIST|0|||
105876316|NCT03428958|365200961|FG011|Overall Study|Progression per RECIST|0|||
105876317|NCT03428958|365200962|FG012|Overall Study|Progression per RECIST|1|||
105876318|NCT03428958|365200963|FG013|Overall Study|Progression per RECIST|0|||
105876319|NCT03428958|365200964|FG014|Overall Study|Progression per RECIST|0|||
105876320|NCT03428958|365200965|FG015|Overall Study|Progression per RECIST|0|||
105876321|NCT03428958|365200966|FG016|Overall Study|Progression per RECIST|0|||
105876322|NCT03428958|365200950|FG000|Overall Study|Death|2|||
105876323|NCT03428958|365200951|FG001|Overall Study|Death|2|||
105876324|NCT03428958|365200952|FG002|Overall Study|Death|0|||
105876325|NCT03428958|365200953|FG003|Overall Study|Death|0|||
105876326|NCT03428958|365200954|FG004|Overall Study|Death|0|||
105876327|NCT03428958|365200955|FG005|Overall Study|Death|7|||
105876328|NCT03428958|365200956|FG006|Overall Study|Death|9|||
105876329|NCT03428958|365200957|FG007|Overall Study|Death|6|||
105876330|NCT03428958|365200958|FG008|Overall Study|Death|0|||
105876331|NCT03428958|365200959|FG009|Overall Study|Death|0|||
105876332|NCT03428958|365200960|FG010|Overall Study|Death|3|||
105876333|NCT03428958|365200961|FG011|Overall Study|Death|0|||
105876334|NCT03428958|365200962|FG012|Overall Study|Death|4|||
105876335|NCT03428958|365200963|FG013|Overall Study|Death|0|||
105876336|NCT03428958|365200964|FG014|Overall Study|Death|0|||
105876337|NCT03428958|365200965|FG015|Overall Study|Death|0|||
105876338|NCT03428958|365200966|FG016|Overall Study|Death|0|||
105876339|NCT03428958|365200950|FG000|Overall Study|Lost to Follow-up|0|||
105876340|NCT03428958|365200951|FG001|Overall Study|Lost to Follow-up|0|||
105876341|NCT03428958|365200952|FG002|Overall Study|Lost to Follow-up|0|||
105876342|NCT03428958|365200953|FG003|Overall Study|Lost to Follow-up|0|||
105876343|NCT03428958|365200954|FG004|Overall Study|Lost to Follow-up|0|||
105876344|NCT03428958|365200955|FG005|Overall Study|Lost to Follow-up|1|||
105876345|NCT03428958|365200956|FG006|Overall Study|Lost to Follow-up|1|||
105876346|NCT03428958|365200957|FG007|Overall Study|Lost to Follow-up|0|||
105876347|NCT03428958|365200958|FG008|Overall Study|Lost to Follow-up|0|||
105876348|NCT03428958|365200959|FG009|Overall Study|Lost to Follow-up|0|||
105876349|NCT03428958|365200960|FG010|Overall Study|Lost to Follow-up|0|||
105876350|NCT03428958|365200961|FG011|Overall Study|Lost to Follow-up|0|||
105876351|NCT03428958|365200962|FG012|Overall Study|Lost to Follow-up|0|||
105876352|NCT03428958|365200963|FG013|Overall Study|Lost to Follow-up|0|||
105876353|NCT03428958|365200964|FG014|Overall Study|Lost to Follow-up|0|||
105876354|NCT03428958|365200965|FG015|Overall Study|Lost to Follow-up|0|||
105876355|NCT03428958|365200966|FG016|Overall Study|Lost to Follow-up|0|||
105876356|NCT03428958|365200950|FG000|Overall Study|Physician/Sponsor Decision|1|||
105876357|NCT03428958|365200951|FG001|Overall Study|Physician/Sponsor Decision|0|||
105876358|NCT03428958|365200952|FG002|Overall Study|Physician/Sponsor Decision|1|||
105876359|NCT03428958|365200953|FG003|Overall Study|Physician/Sponsor Decision|0|||
105876360|NCT03428958|365200954|FG004|Overall Study|Physician/Sponsor Decision|0|||
105876361|NCT03428958|365200955|FG005|Overall Study|Physician/Sponsor Decision|2|||
105876362|NCT03428958|365200956|FG006|Overall Study|Physician/Sponsor Decision|2|||
105876363|NCT03428958|365200957|FG007|Overall Study|Physician/Sponsor Decision|2|||
105659510|NCT02635386|364417350|FG003|Overall Study|side effects|4|||
105876364|NCT03428958|365200958|FG008|Overall Study|Physician/Sponsor Decision|0|||
105876365|NCT03428958|365200959|FG009|Overall Study|Physician/Sponsor Decision|0|||
105876366|NCT03428958|365200960|FG010|Overall Study|Physician/Sponsor Decision|2|||
105876367|NCT03428958|365200961|FG011|Overall Study|Physician/Sponsor Decision|0|||
105876368|NCT03428958|365200962|FG012|Overall Study|Physician/Sponsor Decision|4|||
105876369|NCT03428958|365200963|FG013|Overall Study|Physician/Sponsor Decision|0|||
105876370|NCT03428958|365200964|FG014|Overall Study|Physician/Sponsor Decision|0|||
105876371|NCT03428958|365200965|FG015|Overall Study|Physician/Sponsor Decision|0|||
105876372|NCT03428958|365200966|FG016|Overall Study|Physician/Sponsor Decision|0|||
105876373|NCT03428958|365200950|FG000|Overall Study|Withdrawal by Subject|0|||
105876374|NCT03428958|365200951|FG001|Overall Study|Withdrawal by Subject|0|||
105876375|NCT03428958|365200952|FG002|Overall Study|Withdrawal by Subject|2|||
105876376|NCT03428958|365200953|FG003|Overall Study|Withdrawal by Subject|0|||
105876377|NCT03428958|365200954|FG004|Overall Study|Withdrawal by Subject|0|||
105876378|NCT03428958|365200955|FG005|Overall Study|Withdrawal by Subject|2|||
105876379|NCT03428958|365200956|FG006|Overall Study|Withdrawal by Subject|4|||
105876380|NCT03428958|365200957|FG007|Overall Study|Withdrawal by Subject|1|||
105876381|NCT03428958|365200958|FG008|Overall Study|Withdrawal by Subject|0|||
105876382|NCT03428958|365200959|FG009|Overall Study|Withdrawal by Subject|0|||
105876383|NCT03428958|365200960|FG010|Overall Study|Withdrawal by Subject|0|||
105876384|NCT03428958|365200961|FG011|Overall Study|Withdrawal by Subject|0|||
105876385|NCT03428958|365200962|FG012|Overall Study|Withdrawal by Subject|0|||
105876386|NCT03428958|365200963|FG013|Overall Study|Withdrawal by Subject|0|||
105876387|NCT03428958|365200964|FG014|Overall Study|Withdrawal by Subject|0|||
105876388|NCT03428958|365200965|FG015|Overall Study|Withdrawal by Subject|0|||
105876389|NCT03428958|365200966|FG016|Overall Study|Withdrawal by Subject|0|||
105876390|NCT05258773|365200967|FG000|Overall Study|Screen Failure|1|||
105876391|NCT05258773|365200968|FG001|Overall Study|Screen Failure|1|||
105876392|NCT05258773|365200967|FG000|Overall Study|Adverse Event|1|||
105876393|NCT05258773|365200968|FG001|Overall Study|Adverse Event|0|||
105876394|NCT05258773|365200967|FG000|Overall Study|Withdrawal by Subject|0|||
105876395|NCT05258773|365200968|FG001|Overall Study|Withdrawal by Subject|1|||
105876396|NCT01127256|365200969|FG000|Overall Study|Adverse Event|13|||
105876397|NCT01127256|365200970|FG001|Overall Study|Adverse Event|13|||
105876398|NCT01127256|365200969|FG000|Overall Study|Lack of Efficacy|4|||
105876399|NCT01127256|365200970|FG001|Overall Study|Lack of Efficacy|0|||
105876400|NCT01127256|365200969|FG000|Overall Study|Lost to Follow-up|16|||
105876401|NCT01127256|365200970|FG001|Overall Study|Lost to Follow-up|17|||
105876402|NCT01127256|365200969|FG000|Overall Study|Withdrawal by Subject|5|||
105876403|NCT01127256|365200970|FG001|Overall Study|Withdrawal by Subject|9|||
105876404|NCT01127256|365200969|FG000|Overall Study|Protocol Violation|1|||
105876405|NCT01127256|365200970|FG001|Overall Study|Protocol Violation|0|||
105876406|NCT01922037|365200971|FG000|Overall Study|Withdrawal by Subject|2|||
105876407|NCT01922037|365200972|FG001|Overall Study|Withdrawal by Subject|44|||
105876408|NCT01922037|365200971|FG000|Overall Study|Adverse Event|1|||
105876409|NCT01922037|365200972|FG001|Overall Study|Adverse Event|7|||
105876410|NCT01922037|365200971|FG000|Overall Study|Death|0|||
105876411|NCT01922037|365200972|FG001|Overall Study|Death|5|||
105876412|NCT01922037|365200971|FG000|Overall Study|Pregnancy|0|||
105876413|NCT01922037|365200972|FG001|Overall Study|Pregnancy|2|||
105876414|NCT01922037|365200971|FG000|Overall Study|Participant non-compliance|4|||
105876415|NCT01922037|365200972|FG001|Overall Study|Participant non-compliance|46|||
105876416|NCT01922037|365200971|FG000|Overall Study|Investigator/Sponsor decision|1|||
105876417|NCT01922037|365200972|FG001|Overall Study|Investigator/Sponsor decision|4|||
105876418|NCT01922037|365200971|FG000|Overall Study|Other unspecified|2|||
105876419|NCT01922037|365200972|FG001|Overall Study|Other unspecified|66|||
105876420|NCT02068508|365200973|FG000|Overall Study|Case report forms uncollected|27|||
105876421|NCT02068508|365200973|FG000|Overall Study|Patient did not visit the study site|1|||
105876422|NCT02068508|365200973|FG000|Overall Study|Protocol Violation|4|||
105876423|NCT00813150|365200974|FG000|Treatment Period|Adverse Event|16|||
105876424|NCT00813150|365200975|FG001|Treatment Period|Adverse Event|15|||
105876425|NCT00813150|365200974|FG000|Treatment Period|Death|2|||
105876426|NCT00813150|365200975|FG001|Treatment Period|Death|0|||
105876427|NCT00813150|365200974|FG000|Treatment Period|Progressive disease|1|||
105876428|NCT00813150|365200975|FG001|Treatment Period|Progressive disease|0|||
105876429|NCT00813150|365200974|FG000|Treatment Period|Complete response|0|||
105876430|NCT00813150|365200975|FG001|Treatment Period|Complete response|1|||
105876431|NCT00813150|365200974|FG000|Treatment Period|Stable disease|1|||
105876432|NCT00813150|365200975|FG001|Treatment Period|Stable disease|2|||
105876433|NCT00813150|365200974|FG000|Treatment Period|Protocol Violation|3|||
105876434|NCT00813150|365200975|FG001|Treatment Period|Protocol Violation|4|||
105876435|NCT00813150|365200974|FG000|Treatment Period|Withdrawal by Subject|5|||
105657996|NCT04962698|364411970|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
105876436|NCT00813150|365200975|FG001|Treatment Period|Withdrawal by Subject|3|||
105876437|NCT00813150|365200974|FG000|Treatment Period|Non compliance|0|||
105876438|NCT00813150|365200975|FG001|Treatment Period|Non compliance|1|||
105876439|NCT00813150|365200974|FG000|Treatment Period|Reason not specified|3|||
105876440|NCT00813150|365200975|FG001|Treatment Period|Reason not specified|4|||
105876441|NCT00813150|365200974|FG000|Treatment Period|Data not available|1|||
105876442|NCT00813150|365200975|FG001|Treatment Period|Data not available|2|||
105876443|NCT00813150|365200974|FG000|Long Term Follow-up|Death|0|||
105876444|NCT00813150|365200975|FG001|Long Term Follow-up|Death|4|||
105876445|NCT00813150|365200974|FG000|Long Term Follow-up|Other|0|||
105876446|NCT00813150|365200975|FG001|Long Term Follow-up|Other|3|||
105876447|NCT00813150|365200974|FG000|Long Term Follow-up|Lost to Follow-up|2|||
105876448|NCT00813150|365200975|FG001|Long Term Follow-up|Lost to Follow-up|0|||
105876449|NCT00813150|365200974|FG000|Long Term Follow-up|Progression/Relapse|22|||
105876450|NCT00813150|365200975|FG001|Long Term Follow-up|Progression/Relapse|24|||
105876451|NCT03103087|365200980|FG000|Overall Study|Did not receive any study drug|1|||
105876452|NCT03103087|365200981|FG001|Overall Study|Did not receive any study drug|0|||
105876453|NCT03103087|365200982|FG002|Overall Study|Did not receive any study drug|0|||
105876454|NCT03103087|365200980|FG000|Overall Study|Protocol Violation|1|||
105876455|NCT03103087|365200981|FG001|Overall Study|Protocol Violation|2|||
105876456|NCT03103087|365200982|FG002|Overall Study|Protocol Violation|1|||
105876457|NCT03103087|365200980|FG000|Overall Study|Lack of Efficacy|2|||
105876458|NCT03103087|365200981|FG001|Overall Study|Lack of Efficacy|1|||
105876459|NCT03103087|365200982|FG002|Overall Study|Lack of Efficacy|1|||
105876460|NCT03103087|365200980|FG000|Overall Study|Pregnancy|0|||
105876461|NCT03103087|365200981|FG001|Overall Study|Pregnancy|0|||
105876462|NCT03103087|365200982|FG002|Overall Study|Pregnancy|1|||
105876463|NCT03103087|365200980|FG000|Overall Study|Adverse Event|2|||
105876464|NCT03103087|365200981|FG001|Overall Study|Adverse Event|15|||
105876465|NCT03103087|365200982|FG002|Overall Study|Adverse Event|6|||
105876466|NCT03103087|365200980|FG000|Overall Study|Withdrawal by Subject|13|||
105876467|NCT03103087|365200981|FG001|Overall Study|Withdrawal by Subject|6|||
105876468|NCT03103087|365200982|FG002|Overall Study|Withdrawal by Subject|6|||
105876469|NCT03103087|365200980|FG000|Overall Study|Lost to Follow-up|4|||
105876470|NCT03103087|365200981|FG001|Overall Study|Lost to Follow-up|2|||
105876471|NCT03103087|365200982|FG002|Overall Study|Lost to Follow-up|7|||
105876472|NCT03103087|365200980|FG000|Overall Study|Other reason not reported|1|||
105876473|NCT03103087|365200981|FG001|Overall Study|Other reason not reported|3|||
105876474|NCT03103087|365200982|FG002|Overall Study|Other reason not reported|5|||
105876475|NCT00075816|365200983|FG000|Overall Study|Did not undergo transplantation|14|||
105876476|NCT00075816|365200984|FG001|Overall Study|Did not undergo transplantation|11|||
105876477|NCT01467713|365200985|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
105876478|NCT01467713|365200986|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
105876479|NCT01467713|365200987|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
105876480|NCT01467713|365200988|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
105876481|NCT01467713|365200985|FG000|Overall Study|Major Protocol Deviation|2|||
105876482|NCT01467713|365200986|FG001|Overall Study|Major Protocol Deviation|4|||
105876483|NCT01467713|365200987|FG002|Overall Study|Major Protocol Deviation|4|||
105876484|NCT01467713|365200988|FG003|Overall Study|Major Protocol Deviation|1|||
105876485|NCT01467713|365200985|FG000|Overall Study|Lost to Follow-up|9|||
105876486|NCT01467713|365200986|FG001|Overall Study|Lost to Follow-up|12|||
105876487|NCT01467713|365200987|FG002|Overall Study|Lost to Follow-up|6|||
105876488|NCT01467713|365200988|FG003|Overall Study|Lost to Follow-up|9|||
105876489|NCT01467713|365200985|FG000|Overall Study|Voluntary Withdrawal|18|||
105876490|NCT01467713|365200986|FG001|Overall Study|Voluntary Withdrawal|14|||
105876491|NCT01467713|365200987|FG002|Overall Study|Voluntary Withdrawal|21|||
105876492|NCT01467713|365200988|FG003|Overall Study|Voluntary Withdrawal|20|||
105876493|NCT01467713|365200985|FG000|Overall Study|Study Termination|23|||
105876494|NCT01467713|365200986|FG001|Overall Study|Study Termination|33|||
105876495|NCT01467713|365200987|FG002|Overall Study|Study Termination|28|||
105876496|NCT01467713|365200988|FG003|Overall Study|Study Termination|29|||
105876497|NCT01467713|365200985|FG000|Overall Study|Pregnancy|0|||
105876498|NCT01467713|365200986|FG001|Overall Study|Pregnancy|1|||
105876499|NCT01467713|365200987|FG002|Overall Study|Pregnancy|1|||
105876500|NCT01467713|365200988|FG003|Overall Study|Pregnancy|3|||
105876501|NCT01467713|365200985|FG000|Overall Study|Relapse|35|||
105876502|NCT01467713|365200986|FG001|Overall Study|Relapse|25|||
105876503|NCT01467713|365200987|FG002|Overall Study|Relapse|28|||
105876504|NCT01467713|365200988|FG003|Overall Study|Relapse|35|||
105876505|NCT01467713|365200985|FG000|Overall Study|Reason not Specified|6|||
105876506|NCT01467713|365200986|FG001|Overall Study|Reason not Specified|11|||
105876507|NCT01467713|365200987|FG002|Overall Study|Reason not Specified|8|||
105876508|NCT01467713|365200988|FG003|Overall Study|Reason not Specified|7|||
105876509|NCT02445248|365200993|FG000|Overall Study|Death|45|||
105876510|NCT02445248|365200994|FG001|Overall Study|Death|12|||
105876511|NCT02445248|365200993|FG000|Overall Study|Progressive disease|13|||
105876512|NCT02445248|365200994|FG001|Overall Study|Progressive disease|1|||
105876513|NCT02445248|365200993|FG000|Overall Study|Subject decision|8|||
105657997|NCT04962698|364411971|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
105657998|NCT04962698|364411970|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
105876514|NCT02445248|365200994|FG001|Overall Study|Subject decision|0|||
105876515|NCT02445248|365200993|FG000|Overall Study|Physician Decision|5|||
105876516|NCT02445248|365200994|FG001|Overall Study|Physician Decision|0|||
105876517|NCT02445248|365200993|FG000|Overall Study|Adverse Event|1|||
105876518|NCT02445248|365200994|FG001|Overall Study|Adverse Event|0|||
105876519|NCT02445248|365200993|FG000|Overall Study|Lost to Follow-up|1|||
105876520|NCT02445248|365200994|FG001|Overall Study|Lost to Follow-up|0|||
105876521|NCT03096314|365200997|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
105876522|NCT03096314|365200998|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
105876523|NCT03875508|365201001|FG000|Overall Study|Adverse Event|1|||
105876524|NCT03875508|365201001|FG000|Overall Study|Lost to Follow-up|8|||
105876525|NCT03875508|365201001|FG000|Overall Study|Lack of Efficacy|1|||
105876526|NCT03875508|365201001|FG000|Overall Study|Other, not specified|2|||
105876527|NCT03214224|365201002|FG000|Overall Study|Protocol Violation|1|||
105876528|NCT03214224|365201002|FG000|Overall Study|Withdrawal by Subject|2|||
105876529|NCT03214224|365201002|FG000|Overall Study|Practice controls or therapists|6|||
105876530|NCT03802825|365201011|FG000|Overall Study|Lost to follow-up for intervention|12|||
105876531|NCT03802825|365201012|FG001|Overall Study|Lost to follow-up for intervention|3|||
105876532|NCT03802825|365201011|FG000|Overall Study|Received only 1 component of intervention|0|||
105876533|NCT03802825|365201012|FG001|Overall Study|Received only 1 component of intervention|13|||
105876534|NCT00568451|365201013|FG000|Overall Study|Disease Progression|0|||
105876535|NCT00568451|365201014|FG001|Overall Study|Disease Progression|0|||
105876536|NCT00568451|365201015|FG002|Overall Study|Disease Progression|2|||
105876537|NCT00568451|365201016|FG003|Overall Study|Disease Progression|7|||
105876538|NCT01930162|365201017|FG000|Overall Study|Abnormal test procedure result(s)|4|||
105876539|NCT01930162|365201017|FG000|Overall Study|Death|1|||
105876540|NCT03428152|365201019|FG000|Overall Study|Physician Decision|4|||
105876541|NCT03428152|365201020|FG001|Overall Study|Physician Decision|2|||
105876542|NCT03428152|365201019|FG000|Overall Study|Protocol Violation|3|||
105876543|NCT03428152|365201020|FG001|Overall Study|Protocol Violation|5|||
105876544|NCT03428152|365201019|FG000|Overall Study|Lack of Efficacy|0|||
105876545|NCT03428152|365201020|FG001|Overall Study|Lack of Efficacy|4|||
105876546|NCT01686373|365201021|FG000|Overall Study|Lost to Follow-up|3|||
105876547|NCT01686373|365201022|FG001|Overall Study|Lost to Follow-up|0|||
105876548|NCT01686373|365201021|FG000|Overall Study|Withdrawal by Subject|0|||
105876549|NCT01686373|365201022|FG001|Overall Study|Withdrawal by Subject|1|||
105876550|NCT01686373|365201021|FG000|Overall Study|Adverse Event|0|||
105876551|NCT01686373|365201022|FG001|Overall Study|Adverse Event|1|||
105876552|NCT00360282|365201023|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
105876553|NCT00360282|365201024|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
105876554|NCT00360282|365201025|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
105876555|NCT00360282|365201026|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
105876556|NCT00360282|365201023|FG000|Second Intervention|Adverse Event|0|||
105876557|NCT00360282|365201024|FG001|Second Intervention|Adverse Event|1|||
105876558|NCT00360282|365201025|FG002|Second Intervention|Adverse Event|0|||
105876559|NCT00360282|365201026|FG003|Second Intervention|Adverse Event|0|||
105876560|NCT04537078|365201027|FG000|Overall Study|Protocol Violation|3|||
105876561|NCT04537078|365201028|FG001|Overall Study|Protocol Violation|2|||
105876562|NCT04537078|365201027|FG000|Overall Study|Lost to Follow-up|1|||
105876563|NCT04537078|365201028|FG001|Overall Study|Lost to Follow-up|0|||
105876564|NCT04537078|365201027|FG000|Overall Study|Withdrawal by Subject|0|||
105876565|NCT04537078|365201028|FG001|Overall Study|Withdrawal by Subject|1|||
105876566|NCT01568892|365201029|FG000|Open-label Phase|Adverse Event|2|||
105876567|NCT01568892|365201030|FG001|Open-label Phase|Adverse Event|0|||
105876568|NCT01568892|365201029|FG000|Open-label Phase|Lack of Efficacy|4|||
105876569|NCT01568892|365201030|FG001|Open-label Phase|Lack of Efficacy|2|||
105876570|NCT01568892|365201029|FG000|Open-label Phase|Lost to Follow-up|0|||
105876571|NCT01568892|365201030|FG001|Open-label Phase|Lost to Follow-up|1|||
105876572|NCT01697748|365201035|FG000|Overall Study|ineligible skin incision|1|||
105876573|NCT01697748|365201036|FG001|Overall Study|ineligible skin incision|2|||
105876574|NCT01697748|365201035|FG000|Overall Study|ineligible uterine incision|4|||
105876575|NCT01697748|365201036|FG001|Overall Study|ineligible uterine incision|1|||
105876576|NCT01697748|365201035|FG000|Overall Study|Lost to Follow-up|53|||
105876577|NCT01697748|365201036|FG001|Overall Study|Lost to Follow-up|65|||
105876578|NCT01058642|365201037|FG000|Treatment Period 1|Adverse Event|0|||
105876579|NCT01058642|365201038|FG001|Treatment Period 1|Adverse Event|1|||
105876580|NCT01058642|365201039|FG002|Treatment Period 1|Adverse Event|1|||
105876581|NCT01058642|365201040|FG003|Treatment Period 1|Adverse Event|0|||
105876582|NCT01058642|365201037|FG000|Treatment Period 1|Physician Decision|0|||
105876583|NCT01058642|365201038|FG001|Treatment Period 1|Physician Decision|0|||
105876584|NCT01058642|365201039|FG002|Treatment Period 1|Physician Decision|1|||
105876585|NCT01058642|365201040|FG003|Treatment Period 1|Physician Decision|0|||
105876586|NCT01058642|365201037|FG000|Treatment Period 1|Withdrawal by Subject|1|||
105876587|NCT01058642|365201038|FG001|Treatment Period 1|Withdrawal by Subject|0|||
105876588|NCT01058642|365201039|FG002|Treatment Period 1|Withdrawal by Subject|0|||
105876589|NCT01058642|365201040|FG003|Treatment Period 1|Withdrawal by Subject|0|||
105876590|NCT01058642|365201037|FG000|Treatment Period 1|Lack of Efficacy|0|||
105876591|NCT01058642|365201038|FG001|Treatment Period 1|Lack of Efficacy|0|||
105876592|NCT01058642|365201039|FG002|Treatment Period 1|Lack of Efficacy|0|||
105876593|NCT01058642|365201040|FG003|Treatment Period 1|Lack of Efficacy|1|||
105876594|NCT01058642|365201037|FG000|Treatment Period 1|Protocol Violation|0|||
105876595|NCT01058642|365201038|FG001|Treatment Period 1|Protocol Violation|0|||
105876596|NCT01058642|365201039|FG002|Treatment Period 1|Protocol Violation|0|||
105876597|NCT01058642|365201040|FG003|Treatment Period 1|Protocol Violation|1|||
105876598|NCT01058642|365201037|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
105876599|NCT01058642|365201038|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
105659511|NCT02635386|364417351|FG004|Overall Study|side effects|6|||
105876600|NCT01058642|365201039|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
105876601|NCT01058642|365201040|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
105876602|NCT01256450|365201041|FG000|Open-label Titration|Adverse Event|39|||
105876603|NCT01256450|365201042|FG001|Open-label Titration|Adverse Event|0|||
105876604|NCT01256450|365201043|FG002|Open-label Titration|Adverse Event|0|||
105876605|NCT01256450|365201041|FG000|Open-label Titration|Lost to Follow-up|7|||
105876606|NCT01256450|365201042|FG001|Open-label Titration|Lost to Follow-up|0|||
105876607|NCT01256450|365201043|FG002|Open-label Titration|Lost to Follow-up|0|||
105876608|NCT01256450|365201041|FG000|Open-label Titration|Lack of analgesic effect|30|||
105876609|NCT01256450|365201042|FG001|Open-label Titration|Lack of analgesic effect|0|||
105876610|NCT01256450|365201043|FG002|Open-label Titration|Lack of analgesic effect|0|||
105876611|NCT01256450|365201041|FG000|Open-label Titration|Non-compliance|9|||
105876612|NCT01256450|365201042|FG001|Open-label Titration|Non-compliance|0|||
105876613|NCT01256450|365201043|FG002|Open-label Titration|Non-compliance|0|||
105876614|NCT01256450|365201041|FG000|Open-label Titration|Screen failure|1|||
105876615|NCT01256450|365201042|FG001|Open-label Titration|Screen failure|0|||
105876616|NCT01256450|365201043|FG002|Open-label Titration|Screen failure|0|||
105876617|NCT01256450|365201041|FG000|Open-label Titration|Other|13|||
105876618|NCT01256450|365201042|FG001|Open-label Titration|Other|0|||
105876619|NCT01256450|365201043|FG002|Open-label Titration|Other|0|||
105876620|NCT01256450|365201041|FG000|Double-blind Treatment|Adverse Event|0|||
105876621|NCT01256450|365201042|FG001|Double-blind Treatment|Adverse Event|8|||
105876622|NCT01256450|365201043|FG002|Double-blind Treatment|Adverse Event|6|||
105876623|NCT01256450|365201041|FG000|Double-blind Treatment|Lost to Follow-up|0|||
105876624|NCT01256450|365201042|FG001|Double-blind Treatment|Lost to Follow-up|1|||
105876625|NCT01256450|365201043|FG002|Double-blind Treatment|Lost to Follow-up|7|||
105876626|NCT01256450|365201041|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
105876627|NCT01256450|365201042|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
105876628|NCT01256450|365201043|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
105876629|NCT01256450|365201041|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
105876630|NCT01256450|365201042|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
105876631|NCT01256450|365201043|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
105876632|NCT01256450|365201041|FG000|Double-blind Treatment|Non-compliance|0|||
105876633|NCT01256450|365201042|FG001|Double-blind Treatment|Non-compliance|5|||
105876634|NCT01256450|365201043|FG002|Double-blind Treatment|Non-compliance|4|||
105876635|NCT01256450|365201041|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
105876636|NCT01256450|365201042|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
105876637|NCT01256450|365201043|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
105876638|NCT01256450|365201041|FG000|Double-blind Treatment|Other|0|||
105876639|NCT01256450|365201042|FG001|Double-blind Treatment|Other|9|||
105876640|NCT01256450|365201043|FG002|Double-blind Treatment|Other|12|||
105876641|NCT03866512|365201044|FG000|Overall Study|Lost to Follow-up|1|||
105876642|NCT03866512|365201045|FG001|Overall Study|Lost to Follow-up|2|||
105876643|NCT03866512|365201046|FG002|Overall Study|Lost to Follow-up|1|||
105876644|NCT03866512|365201044|FG000|Overall Study|Cannulation issues|0|||
105876645|NCT03866512|365201045|FG001|Overall Study|Cannulation issues|1|||
105876646|NCT03866512|365201046|FG002|Overall Study|Cannulation issues|2|||
105876647|NCT00997373|365201047|FG000|Overall Study|Withdrawal by Subject|5|||
105876648|NCT00997373|365201048|FG001|Overall Study|Withdrawal by Subject|0|||
105876649|NCT00997373|365201047|FG000|Overall Study|wrong tumor type|4|||
105876650|NCT00997373|365201048|FG001|Overall Study|wrong tumor type|0|||
105876651|NCT00997373|365201047|FG000|Overall Study|could not have hysterectomy|6|||
105876652|NCT00997373|365201048|FG001|Overall Study|could not have hysterectomy|0|||
105876653|NCT03809663|365201049|FG000|Overall Study|Decision by sponsor|24|||
105876654|NCT03809663|365201050|FG001|Overall Study|Decision by sponsor|18|||
105876655|NCT03809663|365201051|FG002|Overall Study|Decision by sponsor|20|||
105876656|NCT03809663|365201052|FG003|Overall Study|Decision by sponsor|20|||
105876657|NCT03809663|365201053|FG004|Overall Study|Decision by sponsor|0|||
105876658|NCT03809663|365201054|FG005|Overall Study|Decision by sponsor|0|||
105876659|NCT03809663|365201049|FG000|Overall Study|Withdrawal by Subject|26|||
105876660|NCT03809663|365201050|FG001|Overall Study|Withdrawal by Subject|22|||
105876661|NCT03809663|365201051|FG002|Overall Study|Withdrawal by Subject|27|||
105876662|NCT03809663|365201052|FG003|Overall Study|Withdrawal by Subject|26|||
105876663|NCT03809663|365201053|FG004|Overall Study|Withdrawal by Subject|0|||
105876664|NCT03809663|365201054|FG005|Overall Study|Withdrawal by Subject|0|||
105876665|NCT03809663|365201049|FG000|Overall Study|Lost to Follow-up|1|||
105876666|NCT03809663|365201050|FG001|Overall Study|Lost to Follow-up|4|||
105876667|NCT03809663|365201051|FG002|Overall Study|Lost to Follow-up|1|||
105876668|NCT03809663|365201052|FG003|Overall Study|Lost to Follow-up|1|||
105876669|NCT03809663|365201053|FG004|Overall Study|Lost to Follow-up|0|||
105876670|NCT03809663|365201054|FG005|Overall Study|Lost to Follow-up|0|||
105876671|NCT02275819|365201057|FG000|Overall Study|Adverse Event|0|||
105876672|NCT02275819|365201058|FG001|Overall Study|Adverse Event|1|||
105876673|NCT00777296|365201059|FG000|Overall Study|Adverse Event|0|||
105876674|NCT00777296|365201060|FG001|Overall Study|Adverse Event|1|||
105876675|NCT00777296|365201061|FG002|Overall Study|Adverse Event|0|||
105876676|NCT00777296|365201062|FG003|Overall Study|Adverse Event|1|||
105876677|NCT00777296|365201059|FG000|Overall Study|Withdrawal by Subject|1|||
105876678|NCT00777296|365201060|FG001|Overall Study|Withdrawal by Subject|0|||
105876679|NCT00777296|365201061|FG002|Overall Study|Withdrawal by Subject|0|||
105876680|NCT00777296|365201062|FG003|Overall Study|Withdrawal by Subject|0|||
105876681|NCT00777296|365201059|FG000|Overall Study|CRF form not completed|0|||
105876682|NCT00777296|365201060|FG001|Overall Study|CRF form not completed|0|||
105876683|NCT00777296|365201061|FG002|Overall Study|CRF form not completed|2|||
105876684|NCT00777296|365201062|FG003|Overall Study|CRF form not completed|0|||
105876685|NCT00931255|365201066|FG000|Overall Study|Follow up biopsy not done|2|||
105876686|NCT00931255|365201067|FG001|Overall Study|Follow up biopsy not done|3|||
105876687|NCT05000164|365201069|FG000|Overall Study|Adverse Event|1|||
105876688|NCT05000164|365201069|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
105876689|NCT05000164|365201069|FG000|Overall Study|Lens Discomfort|3|||
105876690|NCT05000164|365201069|FG000|Overall Study|Withdrew Consent during Study|2|||
105876691|NCT05000164|365201069|FG000|Overall Study|Subject Withdrawn by PI|2|||
105876692|NCT05000164|365201069|FG000|Overall Study|Other Fractured Test Article|1|||
105876693|NCT03493854|365201070|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
105876694|NCT03493854|365201071|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
105876695|NCT03493854|365201070|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
105876696|NCT03493854|365201071|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
105876697|NCT03493854|365201070|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
105876698|NCT03493854|365201071|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
105876699|NCT03493854|365201070|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
105876700|NCT03493854|365201071|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
105876701|NCT03493854|365201070|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
105876702|NCT03493854|365201071|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
105876703|NCT03493854|365201070|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
105876704|NCT03493854|365201071|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
105876705|NCT03493854|365201070|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
105876706|NCT03493854|365201071|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
105876707|NCT03493854|365201070|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
105876708|NCT03493854|365201071|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
105876709|NCT03493854|365201070|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
105876710|NCT03493854|365201071|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
105876711|NCT03493854|365201070|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
105876712|NCT03493854|365201071|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
105876713|NCT03493854|365201070|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
105876714|NCT03493854|365201071|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
105876715|NCT03493854|365201070|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
105876716|NCT03493854|365201071|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
105876717|NCT03493854|365201070|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
105876718|NCT03493854|365201071|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
105876719|NCT03493854|365201070|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
105876720|NCT03493854|365201071|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
105876721|NCT03493854|365201070|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
105876722|NCT03493854|365201071|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
105876723|NCT03493854|365201070|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
105876724|NCT03493854|365201071|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
105876725|NCT03493854|365201070|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
105876726|NCT03493854|365201071|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
105876727|NCT03493854|365201070|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
105876728|NCT03493854|365201071|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
105876729|NCT01753570|365201072|FG000|Overall Study|Adverse Event|1|||
105876730|NCT01753570|365201073|FG001|Overall Study|Adverse Event|0|||
105876731|NCT01753570|365201074|FG002|Overall Study|Adverse Event|1|||
105876732|NCT01753570|365201072|FG000|Overall Study|Physician Decision|0|||
105876733|NCT01753570|365201073|FG001|Overall Study|Physician Decision|1|||
105876734|NCT01753570|365201074|FG002|Overall Study|Physician Decision|0|||
105876735|NCT01753570|365201072|FG000|Overall Study|Withdrawal by Subject|1|||
105876736|NCT01753570|365201073|FG001|Overall Study|Withdrawal by Subject|4|||
105876737|NCT01753570|365201074|FG002|Overall Study|Withdrawal by Subject|0|||
105876738|NCT01000155|365201075|FG000|Overall Study|Withdrawal by Subject|1|||
105876739|NCT01000155|365201075|FG000|Overall Study|Adverse Event|1|||
105876740|NCT00720213|365201080|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
105876741|NCT00720213|365201081|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
105876742|NCT00720213|365201082|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
105876743|NCT01808066|365201084|FG000|Overall Study|Withdrawal by Subject|15|||
105657999|NCT04962698|364411971|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
105876744|NCT00806403|365201089|FG000|Overall Study|Death|4|||
105876745|NCT00806403|365201090|FG001|Overall Study|Death|3|||
105876746|NCT00884117|365201091|FG000|Overall Study|Adverse Event|2|||
105876747|NCT00884117|365201091|FG000|Overall Study|Withdrawal by Subject|89|||
105876748|NCT00884117|365201091|FG000|Overall Study|Death|3|||
105876749|NCT00884117|365201091|FG000|Overall Study|Lost to Follow-up|143|||
105876750|NCT00884117|365201091|FG000|Overall Study|Other|12|||
105876751|NCT01753310|365201092|FG000|Overall Study|Entered into open label extension study|25|||
105876752|NCT01753310|365201093|FG001|Overall Study|Entered into open label extension study|22|||
105876753|NCT01753310|365201092|FG000|Overall Study|Adverse Event|1|||
105876754|NCT01753310|365201093|FG001|Overall Study|Adverse Event|0|||
105876755|NCT01753310|365201092|FG000|Overall Study|Lost to Follow-up|2|||
105876756|NCT01753310|365201093|FG001|Overall Study|Lost to Follow-up|0|||
105876757|NCT01753310|365201092|FG000|Overall Study|Subject decision|2|||
105876758|NCT01753310|365201093|FG001|Overall Study|Subject decision|2|||
105876759|NCT01753310|365201092|FG000|Overall Study|Sponsor decision|1|||
105876760|NCT01753310|365201093|FG001|Overall Study|Sponsor decision|0|||
105876761|NCT01753310|365201092|FG000|Overall Study|Withdrawal by Subject|1|||
105876762|NCT01753310|365201093|FG001|Overall Study|Withdrawal by Subject|0|||
105876763|NCT02946463|365201094|FG000|Primary Evaluation Period|Physician Decision|0|||
105876764|NCT02946463|365201095|FG001|Primary Evaluation Period|Physician Decision|1|||
105876765|NCT02946463|365201096|FG002|Primary Evaluation Period|Physician Decision|0|||
105876766|NCT02946463|365201097|FG003|Primary Evaluation Period|Physician Decision|0|||
105876767|NCT02946463|365201094|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
105876768|NCT02946463|365201095|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
105876769|NCT02946463|365201096|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
105876770|NCT02946463|365201097|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
105876771|NCT02946463|365201094|FG000|Extension Period|Death|4|||
105876772|NCT02946463|365201095|FG001|Extension Period|Death|4|||
105876773|NCT02946463|365201096|FG002|Extension Period|Death|0|||
105876774|NCT02946463|365201097|FG003|Extension Period|Death|0|||
105876775|NCT02946463|365201094|FG000|Extension Period|Withdrawal by Subject|4|||
105876776|NCT02946463|365201095|FG001|Extension Period|Withdrawal by Subject|3|||
105876777|NCT02946463|365201096|FG002|Extension Period|Withdrawal by Subject|0|||
105876778|NCT02946463|365201097|FG003|Extension Period|Withdrawal by Subject|0|||
105876779|NCT02946463|365201094|FG000|Extension Period|Other than specified|2|||
105876780|NCT02946463|365201095|FG001|Extension Period|Other than specified|3|||
105876781|NCT02946463|365201096|FG002|Extension Period|Other than specified|2|||
105876782|NCT02946463|365201097|FG003|Extension Period|Other than specified|0|||
105876783|NCT02946463|365201094|FG000|Extension Period|Physician Decision|1|||
105876784|NCT02946463|365201095|FG001|Extension Period|Physician Decision|4|||
105876785|NCT02946463|365201096|FG002|Extension Period|Physician Decision|0|||
105876786|NCT02946463|365201097|FG003|Extension Period|Physician Decision|0|||
105876787|NCT02946463|365201094|FG000|Extension Period|Pregnancy|3|||
105876788|NCT02946463|365201095|FG001|Extension Period|Pregnancy|1|||
105876789|NCT02946463|365201096|FG002|Extension Period|Pregnancy|0|||
105876790|NCT02946463|365201097|FG003|Extension Period|Pregnancy|0|||
105876791|NCT02946463|365201094|FG000|Extension Period|Adverse Event|1|||
105876792|NCT02946463|365201095|FG001|Extension Period|Adverse Event|2|||
105876793|NCT02946463|365201096|FG002|Extension Period|Adverse Event|0|||
105876794|NCT02946463|365201097|FG003|Extension Period|Adverse Event|0|||
105876795|NCT02946463|365201094|FG000|Extension Period|Lost to Follow-up|1|||
105876796|NCT02946463|365201095|FG001|Extension Period|Lost to Follow-up|0|||
105876797|NCT02946463|365201096|FG002|Extension Period|Lost to Follow-up|0|||
105876798|NCT02946463|365201097|FG003|Extension Period|Lost to Follow-up|0|||
105876799|NCT01956773|365201098|FG000|Overall Study|Lost to Follow-up|628|||
105876800|NCT01956773|365201099|FG001|Overall Study|Lost to Follow-up|1|||
105876801|NCT03267212|365201102|FG000|First Intervention|Lost to Follow-up|0|||
105876802|NCT03267212|365201103|FG001|First Intervention|Lost to Follow-up|2|||
105876803|NCT03267212|365201102|FG000|First Intervention|Withdrawal by Subject|1|||
105876804|NCT03267212|365201103|FG001|First Intervention|Withdrawal by Subject|1|||
105876805|NCT03267212|365201102|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
105876806|NCT03267212|365201103|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
105876807|NCT02907177|365201104|FG000|Overall Study|Death|0|||
105876808|NCT02907177|365201105|FG001|Overall Study|Death|1|||
105876809|NCT02907177|365201104|FG000|Overall Study|Physician Decision|3|||
105876810|NCT02907177|365201105|FG001|Overall Study|Physician Decision|3|||
105876811|NCT02907177|365201104|FG000|Overall Study|Withdrawal by Subject|15|||
105876812|NCT02907177|365201105|FG001|Overall Study|Withdrawal by Subject|7|||
105876813|NCT02907177|365201104|FG000|Overall Study|Sponsor's Decision|50|||
105876814|NCT02907177|365201105|FG001|Overall Study|Sponsor's Decision|57|||
105876815|NCT02505217|365201106|FG000|Overall Study|Withdrawal by Subject|1|||
105876816|NCT02505217|365201107|FG001|Overall Study|Withdrawal by Subject|2|||
105876817|NCT01289678|365201108|FG000|Overall Study|Physician Decision|6|||
105876818|NCT00991887|365201109|FG000|Overall Study|Lost to Follow-up|2|||
105876819|NCT00991887|365201110|FG001|Overall Study|Lost to Follow-up|1|||
105876820|NCT00468819|365201111|FG000|Overall Study|Withdrawal by Subject|4|||
105876821|NCT00468819|365201112|FG001|Overall Study|Withdrawal by Subject|0|||
105876822|NCT00468819|365201113|FG002|Overall Study|Withdrawal by Subject|1|||
105876823|NCT00468819|365201111|FG000|Overall Study|Lost to Follow-up|0|||
105876824|NCT00468819|365201112|FG001|Overall Study|Lost to Follow-up|0|||
105876825|NCT00468819|365201113|FG002|Overall Study|Lost to Follow-up|1|||
105876826|NCT00468819|365201111|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
105876827|NCT00468819|365201112|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
105876828|NCT00468819|365201113|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
105876829|NCT00946920|365201114|FG000|Overall Study|Withdrawal by Subject|28|||
105876830|NCT00946920|365201115|FG001|Overall Study|Withdrawal by Subject|15|||
105876831|NCT00946920|365201114|FG000|Overall Study|Lost to Follow-up|2|||
105876832|NCT00946920|365201115|FG001|Overall Study|Lost to Follow-up|2|||
105876833|NCT00946920|365201114|FG000|Overall Study|Physician Decision|5|||
105876834|NCT00946920|365201115|FG001|Overall Study|Physician Decision|2|||
105876835|NCT00946920|365201114|FG000|Overall Study|Adverse Event|41|||
105876836|NCT00946920|365201115|FG001|Overall Study|Adverse Event|14|||
105876837|NCT00946920|365201114|FG000|Overall Study|Protocol Violation|16|||
105876838|NCT00946920|365201115|FG001|Overall Study|Protocol Violation|8|||
105876839|NCT00946920|365201114|FG000|Overall Study|Miscellaneous reasons|18|||
105876840|NCT00946920|365201115|FG001|Overall Study|Miscellaneous reasons|3|||
105876841|NCT02492867|365201118|FG000|Overall Study|Alternate therapy|1|||
105876842|NCT02492867|365201118|FG000|Overall Study|Withdrawal by Subject|2|||
105876843|NCT02492867|365201118|FG000|Overall Study|Disease progression after treatment started|1|||
105876844|NCT02492867|365201118|FG000|Overall Study|Death|1|||
105876845|NCT00153179|365201121|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
105876846|NCT00153179|365201122|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
105876847|NCT00153179|365201123|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
105876848|NCT00153179|365201124|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
105876849|NCT03644342|365201127|FG000|Overall Study|Adverse Event|2|||
105876850|NCT03644342|365201128|FG001|Overall Study|Adverse Event|0|||
105876851|NCT03644342|365201127|FG000|Overall Study|Protocol Violation|0|||
105876852|NCT03644342|365201128|FG001|Overall Study|Protocol Violation|1|||
105876853|NCT01662492|365201133|FG000|Overall Study|Other miscellaneous reasons.|1|||
105876854|NCT01662492|365201134|FG001|Overall Study|Other miscellaneous reasons.|0|||
105876855|NCT01662492|365201135|FG002|Overall Study|Other miscellaneous reasons.|1|||
105876856|NCT01662492|365201133|FG000|Overall Study|Withdrawal by Subject|0|||
105876857|NCT01662492|365201134|FG001|Overall Study|Withdrawal by Subject|0|||
105876858|NCT01662492|365201135|FG002|Overall Study|Withdrawal by Subject|1|||
105876859|NCT01662492|365201133|FG000|Overall Study|Protocol Violation|1|||
105876860|NCT01662492|365201134|FG001|Overall Study|Protocol Violation|0|||
105876861|NCT01662492|365201135|FG002|Overall Study|Protocol Violation|0|||
105876862|NCT01662492|365201133|FG000|Overall Study|Lost to Follow-up|0|||
105876863|NCT01662492|365201134|FG001|Overall Study|Lost to Follow-up|0|||
105876864|NCT01662492|365201135|FG002|Overall Study|Lost to Follow-up|2|||
105876865|NCT01662492|365201133|FG000|Overall Study|Lack of Efficacy|1|||
105876866|NCT01662492|365201134|FG001|Overall Study|Lack of Efficacy|1|||
105876867|NCT01662492|365201135|FG002|Overall Study|Lack of Efficacy|2|||
105876868|NCT02596971|365203460|FG000|Overall Study|Death|5|||
105876869|NCT02596971|365203461|FG001|Overall Study|Death|1|||
105876870|NCT02596971|365203462|FG002|Overall Study|Death|5|||
105876871|NCT02596971|365203460|FG000|Overall Study|Withdrawal by Subject|5|||
105876872|NCT02596971|365203461|FG001|Overall Study|Withdrawal by Subject|1|||
105876873|NCT02596971|365203462|FG002|Overall Study|Withdrawal by Subject|4|||
105876874|NCT01401361|365203463|FG000|Overall Study|Withdrawal by Subject|16|||
105876875|NCT01401361|365203463|FG000|Overall Study|Lack of Efficacy|6|||
105876876|NCT01401361|365203463|FG000|Overall Study|Physician Decision|1|||
105876877|NCT01401361|365203463|FG000|Overall Study|Lost to Follow-up|3|||
105876878|NCT01401361|365203463|FG000|Overall Study|Subject/family decision post procedure|2|||
105876879|NCT00595920|365203466|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
105876880|NCT03048747|365203467|FG000|Overall Study|Adverse Event|2|||
105876881|NCT03048747|365203467|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
105876882|NCT03048747|365203467|FG000|Overall Study|Physician Decision|1|||
105876883|NCT00824772|365203468|FG000|Overall Study|Withdrawal by Subject|8|||
105876884|NCT00611923|365203469|FG000|Overall Study|Withdrawal by Subject|2|||
105876885|NCT00611923|365203470|FG001|Overall Study|Withdrawal by Subject|2|||
105876886|NCT03588910|365203471|FG000|Overall Study|Withdrawal by Subject|1|||
105876887|NCT03588910|365203472|FG001|Overall Study|Withdrawal by Subject|0|||
105876888|NCT03588910|365203471|FG000|Overall Study|Allergy|2|||
105876889|NCT03588910|365203472|FG001|Overall Study|Allergy|0|||
105876890|NCT03588910|365203471|FG000|Overall Study|Protocol Violation|0|||
105876891|NCT03588910|365203472|FG001|Overall Study|Protocol Violation|3|||
105876892|NCT03588910|365203471|FG000|Overall Study|Did not complete Day 1 Survey|5|||
105876893|NCT03588910|365203472|FG001|Overall Study|Did not complete Day 1 Survey|10|||
105876894|NCT03588910|365203471|FG000|Overall Study|Did not complete Day 7 Survey|5|||
105876895|NCT03588910|365203472|FG001|Overall Study|Did not complete Day 7 Survey|2|||
105876896|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
105876897|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
105658000|NCT04962698|364411970|FG000|Virtual-hand Interaction|Technical difficulty|1|||
105658001|NCT04962698|364411971|FG001|Virtual-hand Interaction|Technical difficulty|0|||
105658002|NCT04962698|364411970|FG000|Robotic Action Observation|Technical difficulty|1|||
105658003|NCT04962698|364411971|FG001|Robotic Action Observation|Technical difficulty|0|||
105658004|NCT04962698|364411970|FG000|Rest|Technical difficulty|1|||
105658005|NCT04962698|364411971|FG001|Rest|Technical difficulty|0|||
105658006|NCT04962698|364411970|FG000|Rest|Exclusion criteria met after enrollment|0|||
105658007|NCT04962698|364411971|FG001|Rest|Exclusion criteria met after enrollment|2|||
105658008|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
105658009|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
105658010|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
105658011|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
105658012|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
105658013|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
105658014|NCT03201900|364411972|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
105658015|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
105658016|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
105658017|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
105658018|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
105658019|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
105658020|NCT03201900|364411972|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
105658021|NCT02971228|364411988|FG000|Overall Study|Withdrawal by Subject|1|||
105658022|NCT02971228|364411989|FG001|Overall Study|Withdrawal by Subject|1|||
105658023|NCT02971228|364411990|FG002|Overall Study|Withdrawal by Subject|0|||
105658024|NCT02971228|364411991|FG003|Overall Study|Withdrawal by Subject|0|||
105658025|NCT02971228|364411992|FG004|Overall Study|Withdrawal by Subject|0|||
105658026|NCT02971228|364411988|FG000|Overall Study|Logistical challenges|0|||
105658027|NCT02971228|364411989|FG001|Overall Study|Logistical challenges|1|||
105876898|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
105876899|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
105876900|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
105876901|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
105876902|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
105876903|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
105876904|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
105876905|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
105876906|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
105876907|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
105876908|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
105658028|NCT02971228|364411990|FG002|Overall Study|Logistical challenges|0|||
105658029|NCT02971228|364411991|FG003|Overall Study|Logistical challenges|0|||
105658030|NCT02971228|364411992|FG004|Overall Study|Logistical challenges|0|||
105658031|NCT01233999|364411995|FG000|Overall Study|Withdrawal by Subject|1|||
105658032|NCT01233999|364411995|FG000|Overall Study|Lost to Follow-up|1|||
105658033|NCT03082612|364411996|FG000|Overall Study|Lost to Follow-up|2|||
105658034|NCT03082612|364411997|FG001|Overall Study|Lost to Follow-up|0|||
105658035|NCT03414047|364412000|FG000|Overall Study|Adverse Event|0|||
105658036|NCT03414047|364412001|FG001|Overall Study|Adverse Event|0|||
105658037|NCT03414047|364412002|FG002|Overall Study|Adverse Event|1|||
105876909|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
105876910|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
105876911|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
105876912|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
105876913|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
105876914|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
105876915|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
105876916|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
105876917|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
105876918|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
105876919|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
105876920|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
105876921|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
105876922|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
105876923|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
105876924|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
105876925|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
105876926|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
105658038|NCT03414047|364412003|FG003|Overall Study|Adverse Event|1|||
105658039|NCT03414047|364412000|FG000|Overall Study|Physician Decision|1|||
105658040|NCT03414047|364412001|FG001|Overall Study|Physician Decision|0|||
105876927|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
105876928|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
105876929|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
105876930|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
105876931|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
105876932|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
105876933|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
105876934|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
105876935|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
105876936|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
105876937|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
105876938|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
105876939|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
105876940|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
105876941|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
105876942|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
105876943|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
105876944|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
105876945|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
105876946|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
105876947|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
105876948|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Site closed|0|||
105876949|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Site closed|0|||
105876950|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Site closed|1|||
105876951|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Site closed|0|||
105876952|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
105876953|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
105876954|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
105876955|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
105876956|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
105876957|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
105876958|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
105876959|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
105876960|NCT00838903|365203473|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
105876961|NCT00838903|365203474|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
105876962|NCT00838903|365203475|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
105876963|NCT00838903|365203476|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
105876964|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
105876965|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
105876966|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
105876967|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
105876968|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
105876969|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
105876970|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
105876971|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
105876972|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
105876973|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
105876974|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
105876975|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
105876976|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
105876977|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
105876978|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
105876979|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
105876980|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
105876981|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
105876982|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
105876983|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
105876984|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
105876985|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
105876986|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
105876987|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
105876988|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
105876989|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
105876990|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
105876991|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
105876992|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
105876993|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
105876994|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
105876995|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
105876996|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
105876997|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
105876998|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
105876999|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
105877000|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
105877001|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
105877002|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
105877003|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
105877004|NCT00838903|365203473|FG000|Follow-up Period (8 Weeks)|Missing|1|||
105877005|NCT00838903|365203474|FG001|Follow-up Period (8 Weeks)|Missing|2|||
105877006|NCT00838903|365203475|FG002|Follow-up Period (8 Weeks)|Missing|1|||
105877007|NCT00838903|365203476|FG003|Follow-up Period (8 Weeks)|Missing|1|||
105877008|NCT04565145|365203477|FG000|Overall Study|Withdrawal by Subject|1|||
105877009|NCT04565145|365203478|FG001|Overall Study|Withdrawal by Subject|1|||
105877010|NCT00536939|365203479|FG000|Overall Study|Withdrawal by Subject|1|||
105877011|NCT00536939|365203480|FG001|Overall Study|Withdrawal by Subject|0|||
105877012|NCT00536939|365203479|FG000|Overall Study|Other Complicating Disease|1|||
105877013|NCT00536939|365203480|FG001|Overall Study|Other Complicating Disease|0|||
105877014|NCT02512302|365203481|FG000|Period 1|Adverse Event|0|||
105877015|NCT02512302|365203482|FG001|Period 1|Adverse Event|1|||
105877016|NCT02512302|365203483|FG002|Period 1|Adverse Event|0|||
105877017|NCT02512302|365203484|FG003|Period 1|Adverse Event|0|||
105877018|NCT02512302|365203485|FG004|Period 1|Adverse Event|0|||
105877019|NCT02512302|365203486|FG005|Period 1|Adverse Event|0|||
105877020|NCT02512302|365203487|FG006|Period 1|Adverse Event|0|||
105877021|NCT02512302|365203488|FG007|Period 1|Adverse Event|0|||
105877022|NCT02512302|365203489|FG008|Period 1|Adverse Event|0|||
105877023|NCT02512302|365203490|FG009|Period 1|Adverse Event|0|||
105877024|NCT02512302|365203481|FG000|Period 2|Adverse Event|0|||
105877025|NCT02512302|365203482|FG001|Period 2|Adverse Event|0|||
105877026|NCT02512302|365203483|FG002|Period 2|Adverse Event|0|||
105877027|NCT02512302|365203484|FG003|Period 2|Adverse Event|0|||
105877028|NCT02512302|365203485|FG004|Period 2|Adverse Event|0|||
105877029|NCT02512302|365203486|FG005|Period 2|Adverse Event|0|||
105877030|NCT02512302|365203487|FG006|Period 2|Adverse Event|0|||
105877031|NCT02512302|365203488|FG007|Period 2|Adverse Event|0|||
105877032|NCT02512302|365203489|FG008|Period 2|Adverse Event|0|||
105877033|NCT02512302|365203490|FG009|Period 2|Adverse Event|1|||
105877034|NCT02512302|365203481|FG000|Period 3|Lost to Follow-up|0|||
105877035|NCT02512302|365203482|FG001|Period 3|Lost to Follow-up|0|||
105877036|NCT02512302|365203483|FG002|Period 3|Lost to Follow-up|1|||
105877037|NCT02512302|365203484|FG003|Period 3|Lost to Follow-up|0|||
105877038|NCT02512302|365203485|FG004|Period 3|Lost to Follow-up|0|||
105877039|NCT02512302|365203486|FG005|Period 3|Lost to Follow-up|0|||
105877040|NCT02512302|365203487|FG006|Period 3|Lost to Follow-up|0|||
105877041|NCT02512302|365203488|FG007|Period 3|Lost to Follow-up|0|||
105877042|NCT02512302|365203489|FG008|Period 3|Lost to Follow-up|0|||
105877043|NCT02512302|365203490|FG009|Period 3|Lost to Follow-up|0|||
105877044|NCT02512302|365203481|FG000|Period 4|Adverse Event|0|||
105877045|NCT02512302|365203482|FG001|Period 4|Adverse Event|0|||
105877046|NCT02512302|365203483|FG002|Period 4|Adverse Event|0|||
105877047|NCT02512302|365203484|FG003|Period 4|Adverse Event|0|||
105877048|NCT02512302|365203485|FG004|Period 4|Adverse Event|0|||
105877049|NCT02512302|365203486|FG005|Period 4|Adverse Event|0|||
105877050|NCT02512302|365203487|FG006|Period 4|Adverse Event|1|||
105877051|NCT02512302|365203488|FG007|Period 4|Adverse Event|0|||
105877052|NCT02512302|365203489|FG008|Period 4|Adverse Event|0|||
105877053|NCT02512302|365203490|FG009|Period 4|Adverse Event|0|||
105877054|NCT00471822|365203491|FG000|Overall Study|Protocol Violation|2|||
105877055|NCT04168112|365203494|FG000|Overall Study|Lost to Follow-up|1|||
105877056|NCT04168112|365203495|FG001|Overall Study|Lost to Follow-up|0|||
105877057|NCT04168112|365203494|FG000|Overall Study|Withdrawal by Subject|1|||
105877058|NCT04168112|365203495|FG001|Overall Study|Withdrawal by Subject|0|||
105877059|NCT01735916|365203496|FG000|Overall Study|Subject not eligible to be randomized|11|||
105877060|NCT01735916|365203497|FG001|Overall Study|Subject not eligible to be randomized|0|||
105877061|NCT01735916|365203498|FG002|Overall Study|Subject not eligible to be randomized|0|||
105877062|NCT01735916|365203496|FG000|Overall Study|Early termination of study by sponsor|4|||
105877063|NCT01735916|365203497|FG001|Overall Study|Early termination of study by sponsor|19|||
105877064|NCT01735916|365203498|FG002|Overall Study|Early termination of study by sponsor|7|||
105877065|NCT01735916|365203496|FG000|Overall Study|Withdrawal by Subject|3|||
105877066|NCT01735916|365203497|FG001|Overall Study|Withdrawal by Subject|0|||
105877067|NCT01735916|365203498|FG002|Overall Study|Withdrawal by Subject|0|||
105877068|NCT02955355|365203504|FG000|Overall Study|Adverse Event|4|||
105877069|NCT02955355|365203504|FG000|Overall Study|Death|1|||
105877070|NCT02955355|365203504|FG000|Overall Study|Physician Decision|21|||
105877071|NCT02955355|365203504|FG000|Overall Study|Site Terminated by Sponsor|35|||
105877072|NCT02955355|365203504|FG000|Overall Study|Withdrawal by Subject|19|||
105877073|NCT02955355|365203504|FG000|Overall Study|Reason Not Specified|5|||
105877074|NCT02612623|365203505|FG000|Overall Study|Withdrawal by Subject|0|||
105877075|NCT02612623|365203506|FG001|Overall Study|Withdrawal by Subject|1|||
105877076|NCT02612623|365203507|FG002|Overall Study|Withdrawal by Subject|0|||
105877077|NCT02612623|365203508|FG003|Overall Study|Withdrawal by Subject|0|||
105877078|NCT02612623|365203505|FG000|Overall Study|Adverse Event|1|||
105877079|NCT02612623|365203506|FG001|Overall Study|Adverse Event|0|||
105877080|NCT02612623|365203507|FG002|Overall Study|Adverse Event|1|||
105877081|NCT02612623|365203508|FG003|Overall Study|Adverse Event|0|||
105877082|NCT00333983|365203509|FG000|Overall Study|Lost to Follow-up|2|||
105877083|NCT00333983|365203510|FG001|Overall Study|Lost to Follow-up|1|||
105877084|NCT00333983|365203511|FG002|Overall Study|Lost to Follow-up|0|||
105877085|NCT00333983|365203509|FG000|Overall Study|Adverse Event|1|||
105877086|NCT00333983|365203510|FG001|Overall Study|Adverse Event|1|||
105877087|NCT00333983|365203511|FG002|Overall Study|Adverse Event|1|||
105877088|NCT00333983|365203509|FG000|Overall Study|Withdrawal by Subject|0|||
105877089|NCT00333983|365203510|FG001|Overall Study|Withdrawal by Subject|3|||
105877090|NCT00333983|365203511|FG002|Overall Study|Withdrawal by Subject|1|||
105877091|NCT04227197|365203512|FG000|Randomization|Protocol Violation|1|||
105877092|NCT04227197|365203513|FG001|Randomization|Protocol Violation|0|||
105877093|NCT04227197|365203512|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
105877094|NCT04227197|365203513|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
105877095|NCT04227197|365203512|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
105877096|NCT04227197|365203513|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
105877097|NCT04227197|365203512|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
105877098|NCT04227197|365203513|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
105877099|NCT04227197|365203512|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
105877100|NCT04227197|365203513|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
105877101|NCT04227197|365203512|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
105877102|NCT04227197|365203513|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
105877103|NCT04227197|365203512|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
105877104|NCT04227197|365203513|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
105877105|NCT00833105|365203514|FG000|Overall Study|Withdrawal by Subject|1|||
105877106|NCT00833105|365203514|FG000|Overall Study|Adverse Event|2|||
105877107|NCT03656068|365203519|FG000|Overall Study|Withdrawal by Subject|4|||
105877108|NCT03656068|365203519|FG000|Overall Study|Adverse Event|1|||
105877109|NCT04335123|365203520|FG000|Overall Study|Withdrawal by Subject|2|||
105877110|NCT04335123|365203521|FG001|Overall Study|Withdrawal by Subject|0|||
105877111|NCT04335123|365203520|FG000|Overall Study|Physician Decision|2|||
105877112|NCT04335123|365203521|FG001|Overall Study|Physician Decision|0|||
105877113|NCT02712320|365203522|FG000|Overall Study|Lost to Follow-up|1|||
105877114|NCT02712320|365203522|FG000|Overall Study|Withdrawal by Subject|1|||
105877115|NCT02712320|365203522|FG000|Overall Study|Transferred to another facility|1|||
105877116|NCT02712320|365203522|FG000|Overall Study|Treating with the prohibited medications|2|||
105877117|NCT00063934|365203525|FG000|Overall Study|Ineligible|1|||
105877118|NCT05266053|365203526|FG000|Overall Study|Withdrawal by Subject|8|||
105877119|NCT05266053|365203527|FG001|Overall Study|Withdrawal by Subject|4|||
105877120|NCT01343043|365203529|FG000|Overall Study|Disease progression before treatment|1|||
105877121|NCT01343043|365203530|FG001|Overall Study|Disease progression before treatment|0|||
105877122|NCT01343043|365203531|FG002|Overall Study|Disease progression before treatment|0|||
105877123|NCT01343043|365203532|FG003|Overall Study|Disease progression before treatment|0|||
105877124|NCT01343043|365203529|FG000|Overall Study|Withdrawal by Subject|1|||
105877125|NCT01343043|365203530|FG001|Overall Study|Withdrawal by Subject|0|||
105877126|NCT01343043|365203531|FG002|Overall Study|Withdrawal by Subject|0|||
105877127|NCT01343043|365203532|FG003|Overall Study|Withdrawal by Subject|0|||
105877128|NCT01343043|365203529|FG000|Overall Study|Death|1|||
105877129|NCT01343043|365203530|FG001|Overall Study|Death|1|||
105877130|NCT01343043|365203531|FG002|Overall Study|Death|0|||
105877131|NCT01343043|365203532|FG003|Overall Study|Death|1|||
105877132|NCT01017874|365203533|FG000|Overall Study|Withdrawal by Subject|23|||
105877133|NCT01017874|365203534|FG001|Overall Study|Withdrawal by Subject|20|||
105877134|NCT01017874|365203533|FG000|Overall Study|Sponsor decision|3|||
105877135|NCT01017874|365203534|FG001|Overall Study|Sponsor decision|1|||
105877136|NCT01017874|365203533|FG000|Overall Study|Lost to Follow-up|3|||
105877137|NCT01017874|365203534|FG001|Overall Study|Lost to Follow-up|2|||
105877138|NCT01017874|365203533|FG000|Overall Study|Physician Decision|1|||
105877139|NCT01017874|365203534|FG001|Overall Study|Physician Decision|3|||
105877140|NCT00925704|365203535|FG000|First Intervention|Withdrew consent|0|||
105658041|NCT03414047|364412002|FG002|Overall Study|Physician Decision|0|||
105877141|NCT00925704|365203536|FG001|First Intervention|Withdrew consent|0|||
105877142|NCT00925704|365203537|FG002|First Intervention|Withdrew consent|0|||
105877143|NCT00925704|365203538|FG003|First Intervention|Withdrew consent|1|||
105877144|NCT00925704|365203539|FG004|First Intervention|Withdrew consent|1|||
105877145|NCT00925704|365203540|FG005|First Intervention|Withdrew consent|0|||
105877146|NCT00925704|365203535|FG000|Second Intervention|Withdrawal by Subject|1|||
105877147|NCT00925704|365203536|FG001|Second Intervention|Withdrawal by Subject|0|||
105877148|NCT00925704|365203537|FG002|Second Intervention|Withdrawal by Subject|0|||
105877149|NCT00925704|365203538|FG003|Second Intervention|Withdrawal by Subject|0|||
105877150|NCT00925704|365203539|FG004|Second Intervention|Withdrawal by Subject|1|||
105877151|NCT00925704|365203540|FG005|Second Intervention|Withdrawal by Subject|0|||
105877152|NCT00925704|365203535|FG000|Third Intervention|Withdrew consent|0|||
105877153|NCT00925704|365203536|FG001|Third Intervention|Withdrew consent|0|||
105877154|NCT00925704|365203537|FG002|Third Intervention|Withdrew consent|0|||
105877155|NCT00925704|365203538|FG003|Third Intervention|Withdrew consent|0|||
105877156|NCT00925704|365203539|FG004|Third Intervention|Withdrew consent|0|||
105877157|NCT00925704|365203540|FG005|Third Intervention|Withdrew consent|1|||
105877158|NCT02996968|365203541|FG000|Overall Study|Withdrawal by Subject|1|||
105877159|NCT02996968|365203542|FG001|Overall Study|Withdrawal by Subject|0|||
105877160|NCT00502242|365203543|FG000|Overall Study|Lack of Efficacy|1|||
105877161|NCT00502242|365203544|FG001|Overall Study|Lack of Efficacy|11|||
105877162|NCT00502242|365203543|FG000|Overall Study|Adverse Event|31|||
105877163|NCT00502242|365203544|FG001|Overall Study|Adverse Event|20|||
105877164|NCT00502242|365203543|FG000|Overall Study|Physician Decision|2|||
105877165|NCT00502242|365203544|FG001|Overall Study|Physician Decision|3|||
105877166|NCT00502242|365203543|FG000|Overall Study|Other - Unspecified|8|||
105877167|NCT00502242|365203544|FG001|Overall Study|Other - Unspecified|14|||
105877168|NCT00502242|365203543|FG000|Overall Study|Protocol Violation|3|||
105877169|NCT00502242|365203544|FG001|Overall Study|Protocol Violation|1|||
105877170|NCT00502242|365203543|FG000|Overall Study|Withdrawal by Subject|6|||
105877171|NCT00502242|365203544|FG001|Overall Study|Withdrawal by Subject|7|||
105877172|NCT03817853|365203545|FG000|Induction Phase|Adverse Event|5|||
105877173|NCT03817853|365203546|FG001|Induction Phase|Adverse Event|0|||
105877174|NCT03817853|365203547|FG002|Induction Phase|Adverse Event|0|||
105877175|NCT03817853|365203545|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
105877176|NCT03817853|365203546|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
105877177|NCT03817853|365203547|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
105877178|NCT03817853|365203545|FG000|Induction Phase|Physician Decision|2|||
105877179|NCT03817853|365203546|FG001|Induction Phase|Physician Decision|0|||
105877180|NCT03817853|365203547|FG002|Induction Phase|Physician Decision|0|||
105877181|NCT03817853|365203545|FG000|Induction Phase|Progressive Disease|6|||
105877182|NCT03817853|365203546|FG001|Induction Phase|Progressive Disease|0|||
105877183|NCT03817853|365203547|FG002|Induction Phase|Progressive Disease|0|||
105877184|NCT03817853|365203545|FG000|Induction Phase|Withdrawal by Subject|4|||
105877185|NCT03817853|365203546|FG001|Induction Phase|Withdrawal by Subject|0|||
105877186|NCT03817853|365203547|FG002|Induction Phase|Withdrawal by Subject|0|||
105877187|NCT03817853|365203545|FG000|Maintenance Phase|Adverse Event|0|||
105877188|NCT03817853|365203546|FG001|Maintenance Phase|Adverse Event|8|||
105877189|NCT03817853|365203547|FG002|Maintenance Phase|Adverse Event|0|||
105877190|NCT03817853|365203545|FG000|Maintenance Phase|Death|0|||
105877191|NCT03817853|365203546|FG001|Maintenance Phase|Death|5|||
105877192|NCT03817853|365203547|FG002|Maintenance Phase|Death|0|||
105877193|NCT03817853|365203545|FG000|Maintenance Phase|Progressive Disease|0|||
105877194|NCT03817853|365203546|FG001|Maintenance Phase|Progressive Disease|7|||
105877195|NCT03817853|365203547|FG002|Maintenance Phase|Progressive Disease|0|||
105877196|NCT03817853|365203545|FG000|Maintenance Phase|Withdrawal by Subject|0|||
105877197|NCT03817853|365203546|FG001|Maintenance Phase|Withdrawal by Subject|2|||
105877198|NCT03817853|365203547|FG002|Maintenance Phase|Withdrawal by Subject|0|||
105877199|NCT03817853|365203545|FG000|Maintenance Phase|Physician Decision|0|||
105877200|NCT03817853|365203546|FG001|Maintenance Phase|Physician Decision|1|||
105877201|NCT03817853|365203547|FG002|Maintenance Phase|Physician Decision|0|||
105877202|NCT03817853|365203545|FG000|Maintenance Phase|Various reasons|0|||
105877203|NCT03817853|365203546|FG001|Maintenance Phase|Various reasons|4|||
105877204|NCT03817853|365203547|FG002|Maintenance Phase|Various reasons|0|||
105877205|NCT03817853|365203545|FG000|Maintenance Phase|Protocol Deviation|0|||
105877206|NCT03817853|365203546|FG001|Maintenance Phase|Protocol Deviation|1|||
105877207|NCT03817853|365203547|FG002|Maintenance Phase|Protocol Deviation|0|||
105877208|NCT03817853|365203545|FG000|Follow-up Phase|Adverse Event|0|||
105877209|NCT03817853|365203546|FG001|Follow-up Phase|Adverse Event|0|||
105877210|NCT03817853|365203547|FG002|Follow-up Phase|Adverse Event|2|||
105877211|NCT03817853|365203545|FG000|Follow-up Phase|Death|0|||
105877212|NCT03817853|365203546|FG001|Follow-up Phase|Death|0|||
105877213|NCT03817853|365203547|FG002|Follow-up Phase|Death|1|||
105658042|NCT03414047|364412003|FG003|Overall Study|Physician Decision|1|||
105877214|NCT03817853|365203545|FG000|Follow-up Phase|Progressive Disease|0|||
105877215|NCT03817853|365203546|FG001|Follow-up Phase|Progressive Disease|0|||
105877216|NCT03817853|365203547|FG002|Follow-up Phase|Progressive Disease|3|||
105877217|NCT03817853|365203545|FG000|Follow-up Phase|Withdrawal by Subject|0|||
105877218|NCT03817853|365203546|FG001|Follow-up Phase|Withdrawal by Subject|0|||
105877219|NCT03817853|365203547|FG002|Follow-up Phase|Withdrawal by Subject|1|||
105877220|NCT01293695|365203554|FG000|Overall Study|Withdrawal by Subject|7|||
105877221|NCT01293695|365203555|FG001|Overall Study|Withdrawal by Subject|1|||
105877222|NCT01293695|365203554|FG000|Overall Study|Lost to Follow-up|8|||
105877223|NCT01293695|365203555|FG001|Overall Study|Lost to Follow-up|6|||
105877224|NCT02570308|365203556|FG000|Overall Study|Death|1|||
105877225|NCT02570308|365203557|FG001|Overall Study|Death|5|||
105877226|NCT02570308|365203558|FG002|Overall Study|Death|4|||
105877227|NCT02570308|365203559|FG003|Overall Study|Death|4|||
105877228|NCT02570308|365203560|FG004|Overall Study|Death|69|||
105877229|NCT02570308|365203556|FG000|Overall Study|Lost to Follow-up|0|||
105877230|NCT02570308|365203557|FG001|Overall Study|Lost to Follow-up|0|||
105877231|NCT02570308|365203558|FG002|Overall Study|Lost to Follow-up|0|||
105877232|NCT02570308|365203559|FG003|Overall Study|Lost to Follow-up|0|||
105877233|NCT02570308|365203560|FG004|Overall Study|Lost to Follow-up|2|||
105877234|NCT02570308|365203556|FG000|Overall Study|Withdrawal by Subject|0|||
105877235|NCT02570308|365203557|FG001|Overall Study|Withdrawal by Subject|0|||
105877236|NCT02570308|365203558|FG002|Overall Study|Withdrawal by Subject|0|||
105877237|NCT02570308|365203559|FG003|Overall Study|Withdrawal by Subject|0|||
105877238|NCT02570308|365203560|FG004|Overall Study|Withdrawal by Subject|1|||
105877239|NCT02570308|365203556|FG000|Overall Study|Other|0|||
105877240|NCT02570308|365203557|FG001|Overall Study|Other|0|||
105877241|NCT02570308|365203558|FG002|Overall Study|Other|0|||
105877242|NCT02570308|365203559|FG003|Overall Study|Other|0|||
105877243|NCT02570308|365203560|FG004|Overall Study|Other|2|||
105877244|NCT00314340|365203561|FG000|Overall Study|lost interest|1|||
105877245|NCT01620138|365203564|FG000|Overall Study|Withdrawal by Subject|3|||
105877246|NCT01620138|365203565|FG001|Overall Study|Withdrawal by Subject|0|||
105877247|NCT01620138|365203564|FG000|Overall Study|Lack of Efficacy|1|||
105877248|NCT01620138|365203565|FG001|Overall Study|Lack of Efficacy|0|||
105877249|NCT01620138|365203564|FG000|Overall Study|Adverse Event|2|||
105877250|NCT01620138|365203565|FG001|Overall Study|Adverse Event|0|||
105877251|NCT02069015|365203566|FG000|Overall Study|Lost to Follow-up|39|||
105877252|NCT02069015|365203567|FG001|Overall Study|Lost to Follow-up|32|||
105877253|NCT02069015|365203566|FG000|Overall Study|Withdrawal by Subject|1|||
105877254|NCT02069015|365203567|FG001|Overall Study|Withdrawal by Subject|1|||
105877255|NCT00791778|365203568|FG000|Double-blind Treatment|Adverse Event|49|||
105877256|NCT00791778|365203569|FG001|Double-blind Treatment|Adverse Event|9|||
105877257|NCT00791778|365203568|FG000|Double-blind Treatment|Physician Decision|6|||
105877258|NCT00791778|365203569|FG001|Double-blind Treatment|Physician Decision|26|||
105877259|NCT00791778|365203568|FG000|Double-blind Treatment|Protocol Violation|0|||
105877260|NCT00791778|365203569|FG001|Double-blind Treatment|Protocol Violation|4|||
105877261|NCT00791778|365203568|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
105877262|NCT00791778|365203569|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
105877263|NCT00791778|365203568|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
105877264|NCT00791778|365203569|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
105877265|NCT00791778|365203568|FG000|Follow-up|Withdrawal by Subject|3|||
105877266|NCT00791778|365203569|FG001|Follow-up|Withdrawal by Subject|0|||
105877267|NCT00791778|365203568|FG000|Follow-up|Lost to Follow-up|2|||
105877268|NCT00791778|365203569|FG001|Follow-up|Lost to Follow-up|1|||
105877269|NCT01082328|365203570|FG000|Overall Study|Adverse Event|1|||
105877270|NCT00957801|365203573|FG000|Overall Study|Withdrawal by Subject|0|||
105877271|NCT00957801|365203574|FG001|Overall Study|Withdrawal by Subject|0|||
105877272|NCT00957801|365203575|FG002|Overall Study|Withdrawal by Subject|0|||
105877273|NCT00957801|365203576|FG003|Overall Study|Withdrawal by Subject|1|||
105877274|NCT02841995|365203581|FG000|Overall Study|Disease progression|5|||
105877275|NCT02841995|365203582|FG001|Overall Study|Disease progression|11|||
105877276|NCT02841995|365203583|FG002|Overall Study|Disease progression|8|||
105877277|NCT02841995|365203581|FG000|Overall Study|Withdrawal by Subject|2|||
105877278|NCT02841995|365203582|FG001|Overall Study|Withdrawal by Subject|4|||
105877279|NCT02841995|365203583|FG002|Overall Study|Withdrawal by Subject|4|||
105877280|NCT02841995|365203581|FG000|Overall Study|Adverse Event|2|||
105877281|NCT02841995|365203582|FG001|Overall Study|Adverse Event|0|||
105877282|NCT02841995|365203583|FG002|Overall Study|Adverse Event|1|||
105877283|NCT02841995|365203581|FG000|Overall Study|Investigator decision|2|||
105877284|NCT02841995|365203582|FG001|Overall Study|Investigator decision|0|||
105877285|NCT02841995|365203583|FG002|Overall Study|Investigator decision|1|||
105877286|NCT02841995|365203581|FG000|Overall Study|Death|0|||
105877287|NCT02841995|365203582|FG001|Overall Study|Death|0|||
105877288|NCT02841995|365203583|FG002|Overall Study|Death|2|||
105877289|NCT02841995|365203581|FG000|Overall Study|Noncompliance to protocol|1|||
105877290|NCT02841995|365203582|FG001|Overall Study|Noncompliance to protocol|0|||
105877291|NCT02841995|365203583|FG002|Overall Study|Noncompliance to protocol|0|||
105877292|NCT02841995|365203581|FG000|Overall Study|Sponsor decision|1|||
105877293|NCT02841995|365203582|FG001|Overall Study|Sponsor decision|0|||
105877294|NCT02841995|365203583|FG002|Overall Study|Sponsor decision|0|||
105877295|NCT02841995|365203581|FG000|Overall Study|Other|4|||
105877296|NCT02841995|365203582|FG001|Overall Study|Other|1|||
105877297|NCT02841995|365203583|FG002|Overall Study|Other|5|||
105877298|NCT00630825|365203584|FG000|Overall Study|Adverse Event|4|||
105877299|NCT00630825|365203585|FG001|Overall Study|Adverse Event|4|||
105877300|NCT00630825|365203586|FG002|Overall Study|Adverse Event|3|||
105877301|NCT00630825|365203587|FG003|Overall Study|Adverse Event|1|||
105877302|NCT00630825|365203584|FG000|Overall Study|Entry Criteria Not Met|1|||
105877303|NCT00630825|365203585|FG001|Overall Study|Entry Criteria Not Met|0|||
105877304|NCT00630825|365203586|FG002|Overall Study|Entry Criteria Not Met|2|||
105877305|NCT00630825|365203587|FG003|Overall Study|Entry Criteria Not Met|1|||
105877306|NCT00630825|365203584|FG000|Overall Study|Lost to Follow-up|1|||
105877307|NCT00630825|365203585|FG001|Overall Study|Lost to Follow-up|1|||
105877308|NCT00630825|365203586|FG002|Overall Study|Lost to Follow-up|1|||
105877309|NCT00630825|365203587|FG003|Overall Study|Lost to Follow-up|1|||
105877310|NCT00630825|365203584|FG000|Overall Study|Physician Decision|1|||
105877311|NCT00630825|365203585|FG001|Overall Study|Physician Decision|0|||
105877312|NCT00630825|365203586|FG002|Overall Study|Physician Decision|0|||
105877313|NCT00630825|365203587|FG003|Overall Study|Physician Decision|0|||
105877314|NCT00630825|365203584|FG000|Overall Study|Withdrawal by Subject|2|||
105877315|NCT00630825|365203585|FG001|Overall Study|Withdrawal by Subject|2|||
105877316|NCT00630825|365203586|FG002|Overall Study|Withdrawal by Subject|2|||
105877317|NCT00630825|365203587|FG003|Overall Study|Withdrawal by Subject|3|||
105877318|NCT02042014|365203588|FG000|Overall Study|Adverse Event|1|||
105877319|NCT02042014|365203588|FG000|Overall Study|Physician Decision|7|||
105877320|NCT03762265|365203589|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
105877321|NCT03762265|365203590|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
105877322|NCT03762265|365203589|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
105877323|NCT03762265|365203590|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
105877324|NCT03762265|365203589|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
105877325|NCT03762265|365203590|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
105877326|NCT03762265|365203589|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
105877327|NCT03762265|365203590|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
105877328|NCT03762265|365203589|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
105877329|NCT03762265|365203590|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
105877330|NCT03762265|365203589|FG000|BT Period: Weeks 1 to 37|Other|0|||
105877331|NCT03762265|365203590|FG001|BT Period: Weeks 1 to 37|Other|1|||
105877332|NCT03762265|365203589|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
105877333|NCT03762265|365203590|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
105877334|NCT03762265|365203589|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
105877335|NCT03762265|365203590|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
105877336|NCT03762265|365203589|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
105877337|NCT03762265|365203590|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
105877338|NCT03762265|365203589|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
105877339|NCT03762265|365203590|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
105877340|NCT03762265|365203589|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
105877341|NCT03762265|365203590|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
105877342|NCT03762265|365203589|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
105877343|NCT03762265|365203590|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
105877344|NCT03762265|365203589|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
105877345|NCT03762265|365203590|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
105877346|NCT03762265|365203589|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
105877347|NCT03762265|365203590|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
105877348|NCT03762265|365203589|FG000|LTE Period: Weeks 61 to 109|Other|1|||
105877349|NCT03762265|365203590|FG001|LTE Period: Weeks 61 to 109|Other|0|||
105877350|NCT04739800|365203593|FG000|Overall Study|Adverse Event|2|||
105877351|NCT04739800|365203594|FG001|Overall Study|Adverse Event|1|||
105877352|NCT04739800|365203595|FG002|Overall Study|Adverse Event|4|||
105877353|NCT04739800|365203596|FG003|Overall Study|Adverse Event|5|||
105877354|NCT04739800|365203593|FG000|Overall Study|Never Treated|2|||
105877355|NCT04739800|365203594|FG001|Overall Study|Never Treated|0|||
105877356|NCT04739800|365203595|FG002|Overall Study|Never Treated|1|||
105877357|NCT04739800|365203596|FG003|Overall Study|Never Treated|1|||
105877358|NCT04739800|365203593|FG000|Overall Study|On Treatment|5|||
105877359|NCT04739800|365203594|FG001|Overall Study|On Treatment|9|||
105877360|NCT04739800|365203595|FG002|Overall Study|On Treatment|9|||
105877361|NCT04739800|365203596|FG003|Overall Study|On Treatment|9|||
105877362|NCT04739800|365203593|FG000|Overall Study|Symptomatic Deterioration|1|||
105877363|NCT04739800|365203594|FG001|Overall Study|Symptomatic Deterioration|1|||
105877364|NCT04739800|365203595|FG002|Overall Study|Symptomatic Deterioration|3|||
105877365|NCT04739800|365203596|FG003|Overall Study|Symptomatic Deterioration|0|||
105877366|NCT04739800|365203593|FG000|Overall Study|Withdrawal by Subject|1|||
105877367|NCT04739800|365203594|FG001|Overall Study|Withdrawal by Subject|2|||
105877368|NCT04739800|365203595|FG002|Overall Study|Withdrawal by Subject|1|||
105877369|NCT04739800|365203596|FG003|Overall Study|Withdrawal by Subject|3|||
105877370|NCT04739800|365203593|FG000|Overall Study|Other Reason|1|||
105877371|NCT04739800|365203594|FG001|Overall Study|Other Reason|3|||
105877372|NCT04739800|365203595|FG002|Overall Study|Other Reason|5|||
105877373|NCT04739800|365203596|FG003|Overall Study|Other Reason|4|||
105877374|NCT00450437|365203599|FG000|Overall Study|Withdrawal by Subject|10|||
105877375|NCT00450437|365203600|FG001|Overall Study|Withdrawal by Subject|2|||
105877376|NCT00450437|365203601|FG002|Overall Study|Withdrawal by Subject|0|||
105877377|NCT00450437|365203602|FG003|Overall Study|Withdrawal by Subject|1|||
105877378|NCT00450437|365203599|FG000|Overall Study|Lost to Follow-up|31|||
105877379|NCT00450437|365203600|FG001|Overall Study|Lost to Follow-up|12|||
105877380|NCT00450437|365203601|FG002|Overall Study|Lost to Follow-up|19|||
105877381|NCT00450437|365203602|FG003|Overall Study|Lost to Follow-up|9|||
105877382|NCT00450437|365203599|FG000|Overall Study|Protocol Violation|0|||
105877383|NCT00450437|365203600|FG001|Overall Study|Protocol Violation|1|||
105877384|NCT00450437|365203601|FG002|Overall Study|Protocol Violation|0|||
105877385|NCT00450437|365203602|FG003|Overall Study|Protocol Violation|1|||
105877386|NCT00450437|365203599|FG000|Overall Study|Inappropriate enrollment|4|||
105877387|NCT00450437|365203600|FG001|Overall Study|Inappropriate enrollment|1|||
105877388|NCT00450437|365203601|FG002|Overall Study|Inappropriate enrollment|3|||
105877389|NCT00450437|365203602|FG003|Overall Study|Inappropriate enrollment|0|||
105877390|NCT00450437|365203599|FG000|Overall Study|Administrative reason|0|||
105877391|NCT00450437|365203600|FG001|Overall Study|Administrative reason|0|||
105877392|NCT00450437|365203601|FG002|Overall Study|Administrative reason|1|||
105877393|NCT00450437|365203602|FG003|Overall Study|Administrative reason|0|||
105877394|NCT00450437|365203599|FG000|Overall Study|Unable to Classify|1|||
105877395|NCT00450437|365203600|FG001|Overall Study|Unable to Classify|0|||
105877396|NCT00450437|365203601|FG002|Overall Study|Unable to Classify|1|||
105877397|NCT00450437|365203602|FG003|Overall Study|Unable to Classify|0|||
105877398|NCT01827111|365203603|FG000|Overall Study|Disease Progression|1|||
105877399|NCT00226499|365203615|FG000|Overall Study|Adverse Event|10|||
105877400|NCT00226499|365203616|FG001|Overall Study|Adverse Event|6|||
105877401|NCT00226499|365203617|FG002|Overall Study|Adverse Event|3|||
105877402|NCT00226499|365203615|FG000|Overall Study|Others|1064|||
105877403|NCT00226499|365203616|FG001|Overall Study|Others|1066|||
105877404|NCT00226499|365203617|FG002|Overall Study|Others|356|||
105877405|NCT00122382|365203618|FG000|Double-Blind Study|Adverse Event|9|||
105877406|NCT00122382|365203619|FG001|Double-Blind Study|Adverse Event|11|||
105877407|NCT00122382|365203620|FG002|Double-Blind Study|Adverse Event|0|||
105877408|NCT00122382|365203618|FG000|Double-Blind Study|Death|2|||
105877409|NCT00122382|365203619|FG001|Double-Blind Study|Death|2|||
105877410|NCT00122382|365203620|FG002|Double-Blind Study|Death|0|||
105877411|NCT00122382|365203618|FG000|Double-Blind Study|Lack of Efficacy|0|||
105877412|NCT00122382|365203619|FG001|Double-Blind Study|Lack of Efficacy|8|||
105877413|NCT00122382|365203620|FG002|Double-Blind Study|Lack of Efficacy|0|||
105877414|NCT00122382|365203618|FG000|Double-Blind Study|Lost to Follow-up|2|||
105877415|NCT00122382|365203619|FG001|Double-Blind Study|Lost to Follow-up|1|||
105877416|NCT00122382|365203620|FG002|Double-Blind Study|Lost to Follow-up|0|||
105877417|NCT00122382|365203618|FG000|Double-Blind Study|Pregnancy|2|||
105877418|NCT00122382|365203619|FG001|Double-Blind Study|Pregnancy|0|||
105877419|NCT00122382|365203620|FG002|Double-Blind Study|Pregnancy|0|||
105877420|NCT00122382|365203618|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
105877421|NCT00122382|365203619|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
105877422|NCT00122382|365203620|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
105877423|NCT00122382|365203618|FG000|Double-Blind Study|Withdrawal of Consent|7|||
105877424|NCT00122382|365203619|FG001|Double-Blind Study|Withdrawal of Consent|3|||
105877425|NCT00122382|365203620|FG002|Double-Blind Study|Withdrawal of Consent|0|||
105877426|NCT00122382|365203618|FG000|Double-Blind Study|Protocol Violation|1|||
105877427|NCT00122382|365203619|FG001|Double-Blind Study|Protocol Violation|0|||
105877428|NCT00122382|365203620|FG002|Double-Blind Study|Protocol Violation|0|||
105877429|NCT00122382|365203618|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
105877430|NCT00122382|365203619|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
105877431|NCT00122382|365203620|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
105877432|NCT00122382|365203618|FG000|Double-Blind Study|Randomized but not treated|0|||
105877433|NCT00122382|365203619|FG001|Double-Blind Study|Randomized but not treated|2|||
105877434|NCT00122382|365203620|FG002|Double-Blind Study|Randomized but not treated|0|||
105877435|NCT00122382|365203618|FG000|Open-Label Study|Adverse Event|0|||
105877436|NCT00122382|365203619|FG001|Open-Label Study|Adverse Event|0|||
105877437|NCT00122382|365203620|FG002|Open-Label Study|Adverse Event|11|||
105877438|NCT00122382|365203618|FG000|Open-Label Study|Death|0|||
105877439|NCT00122382|365203619|FG001|Open-Label Study|Death|0|||
105877440|NCT00122382|365203620|FG002|Open-Label Study|Death|2|||
105877441|NCT00122382|365203618|FG000|Open-Label Study|Lack of Efficacy|0|||
105877442|NCT00122382|365203619|FG001|Open-Label Study|Lack of Efficacy|0|||
105877443|NCT00122382|365203620|FG002|Open-Label Study|Lack of Efficacy|3|||
105877444|NCT00122382|365203618|FG000|Open-Label Study|Lost to Follow-up|0|||
105877445|NCT00122382|365203619|FG001|Open-Label Study|Lost to Follow-up|0|||
105877446|NCT00122382|365203620|FG002|Open-Label Study|Lost to Follow-up|3|||
105877447|NCT00122382|365203618|FG000|Open-Label Study|Pregnancy|0|||
105877448|NCT00122382|365203619|FG001|Open-Label Study|Pregnancy|0|||
105877449|NCT00122382|365203620|FG002|Open-Label Study|Pregnancy|2|||
105877450|NCT00122382|365203618|FG000|Open-Label Study|Poor/Non-Compliance|0|||
105877451|NCT00122382|365203619|FG001|Open-Label Study|Poor/Non-Compliance|0|||
105877452|NCT00122382|365203620|FG002|Open-Label Study|Poor/Non-Compliance|1|||
105877453|NCT00122382|365203618|FG000|Open-Label Study|Withdrawal of Consent|0|||
105877454|NCT00122382|365203619|FG001|Open-Label Study|Withdrawal of Consent|0|||
105877455|NCT00122382|365203620|FG002|Open-Label Study|Withdrawal of Consent|4|||
105877456|NCT02040805|365203622|FG000|Overall Study|Lost to Follow-up|14|||
105877457|NCT02040805|365203623|FG001|Overall Study|Lost to Follow-up|9|||
105877458|NCT02040805|365203622|FG000|Overall Study|Withdrawal by Subject|28|||
105877459|NCT02040805|365203623|FG001|Overall Study|Withdrawal by Subject|41|||
105877460|NCT00359424|365203627|FG000|Overall Study|Death|99|||
105877461|NCT00359424|365203628|FG001|Overall Study|Death|58|||
105877462|NCT00359424|365203627|FG000|Overall Study|Lost to Follow-up|19|||
105877463|NCT00359424|365203628|FG001|Overall Study|Lost to Follow-up|7|||
105877464|NCT00359424|365203627|FG000|Overall Study|Withdrawal by Subject|10|||
105877465|NCT00359424|365203628|FG001|Overall Study|Withdrawal by Subject|2|||
105877466|NCT00359424|365203627|FG000|Overall Study|follow up not conducted|2|||
105877467|NCT00359424|365203628|FG001|Overall Study|follow up not conducted|0|||
105877468|NCT03194542|365203629|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
105877469|NCT03194542|365203630|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
105877470|NCT03194542|365203631|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
105877471|NCT03194542|365203632|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
105877472|NCT03194542|365203629|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
105877473|NCT03194542|365203630|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
105877474|NCT03194542|365203631|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
105877475|NCT03194542|365203632|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
105877476|NCT03194542|365203629|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
105877477|NCT03194542|365203630|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
105877478|NCT03194542|365203631|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
105877479|NCT03194542|365203632|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
105877480|NCT03194542|365203629|FG000|Overall Study|Loss of Response|4|||
105877481|NCT03194542|365203630|FG001|Overall Study|Loss of Response|2|||
105877482|NCT03194542|365203631|FG002|Overall Study|Loss of Response|3|||
105877483|NCT03194542|365203632|FG003|Overall Study|Loss of Response|4|||
105877484|NCT03194542|365203629|FG000|Overall Study|Physician Decision|0|||
105877485|NCT03194542|365203630|FG001|Overall Study|Physician Decision|1|||
105877486|NCT03194542|365203631|FG002|Overall Study|Physician Decision|0|||
105877487|NCT03194542|365203632|FG003|Overall Study|Physician Decision|0|||
105877488|NCT03194542|365203629|FG000|Overall Study|Lack of Efficacy|2|||
105877489|NCT03194542|365203630|FG001|Overall Study|Lack of Efficacy|2|||
105877490|NCT03194542|365203631|FG002|Overall Study|Lack of Efficacy|2|||
105877491|NCT03194542|365203632|FG003|Overall Study|Lack of Efficacy|6|||
105877492|NCT03194542|365203629|FG000|Overall Study|Withdrawal by Subject|2|||
105877493|NCT03194542|365203630|FG001|Overall Study|Withdrawal by Subject|1|||
105877494|NCT03194542|365203631|FG002|Overall Study|Withdrawal by Subject|5|||
105877495|NCT03194542|365203632|FG003|Overall Study|Withdrawal by Subject|4|||
105877496|NCT03194542|365203629|FG000|Overall Study|Progressive Disease|1|||
105877497|NCT03194542|365203630|FG001|Overall Study|Progressive Disease|0|||
105877498|NCT03194542|365203631|FG002|Overall Study|Progressive Disease|1|||
105877499|NCT03194542|365203632|FG003|Overall Study|Progressive Disease|1|||
105877500|NCT03194542|365203629|FG000|Overall Study|Adverse Event|1|||
105877501|NCT03194542|365203630|FG001|Overall Study|Adverse Event|2|||
105877502|NCT03194542|365203631|FG002|Overall Study|Adverse Event|0|||
105877503|NCT03194542|365203632|FG003|Overall Study|Adverse Event|5|||
105877504|NCT03194542|365203629|FG000|Overall Study|Death|1|||
105877505|NCT03194542|365203630|FG001|Overall Study|Death|2|||
105877506|NCT03194542|365203631|FG002|Overall Study|Death|0|||
105877507|NCT03194542|365203632|FG003|Overall Study|Death|5|||
105877508|NCT03194542|365203629|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
105877509|NCT03194542|365203630|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
105877510|NCT03194542|365203631|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
105877511|NCT03194542|365203632|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
105877512|NCT01591096|365203636|FG000|Overall Study|Adverse Event|1|||
105877513|NCT01831635|365203637|FG000|Overall Study|Withdrawal by Subject|0|||
105877514|NCT01831635|365203638|FG001|Overall Study|Withdrawal by Subject|2|||
105877515|NCT01831635|365203639|FG002|Overall Study|Withdrawal by Subject|0|||
105877516|NCT01408303|365203642|FG000|Overall Study|Adverse Event|3|||
105877517|NCT01408303|365203643|FG001|Overall Study|Adverse Event|7|||
105877518|NCT01408303|365203644|FG002|Overall Study|Adverse Event|2|||
105877519|NCT01408303|365203642|FG000|Overall Study|Lost to Follow-up|0|||
105877520|NCT01408303|365203643|FG001|Overall Study|Lost to Follow-up|1|||
105877521|NCT01408303|365203644|FG002|Overall Study|Lost to Follow-up|2|||
105877522|NCT01408303|365203642|FG000|Overall Study|Withdrawal by Subject|2|||
105877523|NCT01408303|365203643|FG001|Overall Study|Withdrawal by Subject|3|||
105877524|NCT01408303|365203644|FG002|Overall Study|Withdrawal by Subject|1|||
105877525|NCT01408303|365203642|FG000|Overall Study|Protocol Violation|0|||
105877526|NCT01408303|365203643|FG001|Overall Study|Protocol Violation|1|||
105877527|NCT01408303|365203644|FG002|Overall Study|Protocol Violation|0|||
105877528|NCT01408303|365203642|FG000|Overall Study|Noncompliance|1|||
105877529|NCT01408303|365203643|FG001|Overall Study|Noncompliance|0|||
105877530|NCT01408303|365203644|FG002|Overall Study|Noncompliance|1|||
105877531|NCT04577404|365203645|FG000|Overall Study|Adverse Event|31|||
105877532|NCT04577404|365203645|FG000|Overall Study|Death|1|||
105877533|NCT04577404|365203645|FG000|Overall Study|Lack of Efficacy|3|||
105877534|NCT04577404|365203645|FG000|Overall Study|Physician Decision|7|||
105877535|NCT04577404|365203645|FG000|Overall Study|Withdrawal by Subject|21|||
105877536|NCT04577404|365203645|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
105877537|NCT03349060|365205559|FG000|Overall Study|Adverse Event|9|||
105877538|NCT03349060|365205560|FG001|Overall Study|Adverse Event|9|||
105877539|NCT03349060|365205561|FG002|Overall Study|Adverse Event|7|||
105877540|NCT03349060|365205559|FG000|Overall Study|Lack of Efficacy|1|||
105877541|NCT03349060|365205560|FG001|Overall Study|Lack of Efficacy|0|||
105877542|NCT03349060|365205561|FG002|Overall Study|Lack of Efficacy|2|||
105877543|NCT03349060|365205559|FG000|Overall Study|Lost to Follow-up|2|||
105877544|NCT03349060|365205560|FG001|Overall Study|Lost to Follow-up|1|||
105877545|NCT03349060|365205561|FG002|Overall Study|Lost to Follow-up|1|||
105877546|NCT03349060|365205559|FG000|Overall Study|Protocol Violation|2|||
105877547|NCT03349060|365205560|FG001|Overall Study|Protocol Violation|2|||
105877548|NCT03349060|365205561|FG002|Overall Study|Protocol Violation|1|||
105877549|NCT03349060|365205559|FG000|Overall Study|Withdrawal by Subject|5|||
105877550|NCT03349060|365205560|FG001|Overall Study|Withdrawal by Subject|3|||
105877551|NCT03349060|365205561|FG002|Overall Study|Withdrawal by Subject|4|||
105877552|NCT03349060|365205559|FG000|Overall Study|Medication error,no linked adverse event|0|||
105877553|NCT03349060|365205560|FG001|Overall Study|Medication error,no linked adverse event|0|||
105877554|NCT03349060|365205561|FG002|Overall Study|Medication error,no linked adverse event|1|||
105877555|NCT03349060|365205559|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
105877556|NCT03349060|365205560|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
105877557|NCT03349060|365205561|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
105877558|NCT03349060|365205559|FG000|Overall Study|Other|2|||
105877559|NCT03349060|365205560|FG001|Overall Study|Other|1|||
105877560|NCT03349060|365205561|FG002|Overall Study|Other|0|||
105877561|NCT02861586|365205562|FG000|Overall Study|Withdrawal by Subject|1|||
105877562|NCT02861586|365205563|FG001|Overall Study|Withdrawal by Subject|2|||
105877563|NCT02861586|365205564|FG002|Overall Study|Withdrawal by Subject|0|||
105877564|NCT02861586|365205565|FG003|Overall Study|Withdrawal by Subject|0|||
105877565|NCT02861586|365205566|FG004|Overall Study|Withdrawal by Subject|0|||
105877566|NCT02861586|365205567|FG005|Overall Study|Withdrawal by Subject|1|||
105877567|NCT02861586|365205568|FG006|Overall Study|Withdrawal by Subject|1|||
105877568|NCT02861586|365205569|FG007|Overall Study|Withdrawal by Subject|0|||
105877569|NCT02861586|365205562|FG000|Overall Study|Lost to Follow-up|3|||
105877570|NCT02861586|365205563|FG001|Overall Study|Lost to Follow-up|1|||
105877571|NCT02861586|365205564|FG002|Overall Study|Lost to Follow-up|1|||
105877572|NCT02861586|365205565|FG003|Overall Study|Lost to Follow-up|0|||
105877573|NCT02861586|365205566|FG004|Overall Study|Lost to Follow-up|0|||
105877574|NCT02861586|365205567|FG005|Overall Study|Lost to Follow-up|3|||
105877575|NCT02861586|365205568|FG006|Overall Study|Lost to Follow-up|0|||
105877576|NCT02861586|365205569|FG007|Overall Study|Lost to Follow-up|0|||
105877577|NCT02861586|365205562|FG000|Overall Study|Adverse Event|0|||
105877578|NCT02861586|365205563|FG001|Overall Study|Adverse Event|0|||
105877579|NCT02861586|365205564|FG002|Overall Study|Adverse Event|0|||
105877580|NCT02861586|365205565|FG003|Overall Study|Adverse Event|0|||
105877581|NCT02861586|365205566|FG004|Overall Study|Adverse Event|0|||
105877582|NCT02861586|365205567|FG005|Overall Study|Adverse Event|1|||
105877583|NCT02861586|365205568|FG006|Overall Study|Adverse Event|0|||
105877584|NCT02861586|365205569|FG007|Overall Study|Adverse Event|0|||
105877585|NCT00955409|365205572|FG000|Overall Study|Lack of Efficacy|1|||
105877586|NCT00955409|365205573|FG001|Overall Study|Lack of Efficacy|0|||
105877587|NCT00955409|365205574|FG002|Overall Study|Lack of Efficacy|0|||
105877588|NCT00955409|365205575|FG003|Overall Study|Lack of Efficacy|0|||
105877589|NCT00955409|365205576|FG004|Overall Study|Lack of Efficacy|0|||
105877590|NCT00955409|365205577|FG005|Overall Study|Lack of Efficacy|0|||
105877591|NCT00955409|365205578|FG006|Overall Study|Lack of Efficacy|0|||
105877592|NCT00955409|365205579|FG007|Overall Study|Lack of Efficacy|0|||
105877593|NCT00955409|365205580|FG008|Overall Study|Lack of Efficacy|0|||
105877594|NCT00955409|365205581|FG009|Overall Study|Lack of Efficacy|0|||
105877595|NCT00955409|365205572|FG000|Overall Study|Withdrawal by Subject|1|||
105877596|NCT00955409|365205573|FG001|Overall Study|Withdrawal by Subject|0|||
105877597|NCT00955409|365205574|FG002|Overall Study|Withdrawal by Subject|5|||
105877598|NCT00955409|365205575|FG003|Overall Study|Withdrawal by Subject|2|||
105877599|NCT00955409|365205576|FG004|Overall Study|Withdrawal by Subject|0|||
105877600|NCT00955409|365205577|FG005|Overall Study|Withdrawal by Subject|0|||
105877601|NCT00955409|365205578|FG006|Overall Study|Withdrawal by Subject|2|||
105877602|NCT00955409|365205579|FG007|Overall Study|Withdrawal by Subject|0|||
105877603|NCT00955409|365205580|FG008|Overall Study|Withdrawal by Subject|1|||
105877604|NCT00955409|365205581|FG009|Overall Study|Withdrawal by Subject|0|||
105877605|NCT00955409|365205572|FG000|Overall Study|Caregiver Request|2|||
105877606|NCT00955409|365205573|FG001|Overall Study|Caregiver Request|0|||
105877607|NCT00955409|365205574|FG002|Overall Study|Caregiver Request|6|||
105877608|NCT00955409|365205575|FG003|Overall Study|Caregiver Request|5|||
105877609|NCT00955409|365205576|FG004|Overall Study|Caregiver Request|0|||
105877610|NCT00955409|365205577|FG005|Overall Study|Caregiver Request|2|||
105877611|NCT00955409|365205578|FG006|Overall Study|Caregiver Request|3|||
105877612|NCT00955409|365205579|FG007|Overall Study|Caregiver Request|1|||
105877613|NCT00955409|365205580|FG008|Overall Study|Caregiver Request|3|||
105877614|NCT00955409|365205581|FG009|Overall Study|Caregiver Request|0|||
105877615|NCT00955409|365205572|FG000|Overall Study|Investigator Request|0|||
105877616|NCT00955409|365205573|FG001|Overall Study|Investigator Request|0|||
105877617|NCT00955409|365205574|FG002|Overall Study|Investigator Request|1|||
105877618|NCT00955409|365205575|FG003|Overall Study|Investigator Request|0|||
105877619|NCT00955409|365205576|FG004|Overall Study|Investigator Request|0|||
105877620|NCT00955409|365205577|FG005|Overall Study|Investigator Request|0|||
105877621|NCT00955409|365205578|FG006|Overall Study|Investigator Request|0|||
105877622|NCT00955409|365205579|FG007|Overall Study|Investigator Request|0|||
105877623|NCT00955409|365205580|FG008|Overall Study|Investigator Request|0|||
105877624|NCT00955409|365205581|FG009|Overall Study|Investigator Request|0|||
105877625|NCT00955409|365205572|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
105877626|NCT00955409|365205573|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
105877627|NCT00955409|365205574|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
105877628|NCT00955409|365205575|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
105877629|NCT00955409|365205576|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
105877630|NCT00955409|365205577|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
105877631|NCT00955409|365205578|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
105877632|NCT00955409|365205579|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
105877633|NCT00955409|365205580|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
105877634|NCT00955409|365205581|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
105877635|NCT00955409|365205572|FG000|Overall Study|Lost to Follow-up|0|||
105877636|NCT00955409|365205573|FG001|Overall Study|Lost to Follow-up|0|||
105877637|NCT00955409|365205574|FG002|Overall Study|Lost to Follow-up|1|||
105877638|NCT00955409|365205575|FG003|Overall Study|Lost to Follow-up|0|||
105877639|NCT00955409|365205576|FG004|Overall Study|Lost to Follow-up|0|||
105877640|NCT00955409|365205577|FG005|Overall Study|Lost to Follow-up|0|||
105877641|NCT00955409|365205578|FG006|Overall Study|Lost to Follow-up|1|||
105877642|NCT00955409|365205579|FG007|Overall Study|Lost to Follow-up|0|||
105877643|NCT00955409|365205580|FG008|Overall Study|Lost to Follow-up|0|||
105877644|NCT00955409|365205581|FG009|Overall Study|Lost to Follow-up|0|||
105877645|NCT00955409|365205572|FG000|Overall Study|Failed to Return|2|||
105877646|NCT00955409|365205573|FG001|Overall Study|Failed to Return|0|||
105877647|NCT00955409|365205574|FG002|Overall Study|Failed to Return|0|||
105877648|NCT00955409|365205575|FG003|Overall Study|Failed to Return|0|||
105877649|NCT00955409|365205576|FG004|Overall Study|Failed to Return|0|||
105877650|NCT00955409|365205577|FG005|Overall Study|Failed to Return|0|||
105877651|NCT00955409|365205578|FG006|Overall Study|Failed to Return|0|||
105877652|NCT00955409|365205579|FG007|Overall Study|Failed to Return|2|||
105877653|NCT00955409|365205580|FG008|Overall Study|Failed to Return|0|||
105877654|NCT00955409|365205581|FG009|Overall Study|Failed to Return|0|||
105877655|NCT00955409|365205572|FG000|Overall Study|Adverse Event (AE)|2|||
105877656|NCT00955409|365205573|FG001|Overall Study|Adverse Event (AE)|0|||
105877657|NCT00955409|365205574|FG002|Overall Study|Adverse Event (AE)|0|||
105877658|NCT00955409|365205575|FG003|Overall Study|Adverse Event (AE)|0|||
105877659|NCT00955409|365205576|FG004|Overall Study|Adverse Event (AE)|0|||
105877660|NCT00955409|365205577|FG005|Overall Study|Adverse Event (AE)|1|||
105877661|NCT00955409|365205578|FG006|Overall Study|Adverse Event (AE)|2|||
105877662|NCT00955409|365205579|FG007|Overall Study|Adverse Event (AE)|0|||
105877663|NCT00955409|365205580|FG008|Overall Study|Adverse Event (AE)|2|||
105877664|NCT00955409|365205581|FG009|Overall Study|Adverse Event (AE)|0|||
105877665|NCT00955409|365205572|FG000|Overall Study|Reason not Specified|2|||
105877666|NCT00955409|365205573|FG001|Overall Study|Reason not Specified|1|||
105877667|NCT00955409|365205574|FG002|Overall Study|Reason not Specified|13|||
105877668|NCT00955409|365205575|FG003|Overall Study|Reason not Specified|1|||
105877669|NCT00955409|365205576|FG004|Overall Study|Reason not Specified|2|||
105877670|NCT00955409|365205577|FG005|Overall Study|Reason not Specified|0|||
105877671|NCT00955409|365205578|FG006|Overall Study|Reason not Specified|16|||
105877672|NCT00955409|365205579|FG007|Overall Study|Reason not Specified|0|||
105877673|NCT00955409|365205580|FG008|Overall Study|Reason not Specified|8|||
105877674|NCT00955409|365205581|FG009|Overall Study|Reason not Specified|1|||
105877675|NCT00570687|365205582|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877676|NCT00570687|365205583|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877677|NCT00570687|365205584|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877678|NCT00570687|365205585|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877679|NCT00570687|365205586|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
105877680|NCT00570687|365205587|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
105877681|NCT00570687|365205588|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
105877682|NCT00570687|365205589|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
105877683|NCT00570687|365205590|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
105877684|NCT00570687|365205591|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
105877685|NCT00570687|365205582|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877686|NCT00570687|365205583|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877687|NCT00570687|365205584|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877688|NCT00570687|365205585|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877689|NCT00570687|365205586|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877690|NCT00570687|365205587|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877691|NCT00570687|365205588|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877692|NCT00570687|365205589|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877693|NCT00570687|365205590|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
105877694|NCT00570687|365205591|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877695|NCT00570687|365205582|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877696|NCT00570687|365205583|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877697|NCT00570687|365205584|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877698|NCT00570687|365205585|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877699|NCT00570687|365205586|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877700|NCT00570687|365205587|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877701|NCT00570687|365205588|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
105877702|NCT00570687|365205589|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877703|NCT00570687|365205590|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877704|NCT00570687|365205591|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
105877705|NCT00803790|365205592|FG000|Period 1|Adverse Event|0|||
105877706|NCT00803790|365205593|FG001|Period 1|Adverse Event|1|||
105877707|NCT00803790|365205594|FG002|Period 1|Adverse Event|0|||
105877708|NCT00803790|365205595|FG003|Period 1|Adverse Event|0|||
105877709|NCT00803790|365205592|FG000|Period 1|Lost to Follow-up|1|||
105877710|NCT00803790|365205593|FG001|Period 1|Lost to Follow-up|2|||
105877711|NCT00803790|365205594|FG002|Period 1|Lost to Follow-up|0|||
105877712|NCT00803790|365205595|FG003|Period 1|Lost to Follow-up|0|||
105877713|NCT00803790|365205592|FG000|Period 1|Withdrawal by Subject|8|||
105877714|NCT00803790|365205593|FG001|Period 1|Withdrawal by Subject|6|||
105877715|NCT00803790|365205594|FG002|Period 1|Withdrawal by Subject|0|||
105877716|NCT00803790|365205595|FG003|Period 1|Withdrawal by Subject|0|||
105877717|NCT00803790|365205592|FG000|Period 1|positive drug screen or personal reasons|0|||
105877718|NCT00803790|365205593|FG001|Period 1|positive drug screen or personal reasons|3|||
105877719|NCT00803790|365205594|FG002|Period 1|positive drug screen or personal reasons|0|||
105877720|NCT00803790|365205595|FG003|Period 1|positive drug screen or personal reasons|4|||
105877721|NCT00803790|365205592|FG000|Period 1|Protocol Violation|0|||
105877722|NCT00803790|365205593|FG001|Period 1|Protocol Violation|0|||
105877723|NCT00803790|365205594|FG002|Period 1|Protocol Violation|1|||
105877724|NCT00803790|365205595|FG003|Period 1|Protocol Violation|0|||
105877725|NCT00803790|365205592|FG000|Period 2|Adverse Event|0|||
105877726|NCT00803790|365205593|FG001|Period 2|Adverse Event|0|||
105877727|NCT00803790|365205594|FG002|Period 2|Adverse Event|1|||
105877728|NCT00803790|365205595|FG003|Period 2|Adverse Event|1|||
105877729|NCT00803790|365205592|FG000|Period 2|Withdrawal by Subject|1|||
105877730|NCT00803790|365205593|FG001|Period 2|Withdrawal by Subject|0|||
105877731|NCT00803790|365205594|FG002|Period 2|Withdrawal by Subject|0|||
105877732|NCT00803790|365205595|FG003|Period 2|Withdrawal by Subject|0|||
105877733|NCT00803790|365205592|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
105877734|NCT00803790|365205593|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
105877735|NCT00803790|365205594|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
105877736|NCT00803790|365205595|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
105877737|NCT03055338|365205596|FG000|Overall Study|Lost to Follow-up|9|||
105877738|NCT03055338|365205597|FG001|Overall Study|Lost to Follow-up|2|||
105877739|NCT03055338|365205598|FG002|Overall Study|Lost to Follow-up|3|||
105877740|NCT03055338|365205596|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
105877741|NCT03055338|365205597|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
105877742|NCT03055338|365205598|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
105877743|NCT03055338|365205596|FG000|Overall Study|Physician Decision|0|||
105877744|NCT03055338|365205597|FG001|Overall Study|Physician Decision|0|||
105877745|NCT03055338|365205598|FG002|Overall Study|Physician Decision|2|||
105877746|NCT03055338|365205596|FG000|Overall Study|Withdrawal by Subject|9|||
105877747|NCT03055338|365205597|FG001|Overall Study|Withdrawal by Subject|8|||
105877748|NCT03055338|365205598|FG002|Overall Study|Withdrawal by Subject|7|||
105877749|NCT02151851|365205601|FG000|Overall Study|Lack of Efficacy|67|||
105877750|NCT02151851|365205602|FG001|Overall Study|Lack of Efficacy|94|||
105877751|NCT02151851|365205601|FG000|Overall Study|Protocol Violation|0|||
105877752|NCT02151851|365205602|FG001|Overall Study|Protocol Violation|1|||
105877753|NCT02151851|365205601|FG000|Overall Study|Withdrawal by Subject|2|||
105877754|NCT02151851|365205602|FG001|Overall Study|Withdrawal by Subject|5|||
105877755|NCT02151851|365205601|FG000|Overall Study|Medical impairment|1|||
105877756|NCT02151851|365205602|FG001|Overall Study|Medical impairment|0|||
105877757|NCT02151851|365205601|FG000|Overall Study|Low compliance to study visits|0|||
105877758|NCT02151851|365205602|FG001|Overall Study|Low compliance to study visits|1|||
105877759|NCT02151851|365205601|FG000|Overall Study|Subject entered into study in error|0|||
105877760|NCT02151851|365205602|FG001|Overall Study|Subject entered into study in error|1|||
105877761|NCT02151851|365205601|FG000|Overall Study|Adverse Event|6|||
105877762|NCT02151851|365205602|FG001|Overall Study|Adverse Event|28|||
105877763|NCT02159053|365205603|FG000|Overall Study|Death|2|||
105877764|NCT02159053|365205604|FG001|Overall Study|Death|0|||
105877765|NCT02159053|365205605|FG002|Overall Study|Death|1|||
105877766|NCT02159053|365205603|FG000|Overall Study|Physician Decision|0|||
105877767|NCT02159053|365205604|FG001|Overall Study|Physician Decision|1|||
105877768|NCT02159053|365205605|FG002|Overall Study|Physician Decision|1|||
105877769|NCT02159053|365205603|FG000|Overall Study|Lack of Efficacy|3|||
105877770|NCT02159053|365205604|FG001|Overall Study|Lack of Efficacy|4|||
105877771|NCT02159053|365205605|FG002|Overall Study|Lack of Efficacy|7|||
105877772|NCT02159053|365205603|FG000|Overall Study|Adverse Event|7|||
105877773|NCT02159053|365205604|FG001|Overall Study|Adverse Event|6|||
105877774|NCT02159053|365205605|FG002|Overall Study|Adverse Event|5|||
105877775|NCT02159053|365205603|FG000|Overall Study|Participants/guardian decision|8|||
105877776|NCT02159053|365205604|FG001|Overall Study|Participants/guardian decision|10|||
105877777|NCT02159053|365205605|FG002|Overall Study|Participants/guardian decision|6|||
105877778|NCT01540487|365205612|FG000|Overall Study|Protocol Violation|1|||
105877779|NCT01540487|365205613|FG001|Overall Study|Protocol Violation|0|||
105877780|NCT04846569|365205621|FG000|Overall Study|Withdrawal by Subject|3|||
105877781|NCT04846569|365205622|FG001|Overall Study|Withdrawal by Subject|1|||
105877782|NCT01217112|365205623|FG000|Overall Study|Adverse Event|0|||
105877783|NCT01217112|365205624|FG001|Overall Study|Adverse Event|2|||
105877784|NCT01217112|365205625|FG002|Overall Study|Adverse Event|0|||
105877785|NCT01217112|365205626|FG003|Overall Study|Adverse Event|2|||
105877786|NCT01217112|365205627|FG004|Overall Study|Adverse Event|0|||
105877787|NCT01217112|365205623|FG000|Overall Study|Withdrawal by Subject|0|||
105877788|NCT01217112|365205624|FG001|Overall Study|Withdrawal by Subject|0|||
105877789|NCT01217112|365205625|FG002|Overall Study|Withdrawal by Subject|1|||
105877790|NCT01217112|365205626|FG003|Overall Study|Withdrawal by Subject|0|||
105877791|NCT01217112|365205627|FG004|Overall Study|Withdrawal by Subject|0|||
105877792|NCT01217112|365205623|FG000|Overall Study|Physician Decision|0|||
105877793|NCT01217112|365205624|FG001|Overall Study|Physician Decision|0|||
105877794|NCT01217112|365205625|FG002|Overall Study|Physician Decision|0|||
105877795|NCT01217112|365205626|FG003|Overall Study|Physician Decision|0|||
105877796|NCT01217112|365205627|FG004|Overall Study|Physician Decision|1|||
105877797|NCT00351468|365205628|FG000|Overall Study|Adverse Event|42|||
105877798|NCT00351468|365205628|FG000|Overall Study|Withdrawal by Subject|39|||
105877799|NCT00351468|365205628|FG000|Overall Study|Various -follow up w clinical team|39|||
105877800|NCT00351468|365205628|FG000|Overall Study|Lack of Efficacy|32|||
105877801|NCT00351468|365205628|FG000|Overall Study|Non-compliance|8|||
105877802|NCT00351468|365205628|FG000|Overall Study|Lost to Follow-up|4|||
105877803|NCT00351468|365205628|FG000|Overall Study|Protocol Violation|3|||
105877804|NCT01894841|365205629|FG000|Overall Study|Withdrawal by Subject|9|||
105877805|NCT01894841|365205630|FG001|Overall Study|Withdrawal by Subject|4|||
105877806|NCT01894841|365205629|FG000|Overall Study|Withdrawn by investigator|2|||
105877807|NCT01894841|365205630|FG001|Overall Study|Withdrawn by investigator|2|||
105877808|NCT01894841|365205629|FG000|Overall Study|Lost to Follow-up|7|||
105877809|NCT01894841|365205630|FG001|Overall Study|Lost to Follow-up|3|||
105877810|NCT00683618|365205635|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
105877811|NCT00683618|365205636|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
105877812|NCT00683618|365205637|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
105877813|NCT00683618|365205635|FG000|Randomised Treatment Period|Protocol Violation|0|||
105877814|NCT00683618|365205636|FG001|Randomised Treatment Period|Protocol Violation|1|||
105877815|NCT00683618|365205637|FG002|Randomised Treatment Period|Protocol Violation|0|||
105877816|NCT00683618|365205635|FG000|Randomised Treatment Period|Adverse Event|2|||
105877817|NCT00683618|365205636|FG001|Randomised Treatment Period|Adverse Event|0|||
105877818|NCT00683618|365205637|FG002|Randomised Treatment Period|Adverse Event|2|||
105877819|NCT00683618|365205635|FG000|Randomised Treatment Period|Reason not provided|0|||
105877820|NCT00683618|365205636|FG001|Randomised Treatment Period|Reason not provided|0|||
105877821|NCT00683618|365205637|FG002|Randomised Treatment Period|Reason not provided|2|||
105877822|NCT00683618|365205635|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
105877823|NCT00683618|365205636|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
105659588|NCT03845023|364417396|FG003|Follow-Up (14 Days)|Adverse Event|1|||
105877824|NCT00683618|365205637|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
105877825|NCT00683618|365205635|FG000|Extension Treatment Period|Adverse Event|1|||
105877826|NCT00683618|365205636|FG001|Extension Treatment Period|Adverse Event|0|||
105877827|NCT00683618|365205637|FG002|Extension Treatment Period|Adverse Event|0|||
105877828|NCT00683618|365205635|FG000|Extension Treatment Period|Protocol Violation|1|||
105877829|NCT00683618|365205636|FG001|Extension Treatment Period|Protocol Violation|0|||
105877830|NCT00683618|365205637|FG002|Extension Treatment Period|Protocol Violation|0|||
105877831|NCT00529087|365205638|FG000|Overall Study|Adverse Event|10|||
105877832|NCT00529087|365205639|FG001|Overall Study|Adverse Event|13|||
105877833|NCT00529087|365205640|FG002|Overall Study|Adverse Event|4|||
105877834|NCT00529087|365205638|FG000|Overall Study|Lost to Follow-up|6|||
105877835|NCT00529087|365205639|FG001|Overall Study|Lost to Follow-up|4|||
105877836|NCT00529087|365205640|FG002|Overall Study|Lost to Follow-up|1|||
105877837|NCT00529087|365205638|FG000|Overall Study|Protocol Violation|8|||
105877838|NCT00529087|365205639|FG001|Overall Study|Protocol Violation|7|||
105877839|NCT00529087|365205640|FG002|Overall Study|Protocol Violation|6|||
105877840|NCT00529087|365205638|FG000|Overall Study|Withdrawal by Subject|3|||
105877841|NCT00529087|365205639|FG001|Overall Study|Withdrawal by Subject|3|||
105877842|NCT00529087|365205640|FG002|Overall Study|Withdrawal by Subject|3|||
105877843|NCT00529087|365205638|FG000|Overall Study|Protocol deviation|1|||
105877844|NCT00529087|365205639|FG001|Overall Study|Protocol deviation|1|||
105877845|NCT00529087|365205640|FG002|Overall Study|Protocol deviation|2|||
105877846|NCT00318474|365205641|FG000|Overall Study|Adverse Event|1|||
105877847|NCT00318474|365205642|FG001|Overall Study|Adverse Event|1|||
105877848|NCT00318474|365205641|FG000|Overall Study|Lost to Follow-up|0|||
105877849|NCT00318474|365205642|FG001|Overall Study|Lost to Follow-up|1|||
105877850|NCT00318474|365205641|FG000|Overall Study|Pregnancy|0|||
105877851|NCT00318474|365205642|FG001|Overall Study|Pregnancy|2|||
105877852|NCT00318474|365205641|FG000|Overall Study|Protocol Violation|1|||
105877853|NCT00318474|365205642|FG001|Overall Study|Protocol Violation|0|||
105877854|NCT00318474|365205641|FG000|Overall Study|Withdrawal by Subject|3|||
105877855|NCT00318474|365205642|FG001|Overall Study|Withdrawal by Subject|2|||
105877856|NCT00318474|365205641|FG000|Overall Study|Fall in GFR|3|||
105877857|NCT00318474|365205642|FG001|Overall Study|Fall in GFR|3|||
105877858|NCT00318474|365205641|FG000|Overall Study|Post-therapy hyperflycemia|0|||
105877859|NCT00318474|365205642|FG001|Overall Study|Post-therapy hyperflycemia|1|||
105877860|NCT00318474|365205641|FG000|Overall Study|Trial terminated|10|||
105877861|NCT00318474|365205642|FG001|Overall Study|Trial terminated|7|||
105877862|NCT01611935|365205647|FG000|Overall Study|Family Declined Participation|1|||
105877863|NCT01611935|365205648|FG001|Overall Study|Family Declined Participation|0|||
105877864|NCT00457002|365205649|FG000|Overall Study|Death|40|||
105877865|NCT00457002|365205650|FG001|Overall Study|Death|47|||
105877866|NCT00457002|365205649|FG000|Overall Study|Adverse Event|284|||
105877867|NCT00457002|365205650|FG001|Overall Study|Adverse Event|260|||
105877868|NCT00457002|365205649|FG000|Overall Study|Withdrawal by Subject|299|||
105877869|NCT00457002|365205650|FG001|Overall Study|Withdrawal by Subject|271|||
105877870|NCT00457002|365205649|FG000|Overall Study|Lost to Follow-up|72|||
105877871|NCT00457002|365205650|FG001|Overall Study|Lost to Follow-up|71|||
105877872|NCT00457002|365205649|FG000|Overall Study|Poor/Non-compliance|46|||
105877873|NCT00457002|365205650|FG001|Overall Study|Poor/Non-compliance|33|||
105877874|NCT00457002|365205649|FG000|Overall Study|No longer met criteria|41|||
105877875|NCT00457002|365205650|FG001|Overall Study|No longer met criteria|37|||
105877876|NCT00457002|365205649|FG000|Overall Study|Administrative reason by Sponsor|1|||
105877877|NCT00457002|365205650|FG001|Overall Study|Administrative reason by Sponsor|0|||
105877878|NCT00457002|365205649|FG000|Overall Study|non-specified|29|||
105877879|NCT00457002|365205650|FG001|Overall Study|non-specified|38|||
105877880|NCT00457002|365205649|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
105877881|NCT00457002|365205650|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
105877882|NCT03318861|365205658|FG000|Overall Study|Death|2|||
105877883|NCT03318861|365205659|FG001|Overall Study|Death|3|||
105877884|NCT03318861|365205660|FG002|Overall Study|Death|3|||
105877885|NCT03318861|365205661|FG003|Overall Study|Death|2|||
105877886|NCT03318861|365205662|FG004|Overall Study|Death|2|||
105877887|NCT03318861|365205658|FG000|Overall Study|Enrolled But Never Treated|0|||
105877888|NCT03318861|365205659|FG001|Overall Study|Enrolled But Never Treated|1|||
105877889|NCT03318861|365205660|FG002|Overall Study|Enrolled But Never Treated|0|||
105877890|NCT03318861|365205661|FG003|Overall Study|Enrolled But Never Treated|1|||
105877891|NCT03318861|365205662|FG004|Overall Study|Enrolled But Never Treated|1|||
105877892|NCT03318861|365205658|FG000|Overall Study|Informed Consent Withdraw|0|||
105877893|NCT03318861|365205659|FG001|Overall Study|Informed Consent Withdraw|0|||
105877894|NCT03318861|365205660|FG002|Overall Study|Informed Consent Withdraw|0|||
105877895|NCT03318861|365205661|FG003|Overall Study|Informed Consent Withdraw|1|||
105877896|NCT03318861|365205662|FG004|Overall Study|Informed Consent Withdraw|0|||
105877897|NCT03318861|365205658|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
105877898|NCT03318861|365205659|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
105658043|NCT03414047|364412000|FG000|Overall Study|Withdrawal by Subject|1|||
105877899|NCT03318861|365205660|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
105877900|NCT03318861|365205661|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
105877901|NCT03318861|365205662|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
105877902|NCT00917852|365205663|FG000|Overall Study|Death|6|||
105877903|NCT00570141|365205664|FG000|Overall Study|Adverse Event|1|||
105877904|NCT00570141|365205664|FG000|Overall Study|Missed visits|1|||
105877905|NCT00570141|365205664|FG000|Overall Study|Lost to Follow-up|1|||
105877906|NCT00712712|365205668|FG000|Overall Study|Protocol Violation|11|||
105877907|NCT00712712|365205668|FG000|Overall Study|Radiofrequency not done|3|||
105877908|NCT00712712|365205668|FG000|Overall Study|Death|8|||
105877909|NCT00712712|365205668|FG000|Overall Study|Withdrawal by Subject|1|||
105877910|NCT02044302|365205671|FG000|Overall Study|study terminated|2|||
105877911|NCT02044302|365205672|FG001|Overall Study|study terminated|0|||
105877912|NCT03207815|365205675|FG000|Overall Study|Protocol Violation|3|||
105877913|NCT03207815|365205676|FG001|Overall Study|Protocol Violation|1|||
105877914|NCT03207815|365205675|FG000|Overall Study|Adverse Event|1|||
105877915|NCT03207815|365205676|FG001|Overall Study|Adverse Event|2|||
105877916|NCT03207815|365205675|FG000|Overall Study|Lost to Follow-up|1|||
105877917|NCT03207815|365205676|FG001|Overall Study|Lost to Follow-up|2|||
105877918|NCT03207815|365205675|FG000|Overall Study|Investigator's Discretion|1|||
105877919|NCT03207815|365205676|FG001|Overall Study|Investigator's Discretion|1|||
105877920|NCT03207815|365205675|FG000|Overall Study|Lack of Efficacy|0|||
105877921|NCT03207815|365205676|FG001|Overall Study|Lack of Efficacy|1|||
105877922|NCT03207815|365205675|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
105877923|NCT03207815|365205676|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
105877924|NCT03207815|365205675|FG000|Overall Study|Withdrew Consent|1|||
105877925|NCT03207815|365205676|FG001|Overall Study|Withdrew Consent|0|||
105877926|NCT01671007|365205677|FG000|Overall Study|Other reasons than listed|166|||
105877927|NCT01671007|365205678|FG001|Overall Study|Other reasons than listed|373|||
105877928|NCT01671007|365205679|FG002|Overall Study|Other reasons than listed|197|||
105877929|NCT01671007|365205680|FG003|Overall Study|Other reasons than listed|228|||
105877930|NCT01671007|365205681|FG004|Overall Study|Other reasons than listed|14|||
105877931|NCT01671007|365205682|FG005|Overall Study|Other reasons than listed|71|||
105877932|NCT01671007|365205683|FG006|Overall Study|Other reasons than listed|17|||
105877933|NCT01671007|365205684|FG007|Overall Study|Other reasons than listed|66|||
105877934|NCT01671007|365205685|FG008|Overall Study|Other reasons than listed|0|||
105877935|NCT01671007|365205677|FG000|Overall Study|Withdrawal by Subject|36|||
105877936|NCT01671007|365205678|FG001|Overall Study|Withdrawal by Subject|59|||
105877937|NCT01671007|365205679|FG002|Overall Study|Withdrawal by Subject|53|||
105877938|NCT01671007|365205680|FG003|Overall Study|Withdrawal by Subject|58|||
105877939|NCT01671007|365205681|FG004|Overall Study|Withdrawal by Subject|4|||
105877940|NCT01671007|365205682|FG005|Overall Study|Withdrawal by Subject|15|||
105877941|NCT01671007|365205683|FG006|Overall Study|Withdrawal by Subject|1|||
105877942|NCT01671007|365205684|FG007|Overall Study|Withdrawal by Subject|19|||
105877943|NCT01671007|365205685|FG008|Overall Study|Withdrawal by Subject|0|||
105877944|NCT01671007|365205677|FG000|Overall Study|Lost to Follow-up|93|||
105877945|NCT01671007|365205678|FG001|Overall Study|Lost to Follow-up|142|||
105877946|NCT01671007|365205679|FG002|Overall Study|Lost to Follow-up|91|||
105877947|NCT01671007|365205680|FG003|Overall Study|Lost to Follow-up|63|||
105877948|NCT01671007|365205681|FG004|Overall Study|Lost to Follow-up|7|||
105877949|NCT01671007|365205682|FG005|Overall Study|Lost to Follow-up|20|||
105877950|NCT01671007|365205683|FG006|Overall Study|Lost to Follow-up|2|||
105877951|NCT01671007|365205684|FG007|Overall Study|Lost to Follow-up|28|||
105877952|NCT01671007|365205685|FG008|Overall Study|Lost to Follow-up|0|||
105877953|NCT01671007|365205677|FG000|Overall Study|No end of study case report form|3|||
105877954|NCT01671007|365205678|FG001|Overall Study|No end of study case report form|1|||
105877955|NCT01671007|365205679|FG002|Overall Study|No end of study case report form|0|||
105877956|NCT01671007|365205680|FG003|Overall Study|No end of study case report form|2|||
105877957|NCT01671007|365205681|FG004|Overall Study|No end of study case report form|0|||
105877958|NCT01671007|365205682|FG005|Overall Study|No end of study case report form|0|||
105877959|NCT01671007|365205683|FG006|Overall Study|No end of study case report form|0|||
105877960|NCT01671007|365205684|FG007|Overall Study|No end of study case report form|0|||
105877961|NCT01671007|365205685|FG008|Overall Study|No end of study case report form|0|||
105877962|NCT01671007|365205677|FG000|Overall Study|Not eligible|23|||
105877963|NCT01671007|365205678|FG001|Overall Study|Not eligible|76|||
105877964|NCT01671007|365205679|FG002|Overall Study|Not eligible|25|||
105877965|NCT01671007|365205680|FG003|Overall Study|Not eligible|17|||
105877966|NCT01671007|365205681|FG004|Overall Study|Not eligible|0|||
105877967|NCT01671007|365205682|FG005|Overall Study|Not eligible|6|||
105877968|NCT01671007|365205683|FG006|Overall Study|Not eligible|1|||
105877969|NCT01671007|365205684|FG007|Overall Study|Not eligible|19|||
105877970|NCT01671007|365205685|FG008|Overall Study|Not eligible|0|||
105877971|NCT01286467|365205686|FG000|Overall Study|Death|1|||
105877972|NCT01286467|365205687|FG001|Overall Study|Death|1|||
105877973|NCT01286467|365205688|FG002|Overall Study|Death|1|||
105877974|NCT01286467|365205689|FG003|Overall Study|Death|0|||
105877975|NCT01286467|365205686|FG000|Overall Study|Lost to Follow-up|0|||
105877976|NCT01286467|365205687|FG001|Overall Study|Lost to Follow-up|0|||
105877977|NCT01286467|365205688|FG002|Overall Study|Lost to Follow-up|0|||
105877978|NCT01286467|365205689|FG003|Overall Study|Lost to Follow-up|1|||
105877979|NCT01286467|365205686|FG000|Overall Study|Withdrawal by Subject|0|||
105877980|NCT01286467|365205687|FG001|Overall Study|Withdrawal by Subject|0|||
105877981|NCT01286467|365205688|FG002|Overall Study|Withdrawal by Subject|1|||
105877982|NCT01286467|365205689|FG003|Overall Study|Withdrawal by Subject|0|||
105877983|NCT01286467|365205686|FG000|Overall Study|Physician Decision|0|||
105877984|NCT01286467|365205687|FG001|Overall Study|Physician Decision|0|||
105877985|NCT01286467|365205688|FG002|Overall Study|Physician Decision|0|||
105877986|NCT01286467|365205689|FG003|Overall Study|Physician Decision|1|||
105877987|NCT01286467|365205686|FG000|Overall Study|Disease progression|3|||
105877988|NCT01286467|365205687|FG001|Overall Study|Disease progression|2|||
105877989|NCT01286467|365205688|FG002|Overall Study|Disease progression|2|||
105877990|NCT01286467|365205689|FG003|Overall Study|Disease progression|3|||
105877991|NCT01286467|365205686|FG000|Overall Study|Adverse Event|0|||
105877992|NCT01286467|365205687|FG001|Overall Study|Adverse Event|1|||
105877993|NCT01286467|365205688|FG002|Overall Study|Adverse Event|2|||
105877994|NCT01286467|365205689|FG003|Overall Study|Adverse Event|3|||
105877995|NCT01286467|365205686|FG000|Overall Study|Study drug stop longer than 14 days|0|||
105877996|NCT01286467|365205687|FG001|Overall Study|Study drug stop longer than 14 days|0|||
105877997|NCT01286467|365205688|FG002|Overall Study|Study drug stop longer than 14 days|1|||
105877998|NCT01286467|365205689|FG003|Overall Study|Study drug stop longer than 14 days|0|||
105877999|NCT00442897|365205690|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
105878000|NCT00442897|365205691|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
105878001|NCT00442897|365205690|FG000|Base Study (12 Week Follow-up)|Death|0|||
105878002|NCT00442897|365205691|FG001|Base Study (12 Week Follow-up)|Death|1|||
105878003|NCT00442897|365205690|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
105878004|NCT00442897|365205691|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
105878005|NCT00442897|365205690|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
105878006|NCT00442897|365205691|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
105878007|NCT00442897|365205690|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
105878008|NCT00442897|365205691|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
105878009|NCT00442897|365205690|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
105878010|NCT00442897|365205691|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
105878011|NCT00442897|365205690|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
105878012|NCT00442897|365205691|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
105878013|NCT00442897|365205690|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
105878014|NCT00442897|365205691|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
105878015|NCT02182843|365205692|FG000|Overall Study|Withdrawal by Subject|7|||
105878016|NCT02182843|365205692|FG000|Overall Study|Lost to Follow-up|2|||
105878017|NCT02182843|365205692|FG000|Overall Study|Adverse Event|1|||
105878018|NCT04548193|365205698|FG000|Overall Study|Lost to Follow-up|0|||
105878019|NCT04548193|365205699|FG001|Overall Study|Lost to Follow-up|1|||
105878020|NCT04548193|365205698|FG000|Overall Study|Death|0|||
105878021|NCT04548193|365205699|FG001|Overall Study|Death|1|||
105878022|NCT04548193|365205698|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
105878023|NCT04548193|365205699|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
105878024|NCT04548193|365205698|FG000|Overall Study|Withdrawal by Subject|2|||
105878025|NCT04548193|365205699|FG001|Overall Study|Withdrawal by Subject|2|||
105878026|NCT03889418|365205707|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
105878027|NCT03889418|365205708|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878028|NCT03889418|365205709|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878029|NCT03889418|365205710|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878030|NCT03889418|365205711|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878031|NCT03889418|365205712|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878032|NCT03889418|365205713|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878033|NCT03889418|365205714|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878034|NCT03889418|365205715|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878035|NCT03889418|365205716|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
105878036|NCT03889418|365205707|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105878037|NCT03889418|365205708|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
105878038|NCT03889418|365205709|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
105878039|NCT03889418|365205710|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105878040|NCT03889418|365205711|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105878041|NCT03889418|365205712|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105878042|NCT03889418|365205713|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105878043|NCT03889418|365205714|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105878044|NCT03889418|365205715|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105878045|NCT03889418|365205716|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
105878046|NCT03889418|365205707|FG000|October-December 2019 (Month 7-9)|Death|0|||
105878047|NCT03889418|365205708|FG001|October-December 2019 (Month 7-9)|Death|0|||
105878048|NCT03889418|365205709|FG002|October-December 2019 (Month 7-9)|Death|0|||
105878049|NCT03889418|365205710|FG003|October-December 2019 (Month 7-9)|Death|0|||
105878050|NCT03889418|365205711|FG004|October-December 2019 (Month 7-9)|Death|0|||
105878051|NCT03889418|365205712|FG005|October-December 2019 (Month 7-9)|Death|0|||
105878052|NCT03889418|365205713|FG006|October-December 2019 (Month 7-9)|Death|0|||
105878053|NCT03889418|365205714|FG007|October-December 2019 (Month 7-9)|Death|0|||
105878054|NCT03889418|365205715|FG008|October-December 2019 (Month 7-9)|Death|1|||
105878055|NCT03889418|365205716|FG009|October-December 2019 (Month 7-9)|Death|0|||
105878056|NCT03889418|365205707|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105878057|NCT03889418|365205708|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105878058|NCT03889418|365205709|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105878059|NCT03889418|365205710|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
105878060|NCT03889418|365205711|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105878061|NCT03889418|365205712|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105878062|NCT03889418|365205713|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105878063|NCT03889418|365205714|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
105878064|NCT03889418|365205715|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105878065|NCT03889418|365205716|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
105878066|NCT03889418|365205707|FG000|April - June 2020 (Month 13-15)|Death|0|||
105878067|NCT03889418|365205708|FG001|April - June 2020 (Month 13-15)|Death|1|||
105878068|NCT03889418|365205709|FG002|April - June 2020 (Month 13-15)|Death|0|||
105878069|NCT03889418|365205710|FG003|April - June 2020 (Month 13-15)|Death|0|||
105878070|NCT03889418|365205711|FG004|April - June 2020 (Month 13-15)|Death|0|||
105878071|NCT03889418|365205712|FG005|April - June 2020 (Month 13-15)|Death|0|||
105878072|NCT03889418|365205713|FG006|April - June 2020 (Month 13-15)|Death|0|||
105878073|NCT03889418|365205714|FG007|April - June 2020 (Month 13-15)|Death|0|||
105878074|NCT03889418|365205715|FG008|April - June 2020 (Month 13-15)|Death|0|||
105878075|NCT03889418|365205716|FG009|April - June 2020 (Month 13-15)|Death|0|||
105878076|NCT03889418|365205707|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878077|NCT03889418|365205708|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878078|NCT03889418|365205709|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878079|NCT03889418|365205710|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
105878080|NCT03889418|365205711|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878081|NCT03889418|365205712|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878082|NCT03889418|365205713|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878083|NCT03889418|365205714|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878084|NCT03889418|365205715|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878085|NCT03889418|365205716|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
105878086|NCT03889418|365205707|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
105878087|NCT03889418|365205708|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
105878088|NCT03889418|365205709|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
105878089|NCT03889418|365205710|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
105878090|NCT03889418|365205711|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
105878091|NCT03889418|365205712|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
105878092|NCT03889418|365205713|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
105878093|NCT03889418|365205714|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
105878094|NCT03889418|365205715|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
105878095|NCT03889418|365205716|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
105878096|NCT03889418|365205707|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105878097|NCT03889418|365205708|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
105878098|NCT03889418|365205709|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
105878099|NCT03889418|365205710|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
105878100|NCT03889418|365205711|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105878101|NCT03889418|365205712|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105878102|NCT03889418|365205713|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105878103|NCT03889418|365205714|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
105878104|NCT03889418|365205715|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
105878105|NCT03889418|365205716|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
105878106|NCT01139125|365205720|FG000|Overall Study|Withdrawal by Subject|1|||
105878107|NCT03751098|365205721|FG000|Overall Study|Withdrawal by Subject|0|||
105878108|NCT03751098|365205722|FG001|Overall Study|Withdrawal by Subject|1|||
105878109|NCT02220764|365205725|FG000|Overall Study|Lost to Follow-up|3|||
105878110|NCT02220764|365205726|FG001|Overall Study|Lost to Follow-up|1|||
105878111|NCT02220764|365205725|FG000|Overall Study|Death|1|||
105878112|NCT02220764|365205726|FG001|Overall Study|Death|0|||
105878113|NCT00739661|365205727|FG000|Overall Study|Adverse Event|2|||
105878114|NCT00739661|365205728|FG001|Overall Study|Adverse Event|0|||
105878115|NCT00739661|365205727|FG000|Overall Study|Physician decision to withdraw patient|1|||
105878116|NCT00739661|365205728|FG001|Overall Study|Physician decision to withdraw patient|0|||
105878117|NCT00739661|365205727|FG000|Overall Study|Patient decision to withdraw|9|||
105878118|NCT00739661|365205728|FG001|Overall Study|Patient decision to withdraw|4|||
105878119|NCT00739661|365205727|FG000|Overall Study|Disease progression, radiographic|33|||
105878120|NCT00739661|365205728|FG001|Overall Study|Disease progression, radiographic|37|||
105878121|NCT00739661|365205727|FG000|Overall Study|Reason for discontinuation not available|1|||
105878122|NCT00739661|365205728|FG001|Overall Study|Reason for discontinuation not available|1|||
105878123|NCT02198664|365205729|FG000|Overall Study|Adverse Event|2|||
105878124|NCT02198664|365205730|FG001|Overall Study|Adverse Event|0|||
105878125|NCT02198664|365205729|FG000|Overall Study|Withdrawal by Subject|11|||
105878126|NCT02198664|365205730|FG001|Overall Study|Withdrawal by Subject|8|||
105878127|NCT02198664|365205729|FG000|Overall Study|Failure to tolerate|2|||
105878128|NCT02198664|365205730|FG001|Overall Study|Failure to tolerate|0|||
105878129|NCT02198664|365205729|FG000|Overall Study|Not stated|1|||
105878130|NCT02198664|365205730|FG001|Overall Study|Not stated|0|||
105878131|NCT05343364|365205733|FG000|Overall Study|Miscellaneous|0|||
105878132|NCT05343364|365205734|FG001|Overall Study|Miscellaneous|1|||
105878133|NCT01252095|365205737|FG000|Overall Study|Disease progression|1|||
105878134|NCT01252095|365205738|FG001|Overall Study|Disease progression|0|||
105878135|NCT01139775|365205739|FG000|Overall Study|Adverse Event|0|||
105878136|NCT01139775|365205740|FG001|Overall Study|Adverse Event|6|||
105878137|NCT01139775|365205741|FG002|Overall Study|Adverse Event|2|||
105878138|NCT01139775|365205739|FG000|Overall Study|Protocol Violation|0|||
105878139|NCT01139775|365205740|FG001|Overall Study|Protocol Violation|5|||
105878140|NCT01139775|365205741|FG002|Overall Study|Protocol Violation|0|||
105878141|NCT01139775|365205739|FG000|Overall Study|Withdrawal by Subject|1|||
105878142|NCT01139775|365205740|FG001|Overall Study|Withdrawal by Subject|0|||
105878143|NCT01139775|365205741|FG002|Overall Study|Withdrawal by Subject|2|||
105878144|NCT01139775|365205739|FG000|Overall Study|Physician Decision|0|||
105878145|NCT01139775|365205740|FG001|Overall Study|Physician Decision|2|||
105878146|NCT01139775|365205741|FG002|Overall Study|Physician Decision|2|||
105878147|NCT00594165|365205744|FG000|Overall Study|Major protocol violation|1|||
105878148|NCT00594165|365205744|FG000|Overall Study|Lack of Efficacy|12|||
105878149|NCT00594165|365205744|FG000|Overall Study|Adverse Event|52|||
105878150|NCT00594165|365205744|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
105878151|NCT00594165|365205744|FG000|Overall Study|Subject withdrew consent|27|||
105878152|NCT00594165|365205744|FG000|Overall Study|Study ended per sponsor|102|||
105878153|NCT00594165|365205744|FG000|Overall Study|Lost to Follow-up|4|||
105878154|NCT00594165|365205744|FG000|Overall Study|Other: PI discretion|5|||
105878155|NCT00594165|365205744|FG000|Overall Study|Other: Subject moving|3|||
105878156|NCT00594165|365205744|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
105878157|NCT00594165|365205744|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
105878158|NCT00594165|365205744|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
105878159|NCT00594165|365205744|FG000|Overall Study|Other: Site terminated participation|2|||
105878160|NCT03193853|365205745|FG000|Overall Study|Death|6|||
105878161|NCT02169271|365205746|FG000|Overall Study|Protocol Violation|1|||
105878162|NCT02169271|365205747|FG001|Overall Study|Protocol Violation|2|||
105878163|NCT00503698|365205749|FG000|Overall Study|Protocol Violation|5|||
105878164|NCT00503698|365205750|FG001|Overall Study|Protocol Violation|6|||
105878165|NCT00503698|365205749|FG000|Overall Study|Adverse Event|52|||
105878166|NCT00503698|365205750|FG001|Overall Study|Adverse Event|41|||
105878167|NCT00503698|365205749|FG000|Overall Study|Death|1|||
105878168|NCT00503698|365205750|FG001|Overall Study|Death|0|||
105878169|NCT00503698|365205749|FG000|Overall Study|Lack of Efficacy|3|||
105878170|NCT00503698|365205750|FG001|Overall Study|Lack of Efficacy|4|||
105878171|NCT00503698|365205749|FG000|Overall Study|Trial terminated|216|||
105878172|NCT00503698|365205750|FG001|Overall Study|Trial terminated|253|||
105878173|NCT00503698|365205749|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
105878174|NCT00503698|365205750|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
105878175|NCT00503698|365205749|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
105878176|NCT00503698|365205750|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
105878177|NCT00503698|365205749|FG000|Overall Study|Any condition in exclusion criteria|4|||
105878178|NCT00503698|365205750|FG001|Overall Study|Any condition in exclusion criteria|6|||
105878179|NCT00503698|365205749|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
105878180|NCT00503698|365205750|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
105878181|NCT00503698|365205749|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
105878182|NCT00503698|365205750|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
105878183|NCT00503698|365205749|FG000|Overall Study|Critically ill|2|||
105878184|NCT00503698|365205750|FG001|Overall Study|Critically ill|0|||
105878185|NCT00503698|365205749|FG000|Overall Study|Unclassified|48|||
105878186|NCT00503698|365205750|FG001|Overall Study|Unclassified|32|||
105878187|NCT00503698|365205749|FG000|Overall Study|Not exposed to trial drug|11|||
105878188|NCT00503698|365205750|FG001|Overall Study|Not exposed to trial drug|6|||
105878189|NCT01367886|365205751|FG000|Overall Study|Lost to Follow-up|4|||
105878190|NCT01367886|365205751|FG000|Overall Study|Lack of Efficacy|2|||
105878191|NCT01367886|365205751|FG000|Overall Study|Death|1|||
105878192|NCT01611883|365205752|FG000|Overall Study|Adverse Event|1|||
105878193|NCT01611883|365205753|FG001|Overall Study|Adverse Event|1|||
105878194|NCT06868654|365205754|FG000|Overall Study|Death|4|||
105878195|NCT06868654|365205755|FG001|Overall Study|Death|14|||
105878196|NCT06868654|365205754|FG000|Overall Study|Lost to Follow-up|0|||
105878197|NCT06868654|365205755|FG001|Overall Study|Lost to Follow-up|1|||
105878198|NCT06868654|365205754|FG000|Overall Study|Withdrawal by Subject|5|||
105878199|NCT06868654|365205755|FG001|Overall Study|Withdrawal by Subject|3|||
105878200|NCT06868654|365205754|FG000|Overall Study|Physician Decision|0|||
105878201|NCT06868654|365205755|FG001|Overall Study|Physician Decision|1|||
105878202|NCT06868654|365205754|FG000|Overall Study|Ongoing|23|||
105878203|NCT06868654|365205755|FG001|Overall Study|Ongoing|21|||
105878204|NCT00866281|365207901|FG000|Overall Study|Adverse Event|1|||
105878205|NCT00866281|365207902|FG001|Overall Study|Adverse Event|0|||
105878206|NCT00866281|365207901|FG000|Overall Study|Withdrawal by participants|3|||
105878207|NCT00866281|365207902|FG001|Overall Study|Withdrawal by participants|0|||
105878208|NCT00866281|365207901|FG000|Overall Study|Disease progression|3|||
105878209|NCT00866281|365207902|FG001|Overall Study|Disease progression|11|||
105878210|NCT00866281|365207901|FG000|Overall Study|New cancer therapy|0|||
105878211|NCT00866281|365207902|FG001|Overall Study|New cancer therapy|4|||
105878212|NCT01100086|365207903|FG000|Period 1|Withdrawal by Subject|1|||
105878213|NCT01100086|365207904|FG001|Period 1|Withdrawal by Subject|0|||
105878214|NCT02954601|365207906|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
105878215|NCT02954601|365207907|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
105878216|NCT02954601|365207908|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
105878217|NCT02954601|365207909|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
105878218|NCT00471081|365207911|FG000|Active Phase|Protocol Violation|1|||
105878219|NCT00471081|365207912|FG001|Active Phase|Protocol Violation|1|||
105878220|NCT00471081|365207911|FG000|Active Phase|Withdrawal by Subject|0|||
105878221|NCT00471081|365207912|FG001|Active Phase|Withdrawal by Subject|3|||
105878222|NCT00471081|365207911|FG000|Active Phase|Lost to Follow-up|0|||
105878223|NCT00471081|365207912|FG001|Active Phase|Lost to Follow-up|1|||
105878224|NCT00471081|365207911|FG000|Active Phase|Lost health plan/insurance|1|||
105878225|NCT00471081|365207912|FG001|Active Phase|Lost health plan/insurance|8|||
105878226|NCT00471081|365207911|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
105878227|NCT00471081|365207912|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
105878228|NCT00471081|365207911|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
105878229|NCT00471081|365207912|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
105878230|NCT00471081|365207911|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
105878231|NCT00471081|365207912|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
105878232|NCT02844933|365207913|FG000|Overall Study|Discontinued due to premature termination of study|3|||
105878233|NCT02844933|365207914|FG001|Overall Study|Discontinued due to premature termination of study|2|||
105878234|NCT02275546|365207918|FG000|Treatment Period 2|Withdrawal by Subject|2|||
105878235|NCT02275546|365207919|FG001|Treatment Period 2|Withdrawal by Subject|1|||
105878236|NCT02275546|365207918|FG000|Treatment Period 2|Protocol Violation|0|||
105878237|NCT02275546|365207919|FG001|Treatment Period 2|Protocol Violation|1|||
105878238|NCT00454246|365207920|FG000|Overall Study|Adverse Event|2|||
105878239|NCT00454246|365207921|FG001|Overall Study|Adverse Event|2|||
105878240|NCT00454246|365207922|FG002|Overall Study|Adverse Event|0|||
105878241|NCT00454246|365207920|FG000|Overall Study|Violation of selection criteria at entry|6|||
105878242|NCT00454246|365207921|FG001|Overall Study|Violation of selection criteria at entry|0|||
105878243|NCT00454246|365207922|FG002|Overall Study|Violation of selection criteria at entry|0|||
105878244|NCT00454246|365207920|FG000|Overall Study|Protocol Violation|1|||
105878245|NCT00454246|365207921|FG001|Overall Study|Protocol Violation|0|||
105878246|NCT00454246|365207922|FG002|Overall Study|Protocol Violation|0|||
105878247|NCT00454246|365207920|FG000|Overall Study|Refused Treatment|1|||
105878248|NCT00454246|365207921|FG001|Overall Study|Refused Treatment|1|||
105878249|NCT00454246|365207922|FG002|Overall Study|Refused Treatment|0|||
105878250|NCT00454246|365207920|FG000|Overall Study|Failure to return|1|||
105878251|NCT00454246|365207921|FG001|Overall Study|Failure to return|0|||
105878252|NCT00454246|365207922|FG002|Overall Study|Failure to return|0|||
105878253|NCT00454246|365207920|FG000|Overall Study|Early termination of study|62|||
105878254|NCT00454246|365207921|FG001|Overall Study|Early termination of study|26|||
105878255|NCT00454246|365207922|FG002|Overall Study|Early termination of study|9|||
105878256|NCT02283268|365207923|FG000|Overall Study|Withdrawal by Subject|1|||
105878257|NCT00729612|365207932|FG000|Overall Study|Non evaluable for response|10|||
105878258|NCT01609010|365207937|FG000|Overall Study|Stable disease (SD)|22|||
105878259|NCT01609010|365207938|FG001|Overall Study|Stable disease (SD)|16|||
105878260|NCT01609010|365207937|FG000|Overall Study|Progressive disease (PD)|8|||
105878261|NCT01609010|365207938|FG001|Overall Study|Progressive disease (PD)|10|||
105878262|NCT01609010|365207937|FG000|Overall Study|Adverse Event|3|||
105878263|NCT01609010|365207938|FG001|Overall Study|Adverse Event|6|||
105878264|NCT01609010|365207937|FG000|Overall Study|Withdrawal by Subject|2|||
105878265|NCT01609010|365207938|FG001|Overall Study|Withdrawal by Subject|2|||
105878266|NCT01609010|365207937|FG000|Overall Study|Other|2|||
105878267|NCT01609010|365207938|FG001|Overall Study|Other|0|||
105878268|NCT01609010|365207937|FG000|Overall Study|Other malignancy|1|||
105878269|NCT01609010|365207938|FG001|Overall Study|Other malignancy|0|||
105878270|NCT01609010|365207937|FG000|Overall Study|Pathology review|2|||
105878271|NCT01609010|365207938|FG001|Overall Study|Pathology review|1|||
105878272|NCT01609010|365207937|FG000|Overall Study|Protocol Violation|1|||
105878273|NCT01609010|365207938|FG001|Overall Study|Protocol Violation|1|||
105878274|NCT01609010|365207937|FG000|Overall Study|New cancer|1|||
105878275|NCT01609010|365207938|FG001|Overall Study|New cancer|0|||
105878276|NCT01609010|365207937|FG000|Overall Study|Lost to Follow-up|1|||
105878277|NCT01609010|365207938|FG001|Overall Study|Lost to Follow-up|1|||
105878278|NCT05486091|365207939|FG000|Overall Study|Withdrawal by Subject|1|||
105878279|NCT05486091|365207939|FG000|Overall Study|Lost to Follow-up|2|||
105878280|NCT05344560|365207940|FG000|Period 1|Subject out of visit window|1|||
105878281|NCT05344560|365207941|FG001|Period 1|Subject out of visit window|1|||
105878282|NCT05344560|365207940|FG000|Period 2|Covid-19 Related|1|||
105878283|NCT05344560|365207941|FG001|Period 2|Covid-19 Related|0|||
105878284|NCT05344560|365207940|FG000|Period 2|Adverse Event|1|||
105878285|NCT05344560|365207941|FG001|Period 2|Adverse Event|0|||
105878286|NCT05344560|365207940|FG000|Period 2|Subject out of visit window|1|||
105878287|NCT05344560|365207941|FG001|Period 2|Subject out of visit window|1|||
105878288|NCT05344560|365207940|FG000|Period 3|Subject out of visit window|1|||
105878289|NCT05344560|365207941|FG001|Period 3|Subject out of visit window|0|||
105878290|NCT02626026|365207946|FG000|Overall Study|Randomized but Never Treated|0|||
105878291|NCT02626026|365207947|FG001|Overall Study|Randomized but Never Treated|0|||
105878292|NCT02626026|365207948|FG002|Overall Study|Randomized but Never Treated|0|||
105878293|NCT02626026|365207949|FG003|Overall Study|Randomized but Never Treated|0|||
105878294|NCT02626026|365207950|FG004|Overall Study|Randomized but Never Treated|1|||
105878295|NCT02626026|365207951|FG005|Overall Study|Randomized but Never Treated|0|||
105878296|NCT04630002|365207956|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
105878297|NCT04630002|365207957|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
105878298|NCT04630002|365207958|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
105878299|NCT04630002|365207956|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
105878300|NCT04630002|365207957|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
105878301|NCT04630002|365207958|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
105878302|NCT04630002|365207956|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
105878303|NCT04630002|365207957|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
105878304|NCT04630002|365207958|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
105878305|NCT04630002|365207956|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
105878306|NCT04630002|365207957|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
105878307|NCT04630002|365207958|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
105878308|NCT04630002|365207956|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
105878309|NCT04630002|365207957|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
105878310|NCT04630002|365207958|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
105878311|NCT04630002|365207956|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
105878312|NCT04630002|365207957|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
105878313|NCT04630002|365207958|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
105878314|NCT04630002|365207956|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
105878315|NCT04630002|365207957|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
105878316|NCT04630002|365207958|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
105878317|NCT04630002|365207956|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
105878318|NCT04630002|365207957|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
105878319|NCT04630002|365207958|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
105878320|NCT01704495|365207959|FG000|Subjects Randomized|Other Reason|3|||
105878321|NCT01704495|365207960|FG001|Subjects Randomized|Other Reason|2|||
105878322|NCT01704495|365207961|FG002|Subjects Randomized|Other Reason|3|||
105878323|NCT01704495|365207962|FG003|Subjects Randomized|Other Reason|2|||
105878324|NCT01704495|365207959|FG000|Subjects Randomized|Discontinuation criteria met|4|||
105878325|NCT01704495|365207960|FG001|Subjects Randomized|Discontinuation criteria met|2|||
105878326|NCT01704495|365207961|FG002|Subjects Randomized|Discontinuation criteria met|2|||
105878327|NCT01704495|365207962|FG003|Subjects Randomized|Discontinuation criteria met|0|||
105878328|NCT01704495|365207959|FG000|Subjects Randomized|Adverse Event|8|||
105878329|NCT01704495|365207960|FG001|Subjects Randomized|Adverse Event|2|||
105878330|NCT01704495|365207961|FG002|Subjects Randomized|Adverse Event|0|||
105878331|NCT01704495|365207962|FG003|Subjects Randomized|Adverse Event|7|||
105878332|NCT01704495|365207959|FG000|Subjects Randomized|Withdrawal by Subject|5|||
105878333|NCT01704495|365207960|FG001|Subjects Randomized|Withdrawal by Subject|5|||
105878334|NCT01704495|365207961|FG002|Subjects Randomized|Withdrawal by Subject|5|||
105878335|NCT01704495|365207962|FG003|Subjects Randomized|Withdrawal by Subject|5|||
105878336|NCT01704495|365207959|FG000|Subjects Randomized|Protocol Violation|1|||
105878337|NCT01704495|365207960|FG001|Subjects Randomized|Protocol Violation|1|||
105878338|NCT01704495|365207961|FG002|Subjects Randomized|Protocol Violation|2|||
105878339|NCT01704495|365207962|FG003|Subjects Randomized|Protocol Violation|0|||
105878340|NCT01704495|365207959|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
105878341|NCT01704495|365207960|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
105878342|NCT01704495|365207961|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
105878343|NCT01704495|365207962|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
105878344|NCT01704495|365207959|FG000|Optional Safety Extension|Adverse Event|0|||
105878345|NCT01704495|365207960|FG001|Optional Safety Extension|Adverse Event|4|||
105878346|NCT01704495|365207961|FG002|Optional Safety Extension|Adverse Event|0|||
105878347|NCT01704495|365207962|FG003|Optional Safety Extension|Adverse Event|1|||
105878348|NCT01704495|365207959|FG000|Optional Safety Extension|Other reason|27|||
105878349|NCT01704495|365207960|FG001|Optional Safety Extension|Other reason|29|||
105878350|NCT01704495|365207961|FG002|Optional Safety Extension|Other reason|30|||
105878351|NCT01704495|365207962|FG003|Optional Safety Extension|Other reason|28|||
105878352|NCT01704495|365207959|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
105878353|NCT01704495|365207960|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
105878354|NCT01704495|365207961|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
105878355|NCT01704495|365207962|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
105878356|NCT02375971|365207963|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
105878357|NCT02375971|365207964|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
105878358|NCT02375971|365207965|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
105878359|NCT02375971|365207963|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
105878360|NCT02375971|365207964|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
105878361|NCT02375971|365207965|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
105878362|NCT02375971|365207963|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
105878363|NCT02375971|365207964|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
105878364|NCT02375971|365207965|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
105878365|NCT02375971|365207963|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
105878366|NCT02375971|365207964|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
105878367|NCT02375971|365207965|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
105878368|NCT02375971|365207963|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
105878369|NCT02375971|365207964|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
105878370|NCT02375971|365207965|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
105878371|NCT02375971|365207963|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
105878372|NCT02375971|365207964|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
105878373|NCT02375971|365207965|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
105878374|NCT02375971|365207963|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
105878375|NCT02375971|365207964|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
105878376|NCT02375971|365207965|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
105878377|NCT02375971|365207963|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
105878378|NCT02375971|365207964|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
105878379|NCT02375971|365207965|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
105878380|NCT00891020|365207970|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
105878381|NCT00891020|365207971|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
105878382|NCT00891020|365207972|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
105878383|NCT00891020|365207970|FG000|24 Week Treatment Period|Death|0|||
105878384|NCT00891020|365207971|FG001|24 Week Treatment Period|Death|2|||
105878385|NCT00891020|365207972|FG002|24 Week Treatment Period|Death|0|||
105878386|NCT00891020|365207970|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
105878387|NCT00891020|365207971|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
105878388|NCT00891020|365207972|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
105878389|NCT00891020|365207970|FG000|24 Week Treatment Period|Failure to return|4|||
105878390|NCT00891020|365207971|FG001|24 Week Treatment Period|Failure to return|5|||
105878391|NCT00891020|365207972|FG002|24 Week Treatment Period|Failure to return|5|||
105878392|NCT00891020|365207970|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
105878393|NCT00891020|365207971|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
105878394|NCT00891020|365207972|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
105878395|NCT00891020|365207970|FG000|24 Week Treatment Period|Other protocol violation|1|||
105878396|NCT00891020|365207971|FG001|24 Week Treatment Period|Other protocol violation|1|||
105878397|NCT00891020|365207972|FG002|24 Week Treatment Period|Other protocol violation|2|||
105878398|NCT00891020|365207970|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
105878399|NCT00891020|365207971|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
105878400|NCT00891020|365207972|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
105878401|NCT00891020|365207970|FG000|24 Week Treatment Period|Withdrew consent|6|||
105878402|NCT00891020|365207971|FG001|24 Week Treatment Period|Withdrew consent|3|||
105878403|NCT00891020|365207972|FG002|24 Week Treatment Period|Withdrew consent|15|||
105878404|NCT00891020|365207970|FG000|24 Week Treatment Period|Administrative/Other|5|||
105878405|NCT00891020|365207971|FG001|24 Week Treatment Period|Administrative/Other|6|||
105878406|NCT00891020|365207972|FG002|24 Week Treatment Period|Administrative/Other|1|||
105878407|NCT00891020|365207970|FG000|Long-term Extension Period|Adverse Event|1|||
105878408|NCT00891020|365207971|FG001|Long-term Extension Period|Adverse Event|11|||
105878409|NCT00891020|365207972|FG002|Long-term Extension Period|Adverse Event|10|||
105878410|NCT00891020|365207970|FG000|Long-term Extension Period|Death|0|||
105878411|NCT00891020|365207971|FG001|Long-term Extension Period|Death|0|||
105878412|NCT00891020|365207972|FG002|Long-term Extension Period|Death|1|||
105878413|NCT00891020|365207970|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
105878414|NCT00891020|365207971|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
105878415|NCT00891020|365207972|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
105878416|NCT00891020|365207970|FG000|Long-term Extension Period|Protocol Violation|0|||
105878417|NCT00891020|365207971|FG001|Long-term Extension Period|Protocol Violation|1|||
105878418|NCT00891020|365207972|FG002|Long-term Extension Period|Protocol Violation|1|||
105878419|NCT00891020|365207970|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
105878420|NCT00891020|365207971|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
105878421|NCT00891020|365207972|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
105878422|NCT00891020|365207970|FG000|Long-term Extension Period|Failure to return|0|||
105878423|NCT00891020|365207971|FG001|Long-term Extension Period|Failure to return|2|||
105878424|NCT00891020|365207972|FG002|Long-term Extension Period|Failure to return|3|||
105878425|NCT00891020|365207970|FG000|Long-term Extension Period|Administrative|1|||
105878426|NCT00891020|365207971|FG001|Long-term Extension Period|Administrative|2|||
105878427|NCT00891020|365207972|FG002|Long-term Extension Period|Administrative|2|||
105878428|NCT04177095|365207976|FG000|Overall Study|Withdrawal by Subject|3|||
105878429|NCT04177095|365207976|FG000|Overall Study|Screen Failure|3|||
105878430|NCT04177095|365207976|FG000|Overall Study|Problems with the Trugraf assay|1|||
105878431|NCT02211209|365207977|FG000|Overall Study|Investigator judgment|0|||
105878432|NCT02211209|365207978|FG001|Overall Study|Investigator judgment|1|||
105878433|NCT02211209|365207977|FG000|Overall Study|Voluntary withdrawal|1|||
105878434|NCT02211209|365207978|FG001|Overall Study|Voluntary withdrawal|4|||
105878435|NCT02211209|365207977|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
105878436|NCT02211209|365207978|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
105878437|NCT02211209|365207977|FG000|Overall Study|Reason Not Specified|1|||
105878438|NCT02211209|365207978|FG001|Overall Study|Reason Not Specified|0|||
105878439|NCT00092118|365207979|FG000|Overall Study|Adverse Event|35|||
105878440|NCT00092118|365207980|FG001|Overall Study|Adverse Event|32|||
105878441|NCT00092118|365207979|FG000|Overall Study|Lack of Efficacy|12|||
105878442|NCT00092118|365207980|FG001|Overall Study|Lack of Efficacy|14|||
105878443|NCT00092118|365207979|FG000|Overall Study|Lost to Follow-up|4|||
105878444|NCT00092118|365207980|FG001|Overall Study|Lost to Follow-up|3|||
105878445|NCT00092118|365207979|FG000|Overall Study|Protocol Violation|23|||
105878446|NCT00092118|365207980|FG001|Overall Study|Protocol Violation|25|||
105878447|NCT00092118|365207979|FG000|Overall Study|Withdrawal by Subject|4|||
105878448|NCT00092118|365207980|FG001|Overall Study|Withdrawal by Subject|10|||
105878449|NCT00092118|365207979|FG000|Overall Study|Other|6|||
105878450|NCT00092118|365207980|FG001|Overall Study|Other|5|||
105878451|NCT02259010|365207981|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
105878452|NCT02462603|365207982|FG000|Overall Study|Investigator Decision|1|||
105878453|NCT02462603|365207982|FG000|Overall Study|Non-Compliance|1|||
105878454|NCT02462603|365207982|FG000|Overall Study|Withdrawal by Subject|2|||
105878455|NCT04762160|365207983|FG000|Overall Study|Study terminated early due to business reasons|5|||
105878456|NCT01537042|365207987|FG000|Overall Study|Adverse Event|0|||
105878457|NCT01537042|365207988|FG001|Overall Study|Adverse Event|2|||
105878458|NCT01537042|365207987|FG000|Overall Study|Lack of Efficacy|0|||
105878459|NCT01537042|365207988|FG001|Overall Study|Lack of Efficacy|1|||
105878460|NCT01537042|365207987|FG000|Overall Study|Protocol Violation|0|||
105878461|NCT01537042|365207988|FG001|Overall Study|Protocol Violation|1|||
105878462|NCT01537042|365207987|FG000|Overall Study|Other|0|||
105878463|NCT01537042|365207988|FG001|Overall Study|Other|1|||
105878464|NCT03655405|365207989|FG000|Overall Study|Death after initial data collection|4|||
105878465|NCT03655405|365207990|FG001|Overall Study|Death after initial data collection|2|||
105878466|NCT03655405|365207989|FG000|Overall Study|Died before initial data collection|1|||
105878467|NCT03655405|365207990|FG001|Overall Study|Died before initial data collection|2|||
105878468|NCT03655405|365207989|FG000|Overall Study|Protocol Violation|0|||
105878469|NCT03655405|365207990|FG001|Overall Study|Protocol Violation|1|||
105878470|NCT01779440|365207991|FG000|Overall Study|Withdrawal by Subject|3|||
105878471|NCT01779440|365207992|FG001|Overall Study|Withdrawal by Subject|5|||
105878472|NCT01205269|365207993|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105878473|NCT01205269|365207994|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105878474|NCT01205269|365207995|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105878475|NCT01205269|365207996|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
105878476|NCT01205269|365207997|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105878477|NCT01205269|365207998|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
105878478|NCT01804946|365207999|FG000|Overall Study|Protocol Violation|1|||
105878479|NCT01804946|365208000|FG001|Overall Study|Protocol Violation|0|||
105878480|NCT01804946|365207999|FG000|Overall Study|Adverse Event|0|||
105878481|NCT01804946|365208000|FG001|Overall Study|Adverse Event|1|||
105878482|NCT01804946|365207999|FG000|Overall Study|Insufficient data available|0|||
105878483|NCT01804946|365208000|FG001|Overall Study|Insufficient data available|1|||
105878484|NCT01804946|365207999|FG000|Overall Study|Do not meet inclusion criteria|1|||
105878485|NCT01804946|365208000|FG001|Overall Study|Do not meet inclusion criteria|2|||
105878486|NCT01207687|365208001|FG000|Overall Study|Adverse Event|1|||
105878487|NCT01207687|365208001|FG000|Overall Study|Withdrawal by Subject|1|||
105878488|NCT02859337|365208002|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
105878489|NCT02859337|365208003|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
105878490|NCT02859337|365208004|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
105878491|NCT02859337|365208002|FG000|Overall Study|Withdrawal by Subject|3|||
105878492|NCT02859337|365208003|FG001|Overall Study|Withdrawal by Subject|1|||
105878493|NCT02859337|365208004|FG002|Overall Study|Withdrawal by Subject|0|||
105878494|NCT02859337|365208002|FG000|Overall Study|Lost to Follow-up|1|||
105878495|NCT02859337|365208003|FG001|Overall Study|Lost to Follow-up|0|||
105878496|NCT02859337|365208004|FG002|Overall Study|Lost to Follow-up|0|||
105878497|NCT00722137|365208005|FG000|Overall Study|Overt Disease Progression|5|||
105878498|NCT00722137|365208006|FG001|Overall Study|Overt Disease Progression|4|||
105878499|NCT00722137|365208005|FG000|Overall Study|Adverse Event|17|||
105878500|NCT00722137|365208006|FG001|Overall Study|Adverse Event|21|||
105878501|NCT00722137|365208005|FG000|Overall Study|Death|12|||
105878502|NCT00722137|365208006|FG001|Overall Study|Death|7|||
105878503|NCT00722137|365208005|FG000|Overall Study|Withdrawal by Subject|6|||
105878504|NCT00722137|365208006|FG001|Overall Study|Withdrawal by Subject|9|||
105878505|NCT00722137|365208005|FG000|Overall Study|Other Reason Unknown|3|||
105878506|NCT00722137|365208006|FG001|Overall Study|Other Reason Unknown|4|||
105878507|NCT00722137|365208005|FG000|Overall Study|Randomized But Not Treated|2|||
105878508|NCT00722137|365208006|FG001|Overall Study|Randomized But Not Treated|3|||
105878509|NCT01486446|365208007|FG000|Overall Study|Adverse Event|1|||
105878510|NCT01486446|365208008|FG001|Overall Study|Adverse Event|0|||
105878511|NCT00523848|365208009|FG000|Overall Study|Adverse Event|11|||
105878512|NCT00523848|365208009|FG000|Overall Study|Withdrawal by Subject|2|||
105878513|NCT00523848|365208009|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
105878514|NCT00523848|365208009|FG000|Overall Study|Disease Progression|5|||
105878515|NCT00523848|365208009|FG000|Overall Study|Other, unspecified|4|||
105878516|NCT01801865|365208010|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
105878517|NCT01801865|365208010|FG000|Overall Study|Physician Decision|7|||
105878518|NCT00985504|365208019|FG000|Acute Treatment Period|Adverse Event|3|||
105878519|NCT00985504|365208020|FG001|Acute Treatment Period|Adverse Event|4|||
105878520|NCT00985504|365208019|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
105878521|NCT00985504|365208020|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
105878522|NCT00985504|365208019|FG000|Acute Treatment Period|Protocol Violation|2|||
105878523|NCT00985504|365208020|FG001|Acute Treatment Period|Protocol Violation|0|||
105878524|NCT00985504|365208019|FG000|Acute Treatment Period|Sponsor Decision|0|||
105878525|NCT00985504|365208020|FG001|Acute Treatment Period|Sponsor Decision|1|||
105878526|NCT00985504|365208019|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
105878527|NCT00985504|365208020|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
105878528|NCT00985504|365208019|FG000|Optimization Period|Adverse Event|7|||
105878529|NCT00985504|365208020|FG001|Optimization Period|Adverse Event|9|||
105878530|NCT00985504|365208019|FG000|Optimization Period|Death|0|||
105878531|NCT00985504|365208020|FG001|Optimization Period|Death|1|||
105878532|NCT00985504|365208019|FG000|Optimization Period|Lack of Efficacy|5|||
105878533|NCT00985504|365208020|FG001|Optimization Period|Lack of Efficacy|3|||
105878534|NCT00985504|365208019|FG000|Optimization Period|Lost to Follow-up|0|||
105878535|NCT00985504|365208020|FG001|Optimization Period|Lost to Follow-up|1|||
105878536|NCT00985504|365208019|FG000|Optimization Period|Physician Decision|1|||
105878537|NCT00985504|365208020|FG001|Optimization Period|Physician Decision|0|||
105878538|NCT00985504|365208019|FG000|Optimization Period|Protocol Violation|3|||
105878539|NCT00985504|365208020|FG001|Optimization Period|Protocol Violation|1|||
105878540|NCT00985504|365208019|FG000|Optimization Period|Withdrawal by Subject|10|||
105878541|NCT00985504|365208020|FG001|Optimization Period|Withdrawal by Subject|8|||
105878542|NCT03711786|365208022|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
105878543|NCT03711786|365208023|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
105878544|NCT03711786|365208022|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
105878545|NCT03711786|365208023|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
105878546|NCT03711786|365208022|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
105878547|NCT03711786|365208023|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
105878548|NCT03711786|365208022|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
105878549|NCT03711786|365208023|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
105878550|NCT03711786|365208022|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
105878551|NCT03711786|365208023|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
105878552|NCT03711786|365208022|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
105878553|NCT03711786|365208023|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
105878554|NCT00669669|365208024|FG000|Overall Study|To late to start treatment|1|||
105878555|NCT00848718|365208025|FG000|Overall Study|Adverse Event|2|||
105878556|NCT00848718|365208026|FG001|Overall Study|Adverse Event|2|||
105878557|NCT00848718|365208027|FG002|Overall Study|Adverse Event|1|||
105878558|NCT00848718|365208028|FG003|Overall Study|Adverse Event|1|||
105878559|NCT00848718|365208029|FG004|Overall Study|Adverse Event|1|||
105878560|NCT00848718|365208030|FG005|Overall Study|Adverse Event|0|||
105878561|NCT00848718|365208031|FG006|Overall Study|Adverse Event|0|||
105878562|NCT00848718|365208032|FG007|Overall Study|Adverse Event|1|||
105878563|NCT00848718|365208033|FG008|Overall Study|Adverse Event|1|||
105878564|NCT00848718|365208034|FG009|Overall Study|Adverse Event|0|||
105878565|NCT00848718|365208035|FG010|Overall Study|Adverse Event|0|||
105878566|NCT00848718|365208036|FG011|Overall Study|Adverse Event|0|||
105878567|NCT00848718|365208037|FG012|Overall Study|Adverse Event|2|||
105878568|NCT00848718|365208025|FG000|Overall Study|Lack of Efficacy|0|||
105878569|NCT00848718|365208026|FG001|Overall Study|Lack of Efficacy|0|||
105878570|NCT00848718|365208027|FG002|Overall Study|Lack of Efficacy|1|||
105878571|NCT00848718|365208028|FG003|Overall Study|Lack of Efficacy|0|||
105878572|NCT00848718|365208029|FG004|Overall Study|Lack of Efficacy|0|||
105878573|NCT00848718|365208030|FG005|Overall Study|Lack of Efficacy|0|||
105878574|NCT00848718|365208031|FG006|Overall Study|Lack of Efficacy|1|||
105878575|NCT00848718|365208032|FG007|Overall Study|Lack of Efficacy|0|||
105878576|NCT00848718|365208033|FG008|Overall Study|Lack of Efficacy|0|||
105878577|NCT00848718|365208034|FG009|Overall Study|Lack of Efficacy|0|||
105878578|NCT00848718|365208035|FG010|Overall Study|Lack of Efficacy|0|||
105878579|NCT00848718|365208036|FG011|Overall Study|Lack of Efficacy|0|||
105878580|NCT00848718|365208037|FG012|Overall Study|Lack of Efficacy|0|||
105878581|NCT00848718|365208025|FG000|Overall Study|Physician Decision|0|||
105878582|NCT00848718|365208026|FG001|Overall Study|Physician Decision|1|||
105878583|NCT00848718|365208027|FG002|Overall Study|Physician Decision|0|||
105878584|NCT00848718|365208028|FG003|Overall Study|Physician Decision|0|||
105878585|NCT00848718|365208029|FG004|Overall Study|Physician Decision|1|||
105878586|NCT00848718|365208030|FG005|Overall Study|Physician Decision|1|||
105878587|NCT00848718|365208031|FG006|Overall Study|Physician Decision|0|||
105878588|NCT00848718|365208032|FG007|Overall Study|Physician Decision|0|||
105878589|NCT00848718|365208033|FG008|Overall Study|Physician Decision|1|||
105878590|NCT00848718|365208034|FG009|Overall Study|Physician Decision|2|||
105878591|NCT00848718|365208035|FG010|Overall Study|Physician Decision|0|||
105878592|NCT00848718|365208036|FG011|Overall Study|Physician Decision|0|||
105878593|NCT00848718|365208037|FG012|Overall Study|Physician Decision|1|||
105878594|NCT00848718|365208025|FG000|Overall Study|Progressive disease before treatment|1|||
105878595|NCT00848718|365208026|FG001|Overall Study|Progressive disease before treatment|5|||
105878596|NCT00848718|365208027|FG002|Overall Study|Progressive disease before treatment|1|||
105878597|NCT00848718|365208028|FG003|Overall Study|Progressive disease before treatment|3|||
105878598|NCT00848718|365208029|FG004|Overall Study|Progressive disease before treatment|4|||
105878599|NCT00848718|365208030|FG005|Overall Study|Progressive disease before treatment|4|||
105878600|NCT00848718|365208031|FG006|Overall Study|Progressive disease before treatment|2|||
105878601|NCT00848718|365208032|FG007|Overall Study|Progressive disease before treatment|1|||
105878602|NCT00848718|365208033|FG008|Overall Study|Progressive disease before treatment|2|||
105878603|NCT00848718|365208034|FG009|Overall Study|Progressive disease before treatment|7|||
105878604|NCT00848718|365208035|FG010|Overall Study|Progressive disease before treatment|3|||
105878605|NCT00848718|365208036|FG011|Overall Study|Progressive disease before treatment|6|||
105878606|NCT00848718|365208037|FG012|Overall Study|Progressive disease before treatment|2|||
105878607|NCT00848718|365208025|FG000|Overall Study|Protocol Violation|0|||
105878608|NCT00848718|365208026|FG001|Overall Study|Protocol Violation|1|||
105878609|NCT00848718|365208027|FG002|Overall Study|Protocol Violation|0|||
105878610|NCT00848718|365208028|FG003|Overall Study|Protocol Violation|0|||
105878611|NCT00848718|365208029|FG004|Overall Study|Protocol Violation|0|||
105878612|NCT00848718|365208030|FG005|Overall Study|Protocol Violation|0|||
105878613|NCT00848718|365208031|FG006|Overall Study|Protocol Violation|0|||
105878614|NCT00848718|365208032|FG007|Overall Study|Protocol Violation|1|||
105878615|NCT00848718|365208033|FG008|Overall Study|Protocol Violation|0|||
105878616|NCT00848718|365208034|FG009|Overall Study|Protocol Violation|0|||
105878617|NCT00848718|365208035|FG010|Overall Study|Protocol Violation|0|||
105878618|NCT00848718|365208036|FG011|Overall Study|Protocol Violation|0|||
105878619|NCT00848718|365208037|FG012|Overall Study|Protocol Violation|1|||
105878620|NCT00848718|365208025|FG000|Overall Study|Withdrawal by Subject|1|||
105878621|NCT00848718|365208026|FG001|Overall Study|Withdrawal by Subject|0|||
105878622|NCT00848718|365208027|FG002|Overall Study|Withdrawal by Subject|0|||
105878623|NCT00848718|365208028|FG003|Overall Study|Withdrawal by Subject|1|||
105878624|NCT00848718|365208029|FG004|Overall Study|Withdrawal by Subject|0|||
105878625|NCT00848718|365208030|FG005|Overall Study|Withdrawal by Subject|0|||
105878626|NCT00848718|365208031|FG006|Overall Study|Withdrawal by Subject|0|||
105878627|NCT00848718|365208032|FG007|Overall Study|Withdrawal by Subject|0|||
105878628|NCT00848718|365208033|FG008|Overall Study|Withdrawal by Subject|0|||
105878629|NCT00848718|365208034|FG009|Overall Study|Withdrawal by Subject|0|||
105878630|NCT00848718|365208035|FG010|Overall Study|Withdrawal by Subject|1|||
105878631|NCT00848718|365208036|FG011|Overall Study|Withdrawal by Subject|0|||
105878632|NCT00848718|365208037|FG012|Overall Study|Withdrawal by Subject|0|||
105878633|NCT00848718|365208025|FG000|Overall Study|Progressive disease during treatment|3|||
105878634|NCT00848718|365208026|FG001|Overall Study|Progressive disease during treatment|0|||
105878635|NCT00848718|365208027|FG002|Overall Study|Progressive disease during treatment|3|||
105878636|NCT00848718|365208028|FG003|Overall Study|Progressive disease during treatment|0|||
105878637|NCT00848718|365208029|FG004|Overall Study|Progressive disease during treatment|0|||
105878638|NCT00848718|365208030|FG005|Overall Study|Progressive disease during treatment|0|||
105878639|NCT00848718|365208031|FG006|Overall Study|Progressive disease during treatment|0|||
105878640|NCT00848718|365208032|FG007|Overall Study|Progressive disease during treatment|2|||
105878641|NCT00848718|365208033|FG008|Overall Study|Progressive disease during treatment|0|||
105878642|NCT00848718|365208034|FG009|Overall Study|Progressive disease during treatment|0|||
105878643|NCT00848718|365208035|FG010|Overall Study|Progressive disease during treatment|0|||
105878644|NCT00848718|365208036|FG011|Overall Study|Progressive disease during treatment|0|||
105878645|NCT00848718|365208037|FG012|Overall Study|Progressive disease during treatment|2|||
105878646|NCT04200651|365208038|FG000|Overall Study|Moved to another country during follow-up|2|||
105878647|NCT04200651|365208039|FG001|Overall Study|Moved to another country during follow-up|2|||
105878648|NCT04200651|365208038|FG000|Overall Study|Lost to Follow-up|1|||
105878649|NCT04200651|365208039|FG001|Overall Study|Lost to Follow-up|3|||
105878650|NCT00030901|365208043|FG000|Initial Registration|Ineligible|167|||
105878651|NCT00030901|365208044|FG001|Initial Registration|Ineligible|0|||
105878652|NCT00030901|365208045|FG002|Initial Registration|Ineligible|0|||
105878653|NCT00030901|365208043|FG000|Randomization|Adverse Event|0|||
105878654|NCT00030901|365208044|FG001|Randomization|Adverse Event|11|||
105878655|NCT00030901|365208045|FG002|Randomization|Adverse Event|7|||
105878656|NCT00030901|365208043|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
105878657|NCT00030901|365208044|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
105878658|NCT00030901|365208045|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
105878659|NCT00030901|365208043|FG000|Randomization|Progression/Relapse|0|||
105878660|NCT00030901|365208044|FG001|Randomization|Progression/Relapse|22|||
105878661|NCT00030901|365208045|FG002|Randomization|Progression/Relapse|21|||
105878662|NCT00030901|365208043|FG000|Randomization|Death|0|||
105878663|NCT00030901|365208044|FG001|Randomization|Death|1|||
105878664|NCT00030901|365208045|FG002|Randomization|Death|3|||
105878665|NCT00030901|365208043|FG000|Randomization|Other|0|||
105878666|NCT00030901|365208044|FG001|Randomization|Other|36|||
105878667|NCT00030901|365208045|FG002|Randomization|Other|33|||
105878668|NCT00030901|365208043|FG000|Randomization|Ineligible|0|||
105658044|NCT03414047|364412001|FG001|Overall Study|Withdrawal by Subject|0|||
105658045|NCT03414047|364412002|FG002|Overall Study|Withdrawal by Subject|2|||
105658046|NCT03414047|364412003|FG003|Overall Study|Withdrawal by Subject|0|||
105658047|NCT00025506|364412004|FG000|Overall Study|Ineligible: clerical error|1|||
105658048|NCT00025506|364412004|FG000|Overall Study|Ineligible: wrong cell type|5|||
105658049|NCT00025506|364412004|FG000|Overall Study|Ineligible: inadequate pathology|2|||
105658050|NCT00025506|364412004|FG000|Overall Study|Never Treated|2|||
105658051|NCT01321723|364412005|FG000|Overall Study|Adverse Event|3|||
105658052|NCT01321723|364412006|FG001|Overall Study|Adverse Event|5|||
105658053|NCT01321723|364412007|FG002|Overall Study|Adverse Event|2|||
105658054|NCT01321723|364412005|FG000|Overall Study|Withdrawal by Subject|2|||
105658055|NCT01321723|364412006|FG001|Overall Study|Withdrawal by Subject|0|||
105658056|NCT01321723|364412007|FG002|Overall Study|Withdrawal by Subject|2|||
105658057|NCT01710800|364412008|FG000|Overall Study|Withdrawal by Subject|21|||
105658058|NCT01710800|364412008|FG000|Overall Study|Protocol Violation|1|||
105658059|NCT02586415|364412009|FG000|Overall Study|Death|13|||
105658060|NCT02586415|364412010|FG001|Overall Study|Death|23|||
105658061|NCT02586415|364412009|FG000|Overall Study|Lost to Follow-up|1|||
105658062|NCT02586415|364412010|FG001|Overall Study|Lost to Follow-up|2|||
105658063|NCT00827775|364412011|FG000|Overall Study|Withdrawal by Subject|0|||
105658064|NCT00827775|364412012|FG001|Overall Study|Withdrawal by Subject|5|||
105658065|NCT02872311|364412014|FG000|Overall Study|Death|2|||
105658066|NCT02872311|364412015|FG001|Overall Study|Death|0|||
105658067|NCT02872311|364412016|FG002|Overall Study|Death|0|||
105658068|NCT02872311|364412017|FG003|Overall Study|Death|0|||
105658069|NCT02872311|364412018|FG004|Overall Study|Death|0|||
105658070|NCT02872311|364412014|FG000|Overall Study|Lost to Follow-up|2|||
105658071|NCT02872311|364412015|FG001|Overall Study|Lost to Follow-up|0|||
105658072|NCT02872311|364412016|FG002|Overall Study|Lost to Follow-up|0|||
105658073|NCT02872311|364412017|FG003|Overall Study|Lost to Follow-up|0|||
105658074|NCT02872311|364412018|FG004|Overall Study|Lost to Follow-up|0|||
105658075|NCT02872311|364412014|FG000|Overall Study|Protocol Violation|0|||
105658076|NCT02872311|364412015|FG001|Overall Study|Protocol Violation|2|||
105658077|NCT02872311|364412016|FG002|Overall Study|Protocol Violation|1|||
105658078|NCT02872311|364412017|FG003|Overall Study|Protocol Violation|0|||
105658079|NCT02872311|364412018|FG004|Overall Study|Protocol Violation|0|||
105658080|NCT01585298|364412019|FG000|Overall Study|Study completion was not documented.|1|||
105658081|NCT01585298|364412019|FG000|Overall Study|Protocol deviation|1|||
105658082|NCT01585298|364412019|FG000|Overall Study|Administrative problems|4|||
105658083|NCT01585298|364412019|FG000|Overall Study|Lost to Follow-up|2|||
105658084|NCT01585298|364412019|FG000|Overall Study|Withdrawal by Subject|4|||
105658085|NCT01585298|364412019|FG000|Overall Study|Abnormal test procedure results|1|||
105658086|NCT01585298|364412019|FG000|Overall Study|Adverse Event|24|||
105658087|NCT00511797|364412020|FG000|Overall Study|Adverse Event|1|||
105658088|NCT00511797|364412021|FG001|Overall Study|Adverse Event|2|||
105658089|NCT00511797|364412022|FG002|Overall Study|Adverse Event|2|||
105658090|NCT00511797|364412023|FG003|Overall Study|Adverse Event|2|||
105658091|NCT00511797|364412020|FG000|Overall Study|Lost to Follow-up|1|||
105658092|NCT00511797|364412021|FG001|Overall Study|Lost to Follow-up|0|||
105658093|NCT00511797|364412022|FG002|Overall Study|Lost to Follow-up|0|||
105658094|NCT00511797|364412023|FG003|Overall Study|Lost to Follow-up|1|||
105658095|NCT00511797|364412020|FG000|Overall Study|Pregnancy|0|||
105658096|NCT00511797|364412021|FG001|Overall Study|Pregnancy|0|||
105658097|NCT00511797|364412022|FG002|Overall Study|Pregnancy|0|||
105658098|NCT00511797|364412023|FG003|Overall Study|Pregnancy|1|||
105658099|NCT00511797|364412020|FG000|Overall Study|Protocol Violation|0|||
105658100|NCT00511797|364412021|FG001|Overall Study|Protocol Violation|2|||
105658101|NCT00511797|364412022|FG002|Overall Study|Protocol Violation|2|||
105658102|NCT00511797|364412023|FG003|Overall Study|Protocol Violation|3|||
105658103|NCT00511797|364412020|FG000|Overall Study|Withdrawal by Subject|3|||
105658104|NCT00511797|364412021|FG001|Overall Study|Withdrawal by Subject|3|||
105658105|NCT00511797|364412022|FG002|Overall Study|Withdrawal by Subject|4|||
105658106|NCT00511797|364412023|FG003|Overall Study|Withdrawal by Subject|2|||
105658107|NCT00511797|364412020|FG000|Overall Study|Never dispensed|1|||
105658108|NCT00511797|364412021|FG001|Overall Study|Never dispensed|0|||
105658109|NCT00511797|364412022|FG002|Overall Study|Never dispensed|1|||
105658110|NCT00511797|364412023|FG003|Overall Study|Never dispensed|3|||
105658111|NCT00511797|364412020|FG000|Overall Study|Study drug not taken|0|||
105658112|NCT00511797|364412021|FG001|Overall Study|Study drug not taken|1|||
105658113|NCT00511797|364412022|FG002|Overall Study|Study drug not taken|0|||
105658114|NCT00511797|364412023|FG003|Overall Study|Study drug not taken|1|||
105658115|NCT00511797|364412020|FG000|Overall Study|Partially missing diary|0|||
105658116|NCT00511797|364412021|FG001|Overall Study|Partially missing diary|0|||
105658117|NCT00511797|364412022|FG002|Overall Study|Partially missing diary|1|||
105658118|NCT00511797|364412023|FG003|Overall Study|Partially missing diary|0|||
105658119|NCT00511797|364412020|FG000|Overall Study|Other (moving etc)|1|||
105658120|NCT00511797|364412021|FG001|Overall Study|Other (moving etc)|0|||
105658121|NCT00511797|364412022|FG002|Overall Study|Other (moving etc)|1|||
105658122|NCT00511797|364412023|FG003|Overall Study|Other (moving etc)|2|||
105658123|NCT01313624|364412024|FG000|Double-Blind Phase|Adverse Event|27|||
105658124|NCT01313624|364412025|FG001|Double-Blind Phase|Adverse Event|4|||
105658125|NCT01313624|364412024|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
105658126|NCT01313624|364412025|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
105658127|NCT01313624|364412024|FG000|Double-Blind Phase|Lost to Follow-up|0|||
105658128|NCT01313624|364412025|FG001|Double-Blind Phase|Lost to Follow-up|2|||
105658129|NCT01313624|364412024|FG000|Double-Blind Phase|Physician Decision|1|||
105658130|NCT01313624|364412025|FG001|Double-Blind Phase|Physician Decision|0|||
105658131|NCT01313624|364412024|FG000|Double-Blind Phase|Lack of Efficacy|1|||
105658132|NCT01313624|364412025|FG001|Double-Blind Phase|Lack of Efficacy|0|||
105658133|NCT01313624|364412024|FG000|Open-Label Phase|Adverse Event|1|||
105658134|NCT01313624|364412025|FG001|Open-Label Phase|Adverse Event|10|||
105658135|NCT01313624|364412024|FG000|Open-Label Phase|Withdrawal by Subject|2|||
105658136|NCT01313624|364412025|FG001|Open-Label Phase|Withdrawal by Subject|2|||
105658137|NCT01313624|364412024|FG000|Open-Label Phase|Lost to Follow-up|1|||
105658138|NCT01313624|364412025|FG001|Open-Label Phase|Lost to Follow-up|1|||
105658139|NCT02143063|364412029|FG000|Overall Study|Lost to Follow-up|16|||
105658140|NCT02143063|364412030|FG001|Overall Study|Lost to Follow-up|28|||
105658141|NCT02143063|364412031|FG002|Overall Study|Lost to Follow-up|29|||
105658142|NCT02143063|364412029|FG000|Overall Study|Withdrawal by Subject|0|||
105658143|NCT02143063|364412030|FG001|Overall Study|Withdrawal by Subject|1|||
105658144|NCT02143063|364412031|FG002|Overall Study|Withdrawal by Subject|0|||
105658145|NCT02143063|364412029|FG000|Overall Study|Death|0|||
105658146|NCT02143063|364412030|FG001|Overall Study|Death|1|||
105658147|NCT02143063|364412031|FG002|Overall Study|Death|1|||
105658148|NCT01157377|364412034|FG000|Overall Study|Lost to Follow-up|0|||
105658149|NCT01157377|364412035|FG001|Overall Study|Lost to Follow-up|0|||
105658150|NCT01157377|364412036|FG002|Overall Study|Lost to Follow-up|1|||
105658151|NCT01157377|364412037|FG003|Overall Study|Lost to Follow-up|0|||
105658152|NCT01157377|364412038|FG004|Overall Study|Lost to Follow-up|1|||
105658153|NCT01157377|364412039|FG005|Overall Study|Lost to Follow-up|1|||
105658154|NCT01157377|364412040|FG006|Overall Study|Lost to Follow-up|0|||
105658155|NCT01157377|364412034|FG000|Overall Study|Personal Reasons|2|||
105658156|NCT01157377|364412035|FG001|Overall Study|Personal Reasons|1|||
105658157|NCT01157377|364412036|FG002|Overall Study|Personal Reasons|0|||
105658158|NCT01157377|364412037|FG003|Overall Study|Personal Reasons|1|||
105658159|NCT01157377|364412038|FG004|Overall Study|Personal Reasons|0|||
105658160|NCT01157377|364412039|FG005|Overall Study|Personal Reasons|0|||
105658161|NCT01157377|364412040|FG006|Overall Study|Personal Reasons|0|||
105658162|NCT01157377|364412034|FG000|Overall Study|Protocol Violation|0|||
105658163|NCT01157377|364412035|FG001|Overall Study|Protocol Violation|0|||
105658164|NCT01157377|364412036|FG002|Overall Study|Protocol Violation|0|||
105658165|NCT01157377|364412037|FG003|Overall Study|Protocol Violation|0|||
105658166|NCT01157377|364412038|FG004|Overall Study|Protocol Violation|0|||
105658167|NCT01157377|364412039|FG005|Overall Study|Protocol Violation|1|||
105658168|NCT01157377|364412040|FG006|Overall Study|Protocol Violation|0|||
105658169|NCT01157377|364412034|FG000|Overall Study|Lack of Efficacy|0|||
105658170|NCT01157377|364412035|FG001|Overall Study|Lack of Efficacy|0|||
105658171|NCT01157377|364412036|FG002|Overall Study|Lack of Efficacy|0|||
105658172|NCT01157377|364412037|FG003|Overall Study|Lack of Efficacy|0|||
105658173|NCT01157377|364412038|FG004|Overall Study|Lack of Efficacy|0|||
105658174|NCT01157377|364412039|FG005|Overall Study|Lack of Efficacy|0|||
105658175|NCT01157377|364412040|FG006|Overall Study|Lack of Efficacy|1|||
105658176|NCT01157377|364412034|FG000|Overall Study|Other Miscellaneous Reasons|0|||
105658177|NCT01157377|364412035|FG001|Overall Study|Other Miscellaneous Reasons|2|||
105658178|NCT01157377|364412036|FG002|Overall Study|Other Miscellaneous Reasons|0|||
105658179|NCT01157377|364412037|FG003|Overall Study|Other Miscellaneous Reasons|0|||
105658180|NCT01157377|364412038|FG004|Overall Study|Other Miscellaneous Reasons|1|||
105658181|NCT01157377|364412039|FG005|Overall Study|Other Miscellaneous Reasons|1|||
105658182|NCT01157377|364412040|FG006|Overall Study|Other Miscellaneous Reasons|1|||
105658183|NCT05523219|364412041|FG000|Overall Study|Wrong inclusion|1|||
105658184|NCT05523219|364412041|FG000|Overall Study|Lost to Follow-up|7|||
105658185|NCT01702519|364412042|FG000|Washout Period|Lost to Follow-up|1|||
105658186|NCT01702519|364412043|FG001|Washout Period|Lost to Follow-up|0|||
105658187|NCT01702519|364412042|FG000|Washout Period|Withdrawal by Subject|0|||
105658188|NCT01702519|364412043|FG001|Washout Period|Withdrawal by Subject|2|||
105658189|NCT00826228|364414115|FG000|Overall Study|Withdrawal by Subject|1|||
105658190|NCT03475056|364414116|FG000|Overall Study|Lost to Follow-up|0|||
105658191|NCT03475056|364414117|FG001|Overall Study|Lost to Follow-up|1|||
105658192|NCT03475056|364414116|FG000|Overall Study|Moved from Area|0|||
105658193|NCT03475056|364414117|FG001|Overall Study|Moved from Area|2|||
105658194|NCT02080403|364414118|FG000|Overall Study|Adverse Event|5|||
105658195|NCT02080403|364414119|FG001|Overall Study|Adverse Event|1|||
105658196|NCT02080403|364414118|FG000|Overall Study|Death|0|||
105658197|NCT02080403|364414119|FG001|Overall Study|Death|2|||
105658198|NCT02080403|364414118|FG000|Overall Study|Lost to Follow-up|2|||
105658199|NCT02080403|364414119|FG001|Overall Study|Lost to Follow-up|0|||
105658200|NCT02080403|364414118|FG000|Overall Study|Pregnancy|0|||
105658201|NCT02080403|364414119|FG001|Overall Study|Pregnancy|1|||
105658202|NCT02080403|364414118|FG000|Overall Study|Protocol Violation|3|||
105658203|NCT02080403|364414119|FG001|Overall Study|Protocol Violation|7|||
105658204|NCT02080403|364414118|FG000|Overall Study|Withdrawal by Subject|5|||
105658205|NCT02080403|364414119|FG001|Overall Study|Withdrawal by Subject|1|||
105658206|NCT01999972|364414120|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
105658207|NCT01999972|364414121|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
105658208|NCT01999972|364414122|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
105658209|NCT01999972|364414123|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
105658210|NCT01999972|364414124|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
105658211|NCT01999972|364414125|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
105658212|NCT01999972|364414120|FG000|Dose Escalation Part|Death|0|||
105658213|NCT01999972|364414121|FG001|Dose Escalation Part|Death|1|||
105658214|NCT01999972|364414122|FG002|Dose Escalation Part|Death|0|||
105658215|NCT01999972|364414123|FG003|Dose Escalation Part|Death|0|||
105658216|NCT01999972|364414124|FG004|Dose Escalation Part|Death|0|||
105658217|NCT01999972|364414125|FG005|Dose Escalation Part|Death|0|||
105658218|NCT01999972|364414120|FG000|Dose Escalation Part|Enrolled but not treated|0|||
105658219|NCT01999972|364414121|FG001|Dose Escalation Part|Enrolled but not treated|0|||
105658220|NCT01999972|364414122|FG002|Dose Escalation Part|Enrolled but not treated|1|||
105658221|NCT01999972|364414123|FG003|Dose Escalation Part|Enrolled but not treated|1|||
105658222|NCT01999972|364414124|FG004|Dose Escalation Part|Enrolled but not treated|0|||
105658223|NCT01999972|364414125|FG005|Dose Escalation Part|Enrolled but not treated|0|||
105658224|NCT01999972|364414120|FG000|Dose Escalation Part|Disease progression|3|||
105658225|NCT01999972|364414121|FG001|Dose Escalation Part|Disease progression|2|||
105658226|NCT01999972|364414122|FG002|Dose Escalation Part|Disease progression|3|||
105658227|NCT01999972|364414123|FG003|Dose Escalation Part|Disease progression|6|||
105658228|NCT01999972|364414124|FG004|Dose Escalation Part|Disease progression|0|||
105658229|NCT01999972|364414125|FG005|Dose Escalation Part|Disease progression|0|||
105658230|NCT01999972|364414120|FG000|Dose Escalation Part|Adverse Event|0|||
105658231|NCT01999972|364414121|FG001|Dose Escalation Part|Adverse Event|0|||
105658232|NCT01999972|364414122|FG002|Dose Escalation Part|Adverse Event|0|||
105658233|NCT01999972|364414123|FG003|Dose Escalation Part|Adverse Event|2|||
105658234|NCT01999972|364414124|FG004|Dose Escalation Part|Adverse Event|0|||
105658235|NCT01999972|364414125|FG005|Dose Escalation Part|Adverse Event|0|||
105658236|NCT01999972|364414120|FG000|Dose Escalation Part|Global deterioration of health status|1|||
105658237|NCT01999972|364414121|FG001|Dose Escalation Part|Global deterioration of health status|0|||
105658238|NCT01999972|364414122|FG002|Dose Escalation Part|Global deterioration of health status|0|||
105658239|NCT01999972|364414123|FG003|Dose Escalation Part|Global deterioration of health status|1|||
105658240|NCT01999972|364414124|FG004|Dose Escalation Part|Global deterioration of health status|0|||
105658241|NCT01999972|364414125|FG005|Dose Escalation Part|Global deterioration of health status|0|||
105658242|NCT01999972|364414120|FG000|Dose Expansion Part|Death|0|||
105658243|NCT01999972|364414121|FG001|Dose Expansion Part|Death|0|||
105658244|NCT01999972|364414122|FG002|Dose Expansion Part|Death|0|||
105658245|NCT01999972|364414123|FG003|Dose Expansion Part|Death|0|||
105658246|NCT01999972|364414124|FG004|Dose Expansion Part|Death|2|||
105658247|NCT01999972|364414125|FG005|Dose Expansion Part|Death|1|||
105658248|NCT01999972|364414120|FG000|Dose Expansion Part|Disease progression|0|||
105658249|NCT01999972|364414121|FG001|Dose Expansion Part|Disease progression|0|||
105658250|NCT01999972|364414122|FG002|Dose Expansion Part|Disease progression|0|||
105658251|NCT01999972|364414123|FG003|Dose Expansion Part|Disease progression|0|||
105658252|NCT01999972|364414124|FG004|Dose Expansion Part|Disease progression|9|||
105658253|NCT01999972|364414125|FG005|Dose Expansion Part|Disease progression|3|||
105658254|NCT01999972|364414120|FG000|Dose Expansion Part|Sponsor decision|0|||
105658255|NCT01999972|364414121|FG001|Dose Expansion Part|Sponsor decision|0|||
105658256|NCT01999972|364414122|FG002|Dose Expansion Part|Sponsor decision|0|||
105658257|NCT01999972|364414123|FG003|Dose Expansion Part|Sponsor decision|0|||
105658258|NCT01999972|364414124|FG004|Dose Expansion Part|Sponsor decision|1|||
105658259|NCT01999972|364414125|FG005|Dose Expansion Part|Sponsor decision|0|||
105658260|NCT01999972|364414120|FG000|Dose Expansion Part|Adverse Event|0|||
105658261|NCT01999972|364414121|FG001|Dose Expansion Part|Adverse Event|0|||
105658262|NCT01999972|364414122|FG002|Dose Expansion Part|Adverse Event|0|||
105658263|NCT01999972|364414123|FG003|Dose Expansion Part|Adverse Event|0|||
105658264|NCT01999972|364414124|FG004|Dose Expansion Part|Adverse Event|4|||
105658265|NCT01999972|364414125|FG005|Dose Expansion Part|Adverse Event|2|||
105658266|NCT01999972|364414120|FG000|Dose Expansion Part|Participant's non-compliance|0|||
105658267|NCT01999972|364414121|FG001|Dose Expansion Part|Participant's non-compliance|0|||
105658268|NCT01999972|364414122|FG002|Dose Expansion Part|Participant's non-compliance|0|||
105658269|NCT01999972|364414123|FG003|Dose Expansion Part|Participant's non-compliance|0|||
105658270|NCT01999972|364414124|FG004|Dose Expansion Part|Participant's non-compliance|0|||
105658271|NCT01999972|364414125|FG005|Dose Expansion Part|Participant's non-compliance|1|||
105658272|NCT01999972|364414120|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
105658273|NCT01999972|364414121|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
105658274|NCT01999972|364414122|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
105658275|NCT01999972|364414123|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
105658276|NCT01999972|364414124|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
105658277|NCT01999972|364414125|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
105658278|NCT01999972|364414120|FG000|Dose Expansion Part|Changed to standard of care|0|||
105658279|NCT01999972|364414121|FG001|Dose Expansion Part|Changed to standard of care|0|||
105658280|NCT01999972|364414122|FG002|Dose Expansion Part|Changed to standard of care|0|||
105658281|NCT01999972|364414123|FG003|Dose Expansion Part|Changed to standard of care|0|||
105658282|NCT01999972|364414124|FG004|Dose Expansion Part|Changed to standard of care|1|||
105658283|NCT01999972|364414125|FG005|Dose Expansion Part|Changed to standard of care|0|||
105658284|NCT02210208|364414126|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
105658285|NCT02210208|364414126|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
105658286|NCT02210208|364414126|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
105658287|NCT02826798|364414130|FG000|Overall Study|Withdrawal by Subject|0|||
105658288|NCT02826798|364414131|FG001|Overall Study|Withdrawal by Subject|1|||
105658289|NCT02826798|364414132|FG002|Overall Study|Withdrawal by Subject|0|||
105658290|NCT02826798|364414133|FG003|Overall Study|Withdrawal by Subject|1|||
105658291|NCT02826798|364414134|FG004|Overall Study|Withdrawal by Subject|0|||
105658292|NCT02202109|364414135|FG000|Overall Study|Lost to Follow-up|88|||
105658293|NCT02202109|364414136|FG001|Overall Study|Lost to Follow-up|87|||
105658294|NCT02202109|364414135|FG000|Overall Study|Withdrawal by Subject|2|||
105658295|NCT02202109|364414136|FG001|Overall Study|Withdrawal by Subject|0|||
105658296|NCT01722045|364414140|FG000|Overall Study|Adverse Event|8|||
105658297|NCT01722045|364414140|FG000|Overall Study|Death|3|||
105658298|NCT01722045|364414140|FG000|Overall Study|Withdrawal by Subject|8|||
105658299|NCT01722045|364414140|FG000|Overall Study|Lost to Follow-up|4|||
105658300|NCT01722045|364414140|FG000|Overall Study|Protocol Deviation|1|||
105658301|NCT01722045|364414140|FG000|Overall Study|Physician Decision|3|||
105658302|NCT01722045|364414140|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
105658303|NCT01333111|364414141|FG000|Overall Study|patient undergoing major surgery|0|||
105658304|NCT01333111|364414142|FG001|Overall Study|patient undergoing major surgery|2|||
105658305|NCT01333111|364414143|FG002|Overall Study|patient undergoing major surgery|0|||
105658306|NCT01333111|364414141|FG000|Overall Study|personal reasons|0|||
105658307|NCT01333111|364414142|FG001|Overall Study|personal reasons|0|||
105658308|NCT01333111|364414143|FG002|Overall Study|personal reasons|1|||
105658309|NCT01333111|364414141|FG000|Overall Study|unclassified|1|||
105658310|NCT01333111|364414142|FG001|Overall Study|unclassified|0|||
105658311|NCT01333111|364414143|FG002|Overall Study|unclassified|0|||
105658312|NCT01333111|364414141|FG000|Overall Study|withdrawal criteria|0|||
105658313|NCT01333111|364414142|FG001|Overall Study|withdrawal criteria|1|||
105658314|NCT01333111|364414143|FG002|Overall Study|withdrawal criteria|0|||
105658315|NCT01333111|364414141|FG000|Overall Study|Non-compliance|1|||
105658316|NCT01333111|364414142|FG001|Overall Study|Non-compliance|0|||
105658317|NCT01333111|364414143|FG002|Overall Study|Non-compliance|0|||
105658318|NCT01333111|364414141|FG000|Overall Study|Ineffective therapy|0|||
105658319|NCT01333111|364414142|FG001|Overall Study|Ineffective therapy|0|||
105658320|NCT01333111|364414143|FG002|Overall Study|Ineffective therapy|1|||
105658321|NCT00612352|364414144|FG000|Overall Study|Adverse Event|1|||
105658322|NCT00612352|364414145|FG001|Overall Study|Adverse Event|0|||
105658323|NCT00612352|364414144|FG000|Overall Study|Withdrawal by Subject|3|||
105658324|NCT00612352|364414145|FG001|Overall Study|Withdrawal by Subject|5|||
105658325|NCT00612352|364414144|FG000|Overall Study|moved out of state|1|||
105658326|NCT00612352|364414145|FG001|Overall Study|moved out of state|0|||
105658327|NCT00612352|364414144|FG000|Overall Study|didn't return calls/show up on test date|4|||
105658328|NCT00612352|364414145|FG001|Overall Study|didn't return calls/show up on test date|1|||
105658329|NCT00760513|364414150|FG000|Overall Study|Withdrawal by Subject|5|||
105658330|NCT00760513|364414151|FG001|Overall Study|Withdrawal by Subject|7|||
105658331|NCT00908349|364414152|FG000|Overall Study|Adverse Event|10|||
105658332|NCT00908349|364414152|FG000|Overall Study|Withdrawal by Subject|9|||
105658333|NCT00908349|364414152|FG000|Overall Study|Physician Decision|5|||
105658334|NCT00908349|364414152|FG000|Overall Study|Lost to Follow-up|5|||
105658335|NCT00908349|364414152|FG000|Overall Study|Various|6|||
105658336|NCT04523207|364414154|FG000|Overall Study|Adverse Event|5|||
105658337|NCT04523207|364414155|FG001|Overall Study|Adverse Event|1|||
105658338|NCT04523207|364414154|FG000|Overall Study|Lost to Follow-up|2|||
105658339|NCT04523207|364414155|FG001|Overall Study|Lost to Follow-up|0|||
105658340|NCT04523207|364414154|FG000|Overall Study|Withdrawal by Subject|2|||
105658341|NCT04523207|364414155|FG001|Overall Study|Withdrawal by Subject|0|||
105658342|NCT04523207|364414154|FG000|Overall Study|Progressive Disease|2|||
105658343|NCT04523207|364414155|FG001|Overall Study|Progressive Disease|1|||
105658344|NCT04523207|364414154|FG000|Overall Study|Other|7|||
105658345|NCT04523207|364414155|FG001|Overall Study|Other|1|||
105658346|NCT00487552|364414156|FG000|Overall Study|Unsuccessful magnet placements|3|||
105658347|NCT00487552|364414156|FG000|Overall Study|Death due to progressive malignancy|2|||
105658348|NCT00487552|364414156|FG000|Overall Study|Stent not placed|1|||
105658349|NCT02412111|364414157|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
105658350|NCT02412111|364414158|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
105658351|NCT02412111|364414159|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
105878669|NCT00030901|365208044|FG001|Randomization|Ineligible|15|||
105658352|NCT02412111|364414157|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
105658353|NCT02412111|364414158|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
105658354|NCT02412111|364414159|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
105658355|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
105658356|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
105658357|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
105658358|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
105658359|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
105658360|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
105658361|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
105658362|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
105658363|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
105658364|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
105658365|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
105658366|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
105658367|NCT02412111|364414157|FG000|Active Comparator Period (8 Weeks)|Other|0|||
105658368|NCT02412111|364414158|FG001|Active Comparator Period (8 Weeks)|Other|0|||
105658369|NCT02412111|364414159|FG002|Active Comparator Period (8 Weeks)|Other|2|||
105658370|NCT00320398|364414160|FG000|Overall Study|Adverse Event|1|||
105658371|NCT00320398|364414161|FG001|Overall Study|Adverse Event|4|||
105658372|NCT00320398|364414160|FG000|Overall Study|Other|1|||
105658373|NCT00320398|364414161|FG001|Overall Study|Other|0|||
105658374|NCT04702893|364414162|FG000|Overall Study|Other reasons than listed|11|||
105658375|NCT04702893|364414162|FG000|Overall Study|Withdrawal by Subject|3|||
105658376|NCT04702893|364414162|FG000|Overall Study|Lost to Follow-up|7|||
105658377|NCT04702893|364414162|FG000|Overall Study|Death|10|||
105658378|NCT04702893|364414162|FG000|Overall Study|Not treated|6|||
105658379|NCT04469465|364414163|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
105658380|NCT04469465|364414164|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
105658381|NCT04469465|364414163|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
105658382|NCT04469465|364414164|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
105658383|NCT04469465|364414163|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
105658384|NCT04469465|364414164|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
105658385|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
105658386|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
105658387|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
105658388|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
105658389|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
105658390|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
105658391|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Death|0|||
105658392|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Death|1|||
105658393|NCT04469465|364414163|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
105658394|NCT04469465|364414164|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
105658395|NCT04190225|364414165|FG000|Overall Study|Lost to Follow-up|2|||
105658396|NCT04190225|364414166|FG001|Overall Study|Lost to Follow-up|3|||
105658397|NCT04190225|364414165|FG000|Overall Study|Withdrawal by Subject|3|||
105658398|NCT04190225|364414166|FG001|Overall Study|Withdrawal by Subject|2|||
105658399|NCT04190225|364414165|FG000|Overall Study|Unrelated health condition|2|||
105658400|NCT04190225|364414166|FG001|Overall Study|Unrelated health condition|0|||
105658401|NCT02624869|364414169|FG000|Overall Study|Lost to Follow-up|0|||
105658402|NCT02624869|364414170|FG001|Overall Study|Lost to Follow-up|0|||
105658403|NCT02624869|364414171|FG002|Overall Study|Lost to Follow-up|1|||
105658404|NCT02624869|364414169|FG000|Overall Study|Withdrawal by Subject|1|||
105658405|NCT02624869|364414170|FG001|Overall Study|Withdrawal by Subject|3|||
105658406|NCT02624869|364414171|FG002|Overall Study|Withdrawal by Subject|1|||
105658407|NCT02994784|364414172|FG000|6 Months Follow-up|Lost to Follow-up|3|||
105658408|NCT04238520|364414174|FG000|Overall Study|Withdrawal by Subject|1|||
105658409|NCT04238520|364414175|FG001|Overall Study|Withdrawal by Subject|1|||
105658410|NCT04238520|364414174|FG000|Overall Study|Lost to Follow-up|1|||
105658411|NCT04238520|364414175|FG001|Overall Study|Lost to Follow-up|2|||
105658412|NCT04238520|364414174|FG000|Overall Study|Death|0|||
105658413|NCT04238520|364414175|FG001|Overall Study|Death|2|||
105658414|NCT04238520|364414174|FG000|Overall Study|Unsafe home environment for research staff|0|||
105658415|NCT04238520|364414175|FG001|Overall Study|Unsafe home environment for research staff|1|||
105658416|NCT01470599|364414176|FG000|Overall Study|Did not meet entrance criteria|1|||
105658417|NCT01470599|364414177|FG001|Overall Study|Did not meet entrance criteria|0|||
105658418|NCT01470599|364414176|FG000|Overall Study|Lost to Follow-up|2|||
105658419|NCT01470599|364414177|FG001|Overall Study|Lost to Follow-up|1|||
105658420|NCT01470599|364414176|FG000|Overall Study|Withdrawal by Subject|3|||
105658421|NCT01470599|364414177|FG001|Overall Study|Withdrawal by Subject|4|||
105658422|NCT01470599|364414176|FG000|Overall Study|Other|1|||
105658423|NCT01470599|364414177|FG001|Overall Study|Other|0|||
105658424|NCT01470599|364414176|FG000|Overall Study|Protocol Violation|3|||
105658425|NCT01470599|364414177|FG001|Overall Study|Protocol Violation|1|||
105658426|NCT01470599|364414176|FG000|Overall Study|Adverse event related to study drug|2|||
105658427|NCT01470599|364414177|FG001|Overall Study|Adverse event related to study drug|5|||
105658428|NCT01470599|364414176|FG000|Overall Study|Insufficient clinical response|6|||
105658429|NCT01470599|364414177|FG001|Overall Study|Insufficient clinical response|27|||
105658430|NCT01470599|364414176|FG000|Overall Study|Adverse event not related to study drug|1|||
105658431|NCT01470599|364414177|FG001|Overall Study|Adverse event not related to study drug|5|||
105658432|NCT01917006|364414178|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
105658433|NCT01917006|364414179|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
105658434|NCT01917006|364414180|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
105658435|NCT01917006|364414181|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
105658436|NCT01917006|364414182|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
105658437|NCT01917006|364414183|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
105658438|NCT01917006|364414184|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
105658439|NCT01917006|364414185|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
105658440|NCT01917006|364414178|FG000|Randomized-treatment Period|Personal Reasons|0|||
105658441|NCT01917006|364414179|FG001|Randomized-treatment Period|Personal Reasons|0|||
105658442|NCT01917006|364414180|FG002|Randomized-treatment Period|Personal Reasons|0|||
105658443|NCT01917006|364414181|FG003|Randomized-treatment Period|Personal Reasons|0|||
105658444|NCT01917006|364414182|FG004|Randomized-treatment Period|Personal Reasons|0|||
105658445|NCT01917006|364414183|FG005|Randomized-treatment Period|Personal Reasons|1|||
105658446|NCT01917006|364414184|FG006|Randomized-treatment Period|Personal Reasons|0|||
105658447|NCT01917006|364414185|FG007|Randomized-treatment Period|Personal Reasons|0|||
105658448|NCT01917006|364414178|FG000|Randomized-treatment Period|Protocol Violation|1|||
105658449|NCT01917006|364414179|FG001|Randomized-treatment Period|Protocol Violation|0|||
105658450|NCT01917006|364414180|FG002|Randomized-treatment Period|Protocol Violation|0|||
105658451|NCT01917006|364414181|FG003|Randomized-treatment Period|Protocol Violation|0|||
105658452|NCT01917006|364414182|FG004|Randomized-treatment Period|Protocol Violation|0|||
105658453|NCT01917006|364414183|FG005|Randomized-treatment Period|Protocol Violation|0|||
105658454|NCT01917006|364414184|FG006|Randomized-treatment Period|Protocol Violation|0|||
105658455|NCT01917006|364414185|FG007|Randomized-treatment Period|Protocol Violation|0|||
105658456|NCT01917006|364414178|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658457|NCT01917006|364414179|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658458|NCT01917006|364414180|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658459|NCT01917006|364414181|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658460|NCT01917006|364414182|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658461|NCT01917006|364414183|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658462|NCT01917006|364414184|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
105658463|NCT01917006|364414185|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
105658464|NCT01917006|364414178|FG000|Open-label Period|Adverse Event|0|||
105658465|NCT01917006|364414179|FG001|Open-label Period|Adverse Event|0|||
105658466|NCT01917006|364414180|FG002|Open-label Period|Adverse Event|0|||
105658467|NCT01917006|364414181|FG003|Open-label Period|Adverse Event|0|||
105658468|NCT01917006|364414182|FG004|Open-label Period|Adverse Event|0|||
105658469|NCT01917006|364414183|FG005|Open-label Period|Adverse Event|0|||
105658470|NCT01917006|364414184|FG006|Open-label Period|Adverse Event|0|||
105658471|NCT01917006|364414185|FG007|Open-label Period|Adverse Event|1|||
105658472|NCT01917006|364414178|FG000|Open-label Period|Lost to Follow-up|0|||
105658473|NCT01917006|364414179|FG001|Open-label Period|Lost to Follow-up|0|||
105658474|NCT01917006|364414180|FG002|Open-label Period|Lost to Follow-up|0|||
105658475|NCT01917006|364414181|FG003|Open-label Period|Lost to Follow-up|0|||
105658476|NCT01917006|364414182|FG004|Open-label Period|Lost to Follow-up|0|||
105658477|NCT01917006|364414183|FG005|Open-label Period|Lost to Follow-up|0|||
105658478|NCT01917006|364414184|FG006|Open-label Period|Lost to Follow-up|0|||
105658479|NCT01917006|364414185|FG007|Open-label Period|Lost to Follow-up|1|||
105658480|NCT02447432|364414188|FG000|Epoch 001|Adverse Event|1|||
105658481|NCT02447432|364414189|FG001|Epoch 001|Adverse Event|1|||
105658482|NCT02447432|364414188|FG000|Epoch 001|Withdrawal by Subject|0|||
105658483|NCT02447432|364414189|FG001|Epoch 001|Withdrawal by Subject|4|||
105658484|NCT02447432|364414188|FG000|Epoch 001|Migrated/moved from study area|3|||
105658485|NCT02447432|364414189|FG001|Epoch 001|Migrated/moved from study area|5|||
105658486|NCT02447432|364414188|FG000|Epoch 001|Lost to Follow-up|1|||
105658487|NCT02447432|364414189|FG001|Epoch 001|Lost to Follow-up|3|||
105658488|NCT00719043|364414190|FG000|Overall Study|Adverse Event|5|||
105658489|NCT00719043|364414191|FG001|Overall Study|Adverse Event|1|||
105658490|NCT00719043|364414192|FG002|Overall Study|Adverse Event|2|||
105658491|NCT00719043|364414193|FG003|Overall Study|Adverse Event|2|||
105658492|NCT00719043|364414194|FG004|Overall Study|Adverse Event|1|||
105658493|NCT00719043|364414195|FG005|Overall Study|Adverse Event|4|||
105658494|NCT00719043|364414196|FG006|Overall Study|Adverse Event|4|||
105658495|NCT00719043|364414190|FG000|Overall Study|Lost to Follow-up|14|||
105658496|NCT00719043|364414191|FG001|Overall Study|Lost to Follow-up|10|||
105658497|NCT00719043|364414192|FG002|Overall Study|Lost to Follow-up|8|||
105658498|NCT00719043|364414193|FG003|Overall Study|Lost to Follow-up|9|||
105658499|NCT00719043|364414194|FG004|Overall Study|Lost to Follow-up|10|||
105658500|NCT00719043|364414195|FG005|Overall Study|Lost to Follow-up|9|||
105658501|NCT00719043|364414196|FG006|Overall Study|Lost to Follow-up|9|||
105658502|NCT00719043|364414190|FG000|Overall Study|Protocol Violation|0|||
105658503|NCT00719043|364414191|FG001|Overall Study|Protocol Violation|0|||
105658504|NCT00719043|364414192|FG002|Overall Study|Protocol Violation|0|||
105658505|NCT00719043|364414193|FG003|Overall Study|Protocol Violation|0|||
105658506|NCT00719043|364414194|FG004|Overall Study|Protocol Violation|0|||
105658507|NCT00719043|364414195|FG005|Overall Study|Protocol Violation|1|||
105658508|NCT00719043|364414196|FG006|Overall Study|Protocol Violation|0|||
105658509|NCT00719043|364414190|FG000|Overall Study|Other|1|||
105658510|NCT00719043|364414191|FG001|Overall Study|Other|0|||
105658511|NCT00719043|364414192|FG002|Overall Study|Other|1|||
105658512|NCT00719043|364414193|FG003|Overall Study|Other|2|||
105658513|NCT00719043|364414194|FG004|Overall Study|Other|0|||
105658514|NCT00719043|364414195|FG005|Overall Study|Other|2|||
105658515|NCT00719043|364414196|FG006|Overall Study|Other|1|||
105658516|NCT00719043|364414190|FG000|Overall Study|Withdrawal by Subject|12|||
105658517|NCT00719043|364414191|FG001|Overall Study|Withdrawal by Subject|14|||
105658518|NCT00719043|364414192|FG002|Overall Study|Withdrawal by Subject|9|||
105658519|NCT00719043|364414193|FG003|Overall Study|Withdrawal by Subject|10|||
105658520|NCT00719043|364414194|FG004|Overall Study|Withdrawal by Subject|16|||
105658521|NCT00719043|364414195|FG005|Overall Study|Withdrawal by Subject|18|||
105658522|NCT00719043|364414196|FG006|Overall Study|Withdrawal by Subject|14|||
105658523|NCT00813098|364414197|FG000|Overall Study|Adverse Event|2|||
105658524|NCT00813098|364414198|FG001|Overall Study|Adverse Event|4|||
105658525|NCT00813098|364414199|FG002|Overall Study|Adverse Event|1|||
105658526|NCT00813098|364414197|FG000|Overall Study|Withdrawal by Subject|0|||
105658527|NCT00813098|364414198|FG001|Overall Study|Withdrawal by Subject|1|||
105658528|NCT00813098|364414199|FG002|Overall Study|Withdrawal by Subject|0|||
105658529|NCT00813098|364414197|FG000|Overall Study|Inability to complete study procedures|1|||
105658530|NCT00813098|364414198|FG001|Overall Study|Inability to complete study procedures|0|||
105658531|NCT00813098|364414199|FG002|Overall Study|Inability to complete study procedures|0|||
105658532|NCT00813098|364414197|FG000|Overall Study|Lost to Follow-up|0|||
105658533|NCT00813098|364414198|FG001|Overall Study|Lost to Follow-up|1|||
105658534|NCT00813098|364414199|FG002|Overall Study|Lost to Follow-up|0|||
105658535|NCT00813098|364414197|FG000|Overall Study|Protocol Violation|0|||
105658536|NCT00813098|364414198|FG001|Overall Study|Protocol Violation|0|||
105658537|NCT00813098|364414199|FG002|Overall Study|Protocol Violation|1|||
105658538|NCT00813098|364414197|FG000|Overall Study|Principal Investigator decision|0|||
105658539|NCT00813098|364414198|FG001|Overall Study|Principal Investigator decision|1|||
105658540|NCT00813098|364414199|FG002|Overall Study|Principal Investigator decision|0|||
105658541|NCT00813098|364414197|FG000|Overall Study|Withdrew Consent|0|||
105658542|NCT00813098|364414198|FG001|Overall Study|Withdrew Consent|1|||
105658543|NCT00813098|364414199|FG002|Overall Study|Withdrew Consent|0|||
105658544|NCT00776659|364414205|FG000|Overall Study|Lost to Follow-up|15|||
105658545|NCT00776659|364414205|FG000|Overall Study|Withdrawal by Subject|10|||
105658546|NCT00776659|364414205|FG000|Overall Study|Study Terminated by Sponsor|1|||
105658547|NCT01336205|364414212|FG000|Overall Study|Other|22|||
105658548|NCT01336205|364414213|FG001|Overall Study|Other|9|||
105658549|NCT01336205|364414212|FG000|Overall Study|Lost to Follow-up|40|||
105658550|NCT01336205|364414213|FG001|Overall Study|Lost to Follow-up|20|||
105658551|NCT01336205|364414212|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
105658552|NCT01336205|364414213|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
105658553|NCT01336205|364414212|FG000|Overall Study|Lack of Efficacy|4|||
105658554|NCT01336205|364414213|FG001|Overall Study|Lack of Efficacy|0|||
105658555|NCT01336205|364414212|FG000|Overall Study|Severe noncompliance with protocol|9|||
105658556|NCT01336205|364414213|FG001|Overall Study|Severe noncompliance with protocol|2|||
105658557|NCT01336205|364414212|FG000|Overall Study|Adverse Event|56|||
105658558|NCT01336205|364414213|FG001|Overall Study|Adverse Event|6|||
105658559|NCT01336205|364414212|FG000|Overall Study|Death|1|||
105658560|NCT01336205|364414213|FG001|Overall Study|Death|1|||
105658561|NCT01336205|364414212|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
105658562|NCT01336205|364414213|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
105658563|NCT01336205|364414212|FG000|Overall Study|Withdrawal by Subject|72|||
105658564|NCT01336205|364414213|FG001|Overall Study|Withdrawal by Subject|38|||
105658565|NCT01336205|364414212|FG000|Overall Study|Did not receive treatment|4|||
105658566|NCT01336205|364414213|FG001|Overall Study|Did not receive treatment|0|||
105658567|NCT01006616|364414214|FG000|Period 1 (6 Months)|Adverse Event|10|||
105658568|NCT01006616|364414215|FG001|Period 1 (6 Months)|Adverse Event|31|||
105658569|NCT01006616|364414216|FG002|Period 1 (6 Months)|Adverse Event|37|||
105658570|NCT01006616|364414217|FG003|Period 1 (6 Months)|Adverse Event|9|||
105658571|NCT01006616|364414214|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
105658572|NCT01006616|364414215|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
105658573|NCT01006616|364414216|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
105658574|NCT01006616|364414217|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
105658575|NCT01006616|364414214|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
105658576|NCT01006616|364414215|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
105658577|NCT01006616|364414216|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
105658578|NCT01006616|364414217|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
105658579|NCT01006616|364414214|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
105658580|NCT01006616|364414215|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
105658581|NCT01006616|364414216|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
105658582|NCT01006616|364414217|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
105658583|NCT01006616|364414214|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
105658584|NCT01006616|364414215|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
105658585|NCT01006616|364414216|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
105658586|NCT01006616|364414217|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
105658587|NCT01006616|364414214|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
105658588|NCT01006616|364414215|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
105658589|NCT01006616|364414216|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
105658590|NCT01006616|364414217|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
105658591|NCT01006616|364414214|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
105658592|NCT01006616|364414215|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
105658593|NCT01006616|364414216|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
105658594|NCT01006616|364414217|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
105658595|NCT01006616|364414214|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
105658596|NCT01006616|364414215|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
105658597|NCT01006616|364414216|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
105658598|NCT01006616|364414217|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
105658599|NCT01006616|364414214|FG000|Period 1 (6 Months)|Not Treated|0|||
105658600|NCT01006616|364414215|FG001|Period 1 (6 Months)|Not Treated|0|||
105658601|NCT01006616|364414216|FG002|Period 1 (6 Months)|Not Treated|1|||
105658602|NCT01006616|364414217|FG003|Period 1 (6 Months)|Not Treated|1|||
105658603|NCT01006616|364414214|FG000|Period 2 (18 Months)|Adverse Event|6|||
105658604|NCT01006616|364414215|FG001|Period 2 (18 Months)|Adverse Event|6|||
105658605|NCT01006616|364414216|FG002|Period 2 (18 Months)|Adverse Event|6|||
105658606|NCT01006616|364414217|FG003|Period 2 (18 Months)|Adverse Event|4|||
105658607|NCT01006616|364414214|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
105658608|NCT01006616|364414215|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
105658609|NCT01006616|364414216|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
105658610|NCT01006616|364414217|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
105658611|NCT01006616|364414214|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
105658612|NCT01006616|364414215|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
105658613|NCT01006616|364414216|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
105658614|NCT01006616|364414217|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
105658615|NCT01006616|364414214|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
105658616|NCT01006616|364414215|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
105658617|NCT01006616|364414216|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
105658618|NCT01006616|364414217|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
105658619|NCT01006616|364414214|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
105658620|NCT01006616|364414215|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
105658621|NCT01006616|364414216|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
105658622|NCT01006616|364414217|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
105658623|NCT01006616|364414214|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
105658624|NCT01006616|364414215|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
105658625|NCT01006616|364414216|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
105658626|NCT01006616|364414217|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
105658627|NCT01006616|364414214|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
105658628|NCT01006616|364414215|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
105658629|NCT01006616|364414216|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
105658630|NCT01006616|364414217|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
105658631|NCT01006616|364414214|FG000|Period 2 (18 Months)|Study Terminated|63|||
105658632|NCT01006616|364414215|FG001|Period 2 (18 Months)|Study Terminated|46|||
105658633|NCT01006616|364414216|FG002|Period 2 (18 Months)|Study Terminated|44|||
105658634|NCT01006616|364414217|FG003|Period 2 (18 Months)|Study Terminated|70|||
105658635|NCT03672175|364414218|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
105658636|NCT03672175|364414219|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
105658637|NCT03672175|364414220|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
105658638|NCT03672175|364414218|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
105658639|NCT03672175|364414219|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
105658640|NCT03672175|364414220|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
105658641|NCT03672175|364414218|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
105658642|NCT03672175|364414219|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
105658643|NCT03672175|364414220|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
105658644|NCT03672175|364414218|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
105658645|NCT03672175|364414219|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
105658646|NCT03672175|364414220|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
105658647|NCT03672175|364414218|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
105658648|NCT03672175|364414219|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
105658649|NCT03672175|364414220|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
105658650|NCT03672175|364414218|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
105658651|NCT03672175|364414219|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
105658652|NCT03672175|364414220|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
105658653|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
105658654|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
105658655|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
105658656|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
105658657|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
105658658|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
105658659|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
105658660|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
105658661|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
105658662|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
105658663|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
105658664|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
105658665|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
105658666|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
105658667|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
105658668|NCT03672175|364414218|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
105658669|NCT03672175|364414219|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
105658670|NCT03672175|364414220|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
105658671|NCT00129649|364414221|FG000|Overall Study|Withdrawal by Subject|76|||
105658672|NCT00129649|364414222|FG001|Overall Study|Withdrawal by Subject|65|||
105658673|NCT02482935|364414226|FG000|Period 1|Withdrawal by Subject|1|||
105658674|NCT02482935|364414227|FG001|Period 1|Withdrawal by Subject|0|||
105658675|NCT02835092|364414228|FG000|Overall Study|Withdrawal by Subject|3|||
105658676|NCT02835092|364414229|FG001|Overall Study|Withdrawal by Subject|6|||
105658677|NCT02835092|364414230|FG002|Overall Study|Withdrawal by Subject|3|||
105658678|NCT02835092|364414228|FG000|Overall Study|Lost to Follow-up|0|||
105658679|NCT02835092|364414229|FG001|Overall Study|Lost to Follow-up|2|||
105658680|NCT02835092|364414230|FG002|Overall Study|Lost to Follow-up|0|||
105658681|NCT04952701|364414231|FG000|Control Lens|Physician Decision|4|||
105658682|NCT04952701|364414231|FG000|Test Lens|Physician Decision|1|||
105658683|NCT00905034|364414233|FG000|Overall Study|Withdrawal by Subject|1|||
105658684|NCT03409731|364414234|FG000|Overall Study|Withdrawal by Subject|17|||
105658685|NCT03409731|364414234|FG000|Overall Study|Death|4|||
105658686|NCT00217022|364414235|FG000|Overall Study|Withdrawal by Subject|1|||
105658687|NCT00217022|364414236|FG001|Overall Study|Withdrawal by Subject|1|||
105658688|NCT02725567|364414240|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
105658689|NCT02725567|364414241|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
105658690|NCT02725567|364414240|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
105658691|NCT02725567|364414241|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
105658692|NCT02725567|364414240|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
105658693|NCT02725567|364414241|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
105658694|NCT00878553|364414242|FG000|Sleep Study|Withdrawal by Subject|2|||
105658695|NCT00878553|364414243|FG001|Sleep Study|Withdrawal by Subject|0|||
105658696|NCT00878553|364414244|FG002|Sleep Study|Withdrawal by Subject|0|||
105658697|NCT00878553|364414245|FG003|Sleep Study|Withdrawal by Subject|0|||
105658698|NCT00878553|364414246|FG004|Sleep Study|Withdrawal by Subject|0|||
105658699|NCT00878553|364414242|FG000|Sleep Study|Lost to Follow-up|1|||
105658700|NCT00878553|364414243|FG001|Sleep Study|Lost to Follow-up|0|||
105658701|NCT00878553|364414244|FG002|Sleep Study|Lost to Follow-up|0|||
105658702|NCT00878553|364414245|FG003|Sleep Study|Lost to Follow-up|0|||
105658703|NCT00878553|364414246|FG004|Sleep Study|Lost to Follow-up|0|||
105658704|NCT00878553|364414242|FG000|Sleep Study|car accident|1|||
105658705|NCT00878553|364414243|FG001|Sleep Study|car accident|0|||
105658706|NCT00878553|364414244|FG002|Sleep Study|car accident|0|||
105658707|NCT00878553|364414245|FG003|Sleep Study|car accident|0|||
105658708|NCT00878553|364414246|FG004|Sleep Study|car accident|0|||
105658709|NCT00878553|364414242|FG000|Sleep Study|family emergency|1|||
105658710|NCT00878553|364414243|FG001|Sleep Study|family emergency|0|||
105658711|NCT00878553|364414244|FG002|Sleep Study|family emergency|0|||
105658712|NCT00878553|364414245|FG003|Sleep Study|family emergency|0|||
105658713|NCT00878553|364414246|FG004|Sleep Study|family emergency|0|||
105658714|NCT00878553|364414242|FG000|PK Study|Withdrawal by Subject|0|||
105658715|NCT00878553|364414243|FG001|PK Study|Withdrawal by Subject|0|||
105658716|NCT00878553|364414244|FG002|PK Study|Withdrawal by Subject|0|||
105658717|NCT00878553|364414245|FG003|PK Study|Withdrawal by Subject|1|||
105658718|NCT00878553|364414246|FG004|PK Study|Withdrawal by Subject|0|||
105658719|NCT00912223|364414247|FG000|Overall Study|Withdrawal by Subject|1|||
105658720|NCT00912223|364414247|FG000|Overall Study|Not transplanted|1|||
105658721|NCT00912223|364414247|FG000|Overall Study|Transformed disease|1|||
105658722|NCT00623363|364414248|FG000|Overall Study|Adverse Event|2|||
105658723|NCT00623363|364414249|FG001|Overall Study|Adverse Event|2|||
105658724|NCT00621192|364414250|FG000|Overall Study|Withdrawal by Subject|0|||
105658725|NCT00621192|364414251|FG001|Overall Study|Withdrawal by Subject|0|||
105658726|NCT00621192|364414252|FG002|Overall Study|Withdrawal by Subject|2|||
105658727|NCT00621192|364414253|FG003|Overall Study|Withdrawal by Subject|0|||
105658728|NCT00621192|364414250|FG000|Overall Study|Physician Decision|1|||
105658729|NCT00621192|364414251|FG001|Overall Study|Physician Decision|3|||
105658730|NCT00621192|364414252|FG002|Overall Study|Physician Decision|0|||
105658731|NCT00621192|364414253|FG003|Overall Study|Physician Decision|0|||
105658732|NCT00621192|364414250|FG000|Overall Study|Protocol Violation|1|||
105658733|NCT00621192|364414251|FG001|Overall Study|Protocol Violation|0|||
105658734|NCT00621192|364414252|FG002|Overall Study|Protocol Violation|0|||
105658735|NCT00621192|364414253|FG003|Overall Study|Protocol Violation|1|||
105658736|NCT00621192|364414250|FG000|Overall Study|Adverse Event|0|||
105658737|NCT00621192|364414251|FG001|Overall Study|Adverse Event|1|||
105658738|NCT00621192|364414252|FG002|Overall Study|Adverse Event|0|||
105658739|NCT00621192|364414253|FG003|Overall Study|Adverse Event|1|||
105658740|NCT00621192|364414250|FG000|Overall Study|Death|2|||
105658741|NCT00621192|364414251|FG001|Overall Study|Death|5|||
105658742|NCT00621192|364414252|FG002|Overall Study|Death|0|||
105658743|NCT00621192|364414253|FG003|Overall Study|Death|0|||
105658744|NCT00621192|364414250|FG000|Overall Study|Final Assessments not Completed|0|||
105658745|NCT00621192|364414251|FG001|Overall Study|Final Assessments not Completed|0|||
105658746|NCT00621192|364414252|FG002|Overall Study|Final Assessments not Completed|3|||
105658747|NCT00621192|364414253|FG003|Overall Study|Final Assessments not Completed|1|||
105658748|NCT02725528|364414254|FG000|Overall Study|Lost to Follow-up|1|||
105658749|NCT02725528|364414255|FG001|Overall Study|Lost to Follow-up|4|||
105658750|NCT02725528|364414254|FG000|Overall Study|Withdrawal by Subject|0|||
105658751|NCT02725528|364414255|FG001|Overall Study|Withdrawal by Subject|1|||
105658752|NCT01781832|364414256|FG000|Overall Study|Withdrawal by Subject|1|||
105658753|NCT01163474|364414257|FG000|Overall Study|Withdrawal by Subject|1|||
105658754|NCT01163474|364414257|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
105658755|NCT01163474|364414257|FG000|Overall Study|Lost to Follow-up|3|||
105658756|NCT00087555|364414258|FG000|Overall Study|Adverse Event|3|||
105658757|NCT00087555|364414259|FG001|Overall Study|Adverse Event|6|||
105658758|NCT00087555|364414260|FG002|Overall Study|Adverse Event|14|||
105658759|NCT00087555|364414258|FG000|Overall Study|Lost to Follow-up|0|||
105658760|NCT00087555|364414259|FG001|Overall Study|Lost to Follow-up|1|||
105658761|NCT00087555|364414260|FG002|Overall Study|Lost to Follow-up|1|||
105658762|NCT00087555|364414258|FG000|Overall Study|Non - Compliance|1|||
105658763|NCT00087555|364414259|FG001|Overall Study|Non - Compliance|0|||
105658764|NCT00087555|364414260|FG002|Overall Study|Non - Compliance|0|||
105658765|NCT00087555|364414258|FG000|Overall Study|Protocol Violation|0|||
105658766|NCT00087555|364414259|FG001|Overall Study|Protocol Violation|0|||
105658767|NCT00087555|364414260|FG002|Overall Study|Protocol Violation|2|||
105658768|NCT00087555|364414258|FG000|Overall Study|Screen Failure|1|||
105658769|NCT00087555|364414259|FG001|Overall Study|Screen Failure|1|||
105658770|NCT00087555|364414260|FG002|Overall Study|Screen Failure|0|||
105658771|NCT00087555|364414258|FG000|Overall Study|Pregnancy|0|||
105658772|NCT00087555|364414259|FG001|Overall Study|Pregnancy|1|||
105658773|NCT00087555|364414260|FG002|Overall Study|Pregnancy|1|||
105658774|NCT00087555|364414258|FG000|Overall Study|Withdrawal by Subject|3|||
105658775|NCT00087555|364414259|FG001|Overall Study|Withdrawal by Subject|2|||
105658776|NCT00087555|364414260|FG002|Overall Study|Withdrawal by Subject|1|||
105658777|NCT00087555|364414258|FG000|Overall Study|Lack of Efficacy|2|||
105658778|NCT00087555|364414259|FG001|Overall Study|Lack of Efficacy|0|||
105658779|NCT00087555|364414260|FG002|Overall Study|Lack of Efficacy|1|||
105658780|NCT00087555|364414258|FG000|Overall Study|Non Compliance|0|||
105658781|NCT00087555|364414259|FG001|Overall Study|Non Compliance|0|||
105658782|NCT00087555|364414260|FG002|Overall Study|Non Compliance|1|||
105658783|NCT00087555|364414258|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
105658784|NCT00087555|364414259|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
105658785|NCT00087555|364414260|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
105658786|NCT00087555|364414258|FG000|Overall Study|Patient wanted to go back on Med|1|||
105658787|NCT00087555|364414259|FG001|Overall Study|Patient wanted to go back on Med|0|||
105658788|NCT00087555|364414260|FG002|Overall Study|Patient wanted to go back on Med|0|||
105658789|NCT02024750|364414261|FG000|Overall Study|Withdrawal by Subject|2|||
105658790|NCT02024750|364414262|FG001|Overall Study|Withdrawal by Subject|1|||
105658791|NCT01161628|364414263|FG000|Overall Study|Death|6|||
105658792|NCT01161628|364414263|FG000|Overall Study|Lack of Efficacy|2|||
105658793|NCT03029819|364414264|FG000|Overall Study|Lost to Follow-up|3|||
105658794|NCT03029819|364414265|FG001|Overall Study|Lost to Follow-up|5|||
105658795|NCT03029819|364414264|FG000|Overall Study|Removed due to disruptive behavior|0|||
105658796|NCT03029819|364414265|FG001|Overall Study|Removed due to disruptive behavior|1|||
105658797|NCT03797989|364414275|FG000|VAC069A|Withdrawal by Subject|0|||
105658798|NCT03797989|364414276|FG001|VAC069A|Withdrawal by Subject|0|||
105658799|NCT03797989|364414277|FG002|VAC069A|Withdrawal by Subject|1|||
105658800|NCT03797989|364414278|FG003|VAC069A|Withdrawal by Subject|0|||
105658801|NCT03797989|364414279|FG004|VAC069A|Withdrawal by Subject|0|||
105658802|NCT03797989|364414280|FG005|VAC069A|Withdrawal by Subject|0|||
105658803|NCT03797989|364414281|FG006|VAC069A|Withdrawal by Subject|0|||
105658804|NCT03797989|364414282|FG007|VAC069A|Withdrawal by Subject|0|||
105658805|NCT03797989|364414283|FG008|VAC069A|Withdrawal by Subject|0|||
105658806|NCT03797989|364414284|FG009|VAC069A|Withdrawal by Subject|0|||
105658807|NCT03797989|364414285|FG010|VAC069A|Withdrawal by Subject|0|||
105658808|NCT03797989|364414286|FG011|VAC069A|Withdrawal by Subject|0|||
105658809|NCT00604188|364414287|FG000|Overall Study|Adverse Event|1|||
105658810|NCT00604188|364414288|FG001|Overall Study|Adverse Event|4|||
105658811|NCT00604188|364414287|FG000|Overall Study|Lost to Follow-up|17|||
105658812|NCT00604188|364414288|FG001|Overall Study|Lost to Follow-up|15|||
105658813|NCT00604188|364414287|FG000|Overall Study|Withdrawal by Subject|5|||
105658814|NCT00604188|364414288|FG001|Overall Study|Withdrawal by Subject|1|||
105658815|NCT00604188|364414287|FG000|Overall Study|Non-compliance with protocol|4|||
105658816|NCT00604188|364414288|FG001|Overall Study|Non-compliance with protocol|4|||
105658817|NCT00604188|364414287|FG000|Overall Study|Did not receive study drug|0|||
105658818|NCT00604188|364414288|FG001|Overall Study|Did not receive study drug|1|||
105658819|NCT02647645|364414289|FG000|Overall Study|Lost to Follow-up|2|||
105658820|NCT02647645|364414290|FG001|Overall Study|Lost to Follow-up|1|||
105658821|NCT00664105|364415648|FG000|Overall Study|Death|3|||
105658822|NCT00664105|364415648|FG000|Overall Study|Withdrawal by Subject|5|||
105658823|NCT00664105|364415648|FG000|Overall Study|Adverse Event|9|||
105658824|NCT00664105|364415648|FG000|Overall Study|Disease progression|7|||
105658825|NCT03602586|364415649|FG000|Overall Study|Withdrawal by Subject|3|||
105658826|NCT00362375|364415650|FG000|Overall Study|Lost to Follow-up|40|||
105658827|NCT00362375|364415651|FG001|Overall Study|Lost to Follow-up|35|||
105658828|NCT02106195|364415652|FG000|Overall Study|Adverse Event|2|||
105658829|NCT02106195|364415652|FG000|Overall Study|Protocol Violation|1|||
105658830|NCT00943618|364415653|FG000|Overall Study|Lost to Follow-up|38|||
105658831|NCT00943618|364415654|FG001|Overall Study|Lost to Follow-up|48|||
105658832|NCT00943618|364415655|FG002|Overall Study|Lost to Follow-up|20|||
105658833|NCT00943618|364415653|FG000|Overall Study|Discontinued Medication|17|||
105658834|NCT00943618|364415654|FG001|Overall Study|Discontinued Medication|29|||
105658835|NCT00943618|364415655|FG002|Overall Study|Discontinued Medication|11|||
105658836|NCT03062449|364415658|FG000|Overall Study|Withdrawal by Subject|7|||
105658837|NCT03062449|364415659|FG001|Overall Study|Withdrawal by Subject|1|||
105658838|NCT04014790|364415662|FG000|Overall Study|Death|4|||
105658839|NCT04014790|364415662|FG000|Overall Study|Adverse Event|1|||
105658840|NCT04014790|364415662|FG000|Overall Study|Withdrawal by Subject|1|||
105658841|NCT01004185|364415665|FG000|Overall Study|Adverse Event|1|||
105658842|NCT01004185|364415666|FG001|Overall Study|Adverse Event|1|||
105658843|NCT01004185|364415665|FG000|Overall Study|Lost to Follow-up|0|||
105658844|NCT01004185|364415666|FG001|Overall Study|Lost to Follow-up|1|||
105658845|NCT01004185|364415665|FG000|Overall Study|Lack of Efficacy|2|||
105658846|NCT01004185|364415666|FG001|Overall Study|Lack of Efficacy|1|||
105658847|NCT01004185|364415665|FG000|Overall Study|Sponsor Terminated Study|4|||
105658848|NCT01004185|364415666|FG001|Overall Study|Sponsor Terminated Study|5|||
105658849|NCT01004185|364415665|FG000|Overall Study|Withdrawal by Subject|2|||
105658850|NCT01004185|364415666|FG001|Overall Study|Withdrawal by Subject|1|||
105658851|NCT01379703|364415667|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
105658852|NCT01379703|364415668|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
105658853|NCT01379703|364415669|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
105658854|NCT01379703|364415667|FG000|Study Start Through 9 Months|Adverse Event|0|||
105658855|NCT01379703|364415668|FG001|Study Start Through 9 Months|Adverse Event|14|||
105658856|NCT01379703|364415669|FG002|Study Start Through 9 Months|Adverse Event|10|||
105658857|NCT01379703|364415667|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
105658858|NCT01379703|364415668|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
105658859|NCT01379703|364415669|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
105658860|NCT01379703|364415667|FG000|Study Start Through 9 Months|Treatment Failure|0|||
105658861|NCT01379703|364415668|FG001|Study Start Through 9 Months|Treatment Failure|2|||
105658862|NCT01379703|364415669|FG002|Study Start Through 9 Months|Treatment Failure|2|||
105658863|NCT01379703|364415667|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
105658864|NCT01379703|364415668|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
105658865|NCT01379703|364415669|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
105658866|NCT01379703|364415667|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
105658867|NCT01379703|364415668|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
105658868|NCT01379703|364415669|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
105658869|NCT01379703|364415667|FG000|Study Start Through 9 Months|Medication not available|0|||
105658870|NCT01379703|364415668|FG001|Study Start Through 9 Months|Medication not available|2|||
105658871|NCT01379703|364415669|FG002|Study Start Through 9 Months|Medication not available|1|||
105658872|NCT01379703|364415667|FG000|Study Start Through 9 Months|Poor general condition|0|||
105658873|NCT01379703|364415668|FG001|Study Start Through 9 Months|Poor general condition|1|||
105658874|NCT01379703|364415669|FG002|Study Start Through 9 Months|Poor general condition|0|||
105658875|NCT01379703|364415667|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
105658876|NCT01379703|364415668|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
105658877|NCT01379703|364415669|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
105768765|NCT03399786|364804541|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
105768766|NCT03399786|364804542|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
105658878|NCT01379703|364415667|FG000|Study Start Through 9 Months|Reason unknown|2|||
105768767|NCT03399786|364804539|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
105768768|NCT03399786|364804540|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
105658879|NCT01379703|364415668|FG001|Study Start Through 9 Months|Reason unknown|31|||
105658880|NCT01379703|364415669|FG002|Study Start Through 9 Months|Reason unknown|24|||
105658881|NCT01379703|364415667|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
105658882|NCT01379703|364415668|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
105658883|NCT01379703|364415669|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
105658884|NCT01379703|364415667|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
105658885|NCT01379703|364415668|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
105658886|NCT01379703|364415669|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
105658887|NCT01379703|364415667|FG000|9 Months Through 18 Months|Adverse Event|0|||
105658888|NCT01379703|364415668|FG001|9 Months Through 18 Months|Adverse Event|6|||
105658889|NCT01379703|364415669|FG002|9 Months Through 18 Months|Adverse Event|0|||
105658890|NCT01379703|364415667|FG000|9 Months Through 18 Months|Treatment failure|0|||
105658891|NCT01379703|364415668|FG001|9 Months Through 18 Months|Treatment failure|5|||
105658892|NCT01379703|364415669|FG002|9 Months Through 18 Months|Treatment failure|0|||
105658893|NCT01379703|364415667|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
105658894|NCT01379703|364415668|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
105658895|NCT01379703|364415669|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
105658896|NCT01379703|364415667|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
105658897|NCT01379703|364415668|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
105658898|NCT01379703|364415669|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
105658899|NCT01379703|364415667|FG000|9 Months Through 18 Months|Fatigue|0|||
105658900|NCT01379703|364415668|FG001|9 Months Through 18 Months|Fatigue|1|||
105658901|NCT01379703|364415669|FG002|9 Months Through 18 Months|Fatigue|0|||
105658902|NCT01379703|364415667|FG000|9 Months Through 18 Months|Reason Unknown|0|||
105658903|NCT01379703|364415668|FG001|9 Months Through 18 Months|Reason Unknown|23|||
105658904|NCT01379703|364415669|FG002|9 Months Through 18 Months|Reason Unknown|0|||
105658905|NCT03481556|364415670|FG000|Overall Study|Adverse Event|1|||
105658906|NCT03481556|364415671|FG001|Overall Study|Adverse Event|0|||
105658907|NCT03481556|364415672|FG002|Overall Study|Adverse Event|0|||
105658908|NCT03481556|364415673|FG003|Overall Study|Adverse Event|0|||
105658909|NCT03481556|364415670|FG000|Overall Study|Death|4|||
105658910|NCT03481556|364415671|FG001|Overall Study|Death|2|||
105658911|NCT03481556|364415672|FG002|Overall Study|Death|3|||
105658912|NCT03481556|364415673|FG003|Overall Study|Death|16|||
105658913|NCT03481556|364415670|FG000|Overall Study|Study Terminated by Sponsor|10|||
105658914|NCT03481556|364415671|FG001|Overall Study|Study Terminated by Sponsor|5|||
105658915|NCT03481556|364415672|FG002|Overall Study|Study Terminated by Sponsor|2|||
105658916|NCT03481556|364415673|FG003|Overall Study|Study Terminated by Sponsor|9|||
105658917|NCT01172639|364415674|FG000|Overall Study|Death|1|||
105658918|NCT01172639|364415675|FG001|Overall Study|Death|1|||
105658919|NCT01172639|364415676|FG002|Overall Study|Death|0|||
105658920|NCT01172639|364415677|FG003|Overall Study|Death|0|||
105658921|NCT01172639|364415678|FG004|Overall Study|Death|0|||
105658922|NCT01172639|364415674|FG000|Overall Study|Lost to Follow-up|9|||
105658923|NCT01172639|364415675|FG001|Overall Study|Lost to Follow-up|7|||
105658924|NCT01172639|364415676|FG002|Overall Study|Lost to Follow-up|11|||
105658925|NCT01172639|364415677|FG003|Overall Study|Lost to Follow-up|6|||
105658926|NCT01172639|364415678|FG004|Overall Study|Lost to Follow-up|6|||
105658927|NCT01172639|364415674|FG000|Overall Study|Withdrawal by Subject|3|||
105658928|NCT01172639|364415675|FG001|Overall Study|Withdrawal by Subject|3|||
105658929|NCT01172639|364415676|FG002|Overall Study|Withdrawal by Subject|5|||
105658930|NCT01172639|364415677|FG003|Overall Study|Withdrawal by Subject|5|||
105658931|NCT01172639|364415678|FG004|Overall Study|Withdrawal by Subject|0|||
105658932|NCT01316887|364415679|FG000|Overall Study|Adverse Event|13|||
105658933|NCT01316887|364415680|FG001|Overall Study|Adverse Event|21|||
105658934|NCT01316887|364415681|FG002|Overall Study|Adverse Event|17|||
105658935|NCT01316887|364415679|FG000|Overall Study|Lack of Efficacy|9|||
105658936|NCT01316887|364415680|FG001|Overall Study|Lack of Efficacy|3|||
105658937|NCT01316887|364415681|FG002|Overall Study|Lack of Efficacy|1|||
105658938|NCT01316887|364415679|FG000|Overall Study|Protocol Violation|2|||
105658939|NCT01316887|364415680|FG001|Overall Study|Protocol Violation|6|||
105658940|NCT01316887|364415681|FG002|Overall Study|Protocol Violation|6|||
105658941|NCT01316887|364415679|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
105658942|NCT01316887|364415680|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
105658943|NCT01316887|364415681|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
105658944|NCT01316887|364415679|FG000|Overall Study|Study Closed/Terminated|2|||
105658945|NCT01316887|364415680|FG001|Overall Study|Study Closed/Terminated|4|||
105658946|NCT01316887|364415681|FG002|Overall Study|Study Closed/Terminated|3|||
105658947|NCT01316887|364415679|FG000|Overall Study|Lost to Follow-up|1|||
105658948|NCT01316887|364415680|FG001|Overall Study|Lost to Follow-up|7|||
105658949|NCT01316887|364415681|FG002|Overall Study|Lost to Follow-up|5|||
105658950|NCT01316887|364415679|FG000|Overall Study|Withdrawal by Subject|8|||
105658951|NCT01316887|364415680|FG001|Overall Study|Withdrawal by Subject|16|||
105658952|NCT01316887|364415681|FG002|Overall Study|Withdrawal by Subject|15|||
105658953|NCT00469456|364415682|FG000|Overall Study|Adverse Event|4|||
105658954|NCT00469456|364415683|FG001|Overall Study|Adverse Event|3|||
105658955|NCT00469456|364415682|FG000|Overall Study|Protocol Violation|1|||
105658956|NCT00469456|364415683|FG001|Overall Study|Protocol Violation|0|||
105658957|NCT00469456|364415682|FG000|Overall Study|Withdrawal by Subject|4|||
105658958|NCT00469456|364415683|FG001|Overall Study|Withdrawal by Subject|1|||
105658959|NCT00704171|364415687|FG000|Overall Study|Withdrawal by Subject|1|||
105658960|NCT00704171|364415688|FG001|Overall Study|Withdrawal by Subject|0|||
105658961|NCT03634839|364415689|FG000|First Intervention (2 Hours)|Adverse Event|0|||
105658962|NCT03634839|364415690|FG001|First Intervention (2 Hours)|Adverse Event|2|||
105658963|NCT02647788|364415691|FG000|Overall Study|Lost to Follow-up|13|||
105658964|NCT02647788|364415692|FG001|Overall Study|Lost to Follow-up|11|||
105658965|NCT02647788|364415691|FG000|Overall Study|Did not want opiate|0|||
105658966|NCT02647788|364415692|FG001|Overall Study|Did not want opiate|1|||
105658967|NCT02647788|364415691|FG000|Overall Study|Withdrawal by Subject|1|||
105658968|NCT02647788|364415692|FG001|Overall Study|Withdrawal by Subject|0|||
105658969|NCT02647788|364415691|FG000|Overall Study|Felt itchy with assigned medication|1|||
105658970|NCT02647788|364415692|FG001|Overall Study|Felt itchy with assigned medication|0|||
105658971|NCT02647788|364415691|FG000|Overall Study|Felt nauseous with assigned medication|1|||
105658972|NCT02647788|364415692|FG001|Overall Study|Felt nauseous with assigned medication|1|||
105658973|NCT00233389|364415693|FG000|Overall Study|Adverse Event|5|||
105658974|NCT00233389|364415694|FG001|Overall Study|Adverse Event|5|||
105658975|NCT00233389|364415693|FG000|Overall Study|Lack of Efficacy|11|||
105658976|NCT00233389|364415694|FG001|Overall Study|Lack of Efficacy|8|||
105658977|NCT00233389|364415693|FG000|Overall Study|Lost to Follow-up|1|||
105658978|NCT00233389|364415694|FG001|Overall Study|Lost to Follow-up|1|||
105658979|NCT00233389|364415693|FG000|Overall Study|Physician Decision|1|||
105658980|NCT00233389|364415694|FG001|Overall Study|Physician Decision|0|||
105658981|NCT00233389|364415693|FG000|Overall Study|Protocol Violation|0|||
105658982|NCT00233389|364415694|FG001|Overall Study|Protocol Violation|1|||
105658983|NCT00233389|364415693|FG000|Overall Study|Withdrawal by Subject|0|||
105658984|NCT00233389|364415694|FG001|Overall Study|Withdrawal by Subject|1|||
105658985|NCT01898442|364415695|FG000|Overall Study|Hemolysis/technical problems|1|||
105658986|NCT01898442|364415696|FG001|Overall Study|Hemolysis/technical problems|2|||
105658987|NCT01898442|364415697|FG002|Overall Study|Hemolysis/technical problems|2|||
105658988|NCT01898442|364415695|FG000|Overall Study|Patient vomited pills|0|||
105658989|NCT01898442|364415696|FG001|Overall Study|Patient vomited pills|0|||
105658990|NCT01898442|364415697|FG002|Overall Study|Patient vomited pills|1|||
105658991|NCT00255944|364415698|FG000|Overall Study|Lost to Follow-up|797|||
105658992|NCT00255944|364415699|FG001|Overall Study|Lost to Follow-up|834|||
105658993|NCT05178979|364415700|FG000|Overall Study|Death|0|||
105658994|NCT05178979|364415701|FG001|Overall Study|Death|5|||
105658995|NCT05178979|364415702|FG002|Overall Study|Death|0|||
105658996|NCT05178979|364415703|FG003|Overall Study|Death|3|||
105658997|NCT05178979|364415700|FG000|Overall Study|Adverse Event|0|||
105658998|NCT05178979|364415701|FG001|Overall Study|Adverse Event|1|||
105658999|NCT05178979|364415702|FG002|Overall Study|Adverse Event|0|||
105659000|NCT05178979|364415703|FG003|Overall Study|Adverse Event|0|||
105659001|NCT05178979|364415700|FG000|Overall Study|Lost to Follow-up|1|||
105659002|NCT05178979|364415701|FG001|Overall Study|Lost to Follow-up|8|||
105659003|NCT05178979|364415702|FG002|Overall Study|Lost to Follow-up|3|||
105659004|NCT05178979|364415703|FG003|Overall Study|Lost to Follow-up|8|||
105659005|NCT01129115|364415705|FG000|Overall Study|Adverse Event|1|||
105659006|NCT01129115|364415706|FG001|Overall Study|Adverse Event|2|||
105659007|NCT01129115|364415707|FG002|Overall Study|Adverse Event|3|||
105659008|NCT01129115|364415708|FG003|Overall Study|Adverse Event|3|||
105659009|NCT01129115|364415705|FG000|Overall Study|Withdrawal by Subject|1|||
105659010|NCT01129115|364415706|FG001|Overall Study|Withdrawal by Subject|3|||
105659011|NCT01129115|364415707|FG002|Overall Study|Withdrawal by Subject|1|||
105659012|NCT01129115|364415708|FG003|Overall Study|Withdrawal by Subject|4|||
105659013|NCT01129115|364415705|FG000|Overall Study|Protocol Violation|0|||
105878670|NCT00030901|365208045|FG002|Randomization|Ineligible|14|||
105659014|NCT01129115|364415706|FG001|Overall Study|Protocol Violation|2|||
105659015|NCT01129115|364415707|FG002|Overall Study|Protocol Violation|2|||
105659016|NCT01129115|364415708|FG003|Overall Study|Protocol Violation|2|||
105659017|NCT01747837|364415710|FG000|Overall Study|Lost to Follow-up|5|||
105659018|NCT01747837|364415711|FG001|Overall Study|Lost to Follow-up|2|||
105659019|NCT01747837|364415710|FG000|Overall Study|Death|4|||
105659020|NCT01747837|364415711|FG001|Overall Study|Death|4|||
105659021|NCT00817336|364415713|FG000|Overall Study|Withdrawal by Subject|1|||
105659022|NCT00817336|364415714|FG001|Overall Study|Withdrawal by Subject|1|||
105659023|NCT01435798|364415715|FG000|Overall Study|Withdrawal by Subject|1|||
105659024|NCT02108652|364415716|FG000|Overall Study|Death|253|||
105659025|NCT02108652|364415716|FG000|Overall Study|Lost to Follow-up|2|||
105659026|NCT02108652|364415716|FG000|Overall Study|Withdrawal by Subject|16|||
105659027|NCT02108652|364415716|FG000|Overall Study|Study Terminated By Sponsor|31|||
105659028|NCT02108652|364415716|FG000|Overall Study|Non-Compliance|1|||
105659029|NCT02108652|364415716|FG000|Overall Study|Physician Decision|6|||
105659030|NCT02108652|364415716|FG000|Overall Study|Progression Of Disease|1|||
105659031|NCT01182181|364415717|FG000|First Intervention|Adverse Event|1|||
105659032|NCT01182181|364415718|FG001|First Intervention|Adverse Event|0|||
105659033|NCT01182181|364415717|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
105659034|NCT01182181|364415718|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
105659035|NCT01121913|364415719|FG000|First Intervention Period|Adverse Event|0|||
105659036|NCT01121913|364415720|FG001|First Intervention Period|Adverse Event|0|||
105659037|NCT01121913|364415721|FG002|First Intervention Period|Adverse Event|1|||
105659038|NCT01121913|364415722|FG003|First Intervention Period|Adverse Event|0|||
105659039|NCT01121913|364415719|FG000|First Washout Period|Withdrawal by Subject|1|||
105659040|NCT01121913|364415720|FG001|First Washout Period|Withdrawal by Subject|0|||
105659041|NCT01121913|364415721|FG002|First Washout Period|Withdrawal by Subject|0|||
105659042|NCT01121913|364415722|FG003|First Washout Period|Withdrawal by Subject|0|||
105659043|NCT01121913|364415719|FG000|Second Intervention Period|Adverse Event|0|||
105659044|NCT01121913|364415720|FG001|Second Intervention Period|Adverse Event|0|||
105659045|NCT01121913|364415721|FG002|Second Intervention Period|Adverse Event|1|||
105659046|NCT01121913|364415722|FG003|Second Intervention Period|Adverse Event|0|||
105659047|NCT01121913|364415719|FG000|Second Washout Period|Withdrawal by Subject|0|||
105659048|NCT01121913|364415720|FG001|Second Washout Period|Withdrawal by Subject|0|||
105659049|NCT01121913|364415721|FG002|Second Washout Period|Withdrawal by Subject|1|||
105659050|NCT01121913|364415722|FG003|Second Washout Period|Withdrawal by Subject|0|||
105659051|NCT01121913|364415719|FG000|Third Washout Period|Adverse Event|1|||
105659052|NCT01121913|364415720|FG001|Third Washout Period|Adverse Event|0|||
105659053|NCT01121913|364415721|FG002|Third Washout Period|Adverse Event|0|||
105659054|NCT01121913|364415722|FG003|Third Washout Period|Adverse Event|0|||
105659055|NCT03845075|364415723|FG000|Part 1 - DB|Withdrawal by Subject|1|||
105659056|NCT03845075|364415724|FG001|Part 1 - DB|Withdrawal by Subject|1|||
105659057|NCT03845075|364415725|FG002|Part 1 - DB|Withdrawal by Subject|0|||
105659058|NCT03845075|364415726|FG003|Part 1 - DB|Withdrawal by Subject|0|||
105659059|NCT03845075|364415723|FG000|Part 1 - DB|Adverse Event|0|||
105659060|NCT03845075|364415724|FG001|Part 1 - DB|Adverse Event|1|||
105659061|NCT03845075|364415725|FG002|Part 1 - DB|Adverse Event|0|||
105659062|NCT03845075|364415726|FG003|Part 1 - DB|Adverse Event|0|||
105659063|NCT03845075|364415723|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
105659064|NCT03845075|364415724|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
105659065|NCT03845075|364415725|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
105659066|NCT03845075|364415726|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
105659067|NCT00935259|364415727|FG000|Period 1|Administrative (scheduling conflict)|1|||
105659068|NCT00935259|364415728|FG001|Period 1|Administrative (scheduling conflict)|1|||
105659069|NCT02019641|364415729|FG000|10-Week Follow up|Withdrawal by investigator|2|||
105659070|NCT02019641|364415730|FG001|10-Week Follow up|Withdrawal by investigator|0|||
105659071|NCT02019641|364415731|FG002|10-Week Follow up|Withdrawal by investigator|0|||
105659072|NCT02019641|364415729|FG000|10-Week Follow up|Withdrawal by Subject|1|||
105659073|NCT02019641|364415730|FG001|10-Week Follow up|Withdrawal by Subject|1|||
105659074|NCT02019641|364415731|FG002|10-Week Follow up|Withdrawal by Subject|0|||
105659075|NCT02019641|364415729|FG000|20-Week Follow up|Withdrawal by investigator|0|||
105659076|NCT02019641|364415730|FG001|20-Week Follow up|Withdrawal by investigator|0|||
105659077|NCT02019641|364415731|FG002|20-Week Follow up|Withdrawal by investigator|1|||
105659078|NCT06390826|364415732|FG000|Overall Study|Never Start Protocol Therapy|1|||
105659079|NCT06390826|364415732|FG000|Overall Study|Adverse Event|1|||
105659080|NCT06390826|364415732|FG000|Overall Study|Disease Progression|8|||
105659081|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659082|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659083|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
105659084|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659085|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659086|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659087|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
105659088|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
105659089|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
105659090|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
105659091|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
105659092|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
105659093|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
105659094|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
105659095|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
105659096|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
105659097|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659098|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659099|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
105659100|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
105659101|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659102|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659103|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659104|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
105659105|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
105659106|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
105659107|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
105659108|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
105659109|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
105659110|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
105659111|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
105659112|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
105659113|NCT00937521|364415734|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
105659114|NCT00937521|364415735|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659115|NCT00937521|364415736|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105768769|NCT03399786|364804541|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
105768770|NCT03399786|364804542|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
105768771|NCT00887068|364804549|FG000|Overall Study|Withdrawal by Subject|2|||
105768772|NCT00887068|364804550|FG001|Overall Study|Withdrawal by Subject|0|||
105768773|NCT00887068|364804549|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
105768774|NCT00887068|364804550|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
105768775|NCT01388491|364804556|FG000|Overall Study|Adverse Event|10|||
105768776|NCT01388491|364804557|FG001|Overall Study|Adverse Event|9|||
105768777|NCT01388491|364804556|FG000|Overall Study|Sponsor Request|9|||
105768778|NCT01388491|364804557|FG001|Overall Study|Sponsor Request|7|||
105768779|NCT01388491|364804556|FG000|Overall Study|Withdrawal by Subject|6|||
105768780|NCT01388491|364804557|FG001|Overall Study|Withdrawal by Subject|10|||
105768781|NCT01388491|364804556|FG000|Overall Study|Lost to Follow-up|4|||
105768782|NCT01388491|364804557|FG001|Overall Study|Lost to Follow-up|3|||
105768783|NCT01388491|364804556|FG000|Overall Study|Protocol Violation|2|||
105768784|NCT01388491|364804557|FG001|Overall Study|Protocol Violation|0|||
105768785|NCT01388491|364804556|FG000|Overall Study|Noncompliance|2|||
105768786|NCT01388491|364804557|FG001|Overall Study|Noncompliance|0|||
105768787|NCT01388491|364804556|FG000|Overall Study|Pregnancy|1|||
105768788|NCT01388491|364804557|FG001|Overall Study|Pregnancy|0|||
105768789|NCT02116361|364804562|FG000|Overall Study|Pregnancy|0|||
105768790|NCT02116361|364804563|FG001|Overall Study|Pregnancy|0|||
105768791|NCT02116361|364804564|FG002|Overall Study|Pregnancy|0|||
105768792|NCT02116361|364804565|FG003|Overall Study|Pregnancy|1|||
105768793|NCT02116361|364804562|FG000|Overall Study|Protocol Violation|1|||
105768794|NCT02116361|364804563|FG001|Overall Study|Protocol Violation|0|||
105768795|NCT02116361|364804564|FG002|Overall Study|Protocol Violation|0|||
105768796|NCT02116361|364804565|FG003|Overall Study|Protocol Violation|2|||
105768797|NCT02116361|364804562|FG000|Overall Study|Physician Decision|2|||
105768798|NCT02116361|364804563|FG001|Overall Study|Physician Decision|3|||
105768799|NCT02116361|364804564|FG002|Overall Study|Physician Decision|0|||
105768800|NCT02116361|364804565|FG003|Overall Study|Physician Decision|0|||
105768801|NCT02116361|364804562|FG000|Overall Study|Adverse Event|1|||
105768802|NCT02116361|364804563|FG001|Overall Study|Adverse Event|0|||
105768803|NCT02116361|364804564|FG002|Overall Study|Adverse Event|0|||
105768804|NCT02116361|364804565|FG003|Overall Study|Adverse Event|3|||
105768805|NCT02116361|364804562|FG000|Overall Study|Other Reasons|3|||
105768806|NCT02116361|364804563|FG001|Overall Study|Other Reasons|3|||
105768807|NCT02116361|364804564|FG002|Overall Study|Other Reasons|3|||
105768808|NCT02116361|364804565|FG003|Overall Study|Other Reasons|3|||
105768809|NCT02116361|364804562|FG000|Overall Study|Lack of Efficacy|5|||
105768810|NCT02116361|364804563|FG001|Overall Study|Lack of Efficacy|7|||
105768811|NCT02116361|364804564|FG002|Overall Study|Lack of Efficacy|4|||
105768812|NCT02116361|364804565|FG003|Overall Study|Lack of Efficacy|3|||
105768813|NCT02116361|364804562|FG000|Overall Study|Lost to Follow-up|4|||
105768814|NCT02116361|364804563|FG001|Overall Study|Lost to Follow-up|5|||
105768815|NCT02116361|364804564|FG002|Overall Study|Lost to Follow-up|7|||
105768816|NCT02116361|364804565|FG003|Overall Study|Lost to Follow-up|5|||
105768817|NCT02116361|364804562|FG000|Overall Study|Personal Reasons|6|||
105768818|NCT02116361|364804563|FG001|Overall Study|Personal Reasons|6|||
105768819|NCT02116361|364804564|FG002|Overall Study|Personal Reasons|4|||
105768820|NCT02116361|364804565|FG003|Overall Study|Personal Reasons|9|||
105768821|NCT02116361|364804562|FG000|Overall Study|Investigator Decision - Relapse|9|||
105768822|NCT02116361|364804563|FG001|Overall Study|Investigator Decision - Relapse|7|||
105768823|NCT02116361|364804564|FG002|Overall Study|Investigator Decision - Relapse|8|||
105768824|NCT02116361|364804565|FG003|Overall Study|Investigator Decision - Relapse|5|||
105768825|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
105768826|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
105768827|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
105768828|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
105768829|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
105768830|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
105768831|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
105768832|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
105768833|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
105768834|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
105768835|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
105768836|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
105768837|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
105768838|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105768839|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105768840|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
105768841|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
105768842|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
105768843|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
105768844|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
105768845|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
105768846|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
105768847|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
105768848|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
105768849|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
105768850|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
105768851|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
105768852|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
105768853|NCT03227224|364804566|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
105768854|NCT03227224|364804567|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
105768855|NCT03227224|364804568|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
105768856|NCT03227224|364804569|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
105768857|NCT03227224|364804566|FG000|Follow-up Phase (2 Weeks)|Other|4|||
105768858|NCT03227224|364804567|FG001|Follow-up Phase (2 Weeks)|Other|4|||
105768859|NCT03227224|364804568|FG002|Follow-up Phase (2 Weeks)|Other|6|||
105768860|NCT03227224|364804569|FG003|Follow-up Phase (2 Weeks)|Other|3|||
105768861|NCT02406027|364804570|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768862|NCT02406027|364804571|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
105768863|NCT02406027|364804572|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
105768864|NCT02406027|364804573|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768865|NCT02406027|364804574|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768866|NCT02406027|364804575|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768867|NCT02406027|364804576|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
105768868|NCT02406027|364804570|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
105768869|NCT02406027|364804571|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768870|NCT02406027|364804572|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
105768871|NCT02406027|364804573|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768872|NCT02406027|364804574|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768873|NCT02406027|364804575|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768874|NCT02406027|364804576|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
105768875|NCT02406027|364804570|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
105768876|NCT02406027|364804571|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
105768877|NCT02406027|364804572|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
105768878|NCT02406027|364804573|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
105768879|NCT02406027|364804574|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
105768880|NCT02406027|364804575|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
105768881|NCT02406027|364804576|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
105768882|NCT02406027|364804570|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
105768883|NCT02406027|364804571|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768884|NCT02406027|364804572|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
105768885|NCT02406027|364804573|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768886|NCT02406027|364804574|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768887|NCT02406027|364804575|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768888|NCT02406027|364804576|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
105768889|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
105768890|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
105768891|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
105768892|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
105768893|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
105768894|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
105768895|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
105768896|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
105768897|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
105768898|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
105768899|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
105768900|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
105768901|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
105768902|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
105768903|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
105768904|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
105768905|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
105768906|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
105768907|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
105768908|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
105768909|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
105768910|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
105768911|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
105768912|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
105768913|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
105768914|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
105768915|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
105768916|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
105768917|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768918|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768919|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768920|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768921|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768922|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
105768923|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
105768924|NCT02406027|364804570|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768925|NCT02406027|364804571|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768926|NCT02406027|364804572|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768927|NCT02406027|364804573|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768928|NCT02406027|364804574|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
105768929|NCT02406027|364804575|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768930|NCT02406027|364804576|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
105768931|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
105768932|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
105768933|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
105768934|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
105768935|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Other|13|||
105768936|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
105768937|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
105768938|NCT02497287|364804577|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
105768939|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
105768940|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
105768941|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
105768942|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
105768943|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
105768944|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
105768945|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
105768946|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
105768947|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
105768948|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
105768949|NCT02497287|364804577|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
105768950|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
105768951|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
105768952|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
105768953|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
105768954|NCT02497287|364804577|FG000|Follow-up Phase (4 Week)|Other|1|||
105768955|NCT02254304|364804583|FG000|Overall Study|Adverse Event|2|||
105768956|NCT02254304|364804584|FG001|Overall Study|Adverse Event|1|||
105768957|NCT02254304|364804583|FG000|Overall Study|Lost to Follow-up|2|||
105768958|NCT02254304|364804584|FG001|Overall Study|Lost to Follow-up|2|||
105768959|NCT02254304|364804583|FG000|Overall Study|Protocol Violation|1|||
105768960|NCT02254304|364804584|FG001|Overall Study|Protocol Violation|0|||
105768961|NCT02254304|364804583|FG000|Overall Study|Withdrawal by Subject|3|||
105768962|NCT02254304|364804584|FG001|Overall Study|Withdrawal by Subject|0|||
105768963|NCT02254304|364804583|FG000|Overall Study|Injection site pain and Injection fear|1|||
105768964|NCT02254304|364804584|FG001|Overall Study|Injection site pain and Injection fear|0|||
105768965|NCT02254304|364804583|FG000|Overall Study|Personal causes|4|||
105768966|NCT02254304|364804584|FG001|Overall Study|Personal causes|1|||
105768967|NCT02254304|364804583|FG000|Overall Study|Personal decision|1|||
105768968|NCT02254304|364804584|FG001|Overall Study|Personal decision|0|||
105768969|NCT00464620|364805679|FG000|Overall Study|Physician Decision|1|||
105768970|NCT00464620|364805680|FG001|Overall Study|Physician Decision|0|||
105768971|NCT00464620|364805681|FG002|Overall Study|Physician Decision|0|||
105768972|NCT00464620|364805679|FG000|Overall Study|Withdrawal by Subject|1|||
105768973|NCT00464620|364805680|FG001|Overall Study|Withdrawal by Subject|0|||
105768974|NCT00464620|364805681|FG002|Overall Study|Withdrawal by Subject|3|||
105768975|NCT00464620|364805679|FG000|Overall Study|Ineligible sarcoma subtype|0|||
105768976|NCT00464620|364805680|FG001|Overall Study|Ineligible sarcoma subtype|2|||
105768977|NCT00464620|364805681|FG002|Overall Study|Ineligible sarcoma subtype|2|||
105768978|NCT00464620|364805679|FG000|Overall Study|Use of prohibited concomitant medication|0|||
105768979|NCT00464620|364805680|FG001|Overall Study|Use of prohibited concomitant medication|0|||
105768980|NCT00464620|364805681|FG002|Overall Study|Use of prohibited concomitant medication|2|||
105768981|NCT01080625|364805688|FG000|Overall Study|Physician Decision|0|||
105768982|NCT01080625|364805689|FG001|Overall Study|Physician Decision|2|||
105768983|NCT01080625|364805690|FG002|Overall Study|Physician Decision|1|||
105768984|NCT00589602|364805694|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
105768985|NCT03887052|364805702|FG000|Overall Study|Adverse Event|2|||
105768986|NCT03887052|364805702|FG000|Overall Study|Physician Decision|2|||
105768987|NCT03887052|364805702|FG000|Overall Study|Withdrawal by Subject|3|||
105768988|NCT03887052|364805702|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
105768989|NCT03887052|364805702|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
105768990|NCT03687827|364805704|FG000|Treatment Period 1|Death|0|||
105768991|NCT03687827|364805705|FG001|Treatment Period 1|Death|1|||
105768992|NCT03687827|364805704|FG000|Treatment Period 1|Lost to Follow-up|2|||
105768993|NCT03687827|364805705|FG001|Treatment Period 1|Lost to Follow-up|2|||
105768994|NCT03687827|364805704|FG000|Treatment Period 1|Physician Decision|5|||
105768995|NCT03687827|364805705|FG001|Treatment Period 1|Physician Decision|2|||
105768996|NCT03687827|364805704|FG000|Treatment Period 1|Withdrawal by Subject|7|||
105768997|NCT03687827|364805705|FG001|Treatment Period 1|Withdrawal by Subject|3|||
105768998|NCT03687827|364805704|FG000|Treatment Period 2|Physician Decision|4|||
105768999|NCT03687827|364805705|FG001|Treatment Period 2|Physician Decision|1|||
105769000|NCT03687827|364805704|FG000|Treatment Period 2|Withdrawal by Subject|1|||
105769001|NCT03687827|364805705|FG001|Treatment Period 2|Withdrawal by Subject|2|||
105769002|NCT00068822|364805706|FG000|First Randomized Intervention|Lost to Follow-up|1|||
105769003|NCT00068822|364805707|FG001|First Randomized Intervention|Lost to Follow-up|2|||
105769004|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
105769005|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
105769006|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
105769007|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
105769008|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
105769009|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
105769010|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
105769011|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
105769012|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
105769013|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
105769014|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
105769015|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
105769016|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
105769017|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
105769018|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
105769019|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
105769020|NCT01291511|364805708|FG000|Cross-Titration and Stabilization Phase|Death|1|||
105769021|NCT01291511|364805709|FG001|Cross-Titration and Stabilization Phase|Death|0|||
105769022|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
105769023|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
105769024|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
105769025|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
105769026|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
105769027|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
105769028|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
105769029|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
105769030|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
105769031|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
105769032|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
105769033|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
105769034|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
105769035|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
105769036|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
105769037|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
105769038|NCT01291511|364805708|FG000|Double-blind Relapse Prevention Phase|Death|1|||
105769039|NCT01291511|364805709|FG001|Double-blind Relapse Prevention Phase|Death|0|||
105769040|NCT00981292|364805710|FG000|Day 1|Protocol Violation|1|||
105769041|NCT00981292|364805711|FG001|Day 1|Protocol Violation|0|||
105769042|NCT00981292|364805712|FG002|Day 1|Protocol Violation|0|||
105769043|NCT00981292|364805713|FG003|Day 1|Protocol Violation|0|||
105769044|NCT00981292|364805714|FG004|Day 1|Protocol Violation|0|||
105769045|NCT00981292|364805715|FG005|Day 1|Protocol Violation|2|||
105769046|NCT00981292|364805710|FG000|Day 2|Protocol Violation|2|||
105769047|NCT00981292|364805711|FG001|Day 2|Protocol Violation|0|||
105769048|NCT00981292|364805712|FG002|Day 2|Protocol Violation|0|||
105769049|NCT00981292|364805713|FG003|Day 2|Protocol Violation|0|||
105769050|NCT00981292|364805714|FG004|Day 2|Protocol Violation|0|||
105769051|NCT00981292|364805715|FG005|Day 2|Protocol Violation|0|||
105769052|NCT00981292|364805710|FG000|Day 3|Protocol Violation|0|||
105769053|NCT00981292|364805711|FG001|Day 3|Protocol Violation|0|||
105769054|NCT00981292|364805712|FG002|Day 3|Protocol Violation|0|||
105769055|NCT00981292|364805713|FG003|Day 3|Protocol Violation|0|||
105769056|NCT00981292|364805714|FG004|Day 3|Protocol Violation|0|||
105769057|NCT00981292|364805715|FG005|Day 3|Protocol Violation|1|||
105769058|NCT00939341|364805716|FG000|Overall Study|Adverse Event|15|||
105769059|NCT00939341|364805716|FG000|Overall Study|Pregnancy|1|||
105769060|NCT00939341|364805716|FG000|Overall Study|Lost to Follow-up|23|||
105769061|NCT00939341|364805716|FG000|Overall Study|Withdrawal by Subject|13|||
105769062|NCT00939341|364805716|FG000|Overall Study|Protocol Violation|6|||
105769063|NCT00939341|364805716|FG000|Overall Study|Incorrect enrolment|8|||
105769064|NCT01131130|364805717|FG000|Period 1 - Baseline|Pregnancy|1|||
105769065|NCT01131130|364805717|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
105769066|NCT00557323|364805720|FG000|Overall Study|Death|3|||
105769067|NCT00557323|364805720|FG000|Overall Study|Withdrawal by Subject|2|||
105769068|NCT00557323|364805720|FG000|Overall Study|Administrative change|2|||
105769069|NCT00498368|364805730|FG000|Overall Study|Withdrawal by Subject|3|||
105769070|NCT00498368|364805731|FG001|Overall Study|Withdrawal by Subject|2|||
105769071|NCT02266004|364805732|FG000|Overall Study|unrelated adverse event|1|||
105769072|NCT02266004|364805732|FG000|Overall Study|Physician Decision|1|||
105769073|NCT02736929|364805734|FG000|Main Study|Lost to Follow-up|7|||
105769074|NCT02736929|364805735|FG001|Main Study|Lost to Follow-up|1|||
105769075|NCT02736929|364805736|FG002|Main Study|Lost to Follow-up|0|||
105769076|NCT02736929|364805734|FG000|Main Study|Withdrawal by Subject|1|||
105769077|NCT02736929|364805735|FG001|Main Study|Withdrawal by Subject|1|||
105769078|NCT02736929|364805736|FG002|Main Study|Withdrawal by Subject|0|||
105769079|NCT02736929|364805734|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
105769080|NCT02736929|364805735|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
105769081|NCT02736929|364805736|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
105769082|NCT00610207|364805737|FG000|Overall Study|Lost to Follow-up|3|||
105769083|NCT03369704|364805741|FG000|Treatment Epoch|technical problems|1|||
105769084|NCT03369704|364805742|FG001|Treatment Epoch|technical problems|0|||
105769085|NCT03369704|364805741|FG000|Treatment Epoch|Protocol Violation|1|||
105769086|NCT03369704|364805742|FG001|Treatment Epoch|Protocol Violation|0|||
105769087|NCT03369704|364805741|FG000|Treatment Epoch|Lost to Follow-up|0|||
105769088|NCT03369704|364805742|FG001|Treatment Epoch|Lost to Follow-up|1|||
105769089|NCT03369704|364805741|FG000|Treatment Epoch|Lack of Efficacy|0|||
105769090|NCT03369704|364805742|FG001|Treatment Epoch|Lack of Efficacy|2|||
105769091|NCT03369704|364805741|FG000|Treatment Epoch|Adverse Event|2|||
105769092|NCT03369704|364805742|FG001|Treatment Epoch|Adverse Event|0|||
105769093|NCT03369704|364805741|FG000|Follow-up Epoch|Lost to Follow-up|1|||
105769094|NCT03369704|364805742|FG001|Follow-up Epoch|Lost to Follow-up|0|||
105769095|NCT01600105|364805743|FG000|Total Participants|Withdrawal by Subject|1|||
105769096|NCT01600105|364805744|FG001|Total Participants|Withdrawal by Subject|0|||
105769097|NCT01600105|364805743|FG000|Total Participants|No images in PACS|10|||
105769098|NCT01600105|364805744|FG001|Total Participants|No images in PACS|0|||
105769099|NCT01600105|364805743|FG000|Total Participants|Insufficient image quality|30|||
105769100|NCT01600105|364805744|FG001|Total Participants|Insufficient image quality|10|||
105769101|NCT01600105|364805743|FG000|Sub Study I|Insufficient image quality|0|||
105769102|NCT01600105|364805744|FG001|Sub Study I|Insufficient image quality|10|||
105769103|NCT01600105|364805743|FG000|Sub Study II|Withdrawal by Subject|1|||
105769104|NCT01600105|364805744|FG001|Sub Study II|Withdrawal by Subject|0|||
105769105|NCT01600105|364805743|FG000|Sub Study II|No images in PACS|1|||
105769106|NCT01600105|364805744|FG001|Sub Study II|No images in PACS|0|||
105769107|NCT01600105|364805743|FG000|Sub Study II|Insufficient image quality|3|||
105769108|NCT01600105|364805744|FG001|Sub Study II|Insufficient image quality|0|||
105769109|NCT01600105|364805743|FG000|Sub Study III|Insufficient image quality|5|||
105769110|NCT01600105|364805744|FG001|Sub Study III|Insufficient image quality|0|||
105769111|NCT01600105|364805743|FG000|Sub Study V|Poor Image Quality|2|||
105769112|NCT01600105|364805744|FG001|Sub Study V|Poor Image Quality|0|||
105769113|NCT04007367|364805745|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
105769114|NCT04007367|364805746|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
105769115|NCT04007367|364805747|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
105769116|NCT04007367|364805745|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
105769117|NCT04007367|364805746|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
105769118|NCT04007367|364805747|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
105769119|NCT04007367|364805745|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
105769120|NCT04007367|364805746|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
105769121|NCT04007367|364805747|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
105769122|NCT04007367|364805745|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
105769123|NCT04007367|364805746|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
105769124|NCT04007367|364805747|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
105769125|NCT04007367|364805745|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
105769126|NCT04007367|364805746|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
105769127|NCT04007367|364805747|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
105769128|NCT04043416|364805750|FG000|Washout|Change in health condition|0|||
105769129|NCT04043416|364805751|FG001|Washout|Change in health condition|1|||
105769130|NCT02865928|364805752|FG000|Overall Study|Withdrawal by Subject|1|||
105769131|NCT02865928|364805753|FG001|Overall Study|Withdrawal by Subject|0|||
105769132|NCT02865928|364805752|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
105769133|NCT02865928|364805753|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
105769134|NCT02865928|364805752|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
105769135|NCT02865928|364805753|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
105769136|NCT01512693|364805756|FG000|Overall Study|Withdrawal by Subject|0|||
105769137|NCT01512693|364805757|FG001|Overall Study|Withdrawal by Subject|1|||
105769138|NCT01975376|364805758|FG000|Overall Study|Adverse Event|5|||
105769139|NCT01975376|364805759|FG001|Overall Study|Adverse Event|5|||
105769140|NCT01975376|364805758|FG000|Overall Study|Death|65|||
105769141|NCT01975376|364805759|FG001|Overall Study|Death|72|||
105769142|NCT01975376|364805758|FG000|Overall Study|Lost to Follow-up|70|||
105878671|NCT01806051|365208046|FG000|Overall Study|Withdrawal by Subject|6|||
105878672|NCT01205776|365208047|FG000|Overall Study|Lost to Follow-up|53|||
105878673|NCT01205776|365208048|FG001|Overall Study|Lost to Follow-up|61|||
105878674|NCT01205776|365208047|FG000|Overall Study|Withdrawal by Subject|11|||
105878675|NCT01205776|365208048|FG001|Overall Study|Withdrawal by Subject|34|||
105878676|NCT03225105|365208053|FG000|Overall Study|Withdrawal by Subject|1|||
105878677|NCT03225105|365208054|FG001|Overall Study|Withdrawal by Subject|0|||
105878678|NCT03225105|365208055|FG002|Overall Study|Withdrawal by Subject|0|||
105878679|NCT03225105|365208056|FG003|Overall Study|Withdrawal by Subject|0|||
105878680|NCT03225105|365208053|FG000|Overall Study|Death|0|||
105878681|NCT03225105|365208054|FG001|Overall Study|Death|4|||
105878682|NCT03225105|365208055|FG002|Overall Study|Death|2|||
105878683|NCT03225105|365208056|FG003|Overall Study|Death|0|||
105769143|NCT01975376|364805759|FG001|Overall Study|Lost to Follow-up|66|||
105769144|NCT01975376|364805758|FG000|Overall Study|Withdrew consent|68|||
105878684|NCT03225105|365208053|FG000|Overall Study|Study termination per Sponsor Decision|2|||
105878685|NCT03225105|365208054|FG001|Overall Study|Study termination per Sponsor Decision|0|||
105878686|NCT03225105|365208055|FG002|Overall Study|Study termination per Sponsor Decision|3|||
105878687|NCT03225105|365208056|FG003|Overall Study|Study termination per Sponsor Decision|3|||
105878688|NCT04031846|365208057|FG000|Overall Study|Lost to Follow-up|4|||
105878689|NCT04031846|365208058|FG001|Overall Study|Lost to Follow-up|4|||
105878690|NCT04031846|365208057|FG000|Overall Study|Physician Decision|0|||
105878691|NCT04031846|365208058|FG001|Overall Study|Physician Decision|1|||
105878692|NCT04031846|365208057|FG000|Overall Study|Protocol Violation|1|||
105878693|NCT04031846|365208058|FG001|Overall Study|Protocol Violation|1|||
105769145|NCT01975376|364805759|FG001|Overall Study|Withdrew consent|62|||
105769146|NCT01975376|364805758|FG000|Overall Study|Other|2|||
105769147|NCT01975376|364805759|FG001|Overall Study|Other|4|||
105769148|NCT01975376|364805758|FG000|Overall Study|Randomized, Not Treated|16|||
105769149|NCT01975376|364805759|FG001|Overall Study|Randomized, Not Treated|8|||
105769150|NCT02343952|364805762|FG000|Study Treatment|Disease Progression|23|||
105769151|NCT02343952|364805762|FG000|Study Treatment|Death|3|||
105769152|NCT02343952|364805762|FG000|Study Treatment|Adverse Event|19|||
105769153|NCT02343952|364805762|FG000|Study Treatment|Withdrawal by Subject|7|||
105769154|NCT02343952|364805762|FG000|Study Treatment|other complicating Diseases|1|||
105769155|NCT02343952|364805762|FG000|Follow up|Withdrawal by Subject|3|||
105769156|NCT02343952|364805762|FG000|Follow up|Death|33|||
105769157|NCT02343952|364805762|FG000|Follow up|Patient does not meet eligibility for study.|1|||
105769158|NCT02343952|364805762|FG000|Follow up|Research department closed by the practice.|5|||
105769159|NCT02343952|364805762|FG000|Follow up|Patient went home to Russia|1|||
105769160|NCT02343952|364805762|FG000|Follow up|Disease Progression|1|||
105769161|NCT02343952|364805762|FG000|Follow up|study terminated|1|||
105769162|NCT01947894|364805767|FG000|Overall Study|Other|3|||
105769163|NCT01947894|364805768|FG001|Overall Study|Other|4|||
105769164|NCT01947894|364805769|FG002|Overall Study|Other|3|||
105769165|NCT01947894|364805767|FG000|Overall Study|Withdrawal by Subject|12|||
105769166|NCT01947894|364805768|FG001|Overall Study|Withdrawal by Subject|4|||
105769167|NCT01947894|364805769|FG002|Overall Study|Withdrawal by Subject|1|||
105878694|NCT04031846|365208057|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
105878695|NCT04031846|365208058|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
105878696|NCT02431676|365208059|FG000|Overall Study|no lab obtained|0|||
105878697|NCT02431676|365208060|FG001|Overall Study|no lab obtained|1|||
105769168|NCT01947894|364805767|FG000|Overall Study|Death|12|||
105769169|NCT01947894|364805768|FG001|Overall Study|Death|1|||
105769170|NCT01947894|364805769|FG002|Overall Study|Death|0|||
105769171|NCT01947894|364805767|FG000|Overall Study|Physician Decision|2|||
105769172|NCT01947894|364805768|FG001|Overall Study|Physician Decision|0|||
105769173|NCT01947894|364805769|FG002|Overall Study|Physician Decision|0|||
105769174|NCT01947894|364805767|FG000|Overall Study|Adverse Event|5|||
105769175|NCT01947894|364805768|FG001|Overall Study|Adverse Event|1|||
105769176|NCT01947894|364805769|FG002|Overall Study|Adverse Event|0|||
105769177|NCT01947894|364805767|FG000|Overall Study|Switched to other growth hormone brand|53|||
105769178|NCT01947894|364805768|FG001|Overall Study|Switched to other growth hormone brand|8|||
105769179|NCT01947894|364805769|FG002|Overall Study|Switched to other growth hormone brand|23|||
105769180|NCT01302691|364805772|FG000|Overall Study|Adverse Event|2|||
105769181|NCT01302691|364805773|FG001|Overall Study|Adverse Event|0|||
105769182|NCT01302691|364805772|FG000|Overall Study|Death|0|||
105769183|NCT01302691|364805773|FG001|Overall Study|Death|1|||
105769184|NCT01302691|364805772|FG000|Overall Study|Lost to Follow-up|1|||
105769185|NCT01302691|364805773|FG001|Overall Study|Lost to Follow-up|0|||
105769186|NCT01302691|364805772|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
105769187|NCT01302691|364805773|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
105769188|NCT01302691|364805772|FG000|Overall Study|Physician Decision|0|||
105769189|NCT01302691|364805773|FG001|Overall Study|Physician Decision|1|||
105769190|NCT01302691|364805772|FG000|Overall Study|Protocol Violation|1|||
105769191|NCT01302691|364805773|FG001|Overall Study|Protocol Violation|0|||
105769192|NCT00423592|364805774|FG000|Overall Study|Adverse Event (through Week 12)|2|||
105769193|NCT00423592|364805774|FG000|Overall Study|Adverse Event (post Week 12)|5|||
105769194|NCT03446612|364805775|FG000|Overall Study|Protocol defined stopping criteria|0|||
105878698|NCT02431676|365208061|FG002|Overall Study|no lab obtained|2|||
105878699|NCT00571727|365208062|FG000|Overall Study|Did not enter in this study|1|||
105878700|NCT00571727|365208062|FG000|Overall Study|Non-compliance|4|||
105878701|NCT00571727|365208062|FG000|Overall Study|Lost to Follow-up|30|||
105878702|NCT00571727|365208062|FG000|Overall Study|Poor growth|1|||
105878703|NCT00571727|365208062|FG000|Overall Study|Parent/patient decision|2|||
105878704|NCT00571727|365208062|FG000|Overall Study|Participant transferred to commercial drug|14|||
105878705|NCT00571727|365208062|FG000|Overall Study|Unable to provide study drug|6|||
105878706|NCT00571727|365208062|FG000|Overall Study|On-treatment at end of study|8|||
105878707|NCT01777282|365208063|FG000|Overall Study|Persistent Hyperglycemia|0|||
105878708|NCT01777282|365208064|FG001|Overall Study|Persistent Hyperglycemia|0|||
105878709|NCT01777282|365208065|FG002|Overall Study|Persistent Hyperglycemia|1|||
105878710|NCT01777282|365208066|FG003|Overall Study|Persistent Hyperglycemia|0|||
105878711|NCT01777282|365208067|FG004|Overall Study|Persistent Hyperglycemia|0|||
105878712|NCT01777282|365208063|FG000|Overall Study|New Antidiabetic Medication|0|||
105878713|NCT01777282|365208064|FG001|Overall Study|New Antidiabetic Medication|0|||
105878714|NCT01777282|365208065|FG002|Overall Study|New Antidiabetic Medication|1|||
105878715|NCT01777282|365208066|FG003|Overall Study|New Antidiabetic Medication|0|||
105878716|NCT01777282|365208067|FG004|Overall Study|New Antidiabetic Medication|0|||
105769195|NCT03446612|364805776|FG001|Overall Study|Protocol defined stopping criteria|1|||
105769196|NCT03934203|364805779|FG000|Overall Study|Adverse Event|0|||
105769197|NCT03934203|364805780|FG001|Overall Study|Adverse Event|0|||
105769198|NCT03934203|364805781|FG002|Overall Study|Adverse Event|1|||
105878717|NCT01777282|365208063|FG000|Overall Study|Adverse Event|4|||
105878718|NCT01777282|365208064|FG001|Overall Study|Adverse Event|4|||
105878719|NCT01777282|365208065|FG002|Overall Study|Adverse Event|2|||
105878720|NCT01777282|365208066|FG003|Overall Study|Adverse Event|1|||
105878721|NCT01777282|365208067|FG004|Overall Study|Adverse Event|3|||
105878722|NCT01777282|365208063|FG000|Overall Study|Withdrawal by Subject|4|||
105878723|NCT01777282|365208064|FG001|Overall Study|Withdrawal by Subject|0|||
105878724|NCT01777282|365208065|FG002|Overall Study|Withdrawal by Subject|0|||
105878725|NCT01777282|365208066|FG003|Overall Study|Withdrawal by Subject|1|||
105878726|NCT01777282|365208067|FG004|Overall Study|Withdrawal by Subject|2|||
105878727|NCT01777282|365208063|FG000|Overall Study|Protocol Violation|2|||
105878728|NCT01777282|365208064|FG001|Overall Study|Protocol Violation|0|||
105878729|NCT01777282|365208065|FG002|Overall Study|Protocol Violation|1|||
105878730|NCT01777282|365208066|FG003|Overall Study|Protocol Violation|0|||
105878731|NCT01777282|365208067|FG004|Overall Study|Protocol Violation|2|||
105878732|NCT01777282|365208063|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
105878733|NCT01777282|365208064|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
105878734|NCT01777282|365208065|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
105878735|NCT01777282|365208066|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
105878736|NCT01777282|365208067|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
105878737|NCT00764660|365208071|FG000|Overall Study|Adverse Event|6|||
105878738|NCT00764660|365208072|FG001|Overall Study|Adverse Event|3|||
105878739|NCT00764660|365208071|FG000|Overall Study|Lost to Follow-up|3|||
105878740|NCT00764660|365208072|FG001|Overall Study|Lost to Follow-up|4|||
105878741|NCT00764660|365208071|FG000|Overall Study|Withdrawal by Subject|7|||
105878742|NCT00764660|365208072|FG001|Overall Study|Withdrawal by Subject|3|||
105878743|NCT00764660|365208071|FG000|Overall Study|Noncompliance With Protocol|5|||
105878744|NCT00764660|365208072|FG001|Overall Study|Noncompliance With Protocol|1|||
105769199|NCT03934203|364805782|FG003|Overall Study|Adverse Event|0|||
105769200|NCT03934203|364805783|FG004|Overall Study|Adverse Event|1|||
105769201|NCT03934203|364805784|FG005|Overall Study|Adverse Event|0|||
105769202|NCT03934203|364805785|FG006|Overall Study|Adverse Event|2|||
105769203|NCT03934203|364805786|FG007|Overall Study|Adverse Event|0|||
105769204|NCT03934203|364805787|FG008|Overall Study|Adverse Event|0|||
105769205|NCT03934203|364805788|FG009|Overall Study|Adverse Event|0|||
105769206|NCT03934203|364805789|FG010|Overall Study|Adverse Event|0|||
105769207|NCT03934203|364805790|FG011|Overall Study|Adverse Event|0|||
105769208|NCT03934203|364805791|FG012|Overall Study|Adverse Event|0|||
105769209|NCT03934203|364805792|FG013|Overall Study|Adverse Event|1|||
105769210|NCT03934203|364805793|FG014|Overall Study|Adverse Event|0|||
105769211|NCT03796195|364805796|FG000|Overall Study|Study closed early|1|||
105769212|NCT04195750|364805800|FG000|Overall Study|Death|245|||
105878745|NCT00764660|365208071|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
105878746|NCT00764660|365208072|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
105878747|NCT01131455|365208073|FG000|Overall Study|Death of PI|6|||
105878748|NCT01131455|365208074|FG001|Overall Study|Death of PI|4|||
105878749|NCT01131455|365208075|FG002|Overall Study|Death of PI|0|||
105987553|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
105987554|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
105987555|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
105987556|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
105987557|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
105987558|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
105987559|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
105987560|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
105987561|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
105987562|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
105987563|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
105987564|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
105987565|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
105987566|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
105987567|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
105987568|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
105987569|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
105987570|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
105987571|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
105987572|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
105987573|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
105987574|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
105987575|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
105987576|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
105987577|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
105987578|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
105987579|NCT03464019|365614486|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
105987580|NCT03464019|365614487|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
105659116|NCT00937521|364415737|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659117|NCT00937521|364415738|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659118|NCT00937521|364415739|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659119|NCT00937521|364415740|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
105659120|NCT00937521|364415741|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
105659121|NCT00937521|364415734|FG000|Booster Phase|Adverse Event|0|||
105659122|NCT00937521|364415735|FG001|Booster Phase|Adverse Event|0|||
105659123|NCT00937521|364415736|FG002|Booster Phase|Adverse Event|0|||
105659124|NCT00937521|364415737|FG003|Booster Phase|Adverse Event|0|||
105659125|NCT00937521|364415738|FG004|Booster Phase|Adverse Event|0|||
105659126|NCT00937521|364415739|FG005|Booster Phase|Adverse Event|0|||
105659127|NCT00937521|364415740|FG006|Booster Phase|Adverse Event|1|||
105659128|NCT00937521|364415741|FG007|Booster Phase|Adverse Event|0|||
105659129|NCT00937521|364415734|FG000|Booster Phase|Withdrawal by Subject|1|||
105659130|NCT00937521|364415735|FG001|Booster Phase|Withdrawal by Subject|0|||
105659131|NCT00937521|364415736|FG002|Booster Phase|Withdrawal by Subject|0|||
105659132|NCT00937521|364415737|FG003|Booster Phase|Withdrawal by Subject|1|||
105659133|NCT00937521|364415738|FG004|Booster Phase|Withdrawal by Subject|0|||
105659134|NCT00937521|364415739|FG005|Booster Phase|Withdrawal by Subject|0|||
105659135|NCT00937521|364415740|FG006|Booster Phase|Withdrawal by Subject|0|||
105659136|NCT00937521|364415741|FG007|Booster Phase|Withdrawal by Subject|2|||
105659137|NCT00937521|364415734|FG000|Booster Phase|Lost to Follow-up|2|||
105659138|NCT00937521|364415735|FG001|Booster Phase|Lost to Follow-up|2|||
105659139|NCT00937521|364415736|FG002|Booster Phase|Lost to Follow-up|4|||
105659140|NCT00937521|364415737|FG003|Booster Phase|Lost to Follow-up|2|||
105659141|NCT00937521|364415738|FG004|Booster Phase|Lost to Follow-up|4|||
105659142|NCT00937521|364415739|FG005|Booster Phase|Lost to Follow-up|4|||
105659143|NCT00937521|364415740|FG006|Booster Phase|Lost to Follow-up|3|||
105659144|NCT00937521|364415741|FG007|Booster Phase|Lost to Follow-up|0|||
105659145|NCT00937521|364415734|FG000|Booster Phase|Administrative Reason|0|||
105659146|NCT00937521|364415735|FG001|Booster Phase|Administrative Reason|0|||
105659147|NCT00937521|364415736|FG002|Booster Phase|Administrative Reason|1|||
105659148|NCT00937521|364415737|FG003|Booster Phase|Administrative Reason|0|||
105659149|NCT00937521|364415738|FG004|Booster Phase|Administrative Reason|1|||
105659150|NCT00937521|364415739|FG005|Booster Phase|Administrative Reason|1|||
105659151|NCT00937521|364415740|FG006|Booster Phase|Administrative Reason|0|||
105659152|NCT00937521|364415741|FG007|Booster Phase|Administrative Reason|0|||
105659153|NCT00937521|364415734|FG000|Booster Phase|Protocol Deviation|0|||
105659154|NCT00937521|364415735|FG001|Booster Phase|Protocol Deviation|0|||
105659155|NCT00937521|364415736|FG002|Booster Phase|Protocol Deviation|0|||
105659156|NCT00937521|364415737|FG003|Booster Phase|Protocol Deviation|0|||
105659157|NCT00937521|364415738|FG004|Booster Phase|Protocol Deviation|0|||
105659158|NCT00937521|364415739|FG005|Booster Phase|Protocol Deviation|0|||
105659159|NCT00937521|364415740|FG006|Booster Phase|Protocol Deviation|1|||
105659160|NCT00937521|364415741|FG007|Booster Phase|Protocol Deviation|0|||
105659161|NCT00874497|364415745|FG000|Overall Study|Lost to Follow-up|2|||
105659162|NCT00874497|364415746|FG001|Overall Study|Lost to Follow-up|4|||
105659163|NCT00874497|364415745|FG000|Overall Study|Adverse Event|9|||
105659164|NCT00874497|364415746|FG001|Overall Study|Adverse Event|4|||
105659165|NCT00874497|364415745|FG000|Overall Study|Sponsor Discontinued Trial|7|||
105659166|NCT00874497|364415746|FG001|Overall Study|Sponsor Discontinued Trial|3|||
105659167|NCT00874497|364415745|FG000|Overall Study|Met Withdrawal Criteria|4|||
105659168|NCT00874497|364415746|FG001|Overall Study|Met Withdrawal Criteria|2|||
105769213|NCT04195750|364805801|FG001|Overall Study|Death|253|||
105769214|NCT04195750|364805802|FG002|Overall Study|Death|5|||
105659169|NCT00874497|364415745|FG000|Overall Study|Physician Decision|1|||
105659170|NCT00874497|364415746|FG001|Overall Study|Physician Decision|1|||
105659171|NCT00874497|364415745|FG000|Overall Study|Withdrawal by Subject|5|||
105659172|NCT00874497|364415746|FG001|Overall Study|Withdrawal by Subject|4|||
105659173|NCT04035577|364415747|FG000|Overall Study|Lost to Follow-up|1|||
105659174|NCT04035577|364415747|FG000|Overall Study|Withdrawal by Subject|1|||
105659175|NCT00846768|364415748|FG000|Overall Study|Adverse Event|0|||
105659176|NCT00846768|364415749|FG001|Overall Study|Adverse Event|1|||
105659177|NCT00846768|364415750|FG002|Overall Study|Adverse Event|0|||
105659178|NCT00846768|364415751|FG003|Overall Study|Adverse Event|0|||
105659179|NCT01721746|364415752|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
105659180|NCT01721746|364415753|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
105659181|NCT01721746|364415752|FG000|Pre-Treatment|Withdrawal by Subject|1|||
105659182|NCT01721746|364415753|FG001|Pre-Treatment|Withdrawal by Subject|16|||
105659183|NCT01721746|364415752|FG000|Pre-Treatment|Poor/Non-compliance|1|||
105659184|NCT01721746|364415753|FG001|Pre-Treatment|Poor/Non-compliance|0|||
105659185|NCT01721746|364415752|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
105659186|NCT01721746|364415753|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
105659187|NCT01721746|364415752|FG000|Treatment|Disease Progression|192|||
105659188|NCT01721746|364415753|FG001|Treatment|Disease Progression|74|||
105659189|NCT01721746|364415752|FG000|Treatment|Study Drug Toxicity|19|||
105659190|NCT01721746|364415753|FG001|Treatment|Study Drug Toxicity|11|||
105769215|NCT04195750|364805800|FG000|Overall Study|Physician Decision|0|||
105769216|NCT04195750|364805801|FG001|Overall Study|Physician Decision|1|||
105769217|NCT04195750|364805802|FG002|Overall Study|Physician Decision|0|||
105769218|NCT04195750|364805800|FG000|Overall Study|Withdrawal by Subject|9|||
105769219|NCT04195750|364805801|FG001|Overall Study|Withdrawal by Subject|8|||
105769220|NCT04195750|364805802|FG002|Overall Study|Withdrawal by Subject|0|||
105769221|NCT04195750|364805800|FG000|Overall Study|Ongoing|120|||
105769222|NCT04195750|364805801|FG001|Overall Study|Ongoing|110|||
105769223|NCT04195750|364805802|FG002|Overall Study|Ongoing|4|||
105769224|NCT01226472|364805806|FG000|Overall Study|Progressive Disease|1|||
105769225|NCT03573804|364805807|FG000|Overall Study|claustrophobia or MRI table problems|10|||
105987581|NCT03464019|365614488|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
105987582|NCT00193180|365614489|FG000|Overall Study|Lack of Efficacy|1|||
105987583|NCT00193180|365614489|FG000|Overall Study|Adverse Event|8|||
105987584|NCT00193180|365614489|FG000|Overall Study|Protocol Violation|1|||
105987585|NCT01357551|365614490|FG000|Overall Study|Withdrawal by Subject|6|||
105987586|NCT01357551|365614491|FG001|Overall Study|Withdrawal by Subject|4|||
105987587|NCT01357551|365614490|FG000|Overall Study|Death|0|||
105987588|NCT01357551|365614491|FG001|Overall Study|Death|1|||
105987589|NCT01357551|365614490|FG000|Overall Study|Lost to Follow-up|16|||
105987590|NCT01357551|365614491|FG001|Overall Study|Lost to Follow-up|6|||
105987591|NCT01272635|365614492|FG000|Overall Study|Lost to Follow-up|31|||
105987592|NCT01272635|365614493|FG001|Overall Study|Lost to Follow-up|20|||
105987593|NCT01272635|365614494|FG002|Overall Study|Lost to Follow-up|31|||
105987594|NCT01272635|365614495|FG003|Overall Study|Lost to Follow-up|23|||
105987595|NCT00891228|365614498|FG000|Overall Study|Adverse Event|0|||
105987596|NCT00891228|365614499|FG001|Overall Study|Adverse Event|2|||
105987597|NCT00891228|365614500|FG002|Overall Study|Adverse Event|3|||
105987598|NCT00891228|365614498|FG000|Overall Study|Withdrawal by Subject|2|||
105987599|NCT00891228|365614499|FG001|Overall Study|Withdrawal by Subject|4|||
105987600|NCT00891228|365614500|FG002|Overall Study|Withdrawal by Subject|5|||
105987601|NCT00891228|365614498|FG000|Overall Study|Protocol Violation|3|||
105987602|NCT00891228|365614499|FG001|Overall Study|Protocol Violation|1|||
105987603|NCT00891228|365614500|FG002|Overall Study|Protocol Violation|2|||
105987604|NCT00891228|365614498|FG000|Overall Study|Physician Decision|2|||
105987605|NCT00891228|365614499|FG001|Overall Study|Physician Decision|1|||
105987606|NCT00891228|365614500|FG002|Overall Study|Physician Decision|0|||
105987607|NCT00891228|365614498|FG000|Overall Study|Lost to Follow-up|4|||
105987608|NCT00891228|365614499|FG001|Overall Study|Lost to Follow-up|4|||
105987609|NCT00891228|365614500|FG002|Overall Study|Lost to Follow-up|5|||
105987610|NCT00891228|365614498|FG000|Overall Study|Pregnancy|0|||
105987611|NCT00891228|365614499|FG001|Overall Study|Pregnancy|1|||
105987612|NCT00891228|365614500|FG002|Overall Study|Pregnancy|0|||
105987613|NCT04541628|365614503|FG000|Overall Study|Study Terminated|1|||
105987614|NCT04541628|365614504|FG001|Overall Study|Study Terminated|1|||
105987615|NCT04541628|365614505|FG002|Overall Study|Study Terminated|1|||
105987616|NCT02141360|365614507|FG000|Overall Study|Withdrawal by Subject|6|||
105987617|NCT02141360|365614508|FG001|Overall Study|Withdrawal by Subject|0|||
105987618|NCT02141360|365614509|FG002|Overall Study|Withdrawal by Subject|0|||
105987619|NCT02141360|365614507|FG000|Overall Study|Study Terminated before Visit|1|||
105987620|NCT02141360|365614508|FG001|Overall Study|Study Terminated before Visit|0|||
105987621|NCT02141360|365614509|FG002|Overall Study|Study Terminated before Visit|0|||
105987622|NCT00455143|365614512|FG000|Overall Study|Physician Decision|1|||
105987623|NCT00455143|365614512|FG000|Overall Study|Withdrawal by Subject|1|||
105987624|NCT00455143|365614512|FG000|Overall Study|Staff was not avail to follow patient|2|||
105659191|NCT01721746|364415752|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
105987625|NCT00455143|365614512|FG000|Overall Study|No longer met Inclusion Criteria|1|||
105987626|NCT00455143|365614512|FG000|Overall Study|Surgical time, staff not available|1|||
105987627|NCT01423916|365614513|FG000|Overall Study|Adverse Event|5|||
105987628|NCT01423916|365614514|FG001|Overall Study|Adverse Event|9|||
105987629|NCT01423916|365614515|FG002|Overall Study|Adverse Event|2|||
105987630|NCT01423916|365614513|FG000|Overall Study|Met Withdrawal Criteria|1|||
105987631|NCT01423916|365614514|FG001|Overall Study|Met Withdrawal Criteria|1|||
105987632|NCT01423916|365614515|FG002|Overall Study|Met Withdrawal Criteria|1|||
105987633|NCT01423916|365614513|FG000|Overall Study|Physician Decision|1|||
105987634|NCT01423916|365614514|FG001|Overall Study|Physician Decision|0|||
105987635|NCT01423916|365614515|FG002|Overall Study|Physician Decision|1|||
105987636|NCT01423916|365614513|FG000|Overall Study|Withdrawal by Subject|3|||
105987637|NCT01423916|365614514|FG001|Overall Study|Withdrawal by Subject|10|||
105987638|NCT01423916|365614515|FG002|Overall Study|Withdrawal by Subject|3|||
105987639|NCT01423916|365614513|FG000|Overall Study|Protocol Deviation|1|||
105987640|NCT01423916|365614514|FG001|Overall Study|Protocol Deviation|0|||
105987641|NCT01423916|365614515|FG002|Overall Study|Protocol Deviation|0|||
105987642|NCT04856904|365614516|FG000|Overall Study|Physician Decision|1|||
105987643|NCT04856904|365614517|FG001|Overall Study|Physician Decision|1|||
105987644|NCT04856904|365614516|FG000|Overall Study|Withdrawal by Subject|13|||
105987645|NCT04856904|365614517|FG001|Overall Study|Withdrawal by Subject|13|||
105987646|NCT04856904|365614516|FG000|Overall Study|Adverse Event|1|||
105987647|NCT04856904|365614517|FG001|Overall Study|Adverse Event|1|||
105987648|NCT04856904|365614516|FG000|Overall Study|Non-compliance with study drug|1|||
105987649|NCT04856904|365614517|FG001|Overall Study|Non-compliance with study drug|1|||
105987650|NCT04856904|365614516|FG000|Overall Study|Lost to Follow-up|4|||
105987651|NCT04856904|365614517|FG001|Overall Study|Lost to Follow-up|4|||
105987652|NCT04856904|365614516|FG000|Overall Study|Withdrawal by Subject|1|||
105987653|NCT04856904|365614517|FG001|Overall Study|Withdrawal by Subject|1|||
105987654|NCT04856904|365614516|FG000|Overall Study|Protocol Violation|1|||
105987655|NCT04856904|365614517|FG001|Overall Study|Protocol Violation|1|||
105987656|NCT00077649|365614518|FG000|Overall Study|Adverse Event|5|||
105987657|NCT00077649|365614519|FG001|Overall Study|Adverse Event|1|||
105987658|NCT00077649|365614520|FG002|Overall Study|Adverse Event|7|||
105987659|NCT00077649|365614521|FG003|Overall Study|Adverse Event|9|||
105987660|NCT00077649|365614518|FG000|Overall Study|Lack of Efficacy|5|||
105987661|NCT00077649|365614519|FG001|Overall Study|Lack of Efficacy|3|||
105987662|NCT00077649|365614520|FG002|Overall Study|Lack of Efficacy|3|||
105987663|NCT00077649|365614521|FG003|Overall Study|Lack of Efficacy|2|||
105987664|NCT00077649|365614518|FG000|Overall Study|Withdrawal by Subject|0|||
105987665|NCT00077649|365614519|FG001|Overall Study|Withdrawal by Subject|1|||
105987666|NCT00077649|365614520|FG002|Overall Study|Withdrawal by Subject|1|||
105987667|NCT00077649|365614521|FG003|Overall Study|Withdrawal by Subject|2|||
105987668|NCT00077649|365614518|FG000|Overall Study|Lost to Follow-up|2|||
105987669|NCT00077649|365614519|FG001|Overall Study|Lost to Follow-up|2|||
105987670|NCT00077649|365614520|FG002|Overall Study|Lost to Follow-up|3|||
105987671|NCT00077649|365614521|FG003|Overall Study|Lost to Follow-up|2|||
105987672|NCT00077649|365614518|FG000|Overall Study|Abnormality of Laboratory Test|1|||
105987673|NCT00077649|365614519|FG001|Overall Study|Abnormality of Laboratory Test|2|||
105987674|NCT00077649|365614520|FG002|Overall Study|Abnormality of Laboratory Test|1|||
105987675|NCT00077649|365614521|FG003|Overall Study|Abnormality of Laboratory Test|2|||
105987676|NCT00077649|365614518|FG000|Overall Study|Randomized but never dosed|1|||
105987677|NCT00077649|365614519|FG001|Overall Study|Randomized but never dosed|0|||
105987678|NCT00077649|365614520|FG002|Overall Study|Randomized but never dosed|0|||
105987679|NCT00077649|365614521|FG003|Overall Study|Randomized but never dosed|0|||
105987680|NCT01009086|365614527|FG000|Overall Study|Lack of Efficacy|16|||
105987681|NCT01009086|365614528|FG001|Overall Study|Lack of Efficacy|15|||
105987682|NCT01009086|365614529|FG002|Overall Study|Lack of Efficacy|9|||
105987683|NCT01009086|365614527|FG000|Overall Study|Lost to Follow-up|4|||
105987684|NCT01009086|365614528|FG001|Overall Study|Lost to Follow-up|5|||
105987685|NCT01009086|365614529|FG002|Overall Study|Lost to Follow-up|3|||
105987686|NCT01009086|365614527|FG000|Overall Study|Adverse Event|12|||
105987687|NCT01009086|365614528|FG001|Overall Study|Adverse Event|11|||
105987688|NCT01009086|365614529|FG002|Overall Study|Adverse Event|8|||
105987689|NCT01009086|365614527|FG000|Overall Study|Withdrawal by Subject|9|||
105987690|NCT01009086|365614528|FG001|Overall Study|Withdrawal by Subject|11|||
105987691|NCT01009086|365614529|FG002|Overall Study|Withdrawal by Subject|13|||
105987692|NCT01009086|365614527|FG000|Overall Study|Other|3|||
105987693|NCT01009086|365614528|FG001|Overall Study|Other|5|||
105987694|NCT01009086|365614529|FG002|Overall Study|Other|1|||
105987695|NCT01424228|365614530|FG000|Overall Study|Withdrawal by Subject|27|||
105987696|NCT01424228|365614531|FG001|Overall Study|Withdrawal by Subject|11|||
105987697|NCT01424228|365614530|FG000|Overall Study|Adverse Event|10|||
105987698|NCT01424228|365614531|FG001|Overall Study|Adverse Event|14|||
105987699|NCT01424228|365614530|FG000|Overall Study|Sponsor's decision|9|||
105987700|NCT01424228|365614531|FG001|Overall Study|Sponsor's decision|12|||
105987701|NCT01424228|365614530|FG000|Overall Study|Lack of Efficacy|5|||
105987702|NCT01424228|365614531|FG001|Overall Study|Lack of Efficacy|7|||
105987703|NCT01424228|365614530|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
105987704|NCT01424228|365614531|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
105987705|NCT01424228|365614530|FG000|Overall Study|Non-compliance|2|||
105987706|NCT01424228|365614531|FG001|Overall Study|Non-compliance|0|||
105987707|NCT01424228|365614530|FG000|Overall Study|Worsening of symptoms|1|||
105987708|NCT01424228|365614531|FG001|Overall Study|Worsening of symptoms|0|||
105987709|NCT01424228|365614530|FG000|Overall Study|Unplanned journey|0|||
105987710|NCT01424228|365614531|FG001|Overall Study|Unplanned journey|1|||
105987711|NCT01336023|365614534|FG000|Week 0 to Week 26|Adverse Event|8|||
105987712|NCT01336023|365614535|FG001|Week 0 to Week 26|Adverse Event|10|||
105987713|NCT01336023|365614536|FG002|Week 0 to Week 26|Adverse Event|24|||
105987714|NCT01336023|365614534|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
105987715|NCT01336023|365614535|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
105987716|NCT01336023|365614536|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
105987717|NCT01336023|365614534|FG000|Week 0 to Week 26|Protocol Violation|1|||
105987718|NCT01336023|365614535|FG001|Week 0 to Week 26|Protocol Violation|2|||
105987719|NCT01336023|365614536|FG002|Week 0 to Week 26|Protocol Violation|0|||
105987720|NCT01336023|365614534|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
105987721|NCT01336023|365614535|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
105987722|NCT01336023|365614536|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
105987723|NCT01336023|365614534|FG000|Week 0 to Week 26|Unclassified|5|||
105987724|NCT01336023|365614535|FG001|Week 0 to Week 26|Unclassified|16|||
105987725|NCT01336023|365614536|FG002|Week 0 to Week 26|Unclassified|9|||
105987726|NCT01336023|365614534|FG000|Week 27 to 52|Adverse Event|1|||
105987727|NCT01336023|365614535|FG001|Week 27 to 52|Adverse Event|5|||
105987728|NCT01336023|365614536|FG002|Week 27 to 52|Adverse Event|2|||
105987729|NCT01336023|365614534|FG000|Week 27 to 52|Protocol Violation|0|||
105987730|NCT01336023|365614535|FG001|Week 27 to 52|Protocol Violation|2|||
105987731|NCT01336023|365614536|FG002|Week 27 to 52|Protocol Violation|1|||
105987732|NCT01336023|365614534|FG000|Week 27 to 52|Withdrawal Criteria|14|||
105987733|NCT01336023|365614535|FG001|Week 27 to 52|Withdrawal Criteria|19|||
105987734|NCT01336023|365614536|FG002|Week 27 to 52|Withdrawal Criteria|16|||
105987735|NCT01336023|365614534|FG000|Week 27 to 52|Unclassified|13|||
105987736|NCT01336023|365614535|FG001|Week 27 to 52|Unclassified|18|||
105987737|NCT01336023|365614536|FG002|Week 27 to 52|Unclassified|9|||
105987738|NCT01853878|365614540|FG000|Overall Study|Recurrence|2|||
105987739|NCT01853878|365614541|FG001|Overall Study|Recurrence|0|||
105987740|NCT01853878|365614540|FG000|Overall Study|Adverse Event|2|||
105987741|NCT01853878|365614541|FG001|Overall Study|Adverse Event|0|||
105987742|NCT01853878|365614540|FG000|Overall Study|Withdrawal by Subject|3|||
105987743|NCT01853878|365614541|FG001|Overall Study|Withdrawal by Subject|1|||
105987744|NCT01853878|365614540|FG000|Overall Study|Migrated/moved from the study area|1|||
105987745|NCT01853878|365614541|FG001|Overall Study|Migrated/moved from the study area|0|||
105987746|NCT01853878|365614540|FG000|Overall Study|Other|55|||
105987747|NCT01853878|365614541|FG001|Overall Study|Other|43|||
105987748|NCT03997825|365614542|FG000|Overall Study|Death|3|||
105987749|NCT03997825|365614542|FG000|Overall Study|Lost to Follow-up|10|||
105987750|NCT03997825|365614542|FG000|Overall Study|Withdrawal by Subject|3|||
105987751|NCT03997825|365614542|FG000|Overall Study|Refused participation|1|||
105987752|NCT03262441|365614547|FG000|Overall Study|Withdrawal by Subject|1|||
105987753|NCT01196416|365614550|FG000|Overall Study|Withdrawal by Subject|2|||
105987754|NCT05090852|365614551|FG000|Overall Study|Physician Decision|5|||
105987755|NCT03244826|365614552|FG000|Overall Study|Withdrawal by Subject|2|||
105987756|NCT03244826|365614553|FG001|Overall Study|Withdrawal by Subject|0|||
105987757|NCT03244826|365614552|FG000|Overall Study|Transplant delayed or withdrawn|12|||
105987758|NCT03244826|365614553|FG001|Overall Study|Transplant delayed or withdrawn|10|||
105987759|NCT02673684|365614554|FG000|Overall Study|Study not completed d/t loss of funding|9|||
105987760|NCT02673684|365614555|FG001|Overall Study|Study not completed d/t loss of funding|8|||
105987761|NCT02828020|365614559|FG000|Treatment Period|Adverse Event|3|||
105987762|NCT02828020|365614560|FG001|Treatment Period|Adverse Event|1|||
105987763|NCT02828020|365614561|FG002|Treatment Period|Adverse Event|1|||
105987764|NCT02828020|365614559|FG000|Treatment Period|Withdrawal of Consent|10|||
105987765|NCT02828020|365614560|FG001|Treatment Period|Withdrawal of Consent|14|||
105987766|NCT02828020|365614561|FG002|Treatment Period|Withdrawal of Consent|9|||
105987767|NCT02828020|365614559|FG000|Treatment Period|Lost to Follow-up|21|||
105987768|NCT02828020|365614560|FG001|Treatment Period|Lost to Follow-up|24|||
105987769|NCT02828020|365614561|FG002|Treatment Period|Lost to Follow-up|18|||
105987770|NCT02828020|365614559|FG000|Treatment Period|Lack of Qualifying Event|44|||
105987771|NCT02828020|365614560|FG001|Treatment Period|Lack of Qualifying Event|53|||
105987772|NCT02828020|365614561|FG002|Treatment Period|Lack of Qualifying Event|43|||
105987773|NCT02828020|365614559|FG000|Treatment Period|Pregnancy|0|||
105987774|NCT02828020|365614560|FG001|Treatment Period|Pregnancy|2|||
105987775|NCT02828020|365614561|FG002|Treatment Period|Pregnancy|0|||
105987776|NCT02828020|365614559|FG000|Treatment Period|Protocol Violation|2|||
105987777|NCT02828020|365614560|FG001|Treatment Period|Protocol Violation|4|||
105987778|NCT02828020|365614561|FG002|Treatment Period|Protocol Violation|7|||
105987779|NCT02828020|365614559|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
105987780|NCT02828020|365614560|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
105987781|NCT02828020|365614561|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
105987782|NCT02828020|365614559|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
105987783|NCT02828020|365614560|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
105987784|NCT02828020|365614561|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
105987785|NCT02828020|365614559|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
105987786|NCT02828020|365614560|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
105987787|NCT02828020|365614561|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
105987788|NCT02828020|365614559|FG000|Safety Follow-up Period|Protocol Violation|0|||
105987789|NCT02828020|365614560|FG001|Safety Follow-up Period|Protocol Violation|2|||
105987790|NCT02828020|365614561|FG002|Safety Follow-up Period|Protocol Violation|1|||
105987791|NCT02828020|365614559|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
105987792|NCT02828020|365614560|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
105987793|NCT02828020|365614561|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
105987794|NCT03688620|365614562|FG000|Overall Study|Other|0|||
105987795|NCT03688620|365614563|FG001|Overall Study|Other|0|||
105987796|NCT03688620|365614564|FG002|Overall Study|Other|1|||
105987797|NCT03688620|365614562|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
105987798|NCT03688620|365614563|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
105987799|NCT03688620|365614564|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
105987800|NCT03688620|365614562|FG000|Overall Study|Lost to Follow-up|16|||
105987801|NCT03688620|365614563|FG001|Overall Study|Lost to Follow-up|0|||
105987802|NCT03688620|365614564|FG002|Overall Study|Lost to Follow-up|1|||
105987803|NCT03688620|365614562|FG000|Overall Study|Withdrawal by Subject|0|||
105987804|NCT03688620|365614563|FG001|Overall Study|Withdrawal by Subject|0|||
105987805|NCT03688620|365614564|FG002|Overall Study|Withdrawal by Subject|6|||
105987806|NCT01008904|365614565|FG000|Overall Study|Lost to Follow-up|1|||
105987807|NCT01008904|365614565|FG000|Overall Study|Adverse Event|2|||
105987808|NCT01008904|365614565|FG000|Overall Study|unexpected unrelated surgery|1|||
105987809|NCT00379912|365614566|FG000|Overall Study|Lack of Efficacy|1|||
105987810|NCT00379912|365614567|FG001|Overall Study|Lack of Efficacy|0|||
105987811|NCT01138501|365614568|FG000|Overall Study|Protocol Violation|2|||
105987812|NCT01138501|365614568|FG000|Overall Study|Withdrawal by Subject|3|||
105987813|NCT02292706|365614573|FG000|Overall Study|Lost to Follow-up|20|||
105987814|NCT02292706|365614574|FG001|Overall Study|Lost to Follow-up|44|||
105987815|NCT02292706|365614575|FG002|Overall Study|Lost to Follow-up|24|||
105987816|NCT02292706|365614576|FG003|Overall Study|Lost to Follow-up|61|||
105987817|NCT02292706|365614577|FG004|Overall Study|Lost to Follow-up|21|||
105987818|NCT02292706|365614578|FG005|Overall Study|Lost to Follow-up|52|||
105987819|NCT02292706|365614579|FG006|Overall Study|Lost to Follow-up|25|||
105987820|NCT02292706|365614580|FG007|Overall Study|Lost to Follow-up|0|||
105987821|NCT02292706|365614573|FG000|Overall Study|Withdrew consent|15|||
105987822|NCT02292706|365614574|FG001|Overall Study|Withdrew consent|56|||
105987823|NCT02292706|365614575|FG002|Overall Study|Withdrew consent|43|||
105987824|NCT02292706|365614576|FG003|Overall Study|Withdrew consent|36|||
105987825|NCT02292706|365614577|FG004|Overall Study|Withdrew consent|13|||
105987826|NCT02292706|365614578|FG005|Overall Study|Withdrew consent|51|||
105987827|NCT02292706|365614579|FG006|Overall Study|Withdrew consent|20|||
105987828|NCT02292706|365614580|FG007|Overall Study|Withdrew consent|0|||
105987829|NCT02292706|365614573|FG000|Overall Study|Death|3|||
105987830|NCT02292706|365614574|FG001|Overall Study|Death|11|||
105987831|NCT02292706|365614575|FG002|Overall Study|Death|16|||
105987832|NCT02292706|365614576|FG003|Overall Study|Death|22|||
105987833|NCT02292706|365614577|FG004|Overall Study|Death|8|||
105987834|NCT02292706|365614578|FG005|Overall Study|Death|17|||
105987835|NCT02292706|365614579|FG006|Overall Study|Death|3|||
105987836|NCT02292706|365614580|FG007|Overall Study|Death|0|||
105987837|NCT02292706|365614573|FG000|Overall Study|Study terminated by sponsor|0|||
105987838|NCT02292706|365614574|FG001|Overall Study|Study terminated by sponsor|9|||
105987839|NCT02292706|365614575|FG002|Overall Study|Study terminated by sponsor|4|||
105987840|NCT02292706|365614576|FG003|Overall Study|Study terminated by sponsor|21|||
105987841|NCT02292706|365614577|FG004|Overall Study|Study terminated by sponsor|11|||
105987842|NCT02292706|365614578|FG005|Overall Study|Study terminated by sponsor|13|||
105987843|NCT02292706|365614579|FG006|Overall Study|Study terminated by sponsor|3|||
105987844|NCT02292706|365614580|FG007|Overall Study|Study terminated by sponsor|0|||
105987845|NCT02292706|365614573|FG000|Overall Study|Investigator's discretion|4|||
105987846|NCT02292706|365614574|FG001|Overall Study|Investigator's discretion|9|||
105987847|NCT02292706|365614575|FG002|Overall Study|Investigator's discretion|7|||
105987848|NCT02292706|365614576|FG003|Overall Study|Investigator's discretion|11|||
105987849|NCT02292706|365614577|FG004|Overall Study|Investigator's discretion|4|||
105987850|NCT02292706|365614578|FG005|Overall Study|Investigator's discretion|10|||
105987851|NCT02292706|365614579|FG006|Overall Study|Investigator's discretion|1|||
105987852|NCT02292706|365614580|FG007|Overall Study|Investigator's discretion|0|||
105987853|NCT02292706|365614573|FG000|Overall Study|Liver transplant|1|||
105987854|NCT02292706|365614574|FG001|Overall Study|Liver transplant|1|||
105987855|NCT02292706|365614575|FG002|Overall Study|Liver transplant|11|||
105987856|NCT02292706|365614576|FG003|Overall Study|Liver transplant|16|||
105987857|NCT02292706|365614577|FG004|Overall Study|Liver transplant|5|||
105987858|NCT02292706|365614578|FG005|Overall Study|Liver transplant|6|||
105987859|NCT02292706|365614579|FG006|Overall Study|Liver transplant|5|||
105987860|NCT02292706|365614580|FG007|Overall Study|Liver transplant|0|||
105987861|NCT02292706|365614573|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
105987862|NCT02292706|365614574|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
105987863|NCT02292706|365614575|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
105987864|NCT02292706|365614576|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
105987865|NCT02292706|365614577|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
105987866|NCT02292706|365614578|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
105987867|NCT02292706|365614579|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
105987868|NCT02292706|365614580|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
105987869|NCT02292706|365614573|FG000|Overall Study|Subject terminated by sponsor|1|||
105987870|NCT02292706|365614574|FG001|Overall Study|Subject terminated by sponsor|0|||
105987871|NCT02292706|365614575|FG002|Overall Study|Subject terminated by sponsor|0|||
105987872|NCT02292706|365614576|FG003|Overall Study|Subject terminated by sponsor|2|||
105987873|NCT02292706|365614577|FG004|Overall Study|Subject terminated by sponsor|1|||
105987874|NCT02292706|365614578|FG005|Overall Study|Subject terminated by sponsor|0|||
105987875|NCT02292706|365614579|FG006|Overall Study|Subject terminated by sponsor|0|||
105987876|NCT02292706|365614580|FG007|Overall Study|Subject terminated by sponsor|0|||
105987877|NCT02292706|365614573|FG000|Overall Study|Missing|0|||
105987878|NCT02292706|365614574|FG001|Overall Study|Missing|0|||
105987879|NCT02292706|365614575|FG002|Overall Study|Missing|1|||
105987880|NCT02292706|365614576|FG003|Overall Study|Missing|1|||
105987881|NCT02292706|365614577|FG004|Overall Study|Missing|0|||
105987882|NCT02292706|365614578|FG005|Overall Study|Missing|1|||
105987883|NCT02292706|365614579|FG006|Overall Study|Missing|0|||
105987884|NCT02292706|365614580|FG007|Overall Study|Missing|0|||
105987885|NCT02292706|365614573|FG000|Overall Study|Virologic relapse or reinfection|1|||
105987886|NCT02292706|365614574|FG001|Overall Study|Virologic relapse or reinfection|0|||
105987887|NCT02292706|365614575|FG002|Overall Study|Virologic relapse or reinfection|0|||
105987888|NCT02292706|365614576|FG003|Overall Study|Virologic relapse or reinfection|1|||
105987889|NCT02292706|365614577|FG004|Overall Study|Virologic relapse or reinfection|0|||
105987890|NCT02292706|365614578|FG005|Overall Study|Virologic relapse or reinfection|1|||
105987891|NCT02292706|365614579|FG006|Overall Study|Virologic relapse or reinfection|0|||
105987892|NCT02292706|365614580|FG007|Overall Study|Virologic relapse or reinfection|0|||
105987893|NCT01990612|365614581|FG000|Overall Study|Lost to Follow-up|2|||
105987894|NCT01990612|365614582|FG001|Overall Study|Lost to Follow-up|1|||
105987895|NCT01990612|365614581|FG000|Overall Study|Withdrawal by Subject|5|||
105987896|NCT01990612|365614582|FG001|Overall Study|Withdrawal by Subject|2|||
105987897|NCT01630889|365614585|FG000|Overall Study|Death|2|||
105987898|NCT01630889|365614585|FG000|Overall Study|Withdrawal by Subject|1|||
105987899|NCT01630889|365614585|FG000|Overall Study|Other than Specified|2|||
105987900|NCT01630889|365614585|FG000|Overall Study|Lost to Follow-up|4|||
105987901|NCT01630889|365614585|FG000|Overall Study|Other|1|||
105987902|NCT02980133|365614586|FG000|Overall Study|Other than specified|1|||
105987903|NCT02980133|365614587|FG001|Overall Study|Other than specified|1|||
105987904|NCT02980133|365614588|FG002|Overall Study|Other than specified|2|||
105987905|NCT02980133|365614589|FG003|Overall Study|Other than specified|2|||
105987906|NCT02980133|365614586|FG000|Overall Study|Lost to Follow-up|0|||
105987907|NCT02980133|365614587|FG001|Overall Study|Lost to Follow-up|0|||
105987908|NCT02980133|365614588|FG002|Overall Study|Lost to Follow-up|1|||
105987909|NCT02980133|365614589|FG003|Overall Study|Lost to Follow-up|3|||
105987910|NCT02980133|365614586|FG000|Overall Study|Protocol Violation|0|||
105987911|NCT02980133|365614587|FG001|Overall Study|Protocol Violation|1|||
105987912|NCT02980133|365614588|FG002|Overall Study|Protocol Violation|0|||
105987913|NCT02980133|365614589|FG003|Overall Study|Protocol Violation|0|||
105987914|NCT02980133|365614586|FG000|Overall Study|Withdrawal by parent/guardian|6|||
105987915|NCT02980133|365614587|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105987916|NCT02980133|365614588|FG002|Overall Study|Withdrawal by parent/guardian|3|||
105987917|NCT02980133|365614589|FG003|Overall Study|Withdrawal by parent/guardian|1|||
105987918|NCT02980133|365614586|FG000|Overall Study|Withdrawal by Subject|0|||
105987919|NCT02980133|365614587|FG001|Overall Study|Withdrawal by Subject|0|||
105987920|NCT02980133|365614588|FG002|Overall Study|Withdrawal by Subject|1|||
105987921|NCT02980133|365614589|FG003|Overall Study|Withdrawal by Subject|0|||
105987922|NCT01345669|365614596|FG000|Overall Study|Primary tumour recurrence|53|||
105987923|NCT01345669|365614597|FG001|Overall Study|Primary tumour recurrence|32|||
105987924|NCT01345669|365614596|FG000|Overall Study|Second primary tumour|4|||
105987925|NCT01345669|365614597|FG001|Overall Study|Second primary tumour|3|||
105987926|NCT01345669|365614596|FG000|Overall Study|Adverse Event|63|||
105987927|NCT01345669|365614597|FG001|Overall Study|Adverse Event|9|||
105987928|NCT01345669|365614596|FG000|Overall Study|Protocol Violation|3|||
105987929|NCT01345669|365614597|FG001|Overall Study|Protocol Violation|1|||
105987930|NCT01345669|365614596|FG000|Overall Study|Lost to Follow-up|1|||
105987931|NCT01345669|365614597|FG001|Overall Study|Lost to Follow-up|1|||
105987932|NCT01345669|365614596|FG000|Overall Study|Withdrawal by Subject|52|||
105987933|NCT01345669|365614597|FG001|Overall Study|Withdrawal by Subject|13|||
105987934|NCT01345669|365614596|FG000|Overall Study|Other Reasons|111|||
105987935|NCT01345669|365614597|FG001|Overall Study|Other Reasons|60|||
105987936|NCT00118430|365614606|FG000|Overall Study|Withdrawal by Subject|6|||
105987937|NCT00118430|365614607|FG001|Overall Study|Withdrawal by Subject|2|||
105987938|NCT00118430|365614608|FG002|Overall Study|Withdrawal by Subject|0|||
105987939|NCT00118430|365614606|FG000|Overall Study|Lost to Follow-up|15|||
105987940|NCT00118430|365614607|FG001|Overall Study|Lost to Follow-up|22|||
105987941|NCT00118430|365614608|FG002|Overall Study|Lost to Follow-up|28|||
105987942|NCT03890367|365614609|FG000|Overall Study|Withdrawal by parent/guardian|1|||
105987943|NCT03890367|365614610|FG001|Overall Study|Withdrawal by parent/guardian|3|||
105987944|NCT03890367|365614611|FG002|Overall Study|Withdrawal by parent/guardian|0|||
105987945|NCT03890367|365614609|FG000|Overall Study|Protocol deviation|2|||
105987946|NCT03890367|365614610|FG001|Overall Study|Protocol deviation|2|||
105987947|NCT03890367|365614611|FG002|Overall Study|Protocol deviation|1|||
105987948|NCT03890367|365614609|FG000|Overall Study|Lost to Follow-up|1|||
105987949|NCT03890367|365614610|FG001|Overall Study|Lost to Follow-up|1|||
105987950|NCT03890367|365614611|FG002|Overall Study|Lost to Follow-up|0|||
105987951|NCT04412707|365614612|FG000|Cycle 1|Death|0|||
105987952|NCT04412707|365614613|FG001|Cycle 1|Death|3|||
105987953|NCT04412707|365614612|FG000|Cycle 1|Disease progression|1|||
105987954|NCT04412707|365614613|FG001|Cycle 1|Disease progression|2|||
105987955|NCT04412707|365614612|FG000|Cycle 2|Death|0|||
105987956|NCT04412707|365614613|FG001|Cycle 2|Death|1|||
105987957|NCT04412707|365614612|FG000|Cycle 2|Disease progression|3|||
105987958|NCT04412707|365614613|FG001|Cycle 2|Disease progression|0|||
105987959|NCT04412707|365614612|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
105987960|NCT04412707|365614613|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
105987961|NCT04412707|365614612|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
105987962|NCT04412707|365614613|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
105987963|NCT04412707|365614612|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
105987964|NCT04412707|365614613|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
105987965|NCT04412707|365614612|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
105987966|NCT04412707|365614613|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
105987967|NCT00547521|365614614|FG000|Short Term Study (4 Months)|Adverse Event|1|||
105987968|NCT00547521|365614615|FG001|Short Term Study (4 Months)|Adverse Event|0|||
105987969|NCT00547521|365614614|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
105987970|NCT00547521|365614615|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
105987971|NCT00547521|365614614|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
105987972|NCT00547521|365614615|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
105987973|NCT00547521|365614614|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
105987974|NCT00547521|365614615|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
105987975|NCT00547521|365614614|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
105987976|NCT00547521|365614615|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
105987977|NCT00547521|365614614|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
105987978|NCT00547521|365614615|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
105987979|NCT00547521|365614614|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
105987980|NCT00547521|365614615|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
105987981|NCT00547521|365614614|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
105987982|NCT00547521|365614615|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
105987983|NCT00547521|365614614|FG000|Long Term Extension (LTE) Study|Other|0|||
105987984|NCT00547521|365614615|FG001|Long Term Extension (LTE) Study|Other|2|||
105987985|NCT00547521|365614614|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
105987986|NCT00547521|365614615|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
106097400|NCT01715805|366014394|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
106097401|NCT01715805|366014395|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
106097402|NCT01715805|366014396|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
106097403|NCT01715805|366014397|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
106097404|NCT01715805|366014394|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
106097405|NCT01715805|366014395|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
106097406|NCT01715805|366014396|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
106097407|NCT01715805|366014397|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
106097408|NCT01715805|366014394|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
106097409|NCT01715805|366014395|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
106097410|NCT01715805|366014396|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
106097411|NCT01715805|366014397|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
106097412|NCT01715805|366014394|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
106097413|NCT01715805|366014395|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
106097414|NCT01715805|366014396|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
106097415|NCT01715805|366014397|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
106097416|NCT01715805|366014394|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
106097417|NCT01715805|366014395|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
106097418|NCT01715805|366014396|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
106097419|NCT01715805|366014397|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
106097420|NCT01715805|366014394|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
106097421|NCT01715805|366014395|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
106097422|NCT01715805|366014396|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
106097423|NCT01715805|366014397|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
106097424|NCT01715805|366014394|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
106097425|NCT01715805|366014395|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
106097426|NCT01715805|366014396|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
106097427|NCT01715805|366014397|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
106097428|NCT01715805|366014394|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
106097429|NCT01715805|366014395|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
106097430|NCT01715805|366014396|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
106097431|NCT01715805|366014397|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
106097432|NCT01715805|366014394|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
106097433|NCT01715805|366014395|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
106097434|NCT01715805|366014396|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
106097435|NCT01715805|366014397|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
106097436|NCT02647359|366014398|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
106097437|NCT02647359|366014399|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
106097438|NCT02647359|366014398|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
106097439|NCT02647359|366014399|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
106097440|NCT02647359|366014398|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
106097441|NCT02647359|366014399|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
106097442|NCT02647359|366014398|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
106097443|NCT02647359|366014399|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
106097444|NCT02647359|366014398|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
106097445|NCT02647359|366014399|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
106097446|NCT02647359|366014398|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
106097447|NCT02647359|366014399|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
106097448|NCT01310036|366014400|FG000|Overall Study|Administrative/other|10|||
106097449|NCT01310036|366014400|FG000|Overall Study|Withdrew Consent|11|||
106097450|NCT01310036|366014400|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
106097451|NCT01310036|366014400|FG000|Overall Study|Progression of Disease|164|||
106097452|NCT01310036|366014400|FG000|Overall Study|Death|1|||
106097453|NCT01310036|366014400|FG000|Overall Study|Adverse event or intercurrent illness|12|||
106097454|NCT02043782|366014401|FG000|Period 1|Adverse Event|0|||
106097455|NCT02043782|366014402|FG001|Period 1|Adverse Event|0|||
106097456|NCT02043782|366014403|FG002|Period 1|Adverse Event|1|||
106097457|NCT02043782|366014404|FG003|Period 1|Adverse Event|0|||
106097458|NCT02043782|366014405|FG004|Period 1|Adverse Event|0|||
106097459|NCT02043782|366014406|FG005|Period 1|Adverse Event|0|||
106097460|NCT00874029|366014407|FG000|Overall Study|Withdrawal by Subject|10|||
106097461|NCT00874029|366014407|FG000|Overall Study|Pregnancy|4|||
106097462|NCT00874029|366014407|FG000|Overall Study|Physician Decision|1|||
106097463|NCT00874029|366014407|FG000|Overall Study|Adverse Event|1|||
106097464|NCT00874029|366014407|FG000|Overall Study|Lost to Follow-up|5|||
106097465|NCT03359096|366014408|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
106097466|NCT03359096|366014409|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
106097467|NCT03359096|366014408|FG000|First Intervention (4 Weeks)|Death|1|||
106097468|NCT03359096|366014409|FG001|First Intervention (4 Weeks)|Death|0|||
106097469|NCT03359096|366014408|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
106097470|NCT03359096|366014409|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
106097471|NCT00965523|366014410|FG000|Study 221|Progressive Disease|4|||
106097472|NCT00965523|366014410|FG000|Study 221|Physician Decision|3|||
106097473|NCT00965523|366014410|FG000|Study 224|Progressive Disease|5|||
106097474|NCT00965523|366014410|FG000|Study 224|Physician Decision|1|||
106097475|NCT02310750|366014413|FG000|HP Period 1|Lost to Follow-up|0|||
106097476|NCT02310750|366014414|FG001|HP Period 1|Lost to Follow-up|0|||
106097477|NCT02310750|366014415|FG002|HP Period 1|Lost to Follow-up|0|||
106097478|NCT02310750|366014416|FG003|HP Period 1|Lost to Follow-up|0|||
106097479|NCT02310750|366014417|FG004|HP Period 1|Lost to Follow-up|0|||
106097480|NCT02310750|366014418|FG005|HP Period 1|Lost to Follow-up|0|||
106097481|NCT02310750|366014419|FG006|HP Period 1|Lost to Follow-up|1|||
106097482|NCT02310750|366014420|FG007|HP Period 1|Lost to Follow-up|0|||
106097483|NCT02310750|366014421|FG008|HP Period 1|Lost to Follow-up|0|||
106097484|NCT02310750|366014422|FG009|HP Period 1|Lost to Follow-up|0|||
106097485|NCT02310750|366014423|FG010|HP Period 1|Lost to Follow-up|0|||
106097486|NCT02310750|366014424|FG011|HP Period 1|Lost to Follow-up|0|||
106097487|NCT02310750|366014425|FG012|HP Period 1|Lost to Follow-up|0|||
106097488|NCT02310750|366014426|FG013|HP Period 1|Lost to Follow-up|0|||
106097489|NCT02310750|366014427|FG014|HP Period 1|Lost to Follow-up|0|||
106097490|NCT02310750|366014428|FG015|HP Period 1|Lost to Follow-up|0|||
106097491|NCT02310750|366014413|FG000|HP Period 1|Withdrawal by Subject|1|||
106097492|NCT02310750|366014414|FG001|HP Period 1|Withdrawal by Subject|0|||
106097493|NCT02310750|366014415|FG002|HP Period 1|Withdrawal by Subject|0|||
106097494|NCT02310750|366014416|FG003|HP Period 1|Withdrawal by Subject|1|||
106097495|NCT02310750|366014417|FG004|HP Period 1|Withdrawal by Subject|0|||
106097496|NCT02310750|366014418|FG005|HP Period 1|Withdrawal by Subject|0|||
106097497|NCT02310750|366014419|FG006|HP Period 1|Withdrawal by Subject|0|||
106097498|NCT02310750|366014420|FG007|HP Period 1|Withdrawal by Subject|0|||
106097499|NCT02310750|366014421|FG008|HP Period 1|Withdrawal by Subject|0|||
106097500|NCT02310750|366014422|FG009|HP Period 1|Withdrawal by Subject|0|||
106097501|NCT02310750|366014423|FG010|HP Period 1|Withdrawal by Subject|0|||
106097502|NCT02310750|366014424|FG011|HP Period 1|Withdrawal by Subject|0|||
106097503|NCT02310750|366014425|FG012|HP Period 1|Withdrawal by Subject|0|||
106097504|NCT02310750|366014426|FG013|HP Period 1|Withdrawal by Subject|0|||
106097505|NCT02310750|366014427|FG014|HP Period 1|Withdrawal by Subject|0|||
106097506|NCT02310750|366014428|FG015|HP Period 1|Withdrawal by Subject|0|||
106097507|NCT02310750|366014413|FG000|HP Washout 1|Lost to Follow-up|0|||
106097508|NCT02310750|366014414|FG001|HP Washout 1|Lost to Follow-up|0|||
106097509|NCT02310750|366014415|FG002|HP Washout 1|Lost to Follow-up|1|||
106097510|NCT02310750|366014416|FG003|HP Washout 1|Lost to Follow-up|1|||
106097511|NCT02310750|366014417|FG004|HP Washout 1|Lost to Follow-up|2|||
106097512|NCT02310750|366014418|FG005|HP Washout 1|Lost to Follow-up|2|||
106097513|NCT02310750|366014419|FG006|HP Washout 1|Lost to Follow-up|3|||
106097514|NCT02310750|366014420|FG007|HP Washout 1|Lost to Follow-up|0|||
106097515|NCT02310750|366014421|FG008|HP Washout 1|Lost to Follow-up|0|||
106097516|NCT02310750|366014422|FG009|HP Washout 1|Lost to Follow-up|0|||
106097517|NCT02310750|366014423|FG010|HP Washout 1|Lost to Follow-up|0|||
106097518|NCT02310750|366014424|FG011|HP Washout 1|Lost to Follow-up|0|||
106097519|NCT02310750|366014425|FG012|HP Washout 1|Lost to Follow-up|0|||
106097520|NCT02310750|366014426|FG013|HP Washout 1|Lost to Follow-up|0|||
106097521|NCT02310750|366014427|FG014|HP Washout 1|Lost to Follow-up|0|||
106097522|NCT02310750|366014428|FG015|HP Washout 1|Lost to Follow-up|0|||
106097523|NCT02310750|366014413|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097524|NCT02310750|366014414|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097525|NCT02310750|366014415|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097526|NCT02310750|366014416|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
106097527|NCT02310750|366014417|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097528|NCT02310750|366014418|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
106097529|NCT02310750|366014419|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097530|NCT02310750|366014420|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097531|NCT02310750|366014421|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
106097532|NCT02310750|366014422|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
106097533|NCT02310750|366014423|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097534|NCT02310750|366014424|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097535|NCT02310750|366014425|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097536|NCT02310750|366014426|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097537|NCT02310750|366014427|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097538|NCT02310750|366014428|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
106097539|NCT02310750|366014413|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097540|NCT02310750|366014414|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097541|NCT02310750|366014415|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097542|NCT02310750|366014416|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097543|NCT02310750|366014417|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097544|NCT02310750|366014418|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097545|NCT02310750|366014419|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097546|NCT02310750|366014420|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097547|NCT02310750|366014421|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097548|NCT02310750|366014422|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
106097549|NCT02310750|366014423|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097550|NCT02310750|366014424|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097551|NCT02310750|366014425|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097552|NCT02310750|366014426|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097553|NCT02310750|366014427|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097554|NCT02310750|366014428|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
106097555|NCT02310750|366014413|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097556|NCT02310750|366014414|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097557|NCT02310750|366014415|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097558|NCT02310750|366014416|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097559|NCT02310750|366014417|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097560|NCT02310750|366014418|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097561|NCT02310750|366014419|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097562|NCT02310750|366014420|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
106097563|NCT02310750|366014421|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
106097564|NCT02310750|366014422|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
106097565|NCT02310750|366014423|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097566|NCT02310750|366014424|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097567|NCT02310750|366014425|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097568|NCT02310750|366014426|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097569|NCT02310750|366014427|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097570|NCT02310750|366014428|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
106097571|NCT02310750|366014413|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097572|NCT02310750|366014414|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097573|NCT02310750|366014415|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097574|NCT02310750|366014416|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097575|NCT02310750|366014417|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097576|NCT02310750|366014418|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097577|NCT02310750|366014419|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097578|NCT02310750|366014420|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
106097579|NCT02310750|366014421|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
106097580|NCT02310750|366014422|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097581|NCT02310750|366014423|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097582|NCT02310750|366014424|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097583|NCT02310750|366014425|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097584|NCT02310750|366014426|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097585|NCT02310750|366014427|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097586|NCT02310750|366014428|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
106097587|NCT02310750|366014413|FG000|HP Washout 2|Lost to Follow-up|0|||
106097588|NCT02310750|366014414|FG001|HP Washout 2|Lost to Follow-up|0|||
106097589|NCT02310750|366014415|FG002|HP Washout 2|Lost to Follow-up|0|||
106097590|NCT02310750|366014416|FG003|HP Washout 2|Lost to Follow-up|0|||
106097591|NCT02310750|366014417|FG004|HP Washout 2|Lost to Follow-up|1|||
106097592|NCT02310750|366014418|FG005|HP Washout 2|Lost to Follow-up|0|||
106097593|NCT02310750|366014419|FG006|HP Washout 2|Lost to Follow-up|7|||
106097594|NCT02310750|366014420|FG007|HP Washout 2|Lost to Follow-up|0|||
106097595|NCT02310750|366014421|FG008|HP Washout 2|Lost to Follow-up|0|||
106097596|NCT02310750|366014422|FG009|HP Washout 2|Lost to Follow-up|0|||
106097597|NCT02310750|366014423|FG010|HP Washout 2|Lost to Follow-up|0|||
106097598|NCT02310750|366014424|FG011|HP Washout 2|Lost to Follow-up|0|||
106097599|NCT02310750|366014425|FG012|HP Washout 2|Lost to Follow-up|0|||
106097600|NCT02310750|366014426|FG013|HP Washout 2|Lost to Follow-up|0|||
106097601|NCT02310750|366014427|FG014|HP Washout 2|Lost to Follow-up|0|||
106097602|NCT02310750|366014428|FG015|HP Washout 2|Lost to Follow-up|0|||
106097603|NCT02232893|366014433|FG000|Overall Study|Withdrawal by Subject|4|||
106097604|NCT02232893|366014434|FG001|Overall Study|Withdrawal by Subject|1|||
106097605|NCT02232893|366014433|FG000|Overall Study|Adverse Event|0|||
106097606|NCT02232893|366014434|FG001|Overall Study|Adverse Event|1|||
106097607|NCT02232893|366014433|FG000|Overall Study|Sponsor request early termination|0|||
106097608|NCT02232893|366014434|FG001|Overall Study|Sponsor request early termination|1|||
106097609|NCT02232893|366014433|FG000|Overall Study|Developed exclusion criteria|0|||
106097610|NCT02232893|366014434|FG001|Overall Study|Developed exclusion criteria|1|||
106097611|NCT02232893|366014433|FG000|Overall Study|Other|0|||
106097612|NCT02232893|366014434|FG001|Overall Study|Other|3|||
106097613|NCT01297062|366014437|FG000|Overall Study|Adverse Event|2|||
106097614|NCT01297062|366014438|FG001|Overall Study|Adverse Event|0|||
106097615|NCT01297062|366014439|FG002|Overall Study|Adverse Event|1|||
106097616|NCT01297062|366014440|FG003|Overall Study|Adverse Event|0|||
106097617|NCT01297062|366014441|FG004|Overall Study|Adverse Event|0|||
106097618|NCT01297062|366014442|FG005|Overall Study|Adverse Event|0|||
106097619|NCT01297062|366014443|FG006|Overall Study|Adverse Event|0|||
106097620|NCT01297062|366014437|FG000|Overall Study|Physician Decision|1|||
106097621|NCT01297062|366014438|FG001|Overall Study|Physician Decision|0|||
106097622|NCT01297062|366014439|FG002|Overall Study|Physician Decision|1|||
106097623|NCT01297062|366014440|FG003|Overall Study|Physician Decision|0|||
106097624|NCT01297062|366014441|FG004|Overall Study|Physician Decision|0|||
106097625|NCT01297062|366014442|FG005|Overall Study|Physician Decision|0|||
106097626|NCT01297062|366014443|FG006|Overall Study|Physician Decision|6|||
106097627|NCT01297062|366014437|FG000|Overall Study|Protocol Violation|0|||
106097628|NCT01297062|366014438|FG001|Overall Study|Protocol Violation|0|||
106097629|NCT01297062|366014439|FG002|Overall Study|Protocol Violation|0|||
106097630|NCT01297062|366014440|FG003|Overall Study|Protocol Violation|0|||
106097631|NCT01297062|366014441|FG004|Overall Study|Protocol Violation|1|||
106097632|NCT01297062|366014442|FG005|Overall Study|Protocol Violation|0|||
106097633|NCT01297062|366014443|FG006|Overall Study|Protocol Violation|0|||
106097634|NCT01297062|366014437|FG000|Overall Study|Subject Decision|1|||
106097635|NCT01297062|366014438|FG001|Overall Study|Subject Decision|1|||
106097636|NCT01297062|366014439|FG002|Overall Study|Subject Decision|0|||
106097637|NCT01297062|366014440|FG003|Overall Study|Subject Decision|1|||
106097638|NCT01297062|366014441|FG004|Overall Study|Subject Decision|1|||
106097639|NCT01297062|366014442|FG005|Overall Study|Subject Decision|1|||
106097640|NCT01297062|366014443|FG006|Overall Study|Subject Decision|2|||
106097641|NCT01196975|366014445|FG000|Overall Study|Adverse Event|2|||
106097642|NCT01196975|366014446|FG001|Overall Study|Adverse Event|2|||
106097643|NCT01196975|366014447|FG002|Overall Study|Adverse Event|0|||
106097644|NCT01196975|366014448|FG003|Overall Study|Adverse Event|0|||
106097645|NCT01196975|366014449|FG004|Overall Study|Adverse Event|2|||
106097646|NCT01196975|366014445|FG000|Overall Study|Withdrawal by Subject|2|||
106097647|NCT01196975|366014446|FG001|Overall Study|Withdrawal by Subject|1|||
106097648|NCT01196975|366014447|FG002|Overall Study|Withdrawal by Subject|0|||
106097649|NCT01196975|366014448|FG003|Overall Study|Withdrawal by Subject|1|||
106097650|NCT01196975|366014449|FG004|Overall Study|Withdrawal by Subject|0|||
106097651|NCT01196975|366014445|FG000|Overall Study|Lost to Follow-up|11|||
106097652|NCT01196975|366014446|FG001|Overall Study|Lost to Follow-up|6|||
106097653|NCT01196975|366014447|FG002|Overall Study|Lost to Follow-up|5|||
106097654|NCT01196975|366014448|FG003|Overall Study|Lost to Follow-up|5|||
106097655|NCT01196975|366014449|FG004|Overall Study|Lost to Follow-up|11|||
106097656|NCT01365494|366014450|FG000|Overall Study|Adverse Event|1|||
106097657|NCT01365494|366014451|FG001|Overall Study|Adverse Event|0|||
106097658|NCT01365494|366014450|FG000|Overall Study|Withdrawal by Subject|0|||
106097659|NCT01365494|366014451|FG001|Overall Study|Withdrawal by Subject|1|||
106097660|NCT01365494|366014450|FG000|Overall Study|Lost to Follow-up|1|||
106097661|NCT01365494|366014451|FG001|Overall Study|Lost to Follow-up|2|||
106097662|NCT01664078|366014452|FG000|Overall Study|Death|9|||
106097663|NCT01664078|366014452|FG000|Overall Study|Withdrawal by Subject|4|||
106097664|NCT01664078|366014452|FG000|Overall Study|Lost to Follow-up|2|||
106097665|NCT01664078|366014452|FG000|Overall Study|missed 5 year visit|1|||
106097666|NCT01664078|366014452|FG000|Overall Study|Other|53|||
106097667|NCT03394924|366014456|FG000|Overall Study|Adverse Event|0|||
106097668|NCT03394924|366014457|FG001|Overall Study|Adverse Event|5|||
106097669|NCT03394924|366014458|FG002|Overall Study|Adverse Event|0|||
106097670|NCT03394924|366014456|FG000|Overall Study|Withdrawal by Subject|2|||
106097671|NCT03394924|366014457|FG001|Overall Study|Withdrawal by Subject|0|||
106097672|NCT03394924|366014458|FG002|Overall Study|Withdrawal by Subject|0|||
106097673|NCT03394924|366014456|FG000|Overall Study|Lost to Follow-up|0|||
106097674|NCT03394924|366014457|FG001|Overall Study|Lost to Follow-up|1|||
106097675|NCT03394924|366014458|FG002|Overall Study|Lost to Follow-up|0|||
106097676|NCT03394924|366014456|FG000|Overall Study|Did not meet all inclusion criteria|1|||
106097677|NCT03394924|366014457|FG001|Overall Study|Did not meet all inclusion criteria|0|||
106097678|NCT03394924|366014458|FG002|Overall Study|Did not meet all inclusion criteria|0|||
106097679|NCT01410448|366014466|FG000|Overall Study|No conversion to everolimus|0|||
106097680|NCT01410448|366014467|FG001|Overall Study|No conversion to everolimus|24|||
106097681|NCT01410448|366014466|FG000|Overall Study|Graft loss|4|||
106097682|NCT01410448|366014467|FG001|Overall Study|Graft loss|1|||
106097683|NCT01410448|366014466|FG000|Overall Study|Administrative issues|2|||
106097684|NCT01410448|366014467|FG001|Overall Study|Administrative issues|1|||
106097685|NCT01410448|366014466|FG000|Overall Study|Lost to Follow-up|1|||
106097686|NCT01410448|366014467|FG001|Overall Study|Lost to Follow-up|0|||
106097687|NCT01410448|366014466|FG000|Overall Study|Withdrawal by Subject|3|||
106097688|NCT01410448|366014467|FG001|Overall Study|Withdrawal by Subject|2|||
106097689|NCT01410448|366014466|FG000|Overall Study|Protocol Violation|0|||
106097690|NCT01410448|366014467|FG001|Overall Study|Protocol Violation|4|||
106097691|NCT01410448|366014466|FG000|Overall Study|Death|2|||
106097692|NCT01410448|366014467|FG001|Overall Study|Death|3|||
106097693|NCT01218438|366014468|FG000|Epoch 1|Physician Decision|2|||
106097694|NCT01218438|366014468|FG000|Epoch 1|Adverse Event|1|||
106097695|NCT01218438|366014468|FG000|Epoch 3|Withdrawal by Subject|3|||
106097696|NCT01218438|366014468|FG000|Epoch 3|Adverse Event|1|||
106097697|NCT01218438|366014468|FG000|Epoch 4|Physician Decision|1|||
106097698|NCT01218438|366014468|FG000|Epoch 4|Withdrawal by Subject|2|||
106097699|NCT01218646|366014471|FG000|Overall Study|Adverse Event|0|||
106097700|NCT01218646|366014472|FG001|Overall Study|Adverse Event|0|||
106097701|NCT01218646|366014473|FG002|Overall Study|Adverse Event|1|||
106097702|NCT01218646|366014474|FG003|Overall Study|Adverse Event|0|||
106097703|NCT01218646|366014471|FG000|Overall Study|Lost to Follow-up|1|||
106097704|NCT01218646|366014472|FG001|Overall Study|Lost to Follow-up|0|||
106097705|NCT01218646|366014473|FG002|Overall Study|Lost to Follow-up|0|||
106097706|NCT01218646|366014474|FG003|Overall Study|Lost to Follow-up|0|||
106097707|NCT01218646|366014471|FG000|Overall Study|Protocol Violation|0|||
106097708|NCT01218646|366014472|FG001|Overall Study|Protocol Violation|0|||
106097709|NCT01218646|366014473|FG002|Overall Study|Protocol Violation|1|||
106097710|NCT01218646|366014474|FG003|Overall Study|Protocol Violation|1|||
106097711|NCT05819749|366014475|FG000|Overall Study|Lost to Follow-up|1|||
106097712|NCT03120624|366014476|FG000|Overall Study|Withdrawal by Subject|0|||
106097713|NCT03120624|366014477|FG001|Overall Study|Withdrawal by Subject|1|||
106097714|NCT03120624|366014478|FG002|Overall Study|Withdrawal by Subject|0|||
106097715|NCT03120624|366014479|FG003|Overall Study|Withdrawal by Subject|0|||
106097716|NCT03120624|366014480|FG004|Overall Study|Withdrawal by Subject|0|||
106097717|NCT03120624|366014481|FG005|Overall Study|Withdrawal by Subject|0|||
106097718|NCT03120624|366014482|FG006|Overall Study|Withdrawal by Subject|0|||
106097719|NCT03120624|366014483|FG007|Overall Study|Withdrawal by Subject|0|||
106097720|NCT05437510|366014484|FG000|Overall Study|Adverse Event|1|||
106097721|NCT05437510|366014485|FG001|Overall Study|Adverse Event|1|||
106097722|NCT05437510|366014484|FG000|Overall Study|Protocol Deviation|1|||
106097723|NCT05437510|366014485|FG001|Overall Study|Protocol Deviation|6|||
106097724|NCT05437510|366014484|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
106097725|NCT05437510|366014485|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
106097726|NCT05437510|366014484|FG000|Overall Study|Lost to Follow-up|219|||
106097727|NCT05437510|366014485|FG001|Overall Study|Lost to Follow-up|289|||
106097728|NCT05437510|366014484|FG000|Overall Study|Ongoing in the Study Extension|1387|||
106097729|NCT05437510|366014485|FG001|Overall Study|Ongoing in the Study Extension|1352|||
105659192|NCT01721746|364415753|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
105659193|NCT01721746|364415752|FG000|Treatment|Participant request to discontinue Study treatment|26|||
105659194|NCT01721746|364415753|FG001|Treatment|Participant request to discontinue Study treatment|7|||
105659195|NCT01721746|364415752|FG000|Treatment|Participant withdrew consent|4|||
105659196|NCT01721746|364415753|FG001|Treatment|Participant withdrew consent|2|||
105659197|NCT01721746|364415752|FG000|Treatment|Maximum Clinical Benefit|9|||
105659198|NCT01721746|364415753|FG001|Treatment|Maximum Clinical Benefit|3|||
105659199|NCT01721746|364415752|FG000|Treatment|Poor/Non-compliance|2|||
105659200|NCT01721746|364415753|FG001|Treatment|Poor/Non-compliance|0|||
105659201|NCT01721746|364415752|FG000|Treatment|Participant no longer met Study criteria|4|||
105659202|NCT01721746|364415753|FG001|Treatment|Participant no longer met Study criteria|0|||
105659203|NCT01721746|364415752|FG000|Treatment|Other reasons|6|||
105659204|NCT01721746|364415753|FG001|Treatment|Other reasons|2|||
105659205|NCT00644878|364415754|FG000|Overall Study|Adverse Event|2|||
105659206|NCT00644878|364415754|FG000|Overall Study|Abnormal laboratory value|3|||
105659207|NCT00644878|364415754|FG000|Overall Study|Protocol deviation|2|||
105659208|NCT00644878|364415754|FG000|Overall Study|Treatment duration completed as per protocol|11|||
105659209|NCT00239681|364415755|FG000|Overall Study|Adverse Event|100|||
105659210|NCT00239681|364415756|FG001|Overall Study|Adverse Event|99|||
105659211|NCT00239681|364415755|FG000|Overall Study|Withdrawal by Subject|458|||
105659212|NCT00239681|364415756|FG001|Overall Study|Withdrawal by Subject|489|||
105659213|NCT00239681|364415755|FG000|Overall Study|Lost to Follow-up|28|||
105659214|NCT00239681|364415756|FG001|Overall Study|Lost to Follow-up|22|||
105659215|NCT00239681|364415755|FG000|Overall Study|Protocol Violation|4|||
105659216|NCT00239681|364415756|FG001|Overall Study|Protocol Violation|4|||
105659217|NCT00239681|364415755|FG000|Overall Study|Physician Decision|13|||
105659218|NCT00239681|364415756|FG001|Overall Study|Physician Decision|17|||
105659219|NCT00239681|364415755|FG000|Overall Study|No information chacked on CaseReportForm|90|||
105659220|NCT00239681|364415756|FG001|Overall Study|No information chacked on CaseReportForm|84|||
105659221|NCT03599622|364415757|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
105659222|NCT03599622|364415758|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
105659223|NCT03599622|364415759|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
105659224|NCT03599622|364415760|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
105659225|NCT03599622|364415757|FG000|Pre-Treatment Period|Other reasons|1|||
105659226|NCT03599622|364415758|FG001|Pre-Treatment Period|Other reasons|1|||
105659227|NCT03599622|364415759|FG002|Pre-Treatment Period|Other reasons|1|||
105659228|NCT03599622|364415760|FG003|Pre-Treatment Period|Other reasons|0|||
105659229|NCT03599622|364415757|FG000|Treatment Period|Adverse Event|11|||
105659230|NCT03599622|364415758|FG001|Treatment Period|Adverse Event|20|||
105659231|NCT03599622|364415759|FG002|Treatment Period|Adverse Event|18|||
105659232|NCT03599622|364415760|FG003|Treatment Period|Adverse Event|2|||
105659233|NCT03599622|364415757|FG000|Treatment Period|Lack of Efficacy|18|||
105659234|NCT03599622|364415758|FG001|Treatment Period|Lack of Efficacy|12|||
105659235|NCT03599622|364415759|FG002|Treatment Period|Lack of Efficacy|13|||
105659236|NCT03599622|364415760|FG003|Treatment Period|Lack of Efficacy|2|||
105659237|NCT03599622|364415757|FG000|Treatment Period|Withdrawal by Subject|5|||
105659238|NCT03599622|364415758|FG001|Treatment Period|Withdrawal by Subject|11|||
105659239|NCT03599622|364415759|FG002|Treatment Period|Withdrawal by Subject|16|||
105659240|NCT03599622|364415760|FG003|Treatment Period|Withdrawal by Subject|1|||
105659241|NCT03599622|364415757|FG000|Treatment Period|Other reasons|4|||
105659242|NCT03599622|364415758|FG001|Treatment Period|Other reasons|6|||
105659243|NCT03599622|364415759|FG002|Treatment Period|Other reasons|7|||
105659244|NCT03599622|364415760|FG003|Treatment Period|Other reasons|0|||
105659245|NCT03599622|364415757|FG000|Treatment Period|Lost to Follow-up|1|||
105659246|NCT03599622|364415758|FG001|Treatment Period|Lost to Follow-up|0|||
105659247|NCT03599622|364415759|FG002|Treatment Period|Lost to Follow-up|0|||
105659248|NCT03599622|364415760|FG003|Treatment Period|Lost to Follow-up|0|||
105659249|NCT03599622|364415757|FG000|Treatment Period|Study terminated by sponsor|7|||
105659250|NCT03599622|364415758|FG001|Treatment Period|Study terminated by sponsor|20|||
105659251|NCT03599622|364415759|FG002|Treatment Period|Study terminated by sponsor|15|||
105659252|NCT03599622|364415760|FG003|Treatment Period|Study terminated by sponsor|0|||
105659253|NCT03599622|364415757|FG000|Treatment Period|Site terminated by sponsor|0|||
105659254|NCT03599622|364415758|FG001|Treatment Period|Site terminated by sponsor|1|||
105659255|NCT03599622|364415759|FG002|Treatment Period|Site terminated by sponsor|0|||
105659256|NCT03599622|364415760|FG003|Treatment Period|Site terminated by sponsor|0|||
105659257|NCT00665223|364415762|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
105659258|NCT00665223|364415763|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
105659341|NCT00551135|364417280|FG000|Overall Study|Withdrawal by Subject|1|||
105659342|NCT00551135|364417281|FG001|Overall Study|Withdrawal by Subject|0|||
105659343|NCT00551135|364417282|FG002|Overall Study|Withdrawal by Subject|3|||
105659344|NCT00551135|364417283|FG003|Overall Study|Withdrawal by Subject|1|||
105659345|NCT02165397|364417286|FG000|Overall Study|Death|7|||
105659346|NCT02165397|364417287|FG001|Overall Study|Death|10|||
105659347|NCT02165397|364417288|FG002|Overall Study|Death|8|||
105659348|NCT02165397|364417286|FG000|Overall Study|Lost to Follow-up|1|||
105659349|NCT02165397|364417287|FG001|Overall Study|Lost to Follow-up|3|||
105659350|NCT02165397|364417288|FG002|Overall Study|Lost to Follow-up|0|||
105659351|NCT02165397|364417286|FG000|Overall Study|Withdrawal by Subject|6|||
105659352|NCT02165397|364417287|FG001|Overall Study|Withdrawal by Subject|6|||
105659353|NCT02165397|364417288|FG002|Overall Study|Withdrawal by Subject|1|||
105659354|NCT02165397|364417286|FG000|Overall Study|Other, Not Specified|0|||
105659355|NCT02165397|364417287|FG001|Overall Study|Other, Not Specified|0|||
105659356|NCT02165397|364417288|FG002|Overall Study|Other, Not Specified|1|||
105659357|NCT03898960|364417289|FG000|Overall Study|Death|10|||
105659358|NCT00548847|364417290|FG000|Overall Study|Disease progression|7|||
105659359|NCT03297398|364417291|FG000|Overall Study|Sponsor's decision|6|||
105659360|NCT03297398|364417292|FG001|Overall Study|Sponsor's decision|9|||
105659361|NCT03297398|364417293|FG002|Overall Study|Sponsor's decision|7|||
105659362|NCT03297398|364417291|FG000|Overall Study|Adverse Event|1|||
105659363|NCT03297398|364417292|FG001|Overall Study|Adverse Event|4|||
105659364|NCT03297398|364417293|FG002|Overall Study|Adverse Event|4|||
105659365|NCT03297398|364417291|FG000|Overall Study|Withdrawal by Subject|1|||
105659366|NCT03297398|364417292|FG001|Overall Study|Withdrawal by Subject|2|||
105659367|NCT03297398|364417293|FG002|Overall Study|Withdrawal by Subject|2|||
105659368|NCT03297398|364417291|FG000|Overall Study|Protocol Violation|0|||
105659369|NCT03297398|364417292|FG001|Overall Study|Protocol Violation|2|||
105659370|NCT03297398|364417293|FG002|Overall Study|Protocol Violation|0|||
105659371|NCT03297398|364417291|FG000|Overall Study|Physician Decision|0|||
105659372|NCT03297398|364417292|FG001|Overall Study|Physician Decision|0|||
105659373|NCT03297398|364417293|FG002|Overall Study|Physician Decision|1|||
105659374|NCT03297398|364417291|FG000|Overall Study|Lost to Follow-up|0|||
105659375|NCT03297398|364417292|FG001|Overall Study|Lost to Follow-up|0|||
105659376|NCT03297398|364417293|FG002|Overall Study|Lost to Follow-up|1|||
105659377|NCT04175912|364417296|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
105659378|NCT04175912|364417297|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
105659379|NCT04175912|364417296|FG000|Overall Study|Adverse Event|0|||
105659380|NCT04175912|364417297|FG001|Overall Study|Adverse Event|3|||
105659381|NCT04175912|364417296|FG000|Overall Study|Never started treatment|3|||
105659382|NCT04175912|364417297|FG001|Overall Study|Never started treatment|3|||
105659383|NCT04175912|364417296|FG000|Overall Study|Death|0|||
105659384|NCT04175912|364417297|FG001|Overall Study|Death|1|||
105659385|NCT01322009|364417307|FG000|Overall Study|Death|0|||
105659386|NCT01322009|364417308|FG001|Overall Study|Death|1|||
105659387|NCT01322009|364417307|FG000|Overall Study|Adverse Event|0|||
105659388|NCT01322009|364417308|FG001|Overall Study|Adverse Event|1|||
105659389|NCT01322009|364417307|FG000|Overall Study|ng tube discontinued|0|||
105659390|NCT01322009|364417308|FG001|Overall Study|ng tube discontinued|1|||
105659391|NCT04081389|364417309|FG000|Overall Study|Withdrawal by Subject|0|||
105659392|NCT04081389|364417310|FG001|Overall Study|Withdrawal by Subject|0|||
105659393|NCT04081389|364417311|FG002|Overall Study|Withdrawal by Subject|1|||
105659394|NCT04081389|364417312|FG003|Overall Study|Withdrawal by Subject|0|||
105659395|NCT02980705|364417313|FG000|Overall Study|Adverse Event|0|||
105659396|NCT02980705|364417314|FG001|Overall Study|Adverse Event|1|||
105659397|NCT02980705|364417313|FG000|Overall Study|Withdrawal by Subject|6|||
105659398|NCT02980705|364417314|FG001|Overall Study|Withdrawal by Subject|9|||
105659399|NCT02980705|364417313|FG000|Overall Study|withdrew participation|0|||
105659400|NCT02980705|364417314|FG001|Overall Study|withdrew participation|1|||
105659401|NCT02980705|364417313|FG000|Overall Study|Lost to Follow-up|2|||
105659402|NCT02980705|364417314|FG001|Overall Study|Lost to Follow-up|0|||
105659403|NCT02447718|364417315|FG000|Overall Study|Lost to Follow-up|8|||
105659404|NCT02447718|364417316|FG001|Overall Study|Lost to Follow-up|0|||
105659405|NCT02447718|364417315|FG000|Overall Study|Withdrawal by Subject|3|||
105659406|NCT02447718|364417316|FG001|Overall Study|Withdrawal by Subject|0|||
105659407|NCT02447718|364417315|FG000|Overall Study|Screen Failure|1|||
105659408|NCT02447718|364417316|FG001|Overall Study|Screen Failure|0|||
105659409|NCT02138253|364417317|FG000|Overall Study|Adverse Event|3|||
105659410|NCT02138253|364417318|FG001|Overall Study|Adverse Event|3|||
105659411|NCT02138253|364417317|FG000|Overall Study|Lost to Follow-up|2|||
105659412|NCT02138253|364417318|FG001|Overall Study|Lost to Follow-up|1|||
105659413|NCT02138253|364417317|FG000|Overall Study|Physician Decision|2|||
105659414|NCT02138253|364417318|FG001|Overall Study|Physician Decision|0|||
105659415|NCT02138253|364417317|FG000|Overall Study|Non compliance|1|||
105659416|NCT02138253|364417318|FG001|Overall Study|Non compliance|0|||
105659417|NCT02138253|364417317|FG000|Overall Study|Withdrawal by Subject|1|||
105659418|NCT02138253|364417318|FG001|Overall Study|Withdrawal by Subject|0|||
105659419|NCT00002597|364417319|FG000|Overall Study|Protocol Violation|19|||
105659421|NCT00002597|364417319|FG000|Overall Study|Withdrawal by Subject|7|||
105659422|NCT00002597|364417320|FG001|Overall Study|Withdrawal by Subject|6|||
105659423|NCT01426113|364417321|FG000|Overall Study|Study Discontinued|1|||
105659424|NCT01426113|364417322|FG001|Overall Study|Study Discontinued|1|||
105659425|NCT01426113|364417321|FG000|Overall Study|Adverse Event|0|||
105659426|NCT01426113|364417322|FG001|Overall Study|Adverse Event|1|||
105659427|NCT02654132|364417323|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
105659428|NCT02654132|364417324|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
105659429|NCT02654132|364417323|FG000|Treatment Period|Disease progression|43|||
105659430|NCT02654132|364417324|FG001|Treatment Period|Disease progression|38|||
105659431|NCT02654132|364417323|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
105659432|NCT02654132|364417324|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
105659433|NCT02654132|364417323|FG000|Treatment Period|Other reasons|4|||
105659434|NCT02654132|364417324|FG001|Treatment Period|Other reasons|2|||
105659435|NCT02654132|364417323|FG000|Treatment Period|Study drug toxicity|2|||
105659436|NCT02654132|364417324|FG001|Treatment Period|Study drug toxicity|2|||
105659437|NCT02654132|364417323|FG000|Treatment Period|Withdrawal by Subject|2|||
105659438|NCT02654132|364417324|FG001|Treatment Period|Withdrawal by Subject|1|||
105659439|NCT02654132|364417323|FG000|Treatment Period|Maximum Clinical Benefit|0|||
105659440|NCT02654132|364417324|FG001|Treatment Period|Maximum Clinical Benefit|2|||
105659441|NCT02654132|364417323|FG000|Treatment Period|Participant request to discontinue|2|||
105659442|NCT02654132|364417324|FG001|Treatment Period|Participant request to discontinue|0|||
105659443|NCT02654132|364417323|FG000|Treatment Period|Administrative reasons by sponsor|0|||
105659444|NCT02654132|364417324|FG001|Treatment Period|Administrative reasons by sponsor|1|||
105659445|NCT02654132|364417323|FG000|Treatment Period|Death|1|||
105659446|NCT02654132|364417324|FG001|Treatment Period|Death|0|||
105659447|NCT00468130|364417329|FG000|Overall Study|Adverse Event|2|||
105659448|NCT00468130|364417330|FG001|Overall Study|Adverse Event|1|||
105659449|NCT00468130|364417329|FG000|Overall Study|Withdrawal by Subject|0|||
105659450|NCT00468130|364417330|FG001|Overall Study|Withdrawal by Subject|1|||
105659451|NCT02485899|364417331|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
105659452|NCT02485899|364417332|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
105659453|NCT02485899|364417331|FG000|Overall Study|Withdrawal by Subject|1|||
105659454|NCT02485899|364417332|FG001|Overall Study|Withdrawal by Subject|0|||
105659455|NCT02485899|364417331|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
105659456|NCT02485899|364417332|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
105659457|NCT00436956|364417333|FG000|Overall Study|Not evaluable|1|||
105659458|NCT00436956|364417334|FG001|Overall Study|Not evaluable|0|||
105659459|NCT01918371|364417335|FG000|Overall Study|Missing Data|1|||
105659460|NCT01918371|364417336|FG001|Overall Study|Missing Data|1|||
105659461|NCT01006889|364417337|FG000|Overall Study|Withdrawal by Subject|3|||
105659462|NCT01130168|364417338|FG000|Period 1|Withdrawal by Subject|0|||
105659463|NCT01130168|364417339|FG001|Period 1|Withdrawal by Subject|1|||
105659464|NCT01130168|364417340|FG002|Period 1|Withdrawal by Subject|0|||
105659465|NCT01130168|364417341|FG003|Period 1|Withdrawal by Subject|1|||
105659466|NCT01130168|364417342|FG004|Period 1|Withdrawal by Subject|0|||
105659467|NCT01130168|364417343|FG005|Period 1|Withdrawal by Subject|0|||
105659468|NCT01130168|364417338|FG000|Period 1|Discontinued For Other Reason|0|||
105659469|NCT01130168|364417339|FG001|Period 1|Discontinued For Other Reason|0|||
105659470|NCT01130168|364417340|FG002|Period 1|Discontinued For Other Reason|1|||
105659471|NCT01130168|364417341|FG003|Period 1|Discontinued For Other Reason|1|||
105659472|NCT01130168|364417342|FG004|Period 1|Discontinued For Other Reason|0|||
105659473|NCT01130168|364417343|FG005|Period 1|Discontinued For Other Reason|0|||
105659474|NCT01130168|364417338|FG000|Period 1|Adverse Event|0|||
105659475|NCT01130168|364417339|FG001|Period 1|Adverse Event|0|||
105659476|NCT01130168|364417340|FG002|Period 1|Adverse Event|0|||
105659477|NCT01130168|364417341|FG003|Period 1|Adverse Event|1|||
105659478|NCT01130168|364417342|FG004|Period 1|Adverse Event|0|||
105659479|NCT01130168|364417343|FG005|Period 1|Adverse Event|0|||
105659480|NCT02569957|364417344|FG000|Overall Study|Withdrawal by Subject|0|||
105659481|NCT02569957|364417345|FG001|Overall Study|Withdrawal by Subject|1|||
105659482|NCT02635386|364417347|FG000|Overall Study|Pregnancy|2|||
105659483|NCT02635386|364417348|FG001|Overall Study|Pregnancy|0|||
105659484|NCT02635386|364417349|FG002|Overall Study|Pregnancy|0|||
105659485|NCT02635386|364417350|FG003|Overall Study|Pregnancy|0|||
105659486|NCT02635386|364417351|FG004|Overall Study|Pregnancy|2|||
105659487|NCT02635386|364417347|FG000|Overall Study|Withdrawal by Subject|1|||
105659488|NCT02635386|364417348|FG001|Overall Study|Withdrawal by Subject|1|||
105659489|NCT02635386|364417349|FG002|Overall Study|Withdrawal by Subject|0|||
105659490|NCT02635386|364417350|FG003|Overall Study|Withdrawal by Subject|1|||
105659491|NCT02635386|364417351|FG004|Overall Study|Withdrawal by Subject|0|||
105659492|NCT02635386|364417347|FG000|Overall Study|Physician Decision|0|||
105659493|NCT02635386|364417348|FG001|Overall Study|Physician Decision|1|||
105659494|NCT02635386|364417349|FG002|Overall Study|Physician Decision|0|||
105659495|NCT02635386|364417350|FG003|Overall Study|Physician Decision|0|||
105659496|NCT02635386|364417351|FG004|Overall Study|Physician Decision|0|||
105659497|NCT02635386|364417347|FG000|Overall Study|Moved Out of State|0|||
105659512|NCT02635386|364417347|FG000|Overall Study|needed other major surgery|0|||
105659513|NCT02635386|364417348|FG001|Overall Study|needed other major surgery|1|||
105659514|NCT02635386|364417349|FG002|Overall Study|needed other major surgery|0|||
105659515|NCT02635386|364417350|FG003|Overall Study|needed other major surgery|0|||
105659516|NCT02635386|364417351|FG004|Overall Study|needed other major surgery|0|||
105659517|NCT02635386|364417347|FG000|Overall Study|Other medical problems not drug related|0|||
105659518|NCT02635386|364417348|FG001|Overall Study|Other medical problems not drug related|0|||
105659519|NCT02635386|364417349|FG002|Overall Study|Other medical problems not drug related|0|||
105659520|NCT02635386|364417350|FG003|Overall Study|Other medical problems not drug related|1|||
105659521|NCT02635386|364417351|FG004|Overall Study|Other medical problems not drug related|0|||
105659522|NCT02719743|364417352|FG000|Overall Study|Consent withdrawal|0|||
105659523|NCT02719743|364417353|FG001|Overall Study|Consent withdrawal|2|||
105659524|NCT02719743|364417354|FG002|Overall Study|Consent withdrawal|0|||
105659525|NCT02719743|364417355|FG003|Overall Study|Consent withdrawal|1|||
105659526|NCT02719743|364417356|FG004|Overall Study|Consent withdrawal|0|||
105659527|NCT02719743|364417352|FG000|Overall Study|Migrated/moved from study area|0|||
105659528|NCT02719743|364417353|FG001|Overall Study|Migrated/moved from study area|0|||
105659529|NCT02719743|364417354|FG002|Overall Study|Migrated/moved from study area|0|||
105659530|NCT02719743|364417355|FG003|Overall Study|Migrated/moved from study area|0|||
105659531|NCT02719743|364417356|FG004|Overall Study|Migrated/moved from study area|2|||
105659532|NCT02719743|364417352|FG000|Overall Study|Lost to Follow-up|1|||
105659533|NCT02719743|364417353|FG001|Overall Study|Lost to Follow-up|1|||
105659534|NCT02719743|364417354|FG002|Overall Study|Lost to Follow-up|0|||
105659535|NCT02719743|364417355|FG003|Overall Study|Lost to Follow-up|0|||
105659536|NCT02719743|364417356|FG004|Overall Study|Lost to Follow-up|0|||
105659537|NCT01209598|364417359|FG000|Overall Study|Withdrawal by Subject|1|||
105659538|NCT01209598|364417360|FG001|Overall Study|Withdrawal by Subject|0|||
105659539|NCT02062645|364417363|FG000|Overall Study|Adverse Event|2|||
105659540|NCT02062645|364417363|FG000|Overall Study|Protocol Violation|8|||
105659541|NCT02062645|364417363|FG000|Overall Study|Lost to Follow-up|5|||
105659542|NCT02804399|364417364|FG000|Period 2|Adverse Event|0|||
105659543|NCT02804399|364417365|FG001|Period 2|Adverse Event|1|||
105659544|NCT00572533|364417366|FG000|Overall Study|Death|4|||
105659545|NCT00572533|364417367|FG001|Overall Study|Death|1|||
105659546|NCT00572533|364417366|FG000|Overall Study|Received Kidney Transplant|2|||
105659547|NCT00572533|364417367|FG001|Overall Study|Received Kidney Transplant|1|||
105659548|NCT00572533|364417366|FG000|Overall Study|Social Issues|1|||
105659549|NCT00572533|364417367|FG001|Overall Study|Social Issues|0|||
105659550|NCT00572533|364417366|FG000|Overall Study|Transfer out of Facility|0|||
105659551|NCT00572533|364417367|FG001|Overall Study|Transfer out of Facility|1|||
105659552|NCT00798304|364417371|FG000|Overall Study|Adverse Event|0|||
105659553|NCT00798304|364417372|FG001|Overall Study|Adverse Event|1|||
105659554|NCT00798304|364417373|FG002|Overall Study|Adverse Event|1|||
105659555|NCT00798304|364417371|FG000|Overall Study|Discontinuation by Sponsor|14|||
105659556|NCT00798304|364417372|FG001|Overall Study|Discontinuation by Sponsor|21|||
105659557|NCT00798304|364417373|FG002|Overall Study|Discontinuation by Sponsor|9|||
105659558|NCT02168478|364417375|FG000|Overall Study|Withdrawal by Subject|1|||
105659559|NCT02168478|364417375|FG000|Overall Study|Did Not Consent to Participation|2|||
105659560|NCT02168478|364417375|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
105659561|NCT01062971|364417378|FG000|Overall Study|Protocol Violation|1|||
105659562|NCT01062971|364417379|FG001|Overall Study|Protocol Violation|3|||
105659563|NCT01062971|364417378|FG000|Overall Study|Lost to Follow-up|3|||
105659564|NCT01062971|364417379|FG001|Overall Study|Lost to Follow-up|4|||
105659565|NCT00927901|364417388|FG000|Treatment Period 1|Subject withdrew consent|0|||
105659566|NCT00927901|364417389|FG001|Treatment Period 1|Subject withdrew consent|0|||
105659567|NCT00927901|364417390|FG002|Treatment Period 1|Subject withdrew consent|1|||
105659568|NCT00927901|364417391|FG003|Treatment Period 1|Subject withdrew consent|0|||
105659569|NCT00927901|364417388|FG000|Treatment Period 4|Adverse Event|0|||
105659570|NCT00927901|364417389|FG001|Treatment Period 4|Adverse Event|0|||
105659571|NCT00927901|364417390|FG002|Treatment Period 4|Adverse Event|0|||
105659572|NCT00927901|364417391|FG003|Treatment Period 4|Adverse Event|1|||
105659573|NCT00927901|364417388|FG000|Treatment Period 4|Subject withdrew consent|0|||
105659574|NCT00927901|364417389|FG001|Treatment Period 4|Subject withdrew consent|0|||
105659575|NCT00927901|364417390|FG002|Treatment Period 4|Subject withdrew consent|1|||
105659576|NCT00927901|364417391|FG003|Treatment Period 4|Subject withdrew consent|0|||
105659577|NCT02344173|364417392|FG000|Procedure|Ablation Procedure Not Performed|7|||
105659578|NCT02344173|364417392|FG000|12-month Visit|Death|8|||
105659579|NCT02344173|364417392|FG000|12-month Visit|Withdrawal by Subject|30|||
105659580|NCT02344173|364417392|FG000|12-month Visit|Lost to Follow-up|58|||
105659581|NCT03845023|364417393|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
105659582|NCT03845023|364417394|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
105659583|NCT03845023|364417395|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
105659584|NCT03845023|364417396|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
105659585|NCT03845023|364417393|FG000|Follow-Up (14 Days)|Adverse Event|0|||
105659586|NCT03845023|364417394|FG001|Follow-Up (14 Days)|Adverse Event|0|||
105659587|NCT03845023|364417395|FG002|Follow-Up (14 Days)|Adverse Event|1|||
105659589|NCT01087814|364417399|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
105659590|NCT01087814|364417400|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
105659591|NCT01087814|364417399|FG000|Second Intervention (5 Days)|Physician Decision|1|||
105659592|NCT01087814|364417400|FG001|Second Intervention (5 Days)|Physician Decision|0|||
105659593|NCT01263925|364417405|FG000|Overall Study|Protocol Violation|1|||
105659594|NCT01263925|364417406|FG001|Overall Study|Protocol Violation|0|||
105659595|NCT01263925|364417405|FG000|Overall Study|Lack of Efficacy|0|||
105659596|NCT01263925|364417406|FG001|Overall Study|Lack of Efficacy|1|||
105659597|NCT01263925|364417405|FG000|Overall Study|Adverse Event|23|||
105659598|NCT01263925|364417406|FG001|Overall Study|Adverse Event|22|||
105659599|NCT01263925|364417405|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
105659600|NCT01263925|364417406|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
105659601|NCT01263925|364417405|FG000|Overall Study|Withdrawal by Subject|6|||
105659602|NCT01263925|364417406|FG001|Overall Study|Withdrawal by Subject|8|||
105659603|NCT01263925|364417405|FG000|Overall Study|Other|4|||
105659604|NCT01263925|364417406|FG001|Overall Study|Other|4|||
105659605|NCT01263925|364417405|FG000|Overall Study|Lost to Follow-up|3|||
105659606|NCT01263925|364417406|FG001|Overall Study|Lost to Follow-up|1|||
105659607|NCT01263925|364417405|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
105659608|NCT01263925|364417406|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
105659609|NCT01263925|364417405|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
105659610|NCT01263925|364417406|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
105659611|NCT01263925|364417405|FG000|Overall Study|AE/ Withdrawal|1|||
105659612|NCT01263925|364417406|FG001|Overall Study|AE/ Withdrawal|4|||
105659613|NCT01263925|364417405|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
105659614|NCT01263925|364417406|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
105659615|NCT01263925|364417405|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
105659616|NCT01263925|364417406|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
105659617|NCT01263925|364417405|FG000|Overall Study|Withdrawal/ Not specified|0|||
105659618|NCT01263925|364417406|FG001|Overall Study|Withdrawal/ Not specified|1|||
105659619|NCT02918292|364417409|FG000|Study Enrollment Prior to Transplant|Death|1|||
105659620|NCT02918292|364417409|FG000|Study Follow up After Transplant|Death|6|||
105659621|NCT00715117|364417411|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
105659622|NCT00715117|364417412|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
105659623|NCT01482429|364417413|FG000|Care Usual|Protocol Violation|0|||
105659624|NCT01482429|364417414|FG001|Care Usual|Protocol Violation|172|||
105659625|NCT01482429|364417413|FG000|Care Usual|Lost to Follow-up|0|||
105659626|NCT01482429|364417414|FG001|Care Usual|Lost to Follow-up|1|||
105659627|NCT01482429|364417413|FG000|Protocol|Protocol Violation|275|||
105659628|NCT01482429|364417414|FG001|Protocol|Protocol Violation|0|||
105659629|NCT03783871|364417418|FG000|Overall Study|Withdrawal by Subject|15|||
105659630|NCT03783871|364417418|FG000|Overall Study|Death|13|||
105659631|NCT03783871|364417418|FG000|Overall Study|Lost to Follow-up|2|||
105659632|NCT03595878|364417423|FG000|Overall Study|Death|2|||
105659633|NCT03595878|364417424|FG001|Overall Study|Death|1|||
105659634|NCT03595878|364417425|FG002|Overall Study|Death|0|||
105659635|NCT03595878|364417423|FG000|Overall Study|Disease progression|2|||
105659636|NCT03595878|364417424|FG001|Overall Study|Disease progression|1|||
105659637|NCT03595878|364417425|FG002|Overall Study|Disease progression|2|||
105659638|NCT03036124|364417426|FG000|Overall Study|Lost to Follow-up|0|||
105659639|NCT03036124|364417427|FG001|Overall Study|Lost to Follow-up|2|||
105659640|NCT03036124|364417426|FG000|Overall Study|Withdrawal by Subject|5|||
105659641|NCT03036124|364417427|FG001|Overall Study|Withdrawal by Subject|4|||
